<SEC-DOCUMENT>0001651944-22-000027.txt : 20220808
<SEC-HEADER>0001651944-22-000027.hdr.sgml : 20220808
<ACCEPTANCE-DATETIME>20220808162231
ACCESSION NUMBER:		0001651944-22-000027
CONFORMED SUBMISSION TYPE:	10-Q
PUBLIC DOCUMENT COUNT:		69
CONFORMED PERIOD OF REPORT:	20220630
FILED AS OF DATE:		20220808
DATE AS OF CHANGE:		20220808

FILER:

	COMPANY DATA:	
		COMPANY CONFORMED NAME:			DermTech, Inc.
		CENTRAL INDEX KEY:			0001651944
		STANDARD INDUSTRIAL CLASSIFICATION:	SERVICES-MEDICAL LABORATORIES [8071]
		IRS NUMBER:				842870849
		STATE OF INCORPORATION:			DE
		FISCAL YEAR END:			1231

	FILING VALUES:
		FORM TYPE:		10-Q
		SEC ACT:		1934 Act
		SEC FILE NUMBER:	001-38118
		FILM NUMBER:		221144717

	BUSINESS ADDRESS:	
		STREET 1:		11099 N. TORREY PINES ROAD
		STREET 2:		SUITE 100
		CITY:			LA JOLLA
		STATE:			CA
		ZIP:			92037
		BUSINESS PHONE:		858-450-4222

	MAIL ADDRESS:	
		STREET 1:		11099 N. TORREY PINES ROAD
		STREET 2:		SUITE 100
		CITY:			LA JOLLA
		STATE:			CA
		ZIP:			92037

	FORMER COMPANY:	
		FORMER CONFORMED NAME:	Constellation Alpha Capital Corp.
		DATE OF NAME CHANGE:	20150827
</SEC-HEADER>
<DOCUMENT>
<TYPE>10-Q
<SEQUENCE>1
<FILENAME>dmtk-20220630.htm
<DESCRIPTION>10-Q
<TEXT>
<XBRL>
<?xml version="1.0" ?><!--XBRL Document Created with Wdesk from Workiva--><!--Copyright 2022 Workiva--><!--r:00c1bec6-bc29-44ad-a3fa-8dd942e770ac,g:dd828811-c245-4da7-9eef-30b71a6b7e18,d:ae5a9be0eb9445d192fae822d22be09f--><html xmlns:dmtk="http://dermtech.com/20220630" xmlns:iso4217="http://www.xbrl.org/2003/iso4217" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:dei="http://xbrl.sec.gov/dei/2022" xmlns:ixt="http://www.xbrl.org/inlineXBRL/transformation/2020-02-12" xmlns:xbrli="http://www.xbrl.org/2003/instance" xmlns="http://www.w3.org/1999/xhtml" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:us-gaap="http://fasb.org/us-gaap/2022" xmlns:utr="http://www.xbrl.org/2009/utr" xmlns:ix="http://www.xbrl.org/2013/inlineXBRL" xmlns:ixt-sec="http://www.sec.gov/inlineXBRL/transformation/2015-08-31" xmlns:xbrldi="http://xbrl.org/2006/xbrldi" xmlns:srt="http://fasb.org/srt/2022" xml:lang="en-US"><head><meta http-equiv="Content-Type" content="text/html"/>


<title>dmtk-20220630</title></head><body><div style="display:none"><ix:header><ix:hidden><ix:nonNumeric contextRef="ia855382ada1f4f28aa8ef6da692ff177_D20220101-20220630" name="dei:EntityCentralIndexKey" id="id3VybDovL2RvY3MudjEvZG9jOmFlNWE5YmUwZWI5NDQ1ZDE5MmZhZTgyMmQyMmJlMDlmL3NlYzphZTVhOWJlMGViOTQ0NWQxOTJmYWU4MjJkMjJiZTA5Zl80L2ZyYWc6OWRhMWI2YjY4YjM2NDBmMjgyYzc2MzFiNWJlM2E2ZjUvdGFibGU6ZDcxMjQxZjU3MDViNDc4MDhmOGZkNzczN2MwM2Y2OWMvdGFibGVyYW5nZTpkNzEyNDFmNTcwNWI0NzgwOGY4ZmQ3NzM3YzAzZjY5Y18yLTEtMS0xLTYyNg_b37992aa-9313-4acc-9018-d5b0bc581d47">0001651944</ix:nonNumeric><ix:nonNumeric contextRef="ia855382ada1f4f28aa8ef6da692ff177_D20220101-20220630" name="dei:CurrentFiscalYearEndDate" format="ixt:date-month-day" id="id3VybDovL2RvY3MudjEvZG9jOmFlNWE5YmUwZWI5NDQ1ZDE5MmZhZTgyMmQyMmJlMDlmL3NlYzphZTVhOWJlMGViOTQ0NWQxOTJmYWU4MjJkMjJiZTA5Zl80L2ZyYWc6OWRhMWI2YjY4YjM2NDBmMjgyYzc2MzFiNWJlM2E2ZjUvdGFibGU6ZDcxMjQxZjU3MDViNDc4MDhmOGZkNzczN2MwM2Y2OWMvdGFibGVyYW5nZTpkNzEyNDFmNTcwNWI0NzgwOGY4ZmQ3NzM3YzAzZjY5Y18zLTEtMS0xLTYyNg_ca7fed0f-9b9e-493e-ac4c-616ce01da6fe">12-31</ix:nonNumeric><ix:nonNumeric contextRef="ia855382ada1f4f28aa8ef6da692ff177_D20220101-20220630" name="dei:DocumentFiscalYearFocus" id="id3VybDovL2RvY3MudjEvZG9jOmFlNWE5YmUwZWI5NDQ1ZDE5MmZhZTgyMmQyMmJlMDlmL3NlYzphZTVhOWJlMGViOTQ0NWQxOTJmYWU4MjJkMjJiZTA5Zl80L2ZyYWc6OWRhMWI2YjY4YjM2NDBmMjgyYzc2MzFiNWJlM2E2ZjUvdGFibGU6ZDcxMjQxZjU3MDViNDc4MDhmOGZkNzczN2MwM2Y2OWMvdGFibGVyYW5nZTpkNzEyNDFmNTcwNWI0NzgwOGY4ZmQ3NzM3YzAzZjY5Y180LTEtMS0xLTYyNg_9469af44-fcfe-42e1-b110-2a4983aac827">2022</ix:nonNumeric><ix:nonNumeric contextRef="ia855382ada1f4f28aa8ef6da692ff177_D20220101-20220630" name="dei:DocumentFiscalPeriodFocus" id="id3VybDovL2RvY3MudjEvZG9jOmFlNWE5YmUwZWI5NDQ1ZDE5MmZhZTgyMmQyMmJlMDlmL3NlYzphZTVhOWJlMGViOTQ0NWQxOTJmYWU4MjJkMjJiZTA5Zl80L2ZyYWc6OWRhMWI2YjY4YjM2NDBmMjgyYzc2MzFiNWJlM2E2ZjUvdGFibGU6ZDcxMjQxZjU3MDViNDc4MDhmOGZkNzczN2MwM2Y2OWMvdGFibGVyYW5nZTpkNzEyNDFmNTcwNWI0NzgwOGY4ZmQ3NzM3YzAzZjY5Y181LTEtMS0xLTYyNg_5d8a309d-f5e9-405f-9e88-fa88e6e1532a">Q2</ix:nonNumeric><ix:nonNumeric contextRef="ia855382ada1f4f28aa8ef6da692ff177_D20220101-20220630" name="dei:AmendmentFlag" format="ixt:fixed-false" id="id3VybDovL2RvY3MudjEvZG9jOmFlNWE5YmUwZWI5NDQ1ZDE5MmZhZTgyMmQyMmJlMDlmL3NlYzphZTVhOWJlMGViOTQ0NWQxOTJmYWU4MjJkMjJiZTA5Zl80L2ZyYWc6OWRhMWI2YjY4YjM2NDBmMjgyYzc2MzFiNWJlM2E2ZjUvdGFibGU6ZDcxMjQxZjU3MDViNDc4MDhmOGZkNzczN2MwM2Y2OWMvdGFibGVyYW5nZTpkNzEyNDFmNTcwNWI0NzgwOGY4ZmQ3NzM3YzAzZjY5Y182LTEtMS0xLTYyNg_4c05cf63-5751-48aa-8470-616b9def7439">false</ix:nonNumeric><ix:nonNumeric contextRef="if83fbbc281954a99aa695fe8757b3e08_D20220101-20220630" name="us-gaap:PropertyPlantAndEquipmentUsefulLife" id="id3VybDovL2RvY3MudjEvZG9jOmFlNWE5YmUwZWI5NDQ1ZDE5MmZhZTgyMmQyMmJlMDlmL3NlYzphZTVhOWJlMGViOTQ0NWQxOTJmYWU4MjJkMjJiZTA5Zl8zNy9mcmFnOjQ4OGNkZjBhODVlYzRiMDliYWFiN2JhZTlhODA5YjcwL3RleHRyZWdpb246NDg4Y2RmMGE4NWVjNGIwOWJhYWI3YmFlOWE4MDliNzBfMTQ0NDA_b7f0ce5d-c748-4105-a8ca-a2d7278a0959">P2Y</ix:nonNumeric><ix:nonNumeric contextRef="i4e7d7d7304c048ca82f068a9a195f83b_I20220630" name="us-gaap:RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionPeriod1" id="id3VybDovL2RvY3MudjEvZG9jOmFlNWE5YmUwZWI5NDQ1ZDE5MmZhZTgyMmQyMmJlMDlmL3NlYzphZTVhOWJlMGViOTQ0NWQxOTJmYWU4MjJkMjJiZTA5Zl8zNy9mcmFnOjQ4OGNkZjBhODVlYzRiMDliYWFiN2JhZTlhODA5YjcwL3RleHRyZWdpb246NDg4Y2RmMGE4NWVjNGIwOWJhYWI3YmFlOWE4MDliNzBfMjUxODY_b4f0c6ee-fd6c-49c3-80df-d66815f5e42f">P2Y</ix:nonNumeric><ix:nonFraction unitRef="number" contextRef="i93b0b8d9a4ba4307b9aa1d2e18a0e2c3_D20190829-20190829" decimals="1" name="us-gaap:StockholdersEquityNoteStockSplitConversionRatio1" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmFlNWE5YmUwZWI5NDQ1ZDE5MmZhZTgyMmQyMmJlMDlmL3NlYzphZTVhOWJlMGViOTQ0NWQxOTJmYWU4MjJkMjJiZTA5Zl80MC9mcmFnOjY4ZTEzYjk4NTAxZTRkYzU5NGVlMWQ4ZjA2NzQ4Zjk1L3RhYmxlOmVkYTM5MWVkZGQyYjQyNzJhYjE3ZWMzYzBiYTM3MTE3L3RhYmxlcmFuZ2U6ZWRhMzkxZWRkZDJiNDI3MmFiMTdlYzNjMGJhMzcxMTdfMi0xLTEtMS02MjY_59d4e361-9efb-4340-bbe9-78823febe876">0.5</ix:nonFraction><ix:nonFraction unitRef="shares" contextRef="i634967fade134dc69b40f7ae53806ba8_I20220630" decimals="INF" name="us-gaap:ClassOfWarrantOrRightNumberOfSecuritiesCalledByEachWarrantOrRight" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmFlNWE5YmUwZWI5NDQ1ZDE5MmZhZTgyMmQyMmJlMDlmL3NlYzphZTVhOWJlMGViOTQ0NWQxOTJmYWU4MjJkMjJiZTA5Zl80OS9mcmFnOjg0NmM4Nzk4ZmU0MDQyZjA4YTJmY2E4MTExOTk0NmU5L3RhYmxlOjIzNzRiZjMzNDc2MjQ0Mzg5NjllMjM4Njc1NzEwZDNhL3RhYmxlcmFuZ2U6MjM3NGJmMzM0NzYyNDQzODk2OWUyMzg2NzU3MTBkM2FfMi0xLTEtMS02MjY_c90f118e-6e82-4e86-b4e2-e33185fe4375">0.25</ix:nonFraction><ix:nonFraction unitRef="shares" contextRef="ia9537308acbd431f87e3b44d01741f2c_I20220630" decimals="INF" name="us-gaap:ClassOfWarrantOrRightNumberOfSecuritiesCalledByEachWarrantOrRight" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmFlNWE5YmUwZWI5NDQ1ZDE5MmZhZTgyMmQyMmJlMDlmL3NlYzphZTVhOWJlMGViOTQ0NWQxOTJmYWU4MjJkMjJiZTA5Zl80OS9mcmFnOjg0NmM4Nzk4ZmU0MDQyZjA4YTJmY2E4MTExOTk0NmU5L3RhYmxlOjIzNzRiZjMzNDc2MjQ0Mzg5NjllMjM4Njc1NzEwZDNhL3RhYmxlcmFuZ2U6MjM3NGJmMzM0NzYyNDQzODk2OWUyMzg2NzU3MTBkM2FfMi0xLTEtMS02MjY_ea6aab91-1291-4b0f-a29f-1b71eb81e969">0.25</ix:nonFraction><ix:nonFraction unitRef="warrant" contextRef="ie2a82877a32d4e80a7f2d54460a79dcd_D20220101-20220630" decimals="INF" name="dmtk:NumberOfWarrantsEntitleHolderToPurchaseOneShare" format="ixt-sec:numwordsen" id="id3VybDovL2RvY3MudjEvZG9jOmFlNWE5YmUwZWI5NDQ1ZDE5MmZhZTgyMmQyMmJlMDlmL3NlYzphZTVhOWJlMGViOTQ0NWQxOTJmYWU4MjJkMjJiZTA5Zl80OS9mcmFnOjg0NmM4Nzk4ZmU0MDQyZjA4YTJmY2E4MTExOTk0NmU5L3RleHRyZWdpb246ODQ2Yzg3OThmZTQwNDJmMDhhMmZjYTgxMTE5OTQ2ZTlfMzI5ODUzNDg4MzQyNQ_9fdf8ca0-eea5-40e2-b781-30f40b3dd2c4">four</ix:nonFraction><ix:nonNumeric contextRef="i53405b48f5954e23b556c40be1389d0c_I20220630" name="us-gaap:LesseeOperatingLeaseRemainingLeaseTerm" format="ixt-sec:durwordsen" id="id3VybDovL2RvY3MudjEvZG9jOmFlNWE5YmUwZWI5NDQ1ZDE5MmZhZTgyMmQyMmJlMDlmL3NlYzphZTVhOWJlMGViOTQ0NWQxOTJmYWU4MjJkMjJiZTA5Zl80MTMvZnJhZzpmZGQ1ODk4MWFkZTg0M2M3YTFiNmNhYmIxZWE0YjFjZS90ZXh0cmVnaW9uOmZkZDU4OTgxYWRlODQzYzdhMWI2Y2FiYjFlYTRiMWNlXzMyOTg1MzQ4ODM0NzA_1a89299a-757b-4a42-b393-0135eed5e2b9">ten years, six months</ix:nonNumeric></ix:hidden><ix:references xml:lang="en-US"><link:schemaRef xlink:type="simple" xlink:href="dmtk-20220630.xsd"></link:schemaRef></ix:references><ix:resources><xbrli:context id="ia855382ada1f4f28aa8ef6da692ff177_D20220101-20220630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001651944</xbrli:identifier></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i0bb8b8c526d842f2a0e174c1375916cd_I20220805"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001651944</xbrli:identifier></xbrli:entity><xbrli:period><xbrli:instant>2022-08-05</xbrli:instant></xbrli:period></xbrli:context><xbrli:unit id="shares"><xbrli:measure>xbrli:shares</xbrli:measure></xbrli:unit><xbrli:context id="i4c8f247d12134a9886d56e1c8b024425_I20220630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001651944</xbrli:identifier></xbrli:entity><xbrli:period><xbrli:instant>2022-06-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:unit id="usd"><xbrli:measure>iso4217:USD</xbrli:measure></xbrli:unit><xbrli:context id="i87bf777ccf5f4f93bc9be7a2cbba61c1_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001651944</xbrli:identifier></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:unit id="usdPerShare"><xbrli:divide><xbrli:unitNumerator><xbrli:measure>iso4217:USD</xbrli:measure></xbrli:unitNumerator><xbrli:unitDenominator><xbrli:measure>xbrli:shares</xbrli:measure></xbrli:unitDenominator></xbrli:divide></xbrli:unit><xbrli:context id="i6e93ea7e6de54e3b99964d226c95da1b_D20220401-20220630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001651944</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">dmtk:AssayMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-04-01</xbrli:startDate><xbrli:endDate>2022-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i37138912f4f54957978d26b438559810_D20210401-20210630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001651944</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">dmtk:AssayMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-04-01</xbrli:startDate><xbrli:endDate>2021-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i162096998d12445db5b600d98dd798a7_D20220101-20220630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001651944</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">dmtk:AssayMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ib998ae4e71544a4aa86f6166fce08ce5_D20210101-20210630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001651944</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">dmtk:AssayMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i78ce1dff723a4a809549de43dc758409_D20220401-20220630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001651944</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">dmtk:ContractualActivitiesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-04-01</xbrli:startDate><xbrli:endDate>2022-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i56c0d5eff1614a048c29e3f98fd6e1bd_D20210401-20210630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001651944</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">dmtk:ContractualActivitiesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-04-01</xbrli:startDate><xbrli:endDate>2021-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i615ec51fc143458883f5b2236ee7fa4e_D20220101-20220630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001651944</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">dmtk:ContractualActivitiesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i3b92d912bf1a4d219b2f1cafa797b274_D20210101-20210630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001651944</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">dmtk:ContractualActivitiesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i2c5f0f28773744e5a2e202f2943ae976_D20220401-20220630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001651944</xbrli:identifier></xbrli:entity><xbrli:period><xbrli:startDate>2022-04-01</xbrli:startDate><xbrli:endDate>2022-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="id7bb773872394047ba26aa8a7a0f4d56_D20210401-20210630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001651944</xbrli:identifier></xbrli:entity><xbrli:period><xbrli:startDate>2021-04-01</xbrli:startDate><xbrli:endDate>2021-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="idaa4f31ca59a4a17a59c2580b97791ca_D20210101-20210630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001651944</xbrli:identifier></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i8dc9000c668a4aa984be19fb8519665b_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001651944</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i152c9be1ba1e447486e5a7897ca085e6_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001651944</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i922bc272fcd34b919d4804d77d0e0c27_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001651944</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedNetUnrealizedInvestmentGainLossMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i9abcd2f792c74d59a334b58470c92ee1_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001651944</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ibdd6f077db7e4453b764a24795f4ccab_D20220101-20220331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001651944</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i0c3fc5bff94f42de9cc243e9bac95218_D20220101-20220331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001651944</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i73a86f0089f6462d9bcb14d0d7b333b6_D20220101-20220331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001651944</xbrli:identifier></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i3b22eec6726b4166a994d025bc0ced72_D20220101-20220331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001651944</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedNetUnrealizedInvestmentGainLossMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ic42372bda74e4cccb938ae9846b0efa8_D20220101-20220331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001651944</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i39d067b2de814fdd942ed3afbc265b36_I20220331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001651944</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ie3d1daa21e224cc7bf51143498f4f8dc_I20220331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001651944</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ieaf99c642b3e451383632209bf030fa1_I20220331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001651944</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedNetUnrealizedInvestmentGainLossMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i842f2362497347869b657ca3d4a18b0e_I20220331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001651944</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="id801924f698f4fbab568e7483b1a98ca_I20220331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001651944</xbrli:identifier></xbrli:entity><xbrli:period><xbrli:instant>2022-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i3ac147ed027b4fccb1eb3b3b35fff118_D20220401-20220630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001651944</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-04-01</xbrli:startDate><xbrli:endDate>2022-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i5a6efd2e4aae4e7c98a64843742ef0b5_D20220401-20220630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001651944</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-04-01</xbrli:startDate><xbrli:endDate>2022-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i121c1a6b16ed46b4b77fad9886993828_D20220401-20220630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001651944</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedNetUnrealizedInvestmentGainLossMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-04-01</xbrli:startDate><xbrli:endDate>2022-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i6d917ab3db164f9196c80ba779ef6876_D20220401-20220630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001651944</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-04-01</xbrli:startDate><xbrli:endDate>2022-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ia9537308acbd431f87e3b44d01741f2c_I20220630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001651944</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-06-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ib9ab9bb551934102bae2904f11a4da20_I20220630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001651944</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-06-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i85b53adede47405198bcfa9202c16b00_I20220630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001651944</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedNetUnrealizedInvestmentGainLossMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-06-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i506a0b63797b4ba099490022c868c239_I20220630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001651944</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-06-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="idf41ea014db640f1a2c27c2a769a0f37_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001651944</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i770f7a8689db49a0b1de542ddda20759_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001651944</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i5a3aac1f37e54bf194da81ac901f5ea9_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001651944</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedNetUnrealizedInvestmentGainLossMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i8c8de78a03884c5eb87d8bfff7cb6c1c_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001651944</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i299927d2cdfe46deaac8ee64dc7dce6c_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001651944</xbrli:identifier></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i9765c83c10a4499099d3ccc0868af9be_I20210331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001651944</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i936fe08107a14d5c927b5fa13e2af2c5_D20210101-20210331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001651944</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i3f5ee0c6315d458da591b98ccf0afb7c_D20210101-20210331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001651944</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="icf9848cee57f48e1abdd659c090042db_D20210101-20210331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001651944</xbrli:identifier></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i7ae4ca8a5bb543418bbae64ee99ea8fb_D20210101-20210331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001651944</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedNetUnrealizedInvestmentGainLossMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i7f3382225eda41b397ed5315a35090fd_D20210101-20210331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001651944</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i7a5dc2cad8ab4a63b151726096e30d08_I20210331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001651944</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ib3a71fad6fed4582857b2c1740f068d3_I20210331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001651944</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedNetUnrealizedInvestmentGainLossMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i8a2b15e19ec44c569f05077b9a65f5bc_I20210331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001651944</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i8003b21ff858443fa0b721090f35eb8c_I20210331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001651944</xbrli:identifier></xbrli:entity><xbrli:period><xbrli:instant>2021-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="if87a65d6f2c04499a52e6465b24b991a_D20210401-20210630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001651944</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-04-01</xbrli:startDate><xbrli:endDate>2021-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="idd2a0e0d7f8047ff823261ca459e9548_D20210401-20210630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001651944</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-04-01</xbrli:startDate><xbrli:endDate>2021-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ibf2eeb1965ed4f85aabca9700183b6c8_I20210630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001651944</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:SubsidiarySaleOfStockAxis">dmtk:AtTheMarketOfferingMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-06-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="if148116e5f8f42ec91f0eb17fe3ed6f0_D20210401-20210630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001651944</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedNetUnrealizedInvestmentGainLossMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-04-01</xbrli:startDate><xbrli:endDate>2021-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="idc14b05f084b42dcbd02996ad7fb090f_D20210401-20210630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001651944</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-04-01</xbrli:startDate><xbrli:endDate>2021-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i962e0f9643f54946bc90520b7ea86c76_I20210630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001651944</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-06-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i53a3c2269f654f2fb4637cd7af974436_I20210630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001651944</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-06-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i398f2a559ab64f81bd1a007c9fc04a0a_I20210630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001651944</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedNetUnrealizedInvestmentGainLossMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-06-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ice91fd1c5683472191e0ebaa1eed5a8a_I20210630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001651944</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-06-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ie036f155bf0e43bd97ef05b5b46857eb_I20210630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001651944</xbrli:identifier></xbrli:entity><xbrli:period><xbrli:instant>2021-06-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="iaa3380e4cf5a462aa71b09fba6701de9_D20220101-20220630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001651944</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:SubsidiarySaleOfStockAxis">dmtk:PublicFollowOnOfferingMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ia87d864973504d67affd22c2a1bdc40c_D20210101-20210630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001651944</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:SubsidiarySaleOfStockAxis">dmtk:PublicFollowOnOfferingMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i1c2f494e495e4547bd1776a4d5cb5c64_D20220101-20220630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001651944</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:SubsidiarySaleOfStockAxis">dmtk:AtTheMarketOfferingMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i07f957c639484f23a8527b87b9caff7d_D20210101-20210630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001651944</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:SubsidiarySaleOfStockAxis">dmtk:AtTheMarketOfferingMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="if83fbbc281954a99aa695fe8757b3e08_D20220101-20220630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001651944</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:RangeAxis">srt:MinimumMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i9069aff5693b479db8eb460a09c920a0_D20220101-20220630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001651944</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:RangeAxis">srt:MaximumMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i6013cc6ffa8a44399380d7ab2a84d3ef_D20220401-20220630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001651944</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">dmtk:AmortizationOfLaboratoryEquipmentAcquiredUnderFinanceLeasesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-04-01</xbrli:startDate><xbrli:endDate>2022-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i746f81de13474498bf13734eea25d645_D20210401-20210630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001651944</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">dmtk:AmortizationOfLaboratoryEquipmentAcquiredUnderFinanceLeasesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-04-01</xbrli:startDate><xbrli:endDate>2021-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i74a9fc9070b8404997fc0c10022dc50e_D20220101-20220630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001651944</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">dmtk:AmortizationOfLaboratoryEquipmentAcquiredUnderFinanceLeasesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i3e76258aea994808ac778298cc3389ab_D20210101-20210630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001651944</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">dmtk:AmortizationOfLaboratoryEquipmentAcquiredUnderFinanceLeasesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ic89cf2db98344df4a59437fe3569a1d2_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001651944</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">dmtk:AssetsHeldUnderFinanceLeasesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="if5c0f2a68220406b8c328b2744af6512_I20220630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001651944</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">dmtk:AssetsHeldUnderFinanceLeasesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-06-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i72b0a574a3fc4d02a8355d41f4d3c3f7_D20220101-20220630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001651944</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">dmtk:AssetsHeldUnderFinanceLeasesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i90781b7d5b3d4c93943bc5e09860112d_D20210101-20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001651944</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">dmtk:AssetsHeldUnderFinanceLeasesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:unit id="revenuestream"><xbrli:measure>dmtk:revenueStream</xbrli:measure></xbrli:unit><xbrli:context id="i44ab42a102594fac87f06c1ef8c068f7_D20220401-20220630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001651944</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">dmtk:ContractRevenueAdhesivePatchKitsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-04-01</xbrli:startDate><xbrli:endDate>2022-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i37bb372a6a6f42ad835fe2ef8ee1273a_D20210401-20210630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001651944</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">dmtk:ContractRevenueAdhesivePatchKitsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-04-01</xbrli:startDate><xbrli:endDate>2021-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ibaf8664002d140989e8264c6adb89fa7_D20220101-20220630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001651944</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">dmtk:ContractRevenueAdhesivePatchKitsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="iddc9e2beb1bb4562969f72a76d146829_D20210101-20210630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001651944</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">dmtk:ContractRevenueAdhesivePatchKitsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i97ac1b6997a14b74b531fc469df2694d_D20220401-20220630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001651944</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">dmtk:ContractRevenueRNAExtractionsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-04-01</xbrli:startDate><xbrli:endDate>2022-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ib4f6baa70c784ecf9d59a3a86366bfc9_D20210401-20210630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001651944</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">dmtk:ContractRevenueRNAExtractionsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-04-01</xbrli:startDate><xbrli:endDate>2021-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i84a94952fcc541d9a3ed53a9fbe72d3f_D20220101-20220630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001651944</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">dmtk:ContractRevenueRNAExtractionsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ia31f87e1f0644450bcc68070a72f9423_D20210101-20210630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001651944</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">dmtk:ContractRevenueRNAExtractionsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i2f689fb0f6dd4303b138b093b1056dd9_D20220401-20220630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001651944</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">dmtk:ContractRevenueProjectManagementFeesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-04-01</xbrli:startDate><xbrli:endDate>2022-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i8648dde9ea3c4420a2537a1ebd36ce55_D20210401-20210630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001651944</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">dmtk:ContractRevenueProjectManagementFeesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-04-01</xbrli:startDate><xbrli:endDate>2021-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i7ce185f90d7b4357a581d645d094bd60_D20220101-20220630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001651944</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">dmtk:ContractRevenueProjectManagementFeesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="iba453607677b41a9a058e0d3ee2c4186_D20210101-20210630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001651944</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">dmtk:ContractRevenueProjectManagementFeesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ibe700613e5304875bdd1ff268a855e3b_D20220401-20220630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001651944</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">dmtk:AssayRevenuePayorAMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByTypeAxis">us-gaap:CustomerConcentrationRiskMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByBenchmarkAxis">us-gaap:SalesRevenueNetMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-04-01</xbrli:startDate><xbrli:endDate>2022-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:unit id="number"><xbrli:measure>xbrli:pure</xbrli:measure></xbrli:unit><xbrli:context id="id2fc2250bf344e37938b871f12d01a85_D20210401-20210630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001651944</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">dmtk:AssayRevenuePayorAMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByTypeAxis">us-gaap:CustomerConcentrationRiskMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByBenchmarkAxis">us-gaap:SalesRevenueNetMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-04-01</xbrli:startDate><xbrli:endDate>2021-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i79283405fe744adabc208118150149f3_D20220101-20220630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001651944</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">dmtk:AssayRevenuePayorAMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByTypeAxis">us-gaap:CustomerConcentrationRiskMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByBenchmarkAxis">us-gaap:SalesRevenueNetMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i0a6d383e97df42d3a6810885b8aee9e8_D20210101-20210630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001651944</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">dmtk:AssayRevenuePayorAMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByTypeAxis">us-gaap:CustomerConcentrationRiskMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByBenchmarkAxis">us-gaap:SalesRevenueNetMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="icab6abad6fea44f5ae78f4cbcce5b550_D20220101-20220630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001651944</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">dmtk:AssayRevenuePayorAMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByBenchmarkAxis">us-gaap:AccountsReceivableMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByTypeAxis">us-gaap:CustomerConcentrationRiskMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ifb4b0086847d4c79aed7244eb498c89a_D20210101-20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001651944</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">dmtk:AssayRevenuePayorAMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByBenchmarkAxis">us-gaap:AccountsReceivableMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByTypeAxis">us-gaap:CustomerConcentrationRiskMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ibc3b0a82341c40d6abc97b51b82572a2_D20220101-20220630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001651944</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByBenchmarkAxis">us-gaap:AccountsReceivableMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByTypeAxis">us-gaap:CustomerConcentrationRiskMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">dmtk:AssayRevenuePayorBMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i024422eccd5d4383a66fc3f37bffe425_D20210101-20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001651944</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByBenchmarkAxis">us-gaap:AccountsReceivableMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByTypeAxis">us-gaap:CustomerConcentrationRiskMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">dmtk:AssayRevenuePayorBMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i4e7d7d7304c048ca82f068a9a195f83b_I20220630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001651944</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:RangeAxis">srt:MinimumMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-06-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i87a77119b42946ecbfc4ea54841338c0_I20220630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001651944</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:RangeAxis">srt:MaximumMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-06-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i6635c095eae0429e88a27cd2f8145dc1_I20220630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001651944</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">dmtk:AssayMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-06-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i4d3ad48c30c04410bf8a55d9dabb735e_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001651944</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">dmtk:AssayMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="icfa56764c3ac46e89e85c1c2e548d685_I20220630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001651944</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">dmtk:ContractualActivitiesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-06-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i204f9e4e483143659a51c94f43ce8d11_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001651944</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">dmtk:ContractualActivitiesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ie94c263c6992432a815e971cc90962ff_D20220101-20220630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001651944</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis">us-gaap:WarrantMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i7ba402f3c4df43af97329ebc435cae8c_D20220401-20220630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001651944</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis">us-gaap:WarrantMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-04-01</xbrli:startDate><xbrli:endDate>2022-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i2823faffcae54e5d93a6030da77ad512_D20220101-20220630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001651944</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis">dmtk:StockOptionsAndRestrictedStockUnitsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i4691cb5ab9d44fe4bb012ab3099c548d_D20220401-20220630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001651944</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis">dmtk:StockOptionsAndRestrictedStockUnitsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-04-01</xbrli:startDate><xbrli:endDate>2022-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="icb0e8ee0be634262b34d17ccb551b284_D20210101-20210630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001651944</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis">us-gaap:WarrantMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i249d87c65f444c66a0d32f915d17cf47_D20210401-20210630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001651944</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis">us-gaap:WarrantMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-04-01</xbrli:startDate><xbrli:endDate>2021-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i8302e4a3b08c40939cfabd8d8c7827e0_D20210401-20210630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001651944</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis">dmtk:StockOptionsAndRestrictedStockUnitsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-04-01</xbrli:startDate><xbrli:endDate>2021-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="idde3250874484b9b9fbc3ab3b93032eb_D20210101-20210630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001651944</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis">dmtk:StockOptionsAndRestrictedStockUnitsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="if758224c2e474796966c7a56ed966de8_I20220630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001651944</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-06-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="if8fdbfd7ecbc4f1e83abd5532a4f2776_I20220630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001651944</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-06-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="id460d49e6dc845ddb03e35bcd01b0a02_I20220630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001651944</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-06-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i6f6e047d4cc946d5ab745668b1e79366_I20220630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001651944</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-06-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i41653ba801c2441dbaca0c02a6789086_I20220630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001651944</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:CorporateDebtSecuritiesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-06-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="iea92d61cbcce431fa5e4090b90791f94_I20220630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001651944</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:CorporateDebtSecuritiesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-06-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i5b506509888b48d6a34efce6ba8f7e6e_I20220630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001651944</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:CorporateDebtSecuritiesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-06-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ie45f0b654eec485abbe4c0f2ba779d49_I20220630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001651944</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:CorporateDebtSecuritiesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-06-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i37da1f18c957414ba4dec5d09fe5fce0_I20220630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001651944</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:MunicipalNotesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-06-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i04cf5fc9b6ef4515a8ce5817a046a654_I20220630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001651944</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:MunicipalNotesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-06-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ibc090232bd5e457e8df72d86df61cf31_I20220630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001651944</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:MunicipalNotesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-06-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="id3e9e3b412de4937a9a4ce62ef9086bd_I20220630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001651944</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:MunicipalNotesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-06-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i7a19194e0b6946c5a1307bef5ce3e7ea_I20220630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001651944</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:USGovernmentAgenciesShorttermDebtSecuritiesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-06-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i48acc600f436461fa46eb2fc48d5b8a3_I20220630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001651944</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:USGovernmentAgenciesShorttermDebtSecuritiesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-06-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ic46c00dd86944457b5ff2e30e0e14027_I20220630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001651944</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:USGovernmentAgenciesShorttermDebtSecuritiesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-06-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i7d779ec4227844e9a0d3371962d37354_I20220630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001651944</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:USGovernmentAgenciesShorttermDebtSecuritiesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-06-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="id0495dc386634c17abe35f6f0b1c1cde_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001651944</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i22164451262946e4b9911f313b7610c1_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001651944</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ica20d3fdf2ff41fdb31ad57ccb72924b_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001651944</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ie7dec283b83b43f99e003b79ec165d54_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001651944</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ia276a40ecef74c489871bb3ea4f6856b_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001651944</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:CorporateDebtSecuritiesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="icf26e4a3bbe94872997aa67085685e63_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001651944</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:CorporateDebtSecuritiesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i03ca2eb28be548fea6832470239a3e99_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001651944</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:CorporateDebtSecuritiesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ieff44cf249a64087acf6cb16f4815cb7_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001651944</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:CorporateDebtSecuritiesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i849cb6bacde4475a95c34f5707ff57c7_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001651944</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:MunicipalNotesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="iad8908ee30bb4929b29d53cdc31fbd4f_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001651944</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:MunicipalNotesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="id6a19bedaa7c4ff8a89b8887ce0c3750_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001651944</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:MunicipalNotesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i319102f511954bcdb477a84723258d83_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001651944</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:MunicipalNotesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i14a147d5e6494412ae4b21fe8bfddff7_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001651944</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:USGovernmentAgenciesShorttermDebtSecuritiesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i4c05f919d71b4b4cb753c74dcc787cf4_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001651944</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:USGovernmentAgenciesShorttermDebtSecuritiesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="if678e473179340e9834400c14da4f7d6_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001651944</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:USGovernmentAgenciesShorttermDebtSecuritiesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i4f60362ab2e44b07bbde43a025d24bba_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001651944</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:USGovernmentAgenciesShorttermDebtSecuritiesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i2ff3fea135c346deae31b3b343050a34_D20220401-20220630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001651944</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:WarrantyRightsAndObligationsFairValueOptionMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-04-01</xbrli:startDate><xbrli:endDate>2022-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ifd6a2c580c134e25811ac19c23b2c1e5_D20210401-20210630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001651944</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:WarrantyRightsAndObligationsFairValueOptionMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-04-01</xbrli:startDate><xbrli:endDate>2021-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ib3db0d13e848432a9c205ce797c080f8_D20220101-20220630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001651944</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:WarrantyRightsAndObligationsFairValueOptionMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i08f348302fbc42c98a41fcaf5cfcde43_D20210101-20210630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001651944</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:WarrantyRightsAndObligationsFairValueOptionMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ife1b36ccabe240edb9560e64d1ffa4bc_D20220101-20220630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001651944</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:WarrantyRightsAndObligationsFairValueOptionMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:RangeAxis">srt:MinimumMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i40659e4bf5494460828fbdb823038ea6_D20220101-20220630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001651944</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:WarrantyRightsAndObligationsFairValueOptionMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:RangeAxis">srt:MaximumMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i2c2735b81bcc42bf8feeaa459dfad074_D20210101-20210630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001651944</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:WarrantyRightsAndObligationsFairValueOptionMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:RangeAxis">srt:MinimumMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ibf907753dcd34608bb600dff616c1c77_D20210101-20210630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001651944</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:WarrantyRightsAndObligationsFairValueOptionMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:RangeAxis">srt:MaximumMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i0e8a6876eeb946269d2c2405fcb009b4_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001651944</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByLiabilityClassAxis">dmtk:WarrantLiabilityMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i4030b6b173eb4417a8b8aa5024f71cc6_D20220101-20220331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001651944</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByLiabilityClassAxis">dmtk:WarrantLiabilityMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i253fb10d701144a8b699b8f06a9a82fd_I20220331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001651944</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByLiabilityClassAxis">dmtk:WarrantLiabilityMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i166b12bbf79f408e95f28a9eeaa9d48d_D20220401-20220630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001651944</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByLiabilityClassAxis">dmtk:WarrantLiabilityMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-04-01</xbrli:startDate><xbrli:endDate>2022-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ia41275e687284fbe8c0cd8cfc3637073_I20220630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001651944</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByLiabilityClassAxis">dmtk:WarrantLiabilityMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-06-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ieb434e1a310d48ce8a877397d66245d6_I20220630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001651944</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">dmtk:RestrictedCashMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-06-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="if16c69c24d79407cacc36646afe73f31_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001651944</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">dmtk:RestrictedCashMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i93b0b8d9a4ba4307b9aa1d2e18a0e2c3_D20190829-20190829"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001651944</xbrli:identifier></xbrli:entity><xbrli:period><xbrli:startDate>2019-08-29</xbrli:startDate><xbrli:endDate>2019-08-29</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="if86a878c756a461abc20e5dc5cf1667c_I20220630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001651944</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:CorporateDebtSecuritiesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-06-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ibd768261001c4410bcbcfa14c060fd74_I20220630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001651944</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:MunicipalNotesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-06-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i9b0f17d8e871417bbb113b30e575a8a5_I20220630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001651944</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:USGovernmentAgenciesShorttermDebtSecuritiesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-06-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i267f31f0cb5a4cb5bd58dd78cd514f48_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001651944</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:CorporateDebtSecuritiesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i3ec37ec0a1104b00bb3614670349fb31_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001651944</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:MunicipalNotesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i10f3d8ad519640d9bc20a9ada45d58e7_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001651944</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:USGovernmentAgenciesShorttermDebtSecuritiesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ia4a7fd782f30475da7d3133d9c168885_D20201110-20201110"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001651944</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionsByRelatedPartyAxis">dmtk:CowenLimitedLiabilityCompanyMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-11-10</xbrli:startDate><xbrli:endDate>2020-11-10</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i415678d9707341f4acccc0fba869131d_D20201110-20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001651944</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionsByRelatedPartyAxis">dmtk:CowenLimitedLiabilityCompanyMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-11-10</xbrli:startDate><xbrli:endDate>2020-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i305721ec0ffb416391e577b9071cbf15_D20220101-20220630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001651944</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionsByRelatedPartyAxis">dmtk:CowenLimitedLiabilityCompanyMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="if05c806895254e84952b9538ed102dac_D20210101-20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001651944</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionsByRelatedPartyAxis">dmtk:CowenLimitedLiabilityCompanyMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i7d0e216f45ca4f518d2c2732a59322ab_D20210106-20210106"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001651944</xbrli:identifier></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-06</xbrli:startDate><xbrli:endDate>2021-01-06</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ic368d6fe62464ba5bac452fa161672d6_D20210111-20210111"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001651944</xbrli:identifier></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-11</xbrli:startDate><xbrli:endDate>2021-01-11</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="icbaabbad817c4953a4cfd55f31fb248d_I20210111"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001651944</xbrli:identifier></xbrli:entity><xbrli:period><xbrli:instant>2021-01-11</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i6732e83066a44277a8539ee4f29b7c2f_D20170623-20170623"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001651944</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:ClassOfWarrantOrRightAxis">dmtk:SpecialPurposeAcquisitionCompaniesWarrantsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2017-06-23</xbrli:startDate><xbrli:endDate>2017-06-23</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i310af3399c354a2194fb2cb2350604d4_D20170623-20170623"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001651944</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:ClassOfWarrantOrRightAxis">dmtk:PublicSpecialPurposeAcquisitionCompaniesWarrantsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2017-06-23</xbrli:startDate><xbrli:endDate>2017-06-23</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i452e14998aaf4b87b88a33470c2536e4_D20170623-20170623"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001651944</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:ClassOfWarrantOrRightAxis">dmtk:PrivateSpecialPurposeAcquisitionCompaniesWarrantsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2017-06-23</xbrli:startDate><xbrli:endDate>2017-06-23</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i634967fade134dc69b40f7ae53806ba8_I20220630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001651944</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:ClassOfWarrantOrRightAxis">dmtk:SpecialPurposeAcquisitionCompaniesWarrantsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-06-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i21b78556448b464cb21d8774cfc796ea_I20210630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001651944</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:ClassOfWarrantOrRightAxis">dmtk:SpecialPurposeAcquisitionCompaniesWarrantsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-06-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="iec153eacdc1c48dbb3a7a5f42f8d0173_D20210101-20210630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001651944</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:ClassOfWarrantOrRightAxis">dmtk:SpecialPurposeAcquisitionCompaniesWarrantsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i803095f015594543bf9205dfd151c02e_I20220630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001651944</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:ClassOfWarrantOrRightAxis">dmtk:SpecialPurposeAcquisitionCompaniesWarrantsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-06-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i9641b453cb244341906e0d3f67453c08_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001651944</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:ClassOfWarrantOrRightAxis">dmtk:SpecialPurposeAcquisitionCompaniesWarrantsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i0d9404419f2a4713a7b20a9438a2268d_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001651944</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:ClassOfWarrantOrRightAxis">dmtk:PrivateSpecialPurposeAcquisitionCompaniesWarrantsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i80e526858964456d8f479d0e2dd63ca5_I20220630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001651944</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:ClassOfWarrantOrRightAxis">dmtk:PrivateSpecialPurposeAcquisitionCompaniesWarrantsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-06-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i5e6cf29a894e475589e2bb8262ac9033_D20150101-20161231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001651944</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:ClassOfWarrantOrRightAxis">dmtk:PlacementAgentWarrantsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2015-01-01</xbrli:startDate><xbrli:endDate>2016-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ic92102edfd1342a192f438b00ef88200_I20161231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001651944</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:ClassOfWarrantOrRightAxis">dmtk:PlacementAgentWarrantsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2016-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ic2ffccea2c90436fac0e9812ff060041_I20161231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001651944</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:ClassOfWarrantOrRightAxis">dmtk:PlacementAgentWarrantsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2016-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="if35ae65dc07b452292756d42575f3dae_D20160101-20181231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001651944</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:ClassOfWarrantOrRightAxis">dmtk:PlacementAgentWarrantsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2016-01-01</xbrli:startDate><xbrli:endDate>2018-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i4159027d930b496eab94ec0daf363261_I20181231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001651944</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:ClassOfWarrantOrRightAxis">dmtk:PlacementAgentWarrantsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2018-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="id7e5b24c3bb74b83a74aa64a7d327d4c_I20181231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001651944</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:ClassOfWarrantOrRightAxis">dmtk:PlacementAgentWarrantsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2018-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="icf734323352a4de0a023df6ea904aaac_D20200101-20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001651944</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:ClassOfWarrantOrRightAxis">dmtk:PlacementAgentWarrantsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">dmtk:TwoThousandEighteenConvertibleBridgeNotesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ibcc5eb12a4734bb39f49618ab345bde8_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001651944</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:ClassOfWarrantOrRightAxis">dmtk:PlacementAgentWarrantsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">dmtk:TwoThousandEighteenConvertibleBridgeNotesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ifa5f19791fc8441d87a405ff98a53015_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001651944</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:ClassOfWarrantOrRightAxis">dmtk:PlacementAgentWarrantsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">dmtk:TwoThousandEighteenConvertibleBridgeNotesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i2d6f98c2698e45af8da68430b3bfc742_I20220630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001651944</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:ClassOfWarrantOrRightAxis">dmtk:PlacementAgentWarrantsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-06-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="if706627078bd4aa4984495209ba461b8_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001651944</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:ClassOfWarrantOrRightAxis">dmtk:PlacementAgentWarrantsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i992097fa23d64aaa9f9ec09579943582_D20220401-20220630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001651944</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:PlanNameAxis">dmtk:TwoThousandTwentyEquityIncentivePlanMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-04-01</xbrli:startDate><xbrli:endDate>2022-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i0150b39d62c349949c09dc704f452a68_D20210401-20210630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001651944</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:PlanNameAxis">dmtk:TwoThousandTwentyEquityIncentivePlanMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-04-01</xbrli:startDate><xbrli:endDate>2021-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ie02bb53f63db46709e0bad3ea42b396b_D20220101-20220630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001651944</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:PlanNameAxis">dmtk:TwoThousandTwentyEquityIncentivePlanMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i8e399d9e39504b2691c985ca006cfc1c_D20210101-20210630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001651944</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:PlanNameAxis">dmtk:TwoThousandTwentyEquityIncentivePlanMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i45707f534a744db3b91064008ec1faf3_D20210401-20210630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001651944</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:PlanNameAxis">dmtk:TwoThousandTwentyEmployeeStockPurchasePlanMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-04-01</xbrli:startDate><xbrli:endDate>2021-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i017b877f28974f268d6f8d65791f6ccf_D20220101-20220630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001651944</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:PlanNameAxis">dmtk:TwoThousandTwentyEmployeeStockPurchasePlanMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i39b710f935eb45c28f101a01178659a1_D20210101-20210630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001651944</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:PlanNameAxis">dmtk:TwoThousandTwentyEmployeeStockPurchasePlanMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ia5465b10658f4233ba1e4baa3b943676_D20220101-20220630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001651944</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:PlanNameAxis">dmtk:TwoThousandTwentyEmployeeStockPurchasePlanMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:RangeAxis">srt:MinimumMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i88ad33d9abe64251a7d9379cd17f4be1_D20220101-20220630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001651944</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:PlanNameAxis">dmtk:TwoThousandTwentyEmployeeStockPurchasePlanMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:RangeAxis">srt:MaximumMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i1f1b6534cfc84ab0b6dde0c9dbabe32b_D20210101-20210630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001651944</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:PlanNameAxis">dmtk:TwoThousandTwentyEmployeeStockPurchasePlanMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:RangeAxis">srt:MinimumMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i8b65a3d5fc034de0bf1cc21839d1b39d_D20210101-20210630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001651944</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:PlanNameAxis">dmtk:TwoThousandTwentyEmployeeStockPurchasePlanMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:RangeAxis">srt:MaximumMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i34efb5ee40034834b0612db07b6ac538_D20220401-20220630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001651944</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:CostOfSalesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-04-01</xbrli:startDate><xbrli:endDate>2022-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i7756f068adac47afb60baa468c5ef026_D20210401-20210630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001651944</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:CostOfSalesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-04-01</xbrli:startDate><xbrli:endDate>2021-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i17e61074c4514eaf99a53572cb0fcf74_D20220101-20220630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001651944</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:CostOfSalesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="id38910781e2b4e58a9f2b8f671bfed35_D20210101-20210630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001651944</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:CostOfSalesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i8cb435a01219406ba1ef713635ac68ba_D20220401-20220630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001651944</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:SellingAndMarketingExpenseMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-04-01</xbrli:startDate><xbrli:endDate>2022-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i86954732d12643d381b4531c01ebcfd8_D20210401-20210630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001651944</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:SellingAndMarketingExpenseMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-04-01</xbrli:startDate><xbrli:endDate>2021-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i778b6ff1b3184f42864e9d757af2f4bd_D20220101-20220630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001651944</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:SellingAndMarketingExpenseMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ie6d29520a2674f6d9a7271efc6289984_D20210101-20210630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001651944</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:SellingAndMarketingExpenseMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i561a7e21ce6a40039dc3d34e1397766f_D20220401-20220630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001651944</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:ResearchAndDevelopmentExpenseMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-04-01</xbrli:startDate><xbrli:endDate>2022-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i6ddfec946a484290af96cb60df8d77ed_D20210401-20210630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001651944</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:ResearchAndDevelopmentExpenseMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-04-01</xbrli:startDate><xbrli:endDate>2021-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i8910e2a23b804411a94de3c030ee3d6d_D20220101-20220630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001651944</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:ResearchAndDevelopmentExpenseMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i35128ab55fdf4102bca836a519340c7f_D20210101-20210630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001651944</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:ResearchAndDevelopmentExpenseMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ie9748d2474c1470fbedee2cfc150c874_D20220401-20220630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001651944</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:GeneralAndAdministrativeExpenseMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-04-01</xbrli:startDate><xbrli:endDate>2022-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="if42f9fcfc62a442c8ed23e75ddd4b6dd_D20210401-20210630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001651944</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:GeneralAndAdministrativeExpenseMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-04-01</xbrli:startDate><xbrli:endDate>2021-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i50a7a6d1a7004169afd4ead8587d96b6_D20220101-20220630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001651944</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:GeneralAndAdministrativeExpenseMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i3ff371283df84968a8de2a698b44e5b1_D20210101-20210630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001651944</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:GeneralAndAdministrativeExpenseMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i3c1e467c7bea456e8c41b0e455ef5730_D20220101-20220630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001651944</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:PlanNameAxis">dmtk:TwoThousandTenStockPlanMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i58d1b32270b14657a2a11820d5e6fa8d_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001651944</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:PlanNameAxis">dmtk:TwoThousandTenStockPlanMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i5bd0ece4c3a9433ebf7e6f8058d14235_I20220630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001651944</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:PlanNameAxis">dmtk:TwoThousandTenStockPlanMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-06-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ied7a9ca9fd8040d59887525878d7cb79_D20220101-20220630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001651944</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:PlanNameAxis">dmtk:TwoThousandTwentyEquityIncentivePlanMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">dmtk:IncentiveAndNonQualifiedStockOptionsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:RangeAxis">srt:MinimumMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i2cb3f2789d9344f9a1099880c2a6b6ac_D20220101-20220630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001651944</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:PlanNameAxis">dmtk:TwoThousandTwentyEquityIncentivePlanMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">dmtk:IncentiveStockOptionsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:RangeAxis">srt:MinimumMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i695be12a2aa14dffb874c1e74a980c5b_D20220101-20220630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001651944</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:PlanNameAxis">dmtk:TwoThousandTwentyEquityIncentivePlanMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:RangeAxis">srt:MaximumMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i57b5170b75b149df8f3952976e4aeb64_I20220630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001651944</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:PlanNameAxis">dmtk:TwoThousandTwentyEquityIncentivePlanMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-06-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="id1f6d22436f64f38a4bd51d0074f4a35_I20220630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001651944</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:PlanNameAxis">dmtk:TwoThousandTwentyEquityIncentivePlanMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:RangeAxis">srt:MaximumMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-06-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i22cf6cdf250d424385f207471e8ff450_I20220630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001651944</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:PlanNameAxis">dmtk:TwoThousandTwentyEmployeeStockPurchasePlanMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:RangeAxis">srt:MaximumMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-06-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i6808a2674aa947cbae46fd4581d39941_I20220630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001651944</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:PlanNameAxis">dmtk:TwoThousandTwentyEmployeeStockPurchasePlanMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-06-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="idae0e59d93ee49ada1896eeec302b5ad_D20210228-20210228"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001651944</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:PlanNameAxis">dmtk:TwoThousandTwentyEmployeeStockPurchasePlanMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-02-28</xbrli:startDate><xbrli:endDate>2021-02-28</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i4953bff07aa94f8085ce64eca01ff01c_D20210801-20210831"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001651944</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:PlanNameAxis">dmtk:TwoThousandTwentyEmployeeStockPurchasePlanMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-08-01</xbrli:startDate><xbrli:endDate>2021-08-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i90db9a89ea084897a01e19ee9ba1df7d_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001651944</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:PlanNameAxis">dmtk:TwoThousandTwentyEmployeeStockPurchasePlanMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="if90b738ac124410e8756188bb3849132_I20220101"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001651944</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:PlanNameAxis">dmtk:TwoThousandTwentyEmployeeStockPurchasePlanMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-01-01</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i93962a6eeb67470a9a84c74d9a0daa4b_I20220228"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001651944</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:PlanNameAxis">dmtk:TwoThousandTwentyEmployeeStockPurchasePlanMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-02-28</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i3ae776d8a361420b98e7812cbc296a23_I20220630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001651944</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:ClassOfWarrantOrRightAxis">dmtk:ManagementWarrantsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-06-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="icceae5e000e140b89495ae9f074cbf03_I20220630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001651944</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:ClassOfWarrantOrRightAxis">dmtk:ManagementWarrantsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-06-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i17c79d92ed9747bf964a280f627bbb4a_D20220101-20220630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001651944</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:ClassOfWarrantOrRightAxis">dmtk:ManagementWarrantsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="id48e52918d994150b696caa21ce59a38_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001651944</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:ClassOfWarrantOrRightAxis">dmtk:ManagementWarrantsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i224d7d5c13f4473abacadb433d8efcf9_I20220630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001651944</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">dmtk:WarrantsToPurchaseCommonStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-06-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i3e751586f58d4d01a1fef025f865d0f3_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001651944</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">dmtk:WarrantsToPurchaseCommonStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i518ef87c81764e97bfd3d740d82300fd_I20220630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001651944</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">dmtk:SpecialPurposeAcquisitionCompanyWarrantsToPurchaseCommonStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-06-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ib8e1d5497a8844f49561a3c895942e21_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001651944</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">dmtk:SpecialPurposeAcquisitionCompanyWarrantsToPurchaseCommonStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="id85b86a3ec0547afa49b47ee6b523100_I20220630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001651944</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:EmployeeStockOptionMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-06-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="if9fd57fab22a46b58a6fed555cc40670_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001651944</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:EmployeeStockOptionMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="if59386ad3a864f49b56cf8b203a0bfc9_I20220630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001651944</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:RestrictedStockUnitsRSUMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-06-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ia2ce86db98734669afba2e88fbc221c0_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001651944</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:RestrictedStockUnitsRSUMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="idff1708d659844a99149a2c6dc434bbc_I20220630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001651944</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">dmtk:AuthorizedForFutureEquityGrantsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-06-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ia222e6a529804adeb78574b8095520eb_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001651944</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">dmtk:AuthorizedForFutureEquityGrantsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="if28f5d136fda458d8a8446a128205c60_I20220630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001651944</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">dmtk:AuthorizedForFutureESPPPurchasesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-06-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i5cb5de1a181c4857a7d503c399e272c8_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001651944</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">dmtk:AuthorizedForFutureESPPPurchasesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ie2a82877a32d4e80a7f2d54460a79dcd_D20220101-20220630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001651944</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:ClassOfWarrantOrRightAxis">dmtk:SpecialPurposeAcquisitionCompaniesWarrantsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:unit id="warrant"><xbrli:measure>dmtk:Warrant</xbrli:measure></xbrli:unit><xbrli:context id="if694b668e6db42e59488d953f4800965_D20220101-20220630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001651944</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:AdjustmentsForNewAccountingPronouncementsAxis">us-gaap:AccountingStandardsUpdate201602Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i637644f310444bb4bb137883228ca16b_D20220101-20220630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001651944</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:CumulativeEffectPeriodOfAdoptionAxis">srt:CumulativeEffectPeriodOfAdoptionAdjustmentMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:AdjustmentsForNewAccountingPronouncementsAxis">us-gaap:AccountingStandardsUpdate201602Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i4628e2bd4b3a484e9970f7b8d824bdca_D20220101-20220630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001651944</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:CumulativeEffectPeriodOfAdoptionAxis">srt:CumulativeEffectPeriodOfAdoptionAdjustedBalanceMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:AdjustmentsForNewAccountingPronouncementsAxis">us-gaap:AccountingStandardsUpdate201602Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ia085e149f0584e4aa75cec6634a0ee91_I20220630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001651944</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:AdjustmentsForNewAccountingPronouncementsAxis">us-gaap:AccountingStandardsUpdate201602Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-06-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ie929f48c345b4dcab48cd9079f2d2e62_I20220630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001651944</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:CumulativeEffectPeriodOfAdoptionAxis">srt:CumulativeEffectPeriodOfAdoptionAdjustmentMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:AdjustmentsForNewAccountingPronouncementsAxis">us-gaap:AccountingStandardsUpdate201602Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-06-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i833f3dceaa1b4ef5bcdfa449605a0a35_I20220630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001651944</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:CumulativeEffectPeriodOfAdoptionAxis">srt:CumulativeEffectPeriodOfAdoptionAdjustedBalanceMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:AdjustmentsForNewAccountingPronouncementsAxis">us-gaap:AccountingStandardsUpdate201602Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-06-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="icf690a1cf0024305b7396da4cb697adc_D20210101-20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001651944</xbrli:identifier></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i4ac87f578df0406d99e77dc768764559_D20220401-20220630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001651944</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:InterestIncomeMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-04-01</xbrli:startDate><xbrli:endDate>2022-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ie146fe37064c4413b6d561285cac9dcd_D20210401-20210630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001651944</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:InterestIncomeMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-04-01</xbrli:startDate><xbrli:endDate>2021-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i69bf0330ac3a4009ac4cc9f072eb2145_D20220101-20220630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001651944</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:InterestIncomeMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ia60e98d0ecdb4e6fac0242d43b27bd2b_D20210101-20210630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001651944</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:InterestIncomeMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i1618d3c7213a4aa5a35fb7ebe4eea53b_D20210701-20210701"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001651944</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:CounterpartyNameAxis">dmtk:KilroyRealtyLPMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-07-01</xbrli:startDate><xbrli:endDate>2021-07-01</xbrli:endDate></xbrli:period></xbrli:context><xbrli:unit id="sqft"><xbrli:measure>utr:sqft</xbrli:measure></xbrli:unit><xbrli:unit id="usdPerSqft"><xbrli:divide><xbrli:unitNumerator><xbrli:measure>iso4217:USD</xbrli:measure></xbrli:unitNumerator><xbrli:unitDenominator><xbrli:measure>utr:sqft</xbrli:measure></xbrli:unitDenominator></xbrli:divide></xbrli:unit><xbrli:context id="icbcfccaf50f84ffca456a076d115a21c_I20210701"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001651944</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:CounterpartyNameAxis">dmtk:KilroyRealtyLPMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-07-01</xbrli:instant></xbrli:period></xbrli:context><xbrli:unit id="phase"><xbrli:measure>dmtk:phase</xbrli:measure></xbrli:unit><xbrli:context id="i53405b48f5954e23b556c40be1389d0c_I20220630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001651944</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:CounterpartyNameAxis">dmtk:KilroyRealtyLPMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-06-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:unit id="period"><xbrli:measure>dmtk:period</xbrli:measure></xbrli:unit><xbrli:context id="i75aabbdde1174af48e324feb000a8af2_I20220331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001651944</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:CounterpartyNameAxis">dmtk:KilroyRealtyLPMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i9841b134190d454987c9c0ed787bc2e8_D20220401-20220430"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001651944</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="dmtk:LeaseAmendmentsAxis">dmtk:FirstAmendmentMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:CounterpartyNameAxis">dmtk:KilroyRealtyLPMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-04-01</xbrli:startDate><xbrli:endDate>2022-04-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i87140271b1e742e28e8d60cec9e90bf4_I20220430"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001651944</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="dmtk:LeaseAmendmentsAxis">dmtk:FirstAmendmentMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:CounterpartyNameAxis">dmtk:KilroyRealtyLPMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-04-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="if757ed00e77b443b929b902040ede6fe_D20220422-20220422"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001651944</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:CounterpartyNameAxis">dmtk:KilroyRealtyLPMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="dmtk:LeaseAmendmentsAxis">dmtk:SecondAmendmentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-04-22</xbrli:startDate><xbrli:endDate>2022-04-22</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i21d961efb50e46f8a491229d676e3cca_I20220430"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001651944</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:CounterpartyNameAxis">dmtk:KilroyRealtyLPMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="dmtk:LeaseAmendmentsAxis">dmtk:SecondAmendmentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-04-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i31c7d90c2ed74429be6d97f4216d8b3b_D20220422-20220422"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001651944</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:CounterpartyNameAxis">dmtk:KilroyRealtyLPMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-04-22</xbrli:startDate><xbrli:endDate>2022-04-22</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i40b956e3abae4c74a57f8271e4e2cc81_I20220430"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001651944</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:CounterpartyNameAxis">dmtk:KilroyRealtyLPMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-04-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="iefc8a51c0ee64a2e92b3f718d0d8914b_D20220401-20220430"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001651944</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:CounterpartyNameAxis">dmtk:KilroyRealtyLPMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-04-01</xbrli:startDate><xbrli:endDate>2022-04-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i2d28646a716649a3bf03b33932b88ddc_I20220630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001651944</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:CounterpartyNameAxis">dmtk:KilroyRealtyLPMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:RestrictedCashAndCashEquivalentsCashAndCashEquivalentsAxis">us-gaap:DemandDepositsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:CreditFacilityAxis">us-gaap:LetterOfCreditMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-06-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i5c5f906de07546fbad68db3bc16af2da_D20220401-20220430"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001651944</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:CounterpartyNameAxis">dmtk:KilroyRealtyLPMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:RestrictedCashAndCashEquivalentsCashAndCashEquivalentsAxis">us-gaap:DemandDepositsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:CreditFacilityAxis">us-gaap:LetterOfCreditMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-04-01</xbrli:startDate><xbrli:endDate>2022-04-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ie106f93322ee42508b7a8c0522c1e6f8_I20220430"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001651944</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:CounterpartyNameAxis">dmtk:KilroyRealtyLPMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:RestrictedCashAndCashEquivalentsCashAndCashEquivalentsAxis">us-gaap:DemandDepositsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:CreditFacilityAxis">us-gaap:LetterOfCreditMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-04-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ie247503b8ef34dcca0fca78fe783bff5_I20220630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001651944</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:CounterpartyNameAxis">dmtk:KilroyRealtyLPMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:RestrictedCashAndCashEquivalentsCashAndCashEquivalentsAxis">us-gaap:DemandDepositsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:CreditFacilityAxis">us-gaap:StandbyLettersOfCreditMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-06-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i4976bcc83f7e4c978a094cc7482066ef_I20210101"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001651944</xbrli:identifier></xbrli:entity><xbrli:period><xbrli:instant>2021-01-01</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i4d87d8619b7b49828e0354d3459d6bc4_D20220401-20220630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001651944</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionAxis">dmtk:EVERSANALifeScienceServicesLLCMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionsByRelatedPartyAxis">dmtk:SpouseOfChiefCommercialOfficerMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-04-01</xbrli:startDate><xbrli:endDate>2022-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="iebe17418c5534164a125df7ed43c5ece_D20210401-20210630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001651944</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionAxis">dmtk:EVERSANALifeScienceServicesLLCMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionsByRelatedPartyAxis">dmtk:SpouseOfChiefCommercialOfficerMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-04-01</xbrli:startDate><xbrli:endDate>2021-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i0e1b8915a8614ad387c31cb5b81538f7_D20220101-20220630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001651944</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionAxis">dmtk:EVERSANALifeScienceServicesLLCMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionsByRelatedPartyAxis">dmtk:SpouseOfChiefCommercialOfficerMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i681d541e73e1469a92851dbf2e1a96d4_D20210101-20210630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001651944</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionAxis">dmtk:EVERSANALifeScienceServicesLLCMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionsByRelatedPartyAxis">dmtk:SpouseOfChiefCommercialOfficerMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ia139293fe3d744eea1b17b968bfcf5ad_D20191001-20191001"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001651944</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:RangeAxis">srt:MaximumMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionsByRelatedPartyAxis">dmtk:BrotherOfChiefExecutiveOfficerMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionAxis">dmtk:DermTechOperationsIncMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-10-01</xbrli:startDate><xbrli:endDate>2019-10-01</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="id5e6d28f8a04434285646197def78617_D20200511-20200511"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001651944</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionsByRelatedPartyAxis">dmtk:BrotherOfChiefExecutiveOfficerMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionAxis">dmtk:DermTechOperationsIncMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-05-11</xbrli:startDate><xbrli:endDate>2020-05-11</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i651d86ca5e54467a910cc1cdb8f31f8d_I20210102"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001651944</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionsByRelatedPartyAxis">dmtk:BrotherOfChiefExecutiveOfficerMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionAxis">dmtk:DermTechOperationsIncMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-01-02</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="iee689bdd0154474d9e8d1bbbcec743b6_D20201111-20201111"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001651944</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionsByRelatedPartyAxis">dmtk:BrotherOfChiefExecutiveOfficerMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionAxis">dmtk:DermTechOperationsIncMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-11-11</xbrli:startDate><xbrli:endDate>2020-11-11</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ib0f91fba366d40acba994eb5d6addb9c_D20210226-20210226"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001651944</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionsByRelatedPartyAxis">dmtk:BrotherOfChiefExecutiveOfficerMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionAxis">dmtk:DermTechOperationsIncMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-02-26</xbrli:startDate><xbrli:endDate>2021-02-26</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i945b8bc570ef4af69046201719baea0d_D20220401-20220630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001651944</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionsByRelatedPartyAxis">dmtk:BrotherOfChiefExecutiveOfficerMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionAxis">dmtk:DermTechOperationsIncMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-04-01</xbrli:startDate><xbrli:endDate>2022-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="idfbaf207ccb145e0804dfb68b580e154_D20210401-20210630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001651944</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionsByRelatedPartyAxis">dmtk:BrotherOfChiefExecutiveOfficerMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionAxis">dmtk:DermTechOperationsIncMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-04-01</xbrli:startDate><xbrli:endDate>2021-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i0d7a163c3890488dae0c374a84f12aa0_D20220101-20220630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001651944</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionsByRelatedPartyAxis">dmtk:BrotherOfChiefExecutiveOfficerMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionAxis">dmtk:DermTechOperationsIncMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i690d64dd56474cd880eacb6ae348633b_D20210101-20210630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001651944</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionsByRelatedPartyAxis">dmtk:BrotherOfChiefExecutiveOfficerMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionAxis">dmtk:DermTechOperationsIncMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-06-30</xbrli:endDate></xbrli:period></xbrli:context></ix:resources></ix:header></div><div id="iae5a9be0eb9445d192fae822d22be09f_1"></div><div style="min-height:45pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#iae5a9be0eb9445d192fae822d22be09f_7">Table of Contents</a></span></div></div><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:98.900%"></td><td style="width:0.1%"></td></tr><tr style="height:3pt"><td colspan="3" style="border-bottom:3pt double #000;padding:0 1pt"></td></tr></table></div><div style="margin-top:4pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:18pt;font-weight:700;line-height:120%">UNITED STATES</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:18pt;font-weight:700;line-height:120%">SECURITIES AND EXCHANGE COMMISSION</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%">WASHINGTON, DC 20549</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%">________________________</span></div><div style="margin-top:4pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:18pt;font-weight:700;line-height:120%">FORM <ix:nonNumeric contextRef="ia855382ada1f4f28aa8ef6da692ff177_D20220101-20220630" name="dei:DocumentType" id="id3VybDovL2RvY3MudjEvZG9jOmFlNWE5YmUwZWI5NDQ1ZDE5MmZhZTgyMmQyMmJlMDlmL3NlYzphZTVhOWJlMGViOTQ0NWQxOTJmYWU4MjJkMjJiZTA5Zl8xL2ZyYWc6MTEwYjcyOWI5NDIwNDk4OGIyZDUxYzJhZTFlYzRlNjIvdGV4dHJlZ2lvbjoxMTBiNzI5Yjk0MjA0OTg4YjJkNTFjMmFlMWVjNGU2Ml8yMDc0_a02491b7-39ce-4593-99ec-f39893d1a370">10-Q</ix:nonNumeric></span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%">________________________</span></div><div style="margin-top:4pt;padding-left:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%">Mark One)</span></div><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:2.384%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:95.416%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Wingdings',sans-serif;font-size:10pt;font-weight:700;line-height:114%"><ix:nonNumeric contextRef="ia855382ada1f4f28aa8ef6da692ff177_D20220101-20220630" name="dei:DocumentQuarterlyReport" format="ixt:fixed-true" id="id3VybDovL2RvY3MudjEvZG9jOmFlNWE5YmUwZWI5NDQ1ZDE5MmZhZTgyMmQyMmJlMDlmL3NlYzphZTVhOWJlMGViOTQ0NWQxOTJmYWU4MjJkMjJiZTA5Zl8xL2ZyYWc6MTEwYjcyOWI5NDIwNDk4OGIyZDUxYzJhZTFlYzRlNjIvdGFibGU6MTc4ODU5ZDFkMDVlNGIwOGE3ZTFjMDZkYjk0ZmY4MmIvdGFibGVyYW5nZToxNzg4NTlkMWQwNWU0YjA4YTdlMWMwNmRiOTRmZjgyYl8wLTAtMS0xLTYyNg_4b9de10f-c8aa-4a99-af44-b47d444ff57d">x</ix:nonNumeric></span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934</span></td></tr></table></div><div style="margin-top:4pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">For the quarterly period ended <ix:nonNumeric contextRef="ia855382ada1f4f28aa8ef6da692ff177_D20220101-20220630" name="dei:DocumentPeriodEndDate" format="ixt:date-monthname-day-year-en" id="id3VybDovL2RvY3MudjEvZG9jOmFlNWE5YmUwZWI5NDQ1ZDE5MmZhZTgyMmQyMmJlMDlmL3NlYzphZTVhOWJlMGViOTQ0NWQxOTJmYWU4MjJkMjJiZTA5Zl8xL2ZyYWc6MTEwYjcyOWI5NDIwNDk4OGIyZDUxYzJhZTFlYzRlNjIvdGV4dHJlZ2lvbjoxMTBiNzI5Yjk0MjA0OTg4YjJkNTFjMmFlMWVjNGU2Ml8xODA_8815485c-4214-4eb6-8fca-4f3bdf163866">June 30, 2022</ix:nonNumeric></span></div><div style="margin-top:4pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">OR</span></div><div style="margin-top:4pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:2.384%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:95.416%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Wingdings',sans-serif;font-size:10pt;font-weight:700;line-height:114%"><ix:nonNumeric contextRef="ia855382ada1f4f28aa8ef6da692ff177_D20220101-20220630" name="dei:DocumentTransitionReport" format="ixt:fixed-false" id="id3VybDovL2RvY3MudjEvZG9jOmFlNWE5YmUwZWI5NDQ1ZDE5MmZhZTgyMmQyMmJlMDlmL3NlYzphZTVhOWJlMGViOTQ0NWQxOTJmYWU4MjJkMjJiZTA5Zl8xL2ZyYWc6MTEwYjcyOWI5NDIwNDk4OGIyZDUxYzJhZTFlYzRlNjIvdGFibGU6NGEzNmZkNTZhMDM2NDI2ZWJlNzRlZmNhM2VhMDcxOGYvdGFibGVyYW5nZTo0YTM2ZmQ1NmEwMzY0MjZlYmU3NGVmY2EzZWEwNzE4Zl8wLTAtMS0xLTYyNg_bd7f6fd4-16e1-4c1a-90f7-2158598be3a3">o</ix:nonNumeric></span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934</span></td></tr></table></div><div style="margin-top:4pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">For the transition period from&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;to&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;</span></div><div style="margin-top:4pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Commission File Number: <ix:nonNumeric contextRef="ia855382ada1f4f28aa8ef6da692ff177_D20220101-20220630" name="dei:EntityFileNumber" id="id3VybDovL2RvY3MudjEvZG9jOmFlNWE5YmUwZWI5NDQ1ZDE5MmZhZTgyMmQyMmJlMDlmL3NlYzphZTVhOWJlMGViOTQ0NWQxOTJmYWU4MjJkMjJiZTA5Zl8xL2ZyYWc6MTEwYjcyOWI5NDIwNDk4OGIyZDUxYzJhZTFlYzRlNjIvdGV4dHJlZ2lvbjoxMTBiNzI5Yjk0MjA0OTg4YjJkNTFjMmFlMWVjNGU2Ml8yMDc1_3b33700f-c0d3-49cf-994a-de9df63e23e4">001-38118</ix:nonNumeric></span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%">________________________</span></div><div style="margin-top:4pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:24pt;font-weight:700;line-height:120%"><ix:nonNumeric contextRef="ia855382ada1f4f28aa8ef6da692ff177_D20220101-20220630" name="dei:EntityRegistrantName" id="id3VybDovL2RvY3MudjEvZG9jOmFlNWE5YmUwZWI5NDQ1ZDE5MmZhZTgyMmQyMmJlMDlmL3NlYzphZTVhOWJlMGViOTQ0NWQxOTJmYWU4MjJkMjJiZTA5Zl8xL2ZyYWc6MTEwYjcyOWI5NDIwNDk4OGIyZDUxYzJhZTFlYzRlNjIvdGV4dHJlZ2lvbjoxMTBiNzI5Yjk0MjA0OTg4YjJkNTFjMmFlMWVjNGU2Ml8yMDY4_66843833-b862-4f02-b4a5-dfe6b68b67e0">DERMTECH, INC.</ix:nonNumeric></span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">(Exact Name of Registrant as Specified in its Charter)</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%">________________________</span></div><div style="margin-top:4pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:48.900%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:48.900%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:114%"><ix:nonNumeric contextRef="ia855382ada1f4f28aa8ef6da692ff177_D20220101-20220630" name="dei:EntityIncorporationStateCountryCode" format="ixt-sec:stateprovnameen" id="id3VybDovL2RvY3MudjEvZG9jOmFlNWE5YmUwZWI5NDQ1ZDE5MmZhZTgyMmQyMmJlMDlmL3NlYzphZTVhOWJlMGViOTQ0NWQxOTJmYWU4MjJkMjJiZTA5Zl8xL2ZyYWc6MTEwYjcyOWI5NDIwNDk4OGIyZDUxYzJhZTFlYzRlNjIvdGFibGU6YTYxZDg4ZmExMjExNDUwZmE5OTE3N2Y5YjNmYThjNGEvdGFibGVyYW5nZTphNjFkODhmYTEyMTE0NTBmYTk5MTc3ZjliM2ZhOGM0YV8wLTAtMS0xLTYyNg_19864843-c034-4329-a5eb-e871da78f2df">Delaware</ix:nonNumeric></span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:114%"><ix:nonNumeric contextRef="ia855382ada1f4f28aa8ef6da692ff177_D20220101-20220630" name="dei:EntityTaxIdentificationNumber" id="id3VybDovL2RvY3MudjEvZG9jOmFlNWE5YmUwZWI5NDQ1ZDE5MmZhZTgyMmQyMmJlMDlmL3NlYzphZTVhOWJlMGViOTQ0NWQxOTJmYWU4MjJkMjJiZTA5Zl8xL2ZyYWc6MTEwYjcyOWI5NDIwNDk4OGIyZDUxYzJhZTFlYzRlNjIvdGFibGU6YTYxZDg4ZmExMjExNDUwZmE5OTE3N2Y5YjNmYThjNGEvdGFibGVyYW5nZTphNjFkODhmYTEyMTE0NTBmYTk5MTc3ZjliM2ZhOGM0YV8wLTEtMS0xLTYyNg_e0da9391-bbf8-49b4-bec6-ca82ba470c05">84-2870849</ix:nonNumeric></span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:120%">(State or other jurisdiction of<br/>incorporation or organization)</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:120%">(I.R.S. Employer<br/>Identification No.)</span></td></tr><tr style="height:8pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="margin-top:10pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"><ix:nonNumeric contextRef="ia855382ada1f4f28aa8ef6da692ff177_D20220101-20220630" name="dei:EntityAddressAddressLine1" id="id3VybDovL2RvY3MudjEvZG9jOmFlNWE5YmUwZWI5NDQ1ZDE5MmZhZTgyMmQyMmJlMDlmL3NlYzphZTVhOWJlMGViOTQ0NWQxOTJmYWU4MjJkMjJiZTA5Zl8xL2ZyYWc6MTEwYjcyOWI5NDIwNDk4OGIyZDUxYzJhZTFlYzRlNjIvdGFibGU6YTYxZDg4ZmExMjExNDUwZmE5OTE3N2Y5YjNmYThjNGEvdGFibGVyYW5nZTphNjFkODhmYTEyMTE0NTBmYTk5MTc3ZjliM2ZhOGM0YV8zLTAtMS0xLTYyNi90ZXh0cmVnaW9uOjkzZDgwZDE5NzFlZDRmNDFiMzgzODJkMDlkNTA1NjM2XzU_94bdcd6f-3c47-4637-a870-ba9a1313a426">11099 N. Torrey Pines Road</ix:nonNumeric>, <ix:nonNumeric contextRef="ia855382ada1f4f28aa8ef6da692ff177_D20220101-20220630" name="dei:EntityAddressAddressLine2" id="id3VybDovL2RvY3MudjEvZG9jOmFlNWE5YmUwZWI5NDQ1ZDE5MmZhZTgyMmQyMmJlMDlmL3NlYzphZTVhOWJlMGViOTQ0NWQxOTJmYWU4MjJkMjJiZTA5Zl8xL2ZyYWc6MTEwYjcyOWI5NDIwNDk4OGIyZDUxYzJhZTFlYzRlNjIvdGFibGU6YTYxZDg4ZmExMjExNDUwZmE5OTE3N2Y5YjNmYThjNGEvdGFibGVyYW5nZTphNjFkODhmYTEyMTE0NTBmYTk5MTc3ZjliM2ZhOGM0YV8zLTAtMS0xLTYyNi90ZXh0cmVnaW9uOjkzZDgwZDE5NzFlZDRmNDFiMzgzODJkMDlkNTA1NjM2Xzk_22db0309-5cd3-4d32-825d-e629540113f7">Suite 100</ix:nonNumeric></span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"><ix:nonNumeric contextRef="ia855382ada1f4f28aa8ef6da692ff177_D20220101-20220630" name="dei:EntityAddressCityOrTown" id="id3VybDovL2RvY3MudjEvZG9jOmFlNWE5YmUwZWI5NDQ1ZDE5MmZhZTgyMmQyMmJlMDlmL3NlYzphZTVhOWJlMGViOTQ0NWQxOTJmYWU4MjJkMjJiZTA5Zl8xL2ZyYWc6MTEwYjcyOWI5NDIwNDk4OGIyZDUxYzJhZTFlYzRlNjIvdGFibGU6YTYxZDg4ZmExMjExNDUwZmE5OTE3N2Y5YjNmYThjNGEvdGFibGVyYW5nZTphNjFkODhmYTEyMTE0NTBmYTk5MTc3ZjliM2ZhOGM0YV8zLTAtMS0xLTYyNi90ZXh0cmVnaW9uOjkzZDgwZDE5NzFlZDRmNDFiMzgzODJkMDlkNTA1NjM2XzEy_e1ea5c6a-3719-435b-ae0c-dad9e1dbce96">La Jolla</ix:nonNumeric>, <ix:nonNumeric contextRef="ia855382ada1f4f28aa8ef6da692ff177_D20220101-20220630" name="dei:EntityAddressStateOrProvince" id="id3VybDovL2RvY3MudjEvZG9jOmFlNWE5YmUwZWI5NDQ1ZDE5MmZhZTgyMmQyMmJlMDlmL3NlYzphZTVhOWJlMGViOTQ0NWQxOTJmYWU4MjJkMjJiZTA5Zl8xL2ZyYWc6MTEwYjcyOWI5NDIwNDk4OGIyZDUxYzJhZTFlYzRlNjIvdGFibGU6YTYxZDg4ZmExMjExNDUwZmE5OTE3N2Y5YjNmYThjNGEvdGFibGVyYW5nZTphNjFkODhmYTEyMTE0NTBmYTk5MTc3ZjliM2ZhOGM0YV8zLTAtMS0xLTYyNi90ZXh0cmVnaW9uOjkzZDgwZDE5NzFlZDRmNDFiMzgzODJkMDlkNTA1NjM2XzE2_5239fb48-2e3d-43e7-a70f-4f1170e81d06">CA</ix:nonNumeric></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"><ix:nonNumeric contextRef="ia855382ada1f4f28aa8ef6da692ff177_D20220101-20220630" name="dei:EntityAddressPostalZipCode" id="id3VybDovL2RvY3MudjEvZG9jOmFlNWE5YmUwZWI5NDQ1ZDE5MmZhZTgyMmQyMmJlMDlmL3NlYzphZTVhOWJlMGViOTQ0NWQxOTJmYWU4MjJkMjJiZTA5Zl8xL2ZyYWc6MTEwYjcyOWI5NDIwNDk4OGIyZDUxYzJhZTFlYzRlNjIvdGFibGU6YTYxZDg4ZmExMjExNDUwZmE5OTE3N2Y5YjNmYThjNGEvdGFibGVyYW5nZTphNjFkODhmYTEyMTE0NTBmYTk5MTc3ZjliM2ZhOGM0YV8zLTEtMS0xLTYyNg_5a67e34e-3943-4502-b3b4-eb68170f3a0d">92037</ix:nonNumeric></span></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:120%">(Address of principal executive offices)</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:120%">(Zip Code)</span></td></tr></table></div><div style="margin-top:4pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Registrant&#8217;s telephone number, including area code: </span><span style="color:#231f20;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:120%">(<ix:nonNumeric contextRef="ia855382ada1f4f28aa8ef6da692ff177_D20220101-20220630" name="dei:CityAreaCode" id="id3VybDovL2RvY3MudjEvZG9jOmFlNWE5YmUwZWI5NDQ1ZDE5MmZhZTgyMmQyMmJlMDlmL3NlYzphZTVhOWJlMGViOTQ0NWQxOTJmYWU4MjJkMjJiZTA5Zl8xL2ZyYWc6MTEwYjcyOWI5NDIwNDk4OGIyZDUxYzJhZTFlYzRlNjIvdGV4dHJlZ2lvbjoxMTBiNzI5Yjk0MjA0OTg4YjJkNTFjMmFlMWVjNGU2Ml8yMDY5_ee497845-fc49-441e-beb8-23e14d5ce94b">858</ix:nonNumeric>) <ix:nonNumeric contextRef="ia855382ada1f4f28aa8ef6da692ff177_D20220101-20220630" name="dei:LocalPhoneNumber" id="id3VybDovL2RvY3MudjEvZG9jOmFlNWE5YmUwZWI5NDQ1ZDE5MmZhZTgyMmQyMmJlMDlmL3NlYzphZTVhOWJlMGViOTQ0NWQxOTJmYWU4MjJkMjJiZTA5Zl8xL2ZyYWc6MTEwYjcyOWI5NDIwNDk4OGIyZDUxYzJhZTFlYzRlNjIvdGV4dHJlZ2lvbjoxMTBiNzI5Yjk0MjA0OTg4YjJkNTFjMmFlMWVjNGU2Ml8yMDcw_1be21261-9b3c-4a84-b475-2d04393aed1f">450-4222</ix:nonNumeric></span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%">________________________</span></div><div style="margin-top:4pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Securities registered pursuant to Section 12(b) of the Act:</span></div><div style="margin-top:4pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:38.293%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:20.112%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:38.295%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%">Title of each class</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%">Trading<br/>Symbol(s)</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%">Name of each exchange on which registered</span></td></tr><tr><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"><ix:nonNumeric contextRef="ia855382ada1f4f28aa8ef6da692ff177_D20220101-20220630" name="dei:Security12bTitle" id="id3VybDovL2RvY3MudjEvZG9jOmFlNWE5YmUwZWI5NDQ1ZDE5MmZhZTgyMmQyMmJlMDlmL3NlYzphZTVhOWJlMGViOTQ0NWQxOTJmYWU4MjJkMjJiZTA5Zl8xL2ZyYWc6MTEwYjcyOWI5NDIwNDk4OGIyZDUxYzJhZTFlYzRlNjIvdGFibGU6Yjc2NGU0OTJjODM2NDhiY2I1ODA3YjFkNmFlMGNiNmEvdGFibGVyYW5nZTpiNzY0ZTQ5MmM4MzY0OGJjYjU4MDdiMWQ2YWUwY2I2YV8xLTAtMS0xLTYyNg_ae603770-cf29-4e68-95dd-090e070deb50">Common Stock, par value $0.0001 per share</ix:nonNumeric></span></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"><ix:nonNumeric contextRef="ia855382ada1f4f28aa8ef6da692ff177_D20220101-20220630" name="dei:TradingSymbol" id="id3VybDovL2RvY3MudjEvZG9jOmFlNWE5YmUwZWI5NDQ1ZDE5MmZhZTgyMmQyMmJlMDlmL3NlYzphZTVhOWJlMGViOTQ0NWQxOTJmYWU4MjJkMjJiZTA5Zl8xL2ZyYWc6MTEwYjcyOWI5NDIwNDk4OGIyZDUxYzJhZTFlYzRlNjIvdGFibGU6Yjc2NGU0OTJjODM2NDhiY2I1ODA3YjFkNmFlMGNiNmEvdGFibGVyYW5nZTpiNzY0ZTQ5MmM4MzY0OGJjYjU4MDdiMWQ2YWUwY2I2YV8xLTEtMS0xLTYyNg_dec0d27d-60f1-4d6a-9a1a-28d93152fa52">DMTK</ix:nonNumeric></span></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">The <ix:nonNumeric contextRef="ia855382ada1f4f28aa8ef6da692ff177_D20220101-20220630" name="dei:SecurityExchangeName" format="ixt-sec:exchnameen" id="id3VybDovL2RvY3MudjEvZG9jOmFlNWE5YmUwZWI5NDQ1ZDE5MmZhZTgyMmQyMmJlMDlmL3NlYzphZTVhOWJlMGViOTQ0NWQxOTJmYWU4MjJkMjJiZTA5Zl8xL2ZyYWc6MTEwYjcyOWI5NDIwNDk4OGIyZDUxYzJhZTFlYzRlNjIvdGFibGU6Yjc2NGU0OTJjODM2NDhiY2I1ODA3YjFkNmFlMGNiNmEvdGFibGVyYW5nZTpiNzY0ZTQ5MmM4MzY0OGJjYjU4MDdiMWQ2YWUwY2I2YV8xLTItMS0xLTYyNi90ZXh0cmVnaW9uOjVmMGU5YWRiYzZjZjRlZGQ5YzI3NjdlZDEzNmJhYjVkXzg_bf1023b4-d69c-45f1-92bd-49443502ebb4">Nasdaq</ix:nonNumeric> Capital Market</span></div></td></tr></table></div><div style="margin-top:4pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Indicate by check mark whether the registrant (1) has filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that the registrant was required to file such reports), and (2) has been subject to such filing requirements for the past 90 days   <ix:nonNumeric contextRef="ia855382ada1f4f28aa8ef6da692ff177_D20220101-20220630" name="dei:EntityCurrentReportingStatus" id="id3VybDovL2RvY3MudjEvZG9jOmFlNWE5YmUwZWI5NDQ1ZDE5MmZhZTgyMmQyMmJlMDlmL3NlYzphZTVhOWJlMGViOTQ0NWQxOTJmYWU4MjJkMjJiZTA5Zl8xL2ZyYWc6MTEwYjcyOWI5NDIwNDk4OGIyZDUxYzJhZTFlYzRlNjIvdGV4dHJlZ2lvbjoxMTBiNzI5Yjk0MjA0OTg4YjJkNTFjMmFlMWVjNGU2Ml8yMDc4_75b19a18-72c9-4803-878a-10f48cafd5fa">Yes</ix:nonNumeric> </span><span style="color:#000000;font-family:'Wingdings',sans-serif;font-size:9pt;font-weight:400;line-height:120%">x</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%"> </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"> No </span><span style="color:#000000;font-family:'Wingdings',sans-serif;font-size:9pt;font-weight:400;line-height:120%">o</span></div><div style="margin-top:4pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Indicate by check mark whether the registrant has submitted electronically every Interactive Data File required to be submitted pursuant to Rule 405 of Regulation S-T (&#167;232.405 of this chapter) during the preceding 12 months (or for such shorter period that the registrant was required to submit such files).   <ix:nonNumeric contextRef="ia855382ada1f4f28aa8ef6da692ff177_D20220101-20220630" name="dei:EntityInteractiveDataCurrent" id="id3VybDovL2RvY3MudjEvZG9jOmFlNWE5YmUwZWI5NDQ1ZDE5MmZhZTgyMmQyMmJlMDlmL3NlYzphZTVhOWJlMGViOTQ0NWQxOTJmYWU4MjJkMjJiZTA5Zl8xL2ZyYWc6MTEwYjcyOWI5NDIwNDk4OGIyZDUxYzJhZTFlYzRlNjIvdGV4dHJlZ2lvbjoxMTBiNzI5Yjk0MjA0OTg4YjJkNTFjMmFlMWVjNGU2Ml8yMDcx_5b61d521-98ef-4383-8abf-109523284e81">Yes</ix:nonNumeric> </span><span style="color:#000000;font-family:'Wingdings',sans-serif;font-size:9pt;font-weight:400;line-height:120%">x</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%"> </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"> No </span><span style="color:#000000;font-family:'Wingdings',sans-serif;font-size:9pt;font-weight:400;line-height:120%">o</span></div><div style="margin-top:4pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Indicate by check mark whether the registrant is a large accelerated filer, an accelerated filer, a non-accelerated filer, smaller reporting company, or an emerging growth company. See the definitions of &#8220;large accelerated filer,&#8221; &#8220;accelerated filer,&#8221; &#8220;smaller reporting company,&#8221; and &#8220;emerging growth company&#8221; in Rule 12b-2 of the Exchange Act.</span></div><div style="margin-top:4pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:30.112%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:1.930%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:30.415%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:30.112%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:1.931%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonNumeric contextRef="ia855382ada1f4f28aa8ef6da692ff177_D20220101-20220630" name="dei:EntityFilerCategory" format="ixt-sec:entityfilercategoryen" id="id3VybDovL2RvY3MudjEvZG9jOmFlNWE5YmUwZWI5NDQ1ZDE5MmZhZTgyMmQyMmJlMDlmL3NlYzphZTVhOWJlMGViOTQ0NWQxOTJmYWU4MjJkMjJiZTA5Zl8xL2ZyYWc6MTEwYjcyOWI5NDIwNDk4OGIyZDUxYzJhZTFlYzRlNjIvdGFibGU6NGNlNzg5MjU0Mzg1NDFhOGEyZjAxYjkyZTQ0YWIwODkvdGFibGVyYW5nZTo0Y2U3ODkyNTQzODU0MWE4YTJmMDFiOTJlNDRhYjA4OV8wLTAtMS0xLTYzOTM_86d48a4f-2505-4f4b-8b52-1cb9fa12dc44">Large accelerated filer</ix:nonNumeric></span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Wingdings',sans-serif;font-size:9pt;font-weight:400;line-height:100%">x</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Accelerated filer</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Wingdings',sans-serif;font-size:9pt;font-weight:400;line-height:100%">o</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Non-accelerated filer</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Wingdings',sans-serif;font-size:9pt;font-weight:400;line-height:100%">o</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Smaller reporting company</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Wingdings',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonNumeric contextRef="ia855382ada1f4f28aa8ef6da692ff177_D20220101-20220630" name="dei:EntitySmallBusiness" format="ixt:fixed-true" id="id3VybDovL2RvY3MudjEvZG9jOmFlNWE5YmUwZWI5NDQ1ZDE5MmZhZTgyMmQyMmJlMDlmL3NlYzphZTVhOWJlMGViOTQ0NWQxOTJmYWU4MjJkMjJiZTA5Zl8xL2ZyYWc6MTEwYjcyOWI5NDIwNDk4OGIyZDUxYzJhZTFlYzRlNjIvdGFibGU6NGNlNzg5MjU0Mzg1NDFhOGEyZjAxYjkyZTQ0YWIwODkvdGFibGVyYW5nZTo0Y2U3ODkyNTQzODU0MWE4YTJmMDFiOTJlNDRhYjA4OV8xLTQtMS0xLTYyNg_70f978f2-9417-4e78-a57e-80b419fca3d5">x</ix:nonNumeric></span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Emerging growth company</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Wingdings',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonNumeric contextRef="ia855382ada1f4f28aa8ef6da692ff177_D20220101-20220630" name="dei:EntityEmergingGrowthCompany" format="ixt:fixed-false" id="id3VybDovL2RvY3MudjEvZG9jOmFlNWE5YmUwZWI5NDQ1ZDE5MmZhZTgyMmQyMmJlMDlmL3NlYzphZTVhOWJlMGViOTQ0NWQxOTJmYWU4MjJkMjJiZTA5Zl8xL2ZyYWc6MTEwYjcyOWI5NDIwNDk4OGIyZDUxYzJhZTFlYzRlNjIvdGFibGU6NGNlNzg5MjU0Mzg1NDFhOGEyZjAxYjkyZTQ0YWIwODkvdGFibGVyYW5nZTo0Y2U3ODkyNTQzODU0MWE4YTJmMDFiOTJlNDRhYjA4OV8yLTEtMS0xLTYyNg_03158dd6-d5f3-4f58-946f-952b46a68910">o</ix:nonNumeric></span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr></table></div><div style="margin-top:4pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. </span><span style="color:#000000;font-family:'Wingdings',sans-serif;font-size:9pt;font-weight:400;line-height:120%">o</span></div><div style="margin-top:4pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Indicate by check mark whether the registrant is a shell company (as defined in Rule 12b-2 of the Exchange Act). Yes </span><span style="color:#000000;font-family:'Wingdings',sans-serif;font-size:9pt;font-weight:400;line-height:120%"><ix:nonNumeric contextRef="ia855382ada1f4f28aa8ef6da692ff177_D20220101-20220630" name="dei:EntityShellCompany" format="ixt:fixed-false" id="id3VybDovL2RvY3MudjEvZG9jOmFlNWE5YmUwZWI5NDQ1ZDE5MmZhZTgyMmQyMmJlMDlmL3NlYzphZTVhOWJlMGViOTQ0NWQxOTJmYWU4MjJkMjJiZTA5Zl8xL2ZyYWc6MTEwYjcyOWI5NDIwNDk4OGIyZDUxYzJhZTFlYzRlNjIvdGV4dHJlZ2lvbjoxMTBiNzI5Yjk0MjA0OTg4YjJkNTFjMmFlMWVjNGU2Ml8yMDcy_b5707ac4-7202-41e2-8a5e-c915e866cd62">o</ix:nonNumeric></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"> No </span><span style="color:#000000;font-family:'Wingdings',sans-serif;font-size:9pt;font-weight:400;line-height:120%">x</span></div><div style="margin-top:4pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">As of August&#160;5, 2022, the registrant had <ix:nonFraction unitRef="shares" contextRef="i0bb8b8c526d842f2a0e174c1375916cd_I20220805" decimals="INF" name="dei:EntityCommonStockSharesOutstanding" format="ixt:num-dot-decimal" id="id3VybDovL2RvY3MudjEvZG9jOmFlNWE5YmUwZWI5NDQ1ZDE5MmZhZTgyMmQyMmJlMDlmL3NlYzphZTVhOWJlMGViOTQ0NWQxOTJmYWU4MjJkMjJiZTA5Zl8xL2ZyYWc6MTEwYjcyOWI5NDIwNDk4OGIyZDUxYzJhZTFlYzRlNjIvdGV4dHJlZ2lvbjoxMTBiNzI5Yjk0MjA0OTg4YjJkNTFjMmFlMWVjNGU2Ml8yMDcz_bff59164-1be3-4748-bd79-246aad88bab9">30,039,946</ix:nonFraction> shares of common stock, $0.0001 par value per share, outstanding.</span></div><div style="margin-top:4pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:98.900%"></td><td style="width:0.1%"></td></tr><tr style="height:3pt"><td colspan="3" style="border-bottom:3pt double #000;padding:0 1pt"></td></tr></table></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="margin-top:12pt;text-align:center"><span><br/></span></div></div></div><div id="iae5a9be0eb9445d192fae822d22be09f_7"></div><hr style="page-break-after:always"/><div style="min-height:45pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#iae5a9be0eb9445d192fae822d22be09f_7">Table of Contents</a></span></div></div><div style="margin-top:12pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Table of Contents</span></div><div style="margin-top:12pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:9.051%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:80.718%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:6.931%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Page</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><a style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%;text-decoration:none" href="#iae5a9be0eb9445d192fae822d22be09f_10">PART I.</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#iae5a9be0eb9445d192fae822d22be09f_10">FINANCIAL INFORMATION</a></span></div></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><a style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:none" href="#iae5a9be0eb9445d192fae822d22be09f_10">1</a></span></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><a style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:none" href="#iae5a9be0eb9445d192fae822d22be09f_13">Item 1.</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#iae5a9be0eb9445d192fae822d22be09f_13">Financial Statements (Unaudited)</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><a style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:none" href="#iae5a9be0eb9445d192fae822d22be09f_13">1</a></span></div></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline">Condensed Consolidated Balance Sheets as of June 30, 2022 and December 31, 2021</span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><a style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:none" href="#iae5a9be0eb9445d192fae822d22be09f_16">1</a></span></div></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%;text-decoration:underline" href="#iae5a9be0eb9445d192fae822d22be09f_19">Condensed Consolidated Statements of Operations for the Three and Six Months Ended June 30, 2022 and 2021</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><a style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:none" href="#iae5a9be0eb9445d192fae822d22be09f_19">2</a></span></div></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#iae5a9be0eb9445d192fae822d22be09f_22">Condensed Consolidated Statements of Comprehensive Loss for the Three and Six Months Ended June 30, 2022 and 2021</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><a style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:none" href="#iae5a9be0eb9445d192fae822d22be09f_22">3</a></span></div></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#iae5a9be0eb9445d192fae822d22be09f_28">Condensed Consolidated Statements of Stockholders&#8217; Equity for the Three and Six Months Ended June 30, 2022</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><a style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:none" href="#iae5a9be0eb9445d192fae822d22be09f_28">4</a></span></div></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#iae5a9be0eb9445d192fae822d22be09f_28">Condensed Consolidated Statements of Stockholders&#8217; Equity for the Three and Six Months Ended June 30, 2021</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><a style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:none" href="#iae5a9be0eb9445d192fae822d22be09f_25">5</a></span></div></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#iae5a9be0eb9445d192fae822d22be09f_31">Condensed Consolidated Statements of Cash Flows for the Six </a><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#iae5a9be0eb9445d192fae822d22be09f_31">Months Ended June 30, 2022 and 2021</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><a style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:none" href="#iae5a9be0eb9445d192fae822d22be09f_31">6</a></span></div></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#iae5a9be0eb9445d192fae822d22be09f_34">Notes to Unaudited Condensed Consolidated Financial Statements</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><a style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:none" href="#iae5a9be0eb9445d192fae822d22be09f_34">7</a></span></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><a style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:none" href="#iae5a9be0eb9445d192fae822d22be09f_67">Item 2.</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#iae5a9be0eb9445d192fae822d22be09f_67">Management&#8217;s Discussion and Analysis of Financial Condition and Results of Operations</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><a style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:none" href="#iae5a9be0eb9445d192fae822d22be09f_67">25</a></span></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><a style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:none" href="#iae5a9be0eb9445d192fae822d22be09f_94">Item 3.</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#iae5a9be0eb9445d192fae822d22be09f_94">Quantitative and Qualitative Disclosures About Market Risk</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><a style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:none" href="#iae5a9be0eb9445d192fae822d22be09f_94">32</a></span></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><a style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:none" href="#iae5a9be0eb9445d192fae822d22be09f_97">Item 4.</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#iae5a9be0eb9445d192fae822d22be09f_97">Controls and Procedures</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><a style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:none" href="#iae5a9be0eb9445d192fae822d22be09f_97">33</a></span></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><a style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%;text-decoration:none" href="#iae5a9be0eb9445d192fae822d22be09f_100">PART II.</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#iae5a9be0eb9445d192fae822d22be09f_100">OTHER INFORMATION</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><a style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:none" href="#iae5a9be0eb9445d192fae822d22be09f_100">34</a></span></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><a style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:none" href="#iae5a9be0eb9445d192fae822d22be09f_103">Item 1.</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#iae5a9be0eb9445d192fae822d22be09f_103">Legal Proceedings</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><a style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:none" href="#iae5a9be0eb9445d192fae822d22be09f_103">34</a></span></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><a style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:none" href="#iae5a9be0eb9445d192fae822d22be09f_106">Item 1A.</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#iae5a9be0eb9445d192fae822d22be09f_106">Risk Factors</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><a style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:none" href="#iae5a9be0eb9445d192fae822d22be09f_106">34</a></span></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><a style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:none" href="#iae5a9be0eb9445d192fae822d22be09f_109">Item 2.</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#iae5a9be0eb9445d192fae822d22be09f_109">Unregistered Sales of Equity Securities and Use of Proceeds</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><a style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:none" href="#iae5a9be0eb9445d192fae822d22be09f_109">34</a></span></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><a style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:none" href="#iae5a9be0eb9445d192fae822d22be09f_428">Item 5.</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#iae5a9be0eb9445d192fae822d22be09f_428">Other </a><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#iae5a9be0eb9445d192fae822d22be09f_428">Information</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><a style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:none" href="#iae5a9be0eb9445d192fae822d22be09f_428">3</a><a style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:none" href="#iae5a9be0eb9445d192fae822d22be09f_428">3</a></span></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><a style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:none" href="#iae5a9be0eb9445d192fae822d22be09f_112">Item 6.</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#iae5a9be0eb9445d192fae822d22be09f_112">Exhibits</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><a style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:none" href="#iae5a9be0eb9445d192fae822d22be09f_112">35</a></span></div></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#iae5a9be0eb9445d192fae822d22be09f_115">Signatures</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><a style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:none" href="#iae5a9be0eb9445d192fae822d22be09f_115">36</a></span></div></td></tr></table></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="margin-top:12pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">i</span></div></div></div><div id="iae5a9be0eb9445d192fae822d22be09f_10"></div><hr style="page-break-after:always"/><div style="min-height:45pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#iae5a9be0eb9445d192fae822d22be09f_7">Table of Contents</a></span></div></div><div style="margin-top:18pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">PART I&#8212;FINANCIAL INFORMATION</span></div><div id="iae5a9be0eb9445d192fae822d22be09f_13"></div><div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Item 1. Financial Statements.</span></div><div id="iae5a9be0eb9445d192fae822d22be09f_16"></div><div style="margin-top:12pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">DERMTECH, INC.</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Condensed Consolidated Balance Sheets</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">(in thousands, except share and per share data)</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">(Unaudited)</span></div><div style="margin-top:12pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:71.930%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.081%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.406%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.083%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">June 30, 2022</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">December 31, 2021</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Assets</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Current assets:</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cash and cash equivalents</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i4c8f247d12134a9886d56e1c8b024425_I20220630" decimals="-3" name="us-gaap:CashAndCashEquivalentsAtCarryingValue" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmFlNWE5YmUwZWI5NDQ1ZDE5MmZhZTgyMmQyMmJlMDlmL3NlYzphZTVhOWJlMGViOTQ0NWQxOTJmYWU4MjJkMjJiZTA5Zl8xNi9mcmFnOmJjOWYxMWM1NjlkZjQyNzdhZDc1YjA3NzcyY2Q2NWQzL3RhYmxlOmNlMDdiOGQ2NDYwMDRjNDRhNDI1ZWY3YTgxZjQwMGI0L3RhYmxlcmFuZ2U6Y2UwN2I4ZDY0NjAwNGM0NGE0MjVlZjdhODFmNDAwYjRfMy0xLTEtMS02MjY_19c28462-1873-409f-b354-da27a44cedd4">120,333</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i87bf777ccf5f4f93bc9be7a2cbba61c1_I20211231" decimals="-3" name="us-gaap:CashAndCashEquivalentsAtCarryingValue" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmFlNWE5YmUwZWI5NDQ1ZDE5MmZhZTgyMmQyMmJlMDlmL3NlYzphZTVhOWJlMGViOTQ0NWQxOTJmYWU4MjJkMjJiZTA5Zl8xNi9mcmFnOmJjOWYxMWM1NjlkZjQyNzdhZDc1YjA3NzcyY2Q2NWQzL3RhYmxlOmNlMDdiOGQ2NDYwMDRjNDRhNDI1ZWY3YTgxZjQwMGI0L3RhYmxlcmFuZ2U6Y2UwN2I4ZDY0NjAwNGM0NGE0MjVlZjdhODFmNDAwYjRfMy0zLTEtMS02MjY_208ad801-618f-457a-bdf5-e00a9b0011f2">176,882</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Short-term marketable securities</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i4c8f247d12134a9886d56e1c8b024425_I20220630" decimals="-3" name="us-gaap:MarketableSecuritiesCurrent" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmFlNWE5YmUwZWI5NDQ1ZDE5MmZhZTgyMmQyMmJlMDlmL3NlYzphZTVhOWJlMGViOTQ0NWQxOTJmYWU4MjJkMjJiZTA5Zl8xNi9mcmFnOmJjOWYxMWM1NjlkZjQyNzdhZDc1YjA3NzcyY2Q2NWQzL3RhYmxlOmNlMDdiOGQ2NDYwMDRjNDRhNDI1ZWY3YTgxZjQwMGI0L3RhYmxlcmFuZ2U6Y2UwN2I4ZDY0NjAwNGM0NGE0MjVlZjdhODFmNDAwYjRfNC0xLTEtMS02MjY_7477f116-c77e-4704-8e41-1853cee793e4">53,457</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i87bf777ccf5f4f93bc9be7a2cbba61c1_I20211231" decimals="-3" name="us-gaap:MarketableSecuritiesCurrent" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmFlNWE5YmUwZWI5NDQ1ZDE5MmZhZTgyMmQyMmJlMDlmL3NlYzphZTVhOWJlMGViOTQ0NWQxOTJmYWU4MjJkMjJiZTA5Zl8xNi9mcmFnOmJjOWYxMWM1NjlkZjQyNzdhZDc1YjA3NzcyY2Q2NWQzL3RhYmxlOmNlMDdiOGQ2NDYwMDRjNDRhNDI1ZWY3YTgxZjQwMGI0L3RhYmxlcmFuZ2U6Y2UwN2I4ZDY0NjAwNGM0NGE0MjVlZjdhODFmNDAwYjRfNC0zLTEtMS02MjY_a9a1c436-b2b1-403a-8b03-f19133bc15a1">48,449</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Accounts receivable</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i4c8f247d12134a9886d56e1c8b024425_I20220630" decimals="-3" name="us-gaap:AccountsReceivableNetCurrent" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmFlNWE5YmUwZWI5NDQ1ZDE5MmZhZTgyMmQyMmJlMDlmL3NlYzphZTVhOWJlMGViOTQ0NWQxOTJmYWU4MjJkMjJiZTA5Zl8xNi9mcmFnOmJjOWYxMWM1NjlkZjQyNzdhZDc1YjA3NzcyY2Q2NWQzL3RhYmxlOmNlMDdiOGQ2NDYwMDRjNDRhNDI1ZWY3YTgxZjQwMGI0L3RhYmxlcmFuZ2U6Y2UwN2I4ZDY0NjAwNGM0NGE0MjVlZjdhODFmNDAwYjRfNS0xLTEtMS02MjY_aeb7cbba-a1b8-44cc-9366-b905817bb815">5,962</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i87bf777ccf5f4f93bc9be7a2cbba61c1_I20211231" decimals="-3" name="us-gaap:AccountsReceivableNetCurrent" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmFlNWE5YmUwZWI5NDQ1ZDE5MmZhZTgyMmQyMmJlMDlmL3NlYzphZTVhOWJlMGViOTQ0NWQxOTJmYWU4MjJkMjJiZTA5Zl8xNi9mcmFnOmJjOWYxMWM1NjlkZjQyNzdhZDc1YjA3NzcyY2Q2NWQzL3RhYmxlOmNlMDdiOGQ2NDYwMDRjNDRhNDI1ZWY3YTgxZjQwMGI0L3RhYmxlcmFuZ2U6Y2UwN2I4ZDY0NjAwNGM0NGE0MjVlZjdhODFmNDAwYjRfNS0zLTEtMS02MjY_a582f496-41ab-439a-b3ce-02b021ae2061">3,847</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Inventory</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i4c8f247d12134a9886d56e1c8b024425_I20220630" decimals="-3" name="us-gaap:InventoryNet" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmFlNWE5YmUwZWI5NDQ1ZDE5MmZhZTgyMmQyMmJlMDlmL3NlYzphZTVhOWJlMGViOTQ0NWQxOTJmYWU4MjJkMjJiZTA5Zl8xNi9mcmFnOmJjOWYxMWM1NjlkZjQyNzdhZDc1YjA3NzcyY2Q2NWQzL3RhYmxlOmNlMDdiOGQ2NDYwMDRjNDRhNDI1ZWY3YTgxZjQwMGI0L3RhYmxlcmFuZ2U6Y2UwN2I4ZDY0NjAwNGM0NGE0MjVlZjdhODFmNDAwYjRfNi0xLTEtMS02MjY_41fa4f74-b1bf-41f4-8956-ade0f89831e7">1,432</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i87bf777ccf5f4f93bc9be7a2cbba61c1_I20211231" decimals="-3" name="us-gaap:InventoryNet" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmFlNWE5YmUwZWI5NDQ1ZDE5MmZhZTgyMmQyMmJlMDlmL3NlYzphZTVhOWJlMGViOTQ0NWQxOTJmYWU4MjJkMjJiZTA5Zl8xNi9mcmFnOmJjOWYxMWM1NjlkZjQyNzdhZDc1YjA3NzcyY2Q2NWQzL3RhYmxlOmNlMDdiOGQ2NDYwMDRjNDRhNDI1ZWY3YTgxZjQwMGI0L3RhYmxlcmFuZ2U6Y2UwN2I4ZDY0NjAwNGM0NGE0MjVlZjdhODFmNDAwYjRfNi0zLTEtMS02MjY_16ad1aae-2ba9-4c78-8efb-77e3396e7848">480</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Prepaid expenses and other current assets</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i4c8f247d12134a9886d56e1c8b024425_I20220630" decimals="-3" name="us-gaap:PrepaidExpenseAndOtherAssetsCurrent" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmFlNWE5YmUwZWI5NDQ1ZDE5MmZhZTgyMmQyMmJlMDlmL3NlYzphZTVhOWJlMGViOTQ0NWQxOTJmYWU4MjJkMjJiZTA5Zl8xNi9mcmFnOmJjOWYxMWM1NjlkZjQyNzdhZDc1YjA3NzcyY2Q2NWQzL3RhYmxlOmNlMDdiOGQ2NDYwMDRjNDRhNDI1ZWY3YTgxZjQwMGI0L3RhYmxlcmFuZ2U6Y2UwN2I4ZDY0NjAwNGM0NGE0MjVlZjdhODFmNDAwYjRfNy0xLTEtMS02MjY_150e10c3-0995-4e51-8036-67d51ece2905">2,681</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i87bf777ccf5f4f93bc9be7a2cbba61c1_I20211231" decimals="-3" name="us-gaap:PrepaidExpenseAndOtherAssetsCurrent" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmFlNWE5YmUwZWI5NDQ1ZDE5MmZhZTgyMmQyMmJlMDlmL3NlYzphZTVhOWJlMGViOTQ0NWQxOTJmYWU4MjJkMjJiZTA5Zl8xNi9mcmFnOmJjOWYxMWM1NjlkZjQyNzdhZDc1YjA3NzcyY2Q2NWQzL3RhYmxlOmNlMDdiOGQ2NDYwMDRjNDRhNDI1ZWY3YTgxZjQwMGI0L3RhYmxlcmFuZ2U6Y2UwN2I4ZDY0NjAwNGM0NGE0MjVlZjdhODFmNDAwYjRfNy0zLTEtMS02MjY_483967cc-3697-4fbc-83af-1de64655a11c">3,166</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 37pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total current assets</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i4c8f247d12134a9886d56e1c8b024425_I20220630" decimals="-3" name="us-gaap:AssetsCurrent" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmFlNWE5YmUwZWI5NDQ1ZDE5MmZhZTgyMmQyMmJlMDlmL3NlYzphZTVhOWJlMGViOTQ0NWQxOTJmYWU4MjJkMjJiZTA5Zl8xNi9mcmFnOmJjOWYxMWM1NjlkZjQyNzdhZDc1YjA3NzcyY2Q2NWQzL3RhYmxlOmNlMDdiOGQ2NDYwMDRjNDRhNDI1ZWY3YTgxZjQwMGI0L3RhYmxlcmFuZ2U6Y2UwN2I4ZDY0NjAwNGM0NGE0MjVlZjdhODFmNDAwYjRfOC0xLTEtMS02MjY_0654893a-672f-4add-84c3-59fd1516d6be">183,865</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i87bf777ccf5f4f93bc9be7a2cbba61c1_I20211231" decimals="-3" name="us-gaap:AssetsCurrent" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmFlNWE5YmUwZWI5NDQ1ZDE5MmZhZTgyMmQyMmJlMDlmL3NlYzphZTVhOWJlMGViOTQ0NWQxOTJmYWU4MjJkMjJiZTA5Zl8xNi9mcmFnOmJjOWYxMWM1NjlkZjQyNzdhZDc1YjA3NzcyY2Q2NWQzL3RhYmxlOmNlMDdiOGQ2NDYwMDRjNDRhNDI1ZWY3YTgxZjQwMGI0L3RhYmxlcmFuZ2U6Y2UwN2I4ZDY0NjAwNGM0NGE0MjVlZjdhODFmNDAwYjRfOC0zLTEtMS02MjY_71e40d52-808b-4758-8956-bbbf8d96d639">232,824</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Property and equipment, net</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i4c8f247d12134a9886d56e1c8b024425_I20220630" decimals="-3" name="us-gaap:PropertyPlantAndEquipmentNet" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmFlNWE5YmUwZWI5NDQ1ZDE5MmZhZTgyMmQyMmJlMDlmL3NlYzphZTVhOWJlMGViOTQ0NWQxOTJmYWU4MjJkMjJiZTA5Zl8xNi9mcmFnOmJjOWYxMWM1NjlkZjQyNzdhZDc1YjA3NzcyY2Q2NWQzL3RhYmxlOmNlMDdiOGQ2NDYwMDRjNDRhNDI1ZWY3YTgxZjQwMGI0L3RhYmxlcmFuZ2U6Y2UwN2I4ZDY0NjAwNGM0NGE0MjVlZjdhODFmNDAwYjRfOS0xLTEtMS02MjY_fc67d20c-ab3b-4d17-9138-21cfb12b91b8">4,916</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i87bf777ccf5f4f93bc9be7a2cbba61c1_I20211231" decimals="-3" name="us-gaap:PropertyPlantAndEquipmentNet" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmFlNWE5YmUwZWI5NDQ1ZDE5MmZhZTgyMmQyMmJlMDlmL3NlYzphZTVhOWJlMGViOTQ0NWQxOTJmYWU4MjJkMjJiZTA5Zl8xNi9mcmFnOmJjOWYxMWM1NjlkZjQyNzdhZDc1YjA3NzcyY2Q2NWQzL3RhYmxlOmNlMDdiOGQ2NDYwMDRjNDRhNDI1ZWY3YTgxZjQwMGI0L3RhYmxlcmFuZ2U6Y2UwN2I4ZDY0NjAwNGM0NGE0MjVlZjdhODFmNDAwYjRfOS0zLTEtMS02MjY_84831938-2d74-4381-b053-5e5a8b30281d">4,549</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Operating lease right-of-use assets</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i4c8f247d12134a9886d56e1c8b024425_I20220630" decimals="-3" name="us-gaap:OperatingLeaseRightOfUseAsset" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmFlNWE5YmUwZWI5NDQ1ZDE5MmZhZTgyMmQyMmJlMDlmL3NlYzphZTVhOWJlMGViOTQ0NWQxOTJmYWU4MjJkMjJiZTA5Zl8xNi9mcmFnOmJjOWYxMWM1NjlkZjQyNzdhZDc1YjA3NzcyY2Q2NWQzL3RhYmxlOmNlMDdiOGQ2NDYwMDRjNDRhNDI1ZWY3YTgxZjQwMGI0L3RhYmxlcmFuZ2U6Y2UwN2I4ZDY0NjAwNGM0NGE0MjVlZjdhODFmNDAwYjRfMTAtMS0xLTEtNjI2_2d65198e-8e26-4582-8935-46a37f66c1ff">23,694</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i87bf777ccf5f4f93bc9be7a2cbba61c1_I20211231" decimals="-3" name="us-gaap:OperatingLeaseRightOfUseAsset" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmFlNWE5YmUwZWI5NDQ1ZDE5MmZhZTgyMmQyMmJlMDlmL3NlYzphZTVhOWJlMGViOTQ0NWQxOTJmYWU4MjJkMjJiZTA5Zl8xNi9mcmFnOmJjOWYxMWM1NjlkZjQyNzdhZDc1YjA3NzcyY2Q2NWQzL3RhYmxlOmNlMDdiOGQ2NDYwMDRjNDRhNDI1ZWY3YTgxZjQwMGI0L3RhYmxlcmFuZ2U6Y2UwN2I4ZDY0NjAwNGM0NGE0MjVlZjdhODFmNDAwYjRfMTAtMy0xLTEtNjI2_5f6dddb6-81d4-4ed2-ad4e-e696f011ad8a">7,744</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Restricted cash</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i4c8f247d12134a9886d56e1c8b024425_I20220630" decimals="-3" name="us-gaap:RestrictedCashNoncurrent" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmFlNWE5YmUwZWI5NDQ1ZDE5MmZhZTgyMmQyMmJlMDlmL3NlYzphZTVhOWJlMGViOTQ0NWQxOTJmYWU4MjJkMjJiZTA5Zl8xNi9mcmFnOmJjOWYxMWM1NjlkZjQyNzdhZDc1YjA3NzcyY2Q2NWQzL3RhYmxlOmNlMDdiOGQ2NDYwMDRjNDRhNDI1ZWY3YTgxZjQwMGI0L3RhYmxlcmFuZ2U6Y2UwN2I4ZDY0NjAwNGM0NGE0MjVlZjdhODFmNDAwYjRfMTEtMS0xLTEtNjI2_6f577974-c61b-4a0b-a793-25a301b63741">3,470</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i87bf777ccf5f4f93bc9be7a2cbba61c1_I20211231" decimals="-3" name="us-gaap:RestrictedCashNoncurrent" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmFlNWE5YmUwZWI5NDQ1ZDE5MmZhZTgyMmQyMmJlMDlmL3NlYzphZTVhOWJlMGViOTQ0NWQxOTJmYWU4MjJkMjJiZTA5Zl8xNi9mcmFnOmJjOWYxMWM1NjlkZjQyNzdhZDc1YjA3NzcyY2Q2NWQzL3RhYmxlOmNlMDdiOGQ2NDYwMDRjNDRhNDI1ZWY3YTgxZjQwMGI0L3RhYmxlcmFuZ2U6Y2UwN2I4ZDY0NjAwNGM0NGE0MjVlZjdhODFmNDAwYjRfMTEtMy0xLTEtNjI2_a7cbeeba-1893-4c95-be78-b398f0088e34">3,025</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other assets</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i4c8f247d12134a9886d56e1c8b024425_I20220630" decimals="-3" name="us-gaap:OtherAssetsNoncurrent" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmFlNWE5YmUwZWI5NDQ1ZDE5MmZhZTgyMmQyMmJlMDlmL3NlYzphZTVhOWJlMGViOTQ0NWQxOTJmYWU4MjJkMjJiZTA5Zl8xNi9mcmFnOmJjOWYxMWM1NjlkZjQyNzdhZDc1YjA3NzcyY2Q2NWQzL3RhYmxlOmNlMDdiOGQ2NDYwMDRjNDRhNDI1ZWY3YTgxZjQwMGI0L3RhYmxlcmFuZ2U6Y2UwN2I4ZDY0NjAwNGM0NGE0MjVlZjdhODFmNDAwYjRfMTItMS0xLTEtNjI2_5d6921b5-b0cc-45ec-9699-f77166122b54">167</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i87bf777ccf5f4f93bc9be7a2cbba61c1_I20211231" decimals="-3" name="us-gaap:OtherAssetsNoncurrent" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmFlNWE5YmUwZWI5NDQ1ZDE5MmZhZTgyMmQyMmJlMDlmL3NlYzphZTVhOWJlMGViOTQ0NWQxOTJmYWU4MjJkMjJiZTA5Zl8xNi9mcmFnOmJjOWYxMWM1NjlkZjQyNzdhZDc1YjA3NzcyY2Q2NWQzL3RhYmxlOmNlMDdiOGQ2NDYwMDRjNDRhNDI1ZWY3YTgxZjQwMGI0L3RhYmxlcmFuZ2U6Y2UwN2I4ZDY0NjAwNGM0NGE0MjVlZjdhODFmNDAwYjRfMTItMy0xLTEtNjI2_27ee53c6-ac08-4781-ab0e-cd89d1ddc18c">167</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 37pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total assets</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i4c8f247d12134a9886d56e1c8b024425_I20220630" decimals="-3" name="us-gaap:Assets" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmFlNWE5YmUwZWI5NDQ1ZDE5MmZhZTgyMmQyMmJlMDlmL3NlYzphZTVhOWJlMGViOTQ0NWQxOTJmYWU4MjJkMjJiZTA5Zl8xNi9mcmFnOmJjOWYxMWM1NjlkZjQyNzdhZDc1YjA3NzcyY2Q2NWQzL3RhYmxlOmNlMDdiOGQ2NDYwMDRjNDRhNDI1ZWY3YTgxZjQwMGI0L3RhYmxlcmFuZ2U6Y2UwN2I4ZDY0NjAwNGM0NGE0MjVlZjdhODFmNDAwYjRfMTMtMS0xLTEtNjI2_b60f5d42-c89e-4b9f-93b0-cd6859cd7f05">216,112</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i87bf777ccf5f4f93bc9be7a2cbba61c1_I20211231" decimals="-3" name="us-gaap:Assets" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmFlNWE5YmUwZWI5NDQ1ZDE5MmZhZTgyMmQyMmJlMDlmL3NlYzphZTVhOWJlMGViOTQ0NWQxOTJmYWU4MjJkMjJiZTA5Zl8xNi9mcmFnOmJjOWYxMWM1NjlkZjQyNzdhZDc1YjA3NzcyY2Q2NWQzL3RhYmxlOmNlMDdiOGQ2NDYwMDRjNDRhNDI1ZWY3YTgxZjQwMGI0L3RhYmxlcmFuZ2U6Y2UwN2I4ZDY0NjAwNGM0NGE0MjVlZjdhODFmNDAwYjRfMTMtMy0xLTEtNjI2_41e66a45-977f-4edf-95e6-b79e899bbbdd">248,309</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Liabilities and Stockholders&#8217; Equity</span></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Current liabilities:</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Accounts payable</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i4c8f247d12134a9886d56e1c8b024425_I20220630" decimals="-3" name="us-gaap:AccountsPayableCurrent" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmFlNWE5YmUwZWI5NDQ1ZDE5MmZhZTgyMmQyMmJlMDlmL3NlYzphZTVhOWJlMGViOTQ0NWQxOTJmYWU4MjJkMjJiZTA5Zl8xNi9mcmFnOmJjOWYxMWM1NjlkZjQyNzdhZDc1YjA3NzcyY2Q2NWQzL3RhYmxlOmNlMDdiOGQ2NDYwMDRjNDRhNDI1ZWY3YTgxZjQwMGI0L3RhYmxlcmFuZ2U6Y2UwN2I4ZDY0NjAwNGM0NGE0MjVlZjdhODFmNDAwYjRfMTYtMS0xLTEtNjI2_e8b36645-abca-4255-bf38-3ce6e522da70">861</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i87bf777ccf5f4f93bc9be7a2cbba61c1_I20211231" decimals="-3" name="us-gaap:AccountsPayableCurrent" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmFlNWE5YmUwZWI5NDQ1ZDE5MmZhZTgyMmQyMmJlMDlmL3NlYzphZTVhOWJlMGViOTQ0NWQxOTJmYWU4MjJkMjJiZTA5Zl8xNi9mcmFnOmJjOWYxMWM1NjlkZjQyNzdhZDc1YjA3NzcyY2Q2NWQzL3RhYmxlOmNlMDdiOGQ2NDYwMDRjNDRhNDI1ZWY3YTgxZjQwMGI0L3RhYmxlcmFuZ2U6Y2UwN2I4ZDY0NjAwNGM0NGE0MjVlZjdhODFmNDAwYjRfMTYtMy0xLTEtNjI2_d33da315-fbc3-4aee-9b22-6d24c5a37352">2,880</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Accrued compensation</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i4c8f247d12134a9886d56e1c8b024425_I20220630" decimals="-3" name="us-gaap:EmployeeRelatedLiabilitiesCurrent" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmFlNWE5YmUwZWI5NDQ1ZDE5MmZhZTgyMmQyMmJlMDlmL3NlYzphZTVhOWJlMGViOTQ0NWQxOTJmYWU4MjJkMjJiZTA5Zl8xNi9mcmFnOmJjOWYxMWM1NjlkZjQyNzdhZDc1YjA3NzcyY2Q2NWQzL3RhYmxlOmNlMDdiOGQ2NDYwMDRjNDRhNDI1ZWY3YTgxZjQwMGI0L3RhYmxlcmFuZ2U6Y2UwN2I4ZDY0NjAwNGM0NGE0MjVlZjdhODFmNDAwYjRfMTctMS0xLTEtNjI2_3179208d-581c-4790-9149-de906387f231">7,818</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i87bf777ccf5f4f93bc9be7a2cbba61c1_I20211231" decimals="-3" name="us-gaap:EmployeeRelatedLiabilitiesCurrent" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmFlNWE5YmUwZWI5NDQ1ZDE5MmZhZTgyMmQyMmJlMDlmL3NlYzphZTVhOWJlMGViOTQ0NWQxOTJmYWU4MjJkMjJiZTA5Zl8xNi9mcmFnOmJjOWYxMWM1NjlkZjQyNzdhZDc1YjA3NzcyY2Q2NWQzL3RhYmxlOmNlMDdiOGQ2NDYwMDRjNDRhNDI1ZWY3YTgxZjQwMGI0L3RhYmxlcmFuZ2U6Y2UwN2I4ZDY0NjAwNGM0NGE0MjVlZjdhODFmNDAwYjRfMTctMy0xLTEtNjI2_0435afef-4f41-4005-b4c0-f1c08da5682a">5,120</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Accrued liabilities</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i4c8f247d12134a9886d56e1c8b024425_I20220630" decimals="-3" name="us-gaap:AccruedLiabilitiesCurrent" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmFlNWE5YmUwZWI5NDQ1ZDE5MmZhZTgyMmQyMmJlMDlmL3NlYzphZTVhOWJlMGViOTQ0NWQxOTJmYWU4MjJkMjJiZTA5Zl8xNi9mcmFnOmJjOWYxMWM1NjlkZjQyNzdhZDc1YjA3NzcyY2Q2NWQzL3RhYmxlOmNlMDdiOGQ2NDYwMDRjNDRhNDI1ZWY3YTgxZjQwMGI0L3RhYmxlcmFuZ2U6Y2UwN2I4ZDY0NjAwNGM0NGE0MjVlZjdhODFmNDAwYjRfMTgtMS0xLTEtNjI2_12355abb-ae0c-4b16-818d-6403a7bde9b1">3,272</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i87bf777ccf5f4f93bc9be7a2cbba61c1_I20211231" decimals="-3" name="us-gaap:AccruedLiabilitiesCurrent" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmFlNWE5YmUwZWI5NDQ1ZDE5MmZhZTgyMmQyMmJlMDlmL3NlYzphZTVhOWJlMGViOTQ0NWQxOTJmYWU4MjJkMjJiZTA5Zl8xNi9mcmFnOmJjOWYxMWM1NjlkZjQyNzdhZDc1YjA3NzcyY2Q2NWQzL3RhYmxlOmNlMDdiOGQ2NDYwMDRjNDRhNDI1ZWY3YTgxZjQwMGI0L3RhYmxlcmFuZ2U6Y2UwN2I4ZDY0NjAwNGM0NGE0MjVlZjdhODFmNDAwYjRfMTgtMy0xLTEtNjI2_1ea3fe33-5cc5-46d3-ab7c-72509f339fe7">1,227</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Short-term deferred revenue</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i4c8f247d12134a9886d56e1c8b024425_I20220630" decimals="-3" name="us-gaap:DeferredRevenueCurrent" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmFlNWE5YmUwZWI5NDQ1ZDE5MmZhZTgyMmQyMmJlMDlmL3NlYzphZTVhOWJlMGViOTQ0NWQxOTJmYWU4MjJkMjJiZTA5Zl8xNi9mcmFnOmJjOWYxMWM1NjlkZjQyNzdhZDc1YjA3NzcyY2Q2NWQzL3RhYmxlOmNlMDdiOGQ2NDYwMDRjNDRhNDI1ZWY3YTgxZjQwMGI0L3RhYmxlcmFuZ2U6Y2UwN2I4ZDY0NjAwNGM0NGE0MjVlZjdhODFmNDAwYjRfMTktMS0xLTEtNjI2_e9e52a55-b2f3-43fc-8835-4a8f5ccccf91">1,310</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i87bf777ccf5f4f93bc9be7a2cbba61c1_I20211231" decimals="-3" name="us-gaap:DeferredRevenueCurrent" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmFlNWE5YmUwZWI5NDQ1ZDE5MmZhZTgyMmQyMmJlMDlmL3NlYzphZTVhOWJlMGViOTQ0NWQxOTJmYWU4MjJkMjJiZTA5Zl8xNi9mcmFnOmJjOWYxMWM1NjlkZjQyNzdhZDc1YjA3NzcyY2Q2NWQzL3RhYmxlOmNlMDdiOGQ2NDYwMDRjNDRhNDI1ZWY3YTgxZjQwMGI0L3RhYmxlcmFuZ2U6Y2UwN2I4ZDY0NjAwNGM0NGE0MjVlZjdhODFmNDAwYjRfMTktMy0xLTEtNjI2_84d4c2c6-1513-41e1-9cc0-e51ab49852b7">1,380</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Current portion of operating lease liabilities</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i4c8f247d12134a9886d56e1c8b024425_I20220630" decimals="-3" name="us-gaap:OperatingLeaseLiabilityCurrent" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmFlNWE5YmUwZWI5NDQ1ZDE5MmZhZTgyMmQyMmJlMDlmL3NlYzphZTVhOWJlMGViOTQ0NWQxOTJmYWU4MjJkMjJiZTA5Zl8xNi9mcmFnOmJjOWYxMWM1NjlkZjQyNzdhZDc1YjA3NzcyY2Q2NWQzL3RhYmxlOmNlMDdiOGQ2NDYwMDRjNDRhNDI1ZWY3YTgxZjQwMGI0L3RhYmxlcmFuZ2U6Y2UwN2I4ZDY0NjAwNGM0NGE0MjVlZjdhODFmNDAwYjRfMjAtMS0xLTEtNjI2_67ec3aac-9ab4-4631-99f7-ebddf155815b">1,693</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i87bf777ccf5f4f93bc9be7a2cbba61c1_I20211231" decimals="-3" name="us-gaap:OperatingLeaseLiabilityCurrent" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmFlNWE5YmUwZWI5NDQ1ZDE5MmZhZTgyMmQyMmJlMDlmL3NlYzphZTVhOWJlMGViOTQ0NWQxOTJmYWU4MjJkMjJiZTA5Zl8xNi9mcmFnOmJjOWYxMWM1NjlkZjQyNzdhZDc1YjA3NzcyY2Q2NWQzL3RhYmxlOmNlMDdiOGQ2NDYwMDRjNDRhNDI1ZWY3YTgxZjQwMGI0L3RhYmxlcmFuZ2U6Y2UwN2I4ZDY0NjAwNGM0NGE0MjVlZjdhODFmNDAwYjRfMjAtMy0xLTEtNjI2_c0c06080-4fe6-4ccd-ba9d-5187f5777f2c">1,453</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Current portion of finance lease obligations</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i4c8f247d12134a9886d56e1c8b024425_I20220630" decimals="-3" name="us-gaap:FinanceLeaseLiabilityCurrent" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmFlNWE5YmUwZWI5NDQ1ZDE5MmZhZTgyMmQyMmJlMDlmL3NlYzphZTVhOWJlMGViOTQ0NWQxOTJmYWU4MjJkMjJiZTA5Zl8xNi9mcmFnOmJjOWYxMWM1NjlkZjQyNzdhZDc1YjA3NzcyY2Q2NWQzL3RhYmxlOmNlMDdiOGQ2NDYwMDRjNDRhNDI1ZWY3YTgxZjQwMGI0L3RhYmxlcmFuZ2U6Y2UwN2I4ZDY0NjAwNGM0NGE0MjVlZjdhODFmNDAwYjRfMjEtMS0xLTEtNjI2_7cac9871-5067-41c5-b3a4-c507423c6aec">134</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i87bf777ccf5f4f93bc9be7a2cbba61c1_I20211231" decimals="-3" name="us-gaap:FinanceLeaseLiabilityCurrent" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmFlNWE5YmUwZWI5NDQ1ZDE5MmZhZTgyMmQyMmJlMDlmL3NlYzphZTVhOWJlMGViOTQ0NWQxOTJmYWU4MjJkMjJiZTA5Zl8xNi9mcmFnOmJjOWYxMWM1NjlkZjQyNzdhZDc1YjA3NzcyY2Q2NWQzL3RhYmxlOmNlMDdiOGQ2NDYwMDRjNDRhNDI1ZWY3YTgxZjQwMGI0L3RhYmxlcmFuZ2U6Y2UwN2I4ZDY0NjAwNGM0NGE0MjVlZjdhODFmNDAwYjRfMjEtMy0xLTEtNjI2_5261e5fa-7853-4fb3-9fe9-6293b2cf6e42">121</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 37pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total current liabilities</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i4c8f247d12134a9886d56e1c8b024425_I20220630" decimals="-3" name="us-gaap:LiabilitiesCurrent" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmFlNWE5YmUwZWI5NDQ1ZDE5MmZhZTgyMmQyMmJlMDlmL3NlYzphZTVhOWJlMGViOTQ0NWQxOTJmYWU4MjJkMjJiZTA5Zl8xNi9mcmFnOmJjOWYxMWM1NjlkZjQyNzdhZDc1YjA3NzcyY2Q2NWQzL3RhYmxlOmNlMDdiOGQ2NDYwMDRjNDRhNDI1ZWY3YTgxZjQwMGI0L3RhYmxlcmFuZ2U6Y2UwN2I4ZDY0NjAwNGM0NGE0MjVlZjdhODFmNDAwYjRfMjItMS0xLTEtNjI2_155f7fc6-7bb2-4e61-8a9b-baa62ffc72aa">15,088</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i87bf777ccf5f4f93bc9be7a2cbba61c1_I20211231" decimals="-3" name="us-gaap:LiabilitiesCurrent" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmFlNWE5YmUwZWI5NDQ1ZDE5MmZhZTgyMmQyMmJlMDlmL3NlYzphZTVhOWJlMGViOTQ0NWQxOTJmYWU4MjJkMjJiZTA5Zl8xNi9mcmFnOmJjOWYxMWM1NjlkZjQyNzdhZDc1YjA3NzcyY2Q2NWQzL3RhYmxlOmNlMDdiOGQ2NDYwMDRjNDRhNDI1ZWY3YTgxZjQwMGI0L3RhYmxlcmFuZ2U6Y2UwN2I4ZDY0NjAwNGM0NGE0MjVlZjdhODFmNDAwYjRfMjItMy0xLTEtNjI2_95f56f30-9790-4371-9cf2-ba957ac03b13">12,181</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Warrant liability</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i4c8f247d12134a9886d56e1c8b024425_I20220630" decimals="-3" name="us-gaap:WarrantsAndRightsOutstanding" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmFlNWE5YmUwZWI5NDQ1ZDE5MmZhZTgyMmQyMmJlMDlmL3NlYzphZTVhOWJlMGViOTQ0NWQxOTJmYWU4MjJkMjJiZTA5Zl8xNi9mcmFnOmJjOWYxMWM1NjlkZjQyNzdhZDc1YjA3NzcyY2Q2NWQzL3RhYmxlOmNlMDdiOGQ2NDYwMDRjNDRhNDI1ZWY3YTgxZjQwMGI0L3RhYmxlcmFuZ2U6Y2UwN2I4ZDY0NjAwNGM0NGE0MjVlZjdhODFmNDAwYjRfMjQtMS0xLTEtNjI2_22ab1b64-c428-4fee-9679-398ce86f8f32">24</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i87bf777ccf5f4f93bc9be7a2cbba61c1_I20211231" decimals="-3" name="us-gaap:WarrantsAndRightsOutstanding" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmFlNWE5YmUwZWI5NDQ1ZDE5MmZhZTgyMmQyMmJlMDlmL3NlYzphZTVhOWJlMGViOTQ0NWQxOTJmYWU4MjJkMjJiZTA5Zl8xNi9mcmFnOmJjOWYxMWM1NjlkZjQyNzdhZDc1YjA3NzcyY2Q2NWQzL3RhYmxlOmNlMDdiOGQ2NDYwMDRjNDRhNDI1ZWY3YTgxZjQwMGI0L3RhYmxlcmFuZ2U6Y2UwN2I4ZDY0NjAwNGM0NGE0MjVlZjdhODFmNDAwYjRfMjQtMy0xLTEtNjI2_5fd78fa9-a39c-4b83-9166-dc620d0018af">146</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Long-term finance lease obligations, less current portion</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i4c8f247d12134a9886d56e1c8b024425_I20220630" decimals="-3" name="us-gaap:FinanceLeaseLiabilityNoncurrent" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmFlNWE5YmUwZWI5NDQ1ZDE5MmZhZTgyMmQyMmJlMDlmL3NlYzphZTVhOWJlMGViOTQ0NWQxOTJmYWU4MjJkMjJiZTA5Zl8xNi9mcmFnOmJjOWYxMWM1NjlkZjQyNzdhZDc1YjA3NzcyY2Q2NWQzL3RhYmxlOmNlMDdiOGQ2NDYwMDRjNDRhNDI1ZWY3YTgxZjQwMGI0L3RhYmxlcmFuZ2U6Y2UwN2I4ZDY0NjAwNGM0NGE0MjVlZjdhODFmNDAwYjRfMjYtMS0xLTEtNjI2_7c65afbc-c8fd-45b5-b097-7358548404db">111</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i87bf777ccf5f4f93bc9be7a2cbba61c1_I20211231" decimals="-3" name="us-gaap:FinanceLeaseLiabilityNoncurrent" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmFlNWE5YmUwZWI5NDQ1ZDE5MmZhZTgyMmQyMmJlMDlmL3NlYzphZTVhOWJlMGViOTQ0NWQxOTJmYWU4MjJkMjJiZTA5Zl8xNi9mcmFnOmJjOWYxMWM1NjlkZjQyNzdhZDc1YjA3NzcyY2Q2NWQzL3RhYmxlOmNlMDdiOGQ2NDYwMDRjNDRhNDI1ZWY3YTgxZjQwMGI0L3RhYmxlcmFuZ2U6Y2UwN2I4ZDY0NjAwNGM0NGE0MjVlZjdhODFmNDAwYjRfMjYtMy0xLTEtNjI2_d9aa1088-589f-45d0-ab29-532d470b0d2e">136</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Operating lease liabilities, long-term</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i4c8f247d12134a9886d56e1c8b024425_I20220630" decimals="-3" name="us-gaap:OperatingLeaseLiabilityNoncurrent" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmFlNWE5YmUwZWI5NDQ1ZDE5MmZhZTgyMmQyMmJlMDlmL3NlYzphZTVhOWJlMGViOTQ0NWQxOTJmYWU4MjJkMjJiZTA5Zl8xNi9mcmFnOmJjOWYxMWM1NjlkZjQyNzdhZDc1YjA3NzcyY2Q2NWQzL3RhYmxlOmNlMDdiOGQ2NDYwMDRjNDRhNDI1ZWY3YTgxZjQwMGI0L3RhYmxlcmFuZ2U6Y2UwN2I4ZDY0NjAwNGM0NGE0MjVlZjdhODFmNDAwYjRfMjctMS0xLTEtNjk3_f41033a5-1f32-47e1-b486-4c5c10a93d9b">22,312</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i87bf777ccf5f4f93bc9be7a2cbba61c1_I20211231" decimals="-3" name="us-gaap:OperatingLeaseLiabilityNoncurrent" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmFlNWE5YmUwZWI5NDQ1ZDE5MmZhZTgyMmQyMmJlMDlmL3NlYzphZTVhOWJlMGViOTQ0NWQxOTJmYWU4MjJkMjJiZTA5Zl8xNi9mcmFnOmJjOWYxMWM1NjlkZjQyNzdhZDc1YjA3NzcyY2Q2NWQzL3RhYmxlOmNlMDdiOGQ2NDYwMDRjNDRhNDI1ZWY3YTgxZjQwMGI0L3RhYmxlcmFuZ2U6Y2UwN2I4ZDY0NjAwNGM0NGE0MjVlZjdhODFmNDAwYjRfMjctMy0xLTEtNjk3_17faf56a-95eb-4fb6-b1a1-38b09c58f3f1">6,148</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 37pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total liabilities</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i4c8f247d12134a9886d56e1c8b024425_I20220630" decimals="-3" name="us-gaap:Liabilities" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmFlNWE5YmUwZWI5NDQ1ZDE5MmZhZTgyMmQyMmJlMDlmL3NlYzphZTVhOWJlMGViOTQ0NWQxOTJmYWU4MjJkMjJiZTA5Zl8xNi9mcmFnOmJjOWYxMWM1NjlkZjQyNzdhZDc1YjA3NzcyY2Q2NWQzL3RhYmxlOmNlMDdiOGQ2NDYwMDRjNDRhNDI1ZWY3YTgxZjQwMGI0L3RhYmxlcmFuZ2U6Y2UwN2I4ZDY0NjAwNGM0NGE0MjVlZjdhODFmNDAwYjRfMjctMS0xLTEtNjI2_9759e12e-65cf-4281-b5c1-3931b2fbc4d1">37,535</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i87bf777ccf5f4f93bc9be7a2cbba61c1_I20211231" decimals="-3" name="us-gaap:Liabilities" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmFlNWE5YmUwZWI5NDQ1ZDE5MmZhZTgyMmQyMmJlMDlmL3NlYzphZTVhOWJlMGViOTQ0NWQxOTJmYWU4MjJkMjJiZTA5Zl8xNi9mcmFnOmJjOWYxMWM1NjlkZjQyNzdhZDc1YjA3NzcyY2Q2NWQzL3RhYmxlOmNlMDdiOGQ2NDYwMDRjNDRhNDI1ZWY3YTgxZjQwMGI0L3RhYmxlcmFuZ2U6Y2UwN2I4ZDY0NjAwNGM0NGE0MjVlZjdhODFmNDAwYjRfMjctMy0xLTEtNjI2_6f6acea3-8265-42be-b39c-0df4c1a40a5c">18,611</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Stockholders&#8217; equity:</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:27pt;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Common stock, $<ix:nonFraction unitRef="usdPerShare" contextRef="i87bf777ccf5f4f93bc9be7a2cbba61c1_I20211231" decimals="INF" name="us-gaap:CommonStockParOrStatedValuePerShare" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmFlNWE5YmUwZWI5NDQ1ZDE5MmZhZTgyMmQyMmJlMDlmL3NlYzphZTVhOWJlMGViOTQ0NWQxOTJmYWU4MjJkMjJiZTA5Zl8xNi9mcmFnOmJjOWYxMWM1NjlkZjQyNzdhZDc1YjA3NzcyY2Q2NWQzL3RhYmxlOmNlMDdiOGQ2NDYwMDRjNDRhNDI1ZWY3YTgxZjQwMGI0L3RhYmxlcmFuZ2U6Y2UwN2I4ZDY0NjAwNGM0NGE0MjVlZjdhODFmNDAwYjRfMjktMC0xLTEtNjI2L3RleHRyZWdpb246ZWM2NGNlM2UxMmFkNGJiNWE1NWVhM2QzZGQ1MzI4MWVfMTg_b4fb904c-2377-4972-bbfe-6fb369132e0c"><ix:nonFraction unitRef="usdPerShare" contextRef="i4c8f247d12134a9886d56e1c8b024425_I20220630" decimals="INF" name="us-gaap:CommonStockParOrStatedValuePerShare" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmFlNWE5YmUwZWI5NDQ1ZDE5MmZhZTgyMmQyMmJlMDlmL3NlYzphZTVhOWJlMGViOTQ0NWQxOTJmYWU4MjJkMjJiZTA5Zl8xNi9mcmFnOmJjOWYxMWM1NjlkZjQyNzdhZDc1YjA3NzcyY2Q2NWQzL3RhYmxlOmNlMDdiOGQ2NDYwMDRjNDRhNDI1ZWY3YTgxZjQwMGI0L3RhYmxlcmFuZ2U6Y2UwN2I4ZDY0NjAwNGM0NGE0MjVlZjdhODFmNDAwYjRfMjktMC0xLTEtNjI2L3RleHRyZWdpb246ZWM2NGNlM2UxMmFkNGJiNWE1NWVhM2QzZGQ1MzI4MWVfMTg_d0fdbc64-e206-4645-b9c0-8d4d7b1e8642">0.0001</ix:nonFraction></ix:nonFraction> par value per share; <ix:nonFraction unitRef="shares" contextRef="i87bf777ccf5f4f93bc9be7a2cbba61c1_I20211231" decimals="INF" name="us-gaap:CommonStockSharesAuthorized" format="ixt:num-dot-decimal" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmFlNWE5YmUwZWI5NDQ1ZDE5MmZhZTgyMmQyMmJlMDlmL3NlYzphZTVhOWJlMGViOTQ0NWQxOTJmYWU4MjJkMjJiZTA5Zl8xNi9mcmFnOmJjOWYxMWM1NjlkZjQyNzdhZDc1YjA3NzcyY2Q2NWQzL3RhYmxlOmNlMDdiOGQ2NDYwMDRjNDRhNDI1ZWY3YTgxZjQwMGI0L3RhYmxlcmFuZ2U6Y2UwN2I4ZDY0NjAwNGM0NGE0MjVlZjdhODFmNDAwYjRfMjktMC0xLTEtNjI2L3RleHRyZWdpb246ZWM2NGNlM2UxMmFkNGJiNWE1NWVhM2QzZGQ1MzI4MWVfNDI_6d64a2db-1c22-4095-a89e-cfbc65f71554"><ix:nonFraction unitRef="shares" contextRef="i4c8f247d12134a9886d56e1c8b024425_I20220630" decimals="INF" name="us-gaap:CommonStockSharesAuthorized" format="ixt:num-dot-decimal" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmFlNWE5YmUwZWI5NDQ1ZDE5MmZhZTgyMmQyMmJlMDlmL3NlYzphZTVhOWJlMGViOTQ0NWQxOTJmYWU4MjJkMjJiZTA5Zl8xNi9mcmFnOmJjOWYxMWM1NjlkZjQyNzdhZDc1YjA3NzcyY2Q2NWQzL3RhYmxlOmNlMDdiOGQ2NDYwMDRjNDRhNDI1ZWY3YTgxZjQwMGI0L3RhYmxlcmFuZ2U6Y2UwN2I4ZDY0NjAwNGM0NGE0MjVlZjdhODFmNDAwYjRfMjktMC0xLTEtNjI2L3RleHRyZWdpb246ZWM2NGNlM2UxMmFkNGJiNWE1NWVhM2QzZGQ1MzI4MWVfNDI_7a900281-4c9f-40c1-8008-ea3365f90df6">50,000,000</ix:nonFraction></ix:nonFraction> shares authorized as of June&#160;30, 2022 and December&#160;31, 2021; <ix:nonFraction unitRef="shares" contextRef="i4c8f247d12134a9886d56e1c8b024425_I20220630" decimals="INF" name="us-gaap:CommonStockSharesIssued" format="ixt:num-dot-decimal" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmFlNWE5YmUwZWI5NDQ1ZDE5MmZhZTgyMmQyMmJlMDlmL3NlYzphZTVhOWJlMGViOTQ0NWQxOTJmYWU4MjJkMjJiZTA5Zl8xNi9mcmFnOmJjOWYxMWM1NjlkZjQyNzdhZDc1YjA3NzcyY2Q2NWQzL3RhYmxlOmNlMDdiOGQ2NDYwMDRjNDRhNDI1ZWY3YTgxZjQwMGI0L3RhYmxlcmFuZ2U6Y2UwN2I4ZDY0NjAwNGM0NGE0MjVlZjdhODFmNDAwYjRfMjktMC0xLTEtNjI2L3RleHRyZWdpb246ZWM2NGNlM2UxMmFkNGJiNWE1NWVhM2QzZGQ1MzI4MWVfODA_2bc0a47d-555f-40a4-bdd9-6b013158252e"><ix:nonFraction unitRef="shares" contextRef="i4c8f247d12134a9886d56e1c8b024425_I20220630" decimals="INF" name="us-gaap:CommonStockSharesOutstanding" format="ixt:num-dot-decimal" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmFlNWE5YmUwZWI5NDQ1ZDE5MmZhZTgyMmQyMmJlMDlmL3NlYzphZTVhOWJlMGViOTQ0NWQxOTJmYWU4MjJkMjJiZTA5Zl8xNi9mcmFnOmJjOWYxMWM1NjlkZjQyNzdhZDc1YjA3NzcyY2Q2NWQzL3RhYmxlOmNlMDdiOGQ2NDYwMDRjNDRhNDI1ZWY3YTgxZjQwMGI0L3RhYmxlcmFuZ2U6Y2UwN2I4ZDY0NjAwNGM0NGE0MjVlZjdhODFmNDAwYjRfMjktMC0xLTEtNjI2L3RleHRyZWdpb246ZWM2NGNlM2UxMmFkNGJiNWE1NWVhM2QzZGQ1MzI4MWVfODA_8222f86e-da45-47f2-a926-3251245c7824">30,038,447</ix:nonFraction></ix:nonFraction> and <ix:nonFraction unitRef="shares" contextRef="i87bf777ccf5f4f93bc9be7a2cbba61c1_I20211231" decimals="INF" name="us-gaap:CommonStockSharesIssued" format="ixt:num-dot-decimal" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmFlNWE5YmUwZWI5NDQ1ZDE5MmZhZTgyMmQyMmJlMDlmL3NlYzphZTVhOWJlMGViOTQ0NWQxOTJmYWU4MjJkMjJiZTA5Zl8xNi9mcmFnOmJjOWYxMWM1NjlkZjQyNzdhZDc1YjA3NzcyY2Q2NWQzL3RhYmxlOmNlMDdiOGQ2NDYwMDRjNDRhNDI1ZWY3YTgxZjQwMGI0L3RhYmxlcmFuZ2U6Y2UwN2I4ZDY0NjAwNGM0NGE0MjVlZjdhODFmNDAwYjRfMjktMC0xLTEtNjI2L3RleHRyZWdpb246ZWM2NGNlM2UxMmFkNGJiNWE1NWVhM2QzZGQ1MzI4MWVfODc_7c91ead6-a9e4-4fc5-8cf6-a5de72be1ac9"><ix:nonFraction unitRef="shares" contextRef="i87bf777ccf5f4f93bc9be7a2cbba61c1_I20211231" decimals="INF" name="us-gaap:CommonStockSharesOutstanding" format="ixt:num-dot-decimal" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmFlNWE5YmUwZWI5NDQ1ZDE5MmZhZTgyMmQyMmJlMDlmL3NlYzphZTVhOWJlMGViOTQ0NWQxOTJmYWU4MjJkMjJiZTA5Zl8xNi9mcmFnOmJjOWYxMWM1NjlkZjQyNzdhZDc1YjA3NzcyY2Q2NWQzL3RhYmxlOmNlMDdiOGQ2NDYwMDRjNDRhNDI1ZWY3YTgxZjQwMGI0L3RhYmxlcmFuZ2U6Y2UwN2I4ZDY0NjAwNGM0NGE0MjVlZjdhODFmNDAwYjRfMjktMC0xLTEtNjI2L3RleHRyZWdpb246ZWM2NGNlM2UxMmFkNGJiNWE1NWVhM2QzZGQ1MzI4MWVfODc_fb1da55b-e6e2-4666-bf92-9f61eb11d95e">29,772,922</ix:nonFraction></ix:nonFraction> shares issued and outstanding at June&#160;30, 2022 and December&#160;31, 2021, respectively</span></div></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i4c8f247d12134a9886d56e1c8b024425_I20220630" decimals="-3" name="us-gaap:CommonStockValue" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmFlNWE5YmUwZWI5NDQ1ZDE5MmZhZTgyMmQyMmJlMDlmL3NlYzphZTVhOWJlMGViOTQ0NWQxOTJmYWU4MjJkMjJiZTA5Zl8xNi9mcmFnOmJjOWYxMWM1NjlkZjQyNzdhZDc1YjA3NzcyY2Q2NWQzL3RhYmxlOmNlMDdiOGQ2NDYwMDRjNDRhNDI1ZWY3YTgxZjQwMGI0L3RhYmxlcmFuZ2U6Y2UwN2I4ZDY0NjAwNGM0NGE0MjVlZjdhODFmNDAwYjRfMjktMS0xLTEtNjI2_0471788c-ba7f-404a-9aaa-8cb1c33d9903">3</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i87bf777ccf5f4f93bc9be7a2cbba61c1_I20211231" decimals="-3" name="us-gaap:CommonStockValue" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmFlNWE5YmUwZWI5NDQ1ZDE5MmZhZTgyMmQyMmJlMDlmL3NlYzphZTVhOWJlMGViOTQ0NWQxOTJmYWU4MjJkMjJiZTA5Zl8xNi9mcmFnOmJjOWYxMWM1NjlkZjQyNzdhZDc1YjA3NzcyY2Q2NWQzL3RhYmxlOmNlMDdiOGQ2NDYwMDRjNDRhNDI1ZWY3YTgxZjQwMGI0L3RhYmxlcmFuZ2U6Y2UwN2I4ZDY0NjAwNGM0NGE0MjVlZjdhODFmNDAwYjRfMjktMy0xLTEtNjI2_ca5d919e-686a-4734-84ac-2d802effd7c3">3</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Additional paid-in capital</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i4c8f247d12134a9886d56e1c8b024425_I20220630" decimals="-3" name="us-gaap:AdditionalPaidInCapitalCommonStock" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmFlNWE5YmUwZWI5NDQ1ZDE5MmZhZTgyMmQyMmJlMDlmL3NlYzphZTVhOWJlMGViOTQ0NWQxOTJmYWU4MjJkMjJiZTA5Zl8xNi9mcmFnOmJjOWYxMWM1NjlkZjQyNzdhZDc1YjA3NzcyY2Q2NWQzL3RhYmxlOmNlMDdiOGQ2NDYwMDRjNDRhNDI1ZWY3YTgxZjQwMGI0L3RhYmxlcmFuZ2U6Y2UwN2I4ZDY0NjAwNGM0NGE0MjVlZjdhODFmNDAwYjRfMzAtMS0xLTEtNjI2_135a8620-0946-44cd-9fae-442bc749c5b5">445,491</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i87bf777ccf5f4f93bc9be7a2cbba61c1_I20211231" decimals="-3" name="us-gaap:AdditionalPaidInCapitalCommonStock" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmFlNWE5YmUwZWI5NDQ1ZDE5MmZhZTgyMmQyMmJlMDlmL3NlYzphZTVhOWJlMGViOTQ0NWQxOTJmYWU4MjJkMjJiZTA5Zl8xNi9mcmFnOmJjOWYxMWM1NjlkZjQyNzdhZDc1YjA3NzcyY2Q2NWQzL3RhYmxlOmNlMDdiOGQ2NDYwMDRjNDRhNDI1ZWY3YTgxZjQwMGI0L3RhYmxlcmFuZ2U6Y2UwN2I4ZDY0NjAwNGM0NGE0MjVlZjdhODFmNDAwYjRfMzAtMy0xLTEtNjI2_4d05958d-7a57-4b14-8644-27f784e82417">436,183</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Accumulated other comprehensive loss</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i4c8f247d12134a9886d56e1c8b024425_I20220630" decimals="-3" sign="-" name="us-gaap:AccumulatedOtherComprehensiveIncomeLossNetOfTax" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmFlNWE5YmUwZWI5NDQ1ZDE5MmZhZTgyMmQyMmJlMDlmL3NlYzphZTVhOWJlMGViOTQ0NWQxOTJmYWU4MjJkMjJiZTA5Zl8xNi9mcmFnOmJjOWYxMWM1NjlkZjQyNzdhZDc1YjA3NzcyY2Q2NWQzL3RhYmxlOmNlMDdiOGQ2NDYwMDRjNDRhNDI1ZWY3YTgxZjQwMGI0L3RhYmxlcmFuZ2U6Y2UwN2I4ZDY0NjAwNGM0NGE0MjVlZjdhODFmNDAwYjRfMzEtMS0xLTEtNjI2_e7372875-0a16-4671-a15c-bea8b3d4d118">865</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i87bf777ccf5f4f93bc9be7a2cbba61c1_I20211231" decimals="-3" sign="-" name="us-gaap:AccumulatedOtherComprehensiveIncomeLossNetOfTax" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmFlNWE5YmUwZWI5NDQ1ZDE5MmZhZTgyMmQyMmJlMDlmL3NlYzphZTVhOWJlMGViOTQ0NWQxOTJmYWU4MjJkMjJiZTA5Zl8xNi9mcmFnOmJjOWYxMWM1NjlkZjQyNzdhZDc1YjA3NzcyY2Q2NWQzL3RhYmxlOmNlMDdiOGQ2NDYwMDRjNDRhNDI1ZWY3YTgxZjQwMGI0L3RhYmxlcmFuZ2U6Y2UwN2I4ZDY0NjAwNGM0NGE0MjVlZjdhODFmNDAwYjRfMzEtMy0xLTEtNjI2_504e39f2-ab2d-4a9f-a6b8-affb01475e4c">124</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Accumulated deficit</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i4c8f247d12134a9886d56e1c8b024425_I20220630" decimals="-3" sign="-" name="us-gaap:RetainedEarningsAccumulatedDeficit" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmFlNWE5YmUwZWI5NDQ1ZDE5MmZhZTgyMmQyMmJlMDlmL3NlYzphZTVhOWJlMGViOTQ0NWQxOTJmYWU4MjJkMjJiZTA5Zl8xNi9mcmFnOmJjOWYxMWM1NjlkZjQyNzdhZDc1YjA3NzcyY2Q2NWQzL3RhYmxlOmNlMDdiOGQ2NDYwMDRjNDRhNDI1ZWY3YTgxZjQwMGI0L3RhYmxlcmFuZ2U6Y2UwN2I4ZDY0NjAwNGM0NGE0MjVlZjdhODFmNDAwYjRfMzItMS0xLTEtNjI2_a3b960c5-4c09-46e3-969f-cad6bfcab856">266,052</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i87bf777ccf5f4f93bc9be7a2cbba61c1_I20211231" decimals="-3" sign="-" name="us-gaap:RetainedEarningsAccumulatedDeficit" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmFlNWE5YmUwZWI5NDQ1ZDE5MmZhZTgyMmQyMmJlMDlmL3NlYzphZTVhOWJlMGViOTQ0NWQxOTJmYWU4MjJkMjJiZTA5Zl8xNi9mcmFnOmJjOWYxMWM1NjlkZjQyNzdhZDc1YjA3NzcyY2Q2NWQzL3RhYmxlOmNlMDdiOGQ2NDYwMDRjNDRhNDI1ZWY3YTgxZjQwMGI0L3RhYmxlcmFuZ2U6Y2UwN2I4ZDY0NjAwNGM0NGE0MjVlZjdhODFmNDAwYjRfMzItMy0xLTEtNjI2_9d91a5f1-6365-4dc6-af18-1a320a6d56ec">206,364</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 37pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total stockholders&#8217; equity</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i4c8f247d12134a9886d56e1c8b024425_I20220630" decimals="-3" name="us-gaap:StockholdersEquity" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmFlNWE5YmUwZWI5NDQ1ZDE5MmZhZTgyMmQyMmJlMDlmL3NlYzphZTVhOWJlMGViOTQ0NWQxOTJmYWU4MjJkMjJiZTA5Zl8xNi9mcmFnOmJjOWYxMWM1NjlkZjQyNzdhZDc1YjA3NzcyY2Q2NWQzL3RhYmxlOmNlMDdiOGQ2NDYwMDRjNDRhNDI1ZWY3YTgxZjQwMGI0L3RhYmxlcmFuZ2U6Y2UwN2I4ZDY0NjAwNGM0NGE0MjVlZjdhODFmNDAwYjRfMzMtMS0xLTEtNjI2_e2708b4e-2dea-415e-a8b4-d5b7b51a1362">178,577</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i87bf777ccf5f4f93bc9be7a2cbba61c1_I20211231" decimals="-3" name="us-gaap:StockholdersEquity" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmFlNWE5YmUwZWI5NDQ1ZDE5MmZhZTgyMmQyMmJlMDlmL3NlYzphZTVhOWJlMGViOTQ0NWQxOTJmYWU4MjJkMjJiZTA5Zl8xNi9mcmFnOmJjOWYxMWM1NjlkZjQyNzdhZDc1YjA3NzcyY2Q2NWQzL3RhYmxlOmNlMDdiOGQ2NDYwMDRjNDRhNDI1ZWY3YTgxZjQwMGI0L3RhYmxlcmFuZ2U6Y2UwN2I4ZDY0NjAwNGM0NGE0MjVlZjdhODFmNDAwYjRfMzMtMy0xLTEtNjI2_6a274869-f17c-4c59-acab-c3b999f17b8e">229,698</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 37pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total liabilities and stockholders&#8217; equity</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i4c8f247d12134a9886d56e1c8b024425_I20220630" decimals="-3" name="us-gaap:LiabilitiesAndStockholdersEquity" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmFlNWE5YmUwZWI5NDQ1ZDE5MmZhZTgyMmQyMmJlMDlmL3NlYzphZTVhOWJlMGViOTQ0NWQxOTJmYWU4MjJkMjJiZTA5Zl8xNi9mcmFnOmJjOWYxMWM1NjlkZjQyNzdhZDc1YjA3NzcyY2Q2NWQzL3RhYmxlOmNlMDdiOGQ2NDYwMDRjNDRhNDI1ZWY3YTgxZjQwMGI0L3RhYmxlcmFuZ2U6Y2UwN2I4ZDY0NjAwNGM0NGE0MjVlZjdhODFmNDAwYjRfMzQtMS0xLTEtNjI2_51628990-6f0c-4ca5-be82-1ea9f80c0a1b">216,112</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i87bf777ccf5f4f93bc9be7a2cbba61c1_I20211231" decimals="-3" name="us-gaap:LiabilitiesAndStockholdersEquity" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmFlNWE5YmUwZWI5NDQ1ZDE5MmZhZTgyMmQyMmJlMDlmL3NlYzphZTVhOWJlMGViOTQ0NWQxOTJmYWU4MjJkMjJiZTA5Zl8xNi9mcmFnOmJjOWYxMWM1NjlkZjQyNzdhZDc1YjA3NzcyY2Q2NWQzL3RhYmxlOmNlMDdiOGQ2NDYwMDRjNDRhNDI1ZWY3YTgxZjQwMGI0L3RhYmxlcmFuZ2U6Y2UwN2I4ZDY0NjAwNGM0NGE0MjVlZjdhODFmNDAwYjRfMzQtMy0xLTEtNjI2_de9dfecb-e889-4ce2-aef6-0b839c3fe4c5">248,309</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><div style="margin-top:12pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">See accompanying notes to unaudited condensed consolidated financial statements.</span></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">1</span></div></div></div><div id="iae5a9be0eb9445d192fae822d22be09f_19"></div><hr style="page-break-after:always"/><div style="min-height:45pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#iae5a9be0eb9445d192fae822d22be09f_7">Table of Contents</a></span></div></div><div style="margin-top:12pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">DERMTECH, INC.</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Condensed Consolidated Statements of Operations </span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">(in thousands, except share and per share data)</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">(Unaudited)</span></div><div style="margin-top:12pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:44.354%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.081%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.406%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.081%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.406%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.081%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.406%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.085%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Three Months Ended June 30,</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Six Months Ended June 30,</span></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2021</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Revenues:</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Assay revenue</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i6e93ea7e6de54e3b99964d226c95da1b_D20220401-20220630" decimals="-3" name="us-gaap:RevenueFromContractWithCustomerIncludingAssessedTax" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmFlNWE5YmUwZWI5NDQ1ZDE5MmZhZTgyMmQyMmJlMDlmL3NlYzphZTVhOWJlMGViOTQ0NWQxOTJmYWU4MjJkMjJiZTA5Zl8xOS9mcmFnOmE1NTY4MGVlYzE3MzRiYjU4MWRkMDMwM2I4MjVjM2FlL3RhYmxlOjhhZTZlM2VjMmI5NDRjZjA5NDg4ZDVlZWIzOWQyZTQ4L3RhYmxlcmFuZ2U6OGFlNmUzZWMyYjk0NGNmMDk0ODhkNWVlYjM5ZDJlNDhfMy0xLTEtMS02MjY_1952f741-609f-4017-8e15-7a91b3c29d1f">4,147</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i37138912f4f54957978d26b438559810_D20210401-20210630" decimals="-3" name="us-gaap:RevenueFromContractWithCustomerIncludingAssessedTax" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmFlNWE5YmUwZWI5NDQ1ZDE5MmZhZTgyMmQyMmJlMDlmL3NlYzphZTVhOWJlMGViOTQ0NWQxOTJmYWU4MjJkMjJiZTA5Zl8xOS9mcmFnOmE1NTY4MGVlYzE3MzRiYjU4MWRkMDMwM2I4MjVjM2FlL3RhYmxlOjhhZTZlM2VjMmI5NDRjZjA5NDg4ZDVlZWIzOWQyZTQ4L3RhYmxlcmFuZ2U6OGFlNmUzZWMyYjk0NGNmMDk0ODhkNWVlYjM5ZDJlNDhfMy0zLTEtMS02MjY_7c1c61b0-c399-4621-8694-7cc7d46478fd">2,910</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i162096998d12445db5b600d98dd798a7_D20220101-20220630" decimals="-3" name="us-gaap:RevenueFromContractWithCustomerIncludingAssessedTax" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmFlNWE5YmUwZWI5NDQ1ZDE5MmZhZTgyMmQyMmJlMDlmL3NlYzphZTVhOWJlMGViOTQ0NWQxOTJmYWU4MjJkMjJiZTA5Zl8xOS9mcmFnOmE1NTY4MGVlYzE3MzRiYjU4MWRkMDMwM2I4MjVjM2FlL3RhYmxlOjhhZTZlM2VjMmI5NDRjZjA5NDg4ZDVlZWIzOWQyZTQ4L3RhYmxlcmFuZ2U6OGFlNmUzZWMyYjk0NGNmMDk0ODhkNWVlYjM5ZDJlNDhfMy01LTEtMS02MjY_35dfa1e7-4d95-40ab-bdfb-22ea4d262a85">7,665</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib998ae4e71544a4aa86f6166fce08ce5_D20210101-20210630" decimals="-3" name="us-gaap:RevenueFromContractWithCustomerIncludingAssessedTax" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmFlNWE5YmUwZWI5NDQ1ZDE5MmZhZTgyMmQyMmJlMDlmL3NlYzphZTVhOWJlMGViOTQ0NWQxOTJmYWU4MjJkMjJiZTA5Zl8xOS9mcmFnOmE1NTY4MGVlYzE3MzRiYjU4MWRkMDMwM2I4MjVjM2FlL3RhYmxlOjhhZTZlM2VjMmI5NDRjZjA5NDg4ZDVlZWIzOWQyZTQ4L3RhYmxlcmFuZ2U6OGFlNmUzZWMyYjk0NGNmMDk0ODhkNWVlYjM5ZDJlNDhfMy03LTEtMS02MjY_5de820c0-b680-46a1-bfb0-d3f6461e5bda">5,100</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Contract revenue</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i78ce1dff723a4a809549de43dc758409_D20220401-20220630" decimals="-3" name="us-gaap:RevenueFromContractWithCustomerIncludingAssessedTax" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmFlNWE5YmUwZWI5NDQ1ZDE5MmZhZTgyMmQyMmJlMDlmL3NlYzphZTVhOWJlMGViOTQ0NWQxOTJmYWU4MjJkMjJiZTA5Zl8xOS9mcmFnOmE1NTY4MGVlYzE3MzRiYjU4MWRkMDMwM2I4MjVjM2FlL3RhYmxlOjhhZTZlM2VjMmI5NDRjZjA5NDg4ZDVlZWIzOWQyZTQ4L3RhYmxlcmFuZ2U6OGFlNmUzZWMyYjk0NGNmMDk0ODhkNWVlYjM5ZDJlNDhfNC0xLTEtMS02MjY_75d79c09-0cbb-4e06-8f35-552a51f5d4b7">86</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i56c0d5eff1614a048c29e3f98fd6e1bd_D20210401-20210630" decimals="-3" name="us-gaap:RevenueFromContractWithCustomerIncludingAssessedTax" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmFlNWE5YmUwZWI5NDQ1ZDE5MmZhZTgyMmQyMmJlMDlmL3NlYzphZTVhOWJlMGViOTQ0NWQxOTJmYWU4MjJkMjJiZTA5Zl8xOS9mcmFnOmE1NTY4MGVlYzE3MzRiYjU4MWRkMDMwM2I4MjVjM2FlL3RhYmxlOjhhZTZlM2VjMmI5NDRjZjA5NDg4ZDVlZWIzOWQyZTQ4L3RhYmxlcmFuZ2U6OGFlNmUzZWMyYjk0NGNmMDk0ODhkNWVlYjM5ZDJlNDhfNC0zLTEtMS02MjY_2319375f-5653-4e81-a911-8babd95cba8d">209</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i615ec51fc143458883f5b2236ee7fa4e_D20220101-20220630" decimals="-3" name="us-gaap:RevenueFromContractWithCustomerIncludingAssessedTax" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmFlNWE5YmUwZWI5NDQ1ZDE5MmZhZTgyMmQyMmJlMDlmL3NlYzphZTVhOWJlMGViOTQ0NWQxOTJmYWU4MjJkMjJiZTA5Zl8xOS9mcmFnOmE1NTY4MGVlYzE3MzRiYjU4MWRkMDMwM2I4MjVjM2FlL3RhYmxlOjhhZTZlM2VjMmI5NDRjZjA5NDg4ZDVlZWIzOWQyZTQ4L3RhYmxlcmFuZ2U6OGFlNmUzZWMyYjk0NGNmMDk0ODhkNWVlYjM5ZDJlNDhfNC01LTEtMS02MjY_82b17412-c081-4458-bc84-201df85bb5cf">286</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i3b92d912bf1a4d219b2f1cafa797b274_D20210101-20210630" decimals="-3" name="us-gaap:RevenueFromContractWithCustomerIncludingAssessedTax" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmFlNWE5YmUwZWI5NDQ1ZDE5MmZhZTgyMmQyMmJlMDlmL3NlYzphZTVhOWJlMGViOTQ0NWQxOTJmYWU4MjJkMjJiZTA5Zl8xOS9mcmFnOmE1NTY4MGVlYzE3MzRiYjU4MWRkMDMwM2I4MjVjM2FlL3RhYmxlOjhhZTZlM2VjMmI5NDRjZjA5NDg4ZDVlZWIzOWQyZTQ4L3RhYmxlcmFuZ2U6OGFlNmUzZWMyYjk0NGNmMDk0ODhkNWVlYjM5ZDJlNDhfNC03LTEtMS02MjY_a923facf-c35e-42c5-9ce2-37dfee0f29c8">543</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 37pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total revenues</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i2c5f0f28773744e5a2e202f2943ae976_D20220401-20220630" decimals="-3" name="us-gaap:RevenueFromContractWithCustomerIncludingAssessedTax" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmFlNWE5YmUwZWI5NDQ1ZDE5MmZhZTgyMmQyMmJlMDlmL3NlYzphZTVhOWJlMGViOTQ0NWQxOTJmYWU4MjJkMjJiZTA5Zl8xOS9mcmFnOmE1NTY4MGVlYzE3MzRiYjU4MWRkMDMwM2I4MjVjM2FlL3RhYmxlOjhhZTZlM2VjMmI5NDRjZjA5NDg4ZDVlZWIzOWQyZTQ4L3RhYmxlcmFuZ2U6OGFlNmUzZWMyYjk0NGNmMDk0ODhkNWVlYjM5ZDJlNDhfNS0xLTEtMS02MjY_88c00e36-6940-4623-9248-97319c7d1568">4,233</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="id7bb773872394047ba26aa8a7a0f4d56_D20210401-20210630" decimals="-3" name="us-gaap:RevenueFromContractWithCustomerIncludingAssessedTax" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmFlNWE5YmUwZWI5NDQ1ZDE5MmZhZTgyMmQyMmJlMDlmL3NlYzphZTVhOWJlMGViOTQ0NWQxOTJmYWU4MjJkMjJiZTA5Zl8xOS9mcmFnOmE1NTY4MGVlYzE3MzRiYjU4MWRkMDMwM2I4MjVjM2FlL3RhYmxlOjhhZTZlM2VjMmI5NDRjZjA5NDg4ZDVlZWIzOWQyZTQ4L3RhYmxlcmFuZ2U6OGFlNmUzZWMyYjk0NGNmMDk0ODhkNWVlYjM5ZDJlNDhfNS0zLTEtMS02MjY_dce97772-8a67-44be-8114-22ead368b73b">3,119</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ia855382ada1f4f28aa8ef6da692ff177_D20220101-20220630" decimals="-3" name="us-gaap:RevenueFromContractWithCustomerIncludingAssessedTax" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmFlNWE5YmUwZWI5NDQ1ZDE5MmZhZTgyMmQyMmJlMDlmL3NlYzphZTVhOWJlMGViOTQ0NWQxOTJmYWU4MjJkMjJiZTA5Zl8xOS9mcmFnOmE1NTY4MGVlYzE3MzRiYjU4MWRkMDMwM2I4MjVjM2FlL3RhYmxlOjhhZTZlM2VjMmI5NDRjZjA5NDg4ZDVlZWIzOWQyZTQ4L3RhYmxlcmFuZ2U6OGFlNmUzZWMyYjk0NGNmMDk0ODhkNWVlYjM5ZDJlNDhfNS01LTEtMS02MjY_0c691900-7592-4eb1-9521-f3a07a224d0e">7,951</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="idaa4f31ca59a4a17a59c2580b97791ca_D20210101-20210630" decimals="-3" name="us-gaap:RevenueFromContractWithCustomerIncludingAssessedTax" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmFlNWE5YmUwZWI5NDQ1ZDE5MmZhZTgyMmQyMmJlMDlmL3NlYzphZTVhOWJlMGViOTQ0NWQxOTJmYWU4MjJkMjJiZTA5Zl8xOS9mcmFnOmE1NTY4MGVlYzE3MzRiYjU4MWRkMDMwM2I4MjVjM2FlL3RhYmxlOjhhZTZlM2VjMmI5NDRjZjA5NDg4ZDVlZWIzOWQyZTQ4L3RhYmxlcmFuZ2U6OGFlNmUzZWMyYjk0NGNmMDk0ODhkNWVlYjM5ZDJlNDhfNS03LTEtMS02MjY_91ddc6be-f4d9-496a-8c5c-b4446f1490c3">5,643</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cost of revenues:</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cost of assay revenue</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i6e93ea7e6de54e3b99964d226c95da1b_D20220401-20220630" decimals="-3" name="us-gaap:CostOfRevenue" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmFlNWE5YmUwZWI5NDQ1ZDE5MmZhZTgyMmQyMmJlMDlmL3NlYzphZTVhOWJlMGViOTQ0NWQxOTJmYWU4MjJkMjJiZTA5Zl8xOS9mcmFnOmE1NTY4MGVlYzE3MzRiYjU4MWRkMDMwM2I4MjVjM2FlL3RhYmxlOjhhZTZlM2VjMmI5NDRjZjA5NDg4ZDVlZWIzOWQyZTQ4L3RhYmxlcmFuZ2U6OGFlNmUzZWMyYjk0NGNmMDk0ODhkNWVlYjM5ZDJlNDhfNy0xLTEtMS02MjY_ef1464b6-9d44-498e-bcc5-af6740c82b44">3,236</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i37138912f4f54957978d26b438559810_D20210401-20210630" decimals="-3" name="us-gaap:CostOfRevenue" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmFlNWE5YmUwZWI5NDQ1ZDE5MmZhZTgyMmQyMmJlMDlmL3NlYzphZTVhOWJlMGViOTQ0NWQxOTJmYWU4MjJkMjJiZTA5Zl8xOS9mcmFnOmE1NTY4MGVlYzE3MzRiYjU4MWRkMDMwM2I4MjVjM2FlL3RhYmxlOjhhZTZlM2VjMmI5NDRjZjA5NDg4ZDVlZWIzOWQyZTQ4L3RhYmxlcmFuZ2U6OGFlNmUzZWMyYjk0NGNmMDk0ODhkNWVlYjM5ZDJlNDhfNy0zLTEtMS02MjY_a906e624-b88b-47cf-8d07-5b92d62ccea8">2,604</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i162096998d12445db5b600d98dd798a7_D20220101-20220630" decimals="-3" name="us-gaap:CostOfRevenue" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmFlNWE5YmUwZWI5NDQ1ZDE5MmZhZTgyMmQyMmJlMDlmL3NlYzphZTVhOWJlMGViOTQ0NWQxOTJmYWU4MjJkMjJiZTA5Zl8xOS9mcmFnOmE1NTY4MGVlYzE3MzRiYjU4MWRkMDMwM2I4MjVjM2FlL3RhYmxlOjhhZTZlM2VjMmI5NDRjZjA5NDg4ZDVlZWIzOWQyZTQ4L3RhYmxlcmFuZ2U6OGFlNmUzZWMyYjk0NGNmMDk0ODhkNWVlYjM5ZDJlNDhfNy01LTEtMS02MjY_4031a8ca-bc57-4534-a104-b7311df0e280">6,766</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib998ae4e71544a4aa86f6166fce08ce5_D20210101-20210630" decimals="-3" name="us-gaap:CostOfRevenue" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmFlNWE5YmUwZWI5NDQ1ZDE5MmZhZTgyMmQyMmJlMDlmL3NlYzphZTVhOWJlMGViOTQ0NWQxOTJmYWU4MjJkMjJiZTA5Zl8xOS9mcmFnOmE1NTY4MGVlYzE3MzRiYjU4MWRkMDMwM2I4MjVjM2FlL3RhYmxlOjhhZTZlM2VjMmI5NDRjZjA5NDg4ZDVlZWIzOWQyZTQ4L3RhYmxlcmFuZ2U6OGFlNmUzZWMyYjk0NGNmMDk0ODhkNWVlYjM5ZDJlNDhfNy03LTEtMS02MjY_f51f344a-203b-411c-a1d6-b9ca3eae3347">4,575</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cost of contract revenue</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i78ce1dff723a4a809549de43dc758409_D20220401-20220630" decimals="-3" name="us-gaap:CostOfRevenue" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmFlNWE5YmUwZWI5NDQ1ZDE5MmZhZTgyMmQyMmJlMDlmL3NlYzphZTVhOWJlMGViOTQ0NWQxOTJmYWU4MjJkMjJiZTA5Zl8xOS9mcmFnOmE1NTY4MGVlYzE3MzRiYjU4MWRkMDMwM2I4MjVjM2FlL3RhYmxlOjhhZTZlM2VjMmI5NDRjZjA5NDg4ZDVlZWIzOWQyZTQ4L3RhYmxlcmFuZ2U6OGFlNmUzZWMyYjk0NGNmMDk0ODhkNWVlYjM5ZDJlNDhfOC0xLTEtMS02MjY_d1c09510-786c-4062-bfdb-03868b9b9ff0">37</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i56c0d5eff1614a048c29e3f98fd6e1bd_D20210401-20210630" decimals="-3" name="us-gaap:CostOfRevenue" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmFlNWE5YmUwZWI5NDQ1ZDE5MmZhZTgyMmQyMmJlMDlmL3NlYzphZTVhOWJlMGViOTQ0NWQxOTJmYWU4MjJkMjJiZTA5Zl8xOS9mcmFnOmE1NTY4MGVlYzE3MzRiYjU4MWRkMDMwM2I4MjVjM2FlL3RhYmxlOjhhZTZlM2VjMmI5NDRjZjA5NDg4ZDVlZWIzOWQyZTQ4L3RhYmxlcmFuZ2U6OGFlNmUzZWMyYjk0NGNmMDk0ODhkNWVlYjM5ZDJlNDhfOC0zLTEtMS02MjY_d8aa20ef-0b38-4888-bd03-2d25f809437e">20</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i615ec51fc143458883f5b2236ee7fa4e_D20220101-20220630" decimals="-3" name="us-gaap:CostOfRevenue" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmFlNWE5YmUwZWI5NDQ1ZDE5MmZhZTgyMmQyMmJlMDlmL3NlYzphZTVhOWJlMGViOTQ0NWQxOTJmYWU4MjJkMjJiZTA5Zl8xOS9mcmFnOmE1NTY4MGVlYzE3MzRiYjU4MWRkMDMwM2I4MjVjM2FlL3RhYmxlOjhhZTZlM2VjMmI5NDRjZjA5NDg4ZDVlZWIzOWQyZTQ4L3RhYmxlcmFuZ2U6OGFlNmUzZWMyYjk0NGNmMDk0ODhkNWVlYjM5ZDJlNDhfOC01LTEtMS02MjY_94908829-8294-40a1-ba92-6f6718970b0c">61</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i3b92d912bf1a4d219b2f1cafa797b274_D20210101-20210630" decimals="-3" name="us-gaap:CostOfRevenue" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmFlNWE5YmUwZWI5NDQ1ZDE5MmZhZTgyMmQyMmJlMDlmL3NlYzphZTVhOWJlMGViOTQ0NWQxOTJmYWU4MjJkMjJiZTA5Zl8xOS9mcmFnOmE1NTY4MGVlYzE3MzRiYjU4MWRkMDMwM2I4MjVjM2FlL3RhYmxlOjhhZTZlM2VjMmI5NDRjZjA5NDg4ZDVlZWIzOWQyZTQ4L3RhYmxlcmFuZ2U6OGFlNmUzZWMyYjk0NGNmMDk0ODhkNWVlYjM5ZDJlNDhfOC03LTEtMS02MjY_084449e6-ffdb-42a3-9a36-0c4a0831b086">51</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 37pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total cost of revenues</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i2c5f0f28773744e5a2e202f2943ae976_D20220401-20220630" decimals="-3" name="us-gaap:CostOfRevenue" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmFlNWE5YmUwZWI5NDQ1ZDE5MmZhZTgyMmQyMmJlMDlmL3NlYzphZTVhOWJlMGViOTQ0NWQxOTJmYWU4MjJkMjJiZTA5Zl8xOS9mcmFnOmE1NTY4MGVlYzE3MzRiYjU4MWRkMDMwM2I4MjVjM2FlL3RhYmxlOjhhZTZlM2VjMmI5NDRjZjA5NDg4ZDVlZWIzOWQyZTQ4L3RhYmxlcmFuZ2U6OGFlNmUzZWMyYjk0NGNmMDk0ODhkNWVlYjM5ZDJlNDhfOS0xLTEtMS02MjY_9ba656e4-181b-4152-bfa1-31c99481fe51">3,273</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="id7bb773872394047ba26aa8a7a0f4d56_D20210401-20210630" decimals="-3" name="us-gaap:CostOfRevenue" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmFlNWE5YmUwZWI5NDQ1ZDE5MmZhZTgyMmQyMmJlMDlmL3NlYzphZTVhOWJlMGViOTQ0NWQxOTJmYWU4MjJkMjJiZTA5Zl8xOS9mcmFnOmE1NTY4MGVlYzE3MzRiYjU4MWRkMDMwM2I4MjVjM2FlL3RhYmxlOjhhZTZlM2VjMmI5NDRjZjA5NDg4ZDVlZWIzOWQyZTQ4L3RhYmxlcmFuZ2U6OGFlNmUzZWMyYjk0NGNmMDk0ODhkNWVlYjM5ZDJlNDhfOS0zLTEtMS02MjY_9ef6ce82-8994-4275-bd0d-d7d5cddb531e">2,624</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ia855382ada1f4f28aa8ef6da692ff177_D20220101-20220630" decimals="-3" name="us-gaap:CostOfRevenue" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmFlNWE5YmUwZWI5NDQ1ZDE5MmZhZTgyMmQyMmJlMDlmL3NlYzphZTVhOWJlMGViOTQ0NWQxOTJmYWU4MjJkMjJiZTA5Zl8xOS9mcmFnOmE1NTY4MGVlYzE3MzRiYjU4MWRkMDMwM2I4MjVjM2FlL3RhYmxlOjhhZTZlM2VjMmI5NDRjZjA5NDg4ZDVlZWIzOWQyZTQ4L3RhYmxlcmFuZ2U6OGFlNmUzZWMyYjk0NGNmMDk0ODhkNWVlYjM5ZDJlNDhfOS01LTEtMS02MjY_de2afb7c-32ca-47a2-b1e0-16e9b5d461b1">6,827</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="idaa4f31ca59a4a17a59c2580b97791ca_D20210101-20210630" decimals="-3" name="us-gaap:CostOfRevenue" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmFlNWE5YmUwZWI5NDQ1ZDE5MmZhZTgyMmQyMmJlMDlmL3NlYzphZTVhOWJlMGViOTQ0NWQxOTJmYWU4MjJkMjJiZTA5Zl8xOS9mcmFnOmE1NTY4MGVlYzE3MzRiYjU4MWRkMDMwM2I4MjVjM2FlL3RhYmxlOjhhZTZlM2VjMmI5NDRjZjA5NDg4ZDVlZWIzOWQyZTQ4L3RhYmxlcmFuZ2U6OGFlNmUzZWMyYjk0NGNmMDk0ODhkNWVlYjM5ZDJlNDhfOS03LTEtMS02MjY_67957f0d-5275-47c4-842d-bd29efaddf05">4,626</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 37pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Gross profit</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i2c5f0f28773744e5a2e202f2943ae976_D20220401-20220630" decimals="-3" name="us-gaap:GrossProfit" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmFlNWE5YmUwZWI5NDQ1ZDE5MmZhZTgyMmQyMmJlMDlmL3NlYzphZTVhOWJlMGViOTQ0NWQxOTJmYWU4MjJkMjJiZTA5Zl8xOS9mcmFnOmE1NTY4MGVlYzE3MzRiYjU4MWRkMDMwM2I4MjVjM2FlL3RhYmxlOjhhZTZlM2VjMmI5NDRjZjA5NDg4ZDVlZWIzOWQyZTQ4L3RhYmxlcmFuZ2U6OGFlNmUzZWMyYjk0NGNmMDk0ODhkNWVlYjM5ZDJlNDhfMTAtMS0xLTEtNjI2_08fe76f0-d0f7-45b8-b0be-b77a712864d2">960</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="id7bb773872394047ba26aa8a7a0f4d56_D20210401-20210630" decimals="-3" name="us-gaap:GrossProfit" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmFlNWE5YmUwZWI5NDQ1ZDE5MmZhZTgyMmQyMmJlMDlmL3NlYzphZTVhOWJlMGViOTQ0NWQxOTJmYWU4MjJkMjJiZTA5Zl8xOS9mcmFnOmE1NTY4MGVlYzE3MzRiYjU4MWRkMDMwM2I4MjVjM2FlL3RhYmxlOjhhZTZlM2VjMmI5NDRjZjA5NDg4ZDVlZWIzOWQyZTQ4L3RhYmxlcmFuZ2U6OGFlNmUzZWMyYjk0NGNmMDk0ODhkNWVlYjM5ZDJlNDhfMTAtMy0xLTEtNjI2_015e274b-e779-4757-8d7f-3f48973625e3">495</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ia855382ada1f4f28aa8ef6da692ff177_D20220101-20220630" decimals="-3" name="us-gaap:GrossProfit" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmFlNWE5YmUwZWI5NDQ1ZDE5MmZhZTgyMmQyMmJlMDlmL3NlYzphZTVhOWJlMGViOTQ0NWQxOTJmYWU4MjJkMjJiZTA5Zl8xOS9mcmFnOmE1NTY4MGVlYzE3MzRiYjU4MWRkMDMwM2I4MjVjM2FlL3RhYmxlOjhhZTZlM2VjMmI5NDRjZjA5NDg4ZDVlZWIzOWQyZTQ4L3RhYmxlcmFuZ2U6OGFlNmUzZWMyYjk0NGNmMDk0ODhkNWVlYjM5ZDJlNDhfMTAtNS0xLTEtNjI2_1738b2c0-7248-424a-876f-8cadb3d53ace">1,124</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="idaa4f31ca59a4a17a59c2580b97791ca_D20210101-20210630" decimals="-3" name="us-gaap:GrossProfit" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmFlNWE5YmUwZWI5NDQ1ZDE5MmZhZTgyMmQyMmJlMDlmL3NlYzphZTVhOWJlMGViOTQ0NWQxOTJmYWU4MjJkMjJiZTA5Zl8xOS9mcmFnOmE1NTY4MGVlYzE3MzRiYjU4MWRkMDMwM2I4MjVjM2FlL3RhYmxlOjhhZTZlM2VjMmI5NDRjZjA5NDg4ZDVlZWIzOWQyZTQ4L3RhYmxlcmFuZ2U6OGFlNmUzZWMyYjk0NGNmMDk0ODhkNWVlYjM5ZDJlNDhfMTAtNy0xLTEtNjI2_90fee735-bddd-417b-8394-e08270d15e9f">1,017</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Operating expenses:</span></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Sales and marketing</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i2c5f0f28773744e5a2e202f2943ae976_D20220401-20220630" decimals="-3" name="us-gaap:SellingAndMarketingExpense" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmFlNWE5YmUwZWI5NDQ1ZDE5MmZhZTgyMmQyMmJlMDlmL3NlYzphZTVhOWJlMGViOTQ0NWQxOTJmYWU4MjJkMjJiZTA5Zl8xOS9mcmFnOmE1NTY4MGVlYzE3MzRiYjU4MWRkMDMwM2I4MjVjM2FlL3RhYmxlOjhhZTZlM2VjMmI5NDRjZjA5NDg4ZDVlZWIzOWQyZTQ4L3RhYmxlcmFuZ2U6OGFlNmUzZWMyYjk0NGNmMDk0ODhkNWVlYjM5ZDJlNDhfMTItMS0xLTEtNjI2_ff40f361-62bc-4685-98f5-1491f8cd6a8b">15,001</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="id7bb773872394047ba26aa8a7a0f4d56_D20210401-20210630" decimals="-3" name="us-gaap:SellingAndMarketingExpense" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmFlNWE5YmUwZWI5NDQ1ZDE5MmZhZTgyMmQyMmJlMDlmL3NlYzphZTVhOWJlMGViOTQ0NWQxOTJmYWU4MjJkMjJiZTA5Zl8xOS9mcmFnOmE1NTY4MGVlYzE3MzRiYjU4MWRkMDMwM2I4MjVjM2FlL3RhYmxlOjhhZTZlM2VjMmI5NDRjZjA5NDg4ZDVlZWIzOWQyZTQ4L3RhYmxlcmFuZ2U6OGFlNmUzZWMyYjk0NGNmMDk0ODhkNWVlYjM5ZDJlNDhfMTItMy0xLTEtNjI2_406a7395-a4cd-4631-a48c-af28947a3398">7,907</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ia855382ada1f4f28aa8ef6da692ff177_D20220101-20220630" decimals="-3" name="us-gaap:SellingAndMarketingExpense" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmFlNWE5YmUwZWI5NDQ1ZDE5MmZhZTgyMmQyMmJlMDlmL3NlYzphZTVhOWJlMGViOTQ0NWQxOTJmYWU4MjJkMjJiZTA5Zl8xOS9mcmFnOmE1NTY4MGVlYzE3MzRiYjU4MWRkMDMwM2I4MjVjM2FlL3RhYmxlOjhhZTZlM2VjMmI5NDRjZjA5NDg4ZDVlZWIzOWQyZTQ4L3RhYmxlcmFuZ2U6OGFlNmUzZWMyYjk0NGNmMDk0ODhkNWVlYjM5ZDJlNDhfMTItNS0xLTEtNjI2_31f58e47-7d64-46bd-ba27-4a9b1c0856da">30,444</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="idaa4f31ca59a4a17a59c2580b97791ca_D20210101-20210630" decimals="-3" name="us-gaap:SellingAndMarketingExpense" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmFlNWE5YmUwZWI5NDQ1ZDE5MmZhZTgyMmQyMmJlMDlmL3NlYzphZTVhOWJlMGViOTQ0NWQxOTJmYWU4MjJkMjJiZTA5Zl8xOS9mcmFnOmE1NTY4MGVlYzE3MzRiYjU4MWRkMDMwM2I4MjVjM2FlL3RhYmxlOjhhZTZlM2VjMmI5NDRjZjA5NDg4ZDVlZWIzOWQyZTQ4L3RhYmxlcmFuZ2U6OGFlNmUzZWMyYjk0NGNmMDk0ODhkNWVlYjM5ZDJlNDhfMTItNy0xLTEtNjI2_14533e33-c499-40c7-ad55-c560941176f7">14,419</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Research and development</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i2c5f0f28773744e5a2e202f2943ae976_D20220401-20220630" decimals="-3" name="us-gaap:ResearchAndDevelopmentExpense" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmFlNWE5YmUwZWI5NDQ1ZDE5MmZhZTgyMmQyMmJlMDlmL3NlYzphZTVhOWJlMGViOTQ0NWQxOTJmYWU4MjJkMjJiZTA5Zl8xOS9mcmFnOmE1NTY4MGVlYzE3MzRiYjU4MWRkMDMwM2I4MjVjM2FlL3RhYmxlOjhhZTZlM2VjMmI5NDRjZjA5NDg4ZDVlZWIzOWQyZTQ4L3RhYmxlcmFuZ2U6OGFlNmUzZWMyYjk0NGNmMDk0ODhkNWVlYjM5ZDJlNDhfMTMtMS0xLTEtNjI2_038cf629-b883-4c0c-9eb6-6a2e94bb6a85">6,915</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="id7bb773872394047ba26aa8a7a0f4d56_D20210401-20210630" decimals="-3" name="us-gaap:ResearchAndDevelopmentExpense" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmFlNWE5YmUwZWI5NDQ1ZDE5MmZhZTgyMmQyMmJlMDlmL3NlYzphZTVhOWJlMGViOTQ0NWQxOTJmYWU4MjJkMjJiZTA5Zl8xOS9mcmFnOmE1NTY4MGVlYzE3MzRiYjU4MWRkMDMwM2I4MjVjM2FlL3RhYmxlOjhhZTZlM2VjMmI5NDRjZjA5NDg4ZDVlZWIzOWQyZTQ4L3RhYmxlcmFuZ2U6OGFlNmUzZWMyYjk0NGNmMDk0ODhkNWVlYjM5ZDJlNDhfMTMtMy0xLTEtNjI2_8f01ea47-684b-4e31-8577-eb8e89f79e73">3,594</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ia855382ada1f4f28aa8ef6da692ff177_D20220101-20220630" decimals="-3" name="us-gaap:ResearchAndDevelopmentExpense" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmFlNWE5YmUwZWI5NDQ1ZDE5MmZhZTgyMmQyMmJlMDlmL3NlYzphZTVhOWJlMGViOTQ0NWQxOTJmYWU4MjJkMjJiZTA5Zl8xOS9mcmFnOmE1NTY4MGVlYzE3MzRiYjU4MWRkMDMwM2I4MjVjM2FlL3RhYmxlOjhhZTZlM2VjMmI5NDRjZjA5NDg4ZDVlZWIzOWQyZTQ4L3RhYmxlcmFuZ2U6OGFlNmUzZWMyYjk0NGNmMDk0ODhkNWVlYjM5ZDJlNDhfMTMtNS0xLTEtNjI2_216659c4-3f26-45f4-8a5b-ec7cdd66767c">13,253</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="idaa4f31ca59a4a17a59c2580b97791ca_D20210101-20210630" decimals="-3" name="us-gaap:ResearchAndDevelopmentExpense" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmFlNWE5YmUwZWI5NDQ1ZDE5MmZhZTgyMmQyMmJlMDlmL3NlYzphZTVhOWJlMGViOTQ0NWQxOTJmYWU4MjJkMjJiZTA5Zl8xOS9mcmFnOmE1NTY4MGVlYzE3MzRiYjU4MWRkMDMwM2I4MjVjM2FlL3RhYmxlOjhhZTZlM2VjMmI5NDRjZjA5NDg4ZDVlZWIzOWQyZTQ4L3RhYmxlcmFuZ2U6OGFlNmUzZWMyYjk0NGNmMDk0ODhkNWVlYjM5ZDJlNDhfMTMtNy0xLTEtNjI2_87a99e1f-eb71-4096-892e-471321b15e94">5,845</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">General and administrative</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i2c5f0f28773744e5a2e202f2943ae976_D20220401-20220630" decimals="-3" name="us-gaap:GeneralAndAdministrativeExpense" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmFlNWE5YmUwZWI5NDQ1ZDE5MmZhZTgyMmQyMmJlMDlmL3NlYzphZTVhOWJlMGViOTQ0NWQxOTJmYWU4MjJkMjJiZTA5Zl8xOS9mcmFnOmE1NTY4MGVlYzE3MzRiYjU4MWRkMDMwM2I4MjVjM2FlL3RhYmxlOjhhZTZlM2VjMmI5NDRjZjA5NDg4ZDVlZWIzOWQyZTQ4L3RhYmxlcmFuZ2U6OGFlNmUzZWMyYjk0NGNmMDk0ODhkNWVlYjM5ZDJlNDhfMTQtMS0xLTEtNjI2_5df10db2-c4f3-46c5-b720-9aff88e80760">8,878</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="id7bb773872394047ba26aa8a7a0f4d56_D20210401-20210630" decimals="-3" name="us-gaap:GeneralAndAdministrativeExpense" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmFlNWE5YmUwZWI5NDQ1ZDE5MmZhZTgyMmQyMmJlMDlmL3NlYzphZTVhOWJlMGViOTQ0NWQxOTJmYWU4MjJkMjJiZTA5Zl8xOS9mcmFnOmE1NTY4MGVlYzE3MzRiYjU4MWRkMDMwM2I4MjVjM2FlL3RhYmxlOjhhZTZlM2VjMmI5NDRjZjA5NDg4ZDVlZWIzOWQyZTQ4L3RhYmxlcmFuZ2U6OGFlNmUzZWMyYjk0NGNmMDk0ODhkNWVlYjM5ZDJlNDhfMTQtMy0xLTEtNjI2_28ce5d11-5c6d-4598-9033-7776e539b391">6,301</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ia855382ada1f4f28aa8ef6da692ff177_D20220101-20220630" decimals="-3" name="us-gaap:GeneralAndAdministrativeExpense" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmFlNWE5YmUwZWI5NDQ1ZDE5MmZhZTgyMmQyMmJlMDlmL3NlYzphZTVhOWJlMGViOTQ0NWQxOTJmYWU4MjJkMjJiZTA5Zl8xOS9mcmFnOmE1NTY4MGVlYzE3MzRiYjU4MWRkMDMwM2I4MjVjM2FlL3RhYmxlOjhhZTZlM2VjMmI5NDRjZjA5NDg4ZDVlZWIzOWQyZTQ4L3RhYmxlcmFuZ2U6OGFlNmUzZWMyYjk0NGNmMDk0ODhkNWVlYjM5ZDJlNDhfMTQtNS0xLTEtNjI2_792ae4f5-9777-4613-af02-b152f97d710b">17,452</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="idaa4f31ca59a4a17a59c2580b97791ca_D20210101-20210630" decimals="-3" name="us-gaap:GeneralAndAdministrativeExpense" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmFlNWE5YmUwZWI5NDQ1ZDE5MmZhZTgyMmQyMmJlMDlmL3NlYzphZTVhOWJlMGViOTQ0NWQxOTJmYWU4MjJkMjJiZTA5Zl8xOS9mcmFnOmE1NTY4MGVlYzE3MzRiYjU4MWRkMDMwM2I4MjVjM2FlL3RhYmxlOjhhZTZlM2VjMmI5NDRjZjA5NDg4ZDVlZWIzOWQyZTQ4L3RhYmxlcmFuZ2U6OGFlNmUzZWMyYjk0NGNmMDk0ODhkNWVlYjM5ZDJlNDhfMTQtNy0xLTEtNjI2_21f80125-a4e1-4f4c-8f23-c873dcc88935">11,473</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 37pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total operating expenses</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i2c5f0f28773744e5a2e202f2943ae976_D20220401-20220630" decimals="-3" name="us-gaap:OperatingExpenses" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmFlNWE5YmUwZWI5NDQ1ZDE5MmZhZTgyMmQyMmJlMDlmL3NlYzphZTVhOWJlMGViOTQ0NWQxOTJmYWU4MjJkMjJiZTA5Zl8xOS9mcmFnOmE1NTY4MGVlYzE3MzRiYjU4MWRkMDMwM2I4MjVjM2FlL3RhYmxlOjhhZTZlM2VjMmI5NDRjZjA5NDg4ZDVlZWIzOWQyZTQ4L3RhYmxlcmFuZ2U6OGFlNmUzZWMyYjk0NGNmMDk0ODhkNWVlYjM5ZDJlNDhfMTUtMS0xLTEtNjI2_c5f37b70-b7f5-454e-b04f-a78bb6cff6a8">30,794</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="id7bb773872394047ba26aa8a7a0f4d56_D20210401-20210630" decimals="-3" name="us-gaap:OperatingExpenses" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmFlNWE5YmUwZWI5NDQ1ZDE5MmZhZTgyMmQyMmJlMDlmL3NlYzphZTVhOWJlMGViOTQ0NWQxOTJmYWU4MjJkMjJiZTA5Zl8xOS9mcmFnOmE1NTY4MGVlYzE3MzRiYjU4MWRkMDMwM2I4MjVjM2FlL3RhYmxlOjhhZTZlM2VjMmI5NDRjZjA5NDg4ZDVlZWIzOWQyZTQ4L3RhYmxlcmFuZ2U6OGFlNmUzZWMyYjk0NGNmMDk0ODhkNWVlYjM5ZDJlNDhfMTUtMy0xLTEtNjI2_0640b772-07c8-467c-9ca9-23cbc759f852">17,802</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ia855382ada1f4f28aa8ef6da692ff177_D20220101-20220630" decimals="-3" name="us-gaap:OperatingExpenses" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmFlNWE5YmUwZWI5NDQ1ZDE5MmZhZTgyMmQyMmJlMDlmL3NlYzphZTVhOWJlMGViOTQ0NWQxOTJmYWU4MjJkMjJiZTA5Zl8xOS9mcmFnOmE1NTY4MGVlYzE3MzRiYjU4MWRkMDMwM2I4MjVjM2FlL3RhYmxlOjhhZTZlM2VjMmI5NDRjZjA5NDg4ZDVlZWIzOWQyZTQ4L3RhYmxlcmFuZ2U6OGFlNmUzZWMyYjk0NGNmMDk0ODhkNWVlYjM5ZDJlNDhfMTUtNS0xLTEtNjI2_a9ad70fb-c63f-46ba-8a70-f23c6a149f08">61,149</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="idaa4f31ca59a4a17a59c2580b97791ca_D20210101-20210630" decimals="-3" name="us-gaap:OperatingExpenses" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmFlNWE5YmUwZWI5NDQ1ZDE5MmZhZTgyMmQyMmJlMDlmL3NlYzphZTVhOWJlMGViOTQ0NWQxOTJmYWU4MjJkMjJiZTA5Zl8xOS9mcmFnOmE1NTY4MGVlYzE3MzRiYjU4MWRkMDMwM2I4MjVjM2FlL3RhYmxlOjhhZTZlM2VjMmI5NDRjZjA5NDg4ZDVlZWIzOWQyZTQ4L3RhYmxlcmFuZ2U6OGFlNmUzZWMyYjk0NGNmMDk0ODhkNWVlYjM5ZDJlNDhfMTUtNy0xLTEtNjI2_8deb7b55-da53-46d3-8cd7-8ee5b2850eb0">31,737</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 37pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Loss from operations</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i2c5f0f28773744e5a2e202f2943ae976_D20220401-20220630" decimals="-3" sign="-" name="us-gaap:OperatingIncomeLoss" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmFlNWE5YmUwZWI5NDQ1ZDE5MmZhZTgyMmQyMmJlMDlmL3NlYzphZTVhOWJlMGViOTQ0NWQxOTJmYWU4MjJkMjJiZTA5Zl8xOS9mcmFnOmE1NTY4MGVlYzE3MzRiYjU4MWRkMDMwM2I4MjVjM2FlL3RhYmxlOjhhZTZlM2VjMmI5NDRjZjA5NDg4ZDVlZWIzOWQyZTQ4L3RhYmxlcmFuZ2U6OGFlNmUzZWMyYjk0NGNmMDk0ODhkNWVlYjM5ZDJlNDhfMTYtMS0xLTEtNjI2_730135af-33ae-4402-bb0b-0a85cc2090c3">29,834</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="id7bb773872394047ba26aa8a7a0f4d56_D20210401-20210630" decimals="-3" sign="-" name="us-gaap:OperatingIncomeLoss" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmFlNWE5YmUwZWI5NDQ1ZDE5MmZhZTgyMmQyMmJlMDlmL3NlYzphZTVhOWJlMGViOTQ0NWQxOTJmYWU4MjJkMjJiZTA5Zl8xOS9mcmFnOmE1NTY4MGVlYzE3MzRiYjU4MWRkMDMwM2I4MjVjM2FlL3RhYmxlOjhhZTZlM2VjMmI5NDRjZjA5NDg4ZDVlZWIzOWQyZTQ4L3RhYmxlcmFuZ2U6OGFlNmUzZWMyYjk0NGNmMDk0ODhkNWVlYjM5ZDJlNDhfMTYtMy0xLTEtNjI2_e6d68257-a07b-4ccb-980f-0db05e98e4fa">17,307</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ia855382ada1f4f28aa8ef6da692ff177_D20220101-20220630" decimals="-3" sign="-" name="us-gaap:OperatingIncomeLoss" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmFlNWE5YmUwZWI5NDQ1ZDE5MmZhZTgyMmQyMmJlMDlmL3NlYzphZTVhOWJlMGViOTQ0NWQxOTJmYWU4MjJkMjJiZTA5Zl8xOS9mcmFnOmE1NTY4MGVlYzE3MzRiYjU4MWRkMDMwM2I4MjVjM2FlL3RhYmxlOjhhZTZlM2VjMmI5NDRjZjA5NDg4ZDVlZWIzOWQyZTQ4L3RhYmxlcmFuZ2U6OGFlNmUzZWMyYjk0NGNmMDk0ODhkNWVlYjM5ZDJlNDhfMTYtNS0xLTEtNjI2_8f0411e9-627f-4f4c-8bfb-720f64b1edcc">60,025</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="idaa4f31ca59a4a17a59c2580b97791ca_D20210101-20210630" decimals="-3" sign="-" name="us-gaap:OperatingIncomeLoss" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmFlNWE5YmUwZWI5NDQ1ZDE5MmZhZTgyMmQyMmJlMDlmL3NlYzphZTVhOWJlMGViOTQ0NWQxOTJmYWU4MjJkMjJiZTA5Zl8xOS9mcmFnOmE1NTY4MGVlYzE3MzRiYjU4MWRkMDMwM2I4MjVjM2FlL3RhYmxlOjhhZTZlM2VjMmI5NDRjZjA5NDg4ZDVlZWIzOWQyZTQ4L3RhYmxlcmFuZ2U6OGFlNmUzZWMyYjk0NGNmMDk0ODhkNWVlYjM5ZDJlNDhfMTYtNy0xLTEtNjI2_d27f1ed6-8f72-407b-b31f-f24c72508a90">30,720</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other income/(expense):</span></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Interest income, net</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i2c5f0f28773744e5a2e202f2943ae976_D20220401-20220630" decimals="-3" name="us-gaap:InterestIncomeExpenseNonoperatingNet" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmFlNWE5YmUwZWI5NDQ1ZDE5MmZhZTgyMmQyMmJlMDlmL3NlYzphZTVhOWJlMGViOTQ0NWQxOTJmYWU4MjJkMjJiZTA5Zl8xOS9mcmFnOmE1NTY4MGVlYzE3MzRiYjU4MWRkMDMwM2I4MjVjM2FlL3RhYmxlOjhhZTZlM2VjMmI5NDRjZjA5NDg4ZDVlZWIzOWQyZTQ4L3RhYmxlcmFuZ2U6OGFlNmUzZWMyYjk0NGNmMDk0ODhkNWVlYjM5ZDJlNDhfMTgtMS0xLTEtNjI2_60d06780-bc6e-49b6-ad95-a007ecf0dabd">149</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="id7bb773872394047ba26aa8a7a0f4d56_D20210401-20210630" decimals="-3" name="us-gaap:InterestIncomeExpenseNonoperatingNet" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmFlNWE5YmUwZWI5NDQ1ZDE5MmZhZTgyMmQyMmJlMDlmL3NlYzphZTVhOWJlMGViOTQ0NWQxOTJmYWU4MjJkMjJiZTA5Zl8xOS9mcmFnOmE1NTY4MGVlYzE3MzRiYjU4MWRkMDMwM2I4MjVjM2FlL3RhYmxlOjhhZTZlM2VjMmI5NDRjZjA5NDg4ZDVlZWIzOWQyZTQ4L3RhYmxlcmFuZ2U6OGFlNmUzZWMyYjk0NGNmMDk0ODhkNWVlYjM5ZDJlNDhfMTgtMy0xLTEtNjI2_0e039559-2ee7-4e39-b37b-83b18d2e6b92">35</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ia855382ada1f4f28aa8ef6da692ff177_D20220101-20220630" decimals="-3" name="us-gaap:InterestIncomeExpenseNonoperatingNet" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmFlNWE5YmUwZWI5NDQ1ZDE5MmZhZTgyMmQyMmJlMDlmL3NlYzphZTVhOWJlMGViOTQ0NWQxOTJmYWU4MjJkMjJiZTA5Zl8xOS9mcmFnOmE1NTY4MGVlYzE3MzRiYjU4MWRkMDMwM2I4MjVjM2FlL3RhYmxlOjhhZTZlM2VjMmI5NDRjZjA5NDg4ZDVlZWIzOWQyZTQ4L3RhYmxlcmFuZ2U6OGFlNmUzZWMyYjk0NGNmMDk0ODhkNWVlYjM5ZDJlNDhfMTgtNS0xLTEtNjI2_675097e4-9502-4a94-9906-f3ba67811fe6">215</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="idaa4f31ca59a4a17a59c2580b97791ca_D20210101-20210630" decimals="-3" name="us-gaap:InterestIncomeExpenseNonoperatingNet" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmFlNWE5YmUwZWI5NDQ1ZDE5MmZhZTgyMmQyMmJlMDlmL3NlYzphZTVhOWJlMGViOTQ0NWQxOTJmYWU4MjJkMjJiZTA5Zl8xOS9mcmFnOmE1NTY4MGVlYzE3MzRiYjU4MWRkMDMwM2I4MjVjM2FlL3RhYmxlOjhhZTZlM2VjMmI5NDRjZjA5NDg4ZDVlZWIzOWQyZTQ4L3RhYmxlcmFuZ2U6OGFlNmUzZWMyYjk0NGNmMDk0ODhkNWVlYjM5ZDJlNDhfMTgtNy0xLTEtNjI2_4d77a4f5-eef9-470f-a416-f8be8e57973e">69</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Change in fair value of warrant liability</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i2c5f0f28773744e5a2e202f2943ae976_D20220401-20220630" decimals="-3" sign="-" name="us-gaap:FairValueAdjustmentOfWarrants" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmFlNWE5YmUwZWI5NDQ1ZDE5MmZhZTgyMmQyMmJlMDlmL3NlYzphZTVhOWJlMGViOTQ0NWQxOTJmYWU4MjJkMjJiZTA5Zl8xOS9mcmFnOmE1NTY4MGVlYzE3MzRiYjU4MWRkMDMwM2I4MjVjM2FlL3RhYmxlOjhhZTZlM2VjMmI5NDRjZjA5NDg4ZDVlZWIzOWQyZTQ4L3RhYmxlcmFuZ2U6OGFlNmUzZWMyYjk0NGNmMDk0ODhkNWVlYjM5ZDJlNDhfMTktMS0xLTEtNjI2_1665b506-c378-491e-a2ba-7a88a26ccc2d">105</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="id7bb773872394047ba26aa8a7a0f4d56_D20210401-20210630" decimals="-3" sign="-" name="us-gaap:FairValueAdjustmentOfWarrants" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmFlNWE5YmUwZWI5NDQ1ZDE5MmZhZTgyMmQyMmJlMDlmL3NlYzphZTVhOWJlMGViOTQ0NWQxOTJmYWU4MjJkMjJiZTA5Zl8xOS9mcmFnOmE1NTY4MGVlYzE3MzRiYjU4MWRkMDMwM2I4MjVjM2FlL3RhYmxlOjhhZTZlM2VjMmI5NDRjZjA5NDg4ZDVlZWIzOWQyZTQ4L3RhYmxlcmFuZ2U6OGFlNmUzZWMyYjk0NGNmMDk0ODhkNWVlYjM5ZDJlNDhfMTktMy0xLTEtNjI2_013ab475-6c7d-4b1b-97db-7ca2038bfe81">170</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ia855382ada1f4f28aa8ef6da692ff177_D20220101-20220630" decimals="-3" sign="-" name="us-gaap:FairValueAdjustmentOfWarrants" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmFlNWE5YmUwZWI5NDQ1ZDE5MmZhZTgyMmQyMmJlMDlmL3NlYzphZTVhOWJlMGViOTQ0NWQxOTJmYWU4MjJkMjJiZTA5Zl8xOS9mcmFnOmE1NTY4MGVlYzE3MzRiYjU4MWRkMDMwM2I4MjVjM2FlL3RhYmxlOjhhZTZlM2VjMmI5NDRjZjA5NDg4ZDVlZWIzOWQyZTQ4L3RhYmxlcmFuZ2U6OGFlNmUzZWMyYjk0NGNmMDk0ODhkNWVlYjM5ZDJlNDhfMTktNS0xLTEtNjI2_7c8c8e54-8602-4548-8e1f-6b179990fd57">122</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="idaa4f31ca59a4a17a59c2580b97791ca_D20210101-20210630" decimals="-3" name="us-gaap:FairValueAdjustmentOfWarrants" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmFlNWE5YmUwZWI5NDQ1ZDE5MmZhZTgyMmQyMmJlMDlmL3NlYzphZTVhOWJlMGViOTQ0NWQxOTJmYWU4MjJkMjJiZTA5Zl8xOS9mcmFnOmE1NTY4MGVlYzE3MzRiYjU4MWRkMDMwM2I4MjVjM2FlL3RhYmxlOjhhZTZlM2VjMmI5NDRjZjA5NDg4ZDVlZWIzOWQyZTQ4L3RhYmxlcmFuZ2U6OGFlNmUzZWMyYjk0NGNmMDk0ODhkNWVlYjM5ZDJlNDhfMTktNy0xLTEtNjI2_eb2be508-f6a0-42b4-ac5e-ae25e3f42954">1,519</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 37pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total other income/(expense)</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i2c5f0f28773744e5a2e202f2943ae976_D20220401-20220630" decimals="-3" name="us-gaap:NonoperatingIncomeExpense" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmFlNWE5YmUwZWI5NDQ1ZDE5MmZhZTgyMmQyMmJlMDlmL3NlYzphZTVhOWJlMGViOTQ0NWQxOTJmYWU4MjJkMjJiZTA5Zl8xOS9mcmFnOmE1NTY4MGVlYzE3MzRiYjU4MWRkMDMwM2I4MjVjM2FlL3RhYmxlOjhhZTZlM2VjMmI5NDRjZjA5NDg4ZDVlZWIzOWQyZTQ4L3RhYmxlcmFuZ2U6OGFlNmUzZWMyYjk0NGNmMDk0ODhkNWVlYjM5ZDJlNDhfMjAtMS0xLTEtNjI2_939705ee-6f40-4653-aca4-f2c1d3bf5c44">254</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="id7bb773872394047ba26aa8a7a0f4d56_D20210401-20210630" decimals="-3" name="us-gaap:NonoperatingIncomeExpense" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmFlNWE5YmUwZWI5NDQ1ZDE5MmZhZTgyMmQyMmJlMDlmL3NlYzphZTVhOWJlMGViOTQ0NWQxOTJmYWU4MjJkMjJiZTA5Zl8xOS9mcmFnOmE1NTY4MGVlYzE3MzRiYjU4MWRkMDMwM2I4MjVjM2FlL3RhYmxlOjhhZTZlM2VjMmI5NDRjZjA5NDg4ZDVlZWIzOWQyZTQ4L3RhYmxlcmFuZ2U6OGFlNmUzZWMyYjk0NGNmMDk0ODhkNWVlYjM5ZDJlNDhfMjAtMy0xLTEtNjI2_8880fbc8-3db4-475a-82ea-b780e56f4090">205</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ia855382ada1f4f28aa8ef6da692ff177_D20220101-20220630" decimals="-3" name="us-gaap:NonoperatingIncomeExpense" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmFlNWE5YmUwZWI5NDQ1ZDE5MmZhZTgyMmQyMmJlMDlmL3NlYzphZTVhOWJlMGViOTQ0NWQxOTJmYWU4MjJkMjJiZTA5Zl8xOS9mcmFnOmE1NTY4MGVlYzE3MzRiYjU4MWRkMDMwM2I4MjVjM2FlL3RhYmxlOjhhZTZlM2VjMmI5NDRjZjA5NDg4ZDVlZWIzOWQyZTQ4L3RhYmxlcmFuZ2U6OGFlNmUzZWMyYjk0NGNmMDk0ODhkNWVlYjM5ZDJlNDhfMjAtNS0xLTEtNjI2_b4a6153a-d907-4543-8f4f-c4360487e984">337</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="idaa4f31ca59a4a17a59c2580b97791ca_D20210101-20210630" decimals="-3" sign="-" name="us-gaap:NonoperatingIncomeExpense" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmFlNWE5YmUwZWI5NDQ1ZDE5MmZhZTgyMmQyMmJlMDlmL3NlYzphZTVhOWJlMGViOTQ0NWQxOTJmYWU4MjJkMjJiZTA5Zl8xOS9mcmFnOmE1NTY4MGVlYzE3MzRiYjU4MWRkMDMwM2I4MjVjM2FlL3RhYmxlOjhhZTZlM2VjMmI5NDRjZjA5NDg4ZDVlZWIzOWQyZTQ4L3RhYmxlcmFuZ2U6OGFlNmUzZWMyYjk0NGNmMDk0ODhkNWVlYjM5ZDJlNDhfMjAtNy0xLTEtNjI2_a125fb10-7735-4f60-970c-a0315678e596">1,450</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 37pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net loss</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i2c5f0f28773744e5a2e202f2943ae976_D20220401-20220630" decimals="-3" sign="-" name="us-gaap:NetIncomeLoss" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmFlNWE5YmUwZWI5NDQ1ZDE5MmZhZTgyMmQyMmJlMDlmL3NlYzphZTVhOWJlMGViOTQ0NWQxOTJmYWU4MjJkMjJiZTA5Zl8xOS9mcmFnOmE1NTY4MGVlYzE3MzRiYjU4MWRkMDMwM2I4MjVjM2FlL3RhYmxlOjhhZTZlM2VjMmI5NDRjZjA5NDg4ZDVlZWIzOWQyZTQ4L3RhYmxlcmFuZ2U6OGFlNmUzZWMyYjk0NGNmMDk0ODhkNWVlYjM5ZDJlNDhfMjEtMS0xLTEtNjI2_5db39739-e94f-4bdf-aed3-d9981cfa2d36">29,580</ix:nonFraction>)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="id7bb773872394047ba26aa8a7a0f4d56_D20210401-20210630" decimals="-3" sign="-" name="us-gaap:NetIncomeLoss" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmFlNWE5YmUwZWI5NDQ1ZDE5MmZhZTgyMmQyMmJlMDlmL3NlYzphZTVhOWJlMGViOTQ0NWQxOTJmYWU4MjJkMjJiZTA5Zl8xOS9mcmFnOmE1NTY4MGVlYzE3MzRiYjU4MWRkMDMwM2I4MjVjM2FlL3RhYmxlOjhhZTZlM2VjMmI5NDRjZjA5NDg4ZDVlZWIzOWQyZTQ4L3RhYmxlcmFuZ2U6OGFlNmUzZWMyYjk0NGNmMDk0ODhkNWVlYjM5ZDJlNDhfMjEtMy0xLTEtNjI2_bf46df11-83a1-455a-a018-f69fafafec55">17,102</ix:nonFraction>)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ia855382ada1f4f28aa8ef6da692ff177_D20220101-20220630" decimals="-3" sign="-" name="us-gaap:NetIncomeLoss" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmFlNWE5YmUwZWI5NDQ1ZDE5MmZhZTgyMmQyMmJlMDlmL3NlYzphZTVhOWJlMGViOTQ0NWQxOTJmYWU4MjJkMjJiZTA5Zl8xOS9mcmFnOmE1NTY4MGVlYzE3MzRiYjU4MWRkMDMwM2I4MjVjM2FlL3RhYmxlOjhhZTZlM2VjMmI5NDRjZjA5NDg4ZDVlZWIzOWQyZTQ4L3RhYmxlcmFuZ2U6OGFlNmUzZWMyYjk0NGNmMDk0ODhkNWVlYjM5ZDJlNDhfMjEtNS0xLTEtNjI2_234d2895-1d78-45aa-a750-64d6c896996e">59,688</ix:nonFraction>)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="idaa4f31ca59a4a17a59c2580b97791ca_D20210101-20210630" decimals="-3" sign="-" name="us-gaap:NetIncomeLoss" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmFlNWE5YmUwZWI5NDQ1ZDE5MmZhZTgyMmQyMmJlMDlmL3NlYzphZTVhOWJlMGViOTQ0NWQxOTJmYWU4MjJkMjJiZTA5Zl8xOS9mcmFnOmE1NTY4MGVlYzE3MzRiYjU4MWRkMDMwM2I4MjVjM2FlL3RhYmxlOjhhZTZlM2VjMmI5NDRjZjA5NDg4ZDVlZWIzOWQyZTQ4L3RhYmxlcmFuZ2U6OGFlNmUzZWMyYjk0NGNmMDk0ODhkNWVlYjM5ZDJlNDhfMjEtNy0xLTEtNjI2_59eabc2f-f5cf-4327-b91f-5cfd6ce95a9e">32,170</ix:nonFraction>)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 10pt;text-align:left;text-indent:-9pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Weighted average shares outstanding used in computing net loss per share, basic and diluted</span></td><td colspan="2" style="background-color:#cceeff;border-top:3pt double #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i2c5f0f28773744e5a2e202f2943ae976_D20220401-20220630" decimals="INF" name="us-gaap:WeightedAverageNumberOfSharesOutstandingBasic" format="ixt:num-dot-decimal" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmFlNWE5YmUwZWI5NDQ1ZDE5MmZhZTgyMmQyMmJlMDlmL3NlYzphZTVhOWJlMGViOTQ0NWQxOTJmYWU4MjJkMjJiZTA5Zl8xOS9mcmFnOmE1NTY4MGVlYzE3MzRiYjU4MWRkMDMwM2I4MjVjM2FlL3RhYmxlOjhhZTZlM2VjMmI5NDRjZjA5NDg4ZDVlZWIzOWQyZTQ4L3RhYmxlcmFuZ2U6OGFlNmUzZWMyYjk0NGNmMDk0ODhkNWVlYjM5ZDJlNDhfMjItMS0xLTEtNjI2_40b26a95-a4ef-4019-84a1-6bb98fdbf281"><ix:nonFraction unitRef="shares" contextRef="i2c5f0f28773744e5a2e202f2943ae976_D20220401-20220630" decimals="INF" name="us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding" format="ixt:num-dot-decimal" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmFlNWE5YmUwZWI5NDQ1ZDE5MmZhZTgyMmQyMmJlMDlmL3NlYzphZTVhOWJlMGViOTQ0NWQxOTJmYWU4MjJkMjJiZTA5Zl8xOS9mcmFnOmE1NTY4MGVlYzE3MzRiYjU4MWRkMDMwM2I4MjVjM2FlL3RhYmxlOjhhZTZlM2VjMmI5NDRjZjA5NDg4ZDVlZWIzOWQyZTQ4L3RhYmxlcmFuZ2U6OGFlNmUzZWMyYjk0NGNmMDk0ODhkNWVlYjM5ZDJlNDhfMjItMS0xLTEtNjI2_75e2cb55-c66a-4ebf-90ad-fd4907a8a377">29,964,849</ix:nonFraction></ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:3pt double #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:3pt double #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="id7bb773872394047ba26aa8a7a0f4d56_D20210401-20210630" decimals="INF" name="us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding" format="ixt:num-dot-decimal" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmFlNWE5YmUwZWI5NDQ1ZDE5MmZhZTgyMmQyMmJlMDlmL3NlYzphZTVhOWJlMGViOTQ0NWQxOTJmYWU4MjJkMjJiZTA5Zl8xOS9mcmFnOmE1NTY4MGVlYzE3MzRiYjU4MWRkMDMwM2I4MjVjM2FlL3RhYmxlOjhhZTZlM2VjMmI5NDRjZjA5NDg4ZDVlZWIzOWQyZTQ4L3RhYmxlcmFuZ2U6OGFlNmUzZWMyYjk0NGNmMDk0ODhkNWVlYjM5ZDJlNDhfMjItMy0xLTEtNjI2_4036fdc8-b795-43f5-85cf-acab646b67a0"><ix:nonFraction unitRef="shares" contextRef="id7bb773872394047ba26aa8a7a0f4d56_D20210401-20210630" decimals="INF" name="us-gaap:WeightedAverageNumberOfSharesOutstandingBasic" format="ixt:num-dot-decimal" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmFlNWE5YmUwZWI5NDQ1ZDE5MmZhZTgyMmQyMmJlMDlmL3NlYzphZTVhOWJlMGViOTQ0NWQxOTJmYWU4MjJkMjJiZTA5Zl8xOS9mcmFnOmE1NTY4MGVlYzE3MzRiYjU4MWRkMDMwM2I4MjVjM2FlL3RhYmxlOjhhZTZlM2VjMmI5NDRjZjA5NDg4ZDVlZWIzOWQyZTQ4L3RhYmxlcmFuZ2U6OGFlNmUzZWMyYjk0NGNmMDk0ODhkNWVlYjM5ZDJlNDhfMjItMy0xLTEtNjI2_fed12146-07c3-48bf-be32-0d482102efd6">28,979,148</ix:nonFraction></ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:3pt double #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:3pt double #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="ia855382ada1f4f28aa8ef6da692ff177_D20220101-20220630" decimals="INF" name="us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding" format="ixt:num-dot-decimal" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmFlNWE5YmUwZWI5NDQ1ZDE5MmZhZTgyMmQyMmJlMDlmL3NlYzphZTVhOWJlMGViOTQ0NWQxOTJmYWU4MjJkMjJiZTA5Zl8xOS9mcmFnOmE1NTY4MGVlYzE3MzRiYjU4MWRkMDMwM2I4MjVjM2FlL3RhYmxlOjhhZTZlM2VjMmI5NDRjZjA5NDg4ZDVlZWIzOWQyZTQ4L3RhYmxlcmFuZ2U6OGFlNmUzZWMyYjk0NGNmMDk0ODhkNWVlYjM5ZDJlNDhfMjItNS0xLTEtNjI2_3465c27c-f26e-46d4-8b31-612a00936784"><ix:nonFraction unitRef="shares" contextRef="ia855382ada1f4f28aa8ef6da692ff177_D20220101-20220630" decimals="INF" name="us-gaap:WeightedAverageNumberOfSharesOutstandingBasic" format="ixt:num-dot-decimal" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmFlNWE5YmUwZWI5NDQ1ZDE5MmZhZTgyMmQyMmJlMDlmL3NlYzphZTVhOWJlMGViOTQ0NWQxOTJmYWU4MjJkMjJiZTA5Zl8xOS9mcmFnOmE1NTY4MGVlYzE3MzRiYjU4MWRkMDMwM2I4MjVjM2FlL3RhYmxlOjhhZTZlM2VjMmI5NDRjZjA5NDg4ZDVlZWIzOWQyZTQ4L3RhYmxlcmFuZ2U6OGFlNmUzZWMyYjk0NGNmMDk0ODhkNWVlYjM5ZDJlNDhfMjItNS0xLTEtNjI2_631a0583-f370-4f23-80ee-e599f8f9daa6">29,904,972</ix:nonFraction></ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:3pt double #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:3pt double #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="idaa4f31ca59a4a17a59c2580b97791ca_D20210101-20210630" decimals="INF" name="us-gaap:WeightedAverageNumberOfSharesOutstandingBasic" format="ixt:num-dot-decimal" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmFlNWE5YmUwZWI5NDQ1ZDE5MmZhZTgyMmQyMmJlMDlmL3NlYzphZTVhOWJlMGViOTQ0NWQxOTJmYWU4MjJkMjJiZTA5Zl8xOS9mcmFnOmE1NTY4MGVlYzE3MzRiYjU4MWRkMDMwM2I4MjVjM2FlL3RhYmxlOjhhZTZlM2VjMmI5NDRjZjA5NDg4ZDVlZWIzOWQyZTQ4L3RhYmxlcmFuZ2U6OGFlNmUzZWMyYjk0NGNmMDk0ODhkNWVlYjM5ZDJlNDhfMjItNy0xLTEtNjI2_0def862c-ede7-451f-8124-fceecb61b54e"><ix:nonFraction unitRef="shares" contextRef="idaa4f31ca59a4a17a59c2580b97791ca_D20210101-20210630" decimals="INF" name="us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding" format="ixt:num-dot-decimal" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmFlNWE5YmUwZWI5NDQ1ZDE5MmZhZTgyMmQyMmJlMDlmL3NlYzphZTVhOWJlMGViOTQ0NWQxOTJmYWU4MjJkMjJiZTA5Zl8xOS9mcmFnOmE1NTY4MGVlYzE3MzRiYjU4MWRkMDMwM2I4MjVjM2FlL3RhYmxlOjhhZTZlM2VjMmI5NDRjZjA5NDg4ZDVlZWIzOWQyZTQ4L3RhYmxlcmFuZ2U6OGFlNmUzZWMyYjk0NGNmMDk0ODhkNWVlYjM5ZDJlNDhfMjItNy0xLTEtNjI2_acc8fabd-2ad2-44a5-83a6-937cdd60d147">28,070,539</ix:nonFraction></ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:3pt double #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 10pt;text-align:left;text-indent:-9pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net loss per share of common stock outstanding, basic and diluted</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usdPerShare" contextRef="i2c5f0f28773744e5a2e202f2943ae976_D20220401-20220630" decimals="2" sign="-" name="us-gaap:EarningsPerShareDiluted" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmFlNWE5YmUwZWI5NDQ1ZDE5MmZhZTgyMmQyMmJlMDlmL3NlYzphZTVhOWJlMGViOTQ0NWQxOTJmYWU4MjJkMjJiZTA5Zl8xOS9mcmFnOmE1NTY4MGVlYzE3MzRiYjU4MWRkMDMwM2I4MjVjM2FlL3RhYmxlOjhhZTZlM2VjMmI5NDRjZjA5NDg4ZDVlZWIzOWQyZTQ4L3RhYmxlcmFuZ2U6OGFlNmUzZWMyYjk0NGNmMDk0ODhkNWVlYjM5ZDJlNDhfMjMtMS0xLTEtNjI2_dd3a3527-9c1c-456d-b270-3a5d1cdb674d"><ix:nonFraction unitRef="usdPerShare" contextRef="i2c5f0f28773744e5a2e202f2943ae976_D20220401-20220630" decimals="2" sign="-" name="us-gaap:EarningsPerShareBasic" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmFlNWE5YmUwZWI5NDQ1ZDE5MmZhZTgyMmQyMmJlMDlmL3NlYzphZTVhOWJlMGViOTQ0NWQxOTJmYWU4MjJkMjJiZTA5Zl8xOS9mcmFnOmE1NTY4MGVlYzE3MzRiYjU4MWRkMDMwM2I4MjVjM2FlL3RhYmxlOjhhZTZlM2VjMmI5NDRjZjA5NDg4ZDVlZWIzOWQyZTQ4L3RhYmxlcmFuZ2U6OGFlNmUzZWMyYjk0NGNmMDk0ODhkNWVlYjM5ZDJlNDhfMjMtMS0xLTEtNjI2_efbaad8b-d7aa-463b-91f6-4be2d053a81c">0.99</ix:nonFraction></ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usdPerShare" contextRef="id7bb773872394047ba26aa8a7a0f4d56_D20210401-20210630" decimals="2" sign="-" name="us-gaap:EarningsPerShareBasic" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmFlNWE5YmUwZWI5NDQ1ZDE5MmZhZTgyMmQyMmJlMDlmL3NlYzphZTVhOWJlMGViOTQ0NWQxOTJmYWU4MjJkMjJiZTA5Zl8xOS9mcmFnOmE1NTY4MGVlYzE3MzRiYjU4MWRkMDMwM2I4MjVjM2FlL3RhYmxlOjhhZTZlM2VjMmI5NDRjZjA5NDg4ZDVlZWIzOWQyZTQ4L3RhYmxlcmFuZ2U6OGFlNmUzZWMyYjk0NGNmMDk0ODhkNWVlYjM5ZDJlNDhfMjMtMy0xLTEtNjI2_dbea52f8-63c0-4968-987a-6f03a6f46ac9"><ix:nonFraction unitRef="usdPerShare" contextRef="id7bb773872394047ba26aa8a7a0f4d56_D20210401-20210630" decimals="2" sign="-" name="us-gaap:EarningsPerShareDiluted" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmFlNWE5YmUwZWI5NDQ1ZDE5MmZhZTgyMmQyMmJlMDlmL3NlYzphZTVhOWJlMGViOTQ0NWQxOTJmYWU4MjJkMjJiZTA5Zl8xOS9mcmFnOmE1NTY4MGVlYzE3MzRiYjU4MWRkMDMwM2I4MjVjM2FlL3RhYmxlOjhhZTZlM2VjMmI5NDRjZjA5NDg4ZDVlZWIzOWQyZTQ4L3RhYmxlcmFuZ2U6OGFlNmUzZWMyYjk0NGNmMDk0ODhkNWVlYjM5ZDJlNDhfMjMtMy0xLTEtNjI2_ee0460cf-3e11-453d-885f-35bf538556ac">0.59</ix:nonFraction></ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usdPerShare" contextRef="ia855382ada1f4f28aa8ef6da692ff177_D20220101-20220630" decimals="2" sign="-" name="us-gaap:EarningsPerShareDiluted" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmFlNWE5YmUwZWI5NDQ1ZDE5MmZhZTgyMmQyMmJlMDlmL3NlYzphZTVhOWJlMGViOTQ0NWQxOTJmYWU4MjJkMjJiZTA5Zl8xOS9mcmFnOmE1NTY4MGVlYzE3MzRiYjU4MWRkMDMwM2I4MjVjM2FlL3RhYmxlOjhhZTZlM2VjMmI5NDRjZjA5NDg4ZDVlZWIzOWQyZTQ4L3RhYmxlcmFuZ2U6OGFlNmUzZWMyYjk0NGNmMDk0ODhkNWVlYjM5ZDJlNDhfMjMtNS0xLTEtNjI2_60cd049d-c70e-4c23-a420-f518ae884980"><ix:nonFraction unitRef="usdPerShare" contextRef="ia855382ada1f4f28aa8ef6da692ff177_D20220101-20220630" decimals="2" sign="-" name="us-gaap:EarningsPerShareBasic" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmFlNWE5YmUwZWI5NDQ1ZDE5MmZhZTgyMmQyMmJlMDlmL3NlYzphZTVhOWJlMGViOTQ0NWQxOTJmYWU4MjJkMjJiZTA5Zl8xOS9mcmFnOmE1NTY4MGVlYzE3MzRiYjU4MWRkMDMwM2I4MjVjM2FlL3RhYmxlOjhhZTZlM2VjMmI5NDRjZjA5NDg4ZDVlZWIzOWQyZTQ4L3RhYmxlcmFuZ2U6OGFlNmUzZWMyYjk0NGNmMDk0ODhkNWVlYjM5ZDJlNDhfMjMtNS0xLTEtNjI2_96b0c2a9-a563-4633-bf04-e23aadce179e">2.00</ix:nonFraction></ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usdPerShare" contextRef="idaa4f31ca59a4a17a59c2580b97791ca_D20210101-20210630" decimals="2" sign="-" name="us-gaap:EarningsPerShareBasic" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmFlNWE5YmUwZWI5NDQ1ZDE5MmZhZTgyMmQyMmJlMDlmL3NlYzphZTVhOWJlMGViOTQ0NWQxOTJmYWU4MjJkMjJiZTA5Zl8xOS9mcmFnOmE1NTY4MGVlYzE3MzRiYjU4MWRkMDMwM2I4MjVjM2FlL3RhYmxlOjhhZTZlM2VjMmI5NDRjZjA5NDg4ZDVlZWIzOWQyZTQ4L3RhYmxlcmFuZ2U6OGFlNmUzZWMyYjk0NGNmMDk0ODhkNWVlYjM5ZDJlNDhfMjMtNy0xLTEtNjI2_2ad3ce28-f3b8-4ce1-a918-892a807e3587"><ix:nonFraction unitRef="usdPerShare" contextRef="idaa4f31ca59a4a17a59c2580b97791ca_D20210101-20210630" decimals="2" sign="-" name="us-gaap:EarningsPerShareDiluted" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmFlNWE5YmUwZWI5NDQ1ZDE5MmZhZTgyMmQyMmJlMDlmL3NlYzphZTVhOWJlMGViOTQ0NWQxOTJmYWU4MjJkMjJiZTA5Zl8xOS9mcmFnOmE1NTY4MGVlYzE3MzRiYjU4MWRkMDMwM2I4MjVjM2FlL3RhYmxlOjhhZTZlM2VjMmI5NDRjZjA5NDg4ZDVlZWIzOWQyZTQ4L3RhYmxlcmFuZ2U6OGFlNmUzZWMyYjk0NGNmMDk0ODhkNWVlYjM5ZDJlNDhfMjMtNy0xLTEtNjI2_addf9680-f80c-4ed2-983e-3205babdd636">1.15</ix:nonFraction></ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><div style="margin-top:12pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">See accompanying notes to unaudited condensed consolidated financial statements.</span></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">2</span></div></div></div><div id="iae5a9be0eb9445d192fae822d22be09f_22"></div><hr style="page-break-after:always"/><div style="min-height:45pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#iae5a9be0eb9445d192fae822d22be09f_7">Table of Contents</a></span></div></div><div style="margin-top:12pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">DERMTECH, INC.</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Condensed Consolidated Statements of Comprehensive Loss</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">(in thousands)</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">(Unaudited)</span></div><div style="margin-top:12pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:44.354%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.081%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.406%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.081%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.406%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.081%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.406%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.085%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Three Months Ended June 30,</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Six Months Ended June 30,</span></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2021</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net loss</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i2c5f0f28773744e5a2e202f2943ae976_D20220401-20220630" decimals="-3" sign="-" name="us-gaap:NetIncomeLoss" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmFlNWE5YmUwZWI5NDQ1ZDE5MmZhZTgyMmQyMmJlMDlmL3NlYzphZTVhOWJlMGViOTQ0NWQxOTJmYWU4MjJkMjJiZTA5Zl8yMi9mcmFnOjVlYmVjNTcxMTlmYjQyZGM5ZWRlN2UyZTBiNzJlZmQwL3RhYmxlOmM5M2FlN2Y0MDZlNTQ1Y2M5YzIwYzc5OTcyZGMzZjM3L3RhYmxlcmFuZ2U6YzkzYWU3ZjQwNmU1NDVjYzljMjBjNzk5NzJkYzNmMzdfMi0xLTEtMS02MjY_bff17ef3-3717-407b-9c66-a23cc683a064">29,580</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="id7bb773872394047ba26aa8a7a0f4d56_D20210401-20210630" decimals="-3" sign="-" name="us-gaap:NetIncomeLoss" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmFlNWE5YmUwZWI5NDQ1ZDE5MmZhZTgyMmQyMmJlMDlmL3NlYzphZTVhOWJlMGViOTQ0NWQxOTJmYWU4MjJkMjJiZTA5Zl8yMi9mcmFnOjVlYmVjNTcxMTlmYjQyZGM5ZWRlN2UyZTBiNzJlZmQwL3RhYmxlOmM5M2FlN2Y0MDZlNTQ1Y2M5YzIwYzc5OTcyZGMzZjM3L3RhYmxlcmFuZ2U6YzkzYWU3ZjQwNmU1NDVjYzljMjBjNzk5NzJkYzNmMzdfMi0zLTEtMS02MjY_d21a3d59-7712-499b-af02-98bd53928efa">17,102</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ia855382ada1f4f28aa8ef6da692ff177_D20220101-20220630" decimals="-3" sign="-" name="us-gaap:NetIncomeLoss" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmFlNWE5YmUwZWI5NDQ1ZDE5MmZhZTgyMmQyMmJlMDlmL3NlYzphZTVhOWJlMGViOTQ0NWQxOTJmYWU4MjJkMjJiZTA5Zl8yMi9mcmFnOjVlYmVjNTcxMTlmYjQyZGM5ZWRlN2UyZTBiNzJlZmQwL3RhYmxlOmM5M2FlN2Y0MDZlNTQ1Y2M5YzIwYzc5OTcyZGMzZjM3L3RhYmxlcmFuZ2U6YzkzYWU3ZjQwNmU1NDVjYzljMjBjNzk5NzJkYzNmMzdfMi01LTEtMS02MjY_68635b92-7620-48c6-abb9-9935fb4516a5">59,688</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="idaa4f31ca59a4a17a59c2580b97791ca_D20210101-20210630" decimals="-3" sign="-" name="us-gaap:NetIncomeLoss" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmFlNWE5YmUwZWI5NDQ1ZDE5MmZhZTgyMmQyMmJlMDlmL3NlYzphZTVhOWJlMGViOTQ0NWQxOTJmYWU4MjJkMjJiZTA5Zl8yMi9mcmFnOjVlYmVjNTcxMTlmYjQyZGM5ZWRlN2UyZTBiNzJlZmQwL3RhYmxlOmM5M2FlN2Y0MDZlNTQ1Y2M5YzIwYzc5OTcyZGMzZjM3L3RhYmxlcmFuZ2U6YzkzYWU3ZjQwNmU1NDVjYzljMjBjNzk5NzJkYzNmMzdfMi03LTEtMS02MjY_6f05f163-491b-4d36-b00f-8f8e4b6339e1">32,170</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Unrealized net (loss)/gain on available-for-sale <br/>&#160;&#160;&#160;&#160;marketable securities</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i2c5f0f28773744e5a2e202f2943ae976_D20220401-20220630" decimals="-3" sign="-" name="us-gaap:OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmFlNWE5YmUwZWI5NDQ1ZDE5MmZhZTgyMmQyMmJlMDlmL3NlYzphZTVhOWJlMGViOTQ0NWQxOTJmYWU4MjJkMjJiZTA5Zl8yMi9mcmFnOjVlYmVjNTcxMTlmYjQyZGM5ZWRlN2UyZTBiNzJlZmQwL3RhYmxlOmM5M2FlN2Y0MDZlNTQ1Y2M5YzIwYzc5OTcyZGMzZjM3L3RhYmxlcmFuZ2U6YzkzYWU3ZjQwNmU1NDVjYzljMjBjNzk5NzJkYzNmMzdfMy0xLTEtMS02MjY_50920dd5-2b5d-4a9d-8912-2b1c5dbe42c8">171</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="id7bb773872394047ba26aa8a7a0f4d56_D20210401-20210630" decimals="-3" sign="-" name="us-gaap:OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmFlNWE5YmUwZWI5NDQ1ZDE5MmZhZTgyMmQyMmJlMDlmL3NlYzphZTVhOWJlMGViOTQ0NWQxOTJmYWU4MjJkMjJiZTA5Zl8yMi9mcmFnOjVlYmVjNTcxMTlmYjQyZGM5ZWRlN2UyZTBiNzJlZmQwL3RhYmxlOmM5M2FlN2Y0MDZlNTQ1Y2M5YzIwYzc5OTcyZGMzZjM3L3RhYmxlcmFuZ2U6YzkzYWU3ZjQwNmU1NDVjYzljMjBjNzk5NzJkYzNmMzdfMy0zLTEtMS02MjY_67dd271e-c231-4875-bd86-eb107ff488cd">6</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ia855382ada1f4f28aa8ef6da692ff177_D20220101-20220630" decimals="-3" sign="-" name="us-gaap:OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmFlNWE5YmUwZWI5NDQ1ZDE5MmZhZTgyMmQyMmJlMDlmL3NlYzphZTVhOWJlMGViOTQ0NWQxOTJmYWU4MjJkMjJiZTA5Zl8yMi9mcmFnOjVlYmVjNTcxMTlmYjQyZGM5ZWRlN2UyZTBiNzJlZmQwL3RhYmxlOmM5M2FlN2Y0MDZlNTQ1Y2M5YzIwYzc5OTcyZGMzZjM3L3RhYmxlcmFuZ2U6YzkzYWU3ZjQwNmU1NDVjYzljMjBjNzk5NzJkYzNmMzdfMy01LTEtMS02MjY_80843abc-5395-4e2c-ad2e-c92b98e0dcc8">741</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="idaa4f31ca59a4a17a59c2580b97791ca_D20210101-20210630" decimals="-3" name="us-gaap:OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmFlNWE5YmUwZWI5NDQ1ZDE5MmZhZTgyMmQyMmJlMDlmL3NlYzphZTVhOWJlMGViOTQ0NWQxOTJmYWU4MjJkMjJiZTA5Zl8yMi9mcmFnOjVlYmVjNTcxMTlmYjQyZGM5ZWRlN2UyZTBiNzJlZmQwL3RhYmxlOmM5M2FlN2Y0MDZlNTQ1Y2M5YzIwYzc5OTcyZGMzZjM3L3RhYmxlcmFuZ2U6YzkzYWU3ZjQwNmU1NDVjYzljMjBjNzk5NzJkYzNmMzdfMy03LTEtMS02MjY_4e3f084e-2f0c-4a74-b8d1-773c4fa6e687">3</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Comprehensive loss</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i2c5f0f28773744e5a2e202f2943ae976_D20220401-20220630" decimals="-3" sign="-" name="us-gaap:ComprehensiveIncomeNetOfTax" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmFlNWE5YmUwZWI5NDQ1ZDE5MmZhZTgyMmQyMmJlMDlmL3NlYzphZTVhOWJlMGViOTQ0NWQxOTJmYWU4MjJkMjJiZTA5Zl8yMi9mcmFnOjVlYmVjNTcxMTlmYjQyZGM5ZWRlN2UyZTBiNzJlZmQwL3RhYmxlOmM5M2FlN2Y0MDZlNTQ1Y2M5YzIwYzc5OTcyZGMzZjM3L3RhYmxlcmFuZ2U6YzkzYWU3ZjQwNmU1NDVjYzljMjBjNzk5NzJkYzNmMzdfNC0xLTEtMS02MjY_3ba6b198-7068-42e6-821a-a4e55f21559f">29,751</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="id7bb773872394047ba26aa8a7a0f4d56_D20210401-20210630" decimals="-3" sign="-" name="us-gaap:ComprehensiveIncomeNetOfTax" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmFlNWE5YmUwZWI5NDQ1ZDE5MmZhZTgyMmQyMmJlMDlmL3NlYzphZTVhOWJlMGViOTQ0NWQxOTJmYWU4MjJkMjJiZTA5Zl8yMi9mcmFnOjVlYmVjNTcxMTlmYjQyZGM5ZWRlN2UyZTBiNzJlZmQwL3RhYmxlOmM5M2FlN2Y0MDZlNTQ1Y2M5YzIwYzc5OTcyZGMzZjM3L3RhYmxlcmFuZ2U6YzkzYWU3ZjQwNmU1NDVjYzljMjBjNzk5NzJkYzNmMzdfNC0zLTEtMS02MjY_1376e460-53d6-4ae3-9bb2-a11296f1fe1d">17,108</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ia855382ada1f4f28aa8ef6da692ff177_D20220101-20220630" decimals="-3" sign="-" name="us-gaap:ComprehensiveIncomeNetOfTax" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmFlNWE5YmUwZWI5NDQ1ZDE5MmZhZTgyMmQyMmJlMDlmL3NlYzphZTVhOWJlMGViOTQ0NWQxOTJmYWU4MjJkMjJiZTA5Zl8yMi9mcmFnOjVlYmVjNTcxMTlmYjQyZGM5ZWRlN2UyZTBiNzJlZmQwL3RhYmxlOmM5M2FlN2Y0MDZlNTQ1Y2M5YzIwYzc5OTcyZGMzZjM3L3RhYmxlcmFuZ2U6YzkzYWU3ZjQwNmU1NDVjYzljMjBjNzk5NzJkYzNmMzdfNC01LTEtMS02MjY_501b079e-a93f-4010-9e0c-b4b2e53397e5">60,429</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="idaa4f31ca59a4a17a59c2580b97791ca_D20210101-20210630" decimals="-3" sign="-" name="us-gaap:ComprehensiveIncomeNetOfTax" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmFlNWE5YmUwZWI5NDQ1ZDE5MmZhZTgyMmQyMmJlMDlmL3NlYzphZTVhOWJlMGViOTQ0NWQxOTJmYWU4MjJkMjJiZTA5Zl8yMi9mcmFnOjVlYmVjNTcxMTlmYjQyZGM5ZWRlN2UyZTBiNzJlZmQwL3RhYmxlOmM5M2FlN2Y0MDZlNTQ1Y2M5YzIwYzc5OTcyZGMzZjM3L3RhYmxlcmFuZ2U6YzkzYWU3ZjQwNmU1NDVjYzljMjBjNzk5NzJkYzNmMzdfNC03LTEtMS02MjY_48a0c045-5fa5-4e95-9e71-29170391dff8">32,167</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><div style="margin-top:12pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">See accompanying notes to unaudited condensed consolidated financial statements.</span></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">3</span></div></div></div><div id="iae5a9be0eb9445d192fae822d22be09f_28"></div><hr style="page-break-after:always"/><div style="min-height:45pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#iae5a9be0eb9445d192fae822d22be09f_7">Table of Contents</a></span></div></div><div style="margin-top:12pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">DERMTECH, INC.</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Condensed Consolidated Statements of Stockholders&#8217; Equity</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">(in thousands, except share and per share data)</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">(Unaudited)</span></div><div style="margin-top:12pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:38.677%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.566%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.244%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.566%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.244%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.566%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.244%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.566%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.244%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.566%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.244%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.573%"></td><td style="width:0.1%"></td></tr><tr style="height:24pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:120%">Common stock</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" rowspan="2" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:120%">Additional<br/>paid-in<br/>capital</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" rowspan="2" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:120%">Accumulated<br/>other<br/>comprehensive<br/>loss</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" rowspan="2" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:120%">Accumulated<br/>deficit</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" rowspan="2" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:120%">Total<br/>stockholders&#8217;<br/>equity</span></td></tr><tr style="height:12pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Shares</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Amount</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Balance, December 31, 2021</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i8dc9000c668a4aa984be19fb8519665b_I20211231" decimals="INF" name="us-gaap:SharesOutstanding" format="ixt:num-dot-decimal" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmFlNWE5YmUwZWI5NDQ1ZDE5MmZhZTgyMmQyMmJlMDlmL3NlYzphZTVhOWJlMGViOTQ0NWQxOTJmYWU4MjJkMjJiZTA5Zl8yOC9mcmFnOmU0Nzg5YmZkNzY5YTRjYzc4NjI0YWU3MmUwNTE0OGM5L3RhYmxlOmQ4ZjY5OTZmZjM0ZDRlNGNiMmI2MjY3NTBkYTMxYTFiL3RhYmxlcmFuZ2U6ZDhmNjk5NmZmMzRkNGU0Y2IyYjYyNjc1MGRhMzFhMWJfMi0xLTEtMS02MjY_d181dd62-04a6-4e6a-b906-8398807ab6b1">29,772,922</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i8dc9000c668a4aa984be19fb8519665b_I20211231" decimals="-3" name="us-gaap:StockholdersEquity" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmFlNWE5YmUwZWI5NDQ1ZDE5MmZhZTgyMmQyMmJlMDlmL3NlYzphZTVhOWJlMGViOTQ0NWQxOTJmYWU4MjJkMjJiZTA5Zl8yOC9mcmFnOmU0Nzg5YmZkNzY5YTRjYzc4NjI0YWU3MmUwNTE0OGM5L3RhYmxlOmQ4ZjY5OTZmZjM0ZDRlNGNiMmI2MjY3NTBkYTMxYTFiL3RhYmxlcmFuZ2U6ZDhmNjk5NmZmMzRkNGU0Y2IyYjYyNjc1MGRhMzFhMWJfMi0zLTEtMS02MjY_5b5ff646-f8ea-40f1-87b0-8548d8b7ba5b">3</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i152c9be1ba1e447486e5a7897ca085e6_I20211231" decimals="-3" name="us-gaap:StockholdersEquity" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmFlNWE5YmUwZWI5NDQ1ZDE5MmZhZTgyMmQyMmJlMDlmL3NlYzphZTVhOWJlMGViOTQ0NWQxOTJmYWU4MjJkMjJiZTA5Zl8yOC9mcmFnOmU0Nzg5YmZkNzY5YTRjYzc4NjI0YWU3MmUwNTE0OGM5L3RhYmxlOmQ4ZjY5OTZmZjM0ZDRlNGNiMmI2MjY3NTBkYTMxYTFiL3RhYmxlcmFuZ2U6ZDhmNjk5NmZmMzRkNGU0Y2IyYjYyNjc1MGRhMzFhMWJfMi01LTEtMS02MjY_688d6665-2b64-4cb0-b012-ff304738742c">436,183</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i922bc272fcd34b919d4804d77d0e0c27_I20211231" decimals="-3" sign="-" name="us-gaap:StockholdersEquity" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmFlNWE5YmUwZWI5NDQ1ZDE5MmZhZTgyMmQyMmJlMDlmL3NlYzphZTVhOWJlMGViOTQ0NWQxOTJmYWU4MjJkMjJiZTA5Zl8yOC9mcmFnOmU0Nzg5YmZkNzY5YTRjYzc4NjI0YWU3MmUwNTE0OGM5L3RhYmxlOmQ4ZjY5OTZmZjM0ZDRlNGNiMmI2MjY3NTBkYTMxYTFiL3RhYmxlcmFuZ2U6ZDhmNjk5NmZmMzRkNGU0Y2IyYjYyNjc1MGRhMzFhMWJfMi03LTEtMS02MjY_9a23f27f-ddcd-4a93-9f4e-5048bd308dbb">124</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i9abcd2f792c74d59a334b58470c92ee1_I20211231" decimals="-3" sign="-" name="us-gaap:StockholdersEquity" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmFlNWE5YmUwZWI5NDQ1ZDE5MmZhZTgyMmQyMmJlMDlmL3NlYzphZTVhOWJlMGViOTQ0NWQxOTJmYWU4MjJkMjJiZTA5Zl8yOC9mcmFnOmU0Nzg5YmZkNzY5YTRjYzc4NjI0YWU3MmUwNTE0OGM5L3RhYmxlOmQ4ZjY5OTZmZjM0ZDRlNGNiMmI2MjY3NTBkYTMxYTFiL3RhYmxlcmFuZ2U6ZDhmNjk5NmZmMzRkNGU0Y2IyYjYyNjc1MGRhMzFhMWJfMi05LTEtMS02MjY_c2b199c2-bb04-4748-91b3-c052f74120be">206,364</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i87bf777ccf5f4f93bc9be7a2cbba61c1_I20211231" decimals="-3" name="us-gaap:StockholdersEquity" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmFlNWE5YmUwZWI5NDQ1ZDE5MmZhZTgyMmQyMmJlMDlmL3NlYzphZTVhOWJlMGViOTQ0NWQxOTJmYWU4MjJkMjJiZTA5Zl8yOC9mcmFnOmU0Nzg5YmZkNzY5YTRjYzc4NjI0YWU3MmUwNTE0OGM5L3RhYmxlOmQ4ZjY5OTZmZjM0ZDRlNGNiMmI2MjY3NTBkYTMxYTFiL3RhYmxlcmFuZ2U6ZDhmNjk5NmZmMzRkNGU0Y2IyYjYyNjc1MGRhMzFhMWJfMi0xMS0xLTEtNjI2_18706d63-fcfd-4fc1-a05e-ba02fca9b7e3">229,698</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 10pt;text-align:left;text-indent:-9pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Issuance of common stock from option exercises and RSU releases</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="ibdd6f077db7e4453b764a24795f4ccab_D20220101-20220331" decimals="INF" name="dmtk:StockIssuedDuringPeriodSharesStockOptionsExercisedAndRSURelease" format="ixt:num-dot-decimal" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmFlNWE5YmUwZWI5NDQ1ZDE5MmZhZTgyMmQyMmJlMDlmL3NlYzphZTVhOWJlMGViOTQ0NWQxOTJmYWU4MjJkMjJiZTA5Zl8yOC9mcmFnOmU0Nzg5YmZkNzY5YTRjYzc4NjI0YWU3MmUwNTE0OGM5L3RhYmxlOmQ4ZjY5OTZmZjM0ZDRlNGNiMmI2MjY3NTBkYTMxYTFiL3RhYmxlcmFuZ2U6ZDhmNjk5NmZmMzRkNGU0Y2IyYjYyNjc1MGRhMzFhMWJfNC0xLTEtMS02MjY_a4c5093b-27d4-4b7f-a680-2dcdcdd3ed6e">109,275</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i0c3fc5bff94f42de9cc243e9bac95218_D20220101-20220331" decimals="-3" name="dmtk:StockIssuedDuringPeriodValueStockOptionsExercisedAndRSURelease" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmFlNWE5YmUwZWI5NDQ1ZDE5MmZhZTgyMmQyMmJlMDlmL3NlYzphZTVhOWJlMGViOTQ0NWQxOTJmYWU4MjJkMjJiZTA5Zl8yOC9mcmFnOmU0Nzg5YmZkNzY5YTRjYzc4NjI0YWU3MmUwNTE0OGM5L3RhYmxlOmQ4ZjY5OTZmZjM0ZDRlNGNiMmI2MjY3NTBkYTMxYTFiL3RhYmxlcmFuZ2U6ZDhmNjk5NmZmMzRkNGU0Y2IyYjYyNjc1MGRhMzFhMWJfNC01LTEtMS02MjY_01aa6dab-2b08-41fb-8bf8-671d3b95f46d">40</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i73a86f0089f6462d9bcb14d0d7b333b6_D20220101-20220331" decimals="-3" name="dmtk:StockIssuedDuringPeriodValueStockOptionsExercisedAndRSURelease" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmFlNWE5YmUwZWI5NDQ1ZDE5MmZhZTgyMmQyMmJlMDlmL3NlYzphZTVhOWJlMGViOTQ0NWQxOTJmYWU4MjJkMjJiZTA5Zl8yOC9mcmFnOmU0Nzg5YmZkNzY5YTRjYzc4NjI0YWU3MmUwNTE0OGM5L3RhYmxlOmQ4ZjY5OTZmZjM0ZDRlNGNiMmI2MjY3NTBkYTMxYTFiL3RhYmxlcmFuZ2U6ZDhmNjk5NmZmMzRkNGU0Y2IyYjYyNjc1MGRhMzFhMWJfNC0xMS0xLTEtNjI2_9f0f4d85-ca07-4cfd-aca5-cc9c76c5c294">40</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 10pt;text-align:left;text-indent:-9pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Issuance of common stock from warrant exercises</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="ibdd6f077db7e4453b764a24795f4ccab_D20220101-20220331" decimals="INF" name="dmtk:AdjustmentsToAdditionalPaidInCapitalWarrantIssuedShares" format="ixt:num-dot-decimal" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmFlNWE5YmUwZWI5NDQ1ZDE5MmZhZTgyMmQyMmJlMDlmL3NlYzphZTVhOWJlMGViOTQ0NWQxOTJmYWU4MjJkMjJiZTA5Zl8yOC9mcmFnOmU0Nzg5YmZkNzY5YTRjYzc4NjI0YWU3MmUwNTE0OGM5L3RhYmxlOmQ4ZjY5OTZmZjM0ZDRlNGNiMmI2MjY3NTBkYTMxYTFiL3RhYmxlcmFuZ2U6ZDhmNjk5NmZmMzRkNGU0Y2IyYjYyNjc1MGRhMzFhMWJfNS0xLTEtMS02MjY_7e0f88f1-0dbf-458d-947b-6b40d492ac91">11,101</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i0c3fc5bff94f42de9cc243e9bac95218_D20220101-20220331" decimals="-3" name="us-gaap:AdjustmentsToAdditionalPaidInCapitalWarrantIssued" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmFlNWE5YmUwZWI5NDQ1ZDE5MmZhZTgyMmQyMmJlMDlmL3NlYzphZTVhOWJlMGViOTQ0NWQxOTJmYWU4MjJkMjJiZTA5Zl8yOC9mcmFnOmU0Nzg5YmZkNzY5YTRjYzc4NjI0YWU3MmUwNTE0OGM5L3RhYmxlOmQ4ZjY5OTZmZjM0ZDRlNGNiMmI2MjY3NTBkYTMxYTFiL3RhYmxlcmFuZ2U6ZDhmNjk5NmZmMzRkNGU0Y2IyYjYyNjc1MGRhMzFhMWJfNS01LTEtMS02MjY_460f90f8-2944-406f-acd1-e57fa1781652">12</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i73a86f0089f6462d9bcb14d0d7b333b6_D20220101-20220331" decimals="-3" name="us-gaap:AdjustmentsToAdditionalPaidInCapitalWarrantIssued" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmFlNWE5YmUwZWI5NDQ1ZDE5MmZhZTgyMmQyMmJlMDlmL3NlYzphZTVhOWJlMGViOTQ0NWQxOTJmYWU4MjJkMjJiZTA5Zl8yOC9mcmFnOmU0Nzg5YmZkNzY5YTRjYzc4NjI0YWU3MmUwNTE0OGM5L3RhYmxlOmQ4ZjY5OTZmZjM0ZDRlNGNiMmI2MjY3NTBkYTMxYTFiL3RhYmxlcmFuZ2U6ZDhmNjk5NmZmMzRkNGU0Y2IyYjYyNjc1MGRhMzFhMWJfNS0xMS0xLTEtNjI2_c6de2db0-9ec3-4d64-9da1-fca8ff059f5b">12</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 10pt;text-align:left;text-indent:-9pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Issuance of common stock from Employee Stock Purchase Plan</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="ibdd6f077db7e4453b764a24795f4ccab_D20220101-20220331" decimals="INF" name="us-gaap:StockIssuedDuringPeriodSharesEmployeeStockPurchasePlans" format="ixt:num-dot-decimal" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmFlNWE5YmUwZWI5NDQ1ZDE5MmZhZTgyMmQyMmJlMDlmL3NlYzphZTVhOWJlMGViOTQ0NWQxOTJmYWU4MjJkMjJiZTA5Zl8yOC9mcmFnOmU0Nzg5YmZkNzY5YTRjYzc4NjI0YWU3MmUwNTE0OGM5L3RhYmxlOmQ4ZjY5OTZmZjM0ZDRlNGNiMmI2MjY3NTBkYTMxYTFiL3RhYmxlcmFuZ2U6ZDhmNjk5NmZmMzRkNGU0Y2IyYjYyNjc1MGRhMzFhMWJfNi0xLTEtMS02MjY_86cc42b2-31d3-4523-acea-b839f61c59b5">47,339</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i0c3fc5bff94f42de9cc243e9bac95218_D20220101-20220331" decimals="-3" name="us-gaap:StockIssuedDuringPeriodValueEmployeeStockPurchasePlan" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmFlNWE5YmUwZWI5NDQ1ZDE5MmZhZTgyMmQyMmJlMDlmL3NlYzphZTVhOWJlMGViOTQ0NWQxOTJmYWU4MjJkMjJiZTA5Zl8yOC9mcmFnOmU0Nzg5YmZkNzY5YTRjYzc4NjI0YWU3MmUwNTE0OGM5L3RhYmxlOmQ4ZjY5OTZmZjM0ZDRlNGNiMmI2MjY3NTBkYTMxYTFiL3RhYmxlcmFuZ2U6ZDhmNjk5NmZmMzRkNGU0Y2IyYjYyNjc1MGRhMzFhMWJfNi01LTEtMS02MjY_cff375a9-cbb2-436d-8cbd-5a5a9867d85a">515</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i73a86f0089f6462d9bcb14d0d7b333b6_D20220101-20220331" decimals="-3" name="us-gaap:StockIssuedDuringPeriodValueEmployeeStockPurchasePlan" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmFlNWE5YmUwZWI5NDQ1ZDE5MmZhZTgyMmQyMmJlMDlmL3NlYzphZTVhOWJlMGViOTQ0NWQxOTJmYWU4MjJkMjJiZTA5Zl8yOC9mcmFnOmU0Nzg5YmZkNzY5YTRjYzc4NjI0YWU3MmUwNTE0OGM5L3RhYmxlOmQ4ZjY5OTZmZjM0ZDRlNGNiMmI2MjY3NTBkYTMxYTFiL3RhYmxlcmFuZ2U6ZDhmNjk5NmZmMzRkNGU0Y2IyYjYyNjc1MGRhMzFhMWJfNi0xMS0xLTEtNjI2_ea48f6a7-77ae-4b4d-be7b-1e6f3b7e2f1e">515</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 10pt;text-align:left;text-indent:-9pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Unrealized net loss on available-for-sale marketable securities</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i3b22eec6726b4166a994d025bc0ced72_D20220101-20220331" decimals="-3" sign="-" name="us-gaap:OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmFlNWE5YmUwZWI5NDQ1ZDE5MmZhZTgyMmQyMmJlMDlmL3NlYzphZTVhOWJlMGViOTQ0NWQxOTJmYWU4MjJkMjJiZTA5Zl8yOC9mcmFnOmU0Nzg5YmZkNzY5YTRjYzc4NjI0YWU3MmUwNTE0OGM5L3RhYmxlOmQ4ZjY5OTZmZjM0ZDRlNGNiMmI2MjY3NTBkYTMxYTFiL3RhYmxlcmFuZ2U6ZDhmNjk5NmZmMzRkNGU0Y2IyYjYyNjc1MGRhMzFhMWJfNy03LTEtMS02MjY_f95f0431-b191-4f39-9260-a3840976f65b">570</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i73a86f0089f6462d9bcb14d0d7b333b6_D20220101-20220331" decimals="-3" sign="-" name="us-gaap:OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmFlNWE5YmUwZWI5NDQ1ZDE5MmZhZTgyMmQyMmJlMDlmL3NlYzphZTVhOWJlMGViOTQ0NWQxOTJmYWU4MjJkMjJiZTA5Zl8yOC9mcmFnOmU0Nzg5YmZkNzY5YTRjYzc4NjI0YWU3MmUwNTE0OGM5L3RhYmxlOmQ4ZjY5OTZmZjM0ZDRlNGNiMmI2MjY3NTBkYTMxYTFiL3RhYmxlcmFuZ2U6ZDhmNjk5NmZmMzRkNGU0Y2IyYjYyNjc1MGRhMzFhMWJfNy0xMS0xLTEtNjI2_90fa06d0-532f-4e4b-bfb2-94870716750e">570</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Stock-based compensation</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i0c3fc5bff94f42de9cc243e9bac95218_D20220101-20220331" decimals="-3" name="us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmFlNWE5YmUwZWI5NDQ1ZDE5MmZhZTgyMmQyMmJlMDlmL3NlYzphZTVhOWJlMGViOTQ0NWQxOTJmYWU4MjJkMjJiZTA5Zl8yOC9mcmFnOmU0Nzg5YmZkNzY5YTRjYzc4NjI0YWU3MmUwNTE0OGM5L3RhYmxlOmQ4ZjY5OTZmZjM0ZDRlNGNiMmI2MjY3NTBkYTMxYTFiL3RhYmxlcmFuZ2U6ZDhmNjk5NmZmMzRkNGU0Y2IyYjYyNjc1MGRhMzFhMWJfOC01LTEtMS02MjY_52f1bd94-dc48-41e8-b3a3-a052e023b076">3,894</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i73a86f0089f6462d9bcb14d0d7b333b6_D20220101-20220331" decimals="-3" name="us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmFlNWE5YmUwZWI5NDQ1ZDE5MmZhZTgyMmQyMmJlMDlmL3NlYzphZTVhOWJlMGViOTQ0NWQxOTJmYWU4MjJkMjJiZTA5Zl8yOC9mcmFnOmU0Nzg5YmZkNzY5YTRjYzc4NjI0YWU3MmUwNTE0OGM5L3RhYmxlOmQ4ZjY5OTZmZjM0ZDRlNGNiMmI2MjY3NTBkYTMxYTFiL3RhYmxlcmFuZ2U6ZDhmNjk5NmZmMzRkNGU0Y2IyYjYyNjc1MGRhMzFhMWJfOC0xMS0xLTEtNjI2_2a8c89d1-818a-4de8-b765-a150f5fa25f1">3,894</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Net loss</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ic42372bda74e4cccb938ae9846b0efa8_D20220101-20220331" decimals="-3" sign="-" name="us-gaap:NetIncomeLoss" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmFlNWE5YmUwZWI5NDQ1ZDE5MmZhZTgyMmQyMmJlMDlmL3NlYzphZTVhOWJlMGViOTQ0NWQxOTJmYWU4MjJkMjJiZTA5Zl8yOC9mcmFnOmU0Nzg5YmZkNzY5YTRjYzc4NjI0YWU3MmUwNTE0OGM5L3RhYmxlOmQ4ZjY5OTZmZjM0ZDRlNGNiMmI2MjY3NTBkYTMxYTFiL3RhYmxlcmFuZ2U6ZDhmNjk5NmZmMzRkNGU0Y2IyYjYyNjc1MGRhMzFhMWJfMTAtOS0xLTEtNjI2_fae63adb-49b3-4848-a2a2-a9350d249e76">30,108</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i73a86f0089f6462d9bcb14d0d7b333b6_D20220101-20220331" decimals="-3" sign="-" name="us-gaap:NetIncomeLoss" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmFlNWE5YmUwZWI5NDQ1ZDE5MmZhZTgyMmQyMmJlMDlmL3NlYzphZTVhOWJlMGViOTQ0NWQxOTJmYWU4MjJkMjJiZTA5Zl8yOC9mcmFnOmU0Nzg5YmZkNzY5YTRjYzc4NjI0YWU3MmUwNTE0OGM5L3RhYmxlOmQ4ZjY5OTZmZjM0ZDRlNGNiMmI2MjY3NTBkYTMxYTFiL3RhYmxlcmFuZ2U6ZDhmNjk5NmZmMzRkNGU0Y2IyYjYyNjc1MGRhMzFhMWJfMTAtMTEtMS0xLTYyNg_b807a654-f0de-47c2-9670-7450e577410c">30,108</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Balance, March 31, 2022</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i39d067b2de814fdd942ed3afbc265b36_I20220331" decimals="INF" name="us-gaap:SharesOutstanding" format="ixt:num-dot-decimal" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmFlNWE5YmUwZWI5NDQ1ZDE5MmZhZTgyMmQyMmJlMDlmL3NlYzphZTVhOWJlMGViOTQ0NWQxOTJmYWU4MjJkMjJiZTA5Zl8yOC9mcmFnOmU0Nzg5YmZkNzY5YTRjYzc4NjI0YWU3MmUwNTE0OGM5L3RhYmxlOmQ4ZjY5OTZmZjM0ZDRlNGNiMmI2MjY3NTBkYTMxYTFiL3RhYmxlcmFuZ2U6ZDhmNjk5NmZmMzRkNGU0Y2IyYjYyNjc1MGRhMzFhMWJfMTEtMS0xLTEtNjI2_3ac2ca8e-0737-4856-9d37-5297193dd77e">29,940,637</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i39d067b2de814fdd942ed3afbc265b36_I20220331" decimals="-3" name="us-gaap:StockholdersEquity" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmFlNWE5YmUwZWI5NDQ1ZDE5MmZhZTgyMmQyMmJlMDlmL3NlYzphZTVhOWJlMGViOTQ0NWQxOTJmYWU4MjJkMjJiZTA5Zl8yOC9mcmFnOmU0Nzg5YmZkNzY5YTRjYzc4NjI0YWU3MmUwNTE0OGM5L3RhYmxlOmQ4ZjY5OTZmZjM0ZDRlNGNiMmI2MjY3NTBkYTMxYTFiL3RhYmxlcmFuZ2U6ZDhmNjk5NmZmMzRkNGU0Y2IyYjYyNjc1MGRhMzFhMWJfMTEtMy0xLTEtNjI2_11dde216-2539-49e6-997a-04b065fe2e05">3</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ie3d1daa21e224cc7bf51143498f4f8dc_I20220331" decimals="-3" name="us-gaap:StockholdersEquity" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmFlNWE5YmUwZWI5NDQ1ZDE5MmZhZTgyMmQyMmJlMDlmL3NlYzphZTVhOWJlMGViOTQ0NWQxOTJmYWU4MjJkMjJiZTA5Zl8yOC9mcmFnOmU0Nzg5YmZkNzY5YTRjYzc4NjI0YWU3MmUwNTE0OGM5L3RhYmxlOmQ4ZjY5OTZmZjM0ZDRlNGNiMmI2MjY3NTBkYTMxYTFiL3RhYmxlcmFuZ2U6ZDhmNjk5NmZmMzRkNGU0Y2IyYjYyNjc1MGRhMzFhMWJfMTEtNS0xLTEtNjI2_05bfa2f5-6192-447e-abc8-a5e52e134138">440,644</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ieaf99c642b3e451383632209bf030fa1_I20220331" decimals="-3" sign="-" name="us-gaap:StockholdersEquity" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmFlNWE5YmUwZWI5NDQ1ZDE5MmZhZTgyMmQyMmJlMDlmL3NlYzphZTVhOWJlMGViOTQ0NWQxOTJmYWU4MjJkMjJiZTA5Zl8yOC9mcmFnOmU0Nzg5YmZkNzY5YTRjYzc4NjI0YWU3MmUwNTE0OGM5L3RhYmxlOmQ4ZjY5OTZmZjM0ZDRlNGNiMmI2MjY3NTBkYTMxYTFiL3RhYmxlcmFuZ2U6ZDhmNjk5NmZmMzRkNGU0Y2IyYjYyNjc1MGRhMzFhMWJfMTEtNy0xLTEtNjI2_af3177b5-bfda-4955-9460-f8c009e7ff74">694</ix:nonFraction>)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i842f2362497347869b657ca3d4a18b0e_I20220331" decimals="-3" sign="-" name="us-gaap:StockholdersEquity" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmFlNWE5YmUwZWI5NDQ1ZDE5MmZhZTgyMmQyMmJlMDlmL3NlYzphZTVhOWJlMGViOTQ0NWQxOTJmYWU4MjJkMjJiZTA5Zl8yOC9mcmFnOmU0Nzg5YmZkNzY5YTRjYzc4NjI0YWU3MmUwNTE0OGM5L3RhYmxlOmQ4ZjY5OTZmZjM0ZDRlNGNiMmI2MjY3NTBkYTMxYTFiL3RhYmxlcmFuZ2U6ZDhmNjk5NmZmMzRkNGU0Y2IyYjYyNjc1MGRhMzFhMWJfMTEtOS0xLTEtNjI2_151ca0d6-a2d7-49ff-b3ad-bc05d69d1d4b">236,472</ix:nonFraction>)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="id801924f698f4fbab568e7483b1a98ca_I20220331" decimals="-3" name="us-gaap:StockholdersEquity" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmFlNWE5YmUwZWI5NDQ1ZDE5MmZhZTgyMmQyMmJlMDlmL3NlYzphZTVhOWJlMGViOTQ0NWQxOTJmYWU4MjJkMjJiZTA5Zl8yOC9mcmFnOmU0Nzg5YmZkNzY5YTRjYzc4NjI0YWU3MmUwNTE0OGM5L3RhYmxlOmQ4ZjY5OTZmZjM0ZDRlNGNiMmI2MjY3NTBkYTMxYTFiL3RhYmxlcmFuZ2U6ZDhmNjk5NmZmMzRkNGU0Y2IyYjYyNjc1MGRhMzFhMWJfMTEtMTEtMS0xLTYyNg_a8bb8178-04fe-4efe-b417-287fcd864f7f">203,481</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 10pt;text-align:left;text-indent:-9pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Issuance of common stock from RSU releases</span></td><td colspan="2" style="background-color:#cceeff;border-top:3pt double #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i3ac147ed027b4fccb1eb3b3b35fff118_D20220401-20220630" decimals="INF" name="dmtk:StockIssuedDuringPeriodSharesStockOptionsExercisedAndRSURelease" format="ixt:num-dot-decimal" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmFlNWE5YmUwZWI5NDQ1ZDE5MmZhZTgyMmQyMmJlMDlmL3NlYzphZTVhOWJlMGViOTQ0NWQxOTJmYWU4MjJkMjJiZTA5Zl8yOC9mcmFnOmU0Nzg5YmZkNzY5YTRjYzc4NjI0YWU3MmUwNTE0OGM5L3RhYmxlOmQ4ZjY5OTZmZjM0ZDRlNGNiMmI2MjY3NTBkYTMxYTFiL3RhYmxlcmFuZ2U6ZDhmNjk5NmZmMzRkNGU0Y2IyYjYyNjc1MGRhMzFhMWJfMTItMS0xLTEtNjI2_c08d8669-36ce-4388-b525-5f6623b78d0f">88,591</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:3pt double #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:3pt double #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;border-top:3pt double #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:3pt double #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i5a6efd2e4aae4e7c98a64843742ef0b5_D20220401-20220630" decimals="-3" name="dmtk:StockIssuedDuringPeriodValueStockOptionsExercisedAndRSURelease" format="ixt:fixed-zero" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmFlNWE5YmUwZWI5NDQ1ZDE5MmZhZTgyMmQyMmJlMDlmL3NlYzphZTVhOWJlMGViOTQ0NWQxOTJmYWU4MjJkMjJiZTA5Zl8yOC9mcmFnOmU0Nzg5YmZkNzY5YTRjYzc4NjI0YWU3MmUwNTE0OGM5L3RhYmxlOmQ4ZjY5OTZmZjM0ZDRlNGNiMmI2MjY3NTBkYTMxYTFiL3RhYmxlcmFuZ2U6ZDhmNjk5NmZmMzRkNGU0Y2IyYjYyNjc1MGRhMzFhMWJfMTItNS0xLTEtNjI2_72f3518e-8920-402e-836e-172e47a8c5c8">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:3pt double #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:3pt double #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;border-top:3pt double #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:3pt double #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;border-top:3pt double #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:3pt double #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i2c5f0f28773744e5a2e202f2943ae976_D20220401-20220630" decimals="-3" name="dmtk:StockIssuedDuringPeriodValueStockOptionsExercisedAndRSURelease" format="ixt:fixed-zero" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmFlNWE5YmUwZWI5NDQ1ZDE5MmZhZTgyMmQyMmJlMDlmL3NlYzphZTVhOWJlMGViOTQ0NWQxOTJmYWU4MjJkMjJiZTA5Zl8yOC9mcmFnOmU0Nzg5YmZkNzY5YTRjYzc4NjI0YWU3MmUwNTE0OGM5L3RhYmxlOmQ4ZjY5OTZmZjM0ZDRlNGNiMmI2MjY3NTBkYTMxYTFiL3RhYmxlcmFuZ2U6ZDhmNjk5NmZmMzRkNGU0Y2IyYjYyNjc1MGRhMzFhMWJfMTItMTEtMS0xLTYyNg_d2b9d3cd-2795-4871-ada8-ddfb2101584d">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:3pt double #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 10pt;text-align:left;text-indent:-9pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Issuance of common stock from warrant exercises</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i3ac147ed027b4fccb1eb3b3b35fff118_D20220401-20220630" decimals="INF" name="dmtk:AdjustmentsToAdditionalPaidInCapitalWarrantIssuedShares" format="ixt:num-dot-decimal" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmFlNWE5YmUwZWI5NDQ1ZDE5MmZhZTgyMmQyMmJlMDlmL3NlYzphZTVhOWJlMGViOTQ0NWQxOTJmYWU4MjJkMjJiZTA5Zl8yOC9mcmFnOmU0Nzg5YmZkNzY5YTRjYzc4NjI0YWU3MmUwNTE0OGM5L3RhYmxlOmQ4ZjY5OTZmZjM0ZDRlNGNiMmI2MjY3NTBkYTMxYTFiL3RhYmxlcmFuZ2U6ZDhmNjk5NmZmMzRkNGU0Y2IyYjYyNjc1MGRhMzFhMWJfMTQtMS0xLTEtNjI2_9bb63ddb-ed43-4760-afd5-83379986d857">9,219</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i5a6efd2e4aae4e7c98a64843742ef0b5_D20220401-20220630" decimals="-3" name="us-gaap:AdjustmentsToAdditionalPaidInCapitalWarrantIssued" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmFlNWE5YmUwZWI5NDQ1ZDE5MmZhZTgyMmQyMmJlMDlmL3NlYzphZTVhOWJlMGViOTQ0NWQxOTJmYWU4MjJkMjJiZTA5Zl8yOC9mcmFnOmU0Nzg5YmZkNzY5YTRjYzc4NjI0YWU3MmUwNTE0OGM5L3RhYmxlOmQ4ZjY5OTZmZjM0ZDRlNGNiMmI2MjY3NTBkYTMxYTFiL3RhYmxlcmFuZ2U6ZDhmNjk5NmZmMzRkNGU0Y2IyYjYyNjc1MGRhMzFhMWJfMTQtNS0xLTEtNjI2_b4d1146e-b6a6-4c10-9130-0161f95aac16">10</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i2c5f0f28773744e5a2e202f2943ae976_D20220401-20220630" decimals="-3" name="us-gaap:AdjustmentsToAdditionalPaidInCapitalWarrantIssued" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmFlNWE5YmUwZWI5NDQ1ZDE5MmZhZTgyMmQyMmJlMDlmL3NlYzphZTVhOWJlMGViOTQ0NWQxOTJmYWU4MjJkMjJiZTA5Zl8yOC9mcmFnOmU0Nzg5YmZkNzY5YTRjYzc4NjI0YWU3MmUwNTE0OGM5L3RhYmxlOmQ4ZjY5OTZmZjM0ZDRlNGNiMmI2MjY3NTBkYTMxYTFiL3RhYmxlcmFuZ2U6ZDhmNjk5NmZmMzRkNGU0Y2IyYjYyNjc1MGRhMzFhMWJfMTQtMTEtMS0xLTYyNg_30b601a8-4137-464f-aa40-21054ca4f8b7">10</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 10pt;text-align:left;text-indent:-9pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Unrealized net loss on available-for-sale marketable securities</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i121c1a6b16ed46b4b77fad9886993828_D20220401-20220630" decimals="-3" sign="-" name="us-gaap:OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmFlNWE5YmUwZWI5NDQ1ZDE5MmZhZTgyMmQyMmJlMDlmL3NlYzphZTVhOWJlMGViOTQ0NWQxOTJmYWU4MjJkMjJiZTA5Zl8yOC9mcmFnOmU0Nzg5YmZkNzY5YTRjYzc4NjI0YWU3MmUwNTE0OGM5L3RhYmxlOmQ4ZjY5OTZmZjM0ZDRlNGNiMmI2MjY3NTBkYTMxYTFiL3RhYmxlcmFuZ2U6ZDhmNjk5NmZmMzRkNGU0Y2IyYjYyNjc1MGRhMzFhMWJfMTUtNy0xLTEtNjI2_cec8e8db-af9f-49e9-9542-95c85cc5f84b">171</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i2c5f0f28773744e5a2e202f2943ae976_D20220401-20220630" decimals="-3" sign="-" name="us-gaap:OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmFlNWE5YmUwZWI5NDQ1ZDE5MmZhZTgyMmQyMmJlMDlmL3NlYzphZTVhOWJlMGViOTQ0NWQxOTJmYWU4MjJkMjJiZTA5Zl8yOC9mcmFnOmU0Nzg5YmZkNzY5YTRjYzc4NjI0YWU3MmUwNTE0OGM5L3RhYmxlOmQ4ZjY5OTZmZjM0ZDRlNGNiMmI2MjY3NTBkYTMxYTFiL3RhYmxlcmFuZ2U6ZDhmNjk5NmZmMzRkNGU0Y2IyYjYyNjc1MGRhMzFhMWJfMTUtMTEtMS0xLTYyNg_a671b092-a64a-420e-8698-055b62e43d13">171</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Stock-based compensation</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i5a6efd2e4aae4e7c98a64843742ef0b5_D20220401-20220630" decimals="-3" name="us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmFlNWE5YmUwZWI5NDQ1ZDE5MmZhZTgyMmQyMmJlMDlmL3NlYzphZTVhOWJlMGViOTQ0NWQxOTJmYWU4MjJkMjJiZTA5Zl8yOC9mcmFnOmU0Nzg5YmZkNzY5YTRjYzc4NjI0YWU3MmUwNTE0OGM5L3RhYmxlOmQ4ZjY5OTZmZjM0ZDRlNGNiMmI2MjY3NTBkYTMxYTFiL3RhYmxlcmFuZ2U6ZDhmNjk5NmZmMzRkNGU0Y2IyYjYyNjc1MGRhMzFhMWJfMTYtNS0xLTEtNjI2_c96f7516-340b-44ef-b53b-ddcf0c60d2bf">4,837</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i2c5f0f28773744e5a2e202f2943ae976_D20220401-20220630" decimals="-3" name="us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmFlNWE5YmUwZWI5NDQ1ZDE5MmZhZTgyMmQyMmJlMDlmL3NlYzphZTVhOWJlMGViOTQ0NWQxOTJmYWU4MjJkMjJiZTA5Zl8yOC9mcmFnOmU0Nzg5YmZkNzY5YTRjYzc4NjI0YWU3MmUwNTE0OGM5L3RhYmxlOmQ4ZjY5OTZmZjM0ZDRlNGNiMmI2MjY3NTBkYTMxYTFiL3RhYmxlcmFuZ2U6ZDhmNjk5NmZmMzRkNGU0Y2IyYjYyNjc1MGRhMzFhMWJfMTYtMTEtMS0xLTYyNg_cf633023-c5cb-40c5-aaca-30e371f2b7ad">4,837</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Net loss</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i6d917ab3db164f9196c80ba779ef6876_D20220401-20220630" decimals="-3" sign="-" name="us-gaap:NetIncomeLoss" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmFlNWE5YmUwZWI5NDQ1ZDE5MmZhZTgyMmQyMmJlMDlmL3NlYzphZTVhOWJlMGViOTQ0NWQxOTJmYWU4MjJkMjJiZTA5Zl8yOC9mcmFnOmU0Nzg5YmZkNzY5YTRjYzc4NjI0YWU3MmUwNTE0OGM5L3RhYmxlOmQ4ZjY5OTZmZjM0ZDRlNGNiMmI2MjY3NTBkYTMxYTFiL3RhYmxlcmFuZ2U6ZDhmNjk5NmZmMzRkNGU0Y2IyYjYyNjc1MGRhMzFhMWJfMTgtOS0xLTEtNjI2_725ee7b6-44cd-4067-81f9-7d89bcb5be36">29,580</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i2c5f0f28773744e5a2e202f2943ae976_D20220401-20220630" decimals="-3" sign="-" name="us-gaap:NetIncomeLoss" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmFlNWE5YmUwZWI5NDQ1ZDE5MmZhZTgyMmQyMmJlMDlmL3NlYzphZTVhOWJlMGViOTQ0NWQxOTJmYWU4MjJkMjJiZTA5Zl8yOC9mcmFnOmU0Nzg5YmZkNzY5YTRjYzc4NjI0YWU3MmUwNTE0OGM5L3RhYmxlOmQ4ZjY5OTZmZjM0ZDRlNGNiMmI2MjY3NTBkYTMxYTFiL3RhYmxlcmFuZ2U6ZDhmNjk5NmZmMzRkNGU0Y2IyYjYyNjc1MGRhMzFhMWJfMTgtMTEtMS0xLTYyNg_7daab40c-feee-4435-8dad-5f99931ddd1e">29,580</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Balance, June 30, 2022</span></td><td colspan="2" style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="ia9537308acbd431f87e3b44d01741f2c_I20220630" decimals="INF" name="us-gaap:SharesOutstanding" format="ixt:num-dot-decimal" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmFlNWE5YmUwZWI5NDQ1ZDE5MmZhZTgyMmQyMmJlMDlmL3NlYzphZTVhOWJlMGViOTQ0NWQxOTJmYWU4MjJkMjJiZTA5Zl8yOC9mcmFnOmU0Nzg5YmZkNzY5YTRjYzc4NjI0YWU3MmUwNTE0OGM5L3RhYmxlOmQ4ZjY5OTZmZjM0ZDRlNGNiMmI2MjY3NTBkYTMxYTFiL3RhYmxlcmFuZ2U6ZDhmNjk5NmZmMzRkNGU0Y2IyYjYyNjc1MGRhMzFhMWJfMTktMS0xLTEtNjI2_8caa3ffe-71f1-4dec-a6e5-a901e97bf54a">30,038,447</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ia9537308acbd431f87e3b44d01741f2c_I20220630" decimals="-3" name="us-gaap:StockholdersEquity" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmFlNWE5YmUwZWI5NDQ1ZDE5MmZhZTgyMmQyMmJlMDlmL3NlYzphZTVhOWJlMGViOTQ0NWQxOTJmYWU4MjJkMjJiZTA5Zl8yOC9mcmFnOmU0Nzg5YmZkNzY5YTRjYzc4NjI0YWU3MmUwNTE0OGM5L3RhYmxlOmQ4ZjY5OTZmZjM0ZDRlNGNiMmI2MjY3NTBkYTMxYTFiL3RhYmxlcmFuZ2U6ZDhmNjk5NmZmMzRkNGU0Y2IyYjYyNjc1MGRhMzFhMWJfMTktMy0xLTEtNjI2_aba8af4a-350e-41dd-b969-60ad3dd28d18">3</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib9ab9bb551934102bae2904f11a4da20_I20220630" decimals="-3" name="us-gaap:StockholdersEquity" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmFlNWE5YmUwZWI5NDQ1ZDE5MmZhZTgyMmQyMmJlMDlmL3NlYzphZTVhOWJlMGViOTQ0NWQxOTJmYWU4MjJkMjJiZTA5Zl8yOC9mcmFnOmU0Nzg5YmZkNzY5YTRjYzc4NjI0YWU3MmUwNTE0OGM5L3RhYmxlOmQ4ZjY5OTZmZjM0ZDRlNGNiMmI2MjY3NTBkYTMxYTFiL3RhYmxlcmFuZ2U6ZDhmNjk5NmZmMzRkNGU0Y2IyYjYyNjc1MGRhMzFhMWJfMTktNS0xLTEtNjI2_9d91497b-79b9-44e2-81f9-cda15137e767">445,491</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i85b53adede47405198bcfa9202c16b00_I20220630" decimals="-3" sign="-" name="us-gaap:StockholdersEquity" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmFlNWE5YmUwZWI5NDQ1ZDE5MmZhZTgyMmQyMmJlMDlmL3NlYzphZTVhOWJlMGViOTQ0NWQxOTJmYWU4MjJkMjJiZTA5Zl8yOC9mcmFnOmU0Nzg5YmZkNzY5YTRjYzc4NjI0YWU3MmUwNTE0OGM5L3RhYmxlOmQ4ZjY5OTZmZjM0ZDRlNGNiMmI2MjY3NTBkYTMxYTFiL3RhYmxlcmFuZ2U6ZDhmNjk5NmZmMzRkNGU0Y2IyYjYyNjc1MGRhMzFhMWJfMTktNy0xLTEtNjI2_5307b018-2412-4acf-a052-a148babceb34">865</ix:nonFraction>)</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i506a0b63797b4ba099490022c868c239_I20220630" decimals="-3" sign="-" name="us-gaap:StockholdersEquity" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmFlNWE5YmUwZWI5NDQ1ZDE5MmZhZTgyMmQyMmJlMDlmL3NlYzphZTVhOWJlMGViOTQ0NWQxOTJmYWU4MjJkMjJiZTA5Zl8yOC9mcmFnOmU0Nzg5YmZkNzY5YTRjYzc4NjI0YWU3MmUwNTE0OGM5L3RhYmxlOmQ4ZjY5OTZmZjM0ZDRlNGNiMmI2MjY3NTBkYTMxYTFiL3RhYmxlcmFuZ2U6ZDhmNjk5NmZmMzRkNGU0Y2IyYjYyNjc1MGRhMzFhMWJfMTktOS0xLTEtNjI2_5f4b4ad3-8bd8-4fb4-a875-855b0bdc3be1">266,052</ix:nonFraction>)</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i4c8f247d12134a9886d56e1c8b024425_I20220630" decimals="-3" name="us-gaap:StockholdersEquity" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmFlNWE5YmUwZWI5NDQ1ZDE5MmZhZTgyMmQyMmJlMDlmL3NlYzphZTVhOWJlMGViOTQ0NWQxOTJmYWU4MjJkMjJiZTA5Zl8yOC9mcmFnOmU0Nzg5YmZkNzY5YTRjYzc4NjI0YWU3MmUwNTE0OGM5L3RhYmxlOmQ4ZjY5OTZmZjM0ZDRlNGNiMmI2MjY3NTBkYTMxYTFiL3RhYmxlcmFuZ2U6ZDhmNjk5NmZmMzRkNGU0Y2IyYjYyNjc1MGRhMzFhMWJfMTktMTEtMS0xLTYyNg_0c403391-bf80-4b67-8145-b48687c57a70">178,577</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr></table></div><div style="margin-top:12pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">See accompanying notes to unaudited condensed consolidated financial statements.</span></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">4</span></div></div></div><div id="iae5a9be0eb9445d192fae822d22be09f_25"></div><hr style="page-break-after:always"/><div style="min-height:45pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#iae5a9be0eb9445d192fae822d22be09f_7">Table of Contents</a></span></div></div><div style="margin-top:12pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">DERMTECH, INC.</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Condensed Consolidated Statements of Stockholders&#8217; Equity</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">(in thousands, except share and per share data)</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">(Unaudited)</span></div><div style="margin-top:12pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:38.264%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.567%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.439%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.238%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.439%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.238%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.439%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.238%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.439%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.238%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.439%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.238%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.439%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.245%"></td><td style="width:0.1%"></td></tr><tr style="height:25pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:120%">Common stock</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" rowspan="2" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:120%">Additional<br/>paid-in<br/>capital</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" rowspan="2" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:120%">Accumulated<br/>other<br/>comprehensive<br/>income/(loss)</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" rowspan="2" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:120%">Accumulated<br/>deficit</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" rowspan="2" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:120%">Total<br/>stockholders&#8217;<br/>equity</span></td><td colspan="3" style="padding:0 1pt"></td></tr><tr style="height:11pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Shares</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Amount</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Balance, December 31, 2020</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="idf41ea014db640f1a2c27c2a769a0f37_I20201231" decimals="INF" name="us-gaap:SharesOutstanding" format="ixt:num-dot-decimal" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmFlNWE5YmUwZWI5NDQ1ZDE5MmZhZTgyMmQyMmJlMDlmL3NlYzphZTVhOWJlMGViOTQ0NWQxOTJmYWU4MjJkMjJiZTA5Zl8yNS9mcmFnOjc2OWUyMzYyMzg3ZDQ5ZjA4NjU3M2M0YjQ1YWYzMTUyL3RhYmxlOmZiYzA0OWQ5ZjcyZDQxYzRiN2UyZjVlYTZiNzIyZTdkL3RhYmxlcmFuZ2U6ZmJjMDQ5ZDlmNzJkNDFjNGI3ZTJmNWVhNmI3MjJlN2RfMi0xNi0xLTEtNjI2_09c21b1f-6b60-4936-b5ff-08316b865f56">20,740,413</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="idf41ea014db640f1a2c27c2a769a0f37_I20201231" decimals="-3" name="us-gaap:StockholdersEquity" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmFlNWE5YmUwZWI5NDQ1ZDE5MmZhZTgyMmQyMmJlMDlmL3NlYzphZTVhOWJlMGViOTQ0NWQxOTJmYWU4MjJkMjJiZTA5Zl8yNS9mcmFnOjc2OWUyMzYyMzg3ZDQ5ZjA4NjU3M2M0YjQ1YWYzMTUyL3RhYmxlOmZiYzA0OWQ5ZjcyZDQxYzRiN2UyZjVlYTZiNzIyZTdkL3RhYmxlcmFuZ2U6ZmJjMDQ5ZDlmNzJkNDFjNGI3ZTJmNWVhNmI3MjJlN2RfMi0xOC0xLTEtNjI2_6501814a-5a2e-40b7-8b11-b5bfff9b7835">2</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i770f7a8689db49a0b1de542ddda20759_I20201231" decimals="-3" name="us-gaap:StockholdersEquity" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmFlNWE5YmUwZWI5NDQ1ZDE5MmZhZTgyMmQyMmJlMDlmL3NlYzphZTVhOWJlMGViOTQ0NWQxOTJmYWU4MjJkMjJiZTA5Zl8yNS9mcmFnOjc2OWUyMzYyMzg3ZDQ5ZjA4NjU3M2M0YjQ1YWYzMTUyL3RhYmxlOmZiYzA0OWQ5ZjcyZDQxYzRiN2UyZjVlYTZiNzIyZTdkL3RhYmxlcmFuZ2U6ZmJjMDQ5ZDlmNzJkNDFjNGI3ZTJmNWVhNmI3MjJlN2RfMi0yMC0xLTEtNjI2_07f1b3ee-b162-4320-877b-2ee384ce27e0">189,868</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i5a3aac1f37e54bf194da81ac901f5ea9_I20201231" decimals="-3" sign="-" name="us-gaap:StockholdersEquity" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmFlNWE5YmUwZWI5NDQ1ZDE5MmZhZTgyMmQyMmJlMDlmL3NlYzphZTVhOWJlMGViOTQ0NWQxOTJmYWU4MjJkMjJiZTA5Zl8yNS9mcmFnOjc2OWUyMzYyMzg3ZDQ5ZjA4NjU3M2M0YjQ1YWYzMTUyL3RhYmxlOmZiYzA0OWQ5ZjcyZDQxYzRiN2UyZjVlYTZiNzIyZTdkL3RhYmxlcmFuZ2U6ZmJjMDQ5ZDlmNzJkNDFjNGI3ZTJmNWVhNmI3MjJlN2RfMi04LTEtMS0xMTM5_e8d735e4-5532-4b29-83e8-ce055a625779">1</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i8c8de78a03884c5eb87d8bfff7cb6c1c_I20201231" decimals="-3" sign="-" name="us-gaap:StockholdersEquity" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmFlNWE5YmUwZWI5NDQ1ZDE5MmZhZTgyMmQyMmJlMDlmL3NlYzphZTVhOWJlMGViOTQ0NWQxOTJmYWU4MjJkMjJiZTA5Zl8yNS9mcmFnOjc2OWUyMzYyMzg3ZDQ5ZjA4NjU3M2M0YjQ1YWYzMTUyL3RhYmxlOmZiYzA0OWQ5ZjcyZDQxYzRiN2UyZjVlYTZiNzIyZTdkL3RhYmxlcmFuZ2U6ZmJjMDQ5ZDlmNzJkNDFjNGI3ZTJmNWVhNmI3MjJlN2RfMi0yMi0xLTEtNjI2_cd33b0ac-5a28-47ea-ad99-454da022cf91">128,029</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i299927d2cdfe46deaac8ee64dc7dce6c_I20201231" decimals="-3" name="us-gaap:StockholdersEquity" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmFlNWE5YmUwZWI5NDQ1ZDE5MmZhZTgyMmQyMmJlMDlmL3NlYzphZTVhOWJlMGViOTQ0NWQxOTJmYWU4MjJkMjJiZTA5Zl8yNS9mcmFnOjc2OWUyMzYyMzg3ZDQ5ZjA4NjU3M2M0YjQ1YWYzMTUyL3RhYmxlOmZiYzA0OWQ5ZjcyZDQxYzRiN2UyZjVlYTZiNzIyZTdkL3RhYmxlcmFuZ2U6ZmJjMDQ5ZDlmNzJkNDFjNGI3ZTJmNWVhNmI3MjJlN2RfMi0yNC0xLTEtNjI2_f35ef9e2-59e1-42b1-a708-c855c30b0c38">61,840</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:9pt;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:120%">Issuance of common stock at $<ix:nonFraction unitRef="usdPerShare" contextRef="i9765c83c10a4499099d3ccc0868af9be_I20210331" decimals="2" name="us-gaap:SharesIssuedPricePerShare" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmFlNWE5YmUwZWI5NDQ1ZDE5MmZhZTgyMmQyMmJlMDlmL3NlYzphZTVhOWJlMGViOTQ0NWQxOTJmYWU4MjJkMjJiZTA5Zl8yNS9mcmFnOjc2OWUyMzYyMzg3ZDQ5ZjA4NjU3M2M0YjQ1YWYzMTUyL3RhYmxlOmZiYzA0OWQ5ZjcyZDQxYzRiN2UyZjVlYTZiNzIyZTdkL3RhYmxlcmFuZ2U6ZmJjMDQ5ZDlmNzJkNDFjNGI3ZTJmNWVhNmI3MjJlN2RfMy0wLTEtMS02MjYvdGV4dHJlZ2lvbjo0OTU0NWI1YTQ2NjQ0NzAwYjI2MzUzN2YyMTdjZTMxM18zMg_e4109401-af0d-4b0d-9af2-3c49553a14ac">29.50</ix:nonFraction> per share, net of $<ix:nonFraction unitRef="usd" contextRef="i936fe08107a14d5c927b5fa13e2af2c5_D20210101-20210331" decimals="-5" name="us-gaap:AdjustmentsToAdditionalPaidInCapitalStockIssuedIssuanceCosts" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmFlNWE5YmUwZWI5NDQ1ZDE5MmZhZTgyMmQyMmJlMDlmL3NlYzphZTVhOWJlMGViOTQ0NWQxOTJmYWU4MjJkMjJiZTA5Zl8yNS9mcmFnOjc2OWUyMzYyMzg3ZDQ5ZjA4NjU3M2M0YjQ1YWYzMTUyL3RhYmxlOmZiYzA0OWQ5ZjcyZDQxYzRiN2UyZjVlYTZiNzIyZTdkL3RhYmxlcmFuZ2U6ZmJjMDQ5ZDlmNzJkNDFjNGI3ZTJmNWVhNmI3MjJlN2RfMy0wLTEtMS02MjYvdGV4dHJlZ2lvbjo0OTU0NWI1YTQ2NjQ0NzAwYjI2MzUzN2YyMTdjZTMxM181Mw_833ef748-35fe-4d37-9323-db0d1487b95a">9.1</ix:nonFraction> million in issuance costs</span></div></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i936fe08107a14d5c927b5fa13e2af2c5_D20210101-20210331" decimals="INF" name="us-gaap:StockIssuedDuringPeriodSharesNewIssues" format="ixt:num-dot-decimal" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmFlNWE5YmUwZWI5NDQ1ZDE5MmZhZTgyMmQyMmJlMDlmL3NlYzphZTVhOWJlMGViOTQ0NWQxOTJmYWU4MjJkMjJiZTA5Zl8yNS9mcmFnOjc2OWUyMzYyMzg3ZDQ5ZjA4NjU3M2M0YjQ1YWYzMTUyL3RhYmxlOmZiYzA0OWQ5ZjcyZDQxYzRiN2UyZjVlYTZiNzIyZTdkL3RhYmxlcmFuZ2U6ZmJjMDQ5ZDlmNzJkNDFjNGI3ZTJmNWVhNmI3MjJlN2RfMy0xNi0xLTEtNjI2_306aa494-aad1-4b7f-a835-f97921c93290">4,872,881</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i936fe08107a14d5c927b5fa13e2af2c5_D20210101-20210331" decimals="-3" name="us-gaap:StockIssuedDuringPeriodValueNewIssues" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmFlNWE5YmUwZWI5NDQ1ZDE5MmZhZTgyMmQyMmJlMDlmL3NlYzphZTVhOWJlMGViOTQ0NWQxOTJmYWU4MjJkMjJiZTA5Zl8yNS9mcmFnOjc2OWUyMzYyMzg3ZDQ5ZjA4NjU3M2M0YjQ1YWYzMTUyL3RhYmxlOmZiYzA0OWQ5ZjcyZDQxYzRiN2UyZjVlYTZiNzIyZTdkL3RhYmxlcmFuZ2U6ZmJjMDQ5ZDlmNzJkNDFjNGI3ZTJmNWVhNmI3MjJlN2RfMy0xOC0xLTEtNjI2_0f1fe65f-4eb0-47ff-a708-ecc769b18b32">1</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i3f5ee0c6315d458da591b98ccf0afb7c_D20210101-20210331" decimals="-3" name="us-gaap:StockIssuedDuringPeriodValueNewIssues" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmFlNWE5YmUwZWI5NDQ1ZDE5MmZhZTgyMmQyMmJlMDlmL3NlYzphZTVhOWJlMGViOTQ0NWQxOTJmYWU4MjJkMjJiZTA5Zl8yNS9mcmFnOjc2OWUyMzYyMzg3ZDQ5ZjA4NjU3M2M0YjQ1YWYzMTUyL3RhYmxlOmZiYzA0OWQ5ZjcyZDQxYzRiN2UyZjVlYTZiNzIyZTdkL3RhYmxlcmFuZ2U6ZmJjMDQ5ZDlmNzJkNDFjNGI3ZTJmNWVhNmI3MjJlN2RfMy0yMC0xLTEtNjI2_95b95270-f727-4b76-855e-69620503169f">134,581</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="icf9848cee57f48e1abdd659c090042db_D20210101-20210331" decimals="-3" name="us-gaap:StockIssuedDuringPeriodValueNewIssues" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmFlNWE5YmUwZWI5NDQ1ZDE5MmZhZTgyMmQyMmJlMDlmL3NlYzphZTVhOWJlMGViOTQ0NWQxOTJmYWU4MjJkMjJiZTA5Zl8yNS9mcmFnOjc2OWUyMzYyMzg3ZDQ5ZjA4NjU3M2M0YjQ1YWYzMTUyL3RhYmxlOmZiYzA0OWQ5ZjcyZDQxYzRiN2UyZjVlYTZiNzIyZTdkL3RhYmxlcmFuZ2U6ZmJjMDQ5ZDlmNzJkNDFjNGI3ZTJmNWVhNmI3MjJlN2RfMy0yNC0xLTEtNjI2_d6c8cbb9-fe36-46bf-8bc4-ee068832088a">134,582</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 10pt;text-align:left;text-indent:-9pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Issuance of common stock from option exercises and RSU releases</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i936fe08107a14d5c927b5fa13e2af2c5_D20210101-20210331" decimals="INF" name="dmtk:StockIssuedDuringPeriodSharesStockOptionsExercisedAndRSURelease" format="ixt:num-dot-decimal" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmFlNWE5YmUwZWI5NDQ1ZDE5MmZhZTgyMmQyMmJlMDlmL3NlYzphZTVhOWJlMGViOTQ0NWQxOTJmYWU4MjJkMjJiZTA5Zl8yNS9mcmFnOjc2OWUyMzYyMzg3ZDQ5ZjA4NjU3M2M0YjQ1YWYzMTUyL3RhYmxlOmZiYzA0OWQ5ZjcyZDQxYzRiN2UyZjVlYTZiNzIyZTdkL3RhYmxlcmFuZ2U6ZmJjMDQ5ZDlmNzJkNDFjNGI3ZTJmNWVhNmI3MjJlN2RfNi0xNi0xLTEtNjI2_995128ea-49ff-421f-8d3e-58ca5ad951d3">176,673</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i3f5ee0c6315d458da591b98ccf0afb7c_D20210101-20210331" decimals="-3" name="dmtk:StockIssuedDuringPeriodValueStockOptionsExercisedAndRSURelease" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmFlNWE5YmUwZWI5NDQ1ZDE5MmZhZTgyMmQyMmJlMDlmL3NlYzphZTVhOWJlMGViOTQ0NWQxOTJmYWU4MjJkMjJiZTA5Zl8yNS9mcmFnOjc2OWUyMzYyMzg3ZDQ5ZjA4NjU3M2M0YjQ1YWYzMTUyL3RhYmxlOmZiYzA0OWQ5ZjcyZDQxYzRiN2UyZjVlYTZiNzIyZTdkL3RhYmxlcmFuZ2U6ZmJjMDQ5ZDlmNzJkNDFjNGI3ZTJmNWVhNmI3MjJlN2RfNi0yMC0xLTEtNjI2_9581560d-3d75-4308-93db-ec9a10254dd1">408</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="icf9848cee57f48e1abdd659c090042db_D20210101-20210331" decimals="-3" name="dmtk:StockIssuedDuringPeriodValueStockOptionsExercisedAndRSURelease" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmFlNWE5YmUwZWI5NDQ1ZDE5MmZhZTgyMmQyMmJlMDlmL3NlYzphZTVhOWJlMGViOTQ0NWQxOTJmYWU4MjJkMjJiZTA5Zl8yNS9mcmFnOjc2OWUyMzYyMzg3ZDQ5ZjA4NjU3M2M0YjQ1YWYzMTUyL3RhYmxlOmZiYzA0OWQ5ZjcyZDQxYzRiN2UyZjVlYTZiNzIyZTdkL3RhYmxlcmFuZ2U6ZmJjMDQ5ZDlmNzJkNDFjNGI3ZTJmNWVhNmI3MjJlN2RfNi0yNC0xLTEtNjI2_9e4c47df-e147-4786-8795-5b20fff2c647">408</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 10pt;text-align:left;text-indent:-9pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Issuance of common stock from warrant exercises</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i936fe08107a14d5c927b5fa13e2af2c5_D20210101-20210331" decimals="INF" name="dmtk:AdjustmentsToAdditionalPaidInCapitalWarrantIssuedShares" format="ixt:num-dot-decimal" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmFlNWE5YmUwZWI5NDQ1ZDE5MmZhZTgyMmQyMmJlMDlmL3NlYzphZTVhOWJlMGViOTQ0NWQxOTJmYWU4MjJkMjJiZTA5Zl8yNS9mcmFnOjc2OWUyMzYyMzg3ZDQ5ZjA4NjU3M2M0YjQ1YWYzMTUyL3RhYmxlOmZiYzA0OWQ5ZjcyZDQxYzRiN2UyZjVlYTZiNzIyZTdkL3RhYmxlcmFuZ2U6ZmJjMDQ5ZDlmNzJkNDFjNGI3ZTJmNWVhNmI3MjJlN2RfNy0xNi0xLTEtNjI2_5af9a181-7386-4046-b5cb-75293ee821a0">3,089,325</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i3f5ee0c6315d458da591b98ccf0afb7c_D20210101-20210331" decimals="-3" name="us-gaap:AdjustmentsToAdditionalPaidInCapitalWarrantIssued" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmFlNWE5YmUwZWI5NDQ1ZDE5MmZhZTgyMmQyMmJlMDlmL3NlYzphZTVhOWJlMGViOTQ0NWQxOTJmYWU4MjJkMjJiZTA5Zl8yNS9mcmFnOjc2OWUyMzYyMzg3ZDQ5ZjA4NjU3M2M0YjQ1YWYzMTUyL3RhYmxlOmZiYzA0OWQ5ZjcyZDQxYzRiN2UyZjVlYTZiNzIyZTdkL3RhYmxlcmFuZ2U6ZmJjMDQ5ZDlmNzJkNDFjNGI3ZTJmNWVhNmI3MjJlN2RfNy0yMC0xLTEtNjI2_a4a2797e-13e7-4ace-aec9-58d2ad48516b">72,081</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="icf9848cee57f48e1abdd659c090042db_D20210101-20210331" decimals="-3" name="us-gaap:AdjustmentsToAdditionalPaidInCapitalWarrantIssued" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmFlNWE5YmUwZWI5NDQ1ZDE5MmZhZTgyMmQyMmJlMDlmL3NlYzphZTVhOWJlMGViOTQ0NWQxOTJmYWU4MjJkMjJiZTA5Zl8yNS9mcmFnOjc2OWUyMzYyMzg3ZDQ5ZjA4NjU3M2M0YjQ1YWYzMTUyL3RhYmxlOmZiYzA0OWQ5ZjcyZDQxYzRiN2UyZjVlYTZiNzIyZTdkL3RhYmxlcmFuZ2U6ZmJjMDQ5ZDlmNzJkNDFjNGI3ZTJmNWVhNmI3MjJlN2RfNy0yNC0xLTEtNjI2_148f18c1-5b09-4a0f-a44c-1718f160d459">72,081</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 10pt;text-align:left;text-indent:-9pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Issuance of common stock from Employee Stock Purchase Plan</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i936fe08107a14d5c927b5fa13e2af2c5_D20210101-20210331" decimals="INF" name="us-gaap:StockIssuedDuringPeriodSharesEmployeeStockPurchasePlans" format="ixt:num-dot-decimal" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmFlNWE5YmUwZWI5NDQ1ZDE5MmZhZTgyMmQyMmJlMDlmL3NlYzphZTVhOWJlMGViOTQ0NWQxOTJmYWU4MjJkMjJiZTA5Zl8yNS9mcmFnOjc2OWUyMzYyMzg3ZDQ5ZjA4NjU3M2M0YjQ1YWYzMTUyL3RhYmxlOmZiYzA0OWQ5ZjcyZDQxYzRiN2UyZjVlYTZiNzIyZTdkL3RhYmxlcmFuZ2U6ZmJjMDQ5ZDlmNzJkNDFjNGI3ZTJmNWVhNmI3MjJlN2RfOC0xNi0xLTEtNjI2_3e6b2aae-b41f-44cb-81a6-d8bf0de0f930">39,960</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i3f5ee0c6315d458da591b98ccf0afb7c_D20210101-20210331" decimals="-3" name="us-gaap:StockIssuedDuringPeriodValueEmployeeStockPurchasePlan" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmFlNWE5YmUwZWI5NDQ1ZDE5MmZhZTgyMmQyMmJlMDlmL3NlYzphZTVhOWJlMGViOTQ0NWQxOTJmYWU4MjJkMjJiZTA5Zl8yNS9mcmFnOjc2OWUyMzYyMzg3ZDQ5ZjA4NjU3M2M0YjQ1YWYzMTUyL3RhYmxlOmZiYzA0OWQ5ZjcyZDQxYzRiN2UyZjVlYTZiNzIyZTdkL3RhYmxlcmFuZ2U6ZmJjMDQ5ZDlmNzJkNDFjNGI3ZTJmNWVhNmI3MjJlN2RfOC0yMC0xLTEtNjI2_e59c7620-9fd9-4e89-8fc9-de2167a29b3f">392</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="icf9848cee57f48e1abdd659c090042db_D20210101-20210331" decimals="-3" name="us-gaap:StockIssuedDuringPeriodValueEmployeeStockPurchasePlan" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmFlNWE5YmUwZWI5NDQ1ZDE5MmZhZTgyMmQyMmJlMDlmL3NlYzphZTVhOWJlMGViOTQ0NWQxOTJmYWU4MjJkMjJiZTA5Zl8yNS9mcmFnOjc2OWUyMzYyMzg3ZDQ5ZjA4NjU3M2M0YjQ1YWYzMTUyL3RhYmxlOmZiYzA0OWQ5ZjcyZDQxYzRiN2UyZjVlYTZiNzIyZTdkL3RhYmxlcmFuZ2U6ZmJjMDQ5ZDlmNzJkNDFjNGI3ZTJmNWVhNmI3MjJlN2RfOC0yNC0xLTEtNjI2_0ec26110-97bb-4cc7-b56b-7a0301e9e242">392</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Unrealized net gain on available-for-sale marketable securities</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i7ae4ca8a5bb543418bbae64ee99ea8fb_D20210101-20210331" decimals="-3" name="us-gaap:OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmFlNWE5YmUwZWI5NDQ1ZDE5MmZhZTgyMmQyMmJlMDlmL3NlYzphZTVhOWJlMGViOTQ0NWQxOTJmYWU4MjJkMjJiZTA5Zl8yNS9mcmFnOjc2OWUyMzYyMzg3ZDQ5ZjA4NjU3M2M0YjQ1YWYzMTUyL3RhYmxlOmZiYzA0OWQ5ZjcyZDQxYzRiN2UyZjVlYTZiNzIyZTdkL3RhYmxlcmFuZ2U6ZmJjMDQ5ZDlmNzJkNDFjNGI3ZTJmNWVhNmI3MjJlN2RfNy04LTEtMS0xMTA3_73d42481-7443-4b86-a933-1e422c7eff6e">9</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="icf9848cee57f48e1abdd659c090042db_D20210101-20210331" decimals="-3" name="us-gaap:OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmFlNWE5YmUwZWI5NDQ1ZDE5MmZhZTgyMmQyMmJlMDlmL3NlYzphZTVhOWJlMGViOTQ0NWQxOTJmYWU4MjJkMjJiZTA5Zl8yNS9mcmFnOjc2OWUyMzYyMzg3ZDQ5ZjA4NjU3M2M0YjQ1YWYzMTUyL3RhYmxlOmZiYzA0OWQ5ZjcyZDQxYzRiN2UyZjVlYTZiNzIyZTdkL3RhYmxlcmFuZ2U6ZmJjMDQ5ZDlmNzJkNDFjNGI3ZTJmNWVhNmI3MjJlN2RfNy0xMi0xLTEtMTEwNw_e1877e64-11ca-4065-a330-f599fc720bf9">9</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Stock-based compensation</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i3f5ee0c6315d458da591b98ccf0afb7c_D20210101-20210331" decimals="-3" name="us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmFlNWE5YmUwZWI5NDQ1ZDE5MmZhZTgyMmQyMmJlMDlmL3NlYzphZTVhOWJlMGViOTQ0NWQxOTJmYWU4MjJkMjJiZTA5Zl8yNS9mcmFnOjc2OWUyMzYyMzg3ZDQ5ZjA4NjU3M2M0YjQ1YWYzMTUyL3RhYmxlOmZiYzA0OWQ5ZjcyZDQxYzRiN2UyZjVlYTZiNzIyZTdkL3RhYmxlcmFuZ2U6ZmJjMDQ5ZDlmNzJkNDFjNGI3ZTJmNWVhNmI3MjJlN2RfOS0yMC0xLTEtNjI2_3a6d8df2-a668-48d9-abac-a52afc5cbdf1">2,172</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="icf9848cee57f48e1abdd659c090042db_D20210101-20210331" decimals="-3" name="us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmFlNWE5YmUwZWI5NDQ1ZDE5MmZhZTgyMmQyMmJlMDlmL3NlYzphZTVhOWJlMGViOTQ0NWQxOTJmYWU4MjJkMjJiZTA5Zl8yNS9mcmFnOjc2OWUyMzYyMzg3ZDQ5ZjA4NjU3M2M0YjQ1YWYzMTUyL3RhYmxlOmZiYzA0OWQ5ZjcyZDQxYzRiN2UyZjVlYTZiNzIyZTdkL3RhYmxlcmFuZ2U6ZmJjMDQ5ZDlmNzJkNDFjNGI3ZTJmNWVhNmI3MjJlN2RfOS0yNC0xLTEtNjI2_418c4467-5f35-4baf-971e-dd1a4b068a34">2,172</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 10pt;text-align:left;text-indent:-9pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Reclassification of warrant liability due to Private SPAC Warrants not held by original holder</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i3f5ee0c6315d458da591b98ccf0afb7c_D20210101-20210331" decimals="-3" name="dmtk:ReclassificationOfWarrantLiabilityDueToPrivateSPACWarrantsNotHeldByOriginalHolder" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmFlNWE5YmUwZWI5NDQ1ZDE5MmZhZTgyMmQyMmJlMDlmL3NlYzphZTVhOWJlMGViOTQ0NWQxOTJmYWU4MjJkMjJiZTA5Zl8yNS9mcmFnOjc2OWUyMzYyMzg3ZDQ5ZjA4NjU3M2M0YjQ1YWYzMTUyL3RhYmxlOmZiYzA0OWQ5ZjcyZDQxYzRiN2UyZjVlYTZiNzIyZTdkL3RhYmxlcmFuZ2U6ZmJjMDQ5ZDlmNzJkNDFjNGI3ZTJmNWVhNmI3MjJlN2RfOS02LTEtMS0xMTI1_9c7e483a-572b-4c43-b8a7-9ed497dcc114">411</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="icf9848cee57f48e1abdd659c090042db_D20210101-20210331" decimals="-3" name="dmtk:ReclassificationOfWarrantLiabilityDueToPrivateSPACWarrantsNotHeldByOriginalHolder" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmFlNWE5YmUwZWI5NDQ1ZDE5MmZhZTgyMmQyMmJlMDlmL3NlYzphZTVhOWJlMGViOTQ0NWQxOTJmYWU4MjJkMjJiZTA5Zl8yNS9mcmFnOjc2OWUyMzYyMzg3ZDQ5ZjA4NjU3M2M0YjQ1YWYzMTUyL3RhYmxlOmZiYzA0OWQ5ZjcyZDQxYzRiN2UyZjVlYTZiNzIyZTdkL3RhYmxlcmFuZ2U6ZmJjMDQ5ZDlmNzJkNDFjNGI3ZTJmNWVhNmI3MjJlN2RfOS0xMi0xLTEtMTEyNQ_5d490fc4-6af6-4ae9-b03f-2f1788a85d1e">411</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Net loss</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i7f3382225eda41b397ed5315a35090fd_D20210101-20210331" decimals="-3" sign="-" name="us-gaap:NetIncomeLoss" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmFlNWE5YmUwZWI5NDQ1ZDE5MmZhZTgyMmQyMmJlMDlmL3NlYzphZTVhOWJlMGViOTQ0NWQxOTJmYWU4MjJkMjJiZTA5Zl8yNS9mcmFnOjc2OWUyMzYyMzg3ZDQ5ZjA4NjU3M2M0YjQ1YWYzMTUyL3RhYmxlOmZiYzA0OWQ5ZjcyZDQxYzRiN2UyZjVlYTZiNzIyZTdkL3RhYmxlcmFuZ2U6ZmJjMDQ5ZDlmNzJkNDFjNGI3ZTJmNWVhNmI3MjJlN2RfMTAtMjItMS0xLTYyNg_b35e62f7-cb71-4bd9-a538-894d9805bba7">15,068</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="icf9848cee57f48e1abdd659c090042db_D20210101-20210331" decimals="-3" sign="-" name="us-gaap:NetIncomeLoss" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmFlNWE5YmUwZWI5NDQ1ZDE5MmZhZTgyMmQyMmJlMDlmL3NlYzphZTVhOWJlMGViOTQ0NWQxOTJmYWU4MjJkMjJiZTA5Zl8yNS9mcmFnOjc2OWUyMzYyMzg3ZDQ5ZjA4NjU3M2M0YjQ1YWYzMTUyL3RhYmxlOmZiYzA0OWQ5ZjcyZDQxYzRiN2UyZjVlYTZiNzIyZTdkL3RhYmxlcmFuZ2U6ZmJjMDQ5ZDlmNzJkNDFjNGI3ZTJmNWVhNmI3MjJlN2RfMTAtMjQtMS0xLTYyNg_2efafa4a-2c7b-4796-afb8-4c01c9b41ac3">15,068</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Balance, March 31, 2021</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i9765c83c10a4499099d3ccc0868af9be_I20210331" decimals="INF" name="us-gaap:SharesOutstanding" format="ixt:num-dot-decimal" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmFlNWE5YmUwZWI5NDQ1ZDE5MmZhZTgyMmQyMmJlMDlmL3NlYzphZTVhOWJlMGViOTQ0NWQxOTJmYWU4MjJkMjJiZTA5Zl8yNS9mcmFnOjc2OWUyMzYyMzg3ZDQ5ZjA4NjU3M2M0YjQ1YWYzMTUyL3RhYmxlOmZiYzA0OWQ5ZjcyZDQxYzRiN2UyZjVlYTZiNzIyZTdkL3RhYmxlcmFuZ2U6ZmJjMDQ5ZDlmNzJkNDFjNGI3ZTJmNWVhNmI3MjJlN2RfMTEtMTYtMS0xLTYyNg_1b8a3410-2932-4ef3-9ec0-7cba2a1b0167">28,919,252</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i9765c83c10a4499099d3ccc0868af9be_I20210331" decimals="-3" name="us-gaap:StockholdersEquity" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmFlNWE5YmUwZWI5NDQ1ZDE5MmZhZTgyMmQyMmJlMDlmL3NlYzphZTVhOWJlMGViOTQ0NWQxOTJmYWU4MjJkMjJiZTA5Zl8yNS9mcmFnOjc2OWUyMzYyMzg3ZDQ5ZjA4NjU3M2M0YjQ1YWYzMTUyL3RhYmxlOmZiYzA0OWQ5ZjcyZDQxYzRiN2UyZjVlYTZiNzIyZTdkL3RhYmxlcmFuZ2U6ZmJjMDQ5ZDlmNzJkNDFjNGI3ZTJmNWVhNmI3MjJlN2RfMTEtMTgtMS0xLTYyNg_a678fe38-75ed-409c-a76b-914be63359f1">3</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i7a5dc2cad8ab4a63b151726096e30d08_I20210331" decimals="-3" name="us-gaap:StockholdersEquity" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmFlNWE5YmUwZWI5NDQ1ZDE5MmZhZTgyMmQyMmJlMDlmL3NlYzphZTVhOWJlMGViOTQ0NWQxOTJmYWU4MjJkMjJiZTA5Zl8yNS9mcmFnOjc2OWUyMzYyMzg3ZDQ5ZjA4NjU3M2M0YjQ1YWYzMTUyL3RhYmxlOmZiYzA0OWQ5ZjcyZDQxYzRiN2UyZjVlYTZiNzIyZTdkL3RhYmxlcmFuZ2U6ZmJjMDQ5ZDlmNzJkNDFjNGI3ZTJmNWVhNmI3MjJlN2RfMTEtMjAtMS0xLTYyNg_8440fdac-a437-4fe0-af59-c07345c334ce">399,913</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib3a71fad6fed4582857b2c1740f068d3_I20210331" decimals="-3" name="us-gaap:StockholdersEquity" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmFlNWE5YmUwZWI5NDQ1ZDE5MmZhZTgyMmQyMmJlMDlmL3NlYzphZTVhOWJlMGViOTQ0NWQxOTJmYWU4MjJkMjJiZTA5Zl8yNS9mcmFnOjc2OWUyMzYyMzg3ZDQ5ZjA4NjU3M2M0YjQ1YWYzMTUyL3RhYmxlOmZiYzA0OWQ5ZjcyZDQxYzRiN2UyZjVlYTZiNzIyZTdkL3RhYmxlcmFuZ2U6ZmJjMDQ5ZDlmNzJkNDFjNGI3ZTJmNWVhNmI3MjJlN2RfMTEtOC0xLTEtNjM5Ng_c1e3dc3e-6895-43a3-8517-05701b765814">8</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i8a2b15e19ec44c569f05077b9a65f5bc_I20210331" decimals="-3" sign="-" name="us-gaap:StockholdersEquity" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmFlNWE5YmUwZWI5NDQ1ZDE5MmZhZTgyMmQyMmJlMDlmL3NlYzphZTVhOWJlMGViOTQ0NWQxOTJmYWU4MjJkMjJiZTA5Zl8yNS9mcmFnOjc2OWUyMzYyMzg3ZDQ5ZjA4NjU3M2M0YjQ1YWYzMTUyL3RhYmxlOmZiYzA0OWQ5ZjcyZDQxYzRiN2UyZjVlYTZiNzIyZTdkL3RhYmxlcmFuZ2U6ZmJjMDQ5ZDlmNzJkNDFjNGI3ZTJmNWVhNmI3MjJlN2RfMTEtMjItMS0xLTYyNg_998100b1-be6c-4ccb-8e02-6073989a48b7">143,097</ix:nonFraction>)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i8003b21ff858443fa0b721090f35eb8c_I20210331" decimals="-3" name="us-gaap:StockholdersEquity" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmFlNWE5YmUwZWI5NDQ1ZDE5MmZhZTgyMmQyMmJlMDlmL3NlYzphZTVhOWJlMGViOTQ0NWQxOTJmYWU4MjJkMjJiZTA5Zl8yNS9mcmFnOjc2OWUyMzYyMzg3ZDQ5ZjA4NjU3M2M0YjQ1YWYzMTUyL3RhYmxlOmZiYzA0OWQ5ZjcyZDQxYzRiN2UyZjVlYTZiNzIyZTdkL3RhYmxlcmFuZ2U6ZmJjMDQ5ZDlmNzJkNDFjNGI3ZTJmNWVhNmI3MjJlN2RfMTEtMjQtMS0xLTYyNg_e1cde9e2-b419-4b36-8516-4fa6ebc12a1c">256,827</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 10pt;text-align:left;text-indent:-9pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Issuance of common stock from option exercises and RSU releases</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:3pt double #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="if87a65d6f2c04499a52e6465b24b991a_D20210401-20210630" decimals="INF" name="dmtk:StockIssuedDuringPeriodSharesStockOptionsExercisedAndRSURelease" format="ixt:num-dot-decimal" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmFlNWE5YmUwZWI5NDQ1ZDE5MmZhZTgyMmQyMmJlMDlmL3NlYzphZTVhOWJlMGViOTQ0NWQxOTJmYWU4MjJkMjJiZTA5Zl8yNS9mcmFnOjc2OWUyMzYyMzg3ZDQ5ZjA4NjU3M2M0YjQ1YWYzMTUyL3RhYmxlOmZiYzA0OWQ5ZjcyZDQxYzRiN2UyZjVlYTZiNzIyZTdkL3RhYmxlcmFuZ2U6ZmJjMDQ5ZDlmNzJkNDFjNGI3ZTJmNWVhNmI3MjJlN2RfMTMtMTYtMS0xLTYyNg_3d2eb370-c3f2-4dfa-861f-6cbbc88e410e">157,277</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:3pt double #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:3pt double #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;border-top:3pt double #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:3pt double #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="idd2a0e0d7f8047ff823261ca459e9548_D20210401-20210630" decimals="-3" name="dmtk:StockIssuedDuringPeriodValueStockOptionsExercisedAndRSURelease" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmFlNWE5YmUwZWI5NDQ1ZDE5MmZhZTgyMmQyMmJlMDlmL3NlYzphZTVhOWJlMGViOTQ0NWQxOTJmYWU4MjJkMjJiZTA5Zl8yNS9mcmFnOjc2OWUyMzYyMzg3ZDQ5ZjA4NjU3M2M0YjQ1YWYzMTUyL3RhYmxlOmZiYzA0OWQ5ZjcyZDQxYzRiN2UyZjVlYTZiNzIyZTdkL3RhYmxlcmFuZ2U6ZmJjMDQ5ZDlmNzJkNDFjNGI3ZTJmNWVhNmI3MjJlN2RfMTMtMjAtMS0xLTYyNg_976fec50-5ded-4211-9584-4e567ce77099">188</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:3pt double #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:3pt double #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;border-top:3pt double #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:3pt double #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;border-top:3pt double #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:3pt double #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="id7bb773872394047ba26aa8a7a0f4d56_D20210401-20210630" decimals="-3" name="dmtk:StockIssuedDuringPeriodValueStockOptionsExercisedAndRSURelease" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmFlNWE5YmUwZWI5NDQ1ZDE5MmZhZTgyMmQyMmJlMDlmL3NlYzphZTVhOWJlMGViOTQ0NWQxOTJmYWU4MjJkMjJiZTA5Zl8yNS9mcmFnOjc2OWUyMzYyMzg3ZDQ5ZjA4NjU3M2M0YjQ1YWYzMTUyL3RhYmxlOmZiYzA0OWQ5ZjcyZDQxYzRiN2UyZjVlYTZiNzIyZTdkL3RhYmxlcmFuZ2U6ZmJjMDQ5ZDlmNzJkNDFjNGI3ZTJmNWVhNmI3MjJlN2RfMTMtMjQtMS0xLTYyNg_ef462be1-a49b-4fbc-aeed-58501f2fb914">188</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:3pt double #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:9pt;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Issuance of common stock at a weighted average price of $<ix:nonFraction unitRef="usdPerShare" contextRef="ibf2eeb1965ed4f85aabca9700183b6c8_I20210630" decimals="2" name="us-gaap:SharesIssuedPricePerShare" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmFlNWE5YmUwZWI5NDQ1ZDE5MmZhZTgyMmQyMmJlMDlmL3NlYzphZTVhOWJlMGViOTQ0NWQxOTJmYWU4MjJkMjJiZTA5Zl8yNS9mcmFnOjc2OWUyMzYyMzg3ZDQ5ZjA4NjU3M2M0YjQ1YWYzMTUyL3RhYmxlOmZiYzA0OWQ5ZjcyZDQxYzRiN2UyZjVlYTZiNzIyZTdkL3RhYmxlcmFuZ2U6ZmJjMDQ5ZDlmNzJkNDFjNGI3ZTJmNWVhNmI3MjJlN2RfMTMtMC0xLTEtMTMwMS90ZXh0cmVnaW9uOjAzNDViMDBkM2QxZTQ0ODc5NzY2NTc4M2FmZTM4ZDA5XzU0OTc1NTgxNDA0Nw_532fc4fe-a77f-47ff-b9f6-dec3299a4563">46.33</ix:nonFraction> through at-the market offering, net of $<ix:nonFraction unitRef="usd" contextRef="id7bb773872394047ba26aa8a7a0f4d56_D20210401-20210630" decimals="-5" name="us-gaap:AdjustmentsToAdditionalPaidInCapitalStockIssuedIssuanceCosts" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmFlNWE5YmUwZWI5NDQ1ZDE5MmZhZTgyMmQyMmJlMDlmL3NlYzphZTVhOWJlMGViOTQ0NWQxOTJmYWU4MjJkMjJiZTA5Zl8yNS9mcmFnOjc2OWUyMzYyMzg3ZDQ5ZjA4NjU3M2M0YjQ1YWYzMTUyL3RhYmxlOmZiYzA0OWQ5ZjcyZDQxYzRiN2UyZjVlYTZiNzIyZTdkL3RhYmxlcmFuZ2U6ZmJjMDQ5ZDlmNzJkNDFjNGI3ZTJmNWVhNmI3MjJlN2RfMTMtMC0xLTEtMTMwMS90ZXh0cmVnaW9uOjAzNDViMDBkM2QxZTQ0ODc5NzY2NTc4M2FmZTM4ZDA5XzU0OTc1NTgxNDA3NQ_84e8a912-b100-4e21-8915-955428d2f5a0">0.7</ix:nonFraction> million in issuance costs</span></div></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="if87a65d6f2c04499a52e6465b24b991a_D20210401-20210630" decimals="INF" name="us-gaap:StockIssuedDuringPeriodSharesNewIssues" format="ixt:num-dot-decimal" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmFlNWE5YmUwZWI5NDQ1ZDE5MmZhZTgyMmQyMmJlMDlmL3NlYzphZTVhOWJlMGViOTQ0NWQxOTJmYWU4MjJkMjJiZTA5Zl8yNS9mcmFnOjc2OWUyMzYyMzg3ZDQ5ZjA4NjU3M2M0YjQ1YWYzMTUyL3RhYmxlOmZiYzA0OWQ5ZjcyZDQxYzRiN2UyZjVlYTZiNzIyZTdkL3RhYmxlcmFuZ2U6ZmJjMDQ5ZDlmNzJkNDFjNGI3ZTJmNWVhNmI3MjJlN2RfMTMtMi0xLTEtMTM1NA_20621d98-a493-4007-a4c3-f4d0f8c819cb">530,551</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="idd2a0e0d7f8047ff823261ca459e9548_D20210401-20210630" decimals="-3" name="us-gaap:StockIssuedDuringPeriodValueNewIssues" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmFlNWE5YmUwZWI5NDQ1ZDE5MmZhZTgyMmQyMmJlMDlmL3NlYzphZTVhOWJlMGViOTQ0NWQxOTJmYWU4MjJkMjJiZTA5Zl8yNS9mcmFnOjc2OWUyMzYyMzg3ZDQ5ZjA4NjU3M2M0YjQ1YWYzMTUyL3RhYmxlOmZiYzA0OWQ5ZjcyZDQxYzRiN2UyZjVlYTZiNzIyZTdkL3RhYmxlcmFuZ2U6ZmJjMDQ5ZDlmNzJkNDFjNGI3ZTJmNWVhNmI3MjJlN2RfMTMtNi0xLTEtMTM1NA_a08e2c2e-6734-4140-be33-f1dc0992138f">23,836</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="id7bb773872394047ba26aa8a7a0f4d56_D20210401-20210630" decimals="-3" name="us-gaap:StockIssuedDuringPeriodValueNewIssues" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmFlNWE5YmUwZWI5NDQ1ZDE5MmZhZTgyMmQyMmJlMDlmL3NlYzphZTVhOWJlMGViOTQ0NWQxOTJmYWU4MjJkMjJiZTA5Zl8yNS9mcmFnOjc2OWUyMzYyMzg3ZDQ5ZjA4NjU3M2M0YjQ1YWYzMTUyL3RhYmxlOmZiYzA0OWQ5ZjcyZDQxYzRiN2UyZjVlYTZiNzIyZTdkL3RhYmxlcmFuZ2U6ZmJjMDQ5ZDlmNzJkNDFjNGI3ZTJmNWVhNmI3MjJlN2RfMTMtMTItMS0xLTYzOTY_a64cbe9b-9861-497d-843c-3e732ad42f10">23,836</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 10pt;text-align:left;text-indent:-9pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Issuance of common stock from warrant exercises</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="if87a65d6f2c04499a52e6465b24b991a_D20210401-20210630" decimals="INF" name="dmtk:AdjustmentsToAdditionalPaidInCapitalWarrantIssuedShares" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmFlNWE5YmUwZWI5NDQ1ZDE5MmZhZTgyMmQyMmJlMDlmL3NlYzphZTVhOWJlMGViOTQ0NWQxOTJmYWU4MjJkMjJiZTA5Zl8yNS9mcmFnOjc2OWUyMzYyMzg3ZDQ5ZjA4NjU3M2M0YjQ1YWYzMTUyL3RhYmxlOmZiYzA0OWQ5ZjcyZDQxYzRiN2UyZjVlYTZiNzIyZTdkL3RhYmxlcmFuZ2U6ZmJjMDQ5ZDlmNzJkNDFjNGI3ZTJmNWVhNmI3MjJlN2RfMTQtMTYtMS0xLTYyNg_0a66837d-898e-4517-9b6c-5dc23994c849">314</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="idd2a0e0d7f8047ff823261ca459e9548_D20210401-20210630" decimals="-3" name="us-gaap:AdjustmentsToAdditionalPaidInCapitalWarrantIssued" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmFlNWE5YmUwZWI5NDQ1ZDE5MmZhZTgyMmQyMmJlMDlmL3NlYzphZTVhOWJlMGViOTQ0NWQxOTJmYWU4MjJkMjJiZTA5Zl8yNS9mcmFnOjc2OWUyMzYyMzg3ZDQ5ZjA4NjU3M2M0YjQ1YWYzMTUyL3RhYmxlOmZiYzA0OWQ5ZjcyZDQxYzRiN2UyZjVlYTZiNzIyZTdkL3RhYmxlcmFuZ2U6ZmJjMDQ5ZDlmNzJkNDFjNGI3ZTJmNWVhNmI3MjJlN2RfMTQtMjAtMS0xLTYyNg_da5258fa-bf23-4409-bf06-d2dff13774ff">5</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="id7bb773872394047ba26aa8a7a0f4d56_D20210401-20210630" decimals="-3" name="us-gaap:AdjustmentsToAdditionalPaidInCapitalWarrantIssued" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmFlNWE5YmUwZWI5NDQ1ZDE5MmZhZTgyMmQyMmJlMDlmL3NlYzphZTVhOWJlMGViOTQ0NWQxOTJmYWU4MjJkMjJiZTA5Zl8yNS9mcmFnOjc2OWUyMzYyMzg3ZDQ5ZjA4NjU3M2M0YjQ1YWYzMTUyL3RhYmxlOmZiYzA0OWQ5ZjcyZDQxYzRiN2UyZjVlYTZiNzIyZTdkL3RhYmxlcmFuZ2U6ZmJjMDQ5ZDlmNzJkNDFjNGI3ZTJmNWVhNmI3MjJlN2RfMTQtMjQtMS0xLTYyNg_5f34961f-aa1e-4c10-98f7-f51f7b99def9">5</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 10pt;text-align:left;text-indent:-9pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Unrealized net loss on available-for-sale marketable securities</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="if148116e5f8f42ec91f0eb17fe3ed6f0_D20210401-20210630" decimals="-3" sign="-" name="us-gaap:OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmFlNWE5YmUwZWI5NDQ1ZDE5MmZhZTgyMmQyMmJlMDlmL3NlYzphZTVhOWJlMGViOTQ0NWQxOTJmYWU4MjJkMjJiZTA5Zl8yNS9mcmFnOjc2OWUyMzYyMzg3ZDQ5ZjA4NjU3M2M0YjQ1YWYzMTUyL3RhYmxlOmZiYzA0OWQ5ZjcyZDQxYzRiN2UyZjVlYTZiNzIyZTdkL3RhYmxlcmFuZ2U6ZmJjMDQ5ZDlmNzJkNDFjNGI3ZTJmNWVhNmI3MjJlN2RfMTQtOC0xLTEtMTI4OA_796184cb-b12c-4d78-b64a-2a05e440869a">6</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="id7bb773872394047ba26aa8a7a0f4d56_D20210401-20210630" decimals="-3" sign="-" name="us-gaap:OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmFlNWE5YmUwZWI5NDQ1ZDE5MmZhZTgyMmQyMmJlMDlmL3NlYzphZTVhOWJlMGViOTQ0NWQxOTJmYWU4MjJkMjJiZTA5Zl8yNS9mcmFnOjc2OWUyMzYyMzg3ZDQ5ZjA4NjU3M2M0YjQ1YWYzMTUyL3RhYmxlOmZiYzA0OWQ5ZjcyZDQxYzRiN2UyZjVlYTZiNzIyZTdkL3RhYmxlcmFuZ2U6ZmJjMDQ5ZDlmNzJkNDFjNGI3ZTJmNWVhNmI3MjJlN2RfMTUtMjQtMS0xLTYyNg_c03bce47-58a0-429d-9015-ceb720245a70">6</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Stock-based compensation</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="idd2a0e0d7f8047ff823261ca459e9548_D20210401-20210630" decimals="-3" name="us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmFlNWE5YmUwZWI5NDQ1ZDE5MmZhZTgyMmQyMmJlMDlmL3NlYzphZTVhOWJlMGViOTQ0NWQxOTJmYWU4MjJkMjJiZTA5Zl8yNS9mcmFnOjc2OWUyMzYyMzg3ZDQ5ZjA4NjU3M2M0YjQ1YWYzMTUyL3RhYmxlOmZiYzA0OWQ5ZjcyZDQxYzRiN2UyZjVlYTZiNzIyZTdkL3RhYmxlcmFuZ2U6ZmJjMDQ5ZDlmNzJkNDFjNGI3ZTJmNWVhNmI3MjJlN2RfMTYtMjAtMS0xLTYyNg_50b97f9b-4075-43ed-9e42-129ce10a1dfb">3,538</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="id7bb773872394047ba26aa8a7a0f4d56_D20210401-20210630" decimals="-3" name="us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmFlNWE5YmUwZWI5NDQ1ZDE5MmZhZTgyMmQyMmJlMDlmL3NlYzphZTVhOWJlMGViOTQ0NWQxOTJmYWU4MjJkMjJiZTA5Zl8yNS9mcmFnOjc2OWUyMzYyMzg3ZDQ5ZjA4NjU3M2M0YjQ1YWYzMTUyL3RhYmxlOmZiYzA0OWQ5ZjcyZDQxYzRiN2UyZjVlYTZiNzIyZTdkL3RhYmxlcmFuZ2U6ZmJjMDQ5ZDlmNzJkNDFjNGI3ZTJmNWVhNmI3MjJlN2RfMTYtMjQtMS0xLTYyNg_04c0188a-7b89-40c2-9932-45ee043f03c3">3,538</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 10pt;text-align:left;text-indent:-9pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Reclassification of warrant liability due to Private SPAC Warrants not held by original holder</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="id7bb773872394047ba26aa8a7a0f4d56_D20210401-20210630" decimals="-3" name="dmtk:ReclassificationOfWarrantLiabilityDueToPrivateSPACWarrantsNotHeldByOriginalHolder" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmFlNWE5YmUwZWI5NDQ1ZDE5MmZhZTgyMmQyMmJlMDlmL3NlYzphZTVhOWJlMGViOTQ0NWQxOTJmYWU4MjJkMjJiZTA5Zl8yNS9mcmFnOjc2OWUyMzYyMzg3ZDQ5ZjA4NjU3M2M0YjQ1YWYzMTUyL3RhYmxlOmZiYzA0OWQ5ZjcyZDQxYzRiN2UyZjVlYTZiNzIyZTdkL3RhYmxlcmFuZ2U6ZmJjMDQ5ZDlmNzJkNDFjNGI3ZTJmNWVhNmI3MjJlN2RfMTYtNi0xLTEtMTI2Mg_a79a13d7-ac3f-46f1-99cb-53315b324bcb">23</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="id7bb773872394047ba26aa8a7a0f4d56_D20210401-20210630" decimals="-3" name="dmtk:ReclassificationOfWarrantLiabilityDueToPrivateSPACWarrantsNotHeldByOriginalHolder" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmFlNWE5YmUwZWI5NDQ1ZDE5MmZhZTgyMmQyMmJlMDlmL3NlYzphZTVhOWJlMGViOTQ0NWQxOTJmYWU4MjJkMjJiZTA5Zl8yNS9mcmFnOjc2OWUyMzYyMzg3ZDQ5ZjA4NjU3M2M0YjQ1YWYzMTUyL3RhYmxlOmZiYzA0OWQ5ZjcyZDQxYzRiN2UyZjVlYTZiNzIyZTdkL3RhYmxlcmFuZ2U6ZmJjMDQ5ZDlmNzJkNDFjNGI3ZTJmNWVhNmI3MjJlN2RfMTctMTItMS0xLTYzOTY_95822698-75e6-49ae-8eca-5f6077b5ae72">23</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Net loss</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="idc14b05f084b42dcbd02996ad7fb090f_D20210401-20210630" decimals="-3" sign="-" name="us-gaap:NetIncomeLoss" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmFlNWE5YmUwZWI5NDQ1ZDE5MmZhZTgyMmQyMmJlMDlmL3NlYzphZTVhOWJlMGViOTQ0NWQxOTJmYWU4MjJkMjJiZTA5Zl8yNS9mcmFnOjc2OWUyMzYyMzg3ZDQ5ZjA4NjU3M2M0YjQ1YWYzMTUyL3RhYmxlOmZiYzA0OWQ5ZjcyZDQxYzRiN2UyZjVlYTZiNzIyZTdkL3RhYmxlcmFuZ2U6ZmJjMDQ5ZDlmNzJkNDFjNGI3ZTJmNWVhNmI3MjJlN2RfMTctMjItMS0xLTYyNg_06de5545-3f8c-4034-9aee-4b51f0d386d7">17,102</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="id7bb773872394047ba26aa8a7a0f4d56_D20210401-20210630" decimals="-3" sign="-" name="us-gaap:NetIncomeLoss" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmFlNWE5YmUwZWI5NDQ1ZDE5MmZhZTgyMmQyMmJlMDlmL3NlYzphZTVhOWJlMGViOTQ0NWQxOTJmYWU4MjJkMjJiZTA5Zl8yNS9mcmFnOjc2OWUyMzYyMzg3ZDQ5ZjA4NjU3M2M0YjQ1YWYzMTUyL3RhYmxlOmZiYzA0OWQ5ZjcyZDQxYzRiN2UyZjVlYTZiNzIyZTdkL3RhYmxlcmFuZ2U6ZmJjMDQ5ZDlmNzJkNDFjNGI3ZTJmNWVhNmI3MjJlN2RfMTctMjQtMS0xLTYyNg_a4b4ef8c-e307-417b-a2f2-66f45fc4e74e">17,102</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Balance, June 30, 2021</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i962e0f9643f54946bc90520b7ea86c76_I20210630" decimals="INF" name="us-gaap:SharesOutstanding" format="ixt:num-dot-decimal" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmFlNWE5YmUwZWI5NDQ1ZDE5MmZhZTgyMmQyMmJlMDlmL3NlYzphZTVhOWJlMGViOTQ0NWQxOTJmYWU4MjJkMjJiZTA5Zl8yNS9mcmFnOjc2OWUyMzYyMzg3ZDQ5ZjA4NjU3M2M0YjQ1YWYzMTUyL3RhYmxlOmZiYzA0OWQ5ZjcyZDQxYzRiN2UyZjVlYTZiNzIyZTdkL3RhYmxlcmFuZ2U6ZmJjMDQ5ZDlmNzJkNDFjNGI3ZTJmNWVhNmI3MjJlN2RfMTgtMTYtMS0xLTYyNg_6349f5ca-6b3d-49ea-840b-079fddada0e2">29,607,394</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i962e0f9643f54946bc90520b7ea86c76_I20210630" decimals="-3" name="us-gaap:StockholdersEquity" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmFlNWE5YmUwZWI5NDQ1ZDE5MmZhZTgyMmQyMmJlMDlmL3NlYzphZTVhOWJlMGViOTQ0NWQxOTJmYWU4MjJkMjJiZTA5Zl8yNS9mcmFnOjc2OWUyMzYyMzg3ZDQ5ZjA4NjU3M2M0YjQ1YWYzMTUyL3RhYmxlOmZiYzA0OWQ5ZjcyZDQxYzRiN2UyZjVlYTZiNzIyZTdkL3RhYmxlcmFuZ2U6ZmJjMDQ5ZDlmNzJkNDFjNGI3ZTJmNWVhNmI3MjJlN2RfMTgtMTgtMS0xLTYyNg_aab88af8-b247-4302-ae71-89332839626d">3</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i53a3c2269f654f2fb4637cd7af974436_I20210630" decimals="-3" name="us-gaap:StockholdersEquity" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmFlNWE5YmUwZWI5NDQ1ZDE5MmZhZTgyMmQyMmJlMDlmL3NlYzphZTVhOWJlMGViOTQ0NWQxOTJmYWU4MjJkMjJiZTA5Zl8yNS9mcmFnOjc2OWUyMzYyMzg3ZDQ5ZjA4NjU3M2M0YjQ1YWYzMTUyL3RhYmxlOmZiYzA0OWQ5ZjcyZDQxYzRiN2UyZjVlYTZiNzIyZTdkL3RhYmxlcmFuZ2U6ZmJjMDQ5ZDlmNzJkNDFjNGI3ZTJmNWVhNmI3MjJlN2RfMTgtMjAtMS0xLTYyNg_8fb2a3f6-0949-4399-a61e-972367bb4ccb">427,503</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i398f2a559ab64f81bd1a007c9fc04a0a_I20210630" decimals="-3" name="us-gaap:StockholdersEquity" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmFlNWE5YmUwZWI5NDQ1ZDE5MmZhZTgyMmQyMmJlMDlmL3NlYzphZTVhOWJlMGViOTQ0NWQxOTJmYWU4MjJkMjJiZTA5Zl8yNS9mcmFnOjc2OWUyMzYyMzg3ZDQ5ZjA4NjU3M2M0YjQ1YWYzMTUyL3RhYmxlOmZiYzA0OWQ5ZjcyZDQxYzRiN2UyZjVlYTZiNzIyZTdkL3RhYmxlcmFuZ2U6ZmJjMDQ5ZDlmNzJkNDFjNGI3ZTJmNWVhNmI3MjJlN2RfMTktOC0xLTEtNjM5Ng_f5a97f8d-1e57-42bc-8e35-2ab412e5c98d">2</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ice91fd1c5683472191e0ebaa1eed5a8a_I20210630" decimals="-3" sign="-" name="us-gaap:StockholdersEquity" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmFlNWE5YmUwZWI5NDQ1ZDE5MmZhZTgyMmQyMmJlMDlmL3NlYzphZTVhOWJlMGViOTQ0NWQxOTJmYWU4MjJkMjJiZTA5Zl8yNS9mcmFnOjc2OWUyMzYyMzg3ZDQ5ZjA4NjU3M2M0YjQ1YWYzMTUyL3RhYmxlOmZiYzA0OWQ5ZjcyZDQxYzRiN2UyZjVlYTZiNzIyZTdkL3RhYmxlcmFuZ2U6ZmJjMDQ5ZDlmNzJkNDFjNGI3ZTJmNWVhNmI3MjJlN2RfMTgtMjItMS0xLTYyNg_3697ec22-4ada-4b24-80bd-43b258574761">160,199</ix:nonFraction>)</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ie036f155bf0e43bd97ef05b5b46857eb_I20210630" decimals="-3" name="us-gaap:StockholdersEquity" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmFlNWE5YmUwZWI5NDQ1ZDE5MmZhZTgyMmQyMmJlMDlmL3NlYzphZTVhOWJlMGViOTQ0NWQxOTJmYWU4MjJkMjJiZTA5Zl8yNS9mcmFnOjc2OWUyMzYyMzg3ZDQ5ZjA4NjU3M2M0YjQ1YWYzMTUyL3RhYmxlOmZiYzA0OWQ5ZjcyZDQxYzRiN2UyZjVlYTZiNzIyZTdkL3RhYmxlcmFuZ2U6ZmJjMDQ5ZDlmNzJkNDFjNGI3ZTJmNWVhNmI3MjJlN2RfMTgtMjQtMS0xLTYyNg_606548b4-39b4-4b44-9cee-a5ab2ede4ccf">267,309</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr></table></div><div style="margin-top:12pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">See accompanying notes to unaudited condensed consolidated financial statements.</span></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">5</span></div></div></div><div id="iae5a9be0eb9445d192fae822d22be09f_31"></div><hr style="page-break-after:always"/><div style="min-height:45pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#iae5a9be0eb9445d192fae822d22be09f_7">Table of Contents</a></span></div></div><div style="margin-top:12pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">DERMTECH, INC.</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Condensed Consolidated Statements of Cash Flows</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">(in thousands)</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">(Unaudited)</span></div><div style="margin-top:12pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:71.930%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.081%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.406%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.083%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Six Months Ended June 30,</span></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2021</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Cash flows from operating activities:</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 10pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Net loss</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ia855382ada1f4f28aa8ef6da692ff177_D20220101-20220630" decimals="-3" sign="-" name="us-gaap:ProfitLoss" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmFlNWE5YmUwZWI5NDQ1ZDE5MmZhZTgyMmQyMmJlMDlmL3NlYzphZTVhOWJlMGViOTQ0NWQxOTJmYWU4MjJkMjJiZTA5Zl8zMS9mcmFnOmYxYWY1ZjE2MGM5YjRlYTdiNGQ5NDdjNTczMzZhM2ZkL3RhYmxlOjVkOTc3NDgxYzYzYTRlMzY5MWIwOGJkYWEwMTJmMThkL3RhYmxlcmFuZ2U6NWQ5Nzc0ODFjNjNhNGUzNjkxYjA4YmRhYTAxMmYxOGRfMy0xLTEtMS02MjY_00561008-9518-4a71-afcf-9c05f343993a">59,688</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="idaa4f31ca59a4a17a59c2580b97791ca_D20210101-20210630" decimals="-3" sign="-" name="us-gaap:ProfitLoss" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmFlNWE5YmUwZWI5NDQ1ZDE5MmZhZTgyMmQyMmJlMDlmL3NlYzphZTVhOWJlMGViOTQ0NWQxOTJmYWU4MjJkMjJiZTA5Zl8zMS9mcmFnOmYxYWY1ZjE2MGM5YjRlYTdiNGQ5NDdjNTczMzZhM2ZkL3RhYmxlOjVkOTc3NDgxYzYzYTRlMzY5MWIwOGJkYWEwMTJmMThkL3RhYmxlcmFuZ2U6NWQ5Nzc0ODFjNjNhNGUzNjkxYjA4YmRhYTAxMmYxOGRfMy0zLTEtMS02MjY_d2560213-229a-4996-8d8e-5d5f87d52817">32,170</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 10pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Adjustments to reconcile net loss to net cash used in operating activities:</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Depreciation</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ia855382ada1f4f28aa8ef6da692ff177_D20220101-20220630" decimals="-3" name="us-gaap:Depreciation" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmFlNWE5YmUwZWI5NDQ1ZDE5MmZhZTgyMmQyMmJlMDlmL3NlYzphZTVhOWJlMGViOTQ0NWQxOTJmYWU4MjJkMjJiZTA5Zl8zMS9mcmFnOmYxYWY1ZjE2MGM5YjRlYTdiNGQ5NDdjNTczMzZhM2ZkL3RhYmxlOjVkOTc3NDgxYzYzYTRlMzY5MWIwOGJkYWEwMTJmMThkL3RhYmxlcmFuZ2U6NWQ5Nzc0ODFjNjNhNGUzNjkxYjA4YmRhYTAxMmYxOGRfNS0xLTEtMS02MjY_f7ed0a69-1026-4835-acaa-d34fcf55b96d">766</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="idaa4f31ca59a4a17a59c2580b97791ca_D20210101-20210630" decimals="-3" name="us-gaap:Depreciation" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmFlNWE5YmUwZWI5NDQ1ZDE5MmZhZTgyMmQyMmJlMDlmL3NlYzphZTVhOWJlMGViOTQ0NWQxOTJmYWU4MjJkMjJiZTA5Zl8zMS9mcmFnOmYxYWY1ZjE2MGM5YjRlYTdiNGQ5NDdjNTczMzZhM2ZkL3RhYmxlOjVkOTc3NDgxYzYzYTRlMzY5MWIwOGJkYWEwMTJmMThkL3RhYmxlcmFuZ2U6NWQ5Nzc0ODFjNjNhNGUzNjkxYjA4YmRhYTAxMmYxOGRfNS0zLTEtMS02MjY_958fa5c4-e7da-431b-bd09-167ab3098323">401</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Change in fair value of warrant liability</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ia855382ada1f4f28aa8ef6da692ff177_D20220101-20220630" decimals="-3" sign="-" name="us-gaap:FairValueAdjustmentOfWarrants" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmFlNWE5YmUwZWI5NDQ1ZDE5MmZhZTgyMmQyMmJlMDlmL3NlYzphZTVhOWJlMGViOTQ0NWQxOTJmYWU4MjJkMjJiZTA5Zl8zMS9mcmFnOmYxYWY1ZjE2MGM5YjRlYTdiNGQ5NDdjNTczMzZhM2ZkL3RhYmxlOjVkOTc3NDgxYzYzYTRlMzY5MWIwOGJkYWEwMTJmMThkL3RhYmxlcmFuZ2U6NWQ5Nzc0ODFjNjNhNGUzNjkxYjA4YmRhYTAxMmYxOGRfNi0xLTEtMS02MjY_f674e9fb-5b6f-4a0c-997f-4de101e6b525">122</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="idaa4f31ca59a4a17a59c2580b97791ca_D20210101-20210630" decimals="-3" name="us-gaap:FairValueAdjustmentOfWarrants" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmFlNWE5YmUwZWI5NDQ1ZDE5MmZhZTgyMmQyMmJlMDlmL3NlYzphZTVhOWJlMGViOTQ0NWQxOTJmYWU4MjJkMjJiZTA5Zl8zMS9mcmFnOmYxYWY1ZjE2MGM5YjRlYTdiNGQ5NDdjNTczMzZhM2ZkL3RhYmxlOjVkOTc3NDgxYzYzYTRlMzY5MWIwOGJkYWEwMTJmMThkL3RhYmxlcmFuZ2U6NWQ5Nzc0ODFjNjNhNGUzNjkxYjA4YmRhYTAxMmYxOGRfNi0zLTEtMS02MjY_3edb2a26-9283-4939-8577-749e21465783">1,519</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Amortization of operating lease right-of-use assets</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ia855382ada1f4f28aa8ef6da692ff177_D20220101-20220630" decimals="-3" name="us-gaap:OperatingLeaseRightOfUseAssetAmortizationExpense" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmFlNWE5YmUwZWI5NDQ1ZDE5MmZhZTgyMmQyMmJlMDlmL3NlYzphZTVhOWJlMGViOTQ0NWQxOTJmYWU4MjJkMjJiZTA5Zl8zMS9mcmFnOmYxYWY1ZjE2MGM5YjRlYTdiNGQ5NDdjNTczMzZhM2ZkL3RhYmxlOjVkOTc3NDgxYzYzYTRlMzY5MWIwOGJkYWEwMTJmMThkL3RhYmxlcmFuZ2U6NWQ5Nzc0ODFjNjNhNGUzNjkxYjA4YmRhYTAxMmYxOGRfNy0xLTEtMS02MjY_1e4ae753-99fe-49a8-8afc-f713d4c8a544">1,109</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="idaa4f31ca59a4a17a59c2580b97791ca_D20210101-20210630" decimals="-3" name="us-gaap:OperatingLeaseRightOfUseAssetAmortizationExpense" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmFlNWE5YmUwZWI5NDQ1ZDE5MmZhZTgyMmQyMmJlMDlmL3NlYzphZTVhOWJlMGViOTQ0NWQxOTJmYWU4MjJkMjJiZTA5Zl8zMS9mcmFnOmYxYWY1ZjE2MGM5YjRlYTdiNGQ5NDdjNTczMzZhM2ZkL3RhYmxlOjVkOTc3NDgxYzYzYTRlMzY5MWIwOGJkYWEwMTJmMThkL3RhYmxlcmFuZ2U6NWQ5Nzc0ODFjNjNhNGUzNjkxYjA4YmRhYTAxMmYxOGRfNy0zLTEtMS02MjY_2ec0e842-836d-4744-a26e-539bcc7fb1bb">582</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Stock-based compensation</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ia855382ada1f4f28aa8ef6da692ff177_D20220101-20220630" decimals="-3" name="us-gaap:ShareBasedCompensation" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmFlNWE5YmUwZWI5NDQ1ZDE5MmZhZTgyMmQyMmJlMDlmL3NlYzphZTVhOWJlMGViOTQ0NWQxOTJmYWU4MjJkMjJiZTA5Zl8zMS9mcmFnOmYxYWY1ZjE2MGM5YjRlYTdiNGQ5NDdjNTczMzZhM2ZkL3RhYmxlOjVkOTc3NDgxYzYzYTRlMzY5MWIwOGJkYWEwMTJmMThkL3RhYmxlcmFuZ2U6NWQ5Nzc0ODFjNjNhNGUzNjkxYjA4YmRhYTAxMmYxOGRfOC0xLTEtMS02MjY_1f05403c-1b3c-4bcb-8e13-5a03805bdfff">8,731</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="idaa4f31ca59a4a17a59c2580b97791ca_D20210101-20210630" decimals="-3" name="us-gaap:ShareBasedCompensation" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmFlNWE5YmUwZWI5NDQ1ZDE5MmZhZTgyMmQyMmJlMDlmL3NlYzphZTVhOWJlMGViOTQ0NWQxOTJmYWU4MjJkMjJiZTA5Zl8zMS9mcmFnOmYxYWY1ZjE2MGM5YjRlYTdiNGQ5NDdjNTczMzZhM2ZkL3RhYmxlOjVkOTc3NDgxYzYzYTRlMzY5MWIwOGJkYWEwMTJmMThkL3RhYmxlcmFuZ2U6NWQ5Nzc0ODFjNjNhNGUzNjkxYjA4YmRhYTAxMmYxOGRfOC0zLTEtMS02MjY_fd4ff391-c54d-4791-8f25-32dde33823d1">5,710</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Amortization of premiums, net of accretion of discounts on marketable securities</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ia855382ada1f4f28aa8ef6da692ff177_D20220101-20220630" decimals="-3" sign="-" name="us-gaap:AccretionAmortizationOfDiscountsAndPremiumsInvestments" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmFlNWE5YmUwZWI5NDQ1ZDE5MmZhZTgyMmQyMmJlMDlmL3NlYzphZTVhOWJlMGViOTQ0NWQxOTJmYWU4MjJkMjJiZTA5Zl8zMS9mcmFnOmYxYWY1ZjE2MGM5YjRlYTdiNGQ5NDdjNTczMzZhM2ZkL3RhYmxlOjVkOTc3NDgxYzYzYTRlMzY5MWIwOGJkYWEwMTJmMThkL3RhYmxlcmFuZ2U6NWQ5Nzc0ODFjNjNhNGUzNjkxYjA4YmRhYTAxMmYxOGRfOS0xLTEtMS02MjY_1a7a22ae-3c5e-41d2-a849-6cc1b4d7b4a6">283</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="idaa4f31ca59a4a17a59c2580b97791ca_D20210101-20210630" decimals="-3" sign="-" name="us-gaap:AccretionAmortizationOfDiscountsAndPremiumsInvestments" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmFlNWE5YmUwZWI5NDQ1ZDE5MmZhZTgyMmQyMmJlMDlmL3NlYzphZTVhOWJlMGViOTQ0NWQxOTJmYWU4MjJkMjJiZTA5Zl8zMS9mcmFnOmYxYWY1ZjE2MGM5YjRlYTdiNGQ5NDdjNTczMzZhM2ZkL3RhYmxlOjVkOTc3NDgxYzYzYTRlMzY5MWIwOGJkYWEwMTJmMThkL3RhYmxlcmFuZ2U6NWQ5Nzc0ODFjNjNhNGUzNjkxYjA4YmRhYTAxMmYxOGRfOS0zLTEtMS02MjY_a5dce173-c772-4393-90f2-a22870422d64">337</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Loss on disposal of equipment</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ia855382ada1f4f28aa8ef6da692ff177_D20220101-20220630" decimals="-3" sign="-" name="us-gaap:GainLossOnDispositionOfAssets1" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmFlNWE5YmUwZWI5NDQ1ZDE5MmZhZTgyMmQyMmJlMDlmL3NlYzphZTVhOWJlMGViOTQ0NWQxOTJmYWU4MjJkMjJiZTA5Zl8zMS9mcmFnOmYxYWY1ZjE2MGM5YjRlYTdiNGQ5NDdjNTczMzZhM2ZkL3RhYmxlOjVkOTc3NDgxYzYzYTRlMzY5MWIwOGJkYWEwMTJmMThkL3RhYmxlcmFuZ2U6NWQ5Nzc0ODFjNjNhNGUzNjkxYjA4YmRhYTAxMmYxOGRfMTAtMS0xLTEtNjI2_be5ee68b-89ea-48e3-afb2-cca7bc5e98d5">285</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="idaa4f31ca59a4a17a59c2580b97791ca_D20210101-20210630" decimals="-3" sign="-" name="us-gaap:GainLossOnDispositionOfAssets1" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmFlNWE5YmUwZWI5NDQ1ZDE5MmZhZTgyMmQyMmJlMDlmL3NlYzphZTVhOWJlMGViOTQ0NWQxOTJmYWU4MjJkMjJiZTA5Zl8zMS9mcmFnOmYxYWY1ZjE2MGM5YjRlYTdiNGQ5NDdjNTczMzZhM2ZkL3RhYmxlOjVkOTc3NDgxYzYzYTRlMzY5MWIwOGJkYWEwMTJmMThkL3RhYmxlcmFuZ2U6NWQ5Nzc0ODFjNjNhNGUzNjkxYjA4YmRhYTAxMmYxOGRfMTAtMy0xLTEtNjI2_23110378-5328-4de2-bee7-5d1a634e0a50">13</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Changes in operating assets and liabilities:</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 28pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Accounts receivable</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ia855382ada1f4f28aa8ef6da692ff177_D20220101-20220630" decimals="-3" name="us-gaap:IncreaseDecreaseInAccountsReceivable" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmFlNWE5YmUwZWI5NDQ1ZDE5MmZhZTgyMmQyMmJlMDlmL3NlYzphZTVhOWJlMGViOTQ0NWQxOTJmYWU4MjJkMjJiZTA5Zl8zMS9mcmFnOmYxYWY1ZjE2MGM5YjRlYTdiNGQ5NDdjNTczMzZhM2ZkL3RhYmxlOjVkOTc3NDgxYzYzYTRlMzY5MWIwOGJkYWEwMTJmMThkL3RhYmxlcmFuZ2U6NWQ5Nzc0ODFjNjNhNGUzNjkxYjA4YmRhYTAxMmYxOGRfMTItMS0xLTEtNjI2_0b9ac312-ed75-421a-aef8-398ffffadb0f">2,115</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="idaa4f31ca59a4a17a59c2580b97791ca_D20210101-20210630" decimals="-3" name="us-gaap:IncreaseDecreaseInAccountsReceivable" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmFlNWE5YmUwZWI5NDQ1ZDE5MmZhZTgyMmQyMmJlMDlmL3NlYzphZTVhOWJlMGViOTQ0NWQxOTJmYWU4MjJkMjJiZTA5Zl8zMS9mcmFnOmYxYWY1ZjE2MGM5YjRlYTdiNGQ5NDdjNTczMzZhM2ZkL3RhYmxlOjVkOTc3NDgxYzYzYTRlMzY5MWIwOGJkYWEwMTJmMThkL3RhYmxlcmFuZ2U6NWQ5Nzc0ODFjNjNhNGUzNjkxYjA4YmRhYTAxMmYxOGRfMTItMy0xLTEtNjI2_fc3e78ec-b9ec-442b-b317-303d022c4959">705</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 28pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Inventory</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ia855382ada1f4f28aa8ef6da692ff177_D20220101-20220630" decimals="-3" name="us-gaap:IncreaseDecreaseInInventories" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmFlNWE5YmUwZWI5NDQ1ZDE5MmZhZTgyMmQyMmJlMDlmL3NlYzphZTVhOWJlMGViOTQ0NWQxOTJmYWU4MjJkMjJiZTA5Zl8zMS9mcmFnOmYxYWY1ZjE2MGM5YjRlYTdiNGQ5NDdjNTczMzZhM2ZkL3RhYmxlOjVkOTc3NDgxYzYzYTRlMzY5MWIwOGJkYWEwMTJmMThkL3RhYmxlcmFuZ2U6NWQ5Nzc0ODFjNjNhNGUzNjkxYjA4YmRhYTAxMmYxOGRfMTMtMS0xLTEtNjI2_629b4878-9160-484f-af7f-99532d595bae">952</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="idaa4f31ca59a4a17a59c2580b97791ca_D20210101-20210630" decimals="-3" name="us-gaap:IncreaseDecreaseInInventories" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmFlNWE5YmUwZWI5NDQ1ZDE5MmZhZTgyMmQyMmJlMDlmL3NlYzphZTVhOWJlMGViOTQ0NWQxOTJmYWU4MjJkMjJiZTA5Zl8zMS9mcmFnOmYxYWY1ZjE2MGM5YjRlYTdiNGQ5NDdjNTczMzZhM2ZkL3RhYmxlOjVkOTc3NDgxYzYzYTRlMzY5MWIwOGJkYWEwMTJmMThkL3RhYmxlcmFuZ2U6NWQ5Nzc0ODFjNjNhNGUzNjkxYjA4YmRhYTAxMmYxOGRfMTMtMy0xLTEtNjI2_1abab408-bf62-41db-9420-730fc7061e10">393</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 28pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Prepaid expenses and other current assets</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ia855382ada1f4f28aa8ef6da692ff177_D20220101-20220630" decimals="-3" sign="-" name="us-gaap:IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmFlNWE5YmUwZWI5NDQ1ZDE5MmZhZTgyMmQyMmJlMDlmL3NlYzphZTVhOWJlMGViOTQ0NWQxOTJmYWU4MjJkMjJiZTA5Zl8zMS9mcmFnOmYxYWY1ZjE2MGM5YjRlYTdiNGQ5NDdjNTczMzZhM2ZkL3RhYmxlOjVkOTc3NDgxYzYzYTRlMzY5MWIwOGJkYWEwMTJmMThkL3RhYmxlcmFuZ2U6NWQ5Nzc0ODFjNjNhNGUzNjkxYjA4YmRhYTAxMmYxOGRfMTQtMS0xLTEtNjI2_1999a457-717b-4431-a4c1-5290f7f6869f">483</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="idaa4f31ca59a4a17a59c2580b97791ca_D20210101-20210630" decimals="-3" sign="-" name="us-gaap:IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmFlNWE5YmUwZWI5NDQ1ZDE5MmZhZTgyMmQyMmJlMDlmL3NlYzphZTVhOWJlMGViOTQ0NWQxOTJmYWU4MjJkMjJiZTA5Zl8zMS9mcmFnOmYxYWY1ZjE2MGM5YjRlYTdiNGQ5NDdjNTczMzZhM2ZkL3RhYmxlOjVkOTc3NDgxYzYzYTRlMzY5MWIwOGJkYWEwMTJmMThkL3RhYmxlcmFuZ2U6NWQ5Nzc0ODFjNjNhNGUzNjkxYjA4YmRhYTAxMmYxOGRfMTQtMy0xLTEtNjI2_81ef1701-b22a-478c-8f14-54411879a52c">152</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 28pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Operating lease liabilities, net</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ia855382ada1f4f28aa8ef6da692ff177_D20220101-20220630" decimals="-3" sign="-" name="us-gaap:IncreaseDecreaseInOperatingLeaseLiability" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmFlNWE5YmUwZWI5NDQ1ZDE5MmZhZTgyMmQyMmJlMDlmL3NlYzphZTVhOWJlMGViOTQ0NWQxOTJmYWU4MjJkMjJiZTA5Zl8zMS9mcmFnOmYxYWY1ZjE2MGM5YjRlYTdiNGQ5NDdjNTczMzZhM2ZkL3RhYmxlOjVkOTc3NDgxYzYzYTRlMzY5MWIwOGJkYWEwMTJmMThkL3RhYmxlcmFuZ2U6NWQ5Nzc0ODFjNjNhNGUzNjkxYjA4YmRhYTAxMmYxOGRfMTUtMS0xLTEtNjI2_cf16c3e8-4850-4654-a207-fce87647728d">654</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="idaa4f31ca59a4a17a59c2580b97791ca_D20210101-20210630" decimals="-3" sign="-" name="us-gaap:IncreaseDecreaseInOperatingLeaseLiability" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmFlNWE5YmUwZWI5NDQ1ZDE5MmZhZTgyMmQyMmJlMDlmL3NlYzphZTVhOWJlMGViOTQ0NWQxOTJmYWU4MjJkMjJiZTA5Zl8zMS9mcmFnOmYxYWY1ZjE2MGM5YjRlYTdiNGQ5NDdjNTczMzZhM2ZkL3RhYmxlOjVkOTc3NDgxYzYzYTRlMzY5MWIwOGJkYWEwMTJmMThkL3RhYmxlcmFuZ2U6NWQ5Nzc0ODFjNjNhNGUzNjkxYjA4YmRhYTAxMmYxOGRfMTUtMy0xLTEtNjI2_039de427-7866-46cb-82e8-b785649ed830">328</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 28pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Accounts payable, accrued liabilities and deferred revenue</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ia855382ada1f4f28aa8ef6da692ff177_D20220101-20220630" decimals="-3" sign="-" name="us-gaap:IncreaseDecreaseInAccountsPayableAndAccruedLiabilities" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmFlNWE5YmUwZWI5NDQ1ZDE5MmZhZTgyMmQyMmJlMDlmL3NlYzphZTVhOWJlMGViOTQ0NWQxOTJmYWU4MjJkMjJiZTA5Zl8zMS9mcmFnOmYxYWY1ZjE2MGM5YjRlYTdiNGQ5NDdjNTczMzZhM2ZkL3RhYmxlOjVkOTc3NDgxYzYzYTRlMzY5MWIwOGJkYWEwMTJmMThkL3RhYmxlcmFuZ2U6NWQ5Nzc0ODFjNjNhNGUzNjkxYjA4YmRhYTAxMmYxOGRfMTYtMS0xLTEtNjI2_f978319e-f519-45e9-9512-ce6688724f11">53</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="idaa4f31ca59a4a17a59c2580b97791ca_D20210101-20210630" decimals="-3" name="us-gaap:IncreaseDecreaseInAccountsPayableAndAccruedLiabilities" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmFlNWE5YmUwZWI5NDQ1ZDE5MmZhZTgyMmQyMmJlMDlmL3NlYzphZTVhOWJlMGViOTQ0NWQxOTJmYWU4MjJkMjJiZTA5Zl8zMS9mcmFnOmYxYWY1ZjE2MGM5YjRlYTdiNGQ5NDdjNTczMzZhM2ZkL3RhYmxlOjVkOTc3NDgxYzYzYTRlMzY5MWIwOGJkYWEwMTJmMThkL3RhYmxlcmFuZ2U6NWQ5Nzc0ODFjNjNhNGUzNjkxYjA4YmRhYTAxMmYxOGRfMTYtMy0xLTEtNjI2_e863bad4-a2fd-42ca-8842-ac79353f5b5d">263</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 28pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Accrued compensation</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ia855382ada1f4f28aa8ef6da692ff177_D20220101-20220630" decimals="-3" name="us-gaap:IncreaseDecreaseInEmployeeRelatedLiabilities" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmFlNWE5YmUwZWI5NDQ1ZDE5MmZhZTgyMmQyMmJlMDlmL3NlYzphZTVhOWJlMGViOTQ0NWQxOTJmYWU4MjJkMjJiZTA5Zl8zMS9mcmFnOmYxYWY1ZjE2MGM5YjRlYTdiNGQ5NDdjNTczMzZhM2ZkL3RhYmxlOjVkOTc3NDgxYzYzYTRlMzY5MWIwOGJkYWEwMTJmMThkL3RhYmxlcmFuZ2U6NWQ5Nzc0ODFjNjNhNGUzNjkxYjA4YmRhYTAxMmYxOGRfMTctMS0xLTEtNjI2_b18d28e3-a6df-4e31-809f-dbf44f3c92b3">2,698</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="idaa4f31ca59a4a17a59c2580b97791ca_D20210101-20210630" decimals="-3" name="us-gaap:IncreaseDecreaseInEmployeeRelatedLiabilities" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmFlNWE5YmUwZWI5NDQ1ZDE5MmZhZTgyMmQyMmJlMDlmL3NlYzphZTVhOWJlMGViOTQ0NWQxOTJmYWU4MjJkMjJiZTA5Zl8zMS9mcmFnOmYxYWY1ZjE2MGM5YjRlYTdiNGQ5NDdjNTczMzZhM2ZkL3RhYmxlOjVkOTc3NDgxYzYzYTRlMzY5MWIwOGJkYWEwMTJmMThkL3RhYmxlcmFuZ2U6NWQ5Nzc0ODFjNjNhNGUzNjkxYjA4YmRhYTAxMmYxOGRfMTctMy0xLTEtNjI2_4bdfa11a-c280-4dcf-a1aa-0584b47a4cdf">1,092</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 37pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Net cash used in operating activities</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ia855382ada1f4f28aa8ef6da692ff177_D20220101-20220630" decimals="-3" sign="-" name="us-gaap:NetCashProvidedByUsedInOperatingActivities" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmFlNWE5YmUwZWI5NDQ1ZDE5MmZhZTgyMmQyMmJlMDlmL3NlYzphZTVhOWJlMGViOTQ0NWQxOTJmYWU4MjJkMjJiZTA5Zl8zMS9mcmFnOmYxYWY1ZjE2MGM5YjRlYTdiNGQ5NDdjNTczMzZhM2ZkL3RhYmxlOjVkOTc3NDgxYzYzYTRlMzY5MWIwOGJkYWEwMTJmMThkL3RhYmxlcmFuZ2U6NWQ5Nzc0ODFjNjNhNGUzNjkxYjA4YmRhYTAxMmYxOGRfMTgtMS0xLTEtNjI2_580c64fe-6267-471e-9605-fa94154e26d2">49,229</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="idaa4f31ca59a4a17a59c2580b97791ca_D20210101-20210630" decimals="-3" sign="-" name="us-gaap:NetCashProvidedByUsedInOperatingActivities" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmFlNWE5YmUwZWI5NDQ1ZDE5MmZhZTgyMmQyMmJlMDlmL3NlYzphZTVhOWJlMGViOTQ0NWQxOTJmYWU4MjJkMjJiZTA5Zl8zMS9mcmFnOmYxYWY1ZjE2MGM5YjRlYTdiNGQ5NDdjNTczMzZhM2ZkL3RhYmxlOjVkOTc3NDgxYzYzYTRlMzY5MWIwOGJkYWEwMTJmMThkL3RhYmxlcmFuZ2U6NWQ5Nzc0ODFjNjNhNGUzNjkxYjA4YmRhYTAxMmYxOGRfMTgtMy0xLTEtNjI2_e2e6b5f4-6913-4b9d-9866-fc748766fb9e">23,527</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Cash flows from investing activities:</span></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 10pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Purchases of marketable securities</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ia855382ada1f4f28aa8ef6da692ff177_D20220101-20220630" decimals="-3" name="us-gaap:PaymentsToAcquireMarketableSecurities" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmFlNWE5YmUwZWI5NDQ1ZDE5MmZhZTgyMmQyMmJlMDlmL3NlYzphZTVhOWJlMGViOTQ0NWQxOTJmYWU4MjJkMjJiZTA5Zl8zMS9mcmFnOmYxYWY1ZjE2MGM5YjRlYTdiNGQ5NDdjNTczMzZhM2ZkL3RhYmxlOjVkOTc3NDgxYzYzYTRlMzY5MWIwOGJkYWEwMTJmMThkL3RhYmxlcmFuZ2U6NWQ5Nzc0ODFjNjNhNGUzNjkxYjA4YmRhYTAxMmYxOGRfMjAtMS0xLTEtNjI2_98d380b9-2c09-41fb-8cf0-ac71ac6c3f8c">20,171</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="idaa4f31ca59a4a17a59c2580b97791ca_D20210101-20210630" decimals="-3" name="us-gaap:PaymentsToAcquireMarketableSecurities" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmFlNWE5YmUwZWI5NDQ1ZDE5MmZhZTgyMmQyMmJlMDlmL3NlYzphZTVhOWJlMGViOTQ0NWQxOTJmYWU4MjJkMjJiZTA5Zl8zMS9mcmFnOmYxYWY1ZjE2MGM5YjRlYTdiNGQ5NDdjNTczMzZhM2ZkL3RhYmxlOjVkOTc3NDgxYzYzYTRlMzY5MWIwOGJkYWEwMTJmMThkL3RhYmxlcmFuZ2U6NWQ5Nzc0ODFjNjNhNGUzNjkxYjA4YmRhYTAxMmYxOGRfMjAtMy0xLTEtNjI2_2091e497-eaba-4055-8f37-e97ab1b43339">4,899</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 10pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Maturities of marketable securities</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ia855382ada1f4f28aa8ef6da692ff177_D20220101-20220630" decimals="-3" name="dmtk:ProceedsFromMaturityOfMarketableSecurities" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmFlNWE5YmUwZWI5NDQ1ZDE5MmZhZTgyMmQyMmJlMDlmL3NlYzphZTVhOWJlMGViOTQ0NWQxOTJmYWU4MjJkMjJiZTA5Zl8zMS9mcmFnOmYxYWY1ZjE2MGM5YjRlYTdiNGQ5NDdjNTczMzZhM2ZkL3RhYmxlOjVkOTc3NDgxYzYzYTRlMzY5MWIwOGJkYWEwMTJmMThkL3RhYmxlcmFuZ2U6NWQ5Nzc0ODFjNjNhNGUzNjkxYjA4YmRhYTAxMmYxOGRfMjItMS0xLTEtNjI2_b9920c23-29f9-42d8-890e-a32597c77018">14,139</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="idaa4f31ca59a4a17a59c2580b97791ca_D20210101-20210630" decimals="-3" name="dmtk:ProceedsFromMaturityOfMarketableSecurities" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmFlNWE5YmUwZWI5NDQ1ZDE5MmZhZTgyMmQyMmJlMDlmL3NlYzphZTVhOWJlMGViOTQ0NWQxOTJmYWU4MjJkMjJiZTA5Zl8zMS9mcmFnOmYxYWY1ZjE2MGM5YjRlYTdiNGQ5NDdjNTczMzZhM2ZkL3RhYmxlOjVkOTc3NDgxYzYzYTRlMzY5MWIwOGJkYWEwMTJmMThkL3RhYmxlcmFuZ2U6NWQ5Nzc0ODFjNjNhNGUzNjkxYjA4YmRhYTAxMmYxOGRfMjItMy0xLTEtNjI2_e68572d1-c3d1-43a2-8c17-a99ec34a830e">5,450</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 10pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Purchases of property and equipment</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ia855382ada1f4f28aa8ef6da692ff177_D20220101-20220630" decimals="-3" name="us-gaap:PaymentsToAcquirePropertyPlantAndEquipment" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmFlNWE5YmUwZWI5NDQ1ZDE5MmZhZTgyMmQyMmJlMDlmL3NlYzphZTVhOWJlMGViOTQ0NWQxOTJmYWU4MjJkMjJiZTA5Zl8zMS9mcmFnOmYxYWY1ZjE2MGM5YjRlYTdiNGQ5NDdjNTczMzZhM2ZkL3RhYmxlOjVkOTc3NDgxYzYzYTRlMzY5MWIwOGJkYWEwMTJmMThkL3RhYmxlcmFuZ2U6NWQ5Nzc0ODFjNjNhNGUzNjkxYjA4YmRhYTAxMmYxOGRfMjMtMS0xLTEtNjI2_e51302df-83bc-4e61-8012-b0f399a38e36">1,360</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="idaa4f31ca59a4a17a59c2580b97791ca_D20210101-20210630" decimals="-3" name="us-gaap:PaymentsToAcquirePropertyPlantAndEquipment" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmFlNWE5YmUwZWI5NDQ1ZDE5MmZhZTgyMmQyMmJlMDlmL3NlYzphZTVhOWJlMGViOTQ0NWQxOTJmYWU4MjJkMjJiZTA5Zl8zMS9mcmFnOmYxYWY1ZjE2MGM5YjRlYTdiNGQ5NDdjNTczMzZhM2ZkL3RhYmxlOjVkOTc3NDgxYzYzYTRlMzY5MWIwOGJkYWEwMTJmMThkL3RhYmxlcmFuZ2U6NWQ5Nzc0ODFjNjNhNGUzNjkxYjA4YmRhYTAxMmYxOGRfMjMtMy0xLTEtNjI2_01b5aa41-81fc-4120-a170-edd0c78e9074">944</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 37pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Net cash used in investing activities</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ia855382ada1f4f28aa8ef6da692ff177_D20220101-20220630" decimals="-3" sign="-" name="us-gaap:NetCashProvidedByUsedInInvestingActivities" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmFlNWE5YmUwZWI5NDQ1ZDE5MmZhZTgyMmQyMmJlMDlmL3NlYzphZTVhOWJlMGViOTQ0NWQxOTJmYWU4MjJkMjJiZTA5Zl8zMS9mcmFnOmYxYWY1ZjE2MGM5YjRlYTdiNGQ5NDdjNTczMzZhM2ZkL3RhYmxlOjVkOTc3NDgxYzYzYTRlMzY5MWIwOGJkYWEwMTJmMThkL3RhYmxlcmFuZ2U6NWQ5Nzc0ODFjNjNhNGUzNjkxYjA4YmRhYTAxMmYxOGRfMjQtMS0xLTEtNjI2_46a0624b-9f10-478c-ace1-cf03678553be">7,392</ix:nonFraction>)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="idaa4f31ca59a4a17a59c2580b97791ca_D20210101-20210630" decimals="-3" sign="-" name="us-gaap:NetCashProvidedByUsedInInvestingActivities" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmFlNWE5YmUwZWI5NDQ1ZDE5MmZhZTgyMmQyMmJlMDlmL3NlYzphZTVhOWJlMGViOTQ0NWQxOTJmYWU4MjJkMjJiZTA5Zl8zMS9mcmFnOmYxYWY1ZjE2MGM5YjRlYTdiNGQ5NDdjNTczMzZhM2ZkL3RhYmxlOjVkOTc3NDgxYzYzYTRlMzY5MWIwOGJkYWEwMTJmMThkL3RhYmxlcmFuZ2U6NWQ5Nzc0ODFjNjNhNGUzNjkxYjA4YmRhYTAxMmYxOGRfMjQtMy0xLTEtNjI2_504c9aa6-05e8-4b39-b017-3275406b8b44">393</ix:nonFraction>)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Cash flows from financing activities:</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 10pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Proceeds from issuance of common stock in connection with public follow-on offering, net</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iaa3380e4cf5a462aa71b09fba6701de9_D20220101-20220630" decimals="-3" name="us-gaap:ProceedsFromIssuanceOfCommonStock" format="ixt:fixed-zero" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmFlNWE5YmUwZWI5NDQ1ZDE5MmZhZTgyMmQyMmJlMDlmL3NlYzphZTVhOWJlMGViOTQ0NWQxOTJmYWU4MjJkMjJiZTA5Zl8zMS9mcmFnOmYxYWY1ZjE2MGM5YjRlYTdiNGQ5NDdjNTczMzZhM2ZkL3RhYmxlOjVkOTc3NDgxYzYzYTRlMzY5MWIwOGJkYWEwMTJmMThkL3RhYmxlcmFuZ2U6NWQ5Nzc0ODFjNjNhNGUzNjkxYjA4YmRhYTAxMmYxOGRfMjctMS0xLTEtNjI2_21fee083-db75-401b-a995-fa0d0d0a609b">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ia87d864973504d67affd22c2a1bdc40c_D20210101-20210630" decimals="-3" name="us-gaap:ProceedsFromIssuanceOfCommonStock" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmFlNWE5YmUwZWI5NDQ1ZDE5MmZhZTgyMmQyMmJlMDlmL3NlYzphZTVhOWJlMGViOTQ0NWQxOTJmYWU4MjJkMjJiZTA5Zl8zMS9mcmFnOmYxYWY1ZjE2MGM5YjRlYTdiNGQ5NDdjNTczMzZhM2ZkL3RhYmxlOjVkOTc3NDgxYzYzYTRlMzY5MWIwOGJkYWEwMTJmMThkL3RhYmxlcmFuZ2U6NWQ5Nzc0ODFjNjNhNGUzNjkxYjA4YmRhYTAxMmYxOGRfMjctMy0xLTEtNjI2_97f42ccf-3a6e-4dad-bf23-a1ab202b5afd">134,582</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 10pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Proceeds from issuance of common stock in connection with at-the-market offering, net</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i1c2f494e495e4547bd1776a4d5cb5c64_D20220101-20220630" decimals="-3" name="us-gaap:ProceedsFromIssuanceOfCommonStock" format="ixt:fixed-zero" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmFlNWE5YmUwZWI5NDQ1ZDE5MmZhZTgyMmQyMmJlMDlmL3NlYzphZTVhOWJlMGViOTQ0NWQxOTJmYWU4MjJkMjJiZTA5Zl8zMS9mcmFnOmYxYWY1ZjE2MGM5YjRlYTdiNGQ5NDdjNTczMzZhM2ZkL3RhYmxlOjVkOTc3NDgxYzYzYTRlMzY5MWIwOGJkYWEwMTJmMThkL3RhYmxlcmFuZ2U6NWQ5Nzc0ODFjNjNhNGUzNjkxYjA4YmRhYTAxMmYxOGRfMzEtMS0xLTEtNjI2_86348f2d-f9d1-4ed8-a7a2-4da2a5e2399e">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i07f957c639484f23a8527b87b9caff7d_D20210101-20210630" decimals="-3" name="us-gaap:ProceedsFromIssuanceOfCommonStock" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmFlNWE5YmUwZWI5NDQ1ZDE5MmZhZTgyMmQyMmJlMDlmL3NlYzphZTVhOWJlMGViOTQ0NWQxOTJmYWU4MjJkMjJiZTA5Zl8zMS9mcmFnOmYxYWY1ZjE2MGM5YjRlYTdiNGQ5NDdjNTczMzZhM2ZkL3RhYmxlOjVkOTc3NDgxYzYzYTRlMzY5MWIwOGJkYWEwMTJmMThkL3RhYmxlcmFuZ2U6NWQ5Nzc0ODFjNjNhNGUzNjkxYjA4YmRhYTAxMmYxOGRfMzEtMy0xLTEtNjI2_0e28697b-0bb5-4f95-880e-b4c2555a5d6e">23,836</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 10pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Proceeds from exercise of common stock warrants</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ia855382ada1f4f28aa8ef6da692ff177_D20220101-20220630" decimals="-3" name="us-gaap:ProceedsFromWarrantExercises" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmFlNWE5YmUwZWI5NDQ1ZDE5MmZhZTgyMmQyMmJlMDlmL3NlYzphZTVhOWJlMGViOTQ0NWQxOTJmYWU4MjJkMjJiZTA5Zl8zMS9mcmFnOmYxYWY1ZjE2MGM5YjRlYTdiNGQ5NDdjNTczMzZhM2ZkL3RhYmxlOjVkOTc3NDgxYzYzYTRlMzY5MWIwOGJkYWEwMTJmMThkL3RhYmxlcmFuZ2U6NWQ5Nzc0ODFjNjNhNGUzNjkxYjA4YmRhYTAxMmYxOGRfMzItMS0xLTEtNjI2_9f9129d0-9339-434f-b697-e9d1168938a4">22</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="idaa4f31ca59a4a17a59c2580b97791ca_D20210101-20210630" decimals="-3" name="us-gaap:ProceedsFromWarrantExercises" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmFlNWE5YmUwZWI5NDQ1ZDE5MmZhZTgyMmQyMmJlMDlmL3NlYzphZTVhOWJlMGViOTQ0NWQxOTJmYWU4MjJkMjJiZTA5Zl8zMS9mcmFnOmYxYWY1ZjE2MGM5YjRlYTdiNGQ5NDdjNTczMzZhM2ZkL3RhYmxlOjVkOTc3NDgxYzYzYTRlMzY5MWIwOGJkYWEwMTJmMThkL3RhYmxlcmFuZ2U6NWQ5Nzc0ODFjNjNhNGUzNjkxYjA4YmRhYTAxMmYxOGRfMzItMy0xLTEtNjI2_8f624aea-059d-4487-b3f2-de7b71598f2f">69,928</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 10pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Proceeds from RSU releases (par value only) and the exercise of stock options</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ia855382ada1f4f28aa8ef6da692ff177_D20220101-20220630" decimals="-3" name="dmtk:ProceedsFromReleaseOfRSUsAndStockOptionsExercised" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmFlNWE5YmUwZWI5NDQ1ZDE5MmZhZTgyMmQyMmJlMDlmL3NlYzphZTVhOWJlMGViOTQ0NWQxOTJmYWU4MjJkMjJiZTA5Zl8zMS9mcmFnOmYxYWY1ZjE2MGM5YjRlYTdiNGQ5NDdjNTczMzZhM2ZkL3RhYmxlOjVkOTc3NDgxYzYzYTRlMzY5MWIwOGJkYWEwMTJmMThkL3RhYmxlcmFuZ2U6NWQ5Nzc0ODFjNjNhNGUzNjkxYjA4YmRhYTAxMmYxOGRfMzMtMS0xLTEtNjI2_3612c1df-e139-453c-88dd-4dd22bf95810">40</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="idaa4f31ca59a4a17a59c2580b97791ca_D20210101-20210630" decimals="-3" name="dmtk:ProceedsFromReleaseOfRSUsAndStockOptionsExercised" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmFlNWE5YmUwZWI5NDQ1ZDE5MmZhZTgyMmQyMmJlMDlmL3NlYzphZTVhOWJlMGViOTQ0NWQxOTJmYWU4MjJkMjJiZTA5Zl8zMS9mcmFnOmYxYWY1ZjE2MGM5YjRlYTdiNGQ5NDdjNTczMzZhM2ZkL3RhYmxlOjVkOTc3NDgxYzYzYTRlMzY5MWIwOGJkYWEwMTJmMThkL3RhYmxlcmFuZ2U6NWQ5Nzc0ODFjNjNhNGUzNjkxYjA4YmRhYTAxMmYxOGRfMzMtMy0xLTEtNjI2_99c8ca21-6645-4bb7-8d73-c13b515ebcf3">596</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 10pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Proceeds from contributions to the employee stock purchase plan</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ia855382ada1f4f28aa8ef6da692ff177_D20220101-20220630" decimals="-3" name="us-gaap:ProceedsFromStockPlans" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmFlNWE5YmUwZWI5NDQ1ZDE5MmZhZTgyMmQyMmJlMDlmL3NlYzphZTVhOWJlMGViOTQ0NWQxOTJmYWU4MjJkMjJiZTA5Zl8zMS9mcmFnOmYxYWY1ZjE2MGM5YjRlYTdiNGQ5NDdjNTczMzZhM2ZkL3RhYmxlOjVkOTc3NDgxYzYzYTRlMzY5MWIwOGJkYWEwMTJmMThkL3RhYmxlcmFuZ2U6NWQ5Nzc0ODFjNjNhNGUzNjkxYjA4YmRhYTAxMmYxOGRfMzUtMS0xLTEtNjI2_6b86c5cd-981d-4a9d-8542-8b18a1b933e1">515</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="idaa4f31ca59a4a17a59c2580b97791ca_D20210101-20210630" decimals="-3" name="us-gaap:ProceedsFromStockPlans" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmFlNWE5YmUwZWI5NDQ1ZDE5MmZhZTgyMmQyMmJlMDlmL3NlYzphZTVhOWJlMGViOTQ0NWQxOTJmYWU4MjJkMjJiZTA5Zl8zMS9mcmFnOmYxYWY1ZjE2MGM5YjRlYTdiNGQ5NDdjNTczMzZhM2ZkL3RhYmxlOjVkOTc3NDgxYzYzYTRlMzY5MWIwOGJkYWEwMTJmMThkL3RhYmxlcmFuZ2U6NWQ5Nzc0ODFjNjNhNGUzNjkxYjA4YmRhYTAxMmYxOGRfMzUtMy0xLTEtNjI2_e1b8d898-9234-4bd2-bbad-5402aa4b56c5">392</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 10pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Principal repayments of capital lease obligations</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ia855382ada1f4f28aa8ef6da692ff177_D20220101-20220630" decimals="-3" name="us-gaap:RepaymentsOfDebtAndCapitalLeaseObligations" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmFlNWE5YmUwZWI5NDQ1ZDE5MmZhZTgyMmQyMmJlMDlmL3NlYzphZTVhOWJlMGViOTQ0NWQxOTJmYWU4MjJkMjJiZTA5Zl8zMS9mcmFnOmYxYWY1ZjE2MGM5YjRlYTdiNGQ5NDdjNTczMzZhM2ZkL3RhYmxlOjVkOTc3NDgxYzYzYTRlMzY5MWIwOGJkYWEwMTJmMThkL3RhYmxlcmFuZ2U6NWQ5Nzc0ODFjNjNhNGUzNjkxYjA4YmRhYTAxMmYxOGRfMzYtMS0xLTEtNjI2_acf477c5-7f85-4ace-b8fe-35abb5aba1e6">60</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="idaa4f31ca59a4a17a59c2580b97791ca_D20210101-20210630" decimals="-3" name="us-gaap:RepaymentsOfDebtAndCapitalLeaseObligations" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmFlNWE5YmUwZWI5NDQ1ZDE5MmZhZTgyMmQyMmJlMDlmL3NlYzphZTVhOWJlMGViOTQ0NWQxOTJmYWU4MjJkMjJiZTA5Zl8zMS9mcmFnOmYxYWY1ZjE2MGM5YjRlYTdiNGQ5NDdjNTczMzZhM2ZkL3RhYmxlOjVkOTc3NDgxYzYzYTRlMzY5MWIwOGJkYWEwMTJmMThkL3RhYmxlcmFuZ2U6NWQ5Nzc0ODFjNjNhNGUzNjkxYjA4YmRhYTAxMmYxOGRfMzYtMy0xLTEtNjI2_6a005dff-7cdf-4831-9c26-3e9508b4d9d8">53</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 37pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Net cash provided by financing activities</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ia855382ada1f4f28aa8ef6da692ff177_D20220101-20220630" decimals="-3" name="us-gaap:NetCashProvidedByUsedInFinancingActivities" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmFlNWE5YmUwZWI5NDQ1ZDE5MmZhZTgyMmQyMmJlMDlmL3NlYzphZTVhOWJlMGViOTQ0NWQxOTJmYWU4MjJkMjJiZTA5Zl8zMS9mcmFnOmYxYWY1ZjE2MGM5YjRlYTdiNGQ5NDdjNTczMzZhM2ZkL3RhYmxlOjVkOTc3NDgxYzYzYTRlMzY5MWIwOGJkYWEwMTJmMThkL3RhYmxlcmFuZ2U6NWQ5Nzc0ODFjNjNhNGUzNjkxYjA4YmRhYTAxMmYxOGRfMzctMS0xLTEtNjI2_1cb6edd9-6f50-487b-8095-788c583ce882">517</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="idaa4f31ca59a4a17a59c2580b97791ca_D20210101-20210630" decimals="-3" name="us-gaap:NetCashProvidedByUsedInFinancingActivities" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmFlNWE5YmUwZWI5NDQ1ZDE5MmZhZTgyMmQyMmJlMDlmL3NlYzphZTVhOWJlMGViOTQ0NWQxOTJmYWU4MjJkMjJiZTA5Zl8zMS9mcmFnOmYxYWY1ZjE2MGM5YjRlYTdiNGQ5NDdjNTczMzZhM2ZkL3RhYmxlOjVkOTc3NDgxYzYzYTRlMzY5MWIwOGJkYWEwMTJmMThkL3RhYmxlcmFuZ2U6NWQ5Nzc0ODFjNjNhNGUzNjkxYjA4YmRhYTAxMmYxOGRfMzctMy0xLTEtNjI2_a29273f1-7e28-4ac1-b390-a604467cba54">229,281</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 37pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Net (decrease)/increase in cash, cash equivalents and restricted cash</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ia855382ada1f4f28aa8ef6da692ff177_D20220101-20220630" decimals="-3" sign="-" name="us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmFlNWE5YmUwZWI5NDQ1ZDE5MmZhZTgyMmQyMmJlMDlmL3NlYzphZTVhOWJlMGViOTQ0NWQxOTJmYWU4MjJkMjJiZTA5Zl8zMS9mcmFnOmYxYWY1ZjE2MGM5YjRlYTdiNGQ5NDdjNTczMzZhM2ZkL3RhYmxlOjVkOTc3NDgxYzYzYTRlMzY5MWIwOGJkYWEwMTJmMThkL3RhYmxlcmFuZ2U6NWQ5Nzc0ODFjNjNhNGUzNjkxYjA4YmRhYTAxMmYxOGRfMzgtMS0xLTEtNjI2_09552c58-d0d2-4dbd-a7ea-4e4930d08db3">56,104</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="idaa4f31ca59a4a17a59c2580b97791ca_D20210101-20210630" decimals="-3" name="us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmFlNWE5YmUwZWI5NDQ1ZDE5MmZhZTgyMmQyMmJlMDlmL3NlYzphZTVhOWJlMGViOTQ0NWQxOTJmYWU4MjJkMjJiZTA5Zl8zMS9mcmFnOmYxYWY1ZjE2MGM5YjRlYTdiNGQ5NDdjNTczMzZhM2ZkL3RhYmxlOjVkOTc3NDgxYzYzYTRlMzY5MWIwOGJkYWEwMTJmMThkL3RhYmxlcmFuZ2U6NWQ5Nzc0ODFjNjNhNGUzNjkxYjA4YmRhYTAxMmYxOGRfMzgtMy0xLTEtNjI2_1aad1e6d-5f53-4cb2-bcd2-4b3ffb50bfa9">205,361</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Cash, cash equivalents and restricted cash, beginning of period</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i87bf777ccf5f4f93bc9be7a2cbba61c1_I20211231" decimals="-3" name="us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmFlNWE5YmUwZWI5NDQ1ZDE5MmZhZTgyMmQyMmJlMDlmL3NlYzphZTVhOWJlMGViOTQ0NWQxOTJmYWU4MjJkMjJiZTA5Zl8zMS9mcmFnOmYxYWY1ZjE2MGM5YjRlYTdiNGQ5NDdjNTczMzZhM2ZkL3RhYmxlOjVkOTc3NDgxYzYzYTRlMzY5MWIwOGJkYWEwMTJmMThkL3RhYmxlcmFuZ2U6NWQ5Nzc0ODFjNjNhNGUzNjkxYjA4YmRhYTAxMmYxOGRfMzktMS0xLTEtNjI2_e288e249-e015-40bb-b99a-d5bbd95f406b">179,907</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i299927d2cdfe46deaac8ee64dc7dce6c_I20201231" decimals="-3" name="us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmFlNWE5YmUwZWI5NDQ1ZDE5MmZhZTgyMmQyMmJlMDlmL3NlYzphZTVhOWJlMGViOTQ0NWQxOTJmYWU4MjJkMjJiZTA5Zl8zMS9mcmFnOmYxYWY1ZjE2MGM5YjRlYTdiNGQ5NDdjNTczMzZhM2ZkL3RhYmxlOjVkOTc3NDgxYzYzYTRlMzY5MWIwOGJkYWEwMTJmMThkL3RhYmxlcmFuZ2U6NWQ5Nzc0ODFjNjNhNGUzNjkxYjA4YmRhYTAxMmYxOGRfMzktMy0xLTEtNjI2_bf354918-9b84-4d7b-a53b-d743cf51d2ad">24,248</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Cash, cash equivalents and restricted cash, end of period</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i4c8f247d12134a9886d56e1c8b024425_I20220630" decimals="-3" name="us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmFlNWE5YmUwZWI5NDQ1ZDE5MmZhZTgyMmQyMmJlMDlmL3NlYzphZTVhOWJlMGViOTQ0NWQxOTJmYWU4MjJkMjJiZTA5Zl8zMS9mcmFnOmYxYWY1ZjE2MGM5YjRlYTdiNGQ5NDdjNTczMzZhM2ZkL3RhYmxlOjVkOTc3NDgxYzYzYTRlMzY5MWIwOGJkYWEwMTJmMThkL3RhYmxlcmFuZ2U6NWQ5Nzc0ODFjNjNhNGUzNjkxYjA4YmRhYTAxMmYxOGRfNDAtMS0xLTEtNjI2_9c1234b2-7b32-4344-b4ac-b90947eaf87f">123,803</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ie036f155bf0e43bd97ef05b5b46857eb_I20210630" decimals="-3" name="us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmFlNWE5YmUwZWI5NDQ1ZDE5MmZhZTgyMmQyMmJlMDlmL3NlYzphZTVhOWJlMGViOTQ0NWQxOTJmYWU4MjJkMjJiZTA5Zl8zMS9mcmFnOmYxYWY1ZjE2MGM5YjRlYTdiNGQ5NDdjNTczMzZhM2ZkL3RhYmxlOjVkOTc3NDgxYzYzYTRlMzY5MWIwOGJkYWEwMTJmMThkL3RhYmxlcmFuZ2U6NWQ5Nzc0ODFjNjNhNGUzNjkxYjA4YmRhYTAxMmYxOGRfNDAtMy0xLTEtNjI2_7608eb54-c964-437c-b8d7-7b59bc6cd711">229,609</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr style="height:12pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Reconciliation of cash, cash equivalents and restricted cash, end of period:</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 10pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Cash and cash equivalents</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i4c8f247d12134a9886d56e1c8b024425_I20220630" decimals="-3" name="us-gaap:CashAndCashEquivalentsAtCarryingValue" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmFlNWE5YmUwZWI5NDQ1ZDE5MmZhZTgyMmQyMmJlMDlmL3NlYzphZTVhOWJlMGViOTQ0NWQxOTJmYWU4MjJkMjJiZTA5Zl8zMS9mcmFnOmYxYWY1ZjE2MGM5YjRlYTdiNGQ5NDdjNTczMzZhM2ZkL3RhYmxlOjVkOTc3NDgxYzYzYTRlMzY5MWIwOGJkYWEwMTJmMThkL3RhYmxlcmFuZ2U6NWQ5Nzc0ODFjNjNhNGUzNjkxYjA4YmRhYTAxMmYxOGRfMzgtMS0xLTEtMTk0Ng_2a754c0f-c3f9-416a-9a00-71d62f3d7b82">120,333</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ie036f155bf0e43bd97ef05b5b46857eb_I20210630" decimals="-3" name="us-gaap:CashAndCashEquivalentsAtCarryingValue" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmFlNWE5YmUwZWI5NDQ1ZDE5MmZhZTgyMmQyMmJlMDlmL3NlYzphZTVhOWJlMGViOTQ0NWQxOTJmYWU4MjJkMjJiZTA5Zl8zMS9mcmFnOmYxYWY1ZjE2MGM5YjRlYTdiNGQ5NDdjNTczMzZhM2ZkL3RhYmxlOjVkOTc3NDgxYzYzYTRlMzY5MWIwOGJkYWEwMTJmMThkL3RhYmxlcmFuZ2U6NWQ5Nzc0ODFjNjNhNGUzNjkxYjA4YmRhYTAxMmYxOGRfMzgtMy0xLTEtMTk0Ng_d1de29c7-7352-41ac-8f7b-ce9d643113c8">229,609</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 10pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Restricted cash</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i4c8f247d12134a9886d56e1c8b024425_I20220630" decimals="-3" name="us-gaap:RestrictedCash" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmFlNWE5YmUwZWI5NDQ1ZDE5MmZhZTgyMmQyMmJlMDlmL3NlYzphZTVhOWJlMGViOTQ0NWQxOTJmYWU4MjJkMjJiZTA5Zl8zMS9mcmFnOmYxYWY1ZjE2MGM5YjRlYTdiNGQ5NDdjNTczMzZhM2ZkL3RhYmxlOjVkOTc3NDgxYzYzYTRlMzY5MWIwOGJkYWEwMTJmMThkL3RhYmxlcmFuZ2U6NWQ5Nzc0ODFjNjNhNGUzNjkxYjA4YmRhYTAxMmYxOGRfMzktMS0xLTEtMTk0Ng_5aefc990-c72e-43a0-8712-6b42ed06e7ae">3,470</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ie036f155bf0e43bd97ef05b5b46857eb_I20210630" decimals="-3" name="us-gaap:RestrictedCash" format="ixt:fixed-zero" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmFlNWE5YmUwZWI5NDQ1ZDE5MmZhZTgyMmQyMmJlMDlmL3NlYzphZTVhOWJlMGViOTQ0NWQxOTJmYWU4MjJkMjJiZTA5Zl8zMS9mcmFnOmYxYWY1ZjE2MGM5YjRlYTdiNGQ5NDdjNTczMzZhM2ZkL3RhYmxlOjVkOTc3NDgxYzYzYTRlMzY5MWIwOGJkYWEwMTJmMThkL3RhYmxlcmFuZ2U6NWQ5Nzc0ODFjNjNhNGUzNjkxYjA4YmRhYTAxMmYxOGRfMzktMy0xLTEtMTk0Ng_f614336a-d285-45eb-8041-5c7faec5c521">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Total cash, cash equivalents and restricted cash</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i4c8f247d12134a9886d56e1c8b024425_I20220630" decimals="-3" name="us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmFlNWE5YmUwZWI5NDQ1ZDE5MmZhZTgyMmQyMmJlMDlmL3NlYzphZTVhOWJlMGViOTQ0NWQxOTJmYWU4MjJkMjJiZTA5Zl8zMS9mcmFnOmYxYWY1ZjE2MGM5YjRlYTdiNGQ5NDdjNTczMzZhM2ZkL3RhYmxlOjVkOTc3NDgxYzYzYTRlMzY5MWIwOGJkYWEwMTJmMThkL3RhYmxlcmFuZ2U6NWQ5Nzc0ODFjNjNhNGUzNjkxYjA4YmRhYTAxMmYxOGRfNDAtMS0xLTEtMTk0Ng_228eba9a-9331-4b7b-b1e3-113464dcdd16">123,803</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ie036f155bf0e43bd97ef05b5b46857eb_I20210630" decimals="-3" name="us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmFlNWE5YmUwZWI5NDQ1ZDE5MmZhZTgyMmQyMmJlMDlmL3NlYzphZTVhOWJlMGViOTQ0NWQxOTJmYWU4MjJkMjJiZTA5Zl8zMS9mcmFnOmYxYWY1ZjE2MGM5YjRlYTdiNGQ5NDdjNTczMzZhM2ZkL3RhYmxlOjVkOTc3NDgxYzYzYTRlMzY5MWIwOGJkYWEwMTJmMThkL3RhYmxlcmFuZ2U6NWQ5Nzc0ODFjNjNhNGUzNjkxYjA4YmRhYTAxMmYxOGRfNDAtMy0xLTEtMTk0Ng_80822920-5520-4406-b07c-de10e67fb539">229,609</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr style="height:12pt"><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Supplemental cash flow information:</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 10pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Cash paid for interest on finance lease obligations</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ia855382ada1f4f28aa8ef6da692ff177_D20220101-20220630" decimals="-3" name="us-gaap:InterestPaidNet" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmFlNWE5YmUwZWI5NDQ1ZDE5MmZhZTgyMmQyMmJlMDlmL3NlYzphZTVhOWJlMGViOTQ0NWQxOTJmYWU4MjJkMjJiZTA5Zl8zMS9mcmFnOmYxYWY1ZjE2MGM5YjRlYTdiNGQ5NDdjNTczMzZhM2ZkL3RhYmxlOjVkOTc3NDgxYzYzYTRlMzY5MWIwOGJkYWEwMTJmMThkL3RhYmxlcmFuZ2U6NWQ5Nzc0ODFjNjNhNGUzNjkxYjA4YmRhYTAxMmYxOGRfNDItMS0xLTEtNjI2_fa832f37-c0b5-4b6e-ba49-fec14b278f35">7</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="idaa4f31ca59a4a17a59c2580b97791ca_D20210101-20210630" decimals="-3" name="us-gaap:InterestPaidNet" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmFlNWE5YmUwZWI5NDQ1ZDE5MmZhZTgyMmQyMmJlMDlmL3NlYzphZTVhOWJlMGViOTQ0NWQxOTJmYWU4MjJkMjJiZTA5Zl8zMS9mcmFnOmYxYWY1ZjE2MGM5YjRlYTdiNGQ5NDdjNTczMzZhM2ZkL3RhYmxlOjVkOTc3NDgxYzYzYTRlMzY5MWIwOGJkYWEwMTJmMThkL3RhYmxlcmFuZ2U6NWQ5Nzc0ODFjNjNhNGUzNjkxYjA4YmRhYTAxMmYxOGRfNDItMy0xLTEtNjI2_d67d6f7a-909e-4bc7-b05f-e9931effe8a1">8</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Supplemental disclosure of noncash investing and financing activities:</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 10pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Purchases of property and equipment recorded in accounts payable</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ia855382ada1f4f28aa8ef6da692ff177_D20220101-20220630" decimals="-3" name="us-gaap:CapitalExpendituresIncurredButNotYetPaid" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmFlNWE5YmUwZWI5NDQ1ZDE5MmZhZTgyMmQyMmJlMDlmL3NlYzphZTVhOWJlMGViOTQ0NWQxOTJmYWU4MjJkMjJiZTA5Zl8zMS9mcmFnOmYxYWY1ZjE2MGM5YjRlYTdiNGQ5NDdjNTczMzZhM2ZkL3RhYmxlOjVkOTc3NDgxYzYzYTRlMzY5MWIwOGJkYWEwMTJmMThkL3RhYmxlcmFuZ2U6NWQ5Nzc0ODFjNjNhNGUzNjkxYjA4YmRhYTAxMmYxOGRfNDUtMS0xLTEtNjI2_bc8bb211-50dc-4751-aa44-9ac92e38c1fc">11</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="idaa4f31ca59a4a17a59c2580b97791ca_D20210101-20210630" decimals="-3" name="us-gaap:CapitalExpendituresIncurredButNotYetPaid" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmFlNWE5YmUwZWI5NDQ1ZDE5MmZhZTgyMmQyMmJlMDlmL3NlYzphZTVhOWJlMGViOTQ0NWQxOTJmYWU4MjJkMjJiZTA5Zl8zMS9mcmFnOmYxYWY1ZjE2MGM5YjRlYTdiNGQ5NDdjNTczMzZhM2ZkL3RhYmxlOjVkOTc3NDgxYzYzYTRlMzY5MWIwOGJkYWEwMTJmMThkL3RhYmxlcmFuZ2U6NWQ5Nzc0ODFjNjNhNGUzNjkxYjA4YmRhYTAxMmYxOGRfNDUtMy0xLTEtNjI2_19c25aeb-890b-41bc-b227-05842cef5d76">24</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 10pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Reclassification of warrant liability due to Private SPAC Warrants not held by original holder</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ia855382ada1f4f28aa8ef6da692ff177_D20220101-20220630" decimals="-3" name="dmtk:ReclassificationOfWarrantLiabilityDueToPrivateSPACWarrantsNotHeldByOriginalHolder" format="ixt:fixed-zero" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmFlNWE5YmUwZWI5NDQ1ZDE5MmZhZTgyMmQyMmJlMDlmL3NlYzphZTVhOWJlMGViOTQ0NWQxOTJmYWU4MjJkMjJiZTA5Zl8zMS9mcmFnOmYxYWY1ZjE2MGM5YjRlYTdiNGQ5NDdjNTczMzZhM2ZkL3RhYmxlOjVkOTc3NDgxYzYzYTRlMzY5MWIwOGJkYWEwMTJmMThkL3RhYmxlcmFuZ2U6NWQ5Nzc0ODFjNjNhNGUzNjkxYjA4YmRhYTAxMmYxOGRfNDYtMS0xLTEtNjI2_aeeca8b3-2975-4694-a566-c74a6f63a311">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="idaa4f31ca59a4a17a59c2580b97791ca_D20210101-20210630" decimals="-3" name="dmtk:ReclassificationOfWarrantLiabilityDueToPrivateSPACWarrantsNotHeldByOriginalHolder" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmFlNWE5YmUwZWI5NDQ1ZDE5MmZhZTgyMmQyMmJlMDlmL3NlYzphZTVhOWJlMGViOTQ0NWQxOTJmYWU4MjJkMjJiZTA5Zl8zMS9mcmFnOmYxYWY1ZjE2MGM5YjRlYTdiNGQ5NDdjNTczMzZhM2ZkL3RhYmxlOjVkOTc3NDgxYzYzYTRlMzY5MWIwOGJkYWEwMTJmMThkL3RhYmxlcmFuZ2U6NWQ5Nzc0ODFjNjNhNGUzNjkxYjA4YmRhYTAxMmYxOGRfNDYtMy0xLTEtNjI2_7f0a6b2a-c430-4e2f-9b1e-5e10566f0dc6">434</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 10pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Cashless exercise of common stock warrants</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ia855382ada1f4f28aa8ef6da692ff177_D20220101-20220630" decimals="-3" name="dmtk:CashlessExerciseOfCommonStockWarrants" format="ixt:fixed-zero" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmFlNWE5YmUwZWI5NDQ1ZDE5MmZhZTgyMmQyMmJlMDlmL3NlYzphZTVhOWJlMGViOTQ0NWQxOTJmYWU4MjJkMjJiZTA5Zl8zMS9mcmFnOmYxYWY1ZjE2MGM5YjRlYTdiNGQ5NDdjNTczMzZhM2ZkL3RhYmxlOjVkOTc3NDgxYzYzYTRlMzY5MWIwOGJkYWEwMTJmMThkL3RhYmxlcmFuZ2U6NWQ5Nzc0ODFjNjNhNGUzNjkxYjA4YmRhYTAxMmYxOGRfNDctMS0xLTEtNjI2_ad71ec11-b3f4-44e5-879e-ca644f12a50c">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="idaa4f31ca59a4a17a59c2580b97791ca_D20210101-20210630" decimals="-3" name="dmtk:CashlessExerciseOfCommonStockWarrants" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmFlNWE5YmUwZWI5NDQ1ZDE5MmZhZTgyMmQyMmJlMDlmL3NlYzphZTVhOWJlMGViOTQ0NWQxOTJmYWU4MjJkMjJiZTA5Zl8zMS9mcmFnOmYxYWY1ZjE2MGM5YjRlYTdiNGQ5NDdjNTczMzZhM2ZkL3RhYmxlOjVkOTc3NDgxYzYzYTRlMzY5MWIwOGJkYWEwMTJmMThkL3RhYmxlcmFuZ2U6NWQ5Nzc0ODFjNjNhNGUzNjkxYjA4YmRhYTAxMmYxOGRfNDctMy0xLTEtNjI2_1d3dfa15-528b-45ec-8e1f-a56eba10b9cc">2,158</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 10pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Right-of-use assets obtained in exchange for lease obligations</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ia855382ada1f4f28aa8ef6da692ff177_D20220101-20220630" decimals="-3" name="us-gaap:RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmFlNWE5YmUwZWI5NDQ1ZDE5MmZhZTgyMmQyMmJlMDlmL3NlYzphZTVhOWJlMGViOTQ0NWQxOTJmYWU4MjJkMjJiZTA5Zl8zMS9mcmFnOmYxYWY1ZjE2MGM5YjRlYTdiNGQ5NDdjNTczMzZhM2ZkL3RhYmxlOjVkOTc3NDgxYzYzYTRlMzY5MWIwOGJkYWEwMTJmMThkL3RhYmxlcmFuZ2U6NWQ5Nzc0ODFjNjNhNGUzNjkxYjA4YmRhYTAxMmYxOGRfNDgtMS0xLTEtNjI2_d6e77a73-6380-4a15-871b-2a36603cda5b">17,059</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="idaa4f31ca59a4a17a59c2580b97791ca_D20210101-20210630" decimals="-3" name="us-gaap:RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmFlNWE5YmUwZWI5NDQ1ZDE5MmZhZTgyMmQyMmJlMDlmL3NlYzphZTVhOWJlMGViOTQ0NWQxOTJmYWU4MjJkMjJiZTA5Zl8zMS9mcmFnOmYxYWY1ZjE2MGM5YjRlYTdiNGQ5NDdjNTczMzZhM2ZkL3RhYmxlOjVkOTc3NDgxYzYzYTRlMzY5MWIwOGJkYWEwMTJmMThkL3RhYmxlcmFuZ2U6NWQ5Nzc0ODFjNjNhNGUzNjkxYjA4YmRhYTAxMmYxOGRfNDgtMy0xLTEtNjI2_9c6c6ebe-ea94-4161-ba29-cc8e9465e7b6">2,831</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 10pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Property and equipment acquired under finance leases</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ia855382ada1f4f28aa8ef6da692ff177_D20220101-20220630" decimals="-3" name="us-gaap:NoncashOrPartNoncashAcquisitionFixedAssetsAcquired1" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmFlNWE5YmUwZWI5NDQ1ZDE5MmZhZTgyMmQyMmJlMDlmL3NlYzphZTVhOWJlMGViOTQ0NWQxOTJmYWU4MjJkMjJiZTA5Zl8zMS9mcmFnOmYxYWY1ZjE2MGM5YjRlYTdiNGQ5NDdjNTczMzZhM2ZkL3RhYmxlOjVkOTc3NDgxYzYzYTRlMzY5MWIwOGJkYWEwMTJmMThkL3RhYmxlcmFuZ2U6NWQ5Nzc0ODFjNjNhNGUzNjkxYjA4YmRhYTAxMmYxOGRfNDktMS0xLTEtNjI2_70449b45-0266-49e6-b60c-c641371b7161">48</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="idaa4f31ca59a4a17a59c2580b97791ca_D20210101-20210630" decimals="-3" name="us-gaap:NoncashOrPartNoncashAcquisitionFixedAssetsAcquired1" format="ixt:fixed-zero" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmFlNWE5YmUwZWI5NDQ1ZDE5MmZhZTgyMmQyMmJlMDlmL3NlYzphZTVhOWJlMGViOTQ0NWQxOTJmYWU4MjJkMjJiZTA5Zl8zMS9mcmFnOmYxYWY1ZjE2MGM5YjRlYTdiNGQ5NDdjNTczMzZhM2ZkL3RhYmxlOjVkOTc3NDgxYzYzYTRlMzY5MWIwOGJkYWEwMTJmMThkL3RhYmxlcmFuZ2U6NWQ5Nzc0ODFjNjNhNGUzNjkxYjA4YmRhYTAxMmYxOGRfNDktMy0xLTEtNjI2_08755c8e-9c3b-4a3f-8a02-8686c08a922f">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 10pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Change in net unrealized (losses)/gains on available-for-sale marketable securities</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ia855382ada1f4f28aa8ef6da692ff177_D20220101-20220630" decimals="-3" sign="-" name="dmtk:ChangeInUnrealizedGainLossOnAvailableForSaleMarketableSecurities" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmFlNWE5YmUwZWI5NDQ1ZDE5MmZhZTgyMmQyMmJlMDlmL3NlYzphZTVhOWJlMGViOTQ0NWQxOTJmYWU4MjJkMjJiZTA5Zl8zMS9mcmFnOmYxYWY1ZjE2MGM5YjRlYTdiNGQ5NDdjNTczMzZhM2ZkL3RhYmxlOjVkOTc3NDgxYzYzYTRlMzY5MWIwOGJkYWEwMTJmMThkL3RhYmxlcmFuZ2U6NWQ5Nzc0ODFjNjNhNGUzNjkxYjA4YmRhYTAxMmYxOGRfNTAtMS0xLTEtNjI2_e6146fdb-67cc-4c37-a18a-4743bec155c3">741</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="idaa4f31ca59a4a17a59c2580b97791ca_D20210101-20210630" decimals="-3" name="dmtk:ChangeInUnrealizedGainLossOnAvailableForSaleMarketableSecurities" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmFlNWE5YmUwZWI5NDQ1ZDE5MmZhZTgyMmQyMmJlMDlmL3NlYzphZTVhOWJlMGViOTQ0NWQxOTJmYWU4MjJkMjJiZTA5Zl8zMS9mcmFnOmYxYWY1ZjE2MGM5YjRlYTdiNGQ5NDdjNTczMzZhM2ZkL3RhYmxlOjVkOTc3NDgxYzYzYTRlMzY5MWIwOGJkYWEwMTJmMThkL3RhYmxlcmFuZ2U6NWQ5Nzc0ODFjNjNhNGUzNjkxYjA4YmRhYTAxMmYxOGRfNTAtMy0xLTEtNjI2_cbb55498-7105-4f45-8b59-dcc5e1e06718">3</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><div style="margin-top:10pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">See accompanying notes to unaudited condensed consolidated financial statements.</span></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">6</span></div></div></div><div id="iae5a9be0eb9445d192fae822d22be09f_34"></div><hr style="page-break-after:always"/><div style="min-height:45pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#iae5a9be0eb9445d192fae822d22be09f_7">Table of Contents</a></span></div></div><div style="margin-top:12pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">DERMTECH, INC.</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Notes to Unaudited Condensed Consolidated Financial Statements</span></div><div id="iae5a9be0eb9445d192fae822d22be09f_37"></div><div style="margin-top:12pt;padding-left:27pt;text-indent:-27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">1.&#160;&#160;&#160;&#160;<ix:nonNumeric contextRef="ia855382ada1f4f28aa8ef6da692ff177_D20220101-20220630" name="us-gaap:OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureAndSignificantAccountingPoliciesTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOmFlNWE5YmUwZWI5NDQ1ZDE5MmZhZTgyMmQyMmJlMDlmL3NlYzphZTVhOWJlMGViOTQ0NWQxOTJmYWU4MjJkMjJiZTA5Zl8zNy9mcmFnOjQ4OGNkZjBhODVlYzRiMDliYWFiN2JhZTlhODA5YjcwL3RleHRyZWdpb246NDg4Y2RmMGE4NWVjNGIwOWJhYWI3YmFlOWE4MDliNzBfNDYyNTA_5feb932c-094e-412e-ac7c-1d1fefa896a5" continuedAt="i21e2b51a3c674d919cd6f44342a98d3f" escape="true">The Company and a Summary of its Significant Accounting Policies</ix:nonNumeric></span></div><ix:continuation id="i21e2b51a3c674d919cd6f44342a98d3f" continuedAt="i15b7447888b74fd29136353385d31828"><div style="margin-top:15pt;padding-left:27pt;text-indent:-27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">(a)&#160;&#160;&#160;&#160;<ix:nonNumeric contextRef="ia855382ada1f4f28aa8ef6da692ff177_D20220101-20220630" name="us-gaap:NatureOfOperations" id="id3VybDovL2RvY3MudjEvZG9jOmFlNWE5YmUwZWI5NDQ1ZDE5MmZhZTgyMmQyMmJlMDlmL3NlYzphZTVhOWJlMGViOTQ0NWQxOTJmYWU4MjJkMjJiZTA5Zl8zNy9mcmFnOjQ4OGNkZjBhODVlYzRiMDliYWFiN2JhZTlhODA5YjcwL3RleHRyZWdpb246NDg4Y2RmMGE4NWVjNGIwOWJhYWI3YmFlOWE4MDliNzBfNDYyNjM_00a9099f-e35d-4473-a8f6-35e3b0efc740" continuedAt="id755860b50a547cea186bbca6c828606" escape="true">Nature of Operations </ix:nonNumeric></span></div><ix:continuation id="id755860b50a547cea186bbca6c828606"><div style="margin-top:9pt;padding-left:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">On August 29, 2019, DermTech, Inc., formerly known as Constellation Alpha Capital Corp, (the &#8220;Company&#8221;), and DermTech Operations, Inc., formerly known as DermTech, Inc., (&#8220;DermTech Operations&#8221;), consummated the transactions contemplated by the Agreement and Plan of Merger, dated as of May 29, 2019, by and among the Company, DT Merger Sub, Inc., a wholly owned subsidiary of the Company (&#8220;Merger Sub&#8221;), and DermTech Operations. The Company refers to this agreement, as amended by that certain First Amendment to Agreement and Plan of Merger dated as of August 1, 2019, as the Merger Agreement. Pursuant to the Merger Agreement, Merger Sub merged with and into DermTech Operations, with DermTech Operations surviving as a wholly-owned subsidiary of the Company. The Company refers to this transaction as the Business Combination. In connection with and two days prior to the completion of the Business Combination, the Company domesticated from the British Virgin Islands to Delaware. DermTech Operations changed its name from DermTech, Inc. to DermTech Operations, Inc. shortly before the completion of the Business Combination. On August 29, 2019, immediately following the completion of the Business Combination, the Company changed its name from Constellation Alpha Capital Corp. to DermTech, Inc., and then effected a one-for-two reverse stock split of its common stock. </span></div><div style="margin-top:9pt;padding-left:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company is a molecular diagnostic company developing and marketing its Clinical Laboratory Improvement Amendments of 1988 (&#8220;CLIA&#8221;) laboratory services including genomic tests to facilitate the diagnosis of dermatologic conditions including melanoma. The Company has developed a proprietary, non-invasive technique for sampling the surface layers of the skin using an adhesive patch called the DermTech Smart Sticker&#8482; (the &#8220;Smart Sticker&#8221;) to collect biological information for commercial applications in the medical diagnostic field.</span></div><div style="margin-top:9pt;padding-left:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">From the end of the first quarter of 2020 and through the second quarter of 2022, there has been a widespread worldwide impact from the COVID-19 pandemic. The Company is considered an essential business due to the importance of early melanoma detection, which has allowed the Company&#8217;s CLIA laboratory to remain fully operational. The Company implemented additional safety measures in accordance with Centers for Disease Control and Prevention (&#8220;CDC&#8221;), Occupational Safety and Health Administration (&#8220;OSHA&#8221;) and other guidance within its CLIA laboratory operations. Additionally, and during this time, the Company transitioned administrative functions to predominantly remote work. Beginning in March 2020 and continuing through the second quarter of 2022, the ongoing COVID-19 pandemic has reduced patient access to clinician offices for in-person testing and reduced access by the Company&#8217;s sales force for in-office sales calls, which has resulted in a reduced volume of billable samples received during the second quarter of 2022 relative to the Company&#8217;s pre-pandemic expectations. The Company expects the ongoing COVID-19 pandemic to continue to adversely impact billable sample volume until patient access to in-person testing fully resumes, in-office access by the Company&#8217;s sales force returns to pre-pandemic levels, or telemedicine options are more widely adopted. Additionally, the ongoing COVID-19 pandemic has negatively affected and may continue to negatively affect the Company&#8217;s pharmaceutical customers&#8217; clinical trials. The extent to which the COVID-19 pandemic will affect the Company&#8217;s future revenue is uncertain and will depend on the duration and extent of the effects of the ongoing COVID-19 pandemic, including the effects on the Company&#8217;s pharmaceutical customers&#8217; clinical trials.</span></div></ix:continuation><div style="margin-top:15pt;padding-left:27pt;text-indent:-27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">(b)&#160;&#160;&#160;&#160;<ix:nonNumeric contextRef="ia855382ada1f4f28aa8ef6da692ff177_D20220101-20220630" name="us-gaap:BasisOfAccountingPolicyPolicyTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOmFlNWE5YmUwZWI5NDQ1ZDE5MmZhZTgyMmQyMmJlMDlmL3NlYzphZTVhOWJlMGViOTQ0NWQxOTJmYWU4MjJkMjJiZTA5Zl8zNy9mcmFnOjQ4OGNkZjBhODVlYzRiMDliYWFiN2JhZTlhODA5YjcwL3RleHRyZWdpb246NDg4Y2RmMGE4NWVjNGIwOWJhYWI3YmFlOWE4MDliNzBfNDYyNDE_0104ddc6-f405-4a17-a3e4-59336123921d" continuedAt="i87215a13ee1c452694db34426b1429fe" escape="true">Basis of Presentation</ix:nonNumeric></span></div><div style="margin-top:9pt;padding-left:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:continuation id="i87215a13ee1c452694db34426b1429fe" continuedAt="i3c6ec3ffedce41bea41596e2b9563a12">The condensed consolidated financial statements include the accounts of DermTech, Inc. and its subsidiaries. All intercompany balances and transactions among the consolidated entity have been eliminated in consolidation. These unaudited condensed consolidated financial statements have been prepared in accordance with U.S. generally accepted accounting principles (&#8220;U.S. GAAP&#8221;) for interim financial information and with the instructions to Form 10-Q and Article 10 of Securities and Exchange Commission (&#8220;SEC&#8221;), Regulation S-X. Accordingly, these unaudited condensed consolidated financial statements and accompanying notes do not include all the information and disclosures required by U.S. GAAP for complete financial statements and should be read together with the audited consolidated financial statements included in the Company&#8217;s Annual Report on Form 10-K for the fiscal year ended December 31, 2021. In the opinion of management, all adjustments, which include only normal recurring adjustments considered necessary for a fair presentation, have been included. </ix:continuation></span></div></ix:continuation><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">7</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:45pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#iae5a9be0eb9445d192fae822d22be09f_7">Table of Contents</a></span></div></div><ix:continuation id="i15b7447888b74fd29136353385d31828" continuedAt="i2070c45a3fd14471be97585b6d2d170e"><div style="margin-top:9pt;padding-left:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:continuation id="i3c6ec3ffedce41bea41596e2b9563a12">The accompanying unaudited condensed consolidated financial statements reflect the application of certain significant accounting policies as described below and elsewhere in these notes to the unaudited condensed consolidated financial statements. As of June 30, 2022, there have been no material changes in the Company's significant accounting policies from those that were disclosed in the Company&#8217;s Annual Report on Form 10-K for the year ended December 31, 2021.</ix:continuation></span></div><div style="margin-top:15pt;padding-left:27pt;text-indent:-27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">(c)&#160;&#160;&#160;&#160;<ix:nonNumeric contextRef="ia855382ada1f4f28aa8ef6da692ff177_D20220101-20220630" name="us-gaap:PriorPeriodReclassificationAdjustmentDescription" id="id3VybDovL2RvY3MudjEvZG9jOmFlNWE5YmUwZWI5NDQ1ZDE5MmZhZTgyMmQyMmJlMDlmL3NlYzphZTVhOWJlMGViOTQ0NWQxOTJmYWU4MjJkMjJiZTA5Zl8zNy9mcmFnOjQ4OGNkZjBhODVlYzRiMDliYWFiN2JhZTlhODA5YjcwL3RleHRyZWdpb246NDg4Y2RmMGE4NWVjNGIwOWJhYWI3YmFlOWE4MDliNzBfNDYyMzg_d1729152-b764-4729-8889-ca25c3a823f8" continuedAt="ic93e475c0c1b40888a03d2a25e14bb06" escape="true">Reclassifications</ix:nonNumeric></span></div><div style="margin-top:9pt;padding-left:27pt"><ix:continuation id="ic93e475c0c1b40888a03d2a25e14bb06"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Certain prior period information on the condensed consolidated statement of cash flows for the six months ended June 30, 2021 has been reclassified to conform to the current year presentation as a result of adopting Accounting Standards Update ("ASU") No. 2016-02, </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Leases (Topic 842)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> ("ASU 2016-02"). These reclassifications did not have an impact on net cash flows. For additional disclosure and detail, see Note 4 of the notes to the unaudited condensed consolidated financial statements, &#8220;Adoption of ASC 842.&#8221;</span></ix:continuation></div><div style="margin-top:15pt;padding-left:27pt;text-indent:-27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">(d)&#160;&#160;&#160;&#160;<ix:nonNumeric contextRef="ia855382ada1f4f28aa8ef6da692ff177_D20220101-20220630" name="us-gaap:UseOfEstimates" id="id3VybDovL2RvY3MudjEvZG9jOmFlNWE5YmUwZWI5NDQ1ZDE5MmZhZTgyMmQyMmJlMDlmL3NlYzphZTVhOWJlMGViOTQ0NWQxOTJmYWU4MjJkMjJiZTA5Zl8zNy9mcmFnOjQ4OGNkZjBhODVlYzRiMDliYWFiN2JhZTlhODA5YjcwL3RleHRyZWdpb246NDg4Y2RmMGE4NWVjNGIwOWJhYWI3YmFlOWE4MDliNzBfNDYyNTE_39f3a64e-ec66-477e-b404-79ea24ec3c80" continuedAt="i8e2f8e9e70dc4cb2bacf63a645fa79b4" escape="true">Use of Estimates </ix:nonNumeric></span></div><div style="margin-top:9pt;padding-left:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:continuation id="i8e2f8e9e70dc4cb2bacf63a645fa79b4">The preparation of condensed consolidated financial statements in conformity with U.S. GAAP requires that management make estimates and assumptions that affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the date of the condensed consolidated financial statements and the amounts of revenues and expenses reported during the period. On an ongoing basis, management evaluates these estimates and judgments, including but not limited to those related to assay revenue, stock-based compensation, short-term marketable securities, accounts receivable, accrued bonus, warrant liability, right-of-use (&#8220;ROU&#8221;) assets and the realization of deferred tax assets. Actual results may differ from those estimates.</ix:continuation></span></div><div style="margin-top:15pt;padding-left:27pt;text-indent:-27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">(e)&#160;&#160;&#160;&#160;<ix:nonNumeric contextRef="ia855382ada1f4f28aa8ef6da692ff177_D20220101-20220630" name="us-gaap:CashAndCashEquivalentsRestrictedCashAndCashEquivalentsPolicy" id="id3VybDovL2RvY3MudjEvZG9jOmFlNWE5YmUwZWI5NDQ1ZDE5MmZhZTgyMmQyMmJlMDlmL3NlYzphZTVhOWJlMGViOTQ0NWQxOTJmYWU4MjJkMjJiZTA5Zl8zNy9mcmFnOjQ4OGNkZjBhODVlYzRiMDliYWFiN2JhZTlhODA5YjcwL3RleHRyZWdpb246NDg4Y2RmMGE4NWVjNGIwOWJhYWI3YmFlOWE4MDliNzBfNDYyNjQ_03c78806-f3ca-41ea-aa36-dcd7710467de" continuedAt="i527770b1aa864b9f9628f8de6d690aae" escape="true">Cash, Cash Equivalents and Restricted Cash</ix:nonNumeric></span></div><ix:continuation id="i527770b1aa864b9f9628f8de6d690aae"><div style="margin-top:9pt;padding-left:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company considers all highly liquid investments with remaining maturities of three months or less when purchased to be cash equivalents. The Company maintains its cash balances at banks and financial institutions. The balances are insured up to the Federal Deposit Insurance Corporation legal limit. The Company maintains cash balances that have in the past and may, at times, exceed this insured limit. </span></div><div style="margin-top:9pt;padding-left:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Restricted cash consists of cash deposited with a financial institution as collateral for the Company&#8217;s letters of credit for its facility leases. Restricted cash is classified as noncurrent based on the terms of the underlying lease arrangement.</span></div></ix:continuation><div style="margin-top:15pt;padding-left:27pt;text-indent:-27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">(f)&#160;&#160;&#160;&#160;<ix:nonNumeric contextRef="ia855382ada1f4f28aa8ef6da692ff177_D20220101-20220630" name="us-gaap:PropertyPlantAndEquipmentPolicyTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOmFlNWE5YmUwZWI5NDQ1ZDE5MmZhZTgyMmQyMmJlMDlmL3NlYzphZTVhOWJlMGViOTQ0NWQxOTJmYWU4MjJkMjJiZTA5Zl8zNy9mcmFnOjQ4OGNkZjBhODVlYzRiMDliYWFiN2JhZTlhODA5YjcwL3RleHRyZWdpb246NDg4Y2RmMGE4NWVjNGIwOWJhYWI3YmFlOWE4MDliNzBfNDYyNTI_6fa27ab8-94d9-4562-9c38-7bcf7ea9071a" continuedAt="ib3c2dc08e5764fe38a783c226a52a5d6" escape="true">Property and Equipment, Net </ix:nonNumeric></span></div><div style="margin-top:9pt;padding-left:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:continuation id="ib3c2dc08e5764fe38a783c226a52a5d6" continuedAt="i2f98fad894bd4aa199f54383e023d89c">Property and equipment, net is recorded at cost less accumulated depreciation. Property and equipment consists mainly of assets such as leasehold improvements, office, computer and laboratory equipment, including laboratory equipment acquired under finance lease arrangements. Depreciation is computed using the straight-line method over the estimated useful lives of the assets, which range from <span style="-sec-ix-hidden:id3VybDovL2RvY3MudjEvZG9jOmFlNWE5YmUwZWI5NDQ1ZDE5MmZhZTgyMmQyMmJlMDlmL3NlYzphZTVhOWJlMGViOTQ0NWQxOTJmYWU4MjJkMjJiZTA5Zl8zNy9mcmFnOjQ4OGNkZjBhODVlYzRiMDliYWFiN2JhZTlhODA5YjcwL3RleHRyZWdpb246NDg4Y2RmMGE4NWVjNGIwOWJhYWI3YmFlOWE4MDliNzBfMTQ0NDA_b7f0ce5d-c748-4105-a8ca-a2d7278a0959">two</span> to <ix:nonNumeric contextRef="i9069aff5693b479db8eb460a09c920a0_D20220101-20220630" name="us-gaap:PropertyPlantAndEquipmentUsefulLife" format="ixt-sec:durwordsen" id="id3VybDovL2RvY3MudjEvZG9jOmFlNWE5YmUwZWI5NDQ1ZDE5MmZhZTgyMmQyMmJlMDlmL3NlYzphZTVhOWJlMGViOTQ0NWQxOTJmYWU4MjJkMjJiZTA5Zl8zNy9mcmFnOjQ4OGNkZjBhODVlYzRiMDliYWFiN2JhZTlhODA5YjcwL3RleHRyZWdpb246NDg4Y2RmMGE4NWVjNGIwOWJhYWI3YmFlOWE4MDliNzBfMTQ0NDY_82c45ac1-77c4-4bfb-a17b-ac011ec8aa27">eleven years</ix:nonNumeric>. Leasehold improvements are depreciated over the shorter of the remaining term of the lease or the useful life of the asset. The Company recorded depreciation expense of $<ix:nonFraction unitRef="usd" contextRef="i2c5f0f28773744e5a2e202f2943ae976_D20220401-20220630" decimals="-5" name="us-gaap:Depreciation" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmFlNWE5YmUwZWI5NDQ1ZDE5MmZhZTgyMmQyMmJlMDlmL3NlYzphZTVhOWJlMGViOTQ0NWQxOTJmYWU4MjJkMjJiZTA5Zl8zNy9mcmFnOjQ4OGNkZjBhODVlYzRiMDliYWFiN2JhZTlhODA5YjcwL3RleHRyZWdpb246NDg4Y2RmMGE4NWVjNGIwOWJhYWI3YmFlOWE4MDliNzBfMTQ2MTk_e0d25151-be27-40c3-ab98-907592e11339">0.4</ix:nonFraction> million and $<ix:nonFraction unitRef="usd" contextRef="id7bb773872394047ba26aa8a7a0f4d56_D20210401-20210630" decimals="-5" name="us-gaap:Depreciation" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmFlNWE5YmUwZWI5NDQ1ZDE5MmZhZTgyMmQyMmJlMDlmL3NlYzphZTVhOWJlMGViOTQ0NWQxOTJmYWU4MjJkMjJiZTA5Zl8zNy9mcmFnOjQ4OGNkZjBhODVlYzRiMDliYWFiN2JhZTlhODA5YjcwL3RleHRyZWdpb246NDg4Y2RmMGE4NWVjNGIwOWJhYWI3YmFlOWE4MDliNzBfMTQ2MjY_095d9948-2f33-48f4-aef8-c3e1292bb556">0.2</ix:nonFraction> million for the three months ended June&#160;30, 2022 and 2021, respectively, which includes amortization of laboratory equipment acquired under finance leases (previously referred to as &#8220;capital leases&#8221;) of $<ix:nonFraction unitRef="usd" contextRef="i6013cc6ffa8a44399380d7ab2a84d3ef_D20220401-20220630" decimals="-3" name="us-gaap:Depreciation" format="ixt:num-dot-decimal" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmFlNWE5YmUwZWI5NDQ1ZDE5MmZhZTgyMmQyMmJlMDlmL3NlYzphZTVhOWJlMGViOTQ0NWQxOTJmYWU4MjJkMjJiZTA5Zl8zNy9mcmFnOjQ4OGNkZjBhODVlYzRiMDliYWFiN2JhZTlhODA5YjcwL3RleHRyZWdpb246NDg4Y2RmMGE4NWVjNGIwOWJhYWI3YmFlOWE4MDliNzBfMTQ4MTE_9a5d5cd1-b700-4935-9b95-b736ebdbbbfe">21,000</ix:nonFraction> and $<ix:nonFraction unitRef="usd" contextRef="i746f81de13474498bf13734eea25d645_D20210401-20210630" decimals="-3" name="us-gaap:Depreciation" format="ixt:num-dot-decimal" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmFlNWE5YmUwZWI5NDQ1ZDE5MmZhZTgyMmQyMmJlMDlmL3NlYzphZTVhOWJlMGViOTQ0NWQxOTJmYWU4MjJkMjJiZTA5Zl8zNy9mcmFnOjQ4OGNkZjBhODVlYzRiMDliYWFiN2JhZTlhODA5YjcwL3RleHRyZWdpb246NDg4Y2RmMGE4NWVjNGIwOWJhYWI3YmFlOWE4MDliNzBfMTQ4MTg_61d0e157-3929-492d-a267-c3983b2dda18">17,000</ix:nonFraction> for the three months ended June&#160;30, 2022 and 2021, respectively. The Company recorded depreciation expense of $<ix:nonFraction unitRef="usd" contextRef="ia855382ada1f4f28aa8ef6da692ff177_D20220101-20220630" decimals="-5" name="us-gaap:Depreciation" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmFlNWE5YmUwZWI5NDQ1ZDE5MmZhZTgyMmQyMmJlMDlmL3NlYzphZTVhOWJlMGViOTQ0NWQxOTJmYWU4MjJkMjJiZTA5Zl8zNy9mcmFnOjQ4OGNkZjBhODVlYzRiMDliYWFiN2JhZTlhODA5YjcwL3RleHRyZWdpb246NDg4Y2RmMGE4NWVjNGIwOWJhYWI3YmFlOWE4MDliNzBfMTQ5MTg_d7761aa4-cf2c-4f62-8586-f52e9a5553f1">0.8</ix:nonFraction> million and $<ix:nonFraction unitRef="usd" contextRef="idaa4f31ca59a4a17a59c2580b97791ca_D20210101-20210630" decimals="-5" name="us-gaap:Depreciation" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmFlNWE5YmUwZWI5NDQ1ZDE5MmZhZTgyMmQyMmJlMDlmL3NlYzphZTVhOWJlMGViOTQ0NWQxOTJmYWU4MjJkMjJiZTA5Zl8zNy9mcmFnOjQ4OGNkZjBhODVlYzRiMDliYWFiN2JhZTlhODA5YjcwL3RleHRyZWdpb246NDg4Y2RmMGE4NWVjNGIwOWJhYWI3YmFlOWE4MDliNzBfMTQ5MjU_87bf0253-0479-4868-96d1-1f40bc0d9183">0.4</ix:nonFraction> million for the six months ended June&#160;30, 2022 and 2021, respectively, which includes amortization of laboratory equipment acquired under finance leases of $<ix:nonFraction unitRef="usd" contextRef="i74a9fc9070b8404997fc0c10022dc50e_D20220101-20220630" decimals="-3" name="us-gaap:Depreciation" format="ixt:num-dot-decimal" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmFlNWE5YmUwZWI5NDQ1ZDE5MmZhZTgyMmQyMmJlMDlmL3NlYzphZTVhOWJlMGViOTQ0NWQxOTJmYWU4MjJkMjJiZTA5Zl8zNy9mcmFnOjQ4OGNkZjBhODVlYzRiMDliYWFiN2JhZTlhODA5YjcwL3RleHRyZWdpb246NDg4Y2RmMGE4NWVjNGIwOWJhYWI3YmFlOWE4MDliNzBfMTUwNjI_aa930421-94f9-4150-94d2-208f984bf772">41,000</ix:nonFraction> and $<ix:nonFraction unitRef="usd" contextRef="i3e76258aea994808ac778298cc3389ab_D20210101-20210630" decimals="-3" name="us-gaap:Depreciation" format="ixt:num-dot-decimal" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmFlNWE5YmUwZWI5NDQ1ZDE5MmZhZTgyMmQyMmJlMDlmL3NlYzphZTVhOWJlMGViOTQ0NWQxOTJmYWU4MjJkMjJiZTA5Zl8zNy9mcmFnOjQ4OGNkZjBhODVlYzRiMDliYWFiN2JhZTlhODA5YjcwL3RleHRyZWdpb246NDg4Y2RmMGE4NWVjNGIwOWJhYWI3YmFlOWE4MDliNzBfMTUwNjk_ae9523ab-41ba-4af5-8592-21966058c48c">34,000</ix:nonFraction> for the six months ended June&#160;30, 2022 and 2021, respectively. </ix:continuation></span></div></ix:continuation><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">8</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:45pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#iae5a9be0eb9445d192fae822d22be09f_7">Table of Contents</a></span></div></div><ix:continuation id="i2070c45a3fd14471be97585b6d2d170e" continuedAt="i9af394cb499b4287a6cf7bb638bf3518"><div style="margin-top:9pt;padding-left:27pt"><ix:continuation id="i2f98fad894bd4aa199f54383e023d89c" continuedAt="i72830c563ff8400795301a209a86007a"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Amortization of assets that are recorded under finance leases in depreciation expense is included in cost of revenues on the condensed consolidated statements of operations. Gross assets recorded under finance leases were $<ix:nonFraction unitRef="usd" contextRef="ic89cf2db98344df4a59437fe3569a1d2_I20211231" decimals="-5" name="us-gaap:PropertyPlantAndEquipmentGross" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmFlNWE5YmUwZWI5NDQ1ZDE5MmZhZTgyMmQyMmJlMDlmL3NlYzphZTVhOWJlMGViOTQ0NWQxOTJmYWU4MjJkMjJiZTA5Zl8zNy9mcmFnOjQ4OGNkZjBhODVlYzRiMDliYWFiN2JhZTlhODA5YjcwL3RleHRyZWdpb246NDg4Y2RmMGE4NWVjNGIwOWJhYWI3YmFlOWE4MDliNzBfMTUzNDM_adb4fe1c-7364-446f-ba49-0e138ec0101d"><ix:nonFraction unitRef="usd" contextRef="if5c0f2a68220406b8c328b2744af6512_I20220630" decimals="-5" name="us-gaap:PropertyPlantAndEquipmentGross" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmFlNWE5YmUwZWI5NDQ1ZDE5MmZhZTgyMmQyMmJlMDlmL3NlYzphZTVhOWJlMGViOTQ0NWQxOTJmYWU4MjJkMjJiZTA5Zl8zNy9mcmFnOjQ4OGNkZjBhODVlYzRiMDliYWFiN2JhZTlhODA5YjcwL3RleHRyZWdpb246NDg4Y2RmMGE4NWVjNGIwOWJhYWI3YmFlOWE4MDliNzBfMTUzNDM_b9af2a6f-e493-4714-9a73-ba49bfaeea88">0.4</ix:nonFraction></ix:nonFraction> million as of June&#160;30, 2022 and December&#160;31, 2021. Accumulated amortization associated with finance leases was $<ix:nonFraction unitRef="usd" contextRef="i72b0a574a3fc4d02a8355d41f4d3c3f7_D20220101-20220630" decimals="-5" name="us-gaap:DepreciationAndAmortization" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmFlNWE5YmUwZWI5NDQ1ZDE5MmZhZTgyMmQyMmJlMDlmL3NlYzphZTVhOWJlMGViOTQ0NWQxOTJmYWU4MjJkMjJiZTA5Zl8zNy9mcmFnOjQ4OGNkZjBhODVlYzRiMDliYWFiN2JhZTlhODA5YjcwL3RleHRyZWdpb246NDg4Y2RmMGE4NWVjNGIwOWJhYWI3YmFlOWE4MDliNzBfMTU0NDQ_91ff4285-a018-4b69-901c-f65ccfcd204d"><ix:nonFraction unitRef="usd" contextRef="i90781b7d5b3d4c93943bc5e09860112d_D20210101-20211231" decimals="-5" name="us-gaap:DepreciationAndAmortization" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmFlNWE5YmUwZWI5NDQ1ZDE5MmZhZTgyMmQyMmJlMDlmL3NlYzphZTVhOWJlMGViOTQ0NWQxOTJmYWU4MjJkMjJiZTA5Zl8zNy9mcmFnOjQ4OGNkZjBhODVlYzRiMDliYWFiN2JhZTlhODA5YjcwL3RleHRyZWdpb246NDg4Y2RmMGE4NWVjNGIwOWJhYWI3YmFlOWE4MDliNzBfMTU0NDQ_f3995695-affd-40bc-adf2-bba31f5094f5">0.1</ix:nonFraction></ix:nonFraction> million as of June&#160;30, 2022 and December&#160;31, 2021. Maintenance and repairs are expensed as incurred, and material improvements are capitalized. When assets are retired or otherwise disposed of, the cost and accumulated depreciation are removed from the balance sheet and any resulting gain or loss is reflected in the condensed consolidated statements of operations in the period realized. </span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company disposed of $<ix:nonFraction unitRef="usd" contextRef="i2c5f0f28773744e5a2e202f2943ae976_D20220401-20220630" decimals="-5" name="us-gaap:PropertyPlantAndEquipmentDisposals" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmFlNWE5YmUwZWI5NDQ1ZDE5MmZhZTgyMmQyMmJlMDlmL3NlYzphZTVhOWJlMGViOTQ0NWQxOTJmYWU4MjJkMjJiZTA5Zl8zNy9mcmFnOjQ4OGNkZjBhODVlYzRiMDliYWFiN2JhZTlhODA5YjcwL3RleHRyZWdpb246NDg4Y2RmMGE4NWVjNGIwOWJhYWI3YmFlOWE4MDliNzBfMTU4NDg_4493a068-3ee4-44e8-9025-ea0e7e7f5320">0.3</ix:nonFraction> million of equipment for the three months ended June&#160;30, 2022 and <ix:nonFraction unitRef="usd" contextRef="id7bb773872394047ba26aa8a7a0f4d56_D20210401-20210630" decimals="INF" name="us-gaap:PropertyPlantAndEquipmentDisposals" format="ixt-sec:numwordsen" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmFlNWE5YmUwZWI5NDQ1ZDE5MmZhZTgyMmQyMmJlMDlmL3NlYzphZTVhOWJlMGViOTQ0NWQxOTJmYWU4MjJkMjJiZTA5Zl8zNy9mcmFnOjQ4OGNkZjBhODVlYzRiMDliYWFiN2JhZTlhODA5YjcwL3RleHRyZWdpb246NDg4Y2RmMGE4NWVjNGIwOWJhYWI3YmFlOWE4MDliNzBfMTY0OTI2NzYxODA2MQ_a1f644cc-5911-4502-a592-4c7892fc1889">no</ix:nonFraction> equipment for the three months ended June&#160;30, 2021</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">. The Company disposed of $<ix:nonFraction unitRef="usd" contextRef="ia855382ada1f4f28aa8ef6da692ff177_D20220101-20220630" decimals="-5" name="us-gaap:PropertyPlantAndEquipmentDisposals" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmFlNWE5YmUwZWI5NDQ1ZDE5MmZhZTgyMmQyMmJlMDlmL3NlYzphZTVhOWJlMGViOTQ0NWQxOTJmYWU4MjJkMjJiZTA5Zl8zNy9mcmFnOjQ4OGNkZjBhODVlYzRiMDliYWFiN2JhZTlhODA5YjcwL3RleHRyZWdpb246NDg4Y2RmMGE4NWVjNGIwOWJhYWI3YmFlOWE4MDliNzBfMTU5NDc_b5cf91a9-69e7-48c4-b7ae-91dad4777644">0.3</ix:nonFraction> million and $<ix:nonFraction unitRef="usd" contextRef="idaa4f31ca59a4a17a59c2580b97791ca_D20210101-20210630" decimals="-3" name="us-gaap:PropertyPlantAndEquipmentDisposals" format="ixt:num-dot-decimal" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmFlNWE5YmUwZWI5NDQ1ZDE5MmZhZTgyMmQyMmJlMDlmL3NlYzphZTVhOWJlMGViOTQ0NWQxOTJmYWU4MjJkMjJiZTA5Zl8zNy9mcmFnOjQ4OGNkZjBhODVlYzRiMDliYWFiN2JhZTlhODA5YjcwL3RleHRyZWdpb246NDg4Y2RmMGE4NWVjNGIwOWJhYWI3YmFlOWE4MDliNzBfMTU5NTQ_8e05f5da-7a08-459e-a24f-5f2c34d82068">13,000</ix:nonFraction> of equipment for the six months ended June&#160;30, 2022 and </span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">2021</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">, respectively. </span></ix:continuation><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:continuation id="i72830c563ff8400795301a209a86007a">The Company assesses its long-lived assets, consisting primarily of property and equipment, for impairment when material events or changes in circumstances indicate that the carrying value may not be recoverable.</ix:continuation> There were <ix:nonFraction unitRef="usd" contextRef="id7bb773872394047ba26aa8a7a0f4d56_D20210401-20210630" decimals="INF" name="us-gaap:ImpairmentOfLongLivedAssetsToBeDisposedOf" format="ixt:fixed-zero" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmFlNWE5YmUwZWI5NDQ1ZDE5MmZhZTgyMmQyMmJlMDlmL3NlYzphZTVhOWJlMGViOTQ0NWQxOTJmYWU4MjJkMjJiZTA5Zl8zNy9mcmFnOjQ4OGNkZjBhODVlYzRiMDliYWFiN2JhZTlhODA5YjcwL3RleHRyZWdpb246NDg4Y2RmMGE4NWVjNGIwOWJhYWI3YmFlOWE4MDliNzBfMTYyNDM_1b78d049-02ba-401c-b769-afe18d8123fc"><ix:nonFraction unitRef="usd" contextRef="ia855382ada1f4f28aa8ef6da692ff177_D20220101-20220630" decimals="INF" name="us-gaap:ImpairmentOfLongLivedAssetsToBeDisposedOf" format="ixt:fixed-zero" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmFlNWE5YmUwZWI5NDQ1ZDE5MmZhZTgyMmQyMmJlMDlmL3NlYzphZTVhOWJlMGViOTQ0NWQxOTJmYWU4MjJkMjJiZTA5Zl8zNy9mcmFnOjQ4OGNkZjBhODVlYzRiMDliYWFiN2JhZTlhODA5YjcwL3RleHRyZWdpb246NDg4Y2RmMGE4NWVjNGIwOWJhYWI3YmFlOWE4MDliNzBfMTYyNDM_236f9072-c8ab-4e17-aba7-4965cc4edcc3"><ix:nonFraction unitRef="usd" contextRef="idaa4f31ca59a4a17a59c2580b97791ca_D20210101-20210630" decimals="INF" name="us-gaap:ImpairmentOfLongLivedAssetsToBeDisposedOf" format="ixt:fixed-zero" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmFlNWE5YmUwZWI5NDQ1ZDE5MmZhZTgyMmQyMmJlMDlmL3NlYzphZTVhOWJlMGViOTQ0NWQxOTJmYWU4MjJkMjJiZTA5Zl8zNy9mcmFnOjQ4OGNkZjBhODVlYzRiMDliYWFiN2JhZTlhODA5YjcwL3RleHRyZWdpb246NDg4Y2RmMGE4NWVjNGIwOWJhYWI3YmFlOWE4MDliNzBfMTYyNDM_84d97e54-efab-49bf-abf2-75378115e828"><ix:nonFraction unitRef="usd" contextRef="i2c5f0f28773744e5a2e202f2943ae976_D20220401-20220630" decimals="INF" name="us-gaap:ImpairmentOfLongLivedAssetsToBeDisposedOf" format="ixt:fixed-zero" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmFlNWE5YmUwZWI5NDQ1ZDE5MmZhZTgyMmQyMmJlMDlmL3NlYzphZTVhOWJlMGViOTQ0NWQxOTJmYWU4MjJkMjJiZTA5Zl8zNy9mcmFnOjQ4OGNkZjBhODVlYzRiMDliYWFiN2JhZTlhODA5YjcwL3RleHRyZWdpb246NDg4Y2RmMGE4NWVjNGIwOWJhYWI3YmFlOWE4MDliNzBfMTYyNDM_e72f3feb-c1a2-4903-ae61-c1d3fb39dab4">no</ix:nonFraction></ix:nonFraction></ix:nonFraction></ix:nonFraction> impairment losses for the three or six months ended June&#160;30, 2022 and 2021</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">. </span></div><div style="margin-top:15pt;padding-left:27pt;text-indent:-27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">(g)&#160;&#160;&#160;&#160;<ix:nonNumeric contextRef="ia855382ada1f4f28aa8ef6da692ff177_D20220101-20220630" name="us-gaap:ConcentrationRiskCreditRisk" id="id3VybDovL2RvY3MudjEvZG9jOmFlNWE5YmUwZWI5NDQ1ZDE5MmZhZTgyMmQyMmJlMDlmL3NlYzphZTVhOWJlMGViOTQ0NWQxOTJmYWU4MjJkMjJiZTA5Zl8zNy9mcmFnOjQ4OGNkZjBhODVlYzRiMDliYWFiN2JhZTlhODA5YjcwL3RleHRyZWdpb246NDg4Y2RmMGE4NWVjNGIwOWJhYWI3YmFlOWE4MDliNzBfNDYyNDA_8e9aa319-f9b2-40ad-9626-b1ba40871d45" continuedAt="i825d37463ecc46f082315c75272bbe64" escape="true">Concentration of Credit Risk </ix:nonNumeric></span></div><div style="margin-top:9pt;padding-left:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:continuation id="i825d37463ecc46f082315c75272bbe64">Financial instruments that potentially subject the Company to significant concentrations of credit risk consist primarily of cash and cash equivalents. As of June&#160;30, 2022, the Company maintained $<ix:nonFraction unitRef="usd" contextRef="i4c8f247d12134a9886d56e1c8b024425_I20220630" decimals="-5" name="us-gaap:DepositsMoneyMarketDeposits" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmFlNWE5YmUwZWI5NDQ1ZDE5MmZhZTgyMmQyMmJlMDlmL3NlYzphZTVhOWJlMGViOTQ0NWQxOTJmYWU4MjJkMjJiZTA5Zl8zNy9mcmFnOjQ4OGNkZjBhODVlYzRiMDliYWFiN2JhZTlhODA5YjcwL3RleHRyZWdpb246NDg4Y2RmMGE4NWVjNGIwOWJhYWI3YmFlOWE4MDliNzBfMTcyMTI_38ca6669-84c5-4426-b4bd-750011a5c506">87.1</ix:nonFraction> million in a sweep account, which maintains cash balances throughout various interest-bearing bank accounts under the $<ix:nonFraction unitRef="usd" contextRef="i4c8f247d12134a9886d56e1c8b024425_I20220630" decimals="-3" name="us-gaap:CashFDICInsuredAmount" format="ixt:num-dot-decimal" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmFlNWE5YmUwZWI5NDQ1ZDE5MmZhZTgyMmQyMmJlMDlmL3NlYzphZTVhOWJlMGViOTQ0NWQxOTJmYWU4MjJkMjJiZTA5Zl8zNy9mcmFnOjQ4OGNkZjBhODVlYzRiMDliYWFiN2JhZTlhODA5YjcwL3RleHRyZWdpb246NDg4Y2RmMGE4NWVjNGIwOWJhYWI3YmFlOWE4MDliNzBfMTczMjU_44eeb4ec-f687-4b64-ba63-70e1c22cc0e0">250,000</ix:nonFraction> insurance limit provided by the Federal Deposit Insurance Corporation for one federally insured financial institution.</ix:continuation> Approximately $<ix:nonFraction unitRef="usd" contextRef="i4c8f247d12134a9886d56e1c8b024425_I20220630" decimals="-5" name="us-gaap:CashUninsuredAmount" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmFlNWE5YmUwZWI5NDQ1ZDE5MmZhZTgyMmQyMmJlMDlmL3NlYzphZTVhOWJlMGViOTQ0NWQxOTJmYWU4MjJkMjJiZTA5Zl8zNy9mcmFnOjQ4OGNkZjBhODVlYzRiMDliYWFiN2JhZTlhODA5YjcwL3RleHRyZWdpb246NDg4Y2RmMGE4NWVjNGIwOWJhYWI3YmFlOWE4MDliNzBfMTc0NjE_91c48128-e956-44bb-bfd3-97f12ff55392">2.5</ix:nonFraction> million was held in excess of the Federal Deposit Insurance Corporation insured limit as of June&#160;30, 2022. The Company has not experienced any losses in such accounts. </span></div><div style="margin-top:15pt;padding-left:27pt;text-indent:-27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">(h)&#160;&#160;&#160;&#160;<ix:nonNumeric contextRef="ia855382ada1f4f28aa8ef6da692ff177_D20220101-20220630" name="us-gaap:RevenueRecognitionPolicyTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOmFlNWE5YmUwZWI5NDQ1ZDE5MmZhZTgyMmQyMmJlMDlmL3NlYzphZTVhOWJlMGViOTQ0NWQxOTJmYWU4MjJkMjJiZTA5Zl8zNy9mcmFnOjQ4OGNkZjBhODVlYzRiMDliYWFiN2JhZTlhODA5YjcwL3RleHRyZWdpb246NDg4Y2RmMGE4NWVjNGIwOWJhYWI3YmFlOWE4MDliNzBfNDYyMzU_8ff041ba-ee52-43f9-a2ae-ba6a97558a2e" continuedAt="i31065e39f2b7436385fcaf83e894aa61" escape="true">Revenue Recognition </ix:nonNumeric></span></div><ix:continuation id="i31065e39f2b7436385fcaf83e894aa61" continuedAt="i36e78dbfa1e040c382df2bc082c23df0"><div style="margin-top:9pt;padding-left:27pt"><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company&#8217;s revenue is generated from <ix:nonFraction unitRef="revenuestream" contextRef="ia855382ada1f4f28aa8ef6da692ff177_D20220101-20220630" decimals="INF" name="dmtk:NumberOfRevenueStreams" format="ixt-sec:numwordsen" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmFlNWE5YmUwZWI5NDQ1ZDE5MmZhZTgyMmQyMmJlMDlmL3NlYzphZTVhOWJlMGViOTQ0NWQxOTJmYWU4MjJkMjJiZTA5Zl8zNy9mcmFnOjQ4OGNkZjBhODVlYzRiMDliYWFiN2JhZTlhODA5YjcwL3RleHRyZWdpb246NDg4Y2RmMGE4NWVjNGIwOWJhYWI3YmFlOWE4MDliNzBfMTk0OTg_b9496efe-a565-42b8-b32a-a11019469f11">two</ix:nonFraction> revenue streams: contract revenue and assay revenue. The Company accounts for revenue in accordance with Accounting Standards Codification (&#8220;ASC&#8221;) Topic 606, Revenue from Contracts with Customers (&#8220;ASC 606&#8221;). The core principle of ASC 606 is that the Company recognizes revenue to depict the transfer of promised goods or services to customers in an amount that reflects the consideration to which the Company expects to be entitled in exchange for those goods or services. The ASC 606 revenue recognition model consists of the following five steps: (1) identify the contracts with a customer, (2) identify the performance obligations in the contract, (3) determine the transaction price, (4) allocate the transaction price to the performance obligations in the contract and (5) recognize revenue when (or as) the entity satisfies a performance obligation.</span></div><div style="margin-top:9pt;padding-left:27pt"><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company recognizes revenue from its assay and contract services in accordance with the core principles and key aspects considered by the Company. These considerations are described in detail below, first for Assay Revenue and then for Contract Revenue.</span></div><div style="margin-top:15pt;padding-left:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Assay Revenue </span></div><div style="margin-top:9pt;padding-left:27pt"><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company generates revenues from its Pigmented Lesion Assay (&#8220;PLA&#8221;) and PLA</span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">plus</span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> (now referred to as the DermTech Melanoma Test or &#8220;DMT&#8221; which may consist at the option of the ordering clinician of either (i) the PLA or (ii) the PLA and PLA</span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">plus</span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">), which assists a clinician&#8217;s diagnosis of melanoma in patients. The Company provides prescribing clinicians with its Smart Sticker to perform non-invasive skin biopsies of clinically ambiguous pigmented skin lesions on patients. The Company also offers clinicians a telemedicine solution where they can request the Smart Sticker collection kit be sent to the patient&#8217;s home for a clinician-guided remote collection on ambiguous pigmented skin lesions. A patient can also initiate the process by downloading the Company&#8217;s telemedicine app, DermTech Connect, which uses store-and-forward technology to allow the patient to take a picture of a suspicious lesion with their phone and have the picture reviewed by an independent clinician who is subscribing to the DermTech Connect platform to assess the suspicious lesion, and if medically necessary, order a DMT where a collection kit would be sent to the patient&#8217;s home. The DermTech Connect app and telemedicine service were initially beta tested in Florida and is currently available in most states where permitted by law and applicable standards of practice guidelines. Once the sample is collected by the patient via the telemedicine solution or by a healthcare clinician in person, it is returned to the Company&#8217;s CLIA laboratory for analysis. The patient&#8217;s ribonucleic acid (&#8220;RNA&#8221;) and deoxyribonucleic acid (&#8220;DNA&#8221;) are extracted from the Smart Sticker and analyzed using gene expression and sequencing technology to determine if the pigmented skin lesion contains certain genomic features indicative of melanoma. Upon completion of the gene expression analysis, a final report is drafted and provided to the clinician detailing the test results for the pigmented skin lesion indicating whether the sample collected is indicative of melanoma or not. </span></div></ix:continuation></ix:continuation><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">9</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:45pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#iae5a9be0eb9445d192fae822d22be09f_7">Table of Contents</a></span></div></div><ix:continuation id="i9af394cb499b4287a6cf7bb638bf3518" continuedAt="i4bfa2e06997543188dd7f85498a9db75"><ix:continuation id="i36e78dbfa1e040c382df2bc082c23df0" continuedAt="i6d03aad1849d47bb9823732c0cd3b962"><div style="margin-top:9pt;padding-left:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company periodically updates its estimate of the variable consideration recognized for previously delivered performance obligations. These updates resulted in an additional $<ix:nonFraction unitRef="usd" contextRef="i2c5f0f28773744e5a2e202f2943ae976_D20220401-20220630" decimals="-5" name="dmtk:RevenuePerformanceObligationSatisfiedVariableConsiderationUpdateIncreaseDecreaseInRevenue" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmFlNWE5YmUwZWI5NDQ1ZDE5MmZhZTgyMmQyMmJlMDlmL3NlYzphZTVhOWJlMGViOTQ0NWQxOTJmYWU4MjJkMjJiZTA5Zl8zNy9mcmFnOjQ4OGNkZjBhODVlYzRiMDliYWFiN2JhZTlhODA5YjcwL3RleHRyZWdpb246NDg4Y2RmMGE4NWVjNGIwOWJhYWI3YmFlOWE4MDliNzBfMTY0OTI2NzYyMzIwNw_e5340a77-d395-4746-8c67-1c29f011dd0c">0.1</ix:nonFraction> million and $<ix:nonFraction unitRef="usd" contextRef="ia855382ada1f4f28aa8ef6da692ff177_D20220101-20220630" decimals="-3" name="dmtk:RevenuePerformanceObligationSatisfiedVariableConsiderationUpdateIncreaseDecreaseInRevenue" format="ixt:num-dot-decimal" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmFlNWE5YmUwZWI5NDQ1ZDE5MmZhZTgyMmQyMmJlMDlmL3NlYzphZTVhOWJlMGViOTQ0NWQxOTJmYWU4MjJkMjJiZTA5Zl8zNy9mcmFnOjQ4OGNkZjBhODVlYzRiMDliYWFiN2JhZTlhODA5YjcwL3RleHRyZWdpb246NDg4Y2RmMGE4NWVjNGIwOWJhYWI3YmFlOWE4MDliNzBfMTY0OTI2NzYyMzI2Mw_4c23f30b-2c31-410c-9409-198a63775e37">8,000</ix:nonFraction> of revenue reported for the three and six months ended June 30, 2022, respectively, and an additional $<ix:nonFraction unitRef="usd" contextRef="id7bb773872394047ba26aa8a7a0f4d56_D20210401-20210630" decimals="-5" name="dmtk:RevenuePerformanceObligationSatisfiedVariableConsiderationUpdateIncreaseDecreaseInRevenue" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmFlNWE5YmUwZWI5NDQ1ZDE5MmZhZTgyMmQyMmJlMDlmL3NlYzphZTVhOWJlMGViOTQ0NWQxOTJmYWU4MjJkMjJiZTA5Zl8zNy9mcmFnOjQ4OGNkZjBhODVlYzRiMDliYWFiN2JhZTlhODA5YjcwL3RleHRyZWdpb246NDg4Y2RmMGE4NWVjNGIwOWJhYWI3YmFlOWE4MDliNzBfMTY0OTI2NzYyMzIyNQ_2f739d2b-5772-40d5-9631-9603528c6283">0.1</ix:nonFraction> million and $<ix:nonFraction unitRef="usd" contextRef="idaa4f31ca59a4a17a59c2580b97791ca_D20210101-20210630" decimals="-5" name="dmtk:RevenuePerformanceObligationSatisfiedVariableConsiderationUpdateIncreaseDecreaseInRevenue" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmFlNWE5YmUwZWI5NDQ1ZDE5MmZhZTgyMmQyMmJlMDlmL3NlYzphZTVhOWJlMGViOTQ0NWQxOTJmYWU4MjJkMjJiZTA5Zl8zNy9mcmFnOjQ4OGNkZjBhODVlYzRiMDliYWFiN2JhZTlhODA5YjcwL3RleHRyZWdpb246NDg4Y2RmMGE4NWVjNGIwOWJhYWI3YmFlOWE4MDliNzBfMTY0OTI2NzYyMzI0Mw_aecdea65-b6c2-4baa-b103-0a48e229b5f0">0.1</ix:nonFraction>&#160;million of revenue reported for the three and six months ended June 30, 2021, respectively. These amounts included (i) adjustments for actual collections versus estimated variable consideration as of the beginning of the reporting period and (ii) cash collections and the related recognition of revenue in the current period for tests delivered in prior periods due to the release of the constraint on variable consideration, offset by (iii) reductions in revenue for the accrual for reimbursement claims and settlements.</span></div><div style="margin-top:15pt;padding-left:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Contract Revenue</span></div><div style="padding-left:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">Contract revenue is generated from the sale of laboratory services and Smart Stickers to third-party companies through contract research agreements. Revenues are generated from providing genomic services to facilitate the development of drugs designed to treat dermatologic conditions. The provision of services may include sample collection using the Company&#8217;s Smart Sticker, assay development for research partners, patient segmentation and stratification, extraction, isolation, expression, amplification and detection of RNA, DNA, protein and microbiome, including data analysis and reporting.</span></div></ix:continuation><div style="margin-top:15pt;padding-left:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">(a) Disaggregation of Revenue </span></div><ix:nonNumeric contextRef="ia855382ada1f4f28aa8ef6da692ff177_D20220101-20220630" name="us-gaap:DisaggregationOfRevenueTableTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOmFlNWE5YmUwZWI5NDQ1ZDE5MmZhZTgyMmQyMmJlMDlmL3NlYzphZTVhOWJlMGViOTQ0NWQxOTJmYWU4MjJkMjJiZTA5Zl8zNy9mcmFnOjQ4OGNkZjBhODVlYzRiMDliYWFiN2JhZTlhODA5YjcwL3RleHRyZWdpb246NDg4Y2RmMGE4NWVjNGIwOWJhYWI3YmFlOWE4MDliNzBfNDYyNTM_2a2938a3-03bd-4cb1-b98c-b77cf1dc993e" escape="true"><div style="margin-top:9pt;padding-left:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table presents the Company&#8217;s revenues disaggregated by revenue source during the three and six months ended June&#160;30, 2022 and 2021 (in thousands):</span></div><div style="margin-top:12pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:44.354%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.081%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.406%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.081%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.406%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.081%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.406%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.085%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Three Months Ended June 30,</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Six Months Ended June 30,</span></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2021</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Assay Revenue</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">DermTech Melanoma Test</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i6e93ea7e6de54e3b99964d226c95da1b_D20220401-20220630" decimals="-3" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmFlNWE5YmUwZWI5NDQ1ZDE5MmZhZTgyMmQyMmJlMDlmL3NlYzphZTVhOWJlMGViOTQ0NWQxOTJmYWU4MjJkMjJiZTA5Zl8zNy9mcmFnOjQ4OGNkZjBhODVlYzRiMDliYWFiN2JhZTlhODA5YjcwL3RhYmxlOjY4ZWE0MGIyMGE2YTQyOTM4ZDIyNTQxOTRjZjIxYTExL3RhYmxlcmFuZ2U6NjhlYTQwYjIwYTZhNDI5MzhkMjI1NDE5NGNmMjFhMTFfMy0xLTEtMS02MjY_24338e86-0ec9-4680-9a11-fa2432e0627a">4,147</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i37138912f4f54957978d26b438559810_D20210401-20210630" decimals="-3" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmFlNWE5YmUwZWI5NDQ1ZDE5MmZhZTgyMmQyMmJlMDlmL3NlYzphZTVhOWJlMGViOTQ0NWQxOTJmYWU4MjJkMjJiZTA5Zl8zNy9mcmFnOjQ4OGNkZjBhODVlYzRiMDliYWFiN2JhZTlhODA5YjcwL3RhYmxlOjY4ZWE0MGIyMGE2YTQyOTM4ZDIyNTQxOTRjZjIxYTExL3RhYmxlcmFuZ2U6NjhlYTQwYjIwYTZhNDI5MzhkMjI1NDE5NGNmMjFhMTFfMy0zLTEtMS02MjY_7426fee5-e8a8-42a1-bb2f-225f69a22431">2,910</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i162096998d12445db5b600d98dd798a7_D20220101-20220630" decimals="-3" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmFlNWE5YmUwZWI5NDQ1ZDE5MmZhZTgyMmQyMmJlMDlmL3NlYzphZTVhOWJlMGViOTQ0NWQxOTJmYWU4MjJkMjJiZTA5Zl8zNy9mcmFnOjQ4OGNkZjBhODVlYzRiMDliYWFiN2JhZTlhODA5YjcwL3RhYmxlOjY4ZWE0MGIyMGE2YTQyOTM4ZDIyNTQxOTRjZjIxYTExL3RhYmxlcmFuZ2U6NjhlYTQwYjIwYTZhNDI5MzhkMjI1NDE5NGNmMjFhMTFfMy01LTEtMS02MjY_1198b2bd-9fa7-4a8a-9141-905891b3bc1a">7,665</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib998ae4e71544a4aa86f6166fce08ce5_D20210101-20210630" decimals="-3" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmFlNWE5YmUwZWI5NDQ1ZDE5MmZhZTgyMmQyMmJlMDlmL3NlYzphZTVhOWJlMGViOTQ0NWQxOTJmYWU4MjJkMjJiZTA5Zl8zNy9mcmFnOjQ4OGNkZjBhODVlYzRiMDliYWFiN2JhZTlhODA5YjcwL3RhYmxlOjY4ZWE0MGIyMGE2YTQyOTM4ZDIyNTQxOTRjZjIxYTExL3RhYmxlcmFuZ2U6NjhlYTQwYjIwYTZhNDI5MzhkMjI1NDE5NGNmMjFhMTFfMy03LTEtMS02MjY_237ddbb3-193a-4c77-8cb7-d4cc936393a1">5,100</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Contract Revenue</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Adhesive patch kits</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i44ab42a102594fac87f06c1ef8c068f7_D20220401-20220630" decimals="-3" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmFlNWE5YmUwZWI5NDQ1ZDE5MmZhZTgyMmQyMmJlMDlmL3NlYzphZTVhOWJlMGViOTQ0NWQxOTJmYWU4MjJkMjJiZTA5Zl8zNy9mcmFnOjQ4OGNkZjBhODVlYzRiMDliYWFiN2JhZTlhODA5YjcwL3RhYmxlOjY4ZWE0MGIyMGE2YTQyOTM4ZDIyNTQxOTRjZjIxYTExL3RhYmxlcmFuZ2U6NjhlYTQwYjIwYTZhNDI5MzhkMjI1NDE5NGNmMjFhMTFfNS0xLTEtMS02MjY_a4a9197e-d4a7-4045-82d2-aa541b0a6cb6">38</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i37bb372a6a6f42ad835fe2ef8ee1273a_D20210401-20210630" decimals="-3" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmFlNWE5YmUwZWI5NDQ1ZDE5MmZhZTgyMmQyMmJlMDlmL3NlYzphZTVhOWJlMGViOTQ0NWQxOTJmYWU4MjJkMjJiZTA5Zl8zNy9mcmFnOjQ4OGNkZjBhODVlYzRiMDliYWFiN2JhZTlhODA5YjcwL3RhYmxlOjY4ZWE0MGIyMGE2YTQyOTM4ZDIyNTQxOTRjZjIxYTExL3RhYmxlcmFuZ2U6NjhlYTQwYjIwYTZhNDI5MzhkMjI1NDE5NGNmMjFhMTFfNS0zLTEtMS02MjY_2c59425e-bc89-4534-b4be-80a25f883c64">125</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ibaf8664002d140989e8264c6adb89fa7_D20220101-20220630" decimals="-3" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmFlNWE5YmUwZWI5NDQ1ZDE5MmZhZTgyMmQyMmJlMDlmL3NlYzphZTVhOWJlMGViOTQ0NWQxOTJmYWU4MjJkMjJiZTA5Zl8zNy9mcmFnOjQ4OGNkZjBhODVlYzRiMDliYWFiN2JhZTlhODA5YjcwL3RhYmxlOjY4ZWE0MGIyMGE2YTQyOTM4ZDIyNTQxOTRjZjIxYTExL3RhYmxlcmFuZ2U6NjhlYTQwYjIwYTZhNDI5MzhkMjI1NDE5NGNmMjFhMTFfNS01LTEtMS02MjY_58f9708d-60f3-43ec-a7bf-eee35df0e4b3">104</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iddc9e2beb1bb4562969f72a76d146829_D20210101-20210630" decimals="-3" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmFlNWE5YmUwZWI5NDQ1ZDE5MmZhZTgyMmQyMmJlMDlmL3NlYzphZTVhOWJlMGViOTQ0NWQxOTJmYWU4MjJkMjJiZTA5Zl8zNy9mcmFnOjQ4OGNkZjBhODVlYzRiMDliYWFiN2JhZTlhODA5YjcwL3RhYmxlOjY4ZWE0MGIyMGE2YTQyOTM4ZDIyNTQxOTRjZjIxYTExL3RhYmxlcmFuZ2U6NjhlYTQwYjIwYTZhNDI5MzhkMjI1NDE5NGNmMjFhMTFfNS03LTEtMS02MjY_00a914aa-9ae8-4c3e-afb3-47f0d67bad3d">314</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">RNA extractions</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i97ac1b6997a14b74b531fc469df2694d_D20220401-20220630" decimals="-3" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" format="ixt:fixed-zero" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmFlNWE5YmUwZWI5NDQ1ZDE5MmZhZTgyMmQyMmJlMDlmL3NlYzphZTVhOWJlMGViOTQ0NWQxOTJmYWU4MjJkMjJiZTA5Zl8zNy9mcmFnOjQ4OGNkZjBhODVlYzRiMDliYWFiN2JhZTlhODA5YjcwL3RhYmxlOjY4ZWE0MGIyMGE2YTQyOTM4ZDIyNTQxOTRjZjIxYTExL3RhYmxlcmFuZ2U6NjhlYTQwYjIwYTZhNDI5MzhkMjI1NDE5NGNmMjFhMTFfNi0xLTEtMS02MjY_2da3fd2f-cd6d-4b57-b0c0-39be62885154">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib4f6baa70c784ecf9d59a3a86366bfc9_D20210401-20210630" decimals="-3" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmFlNWE5YmUwZWI5NDQ1ZDE5MmZhZTgyMmQyMmJlMDlmL3NlYzphZTVhOWJlMGViOTQ0NWQxOTJmYWU4MjJkMjJiZTA5Zl8zNy9mcmFnOjQ4OGNkZjBhODVlYzRiMDliYWFiN2JhZTlhODA5YjcwL3RhYmxlOjY4ZWE0MGIyMGE2YTQyOTM4ZDIyNTQxOTRjZjIxYTExL3RhYmxlcmFuZ2U6NjhlYTQwYjIwYTZhNDI5MzhkMjI1NDE5NGNmMjFhMTFfNi0zLTEtMS02MjY_1980d484-45b2-48d9-9771-74a784103e47">35</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i84a94952fcc541d9a3ed53a9fbe72d3f_D20220101-20220630" decimals="-3" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmFlNWE5YmUwZWI5NDQ1ZDE5MmZhZTgyMmQyMmJlMDlmL3NlYzphZTVhOWJlMGViOTQ0NWQxOTJmYWU4MjJkMjJiZTA5Zl8zNy9mcmFnOjQ4OGNkZjBhODVlYzRiMDliYWFiN2JhZTlhODA5YjcwL3RhYmxlOjY4ZWE0MGIyMGE2YTQyOTM4ZDIyNTQxOTRjZjIxYTExL3RhYmxlcmFuZ2U6NjhlYTQwYjIwYTZhNDI5MzhkMjI1NDE5NGNmMjFhMTFfNi01LTEtMS02MjY_d2f64959-63a9-4e74-bc94-f9729cca1057">110</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ia31f87e1f0644450bcc68070a72f9423_D20210101-20210630" decimals="-3" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmFlNWE5YmUwZWI5NDQ1ZDE5MmZhZTgyMmQyMmJlMDlmL3NlYzphZTVhOWJlMGViOTQ0NWQxOTJmYWU4MjJkMjJiZTA5Zl8zNy9mcmFnOjQ4OGNkZjBhODVlYzRiMDliYWFiN2JhZTlhODA5YjcwL3RhYmxlOjY4ZWE0MGIyMGE2YTQyOTM4ZDIyNTQxOTRjZjIxYTExL3RhYmxlcmFuZ2U6NjhlYTQwYjIwYTZhNDI5MzhkMjI1NDE5NGNmMjFhMTFfNi03LTEtMS02MjY_732b7949-fdd8-4626-a07b-3508753a117d">139</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Project management fees</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i2f689fb0f6dd4303b138b093b1056dd9_D20220401-20220630" decimals="-3" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmFlNWE5YmUwZWI5NDQ1ZDE5MmZhZTgyMmQyMmJlMDlmL3NlYzphZTVhOWJlMGViOTQ0NWQxOTJmYWU4MjJkMjJiZTA5Zl8zNy9mcmFnOjQ4OGNkZjBhODVlYzRiMDliYWFiN2JhZTlhODA5YjcwL3RhYmxlOjY4ZWE0MGIyMGE2YTQyOTM4ZDIyNTQxOTRjZjIxYTExL3RhYmxlcmFuZ2U6NjhlYTQwYjIwYTZhNDI5MzhkMjI1NDE5NGNmMjFhMTFfNy0xLTEtMS02MjY_77b277c8-8e5b-41ed-b9b7-8865f37739dc">48</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i8648dde9ea3c4420a2537a1ebd36ce55_D20210401-20210630" decimals="-3" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmFlNWE5YmUwZWI5NDQ1ZDE5MmZhZTgyMmQyMmJlMDlmL3NlYzphZTVhOWJlMGViOTQ0NWQxOTJmYWU4MjJkMjJiZTA5Zl8zNy9mcmFnOjQ4OGNkZjBhODVlYzRiMDliYWFiN2JhZTlhODA5YjcwL3RhYmxlOjY4ZWE0MGIyMGE2YTQyOTM4ZDIyNTQxOTRjZjIxYTExL3RhYmxlcmFuZ2U6NjhlYTQwYjIwYTZhNDI5MzhkMjI1NDE5NGNmMjFhMTFfNy0zLTEtMS02MjY_0b375c2b-83a7-44dc-bb27-de631a105401">49</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i7ce185f90d7b4357a581d645d094bd60_D20220101-20220630" decimals="-3" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmFlNWE5YmUwZWI5NDQ1ZDE5MmZhZTgyMmQyMmJlMDlmL3NlYzphZTVhOWJlMGViOTQ0NWQxOTJmYWU4MjJkMjJiZTA5Zl8zNy9mcmFnOjQ4OGNkZjBhODVlYzRiMDliYWFiN2JhZTlhODA5YjcwL3RhYmxlOjY4ZWE0MGIyMGE2YTQyOTM4ZDIyNTQxOTRjZjIxYTExL3RhYmxlcmFuZ2U6NjhlYTQwYjIwYTZhNDI5MzhkMjI1NDE5NGNmMjFhMTFfNy01LTEtMS02MjY_f8d17b94-64ef-447b-856d-e9a5ff5e998c">72</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iba453607677b41a9a058e0d3ee2c4186_D20210101-20210630" decimals="-3" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmFlNWE5YmUwZWI5NDQ1ZDE5MmZhZTgyMmQyMmJlMDlmL3NlYzphZTVhOWJlMGViOTQ0NWQxOTJmYWU4MjJkMjJiZTA5Zl8zNy9mcmFnOjQ4OGNkZjBhODVlYzRiMDliYWFiN2JhZTlhODA5YjcwL3RhYmxlOjY4ZWE0MGIyMGE2YTQyOTM4ZDIyNTQxOTRjZjIxYTExL3RhYmxlcmFuZ2U6NjhlYTQwYjIwYTZhNDI5MzhkMjI1NDE5NGNmMjFhMTFfNy03LTEtMS02MjY_cca7872d-338b-4955-9fb1-c3eca0f7fd97">90</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total revenues</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i2c5f0f28773744e5a2e202f2943ae976_D20220401-20220630" decimals="-3" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmFlNWE5YmUwZWI5NDQ1ZDE5MmZhZTgyMmQyMmJlMDlmL3NlYzphZTVhOWJlMGViOTQ0NWQxOTJmYWU4MjJkMjJiZTA5Zl8zNy9mcmFnOjQ4OGNkZjBhODVlYzRiMDliYWFiN2JhZTlhODA5YjcwL3RhYmxlOjY4ZWE0MGIyMGE2YTQyOTM4ZDIyNTQxOTRjZjIxYTExL3RhYmxlcmFuZ2U6NjhlYTQwYjIwYTZhNDI5MzhkMjI1NDE5NGNmMjFhMTFfOC0xLTEtMS02MjY_c5b729af-f8e4-4d77-96ed-e08c18c9d7f3">4,233</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="id7bb773872394047ba26aa8a7a0f4d56_D20210401-20210630" decimals="-3" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmFlNWE5YmUwZWI5NDQ1ZDE5MmZhZTgyMmQyMmJlMDlmL3NlYzphZTVhOWJlMGViOTQ0NWQxOTJmYWU4MjJkMjJiZTA5Zl8zNy9mcmFnOjQ4OGNkZjBhODVlYzRiMDliYWFiN2JhZTlhODA5YjcwL3RhYmxlOjY4ZWE0MGIyMGE2YTQyOTM4ZDIyNTQxOTRjZjIxYTExL3RhYmxlcmFuZ2U6NjhlYTQwYjIwYTZhNDI5MzhkMjI1NDE5NGNmMjFhMTFfOC0zLTEtMS02MjY_b8f88667-4982-42c9-8019-3c7d6c1c1242">3,119</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ia855382ada1f4f28aa8ef6da692ff177_D20220101-20220630" decimals="-3" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmFlNWE5YmUwZWI5NDQ1ZDE5MmZhZTgyMmQyMmJlMDlmL3NlYzphZTVhOWJlMGViOTQ0NWQxOTJmYWU4MjJkMjJiZTA5Zl8zNy9mcmFnOjQ4OGNkZjBhODVlYzRiMDliYWFiN2JhZTlhODA5YjcwL3RhYmxlOjY4ZWE0MGIyMGE2YTQyOTM4ZDIyNTQxOTRjZjIxYTExL3RhYmxlcmFuZ2U6NjhlYTQwYjIwYTZhNDI5MzhkMjI1NDE5NGNmMjFhMTFfOC01LTEtMS02MjY_69a91d8b-0bc6-4a4c-9628-78875cd47032">7,951</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="idaa4f31ca59a4a17a59c2580b97791ca_D20210101-20210630" decimals="-3" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmFlNWE5YmUwZWI5NDQ1ZDE5MmZhZTgyMmQyMmJlMDlmL3NlYzphZTVhOWJlMGViOTQ0NWQxOTJmYWU4MjJkMjJiZTA5Zl8zNy9mcmFnOjQ4OGNkZjBhODVlYzRiMDliYWFiN2JhZTlhODA5YjcwL3RhYmxlOjY4ZWE0MGIyMGE2YTQyOTM4ZDIyNTQxOTRjZjIxYTExL3RhYmxlcmFuZ2U6NjhlYTQwYjIwYTZhNDI5MzhkMjI1NDE5NGNmMjFhMTFfOC03LTEtMS02MjY_56316e50-3874-4e46-8107-1711b0379bd0">5,643</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div></ix:nonNumeric><ix:nonNumeric contextRef="ia855382ada1f4f28aa8ef6da692ff177_D20220101-20220630" name="us-gaap:ScheduleOfProductInformationTableTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOmFlNWE5YmUwZWI5NDQ1ZDE5MmZhZTgyMmQyMmJlMDlmL3NlYzphZTVhOWJlMGViOTQ0NWQxOTJmYWU4MjJkMjJiZTA5Zl8zNy9mcmFnOjQ4OGNkZjBhODVlYzRiMDliYWFiN2JhZTlhODA5YjcwL3RleHRyZWdpb246NDg4Y2RmMGE4NWVjNGIwOWJhYWI3YmFlOWE4MDliNzBfNDYyMzY_a99c6f7a-b568-4101-b36b-cd9893fe9c8f" escape="true"><div style="margin-top:9pt;padding-left:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table sets forth the percentages of total revenue or accounts receivable for the Company&#8217;s third-party payors that represent 10% or more of the respective amounts for the periods shown:</span></div><div style="margin-top:12pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:16.778%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.081%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.406%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.081%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.406%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.081%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.406%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.081%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.406%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.081%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.406%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.087%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="21" style="border-bottom:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Total Revenues</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Accounts Receivable </span></td></tr><tr style="height:12pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Three Months Ended June 30,</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="9" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Six Months Ended June 30,</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" rowspan="2" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">As of June 30, 2022</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" rowspan="2" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">As of December 31, 2021</span></td></tr><tr style="height:12pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Assay Revenue</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Payor A</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="ibe700613e5304875bdd1ff268a855e3b_D20220401-20220630" decimals="2" name="us-gaap:ConcentrationRiskPercentage1" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOmFlNWE5YmUwZWI5NDQ1ZDE5MmZhZTgyMmQyMmJlMDlmL3NlYzphZTVhOWJlMGViOTQ0NWQxOTJmYWU4MjJkMjJiZTA5Zl8zNy9mcmFnOjQ4OGNkZjBhODVlYzRiMDliYWFiN2JhZTlhODA5YjcwL3RhYmxlOjNhMjUwMjY2OTI3MzQ3OGE4ZWNlNzU0MjJkMDNhYTQzL3RhYmxlcmFuZ2U6M2EyNTAyNjY5MjczNDc4YThlY2U3NTQyMmQwM2FhNDNfNC0xLTEtMS02MjY_e3d7f682-921f-4482-b894-1d157061e67b">47</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="id2fc2250bf344e37938b871f12d01a85_D20210401-20210630" decimals="2" name="us-gaap:ConcentrationRiskPercentage1" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOmFlNWE5YmUwZWI5NDQ1ZDE5MmZhZTgyMmQyMmJlMDlmL3NlYzphZTVhOWJlMGViOTQ0NWQxOTJmYWU4MjJkMjJiZTA5Zl8zNy9mcmFnOjQ4OGNkZjBhODVlYzRiMDliYWFiN2JhZTlhODA5YjcwL3RhYmxlOjNhMjUwMjY2OTI3MzQ3OGE4ZWNlNzU0MjJkMDNhYTQzL3RhYmxlcmFuZ2U6M2EyNTAyNjY5MjczNDc4YThlY2U3NTQyMmQwM2FhNDNfNC0zLTEtMS02MjY_b19b00c3-a752-498d-86da-2ebaf09237fa">36</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="i79283405fe744adabc208118150149f3_D20220101-20220630" decimals="2" name="us-gaap:ConcentrationRiskPercentage1" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOmFlNWE5YmUwZWI5NDQ1ZDE5MmZhZTgyMmQyMmJlMDlmL3NlYzphZTVhOWJlMGViOTQ0NWQxOTJmYWU4MjJkMjJiZTA5Zl8zNy9mcmFnOjQ4OGNkZjBhODVlYzRiMDliYWFiN2JhZTlhODA5YjcwL3RhYmxlOjNhMjUwMjY2OTI3MzQ3OGE4ZWNlNzU0MjJkMDNhYTQzL3RhYmxlcmFuZ2U6M2EyNTAyNjY5MjczNDc4YThlY2U3NTQyMmQwM2FhNDNfNC01LTEtMS02MjY_0b152ce2-f3b0-40df-ba05-4edf08ae181b">39</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="i0a6d383e97df42d3a6810885b8aee9e8_D20210101-20210630" decimals="2" name="us-gaap:ConcentrationRiskPercentage1" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOmFlNWE5YmUwZWI5NDQ1ZDE5MmZhZTgyMmQyMmJlMDlmL3NlYzphZTVhOWJlMGViOTQ0NWQxOTJmYWU4MjJkMjJiZTA5Zl8zNy9mcmFnOjQ4OGNkZjBhODVlYzRiMDliYWFiN2JhZTlhODA5YjcwL3RhYmxlOjNhMjUwMjY2OTI3MzQ3OGE4ZWNlNzU0MjJkMDNhYTQzL3RhYmxlcmFuZ2U6M2EyNTAyNjY5MjczNDc4YThlY2U3NTQyMmQwM2FhNDNfNC03LTEtMS02MjY_8fa9ea91-1ac1-429f-a1ee-1b7e15b4ffd6">34</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="icab6abad6fea44f5ae78f4cbcce5b550_D20220101-20220630" decimals="2" name="us-gaap:ConcentrationRiskPercentage1" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOmFlNWE5YmUwZWI5NDQ1ZDE5MmZhZTgyMmQyMmJlMDlmL3NlYzphZTVhOWJlMGViOTQ0NWQxOTJmYWU4MjJkMjJiZTA5Zl8zNy9mcmFnOjQ4OGNkZjBhODVlYzRiMDliYWFiN2JhZTlhODA5YjcwL3RhYmxlOjNhMjUwMjY2OTI3MzQ3OGE4ZWNlNzU0MjJkMDNhYTQzL3RhYmxlcmFuZ2U6M2EyNTAyNjY5MjczNDc4YThlY2U3NTQyMmQwM2FhNDNfNC05LTEtMS02MjY_85644cbc-ccc3-43ee-b75b-ea0fae8dcd16">21</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="ifb4b0086847d4c79aed7244eb498c89a_D20210101-20211231" decimals="2" name="us-gaap:ConcentrationRiskPercentage1" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOmFlNWE5YmUwZWI5NDQ1ZDE5MmZhZTgyMmQyMmJlMDlmL3NlYzphZTVhOWJlMGViOTQ0NWQxOTJmYWU4MjJkMjJiZTA5Zl8zNy9mcmFnOjQ4OGNkZjBhODVlYzRiMDliYWFiN2JhZTlhODA5YjcwL3RhYmxlOjNhMjUwMjY2OTI3MzQ3OGE4ZWNlNzU0MjJkMDNhYTQzL3RhYmxlcmFuZ2U6M2EyNTAyNjY5MjczNDc4YThlY2U3NTQyMmQwM2FhNDNfNC0xMS0xLTEtNjI2_6fd66e02-e207-4e3b-af4f-8cb627e9a623">23</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Payor B</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">*</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">*</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">*</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">*</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="ibc3b0a82341c40d6abc97b51b82572a2_D20220101-20220630" decimals="2" name="us-gaap:ConcentrationRiskPercentage1" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOmFlNWE5YmUwZWI5NDQ1ZDE5MmZhZTgyMmQyMmJlMDlmL3NlYzphZTVhOWJlMGViOTQ0NWQxOTJmYWU4MjJkMjJiZTA5Zl8zNy9mcmFnOjQ4OGNkZjBhODVlYzRiMDliYWFiN2JhZTlhODA5YjcwL3RhYmxlOjNhMjUwMjY2OTI3MzQ3OGE4ZWNlNzU0MjJkMDNhYTQzL3RhYmxlcmFuZ2U6M2EyNTAyNjY5MjczNDc4YThlY2U3NTQyMmQwM2FhNDNfNS05LTEtMS02MjY_c2f22e92-4cf1-405a-bc92-1f5aa3996c9f">15</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="i024422eccd5d4383a66fc3f37bffe425_D20210101-20211231" decimals="2" name="us-gaap:ConcentrationRiskPercentage1" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOmFlNWE5YmUwZWI5NDQ1ZDE5MmZhZTgyMmQyMmJlMDlmL3NlYzphZTVhOWJlMGViOTQ0NWQxOTJmYWU4MjJkMjJiZTA5Zl8zNy9mcmFnOjQ4OGNkZjBhODVlYzRiMDliYWFiN2JhZTlhODA5YjcwL3RhYmxlOjNhMjUwMjY2OTI3MzQ3OGE4ZWNlNzU0MjJkMDNhYTQzL3RhYmxlcmFuZ2U6M2EyNTAyNjY5MjczNDc4YThlY2U3NTQyMmQwM2FhNDNfNS0xMS0xLTEtNjI2_7fc1509c-f6b9-4ebd-ad08-10aee69742f4">15</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr></table></div><div style="margin-top:6pt;padding-left:36pt;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">*</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%;padding-left:4pt">Less than 10%</span></div></ix:nonNumeric><div style="margin-top:9pt;padding-left:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">There were no other third-party payors or pharmaceutical customers that individually accounted for more than 10% of the Company&#8217;s total revenue or accounts receivable for the periods shown in the table above.</span></div><div style="margin-top:15pt;padding-left:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">(b) <ix:continuation id="i6d03aad1849d47bb9823732c0cd3b962" continuedAt="ie4fca792c26f495e99ac04237e91edc7">Deferred Revenue and Remaining Performance Obligations</ix:continuation></span></div><ix:continuation id="ie4fca792c26f495e99ac04237e91edc7" continuedAt="i919ece6ed6934a0598c561ea88f0cde8"><div style="margin-top:9pt;padding-left:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The timing of revenue recognition, billings and cash collections results in billed accounts receivable and deferred revenue on the condensed consolidated balance sheets.</span></div><div style="margin-top:9pt;padding-left:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In a majority of historical agreements that produced contract revenue, the Company received a substantial up-front payment and additional payments upon the achievement of various milestones over the life of the agreement. This results in deferred revenue and is relieved upon delivery of the applicable Smart Stickers or RNA extraction results. Changes in accounts receivable and deferred revenue were not materially impacted by any other factors.</span></div></ix:continuation></ix:continuation><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">10</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:45pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#iae5a9be0eb9445d192fae822d22be09f_7">Table of Contents</a></span></div></div><ix:continuation id="i4bfa2e06997543188dd7f85498a9db75" continuedAt="i388bd0dc294b46c5a1608e9f63a2d772"><div style="margin-top:9pt;padding-left:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:continuation id="i919ece6ed6934a0598c561ea88f0cde8" continuedAt="i224ab91a86e744379fe2ae9cac8f8598">The Company records a deferred revenue liability if a customer pays consideration before the Company transfers a good or service to the customer. Deferred revenue primarily represents upfront milestone payments, for which consideration is received prior to when goods/services are completed or delivered. Upfront fees that are estimated to be recognized as revenue more than one year from the date of collection are classified as long-term deferred revenue. Short-term deferred revenue as of June&#160;30, 2022 and December&#160;31, 2021 was $<ix:nonFraction unitRef="usd" contextRef="i4c8f247d12134a9886d56e1c8b024425_I20220630" decimals="-5" name="us-gaap:DeferredRevenueCurrent" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmFlNWE5YmUwZWI5NDQ1ZDE5MmZhZTgyMmQyMmJlMDlmL3NlYzphZTVhOWJlMGViOTQ0NWQxOTJmYWU4MjJkMjJiZTA5Zl8zNy9mcmFnOjQ4OGNkZjBhODVlYzRiMDliYWFiN2JhZTlhODA5YjcwL3RleHRyZWdpb246NDg4Y2RmMGE4NWVjNGIwOWJhYWI3YmFlOWE4MDliNzBfMjQzMTE_1830644f-b8da-4294-8727-84ac1f2fcda4">1.3</ix:nonFraction> million and $<ix:nonFraction unitRef="usd" contextRef="i87bf777ccf5f4f93bc9be7a2cbba61c1_I20211231" decimals="-5" name="us-gaap:DeferredRevenueCurrent" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmFlNWE5YmUwZWI5NDQ1ZDE5MmZhZTgyMmQyMmJlMDlmL3NlYzphZTVhOWJlMGViOTQ0NWQxOTJmYWU4MjJkMjJiZTA5Zl8zNy9mcmFnOjQ4OGNkZjBhODVlYzRiMDliYWFiN2JhZTlhODA5YjcwL3RleHRyZWdpb246NDg4Y2RmMGE4NWVjNGIwOWJhYWI3YmFlOWE4MDliNzBfMjQzMTg_de56695f-fe28-434c-9418-9905c7a59c54">1.4</ix:nonFraction> million, respectively. </ix:continuation></span></div><div style="margin-top:9pt;padding-left:27pt"><ix:continuation id="i224ab91a86e744379fe2ae9cac8f8598" continuedAt="i7122dfaa87b24c2196f9d6a106d69ec5"><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Remaining performance obligations include deferred revenue and amounts the Company expects to receive for goods and services that have not yet been delivered or provided under existing agreements. For agreements that have an original duration of one year </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">or</span></ix:continuation><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:continuation id="i7122dfaa87b24c2196f9d6a106d69ec5"> less, the Company has elected the practical expedient applicable to such agreements and does not disclose the remaining performance obligations at the end of each reporting period.</ix:continuation> As of June&#160;30, 2022, the estimated revenue expected to be recognized in future periods related to performance obligations that are unsatisfied for executed agreements with an original duration of one year or more was approximatel</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">y $<ix:nonFraction unitRef="usd" contextRef="i4c8f247d12134a9886d56e1c8b024425_I20220630" decimals="-5" name="us-gaap:RevenueRemainingPerformanceObligation" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmFlNWE5YmUwZWI5NDQ1ZDE5MmZhZTgyMmQyMmJlMDlmL3NlYzphZTVhOWJlMGViOTQ0NWQxOTJmYWU4MjJkMjJiZTA5Zl8zNy9mcmFnOjQ4OGNkZjBhODVlYzRiMDliYWFiN2JhZTlhODA5YjcwL3RleHRyZWdpb246NDg4Y2RmMGE4NWVjNGIwOWJhYWI3YmFlOWE4MDliNzBfMjUwNjg_e08aba90-e827-4a8d-b63b-110a9017b9a9">0.1</ix:nonFraction> million</span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">. The Company expects to recognize revenue on the majority of these remaining performance obligations over the next <span style="-sec-ix-hidden:id3VybDovL2RvY3MudjEvZG9jOmFlNWE5YmUwZWI5NDQ1ZDE5MmZhZTgyMmQyMmJlMDlmL3NlYzphZTVhOWJlMGViOTQ0NWQxOTJmYWU4MjJkMjJiZTA5Zl8zNy9mcmFnOjQ4OGNkZjBhODVlYzRiMDliYWFiN2JhZTlhODA5YjcwL3RleHRyZWdpb246NDg4Y2RmMGE4NWVjNGIwOWJhYWI3YmFlOWE4MDliNzBfMjUxODY_b4f0c6ee-fd6c-49c3-80df-d66815f5e42f">two</span> to <ix:nonNumeric contextRef="i87a77119b42946ecbfc4ea54841338c0_I20220630" name="us-gaap:RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionPeriod1" format="ixt-sec:durwordsen" id="id3VybDovL2RvY3MudjEvZG9jOmFlNWE5YmUwZWI5NDQ1ZDE5MmZhZTgyMmQyMmJlMDlmL3NlYzphZTVhOWJlMGViOTQ0NWQxOTJmYWU4MjJkMjJiZTA5Zl8zNy9mcmFnOjQ4OGNkZjBhODVlYzRiMDliYWFiN2JhZTlhODA5YjcwL3RleHRyZWdpb246NDg4Y2RmMGE4NWVjNGIwOWJhYWI3YmFlOWE4MDliNzBfMjUxOTI_de202005-51e3-4004-bf39-146510089ec3">three years</ix:nonNumeric>.</span></div><div style="margin-top:15pt;padding-left:27pt;text-indent:-27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">(i)&#160;&#160;&#160;&#160;<ix:nonNumeric contextRef="ia855382ada1f4f28aa8ef6da692ff177_D20220101-20220630" name="us-gaap:ReceivablesPolicyTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOmFlNWE5YmUwZWI5NDQ1ZDE5MmZhZTgyMmQyMmJlMDlmL3NlYzphZTVhOWJlMGViOTQ0NWQxOTJmYWU4MjJkMjJiZTA5Zl8zNy9mcmFnOjQ4OGNkZjBhODVlYzRiMDliYWFiN2JhZTlhODA5YjcwL3RleHRyZWdpb246NDg4Y2RmMGE4NWVjNGIwOWJhYWI3YmFlOWE4MDliNzBfNDYyNTY_13134795-6e16-49f1-80d1-4b23fa7d8982" continuedAt="iad350cd41aa44d24b5534a63c061cd5a" escape="true">Accounts Receivable </ix:nonNumeric></span></div><ix:continuation id="iad350cd41aa44d24b5534a63c061cd5a" continuedAt="ib173553905594bf6992404c875f44b68"><div style="margin-top:15pt;padding-left:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Assay Accounts Receivable </span></div><div style="margin-top:9pt;padding-left:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Due to the nature of the Company&#8217;s assay revenue, it can take a significant amount of time to collect upon billed tests. The Company prepares an analysis on reimbursement collections and data obtained for each financial reporting period to determine the amount of receivables to be recorded relating to tests performed in the applicable period. The Company generally does not perform evaluations of customers&#8217; financial condition and generally does not require collateral. Accounts receivables are written off when all efforts to collect the balance have been exhausted. Adjustments for implicit price concessions attributable to variable consideration are incorporated into the measurement of the accounts receivable balances. The Company recorded $<ix:nonFraction unitRef="usd" contextRef="i6635c095eae0429e88a27cd2f8145dc1_I20220630" decimals="-5" name="us-gaap:AccountsReceivableGrossCurrent" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmFlNWE5YmUwZWI5NDQ1ZDE5MmZhZTgyMmQyMmJlMDlmL3NlYzphZTVhOWJlMGViOTQ0NWQxOTJmYWU4MjJkMjJiZTA5Zl8zNy9mcmFnOjQ4OGNkZjBhODVlYzRiMDliYWFiN2JhZTlhODA5YjcwL3RleHRyZWdpb246NDg4Y2RmMGE4NWVjNGIwOWJhYWI3YmFlOWE4MDliNzBfMjYwMzI_faedf6c0-c424-47bd-b8cb-37da755c2e75">5.8</ix:nonFraction> million and $<ix:nonFraction unitRef="usd" contextRef="i4d3ad48c30c04410bf8a55d9dabb735e_I20211231" decimals="-5" name="us-gaap:AccountsReceivableGrossCurrent" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmFlNWE5YmUwZWI5NDQ1ZDE5MmZhZTgyMmQyMmJlMDlmL3NlYzphZTVhOWJlMGViOTQ0NWQxOTJmYWU4MjJkMjJiZTA5Zl8zNy9mcmFnOjQ4OGNkZjBhODVlYzRiMDliYWFiN2JhZTlhODA5YjcwL3RleHRyZWdpb246NDg4Y2RmMGE4NWVjNGIwOWJhYWI3YmFlOWE4MDliNzBfMjYwMzk_7b165ef9-e0c7-4e59-97ee-4d059fbdbd53">3.6</ix:nonFraction> million of gross assay accounts receivable as of June&#160;30, 2022 and December&#160;31, 2021, respectively. Accounts receivable as of June&#160;30, 2022 included unbilled accounts receivable of $<ix:nonFraction unitRef="usd" contextRef="i4c8f247d12134a9886d56e1c8b024425_I20220630" decimals="-5" name="us-gaap:UnbilledReceivablesCurrent" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmFlNWE5YmUwZWI5NDQ1ZDE5MmZhZTgyMmQyMmJlMDlmL3NlYzphZTVhOWJlMGViOTQ0NWQxOTJmYWU4MjJkMjJiZTA5Zl8zNy9mcmFnOjQ4OGNkZjBhODVlYzRiMDliYWFiN2JhZTlhODA5YjcwL3RleHRyZWdpb246NDg4Y2RmMGE4NWVjNGIwOWJhYWI3YmFlOWE4MDliNzBfNTQ5NzU1OTg0MDM5_427b9ff1-f940-4597-8a8e-f5f4663e4101">0.3</ix:nonFraction> million. </span></div><div style="margin-top:15pt;padding-left:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Contract Accounts Receivable </span></div></ix:continuation><div style="margin-top:9pt;padding-left:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:continuation id="ib173553905594bf6992404c875f44b68">Contract accounts receivable are recorded at the net invoice value and are not interest bearing. The Company reserves specific receivables if collectability is no longer reasonably assured, and as of June&#160;30, 2022, the Company did not maintain any reserves over contract receivables as they relate to large established credit worthy customers. The Company re-evaluates such reserves on a regular basis and adjusts its reserves as needed. Once a receivable is deemed to be uncollectible, such balance is charged against the reserve.</ix:continuation> The Company recorded $<ix:nonFraction unitRef="usd" contextRef="icfa56764c3ac46e89e85c1c2e548d685_I20220630" decimals="-5" name="us-gaap:AccountsReceivableNetCurrent" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmFlNWE5YmUwZWI5NDQ1ZDE5MmZhZTgyMmQyMmJlMDlmL3NlYzphZTVhOWJlMGViOTQ0NWQxOTJmYWU4MjJkMjJiZTA5Zl8zNy9mcmFnOjQ4OGNkZjBhODVlYzRiMDliYWFiN2JhZTlhODA5YjcwL3RleHRyZWdpb246NDg4Y2RmMGE4NWVjNGIwOWJhYWI3YmFlOWE4MDliNzBfMjY2ODE_a0050c56-04a9-4da7-b990-4b60dfa1612f">0.2</ix:nonFraction> million and $<ix:nonFraction unitRef="usd" contextRef="i204f9e4e483143659a51c94f43ce8d11_I20211231" decimals="-5" name="us-gaap:AccountsReceivableNetCurrent" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmFlNWE5YmUwZWI5NDQ1ZDE5MmZhZTgyMmQyMmJlMDlmL3NlYzphZTVhOWJlMGViOTQ0NWQxOTJmYWU4MjJkMjJiZTA5Zl8zNy9mcmFnOjQ4OGNkZjBhODVlYzRiMDliYWFiN2JhZTlhODA5YjcwL3RleHRyZWdpb246NDg4Y2RmMGE4NWVjNGIwOWJhYWI3YmFlOWE4MDliNzBfMjY2ODg_ee28a702-1dd4-422f-b3cc-dfec927624aa">0.2</ix:nonFraction> million of contract accounts receivable as of June&#160;30, 2022 and December&#160;31, 2021, respectively. </span></div><div style="margin-top:15pt;padding-left:27pt;text-indent:-27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">(j)&#160;&#160;&#160;&#160;<ix:nonNumeric contextRef="ia855382ada1f4f28aa8ef6da692ff177_D20220101-20220630" name="us-gaap:EarningsPerSharePolicyTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOmFlNWE5YmUwZWI5NDQ1ZDE5MmZhZTgyMmQyMmJlMDlmL3NlYzphZTVhOWJlMGViOTQ0NWQxOTJmYWU4MjJkMjJiZTA5Zl8zNy9mcmFnOjQ4OGNkZjBhODVlYzRiMDliYWFiN2JhZTlhODA5YjcwL3RleHRyZWdpb246NDg4Y2RmMGE4NWVjNGIwOWJhYWI3YmFlOWE4MDliNzBfNDYyNDU_6e9eefb5-9ad8-45c2-8d6e-cbf08144188e" continuedAt="i8da30ea18e2249649cc17e8b3d070518" escape="true">Net Loss Per Share </ix:nonNumeric></span></div><div style="margin-top:9pt;padding-left:27pt"><ix:continuation id="i8da30ea18e2249649cc17e8b3d070518"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Basic and diluted net loss per share of common stock is determined by dividing net loss applicable to holders of common stock by the weighted average number of shares of common stock outstanding during the period. Because there is a net loss attributable to holders of common stock during the three and six months ended June&#160;30, 2022 and 2021, the outstanding common stock warrants, stock options, and restricted stock units (&#8220;RSUs&#8221;) have been excluded from the calculation of diluted loss per share of common stock because their effect would be anti-dilutive. Therefore, the weighted average shares used to calculate both basic and diluted loss per share are the same. Diluted net loss per share of common stock for the three and six</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"> </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">months ended June&#160;30, 2022 excludes the effect of anti-dilutive equity instruments including <ix:nonFraction unitRef="shares" contextRef="ie94c263c6992432a815e971cc90962ff_D20220101-20220630" decimals="INF" name="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount" format="ixt:num-dot-decimal" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmFlNWE5YmUwZWI5NDQ1ZDE5MmZhZTgyMmQyMmJlMDlmL3NlYzphZTVhOWJlMGViOTQ0NWQxOTJmYWU4MjJkMjJiZTA5Zl8zNy9mcmFnOjQ4OGNkZjBhODVlYzRiMDliYWFiN2JhZTlhODA5YjcwL3RleHRyZWdpb246NDg4Y2RmMGE4NWVjNGIwOWJhYWI3YmFlOWE4MDliNzBfMjg0ODU_631d124d-43fe-4385-90f6-11ece7ea1119"><ix:nonFraction unitRef="shares" contextRef="i7ba402f3c4df43af97329ebc435cae8c_D20220401-20220630" decimals="INF" name="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount" format="ixt:num-dot-decimal" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmFlNWE5YmUwZWI5NDQ1ZDE5MmZhZTgyMmQyMmJlMDlmL3NlYzphZTVhOWJlMGViOTQ0NWQxOTJmYWU4MjJkMjJiZTA5Zl8zNy9mcmFnOjQ4OGNkZjBhODVlYzRiMDliYWFiN2JhZTlhODA5YjcwL3RleHRyZWdpb246NDg4Y2RmMGE4NWVjNGIwOWJhYWI3YmFlOWE4MDliNzBfMjg0ODU_725ef6cc-c7e8-4ac6-8ecb-15530aedd97b">714,261</ix:nonFraction></ix:nonFraction> shares of common stock issuable upon the exercise of outstanding common stock warrants and <ix:nonFraction unitRef="shares" contextRef="i2823faffcae54e5d93a6030da77ad512_D20220101-20220630" decimals="INF" name="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount" format="ixt:num-dot-decimal" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmFlNWE5YmUwZWI5NDQ1ZDE5MmZhZTgyMmQyMmJlMDlmL3NlYzphZTVhOWJlMGViOTQ0NWQxOTJmYWU4MjJkMjJiZTA5Zl8zNy9mcmFnOjQ4OGNkZjBhODVlYzRiMDliYWFiN2JhZTlhODA5YjcwL3RleHRyZWdpb246NDg4Y2RmMGE4NWVjNGIwOWJhYWI3YmFlOWE4MDliNzBfMjg1Nzk_49ddfe7f-fdf7-432a-8374-2b9efba34cb2"><ix:nonFraction unitRef="shares" contextRef="i4691cb5ab9d44fe4bb012ab3099c548d_D20220401-20220630" decimals="INF" name="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount" format="ixt:num-dot-decimal" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmFlNWE5YmUwZWI5NDQ1ZDE5MmZhZTgyMmQyMmJlMDlmL3NlYzphZTVhOWJlMGViOTQ0NWQxOTJmYWU4MjJkMjJiZTA5Zl8zNy9mcmFnOjQ4OGNkZjBhODVlYzRiMDliYWFiN2JhZTlhODA5YjcwL3RleHRyZWdpb246NDg4Y2RmMGE4NWVjNGIwOWJhYWI3YmFlOWE4MDliNzBfMjg1Nzk_4bc2ca5a-4a6b-4a11-bbf1-6f2759b731da">4,670,069</ix:nonFraction></ix:nonFraction> shares of common stock issuable upon the exercise of stock options and release of RSUs. Diluted net loss per share of common stock for the three and six</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"> </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">months ended June&#160;30, 2021 excludes the effect of anti-dilutive equity instruments including <ix:nonFraction unitRef="shares" contextRef="icb0e8ee0be634262b34d17ccb551b284_D20210101-20210630" decimals="INF" name="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount" format="ixt:num-dot-decimal" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmFlNWE5YmUwZWI5NDQ1ZDE5MmZhZTgyMmQyMmJlMDlmL3NlYzphZTVhOWJlMGViOTQ0NWQxOTJmYWU4MjJkMjJiZTA5Zl8zNy9mcmFnOjQ4OGNkZjBhODVlYzRiMDliYWFiN2JhZTlhODA5YjcwL3RleHRyZWdpb246NDg4Y2RmMGE4NWVjNGIwOWJhYWI3YmFlOWE4MDliNzBfMjg4MDY_1abeaaec-4c08-43d7-abb9-bc9181c2c97f"><ix:nonFraction unitRef="shares" contextRef="i249d87c65f444c66a0d32f915d17cf47_D20210401-20210630" decimals="INF" name="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount" format="ixt:num-dot-decimal" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmFlNWE5YmUwZWI5NDQ1ZDE5MmZhZTgyMmQyMmJlMDlmL3NlYzphZTVhOWJlMGViOTQ0NWQxOTJmYWU4MjJkMjJiZTA5Zl8zNy9mcmFnOjQ4OGNkZjBhODVlYzRiMDliYWFiN2JhZTlhODA5YjcwL3RleHRyZWdpb246NDg4Y2RmMGE4NWVjNGIwOWJhYWI3YmFlOWE4MDliNzBfMjg4MDY_f8899170-c295-413f-bc7f-f6993f052878">749,210</ix:nonFraction></ix:nonFraction> shares of common stock then issuable upon the exercise of outstanding warrants and <ix:nonFraction unitRef="shares" contextRef="i8302e4a3b08c40939cfabd8d8c7827e0_D20210401-20210630" decimals="INF" name="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount" format="ixt:num-dot-decimal" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmFlNWE5YmUwZWI5NDQ1ZDE5MmZhZTgyMmQyMmJlMDlmL3NlYzphZTVhOWJlMGViOTQ0NWQxOTJmYWU4MjJkMjJiZTA5Zl8zNy9mcmFnOjQ4OGNkZjBhODVlYzRiMDliYWFiN2JhZTlhODA5YjcwL3RleHRyZWdpb246NDg4Y2RmMGE4NWVjNGIwOWJhYWI3YmFlOWE4MDliNzBfMjg4OTI_2c1481f2-7a14-471f-9276-2aa16f57b812"><ix:nonFraction unitRef="shares" contextRef="idde3250874484b9b9fbc3ab3b93032eb_D20210101-20210630" decimals="INF" name="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount" format="ixt:num-dot-decimal" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmFlNWE5YmUwZWI5NDQ1ZDE5MmZhZTgyMmQyMmJlMDlmL3NlYzphZTVhOWJlMGViOTQ0NWQxOTJmYWU4MjJkMjJiZTA5Zl8zNy9mcmFnOjQ4OGNkZjBhODVlYzRiMDliYWFiN2JhZTlhODA5YjcwL3RleHRyZWdpb246NDg4Y2RmMGE4NWVjNGIwOWJhYWI3YmFlOWE4MDliNzBfMjg4OTI_49d1b508-193f-4010-8d27-d26871dbc168">2,469,816</ix:nonFraction></ix:nonFraction> shares of common stock then issuable upon the exercise of stock options and release of RSUs.</span></ix:continuation></div></ix:continuation><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">11</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:45pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#iae5a9be0eb9445d192fae822d22be09f_7">Table of Contents</a></span></div></div><ix:continuation id="i388bd0dc294b46c5a1608e9f63a2d772" continuedAt="i600ec168dc9f4864a0bbedc0cbbd0af5"><div style="margin-top:15pt;padding-left:27pt;text-indent:-27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">(k)&#160;&#160;&#160;&#160;<ix:nonNumeric contextRef="ia855382ada1f4f28aa8ef6da692ff177_D20220101-20220630" name="us-gaap:FairValueMeasurementPolicyPolicyTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOmFlNWE5YmUwZWI5NDQ1ZDE5MmZhZTgyMmQyMmJlMDlmL3NlYzphZTVhOWJlMGViOTQ0NWQxOTJmYWU4MjJkMjJiZTA5Zl8zNy9mcmFnOjQ4OGNkZjBhODVlYzRiMDliYWFiN2JhZTlhODA5YjcwL3RleHRyZWdpb246NDg4Y2RmMGE4NWVjNGIwOWJhYWI3YmFlOWE4MDliNzBfNDYyNjc_ede8b027-56df-474f-903a-756e588d6fc6" continuedAt="i64218885393c4b50ae0c4529b6d54320" escape="true">Fair Value Measurements</ix:nonNumeric></span></div><div style="margin-top:9pt;padding-left:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:continuation id="i64218885393c4b50ae0c4529b6d54320" continuedAt="i80bb7425691246c2807df365549eaac4">The Company measures certain financial assets and liabilities at fair value on a recurring basis. Fair value is defined as the price that would be received to sell an asset or paid to transfer a liability (an exit price) in an orderly transaction between market participants at the measurement date. The Company uses a three-tier fair value hierarchy to prioritize the inputs used in the Company&#8217;s fair value measurements. These tiers include: Level 1, defined as observable inputs such as quoted prices in active markets for identical assets; Level 2, defined as inputs other than quoted prices in active markets that are either directly or indirectly observable; and Level 3, defined as unobservable inputs in which little or no market data exists, therefore requiring an entity to develop its own assumptions.</ix:continuation> </span></div><ix:nonNumeric contextRef="ia855382ada1f4f28aa8ef6da692ff177_D20220101-20220630" name="us-gaap:ScheduleOfFairValueAssetsAndLiabilitiesMeasuredOnRecurringBasisTableTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOmFlNWE5YmUwZWI5NDQ1ZDE5MmZhZTgyMmQyMmJlMDlmL3NlYzphZTVhOWJlMGViOTQ0NWQxOTJmYWU4MjJkMjJiZTA5Zl8zNy9mcmFnOjQ4OGNkZjBhODVlYzRiMDliYWFiN2JhZTlhODA5YjcwL3RleHRyZWdpb246NDg4Y2RmMGE4NWVjNGIwOWJhYWI3YmFlOWE4MDliNzBfNDYyNjE_6b78fcfb-da46-4d85-87e5-1874376a4243" escape="true"><div style="margin-top:9pt;padding-left:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table provides a summary of the assets and liabilities that are measured at fair value on a recurring basis as of June&#160;30, 2022 (in thousands): </span></div><div style="margin-top:12pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:44.354%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.081%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.406%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.081%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.406%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.081%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.406%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.085%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="21" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">June 30, 2022</span></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Level 1</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Level 2</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Level 3</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Total</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Assets:</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cash equivalents</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if758224c2e474796966c7a56ed966de8_I20220630" decimals="-3" name="us-gaap:CashEquivalentsAtCarryingValue" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmFlNWE5YmUwZWI5NDQ1ZDE5MmZhZTgyMmQyMmJlMDlmL3NlYzphZTVhOWJlMGViOTQ0NWQxOTJmYWU4MjJkMjJiZTA5Zl8zNy9mcmFnOjQ4OGNkZjBhODVlYzRiMDliYWFiN2JhZTlhODA5YjcwL3RhYmxlOjBhMmUxZWYwOGVmNjQ4ZWI4Y2MxNTJjZTRmNmM3YjgxL3RhYmxlcmFuZ2U6MGEyZTFlZjA4ZWY2NDhlYjhjYzE1MmNlNGY2YzdiODFfMy0xLTEtMS02MjY_49514757-b30b-4cfc-a04a-1ec2036c5db8">30,723</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if8fdbfd7ecbc4f1e83abd5532a4f2776_I20220630" decimals="-3" name="us-gaap:CashEquivalentsAtCarryingValue" format="ixt:fixed-zero" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmFlNWE5YmUwZWI5NDQ1ZDE5MmZhZTgyMmQyMmJlMDlmL3NlYzphZTVhOWJlMGViOTQ0NWQxOTJmYWU4MjJkMjJiZTA5Zl8zNy9mcmFnOjQ4OGNkZjBhODVlYzRiMDliYWFiN2JhZTlhODA5YjcwL3RhYmxlOjBhMmUxZWYwOGVmNjQ4ZWI4Y2MxNTJjZTRmNmM3YjgxL3RhYmxlcmFuZ2U6MGEyZTFlZjA4ZWY2NDhlYjhjYzE1MmNlNGY2YzdiODFfMy0zLTEtMS02MjY_391a5243-c586-4b19-a303-c57cb625d1ba">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="id460d49e6dc845ddb03e35bcd01b0a02_I20220630" decimals="-3" name="us-gaap:CashEquivalentsAtCarryingValue" format="ixt:fixed-zero" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmFlNWE5YmUwZWI5NDQ1ZDE5MmZhZTgyMmQyMmJlMDlmL3NlYzphZTVhOWJlMGViOTQ0NWQxOTJmYWU4MjJkMjJiZTA5Zl8zNy9mcmFnOjQ4OGNkZjBhODVlYzRiMDliYWFiN2JhZTlhODA5YjcwL3RhYmxlOjBhMmUxZWYwOGVmNjQ4ZWI4Y2MxNTJjZTRmNmM3YjgxL3RhYmxlcmFuZ2U6MGEyZTFlZjA4ZWY2NDhlYjhjYzE1MmNlNGY2YzdiODFfMy01LTEtMS02MjY_41fa9109-42a5-4d83-9482-63fa29ce7a98">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i6f6e047d4cc946d5ab745668b1e79366_I20220630" decimals="-3" name="us-gaap:CashEquivalentsAtCarryingValue" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmFlNWE5YmUwZWI5NDQ1ZDE5MmZhZTgyMmQyMmJlMDlmL3NlYzphZTVhOWJlMGViOTQ0NWQxOTJmYWU4MjJkMjJiZTA5Zl8zNy9mcmFnOjQ4OGNkZjBhODVlYzRiMDliYWFiN2JhZTlhODA5YjcwL3RhYmxlOjBhMmUxZWYwOGVmNjQ4ZWI4Y2MxNTJjZTRmNmM3YjgxL3RhYmxlcmFuZ2U6MGEyZTFlZjA4ZWY2NDhlYjhjYzE1MmNlNGY2YzdiODFfMy03LTEtMS02MjY_5ea852fe-03c5-4c13-a41b-b6852b9b3a73">30,723</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Restricted cash</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if758224c2e474796966c7a56ed966de8_I20220630" decimals="-3" name="us-gaap:RestrictedCashNoncurrent" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmFlNWE5YmUwZWI5NDQ1ZDE5MmZhZTgyMmQyMmJlMDlmL3NlYzphZTVhOWJlMGViOTQ0NWQxOTJmYWU4MjJkMjJiZTA5Zl8zNy9mcmFnOjQ4OGNkZjBhODVlYzRiMDliYWFiN2JhZTlhODA5YjcwL3RhYmxlOjBhMmUxZWYwOGVmNjQ4ZWI4Y2MxNTJjZTRmNmM3YjgxL3RhYmxlcmFuZ2U6MGEyZTFlZjA4ZWY2NDhlYjhjYzE1MmNlNGY2YzdiODFfNC0xLTEtMS02MjY_c6a88e5f-cbe2-49e0-bbb6-fdb799dfe987">3,470</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if8fdbfd7ecbc4f1e83abd5532a4f2776_I20220630" decimals="-3" name="us-gaap:RestrictedCashNoncurrent" format="ixt:fixed-zero" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmFlNWE5YmUwZWI5NDQ1ZDE5MmZhZTgyMmQyMmJlMDlmL3NlYzphZTVhOWJlMGViOTQ0NWQxOTJmYWU4MjJkMjJiZTA5Zl8zNy9mcmFnOjQ4OGNkZjBhODVlYzRiMDliYWFiN2JhZTlhODA5YjcwL3RhYmxlOjBhMmUxZWYwOGVmNjQ4ZWI4Y2MxNTJjZTRmNmM3YjgxL3RhYmxlcmFuZ2U6MGEyZTFlZjA4ZWY2NDhlYjhjYzE1MmNlNGY2YzdiODFfNC0zLTEtMS02MjY_bb173420-6d18-4f01-af59-3a4cb1f66326">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="id460d49e6dc845ddb03e35bcd01b0a02_I20220630" decimals="-3" name="us-gaap:RestrictedCashNoncurrent" format="ixt:fixed-zero" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmFlNWE5YmUwZWI5NDQ1ZDE5MmZhZTgyMmQyMmJlMDlmL3NlYzphZTVhOWJlMGViOTQ0NWQxOTJmYWU4MjJkMjJiZTA5Zl8zNy9mcmFnOjQ4OGNkZjBhODVlYzRiMDliYWFiN2JhZTlhODA5YjcwL3RhYmxlOjBhMmUxZWYwOGVmNjQ4ZWI4Y2MxNTJjZTRmNmM3YjgxL3RhYmxlcmFuZ2U6MGEyZTFlZjA4ZWY2NDhlYjhjYzE1MmNlNGY2YzdiODFfNC01LTEtMS02MjY_9a112aaf-cce6-4d67-bdb6-677074ebea1d">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i6f6e047d4cc946d5ab745668b1e79366_I20220630" decimals="-3" name="us-gaap:RestrictedCashNoncurrent" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmFlNWE5YmUwZWI5NDQ1ZDE5MmZhZTgyMmQyMmJlMDlmL3NlYzphZTVhOWJlMGViOTQ0NWQxOTJmYWU4MjJkMjJiZTA5Zl8zNy9mcmFnOjQ4OGNkZjBhODVlYzRiMDliYWFiN2JhZTlhODA5YjcwL3RhYmxlOjBhMmUxZWYwOGVmNjQ4ZWI4Y2MxNTJjZTRmNmM3YjgxL3RhYmxlcmFuZ2U6MGEyZTFlZjA4ZWY2NDhlYjhjYzE1MmNlNGY2YzdiODFfNC03LTEtMS02MjY_8aed2cf7-ddfe-464b-aac0-5aebc3826f26">3,470</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Marketable securities, available for sale:</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Corporate debt securities</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i41653ba801c2441dbaca0c02a6789086_I20220630" decimals="-3" name="us-gaap:AvailableForSaleSecuritiesDebtSecurities" format="ixt:fixed-zero" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmFlNWE5YmUwZWI5NDQ1ZDE5MmZhZTgyMmQyMmJlMDlmL3NlYzphZTVhOWJlMGViOTQ0NWQxOTJmYWU4MjJkMjJiZTA5Zl8zNy9mcmFnOjQ4OGNkZjBhODVlYzRiMDliYWFiN2JhZTlhODA5YjcwL3RhYmxlOjBhMmUxZWYwOGVmNjQ4ZWI4Y2MxNTJjZTRmNmM3YjgxL3RhYmxlcmFuZ2U6MGEyZTFlZjA4ZWY2NDhlYjhjYzE1MmNlNGY2YzdiODFfNi0xLTEtMS02MjY_98a72e14-2729-4395-abdb-dcf379e455a1">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iea92d61cbcce431fa5e4090b90791f94_I20220630" decimals="-3" name="us-gaap:AvailableForSaleSecuritiesDebtSecurities" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmFlNWE5YmUwZWI5NDQ1ZDE5MmZhZTgyMmQyMmJlMDlmL3NlYzphZTVhOWJlMGViOTQ0NWQxOTJmYWU4MjJkMjJiZTA5Zl8zNy9mcmFnOjQ4OGNkZjBhODVlYzRiMDliYWFiN2JhZTlhODA5YjcwL3RhYmxlOjBhMmUxZWYwOGVmNjQ4ZWI4Y2MxNTJjZTRmNmM3YjgxL3RhYmxlcmFuZ2U6MGEyZTFlZjA4ZWY2NDhlYjhjYzE1MmNlNGY2YzdiODFfNi0zLTEtMS02MjY_b72306ed-53e2-4559-bf62-e7c4e6045012">15,092</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i5b506509888b48d6a34efce6ba8f7e6e_I20220630" decimals="-3" name="us-gaap:AvailableForSaleSecuritiesDebtSecurities" format="ixt:fixed-zero" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmFlNWE5YmUwZWI5NDQ1ZDE5MmZhZTgyMmQyMmJlMDlmL3NlYzphZTVhOWJlMGViOTQ0NWQxOTJmYWU4MjJkMjJiZTA5Zl8zNy9mcmFnOjQ4OGNkZjBhODVlYzRiMDliYWFiN2JhZTlhODA5YjcwL3RhYmxlOjBhMmUxZWYwOGVmNjQ4ZWI4Y2MxNTJjZTRmNmM3YjgxL3RhYmxlcmFuZ2U6MGEyZTFlZjA4ZWY2NDhlYjhjYzE1MmNlNGY2YzdiODFfNi01LTEtMS02MjY_67deb25a-52e1-4e8b-a56f-419eeeec1986">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ie45f0b654eec485abbe4c0f2ba779d49_I20220630" decimals="-3" name="us-gaap:AvailableForSaleSecuritiesDebtSecurities" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmFlNWE5YmUwZWI5NDQ1ZDE5MmZhZTgyMmQyMmJlMDlmL3NlYzphZTVhOWJlMGViOTQ0NWQxOTJmYWU4MjJkMjJiZTA5Zl8zNy9mcmFnOjQ4OGNkZjBhODVlYzRiMDliYWFiN2JhZTlhODA5YjcwL3RhYmxlOjBhMmUxZWYwOGVmNjQ4ZWI4Y2MxNTJjZTRmNmM3YjgxL3RhYmxlcmFuZ2U6MGEyZTFlZjA4ZWY2NDhlYjhjYzE1MmNlNGY2YzdiODFfNi03LTEtMS02MjY_764b4e97-26de-4e78-a5df-60882d8a050a">15,092</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Municipal debt securities</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i37da1f18c957414ba4dec5d09fe5fce0_I20220630" decimals="-3" name="us-gaap:AvailableForSaleSecuritiesDebtSecurities" format="ixt:fixed-zero" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmFlNWE5YmUwZWI5NDQ1ZDE5MmZhZTgyMmQyMmJlMDlmL3NlYzphZTVhOWJlMGViOTQ0NWQxOTJmYWU4MjJkMjJiZTA5Zl8zNy9mcmFnOjQ4OGNkZjBhODVlYzRiMDliYWFiN2JhZTlhODA5YjcwL3RhYmxlOjBhMmUxZWYwOGVmNjQ4ZWI4Y2MxNTJjZTRmNmM3YjgxL3RhYmxlcmFuZ2U6MGEyZTFlZjA4ZWY2NDhlYjhjYzE1MmNlNGY2YzdiODFfNy0xLTEtMS02MjY_7551aea1-6051-4464-8a50-0998287b9fe8">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i04cf5fc9b6ef4515a8ce5817a046a654_I20220630" decimals="-3" name="us-gaap:AvailableForSaleSecuritiesDebtSecurities" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmFlNWE5YmUwZWI5NDQ1ZDE5MmZhZTgyMmQyMmJlMDlmL3NlYzphZTVhOWJlMGViOTQ0NWQxOTJmYWU4MjJkMjJiZTA5Zl8zNy9mcmFnOjQ4OGNkZjBhODVlYzRiMDliYWFiN2JhZTlhODA5YjcwL3RhYmxlOjBhMmUxZWYwOGVmNjQ4ZWI4Y2MxNTJjZTRmNmM3YjgxL3RhYmxlcmFuZ2U6MGEyZTFlZjA4ZWY2NDhlYjhjYzE1MmNlNGY2YzdiODFfNy0zLTEtMS02MjY_079a3672-d10d-44c2-b4f7-95db68b79399">3,641</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ibc090232bd5e457e8df72d86df61cf31_I20220630" decimals="-3" name="us-gaap:AvailableForSaleSecuritiesDebtSecurities" format="ixt:fixed-zero" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmFlNWE5YmUwZWI5NDQ1ZDE5MmZhZTgyMmQyMmJlMDlmL3NlYzphZTVhOWJlMGViOTQ0NWQxOTJmYWU4MjJkMjJiZTA5Zl8zNy9mcmFnOjQ4OGNkZjBhODVlYzRiMDliYWFiN2JhZTlhODA5YjcwL3RhYmxlOjBhMmUxZWYwOGVmNjQ4ZWI4Y2MxNTJjZTRmNmM3YjgxL3RhYmxlcmFuZ2U6MGEyZTFlZjA4ZWY2NDhlYjhjYzE1MmNlNGY2YzdiODFfNy01LTEtMS02MjY_febe6f08-f64f-4d53-b46d-0553067c508e">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="id3e9e3b412de4937a9a4ce62ef9086bd_I20220630" decimals="-3" name="us-gaap:AvailableForSaleSecuritiesDebtSecurities" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmFlNWE5YmUwZWI5NDQ1ZDE5MmZhZTgyMmQyMmJlMDlmL3NlYzphZTVhOWJlMGViOTQ0NWQxOTJmYWU4MjJkMjJiZTA5Zl8zNy9mcmFnOjQ4OGNkZjBhODVlYzRiMDliYWFiN2JhZTlhODA5YjcwL3RhYmxlOjBhMmUxZWYwOGVmNjQ4ZWI4Y2MxNTJjZTRmNmM3YjgxL3RhYmxlcmFuZ2U6MGEyZTFlZjA4ZWY2NDhlYjhjYzE1MmNlNGY2YzdiODFfNy03LTEtMS02MjY_37373927-4260-49fa-b648-61f76ca89698">3,641</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">U.S. government debt securities</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i7a19194e0b6946c5a1307bef5ce3e7ea_I20220630" decimals="-3" name="us-gaap:AvailableForSaleSecuritiesDebtSecurities" format="ixt:fixed-zero" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmFlNWE5YmUwZWI5NDQ1ZDE5MmZhZTgyMmQyMmJlMDlmL3NlYzphZTVhOWJlMGViOTQ0NWQxOTJmYWU4MjJkMjJiZTA5Zl8zNy9mcmFnOjQ4OGNkZjBhODVlYzRiMDliYWFiN2JhZTlhODA5YjcwL3RhYmxlOjBhMmUxZWYwOGVmNjQ4ZWI4Y2MxNTJjZTRmNmM3YjgxL3RhYmxlcmFuZ2U6MGEyZTFlZjA4ZWY2NDhlYjhjYzE1MmNlNGY2YzdiODFfOC0xLTEtMS02MjY_2613e3f1-0c55-4af8-9d8b-2b9dc921f7eb">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i48acc600f436461fa46eb2fc48d5b8a3_I20220630" decimals="-3" name="us-gaap:AvailableForSaleSecuritiesDebtSecurities" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmFlNWE5YmUwZWI5NDQ1ZDE5MmZhZTgyMmQyMmJlMDlmL3NlYzphZTVhOWJlMGViOTQ0NWQxOTJmYWU4MjJkMjJiZTA5Zl8zNy9mcmFnOjQ4OGNkZjBhODVlYzRiMDliYWFiN2JhZTlhODA5YjcwL3RhYmxlOjBhMmUxZWYwOGVmNjQ4ZWI4Y2MxNTJjZTRmNmM3YjgxL3RhYmxlcmFuZ2U6MGEyZTFlZjA4ZWY2NDhlYjhjYzE1MmNlNGY2YzdiODFfOC0zLTEtMS02MjY_da9bef21-bd27-43c2-a295-d59106bd76bd">34,724</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic46c00dd86944457b5ff2e30e0e14027_I20220630" decimals="-3" name="us-gaap:AvailableForSaleSecuritiesDebtSecurities" format="ixt:fixed-zero" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmFlNWE5YmUwZWI5NDQ1ZDE5MmZhZTgyMmQyMmJlMDlmL3NlYzphZTVhOWJlMGViOTQ0NWQxOTJmYWU4MjJkMjJiZTA5Zl8zNy9mcmFnOjQ4OGNkZjBhODVlYzRiMDliYWFiN2JhZTlhODA5YjcwL3RhYmxlOjBhMmUxZWYwOGVmNjQ4ZWI4Y2MxNTJjZTRmNmM3YjgxL3RhYmxlcmFuZ2U6MGEyZTFlZjA4ZWY2NDhlYjhjYzE1MmNlNGY2YzdiODFfOC01LTEtMS02MjY_74c94020-0c63-482a-8e4a-7d3841ed52a8">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i7d779ec4227844e9a0d3371962d37354_I20220630" decimals="-3" name="us-gaap:AvailableForSaleSecuritiesDebtSecurities" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmFlNWE5YmUwZWI5NDQ1ZDE5MmZhZTgyMmQyMmJlMDlmL3NlYzphZTVhOWJlMGViOTQ0NWQxOTJmYWU4MjJkMjJiZTA5Zl8zNy9mcmFnOjQ4OGNkZjBhODVlYzRiMDliYWFiN2JhZTlhODA5YjcwL3RhYmxlOjBhMmUxZWYwOGVmNjQ4ZWI4Y2MxNTJjZTRmNmM3YjgxL3RhYmxlcmFuZ2U6MGEyZTFlZjA4ZWY2NDhlYjhjYzE1MmNlNGY2YzdiODFfOC03LTEtMS02MjY_27b64eda-0adf-4c47-a059-ed62999a076c">34,724</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total marketable securities, available for sale</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if758224c2e474796966c7a56ed966de8_I20220630" decimals="-3" name="us-gaap:AvailableForSaleSecuritiesDebtSecurities" format="ixt:fixed-zero" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmFlNWE5YmUwZWI5NDQ1ZDE5MmZhZTgyMmQyMmJlMDlmL3NlYzphZTVhOWJlMGViOTQ0NWQxOTJmYWU4MjJkMjJiZTA5Zl8zNy9mcmFnOjQ4OGNkZjBhODVlYzRiMDliYWFiN2JhZTlhODA5YjcwL3RhYmxlOjBhMmUxZWYwOGVmNjQ4ZWI4Y2MxNTJjZTRmNmM3YjgxL3RhYmxlcmFuZ2U6MGEyZTFlZjA4ZWY2NDhlYjhjYzE1MmNlNGY2YzdiODFfOS0xLTEtMS02MjY_6af52d6d-de0c-45e5-b5f6-de6967e5cfea">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if8fdbfd7ecbc4f1e83abd5532a4f2776_I20220630" decimals="-3" name="us-gaap:AvailableForSaleSecuritiesDebtSecurities" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmFlNWE5YmUwZWI5NDQ1ZDE5MmZhZTgyMmQyMmJlMDlmL3NlYzphZTVhOWJlMGViOTQ0NWQxOTJmYWU4MjJkMjJiZTA5Zl8zNy9mcmFnOjQ4OGNkZjBhODVlYzRiMDliYWFiN2JhZTlhODA5YjcwL3RhYmxlOjBhMmUxZWYwOGVmNjQ4ZWI4Y2MxNTJjZTRmNmM3YjgxL3RhYmxlcmFuZ2U6MGEyZTFlZjA4ZWY2NDhlYjhjYzE1MmNlNGY2YzdiODFfOS0zLTEtMS02MjY_f6490113-b901-462e-9c4b-a6b5fefd17d1">53,457</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="id460d49e6dc845ddb03e35bcd01b0a02_I20220630" decimals="-3" name="us-gaap:AvailableForSaleSecuritiesDebtSecurities" format="ixt:fixed-zero" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmFlNWE5YmUwZWI5NDQ1ZDE5MmZhZTgyMmQyMmJlMDlmL3NlYzphZTVhOWJlMGViOTQ0NWQxOTJmYWU4MjJkMjJiZTA5Zl8zNy9mcmFnOjQ4OGNkZjBhODVlYzRiMDliYWFiN2JhZTlhODA5YjcwL3RhYmxlOjBhMmUxZWYwOGVmNjQ4ZWI4Y2MxNTJjZTRmNmM3YjgxL3RhYmxlcmFuZ2U6MGEyZTFlZjA4ZWY2NDhlYjhjYzE1MmNlNGY2YzdiODFfOS01LTEtMS02MjY_1bad5ab3-bc9f-4945-a74c-c0781018825c">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i6f6e047d4cc946d5ab745668b1e79366_I20220630" decimals="-3" name="us-gaap:AvailableForSaleSecuritiesDebtSecurities" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmFlNWE5YmUwZWI5NDQ1ZDE5MmZhZTgyMmQyMmJlMDlmL3NlYzphZTVhOWJlMGViOTQ0NWQxOTJmYWU4MjJkMjJiZTA5Zl8zNy9mcmFnOjQ4OGNkZjBhODVlYzRiMDliYWFiN2JhZTlhODA5YjcwL3RhYmxlOjBhMmUxZWYwOGVmNjQ4ZWI4Y2MxNTJjZTRmNmM3YjgxL3RhYmxlcmFuZ2U6MGEyZTFlZjA4ZWY2NDhlYjhjYzE1MmNlNGY2YzdiODFfOS03LTEtMS02MjY_21b6978c-3773-41de-a200-5460c827b6c2">53,457</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Total assets measured at fair value on a recurring basis</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if758224c2e474796966c7a56ed966de8_I20220630" decimals="-3" name="us-gaap:AssetsFairValueDisclosure" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmFlNWE5YmUwZWI5NDQ1ZDE5MmZhZTgyMmQyMmJlMDlmL3NlYzphZTVhOWJlMGViOTQ0NWQxOTJmYWU4MjJkMjJiZTA5Zl8zNy9mcmFnOjQ4OGNkZjBhODVlYzRiMDliYWFiN2JhZTlhODA5YjcwL3RhYmxlOjBhMmUxZWYwOGVmNjQ4ZWI4Y2MxNTJjZTRmNmM3YjgxL3RhYmxlcmFuZ2U6MGEyZTFlZjA4ZWY2NDhlYjhjYzE1MmNlNGY2YzdiODFfMTAtMS0xLTEtNjI2_8fd5d4a4-08eb-40c9-b34b-1bd8c25a4dbd">34,193</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if8fdbfd7ecbc4f1e83abd5532a4f2776_I20220630" decimals="-3" name="us-gaap:AssetsFairValueDisclosure" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmFlNWE5YmUwZWI5NDQ1ZDE5MmZhZTgyMmQyMmJlMDlmL3NlYzphZTVhOWJlMGViOTQ0NWQxOTJmYWU4MjJkMjJiZTA5Zl8zNy9mcmFnOjQ4OGNkZjBhODVlYzRiMDliYWFiN2JhZTlhODA5YjcwL3RhYmxlOjBhMmUxZWYwOGVmNjQ4ZWI4Y2MxNTJjZTRmNmM3YjgxL3RhYmxlcmFuZ2U6MGEyZTFlZjA4ZWY2NDhlYjhjYzE1MmNlNGY2YzdiODFfMTAtMy0xLTEtNjI2_c1975ed6-3764-45d4-b0ea-bd5b850c447a">53,457</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="id460d49e6dc845ddb03e35bcd01b0a02_I20220630" decimals="-3" name="us-gaap:AssetsFairValueDisclosure" format="ixt:fixed-zero" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmFlNWE5YmUwZWI5NDQ1ZDE5MmZhZTgyMmQyMmJlMDlmL3NlYzphZTVhOWJlMGViOTQ0NWQxOTJmYWU4MjJkMjJiZTA5Zl8zNy9mcmFnOjQ4OGNkZjBhODVlYzRiMDliYWFiN2JhZTlhODA5YjcwL3RhYmxlOjBhMmUxZWYwOGVmNjQ4ZWI4Y2MxNTJjZTRmNmM3YjgxL3RhYmxlcmFuZ2U6MGEyZTFlZjA4ZWY2NDhlYjhjYzE1MmNlNGY2YzdiODFfMTAtNS0xLTEtNjI2_bfdf0787-985b-430e-846d-690d77a2bde7">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i6f6e047d4cc946d5ab745668b1e79366_I20220630" decimals="-3" name="us-gaap:AssetsFairValueDisclosure" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmFlNWE5YmUwZWI5NDQ1ZDE5MmZhZTgyMmQyMmJlMDlmL3NlYzphZTVhOWJlMGViOTQ0NWQxOTJmYWU4MjJkMjJiZTA5Zl8zNy9mcmFnOjQ4OGNkZjBhODVlYzRiMDliYWFiN2JhZTlhODA5YjcwL3RhYmxlOjBhMmUxZWYwOGVmNjQ4ZWI4Y2MxNTJjZTRmNmM3YjgxL3RhYmxlcmFuZ2U6MGEyZTFlZjA4ZWY2NDhlYjhjYzE1MmNlNGY2YzdiODFfMTAtNy0xLTEtNjI2_98e7e032-2de7-4209-a70f-66a512d17f52">87,650</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr style="height:15pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Liabilities:</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Warrant liability</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if758224c2e474796966c7a56ed966de8_I20220630" decimals="-3" name="dmtk:WarrantLiabilityFairValueDisclosure" format="ixt:fixed-zero" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmFlNWE5YmUwZWI5NDQ1ZDE5MmZhZTgyMmQyMmJlMDlmL3NlYzphZTVhOWJlMGViOTQ0NWQxOTJmYWU4MjJkMjJiZTA5Zl8zNy9mcmFnOjQ4OGNkZjBhODVlYzRiMDliYWFiN2JhZTlhODA5YjcwL3RhYmxlOjBhMmUxZWYwOGVmNjQ4ZWI4Y2MxNTJjZTRmNmM3YjgxL3RhYmxlcmFuZ2U6MGEyZTFlZjA4ZWY2NDhlYjhjYzE1MmNlNGY2YzdiODFfMTMtMS0xLTEtNjI2_c1526d36-5315-481b-a091-204837ec8932">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if8fdbfd7ecbc4f1e83abd5532a4f2776_I20220630" decimals="-3" name="dmtk:WarrantLiabilityFairValueDisclosure" format="ixt:fixed-zero" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmFlNWE5YmUwZWI5NDQ1ZDE5MmZhZTgyMmQyMmJlMDlmL3NlYzphZTVhOWJlMGViOTQ0NWQxOTJmYWU4MjJkMjJiZTA5Zl8zNy9mcmFnOjQ4OGNkZjBhODVlYzRiMDliYWFiN2JhZTlhODA5YjcwL3RhYmxlOjBhMmUxZWYwOGVmNjQ4ZWI4Y2MxNTJjZTRmNmM3YjgxL3RhYmxlcmFuZ2U6MGEyZTFlZjA4ZWY2NDhlYjhjYzE1MmNlNGY2YzdiODFfMTMtMy0xLTEtNjI2_4114f13b-af69-4876-b1c5-8d9962ed8cf8">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="id460d49e6dc845ddb03e35bcd01b0a02_I20220630" decimals="-3" name="dmtk:WarrantLiabilityFairValueDisclosure" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmFlNWE5YmUwZWI5NDQ1ZDE5MmZhZTgyMmQyMmJlMDlmL3NlYzphZTVhOWJlMGViOTQ0NWQxOTJmYWU4MjJkMjJiZTA5Zl8zNy9mcmFnOjQ4OGNkZjBhODVlYzRiMDliYWFiN2JhZTlhODA5YjcwL3RhYmxlOjBhMmUxZWYwOGVmNjQ4ZWI4Y2MxNTJjZTRmNmM3YjgxL3RhYmxlcmFuZ2U6MGEyZTFlZjA4ZWY2NDhlYjhjYzE1MmNlNGY2YzdiODFfMTMtNS0xLTEtNjI2_1fb83491-cc78-4b9f-be71-5370a20e9ce1">24</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i6f6e047d4cc946d5ab745668b1e79366_I20220630" decimals="-3" name="dmtk:WarrantLiabilityFairValueDisclosure" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmFlNWE5YmUwZWI5NDQ1ZDE5MmZhZTgyMmQyMmJlMDlmL3NlYzphZTVhOWJlMGViOTQ0NWQxOTJmYWU4MjJkMjJiZTA5Zl8zNy9mcmFnOjQ4OGNkZjBhODVlYzRiMDliYWFiN2JhZTlhODA5YjcwL3RhYmxlOjBhMmUxZWYwOGVmNjQ4ZWI4Y2MxNTJjZTRmNmM3YjgxL3RhYmxlcmFuZ2U6MGEyZTFlZjA4ZWY2NDhlYjhjYzE1MmNlNGY2YzdiODFfMTMtNy0xLTEtNjI2_06d5db3b-f058-417e-a5eb-9f9ea4e70861">24</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Total liabilities measured at fair value on a recurring basis</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if758224c2e474796966c7a56ed966de8_I20220630" decimals="-3" name="us-gaap:LiabilitiesFairValueDisclosure" format="ixt:fixed-zero" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmFlNWE5YmUwZWI5NDQ1ZDE5MmZhZTgyMmQyMmJlMDlmL3NlYzphZTVhOWJlMGViOTQ0NWQxOTJmYWU4MjJkMjJiZTA5Zl8zNy9mcmFnOjQ4OGNkZjBhODVlYzRiMDliYWFiN2JhZTlhODA5YjcwL3RhYmxlOjBhMmUxZWYwOGVmNjQ4ZWI4Y2MxNTJjZTRmNmM3YjgxL3RhYmxlcmFuZ2U6MGEyZTFlZjA4ZWY2NDhlYjhjYzE1MmNlNGY2YzdiODFfMTQtMS0xLTEtNjI2_a88068ec-bcd1-4fb2-b121-a43b34c04e7c">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if8fdbfd7ecbc4f1e83abd5532a4f2776_I20220630" decimals="-3" name="us-gaap:LiabilitiesFairValueDisclosure" format="ixt:fixed-zero" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmFlNWE5YmUwZWI5NDQ1ZDE5MmZhZTgyMmQyMmJlMDlmL3NlYzphZTVhOWJlMGViOTQ0NWQxOTJmYWU4MjJkMjJiZTA5Zl8zNy9mcmFnOjQ4OGNkZjBhODVlYzRiMDliYWFiN2JhZTlhODA5YjcwL3RhYmxlOjBhMmUxZWYwOGVmNjQ4ZWI4Y2MxNTJjZTRmNmM3YjgxL3RhYmxlcmFuZ2U6MGEyZTFlZjA4ZWY2NDhlYjhjYzE1MmNlNGY2YzdiODFfMTQtMy0xLTEtNjI2_b7b8c40a-08b7-4086-ad97-ebf320fa237e">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="id460d49e6dc845ddb03e35bcd01b0a02_I20220630" decimals="-3" name="us-gaap:LiabilitiesFairValueDisclosure" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmFlNWE5YmUwZWI5NDQ1ZDE5MmZhZTgyMmQyMmJlMDlmL3NlYzphZTVhOWJlMGViOTQ0NWQxOTJmYWU4MjJkMjJiZTA5Zl8zNy9mcmFnOjQ4OGNkZjBhODVlYzRiMDliYWFiN2JhZTlhODA5YjcwL3RhYmxlOjBhMmUxZWYwOGVmNjQ4ZWI4Y2MxNTJjZTRmNmM3YjgxL3RhYmxlcmFuZ2U6MGEyZTFlZjA4ZWY2NDhlYjhjYzE1MmNlNGY2YzdiODFfMTQtNS0xLTEtNjI2_1707f1b4-5536-4178-bb3a-67d30dff0e50">24</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i6f6e047d4cc946d5ab745668b1e79366_I20220630" decimals="-3" name="us-gaap:LiabilitiesFairValueDisclosure" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmFlNWE5YmUwZWI5NDQ1ZDE5MmZhZTgyMmQyMmJlMDlmL3NlYzphZTVhOWJlMGViOTQ0NWQxOTJmYWU4MjJkMjJiZTA5Zl8zNy9mcmFnOjQ4OGNkZjBhODVlYzRiMDliYWFiN2JhZTlhODA5YjcwL3RhYmxlOjBhMmUxZWYwOGVmNjQ4ZWI4Y2MxNTJjZTRmNmM3YjgxL3RhYmxlcmFuZ2U6MGEyZTFlZjA4ZWY2NDhlYjhjYzE1MmNlNGY2YzdiODFfMTQtNy0xLTEtNjI2_2a87d2b5-6be1-4d9b-8b8f-94e7080fa937">24</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><div style="margin-top:9pt;padding-left:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table provides a summary of the assets and liabilities that are measured at fair value on a recurring basis as of December&#160;31, 2021 (in thousands): </span></div><div style="margin-top:12pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:44.354%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.081%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.406%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.081%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.406%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.081%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.406%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.085%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="21" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">December 31, 2021</span></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Level 1</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Level 2</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Level 3</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Total</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Assets:</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cash equivalents</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="id0495dc386634c17abe35f6f0b1c1cde_I20211231" decimals="-3" name="us-gaap:CashEquivalentsAtCarryingValue" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmFlNWE5YmUwZWI5NDQ1ZDE5MmZhZTgyMmQyMmJlMDlmL3NlYzphZTVhOWJlMGViOTQ0NWQxOTJmYWU4MjJkMjJiZTA5Zl8zNy9mcmFnOjQ4OGNkZjBhODVlYzRiMDliYWFiN2JhZTlhODA5YjcwL3RhYmxlOmJlMGVkYmJlNTg1NDQyNWQ5YTZhODA0OWNiYzMxOGIyL3RhYmxlcmFuZ2U6YmUwZWRiYmU1ODU0NDI1ZDlhNmE4MDQ5Y2JjMzE4YjJfMy0xLTEtMS02MjY_edded454-8571-40c5-a006-cb69aa574d8d">16,380</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i22164451262946e4b9911f313b7610c1_I20211231" decimals="-3" name="us-gaap:CashEquivalentsAtCarryingValue" format="ixt:fixed-zero" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmFlNWE5YmUwZWI5NDQ1ZDE5MmZhZTgyMmQyMmJlMDlmL3NlYzphZTVhOWJlMGViOTQ0NWQxOTJmYWU4MjJkMjJiZTA5Zl8zNy9mcmFnOjQ4OGNkZjBhODVlYzRiMDliYWFiN2JhZTlhODA5YjcwL3RhYmxlOmJlMGVkYmJlNTg1NDQyNWQ5YTZhODA0OWNiYzMxOGIyL3RhYmxlcmFuZ2U6YmUwZWRiYmU1ODU0NDI1ZDlhNmE4MDQ5Y2JjMzE4YjJfMy0zLTEtMS02MjY_ff871978-e33b-40cf-88f6-a1d4635927ef">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ica20d3fdf2ff41fdb31ad57ccb72924b_I20211231" decimals="-3" name="us-gaap:CashEquivalentsAtCarryingValue" format="ixt:fixed-zero" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmFlNWE5YmUwZWI5NDQ1ZDE5MmZhZTgyMmQyMmJlMDlmL3NlYzphZTVhOWJlMGViOTQ0NWQxOTJmYWU4MjJkMjJiZTA5Zl8zNy9mcmFnOjQ4OGNkZjBhODVlYzRiMDliYWFiN2JhZTlhODA5YjcwL3RhYmxlOmJlMGVkYmJlNTg1NDQyNWQ5YTZhODA0OWNiYzMxOGIyL3RhYmxlcmFuZ2U6YmUwZWRiYmU1ODU0NDI1ZDlhNmE4MDQ5Y2JjMzE4YjJfMy01LTEtMS02MjY_325fdf6c-8093-41d7-b902-fb8465225eb6">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ie7dec283b83b43f99e003b79ec165d54_I20211231" decimals="-3" name="us-gaap:CashEquivalentsAtCarryingValue" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmFlNWE5YmUwZWI5NDQ1ZDE5MmZhZTgyMmQyMmJlMDlmL3NlYzphZTVhOWJlMGViOTQ0NWQxOTJmYWU4MjJkMjJiZTA5Zl8zNy9mcmFnOjQ4OGNkZjBhODVlYzRiMDliYWFiN2JhZTlhODA5YjcwL3RhYmxlOmJlMGVkYmJlNTg1NDQyNWQ5YTZhODA0OWNiYzMxOGIyL3RhYmxlcmFuZ2U6YmUwZWRiYmU1ODU0NDI1ZDlhNmE4MDQ5Y2JjMzE4YjJfMy03LTEtMS02MjY_c60a9f51-d45d-4ad3-af1e-9da44cbf21b9">16,380</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Restricted cash</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="id0495dc386634c17abe35f6f0b1c1cde_I20211231" decimals="-3" name="us-gaap:RestrictedCashNoncurrent" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmFlNWE5YmUwZWI5NDQ1ZDE5MmZhZTgyMmQyMmJlMDlmL3NlYzphZTVhOWJlMGViOTQ0NWQxOTJmYWU4MjJkMjJiZTA5Zl8zNy9mcmFnOjQ4OGNkZjBhODVlYzRiMDliYWFiN2JhZTlhODA5YjcwL3RhYmxlOmJlMGVkYmJlNTg1NDQyNWQ5YTZhODA0OWNiYzMxOGIyL3RhYmxlcmFuZ2U6YmUwZWRiYmU1ODU0NDI1ZDlhNmE4MDQ5Y2JjMzE4YjJfNC0xLTEtMS0yMzAz_5c78599d-9aaa-4109-ada2-52704c53b02b">3,025</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"><ix:nonFraction unitRef="usd" contextRef="i22164451262946e4b9911f313b7610c1_I20211231" xsi:nil="true" name="us-gaap:RestrictedCashNoncurrent" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmFlNWE5YmUwZWI5NDQ1ZDE5MmZhZTgyMmQyMmJlMDlmL3NlYzphZTVhOWJlMGViOTQ0NWQxOTJmYWU4MjJkMjJiZTA5Zl8zNy9mcmFnOjQ4OGNkZjBhODVlYzRiMDliYWFiN2JhZTlhODA5YjcwL3RhYmxlOmJlMGVkYmJlNTg1NDQyNWQ5YTZhODA0OWNiYzMxOGIyL3RhYmxlcmFuZ2U6YmUwZWRiYmU1ODU0NDI1ZDlhNmE4MDQ5Y2JjMzE4YjJfNC0zLTEtMS03NTYx_a2a82b6f-de84-45a5-a6a9-be825ae2502c"></ix:nonFraction></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"><ix:nonFraction unitRef="usd" contextRef="ica20d3fdf2ff41fdb31ad57ccb72924b_I20211231" xsi:nil="true" name="us-gaap:RestrictedCashNoncurrent" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmFlNWE5YmUwZWI5NDQ1ZDE5MmZhZTgyMmQyMmJlMDlmL3NlYzphZTVhOWJlMGViOTQ0NWQxOTJmYWU4MjJkMjJiZTA5Zl8zNy9mcmFnOjQ4OGNkZjBhODVlYzRiMDliYWFiN2JhZTlhODA5YjcwL3RhYmxlOmJlMGVkYmJlNTg1NDQyNWQ5YTZhODA0OWNiYzMxOGIyL3RhYmxlcmFuZ2U6YmUwZWRiYmU1ODU0NDI1ZDlhNmE4MDQ5Y2JjMzE4YjJfNC01LTEtMS03NTYx_a3f4d73c-3825-4266-be6a-1f65306be035"></ix:nonFraction></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ie7dec283b83b43f99e003b79ec165d54_I20211231" decimals="-3" name="us-gaap:RestrictedCashNoncurrent" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmFlNWE5YmUwZWI5NDQ1ZDE5MmZhZTgyMmQyMmJlMDlmL3NlYzphZTVhOWJlMGViOTQ0NWQxOTJmYWU4MjJkMjJiZTA5Zl8zNy9mcmFnOjQ4OGNkZjBhODVlYzRiMDliYWFiN2JhZTlhODA5YjcwL3RhYmxlOmJlMGVkYmJlNTg1NDQyNWQ5YTZhODA0OWNiYzMxOGIyL3RhYmxlcmFuZ2U6YmUwZWRiYmU1ODU0NDI1ZDlhNmE4MDQ5Y2JjMzE4YjJfNC03LTEtMS0yMzAz_5e294ab7-af3d-4a88-8bbf-3bfbc98004a9">3,025</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Marketable securities, available for sale:</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Corporate debt</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ia276a40ecef74c489871bb3ea4f6856b_I20211231" decimals="-3" name="us-gaap:AvailableForSaleSecuritiesDebtSecurities" format="ixt:fixed-zero" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmFlNWE5YmUwZWI5NDQ1ZDE5MmZhZTgyMmQyMmJlMDlmL3NlYzphZTVhOWJlMGViOTQ0NWQxOTJmYWU4MjJkMjJiZTA5Zl8zNy9mcmFnOjQ4OGNkZjBhODVlYzRiMDliYWFiN2JhZTlhODA5YjcwL3RhYmxlOmJlMGVkYmJlNTg1NDQyNWQ5YTZhODA0OWNiYzMxOGIyL3RhYmxlcmFuZ2U6YmUwZWRiYmU1ODU0NDI1ZDlhNmE4MDQ5Y2JjMzE4YjJfNi0xLTEtMS02MjY_0442ff7d-36a3-4f09-933c-ed41e7c89371">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="icf26e4a3bbe94872997aa67085685e63_I20211231" decimals="-3" name="us-gaap:AvailableForSaleSecuritiesDebtSecurities" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmFlNWE5YmUwZWI5NDQ1ZDE5MmZhZTgyMmQyMmJlMDlmL3NlYzphZTVhOWJlMGViOTQ0NWQxOTJmYWU4MjJkMjJiZTA5Zl8zNy9mcmFnOjQ4OGNkZjBhODVlYzRiMDliYWFiN2JhZTlhODA5YjcwL3RhYmxlOmJlMGVkYmJlNTg1NDQyNWQ5YTZhODA0OWNiYzMxOGIyL3RhYmxlcmFuZ2U6YmUwZWRiYmU1ODU0NDI1ZDlhNmE4MDQ5Y2JjMzE4YjJfNi0zLTEtMS02MjY_b4c4b3bb-d8d4-4e16-bab3-c6004495046b">15,352</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i03ca2eb28be548fea6832470239a3e99_I20211231" decimals="-3" name="us-gaap:AvailableForSaleSecuritiesDebtSecurities" format="ixt:fixed-zero" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmFlNWE5YmUwZWI5NDQ1ZDE5MmZhZTgyMmQyMmJlMDlmL3NlYzphZTVhOWJlMGViOTQ0NWQxOTJmYWU4MjJkMjJiZTA5Zl8zNy9mcmFnOjQ4OGNkZjBhODVlYzRiMDliYWFiN2JhZTlhODA5YjcwL3RhYmxlOmJlMGVkYmJlNTg1NDQyNWQ5YTZhODA0OWNiYzMxOGIyL3RhYmxlcmFuZ2U6YmUwZWRiYmU1ODU0NDI1ZDlhNmE4MDQ5Y2JjMzE4YjJfNi01LTEtMS02MjY_cb7c1b7b-1036-476c-9f8e-309533f511f1">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ieff44cf249a64087acf6cb16f4815cb7_I20211231" decimals="-3" name="us-gaap:AvailableForSaleSecuritiesDebtSecurities" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmFlNWE5YmUwZWI5NDQ1ZDE5MmZhZTgyMmQyMmJlMDlmL3NlYzphZTVhOWJlMGViOTQ0NWQxOTJmYWU4MjJkMjJiZTA5Zl8zNy9mcmFnOjQ4OGNkZjBhODVlYzRiMDliYWFiN2JhZTlhODA5YjcwL3RhYmxlOmJlMGVkYmJlNTg1NDQyNWQ5YTZhODA0OWNiYzMxOGIyL3RhYmxlcmFuZ2U6YmUwZWRiYmU1ODU0NDI1ZDlhNmE4MDQ5Y2JjMzE4YjJfNi03LTEtMS02MjY_02adb784-3bc7-4a5f-b2b7-05f3f6ba6ed1">15,352</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Municipal debt securities</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i849cb6bacde4475a95c34f5707ff57c7_I20211231" decimals="-3" name="us-gaap:AvailableForSaleSecuritiesDebtSecurities" format="ixt:fixed-zero" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmFlNWE5YmUwZWI5NDQ1ZDE5MmZhZTgyMmQyMmJlMDlmL3NlYzphZTVhOWJlMGViOTQ0NWQxOTJmYWU4MjJkMjJiZTA5Zl8zNy9mcmFnOjQ4OGNkZjBhODVlYzRiMDliYWFiN2JhZTlhODA5YjcwL3RhYmxlOmJlMGVkYmJlNTg1NDQyNWQ5YTZhODA0OWNiYzMxOGIyL3RhYmxlcmFuZ2U6YmUwZWRiYmU1ODU0NDI1ZDlhNmE4MDQ5Y2JjMzE4YjJfNy0xLTEtMS02MjY_57cd7e13-04ed-4a27-a165-bb7b5480bbf4">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iad8908ee30bb4929b29d53cdc31fbd4f_I20211231" decimals="-3" name="us-gaap:AvailableForSaleSecuritiesDebtSecurities" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmFlNWE5YmUwZWI5NDQ1ZDE5MmZhZTgyMmQyMmJlMDlmL3NlYzphZTVhOWJlMGViOTQ0NWQxOTJmYWU4MjJkMjJiZTA5Zl8zNy9mcmFnOjQ4OGNkZjBhODVlYzRiMDliYWFiN2JhZTlhODA5YjcwL3RhYmxlOmJlMGVkYmJlNTg1NDQyNWQ5YTZhODA0OWNiYzMxOGIyL3RhYmxlcmFuZ2U6YmUwZWRiYmU1ODU0NDI1ZDlhNmE4MDQ5Y2JjMzE4YjJfNy0zLTEtMS02MjY_ca6fdc70-b576-4aee-9363-5d771f8ab7b9">7,412</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="id6a19bedaa7c4ff8a89b8887ce0c3750_I20211231" decimals="-3" name="us-gaap:AvailableForSaleSecuritiesDebtSecurities" format="ixt:fixed-zero" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmFlNWE5YmUwZWI5NDQ1ZDE5MmZhZTgyMmQyMmJlMDlmL3NlYzphZTVhOWJlMGViOTQ0NWQxOTJmYWU4MjJkMjJiZTA5Zl8zNy9mcmFnOjQ4OGNkZjBhODVlYzRiMDliYWFiN2JhZTlhODA5YjcwL3RhYmxlOmJlMGVkYmJlNTg1NDQyNWQ5YTZhODA0OWNiYzMxOGIyL3RhYmxlcmFuZ2U6YmUwZWRiYmU1ODU0NDI1ZDlhNmE4MDQ5Y2JjMzE4YjJfNy01LTEtMS02MjY_68f87b4d-90b7-4053-a61d-e45fae141ec9">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i319102f511954bcdb477a84723258d83_I20211231" decimals="-3" name="us-gaap:AvailableForSaleSecuritiesDebtSecurities" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmFlNWE5YmUwZWI5NDQ1ZDE5MmZhZTgyMmQyMmJlMDlmL3NlYzphZTVhOWJlMGViOTQ0NWQxOTJmYWU4MjJkMjJiZTA5Zl8zNy9mcmFnOjQ4OGNkZjBhODVlYzRiMDliYWFiN2JhZTlhODA5YjcwL3RhYmxlOmJlMGVkYmJlNTg1NDQyNWQ5YTZhODA0OWNiYzMxOGIyL3RhYmxlcmFuZ2U6YmUwZWRiYmU1ODU0NDI1ZDlhNmE4MDQ5Y2JjMzE4YjJfNy03LTEtMS02MjY_02af0cf7-66be-4a2e-b5b7-baa4ea230bb1">7,412</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">U.S. government debt securities</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i14a147d5e6494412ae4b21fe8bfddff7_I20211231" decimals="-3" name="us-gaap:AvailableForSaleSecuritiesDebtSecurities" format="ixt:fixed-zero" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmFlNWE5YmUwZWI5NDQ1ZDE5MmZhZTgyMmQyMmJlMDlmL3NlYzphZTVhOWJlMGViOTQ0NWQxOTJmYWU4MjJkMjJiZTA5Zl8zNy9mcmFnOjQ4OGNkZjBhODVlYzRiMDliYWFiN2JhZTlhODA5YjcwL3RhYmxlOmJlMGVkYmJlNTg1NDQyNWQ5YTZhODA0OWNiYzMxOGIyL3RhYmxlcmFuZ2U6YmUwZWRiYmU1ODU0NDI1ZDlhNmE4MDQ5Y2JjMzE4YjJfOC0xLTEtMS02MjY_85580063-07e0-4d5a-815f-4a9980ebeb2e">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i4c05f919d71b4b4cb753c74dcc787cf4_I20211231" decimals="-3" name="us-gaap:AvailableForSaleSecuritiesDebtSecurities" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmFlNWE5YmUwZWI5NDQ1ZDE5MmZhZTgyMmQyMmJlMDlmL3NlYzphZTVhOWJlMGViOTQ0NWQxOTJmYWU4MjJkMjJiZTA5Zl8zNy9mcmFnOjQ4OGNkZjBhODVlYzRiMDliYWFiN2JhZTlhODA5YjcwL3RhYmxlOmJlMGVkYmJlNTg1NDQyNWQ5YTZhODA0OWNiYzMxOGIyL3RhYmxlcmFuZ2U6YmUwZWRiYmU1ODU0NDI1ZDlhNmE4MDQ5Y2JjMzE4YjJfOC0zLTEtMS02MjY_20e99fa4-be3f-4fc1-99d2-0f5bc7eb4335">25,685</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if678e473179340e9834400c14da4f7d6_I20211231" decimals="-3" name="us-gaap:AvailableForSaleSecuritiesDebtSecurities" format="ixt:fixed-zero" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmFlNWE5YmUwZWI5NDQ1ZDE5MmZhZTgyMmQyMmJlMDlmL3NlYzphZTVhOWJlMGViOTQ0NWQxOTJmYWU4MjJkMjJiZTA5Zl8zNy9mcmFnOjQ4OGNkZjBhODVlYzRiMDliYWFiN2JhZTlhODA5YjcwL3RhYmxlOmJlMGVkYmJlNTg1NDQyNWQ5YTZhODA0OWNiYzMxOGIyL3RhYmxlcmFuZ2U6YmUwZWRiYmU1ODU0NDI1ZDlhNmE4MDQ5Y2JjMzE4YjJfOC01LTEtMS02MjY_d40ae057-efd7-4904-bde8-67f8c74a5e8a">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i4f60362ab2e44b07bbde43a025d24bba_I20211231" decimals="-3" name="us-gaap:AvailableForSaleSecuritiesDebtSecurities" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmFlNWE5YmUwZWI5NDQ1ZDE5MmZhZTgyMmQyMmJlMDlmL3NlYzphZTVhOWJlMGViOTQ0NWQxOTJmYWU4MjJkMjJiZTA5Zl8zNy9mcmFnOjQ4OGNkZjBhODVlYzRiMDliYWFiN2JhZTlhODA5YjcwL3RhYmxlOmJlMGVkYmJlNTg1NDQyNWQ5YTZhODA0OWNiYzMxOGIyL3RhYmxlcmFuZ2U6YmUwZWRiYmU1ODU0NDI1ZDlhNmE4MDQ5Y2JjMzE4YjJfOC03LTEtMS02MjY_1c88ab1d-4e78-403b-84f6-bb41245b4764">25,685</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total marketable securities, available for sale</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="id0495dc386634c17abe35f6f0b1c1cde_I20211231" decimals="-3" name="us-gaap:AvailableForSaleSecuritiesDebtSecurities" format="ixt:fixed-zero" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmFlNWE5YmUwZWI5NDQ1ZDE5MmZhZTgyMmQyMmJlMDlmL3NlYzphZTVhOWJlMGViOTQ0NWQxOTJmYWU4MjJkMjJiZTA5Zl8zNy9mcmFnOjQ4OGNkZjBhODVlYzRiMDliYWFiN2JhZTlhODA5YjcwL3RhYmxlOmJlMGVkYmJlNTg1NDQyNWQ5YTZhODA0OWNiYzMxOGIyL3RhYmxlcmFuZ2U6YmUwZWRiYmU1ODU0NDI1ZDlhNmE4MDQ5Y2JjMzE4YjJfOS0xLTEtMS02MjY_9773285d-3a04-4317-a212-8780b4da725a">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i22164451262946e4b9911f313b7610c1_I20211231" decimals="-3" name="us-gaap:AvailableForSaleSecuritiesDebtSecurities" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmFlNWE5YmUwZWI5NDQ1ZDE5MmZhZTgyMmQyMmJlMDlmL3NlYzphZTVhOWJlMGViOTQ0NWQxOTJmYWU4MjJkMjJiZTA5Zl8zNy9mcmFnOjQ4OGNkZjBhODVlYzRiMDliYWFiN2JhZTlhODA5YjcwL3RhYmxlOmJlMGVkYmJlNTg1NDQyNWQ5YTZhODA0OWNiYzMxOGIyL3RhYmxlcmFuZ2U6YmUwZWRiYmU1ODU0NDI1ZDlhNmE4MDQ5Y2JjMzE4YjJfOS0zLTEtMS02MjY_8a1aec09-27e1-4c88-b1bb-a4f81c077158">48,449</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ica20d3fdf2ff41fdb31ad57ccb72924b_I20211231" decimals="-3" name="us-gaap:AvailableForSaleSecuritiesDebtSecurities" format="ixt:fixed-zero" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmFlNWE5YmUwZWI5NDQ1ZDE5MmZhZTgyMmQyMmJlMDlmL3NlYzphZTVhOWJlMGViOTQ0NWQxOTJmYWU4MjJkMjJiZTA5Zl8zNy9mcmFnOjQ4OGNkZjBhODVlYzRiMDliYWFiN2JhZTlhODA5YjcwL3RhYmxlOmJlMGVkYmJlNTg1NDQyNWQ5YTZhODA0OWNiYzMxOGIyL3RhYmxlcmFuZ2U6YmUwZWRiYmU1ODU0NDI1ZDlhNmE4MDQ5Y2JjMzE4YjJfOS01LTEtMS02MjY_efd882ae-b73b-4cda-bed2-60a3e62a7f99">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ie7dec283b83b43f99e003b79ec165d54_I20211231" decimals="-3" name="us-gaap:AvailableForSaleSecuritiesDebtSecurities" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmFlNWE5YmUwZWI5NDQ1ZDE5MmZhZTgyMmQyMmJlMDlmL3NlYzphZTVhOWJlMGViOTQ0NWQxOTJmYWU4MjJkMjJiZTA5Zl8zNy9mcmFnOjQ4OGNkZjBhODVlYzRiMDliYWFiN2JhZTlhODA5YjcwL3RhYmxlOmJlMGVkYmJlNTg1NDQyNWQ5YTZhODA0OWNiYzMxOGIyL3RhYmxlcmFuZ2U6YmUwZWRiYmU1ODU0NDI1ZDlhNmE4MDQ5Y2JjMzE4YjJfOS03LTEtMS02MjY_c139b22f-b298-4f43-9778-ddeaf0cc3248">48,449</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Total assets measured at fair value on a recurring basis</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="id0495dc386634c17abe35f6f0b1c1cde_I20211231" decimals="-3" name="us-gaap:AssetsFairValueDisclosure" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmFlNWE5YmUwZWI5NDQ1ZDE5MmZhZTgyMmQyMmJlMDlmL3NlYzphZTVhOWJlMGViOTQ0NWQxOTJmYWU4MjJkMjJiZTA5Zl8zNy9mcmFnOjQ4OGNkZjBhODVlYzRiMDliYWFiN2JhZTlhODA5YjcwL3RhYmxlOmJlMGVkYmJlNTg1NDQyNWQ5YTZhODA0OWNiYzMxOGIyL3RhYmxlcmFuZ2U6YmUwZWRiYmU1ODU0NDI1ZDlhNmE4MDQ5Y2JjMzE4YjJfMTAtMS0xLTEtNjI2_48f14009-24ae-4b99-91a6-0a3505de5b59">19,405</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i22164451262946e4b9911f313b7610c1_I20211231" decimals="-3" name="us-gaap:AssetsFairValueDisclosure" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmFlNWE5YmUwZWI5NDQ1ZDE5MmZhZTgyMmQyMmJlMDlmL3NlYzphZTVhOWJlMGViOTQ0NWQxOTJmYWU4MjJkMjJiZTA5Zl8zNy9mcmFnOjQ4OGNkZjBhODVlYzRiMDliYWFiN2JhZTlhODA5YjcwL3RhYmxlOmJlMGVkYmJlNTg1NDQyNWQ5YTZhODA0OWNiYzMxOGIyL3RhYmxlcmFuZ2U6YmUwZWRiYmU1ODU0NDI1ZDlhNmE4MDQ5Y2JjMzE4YjJfMTAtMy0xLTEtNjI2_4795b0a5-be61-4344-a167-e168dbf7167a">48,449</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ica20d3fdf2ff41fdb31ad57ccb72924b_I20211231" decimals="-3" name="us-gaap:AssetsFairValueDisclosure" format="ixt:fixed-zero" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmFlNWE5YmUwZWI5NDQ1ZDE5MmZhZTgyMmQyMmJlMDlmL3NlYzphZTVhOWJlMGViOTQ0NWQxOTJmYWU4MjJkMjJiZTA5Zl8zNy9mcmFnOjQ4OGNkZjBhODVlYzRiMDliYWFiN2JhZTlhODA5YjcwL3RhYmxlOmJlMGVkYmJlNTg1NDQyNWQ5YTZhODA0OWNiYzMxOGIyL3RhYmxlcmFuZ2U6YmUwZWRiYmU1ODU0NDI1ZDlhNmE4MDQ5Y2JjMzE4YjJfMTAtNS0xLTEtNjI2_caebf75d-707e-4cd0-9426-b3620f0c4dae">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ie7dec283b83b43f99e003b79ec165d54_I20211231" decimals="-3" name="us-gaap:AssetsFairValueDisclosure" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmFlNWE5YmUwZWI5NDQ1ZDE5MmZhZTgyMmQyMmJlMDlmL3NlYzphZTVhOWJlMGViOTQ0NWQxOTJmYWU4MjJkMjJiZTA5Zl8zNy9mcmFnOjQ4OGNkZjBhODVlYzRiMDliYWFiN2JhZTlhODA5YjcwL3RhYmxlOmJlMGVkYmJlNTg1NDQyNWQ5YTZhODA0OWNiYzMxOGIyL3RhYmxlcmFuZ2U6YmUwZWRiYmU1ODU0NDI1ZDlhNmE4MDQ5Y2JjMzE4YjJfMTAtNy0xLTEtNjI2_69ac51e8-e24e-4978-9553-2e1bd65c177b">67,854</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr style="height:15pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Liabilities:</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Warrant liability</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="id0495dc386634c17abe35f6f0b1c1cde_I20211231" decimals="-3" name="dmtk:WarrantLiabilityFairValueDisclosure" format="ixt:fixed-zero" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmFlNWE5YmUwZWI5NDQ1ZDE5MmZhZTgyMmQyMmJlMDlmL3NlYzphZTVhOWJlMGViOTQ0NWQxOTJmYWU4MjJkMjJiZTA5Zl8zNy9mcmFnOjQ4OGNkZjBhODVlYzRiMDliYWFiN2JhZTlhODA5YjcwL3RhYmxlOmJlMGVkYmJlNTg1NDQyNWQ5YTZhODA0OWNiYzMxOGIyL3RhYmxlcmFuZ2U6YmUwZWRiYmU1ODU0NDI1ZDlhNmE4MDQ5Y2JjMzE4YjJfMTMtMS0xLTEtNjI2_0f1f3fab-9404-4fe9-8849-28abe3304c4d">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i22164451262946e4b9911f313b7610c1_I20211231" decimals="-3" name="dmtk:WarrantLiabilityFairValueDisclosure" format="ixt:fixed-zero" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmFlNWE5YmUwZWI5NDQ1ZDE5MmZhZTgyMmQyMmJlMDlmL3NlYzphZTVhOWJlMGViOTQ0NWQxOTJmYWU4MjJkMjJiZTA5Zl8zNy9mcmFnOjQ4OGNkZjBhODVlYzRiMDliYWFiN2JhZTlhODA5YjcwL3RhYmxlOmJlMGVkYmJlNTg1NDQyNWQ5YTZhODA0OWNiYzMxOGIyL3RhYmxlcmFuZ2U6YmUwZWRiYmU1ODU0NDI1ZDlhNmE4MDQ5Y2JjMzE4YjJfMTMtMy0xLTEtNjI2_dba2adde-cc46-4668-89c1-209499f6f6f1">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ica20d3fdf2ff41fdb31ad57ccb72924b_I20211231" decimals="-3" name="dmtk:WarrantLiabilityFairValueDisclosure" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmFlNWE5YmUwZWI5NDQ1ZDE5MmZhZTgyMmQyMmJlMDlmL3NlYzphZTVhOWJlMGViOTQ0NWQxOTJmYWU4MjJkMjJiZTA5Zl8zNy9mcmFnOjQ4OGNkZjBhODVlYzRiMDliYWFiN2JhZTlhODA5YjcwL3RhYmxlOmJlMGVkYmJlNTg1NDQyNWQ5YTZhODA0OWNiYzMxOGIyL3RhYmxlcmFuZ2U6YmUwZWRiYmU1ODU0NDI1ZDlhNmE4MDQ5Y2JjMzE4YjJfMTMtNS0xLTEtNjI2_a84b1005-7d9f-402a-95ae-c143f4a53d02">146</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ie7dec283b83b43f99e003b79ec165d54_I20211231" decimals="-3" name="dmtk:WarrantLiabilityFairValueDisclosure" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmFlNWE5YmUwZWI5NDQ1ZDE5MmZhZTgyMmQyMmJlMDlmL3NlYzphZTVhOWJlMGViOTQ0NWQxOTJmYWU4MjJkMjJiZTA5Zl8zNy9mcmFnOjQ4OGNkZjBhODVlYzRiMDliYWFiN2JhZTlhODA5YjcwL3RhYmxlOmJlMGVkYmJlNTg1NDQyNWQ5YTZhODA0OWNiYzMxOGIyL3RhYmxlcmFuZ2U6YmUwZWRiYmU1ODU0NDI1ZDlhNmE4MDQ5Y2JjMzE4YjJfMTMtNy0xLTEtNjI2_c22c11cc-df99-42aa-9877-76db806d2004">146</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Total liabilities measured at fair value on a recurring basis</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="id0495dc386634c17abe35f6f0b1c1cde_I20211231" decimals="-3" name="us-gaap:LiabilitiesFairValueDisclosure" format="ixt:fixed-zero" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmFlNWE5YmUwZWI5NDQ1ZDE5MmZhZTgyMmQyMmJlMDlmL3NlYzphZTVhOWJlMGViOTQ0NWQxOTJmYWU4MjJkMjJiZTA5Zl8zNy9mcmFnOjQ4OGNkZjBhODVlYzRiMDliYWFiN2JhZTlhODA5YjcwL3RhYmxlOmJlMGVkYmJlNTg1NDQyNWQ5YTZhODA0OWNiYzMxOGIyL3RhYmxlcmFuZ2U6YmUwZWRiYmU1ODU0NDI1ZDlhNmE4MDQ5Y2JjMzE4YjJfMTQtMS0xLTEtNjI2_971b1ca1-771d-4659-b294-2d8754dfac0e">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i22164451262946e4b9911f313b7610c1_I20211231" decimals="-3" name="us-gaap:LiabilitiesFairValueDisclosure" format="ixt:fixed-zero" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmFlNWE5YmUwZWI5NDQ1ZDE5MmZhZTgyMmQyMmJlMDlmL3NlYzphZTVhOWJlMGViOTQ0NWQxOTJmYWU4MjJkMjJiZTA5Zl8zNy9mcmFnOjQ4OGNkZjBhODVlYzRiMDliYWFiN2JhZTlhODA5YjcwL3RhYmxlOmJlMGVkYmJlNTg1NDQyNWQ5YTZhODA0OWNiYzMxOGIyL3RhYmxlcmFuZ2U6YmUwZWRiYmU1ODU0NDI1ZDlhNmE4MDQ5Y2JjMzE4YjJfMTQtMy0xLTEtNjI2_15bbecde-fe27-4d48-9848-beaf7e73fdee">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ica20d3fdf2ff41fdb31ad57ccb72924b_I20211231" decimals="-3" name="us-gaap:LiabilitiesFairValueDisclosure" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmFlNWE5YmUwZWI5NDQ1ZDE5MmZhZTgyMmQyMmJlMDlmL3NlYzphZTVhOWJlMGViOTQ0NWQxOTJmYWU4MjJkMjJiZTA5Zl8zNy9mcmFnOjQ4OGNkZjBhODVlYzRiMDliYWFiN2JhZTlhODA5YjcwL3RhYmxlOmJlMGVkYmJlNTg1NDQyNWQ5YTZhODA0OWNiYzMxOGIyL3RhYmxlcmFuZ2U6YmUwZWRiYmU1ODU0NDI1ZDlhNmE4MDQ5Y2JjMzE4YjJfMTQtNS0xLTEtNjI2_351b16ff-41a9-4449-b48e-252f3319e25b">146</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ie7dec283b83b43f99e003b79ec165d54_I20211231" decimals="-3" name="us-gaap:LiabilitiesFairValueDisclosure" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmFlNWE5YmUwZWI5NDQ1ZDE5MmZhZTgyMmQyMmJlMDlmL3NlYzphZTVhOWJlMGViOTQ0NWQxOTJmYWU4MjJkMjJiZTA5Zl8zNy9mcmFnOjQ4OGNkZjBhODVlYzRiMDliYWFiN2JhZTlhODA5YjcwL3RhYmxlOmJlMGVkYmJlNTg1NDQyNWQ5YTZhODA0OWNiYzMxOGIyL3RhYmxlcmFuZ2U6YmUwZWRiYmU1ODU0NDI1ZDlhNmE4MDQ5Y2JjMzE4YjJfMTQtNy0xLTEtNjI2_3efdd1c0-c71d-457f-a66f-a673e525bdab">146</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div></ix:nonNumeric></ix:continuation><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">12</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:45pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#iae5a9be0eb9445d192fae822d22be09f_7">Table of Contents</a></span></div></div><ix:continuation id="i600ec168dc9f4864a0bbedc0cbbd0af5"><ix:continuation id="i80bb7425691246c2807df365549eaac4" continuedAt="ia4d5ef225040439689cc1ee5a26577a7"><div style="margin-top:9pt;padding-left:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company&#8217;s marketable debt securities are classified as available-for-sale securities based on management's intentions and are at Level 2 of the fair value hierarchy, as these investment securities are valued based upon quoted prices for identical or similar instruments in markets that are not active. The Company has classified marketable securities with original maturities of greater than one year as short-term investments based upon the Company&#8217;s ability to use all of those marketable securities to satisfy the liquidity needs of the Company&#8217;s current operations.</span></div><div style="margin-top:9pt;padding-left:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The fair value of the Private SPAC Warrants (as defined below) was determined using the Black-Scholes-Merton valuation model and included an unobservable input: expected volatility. Expected volatility is considered by the Company to be an unobservable input and is calculated using a weighted average of historical volatilities of a combination of the Company and peer companies, due to the lack of sufficient historical data of the Company&#8217;s own stock price. The model also incorporated several observable assumptions at each valuation date including: the price of the Company&#8217;s common stock on the date of valuation, the remaining contractual term of the warrant and the risk-free interest rate over the remaining term.</span></div></ix:continuation><ix:nonNumeric contextRef="ia855382ada1f4f28aa8ef6da692ff177_D20220101-20220630" name="us-gaap:ScheduleOfShareBasedPaymentAwardEmployeeStockPurchasePlanValuationAssumptionsTableTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOmFlNWE5YmUwZWI5NDQ1ZDE5MmZhZTgyMmQyMmJlMDlmL3NlYzphZTVhOWJlMGViOTQ0NWQxOTJmYWU4MjJkMjJiZTA5Zl8zNy9mcmFnOjQ4OGNkZjBhODVlYzRiMDliYWFiN2JhZTlhODA5YjcwL3RleHRyZWdpb246NDg4Y2RmMGE4NWVjNGIwOWJhYWI3YmFlOWE4MDliNzBfNDk0NzgwMjQ4ODMyMw_56359129-320f-4338-b122-70fb37d96f62" continuedAt="iad8da31150ff464ca3b18f10ffb3a72c" escape="true"><div style="margin-top:9pt;padding-left:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following assumptions were used to calculate the fair value of the Company&#8217;s warrant liability using the Black-Scholes-Merton valuation model:</span></div><div style="margin-top:12pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:32.233%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:15.112%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.406%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:15.112%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.406%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:15.112%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.406%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:15.113%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Three Months Ended June 30,</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Six Months Ended June 30,</span></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2021</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Assumed risk-free interest rate</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="i2ff3fea135c346deae31b3b343050a34_D20220401-20220630" decimals="4" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOmFlNWE5YmUwZWI5NDQ1ZDE5MmZhZTgyMmQyMmJlMDlmL3NlYzphZTVhOWJlMGViOTQ0NWQxOTJmYWU4MjJkMjJiZTA5Zl8zNy9mcmFnOjQ4OGNkZjBhODVlYzRiMDliYWFiN2JhZTlhODA5YjcwL3RhYmxlOmJlZmZiODc1NTNmNzQxYjVhZjFiZTQwMTA3M2ExOWQwL3RhYmxlcmFuZ2U6YmVmZmI4NzU1M2Y3NDFiNWFmMWJlNDAxMDczYTE5ZDBfMi0xLTEtMS0yMzQy_c019fb2e-0826-402e-b17c-2d0c472e5ad1">2.96</ix:nonFraction>%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="ifd6a2c580c134e25811ac19c23b2c1e5_D20210401-20210630" decimals="4" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOmFlNWE5YmUwZWI5NDQ1ZDE5MmZhZTgyMmQyMmJlMDlmL3NlYzphZTVhOWJlMGViOTQ0NWQxOTJmYWU4MjJkMjJiZTA5Zl8zNy9mcmFnOjQ4OGNkZjBhODVlYzRiMDliYWFiN2JhZTlhODA5YjcwL3RhYmxlOmJlZmZiODc1NTNmNzQxYjVhZjFiZTQwMTA3M2ExOWQwL3RhYmxlcmFuZ2U6YmVmZmI4NzU1M2Y3NDFiNWFmMWJlNDAxMDczYTE5ZDBfMi0zLTEtMS0yMzQy_f82dd7b4-464d-41dc-b3a8-609e997298f5">0.46</ix:nonFraction>%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="ib3db0d13e848432a9c205ce797c080f8_D20220101-20220630" decimals="4" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMinimum" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOmFlNWE5YmUwZWI5NDQ1ZDE5MmZhZTgyMmQyMmJlMDlmL3NlYzphZTVhOWJlMGViOTQ0NWQxOTJmYWU4MjJkMjJiZTA5Zl8zNy9mcmFnOjQ4OGNkZjBhODVlYzRiMDliYWFiN2JhZTlhODA5YjcwL3RhYmxlOmJlZmZiODc1NTNmNzQxYjVhZjFiZTQwMTA3M2ExOWQwL3RhYmxlcmFuZ2U6YmVmZmI4NzU1M2Y3NDFiNWFmMWJlNDAxMDczYTE5ZDBfMi01LTEtMS0yMzQyL3RleHRyZWdpb246MTU0YjJhOGZlODQzNGUzM2ExZDEzOTI0ZDI2ODg0NDNfNTQ5NzU1ODEzOTEx_656ecbe0-1e5a-4c49-9750-2167a4272d3b">2.37</ix:nonFraction>% -<ix:nonFraction unitRef="number" contextRef="ib3db0d13e848432a9c205ce797c080f8_D20220101-20220630" decimals="4" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMaximum" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOmFlNWE5YmUwZWI5NDQ1ZDE5MmZhZTgyMmQyMmJlMDlmL3NlYzphZTVhOWJlMGViOTQ0NWQxOTJmYWU4MjJkMjJiZTA5Zl8zNy9mcmFnOjQ4OGNkZjBhODVlYzRiMDliYWFiN2JhZTlhODA5YjcwL3RhYmxlOmJlZmZiODc1NTNmNzQxYjVhZjFiZTQwMTA3M2ExOWQwL3RhYmxlcmFuZ2U6YmVmZmI4NzU1M2Y3NDFiNWFmMWJlNDAxMDczYTE5ZDBfMi01LTEtMS0yMzQyL3RleHRyZWdpb246MTU0YjJhOGZlODQzNGUzM2ExZDEzOTI0ZDI2ODg0NDNfNTQ5NzU1ODEzOTIx_947f6c16-7dc8-4c10-8774-1eee746fec4e">2.96</ix:nonFraction>%</span></div></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="i08f348302fbc42c98a41fcaf5cfcde43_D20210101-20210630" decimals="4" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMinimum" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOmFlNWE5YmUwZWI5NDQ1ZDE5MmZhZTgyMmQyMmJlMDlmL3NlYzphZTVhOWJlMGViOTQ0NWQxOTJmYWU4MjJkMjJiZTA5Zl8zNy9mcmFnOjQ4OGNkZjBhODVlYzRiMDliYWFiN2JhZTlhODA5YjcwL3RhYmxlOmJlZmZiODc1NTNmNzQxYjVhZjFiZTQwMTA3M2ExOWQwL3RhYmxlcmFuZ2U6YmVmZmI4NzU1M2Y3NDFiNWFmMWJlNDAxMDczYTE5ZDBfMi03LTEtMS0yMzQyL3RleHRyZWdpb246NzU5MWVmMmQwYTg3NDE2ZjgyNGI4YjU5M2UyYTcyNzFfNTQ5NzU1ODEzOTIy_d515e97b-4ea3-4fb7-857f-e8d6abdd8767">0.46</ix:nonFraction>% - <ix:nonFraction unitRef="number" contextRef="i08f348302fbc42c98a41fcaf5cfcde43_D20210101-20210630" decimals="4" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMaximum" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOmFlNWE5YmUwZWI5NDQ1ZDE5MmZhZTgyMmQyMmJlMDlmL3NlYzphZTVhOWJlMGViOTQ0NWQxOTJmYWU4MjJkMjJiZTA5Zl8zNy9mcmFnOjQ4OGNkZjBhODVlYzRiMDliYWFiN2JhZTlhODA5YjcwL3RhYmxlOmJlZmZiODc1NTNmNzQxYjVhZjFiZTQwMTA3M2ExOWQwL3RhYmxlcmFuZ2U6YmVmZmI4NzU1M2Y3NDFiNWFmMWJlNDAxMDczYTE5ZDBfMi03LTEtMS0yMzQyL3RleHRyZWdpb246NzU5MWVmMmQwYTg3NDE2ZjgyNGI4YjU5M2UyYTcyNzFfNTQ5NzU1ODEzOTE1_78a22e10-6d97-4dc5-9dd2-e483b26c7169">0.64</ix:nonFraction>%</span></div></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Assumed volatility</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="i2ff3fea135c346deae31b3b343050a34_D20220401-20220630" decimals="4" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOmFlNWE5YmUwZWI5NDQ1ZDE5MmZhZTgyMmQyMmJlMDlmL3NlYzphZTVhOWJlMGViOTQ0NWQxOTJmYWU4MjJkMjJiZTA5Zl8zNy9mcmFnOjQ4OGNkZjBhODVlYzRiMDliYWFiN2JhZTlhODA5YjcwL3RhYmxlOmJlZmZiODc1NTNmNzQxYjVhZjFiZTQwMTA3M2ExOWQwL3RhYmxlcmFuZ2U6YmVmZmI4NzU1M2Y3NDFiNWFmMWJlNDAxMDczYTE5ZDBfMy0xLTEtMS0yMzQy_c3e54528-86f7-4e4c-894e-aeae36027bbb">96.21</ix:nonFraction>%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="ifd6a2c580c134e25811ac19c23b2c1e5_D20210401-20210630" decimals="4" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOmFlNWE5YmUwZWI5NDQ1ZDE5MmZhZTgyMmQyMmJlMDlmL3NlYzphZTVhOWJlMGViOTQ0NWQxOTJmYWU4MjJkMjJiZTA5Zl8zNy9mcmFnOjQ4OGNkZjBhODVlYzRiMDliYWFiN2JhZTlhODA5YjcwL3RhYmxlOmJlZmZiODc1NTNmNzQxYjVhZjFiZTQwMTA3M2ExOWQwL3RhYmxlcmFuZ2U6YmVmZmI4NzU1M2Y3NDFiNWFmMWJlNDAxMDczYTE5ZDBfMy0zLTEtMS0yNDAw_bdb36b92-8839-4fe7-a208-dc2e6d880123">88.28</ix:nonFraction>%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="ib3db0d13e848432a9c205ce797c080f8_D20220101-20220630" decimals="4" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRateMinimum" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOmFlNWE5YmUwZWI5NDQ1ZDE5MmZhZTgyMmQyMmJlMDlmL3NlYzphZTVhOWJlMGViOTQ0NWQxOTJmYWU4MjJkMjJiZTA5Zl8zNy9mcmFnOjQ4OGNkZjBhODVlYzRiMDliYWFiN2JhZTlhODA5YjcwL3RhYmxlOmJlZmZiODc1NTNmNzQxYjVhZjFiZTQwMTA3M2ExOWQwL3RhYmxlcmFuZ2U6YmVmZmI4NzU1M2Y3NDFiNWFmMWJlNDAxMDczYTE5ZDBfMy01LTEtMS0yMzQyL3RleHRyZWdpb246YzM5ZWIxNmJlMGZhNDVhZjk0ZjJmZTE5NDEzYzg3MDJfNTQ5NzU1ODEzOTEw_9def1834-da53-40b2-b42c-8d461adb438d">92.77</ix:nonFraction>% - <ix:nonFraction unitRef="number" contextRef="ib3db0d13e848432a9c205ce797c080f8_D20220101-20220630" decimals="4" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRateMaximum" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOmFlNWE5YmUwZWI5NDQ1ZDE5MmZhZTgyMmQyMmJlMDlmL3NlYzphZTVhOWJlMGViOTQ0NWQxOTJmYWU4MjJkMjJiZTA5Zl8zNy9mcmFnOjQ4OGNkZjBhODVlYzRiMDliYWFiN2JhZTlhODA5YjcwL3RhYmxlOmJlZmZiODc1NTNmNzQxYjVhZjFiZTQwMTA3M2ExOWQwL3RhYmxlcmFuZ2U6YmVmZmI4NzU1M2Y3NDFiNWFmMWJlNDAxMDczYTE5ZDBfMy01LTEtMS0yMzQyL3RleHRyZWdpb246YzM5ZWIxNmJlMGZhNDVhZjk0ZjJmZTE5NDEzYzg3MDJfNTQ5NzU1ODEzOTE1_486985cf-afff-4162-b1f6-4af9fe3827c6">96.21</ix:nonFraction>%</span></div></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="i08f348302fbc42c98a41fcaf5cfcde43_D20210101-20210630" decimals="4" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRateMinimum" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOmFlNWE5YmUwZWI5NDQ1ZDE5MmZhZTgyMmQyMmJlMDlmL3NlYzphZTVhOWJlMGViOTQ0NWQxOTJmYWU4MjJkMjJiZTA5Zl8zNy9mcmFnOjQ4OGNkZjBhODVlYzRiMDliYWFiN2JhZTlhODA5YjcwL3RhYmxlOmJlZmZiODc1NTNmNzQxYjVhZjFiZTQwMTA3M2ExOWQwL3RhYmxlcmFuZ2U6YmVmZmI4NzU1M2Y3NDFiNWFmMWJlNDAxMDczYTE5ZDBfMy03LTEtMS0yMzQyL3RleHRyZWdpb246NDljN2M2YWE2NDhmNGM4NWJhMGE1MTlmYmQ4ZDM5YmVfNTQ5NzU1ODEzOTEz_1f939578-ec86-4f44-8944-b24883014158">85.85</ix:nonFraction>% - <ix:nonFraction unitRef="number" contextRef="i08f348302fbc42c98a41fcaf5cfcde43_D20210101-20210630" decimals="4" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRateMaximum" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOmFlNWE5YmUwZWI5NDQ1ZDE5MmZhZTgyMmQyMmJlMDlmL3NlYzphZTVhOWJlMGViOTQ0NWQxOTJmYWU4MjJkMjJiZTA5Zl8zNy9mcmFnOjQ4OGNkZjBhODVlYzRiMDliYWFiN2JhZTlhODA5YjcwL3RhYmxlOmJlZmZiODc1NTNmNzQxYjVhZjFiZTQwMTA3M2ExOWQwL3RhYmxlcmFuZ2U6YmVmZmI4NzU1M2Y3NDFiNWFmMWJlNDAxMDczYTE5ZDBfMy03LTEtMS0yMzQyL3RleHRyZWdpb246NDljN2M2YWE2NDhmNGM4NWJhMGE1MTlmYmQ4ZDM5YmVfNTQ5NzU1ODEzOTIy_32caf6ea-2b28-484e-954f-1a4c488f7233">88.28</ix:nonFraction>%</span></div></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Expected term</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonNumeric contextRef="i2ff3fea135c346deae31b3b343050a34_D20220401-20220630" name="us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1" format="ixt-sec:duryear" id="id3VybDovL2RvY3MudjEvZG9jOmFlNWE5YmUwZWI5NDQ1ZDE5MmZhZTgyMmQyMmJlMDlmL3NlYzphZTVhOWJlMGViOTQ0NWQxOTJmYWU4MjJkMjJiZTA5Zl8zNy9mcmFnOjQ4OGNkZjBhODVlYzRiMDliYWFiN2JhZTlhODA5YjcwL3RhYmxlOmJlZmZiODc1NTNmNzQxYjVhZjFiZTQwMTA3M2ExOWQwL3RhYmxlcmFuZ2U6YmVmZmI4NzU1M2Y3NDFiNWFmMWJlNDAxMDczYTE5ZDBfNC0xLTEtMS0yMzQy_363fe65e-bb07-42ea-833c-54619a980863">2.17</ix:nonNumeric> years</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonNumeric contextRef="ifd6a2c580c134e25811ac19c23b2c1e5_D20210401-20210630" name="us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1" format="ixt-sec:duryear" id="id3VybDovL2RvY3MudjEvZG9jOmFlNWE5YmUwZWI5NDQ1ZDE5MmZhZTgyMmQyMmJlMDlmL3NlYzphZTVhOWJlMGViOTQ0NWQxOTJmYWU4MjJkMjJiZTA5Zl8zNy9mcmFnOjQ4OGNkZjBhODVlYzRiMDliYWFiN2JhZTlhODA5YjcwL3RhYmxlOmJlZmZiODc1NTNmNzQxYjVhZjFiZTQwMTA3M2ExOWQwL3RhYmxlcmFuZ2U6YmVmZmI4NzU1M2Y3NDFiNWFmMWJlNDAxMDczYTE5ZDBfNC0zLTEtMS0yMzQy_62366a62-72e3-430e-b953-5e59e83b09c1">3.17</ix:nonNumeric> years</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonNumeric contextRef="ife1b36ccabe240edb9560e64d1ffa4bc_D20220101-20220630" name="us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1" format="ixt-sec:duryear" id="id3VybDovL2RvY3MudjEvZG9jOmFlNWE5YmUwZWI5NDQ1ZDE5MmZhZTgyMmQyMmJlMDlmL3NlYzphZTVhOWJlMGViOTQ0NWQxOTJmYWU4MjJkMjJiZTA5Zl8zNy9mcmFnOjQ4OGNkZjBhODVlYzRiMDliYWFiN2JhZTlhODA5YjcwL3RhYmxlOmJlZmZiODc1NTNmNzQxYjVhZjFiZTQwMTA3M2ExOWQwL3RhYmxlcmFuZ2U6YmVmZmI4NzU1M2Y3NDFiNWFmMWJlNDAxMDczYTE5ZDBfNC01LTEtMS0yMzQyL3RleHRyZWdpb246NjdiMWMwYTA3OGRlNGUxMGE3ZTI1MmIwYTYwNjI2ODZfNA_0798932c-4140-412c-91e3-e5489cba1870">2.17</ix:nonNumeric> - <ix:nonNumeric contextRef="i40659e4bf5494460828fbdb823038ea6_D20220101-20220630" name="us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1" format="ixt-sec:duryear" id="id3VybDovL2RvY3MudjEvZG9jOmFlNWE5YmUwZWI5NDQ1ZDE5MmZhZTgyMmQyMmJlMDlmL3NlYzphZTVhOWJlMGViOTQ0NWQxOTJmYWU4MjJkMjJiZTA5Zl8zNy9mcmFnOjQ4OGNkZjBhODVlYzRiMDliYWFiN2JhZTlhODA5YjcwL3RhYmxlOmJlZmZiODc1NTNmNzQxYjVhZjFiZTQwMTA3M2ExOWQwL3RhYmxlcmFuZ2U6YmVmZmI4NzU1M2Y3NDFiNWFmMWJlNDAxMDczYTE5ZDBfNC01LTEtMS0yMzQyL3RleHRyZWdpb246NjdiMWMwYTA3OGRlNGUxMGE3ZTI1MmIwYTYwNjI2ODZfOQ_ee78bd37-5054-41e2-9899-e98e0bae4960">2.42</ix:nonNumeric> years</span></div></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonNumeric contextRef="i2c2735b81bcc42bf8feeaa459dfad074_D20210101-20210630" name="us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1" format="ixt-sec:duryear" id="id3VybDovL2RvY3MudjEvZG9jOmFlNWE5YmUwZWI5NDQ1ZDE5MmZhZTgyMmQyMmJlMDlmL3NlYzphZTVhOWJlMGViOTQ0NWQxOTJmYWU4MjJkMjJiZTA5Zl8zNy9mcmFnOjQ4OGNkZjBhODVlYzRiMDliYWFiN2JhZTlhODA5YjcwL3RhYmxlOmJlZmZiODc1NTNmNzQxYjVhZjFiZTQwMTA3M2ExOWQwL3RhYmxlcmFuZ2U6YmVmZmI4NzU1M2Y3NDFiNWFmMWJlNDAxMDczYTE5ZDBfNC03LTEtMS0yMzQyL3RleHRyZWdpb246OWVjNjA0NGIzYTRhNDQ4MzkyMTFlY2U0MTJiNGEyZmFfNA_bb8ef718-488a-409a-83d7-0f858af95fea">3.17</ix:nonNumeric> - <ix:nonNumeric contextRef="ibf907753dcd34608bb600dff616c1c77_D20210101-20210630" name="us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1" format="ixt-sec:duryear" id="id3VybDovL2RvY3MudjEvZG9jOmFlNWE5YmUwZWI5NDQ1ZDE5MmZhZTgyMmQyMmJlMDlmL3NlYzphZTVhOWJlMGViOTQ0NWQxOTJmYWU4MjJkMjJiZTA5Zl8zNy9mcmFnOjQ4OGNkZjBhODVlYzRiMDliYWFiN2JhZTlhODA5YjcwL3RhYmxlOmJlZmZiODc1NTNmNzQxYjVhZjFiZTQwMTA3M2ExOWQwL3RhYmxlcmFuZ2U6YmVmZmI4NzU1M2Y3NDFiNWFmMWJlNDAxMDczYTE5ZDBfNC03LTEtMS0yMzQyL3RleHRyZWdpb246OWVjNjA0NGIzYTRhNDQ4MzkyMTFlY2U0MTJiNGEyZmFfOQ_f4b22cfe-33bf-4f50-87dd-0c68e8059f46">3.42</ix:nonNumeric> years</span></div></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Expected dividend yield</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="i2ff3fea135c346deae31b3b343050a34_D20220401-20220630" decimals="2" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate" format="ixt:fixed-zero" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmFlNWE5YmUwZWI5NDQ1ZDE5MmZhZTgyMmQyMmJlMDlmL3NlYzphZTVhOWJlMGViOTQ0NWQxOTJmYWU4MjJkMjJiZTA5Zl8zNy9mcmFnOjQ4OGNkZjBhODVlYzRiMDliYWFiN2JhZTlhODA5YjcwL3RhYmxlOmJlZmZiODc1NTNmNzQxYjVhZjFiZTQwMTA3M2ExOWQwL3RhYmxlcmFuZ2U6YmVmZmI4NzU1M2Y3NDFiNWFmMWJlNDAxMDczYTE5ZDBfNS0xLTEtMS0yMzQy_cb338f92-9896-4b38-b036-fd69ce9c1204">&#8212;</ix:nonFraction></span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="ifd6a2c580c134e25811ac19c23b2c1e5_D20210401-20210630" decimals="2" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate" format="ixt:fixed-zero" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmFlNWE5YmUwZWI5NDQ1ZDE5MmZhZTgyMmQyMmJlMDlmL3NlYzphZTVhOWJlMGViOTQ0NWQxOTJmYWU4MjJkMjJiZTA5Zl8zNy9mcmFnOjQ4OGNkZjBhODVlYzRiMDliYWFiN2JhZTlhODA5YjcwL3RhYmxlOmJlZmZiODc1NTNmNzQxYjVhZjFiZTQwMTA3M2ExOWQwL3RhYmxlcmFuZ2U6YmVmZmI4NzU1M2Y3NDFiNWFmMWJlNDAxMDczYTE5ZDBfNS0zLTEtMS0yMzQy_ae37c91a-cea1-47bc-9181-4b726f6fd04e">&#8212;</ix:nonFraction></span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="ib3db0d13e848432a9c205ce797c080f8_D20220101-20220630" decimals="2" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate" format="ixt:fixed-zero" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmFlNWE5YmUwZWI5NDQ1ZDE5MmZhZTgyMmQyMmJlMDlmL3NlYzphZTVhOWJlMGViOTQ0NWQxOTJmYWU4MjJkMjJiZTA5Zl8zNy9mcmFnOjQ4OGNkZjBhODVlYzRiMDliYWFiN2JhZTlhODA5YjcwL3RhYmxlOmJlZmZiODc1NTNmNzQxYjVhZjFiZTQwMTA3M2ExOWQwL3RhYmxlcmFuZ2U6YmVmZmI4NzU1M2Y3NDFiNWFmMWJlNDAxMDczYTE5ZDBfNS01LTEtMS0yMzQy_44cbca07-b922-4812-a62d-619d7fd57cfb">&#8212;</ix:nonFraction></span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="i08f348302fbc42c98a41fcaf5cfcde43_D20210101-20210630" decimals="2" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate" format="ixt:fixed-zero" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmFlNWE5YmUwZWI5NDQ1ZDE5MmZhZTgyMmQyMmJlMDlmL3NlYzphZTVhOWJlMGViOTQ0NWQxOTJmYWU4MjJkMjJiZTA5Zl8zNy9mcmFnOjQ4OGNkZjBhODVlYzRiMDliYWFiN2JhZTlhODA5YjcwL3RhYmxlOmJlZmZiODc1NTNmNzQxYjVhZjFiZTQwMTA3M2ExOWQwL3RhYmxlcmFuZ2U6YmVmZmI4NzU1M2Y3NDFiNWFmMWJlNDAxMDczYTE5ZDBfNS03LTEtMS0yMzQy_724a78d3-f772-47bb-acf2-6f29a2bcfb91">&#8212;</ix:nonFraction></span></td></tr></table></div></ix:nonNumeric><ix:nonNumeric contextRef="ia855382ada1f4f28aa8ef6da692ff177_D20220101-20220630" name="us-gaap:FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOmFlNWE5YmUwZWI5NDQ1ZDE5MmZhZTgyMmQyMmJlMDlmL3NlYzphZTVhOWJlMGViOTQ0NWQxOTJmYWU4MjJkMjJiZTA5Zl8zNy9mcmFnOjQ4OGNkZjBhODVlYzRiMDliYWFiN2JhZTlhODA5YjcwL3RleHRyZWdpb246NDg4Y2RmMGE4NWVjNGIwOWJhYWI3YmFlOWE4MDliNzBfNDYyNDk_5785d44c-cccf-40a3-9a95-50b82c9ad247" escape="true"><div style="margin-top:9pt;padding-left:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table summarizes the changes in the fair value of the Company&#8217;s Level 3 liabilities (in thousands):</span></div><div style="margin-top:12pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:85.718%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.082%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Balance as of December 31, 2021</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i0e8a6876eeb946269d2c2405fcb009b4_I20211231" decimals="-3" name="us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmFlNWE5YmUwZWI5NDQ1ZDE5MmZhZTgyMmQyMmJlMDlmL3NlYzphZTVhOWJlMGViOTQ0NWQxOTJmYWU4MjJkMjJiZTA5Zl8zNy9mcmFnOjQ4OGNkZjBhODVlYzRiMDliYWFiN2JhZTlhODA5YjcwL3RhYmxlOjlmYjdhODAxMjQzODRkOGE5NjQzMWU3OGY5MDZlN2I0L3RhYmxlcmFuZ2U6OWZiN2E4MDEyNDM4NGQ4YTk2NDMxZTc4ZjkwNmU3YjRfMC0xLTEtMS02MjY_83576e0c-3ea9-428c-a825-949438d8d5c2">146</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Change in fair value of warrant liability</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i4030b6b173eb4417a8b8aa5024f71cc6_D20220101-20220331" decimals="-3" sign="-" name="us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityGainLossIncludedInEarnings" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmFlNWE5YmUwZWI5NDQ1ZDE5MmZhZTgyMmQyMmJlMDlmL3NlYzphZTVhOWJlMGViOTQ0NWQxOTJmYWU4MjJkMjJiZTA5Zl8zNy9mcmFnOjQ4OGNkZjBhODVlYzRiMDliYWFiN2JhZTlhODA5YjcwL3RhYmxlOjlmYjdhODAxMjQzODRkOGE5NjQzMWU3OGY5MDZlN2I0L3RhYmxlcmFuZ2U6OWZiN2E4MDEyNDM4NGQ4YTk2NDMxZTc4ZjkwNmU3YjRfMy0xLTEtMS02MjY_1c0434d1-54f9-442d-a074-4960df5c7c6d">17</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Balance as of March 31, 2022</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i253fb10d701144a8b699b8f06a9a82fd_I20220331" decimals="-3" name="us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmFlNWE5YmUwZWI5NDQ1ZDE5MmZhZTgyMmQyMmJlMDlmL3NlYzphZTVhOWJlMGViOTQ0NWQxOTJmYWU4MjJkMjJiZTA5Zl8zNy9mcmFnOjQ4OGNkZjBhODVlYzRiMDliYWFiN2JhZTlhODA5YjcwL3RhYmxlOjlmYjdhODAxMjQzODRkOGE5NjQzMWU3OGY5MDZlN2I0L3RhYmxlcmFuZ2U6OWZiN2E4MDEyNDM4NGQ4YTk2NDMxZTc4ZjkwNmU3YjRfNC0xLTEtMS02MjY_dfe9ac51-cdc8-40fa-a532-2c38b12ce703">129</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Change in fair value of warrant liability</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i166b12bbf79f408e95f28a9eeaa9d48d_D20220401-20220630" decimals="-3" sign="-" name="us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityGainLossIncludedInEarnings" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmFlNWE5YmUwZWI5NDQ1ZDE5MmZhZTgyMmQyMmJlMDlmL3NlYzphZTVhOWJlMGViOTQ0NWQxOTJmYWU4MjJkMjJiZTA5Zl8zNy9mcmFnOjQ4OGNkZjBhODVlYzRiMDliYWFiN2JhZTlhODA5YjcwL3RhYmxlOjlmYjdhODAxMjQzODRkOGE5NjQzMWU3OGY5MDZlN2I0L3RhYmxlcmFuZ2U6OWZiN2E4MDEyNDM4NGQ4YTk2NDMxZTc4ZjkwNmU3YjRfNy0xLTEtMS02MjY_79f8ce7f-ab9d-4af6-968b-1eb4fd180b92">105</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Balance as of June 30, 2022</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ia41275e687284fbe8c0cd8cfc3637073_I20220630" decimals="-3" name="us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmFlNWE5YmUwZWI5NDQ1ZDE5MmZhZTgyMmQyMmJlMDlmL3NlYzphZTVhOWJlMGViOTQ0NWQxOTJmYWU4MjJkMjJiZTA5Zl8zNy9mcmFnOjQ4OGNkZjBhODVlYzRiMDliYWFiN2JhZTlhODA5YjcwL3RhYmxlOjlmYjdhODAxMjQzODRkOGE5NjQzMWU3OGY5MDZlN2I0L3RhYmxlcmFuZ2U6OWZiN2E4MDEyNDM4NGQ4YTk2NDMxZTc4ZjkwNmU3YjRfOC0xLTEtMS02MjY_142ce3d5-565b-4669-85e5-d5060bd53b1b">24</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div></ix:nonNumeric><ix:continuation id="ia4d5ef225040439689cc1ee5a26577a7"><div style="margin-top:9pt;padding-left:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">As of June&#160;30, 2022 and December&#160;31, 2021, the Company maintains letters of credit of $<ix:nonFraction unitRef="usd" contextRef="ieb434e1a310d48ce8a877397d66245d6_I20220630" decimals="-5" name="us-gaap:LettersOfCreditOutstandingAmount" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmFlNWE5YmUwZWI5NDQ1ZDE5MmZhZTgyMmQyMmJlMDlmL3NlYzphZTVhOWJlMGViOTQ0NWQxOTJmYWU4MjJkMjJiZTA5Zl8zNy9mcmFnOjQ4OGNkZjBhODVlYzRiMDliYWFiN2JhZTlhODA5YjcwL3RleHRyZWdpb246NDg4Y2RmMGE4NWVjNGIwOWJhYWI3YmFlOWE4MDliNzBfMzY4NDY_f8d5690c-477f-417e-8674-ee20b0612974">3.5</ix:nonFraction> million and $<ix:nonFraction unitRef="usd" contextRef="if16c69c24d79407cacc36646afe73f31_I20211231" decimals="-5" name="us-gaap:LettersOfCreditOutstandingAmount" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmFlNWE5YmUwZWI5NDQ1ZDE5MmZhZTgyMmQyMmJlMDlmL3NlYzphZTVhOWJlMGViOTQ0NWQxOTJmYWU4MjJkMjJiZTA5Zl8zNy9mcmFnOjQ4OGNkZjBhODVlYzRiMDliYWFiN2JhZTlhODA5YjcwL3RleHRyZWdpb246NDg4Y2RmMGE4NWVjNGIwOWJhYWI3YmFlOWE4MDliNzBfMzY4NTM_9d5ca0a0-a56e-4aa0-897f-60711df9b503">3.0</ix:nonFraction>&#160;million, respectively, related to its lease arrangements, which are secured by money market accounts in accordance with certain of its lease agreements. The amounts are recorded at fair value using Level 1 inputs and included as restricted cash in the condensed consolidated balance sheets.</span></div><div style="margin-top:9pt;padding-left:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company believes the carrying amount of cash and cash equivalents, accounts payable and accrued expenses approximate their estimated fair values due to the short-term nature of these accounts.</span></div></ix:continuation><div style="margin-top:15pt;padding-left:27pt;text-indent:-27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">(l)&#160;&#160;&#160;&#160;<ix:nonNumeric contextRef="ia855382ada1f4f28aa8ef6da692ff177_D20220101-20220630" name="us-gaap:NewAccountingPronouncementsPolicyPolicyTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOmFlNWE5YmUwZWI5NDQ1ZDE5MmZhZTgyMmQyMmJlMDlmL3NlYzphZTVhOWJlMGViOTQ0NWQxOTJmYWU4MjJkMjJiZTA5Zl8zNy9mcmFnOjQ4OGNkZjBhODVlYzRiMDliYWFiN2JhZTlhODA5YjcwL3RleHRyZWdpb246NDg4Y2RmMGE4NWVjNGIwOWJhYWI3YmFlOWE4MDliNzBfNDYyNjA_cd04335a-1120-430d-aa7d-1a5023bd9291" continuedAt="i5178da05945340d3b8f8cca14a4fbc86" escape="true">Accounting Pronouncements Issued But Not Yet Effective </ix:nonNumeric></span></div><ix:continuation id="i5178da05945340d3b8f8cca14a4fbc86" continuedAt="i35c1ccb484504fbfb06c20c462f705d9"><div style="margin-top:9pt;padding-left:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In June 2022, the Financial Accounting Standards Board issued ASU No. 2022-03, </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Fair Value Measurement of Equity Securities Subject to Contractual Sale Restrictions </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">("ASU 2022-03"). Under the guidance of ASU 2022-03, a contractual restriction on the sale of an equity security is not considered in measuring the security's fair value. ASU 2022-03 also requires certain disclosures for equity securities that are subject to contractual restrictions. For public business entities, the provisions of ASU 2022-03 are effective for fiscal years beginning after December 15, 2023, and interim periods within those fiscal years. For all other entities, the amendments are effective for fiscal years beginning after December 15, 2024, and interim periods within those fiscal years. Early adoption is permitted for both interim and annual financial statements that have not yet been issued or made available for issuance. The Company is still evaluating the impact of this pronouncement on the consolidated financial statements.</span></div><div style="margin-top:9pt;padding-left:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company does not believe that any other recently issued, but not yet effective accounting pronouncements, if adopted, would have a material impact on its condensed consolidated financial statements or disclosures.</span></div></ix:continuation></ix:continuation><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">13</span></div></div></div><div id="iae5a9be0eb9445d192fae822d22be09f_43"></div><hr style="page-break-after:always"/><div style="min-height:45pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#iae5a9be0eb9445d192fae822d22be09f_7">Table of Contents</a></span></div></div><div style="margin-top:15pt;padding-left:27pt;text-indent:-27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">2.&#160;&#160;&#160;&#160;<ix:nonNumeric contextRef="ia855382ada1f4f28aa8ef6da692ff177_D20220101-20220630" name="us-gaap:SupplementalBalanceSheetDisclosuresTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOmFlNWE5YmUwZWI5NDQ1ZDE5MmZhZTgyMmQyMmJlMDlmL3NlYzphZTVhOWJlMGViOTQ0NWQxOTJmYWU4MjJkMjJiZTA5Zl80My9mcmFnOmIzZWFmOGZlNmQ2MzQzYmVhMWUwZDUzYjc5MGQ5Njg2L3RleHRyZWdpb246YjNlYWY4ZmU2ZDYzNDNiZWExZTBkNTNiNzkwZDk2ODZfMTMwOA_683c36a4-345d-4ee7-9d5e-c212b3e14aad" continuedAt="ia5402028ca974ee1998bc52d36f521ee" escape="true">Balance Sheet Details</ix:nonNumeric></span></div><ix:continuation id="ia5402028ca974ee1998bc52d36f521ee" continuedAt="id3fd88b767944490adc1f26a1fa8e53e"><div style="margin-top:15pt;padding-left:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Short-Term Marketable Securities</span></div><ix:nonNumeric contextRef="ia855382ada1f4f28aa8ef6da692ff177_D20220101-20220630" name="us-gaap:DebtSecuritiesAvailableForSaleTableTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOmFlNWE5YmUwZWI5NDQ1ZDE5MmZhZTgyMmQyMmJlMDlmL3NlYzphZTVhOWJlMGViOTQ0NWQxOTJmYWU4MjJkMjJiZTA5Zl80My9mcmFnOmIzZWFmOGZlNmQ2MzQzYmVhMWUwZDUzYjc5MGQ5Njg2L3RleHRyZWdpb246YjNlYWY4ZmU2ZDYzNDNiZWExZTBkNTNiNzkwZDk2ODZfMTMwOQ_80275b72-dffb-429b-b1a3-5a12a89d4d4e" escape="true"><div style="margin-top:9pt;padding-left:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The amortized cost, gross unrealized holding gains, gross unrealized holding losses, and fair value of debt securities classified as available-for-sale securities by major security type and class of security as of June&#160;30, 2022 were as follows (in thousands):</span></div><div style="margin-top:12pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:44.354%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.081%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.406%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.081%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.406%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.081%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.406%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.085%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="21" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">June 30, 2022</span></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Amortized Cost</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Gross Unrealized<br/>Gains</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Gross Unrealized<br/>Losses</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Estimated<br/>Market<br/>Value</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Short-term marketable securities, available-for-sale:</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Corporate debt securities</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if86a878c756a461abc20e5dc5cf1667c_I20220630" decimals="-3" name="us-gaap:AvailableForSaleDebtSecuritiesAmortizedCostBasis" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmFlNWE5YmUwZWI5NDQ1ZDE5MmZhZTgyMmQyMmJlMDlmL3NlYzphZTVhOWJlMGViOTQ0NWQxOTJmYWU4MjJkMjJiZTA5Zl80My9mcmFnOmIzZWFmOGZlNmQ2MzQzYmVhMWUwZDUzYjc5MGQ5Njg2L3RhYmxlOjMxYTQ1NzVlZTMxMDQ4ZDFhZGFiYmFmYjliZDg0OWZhL3RhYmxlcmFuZ2U6MzFhNDU3NWVlMzEwNDhkMWFkYWJiYWZiOWJkODQ5ZmFfMy0xLTEtMS02MjY_fd653a49-3e92-4d5d-8e61-8c301982d6e7">15,361</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if86a878c756a461abc20e5dc5cf1667c_I20220630" decimals="-3" name="us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax" format="ixt:fixed-zero" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmFlNWE5YmUwZWI5NDQ1ZDE5MmZhZTgyMmQyMmJlMDlmL3NlYzphZTVhOWJlMGViOTQ0NWQxOTJmYWU4MjJkMjJiZTA5Zl80My9mcmFnOmIzZWFmOGZlNmQ2MzQzYmVhMWUwZDUzYjc5MGQ5Njg2L3RhYmxlOjMxYTQ1NzVlZTMxMDQ4ZDFhZGFiYmFmYjliZDg0OWZhL3RhYmxlcmFuZ2U6MzFhNDU3NWVlMzEwNDhkMWFkYWJiYWZiOWJkODQ5ZmFfMy0zLTEtMS02MjY_250fb7ab-d7a2-45a4-a98a-c0a7afd82ad9">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="if86a878c756a461abc20e5dc5cf1667c_I20220630" decimals="-3" name="us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmFlNWE5YmUwZWI5NDQ1ZDE5MmZhZTgyMmQyMmJlMDlmL3NlYzphZTVhOWJlMGViOTQ0NWQxOTJmYWU4MjJkMjJiZTA5Zl80My9mcmFnOmIzZWFmOGZlNmQ2MzQzYmVhMWUwZDUzYjc5MGQ5Njg2L3RhYmxlOjMxYTQ1NzVlZTMxMDQ4ZDFhZGFiYmFmYjliZDg0OWZhL3RhYmxlcmFuZ2U6MzFhNDU3NWVlMzEwNDhkMWFkYWJiYWZiOWJkODQ5ZmFfMy01LTEtMS02MjY_8a87f886-c09b-4c6e-abfd-9ca77c9992cd">269</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if86a878c756a461abc20e5dc5cf1667c_I20220630" decimals="-3" name="us-gaap:AvailableForSaleSecuritiesDebtSecurities" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmFlNWE5YmUwZWI5NDQ1ZDE5MmZhZTgyMmQyMmJlMDlmL3NlYzphZTVhOWJlMGViOTQ0NWQxOTJmYWU4MjJkMjJiZTA5Zl80My9mcmFnOmIzZWFmOGZlNmQ2MzQzYmVhMWUwZDUzYjc5MGQ5Njg2L3RhYmxlOjMxYTQ1NzVlZTMxMDQ4ZDFhZGFiYmFmYjliZDg0OWZhL3RhYmxlcmFuZ2U6MzFhNDU3NWVlMzEwNDhkMWFkYWJiYWZiOWJkODQ5ZmFfMy03LTEtMS02MjY_3fca73b7-e773-46be-8130-e421485cf26b">15,092</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Municipal debt securities</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ibd768261001c4410bcbcfa14c060fd74_I20220630" decimals="-3" name="us-gaap:AvailableForSaleDebtSecuritiesAmortizedCostBasis" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmFlNWE5YmUwZWI5NDQ1ZDE5MmZhZTgyMmQyMmJlMDlmL3NlYzphZTVhOWJlMGViOTQ0NWQxOTJmYWU4MjJkMjJiZTA5Zl80My9mcmFnOmIzZWFmOGZlNmQ2MzQzYmVhMWUwZDUzYjc5MGQ5Njg2L3RhYmxlOjMxYTQ1NzVlZTMxMDQ4ZDFhZGFiYmFmYjliZDg0OWZhL3RhYmxlcmFuZ2U6MzFhNDU3NWVlMzEwNDhkMWFkYWJiYWZiOWJkODQ5ZmFfNC0xLTEtMS02MjY_942ccb5e-8716-405e-9eea-51a77a7eb68e">3,666</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ibd768261001c4410bcbcfa14c060fd74_I20220630" decimals="-3" name="us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax" format="ixt:fixed-zero" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmFlNWE5YmUwZWI5NDQ1ZDE5MmZhZTgyMmQyMmJlMDlmL3NlYzphZTVhOWJlMGViOTQ0NWQxOTJmYWU4MjJkMjJiZTA5Zl80My9mcmFnOmIzZWFmOGZlNmQ2MzQzYmVhMWUwZDUzYjc5MGQ5Njg2L3RhYmxlOjMxYTQ1NzVlZTMxMDQ4ZDFhZGFiYmFmYjliZDg0OWZhL3RhYmxlcmFuZ2U6MzFhNDU3NWVlMzEwNDhkMWFkYWJiYWZiOWJkODQ5ZmFfNC0zLTEtMS02MjY_9d918720-02a2-4be0-8507-5901b23464d9">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ibd768261001c4410bcbcfa14c060fd74_I20220630" decimals="-3" name="us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmFlNWE5YmUwZWI5NDQ1ZDE5MmZhZTgyMmQyMmJlMDlmL3NlYzphZTVhOWJlMGViOTQ0NWQxOTJmYWU4MjJkMjJiZTA5Zl80My9mcmFnOmIzZWFmOGZlNmQ2MzQzYmVhMWUwZDUzYjc5MGQ5Njg2L3RhYmxlOjMxYTQ1NzVlZTMxMDQ4ZDFhZGFiYmFmYjliZDg0OWZhL3RhYmxlcmFuZ2U6MzFhNDU3NWVlMzEwNDhkMWFkYWJiYWZiOWJkODQ5ZmFfNC01LTEtMS02MjY_7f6ccdce-046c-4d8a-9329-d8da32b2af0e">25</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ibd768261001c4410bcbcfa14c060fd74_I20220630" decimals="-3" name="us-gaap:AvailableForSaleSecuritiesDebtSecurities" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmFlNWE5YmUwZWI5NDQ1ZDE5MmZhZTgyMmQyMmJlMDlmL3NlYzphZTVhOWJlMGViOTQ0NWQxOTJmYWU4MjJkMjJiZTA5Zl80My9mcmFnOmIzZWFmOGZlNmQ2MzQzYmVhMWUwZDUzYjc5MGQ5Njg2L3RhYmxlOjMxYTQ1NzVlZTMxMDQ4ZDFhZGFiYmFmYjliZDg0OWZhL3RhYmxlcmFuZ2U6MzFhNDU3NWVlMzEwNDhkMWFkYWJiYWZiOWJkODQ5ZmFfNC03LTEtMS02MjY_4b867e72-b04d-40ce-a868-939dbfb9df0c">3,641</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">U.S. government debt securities</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i9b0f17d8e871417bbb113b30e575a8a5_I20220630" decimals="-3" name="us-gaap:AvailableForSaleDebtSecuritiesAmortizedCostBasis" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmFlNWE5YmUwZWI5NDQ1ZDE5MmZhZTgyMmQyMmJlMDlmL3NlYzphZTVhOWJlMGViOTQ0NWQxOTJmYWU4MjJkMjJiZTA5Zl80My9mcmFnOmIzZWFmOGZlNmQ2MzQzYmVhMWUwZDUzYjc5MGQ5Njg2L3RhYmxlOjMxYTQ1NzVlZTMxMDQ4ZDFhZGFiYmFmYjliZDg0OWZhL3RhYmxlcmFuZ2U6MzFhNDU3NWVlMzEwNDhkMWFkYWJiYWZiOWJkODQ5ZmFfNS0xLTEtMS02MjY_59a04494-b970-4715-bc5c-2697e1bb4d6b">35,295</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i9b0f17d8e871417bbb113b30e575a8a5_I20220630" decimals="-3" name="us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmFlNWE5YmUwZWI5NDQ1ZDE5MmZhZTgyMmQyMmJlMDlmL3NlYzphZTVhOWJlMGViOTQ0NWQxOTJmYWU4MjJkMjJiZTA5Zl80My9mcmFnOmIzZWFmOGZlNmQ2MzQzYmVhMWUwZDUzYjc5MGQ5Njg2L3RhYmxlOjMxYTQ1NzVlZTMxMDQ4ZDFhZGFiYmFmYjliZDg0OWZhL3RhYmxlcmFuZ2U6MzFhNDU3NWVlMzEwNDhkMWFkYWJiYWZiOWJkODQ5ZmFfNS0zLTEtMS02MjY_4b725a76-da5f-4d0e-b126-08f828dbe8fa">9</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i9b0f17d8e871417bbb113b30e575a8a5_I20220630" decimals="-3" name="us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmFlNWE5YmUwZWI5NDQ1ZDE5MmZhZTgyMmQyMmJlMDlmL3NlYzphZTVhOWJlMGViOTQ0NWQxOTJmYWU4MjJkMjJiZTA5Zl80My9mcmFnOmIzZWFmOGZlNmQ2MzQzYmVhMWUwZDUzYjc5MGQ5Njg2L3RhYmxlOjMxYTQ1NzVlZTMxMDQ4ZDFhZGFiYmFmYjliZDg0OWZhL3RhYmxlcmFuZ2U6MzFhNDU3NWVlMzEwNDhkMWFkYWJiYWZiOWJkODQ5ZmFfNS01LTEtMS02MjY_a9eeeb52-859e-4bc2-960b-084f0604d7aa">580</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i9b0f17d8e871417bbb113b30e575a8a5_I20220630" decimals="-3" name="us-gaap:AvailableForSaleSecuritiesDebtSecurities" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmFlNWE5YmUwZWI5NDQ1ZDE5MmZhZTgyMmQyMmJlMDlmL3NlYzphZTVhOWJlMGViOTQ0NWQxOTJmYWU4MjJkMjJiZTA5Zl80My9mcmFnOmIzZWFmOGZlNmQ2MzQzYmVhMWUwZDUzYjc5MGQ5Njg2L3RhYmxlOjMxYTQ1NzVlZTMxMDQ4ZDFhZGFiYmFmYjliZDg0OWZhL3RhYmxlcmFuZ2U6MzFhNDU3NWVlMzEwNDhkMWFkYWJiYWZiOWJkODQ5ZmFfNS03LTEtMS02MjY_02b633f1-4285-4517-9fbf-58c855e6cffe">34,724</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 28pt;text-align:left;text-indent:-9pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total short-term marketable securities, available-for-sale</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i4c8f247d12134a9886d56e1c8b024425_I20220630" decimals="-3" name="us-gaap:AvailableForSaleDebtSecuritiesAmortizedCostBasis" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmFlNWE5YmUwZWI5NDQ1ZDE5MmZhZTgyMmQyMmJlMDlmL3NlYzphZTVhOWJlMGViOTQ0NWQxOTJmYWU4MjJkMjJiZTA5Zl80My9mcmFnOmIzZWFmOGZlNmQ2MzQzYmVhMWUwZDUzYjc5MGQ5Njg2L3RhYmxlOjMxYTQ1NzVlZTMxMDQ4ZDFhZGFiYmFmYjliZDg0OWZhL3RhYmxlcmFuZ2U6MzFhNDU3NWVlMzEwNDhkMWFkYWJiYWZiOWJkODQ5ZmFfNi0xLTEtMS02MjY_3e9a9200-a341-488d-90fc-bcda5730311f">54,322</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i4c8f247d12134a9886d56e1c8b024425_I20220630" decimals="-3" name="us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmFlNWE5YmUwZWI5NDQ1ZDE5MmZhZTgyMmQyMmJlMDlmL3NlYzphZTVhOWJlMGViOTQ0NWQxOTJmYWU4MjJkMjJiZTA5Zl80My9mcmFnOmIzZWFmOGZlNmQ2MzQzYmVhMWUwZDUzYjc5MGQ5Njg2L3RhYmxlOjMxYTQ1NzVlZTMxMDQ4ZDFhZGFiYmFmYjliZDg0OWZhL3RhYmxlcmFuZ2U6MzFhNDU3NWVlMzEwNDhkMWFkYWJiYWZiOWJkODQ5ZmFfNi0zLTEtMS02MjY_46c892eb-a18d-4060-bd8d-48cdd022f41b">9</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i4c8f247d12134a9886d56e1c8b024425_I20220630" decimals="-3" name="us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmFlNWE5YmUwZWI5NDQ1ZDE5MmZhZTgyMmQyMmJlMDlmL3NlYzphZTVhOWJlMGViOTQ0NWQxOTJmYWU4MjJkMjJiZTA5Zl80My9mcmFnOmIzZWFmOGZlNmQ2MzQzYmVhMWUwZDUzYjc5MGQ5Njg2L3RhYmxlOjMxYTQ1NzVlZTMxMDQ4ZDFhZGFiYmFmYjliZDg0OWZhL3RhYmxlcmFuZ2U6MzFhNDU3NWVlMzEwNDhkMWFkYWJiYWZiOWJkODQ5ZmFfNi01LTEtMS02MjY_813aa756-108e-481c-b425-5c0d9da112b0">874</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i4c8f247d12134a9886d56e1c8b024425_I20220630" decimals="-3" name="us-gaap:AvailableForSaleSecuritiesDebtSecurities" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmFlNWE5YmUwZWI5NDQ1ZDE5MmZhZTgyMmQyMmJlMDlmL3NlYzphZTVhOWJlMGViOTQ0NWQxOTJmYWU4MjJkMjJiZTA5Zl80My9mcmFnOmIzZWFmOGZlNmQ2MzQzYmVhMWUwZDUzYjc5MGQ5Njg2L3RhYmxlOjMxYTQ1NzVlZTMxMDQ4ZDFhZGFiYmFmYjliZDg0OWZhL3RhYmxlcmFuZ2U6MzFhNDU3NWVlMzEwNDhkMWFkYWJiYWZiOWJkODQ5ZmFfNi03LTEtMS02MjY_57b9650b-165a-4887-8f1d-204084c19975">53,457</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><div style="margin-top:9pt;padding-left:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The amortized cost, gross unrealized holding gains, gross unrealized holding losses, and fair value of debt securities classified as available-for-sale securities by major security type and class of security as of December&#160;31, 2021 were as follows (in thousands):</span></div><div style="margin-top:12pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:44.354%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.081%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.406%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.081%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.406%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.081%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.406%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.085%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="21" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">December 31, 2021</span></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Amortized Cost</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Gross Unrealized<br/>Gains</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Gross Unrealized<br/>Losses</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Estimated<br/>Market<br/>Value</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Short-term marketable securities, available-for-sale:</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Corporate debt securities</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i267f31f0cb5a4cb5bd58dd78cd514f48_I20211231" decimals="-3" name="us-gaap:AvailableForSaleDebtSecuritiesAmortizedCostBasis" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmFlNWE5YmUwZWI5NDQ1ZDE5MmZhZTgyMmQyMmJlMDlmL3NlYzphZTVhOWJlMGViOTQ0NWQxOTJmYWU4MjJkMjJiZTA5Zl80My9mcmFnOmIzZWFmOGZlNmQ2MzQzYmVhMWUwZDUzYjc5MGQ5Njg2L3RhYmxlOmIyYmE0MDBlYmE4MDRiNzI5YzU5NzZlZWRmZDQ1NDAxL3RhYmxlcmFuZ2U6YjJiYTQwMGViYTgwNGI3MjljNTk3NmVlZGZkNDU0MDFfMy0xLTEtMS02MjY_ae6c3088-c11a-4ae9-b141-c24ee6d8421d">15,385</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i267f31f0cb5a4cb5bd58dd78cd514f48_I20211231" decimals="-3" name="us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax" format="ixt:fixed-zero" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmFlNWE5YmUwZWI5NDQ1ZDE5MmZhZTgyMmQyMmJlMDlmL3NlYzphZTVhOWJlMGViOTQ0NWQxOTJmYWU4MjJkMjJiZTA5Zl80My9mcmFnOmIzZWFmOGZlNmQ2MzQzYmVhMWUwZDUzYjc5MGQ5Njg2L3RhYmxlOmIyYmE0MDBlYmE4MDRiNzI5YzU5NzZlZWRmZDQ1NDAxL3RhYmxlcmFuZ2U6YjJiYTQwMGViYTgwNGI3MjljNTk3NmVlZGZkNDU0MDFfMy0zLTEtMS02MjY_95a892cd-e4c8-4b42-8438-0f7c352ceef9">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i267f31f0cb5a4cb5bd58dd78cd514f48_I20211231" decimals="-3" name="us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmFlNWE5YmUwZWI5NDQ1ZDE5MmZhZTgyMmQyMmJlMDlmL3NlYzphZTVhOWJlMGViOTQ0NWQxOTJmYWU4MjJkMjJiZTA5Zl80My9mcmFnOmIzZWFmOGZlNmQ2MzQzYmVhMWUwZDUzYjc5MGQ5Njg2L3RhYmxlOmIyYmE0MDBlYmE4MDRiNzI5YzU5NzZlZWRmZDQ1NDAxL3RhYmxlcmFuZ2U6YjJiYTQwMGViYTgwNGI3MjljNTk3NmVlZGZkNDU0MDFfMy01LTEtMS02MjY_741e9182-72ff-4052-bc79-7fb464c26512">33</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i267f31f0cb5a4cb5bd58dd78cd514f48_I20211231" decimals="-3" name="us-gaap:AvailableForSaleSecuritiesDebtSecurities" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmFlNWE5YmUwZWI5NDQ1ZDE5MmZhZTgyMmQyMmJlMDlmL3NlYzphZTVhOWJlMGViOTQ0NWQxOTJmYWU4MjJkMjJiZTA5Zl80My9mcmFnOmIzZWFmOGZlNmQ2MzQzYmVhMWUwZDUzYjc5MGQ5Njg2L3RhYmxlOmIyYmE0MDBlYmE4MDRiNzI5YzU5NzZlZWRmZDQ1NDAxL3RhYmxlcmFuZ2U6YjJiYTQwMGViYTgwNGI3MjljNTk3NmVlZGZkNDU0MDFfMy03LTEtMS02MjY_17aa234f-d22a-4fef-b431-484b0c9845e6">15,352</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Municipal debt securities</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i3ec37ec0a1104b00bb3614670349fb31_I20211231" decimals="-3" name="us-gaap:AvailableForSaleDebtSecuritiesAmortizedCostBasis" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmFlNWE5YmUwZWI5NDQ1ZDE5MmZhZTgyMmQyMmJlMDlmL3NlYzphZTVhOWJlMGViOTQ0NWQxOTJmYWU4MjJkMjJiZTA5Zl80My9mcmFnOmIzZWFmOGZlNmQ2MzQzYmVhMWUwZDUzYjc5MGQ5Njg2L3RhYmxlOmIyYmE0MDBlYmE4MDRiNzI5YzU5NzZlZWRmZDQ1NDAxL3RhYmxlcmFuZ2U6YjJiYTQwMGViYTgwNGI3MjljNTk3NmVlZGZkNDU0MDFfNC0xLTEtMS02MjY_50652c22-ae4c-4393-a79b-6f04644786cc">7,417</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i3ec37ec0a1104b00bb3614670349fb31_I20211231" decimals="-3" name="us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax" format="ixt:fixed-zero" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmFlNWE5YmUwZWI5NDQ1ZDE5MmZhZTgyMmQyMmJlMDlmL3NlYzphZTVhOWJlMGViOTQ0NWQxOTJmYWU4MjJkMjJiZTA5Zl80My9mcmFnOmIzZWFmOGZlNmQ2MzQzYmVhMWUwZDUzYjc5MGQ5Njg2L3RhYmxlOmIyYmE0MDBlYmE4MDRiNzI5YzU5NzZlZWRmZDQ1NDAxL3RhYmxlcmFuZ2U6YjJiYTQwMGViYTgwNGI3MjljNTk3NmVlZGZkNDU0MDFfNC0zLTEtMS02MjY_e318053a-7c30-4078-890d-e26bfa5d97ac">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i3ec37ec0a1104b00bb3614670349fb31_I20211231" decimals="-3" name="us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmFlNWE5YmUwZWI5NDQ1ZDE5MmZhZTgyMmQyMmJlMDlmL3NlYzphZTVhOWJlMGViOTQ0NWQxOTJmYWU4MjJkMjJiZTA5Zl80My9mcmFnOmIzZWFmOGZlNmQ2MzQzYmVhMWUwZDUzYjc5MGQ5Njg2L3RhYmxlOmIyYmE0MDBlYmE4MDRiNzI5YzU5NzZlZWRmZDQ1NDAxL3RhYmxlcmFuZ2U6YjJiYTQwMGViYTgwNGI3MjljNTk3NmVlZGZkNDU0MDFfNC01LTEtMS02MjY_4b63c438-dd26-4b0e-936a-2fad526e756b">5</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i3ec37ec0a1104b00bb3614670349fb31_I20211231" decimals="-3" name="us-gaap:AvailableForSaleSecuritiesDebtSecurities" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmFlNWE5YmUwZWI5NDQ1ZDE5MmZhZTgyMmQyMmJlMDlmL3NlYzphZTVhOWJlMGViOTQ0NWQxOTJmYWU4MjJkMjJiZTA5Zl80My9mcmFnOmIzZWFmOGZlNmQ2MzQzYmVhMWUwZDUzYjc5MGQ5Njg2L3RhYmxlOmIyYmE0MDBlYmE4MDRiNzI5YzU5NzZlZWRmZDQ1NDAxL3RhYmxlcmFuZ2U6YjJiYTQwMGViYTgwNGI3MjljNTk3NmVlZGZkNDU0MDFfNC03LTEtMS02MjY_cb9ea96d-0d70-4ec5-abfa-0551cf2b37b1">7,412</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">U.S. government debt securities</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i10f3d8ad519640d9bc20a9ada45d58e7_I20211231" decimals="-3" name="us-gaap:AvailableForSaleDebtSecuritiesAmortizedCostBasis" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmFlNWE5YmUwZWI5NDQ1ZDE5MmZhZTgyMmQyMmJlMDlmL3NlYzphZTVhOWJlMGViOTQ0NWQxOTJmYWU4MjJkMjJiZTA5Zl80My9mcmFnOmIzZWFmOGZlNmQ2MzQzYmVhMWUwZDUzYjc5MGQ5Njg2L3RhYmxlOmIyYmE0MDBlYmE4MDRiNzI5YzU5NzZlZWRmZDQ1NDAxL3RhYmxlcmFuZ2U6YjJiYTQwMGViYTgwNGI3MjljNTk3NmVlZGZkNDU0MDFfNS0xLTEtMS02MjY_04ad8e69-0080-47b5-b08b-aaf7d80d2ff9">25,771</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i10f3d8ad519640d9bc20a9ada45d58e7_I20211231" decimals="-3" name="us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmFlNWE5YmUwZWI5NDQ1ZDE5MmZhZTgyMmQyMmJlMDlmL3NlYzphZTVhOWJlMGViOTQ0NWQxOTJmYWU4MjJkMjJiZTA5Zl80My9mcmFnOmIzZWFmOGZlNmQ2MzQzYmVhMWUwZDUzYjc5MGQ5Njg2L3RhYmxlOmIyYmE0MDBlYmE4MDRiNzI5YzU5NzZlZWRmZDQ1NDAxL3RhYmxlcmFuZ2U6YjJiYTQwMGViYTgwNGI3MjljNTk3NmVlZGZkNDU0MDFfNS0zLTEtMS02MjY_c10146d4-4350-48b4-8992-74cbc69a1eb0">1</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i10f3d8ad519640d9bc20a9ada45d58e7_I20211231" decimals="-3" name="us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmFlNWE5YmUwZWI5NDQ1ZDE5MmZhZTgyMmQyMmJlMDlmL3NlYzphZTVhOWJlMGViOTQ0NWQxOTJmYWU4MjJkMjJiZTA5Zl80My9mcmFnOmIzZWFmOGZlNmQ2MzQzYmVhMWUwZDUzYjc5MGQ5Njg2L3RhYmxlOmIyYmE0MDBlYmE4MDRiNzI5YzU5NzZlZWRmZDQ1NDAxL3RhYmxlcmFuZ2U6YjJiYTQwMGViYTgwNGI3MjljNTk3NmVlZGZkNDU0MDFfNS01LTEtMS02MjY_472ce746-74f7-4768-877f-b2caa87edd9b">87</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i10f3d8ad519640d9bc20a9ada45d58e7_I20211231" decimals="-3" name="us-gaap:AvailableForSaleSecuritiesDebtSecurities" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmFlNWE5YmUwZWI5NDQ1ZDE5MmZhZTgyMmQyMmJlMDlmL3NlYzphZTVhOWJlMGViOTQ0NWQxOTJmYWU4MjJkMjJiZTA5Zl80My9mcmFnOmIzZWFmOGZlNmQ2MzQzYmVhMWUwZDUzYjc5MGQ5Njg2L3RhYmxlOmIyYmE0MDBlYmE4MDRiNzI5YzU5NzZlZWRmZDQ1NDAxL3RhYmxlcmFuZ2U6YjJiYTQwMGViYTgwNGI3MjljNTk3NmVlZGZkNDU0MDFfNS03LTEtMS02MjY_2e86c763-5890-4b06-9575-9dc4d109a15b">25,685</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 28pt;text-align:left;text-indent:-9pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total short-term marketable securities, available-for-sale</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i87bf777ccf5f4f93bc9be7a2cbba61c1_I20211231" decimals="-3" name="us-gaap:AvailableForSaleDebtSecuritiesAmortizedCostBasis" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmFlNWE5YmUwZWI5NDQ1ZDE5MmZhZTgyMmQyMmJlMDlmL3NlYzphZTVhOWJlMGViOTQ0NWQxOTJmYWU4MjJkMjJiZTA5Zl80My9mcmFnOmIzZWFmOGZlNmQ2MzQzYmVhMWUwZDUzYjc5MGQ5Njg2L3RhYmxlOmIyYmE0MDBlYmE4MDRiNzI5YzU5NzZlZWRmZDQ1NDAxL3RhYmxlcmFuZ2U6YjJiYTQwMGViYTgwNGI3MjljNTk3NmVlZGZkNDU0MDFfNi0xLTEtMS02MjY_0dc1d574-4472-4159-98cb-c2bcadd4c25b">48,573</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i87bf777ccf5f4f93bc9be7a2cbba61c1_I20211231" decimals="-3" name="us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmFlNWE5YmUwZWI5NDQ1ZDE5MmZhZTgyMmQyMmJlMDlmL3NlYzphZTVhOWJlMGViOTQ0NWQxOTJmYWU4MjJkMjJiZTA5Zl80My9mcmFnOmIzZWFmOGZlNmQ2MzQzYmVhMWUwZDUzYjc5MGQ5Njg2L3RhYmxlOmIyYmE0MDBlYmE4MDRiNzI5YzU5NzZlZWRmZDQ1NDAxL3RhYmxlcmFuZ2U6YjJiYTQwMGViYTgwNGI3MjljNTk3NmVlZGZkNDU0MDFfNi0zLTEtMS02MjY_2361f021-c335-40c4-9f58-df41d072715b">1</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i87bf777ccf5f4f93bc9be7a2cbba61c1_I20211231" decimals="-3" name="us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmFlNWE5YmUwZWI5NDQ1ZDE5MmZhZTgyMmQyMmJlMDlmL3NlYzphZTVhOWJlMGViOTQ0NWQxOTJmYWU4MjJkMjJiZTA5Zl80My9mcmFnOmIzZWFmOGZlNmQ2MzQzYmVhMWUwZDUzYjc5MGQ5Njg2L3RhYmxlOmIyYmE0MDBlYmE4MDRiNzI5YzU5NzZlZWRmZDQ1NDAxL3RhYmxlcmFuZ2U6YjJiYTQwMGViYTgwNGI3MjljNTk3NmVlZGZkNDU0MDFfNi01LTEtMS02MjY_05246fb4-5fd8-46ec-b47c-6b7290e1b6c2">125</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i87bf777ccf5f4f93bc9be7a2cbba61c1_I20211231" decimals="-3" name="us-gaap:AvailableForSaleSecuritiesDebtSecurities" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmFlNWE5YmUwZWI5NDQ1ZDE5MmZhZTgyMmQyMmJlMDlmL3NlYzphZTVhOWJlMGViOTQ0NWQxOTJmYWU4MjJkMjJiZTA5Zl80My9mcmFnOmIzZWFmOGZlNmQ2MzQzYmVhMWUwZDUzYjc5MGQ5Njg2L3RhYmxlOmIyYmE0MDBlYmE4MDRiNzI5YzU5NzZlZWRmZDQ1NDAxL3RhYmxlcmFuZ2U6YjJiYTQwMGViYTgwNGI3MjljNTk3NmVlZGZkNDU0MDFfNi03LTEtMS02MjY_6cb0e050-f107-4696-a036-9ac0200f0fca">48,449</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div></ix:nonNumeric><div style="margin-top:9pt;padding-left:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">As of June&#160;30, 2022, the estimated market value of debt securities with contractual maturities of less than twelve months was $<ix:nonFraction unitRef="usd" contextRef="i4c8f247d12134a9886d56e1c8b024425_I20220630" decimals="-5" name="dmtk:EstimatedMarketValueOfDebtSecuritiesWithContractualMaturitiesOfLessThan12Months" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmFlNWE5YmUwZWI5NDQ1ZDE5MmZhZTgyMmQyMmJlMDlmL3NlYzphZTVhOWJlMGViOTQ0NWQxOTJmYWU4MjJkMjJiZTA5Zl80My9mcmFnOmIzZWFmOGZlNmQ2MzQzYmVhMWUwZDUzYjc5MGQ5Njg2L3RleHRyZWdpb246YjNlYWY4ZmU2ZDYzNDNiZWExZTBkNTNiNzkwZDk2ODZfNjgw_9052912c-15ef-411a-8017-4326fa9dc702">25.8</ix:nonFraction> million; the remaining debt securities that the Company held at that date had an estimated market value of $<ix:nonFraction unitRef="usd" contextRef="i4c8f247d12134a9886d56e1c8b024425_I20220630" decimals="-5" name="dmtk:EstimatedMarketValueOfRemainingDebtSecuritiesWithContractualMaturitiesOfUpTo23Months" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmFlNWE5YmUwZWI5NDQ1ZDE5MmZhZTgyMmQyMmJlMDlmL3NlYzphZTVhOWJlMGViOTQ0NWQxOTJmYWU4MjJkMjJiZTA5Zl80My9mcmFnOmIzZWFmOGZlNmQ2MzQzYmVhMWUwZDUzYjc5MGQ5Njg2L3RleHRyZWdpb246YjNlYWY4ZmU2ZDYzNDNiZWExZTBkNTNiNzkwZDk2ODZfNzcz_dc7bae55-96a3-450b-ad3e-8bd9f0f1aba1">27.7</ix:nonFraction> million and contractual maturities of up to 23 months. As of December&#160;31, 2021, the estimated market value of debt securities with contractual maturities of less than twelve months was $<ix:nonFraction unitRef="usd" contextRef="i87bf777ccf5f4f93bc9be7a2cbba61c1_I20211231" decimals="-5" name="dmtk:EstimatedMarketValueOfDebtSecuritiesWithContractualMaturitiesOfLessThan12Months" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmFlNWE5YmUwZWI5NDQ1ZDE5MmZhZTgyMmQyMmJlMDlmL3NlYzphZTVhOWJlMGViOTQ0NWQxOTJmYWU4MjJkMjJiZTA5Zl80My9mcmFnOmIzZWFmOGZlNmQ2MzQzYmVhMWUwZDUzYjc5MGQ5Njg2L3RleHRyZWdpb246YjNlYWY4ZmU2ZDYzNDNiZWExZTBkNTNiNzkwZDk2ODZfOTM4_2c6a20f0-bf28-43fa-8256-5325c212acde">21.2</ix:nonFraction> million; the remaining debt securities that the Company held at that date had an estimated market value of $<ix:nonFraction unitRef="usd" contextRef="i87bf777ccf5f4f93bc9be7a2cbba61c1_I20211231" decimals="-5" name="dmtk:EstimatedMarketValueOfRemainingDebtSecuritiesWithContractualMaturitiesOfUpTo23Months" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmFlNWE5YmUwZWI5NDQ1ZDE5MmZhZTgyMmQyMmJlMDlmL3NlYzphZTVhOWJlMGViOTQ0NWQxOTJmYWU4MjJkMjJiZTA5Zl80My9mcmFnOmIzZWFmOGZlNmQ2MzQzYmVhMWUwZDUzYjc5MGQ5Njg2L3RleHRyZWdpb246YjNlYWY4ZmU2ZDYzNDNiZWExZTBkNTNiNzkwZDk2ODZfMTA5OTUxMTYyOTA4OQ_8d0ccd15-f4d2-41d7-8416-7583a973197e">27.2</ix:nonFraction> million and contractual maturities of up to 23 months.</span></div><div style="margin-top:9pt;padding-left:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company evaluates securities with unrealized losses to determine whether such losses, if any, are due to credit-related factors. It was determined that <ix:nonFraction unitRef="usd" contextRef="i4c8f247d12134a9886d56e1c8b024425_I20220630" decimals="INF" name="dmtk:CreditLosses" format="ixt:fixed-zero" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmFlNWE5YmUwZWI5NDQ1ZDE5MmZhZTgyMmQyMmJlMDlmL3NlYzphZTVhOWJlMGViOTQ0NWQxOTJmYWU4MjJkMjJiZTA5Zl80My9mcmFnOmIzZWFmOGZlNmQ2MzQzYmVhMWUwZDUzYjc5MGQ5Njg2L3RleHRyZWdpb246YjNlYWY4ZmU2ZDYzNDNiZWExZTBkNTNiNzkwZDk2ODZfMTA5OTUxMTYyOTczMQ_05352dac-1f19-4dde-a2ca-d83d8243e473"><ix:nonFraction unitRef="usd" contextRef="i87bf777ccf5f4f93bc9be7a2cbba61c1_I20211231" decimals="INF" name="dmtk:CreditLosses" format="ixt:fixed-zero" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmFlNWE5YmUwZWI5NDQ1ZDE5MmZhZTgyMmQyMmJlMDlmL3NlYzphZTVhOWJlMGViOTQ0NWQxOTJmYWU4MjJkMjJiZTA5Zl80My9mcmFnOmIzZWFmOGZlNmQ2MzQzYmVhMWUwZDUzYjc5MGQ5Njg2L3RleHRyZWdpb246YjNlYWY4ZmU2ZDYzNDNiZWExZTBkNTNiNzkwZDk2ODZfMTA5OTUxMTYyOTczMQ_9598966c-e42c-45ed-a8c3-eb01f8502c6f">no</ix:nonFraction></ix:nonFraction> credit losses existed as of June&#160;30, 2022 or December&#160;31, 2021, because the change in market value for those securities in an unrealized loss position has resulted from fluctuating interest rates rather than a deterioration of the credit worthiness of the issuers. Gross realized gains and losses on the Company&#8217;s debt securities for the three and six months ended June&#160;30, 2022 and 2021 were not significant.</span></div></ix:continuation><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">14</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:45pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#iae5a9be0eb9445d192fae822d22be09f_7">Table of Contents</a></span></div></div><ix:continuation id="id3fd88b767944490adc1f26a1fa8e53e"><div style="margin-top:15pt;padding-left:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Prepaid Expenses and Property and Equipment, Net</span></div><ix:nonNumeric contextRef="ia855382ada1f4f28aa8ef6da692ff177_D20220101-20220630" name="dmtk:ScheduleOfPrepaidExpensesAndPropertyAndEquipmentTableTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOmFlNWE5YmUwZWI5NDQ1ZDE5MmZhZTgyMmQyMmJlMDlmL3NlYzphZTVhOWJlMGViOTQ0NWQxOTJmYWU4MjJkMjJiZTA5Zl80My9mcmFnOmIzZWFmOGZlNmQ2MzQzYmVhMWUwZDUzYjc5MGQ5Njg2L3RleHRyZWdpb246YjNlYWY4ZmU2ZDYzNDNiZWExZTBkNTNiNzkwZDk2ODZfMTMxMA_f16c0dc2-8785-480a-baaf-7505f3c878db" escape="true"><div style="margin-top:9pt;padding-left:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Condensed consolidated balance sheet details are as follows (in thousands): </span></div><div style="margin-top:12pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:71.930%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.081%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.406%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.083%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">June 30,<br/>2022</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">December 31,<br/>2021</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Prepaid expenses and other current assets:</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Prepaid insurance</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i4c8f247d12134a9886d56e1c8b024425_I20220630" decimals="-3" name="us-gaap:PrepaidInsurance" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmFlNWE5YmUwZWI5NDQ1ZDE5MmZhZTgyMmQyMmJlMDlmL3NlYzphZTVhOWJlMGViOTQ0NWQxOTJmYWU4MjJkMjJiZTA5Zl80My9mcmFnOmIzZWFmOGZlNmQ2MzQzYmVhMWUwZDUzYjc5MGQ5Njg2L3RhYmxlOjAzYjg1ZTAwZDljNjRlOTZhYzllODA4NjY2MzMwN2YyL3RhYmxlcmFuZ2U6MDNiODVlMDBkOWM2NGU5NmFjOWU4MDg2NjYzMzA3ZjJfMi0xLTEtMS02MjY_d188ea62-da95-4a10-8b0f-376646ce9cfe">806</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i87bf777ccf5f4f93bc9be7a2cbba61c1_I20211231" decimals="-3" name="us-gaap:PrepaidInsurance" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmFlNWE5YmUwZWI5NDQ1ZDE5MmZhZTgyMmQyMmJlMDlmL3NlYzphZTVhOWJlMGViOTQ0NWQxOTJmYWU4MjJkMjJiZTA5Zl80My9mcmFnOmIzZWFmOGZlNmQ2MzQzYmVhMWUwZDUzYjc5MGQ5Njg2L3RhYmxlOjAzYjg1ZTAwZDljNjRlOTZhYzllODA4NjY2MzMwN2YyL3RhYmxlcmFuZ2U6MDNiODVlMDBkOWM2NGU5NmFjOWU4MDg2NjYzMzA3ZjJfMi0zLTEtMS02MjY_c404474c-0ccd-4d5c-a71e-9f42241deec2">1,801</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Prepaid trade shows</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i4c8f247d12134a9886d56e1c8b024425_I20220630" decimals="-3" name="dmtk:PrepaidTradeShowsCurrent" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmFlNWE5YmUwZWI5NDQ1ZDE5MmZhZTgyMmQyMmJlMDlmL3NlYzphZTVhOWJlMGViOTQ0NWQxOTJmYWU4MjJkMjJiZTA5Zl80My9mcmFnOmIzZWFmOGZlNmQ2MzQzYmVhMWUwZDUzYjc5MGQ5Njg2L3RhYmxlOjAzYjg1ZTAwZDljNjRlOTZhYzllODA4NjY2MzMwN2YyL3RhYmxlcmFuZ2U6MDNiODVlMDBkOWM2NGU5NmFjOWU4MDg2NjYzMzA3ZjJfMy0xLTEtMS02MjY_ed04f9dd-112c-443b-a911-64870d932bc6">241</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i87bf777ccf5f4f93bc9be7a2cbba61c1_I20211231" decimals="-3" name="dmtk:PrepaidTradeShowsCurrent" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmFlNWE5YmUwZWI5NDQ1ZDE5MmZhZTgyMmQyMmJlMDlmL3NlYzphZTVhOWJlMGViOTQ0NWQxOTJmYWU4MjJkMjJiZTA5Zl80My9mcmFnOmIzZWFmOGZlNmQ2MzQzYmVhMWUwZDUzYjc5MGQ5Njg2L3RhYmxlOjAzYjg1ZTAwZDljNjRlOTZhYzllODA4NjY2MzMwN2YyL3RhYmxlcmFuZ2U6MDNiODVlMDBkOWM2NGU5NmFjOWU4MDg2NjYzMzA3ZjJfMy0zLTEtMS02MjY_4fc630b1-a3a1-40ec-957e-ea25c63c69d5">440</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Prepaid software fees</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i4c8f247d12134a9886d56e1c8b024425_I20220630" decimals="-3" name="dmtk:PrepaidSoftwareFees" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmFlNWE5YmUwZWI5NDQ1ZDE5MmZhZTgyMmQyMmJlMDlmL3NlYzphZTVhOWJlMGViOTQ0NWQxOTJmYWU4MjJkMjJiZTA5Zl80My9mcmFnOmIzZWFmOGZlNmQ2MzQzYmVhMWUwZDUzYjc5MGQ5Njg2L3RhYmxlOjAzYjg1ZTAwZDljNjRlOTZhYzllODA4NjY2MzMwN2YyL3RhYmxlcmFuZ2U6MDNiODVlMDBkOWM2NGU5NmFjOWU4MDg2NjYzMzA3ZjJfNC0xLTEtMS02MjY_a851049d-0e3a-4308-91a8-eba7267b74b8">907</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i87bf777ccf5f4f93bc9be7a2cbba61c1_I20211231" decimals="-3" name="dmtk:PrepaidSoftwareFees" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmFlNWE5YmUwZWI5NDQ1ZDE5MmZhZTgyMmQyMmJlMDlmL3NlYzphZTVhOWJlMGViOTQ0NWQxOTJmYWU4MjJkMjJiZTA5Zl80My9mcmFnOmIzZWFmOGZlNmQ2MzQzYmVhMWUwZDUzYjc5MGQ5Njg2L3RhYmxlOjAzYjg1ZTAwZDljNjRlOTZhYzllODA4NjY2MzMwN2YyL3RhYmxlcmFuZ2U6MDNiODVlMDBkOWM2NGU5NmFjOWU4MDg2NjYzMzA3ZjJfNC0zLTEtMS02MjY_ec97a46b-62fc-4bc2-8307-15aa14e9d902">551</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Prepaid employee compensation</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i4c8f247d12134a9886d56e1c8b024425_I20220630" decimals="-3" name="dmtk:PrepaidEmployeeCompensation" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmFlNWE5YmUwZWI5NDQ1ZDE5MmZhZTgyMmQyMmJlMDlmL3NlYzphZTVhOWJlMGViOTQ0NWQxOTJmYWU4MjJkMjJiZTA5Zl80My9mcmFnOmIzZWFmOGZlNmQ2MzQzYmVhMWUwZDUzYjc5MGQ5Njg2L3RhYmxlOjAzYjg1ZTAwZDljNjRlOTZhYzllODA4NjY2MzMwN2YyL3RhYmxlcmFuZ2U6MDNiODVlMDBkOWM2NGU5NmFjOWU4MDg2NjYzMzA3ZjJfNi0xLTEtMS02MjY_61aea309-26dc-4506-b473-3d81fce1896f">227</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i87bf777ccf5f4f93bc9be7a2cbba61c1_I20211231" decimals="-3" name="dmtk:PrepaidEmployeeCompensation" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmFlNWE5YmUwZWI5NDQ1ZDE5MmZhZTgyMmQyMmJlMDlmL3NlYzphZTVhOWJlMGViOTQ0NWQxOTJmYWU4MjJkMjJiZTA5Zl80My9mcmFnOmIzZWFmOGZlNmQ2MzQzYmVhMWUwZDUzYjc5MGQ5Njg2L3RhYmxlOjAzYjg1ZTAwZDljNjRlOTZhYzllODA4NjY2MzMwN2YyL3RhYmxlcmFuZ2U6MDNiODVlMDBkOWM2NGU5NmFjOWU4MDg2NjYzMzA3ZjJfNi0zLTEtMS02MjY_37813e9c-067e-41d1-bf5b-a6f957127fe5">238</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other current assets</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i4c8f247d12134a9886d56e1c8b024425_I20220630" decimals="-3" name="us-gaap:OtherAssetsCurrent" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmFlNWE5YmUwZWI5NDQ1ZDE5MmZhZTgyMmQyMmJlMDlmL3NlYzphZTVhOWJlMGViOTQ0NWQxOTJmYWU4MjJkMjJiZTA5Zl80My9mcmFnOmIzZWFmOGZlNmQ2MzQzYmVhMWUwZDUzYjc5MGQ5Njg2L3RhYmxlOjAzYjg1ZTAwZDljNjRlOTZhYzllODA4NjY2MzMwN2YyL3RhYmxlcmFuZ2U6MDNiODVlMDBkOWM2NGU5NmFjOWU4MDg2NjYzMzA3ZjJfNy0xLTEtMS02MjY_002159a5-1b8d-44c3-add1-d21c5bacd28a">500</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i87bf777ccf5f4f93bc9be7a2cbba61c1_I20211231" decimals="-3" name="us-gaap:OtherAssetsCurrent" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmFlNWE5YmUwZWI5NDQ1ZDE5MmZhZTgyMmQyMmJlMDlmL3NlYzphZTVhOWJlMGViOTQ0NWQxOTJmYWU4MjJkMjJiZTA5Zl80My9mcmFnOmIzZWFmOGZlNmQ2MzQzYmVhMWUwZDUzYjc5MGQ5Njg2L3RhYmxlOjAzYjg1ZTAwZDljNjRlOTZhYzllODA4NjY2MzMwN2YyL3RhYmxlcmFuZ2U6MDNiODVlMDBkOWM2NGU5NmFjOWU4MDg2NjYzMzA3ZjJfNy0zLTEtMS02MjY_0d96facc-e3f7-4411-971f-e105766cd8b9">136</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total prepaid expenses and other current assets</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i4c8f247d12134a9886d56e1c8b024425_I20220630" decimals="-3" name="us-gaap:PrepaidExpenseAndOtherAssetsCurrent" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmFlNWE5YmUwZWI5NDQ1ZDE5MmZhZTgyMmQyMmJlMDlmL3NlYzphZTVhOWJlMGViOTQ0NWQxOTJmYWU4MjJkMjJiZTA5Zl80My9mcmFnOmIzZWFmOGZlNmQ2MzQzYmVhMWUwZDUzYjc5MGQ5Njg2L3RhYmxlOjAzYjg1ZTAwZDljNjRlOTZhYzllODA4NjY2MzMwN2YyL3RhYmxlcmFuZ2U6MDNiODVlMDBkOWM2NGU5NmFjOWU4MDg2NjYzMzA3ZjJfOC0xLTEtMS02MjY_7ee5b6b0-7ddc-4251-86ad-2b2aad82574d">2,681</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i87bf777ccf5f4f93bc9be7a2cbba61c1_I20211231" decimals="-3" name="us-gaap:PrepaidExpenseAndOtherAssetsCurrent" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmFlNWE5YmUwZWI5NDQ1ZDE5MmZhZTgyMmQyMmJlMDlmL3NlYzphZTVhOWJlMGViOTQ0NWQxOTJmYWU4MjJkMjJiZTA5Zl80My9mcmFnOmIzZWFmOGZlNmQ2MzQzYmVhMWUwZDUzYjc5MGQ5Njg2L3RhYmxlOjAzYjg1ZTAwZDljNjRlOTZhYzllODA4NjY2MzMwN2YyL3RhYmxlcmFuZ2U6MDNiODVlMDBkOWM2NGU5NmFjOWU4MDg2NjYzMzA3ZjJfOC0zLTEtMS02MjY_4749c4b3-4369-476b-9521-e689c050431b">3,166</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Property and equipment, gross:</span></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Laboratory equipment</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i4c8f247d12134a9886d56e1c8b024425_I20220630" decimals="-3" name="us-gaap:MachineryAndEquipmentGross" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmFlNWE5YmUwZWI5NDQ1ZDE5MmZhZTgyMmQyMmJlMDlmL3NlYzphZTVhOWJlMGViOTQ0NWQxOTJmYWU4MjJkMjJiZTA5Zl80My9mcmFnOmIzZWFmOGZlNmQ2MzQzYmVhMWUwZDUzYjc5MGQ5Njg2L3RhYmxlOjAzYjg1ZTAwZDljNjRlOTZhYzllODA4NjY2MzMwN2YyL3RhYmxlcmFuZ2U6MDNiODVlMDBkOWM2NGU5NmFjOWU4MDg2NjYzMzA3ZjJfMTAtMS0xLTEtNjI2_06b7848f-114c-413f-b81f-e14cee9c784b">4,856</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i87bf777ccf5f4f93bc9be7a2cbba61c1_I20211231" decimals="-3" name="us-gaap:MachineryAndEquipmentGross" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmFlNWE5YmUwZWI5NDQ1ZDE5MmZhZTgyMmQyMmJlMDlmL3NlYzphZTVhOWJlMGViOTQ0NWQxOTJmYWU4MjJkMjJiZTA5Zl80My9mcmFnOmIzZWFmOGZlNmQ2MzQzYmVhMWUwZDUzYjc5MGQ5Njg2L3RhYmxlOjAzYjg1ZTAwZDljNjRlOTZhYzllODA4NjY2MzMwN2YyL3RhYmxlcmFuZ2U6MDNiODVlMDBkOWM2NGU5NmFjOWU4MDg2NjYzMzA3ZjJfMTAtMy0xLTEtNjI2_df6608d9-f0fe-4042-b638-ba6d85efc61f">4,805</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Computer equipment</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i4c8f247d12134a9886d56e1c8b024425_I20220630" decimals="-3" name="dmtk:ComputerEquipmentGross" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmFlNWE5YmUwZWI5NDQ1ZDE5MmZhZTgyMmQyMmJlMDlmL3NlYzphZTVhOWJlMGViOTQ0NWQxOTJmYWU4MjJkMjJiZTA5Zl80My9mcmFnOmIzZWFmOGZlNmQ2MzQzYmVhMWUwZDUzYjc5MGQ5Njg2L3RhYmxlOjAzYjg1ZTAwZDljNjRlOTZhYzllODA4NjY2MzMwN2YyL3RhYmxlcmFuZ2U6MDNiODVlMDBkOWM2NGU5NmFjOWU4MDg2NjYzMzA3ZjJfMTEtMS0xLTEtNjI2_43ff926c-89cb-4cd4-af8b-9fb6cd4b02a8">396</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i87bf777ccf5f4f93bc9be7a2cbba61c1_I20211231" decimals="-3" name="dmtk:ComputerEquipmentGross" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmFlNWE5YmUwZWI5NDQ1ZDE5MmZhZTgyMmQyMmJlMDlmL3NlYzphZTVhOWJlMGViOTQ0NWQxOTJmYWU4MjJkMjJiZTA5Zl80My9mcmFnOmIzZWFmOGZlNmQ2MzQzYmVhMWUwZDUzYjc5MGQ5Njg2L3RhYmxlOjAzYjg1ZTAwZDljNjRlOTZhYzllODA4NjY2MzMwN2YyL3RhYmxlcmFuZ2U6MDNiODVlMDBkOWM2NGU5NmFjOWU4MDg2NjYzMzA3ZjJfMTEtMy0xLTEtNjI2_60169e47-01eb-488f-a233-2c5b50463e81">171</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Furniture and fixtures</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i4c8f247d12134a9886d56e1c8b024425_I20220630" decimals="-3" name="us-gaap:FurnitureAndFixturesGross" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmFlNWE5YmUwZWI5NDQ1ZDE5MmZhZTgyMmQyMmJlMDlmL3NlYzphZTVhOWJlMGViOTQ0NWQxOTJmYWU4MjJkMjJiZTA5Zl80My9mcmFnOmIzZWFmOGZlNmQ2MzQzYmVhMWUwZDUzYjc5MGQ5Njg2L3RhYmxlOjAzYjg1ZTAwZDljNjRlOTZhYzllODA4NjY2MzMwN2YyL3RhYmxlcmFuZ2U6MDNiODVlMDBkOWM2NGU5NmFjOWU4MDg2NjYzMzA3ZjJfMTItMS0xLTEtNjI2_b97bf0c0-3a62-4634-8174-71b073cd5ea6">555</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i87bf777ccf5f4f93bc9be7a2cbba61c1_I20211231" decimals="-3" name="us-gaap:FurnitureAndFixturesGross" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmFlNWE5YmUwZWI5NDQ1ZDE5MmZhZTgyMmQyMmJlMDlmL3NlYzphZTVhOWJlMGViOTQ0NWQxOTJmYWU4MjJkMjJiZTA5Zl80My9mcmFnOmIzZWFmOGZlNmQ2MzQzYmVhMWUwZDUzYjc5MGQ5Njg2L3RhYmxlOjAzYjg1ZTAwZDljNjRlOTZhYzllODA4NjY2MzMwN2YyL3RhYmxlcmFuZ2U6MDNiODVlMDBkOWM2NGU5NmFjOWU4MDg2NjYzMzA3ZjJfMTItMy0xLTEtNjI2_dc32e420-1068-4dad-979d-36294b26c7aa">124</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Leasehold improvements</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i4c8f247d12134a9886d56e1c8b024425_I20220630" decimals="-3" name="us-gaap:LeaseholdImprovementsGross" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmFlNWE5YmUwZWI5NDQ1ZDE5MmZhZTgyMmQyMmJlMDlmL3NlYzphZTVhOWJlMGViOTQ0NWQxOTJmYWU4MjJkMjJiZTA5Zl80My9mcmFnOmIzZWFmOGZlNmQ2MzQzYmVhMWUwZDUzYjc5MGQ5Njg2L3RhYmxlOjAzYjg1ZTAwZDljNjRlOTZhYzllODA4NjY2MzMwN2YyL3RhYmxlcmFuZ2U6MDNiODVlMDBkOWM2NGU5NmFjOWU4MDg2NjYzMzA3ZjJfMTMtMS0xLTEtNjI2_4959c27e-2026-4000-9d7d-e603a594d37c">1,208</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i87bf777ccf5f4f93bc9be7a2cbba61c1_I20211231" decimals="-3" name="us-gaap:LeaseholdImprovementsGross" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmFlNWE5YmUwZWI5NDQ1ZDE5MmZhZTgyMmQyMmJlMDlmL3NlYzphZTVhOWJlMGViOTQ0NWQxOTJmYWU4MjJkMjJiZTA5Zl80My9mcmFnOmIzZWFmOGZlNmQ2MzQzYmVhMWUwZDUzYjc5MGQ5Njg2L3RhYmxlOjAzYjg1ZTAwZDljNjRlOTZhYzllODA4NjY2MzMwN2YyL3RhYmxlcmFuZ2U6MDNiODVlMDBkOWM2NGU5NmFjOWU4MDg2NjYzMzA3ZjJfMTMtMy0xLTEtNjI2_e1ba4463-d049-4a25-8af7-796b14092429">1,074</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Construction-in-progress</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i4c8f247d12134a9886d56e1c8b024425_I20220630" decimals="-3" name="us-gaap:ConstructionInProgressGross" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmFlNWE5YmUwZWI5NDQ1ZDE5MmZhZTgyMmQyMmJlMDlmL3NlYzphZTVhOWJlMGViOTQ0NWQxOTJmYWU4MjJkMjJiZTA5Zl80My9mcmFnOmIzZWFmOGZlNmQ2MzQzYmVhMWUwZDUzYjc5MGQ5Njg2L3RhYmxlOjAzYjg1ZTAwZDljNjRlOTZhYzllODA4NjY2MzMwN2YyL3RhYmxlcmFuZ2U6MDNiODVlMDBkOWM2NGU5NmFjOWU4MDg2NjYzMzA3ZjJfMTQtMS0xLTEtMjY2MA_2b1b36bd-6bab-4ea0-a3af-7755927d175d">139</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i87bf777ccf5f4f93bc9be7a2cbba61c1_I20211231" decimals="-3" name="us-gaap:ConstructionInProgressGross" format="ixt:fixed-zero" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmFlNWE5YmUwZWI5NDQ1ZDE5MmZhZTgyMmQyMmJlMDlmL3NlYzphZTVhOWJlMGViOTQ0NWQxOTJmYWU4MjJkMjJiZTA5Zl80My9mcmFnOmIzZWFmOGZlNmQ2MzQzYmVhMWUwZDUzYjc5MGQ5Njg2L3RhYmxlOjAzYjg1ZTAwZDljNjRlOTZhYzllODA4NjY2MzMwN2YyL3RhYmxlcmFuZ2U6MDNiODVlMDBkOWM2NGU5NmFjOWU4MDg2NjYzMzA3ZjJfMTQtMy0xLTEtMjY1Mg_000460d2-9807-42cc-bda1-cb68e4b8d386">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total property and equipment, gross</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i4c8f247d12134a9886d56e1c8b024425_I20220630" decimals="-3" name="us-gaap:PropertyPlantAndEquipmentGross" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmFlNWE5YmUwZWI5NDQ1ZDE5MmZhZTgyMmQyMmJlMDlmL3NlYzphZTVhOWJlMGViOTQ0NWQxOTJmYWU4MjJkMjJiZTA5Zl80My9mcmFnOmIzZWFmOGZlNmQ2MzQzYmVhMWUwZDUzYjc5MGQ5Njg2L3RhYmxlOjAzYjg1ZTAwZDljNjRlOTZhYzllODA4NjY2MzMwN2YyL3RhYmxlcmFuZ2U6MDNiODVlMDBkOWM2NGU5NmFjOWU4MDg2NjYzMzA3ZjJfMTQtMS0xLTEtNjI2_6f42bed2-84bf-4b36-a35c-4218259a1a41">7,154</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i87bf777ccf5f4f93bc9be7a2cbba61c1_I20211231" decimals="-3" name="us-gaap:PropertyPlantAndEquipmentGross" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmFlNWE5YmUwZWI5NDQ1ZDE5MmZhZTgyMmQyMmJlMDlmL3NlYzphZTVhOWJlMGViOTQ0NWQxOTJmYWU4MjJkMjJiZTA5Zl80My9mcmFnOmIzZWFmOGZlNmQ2MzQzYmVhMWUwZDUzYjc5MGQ5Njg2L3RhYmxlOjAzYjg1ZTAwZDljNjRlOTZhYzllODA4NjY2MzMwN2YyL3RhYmxlcmFuZ2U6MDNiODVlMDBkOWM2NGU5NmFjOWU4MDg2NjYzMzA3ZjJfMTQtMy0xLTEtNjI2_30487ddc-0d3f-4baa-89fe-4001d4d3e232">6,174</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Less accumulated depreciation</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i4c8f247d12134a9886d56e1c8b024425_I20220630" decimals="-3" name="us-gaap:AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmFlNWE5YmUwZWI5NDQ1ZDE5MmZhZTgyMmQyMmJlMDlmL3NlYzphZTVhOWJlMGViOTQ0NWQxOTJmYWU4MjJkMjJiZTA5Zl80My9mcmFnOmIzZWFmOGZlNmQ2MzQzYmVhMWUwZDUzYjc5MGQ5Njg2L3RhYmxlOjAzYjg1ZTAwZDljNjRlOTZhYzllODA4NjY2MzMwN2YyL3RhYmxlcmFuZ2U6MDNiODVlMDBkOWM2NGU5NmFjOWU4MDg2NjYzMzA3ZjJfMTUtMS0xLTEtNjI2_0aa50ed5-4b2e-4d7c-918a-8056bfb41df3">2,238</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i87bf777ccf5f4f93bc9be7a2cbba61c1_I20211231" decimals="-3" name="us-gaap:AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmFlNWE5YmUwZWI5NDQ1ZDE5MmZhZTgyMmQyMmJlMDlmL3NlYzphZTVhOWJlMGViOTQ0NWQxOTJmYWU4MjJkMjJiZTA5Zl80My9mcmFnOmIzZWFmOGZlNmQ2MzQzYmVhMWUwZDUzYjc5MGQ5Njg2L3RhYmxlOjAzYjg1ZTAwZDljNjRlOTZhYzllODA4NjY2MzMwN2YyL3RhYmxlcmFuZ2U6MDNiODVlMDBkOWM2NGU5NmFjOWU4MDg2NjYzMzA3ZjJfMTUtMy0xLTEtNjI2_868fb7ec-dd9d-4de8-b77a-4ceea687f1b2">1,625</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total property and equipment, net</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i4c8f247d12134a9886d56e1c8b024425_I20220630" decimals="-3" name="us-gaap:PropertyPlantAndEquipmentNet" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmFlNWE5YmUwZWI5NDQ1ZDE5MmZhZTgyMmQyMmJlMDlmL3NlYzphZTVhOWJlMGViOTQ0NWQxOTJmYWU4MjJkMjJiZTA5Zl80My9mcmFnOmIzZWFmOGZlNmQ2MzQzYmVhMWUwZDUzYjc5MGQ5Njg2L3RhYmxlOjAzYjg1ZTAwZDljNjRlOTZhYzllODA4NjY2MzMwN2YyL3RhYmxlcmFuZ2U6MDNiODVlMDBkOWM2NGU5NmFjOWU4MDg2NjYzMzA3ZjJfMTYtMS0xLTEtNjI2_db79321a-dab6-4921-9e42-a95b715e2500">4,916</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i87bf777ccf5f4f93bc9be7a2cbba61c1_I20211231" decimals="-3" name="us-gaap:PropertyPlantAndEquipmentNet" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmFlNWE5YmUwZWI5NDQ1ZDE5MmZhZTgyMmQyMmJlMDlmL3NlYzphZTVhOWJlMGViOTQ0NWQxOTJmYWU4MjJkMjJiZTA5Zl80My9mcmFnOmIzZWFmOGZlNmQ2MzQzYmVhMWUwZDUzYjc5MGQ5Njg2L3RhYmxlOjAzYjg1ZTAwZDljNjRlOTZhYzllODA4NjY2MzMwN2YyL3RhYmxlcmFuZ2U6MDNiODVlMDBkOWM2NGU5NmFjOWU4MDg2NjYzMzA3ZjJfMTYtMy0xLTEtNjI2_c209d0fc-f3cf-49bc-b74c-7f758c173e4e">4,549</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div></ix:nonNumeric><div style="margin-top:15pt;padding-left:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Accrued Compensation and Accrued Liabilities </span></div><ix:nonNumeric contextRef="ia855382ada1f4f28aa8ef6da692ff177_D20220101-20220630" name="us-gaap:ScheduleOfAccountsPayableAndAccruedLiabilitiesTableTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOmFlNWE5YmUwZWI5NDQ1ZDE5MmZhZTgyMmQyMmJlMDlmL3NlYzphZTVhOWJlMGViOTQ0NWQxOTJmYWU4MjJkMjJiZTA5Zl80My9mcmFnOmIzZWFmOGZlNmQ2MzQzYmVhMWUwZDUzYjc5MGQ5Njg2L3RleHRyZWdpb246YjNlYWY4ZmU2ZDYzNDNiZWExZTBkNTNiNzkwZDk2ODZfMTMxMQ_ce148590-79f5-4547-8a73-fb23202a88a9" escape="true"><div style="margin-top:9pt;padding-left:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Condensed consolidated balance sheet details are as follows (in thousands):</span></div><div style="margin-top:12pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:71.930%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.081%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.406%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.083%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">June 30,<br/>2022</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">December 31,<br/>2021</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Accrued compensation:</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Accrued paid time off</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i4c8f247d12134a9886d56e1c8b024425_I20220630" decimals="-3" name="us-gaap:AccruedVacationCurrent" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmFlNWE5YmUwZWI5NDQ1ZDE5MmZhZTgyMmQyMmJlMDlmL3NlYzphZTVhOWJlMGViOTQ0NWQxOTJmYWU4MjJkMjJiZTA5Zl80My9mcmFnOmIzZWFmOGZlNmQ2MzQzYmVhMWUwZDUzYjc5MGQ5Njg2L3RhYmxlOmVlMzA5YTdhNmY1YzQwOTI4OGJhODVhMmVlOGY2ZmIxL3RhYmxlcmFuZ2U6ZWUzMDlhN2E2ZjVjNDA5Mjg4YmE4NWEyZWU4ZjZmYjFfMi0xLTEtMS02MjY_6793fb02-ad81-4cb8-83b4-c66112c9903a">1,689</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i87bf777ccf5f4f93bc9be7a2cbba61c1_I20211231" decimals="-3" name="us-gaap:AccruedVacationCurrent" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmFlNWE5YmUwZWI5NDQ1ZDE5MmZhZTgyMmQyMmJlMDlmL3NlYzphZTVhOWJlMGViOTQ0NWQxOTJmYWU4MjJkMjJiZTA5Zl80My9mcmFnOmIzZWFmOGZlNmQ2MzQzYmVhMWUwZDUzYjc5MGQ5Njg2L3RhYmxlOmVlMzA5YTdhNmY1YzQwOTI4OGJhODVhMmVlOGY2ZmIxL3RhYmxlcmFuZ2U6ZWUzMDlhN2E2ZjVjNDA5Mjg4YmE4NWEyZWU4ZjZmYjFfMi0zLTEtMS02MjY_3c1a4c33-d13f-49cc-b1e0-79eb604817d0">1,245</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Accrued wages, bonus and other</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i4c8f247d12134a9886d56e1c8b024425_I20220630" decimals="-3" name="dmtk:AccruedBonusAndDeferredCompensationCurrent" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmFlNWE5YmUwZWI5NDQ1ZDE5MmZhZTgyMmQyMmJlMDlmL3NlYzphZTVhOWJlMGViOTQ0NWQxOTJmYWU4MjJkMjJiZTA5Zl80My9mcmFnOmIzZWFmOGZlNmQ2MzQzYmVhMWUwZDUzYjc5MGQ5Njg2L3RhYmxlOmVlMzA5YTdhNmY1YzQwOTI4OGJhODVhMmVlOGY2ZmIxL3RhYmxlcmFuZ2U6ZWUzMDlhN2E2ZjVjNDA5Mjg4YmE4NWEyZWU4ZjZmYjFfMy0xLTEtMS02MjY_c29533d4-936f-4a3d-a249-4c9224110b67">6,129</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i87bf777ccf5f4f93bc9be7a2cbba61c1_I20211231" decimals="-3" name="dmtk:AccruedBonusAndDeferredCompensationCurrent" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmFlNWE5YmUwZWI5NDQ1ZDE5MmZhZTgyMmQyMmJlMDlmL3NlYzphZTVhOWJlMGViOTQ0NWQxOTJmYWU4MjJkMjJiZTA5Zl80My9mcmFnOmIzZWFmOGZlNmQ2MzQzYmVhMWUwZDUzYjc5MGQ5Njg2L3RhYmxlOmVlMzA5YTdhNmY1YzQwOTI4OGJhODVhMmVlOGY2ZmIxL3RhYmxlcmFuZ2U6ZWUzMDlhN2E2ZjVjNDA5Mjg4YmE4NWEyZWU4ZjZmYjFfMy0zLTEtMS02MjY_09149e9e-5934-4c90-be9d-dc5bfc347532">3,875</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total accrued compensation</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i4c8f247d12134a9886d56e1c8b024425_I20220630" decimals="-3" name="us-gaap:EmployeeRelatedLiabilitiesCurrent" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmFlNWE5YmUwZWI5NDQ1ZDE5MmZhZTgyMmQyMmJlMDlmL3NlYzphZTVhOWJlMGViOTQ0NWQxOTJmYWU4MjJkMjJiZTA5Zl80My9mcmFnOmIzZWFmOGZlNmQ2MzQzYmVhMWUwZDUzYjc5MGQ5Njg2L3RhYmxlOmVlMzA5YTdhNmY1YzQwOTI4OGJhODVhMmVlOGY2ZmIxL3RhYmxlcmFuZ2U6ZWUzMDlhN2E2ZjVjNDA5Mjg4YmE4NWEyZWU4ZjZmYjFfNC0xLTEtMS02MjY_95b23e02-27c4-4a39-8d54-80aca1ba5d3f">7,818</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i87bf777ccf5f4f93bc9be7a2cbba61c1_I20211231" decimals="-3" name="us-gaap:EmployeeRelatedLiabilitiesCurrent" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmFlNWE5YmUwZWI5NDQ1ZDE5MmZhZTgyMmQyMmJlMDlmL3NlYzphZTVhOWJlMGViOTQ0NWQxOTJmYWU4MjJkMjJiZTA5Zl80My9mcmFnOmIzZWFmOGZlNmQ2MzQzYmVhMWUwZDUzYjc5MGQ5Njg2L3RhYmxlOmVlMzA5YTdhNmY1YzQwOTI4OGJhODVhMmVlOGY2ZmIxL3RhYmxlcmFuZ2U6ZWUzMDlhN2E2ZjVjNDA5Mjg4YmE4NWEyZWU4ZjZmYjFfNC0zLTEtMS02MjY_ade3de29-bbaa-417e-aef2-a8182fca69a4">5,120</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Accrued liabilities:</span></td><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Accrued consulting services</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i4c8f247d12134a9886d56e1c8b024425_I20220630" decimals="-3" name="dmtk:AccruedConsultingServicesCurrent" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmFlNWE5YmUwZWI5NDQ1ZDE5MmZhZTgyMmQyMmJlMDlmL3NlYzphZTVhOWJlMGViOTQ0NWQxOTJmYWU4MjJkMjJiZTA5Zl80My9mcmFnOmIzZWFmOGZlNmQ2MzQzYmVhMWUwZDUzYjc5MGQ5Njg2L3RhYmxlOmVlMzA5YTdhNmY1YzQwOTI4OGJhODVhMmVlOGY2ZmIxL3RhYmxlcmFuZ2U6ZWUzMDlhN2E2ZjVjNDA5Mjg4YmE4NWEyZWU4ZjZmYjFfNi0xLTEtMS02MjY_8a729e43-6bbd-43c1-b392-e948a1c81aa7">2,201</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i87bf777ccf5f4f93bc9be7a2cbba61c1_I20211231" decimals="-3" name="dmtk:AccruedConsultingServicesCurrent" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmFlNWE5YmUwZWI5NDQ1ZDE5MmZhZTgyMmQyMmJlMDlmL3NlYzphZTVhOWJlMGViOTQ0NWQxOTJmYWU4MjJkMjJiZTA5Zl80My9mcmFnOmIzZWFmOGZlNmQ2MzQzYmVhMWUwZDUzYjc5MGQ5Njg2L3RhYmxlOmVlMzA5YTdhNmY1YzQwOTI4OGJhODVhMmVlOGY2ZmIxL3RhYmxlcmFuZ2U6ZWUzMDlhN2E2ZjVjNDA5Mjg4YmE4NWEyZWU4ZjZmYjFfNi0zLTEtMS02MjY_61c05cae-356b-4a24-b1ea-71f4ef0d6ad8">775</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other accrued expenses</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i4c8f247d12134a9886d56e1c8b024425_I20220630" decimals="-3" name="us-gaap:OtherAccruedLiabilitiesCurrent" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmFlNWE5YmUwZWI5NDQ1ZDE5MmZhZTgyMmQyMmJlMDlmL3NlYzphZTVhOWJlMGViOTQ0NWQxOTJmYWU4MjJkMjJiZTA5Zl80My9mcmFnOmIzZWFmOGZlNmQ2MzQzYmVhMWUwZDUzYjc5MGQ5Njg2L3RhYmxlOmVlMzA5YTdhNmY1YzQwOTI4OGJhODVhMmVlOGY2ZmIxL3RhYmxlcmFuZ2U6ZWUzMDlhN2E2ZjVjNDA5Mjg4YmE4NWEyZWU4ZjZmYjFfNy0xLTEtMS02MjY_fbac11e3-df60-421f-868b-13b3e09d2087">1,071</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i87bf777ccf5f4f93bc9be7a2cbba61c1_I20211231" decimals="-3" name="us-gaap:OtherAccruedLiabilitiesCurrent" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmFlNWE5YmUwZWI5NDQ1ZDE5MmZhZTgyMmQyMmJlMDlmL3NlYzphZTVhOWJlMGViOTQ0NWQxOTJmYWU4MjJkMjJiZTA5Zl80My9mcmFnOmIzZWFmOGZlNmQ2MzQzYmVhMWUwZDUzYjc5MGQ5Njg2L3RhYmxlOmVlMzA5YTdhNmY1YzQwOTI4OGJhODVhMmVlOGY2ZmIxL3RhYmxlcmFuZ2U6ZWUzMDlhN2E2ZjVjNDA5Mjg4YmE4NWEyZWU4ZjZmYjFfNy0zLTEtMS02MjY_f6fba14a-d337-4abd-92ae-b91ddc5cad3c">452</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total accrued liabilities</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i4c8f247d12134a9886d56e1c8b024425_I20220630" decimals="-3" name="us-gaap:AccruedLiabilitiesCurrent" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmFlNWE5YmUwZWI5NDQ1ZDE5MmZhZTgyMmQyMmJlMDlmL3NlYzphZTVhOWJlMGViOTQ0NWQxOTJmYWU4MjJkMjJiZTA5Zl80My9mcmFnOmIzZWFmOGZlNmQ2MzQzYmVhMWUwZDUzYjc5MGQ5Njg2L3RhYmxlOmVlMzA5YTdhNmY1YzQwOTI4OGJhODVhMmVlOGY2ZmIxL3RhYmxlcmFuZ2U6ZWUzMDlhN2E2ZjVjNDA5Mjg4YmE4NWEyZWU4ZjZmYjFfOC0xLTEtMS02MjY_d6d9d88e-dca0-4d50-8616-9f4cdd3f6126">3,272</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i87bf777ccf5f4f93bc9be7a2cbba61c1_I20211231" decimals="-3" name="us-gaap:AccruedLiabilitiesCurrent" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmFlNWE5YmUwZWI5NDQ1ZDE5MmZhZTgyMmQyMmJlMDlmL3NlYzphZTVhOWJlMGViOTQ0NWQxOTJmYWU4MjJkMjJiZTA5Zl80My9mcmFnOmIzZWFmOGZlNmQ2MzQzYmVhMWUwZDUzYjc5MGQ5Njg2L3RhYmxlOmVlMzA5YTdhNmY1YzQwOTI4OGJhODVhMmVlOGY2ZmIxL3RhYmxlcmFuZ2U6ZWUzMDlhN2E2ZjVjNDA5Mjg4YmE4NWEyZWU4ZjZmYjFfOC0zLTEtMS02MjY_d6425747-c131-407a-8569-f93df4a51875">1,227</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div></ix:nonNumeric></ix:continuation><div id="iae5a9be0eb9445d192fae822d22be09f_46"></div><div style="margin-top:15pt;padding-left:27pt;text-indent:-27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">3.&#160;&#160;&#160;&#160;<ix:nonNumeric contextRef="ia855382ada1f4f28aa8ef6da692ff177_D20220101-20220630" name="us-gaap:StockholdersEquityNoteDisclosureTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOmFlNWE5YmUwZWI5NDQ1ZDE5MmZhZTgyMmQyMmJlMDlmL3NlYzphZTVhOWJlMGViOTQ0NWQxOTJmYWU4MjJkMjJiZTA5Zl80Ni9mcmFnOjU5ZmVhYTYxNWVlYjRmZTJhOGQ1ZTQ5NTRkNjk5MzFiL3RleHRyZWdpb246NTlmZWFhNjE1ZWViNGZlMmE4ZDVlNDk1NGQ2OTkzMWJfMTU2NDU_f1fba61c-ec06-4d98-8c7f-c1146ea48c04" continuedAt="if78c5e8af9604e16914f205b9725fad9" escape="true">Stockholders&#8217; Equity</ix:nonNumeric></span></div><ix:continuation id="if78c5e8af9604e16914f205b9725fad9" continuedAt="i4174c8ddfcc54e79bcdf7b92b95558b5"><div style="margin-top:15pt;padding-left:27pt;text-indent:-27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">(a)&#160;&#160;&#160;&#160;Classes of Stock </span></div><div style="margin-top:9pt;padding-left:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company&#8217;s amended and restated certificate of incorporation authorizes it to issue <ix:nonFraction unitRef="shares" contextRef="i4c8f247d12134a9886d56e1c8b024425_I20220630" decimals="INF" name="us-gaap:CommonStockSharesAuthorized" format="ixt:num-dot-decimal" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmFlNWE5YmUwZWI5NDQ1ZDE5MmZhZTgyMmQyMmJlMDlmL3NlYzphZTVhOWJlMGViOTQ0NWQxOTJmYWU4MjJkMjJiZTA5Zl80Ni9mcmFnOjU5ZmVhYTYxNWVlYjRmZTJhOGQ1ZTQ5NTRkNjk5MzFiL3RleHRyZWdpb246NTlmZWFhNjE1ZWViNGZlMmE4ZDVlNDk1NGQ2OTkzMWJfMTcw_ea0bf930-7bc9-46bb-a89d-ba5407dc1f18">50,000,000</ix:nonFraction> shares of common stock and <ix:nonFraction unitRef="shares" contextRef="i4c8f247d12134a9886d56e1c8b024425_I20220630" decimals="INF" name="us-gaap:PreferredStockSharesAuthorized" format="ixt:num-dot-decimal" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmFlNWE5YmUwZWI5NDQ1ZDE5MmZhZTgyMmQyMmJlMDlmL3NlYzphZTVhOWJlMGViOTQ0NWQxOTJmYWU4MjJkMjJiZTA5Zl80Ni9mcmFnOjU5ZmVhYTYxNWVlYjRmZTJhOGQ1ZTQ5NTRkNjk5MzFiL3RleHRyZWdpb246NTlmZWFhNjE1ZWViNGZlMmE4ZDVlNDk1NGQ2OTkzMWJfMjAw_2848efef-2db0-4a5b-aa1a-bd41a9abf3a3">5,000,000</ix:nonFraction> shares of preferred stock. Both classes of stock have a par value of $<ix:nonFraction unitRef="usdPerShare" contextRef="i4c8f247d12134a9886d56e1c8b024425_I20220630" decimals="INF" name="us-gaap:PreferredStockParOrStatedValuePerShare" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmFlNWE5YmUwZWI5NDQ1ZDE5MmZhZTgyMmQyMmJlMDlmL3NlYzphZTVhOWJlMGViOTQ0NWQxOTJmYWU4MjJkMjJiZTA5Zl80Ni9mcmFnOjU5ZmVhYTYxNWVlYjRmZTJhOGQ1ZTQ5NTRkNjk5MzFiL3RleHRyZWdpb246NTlmZWFhNjE1ZWViNGZlMmE4ZDVlNDk1NGQ2OTkzMWJfMjcy_04da5637-a3c6-4015-87a5-02956f57f902"><ix:nonFraction unitRef="usdPerShare" contextRef="i4c8f247d12134a9886d56e1c8b024425_I20220630" decimals="INF" name="us-gaap:CommonStockParOrStatedValuePerShare" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmFlNWE5YmUwZWI5NDQ1ZDE5MmZhZTgyMmQyMmJlMDlmL3NlYzphZTVhOWJlMGViOTQ0NWQxOTJmYWU4MjJkMjJiZTA5Zl80Ni9mcmFnOjU5ZmVhYTYxNWVlYjRmZTJhOGQ1ZTQ5NTRkNjk5MzFiL3RleHRyZWdpb246NTlmZWFhNjE1ZWViNGZlMmE4ZDVlNDk1NGQ2OTkzMWJfMjcy_97f7c7c1-688b-4f7c-a6ed-6d91cf3c3446">0.0001</ix:nonFraction></ix:nonFraction> per share. </span></div></ix:continuation><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">15</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:45pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#iae5a9be0eb9445d192fae822d22be09f_7">Table of Contents</a></span></div></div><ix:continuation id="i4174c8ddfcc54e79bcdf7b92b95558b5" continuedAt="ifada9eab3127421fb0e1b97f5c01218e"><div style="margin-top:15pt;padding-left:27pt;text-indent:-27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">(b)&#160;&#160;&#160;&#160;At-The Market Offering</span></div><div style="margin-top:9pt;padding-left:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">On November&#160;10, 2020, the Company entered into a sales agreement (the &#8220;Sales Agreement&#8221;) with Cowen and Company, LLC ("Cowen") relating to the sale of shares of the Company&#8217;s common stock from time to time with an aggregate offering price of up to $<ix:nonFraction unitRef="usd" contextRef="ia4a7fd782f30475da7d3133d9c168885_D20201110-20201110" decimals="-5" name="us-gaap:StockIssuedDuringPeriodValueNewIssues" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmFlNWE5YmUwZWI5NDQ1ZDE5MmZhZTgyMmQyMmJlMDlmL3NlYzphZTVhOWJlMGViOTQ0NWQxOTJmYWU4MjJkMjJiZTA5Zl80Ni9mcmFnOjU5ZmVhYTYxNWVlYjRmZTJhOGQ1ZTQ5NTRkNjk5MzFiL3RleHRyZWdpb246NTlmZWFhNjE1ZWViNGZlMmE4ZDVlNDk1NGQ2OTkzMWJfNDY3OA_eb83a798-9cc3-4067-a567-b2f508ebdf92">50.0</ix:nonFraction> million. During 2020, the Company issued an aggregate of <ix:nonFraction unitRef="shares" contextRef="i415678d9707341f4acccc0fba869131d_D20201110-20201231" decimals="INF" name="us-gaap:StockIssuedDuringPeriodSharesNewIssues" format="ixt:num-dot-decimal" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmFlNWE5YmUwZWI5NDQ1ZDE5MmZhZTgyMmQyMmJlMDlmL3NlYzphZTVhOWJlMGViOTQ0NWQxOTJmYWU4MjJkMjJiZTA5Zl80Ni9mcmFnOjU5ZmVhYTYxNWVlYjRmZTJhOGQ1ZTQ5NTRkNjk5MzFiL3RleHRyZWdpb246NTlmZWFhNjE1ZWViNGZlMmE4ZDVlNDk1NGQ2OTkzMWJfNDcyOA_c4e6d28b-ffba-48aa-bc68-c610c5fa49d3">951,792</ix:nonFraction> shares of common stock pursuant to the Sales Agreement at a weighted average purchase price of $<ix:nonFraction unitRef="usdPerShare" contextRef="i415678d9707341f4acccc0fba869131d_D20201110-20201231" decimals="2" name="dmtk:WeightedAveragePurchasePricePerShareInOffering" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmFlNWE5YmUwZWI5NDQ1ZDE5MmZhZTgyMmQyMmJlMDlmL3NlYzphZTVhOWJlMGViOTQ0NWQxOTJmYWU4MjJkMjJiZTA5Zl80Ni9mcmFnOjU5ZmVhYTYxNWVlYjRmZTJhOGQ1ZTQ5NTRkNjk5MzFiL3RleHRyZWdpb246NTlmZWFhNjE1ZWViNGZlMmE4ZDVlNDk1NGQ2OTkzMWJfNDgyNg_290a1f59-a8d1-476d-b1f3-c09ff6065d87">20.97</ix:nonFraction> resulting in aggregate gross proceeds of approximately $<ix:nonFraction unitRef="usd" contextRef="i415678d9707341f4acccc0fba869131d_D20201110-20201231" decimals="-5" name="dmtk:GrossProceedsFromIssuanceOfCommonStock" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmFlNWE5YmUwZWI5NDQ1ZDE5MmZhZTgyMmQyMmJlMDlmL3NlYzphZTVhOWJlMGViOTQ0NWQxOTJmYWU4MjJkMjJiZTA5Zl80Ni9mcmFnOjU5ZmVhYTYxNWVlYjRmZTJhOGQ1ZTQ5NTRkNjk5MzFiL3RleHRyZWdpb246NTlmZWFhNjE1ZWViNGZlMmE4ZDVlNDk1NGQ2OTkzMWJfNDg4NA_8abc91c0-1777-43a9-aecb-5361d3024cfa">20.0</ix:nonFraction> million, reduced by $<ix:nonFraction unitRef="usd" contextRef="i415678d9707341f4acccc0fba869131d_D20201110-20201231" decimals="-5" sign="-" name="dmtk:IncreaseDecreaseInStockIssuanceCosts" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmFlNWE5YmUwZWI5NDQ1ZDE5MmZhZTgyMmQyMmJlMDlmL3NlYzphZTVhOWJlMGViOTQ0NWQxOTJmYWU4MjJkMjJiZTA5Zl80Ni9mcmFnOjU5ZmVhYTYxNWVlYjRmZTJhOGQ1ZTQ5NTRkNjk5MzFiL3RleHRyZWdpb246NTlmZWFhNjE1ZWViNGZlMmE4ZDVlNDk1NGQ2OTkzMWJfNDg5OQ_1a18e2ca-04ee-40b2-ba64-9c8f1ef00ab2">0.9</ix:nonFraction> million in issuance costs, resulting in net proceeds to the Company of approximately $<ix:nonFraction unitRef="usd" contextRef="i415678d9707341f4acccc0fba869131d_D20201110-20201231" decimals="-5" name="us-gaap:ProceedsFromIssuanceOfCommonStock" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmFlNWE5YmUwZWI5NDQ1ZDE5MmZhZTgyMmQyMmJlMDlmL3NlYzphZTVhOWJlMGViOTQ0NWQxOTJmYWU4MjJkMjJiZTA5Zl80Ni9mcmFnOjU5ZmVhYTYxNWVlYjRmZTJhOGQ1ZTQ5NTRkNjk5MzFiL3RleHRyZWdpb246NTlmZWFhNjE1ZWViNGZlMmE4ZDVlNDk1NGQ2OTkzMWJfNDk3OQ_17ed7c3a-0602-4e36-bab4-ca6fd58a817d">19.1</ix:nonFraction> million. For the six months ended June&#160;30, 2022, the Company did <ix:nonFraction unitRef="shares" contextRef="i305721ec0ffb416391e577b9071cbf15_D20220101-20220630" decimals="INF" name="us-gaap:StockIssuedDuringPeriodSharesNewIssues" format="ixt:fixed-zero" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmFlNWE5YmUwZWI5NDQ1ZDE5MmZhZTgyMmQyMmJlMDlmL3NlYzphZTVhOWJlMGViOTQ0NWQxOTJmYWU4MjJkMjJiZTA5Zl80Ni9mcmFnOjU5ZmVhYTYxNWVlYjRmZTJhOGQ1ZTQ5NTRkNjk5MzFiL3RleHRyZWdpb246NTlmZWFhNjE1ZWViNGZlMmE4ZDVlNDk1NGQ2OTkzMWJfNTAzMA_5409aed0-11af-484d-a91b-770b2673a880">not</ix:nonFraction> issue any shares pursuant to the Sales Agreement. For the year ended December 31, 2021, the Company issued an aggregate of <ix:nonFraction unitRef="shares" contextRef="if05c806895254e84952b9538ed102dac_D20210101-20211231" decimals="INF" name="us-gaap:StockIssuedDuringPeriodSharesNewIssues" format="ixt:num-dot-decimal" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmFlNWE5YmUwZWI5NDQ1ZDE5MmZhZTgyMmQyMmJlMDlmL3NlYzphZTVhOWJlMGViOTQ0NWQxOTJmYWU4MjJkMjJiZTA5Zl80Ni9mcmFnOjU5ZmVhYTYxNWVlYjRmZTJhOGQ1ZTQ5NTRkNjk5MzFiL3RleHRyZWdpb246NTlmZWFhNjE1ZWViNGZlMmE4ZDVlNDk1NGQ2OTkzMWJfNTE0Ng_ba93f6a9-1ac1-4ee6-9a6d-e01131b01cff">530,551</ix:nonFraction> shares of common stock pursuant to the Sales Agreement at a weighted average purchase price of $<ix:nonFraction unitRef="usdPerShare" contextRef="if05c806895254e84952b9538ed102dac_D20210101-20211231" decimals="2" name="dmtk:WeightedAveragePurchasePricePerShareInOffering" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmFlNWE5YmUwZWI5NDQ1ZDE5MmZhZTgyMmQyMmJlMDlmL3NlYzphZTVhOWJlMGViOTQ0NWQxOTJmYWU4MjJkMjJiZTA5Zl80Ni9mcmFnOjU5ZmVhYTYxNWVlYjRmZTJhOGQ1ZTQ5NTRkNjk5MzFiL3RleHRyZWdpb246NTlmZWFhNjE1ZWViNGZlMmE4ZDVlNDk1NGQ2OTkzMWJfNTI0NA_aae49c07-7dac-4abd-869c-f76b078c4b92">46.33</ix:nonFraction> resulting in aggregate gross proceeds of approximately $<ix:nonFraction unitRef="usd" contextRef="if05c806895254e84952b9538ed102dac_D20210101-20211231" decimals="-5" name="dmtk:GrossProceedsFromIssuanceOfCommonStock" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmFlNWE5YmUwZWI5NDQ1ZDE5MmZhZTgyMmQyMmJlMDlmL3NlYzphZTVhOWJlMGViOTQ0NWQxOTJmYWU4MjJkMjJiZTA5Zl80Ni9mcmFnOjU5ZmVhYTYxNWVlYjRmZTJhOGQ1ZTQ5NTRkNjk5MzFiL3RleHRyZWdpb246NTlmZWFhNjE1ZWViNGZlMmE4ZDVlNDk1NGQ2OTkzMWJfNTMwMg_35773268-0256-4483-976e-de1cc22c0c90">24.6</ix:nonFraction> million, reduced by $<ix:nonFraction unitRef="usd" contextRef="if05c806895254e84952b9538ed102dac_D20210101-20211231" decimals="-5" sign="-" name="dmtk:IncreaseDecreaseInStockIssuanceCosts" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmFlNWE5YmUwZWI5NDQ1ZDE5MmZhZTgyMmQyMmJlMDlmL3NlYzphZTVhOWJlMGViOTQ0NWQxOTJmYWU4MjJkMjJiZTA5Zl80Ni9mcmFnOjU5ZmVhYTYxNWVlYjRmZTJhOGQ1ZTQ5NTRkNjk5MzFiL3RleHRyZWdpb246NTlmZWFhNjE1ZWViNGZlMmE4ZDVlNDk1NGQ2OTkzMWJfNTMxNw_df49cb76-76e7-41d8-9fac-32bcfd00636c">0.7</ix:nonFraction> million in issuance costs, resulting in net proceeds to the Company of approximately $<ix:nonFraction unitRef="usd" contextRef="if05c806895254e84952b9538ed102dac_D20210101-20211231" decimals="-5" name="us-gaap:ProceedsFromIssuanceOfCommonStock" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmFlNWE5YmUwZWI5NDQ1ZDE5MmZhZTgyMmQyMmJlMDlmL3NlYzphZTVhOWJlMGViOTQ0NWQxOTJmYWU4MjJkMjJiZTA5Zl80Ni9mcmFnOjU5ZmVhYTYxNWVlYjRmZTJhOGQ1ZTQ5NTRkNjk5MzFiL3RleHRyZWdpb246NTlmZWFhNjE1ZWViNGZlMmE4ZDVlNDk1NGQ2OTkzMWJfNTM5Nw_f05be259-bd67-4c6d-a3d1-a49de94d7f5c">23.8</ix:nonFraction> million. </span></div><div style="margin-top:15pt;padding-left:27pt;text-indent:-27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">(c)&#160;&#160;&#160;&#160;2021 Underwritten Public Offering </span></div><div style="margin-top:9pt;padding-left:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">On January&#160;6, 2021, the Company entered into an Underwriting Agreement with Cowen and William Blair &amp; Company, L.L.C. as representatives of several underwriters (the "Underwriters"). The Company agreed to issue and sell up to <ix:nonFraction unitRef="shares" contextRef="i7d0e216f45ca4f518d2c2732a59322ab_D20210106-20210106" decimals="INF" name="us-gaap:StockIssuedDuringPeriodSharesNewIssues" format="ixt:num-dot-decimal" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmFlNWE5YmUwZWI5NDQ1ZDE5MmZhZTgyMmQyMmJlMDlmL3NlYzphZTVhOWJlMGViOTQ0NWQxOTJmYWU4MjJkMjJiZTA5Zl80Ni9mcmFnOjU5ZmVhYTYxNWVlYjRmZTJhOGQ1ZTQ5NTRkNjk5MzFiL3RleHRyZWdpb246NTlmZWFhNjE1ZWViNGZlMmE4ZDVlNDk1NGQ2OTkzMWJfNTY3MQ_038c7aa1-5514-4ac2-8f79-0369a3ee8b1b">4,237,288</ix:nonFraction> shares of its common stock including up to <ix:nonFraction unitRef="shares" contextRef="i7d0e216f45ca4f518d2c2732a59322ab_D20210106-20210106" decimals="INF" name="dmtk:StockPurchasedByUnderwritersPursuantToOptionGranted" format="ixt:num-dot-decimal" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmFlNWE5YmUwZWI5NDQ1ZDE5MmZhZTgyMmQyMmJlMDlmL3NlYzphZTVhOWJlMGViOTQ0NWQxOTJmYWU4MjJkMjJiZTA5Zl80Ni9mcmFnOjU5ZmVhYTYxNWVlYjRmZTJhOGQ1ZTQ5NTRkNjk5MzFiL3RleHRyZWdpb246NTlmZWFhNjE1ZWViNGZlMmE4ZDVlNDk1NGQ2OTkzMWJfNTcxNw_bb66526b-9001-4b89-81d8-46c4f35a2396">635,593</ix:nonFraction> shares that could be purchased by the Underwriters pursuant to a <ix:nonNumeric contextRef="i7d0e216f45ca4f518d2c2732a59322ab_D20210106-20210106" name="dmtk:UnderwritersGrantPeriodOption" format="ixt-sec:durday" id="id3VybDovL2RvY3MudjEvZG9jOmFlNWE5YmUwZWI5NDQ1ZDE5MmZhZTgyMmQyMmJlMDlmL3NlYzphZTVhOWJlMGViOTQ0NWQxOTJmYWU4MjJkMjJiZTA5Zl80Ni9mcmFnOjU5ZmVhYTYxNWVlYjRmZTJhOGQ1ZTQ5NTRkNjk5MzFiL3RleHRyZWdpb246NTlmZWFhNjE1ZWViNGZlMmE4ZDVlNDk1NGQ2OTkzMWJfNTc4NQ_b873f152-13ae-4227-bff9-8846bc009bea">30</ix:nonNumeric>-day option granted to the Underwriters by the Company. On January&#160;11, 2021, the Company closed the underwritten public offering of <ix:nonFraction unitRef="shares" contextRef="ic368d6fe62464ba5bac452fa161672d6_D20210111-20210111" decimals="INF" name="us-gaap:SaleOfStockNumberOfSharesIssuedInTransaction" format="ixt:num-dot-decimal" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmFlNWE5YmUwZWI5NDQ1ZDE5MmZhZTgyMmQyMmJlMDlmL3NlYzphZTVhOWJlMGViOTQ0NWQxOTJmYWU4MjJkMjJiZTA5Zl80Ni9mcmFnOjU5ZmVhYTYxNWVlYjRmZTJhOGQ1ZTQ5NTRkNjk5MzFiL3RleHRyZWdpb246NTlmZWFhNjE1ZWViNGZlMmE4ZDVlNDk1NGQ2OTkzMWJfNTkwNQ_629a00c5-9831-4bdf-9c74-e32ac7301ea4">4,872,881</ix:nonFraction> shares of its common stock, which included the exercise in full by the Underwriters of their option to purchase up to <ix:nonFraction unitRef="shares" contextRef="ic368d6fe62464ba5bac452fa161672d6_D20210111-20210111" decimals="INF" name="dmtk:StockPurchasedByUnderwritersPursuantToOptionGranted" format="ixt:num-dot-decimal" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmFlNWE5YmUwZWI5NDQ1ZDE5MmZhZTgyMmQyMmJlMDlmL3NlYzphZTVhOWJlMGViOTQ0NWQxOTJmYWU4MjJkMjJiZTA5Zl80Ni9mcmFnOjU5ZmVhYTYxNWVlYjRmZTJhOGQ1ZTQ5NTRkNjk5MzFiL3RleHRyZWdpb246NTlmZWFhNjE1ZWViNGZlMmE4ZDVlNDk1NGQ2OTkzMWJfNjAyNg_3ca58b52-13c9-4262-bdc3-c2062b79527f">635,593</ix:nonFraction> additional shares, at a price to the public of $<ix:nonFraction unitRef="usdPerShare" contextRef="icbaabbad817c4953a4cfd55f31fb248d_I20210111" decimals="INF" name="us-gaap:SaleOfStockPricePerShare" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmFlNWE5YmUwZWI5NDQ1ZDE5MmZhZTgyMmQyMmJlMDlmL3NlYzphZTVhOWJlMGViOTQ0NWQxOTJmYWU4MjJkMjJiZTA5Zl80Ni9mcmFnOjU5ZmVhYTYxNWVlYjRmZTJhOGQ1ZTQ5NTRkNjk5MzFiL3RleHRyZWdpb246NTlmZWFhNjE1ZWViNGZlMmE4ZDVlNDk1NGQ2OTkzMWJfNjA3Ng_5cf996a6-9c17-4bb2-b1c2-cdfc58924ad4">29.50</ix:nonFraction> per share. The Company received aggregate gross proceeds of approximately $<ix:nonFraction unitRef="usd" contextRef="ic368d6fe62464ba5bac452fa161672d6_D20210111-20210111" decimals="-5" name="dmtk:GrossProceedsFromOfferingBeforeDeductingUnderwritingDiscountsAndCommissionsAndOtherOfferingExpenses" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmFlNWE5YmUwZWI5NDQ1ZDE5MmZhZTgyMmQyMmJlMDlmL3NlYzphZTVhOWJlMGViOTQ0NWQxOTJmYWU4MjJkMjJiZTA5Zl80Ni9mcmFnOjU5ZmVhYTYxNWVlYjRmZTJhOGQ1ZTQ5NTRkNjk5MzFiL3RleHRyZWdpb246NTlmZWFhNjE1ZWViNGZlMmE4ZDVlNDk1NGQ2OTkzMWJfNjE1Mw_57628e24-1a9b-45a1-bc09-35ba9e93846c">143.7</ix:nonFraction> million, and net proceeds of approximately $<ix:nonFraction unitRef="usd" contextRef="ic368d6fe62464ba5bac452fa161672d6_D20210111-20210111" decimals="-5" name="us-gaap:ProceedsFromIssuanceOfCommonStock" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmFlNWE5YmUwZWI5NDQ1ZDE5MmZhZTgyMmQyMmJlMDlmL3NlYzphZTVhOWJlMGViOTQ0NWQxOTJmYWU4MjJkMjJiZTA5Zl80Ni9mcmFnOjU5ZmVhYTYxNWVlYjRmZTJhOGQ1ZTQ5NTRkNjk5MzFiL3RleHRyZWdpb246NTlmZWFhNjE1ZWViNGZlMmE4ZDVlNDk1NGQ2OTkzMWJfNjE5MQ_01019b3e-c1f8-4fde-87f2-06b6ee7bd7d3">134.6</ix:nonFraction> million, after deducting underwriting discounts and commissions and other offering expenses.</span></div><div style="margin-top:15pt;padding-left:27pt;text-indent:-27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">(d)&#160;&#160;&#160;&#160;Warrants </span></div><div style="margin-top:15pt;padding-left:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">SPAC Warrants </span></div><div style="margin-top:9pt;padding-left:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company previously issued a total of <ix:nonFraction unitRef="shares" contextRef="i6732e83066a44277a8539ee4f29b7c2f_D20170623-20170623" decimals="INF" name="dmtk:ClassOfWarrantOrRightWarrantsOrRightsIssuedToPurchaseCommonStock" format="ixt:num-dot-decimal" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmFlNWE5YmUwZWI5NDQ1ZDE5MmZhZTgyMmQyMmJlMDlmL3NlYzphZTVhOWJlMGViOTQ0NWQxOTJmYWU4MjJkMjJiZTA5Zl80Ni9mcmFnOjU5ZmVhYTYxNWVlYjRmZTJhOGQ1ZTQ5NTRkNjk5MzFiL3RleHRyZWdpb246NTlmZWFhNjE1ZWViNGZlMmE4ZDVlNDk1NGQ2OTkzMWJfNjM0OQ_e244d404-cb17-4cf5-a8cf-05b8966608ee">14,936,250</ix:nonFraction> SPAC Warrants to purchase common stock in public and private placement offerings which were consummated on June&#160;23, 2017. As part of the public offering, the Company issued <ix:nonFraction unitRef="shares" contextRef="i310af3399c354a2194fb2cb2350604d4_D20170623-20170623" decimals="INF" name="dmtk:ClassOfWarrantOrRightWarrantsOrRightsIssuedToPurchaseCommonStock" format="ixt:num-dot-decimal" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmFlNWE5YmUwZWI5NDQ1ZDE5MmZhZTgyMmQyMmJlMDlmL3NlYzphZTVhOWJlMGViOTQ0NWQxOTJmYWU4MjJkMjJiZTA5Zl80Ni9mcmFnOjU5ZmVhYTYxNWVlYjRmZTJhOGQ1ZTQ5NTRkNjk5MzFiL3RleHRyZWdpb246NTlmZWFhNjE1ZWViNGZlMmE4ZDVlNDk1NGQ2OTkzMWJfNjUxNA_61123fb1-3269-44b6-ba89-32bdd96502f3">14,375,000</ix:nonFraction> warrants ("Public SPAC Warrants") and as part of the private placement offering, the Company issued <ix:nonFraction unitRef="shares" contextRef="i452e14998aaf4b87b88a33470c2536e4_D20170623-20170623" decimals="INF" name="dmtk:ClassOfWarrantOrRightWarrantsOrRightsIssuedToPurchaseCommonStock" format="ixt:num-dot-decimal" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmFlNWE5YmUwZWI5NDQ1ZDE5MmZhZTgyMmQyMmJlMDlmL3NlYzphZTVhOWJlMGViOTQ0NWQxOTJmYWU4MjJkMjJiZTA5Zl80Ni9mcmFnOjU5ZmVhYTYxNWVlYjRmZTJhOGQ1ZTQ5NTRkNjk5MzFiL3RleHRyZWdpb246NTlmZWFhNjE1ZWViNGZlMmE4ZDVlNDk1NGQ2OTkzMWJfNjYwNQ_a6008b44-3ea0-4344-bf52-484d98f1437e">561,250</ix:nonFraction> warrants ("Private SPAC Warrants"). The SPAC Warrants have a <ix:nonNumeric contextRef="i4c8f247d12134a9886d56e1c8b024425_I20220630" name="us-gaap:WarrantsAndRightsOutstandingTerm" format="ixt-sec:durwordsen" id="id3VybDovL2RvY3MudjEvZG9jOmFlNWE5YmUwZWI5NDQ1ZDE5MmZhZTgyMmQyMmJlMDlmL3NlYzphZTVhOWJlMGViOTQ0NWQxOTJmYWU4MjJkMjJiZTA5Zl80Ni9mcmFnOjU5ZmVhYTYxNWVlYjRmZTJhOGQ1ZTQ5NTRkNjk5MzFiL3RleHRyZWdpb246NTlmZWFhNjE1ZWViNGZlMmE4ZDVlNDk1NGQ2OTkzMWJfMzI5ODUzNDkwNzU4NQ_e08eedac-7919-4177-aa93-999af8648fcb">five-year</ix:nonNumeric> life from the date the Business Combination was consummated and every four SPAC Warrants entitle the holder to purchase one whole share of common stock at an exercise price of $<ix:nonFraction unitRef="usdPerShare" contextRef="i634967fade134dc69b40f7ae53806ba8_I20220630" decimals="2" name="us-gaap:ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmFlNWE5YmUwZWI5NDQ1ZDE5MmZhZTgyMmQyMmJlMDlmL3NlYzphZTVhOWJlMGViOTQ0NWQxOTJmYWU4MjJkMjJiZTA5Zl80Ni9mcmFnOjU5ZmVhYTYxNWVlYjRmZTJhOGQ1ZTQ5NTRkNjk5MzFiL3RleHRyZWdpb246NTlmZWFhNjE1ZWViNGZlMmE4ZDVlNDk1NGQ2OTkzMWJfNjg0Mg_bdc04842-68ec-4593-b9d2-7a0cb31c8207">23.00</ix:nonFraction> per whole share.</span></div><div style="margin-top:9pt;padding-left:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Private SPAC Warrants are identical to the Public SPAC Warrants, but they (i) are exercisable either for cash or on a cashless basis at the holder&#8217;s option, (ii) are not redeemable by the Company as long as such warrants are held by the initial purchasers or their affiliates and permitted transferees, and (iii) may be subject to the limitations on exercise as specified in the warrant agreement. As a result of these difference in features between the Public SPAC Warrants and Private SPAC Warrants, the Company concluded that the Private SPAC Warrants should be classified as a liability, if still held by the original Private SPAC Warrant holder, and marked to market each financial reporting period in the Company&#8217;s statement of operations.</span></div><div style="margin-top:9pt;padding-left:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Between January 1, 2021 and June&#160;30, 2021, a total of <ix:nonFraction unitRef="shares" contextRef="i21b78556448b464cb21d8774cfc796ea_I20210630" decimals="INF" name="us-gaap:ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights" format="ixt:num-dot-decimal" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmFlNWE5YmUwZWI5NDQ1ZDE5MmZhZTgyMmQyMmJlMDlmL3NlYzphZTVhOWJlMGViOTQ0NWQxOTJmYWU4MjJkMjJiZTA5Zl80Ni9mcmFnOjU5ZmVhYTYxNWVlYjRmZTJhOGQ1ZTQ5NTRkNjk5MzFiL3RleHRyZWdpb246NTlmZWFhNjE1ZWViNGZlMmE4ZDVlNDk1NGQ2OTkzMWJfMTA5OTUxMTY0OTUyMQ_0ecae292-fc28-4555-b6f1-fdf2a4f78188">12,120,397</ix:nonFraction> SPAC Warrants were exercised, resulting in the Company&#8217;s issuance of <ix:nonFraction unitRef="shares" contextRef="iec153eacdc1c48dbb3a7a5f42f8d0173_D20210101-20210630" decimals="INF" name="dmtk:CommonSharesIssuedUponExerciseOfWarrants" format="ixt:num-dot-decimal" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmFlNWE5YmUwZWI5NDQ1ZDE5MmZhZTgyMmQyMmJlMDlmL3NlYzphZTVhOWJlMGViOTQ0NWQxOTJmYWU4MjJkMjJiZTA5Zl80Ni9mcmFnOjU5ZmVhYTYxNWVlYjRmZTJhOGQ1ZTQ5NTRkNjk5MzFiL3RleHRyZWdpb246NTlmZWFhNjE1ZWViNGZlMmE4ZDVlNDk1NGQ2OTkzMWJfMTA5OTUxMTY0OTUzMw_67744dce-bde1-44fc-918a-67a4346201ad">3,030,092</ix:nonFraction> shares of common stock and the receipt of $<ix:nonFraction unitRef="usd" contextRef="iec153eacdc1c48dbb3a7a5f42f8d0173_D20210101-20210630" decimals="-5" name="us-gaap:ProceedsFromWarrantExercises" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmFlNWE5YmUwZWI5NDQ1ZDE5MmZhZTgyMmQyMmJlMDlmL3NlYzphZTVhOWJlMGViOTQ0NWQxOTJmYWU4MjJkMjJiZTA5Zl80Ni9mcmFnOjU5ZmVhYTYxNWVlYjRmZTJhOGQ1ZTQ5NTRkNjk5MzFiL3RleHRyZWdpb246NTlmZWFhNjE1ZWViNGZlMmE4ZDVlNDk1NGQ2OTkzMWJfMTA5OTUxMTY0OTU0OQ_b8e6a795-e36e-44b2-8726-7b351adad2a1">69.7</ix:nonFraction>&#160;million in gross proceeds. </span></div><div style="margin-top:9pt;padding-left:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Outstanding SPAC Warrants totaled <ix:nonFraction unitRef="shares" contextRef="i803095f015594543bf9205dfd151c02e_I20220630" decimals="INF" name="us-gaap:ClassOfWarrantOrRightOutstanding" format="ixt:num-dot-decimal" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmFlNWE5YmUwZWI5NDQ1ZDE5MmZhZTgyMmQyMmJlMDlmL3NlYzphZTVhOWJlMGViOTQ0NWQxOTJmYWU4MjJkMjJiZTA5Zl80Ni9mcmFnOjU5ZmVhYTYxNWVlYjRmZTJhOGQ1ZTQ5NTRkNjk5MzFiL3RleHRyZWdpb246NTlmZWFhNjE1ZWViNGZlMmE4ZDVlNDk1NGQ2OTkzMWJfNzgyOQ_4b0cfcd1-d17b-4372-8c22-e1f30c5e8ff5"><ix:nonFraction unitRef="shares" contextRef="i9641b453cb244341906e0d3f67453c08_I20211231" decimals="INF" name="us-gaap:ClassOfWarrantOrRightOutstanding" format="ixt:num-dot-decimal" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmFlNWE5YmUwZWI5NDQ1ZDE5MmZhZTgyMmQyMmJlMDlmL3NlYzphZTVhOWJlMGViOTQ0NWQxOTJmYWU4MjJkMjJiZTA5Zl80Ni9mcmFnOjU5ZmVhYTYxNWVlYjRmZTJhOGQ1ZTQ5NTRkNjk5MzFiL3RleHRyZWdpb246NTlmZWFhNjE1ZWViNGZlMmE4ZDVlNDk1NGQ2OTkzMWJfNzgyOQ_bf3b148a-58ce-4c14-bdb4-4fe37a330ad1">2,815,853</ix:nonFraction></ix:nonFraction> as of June&#160;30, 2022 and December&#160;31, 2021. Private SPAC Warrants that were still owned by the original holder totaled <ix:nonFraction unitRef="shares" contextRef="i0d9404419f2a4713a7b20a9438a2268d_I20211231" decimals="INF" name="us-gaap:ClassOfWarrantOrRightOutstanding" format="ixt:num-dot-decimal" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmFlNWE5YmUwZWI5NDQ1ZDE5MmZhZTgyMmQyMmJlMDlmL3NlYzphZTVhOWJlMGViOTQ0NWQxOTJmYWU4MjJkMjJiZTA5Zl80Ni9mcmFnOjU5ZmVhYTYxNWVlYjRmZTJhOGQ1ZTQ5NTRkNjk5MzFiL3RleHRyZWdpb246NTlmZWFhNjE1ZWViNGZlMmE4ZDVlNDk1NGQ2OTkzMWJfNzk0NQ_01be8917-61c6-4f82-948d-012478807389"><ix:nonFraction unitRef="shares" contextRef="i80e526858964456d8f479d0e2dd63ca5_I20220630" decimals="INF" name="us-gaap:ClassOfWarrantOrRightOutstanding" format="ixt:num-dot-decimal" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmFlNWE5YmUwZWI5NDQ1ZDE5MmZhZTgyMmQyMmJlMDlmL3NlYzphZTVhOWJlMGViOTQ0NWQxOTJmYWU4MjJkMjJiZTA5Zl80Ni9mcmFnOjU5ZmVhYTYxNWVlYjRmZTJhOGQ1ZTQ5NTRkNjk5MzFiL3RleHRyZWdpb246NTlmZWFhNjE1ZWViNGZlMmE4ZDVlNDk1NGQ2OTkzMWJfNzk0NQ_e55c3c0b-f82c-492d-916f-8f54a31357b8">80,350</ix:nonFraction></ix:nonFraction> as of June&#160;30, 2022 and December&#160;31, 2021.</span></div></ix:continuation><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">16</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:45pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#iae5a9be0eb9445d192fae822d22be09f_7">Table of Contents</a></span></div></div><ix:continuation id="ifada9eab3127421fb0e1b97f5c01218e" continuedAt="i73abf7a810af41f598fc7e1a4caba948"><div style="margin-top:15pt;padding-left:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Placement Agent Warrants</span></div><div style="margin-top:9pt;padding-left:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In connection with several of DermTech Operations&#8217; financings that took place between 2015 and 2018, DermTech Operations engaged a registered placement agent to assist in marketing and selling of common and preferred units. From 2015 to 2016, DermTech Operations issued <ix:nonFraction unitRef="shares" contextRef="i5e6cf29a894e475589e2bb8262ac9033_D20150101-20161231" decimals="INF" name="dmtk:ClassOfWarrantOrRightWarrantsOrRightsIssuedToPurchaseCommonStock" format="ixt:num-dot-decimal" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmFlNWE5YmUwZWI5NDQ1ZDE5MmZhZTgyMmQyMmJlMDlmL3NlYzphZTVhOWJlMGViOTQ0NWQxOTJmYWU4MjJkMjJiZTA5Zl80Ni9mcmFnOjU5ZmVhYTYxNWVlYjRmZTJhOGQ1ZTQ5NTRkNjk5MzFiL3RleHRyZWdpb246NTlmZWFhNjE1ZWViNGZlMmE4ZDVlNDk1NGQ2OTkzMWJfODc2Nw_4617e945-e259-436b-992c-95c7d5ba3a97">168,522</ix:nonFraction> <ix:nonNumeric contextRef="ic92102edfd1342a192f438b00ef88200_I20161231" name="us-gaap:WarrantsAndRightsOutstandingTerm" format="ixt-sec:durwordsen" id="id3VybDovL2RvY3MudjEvZG9jOmFlNWE5YmUwZWI5NDQ1ZDE5MmZhZTgyMmQyMmJlMDlmL3NlYzphZTVhOWJlMGViOTQ0NWQxOTJmYWU4MjJkMjJiZTA5Zl80Ni9mcmFnOjU5ZmVhYTYxNWVlYjRmZTJhOGQ1ZTQ5NTRkNjk5MzFiL3RleHRyZWdpb246NTlmZWFhNjE1ZWViNGZlMmE4ZDVlNDk1NGQ2OTkzMWJfMTU2NDc_256055f8-6f8b-4db1-a775-79f4eb2367ef">seven-year</ix:nonNumeric> warrants to purchase <ix:nonFraction unitRef="shares" contextRef="ic2ffccea2c90436fac0e9812ff060041_I20161231" decimals="INF" name="us-gaap:ClassOfWarrantOrRightNumberOfSecuritiesCalledByEachWarrantOrRight" format="ixt-sec:numwordsen" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmFlNWE5YmUwZWI5NDQ1ZDE5MmZhZTgyMmQyMmJlMDlmL3NlYzphZTVhOWJlMGViOTQ0NWQxOTJmYWU4MjJkMjJiZTA5Zl80Ni9mcmFnOjU5ZmVhYTYxNWVlYjRmZTJhOGQ1ZTQ5NTRkNjk5MzFiL3RleHRyZWdpb246NTlmZWFhNjE1ZWViNGZlMmE4ZDVlNDk1NGQ2OTkzMWJfODc5OQ_df1602f6-5202-4b8d-b8be-797e04760cad">one</ix:nonFraction> share of common stock each at an exercise price of $<ix:nonFraction unitRef="usdPerShare" contextRef="ic2ffccea2c90436fac0e9812ff060041_I20161231" decimals="INF" name="us-gaap:ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmFlNWE5YmUwZWI5NDQ1ZDE5MmZhZTgyMmQyMmJlMDlmL3NlYzphZTVhOWJlMGViOTQ0NWQxOTJmYWU4MjJkMjJiZTA5Zl80Ni9mcmFnOjU5ZmVhYTYxNWVlYjRmZTJhOGQ1ZTQ5NTRkNjk5MzFiL3RleHRyZWdpb246NTlmZWFhNjE1ZWViNGZlMmE4ZDVlNDk1NGQ2OTkzMWJfODg1Mw_69790e40-8ade-4ebc-9b8d-6fccc7e1c8a8">8.68</ix:nonFraction> per share. From 2016 to 2018, DermTech Operations issued <ix:nonFraction unitRef="shares" contextRef="if35ae65dc07b452292756d42575f3dae_D20160101-20181231" decimals="INF" name="dmtk:ClassOfWarrantOrRightWarrantsOrRightsIssuedToPurchaseCommonStock" format="ixt:num-dot-decimal" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmFlNWE5YmUwZWI5NDQ1ZDE5MmZhZTgyMmQyMmJlMDlmL3NlYzphZTVhOWJlMGViOTQ0NWQxOTJmYWU4MjJkMjJiZTA5Zl80Ni9mcmFnOjU5ZmVhYTYxNWVlYjRmZTJhOGQ1ZTQ5NTRkNjk5MzFiL3RleHRyZWdpb246NTlmZWFhNjE1ZWViNGZlMmE4ZDVlNDk1NGQ2OTkzMWJfODkxMw_9fd4e2e4-9d61-4e75-b1a4-22ef2f41d2a2">72,658</ix:nonFraction> <ix:nonNumeric contextRef="i4159027d930b496eab94ec0daf363261_I20181231" name="us-gaap:WarrantsAndRightsOutstandingTerm" format="ixt-sec:durwordsen" id="id3VybDovL2RvY3MudjEvZG9jOmFlNWE5YmUwZWI5NDQ1ZDE5MmZhZTgyMmQyMmJlMDlmL3NlYzphZTVhOWJlMGViOTQ0NWQxOTJmYWU4MjJkMjJiZTA5Zl80Ni9mcmFnOjU5ZmVhYTYxNWVlYjRmZTJhOGQ1ZTQ5NTRkNjk5MzFiL3RleHRyZWdpb246NTlmZWFhNjE1ZWViNGZlMmE4ZDVlNDk1NGQ2OTkzMWJfMTU2NDg_840181cf-4e82-4a0e-a8c2-419126695c9c">seven-year</ix:nonNumeric> warrants to purchase <ix:nonFraction unitRef="shares" contextRef="id7e5b24c3bb74b83a74aa64a7d327d4c_I20181231" decimals="INF" name="us-gaap:ClassOfWarrantOrRightNumberOfSecuritiesCalledByEachWarrantOrRight" format="ixt-sec:numwordsen" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmFlNWE5YmUwZWI5NDQ1ZDE5MmZhZTgyMmQyMmJlMDlmL3NlYzphZTVhOWJlMGViOTQ0NWQxOTJmYWU4MjJkMjJiZTA5Zl80Ni9mcmFnOjU5ZmVhYTYxNWVlYjRmZTJhOGQ1ZTQ5NTRkNjk5MzFiL3RleHRyZWdpb246NTlmZWFhNjE1ZWViNGZlMmE4ZDVlNDk1NGQ2OTkzMWJfODk0NQ_36ee496e-3ca6-4314-81c4-fb6d58375bc8">one</ix:nonFraction> share of common stock at an exercise price of $<ix:nonFraction unitRef="usdPerShare" contextRef="id7e5b24c3bb74b83a74aa64a7d327d4c_I20181231" decimals="INF" name="us-gaap:ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmFlNWE5YmUwZWI5NDQ1ZDE5MmZhZTgyMmQyMmJlMDlmL3NlYzphZTVhOWJlMGViOTQ0NWQxOTJmYWU4MjJkMjJiZTA5Zl80Ni9mcmFnOjU5ZmVhYTYxNWVlYjRmZTJhOGQ1ZTQ5NTRkNjk5MzFiL3RleHRyZWdpb246NTlmZWFhNjE1ZWViNGZlMmE4ZDVlNDk1NGQ2OTkzMWJfODk5NA_fc7fb5f2-e7dc-4c08-8210-7aaf3f8248a1">9.54</ix:nonFraction> per share. In 2020, the Company issued <ix:nonFraction unitRef="shares" contextRef="icf734323352a4de0a023df6ea904aaac_D20200101-20201231" decimals="INF" name="dmtk:ClassOfWarrantOrRightWarrantsOrRightsIssuedToPurchaseCommonStock" format="ixt:num-dot-decimal" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmFlNWE5YmUwZWI5NDQ1ZDE5MmZhZTgyMmQyMmJlMDlmL3NlYzphZTVhOWJlMGViOTQ0NWQxOTJmYWU4MjJkMjJiZTA5Zl80Ni9mcmFnOjU5ZmVhYTYxNWVlYjRmZTJhOGQ1ZTQ5NTRkNjk5MzFiL3RleHRyZWdpb246NTlmZWFhNjE1ZWViNGZlMmE4ZDVlNDk1NGQ2OTkzMWJfOTAzNg_ec2cfd4e-43f6-4696-ad20-0f8a407fce46">15,724</ix:nonFraction> <ix:nonNumeric contextRef="ibcc5eb12a4734bb39f49618ab345bde8_I20201231" name="us-gaap:WarrantsAndRightsOutstandingTerm" format="ixt-sec:durwordsen" id="id3VybDovL2RvY3MudjEvZG9jOmFlNWE5YmUwZWI5NDQ1ZDE5MmZhZTgyMmQyMmJlMDlmL3NlYzphZTVhOWJlMGViOTQ0NWQxOTJmYWU4MjJkMjJiZTA5Zl80Ni9mcmFnOjU5ZmVhYTYxNWVlYjRmZTJhOGQ1ZTQ5NTRkNjk5MzFiL3RleHRyZWdpb246NTlmZWFhNjE1ZWViNGZlMmE4ZDVlNDk1NGQ2OTkzMWJfMTU2NDE_a62e2548-5d7a-45e5-966e-07f06da386d2">seven-year</ix:nonNumeric> warrants to purchase <ix:nonFraction unitRef="shares" contextRef="ifa5f19791fc8441d87a405ff98a53015_I20201231" decimals="INF" name="us-gaap:ClassOfWarrantOrRightNumberOfSecuritiesCalledByEachWarrantOrRight" format="ixt-sec:numwordsen" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmFlNWE5YmUwZWI5NDQ1ZDE5MmZhZTgyMmQyMmJlMDlmL3NlYzphZTVhOWJlMGViOTQ0NWQxOTJmYWU4MjJkMjJiZTA5Zl80Ni9mcmFnOjU5ZmVhYTYxNWVlYjRmZTJhOGQ1ZTQ5NTRkNjk5MzFiL3RleHRyZWdpb246NTlmZWFhNjE1ZWViNGZlMmE4ZDVlNDk1NGQ2OTkzMWJfOTA2OA_cc97f7a2-a3fc-4d82-a181-064408055752">one</ix:nonFraction> share of common stock at an exercise price of $<ix:nonFraction unitRef="usdPerShare" contextRef="ifa5f19791fc8441d87a405ff98a53015_I20201231" decimals="INF" name="us-gaap:ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmFlNWE5YmUwZWI5NDQ1ZDE5MmZhZTgyMmQyMmJlMDlmL3NlYzphZTVhOWJlMGViOTQ0NWQxOTJmYWU4MjJkMjJiZTA5Zl80Ni9mcmFnOjU5ZmVhYTYxNWVlYjRmZTJhOGQ1ZTQ5NTRkNjk5MzFiL3RleHRyZWdpb246NTlmZWFhNjE1ZWViNGZlMmE4ZDVlNDk1NGQ2OTkzMWJfOTExNw_eb283961-b214-4e3b-ba4d-64f89f40470e">9.54</ix:nonFraction> per share in connection with the Company&#8217;s 2018 bridge note financing. Outstanding placement agent warrants totaled <ix:nonFraction unitRef="shares" contextRef="i2d6f98c2698e45af8da68430b3bfc742_I20220630" decimals="INF" name="us-gaap:ClassOfWarrantOrRightOutstanding" format="ixt:num-dot-decimal" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmFlNWE5YmUwZWI5NDQ1ZDE5MmZhZTgyMmQyMmJlMDlmL3NlYzphZTVhOWJlMGViOTQ0NWQxOTJmYWU4MjJkMjJiZTA5Zl80Ni9mcmFnOjU5ZmVhYTYxNWVlYjRmZTJhOGQ1ZTQ5NTRkNjk5MzFiL3RleHRyZWdpb246NTlmZWFhNjE1ZWViNGZlMmE4ZDVlNDk1NGQ2OTkzMWJfOTIzNw_2eb6a8e6-2553-4570-a31e-90db7b3e5c24"><ix:nonFraction unitRef="shares" contextRef="if706627078bd4aa4984495209ba461b8_I20211231" decimals="INF" name="us-gaap:ClassOfWarrantOrRightOutstanding" format="ixt:num-dot-decimal" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmFlNWE5YmUwZWI5NDQ1ZDE5MmZhZTgyMmQyMmJlMDlmL3NlYzphZTVhOWJlMGViOTQ0NWQxOTJmYWU4MjJkMjJiZTA5Zl80Ni9mcmFnOjU5ZmVhYTYxNWVlYjRmZTJhOGQ1ZTQ5NTRkNjk5MzFiL3RleHRyZWdpb246NTlmZWFhNjE1ZWViNGZlMmE4ZDVlNDk1NGQ2OTkzMWJfOTIzNw_e94996f7-4833-4c20-a0d9-faad8a795a7d">10,039</ix:nonFraction></ix:nonFraction> as of June&#160;30, 2022 and December&#160;31, 2021.</span></div><div style="margin-top:15pt;padding-left:27pt;text-indent:-27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">(i)&#160;&#160;&#160;&#160;Stock-Based Compensation </span></div><ix:continuation id="iad8da31150ff464ca3b18f10ffb3a72c"><div style="margin-top:9pt;padding-left:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table sets forth assumptions used to determine the fair value of each option on the date of grant issued under the 2020 Equity Incentive Plan:</span></div><div style="margin-top:12pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:32.233%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:15.112%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.406%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:15.112%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.406%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:15.112%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.406%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:15.113%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Three Months Ended June 30,</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Six Months Ended June 30,</span></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2021</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Assumed risk-free interest rate</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="i992097fa23d64aaa9f9ec09579943582_D20220401-20220630" decimals="4" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOmFlNWE5YmUwZWI5NDQ1ZDE5MmZhZTgyMmQyMmJlMDlmL3NlYzphZTVhOWJlMGViOTQ0NWQxOTJmYWU4MjJkMjJiZTA5Zl80Ni9mcmFnOjU5ZmVhYTYxNWVlYjRmZTJhOGQ1ZTQ5NTRkNjk5MzFiL3RhYmxlOmY3NTVmOTMwMjQyZDRhOThiY2I4ZTNlOGIyMzhhNDE0L3RhYmxlcmFuZ2U6Zjc1NWY5MzAyNDJkNGE5OGJjYjhlM2U4YjIzOGE0MTRfMi0xLTEtMS0yODg3_92c81ff3-6f76-4bb0-a640-1fc92c400092">2.97</ix:nonFraction>%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="i0150b39d62c349949c09dc704f452a68_D20210401-20210630" decimals="4" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMinimum" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOmFlNWE5YmUwZWI5NDQ1ZDE5MmZhZTgyMmQyMmJlMDlmL3NlYzphZTVhOWJlMGViOTQ0NWQxOTJmYWU4MjJkMjJiZTA5Zl80Ni9mcmFnOjU5ZmVhYTYxNWVlYjRmZTJhOGQ1ZTQ5NTRkNjk5MzFiL3RhYmxlOmY3NTVmOTMwMjQyZDRhOThiY2I4ZTNlOGIyMzhhNDE0L3RhYmxlcmFuZ2U6Zjc1NWY5MzAyNDJkNGE5OGJjYjhlM2U4YjIzOGE0MTRfMi0zLTEtMS0yODg3L3RleHRyZWdpb246MmMwZjA5NThiYmU0NDQyZjk1YTU2ZDIyMWRkMTEyZGRfNTQ5NzU1ODEzOTIy_9822e69f-07c9-4caf-a020-8687cf72e5b4">1.03</ix:nonFraction>% - <ix:nonFraction unitRef="number" contextRef="i0150b39d62c349949c09dc704f452a68_D20210401-20210630" decimals="4" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMaximum" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOmFlNWE5YmUwZWI5NDQ1ZDE5MmZhZTgyMmQyMmJlMDlmL3NlYzphZTVhOWJlMGViOTQ0NWQxOTJmYWU4MjJkMjJiZTA5Zl80Ni9mcmFnOjU5ZmVhYTYxNWVlYjRmZTJhOGQ1ZTQ5NTRkNjk5MzFiL3RhYmxlOmY3NTVmOTMwMjQyZDRhOThiY2I4ZTNlOGIyMzhhNDE0L3RhYmxlcmFuZ2U6Zjc1NWY5MzAyNDJkNGE5OGJjYjhlM2U4YjIzOGE0MTRfMi0zLTEtMS0yODg3L3RleHRyZWdpb246MmMwZjA5NThiYmU0NDQyZjk1YTU2ZDIyMWRkMTEyZGRfNTQ5NzU1ODEzOTE3_d56181a1-98a9-4dfb-8bd4-e5325deb97ba">1.07</ix:nonFraction>%</span></div></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="ie02bb53f63db46709e0bad3ea42b396b_D20220101-20220630" decimals="4" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOmFlNWE5YmUwZWI5NDQ1ZDE5MmZhZTgyMmQyMmJlMDlmL3NlYzphZTVhOWJlMGViOTQ0NWQxOTJmYWU4MjJkMjJiZTA5Zl80Ni9mcmFnOjU5ZmVhYTYxNWVlYjRmZTJhOGQ1ZTQ5NTRkNjk5MzFiL3RhYmxlOmY3NTVmOTMwMjQyZDRhOThiY2I4ZTNlOGIyMzhhNDE0L3RhYmxlcmFuZ2U6Zjc1NWY5MzAyNDJkNGE5OGJjYjhlM2U4YjIzOGE0MTRfMi01LTEtMS0yODg3L3RleHRyZWdpb246OTE3MmJmN2IyMTA1NDM5OGEwNDEyNzBjMDM5YzIyNTRfNA_b2417896-659e-4802-8ea7-3f4815422566">2.97</ix:nonFraction>% </span></div></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="i8e399d9e39504b2691c985ca006cfc1c_D20210101-20210630" decimals="4" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMinimum" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOmFlNWE5YmUwZWI5NDQ1ZDE5MmZhZTgyMmQyMmJlMDlmL3NlYzphZTVhOWJlMGViOTQ0NWQxOTJmYWU4MjJkMjJiZTA5Zl80Ni9mcmFnOjU5ZmVhYTYxNWVlYjRmZTJhOGQ1ZTQ5NTRkNjk5MzFiL3RhYmxlOmY3NTVmOTMwMjQyZDRhOThiY2I4ZTNlOGIyMzhhNDE0L3RhYmxlcmFuZ2U6Zjc1NWY5MzAyNDJkNGE5OGJjYjhlM2U4YjIzOGE0MTRfMi03LTEtMS0yODg3L3RleHRyZWdpb246YTAyYjgzY2NhYmE5NDNhODg3Zjg5ZGVjMTc0ZGM4YmNfNA_64b7c198-b940-45a6-b16f-13e436c997d6">0.52</ix:nonFraction>% - <ix:nonFraction unitRef="number" contextRef="i8e399d9e39504b2691c985ca006cfc1c_D20210101-20210630" decimals="4" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMaximum" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOmFlNWE5YmUwZWI5NDQ1ZDE5MmZhZTgyMmQyMmJlMDlmL3NlYzphZTVhOWJlMGViOTQ0NWQxOTJmYWU4MjJkMjJiZTA5Zl80Ni9mcmFnOjU5ZmVhYTYxNWVlYjRmZTJhOGQ1ZTQ5NTRkNjk5MzFiL3RhYmxlOmY3NTVmOTMwMjQyZDRhOThiY2I4ZTNlOGIyMzhhNDE0L3RhYmxlcmFuZ2U6Zjc1NWY5MzAyNDJkNGE5OGJjYjhlM2U4YjIzOGE0MTRfMi03LTEtMS0yODg3L3RleHRyZWdpb246YTAyYjgzY2NhYmE5NDNhODg3Zjg5ZGVjMTc0ZGM4YmNfOQ_2908e7f5-58e3-4ccc-b4ac-289de19a034d">1.13</ix:nonFraction>%</span></div></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Assumed volatility</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="i992097fa23d64aaa9f9ec09579943582_D20220401-20220630" decimals="4" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOmFlNWE5YmUwZWI5NDQ1ZDE5MmZhZTgyMmQyMmJlMDlmL3NlYzphZTVhOWJlMGViOTQ0NWQxOTJmYWU4MjJkMjJiZTA5Zl80Ni9mcmFnOjU5ZmVhYTYxNWVlYjRmZTJhOGQ1ZTQ5NTRkNjk5MzFiL3RhYmxlOmY3NTVmOTMwMjQyZDRhOThiY2I4ZTNlOGIyMzhhNDE0L3RhYmxlcmFuZ2U6Zjc1NWY5MzAyNDJkNGE5OGJjYjhlM2U4YjIzOGE0MTRfMy0xLTEtMS0yODg3_42e9926e-95d9-415d-9942-5de1014cd6ba">81.65</ix:nonFraction>%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="i0150b39d62c349949c09dc704f452a68_D20210401-20210630" decimals="4" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOmFlNWE5YmUwZWI5NDQ1ZDE5MmZhZTgyMmQyMmJlMDlmL3NlYzphZTVhOWJlMGViOTQ0NWQxOTJmYWU4MjJkMjJiZTA5Zl80Ni9mcmFnOjU5ZmVhYTYxNWVlYjRmZTJhOGQ1ZTQ5NTRkNjk5MzFiL3RhYmxlOmY3NTVmOTMwMjQyZDRhOThiY2I4ZTNlOGIyMzhhNDE0L3RhYmxlcmFuZ2U6Zjc1NWY5MzAyNDJkNGE5OGJjYjhlM2U4YjIzOGE0MTRfMy0zLTEtMS0yODg3_eb37d1a6-7a69-4a36-86d5-28b3f3e59234">77.69</ix:nonFraction>%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="ie02bb53f63db46709e0bad3ea42b396b_D20220101-20220630" decimals="4" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOmFlNWE5YmUwZWI5NDQ1ZDE5MmZhZTgyMmQyMmJlMDlmL3NlYzphZTVhOWJlMGViOTQ0NWQxOTJmYWU4MjJkMjJiZTA5Zl80Ni9mcmFnOjU5ZmVhYTYxNWVlYjRmZTJhOGQ1ZTQ5NTRkNjk5MzFiL3RhYmxlOmY3NTVmOTMwMjQyZDRhOThiY2I4ZTNlOGIyMzhhNDE0L3RhYmxlcmFuZ2U6Zjc1NWY5MzAyNDJkNGE5OGJjYjhlM2U4YjIzOGE0MTRfMy01LTEtMS0yODg3_a25752a6-e4fd-4342-b048-7767baa96304">81.65</ix:nonFraction>%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="i8e399d9e39504b2691c985ca006cfc1c_D20210101-20210630" decimals="4" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRateMinimum" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOmFlNWE5YmUwZWI5NDQ1ZDE5MmZhZTgyMmQyMmJlMDlmL3NlYzphZTVhOWJlMGViOTQ0NWQxOTJmYWU4MjJkMjJiZTA5Zl80Ni9mcmFnOjU5ZmVhYTYxNWVlYjRmZTJhOGQ1ZTQ5NTRkNjk5MzFiL3RhYmxlOmY3NTVmOTMwMjQyZDRhOThiY2I4ZTNlOGIyMzhhNDE0L3RhYmxlcmFuZ2U6Zjc1NWY5MzAyNDJkNGE5OGJjYjhlM2U4YjIzOGE0MTRfMy03LTEtMS0yODg3L3RleHRyZWdpb246ZjQ4MzBiNjExNjM1NDY0ZGJkYWZiMDdiYmIxYWI1Y2FfNA_4b0c2d89-22f6-499f-9266-1bea738fb1c0">74.88</ix:nonFraction>% - <ix:nonFraction unitRef="number" contextRef="i8e399d9e39504b2691c985ca006cfc1c_D20210101-20210630" decimals="4" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRateMaximum" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOmFlNWE5YmUwZWI5NDQ1ZDE5MmZhZTgyMmQyMmJlMDlmL3NlYzphZTVhOWJlMGViOTQ0NWQxOTJmYWU4MjJkMjJiZTA5Zl80Ni9mcmFnOjU5ZmVhYTYxNWVlYjRmZTJhOGQ1ZTQ5NTRkNjk5MzFiL3RhYmxlOmY3NTVmOTMwMjQyZDRhOThiY2I4ZTNlOGIyMzhhNDE0L3RhYmxlcmFuZ2U6Zjc1NWY5MzAyNDJkNGE5OGJjYjhlM2U4YjIzOGE0MTRfMy03LTEtMS0yODg3L3RleHRyZWdpb246ZjQ4MzBiNjExNjM1NDY0ZGJkYWZiMDdiYmIxYWI1Y2FfOQ_b617a5e9-a35d-4ca5-83a4-90cb15aaa372">77.69</ix:nonFraction>%</span></div></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Expected option term</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonNumeric contextRef="i992097fa23d64aaa9f9ec09579943582_D20220401-20220630" name="us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1" format="ixt-sec:duryear" id="id3VybDovL2RvY3MudjEvZG9jOmFlNWE5YmUwZWI5NDQ1ZDE5MmZhZTgyMmQyMmJlMDlmL3NlYzphZTVhOWJlMGViOTQ0NWQxOTJmYWU4MjJkMjJiZTA5Zl80Ni9mcmFnOjU5ZmVhYTYxNWVlYjRmZTJhOGQ1ZTQ5NTRkNjk5MzFiL3RhYmxlOmY3NTVmOTMwMjQyZDRhOThiY2I4ZTNlOGIyMzhhNDE0L3RhYmxlcmFuZ2U6Zjc1NWY5MzAyNDJkNGE5OGJjYjhlM2U4YjIzOGE0MTRfNC0xLTEtMS0yODg3_de89e699-ce2d-4474-ba99-51d44b03466f">6.08</ix:nonNumeric> years</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonNumeric contextRef="i0150b39d62c349949c09dc704f452a68_D20210401-20210630" name="us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1" format="ixt-sec:duryear" id="id3VybDovL2RvY3MudjEvZG9jOmFlNWE5YmUwZWI5NDQ1ZDE5MmZhZTgyMmQyMmJlMDlmL3NlYzphZTVhOWJlMGViOTQ0NWQxOTJmYWU4MjJkMjJiZTA5Zl80Ni9mcmFnOjU5ZmVhYTYxNWVlYjRmZTJhOGQ1ZTQ5NTRkNjk5MzFiL3RhYmxlOmY3NTVmOTMwMjQyZDRhOThiY2I4ZTNlOGIyMzhhNDE0L3RhYmxlcmFuZ2U6Zjc1NWY5MzAyNDJkNGE5OGJjYjhlM2U4YjIzOGE0MTRfNC0zLTEtMS0yODg3_c6134333-9742-4f5c-8841-c48b009ab02c">6.08</ix:nonNumeric> years</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonNumeric contextRef="ie02bb53f63db46709e0bad3ea42b396b_D20220101-20220630" name="us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1" format="ixt-sec:duryear" id="id3VybDovL2RvY3MudjEvZG9jOmFlNWE5YmUwZWI5NDQ1ZDE5MmZhZTgyMmQyMmJlMDlmL3NlYzphZTVhOWJlMGViOTQ0NWQxOTJmYWU4MjJkMjJiZTA5Zl80Ni9mcmFnOjU5ZmVhYTYxNWVlYjRmZTJhOGQ1ZTQ5NTRkNjk5MzFiL3RhYmxlOmY3NTVmOTMwMjQyZDRhOThiY2I4ZTNlOGIyMzhhNDE0L3RhYmxlcmFuZ2U6Zjc1NWY5MzAyNDJkNGE5OGJjYjhlM2U4YjIzOGE0MTRfNC01LTEtMS0yODg3_0903b9ee-40b1-4c8c-8387-6d51ffbb1efe">6.08</ix:nonNumeric> years</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonNumeric contextRef="i8e399d9e39504b2691c985ca006cfc1c_D20210101-20210630" name="us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1" format="ixt-sec:duryear" id="id3VybDovL2RvY3MudjEvZG9jOmFlNWE5YmUwZWI5NDQ1ZDE5MmZhZTgyMmQyMmJlMDlmL3NlYzphZTVhOWJlMGViOTQ0NWQxOTJmYWU4MjJkMjJiZTA5Zl80Ni9mcmFnOjU5ZmVhYTYxNWVlYjRmZTJhOGQ1ZTQ5NTRkNjk5MzFiL3RhYmxlOmY3NTVmOTMwMjQyZDRhOThiY2I4ZTNlOGIyMzhhNDE0L3RhYmxlcmFuZ2U6Zjc1NWY5MzAyNDJkNGE5OGJjYjhlM2U4YjIzOGE0MTRfNC03LTEtMS0yODg3_ffab2a76-3b0d-4a5e-9048-e1a2de30b004">6.08</ix:nonNumeric> years</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Expected dividend yield</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="i992097fa23d64aaa9f9ec09579943582_D20220401-20220630" decimals="4" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate" format="ixt:fixed-zero" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOmFlNWE5YmUwZWI5NDQ1ZDE5MmZhZTgyMmQyMmJlMDlmL3NlYzphZTVhOWJlMGViOTQ0NWQxOTJmYWU4MjJkMjJiZTA5Zl80Ni9mcmFnOjU5ZmVhYTYxNWVlYjRmZTJhOGQ1ZTQ5NTRkNjk5MzFiL3RhYmxlOmY3NTVmOTMwMjQyZDRhOThiY2I4ZTNlOGIyMzhhNDE0L3RhYmxlcmFuZ2U6Zjc1NWY5MzAyNDJkNGE5OGJjYjhlM2U4YjIzOGE0MTRfNS0xLTEtMS0yODg3_8ab80a0b-2894-44e1-aa03-9631d773b835">&#8212;</ix:nonFraction></span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="i0150b39d62c349949c09dc704f452a68_D20210401-20210630" decimals="4" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate" format="ixt:fixed-zero" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOmFlNWE5YmUwZWI5NDQ1ZDE5MmZhZTgyMmQyMmJlMDlmL3NlYzphZTVhOWJlMGViOTQ0NWQxOTJmYWU4MjJkMjJiZTA5Zl80Ni9mcmFnOjU5ZmVhYTYxNWVlYjRmZTJhOGQ1ZTQ5NTRkNjk5MzFiL3RhYmxlOmY3NTVmOTMwMjQyZDRhOThiY2I4ZTNlOGIyMzhhNDE0L3RhYmxlcmFuZ2U6Zjc1NWY5MzAyNDJkNGE5OGJjYjhlM2U4YjIzOGE0MTRfNS0zLTEtMS0yODg3_d0eb6c9a-b77d-4684-8846-f275136260a2">&#8212;</ix:nonFraction></span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="ie02bb53f63db46709e0bad3ea42b396b_D20220101-20220630" decimals="4" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate" format="ixt:fixed-zero" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOmFlNWE5YmUwZWI5NDQ1ZDE5MmZhZTgyMmQyMmJlMDlmL3NlYzphZTVhOWJlMGViOTQ0NWQxOTJmYWU4MjJkMjJiZTA5Zl80Ni9mcmFnOjU5ZmVhYTYxNWVlYjRmZTJhOGQ1ZTQ5NTRkNjk5MzFiL3RhYmxlOmY3NTVmOTMwMjQyZDRhOThiY2I4ZTNlOGIyMzhhNDE0L3RhYmxlcmFuZ2U6Zjc1NWY5MzAyNDJkNGE5OGJjYjhlM2U4YjIzOGE0MTRfNS01LTEtMS0yODg3_d961c9b5-7f84-41a7-ae87-c3790f501e85">&#8212;</ix:nonFraction></span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="i8e399d9e39504b2691c985ca006cfc1c_D20210101-20210630" decimals="4" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate" format="ixt:fixed-zero" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOmFlNWE5YmUwZWI5NDQ1ZDE5MmZhZTgyMmQyMmJlMDlmL3NlYzphZTVhOWJlMGViOTQ0NWQxOTJmYWU4MjJkMjJiZTA5Zl80Ni9mcmFnOjU5ZmVhYTYxNWVlYjRmZTJhOGQ1ZTQ5NTRkNjk5MzFiL3RhYmxlOmY3NTVmOTMwMjQyZDRhOThiY2I4ZTNlOGIyMzhhNDE0L3RhYmxlcmFuZ2U6Zjc1NWY5MzAyNDJkNGE5OGJjYjhlM2U4YjIzOGE0MTRfNS03LTEtMS0yODg3_992d3ad4-c421-4f30-bcdb-86494b8774ae">&#8212;</ix:nonFraction></span></td></tr></table></div><div style="margin-top:9pt;padding-left:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table sets forth assumptions used to determine the fair value of the purchase rights issued under the 2020 Employee Stock Purchase Plan (the &#8220;ESPP&#8221;):</span></div><div style="margin-top:12pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:32.233%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:15.112%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.406%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:15.112%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.406%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:15.112%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.406%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:15.113%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Three Months Ended June 30,</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Six Months Ended June 30,</span></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2021</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Assumed risk-free interest rate</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1)</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="i45707f534a744db3b91064008ec1faf3_D20210401-20210630" decimals="4" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOmFlNWE5YmUwZWI5NDQ1ZDE5MmZhZTgyMmQyMmJlMDlmL3NlYzphZTVhOWJlMGViOTQ0NWQxOTJmYWU4MjJkMjJiZTA5Zl80Ni9mcmFnOjU5ZmVhYTYxNWVlYjRmZTJhOGQ1ZTQ5NTRkNjk5MzFiL3RhYmxlOjU0ZWY3ZGFiYThhMDRmMmU4NDBmOTRiYzdjOWRiNGUwL3RhYmxlcmFuZ2U6NTRlZjdkYWJhOGEwNGYyZTg0MGY5NGJjN2M5ZGI0ZTBfMi0zLTEtMS0yODg3_2e443b4a-eb15-476a-ab55-a43a858f5566">0.10</ix:nonFraction>%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="i017b877f28974f268d6f8d65791f6ccf_D20220101-20220630" decimals="4" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMinimum" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOmFlNWE5YmUwZWI5NDQ1ZDE5MmZhZTgyMmQyMmJlMDlmL3NlYzphZTVhOWJlMGViOTQ0NWQxOTJmYWU4MjJkMjJiZTA5Zl80Ni9mcmFnOjU5ZmVhYTYxNWVlYjRmZTJhOGQ1ZTQ5NTRkNjk5MzFiL3RhYmxlOjU0ZWY3ZGFiYThhMDRmMmU4NDBmOTRiYzdjOWRiNGUwL3RhYmxlcmFuZ2U6NTRlZjdkYWJhOGEwNGYyZTg0MGY5NGJjN2M5ZGI0ZTBfMi01LTEtMS0yODg3L3RleHRyZWdpb246Yjc0NGIyZTQ0YTM1NDJmNmI3NDE4MjlkNDk4Yjk4ODBfNA_d79db3a9-f849-44aa-b49c-58b674a6ef1e">0.05</ix:nonFraction>% - <ix:nonFraction unitRef="number" contextRef="i017b877f28974f268d6f8d65791f6ccf_D20220101-20220630" decimals="4" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMaximum" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOmFlNWE5YmUwZWI5NDQ1ZDE5MmZhZTgyMmQyMmJlMDlmL3NlYzphZTVhOWJlMGViOTQ0NWQxOTJmYWU4MjJkMjJiZTA5Zl80Ni9mcmFnOjU5ZmVhYTYxNWVlYjRmZTJhOGQ1ZTQ5NTRkNjk5MzFiL3RhYmxlOjU0ZWY3ZGFiYThhMDRmMmU4NDBmOTRiYzdjOWRiNGUwL3RhYmxlcmFuZ2U6NTRlZjdkYWJhOGEwNGYyZTg0MGY5NGJjN2M5ZGI0ZTBfMi01LTEtMS0yODg3L3RleHRyZWdpb246Yjc0NGIyZTQ0YTM1NDJmNmI3NDE4MjlkNDk4Yjk4ODBfOQ_40b5c09d-f407-48f1-904c-2cf9ebedfac0">0.22</ix:nonFraction>%</span></div></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="i39b710f935eb45c28f101a01178659a1_D20210101-20210630" decimals="4" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMinimum" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOmFlNWE5YmUwZWI5NDQ1ZDE5MmZhZTgyMmQyMmJlMDlmL3NlYzphZTVhOWJlMGViOTQ0NWQxOTJmYWU4MjJkMjJiZTA5Zl80Ni9mcmFnOjU5ZmVhYTYxNWVlYjRmZTJhOGQ1ZTQ5NTRkNjk5MzFiL3RhYmxlOjU0ZWY3ZGFiYThhMDRmMmU4NDBmOTRiYzdjOWRiNGUwL3RhYmxlcmFuZ2U6NTRlZjdkYWJhOGEwNGYyZTg0MGY5NGJjN2M5ZGI0ZTBfMi03LTEtMS0yODg3L3RleHRyZWdpb246YjNiY2RiNzQ0ZjhkNDlmNDhlOTBhZGIxMjNkOWRmMDFfMTA5OTUxMTYyNzc4OA_8520479f-0e89-43f4-9391-0e2d6181222e">0.10</ix:nonFraction>% - <ix:nonFraction unitRef="number" contextRef="i39b710f935eb45c28f101a01178659a1_D20210101-20210630" decimals="4" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMaximum" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOmFlNWE5YmUwZWI5NDQ1ZDE5MmZhZTgyMmQyMmJlMDlmL3NlYzphZTVhOWJlMGViOTQ0NWQxOTJmYWU4MjJkMjJiZTA5Zl80Ni9mcmFnOjU5ZmVhYTYxNWVlYjRmZTJhOGQ1ZTQ5NTRkNjk5MzFiL3RhYmxlOjU0ZWY3ZGFiYThhMDRmMmU4NDBmOTRiYzdjOWRiNGUwL3RhYmxlcmFuZ2U6NTRlZjdkYWJhOGEwNGYyZTg0MGY5NGJjN2M5ZGI0ZTBfMi03LTEtMS0yODg3L3RleHRyZWdpb246YjNiY2RiNzQ0ZjhkNDlmNDhlOTBhZGIxMjNkOWRmMDFfMTA5OTUxMTYyNzc5Mg_8a6ffecb-fcc4-47de-871c-0bd1e3759b3e">0.18</ix:nonFraction>%</span></div></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Assumed volatility</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1)</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="i45707f534a744db3b91064008ec1faf3_D20210401-20210630" decimals="4" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOmFlNWE5YmUwZWI5NDQ1ZDE5MmZhZTgyMmQyMmJlMDlmL3NlYzphZTVhOWJlMGViOTQ0NWQxOTJmYWU4MjJkMjJiZTA5Zl80Ni9mcmFnOjU5ZmVhYTYxNWVlYjRmZTJhOGQ1ZTQ5NTRkNjk5MzFiL3RhYmxlOjU0ZWY3ZGFiYThhMDRmMmU4NDBmOTRiYzdjOWRiNGUwL3RhYmxlcmFuZ2U6NTRlZjdkYWJhOGEwNGYyZTg0MGY5NGJjN2M5ZGI0ZTBfMy0zLTEtMS0yODg3_08fd6399-99c8-4fee-9135-0a09ff060e2b">69.34</ix:nonFraction>%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="i017b877f28974f268d6f8d65791f6ccf_D20220101-20220630" decimals="4" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRateMinimum" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOmFlNWE5YmUwZWI5NDQ1ZDE5MmZhZTgyMmQyMmJlMDlmL3NlYzphZTVhOWJlMGViOTQ0NWQxOTJmYWU4MjJkMjJiZTA5Zl80Ni9mcmFnOjU5ZmVhYTYxNWVlYjRmZTJhOGQ1ZTQ5NTRkNjk5MzFiL3RhYmxlOjU0ZWY3ZGFiYThhMDRmMmU4NDBmOTRiYzdjOWRiNGUwL3RhYmxlcmFuZ2U6NTRlZjdkYWJhOGEwNGYyZTg0MGY5NGJjN2M5ZGI0ZTBfMy01LTEtMS0yODg3L3RleHRyZWdpb246YWY4ZGVmNzNjMDMzNDJiZDk4ZDM3N2NkMmI1OGU3ZjRfNA_491af0cc-cdbc-442b-a842-5b5a20e315a8">52.58</ix:nonFraction>% - <ix:nonFraction unitRef="number" contextRef="i017b877f28974f268d6f8d65791f6ccf_D20220101-20220630" decimals="4" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRateMaximum" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOmFlNWE5YmUwZWI5NDQ1ZDE5MmZhZTgyMmQyMmJlMDlmL3NlYzphZTVhOWJlMGViOTQ0NWQxOTJmYWU4MjJkMjJiZTA5Zl80Ni9mcmFnOjU5ZmVhYTYxNWVlYjRmZTJhOGQ1ZTQ5NTRkNjk5MzFiL3RhYmxlOjU0ZWY3ZGFiYThhMDRmMmU4NDBmOTRiYzdjOWRiNGUwL3RhYmxlcmFuZ2U6NTRlZjdkYWJhOGEwNGYyZTg0MGY5NGJjN2M5ZGI0ZTBfMy01LTEtMS0yODg3L3RleHRyZWdpb246YWY4ZGVmNzNjMDMzNDJiZDk4ZDM3N2NkMmI1OGU3ZjRfOQ_5143ed57-5700-4a85-85ea-e9a9c5e1a942">64.55</ix:nonFraction>%</span></div></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="i39b710f935eb45c28f101a01178659a1_D20210101-20210630" decimals="4" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRateMinimum" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOmFlNWE5YmUwZWI5NDQ1ZDE5MmZhZTgyMmQyMmJlMDlmL3NlYzphZTVhOWJlMGViOTQ0NWQxOTJmYWU4MjJkMjJiZTA5Zl80Ni9mcmFnOjU5ZmVhYTYxNWVlYjRmZTJhOGQ1ZTQ5NTRkNjk5MzFiL3RhYmxlOjU0ZWY3ZGFiYThhMDRmMmU4NDBmOTRiYzdjOWRiNGUwL3RhYmxlcmFuZ2U6NTRlZjdkYWJhOGEwNGYyZTg0MGY5NGJjN2M5ZGI0ZTBfMy03LTEtMS0yODg3L3RleHRyZWdpb246YTljMzcwNjMzZmNhNGNlNDk4YTZiZDk1YTgwMzQwMjNfMTA5OTUxMTYyNzc4OA_8ad0dfe4-1d5d-4c4b-a81c-3585b90fbd22">68.44</ix:nonFraction>% - <ix:nonFraction unitRef="number" contextRef="i39b710f935eb45c28f101a01178659a1_D20210101-20210630" decimals="4" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRateMaximum" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOmFlNWE5YmUwZWI5NDQ1ZDE5MmZhZTgyMmQyMmJlMDlmL3NlYzphZTVhOWJlMGViOTQ0NWQxOTJmYWU4MjJkMjJiZTA5Zl80Ni9mcmFnOjU5ZmVhYTYxNWVlYjRmZTJhOGQ1ZTQ5NTRkNjk5MzFiL3RhYmxlOjU0ZWY3ZGFiYThhMDRmMmU4NDBmOTRiYzdjOWRiNGUwL3RhYmxlcmFuZ2U6NTRlZjdkYWJhOGEwNGYyZTg0MGY5NGJjN2M5ZGI0ZTBfMy03LTEtMS0yODg3L3RleHRyZWdpb246YTljMzcwNjMzZmNhNGNlNDk4YTZiZDk1YTgwMzQwMjNfMTA5OTUxMTYyNzc5Mg_895566a8-2b94-46c1-a90c-4e99e0963f5b">69.34</ix:nonFraction>%</span></div></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Expected option term</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1)</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonNumeric contextRef="i45707f534a744db3b91064008ec1faf3_D20210401-20210630" name="us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1" format="ixt-sec:duryear" id="id3VybDovL2RvY3MudjEvZG9jOmFlNWE5YmUwZWI5NDQ1ZDE5MmZhZTgyMmQyMmJlMDlmL3NlYzphZTVhOWJlMGViOTQ0NWQxOTJmYWU4MjJkMjJiZTA5Zl80Ni9mcmFnOjU5ZmVhYTYxNWVlYjRmZTJhOGQ1ZTQ5NTRkNjk5MzFiL3RhYmxlOjU0ZWY3ZGFiYThhMDRmMmU4NDBmOTRiYzdjOWRiNGUwL3RhYmxlcmFuZ2U6NTRlZjdkYWJhOGEwNGYyZTg0MGY5NGJjN2M5ZGI0ZTBfNC0zLTEtMS0yODg3_1dede3d8-6b60-424d-bd23-d525f4c3791e">0.50</ix:nonNumeric> years</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonNumeric contextRef="ia5465b10658f4233ba1e4baa3b943676_D20220101-20220630" name="us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1" format="ixt-sec:duryear" id="id3VybDovL2RvY3MudjEvZG9jOmFlNWE5YmUwZWI5NDQ1ZDE5MmZhZTgyMmQyMmJlMDlmL3NlYzphZTVhOWJlMGViOTQ0NWQxOTJmYWU4MjJkMjJiZTA5Zl80Ni9mcmFnOjU5ZmVhYTYxNWVlYjRmZTJhOGQ1ZTQ5NTRkNjk5MzFiL3RhYmxlOjU0ZWY3ZGFiYThhMDRmMmU4NDBmOTRiYzdjOWRiNGUwL3RhYmxlcmFuZ2U6NTRlZjdkYWJhOGEwNGYyZTg0MGY5NGJjN2M5ZGI0ZTBfNC01LTEtMS0yODg3L3RleHRyZWdpb246ZmIzZjJkMWRjOTQ2NGQyYmEwNGY1Y2VhMWY5ZGFiMzNfNA_bf21b9e2-662e-460a-84a3-181380b2a7b9">0.49</ix:nonNumeric> - <ix:nonNumeric contextRef="i88ad33d9abe64251a7d9379cd17f4be1_D20220101-20220630" name="us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1" format="ixt-sec:duryear" id="id3VybDovL2RvY3MudjEvZG9jOmFlNWE5YmUwZWI5NDQ1ZDE5MmZhZTgyMmQyMmJlMDlmL3NlYzphZTVhOWJlMGViOTQ0NWQxOTJmYWU4MjJkMjJiZTA5Zl80Ni9mcmFnOjU5ZmVhYTYxNWVlYjRmZTJhOGQ1ZTQ5NTRkNjk5MzFiL3RhYmxlOjU0ZWY3ZGFiYThhMDRmMmU4NDBmOTRiYzdjOWRiNGUwL3RhYmxlcmFuZ2U6NTRlZjdkYWJhOGEwNGYyZTg0MGY5NGJjN2M5ZGI0ZTBfNC01LTEtMS0yODg3L3RleHRyZWdpb246ZmIzZjJkMWRjOTQ2NGQyYmEwNGY1Y2VhMWY5ZGFiMzNfOQ_94aa5647-88f5-422d-96f3-b1edc14ce0ef">0.50</ix:nonNumeric> years</span></div></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonNumeric contextRef="i1f1b6534cfc84ab0b6dde0c9dbabe32b_D20210101-20210630" name="us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1" format="ixt-sec:duryear" id="id3VybDovL2RvY3MudjEvZG9jOmFlNWE5YmUwZWI5NDQ1ZDE5MmZhZTgyMmQyMmJlMDlmL3NlYzphZTVhOWJlMGViOTQ0NWQxOTJmYWU4MjJkMjJiZTA5Zl80Ni9mcmFnOjU5ZmVhYTYxNWVlYjRmZTJhOGQ1ZTQ5NTRkNjk5MzFiL3RhYmxlOjU0ZWY3ZGFiYThhMDRmMmU4NDBmOTRiYzdjOWRiNGUwL3RhYmxlcmFuZ2U6NTRlZjdkYWJhOGEwNGYyZTg0MGY5NGJjN2M5ZGI0ZTBfNC03LTEtMS0yODg3L3RleHRyZWdpb246ZWY2NDk2ZGE0NzU2NDYyYjk5ZjBjNjhiOGVjYmVkOTJfMTA5OTUxMTYyNzc4OA_14b695f8-b7c1-4f93-96fd-9e2f4c63d9ce">0.49</ix:nonNumeric> - <ix:nonNumeric contextRef="i8b65a3d5fc034de0bf1cc21839d1b39d_D20210101-20210630" name="us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1" format="ixt-sec:duryear" id="id3VybDovL2RvY3MudjEvZG9jOmFlNWE5YmUwZWI5NDQ1ZDE5MmZhZTgyMmQyMmJlMDlmL3NlYzphZTVhOWJlMGViOTQ0NWQxOTJmYWU4MjJkMjJiZTA5Zl80Ni9mcmFnOjU5ZmVhYTYxNWVlYjRmZTJhOGQ1ZTQ5NTRkNjk5MzFiL3RhYmxlOjU0ZWY3ZGFiYThhMDRmMmU4NDBmOTRiYzdjOWRiNGUwL3RhYmxlcmFuZ2U6NTRlZjdkYWJhOGEwNGYyZTg0MGY5NGJjN2M5ZGI0ZTBfNC03LTEtMS0yODg3L3RleHRyZWdpb246ZWY2NDk2ZGE0NzU2NDYyYjk5ZjBjNjhiOGVjYmVkOTJfMTA5OTUxMTYyNzc5Mg_34f3f724-ef15-49a4-972b-3ed90eda5f75">0.50</ix:nonNumeric> years</span></div></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Expected dividend yield</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1)</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="i45707f534a744db3b91064008ec1faf3_D20210401-20210630" decimals="4" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate" format="ixt:fixed-zero" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmFlNWE5YmUwZWI5NDQ1ZDE5MmZhZTgyMmQyMmJlMDlmL3NlYzphZTVhOWJlMGViOTQ0NWQxOTJmYWU4MjJkMjJiZTA5Zl80Ni9mcmFnOjU5ZmVhYTYxNWVlYjRmZTJhOGQ1ZTQ5NTRkNjk5MzFiL3RhYmxlOjU0ZWY3ZGFiYThhMDRmMmU4NDBmOTRiYzdjOWRiNGUwL3RhYmxlcmFuZ2U6NTRlZjdkYWJhOGEwNGYyZTg0MGY5NGJjN2M5ZGI0ZTBfNS0zLTEtMS0yODg3_4f42e10e-9f2f-40c0-a46b-aa716866feeb">&#8212;</ix:nonFraction></span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="i017b877f28974f268d6f8d65791f6ccf_D20220101-20220630" decimals="4" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate" format="ixt:fixed-zero" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmFlNWE5YmUwZWI5NDQ1ZDE5MmZhZTgyMmQyMmJlMDlmL3NlYzphZTVhOWJlMGViOTQ0NWQxOTJmYWU4MjJkMjJiZTA5Zl80Ni9mcmFnOjU5ZmVhYTYxNWVlYjRmZTJhOGQ1ZTQ5NTRkNjk5MzFiL3RhYmxlOjU0ZWY3ZGFiYThhMDRmMmU4NDBmOTRiYzdjOWRiNGUwL3RhYmxlcmFuZ2U6NTRlZjdkYWJhOGEwNGYyZTg0MGY5NGJjN2M5ZGI0ZTBfNS01LTEtMS0yODg3_54361509-faff-4097-9c30-f0e0a3a24dcf">&#8212;</ix:nonFraction></span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="i39b710f935eb45c28f101a01178659a1_D20210101-20210630" decimals="4" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate" format="ixt:fixed-zero" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmFlNWE5YmUwZWI5NDQ1ZDE5MmZhZTgyMmQyMmJlMDlmL3NlYzphZTVhOWJlMGViOTQ0NWQxOTJmYWU4MjJkMjJiZTA5Zl80Ni9mcmFnOjU5ZmVhYTYxNWVlYjRmZTJhOGQ1ZTQ5NTRkNjk5MzFiL3RhYmxlOjU0ZWY3ZGFiYThhMDRmMmU4NDBmOTRiYzdjOWRiNGUwL3RhYmxlcmFuZ2U6NTRlZjdkYWJhOGEwNGYyZTg0MGY5NGJjN2M5ZGI0ZTBfNS03LTEtMS0yODg3_09316334-e2d7-4c93-97c6-6711662fc62b">&#8212;</ix:nonFraction></span></td></tr></table></div><div style="padding-left:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(1) There were no ESPP purchases under its 2020 Employee Stock Purchase Plan during the period.</span></div></ix:continuation><ix:nonNumeric contextRef="ia855382ada1f4f28aa8ef6da692ff177_D20220101-20220630" name="us-gaap:DisclosureOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOmFlNWE5YmUwZWI5NDQ1ZDE5MmZhZTgyMmQyMmJlMDlmL3NlYzphZTVhOWJlMGViOTQ0NWQxOTJmYWU4MjJkMjJiZTA5Zl80Ni9mcmFnOjU5ZmVhYTYxNWVlYjRmZTJhOGQ1ZTQ5NTRkNjk5MzFiL3RleHRyZWdpb246NTlmZWFhNjE1ZWViNGZlMmE4ZDVlNDk1NGQ2OTkzMWJfMzI5ODUzNDkwODcxMQ_d83e84a5-e9a2-42ed-b744-76fe250b02ab" escape="true"><div style="margin-top:9pt;padding-left:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Stock-based compensation expense for employee options, RSUs, the purchase rights issued under the ESPP, and consultant options was recorded in the condensed consolidated statements of operations as follows (in thousands):</span></div><div style="margin-top:6pt;padding-left:27pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:95.000%"><tr><td style="width:1.0%"></td><td style="width:41.483%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.775%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.437%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.775%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.437%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.775%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.437%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.781%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Three Months Ended June 30,</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Six Months Ended June 30,</span></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2021</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cost of revenue</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i34efb5ee40034834b0612db07b6ac538_D20220401-20220630" decimals="-3" name="us-gaap:AllocatedShareBasedCompensationExpense" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmFlNWE5YmUwZWI5NDQ1ZDE5MmZhZTgyMmQyMmJlMDlmL3NlYzphZTVhOWJlMGViOTQ0NWQxOTJmYWU4MjJkMjJiZTA5Zl80Ni9mcmFnOjU5ZmVhYTYxNWVlYjRmZTJhOGQ1ZTQ5NTRkNjk5MzFiL3RhYmxlOjJmNzdkOGFmNjVjMTQ5ZGU5Y2M1MTBhYmUwZGIzZWFkL3RhYmxlcmFuZ2U6MmY3N2Q4YWY2NWMxNDlkZTljYzUxMGFiZTBkYjNlYWRfMi0xLTEtMS05MDc1_3018bbc8-b08e-4f3f-9ce1-7c35e9d43e8f">298</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i7756f068adac47afb60baa468c5ef026_D20210401-20210630" decimals="-3" name="us-gaap:AllocatedShareBasedCompensationExpense" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmFlNWE5YmUwZWI5NDQ1ZDE5MmZhZTgyMmQyMmJlMDlmL3NlYzphZTVhOWJlMGViOTQ0NWQxOTJmYWU4MjJkMjJiZTA5Zl80Ni9mcmFnOjU5ZmVhYTYxNWVlYjRmZTJhOGQ1ZTQ5NTRkNjk5MzFiL3RhYmxlOjJmNzdkOGFmNjVjMTQ5ZGU5Y2M1MTBhYmUwZGIzZWFkL3RhYmxlcmFuZ2U6MmY3N2Q4YWY2NWMxNDlkZTljYzUxMGFiZTBkYjNlYWRfMi0zLTEtMS05MTU1_37d092fb-37fa-430b-bee2-fa18e994fcf1">259</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i17e61074c4514eaf99a53572cb0fcf74_D20220101-20220630" decimals="-3" name="us-gaap:AllocatedShareBasedCompensationExpense" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmFlNWE5YmUwZWI5NDQ1ZDE5MmZhZTgyMmQyMmJlMDlmL3NlYzphZTVhOWJlMGViOTQ0NWQxOTJmYWU4MjJkMjJiZTA5Zl80Ni9mcmFnOjU5ZmVhYTYxNWVlYjRmZTJhOGQ1ZTQ5NTRkNjk5MzFiL3RhYmxlOjJmNzdkOGFmNjVjMTQ5ZGU5Y2M1MTBhYmUwZGIzZWFkL3RhYmxlcmFuZ2U6MmY3N2Q4YWY2NWMxNDlkZTljYzUxMGFiZTBkYjNlYWRfMi01LTEtMS05MDc1_d692a090-9db9-4b17-b7ec-5c89e474301b">633</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="id38910781e2b4e58a9f2b8f671bfed35_D20210101-20210630" decimals="-3" name="us-gaap:AllocatedShareBasedCompensationExpense" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmFlNWE5YmUwZWI5NDQ1ZDE5MmZhZTgyMmQyMmJlMDlmL3NlYzphZTVhOWJlMGViOTQ0NWQxOTJmYWU4MjJkMjJiZTA5Zl80Ni9mcmFnOjU5ZmVhYTYxNWVlYjRmZTJhOGQ1ZTQ5NTRkNjk5MzFiL3RhYmxlOjJmNzdkOGFmNjVjMTQ5ZGU5Y2M1MTBhYmUwZGIzZWFkL3RhYmxlcmFuZ2U6MmY3N2Q4YWY2NWMxNDlkZTljYzUxMGFiZTBkYjNlYWRfMi03LTEtMS05MDc1_5de7bfab-98c9-4c15-8fa8-062ef992d6cf">410</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Sales and marketing</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i8cb435a01219406ba1ef713635ac68ba_D20220401-20220630" decimals="-3" name="us-gaap:AllocatedShareBasedCompensationExpense" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmFlNWE5YmUwZWI5NDQ1ZDE5MmZhZTgyMmQyMmJlMDlmL3NlYzphZTVhOWJlMGViOTQ0NWQxOTJmYWU4MjJkMjJiZTA5Zl80Ni9mcmFnOjU5ZmVhYTYxNWVlYjRmZTJhOGQ1ZTQ5NTRkNjk5MzFiL3RhYmxlOjJmNzdkOGFmNjVjMTQ5ZGU5Y2M1MTBhYmUwZGIzZWFkL3RhYmxlcmFuZ2U6MmY3N2Q4YWY2NWMxNDlkZTljYzUxMGFiZTBkYjNlYWRfMy0xLTEtMS05MDc1_4177bab7-ab74-4356-9474-bebff80ec2b1">1,067</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i86954732d12643d381b4531c01ebcfd8_D20210401-20210630" decimals="-3" name="us-gaap:AllocatedShareBasedCompensationExpense" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmFlNWE5YmUwZWI5NDQ1ZDE5MmZhZTgyMmQyMmJlMDlmL3NlYzphZTVhOWJlMGViOTQ0NWQxOTJmYWU4MjJkMjJiZTA5Zl80Ni9mcmFnOjU5ZmVhYTYxNWVlYjRmZTJhOGQ1ZTQ5NTRkNjk5MzFiL3RhYmxlOjJmNzdkOGFmNjVjMTQ5ZGU5Y2M1MTBhYmUwZGIzZWFkL3RhYmxlcmFuZ2U6MmY3N2Q4YWY2NWMxNDlkZTljYzUxMGFiZTBkYjNlYWRfMy0zLTEtMS05MTU1_27e16b1a-a871-4fab-b9e2-6e051d1ccc64">935</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i778b6ff1b3184f42864e9d757af2f4bd_D20220101-20220630" decimals="-3" name="us-gaap:AllocatedShareBasedCompensationExpense" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmFlNWE5YmUwZWI5NDQ1ZDE5MmZhZTgyMmQyMmJlMDlmL3NlYzphZTVhOWJlMGViOTQ0NWQxOTJmYWU4MjJkMjJiZTA5Zl80Ni9mcmFnOjU5ZmVhYTYxNWVlYjRmZTJhOGQ1ZTQ5NTRkNjk5MzFiL3RhYmxlOjJmNzdkOGFmNjVjMTQ5ZGU5Y2M1MTBhYmUwZGIzZWFkL3RhYmxlcmFuZ2U6MmY3N2Q4YWY2NWMxNDlkZTljYzUxMGFiZTBkYjNlYWRfMy01LTEtMS05MDc1_3c900124-68db-4b8f-8430-f002cda038eb">2,528</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ie6d29520a2674f6d9a7271efc6289984_D20210101-20210630" decimals="-3" name="us-gaap:AllocatedShareBasedCompensationExpense" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmFlNWE5YmUwZWI5NDQ1ZDE5MmZhZTgyMmQyMmJlMDlmL3NlYzphZTVhOWJlMGViOTQ0NWQxOTJmYWU4MjJkMjJiZTA5Zl80Ni9mcmFnOjU5ZmVhYTYxNWVlYjRmZTJhOGQ1ZTQ5NTRkNjk5MzFiL3RhYmxlOjJmNzdkOGFmNjVjMTQ5ZGU5Y2M1MTBhYmUwZGIzZWFkL3RhYmxlcmFuZ2U6MmY3N2Q4YWY2NWMxNDlkZTljYzUxMGFiZTBkYjNlYWRfMy03LTEtMS05MDc1_6c7550e0-9683-46cc-9710-d834278e5bb0">1,482</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Research and development</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i561a7e21ce6a40039dc3d34e1397766f_D20220401-20220630" decimals="-3" name="us-gaap:AllocatedShareBasedCompensationExpense" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmFlNWE5YmUwZWI5NDQ1ZDE5MmZhZTgyMmQyMmJlMDlmL3NlYzphZTVhOWJlMGViOTQ0NWQxOTJmYWU4MjJkMjJiZTA5Zl80Ni9mcmFnOjU5ZmVhYTYxNWVlYjRmZTJhOGQ1ZTQ5NTRkNjk5MzFiL3RhYmxlOjJmNzdkOGFmNjVjMTQ5ZGU5Y2M1MTBhYmUwZGIzZWFkL3RhYmxlcmFuZ2U6MmY3N2Q4YWY2NWMxNDlkZTljYzUxMGFiZTBkYjNlYWRfNC0xLTEtMS05MDg5_a63740ea-9204-4b28-b502-53e6b9c524fd">1,330</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i6ddfec946a484290af96cb60df8d77ed_D20210401-20210630" decimals="-3" name="us-gaap:AllocatedShareBasedCompensationExpense" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmFlNWE5YmUwZWI5NDQ1ZDE5MmZhZTgyMmQyMmJlMDlmL3NlYzphZTVhOWJlMGViOTQ0NWQxOTJmYWU4MjJkMjJiZTA5Zl80Ni9mcmFnOjU5ZmVhYTYxNWVlYjRmZTJhOGQ1ZTQ5NTRkNjk5MzFiL3RhYmxlOjJmNzdkOGFmNjVjMTQ5ZGU5Y2M1MTBhYmUwZGIzZWFkL3RhYmxlcmFuZ2U6MmY3N2Q4YWY2NWMxNDlkZTljYzUxMGFiZTBkYjNlYWRfNC0zLTEtMS05MTU1_92145442-5788-4ce5-a8dc-ee2850e6d0a3">515</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i8910e2a23b804411a94de3c030ee3d6d_D20220101-20220630" decimals="-3" name="us-gaap:AllocatedShareBasedCompensationExpense" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmFlNWE5YmUwZWI5NDQ1ZDE5MmZhZTgyMmQyMmJlMDlmL3NlYzphZTVhOWJlMGViOTQ0NWQxOTJmYWU4MjJkMjJiZTA5Zl80Ni9mcmFnOjU5ZmVhYTYxNWVlYjRmZTJhOGQ1ZTQ5NTRkNjk5MzFiL3RhYmxlOjJmNzdkOGFmNjVjMTQ5ZGU5Y2M1MTBhYmUwZGIzZWFkL3RhYmxlcmFuZ2U6MmY3N2Q4YWY2NWMxNDlkZTljYzUxMGFiZTBkYjNlYWRfNC01LTEtMS05MTU1_1a1c96ce-1044-4eab-b568-8b86a1bcc4b2">1,825</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i35128ab55fdf4102bca836a519340c7f_D20210101-20210630" decimals="-3" name="us-gaap:AllocatedShareBasedCompensationExpense" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmFlNWE5YmUwZWI5NDQ1ZDE5MmZhZTgyMmQyMmJlMDlmL3NlYzphZTVhOWJlMGViOTQ0NWQxOTJmYWU4MjJkMjJiZTA5Zl80Ni9mcmFnOjU5ZmVhYTYxNWVlYjRmZTJhOGQ1ZTQ5NTRkNjk5MzFiL3RhYmxlOjJmNzdkOGFmNjVjMTQ5ZGU5Y2M1MTBhYmUwZGIzZWFkL3RhYmxlcmFuZ2U6MmY3N2Q4YWY2NWMxNDlkZTljYzUxMGFiZTBkYjNlYWRfNC03LTEtMS05MTU1_82020732-599c-4b4b-9303-3c14942f5384">829</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">General and administrative</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ie9748d2474c1470fbedee2cfc150c874_D20220401-20220630" decimals="-3" name="us-gaap:AllocatedShareBasedCompensationExpense" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmFlNWE5YmUwZWI5NDQ1ZDE5MmZhZTgyMmQyMmJlMDlmL3NlYzphZTVhOWJlMGViOTQ0NWQxOTJmYWU4MjJkMjJiZTA5Zl80Ni9mcmFnOjU5ZmVhYTYxNWVlYjRmZTJhOGQ1ZTQ5NTRkNjk5MzFiL3RhYmxlOjJmNzdkOGFmNjVjMTQ5ZGU5Y2M1MTBhYmUwZGIzZWFkL3RhYmxlcmFuZ2U6MmY3N2Q4YWY2NWMxNDlkZTljYzUxMGFiZTBkYjNlYWRfNC0xLTEtMS05MDc1_042134d8-bf69-498f-88db-8200572e8032">2,142</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if42f9fcfc62a442c8ed23e75ddd4b6dd_D20210401-20210630" decimals="-3" name="us-gaap:AllocatedShareBasedCompensationExpense" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmFlNWE5YmUwZWI5NDQ1ZDE5MmZhZTgyMmQyMmJlMDlmL3NlYzphZTVhOWJlMGViOTQ0NWQxOTJmYWU4MjJkMjJiZTA5Zl80Ni9mcmFnOjU5ZmVhYTYxNWVlYjRmZTJhOGQ1ZTQ5NTRkNjk5MzFiL3RhYmxlOjJmNzdkOGFmNjVjMTQ5ZGU5Y2M1MTBhYmUwZGIzZWFkL3RhYmxlcmFuZ2U6MmY3N2Q4YWY2NWMxNDlkZTljYzUxMGFiZTBkYjNlYWRfNS0zLTEtMS05MTU1_e7d0734b-66db-4c0f-97e7-d556af120c68">1,829</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i50a7a6d1a7004169afd4ead8587d96b6_D20220101-20220630" decimals="-3" name="us-gaap:AllocatedShareBasedCompensationExpense" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmFlNWE5YmUwZWI5NDQ1ZDE5MmZhZTgyMmQyMmJlMDlmL3NlYzphZTVhOWJlMGViOTQ0NWQxOTJmYWU4MjJkMjJiZTA5Zl80Ni9mcmFnOjU5ZmVhYTYxNWVlYjRmZTJhOGQ1ZTQ5NTRkNjk5MzFiL3RhYmxlOjJmNzdkOGFmNjVjMTQ5ZGU5Y2M1MTBhYmUwZGIzZWFkL3RhYmxlcmFuZ2U6MmY3N2Q4YWY2NWMxNDlkZTljYzUxMGFiZTBkYjNlYWRfNC01LTEtMS05MDc1_07c012ce-45b8-4cb7-9cfb-3499e3538c9b">3,745</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i3ff371283df84968a8de2a698b44e5b1_D20210101-20210630" decimals="-3" name="us-gaap:AllocatedShareBasedCompensationExpense" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmFlNWE5YmUwZWI5NDQ1ZDE5MmZhZTgyMmQyMmJlMDlmL3NlYzphZTVhOWJlMGViOTQ0NWQxOTJmYWU4MjJkMjJiZTA5Zl80Ni9mcmFnOjU5ZmVhYTYxNWVlYjRmZTJhOGQ1ZTQ5NTRkNjk5MzFiL3RhYmxlOjJmNzdkOGFmNjVjMTQ5ZGU5Y2M1MTBhYmUwZGIzZWFkL3RhYmxlcmFuZ2U6MmY3N2Q4YWY2NWMxNDlkZTljYzUxMGFiZTBkYjNlYWRfNC03LTEtMS05MDc1_f2e94e61-9046-4d16-83ec-8156ab222d58">2,989</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total stock-based compensation</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i2c5f0f28773744e5a2e202f2943ae976_D20220401-20220630" decimals="-3" name="us-gaap:AllocatedShareBasedCompensationExpense" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmFlNWE5YmUwZWI5NDQ1ZDE5MmZhZTgyMmQyMmJlMDlmL3NlYzphZTVhOWJlMGViOTQ0NWQxOTJmYWU4MjJkMjJiZTA5Zl80Ni9mcmFnOjU5ZmVhYTYxNWVlYjRmZTJhOGQ1ZTQ5NTRkNjk5MzFiL3RhYmxlOjJmNzdkOGFmNjVjMTQ5ZGU5Y2M1MTBhYmUwZGIzZWFkL3RhYmxlcmFuZ2U6MmY3N2Q4YWY2NWMxNDlkZTljYzUxMGFiZTBkYjNlYWRfNi0xLTEtMS05MDg5_c2087f84-a91f-45dd-9fd4-94a85fe238ef">4,837</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="id7bb773872394047ba26aa8a7a0f4d56_D20210401-20210630" decimals="-3" name="us-gaap:AllocatedShareBasedCompensationExpense" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmFlNWE5YmUwZWI5NDQ1ZDE5MmZhZTgyMmQyMmJlMDlmL3NlYzphZTVhOWJlMGViOTQ0NWQxOTJmYWU4MjJkMjJiZTA5Zl80Ni9mcmFnOjU5ZmVhYTYxNWVlYjRmZTJhOGQ1ZTQ5NTRkNjk5MzFiL3RhYmxlOjJmNzdkOGFmNjVjMTQ5ZGU5Y2M1MTBhYmUwZGIzZWFkL3RhYmxlcmFuZ2U6MmY3N2Q4YWY2NWMxNDlkZTljYzUxMGFiZTBkYjNlYWRfNi0zLTEtMS05MTY2_4e82cb45-ec55-49df-bd02-fca4a5bb30b9">3,538</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ia855382ada1f4f28aa8ef6da692ff177_D20220101-20220630" decimals="-3" name="us-gaap:AllocatedShareBasedCompensationExpense" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmFlNWE5YmUwZWI5NDQ1ZDE5MmZhZTgyMmQyMmJlMDlmL3NlYzphZTVhOWJlMGViOTQ0NWQxOTJmYWU4MjJkMjJiZTA5Zl80Ni9mcmFnOjU5ZmVhYTYxNWVlYjRmZTJhOGQ1ZTQ5NTRkNjk5MzFiL3RhYmxlOjJmNzdkOGFmNjVjMTQ5ZGU5Y2M1MTBhYmUwZGIzZWFkL3RhYmxlcmFuZ2U6MmY3N2Q4YWY2NWMxNDlkZTljYzUxMGFiZTBkYjNlYWRfNi01LTEtMS05MTY2_3e5732a0-a641-41d4-b8f3-17252bda9857">8,731</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="idaa4f31ca59a4a17a59c2580b97791ca_D20210101-20210630" decimals="-3" name="us-gaap:AllocatedShareBasedCompensationExpense" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmFlNWE5YmUwZWI5NDQ1ZDE5MmZhZTgyMmQyMmJlMDlmL3NlYzphZTVhOWJlMGViOTQ0NWQxOTJmYWU4MjJkMjJiZTA5Zl80Ni9mcmFnOjU5ZmVhYTYxNWVlYjRmZTJhOGQ1ZTQ5NTRkNjk5MzFiL3RhYmxlOjJmNzdkOGFmNjVjMTQ5ZGU5Y2M1MTBhYmUwZGIzZWFkL3RhYmxlcmFuZ2U6MmY3N2Q4YWY2NWMxNDlkZTljYzUxMGFiZTBkYjNlYWRfNi03LTEtMS05MTY2_ac0d958a-c7cc-4d84-b324-0be7be15c2fe">5,710</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div></ix:nonNumeric><div style="margin-top:9pt;padding-left:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The total compensation cost related to non-vested awards not yet recognized as of June&#160;30, 2022 was $<ix:nonFraction unitRef="usd" contextRef="i4c8f247d12134a9886d56e1c8b024425_I20220630" decimals="-5" name="us-gaap:EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmFlNWE5YmUwZWI5NDQ1ZDE5MmZhZTgyMmQyMmJlMDlmL3NlYzphZTVhOWJlMGViOTQ0NWQxOTJmYWU4MjJkMjJiZTA5Zl80Ni9mcmFnOjU5ZmVhYTYxNWVlYjRmZTJhOGQ1ZTQ5NTRkNjk5MzFiL3RleHRyZWdpb246NTlmZWFhNjE1ZWViNGZlMmE4ZDVlNDk1NGQ2OTkzMWJfMTA5OTUxMTY1MTE0Ng_17825316-bbcf-44bc-9f12-2d949e16e8fa">50.3</ix:nonFraction> million, which is expected to be recognized over a weighted average term of <ix:nonNumeric contextRef="ia855382ada1f4f28aa8ef6da692ff177_D20220101-20220630" name="us-gaap:EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1" format="ixt-sec:duryear" id="id3VybDovL2RvY3MudjEvZG9jOmFlNWE5YmUwZWI5NDQ1ZDE5MmZhZTgyMmQyMmJlMDlmL3NlYzphZTVhOWJlMGViOTQ0NWQxOTJmYWU4MjJkMjJiZTA5Zl80Ni9mcmFnOjU5ZmVhYTYxNWVlYjRmZTJhOGQ1ZTQ5NTRkNjk5MzFiL3RleHRyZWdpb246NTlmZWFhNjE1ZWViNGZlMmE4ZDVlNDk1NGQ2OTkzMWJfMTA5OTUxMTY1MTIxOA_dc42ff35-4a7c-4402-a0ca-f88f0769efd5">2.90</ix:nonNumeric> years. </span></div></ix:continuation><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">17</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:45pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#iae5a9be0eb9445d192fae822d22be09f_7">Table of Contents</a></span></div></div><ix:continuation id="i73abf7a810af41f598fc7e1a4caba948" continuedAt="if5c54729d75441aca017c4d4a6948ecc"><div style="margin-top:15pt;padding-left:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">2010 Stock Plan</span></div><div style="margin-top:9pt;padding-left:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In connection with the Business Combination, the Company assumed the DermTech Operations&#8217; Amended and Restated 2010 Stock Plan (the &#8220;2010 Plan&#8221;), which provided for the granting of incentive and non-statutory stock options and restricted stock purchase rights and bonus awards. The contractual term of options granted under the 2010 Plan was <ix:nonNumeric contextRef="i3c1e467c7bea456e8c41b0e455ef5730_D20220101-20220630" name="us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardExpirationPeriod" format="ixt-sec:durwordsen" id="id3VybDovL2RvY3MudjEvZG9jOmFlNWE5YmUwZWI5NDQ1ZDE5MmZhZTgyMmQyMmJlMDlmL3NlYzphZTVhOWJlMGViOTQ0NWQxOTJmYWU4MjJkMjJiZTA5Zl80Ni9mcmFnOjU5ZmVhYTYxNWVlYjRmZTJhOGQ1ZTQ5NTRkNjk5MzFiL3RleHRyZWdpb246NTlmZWFhNjE1ZWViNGZlMmE4ZDVlNDk1NGQ2OTkzMWJfMTAyOTk_ba9518b0-b0cb-4865-8a40-692c14679298">ten years</ix:nonNumeric>. Vesting provisions varied based on the specific terms of the individual option awards. At the Company&#8217;s annual meeting held on May 26, 2020, the Company&#8217;s shareholders voted to approve the DermTech, Inc. 2020 Equity Incentive Plan (the &#8220;2020 Plan&#8221;), which terminated the 2010 Plan. No additional awards will be granted under the 2010 Plan, however, all outstanding awards under the 2010 Plan remain in effect. <ix:nonFraction unitRef="shares" contextRef="i58d1b32270b14657a2a11820d5e6fa8d_I20211231" decimals="INF" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant" format="ixt:fixed-zero" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmFlNWE5YmUwZWI5NDQ1ZDE5MmZhZTgyMmQyMmJlMDlmL3NlYzphZTVhOWJlMGViOTQ0NWQxOTJmYWU4MjJkMjJiZTA5Zl80Ni9mcmFnOjU5ZmVhYTYxNWVlYjRmZTJhOGQ1ZTQ5NTRkNjk5MzFiL3RleHRyZWdpb246NTlmZWFhNjE1ZWViNGZlMmE4ZDVlNDk1NGQ2OTkzMWJfMTA3MTM_0af7f956-33f1-4881-afd4-2f10cd64649a"><ix:nonFraction unitRef="shares" contextRef="i5bd0ece4c3a9433ebf7e6f8058d14235_I20220630" decimals="INF" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant" format="ixt:fixed-zero" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmFlNWE5YmUwZWI5NDQ1ZDE5MmZhZTgyMmQyMmJlMDlmL3NlYzphZTVhOWJlMGViOTQ0NWQxOTJmYWU4MjJkMjJiZTA5Zl80Ni9mcmFnOjU5ZmVhYTYxNWVlYjRmZTJhOGQ1ZTQ5NTRkNjk5MzFiL3RleHRyZWdpb246NTlmZWFhNjE1ZWViNGZlMmE4ZDVlNDk1NGQ2OTkzMWJfMTA3MTM_c62cbef5-559b-447e-971b-ddfb3a68e731">No</ix:nonFraction></ix:nonFraction> shares remained available for issuance pursuant to future grants under the 2010 Plan as of June&#160;30, 2022 and December&#160;31, 2021, respectively. </span></div><div style="margin-top:15pt;padding-left:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">2020 Equity Incentive Plan</span></div><div style="margin-top:9pt;padding-left:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">On May 26, 2020, the Company&#8217;s stockholders approved the adoption of the 2020 Plan, which provides for the granting of incentive and non-qualified stock options, restricted stock and stock-based awards. Under the 2020 Plan, incentive and non-qualified stock options may be granted at not less than <ix:nonFraction unitRef="number" contextRef="ied7a9ca9fd8040d59887525878d7cb79_D20220101-20220630" decimals="INF" name="us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardPurchasePriceOfCommonStockPercent" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOmFlNWE5YmUwZWI5NDQ1ZDE5MmZhZTgyMmQyMmJlMDlmL3NlYzphZTVhOWJlMGViOTQ0NWQxOTJmYWU4MjJkMjJiZTA5Zl80Ni9mcmFnOjU5ZmVhYTYxNWVlYjRmZTJhOGQ1ZTQ5NTRkNjk5MzFiL3RleHRyZWdpb246NTlmZWFhNjE1ZWViNGZlMmE4ZDVlNDk1NGQ2OTkzMWJfMTExNTg_5a097d53-8b65-4ed8-85bf-be6fe02ebdb2">100</ix:nonFraction>% of the fair market value of the Company&#8217;s common stock on the date of grant. If an incentive stock option is granted to an individual who owns more than 10% of the combined voting power of all classes of the Company&#8217;s capital stock, the exercise price may not be less than <ix:nonFraction unitRef="number" contextRef="i2cb3f2789d9344f9a1099880c2a6b6ac_D20220101-20220630" decimals="INF" name="us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardPurchasePriceOfCommonStockPercent" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOmFlNWE5YmUwZWI5NDQ1ZDE5MmZhZTgyMmQyMmJlMDlmL3NlYzphZTVhOWJlMGViOTQ0NWQxOTJmYWU4MjJkMjJiZTA5Zl80Ni9mcmFnOjU5ZmVhYTYxNWVlYjRmZTJhOGQ1ZTQ5NTRkNjk5MzFiL3RleHRyZWdpb246NTlmZWFhNjE1ZWViNGZlMmE4ZDVlNDk1NGQ2OTkzMWJfMTE0MzQ_13220b51-9f91-4f01-b385-6d63678e793c">110</ix:nonFraction>% of the fair market value of the Company&#8217;s common stock on the date of grant and the term of the option may not be longer than <ix:nonNumeric contextRef="i695be12a2aa14dffb874c1e74a980c5b_D20220101-20220630" name="dmtk:EquityIncentivePlanOptionTerm" format="ixt-sec:durwordsen" id="id3VybDovL2RvY3MudjEvZG9jOmFlNWE5YmUwZWI5NDQ1ZDE5MmZhZTgyMmQyMmJlMDlmL3NlYzphZTVhOWJlMGViOTQ0NWQxOTJmYWU4MjJkMjJiZTA5Zl80Ni9mcmFnOjU5ZmVhYTYxNWVlYjRmZTJhOGQ1ZTQ5NTRkNjk5MzFiL3RleHRyZWdpb246NTlmZWFhNjE1ZWViNGZlMmE4ZDVlNDk1NGQ2OTkzMWJfMTE1NjM_b862ee01-cb8f-4ad0-a6e0-c1804827f156">five years</ix:nonNumeric>.</span></div><div style="margin-top:9pt;padding-left:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The 2020 Plan authorizes the Company to issue up to <ix:nonFraction unitRef="shares" contextRef="i57b5170b75b149df8f3952976e4aeb64_I20220630" decimals="INF" name="us-gaap:CommonStockSharesAuthorized" format="ixt:num-dot-decimal" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmFlNWE5YmUwZWI5NDQ1ZDE5MmZhZTgyMmQyMmJlMDlmL3NlYzphZTVhOWJlMGViOTQ0NWQxOTJmYWU4MjJkMjJiZTA5Zl80Ni9mcmFnOjU5ZmVhYTYxNWVlYjRmZTJhOGQ1ZTQ5NTRkNjk5MzFiL3RleHRyZWdpb246NTlmZWFhNjE1ZWViNGZlMmE4ZDVlNDk1NGQ2OTkzMWJfMTE2MTk_6e1360f6-44bf-45a9-8c66-41dabebbf9c3">1,900,000</ix:nonFraction> shares of the Company&#8217;s common stock pursuant to awards granted under the 2020 Plan, plus the number of shares underlying any stock option and other stock-based awards previously granted under the 2010 Plan that are forfeited, canceled, or terminated (other than by exercise) on or after May 26, 2020; provided that no more than <ix:nonFraction unitRef="shares" contextRef="id1f6d22436f64f38a4bd51d0074f4a35_I20220630" decimals="INF" name="us-gaap:SharesIssued" format="ixt:num-dot-decimal" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmFlNWE5YmUwZWI5NDQ1ZDE5MmZhZTgyMmQyMmJlMDlmL3NlYzphZTVhOWJlMGViOTQ0NWQxOTJmYWU4MjJkMjJiZTA5Zl80Ni9mcmFnOjU5ZmVhYTYxNWVlYjRmZTJhOGQ1ZTQ5NTRkNjk5MzFiL3RleHRyZWdpb246NTlmZWFhNjE1ZWViNGZlMmE4ZDVlNDk1NGQ2OTkzMWJfMTE5NTE_0c8f7d1e-e4b5-46a0-988d-d572e96d901a">1,400,000</ix:nonFraction> shares may be added to the 2020 Plan pursuant to such forfeitures, cancellations and terminations. In addition, the number of shares available for issuance under the 2020 Plan will automatically increase on the first day of each fiscal year beginning in fiscal year 2021 and ending on the second day of fiscal year 2025, by an amount equal to the smaller of (i) <ix:nonFraction unitRef="number" contextRef="ie02bb53f63db46709e0bad3ea42b396b_D20220101-20220630" decimals="INF" name="dmtk:CommonStockOutstandingPercentage" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOmFlNWE5YmUwZWI5NDQ1ZDE5MmZhZTgyMmQyMmJlMDlmL3NlYzphZTVhOWJlMGViOTQ0NWQxOTJmYWU4MjJkMjJiZTA5Zl80Ni9mcmFnOjU5ZmVhYTYxNWVlYjRmZTJhOGQ1ZTQ5NTRkNjk5MzFiL3RleHRyZWdpb246NTlmZWFhNjE1ZWViNGZlMmE4ZDVlNDk1NGQ2OTkzMWJfMTIzMTQ_1a30a0ab-7cd2-436f-9091-ba4505fee9ed">3.5</ix:nonFraction>% of the number of shares of common stock outstanding on such date and (ii) an amount determined by the administrator of the 2020 Plan. The 2020 Plan will expire on April 12, 2030 or an earlier date approved by a vote of the Company&#8217;s stockholders or board of directors. The contractual term of options granted under the 2020 Plan is not more than <ix:nonNumeric contextRef="ie02bb53f63db46709e0bad3ea42b396b_D20220101-20220630" name="us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardExpirationPeriod" format="ixt-sec:durwordsen" id="id3VybDovL2RvY3MudjEvZG9jOmFlNWE5YmUwZWI5NDQ1ZDE5MmZhZTgyMmQyMmJlMDlmL3NlYzphZTVhOWJlMGViOTQ0NWQxOTJmYWU4MjJkMjJiZTA5Zl80Ni9mcmFnOjU5ZmVhYTYxNWVlYjRmZTJhOGQ1ZTQ5NTRkNjk5MzFiL3RleHRyZWdpb246NTlmZWFhNjE1ZWViNGZlMmE4ZDVlNDk1NGQ2OTkzMWJfMTI2NjM_756d5814-1cd0-4a2d-95b2-b93204836dfa">ten years</ix:nonNumeric>. Vesting provisions vary based on the specific terms of the individual option awards. <ix:nonFraction unitRef="shares" contextRef="i57b5170b75b149df8f3952976e4aeb64_I20220630" decimals="INF" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant" format="ixt:num-dot-decimal" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmFlNWE5YmUwZWI5NDQ1ZDE5MmZhZTgyMmQyMmJlMDlmL3NlYzphZTVhOWJlMGViOTQ0NWQxOTJmYWU4MjJkMjJiZTA5Zl80Ni9mcmFnOjU5ZmVhYTYxNWVlYjRmZTJhOGQ1ZTQ5NTRkNjk5MzFiL3RleHRyZWdpb246NTlmZWFhNjE1ZWViNGZlMmE4ZDVlNDk1NGQ2OTkzMWJfMTI3NTI_8084554e-e967-4a31-b4ca-834767d8b4ec">431,107</ix:nonFraction> shares remained available for future grant under the 2020 Plan as of June&#160;30, 2022.</span></div><div style="margin-top:15pt;padding-left:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">2020 Employee Stock Purchase Plan</span></div><div style="margin-top:9pt;padding-left:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">On May 26, 2020, the Company&#8217;s stockholders approved the adoption of the ESPP, which allows for full-time and certain part-time employees of the Company to purchase shares of common stock at a discount to fair market value. Eligible employees enroll in a six-month offering period during the open enrollment period prior to the start of that offering period. A new offering period begins approximately every March 1 and September 1. At the end of each offering period, the accumulated contributions are used to purchase shares of the Company&#8217;s common stock. Shares are purchased at a price equal to <ix:nonFraction unitRef="number" contextRef="i017b877f28974f268d6f8d65791f6ccf_D20220101-20220630" decimals="INF" name="dmtk:PercentageOfPriceAtSharesPurchased" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOmFlNWE5YmUwZWI5NDQ1ZDE5MmZhZTgyMmQyMmJlMDlmL3NlYzphZTVhOWJlMGViOTQ0NWQxOTJmYWU4MjJkMjJiZTA5Zl80Ni9mcmFnOjU5ZmVhYTYxNWVlYjRmZTJhOGQ1ZTQ5NTRkNjk5MzFiL3RleHRyZWdpb246NTlmZWFhNjE1ZWViNGZlMmE4ZDVlNDk1NGQ2OTkzMWJfMTM1MTM_a886124a-98d2-483d-815d-c672dc806856">85</ix:nonFraction>% of the lower of: (i) the fair market value of the Company&#8217;s common stock on the first business day of an offering period or (ii) the fair market value of the Company&#8217;s common stock on the last business day of an offering period. </span></div><div style="margin-top:9pt;padding-left:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The ESPP authorizes the Company to issue up to <ix:nonFraction unitRef="shares" contextRef="i22cf6cdf250d424385f207471e8ff450_I20220630" decimals="INF" name="us-gaap:CommonStockCapitalSharesReservedForFutureIssuance" format="ixt:num-dot-decimal" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmFlNWE5YmUwZWI5NDQ1ZDE5MmZhZTgyMmQyMmJlMDlmL3NlYzphZTVhOWJlMGViOTQ0NWQxOTJmYWU4MjJkMjJiZTA5Zl80Ni9mcmFnOjU5ZmVhYTYxNWVlYjRmZTJhOGQ1ZTQ5NTRkNjk5MzFiL3RleHRyZWdpb246NTlmZWFhNjE1ZWViNGZlMmE4ZDVlNDk1NGQ2OTkzMWJfMTM3OTM_b455c170-6b22-4b9c-a996-93b5c283a178">400,000</ix:nonFraction> shares of the Company&#8217;s common stock. In addition, the number of shares available for issuance under the ESPP will automatically increase on the first day of each of the Company&#8217;s fiscal years beginning in 2021 and ending on the first day of 2030, in an amount equal to the lesser of (i) <ix:nonFraction unitRef="shares" contextRef="i6808a2674aa947cbae46fd4581d39941_I20220630" decimals="INF" name="us-gaap:SharesIssued" format="ixt:num-dot-decimal" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmFlNWE5YmUwZWI5NDQ1ZDE5MmZhZTgyMmQyMmJlMDlmL3NlYzphZTVhOWJlMGViOTQ0NWQxOTJmYWU4MjJkMjJiZTA5Zl80Ni9mcmFnOjU5ZmVhYTYxNWVlYjRmZTJhOGQ1ZTQ5NTRkNjk5MzFiL3RleHRyZWdpb246NTlmZWFhNjE1ZWViNGZlMmE4ZDVlNDk1NGQ2OTkzMWJfMTQwODI_1b25dcfc-a6db-4b68-a744-9492d641ba55">300,000</ix:nonFraction> shares, (ii) <ix:nonFraction unitRef="number" contextRef="i017b877f28974f268d6f8d65791f6ccf_D20220101-20220630" decimals="INF" name="dmtk:CommonStockOutstandingPercentage" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOmFlNWE5YmUwZWI5NDQ1ZDE5MmZhZTgyMmQyMmJlMDlmL3NlYzphZTVhOWJlMGViOTQ0NWQxOTJmYWU4MjJkMjJiZTA5Zl80Ni9mcmFnOjU5ZmVhYTYxNWVlYjRmZTJhOGQ1ZTQ5NTRkNjk5MzFiL3RleHRyZWdpb246NTlmZWFhNjE1ZWViNGZlMmE4ZDVlNDk1NGQ2OTkzMWJfMTQwOTg_61d4f4b7-4d4a-4eec-8198-b2819c5ae84e">1</ix:nonFraction>% of the shares of Company common stock outstanding on the last day of the immediately preceding fiscal year, or (iii) such lesser number of shares as is determined by the board of directors of the Company, subject to adjustment upon changes in capitalization of the Company. On February 28, 2021 and August 31, 2021, the Company issued <ix:nonFraction unitRef="shares" contextRef="idae0e59d93ee49ada1896eeec302b5ad_D20210228-20210228" decimals="INF" name="us-gaap:StockIssuedDuringPeriodSharesNewIssues" format="ixt:num-dot-decimal" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmFlNWE5YmUwZWI5NDQ1ZDE5MmZhZTgyMmQyMmJlMDlmL3NlYzphZTVhOWJlMGViOTQ0NWQxOTJmYWU4MjJkMjJiZTA5Zl80Ni9mcmFnOjU5ZmVhYTYxNWVlYjRmZTJhOGQ1ZTQ5NTRkNjk5MzFiL3RleHRyZWdpb246NTlmZWFhNjE1ZWViNGZlMmE4ZDVlNDk1NGQ2OTkzMWJfMTQ0MjE_3b4f9be6-3cd2-4798-adef-eee50c89a2c2">39,960</ix:nonFraction> and <ix:nonFraction unitRef="shares" contextRef="i4953bff07aa94f8085ce64eca01ff01c_D20210801-20210831" decimals="INF" name="us-gaap:StockIssuedDuringPeriodSharesNewIssues" format="ixt:num-dot-decimal" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmFlNWE5YmUwZWI5NDQ1ZDE5MmZhZTgyMmQyMmJlMDlmL3NlYzphZTVhOWJlMGViOTQ0NWQxOTJmYWU4MjJkMjJiZTA5Zl80Ni9mcmFnOjU5ZmVhYTYxNWVlYjRmZTJhOGQ1ZTQ5NTRkNjk5MzFiL3RleHRyZWdpb246NTlmZWFhNjE1ZWViNGZlMmE4ZDVlNDk1NGQ2OTkzMWJfMTQ0Mjg_4bf7aa9d-b85a-412c-b8d2-528ea5ca60e2">18,155</ix:nonFraction> shares of its common stock, respectively, pursuant to scheduled purchases under the ESPP. As of December&#160;31, 2021, <ix:nonFraction unitRef="shares" contextRef="i90db9a89ea084897a01e19ee9ba1df7d_I20211231" decimals="INF" name="us-gaap:CommonStockCapitalSharesReservedForFutureIssuance" format="ixt:num-dot-decimal" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmFlNWE5YmUwZWI5NDQ1ZDE5MmZhZTgyMmQyMmJlMDlmL3NlYzphZTVhOWJlMGViOTQ0NWQxOTJmYWU4MjJkMjJiZTA5Zl80Ni9mcmFnOjU5ZmVhYTYxNWVlYjRmZTJhOGQ1ZTQ5NTRkNjk5MzFiL3RleHRyZWdpb246NTlmZWFhNjE1ZWViNGZlMmE4ZDVlNDk1NGQ2OTkzMWJfMTQ1MzE_6f878e1d-378f-421c-ba98-f5f6b3d1128e">549,289</ix:nonFraction> shares of common stock were reserved for future issuance under the ESPP. On January&#160;1, 2022, an additional <ix:nonFraction unitRef="shares" contextRef="if90b738ac124410e8756188bb3849132_I20220101" decimals="INF" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant" format="ixt:num-dot-decimal" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmFlNWE5YmUwZWI5NDQ1ZDE5MmZhZTgyMmQyMmJlMDlmL3NlYzphZTVhOWJlMGViOTQ0NWQxOTJmYWU4MjJkMjJiZTA5Zl80Ni9mcmFnOjU5ZmVhYTYxNWVlYjRmZTJhOGQ1ZTQ5NTRkNjk5MzFiL3RleHRyZWdpb246NTlmZWFhNjE1ZWViNGZlMmE4ZDVlNDk1NGQ2OTkzMWJfMTQ2Mjg_a2a81a32-c8bd-41f4-86d9-729b5fc3ece0">297,729</ix:nonFraction> shares became available under the ESPP pursuant to an automatic annual increase. On February&#160;28, 2022, the Company issued <ix:nonFraction unitRef="shares" contextRef="i93962a6eeb67470a9a84c74d9a0daa4b_I20220228" decimals="INF" name="us-gaap:CommonStockSharesIssued" format="ixt:num-dot-decimal" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmFlNWE5YmUwZWI5NDQ1ZDE5MmZhZTgyMmQyMmJlMDlmL3NlYzphZTVhOWJlMGViOTQ0NWQxOTJmYWU4MjJkMjJiZTA5Zl80Ni9mcmFnOjU5ZmVhYTYxNWVlYjRmZTJhOGQ1ZTQ5NTRkNjk5MzFiL3RleHRyZWdpb246NTlmZWFhNjE1ZWViNGZlMmE4ZDVlNDk1NGQ2OTkzMWJfMjE5OTAyMzI4MDA3MA_69da5455-cbc6-4af0-92f5-91122168a053">47,339</ix:nonFraction> shares of its common stock pursuant to scheduled purchases under the ESPP. <ix:nonFraction unitRef="shares" contextRef="i6808a2674aa947cbae46fd4581d39941_I20220630" decimals="INF" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant" format="ixt:num-dot-decimal" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmFlNWE5YmUwZWI5NDQ1ZDE5MmZhZTgyMmQyMmJlMDlmL3NlYzphZTVhOWJlMGViOTQ0NWQxOTJmYWU4MjJkMjJiZTA5Zl80Ni9mcmFnOjU5ZmVhYTYxNWVlYjRmZTJhOGQ1ZTQ5NTRkNjk5MzFiL3RleHRyZWdpb246NTlmZWFhNjE1ZWViNGZlMmE4ZDVlNDk1NGQ2OTkzMWJfMTQ3MTI_5b97cb2a-3acc-4e30-ad0a-50be504aeb46">799,679</ix:nonFraction> shares remained available for future grant under the ESPP as of June&#160;30, 2022.</span></div></ix:continuation><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">18</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:45pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#iae5a9be0eb9445d192fae822d22be09f_7">Table of Contents</a></span></div></div><ix:continuation id="if5c54729d75441aca017c4d4a6948ecc"><div style="margin-top:15pt;padding-left:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Management Warrants</span></div><div style="margin-top:9pt;padding-left:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Warrants to purchase DermTech Operations common stock were issued to executive officers of DermTech Operations in lieu of issuing certain stock options (the &#8220;Management Warrants&#8221;). The Management Warrants were assumed by the Company in connection with the Business Combination. The Management Warrants have a <ix:nonNumeric contextRef="i3ae776d8a361420b98e7812cbc296a23_I20220630" name="us-gaap:WarrantsAndRightsOutstandingTerm" format="ixt-sec:durwordsen" id="id3VybDovL2RvY3MudjEvZG9jOmFlNWE5YmUwZWI5NDQ1ZDE5MmZhZTgyMmQyMmJlMDlmL3NlYzphZTVhOWJlMGViOTQ0NWQxOTJmYWU4MjJkMjJiZTA5Zl80Ni9mcmFnOjU5ZmVhYTYxNWVlYjRmZTJhOGQ1ZTQ5NTRkNjk5MzFiL3RleHRyZWdpb246NTlmZWFhNjE1ZWViNGZlMmE4ZDVlNDk1NGQ2OTkzMWJfMTU2NDI_a2287e32-ad45-4ce5-b6ac-b0ea2f0ca4c6">ten-year</ix:nonNumeric> life and are exercisable for Company common stock at $<ix:nonFraction unitRef="usdPerShare" contextRef="icceae5e000e140b89495ae9f074cbf03_I20220630" decimals="INF" name="us-gaap:ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmFlNWE5YmUwZWI5NDQ1ZDE5MmZhZTgyMmQyMmJlMDlmL3NlYzphZTVhOWJlMGViOTQ0NWQxOTJmYWU4MjJkMjJiZTA5Zl80Ni9mcmFnOjU5ZmVhYTYxNWVlYjRmZTJhOGQ1ZTQ5NTRkNjk5MzFiL3RleHRyZWdpb246NTlmZWFhNjE1ZWViNGZlMmE4ZDVlNDk1NGQ2OTkzMWJfMTUxNzM_ba873f7b-db75-43bf-a744-875d51e875e6">1.08</ix:nonFraction> per share. For the six months ended June&#160;30, 2022, the Company issued <ix:nonFraction unitRef="shares" contextRef="icceae5e000e140b89495ae9f074cbf03_I20220630" decimals="INF" name="us-gaap:ClassOfWarrantOrRightNumberOfSecuritiesCalledByEachWarrantOrRight" format="ixt:num-dot-decimal" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmFlNWE5YmUwZWI5NDQ1ZDE5MmZhZTgyMmQyMmJlMDlmL3NlYzphZTVhOWJlMGViOTQ0NWQxOTJmYWU4MjJkMjJiZTA5Zl80Ni9mcmFnOjU5ZmVhYTYxNWVlYjRmZTJhOGQ1ZTQ5NTRkNjk5MzFiL3RleHRyZWdpb246NTlmZWFhNjE1ZWViNGZlMmE4ZDVlNDk1NGQ2OTkzMWJfMjE5OTAyMzI4MDEzNA_1d16e851-3a0a-4727-9615-2916c814c54e">20,320</ix:nonFraction> shares of common stock pursuant to the exercise of Management Warrants. The Management Warrants vested monthly over a <ix:nonNumeric contextRef="i17c79d92ed9747bf964a280f627bbb4a_D20220101-20220630" name="dmtk:WarrantsVestingPeriod" format="ixt-sec:durwordsen" id="id3VybDovL2RvY3MudjEvZG9jOmFlNWE5YmUwZWI5NDQ1ZDE5MmZhZTgyMmQyMmJlMDlmL3NlYzphZTVhOWJlMGViOTQ0NWQxOTJmYWU4MjJkMjJiZTA5Zl80Ni9mcmFnOjU5ZmVhYTYxNWVlYjRmZTJhOGQ1ZTQ5NTRkNjk5MzFiL3RleHRyZWdpb246NTlmZWFhNjE1ZWViNGZlMmE4ZDVlNDk1NGQ2OTkzMWJfMTU2NDM_a46d6470-fc96-400d-aa8a-5a4323f6ba38">four-year</ix:nonNumeric> period. Outstanding Management Warrants totaled <ix:nonFraction unitRef="shares" contextRef="i3ae776d8a361420b98e7812cbc296a23_I20220630" decimals="INF" name="us-gaap:ClassOfWarrantOrRightOutstanding" format="ixt:fixed-zero" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmFlNWE5YmUwZWI5NDQ1ZDE5MmZhZTgyMmQyMmJlMDlmL3NlYzphZTVhOWJlMGViOTQ0NWQxOTJmYWU4MjJkMjJiZTA5Zl80Ni9mcmFnOjU5ZmVhYTYxNWVlYjRmZTJhOGQ1ZTQ5NTRkNjk5MzFiL3RleHRyZWdpb246NTlmZWFhNjE1ZWViNGZlMmE4ZDVlNDk1NGQ2OTkzMWJfMTUyODk_784b9ec4-ffd5-4be2-b968-2183a5106ddd">zero</ix:nonFraction> and <ix:nonFraction unitRef="shares" contextRef="id48e52918d994150b696caa21ce59a38_I20211231" decimals="INF" name="us-gaap:ClassOfWarrantOrRightOutstanding" format="ixt:num-dot-decimal" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmFlNWE5YmUwZWI5NDQ1ZDE5MmZhZTgyMmQyMmJlMDlmL3NlYzphZTVhOWJlMGViOTQ0NWQxOTJmYWU4MjJkMjJiZTA5Zl80Ni9mcmFnOjU5ZmVhYTYxNWVlYjRmZTJhOGQ1ZTQ5NTRkNjk5MzFiL3RleHRyZWdpb246NTlmZWFhNjE1ZWViNGZlMmE4ZDVlNDk1NGQ2OTkzMWJfMTUyOTY_e9ed1f79-08ca-4043-9350-5ed0b7a9cb99">22,320</ix:nonFraction> as of June&#160;30, 2022 and December&#160;31, 2021, respectively.</span></div><div style="margin-top:15pt;padding-left:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Common Stock Reserved for Future Issuance </span></div><ix:nonNumeric contextRef="ia855382ada1f4f28aa8ef6da692ff177_D20220101-20220630" name="us-gaap:ScheduleOfStockByClassTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOmFlNWE5YmUwZWI5NDQ1ZDE5MmZhZTgyMmQyMmJlMDlmL3NlYzphZTVhOWJlMGViOTQ0NWQxOTJmYWU4MjJkMjJiZTA5Zl80Ni9mcmFnOjU5ZmVhYTYxNWVlYjRmZTJhOGQ1ZTQ5NTRkNjk5MzFiL3RleHRyZWdpb246NTlmZWFhNjE1ZWViNGZlMmE4ZDVlNDk1NGQ2OTkzMWJfMTU2NDQ_c41fa990-3203-4ae5-9b88-1ad3490ff97b" escape="true"><div style="margin-top:9pt;padding-left:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Common stock reserved for future issuance consists of the following as of June&#160;30, 2022 and December&#160;31, 2021 (in thousands): </span></div><div style="margin-top:12pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:71.930%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.081%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.406%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.083%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">June 30,<br/>2022</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">December 31,<br/>2021</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Warrants to purchase common stock</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i224d7d5c13f4473abacadb433d8efcf9_I20220630" decimals="INF" name="us-gaap:CommonStockCapitalSharesReservedForFutureIssuance" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmFlNWE5YmUwZWI5NDQ1ZDE5MmZhZTgyMmQyMmJlMDlmL3NlYzphZTVhOWJlMGViOTQ0NWQxOTJmYWU4MjJkMjJiZTA5Zl80Ni9mcmFnOjU5ZmVhYTYxNWVlYjRmZTJhOGQ1ZTQ5NTRkNjk5MzFiL3RhYmxlOjA3OGQyMjlmN2EyYTQ2NDk5MTg3M2U2MzAyNGFmNTdkL3RhYmxlcmFuZ2U6MDc4ZDIyOWY3YTJhNDY0OTkxODczZTYzMDI0YWY1N2RfMS0xLTEtMS02MjY_5c1c5eed-8341-4aa3-9da9-73e2ac824be5">10</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i3e751586f58d4d01a1fef025f865d0f3_I20211231" decimals="INF" name="us-gaap:CommonStockCapitalSharesReservedForFutureIssuance" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmFlNWE5YmUwZWI5NDQ1ZDE5MmZhZTgyMmQyMmJlMDlmL3NlYzphZTVhOWJlMGViOTQ0NWQxOTJmYWU4MjJkMjJiZTA5Zl80Ni9mcmFnOjU5ZmVhYTYxNWVlYjRmZTJhOGQ1ZTQ5NTRkNjk5MzFiL3RhYmxlOjA3OGQyMjlmN2EyYTQ2NDk5MTg3M2U2MzAyNGFmNTdkL3RhYmxlcmFuZ2U6MDc4ZDIyOWY3YTJhNDY0OTkxODczZTYzMDI0YWY1N2RfMS0zLTEtMS02MjY_9a5e87ba-e069-43b1-8500-f1c5cdc61e94">31</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">SPAC Warrants to purchase common stock*</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i518ef87c81764e97bfd3d740d82300fd_I20220630" decimals="INF" name="us-gaap:CommonStockCapitalSharesReservedForFutureIssuance" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmFlNWE5YmUwZWI5NDQ1ZDE5MmZhZTgyMmQyMmJlMDlmL3NlYzphZTVhOWJlMGViOTQ0NWQxOTJmYWU4MjJkMjJiZTA5Zl80Ni9mcmFnOjU5ZmVhYTYxNWVlYjRmZTJhOGQ1ZTQ5NTRkNjk5MzFiL3RhYmxlOjA3OGQyMjlmN2EyYTQ2NDk5MTg3M2U2MzAyNGFmNTdkL3RhYmxlcmFuZ2U6MDc4ZDIyOWY3YTJhNDY0OTkxODczZTYzMDI0YWY1N2RfMi0xLTEtMS02MjY_a11d4ac0-6f41-4e08-b735-9271645f34ff">704</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="ib8e1d5497a8844f49561a3c895942e21_I20211231" decimals="INF" name="us-gaap:CommonStockCapitalSharesReservedForFutureIssuance" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmFlNWE5YmUwZWI5NDQ1ZDE5MmZhZTgyMmQyMmJlMDlmL3NlYzphZTVhOWJlMGViOTQ0NWQxOTJmYWU4MjJkMjJiZTA5Zl80Ni9mcmFnOjU5ZmVhYTYxNWVlYjRmZTJhOGQ1ZTQ5NTRkNjk5MzFiL3RhYmxlOjA3OGQyMjlmN2EyYTQ2NDk5MTg3M2U2MzAyNGFmNTdkL3RhYmxlcmFuZ2U6MDc4ZDIyOWY3YTJhNDY0OTkxODczZTYzMDI0YWY1N2RfMi0zLTEtMS02MjY_666ad634-2d38-4e85-8257-bb290b20e131">704</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Stock options issued and outstanding</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="id85b86a3ec0547afa49b47ee6b523100_I20220630" decimals="INF" name="us-gaap:CommonStockCapitalSharesReservedForFutureIssuance" format="ixt:num-dot-decimal" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmFlNWE5YmUwZWI5NDQ1ZDE5MmZhZTgyMmQyMmJlMDlmL3NlYzphZTVhOWJlMGViOTQ0NWQxOTJmYWU4MjJkMjJiZTA5Zl80Ni9mcmFnOjU5ZmVhYTYxNWVlYjRmZTJhOGQ1ZTQ5NTRkNjk5MzFiL3RhYmxlOjA3OGQyMjlmN2EyYTQ2NDk5MTg3M2U2MzAyNGFmNTdkL3RhYmxlcmFuZ2U6MDc4ZDIyOWY3YTJhNDY0OTkxODczZTYzMDI0YWY1N2RfMy0xLTEtMS02MjY_7f059d5a-2386-42e1-b8ec-26d71cc70fc5">1,758</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="if9fd57fab22a46b58a6fed555cc40670_I20211231" decimals="INF" name="us-gaap:CommonStockCapitalSharesReservedForFutureIssuance" format="ixt:num-dot-decimal" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmFlNWE5YmUwZWI5NDQ1ZDE5MmZhZTgyMmQyMmJlMDlmL3NlYzphZTVhOWJlMGViOTQ0NWQxOTJmYWU4MjJkMjJiZTA5Zl80Ni9mcmFnOjU5ZmVhYTYxNWVlYjRmZTJhOGQ1ZTQ5NTRkNjk5MzFiL3RhYmxlOjA3OGQyMjlmN2EyYTQ2NDk5MTg3M2U2MzAyNGFmNTdkL3RhYmxlcmFuZ2U6MDc4ZDIyOWY3YTJhNDY0OTkxODczZTYzMDI0YWY1N2RfMy0zLTEtMS02MjY_b12a7706-0fc9-4e14-a0b1-c189ccd8ebdd">1,721</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">RSUs issued and outstanding</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="if59386ad3a864f49b56cf8b203a0bfc9_I20220630" decimals="INF" name="us-gaap:CommonStockCapitalSharesReservedForFutureIssuance" format="ixt:num-dot-decimal" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmFlNWE5YmUwZWI5NDQ1ZDE5MmZhZTgyMmQyMmJlMDlmL3NlYzphZTVhOWJlMGViOTQ0NWQxOTJmYWU4MjJkMjJiZTA5Zl80Ni9mcmFnOjU5ZmVhYTYxNWVlYjRmZTJhOGQ1ZTQ5NTRkNjk5MzFiL3RhYmxlOjA3OGQyMjlmN2EyYTQ2NDk5MTg3M2U2MzAyNGFmNTdkL3RhYmxlcmFuZ2U6MDc4ZDIyOWY3YTJhNDY0OTkxODczZTYzMDI0YWY1N2RfNC0xLTEtMS02MjY_0ebeb701-4e78-4f43-91e9-6ff835de1864">2,912</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="ia2ce86db98734669afba2e88fbc221c0_I20211231" decimals="INF" name="us-gaap:CommonStockCapitalSharesReservedForFutureIssuance" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmFlNWE5YmUwZWI5NDQ1ZDE5MmZhZTgyMmQyMmJlMDlmL3NlYzphZTVhOWJlMGViOTQ0NWQxOTJmYWU4MjJkMjJiZTA5Zl80Ni9mcmFnOjU5ZmVhYTYxNWVlYjRmZTJhOGQ1ZTQ5NTRkNjk5MzFiL3RhYmxlOjA3OGQyMjlmN2EyYTQ2NDk5MTg3M2U2MzAyNGFmNTdkL3RhYmxlcmFuZ2U6MDc4ZDIyOWY3YTJhNDY0OTkxODczZTYzMDI0YWY1N2RfNC0zLTEtMS02MjY_37bc2f68-dfac-40ab-9837-3e1ad821fb03">983</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Authorized for future equity grants</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="idff1708d659844a99149a2c6dc434bbc_I20220630" decimals="INF" name="us-gaap:CommonStockCapitalSharesReservedForFutureIssuance" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmFlNWE5YmUwZWI5NDQ1ZDE5MmZhZTgyMmQyMmJlMDlmL3NlYzphZTVhOWJlMGViOTQ0NWQxOTJmYWU4MjJkMjJiZTA5Zl80Ni9mcmFnOjU5ZmVhYTYxNWVlYjRmZTJhOGQ1ZTQ5NTRkNjk5MzFiL3RhYmxlOjA3OGQyMjlmN2EyYTQ2NDk5MTg3M2U2MzAyNGFmNTdkL3RhYmxlcmFuZ2U6MDc4ZDIyOWY3YTJhNDY0OTkxODczZTYzMDI0YWY1N2RfNS0xLTEtMS02MjY_5202f3b4-773f-4759-bd41-14440abde7e1">431</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="ia222e6a529804adeb78574b8095520eb_I20211231" decimals="INF" name="us-gaap:CommonStockCapitalSharesReservedForFutureIssuance" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmFlNWE5YmUwZWI5NDQ1ZDE5MmZhZTgyMmQyMmJlMDlmL3NlYzphZTVhOWJlMGViOTQ0NWQxOTJmYWU4MjJkMjJiZTA5Zl80Ni9mcmFnOjU5ZmVhYTYxNWVlYjRmZTJhOGQ1ZTQ5NTRkNjk5MzFiL3RhYmxlOjA3OGQyMjlmN2EyYTQ2NDk5MTg3M2U2MzAyNGFmNTdkL3RhYmxlcmFuZ2U6MDc4ZDIyOWY3YTJhNDY0OTkxODczZTYzMDI0YWY1N2RfNS0zLTEtMS02MjY_7e65f248-0d1a-4786-8f72-85a6dfe63739">603</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Authorized for future ESPP purchases</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="if28f5d136fda458d8a8446a128205c60_I20220630" decimals="INF" name="us-gaap:CommonStockCapitalSharesReservedForFutureIssuance" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmFlNWE5YmUwZWI5NDQ1ZDE5MmZhZTgyMmQyMmJlMDlmL3NlYzphZTVhOWJlMGViOTQ0NWQxOTJmYWU4MjJkMjJiZTA5Zl80Ni9mcmFnOjU5ZmVhYTYxNWVlYjRmZTJhOGQ1ZTQ5NTRkNjk5MzFiL3RhYmxlOjA3OGQyMjlmN2EyYTQ2NDk5MTg3M2U2MzAyNGFmNTdkL3RhYmxlcmFuZ2U6MDc4ZDIyOWY3YTJhNDY0OTkxODczZTYzMDI0YWY1N2RfNi0xLTEtMS02MjY_11dae19b-bac2-4e91-b29b-42e4ee663045">800</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i5cb5de1a181c4857a7d503c399e272c8_I20211231" decimals="INF" name="us-gaap:CommonStockCapitalSharesReservedForFutureIssuance" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmFlNWE5YmUwZWI5NDQ1ZDE5MmZhZTgyMmQyMmJlMDlmL3NlYzphZTVhOWJlMGViOTQ0NWQxOTJmYWU4MjJkMjJiZTA5Zl80Ni9mcmFnOjU5ZmVhYTYxNWVlYjRmZTJhOGQ1ZTQ5NTRkNjk5MzFiL3RhYmxlOjA3OGQyMjlmN2EyYTQ2NDk5MTg3M2U2MzAyNGFmNTdkL3RhYmxlcmFuZ2U6MDc4ZDIyOWY3YTJhNDY0OTkxODczZTYzMDI0YWY1N2RfNi0zLTEtMS02MjY_8f0c76bf-f42d-45f6-afc8-496c8a5b8b27">549</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total common stock reserved for future issuance</span></td><td colspan="2" style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i4c8f247d12134a9886d56e1c8b024425_I20220630" decimals="INF" name="us-gaap:CommonStockCapitalSharesReservedForFutureIssuance" format="ixt:num-dot-decimal" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmFlNWE5YmUwZWI5NDQ1ZDE5MmZhZTgyMmQyMmJlMDlmL3NlYzphZTVhOWJlMGViOTQ0NWQxOTJmYWU4MjJkMjJiZTA5Zl80Ni9mcmFnOjU5ZmVhYTYxNWVlYjRmZTJhOGQ1ZTQ5NTRkNjk5MzFiL3RhYmxlOjA3OGQyMjlmN2EyYTQ2NDk5MTg3M2U2MzAyNGFmNTdkL3RhYmxlcmFuZ2U6MDc4ZDIyOWY3YTJhNDY0OTkxODczZTYzMDI0YWY1N2RfNy0xLTEtMS02MjY_4b8b4107-2ebd-42e6-94c7-97279afb4151">6,615</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i87bf777ccf5f4f93bc9be7a2cbba61c1_I20211231" decimals="INF" name="us-gaap:CommonStockCapitalSharesReservedForFutureIssuance" format="ixt:num-dot-decimal" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmFlNWE5YmUwZWI5NDQ1ZDE5MmZhZTgyMmQyMmJlMDlmL3NlYzphZTVhOWJlMGViOTQ0NWQxOTJmYWU4MjJkMjJiZTA5Zl80Ni9mcmFnOjU5ZmVhYTYxNWVlYjRmZTJhOGQ1ZTQ5NTRkNjk5MzFiL3RhYmxlOjA3OGQyMjlmN2EyYTQ2NDk5MTg3M2U2MzAyNGFmNTdkL3RhYmxlcmFuZ2U6MDc4ZDIyOWY3YTJhNDY0OTkxODczZTYzMDI0YWY1N2RfNy0zLTEtMS02MjY_29e35e17-f692-43c1-b53f-5336e9d071b1">4,591</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><div style="margin-top:9pt;padding-left:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">*<ix:nonFraction unitRef="warrant" contextRef="ie2a82877a32d4e80a7f2d54460a79dcd_D20220101-20220630" decimals="INF" name="dmtk:NumberOfWarrantsEntitleHolderToPurchaseOneShare" format="ixt-sec:numwordsen" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmFlNWE5YmUwZWI5NDQ1ZDE5MmZhZTgyMmQyMmJlMDlmL3NlYzphZTVhOWJlMGViOTQ0NWQxOTJmYWU4MjJkMjJiZTA5Zl80Ni9mcmFnOjU5ZmVhYTYxNWVlYjRmZTJhOGQ1ZTQ5NTRkNjk5MzFiL3RleHRyZWdpb246NTlmZWFhNjE1ZWViNGZlMmE4ZDVlNDk1NGQ2OTkzMWJfMTU0Nzc_01647967-9780-42f4-9c1a-e72ff750dd0c">Four</ix:nonFraction> SPAC Warrants are needed to purchase one share of common stock. The numbers presented above reflect the amount of shares of common stock underlying SPAC Warrants.</span></div></ix:nonNumeric></ix:continuation><div id="iae5a9be0eb9445d192fae822d22be09f_55"></div><div style="margin-top:15pt;padding-left:27pt;text-indent:-27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">4.&#160;&#160;&#160;&#160;<ix:nonNumeric contextRef="ia855382ada1f4f28aa8ef6da692ff177_D20220101-20220630" name="us-gaap:CommitmentsDisclosureTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOmFlNWE5YmUwZWI5NDQ1ZDE5MmZhZTgyMmQyMmJlMDlmL3NlYzphZTVhOWJlMGViOTQ0NWQxOTJmYWU4MjJkMjJiZTA5Zl81NS9mcmFnOjgzZWFhMzRhOThhOTQ3YWQ4ZDYzODA0Nzc5NGYxYjhmL3RleHRyZWdpb246ODNlYWEzNGE5OGE5NDdhZDhkNjM4MDQ3Nzk0ZjFiOGZfODM5Mw_4a279fc1-8150-428a-94e6-952e7af0b949" continuedAt="i36fe41ab377a4d52b32b23a8b98ce323" escape="true">Leases, Commitments and Contingencies</ix:nonNumeric></span></div><ix:continuation id="i36fe41ab377a4d52b32b23a8b98ce323" continuedAt="i3c0011c0a5f74865861e28cc1c86f1bd"><div style="margin-top:15pt;padding-left:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"><ix:continuation id="i35c1ccb484504fbfb06c20c462f705d9" continuedAt="i8995b42d94184a17bfdc0ec8db30a970">Adoption of ASC 842</ix:continuation></span></div><div style="margin-top:9pt;padding-left:27pt"><ix:continuation id="i8995b42d94184a17bfdc0ec8db30a970" continuedAt="i50913233bbb046abbf238100fb7321ff"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In the third quarter of 2021, the Company adopted ASU 2016-02</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">, </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">and</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"> </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">ASC</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"> </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Topic</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"> </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">842, </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Leases</span></ix:continuation><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:continuation id="i50913233bbb046abbf238100fb7321ff"> (&#8220;ASC 842&#8221;) using the modified retrospective approach with an effective date of January 1, 2021. The adoption had no effect on the condensed consolidated statements of operations for the three and six months ended June 30, 2021. Net cash (used in) provided by operating activities, investing activities or financing activities for the six months ended June 30, 2021 were also unchanged, but the presentation of certain prior period amounts within the operating activities section of the condensed consolidated statements of cash flows have been retrospectively adjusted to give effect to the adoption of ASC 842.</ix:continuation> <ix:nonNumeric contextRef="ia855382ada1f4f28aa8ef6da692ff177_D20220101-20220630" name="us-gaap:ScheduleOfNewAccountingPronouncementsAndChangesInAccountingPrinciplesTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOmFlNWE5YmUwZWI5NDQ1ZDE5MmZhZTgyMmQyMmJlMDlmL3NlYzphZTVhOWJlMGViOTQ0NWQxOTJmYWU4MjJkMjJiZTA5Zl81NS9mcmFnOjgzZWFhMzRhOThhOTQ3YWQ4ZDYzODA0Nzc5NGYxYjhmL3RleHRyZWdpb246ODNlYWEzNGE5OGE5NDdhZDhkNjM4MDQ3Nzk0ZjFiOGZfMzI5ODUzNDkzODcyMQ_67b098c4-d2fd-425b-afb8-e8a87dadef7b" continuedAt="iceca81be7b934e6da8a145a6d120a851" escape="true">The changes are set forth in the table below (in thousands):</ix:nonNumeric></span></div><div style="margin-top:6pt;padding-left:27pt"><ix:continuation id="iceca81be7b934e6da8a145a6d120a851"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:62.081%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.021%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.406%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.263%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.406%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.023%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.5pt;font-weight:700;line-height:100%">Six Months Ended June 30, 2021</span></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.5pt;font-weight:700;line-height:100%">Before Adoption of ASC 842</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.5pt;font-weight:700;line-height:100%">Effect of Adoption</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.5pt;font-weight:700;line-height:100%">After Adoption of ASC 842</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:700;line-height:100%">Effect on Condensed Consolidated Statements of Cash Flows</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Cash flows from operating activities:</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Adjustments to reconcile net loss to net cash used in operating activities:</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 17.5pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Amortization of operating lease right-of-use assets</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if694b668e6db42e59488d953f4800965_D20220101-20220630" decimals="-3" name="us-gaap:OperatingLeaseRightOfUseAssetAmortizationExpense" format="ixt:fixed-zero" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmFlNWE5YmUwZWI5NDQ1ZDE5MmZhZTgyMmQyMmJlMDlmL3NlYzphZTVhOWJlMGViOTQ0NWQxOTJmYWU4MjJkMjJiZTA5Zl81NS9mcmFnOjgzZWFhMzRhOThhOTQ3YWQ4ZDYzODA0Nzc5NGYxYjhmL3RhYmxlOjE4ZWI5MDI1MzlhOTQyMjliMzYwYzYyMGVjNmEyZjY0L3RhYmxlcmFuZ2U6MThlYjkwMjUzOWE5NDIyOWIzNjBjNjIwZWM2YTJmNjRfNS0xLTEtMS05MjQ4_971e609c-14b5-44e0-8912-3c1490a46dd7">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i637644f310444bb4bb137883228ca16b_D20220101-20220630" decimals="-3" name="us-gaap:OperatingLeaseRightOfUseAssetAmortizationExpense" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmFlNWE5YmUwZWI5NDQ1ZDE5MmZhZTgyMmQyMmJlMDlmL3NlYzphZTVhOWJlMGViOTQ0NWQxOTJmYWU4MjJkMjJiZTA5Zl81NS9mcmFnOjgzZWFhMzRhOThhOTQ3YWQ4ZDYzODA0Nzc5NGYxYjhmL3RhYmxlOjE4ZWI5MDI1MzlhOTQyMjliMzYwYzYyMGVjNmEyZjY0L3RhYmxlcmFuZ2U6MThlYjkwMjUzOWE5NDIyOWIzNjBjNjIwZWM2YTJmNjRfNS0zLTEtMS05MjQ4_15e0dd50-6eb5-4f1e-a863-4b5c10af28f0">582</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i4628e2bd4b3a484e9970f7b8d824bdca_D20220101-20220630" decimals="-3" name="us-gaap:OperatingLeaseRightOfUseAssetAmortizationExpense" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmFlNWE5YmUwZWI5NDQ1ZDE5MmZhZTgyMmQyMmJlMDlmL3NlYzphZTVhOWJlMGViOTQ0NWQxOTJmYWU4MjJkMjJiZTA5Zl81NS9mcmFnOjgzZWFhMzRhOThhOTQ3YWQ4ZDYzODA0Nzc5NGYxYjhmL3RhYmxlOjE4ZWI5MDI1MzlhOTQyMjliMzYwYzYyMGVjNmEyZjY0L3RhYmxlcmFuZ2U6MThlYjkwMjUzOWE5NDIyOWIzNjBjNjIwZWM2YTJmNjRfNS01LTEtMS05MjQ4_031361b0-5af8-49b6-a0a3-e1001b9e58ae">582</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Change in operating assets and liabilities:</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 11.5pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Operating lease liabilities, net</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ia085e149f0584e4aa75cec6634a0ee91_I20220630" decimals="-3" name="us-gaap:OperatingLeaseLiability" format="ixt:fixed-zero" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmFlNWE5YmUwZWI5NDQ1ZDE5MmZhZTgyMmQyMmJlMDlmL3NlYzphZTVhOWJlMGViOTQ0NWQxOTJmYWU4MjJkMjJiZTA5Zl81NS9mcmFnOjgzZWFhMzRhOThhOTQ3YWQ4ZDYzODA0Nzc5NGYxYjhmL3RhYmxlOjE4ZWI5MDI1MzlhOTQyMjliMzYwYzYyMGVjNmEyZjY0L3RhYmxlcmFuZ2U6MThlYjkwMjUzOWE5NDIyOWIzNjBjNjIwZWM2YTJmNjRfNy0xLTEtMS05MjQ4_63e0f18c-8281-41f5-87f3-57c08a26a2d9">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ie929f48c345b4dcab48cd9079f2d2e62_I20220630" decimals="-3" sign="-" name="us-gaap:OperatingLeaseLiability" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmFlNWE5YmUwZWI5NDQ1ZDE5MmZhZTgyMmQyMmJlMDlmL3NlYzphZTVhOWJlMGViOTQ0NWQxOTJmYWU4MjJkMjJiZTA5Zl81NS9mcmFnOjgzZWFhMzRhOThhOTQ3YWQ4ZDYzODA0Nzc5NGYxYjhmL3RhYmxlOjE4ZWI5MDI1MzlhOTQyMjliMzYwYzYyMGVjNmEyZjY0L3RhYmxlcmFuZ2U6MThlYjkwMjUzOWE5NDIyOWIzNjBjNjIwZWM2YTJmNjRfNy0zLTEtMS05MjQ4_9cbc218b-691c-4120-b9a2-8f4ed3ac7a7e">328</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i833f3dceaa1b4ef5bcdfa449605a0a35_I20220630" decimals="-3" sign="-" name="us-gaap:OperatingLeaseLiability" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmFlNWE5YmUwZWI5NDQ1ZDE5MmZhZTgyMmQyMmJlMDlmL3NlYzphZTVhOWJlMGViOTQ0NWQxOTJmYWU4MjJkMjJiZTA5Zl81NS9mcmFnOjgzZWFhMzRhOThhOTQ3YWQ4ZDYzODA0Nzc5NGYxYjhmL3RhYmxlOjE4ZWI5MDI1MzlhOTQyMjliMzYwYzYyMGVjNmEyZjY0L3RhYmxlcmFuZ2U6MThlYjkwMjUzOWE5NDIyOWIzNjBjNjIwZWM2YTJmNjRfNy01LTEtMS05MjQ4_a01d06cb-04d4-4ec1-8471-1113a111038b">328</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 11.5pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Other liabilities</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ia085e149f0584e4aa75cec6634a0ee91_I20220630" decimals="-3" name="us-gaap:OtherLiabilities" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmFlNWE5YmUwZWI5NDQ1ZDE5MmZhZTgyMmQyMmJlMDlmL3NlYzphZTVhOWJlMGViOTQ0NWQxOTJmYWU4MjJkMjJiZTA5Zl81NS9mcmFnOjgzZWFhMzRhOThhOTQ3YWQ4ZDYzODA0Nzc5NGYxYjhmL3RhYmxlOjE4ZWI5MDI1MzlhOTQyMjliMzYwYzYyMGVjNmEyZjY0L3RhYmxlcmFuZ2U6MThlYjkwMjUzOWE5NDIyOWIzNjBjNjIwZWM2YTJmNjRfOC0xLTEtMS05MjQ4_f7e017e8-17c3-471d-a5c4-a6afb738cd0a">254</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ie929f48c345b4dcab48cd9079f2d2e62_I20220630" decimals="-3" sign="-" name="us-gaap:OtherLiabilities" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmFlNWE5YmUwZWI5NDQ1ZDE5MmZhZTgyMmQyMmJlMDlmL3NlYzphZTVhOWJlMGViOTQ0NWQxOTJmYWU4MjJkMjJiZTA5Zl81NS9mcmFnOjgzZWFhMzRhOThhOTQ3YWQ4ZDYzODA0Nzc5NGYxYjhmL3RhYmxlOjE4ZWI5MDI1MzlhOTQyMjliMzYwYzYyMGVjNmEyZjY0L3RhYmxlcmFuZ2U6MThlYjkwMjUzOWE5NDIyOWIzNjBjNjIwZWM2YTJmNjRfOC0zLTEtMS05MjQ4_868b448d-ebd1-49d2-90bc-dbd98d1b53e7">254</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i833f3dceaa1b4ef5bcdfa449605a0a35_I20220630" decimals="-3" name="us-gaap:OtherLiabilities" format="ixt:fixed-zero" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmFlNWE5YmUwZWI5NDQ1ZDE5MmZhZTgyMmQyMmJlMDlmL3NlYzphZTVhOWJlMGViOTQ0NWQxOTJmYWU4MjJkMjJiZTA5Zl81NS9mcmFnOjgzZWFhMzRhOThhOTQ3YWQ4ZDYzODA0Nzc5NGYxYjhmL3RhYmxlOjE4ZWI5MDI1MzlhOTQyMjliMzYwYzYyMGVjNmEyZjY0L3RhYmxlcmFuZ2U6MThlYjkwMjUzOWE5NDIyOWIzNjBjNjIwZWM2YTJmNjRfOC01LTEtMS05MjQ4_3ce0c228-056b-48d5-b8b8-e6a300bc02da">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></ix:continuation></div></ix:continuation><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">19</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:45pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#iae5a9be0eb9445d192fae822d22be09f_7">Table of Contents</a></span></div></div><ix:continuation id="i3c0011c0a5f74865861e28cc1c86f1bd" continuedAt="i38f597c360a446098694a56850d5fa59"><div style="margin-top:15pt;padding-left:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Finance Leases</span></div><div style="margin-top:9pt;padding-left:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company leases certain laboratory equipment from various third parties, through equipment finance leases (previously referred to as &#8220;capital leases&#8221;). These leases either include a bargain purchase option or the terms of the leases are at least <ix:nonFraction unitRef="number" contextRef="ia855382ada1f4f28aa8ef6da692ff177_D20220101-20220630" decimals="2" name="dmtk:PercentageOfUsefulLivesOfAssets" format="ixt:num-dot-decimal" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOmFlNWE5YmUwZWI5NDQ1ZDE5MmZhZTgyMmQyMmJlMDlmL3NlYzphZTVhOWJlMGViOTQ0NWQxOTJmYWU4MjJkMjJiZTA5Zl81NS9mcmFnOjgzZWFhMzRhOThhOTQ3YWQ4ZDYzODA0Nzc5NGYxYjhmL3RleHRyZWdpb246ODNlYWEzNGE5OGE5NDdhZDhkNjM4MDQ3Nzk0ZjFiOGZfMzEw_a120d09c-b376-4707-94af-a93378e65d2a">75</ix:nonFraction> percent of the useful lives of the assets and are therefore classified as finance leases. These leases are capitalized in property and equipment, net on the accompanying condensed consolidated balance sheets. Initial asset values and finance lease obligations are based on the present value of future minimum lease payments. Gross assets recorded under finance leases were $<ix:nonFraction unitRef="usd" contextRef="if5c0f2a68220406b8c328b2744af6512_I20220630" decimals="-5" name="us-gaap:PropertyPlantAndEquipmentGross" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmFlNWE5YmUwZWI5NDQ1ZDE5MmZhZTgyMmQyMmJlMDlmL3NlYzphZTVhOWJlMGViOTQ0NWQxOTJmYWU4MjJkMjJiZTA5Zl81NS9mcmFnOjgzZWFhMzRhOThhOTQ3YWQ4ZDYzODA0Nzc5NGYxYjhmL3RleHRyZWdpb246ODNlYWEzNGE5OGE5NDdhZDhkNjM4MDQ3Nzk0ZjFiOGZfNjc4_da9e8f61-5c57-4d49-ac71-2e0e753db619">0.4</ix:nonFraction> million and $<ix:nonFraction unitRef="usd" contextRef="ic89cf2db98344df4a59437fe3569a1d2_I20211231" decimals="-5" name="us-gaap:PropertyPlantAndEquipmentGross" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmFlNWE5YmUwZWI5NDQ1ZDE5MmZhZTgyMmQyMmJlMDlmL3NlYzphZTVhOWJlMGViOTQ0NWQxOTJmYWU4MjJkMjJiZTA5Zl81NS9mcmFnOjgzZWFhMzRhOThhOTQ3YWQ4ZDYzODA0Nzc5NGYxYjhmL3RleHRyZWdpb246ODNlYWEzNGE5OGE5NDdhZDhkNjM4MDQ3Nzk0ZjFiOGZfNjg1_bcf371ab-5fa3-40a6-9147-623efa6cd5e0">0.4</ix:nonFraction> million as of June&#160;30, 2022 and December&#160;31, 2021, respectively. Accumulated amortization associated with finance leases was $<ix:nonFraction unitRef="usd" contextRef="ia855382ada1f4f28aa8ef6da692ff177_D20220101-20220630" decimals="-5" name="us-gaap:DepreciationAndAmortization" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmFlNWE5YmUwZWI5NDQ1ZDE5MmZhZTgyMmQyMmJlMDlmL3NlYzphZTVhOWJlMGViOTQ0NWQxOTJmYWU4MjJkMjJiZTA5Zl81NS9mcmFnOjgzZWFhMzRhOThhOTQ3YWQ4ZDYzODA0Nzc5NGYxYjhmL3RleHRyZWdpb246ODNlYWEzNGE5OGE5NDdhZDhkNjM4MDQ3Nzk0ZjFiOGZfNzc5_10d07f45-cb5d-448e-829f-371aaf51043e">0.1</ix:nonFraction> million and $<ix:nonFraction unitRef="usd" contextRef="icf690a1cf0024305b7396da4cb697adc_D20210101-20211231" decimals="-5" name="us-gaap:DepreciationAndAmortization" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmFlNWE5YmUwZWI5NDQ1ZDE5MmZhZTgyMmQyMmJlMDlmL3NlYzphZTVhOWJlMGViOTQ0NWQxOTJmYWU4MjJkMjJiZTA5Zl81NS9mcmFnOjgzZWFhMzRhOThhOTQ3YWQ4ZDYzODA0Nzc5NGYxYjhmL3RleHRyZWdpb246ODNlYWEzNGE5OGE5NDdhZDhkNjM4MDQ3Nzk0ZjFiOGZfNzg2_7f4db4d8-0efc-4220-a68b-4ebbb2444ff3">0.1</ix:nonFraction> million as of June&#160;30, 2022 and December&#160;31, 2021, respectively. Total finance lease interest expense was approximately $<ix:nonFraction unitRef="usd" contextRef="i4ac87f578df0406d99e77dc768764559_D20220401-20220630" decimals="-3" name="us-gaap:FinanceLeaseInterestExpense" format="ixt:num-dot-decimal" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmFlNWE5YmUwZWI5NDQ1ZDE5MmZhZTgyMmQyMmJlMDlmL3NlYzphZTVhOWJlMGViOTQ0NWQxOTJmYWU4MjJkMjJiZTA5Zl81NS9mcmFnOjgzZWFhMzRhOThhOTQ3YWQ4ZDYzODA0Nzc5NGYxYjhmL3RleHRyZWdpb246ODNlYWEzNGE5OGE5NDdhZDhkNjM4MDQ3Nzk0ZjFiOGZfODc1_5920b682-1687-44bb-b511-ada2b212470b">3,000</ix:nonFraction> and $<ix:nonFraction unitRef="usd" contextRef="ie146fe37064c4413b6d561285cac9dcd_D20210401-20210630" decimals="-3" name="us-gaap:FinanceLeaseInterestExpense" format="ixt:num-dot-decimal" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmFlNWE5YmUwZWI5NDQ1ZDE5MmZhZTgyMmQyMmJlMDlmL3NlYzphZTVhOWJlMGViOTQ0NWQxOTJmYWU4MjJkMjJiZTA5Zl81NS9mcmFnOjgzZWFhMzRhOThhOTQ3YWQ4ZDYzODA0Nzc5NGYxYjhmL3RleHRyZWdpb246ODNlYWEzNGE5OGE5NDdhZDhkNjM4MDQ3Nzk0ZjFiOGZfODgz_8d5bfc4e-febe-4836-ba26-ccf499f77d4d">4,000</ix:nonFraction> for the three months ended June&#160;30, 2022 and 2021, respectively, and $<ix:nonFraction unitRef="usd" contextRef="i69bf0330ac3a4009ac4cc9f072eb2145_D20220101-20220630" decimals="-3" name="us-gaap:FinanceLeaseInterestExpense" format="ixt:num-dot-decimal" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmFlNWE5YmUwZWI5NDQ1ZDE5MmZhZTgyMmQyMmJlMDlmL3NlYzphZTVhOWJlMGViOTQ0NWQxOTJmYWU4MjJkMjJiZTA5Zl81NS9mcmFnOjgzZWFhMzRhOThhOTQ3YWQ4ZDYzODA0Nzc5NGYxYjhmL3RleHRyZWdpb246ODNlYWEzNGE5OGE5NDdhZDhkNjM4MDQ3Nzk0ZjFiOGZfOTQy_f5927bce-d2e8-43ed-bd41-8f1c2847636f">7,000</ix:nonFraction> and $<ix:nonFraction unitRef="usd" contextRef="ia60e98d0ecdb4e6fac0242d43b27bd2b_D20210101-20210630" decimals="-3" name="us-gaap:FinanceLeaseInterestExpense" format="ixt:num-dot-decimal" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmFlNWE5YmUwZWI5NDQ1ZDE5MmZhZTgyMmQyMmJlMDlmL3NlYzphZTVhOWJlMGViOTQ0NWQxOTJmYWU4MjJkMjJiZTA5Zl81NS9mcmFnOjgzZWFhMzRhOThhOTQ3YWQ4ZDYzODA0Nzc5NGYxYjhmL3RleHRyZWdpb246ODNlYWEzNGE5OGE5NDdhZDhkNjM4MDQ3Nzk0ZjFiOGZfOTQ5_833dfaac-b76f-40b2-9f55-1cbcd0d8130e">8,000</ix:nonFraction> for the six months ended June 30, 2022 and 2021, respectively, and is included within interest income, net on the condensed consolidated statements of operations. <ix:nonNumeric contextRef="ia855382ada1f4f28aa8ef6da692ff177_D20220101-20220630" name="dmtk:ScheduleOfLongTermFinanceLeaseObligationsTableTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOmFlNWE5YmUwZWI5NDQ1ZDE5MmZhZTgyMmQyMmJlMDlmL3NlYzphZTVhOWJlMGViOTQ0NWQxOTJmYWU4MjJkMjJiZTA5Zl81NS9mcmFnOjgzZWFhMzRhOThhOTQ3YWQ4ZDYzODA0Nzc5NGYxYjhmL3RleHRyZWdpb246ODNlYWEzNGE5OGE5NDdhZDhkNjM4MDQ3Nzk0ZjFiOGZfODM4OQ_bd2fbe8e-a78a-49fe-b6de-f34c9d0faf12" continuedAt="i137b9be976fa4147afea0fa0eab5220b" escape="true">Long-term finance lease obligations are as follows (in thousands): </ix:nonNumeric></span></div><div style="margin-top:12pt"><ix:continuation id="i137b9be976fa4147afea0fa0eab5220b"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.696%"><tr><td style="width:1.0%"></td><td style="width:69.264%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:13.337%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.407%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:13.492%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">June 30, 2022</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">December 31, 2021</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Gross finance lease obligations</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i4c8f247d12134a9886d56e1c8b024425_I20220630" decimals="-3" name="us-gaap:FinanceLeaseLiabilityPaymentsDue" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmFlNWE5YmUwZWI5NDQ1ZDE5MmZhZTgyMmQyMmJlMDlmL3NlYzphZTVhOWJlMGViOTQ0NWQxOTJmYWU4MjJkMjJiZTA5Zl81NS9mcmFnOjgzZWFhMzRhOThhOTQ3YWQ4ZDYzODA0Nzc5NGYxYjhmL3RhYmxlOjRjZmU2NzU5NGU0ZDQ3NzFhNTE0YTc3NGIxNzE4ODg0L3RhYmxlcmFuZ2U6NGNmZTY3NTk0ZTRkNDc3MWE1MTRhNzc0YjE3MTg4ODRfMS0xLTEtMS02MjY_02262fa4-237b-4626-acc6-8ee499d17f43">262</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i87bf777ccf5f4f93bc9be7a2cbba61c1_I20211231" decimals="-3" name="us-gaap:FinanceLeaseLiabilityPaymentsDue" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmFlNWE5YmUwZWI5NDQ1ZDE5MmZhZTgyMmQyMmJlMDlmL3NlYzphZTVhOWJlMGViOTQ0NWQxOTJmYWU4MjJkMjJiZTA5Zl81NS9mcmFnOjgzZWFhMzRhOThhOTQ3YWQ4ZDYzODA0Nzc5NGYxYjhmL3RhYmxlOjRjZmU2NzU5NGU0ZDQ3NzFhNTE0YTc3NGIxNzE4ODg0L3RhYmxlcmFuZ2U6NGNmZTY3NTk0ZTRkNDc3MWE1MTRhNzc0YjE3MTg4ODRfMS0zLTEtMS02MjY_c3a4ebb2-78ef-4fb3-80c1-2eb0862ace11">274</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Less imputed interest</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i4c8f247d12134a9886d56e1c8b024425_I20220630" decimals="-3" name="us-gaap:FinanceLeaseLiabilityUndiscountedExcessAmount" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmFlNWE5YmUwZWI5NDQ1ZDE5MmZhZTgyMmQyMmJlMDlmL3NlYzphZTVhOWJlMGViOTQ0NWQxOTJmYWU4MjJkMjJiZTA5Zl81NS9mcmFnOjgzZWFhMzRhOThhOTQ3YWQ4ZDYzODA0Nzc5NGYxYjhmL3RhYmxlOjRjZmU2NzU5NGU0ZDQ3NzFhNTE0YTc3NGIxNzE4ODg0L3RhYmxlcmFuZ2U6NGNmZTY3NTk0ZTRkNDc3MWE1MTRhNzc0YjE3MTg4ODRfMi0xLTEtMS02MjY_9d86c9ce-42b2-4770-8b5f-de7cc5384c2f">17</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i87bf777ccf5f4f93bc9be7a2cbba61c1_I20211231" decimals="-3" name="us-gaap:FinanceLeaseLiabilityUndiscountedExcessAmount" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmFlNWE5YmUwZWI5NDQ1ZDE5MmZhZTgyMmQyMmJlMDlmL3NlYzphZTVhOWJlMGViOTQ0NWQxOTJmYWU4MjJkMjJiZTA5Zl81NS9mcmFnOjgzZWFhMzRhOThhOTQ3YWQ4ZDYzODA0Nzc5NGYxYjhmL3RhYmxlOjRjZmU2NzU5NGU0ZDQ3NzFhNTE0YTc3NGIxNzE4ODg0L3RhYmxlcmFuZ2U6NGNmZTY3NTk0ZTRkNDc3MWE1MTRhNzc0YjE3MTg4ODRfMi0zLTEtMS02MjY_cc7e8dca-678c-4bda-91b2-563e2d43fd4b">17</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Present value of net minimum lease payments</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i4c8f247d12134a9886d56e1c8b024425_I20220630" decimals="-3" name="us-gaap:FinanceLeaseLiability" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmFlNWE5YmUwZWI5NDQ1ZDE5MmZhZTgyMmQyMmJlMDlmL3NlYzphZTVhOWJlMGViOTQ0NWQxOTJmYWU4MjJkMjJiZTA5Zl81NS9mcmFnOjgzZWFhMzRhOThhOTQ3YWQ4ZDYzODA0Nzc5NGYxYjhmL3RhYmxlOjRjZmU2NzU5NGU0ZDQ3NzFhNTE0YTc3NGIxNzE4ODg0L3RhYmxlcmFuZ2U6NGNmZTY3NTk0ZTRkNDc3MWE1MTRhNzc0YjE3MTg4ODRfMy0xLTEtMS02MjY_6382b51a-9ba5-44fe-b963-9e1ca41eaeb2">245</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i87bf777ccf5f4f93bc9be7a2cbba61c1_I20211231" decimals="-3" name="us-gaap:FinanceLeaseLiability" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmFlNWE5YmUwZWI5NDQ1ZDE5MmZhZTgyMmQyMmJlMDlmL3NlYzphZTVhOWJlMGViOTQ0NWQxOTJmYWU4MjJkMjJiZTA5Zl81NS9mcmFnOjgzZWFhMzRhOThhOTQ3YWQ4ZDYzODA0Nzc5NGYxYjhmL3RhYmxlOjRjZmU2NzU5NGU0ZDQ3NzFhNTE0YTc3NGIxNzE4ODg0L3RhYmxlcmFuZ2U6NGNmZTY3NTk0ZTRkNDc3MWE1MTRhNzc0YjE3MTg4ODRfMy0zLTEtMS02MjY_a2e85bc7-086b-42e4-bae5-8379d9c70cb4">257</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Less current portion of finance lease obligations</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i4c8f247d12134a9886d56e1c8b024425_I20220630" decimals="-3" name="us-gaap:FinanceLeaseLiabilityCurrent" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmFlNWE5YmUwZWI5NDQ1ZDE5MmZhZTgyMmQyMmJlMDlmL3NlYzphZTVhOWJlMGViOTQ0NWQxOTJmYWU4MjJkMjJiZTA5Zl81NS9mcmFnOjgzZWFhMzRhOThhOTQ3YWQ4ZDYzODA0Nzc5NGYxYjhmL3RhYmxlOjRjZmU2NzU5NGU0ZDQ3NzFhNTE0YTc3NGIxNzE4ODg0L3RhYmxlcmFuZ2U6NGNmZTY3NTk0ZTRkNDc3MWE1MTRhNzc0YjE3MTg4ODRfNC0xLTEtMS02MjY_b58bda5d-a491-45bd-875c-9b0da96bda86">134</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i87bf777ccf5f4f93bc9be7a2cbba61c1_I20211231" decimals="-3" name="us-gaap:FinanceLeaseLiabilityCurrent" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmFlNWE5YmUwZWI5NDQ1ZDE5MmZhZTgyMmQyMmJlMDlmL3NlYzphZTVhOWJlMGViOTQ0NWQxOTJmYWU4MjJkMjJiZTA5Zl81NS9mcmFnOjgzZWFhMzRhOThhOTQ3YWQ4ZDYzODA0Nzc5NGYxYjhmL3RhYmxlOjRjZmU2NzU5NGU0ZDQ3NzFhNTE0YTc3NGIxNzE4ODg0L3RhYmxlcmFuZ2U6NGNmZTY3NTk0ZTRkNDc3MWE1MTRhNzc0YjE3MTg4ODRfNC0zLTEtMS02MjY_c9416b28-4af0-4ed7-992b-753f0d149012">121</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total long-term finance lease obligations</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i4c8f247d12134a9886d56e1c8b024425_I20220630" decimals="-3" name="us-gaap:FinanceLeaseLiabilityNoncurrent" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmFlNWE5YmUwZWI5NDQ1ZDE5MmZhZTgyMmQyMmJlMDlmL3NlYzphZTVhOWJlMGViOTQ0NWQxOTJmYWU4MjJkMjJiZTA5Zl81NS9mcmFnOjgzZWFhMzRhOThhOTQ3YWQ4ZDYzODA0Nzc5NGYxYjhmL3RhYmxlOjRjZmU2NzU5NGU0ZDQ3NzFhNTE0YTc3NGIxNzE4ODg0L3RhYmxlcmFuZ2U6NGNmZTY3NTk0ZTRkNDc3MWE1MTRhNzc0YjE3MTg4ODRfNS0xLTEtMS02MjY_7a296330-5158-4e62-9d5b-cd472d1388c8">111</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i87bf777ccf5f4f93bc9be7a2cbba61c1_I20211231" decimals="-3" name="us-gaap:FinanceLeaseLiabilityNoncurrent" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmFlNWE5YmUwZWI5NDQ1ZDE5MmZhZTgyMmQyMmJlMDlmL3NlYzphZTVhOWJlMGViOTQ0NWQxOTJmYWU4MjJkMjJiZTA5Zl81NS9mcmFnOjgzZWFhMzRhOThhOTQ3YWQ4ZDYzODA0Nzc5NGYxYjhmL3RhYmxlOjRjZmU2NzU5NGU0ZDQ3NzFhNTE0YTc3NGIxNzE4ODg0L3RhYmxlcmFuZ2U6NGNmZTY3NTk0ZTRkNDc3MWE1MTRhNzc0YjE3MTg4ODRfNS0zLTEtMS02MjY_6f6997b2-c6eb-45e8-95ef-732408eb219f">136</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></ix:continuation></div><div style="margin-top:15pt;padding-left:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Operating Leases</span></div><div style="margin-top:15pt;padding-left:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Del Mar Heights Lease </span></div><div style="margin-top:9pt;padding-left:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">On July&#160;1, 2021, the Company entered into an Office Lease (the &#8220;Del Mar Lease&#8221;) with Kilroy Realty, L.P. (the &#8220;Landlord&#8221;), with respect to an aggregate of <ix:nonFraction unitRef="sqft" contextRef="i1618d3c7213a4aa5a35fb7ebe4eea53b_D20210701-20210701" decimals="INF" name="dmtk:AreaOfBuilding" format="ixt:num-dot-decimal" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmFlNWE5YmUwZWI5NDQ1ZDE5MmZhZTgyMmQyMmJlMDlmL3NlYzphZTVhOWJlMGViOTQ0NWQxOTJmYWU4MjJkMjJiZTA5Zl81NS9mcmFnOjgzZWFhMzRhOThhOTQ3YWQ4ZDYzODA0Nzc5NGYxYjhmL3RleHRyZWdpb246ODNlYWEzNGE5OGE5NDdhZDhkNjM4MDQ3Nzk0ZjFiOGZfMTM1NA_7df34cab-c5cf-45f3-9612-d0c9fa57b574">95,997</ix:nonFraction> rentable square feet consisting of the entire building located at 12340 El Camino Real, San Diego, California 92130 (the &#8220;Entire Premises&#8221;). The Entire Premises covered by the Del Mar Lease will serve as the Company&#8217;s new principal office.</span></div><div style="margin-top:9pt;padding-left:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Del Mar Lease provides for a tenant improvement allowance of $<ix:nonFraction unitRef="usdPerSqft" contextRef="i1618d3c7213a4aa5a35fb7ebe4eea53b_D20210701-20210701" decimals="2" name="dmtk:TenantImprovementAllowancePerRentableSquareFoot" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmFlNWE5YmUwZWI5NDQ1ZDE5MmZhZTgyMmQyMmJlMDlmL3NlYzphZTVhOWJlMGViOTQ0NWQxOTJmYWU4MjJkMjJiZTA5Zl81NS9mcmFnOjgzZWFhMzRhOThhOTQ3YWQ4ZDYzODA0Nzc5NGYxYjhmL3RleHRyZWdpb246ODNlYWEzNGE5OGE5NDdhZDhkNjM4MDQ3Nzk0ZjFiOGZfMTY1NA_b1902a8c-8500-44b5-ae1e-66bf0aaa48f6">125.00</ix:nonFraction> per rentable square foot of the Entire Premises for a total of $<ix:nonFraction unitRef="usd" contextRef="icbcfccaf50f84ffca456a076d115a21c_I20210701" decimals="-5" name="us-gaap:TenantImprovements" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmFlNWE5YmUwZWI5NDQ1ZDE5MmZhZTgyMmQyMmJlMDlmL3NlYzphZTVhOWJlMGViOTQ0NWQxOTJmYWU4MjJkMjJiZTA5Zl81NS9mcmFnOjgzZWFhMzRhOThhOTQ3YWQ4ZDYzODA0Nzc5NGYxYjhmL3RleHRyZWdpb246ODNlYWEzNGE5OGE5NDdhZDhkNjM4MDQ3Nzk0ZjFiOGZfMTcyMA_4e4fce7f-205a-4675-9f66-21b99612522d">12.0</ix:nonFraction> million that the Landlord will use to fund the installation and/or construction of certain improvements to the Entire Premises in <ix:nonFraction unitRef="phase" contextRef="i4c8f247d12134a9886d56e1c8b024425_I20220630" decimals="INF" name="dmtk:NumberOfImprovementPhases" format="ixt-sec:numwordsen" id="id3VybDovL2RvY3MudjEvZG9jOmFlNWE5YmUwZWI5NDQ1ZDE5MmZhZTgyMmQyMmJlMDlmL3NlYzphZTVhOWJlMGViOTQ0NWQxOTJmYWU4MjJkMjJiZTA5Zl81NS9mcmFnOjgzZWFhMzRhOThhOTQ3YWQ4ZDYzODA0Nzc5NGYxYjhmL3RleHRyZWdpb246ODNlYWEzNGE5OGE5NDdhZDhkNjM4MDQ3Nzk0ZjFiOGZfMzI5ODUzNDkwOTg1OA_5492d5b8-3501-4fc9-be5c-024bb8e6288b">four</ix:nonFraction> phases, with each phase pertaining to a specified portion of the Entire Premises. The initial term of the Del Mar Lease is ten years and six months beginning on the earlier to occur of (i) January 1, 2023 and (ii) the date that Landlord tenders possession of the Phase III Premises (as defined in the Del Mar Lease) to the Company following the substantial completion of the improvements to the Phase III Premises required by the Del Mar Lease (the &#8220;Lease Commencement Date&#8221;). The Company has the option to extend the term of the Lease for <ix:nonFraction unitRef="period" contextRef="i53405b48f5954e23b556c40be1389d0c_I20220630" decimals="INF" name="dmtk:LesseeOperatingLeaseNumberOfRenewalTerms" format="ixt-sec:numwordsen" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmFlNWE5YmUwZWI5NDQ1ZDE5MmZhZTgyMmQyMmJlMDlmL3NlYzphZTVhOWJlMGViOTQ0NWQxOTJmYWU4MjJkMjJiZTA5Zl81NS9mcmFnOjgzZWFhMzRhOThhOTQ3YWQ4ZDYzODA0Nzc5NGYxYjhmL3RleHRyZWdpb246ODNlYWEzNGE5OGE5NDdhZDhkNjM4MDQ3Nzk0ZjFiOGZfMzI5ODUzNDkwOTg2Mg_654e4339-c608-4c48-bb4f-4c60191d7ff0">two</ix:nonFraction> additional <ix:nonNumeric contextRef="i53405b48f5954e23b556c40be1389d0c_I20220630" name="us-gaap:LesseeOperatingLeaseRenewalTerm" format="ixt-sec:durwordsen" id="id3VybDovL2RvY3MudjEvZG9jOmFlNWE5YmUwZWI5NDQ1ZDE5MmZhZTgyMmQyMmJlMDlmL3NlYzphZTVhOWJlMGViOTQ0NWQxOTJmYWU4MjJkMjJiZTA5Zl81NS9mcmFnOjgzZWFhMzRhOThhOTQ3YWQ4ZDYzODA0Nzc5NGYxYjhmL3RleHRyZWdpb246ODNlYWEzNGE5OGE5NDdhZDhkNjM4MDQ3Nzk0ZjFiOGZfMzI5ODUzNDkwOTg2NA_27988201-13d9-4513-be3e-b2bd5c3cdc7b">five-year</ix:nonNumeric> periods, subject to the terms of the Del Mar Lease.</span></div><div style="margin-top:9pt;padding-left:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">As the Landlord tenders possession of each portion of the Entire Premises for which the applicable improvements required by the Del Mar Lease are substantially complete, the Company will be obligated to make monthly payments of base rent with respect to such portion of the Entire Premises as set forth on Schedule 1 to the Del Mar Lease. In the event the Company exercises its option to extend the Del Mar Lease term, the Lease provides for monthly rent payments during the additional <ix:nonNumeric contextRef="i53405b48f5954e23b556c40be1389d0c_I20220630" name="us-gaap:LesseeOperatingLeaseRenewalTerm" format="ixt-sec:durwordsen" id="id3VybDovL2RvY3MudjEvZG9jOmFlNWE5YmUwZWI5NDQ1ZDE5MmZhZTgyMmQyMmJlMDlmL3NlYzphZTVhOWJlMGViOTQ0NWQxOTJmYWU4MjJkMjJiZTA5Zl81NS9mcmFnOjgzZWFhMzRhOThhOTQ3YWQ4ZDYzODA0Nzc5NGYxYjhmL3RleHRyZWdpb246ODNlYWEzNGE5OGE5NDdhZDhkNjM4MDQ3Nzk0ZjFiOGZfMjk1Mw_65f164f0-99bb-48fc-ba48-d851092727cc">five-year</ix:nonNumeric> periods at the then-current market rent as determined in accordance with the Del Mar Lease. In addition to rent, the Del Mar Lease requires the Company to pay additional rent amounts for taxes, insurance, maintenance and other expenses.</span></div><div style="margin-top:9pt;padding-left:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">During year ended December 31, 2021, the Company took initial possession of the first phase of its corporate headquarters, and the Company capitalized a right-of-use asset and related lease liability of $<ix:nonFraction unitRef="usd" contextRef="i53405b48f5954e23b556c40be1389d0c_I20220630" decimals="-5" name="us-gaap:OperatingLeaseLiability" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmFlNWE5YmUwZWI5NDQ1ZDE5MmZhZTgyMmQyMmJlMDlmL3NlYzphZTVhOWJlMGViOTQ0NWQxOTJmYWU4MjJkMjJiZTA5Zl81NS9mcmFnOjgzZWFhMzRhOThhOTQ3YWQ4ZDYzODA0Nzc5NGYxYjhmL3RleHRyZWdpb246ODNlYWEzNGE5OGE5NDdhZDhkNjM4MDQ3Nzk0ZjFiOGZfMzM5NA_60f6c7b3-d309-4496-9790-8bbdbe9c3704"><ix:nonFraction unitRef="usd" contextRef="i53405b48f5954e23b556c40be1389d0c_I20220630" decimals="-5" name="us-gaap:OperatingLeaseRightOfUseAsset" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmFlNWE5YmUwZWI5NDQ1ZDE5MmZhZTgyMmQyMmJlMDlmL3NlYzphZTVhOWJlMGViOTQ0NWQxOTJmYWU4MjJkMjJiZTA5Zl81NS9mcmFnOjgzZWFhMzRhOThhOTQ3YWQ4ZDYzODA0Nzc5NGYxYjhmL3RleHRyZWdpb246ODNlYWEzNGE5OGE5NDdhZDhkNjM4MDQ3Nzk0ZjFiOGZfMzM5NA_e65f907d-1bf0-4c14-8ea3-f6f5bef894d3">5.7</ix:nonFraction></ix:nonFraction> million associated with the first phase. During the three months ended March 31, 2022, the lease for the second phase of the Company&#8217;s corporate headquarters commenced and the Company capitalized a right of use asset and related lease liability of $<ix:nonFraction unitRef="usd" contextRef="i75aabbdde1174af48e324feb000a8af2_I20220331" decimals="-5" name="us-gaap:OperatingLeaseLiability" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmFlNWE5YmUwZWI5NDQ1ZDE5MmZhZTgyMmQyMmJlMDlmL3NlYzphZTVhOWJlMGViOTQ0NWQxOTJmYWU4MjJkMjJiZTA5Zl81NS9mcmFnOjgzZWFhMzRhOThhOTQ3YWQ4ZDYzODA0Nzc5NGYxYjhmL3RleHRyZWdpb246ODNlYWEzNGE5OGE5NDdhZDhkNjM4MDQ3Nzk0ZjFiOGZfMTY0OTI2NzQ5Njg5Mw_608e87ce-970b-4e87-bc7c-44ac908c9bee"><ix:nonFraction unitRef="usd" contextRef="i75aabbdde1174af48e324feb000a8af2_I20220331" decimals="-5" name="us-gaap:OperatingLeaseRightOfUseAsset" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmFlNWE5YmUwZWI5NDQ1ZDE5MmZhZTgyMmQyMmJlMDlmL3NlYzphZTVhOWJlMGViOTQ0NWQxOTJmYWU4MjJkMjJiZTA5Zl81NS9mcmFnOjgzZWFhMzRhOThhOTQ3YWQ4ZDYzODA0Nzc5NGYxYjhmL3RleHRyZWdpb246ODNlYWEzNGE5OGE5NDdhZDhkNjM4MDQ3Nzk0ZjFiOGZfMTY0OTI2NzQ5Njg5Mw_9dfb6908-0bd9-499b-934b-1d7e8d098bf5">15.8</ix:nonFraction></ix:nonFraction>&#160;million. The extension option periods were not considered in the determination of the right-of-use asset or the lease liability as the Company did not consider it reasonably certain that it would exercise such extension options. </span></div></ix:continuation><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">20</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:45pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#iae5a9be0eb9445d192fae822d22be09f_7">Table of Contents</a></span></div></div><ix:continuation id="i38f597c360a446098694a56850d5fa59" continuedAt="i031426c933354ccd8c8eb2177d259e54"><div style="margin-top:15pt;padding-left:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Del Mar Lease Amendments</span></div><div style="margin-top:9pt;padding-left:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">During April 2022, the Company amended the Del Mar Lease through the execution of the First Amendment to Office Lease (the "First Amendment") and the Second Amendment to Office Lease (the "Second Amendment") (collectively, the "Del Mar Lease Amendments"). Pursuant to the First Amendment to the Del Mar Lease, the Company elected to utilize a one-time increase in an additional improvement allowance of $<ix:nonFraction unitRef="usdPerSqft" contextRef="i9841b134190d454987c9c0ed787bc2e8_D20220401-20220430" decimals="2" name="dmtk:IncreaseInTenantImprovementAllowancePerRentableSquareFoot" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmFlNWE5YmUwZWI5NDQ1ZDE5MmZhZTgyMmQyMmJlMDlmL3NlYzphZTVhOWJlMGViOTQ0NWQxOTJmYWU4MjJkMjJiZTA5Zl81NS9mcmFnOjgzZWFhMzRhOThhOTQ3YWQ4ZDYzODA0Nzc5NGYxYjhmL3RleHRyZWdpb246ODNlYWEzNGE5OGE5NDdhZDhkNjM4MDQ3Nzk0ZjFiOGZfMjE5OTAyMzMxMTUyNQ_a5120e21-7f29-4d6a-8ede-69076c2aecdc">25.00</ix:nonFraction> per rentable square foot, which increased the tenant improvement allowance by $<ix:nonFraction unitRef="usd" contextRef="i9841b134190d454987c9c0ed787bc2e8_D20220401-20220430" decimals="-5" name="dmtk:IncreaseInTenantImprovementAllowance" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmFlNWE5YmUwZWI5NDQ1ZDE5MmZhZTgyMmQyMmJlMDlmL3NlYzphZTVhOWJlMGViOTQ0NWQxOTJmYWU4MjJkMjJiZTA5Zl81NS9mcmFnOjgzZWFhMzRhOThhOTQ3YWQ4ZDYzODA0Nzc5NGYxYjhmL3RleHRyZWdpb246ODNlYWEzNGE5OGE5NDdhZDhkNjM4MDQ3Nzk0ZjFiOGZfMTY0OTI2NzQ5NzU3MQ_d1c2c76f-6400-421d-b169-6545d0dcdb1b">2.4</ix:nonFraction> million to $<ix:nonFraction unitRef="usd" contextRef="i87140271b1e742e28e8d60cec9e90bf4_I20220430" decimals="-5" name="us-gaap:TenantImprovements" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmFlNWE5YmUwZWI5NDQ1ZDE5MmZhZTgyMmQyMmJlMDlmL3NlYzphZTVhOWJlMGViOTQ0NWQxOTJmYWU4MjJkMjJiZTA5Zl81NS9mcmFnOjgzZWFhMzRhOThhOTQ3YWQ4ZDYzODA0Nzc5NGYxYjhmL3RleHRyZWdpb246ODNlYWEzNGE5OGE5NDdhZDhkNjM4MDQ3Nzk0ZjFiOGZfMjE5OTAyMzMxMTg5OQ_18f7d991-2ee1-4aa0-aaf5-01b211a998d0">14.4</ix:nonFraction> million, provided under the Del Mar Lease to make certain improvements to the Entire Premises. As a result, the Company will pay an increased monthly base rent to the Landlord, in order to repay costs relating to the additional design and construction. Pursuant to the Second Amendment to the Del Mar Lease, the Company elected to expand the Entire Premises to include <ix:nonFraction unitRef="sqft" contextRef="if757ed00e77b443b929b902040ede6fe_D20220422-20220422" decimals="INF" name="dmtk:RentableAndUsableSquareFeet" format="ixt:num-dot-decimal" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmFlNWE5YmUwZWI5NDQ1ZDE5MmZhZTgyMmQyMmJlMDlmL3NlYzphZTVhOWJlMGViOTQ0NWQxOTJmYWU4MjJkMjJiZTA5Zl81NS9mcmFnOjgzZWFhMzRhOThhOTQ3YWQ4ZDYzODA0Nzc5NGYxYjhmL3RleHRyZWdpb246ODNlYWEzNGE5OGE5NDdhZDhkNjM4MDQ3Nzk0ZjFiOGZfMTY0OTI2NzQ4MDEwNA_dc8de15d-bf6d-424c-9857-9e1d0319782e">14,085</ix:nonFraction> rentable square feet comprising the executive parking level (the &#8220;Expansion Premises&#8221;), which increased the tenant improvement allowance by $<ix:nonFraction unitRef="usd" contextRef="if757ed00e77b443b929b902040ede6fe_D20220422-20220422" decimals="-5" name="dmtk:IncreaseInTenantImprovementAllowance" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmFlNWE5YmUwZWI5NDQ1ZDE5MmZhZTgyMmQyMmJlMDlmL3NlYzphZTVhOWJlMGViOTQ0NWQxOTJmYWU4MjJkMjJiZTA5Zl81NS9mcmFnOjgzZWFhMzRhOThhOTQ3YWQ4ZDYzODA0Nzc5NGYxYjhmL3RleHRyZWdpb246ODNlYWEzNGE5OGE5NDdhZDhkNjM4MDQ3Nzk0ZjFiOGZfMjE5OTAyMzMxMTc5Nw_1ede8b3d-3948-46bd-be07-007a29e29e88">2.1</ix:nonFraction> million to $<ix:nonFraction unitRef="usd" contextRef="i21d961efb50e46f8a491229d676e3cca_I20220430" decimals="-5" name="us-gaap:TenantImprovements" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmFlNWE5YmUwZWI5NDQ1ZDE5MmZhZTgyMmQyMmJlMDlmL3NlYzphZTVhOWJlMGViOTQ0NWQxOTJmYWU4MjJkMjJiZTA5Zl81NS9mcmFnOjgzZWFhMzRhOThhOTQ3YWQ4ZDYzODA0Nzc5NGYxYjhmL3RleHRyZWdpb246ODNlYWEzNGE5OGE5NDdhZDhkNjM4MDQ3Nzk0ZjFiOGZfMjE5OTAyMzMxMTgwNw_83878af4-2a4a-4ee6-bdbc-637a3a6fa720">16.5</ix:nonFraction> million. The Landlord will tender possession of the Expansion Premises following substantial completion of improvements, pursuant to an agreed upon work letter and will run contemporaneously with the term of the Existing Premises. The Company intends to use the additional space for general office and laboratory use. As the Landlord tenders possession of the Expansion Premises, the Company will be obligated to pay the Landlord increased monthly installments of base rent for the Expansion Premises. Upon inclusion of the Expansion Premises, the Company will lease approximately <ix:nonFraction unitRef="sqft" contextRef="i31c7d90c2ed74429be6d97f4216d8b3b_D20220422-20220422" decimals="INF" name="dmtk:AreaOfBuilding" format="ixt:num-dot-decimal" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmFlNWE5YmUwZWI5NDQ1ZDE5MmZhZTgyMmQyMmJlMDlmL3NlYzphZTVhOWJlMGViOTQ0NWQxOTJmYWU4MjJkMjJiZTA5Zl81NS9mcmFnOjgzZWFhMzRhOThhOTQ3YWQ4ZDYzODA0Nzc5NGYxYjhmL3RleHRyZWdpb246ODNlYWEzNGE5OGE5NDdhZDhkNjM4MDQ3Nzk0ZjFiOGZfMTY0OTI2NzQ4MDA3Ng_d86f071d-2913-41b0-8650-fb7901bccb28">110,082</ix:nonFraction> rentable square feet rentable square feet from the Landlord (the &#8220;New Entire Premises&#8221;). </span></div><div style="margin-top:9pt;padding-left:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company evaluated the Del Mar Lease Amendments under ASC 842 and concluded that the Del Mar Lease Amendments would be accounted for as a single contract with the Del Mar Lease because the additional lease payments due to the Del Mar Lease Amendments were not commensurate with ROU asset granted to the Company. Accordingly, the Company remeasured the lease liability using the additional monthly rent payments and the incremental borrowing rate at the effective date of the modification of <ix:nonFraction unitRef="number" contextRef="i40b956e3abae4c74a57f8271e4e2cc81_I20220430" decimals="4" name="dmtk:OperatingLeaseIncrementalBorrowingRateAtEffectiveDate" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOmFlNWE5YmUwZWI5NDQ1ZDE5MmZhZTgyMmQyMmJlMDlmL3NlYzphZTVhOWJlMGViOTQ0NWQxOTJmYWU4MjJkMjJiZTA5Zl81NS9mcmFnOjgzZWFhMzRhOThhOTQ3YWQ4ZDYzODA0Nzc5NGYxYjhmL3RleHRyZWdpb246ODNlYWEzNGE5OGE5NDdhZDhkNjM4MDQ3Nzk0ZjFiOGZfMTY0OTI2NzQ5NTY2OA_aebe7a2a-1e32-4eed-a165-f7eceaa0d770">6.50</ix:nonFraction>%. The remeasurement for the modification resulted in an increase to the lease liability and the ROU asset of approximately $<ix:nonFraction unitRef="usd" contextRef="iefc8a51c0ee64a2e92b3f718d0d8914b_D20220401-20220430" decimals="-5" name="us-gaap:IncreaseDecreaseInOperatingLeaseLiability" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmFlNWE5YmUwZWI5NDQ1ZDE5MmZhZTgyMmQyMmJlMDlmL3NlYzphZTVhOWJlMGViOTQ0NWQxOTJmYWU4MjJkMjJiZTA5Zl81NS9mcmFnOjgzZWFhMzRhOThhOTQ3YWQ4ZDYzODA0Nzc5NGYxYjhmL3RleHRyZWdpb246ODNlYWEzNGE5OGE5NDdhZDhkNjM4MDQ3Nzk0ZjFiOGZfMTY0OTI2NzQ5NTY4Nw_26d78d1f-c6d9-4030-8821-26c57dcd3fa0"><ix:nonFraction unitRef="usd" contextRef="iefc8a51c0ee64a2e92b3f718d0d8914b_D20220401-20220430" decimals="-5" name="dmtk:IncreaseDecreaseInOperatingLeaseRightOfUseAsset" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmFlNWE5YmUwZWI5NDQ1ZDE5MmZhZTgyMmQyMmJlMDlmL3NlYzphZTVhOWJlMGViOTQ0NWQxOTJmYWU4MjJkMjJiZTA5Zl81NS9mcmFnOjgzZWFhMzRhOThhOTQ3YWQ4ZDYzODA0Nzc5NGYxYjhmL3RleHRyZWdpb246ODNlYWEzNGE5OGE5NDdhZDhkNjM4MDQ3Nzk0ZjFiOGZfMTY0OTI2NzQ5NTY4Nw_f415a3a9-6ed0-445a-abaa-90bcfc1f1f2d">1.2</ix:nonFraction></ix:nonFraction> million. </span></div><div style="margin-top:9pt;padding-left:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The extension option periods were not considered in the determination of the right-of-use asset or the lease liability as the Company did not consider it reasonably certain that it would exercise such extension options. Pending execution of the Landlord's obligations to prepare leased spaces for occupancy, the Company expects the operating leases for the additional office and laboratory space to commence on various dates in the year ending December 31, 2022. The Company has an estimated future lease payment obligation of approximately $<ix:nonFraction unitRef="usd" contextRef="i53405b48f5954e23b556c40be1389d0c_I20220630" decimals="-5" name="us-gaap:LesseeOperatingLeaseLiabilityPaymentsDue" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmFlNWE5YmUwZWI5NDQ1ZDE5MmZhZTgyMmQyMmJlMDlmL3NlYzphZTVhOWJlMGViOTQ0NWQxOTJmYWU4MjJkMjJiZTA5Zl81NS9mcmFnOjgzZWFhMzRhOThhOTQ3YWQ4ZDYzODA0Nzc5NGYxYjhmL3RleHRyZWdpb246ODNlYWEzNGE5OGE5NDdhZDhkNjM4MDQ3Nzk0ZjFiOGZfMzk3MQ_ee35bd24-00ae-410b-b3e1-72f7e8e3f9d8">54.4</ix:nonFraction> million related to corporate office facilities that were in the process of being constructed as of June&#160;30, 2022. The lease liabilities and the corresponding right-of-use assets associated with these lease obligations will be recorded upon the commencement date of the operating leases using the Company&#8217;s incremental borrowing rate based on the information available at commencement date in determining the present value of lease payments. The incremental borrowing rate is the rate of interest that a lessee would have to pay to borrow on a collateralized basis over a similar term and at an amount equal to the lease payments in a similar economic environment. The Company calculates its incremental borrowing rates for specific lease terms, used to discount future lease payments, as a function of the U.S. Treasury rate and an indicative Moody&#8217;s rating for operating leases.</span></div><div style="margin-top:9pt;padding-left:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In connection with the original lease agreement, in lieu of a cash security deposit, the Company&#8217;s bank issued a letter of credit on its behalf, which is secured by a deposit, of $<ix:nonFraction unitRef="usd" contextRef="i2d28646a716649a3bf03b33932b88ddc_I20220630" decimals="-5" name="us-gaap:RestrictedCashAndCashEquivalents" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmFlNWE5YmUwZWI5NDQ1ZDE5MmZhZTgyMmQyMmJlMDlmL3NlYzphZTVhOWJlMGViOTQ0NWQxOTJmYWU4MjJkMjJiZTA5Zl81NS9mcmFnOjgzZWFhMzRhOThhOTQ3YWQ4ZDYzODA0Nzc5NGYxYjhmL3RleHRyZWdpb246ODNlYWEzNGE5OGE5NDdhZDhkNjM4MDQ3Nzk0ZjFiOGZfNDQxNg_a53f132e-2031-462a-81f1-914e8ef8198d">3.0</ix:nonFraction> million and is included in restricted cash on the condensed consolidated balance sheet based on the term of the underlying lease. In April 2022, pursuant to the Second Amendment</span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">, </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">the Company&#8217;s bank increased the letter of credit on its behalf</span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> by $<ix:nonFraction unitRef="usd" contextRef="i5c5f906de07546fbad68db3bc16af2da_D20220401-20220430" decimals="-5" name="dmtk:RestrictedCashAndCashEquivalentsIncreaseDecrease" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmFlNWE5YmUwZWI5NDQ1ZDE5MmZhZTgyMmQyMmJlMDlmL3NlYzphZTVhOWJlMGViOTQ0NWQxOTJmYWU4MjJkMjJiZTA5Zl81NS9mcmFnOjgzZWFhMzRhOThhOTQ3YWQ4ZDYzODA0Nzc5NGYxYjhmL3RleHRyZWdpb246ODNlYWEzNGE5OGE5NDdhZDhkNjM4MDQ3Nzk0ZjFiOGZfMTY0OTI2NzQ5NTEwMA_460aa295-18f3-4b8d-aa76-db8a41f094e8">0.5</ix:nonFraction> million, totaling $<ix:nonFraction unitRef="usd" contextRef="ie106f93322ee42508b7a8c0522c1e6f8_I20220430" decimals="-5" name="us-gaap:RestrictedCashAndCashEquivalents" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmFlNWE5YmUwZWI5NDQ1ZDE5MmZhZTgyMmQyMmJlMDlmL3NlYzphZTVhOWJlMGViOTQ0NWQxOTJmYWU4MjJkMjJiZTA5Zl81NS9mcmFnOjgzZWFhMzRhOThhOTQ3YWQ4ZDYzODA0Nzc5NGYxYjhmL3RleHRyZWdpb246ODNlYWEzNGE5OGE5NDdhZDhkNjM4MDQ3Nzk0ZjFiOGZfMTY0OTI2NzQ5NTExNw_1a007871-f7ea-4760-a68b-f270972879d4">3.5</ix:nonFraction> million. </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">As of June&#160;30, 2022, <ix:nonFraction unitRef="usd" contextRef="ie247503b8ef34dcca0fca78fe783bff5_I20220630" decimals="INF" name="us-gaap:RestrictedCashAndCashEquivalents" format="ixt:fixed-zero" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmFlNWE5YmUwZWI5NDQ1ZDE5MmZhZTgyMmQyMmJlMDlmL3NlYzphZTVhOWJlMGViOTQ0NWQxOTJmYWU4MjJkMjJiZTA5Zl81NS9mcmFnOjgzZWFhMzRhOThhOTQ3YWQ4ZDYzODA0Nzc5NGYxYjhmL3RleHRyZWdpb246ODNlYWEzNGE5OGE5NDdhZDhkNjM4MDQ3Nzk0ZjFiOGZfNDU1MQ_0a2fb0b4-d097-4341-aa65-f5030c7c96d1">none</ix:nonFraction> of the standby letter of credit amount has been used.</span></div></ix:continuation><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">21</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:45pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#iae5a9be0eb9445d192fae822d22be09f_7">Table of Contents</a></span></div></div><ix:continuation id="i031426c933354ccd8c8eb2177d259e54" continuedAt="i46f0312b405a49a5afc582e0f0fe4084"><div style="margin-top:15pt;padding-left:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Torrey Pines Lease</span></div><div style="margin-top:9pt;padding-left:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In January&#160;2013, DermTech Operations entered into a non-cancelable lease agreement for its operating facilities in Torrey Pines (the &#8220;Torrey Lease&#8221;). In January&#160;2014, DermTech Operations signed an amendment to the Torrey Lease to extend the term through January&#160;2017. In November&#160;2016, DermTech Operations signed a second amendment to the Torrey Lease to extend the term through March&#160;2022. In August 2019, DermTech Operations signed a third amendment to the Torrey Lease to add additional space, and in September 2019, the Company signed a fourth amendment to the Torrey Lease to add additional space. In February 2020, the Company signed a fifth amendment to the Torrey Lease to add additional space. In connection with the Business Combination, the Company assumed all obligations under the Torrey Lease, as amended, from DermTech Operations. As part of the fifth amendment, the Company was entitled to a tenant improvement allowance for certain costs incurred while performing these improvements in the amount of $<ix:nonFraction unitRef="usd" contextRef="i4c8f247d12134a9886d56e1c8b024425_I20220630" decimals="-5" name="dmtk:TenantImprovementAllowance" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmFlNWE5YmUwZWI5NDQ1ZDE5MmZhZTgyMmQyMmJlMDlmL3NlYzphZTVhOWJlMGViOTQ0NWQxOTJmYWU4MjJkMjJiZTA5Zl81NS9mcmFnOjgzZWFhMzRhOThhOTQ3YWQ4ZDYzODA0Nzc5NGYxYjhmL3RleHRyZWdpb246ODNlYWEzNGE5OGE5NDdhZDhkNjM4MDQ3Nzk0ZjFiOGZfNDgwNQ_d25dded1-54f9-4ef6-961c-6493022c29ba">0.3</ix:nonFraction> million, which amount may be increased by up to $<ix:nonFraction unitRef="usd" contextRef="i9069aff5693b479db8eb460a09c920a0_D20220101-20220630" decimals="-5" name="dmtk:IncreaseInTenantImprovementAllowance" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmFlNWE5YmUwZWI5NDQ1ZDE5MmZhZTgyMmQyMmJlMDlmL3NlYzphZTVhOWJlMGViOTQ0NWQxOTJmYWU4MjJkMjJiZTA5Zl81NS9mcmFnOjgzZWFhMzRhOThhOTQ3YWQ4ZDYzODA0Nzc5NGYxYjhmL3RleHRyZWdpb246ODNlYWEzNGE5OGE5NDdhZDhkNjM4MDQ3Nzk0ZjFiOGZfNDg0OA_0d4e7911-0139-4ff4-84d4-bf433d1380f5">0.1</ix:nonFraction> million at the Company&#8217;s election and subject to a corresponding increase in rent. Under the terms of the facilities leases, the Company is required to pay its proportionate share of property taxes, insurance and normal maintenance costs.</span></div><div style="margin-top:9pt;padding-left:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The lease term for all leased space has an expiration date of April&#160;30, 2023, and an option to extend the lease term on all leased space for <ix:nonFraction unitRef="period" contextRef="i4c8f247d12134a9886d56e1c8b024425_I20220630" decimals="INF" name="dmtk:LesseeOperatingLeaseNumberOfRenewalTerms" format="ixt-sec:numwordsen" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmFlNWE5YmUwZWI5NDQ1ZDE5MmZhZTgyMmQyMmJlMDlmL3NlYzphZTVhOWJlMGViOTQ0NWQxOTJmYWU4MjJkMjJiZTA5Zl81NS9mcmFnOjgzZWFhMzRhOThhOTQ3YWQ4ZDYzODA0Nzc5NGYxYjhmL3RleHRyZWdpb246ODNlYWEzNGE5OGE5NDdhZDhkNjM4MDQ3Nzk0ZjFiOGZfNTQ5NzU1ODY5MjUz_a2d8eaf5-659c-4a63-8f0c-7a914bcd3954">one</ix:nonFraction> additional <ix:nonNumeric contextRef="i4c8f247d12134a9886d56e1c8b024425_I20220630" name="us-gaap:LesseeOperatingLeaseRenewalTerm" format="ixt-sec:durwordsen" id="id3VybDovL2RvY3MudjEvZG9jOmFlNWE5YmUwZWI5NDQ1ZDE5MmZhZTgyMmQyMmJlMDlmL3NlYzphZTVhOWJlMGViOTQ0NWQxOTJmYWU4MjJkMjJiZTA5Zl81NS9mcmFnOjgzZWFhMzRhOThhOTQ3YWQ4ZDYzODA0Nzc5NGYxYjhmL3RleHRyZWdpb246ODNlYWEzNGE5OGE5NDdhZDhkNjM4MDQ3Nzk0ZjFiOGZfMzI5ODUzNDkzODczMg_1362d7dd-e61b-4a93-8894-17753d07f765">three-year</ix:nonNumeric> term, which the Company is not reasonably certain that it will exercise. As such, the Company did not include this option in the determination of the total lease term. On January 1, 2021, in conjunction with the adoption of the guidance in ASU 2016-02, the Company recognized a right-of-use asset and corresponding lease liability for its facility lease as the present value of lease payments not yet paid at January 1, 2021. The right-of-use asset and corresponding lease liability was estimated assuming the remaining lease term of <ix:nonNumeric contextRef="i4976bcc83f7e4c978a094cc7482066ef_I20210101" name="us-gaap:LesseeOperatingLeaseRemainingLeaseTerm" format="ixt-sec:durmonth" id="id3VybDovL2RvY3MudjEvZG9jOmFlNWE5YmUwZWI5NDQ1ZDE5MmZhZTgyMmQyMmJlMDlmL3NlYzphZTVhOWJlMGViOTQ0NWQxOTJmYWU4MjJkMjJiZTA5Zl81NS9mcmFnOjgzZWFhMzRhOThhOTQ3YWQ4ZDYzODA0Nzc5NGYxYjhmL3RleHRyZWdpb246ODNlYWEzNGE5OGE5NDdhZDhkNjM4MDQ3Nzk0ZjFiOGZfNTY4NA_137cb891-8509-46ef-b78a-472bb7751168">28</ix:nonNumeric> months at January&#160;1, 2021, and an estimated discount rate of <ix:nonFraction unitRef="number" contextRef="i4976bcc83f7e4c978a094cc7482066ef_I20210101" decimals="2" name="us-gaap:LesseeOperatingLeaseDiscountRate" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmFlNWE5YmUwZWI5NDQ1ZDE5MmZhZTgyMmQyMmJlMDlmL3NlYzphZTVhOWJlMGViOTQ0NWQxOTJmYWU4MjJkMjJiZTA5Zl81NS9mcmFnOjgzZWFhMzRhOThhOTQ3YWQ4ZDYzODA0Nzc5NGYxYjhmL3RleHRyZWdpb246ODNlYWEzNGE5OGE5NDdhZDhkNjM4MDQ3Nzk0ZjFiOGZfNTcyOA_2d959b2b-5e43-4e58-9efd-f58a8941fc81">4.04</ix:nonFraction>%, which was the Company&#8217;s incremental borrowing rate at the date of adopting ASC 842. The Company recorded a lease liability of $<ix:nonFraction unitRef="usd" contextRef="i4976bcc83f7e4c978a094cc7482066ef_I20210101" decimals="-5" name="us-gaap:OperatingLeaseLiability" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmFlNWE5YmUwZWI5NDQ1ZDE5MmZhZTgyMmQyMmJlMDlmL3NlYzphZTVhOWJlMGViOTQ0NWQxOTJmYWU4MjJkMjJiZTA5Zl81NS9mcmFnOjgzZWFhMzRhOThhOTQ3YWQ4ZDYzODA0Nzc5NGYxYjhmL3RleHRyZWdpb246ODNlYWEzNGE5OGE5NDdhZDhkNjM4MDQ3Nzk0ZjFiOGZfNTg1OA_d02bc1fa-2d19-4283-88f7-af4a3cba1b5c">3.1</ix:nonFraction> million and a right-of-use asset of $<ix:nonFraction unitRef="usd" contextRef="i4976bcc83f7e4c978a094cc7482066ef_I20210101" decimals="-5" name="us-gaap:OperatingLeaseRightOfUseAsset" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmFlNWE5YmUwZWI5NDQ1ZDE5MmZhZTgyMmQyMmJlMDlmL3NlYzphZTVhOWJlMGViOTQ0NWQxOTJmYWU4MjJkMjJiZTA5Zl81NS9mcmFnOjgzZWFhMzRhOThhOTQ3YWQ4ZDYzODA0Nzc5NGYxYjhmL3RleHRyZWdpb246ODNlYWEzNGE5OGE5NDdhZDhkNjM4MDQ3Nzk0ZjFiOGZfNTg4OQ_ac125831-4e1b-4205-a0b6-297514eb2fdb">2.8</ix:nonFraction> million, which is net of $<ix:nonFraction unitRef="usd" contextRef="i4976bcc83f7e4c978a094cc7482066ef_I20210101" decimals="-5" name="dmtk:TenantImprovementAllowance" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmFlNWE5YmUwZWI5NDQ1ZDE5MmZhZTgyMmQyMmJlMDlmL3NlYzphZTVhOWJlMGViOTQ0NWQxOTJmYWU4MjJkMjJiZTA5Zl81NS9mcmFnOjgzZWFhMzRhOThhOTQ3YWQ4ZDYzODA0Nzc5NGYxYjhmL3RleHRyZWdpb246ODNlYWEzNGE5OGE5NDdhZDhkNjM4MDQ3Nzk0ZjFiOGZfNTkwOQ_d714b81e-fafd-4362-9b97-a4b73369a980">0.3</ix:nonFraction> million of the Company&#8217;s previously capitalized tenant improvement allowance and deferred rent, upon adoption.</span></div><ix:nonNumeric contextRef="ia855382ada1f4f28aa8ef6da692ff177_D20220101-20220630" name="us-gaap:LeaseCostTableTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOmFlNWE5YmUwZWI5NDQ1ZDE5MmZhZTgyMmQyMmJlMDlmL3NlYzphZTVhOWJlMGViOTQ0NWQxOTJmYWU4MjJkMjJiZTA5Zl81NS9mcmFnOjgzZWFhMzRhOThhOTQ3YWQ4ZDYzODA0Nzc5NGYxYjhmL3RleHRyZWdpb246ODNlYWEzNGE5OGE5NDdhZDhkNjM4MDQ3Nzk0ZjFiOGZfODM5MQ_06ca15be-bb10-4bfc-b41f-3e812d36fc7f" continuedAt="ie174567d895b415a8fb7eb9c46d1dfc5" escape="true"><div style="margin-top:9pt;padding-left:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The components of lease expense for the three and six months ended June&#160;30, 2022 was as follows (in thousands):</span></div><div style="margin-top:12pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:43.803%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.750%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.390%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.750%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.390%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.750%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.390%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:13.677%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Three Months Ended June 30,</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Six Months Ended June 30,</span></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2021</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Operating lease cost</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 10pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Operating lease cost</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i2c5f0f28773744e5a2e202f2943ae976_D20220401-20220630" decimals="-3" name="us-gaap:OperatingLeaseCost" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmFlNWE5YmUwZWI5NDQ1ZDE5MmZhZTgyMmQyMmJlMDlmL3NlYzphZTVhOWJlMGViOTQ0NWQxOTJmYWU4MjJkMjJiZTA5Zl81NS9mcmFnOjgzZWFhMzRhOThhOTQ3YWQ4ZDYzODA0Nzc5NGYxYjhmL3RhYmxlOmY3NGQzNDMwOWUyMDQxOTY4MzJkNTAwMDc1YWFlZjBmL3RhYmxlcmFuZ2U6Zjc0ZDM0MzA5ZTIwNDE5NjgzMmQ1MDAwNzVhYWVmMGZfMi0xLTEtMS02MjY_c3bcc578-6391-4769-ada3-7d4c3fbcb18a">1,044</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="id7bb773872394047ba26aa8a7a0f4d56_D20210401-20210630" decimals="-3" name="us-gaap:OperatingLeaseCost" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmFlNWE5YmUwZWI5NDQ1ZDE5MmZhZTgyMmQyMmJlMDlmL3NlYzphZTVhOWJlMGViOTQ0NWQxOTJmYWU4MjJkMjJiZTA5Zl81NS9mcmFnOjgzZWFhMzRhOThhOTQ3YWQ4ZDYzODA0Nzc5NGYxYjhmL3RhYmxlOmY3NGQzNDMwOWUyMDQxOTY4MzJkNTAwMDc1YWFlZjBmL3RhYmxlcmFuZ2U6Zjc0ZDM0MzA5ZTIwNDE5NjgzMmQ1MDAwNzVhYWVmMGZfMi0zLTEtMS02MjY_9aa25943-ed98-44f8-8d98-7927ef943bd2">319</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ia855382ada1f4f28aa8ef6da692ff177_D20220101-20220630" decimals="-3" name="us-gaap:OperatingLeaseCost" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmFlNWE5YmUwZWI5NDQ1ZDE5MmZhZTgyMmQyMmJlMDlmL3NlYzphZTVhOWJlMGViOTQ0NWQxOTJmYWU4MjJkMjJiZTA5Zl81NS9mcmFnOjgzZWFhMzRhOThhOTQ3YWQ4ZDYzODA0Nzc5NGYxYjhmL3RhYmxlOmY3NGQzNDMwOWUyMDQxOTY4MzJkNTAwMDc1YWFlZjBmL3RhYmxlcmFuZ2U6Zjc0ZDM0MzA5ZTIwNDE5NjgzMmQ1MDAwNzVhYWVmMGZfMy01LTEtMS0zMDc4_d1dfd3f9-7226-4b58-9037-3a2ee76fbee0">1,667</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="idaa4f31ca59a4a17a59c2580b97791ca_D20210101-20210630" decimals="-3" name="us-gaap:OperatingLeaseCost" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmFlNWE5YmUwZWI5NDQ1ZDE5MmZhZTgyMmQyMmJlMDlmL3NlYzphZTVhOWJlMGViOTQ0NWQxOTJmYWU4MjJkMjJiZTA5Zl81NS9mcmFnOjgzZWFhMzRhOThhOTQ3YWQ4ZDYzODA0Nzc5NGYxYjhmL3RhYmxlOmY3NGQzNDMwOWUyMDQxOTY4MzJkNTAwMDc1YWFlZjBmL3RhYmxlcmFuZ2U6Zjc0ZDM0MzA5ZTIwNDE5NjgzMmQ1MDAwNzVhYWVmMGZfMy03LTEtMS0zMDc4_4d062333-5ddc-4729-b93d-8988c5d84314">638</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Variable lease costs </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.85pt;font-weight:400;line-height:100%;position:relative;top:-3.15pt;vertical-align:baseline">(1)</span></div></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i2c5f0f28773744e5a2e202f2943ae976_D20220401-20220630" decimals="-3" name="us-gaap:VariableLeaseCost" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmFlNWE5YmUwZWI5NDQ1ZDE5MmZhZTgyMmQyMmJlMDlmL3NlYzphZTVhOWJlMGViOTQ0NWQxOTJmYWU4MjJkMjJiZTA5Zl81NS9mcmFnOjgzZWFhMzRhOThhOTQ3YWQ4ZDYzODA0Nzc5NGYxYjhmL3RhYmxlOmY3NGQzNDMwOWUyMDQxOTY4MzJkNTAwMDc1YWFlZjBmL3RhYmxlcmFuZ2U6Zjc0ZDM0MzA5ZTIwNDE5NjgzMmQ1MDAwNzVhYWVmMGZfMy0xLTEtMS02MjY_3c140478-80a5-4a9c-9886-196d183e38ac">303</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="id7bb773872394047ba26aa8a7a0f4d56_D20210401-20210630" decimals="-3" name="us-gaap:VariableLeaseCost" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmFlNWE5YmUwZWI5NDQ1ZDE5MmZhZTgyMmQyMmJlMDlmL3NlYzphZTVhOWJlMGViOTQ0NWQxOTJmYWU4MjJkMjJiZTA5Zl81NS9mcmFnOjgzZWFhMzRhOThhOTQ3YWQ4ZDYzODA0Nzc5NGYxYjhmL3RhYmxlOmY3NGQzNDMwOWUyMDQxOTY4MzJkNTAwMDc1YWFlZjBmL3RhYmxlcmFuZ2U6Zjc0ZDM0MzA5ZTIwNDE5NjgzMmQ1MDAwNzVhYWVmMGZfMy0zLTEtMS02MjY_a9aeaa28-5e95-417f-93ba-f527edabc98b">143</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ia855382ada1f4f28aa8ef6da692ff177_D20220101-20220630" decimals="-3" name="us-gaap:VariableLeaseCost" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmFlNWE5YmUwZWI5NDQ1ZDE5MmZhZTgyMmQyMmJlMDlmL3NlYzphZTVhOWJlMGViOTQ0NWQxOTJmYWU4MjJkMjJiZTA5Zl81NS9mcmFnOjgzZWFhMzRhOThhOTQ3YWQ4ZDYzODA0Nzc5NGYxYjhmL3RhYmxlOmY3NGQzNDMwOWUyMDQxOTY4MzJkNTAwMDc1YWFlZjBmL3RhYmxlcmFuZ2U6Zjc0ZDM0MzA5ZTIwNDE5NjgzMmQ1MDAwNzVhYWVmMGZfNC01LTEtMS0zMDc4_579c9e65-e03d-41d2-9a7c-eb48fb9b6b41">492</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="idaa4f31ca59a4a17a59c2580b97791ca_D20210101-20210630" decimals="-3" name="us-gaap:VariableLeaseCost" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmFlNWE5YmUwZWI5NDQ1ZDE5MmZhZTgyMmQyMmJlMDlmL3NlYzphZTVhOWJlMGViOTQ0NWQxOTJmYWU4MjJkMjJiZTA5Zl81NS9mcmFnOjgzZWFhMzRhOThhOTQ3YWQ4ZDYzODA0Nzc5NGYxYjhmL3RhYmxlOmY3NGQzNDMwOWUyMDQxOTY4MzJkNTAwMDc1YWFlZjBmL3RhYmxlcmFuZ2U6Zjc0ZDM0MzA5ZTIwNDE5NjgzMmQ1MDAwNzVhYWVmMGZfNC03LTEtMS0zMDc4_b2099a5e-b12f-4212-9d45-a9a3395484e9">315</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Total operating lease cost</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i2c5f0f28773744e5a2e202f2943ae976_D20220401-20220630" decimals="-3" name="dmtk:OperatingLeaseCosts" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmFlNWE5YmUwZWI5NDQ1ZDE5MmZhZTgyMmQyMmJlMDlmL3NlYzphZTVhOWJlMGViOTQ0NWQxOTJmYWU4MjJkMjJiZTA5Zl81NS9mcmFnOjgzZWFhMzRhOThhOTQ3YWQ4ZDYzODA0Nzc5NGYxYjhmL3RhYmxlOmY3NGQzNDMwOWUyMDQxOTY4MzJkNTAwMDc1YWFlZjBmL3RhYmxlcmFuZ2U6Zjc0ZDM0MzA5ZTIwNDE5NjgzMmQ1MDAwNzVhYWVmMGZfNC0xLTEtMS02MjY_bb0764b3-75c7-432b-8199-b2eb16625616">1,347</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="id7bb773872394047ba26aa8a7a0f4d56_D20210401-20210630" decimals="-3" name="dmtk:OperatingLeaseCosts" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmFlNWE5YmUwZWI5NDQ1ZDE5MmZhZTgyMmQyMmJlMDlmL3NlYzphZTVhOWJlMGViOTQ0NWQxOTJmYWU4MjJkMjJiZTA5Zl81NS9mcmFnOjgzZWFhMzRhOThhOTQ3YWQ4ZDYzODA0Nzc5NGYxYjhmL3RhYmxlOmY3NGQzNDMwOWUyMDQxOTY4MzJkNTAwMDc1YWFlZjBmL3RhYmxlcmFuZ2U6Zjc0ZDM0MzA5ZTIwNDE5NjgzMmQ1MDAwNzVhYWVmMGZfNC0zLTEtMS02MjY_f5e898ad-2337-48a2-9249-7e762417bd91">462</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ia855382ada1f4f28aa8ef6da692ff177_D20220101-20220630" decimals="-3" name="dmtk:OperatingLeaseCosts" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmFlNWE5YmUwZWI5NDQ1ZDE5MmZhZTgyMmQyMmJlMDlmL3NlYzphZTVhOWJlMGViOTQ0NWQxOTJmYWU4MjJkMjJiZTA5Zl81NS9mcmFnOjgzZWFhMzRhOThhOTQ3YWQ4ZDYzODA0Nzc5NGYxYjhmL3RhYmxlOmY3NGQzNDMwOWUyMDQxOTY4MzJkNTAwMDc1YWFlZjBmL3RhYmxlcmFuZ2U6Zjc0ZDM0MzA5ZTIwNDE5NjgzMmQ1MDAwNzVhYWVmMGZfNS01LTEtMS0zMDc4_df1b772f-a390-458a-b738-5e3495398a1f">2,159</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="idaa4f31ca59a4a17a59c2580b97791ca_D20210101-20210630" decimals="-3" name="dmtk:OperatingLeaseCosts" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmFlNWE5YmUwZWI5NDQ1ZDE5MmZhZTgyMmQyMmJlMDlmL3NlYzphZTVhOWJlMGViOTQ0NWQxOTJmYWU4MjJkMjJiZTA5Zl81NS9mcmFnOjgzZWFhMzRhOThhOTQ3YWQ4ZDYzODA0Nzc5NGYxYjhmL3RhYmxlOmY3NGQzNDMwOWUyMDQxOTY4MzJkNTAwMDc1YWFlZjBmL3RhYmxlcmFuZ2U6Zjc0ZDM0MzA5ZTIwNDE5NjgzMmQ1MDAwNzVhYWVmMGZfNS03LTEtMS0zMDc4_6c66437b-2a26-4336-abe9-0d9ad888747a">953</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr style="height:15pt"><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Finance lease cost</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 10pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Amortization of leased assets</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i2c5f0f28773744e5a2e202f2943ae976_D20220401-20220630" decimals="-3" name="us-gaap:FinanceLeaseRightOfUseAssetAmortization" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmFlNWE5YmUwZWI5NDQ1ZDE5MmZhZTgyMmQyMmJlMDlmL3NlYzphZTVhOWJlMGViOTQ0NWQxOTJmYWU4MjJkMjJiZTA5Zl81NS9mcmFnOjgzZWFhMzRhOThhOTQ3YWQ4ZDYzODA0Nzc5NGYxYjhmL3RhYmxlOmY3NGQzNDMwOWUyMDQxOTY4MzJkNTAwMDc1YWFlZjBmL3RhYmxlcmFuZ2U6Zjc0ZDM0MzA5ZTIwNDE5NjgzMmQ1MDAwNzVhYWVmMGZfNy0xLTEtMS02MjY_bae6998b-cdf1-4493-9459-84d41fe11323">21</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="id7bb773872394047ba26aa8a7a0f4d56_D20210401-20210630" decimals="-3" name="us-gaap:FinanceLeaseRightOfUseAssetAmortization" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmFlNWE5YmUwZWI5NDQ1ZDE5MmZhZTgyMmQyMmJlMDlmL3NlYzphZTVhOWJlMGViOTQ0NWQxOTJmYWU4MjJkMjJiZTA5Zl81NS9mcmFnOjgzZWFhMzRhOThhOTQ3YWQ4ZDYzODA0Nzc5NGYxYjhmL3RhYmxlOmY3NGQzNDMwOWUyMDQxOTY4MzJkNTAwMDc1YWFlZjBmL3RhYmxlcmFuZ2U6Zjc0ZDM0MzA5ZTIwNDE5NjgzMmQ1MDAwNzVhYWVmMGZfNy0zLTEtMS02MjY_fd6edaa9-4205-44d2-a013-3bc80ae9441d">17</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ia855382ada1f4f28aa8ef6da692ff177_D20220101-20220630" decimals="-3" name="us-gaap:FinanceLeaseRightOfUseAssetAmortization" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmFlNWE5YmUwZWI5NDQ1ZDE5MmZhZTgyMmQyMmJlMDlmL3NlYzphZTVhOWJlMGViOTQ0NWQxOTJmYWU4MjJkMjJiZTA5Zl81NS9mcmFnOjgzZWFhMzRhOThhOTQ3YWQ4ZDYzODA0Nzc5NGYxYjhmL3RhYmxlOmY3NGQzNDMwOWUyMDQxOTY4MzJkNTAwMDc1YWFlZjBmL3RhYmxlcmFuZ2U6Zjc0ZDM0MzA5ZTIwNDE5NjgzMmQ1MDAwNzVhYWVmMGZfOC01LTEtMS0zMDky_7ef2a62f-1869-4e60-ad04-52b239ff2ab3">41</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="idaa4f31ca59a4a17a59c2580b97791ca_D20210101-20210630" decimals="-3" name="us-gaap:FinanceLeaseRightOfUseAssetAmortization" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmFlNWE5YmUwZWI5NDQ1ZDE5MmZhZTgyMmQyMmJlMDlmL3NlYzphZTVhOWJlMGViOTQ0NWQxOTJmYWU4MjJkMjJiZTA5Zl81NS9mcmFnOjgzZWFhMzRhOThhOTQ3YWQ4ZDYzODA0Nzc5NGYxYjhmL3RhYmxlOmY3NGQzNDMwOWUyMDQxOTY4MzJkNTAwMDc1YWFlZjBmL3RhYmxlcmFuZ2U6Zjc0ZDM0MzA5ZTIwNDE5NjgzMmQ1MDAwNzVhYWVmMGZfOC03LTEtMS0zMDky_ad5a1b3f-0eb2-4850-b686-8ec09d7f2594">34</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 10pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Interest on lease liabilities</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i2c5f0f28773744e5a2e202f2943ae976_D20220401-20220630" decimals="-3" name="us-gaap:FinanceLeaseInterestExpense" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmFlNWE5YmUwZWI5NDQ1ZDE5MmZhZTgyMmQyMmJlMDlmL3NlYzphZTVhOWJlMGViOTQ0NWQxOTJmYWU4MjJkMjJiZTA5Zl81NS9mcmFnOjgzZWFhMzRhOThhOTQ3YWQ4ZDYzODA0Nzc5NGYxYjhmL3RhYmxlOmY3NGQzNDMwOWUyMDQxOTY4MzJkNTAwMDc1YWFlZjBmL3RhYmxlcmFuZ2U6Zjc0ZDM0MzA5ZTIwNDE5NjgzMmQ1MDAwNzVhYWVmMGZfOC0xLTEtMS02MjY_31a34ab9-4045-44f9-bbc6-adee46ce863d">3</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="id7bb773872394047ba26aa8a7a0f4d56_D20210401-20210630" decimals="-3" name="us-gaap:FinanceLeaseInterestExpense" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmFlNWE5YmUwZWI5NDQ1ZDE5MmZhZTgyMmQyMmJlMDlmL3NlYzphZTVhOWJlMGViOTQ0NWQxOTJmYWU4MjJkMjJiZTA5Zl81NS9mcmFnOjgzZWFhMzRhOThhOTQ3YWQ4ZDYzODA0Nzc5NGYxYjhmL3RhYmxlOmY3NGQzNDMwOWUyMDQxOTY4MzJkNTAwMDc1YWFlZjBmL3RhYmxlcmFuZ2U6Zjc0ZDM0MzA5ZTIwNDE5NjgzMmQ1MDAwNzVhYWVmMGZfOC0zLTEtMS02MjY_33cbbc06-e9a8-4e69-8fb3-b1f6dafec951">4</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ia855382ada1f4f28aa8ef6da692ff177_D20220101-20220630" decimals="-3" name="us-gaap:FinanceLeaseInterestExpense" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmFlNWE5YmUwZWI5NDQ1ZDE5MmZhZTgyMmQyMmJlMDlmL3NlYzphZTVhOWJlMGViOTQ0NWQxOTJmYWU4MjJkMjJiZTA5Zl81NS9mcmFnOjgzZWFhMzRhOThhOTQ3YWQ4ZDYzODA0Nzc5NGYxYjhmL3RhYmxlOmY3NGQzNDMwOWUyMDQxOTY4MzJkNTAwMDc1YWFlZjBmL3RhYmxlcmFuZ2U6Zjc0ZDM0MzA5ZTIwNDE5NjgzMmQ1MDAwNzVhYWVmMGZfOS01LTEtMS0zMDky_29d896f4-1b4c-403f-9830-10c92e31ad1e">7</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="idaa4f31ca59a4a17a59c2580b97791ca_D20210101-20210630" decimals="-3" name="us-gaap:FinanceLeaseInterestExpense" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmFlNWE5YmUwZWI5NDQ1ZDE5MmZhZTgyMmQyMmJlMDlmL3NlYzphZTVhOWJlMGViOTQ0NWQxOTJmYWU4MjJkMjJiZTA5Zl81NS9mcmFnOjgzZWFhMzRhOThhOTQ3YWQ4ZDYzODA0Nzc5NGYxYjhmL3RhYmxlOmY3NGQzNDMwOWUyMDQxOTY4MzJkNTAwMDc1YWFlZjBmL3RhYmxlcmFuZ2U6Zjc0ZDM0MzA5ZTIwNDE5NjgzMmQ1MDAwNzVhYWVmMGZfOS03LTEtMS0zMDky_88537748-0fa9-4468-93e7-7575d7516c68">8</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Total finance lease cost</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i2c5f0f28773744e5a2e202f2943ae976_D20220401-20220630" decimals="-3" name="dmtk:FinanceLeaseCost" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmFlNWE5YmUwZWI5NDQ1ZDE5MmZhZTgyMmQyMmJlMDlmL3NlYzphZTVhOWJlMGViOTQ0NWQxOTJmYWU4MjJkMjJiZTA5Zl81NS9mcmFnOjgzZWFhMzRhOThhOTQ3YWQ4ZDYzODA0Nzc5NGYxYjhmL3RhYmxlOmY3NGQzNDMwOWUyMDQxOTY4MzJkNTAwMDc1YWFlZjBmL3RhYmxlcmFuZ2U6Zjc0ZDM0MzA5ZTIwNDE5NjgzMmQ1MDAwNzVhYWVmMGZfOS0xLTEtMS02MjY_11892418-cef9-4496-9166-00ac00671896">24</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="id7bb773872394047ba26aa8a7a0f4d56_D20210401-20210630" decimals="-3" name="dmtk:FinanceLeaseCost" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmFlNWE5YmUwZWI5NDQ1ZDE5MmZhZTgyMmQyMmJlMDlmL3NlYzphZTVhOWJlMGViOTQ0NWQxOTJmYWU4MjJkMjJiZTA5Zl81NS9mcmFnOjgzZWFhMzRhOThhOTQ3YWQ4ZDYzODA0Nzc5NGYxYjhmL3RhYmxlOmY3NGQzNDMwOWUyMDQxOTY4MzJkNTAwMDc1YWFlZjBmL3RhYmxlcmFuZ2U6Zjc0ZDM0MzA5ZTIwNDE5NjgzMmQ1MDAwNzVhYWVmMGZfOS0zLTEtMS02MjY_690e9c89-e94f-4f43-b42e-48691f68103d">21</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ia855382ada1f4f28aa8ef6da692ff177_D20220101-20220630" decimals="-3" name="dmtk:FinanceLeaseCost" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmFlNWE5YmUwZWI5NDQ1ZDE5MmZhZTgyMmQyMmJlMDlmL3NlYzphZTVhOWJlMGViOTQ0NWQxOTJmYWU4MjJkMjJiZTA5Zl81NS9mcmFnOjgzZWFhMzRhOThhOTQ3YWQ4ZDYzODA0Nzc5NGYxYjhmL3RhYmxlOmY3NGQzNDMwOWUyMDQxOTY4MzJkNTAwMDc1YWFlZjBmL3RhYmxlcmFuZ2U6Zjc0ZDM0MzA5ZTIwNDE5NjgzMmQ1MDAwNzVhYWVmMGZfMTAtNS0xLTEtMzA5Mg_89ec24ff-9a09-4e2b-934f-f668b2e75c56">48</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="idaa4f31ca59a4a17a59c2580b97791ca_D20210101-20210630" decimals="-3" name="dmtk:FinanceLeaseCost" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmFlNWE5YmUwZWI5NDQ1ZDE5MmZhZTgyMmQyMmJlMDlmL3NlYzphZTVhOWJlMGViOTQ0NWQxOTJmYWU4MjJkMjJiZTA5Zl81NS9mcmFnOjgzZWFhMzRhOThhOTQ3YWQ4ZDYzODA0Nzc5NGYxYjhmL3RhYmxlOmY3NGQzNDMwOWUyMDQxOTY4MzJkNTAwMDc1YWFlZjBmL3RhYmxlcmFuZ2U6Zjc0ZDM0MzA5ZTIwNDE5NjgzMmQ1MDAwNzVhYWVmMGZfMTAtNy0xLTEtMzA5Mg_efacc199-07a2-455e-bb83-a045561d05a9">42</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(1) Variable lease costs are primarily related to common area maintenance charges and property taxes.</span></div></ix:nonNumeric></ix:continuation><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">22</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:45pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#iae5a9be0eb9445d192fae822d22be09f_7">Table of Contents</a></span></div></div><ix:continuation id="i46f0312b405a49a5afc582e0f0fe4084" continuedAt="i2a670fd93fac4149b72ae5d75c5cc776"><ix:continuation id="ie174567d895b415a8fb7eb9c46d1dfc5"><div style="margin-top:9pt;padding-left:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Other information related to leases was as shown in the table below. </span></div><div style="margin-top:12pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:68.900%"></td><td style="width:0.1%"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td style="width:0.1%"></td><td style="width:0.406%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:13.293%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.406%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:13.295%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Six Months Ended June 30,</span></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2021</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Cash paid for amounts included in the measurement of lease liabilities:</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 10pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Operating cash flows from operating leases</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ia855382ada1f4f28aa8ef6da692ff177_D20220101-20220630" decimals="-3" name="us-gaap:OperatingLeasePayments" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmFlNWE5YmUwZWI5NDQ1ZDE5MmZhZTgyMmQyMmJlMDlmL3NlYzphZTVhOWJlMGViOTQ0NWQxOTJmYWU4MjJkMjJiZTA5Zl81NS9mcmFnOjgzZWFhMzRhOThhOTQ3YWQ4ZDYzODA0Nzc5NGYxYjhmL3RhYmxlOjlhYjMzYWUwZTNlMDQ1ZGE5MmEzNTAzZmFlODIwMDZmL3RhYmxlcmFuZ2U6OWFiMzNhZTBlM2UwNDVkYTkyYTM1MDNmYWU4MjAwNmZfMy01LTEtMS0zMTUz_dea3cfb9-4599-4480-99ad-0b1a773b4a51">1,179</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="idaa4f31ca59a4a17a59c2580b97791ca_D20210101-20210630" decimals="-3" name="us-gaap:OperatingLeasePayments" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmFlNWE5YmUwZWI5NDQ1ZDE5MmZhZTgyMmQyMmJlMDlmL3NlYzphZTVhOWJlMGViOTQ0NWQxOTJmYWU4MjJkMjJiZTA5Zl81NS9mcmFnOjgzZWFhMzRhOThhOTQ3YWQ4ZDYzODA0Nzc5NGYxYjhmL3RhYmxlOjlhYjMzYWUwZTNlMDQ1ZGE5MmEzNTAzZmFlODIwMDZmL3RhYmxlcmFuZ2U6OWFiMzNhZTBlM2UwNDVkYTkyYTM1MDNmYWU4MjAwNmZfMTQtNy0xLTEtMzEyMw_388a8e99-7aa7-4b45-8742-1d029a643871">684</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 10pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Operating cash flows from finance leases</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ia855382ada1f4f28aa8ef6da692ff177_D20220101-20220630" decimals="-3" name="us-gaap:FinanceLeaseInterestExpense" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmFlNWE5YmUwZWI5NDQ1ZDE5MmZhZTgyMmQyMmJlMDlmL3NlYzphZTVhOWJlMGViOTQ0NWQxOTJmYWU4MjJkMjJiZTA5Zl81NS9mcmFnOjgzZWFhMzRhOThhOTQ3YWQ4ZDYzODA0Nzc5NGYxYjhmL3RhYmxlOjlhYjMzYWUwZTNlMDQ1ZGE5MmEzNTAzZmFlODIwMDZmL3RhYmxlcmFuZ2U6OWFiMzNhZTBlM2UwNDVkYTkyYTM1MDNmYWU4MjAwNmZfNC01LTEtMS0zMTUz_ea690da6-80c9-4d46-8b34-611623810c02">7</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="idaa4f31ca59a4a17a59c2580b97791ca_D20210101-20210630" decimals="-3" name="us-gaap:FinanceLeaseInterestExpense" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmFlNWE5YmUwZWI5NDQ1ZDE5MmZhZTgyMmQyMmJlMDlmL3NlYzphZTVhOWJlMGViOTQ0NWQxOTJmYWU4MjJkMjJiZTA5Zl81NS9mcmFnOjgzZWFhMzRhOThhOTQ3YWQ4ZDYzODA0Nzc5NGYxYjhmL3RhYmxlOjlhYjMzYWUwZTNlMDQ1ZGE5MmEzNTAzZmFlODIwMDZmL3RhYmxlcmFuZ2U6OWFiMzNhZTBlM2UwNDVkYTkyYTM1MDNmYWU4MjAwNmZfMTUtNy0xLTEtMzEyMw_4e10d6d3-a15c-44a0-9eea-f65ce191ca55">8</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 10pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Financing cash flows from finance leases</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ia855382ada1f4f28aa8ef6da692ff177_D20220101-20220630" decimals="-3" name="us-gaap:FinanceLeasePrincipalPayments" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmFlNWE5YmUwZWI5NDQ1ZDE5MmZhZTgyMmQyMmJlMDlmL3NlYzphZTVhOWJlMGViOTQ0NWQxOTJmYWU4MjJkMjJiZTA5Zl81NS9mcmFnOjgzZWFhMzRhOThhOTQ3YWQ4ZDYzODA0Nzc5NGYxYjhmL3RhYmxlOjlhYjMzYWUwZTNlMDQ1ZGE5MmEzNTAzZmFlODIwMDZmL3RhYmxlcmFuZ2U6OWFiMzNhZTBlM2UwNDVkYTkyYTM1MDNmYWU4MjAwNmZfNS01LTEtMS0zMTUz_c5fcf195-fcd8-48b2-937a-8d72800a8337">60</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="idaa4f31ca59a4a17a59c2580b97791ca_D20210101-20210630" decimals="-3" name="us-gaap:FinanceLeasePrincipalPayments" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmFlNWE5YmUwZWI5NDQ1ZDE5MmZhZTgyMmQyMmJlMDlmL3NlYzphZTVhOWJlMGViOTQ0NWQxOTJmYWU4MjJkMjJiZTA5Zl81NS9mcmFnOjgzZWFhMzRhOThhOTQ3YWQ4ZDYzODA0Nzc5NGYxYjhmL3RhYmxlOjlhYjMzYWUwZTNlMDQ1ZGE5MmEzNTAzZmFlODIwMDZmL3RhYmxlcmFuZ2U6OWFiMzNhZTBlM2UwNDVkYTkyYTM1MDNmYWU4MjAwNmZfMTYtNy0xLTEtMzEyMw_832ae879-3aa8-4dff-8f67-526f2936dae3">53</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Right-of-use assets obtained in exchange for lease obligations:</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 10pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Operating leases</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ia855382ada1f4f28aa8ef6da692ff177_D20220101-20220630" decimals="-3" name="us-gaap:RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmFlNWE5YmUwZWI5NDQ1ZDE5MmZhZTgyMmQyMmJlMDlmL3NlYzphZTVhOWJlMGViOTQ0NWQxOTJmYWU4MjJkMjJiZTA5Zl81NS9mcmFnOjgzZWFhMzRhOThhOTQ3YWQ4ZDYzODA0Nzc5NGYxYjhmL3RhYmxlOjlhYjMzYWUwZTNlMDQ1ZGE5MmEzNTAzZmFlODIwMDZmL3RhYmxlcmFuZ2U6OWFiMzNhZTBlM2UwNDVkYTkyYTM1MDNmYWU4MjAwNmZfNi01LTEtMS0zMTUz_8f616ff6-1e85-47e7-8a32-d58dd2e1e0ae">17,059</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="idaa4f31ca59a4a17a59c2580b97791ca_D20210101-20210630" decimals="-3" name="us-gaap:RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmFlNWE5YmUwZWI5NDQ1ZDE5MmZhZTgyMmQyMmJlMDlmL3NlYzphZTVhOWJlMGViOTQ0NWQxOTJmYWU4MjJkMjJiZTA5Zl81NS9mcmFnOjgzZWFhMzRhOThhOTQ3YWQ4ZDYzODA0Nzc5NGYxYjhmL3RhYmxlOjlhYjMzYWUwZTNlMDQ1ZGE5MmEzNTAzZmFlODIwMDZmL3RhYmxlcmFuZ2U6OWFiMzNhZTBlM2UwNDVkYTkyYTM1MDNmYWU4MjAwNmZfMTctNy0xLTEtMzEyMw_15a04c95-b6c0-4ee4-ac0f-ed735efb6137">2,831</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 10pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Finance leases</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ia855382ada1f4f28aa8ef6da692ff177_D20220101-20220630" decimals="-3" name="us-gaap:RightOfUseAssetObtainedInExchangeForFinanceLeaseLiability" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmFlNWE5YmUwZWI5NDQ1ZDE5MmZhZTgyMmQyMmJlMDlmL3NlYzphZTVhOWJlMGViOTQ0NWQxOTJmYWU4MjJkMjJiZTA5Zl81NS9mcmFnOjgzZWFhMzRhOThhOTQ3YWQ4ZDYzODA0Nzc5NGYxYjhmL3RhYmxlOjlhYjMzYWUwZTNlMDQ1ZGE5MmEzNTAzZmFlODIwMDZmL3RhYmxlcmFuZ2U6OWFiMzNhZTBlM2UwNDVkYTkyYTM1MDNmYWU4MjAwNmZfNy01LTEtMS0zMTUz_e4561a12-8ccc-48bb-b1d8-1a452c590d57">48</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="idaa4f31ca59a4a17a59c2580b97791ca_D20210101-20210630" decimals="-3" name="us-gaap:RightOfUseAssetObtainedInExchangeForFinanceLeaseLiability" format="ixt:fixed-zero" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmFlNWE5YmUwZWI5NDQ1ZDE5MmZhZTgyMmQyMmJlMDlmL3NlYzphZTVhOWJlMGViOTQ0NWQxOTJmYWU4MjJkMjJiZTA5Zl81NS9mcmFnOjgzZWFhMzRhOThhOTQ3YWQ4ZDYzODA0Nzc5NGYxYjhmL3RhYmxlOjlhYjMzYWUwZTNlMDQ1ZGE5MmEzNTAzZmFlODIwMDZmL3RhYmxlcmFuZ2U6OWFiMzNhZTBlM2UwNDVkYTkyYTM1MDNmYWU4MjAwNmZfMTgtNy0xLTEtMzEyMw_7699502e-164b-4c1d-8693-83ea58a40af6">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Weighted average remaining lease term in years:</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 10pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Operating leases</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonNumeric contextRef="i4c8f247d12134a9886d56e1c8b024425_I20220630" name="us-gaap:OperatingLeaseWeightedAverageRemainingLeaseTerm1" format="ixt-sec:duryear" id="id3VybDovL2RvY3MudjEvZG9jOmFlNWE5YmUwZWI5NDQ1ZDE5MmZhZTgyMmQyMmJlMDlmL3NlYzphZTVhOWJlMGViOTQ0NWQxOTJmYWU4MjJkMjJiZTA5Zl81NS9mcmFnOjgzZWFhMzRhOThhOTQ3YWQ4ZDYzODA0Nzc5NGYxYjhmL3RhYmxlOjlhYjMzYWUwZTNlMDQ1ZGE5MmEzNTAzZmFlODIwMDZmL3RhYmxlcmFuZ2U6OWFiMzNhZTBlM2UwNDVkYTkyYTM1MDNmYWU4MjAwNmZfOS01LTEtMS0zMTUz_c05a18b5-4ecf-4872-8daf-8320ab8e499c">10.56</ix:nonNumeric></span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonNumeric contextRef="ie036f155bf0e43bd97ef05b5b46857eb_I20210630" name="us-gaap:OperatingLeaseWeightedAverageRemainingLeaseTerm1" format="ixt-sec:duryear" id="id3VybDovL2RvY3MudjEvZG9jOmFlNWE5YmUwZWI5NDQ1ZDE5MmZhZTgyMmQyMmJlMDlmL3NlYzphZTVhOWJlMGViOTQ0NWQxOTJmYWU4MjJkMjJiZTA5Zl81NS9mcmFnOjgzZWFhMzRhOThhOTQ3YWQ4ZDYzODA0Nzc5NGYxYjhmL3RhYmxlOjlhYjMzYWUwZTNlMDQ1ZGE5MmEzNTAzZmFlODIwMDZmL3RhYmxlcmFuZ2U6OWFiMzNhZTBlM2UwNDVkYTkyYTM1MDNmYWU4MjAwNmZfMjAtNy0xLTEtMzEyMw_1f4f7894-8bbc-4d94-8d32-e7d672ded5bd">1.92</ix:nonNumeric></span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 10pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Finance leases</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonNumeric contextRef="i4c8f247d12134a9886d56e1c8b024425_I20220630" name="us-gaap:FinanceLeaseWeightedAverageRemainingLeaseTerm1" format="ixt-sec:duryear" id="id3VybDovL2RvY3MudjEvZG9jOmFlNWE5YmUwZWI5NDQ1ZDE5MmZhZTgyMmQyMmJlMDlmL3NlYzphZTVhOWJlMGViOTQ0NWQxOTJmYWU4MjJkMjJiZTA5Zl81NS9mcmFnOjgzZWFhMzRhOThhOTQ3YWQ4ZDYzODA0Nzc5NGYxYjhmL3RhYmxlOjlhYjMzYWUwZTNlMDQ1ZGE5MmEzNTAzZmFlODIwMDZmL3RhYmxlcmFuZ2U6OWFiMzNhZTBlM2UwNDVkYTkyYTM1MDNmYWU4MjAwNmZfMTAtNS0xLTEtMzE1Mw_c680e76a-4ae2-4917-8d91-8bef092913e5">1.50</ix:nonNumeric></span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonNumeric contextRef="ie036f155bf0e43bd97ef05b5b46857eb_I20210630" name="us-gaap:FinanceLeaseWeightedAverageRemainingLeaseTerm1" format="ixt-sec:duryear" id="id3VybDovL2RvY3MudjEvZG9jOmFlNWE5YmUwZWI5NDQ1ZDE5MmZhZTgyMmQyMmJlMDlmL3NlYzphZTVhOWJlMGViOTQ0NWQxOTJmYWU4MjJkMjJiZTA5Zl81NS9mcmFnOjgzZWFhMzRhOThhOTQ3YWQ4ZDYzODA0Nzc5NGYxYjhmL3RhYmxlOjlhYjMzYWUwZTNlMDQ1ZGE5MmEzNTAzZmFlODIwMDZmL3RhYmxlcmFuZ2U6OWFiMzNhZTBlM2UwNDVkYTkyYTM1MDNmYWU4MjAwNmZfMjEtNy0xLTEtMzEyMw_d7646b9f-fa4d-47a8-8d7c-b06d54bd7980">2.50</ix:nonNumeric></span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Weighted average discount rate:</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 10pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Operating leases</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="i4c8f247d12134a9886d56e1c8b024425_I20220630" decimals="4" name="us-gaap:OperatingLeaseWeightedAverageDiscountRatePercent" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOmFlNWE5YmUwZWI5NDQ1ZDE5MmZhZTgyMmQyMmJlMDlmL3NlYzphZTVhOWJlMGViOTQ0NWQxOTJmYWU4MjJkMjJiZTA5Zl81NS9mcmFnOjgzZWFhMzRhOThhOTQ3YWQ4ZDYzODA0Nzc5NGYxYjhmL3RhYmxlOjlhYjMzYWUwZTNlMDQ1ZGE5MmEzNTAzZmFlODIwMDZmL3RhYmxlcmFuZ2U6OWFiMzNhZTBlM2UwNDVkYTkyYTM1MDNmYWU4MjAwNmZfMTEtNS0xLTEtMzE1Mw_2576fb3c-3baa-4247-990e-744bbba15083">6.39</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="ie036f155bf0e43bd97ef05b5b46857eb_I20210630" decimals="4" name="us-gaap:OperatingLeaseWeightedAverageDiscountRatePercent" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOmFlNWE5YmUwZWI5NDQ1ZDE5MmZhZTgyMmQyMmJlMDlmL3NlYzphZTVhOWJlMGViOTQ0NWQxOTJmYWU4MjJkMjJiZTA5Zl81NS9mcmFnOjgzZWFhMzRhOThhOTQ3YWQ4ZDYzODA0Nzc5NGYxYjhmL3RhYmxlOjlhYjMzYWUwZTNlMDQ1ZGE5MmEzNTAzZmFlODIwMDZmL3RhYmxlcmFuZ2U6OWFiMzNhZTBlM2UwNDVkYTkyYTM1MDNmYWU4MjAwNmZfMjItNy0xLTEtMzEyMw_968e7a5b-9c49-411c-965d-fe11471f1d76">4.04</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 10pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Finance leases</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="i4c8f247d12134a9886d56e1c8b024425_I20220630" decimals="4" name="us-gaap:FinanceLeaseWeightedAverageDiscountRatePercent" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOmFlNWE5YmUwZWI5NDQ1ZDE5MmZhZTgyMmQyMmJlMDlmL3NlYzphZTVhOWJlMGViOTQ0NWQxOTJmYWU4MjJkMjJiZTA5Zl81NS9mcmFnOjgzZWFhMzRhOThhOTQ3YWQ4ZDYzODA0Nzc5NGYxYjhmL3RhYmxlOjlhYjMzYWUwZTNlMDQ1ZGE5MmEzNTAzZmFlODIwMDZmL3RhYmxlcmFuZ2U6OWFiMzNhZTBlM2UwNDVkYTkyYTM1MDNmYWU4MjAwNmZfMTItNS0xLTEtMzE1Mw_a4044565-af41-4354-8a53-54fda801ea90">5.78</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="ie036f155bf0e43bd97ef05b5b46857eb_I20210630" decimals="4" name="us-gaap:FinanceLeaseWeightedAverageDiscountRatePercent" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOmFlNWE5YmUwZWI5NDQ1ZDE5MmZhZTgyMmQyMmJlMDlmL3NlYzphZTVhOWJlMGViOTQ0NWQxOTJmYWU4MjJkMjJiZTA5Zl81NS9mcmFnOjgzZWFhMzRhOThhOTQ3YWQ4ZDYzODA0Nzc5NGYxYjhmL3RhYmxlOjlhYjMzYWUwZTNlMDQ1ZGE5MmEzNTAzZmFlODIwMDZmL3RhYmxlcmFuZ2U6OWFiMzNhZTBlM2UwNDVkYTkyYTM1MDNmYWU4MjAwNmZfMjMtNy0xLTEtMzEyMw_57ed3044-7b00-428a-8593-ac5a2e6d9879">5.54</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">%</span></td></tr></table></div></ix:continuation><ix:nonNumeric contextRef="ia855382ada1f4f28aa8ef6da692ff177_D20220101-20220630" name="dmtk:ScheduleOfFutureMinimumRentalPaymentsForOperatingAndCapitalLeasesTableTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOmFlNWE5YmUwZWI5NDQ1ZDE5MmZhZTgyMmQyMmJlMDlmL3NlYzphZTVhOWJlMGViOTQ0NWQxOTJmYWU4MjJkMjJiZTA5Zl81NS9mcmFnOjgzZWFhMzRhOThhOTQ3YWQ4ZDYzODA0Nzc5NGYxYjhmL3RleHRyZWdpb246ODNlYWEzNGE5OGE5NDdhZDhkNjM4MDQ3Nzk0ZjFiOGZfODM5Mg_0b055f16-59c7-455d-8505-a362658989e9" escape="true"><div style="margin-top:9pt;padding-left:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company&#8217;s future minimum lease payments under operating and financing leases at June&#160;30, 2022 are as follows (in thousands): </span></div><div style="margin-top:12pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:24.203%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:9.051%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.406%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:9.051%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.406%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:9.051%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.406%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:9.051%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.406%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:9.051%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.406%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:9.051%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.406%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:9.055%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2023</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2024</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2025</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2026</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Thereafter</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Total</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Operating lease obligations, including interest</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i4c8f247d12134a9886d56e1c8b024425_I20220630" decimals="-3" name="us-gaap:LesseeOperatingLeaseLiabilityPaymentsRemainderOfFiscalYear" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmFlNWE5YmUwZWI5NDQ1ZDE5MmZhZTgyMmQyMmJlMDlmL3NlYzphZTVhOWJlMGViOTQ0NWQxOTJmYWU4MjJkMjJiZTA5Zl81NS9mcmFnOjgzZWFhMzRhOThhOTQ3YWQ4ZDYzODA0Nzc5NGYxYjhmL3RhYmxlOmJkNjkyNjQ2YTAxNzRiMWQ4ZGY2Y2I2YzA3ZDk1NmZhL3RhYmxlcmFuZ2U6YmQ2OTI2NDZhMDE3NGIxZDhkZjZjYjZjMDdkOTU2ZmFfMS0xLTEtMS02MjY_152fb216-f289-4ca9-bd23-bdce147dd8e8">1,524</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i4c8f247d12134a9886d56e1c8b024425_I20220630" decimals="-3" name="us-gaap:LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmFlNWE5YmUwZWI5NDQ1ZDE5MmZhZTgyMmQyMmJlMDlmL3NlYzphZTVhOWJlMGViOTQ0NWQxOTJmYWU4MjJkMjJiZTA5Zl81NS9mcmFnOjgzZWFhMzRhOThhOTQ3YWQ4ZDYzODA0Nzc5NGYxYjhmL3RhYmxlOmJkNjkyNjQ2YTAxNzRiMWQ4ZGY2Y2I2YzA3ZDk1NmZhL3RhYmxlcmFuZ2U6YmQ2OTI2NDZhMDE3NGIxZDhkZjZjYjZjMDdkOTU2ZmFfMS0zLTEtMS02MjY_05f1685e-cde2-4137-963d-b7417109c2df">2,948</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i4c8f247d12134a9886d56e1c8b024425_I20220630" decimals="-3" name="us-gaap:LesseeOperatingLeaseLiabilityPaymentsDueYearTwo" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmFlNWE5YmUwZWI5NDQ1ZDE5MmZhZTgyMmQyMmJlMDlmL3NlYzphZTVhOWJlMGViOTQ0NWQxOTJmYWU4MjJkMjJiZTA5Zl81NS9mcmFnOjgzZWFhMzRhOThhOTQ3YWQ4ZDYzODA0Nzc5NGYxYjhmL3RhYmxlOmJkNjkyNjQ2YTAxNzRiMWQ4ZGY2Y2I2YzA3ZDk1NmZhL3RhYmxlcmFuZ2U6YmQ2OTI2NDZhMDE3NGIxZDhkZjZjYjZjMDdkOTU2ZmFfMS01LTEtMS02MjY_fad99749-db3f-417e-98da-65b400dfabbc">2,774</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i4c8f247d12134a9886d56e1c8b024425_I20220630" decimals="-3" name="us-gaap:LesseeOperatingLeaseLiabilityPaymentsDueYearThree" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmFlNWE5YmUwZWI5NDQ1ZDE5MmZhZTgyMmQyMmJlMDlmL3NlYzphZTVhOWJlMGViOTQ0NWQxOTJmYWU4MjJkMjJiZTA5Zl81NS9mcmFnOjgzZWFhMzRhOThhOTQ3YWQ4ZDYzODA0Nzc5NGYxYjhmL3RhYmxlOmJkNjkyNjQ2YTAxNzRiMWQ4ZGY2Y2I2YzA3ZDk1NmZhL3RhYmxlcmFuZ2U6YmQ2OTI2NDZhMDE3NGIxZDhkZjZjYjZjMDdkOTU2ZmFfMS03LTEtMS02MjY_cf5c82b0-4683-4dff-a8df-9d720799c1df">2,853</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i4c8f247d12134a9886d56e1c8b024425_I20220630" decimals="-3" name="us-gaap:LesseeOperatingLeaseLiabilityPaymentsDueYearFour" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmFlNWE5YmUwZWI5NDQ1ZDE5MmZhZTgyMmQyMmJlMDlmL3NlYzphZTVhOWJlMGViOTQ0NWQxOTJmYWU4MjJkMjJiZTA5Zl81NS9mcmFnOjgzZWFhMzRhOThhOTQ3YWQ4ZDYzODA0Nzc5NGYxYjhmL3RhYmxlOmJkNjkyNjQ2YTAxNzRiMWQ4ZGY2Y2I2YzA3ZDk1NmZhL3RhYmxlcmFuZ2U6YmQ2OTI2NDZhMDE3NGIxZDhkZjZjYjZjMDdkOTU2ZmFfMS05LTEtMS02MjY_b1977f3c-b38c-49f1-80e1-bbd8482ea598">2,934</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i4c8f247d12134a9886d56e1c8b024425_I20220630" decimals="-3" name="dmtk:LesseeOperatingLeaseLiabilityToBePaidAfterYearFour" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmFlNWE5YmUwZWI5NDQ1ZDE5MmZhZTgyMmQyMmJlMDlmL3NlYzphZTVhOWJlMGViOTQ0NWQxOTJmYWU4MjJkMjJiZTA5Zl81NS9mcmFnOjgzZWFhMzRhOThhOTQ3YWQ4ZDYzODA0Nzc5NGYxYjhmL3RhYmxlOmJkNjkyNjQ2YTAxNzRiMWQ4ZGY2Y2I2YzA3ZDk1NmZhL3RhYmxlcmFuZ2U6YmQ2OTI2NDZhMDE3NGIxZDhkZjZjYjZjMDdkOTU2ZmFfMS0xMS0xLTEtNjI2_3845587d-61d9-44ce-9a7b-fad3beddc980">20,612</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i4c8f247d12134a9886d56e1c8b024425_I20220630" decimals="-3" name="us-gaap:LesseeOperatingLeaseLiabilityPaymentsDue" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmFlNWE5YmUwZWI5NDQ1ZDE5MmZhZTgyMmQyMmJlMDlmL3NlYzphZTVhOWJlMGViOTQ0NWQxOTJmYWU4MjJkMjJiZTA5Zl81NS9mcmFnOjgzZWFhMzRhOThhOTQ3YWQ4ZDYzODA0Nzc5NGYxYjhmL3RhYmxlOmJkNjkyNjQ2YTAxNzRiMWQ4ZGY2Y2I2YzA3ZDk1NmZhL3RhYmxlcmFuZ2U6YmQ2OTI2NDZhMDE3NGIxZDhkZjZjYjZjMDdkOTU2ZmFfMS0xMy0xLTEtNjI2_54361053-b775-4ed7-98e5-420f20767294">33,645</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 10pt;text-align:left;text-indent:-9pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Finance lease obligations, including interest</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i4c8f247d12134a9886d56e1c8b024425_I20220630" decimals="-3" name="us-gaap:FinanceLeaseLiabilityPaymentsRemainderOfFiscalYear" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmFlNWE5YmUwZWI5NDQ1ZDE5MmZhZTgyMmQyMmJlMDlmL3NlYzphZTVhOWJlMGViOTQ0NWQxOTJmYWU4MjJkMjJiZTA5Zl81NS9mcmFnOjgzZWFhMzRhOThhOTQ3YWQ4ZDYzODA0Nzc5NGYxYjhmL3RhYmxlOmJkNjkyNjQ2YTAxNzRiMWQ4ZGY2Y2I2YzA3ZDk1NmZhL3RhYmxlcmFuZ2U6YmQ2OTI2NDZhMDE3NGIxZDhkZjZjYjZjMDdkOTU2ZmFfMi0xLTEtMS02MjY_a60904de-5b86-4d14-849d-26b24e2a94a3">72</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i4c8f247d12134a9886d56e1c8b024425_I20220630" decimals="-3" name="us-gaap:FinanceLeaseLiabilityPaymentsDueNextTwelveMonths" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmFlNWE5YmUwZWI5NDQ1ZDE5MmZhZTgyMmQyMmJlMDlmL3NlYzphZTVhOWJlMGViOTQ0NWQxOTJmYWU4MjJkMjJiZTA5Zl81NS9mcmFnOjgzZWFhMzRhOThhOTQ3YWQ4ZDYzODA0Nzc5NGYxYjhmL3RhYmxlOmJkNjkyNjQ2YTAxNzRiMWQ4ZGY2Y2I2YzA3ZDk1NmZhL3RhYmxlcmFuZ2U6YmQ2OTI2NDZhMDE3NGIxZDhkZjZjYjZjMDdkOTU2ZmFfMi0zLTEtMS02MjY_2da7599d-d51f-433b-b780-492313ae8f14">133</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i4c8f247d12134a9886d56e1c8b024425_I20220630" decimals="-3" name="us-gaap:FinanceLeaseLiabilityPaymentsDueYearTwo" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmFlNWE5YmUwZWI5NDQ1ZDE5MmZhZTgyMmQyMmJlMDlmL3NlYzphZTVhOWJlMGViOTQ0NWQxOTJmYWU4MjJkMjJiZTA5Zl81NS9mcmFnOjgzZWFhMzRhOThhOTQ3YWQ4ZDYzODA0Nzc5NGYxYjhmL3RhYmxlOmJkNjkyNjQ2YTAxNzRiMWQ4ZGY2Y2I2YzA3ZDk1NmZhL3RhYmxlcmFuZ2U6YmQ2OTI2NDZhMDE3NGIxZDhkZjZjYjZjMDdkOTU2ZmFfMi01LTEtMS02MjY_b3ef33e4-498f-4188-9654-09ba7d5c8e8a">19</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i4c8f247d12134a9886d56e1c8b024425_I20220630" decimals="-3" name="us-gaap:FinanceLeaseLiabilityPaymentsDueYearThree" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmFlNWE5YmUwZWI5NDQ1ZDE5MmZhZTgyMmQyMmJlMDlmL3NlYzphZTVhOWJlMGViOTQ0NWQxOTJmYWU4MjJkMjJiZTA5Zl81NS9mcmFnOjgzZWFhMzRhOThhOTQ3YWQ4ZDYzODA0Nzc5NGYxYjhmL3RhYmxlOmJkNjkyNjQ2YTAxNzRiMWQ4ZGY2Y2I2YzA3ZDk1NmZhL3RhYmxlcmFuZ2U6YmQ2OTI2NDZhMDE3NGIxZDhkZjZjYjZjMDdkOTU2ZmFfMi03LTEtMS02MjY_17c27cde-08a3-4783-9297-516b89365f07">19</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i4c8f247d12134a9886d56e1c8b024425_I20220630" decimals="-3" name="us-gaap:FinanceLeaseLiabilityPaymentsDueYearFour" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmFlNWE5YmUwZWI5NDQ1ZDE5MmZhZTgyMmQyMmJlMDlmL3NlYzphZTVhOWJlMGViOTQ0NWQxOTJmYWU4MjJkMjJiZTA5Zl81NS9mcmFnOjgzZWFhMzRhOThhOTQ3YWQ4ZDYzODA0Nzc5NGYxYjhmL3RhYmxlOmJkNjkyNjQ2YTAxNzRiMWQ4ZGY2Y2I2YzA3ZDk1NmZhL3RhYmxlcmFuZ2U6YmQ2OTI2NDZhMDE3NGIxZDhkZjZjYjZjMDdkOTU2ZmFfMi05LTEtMS02MjY_4d9adc20-9c99-4f9c-89c2-f790d36d512c">15</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i4c8f247d12134a9886d56e1c8b024425_I20220630" decimals="-3" name="dmtk:FinanceLeaseLiabilityPaymentsDueAfterYearFour" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmFlNWE5YmUwZWI5NDQ1ZDE5MmZhZTgyMmQyMmJlMDlmL3NlYzphZTVhOWJlMGViOTQ0NWQxOTJmYWU4MjJkMjJiZTA5Zl81NS9mcmFnOjgzZWFhMzRhOThhOTQ3YWQ4ZDYzODA0Nzc5NGYxYjhmL3RhYmxlOmJkNjkyNjQ2YTAxNzRiMWQ4ZGY2Y2I2YzA3ZDk1NmZhL3RhYmxlcmFuZ2U6YmQ2OTI2NDZhMDE3NGIxZDhkZjZjYjZjMDdkOTU2ZmFfMi0xMS0xLTEtNjI2_9f82b374-8b14-454f-ad69-a30d5d729c7a">4</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i4c8f247d12134a9886d56e1c8b024425_I20220630" decimals="-3" name="us-gaap:FinanceLeaseLiabilityPaymentsDue" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmFlNWE5YmUwZWI5NDQ1ZDE5MmZhZTgyMmQyMmJlMDlmL3NlYzphZTVhOWJlMGViOTQ0NWQxOTJmYWU4MjJkMjJiZTA5Zl81NS9mcmFnOjgzZWFhMzRhOThhOTQ3YWQ4ZDYzODA0Nzc5NGYxYjhmL3RhYmxlOmJkNjkyNjQ2YTAxNzRiMWQ4ZGY2Y2I2YzA3ZDk1NmZhL3RhYmxlcmFuZ2U6YmQ2OTI2NDZhMDE3NGIxZDhkZjZjYjZjMDdkOTU2ZmFfMi0xMy0xLTEtNjI2_0ef06d50-5da4-4e45-b03c-0199beef32d6">262</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 16pt;text-align:left;text-indent:-9pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total future minimum lease payments</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i4c8f247d12134a9886d56e1c8b024425_I20220630" decimals="-3" name="dmtk:OperatingAndFinanceLeaseLiabilityPaymentsRemainderOfFiscalYear" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmFlNWE5YmUwZWI5NDQ1ZDE5MmZhZTgyMmQyMmJlMDlmL3NlYzphZTVhOWJlMGViOTQ0NWQxOTJmYWU4MjJkMjJiZTA5Zl81NS9mcmFnOjgzZWFhMzRhOThhOTQ3YWQ4ZDYzODA0Nzc5NGYxYjhmL3RhYmxlOmJkNjkyNjQ2YTAxNzRiMWQ4ZGY2Y2I2YzA3ZDk1NmZhL3RhYmxlcmFuZ2U6YmQ2OTI2NDZhMDE3NGIxZDhkZjZjYjZjMDdkOTU2ZmFfMy0xLTEtMS02MjY_6846f6f3-1c96-4341-9ccd-a19070344983">1,596</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i4c8f247d12134a9886d56e1c8b024425_I20220630" decimals="-3" name="dmtk:OperatingAndFinanceLeaseLiabilityPaymentsDueNextTwelveMonths" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmFlNWE5YmUwZWI5NDQ1ZDE5MmZhZTgyMmQyMmJlMDlmL3NlYzphZTVhOWJlMGViOTQ0NWQxOTJmYWU4MjJkMjJiZTA5Zl81NS9mcmFnOjgzZWFhMzRhOThhOTQ3YWQ4ZDYzODA0Nzc5NGYxYjhmL3RhYmxlOmJkNjkyNjQ2YTAxNzRiMWQ4ZGY2Y2I2YzA3ZDk1NmZhL3RhYmxlcmFuZ2U6YmQ2OTI2NDZhMDE3NGIxZDhkZjZjYjZjMDdkOTU2ZmFfMy0zLTEtMS02MjY_707b0356-0656-49ec-b771-056d1dee6961">3,081</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i4c8f247d12134a9886d56e1c8b024425_I20220630" decimals="-3" name="dmtk:OperatingAndFinanceLeaseLiabilityPaymentsDueYearTwo" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmFlNWE5YmUwZWI5NDQ1ZDE5MmZhZTgyMmQyMmJlMDlmL3NlYzphZTVhOWJlMGViOTQ0NWQxOTJmYWU4MjJkMjJiZTA5Zl81NS9mcmFnOjgzZWFhMzRhOThhOTQ3YWQ4ZDYzODA0Nzc5NGYxYjhmL3RhYmxlOmJkNjkyNjQ2YTAxNzRiMWQ4ZGY2Y2I2YzA3ZDk1NmZhL3RhYmxlcmFuZ2U6YmQ2OTI2NDZhMDE3NGIxZDhkZjZjYjZjMDdkOTU2ZmFfMy01LTEtMS02MjY_a92433e4-46cd-4b0d-9c64-42023c66db40">2,793</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i4c8f247d12134a9886d56e1c8b024425_I20220630" decimals="-3" name="dmtk:OperatingAndFinanceLeaseLiabilityPaymentsDueYearThree" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmFlNWE5YmUwZWI5NDQ1ZDE5MmZhZTgyMmQyMmJlMDlmL3NlYzphZTVhOWJlMGViOTQ0NWQxOTJmYWU4MjJkMjJiZTA5Zl81NS9mcmFnOjgzZWFhMzRhOThhOTQ3YWQ4ZDYzODA0Nzc5NGYxYjhmL3RhYmxlOmJkNjkyNjQ2YTAxNzRiMWQ4ZGY2Y2I2YzA3ZDk1NmZhL3RhYmxlcmFuZ2U6YmQ2OTI2NDZhMDE3NGIxZDhkZjZjYjZjMDdkOTU2ZmFfMy03LTEtMS02MjY_4e006570-3345-40c7-b3fe-700ca7ec859b">2,872</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i4c8f247d12134a9886d56e1c8b024425_I20220630" decimals="-3" name="dmtk:OperatingAndFinanceLeaseLiabilityPaymentsDueYearFour" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmFlNWE5YmUwZWI5NDQ1ZDE5MmZhZTgyMmQyMmJlMDlmL3NlYzphZTVhOWJlMGViOTQ0NWQxOTJmYWU4MjJkMjJiZTA5Zl81NS9mcmFnOjgzZWFhMzRhOThhOTQ3YWQ4ZDYzODA0Nzc5NGYxYjhmL3RhYmxlOmJkNjkyNjQ2YTAxNzRiMWQ4ZGY2Y2I2YzA3ZDk1NmZhL3RhYmxlcmFuZ2U6YmQ2OTI2NDZhMDE3NGIxZDhkZjZjYjZjMDdkOTU2ZmFfMy05LTEtMS02MjY_99433b25-0c3a-4303-b9d3-1c55e9649d96">2,949</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i4c8f247d12134a9886d56e1c8b024425_I20220630" decimals="-3" name="dmtk:OperatingAndFinanceLeaseLiabilityPaymentsDueThereafter" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmFlNWE5YmUwZWI5NDQ1ZDE5MmZhZTgyMmQyMmJlMDlmL3NlYzphZTVhOWJlMGViOTQ0NWQxOTJmYWU4MjJkMjJiZTA5Zl81NS9mcmFnOjgzZWFhMzRhOThhOTQ3YWQ4ZDYzODA0Nzc5NGYxYjhmL3RhYmxlOmJkNjkyNjQ2YTAxNzRiMWQ4ZGY2Y2I2YzA3ZDk1NmZhL3RhYmxlcmFuZ2U6YmQ2OTI2NDZhMDE3NGIxZDhkZjZjYjZjMDdkOTU2ZmFfMy0xMS0xLTEtNjI2_6fa75553-45b0-4f9e-938c-6d0e26a93b7e">20,616</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i4c8f247d12134a9886d56e1c8b024425_I20220630" decimals="-3" name="dmtk:OperatingAndFinanceLeaseLiabilityPaymentsDue" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmFlNWE5YmUwZWI5NDQ1ZDE5MmZhZTgyMmQyMmJlMDlmL3NlYzphZTVhOWJlMGViOTQ0NWQxOTJmYWU4MjJkMjJiZTA5Zl81NS9mcmFnOjgzZWFhMzRhOThhOTQ3YWQ4ZDYzODA0Nzc5NGYxYjhmL3RhYmxlOmJkNjkyNjQ2YTAxNzRiMWQ4ZGY2Y2I2YzA3ZDk1NmZhL3RhYmxlcmFuZ2U6YmQ2OTI2NDZhMDE3NGIxZDhkZjZjYjZjMDdkOTU2ZmFfMy0xMy0xLTEtNjI2_add5ad08-e2ea-48b5-9c08-5fdc4ad22b52">33,907</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div></ix:nonNumeric><div style="margin-top:9pt;padding-left:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Amounts presented in the table above exclude non-cancelable future minimum lease payments for operating leases that have not commenced as of June&#160;30, 2022.</span></div><div style="margin-top:18pt;padding-left:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Legal Proceedings</span></div></ix:continuation><div style="margin-top:9pt;padding-left:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:continuation id="i2a670fd93fac4149b72ae5d75c5cc776">From time to time, the Company may be subject to legal proceedings and claims arising in the ordinary course of business. Management does not believe that the outcome of any of these matters will have a material effect on the Company&#8217;s consolidated financial position, results of operations or cash flows.</ix:continuation> </span></div><div id="iae5a9be0eb9445d192fae822d22be09f_61"></div><div style="margin-top:15pt;padding-left:27pt;text-indent:-27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">5.&#160;&#160;&#160;&#160;<ix:nonNumeric contextRef="ia855382ada1f4f28aa8ef6da692ff177_D20220101-20220630" name="us-gaap:RelatedPartyTransactionsDisclosureTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOmFlNWE5YmUwZWI5NDQ1ZDE5MmZhZTgyMmQyMmJlMDlmL3NlYzphZTVhOWJlMGViOTQ0NWQxOTJmYWU4MjJkMjJiZTA5Zl82MS9mcmFnOjAxODllZTY4MmY0MTQ4NmE5ZDgyMDk4NzAyZjU5YjZkL3RleHRyZWdpb246MDE4OWVlNjgyZjQxNDg2YTlkODIwOTg3MDJmNTliNmRfMTcyNw_7c47a5ed-f8db-4f1b-9870-a6794abac73e" continuedAt="id0ea01a640df45bd8b347a2930e862df" escape="true">Related Party Transactions  </ix:nonNumeric></span></div><div style="margin-top:9pt;padding-left:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:continuation id="id0ea01a640df45bd8b347a2930e862df" continuedAt="ifef5cfdfc1f84ae6837e195d7b59a064">During 2021 and 2022, the Company engaged EVERSANA Life Science Services, LLC (&#8220;EVERSANA&#8221;) to provide certain marketing services to the Company. Leana Wood, the spouse of Todd Wood, the Company&#8217;s Chief Commercial Offer, is an employee of EVERSANA. The Company incurred $<ix:nonFraction unitRef="usd" contextRef="i4d87d8619b7b49828e0354d3459d6bc4_D20220401-20220630" decimals="-5" name="us-gaap:RelatedPartyTransactionSellingGeneralAndAdministrativeExpensesFromTransactionsWithRelatedParty" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmFlNWE5YmUwZWI5NDQ1ZDE5MmZhZTgyMmQyMmJlMDlmL3NlYzphZTVhOWJlMGViOTQ0NWQxOTJmYWU4MjJkMjJiZTA5Zl82MS9mcmFnOjAxODllZTY4MmY0MTQ4NmE5ZDgyMDk4NzAyZjU5YjZkL3RleHRyZWdpb246MDE4OWVlNjgyZjQxNDg2YTlkODIwOTg3MDJmNTliNmRfMzAw_2c93e5e1-a107-4203-b3c2-ce3a3825d89d">0.9</ix:nonFraction> million and $<ix:nonFraction unitRef="usd" contextRef="iebe17418c5534164a125df7ed43c5ece_D20210401-20210630" decimals="-5" name="us-gaap:RelatedPartyTransactionSellingGeneralAndAdministrativeExpensesFromTransactionsWithRelatedParty" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmFlNWE5YmUwZWI5NDQ1ZDE5MmZhZTgyMmQyMmJlMDlmL3NlYzphZTVhOWJlMGViOTQ0NWQxOTJmYWU4MjJkMjJiZTA5Zl82MS9mcmFnOjAxODllZTY4MmY0MTQ4NmE5ZDgyMDk4NzAyZjU5YjZkL3RleHRyZWdpb246MDE4OWVlNjgyZjQxNDg2YTlkODIwOTg3MDJmNTliNmRfMzA3_77ee6fd5-75cf-47df-976e-cb8ddb06679b">0.5</ix:nonFraction> million in costs for the three months ended June&#160;30, 2022 and 2021, respectively, and $<ix:nonFraction unitRef="usd" contextRef="i0e1b8915a8614ad387c31cb5b81538f7_D20220101-20220630" decimals="-5" name="us-gaap:RelatedPartyTransactionSellingGeneralAndAdministrativeExpensesFromTransactionsWithRelatedParty" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmFlNWE5YmUwZWI5NDQ1ZDE5MmZhZTgyMmQyMmJlMDlmL3NlYzphZTVhOWJlMGViOTQ0NWQxOTJmYWU4MjJkMjJiZTA5Zl82MS9mcmFnOjAxODllZTY4MmY0MTQ4NmE5ZDgyMDk4NzAyZjU5YjZkL3RleHRyZWdpb246MDE4OWVlNjgyZjQxNDg2YTlkODIwOTg3MDJmNTliNmRfMzc1_093f0866-2c8f-41b9-90e5-28a12b0f6e15">1.6</ix:nonFraction> million and $<ix:nonFraction unitRef="usd" contextRef="i681d541e73e1469a92851dbf2e1a96d4_D20210101-20210630" decimals="-5" name="us-gaap:RelatedPartyTransactionSellingGeneralAndAdministrativeExpensesFromTransactionsWithRelatedParty" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmFlNWE5YmUwZWI5NDQ1ZDE5MmZhZTgyMmQyMmJlMDlmL3NlYzphZTVhOWJlMGViOTQ0NWQxOTJmYWU4MjJkMjJiZTA5Zl82MS9mcmFnOjAxODllZTY4MmY0MTQ4NmE5ZDgyMDk4NzAyZjU5YjZkL3RleHRyZWdpb246MDE4OWVlNjgyZjQxNDg2YTlkODIwOTg3MDJmNTliNmRfMzgy_adac17bc-76af-42bc-abdd-9f8bc0ba00c6">0.9</ix:nonFraction> million for the six months ended June&#160;30, 2022 and 2021, respectively.</ix:continuation></span></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">23</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:45pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#iae5a9be0eb9445d192fae822d22be09f_7">Table of Contents</a></span></div></div><ix:continuation id="ifef5cfdfc1f84ae6837e195d7b59a064"><div style="margin-top:9pt;padding-left:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">On October&#160;1, 2019, the Company entered into a consulting agreement with Michael Dobak pursuant to which the Company will compensate Michael Dobak, in an amount not to exceed $<ix:nonFraction unitRef="usd" contextRef="ia139293fe3d744eea1b17b968bfcf5ad_D20191001-20191001" decimals="-3" name="us-gaap:RelatedPartyTransactionSellingGeneralAndAdministrativeExpensesFromTransactionsWithRelatedParty" format="ixt:num-dot-decimal" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmFlNWE5YmUwZWI5NDQ1ZDE5MmZhZTgyMmQyMmJlMDlmL3NlYzphZTVhOWJlMGViOTQ0NWQxOTJmYWU4MjJkMjJiZTA5Zl82MS9mcmFnOjAxODllZTY4MmY0MTQ4NmE5ZDgyMDk4NzAyZjU5YjZkL3RleHRyZWdpb246MDE4OWVlNjgyZjQxNDg2YTlkODIwOTg3MDJmNTliNmRfNTk2_cca2b631-7c1e-4685-8045-ac0bfbc66a51">100,000</ix:nonFraction>, for certain public relations and marketing services. On July 28, 2020, the Company and Michael Dobak entered into an amendment to such consulting agreement to modify the terms of Michael Dobak&#8217;s compensation. The amended consulting agreement compensated Michael Dobak $<ix:nonFraction unitRef="usd" contextRef="id5e6d28f8a04434285646197def78617_D20200511-20200511" decimals="-3" name="us-gaap:RelatedPartyTransactionSellingGeneralAndAdministrativeExpensesFromTransactionsWithRelatedParty" format="ixt:num-dot-decimal" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmFlNWE5YmUwZWI5NDQ1ZDE5MmZhZTgyMmQyMmJlMDlmL3NlYzphZTVhOWJlMGViOTQ0NWQxOTJmYWU4MjJkMjJiZTA5Zl82MS9mcmFnOjAxODllZTY4MmY0MTQ4NmE5ZDgyMDk4NzAyZjU5YjZkL3RleHRyZWdpb246MDE4OWVlNjgyZjQxNDg2YTlkODIwOTg3MDJmNTliNmRfODY4_104dbfcb-1789-468a-975a-080af0ce9ec4">15,000</ix:nonFraction> per month for the period May 11, 2020 through June&#160;30, 2021 and also granted him a restricted stock unit award that fully vested in a single installment on August 31, 2020 and represented the contingent right to receive <ix:nonFraction unitRef="shares" contextRef="i651d86ca5e54467a910cc1cdb8f31f8d_I20210102" decimals="INF" name="us-gaap:CommonStockSharesIssued" format="ixt:num-dot-decimal" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmFlNWE5YmUwZWI5NDQ1ZDE5MmZhZTgyMmQyMmJlMDlmL3NlYzphZTVhOWJlMGViOTQ0NWQxOTJmYWU4MjJkMjJiZTA5Zl82MS9mcmFnOjAxODllZTY4MmY0MTQ4NmE5ZDgyMDk4NzAyZjU5YjZkL3RleHRyZWdpb246MDE4OWVlNjgyZjQxNDg2YTlkODIwOTg3MDJmNTliNmRfMTA4MA_1634c30d-35dc-42e9-bc3d-bff79f42ea37">5,000</ix:nonFraction> shares of common stock on January&#160;2, 2021. On November&#160;11, 2020, the Company and Michael Dobak entered into an amendment to such consulting agreement to extend the term through December&#160;31, 2021 with a continued monthly payment of $<ix:nonFraction unitRef="usd" contextRef="iee689bdd0154474d9e8d1bbbcec743b6_D20201111-20201111" decimals="-3" name="us-gaap:RelatedPartyTransactionSellingGeneralAndAdministrativeExpensesFromTransactionsWithRelatedParty" format="ixt:num-dot-decimal" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmFlNWE5YmUwZWI5NDQ1ZDE5MmZhZTgyMmQyMmJlMDlmL3NlYzphZTVhOWJlMGViOTQ0NWQxOTJmYWU4MjJkMjJiZTA5Zl82MS9mcmFnOjAxODllZTY4MmY0MTQ4NmE5ZDgyMDk4NzAyZjU5YjZkL3RleHRyZWdpb246MDE4OWVlNjgyZjQxNDg2YTlkODIwOTg3MDJmNTliNmRfMTI3MQ_9ed5d753-0ed4-4ad3-8ca9-beb663df8dd7">15,000</ix:nonFraction>. On February&#160;26, 2021, the Company and Michael Dobak agreed to extend his agreement through April 30, 2021 with a revised monthly payment of $<ix:nonFraction unitRef="usd" contextRef="ib0f91fba366d40acba994eb5d6addb9c_D20210226-20210226" decimals="-3" name="us-gaap:RelatedPartyTransactionSellingGeneralAndAdministrativeExpensesFromTransactionsWithRelatedParty" format="ixt:num-dot-decimal" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmFlNWE5YmUwZWI5NDQ1ZDE5MmZhZTgyMmQyMmJlMDlmL3NlYzphZTVhOWJlMGViOTQ0NWQxOTJmYWU4MjJkMjJiZTA5Zl82MS9mcmFnOjAxODllZTY4MmY0MTQ4NmE5ZDgyMDk4NzAyZjU5YjZkL3RleHRyZWdpb246MDE4OWVlNjgyZjQxNDg2YTlkODIwOTg3MDJmNTliNmRfMTQwMA_42ed104f-5304-4f9b-8c0c-d4baa92107c1">20,000</ix:nonFraction>. Michael Dobak is the brother of Dr. John Dobak, the Company&#8217;s Chief Executive Officer. The Company incurred <ix:nonFraction unitRef="usd" contextRef="i945b8bc570ef4af69046201719baea0d_D20220401-20220630" decimals="INF" name="us-gaap:RelatedPartyTransactionSellingGeneralAndAdministrativeExpensesFromTransactionsWithRelatedParty" format="ixt:fixed-zero" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmFlNWE5YmUwZWI5NDQ1ZDE5MmZhZTgyMmQyMmJlMDlmL3NlYzphZTVhOWJlMGViOTQ0NWQxOTJmYWU4MjJkMjJiZTA5Zl82MS9mcmFnOjAxODllZTY4MmY0MTQ4NmE5ZDgyMDk4NzAyZjU5YjZkL3RleHRyZWdpb246MDE4OWVlNjgyZjQxNDg2YTlkODIwOTg3MDJmNTliNmRfMTUxMg_7803ae57-c581-40d1-ae8a-29ebb570d6eb">zero</ix:nonFraction> and $<ix:nonFraction unitRef="usd" contextRef="idfbaf207ccb145e0804dfb68b580e154_D20210401-20210630" decimals="-3" name="us-gaap:RelatedPartyTransactionSellingGeneralAndAdministrativeExpensesFromTransactionsWithRelatedParty" format="ixt:num-dot-decimal" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmFlNWE5YmUwZWI5NDQ1ZDE5MmZhZTgyMmQyMmJlMDlmL3NlYzphZTVhOWJlMGViOTQ0NWQxOTJmYWU4MjJkMjJiZTA5Zl82MS9mcmFnOjAxODllZTY4MmY0MTQ4NmE5ZDgyMDk4NzAyZjU5YjZkL3RleHRyZWdpb246MDE4OWVlNjgyZjQxNDg2YTlkODIwOTg3MDJmNTliNmRfMTUxOQ_0a3ee1e6-2c9a-46f3-b961-6e49abdb87e1">20,000</ix:nonFraction> in costs for the three months ended June&#160;30, 2022 and 2021, respectively, and <ix:nonFraction unitRef="usd" contextRef="i0d7a163c3890488dae0c374a84f12aa0_D20220101-20220630" decimals="INF" name="us-gaap:RelatedPartyTransactionSellingGeneralAndAdministrativeExpensesFromTransactionsWithRelatedParty" format="ixt:fixed-zero" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmFlNWE5YmUwZWI5NDQ1ZDE5MmZhZTgyMmQyMmJlMDlmL3NlYzphZTVhOWJlMGViOTQ0NWQxOTJmYWU4MjJkMjJiZTA5Zl82MS9mcmFnOjAxODllZTY4MmY0MTQ4NmE5ZDgyMDk4NzAyZjU5YjZkL3RleHRyZWdpb246MDE4OWVlNjgyZjQxNDg2YTlkODIwOTg3MDJmNTliNmRfNTQ5NzU1ODIwOTA3_20a28361-43d5-4f48-9d5b-c5537f276480">zero</ix:nonFraction> and $<ix:nonFraction unitRef="usd" contextRef="i690d64dd56474cd880eacb6ae348633b_D20210101-20210630" decimals="-5" name="us-gaap:RelatedPartyTransactionSellingGeneralAndAdministrativeExpensesFromTransactionsWithRelatedParty" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmFlNWE5YmUwZWI5NDQ1ZDE5MmZhZTgyMmQyMmJlMDlmL3NlYzphZTVhOWJlMGViOTQ0NWQxOTJmYWU4MjJkMjJiZTA5Zl82MS9mcmFnOjAxODllZTY4MmY0MTQ4NmE5ZDgyMDk4NzAyZjU5YjZkL3RleHRyZWdpb246MDE4OWVlNjgyZjQxNDg2YTlkODIwOTg3MDJmNTliNmRfMTU4Nw_3ec8b251-20d6-4711-84a1-72f9e7045aba">0.1</ix:nonFraction> million for the six months ended June&#160;30, 2022 and 2021.</span></div><div style="margin-top:9pt;padding-left:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">There were <ix:nonFraction unitRef="usd" contextRef="ia855382ada1f4f28aa8ef6da692ff177_D20220101-20220630" decimals="INF" name="us-gaap:RelatedPartyTransactionExpensesFromTransactionsWithRelatedParty" format="ixt:fixed-zero" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmFlNWE5YmUwZWI5NDQ1ZDE5MmZhZTgyMmQyMmJlMDlmL3NlYzphZTVhOWJlMGViOTQ0NWQxOTJmYWU4MjJkMjJiZTA5Zl82MS9mcmFnOjAxODllZTY4MmY0MTQ4NmE5ZDgyMDk4NzAyZjU5YjZkL3RleHRyZWdpb246MDE4OWVlNjgyZjQxNDg2YTlkODIwOTg3MDJmNTliNmRfMTY0NA_b876ff27-5e3a-410e-a6aa-3f10d62e8844"><ix:nonFraction unitRef="usd" contextRef="idaa4f31ca59a4a17a59c2580b97791ca_D20210101-20210630" decimals="INF" name="us-gaap:RelatedPartyTransactionExpensesFromTransactionsWithRelatedParty" format="ixt:fixed-zero" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmFlNWE5YmUwZWI5NDQ1ZDE5MmZhZTgyMmQyMmJlMDlmL3NlYzphZTVhOWJlMGViOTQ0NWQxOTJmYWU4MjJkMjJiZTA5Zl82MS9mcmFnOjAxODllZTY4MmY0MTQ4NmE5ZDgyMDk4NzAyZjU5YjZkL3RleHRyZWdpb246MDE4OWVlNjgyZjQxNDg2YTlkODIwOTg3MDJmNTliNmRfMTY0NA_b96630b3-43a0-4b00-9c81-4e8999061583">no</ix:nonFraction></ix:nonFraction> other related party transactions identified during the six months ended June&#160;30, 2022 and 2021.</span></div></ix:continuation><div id="iae5a9be0eb9445d192fae822d22be09f_64"></div><div style="margin-top:15pt;padding-left:27pt;text-indent:-27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">6<ix:nonNumeric contextRef="ia855382ada1f4f28aa8ef6da692ff177_D20220101-20220630" name="us-gaap:SubsequentEventsTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOmFlNWE5YmUwZWI5NDQ1ZDE5MmZhZTgyMmQyMmJlMDlmL3NlYzphZTVhOWJlMGViOTQ0NWQxOTJmYWU4MjJkMjJiZTA5Zl82NC9mcmFnOjBkOGMwZjc1M2FjNTQyMjRhYzM1YmE5MGNhZjFkZDRlL3RleHRyZWdpb246MGQ4YzBmNzUzYWM1NDIyNGFjMzViYTkwY2FmMWRkNGVfMTc3_70298189-1869-4c48-bf9f-d9a7ffaf6fdb" continuedAt="i5cac44a554464bbbb9c1ef0f5d222485" escape="true">.&#160;&#160;&#160;&#160;Subsequent Events</ix:nonNumeric></span></div><div style="margin-top:9pt;padding-left:27pt"><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:continuation id="i5cac44a554464bbbb9c1ef0f5d222485">The Company considered subsequent events through August&#160;8, 2022, the date the condensed consolidated financial statements were available to be issued, and determined there were no subsequent events that would require recognition or disclosure in the condensed consolidated financial statements.</ix:continuation></span></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">24</span></div></div></div><div id="iae5a9be0eb9445d192fae822d22be09f_67"></div><hr style="page-break-after:always"/><div style="min-height:45pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#iae5a9be0eb9445d192fae822d22be09f_7">Table of Contents</a></span></div></div><div style="margin-top:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Item 2. Management&#8217;s Discussion and Analysis of Financial Condition and Results of Operations.</span></div><div style="margin-top:6pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following Discussion and Analysis of Financial Condition and Results of Operations of DermTech, Inc. (together with its subsidiaries, &#8220;DermTech,&#8221; &#8220;we,&#8221; &#8220;us,&#8221; &#8220;our&#8221; or the &#8220;Company&#8221;) should be read in conjunction with the condensed consolidated financial statements and the related notes thereto included elsewhere in this Quarterly Report on Form 10-Q and the audited condensed consolidated financial statements and notes thereto and Management&#8217;s Discussion and Analysis of Financial Condition and Results of Operations for the fiscal year ended December 31, 2021, included in our Annual Report on Form 10-K filed with the Securities and Exchange Commission, or the SEC, on March 10, 2022.</span></div><div style="margin-top:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">CAUTIONARY NOTE REGARDING FORWARD-LOOKING STATEMENTS</span></div><div style="margin-top:6pt;text-indent:27pt"><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">This report, including the following Management&#8217;s Discussion and Analysis of Financial Condition and Results of Operations, contains forward-looking statements within the meaning of Section 27A of the Securities Act of 1933, as amended, or the Securities Act, and Section 21E of the Securities Exchange Act of 1934, as amended, or the Exchange Act, that are intended to be covered by the &#8220;safe harbor&#8221; created by those sections. All statements, other than statements of historical facts, contained in this report, including statements regarding DermTech&#8217;s or its management&#8217;s intentions, beliefs, expectations and strategies for the future, are forward looking statements. In some cases, you can identify forward-looking statements by terminology such as &#8220;may,&#8221; &#8220;will,&#8221; &#8220;expect,&#8221; &#8220;plan,&#8221; &#8220;anticipate,&#8221; &#8220;believe,&#8221; &#8220;estimate,&#8221; &#8220;intend,&#8221; &#8220;potential&#8221; or &#8220;continue&#8221; or the negative of these terms or other comparable terminology. Forward-looking statements are made as of the date of this report, deal with future events, are subject to various risks and uncertainties, and actual results could differ materially from those anticipated in those forward-looking statements. The risks and uncertainties that could cause actual results to differ materially are more fully described under the heading &#8220;Item 1A. Risk Factors&#8221; in our Annual Report on Form 10-K for the year ended December 31, 2021. We may disclose changes to risk factors or additional risk factors from time to time in our future filings with the SEC. We assume no obligation to update any of the forward-looking statements after the date of this report or to conform these forward-looking statements to actual results.</span></div><div id="iae5a9be0eb9445d192fae822d22be09f_70"></div><div style="margin-top:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Overview </span></div><div style="margin-top:6pt;text-indent:27pt"><span style="color:#231f20;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We are a molecular diagnostic company developing and marketing novel non-invasive genomics tests to aid in the diagnosis and management of various skin conditions, including skin cancer and inflammatory diseases. Our technology provides a more accurate alternative to surgical biopsy, minimizing patient discomfort, scarring, and risk of infection, while maximizing convenience. Our scalable genomics assays are used to non-invasively collect a tissue sample for analysis.</span></div><div style="margin-top:9pt;text-indent:27pt"><span style="color:#231f20;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We are initially commercializing tests that will address unmet needs in the diagnostic pathway of pigmented skin lesions, such as moles or dark colored skin spots. The DMT facilitates the clinical assessment of pigmented skin lesions for melanoma. We initially marketed this test directly to a concentrated group of dermatologists and are currently expanding marketing efforts to a broader group of clinicians and to a small group of primary care providers. The application of our Smart Sticker to collect samples non-invasively may allow us to eventually market the DMT to primary care physicians more broadly, beyond integrated primary care networks, and expand our efforts through telemedicine channels. We process our tests in our high complexity molecular laboratory that is certified under CLIA, College of American Pathologists accredited and New York licensed. We also provide laboratory services to several pharmaceutical companies that access our technology on a contract basis for their clinical trials or other studies to advance new drugs.</span></div><div style="margin-top:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Events, Trends and Uncertainties </span></div><div style="margin-top:6pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The DMT (without the add-on test for TERT) became eligible for Medicare reimbursement on February 10, 2020. Each reference to the DMT in this paragraph refers only to the DMT without the add-on test for TERT. In late October 2019, the American Medical Association provided us with a PLA Code. Pricing of $760 for the PLA Code was published on December 24, 2019 as part of the Clinical Laboratory Fee Schedule for 2020. The final Local Coverage Determination, or LCD, expanded the coverage proposal in the draft LCD from one to two tests per date of service and it allows clinicians to order the DMT if they have sufficient skill and experience to decide whether a pigmented lesion should be biopsied. Our local Medicare Administrative Contractor, Noridian, has issued its own Local Coverage Decision, or Noridian&#8217;s LCD, announcing coverage of the DMT. Even though the effective date of Noridian&#8217;s LCD was June 7, 2020, Noridian began reimbursing us for the DMT as of February 10, 2020. With Medicare coverage granted, we have the opportunity to approach commercial payors, and as a result, we believe that the DMT may generate significant revenues in 2022 and 2023. No LCD currently covers the optional add-on test for TERT available to those ordering the DMT.</span></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">25</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:45pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#iae5a9be0eb9445d192fae822d22be09f_7">Table of Contents</a></span></div></div><div style="margin-top:6pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Despite the grant of Medicare coverage for the DMT (without the add-on test for TERT), uncertainty surrounds commercial payor reimbursement, including governmental and commercial payors, of any test incorporating new technology, including tests developed using our technologies. Because each payor generally determines for its own enrollees or insured patients whether to cover or otherwise establish a policy to reimburse our tests, seeking payor approvals is a time-consuming and costly process. We cannot be certain that coverage for our current tests and our planned future tests will be provided in the future by additional commercial payors or that existing policy decisions or reimbursement levels will remain in place or be fulfilled under existing terms and provisions. If we cannot obtain or maintain coverage and reimbursement from private and governmental payors such as Medicare and Medicaid for our current tests, or new tests or test enhancements that we may develop in the future, our ability to generate revenues could be limited. This may have a material adverse effect on our business, financial condition, results of operation, and cash flows.</span></div><div style="margin-top:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Revenue Effects Related to COVID-19 Pandemic</span></div><div style="margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Assay Revenue</span></div><div style="margin-top:6pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Beginning in March 2020 and continuing through the second quarter of 2022, the ongoing COVID-19 pandemic has reduced patient access to clinician offices for in-person testing and reduced access by our sales force for in-office sales calls, which has resulted in a reduced volume of billable samples received relative to our pre-pandemic expectations. April 2020 billable sample volume was down by approximately 80%, commensurate with the closure of dermatology offices, compared to the average monthly billable sample volume for the two months preceding the beginning of the COVID-19 stay-at-home orders. Despite the downturn in billable samples in April 2020, we saw a stabilization of billable sample volume throughout the rest of the second quarter of 2020 and through the second quarter of 2022 as various states and dermatology offices reopened throughout the country. Despite not all dermatology practices returning to full operations, billable sample volume first exceeded pre&#8209;pandemic levels in July 2020. Billable sample volume for the three months ended June 30, 2022 was 28% higher compared to billable sample volume for the three months ended March 31, 2022. Billable sample volume for the three months ended June 30, 2022 was 56% higher than billable sample volume for the three months ended June 30, 2021. Billable sample volumes could again be negatively impacted by the ongoing COVID-19 pandemic, including as a result of any resurgence of the virus or its variants.</span></div><div style="margin-top:6pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In April 2020, we made available a remote telemedicine collection option for the DMT. Using the remote telemedicine collection option, a clinician can choose to assess the patient&#8217;s skin and suspicious lesion(s) via a telemedicine appointment and, if indicated, submit a patient-specific order to DermTech for the DMT. In this case, a Smart Sticker Collection Kit is then mailed to the patient directly. During a follow-up telemedicine appointment, a clinician instructs and supervises the patient to collect their sample with the Smart Sticker. The patient then returns the collected sample(s) back to DermTech via a pre-labeled shipping envelope for analysis. Test results are made available to the ordering clinician within a few days.</span></div><div style="margin-top:6pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In July 2021, we launched another telemedicine option available to patients through the DermTech Connect mobile application, where permitted by law and consistent with applicable standards of care and practice guidelines. DermTech Connect enables a user to take a picture of a suspicious lesion with their phone and submit the picture to an independent clinician to assess the lesion. As of the date of this report, DermTech Connect is available to patients of clinicians subscribed to DermTech Connect in 44 states. Subscribing clinicians utilizing DermTech Connect charge a pre-determined amount for the patient services and no claims are submitted for reimbursement of the clinical telemedicine services. These subscribing clinicians pay DermTech a fixed amount for use of the DermTech Connect platform. The clinician can also determine, if they deem it medically necessary, to order the DMT, in which case a Smart Sticker Collection Kit is mailed to the patient, followed by at-home self-collection with remote virtual supervision by a DermTech patient liaison. Many state laws and regulations impose various requirements on the practice of telemedicine, the regulatory landscape is evolving and DermTech Connect is not, and may not become, available in all states. The telemedicine market is relatively new and unproven, especially within dermatology, and it is uncertain whether the telemedicine options for the DMT will achieve and sustain high levels of demand, consumer acceptance and market adoption, as well as face challenges in the regulatory landscape, which is complex and evolving.</span></div><div style="margin-top:6pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">While and to the extent that the COVID-19 pandemic continues (including as a result of clinician offices closing again due to a COVID-19 outbreak within the practice, or patients avoiding in-person visits to the dermatology clinic for fear of contracting COVID-19 or any of its viral variants), our revenues will depend to an extent on the willingness of clinicians and their patients to use our telemedicine option for the DMT, as well as on our ability to demonstrate the value of our telemedicine option to health plans and other purchasers of healthcare for beneficiaries. The duration and extent of the effects of the ongoing COVID-19 pandemic are uncertain and have, and may again in the future, adversely affect our revenues by reducing access to clinician offices by patients for in-person testing and by our sales force for in-office sales calls.</span></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">26</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:45pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#iae5a9be0eb9445d192fae822d22be09f_7">Table of Contents</a></span></div></div><div style="margin-top:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Contract Revenue</span></div><div style="margin-top:6pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Contract revenues with pharmaceutical companies relate to ongoing clinical trial contracts and new contracts. Contract revenue can be highly variable as it is dependent on the pharmaceutical customers&#8217; clinical trial progress which can be difficult to forecast due to variability of patient enrollment, drug safety and efficacy and other factors. Many of our historical contracts with third parties were structured to contain milestone billing payments, which typically are advance payments on work yet to be performed. These advanced payments are structured to help fund operations and are included in deferred revenue as the work has not yet been performed. These advance payments will remain in deferred revenue until we process the laboratory portion of the contracts allowing us to recognize the revenue.</span></div><div style="margin-top:6pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The COVID-19 pandemic has negatively affected and may again in the future negatively affect our pharmaceutical customers&#8217; clinical trials. The extent of such effect on our future revenue is uncertain and will depend on the duration and extent of the effects of the ongoing COVID-19 pandemic on our pharmaceutical customers&#8217; clinical trials.</span></div><div style="margin-top:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Optional Add-on Test for TERT (formerly known as PLAplus)</span></div><div style="margin-top:6pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">During the second quarter of 2021, we announced the launch of the optional add-on test for TERT (then known as PLA</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">plus</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">) available to those ordering the DMT, which delivers objective and actionable information to guide clinical management decisions for skin lesions that may be melanoma. This add-on test combines TERT promoter DNA driver mutation analyses as a reflex test to the DMT&#8217;s standard RNA gene expression test. TERT is individually associated with histopathologic features of aggressiveness and poor survival in melanoma. The combined tests elevate the sensitivity from 91% to 97% and maintain a negative predictive value of &gt;99%, resulting in a less than 1% probability of missing melanoma. By combining RNA gene expression and DNA mutation analyses, the DMT provides a highly accurate non-invasive genomic test for enhanced early melanoma detection. For a discussion of the effects of the ongoing COVID-19 pandemic on recognized revenue derived from the DMT, refer to &#8220;Assay Revenue&#8221; under &#8220;Revenue Effects Related to COVID-19 Pandemic&#8221; above.</span></div><div id="iae5a9be0eb9445d192fae822d22be09f_73"></div><div style="margin-top:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Financial Overview </span></div><div style="margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Revenue </span></div><div style="margin-top:6pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We generate revenue through laboratory services that are billed to Medicare, private medical insurance companies and to pharmaceutical companies who order our laboratory services, which can include sample collection kits, assay development, patient segmentation and stratification, genomic analysis, data analysis and reporting. Our revenue is generated from two revenue streams: assay revenue and contract revenue. Assay revenue can be highly variable as it is based on payments received by government and private insurance payors that are and are not under contract and can vary based on patient insurance coverage, deductibles and co-pays. As much of our assay revenue is driven by the samples that are sent by physicians to our central lab for testing, a key performance measure for us is samples that are received and processed by our central lab successfully, also known as billable samples. Our laboratory services are ordered by customers on projects that may span over several years, which makes our contract revenue highly variable. Segments of these contracts may be increased, delayed or eliminated based on the success of each customers&#8217; clinical trials or other factors.</span></div><div style="margin-top:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Operating Expenses </span></div><div style="margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Sales and Marketing Expenses </span></div><div style="margin-top:6pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Sales and marketing expenses are primarily related to our specialty field sales force, market research, reimbursement efforts, conference attendance, public relations, advertising, and general marketing. We expect these expenses could increase significantly if we expand our direct consumer marketing efforts and continue to add to our specialty sales force, marketing and payor access teams in the future.</span></div><div style="margin-top:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Research and Development Expenses </span></div><div style="margin-top:6pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Our research and development ("R&amp;D") expenses consist primarily of salaries and fringe benefits, clinical trials, consulting costs, facilities costs, laboratory costs, equipment expense, and depreciation. We also conduct clinical trials to validate the performance characteristics of our tests and to show medical cost benefit in support of our reimbursement efforts. We expect these expenses could increase significantly as we continue to develop new products and expand the use of our existing products.</span></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">27</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:45pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#iae5a9be0eb9445d192fae822d22be09f_7">Table of Contents</a></span></div></div><div style="margin-top:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">General and Administrative Expenses </span></div><div style="margin-top:6pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Our general and administrative expenses consist of senior management compensation, consulting, legal, billing and collections, human resources, information technology, accounting, insurance, and general business expenses. We expect our general and administrative expenses, especially employee-related costs, including stock-based compensation, insurance, accounting, and legal fees, to continue to increase due to operating as a publicly traded company.</span></div><div id="iae5a9be0eb9445d192fae822d22be09f_76"></div><div style="margin-top:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Financing Activities </span></div><div style="margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">2020 At-The-Market Offering </span></div><div style="margin-top:6pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">On November 10, 2020, the Company entered into a sales agreement with Cowen relating to the sale of shares of the Company&#8217;s common stock from time to time with an aggregate offering price of up to $50.0 million. During 2021, the Company issued an aggregate of 530,551 shares of common stock pursuant to the sales agreement at a weighted average purchase price of $46.33 resulting in aggregate gross proceeds of approximately $24.6 million, reduced by $0.7 million in issuance costs, resulting in net proceeds to the Company of approximately $23.8 million. The Company did not issue or sell any shares of common stock pursuant to the sales agreement in the first half of 2022.</span></div><div style="margin-top:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">2021 Underwritten Public Offering </span></div><div style="margin-top:6pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">On January 6, 2021, the Company, entered into an Underwriting Agreement with Cowen and William Blair &amp; Company, L.L.C. as representatives of several underwriters (the &#8220;Underwriters&#8221;). The Company agreed to issue and sell up to 4,237,288 shares of its common stock including up to 635,593 shares that could be purchased by the Underwriters pursuant to a 30-day option granted to the Underwriters by the Company.</span></div><div style="margin-top:6pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">On January 11, 2021, the Company closed the underwritten public offering of 4,872,881 shares of its common stock, which included the exercise in full by the Underwriters of their option to purchase up to 635,593 additional shares, at a price to the public of $29.50 per share. The Company&#8217;s aggregate gross proceeds from the offering, before deducting underwriting discounts and commissions and other offering expenses, were $143.7 million.</span></div><div id="iae5a9be0eb9445d192fae822d22be09f_79"></div><div style="margin-top:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Results of Operations</span></div><div style="margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Three Months Ended June&#160;30, 2022 and June&#160;30, 2021</span></div><div style="margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Assay Revenue </span></div><div style="margin-top:6pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Assay revenues grew $1.2 million, or 43%, to $4.1 million for the three months ended June&#160;30, 2022 compared to $2.9 million for the three months ended June&#160;30, 2021. Billable samples increased to approximately 18,320 for the three months ended June&#160;30, 2022 compared to approximately 11,750 for the three months ended June&#160;30, 2021. Sample volume is dependent on two major factors: the number of clinicians who order an assay in any given quarter and the number of assays ordered by each clinician during the period. The number of ordering clinicians and the utilization per clinician can vary based on a number of factors including patients presenting with skin cancer conditions, clinician reimbursement, office workflow, market awareness, clinician education and other factors. The ongoing COVID-19 pandemic has negatively affected and may continue to negatively affect our assay revenue by, among other things, limiting patient access to clinician offices for in-person testing and limiting access by our sales force for in-office sales calls. </span></div><div style="margin-top:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Contract Revenue </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> </span></div><div style="margin-top:6pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Contract revenues with pharmaceutical companies decreased $0.1&#160;million, or 59%, to $0.1 million for the three months ended June&#160;30, 2022, compared to $0.2 million for the three months ended June&#160;30, 2021. Contract revenue can be highly variable as it is dependent on the pharmaceutical customers&#8217; clinical trial progress, which can be difficult to forecast due to variability of patient enrollment, drug safety and efficacy and other factors. The ongoing COVID-19 pandemic has negatively affected and may continue to negatively affect our pharmaceutical customers&#8217; clinical trials. The extent of such effect on our future revenue is uncertain and will depend on the duration and extent of the effects of the ongoing COVID-19 pandemic on our pharmaceutical customers&#8217; clinical trials. Many of our contracts with third parties are structured to contain milestone billing payments, which typically are advanced payments on work yet to be performed. These advanced payments are structured to help fund operations and are included in deferred revenue as the work has not yet been performed. As of June&#160;30, 2022, the deferred revenue amount for these contracts, which is the advanced payments minus the value of work performed, was $1.3 million. These advanced payments will remain in deferred revenue until we process the laboratory portion of the contracts allowing us to recognize the revenue.</span></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">28</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:45pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#iae5a9be0eb9445d192fae822d22be09f_7">Table of Contents</a></span></div></div><div style="margin-top:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Cost of Revenue </span></div><div style="margin-top:6pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Cost of revenues increased $0.6&#160;million, or 25%, to $3.3 million for the three months ended June&#160;30, 2022 compared to $2.6 million for the three months ended June&#160;30, 2021. The increase was largely attributable to a higher billable sample volume in 2022, and higher consulting, software and equipment costs, partially offset by streamlined laboratory processes. As of June&#160;30, 2022, a large portion of the costs of revenue are fixed, and these costs include the CLIA facility, quality assurance, management and supervision and equipment calibration and depreciation. The variable cost of revenue expenses incurred primarily relate to compensation-related costs for our laboratory scientists and technicians, laboratory supplies, shipping costs and Smart Sticker Collection Kits. We remain committed to continuing the automation of our laboratory processes in order to become more cost efficient and productive.</span></div><div style="margin-top:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Operating Expenses </span></div><div style="margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Sales and Marketing </span></div><div style="margin-top:6pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Sales and marketing expenses increased $7.1 million, or 90%, to $15.0&#160;million for the three months ended June&#160;30, 2022 compared to $7.9 million for the three months ended June&#160;30, 2021. The increase was primarily attributable to higher compensation-related costs from the expansion of the commercial team, increased spending on marketing and payor infrastructure and activities, and additional software and travel expenses. We could add to our specialty sales force, marketing and payor access teams in the future, and increase spending on direct-to-consumer marketing campaigns, which would collectively increase our sales and marketing expenses significantly.</span></div><div style="margin-top:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Research and Development </span></div><div style="margin-top:6pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">R&amp;D expenses increased $3.3&#160;million, or 92%, to $6.9 million for the three months ended June&#160;30, 2022 compared to $3.6&#160;million for the three months ended June&#160;30, 2021. The increase was due to higher compensation costs of expanding the R&amp;D team, including the addition of some senior leadership, increased clinical trial costs and increased spending on laboratory supplies to support new product development. These expenses could increase as we continue to grow the R&amp;D team and focus on the development of our Luminate test, our basal and squamous cell skin cancer assays and other products in our pipeline.</span></div><div style="margin-top:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">General and Administrative </span></div><div style="margin-top:6pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">General and administrative expenses increased $2.6 million, or 41%, to $8.9&#160;million for the three months ended June&#160;30, 2022 compared to $6.3 million for the three months ended June&#160;30, 2021. The increase was primarily due to higher payroll-related costs and stock-based compensation as we continue to add additional infrastructure such as human resources, billing, information technology and legal resources, and higher consulting expenses, and insurance.</span></div><div style="margin-top:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Interest Income, net </span></div><div style="margin-top:6pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Interest income, net for the three months ended June&#160;30, 2022 was $0.1 million compared to interest income, net of $35,000 for the three months ended June&#160;30, 2021. Interest income, net for the three months ended June&#160;30, 2022 consists primarily of interest earned on our short-term marketable securities.</span></div><div style="margin-top:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Change in Fair Value of Warrant Liability </span></div><div style="margin-top:6pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Change in fair value of warrant liability for the three months ended June&#160;30, 2022 was a gain of $0.1 million compared to a gain of $0.2 million for the three months ended June&#160;30, 2021. The change in fair value of warrant liability is calculated by adjusting the value of the outstanding Private SPAC Warrants held by original holders to the current market value at each reporting period.</span></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">29</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:45pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#iae5a9be0eb9445d192fae822d22be09f_7">Table of Contents</a></span></div></div><div style="margin-top:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Six Months Ended June&#160;30, 2022 and June&#160;30, 2021</span></div><div style="margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Assay Revenue </span></div><div style="margin-top:6pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Assay revenues increased $2.6 million, or 50%, to $7.7 million for the six months ended June 30, 2022 compared to $5.1 million for the six months ended June 30, 2021. Billable samples increased to approximately 32,690 for the six months ended June 30, 2022 compared to approximately 21,150 for the six months ended June 30, 2021. The increase in assay revenue was primarily due to higher billable sample volume. The ongoing COVID-19 pandemic has negatively affected and will continue to negatively affect our assay revenue by, among other things, limiting patient access to clinician offices for in-person testing and limiting access by our sales force for in-office sales calls.</span></div><div style="margin-top:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Contract Revenue </span></div><div style="margin-top:6pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Contract revenues with pharmaceutical companies decreased $0.3 million, or 47%, to $0.3&#160;million for the six months ended June 30, 2022, compared to $0.5&#160;million for the six months ended June 30, 2021. Contract revenue can be highly variable as it is dependent on the pharmaceutical customers&#8217; clinical trial progress, which can be difficult to forecast due to variability of patient enrollment, drug safety and efficacy and other factors. The ongoing COVID-19 pandemic has negatively affected and may continue to negatively affect our pharmaceutical customers&#8217; clinical trials. The extent of such effect on our future revenue is uncertain and will depend on the duration and extent of the effects of the ongoing COVID-19 pandemic on our pharmaceutical customers&#8217; clinical trials. </span></div><div style="margin-top:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Cost of Revenue </span></div><div style="margin-top:6pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Cost of revenues increased $2.2&#160;million, or 48%, to $6.8&#160;million for the six months ended June 30, 2022 compared to $4.6&#160;million for the six months ended June 30, 2021. The increase was largely attributable to a higher billable sample volume in 2022, and higher consulting, software and equipment costs, partially offset by streamlined laboratory processes. As of June&#160;30, 2022, a large portion of the costs of revenue are fixed, and these costs include the CLIA facility, quality assurance, management and supervision and equipment calibration and depreciation. The variable cost of revenue expenses incurred primarily relate to compensation-related costs for our laboratory scientists and technicians, laboratory supplies, shipping costs, equipment maintenance, and utilities. We remain committed to continuing the automation of our laboratory processes in order to become more cost efficient and productive.</span></div><div style="margin-top:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Operating Expenses </span></div><div style="margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Sales and Marketing </span></div><div style="margin-top:6pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Sales and marketing expenses increased $16.0 million, or 111%, to $30.4 million for the six months ended June 30, 2022 compared to $14.4&#160;million for the six months ended June 30, 2021. The increase was primarily attributable to higher compensation-related costs from the expansion of the commercial team, increased spending on marketing and payor infrastructure and activities, and additional software, conference and travel expenses. We could add to our specialty sales force, marketing and payor access teams in the future, and increase spending on direct-to-consumer marketing campaigns, which would collectively increase our sales and marketing expenses significantly.</span></div><div style="margin-top:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Research and Development </span></div><div style="margin-top:6pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">R&amp;D expenses increased $7.4&#160;million, or 127%, to $13.3&#160;million for the six months ended June 30, 2022 compared to $5.8 million for the six months ended June 30, 2021 The increase was due to higher compensation costs of expanding the R&amp;D team, including the addition of some senior leadership, increased clinical trial costs and increased spending on laboratory supplies to support new product development. These expenses could increase as we continue to grow the R&amp;D team and focus on the development of our Luminate test, our basal and squamous cell skin cancer assays and other products in our pipeline.</span></div><div style="margin-top:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">General and Administrative </span></div><div style="margin-top:6pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">General and administrative expenses increased $6.0&#160;million, or 52%, to $17.5&#160;million for the six months ended June 30, 2022 compared to $11.5&#160;million for the six months ended June 30, 2021. The increase was primarily due to higher payroll-related costs and stock-based compensation as we continue to add additional infrastructure such as human resources, billing, information technology and legal resources, and higher consulting expenses and insurance.</span></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">30</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:45pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#iae5a9be0eb9445d192fae822d22be09f_7">Table of Contents</a></span></div></div><div style="margin-top:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Interest Income, net </span></div><div style="margin-top:6pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Interest income, net for the six months ended June 30, 2022 was $0.2 million compared to interest income, net of $69,000 for the six months ended June 30, 2021. Interest income, net for the six months ended June 30, 2022 consists primarily of interest earned on our short-term marketable securities.</span></div><div style="margin-top:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Change in Fair Value of Warrant Liability </span></div><div style="margin-top:6pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Change in fair value of warrant liability for the six months ended June 30, 2022 was a gain of $0.1 million compared to a loss of $1.5 million for the six months ended June 30, 2021. The change in fair value of warrant liability is calculated by adjusting the value of the outstanding Private SPAC Warrants held by original holders to the current market value at each reporting period. </span></div><div id="iae5a9be0eb9445d192fae822d22be09f_82"></div><div style="margin-top:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Liquidity and Capital Resources </span></div><div style="margin-top:6pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We have never been profitable and have historically incurred substantial net losses, including net losses of $36.5 million for the twelve months ended December 31, 2020, $78.3 million for the twelve months ended December 31, 2021 and $59.7&#160;million for the six months ended June 30, 2022. As of June&#160;30, 2022, our accumulated deficit was $266.1 million. For the six months ended June 30, 2022, we had negative operating cash flow of $49.2 million. At the end of 2020 and throughout 2021, we raised approximately $44.5 million in gross proceeds facilitated through our At-the-Market Offering. In addition, we completed the 2021 Underwritten Public Offering in January 2021, which raised a total of $143.7 million in gross proceeds. We have historically financed operations through private placement and public equity offerings.</span></div><div style="margin-top:12pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We expect our losses to continue as a result of costs relating to ongoing R&amp;D expenses, increased general and administrative expenses and increased sales and marketing costs for existing and planned products. These losses have had, and will continue to have, an adverse effect on our working capital. Because of the numerous risks and uncertainties associated with our commercialization and development efforts, we are unable to predict when we will become profitable, and we may never become profitable. Our inability to achieve and then maintain profitability would negatively affect our business, financial condition, results of operations and cash flows.</span></div><div style="margin-top:12pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">As of June&#160;30, 2022, our cash and cash equivalents totaled approximately $120.3 million and short-term marketable securities totaled approximately $53.5 million. Based on our current business operations, we believe our current cash, cash equivalents and short-term marketable securities will be sufficient to meet our anticipated cash requirements for at least the next 12 months. While we believe we have enough capital to fund anticipated operating costs for at least the next 12 months, we expect to incur significant additional operating losses over at least the next several years. We anticipate that we will raise additional capital through equity offerings, debt financings, collaborations or licensing arrangements in order to support our planned operations and to continue developing and commercializing genomic tests. We may also consider raising additional capital in the future to expand our business, to pursue strategic investments or to take advantage of financing opportunities. Our present and future funding requirements will depend on many factors, including:</span></div><div style="margin-top:6pt;padding-left:54pt;text-indent:-27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:23.5pt">our revenue growth rate and ability to generate cash flows from operating activities;</span></div><div style="margin-top:6pt;padding-left:54pt;text-indent:-27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:23.5pt">the willingness of clinicians and their patients to use our telemedicine option for the DMT and the duration and extent of the effects of the ongoing COVID-19 pandemic in reducing patient access to clinician offices for in-person testing and access by our sales force for in-office sales calls;</span></div><div style="margin-top:6pt;padding-left:54pt;text-indent:-27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:23.5pt">the duration and extent of the effects of the ongoing COVID-19 pandemic on our pharmaceutical customers&#8217; clinical trials;</span></div><div style="margin-top:6pt;padding-left:54pt;text-indent:-27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:23.5pt">our sales and marketing and R&amp;D activities;</span></div><div style="margin-top:6pt;padding-left:54pt;text-indent:-27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:23.5pt">effects of competing technological and market developments; </span></div><div style="margin-top:6pt;padding-left:54pt;text-indent:-27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:23.5pt">costs of and potential delays in product development; </span></div><div style="margin-top:6pt;padding-left:54pt;text-indent:-27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:23.5pt">changes in regulatory oversight applicable to our tests; and </span></div><div style="margin-top:6pt;padding-left:54pt;text-indent:-27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:23.5pt">timing of and costs related to future international expansion. </span></div><div style="margin-top:12pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">There can be no assurances as to the availability of additional financing or the terms upon which additional financing may be available to us. If we are unable to obtain sufficient funding at acceptable terms, we may be forced to significantly curtail our operations, and the lack of sufficient funding may have a material adverse impact on our ability to continue as a going concern.</span></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">31</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:45pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#iae5a9be0eb9445d192fae822d22be09f_7">Table of Contents</a></span></div></div><div style="margin-top:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Cash Flow Analysis </span></div><div style="margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Six Months Ended June&#160;30, 2022</span></div><div style="margin-top:6pt;text-indent:27pt"><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Net cash used in operating activities for the six months ended June 30, 2022 totaled $49.2&#160;million, primarily driven by the $59.7 million net loss offset partially by non-cash related items, including $8.7 million in stock-based compensation, $1.1 million in amortization of operating lease right of use assets and $0.8 million in depreciation and $0.3 million in amortization of premiums, net of accretion of discounts on marketable securities. In addition, we had a net cash inflow of $0.6 million through net changes in working capital balances driven primarily by cash inflows of $2.7 million from the increase in accrued compensation and $0.5 million through the decrease of prepaid expenses and other current assets, partially offset by cash outflows of  $1.0 million through the increase of inventory and $0.7 million through the decrease of operating lease liabilities. </span></div><div style="margin-top:12pt;text-indent:27pt"><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Net cash used in investing activities for the six months ended June 30, 2022 totaled $7.4 million, which related to the outflow from the purchase of $20.2 million of marketable securities and $1.4 million from the purchase of equipment offset by the inflow from the maturity of marketable securities of $14.1 million. Additional laboratory equipment investment will be needed to install complex automation systems and other genomic testing equipment needed to expand testing capacity.</span></div><div style="margin-top:12pt;text-indent:27pt"><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Net cash provided by financing activities for the six months ended June 30, 2022 totaled $0.5 million, which was driven primarily by $0.5 million in proceeds from contributions to the employee stock purchase plan.</span></div><div id="iae5a9be0eb9445d192fae822d22be09f_85"></div><div style="margin-top:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Off-Balance Sheet Arrangements</span></div><div style="margin-top:6pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">As of June&#160;30, 2022, we did not have any off-balance sheet arrangements, as such term is defined under Item 303 of Regulation S-K, that have or are reasonably likely to have a current or future effect on our financial condition, changes in financial condition, revenues or expenses, results of operations, liquidity, capital expenditures or capital resources that is material to investors.</span></div><div id="iae5a9be0eb9445d192fae822d22be09f_88"></div><div style="margin-top:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Critical Accounting Policies and Significant Judgments and Estimates </span></div><div style="margin-top:6pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Critical accounting policies, significant judgments, and estimates are those that we believe are most important for the portrayal of the Company&#8217;s financial condition and results, and that require management&#8217;s most subjective and complex judgments. Judgments and uncertainties regarding the application of these policies may result in materially different amounts being reported under various conditions or using different assumptions. There have been no material changes to the critical accounting estimates previously disclosed in the Company&#8217;s Annual Report on Form 10-K for the fiscal year ended December 31, 2021, and disclosed in Note 1(h) of the condensed consolidated financial statements herein.</span></div><div id="iae5a9be0eb9445d192fae822d22be09f_91"></div><div style="margin-top:12pt"><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Recent Accounting Pronouncements</span></div><div style="margin-top:6pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">See Item 1 of Part I, Note 1(l) of the condensed consolidated financial statements herein.</span></div><div id="iae5a9be0eb9445d192fae822d22be09f_94"></div><div style="margin-top:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Item 3. Quantitative and Qualitative Disclosures About Market Risk.</span></div><div style="margin-top:6pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Our cash, cash equivalents, and short-term marketable securities are subject to economic risk which could affect our results of operations, financial condition and cash flows. We manage our exposure to this market risk through our regular operating and financing activities.</span></div><div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Interest Rate Risk</span></div><div style="margin-top:6pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The primary objective of our investment activities is capital preservation to fund operations, while at the same time maximizing investment income without significantly increasing investment risk. To achieve these objectives, our investment policy allows for a portfolio of cash equivalents and investments in a variety of securities, including money market funds, U.S. government debt and corporate debt securities. Due to the short-term and conservative nature of our investments, we do not believe that we have a material exposure to interest rate risk. A 100 basis point change in interest rates would not have a significant impact on the total value of our portfolio.</span></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">32</span></div></div></div><div id="iae5a9be0eb9445d192fae822d22be09f_97"></div><hr style="page-break-after:always"/><div style="min-height:45pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#iae5a9be0eb9445d192fae822d22be09f_7">Table of Contents</a></span></div></div><div style="margin-top:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Item 4. Controls and Procedures.</span></div><div style="margin-top:6pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Disclosure controls and procedures enable us to record, process, summarize and report information required to be included in our Exchange Act filings within the required time period. Our disclosure controls and procedures include controls and procedures designed to ensure that information required to be disclosed by us in the periodic reports filed with the Securities and Exchange Commission is accumulated and communicated to our management, including our principal executive, financial and accounting officers, or persons performing similar functions, as appropriate to allow timely decisions regarding required disclosure.</span></div><div style="margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Evaluation of Disclosure Controls and Procedures</span></div><div style="margin-top:6pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Our management, with the participation of our principal executive officer and our principal financial officer, evaluated the effectiveness of our disclosure controls and procedures as of the end of the period covered by this Quarterly Report on Form 10-Q, as defined in Rule 13a-15(e) and 15d-15(e) promulgated under the Exchange Act. Based upon that evaluation, our principal executive officer and our principal financial officer concluded that, as of December 31, 2021, the Company&#8217;s disclosure controls and procedures were not effective, due to the material weakness in our internal control over financial reporting discussed in Part I, Item 9A&#8212;Controls and Procedures in our Annual Report on Form 10-K for the year ended December 31, 2021.</span></div><div style="margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Material Weakness in Internal Control Over Financial Reporting</span></div><div style="margin-top:6pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">A material weakness in internal control over financial reporting is a deficiency, or combination of deficiencies such that there is a reasonable possibility that a material misstatement of the Company&#8217;s annual or interim financial statements will not be prevented or detected on a timely basis. As the Company could not conclude that controls over the completeness, existence and accuracy of assay revenue and accounts receivable were designed and operating effectively as of December 31, 2021, the Company identified a material weakness in its controls over the financial reporting related to our assay revenue and accounts receivable process. Management identified the need to enhance our risk assessment process, enhance communications with our third-party service organization, and reassess the assay revenue and accounts receivable process to ensure appropriate design and operating effectiveness of controls.</span></div><div style="margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Plan of Remediation of Material Weaknes</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">s</span></div><div style="margin-top:6pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">To remediate these material weaknesses in our internal control over financial reporting related to assay revenue and accounts receivable described in Part I, Item 9A&#8212;Controls and Procedures in our Annual Report on Form 10-K for the year ended December 31, 2021, we plan to implement or improve documentation of alternative internal control procedures to verify the completeness and accuracy of customer contracts received and the delivery of test results. The material weakness cannot be considered remediated until the controls operate for a sufficient period and management has concluded, through testing, that our internal controls are operating effectively.</span></div><div style="margin-top:6pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Other than the changes made in remediating the material weakness described above, there has been no change in the Company&#8217;s internal control over financial reporting that occurred during the quarter ended June 30, 2022 that have materially affected, or is reasonably likely to materially affect, our internal control over financial reporting.</span></div><div style="margin-top:6pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">After giving full consideration to the material weakness referenced above, and the additional analyses and other procedures that we performed to ensure that our condensed consolidated financial statements included in this Quarterly Report on Form 10-Q were prepared in accordance with U.S. GAAP, our management has concluded that our condensed consolidated financial statements present fairly, in all material respects, our financial position, results of operations and cash flows for the periods disclosed in conformity with U.S. GAAP.</span></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">33</span></div></div></div><div id="iae5a9be0eb9445d192fae822d22be09f_100"></div><hr style="page-break-after:always"/><div style="min-height:45pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#iae5a9be0eb9445d192fae822d22be09f_7">Table of Contents</a></span></div></div><div style="margin-top:18pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">PART II&#8212;OTHER INFORMATION</span></div><div id="iae5a9be0eb9445d192fae822d22be09f_103"></div><div style="margin-top:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Item 1. Legal Proceedings.</span></div><div style="margin-top:6pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We are not currently a party to any material legal proceedings. </span></div><div id="iae5a9be0eb9445d192fae822d22be09f_106"></div><div style="margin-top:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Item 1A. Risk Factors.</span></div><div style="margin-top:6pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">There have not been any material changes to the risk factors disclosed in our Annual Report on Form 10-K for the year ended December 31, 2021.</span></div><div id="iae5a9be0eb9445d192fae822d22be09f_109"></div><div style="margin-top:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Item 2. Unregistered Sales of Equity Securities and Use of Proceeds.</span></div><div style="margin-top:6pt;text-indent:27pt"><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Between January 5, 2022 and May 27, 2022, we issued an aggregate of 20,320 shares of common stock pursuant to the exercise of management warrants that were issued by DermTech Operations and assumed by us in connection with the Business Combination. These warrants had an exercise price of $1.08 per share and were exercised for an aggregate exercise price of $21,946.</span></div><div style="margin-top:6pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The issuances of the shares were deemed to be exempt from registration under the Securities Act in reliance on Section 4(a)(2) of the Securities Act. The recipients of the shares represented their intention to acquire the securities for investment only and not with a view to, or for sale in connection with, any distribution thereof, and appropriate legends were affixed to the securities.</span></div><div id="iae5a9be0eb9445d192fae822d22be09f_428"></div><div style="margin-top:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Item 5. Other Information.</span></div><div style="margin-top:6pt;text-indent:27pt"><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">On August 8, 2022, we entered into a Sales Agreement (the &#8220;Sales Agreement&#8221;), with Cowen with respect to an at-the-market offering program under which the Company may offer and sell, from time to time at its sole discretion, shares of its common stock having an aggregate offering price of up to $75.0 million (the &#8220;Placement Shares&#8221;), through Cowen as its sales agent.</span></div><div style="margin-top:6pt;text-indent:27pt"><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Under the Sales Agreement, the Company will set the parameters for the sale of the Placement Shares, including the number of Placement Shares to be issued, the time period during which sales are requested to be made, limitations on the number of Placement Shares that may be sold in any one trading day and any minimum price below which sales may not be made. Subject to the terms of the Sales Agreement, Cowen may sell the Placement Shares by any method permitted by law deemed to be an &#8220;at the market offering&#8221; as defined in Rule 415 of the Securities Act of 1933, as amended, including, without limitation, sales made through the Nasdaq Capital Market or on any other trading market for the Company&#8217;s common stock. Cowen will use commercially reasonable efforts to sell the Placement Shares from time to time, based upon instructions from the Company (including any price, time or size limits or other customary parameters or conditions the Company may impose). The Company will pay Cowen a commission of up to three percent (3%) of the gross sales proceeds of any Placement Shares sold through Cowen under the Sales Agreement, and also has provided Cowen with customary indemnification and contribution rights.</span></div><div style="margin-top:6pt;text-indent:27pt"><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company is not obligated to make any sales of Common Stock under the Sales Agreement. The offering of Placement Shares pursuant to the Sales Agreement will terminate upon the earlier of (i) the sale of all Placement Shares subject to the Sales Agreement or (ii) termination of the Sales Agreement in accordance with its terms.</span></div><div style="margin-top:6pt;text-indent:27pt"><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Any Placement Shares to be offered and sold under the Sales Agreement will be issued and sold pursuant a registration statement to be filed with the Securities and Exchange Commission and a prospectus supplement to be filed in connection with the offer and sale of the Placement Shares pursuant to the Sales Agreement.</span></div><div style="margin-top:6pt;text-indent:27pt"><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">This Quarterly Report on Form 10-Q shall not constitute an offer to sell or the solicitation of an offer to buy the securities discussed herein, nor shall there be any offer, solicitation, or sale of the securities in any state in which such offer, solicitation or sale would be unlawful prior to registration or qualification under the securities laws of any such state</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">.</span></div><div><span><br/></span></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">34</span></div></div></div><div id="iae5a9be0eb9445d192fae822d22be09f_112"></div><hr style="page-break-after:always"/><div style="min-height:45pt;width:100%"><div style="-sec-extract:summary"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#iae5a9be0eb9445d192fae822d22be09f_7">Table of Contents</a></span></div></div><div style="-sec-extract:summary;margin-top:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Item 6. Exhibits.</span></div><div style="margin-top:6pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following documents are filed as part of this Form 10-Q.</span></div><div style="margin-top:12pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:6.690%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.265%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:34.481%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.265%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:6.690%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.265%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:5.876%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.265%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:7.388%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.265%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:6.690%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.527%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.533%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Exhibit<br/>No.</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Description</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Filed<br/>Herewith</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Form</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Incorporated<br/>by Reference<br/>File No.</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Date Filed</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3.1</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="http://www.sec.gov/Archives/edgar/data/1651944/000156459020053008/dmtk-ex31_197.htm">Amended and Restated Certificate of Incorporation of the Company, as amended</a></span></div></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10-Q</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">001-38118</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">11/10/20</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3.2</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="http://www.sec.gov/Archives/edgar/data/1651944/000156459020009838/dmtk-ex32_316.htm">Bylaws of the Company</a></span></div></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10-K</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">001-38118</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3/11/20</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10.1</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="ex101firstamendment-kilroy.htm">First Amendment Office Lease, dated April 22, 2022, by and between the Company and Kilroy Realty, L.P.</a></span></div></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">X</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10.2</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="ex102secondamendment-kilro.htm">Second Amendment of Office Lease, dated April 22, 2022, by and between the Company and Kilroy Realty, L.P.</a></span></div></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">X</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10.3</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="ex103dermtech-secondamende.htm">Second Amended and Restated</a><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="ex103dermtech-secondamende.htm"> </a><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="ex103dermtech-secondamende.htm">Non-Employee</a><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="ex103dermtech-secondamende.htm"> </a><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="ex103dermtech-secondamende.htm">Director</a><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="ex103dermtech-secondamende.htm"> </a><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="ex103dermtech-secondamende.htm">Compensation</a><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="ex103dermtech-secondamende.htm"> </a><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="ex103dermtech-secondamende.htm">Policy</a><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="ex103dermtech-secondamende.htm"> </a><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="ex103dermtech-secondamende.htm">DermTech, Inc</a><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="ex103dermtech-secondamende.htm">.</a></span></div></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">X</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">31.1</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="dmtk-20210630xex311.htm">Certification of Principal Executive Officer Pursuant to Rules 13a-14(a) and 15d-14(a) under the Securities Exchange Act of 1934, as Adopted Pursuant to Section 302 of the Sarbanes-Oxley Act of 2002.</a></span></div></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">X</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">31.2</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="dmtk-20210630xex312.htm">Certification of Principal Financial Officer Pursuant to Rules 13a-14(a) and 15d-14(a) under the Securities Exchange Act of 1934, as Adopted Pursuant to Section 302 of the Sarbanes-Oxley Act of 2002.</a></span></div></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">X</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">32.1*</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="dmtk-20210630xex321.htm">Certification of Principal Executive Officer and Principal Financial Officer Pursuant to 18 U.S.C. Section 1350, as Adopted Pursuant to Section 906 of the Sarbanes-Oxley Act of 2002.</a></span></div></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">X</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr style="height:15pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">101.INS</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Inline XBRL Instance Document</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">X</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">101.SCH</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Inline XBRL Taxonomy Extension Schema Document</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">X</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">101.CAL</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Inline XBRL Taxonomy Extension Calculation Linkbase Document</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">X</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">101.DEF</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Inline XBRL Taxonomy Extension Definition Linkbase Document</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">X</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">101.LAB</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Inline XBRL Taxonomy Extension Label Linkbase Document</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">X</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">101.PRE</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Inline XBRL Taxonomy Extension Presentation Linkbase Document</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">X</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">104</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">The cover page from the Company's Quarterly Report on Form 10-Q for the quarter ended June 30, 2022 has been formatted in Inline XBRL.</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">X</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="21" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">* This certification is being furnished solely to accompany this report pursuant to 18 U.S.C. 1350, and are not being filed for purposes of Section 18 of the Securities Exchange Act of 1934, as amended, and is not to be incorporated by reference into any filing of the registrant, whether made before or after the date hereof, regardless of any general incorporation by reference language in such filing.</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr></table></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="-sec-extract:summary;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">35</span></div></div></div><div id="iae5a9be0eb9445d192fae822d22be09f_115"></div><hr style="page-break-after:always"/><div style="min-height:45pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#iae5a9be0eb9445d192fae822d22be09f_7">Table of Contents</a></span></div></div><div style="margin-top:18pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">SIGNATURES</span></div><div style="margin-top:12pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned thereunto duly authorized.</span></div><div style="margin-top:12pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:43.293%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:2.990%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:50.417%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="6" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">DermTech, Inc.</span></td></tr><tr style="height:15pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Date: August&#160;8, 2022</span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">By:</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">/s/ John Dobak</span></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">John Dobak, M.D.</span></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Chief Executive Officer</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-style:italic;font-weight:400;line-height:100%">(Principal Executive Officer)</span></div></td></tr><tr style="height:15pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Date: August&#160;8, 2022</span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">By:</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">/s/ Kevin Sun</span></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Kevin Sun</span></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Chief Financial Officer</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-style:italic;font-weight:400;line-height:100%">(Principal Financial and Accounting Officer)</span></div></td></tr></table></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">36</span></div></div></div></body></html>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-10.1
<SEQUENCE>2
<FILENAME>ex101firstamendment-kilroy.htm
<DESCRIPTION>EX-10.1
<TEXT>
<!DOCTYPE html PUBLIC "-//W3C//DTD HTML 4.01 Transitional//EN" "http://www.w3.org/TR/html4/loose.dtd"><html><head>
<!-- Document created using Wdesk -->
<!-- Copyright 2022 Workiva -->
<title>Document</title></head><body><div id="i30cd49bfbede4cd5a4dd75a9f0705303_1"></div><div style="min-height:72pt;width:100%"><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:100%">                                                                                                                                  Exhibit </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:14pt;font-weight:700;line-height:100%">10.01</font></div></div><div style="margin-top:12pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:100%;text-decoration:underline">FIRST AMENDMENT TO OFFICE LEASE</font></div><div style="margin-top:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">This FIRST AMENDMENT TO OFFICE LEASE (&#34;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:100%">First Amendment</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#34;) is made and entered into as of April 22, 2022 (the &#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:100%">Effective Date</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#8221;), by and between KILROY REALTY, L.P., a Delaware limited partnership (&#34;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:100%">Landlord</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#34;), and DERMTECH, INC., a Delaware corporation (&#34;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:100%">Tenant</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#34;).</font></div><div style="margin-bottom:12pt;margin-top:24pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">R E C I T A L S </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#58;</font></div><div style="margin-top:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">A.&#160;&#160;&#160;&#160;Landlord and Tenant are parties to the Office Lease dated July 1, 2021 (the &#34;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:100%">Lease</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#34;), whereby Tenant leases 95,997 rentable (76,012 usable) square feet of space (&#34;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:100%">Premises</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#34;) consisting of the entire office building located at 12340 El Camino Real, San Diego, California  92130 (&#34;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:100%">Building</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#34;).</font></div><div style="margin-top:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">B.&#160;&#160;&#160;&#160;Landlord and Tenant desire to enter into this First Amendment to make certain modifications to the Lease, and in connection therewith, Landlord and Tenant desire to amend the Lease as hereinafter provided.</font></div><div style="margin-bottom:12pt;margin-top:24pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">A G R E E M E N T </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#58;</font></div><div style="margin-top:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">NOW, THEREFORE, in consideration of the foregoing recitals and the mutual covenants contained herein, and for other good and valuable consideration, the receipt and sufficiency of which are hereby acknowledged, the parties hereto hereby agree as follows&#58;</font></div><div style="margin-top:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">1.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:100%;padding-left:27pt;text-decoration:underline">Capitalized Terms</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">.  All capitalized terms when used herein shall have the same meaning as is given such terms in the Lease unless expressly superseded by the terms of this First Amendment.</font></div><div style="margin-top:6pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">2.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:100%;padding-left:27pt;text-decoration:underline">Additional Improvement Allowance</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">.  Pursuant to the terms of </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">Section 3.3</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%"> of the Work Letter attached to the Lease, Tenant has the right to utilize the Additional Improvement Allowance in connection with Tenant&#8217;s performance of the Improvements.  In connection with the foregoing, Tenant hereby elects to utilize the entirety of such Additional Improvement Allowance (i.e., with respect to each Phase), and therefore Tenant shall pay the Additional Monthly Base Rent for the entire Premises and the Base Rent for the entire Premises shall be increased by the applicable Additional Monthly Rent.  The schedule below sets forth the Additional Monthly Rent for each Phase of the Premises&#58;</font></div><div style="padding-left:101.8pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:56.570%"><tr><td style="width:1.0%"></td><td style="width:54.990%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:42.810%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="border-left:0.5pt solid #000000;border-top:0.5pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">Phase of Premises</font></td><td colspan="3" style="border-right:0.5pt solid #000000;border-top:0.5pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="margin-top:12pt;padding-left:2.75pt;padding-right:2.75pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">Amount of Additional </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline"><br>Monthly Rent</font></div></td></tr><tr><td colspan="3" style="border-left:0.5pt solid #000000;border-top:0.5pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">Phase I Premises</font></td><td colspan="3" style="border-left:0.5pt solid #000000;border-right:0.5pt solid #000000;border-top:0.5pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">$2,922.53</font></td></tr><tr><td colspan="3" style="border-left:0.5pt solid #000000;border-top:0.5pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">Phase II Premises</font></td><td colspan="3" style="border-left:0.5pt solid #000000;border-right:0.5pt solid #000000;border-top:0.5pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">$8,458.69</font></td></tr><tr><td colspan="3" style="border-left:0.5pt solid #000000;border-top:0.5pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">Phase III Premises</font></td><td colspan="3" style="border-left:0.5pt solid #000000;border-right:0.5pt solid #000000;border-top:0.5pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">$10,136.06</font></td></tr><tr><td colspan="3" style="border-bottom:0.5pt solid #000000;border-left:0.5pt solid #000000;border-top:0.5pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">Phase IV Premises</font></td><td colspan="3" style="border-bottom:0.5pt solid #000000;border-left:0.5pt solid #000000;border-right:0.5pt solid #000000;border-top:0.5pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">$6,454.07</font></td></tr></table></div><div style="margin-top:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">In connection with the foregoing, in order to memorialize the amount of Additional Monthly Rent to be paid by Tenant throughout the Lease Term, the Base Rent schedule set forth on </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:100%;text-decoration:underline">Schedule 1</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%"> attached to the Lease is hereby deleted in its entirety and replaced with the Base </font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:39.284%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:18.130%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:39.286%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">4889-8391-7849.3</font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">377185.00018&#47;U58er IniA&#47;gjn&#47;gjn</font></div></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><font><br></font></div><div style="text-align:right"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#91;First Amendment&#93;</font></div><div style="text-align:right"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#91;DermTech, Inc.&#93;</font></div></td></tr></table></div><div><font><br></font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div><font><br></font></div></div><div style="margin-top:12pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">Rent schedule set forth on </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:100%;text-decoration:underline">Schedule 1</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%"> attached to this First Amendment (which replacement Base Rent schedule includes the applicable amount of Additional Monthly Rent for each Phase of the Premises in addition to the Base Rent initially set forth in the Lease).  </font></div><div style="margin-top:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">3.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:100%;padding-left:27pt;text-decoration:underline">Phase 1 Commencement Date and Phase II Commencement Date</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">.  Landlord and Tenant hereby acknowledge and agree that (i) the Phase I Commencement Date occurred on September 1, 2021, and (ii) the Phase II Commencement Date occurred on March 10, 2022.  </font></div><div style="margin-top:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">4.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:100%;padding-left:27pt;text-decoration:underline">Broker</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">.  Landlord and Tenant hereby warrant to each other that they have had no dealings with any real estate broker or agent in connection with the negotiation of this First Amendment other than Cushman &#38; Wakefield (the &#34;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:100%">Broker</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#34;), and that they know of no other real estate broker or agent who is entitled to a commission in connection with this First Amendment.  Each party agrees to indemnify and defend the other party against and hold the other party harmless from and against any and all claims, demands, losses, liabilities, lawsuits, judgments, and costs and expenses (including, without limitation, reasonable attorneys' fees) with respect to any leasing commission or equivalent compensation alleged to be owing on account of the indemnifying party's dealings with any real estate broker or agent, other than the Broker, occurring by, through, or under the indemnifying party.  The terms of this </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">Section 4</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%"> shall survive the expiration or earlier termination of the term of the Lease, as hereby amended.</font></div><div style="margin-top:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">5.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:100%;padding-left:27pt;text-decoration:underline">Statutory Disclosure and Related Terms</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">.  For purposes of Section 1938(a) of the California Civil Code, Landlord hereby discloses to Tenant, and Tenant hereby acknowledges, that the Premises have not undergone inspection by a Certified Access Specialist (CASp).  </font></div><div style="margin-top:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">6.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:100%;padding-left:27pt;text-decoration:underline">Signatures</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">.  The parties hereto consent and agree that this First Amendment may be signed and&#47;or transmitted by facsimile, e-mail of a .pdf document or using electronic signature technology (e.g., via DocuSign or similar electronic signature technology), and that such signed electronic record shall be valid and as effective to bind the party so signing as a paper copy bearing such party&#8217;s handwritten signature. The parties further consent and agree that (1) to the extent a party signs this First Amendment using electronic signature technology, by clicking &#8220;SIGN&#8221;, such party is signing this First Amendment electronically, and (2) the electronic signatures appearing on this First Amendment shall be treated, for purposes of validity, enforceability and admissibility, the same as handwritten signatures.</font></div><div style="margin-top:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">7.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:100%;padding-left:27pt;text-decoration:underline">No Further Modification</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">.  Except as set forth in this First Amendment, all of the terms and provisions of the Lease shall remain unmodified and in full force and effect.  </font></div><div style="margin-top:12pt;text-align:justify;text-indent:36pt"><font><br></font></div><div style="margin-top:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">IN WITNESS WHEREOF, this First Amendment has been executed as of the day and year first above written.  </font></div><div style="margin-top:0.12pt;text-align:justify;text-indent:0.36pt"><font><br></font></div><div style="margin-top:0.12pt;text-align:justify;text-indent:0.36pt"><font><br></font></div><div style="margin-top:0.12pt;text-align:justify;text-indent:0.36pt"><font><br></font></div><div style="margin-top:0.12pt;text-align:justify;text-indent:0.36pt"><font><br></font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:39.284%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:18.130%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:39.286%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">4889-8391-7849.3</font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">377185.00018&#47;U58er IniA&#47;gjn&#47;gjn</font></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">-2-</font></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><font><br></font></div><div style="text-align:right"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#91;First Amendment&#93;</font></div><div style="text-align:right"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#91;DermTech, Inc.&#93;</font></div></td></tr></table></div><div><font><br></font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div><font><br></font></div></div><div style="margin-top:12pt;text-align:justify;text-indent:0.36pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:96.314%"><tr><td style="width:1.0%"></td><td style="width:32.843%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.377%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:51.480%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:100%">&#34;LANDLORD&#34;&#58;</font></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">REALTY, L.P.,</font></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">a Delaware limited partnership</font></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">By&#58;</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">Kilroy Realty Corporation,</font></td></tr><tr style="height:14pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">Its&#58;  General Partner</font></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">By&#58; &#47;s&#47; Nelson Ackerly </font></td></tr><tr style="height:15pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">Name&#58;</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#160;Nelson Ackerly</font></td></tr><tr style="height:15pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">Its&#58;</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">Senior Vice President, Leasing California </font></td></tr><tr style="height:15pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">By</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#47;s&#47; Annie Coldwell </font></td></tr><tr style="height:14pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">Name&#58;</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">Annie Coldwell</font></td></tr><tr style="height:14pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">Its&#58;</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">Vice President, Leasing </font></td></tr><tr style="height:15pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td></tr><tr style="height:15pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:100%">&#34;TENANT&#34;&#58;</font></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">DERMTECH, INC.,</font></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="margin-top:0.12pt;padding-left:2.75pt;padding-right:2.75pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">a Delaware corporation</font></div></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">By</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#160;&#47;s&#47; John Dobak</font></td></tr><tr style="height:15pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">Name&#58;</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">John Dobak, M.D. </font></td></tr><tr style="height:15pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">Its&#58;</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">CEO</font></td></tr><tr style="height:15pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">By</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#47;s&#47; Kevin Sun </font></td></tr><tr style="height:15pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">Name&#58;</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">Kevin Sun </font></td></tr><tr style="height:15pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">Its&#58;</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">CFO</font></td></tr><tr style="height:15pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td></tr></table></div><div style="margin-top:0.12pt;text-align:justify;text-indent:0.36pt"><font><br></font></div><div style="margin-top:12pt;text-align:justify;text-indent:36pt"><font><br></font></div><div><font><br></font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:39.284%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:18.130%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:39.286%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">4889-8391-7849.3</font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">377185.00018&#47;U58er IniA&#47;gjn&#47;gjn</font></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">-3-</font></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><font><br></font></div><div style="text-align:right"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#91;First Amendment&#93;</font></div><div style="text-align:right"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#91;DermTech, Inc.&#93;</font></div></td></tr></table></div><div><font><br></font></div></div></div><div id="i30cd49bfbede4cd5a4dd75a9f0705303_4"></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div><font><br></font></div></div><div style="margin-bottom:12pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:100%;text-decoration:underline">SCHEDULE 1</font></div><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:100%;text-decoration:underline">BASE RENT</font></div><div style="text-align:center"><font><br></font></div><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:18.095%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:20.881%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:22.274%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:18.249%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:15.001%"></td><td style="width:0.1%"></td></tr><tr><td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:100%">Phase I Premises</font></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">Period</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:2.75pt;padding-right:2.75pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">Monthly<br>Installment<br></font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">of Base Rent</font></div></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">Phase I Commencement Date &#8211; Month 12 thereafter</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">$29,931.33</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">Months 13-24</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">$58,061.25</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">25 - 36</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">$59,715.41</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">37 &#8211; 48</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">$61,419.20</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">49 &#8211; 60</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">$63,174.10</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">61 &#8211; 72</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">$64,981.65</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">73 &#8211; 84</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">$66,843.42</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">85 - 96</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">$68,761.05</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">96 &#8211; 108</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">$70,736.21</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">109 &#8211; 120</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">$72,770.62</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">121 - Lease Expiration Date)</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">$74,866.06</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr></table></div><div><font><br></font></div><div><font><br></font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:39.284%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:18.130%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:39.286%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">4889-8391-7849.3</font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">377185.00018&#47;U58er IniA&#47;gjn&#47;gjn</font></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">SCHEDULE 1</font></div><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">-1-</font></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><font><br></font></div><div style="text-align:right"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#91;First Amendment&#93;</font></div><div style="text-align:right"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#91;DermTech, Inc.&#93;</font></div></td></tr></table></div><div><font><br></font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div><font><br></font></div></div><div><font><br></font></div><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:18.035%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:20.504%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:24.671%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:17.572%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:13.718%"></td><td style="width:0.1%"></td></tr><tr><td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:100%">Phase II Premises</font></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">Period</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:2.75pt;padding-right:2.75pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">Monthly<br>Installment<br></font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">of Base Rent</font></div></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">Phase II Commencement Date &#8211; Month 12 thereafter</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">$86,254.74</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">Months 13-24</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">$167,280.06</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">25 - 36</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">$172,044.70</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">37 &#8211; 48</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">$176,952.28</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">49 &#8211; 60</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">$182,007.09</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">61 &#8211; 72</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">$187,213.54</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">73 &#8211; 84</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">$192,576.19</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">85 - 96</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">$198,099.72</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">96 &#8211; 108</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">$203,788.95</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">109 &#8211; 120</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">$209,648.86</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">121 - Lease Expiration Date)</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">$215,684.56</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr></table></div><div><font><br></font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:39.284%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:18.130%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:39.286%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">4889-8391-7849.3</font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">377185.00018&#47;U58er IniA&#47;gjn&#47;gjn</font></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">SCHEDULE 1</font></div><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">-2-</font></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><font><br></font></div><div style="text-align:right"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#91;First Amendment&#93;</font></div><div style="text-align:right"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#91;DermTech, Inc.&#93;</font></div></td></tr></table></div><div><font><br></font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div><font><br></font></div></div><div><font><br></font></div><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:18.035%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:20.504%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:24.671%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:17.572%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:13.718%"></td><td style="width:0.1%"></td></tr><tr><td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:100%">Phase III Premises</font></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">Period</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:2.75pt;padding-right:2.75pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">Monthly<br>Installment<br></font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">of Base Rent</font></div></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">Phase III Commencement Date &#8211; Month 12 thereafter</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">$101,529.26</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">Months 13-24</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">$196,716.14</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">25 - 36</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">$202,313.54</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">37 &#8211; 48</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">$208,078.86</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">49 &#8211; 60</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">$214,017.14</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">61 &#8211; 72</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">$220,133.57</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">73 &#8211; 84</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">$226,433.50</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">85 - 96</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">$232,922.42</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">96 &#8211; 108</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">$239,606.01</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">109 &#8211; 120</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">$246,490.11</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">121 - Lease Expiration Date)</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">$253,580.73</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr></table></div><div><font><br></font></div><div><font><br></font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:39.284%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:18.130%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:39.286%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">4889-8391-7849.3</font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">377185.00018&#47;U58er IniA&#47;gjn&#47;gjn</font></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">SCHEDULE 1</font></div><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">-3-</font></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><font><br></font></div><div style="text-align:right"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#91;First Amendment&#93;</font></div><div style="text-align:right"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#91;DermTech, Inc.&#93;</font></div></td></tr></table></div><div><font><br></font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div><font><br></font></div></div><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:18.035%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:20.504%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:24.671%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:17.572%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:13.718%"></td><td style="width:0.1%"></td></tr><tr><td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:100%">Phase IV Premises</font></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">Period</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:2.75pt;padding-right:2.75pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">Monthly<br>Installment<br></font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">of Base Rent</font></div></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">Phase IV Commencement Date &#8211; Month 12 thereafter</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">$64,648.07</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">Months 13-24</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">$125,257.67</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">25 - 36</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">$128,821.77</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">37 &#8211; 48</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">$132,492.81</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">49 &#8211; 60</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">$136,273.97</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">61 &#8211; 72</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">$140,168.57</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">73 &#8211; 84</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">$144,180.01</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">85 - 96</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">$148,311.79</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">96 &#8211; 108</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">$152,567.52</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">109 &#8211; 120</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">$156,950.92</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">121 - Lease Expiration Date)</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">$161,465.83</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr style="height:24pt"><td colspan="15" style="padding:0 1pt"></td></tr></table></div><div style="text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">NOTE&#58; The above Base Rent schedule has been determined as if the Phase IV Lease Commencement Date provides for a Lease Term for Phase IV in excess of 120 months, and Landlord and Tenant hereby agree that if the Phase IV Lease Commencement Date does not occur to allow for more than 120 months of Base Rent payments, then such Base Rent schedule shall be deemed to be modified appropriately so that Tenant pays Base Rent through the Lease Expiration Date.</font></div><div style="text-align:center"><font><br></font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:39.284%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:18.130%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:39.286%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">4889-8391-7849.3</font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">377185.00018&#47;U58er IniA&#47;gjn&#47;gjn</font></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">SCHEDULE 1</font></div><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">-4-</font></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><font><br></font></div><div style="text-align:right"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#91;First Amendment&#93;</font></div><div style="text-align:right"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#91;DermTech, Inc.&#93;</font></div></td></tr></table></div><div><font><br></font></div></div></div></body></html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-10.2
<SEQUENCE>3
<FILENAME>ex102secondamendment-kilro.htm
<DESCRIPTION>EX-10.2
<TEXT>
<!DOCTYPE html PUBLIC "-//W3C//DTD HTML 4.01 Transitional//EN" "http://www.w3.org/TR/html4/loose.dtd"><html><head>
<!-- Document created using Wdesk -->
<!-- Copyright 2022 Workiva -->
<title>Document</title></head><body><div id="i5f74f095d9634a0aaed5c3217bf63e6b_1"></div><div style="min-height:72pt;width:100%"><div style="text-align:right"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:100%">Exhibit 10.2</font></div></div><div style="margin-top:12pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:100%;text-decoration:underline">SECOND AMENDMENT TO OFFICE LEASE</font></div><div style="margin-top:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">This SECOND AMENDMENT TO OFFICE LEASE (&#34;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:100%">Second Amendment</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#34;) is made and entered into as of April 22, 2022 (the &#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:100%">Effective Date</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#8221;), by and between KILROY REALTY, L.P., a Delaware limited partnership (&#34;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:100%">Landlord</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#34;), and DERMTECH, INC., a Delaware corporation (&#34;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:100%">Tenant</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#34;).</font></div><div style="margin-bottom:12pt;margin-top:24pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">R E C I T A L S </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#58;</font></div><div style="margin-top:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">A.&#160;&#160;&#160;&#160;Landlord and Tenant are parties to the Office Lease dated July 1, 2021 (the &#34;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:100%">Original</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%"> </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:100%">Lease</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#34;), as amended by that certain First Amendment to Office Lease dated April 22, 2022 (the &#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:100%">First Amendment</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">,&#8221; and together with the Original Lease, the &#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:100%">Lease</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#8221;), whereby Tenant leases 95,997 rentable (76,012 usable) square feet of space (&#34;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:100%">Existing Premises</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#34;) consisting of the entire office building located at 12340 El Camino Real, San Diego, California  92130 (&#34;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:100%">Building</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#34;).</font></div><div style="margin-top:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">B.&#160;&#160;&#160;&#160;Tenant desires to expand the Existing Premises to include that certain space consisting of 14,085 rentable (and usable) square feet of space which is currently the executive parking level of the parking facilities serving the Building (the &#34;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:100%">Expansion Premises</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#34;), as delineated on </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:100%;text-decoration:underline">Exhibit A</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%"> attached hereto and made a part hereof, and to make other modifications to the Lease, and in connection therewith, Landlord and Tenant desire to amend the Lease as hereinafter provided.</font></div><div style="margin-bottom:12pt;margin-top:24pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">A G R E E M E N T </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#58;</font></div><div style="margin-top:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">NOW, THEREFORE, in consideration of the foregoing recitals and the mutual covenants contained herein, and for other good and valuable consideration, the receipt and sufficiency of which are hereby acknowledged, the parties hereto hereby agree as follows&#58;</font></div><div style="margin-top:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">1.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:100%;padding-left:27pt;text-decoration:underline">Capitalized Terms</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">.  All capitalized terms when used herein shall have the same meaning as is given such terms in the Lease unless expressly superseded by the terms of this Second Amendment.</font></div><div style="margin-top:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">2.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:100%;padding-left:27pt;text-decoration:underline">Modification of Premises</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">.  Effective as of the Expansion Possession Date (defined below) (such date is also the &#34;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:100%">Expansion Commencement Date</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#34;) Tenant shall lease from Landlord and Landlord shall lease to Tenant the Expansion Premises.  The date of Landlord's tendering of possession of the Expansion Premises to Tenant following the Substantial Completion of the Expansion Improvements (as defined in the Work Letter) shall be the &#34;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:100%">Expansion</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%"> </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:100%">Possession Date</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#34;.  If for any reason, Landlord is delayed in tendering possession of the Expansion Premises to Tenant by any particular date (including, without limitation, on account of any present tenant or occupant of the Premises not vacating the Premises), Landlord shall not be subject to any Losses for such failure, and the validity of the Lease shall not be impaired.  Consequently, effective upon the Expansion Commencement Date, the Existing Premises shall be increased to include the Expansion Premises.  Landlord and Tenant hereby acknowledge that such addition of the Expansion Premises to the Existing Premises shall, effective as of the Expansion Commencement Date, increase the size of the Premises to 110,082 rentable (and usable) square feet.  The Existing Premises and the Expansion Premises may hereinafter collectively be referred to as the &#34;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:100%">Premises</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">.&#34; </font></div><div style="margin-top:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">3.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:100%;padding-left:27pt;text-decoration:underline">Expansion Term&#59; Extension Options</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">.  The term of Tenant's lease of the Expansion Premises (the &#34;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:100%">Expansion Term</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#34;) shall commence on the Expansion Commencement Date and shall expire coterminously with Tenant's Lease of the Existing </font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:39.284%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:18.130%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:39.286%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">4883-5609-3194.6</font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">377185.00018&#47;U58er IniA&#47;gjn&#47;gjn</font></div></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><font><br></font></div><div style="text-align:right"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#91;Second Amendment&#93;</font></div><div style="text-align:right"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#91;DermTech, Inc.&#93;</font></div></td></tr></table></div><div><font><br></font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div><font><br></font></div></div><div style="margin-top:12pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">Premises on the Lease Expiration Date, unless sooner terminated as provided in the Lease, as hereby amended.  As of the date of this Second Amendment, Tenant&#8217;s Extension Options set forth in </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">Section 2.2</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%"> and </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:100%;text-decoration:underline">Exhibit G</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%"> of the Original Lease shall apply to the entire Premises only (i.e., Tenant must exercise the same with respect to the Existing Premises and the Expansion Premises).</font></div><div style="margin-top:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">4.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:100%;padding-left:27pt;text-decoration:underline">Base Rent</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">.</font></div><div style="margin-top:12pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">4.1.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:100%;padding-left:18pt;text-decoration:underline">Existing Premises</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">.  Notwithstanding anything to the contrary in the Lease, as hereby amended, Tenant shall continue to pay Base Rent for the Existing Premises in accordance with the terms of the Lease.  </font></div><div style="margin-top:12pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">4.2.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:100%;padding-left:18pt;text-decoration:underline">Expansion Premises</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">.  Commencing on the Expansion Commencement Date and continuing throughout the Expansion Term, Tenant shall pay to Landlord monthly installments of Base Rent for the Expansion Premises as follows (which amounts include the Additional Monthly Base Rent for the Expansion Premises as Tenant has elected to utilize the Additional Expansion Improvement Allowance pursuant to the terms of Section 10 below and </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">Section 3.3</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%"> of the Tenant Work Letter attached to this Second Amendment), and otherwise in accordance with the terms of the Lease&#58;</font></div><div style="padding-left:5.4pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:24.884%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:23.466%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:23.781%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:23.469%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="margin-top:12pt;padding-left:2.75pt;padding-right:2.75pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">Period During</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline"><br>Expansion Term</font></div></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="margin-top:12pt;padding-left:2.75pt;padding-right:2.75pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">Monthly Installment</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline"> of Base Rent</font></div></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:middle"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">Expansion Commencement Date &#8211; Month 12 thereafter</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:middle"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">$41,507.56</font></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:middle"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">Months 13 - 24</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:middle"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">$80,382.16</font></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:middle"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">Months 25 - 36</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:middle"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">$82,668.15</font></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:middle"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">Months 37 &#8211; 48</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:middle"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">$85,022.73</font></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:middle"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">Months 49 &#8211; 60</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:middle"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">$87,447.94</font></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:middle"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">Months 61 &#8211; 72</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:middle"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">$89,945.91</font></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:middle"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">Months 73 &#8211; 84</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:middle"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">$92,518.82</font></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:middle"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">Months 85 &#8211; 96</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:middle"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">$95,168.91</font></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:middle"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">Months 97 &#8211; 108</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:middle"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">$97,898.51</font></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:middle"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">Months 109 &#8211; 120</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:middle"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">$100,710.00</font></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:middle"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">Months 121 &#8211; Lease Expiration Date</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:middle"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">$103,605.83</font></td><td colspan="3" style="padding:0 1pt"></td></tr></table></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:39.284%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:18.130%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:39.286%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">-2-</font></div></td><td colspan="3" style="padding:0 1pt"></td></tr></table></div><div><font><br></font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div><font><br></font></div></div><div style="margin-top:12pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">Concurrent with Tenant&#8217;s execution of this Second Amendment, Tenant shall pay to Landlord the Base Rent payable for the Expansion Premises for the first full month of the Expansion Term.</font></div><div style="margin-top:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">5.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:100%;padding-left:27pt;text-decoration:underline">Tenant's Share of Direct Expenses</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">.  </font></div><div style="margin-top:12pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">5.1.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:100%;padding-left:18pt;text-decoration:underline">Existing Premises</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">.  Tenant shall pay Tenant's Share of Direct Expenses in connection with the Existing Premises in accordance with the terms of the Lease, provided that effective as of the Expansion Commencement Date, notwithstanding </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">Section 6</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%"> of the Summary attached to the Original Lease, Tenant&#8217;s Share for each Phase of the Existing Premises shall be as follows&#58;</font></div><div style="margin-top:12pt;padding-left:36pt;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">(a)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;padding-left:22.7pt">Tenant&#8217;s Share for Phase I&#58; 9.2586% of the Building and 5.5833% of the Project.</font></div><div style="margin-top:12pt;padding-left:36pt;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">(b)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;padding-left:22.02pt">Tenant&#8217;s Share for Phase II&#58; 26.6683% and 16.0821%% of the Project.</font></div><div style="margin-top:12pt;padding-left:36pt;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">(c)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;padding-left:22.7pt">Tenant&#8217;s Share for Phase III&#58; 31.3294% and 18.8929% of the Project.</font></div><div style="margin-top:12pt;padding-left:36pt;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">(d)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;padding-left:22.02pt">Tenant&#8217;s Share for Phase IV&#58; 19.9488% and 12.0299% of the Project.  </font></div><div style="margin-top:12pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">5.1.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:100%;padding-left:18pt;text-decoration:underline">Expansion Premises</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">.  Commencing on the Expansion Commencement Date, Tenant shall pay Tenant's Share of Direct Expenses in connection with the Expansion Premises in accordance with the terms of the Lease, provided that with respect to the calculation of Tenant's Share of Direct Expenses in connection with the Expansion Premises, the following shall apply&#58;</font></div><div style="margin-top:12pt;padding-left:108pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">5.2.1  Tenant's Share for the Expansion Premises shall equal 12.7950% of the Building and 7.7159% of the Project&#59; and</font></div><div style="margin-top:12pt;padding-left:108pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">5.2.2  the Base Year shall be the calendar year 2022&#59; provided, however, electricity is separately metered and directly paid by Tenant to the applicable utility provider or, at Landlord's option, to Landlord.</font></div><div style="margin-top:12pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">When the Lease Commencement Date has occurred as to the Entire Premises (including the Expansion Premises) Tenant&#8217;s Share shall equal 100% of the Building, and 60.31% of the Project.  </font></div><div style="margin-top:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">6.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:100%;padding-left:27pt;text-decoration:underline">Expansion Improvements</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">.  Except as specifically set forth herein, Landlord shall not be obligated to provide or pay for any improvement work or services related to the improvement of the Expansion Premises, and Tenant shall accept the Expansion Premises in its presently existing, &#34;as-is&#34; condition, provided that Landlord shall construct the improvements in the Expansion Premises pursuant to the terms of the Work Letter attached hereto as </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:100%;text-decoration:underline">Exhibit&#160;B</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">.  Notwithstanding anything to the contrary herein, if the Condition Subsequent (defined below) is not satisfied and this Second Amendment is terminated pursuant to Section 13 below, then (i) Tenant shall not be responsible for, and shall not be obligated to reimburse Landlord for, any alterations or improvements made by Landlord to the Expansion Premises as of the Effective Date of this Amendment, and (ii) unless otherwise agreed to in writing between Landlord and Tenant, Landlord shall restore the Expansion Premises to its original condition as of the date of the Original Lease and Tenant shall reimburse Landlord for the actual, out-of-pocket costs incurred by Landlord to so restore the Expansion Premises as aforesaid, but only to the condition existing as of the Effective Date of this Second Amendment.</font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:39.284%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:18.130%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:39.286%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">-3-</font></div></td><td colspan="3" style="padding:0 1pt"></td></tr></table></div><div><font><br></font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div><font><br></font></div></div><div style="margin-top:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">7.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:100%;padding-left:27pt;text-decoration:underline">Broker</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">.  Landlord and Tenant hereby warrant to each other that they have had no dealings with any real estate broker or agent in connection with the negotiation of this Second Amendment other than Cushman &#38; Wakefield (the &#34;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:100%">Broker</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#34;), and that they know of no other real estate broker or agent who is entitled to a commission in connection with this Second Amendment.  Each party agrees to indemnify and defend the other party against and hold the other party harmless from and against any and all claims, demands, losses, liabilities, lawsuits, judgments, and costs and expenses (including, without limitation, reasonable attorneys' fees) with respect to any leasing commission or equivalent compensation alleged to be owing on account of the indemnifying party's dealings with any real estate broker or agent, other than the Broker, occurring by, through, or under the indemnifying party.  The terms of this </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">Section 7</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%"> shall survive the expiration or earlier termination of the term of the Lease, as hereby amended.</font></div><div style="margin-top:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">8.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:100%;padding-left:27pt;text-decoration:underline">Parking</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">.  Effective as of the Expansion Commencement Date and continuing throughout the Expansion Term, in connection with Tenant's lease of the Expansion Premises the parking pass ratio set forth in </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">Section 9</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%"> of the Summary attached to the Original Lease shall apply to the Expansion Premises (such passes, the &#34;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:100%">Expansion Parking Passes</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#34;).  Except as set forth in this </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">Section 8</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">, Tenant shall lease the Expansion Parking Passes in accordance with the provisions of </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">Article 28</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%"> of the Original Lease.</font></div><div style="margin-bottom:6pt;margin-top:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">9.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:100%;padding-left:27pt;text-decoration:underline">Letter of Credit</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">.  Landlord and Tenant acknowledge that, in accordance with the Lease Tenant has previously delivered an L-C in the amount of $3,023,905.50.  Notwithstanding anything in the Lease to the contrary, within fourteen (14) days following the date of Tenant&#8217;s execution of this Second Amendment, Tenant shall provide an L-C (via delivery of a new L-C in such amount or an amendment to the existing L-C, which shall in either event be in a form reasonably acceptable to Landlord and in conformance with the terms of the Lease) in the total amount of $3,467,512.44 (the &#34;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:100%">New L-C</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#34;).  In connection with the foregoing, the table in </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">Section 21.3.1</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%"> of the Original Lease setting forth the reduction schedule for the L-C Amount shall be replaced with the following (provided that any reduction shall remain subject to the terms of such Section 21.3.1)&#58;</font></div><div style="padding-left:33.35pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:85.897%"><tr><td style="width:1.0%"></td><td style="width:35.840%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:27.817%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:33.043%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="border-left:0.5pt solid #000000;border-top:0.5pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">Date of Reduction</font></td><td colspan="3" style="border-top:0.5pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">Amount of Reduction</font></td><td colspan="3" style="border-right:0.5pt solid #000000;border-top:0.5pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">Remaining L-C Amount</font></td></tr><tr><td colspan="3" style="border-left:0.5pt solid #000000;border-top:0.5pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><div style="margin-top:12pt;padding-left:2.75pt;padding-right:2.75pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">Third (3</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.8pt;font-weight:400;line-height:100%;position:relative;top:-4.2pt;vertical-align:baseline">rd</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">) anniversary of Phase III Commencement Date</font></div></td><td colspan="3" style="border-left:0.5pt solid #000000;border-top:0.5pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">$1,155,837.48</font></td><td colspan="3" style="border-left:0.5pt solid #000000;border-right:0.5pt solid #000000;border-top:0.5pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">$2,311,674.96</font></td></tr><tr><td colspan="3" style="border-bottom:0.5pt solid #000000;border-left:0.5pt solid #000000;border-top:0.5pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><div style="margin-top:12pt;padding-left:2.75pt;padding-right:2.75pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">Fifth (5</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.8pt;font-weight:400;line-height:100%;position:relative;top:-4.2pt;vertical-align:baseline">th</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">) anniversary of Phase III Commencement Date</font></div></td><td colspan="3" style="border-bottom:0.5pt solid #000000;border-left:0.5pt solid #000000;border-top:0.5pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">$1,155,837.48</font></td><td colspan="3" style="border-bottom:0.5pt solid #000000;border-left:0.5pt solid #000000;border-right:0.5pt solid #000000;border-top:0.5pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">$1,155,837.48</font></td></tr></table></div><div style="margin-top:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">10.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:100%;padding-left:21pt;text-decoration:underline">Additional Expansion Improvement Allowance</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">.  Pursuant to the terms of </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">Section 3.3</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%"> of the Work Letter attached to this Second Amendment, Tenant has the right to utilize the Additional Expansion Improvement Allowance in connection with Tenant&#8217;s performance of the Expansion Improvements.  In connection with the foregoing, Tenant hereby elects to utilize the entirety of such Additional Expansion Improvement Allowance, and therefore Tenant shall pay the Additional Monthly Base Rent for the Expansion Premises and the Base Rent for the Expansion Premises shall be increased by the applicable Additional Monthly Rent for the Expansion Premises, which is $4,182.31.  The Base Rent schedule with respect to the </font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:39.284%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:18.130%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:39.286%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">-4-</font></div></td><td colspan="3" style="padding:0 1pt"></td></tr></table></div><div><font><br></font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div><font><br></font></div></div><div style="margin-top:12pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">Expansion Premises set forth in </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">Section 4.2</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%"> above includes the Additional Monthly Base Rent with respect to the Expansion Premises and the Additional Expansion Improvement Allowance.</font></div><div style="margin-top:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">11.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:100%;padding-left:21pt;text-decoration:underline">Statutory Disclosure and Related Terms</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">.  For purposes of Section 1938(a) of the California Civil Code, Landlord hereby discloses to Tenant, and Tenant hereby acknowledges, that the Expansion Premises have not undergone inspection by a Certified Access Specialist (CASp).  </font></div><div style="margin-top:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">12.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:100%;padding-left:21pt;text-decoration:underline">Signatures</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">.  The parties hereto consent and agree that this Second Amendment may be signed and&#47;or transmitted by facsimile, e-mail of a .pdf document or using electronic signature technology (e.g., via DocuSign or similar electronic signature technology), and that such signed electronic record shall be valid and as effective to bind the party so signing as a paper copy bearing such party&#8217;s handwritten signature. The parties further consent and agree that (1) to the extent a party signs this Second Amendment using electronic signature technology, by clicking &#8220;SIGN&#8221;, such party is signing this Second Amendment electronically, and (2) the electronic signatures appearing on this Second Amendment shall be treated, for purposes of validity, enforceability and admissibility, the same as handwritten signatures.</font></div><div style="margin-top:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">13.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:100%;padding-left:21pt;text-decoration:underline">Effectiveness of this Second Amendment</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">.  Tenant hereby acknowledges that the Expansion Premises is currently the executive parking level of the Building parking facilities and therefore is currently usable for parking only.  Accordingly, Landlord and Tenant hereby acknowledge and agree that, notwithstanding the full execution and delivery of this Second Amendment by Landlord and Tenant, this Second Amendment is expressly conditioned upon the receipt of all required approvals and permits from the applicable governmental authorities with respect to the conversion of the Expansion Premises from a parking area into occupiable space which can be used for the Permitted Use and included as part of the Premises (the &#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:100%">Condition Subsequent</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#8221;).  Landlord shall have no liability whatsoever to Tenant relating to or arising from Landlord&#8217;s inability or failure to cause all or any portion of the Condition Subsequent to be satisfied.  Landlord shall promptly notify Tenant in writing upon the satisfaction of the Condition Subsequent.  The Lease shall remain unmodified and in full force and effect unless and until such time as the Condition Subsequent is satisfied, provided that in the event the Condition Subsequent is not satisfied on or before the date which is nine (9) months following the Effective Date, then this Second Amendment shall be null and void and of no further force or effect, except with respect to the provisions of Section 6 above.  </font></div><div style="margin-top:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">14.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:100%;padding-left:21pt;text-decoration:underline">No Further Modification</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">.  Except as set forth in this Second Amendment, all of the terms and provisions of the Lease shall apply with respect to the Expansion Premises and shall remain unmodified and in full force and effect.  </font></div><div style="margin-top:12pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#91;signatures follow on next page&#93;</font></div><div style="margin-top:12pt;text-align:justify;text-indent:36pt"><font><br></font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:39.284%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:18.130%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:39.286%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">-5-</font></div></td><td colspan="3" style="padding:0 1pt"></td></tr></table></div><div><font><br></font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div><font><br></font></div></div><div style="margin-top:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">IN WITNESS WHEREOF, this Second Amendment has been executed as of the day and year first above written.  </font></div><div style="margin-top:12pt;text-align:justify;text-indent:36pt"><font><br></font></div><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:14.202%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:39.113%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:7.796%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:7.796%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:7.796%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:7.796%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:7.801%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"><div style="margin-top:12pt;padding-left:2.75pt;padding-right:2.75pt;text-align:justify;text-indent:36pt"><font><br></font></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-left:2.75pt;padding-right:2.75pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:100%">&#34;LANDLORD&#34;&#58;</font></div><div style="margin-top:12pt;padding-left:13.5pt;padding-right:2.75pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">REALTY, L.P.,<br>a Delaware limited partnership</font></div><div style="margin-top:12pt;padding-left:42.35pt;padding-right:2.75pt;text-indent:-36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">By&#58;&#160;&#160;&#160;&#160;Kilroy Realty Corporation,<br>a Maryland corporation</font></div><div style="margin-top:12pt;padding-left:74.75pt;padding-right:2.75pt;text-indent:-36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">Its&#58;  General Partner</font></div><div style="margin-top:24pt;padding-left:42.35pt;padding-right:2.75pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:232%">By&#58;&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:232%;text-decoration:underline">&#47;s&#47; Nelson Ackerly&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:232%"><br>Name&#58;&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:232%;text-decoration:underline">Nelson Ackerly&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:232%"><br>Its&#58;&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:232%;text-decoration:underline">Senior Vice President, Leasing Southern California&#160;&#160;&#160;&#160;</font></div><div style="margin-top:18pt;padding-left:42.35pt;padding-right:2.75pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:232%">By&#58;&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:232%;text-decoration:underline">&#47;s&#47; Annie Caldwell&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:232%"><br>Name&#58;&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:232%;text-decoration:underline">Annie Caldwell&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:232%"><br>Its&#58;&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:232%;text-decoration:underline">Vice President, Leasing&#160;&#160;&#160;&#160;</font></div><div style="margin-top:12pt;padding-left:2.75pt;padding-right:2.75pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:100%">&#34;TENANT&#34;&#58;</font></div><div style="margin-top:12pt;padding-left:2.75pt;padding-right:2.75pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">DERMTECH, INC.,</font></div><div style="padding-left:2.75pt;padding-right:2.75pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">a Delaware corporation</font></div><div style="margin-top:30pt;padding-left:2.75pt;padding-right:2.75pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:232%">By&#58;&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:232%;text-decoration:underline">&#47;s&#47; John Dobak&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:232%"><br>Name&#58;&#160;&#160;&#160;&#160;John Dobak, M.D.<br>Its&#58;&#160;&#160;&#160;&#160;CEO</font></div><div style="margin-top:30pt;padding-left:2.75pt;padding-right:2.75pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:232%">By&#58;&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:232%;text-decoration:underline">&#47;s&#47; Kevin Sun&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:232%"><br>Name&#58;&#160;&#160;&#160;&#160;Kevin Sun<br>Its&#58;&#160;&#160;&#160;&#160;CFO</font></div></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr></table></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:39.284%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:18.130%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:39.286%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">-6-</font></div></td><td colspan="3" style="padding:0 1pt"></td></tr></table></div><div><font><br></font></div></div></div><div id="i5f74f095d9634a0aaed5c3217bf63e6b_4"></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div><font><br></font></div></div><div style="margin-bottom:12pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:100%;text-decoration:underline">EXHIBIT A</font></div><div style="margin-top:12pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:100%;text-decoration:underline">OUTLINE OF EXPANSION PREMISES</font></div><div style="margin-top:12pt;text-align:center"><img alt="image_0a.jpg" src="image_0a.jpg" style="height:172px;margin-bottom:5pt;vertical-align:text-bottom;width:157px"><img alt="image_1a.jpg" src="image_1a.jpg" style="height:302px;margin-bottom:5pt;vertical-align:text-bottom;width:624px"></div><div style="margin-top:12pt;text-align:justify;text-indent:36pt"><font><br></font></div><div style="margin-top:12pt;text-align:justify;text-indent:36pt"><font><br></font></div><div style="margin-top:12pt;text-align:justify;text-indent:36pt"><font><br></font></div><div style="margin-top:12pt;text-align:justify;text-indent:36pt"><font><br></font></div><div style="margin-top:12pt;text-align:justify;text-indent:36pt"><font><br></font></div><div style="margin-top:12pt;text-align:justify;text-indent:36pt"><font><br></font></div><div style="margin-top:12pt;text-align:justify;text-indent:36pt"><font><br></font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:39.284%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:18.130%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:39.286%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">4883-5609-3194.6</font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">377185.00018&#47;U58er IniA&#47;gjn&#47;gjn</font></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">EXHIBIT A</font></div><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">-1-</font></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><font><br></font></div><div style="text-align:right"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#91;Second Amendment&#93;</font></div><div style="text-align:right"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#91;DermTech, Inc.&#93;</font></div></td></tr></table></div><div><font><br></font></div></div></div><div id="i5f74f095d9634a0aaed5c3217bf63e6b_7"></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div><font><br></font></div></div><div style="margin-bottom:12pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:100%;text-decoration:underline">EXHIBIT B</font></div><div style="margin-top:12pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:100%;text-decoration:underline">TENANT WORK LETTER</font></div><div style="margin-top:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">This Work Letter shall set forth the terms and conditions relating to the construction of the Expansion Improvements (as defined below).  All capitalized terms used but not otherwise defined herein shall have the meanings ascribed to such terms in the Lease and this Second Amendment.</font></div><div style="margin-top:12pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:100%;text-decoration:underline">SECTION 1</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%"><br><br></font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:100%;text-decoration:underline">POSSESSION</font></div><div style="margin-top:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">Except as specifically set forth in this Second Amendment, this Work Letter and the Lease, Landlord shall tender possession of the Expansion Premises to Tenant in its existing &#34;as-is&#34; condition in accordance with the timing and other terms and conditions set forth in the Lease and this Second Amendment.</font></div><div style="margin-top:12pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:100%;text-decoration:underline">SECTION 2<br><br>EXPANSION IMPROVEMENTS&#59; CHANGE ORDERS</font></div><div style="margin-top:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">2.1&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:100%;text-decoration:underline">Expansion Improvements</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">.  Landlord has selected, and, Tenant has approved, C2 as the general contractor to construct the Expansion Improvements.  Landlord shall cause the installation and&#47;or construction of certain permanently affixed improvements in the Expansion Premises (the &#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:100%">Expansion Improvements</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#8221;) as identified on the that certain set of architectural and engineering drawings prepared by Ware Malcomb, identified as Job No. SDG21-50330-00, and submitted for permitting on 11-15-2021 (the &#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:100%">Working Drawings</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#8221;) (the first page of which is attached hereto as </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:100%;text-decoration:underline">Schedule 1</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">), which Working Drawings were based on the &#34;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:100%">Approved Pricing Plan</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#34; prepared by Ware Malcomb, identified as Job No. SDG21-5033-00, Sheet A05A, a copy of which is attached hereto as </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:100%;text-decoration:underline">Schedule&#160;2</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">, which Approved Pricing Plan has been approved by Landlord and Tenant.  Landlord and Tenant have approved the estimate for the total cost of the Expansion Improvements (which costs have been included in the aggregate estimated costs for the first (1</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.8pt;font-weight:400;line-height:100%;position:relative;top:-4.2pt;vertical-align:baseline">st</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">) and second (2</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.8pt;font-weight:400;line-height:100%;position:relative;top:-4.2pt;vertical-align:baseline">nd</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">) floors of the Premises (identified as Phase 3 therein) set forth in the document titled Project Detail Budget, Cost Proposal #1 with a revision date of 1&#47;19&#47;22, and which was signed by Landlord as of 1&#47;19&#47;22 and signed by Tenant as of 1&#47;20&#47;22 (the &#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:100%">Cost Estimate</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#8221;), which Cost Estimate is attached hereto as </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:100%;text-decoration:underline">Schedule 3</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">.  Tenant shall cooperate with Landlord, as necessary, in connection with the design and construction of the Expansion Improvements, including approving or disapproving any items that require Tenant's approval and providing necessary information, if any, promptly following Tenant's receipt of request therefor. Restoration and removal requirements with respect to the Improvements shall be governed by </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">Article 8</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%"> of the Original Lease.  Responsibility for costs relating the design and construction of the Expansion Improvements, as between Landlord and Tenant, shall be governed by </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">Section 3</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%"> and the other provisions of this Work Letter.  </font></div><div style="margin-top:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">2.2&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:100%;text-decoration:underline">Change Orders</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">.  The term &#34;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:100%">Change Order</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#34; shall mean any modification to the Approved Pricing Plan, Working Drawings and&#47;or Expansion Improvements that are not a natural and logical extension of the improvements depicted on the Approved Pricing Plan, as the same may have been modified from time to time in accordance with this Work Letter, that in each instance are requested by Tenant and approved by Landlord, in Landlord's reasonable discretion. Tenant shall deliver written notice (a &#34;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:100%">Change Notice</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#34;) to Landlord requesting Landlord's approval of any Change Order desired to be made by Tenant, which notice shall set forth in detail the Change Order requested by Tenant.  In connection with any Change Orders that effect the exterior of the Building or can be seen from the exterior of the Building, Landlord </font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:39.284%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:18.130%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:39.286%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">EXHIBIT B</font></div><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">-1-</font></div></td><td colspan="3" style="padding:0 1pt"></td></tr></table></div><div><font><br></font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div><font><br></font></div></div><div style="margin-top:12pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">shall have the right to withhold its consent to any such Change Order in its sole and absolute discretion.  Landlord shall, following its receipt of any Change Notice, either, in Landlord's reasonable discretion, (A)&#160;approve such requested Change Order, or (B)&#160;disapprove such requested Change Order.  If Landlord approves of any Change Order request made by Tenant, Landlord shall provide Tenant with the estimated total cost of the Change Order (including, but not limited to, architectural and engineering fees, construction costs, applicable permit costs and the Change Fee) resulting from such Change Order.  Tenant shall notify Landlord within three (3) days following receipt of the foregoing information from Landlord whether or not Tenant desires to implement the applicable Change Order.  In the event any Change Orders are approved by Landlord and Tenant pursuant to the terms hereof, Landlord shall cause its architect and engineers to incorporate such Change Orders into the Working Drawings.  Except as expressly set forth herein, any Change Orders approved by Landlord pursuant to the terms hereof shall otherwise be treated as Expansion Improvements for purposes of the Lease and this Work Letter.  </font></div><div style="margin-top:12pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:100%;text-decoration:underline">SECTION 3<br><br>COSTS OF CONSTRUCTING EXPANSION IMPROVEMENTS</font></div><div style="margin-top:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">3.1&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:100%;text-decoration:underline">Expansion Improvement Allowance</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">.  Except as expressly provided in this Work Letter, the total costs and expenses incurred by Landlord in connection with the design and construction of the Expansion Improvements (inclusive of, but not limited to, architectural costs, engineering costs, general contractor costs, and the cost of all local and state filing fees, permits and approvals, if any, required to be obtained in order to perform and complete the Expansion Improvements) shall not exceed an aggregate amount equal to $1,760,625.00 (</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-style:italic;font-weight:400;line-height:100%">i.e.,</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%"> $125.00</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:100%"> </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">per rentable square foot of the Expansion Premises) (the &#34;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:100%">Expansion Improvement Allowance</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#34;).  In connection with the foregoing, Landlord hereby agrees that, subject to the Expansion Allowance Deadline, Tenant shall be entitled to use the Expansion Improvement Allowance towards the Improvements to be constructed in the Existing Premises, and in addition, subject to the applicable Allowance Deadlines set forth in the Lease, Tenant shall be entitled to use the Improvement Allowance towards the Expansion Improvements to be constructed in the Expansion Premises.  If Landlord determines that the total cost of the Expansion Improvements (which shall include the &#34;Coordination Fee&#34;, as defined below, as well as all design, construction, installation and other costs) will exceed the Expansion Improvement Allowance, then Tenant shall be solely responsible for all such excess costs which are over and above the Expansion Improvement Allowance (the &#34;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:100%">Over-Allowance Amount</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#34;).  Tenant shall pay any Over-Allowance Amount to Landlord within ten (10) days after demand is made therefor by Landlord from time to time (including, at Landlord's election, prior to the commencement of construction of the Expansion Improvements).  Any Over-Allowance Amount shall be disbursed by Landlord prior to any Landlord provided funds for the costs of construction of the Expansion Improvements. Tenant hereby acknowledges that Landlord shall be entitled to a fee (the &#34;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:100%">Coordination Fee</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#34;) payable by Tenant in an amount equal to three percent (3%) of&#160;the Expansion Improvement Allowance, in consideration for Landlord's coordination and supervision of the performance of the Expansion Improvements, which Coordination Fee may be deducted from the Expansion Improvement Allowance to the extent funds are available.  Notwithstanding any provision to the contrary contained in the Lease or this Work Letter, in no event shall Landlord be obligated to pay for (A) any moving costs or expenses related to Tenant's move-in or occupancy of the Expansion Premises, and&#47;or (B)&#160;any costs or expenses associated with the purchase, installation or maintenance of any furniture (including, but not limited to, the cost of any reception desks, credenzas or chairs, whether identified on the Approved Pricing Plan or not), fixtures, equipment, art, cabling, audio&#47;visual equipment, telecommunications systems, access controls, security systems and equipment, and&#47;or signage related to Tenant's occupancy of the Expansion Premises (collectively, &#34;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:100%">Tenant's FF&#38;E</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#34;).  If the total costs of the Expansion Improvements do not exceed the Expansion Improvement Allowance, any remaining funds upon completion of the Expansion Improvements in accordance with the Working Drawings shall be </font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:39.284%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:18.130%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:39.286%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">EXHIBIT B</font></div><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">-2-</font></div></td><td colspan="3" style="padding:0 1pt"></td></tr></table></div><div><font><br></font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div><font><br></font></div></div><div style="margin-top:12pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">the sole and separate property of Landlord and Tenant shall have no right or claim thereto.  Notwithstanding anything to the contrary contained in this Work Letter, Tenant shall not be entitled to any portion of the Expansion Improvement Allowance for which Tenant has not submitted a request for disbursement to Landlord in compliance with the requirements of </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">Section 4.4</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%"> below on or before the date which is twelve (12) months following the Expansion Commencement Date</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:100%"> </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">(the &#34;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:100%">Expansion</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%"> </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:100%">Allowance Deadline</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#34;), and any such remaining portion of the Expansion Improvement Allowance as of the Expansion Allowance Deadline shall remain with Landlord as its sole property.  </font></div><div style="margin-top:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">3.2&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:100%;text-decoration:underline">Specified Excluded Costs</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">.  Notwithstanding anything to the contrary herein, the cost of the Expansion Improvements to be provided at Landlord&#8217;s sole expense shall include (and Tenant shall have no responsibility for and the Expansion Improvement Allowance shall not be used for) the following&#58;  (a) costs for improvements which are not shown on or described in the approved Working Drawings unless otherwise approved by Tenant&#59; (b) costs incurred due to the presence of hazardous materials in the Expansion Premises or the surrounding area&#59; (c) attorneys' fees incurred in connection with negotiation of construction contracts, and attorneys' fees, experts' fees and other costs in connection with disputes with third parties&#59; (d) interest and other costs of financing construction costs&#59; (e) costs incurred as a consequence of delay (unless to the extent the delay a delay resulting from an event of Force Majeure), construction defects or default by a contractor&#59; (f) costs recoverable by Landlord upon account of warranties and insurance&#59; (g) restoration costs in excess of insurance proceeds as a consequence of casualties&#59; (h) penalties and late charges attributable to Landlord&#8217;s failure to pay construction costs&#59; (i) any alterations required to comply with Applicable Law that are triggered by the fact that tenant improvements are being performed generally, as opposed to compliance work in the Building caused by the particular nature of the Expansion Improvements being constructed&#59; (j) wages, labor and overhead for overtime and premium time unless otherwise agreed upon by the parties&#59; (k) offsite management or other general overhead costs incurred by Landlord other than the Coordination Fee&#59; and (m) construction costs in excess of the approved Cost Estimate, except for increases set forth in approved Change Orders.</font></div><div style="margin-top:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">3.3&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:100%;text-decoration:underline">Additional Improvement Allowance</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">.  Tenant has elected to utilize a one-time increase (the &#34;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:100%">Additional Expansion Improvement Allowance</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#34;) of the Expansion Improvement Allowance in an amount equal to $352,125.00 (i.e., $25.00 per rentable square foot of the Expansion Premises), for the costs relating to the initial design and construction of the Expansion Improvements.&#160; Accordingly, the monthly Base Rent for the Expansion Premises has been increased, as set forth in Section 4.2 of this Second Amendment Above, by an amount equal to $4,182.31 per month of the Expansion Term.&#160; All references in this Work Letter to the &#34;Expansion Improvement Allowance&#34;, shall be deemed to include the Additional Expansion Improvement Allowance (and accordingly the Expansion Allowance Deadline shall apply thereto). </font></div><div style="margin-top:12pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:100%;text-decoration:underline">SECTION 4<br><br>CONTRACTOR'S WARRANTIES AND GUARANTIES</font></div><div style="margin-top:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">Landlord shall obtain a standard one (1) year warranty from the Contractor covering the Expansion Improvements and shall use commercially reasonably efforts to enforce such warranty as to any defects in the Expansion Improvements identified by Tenant within the corresponding warranty period for the Expansion Improvements.</font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:39.284%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:18.130%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:39.286%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">EXHIBIT B</font></div><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">-3-</font></div></td><td colspan="3" style="padding:0 1pt"></td></tr></table></div><div><font><br></font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div><font><br></font></div></div><div style="margin-top:12pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:100%;text-decoration:underline">SECTION 5<br><br>TENANT'S AGENTS</font></div><div style="margin-top:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">Tenant hereby protects, defends, indemnifies and holds Landlord harmless for any loss, claims, damages or delays arising from the actions of any space planner, architect, vendor, contractor, subcontractor or consultant engaged by Tenant with respect to the Expansion Premises, if any.  </font></div><div style="margin-top:12pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:100%;text-decoration:underline">SECTION 6<br><br>INTENTIONALLY OMITTED</font></div><div style="margin-top:12pt;text-align:justify;text-indent:72pt"><font><br></font></div><div style="margin-top:12pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:100%;text-decoration:underline">SECTION 7<br><br>MISCELLANEOUS</font></div><div style="margin-top:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">7.1</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:100%">&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:100%;text-decoration:underline">Tenant's Entry into the Expansion Premises Prior to Substantial Completion</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">.  Provided that Tenant and its agents do not interfere with the construction of the Expansion Improvements, Tenant shall have reasonable access to the Expansion Premises commencing on the date that Landlord estimates is thirty (30) days prior to the Substantial Completion of the Expansion Improvements for the purpose of installing Tenant's FF&#38;E (including Tenant's data and telephone equipment) in the Expansion Premises&#59; provided that such early access shall not be provided until such time that Landlord has reasonably determined that the condition of the Expansion Premises is safe for entry by Tenant and its vendors and that Tenant's activities will not interfere the construction of the Expansion Improvements.  Prior to Tenant's entry into the Expansion Premises as permitted by the terms of this </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">Section 7.1</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">, Tenant shall (i) submit a schedule to Landlord and Contractor, for their approval, which schedule shall detail the timing and purpose of Tenant's entry and (ii) deliver to Landlord the policies or certificates evidencing Tenant's insurance as required under the terms of </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">Section 10.3</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%"> of the Lease.  Tenant's indemnity set forth in </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">Section&#160;10.1</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%"> of the Original Lease shall apply during any such period of early entry by Tenant.</font></div><div style="margin-top:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">7.2</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:100%">&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:100%;text-decoration:underline">Tenant's Representative</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">.  Tenant has designated Kevin Sun, ksun&#64;dermtech, 858-291-7512</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:100%">,</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%"> as its sole representative with respect to the matters set forth in this Work Letter, who, until further notice to Landlord, shall have full authority and responsibility to act on behalf of the Tenant as required in this Work Letter.</font></div><div style="margin-top:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">7.3</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:100%">&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:100%;text-decoration:underline">Landlord's Representative</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">.  Landlord has designated Robert Chambers</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:100%"> </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">(rchambers&#64;kilroyrealty.com, 858.523.2217)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:100%"> </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">as its sole representative with respect to the matters set forth in this Work Letter, who, until further notice to Tenant, shall have full authority and responsibility to act on behalf of the Landlord as required in this Work Letter.</font></div><div style="margin-top:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">7.4</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:100%">&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:100%;text-decoration:underline">Tenant's Agents</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">.  All subcontractors, laborers, materialmen, and suppliers retained directly by Tenant (if any) shall all be union unless otherwise approved by Landlord.  Further, Tenant shall not use (and upon notice from Landlord shall cease using) contractors, services, workmen, labor, materials or equipment that, in Landlord's reasonable judgment, would disturb labor harmony with the workforce or trades engaged in performing other work, labor or services at the Project.  </font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:39.284%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:18.130%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:39.286%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">EXHIBIT B</font></div><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">-4-</font></div></td><td colspan="3" style="padding:0 1pt"></td></tr></table></div><div><font><br></font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div><font><br></font></div></div><div style="margin-top:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">7.5</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:100%">&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:100%;text-decoration:underline">Time is of the Essence</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">.  Time is of the essence under this Work Letter. Unless otherwise indicated, all references herein to a &#34;number of days&#34; shall mean and refer to calendar days.  </font></div><div style="margin-top:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">7.6</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:100%">&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:100%;text-decoration:underline">Tenant's Default</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">.  Notwithstanding any provision to the contrary contained in the Lease or this Work Letter, if any default beyond applicable notice and cure periods by Tenant under the Lease or this Work Letter shall occur (including, without limitation, any failure by Tenant to timely fund any costs which are Tenant's responsibility hereunder), then, in addition to all other rights and remedies granted to Landlord pursuant to the Lease, (i) Landlord may, without any liability whatsoever, cause the cessation of construction of the Expansion Improvements until such time as such default is cured pursuant to the terms of the Lease (in which case, Tenant shall be responsible for any delay in the completion of the Expansion Improvements and any costs occasioned thereby) and (ii) at Landlord's sole election, Tenant shall no longer be entitled to any unfunded portion of the Expansion Improvement Allowance (if any) until such time as such default is cured pursuant to the terms of the Lease.</font></div><div style="margin-top:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">7.7&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:100%;text-decoration:underline">Electronic Notice and Approvals</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">.  Notwithstanding any provision to the contrary contained in the Lease or this Work Letter, Landlord and Tenant may transmit or otherwise deliver any of the notices and&#47;or approvals required under this Work Letter via electronic mail to Tenant's and Landlord's respective representatives identified in </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">Sections 7.2</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%"> and </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">7.3</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%"> of this Work Letter.  The foregoing shall not preclude either party from sending any notices or approvals by any of the other means identified under the &#34;Notices&#34; provision of the Lease.</font></div><div style="margin-top:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">7.8&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:100%;text-decoration:underline">No Constructive Eviction</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">.  Tenant hereby acknowledges that, notwithstanding Tenant's occupancy of the portions of the Premises during the installation and&#47;or construction of the Expansion Improvements, Landlord and Contractor shall be permitted to install and&#47;or construct the Expansion Improvements during, without limitation, normal business hours, and Tenant shall cooperate with Landlord and Contractors, including, without limitation, by providing any needed access to the Premises and by providing a clear working area in the Premises (to the extent required by Landlord) for the installation and&#47;or construction of the Expansion Improvements (including, but not limited to, the moving of Tenant's property away from the area Landlord or Contractor are installing and&#47;or constructing the Expansion Improvements).  Tenant will be responsible for moving Tenant's furniture and fixtures away from the area Landlord or Contractor installing and&#47;or constructing the Expansion Improvements.  In connection therewith, Tenant shall cooperate fully in connection with Landlord's completion of the installation and&#47;or construction of the Expansion Improvements.  Tenant hereby agrees that the installation and&#47;or construction of the Expansion Improvements shall in no way constitute a constructive eviction of Tenant nor entitle Tenant to any abatement of rent or damages of any kind.  Furthermore, Landlord shall have no responsibility, or for any reason be liable, to Tenant for any direct or indirect injury to, or interference with, Tenant's business arising from the installation and&#47;or construction of the Expansion Improvements, nor shall Tenant be entitled to any compensation or damages from Landlord for loss of the use of the whole or any part of the Premises or of Tenant's furniture, fixtures or personal property or improvements resulting from the installation and&#47;or construction of the Expansion Improvements or Landlord's actions in connection with the installation and&#47;or construction of the Expansion Improvements or for any inconvenience or annoyance occasioned by the installation and&#47;or construction of the Expansion Improvements or Landlord's actions in connection with the installation and&#47;or construction of the Expansion Improvements.  Landlord shall use commercially reasonable efforts to perform the Expansion Improvements in a manner designed to minimize interference with Tenant's use of and access to the Premises.</font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:39.284%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:18.130%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:39.286%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">EXHIBIT B</font></div><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">-5-</font></div></td><td colspan="3" style="padding:0 1pt"></td></tr></table></div><div><font><br></font></div></div></div><div id="i5f74f095d9634a0aaed5c3217bf63e6b_10"></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div><font><br></font></div></div><div style="margin-bottom:12pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:100%;text-decoration:underline">SCHEDULE 2</font></div><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:100%;text-decoration:underline">APPROVED WORKING DRAWINGS</font></div><div style="text-align:center"><font><br></font></div><div style="text-align:center"><img alt="image_2a.jpg" src="image_2a.jpg" style="height:453px;margin-bottom:5pt;vertical-align:text-bottom;width:624px"></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:39.284%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:18.130%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:39.286%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">SCHEDULE 2</font></div><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">-1-</font></div></td><td colspan="3" style="padding:0 1pt"></td></tr></table></div><div><font><br></font></div></div></div><div id="i5f74f095d9634a0aaed5c3217bf63e6b_13"></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div><font><br></font></div></div><div style="margin-bottom:12pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:100%;text-decoration:underline">SCHEDULE 2</font></div><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:100%;text-decoration:underline">APPROVED PRICING PLAN</font></div><div style="text-align:center"><font><br></font></div><div style="text-align:center"><img alt="image_3a.jpg" src="image_3a.jpg" style="height:455px;margin-bottom:5pt;vertical-align:text-bottom;width:624px"></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:39.284%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:18.130%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:39.286%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">SCHEDULE 2</font></div><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">-1-</font></div></td><td colspan="3" style="padding:0 1pt"></td></tr></table></div></div></div><div id="i5f74f095d9634a0aaed5c3217bf63e6b_16"></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div><font><br></font></div></div><div style="margin-bottom:12pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:100%;text-decoration:underline">SCHEDULE 3</font></div><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:100%;text-decoration:underline">COST ESTIMATE</font></div><div style="text-align:center"><font><br></font></div><div style="text-align:center"><img alt="image_4a.jpg" src="image_4a.jpg" style="height:547px;margin-bottom:5pt;vertical-align:text-bottom;width:624px"></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:39.284%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:18.130%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:39.286%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">SCHEDULE 3</font></div><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">-1-</font></div></td><td colspan="3" style="padding:0 1pt"></td></tr></table></div><div><font><br></font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div><font><br></font></div></div><div style="text-align:center"><img alt="image_5a.jpg" src="image_5a.jpg" style="height:770px;margin-bottom:5pt;vertical-align:text-bottom;width:624px"></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:39.284%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:18.130%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:39.286%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">SCHEDULE 3</font></div><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">-2-</font></div></td><td colspan="3" style="padding:0 1pt"></td></tr></table></div><div><font><br></font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div><font><br></font></div></div><div style="text-align:center"><img alt="image_6a.jpg" src="image_6a.jpg" style="height:628px;margin-bottom:5pt;vertical-align:text-bottom;width:624px"></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:39.284%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:18.130%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:39.286%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">SCHEDULE 3</font></div><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">-3-</font></div></td><td colspan="3" style="padding:0 1pt"></td></tr></table></div><div><font><br></font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div><font><br></font></div></div><div style="text-align:center"><img alt="image_7a.jpg" src="image_7a.jpg" style="height:791px;margin-bottom:5pt;vertical-align:text-bottom;width:624px"></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:39.284%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:18.130%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:39.286%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">SCHEDULE 3</font></div><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">-4-</font></div></td><td colspan="3" style="padding:0 1pt"></td></tr></table></div><div><font><br></font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div><font><br></font></div></div><div style="text-align:center"><img alt="image_8a.jpg" src="image_8a.jpg" style="height:761px;margin-bottom:5pt;vertical-align:text-bottom;width:624px"></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:39.284%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:18.130%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:39.286%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">SCHEDULE 3</font></div><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">-5-</font></div></td><td colspan="3" style="padding:0 1pt"></td></tr></table></div><div><font><br></font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div><font><br></font></div></div><div style="text-align:center"><img alt="image_9a.jpg" src="image_9a.jpg" style="height:806px;margin-bottom:5pt;vertical-align:text-bottom;width:624px"></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:39.284%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:18.130%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:39.286%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">SCHEDULE 3</font></div><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">-6-</font></div></td><td colspan="3" style="padding:0 1pt"></td></tr></table></div><div><font><br></font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div><font><br></font></div></div><div style="text-align:center"><img alt="image_10a.jpg" src="image_10a.jpg" style="height:536px;margin-bottom:5pt;vertical-align:text-bottom;width:624px"></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:39.284%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:18.130%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:39.286%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">SCHEDULE 3</font></div><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">-7-</font></div></td><td colspan="3" style="padding:0 1pt"></td></tr></table></div><div><font><br></font></div></div></div></body></html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-10.3
<SEQUENCE>4
<FILENAME>ex103dermtech-secondamende.htm
<DESCRIPTION>EX-10.3
<TEXT>
<!DOCTYPE html PUBLIC "-//W3C//DTD HTML 4.01 Transitional//EN" "http://www.w3.org/TR/html4/loose.dtd"><html><head>
<!-- Document created using Wdesk -->
<!-- Copyright 2022 Workiva -->
<title>Document</title></head><body><div id="ie3dcd5afd0ba421db33b7535259c59d8_1"></div><div style="min-height:101.52pt;width:100%"><div style="text-align:right"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:100%">Exhibit 10.3</font></div></div><div style="padding-left:54pt;padding-right:54pt;text-align:center;text-indent:-108pt"><font><br></font></div><div style="padding-left:54pt;padding-right:54pt;text-align:center;text-indent:-108pt"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:12pt;font-weight:700;line-height:100%">Second Amended and Restated</font></div><div style="padding-left:54pt;padding-right:54pt;text-align:center;text-indent:-108pt"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:12pt;font-weight:700;line-height:100%">Non-Employee Director Compensation Policy</font></div><div style="padding-left:54pt;padding-right:54pt;text-align:center;text-indent:-108pt"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:12pt;font-weight:700;line-height:100%">DermTech, Inc.</font></div><div style="padding-left:54pt;padding-right:54pt;text-align:center;text-indent:-108pt"><font><br></font></div><div style="text-align:justify"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:100%">The Board of Directors of DermTech, Inc. (the &#8220;</font><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">Company</font><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#8221;) has approved the following Second Amended and Restated Non-Employee Director Compensation Policy (this &#8220;</font><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">Policy</font><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#8221;), which establishes compensation to be paid to non-employee directors of the Company, effective as of July 18,&#160;2022 (the&#160;&#8220;</font><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">Effective Time</font><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#8221;), to provide an inducement to obtain and retain the services of qualified persons to serve as members of the Company&#8217;s Board of Directors.  This Policy amends and restates the Company&#8217;s Amended and Restated Non-Employee Director Compensation Policy, dated March 28, 2021, in its entirety.</font></div><div style="text-align:justify"><font><br></font></div><div style="text-align:justify"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">Applicable Persons</font></div><div style="text-align:justify"><font><br></font></div><div style="text-align:justify"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;This Policy shall apply to each director of the Company who is not an employee of the Company or any Affiliate (each, a &#8220;</font><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">Non-Employee Director</font><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#8221;).  &#8220;</font><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">Affiliate</font><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#8221; means an entity which is a direct or indirect parent or subsidiary of the Company, as determined pursuant to Section 424 of the Internal Revenue Code of 1986, as amended.</font></div><div style="text-align:justify"><font><br></font></div><div style="text-align:justify"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">Restricted Stock Unit Grants</font></div><div style="text-align:justify"><font><br></font></div><div style="padding-left:54pt;text-align:justify;text-indent:-18pt"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:100%">1.</font><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-style:italic;font-weight:400;line-height:100%;padding-left:9.66pt">Annual Restricted Stock Unit Grants to Incumbent Non-Employee Directors</font></div><div style="text-align:justify"><font><br></font></div><div style="text-align:justify"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;Annually, on the date of the first meeting of the Board of Directors held following the Company&#8217;s annual meeting of stockholders in each year commencing in 2022 (each such meeting, the &#8220;</font><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">Annual&#160;Stockholder Meeting</font><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#8221;), each incumbent Non-Employee Director shall be granted a number of restricted stock units (&#8220;</font><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">RSUs</font><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#8221;) (each RSU representing the contingent right to receive one share of the Company&#8217;s common stock) that represents a market value of $170,000 based on the most-recent closing price of the Company&#8217;s common stock prior to the date of such grant, unless the Compensation Committee of the Board of Directors (the &#8220;</font><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">Compensation Committee</font><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#8221;) determines that such a grant would exceed a burn rate threshold as established by the Compensation Committee based on guidance from compensation consultants or from ISS (or similar organizations), and&#47;or based on its own analysis, in which case the number of RSUs granted may be a reduced (but not by more than 50%) by the Compensation Committee (such grants, the &#8220;</font><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">Annual Grants</font><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#8221;). </font></div><div style="text-align:justify"><font><br></font></div><div style="padding-left:54pt;text-align:justify;text-indent:-18pt"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:100%">2.</font><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-style:italic;font-weight:400;line-height:100%;padding-left:9.66pt">Initial Restricted Stock Unit Grants for Newly Appointed or Elected Directors</font></div><div style="text-align:justify"><font><br></font></div><div style="text-align:justify"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;Each new Non-Employee Director on or after the Effective Time shall be granted a New Director Grant and a Pro Rata Annual Grant, each in the form of RSUs approved by the Board of Directors effective on his or her initial appointment or election to the Board of Directors, as follows&#58;</font></div><div style="text-align:justify"><font><br></font></div><div style="text-align:justify"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:100%">(i) A &#8220;New Director Grant&#8221; consisting of the same number of RSUs as the most recent Annual Grant made to each incumbent Non-Employee Director, unless the Board of Directors or the Compensation Committee determines to adjust this otherwise&#59;</font></div><div style="text-align:justify"><font><br></font></div><div style="text-align:justify"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:100%">(ii) A &#8220;Pro Rata Annual Grant&#8221; consisting of a number of RSUs calculated as follows&#58; (a) that same number of RSUs as the most recent Annual Grant made to each incumbent Non-Employee Director, unless the Board of Directors or the Compensation Committee determines to adjust this otherwise, </font><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-style:italic;font-weight:400;line-height:100%">multiplied by</font><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:100%"> (b) the number of whole months between the date that such new Non-Employee Director is appointed to the Board and the first anniversary of the most recent annual meeting of the stockholders of the Company </font><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-style:italic;font-weight:400;line-height:100%">divided by</font><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:100%"> 12.</font></div><div style="text-align:justify"><font><br></font></div><div style="text-align:justify"><font><br></font></div><div style="padding-left:54pt;text-align:justify;text-indent:-18pt"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:100%">4.</font><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-style:italic;font-weight:400;line-height:100%;padding-left:9.66pt">Terms for All Restricted Stock Unit Grants</font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><font><br></font></div></div></div><hr style="page-break-after:always"><div style="min-height:101.52pt;width:100%"><div style="padding-left:108pt;text-indent:-108pt"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:100%">Second Amended and Restated Non-Employee Director Compensation Policy</font></div><div><font><br></font></div></div><div style="text-align:justify"><font><br></font></div><div style="text-align:justify"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;Unless otherwise specified by the Board of Directors or the Compensation Committee at the time of grant&#58; </font></div><div style="text-align:justify"><font><br></font></div><div style="text-align:justify"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:100%">(i)&#160;Annual Grants shall vest in four equal quarterly installments over the one-year period following the grant date, subject to the continued service of the Non-Employee Director. The release date for the shares underlying the RSUs shall be the date that the RSU grant is fully vested, unless an election is made in advance of the grant for the release date to be the first business day in January of the year following the date that the RSU grant is fully vested.</font></div><div style="text-align:justify"><font><br></font></div><div style="text-align:justify"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:100%">(ii)&#160;New Director Grants shall vest in three equal annual installments over the three-year period following the grant date, subject to the continued service of the Non-Employee Director. The release dates for vested shares underlying the RSUs shall be the three vesting dates described above unless an election is made in advance of the grant for the three release dates to be the first business day in January of the year following each vesting date, respectively.</font></div><div style="text-align:justify"><font><br></font></div><div style="text-align:justify"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:100%">(iii) Pro Rata Annual Grants shall vest in full on the last vesting date of the most recent Annual Grants made prior the grant date such Pro Rata Annual Grants, subject to the continued service of the Non-Employee Director.  The release date for the shares underlying the RSUs shall be the date that the RSUs are fully vested, unless an election is made in advance of the grant for the release date to be the first business day in January of the year following the date that the RSU grant is fully vested. </font></div><div style="text-align:justify"><font><br></font></div><div style="text-align:justify"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:100%">All of the above RSU grants shall contain such other terms and conditions as set forth in the form of Restricted Stock Unit Agreement approved by the Board of Directors or the Compensation Committee.&#160;&#160;&#160;&#160;</font></div><div style="text-align:justify"><font><br></font></div><div style="text-align:justify"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:100%"> </font><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">Annual Fees</font></div><div style="text-align:justify"><font><br></font></div><div style="text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:100%">Each Non-Employee Director serving on the Board of Directors and the Audit Committee, Compensation Committee and&#47;or Nominating and Corporate Governance Committee, as applicable, shall be entitled to annual fees in the following amounts (the &#8220;</font><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">Annual Fees</font><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#8221;)&#58;</font></div><div style="text-align:justify"><font><br></font></div><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:54.669%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:21.976%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:20.055%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="border-left:0.5pt solid #000000;border-top:0.5pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:2.75pt;padding-right:2.75pt;text-align:center"><font><br></font></div><div style="padding-left:2.75pt;padding-right:2.75pt"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:700;line-height:100%">Board of Directors or Committee of Board of Directors</font></div></td><td colspan="3" style="border-left:0.5pt solid #000000;border-top:0.5pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:700;line-height:100%">Annual Retainer Amount for Member</font></td><td colspan="3" style="border-left:0.5pt solid #000000;border-right:0.5pt solid #000000;border-top:0.5pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:700;line-height:100%">Annual Retainer Amount for Chair</font></td></tr><tr><td colspan="3" style="border-left:0.5pt solid #000000;border-top:0.5pt solid #000000;padding:2px 1pt 2px 3.77pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:100%">Board Member</font></td><td colspan="3" style="border-left:0.5pt solid #000000;border-top:0.5pt solid #000000;padding:2px 3.77pt 2px 1pt;text-align:right;vertical-align:top"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:100%">$40,000</font></td><td colspan="3" style="border-left:0.5pt solid #000000;border-right:0.5pt solid #000000;border-top:0.5pt solid #000000;padding:2px 3.77pt 2px 1pt;text-align:right;vertical-align:top"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:100%">$80,000</font></td></tr><tr><td colspan="3" style="border-left:0.5pt solid #000000;border-top:0.5pt solid #000000;padding:2px 1pt 2px 3.77pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:100%">Audit Committee</font></td><td colspan="3" style="border-left:0.5pt solid #000000;border-top:0.5pt solid #000000;padding:2px 3.77pt 2px 1pt;text-align:right;vertical-align:top"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:100%">$10,000</font></td><td colspan="3" style="border-left:0.5pt solid #000000;border-right:0.5pt solid #000000;border-top:0.5pt solid #000000;padding:2px 3.77pt 2px 1pt;text-align:right;vertical-align:top"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:100%">$20,000</font></td></tr><tr><td colspan="3" style="border-left:0.5pt solid #000000;border-top:0.5pt solid #000000;padding:2px 1pt 2px 3.77pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:100%">Compensation Committee</font></td><td colspan="3" style="border-left:0.5pt solid #000000;border-top:0.5pt solid #000000;padding:2px 3.77pt 2px 1pt;text-align:right;vertical-align:top"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:100%">$7,000</font></td><td colspan="3" style="border-left:0.5pt solid #000000;border-right:0.5pt solid #000000;border-top:0.5pt solid #000000;padding:2px 3.77pt 2px 1pt;text-align:right;vertical-align:top"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:100%">$14,000</font></td></tr><tr><td colspan="3" style="border-bottom:0.5pt solid #000000;border-left:0.5pt solid #000000;border-top:0.5pt solid #000000;padding:2px 1pt 2px 3.77pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:100%">Nominating and Corporate Governance Committee</font></td><td colspan="3" style="border-bottom:0.5pt solid #000000;border-left:0.5pt solid #000000;border-top:0.5pt solid #000000;padding:2px 3.77pt 2px 1pt;text-align:right;vertical-align:top"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:100%">$5,000</font></td><td colspan="3" style="border-bottom:0.5pt solid #000000;border-left:0.5pt solid #000000;border-right:0.5pt solid #000000;border-top:0.5pt solid #000000;padding:2px 3.77pt 2px 1pt;text-align:right;vertical-align:top"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:100%">$10,000</font></td></tr></table></div><div style="padding-left:72pt;text-align:justify;text-indent:-72pt"><font><br></font></div><div style="text-align:justify"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:700;line-height:100%">&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:100%">Except as otherwise set forth in this Policy, all Annual Fees shall be paid for the period from January 1 through December 31 of each year. Such Annual Fees shall be paid in cash.  </font></div><div style="text-align:justify"><font><br></font></div><div style="text-align:justify"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;Annual Fees payable to Non-Employee Directors shall be paid quarterly in arrears promptly following the end of each fiscal quarter, provided that (i)&#160;the amount of such payment shall be prorated for any portion of such quarter that such director was not serving in the applicable capacity as a member or chair of the Board of Directors or committee thereof and (ii)&#160;no fee shall be payable in respect of any period prior to the date such director was elected or appointed to serve in the applicable capacity as a member or chair of the Board of Directors or committee thereof.</font></div><div style="text-align:justify"><font><br></font></div><div style="text-align:justify"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">Expenses</font></div><div style="padding-left:108pt;text-align:justify;text-indent:-108pt"><font><br></font></div><div style="text-align:justify"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:700;line-height:100%">&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:100%">Upon presentation of documentation of such expenses reasonably satisfactory to the Company, each Non-Employee Director shall be reimbursed for his or her reasonable out-of-pocket business </font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">2</font></div><div><font><br></font></div></div></div><hr style="page-break-after:always"><div style="min-height:101.52pt;width:100%"><div style="padding-left:108pt;text-indent:-108pt"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:100%">Second Amended and Restated Non-Employee Director Compensation Policy</font></div><div><font><br></font></div></div><div style="text-align:justify"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:100%">expenses incurred in connection with attending meetings of the Board of Directors and committees thereof or in connection with other business related to the Board of Directors. </font></div><div style="text-align:justify"><font><br></font></div><div style="padding-left:108pt;text-align:justify;text-indent:-108pt"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">Amendments</font></div><div style="padding-left:108pt;text-align:justify;text-indent:-108pt"><font><br></font></div><div style="text-align:justify"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:700;line-height:100%">&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:100%">The Compensation Committee shall periodically review this Policy to assess whether any amendments in the type and amount of compensation provided herein should be made and shall make recommendations to the Board of Directors for its approval of any amendments to this Policy.</font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">3</font></div><div><font><br></font></div></div></div></body></html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-31.1
<SEQUENCE>5
<FILENAME>dmtk-20210630xex311.htm
<DESCRIPTION>EX-31.1
<TEXT>
<!DOCTYPE html PUBLIC "-//W3C//DTD HTML 4.01 Transitional//EN" "http://www.w3.org/TR/html4/loose.dtd"><html><head>
<!-- Document created using Wdesk -->
<!-- Copyright 2022 Workiva -->
<title>Document</title></head><body><div id="ice6d2c0696c04b13a8ab475c3e18d322_1"></div><div style="min-height:45pt;width:100%"><div><font><br></font></div></div><div style="margin-top:12pt;text-align:right"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Exhibit 31.1</font></div><div style="margin-top:12pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">CERTIFICATION PURSUANT TO</font></div><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">RULES 13a-14(a) AND 15d-14(a) UNDER THE SECURITIES EXCHANGE ACT OF 1934,</font></div><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">AS ADOPTED PURSUANT TO SECTION 302 OF THE SARBANES-OXLEY ACT OF 2002</font></div><div style="margin-top:12pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">I, John Dobak, certify that&#58;</font></div><div style="margin-top:12pt;padding-left:36pt;text-indent:-36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">1.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:28.5pt">I have reviewed this Quarterly Report on Form 10-Q for the quarterly period ended June&#160;30, 2022 of DermTech, Inc.&#59;</font></div><div style="margin-top:12pt;padding-left:36pt;text-indent:-36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">2.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:28.5pt">Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such statements were made, not misleading with respect to the period covered by this report&#59;</font></div><div style="margin-top:12pt;padding-left:36pt;text-indent:-36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">3.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:28.5pt">Based on my knowledge, the financial statements, and other financial information included in this report, fairly present in all material respects the financial condition, results of operations and cash flows of the registrant as of, and for, the periods presented in this report&#59;</font></div><div style="margin-top:12pt;padding-left:36pt;text-indent:-36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">4.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:28.5pt">The registrant&#8217;s other certifying officer(s) and I are responsible for establishing and maintaining disclosure controls and procedures (as defined in Exchange Act Rules 13a-15(e) and 15d-15(e)) and internal control over financial reporting (as defined in Exchange Act Rules 13a-15(f) and 15d-15(f)) for the registrant and have&#58;</font></div><div style="margin-top:12pt;padding-left:72pt;text-indent:-36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(a)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:24.91pt">Designed such disclosure controls and procedures, or caused such disclosure controls and procedures to be designed under our supervision, to ensure that material information relating to the registrant, including its consolidated subsidiaries, is made known to us by others within those entities, particularly during the period in which this report is being prepared&#59;</font></div><div style="margin-top:12pt;padding-left:72pt;text-indent:-36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(b)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:24.34pt">Designed such internal control over financial reporting, or caused such internal control over financial reporting to be designed under our supervision, to provide reasonable assurance regarding the reliability of financial reporting and the preparation of financial statements for external purposes in accordance with generally accepted accounting principles&#59;</font></div><div style="margin-top:12pt;padding-left:72pt;text-indent:-36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(c)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:24.91pt">Evaluated the effectiveness of the registrant&#8217;s disclosure controls and procedures and presented in this report our conclusions about the effectiveness of the disclosure controls and procedures, as of the end of the period covered by this report based on such evaluation&#59; and</font></div><div style="margin-top:12pt;padding-left:72pt;text-indent:-36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(d)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:24.34pt">Disclosed in this report any change in the registrant&#8217;s internal control over financial reporting that occurred during the registrant&#8217;s most recent fiscal quarter (the registrant&#8217;s fourth fiscal quarter in the case of an annual report) that has materially affected, or is reasonably likely to materially affect, the registrant&#8217;s internal control over financial reporting&#59; and</font></div><div style="margin-top:12pt;padding-left:36pt;text-indent:-36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">5.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:28.5pt">The registrant&#8217;s other certifying officer(s) and I have disclosed, based on our most recent evaluation of internal control over financial reporting, to the registrant&#8217;s auditors and the audit committee of the registrant&#8217;s board of directors (or persons performing the equivalent functions)&#58;</font></div><div style="margin-top:12pt;padding-left:72pt;text-indent:-36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(a)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:24.91pt">All significant deficiencies and material weaknesses in the design or operation of internal control over financial reporting which are reasonably likely to adversely affect the registrant&#8217;s ability to record, process, summarize and report financial information&#59; and</font></div><div style="margin-top:12pt;padding-left:72pt;text-indent:-36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(b)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:24.34pt">Any fraud, whether or not material, that involves management or other employees who have a significant role in the registrant&#8217;s internal control over financial reporting.</font></div><div style="margin-top:12pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:46.930%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:2.990%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:46.780%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Date&#58; August&#160;8, 2022</font></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">By&#58;</font></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#47;s&#47; John Dobak</font></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">John Dobak</font></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Chief Executive Officer</font></div><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(principal executive officer)</font></div></td></tr></table></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><font><br></font></div></div></div></body></html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-31.2
<SEQUENCE>6
<FILENAME>dmtk-20210630xex312.htm
<DESCRIPTION>EX-31.2
<TEXT>
<!DOCTYPE html PUBLIC "-//W3C//DTD HTML 4.01 Transitional//EN" "http://www.w3.org/TR/html4/loose.dtd"><html><head>
<!-- Document created using Wdesk -->
<!-- Copyright 2022 Workiva -->
<title>Document</title></head><body><div id="ia5bfabd11c3b497b85eab72eeed6be69_1"></div><div style="min-height:45pt;width:100%"><div><font><br></font></div></div><div style="margin-top:12pt;text-align:right"><font style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Exhibit 31.2</font></div><div style="margin-top:12pt;text-align:center"><font style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">CERTIFICATION PURSUANT TO</font></div><div style="text-align:center"><font style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">RULES 13a-14(a) AND 15d-14(a) UNDER THE SECURITIES EXCHANGE ACT OF 1934,</font></div><div style="text-align:center"><font style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">AS ADOPTED PURSUANT TO SECTION 302 OF THE SARBANES-OXLEY ACT OF 2002</font></div><div style="margin-top:12pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">I, Kevin Sun, certify that&#58;</font></div><div style="margin-top:12pt;padding-left:36pt;text-indent:-36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">1.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:28.5pt">I have reviewed this Quarterly Report on Form 10-Q for the quarterly period ended June&#160;30, 2022 of DermTech, Inc.&#59;</font></div><div style="margin-top:12pt;padding-left:36pt;text-indent:-36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">2.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:28.5pt">Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such statements were made, not misleading with respect to the period covered by this report&#59;</font></div><div style="margin-top:12pt;padding-left:36pt;text-indent:-36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">3.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:28.5pt">Based on my knowledge, the financial statements, and other financial information included in this report, fairly present in all material respects the financial condition, results of operations and cash flows of the registrant as of, and for, the periods presented in this report&#59;</font></div><div style="margin-top:12pt;padding-left:36pt;text-indent:-36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">4.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:28.5pt">The registrant&#8217;s other certifying officer(s) and I are responsible for establishing and maintaining disclosure controls and procedures (as defined in Exchange Act Rules 13a-15(e) and 15d-15(e)) and internal control over financial reporting (as defined in Exchange Act Rules 13a-15(f) and 15d-15(f)) for the registrant and have&#58;</font></div><div style="margin-top:12pt;padding-left:72pt;text-indent:-36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(a)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:24.91pt">Designed such disclosure controls and procedures, or caused such disclosure controls and procedures to be designed under our supervision, to ensure that material information relating to the registrant, including its consolidated subsidiaries, is made known to us by others within those entities, particularly during the period in which this report is being prepared&#59;</font></div><div style="margin-top:12pt;padding-left:72pt;text-indent:-36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(b)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:24.34pt">Designed such internal control over financial reporting, or caused such internal control over financial reporting to be designed under our supervision, to provide reasonable assurance regarding the reliability of financial reporting and the preparation of financial statements for external purposes in accordance with generally accepted accounting principles&#59;</font></div><div style="margin-top:12pt;padding-left:72pt;text-indent:-36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(c)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:24.91pt">Evaluated the effectiveness of the registrant&#8217;s disclosure controls and procedures and presented in this report our conclusions about the effectiveness of the disclosure controls and procedures, as of the end of the period covered by this report based on such evaluation&#59; and</font></div><div style="margin-top:12pt;padding-left:72pt;text-indent:-36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(d)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:24.34pt">Disclosed in this report any change in the registrant&#8217;s internal control over financial reporting that occurred during the registrant&#8217;s most recent fiscal quarter (the registrant&#8217;s fourth fiscal quarter in the case of an annual report) that has materially affected, or is reasonably likely to materially affect, the registrant&#8217;s internal control over financial reporting&#59; and </font></div><div style="margin-top:12pt;padding-left:36pt;text-indent:-36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">5.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:28.5pt">The registrant&#8217;s other certifying officer(s) and I have disclosed, based on our most recent evaluation of internal control over financial reporting, to the registrant&#8217;s auditors and the audit committee of the registrant&#8217;s board of directors (or persons performing the equivalent functions)&#58;</font></div><div style="margin-top:12pt;padding-left:72pt;text-indent:-36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(a)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:24.91pt">All significant deficiencies and material weaknesses in the design or operation of internal control over financial reporting which are reasonably likely to adversely affect the registrant&#8217;s ability to record, process, summarize and report financial information&#59; and</font></div><div style="margin-top:12pt;padding-left:72pt;text-indent:-36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(b)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:24.34pt">Any fraud, whether or not material, that involves management or other employees who have a significant role in the registrant&#8217;s internal control over financial reporting.</font></div><div style="margin-top:12pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:46.930%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:2.990%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:46.780%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Date&#58; August&#160;8, 2022</font></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">By&#58;</font></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#47;s&#47; Kevin Sun</font></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Kevin Sun</font></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Chief Financial Officer</font></div><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(principal financial and accounting officer)</font></div></td></tr></table></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><font><br></font></div></div></div></body></html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-32.1
<SEQUENCE>7
<FILENAME>dmtk-20210630xex321.htm
<DESCRIPTION>EX-32.1
<TEXT>
<!DOCTYPE html PUBLIC "-//W3C//DTD HTML 4.01 Transitional//EN" "http://www.w3.org/TR/html4/loose.dtd"><html><head>
<!-- Document created using Wdesk -->
<!-- Copyright 2022 Workiva -->
<title>Document</title></head><body><div id="i67496c2283754efda3e60e5d4b3e9d5d_1"></div><div style="min-height:45pt;width:100%"><div><font><br></font></div></div><div style="margin-top:12pt;text-align:right"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Exhibit 32.1</font></div><div style="margin-top:12pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">CERTIFICATION PURSUANT TO</font></div><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">18 U.S.C. SECTION 1350, AS ADOPTED PURSUANT TO</font></div><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">SECTION 906 OF THE SARBANES-OXLEY ACT OF 2002</font></div><div style="margin-top:12pt;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In connection with the Quarterly Report on Form 10-Q for the quarterly period ended June&#160;30, 2022 of DermTech, Inc. (the &#8220;Company&#8221;), as filed with the Securities and Exchange Commission on the date hereof (the &#8220;Report&#8221;), each of the undersigned hereby certifies in his capacity as the specified officer of the Company, pursuant to 18 U.S.C. &#167; 1350, as adopted pursuant to &#167; 906 of the Sarbanes-Oxley Act of 2002, that, to the best of his knowledge&#58;</font></div><div style="margin-top:12pt;padding-left:72pt;text-indent:-36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(1)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:24.34pt">The Report fully complies with the requirements of Section 13(a) or 15(d) of the Securities Exchange Act of 1934&#59; and</font></div><div style="margin-top:12pt;padding-left:72pt;text-indent:-36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(2)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:24.34pt">The information contained in the Report fairly presents, in all material respects, the financial condition and result of operations of the Company.</font></div><div style="margin-top:12pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:46.930%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:2.990%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:46.780%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Date&#58; August&#160;8, 2022</font></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">By&#58;</font></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#47;s&#47; John Dobak</font></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">John Dobak</font></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Chief Executive Officer</font></div><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(principal executive officer)</font></div></td></tr><tr style="height:15pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Date&#58; August&#160;8, 2022</font></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">By&#58;</font></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#47;s&#47; Kevin Sun</font></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Kevin Sun</font></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Chief Financial Officer</font></div><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(principal financial and accounting officer)</font></div></td></tr></table></div><div style="margin-top:12pt;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">This certification accompanies the Quarterly Report on Form 10-Q to which it relates and shall not be deemed filed with the Securities and Exchange Commission or incorporated by reference into any filing of the Company under the Securities Act of 1933, as amended, or the Securities Exchange Act of 1934, as amended (whether made before or after the date of the Form 10-Q), irrespective of any general incorporation language contained in such filing.</font></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><font><br></font></div></div></div></body></html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-101.SCH
<SEQUENCE>8
<FILENAME>dmtk-20220630.xsd
<DESCRIPTION>XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT
<TEXT>
<XBRL>
<?xml version="1.0" encoding="UTF-8"?>

<!--XBRL Document Created with Wdesk from Workiva-->
<!--Copyright 2022 Workiva-->
<!--r:00c1bec6-bc29-44ad-a3fa-8dd942e770ac,g:dd828811-c245-4da7-9eef-30b71a6b7e18-->
<xs:schema xmlns:xs="http://www.w3.org/2001/XMLSchema" xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:dmtk="http://dermtech.com/20220630" xmlns:xbrli="http://www.xbrl.org/2003/instance" xmlns:dtr-types="http://www.xbrl.org/dtr/type/2020-01-21" xmlns:xbrldt="http://xbrl.org/2005/xbrldt" xmlns:srt-types="http://fasb.org/srt-types/2022" attributeFormDefault="unqualified" elementFormDefault="qualified" targetNamespace="http://dermtech.com/20220630">
  <xs:import namespace="http://fasb.org/srt-types/2022" schemaLocation="https://xbrl.fasb.org/srt/2022/elts/srt-types-2022.xsd"/>
  <xs:import namespace="http://fasb.org/srt/2022" schemaLocation="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd"/>
  <xs:import namespace="http://fasb.org/us-gaap/2022" schemaLocation="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd"/>
  <xs:import namespace="http://www.w3.org/1999/xlink" schemaLocation="http://www.xbrl.org/2003/xlink-2003-12-31.xsd"/>
  <xs:import namespace="http://www.xbrl.org/2003/instance" schemaLocation="http://www.xbrl.org/2003/xbrl-instance-2003-12-31.xsd"/>
  <xs:import namespace="http://www.xbrl.org/2003/linkbase" schemaLocation="http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd"/>
  <xs:import namespace="http://www.xbrl.org/dtr/type/2020-01-21" schemaLocation="https://www.xbrl.org/dtr/type/2020-01-21/types.xsd"/>
  <xs:import namespace="http://xbrl.org/2005/xbrldt" schemaLocation="http://www.xbrl.org/2005/xbrldt-2005.xsd"/>
  <xs:import namespace="http://xbrl.sec.gov/dei/2022" schemaLocation="https://xbrl.sec.gov/dei/2022/dei-2022.xsd"/>
  <xs:annotation>
    <xs:appinfo>
      <link:linkbaseRef xmlns:xlink="http://www.w3.org/1999/xlink" xlink:arcrole="http://www.w3.org/1999/xlink/properties/linkbase" xlink:href="dmtk-20220630_lab.xml" xlink:role="http://www.xbrl.org/2003/role/labelLinkbaseRef" xlink:type="simple"/>
      <link:linkbaseRef xmlns:xlink="http://www.w3.org/1999/xlink" xlink:arcrole="http://www.w3.org/1999/xlink/properties/linkbase" xlink:href="dmtk-20220630_pre.xml" xlink:role="http://www.xbrl.org/2003/role/presentationLinkbaseRef" xlink:type="simple"/>
      <link:linkbaseRef xmlns:xlink="http://www.w3.org/1999/xlink" xlink:arcrole="http://www.w3.org/1999/xlink/properties/linkbase" xlink:href="dmtk-20220630_cal.xml" xlink:role="http://www.xbrl.org/2003/role/calculationLinkbaseRef" xlink:type="simple"/>
      <link:linkbaseRef xmlns:xlink="http://www.w3.org/1999/xlink" xlink:arcrole="http://www.w3.org/1999/xlink/properties/linkbase" xlink:href="dmtk-20220630_def.xml" xlink:role="http://www.xbrl.org/2003/role/definitionLinkbaseRef" xlink:type="simple"/>
      <link:roleType id="CoverPage" roleURI="http://dermtech.com/role/CoverPage">
        <link:definition>0001001 - Document - Cover Page</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="CondensedConsolidatedBalanceSheets" roleURI="http://dermtech.com/role/CondensedConsolidatedBalanceSheets">
        <link:definition>1001002 - Statement - Condensed Consolidated Balance Sheets</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="CondensedConsolidatedBalanceSheetsParenthetical" roleURI="http://dermtech.com/role/CondensedConsolidatedBalanceSheetsParenthetical">
        <link:definition>1002003 - Statement - Condensed Consolidated Balance Sheets (Parenthetical)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="CondensedConsolidatedStatementsofOperations" roleURI="http://dermtech.com/role/CondensedConsolidatedStatementsofOperations">
        <link:definition>1003004 - Statement - Condensed Consolidated Statements of Operations</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="CondensedConsolidatedStatementsofComprehensiveLoss" roleURI="http://dermtech.com/role/CondensedConsolidatedStatementsofComprehensiveLoss">
        <link:definition>1004005 - Statement - Condensed Consolidated Statements of Comprehensive Loss</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="CondensedConsolidatedStatementsofStockholdersEquity" roleURI="http://dermtech.com/role/CondensedConsolidatedStatementsofStockholdersEquity">
        <link:definition>1005006 - Statement - Condensed Consolidated Statements of Stockholders&#8217; Equity</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="CondensedConsolidatedStatementsofStockholdersEquityParenthetical" roleURI="http://dermtech.com/role/CondensedConsolidatedStatementsofStockholdersEquityParenthetical">
        <link:definition>1006007 - Statement - Condensed Consolidated Statements of Stockholders&#8217; Equity (Parenthetical)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="CondensedConsolidatedStatementsofCashFlows" roleURI="http://dermtech.com/role/CondensedConsolidatedStatementsofCashFlows">
        <link:definition>1007008 - Statement - Condensed Consolidated Statements of Cash Flows</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="TheCompanyandaSummaryofitsSignificantAccountingPolicies" roleURI="http://dermtech.com/role/TheCompanyandaSummaryofitsSignificantAccountingPolicies">
        <link:definition>2101101 - Disclosure - The Company and a Summary of its Significant Accounting Policies</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="TheCompanyandaSummaryofitsSignificantAccountingPoliciesPolicies" roleURI="http://dermtech.com/role/TheCompanyandaSummaryofitsSignificantAccountingPoliciesPolicies">
        <link:definition>2202201 - Disclosure - The Company and a Summary of its Significant Accounting Policies (Policies)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="TheCompanyandaSummaryofitsSignificantAccountingPoliciesTables" roleURI="http://dermtech.com/role/TheCompanyandaSummaryofitsSignificantAccountingPoliciesTables">
        <link:definition>2303301 - Disclosure - The Company and a Summary of its Significant Accounting Policies (Tables)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="TheCompanyandaSummaryofitsSignificantAccountingPoliciesAdditionalInformationDetails" roleURI="http://dermtech.com/role/TheCompanyandaSummaryofitsSignificantAccountingPoliciesAdditionalInformationDetails">
        <link:definition>2404401 - Disclosure - The Company and a Summary of its Significant Accounting Policies - Additional Information (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="TheCompanyandaSummaryofitsSignificantAccountingPoliciesScheduleofRevenuesDisaggregatedbyRevenueSourceDetails" roleURI="http://dermtech.com/role/TheCompanyandaSummaryofitsSignificantAccountingPoliciesScheduleofRevenuesDisaggregatedbyRevenueSourceDetails">
        <link:definition>2405402 - Disclosure - The Company and a Summary of its Significant Accounting Policies - Schedule of Revenues Disaggregated by Revenue Source (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="TheCompanyandaSummaryofitsSignificantAccountingPoliciesSummaryofPercentagesofTotalRevenueorAccountsReceivableforThirdPartyPayersandPharmaceuticalCustomersDetails" roleURI="http://dermtech.com/role/TheCompanyandaSummaryofitsSignificantAccountingPoliciesSummaryofPercentagesofTotalRevenueorAccountsReceivableforThirdPartyPayersandPharmaceuticalCustomersDetails">
        <link:definition>2406403 - Disclosure - The Company and a Summary of its Significant Accounting Policies - Summary of Percentages of Total Revenue or Accounts Receivable for Third Party Payers and Pharmaceutical Customers (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="TheCompanyandaSummaryofitsSignificantAccountingPoliciesSummaryofAssetsandLiabilitiesMeasuredatFairValueonRecurringBasisDetails" roleURI="http://dermtech.com/role/TheCompanyandaSummaryofitsSignificantAccountingPoliciesSummaryofAssetsandLiabilitiesMeasuredatFairValueonRecurringBasisDetails">
        <link:definition>2407404 - Disclosure - The Company and a Summary of its Significant Accounting Policies - Summary of Assets and Liabilities Measured at Fair Value on Recurring Basis (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="TheCompanyandaSummaryofitsSignificantAccountingPoliciesAssumptionsUsedtoDetermineFairValueofEachOptiononDateofGrantIssuedDetails" roleURI="http://dermtech.com/role/TheCompanyandaSummaryofitsSignificantAccountingPoliciesAssumptionsUsedtoDetermineFairValueofEachOptiononDateofGrantIssuedDetails">
        <link:definition>2408405 - Disclosure - The Company and a Summary of its Significant Accounting Policies - Assumptions Used to Determine Fair Value of Each Option on Date of Grant Issued (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="TheCompanyandaSummaryofitsSignificantAccountingPoliciesSummaryofChangesinFairValueofLevel3LiabilitiesDetails" roleURI="http://dermtech.com/role/TheCompanyandaSummaryofitsSignificantAccountingPoliciesSummaryofChangesinFairValueofLevel3LiabilitiesDetails">
        <link:definition>2409406 - Disclosure - The Company and a Summary of its Significant Accounting Policies - Summary of Changes in Fair Value of Level 3 Liabilities (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="BalanceSheetDetails" roleURI="http://dermtech.com/role/BalanceSheetDetails">
        <link:definition>2110102 - Disclosure - Balance Sheet Details</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="BalanceSheetDetailsTables" roleURI="http://dermtech.com/role/BalanceSheetDetailsTables">
        <link:definition>2311302 - Disclosure - Balance Sheet Details (Tables)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="BalanceSheetDetailsScheduleofShortTermMarketableSecuritiesDetails" roleURI="http://dermtech.com/role/BalanceSheetDetailsScheduleofShortTermMarketableSecuritiesDetails">
        <link:definition>2412407 - Disclosure - Balance Sheet Details - Schedule of Short-Term Marketable Securities (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="BalanceSheetDetailsAdditionalInformationDetails" roleURI="http://dermtech.com/role/BalanceSheetDetailsAdditionalInformationDetails">
        <link:definition>2413408 - Disclosure - Balance Sheet Details - Additional Information (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="BalanceSheetDetailsScheduleofPrepaidExpensesandPPEDetails" roleURI="http://dermtech.com/role/BalanceSheetDetailsScheduleofPrepaidExpensesandPPEDetails">
        <link:definition>2414409 - Disclosure - Balance Sheet Details - Schedule of Prepaid Expenses and PP&amp;E (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="BalanceSheetDetailsScheduleofAccruedCompensationandAccruedLiabilitiesDetails" roleURI="http://dermtech.com/role/BalanceSheetDetailsScheduleofAccruedCompensationandAccruedLiabilitiesDetails">
        <link:definition>2415410 - Disclosure - Balance Sheet Details - Schedule of Accrued Compensation and Accrued Liabilities (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="StockholdersEquity" roleURI="http://dermtech.com/role/StockholdersEquity">
        <link:definition>2116103 - Disclosure - Stockholders' Equity</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="StockholdersEquityTables" roleURI="http://dermtech.com/role/StockholdersEquityTables">
        <link:definition>2317303 - Disclosure - Stockholders' Equity (Tables)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="StockholdersEquityAdditionalInformationDetails" roleURI="http://dermtech.com/role/StockholdersEquityAdditionalInformationDetails">
        <link:definition>2418411 - Disclosure - Stockholders' Equity - Additional Information (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="StockholdersEquityESPPValuationMethodDetails" roleURI="http://dermtech.com/role/StockholdersEquityESPPValuationMethodDetails">
        <link:definition>2419412 - Disclosure - Stockholders' Equity - ESPP Valuation Method (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="StockholdersEquityShareBasedCompensationExpenseDetails" roleURI="http://dermtech.com/role/StockholdersEquityShareBasedCompensationExpenseDetails">
        <link:definition>2420413 - Disclosure - Stockholders' Equity - Share-Based Compensation Expense (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="StockholdersEquitySummaryofCommonStockReservedforFutureIssuanceDetail" roleURI="http://dermtech.com/role/StockholdersEquitySummaryofCommonStockReservedforFutureIssuanceDetail">
        <link:definition>2421414 - Disclosure - Stockholders' Equity - Summary of Common Stock Reserved for Future Issuance (Detail)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="LeasesCommitmentsandContingencies" roleURI="http://dermtech.com/role/LeasesCommitmentsandContingencies">
        <link:definition>2122104 - Disclosure - Leases, Commitments and Contingencies</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="LeasesCommitmentsandContingenciesTables" roleURI="http://dermtech.com/role/LeasesCommitmentsandContingenciesTables">
        <link:definition>2323304 - Disclosure - Leases, Commitments and Contingencies (Tables)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="LeasesCommitmentsandContingenciesAdoptionofASC842Details" roleURI="http://dermtech.com/role/LeasesCommitmentsandContingenciesAdoptionofASC842Details">
        <link:definition>2424415 - Disclosure - Leases, Commitments and Contingencies - Adoption of ASC 842 (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="LeasesCommitmentsandContingenciesAdditionalInformationDetails" roleURI="http://dermtech.com/role/LeasesCommitmentsandContingenciesAdditionalInformationDetails">
        <link:definition>2425416 - Disclosure - Leases, Commitments and Contingencies - Additional Information (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="LeasesCommitmentsandContingenciesScheduleofLongTermFinanceLeaseObligationsDetails" roleURI="http://dermtech.com/role/LeasesCommitmentsandContingenciesScheduleofLongTermFinanceLeaseObligationsDetails">
        <link:definition>2426417 - Disclosure - Leases, Commitments and Contingencies - Schedule of Long Term Finance Lease Obligations (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="LeasesCommitmentsandContingenciesComponentsofLeaseExpenseDetails" roleURI="http://dermtech.com/role/LeasesCommitmentsandContingenciesComponentsofLeaseExpenseDetails">
        <link:definition>2427418 - Disclosure - Leases, Commitments and Contingencies - Components of Lease Expense (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="LeasesCommitmentsandContingenciesFutureMinimumPaymentsDetails" roleURI="http://dermtech.com/role/LeasesCommitmentsandContingenciesFutureMinimumPaymentsDetails">
        <link:definition>2428419 - Disclosure - Leases, Commitments and Contingencies - Future Minimum Payments (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="RelatedPartyTransactions" roleURI="http://dermtech.com/role/RelatedPartyTransactions">
        <link:definition>2129105 - Disclosure - Related Party Transactions</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="RelatedPartyTransactionsAdditionalInformationDetails" roleURI="http://dermtech.com/role/RelatedPartyTransactionsAdditionalInformationDetails">
        <link:definition>2430420 - Disclosure - Related Party Transactions - Additional Information (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="SubsequentEvents" roleURI="http://dermtech.com/role/SubsequentEvents">
        <link:definition>2131106 - Disclosure - Subsequent Events</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
    </xs:appinfo>
  </xs:annotation>
  <xs:element id="dmtk_PercentageOfUsefulLivesOfAssets" abstract="false" name="PercentageOfUsefulLivesOfAssets" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:percentItemType"/>
  <xs:element id="dmtk_OperatingLeaseCostAbstract" abstract="true" name="OperatingLeaseCostAbstract" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="xbrli:stringItemType"/>
  <xs:element id="dmtk_ContractRevenueAdhesivePatchKitsMember" abstract="true" name="ContractRevenueAdhesivePatchKitsMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="dmtk_ReclassificationOfWarrantLiabilityDueToPrivateSPACWarrantsNotHeldByOriginalHolder" abstract="false" name="ReclassificationOfWarrantLiabilityDueToPrivateSPACWarrantsNotHeldByOriginalHolder" nillable="true" xbrli:periodType="duration" xbrli:balance="credit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="dmtk_ContractualActivitiesMember" abstract="true" name="ContractualActivitiesMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="dmtk_CommitmentsAndContingenciesLineItems" abstract="true" name="CommitmentsAndContingenciesLineItems" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="xbrli:stringItemType"/>
  <xs:element id="dmtk_SpecialPurposeAcquisitionCompanyWarrantsToPurchaseCommonStockMember" abstract="true" name="SpecialPurposeAcquisitionCompanyWarrantsToPurchaseCommonStockMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="dmtk_FirstAmendmentMember" abstract="true" name="FirstAmendmentMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="dmtk_RestrictedCashAndCashEquivalentsIncreaseDecrease" abstract="false" name="RestrictedCashAndCashEquivalentsIncreaseDecrease" nillable="true" xbrli:periodType="duration" xbrli:balance="debit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="dmtk_AssayRevenuePayorBMember" abstract="true" name="AssayRevenuePayorBMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="dmtk_PercentageOfPriceAtSharesPurchased" abstract="false" name="PercentageOfPriceAtSharesPurchased" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:percentItemType"/>
  <xs:element id="dmtk_AmortizationOfLaboratoryEquipmentAcquiredUnderFinanceLeasesMember" abstract="true" name="AmortizationOfLaboratoryEquipmentAcquiredUnderFinanceLeasesMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="dmtk_FinanceLeaseLiabilityPaymentsDueAfterYearFour" abstract="false" name="FinanceLeaseLiabilityPaymentsDueAfterYearFour" nillable="true" xbrli:periodType="instant" xbrli:balance="credit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="dmtk_CommonStockOutstandingPercentage" abstract="false" name="CommonStockOutstandingPercentage" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:percentItemType"/>
  <xs:element id="dmtk_StockOptionsAndRestrictedStockUnitsMember" abstract="true" name="StockOptionsAndRestrictedStockUnitsMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="dmtk_TwoThousandTwentyEquityIncentivePlanMember" abstract="true" name="TwoThousandTwentyEquityIncentivePlanMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="dmtk_UnderwritersGrantPeriodOption" abstract="false" name="UnderwritersGrantPeriodOption" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="xbrli:durationItemType"/>
  <xs:element id="dmtk_OperatingAndFinanceLeaseLiabilityPaymentsDue" abstract="false" name="OperatingAndFinanceLeaseLiabilityPaymentsDue" nillable="true" xbrli:periodType="instant" xbrli:balance="credit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="dmtk_OperatingLeaseCosts" abstract="false" name="OperatingLeaseCosts" nillable="true" xbrli:periodType="duration" xbrli:balance="debit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="dmtk_PublicFollowOnOfferingMember" abstract="true" name="PublicFollowOnOfferingMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="dmtk_CashPaidForAmountsIncludedInMeasurementOfLeaseLiabilitiesAbstract" abstract="true" name="CashPaidForAmountsIncludedInMeasurementOfLeaseLiabilitiesAbstract" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="xbrli:stringItemType"/>
  <xs:element id="dmtk_FinanceLeaseCostsAbstract" abstract="true" name="FinanceLeaseCostsAbstract" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="xbrli:stringItemType"/>
  <xs:element id="dmtk_IncreaseDecreaseInOperatingLeaseRightOfUseAsset" abstract="false" name="IncreaseDecreaseInOperatingLeaseRightOfUseAsset" nillable="true" xbrli:periodType="duration" xbrli:balance="debit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="dmtk_GrossProceedsFromIssuanceOfCommonStock" abstract="false" name="GrossProceedsFromIssuanceOfCommonStock" nillable="true" xbrli:periodType="duration" xbrli:balance="debit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="dmtk_RevenuePerformanceObligationSatisfiedVariableConsiderationUpdateIncreaseDecreaseInRevenue" abstract="false" name="RevenuePerformanceObligationSatisfiedVariableConsiderationUpdateIncreaseDecreaseInRevenue" nillable="true" xbrli:periodType="duration" xbrli:balance="credit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="dmtk_FinanceLeaseCost" abstract="false" name="FinanceLeaseCost" nillable="true" xbrli:periodType="duration" xbrli:balance="debit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="dmtk_IncentiveStockOptionsMember" abstract="true" name="IncentiveStockOptionsMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="dmtk_CowenLimitedLiabilityCompanyMember" abstract="true" name="CowenLimitedLiabilityCompanyMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="dmtk_TenantImprovementAllowance" abstract="false" name="TenantImprovementAllowance" nillable="true" xbrli:periodType="instant" xbrli:balance="debit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="dmtk_AuthorizedForFutureEquityGrantsMember" abstract="true" name="AuthorizedForFutureEquityGrantsMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="dmtk_OperatingAndFinanceLeaseLiabilityPaymentsDueYearTwo" abstract="false" name="OperatingAndFinanceLeaseLiabilityPaymentsDueYearTwo" nillable="true" xbrli:periodType="instant" xbrli:balance="credit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="dmtk_EVERSANALifeScienceServicesLLCMember" abstract="true" name="EVERSANALifeScienceServicesLLCMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="dmtk_EstimatedMarketValueOfDebtSecuritiesWithContractualMaturitiesOfLessThan12Months" abstract="false" name="EstimatedMarketValueOfDebtSecuritiesWithContractualMaturitiesOfLessThan12Months" nillable="true" xbrli:periodType="instant" xbrli:balance="debit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="dmtk_SpouseOfChiefCommercialOfficerMember" abstract="true" name="SpouseOfChiefCommercialOfficerMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="dmtk_OperatingAndFinanceLeaseLiabilityPaymentsDueNextTwelveMonths" abstract="false" name="OperatingAndFinanceLeaseLiabilityPaymentsDueNextTwelveMonths" nillable="true" xbrli:periodType="instant" xbrli:balance="credit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="dmtk_IncentiveAndNonQualifiedStockOptionsMember" abstract="true" name="IncentiveAndNonQualifiedStockOptionsMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="dmtk_NumberOfImprovementPhases" abstract="false" name="NumberOfImprovementPhases" nillable="true" xbrli:periodType="instant" substitutionGroup="xbrli:item" type="xbrli:integerItemType"/>
  <xs:element id="dmtk_AccruedBonusAndDeferredCompensationCurrent" abstract="false" name="AccruedBonusAndDeferredCompensationCurrent" nillable="true" xbrli:periodType="instant" xbrli:balance="credit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="dmtk_SpecialPurposeAcquisitionCompaniesWarrantsMember" abstract="true" name="SpecialPurposeAcquisitionCompaniesWarrantsMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="dmtk_StockIssuedDuringPeriodValueStockOptionsExercisedAndRSURelease" abstract="false" name="StockIssuedDuringPeriodValueStockOptionsExercisedAndRSURelease" nillable="true" xbrli:periodType="duration" xbrli:balance="credit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="dmtk_ManagementWarrantsMember" abstract="true" name="ManagementWarrantsMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="dmtk_GrossProceedsFromOfferingBeforeDeductingUnderwritingDiscountsAndCommissionsAndOtherOfferingExpenses" abstract="false" name="GrossProceedsFromOfferingBeforeDeductingUnderwritingDiscountsAndCommissionsAndOtherOfferingExpenses" nillable="true" xbrli:periodType="duration" xbrli:balance="debit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="dmtk_IncreaseInTenantImprovementAllowance" abstract="false" name="IncreaseInTenantImprovementAllowance" nillable="true" xbrli:periodType="duration" xbrli:balance="credit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="dmtk_ComputerEquipmentGross" abstract="false" name="ComputerEquipmentGross" nillable="true" xbrli:periodType="instant" xbrli:balance="debit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="dmtk_DermTechOperationsIncMember" abstract="true" name="DermTechOperationsIncMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="dmtk_TheCompanyAndSummaryOfItsSignificantAccountingPoliciesLineItems" abstract="true" name="TheCompanyAndSummaryOfItsSignificantAccountingPoliciesLineItems" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="xbrli:stringItemType"/>
  <xs:element id="dmtk_ContractRevenueRNAExtractionsMember" abstract="true" name="ContractRevenueRNAExtractionsMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="dmtk_StockPurchasedByUnderwritersPursuantToOptionGranted" abstract="false" name="StockPurchasedByUnderwritersPursuantToOptionGranted" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="xbrli:sharesItemType"/>
  <xs:element id="dmtk_WarrantsToPurchaseCommonStockMember" abstract="true" name="WarrantsToPurchaseCommonStockMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="dmtk_AssetsHeldUnderFinanceLeasesMember" abstract="true" name="AssetsHeldUnderFinanceLeasesMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="dmtk_CommitmentsAndContingenciesTable" abstract="true" name="CommitmentsAndContingenciesTable" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrldt:hypercubeItem" type="xbrli:stringItemType"/>
  <xs:element id="dmtk_PrepaidSoftwareFees" abstract="false" name="PrepaidSoftwareFees" nillable="true" xbrli:periodType="instant" xbrli:balance="debit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="dmtk_PublicSpecialPurposeAcquisitionCompaniesWarrantsMember" abstract="true" name="PublicSpecialPurposeAcquisitionCompaniesWarrantsMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="dmtk_ScheduleOfPrepaidExpensesAndPropertyAndEquipmentTableTextBlock" abstract="false" name="ScheduleOfPrepaidExpensesAndPropertyAndEquipmentTableTextBlock" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:textBlockItemType"/>
  <xs:element id="dmtk_TwoThousandTwentyEmployeeStockPurchasePlanMember" abstract="true" name="TwoThousandTwentyEmployeeStockPurchasePlanMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="dmtk_OperatingAndFinanceLeaseLiabilityPaymentsDueYearFour" abstract="false" name="OperatingAndFinanceLeaseLiabilityPaymentsDueYearFour" nillable="true" xbrli:periodType="instant" xbrli:balance="credit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="dmtk_PrepaidEmployeeCompensation" abstract="false" name="PrepaidEmployeeCompensation" nillable="true" xbrli:periodType="instant" xbrli:balance="debit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="dmtk_PrivateSpecialPurposeAcquisitionCompaniesWarrantsMember" abstract="true" name="PrivateSpecialPurposeAcquisitionCompaniesWarrantsMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="dmtk_TwoThousandTenStockPlanMember" abstract="true" name="TwoThousandTenStockPlanMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="dmtk_ClassOfWarrantOrRightWarrantsOrRightsIssuedToPurchaseCommonStock" abstract="false" name="ClassOfWarrantOrRightWarrantsOrRightsIssuedToPurchaseCommonStock" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="xbrli:sharesItemType"/>
  <xs:element id="dmtk_LeaseAmendmentsAxis" abstract="true" name="LeaseAmendmentsAxis" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrldt:dimensionItem" type="xbrli:stringItemType"/>
  <xs:element id="dmtk_AreaOfBuilding" abstract="false" name="AreaOfBuilding" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:areaItemType"/>
  <xs:element id="dmtk_ScheduleOfFutureMinimumRentalPaymentsForOperatingAndCapitalLeasesTableTextBlock" abstract="false" name="ScheduleOfFutureMinimumRentalPaymentsForOperatingAndCapitalLeasesTableTextBlock" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:textBlockItemType"/>
  <xs:element id="dmtk_WarrantLiabilityMember" abstract="true" name="WarrantLiabilityMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="dmtk_WarrantsVestingPeriod" abstract="false" name="WarrantsVestingPeriod" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="xbrli:durationItemType"/>
  <xs:element id="dmtk_ContractRevenueProjectManagementFeesMember" abstract="true" name="ContractRevenueProjectManagementFeesMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="dmtk_RentableAndUsableSquareFeet" abstract="false" name="RentableAndUsableSquareFeet" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="xbrli:integerItemType"/>
  <xs:element id="dmtk_PlacementAgentWarrantsMember" abstract="true" name="PlacementAgentWarrantsMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="dmtk_AtTheMarketOfferingMember" abstract="true" name="AtTheMarketOfferingMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="dmtk_LesseeOperatingLeaseNumberOfRenewalTerms" abstract="false" name="LesseeOperatingLeaseNumberOfRenewalTerms" nillable="true" xbrli:periodType="instant" substitutionGroup="xbrli:item" type="xbrli:integerItemType"/>
  <xs:element id="dmtk_TenantImprovementAllowancePerRentableSquareFoot" abstract="false" name="TenantImprovementAllowancePerRentableSquareFoot" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="srt-types:perUnitItemType"/>
  <xs:element id="dmtk_OperatingAndFinanceLeaseLiabilityPaymentsDueThereafter" abstract="false" name="OperatingAndFinanceLeaseLiabilityPaymentsDueThereafter" nillable="true" xbrli:periodType="instant" xbrli:balance="credit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="dmtk_CommonSharesIssuedUponExerciseOfWarrants" abstract="false" name="CommonSharesIssuedUponExerciseOfWarrants" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="xbrli:sharesItemType"/>
  <xs:element id="dmtk_TwoThousandEighteenConvertibleBridgeNotesMember" abstract="true" name="TwoThousandEighteenConvertibleBridgeNotesMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="dmtk_TheCompanyAndSummaryOfItsSignificantAccountingPoliciesTable" abstract="true" name="TheCompanyAndSummaryOfItsSignificantAccountingPoliciesTable" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrldt:hypercubeItem" type="xbrli:stringItemType"/>
  <xs:element id="dmtk_WeightedAveragePurchasePricePerShareInOffering" abstract="false" name="WeightedAveragePurchasePricePerShareInOffering" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:perShareItemType"/>
  <xs:element id="dmtk_OperatingAndFinanceLeaseLiabilityPaymentsDueYearThree" abstract="false" name="OperatingAndFinanceLeaseLiabilityPaymentsDueYearThree" nillable="true" xbrli:periodType="instant" xbrli:balance="credit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="dmtk_AdjustmentsToAdditionalPaidInCapitalWarrantIssuedShares" abstract="false" name="AdjustmentsToAdditionalPaidInCapitalWarrantIssuedShares" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="xbrli:sharesItemType"/>
  <xs:element id="dmtk_KilroyRealtyLPMember" abstract="true" name="KilroyRealtyLPMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="dmtk_AuthorizedForFutureESPPPurchasesMember" abstract="true" name="AuthorizedForFutureESPPPurchasesMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="dmtk_LesseeOperatingAndFinanceLeaseLiabilityToBePaidAbstract" abstract="true" name="LesseeOperatingAndFinanceLeaseLiabilityToBePaidAbstract" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="xbrli:stringItemType"/>
  <xs:element id="dmtk_ChangeInUnrealizedGainLossOnAvailableForSaleMarketableSecurities" abstract="false" name="ChangeInUnrealizedGainLossOnAvailableForSaleMarketableSecurities" nillable="true" xbrli:periodType="duration" xbrli:balance="debit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="dmtk_SecondAmendmentMember" abstract="true" name="SecondAmendmentMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="dmtk_AccruedConsultingServicesCurrent" abstract="false" name="AccruedConsultingServicesCurrent" nillable="true" xbrli:periodType="instant" xbrli:balance="credit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="dmtk_EquityIncentivePlanOptionTerm" abstract="false" name="EquityIncentivePlanOptionTerm" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="xbrli:durationItemType"/>
  <xs:element id="dmtk_AssayMember" abstract="true" name="AssayMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="dmtk_ProceedsFromReleaseOfRSUsAndStockOptionsExercised" abstract="false" name="ProceedsFromReleaseOfRSUsAndStockOptionsExercised" nillable="true" xbrli:periodType="duration" xbrli:balance="debit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="dmtk_OperatingLeaseIncrementalBorrowingRateAtEffectiveDate" abstract="false" name="OperatingLeaseIncrementalBorrowingRateAtEffectiveDate" nillable="true" xbrli:periodType="instant" substitutionGroup="xbrli:item" type="dtr-types:percentItemType"/>
  <xs:element id="dmtk_OperatingAndFinanceLeaseLiabilityPaymentsRemainderOfFiscalYear" abstract="false" name="OperatingAndFinanceLeaseLiabilityPaymentsRemainderOfFiscalYear" nillable="true" xbrli:periodType="instant" xbrli:balance="credit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="dmtk_WarrantLiabilityFairValueDisclosure" abstract="false" name="WarrantLiabilityFairValueDisclosure" nillable="true" xbrli:periodType="instant" xbrli:balance="credit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="dmtk_ProceedsFromMaturityOfMarketableSecurities" abstract="false" name="ProceedsFromMaturityOfMarketableSecurities" nillable="true" xbrli:periodType="duration" xbrli:balance="debit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="dmtk_PrepaidTradeShowsCurrent" abstract="false" name="PrepaidTradeShowsCurrent" nillable="true" xbrli:periodType="instant" xbrli:balance="debit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="dmtk_StockIssuedDuringPeriodSharesStockOptionsExercisedAndRSURelease" abstract="false" name="StockIssuedDuringPeriodSharesStockOptionsExercisedAndRSURelease" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="xbrli:sharesItemType"/>
  <xs:element id="dmtk_NumberOfWarrantsEntitleHolderToPurchaseOneShare" abstract="false" name="NumberOfWarrantsEntitleHolderToPurchaseOneShare" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="xbrli:integerItemType"/>
  <xs:element id="dmtk_BrotherOfChiefExecutiveOfficerMember" abstract="true" name="BrotherOfChiefExecutiveOfficerMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="dmtk_IncreaseDecreaseInStockIssuanceCosts" abstract="false" name="IncreaseDecreaseInStockIssuanceCosts" nillable="true" xbrli:periodType="duration" xbrli:balance="credit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="dmtk_LeaseAmendmentsDomain" abstract="true" name="LeaseAmendmentsDomain" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="dmtk_CashlessExerciseOfCommonStockWarrants" abstract="false" name="CashlessExerciseOfCommonStockWarrants" nillable="true" xbrli:periodType="duration" xbrli:balance="credit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="dmtk_RestrictedCashMember" abstract="true" name="RestrictedCashMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="dmtk_IncreaseInTenantImprovementAllowancePerRentableSquareFoot" abstract="false" name="IncreaseInTenantImprovementAllowancePerRentableSquareFoot" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="srt-types:perUnitItemType"/>
  <xs:element id="dmtk_AssayRevenuePayorAMember" abstract="true" name="AssayRevenuePayorAMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="dmtk_NumberOfRevenueStreams" abstract="false" name="NumberOfRevenueStreams" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="xbrli:integerItemType"/>
  <xs:element id="dmtk_CreditLosses" abstract="false" name="CreditLosses" nillable="true" xbrli:periodType="instant" xbrli:balance="debit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="dmtk_LesseeOperatingLeaseLiabilityToBePaidAfterYearFour" abstract="false" name="LesseeOperatingLeaseLiabilityToBePaidAfterYearFour" nillable="true" xbrli:periodType="instant" xbrli:balance="credit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="dmtk_ScheduleOfLongTermFinanceLeaseObligationsTableTextBlock" abstract="false" name="ScheduleOfLongTermFinanceLeaseObligationsTableTextBlock" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:textBlockItemType"/>
  <xs:element id="dmtk_EstimatedMarketValueOfRemainingDebtSecuritiesWithContractualMaturitiesOfUpTo23Months" abstract="false" name="EstimatedMarketValueOfRemainingDebtSecuritiesWithContractualMaturitiesOfUpTo23Months" nillable="true" xbrli:periodType="instant" xbrli:balance="debit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
</xs:schema>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-101.CAL
<SEQUENCE>9
<FILENAME>dmtk-20220630_cal.xml
<DESCRIPTION>XBRL TAXONOMY EXTENSION CALCULATION LINKBASE DOCUMENT
<TEXT>
<XBRL>
<?xml version="1.0" encoding="UTF-8"?>

<!--XBRL Document Created with Wdesk from Workiva-->
<!--Copyright 2022 Workiva-->
<!--r:00c1bec6-bc29-44ad-a3fa-8dd942e770ac,g:dd828811-c245-4da7-9eef-30b71a6b7e18-->
<link:linkbase xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xsi:schemaLocation="http://www.xbrl.org/2003/linkbase http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd">
  <link:roleRef roleURI="http://dermtech.com/role/CondensedConsolidatedBalanceSheets" xlink:type="simple" xlink:href="dmtk-20220630.xsd#CondensedConsolidatedBalanceSheets"/>
  <link:calculationLink xlink:role="http://dermtech.com/role/CondensedConsolidatedBalanceSheets" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilitiesAndStockholdersEquity_c7850503-82e0-4301-92c9-6a15962070ad" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LiabilitiesAndStockholdersEquity"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Liabilities_86cba163-2ebf-48d3-b08d-76018b7e2bbe" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_Liabilities"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_LiabilitiesAndStockholdersEquity_c7850503-82e0-4301-92c9-6a15962070ad" xlink:to="loc_us-gaap_Liabilities_86cba163-2ebf-48d3-b08d-76018b7e2bbe" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockholdersEquity_c5220e94-6d61-439d-bd3c-6847d2e50287" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StockholdersEquity"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_LiabilitiesAndStockholdersEquity_c7850503-82e0-4301-92c9-6a15962070ad" xlink:to="loc_us-gaap_StockholdersEquity_c5220e94-6d61-439d-bd3c-6847d2e50287" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockholdersEquity_ad0b573a-4c01-4201-bbe8-3c59093adfc5" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StockholdersEquity"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockValue_236a219b-4e98-4444-b230-58c970b69848" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CommonStockValue"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_StockholdersEquity_ad0b573a-4c01-4201-bbe8-3c59093adfc5" xlink:to="loc_us-gaap_CommonStockValue_236a219b-4e98-4444-b230-58c970b69848" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AdditionalPaidInCapitalCommonStock_a63b8642-bd94-4885-836e-8367fd589fc1" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AdditionalPaidInCapitalCommonStock"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_StockholdersEquity_ad0b573a-4c01-4201-bbe8-3c59093adfc5" xlink:to="loc_us-gaap_AdditionalPaidInCapitalCommonStock_a63b8642-bd94-4885-836e-8367fd589fc1" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax_baf02273-85bd-44ab-9ace-4730dace05bf" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax"/>
    <link:calculationArc order="3" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_StockholdersEquity_ad0b573a-4c01-4201-bbe8-3c59093adfc5" xlink:to="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax_baf02273-85bd-44ab-9ace-4730dace05bf" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RetainedEarningsAccumulatedDeficit_3d6a6026-496f-4ff4-be56-ed8b44a04fa1" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RetainedEarningsAccumulatedDeficit"/>
    <link:calculationArc order="4" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_StockholdersEquity_ad0b573a-4c01-4201-bbe8-3c59093adfc5" xlink:to="loc_us-gaap_RetainedEarningsAccumulatedDeficit_3d6a6026-496f-4ff4-be56-ed8b44a04fa1" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilitiesCurrent_38969e1c-163e-4422-b918-d11d80ad1efc" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LiabilitiesCurrent"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccountsPayableCurrent_b9d042cb-427a-4624-b1b1-f9d81efab5fd" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AccountsPayableCurrent"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_LiabilitiesCurrent_38969e1c-163e-4422-b918-d11d80ad1efc" xlink:to="loc_us-gaap_AccountsPayableCurrent_b9d042cb-427a-4624-b1b1-f9d81efab5fd" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EmployeeRelatedLiabilitiesCurrent_da5ce39e-a219-4ea5-8817-b5f70e650838" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EmployeeRelatedLiabilitiesCurrent"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_LiabilitiesCurrent_38969e1c-163e-4422-b918-d11d80ad1efc" xlink:to="loc_us-gaap_EmployeeRelatedLiabilitiesCurrent_da5ce39e-a219-4ea5-8817-b5f70e650838" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccruedLiabilitiesCurrent_743968a3-b4d3-4586-992b-77e6dd3e1474" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AccruedLiabilitiesCurrent"/>
    <link:calculationArc order="3" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_LiabilitiesCurrent_38969e1c-163e-4422-b918-d11d80ad1efc" xlink:to="loc_us-gaap_AccruedLiabilitiesCurrent_743968a3-b4d3-4586-992b-77e6dd3e1474" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredRevenueCurrent_b4a4ded3-5c7a-4b37-af58-d8d812c7d224" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DeferredRevenueCurrent"/>
    <link:calculationArc order="4" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_LiabilitiesCurrent_38969e1c-163e-4422-b918-d11d80ad1efc" xlink:to="loc_us-gaap_DeferredRevenueCurrent_b4a4ded3-5c7a-4b37-af58-d8d812c7d224" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeaseLiabilityCurrent_e25be054-35c2-4dce-a983-8a5eb3288589" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OperatingLeaseLiabilityCurrent"/>
    <link:calculationArc order="5" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_LiabilitiesCurrent_38969e1c-163e-4422-b918-d11d80ad1efc" xlink:to="loc_us-gaap_OperatingLeaseLiabilityCurrent_e25be054-35c2-4dce-a983-8a5eb3288589" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FinanceLeaseLiabilityCurrent_aeae80c4-55d4-4f88-a91d-a028f0d6febc" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FinanceLeaseLiabilityCurrent"/>
    <link:calculationArc order="6" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_LiabilitiesCurrent_38969e1c-163e-4422-b918-d11d80ad1efc" xlink:to="loc_us-gaap_FinanceLeaseLiabilityCurrent_aeae80c4-55d4-4f88-a91d-a028f0d6febc" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Assets_2eae954e-0336-4f2a-81ab-ecc0a7c3a687" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_Assets"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AssetsCurrent_c6766920-edaf-455b-916c-4b7411aad44a" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AssetsCurrent"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_Assets_2eae954e-0336-4f2a-81ab-ecc0a7c3a687" xlink:to="loc_us-gaap_AssetsCurrent_c6766920-edaf-455b-916c-4b7411aad44a" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentNet_9bb10642-34d2-4012-b6e5-31a357027688" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PropertyPlantAndEquipmentNet"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_Assets_2eae954e-0336-4f2a-81ab-ecc0a7c3a687" xlink:to="loc_us-gaap_PropertyPlantAndEquipmentNet_9bb10642-34d2-4012-b6e5-31a357027688" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeaseRightOfUseAsset_a9b3a7cf-7900-4b85-8c62-69848c4c29bb" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OperatingLeaseRightOfUseAsset"/>
    <link:calculationArc order="3" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_Assets_2eae954e-0336-4f2a-81ab-ecc0a7c3a687" xlink:to="loc_us-gaap_OperatingLeaseRightOfUseAsset_a9b3a7cf-7900-4b85-8c62-69848c4c29bb" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestrictedCashNoncurrent_106bde7d-fea9-467d-b2f9-4b5f9a2da2b3" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RestrictedCashNoncurrent"/>
    <link:calculationArc order="4" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_Assets_2eae954e-0336-4f2a-81ab-ecc0a7c3a687" xlink:to="loc_us-gaap_RestrictedCashNoncurrent_106bde7d-fea9-467d-b2f9-4b5f9a2da2b3" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherAssetsNoncurrent_724d9410-2ea0-49d2-ae38-53083cad6330" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherAssetsNoncurrent"/>
    <link:calculationArc order="5" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_Assets_2eae954e-0336-4f2a-81ab-ecc0a7c3a687" xlink:to="loc_us-gaap_OtherAssetsNoncurrent_724d9410-2ea0-49d2-ae38-53083cad6330" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Liabilities_e780b719-3715-4e43-934e-38aa7d762282" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_Liabilities"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilitiesCurrent_0e0a036f-179e-460a-b0ab-a30bbbaaa4dc" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LiabilitiesCurrent"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_Liabilities_e780b719-3715-4e43-934e-38aa7d762282" xlink:to="loc_us-gaap_LiabilitiesCurrent_0e0a036f-179e-460a-b0ab-a30bbbaaa4dc" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeaseLiabilityNoncurrent_e5e2479d-aff5-409a-a3ce-435bb77098ef" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OperatingLeaseLiabilityNoncurrent"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_Liabilities_e780b719-3715-4e43-934e-38aa7d762282" xlink:to="loc_us-gaap_OperatingLeaseLiabilityNoncurrent_e5e2479d-aff5-409a-a3ce-435bb77098ef" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_WarrantsAndRightsOutstanding_e7f7df7e-4d26-4ecc-98f5-993e6092e417" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_WarrantsAndRightsOutstanding"/>
    <link:calculationArc order="3" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_Liabilities_e780b719-3715-4e43-934e-38aa7d762282" xlink:to="loc_us-gaap_WarrantsAndRightsOutstanding_e7f7df7e-4d26-4ecc-98f5-993e6092e417" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FinanceLeaseLiabilityNoncurrent_68b65a7a-e1be-4132-b018-335404891aed" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FinanceLeaseLiabilityNoncurrent"/>
    <link:calculationArc order="4" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_Liabilities_e780b719-3715-4e43-934e-38aa7d762282" xlink:to="loc_us-gaap_FinanceLeaseLiabilityNoncurrent_68b65a7a-e1be-4132-b018-335404891aed" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AssetsCurrent_b84d34b1-8909-4508-9b09-d518274f143d" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AssetsCurrent"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashAndCashEquivalentsAtCarryingValue_795f1952-fa9d-48b2-bdda-d65518af9765" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CashAndCashEquivalentsAtCarryingValue"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_AssetsCurrent_b84d34b1-8909-4508-9b09-d518274f143d" xlink:to="loc_us-gaap_CashAndCashEquivalentsAtCarryingValue_795f1952-fa9d-48b2-bdda-d65518af9765" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_MarketableSecuritiesCurrent_2c40d69d-ef22-42c4-b845-e499f33a9bef" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_MarketableSecuritiesCurrent"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_AssetsCurrent_b84d34b1-8909-4508-9b09-d518274f143d" xlink:to="loc_us-gaap_MarketableSecuritiesCurrent_2c40d69d-ef22-42c4-b845-e499f33a9bef" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccountsReceivableNetCurrent_56917905-5904-412e-9999-b038fdcb883b" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AccountsReceivableNetCurrent"/>
    <link:calculationArc order="3" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_AssetsCurrent_b84d34b1-8909-4508-9b09-d518274f143d" xlink:to="loc_us-gaap_AccountsReceivableNetCurrent_56917905-5904-412e-9999-b038fdcb883b" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InventoryNet_1e0be558-26f0-42de-b435-39d797566359" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_InventoryNet"/>
    <link:calculationArc order="4" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_AssetsCurrent_b84d34b1-8909-4508-9b09-d518274f143d" xlink:to="loc_us-gaap_InventoryNet_1e0be558-26f0-42de-b435-39d797566359" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PrepaidExpenseAndOtherAssetsCurrent_bc47920a-93f1-47d7-ad00-a59d1838e760" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PrepaidExpenseAndOtherAssetsCurrent"/>
    <link:calculationArc order="5" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_AssetsCurrent_b84d34b1-8909-4508-9b09-d518274f143d" xlink:to="loc_us-gaap_PrepaidExpenseAndOtherAssetsCurrent_bc47920a-93f1-47d7-ad00-a59d1838e760" xlink:type="arc"/>
  </link:calculationLink>
  <link:roleRef roleURI="http://dermtech.com/role/CondensedConsolidatedStatementsofOperations" xlink:type="simple" xlink:href="dmtk-20220630.xsd#CondensedConsolidatedStatementsofOperations"/>
  <link:calculationLink xlink:role="http://dermtech.com/role/CondensedConsolidatedStatementsofOperations" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetIncomeLoss_5a61be60-bb99-4a59-9d05-a10d3d29d203" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NetIncomeLoss"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingIncomeLoss_0ff58e93-e23e-4d14-be9e-2ef085331a7c" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OperatingIncomeLoss"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetIncomeLoss_5a61be60-bb99-4a59-9d05-a10d3d29d203" xlink:to="loc_us-gaap_OperatingIncomeLoss_0ff58e93-e23e-4d14-be9e-2ef085331a7c" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NonoperatingIncomeExpense_d4ab65e5-bcca-40cc-9769-909b5bcb7063" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NonoperatingIncomeExpense"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetIncomeLoss_5a61be60-bb99-4a59-9d05-a10d3d29d203" xlink:to="loc_us-gaap_NonoperatingIncomeExpense_d4ab65e5-bcca-40cc-9769-909b5bcb7063" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingExpenses_1c78d44e-ef69-4288-b6ad-4cb2464567f4" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OperatingExpenses"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SellingAndMarketingExpense_04055ea9-2761-4955-bb75-24b1fe966367" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SellingAndMarketingExpense"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_OperatingExpenses_1c78d44e-ef69-4288-b6ad-4cb2464567f4" xlink:to="loc_us-gaap_SellingAndMarketingExpense_04055ea9-2761-4955-bb75-24b1fe966367" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ResearchAndDevelopmentExpense_791b50a5-6ea7-4aee-8803-b9b8c9e628a1" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ResearchAndDevelopmentExpense"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_OperatingExpenses_1c78d44e-ef69-4288-b6ad-4cb2464567f4" xlink:to="loc_us-gaap_ResearchAndDevelopmentExpense_791b50a5-6ea7-4aee-8803-b9b8c9e628a1" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GeneralAndAdministrativeExpense_db12759d-cf06-4cfa-9bb9-5f3bb4ae983b" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_GeneralAndAdministrativeExpense"/>
    <link:calculationArc order="3" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_OperatingExpenses_1c78d44e-ef69-4288-b6ad-4cb2464567f4" xlink:to="loc_us-gaap_GeneralAndAdministrativeExpense_db12759d-cf06-4cfa-9bb9-5f3bb4ae983b" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NonoperatingIncomeExpense_efef13bc-a661-4fb6-b8dd-7c5244ec3ea1" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NonoperatingIncomeExpense"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InterestIncomeExpenseNonoperatingNet_2b5206e8-3116-4686-9104-fb40ca04210a" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_InterestIncomeExpenseNonoperatingNet"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NonoperatingIncomeExpense_efef13bc-a661-4fb6-b8dd-7c5244ec3ea1" xlink:to="loc_us-gaap_InterestIncomeExpenseNonoperatingNet_2b5206e8-3116-4686-9104-fb40ca04210a" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueAdjustmentOfWarrants_fe49e96f-f400-4e8f-999a-82fde2dd10e1" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueAdjustmentOfWarrants"/>
    <link:calculationArc order="2" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NonoperatingIncomeExpense_efef13bc-a661-4fb6-b8dd-7c5244ec3ea1" xlink:to="loc_us-gaap_FairValueAdjustmentOfWarrants_fe49e96f-f400-4e8f-999a-82fde2dd10e1" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GrossProfit_22e13679-c92b-41bf-89ed-108210db9b05" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_GrossProfit"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevenueFromContractWithCustomerIncludingAssessedTax_7945d2ca-8a92-4516-b086-b08a218eff84" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RevenueFromContractWithCustomerIncludingAssessedTax"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_GrossProfit_22e13679-c92b-41bf-89ed-108210db9b05" xlink:to="loc_us-gaap_RevenueFromContractWithCustomerIncludingAssessedTax_7945d2ca-8a92-4516-b086-b08a218eff84" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CostOfRevenue_15a49c53-5247-4d33-8e1f-4cd1db5ea0a7" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CostOfRevenue"/>
    <link:calculationArc order="2" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_GrossProfit_22e13679-c92b-41bf-89ed-108210db9b05" xlink:to="loc_us-gaap_CostOfRevenue_15a49c53-5247-4d33-8e1f-4cd1db5ea0a7" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingIncomeLoss_2c1afaf1-880b-4450-aa5d-5f8e82ea7ecb" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OperatingIncomeLoss"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GrossProfit_2ef2221f-bab8-40a3-8554-1d1b6361a4be" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_GrossProfit"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_OperatingIncomeLoss_2c1afaf1-880b-4450-aa5d-5f8e82ea7ecb" xlink:to="loc_us-gaap_GrossProfit_2ef2221f-bab8-40a3-8554-1d1b6361a4be" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingExpenses_47552e55-3ea6-44a4-8be3-24eb4c726513" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OperatingExpenses"/>
    <link:calculationArc order="2" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_OperatingIncomeLoss_2c1afaf1-880b-4450-aa5d-5f8e82ea7ecb" xlink:to="loc_us-gaap_OperatingExpenses_47552e55-3ea6-44a4-8be3-24eb4c726513" xlink:type="arc"/>
  </link:calculationLink>
  <link:roleRef roleURI="http://dermtech.com/role/CondensedConsolidatedStatementsofComprehensiveLoss" xlink:type="simple" xlink:href="dmtk-20220630.xsd#CondensedConsolidatedStatementsofComprehensiveLoss"/>
  <link:calculationLink xlink:role="http://dermtech.com/role/CondensedConsolidatedStatementsofComprehensiveLoss" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ComprehensiveIncomeNetOfTax_ab884344-5a78-4db2-becd-78d6e9636c98" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ComprehensiveIncomeNetOfTax"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetIncomeLoss_11158d93-f80e-4970-9b76-40488c6b79d7" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NetIncomeLoss"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_ComprehensiveIncomeNetOfTax_ab884344-5a78-4db2-becd-78d6e9636c98" xlink:to="loc_us-gaap_NetIncomeLoss_11158d93-f80e-4970-9b76-40488c6b79d7" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax_06f52162-1696-487a-a83a-9f67283dea34" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_ComprehensiveIncomeNetOfTax_ab884344-5a78-4db2-becd-78d6e9636c98" xlink:to="loc_us-gaap_OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax_06f52162-1696-487a-a83a-9f67283dea34" xlink:type="arc"/>
  </link:calculationLink>
  <link:roleRef roleURI="http://dermtech.com/role/CondensedConsolidatedStatementsofCashFlows" xlink:type="simple" xlink:href="dmtk-20220630.xsd#CondensedConsolidatedStatementsofCashFlows"/>
  <link:calculationLink xlink:role="http://dermtech.com/role/CondensedConsolidatedStatementsofCashFlows" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInFinancingActivities_a25b5b49-db42-4e84-84fe-77a3fc0889e2" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NetCashProvidedByUsedInFinancingActivities"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProceedsFromIssuanceOfCommonStock_017e5635-5e09-477a-a0d9-a871006a7c9a" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ProceedsFromIssuanceOfCommonStock"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivities_a25b5b49-db42-4e84-84fe-77a3fc0889e2" xlink:to="loc_us-gaap_ProceedsFromIssuanceOfCommonStock_017e5635-5e09-477a-a0d9-a871006a7c9a" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProceedsFromWarrantExercises_1d198215-604a-4912-bb63-f55bcf36db55" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ProceedsFromWarrantExercises"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivities_a25b5b49-db42-4e84-84fe-77a3fc0889e2" xlink:to="loc_us-gaap_ProceedsFromWarrantExercises_1d198215-604a-4912-bb63-f55bcf36db55" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProceedsFromStockPlans_9a6a9c37-c4d7-44f0-8571-7da674a531e1" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ProceedsFromStockPlans"/>
    <link:calculationArc order="3" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivities_a25b5b49-db42-4e84-84fe-77a3fc0889e2" xlink:to="loc_us-gaap_ProceedsFromStockPlans_9a6a9c37-c4d7-44f0-8571-7da674a531e1" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RepaymentsOfDebtAndCapitalLeaseObligations_d0ccb9d7-dcec-439e-a0cd-57029fa56d48" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RepaymentsOfDebtAndCapitalLeaseObligations"/>
    <link:calculationArc order="4" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivities_a25b5b49-db42-4e84-84fe-77a3fc0889e2" xlink:to="loc_us-gaap_RepaymentsOfDebtAndCapitalLeaseObligations_d0ccb9d7-dcec-439e-a0cd-57029fa56d48" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_dmtk_ProceedsFromReleaseOfRSUsAndStockOptionsExercised_2ec4391b-1be4-4ace-9cb6-0ad01d7af1d1" xlink:href="dmtk-20220630.xsd#dmtk_ProceedsFromReleaseOfRSUsAndStockOptionsExercised"/>
    <link:calculationArc order="5" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivities_a25b5b49-db42-4e84-84fe-77a3fc0889e2" xlink:to="loc_dmtk_ProceedsFromReleaseOfRSUsAndStockOptionsExercised_2ec4391b-1be4-4ace-9cb6-0ad01d7af1d1" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInInvestingActivities_2bec86bb-0b2b-43e3-b0e0-c791afb53228" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NetCashProvidedByUsedInInvestingActivities"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsToAcquirePropertyPlantAndEquipment_04ac444e-0dda-42e4-9cfb-938ead07746c" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PaymentsToAcquirePropertyPlantAndEquipment"/>
    <link:calculationArc order="1" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInInvestingActivities_2bec86bb-0b2b-43e3-b0e0-c791afb53228" xlink:to="loc_us-gaap_PaymentsToAcquirePropertyPlantAndEquipment_04ac444e-0dda-42e4-9cfb-938ead07746c" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsToAcquireMarketableSecurities_e19497d4-9547-4efd-86a3-54ce9415928a" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PaymentsToAcquireMarketableSecurities"/>
    <link:calculationArc order="2" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInInvestingActivities_2bec86bb-0b2b-43e3-b0e0-c791afb53228" xlink:to="loc_us-gaap_PaymentsToAcquireMarketableSecurities_e19497d4-9547-4efd-86a3-54ce9415928a" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_dmtk_ProceedsFromMaturityOfMarketableSecurities_76fb3c97-67cd-4349-8dec-1212593cd791" xlink:href="dmtk-20220630.xsd#dmtk_ProceedsFromMaturityOfMarketableSecurities"/>
    <link:calculationArc order="3" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInInvestingActivities_2bec86bb-0b2b-43e3-b0e0-c791afb53228" xlink:to="loc_dmtk_ProceedsFromMaturityOfMarketableSecurities_76fb3c97-67cd-4349-8dec-1212593cd791" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_9f73edc3-67ae-4538-841f-c452a5173f33" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashAndCashEquivalentsAtCarryingValue_cac99871-46e5-433f-977b-137467a0d6fc" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CashAndCashEquivalentsAtCarryingValue"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_9f73edc3-67ae-4538-841f-c452a5173f33" xlink:to="loc_us-gaap_CashAndCashEquivalentsAtCarryingValue_cac99871-46e5-433f-977b-137467a0d6fc" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestrictedCash_3eb5b4c5-dbb7-4185-844e-2af0965967a1" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RestrictedCash"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_9f73edc3-67ae-4538-841f-c452a5173f33" xlink:to="loc_us-gaap_RestrictedCash_3eb5b4c5-dbb7-4185-844e-2af0965967a1" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_53b39454-9bb2-47dc-9f47-e458c8b7fb5f" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NetCashProvidedByUsedInOperatingActivities"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueAdjustmentOfWarrants_0d73921f-3d80-4205-a1b4-60e1fd03ab71" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueAdjustmentOfWarrants"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_53b39454-9bb2-47dc-9f47-e458c8b7fb5f" xlink:to="loc_us-gaap_FairValueAdjustmentOfWarrants_0d73921f-3d80-4205-a1b4-60e1fd03ab71" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets_8ec6e89e-ba5b-47f4-a9a8-af9bfab9b588" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets"/>
    <link:calculationArc order="2" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_53b39454-9bb2-47dc-9f47-e458c8b7fb5f" xlink:to="loc_us-gaap_IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets_8ec6e89e-ba5b-47f4-a9a8-af9bfab9b588" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProfitLoss_c432ce54-6d03-4802-9808-bebf37026a94" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ProfitLoss"/>
    <link:calculationArc order="3" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_53b39454-9bb2-47dc-9f47-e458c8b7fb5f" xlink:to="loc_us-gaap_ProfitLoss_c432ce54-6d03-4802-9808-bebf37026a94" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInAccountsReceivable_d423c74b-1b90-4181-98b1-ea4f20cb3c50" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncreaseDecreaseInAccountsReceivable"/>
    <link:calculationArc order="4" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_53b39454-9bb2-47dc-9f47-e458c8b7fb5f" xlink:to="loc_us-gaap_IncreaseDecreaseInAccountsReceivable_d423c74b-1b90-4181-98b1-ea4f20cb3c50" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeaseRightOfUseAssetAmortizationExpense_fb389790-ca54-47ee-a8e9-9995b195ff00" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OperatingLeaseRightOfUseAssetAmortizationExpense"/>
    <link:calculationArc order="5" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_53b39454-9bb2-47dc-9f47-e458c8b7fb5f" xlink:to="loc_us-gaap_OperatingLeaseRightOfUseAssetAmortizationExpense_fb389790-ca54-47ee-a8e9-9995b195ff00" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensation_7a63ebc0-cc87-4945-9f75-fd47495d1541" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensation"/>
    <link:calculationArc order="6" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_53b39454-9bb2-47dc-9f47-e458c8b7fb5f" xlink:to="loc_us-gaap_ShareBasedCompensation_7a63ebc0-cc87-4945-9f75-fd47495d1541" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInInventories_a5da042e-8644-481e-944a-11888e2bcb2b" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncreaseDecreaseInInventories"/>
    <link:calculationArc order="7" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_53b39454-9bb2-47dc-9f47-e458c8b7fb5f" xlink:to="loc_us-gaap_IncreaseDecreaseInInventories_a5da042e-8644-481e-944a-11888e2bcb2b" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInEmployeeRelatedLiabilities_a4db04aa-960b-4d61-b0fc-4a5f5a1bb1c1" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncreaseDecreaseInEmployeeRelatedLiabilities"/>
    <link:calculationArc order="8" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_53b39454-9bb2-47dc-9f47-e458c8b7fb5f" xlink:to="loc_us-gaap_IncreaseDecreaseInEmployeeRelatedLiabilities_a4db04aa-960b-4d61-b0fc-4a5f5a1bb1c1" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInOperatingLeaseLiability_bbc1ee50-e2dd-4605-a696-6481da30d0a6" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncreaseDecreaseInOperatingLeaseLiability"/>
    <link:calculationArc order="9" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_53b39454-9bb2-47dc-9f47-e458c8b7fb5f" xlink:to="loc_us-gaap_IncreaseDecreaseInOperatingLeaseLiability_bbc1ee50-e2dd-4605-a696-6481da30d0a6" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GainLossOnDispositionOfAssets1_244dde82-ad0e-4890-888f-6ff60ff79952" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_GainLossOnDispositionOfAssets1"/>
    <link:calculationArc order="10" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_53b39454-9bb2-47dc-9f47-e458c8b7fb5f" xlink:to="loc_us-gaap_GainLossOnDispositionOfAssets1_244dde82-ad0e-4890-888f-6ff60ff79952" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Depreciation_11008ab0-5cf6-4d41-a246-45de30e5dadc" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_Depreciation"/>
    <link:calculationArc order="11" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_53b39454-9bb2-47dc-9f47-e458c8b7fb5f" xlink:to="loc_us-gaap_Depreciation_11008ab0-5cf6-4d41-a246-45de30e5dadc" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInAccountsPayableAndAccruedLiabilities_d06ad2d2-7b95-4099-961d-31a09b085bde" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncreaseDecreaseInAccountsPayableAndAccruedLiabilities"/>
    <link:calculationArc order="12" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_53b39454-9bb2-47dc-9f47-e458c8b7fb5f" xlink:to="loc_us-gaap_IncreaseDecreaseInAccountsPayableAndAccruedLiabilities_d06ad2d2-7b95-4099-961d-31a09b085bde" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccretionAmortizationOfDiscountsAndPremiumsInvestments_b21b5109-bc7b-4cb0-a1c9-29b2fe3a426d" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AccretionAmortizationOfDiscountsAndPremiumsInvestments"/>
    <link:calculationArc order="13" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_53b39454-9bb2-47dc-9f47-e458c8b7fb5f" xlink:to="loc_us-gaap_AccretionAmortizationOfDiscountsAndPremiumsInvestments_b21b5109-bc7b-4cb0-a1c9-29b2fe3a426d" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect_449491e4-d7bd-486d-a1f2-87bdfefee2c2" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_1d22918f-0586-4ea3-9b5d-6916e24c8ed4" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NetCashProvidedByUsedInOperatingActivities"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect_449491e4-d7bd-486d-a1f2-87bdfefee2c2" xlink:to="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_1d22918f-0586-4ea3-9b5d-6916e24c8ed4" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInInvestingActivities_2c8781bc-15c2-411f-b8b3-a17c645f133b" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NetCashProvidedByUsedInInvestingActivities"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect_449491e4-d7bd-486d-a1f2-87bdfefee2c2" xlink:to="loc_us-gaap_NetCashProvidedByUsedInInvestingActivities_2c8781bc-15c2-411f-b8b3-a17c645f133b" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInFinancingActivities_b94dd3ab-06a1-4988-9e8e-fc9f8aca5764" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NetCashProvidedByUsedInFinancingActivities"/>
    <link:calculationArc order="3" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect_449491e4-d7bd-486d-a1f2-87bdfefee2c2" xlink:to="loc_us-gaap_NetCashProvidedByUsedInFinancingActivities_b94dd3ab-06a1-4988-9e8e-fc9f8aca5764" xlink:type="arc"/>
  </link:calculationLink>
  <link:roleRef roleURI="http://dermtech.com/role/TheCompanyandaSummaryofitsSignificantAccountingPoliciesSummaryofAssetsandLiabilitiesMeasuredatFairValueonRecurringBasisDetails" xlink:type="simple" xlink:href="dmtk-20220630.xsd#TheCompanyandaSummaryofitsSignificantAccountingPoliciesSummaryofAssetsandLiabilitiesMeasuredatFairValueonRecurringBasisDetails"/>
  <link:calculationLink xlink:role="http://dermtech.com/role/TheCompanyandaSummaryofitsSignificantAccountingPoliciesSummaryofAssetsandLiabilitiesMeasuredatFairValueonRecurringBasisDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilitiesFairValueDisclosure_ce944bdb-dca9-4927-a1d5-8494c4f091b6" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LiabilitiesFairValueDisclosure"/>
    <link:loc xlink:type="locator" xlink:label="loc_dmtk_WarrantLiabilityFairValueDisclosure_254d489e-ab68-4211-956e-a9b77f19be0f" xlink:href="dmtk-20220630.xsd#dmtk_WarrantLiabilityFairValueDisclosure"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_LiabilitiesFairValueDisclosure_ce944bdb-dca9-4927-a1d5-8494c4f091b6" xlink:to="loc_dmtk_WarrantLiabilityFairValueDisclosure_254d489e-ab68-4211-956e-a9b77f19be0f" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AssetsFairValueDisclosure_5e864a60-c63c-48be-88b0-476151e75811" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AssetsFairValueDisclosure"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashEquivalentsAtCarryingValue_b054d559-bff3-499f-b7e0-b46b6bd9222a" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CashEquivalentsAtCarryingValue"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_AssetsFairValueDisclosure_5e864a60-c63c-48be-88b0-476151e75811" xlink:to="loc_us-gaap_CashEquivalentsAtCarryingValue_b054d559-bff3-499f-b7e0-b46b6bd9222a" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestrictedCashNoncurrent_eba91df1-6bec-455c-a0bb-5162e2d63be1" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RestrictedCashNoncurrent"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_AssetsFairValueDisclosure_5e864a60-c63c-48be-88b0-476151e75811" xlink:to="loc_us-gaap_RestrictedCashNoncurrent_eba91df1-6bec-455c-a0bb-5162e2d63be1" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AvailableForSaleSecuritiesDebtSecurities_230c5b3b-c2da-4a45-96fc-970b7274e965" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AvailableForSaleSecuritiesDebtSecurities"/>
    <link:calculationArc order="3" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_AssetsFairValueDisclosure_5e864a60-c63c-48be-88b0-476151e75811" xlink:to="loc_us-gaap_AvailableForSaleSecuritiesDebtSecurities_230c5b3b-c2da-4a45-96fc-970b7274e965" xlink:type="arc"/>
  </link:calculationLink>
  <link:roleRef roleURI="http://dermtech.com/role/BalanceSheetDetailsScheduleofShortTermMarketableSecuritiesDetails" xlink:type="simple" xlink:href="dmtk-20220630.xsd#BalanceSheetDetailsScheduleofShortTermMarketableSecuritiesDetails"/>
  <link:calculationLink xlink:role="http://dermtech.com/role/BalanceSheetDetailsScheduleofShortTermMarketableSecuritiesDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AvailableForSaleDebtSecuritiesAmortizedCostBasis_179b0d4f-03d2-4e82-be12-ac8452591f5c" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AvailableForSaleDebtSecuritiesAmortizedCostBasis"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax_c8ac8c77-c883-4039-99e1-4cc3b9481d17" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax"/>
    <link:calculationArc order="1" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_AvailableForSaleDebtSecuritiesAmortizedCostBasis_179b0d4f-03d2-4e82-be12-ac8452591f5c" xlink:to="loc_us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax_c8ac8c77-c883-4039-99e1-4cc3b9481d17" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax_0bc04c7a-64c8-4867-8333-08f6ff0c12e0" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_AvailableForSaleDebtSecuritiesAmortizedCostBasis_179b0d4f-03d2-4e82-be12-ac8452591f5c" xlink:to="loc_us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax_0bc04c7a-64c8-4867-8333-08f6ff0c12e0" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AvailableForSaleSecuritiesDebtSecurities_b6f111f3-ed1f-43c3-89ce-fd96ab30563f" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AvailableForSaleSecuritiesDebtSecurities"/>
    <link:calculationArc order="3" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_AvailableForSaleDebtSecuritiesAmortizedCostBasis_179b0d4f-03d2-4e82-be12-ac8452591f5c" xlink:to="loc_us-gaap_AvailableForSaleSecuritiesDebtSecurities_b6f111f3-ed1f-43c3-89ce-fd96ab30563f" xlink:type="arc"/>
  </link:calculationLink>
  <link:roleRef roleURI="http://dermtech.com/role/BalanceSheetDetailsScheduleofPrepaidExpensesandPPEDetails" xlink:type="simple" xlink:href="dmtk-20220630.xsd#BalanceSheetDetailsScheduleofPrepaidExpensesandPPEDetails"/>
  <link:calculationLink xlink:role="http://dermtech.com/role/BalanceSheetDetailsScheduleofPrepaidExpensesandPPEDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PrepaidExpenseAndOtherAssetsCurrent_e5070534-3de6-4bcb-bad4-56b9e389af68" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PrepaidExpenseAndOtherAssetsCurrent"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PrepaidInsurance_a47fd731-93b0-486a-990e-bd721596dcfe" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PrepaidInsurance"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_PrepaidExpenseAndOtherAssetsCurrent_e5070534-3de6-4bcb-bad4-56b9e389af68" xlink:to="loc_us-gaap_PrepaidInsurance_a47fd731-93b0-486a-990e-bd721596dcfe" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_dmtk_PrepaidTradeShowsCurrent_82490d2f-0455-4fd5-a374-cb6e40c0fc50" xlink:href="dmtk-20220630.xsd#dmtk_PrepaidTradeShowsCurrent"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_PrepaidExpenseAndOtherAssetsCurrent_e5070534-3de6-4bcb-bad4-56b9e389af68" xlink:to="loc_dmtk_PrepaidTradeShowsCurrent_82490d2f-0455-4fd5-a374-cb6e40c0fc50" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_dmtk_PrepaidSoftwareFees_4eea5646-a1d8-4fdc-86d6-68fe704d33fc" xlink:href="dmtk-20220630.xsd#dmtk_PrepaidSoftwareFees"/>
    <link:calculationArc order="3" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_PrepaidExpenseAndOtherAssetsCurrent_e5070534-3de6-4bcb-bad4-56b9e389af68" xlink:to="loc_dmtk_PrepaidSoftwareFees_4eea5646-a1d8-4fdc-86d6-68fe704d33fc" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_dmtk_PrepaidEmployeeCompensation_5f637bad-cd68-4eac-87ca-59fec47b8048" xlink:href="dmtk-20220630.xsd#dmtk_PrepaidEmployeeCompensation"/>
    <link:calculationArc order="4" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_PrepaidExpenseAndOtherAssetsCurrent_e5070534-3de6-4bcb-bad4-56b9e389af68" xlink:to="loc_dmtk_PrepaidEmployeeCompensation_5f637bad-cd68-4eac-87ca-59fec47b8048" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherAssetsCurrent_525b6603-78b7-4db7-9aa2-8b9cfe70b84c" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherAssetsCurrent"/>
    <link:calculationArc order="5" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_PrepaidExpenseAndOtherAssetsCurrent_e5070534-3de6-4bcb-bad4-56b9e389af68" xlink:to="loc_us-gaap_OtherAssetsCurrent_525b6603-78b7-4db7-9aa2-8b9cfe70b84c" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentGross_86c10075-6a39-4f29-b7ff-ed60114af814" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PropertyPlantAndEquipmentGross"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FurnitureAndFixturesGross_ac2677fa-0641-493d-8b09-4dd4da18b764" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FurnitureAndFixturesGross"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentGross_86c10075-6a39-4f29-b7ff-ed60114af814" xlink:to="loc_us-gaap_FurnitureAndFixturesGross_ac2677fa-0641-493d-8b09-4dd4da18b764" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_dmtk_ComputerEquipmentGross_a7696f20-6d40-4386-aa31-ed5c0e8fc069" xlink:href="dmtk-20220630.xsd#dmtk_ComputerEquipmentGross"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentGross_86c10075-6a39-4f29-b7ff-ed60114af814" xlink:to="loc_dmtk_ComputerEquipmentGross_a7696f20-6d40-4386-aa31-ed5c0e8fc069" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_MachineryAndEquipmentGross_8447f688-9078-4dab-8ac8-d538fe35ffce" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_MachineryAndEquipmentGross"/>
    <link:calculationArc order="3" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentGross_86c10075-6a39-4f29-b7ff-ed60114af814" xlink:to="loc_us-gaap_MachineryAndEquipmentGross_8447f688-9078-4dab-8ac8-d538fe35ffce" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ConstructionInProgressGross_52913854-699d-4ff4-99c4-76e4fca5e6e3" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ConstructionInProgressGross"/>
    <link:calculationArc order="4" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentGross_86c10075-6a39-4f29-b7ff-ed60114af814" xlink:to="loc_us-gaap_ConstructionInProgressGross_52913854-699d-4ff4-99c4-76e4fca5e6e3" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LeaseholdImprovementsGross_10316d71-c2ce-4a7d-a41a-de19b76b13f7" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LeaseholdImprovementsGross"/>
    <link:calculationArc order="5" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentGross_86c10075-6a39-4f29-b7ff-ed60114af814" xlink:to="loc_us-gaap_LeaseholdImprovementsGross_10316d71-c2ce-4a7d-a41a-de19b76b13f7" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentNet_c100afe4-9b95-4947-a5ea-47179dc3f03d" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PropertyPlantAndEquipmentNet"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentGross_bf5b64d8-52a4-4759-8842-04b932ff1d4e" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PropertyPlantAndEquipmentGross"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentNet_c100afe4-9b95-4947-a5ea-47179dc3f03d" xlink:to="loc_us-gaap_PropertyPlantAndEquipmentGross_bf5b64d8-52a4-4759-8842-04b932ff1d4e" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment_7eaa2ada-449d-49b3-8c06-0351d63a3a71" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment"/>
    <link:calculationArc order="2" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentNet_c100afe4-9b95-4947-a5ea-47179dc3f03d" xlink:to="loc_us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment_7eaa2ada-449d-49b3-8c06-0351d63a3a71" xlink:type="arc"/>
  </link:calculationLink>
  <link:roleRef roleURI="http://dermtech.com/role/BalanceSheetDetailsScheduleofAccruedCompensationandAccruedLiabilitiesDetails" xlink:type="simple" xlink:href="dmtk-20220630.xsd#BalanceSheetDetailsScheduleofAccruedCompensationandAccruedLiabilitiesDetails"/>
  <link:calculationLink xlink:role="http://dermtech.com/role/BalanceSheetDetailsScheduleofAccruedCompensationandAccruedLiabilitiesDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccruedLiabilitiesCurrent_cbd278d7-1894-4729-bedf-ed2bc8727d67" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AccruedLiabilitiesCurrent"/>
    <link:loc xlink:type="locator" xlink:label="loc_dmtk_AccruedConsultingServicesCurrent_705fbab7-6ebf-48ed-8ad7-a890d76a5e5c" xlink:href="dmtk-20220630.xsd#dmtk_AccruedConsultingServicesCurrent"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_AccruedLiabilitiesCurrent_cbd278d7-1894-4729-bedf-ed2bc8727d67" xlink:to="loc_dmtk_AccruedConsultingServicesCurrent_705fbab7-6ebf-48ed-8ad7-a890d76a5e5c" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherAccruedLiabilitiesCurrent_a7a7df68-347c-489e-9fc4-b74a90082f6b" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherAccruedLiabilitiesCurrent"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_AccruedLiabilitiesCurrent_cbd278d7-1894-4729-bedf-ed2bc8727d67" xlink:to="loc_us-gaap_OtherAccruedLiabilitiesCurrent_a7a7df68-347c-489e-9fc4-b74a90082f6b" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EmployeeRelatedLiabilitiesCurrent_98d9bf0d-017e-48b1-85ca-931e25c7503a" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EmployeeRelatedLiabilitiesCurrent"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccruedVacationCurrent_3f613757-4193-4114-93c2-d85a751ac296" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AccruedVacationCurrent"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_EmployeeRelatedLiabilitiesCurrent_98d9bf0d-017e-48b1-85ca-931e25c7503a" xlink:to="loc_us-gaap_AccruedVacationCurrent_3f613757-4193-4114-93c2-d85a751ac296" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_dmtk_AccruedBonusAndDeferredCompensationCurrent_c94121da-dd7a-475e-a190-81235df35eeb" xlink:href="dmtk-20220630.xsd#dmtk_AccruedBonusAndDeferredCompensationCurrent"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_EmployeeRelatedLiabilitiesCurrent_98d9bf0d-017e-48b1-85ca-931e25c7503a" xlink:to="loc_dmtk_AccruedBonusAndDeferredCompensationCurrent_c94121da-dd7a-475e-a190-81235df35eeb" xlink:type="arc"/>
  </link:calculationLink>
  <link:roleRef roleURI="http://dermtech.com/role/LeasesCommitmentsandContingenciesScheduleofLongTermFinanceLeaseObligationsDetails" xlink:type="simple" xlink:href="dmtk-20220630.xsd#LeasesCommitmentsandContingenciesScheduleofLongTermFinanceLeaseObligationsDetails"/>
  <link:calculationLink xlink:role="http://dermtech.com/role/LeasesCommitmentsandContingenciesScheduleofLongTermFinanceLeaseObligationsDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FinanceLeaseLiability_60228f3e-42af-42ac-b5f9-242419e2f759" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FinanceLeaseLiability"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FinanceLeaseLiabilityCurrent_0ae6fa2a-6937-4581-b716-9499c6b1f891" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FinanceLeaseLiabilityCurrent"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_FinanceLeaseLiability_60228f3e-42af-42ac-b5f9-242419e2f759" xlink:to="loc_us-gaap_FinanceLeaseLiabilityCurrent_0ae6fa2a-6937-4581-b716-9499c6b1f891" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FinanceLeaseLiabilityNoncurrent_6500eac1-fc50-46a7-87a8-a9fd29c488ae" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FinanceLeaseLiabilityNoncurrent"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_FinanceLeaseLiability_60228f3e-42af-42ac-b5f9-242419e2f759" xlink:to="loc_us-gaap_FinanceLeaseLiabilityNoncurrent_6500eac1-fc50-46a7-87a8-a9fd29c488ae" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FinanceLeaseLiabilityPaymentsDue_44311604-b586-45ca-a564-66a0950e18a4" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FinanceLeaseLiabilityPaymentsDue"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FinanceLeaseLiabilityUndiscountedExcessAmount_48991b2f-6010-4c0c-ac15-ef46f73c14c5" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FinanceLeaseLiabilityUndiscountedExcessAmount"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_FinanceLeaseLiabilityPaymentsDue_44311604-b586-45ca-a564-66a0950e18a4" xlink:to="loc_us-gaap_FinanceLeaseLiabilityUndiscountedExcessAmount_48991b2f-6010-4c0c-ac15-ef46f73c14c5" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FinanceLeaseLiability_6ea61425-2293-43d2-a567-12d0b12a98da" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FinanceLeaseLiability"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_FinanceLeaseLiabilityPaymentsDue_44311604-b586-45ca-a564-66a0950e18a4" xlink:to="loc_us-gaap_FinanceLeaseLiability_6ea61425-2293-43d2-a567-12d0b12a98da" xlink:type="arc"/>
  </link:calculationLink>
  <link:roleRef roleURI="http://dermtech.com/role/LeasesCommitmentsandContingenciesComponentsofLeaseExpenseDetails" xlink:type="simple" xlink:href="dmtk-20220630.xsd#LeasesCommitmentsandContingenciesComponentsofLeaseExpenseDetails"/>
  <link:calculationLink xlink:role="http://dermtech.com/role/LeasesCommitmentsandContingenciesComponentsofLeaseExpenseDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_dmtk_OperatingLeaseCosts_72bcbcc8-2054-4725-b3cf-bc2032712f5f" xlink:href="dmtk-20220630.xsd#dmtk_OperatingLeaseCosts"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeaseCost_05b68d29-d66d-4d3e-b344-254717bb8b94" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OperatingLeaseCost"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_dmtk_OperatingLeaseCosts_72bcbcc8-2054-4725-b3cf-bc2032712f5f" xlink:to="loc_us-gaap_OperatingLeaseCost_05b68d29-d66d-4d3e-b344-254717bb8b94" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_VariableLeaseCost_a3594f4e-c045-4e0c-8deb-6db7480aadf2" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_VariableLeaseCost"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_dmtk_OperatingLeaseCosts_72bcbcc8-2054-4725-b3cf-bc2032712f5f" xlink:to="loc_us-gaap_VariableLeaseCost_a3594f4e-c045-4e0c-8deb-6db7480aadf2" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_dmtk_FinanceLeaseCost_2af3c23b-1599-4849-a63e-65bbcaf95e36" xlink:href="dmtk-20220630.xsd#dmtk_FinanceLeaseCost"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FinanceLeaseRightOfUseAssetAmortization_10298e84-a408-4ec9-8fc7-6c8e1066741c" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FinanceLeaseRightOfUseAssetAmortization"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_dmtk_FinanceLeaseCost_2af3c23b-1599-4849-a63e-65bbcaf95e36" xlink:to="loc_us-gaap_FinanceLeaseRightOfUseAssetAmortization_10298e84-a408-4ec9-8fc7-6c8e1066741c" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FinanceLeaseInterestExpense_6216bcd5-ef9a-4c84-8408-e12f3e2a0e4d" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FinanceLeaseInterestExpense"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_dmtk_FinanceLeaseCost_2af3c23b-1599-4849-a63e-65bbcaf95e36" xlink:to="loc_us-gaap_FinanceLeaseInterestExpense_6216bcd5-ef9a-4c84-8408-e12f3e2a0e4d" xlink:type="arc"/>
  </link:calculationLink>
</link:linkbase>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-101.DEF
<SEQUENCE>10
<FILENAME>dmtk-20220630_def.xml
<DESCRIPTION>XBRL TAXONOMY EXTENSION DEFINITION LINKBASE DOCUMENT
<TEXT>
<XBRL>
<?xml version="1.0" encoding="UTF-8"?>

<!--XBRL Document Created with Wdesk from Workiva-->
<!--Copyright 2022 Workiva-->
<!--r:00c1bec6-bc29-44ad-a3fa-8dd942e770ac,g:dd828811-c245-4da7-9eef-30b71a6b7e18-->
<link:linkbase xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xmlns:xbrldt="http://xbrl.org/2005/xbrldt" xsi:schemaLocation="http://www.xbrl.org/2003/linkbase http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd">
  <link:arcroleRef arcroleURI="http://xbrl.org/int/dim/arcrole/all" xlink:type="simple" xlink:href="http://www.xbrl.org/2005/xbrldt-2005.xsd#all"/>
  <link:arcroleRef arcroleURI="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:type="simple" xlink:href="http://www.xbrl.org/2005/xbrldt-2005.xsd#hypercube-dimension"/>
  <link:arcroleRef arcroleURI="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:type="simple" xlink:href="http://www.xbrl.org/2005/xbrldt-2005.xsd#dimension-default"/>
  <link:arcroleRef arcroleURI="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:type="simple" xlink:href="http://www.xbrl.org/2005/xbrldt-2005.xsd#dimension-domain"/>
  <link:arcroleRef arcroleURI="http://xbrl.org/int/dim/arcrole/domain-member" xlink:type="simple" xlink:href="http://www.xbrl.org/2005/xbrldt-2005.xsd#domain-member"/>
  <link:roleRef roleURI="http://dermtech.com/role/CondensedConsolidatedStatementsofOperations" xlink:type="simple" xlink:href="dmtk-20220630.xsd#CondensedConsolidatedStatementsofOperations"/>
  <link:definitionLink xlink:role="http://dermtech.com/role/CondensedConsolidatedStatementsofOperations" xlink:type="extended" id="i4aacd415bd1e4c239e0bbcf8db53308f_CondensedConsolidatedStatementsofOperations">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementLineItems_2af1aebd-be4e-4c85-a656-882c109b648f" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StatementLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevenuesAbstract_9b4efb19-04c6-4281-af01-c6759460fabd" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RevenuesAbstract"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_StatementLineItems_2af1aebd-be4e-4c85-a656-882c109b648f" xlink:to="loc_us-gaap_RevenuesAbstract_9b4efb19-04c6-4281-af01-c6759460fabd" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevenueFromContractWithCustomerIncludingAssessedTax_c8cee43e-6a02-4e31-988c-0910b282a838" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RevenueFromContractWithCustomerIncludingAssessedTax"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_RevenuesAbstract_9b4efb19-04c6-4281-af01-c6759460fabd" xlink:to="loc_us-gaap_RevenueFromContractWithCustomerIncludingAssessedTax_c8cee43e-6a02-4e31-988c-0910b282a838" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CostOfRevenueAbstract_751f74ef-4318-41c6-947a-93d860bb37d3" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CostOfRevenueAbstract"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_StatementLineItems_2af1aebd-be4e-4c85-a656-882c109b648f" xlink:to="loc_us-gaap_CostOfRevenueAbstract_751f74ef-4318-41c6-947a-93d860bb37d3" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CostOfRevenue_13f33b09-217e-4eea-b1e0-63de35b616ed" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CostOfRevenue"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_CostOfRevenueAbstract_751f74ef-4318-41c6-947a-93d860bb37d3" xlink:to="loc_us-gaap_CostOfRevenue_13f33b09-217e-4eea-b1e0-63de35b616ed" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GrossProfit_141d12c7-0072-4da2-8778-457944f5ba2c" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_GrossProfit"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_CostOfRevenueAbstract_751f74ef-4318-41c6-947a-93d860bb37d3" xlink:to="loc_us-gaap_GrossProfit_141d12c7-0072-4da2-8778-457944f5ba2c" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingExpensesAbstract_a4334561-cd47-4a61-b1af-59941960d883" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OperatingExpensesAbstract"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_StatementLineItems_2af1aebd-be4e-4c85-a656-882c109b648f" xlink:to="loc_us-gaap_OperatingExpensesAbstract_a4334561-cd47-4a61-b1af-59941960d883" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SellingAndMarketingExpense_fafb1220-9ddc-4e9e-9962-cd97cbae8bc1" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SellingAndMarketingExpense"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_OperatingExpensesAbstract_a4334561-cd47-4a61-b1af-59941960d883" xlink:to="loc_us-gaap_SellingAndMarketingExpense_fafb1220-9ddc-4e9e-9962-cd97cbae8bc1" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ResearchAndDevelopmentExpense_894fbfdb-d9a3-4aed-abfe-fe342ffada73" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ResearchAndDevelopmentExpense"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_OperatingExpensesAbstract_a4334561-cd47-4a61-b1af-59941960d883" xlink:to="loc_us-gaap_ResearchAndDevelopmentExpense_894fbfdb-d9a3-4aed-abfe-fe342ffada73" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GeneralAndAdministrativeExpense_ed3192de-dca1-458c-bc9e-1abb45dbb941" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_GeneralAndAdministrativeExpense"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_OperatingExpensesAbstract_a4334561-cd47-4a61-b1af-59941960d883" xlink:to="loc_us-gaap_GeneralAndAdministrativeExpense_ed3192de-dca1-458c-bc9e-1abb45dbb941" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingExpenses_8a3cf02e-3e8b-473a-aa26-e462fc6af8e1" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OperatingExpenses"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_OperatingExpensesAbstract_a4334561-cd47-4a61-b1af-59941960d883" xlink:to="loc_us-gaap_OperatingExpenses_8a3cf02e-3e8b-473a-aa26-e462fc6af8e1" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingIncomeLoss_17012ba1-8c13-492f-a052-4a2ebcb9e379" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OperatingIncomeLoss"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_StatementLineItems_2af1aebd-be4e-4c85-a656-882c109b648f" xlink:to="loc_us-gaap_OperatingIncomeLoss_17012ba1-8c13-492f-a052-4a2ebcb9e379" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NonoperatingIncomeExpenseAbstract_33e5a4f1-80fc-42be-a4ac-772b90369c13" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NonoperatingIncomeExpenseAbstract"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_StatementLineItems_2af1aebd-be4e-4c85-a656-882c109b648f" xlink:to="loc_us-gaap_NonoperatingIncomeExpenseAbstract_33e5a4f1-80fc-42be-a4ac-772b90369c13" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InterestIncomeExpenseNonoperatingNet_7d54e0d5-5efe-4642-a2c0-103af807eb68" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_InterestIncomeExpenseNonoperatingNet"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_NonoperatingIncomeExpenseAbstract_33e5a4f1-80fc-42be-a4ac-772b90369c13" xlink:to="loc_us-gaap_InterestIncomeExpenseNonoperatingNet_7d54e0d5-5efe-4642-a2c0-103af807eb68" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueAdjustmentOfWarrants_949374e8-0a06-478f-94ff-b3f541e63531" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueAdjustmentOfWarrants"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_NonoperatingIncomeExpenseAbstract_33e5a4f1-80fc-42be-a4ac-772b90369c13" xlink:to="loc_us-gaap_FairValueAdjustmentOfWarrants_949374e8-0a06-478f-94ff-b3f541e63531" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NonoperatingIncomeExpense_992da3fe-7d0f-46eb-80f8-f2d25c252d77" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NonoperatingIncomeExpense"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_NonoperatingIncomeExpenseAbstract_33e5a4f1-80fc-42be-a4ac-772b90369c13" xlink:to="loc_us-gaap_NonoperatingIncomeExpense_992da3fe-7d0f-46eb-80f8-f2d25c252d77" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetIncomeLoss_68a6c3f7-33a2-4edb-bb53-1bf71ae13160" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NetIncomeLoss"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_StatementLineItems_2af1aebd-be4e-4c85-a656-882c109b648f" xlink:to="loc_us-gaap_NetIncomeLoss_68a6c3f7-33a2-4edb-bb53-1bf71ae13160" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic_94ab4263-c080-4a73-96a9-b11556982b00" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_WeightedAverageNumberOfSharesOutstandingBasic"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_StatementLineItems_2af1aebd-be4e-4c85-a656-882c109b648f" xlink:to="loc_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic_94ab4263-c080-4a73-96a9-b11556982b00" xlink:type="arc" order="6"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding_08e3fd73-fbb7-4546-80bc-106a69c6ed30" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_StatementLineItems_2af1aebd-be4e-4c85-a656-882c109b648f" xlink:to="loc_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding_08e3fd73-fbb7-4546-80bc-106a69c6ed30" xlink:type="arc" order="7"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EarningsPerShareBasic_4a3e3124-eee0-4a73-994c-2ddddec0010a" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EarningsPerShareBasic"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_StatementLineItems_2af1aebd-be4e-4c85-a656-882c109b648f" xlink:to="loc_us-gaap_EarningsPerShareBasic_4a3e3124-eee0-4a73-994c-2ddddec0010a" xlink:type="arc" order="8"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EarningsPerShareDiluted_bcd718c1-3b5b-43c7-9ba2-a186ecfbd0bf" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EarningsPerShareDiluted"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_StatementLineItems_2af1aebd-be4e-4c85-a656-882c109b648f" xlink:to="loc_us-gaap_EarningsPerShareDiluted_bcd718c1-3b5b-43c7-9ba2-a186ecfbd0bf" xlink:type="arc" order="9"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementTable_de9271b0-469c-409f-9e91-5dc0b37f57c9" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StatementTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_StatementLineItems_2af1aebd-be4e-4c85-a656-882c109b648f" xlink:to="loc_us-gaap_StatementTable_de9271b0-469c-409f-9e91-5dc0b37f57c9" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ProductOrServiceAxis_0889972a-d70c-449b-b7b2-1c703ad07d55" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_ProductOrServiceAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_StatementTable_de9271b0-469c-409f-9e91-5dc0b37f57c9" xlink:to="loc_srt_ProductOrServiceAxis_0889972a-d70c-449b-b7b2-1c703ad07d55" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ProductsAndServicesDomain_0889972a-d70c-449b-b7b2-1c703ad07d55_default" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_ProductsAndServicesDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_srt_ProductOrServiceAxis_0889972a-d70c-449b-b7b2-1c703ad07d55" xlink:to="loc_srt_ProductsAndServicesDomain_0889972a-d70c-449b-b7b2-1c703ad07d55_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ProductsAndServicesDomain_c4f0baee-2d4c-4df2-8971-58e87ed49022" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_ProductsAndServicesDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_srt_ProductOrServiceAxis_0889972a-d70c-449b-b7b2-1c703ad07d55" xlink:to="loc_srt_ProductsAndServicesDomain_c4f0baee-2d4c-4df2-8971-58e87ed49022" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_dmtk_AssayMember_9b8effeb-2e3d-49bb-839f-06f64efd0c0f" xlink:href="dmtk-20220630.xsd#dmtk_AssayMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_ProductsAndServicesDomain_c4f0baee-2d4c-4df2-8971-58e87ed49022" xlink:to="loc_dmtk_AssayMember_9b8effeb-2e3d-49bb-839f-06f64efd0c0f" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_dmtk_ContractualActivitiesMember_ce9ce47e-5841-4155-80ad-1c34febf9186" xlink:href="dmtk-20220630.xsd#dmtk_ContractualActivitiesMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_ProductsAndServicesDomain_c4f0baee-2d4c-4df2-8971-58e87ed49022" xlink:to="loc_dmtk_ContractualActivitiesMember_ce9ce47e-5841-4155-80ad-1c34febf9186" xlink:type="arc" order="1"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://dermtech.com/role/CondensedConsolidatedStatementsofStockholdersEquity" xlink:type="simple" xlink:href="dmtk-20220630.xsd#CondensedConsolidatedStatementsofStockholdersEquity"/>
  <link:definitionLink xlink:role="http://dermtech.com/role/CondensedConsolidatedStatementsofStockholdersEquity" xlink:type="extended" id="i21a4ec9060784b239fb153d3640e759c_CondensedConsolidatedStatementsofStockholdersEquity">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementLineItems_9c451478-d5f5-4a5c-b620-b3e5208d0027" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StatementLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SharesOutstanding_6853c7de-e48d-453a-aa0e-446456e4ae22" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SharesOutstanding"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_StatementLineItems_9c451478-d5f5-4a5c-b620-b3e5208d0027" xlink:to="loc_us-gaap_SharesOutstanding_6853c7de-e48d-453a-aa0e-446456e4ae22" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockholdersEquity_d53dc868-6db2-4338-95f5-5f5be1716f14" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StockholdersEquity"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_StatementLineItems_9c451478-d5f5-4a5c-b620-b3e5208d0027" xlink:to="loc_us-gaap_StockholdersEquity_d53dc868-6db2-4338-95f5-5f5be1716f14" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockIssuedDuringPeriodSharesNewIssues_d9762a31-08de-41c3-99f9-d7c93787e08d" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StockIssuedDuringPeriodSharesNewIssues"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_StatementLineItems_9c451478-d5f5-4a5c-b620-b3e5208d0027" xlink:to="loc_us-gaap_StockIssuedDuringPeriodSharesNewIssues_d9762a31-08de-41c3-99f9-d7c93787e08d" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockIssuedDuringPeriodValueNewIssues_5c7d8e21-52f0-4362-b97b-b39b0fdf1e8d" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StockIssuedDuringPeriodValueNewIssues"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_StatementLineItems_9c451478-d5f5-4a5c-b620-b3e5208d0027" xlink:to="loc_us-gaap_StockIssuedDuringPeriodValueNewIssues_5c7d8e21-52f0-4362-b97b-b39b0fdf1e8d" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_dmtk_StockIssuedDuringPeriodSharesStockOptionsExercisedAndRSURelease_6b458a48-9114-437e-9107-ff3ebc588911" xlink:href="dmtk-20220630.xsd#dmtk_StockIssuedDuringPeriodSharesStockOptionsExercisedAndRSURelease"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_StatementLineItems_9c451478-d5f5-4a5c-b620-b3e5208d0027" xlink:to="loc_dmtk_StockIssuedDuringPeriodSharesStockOptionsExercisedAndRSURelease_6b458a48-9114-437e-9107-ff3ebc588911" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_dmtk_StockIssuedDuringPeriodValueStockOptionsExercisedAndRSURelease_7845e567-4658-4e99-b43a-67307be83ae6" xlink:href="dmtk-20220630.xsd#dmtk_StockIssuedDuringPeriodValueStockOptionsExercisedAndRSURelease"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_StatementLineItems_9c451478-d5f5-4a5c-b620-b3e5208d0027" xlink:to="loc_dmtk_StockIssuedDuringPeriodValueStockOptionsExercisedAndRSURelease_7845e567-4658-4e99-b43a-67307be83ae6" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_dmtk_AdjustmentsToAdditionalPaidInCapitalWarrantIssuedShares_a009c208-8ca3-43f9-8fff-12aa4ac54d01" xlink:href="dmtk-20220630.xsd#dmtk_AdjustmentsToAdditionalPaidInCapitalWarrantIssuedShares"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_StatementLineItems_9c451478-d5f5-4a5c-b620-b3e5208d0027" xlink:to="loc_dmtk_AdjustmentsToAdditionalPaidInCapitalWarrantIssuedShares_a009c208-8ca3-43f9-8fff-12aa4ac54d01" xlink:type="arc" order="6"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AdjustmentsToAdditionalPaidInCapitalWarrantIssued_31d7cfb0-f5d8-43d2-8f67-4238d7f9a46c" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AdjustmentsToAdditionalPaidInCapitalWarrantIssued"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_StatementLineItems_9c451478-d5f5-4a5c-b620-b3e5208d0027" xlink:to="loc_us-gaap_AdjustmentsToAdditionalPaidInCapitalWarrantIssued_31d7cfb0-f5d8-43d2-8f67-4238d7f9a46c" xlink:type="arc" order="7"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockIssuedDuringPeriodSharesEmployeeStockPurchasePlans_61803863-f049-4670-b1a9-679796cac7e4" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StockIssuedDuringPeriodSharesEmployeeStockPurchasePlans"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_StatementLineItems_9c451478-d5f5-4a5c-b620-b3e5208d0027" xlink:to="loc_us-gaap_StockIssuedDuringPeriodSharesEmployeeStockPurchasePlans_61803863-f049-4670-b1a9-679796cac7e4" xlink:type="arc" order="8"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockIssuedDuringPeriodValueEmployeeStockPurchasePlan_59a2c992-76b1-4dfa-9b09-0b08bc766f54" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StockIssuedDuringPeriodValueEmployeeStockPurchasePlan"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_StatementLineItems_9c451478-d5f5-4a5c-b620-b3e5208d0027" xlink:to="loc_us-gaap_StockIssuedDuringPeriodValueEmployeeStockPurchasePlan_59a2c992-76b1-4dfa-9b09-0b08bc766f54" xlink:type="arc" order="9"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax_7036b9be-782b-4830-a22d-e492a2e27cf4" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_StatementLineItems_9c451478-d5f5-4a5c-b620-b3e5208d0027" xlink:to="loc_us-gaap_OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax_7036b9be-782b-4830-a22d-e492a2e27cf4" xlink:type="arc" order="10"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue_bd5b8989-a4cf-4bb2-af25-f3b7ad9c5e67" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_StatementLineItems_9c451478-d5f5-4a5c-b620-b3e5208d0027" xlink:to="loc_us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue_bd5b8989-a4cf-4bb2-af25-f3b7ad9c5e67" xlink:type="arc" order="11"/>
    <link:loc xlink:type="locator" xlink:label="loc_dmtk_ReclassificationOfWarrantLiabilityDueToPrivateSPACWarrantsNotHeldByOriginalHolder_d655bc4a-c2ab-46b1-ae2e-0ce2743b0cac" xlink:href="dmtk-20220630.xsd#dmtk_ReclassificationOfWarrantLiabilityDueToPrivateSPACWarrantsNotHeldByOriginalHolder"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_StatementLineItems_9c451478-d5f5-4a5c-b620-b3e5208d0027" xlink:to="loc_dmtk_ReclassificationOfWarrantLiabilityDueToPrivateSPACWarrantsNotHeldByOriginalHolder_d655bc4a-c2ab-46b1-ae2e-0ce2743b0cac" xlink:type="arc" order="12"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetIncomeLoss_0c3435fa-61b5-4c38-ac8e-e34deee7331c" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NetIncomeLoss"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_StatementLineItems_9c451478-d5f5-4a5c-b620-b3e5208d0027" xlink:to="loc_us-gaap_NetIncomeLoss_0c3435fa-61b5-4c38-ac8e-e34deee7331c" xlink:type="arc" order="13"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SharesOutstanding_a51cb3a4-b210-47f7-8475-25a5f1e1a8a5" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SharesOutstanding"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockholdersEquity_cd67a1d7-3730-4ba6-ba07-c1f2707ad3c6" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StockholdersEquity"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementTable_10b6eb0c-8506-4921-b45f-f26b77cb681c" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StatementTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_StatementLineItems_9c451478-d5f5-4a5c-b620-b3e5208d0027" xlink:to="loc_us-gaap_StatementTable_10b6eb0c-8506-4921-b45f-f26b77cb681c" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementEquityComponentsAxis_98339414-d941-4fe6-a355-fb9abc08d8f1" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StatementEquityComponentsAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_StatementTable_10b6eb0c-8506-4921-b45f-f26b77cb681c" xlink:to="loc_us-gaap_StatementEquityComponentsAxis_98339414-d941-4fe6-a355-fb9abc08d8f1" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquityComponentDomain_98339414-d941-4fe6-a355-fb9abc08d8f1_default" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EquityComponentDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_StatementEquityComponentsAxis_98339414-d941-4fe6-a355-fb9abc08d8f1" xlink:to="loc_us-gaap_EquityComponentDomain_98339414-d941-4fe6-a355-fb9abc08d8f1_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquityComponentDomain_3bf10d11-ae95-4561-a98c-f63eac81761f" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EquityComponentDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_StatementEquityComponentsAxis_98339414-d941-4fe6-a355-fb9abc08d8f1" xlink:to="loc_us-gaap_EquityComponentDomain_3bf10d11-ae95-4561-a98c-f63eac81761f" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockMember_5684db57-17a2-4af2-ae24-872570abc264" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CommonStockMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_EquityComponentDomain_3bf10d11-ae95-4561-a98c-f63eac81761f" xlink:to="loc_us-gaap_CommonStockMember_5684db57-17a2-4af2-ae24-872570abc264" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AdditionalPaidInCapitalMember_ef76cc4c-9879-4811-8de3-c850ecd3ae69" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AdditionalPaidInCapitalMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_EquityComponentDomain_3bf10d11-ae95-4561-a98c-f63eac81761f" xlink:to="loc_us-gaap_AdditionalPaidInCapitalMember_ef76cc4c-9879-4811-8de3-c850ecd3ae69" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccumulatedNetUnrealizedInvestmentGainLossMember_fe2a588a-7a8b-4886-a541-366453a3bffe" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AccumulatedNetUnrealizedInvestmentGainLossMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_EquityComponentDomain_3bf10d11-ae95-4561-a98c-f63eac81761f" xlink:to="loc_us-gaap_AccumulatedNetUnrealizedInvestmentGainLossMember_fe2a588a-7a8b-4886-a541-366453a3bffe" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RetainedEarningsMember_b7fbe20d-d4da-4733-bafe-09e363a0c33d" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RetainedEarningsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_EquityComponentDomain_3bf10d11-ae95-4561-a98c-f63eac81761f" xlink:to="loc_us-gaap_RetainedEarningsMember_b7fbe20d-d4da-4733-bafe-09e363a0c33d" xlink:type="arc" order="3"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://dermtech.com/role/CondensedConsolidatedStatementsofStockholdersEquityParenthetical" xlink:type="simple" xlink:href="dmtk-20220630.xsd#CondensedConsolidatedStatementsofStockholdersEquityParenthetical"/>
  <link:definitionLink xlink:role="http://dermtech.com/role/CondensedConsolidatedStatementsofStockholdersEquityParenthetical" xlink:type="extended" id="ic3ac90bf8a7a4e138953fb6492df3534_CondensedConsolidatedStatementsofStockholdersEquityParenthetical">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementLineItems_fe4dd4af-81df-4a39-a3a1-fbcb0ed24dcb" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StatementLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SharesIssuedPricePerShare_975523e8-87ec-4b81-8740-eb8e4e7d4e24" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SharesIssuedPricePerShare"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_StatementLineItems_fe4dd4af-81df-4a39-a3a1-fbcb0ed24dcb" xlink:to="loc_us-gaap_SharesIssuedPricePerShare_975523e8-87ec-4b81-8740-eb8e4e7d4e24" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AdjustmentsToAdditionalPaidInCapitalStockIssuedIssuanceCosts_afe3c55f-0766-456c-9cbb-72c5c51b7b7d" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AdjustmentsToAdditionalPaidInCapitalStockIssuedIssuanceCosts"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_StatementLineItems_fe4dd4af-81df-4a39-a3a1-fbcb0ed24dcb" xlink:to="loc_us-gaap_AdjustmentsToAdditionalPaidInCapitalStockIssuedIssuanceCosts_afe3c55f-0766-456c-9cbb-72c5c51b7b7d" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementTable_e93f72ce-8e6b-4394-9a1f-bdaf17d6c330" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StatementTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_StatementLineItems_fe4dd4af-81df-4a39-a3a1-fbcb0ed24dcb" xlink:to="loc_us-gaap_StatementTable_e93f72ce-8e6b-4394-9a1f-bdaf17d6c330" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementEquityComponentsAxis_36b5daf5-b862-4a6b-9d27-2086c33e8cbd" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StatementEquityComponentsAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_StatementTable_e93f72ce-8e6b-4394-9a1f-bdaf17d6c330" xlink:to="loc_us-gaap_StatementEquityComponentsAxis_36b5daf5-b862-4a6b-9d27-2086c33e8cbd" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquityComponentDomain_36b5daf5-b862-4a6b-9d27-2086c33e8cbd_default" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EquityComponentDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_StatementEquityComponentsAxis_36b5daf5-b862-4a6b-9d27-2086c33e8cbd" xlink:to="loc_us-gaap_EquityComponentDomain_36b5daf5-b862-4a6b-9d27-2086c33e8cbd_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquityComponentDomain_cc371fb8-d8ad-460e-8f9e-4a8ed8a8bff3" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EquityComponentDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_StatementEquityComponentsAxis_36b5daf5-b862-4a6b-9d27-2086c33e8cbd" xlink:to="loc_us-gaap_EquityComponentDomain_cc371fb8-d8ad-460e-8f9e-4a8ed8a8bff3" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockMember_16ef982a-d349-456f-9fbf-47cf6a700e9e" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CommonStockMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_EquityComponentDomain_cc371fb8-d8ad-460e-8f9e-4a8ed8a8bff3" xlink:to="loc_us-gaap_CommonStockMember_16ef982a-d349-456f-9fbf-47cf6a700e9e" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SubsidiarySaleOfStockAxis_6380f9e8-fecd-4656-9627-ff0bd2061f06" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SubsidiarySaleOfStockAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_StatementTable_e93f72ce-8e6b-4394-9a1f-bdaf17d6c330" xlink:to="loc_us-gaap_SubsidiarySaleOfStockAxis_6380f9e8-fecd-4656-9627-ff0bd2061f06" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SaleOfStockNameOfTransactionDomain_6380f9e8-fecd-4656-9627-ff0bd2061f06_default" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SaleOfStockNameOfTransactionDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_SubsidiarySaleOfStockAxis_6380f9e8-fecd-4656-9627-ff0bd2061f06" xlink:to="loc_us-gaap_SaleOfStockNameOfTransactionDomain_6380f9e8-fecd-4656-9627-ff0bd2061f06_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SaleOfStockNameOfTransactionDomain_2ec7b192-b364-4655-8d54-bc59312b85b3" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SaleOfStockNameOfTransactionDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_SubsidiarySaleOfStockAxis_6380f9e8-fecd-4656-9627-ff0bd2061f06" xlink:to="loc_us-gaap_SaleOfStockNameOfTransactionDomain_2ec7b192-b364-4655-8d54-bc59312b85b3" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_dmtk_AtTheMarketOfferingMember_f44321ac-ef57-4436-999c-15f15c9d40ee" xlink:href="dmtk-20220630.xsd#dmtk_AtTheMarketOfferingMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SaleOfStockNameOfTransactionDomain_2ec7b192-b364-4655-8d54-bc59312b85b3" xlink:to="loc_dmtk_AtTheMarketOfferingMember_f44321ac-ef57-4436-999c-15f15c9d40ee" xlink:type="arc" order="0"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://dermtech.com/role/CondensedConsolidatedStatementsofCashFlows" xlink:type="simple" xlink:href="dmtk-20220630.xsd#CondensedConsolidatedStatementsofCashFlows"/>
  <link:definitionLink xlink:role="http://dermtech.com/role/CondensedConsolidatedStatementsofCashFlows" xlink:type="extended" id="i581ded2b119c4807bdd3918077d8eb19_CondensedConsolidatedStatementsofCashFlows">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementLineItems_7dcde0ba-6240-4f9b-9270-45c944ca5c64" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StatementLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract_dbac9c29-6cc5-40ff-a7dc-4886c9a80ae9" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_StatementLineItems_7dcde0ba-6240-4f9b-9270-45c944ca5c64" xlink:to="loc_us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract_dbac9c29-6cc5-40ff-a7dc-4886c9a80ae9" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProfitLoss_a0f50877-5984-4b3e-96ae-c641130881ad" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ProfitLoss"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract_dbac9c29-6cc5-40ff-a7dc-4886c9a80ae9" xlink:to="loc_us-gaap_ProfitLoss_a0f50877-5984-4b3e-96ae-c641130881ad" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract_1bec0f85-f7d3-4b74-96f3-b63046131ae8" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract_dbac9c29-6cc5-40ff-a7dc-4886c9a80ae9" xlink:to="loc_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract_1bec0f85-f7d3-4b74-96f3-b63046131ae8" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Depreciation_3b4ad905-fe5e-4473-9bee-3ddefaed2498" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_Depreciation"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract_1bec0f85-f7d3-4b74-96f3-b63046131ae8" xlink:to="loc_us-gaap_Depreciation_3b4ad905-fe5e-4473-9bee-3ddefaed2498" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueAdjustmentOfWarrants_fd4544cf-f2d5-4dc3-afab-57d618088513" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueAdjustmentOfWarrants"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract_1bec0f85-f7d3-4b74-96f3-b63046131ae8" xlink:to="loc_us-gaap_FairValueAdjustmentOfWarrants_fd4544cf-f2d5-4dc3-afab-57d618088513" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeaseRightOfUseAssetAmortizationExpense_7e710cd7-9ea6-4277-9bc3-3292d64afdfe" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OperatingLeaseRightOfUseAssetAmortizationExpense"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract_1bec0f85-f7d3-4b74-96f3-b63046131ae8" xlink:to="loc_us-gaap_OperatingLeaseRightOfUseAssetAmortizationExpense_7e710cd7-9ea6-4277-9bc3-3292d64afdfe" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensation_d0ea38cf-8c87-40a6-a5f2-415ba2784366" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensation"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract_1bec0f85-f7d3-4b74-96f3-b63046131ae8" xlink:to="loc_us-gaap_ShareBasedCompensation_d0ea38cf-8c87-40a6-a5f2-415ba2784366" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccretionAmortizationOfDiscountsAndPremiumsInvestments_959cb319-fb1a-4758-bc28-2366389e6b34" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AccretionAmortizationOfDiscountsAndPremiumsInvestments"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract_1bec0f85-f7d3-4b74-96f3-b63046131ae8" xlink:to="loc_us-gaap_AccretionAmortizationOfDiscountsAndPremiumsInvestments_959cb319-fb1a-4758-bc28-2366389e6b34" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GainLossOnDispositionOfAssets1_04ac0706-8c66-40d8-98c2-a1d28c20745d" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_GainLossOnDispositionOfAssets1"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract_1bec0f85-f7d3-4b74-96f3-b63046131ae8" xlink:to="loc_us-gaap_GainLossOnDispositionOfAssets1_04ac0706-8c66-40d8-98c2-a1d28c20745d" xlink:type="arc" order="6"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInOperatingCapitalAbstract_d49cbba7-8307-4e2e-ba19-cb3c18ba92fc" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncreaseDecreaseInOperatingCapitalAbstract"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract_1bec0f85-f7d3-4b74-96f3-b63046131ae8" xlink:to="loc_us-gaap_IncreaseDecreaseInOperatingCapitalAbstract_d49cbba7-8307-4e2e-ba19-cb3c18ba92fc" xlink:type="arc" order="7"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInAccountsReceivable_7e16bb8c-eca7-486d-b1a9-5e9d90584552" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncreaseDecreaseInAccountsReceivable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncreaseDecreaseInOperatingCapitalAbstract_d49cbba7-8307-4e2e-ba19-cb3c18ba92fc" xlink:to="loc_us-gaap_IncreaseDecreaseInAccountsReceivable_7e16bb8c-eca7-486d-b1a9-5e9d90584552" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInInventories_7a189b64-f791-4fd8-b02a-a21bee33042d" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncreaseDecreaseInInventories"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncreaseDecreaseInOperatingCapitalAbstract_d49cbba7-8307-4e2e-ba19-cb3c18ba92fc" xlink:to="loc_us-gaap_IncreaseDecreaseInInventories_7a189b64-f791-4fd8-b02a-a21bee33042d" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets_615cb9dc-c75b-4167-b5eb-e8e07c806992" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncreaseDecreaseInOperatingCapitalAbstract_d49cbba7-8307-4e2e-ba19-cb3c18ba92fc" xlink:to="loc_us-gaap_IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets_615cb9dc-c75b-4167-b5eb-e8e07c806992" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInOperatingLeaseLiability_5e300b1c-d85f-4f0e-a537-29f374a87daa" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncreaseDecreaseInOperatingLeaseLiability"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncreaseDecreaseInOperatingCapitalAbstract_d49cbba7-8307-4e2e-ba19-cb3c18ba92fc" xlink:to="loc_us-gaap_IncreaseDecreaseInOperatingLeaseLiability_5e300b1c-d85f-4f0e-a537-29f374a87daa" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInAccountsPayableAndAccruedLiabilities_636b54fb-55b9-4cbd-a20f-e83d68d69bf7" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncreaseDecreaseInAccountsPayableAndAccruedLiabilities"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncreaseDecreaseInOperatingCapitalAbstract_d49cbba7-8307-4e2e-ba19-cb3c18ba92fc" xlink:to="loc_us-gaap_IncreaseDecreaseInAccountsPayableAndAccruedLiabilities_636b54fb-55b9-4cbd-a20f-e83d68d69bf7" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInEmployeeRelatedLiabilities_aa798780-7b0f-4886-ba71-f8523ef506ab" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncreaseDecreaseInEmployeeRelatedLiabilities"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncreaseDecreaseInOperatingCapitalAbstract_d49cbba7-8307-4e2e-ba19-cb3c18ba92fc" xlink:to="loc_us-gaap_IncreaseDecreaseInEmployeeRelatedLiabilities_aa798780-7b0f-4886-ba71-f8523ef506ab" xlink:type="arc" order="6"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_e452a2d2-5ae0-44d4-81e3-1ce7fadd358a" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NetCashProvidedByUsedInOperatingActivities"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract_dbac9c29-6cc5-40ff-a7dc-4886c9a80ae9" xlink:to="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_e452a2d2-5ae0-44d4-81e3-1ce7fadd358a" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract_ffba9c8e-842e-4bc8-8ac0-27dd09c9e3d4" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_StatementLineItems_7dcde0ba-6240-4f9b-9270-45c944ca5c64" xlink:to="loc_us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract_ffba9c8e-842e-4bc8-8ac0-27dd09c9e3d4" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsToAcquireMarketableSecurities_f545555c-d958-42c2-a99a-89dc038454e6" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PaymentsToAcquireMarketableSecurities"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract_ffba9c8e-842e-4bc8-8ac0-27dd09c9e3d4" xlink:to="loc_us-gaap_PaymentsToAcquireMarketableSecurities_f545555c-d958-42c2-a99a-89dc038454e6" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_dmtk_ProceedsFromMaturityOfMarketableSecurities_d39933b0-55c3-4309-be65-0e65e301f299" xlink:href="dmtk-20220630.xsd#dmtk_ProceedsFromMaturityOfMarketableSecurities"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract_ffba9c8e-842e-4bc8-8ac0-27dd09c9e3d4" xlink:to="loc_dmtk_ProceedsFromMaturityOfMarketableSecurities_d39933b0-55c3-4309-be65-0e65e301f299" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsToAcquirePropertyPlantAndEquipment_473eccf4-27a0-40fb-9dc3-4ef0b5c366f8" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PaymentsToAcquirePropertyPlantAndEquipment"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract_ffba9c8e-842e-4bc8-8ac0-27dd09c9e3d4" xlink:to="loc_us-gaap_PaymentsToAcquirePropertyPlantAndEquipment_473eccf4-27a0-40fb-9dc3-4ef0b5c366f8" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInInvestingActivities_15a54604-40e0-4448-b36e-222e07414161" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NetCashProvidedByUsedInInvestingActivities"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract_ffba9c8e-842e-4bc8-8ac0-27dd09c9e3d4" xlink:to="loc_us-gaap_NetCashProvidedByUsedInInvestingActivities_15a54604-40e0-4448-b36e-222e07414161" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract_51e468ee-474f-4b99-bd8b-74f538a0699b" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_StatementLineItems_7dcde0ba-6240-4f9b-9270-45c944ca5c64" xlink:to="loc_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract_51e468ee-474f-4b99-bd8b-74f538a0699b" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProceedsFromIssuanceOfCommonStock_1ccfa8da-5f5a-402b-92b8-67c3f71c974d" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ProceedsFromIssuanceOfCommonStock"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract_51e468ee-474f-4b99-bd8b-74f538a0699b" xlink:to="loc_us-gaap_ProceedsFromIssuanceOfCommonStock_1ccfa8da-5f5a-402b-92b8-67c3f71c974d" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProceedsFromWarrantExercises_79e1d724-416f-4339-be0e-e5968f3b02a6" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ProceedsFromWarrantExercises"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract_51e468ee-474f-4b99-bd8b-74f538a0699b" xlink:to="loc_us-gaap_ProceedsFromWarrantExercises_79e1d724-416f-4339-be0e-e5968f3b02a6" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_dmtk_ProceedsFromReleaseOfRSUsAndStockOptionsExercised_6ef95f43-7d00-499b-9f17-238231fec521" xlink:href="dmtk-20220630.xsd#dmtk_ProceedsFromReleaseOfRSUsAndStockOptionsExercised"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract_51e468ee-474f-4b99-bd8b-74f538a0699b" xlink:to="loc_dmtk_ProceedsFromReleaseOfRSUsAndStockOptionsExercised_6ef95f43-7d00-499b-9f17-238231fec521" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProceedsFromStockPlans_5cb99dae-a28c-4959-95c3-2be68db871c1" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ProceedsFromStockPlans"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract_51e468ee-474f-4b99-bd8b-74f538a0699b" xlink:to="loc_us-gaap_ProceedsFromStockPlans_5cb99dae-a28c-4959-95c3-2be68db871c1" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RepaymentsOfDebtAndCapitalLeaseObligations_0c06f478-3a79-47fc-8b66-da0e597072e1" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RepaymentsOfDebtAndCapitalLeaseObligations"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract_51e468ee-474f-4b99-bd8b-74f538a0699b" xlink:to="loc_us-gaap_RepaymentsOfDebtAndCapitalLeaseObligations_0c06f478-3a79-47fc-8b66-da0e597072e1" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInFinancingActivities_e1c8345f-0fbc-4155-9680-3259bf497e9c" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NetCashProvidedByUsedInFinancingActivities"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract_51e468ee-474f-4b99-bd8b-74f538a0699b" xlink:to="loc_us-gaap_NetCashProvidedByUsedInFinancingActivities_e1c8345f-0fbc-4155-9680-3259bf497e9c" xlink:type="arc" order="6"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect_28d29721-17ac-4f50-a100-cc3bc67975a6" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_StatementLineItems_7dcde0ba-6240-4f9b-9270-45c944ca5c64" xlink:to="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect_28d29721-17ac-4f50-a100-cc3bc67975a6" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations_ac214eb7-5599-4226-9841-cc4dfa64aad4" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_StatementLineItems_7dcde0ba-6240-4f9b-9270-45c944ca5c64" xlink:to="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations_ac214eb7-5599-4226-9841-cc4dfa64aad4" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations_f1b5ee54-2030-44a6-91b0-10b0f03e0948" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestrictedCashAndCashEquivalentsAbstract_4d8a4444-5f1f-4829-afe7-793e04bfabfa" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RestrictedCashAndCashEquivalentsAbstract"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_StatementLineItems_7dcde0ba-6240-4f9b-9270-45c944ca5c64" xlink:to="loc_us-gaap_RestrictedCashAndCashEquivalentsAbstract_4d8a4444-5f1f-4829-afe7-793e04bfabfa" xlink:type="arc" order="6"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashAndCashEquivalentsAtCarryingValue_de5a7d63-45ad-4442-943a-cfda7dd7d2d5" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CashAndCashEquivalentsAtCarryingValue"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_RestrictedCashAndCashEquivalentsAbstract_4d8a4444-5f1f-4829-afe7-793e04bfabfa" xlink:to="loc_us-gaap_CashAndCashEquivalentsAtCarryingValue_de5a7d63-45ad-4442-943a-cfda7dd7d2d5" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestrictedCash_13c14ce0-cea0-4afc-897e-e11334349f44" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RestrictedCash"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_RestrictedCashAndCashEquivalentsAbstract_4d8a4444-5f1f-4829-afe7-793e04bfabfa" xlink:to="loc_us-gaap_RestrictedCash_13c14ce0-cea0-4afc-897e-e11334349f44" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_0e55e36f-c2b5-459b-a2b6-fd8734b572d3" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_RestrictedCashAndCashEquivalentsAbstract_4d8a4444-5f1f-4829-afe7-793e04bfabfa" xlink:to="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_0e55e36f-c2b5-459b-a2b6-fd8734b572d3" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SupplementalCashFlowInformationAbstract_698e33fa-342e-44b1-b388-370f38648f44" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SupplementalCashFlowInformationAbstract"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_StatementLineItems_7dcde0ba-6240-4f9b-9270-45c944ca5c64" xlink:to="loc_us-gaap_SupplementalCashFlowInformationAbstract_698e33fa-342e-44b1-b388-370f38648f44" xlink:type="arc" order="7"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InterestPaidNet_87d3888c-f622-4890-9d5b-4f09ec257a66" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_InterestPaidNet"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SupplementalCashFlowInformationAbstract_698e33fa-342e-44b1-b388-370f38648f44" xlink:to="loc_us-gaap_InterestPaidNet_87d3888c-f622-4890-9d5b-4f09ec257a66" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NoncashInvestingAndFinancingItemsAbstract_4c5587da-77c1-4932-a96a-78fd7ad547ad" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NoncashInvestingAndFinancingItemsAbstract"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_StatementLineItems_7dcde0ba-6240-4f9b-9270-45c944ca5c64" xlink:to="loc_us-gaap_NoncashInvestingAndFinancingItemsAbstract_4c5587da-77c1-4932-a96a-78fd7ad547ad" xlink:type="arc" order="8"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CapitalExpendituresIncurredButNotYetPaid_f271cc57-61d5-4d4d-bfca-2333c82c7558" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CapitalExpendituresIncurredButNotYetPaid"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_NoncashInvestingAndFinancingItemsAbstract_4c5587da-77c1-4932-a96a-78fd7ad547ad" xlink:to="loc_us-gaap_CapitalExpendituresIncurredButNotYetPaid_f271cc57-61d5-4d4d-bfca-2333c82c7558" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_dmtk_ReclassificationOfWarrantLiabilityDueToPrivateSPACWarrantsNotHeldByOriginalHolder_bb7c6508-12b5-4875-828d-ea66fc1c3775" xlink:href="dmtk-20220630.xsd#dmtk_ReclassificationOfWarrantLiabilityDueToPrivateSPACWarrantsNotHeldByOriginalHolder"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_NoncashInvestingAndFinancingItemsAbstract_4c5587da-77c1-4932-a96a-78fd7ad547ad" xlink:to="loc_dmtk_ReclassificationOfWarrantLiabilityDueToPrivateSPACWarrantsNotHeldByOriginalHolder_bb7c6508-12b5-4875-828d-ea66fc1c3775" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_dmtk_CashlessExerciseOfCommonStockWarrants_55998ebb-57b9-4bde-bb1a-3a6c5f57a6d0" xlink:href="dmtk-20220630.xsd#dmtk_CashlessExerciseOfCommonStockWarrants"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_NoncashInvestingAndFinancingItemsAbstract_4c5587da-77c1-4932-a96a-78fd7ad547ad" xlink:to="loc_dmtk_CashlessExerciseOfCommonStockWarrants_55998ebb-57b9-4bde-bb1a-3a6c5f57a6d0" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability_f17d4611-45a6-465a-81da-60b53fa98f4c" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_NoncashInvestingAndFinancingItemsAbstract_4c5587da-77c1-4932-a96a-78fd7ad547ad" xlink:to="loc_us-gaap_RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability_f17d4611-45a6-465a-81da-60b53fa98f4c" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NoncashOrPartNoncashAcquisitionFixedAssetsAcquired1_e37a7148-9d57-4be2-b753-894415a5fa95" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NoncashOrPartNoncashAcquisitionFixedAssetsAcquired1"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_NoncashInvestingAndFinancingItemsAbstract_4c5587da-77c1-4932-a96a-78fd7ad547ad" xlink:to="loc_us-gaap_NoncashOrPartNoncashAcquisitionFixedAssetsAcquired1_e37a7148-9d57-4be2-b753-894415a5fa95" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_dmtk_ChangeInUnrealizedGainLossOnAvailableForSaleMarketableSecurities_7318b641-94b5-4fa4-8550-704a72813af2" xlink:href="dmtk-20220630.xsd#dmtk_ChangeInUnrealizedGainLossOnAvailableForSaleMarketableSecurities"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_NoncashInvestingAndFinancingItemsAbstract_4c5587da-77c1-4932-a96a-78fd7ad547ad" xlink:to="loc_dmtk_ChangeInUnrealizedGainLossOnAvailableForSaleMarketableSecurities_7318b641-94b5-4fa4-8550-704a72813af2" xlink:type="arc" order="6"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementTable_eb71ec79-822e-477e-83da-9daeba64c09f" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StatementTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_StatementLineItems_7dcde0ba-6240-4f9b-9270-45c944ca5c64" xlink:to="loc_us-gaap_StatementTable_eb71ec79-822e-477e-83da-9daeba64c09f" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SubsidiarySaleOfStockAxis_5c667b1d-6dce-4ba7-ba0c-8bcbf422f769" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SubsidiarySaleOfStockAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_StatementTable_eb71ec79-822e-477e-83da-9daeba64c09f" xlink:to="loc_us-gaap_SubsidiarySaleOfStockAxis_5c667b1d-6dce-4ba7-ba0c-8bcbf422f769" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SaleOfStockNameOfTransactionDomain_5c667b1d-6dce-4ba7-ba0c-8bcbf422f769_default" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SaleOfStockNameOfTransactionDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_SubsidiarySaleOfStockAxis_5c667b1d-6dce-4ba7-ba0c-8bcbf422f769" xlink:to="loc_us-gaap_SaleOfStockNameOfTransactionDomain_5c667b1d-6dce-4ba7-ba0c-8bcbf422f769_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SaleOfStockNameOfTransactionDomain_375a757e-8bea-4c0d-8d6d-bdd4d4688188" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SaleOfStockNameOfTransactionDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_SubsidiarySaleOfStockAxis_5c667b1d-6dce-4ba7-ba0c-8bcbf422f769" xlink:to="loc_us-gaap_SaleOfStockNameOfTransactionDomain_375a757e-8bea-4c0d-8d6d-bdd4d4688188" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_dmtk_PublicFollowOnOfferingMember_69bed3c5-15f4-4c15-b938-580b6dc5f7c4" xlink:href="dmtk-20220630.xsd#dmtk_PublicFollowOnOfferingMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SaleOfStockNameOfTransactionDomain_375a757e-8bea-4c0d-8d6d-bdd4d4688188" xlink:to="loc_dmtk_PublicFollowOnOfferingMember_69bed3c5-15f4-4c15-b938-580b6dc5f7c4" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_dmtk_AtTheMarketOfferingMember_4906c63b-a728-4e4d-b808-3b6c7b396a88" xlink:href="dmtk-20220630.xsd#dmtk_AtTheMarketOfferingMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SaleOfStockNameOfTransactionDomain_375a757e-8bea-4c0d-8d6d-bdd4d4688188" xlink:to="loc_dmtk_AtTheMarketOfferingMember_4906c63b-a728-4e4d-b808-3b6c7b396a88" xlink:type="arc" order="1"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://dermtech.com/role/TheCompanyandaSummaryofitsSignificantAccountingPoliciesAdditionalInformationDetails" xlink:type="simple" xlink:href="dmtk-20220630.xsd#TheCompanyandaSummaryofitsSignificantAccountingPoliciesAdditionalInformationDetails"/>
  <link:definitionLink xlink:role="http://dermtech.com/role/TheCompanyandaSummaryofitsSignificantAccountingPoliciesAdditionalInformationDetails" xlink:type="extended" id="ie4a77ea3d2cd444db091d334bf78f031_TheCompanyandaSummaryofitsSignificantAccountingPoliciesAdditionalInformationDetails">
    <link:loc xlink:type="locator" xlink:label="loc_dmtk_TheCompanyAndSummaryOfItsSignificantAccountingPoliciesLineItems_a00eadb6-3359-4607-b904-74e98db98f18" xlink:href="dmtk-20220630.xsd#dmtk_TheCompanyAndSummaryOfItsSignificantAccountingPoliciesLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockholdersEquityNoteStockSplitConversionRatio1_7438cb9d-ced0-44b1-9573-579739c9ce53" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StockholdersEquityNoteStockSplitConversionRatio1"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_dmtk_TheCompanyAndSummaryOfItsSignificantAccountingPoliciesLineItems_a00eadb6-3359-4607-b904-74e98db98f18" xlink:to="loc_us-gaap_StockholdersEquityNoteStockSplitConversionRatio1_7438cb9d-ced0-44b1-9573-579739c9ce53" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentUsefulLife_f1d4d914-0611-4a87-9a17-15358337dfc1" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PropertyPlantAndEquipmentUsefulLife"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_dmtk_TheCompanyAndSummaryOfItsSignificantAccountingPoliciesLineItems_a00eadb6-3359-4607-b904-74e98db98f18" xlink:to="loc_us-gaap_PropertyPlantAndEquipmentUsefulLife_f1d4d914-0611-4a87-9a17-15358337dfc1" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Depreciation_56323265-4b63-4235-868e-3e330d591c33" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_Depreciation"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_dmtk_TheCompanyAndSummaryOfItsSignificantAccountingPoliciesLineItems_a00eadb6-3359-4607-b904-74e98db98f18" xlink:to="loc_us-gaap_Depreciation_56323265-4b63-4235-868e-3e330d591c33" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentGross_49dbbd97-e141-4615-b78c-38dd6403d69b" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PropertyPlantAndEquipmentGross"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_dmtk_TheCompanyAndSummaryOfItsSignificantAccountingPoliciesLineItems_a00eadb6-3359-4607-b904-74e98db98f18" xlink:to="loc_us-gaap_PropertyPlantAndEquipmentGross_49dbbd97-e141-4615-b78c-38dd6403d69b" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DepreciationAndAmortization_1e7a291b-2f38-4574-8d5c-b3dd0d2ca82e" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DepreciationAndAmortization"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_dmtk_TheCompanyAndSummaryOfItsSignificantAccountingPoliciesLineItems_a00eadb6-3359-4607-b904-74e98db98f18" xlink:to="loc_us-gaap_DepreciationAndAmortization_1e7a291b-2f38-4574-8d5c-b3dd0d2ca82e" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentDisposals_80859500-9254-46b0-be9d-d94fd56feba5" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PropertyPlantAndEquipmentDisposals"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_dmtk_TheCompanyAndSummaryOfItsSignificantAccountingPoliciesLineItems_a00eadb6-3359-4607-b904-74e98db98f18" xlink:to="loc_us-gaap_PropertyPlantAndEquipmentDisposals_80859500-9254-46b0-be9d-d94fd56feba5" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ImpairmentOfLongLivedAssetsToBeDisposedOf_7003c279-aa48-4f09-bf54-f4893311cb7f" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ImpairmentOfLongLivedAssetsToBeDisposedOf"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_dmtk_TheCompanyAndSummaryOfItsSignificantAccountingPoliciesLineItems_a00eadb6-3359-4607-b904-74e98db98f18" xlink:to="loc_us-gaap_ImpairmentOfLongLivedAssetsToBeDisposedOf_7003c279-aa48-4f09-bf54-f4893311cb7f" xlink:type="arc" order="6"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DepositsMoneyMarketDeposits_a242539c-0f60-4b6f-af15-e3b60e3aa6d6" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DepositsMoneyMarketDeposits"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_dmtk_TheCompanyAndSummaryOfItsSignificantAccountingPoliciesLineItems_a00eadb6-3359-4607-b904-74e98db98f18" xlink:to="loc_us-gaap_DepositsMoneyMarketDeposits_a242539c-0f60-4b6f-af15-e3b60e3aa6d6" xlink:type="arc" order="7"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashFDICInsuredAmount_2883975a-46ca-4472-936d-654ce67a3612" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CashFDICInsuredAmount"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_dmtk_TheCompanyAndSummaryOfItsSignificantAccountingPoliciesLineItems_a00eadb6-3359-4607-b904-74e98db98f18" xlink:to="loc_us-gaap_CashFDICInsuredAmount_2883975a-46ca-4472-936d-654ce67a3612" xlink:type="arc" order="8"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashUninsuredAmount_5c7b9029-f1e9-4e9b-a12e-0823dd6993f9" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CashUninsuredAmount"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_dmtk_TheCompanyAndSummaryOfItsSignificantAccountingPoliciesLineItems_a00eadb6-3359-4607-b904-74e98db98f18" xlink:to="loc_us-gaap_CashUninsuredAmount_5c7b9029-f1e9-4e9b-a12e-0823dd6993f9" xlink:type="arc" order="9"/>
    <link:loc xlink:type="locator" xlink:label="loc_dmtk_NumberOfRevenueStreams_2f3e5c50-2bff-47d2-aa7b-eee52a1d7095" xlink:href="dmtk-20220630.xsd#dmtk_NumberOfRevenueStreams"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_dmtk_TheCompanyAndSummaryOfItsSignificantAccountingPoliciesLineItems_a00eadb6-3359-4607-b904-74e98db98f18" xlink:to="loc_dmtk_NumberOfRevenueStreams_2f3e5c50-2bff-47d2-aa7b-eee52a1d7095" xlink:type="arc" order="10"/>
    <link:loc xlink:type="locator" xlink:label="loc_dmtk_RevenuePerformanceObligationSatisfiedVariableConsiderationUpdateIncreaseDecreaseInRevenue_6a729a6a-5c5b-4412-9026-ccd15c5cd9f6" xlink:href="dmtk-20220630.xsd#dmtk_RevenuePerformanceObligationSatisfiedVariableConsiderationUpdateIncreaseDecreaseInRevenue"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_dmtk_TheCompanyAndSummaryOfItsSignificantAccountingPoliciesLineItems_a00eadb6-3359-4607-b904-74e98db98f18" xlink:to="loc_dmtk_RevenuePerformanceObligationSatisfiedVariableConsiderationUpdateIncreaseDecreaseInRevenue_6a729a6a-5c5b-4412-9026-ccd15c5cd9f6" xlink:type="arc" order="11"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredRevenueCurrent_6f2e072b-ab53-4f55-a1da-295ef6f3078e" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DeferredRevenueCurrent"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_dmtk_TheCompanyAndSummaryOfItsSignificantAccountingPoliciesLineItems_a00eadb6-3359-4607-b904-74e98db98f18" xlink:to="loc_us-gaap_DeferredRevenueCurrent_6f2e072b-ab53-4f55-a1da-295ef6f3078e" xlink:type="arc" order="12"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevenueRemainingPerformanceObligation_7281bf3b-19ef-4ced-94c3-ee27e9e5ef8e" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RevenueRemainingPerformanceObligation"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_dmtk_TheCompanyAndSummaryOfItsSignificantAccountingPoliciesLineItems_a00eadb6-3359-4607-b904-74e98db98f18" xlink:to="loc_us-gaap_RevenueRemainingPerformanceObligation_7281bf3b-19ef-4ced-94c3-ee27e9e5ef8e" xlink:type="arc" order="13"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionPeriod1_ab8cdf48-0284-4d95-a3f2-87beb1954e08" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionPeriod1"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_dmtk_TheCompanyAndSummaryOfItsSignificantAccountingPoliciesLineItems_a00eadb6-3359-4607-b904-74e98db98f18" xlink:to="loc_us-gaap_RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionPeriod1_ab8cdf48-0284-4d95-a3f2-87beb1954e08" xlink:type="arc" order="14"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccountsReceivableGrossCurrent_22a47f88-76a7-4b34-a8d4-2b720799d4e0" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AccountsReceivableGrossCurrent"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_dmtk_TheCompanyAndSummaryOfItsSignificantAccountingPoliciesLineItems_a00eadb6-3359-4607-b904-74e98db98f18" xlink:to="loc_us-gaap_AccountsReceivableGrossCurrent_22a47f88-76a7-4b34-a8d4-2b720799d4e0" xlink:type="arc" order="15"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_UnbilledReceivablesCurrent_9ac7ae56-5aa1-48e5-9ab2-5a8d57c81151" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_UnbilledReceivablesCurrent"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_dmtk_TheCompanyAndSummaryOfItsSignificantAccountingPoliciesLineItems_a00eadb6-3359-4607-b904-74e98db98f18" xlink:to="loc_us-gaap_UnbilledReceivablesCurrent_9ac7ae56-5aa1-48e5-9ab2-5a8d57c81151" xlink:type="arc" order="16"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccountsReceivableNetCurrent_faff052e-6596-451c-b512-6f4513871c09" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AccountsReceivableNetCurrent"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_dmtk_TheCompanyAndSummaryOfItsSignificantAccountingPoliciesLineItems_a00eadb6-3359-4607-b904-74e98db98f18" xlink:to="loc_us-gaap_AccountsReceivableNetCurrent_faff052e-6596-451c-b512-6f4513871c09" xlink:type="arc" order="17"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount_e788b369-27c3-4137-ae3d-253d182f6ff2" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_dmtk_TheCompanyAndSummaryOfItsSignificantAccountingPoliciesLineItems_a00eadb6-3359-4607-b904-74e98db98f18" xlink:to="loc_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount_e788b369-27c3-4137-ae3d-253d182f6ff2" xlink:type="arc" order="18"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LettersOfCreditOutstandingAmount_237869d0-d9ef-4c28-a30c-0b5a46acdf0b" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LettersOfCreditOutstandingAmount"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_dmtk_TheCompanyAndSummaryOfItsSignificantAccountingPoliciesLineItems_a00eadb6-3359-4607-b904-74e98db98f18" xlink:to="loc_us-gaap_LettersOfCreditOutstandingAmount_237869d0-d9ef-4c28-a30c-0b5a46acdf0b" xlink:type="arc" order="19"/>
    <link:loc xlink:type="locator" xlink:label="loc_dmtk_TheCompanyAndSummaryOfItsSignificantAccountingPoliciesTable_95d7a53f-335f-4229-be81-79cd256ffc74" xlink:href="dmtk-20220630.xsd#dmtk_TheCompanyAndSummaryOfItsSignificantAccountingPoliciesTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_dmtk_TheCompanyAndSummaryOfItsSignificantAccountingPoliciesLineItems_a00eadb6-3359-4607-b904-74e98db98f18" xlink:to="loc_dmtk_TheCompanyAndSummaryOfItsSignificantAccountingPoliciesTable_95d7a53f-335f-4229-be81-79cd256ffc74" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentByTypeAxis_8c96c3c0-7d09-4310-8d4c-c39c32653a90" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PropertyPlantAndEquipmentByTypeAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_dmtk_TheCompanyAndSummaryOfItsSignificantAccountingPoliciesTable_95d7a53f-335f-4229-be81-79cd256ffc74" xlink:to="loc_us-gaap_PropertyPlantAndEquipmentByTypeAxis_8c96c3c0-7d09-4310-8d4c-c39c32653a90" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentTypeDomain_8c96c3c0-7d09-4310-8d4c-c39c32653a90_default" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PropertyPlantAndEquipmentTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentByTypeAxis_8c96c3c0-7d09-4310-8d4c-c39c32653a90" xlink:to="loc_us-gaap_PropertyPlantAndEquipmentTypeDomain_8c96c3c0-7d09-4310-8d4c-c39c32653a90_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentTypeDomain_84c1d513-450f-4b3a-b842-8429d41742b9" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PropertyPlantAndEquipmentTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentByTypeAxis_8c96c3c0-7d09-4310-8d4c-c39c32653a90" xlink:to="loc_us-gaap_PropertyPlantAndEquipmentTypeDomain_84c1d513-450f-4b3a-b842-8429d41742b9" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_dmtk_AmortizationOfLaboratoryEquipmentAcquiredUnderFinanceLeasesMember_7a02c9e8-41dd-4f90-8fb8-4476a663494b" xlink:href="dmtk-20220630.xsd#dmtk_AmortizationOfLaboratoryEquipmentAcquiredUnderFinanceLeasesMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentTypeDomain_84c1d513-450f-4b3a-b842-8429d41742b9" xlink:to="loc_dmtk_AmortizationOfLaboratoryEquipmentAcquiredUnderFinanceLeasesMember_7a02c9e8-41dd-4f90-8fb8-4476a663494b" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_dmtk_AssetsHeldUnderFinanceLeasesMember_680df41e-de64-4a58-bef6-acd51f7f242f" xlink:href="dmtk-20220630.xsd#dmtk_AssetsHeldUnderFinanceLeasesMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentTypeDomain_84c1d513-450f-4b3a-b842-8429d41742b9" xlink:to="loc_dmtk_AssetsHeldUnderFinanceLeasesMember_680df41e-de64-4a58-bef6-acd51f7f242f" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeAxis_7ef1799a-aa46-4d9a-aa2a-f20a8d51ba8c" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_RangeAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_dmtk_TheCompanyAndSummaryOfItsSignificantAccountingPoliciesTable_95d7a53f-335f-4229-be81-79cd256ffc74" xlink:to="loc_srt_RangeAxis_7ef1799a-aa46-4d9a-aa2a-f20a8d51ba8c" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeMember_7ef1799a-aa46-4d9a-aa2a-f20a8d51ba8c_default" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_RangeMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_srt_RangeAxis_7ef1799a-aa46-4d9a-aa2a-f20a8d51ba8c" xlink:to="loc_srt_RangeMember_7ef1799a-aa46-4d9a-aa2a-f20a8d51ba8c_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeMember_ae02ff38-145b-456e-b2a5-700d276bd325" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_RangeMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_srt_RangeAxis_7ef1799a-aa46-4d9a-aa2a-f20a8d51ba8c" xlink:to="loc_srt_RangeMember_ae02ff38-145b-456e-b2a5-700d276bd325" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_MinimumMember_e565133e-8985-41ab-b07b-e477471102ec" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_MinimumMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_RangeMember_ae02ff38-145b-456e-b2a5-700d276bd325" xlink:to="loc_srt_MinimumMember_e565133e-8985-41ab-b07b-e477471102ec" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_MaximumMember_8df31568-0415-4ac5-b268-5e521a00d9c5" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_MaximumMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_RangeMember_ae02ff38-145b-456e-b2a5-700d276bd325" xlink:to="loc_srt_MaximumMember_8df31568-0415-4ac5-b268-5e521a00d9c5" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ProductOrServiceAxis_5557e068-9580-46a3-83df-b0251499fe39" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_ProductOrServiceAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_dmtk_TheCompanyAndSummaryOfItsSignificantAccountingPoliciesTable_95d7a53f-335f-4229-be81-79cd256ffc74" xlink:to="loc_srt_ProductOrServiceAxis_5557e068-9580-46a3-83df-b0251499fe39" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ProductsAndServicesDomain_5557e068-9580-46a3-83df-b0251499fe39_default" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_ProductsAndServicesDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_srt_ProductOrServiceAxis_5557e068-9580-46a3-83df-b0251499fe39" xlink:to="loc_srt_ProductsAndServicesDomain_5557e068-9580-46a3-83df-b0251499fe39_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ProductsAndServicesDomain_b45adba5-cd55-4e3e-9f8c-1a8d74e38982" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_ProductsAndServicesDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_srt_ProductOrServiceAxis_5557e068-9580-46a3-83df-b0251499fe39" xlink:to="loc_srt_ProductsAndServicesDomain_b45adba5-cd55-4e3e-9f8c-1a8d74e38982" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_dmtk_AssayMember_089982e5-b150-4147-99b0-43e09d29ddce" xlink:href="dmtk-20220630.xsd#dmtk_AssayMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_ProductsAndServicesDomain_b45adba5-cd55-4e3e-9f8c-1a8d74e38982" xlink:to="loc_dmtk_AssayMember_089982e5-b150-4147-99b0-43e09d29ddce" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_dmtk_ContractualActivitiesMember_fb8f2698-dd9e-4b1b-8aa5-e74acc21570e" xlink:href="dmtk-20220630.xsd#dmtk_ContractualActivitiesMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_ProductsAndServicesDomain_b45adba5-cd55-4e3e-9f8c-1a8d74e38982" xlink:to="loc_dmtk_ContractualActivitiesMember_fb8f2698-dd9e-4b1b-8aa5-e74acc21570e" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis_9b22764a-34fe-4cfb-b1bf-a63aaf5a3e42" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_dmtk_TheCompanyAndSummaryOfItsSignificantAccountingPoliciesTable_95d7a53f-335f-4229-be81-79cd256ffc74" xlink:to="loc_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis_9b22764a-34fe-4cfb-b1bf-a63aaf5a3e42" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AntidilutiveSecuritiesNameDomain_9b22764a-34fe-4cfb-b1bf-a63aaf5a3e42_default" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AntidilutiveSecuritiesNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis_9b22764a-34fe-4cfb-b1bf-a63aaf5a3e42" xlink:to="loc_us-gaap_AntidilutiveSecuritiesNameDomain_9b22764a-34fe-4cfb-b1bf-a63aaf5a3e42_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AntidilutiveSecuritiesNameDomain_cf3f621c-6a3c-4264-a64e-c8dad588553f" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AntidilutiveSecuritiesNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis_9b22764a-34fe-4cfb-b1bf-a63aaf5a3e42" xlink:to="loc_us-gaap_AntidilutiveSecuritiesNameDomain_cf3f621c-6a3c-4264-a64e-c8dad588553f" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_WarrantMember_6fabcf63-2dfc-4292-bfd3-ea7e9623df52" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_WarrantMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_AntidilutiveSecuritiesNameDomain_cf3f621c-6a3c-4264-a64e-c8dad588553f" xlink:to="loc_us-gaap_WarrantMember_6fabcf63-2dfc-4292-bfd3-ea7e9623df52" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_dmtk_StockOptionsAndRestrictedStockUnitsMember_fbdbc0be-ccc8-4d54-814b-4d1e7b1c5c12" xlink:href="dmtk-20220630.xsd#dmtk_StockOptionsAndRestrictedStockUnitsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_AntidilutiveSecuritiesNameDomain_cf3f621c-6a3c-4264-a64e-c8dad588553f" xlink:to="loc_dmtk_StockOptionsAndRestrictedStockUnitsMember_fbdbc0be-ccc8-4d54-814b-4d1e7b1c5c12" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueByFairValueHierarchyLevelAxis_1726d8fb-c4c1-45c0-ab8b-c2bbcb5c3fa6" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueByFairValueHierarchyLevelAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_dmtk_TheCompanyAndSummaryOfItsSignificantAccountingPoliciesTable_95d7a53f-335f-4229-be81-79cd256ffc74" xlink:to="loc_us-gaap_FairValueByFairValueHierarchyLevelAxis_1726d8fb-c4c1-45c0-ab8b-c2bbcb5c3fa6" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_1726d8fb-c4c1-45c0-ab8b-c2bbcb5c3fa6_default" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueMeasurementsFairValueHierarchyDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_FairValueByFairValueHierarchyLevelAxis_1726d8fb-c4c1-45c0-ab8b-c2bbcb5c3fa6" xlink:to="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_1726d8fb-c4c1-45c0-ab8b-c2bbcb5c3fa6_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_37c774ab-38e2-4021-9462-8afa8c1758fc" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueMeasurementsFairValueHierarchyDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_FairValueByFairValueHierarchyLevelAxis_1726d8fb-c4c1-45c0-ab8b-c2bbcb5c3fa6" xlink:to="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_37c774ab-38e2-4021-9462-8afa8c1758fc" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueInputsLevel1Member_7ad0da8b-0851-460c-b3d5-d7336b987b40" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueInputsLevel1Member"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_37c774ab-38e2-4021-9462-8afa8c1758fc" xlink:to="loc_us-gaap_FairValueInputsLevel1Member_7ad0da8b-0851-460c-b3d5-d7336b987b40" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BalanceSheetLocationAxis_36d9a5df-0262-48c1-bfcf-53daf46921c3" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BalanceSheetLocationAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_dmtk_TheCompanyAndSummaryOfItsSignificantAccountingPoliciesTable_95d7a53f-335f-4229-be81-79cd256ffc74" xlink:to="loc_us-gaap_BalanceSheetLocationAxis_36d9a5df-0262-48c1-bfcf-53daf46921c3" xlink:type="arc" order="6"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BalanceSheetLocationDomain_36d9a5df-0262-48c1-bfcf-53daf46921c3_default" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BalanceSheetLocationDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_BalanceSheetLocationAxis_36d9a5df-0262-48c1-bfcf-53daf46921c3" xlink:to="loc_us-gaap_BalanceSheetLocationDomain_36d9a5df-0262-48c1-bfcf-53daf46921c3_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BalanceSheetLocationDomain_2d19ac3a-bdd9-47b0-87de-0ad4e9bca9a5" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BalanceSheetLocationDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_BalanceSheetLocationAxis_36d9a5df-0262-48c1-bfcf-53daf46921c3" xlink:to="loc_us-gaap_BalanceSheetLocationDomain_2d19ac3a-bdd9-47b0-87de-0ad4e9bca9a5" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_dmtk_RestrictedCashMember_0e714c6c-a9e4-443d-b89c-c08750d80f1a" xlink:href="dmtk-20220630.xsd#dmtk_RestrictedCashMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BalanceSheetLocationDomain_2d19ac3a-bdd9-47b0-87de-0ad4e9bca9a5" xlink:to="loc_dmtk_RestrictedCashMember_0e714c6c-a9e4-443d-b89c-c08750d80f1a" xlink:type="arc" order="0"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://dermtech.com/role/TheCompanyandaSummaryofitsSignificantAccountingPoliciesScheduleofRevenuesDisaggregatedbyRevenueSourceDetails" xlink:type="simple" xlink:href="dmtk-20220630.xsd#TheCompanyandaSummaryofitsSignificantAccountingPoliciesScheduleofRevenuesDisaggregatedbyRevenueSourceDetails"/>
  <link:definitionLink xlink:role="http://dermtech.com/role/TheCompanyandaSummaryofitsSignificantAccountingPoliciesScheduleofRevenuesDisaggregatedbyRevenueSourceDetails" xlink:type="extended" id="i5a4b5b5e5a884cb1b08f40fa938f3a19_TheCompanyandaSummaryofitsSignificantAccountingPoliciesScheduleofRevenuesDisaggregatedbyRevenueSourceDetails">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisaggregationOfRevenueLineItems_5ef8eee2-8398-4fd5-ad8f-5e61c66ce689" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DisaggregationOfRevenueLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax_0952b5c2-a505-4af0-a8d2-ba22175ee89c" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DisaggregationOfRevenueLineItems_5ef8eee2-8398-4fd5-ad8f-5e61c66ce689" xlink:to="loc_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax_0952b5c2-a505-4af0-a8d2-ba22175ee89c" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisaggregationOfRevenueTable_31907cb3-c412-4a6a-9de6-e6eec1ed7e97" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DisaggregationOfRevenueTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_DisaggregationOfRevenueLineItems_5ef8eee2-8398-4fd5-ad8f-5e61c66ce689" xlink:to="loc_us-gaap_DisaggregationOfRevenueTable_31907cb3-c412-4a6a-9de6-e6eec1ed7e97" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ProductOrServiceAxis_8fb942e0-b7d4-48d6-8a78-c108cc5a1358" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_ProductOrServiceAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_DisaggregationOfRevenueTable_31907cb3-c412-4a6a-9de6-e6eec1ed7e97" xlink:to="loc_srt_ProductOrServiceAxis_8fb942e0-b7d4-48d6-8a78-c108cc5a1358" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ProductsAndServicesDomain_8fb942e0-b7d4-48d6-8a78-c108cc5a1358_default" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_ProductsAndServicesDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_srt_ProductOrServiceAxis_8fb942e0-b7d4-48d6-8a78-c108cc5a1358" xlink:to="loc_srt_ProductsAndServicesDomain_8fb942e0-b7d4-48d6-8a78-c108cc5a1358_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ProductsAndServicesDomain_0b5a9965-3348-424e-8e70-11910f018739" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_ProductsAndServicesDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_srt_ProductOrServiceAxis_8fb942e0-b7d4-48d6-8a78-c108cc5a1358" xlink:to="loc_srt_ProductsAndServicesDomain_0b5a9965-3348-424e-8e70-11910f018739" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_dmtk_AssayMember_4bdc7221-fa00-48e8-a83d-ac0071e6e7e0" xlink:href="dmtk-20220630.xsd#dmtk_AssayMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_ProductsAndServicesDomain_0b5a9965-3348-424e-8e70-11910f018739" xlink:to="loc_dmtk_AssayMember_4bdc7221-fa00-48e8-a83d-ac0071e6e7e0" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_dmtk_ContractRevenueAdhesivePatchKitsMember_d85e3ad1-aeb4-4611-b299-37c9a5f0b2ab" xlink:href="dmtk-20220630.xsd#dmtk_ContractRevenueAdhesivePatchKitsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_ProductsAndServicesDomain_0b5a9965-3348-424e-8e70-11910f018739" xlink:to="loc_dmtk_ContractRevenueAdhesivePatchKitsMember_d85e3ad1-aeb4-4611-b299-37c9a5f0b2ab" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_dmtk_ContractRevenueRNAExtractionsMember_2c51686f-7537-4660-a298-25a295d128c6" xlink:href="dmtk-20220630.xsd#dmtk_ContractRevenueRNAExtractionsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_ProductsAndServicesDomain_0b5a9965-3348-424e-8e70-11910f018739" xlink:to="loc_dmtk_ContractRevenueRNAExtractionsMember_2c51686f-7537-4660-a298-25a295d128c6" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_dmtk_ContractRevenueProjectManagementFeesMember_ff422d0b-9e30-4645-89fb-ca63b862cf40" xlink:href="dmtk-20220630.xsd#dmtk_ContractRevenueProjectManagementFeesMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_ProductsAndServicesDomain_0b5a9965-3348-424e-8e70-11910f018739" xlink:to="loc_dmtk_ContractRevenueProjectManagementFeesMember_ff422d0b-9e30-4645-89fb-ca63b862cf40" xlink:type="arc" order="3"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://dermtech.com/role/TheCompanyandaSummaryofitsSignificantAccountingPoliciesSummaryofPercentagesofTotalRevenueorAccountsReceivableforThirdPartyPayersandPharmaceuticalCustomersDetails" xlink:type="simple" xlink:href="dmtk-20220630.xsd#TheCompanyandaSummaryofitsSignificantAccountingPoliciesSummaryofPercentagesofTotalRevenueorAccountsReceivableforThirdPartyPayersandPharmaceuticalCustomersDetails"/>
  <link:definitionLink xlink:role="http://dermtech.com/role/TheCompanyandaSummaryofitsSignificantAccountingPoliciesSummaryofPercentagesofTotalRevenueorAccountsReceivableforThirdPartyPayersandPharmaceuticalCustomersDetails" xlink:type="extended" id="i4f060c37ff76464394daf3b8acfd5c77_TheCompanyandaSummaryofitsSignificantAccountingPoliciesSummaryofPercentagesofTotalRevenueorAccountsReceivableforThirdPartyPayersandPharmaceuticalCustomersDetails">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProductInformationLineItems_2d59d880-d4b4-4cfa-a22b-96ce99ff3b56" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ProductInformationLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ConcentrationRiskPercentage1_bf6212de-8734-4d98-ba05-821acd5b8ca0" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ConcentrationRiskPercentage1"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ProductInformationLineItems_2d59d880-d4b4-4cfa-a22b-96ce99ff3b56" xlink:to="loc_us-gaap_ConcentrationRiskPercentage1_bf6212de-8734-4d98-ba05-821acd5b8ca0" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfProductInformationTable_cd66229b-81e0-4515-952e-56bbf18b0068" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfProductInformationTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_ProductInformationLineItems_2d59d880-d4b4-4cfa-a22b-96ce99ff3b56" xlink:to="loc_us-gaap_ScheduleOfProductInformationTable_cd66229b-81e0-4515-952e-56bbf18b0068" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ConcentrationRiskByBenchmarkAxis_f12ef6c8-0fe9-4160-baed-3941f0de8455" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ConcentrationRiskByBenchmarkAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfProductInformationTable_cd66229b-81e0-4515-952e-56bbf18b0068" xlink:to="loc_us-gaap_ConcentrationRiskByBenchmarkAxis_f12ef6c8-0fe9-4160-baed-3941f0de8455" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ConcentrationRiskBenchmarkDomain_f12ef6c8-0fe9-4160-baed-3941f0de8455_default" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ConcentrationRiskBenchmarkDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_ConcentrationRiskByBenchmarkAxis_f12ef6c8-0fe9-4160-baed-3941f0de8455" xlink:to="loc_us-gaap_ConcentrationRiskBenchmarkDomain_f12ef6c8-0fe9-4160-baed-3941f0de8455_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ConcentrationRiskBenchmarkDomain_4b40fa93-04cf-45d6-8c22-ba96151cfac3" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ConcentrationRiskBenchmarkDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_ConcentrationRiskByBenchmarkAxis_f12ef6c8-0fe9-4160-baed-3941f0de8455" xlink:to="loc_us-gaap_ConcentrationRiskBenchmarkDomain_4b40fa93-04cf-45d6-8c22-ba96151cfac3" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SalesRevenueNetMember_4881dee4-f86d-4a1f-a83c-b96e654cb4f2" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SalesRevenueNetMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ConcentrationRiskBenchmarkDomain_4b40fa93-04cf-45d6-8c22-ba96151cfac3" xlink:to="loc_us-gaap_SalesRevenueNetMember_4881dee4-f86d-4a1f-a83c-b96e654cb4f2" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccountsReceivableMember_f48674ef-23c9-4b40-ab01-f263499ea8f9" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AccountsReceivableMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ConcentrationRiskBenchmarkDomain_4b40fa93-04cf-45d6-8c22-ba96151cfac3" xlink:to="loc_us-gaap_AccountsReceivableMember_f48674ef-23c9-4b40-ab01-f263499ea8f9" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ProductOrServiceAxis_1131902d-5360-495f-956f-1f0f9bbac197" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_ProductOrServiceAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfProductInformationTable_cd66229b-81e0-4515-952e-56bbf18b0068" xlink:to="loc_srt_ProductOrServiceAxis_1131902d-5360-495f-956f-1f0f9bbac197" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ProductsAndServicesDomain_1131902d-5360-495f-956f-1f0f9bbac197_default" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_ProductsAndServicesDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_srt_ProductOrServiceAxis_1131902d-5360-495f-956f-1f0f9bbac197" xlink:to="loc_srt_ProductsAndServicesDomain_1131902d-5360-495f-956f-1f0f9bbac197_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ProductsAndServicesDomain_41cc4632-ef30-4e47-9cc1-79c42e9f8da9" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_ProductsAndServicesDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_srt_ProductOrServiceAxis_1131902d-5360-495f-956f-1f0f9bbac197" xlink:to="loc_srt_ProductsAndServicesDomain_41cc4632-ef30-4e47-9cc1-79c42e9f8da9" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_dmtk_AssayRevenuePayorAMember_65271da8-fdc8-4091-b8cf-d0f8a6365414" xlink:href="dmtk-20220630.xsd#dmtk_AssayRevenuePayorAMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_ProductsAndServicesDomain_41cc4632-ef30-4e47-9cc1-79c42e9f8da9" xlink:to="loc_dmtk_AssayRevenuePayorAMember_65271da8-fdc8-4091-b8cf-d0f8a6365414" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_dmtk_AssayRevenuePayorBMember_fb670133-f9a6-421c-8a93-e588dd2b6ea6" xlink:href="dmtk-20220630.xsd#dmtk_AssayRevenuePayorBMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_ProductsAndServicesDomain_41cc4632-ef30-4e47-9cc1-79c42e9f8da9" xlink:to="loc_dmtk_AssayRevenuePayorBMember_fb670133-f9a6-421c-8a93-e588dd2b6ea6" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ConcentrationRiskByTypeAxis_cfd11759-d744-40c6-be16-7f93eea3a1d4" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ConcentrationRiskByTypeAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfProductInformationTable_cd66229b-81e0-4515-952e-56bbf18b0068" xlink:to="loc_us-gaap_ConcentrationRiskByTypeAxis_cfd11759-d744-40c6-be16-7f93eea3a1d4" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ConcentrationRiskTypeDomain_cfd11759-d744-40c6-be16-7f93eea3a1d4_default" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ConcentrationRiskTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_ConcentrationRiskByTypeAxis_cfd11759-d744-40c6-be16-7f93eea3a1d4" xlink:to="loc_us-gaap_ConcentrationRiskTypeDomain_cfd11759-d744-40c6-be16-7f93eea3a1d4_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ConcentrationRiskTypeDomain_43f9c02f-7401-42a7-828b-8f9ee4d0ee64" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ConcentrationRiskTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_ConcentrationRiskByTypeAxis_cfd11759-d744-40c6-be16-7f93eea3a1d4" xlink:to="loc_us-gaap_ConcentrationRiskTypeDomain_43f9c02f-7401-42a7-828b-8f9ee4d0ee64" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CustomerConcentrationRiskMember_ea7a3d48-2cb7-4970-afa4-b9fcccb60599" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CustomerConcentrationRiskMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ConcentrationRiskTypeDomain_43f9c02f-7401-42a7-828b-8f9ee4d0ee64" xlink:to="loc_us-gaap_CustomerConcentrationRiskMember_ea7a3d48-2cb7-4970-afa4-b9fcccb60599" xlink:type="arc" order="0"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://dermtech.com/role/TheCompanyandaSummaryofitsSignificantAccountingPoliciesSummaryofAssetsandLiabilitiesMeasuredatFairValueonRecurringBasisDetails" xlink:type="simple" xlink:href="dmtk-20220630.xsd#TheCompanyandaSummaryofitsSignificantAccountingPoliciesSummaryofAssetsandLiabilitiesMeasuredatFairValueonRecurringBasisDetails"/>
  <link:definitionLink xlink:role="http://dermtech.com/role/TheCompanyandaSummaryofitsSignificantAccountingPoliciesSummaryofAssetsandLiabilitiesMeasuredatFairValueonRecurringBasisDetails" xlink:type="extended" id="i8b68193efa7648abbeefec8570fa983c_TheCompanyandaSummaryofitsSignificantAccountingPoliciesSummaryofAssetsandLiabilitiesMeasuredatFairValueonRecurringBasisDetails">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems_d9a598e3-7abb-4128-9854-0d6a3d85e0ea" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AssetsFairValueDisclosureAbstract_73afe5f2-1dd8-4248-b4e8-ffc91751cca5" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AssetsFairValueDisclosureAbstract"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems_d9a598e3-7abb-4128-9854-0d6a3d85e0ea" xlink:to="loc_us-gaap_AssetsFairValueDisclosureAbstract_73afe5f2-1dd8-4248-b4e8-ffc91751cca5" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashEquivalentsAtCarryingValue_b7be46ed-3b5a-4d61-bbfa-db3193d75efb" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CashEquivalentsAtCarryingValue"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_AssetsFairValueDisclosureAbstract_73afe5f2-1dd8-4248-b4e8-ffc91751cca5" xlink:to="loc_us-gaap_CashEquivalentsAtCarryingValue_b7be46ed-3b5a-4d61-bbfa-db3193d75efb" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestrictedCashNoncurrent_81ddaa82-ce5e-49e6-9cb8-7ada8ac78a04" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RestrictedCashNoncurrent"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_AssetsFairValueDisclosureAbstract_73afe5f2-1dd8-4248-b4e8-ffc91751cca5" xlink:to="loc_us-gaap_RestrictedCashNoncurrent_81ddaa82-ce5e-49e6-9cb8-7ada8ac78a04" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InvestmentsFairValueDisclosureAbstract_3d4756fb-8fe6-4f6f-98aa-373132f045e2" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_InvestmentsFairValueDisclosureAbstract"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_AssetsFairValueDisclosureAbstract_73afe5f2-1dd8-4248-b4e8-ffc91751cca5" xlink:to="loc_us-gaap_InvestmentsFairValueDisclosureAbstract_3d4756fb-8fe6-4f6f-98aa-373132f045e2" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AvailableForSaleSecuritiesDebtSecurities_47d82b68-9cbd-4438-866f-4564d9ba361c" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AvailableForSaleSecuritiesDebtSecurities"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_InvestmentsFairValueDisclosureAbstract_3d4756fb-8fe6-4f6f-98aa-373132f045e2" xlink:to="loc_us-gaap_AvailableForSaleSecuritiesDebtSecurities_47d82b68-9cbd-4438-866f-4564d9ba361c" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AssetsFairValueDisclosure_1e4710de-54d1-4801-961b-1886c4227f41" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AssetsFairValueDisclosure"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_AssetsFairValueDisclosureAbstract_73afe5f2-1dd8-4248-b4e8-ffc91751cca5" xlink:to="loc_us-gaap_AssetsFairValueDisclosure_1e4710de-54d1-4801-961b-1886c4227f41" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilitiesFairValueDisclosureAbstract_18f6f9e6-cc8c-41bf-aa25-3849e43f827c" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LiabilitiesFairValueDisclosureAbstract"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems_d9a598e3-7abb-4128-9854-0d6a3d85e0ea" xlink:to="loc_us-gaap_LiabilitiesFairValueDisclosureAbstract_18f6f9e6-cc8c-41bf-aa25-3849e43f827c" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_dmtk_WarrantLiabilityFairValueDisclosure_3ad25e3a-b56e-42a7-8865-cf67b6f83a49" xlink:href="dmtk-20220630.xsd#dmtk_WarrantLiabilityFairValueDisclosure"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LiabilitiesFairValueDisclosureAbstract_18f6f9e6-cc8c-41bf-aa25-3849e43f827c" xlink:to="loc_dmtk_WarrantLiabilityFairValueDisclosure_3ad25e3a-b56e-42a7-8865-cf67b6f83a49" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilitiesFairValueDisclosure_ab9eb4ce-43a7-4121-9869-a4e81e2be85c" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LiabilitiesFairValueDisclosure"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LiabilitiesFairValueDisclosureAbstract_18f6f9e6-cc8c-41bf-aa25-3849e43f827c" xlink:to="loc_us-gaap_LiabilitiesFairValueDisclosure_ab9eb4ce-43a7-4121-9869-a4e81e2be85c" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable_7384285f-1ae4-404b-a97f-bebef0062cb7" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems_d9a598e3-7abb-4128-9854-0d6a3d85e0ea" xlink:to="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable_7384285f-1ae4-404b-a97f-bebef0062cb7" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FinancialInstrumentAxis_a684fd69-feb9-462f-b238-5a63a0e588a7" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FinancialInstrumentAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable_7384285f-1ae4-404b-a97f-bebef0062cb7" xlink:to="loc_us-gaap_FinancialInstrumentAxis_a684fd69-feb9-462f-b238-5a63a0e588a7" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_a684fd69-feb9-462f-b238-5a63a0e588a7_default" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_FinancialInstrumentAxis_a684fd69-feb9-462f-b238-5a63a0e588a7" xlink:to="loc_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_a684fd69-feb9-462f-b238-5a63a0e588a7_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_e9c8d67f-49d8-4b83-994c-18f009a2ef44" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_FinancialInstrumentAxis_a684fd69-feb9-462f-b238-5a63a0e588a7" xlink:to="loc_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_e9c8d67f-49d8-4b83-994c-18f009a2ef44" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CorporateDebtSecuritiesMember_5a59a329-db41-4eb2-a504-06b48050e83f" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CorporateDebtSecuritiesMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_e9c8d67f-49d8-4b83-994c-18f009a2ef44" xlink:to="loc_us-gaap_CorporateDebtSecuritiesMember_5a59a329-db41-4eb2-a504-06b48050e83f" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_MunicipalNotesMember_d9ec53c8-a8bf-4694-aae4-50ef3becdbaa" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_MunicipalNotesMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_e9c8d67f-49d8-4b83-994c-18f009a2ef44" xlink:to="loc_us-gaap_MunicipalNotesMember_d9ec53c8-a8bf-4694-aae4-50ef3becdbaa" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_USGovernmentAgenciesShorttermDebtSecuritiesMember_91ee0851-c057-4cfb-b8fc-8b1f5f066d62" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_USGovernmentAgenciesShorttermDebtSecuritiesMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_e9c8d67f-49d8-4b83-994c-18f009a2ef44" xlink:to="loc_us-gaap_USGovernmentAgenciesShorttermDebtSecuritiesMember_91ee0851-c057-4cfb-b8fc-8b1f5f066d62" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueByMeasurementFrequencyAxis_5267ab25-acb5-4af8-b960-605140ebe4e0" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueByMeasurementFrequencyAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable_7384285f-1ae4-404b-a97f-bebef0062cb7" xlink:to="loc_us-gaap_FairValueByMeasurementFrequencyAxis_5267ab25-acb5-4af8-b960-605140ebe4e0" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueMeasurementFrequencyDomain_5267ab25-acb5-4af8-b960-605140ebe4e0_default" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueMeasurementFrequencyDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_FairValueByMeasurementFrequencyAxis_5267ab25-acb5-4af8-b960-605140ebe4e0" xlink:to="loc_us-gaap_FairValueMeasurementFrequencyDomain_5267ab25-acb5-4af8-b960-605140ebe4e0_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueMeasurementFrequencyDomain_1c51a0a1-1c79-465e-a528-2cd9e5a79d90" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueMeasurementFrequencyDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_FairValueByMeasurementFrequencyAxis_5267ab25-acb5-4af8-b960-605140ebe4e0" xlink:to="loc_us-gaap_FairValueMeasurementFrequencyDomain_1c51a0a1-1c79-465e-a528-2cd9e5a79d90" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueMeasurementsRecurringMember_0c2e8a74-0641-4fcd-813c-eae4115b0cc7" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueMeasurementsRecurringMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FairValueMeasurementFrequencyDomain_1c51a0a1-1c79-465e-a528-2cd9e5a79d90" xlink:to="loc_us-gaap_FairValueMeasurementsRecurringMember_0c2e8a74-0641-4fcd-813c-eae4115b0cc7" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueByFairValueHierarchyLevelAxis_c076d943-ad67-4fd5-8026-50cacfb2c3ce" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueByFairValueHierarchyLevelAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable_7384285f-1ae4-404b-a97f-bebef0062cb7" xlink:to="loc_us-gaap_FairValueByFairValueHierarchyLevelAxis_c076d943-ad67-4fd5-8026-50cacfb2c3ce" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_c076d943-ad67-4fd5-8026-50cacfb2c3ce_default" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueMeasurementsFairValueHierarchyDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_FairValueByFairValueHierarchyLevelAxis_c076d943-ad67-4fd5-8026-50cacfb2c3ce" xlink:to="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_c076d943-ad67-4fd5-8026-50cacfb2c3ce_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_8ac27ac8-6dbc-4697-a7cb-919fa71b7055" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueMeasurementsFairValueHierarchyDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_FairValueByFairValueHierarchyLevelAxis_c076d943-ad67-4fd5-8026-50cacfb2c3ce" xlink:to="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_8ac27ac8-6dbc-4697-a7cb-919fa71b7055" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueInputsLevel1Member_268b586d-152c-4f6e-9fc2-e8dad47864ad" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueInputsLevel1Member"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_8ac27ac8-6dbc-4697-a7cb-919fa71b7055" xlink:to="loc_us-gaap_FairValueInputsLevel1Member_268b586d-152c-4f6e-9fc2-e8dad47864ad" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueInputsLevel2Member_e2295045-c8e3-4e56-bb6e-be7b79f9f7df" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueInputsLevel2Member"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_8ac27ac8-6dbc-4697-a7cb-919fa71b7055" xlink:to="loc_us-gaap_FairValueInputsLevel2Member_e2295045-c8e3-4e56-bb6e-be7b79f9f7df" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueInputsLevel3Member_af6c5e99-a2a1-4257-b830-efc58d40d128" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueInputsLevel3Member"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_8ac27ac8-6dbc-4697-a7cb-919fa71b7055" xlink:to="loc_us-gaap_FairValueInputsLevel3Member_af6c5e99-a2a1-4257-b830-efc58d40d128" xlink:type="arc" order="2"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://dermtech.com/role/TheCompanyandaSummaryofitsSignificantAccountingPoliciesAssumptionsUsedtoDetermineFairValueofEachOptiononDateofGrantIssuedDetails" xlink:type="simple" xlink:href="dmtk-20220630.xsd#TheCompanyandaSummaryofitsSignificantAccountingPoliciesAssumptionsUsedtoDetermineFairValueofEachOptiononDateofGrantIssuedDetails"/>
  <link:definitionLink xlink:role="http://dermtech.com/role/TheCompanyandaSummaryofitsSignificantAccountingPoliciesAssumptionsUsedtoDetermineFairValueofEachOptiononDateofGrantIssuedDetails" xlink:type="extended" id="i3ed1bb37b88544aa9af498bfb0ca4ccd_TheCompanyandaSummaryofitsSignificantAccountingPoliciesAssumptionsUsedtoDetermineFairValueofEachOptiononDateofGrantIssuedDetails">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_2f43c406-f7ac-4b4a-b065-b91ea6487ecf" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate_80dbe40d-66f9-48c4-b01e-ad7b51ecedeb" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_2f43c406-f7ac-4b4a-b065-b91ea6487ecf" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate_80dbe40d-66f9-48c4-b01e-ad7b51ecedeb" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMinimum_6f97c29a-2fce-428c-b330-026005dc4e55" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMinimum"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_2f43c406-f7ac-4b4a-b065-b91ea6487ecf" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMinimum_6f97c29a-2fce-428c-b330-026005dc4e55" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMaximum_3bbb8b0d-487a-4dcc-8419-8e9c67eb8d92" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMaximum"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_2f43c406-f7ac-4b4a-b065-b91ea6487ecf" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMaximum_3bbb8b0d-487a-4dcc-8419-8e9c67eb8d92" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate_f6f9f7ef-5276-41ba-bedf-bfd68df93245" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_2f43c406-f7ac-4b4a-b065-b91ea6487ecf" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate_f6f9f7ef-5276-41ba-bedf-bfd68df93245" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRateMinimum_f6c1e952-ff05-48b6-a6ba-de7e9d6e19c1" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRateMinimum"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_2f43c406-f7ac-4b4a-b065-b91ea6487ecf" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRateMinimum_f6c1e952-ff05-48b6-a6ba-de7e9d6e19c1" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRateMaximum_f02764ef-9a04-4f62-a0dd-d736cecc9ab0" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRateMaximum"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_2f43c406-f7ac-4b4a-b065-b91ea6487ecf" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRateMaximum_f02764ef-9a04-4f62-a0dd-d736cecc9ab0" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1_83540962-79f0-4737-b9ae-661cd852521a" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_2f43c406-f7ac-4b4a-b065-b91ea6487ecf" xlink:to="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1_83540962-79f0-4737-b9ae-661cd852521a" xlink:type="arc" order="6"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate_31d33db1-225f-47f6-b5f2-98cd3112389c" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_2f43c406-f7ac-4b4a-b065-b91ea6487ecf" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate_31d33db1-225f-47f6-b5f2-98cd3112389c" xlink:type="arc" order="7"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_9c52e45c-8fde-432b-bc2d-d6e85dbbba5c" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_2f43c406-f7ac-4b4a-b065-b91ea6487ecf" xlink:to="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_9c52e45c-8fde-432b-bc2d-d6e85dbbba5c" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeAxis_d8899e4e-7499-4950-8b83-911afcddac6f" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_RangeAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_9c52e45c-8fde-432b-bc2d-d6e85dbbba5c" xlink:to="loc_srt_RangeAxis_d8899e4e-7499-4950-8b83-911afcddac6f" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeMember_d8899e4e-7499-4950-8b83-911afcddac6f_default" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_RangeMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_srt_RangeAxis_d8899e4e-7499-4950-8b83-911afcddac6f" xlink:to="loc_srt_RangeMember_d8899e4e-7499-4950-8b83-911afcddac6f_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeMember_1815cf0a-5ca8-4b37-a859-24fa074f0dca" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_RangeMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_srt_RangeAxis_d8899e4e-7499-4950-8b83-911afcddac6f" xlink:to="loc_srt_RangeMember_1815cf0a-5ca8-4b37-a859-24fa074f0dca" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_MinimumMember_cd0cd1d7-cebd-44b3-bbcd-9348d4f95ddf" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_MinimumMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_RangeMember_1815cf0a-5ca8-4b37-a859-24fa074f0dca" xlink:to="loc_srt_MinimumMember_cd0cd1d7-cebd-44b3-bbcd-9348d4f95ddf" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_MaximumMember_7dcc3e5f-0829-473a-80eb-9c69d2ebe00f" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_MaximumMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_RangeMember_1815cf0a-5ca8-4b37-a859-24fa074f0dca" xlink:to="loc_srt_MaximumMember_7dcc3e5f-0829-473a-80eb-9c69d2ebe00f" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FinancialInstrumentAxis_9e670f38-4423-4f5c-b600-15ecd68dcd3a" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FinancialInstrumentAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_9c52e45c-8fde-432b-bc2d-d6e85dbbba5c" xlink:to="loc_us-gaap_FinancialInstrumentAxis_9e670f38-4423-4f5c-b600-15ecd68dcd3a" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_9e670f38-4423-4f5c-b600-15ecd68dcd3a_default" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_FinancialInstrumentAxis_9e670f38-4423-4f5c-b600-15ecd68dcd3a" xlink:to="loc_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_9e670f38-4423-4f5c-b600-15ecd68dcd3a_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_7ba25e10-fa45-4718-9850-c0f302a5f5d1" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_FinancialInstrumentAxis_9e670f38-4423-4f5c-b600-15ecd68dcd3a" xlink:to="loc_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_7ba25e10-fa45-4718-9850-c0f302a5f5d1" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_WarrantyRightsAndObligationsFairValueOptionMember_9e362d40-8421-43d7-9de5-1a3c9fbfcbd7" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_WarrantyRightsAndObligationsFairValueOptionMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_7ba25e10-fa45-4718-9850-c0f302a5f5d1" xlink:to="loc_us-gaap_WarrantyRightsAndObligationsFairValueOptionMember_9e362d40-8421-43d7-9de5-1a3c9fbfcbd7" xlink:type="arc" order="0"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://dermtech.com/role/TheCompanyandaSummaryofitsSignificantAccountingPoliciesSummaryofChangesinFairValueofLevel3LiabilitiesDetails" xlink:type="simple" xlink:href="dmtk-20220630.xsd#TheCompanyandaSummaryofitsSignificantAccountingPoliciesSummaryofChangesinFairValueofLevel3LiabilitiesDetails"/>
  <link:definitionLink xlink:role="http://dermtech.com/role/TheCompanyandaSummaryofitsSignificantAccountingPoliciesSummaryofChangesinFairValueofLevel3LiabilitiesDetails" xlink:type="extended" id="i3f6ec2d28c274ba6bb05eeb64ba15c08_TheCompanyandaSummaryofitsSignificantAccountingPoliciesSummaryofChangesinFairValueofLevel3LiabilitiesDetails">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationLineItems_7cecc0fe-76d0-4f65-8e97-61ebbae2f340" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationCalculationRollForward_208c6ecd-8623-4c08-b61d-2c4ebdf58626" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationCalculationRollForward"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationLineItems_7cecc0fe-76d0-4f65-8e97-61ebbae2f340" xlink:to="loc_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationCalculationRollForward_208c6ecd-8623-4c08-b61d-2c4ebdf58626" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue_771ffc77-1294-440b-b834-8bed1e7207ac" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationCalculationRollForward_208c6ecd-8623-4c08-b61d-2c4ebdf58626" xlink:to="loc_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue_771ffc77-1294-440b-b834-8bed1e7207ac" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityGainLossIncludedInEarnings_b2dddcb0-9948-4376-89ff-410e6d166d62" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityGainLossIncludedInEarnings"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationCalculationRollForward_208c6ecd-8623-4c08-b61d-2c4ebdf58626" xlink:to="loc_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityGainLossIncludedInEarnings_b2dddcb0-9948-4376-89ff-410e6d166d62" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue_1f424ea3-850b-4b87-a00e-4bf2f86ee70b" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationTable_a38b2232-cf07-4f25-8ce3-e0f1d1d12a79" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationLineItems_7cecc0fe-76d0-4f65-8e97-61ebbae2f340" xlink:to="loc_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationTable_a38b2232-cf07-4f25-8ce3-e0f1d1d12a79" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueByFairValueHierarchyLevelAxis_87445397-af94-4889-b8e9-64296983a1ce" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueByFairValueHierarchyLevelAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationTable_a38b2232-cf07-4f25-8ce3-e0f1d1d12a79" xlink:to="loc_us-gaap_FairValueByFairValueHierarchyLevelAxis_87445397-af94-4889-b8e9-64296983a1ce" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_87445397-af94-4889-b8e9-64296983a1ce_default" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueMeasurementsFairValueHierarchyDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_FairValueByFairValueHierarchyLevelAxis_87445397-af94-4889-b8e9-64296983a1ce" xlink:to="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_87445397-af94-4889-b8e9-64296983a1ce_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_43f5fc5a-b4fc-49c6-baa2-75ea5a30a846" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueMeasurementsFairValueHierarchyDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_FairValueByFairValueHierarchyLevelAxis_87445397-af94-4889-b8e9-64296983a1ce" xlink:to="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_43f5fc5a-b4fc-49c6-baa2-75ea5a30a846" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueInputsLevel3Member_f00931fe-5fbd-480a-a710-1d19ad17c647" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueInputsLevel3Member"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_43f5fc5a-b4fc-49c6-baa2-75ea5a30a846" xlink:to="loc_us-gaap_FairValueInputsLevel3Member_f00931fe-5fbd-480a-a710-1d19ad17c647" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueByLiabilityClassAxis_a4f1c219-bfe1-4bdf-b272-c1c6777c3469" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueByLiabilityClassAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationTable_a38b2232-cf07-4f25-8ce3-e0f1d1d12a79" xlink:to="loc_us-gaap_FairValueByLiabilityClassAxis_a4f1c219-bfe1-4bdf-b272-c1c6777c3469" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationByLiabilityClassDomain_a4f1c219-bfe1-4bdf-b272-c1c6777c3469_default" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationByLiabilityClassDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_FairValueByLiabilityClassAxis_a4f1c219-bfe1-4bdf-b272-c1c6777c3469" xlink:to="loc_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationByLiabilityClassDomain_a4f1c219-bfe1-4bdf-b272-c1c6777c3469_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationByLiabilityClassDomain_3a8ef555-77a1-4cca-8e11-5f6386ba2978" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationByLiabilityClassDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_FairValueByLiabilityClassAxis_a4f1c219-bfe1-4bdf-b272-c1c6777c3469" xlink:to="loc_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationByLiabilityClassDomain_3a8ef555-77a1-4cca-8e11-5f6386ba2978" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_dmtk_WarrantLiabilityMember_33e13ba0-a31c-49ce-bfc8-8da735682c69" xlink:href="dmtk-20220630.xsd#dmtk_WarrantLiabilityMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationByLiabilityClassDomain_3a8ef555-77a1-4cca-8e11-5f6386ba2978" xlink:to="loc_dmtk_WarrantLiabilityMember_33e13ba0-a31c-49ce-bfc8-8da735682c69" xlink:type="arc" order="0"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://dermtech.com/role/BalanceSheetDetailsScheduleofShortTermMarketableSecuritiesDetails" xlink:type="simple" xlink:href="dmtk-20220630.xsd#BalanceSheetDetailsScheduleofShortTermMarketableSecuritiesDetails"/>
  <link:definitionLink xlink:role="http://dermtech.com/role/BalanceSheetDetailsScheduleofShortTermMarketableSecuritiesDetails" xlink:type="extended" id="i1eaebda7f014409b91a6ebc535610ab9_BalanceSheetDetailsScheduleofShortTermMarketableSecuritiesDetails">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InvestmentHoldingsLineItems_18800c31-6235-4f71-9c5f-cf460bf618e6" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_InvestmentHoldingsLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AvailableForSaleDebtSecuritiesAmortizedCostBasis_b2c5abed-7932-45fa-92cb-808ba169abda" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AvailableForSaleDebtSecuritiesAmortizedCostBasis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_InvestmentHoldingsLineItems_18800c31-6235-4f71-9c5f-cf460bf618e6" xlink:to="loc_us-gaap_AvailableForSaleDebtSecuritiesAmortizedCostBasis_b2c5abed-7932-45fa-92cb-808ba169abda" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax_95be59cd-5db4-46ab-87c0-b2236631aac8" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_InvestmentHoldingsLineItems_18800c31-6235-4f71-9c5f-cf460bf618e6" xlink:to="loc_us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax_95be59cd-5db4-46ab-87c0-b2236631aac8" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax_4b2aae84-e2e4-4ffb-a62d-4fad59e969d1" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_InvestmentHoldingsLineItems_18800c31-6235-4f71-9c5f-cf460bf618e6" xlink:to="loc_us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax_4b2aae84-e2e4-4ffb-a62d-4fad59e969d1" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AvailableForSaleSecuritiesDebtSecurities_ec6bae7d-f84e-431b-b960-f81128f9a5dc" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AvailableForSaleSecuritiesDebtSecurities"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_InvestmentHoldingsLineItems_18800c31-6235-4f71-9c5f-cf460bf618e6" xlink:to="loc_us-gaap_AvailableForSaleSecuritiesDebtSecurities_ec6bae7d-f84e-431b-b960-f81128f9a5dc" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InvestmentHoldingsTable_e86812f8-3125-487c-954d-0c0afa5b0766" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_InvestmentHoldingsTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_InvestmentHoldingsLineItems_18800c31-6235-4f71-9c5f-cf460bf618e6" xlink:to="loc_us-gaap_InvestmentHoldingsTable_e86812f8-3125-487c-954d-0c0afa5b0766" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FinancialInstrumentAxis_2450a858-cf51-43df-9bef-fd71f15a85f7" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FinancialInstrumentAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_InvestmentHoldingsTable_e86812f8-3125-487c-954d-0c0afa5b0766" xlink:to="loc_us-gaap_FinancialInstrumentAxis_2450a858-cf51-43df-9bef-fd71f15a85f7" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_2450a858-cf51-43df-9bef-fd71f15a85f7_default" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_FinancialInstrumentAxis_2450a858-cf51-43df-9bef-fd71f15a85f7" xlink:to="loc_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_2450a858-cf51-43df-9bef-fd71f15a85f7_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_9eb0a980-473b-4736-83b8-eb1d0b27ffc8" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_FinancialInstrumentAxis_2450a858-cf51-43df-9bef-fd71f15a85f7" xlink:to="loc_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_9eb0a980-473b-4736-83b8-eb1d0b27ffc8" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CorporateDebtSecuritiesMember_5b028946-ceb3-46d9-a46f-f769441fbda4" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CorporateDebtSecuritiesMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_9eb0a980-473b-4736-83b8-eb1d0b27ffc8" xlink:to="loc_us-gaap_CorporateDebtSecuritiesMember_5b028946-ceb3-46d9-a46f-f769441fbda4" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_MunicipalNotesMember_4d916c72-e579-4a7c-bd55-a4d1debd7a27" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_MunicipalNotesMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_9eb0a980-473b-4736-83b8-eb1d0b27ffc8" xlink:to="loc_us-gaap_MunicipalNotesMember_4d916c72-e579-4a7c-bd55-a4d1debd7a27" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_USGovernmentAgenciesShorttermDebtSecuritiesMember_adf95cd4-4767-48ee-bd2b-fadc21608239" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_USGovernmentAgenciesShorttermDebtSecuritiesMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_9eb0a980-473b-4736-83b8-eb1d0b27ffc8" xlink:to="loc_us-gaap_USGovernmentAgenciesShorttermDebtSecuritiesMember_adf95cd4-4767-48ee-bd2b-fadc21608239" xlink:type="arc" order="2"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://dermtech.com/role/StockholdersEquityAdditionalInformationDetails" xlink:type="simple" xlink:href="dmtk-20220630.xsd#StockholdersEquityAdditionalInformationDetails"/>
  <link:definitionLink xlink:role="http://dermtech.com/role/StockholdersEquityAdditionalInformationDetails" xlink:type="extended" id="ic3d60cc090444b4aa7d542816eebbfac_StockholdersEquityAdditionalInformationDetails">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ClassOfStockLineItems_928bff83-ef8c-46ce-ba61-3f33fb764019" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ClassOfStockLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockSharesAuthorized_9deb75b7-97e5-436b-8b34-cc69be72177c" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CommonStockSharesAuthorized"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ClassOfStockLineItems_928bff83-ef8c-46ce-ba61-3f33fb764019" xlink:to="loc_us-gaap_CommonStockSharesAuthorized_9deb75b7-97e5-436b-8b34-cc69be72177c" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PreferredStockSharesAuthorized_63ec129e-ead1-4de4-8741-d6c149e27f88" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PreferredStockSharesAuthorized"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ClassOfStockLineItems_928bff83-ef8c-46ce-ba61-3f33fb764019" xlink:to="loc_us-gaap_PreferredStockSharesAuthorized_63ec129e-ead1-4de4-8741-d6c149e27f88" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockParOrStatedValuePerShare_df563dac-fdb1-4783-be52-04f9154585e4" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CommonStockParOrStatedValuePerShare"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ClassOfStockLineItems_928bff83-ef8c-46ce-ba61-3f33fb764019" xlink:to="loc_us-gaap_CommonStockParOrStatedValuePerShare_df563dac-fdb1-4783-be52-04f9154585e4" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PreferredStockParOrStatedValuePerShare_293ad831-7320-4be7-9866-d768cdbe5f0d" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PreferredStockParOrStatedValuePerShare"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ClassOfStockLineItems_928bff83-ef8c-46ce-ba61-3f33fb764019" xlink:to="loc_us-gaap_PreferredStockParOrStatedValuePerShare_293ad831-7320-4be7-9866-d768cdbe5f0d" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockIssuedDuringPeriodValueNewIssues_db645b36-ef4d-4217-afcc-0c79a0171af6" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StockIssuedDuringPeriodValueNewIssues"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ClassOfStockLineItems_928bff83-ef8c-46ce-ba61-3f33fb764019" xlink:to="loc_us-gaap_StockIssuedDuringPeriodValueNewIssues_db645b36-ef4d-4217-afcc-0c79a0171af6" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockIssuedDuringPeriodSharesNewIssues_48808a21-5a82-4a9f-8516-7ac22e3c37c7" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StockIssuedDuringPeriodSharesNewIssues"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ClassOfStockLineItems_928bff83-ef8c-46ce-ba61-3f33fb764019" xlink:to="loc_us-gaap_StockIssuedDuringPeriodSharesNewIssues_48808a21-5a82-4a9f-8516-7ac22e3c37c7" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_dmtk_WeightedAveragePurchasePricePerShareInOffering_eb4a4b97-2d59-4915-a5de-56e385d017f7" xlink:href="dmtk-20220630.xsd#dmtk_WeightedAveragePurchasePricePerShareInOffering"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ClassOfStockLineItems_928bff83-ef8c-46ce-ba61-3f33fb764019" xlink:to="loc_dmtk_WeightedAveragePurchasePricePerShareInOffering_eb4a4b97-2d59-4915-a5de-56e385d017f7" xlink:type="arc" order="6"/>
    <link:loc xlink:type="locator" xlink:label="loc_dmtk_GrossProceedsFromIssuanceOfCommonStock_f690d0b4-db2a-4b22-b8cd-d74b46f19475" xlink:href="dmtk-20220630.xsd#dmtk_GrossProceedsFromIssuanceOfCommonStock"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ClassOfStockLineItems_928bff83-ef8c-46ce-ba61-3f33fb764019" xlink:to="loc_dmtk_GrossProceedsFromIssuanceOfCommonStock_f690d0b4-db2a-4b22-b8cd-d74b46f19475" xlink:type="arc" order="7"/>
    <link:loc xlink:type="locator" xlink:label="loc_dmtk_IncreaseDecreaseInStockIssuanceCosts_3dfd266f-0b8d-446c-9344-66e5a31cfe91" xlink:href="dmtk-20220630.xsd#dmtk_IncreaseDecreaseInStockIssuanceCosts"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ClassOfStockLineItems_928bff83-ef8c-46ce-ba61-3f33fb764019" xlink:to="loc_dmtk_IncreaseDecreaseInStockIssuanceCosts_3dfd266f-0b8d-446c-9344-66e5a31cfe91" xlink:type="arc" order="8"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProceedsFromIssuanceOfCommonStock_716a0cdb-12ba-483b-a798-073b25725e2d" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ProceedsFromIssuanceOfCommonStock"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ClassOfStockLineItems_928bff83-ef8c-46ce-ba61-3f33fb764019" xlink:to="loc_us-gaap_ProceedsFromIssuanceOfCommonStock_716a0cdb-12ba-483b-a798-073b25725e2d" xlink:type="arc" order="9"/>
    <link:loc xlink:type="locator" xlink:label="loc_dmtk_StockPurchasedByUnderwritersPursuantToOptionGranted_6900af65-3b17-4f1b-b514-d8b60e0f65de" xlink:href="dmtk-20220630.xsd#dmtk_StockPurchasedByUnderwritersPursuantToOptionGranted"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ClassOfStockLineItems_928bff83-ef8c-46ce-ba61-3f33fb764019" xlink:to="loc_dmtk_StockPurchasedByUnderwritersPursuantToOptionGranted_6900af65-3b17-4f1b-b514-d8b60e0f65de" xlink:type="arc" order="10"/>
    <link:loc xlink:type="locator" xlink:label="loc_dmtk_UnderwritersGrantPeriodOption_5d9c6659-4e5b-4110-b9ab-0f0bdcf239d2" xlink:href="dmtk-20220630.xsd#dmtk_UnderwritersGrantPeriodOption"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ClassOfStockLineItems_928bff83-ef8c-46ce-ba61-3f33fb764019" xlink:to="loc_dmtk_UnderwritersGrantPeriodOption_5d9c6659-4e5b-4110-b9ab-0f0bdcf239d2" xlink:type="arc" order="11"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SaleOfStockNumberOfSharesIssuedInTransaction_f7f48cc3-ac59-4c58-a5f5-a4898aa73bad" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SaleOfStockNumberOfSharesIssuedInTransaction"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ClassOfStockLineItems_928bff83-ef8c-46ce-ba61-3f33fb764019" xlink:to="loc_us-gaap_SaleOfStockNumberOfSharesIssuedInTransaction_f7f48cc3-ac59-4c58-a5f5-a4898aa73bad" xlink:type="arc" order="12"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SaleOfStockPricePerShare_9c9024d1-cd51-4043-8cad-d7a98551c6c4" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SaleOfStockPricePerShare"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ClassOfStockLineItems_928bff83-ef8c-46ce-ba61-3f33fb764019" xlink:to="loc_us-gaap_SaleOfStockPricePerShare_9c9024d1-cd51-4043-8cad-d7a98551c6c4" xlink:type="arc" order="13"/>
    <link:loc xlink:type="locator" xlink:label="loc_dmtk_GrossProceedsFromOfferingBeforeDeductingUnderwritingDiscountsAndCommissionsAndOtherOfferingExpenses_170a1b06-4246-49a8-a4a6-7337db9485a5" xlink:href="dmtk-20220630.xsd#dmtk_GrossProceedsFromOfferingBeforeDeductingUnderwritingDiscountsAndCommissionsAndOtherOfferingExpenses"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ClassOfStockLineItems_928bff83-ef8c-46ce-ba61-3f33fb764019" xlink:to="loc_dmtk_GrossProceedsFromOfferingBeforeDeductingUnderwritingDiscountsAndCommissionsAndOtherOfferingExpenses_170a1b06-4246-49a8-a4a6-7337db9485a5" xlink:type="arc" order="14"/>
    <link:loc xlink:type="locator" xlink:label="loc_dmtk_ClassOfWarrantOrRightWarrantsOrRightsIssuedToPurchaseCommonStock_894a6f61-793b-4561-9dfa-67d3e81df015" xlink:href="dmtk-20220630.xsd#dmtk_ClassOfWarrantOrRightWarrantsOrRightsIssuedToPurchaseCommonStock"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ClassOfStockLineItems_928bff83-ef8c-46ce-ba61-3f33fb764019" xlink:to="loc_dmtk_ClassOfWarrantOrRightWarrantsOrRightsIssuedToPurchaseCommonStock_894a6f61-793b-4561-9dfa-67d3e81df015" xlink:type="arc" order="15"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_WarrantsAndRightsOutstandingTerm_1bc3f260-8017-401e-b3a7-0f3ccc47d1c2" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_WarrantsAndRightsOutstandingTerm"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ClassOfStockLineItems_928bff83-ef8c-46ce-ba61-3f33fb764019" xlink:to="loc_us-gaap_WarrantsAndRightsOutstandingTerm_1bc3f260-8017-401e-b3a7-0f3ccc47d1c2" xlink:type="arc" order="16"/>
    <link:loc xlink:type="locator" xlink:label="loc_dmtk_NumberOfWarrantsEntitleHolderToPurchaseOneShare_ccb9da78-4a04-490b-a26d-e15f297889bd" xlink:href="dmtk-20220630.xsd#dmtk_NumberOfWarrantsEntitleHolderToPurchaseOneShare"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ClassOfStockLineItems_928bff83-ef8c-46ce-ba61-3f33fb764019" xlink:to="loc_dmtk_NumberOfWarrantsEntitleHolderToPurchaseOneShare_ccb9da78-4a04-490b-a26d-e15f297889bd" xlink:type="arc" order="17"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1_c47c69c3-b4e7-45f0-b198-ae64358a2f44" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ClassOfStockLineItems_928bff83-ef8c-46ce-ba61-3f33fb764019" xlink:to="loc_us-gaap_ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1_c47c69c3-b4e7-45f0-b198-ae64358a2f44" xlink:type="arc" order="18"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights_84b4b4e6-8a27-496a-8340-d9eb9f211563" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ClassOfStockLineItems_928bff83-ef8c-46ce-ba61-3f33fb764019" xlink:to="loc_us-gaap_ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights_84b4b4e6-8a27-496a-8340-d9eb9f211563" xlink:type="arc" order="19"/>
    <link:loc xlink:type="locator" xlink:label="loc_dmtk_CommonSharesIssuedUponExerciseOfWarrants_381d624f-02e9-4564-9b40-bc6789c1f3b3" xlink:href="dmtk-20220630.xsd#dmtk_CommonSharesIssuedUponExerciseOfWarrants"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ClassOfStockLineItems_928bff83-ef8c-46ce-ba61-3f33fb764019" xlink:to="loc_dmtk_CommonSharesIssuedUponExerciseOfWarrants_381d624f-02e9-4564-9b40-bc6789c1f3b3" xlink:type="arc" order="20"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProceedsFromWarrantExercises_ee9ddc30-1d16-43dc-bfcf-11bb2cfc9653" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ProceedsFromWarrantExercises"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ClassOfStockLineItems_928bff83-ef8c-46ce-ba61-3f33fb764019" xlink:to="loc_us-gaap_ProceedsFromWarrantExercises_ee9ddc30-1d16-43dc-bfcf-11bb2cfc9653" xlink:type="arc" order="21"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ClassOfWarrantOrRightOutstanding_5801145f-1f10-4e13-8f70-aced4ba96df6" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ClassOfWarrantOrRightOutstanding"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ClassOfStockLineItems_928bff83-ef8c-46ce-ba61-3f33fb764019" xlink:to="loc_us-gaap_ClassOfWarrantOrRightOutstanding_5801145f-1f10-4e13-8f70-aced4ba96df6" xlink:type="arc" order="22"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ClassOfWarrantOrRightNumberOfSecuritiesCalledByEachWarrantOrRight_6ab1c18b-db9c-49a7-aac3-557d05147363" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ClassOfWarrantOrRightNumberOfSecuritiesCalledByEachWarrantOrRight"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ClassOfStockLineItems_928bff83-ef8c-46ce-ba61-3f33fb764019" xlink:to="loc_us-gaap_ClassOfWarrantOrRightNumberOfSecuritiesCalledByEachWarrantOrRight_6ab1c18b-db9c-49a7-aac3-557d05147363" xlink:type="arc" order="23"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized_74e7e75b-c8a3-4df3-9fa6-22c888e60764" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ClassOfStockLineItems_928bff83-ef8c-46ce-ba61-3f33fb764019" xlink:to="loc_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized_74e7e75b-c8a3-4df3-9fa6-22c888e60764" xlink:type="arc" order="24"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1_dcee10a5-48f2-4a0a-a644-ca3637c00236" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ClassOfStockLineItems_928bff83-ef8c-46ce-ba61-3f33fb764019" xlink:to="loc_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1_dcee10a5-48f2-4a0a-a644-ca3637c00236" xlink:type="arc" order="25"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardPurchasePriceOfCommonStockPercent_73916c31-d5e8-4ee1-96f2-b4aae5ce7b96" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardPurchasePriceOfCommonStockPercent"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ClassOfStockLineItems_928bff83-ef8c-46ce-ba61-3f33fb764019" xlink:to="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardPurchasePriceOfCommonStockPercent_73916c31-d5e8-4ee1-96f2-b4aae5ce7b96" xlink:type="arc" order="26"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardExpirationPeriod_38522995-d266-4bb6-a53c-71ad90e92484" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardExpirationPeriod"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ClassOfStockLineItems_928bff83-ef8c-46ce-ba61-3f33fb764019" xlink:to="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardExpirationPeriod_38522995-d266-4bb6-a53c-71ad90e92484" xlink:type="arc" order="27"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant_b43a2f63-f160-4f06-b93b-fd14627cf829" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ClassOfStockLineItems_928bff83-ef8c-46ce-ba61-3f33fb764019" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant_b43a2f63-f160-4f06-b93b-fd14627cf829" xlink:type="arc" order="28"/>
    <link:loc xlink:type="locator" xlink:label="loc_dmtk_EquityIncentivePlanOptionTerm_d302a45d-32a2-4a4f-915a-563d495300e1" xlink:href="dmtk-20220630.xsd#dmtk_EquityIncentivePlanOptionTerm"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ClassOfStockLineItems_928bff83-ef8c-46ce-ba61-3f33fb764019" xlink:to="loc_dmtk_EquityIncentivePlanOptionTerm_d302a45d-32a2-4a4f-915a-563d495300e1" xlink:type="arc" order="29"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SharesIssued_60e3a557-2e9b-48bb-af2b-a61434b16246" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SharesIssued"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ClassOfStockLineItems_928bff83-ef8c-46ce-ba61-3f33fb764019" xlink:to="loc_us-gaap_SharesIssued_60e3a557-2e9b-48bb-af2b-a61434b16246" xlink:type="arc" order="30"/>
    <link:loc xlink:type="locator" xlink:label="loc_dmtk_CommonStockOutstandingPercentage_84c454ed-edc7-42f6-8352-937abbeafe06" xlink:href="dmtk-20220630.xsd#dmtk_CommonStockOutstandingPercentage"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ClassOfStockLineItems_928bff83-ef8c-46ce-ba61-3f33fb764019" xlink:to="loc_dmtk_CommonStockOutstandingPercentage_84c454ed-edc7-42f6-8352-937abbeafe06" xlink:type="arc" order="31"/>
    <link:loc xlink:type="locator" xlink:label="loc_dmtk_PercentageOfPriceAtSharesPurchased_8be98cbf-2327-4b23-911a-80ce6dffab5f" xlink:href="dmtk-20220630.xsd#dmtk_PercentageOfPriceAtSharesPurchased"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ClassOfStockLineItems_928bff83-ef8c-46ce-ba61-3f33fb764019" xlink:to="loc_dmtk_PercentageOfPriceAtSharesPurchased_8be98cbf-2327-4b23-911a-80ce6dffab5f" xlink:type="arc" order="32"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockCapitalSharesReservedForFutureIssuance_329df056-fb7f-478f-b831-40a744df5302" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CommonStockCapitalSharesReservedForFutureIssuance"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ClassOfStockLineItems_928bff83-ef8c-46ce-ba61-3f33fb764019" xlink:to="loc_us-gaap_CommonStockCapitalSharesReservedForFutureIssuance_329df056-fb7f-478f-b831-40a744df5302" xlink:type="arc" order="33"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockSharesIssued_892377de-3e44-4e6e-be51-ee34668e0f5c" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CommonStockSharesIssued"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ClassOfStockLineItems_928bff83-ef8c-46ce-ba61-3f33fb764019" xlink:to="loc_us-gaap_CommonStockSharesIssued_892377de-3e44-4e6e-be51-ee34668e0f5c" xlink:type="arc" order="34"/>
    <link:loc xlink:type="locator" xlink:label="loc_dmtk_WarrantsVestingPeriod_0f45e51a-cb08-4c35-b7bc-a960b4fc25c0" xlink:href="dmtk-20220630.xsd#dmtk_WarrantsVestingPeriod"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ClassOfStockLineItems_928bff83-ef8c-46ce-ba61-3f33fb764019" xlink:to="loc_dmtk_WarrantsVestingPeriod_0f45e51a-cb08-4c35-b7bc-a960b4fc25c0" xlink:type="arc" order="35"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfStockByClassTable_f8f23445-e5f5-451f-b8f7-1b42f26c0490" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfStockByClassTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_ClassOfStockLineItems_928bff83-ef8c-46ce-ba61-3f33fb764019" xlink:to="loc_us-gaap_ScheduleOfStockByClassTable_f8f23445-e5f5-451f-b8f7-1b42f26c0490" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeAxis_3fb656a8-b3c8-40e6-b71d-d800683817a3" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_RangeAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfStockByClassTable_f8f23445-e5f5-451f-b8f7-1b42f26c0490" xlink:to="loc_srt_RangeAxis_3fb656a8-b3c8-40e6-b71d-d800683817a3" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeMember_3fb656a8-b3c8-40e6-b71d-d800683817a3_default" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_RangeMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_srt_RangeAxis_3fb656a8-b3c8-40e6-b71d-d800683817a3" xlink:to="loc_srt_RangeMember_3fb656a8-b3c8-40e6-b71d-d800683817a3_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeMember_3cc7ecf5-d437-4f1f-8b59-4a8acb75d058" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_RangeMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_srt_RangeAxis_3fb656a8-b3c8-40e6-b71d-d800683817a3" xlink:to="loc_srt_RangeMember_3cc7ecf5-d437-4f1f-8b59-4a8acb75d058" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_MinimumMember_45ea3b6b-6a9a-4a9f-a2c5-878e56d00cd4" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_MinimumMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_RangeMember_3cc7ecf5-d437-4f1f-8b59-4a8acb75d058" xlink:to="loc_srt_MinimumMember_45ea3b6b-6a9a-4a9f-a2c5-878e56d00cd4" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_MaximumMember_4aad9716-835d-41bb-b980-748352d4fc7d" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_MaximumMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_RangeMember_3cc7ecf5-d437-4f1f-8b59-4a8acb75d058" xlink:to="loc_srt_MaximumMember_4aad9716-835d-41bb-b980-748352d4fc7d" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementEquityComponentsAxis_5892d6ca-1e7b-446d-851e-682f8acb75ac" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StatementEquityComponentsAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfStockByClassTable_f8f23445-e5f5-451f-b8f7-1b42f26c0490" xlink:to="loc_us-gaap_StatementEquityComponentsAxis_5892d6ca-1e7b-446d-851e-682f8acb75ac" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquityComponentDomain_5892d6ca-1e7b-446d-851e-682f8acb75ac_default" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EquityComponentDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_StatementEquityComponentsAxis_5892d6ca-1e7b-446d-851e-682f8acb75ac" xlink:to="loc_us-gaap_EquityComponentDomain_5892d6ca-1e7b-446d-851e-682f8acb75ac_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquityComponentDomain_f749b762-f0d8-45bf-ad21-0f593e81809a" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EquityComponentDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_StatementEquityComponentsAxis_5892d6ca-1e7b-446d-851e-682f8acb75ac" xlink:to="loc_us-gaap_EquityComponentDomain_f749b762-f0d8-45bf-ad21-0f593e81809a" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockMember_6de37144-2758-42d5-af7b-8e507d887365" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CommonStockMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_EquityComponentDomain_f749b762-f0d8-45bf-ad21-0f593e81809a" xlink:to="loc_us-gaap_CommonStockMember_6de37144-2758-42d5-af7b-8e507d887365" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RelatedPartyTransactionsByRelatedPartyAxis_4c3e7e09-e9df-408a-bd40-84961e41669c" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RelatedPartyTransactionsByRelatedPartyAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfStockByClassTable_f8f23445-e5f5-451f-b8f7-1b42f26c0490" xlink:to="loc_us-gaap_RelatedPartyTransactionsByRelatedPartyAxis_4c3e7e09-e9df-408a-bd40-84961e41669c" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RelatedPartyDomain_4c3e7e09-e9df-408a-bd40-84961e41669c_default" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RelatedPartyDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_RelatedPartyTransactionsByRelatedPartyAxis_4c3e7e09-e9df-408a-bd40-84961e41669c" xlink:to="loc_us-gaap_RelatedPartyDomain_4c3e7e09-e9df-408a-bd40-84961e41669c_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RelatedPartyDomain_9a744bdb-e931-4450-aa65-8535ac80af56" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RelatedPartyDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_RelatedPartyTransactionsByRelatedPartyAxis_4c3e7e09-e9df-408a-bd40-84961e41669c" xlink:to="loc_us-gaap_RelatedPartyDomain_9a744bdb-e931-4450-aa65-8535ac80af56" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_dmtk_CowenLimitedLiabilityCompanyMember_48bf2a53-3d9f-4dce-aefa-a6b9fe9734a9" xlink:href="dmtk-20220630.xsd#dmtk_CowenLimitedLiabilityCompanyMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_RelatedPartyDomain_9a744bdb-e931-4450-aa65-8535ac80af56" xlink:to="loc_dmtk_CowenLimitedLiabilityCompanyMember_48bf2a53-3d9f-4dce-aefa-a6b9fe9734a9" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ClassOfWarrantOrRightAxis_b5d87b7b-0e91-4e62-9cb1-d4254ccded05" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ClassOfWarrantOrRightAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfStockByClassTable_f8f23445-e5f5-451f-b8f7-1b42f26c0490" xlink:to="loc_us-gaap_ClassOfWarrantOrRightAxis_b5d87b7b-0e91-4e62-9cb1-d4254ccded05" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ClassOfWarrantOrRightDomain_b5d87b7b-0e91-4e62-9cb1-d4254ccded05_default" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ClassOfWarrantOrRightDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_ClassOfWarrantOrRightAxis_b5d87b7b-0e91-4e62-9cb1-d4254ccded05" xlink:to="loc_us-gaap_ClassOfWarrantOrRightDomain_b5d87b7b-0e91-4e62-9cb1-d4254ccded05_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ClassOfWarrantOrRightDomain_dadeb2b1-188b-46d9-83a7-9ce3d4c75eff" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ClassOfWarrantOrRightDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_ClassOfWarrantOrRightAxis_b5d87b7b-0e91-4e62-9cb1-d4254ccded05" xlink:to="loc_us-gaap_ClassOfWarrantOrRightDomain_dadeb2b1-188b-46d9-83a7-9ce3d4c75eff" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_dmtk_SpecialPurposeAcquisitionCompaniesWarrantsMember_c86444f3-f998-43ca-9634-69578f79c176" xlink:href="dmtk-20220630.xsd#dmtk_SpecialPurposeAcquisitionCompaniesWarrantsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ClassOfWarrantOrRightDomain_dadeb2b1-188b-46d9-83a7-9ce3d4c75eff" xlink:to="loc_dmtk_SpecialPurposeAcquisitionCompaniesWarrantsMember_c86444f3-f998-43ca-9634-69578f79c176" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_dmtk_PublicSpecialPurposeAcquisitionCompaniesWarrantsMember_808327ba-d110-4204-a8d1-7a8a17d18799" xlink:href="dmtk-20220630.xsd#dmtk_PublicSpecialPurposeAcquisitionCompaniesWarrantsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ClassOfWarrantOrRightDomain_dadeb2b1-188b-46d9-83a7-9ce3d4c75eff" xlink:to="loc_dmtk_PublicSpecialPurposeAcquisitionCompaniesWarrantsMember_808327ba-d110-4204-a8d1-7a8a17d18799" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_dmtk_PrivateSpecialPurposeAcquisitionCompaniesWarrantsMember_76f9af35-2cfa-4d37-a0af-0958ef995b28" xlink:href="dmtk-20220630.xsd#dmtk_PrivateSpecialPurposeAcquisitionCompaniesWarrantsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ClassOfWarrantOrRightDomain_dadeb2b1-188b-46d9-83a7-9ce3d4c75eff" xlink:to="loc_dmtk_PrivateSpecialPurposeAcquisitionCompaniesWarrantsMember_76f9af35-2cfa-4d37-a0af-0958ef995b28" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_dmtk_PlacementAgentWarrantsMember_33908ec1-afba-43c4-9c51-6019c7ef1a4f" xlink:href="dmtk-20220630.xsd#dmtk_PlacementAgentWarrantsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ClassOfWarrantOrRightDomain_dadeb2b1-188b-46d9-83a7-9ce3d4c75eff" xlink:to="loc_dmtk_PlacementAgentWarrantsMember_33908ec1-afba-43c4-9c51-6019c7ef1a4f" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_dmtk_ManagementWarrantsMember_3bb8094c-4170-4531-a651-cec515511135" xlink:href="dmtk-20220630.xsd#dmtk_ManagementWarrantsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ClassOfWarrantOrRightDomain_dadeb2b1-188b-46d9-83a7-9ce3d4c75eff" xlink:to="loc_dmtk_ManagementWarrantsMember_3bb8094c-4170-4531-a651-cec515511135" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentAxis_615a46e4-9e5a-498b-b99e-0869f8fb1e95" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtInstrumentAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfStockByClassTable_f8f23445-e5f5-451f-b8f7-1b42f26c0490" xlink:to="loc_us-gaap_DebtInstrumentAxis_615a46e4-9e5a-498b-b99e-0869f8fb1e95" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentNameDomain_615a46e4-9e5a-498b-b99e-0869f8fb1e95_default" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtInstrumentNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_DebtInstrumentAxis_615a46e4-9e5a-498b-b99e-0869f8fb1e95" xlink:to="loc_us-gaap_DebtInstrumentNameDomain_615a46e4-9e5a-498b-b99e-0869f8fb1e95_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentNameDomain_2933b503-692e-41c8-a34a-07a418b29c6f" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtInstrumentNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_DebtInstrumentAxis_615a46e4-9e5a-498b-b99e-0869f8fb1e95" xlink:to="loc_us-gaap_DebtInstrumentNameDomain_2933b503-692e-41c8-a34a-07a418b29c6f" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_dmtk_TwoThousandEighteenConvertibleBridgeNotesMember_fe3c8d11-20db-4c2e-bbe6-37f39c10d3ad" xlink:href="dmtk-20220630.xsd#dmtk_TwoThousandEighteenConvertibleBridgeNotesMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_2933b503-692e-41c8-a34a-07a418b29c6f" xlink:to="loc_dmtk_TwoThousandEighteenConvertibleBridgeNotesMember_fe3c8d11-20db-4c2e-bbe6-37f39c10d3ad" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PlanNameAxis_3647d14d-387a-46b9-bc79-960aa66ff3ee" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PlanNameAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfStockByClassTable_f8f23445-e5f5-451f-b8f7-1b42f26c0490" xlink:to="loc_us-gaap_PlanNameAxis_3647d14d-387a-46b9-bc79-960aa66ff3ee" xlink:type="arc" order="6"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PlanNameDomain_3647d14d-387a-46b9-bc79-960aa66ff3ee_default" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PlanNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_PlanNameAxis_3647d14d-387a-46b9-bc79-960aa66ff3ee" xlink:to="loc_us-gaap_PlanNameDomain_3647d14d-387a-46b9-bc79-960aa66ff3ee_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PlanNameDomain_7b62e359-94e6-43c0-b92e-0b5e05bd71e8" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PlanNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_PlanNameAxis_3647d14d-387a-46b9-bc79-960aa66ff3ee" xlink:to="loc_us-gaap_PlanNameDomain_7b62e359-94e6-43c0-b92e-0b5e05bd71e8" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_dmtk_TwoThousandTenStockPlanMember_7e5f5726-8354-4ff9-a761-33df2aef9f45" xlink:href="dmtk-20220630.xsd#dmtk_TwoThousandTenStockPlanMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_PlanNameDomain_7b62e359-94e6-43c0-b92e-0b5e05bd71e8" xlink:to="loc_dmtk_TwoThousandTenStockPlanMember_7e5f5726-8354-4ff9-a761-33df2aef9f45" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_dmtk_TwoThousandTwentyEquityIncentivePlanMember_fb5500c3-8c52-44ed-b447-cb9bae78f443" xlink:href="dmtk-20220630.xsd#dmtk_TwoThousandTwentyEquityIncentivePlanMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_PlanNameDomain_7b62e359-94e6-43c0-b92e-0b5e05bd71e8" xlink:to="loc_dmtk_TwoThousandTwentyEquityIncentivePlanMember_fb5500c3-8c52-44ed-b447-cb9bae78f443" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_dmtk_TwoThousandTwentyEmployeeStockPurchasePlanMember_8b180053-ecc4-42ab-ba58-8cd3b0e60709" xlink:href="dmtk-20220630.xsd#dmtk_TwoThousandTwentyEmployeeStockPurchasePlanMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_PlanNameDomain_7b62e359-94e6-43c0-b92e-0b5e05bd71e8" xlink:to="loc_dmtk_TwoThousandTwentyEmployeeStockPurchasePlanMember_8b180053-ecc4-42ab-ba58-8cd3b0e60709" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AwardTypeAxis_36b07ae7-0ab9-4973-abef-539ffeffe724" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AwardTypeAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfStockByClassTable_f8f23445-e5f5-451f-b8f7-1b42f26c0490" xlink:to="loc_us-gaap_AwardTypeAxis_36b07ae7-0ab9-4973-abef-539ffeffe724" xlink:type="arc" order="7"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_36b07ae7-0ab9-4973-abef-539ffeffe724_default" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_AwardTypeAxis_36b07ae7-0ab9-4973-abef-539ffeffe724" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_36b07ae7-0ab9-4973-abef-539ffeffe724_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_c87e4271-1737-415c-91d4-49d9882e1d76" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_AwardTypeAxis_36b07ae7-0ab9-4973-abef-539ffeffe724" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_c87e4271-1737-415c-91d4-49d9882e1d76" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_dmtk_IncentiveStockOptionsMember_6fc10cf5-c1f5-4f11-86ee-23110810f14c" xlink:href="dmtk-20220630.xsd#dmtk_IncentiveStockOptionsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_c87e4271-1737-415c-91d4-49d9882e1d76" xlink:to="loc_dmtk_IncentiveStockOptionsMember_6fc10cf5-c1f5-4f11-86ee-23110810f14c" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_dmtk_IncentiveAndNonQualifiedStockOptionsMember_02340a0c-6eaf-4776-a94c-cf022c71da7d" xlink:href="dmtk-20220630.xsd#dmtk_IncentiveAndNonQualifiedStockOptionsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_c87e4271-1737-415c-91d4-49d9882e1d76" xlink:to="loc_dmtk_IncentiveAndNonQualifiedStockOptionsMember_02340a0c-6eaf-4776-a94c-cf022c71da7d" xlink:type="arc" order="1"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://dermtech.com/role/StockholdersEquityESPPValuationMethodDetails" xlink:type="simple" xlink:href="dmtk-20220630.xsd#StockholdersEquityESPPValuationMethodDetails"/>
  <link:definitionLink xlink:role="http://dermtech.com/role/StockholdersEquityESPPValuationMethodDetails" xlink:type="extended" id="i8964da68b37e48199680b50384111c85_StockholdersEquityESPPValuationMethodDetails">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ClassOfStockLineItems_430b0622-ec0c-4636-9f52-50f291627349" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ClassOfStockLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate_2c29acdd-c225-4e08-88df-94ef01d88c0c" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ClassOfStockLineItems_430b0622-ec0c-4636-9f52-50f291627349" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate_2c29acdd-c225-4e08-88df-94ef01d88c0c" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMinimum_909dcc05-aaa4-4bb4-8809-6388ecd0e297" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMinimum"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ClassOfStockLineItems_430b0622-ec0c-4636-9f52-50f291627349" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMinimum_909dcc05-aaa4-4bb4-8809-6388ecd0e297" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMaximum_54af929b-4376-4f6f-acbb-0b7278d2f5f9" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMaximum"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ClassOfStockLineItems_430b0622-ec0c-4636-9f52-50f291627349" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMaximum_54af929b-4376-4f6f-acbb-0b7278d2f5f9" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate_f380decb-4ff9-42c7-bc8b-fe190cfa5d7e" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ClassOfStockLineItems_430b0622-ec0c-4636-9f52-50f291627349" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate_f380decb-4ff9-42c7-bc8b-fe190cfa5d7e" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRateMinimum_5b192792-9bbb-489b-afee-82c50060647e" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRateMinimum"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ClassOfStockLineItems_430b0622-ec0c-4636-9f52-50f291627349" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRateMinimum_5b192792-9bbb-489b-afee-82c50060647e" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRateMaximum_50e91673-98eb-48f6-982e-52b655c1db40" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRateMaximum"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ClassOfStockLineItems_430b0622-ec0c-4636-9f52-50f291627349" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRateMaximum_50e91673-98eb-48f6-982e-52b655c1db40" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1_3cf07258-11a1-4b6b-9895-bae91e6379f3" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ClassOfStockLineItems_430b0622-ec0c-4636-9f52-50f291627349" xlink:to="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1_3cf07258-11a1-4b6b-9895-bae91e6379f3" xlink:type="arc" order="6"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate_6ef8c1d8-c720-418b-939a-e9d562fd6530" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ClassOfStockLineItems_430b0622-ec0c-4636-9f52-50f291627349" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate_6ef8c1d8-c720-418b-939a-e9d562fd6530" xlink:type="arc" order="7"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfStockByClassTable_ce3207fe-271e-4b73-867f-992c8751afab" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfStockByClassTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_ClassOfStockLineItems_430b0622-ec0c-4636-9f52-50f291627349" xlink:to="loc_us-gaap_ScheduleOfStockByClassTable_ce3207fe-271e-4b73-867f-992c8751afab" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PlanNameAxis_2ee11628-2ee2-4361-a92c-6ee12302517a" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PlanNameAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfStockByClassTable_ce3207fe-271e-4b73-867f-992c8751afab" xlink:to="loc_us-gaap_PlanNameAxis_2ee11628-2ee2-4361-a92c-6ee12302517a" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PlanNameDomain_2ee11628-2ee2-4361-a92c-6ee12302517a_default" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PlanNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_PlanNameAxis_2ee11628-2ee2-4361-a92c-6ee12302517a" xlink:to="loc_us-gaap_PlanNameDomain_2ee11628-2ee2-4361-a92c-6ee12302517a_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PlanNameDomain_6bc8bd4c-af9f-4dd7-a494-d3606b0d38b6" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PlanNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_PlanNameAxis_2ee11628-2ee2-4361-a92c-6ee12302517a" xlink:to="loc_us-gaap_PlanNameDomain_6bc8bd4c-af9f-4dd7-a494-d3606b0d38b6" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_dmtk_TwoThousandTwentyEquityIncentivePlanMember_e3f30022-84f1-4245-8ceb-d5722e341d96" xlink:href="dmtk-20220630.xsd#dmtk_TwoThousandTwentyEquityIncentivePlanMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_PlanNameDomain_6bc8bd4c-af9f-4dd7-a494-d3606b0d38b6" xlink:to="loc_dmtk_TwoThousandTwentyEquityIncentivePlanMember_e3f30022-84f1-4245-8ceb-d5722e341d96" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_dmtk_TwoThousandTwentyEmployeeStockPurchasePlanMember_cfd196d6-9b88-4eed-8107-53eec53d0d5f" xlink:href="dmtk-20220630.xsd#dmtk_TwoThousandTwentyEmployeeStockPurchasePlanMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_PlanNameDomain_6bc8bd4c-af9f-4dd7-a494-d3606b0d38b6" xlink:to="loc_dmtk_TwoThousandTwentyEmployeeStockPurchasePlanMember_cfd196d6-9b88-4eed-8107-53eec53d0d5f" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeAxis_18456c7d-238d-429f-98c3-1287ce6f2ab5" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_RangeAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfStockByClassTable_ce3207fe-271e-4b73-867f-992c8751afab" xlink:to="loc_srt_RangeAxis_18456c7d-238d-429f-98c3-1287ce6f2ab5" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeMember_18456c7d-238d-429f-98c3-1287ce6f2ab5_default" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_RangeMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_srt_RangeAxis_18456c7d-238d-429f-98c3-1287ce6f2ab5" xlink:to="loc_srt_RangeMember_18456c7d-238d-429f-98c3-1287ce6f2ab5_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeMember_16a2eaf8-57ca-482b-84f7-d45327c848da" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_RangeMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_srt_RangeAxis_18456c7d-238d-429f-98c3-1287ce6f2ab5" xlink:to="loc_srt_RangeMember_16a2eaf8-57ca-482b-84f7-d45327c848da" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_MinimumMember_51b3eeb0-5c98-4fd2-86be-c83e601a8695" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_MinimumMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_RangeMember_16a2eaf8-57ca-482b-84f7-d45327c848da" xlink:to="loc_srt_MinimumMember_51b3eeb0-5c98-4fd2-86be-c83e601a8695" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_MaximumMember_2285574b-d8d6-4101-876a-3d8507765c96" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_MaximumMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_RangeMember_16a2eaf8-57ca-482b-84f7-d45327c848da" xlink:to="loc_srt_MaximumMember_2285574b-d8d6-4101-876a-3d8507765c96" xlink:type="arc" order="1"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://dermtech.com/role/StockholdersEquityShareBasedCompensationExpenseDetails" xlink:type="simple" xlink:href="dmtk-20220630.xsd#StockholdersEquityShareBasedCompensationExpenseDetails"/>
  <link:definitionLink xlink:role="http://dermtech.com/role/StockholdersEquityShareBasedCompensationExpenseDetails" xlink:type="extended" id="ia426201caf0a42baae7372e963178b2d_StockholdersEquityShareBasedCompensationExpenseDetails">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_17f3dbe2-cb04-454d-a615-fb9c94b1dd01" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AllocatedShareBasedCompensationExpense_f15c4bca-ceab-4ab7-a9e3-78181a8729da" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AllocatedShareBasedCompensationExpense"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_17f3dbe2-cb04-454d-a615-fb9c94b1dd01" xlink:to="loc_us-gaap_AllocatedShareBasedCompensationExpense_f15c4bca-ceab-4ab7-a9e3-78181a8729da" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_b2fb6620-f905-4f42-983f-9359fedf3176" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_17f3dbe2-cb04-454d-a615-fb9c94b1dd01" xlink:to="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_b2fb6620-f905-4f42-983f-9359fedf3176" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeStatementLocationAxis_8d4902f1-e23d-4897-bd55-a579f3daf15b" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeStatementLocationAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_b2fb6620-f905-4f42-983f-9359fedf3176" xlink:to="loc_us-gaap_IncomeStatementLocationAxis_8d4902f1-e23d-4897-bd55-a579f3daf15b" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeStatementLocationDomain_8d4902f1-e23d-4897-bd55-a579f3daf15b_default" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeStatementLocationDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_IncomeStatementLocationAxis_8d4902f1-e23d-4897-bd55-a579f3daf15b" xlink:to="loc_us-gaap_IncomeStatementLocationDomain_8d4902f1-e23d-4897-bd55-a579f3daf15b_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeStatementLocationDomain_52d82877-dd85-4495-ac3b-8f8e6fd05a23" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeStatementLocationDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_IncomeStatementLocationAxis_8d4902f1-e23d-4897-bd55-a579f3daf15b" xlink:to="loc_us-gaap_IncomeStatementLocationDomain_52d82877-dd85-4495-ac3b-8f8e6fd05a23" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CostOfSalesMember_6cb53a98-6bb3-4853-a487-a91930841084" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CostOfSalesMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncomeStatementLocationDomain_52d82877-dd85-4495-ac3b-8f8e6fd05a23" xlink:to="loc_us-gaap_CostOfSalesMember_6cb53a98-6bb3-4853-a487-a91930841084" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SellingAndMarketingExpenseMember_1e210148-77bf-4d85-92eb-b06e14d22c93" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SellingAndMarketingExpenseMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncomeStatementLocationDomain_52d82877-dd85-4495-ac3b-8f8e6fd05a23" xlink:to="loc_us-gaap_SellingAndMarketingExpenseMember_1e210148-77bf-4d85-92eb-b06e14d22c93" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ResearchAndDevelopmentExpenseMember_5ff43d1b-9d51-4550-9981-648d613dab3b" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ResearchAndDevelopmentExpenseMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncomeStatementLocationDomain_52d82877-dd85-4495-ac3b-8f8e6fd05a23" xlink:to="loc_us-gaap_ResearchAndDevelopmentExpenseMember_5ff43d1b-9d51-4550-9981-648d613dab3b" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GeneralAndAdministrativeExpenseMember_0fdbc97b-429f-42d0-8ef8-202878f6cd62" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_GeneralAndAdministrativeExpenseMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncomeStatementLocationDomain_52d82877-dd85-4495-ac3b-8f8e6fd05a23" xlink:to="loc_us-gaap_GeneralAndAdministrativeExpenseMember_0fdbc97b-429f-42d0-8ef8-202878f6cd62" xlink:type="arc" order="3"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://dermtech.com/role/StockholdersEquitySummaryofCommonStockReservedforFutureIssuanceDetail" xlink:type="simple" xlink:href="dmtk-20220630.xsd#StockholdersEquitySummaryofCommonStockReservedforFutureIssuanceDetail"/>
  <link:definitionLink xlink:role="http://dermtech.com/role/StockholdersEquitySummaryofCommonStockReservedforFutureIssuanceDetail" xlink:type="extended" id="i42b468065c73456f8300e287e7085f2c_StockholdersEquitySummaryofCommonStockReservedforFutureIssuanceDetail">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ClassOfStockLineItems_e233692e-d83d-4833-818e-316f2f34c328" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ClassOfStockLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockCapitalSharesReservedForFutureIssuance_f7f70e83-c049-41c2-9529-3ff86630fb58" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CommonStockCapitalSharesReservedForFutureIssuance"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ClassOfStockLineItems_e233692e-d83d-4833-818e-316f2f34c328" xlink:to="loc_us-gaap_CommonStockCapitalSharesReservedForFutureIssuance_f7f70e83-c049-41c2-9529-3ff86630fb58" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_dmtk_NumberOfWarrantsEntitleHolderToPurchaseOneShare_32784726-9e64-4bfe-9877-9ebf932ef7f8" xlink:href="dmtk-20220630.xsd#dmtk_NumberOfWarrantsEntitleHolderToPurchaseOneShare"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ClassOfStockLineItems_e233692e-d83d-4833-818e-316f2f34c328" xlink:to="loc_dmtk_NumberOfWarrantsEntitleHolderToPurchaseOneShare_32784726-9e64-4bfe-9877-9ebf932ef7f8" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfStockByClassTable_69a5128d-d5ac-478d-a295-ea48e61b25a3" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfStockByClassTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_ClassOfStockLineItems_e233692e-d83d-4833-818e-316f2f34c328" xlink:to="loc_us-gaap_ScheduleOfStockByClassTable_69a5128d-d5ac-478d-a295-ea48e61b25a3" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AwardTypeAxis_ee3da456-8707-47b8-be7f-5fb6df4e6849" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AwardTypeAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfStockByClassTable_69a5128d-d5ac-478d-a295-ea48e61b25a3" xlink:to="loc_us-gaap_AwardTypeAxis_ee3da456-8707-47b8-be7f-5fb6df4e6849" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_ee3da456-8707-47b8-be7f-5fb6df4e6849_default" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_AwardTypeAxis_ee3da456-8707-47b8-be7f-5fb6df4e6849" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_ee3da456-8707-47b8-be7f-5fb6df4e6849_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_4b4fcc2b-7620-42f9-996a-b7a8d48fd2b6" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_AwardTypeAxis_ee3da456-8707-47b8-be7f-5fb6df4e6849" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_4b4fcc2b-7620-42f9-996a-b7a8d48fd2b6" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_dmtk_WarrantsToPurchaseCommonStockMember_cf534fd4-1399-4817-b8cf-9bc631533d88" xlink:href="dmtk-20220630.xsd#dmtk_WarrantsToPurchaseCommonStockMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_4b4fcc2b-7620-42f9-996a-b7a8d48fd2b6" xlink:to="loc_dmtk_WarrantsToPurchaseCommonStockMember_cf534fd4-1399-4817-b8cf-9bc631533d88" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_dmtk_SpecialPurposeAcquisitionCompanyWarrantsToPurchaseCommonStockMember_9fece722-c122-443d-bc49-04081f8d81ce" xlink:href="dmtk-20220630.xsd#dmtk_SpecialPurposeAcquisitionCompanyWarrantsToPurchaseCommonStockMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_4b4fcc2b-7620-42f9-996a-b7a8d48fd2b6" xlink:to="loc_dmtk_SpecialPurposeAcquisitionCompanyWarrantsToPurchaseCommonStockMember_9fece722-c122-443d-bc49-04081f8d81ce" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EmployeeStockOptionMember_23e8708c-326d-46d7-a9df-4daacbfbb3d5" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EmployeeStockOptionMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_4b4fcc2b-7620-42f9-996a-b7a8d48fd2b6" xlink:to="loc_us-gaap_EmployeeStockOptionMember_23e8708c-326d-46d7-a9df-4daacbfbb3d5" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestrictedStockUnitsRSUMember_d6ec5fa4-eb79-4ff1-b80d-7f8123b856ce" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RestrictedStockUnitsRSUMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_4b4fcc2b-7620-42f9-996a-b7a8d48fd2b6" xlink:to="loc_us-gaap_RestrictedStockUnitsRSUMember_d6ec5fa4-eb79-4ff1-b80d-7f8123b856ce" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_dmtk_AuthorizedForFutureEquityGrantsMember_d5768727-3f6c-4e77-9d24-627a51302665" xlink:href="dmtk-20220630.xsd#dmtk_AuthorizedForFutureEquityGrantsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_4b4fcc2b-7620-42f9-996a-b7a8d48fd2b6" xlink:to="loc_dmtk_AuthorizedForFutureEquityGrantsMember_d5768727-3f6c-4e77-9d24-627a51302665" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_dmtk_AuthorizedForFutureESPPPurchasesMember_6da9e3ff-6398-48f3-b740-7fdfb7831c89" xlink:href="dmtk-20220630.xsd#dmtk_AuthorizedForFutureESPPPurchasesMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_4b4fcc2b-7620-42f9-996a-b7a8d48fd2b6" xlink:to="loc_dmtk_AuthorizedForFutureESPPPurchasesMember_6da9e3ff-6398-48f3-b740-7fdfb7831c89" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ClassOfWarrantOrRightAxis_dd043450-805c-4039-ad80-a1f79dfdaa28" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ClassOfWarrantOrRightAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfStockByClassTable_69a5128d-d5ac-478d-a295-ea48e61b25a3" xlink:to="loc_us-gaap_ClassOfWarrantOrRightAxis_dd043450-805c-4039-ad80-a1f79dfdaa28" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ClassOfWarrantOrRightDomain_dd043450-805c-4039-ad80-a1f79dfdaa28_default" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ClassOfWarrantOrRightDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_ClassOfWarrantOrRightAxis_dd043450-805c-4039-ad80-a1f79dfdaa28" xlink:to="loc_us-gaap_ClassOfWarrantOrRightDomain_dd043450-805c-4039-ad80-a1f79dfdaa28_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ClassOfWarrantOrRightDomain_15a498ec-6cc6-4f12-9ff7-4be31f4ade6c" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ClassOfWarrantOrRightDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_ClassOfWarrantOrRightAxis_dd043450-805c-4039-ad80-a1f79dfdaa28" xlink:to="loc_us-gaap_ClassOfWarrantOrRightDomain_15a498ec-6cc6-4f12-9ff7-4be31f4ade6c" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_dmtk_SpecialPurposeAcquisitionCompaniesWarrantsMember_1141927c-c70b-47d6-83eb-74e5ab8e7a6c" xlink:href="dmtk-20220630.xsd#dmtk_SpecialPurposeAcquisitionCompaniesWarrantsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ClassOfWarrantOrRightDomain_15a498ec-6cc6-4f12-9ff7-4be31f4ade6c" xlink:to="loc_dmtk_SpecialPurposeAcquisitionCompaniesWarrantsMember_1141927c-c70b-47d6-83eb-74e5ab8e7a6c" xlink:type="arc" order="0"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://dermtech.com/role/LeasesCommitmentsandContingenciesAdoptionofASC842Details" xlink:type="simple" xlink:href="dmtk-20220630.xsd#LeasesCommitmentsandContingenciesAdoptionofASC842Details"/>
  <link:definitionLink xlink:role="http://dermtech.com/role/LeasesCommitmentsandContingenciesAdoptionofASC842Details" xlink:type="extended" id="if64ab0249f7e47d3aba3eacf840f7602_LeasesCommitmentsandContingenciesAdoptionofASC842Details">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NewAccountingPronouncementsOrChangeInAccountingPrincipleLineItems_3c5d8cdb-cda1-4b52-bf73-92730a1daa7d" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NewAccountingPronouncementsOrChangeInAccountingPrincipleLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract_84f28044-03ff-4187-8529-c22a66687c3d" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_NewAccountingPronouncementsOrChangeInAccountingPrincipleLineItems_3c5d8cdb-cda1-4b52-bf73-92730a1daa7d" xlink:to="loc_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract_84f28044-03ff-4187-8529-c22a66687c3d" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeaseRightOfUseAssetAmortizationExpense_1c9c2025-d18f-4bfc-aec2-ebe66f19cd88" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OperatingLeaseRightOfUseAssetAmortizationExpense"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract_84f28044-03ff-4187-8529-c22a66687c3d" xlink:to="loc_us-gaap_OperatingLeaseRightOfUseAssetAmortizationExpense_1c9c2025-d18f-4bfc-aec2-ebe66f19cd88" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInOtherOperatingAssetsAndLiabilitiesNetAbstract_7e508833-db5b-46de-85f0-de7cab7efff0" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncreaseDecreaseInOtherOperatingAssetsAndLiabilitiesNetAbstract"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_NewAccountingPronouncementsOrChangeInAccountingPrincipleLineItems_3c5d8cdb-cda1-4b52-bf73-92730a1daa7d" xlink:to="loc_us-gaap_IncreaseDecreaseInOtherOperatingAssetsAndLiabilitiesNetAbstract_7e508833-db5b-46de-85f0-de7cab7efff0" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeaseLiability_457b44a0-6a47-4404-bd18-097d1686edf1" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OperatingLeaseLiability"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncreaseDecreaseInOtherOperatingAssetsAndLiabilitiesNetAbstract_7e508833-db5b-46de-85f0-de7cab7efff0" xlink:to="loc_us-gaap_OperatingLeaseLiability_457b44a0-6a47-4404-bd18-097d1686edf1" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherLiabilities_407064a1-c96c-4444-b548-fa6fdd03575b" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherLiabilities"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncreaseDecreaseInOtherOperatingAssetsAndLiabilitiesNetAbstract_7e508833-db5b-46de-85f0-de7cab7efff0" xlink:to="loc_us-gaap_OtherLiabilities_407064a1-c96c-4444-b548-fa6fdd03575b" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NewAccountingPronouncementsOrChangeInAccountingPrincipleTable_9cde0d43-432a-4821-8656-c7beb3b10889" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NewAccountingPronouncementsOrChangeInAccountingPrincipleTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_NewAccountingPronouncementsOrChangeInAccountingPrincipleLineItems_3c5d8cdb-cda1-4b52-bf73-92730a1daa7d" xlink:to="loc_us-gaap_NewAccountingPronouncementsOrChangeInAccountingPrincipleTable_9cde0d43-432a-4821-8656-c7beb3b10889" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AdjustmentsForNewAccountingPronouncementsAxis_08277cd0-78ae-46ad-af14-d327afeb7e3a" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AdjustmentsForNewAccountingPronouncementsAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_NewAccountingPronouncementsOrChangeInAccountingPrincipleTable_9cde0d43-432a-4821-8656-c7beb3b10889" xlink:to="loc_us-gaap_AdjustmentsForNewAccountingPronouncementsAxis_08277cd0-78ae-46ad-af14-d327afeb7e3a" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TypeOfAdoptionMember_08277cd0-78ae-46ad-af14-d327afeb7e3a_default" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_TypeOfAdoptionMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_AdjustmentsForNewAccountingPronouncementsAxis_08277cd0-78ae-46ad-af14-d327afeb7e3a" xlink:to="loc_us-gaap_TypeOfAdoptionMember_08277cd0-78ae-46ad-af14-d327afeb7e3a_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TypeOfAdoptionMember_727d312e-b0dc-4f55-9d9e-351c365b09eb" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_TypeOfAdoptionMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_AdjustmentsForNewAccountingPronouncementsAxis_08277cd0-78ae-46ad-af14-d327afeb7e3a" xlink:to="loc_us-gaap_TypeOfAdoptionMember_727d312e-b0dc-4f55-9d9e-351c365b09eb" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccountingStandardsUpdate201602Member_abd50a96-9760-49c3-92d9-105aa33a5e21" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AccountingStandardsUpdate201602Member"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_TypeOfAdoptionMember_727d312e-b0dc-4f55-9d9e-351c365b09eb" xlink:to="loc_us-gaap_AccountingStandardsUpdate201602Member_abd50a96-9760-49c3-92d9-105aa33a5e21" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_CumulativeEffectPeriodOfAdoptionAxis_a0084a94-3b5f-4e43-b07d-35816cfd43c1" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_CumulativeEffectPeriodOfAdoptionAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_NewAccountingPronouncementsOrChangeInAccountingPrincipleTable_9cde0d43-432a-4821-8656-c7beb3b10889" xlink:to="loc_srt_CumulativeEffectPeriodOfAdoptionAxis_a0084a94-3b5f-4e43-b07d-35816cfd43c1" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_CumulativeEffectPeriodOfAdoptionDomain_a0084a94-3b5f-4e43-b07d-35816cfd43c1_default" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_CumulativeEffectPeriodOfAdoptionDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_srt_CumulativeEffectPeriodOfAdoptionAxis_a0084a94-3b5f-4e43-b07d-35816cfd43c1" xlink:to="loc_srt_CumulativeEffectPeriodOfAdoptionDomain_a0084a94-3b5f-4e43-b07d-35816cfd43c1_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_CumulativeEffectPeriodOfAdoptionDomain_1d0cd232-ac22-42bf-97df-4bb0d94545be" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_CumulativeEffectPeriodOfAdoptionDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_srt_CumulativeEffectPeriodOfAdoptionAxis_a0084a94-3b5f-4e43-b07d-35816cfd43c1" xlink:to="loc_srt_CumulativeEffectPeriodOfAdoptionDomain_1d0cd232-ac22-42bf-97df-4bb0d94545be" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_CumulativeEffectPeriodOfAdoptionAdjustmentMember_af48c331-7859-45a0-ab9e-f159362a5dad" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_CumulativeEffectPeriodOfAdoptionAdjustmentMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_CumulativeEffectPeriodOfAdoptionDomain_1d0cd232-ac22-42bf-97df-4bb0d94545be" xlink:to="loc_srt_CumulativeEffectPeriodOfAdoptionAdjustmentMember_af48c331-7859-45a0-ab9e-f159362a5dad" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_CumulativeEffectPeriodOfAdoptionAdjustedBalanceMember_dce0eaea-a7fd-4f40-babc-a12aff704242" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_CumulativeEffectPeriodOfAdoptionAdjustedBalanceMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_CumulativeEffectPeriodOfAdoptionDomain_1d0cd232-ac22-42bf-97df-4bb0d94545be" xlink:to="loc_srt_CumulativeEffectPeriodOfAdoptionAdjustedBalanceMember_dce0eaea-a7fd-4f40-babc-a12aff704242" xlink:type="arc" order="1"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://dermtech.com/role/LeasesCommitmentsandContingenciesAdditionalInformationDetails" xlink:type="simple" xlink:href="dmtk-20220630.xsd#LeasesCommitmentsandContingenciesAdditionalInformationDetails"/>
  <link:definitionLink xlink:role="http://dermtech.com/role/LeasesCommitmentsandContingenciesAdditionalInformationDetails" xlink:type="extended" id="i6861365b2f594087ab1332133d9a1892_LeasesCommitmentsandContingenciesAdditionalInformationDetails">
    <link:loc xlink:type="locator" xlink:label="loc_dmtk_CommitmentsAndContingenciesLineItems_d24de695-d90c-4388-96d5-68f91264e2aa" xlink:href="dmtk-20220630.xsd#dmtk_CommitmentsAndContingenciesLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_dmtk_PercentageOfUsefulLivesOfAssets_19c0a6eb-0982-45a7-86ee-4117f3852387" xlink:href="dmtk-20220630.xsd#dmtk_PercentageOfUsefulLivesOfAssets"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_dmtk_CommitmentsAndContingenciesLineItems_d24de695-d90c-4388-96d5-68f91264e2aa" xlink:to="loc_dmtk_PercentageOfUsefulLivesOfAssets_19c0a6eb-0982-45a7-86ee-4117f3852387" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentGross_ce623fd2-a345-4796-93cc-e69c010304e3" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PropertyPlantAndEquipmentGross"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_dmtk_CommitmentsAndContingenciesLineItems_d24de695-d90c-4388-96d5-68f91264e2aa" xlink:to="loc_us-gaap_PropertyPlantAndEquipmentGross_ce623fd2-a345-4796-93cc-e69c010304e3" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DepreciationAndAmortization_52f2215d-c827-4709-9624-6170658d03ca" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DepreciationAndAmortization"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_dmtk_CommitmentsAndContingenciesLineItems_d24de695-d90c-4388-96d5-68f91264e2aa" xlink:to="loc_us-gaap_DepreciationAndAmortization_52f2215d-c827-4709-9624-6170658d03ca" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FinanceLeaseInterestExpense_ea558448-4967-45bc-a35c-830f669591b0" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FinanceLeaseInterestExpense"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_dmtk_CommitmentsAndContingenciesLineItems_d24de695-d90c-4388-96d5-68f91264e2aa" xlink:to="loc_us-gaap_FinanceLeaseInterestExpense_ea558448-4967-45bc-a35c-830f669591b0" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_dmtk_AreaOfBuilding_a166278b-bd91-4a6e-93fa-d1630f6119dc" xlink:href="dmtk-20220630.xsd#dmtk_AreaOfBuilding"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_dmtk_CommitmentsAndContingenciesLineItems_d24de695-d90c-4388-96d5-68f91264e2aa" xlink:to="loc_dmtk_AreaOfBuilding_a166278b-bd91-4a6e-93fa-d1630f6119dc" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_dmtk_TenantImprovementAllowancePerRentableSquareFoot_58155933-8326-4440-96ce-8975280baaf0" xlink:href="dmtk-20220630.xsd#dmtk_TenantImprovementAllowancePerRentableSquareFoot"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_dmtk_CommitmentsAndContingenciesLineItems_d24de695-d90c-4388-96d5-68f91264e2aa" xlink:to="loc_dmtk_TenantImprovementAllowancePerRentableSquareFoot_58155933-8326-4440-96ce-8975280baaf0" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TenantImprovements_ffd7f28e-c45f-4069-8089-145f99c4fbec" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_TenantImprovements"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_dmtk_CommitmentsAndContingenciesLineItems_d24de695-d90c-4388-96d5-68f91264e2aa" xlink:to="loc_us-gaap_TenantImprovements_ffd7f28e-c45f-4069-8089-145f99c4fbec" xlink:type="arc" order="6"/>
    <link:loc xlink:type="locator" xlink:label="loc_dmtk_NumberOfImprovementPhases_d7c4ce40-dc8f-4343-a5f3-e8b805909f85" xlink:href="dmtk-20220630.xsd#dmtk_NumberOfImprovementPhases"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_dmtk_CommitmentsAndContingenciesLineItems_d24de695-d90c-4388-96d5-68f91264e2aa" xlink:to="loc_dmtk_NumberOfImprovementPhases_d7c4ce40-dc8f-4343-a5f3-e8b805909f85" xlink:type="arc" order="7"/>
    <link:loc xlink:type="locator" xlink:label="loc_dmtk_LesseeOperatingLeaseNumberOfRenewalTerms_39be3d11-faf8-4719-ac2c-9faffb5b95d7" xlink:href="dmtk-20220630.xsd#dmtk_LesseeOperatingLeaseNumberOfRenewalTerms"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_dmtk_CommitmentsAndContingenciesLineItems_d24de695-d90c-4388-96d5-68f91264e2aa" xlink:to="loc_dmtk_LesseeOperatingLeaseNumberOfRenewalTerms_39be3d11-faf8-4719-ac2c-9faffb5b95d7" xlink:type="arc" order="8"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeOperatingLeaseRenewalTerm_56329a62-f121-4544-96b3-325d5aef48a2" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LesseeOperatingLeaseRenewalTerm"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_dmtk_CommitmentsAndContingenciesLineItems_d24de695-d90c-4388-96d5-68f91264e2aa" xlink:to="loc_us-gaap_LesseeOperatingLeaseRenewalTerm_56329a62-f121-4544-96b3-325d5aef48a2" xlink:type="arc" order="9"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeaseRightOfUseAsset_5b1a2e88-aff4-440d-895f-828b5c2d4e27" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OperatingLeaseRightOfUseAsset"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_dmtk_CommitmentsAndContingenciesLineItems_d24de695-d90c-4388-96d5-68f91264e2aa" xlink:to="loc_us-gaap_OperatingLeaseRightOfUseAsset_5b1a2e88-aff4-440d-895f-828b5c2d4e27" xlink:type="arc" order="10"/>
    <link:loc xlink:type="locator" xlink:label="loc_dmtk_IncreaseInTenantImprovementAllowancePerRentableSquareFoot_1a845905-b90e-4aee-b336-770cdc0fd2b8" xlink:href="dmtk-20220630.xsd#dmtk_IncreaseInTenantImprovementAllowancePerRentableSquareFoot"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_dmtk_CommitmentsAndContingenciesLineItems_d24de695-d90c-4388-96d5-68f91264e2aa" xlink:to="loc_dmtk_IncreaseInTenantImprovementAllowancePerRentableSquareFoot_1a845905-b90e-4aee-b336-770cdc0fd2b8" xlink:type="arc" order="11"/>
    <link:loc xlink:type="locator" xlink:label="loc_dmtk_IncreaseInTenantImprovementAllowance_4d5f9c79-9272-4c00-be4e-22228a16f69a" xlink:href="dmtk-20220630.xsd#dmtk_IncreaseInTenantImprovementAllowance"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_dmtk_CommitmentsAndContingenciesLineItems_d24de695-d90c-4388-96d5-68f91264e2aa" xlink:to="loc_dmtk_IncreaseInTenantImprovementAllowance_4d5f9c79-9272-4c00-be4e-22228a16f69a" xlink:type="arc" order="12"/>
    <link:loc xlink:type="locator" xlink:label="loc_dmtk_RentableAndUsableSquareFeet_57eae4a1-8acf-4da7-a593-48acc4eec80e" xlink:href="dmtk-20220630.xsd#dmtk_RentableAndUsableSquareFeet"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_dmtk_CommitmentsAndContingenciesLineItems_d24de695-d90c-4388-96d5-68f91264e2aa" xlink:to="loc_dmtk_RentableAndUsableSquareFeet_57eae4a1-8acf-4da7-a593-48acc4eec80e" xlink:type="arc" order="13"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeaseLiability_e3bf3edc-09e9-40e2-a1b2-b9c4c5f35c31" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OperatingLeaseLiability"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_dmtk_CommitmentsAndContingenciesLineItems_d24de695-d90c-4388-96d5-68f91264e2aa" xlink:to="loc_us-gaap_OperatingLeaseLiability_e3bf3edc-09e9-40e2-a1b2-b9c4c5f35c31" xlink:type="arc" order="14"/>
    <link:loc xlink:type="locator" xlink:label="loc_dmtk_OperatingLeaseIncrementalBorrowingRateAtEffectiveDate_c79db5ce-e215-46d2-a09e-3b484e3b0e1c" xlink:href="dmtk-20220630.xsd#dmtk_OperatingLeaseIncrementalBorrowingRateAtEffectiveDate"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_dmtk_CommitmentsAndContingenciesLineItems_d24de695-d90c-4388-96d5-68f91264e2aa" xlink:to="loc_dmtk_OperatingLeaseIncrementalBorrowingRateAtEffectiveDate_c79db5ce-e215-46d2-a09e-3b484e3b0e1c" xlink:type="arc" order="15"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInOperatingLeaseLiability_da8be4d5-8fc4-401c-9442-d9534a103a64" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncreaseDecreaseInOperatingLeaseLiability"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_dmtk_CommitmentsAndContingenciesLineItems_d24de695-d90c-4388-96d5-68f91264e2aa" xlink:to="loc_us-gaap_IncreaseDecreaseInOperatingLeaseLiability_da8be4d5-8fc4-401c-9442-d9534a103a64" xlink:type="arc" order="16"/>
    <link:loc xlink:type="locator" xlink:label="loc_dmtk_IncreaseDecreaseInOperatingLeaseRightOfUseAsset_5cecf4b6-8aaf-47ed-8241-7aaf58b70afa" xlink:href="dmtk-20220630.xsd#dmtk_IncreaseDecreaseInOperatingLeaseRightOfUseAsset"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_dmtk_CommitmentsAndContingenciesLineItems_d24de695-d90c-4388-96d5-68f91264e2aa" xlink:to="loc_dmtk_IncreaseDecreaseInOperatingLeaseRightOfUseAsset_5cecf4b6-8aaf-47ed-8241-7aaf58b70afa" xlink:type="arc" order="17"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue_a578da29-d2e2-4229-9bb6-b3100df23470" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_dmtk_CommitmentsAndContingenciesLineItems_d24de695-d90c-4388-96d5-68f91264e2aa" xlink:to="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue_a578da29-d2e2-4229-9bb6-b3100df23470" xlink:type="arc" order="18"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestrictedCashAndCashEquivalents_7dcd93a6-f4c7-493c-8e82-42780dc02ee7" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RestrictedCashAndCashEquivalents"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_dmtk_CommitmentsAndContingenciesLineItems_d24de695-d90c-4388-96d5-68f91264e2aa" xlink:to="loc_us-gaap_RestrictedCashAndCashEquivalents_7dcd93a6-f4c7-493c-8e82-42780dc02ee7" xlink:type="arc" order="19"/>
    <link:loc xlink:type="locator" xlink:label="loc_dmtk_RestrictedCashAndCashEquivalentsIncreaseDecrease_40d328f8-56c6-4253-a877-1dee8f2a3f25" xlink:href="dmtk-20220630.xsd#dmtk_RestrictedCashAndCashEquivalentsIncreaseDecrease"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_dmtk_CommitmentsAndContingenciesLineItems_d24de695-d90c-4388-96d5-68f91264e2aa" xlink:to="loc_dmtk_RestrictedCashAndCashEquivalentsIncreaseDecrease_40d328f8-56c6-4253-a877-1dee8f2a3f25" xlink:type="arc" order="20"/>
    <link:loc xlink:type="locator" xlink:label="loc_dmtk_TenantImprovementAllowance_455eff75-1896-48a5-bf8c-8ed6f2a8be8a" xlink:href="dmtk-20220630.xsd#dmtk_TenantImprovementAllowance"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_dmtk_CommitmentsAndContingenciesLineItems_d24de695-d90c-4388-96d5-68f91264e2aa" xlink:to="loc_dmtk_TenantImprovementAllowance_455eff75-1896-48a5-bf8c-8ed6f2a8be8a" xlink:type="arc" order="21"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeOperatingLeaseRemainingLeaseTerm_7d772107-f704-4903-90bd-982269764357" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LesseeOperatingLeaseRemainingLeaseTerm"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_dmtk_CommitmentsAndContingenciesLineItems_d24de695-d90c-4388-96d5-68f91264e2aa" xlink:to="loc_us-gaap_LesseeOperatingLeaseRemainingLeaseTerm_7d772107-f704-4903-90bd-982269764357" xlink:type="arc" order="22"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeOperatingLeaseDiscountRate_27a1d10e-c583-4bcf-8427-168192d8c385" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LesseeOperatingLeaseDiscountRate"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_dmtk_CommitmentsAndContingenciesLineItems_d24de695-d90c-4388-96d5-68f91264e2aa" xlink:to="loc_us-gaap_LesseeOperatingLeaseDiscountRate_27a1d10e-c583-4bcf-8427-168192d8c385" xlink:type="arc" order="23"/>
    <link:loc xlink:type="locator" xlink:label="loc_dmtk_CommitmentsAndContingenciesTable_2c2294c8-849b-4277-b8fd-f55918436fd9" xlink:href="dmtk-20220630.xsd#dmtk_CommitmentsAndContingenciesTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_dmtk_CommitmentsAndContingenciesLineItems_d24de695-d90c-4388-96d5-68f91264e2aa" xlink:to="loc_dmtk_CommitmentsAndContingenciesTable_2c2294c8-849b-4277-b8fd-f55918436fd9" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentByTypeAxis_a4c11451-65b3-4831-9574-7a95d1b762e8" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PropertyPlantAndEquipmentByTypeAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_dmtk_CommitmentsAndContingenciesTable_2c2294c8-849b-4277-b8fd-f55918436fd9" xlink:to="loc_us-gaap_PropertyPlantAndEquipmentByTypeAxis_a4c11451-65b3-4831-9574-7a95d1b762e8" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentTypeDomain_a4c11451-65b3-4831-9574-7a95d1b762e8_default" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PropertyPlantAndEquipmentTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentByTypeAxis_a4c11451-65b3-4831-9574-7a95d1b762e8" xlink:to="loc_us-gaap_PropertyPlantAndEquipmentTypeDomain_a4c11451-65b3-4831-9574-7a95d1b762e8_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentTypeDomain_e7610053-6abd-42c7-b480-c007f03673d6" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PropertyPlantAndEquipmentTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentByTypeAxis_a4c11451-65b3-4831-9574-7a95d1b762e8" xlink:to="loc_us-gaap_PropertyPlantAndEquipmentTypeDomain_e7610053-6abd-42c7-b480-c007f03673d6" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_dmtk_AssetsHeldUnderFinanceLeasesMember_53df728d-59ae-4d73-8ec9-2adbaa457202" xlink:href="dmtk-20220630.xsd#dmtk_AssetsHeldUnderFinanceLeasesMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentTypeDomain_e7610053-6abd-42c7-b480-c007f03673d6" xlink:to="loc_dmtk_AssetsHeldUnderFinanceLeasesMember_53df728d-59ae-4d73-8ec9-2adbaa457202" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeStatementLocationAxis_65855f13-b6a1-4562-b341-f3f2d3594036" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeStatementLocationAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_dmtk_CommitmentsAndContingenciesTable_2c2294c8-849b-4277-b8fd-f55918436fd9" xlink:to="loc_us-gaap_IncomeStatementLocationAxis_65855f13-b6a1-4562-b341-f3f2d3594036" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeStatementLocationDomain_65855f13-b6a1-4562-b341-f3f2d3594036_default" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeStatementLocationDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_IncomeStatementLocationAxis_65855f13-b6a1-4562-b341-f3f2d3594036" xlink:to="loc_us-gaap_IncomeStatementLocationDomain_65855f13-b6a1-4562-b341-f3f2d3594036_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeStatementLocationDomain_7252fd6e-dab7-4d1a-9355-5e6032ab46ed" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeStatementLocationDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_IncomeStatementLocationAxis_65855f13-b6a1-4562-b341-f3f2d3594036" xlink:to="loc_us-gaap_IncomeStatementLocationDomain_7252fd6e-dab7-4d1a-9355-5e6032ab46ed" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InterestIncomeMember_4b457eb8-7ea5-40f2-8cfd-90339c1aef2f" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_InterestIncomeMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncomeStatementLocationDomain_7252fd6e-dab7-4d1a-9355-5e6032ab46ed" xlink:to="loc_us-gaap_InterestIncomeMember_4b457eb8-7ea5-40f2-8cfd-90339c1aef2f" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_CounterpartyNameAxis_ae208273-23c2-4d85-a96a-400e7a878ed5" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_CounterpartyNameAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_dmtk_CommitmentsAndContingenciesTable_2c2294c8-849b-4277-b8fd-f55918436fd9" xlink:to="loc_srt_CounterpartyNameAxis_ae208273-23c2-4d85-a96a-400e7a878ed5" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RepurchaseAgreementCounterpartyNameDomain_ae208273-23c2-4d85-a96a-400e7a878ed5_default" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_RepurchaseAgreementCounterpartyNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_srt_CounterpartyNameAxis_ae208273-23c2-4d85-a96a-400e7a878ed5" xlink:to="loc_srt_RepurchaseAgreementCounterpartyNameDomain_ae208273-23c2-4d85-a96a-400e7a878ed5_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RepurchaseAgreementCounterpartyNameDomain_4483823c-0592-4742-bde4-7b21b9899455" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_RepurchaseAgreementCounterpartyNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_srt_CounterpartyNameAxis_ae208273-23c2-4d85-a96a-400e7a878ed5" xlink:to="loc_srt_RepurchaseAgreementCounterpartyNameDomain_4483823c-0592-4742-bde4-7b21b9899455" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_dmtk_KilroyRealtyLPMember_b3cb872a-b916-417a-98c2-5358798c6ae1" xlink:href="dmtk-20220630.xsd#dmtk_KilroyRealtyLPMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_RepurchaseAgreementCounterpartyNameDomain_4483823c-0592-4742-bde4-7b21b9899455" xlink:to="loc_dmtk_KilroyRealtyLPMember_b3cb872a-b916-417a-98c2-5358798c6ae1" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CreditFacilityAxis_b964033e-cd1d-4d17-af00-143c0813b7ce" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CreditFacilityAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_dmtk_CommitmentsAndContingenciesTable_2c2294c8-849b-4277-b8fd-f55918436fd9" xlink:to="loc_us-gaap_CreditFacilityAxis_b964033e-cd1d-4d17-af00-143c0813b7ce" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CreditFacilityDomain_b964033e-cd1d-4d17-af00-143c0813b7ce_default" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CreditFacilityDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_CreditFacilityAxis_b964033e-cd1d-4d17-af00-143c0813b7ce" xlink:to="loc_us-gaap_CreditFacilityDomain_b964033e-cd1d-4d17-af00-143c0813b7ce_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CreditFacilityDomain_f3a5c358-cb34-4c88-ba83-02b9d121f472" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CreditFacilityDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_CreditFacilityAxis_b964033e-cd1d-4d17-af00-143c0813b7ce" xlink:to="loc_us-gaap_CreditFacilityDomain_f3a5c358-cb34-4c88-ba83-02b9d121f472" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LetterOfCreditMember_bed0724c-62ae-4016-b157-b00c7d9c9fc9" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LetterOfCreditMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_CreditFacilityDomain_f3a5c358-cb34-4c88-ba83-02b9d121f472" xlink:to="loc_us-gaap_LetterOfCreditMember_bed0724c-62ae-4016-b157-b00c7d9c9fc9" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StandbyLettersOfCreditMember_b76d0bba-9e26-42ce-90a4-5669fc8f0459" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StandbyLettersOfCreditMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_CreditFacilityDomain_f3a5c358-cb34-4c88-ba83-02b9d121f472" xlink:to="loc_us-gaap_StandbyLettersOfCreditMember_b76d0bba-9e26-42ce-90a4-5669fc8f0459" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeAxis_8d5057e0-648e-47b6-8e30-9a724228d866" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_RangeAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_dmtk_CommitmentsAndContingenciesTable_2c2294c8-849b-4277-b8fd-f55918436fd9" xlink:to="loc_srt_RangeAxis_8d5057e0-648e-47b6-8e30-9a724228d866" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeMember_8d5057e0-648e-47b6-8e30-9a724228d866_default" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_RangeMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_srt_RangeAxis_8d5057e0-648e-47b6-8e30-9a724228d866" xlink:to="loc_srt_RangeMember_8d5057e0-648e-47b6-8e30-9a724228d866_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeMember_357a7450-c1e0-4030-8660-fa80b291cee1" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_RangeMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_srt_RangeAxis_8d5057e0-648e-47b6-8e30-9a724228d866" xlink:to="loc_srt_RangeMember_357a7450-c1e0-4030-8660-fa80b291cee1" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_MaximumMember_e6bddf5b-1015-43db-8bc1-69ce5eac7063" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_MaximumMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_RangeMember_357a7450-c1e0-4030-8660-fa80b291cee1" xlink:to="loc_srt_MaximumMember_e6bddf5b-1015-43db-8bc1-69ce5eac7063" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestrictedCashAndCashEquivalentsCashAndCashEquivalentsAxis_992317c1-7272-418b-8938-c23b8b16f1f0" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RestrictedCashAndCashEquivalentsCashAndCashEquivalentsAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_dmtk_CommitmentsAndContingenciesTable_2c2294c8-849b-4277-b8fd-f55918436fd9" xlink:to="loc_us-gaap_RestrictedCashAndCashEquivalentsCashAndCashEquivalentsAxis_992317c1-7272-418b-8938-c23b8b16f1f0" xlink:type="arc" order="6"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestrictedCashAndCashEquivalentsCashAndCashEquivalentsMember_992317c1-7272-418b-8938-c23b8b16f1f0_default" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RestrictedCashAndCashEquivalentsCashAndCashEquivalentsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_RestrictedCashAndCashEquivalentsCashAndCashEquivalentsAxis_992317c1-7272-418b-8938-c23b8b16f1f0" xlink:to="loc_us-gaap_RestrictedCashAndCashEquivalentsCashAndCashEquivalentsMember_992317c1-7272-418b-8938-c23b8b16f1f0_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestrictedCashAndCashEquivalentsCashAndCashEquivalentsMember_67047a88-67f1-4fac-9160-61bf3edde121" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RestrictedCashAndCashEquivalentsCashAndCashEquivalentsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_RestrictedCashAndCashEquivalentsCashAndCashEquivalentsAxis_992317c1-7272-418b-8938-c23b8b16f1f0" xlink:to="loc_us-gaap_RestrictedCashAndCashEquivalentsCashAndCashEquivalentsMember_67047a88-67f1-4fac-9160-61bf3edde121" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DemandDepositsMember_59d689e5-2a99-4cfa-b3aa-361d97a8ebe2" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DemandDepositsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_RestrictedCashAndCashEquivalentsCashAndCashEquivalentsMember_67047a88-67f1-4fac-9160-61bf3edde121" xlink:to="loc_us-gaap_DemandDepositsMember_59d689e5-2a99-4cfa-b3aa-361d97a8ebe2" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_dmtk_LeaseAmendmentsAxis_87b4f953-3f94-4a47-af01-ef85afa3c16c" xlink:href="dmtk-20220630.xsd#dmtk_LeaseAmendmentsAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_dmtk_CommitmentsAndContingenciesTable_2c2294c8-849b-4277-b8fd-f55918436fd9" xlink:to="loc_dmtk_LeaseAmendmentsAxis_87b4f953-3f94-4a47-af01-ef85afa3c16c" xlink:type="arc" order="7"/>
    <link:loc xlink:type="locator" xlink:label="loc_dmtk_LeaseAmendmentsDomain_87b4f953-3f94-4a47-af01-ef85afa3c16c_default" xlink:href="dmtk-20220630.xsd#dmtk_LeaseAmendmentsDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_dmtk_LeaseAmendmentsAxis_87b4f953-3f94-4a47-af01-ef85afa3c16c" xlink:to="loc_dmtk_LeaseAmendmentsDomain_87b4f953-3f94-4a47-af01-ef85afa3c16c_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_dmtk_LeaseAmendmentsDomain_0ad00eab-cda2-40a8-bc0f-7446368ebdc8" xlink:href="dmtk-20220630.xsd#dmtk_LeaseAmendmentsDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_dmtk_LeaseAmendmentsAxis_87b4f953-3f94-4a47-af01-ef85afa3c16c" xlink:to="loc_dmtk_LeaseAmendmentsDomain_0ad00eab-cda2-40a8-bc0f-7446368ebdc8" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_dmtk_FirstAmendmentMember_ee895a40-0837-42e2-a5ab-38cf88555fa2" xlink:href="dmtk-20220630.xsd#dmtk_FirstAmendmentMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_dmtk_LeaseAmendmentsDomain_0ad00eab-cda2-40a8-bc0f-7446368ebdc8" xlink:to="loc_dmtk_FirstAmendmentMember_ee895a40-0837-42e2-a5ab-38cf88555fa2" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_dmtk_SecondAmendmentMember_2f8c14d7-2cd0-43c8-8e51-ed577c43f6d4" xlink:href="dmtk-20220630.xsd#dmtk_SecondAmendmentMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_dmtk_LeaseAmendmentsDomain_0ad00eab-cda2-40a8-bc0f-7446368ebdc8" xlink:to="loc_dmtk_SecondAmendmentMember_2f8c14d7-2cd0-43c8-8e51-ed577c43f6d4" xlink:type="arc" order="1"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://dermtech.com/role/RelatedPartyTransactionsAdditionalInformationDetails" xlink:type="simple" xlink:href="dmtk-20220630.xsd#RelatedPartyTransactionsAdditionalInformationDetails"/>
  <link:definitionLink xlink:role="http://dermtech.com/role/RelatedPartyTransactionsAdditionalInformationDetails" xlink:type="extended" id="i7b0e321d200744df92d9da81c8fdeda4_RelatedPartyTransactionsAdditionalInformationDetails">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RelatedPartyTransactionLineItems_a45f0ba5-689c-41c9-b0fc-7f94dc2e3e4c" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RelatedPartyTransactionLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RelatedPartyTransactionSellingGeneralAndAdministrativeExpensesFromTransactionsWithRelatedParty_a744e7f5-0208-4c77-99b4-065d18ab3988" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RelatedPartyTransactionSellingGeneralAndAdministrativeExpensesFromTransactionsWithRelatedParty"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_RelatedPartyTransactionLineItems_a45f0ba5-689c-41c9-b0fc-7f94dc2e3e4c" xlink:to="loc_us-gaap_RelatedPartyTransactionSellingGeneralAndAdministrativeExpensesFromTransactionsWithRelatedParty_a744e7f5-0208-4c77-99b4-065d18ab3988" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockSharesIssued_eb0ac3de-a229-4203-a2d9-492bc43f549c" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CommonStockSharesIssued"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_RelatedPartyTransactionLineItems_a45f0ba5-689c-41c9-b0fc-7f94dc2e3e4c" xlink:to="loc_us-gaap_CommonStockSharesIssued_eb0ac3de-a229-4203-a2d9-492bc43f549c" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RelatedPartyTransactionExpensesFromTransactionsWithRelatedParty_1dc9c27c-4f4b-4cc5-b136-13e4b305e372" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RelatedPartyTransactionExpensesFromTransactionsWithRelatedParty"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_RelatedPartyTransactionLineItems_a45f0ba5-689c-41c9-b0fc-7f94dc2e3e4c" xlink:to="loc_us-gaap_RelatedPartyTransactionExpensesFromTransactionsWithRelatedParty_1dc9c27c-4f4b-4cc5-b136-13e4b305e372" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfRelatedPartyTransactionsByRelatedPartyTable_7f938250-c13c-4013-98bc-28ebdd02fc95" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfRelatedPartyTransactionsByRelatedPartyTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_RelatedPartyTransactionLineItems_a45f0ba5-689c-41c9-b0fc-7f94dc2e3e4c" xlink:to="loc_us-gaap_ScheduleOfRelatedPartyTransactionsByRelatedPartyTable_7f938250-c13c-4013-98bc-28ebdd02fc95" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RelatedPartyTransactionAxis_70c11db8-c73d-40bb-bf31-a09f0ffb5952" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RelatedPartyTransactionAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfRelatedPartyTransactionsByRelatedPartyTable_7f938250-c13c-4013-98bc-28ebdd02fc95" xlink:to="loc_us-gaap_RelatedPartyTransactionAxis_70c11db8-c73d-40bb-bf31-a09f0ffb5952" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RelatedPartyTransactionDomain_70c11db8-c73d-40bb-bf31-a09f0ffb5952_default" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RelatedPartyTransactionDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_RelatedPartyTransactionAxis_70c11db8-c73d-40bb-bf31-a09f0ffb5952" xlink:to="loc_us-gaap_RelatedPartyTransactionDomain_70c11db8-c73d-40bb-bf31-a09f0ffb5952_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RelatedPartyTransactionDomain_3c78c66c-259b-4549-92d0-f3c9a6714568" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RelatedPartyTransactionDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_RelatedPartyTransactionAxis_70c11db8-c73d-40bb-bf31-a09f0ffb5952" xlink:to="loc_us-gaap_RelatedPartyTransactionDomain_3c78c66c-259b-4549-92d0-f3c9a6714568" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_dmtk_EVERSANALifeScienceServicesLLCMember_ad0ffbdb-d7d3-46f7-8096-3adbbccab0d1" xlink:href="dmtk-20220630.xsd#dmtk_EVERSANALifeScienceServicesLLCMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_RelatedPartyTransactionDomain_3c78c66c-259b-4549-92d0-f3c9a6714568" xlink:to="loc_dmtk_EVERSANALifeScienceServicesLLCMember_ad0ffbdb-d7d3-46f7-8096-3adbbccab0d1" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_dmtk_DermTechOperationsIncMember_d56eae0d-299a-411d-9eb0-fcb7a7cbbf4f" xlink:href="dmtk-20220630.xsd#dmtk_DermTechOperationsIncMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_RelatedPartyTransactionDomain_3c78c66c-259b-4549-92d0-f3c9a6714568" xlink:to="loc_dmtk_DermTechOperationsIncMember_d56eae0d-299a-411d-9eb0-fcb7a7cbbf4f" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RelatedPartyTransactionsByRelatedPartyAxis_48551bbe-a426-492c-affa-fa37aab42e91" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RelatedPartyTransactionsByRelatedPartyAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfRelatedPartyTransactionsByRelatedPartyTable_7f938250-c13c-4013-98bc-28ebdd02fc95" xlink:to="loc_us-gaap_RelatedPartyTransactionsByRelatedPartyAxis_48551bbe-a426-492c-affa-fa37aab42e91" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RelatedPartyDomain_48551bbe-a426-492c-affa-fa37aab42e91_default" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RelatedPartyDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_RelatedPartyTransactionsByRelatedPartyAxis_48551bbe-a426-492c-affa-fa37aab42e91" xlink:to="loc_us-gaap_RelatedPartyDomain_48551bbe-a426-492c-affa-fa37aab42e91_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RelatedPartyDomain_4d915b0a-fe7c-42a5-a0aa-055c22554d67" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RelatedPartyDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_RelatedPartyTransactionsByRelatedPartyAxis_48551bbe-a426-492c-affa-fa37aab42e91" xlink:to="loc_us-gaap_RelatedPartyDomain_4d915b0a-fe7c-42a5-a0aa-055c22554d67" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_dmtk_SpouseOfChiefCommercialOfficerMember_06924935-619c-4631-9b2e-d5699392424f" xlink:href="dmtk-20220630.xsd#dmtk_SpouseOfChiefCommercialOfficerMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_RelatedPartyDomain_4d915b0a-fe7c-42a5-a0aa-055c22554d67" xlink:to="loc_dmtk_SpouseOfChiefCommercialOfficerMember_06924935-619c-4631-9b2e-d5699392424f" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_dmtk_BrotherOfChiefExecutiveOfficerMember_0a0343ce-5e85-44f3-b47b-df542695dbea" xlink:href="dmtk-20220630.xsd#dmtk_BrotherOfChiefExecutiveOfficerMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_RelatedPartyDomain_4d915b0a-fe7c-42a5-a0aa-055c22554d67" xlink:to="loc_dmtk_BrotherOfChiefExecutiveOfficerMember_0a0343ce-5e85-44f3-b47b-df542695dbea" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeAxis_611ab9bc-5568-4c0e-ab98-c5006cbab4d1" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_RangeAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfRelatedPartyTransactionsByRelatedPartyTable_7f938250-c13c-4013-98bc-28ebdd02fc95" xlink:to="loc_srt_RangeAxis_611ab9bc-5568-4c0e-ab98-c5006cbab4d1" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeMember_611ab9bc-5568-4c0e-ab98-c5006cbab4d1_default" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_RangeMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_srt_RangeAxis_611ab9bc-5568-4c0e-ab98-c5006cbab4d1" xlink:to="loc_srt_RangeMember_611ab9bc-5568-4c0e-ab98-c5006cbab4d1_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeMember_d0ff829b-39bd-49c2-b539-7a9c0f0068ca" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_RangeMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_srt_RangeAxis_611ab9bc-5568-4c0e-ab98-c5006cbab4d1" xlink:to="loc_srt_RangeMember_d0ff829b-39bd-49c2-b539-7a9c0f0068ca" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_MaximumMember_855ccdb9-b5c1-41dc-bf6f-430027c95931" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_MaximumMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_RangeMember_d0ff829b-39bd-49c2-b539-7a9c0f0068ca" xlink:to="loc_srt_MaximumMember_855ccdb9-b5c1-41dc-bf6f-430027c95931" xlink:type="arc" order="0"/>
  </link:definitionLink>
</link:linkbase>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-101.LAB
<SEQUENCE>11
<FILENAME>dmtk-20220630_lab.xml
<DESCRIPTION>XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT
<TEXT>
<XBRL>
<?xml version="1.0" encoding="UTF-8"?>

<!--XBRL Document Created with Wdesk from Workiva-->
<!--Copyright 2022 Workiva-->
<!--r:00c1bec6-bc29-44ad-a3fa-8dd942e770ac,g:dd828811-c245-4da7-9eef-30b71a6b7e18-->
<link:linkbase xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xsi:schemaLocation="http://www.xbrl.org/2003/linkbase http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd">
  <link:roleRef roleURI="http://www.xbrl.org/2009/role/negatedPeriodStartLabel" xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedPeriodStartLabel"/>
  <link:roleRef roleURI="http://www.xbrl.org/2009/role/netLabel" xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/net-2009-12-16.xsd#netLabel"/>
  <link:roleRef roleURI="http://www.xbrl.org/2009/role/negatedNetLabel" xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedNetLabel"/>
  <link:roleRef roleURI="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedTerseLabel"/>
  <link:roleRef roleURI="http://www.xbrl.org/2009/role/negatedPeriodEndLabel" xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedPeriodEndLabel"/>
  <link:roleRef roleURI="http://www.xbrl.org/2009/role/negatedLabel" xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedLabel"/>
  <link:roleRef roleURI="http://www.xbrl.org/2009/role/negatedTotalLabel" xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedTotalLabel"/>
  <link:labelLink xlink:role="http://www.xbrl.org/2003/role/link" xlink:type="extended">
    <link:label id="lab_dmtk_BrotherOfChiefExecutiveOfficerMember_bee36a94-4899-48d2-b0d4-a21d095b359c_terseLabel_en-US" xlink:label="lab_dmtk_BrotherOfChiefExecutiveOfficerMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Michael Dobak</link:label>
    <link:label id="lab_dmtk_BrotherOfChiefExecutiveOfficerMember_label_en-US" xlink:label="lab_dmtk_BrotherOfChiefExecutiveOfficerMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Brother Of Chief Executive Officer [Member]</link:label>
    <link:label id="lab_dmtk_BrotherOfChiefExecutiveOfficerMember_documentation_en-US" xlink:label="lab_dmtk_BrotherOfChiefExecutiveOfficerMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Brother of chief executive officer.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dmtk_BrotherOfChiefExecutiveOfficerMember" xlink:href="dmtk-20220630.xsd#dmtk_BrotherOfChiefExecutiveOfficerMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dmtk_BrotherOfChiefExecutiveOfficerMember" xlink:to="lab_dmtk_BrotherOfChiefExecutiveOfficerMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_InvestmentsFairValueDisclosureAbstract_69ffd397-a569-4e9b-80c2-15a6e565f22d_terseLabel_en-US" xlink:label="lab_us-gaap_InvestmentsFairValueDisclosureAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Marketable securities, available for sale:</link:label>
    <link:label id="lab_us-gaap_InvestmentsFairValueDisclosureAbstract_label_en-US" xlink:label="lab_us-gaap_InvestmentsFairValueDisclosureAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Investments, Fair Value Disclosure [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InvestmentsFairValueDisclosureAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_InvestmentsFairValueDisclosureAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_InvestmentsFairValueDisclosureAbstract" xlink:to="lab_us-gaap_InvestmentsFairValueDisclosureAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue_8c67925c-b983-40a1-82ec-58ce1d693f56_terseLabel_en-US" xlink:label="lab_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Total</link:label>
    <link:label id="lab_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue_label_en-US" xlink:label="lab_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Lessee, Operating Lease, Liability, to be Paid</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue" xlink:to="lab_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ProfitLoss_13e02728-4edb-4204-adb1-a7f0100d21fb_terseLabel_en-US" xlink:label="lab_us-gaap_ProfitLoss" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net loss</link:label>
    <link:label id="lab_us-gaap_ProfitLoss_label_en-US" xlink:label="lab_us-gaap_ProfitLoss" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net Income (Loss), Including Portion Attributable to Noncontrolling Interest</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProfitLoss" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ProfitLoss"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ProfitLoss" xlink:to="lab_us-gaap_ProfitLoss" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_RelatedPartyTransactionsAbstract_8d0e4701-3968-45a4-b995-4f860bd2a41f_terseLabel_en-US" xlink:label="lab_us-gaap_RelatedPartyTransactionsAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Related Party Transactions [Abstract]</link:label>
    <link:label id="lab_us-gaap_RelatedPartyTransactionsAbstract_label_en-US" xlink:label="lab_us-gaap_RelatedPartyTransactionsAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Related Party Transactions [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RelatedPartyTransactionsAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RelatedPartyTransactionsAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_RelatedPartyTransactionsAbstract" xlink:to="lab_us-gaap_RelatedPartyTransactionsAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_dmtk_RestrictedCashMember_3ff16a49-e3a9-41e0-b6cb-1bf51b9789ba_terseLabel_en-US" xlink:label="lab_dmtk_RestrictedCashMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Restricted Cash</link:label>
    <link:label id="lab_dmtk_RestrictedCashMember_label_en-US" xlink:label="lab_dmtk_RestrictedCashMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Restricted Cash [Member]</link:label>
    <link:label id="lab_dmtk_RestrictedCashMember_documentation_en-US" xlink:label="lab_dmtk_RestrictedCashMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Restricted Cash.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dmtk_RestrictedCashMember" xlink:href="dmtk-20220630.xsd#dmtk_RestrictedCashMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dmtk_RestrictedCashMember" xlink:to="lab_dmtk_RestrictedCashMember" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityAddressPostalZipCode_84e20e58-d67e-456f-a44b-5ecf9e419f0b_terseLabel_en-US" xlink:label="lab_dei_EntityAddressPostalZipCode" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Address, Postal Zip Code</link:label>
    <link:label id="lab_dei_EntityAddressPostalZipCode_label_en-US" xlink:label="lab_dei_EntityAddressPostalZipCode" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Address, Postal Zip Code</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityAddressPostalZipCode" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityAddressPostalZipCode"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityAddressPostalZipCode" xlink:to="lab_dei_EntityAddressPostalZipCode" xlink:type="arc" order="1"/>
    <link:label id="lab_dmtk_ComputerEquipmentGross_8a8d964e-8860-4faa-88d6-f85f2c925978_terseLabel_en-US" xlink:label="lab_dmtk_ComputerEquipmentGross" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Computer equipment</link:label>
    <link:label id="lab_dmtk_ComputerEquipmentGross_label_en-US" xlink:label="lab_dmtk_ComputerEquipmentGross" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Computer Equipment Gross</link:label>
    <link:label id="lab_dmtk_ComputerEquipmentGross_documentation_en-US" xlink:label="lab_dmtk_ComputerEquipmentGross" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Computer equipment gross.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dmtk_ComputerEquipmentGross" xlink:href="dmtk-20220630.xsd#dmtk_ComputerEquipmentGross"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dmtk_ComputerEquipmentGross" xlink:to="lab_dmtk_ComputerEquipmentGross" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DebtInstrumentAxis_91725c45-390d-40c7-82b1-1099867d73f1_terseLabel_en-US" xlink:label="lab_us-gaap_DebtInstrumentAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Instrument</link:label>
    <link:label id="lab_us-gaap_DebtInstrumentAxis_label_en-US" xlink:label="lab_us-gaap_DebtInstrumentAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Instrument [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtInstrumentAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DebtInstrumentAxis" xlink:to="lab_us-gaap_DebtInstrumentAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FinanceLeaseLiability_016d0a5a-2852-4abd-bf2a-8f011c23d941_totalLabel_en-US" xlink:label="lab_us-gaap_FinanceLeaseLiability" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Present value of net minimum lease payments</link:label>
    <link:label id="lab_us-gaap_FinanceLeaseLiability_label_en-US" xlink:label="lab_us-gaap_FinanceLeaseLiability" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Finance Lease, Liability</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FinanceLeaseLiability" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FinanceLeaseLiability"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FinanceLeaseLiability" xlink:to="lab_us-gaap_FinanceLeaseLiability" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PropertyPlantAndEquipmentGross_4b64a52f-6186-4513-a7c9-e5f8d72243da_verboseLabel_en-US" xlink:label="lab_us-gaap_PropertyPlantAndEquipmentGross" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Gross assets</link:label>
    <link:label id="lab_us-gaap_PropertyPlantAndEquipmentGross_10e1befc-cda4-471b-8ad3-e1360674d243_totalLabel_en-US" xlink:label="lab_us-gaap_PropertyPlantAndEquipmentGross" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Total property and equipment, gross</link:label>
    <link:label id="lab_us-gaap_PropertyPlantAndEquipmentGross_bcec0996-addb-40af-8fc7-e57ed0110fb9_terseLabel_en-US" xlink:label="lab_us-gaap_PropertyPlantAndEquipmentGross" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Gross assets</link:label>
    <link:label id="lab_us-gaap_PropertyPlantAndEquipmentGross_label_en-US" xlink:label="lab_us-gaap_PropertyPlantAndEquipmentGross" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Property, Plant and Equipment, Gross</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentGross" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PropertyPlantAndEquipmentGross"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentGross" xlink:to="lab_us-gaap_PropertyPlantAndEquipmentGross" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_RelatedPartyTransactionExpensesFromTransactionsWithRelatedParty_2f526879-ffd0-4683-a545-15d1465c081b_terseLabel_en-US" xlink:label="lab_us-gaap_RelatedPartyTransactionExpensesFromTransactionsWithRelatedParty" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Related party transaction, other</link:label>
    <link:label id="lab_us-gaap_RelatedPartyTransactionExpensesFromTransactionsWithRelatedParty_label_en-US" xlink:label="lab_us-gaap_RelatedPartyTransactionExpensesFromTransactionsWithRelatedParty" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Related Party Transaction, Expenses from Transactions with Related Party</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RelatedPartyTransactionExpensesFromTransactionsWithRelatedParty" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RelatedPartyTransactionExpensesFromTransactionsWithRelatedParty"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_RelatedPartyTransactionExpensesFromTransactionsWithRelatedParty" xlink:to="lab_us-gaap_RelatedPartyTransactionExpensesFromTransactionsWithRelatedParty" xlink:type="arc" order="1"/>
    <link:label id="lab_dmtk_CommitmentsAndContingenciesTable_0bca094d-e38e-43e3-9095-b9787e67c018_terseLabel_en-US" xlink:label="lab_dmtk_CommitmentsAndContingenciesTable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Commitments And Contingencies [Table]</link:label>
    <link:label id="lab_dmtk_CommitmentsAndContingenciesTable_label_en-US" xlink:label="lab_dmtk_CommitmentsAndContingenciesTable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Commitments And Contingencies [Table]</link:label>
    <link:label id="lab_dmtk_CommitmentsAndContingenciesTable_documentation_en-US" xlink:label="lab_dmtk_CommitmentsAndContingenciesTable" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Commitments and contingencies.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dmtk_CommitmentsAndContingenciesTable" xlink:href="dmtk-20220630.xsd#dmtk_CommitmentsAndContingenciesTable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dmtk_CommitmentsAndContingenciesTable" xlink:to="lab_dmtk_CommitmentsAndContingenciesTable" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncreaseDecreaseInOtherOperatingAssetsAndLiabilitiesNetAbstract_6bcc69bb-7ed3-4a26-b541-5488d4566a79_terseLabel_en-US" xlink:label="lab_us-gaap_IncreaseDecreaseInOtherOperatingAssetsAndLiabilitiesNetAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Change in operating assets and liabilities:</link:label>
    <link:label id="lab_us-gaap_IncreaseDecreaseInOtherOperatingAssetsAndLiabilitiesNetAbstract_label_en-US" xlink:label="lab_us-gaap_IncreaseDecreaseInOtherOperatingAssetsAndLiabilitiesNetAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Increase (Decrease) in Other Operating Assets and Liabilities, Net [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInOtherOperatingAssetsAndLiabilitiesNetAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncreaseDecreaseInOtherOperatingAssetsAndLiabilitiesNetAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncreaseDecreaseInOtherOperatingAssetsAndLiabilitiesNetAbstract" xlink:to="lab_us-gaap_IncreaseDecreaseInOtherOperatingAssetsAndLiabilitiesNetAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_dmtk_AccruedConsultingServicesCurrent_51c00769-add1-4d90-a97f-1d416b9f4061_terseLabel_en-US" xlink:label="lab_dmtk_AccruedConsultingServicesCurrent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accrued consulting services</link:label>
    <link:label id="lab_dmtk_AccruedConsultingServicesCurrent_label_en-US" xlink:label="lab_dmtk_AccruedConsultingServicesCurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accrued Consulting Services Current</link:label>
    <link:label id="lab_dmtk_AccruedConsultingServicesCurrent_documentation_en-US" xlink:label="lab_dmtk_AccruedConsultingServicesCurrent" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accrued consulting services, current.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dmtk_AccruedConsultingServicesCurrent" xlink:href="dmtk-20220630.xsd#dmtk_AccruedConsultingServicesCurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dmtk_AccruedConsultingServicesCurrent" xlink:to="lab_dmtk_AccruedConsultingServicesCurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PrepaidExpenseAndOtherAssetsCurrentAbstract_3bae90f0-4aa2-4c08-b315-63b92f0a9d7a_terseLabel_en-US" xlink:label="lab_us-gaap_PrepaidExpenseAndOtherAssetsCurrentAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Prepaid expenses and other current assets:</link:label>
    <link:label id="lab_us-gaap_PrepaidExpenseAndOtherAssetsCurrentAbstract_label_en-US" xlink:label="lab_us-gaap_PrepaidExpenseAndOtherAssetsCurrentAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Prepaid Expense and Other Assets, Current [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PrepaidExpenseAndOtherAssetsCurrentAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PrepaidExpenseAndOtherAssetsCurrentAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PrepaidExpenseAndOtherAssetsCurrentAbstract" xlink:to="lab_us-gaap_PrepaidExpenseAndOtherAssetsCurrentAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_dmtk_AuthorizedForFutureESPPPurchasesMember_115ac43e-3d1d-42cb-b6d4-201e68f265c3_terseLabel_en-US" xlink:label="lab_dmtk_AuthorizedForFutureESPPPurchasesMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Authorized for future ESPP purchases</link:label>
    <link:label id="lab_dmtk_AuthorizedForFutureESPPPurchasesMember_label_en-US" xlink:label="lab_dmtk_AuthorizedForFutureESPPPurchasesMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Authorized For Future E S P P Purchases [Member]</link:label>
    <link:label id="lab_dmtk_AuthorizedForFutureESPPPurchasesMember_documentation_en-US" xlink:label="lab_dmtk_AuthorizedForFutureESPPPurchasesMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Authorized for future ESPP purchases.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dmtk_AuthorizedForFutureESPPPurchasesMember" xlink:href="dmtk-20220630.xsd#dmtk_AuthorizedForFutureESPPPurchasesMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dmtk_AuthorizedForFutureESPPPurchasesMember" xlink:to="lab_dmtk_AuthorizedForFutureESPPPurchasesMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_b0bb36c3-2ebe-4d24-b2b1-4735e745fbf4_terseLabel_en-US" xlink:label="lab_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Financial Instruments</link:label>
    <link:label id="lab_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_label_en-US" xlink:label="lab_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Financial Instruments [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain" xlink:to="lab_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FinanceLeaseLiabilityPaymentsDueYearFour_da0723cb-3eba-4a39-9362-3c0ec57ae6d1_terseLabel_en-US" xlink:label="lab_us-gaap_FinanceLeaseLiabilityPaymentsDueYearFour" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">2026</link:label>
    <link:label id="lab_us-gaap_FinanceLeaseLiabilityPaymentsDueYearFour_label_en-US" xlink:label="lab_us-gaap_FinanceLeaseLiabilityPaymentsDueYearFour" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Finance Lease, Liability, to be Paid, Year Four</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FinanceLeaseLiabilityPaymentsDueYearFour" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FinanceLeaseLiabilityPaymentsDueYearFour"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FinanceLeaseLiabilityPaymentsDueYearFour" xlink:to="lab_us-gaap_FinanceLeaseLiabilityPaymentsDueYearFour" xlink:type="arc" order="1"/>
    <link:label id="lab_srt_RangeMember_089b3183-4f89-427d-829a-4f4f2184a731_terseLabel_en-US" xlink:label="lab_srt_RangeMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Statistical Measurement</link:label>
    <link:label id="lab_srt_RangeMember_label_en-US" xlink:label="lab_srt_RangeMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Statistical Measurement [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeMember" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_RangeMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_srt_RangeMember" xlink:to="lab_srt_RangeMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LesseeOperatingLeaseDiscountRate_667cb1a9-c6ae-42ca-a858-70851d461778_terseLabel_en-US" xlink:label="lab_us-gaap_LesseeOperatingLeaseDiscountRate" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Estimated discount rate</link:label>
    <link:label id="lab_us-gaap_LesseeOperatingLeaseDiscountRate_label_en-US" xlink:label="lab_us-gaap_LesseeOperatingLeaseDiscountRate" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Lessee, Operating Lease, Discount Rate</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeOperatingLeaseDiscountRate" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LesseeOperatingLeaseDiscountRate"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LesseeOperatingLeaseDiscountRate" xlink:to="lab_us-gaap_LesseeOperatingLeaseDiscountRate" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_Depreciation_a9df2bb7-6089-48dc-a537-bd0c452afacb_terseLabel_en-US" xlink:label="lab_us-gaap_Depreciation" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Depreciation</link:label>
    <link:label id="lab_us-gaap_Depreciation_9c7441d8-3962-4185-b10d-55d693a546fe_verboseLabel_en-US" xlink:label="lab_us-gaap_Depreciation" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Depreciation expense</link:label>
    <link:label id="lab_us-gaap_Depreciation_label_en-US" xlink:label="lab_us-gaap_Depreciation" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Depreciation</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Depreciation" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_Depreciation"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_Depreciation" xlink:to="lab_us-gaap_Depreciation" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OperatingLeaseWeightedAverageDiscountRatePercent_d5e3f642-8311-41b8-95f6-0fe9474b991a_terseLabel_en-US" xlink:label="lab_us-gaap_OperatingLeaseWeightedAverageDiscountRatePercent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Weighted-average discount rate for operating leases (in percent)</link:label>
    <link:label id="lab_us-gaap_OperatingLeaseWeightedAverageDiscountRatePercent_label_en-US" xlink:label="lab_us-gaap_OperatingLeaseWeightedAverageDiscountRatePercent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Operating Lease, Weighted Average Discount Rate, Percent</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeaseWeightedAverageDiscountRatePercent" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OperatingLeaseWeightedAverageDiscountRatePercent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OperatingLeaseWeightedAverageDiscountRatePercent" xlink:to="lab_us-gaap_OperatingLeaseWeightedAverageDiscountRatePercent" xlink:type="arc" order="1"/>
    <link:label id="lab_dmtk_AssetsHeldUnderFinanceLeasesMember_dbd2ea52-6873-4717-b83b-5365655fd3c2_terseLabel_en-US" xlink:label="lab_dmtk_AssetsHeldUnderFinanceLeasesMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Assets Recorded under Finance Leases</link:label>
    <link:label id="lab_dmtk_AssetsHeldUnderFinanceLeasesMember_label_en-US" xlink:label="lab_dmtk_AssetsHeldUnderFinanceLeasesMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Assets Held Under Finance Leases [Member]</link:label>
    <link:label id="lab_dmtk_AssetsHeldUnderFinanceLeasesMember_documentation_en-US" xlink:label="lab_dmtk_AssetsHeldUnderFinanceLeasesMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Assets held under finance leases.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dmtk_AssetsHeldUnderFinanceLeasesMember" xlink:href="dmtk-20220630.xsd#dmtk_AssetsHeldUnderFinanceLeasesMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dmtk_AssetsHeldUnderFinanceLeasesMember" xlink:to="lab_dmtk_AssetsHeldUnderFinanceLeasesMember" xlink:type="arc" order="1"/>
    <link:label id="lab_dmtk_OperatingAndFinanceLeaseLiabilityPaymentsDueYearFour_809209bb-927b-4c5e-b949-90785f85e5a6_terseLabel_en-US" xlink:label="lab_dmtk_OperatingAndFinanceLeaseLiabilityPaymentsDueYearFour" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Total future minimum lease payments due in 2026</link:label>
    <link:label id="lab_dmtk_OperatingAndFinanceLeaseLiabilityPaymentsDueYearFour_label_en-US" xlink:label="lab_dmtk_OperatingAndFinanceLeaseLiabilityPaymentsDueYearFour" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Operating And Finance Lease Liability Payments Due Year Four</link:label>
    <link:label id="lab_dmtk_OperatingAndFinanceLeaseLiabilityPaymentsDueYearFour_documentation_en-US" xlink:label="lab_dmtk_OperatingAndFinanceLeaseLiabilityPaymentsDueYearFour" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Operating and capital lease liability payments due year four.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dmtk_OperatingAndFinanceLeaseLiabilityPaymentsDueYearFour" xlink:href="dmtk-20220630.xsd#dmtk_OperatingAndFinanceLeaseLiabilityPaymentsDueYearFour"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dmtk_OperatingAndFinanceLeaseLiabilityPaymentsDueYearFour" xlink:to="lab_dmtk_OperatingAndFinanceLeaseLiabilityPaymentsDueYearFour" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AdditionalPaidInCapitalCommonStock_6c7e0f43-69ef-486c-ad54-aa3114651403_terseLabel_en-US" xlink:label="lab_us-gaap_AdditionalPaidInCapitalCommonStock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Additional paid-in capital</link:label>
    <link:label id="lab_us-gaap_AdditionalPaidInCapitalCommonStock_label_en-US" xlink:label="lab_us-gaap_AdditionalPaidInCapitalCommonStock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Additional Paid in Capital, Common Stock</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AdditionalPaidInCapitalCommonStock" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AdditionalPaidInCapitalCommonStock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AdditionalPaidInCapitalCommonStock" xlink:to="lab_us-gaap_AdditionalPaidInCapitalCommonStock" xlink:type="arc" order="1"/>
    <link:label id="lab_dmtk_ScheduleOfFutureMinimumRentalPaymentsForOperatingAndCapitalLeasesTableTextBlock_a7e541e8-35b2-4b0d-83e8-74d09299bf97_terseLabel_en-US" xlink:label="lab_dmtk_ScheduleOfFutureMinimumRentalPaymentsForOperatingAndCapitalLeasesTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Future Minimum Lease Payments Under Operating and Financing Leases</link:label>
    <link:label id="lab_dmtk_ScheduleOfFutureMinimumRentalPaymentsForOperatingAndCapitalLeasesTableTextBlock_label_en-US" xlink:label="lab_dmtk_ScheduleOfFutureMinimumRentalPaymentsForOperatingAndCapitalLeasesTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule Of Future Minimum Rental Payments For Operating And Capital Leases Table [Text Block]</link:label>
    <link:label id="lab_dmtk_ScheduleOfFutureMinimumRentalPaymentsForOperatingAndCapitalLeasesTableTextBlock_documentation_en-US" xlink:label="lab_dmtk_ScheduleOfFutureMinimumRentalPaymentsForOperatingAndCapitalLeasesTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of future minimum rental payments for operating and capital leases.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dmtk_ScheduleOfFutureMinimumRentalPaymentsForOperatingAndCapitalLeasesTableTextBlock" xlink:href="dmtk-20220630.xsd#dmtk_ScheduleOfFutureMinimumRentalPaymentsForOperatingAndCapitalLeasesTableTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dmtk_ScheduleOfFutureMinimumRentalPaymentsForOperatingAndCapitalLeasesTableTextBlock" xlink:to="lab_dmtk_ScheduleOfFutureMinimumRentalPaymentsForOperatingAndCapitalLeasesTableTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_dmtk_OperatingAndFinanceLeaseLiabilityPaymentsDueThereafter_c4cc3d82-50ca-4b3e-a9f8-58c8bc92d955_terseLabel_en-US" xlink:label="lab_dmtk_OperatingAndFinanceLeaseLiabilityPaymentsDueThereafter" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Total future minimum lease payments due thereafter</link:label>
    <link:label id="lab_dmtk_OperatingAndFinanceLeaseLiabilityPaymentsDueThereafter_label_en-US" xlink:label="lab_dmtk_OperatingAndFinanceLeaseLiabilityPaymentsDueThereafter" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Operating And Finance Lease Liability Payments Due Thereafter</link:label>
    <link:label id="lab_dmtk_OperatingAndFinanceLeaseLiabilityPaymentsDueThereafter_documentation_en-US" xlink:label="lab_dmtk_OperatingAndFinanceLeaseLiabilityPaymentsDueThereafter" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Operating and capital lease liability payments due thereafter.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dmtk_OperatingAndFinanceLeaseLiabilityPaymentsDueThereafter" xlink:href="dmtk-20220630.xsd#dmtk_OperatingAndFinanceLeaseLiabilityPaymentsDueThereafter"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dmtk_OperatingAndFinanceLeaseLiabilityPaymentsDueThereafter" xlink:to="lab_dmtk_OperatingAndFinanceLeaseLiabilityPaymentsDueThereafter" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FinanceLeaseLiabilityPaymentsDueYearThree_fa0feede-ddd8-4cb4-9e4f-8af106677eb8_terseLabel_en-US" xlink:label="lab_us-gaap_FinanceLeaseLiabilityPaymentsDueYearThree" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">2025</link:label>
    <link:label id="lab_us-gaap_FinanceLeaseLiabilityPaymentsDueYearThree_label_en-US" xlink:label="lab_us-gaap_FinanceLeaseLiabilityPaymentsDueYearThree" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Finance Lease, Liability, to be Paid, Year Three</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FinanceLeaseLiabilityPaymentsDueYearThree" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FinanceLeaseLiabilityPaymentsDueYearThree"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FinanceLeaseLiabilityPaymentsDueYearThree" xlink:to="lab_us-gaap_FinanceLeaseLiabilityPaymentsDueYearThree" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_NetIncomeLoss_18537b0f-3fb0-448d-b41a-8340169495ea_totalLabel_en-US" xlink:label="lab_us-gaap_NetIncomeLoss" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net loss</link:label>
    <link:label id="lab_us-gaap_NetIncomeLoss_47f9886d-7ad3-4855-9bc3-df71355b53eb_terseLabel_en-US" xlink:label="lab_us-gaap_NetIncomeLoss" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net loss</link:label>
    <link:label id="lab_us-gaap_NetIncomeLoss_b0b47cad-76d8-4c91-a023-120273caa062_verboseLabel_en-US" xlink:label="lab_us-gaap_NetIncomeLoss" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net loss</link:label>
    <link:label id="lab_us-gaap_NetIncomeLoss_label_en-US" xlink:label="lab_us-gaap_NetIncomeLoss" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net Income (Loss) Attributable to Parent</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetIncomeLoss" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NetIncomeLoss"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_NetIncomeLoss" xlink:to="lab_us-gaap_NetIncomeLoss" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfShareBasedPaymentAwardEmployeeStockPurchasePlanValuationAssumptionsTableTextBlock_1a8b10ca-70d4-4fb0-8bb0-f502e91f050f_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfShareBasedPaymentAwardEmployeeStockPurchasePlanValuationAssumptionsTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Warrant Liability Valuation Method</link:label>
    <link:label id="lab_us-gaap_ScheduleOfShareBasedPaymentAwardEmployeeStockPurchasePlanValuationAssumptionsTableTextBlock_label_en-US" xlink:label="lab_us-gaap_ScheduleOfShareBasedPaymentAwardEmployeeStockPurchasePlanValuationAssumptionsTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Share-Based Payment Award, Employee Stock Purchase Plan, Valuation Assumptions [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfShareBasedPaymentAwardEmployeeStockPurchasePlanValuationAssumptionsTableTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfShareBasedPaymentAwardEmployeeStockPurchasePlanValuationAssumptionsTableTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfShareBasedPaymentAwardEmployeeStockPurchasePlanValuationAssumptionsTableTextBlock" xlink:to="lab_us-gaap_ScheduleOfShareBasedPaymentAwardEmployeeStockPurchasePlanValuationAssumptionsTableTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount_3b7041e4-4fce-4303-835f-b7b8b5478f53_terseLabel_en-US" xlink:label="lab_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Anti-dilutive equity instruments excluded from diluted net loss per share of common stock</link:label>
    <link:label id="lab_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount_label_en-US" xlink:label="lab_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Antidilutive Securities Excluded from Computation of Earnings Per Share, Amount</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount" xlink:to="lab_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FinanceLeaseLiabilityPaymentsRemainderOfFiscalYear_a5176e13-92a5-4977-ab86-16672b91e7e5_terseLabel_en-US" xlink:label="lab_us-gaap_FinanceLeaseLiabilityPaymentsRemainderOfFiscalYear" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">2022</link:label>
    <link:label id="lab_us-gaap_FinanceLeaseLiabilityPaymentsRemainderOfFiscalYear_label_en-US" xlink:label="lab_us-gaap_FinanceLeaseLiabilityPaymentsRemainderOfFiscalYear" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Finance Lease, Liability, to be Paid, Remainder of Fiscal Year</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FinanceLeaseLiabilityPaymentsRemainderOfFiscalYear" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FinanceLeaseLiabilityPaymentsRemainderOfFiscalYear"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FinanceLeaseLiabilityPaymentsRemainderOfFiscalYear" xlink:to="lab_us-gaap_FinanceLeaseLiabilityPaymentsRemainderOfFiscalYear" xlink:type="arc" order="1"/>
    <link:label id="lab_srt_CumulativeEffectPeriodOfAdoptionAxis_d074a4d1-c7c8-4cf3-bbb0-6b6a0c17c9d9_terseLabel_en-US" xlink:label="lab_srt_CumulativeEffectPeriodOfAdoptionAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cumulative Effect, Period of Adoption [Axis]</link:label>
    <link:label id="lab_srt_CumulativeEffectPeriodOfAdoptionAxis_label_en-US" xlink:label="lab_srt_CumulativeEffectPeriodOfAdoptionAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cumulative Effect, Period of Adoption [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_srt_CumulativeEffectPeriodOfAdoptionAxis" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_CumulativeEffectPeriodOfAdoptionAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_srt_CumulativeEffectPeriodOfAdoptionAxis" xlink:to="lab_srt_CumulativeEffectPeriodOfAdoptionAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OperatingLeaseLiabilitiesPaymentsDueAbstract_702038b2-e9b2-4b19-bf8c-f841654dec2f_terseLabel_en-US" xlink:label="lab_us-gaap_OperatingLeaseLiabilitiesPaymentsDueAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Operating lease obligations, including interest</link:label>
    <link:label id="lab_us-gaap_OperatingLeaseLiabilitiesPaymentsDueAbstract_label_en-US" xlink:label="lab_us-gaap_OperatingLeaseLiabilitiesPaymentsDueAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Lessee, Operating Lease, Liability, to be Paid [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeaseLiabilitiesPaymentsDueAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OperatingLeaseLiabilitiesPaymentsDueAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OperatingLeaseLiabilitiesPaymentsDueAbstract" xlink:to="lab_us-gaap_OperatingLeaseLiabilitiesPaymentsDueAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AccountsReceivableGrossCurrent_b6492d62-8ea8-4fff-b7cb-3065d44278f3_terseLabel_en-US" xlink:label="lab_us-gaap_AccountsReceivableGrossCurrent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accounts receivable gross</link:label>
    <link:label id="lab_us-gaap_AccountsReceivableGrossCurrent_label_en-US" xlink:label="lab_us-gaap_AccountsReceivableGrossCurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accounts Receivable, before Allowance for Credit Loss, Current</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccountsReceivableGrossCurrent" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AccountsReceivableGrossCurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AccountsReceivableGrossCurrent" xlink:to="lab_us-gaap_AccountsReceivableGrossCurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PrepaidInsurance_5a62d64a-1de9-4bd3-9a82-559da9f67157_terseLabel_en-US" xlink:label="lab_us-gaap_PrepaidInsurance" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Prepaid insurance</link:label>
    <link:label id="lab_us-gaap_PrepaidInsurance_label_en-US" xlink:label="lab_us-gaap_PrepaidInsurance" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Prepaid Insurance</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PrepaidInsurance" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PrepaidInsurance"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PrepaidInsurance" xlink:to="lab_us-gaap_PrepaidInsurance" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_EquityComponentDomain_efc94b07-f3e3-49bf-a695-3a706253873e_terseLabel_en-US" xlink:label="lab_us-gaap_EquityComponentDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Equity Component</link:label>
    <link:label id="lab_us-gaap_EquityComponentDomain_label_en-US" xlink:label="lab_us-gaap_EquityComponentDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Equity Component [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquityComponentDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EquityComponentDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_EquityComponentDomain" xlink:to="lab_us-gaap_EquityComponentDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AssetsFairValueDisclosure_47476311-9f98-4ca5-b780-713f479972be_totalLabel_en-US" xlink:label="lab_us-gaap_AssetsFairValueDisclosure" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Total assets measured at fair value on a recurring basis</link:label>
    <link:label id="lab_us-gaap_AssetsFairValueDisclosure_label_en-US" xlink:label="lab_us-gaap_AssetsFairValueDisclosure" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Assets, Fair Value Disclosure</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AssetsFairValueDisclosure" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AssetsFairValueDisclosure"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AssetsFairValueDisclosure" xlink:to="lab_us-gaap_AssetsFairValueDisclosure" xlink:type="arc" order="1"/>
    <link:label id="lab_dmtk_AmortizationOfLaboratoryEquipmentAcquiredUnderFinanceLeasesMember_8733cd73-23e4-47c3-911d-5bd18b057153_terseLabel_en-US" xlink:label="lab_dmtk_AmortizationOfLaboratoryEquipmentAcquiredUnderFinanceLeasesMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Amortization of Laboratory Equipment Acquired under Finance Leases</link:label>
    <link:label id="lab_dmtk_AmortizationOfLaboratoryEquipmentAcquiredUnderFinanceLeasesMember_label_en-US" xlink:label="lab_dmtk_AmortizationOfLaboratoryEquipmentAcquiredUnderFinanceLeasesMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Amortization Of Laboratory Equipment Acquired Under Finance Leases [Member]</link:label>
    <link:label id="lab_dmtk_AmortizationOfLaboratoryEquipmentAcquiredUnderFinanceLeasesMember_documentation_en-US" xlink:label="lab_dmtk_AmortizationOfLaboratoryEquipmentAcquiredUnderFinanceLeasesMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Amortization of laboratory equipment acquired under finance leases.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dmtk_AmortizationOfLaboratoryEquipmentAcquiredUnderFinanceLeasesMember" xlink:href="dmtk-20220630.xsd#dmtk_AmortizationOfLaboratoryEquipmentAcquiredUnderFinanceLeasesMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dmtk_AmortizationOfLaboratoryEquipmentAcquiredUnderFinanceLeasesMember" xlink:to="lab_dmtk_AmortizationOfLaboratoryEquipmentAcquiredUnderFinanceLeasesMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_RepaymentsOfDebtAndCapitalLeaseObligations_01e1a821-9aff-4d52-a9e0-847f43ce2ae7_negatedLabel_en-US" xlink:label="lab_us-gaap_RepaymentsOfDebtAndCapitalLeaseObligations" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Principal repayments of capital lease obligations</link:label>
    <link:label id="lab_us-gaap_RepaymentsOfDebtAndCapitalLeaseObligations_label_en-US" xlink:label="lab_us-gaap_RepaymentsOfDebtAndCapitalLeaseObligations" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Repayments of Debt and Lease Obligation</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RepaymentsOfDebtAndCapitalLeaseObligations" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RepaymentsOfDebtAndCapitalLeaseObligations"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_RepaymentsOfDebtAndCapitalLeaseObligations" xlink:to="lab_us-gaap_RepaymentsOfDebtAndCapitalLeaseObligations" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FinanceLeaseRightOfUseAssetAmortization_eb92cd3c-c5dd-4f74-abce-e105d97ed403_terseLabel_en-US" xlink:label="lab_us-gaap_FinanceLeaseRightOfUseAssetAmortization" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Amortization of leased assets</link:label>
    <link:label id="lab_us-gaap_FinanceLeaseRightOfUseAssetAmortization_label_en-US" xlink:label="lab_us-gaap_FinanceLeaseRightOfUseAssetAmortization" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Finance Lease, Right-of-Use Asset, Amortization</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FinanceLeaseRightOfUseAssetAmortization" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FinanceLeaseRightOfUseAssetAmortization"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FinanceLeaseRightOfUseAssetAmortization" xlink:to="lab_us-gaap_FinanceLeaseRightOfUseAssetAmortization" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_RelatedPartyDomain_db7ce1c7-b7c6-4d87-a3b7-62db27ea71d1_terseLabel_en-US" xlink:label="lab_us-gaap_RelatedPartyDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Related Party</link:label>
    <link:label id="lab_us-gaap_RelatedPartyDomain_label_en-US" xlink:label="lab_us-gaap_RelatedPartyDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Related Party [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RelatedPartyDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RelatedPartyDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_RelatedPartyDomain" xlink:to="lab_us-gaap_RelatedPartyDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FairValueMeasurementPolicyPolicyTextBlock_0941863c-196a-406b-a396-3009d99aa53d_terseLabel_en-US" xlink:label="lab_us-gaap_FairValueMeasurementPolicyPolicyTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Value Measurements</link:label>
    <link:label id="lab_us-gaap_FairValueMeasurementPolicyPolicyTextBlock_label_en-US" xlink:label="lab_us-gaap_FairValueMeasurementPolicyPolicyTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Value Measurement, Policy [Policy Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueMeasurementPolicyPolicyTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueMeasurementPolicyPolicyTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FairValueMeasurementPolicyPolicyTextBlock" xlink:to="lab_us-gaap_FairValueMeasurementPolicyPolicyTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PlanNameAxis_dad2e527-6b5b-4dc7-9b00-39d1e990d343_terseLabel_en-US" xlink:label="lab_us-gaap_PlanNameAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Plan Name</link:label>
    <link:label id="lab_us-gaap_PlanNameAxis_label_en-US" xlink:label="lab_us-gaap_PlanNameAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Plan Name [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PlanNameAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PlanNameAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PlanNameAxis" xlink:to="lab_us-gaap_PlanNameAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_InvestmentHoldingsLineItems_d1b37d68-115b-4491-9dd6-b5b866ceb1cd_terseLabel_en-US" xlink:label="lab_us-gaap_InvestmentHoldingsLineItems" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Investment Holdings [Line Items]</link:label>
    <link:label id="lab_us-gaap_InvestmentHoldingsLineItems_label_en-US" xlink:label="lab_us-gaap_InvestmentHoldingsLineItems" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Investment Holdings [Line Items]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InvestmentHoldingsLineItems" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_InvestmentHoldingsLineItems"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_InvestmentHoldingsLineItems" xlink:to="lab_us-gaap_InvestmentHoldingsLineItems" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_StandbyLettersOfCreditMember_7c3203d3-74de-4f4c-9270-de9561b6ca95_terseLabel_en-US" xlink:label="lab_us-gaap_StandbyLettersOfCreditMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Standby Letter of Credit</link:label>
    <link:label id="lab_us-gaap_StandbyLettersOfCreditMember_label_en-US" xlink:label="lab_us-gaap_StandbyLettersOfCreditMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Standby Letters of Credit [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StandbyLettersOfCreditMember" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StandbyLettersOfCreditMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StandbyLettersOfCreditMember" xlink:to="lab_us-gaap_StandbyLettersOfCreditMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AvailableForSaleSecuritiesDebtSecurities_a0773183-16b1-47e4-93ea-a1cdd0d1203b_terseLabel_en-US" xlink:label="lab_us-gaap_AvailableForSaleSecuritiesDebtSecurities" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Total marketable securities, available for sale</link:label>
    <link:label id="lab_us-gaap_AvailableForSaleSecuritiesDebtSecurities_d39fd93f-aa52-4360-ac33-fe2272f6e00a_verboseLabel_en-US" xlink:label="lab_us-gaap_AvailableForSaleSecuritiesDebtSecurities" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Estimated Market Value</link:label>
    <link:label id="lab_us-gaap_AvailableForSaleSecuritiesDebtSecurities_label_en-US" xlink:label="lab_us-gaap_AvailableForSaleSecuritiesDebtSecurities" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Securities, Available-for-Sale</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AvailableForSaleSecuritiesDebtSecurities" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AvailableForSaleSecuritiesDebtSecurities"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AvailableForSaleSecuritiesDebtSecurities" xlink:to="lab_us-gaap_AvailableForSaleSecuritiesDebtSecurities" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_SupplementalCashFlowInformationAbstract_971a61ee-898f-4ab1-9149-b799909e28c1_terseLabel_en-US" xlink:label="lab_us-gaap_SupplementalCashFlowInformationAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Supplemental cash flow information:</link:label>
    <link:label id="lab_us-gaap_SupplementalCashFlowInformationAbstract_label_en-US" xlink:label="lab_us-gaap_SupplementalCashFlowInformationAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Supplemental Cash Flow Information [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SupplementalCashFlowInformationAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SupplementalCashFlowInformationAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SupplementalCashFlowInformationAbstract" xlink:to="lab_us-gaap_SupplementalCashFlowInformationAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PlanNameDomain_39bf1aea-6821-4014-990c-64a680605a08_terseLabel_en-US" xlink:label="lab_us-gaap_PlanNameDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Plan Name</link:label>
    <link:label id="lab_us-gaap_PlanNameDomain_label_en-US" xlink:label="lab_us-gaap_PlanNameDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Plan Name [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PlanNameDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PlanNameDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PlanNameDomain" xlink:to="lab_us-gaap_PlanNameDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LesseeOperatingLeaseLiabilityPaymentsRemainderOfFiscalYear_85fae7ea-9411-445e-a09f-1703af45c166_terseLabel_en-US" xlink:label="lab_us-gaap_LesseeOperatingLeaseLiabilityPaymentsRemainderOfFiscalYear" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">2022</link:label>
    <link:label id="lab_us-gaap_LesseeOperatingLeaseLiabilityPaymentsRemainderOfFiscalYear_label_en-US" xlink:label="lab_us-gaap_LesseeOperatingLeaseLiabilityPaymentsRemainderOfFiscalYear" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Lessee, Operating Lease, Liability, to be Paid, Remainder of Fiscal Year</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsRemainderOfFiscalYear" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LesseeOperatingLeaseLiabilityPaymentsRemainderOfFiscalYear"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsRemainderOfFiscalYear" xlink:to="lab_us-gaap_LesseeOperatingLeaseLiabilityPaymentsRemainderOfFiscalYear" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_StatementOfCashFlowsAbstract_1105fc72-b89b-4d41-8ddc-e1c37678b0a1_terseLabel_en-US" xlink:label="lab_us-gaap_StatementOfCashFlowsAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Statement of Cash Flows [Abstract]</link:label>
    <link:label id="lab_us-gaap_StatementOfCashFlowsAbstract_label_en-US" xlink:label="lab_us-gaap_StatementOfCashFlowsAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Statement of Cash Flows [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementOfCashFlowsAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StatementOfCashFlowsAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StatementOfCashFlowsAbstract" xlink:to="lab_us-gaap_StatementOfCashFlowsAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityAddressStateOrProvince_d1700fb0-3a7a-4f53-b436-2c84bdf68e4e_terseLabel_en-US" xlink:label="lab_dei_EntityAddressStateOrProvince" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Address, State or Province</link:label>
    <link:label id="lab_dei_EntityAddressStateOrProvince_label_en-US" xlink:label="lab_dei_EntityAddressStateOrProvince" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Address, State or Province</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityAddressStateOrProvince" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityAddressStateOrProvince"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityAddressStateOrProvince" xlink:to="lab_dei_EntityAddressStateOrProvince" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FairValueInputsLevel1Member_615d3be3-dc50-4f9a-97dd-3cc6bd97a61c_terseLabel_en-US" xlink:label="lab_us-gaap_FairValueInputsLevel1Member" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Level 1</link:label>
    <link:label id="lab_us-gaap_FairValueInputsLevel1Member_label_en-US" xlink:label="lab_us-gaap_FairValueInputsLevel1Member" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Value, Inputs, Level 1 [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueInputsLevel1Member" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueInputsLevel1Member"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FairValueInputsLevel1Member" xlink:to="lab_us-gaap_FairValueInputsLevel1Member" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_SharesIssuedPricePerShare_6b52b00f-e4af-4203-ac31-9172a09538f7_terseLabel_en-US" xlink:label="lab_us-gaap_SharesIssuedPricePerShare" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Issuance price per share (in usd per share)</link:label>
    <link:label id="lab_us-gaap_SharesIssuedPricePerShare_label_en-US" xlink:label="lab_us-gaap_SharesIssuedPricePerShare" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Shares Issued, Price Per Share</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SharesIssuedPricePerShare" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SharesIssuedPricePerShare"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SharesIssuedPricePerShare" xlink:to="lab_us-gaap_SharesIssuedPricePerShare" xlink:type="arc" order="1"/>
    <link:label id="lab_dmtk_AuthorizedForFutureEquityGrantsMember_0b23f9fb-f263-45a4-a5eb-d9c0ebcd6d57_terseLabel_en-US" xlink:label="lab_dmtk_AuthorizedForFutureEquityGrantsMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Authorized for future equity grants</link:label>
    <link:label id="lab_dmtk_AuthorizedForFutureEquityGrantsMember_label_en-US" xlink:label="lab_dmtk_AuthorizedForFutureEquityGrantsMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Authorized For Future Equity Grants [Member]</link:label>
    <link:label id="lab_dmtk_AuthorizedForFutureEquityGrantsMember_documentation_en-US" xlink:label="lab_dmtk_AuthorizedForFutureEquityGrantsMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Authorized for future equity grants.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dmtk_AuthorizedForFutureEquityGrantsMember" xlink:href="dmtk-20220630.xsd#dmtk_AuthorizedForFutureEquityGrantsMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dmtk_AuthorizedForFutureEquityGrantsMember" xlink:to="lab_dmtk_AuthorizedForFutureEquityGrantsMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AwardTypeAxis_09f8ed74-0cee-4bf0-a1b5-d7981d929873_terseLabel_en-US" xlink:label="lab_us-gaap_AwardTypeAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Award Type</link:label>
    <link:label id="lab_us-gaap_AwardTypeAxis_label_en-US" xlink:label="lab_us-gaap_AwardTypeAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Award Type [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AwardTypeAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AwardTypeAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AwardTypeAxis" xlink:to="lab_us-gaap_AwardTypeAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_dmtk_ClassOfWarrantOrRightWarrantsOrRightsIssuedToPurchaseCommonStock_91dc0a83-52be-4d1f-bc57-4ec330faad20_terseLabel_en-US" xlink:label="lab_dmtk_ClassOfWarrantOrRightWarrantsOrRightsIssuedToPurchaseCommonStock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Warrants issued to purchase common stock (in shares)</link:label>
    <link:label id="lab_dmtk_ClassOfWarrantOrRightWarrantsOrRightsIssuedToPurchaseCommonStock_label_en-US" xlink:label="lab_dmtk_ClassOfWarrantOrRightWarrantsOrRightsIssuedToPurchaseCommonStock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Class Of Warrant Or Right, Warrants Or Rights Issued To Purchase Common Stock</link:label>
    <link:label id="lab_dmtk_ClassOfWarrantOrRightWarrantsOrRightsIssuedToPurchaseCommonStock_documentation_en-US" xlink:label="lab_dmtk_ClassOfWarrantOrRightWarrantsOrRightsIssuedToPurchaseCommonStock" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Class of warrant or rights issued to purchase common stock.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dmtk_ClassOfWarrantOrRightWarrantsOrRightsIssuedToPurchaseCommonStock" xlink:href="dmtk-20220630.xsd#dmtk_ClassOfWarrantOrRightWarrantsOrRightsIssuedToPurchaseCommonStock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dmtk_ClassOfWarrantOrRightWarrantsOrRightsIssuedToPurchaseCommonStock" xlink:to="lab_dmtk_ClassOfWarrantOrRightWarrantsOrRightsIssuedToPurchaseCommonStock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_NewAccountingPronouncementsOrChangeInAccountingPrincipleLineItems_4f8f6c82-5aee-4a59-b341-80cb2e20fe8c_terseLabel_en-US" xlink:label="lab_us-gaap_NewAccountingPronouncementsOrChangeInAccountingPrincipleLineItems" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">New Accounting Pronouncements or Change in Accounting Principle [Line Items]</link:label>
    <link:label id="lab_us-gaap_NewAccountingPronouncementsOrChangeInAccountingPrincipleLineItems_label_en-US" xlink:label="lab_us-gaap_NewAccountingPronouncementsOrChangeInAccountingPrincipleLineItems" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">New Accounting Pronouncements or Change in Accounting Principle [Line Items]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NewAccountingPronouncementsOrChangeInAccountingPrincipleLineItems" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NewAccountingPronouncementsOrChangeInAccountingPrincipleLineItems"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_NewAccountingPronouncementsOrChangeInAccountingPrincipleLineItems" xlink:to="lab_us-gaap_NewAccountingPronouncementsOrChangeInAccountingPrincipleLineItems" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_NetCashProvidedByUsedInOperatingActivities_09b2d943-036c-4235-88e9-0199d03abb0c_totalLabel_en-US" xlink:label="lab_us-gaap_NetCashProvidedByUsedInOperatingActivities" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net cash used in operating activities</link:label>
    <link:label id="lab_us-gaap_NetCashProvidedByUsedInOperatingActivities_label_en-US" xlink:label="lab_us-gaap_NetCashProvidedByUsedInOperatingActivities" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net Cash Provided by (Used in) Operating Activities</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NetCashProvidedByUsedInOperatingActivities"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities" xlink:to="lab_us-gaap_NetCashProvidedByUsedInOperatingActivities" xlink:type="arc" order="1"/>
    <link:label id="lab_dmtk_TenantImprovementAllowance_990ef37d-466a-4b2d-8718-08e21e32f6a5_terseLabel_en-US" xlink:label="lab_dmtk_TenantImprovementAllowance" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Tenant improvement allowance</link:label>
    <link:label id="lab_dmtk_TenantImprovementAllowance_label_en-US" xlink:label="lab_dmtk_TenantImprovementAllowance" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Tenant Improvement Allowance</link:label>
    <link:label id="lab_dmtk_TenantImprovementAllowance_documentation_en-US" xlink:label="lab_dmtk_TenantImprovementAllowance" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Tenant improvement allowance.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dmtk_TenantImprovementAllowance" xlink:href="dmtk-20220630.xsd#dmtk_TenantImprovementAllowance"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dmtk_TenantImprovementAllowance" xlink:to="lab_dmtk_TenantImprovementAllowance" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OperatingLeaseLiabilityCurrent_86f4442e-094b-4092-b609-eb6fc3e04f41_terseLabel_en-US" xlink:label="lab_us-gaap_OperatingLeaseLiabilityCurrent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Current portion of operating lease liabilities</link:label>
    <link:label id="lab_us-gaap_OperatingLeaseLiabilityCurrent_label_en-US" xlink:label="lab_us-gaap_OperatingLeaseLiabilityCurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Operating Lease, Liability, Current</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeaseLiabilityCurrent" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OperatingLeaseLiabilityCurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OperatingLeaseLiabilityCurrent" xlink:to="lab_us-gaap_OperatingLeaseLiabilityCurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DebtSecuritiesAvailableForSaleTableTextBlock_ba7d7265-8bcd-41cb-9f06-399680b05d5e_terseLabel_en-US" xlink:label="lab_us-gaap_DebtSecuritiesAvailableForSaleTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Short-Term Marketable Securities</link:label>
    <link:label id="lab_us-gaap_DebtSecuritiesAvailableForSaleTableTextBlock_label_en-US" xlink:label="lab_us-gaap_DebtSecuritiesAvailableForSaleTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Securities, Available-for-Sale [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtSecuritiesAvailableForSaleTableTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtSecuritiesAvailableForSaleTableTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DebtSecuritiesAvailableForSaleTableTextBlock" xlink:to="lab_us-gaap_DebtSecuritiesAvailableForSaleTableTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_RelatedPartyTransactionDomain_ba88a3b7-7190-4fcc-8e1a-b7182cdf20ba_terseLabel_en-US" xlink:label="lab_us-gaap_RelatedPartyTransactionDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Related Party Transaction</link:label>
    <link:label id="lab_us-gaap_RelatedPartyTransactionDomain_label_en-US" xlink:label="lab_us-gaap_RelatedPartyTransactionDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Related Party Transaction [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RelatedPartyTransactionDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RelatedPartyTransactionDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_RelatedPartyTransactionDomain" xlink:to="lab_us-gaap_RelatedPartyTransactionDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OtherLiabilities_89807330-f3a9-41b2-924e-a5f5199fc754_terseLabel_en-US" xlink:label="lab_us-gaap_OtherLiabilities" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other liabilities</link:label>
    <link:label id="lab_us-gaap_OtherLiabilities_label_en-US" xlink:label="lab_us-gaap_OtherLiabilities" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Liabilities</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherLiabilities" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherLiabilities"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OtherLiabilities" xlink:to="lab_us-gaap_OtherLiabilities" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FairValueByLiabilityClassAxis_93502ae2-b24b-4f53-b071-245d1cb8ff95_terseLabel_en-US" xlink:label="lab_us-gaap_FairValueByLiabilityClassAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Liability Class</link:label>
    <link:label id="lab_us-gaap_FairValueByLiabilityClassAxis_label_en-US" xlink:label="lab_us-gaap_FairValueByLiabilityClassAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Liability Class [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueByLiabilityClassAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueByLiabilityClassAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FairValueByLiabilityClassAxis" xlink:to="lab_us-gaap_FairValueByLiabilityClassAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_Liabilities_80cf3674-bdf0-442e-b54d-289234a45281_totalLabel_en-US" xlink:label="lab_us-gaap_Liabilities" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Total liabilities</link:label>
    <link:label id="lab_us-gaap_Liabilities_label_en-US" xlink:label="lab_us-gaap_Liabilities" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Liabilities</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Liabilities" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_Liabilities"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_Liabilities" xlink:to="lab_us-gaap_Liabilities" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OperatingLeaseWeightedAverageRemainingLeaseTerm1_2ed9f2ca-11c4-4038-b61b-9e4ff2d3a1de_terseLabel_en-US" xlink:label="lab_us-gaap_OperatingLeaseWeightedAverageRemainingLeaseTerm1" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Weighted-average remaining lease term of operating leases (in years)</link:label>
    <link:label id="lab_us-gaap_OperatingLeaseWeightedAverageRemainingLeaseTerm1_label_en-US" xlink:label="lab_us-gaap_OperatingLeaseWeightedAverageRemainingLeaseTerm1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Operating Lease, Weighted Average Remaining Lease Term</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeaseWeightedAverageRemainingLeaseTerm1" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OperatingLeaseWeightedAverageRemainingLeaseTerm1"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OperatingLeaseWeightedAverageRemainingLeaseTerm1" xlink:to="lab_us-gaap_OperatingLeaseWeightedAverageRemainingLeaseTerm1" xlink:type="arc" order="1"/>
    <link:label id="lab_dmtk_WarrantsVestingPeriod_ec8f07e4-6442-4710-941c-5cc93a0a2db2_terseLabel_en-US" xlink:label="lab_dmtk_WarrantsVestingPeriod" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Warrants vesting period</link:label>
    <link:label id="lab_dmtk_WarrantsVestingPeriod_label_en-US" xlink:label="lab_dmtk_WarrantsVestingPeriod" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Warrants Vesting Period</link:label>
    <link:label id="lab_dmtk_WarrantsVestingPeriod_documentation_en-US" xlink:label="lab_dmtk_WarrantsVestingPeriod" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Warrants vesting period.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dmtk_WarrantsVestingPeriod" xlink:href="dmtk-20220630.xsd#dmtk_WarrantsVestingPeriod"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dmtk_WarrantsVestingPeriod" xlink:to="lab_dmtk_WarrantsVestingPeriod" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_b793b7a0-5372-49b3-b8a0-d4dd3636ab85_terseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share Based Compensation Arrangement By Share Based Payment Award [Line Items]</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-Based Compensation Arrangement by Share-Based Payment Award [Line Items]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract_64fdec66-192e-4684-bdeb-115188b347ff_terseLabel_en-US" xlink:label="lab_us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cash flows from investing activities:</link:label>
    <link:label id="lab_us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract_label_en-US" xlink:label="lab_us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net Cash Provided by (Used in) Investing Activities [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract" xlink:to="lab_us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_StockIssuedDuringPeriodValueNewIssues_f70712d5-02d0-4049-83d4-e09837bc03f8_terseLabel_en-US" xlink:label="lab_us-gaap_StockIssuedDuringPeriodValueNewIssues" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Issuance of stock, net of issuance costs</link:label>
    <link:label id="lab_us-gaap_StockIssuedDuringPeriodValueNewIssues_a34619d8-83ba-433a-842c-fa86c93a90e8_verboseLabel_en-US" xlink:label="lab_us-gaap_StockIssuedDuringPeriodValueNewIssues" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Issuance of preferred stock, total offering amount</link:label>
    <link:label id="lab_us-gaap_StockIssuedDuringPeriodValueNewIssues_label_en-US" xlink:label="lab_us-gaap_StockIssuedDuringPeriodValueNewIssues" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Stock Issued During Period, Value, New Issues</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockIssuedDuringPeriodValueNewIssues" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StockIssuedDuringPeriodValueNewIssues"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StockIssuedDuringPeriodValueNewIssues" xlink:to="lab_us-gaap_StockIssuedDuringPeriodValueNewIssues" xlink:type="arc" order="1"/>
    <link:label id="lab_dmtk_CashlessExerciseOfCommonStockWarrants_8a00be15-b7ca-4676-9d76-e3d7e23cb5e4_terseLabel_en-US" xlink:label="lab_dmtk_CashlessExerciseOfCommonStockWarrants" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cashless exercise of common stock warrants</link:label>
    <link:label id="lab_dmtk_CashlessExerciseOfCommonStockWarrants_label_en-US" xlink:label="lab_dmtk_CashlessExerciseOfCommonStockWarrants" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cashless Exercise Of Common Stock Warrants</link:label>
    <link:label id="lab_dmtk_CashlessExerciseOfCommonStockWarrants_documentation_en-US" xlink:label="lab_dmtk_CashlessExerciseOfCommonStockWarrants" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cashless exercise of common stock warrants.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dmtk_CashlessExerciseOfCommonStockWarrants" xlink:href="dmtk-20220630.xsd#dmtk_CashlessExerciseOfCommonStockWarrants"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dmtk_CashlessExerciseOfCommonStockWarrants" xlink:to="lab_dmtk_CashlessExerciseOfCommonStockWarrants" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityCommonStockSharesOutstanding_a6935cd8-d2e9-4a2e-9e4b-6d991d9836b7_terseLabel_en-US" xlink:label="lab_dei_EntityCommonStockSharesOutstanding" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Common Stock, Shares Outstanding</link:label>
    <link:label id="lab_dei_EntityCommonStockSharesOutstanding_label_en-US" xlink:label="lab_dei_EntityCommonStockSharesOutstanding" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Common Stock, Shares Outstanding</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityCommonStockSharesOutstanding" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityCommonStockSharesOutstanding"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityCommonStockSharesOutstanding" xlink:to="lab_dei_EntityCommonStockSharesOutstanding" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_0dcce0b6-8125-420c-87d3-78b5122f8b57_terseLabel_en-US" xlink:label="lab_us-gaap_FairValueMeasurementsFairValueHierarchyDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Value Hierarchy and NAV</link:label>
    <link:label id="lab_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_label_en-US" xlink:label="lab_us-gaap_FairValueMeasurementsFairValueHierarchyDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Value Hierarchy and NAV [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueMeasurementsFairValueHierarchyDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain" xlink:to="lab_us-gaap_FairValueMeasurementsFairValueHierarchyDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AccumulatedNetUnrealizedInvestmentGainLossMember_0232d9f7-d87e-4de7-8ab7-8ca1a88c8364_terseLabel_en-US" xlink:label="lab_us-gaap_AccumulatedNetUnrealizedInvestmentGainLossMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accumulated other comprehensive income/(loss)</link:label>
    <link:label id="lab_us-gaap_AccumulatedNetUnrealizedInvestmentGainLossMember_label_en-US" xlink:label="lab_us-gaap_AccumulatedNetUnrealizedInvestmentGainLossMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">AOCI, Accumulated Gain (Loss), Debt Securities, Available-for-Sale, Parent [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccumulatedNetUnrealizedInvestmentGainLossMember" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AccumulatedNetUnrealizedInvestmentGainLossMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AccumulatedNetUnrealizedInvestmentGainLossMember" xlink:to="lab_us-gaap_AccumulatedNetUnrealizedInvestmentGainLossMember" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_DocumentType_1e567c74-9250-4812-a15b-2b562a1ccabc_terseLabel_en-US" xlink:label="lab_dei_DocumentType" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Document Type</link:label>
    <link:label id="lab_dei_DocumentType_label_en-US" xlink:label="lab_dei_DocumentType" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Document Type</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_DocumentType" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_DocumentType"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_DocumentType" xlink:to="lab_dei_DocumentType" xlink:type="arc" order="1"/>
    <link:label id="lab_dmtk_GrossProceedsFromIssuanceOfCommonStock_469a4927-c88d-4ed7-af85-e99bb3fd9983_terseLabel_en-US" xlink:label="lab_dmtk_GrossProceedsFromIssuanceOfCommonStock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Gross proceeds from issuance of common stock</link:label>
    <link:label id="lab_dmtk_GrossProceedsFromIssuanceOfCommonStock_label_en-US" xlink:label="lab_dmtk_GrossProceedsFromIssuanceOfCommonStock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Gross Proceeds From Issuance Of Common Stock</link:label>
    <link:label id="lab_dmtk_GrossProceedsFromIssuanceOfCommonStock_documentation_en-US" xlink:label="lab_dmtk_GrossProceedsFromIssuanceOfCommonStock" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Gross proceeds from issuance of common stock.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dmtk_GrossProceedsFromIssuanceOfCommonStock" xlink:href="dmtk-20220630.xsd#dmtk_GrossProceedsFromIssuanceOfCommonStock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dmtk_GrossProceedsFromIssuanceOfCommonStock" xlink:to="lab_dmtk_GrossProceedsFromIssuanceOfCommonStock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PropertyPlantAndEquipmentUsefulLife_64ea7a6b-1cfb-46cb-98e6-acc87569b665_terseLabel_en-US" xlink:label="lab_us-gaap_PropertyPlantAndEquipmentUsefulLife" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Useful life of the assets</link:label>
    <link:label id="lab_us-gaap_PropertyPlantAndEquipmentUsefulLife_label_en-US" xlink:label="lab_us-gaap_PropertyPlantAndEquipmentUsefulLife" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Property, Plant and Equipment, Useful Life</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentUsefulLife" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PropertyPlantAndEquipmentUsefulLife"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentUsefulLife" xlink:to="lab_us-gaap_PropertyPlantAndEquipmentUsefulLife" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ConcentrationRiskBenchmarkDomain_1570f1a3-69ac-4fb0-93a1-7bc2effa1f13_terseLabel_en-US" xlink:label="lab_us-gaap_ConcentrationRiskBenchmarkDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Concentration Risk Benchmark</link:label>
    <link:label id="lab_us-gaap_ConcentrationRiskBenchmarkDomain_label_en-US" xlink:label="lab_us-gaap_ConcentrationRiskBenchmarkDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Concentration Risk Benchmark [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ConcentrationRiskBenchmarkDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ConcentrationRiskBenchmarkDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ConcentrationRiskBenchmarkDomain" xlink:to="lab_us-gaap_ConcentrationRiskBenchmarkDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AssetsFairValueDisclosureAbstract_3b30436d-2447-40d8-b256-547693c9716c_terseLabel_en-US" xlink:label="lab_us-gaap_AssetsFairValueDisclosureAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Assets:</link:label>
    <link:label id="lab_us-gaap_AssetsFairValueDisclosureAbstract_label_en-US" xlink:label="lab_us-gaap_AssetsFairValueDisclosureAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Assets, Fair Value Disclosure [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AssetsFairValueDisclosureAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AssetsFairValueDisclosureAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AssetsFairValueDisclosureAbstract" xlink:to="lab_us-gaap_AssetsFairValueDisclosureAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CostOfRevenueAbstract_20d05f4c-92b8-479d-ad19-ef546909c6b5_terseLabel_en-US" xlink:label="lab_us-gaap_CostOfRevenueAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cost of revenues:</link:label>
    <link:label id="lab_us-gaap_CostOfRevenueAbstract_label_en-US" xlink:label="lab_us-gaap_CostOfRevenueAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cost of Revenue [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CostOfRevenueAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CostOfRevenueAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CostOfRevenueAbstract" xlink:to="lab_us-gaap_CostOfRevenueAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FinanceLeaseLiabilitiesPaymentsDueAbstract_a10fd20c-7a4b-43a7-af23-fc0ae50d95aa_terseLabel_en-US" xlink:label="lab_us-gaap_FinanceLeaseLiabilitiesPaymentsDueAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Finance lease obligations, including interest</link:label>
    <link:label id="lab_us-gaap_FinanceLeaseLiabilitiesPaymentsDueAbstract_label_en-US" xlink:label="lab_us-gaap_FinanceLeaseLiabilitiesPaymentsDueAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Finance Lease, Liability, to be Paid [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FinanceLeaseLiabilitiesPaymentsDueAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FinanceLeaseLiabilitiesPaymentsDueAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FinanceLeaseLiabilitiesPaymentsDueAbstract" xlink:to="lab_us-gaap_FinanceLeaseLiabilitiesPaymentsDueAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_srt_ProductsAndServicesDomain_59962594-6a65-4997-93f4-dad7cfe03f54_terseLabel_en-US" xlink:label="lab_srt_ProductsAndServicesDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Product and Service</link:label>
    <link:label id="lab_srt_ProductsAndServicesDomain_label_en-US" xlink:label="lab_srt_ProductsAndServicesDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Product and Service [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ProductsAndServicesDomain" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_ProductsAndServicesDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_srt_ProductsAndServicesDomain" xlink:to="lab_srt_ProductsAndServicesDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityShellCompany_fa190caf-1169-41da-a760-b85f062c5bdc_terseLabel_en-US" xlink:label="lab_dei_EntityShellCompany" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Shell Company</link:label>
    <link:label id="lab_dei_EntityShellCompany_label_en-US" xlink:label="lab_dei_EntityShellCompany" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Shell Company</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityShellCompany" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityShellCompany"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityShellCompany" xlink:to="lab_dei_EntityShellCompany" xlink:type="arc" order="1"/>
    <link:label id="lab_dmtk_FinanceLeaseLiabilityPaymentsDueAfterYearFour_c5e77b0c-8d68-446c-8fc3-ec4b4f8777e0_terseLabel_en-US" xlink:label="lab_dmtk_FinanceLeaseLiabilityPaymentsDueAfterYearFour" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Thereafter</link:label>
    <link:label id="lab_dmtk_FinanceLeaseLiabilityPaymentsDueAfterYearFour_label_en-US" xlink:label="lab_dmtk_FinanceLeaseLiabilityPaymentsDueAfterYearFour" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Finance Lease Liability Payments Due After Year Four</link:label>
    <link:label id="lab_dmtk_FinanceLeaseLiabilityPaymentsDueAfterYearFour_documentation_en-US" xlink:label="lab_dmtk_FinanceLeaseLiabilityPaymentsDueAfterYearFour" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Finance lease liability payments due after year four.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dmtk_FinanceLeaseLiabilityPaymentsDueAfterYearFour" xlink:href="dmtk-20220630.xsd#dmtk_FinanceLeaseLiabilityPaymentsDueAfterYearFour"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dmtk_FinanceLeaseLiabilityPaymentsDueAfterYearFour" xlink:to="lab_dmtk_FinanceLeaseLiabilityPaymentsDueAfterYearFour" xlink:type="arc" order="1"/>
    <link:label id="lab_dmtk_IncreaseDecreaseInStockIssuanceCosts_b7adfaa9-a58b-4c89-9033-5239d81ed95c_negatedLabel_en-US" xlink:label="lab_dmtk_IncreaseDecreaseInStockIssuanceCosts" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Decrease in issuance costs</link:label>
    <link:label id="lab_dmtk_IncreaseDecreaseInStockIssuanceCosts_label_en-US" xlink:label="lab_dmtk_IncreaseDecreaseInStockIssuanceCosts" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Increase (Decrease) In Stock Issuance Costs</link:label>
    <link:label id="lab_dmtk_IncreaseDecreaseInStockIssuanceCosts_documentation_en-US" xlink:label="lab_dmtk_IncreaseDecreaseInStockIssuanceCosts" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Increase decrease in stock issuance costs.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dmtk_IncreaseDecreaseInStockIssuanceCosts" xlink:href="dmtk-20220630.xsd#dmtk_IncreaseDecreaseInStockIssuanceCosts"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dmtk_IncreaseDecreaseInStockIssuanceCosts" xlink:to="lab_dmtk_IncreaseDecreaseInStockIssuanceCosts" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths_59cca507-8fde-4c9a-8e23-a04b9c2b3716_terseLabel_en-US" xlink:label="lab_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">2023</link:label>
    <link:label id="lab_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths_label_en-US" xlink:label="lab_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Lessee, Operating Lease, Liability, to be Paid, Year One</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths" xlink:to="lab_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FinancialInstrumentAxis_ed25f3f9-09ed-409f-a1ff-1dbc5285bddb_terseLabel_en-US" xlink:label="lab_us-gaap_FinancialInstrumentAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Financial Instrument</link:label>
    <link:label id="lab_us-gaap_FinancialInstrumentAxis_label_en-US" xlink:label="lab_us-gaap_FinancialInstrumentAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Financial Instrument [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FinancialInstrumentAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FinancialInstrumentAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FinancialInstrumentAxis" xlink:to="lab_us-gaap_FinancialInstrumentAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ProceedsFromWarrantExercises_d76fd4cb-9cae-4dee-96d4-06a5619d27c7_terseLabel_en-US" xlink:label="lab_us-gaap_ProceedsFromWarrantExercises" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Proceeds from exercise of common stock warrants</link:label>
    <link:label id="lab_us-gaap_ProceedsFromWarrantExercises_3ee25440-4230-4454-a072-8193629be078_verboseLabel_en-US" xlink:label="lab_us-gaap_ProceedsFromWarrantExercises" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Total proceeds from exercise of public warrants</link:label>
    <link:label id="lab_us-gaap_ProceedsFromWarrantExercises_label_en-US" xlink:label="lab_us-gaap_ProceedsFromWarrantExercises" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Proceeds from Warrant Exercises</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProceedsFromWarrantExercises" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ProceedsFromWarrantExercises"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ProceedsFromWarrantExercises" xlink:to="lab_us-gaap_ProceedsFromWarrantExercises" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_USGovernmentAgenciesShorttermDebtSecuritiesMember_7ff80fa2-4ad6-42c5-9c01-609f8d4a83a3_terseLabel_en-US" xlink:label="lab_us-gaap_USGovernmentAgenciesShorttermDebtSecuritiesMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">U.S. government debt securities</link:label>
    <link:label id="lab_us-gaap_USGovernmentAgenciesShorttermDebtSecuritiesMember_label_en-US" xlink:label="lab_us-gaap_USGovernmentAgenciesShorttermDebtSecuritiesMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">US Government Agencies Short-Term Debt Securities [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_USGovernmentAgenciesShorttermDebtSecuritiesMember" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_USGovernmentAgenciesShorttermDebtSecuritiesMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_USGovernmentAgenciesShorttermDebtSecuritiesMember" xlink:to="lab_us-gaap_USGovernmentAgenciesShorttermDebtSecuritiesMember" xlink:type="arc" order="1"/>
    <link:label id="lab_dmtk_PublicSpecialPurposeAcquisitionCompaniesWarrantsMember_dbc8dd26-cbf5-4263-b59b-023f6d3aedb3_terseLabel_en-US" xlink:label="lab_dmtk_PublicSpecialPurposeAcquisitionCompaniesWarrantsMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Public SPAC Warrants</link:label>
    <link:label id="lab_dmtk_PublicSpecialPurposeAcquisitionCompaniesWarrantsMember_label_en-US" xlink:label="lab_dmtk_PublicSpecialPurposeAcquisitionCompaniesWarrantsMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Public Special Purpose Acquisition Companies Warrants [Member]</link:label>
    <link:label id="lab_dmtk_PublicSpecialPurposeAcquisitionCompaniesWarrantsMember_documentation_en-US" xlink:label="lab_dmtk_PublicSpecialPurposeAcquisitionCompaniesWarrantsMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Public special purpose acquisition companies warrants.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dmtk_PublicSpecialPurposeAcquisitionCompaniesWarrantsMember" xlink:href="dmtk-20220630.xsd#dmtk_PublicSpecialPurposeAcquisitionCompaniesWarrantsMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dmtk_PublicSpecialPurposeAcquisitionCompaniesWarrantsMember" xlink:to="lab_dmtk_PublicSpecialPurposeAcquisitionCompaniesWarrantsMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_SalesRevenueNetMember_43ed95a8-d168-41fb-b21a-527ab39f368b_verboseLabel_en-US" xlink:label="lab_us-gaap_SalesRevenueNetMember" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Total Revenues</link:label>
    <link:label id="lab_us-gaap_SalesRevenueNetMember_label_en-US" xlink:label="lab_us-gaap_SalesRevenueNetMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Revenue Benchmark [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SalesRevenueNetMember" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SalesRevenueNetMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SalesRevenueNetMember" xlink:to="lab_us-gaap_SalesRevenueNetMember" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_DocumentPeriodEndDate_fda4aefb-c867-4fee-b667-c59b337615c8_verboseLabel_en-US" xlink:label="lab_dei_DocumentPeriodEndDate" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Document Period End Date</link:label>
    <link:label id="lab_dei_DocumentPeriodEndDate_label_en-US" xlink:label="lab_dei_DocumentPeriodEndDate" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Document Period End Date</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_DocumentPeriodEndDate" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_DocumentPeriodEndDate"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_DocumentPeriodEndDate" xlink:to="lab_dei_DocumentPeriodEndDate" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FurnitureAndFixturesGross_09315909-d4b3-4cf6-b93c-c0d1db5e1aaf_terseLabel_en-US" xlink:label="lab_us-gaap_FurnitureAndFixturesGross" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Furniture and fixtures</link:label>
    <link:label id="lab_us-gaap_FurnitureAndFixturesGross_label_en-US" xlink:label="lab_us-gaap_FurnitureAndFixturesGross" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Furniture and Fixtures, Gross</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FurnitureAndFixturesGross" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FurnitureAndFixturesGross"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FurnitureAndFixturesGross" xlink:to="lab_us-gaap_FurnitureAndFixturesGross" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AdjustmentsToAdditionalPaidInCapitalStockIssuedIssuanceCosts_b9af715d-5100-4a6b-a8f8-308fb8136a09_verboseLabel_en-US" xlink:label="lab_us-gaap_AdjustmentsToAdditionalPaidInCapitalStockIssuedIssuanceCosts" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Issuance costs</link:label>
    <link:label id="lab_us-gaap_AdjustmentsToAdditionalPaidInCapitalStockIssuedIssuanceCosts_label_en-US" xlink:label="lab_us-gaap_AdjustmentsToAdditionalPaidInCapitalStockIssuedIssuanceCosts" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Adjustments to Additional Paid in Capital, Stock Issued, Issuance Costs</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AdjustmentsToAdditionalPaidInCapitalStockIssuedIssuanceCosts" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AdjustmentsToAdditionalPaidInCapitalStockIssuedIssuanceCosts"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AdjustmentsToAdditionalPaidInCapitalStockIssuedIssuanceCosts" xlink:to="lab_us-gaap_AdjustmentsToAdditionalPaidInCapitalStockIssuedIssuanceCosts" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_Assets_84f13af6-24a4-4874-90d8-ce8d7f94bc78_totalLabel_en-US" xlink:label="lab_us-gaap_Assets" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Total assets</link:label>
    <link:label id="lab_us-gaap_Assets_label_en-US" xlink:label="lab_us-gaap_Assets" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Assets</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Assets" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_Assets"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_Assets" xlink:to="lab_us-gaap_Assets" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncomeStatementLocationAxis_5f04384d-ed77-4b8d-93e2-62ee7ed716ab_terseLabel_en-US" xlink:label="lab_us-gaap_IncomeStatementLocationAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Income Statement Location</link:label>
    <link:label id="lab_us-gaap_IncomeStatementLocationAxis_label_en-US" xlink:label="lab_us-gaap_IncomeStatementLocationAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Income Statement Location [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeStatementLocationAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeStatementLocationAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncomeStatementLocationAxis" xlink:to="lab_us-gaap_IncomeStatementLocationAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis_43b3bbdc-add4-477a-bada-5bbe2fc30161_terseLabel_en-US" xlink:label="lab_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Antidilutive Securities</link:label>
    <link:label id="lab_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis_label_en-US" xlink:label="lab_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Antidilutive Securities [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis" xlink:to="lab_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_SharesIssued_e4624a69-96e6-42f5-92c2-f1921577fe5b_verboseLabel_en-US" xlink:label="lab_us-gaap_SharesIssued" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Shares, issued (in shares)</link:label>
    <link:label id="lab_us-gaap_SharesIssued_label_en-US" xlink:label="lab_us-gaap_SharesIssued" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Shares, Issued</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SharesIssued" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SharesIssued"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SharesIssued" xlink:to="lab_us-gaap_SharesIssued" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfAccountsPayableAndAccruedLiabilitiesTableTextBlock_26289853-5f84-457a-9b8a-bffc0d868995_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfAccountsPayableAndAccruedLiabilitiesTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Accrued Compensation and Accrued Liabilities</link:label>
    <link:label id="lab_us-gaap_ScheduleOfAccountsPayableAndAccruedLiabilitiesTableTextBlock_label_en-US" xlink:label="lab_us-gaap_ScheduleOfAccountsPayableAndAccruedLiabilitiesTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Accounts Payable and Accrued Liabilities [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfAccountsPayableAndAccruedLiabilitiesTableTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfAccountsPayableAndAccruedLiabilitiesTableTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfAccountsPayableAndAccruedLiabilitiesTableTextBlock" xlink:to="lab_us-gaap_ScheduleOfAccountsPayableAndAccruedLiabilitiesTableTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AccruedLiabilitiesCurrent_d9604832-0179-4e88-9ef9-9a2a7e346799_terseLabel_en-US" xlink:label="lab_us-gaap_AccruedLiabilitiesCurrent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accrued liabilities</link:label>
    <link:label id="lab_us-gaap_AccruedLiabilitiesCurrent_b4972b1d-82ae-4918-aebd-ab8e48c9db68_totalLabel_en-US" xlink:label="lab_us-gaap_AccruedLiabilitiesCurrent" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Total accrued liabilities</link:label>
    <link:label id="lab_us-gaap_AccruedLiabilitiesCurrent_label_en-US" xlink:label="lab_us-gaap_AccruedLiabilitiesCurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accrued Liabilities, Current</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccruedLiabilitiesCurrent" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AccruedLiabilitiesCurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AccruedLiabilitiesCurrent" xlink:to="lab_us-gaap_AccruedLiabilitiesCurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_NetCashProvidedByUsedInFinancingActivities_53a657e9-4353-44c9-9304-acb559cd89a4_totalLabel_en-US" xlink:label="lab_us-gaap_NetCashProvidedByUsedInFinancingActivities" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net cash provided by financing activities</link:label>
    <link:label id="lab_us-gaap_NetCashProvidedByUsedInFinancingActivities_label_en-US" xlink:label="lab_us-gaap_NetCashProvidedByUsedInFinancingActivities" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net Cash Provided by (Used in) Financing Activities</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInFinancingActivities" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NetCashProvidedByUsedInFinancingActivities"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivities" xlink:to="lab_us-gaap_NetCashProvidedByUsedInFinancingActivities" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AccountingPoliciesAbstract_afdb1b40-836b-45eb-955b-01bc555d8d36_terseLabel_en-US" xlink:label="lab_us-gaap_AccountingPoliciesAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accounting Policies [Abstract]</link:label>
    <link:label id="lab_us-gaap_AccountingPoliciesAbstract_label_en-US" xlink:label="lab_us-gaap_AccountingPoliciesAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accounting Policies [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccountingPoliciesAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AccountingPoliciesAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AccountingPoliciesAbstract" xlink:to="lab_us-gaap_AccountingPoliciesAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_StockholdersEquityNoteAbstract_c753f209-4fcf-4c03-b680-09812d78b701_terseLabel_en-US" xlink:label="lab_us-gaap_StockholdersEquityNoteAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Stockholders' Equity Note [Abstract]</link:label>
    <link:label id="lab_us-gaap_StockholdersEquityNoteAbstract_label_en-US" xlink:label="lab_us-gaap_StockholdersEquityNoteAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Stockholders' Equity Note [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockholdersEquityNoteAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StockholdersEquityNoteAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StockholdersEquityNoteAbstract" xlink:to="lab_us-gaap_StockholdersEquityNoteAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_EmployeeRelatedLiabilitiesCurrent_eb8b3828-94ee-4782-95bd-32e368696a3e_terseLabel_en-US" xlink:label="lab_us-gaap_EmployeeRelatedLiabilitiesCurrent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accrued compensation</link:label>
    <link:label id="lab_us-gaap_EmployeeRelatedLiabilitiesCurrent_1563152d-7e1c-4b08-971e-d82dbaa80cad_totalLabel_en-US" xlink:label="lab_us-gaap_EmployeeRelatedLiabilitiesCurrent" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Total accrued compensation</link:label>
    <link:label id="lab_us-gaap_EmployeeRelatedLiabilitiesCurrent_label_en-US" xlink:label="lab_us-gaap_EmployeeRelatedLiabilitiesCurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Employee-related Liabilities, Current</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EmployeeRelatedLiabilitiesCurrent" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EmployeeRelatedLiabilitiesCurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_EmployeeRelatedLiabilitiesCurrent" xlink:to="lab_us-gaap_EmployeeRelatedLiabilitiesCurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_VariableLeaseCost_05e44cd3-c916-4a0c-baab-8b9be477ecfc_terseLabel_en-US" xlink:label="lab_us-gaap_VariableLeaseCost" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Variable lease costs</link:label>
    <link:label id="lab_us-gaap_VariableLeaseCost_label_en-US" xlink:label="lab_us-gaap_VariableLeaseCost" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Variable Lease, Cost</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_VariableLeaseCost" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_VariableLeaseCost"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_VariableLeaseCost" xlink:to="lab_us-gaap_VariableLeaseCost" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_StockholdersEquityAbstract_e7280382-028d-4d34-8f80-64198cfa2c76_terseLabel_en-US" xlink:label="lab_us-gaap_StockholdersEquityAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Stockholders&#8217; equity:</link:label>
    <link:label id="lab_us-gaap_StockholdersEquityAbstract_label_en-US" xlink:label="lab_us-gaap_StockholdersEquityAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Stockholders' Equity Attributable to Parent [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockholdersEquityAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StockholdersEquityAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StockholdersEquityAbstract" xlink:to="lab_us-gaap_StockholdersEquityAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PrepaidExpenseAndOtherAssetsCurrent_c832c0a3-50c4-4b18-9dca-adff5f19bdb4_terseLabel_en-US" xlink:label="lab_us-gaap_PrepaidExpenseAndOtherAssetsCurrent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Prepaid expenses and other current assets</link:label>
    <link:label id="lab_us-gaap_PrepaidExpenseAndOtherAssetsCurrent_05ad71f4-725b-43ea-aa7d-63c361e88e97_totalLabel_en-US" xlink:label="lab_us-gaap_PrepaidExpenseAndOtherAssetsCurrent" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Total prepaid expenses and other current assets</link:label>
    <link:label id="lab_us-gaap_PrepaidExpenseAndOtherAssetsCurrent_label_en-US" xlink:label="lab_us-gaap_PrepaidExpenseAndOtherAssetsCurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Prepaid Expense and Other Assets, Current</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PrepaidExpenseAndOtherAssetsCurrent" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PrepaidExpenseAndOtherAssetsCurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PrepaidExpenseAndOtherAssetsCurrent" xlink:to="lab_us-gaap_PrepaidExpenseAndOtherAssetsCurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_srt_CumulativeEffectPeriodOfAdoptionDomain_21ac313c-b6ce-40d4-b34b-4080411d5bd2_terseLabel_en-US" xlink:label="lab_srt_CumulativeEffectPeriodOfAdoptionDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cumulative Effect, Period of Adoption [Domain]</link:label>
    <link:label id="lab_srt_CumulativeEffectPeriodOfAdoptionDomain_label_en-US" xlink:label="lab_srt_CumulativeEffectPeriodOfAdoptionDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cumulative Effect, Period of Adoption [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_srt_CumulativeEffectPeriodOfAdoptionDomain" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_CumulativeEffectPeriodOfAdoptionDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_srt_CumulativeEffectPeriodOfAdoptionDomain" xlink:to="lab_srt_CumulativeEffectPeriodOfAdoptionDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_dmtk_ProceedsFromReleaseOfRSUsAndStockOptionsExercised_65f3f283-aa41-40e3-9139-bd7f3600471c_terseLabel_en-US" xlink:label="lab_dmtk_ProceedsFromReleaseOfRSUsAndStockOptionsExercised" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Proceeds from RSU releases (par value only) and the exercise of stock options</link:label>
    <link:label id="lab_dmtk_ProceedsFromReleaseOfRSUsAndStockOptionsExercised_label_en-US" xlink:label="lab_dmtk_ProceedsFromReleaseOfRSUsAndStockOptionsExercised" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Proceeds From Release Of RSUs And Stock Options Exercised</link:label>
    <link:label id="lab_dmtk_ProceedsFromReleaseOfRSUsAndStockOptionsExercised_documentation_en-US" xlink:label="lab_dmtk_ProceedsFromReleaseOfRSUsAndStockOptionsExercised" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Proceeds From Release Of RSUs And Stock Options Exercised</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dmtk_ProceedsFromReleaseOfRSUsAndStockOptionsExercised" xlink:href="dmtk-20220630.xsd#dmtk_ProceedsFromReleaseOfRSUsAndStockOptionsExercised"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dmtk_ProceedsFromReleaseOfRSUsAndStockOptionsExercised" xlink:to="lab_dmtk_ProceedsFromReleaseOfRSUsAndStockOptionsExercised" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DisclosureOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTextBlock_b4d3788d-5989-4437-a2e8-a1b3bda83da5_terseLabel_en-US" xlink:label="lab_us-gaap_DisclosureOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Disclosure of Share-Based Compensation Arrangements by Share-Based Payment Award</link:label>
    <link:label id="lab_us-gaap_DisclosureOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTextBlock_label_en-US" xlink:label="lab_us-gaap_DisclosureOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Disclosure of Share-Based Compensation Arrangements by Share-Based Payment Award [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisclosureOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DisclosureOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DisclosureOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTextBlock" xlink:to="lab_us-gaap_DisclosureOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FinanceLeaseLiabilityNoncurrent_790a9ac9-15a2-4fc6-8ded-add52f1ff0da_terseLabel_en-US" xlink:label="lab_us-gaap_FinanceLeaseLiabilityNoncurrent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Long-term finance lease obligations, less current portion</link:label>
    <link:label id="lab_us-gaap_FinanceLeaseLiabilityNoncurrent_label_en-US" xlink:label="lab_us-gaap_FinanceLeaseLiabilityNoncurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Finance Lease, Liability, Noncurrent</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FinanceLeaseLiabilityNoncurrent" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FinanceLeaseLiabilityNoncurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FinanceLeaseLiabilityNoncurrent" xlink:to="lab_us-gaap_FinanceLeaseLiabilityNoncurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_dmtk_KilroyRealtyLPMember_17aca436-cb58-4524-b021-e58d651c682a_terseLabel_en-US" xlink:label="lab_dmtk_KilroyRealtyLPMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Kilroy Realty, L.P</link:label>
    <link:label id="lab_dmtk_KilroyRealtyLPMember_label_en-US" xlink:label="lab_dmtk_KilroyRealtyLPMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Kilroy Realty L P [Member]</link:label>
    <link:label id="lab_dmtk_KilroyRealtyLPMember_documentation_en-US" xlink:label="lab_dmtk_KilroyRealtyLPMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Kilroy Realty, L.P.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dmtk_KilroyRealtyLPMember" xlink:href="dmtk-20220630.xsd#dmtk_KilroyRealtyLPMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dmtk_KilroyRealtyLPMember" xlink:to="lab_dmtk_KilroyRealtyLPMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_EmployeeRelatedLiabilitiesCurrentAbstract_010f10ca-e505-452c-b7a0-14a6e5a00930_terseLabel_en-US" xlink:label="lab_us-gaap_EmployeeRelatedLiabilitiesCurrentAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accrued compensation:</link:label>
    <link:label id="lab_us-gaap_EmployeeRelatedLiabilitiesCurrentAbstract_label_en-US" xlink:label="lab_us-gaap_EmployeeRelatedLiabilitiesCurrentAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Employee-related Liabilities, Current [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EmployeeRelatedLiabilitiesCurrentAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EmployeeRelatedLiabilitiesCurrentAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_EmployeeRelatedLiabilitiesCurrentAbstract" xlink:to="lab_us-gaap_EmployeeRelatedLiabilitiesCurrentAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_SupplementalBalanceSheetDisclosuresTextBlock_07b7bbf2-78a1-469d-a4ef-0d3af66de94e_terseLabel_en-US" xlink:label="lab_us-gaap_SupplementalBalanceSheetDisclosuresTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Balance Sheet Details</link:label>
    <link:label id="lab_us-gaap_SupplementalBalanceSheetDisclosuresTextBlock_label_en-US" xlink:label="lab_us-gaap_SupplementalBalanceSheetDisclosuresTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Supplemental Balance Sheet Disclosures [Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SupplementalBalanceSheetDisclosuresTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SupplementalBalanceSheetDisclosuresTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SupplementalBalanceSheetDisclosuresTextBlock" xlink:to="lab_us-gaap_SupplementalBalanceSheetDisclosuresTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncreaseDecreaseInOperatingLeaseLiability_06218a68-04ef-4ad8-bfa9-800dbaea1fcb_terseLabel_en-US" xlink:label="lab_us-gaap_IncreaseDecreaseInOperatingLeaseLiability" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Operating lease liabilities, net</link:label>
    <link:label id="lab_us-gaap_IncreaseDecreaseInOperatingLeaseLiability_1768d0b3-a75a-408c-92f9-08746137fe7e_verboseLabel_en-US" xlink:label="lab_us-gaap_IncreaseDecreaseInOperatingLeaseLiability" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Increase to operating lease liability</link:label>
    <link:label id="lab_us-gaap_IncreaseDecreaseInOperatingLeaseLiability_label_en-US" xlink:label="lab_us-gaap_IncreaseDecreaseInOperatingLeaseLiability" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Increase (Decrease) in Operating Lease Liability</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInOperatingLeaseLiability" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncreaseDecreaseInOperatingLeaseLiability"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncreaseDecreaseInOperatingLeaseLiability" xlink:to="lab_us-gaap_IncreaseDecreaseInOperatingLeaseLiability" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_RelatedPartyTransactionLineItems_83f1e1c7-6c14-4387-b4f4-aa08be00334f_terseLabel_en-US" xlink:label="lab_us-gaap_RelatedPartyTransactionLineItems" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Related Party Transaction [Line Items]</link:label>
    <link:label id="lab_us-gaap_RelatedPartyTransactionLineItems_label_en-US" xlink:label="lab_us-gaap_RelatedPartyTransactionLineItems" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Related Party Transaction [Line Items]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RelatedPartyTransactionLineItems" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RelatedPartyTransactionLineItems"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_RelatedPartyTransactionLineItems" xlink:to="lab_us-gaap_RelatedPartyTransactionLineItems" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_9c4bfcba-2b67-4e54-8b16-eeeb329385ac_terseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Award Type</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Award Type [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights_ce942d4f-8610-4727-878d-f797964ca778_terseLabel_en-US" xlink:label="lab_us-gaap_ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Total number exercised of public warrants (in shares)</link:label>
    <link:label id="lab_us-gaap_ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights_label_en-US" xlink:label="lab_us-gaap_ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Class of Warrant or Right, Number of Securities Called by Warrants or Rights</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights" xlink:to="lab_us-gaap_ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1_736cf13b-044b-4a9d-a2af-76556b9b3ac5_terseLabel_en-US" xlink:label="lab_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Weighted average term expected to be recognized</link:label>
    <link:label id="lab_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1_label_en-US" xlink:label="lab_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-Based Payment Arrangement, Nonvested Award, Cost Not yet Recognized, Period for Recognition</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1" xlink:to="lab_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ReceivablesPolicyTextBlock_20cc4644-d6c0-45df-a2d3-111acbf79c6e_terseLabel_en-US" xlink:label="lab_us-gaap_ReceivablesPolicyTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accounts Receivable</link:label>
    <link:label id="lab_us-gaap_ReceivablesPolicyTextBlock_label_en-US" xlink:label="lab_us-gaap_ReceivablesPolicyTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Receivable [Policy Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ReceivablesPolicyTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ReceivablesPolicyTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ReceivablesPolicyTextBlock" xlink:to="lab_us-gaap_ReceivablesPolicyTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ProceedsFromStockPlans_222d7d40-b07f-4ff7-9f58-9336cd542ce1_terseLabel_en-US" xlink:label="lab_us-gaap_ProceedsFromStockPlans" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Proceeds from contributions to the employee stock purchase plan</link:label>
    <link:label id="lab_us-gaap_ProceedsFromStockPlans_label_en-US" xlink:label="lab_us-gaap_ProceedsFromStockPlans" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Proceeds from Stock Plans</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProceedsFromStockPlans" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ProceedsFromStockPlans"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ProceedsFromStockPlans" xlink:to="lab_us-gaap_ProceedsFromStockPlans" xlink:type="arc" order="1"/>
    <link:label id="lab_dmtk_WarrantLiabilityMember_f1deaf3a-cea3-4fe9-8233-586ef508885b_terseLabel_en-US" xlink:label="lab_dmtk_WarrantLiabilityMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Warrant Liability</link:label>
    <link:label id="lab_dmtk_WarrantLiabilityMember_label_en-US" xlink:label="lab_dmtk_WarrantLiabilityMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Warrant Liability [Member]</link:label>
    <link:label id="lab_dmtk_WarrantLiabilityMember_documentation_en-US" xlink:label="lab_dmtk_WarrantLiabilityMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Warrant liability.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dmtk_WarrantLiabilityMember" xlink:href="dmtk-20220630.xsd#dmtk_WarrantLiabilityMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dmtk_WarrantLiabilityMember" xlink:to="lab_dmtk_WarrantLiabilityMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_GrossProfit_5c36707b-db22-4b50-bbf7-e489bc56b157_totalLabel_en-US" xlink:label="lab_us-gaap_GrossProfit" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Gross profit</link:label>
    <link:label id="lab_us-gaap_GrossProfit_label_en-US" xlink:label="lab_us-gaap_GrossProfit" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Gross Profit</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GrossProfit" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_GrossProfit"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_GrossProfit" xlink:to="lab_us-gaap_GrossProfit" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_RevenueFromContractWithCustomerIncludingAssessedTax_0aee6757-d1bf-452e-b16e-0d9bd11ad578_terseLabel_en-US" xlink:label="lab_us-gaap_RevenueFromContractWithCustomerIncludingAssessedTax" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Total revenues</link:label>
    <link:label id="lab_us-gaap_RevenueFromContractWithCustomerIncludingAssessedTax_label_en-US" xlink:label="lab_us-gaap_RevenueFromContractWithCustomerIncludingAssessedTax" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Revenue from Contract with Customer, Including Assessed Tax</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevenueFromContractWithCustomerIncludingAssessedTax" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RevenueFromContractWithCustomerIncludingAssessedTax"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_RevenueFromContractWithCustomerIncludingAssessedTax" xlink:to="lab_us-gaap_RevenueFromContractWithCustomerIncludingAssessedTax" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityRegistrantName_059b1282-8a1b-429c-9086-9afffe355756_terseLabel_en-US" xlink:label="lab_dei_EntityRegistrantName" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Registrant Name</link:label>
    <link:label id="lab_dei_EntityRegistrantName_label_en-US" xlink:label="lab_dei_EntityRegistrantName" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Registrant Name</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityRegistrantName" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityRegistrantName"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityRegistrantName" xlink:to="lab_dei_EntityRegistrantName" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_StockIssuedDuringPeriodSharesNewIssues_eef2a15f-d345-401c-b7bb-4741c593a270_terseLabel_en-US" xlink:label="lab_us-gaap_StockIssuedDuringPeriodSharesNewIssues" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Issuance of stock, net of issuance costs shares (in shares)</link:label>
    <link:label id="lab_us-gaap_StockIssuedDuringPeriodSharesNewIssues_9cf14e7b-4745-4102-918c-1b371279b6a5_verboseLabel_en-US" xlink:label="lab_us-gaap_StockIssuedDuringPeriodSharesNewIssues" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Issuance of common stock, net of issuance costs shares (in shares)</link:label>
    <link:label id="lab_us-gaap_StockIssuedDuringPeriodSharesNewIssues_label_en-US" xlink:label="lab_us-gaap_StockIssuedDuringPeriodSharesNewIssues" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Stock Issued During Period, Shares, New Issues</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockIssuedDuringPeriodSharesNewIssues" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StockIssuedDuringPeriodSharesNewIssues"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StockIssuedDuringPeriodSharesNewIssues" xlink:to="lab_us-gaap_StockIssuedDuringPeriodSharesNewIssues" xlink:type="arc" order="1"/>
    <link:label id="lab_dmtk_PercentageOfUsefulLivesOfAssets_51628f84-2a47-4fb4-bb5d-2a0a80dc772c_terseLabel_en-US" xlink:label="lab_dmtk_PercentageOfUsefulLivesOfAssets" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Percentage of useful lives of assets</link:label>
    <link:label id="lab_dmtk_PercentageOfUsefulLivesOfAssets_label_en-US" xlink:label="lab_dmtk_PercentageOfUsefulLivesOfAssets" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Percentage Of Useful Lives Of Assets</link:label>
    <link:label id="lab_dmtk_PercentageOfUsefulLivesOfAssets_documentation_en-US" xlink:label="lab_dmtk_PercentageOfUsefulLivesOfAssets" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Percentage of useful lives of assets.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dmtk_PercentageOfUsefulLivesOfAssets" xlink:href="dmtk-20220630.xsd#dmtk_PercentageOfUsefulLivesOfAssets"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dmtk_PercentageOfUsefulLivesOfAssets" xlink:to="lab_dmtk_PercentageOfUsefulLivesOfAssets" xlink:type="arc" order="1"/>
    <link:label id="lab_dmtk_AreaOfBuilding_08e19d47-01cf-4ded-bd60-02e4811c4064_terseLabel_en-US" xlink:label="lab_dmtk_AreaOfBuilding" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Area of building (in square feet)</link:label>
    <link:label id="lab_dmtk_AreaOfBuilding_label_en-US" xlink:label="lab_dmtk_AreaOfBuilding" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Area Of Building</link:label>
    <link:label id="lab_dmtk_AreaOfBuilding_documentation_en-US" xlink:label="lab_dmtk_AreaOfBuilding" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Area of building.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dmtk_AreaOfBuilding" xlink:href="dmtk-20220630.xsd#dmtk_AreaOfBuilding"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dmtk_AreaOfBuilding" xlink:to="lab_dmtk_AreaOfBuilding" xlink:type="arc" order="1"/>
    <link:label id="lab_dmtk_CommonSharesIssuedUponExerciseOfWarrants_750d28c2-2331-432f-8086-f4528180f01e_verboseLabel_en-US" xlink:label="lab_dmtk_CommonSharesIssuedUponExerciseOfWarrants" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Common shares issued upon exercise of warrants (in shares)</link:label>
    <link:label id="lab_dmtk_CommonSharesIssuedUponExerciseOfWarrants_label_en-US" xlink:label="lab_dmtk_CommonSharesIssuedUponExerciseOfWarrants" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Common Shares Issued Upon Exercise Of Warrants</link:label>
    <link:label id="lab_dmtk_CommonSharesIssuedUponExerciseOfWarrants_documentation_en-US" xlink:label="lab_dmtk_CommonSharesIssuedUponExerciseOfWarrants" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Common shares issued upon exercise of warrants.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dmtk_CommonSharesIssuedUponExerciseOfWarrants" xlink:href="dmtk-20220630.xsd#dmtk_CommonSharesIssuedUponExerciseOfWarrants"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dmtk_CommonSharesIssuedUponExerciseOfWarrants" xlink:to="lab_dmtk_CommonSharesIssuedUponExerciseOfWarrants" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_SubsequentEventsTextBlock_f009a034-a547-4177-a03c-221f7a423e2d_terseLabel_en-US" xlink:label="lab_us-gaap_SubsequentEventsTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Subsequent Events</link:label>
    <link:label id="lab_us-gaap_SubsequentEventsTextBlock_label_en-US" xlink:label="lab_us-gaap_SubsequentEventsTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Subsequent Events [Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SubsequentEventsTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SubsequentEventsTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SubsequentEventsTextBlock" xlink:to="lab_us-gaap_SubsequentEventsTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate_81608b03-72dc-4562-b6bc-dbc7b56a6b7d_terseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Expected dividend yield</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-Based Compensation Arrangement by Share-Based Payment Award, Fair Value Assumptions, Expected Dividend Rate</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityAddressCityOrTown_8ff6dc46-2dd2-4cbe-b3d7-7efe849f10b1_terseLabel_en-US" xlink:label="lab_dei_EntityAddressCityOrTown" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Address, City or Town</link:label>
    <link:label id="lab_dei_EntityAddressCityOrTown_label_en-US" xlink:label="lab_dei_EntityAddressCityOrTown" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Address, City or Town</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityAddressCityOrTown" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityAddressCityOrTown"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityAddressCityOrTown" xlink:to="lab_dei_EntityAddressCityOrTown" xlink:type="arc" order="1"/>
    <link:label id="lab_dmtk_IncreaseDecreaseInOperatingLeaseRightOfUseAsset_a3065462-bfc0-45f2-a0ee-279f64eab55e_terseLabel_en-US" xlink:label="lab_dmtk_IncreaseDecreaseInOperatingLeaseRightOfUseAsset" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Increase to operating right-of-use asset</link:label>
    <link:label id="lab_dmtk_IncreaseDecreaseInOperatingLeaseRightOfUseAsset_label_en-US" xlink:label="lab_dmtk_IncreaseDecreaseInOperatingLeaseRightOfUseAsset" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Increase (Decrease) In Operating Lease, Right-Of-Use-Asset</link:label>
    <link:label id="lab_dmtk_IncreaseDecreaseInOperatingLeaseRightOfUseAsset_documentation_en-US" xlink:label="lab_dmtk_IncreaseDecreaseInOperatingLeaseRightOfUseAsset" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Increase (Decrease) In Operating Lease, Right-Of-Use-Asset</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dmtk_IncreaseDecreaseInOperatingLeaseRightOfUseAsset" xlink:href="dmtk-20220630.xsd#dmtk_IncreaseDecreaseInOperatingLeaseRightOfUseAsset"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dmtk_IncreaseDecreaseInOperatingLeaseRightOfUseAsset" xlink:to="lab_dmtk_IncreaseDecreaseInOperatingLeaseRightOfUseAsset" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_TenantImprovements_3e12c9a9-dadb-4201-9bc7-3397e8d24c3e_terseLabel_en-US" xlink:label="lab_us-gaap_TenantImprovements" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Tenant improvements</link:label>
    <link:label id="lab_us-gaap_TenantImprovements_label_en-US" xlink:label="lab_us-gaap_TenantImprovements" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Tenant Improvements</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TenantImprovements" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_TenantImprovements"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_TenantImprovements" xlink:to="lab_us-gaap_TenantImprovements" xlink:type="arc" order="1"/>
    <link:label id="lab_dmtk_StockPurchasedByUnderwritersPursuantToOptionGranted_162ffd12-4b1b-421f-ad62-b66a017dc762_terseLabel_en-US" xlink:label="lab_dmtk_StockPurchasedByUnderwritersPursuantToOptionGranted" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Shares purchased by underwriters (in shares)</link:label>
    <link:label id="lab_dmtk_StockPurchasedByUnderwritersPursuantToOptionGranted_label_en-US" xlink:label="lab_dmtk_StockPurchasedByUnderwritersPursuantToOptionGranted" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Stock Purchased By Underwriters Pursuant To Option Granted</link:label>
    <link:label id="lab_dmtk_StockPurchasedByUnderwritersPursuantToOptionGranted_documentation_en-US" xlink:label="lab_dmtk_StockPurchasedByUnderwritersPursuantToOptionGranted" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Stock purchased by underwriters pursuant to option granted.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dmtk_StockPurchasedByUnderwritersPursuantToOptionGranted" xlink:href="dmtk-20220630.xsd#dmtk_StockPurchasedByUnderwritersPursuantToOptionGranted"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dmtk_StockPurchasedByUnderwritersPursuantToOptionGranted" xlink:to="lab_dmtk_StockPurchasedByUnderwritersPursuantToOptionGranted" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DepositsMoneyMarketDeposits_38674d3e-2dcf-4df2-b06e-bb5f21c57a3d_terseLabel_en-US" xlink:label="lab_us-gaap_DepositsMoneyMarketDeposits" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Sweep account</link:label>
    <link:label id="lab_us-gaap_DepositsMoneyMarketDeposits_label_en-US" xlink:label="lab_us-gaap_DepositsMoneyMarketDeposits" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Deposits, Money Market Deposits</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DepositsMoneyMarketDeposits" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DepositsMoneyMarketDeposits"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DepositsMoneyMarketDeposits" xlink:to="lab_us-gaap_DepositsMoneyMarketDeposits" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OperatingExpensesAbstract_c3b91865-9b6b-4c02-a49f-4bcdddda5379_terseLabel_en-US" xlink:label="lab_us-gaap_OperatingExpensesAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Operating expenses:</link:label>
    <link:label id="lab_us-gaap_OperatingExpensesAbstract_label_en-US" xlink:label="lab_us-gaap_OperatingExpensesAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Operating Expenses [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingExpensesAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OperatingExpensesAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OperatingExpensesAbstract" xlink:to="lab_us-gaap_OperatingExpensesAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_dmtk_CommonStockOutstandingPercentage_c1f4a16f-65bd-4c1f-abb8-d4df28e756c6_terseLabel_en-US" xlink:label="lab_dmtk_CommonStockOutstandingPercentage" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Common stock outstanding percentage</link:label>
    <link:label id="lab_dmtk_CommonStockOutstandingPercentage_label_en-US" xlink:label="lab_dmtk_CommonStockOutstandingPercentage" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Common Stock Outstanding Percentage</link:label>
    <link:label id="lab_dmtk_CommonStockOutstandingPercentage_documentation_en-US" xlink:label="lab_dmtk_CommonStockOutstandingPercentage" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Common stock outstanding percentage.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dmtk_CommonStockOutstandingPercentage" xlink:href="dmtk-20220630.xsd#dmtk_CommonStockOutstandingPercentage"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dmtk_CommonStockOutstandingPercentage" xlink:to="lab_dmtk_CommonStockOutstandingPercentage" xlink:type="arc" order="1"/>
    <link:label id="lab_dmtk_CashPaidForAmountsIncludedInMeasurementOfLeaseLiabilitiesAbstract_a192166c-2913-4e55-b36d-9245c30446d0_terseLabel_en-US" xlink:label="lab_dmtk_CashPaidForAmountsIncludedInMeasurementOfLeaseLiabilitiesAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cash paid for amounts included in the measurement of lease liabilities:</link:label>
    <link:label id="lab_dmtk_CashPaidForAmountsIncludedInMeasurementOfLeaseLiabilitiesAbstract_label_en-US" xlink:label="lab_dmtk_CashPaidForAmountsIncludedInMeasurementOfLeaseLiabilitiesAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cash Paid For Amounts Included In Measurement Of Lease Liabilities [Abstract]</link:label>
    <link:label id="lab_dmtk_CashPaidForAmountsIncludedInMeasurementOfLeaseLiabilitiesAbstract_documentation_en-US" xlink:label="lab_dmtk_CashPaidForAmountsIncludedInMeasurementOfLeaseLiabilitiesAbstract" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cash paid for amounts included in the measurement of lease liabilities.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dmtk_CashPaidForAmountsIncludedInMeasurementOfLeaseLiabilitiesAbstract" xlink:href="dmtk-20220630.xsd#dmtk_CashPaidForAmountsIncludedInMeasurementOfLeaseLiabilitiesAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dmtk_CashPaidForAmountsIncludedInMeasurementOfLeaseLiabilitiesAbstract" xlink:to="lab_dmtk_CashPaidForAmountsIncludedInMeasurementOfLeaseLiabilitiesAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfProductInformationTableTextBlock_ccdf6cfb-7ef5-4448-ac0f-db2c53c81bcc_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfProductInformationTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Summary of Percentages of Total Revenue or Accounts Receivable for Third Party Payers and Pharmaceutical Customers</link:label>
    <link:label id="lab_us-gaap_ScheduleOfProductInformationTableTextBlock_label_en-US" xlink:label="lab_us-gaap_ScheduleOfProductInformationTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Product Information [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfProductInformationTableTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfProductInformationTableTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfProductInformationTableTextBlock" xlink:to="lab_us-gaap_ScheduleOfProductInformationTableTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_srt_MinimumMember_c8d2f69e-a2f2-4a73-85db-4a3626c22b87_terseLabel_en-US" xlink:label="lab_srt_MinimumMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Minimum</link:label>
    <link:label id="lab_srt_MinimumMember_label_en-US" xlink:label="lab_srt_MinimumMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Minimum [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_srt_MinimumMember" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_MinimumMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_srt_MinimumMember" xlink:to="lab_srt_MinimumMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_StatementOfFinancialPositionAbstract_52716b6b-d521-441c-9414-26bbe3bb4bf5_terseLabel_en-US" xlink:label="lab_us-gaap_StatementOfFinancialPositionAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Statement of Financial Position [Abstract]</link:label>
    <link:label id="lab_us-gaap_StatementOfFinancialPositionAbstract_label_en-US" xlink:label="lab_us-gaap_StatementOfFinancialPositionAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Statement of Financial Position [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementOfFinancialPositionAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StatementOfFinancialPositionAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StatementOfFinancialPositionAbstract" xlink:to="lab_us-gaap_StatementOfFinancialPositionAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityEmergingGrowthCompany_a1cbf19b-ef09-4460-bd81-a86780912dbe_terseLabel_en-US" xlink:label="lab_dei_EntityEmergingGrowthCompany" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Emerging Growth Company</link:label>
    <link:label id="lab_dei_EntityEmergingGrowthCompany_label_en-US" xlink:label="lab_dei_EntityEmergingGrowthCompany" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Emerging Growth Company</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityEmergingGrowthCompany" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityEmergingGrowthCompany"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityEmergingGrowthCompany" xlink:to="lab_dei_EntityEmergingGrowthCompany" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CommonStockParOrStatedValuePerShare_c8b5ec6a-2c3d-43c0-8d19-ffb5335a2f65_terseLabel_en-US" xlink:label="lab_us-gaap_CommonStockParOrStatedValuePerShare" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Common stock, par value per share (in usd per share)</link:label>
    <link:label id="lab_us-gaap_CommonStockParOrStatedValuePerShare_1de15eec-a3d7-4808-bb7e-4d788ad1611f_verboseLabel_en-US" xlink:label="lab_us-gaap_CommonStockParOrStatedValuePerShare" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Common stock, par value per share (in usd per share)</link:label>
    <link:label id="lab_us-gaap_CommonStockParOrStatedValuePerShare_label_en-US" xlink:label="lab_us-gaap_CommonStockParOrStatedValuePerShare" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Common Stock, Par or Stated Value Per Share</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockParOrStatedValuePerShare" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CommonStockParOrStatedValuePerShare"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CommonStockParOrStatedValuePerShare" xlink:to="lab_us-gaap_CommonStockParOrStatedValuePerShare" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CommitmentsAndContingenciesDisclosureAbstract_67a6c1f0-e9b3-4127-914e-b8cfd499449e_terseLabel_en-US" xlink:label="lab_us-gaap_CommitmentsAndContingenciesDisclosureAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Commitments and Contingencies Disclosure [Abstract]</link:label>
    <link:label id="lab_us-gaap_CommitmentsAndContingenciesDisclosureAbstract_label_en-US" xlink:label="lab_us-gaap_CommitmentsAndContingenciesDisclosureAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Commitments and Contingencies Disclosure [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommitmentsAndContingenciesDisclosureAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CommitmentsAndContingenciesDisclosureAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CommitmentsAndContingenciesDisclosureAbstract" xlink:to="lab_us-gaap_CommitmentsAndContingenciesDisclosureAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AdjustmentsForNewAccountingPronouncementsAxis_543f83c5-d61d-499d-ae19-b3aabea7ba72_terseLabel_en-US" xlink:label="lab_us-gaap_AdjustmentsForNewAccountingPronouncementsAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accounting Standards Update [Axis]</link:label>
    <link:label id="lab_us-gaap_AdjustmentsForNewAccountingPronouncementsAxis_label_en-US" xlink:label="lab_us-gaap_AdjustmentsForNewAccountingPronouncementsAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accounting Standards Update [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AdjustmentsForNewAccountingPronouncementsAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AdjustmentsForNewAccountingPronouncementsAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AdjustmentsForNewAccountingPronouncementsAxis" xlink:to="lab_us-gaap_AdjustmentsForNewAccountingPronouncementsAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_TradingSymbol_4e66eb83-6d4e-4fda-b92c-ab5587b6ed3d_terseLabel_en-US" xlink:label="lab_dei_TradingSymbol" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Trading Symbol</link:label>
    <link:label id="lab_dei_TradingSymbol_label_en-US" xlink:label="lab_dei_TradingSymbol" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Trading Symbol</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_TradingSymbol" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_TradingSymbol"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_TradingSymbol" xlink:to="lab_dei_TradingSymbol" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityFileNumber_58bd01d9-85f3-4d8e-a6bf-7f6f64b6c756_terseLabel_en-US" xlink:label="lab_dei_EntityFileNumber" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity File Number</link:label>
    <link:label id="lab_dei_EntityFileNumber_label_en-US" xlink:label="lab_dei_EntityFileNumber" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity File Number</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityFileNumber" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityFileNumber"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityFileNumber" xlink:to="lab_dei_EntityFileNumber" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_WarrantyRightsAndObligationsFairValueOptionMember_5a0adab9-6710-4da2-a208-b9104545c3a0_terseLabel_en-US" xlink:label="lab_us-gaap_WarrantyRightsAndObligationsFairValueOptionMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Warranty liability</link:label>
    <link:label id="lab_us-gaap_WarrantyRightsAndObligationsFairValueOptionMember_label_en-US" xlink:label="lab_us-gaap_WarrantyRightsAndObligationsFairValueOptionMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Warranty, Rights and Obligations, Fair Value Option [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_WarrantyRightsAndObligationsFairValueOptionMember" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_WarrantyRightsAndObligationsFairValueOptionMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_WarrantyRightsAndObligationsFairValueOptionMember" xlink:to="lab_us-gaap_WarrantyRightsAndObligationsFairValueOptionMember" xlink:type="arc" order="1"/>
    <link:label id="lab_dmtk_IncentiveStockOptionsMember_c6ba6d27-a00d-4aaa-ae37-5ef349ccdbd8_terseLabel_en-US" xlink:label="lab_dmtk_IncentiveStockOptionsMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Incentive Stock Options</link:label>
    <link:label id="lab_dmtk_IncentiveStockOptionsMember_label_en-US" xlink:label="lab_dmtk_IncentiveStockOptionsMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Incentive Stock Options [Member]</link:label>
    <link:label id="lab_dmtk_IncentiveStockOptionsMember_documentation_en-US" xlink:label="lab_dmtk_IncentiveStockOptionsMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Incentive stock options.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dmtk_IncentiveStockOptionsMember" xlink:href="dmtk-20220630.xsd#dmtk_IncentiveStockOptionsMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dmtk_IncentiveStockOptionsMember" xlink:to="lab_dmtk_IncentiveStockOptionsMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_MunicipalNotesMember_6e03bfe1-de3f-4967-b48c-edc679f28654_terseLabel_en-US" xlink:label="lab_us-gaap_MunicipalNotesMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Municipal debt securities</link:label>
    <link:label id="lab_us-gaap_MunicipalNotesMember_label_en-US" xlink:label="lab_us-gaap_MunicipalNotesMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Municipal Notes [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_MunicipalNotesMember" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_MunicipalNotesMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_MunicipalNotesMember" xlink:to="lab_us-gaap_MunicipalNotesMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ResearchAndDevelopmentExpense_3769d56c-f284-4593-bd57-46aee19b8505_terseLabel_en-US" xlink:label="lab_us-gaap_ResearchAndDevelopmentExpense" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Research and development</link:label>
    <link:label id="lab_us-gaap_ResearchAndDevelopmentExpense_label_en-US" xlink:label="lab_us-gaap_ResearchAndDevelopmentExpense" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Research and Development Expense</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ResearchAndDevelopmentExpense" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ResearchAndDevelopmentExpense"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ResearchAndDevelopmentExpense" xlink:to="lab_us-gaap_ResearchAndDevelopmentExpense" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LeaseholdImprovementsGross_04e10e02-49bd-48ea-ae8d-860d0390fa9e_terseLabel_en-US" xlink:label="lab_us-gaap_LeaseholdImprovementsGross" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Leasehold improvements</link:label>
    <link:label id="lab_us-gaap_LeaseholdImprovementsGross_label_en-US" xlink:label="lab_us-gaap_LeaseholdImprovementsGross" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Leasehold Improvements, Gross</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LeaseholdImprovementsGross" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LeaseholdImprovementsGross"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LeaseholdImprovementsGross" xlink:to="lab_us-gaap_LeaseholdImprovementsGross" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DeferredRevenueCurrent_55241927-b25f-4702-aa3b-2bf36c071d0c_verboseLabel_en-US" xlink:label="lab_us-gaap_DeferredRevenueCurrent" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Short-term deferred revenue</link:label>
    <link:label id="lab_us-gaap_DeferredRevenueCurrent_label_en-US" xlink:label="lab_us-gaap_DeferredRevenueCurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Deferred Revenue, Current</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredRevenueCurrent" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DeferredRevenueCurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DeferredRevenueCurrent" xlink:to="lab_us-gaap_DeferredRevenueCurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationByLiabilityClassDomain_0465d55a-b5e0-4fac-9e7b-831611ff7426_terseLabel_en-US" xlink:label="lab_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationByLiabilityClassDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Value by Liability Class</link:label>
    <link:label id="lab_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationByLiabilityClassDomain_label_en-US" xlink:label="lab_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationByLiabilityClassDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Value by Liability Class [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationByLiabilityClassDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationByLiabilityClassDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationByLiabilityClassDomain" xlink:to="lab_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationByLiabilityClassDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_dmtk_ContractRevenueProjectManagementFeesMember_bc0ae2af-3592-453f-9e22-84b2b9267b08_terseLabel_en-US" xlink:label="lab_dmtk_ContractRevenueProjectManagementFeesMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Project management fees</link:label>
    <link:label id="lab_dmtk_ContractRevenueProjectManagementFeesMember_label_en-US" xlink:label="lab_dmtk_ContractRevenueProjectManagementFeesMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Contract Revenue Project Management Fees [Member]</link:label>
    <link:label id="lab_dmtk_ContractRevenueProjectManagementFeesMember_documentation_en-US" xlink:label="lab_dmtk_ContractRevenueProjectManagementFeesMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Contract revenue project management fees.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dmtk_ContractRevenueProjectManagementFeesMember" xlink:href="dmtk-20220630.xsd#dmtk_ContractRevenueProjectManagementFeesMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dmtk_ContractRevenueProjectManagementFeesMember" xlink:to="lab_dmtk_ContractRevenueProjectManagementFeesMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_RestrictedCashAndCashEquivalents_52bb9b9a-4382-4097-8c5c-9a5395f62d1f_terseLabel_en-US" xlink:label="lab_us-gaap_RestrictedCashAndCashEquivalents" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Restricted cash and cash equivalents</link:label>
    <link:label id="lab_us-gaap_RestrictedCashAndCashEquivalents_label_en-US" xlink:label="lab_us-gaap_RestrictedCashAndCashEquivalents" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Restricted Cash and Cash Equivalents</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestrictedCashAndCashEquivalents" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RestrictedCashAndCashEquivalents"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_RestrictedCashAndCashEquivalents" xlink:to="lab_us-gaap_RestrictedCashAndCashEquivalents" xlink:type="arc" order="1"/>
    <link:label id="lab_dmtk_ProceedsFromMaturityOfMarketableSecurities_baa090e6-7586-4929-8700-31763e5ee88c_terseLabel_en-US" xlink:label="lab_dmtk_ProceedsFromMaturityOfMarketableSecurities" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Maturities of marketable securities</link:label>
    <link:label id="lab_dmtk_ProceedsFromMaturityOfMarketableSecurities_label_en-US" xlink:label="lab_dmtk_ProceedsFromMaturityOfMarketableSecurities" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Proceeds From Maturity Of Marketable Securities</link:label>
    <link:label id="lab_dmtk_ProceedsFromMaturityOfMarketableSecurities_documentation_en-US" xlink:label="lab_dmtk_ProceedsFromMaturityOfMarketableSecurities" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Proceeds From Maturity Of Marketable Securities</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dmtk_ProceedsFromMaturityOfMarketableSecurities" xlink:href="dmtk-20220630.xsd#dmtk_ProceedsFromMaturityOfMarketableSecurities"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dmtk_ProceedsFromMaturityOfMarketableSecurities" xlink:to="lab_dmtk_ProceedsFromMaturityOfMarketableSecurities" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_RestrictedStockUnitsRSUMember_86e120a9-5309-41b9-9aee-4a8ededf165c_terseLabel_en-US" xlink:label="lab_us-gaap_RestrictedStockUnitsRSUMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">RSUs issued and outstanding</link:label>
    <link:label id="lab_us-gaap_RestrictedStockUnitsRSUMember_label_en-US" xlink:label="lab_us-gaap_RestrictedStockUnitsRSUMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Restricted Stock Units (RSUs) [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestrictedStockUnitsRSUMember" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RestrictedStockUnitsRSUMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_RestrictedStockUnitsRSUMember" xlink:to="lab_us-gaap_RestrictedStockUnitsRSUMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ConcentrationRiskByBenchmarkAxis_6591da1b-1265-4032-860c-1ef78b636599_terseLabel_en-US" xlink:label="lab_us-gaap_ConcentrationRiskByBenchmarkAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Concentration Risk Benchmark</link:label>
    <link:label id="lab_us-gaap_ConcentrationRiskByBenchmarkAxis_label_en-US" xlink:label="lab_us-gaap_ConcentrationRiskByBenchmarkAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Concentration Risk Benchmark [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ConcentrationRiskByBenchmarkAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ConcentrationRiskByBenchmarkAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ConcentrationRiskByBenchmarkAxis" xlink:to="lab_us-gaap_ConcentrationRiskByBenchmarkAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_UseOfEstimates_8083771b-f3ad-4db4-8eae-3ef95f6c39ad_terseLabel_en-US" xlink:label="lab_us-gaap_UseOfEstimates" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Use of Estimates</link:label>
    <link:label id="lab_us-gaap_UseOfEstimates_label_en-US" xlink:label="lab_us-gaap_UseOfEstimates" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Use of Estimates, Policy [Policy Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_UseOfEstimates" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_UseOfEstimates"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_UseOfEstimates" xlink:to="lab_us-gaap_UseOfEstimates" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureAndSignificantAccountingPoliciesTextBlock_df9d3277-b438-4ebc-90a6-3e94fc0de8e3_terseLabel_en-US" xlink:label="lab_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureAndSignificantAccountingPoliciesTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">The Company and a Summary of its Significant Accounting Policies</link:label>
    <link:label id="lab_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureAndSignificantAccountingPoliciesTextBlock_label_en-US" xlink:label="lab_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureAndSignificantAccountingPoliciesTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Organization, Consolidation and Presentation of Financial Statements Disclosure and Significant Accounting Policies [Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureAndSignificantAccountingPoliciesTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureAndSignificantAccountingPoliciesTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureAndSignificantAccountingPoliciesTextBlock" xlink:to="lab_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureAndSignificantAccountingPoliciesTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue_0d07fa52-c698-45c3-af0f-f0463db86184_periodStartLabel_en-US" xlink:label="lab_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue" xlink:role="http://www.xbrl.org/2003/role/periodStartLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Beginning balance</link:label>
    <link:label id="lab_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue_cd9fef8e-34a2-46c4-a4f2-ed99a1caff7b_periodEndLabel_en-US" xlink:label="lab_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue" xlink:role="http://www.xbrl.org/2003/role/periodEndLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Ending balance</link:label>
    <link:label id="lab_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue_label_en-US" xlink:label="lab_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Value, Measurement with Unobservable Inputs Reconciliation, Recurring Basis, Liability Value</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue" xlink:to="lab_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_SubsequentEventsAbstract_7ae72001-9643-445f-becd-3a7a14a78f1a_terseLabel_en-US" xlink:label="lab_us-gaap_SubsequentEventsAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Subsequent Events [Abstract]</link:label>
    <link:label id="lab_us-gaap_SubsequentEventsAbstract_label_en-US" xlink:label="lab_us-gaap_SubsequentEventsAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Subsequent Events [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SubsequentEventsAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SubsequentEventsAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SubsequentEventsAbstract" xlink:to="lab_us-gaap_SubsequentEventsAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_dmtk_OperatingAndFinanceLeaseLiabilityPaymentsDueYearThree_78376d5e-4562-4d03-9b47-55dc0d0301ff_terseLabel_en-US" xlink:label="lab_dmtk_OperatingAndFinanceLeaseLiabilityPaymentsDueYearThree" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Total future minimum lease payments due in 2025</link:label>
    <link:label id="lab_dmtk_OperatingAndFinanceLeaseLiabilityPaymentsDueYearThree_label_en-US" xlink:label="lab_dmtk_OperatingAndFinanceLeaseLiabilityPaymentsDueYearThree" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Operating And Finance Lease Liability Payments Due Year Three</link:label>
    <link:label id="lab_dmtk_OperatingAndFinanceLeaseLiabilityPaymentsDueYearThree_documentation_en-US" xlink:label="lab_dmtk_OperatingAndFinanceLeaseLiabilityPaymentsDueYearThree" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Operating and capital lease liability payments due year three.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dmtk_OperatingAndFinanceLeaseLiabilityPaymentsDueYearThree" xlink:href="dmtk-20220630.xsd#dmtk_OperatingAndFinanceLeaseLiabilityPaymentsDueYearThree"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dmtk_OperatingAndFinanceLeaseLiabilityPaymentsDueYearThree" xlink:to="lab_dmtk_OperatingAndFinanceLeaseLiabilityPaymentsDueYearThree" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ConcentrationRiskPercentage1_e04d1d70-12e3-4c9c-8f3b-9db108c34b25_terseLabel_en-US" xlink:label="lab_us-gaap_ConcentrationRiskPercentage1" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Concentration risk, percentage</link:label>
    <link:label id="lab_us-gaap_ConcentrationRiskPercentage1_label_en-US" xlink:label="lab_us-gaap_ConcentrationRiskPercentage1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Concentration Risk, Percentage</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ConcentrationRiskPercentage1" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ConcentrationRiskPercentage1"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ConcentrationRiskPercentage1" xlink:to="lab_us-gaap_ConcentrationRiskPercentage1" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRateMaximum_f8124de6-5792-4e71-a6bb-af1bcbdde911_terseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRateMaximum" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Assumed volatility, maximum</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRateMaximum_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRateMaximum" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-Based Compensation Arrangement by Share-Based Payment Award, Fair Value Assumptions, Expected Volatility Rate, Maximum</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRateMaximum" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRateMaximum"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRateMaximum" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRateMaximum" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncreaseDecreaseInAccountsPayableAndAccruedLiabilities_68edb1b3-c0a3-46b0-bac6-eb3a2d42ea18_terseLabel_en-US" xlink:label="lab_us-gaap_IncreaseDecreaseInAccountsPayableAndAccruedLiabilities" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accounts payable, accrued liabilities and deferred revenue</link:label>
    <link:label id="lab_us-gaap_IncreaseDecreaseInAccountsPayableAndAccruedLiabilities_label_en-US" xlink:label="lab_us-gaap_IncreaseDecreaseInAccountsPayableAndAccruedLiabilities" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Increase (Decrease) in Accounts Payable and Accrued Liabilities</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInAccountsPayableAndAccruedLiabilities" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncreaseDecreaseInAccountsPayableAndAccruedLiabilities"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncreaseDecreaseInAccountsPayableAndAccruedLiabilities" xlink:to="lab_us-gaap_IncreaseDecreaseInAccountsPayableAndAccruedLiabilities" xlink:type="arc" order="1"/>
    <link:label id="lab_dmtk_LeaseAmendmentsAxis_cdf81806-8911-49d8-ae26-562dda7930cf_terseLabel_en-US" xlink:label="lab_dmtk_LeaseAmendmentsAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Lease Amendments [Axis]</link:label>
    <link:label id="lab_dmtk_LeaseAmendmentsAxis_label_en-US" xlink:label="lab_dmtk_LeaseAmendmentsAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Lease Amendments [Axis]</link:label>
    <link:label id="lab_dmtk_LeaseAmendmentsAxis_documentation_en-US" xlink:label="lab_dmtk_LeaseAmendmentsAxis" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Lease Amendments</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dmtk_LeaseAmendmentsAxis" xlink:href="dmtk-20220630.xsd#dmtk_LeaseAmendmentsAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dmtk_LeaseAmendmentsAxis" xlink:to="lab_dmtk_LeaseAmendmentsAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CreditFacilityDomain_b8951967-8e42-4a7a-8273-f4c0f004f0fe_terseLabel_en-US" xlink:label="lab_us-gaap_CreditFacilityDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Credit Facility</link:label>
    <link:label id="lab_us-gaap_CreditFacilityDomain_label_en-US" xlink:label="lab_us-gaap_CreditFacilityDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Credit Facility [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CreditFacilityDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CreditFacilityDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CreditFacilityDomain" xlink:to="lab_us-gaap_CreditFacilityDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1_4ae1ffa6-4334-4599-bd5c-c8f611530901_terseLabel_en-US" xlink:label="lab_us-gaap_ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Exercise price of warrant (in usd per share)</link:label>
    <link:label id="lab_us-gaap_ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1_label_en-US" xlink:label="lab_us-gaap_ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Class of Warrant or Right, Exercise Price of Warrants or Rights</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1" xlink:to="lab_us-gaap_ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_InterestPaidNet_3f343812-1bbe-462d-bcfe-f2ec775e98ee_terseLabel_en-US" xlink:label="lab_us-gaap_InterestPaidNet" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cash paid for interest on finance lease obligations</link:label>
    <link:label id="lab_us-gaap_InterestPaidNet_label_en-US" xlink:label="lab_us-gaap_InterestPaidNet" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Interest Paid, Excluding Capitalized Interest, Operating Activities</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InterestPaidNet" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_InterestPaidNet"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_InterestPaidNet" xlink:to="lab_us-gaap_InterestPaidNet" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_EarningsPerShareBasic_4150319a-8f20-455d-9c4b-cfb1323d7b7c_terseLabel_en-US" xlink:label="lab_us-gaap_EarningsPerShareBasic" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net loss per share of common stock outstanding, basic (in usd per share)</link:label>
    <link:label id="lab_us-gaap_EarningsPerShareBasic_label_en-US" xlink:label="lab_us-gaap_EarningsPerShareBasic" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Earnings Per Share, Basic</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EarningsPerShareBasic" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EarningsPerShareBasic"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_EarningsPerShareBasic" xlink:to="lab_us-gaap_EarningsPerShareBasic" xlink:type="arc" order="1"/>
    <link:label id="lab_dmtk_NumberOfImprovementPhases_7a1a5b3a-c799-40da-9203-5163c455cde2_terseLabel_en-US" xlink:label="lab_dmtk_NumberOfImprovementPhases" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Number of improvement phases</link:label>
    <link:label id="lab_dmtk_NumberOfImprovementPhases_label_en-US" xlink:label="lab_dmtk_NumberOfImprovementPhases" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Number Of Improvement Phases</link:label>
    <link:label id="lab_dmtk_NumberOfImprovementPhases_documentation_en-US" xlink:label="lab_dmtk_NumberOfImprovementPhases" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Number Of Improvement Phases</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dmtk_NumberOfImprovementPhases" xlink:href="dmtk-20220630.xsd#dmtk_NumberOfImprovementPhases"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dmtk_NumberOfImprovementPhases" xlink:to="lab_dmtk_NumberOfImprovementPhases" xlink:type="arc" order="1"/>
    <link:label id="lab_dmtk_UnderwritersGrantPeriodOption_dcebba5d-8a2d-46e4-8008-41e333e5ac45_verboseLabel_en-US" xlink:label="lab_dmtk_UnderwritersGrantPeriodOption" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Number of days granted to underwriters option to purchase</link:label>
    <link:label id="lab_dmtk_UnderwritersGrantPeriodOption_label_en-US" xlink:label="lab_dmtk_UnderwritersGrantPeriodOption" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Underwriters Grant Period Option</link:label>
    <link:label id="lab_dmtk_UnderwritersGrantPeriodOption_documentation_en-US" xlink:label="lab_dmtk_UnderwritersGrantPeriodOption" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Underwriters grant period option.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dmtk_UnderwritersGrantPeriodOption" xlink:href="dmtk-20220630.xsd#dmtk_UnderwritersGrantPeriodOption"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dmtk_UnderwritersGrantPeriodOption" xlink:to="lab_dmtk_UnderwritersGrantPeriodOption" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearThree_6e3dfbc6-738f-4216-99c1-6333d60372a9_terseLabel_en-US" xlink:label="lab_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearThree" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">2025</link:label>
    <link:label id="lab_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearThree_label_en-US" xlink:label="lab_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearThree" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Lessee, Operating Lease, Liability, to be Paid, Year Three</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearThree" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearThree"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearThree" xlink:to="lab_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearThree" xlink:type="arc" order="1"/>
    <link:label id="lab_dmtk_SpecialPurposeAcquisitionCompaniesWarrantsMember_42fc0a44-8728-4434-90bb-6214cb81a127_terseLabel_en-US" xlink:label="lab_dmtk_SpecialPurposeAcquisitionCompaniesWarrantsMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">SPAC Warrants</link:label>
    <link:label id="lab_dmtk_SpecialPurposeAcquisitionCompaniesWarrantsMember_label_en-US" xlink:label="lab_dmtk_SpecialPurposeAcquisitionCompaniesWarrantsMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Special Purpose Acquisition Companies Warrants [Member]</link:label>
    <link:label id="lab_dmtk_SpecialPurposeAcquisitionCompaniesWarrantsMember_documentation_en-US" xlink:label="lab_dmtk_SpecialPurposeAcquisitionCompaniesWarrantsMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Special purpose acquisition companies warrants.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dmtk_SpecialPurposeAcquisitionCompaniesWarrantsMember" xlink:href="dmtk-20220630.xsd#dmtk_SpecialPurposeAcquisitionCompaniesWarrantsMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dmtk_SpecialPurposeAcquisitionCompaniesWarrantsMember" xlink:to="lab_dmtk_SpecialPurposeAcquisitionCompaniesWarrantsMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ConstructionInProgressGross_cca13e54-68ec-4705-9ccc-eecb75fb3cc5_terseLabel_en-US" xlink:label="lab_us-gaap_ConstructionInProgressGross" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Construction-in-progress</link:label>
    <link:label id="lab_us-gaap_ConstructionInProgressGross_label_en-US" xlink:label="lab_us-gaap_ConstructionInProgressGross" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Construction in Progress, Gross</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ConstructionInProgressGross" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ConstructionInProgressGross"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ConstructionInProgressGross" xlink:to="lab_us-gaap_ConstructionInProgressGross" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_NewAccountingPronouncementsOrChangeInAccountingPrincipleTable_d93dec95-e7a5-4b7f-b910-a7d1fbb29112_terseLabel_en-US" xlink:label="lab_us-gaap_NewAccountingPronouncementsOrChangeInAccountingPrincipleTable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accounting Standards Update and Change in Accounting Principle [Table]</link:label>
    <link:label id="lab_us-gaap_NewAccountingPronouncementsOrChangeInAccountingPrincipleTable_label_en-US" xlink:label="lab_us-gaap_NewAccountingPronouncementsOrChangeInAccountingPrincipleTable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accounting Standards Update and Change in Accounting Principle [Table]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NewAccountingPronouncementsOrChangeInAccountingPrincipleTable" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NewAccountingPronouncementsOrChangeInAccountingPrincipleTable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_NewAccountingPronouncementsOrChangeInAccountingPrincipleTable" xlink:to="lab_us-gaap_NewAccountingPronouncementsOrChangeInAccountingPrincipleTable" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ConcentrationRiskTypeDomain_4bb4a763-36c4-418e-942a-68242cc7306a_terseLabel_en-US" xlink:label="lab_us-gaap_ConcentrationRiskTypeDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Concentration Risk Type</link:label>
    <link:label id="lab_us-gaap_ConcentrationRiskTypeDomain_label_en-US" xlink:label="lab_us-gaap_ConcentrationRiskTypeDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Concentration Risk Type [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ConcentrationRiskTypeDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ConcentrationRiskTypeDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ConcentrationRiskTypeDomain" xlink:to="lab_us-gaap_ConcentrationRiskTypeDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_srt_RepurchaseAgreementCounterpartyNameDomain_72e24b94-6196-4371-8003-e494b626c187_terseLabel_en-US" xlink:label="lab_srt_RepurchaseAgreementCounterpartyNameDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Counterparty Name</link:label>
    <link:label id="lab_srt_RepurchaseAgreementCounterpartyNameDomain_label_en-US" xlink:label="lab_srt_RepurchaseAgreementCounterpartyNameDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Counterparty Name [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RepurchaseAgreementCounterpartyNameDomain" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_RepurchaseAgreementCounterpartyNameDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_srt_RepurchaseAgreementCounterpartyNameDomain" xlink:to="lab_srt_RepurchaseAgreementCounterpartyNameDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_SellingAndMarketingExpense_60704a92-8f0d-442e-91ed-6d4c6b5410b8_terseLabel_en-US" xlink:label="lab_us-gaap_SellingAndMarketingExpense" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Sales and marketing</link:label>
    <link:label id="lab_us-gaap_SellingAndMarketingExpense_label_en-US" xlink:label="lab_us-gaap_SellingAndMarketingExpense" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Selling and Marketing Expense</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SellingAndMarketingExpense" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SellingAndMarketingExpense"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SellingAndMarketingExpense" xlink:to="lab_us-gaap_SellingAndMarketingExpense" xlink:type="arc" order="1"/>
    <link:label id="lab_dmtk_PublicFollowOnOfferingMember_f3a9c8de-c5a6-418d-9c87-0cd8e6d3b8dd_terseLabel_en-US" xlink:label="lab_dmtk_PublicFollowOnOfferingMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Public Follow-on Offering</link:label>
    <link:label id="lab_dmtk_PublicFollowOnOfferingMember_label_en-US" xlink:label="lab_dmtk_PublicFollowOnOfferingMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Public Follow On Offering [Member]</link:label>
    <link:label id="lab_dmtk_PublicFollowOnOfferingMember_documentation_en-US" xlink:label="lab_dmtk_PublicFollowOnOfferingMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Public follow on offering.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dmtk_PublicFollowOnOfferingMember" xlink:href="dmtk-20220630.xsd#dmtk_PublicFollowOnOfferingMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dmtk_PublicFollowOnOfferingMember" xlink:to="lab_dmtk_PublicFollowOnOfferingMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_StockholdersEquity_b1466e96-baf2-4985-a1b9-83763f722c01_totalLabel_en-US" xlink:label="lab_us-gaap_StockholdersEquity" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Total stockholders&#8217; equity</link:label>
    <link:label id="lab_us-gaap_StockholdersEquity_02cb2143-106a-4d34-b6e4-e2d6aa3b1d69_periodStartLabel_en-US" xlink:label="lab_us-gaap_StockholdersEquity" xlink:role="http://www.xbrl.org/2003/role/periodStartLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Beginning balance</link:label>
    <link:label id="lab_us-gaap_StockholdersEquity_6ee93306-47ee-413d-a1b7-e6a603f3a663_periodEndLabel_en-US" xlink:label="lab_us-gaap_StockholdersEquity" xlink:role="http://www.xbrl.org/2003/role/periodEndLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Ending balance</link:label>
    <link:label id="lab_us-gaap_StockholdersEquity_label_en-US" xlink:label="lab_us-gaap_StockholdersEquity" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Stockholders' Equity Attributable to Parent</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockholdersEquity" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StockholdersEquity"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StockholdersEquity" xlink:to="lab_us-gaap_StockholdersEquity" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations_321bec9e-08fb-4d4a-98ac-67a2da77b9a7_periodStartLabel_en-US" xlink:label="lab_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations" xlink:role="http://www.xbrl.org/2003/role/periodStartLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cash, cash equivalents and restricted cash, beginning of period</link:label>
    <link:label id="lab_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations_e0ddaffd-40f8-4f68-a0be-e4e9ab85e56b_periodEndLabel_en-US" xlink:label="lab_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations" xlink:role="http://www.xbrl.org/2003/role/periodEndLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cash, cash equivalents and restricted cash, end of period</link:label>
    <link:label id="lab_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations_label_en-US" xlink:label="lab_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cash, Cash Equivalents, Restricted Cash, and Restricted Cash Equivalents, Including Disposal Group and Discontinued Operations</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations" xlink:to="lab_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_RightOfUseAssetObtainedInExchangeForFinanceLeaseLiability_2b69a4f5-ac62-4f67-ac4c-d3ea5d11039a_terseLabel_en-US" xlink:label="lab_us-gaap_RightOfUseAssetObtainedInExchangeForFinanceLeaseLiability" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Right-of-use assets obtained in exchange for finance lease obligations</link:label>
    <link:label id="lab_us-gaap_RightOfUseAssetObtainedInExchangeForFinanceLeaseLiability_label_en-US" xlink:label="lab_us-gaap_RightOfUseAssetObtainedInExchangeForFinanceLeaseLiability" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Right-of-Use Asset Obtained in Exchange for Finance Lease Liability</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RightOfUseAssetObtainedInExchangeForFinanceLeaseLiability" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RightOfUseAssetObtainedInExchangeForFinanceLeaseLiability"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_RightOfUseAssetObtainedInExchangeForFinanceLeaseLiability" xlink:to="lab_us-gaap_RightOfUseAssetObtainedInExchangeForFinanceLeaseLiability" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityInteractiveDataCurrent_4acdcde3-489c-4396-a956-64572ca7eedd_terseLabel_en-US" xlink:label="lab_dei_EntityInteractiveDataCurrent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Interactive Data Current</link:label>
    <link:label id="lab_dei_EntityInteractiveDataCurrent_label_en-US" xlink:label="lab_dei_EntityInteractiveDataCurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Interactive Data Current</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityInteractiveDataCurrent" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityInteractiveDataCurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityInteractiveDataCurrent" xlink:to="lab_dei_EntityInteractiveDataCurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_dmtk_EVERSANALifeScienceServicesLLCMember_21f6447f-75c5-42c2-8348-3f40372b5e05_terseLabel_en-US" xlink:label="lab_dmtk_EVERSANALifeScienceServicesLLCMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">EVERSANA</link:label>
    <link:label id="lab_dmtk_EVERSANALifeScienceServicesLLCMember_label_en-US" xlink:label="lab_dmtk_EVERSANALifeScienceServicesLLCMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">EVERSANA Life Science Services LLC [Member]</link:label>
    <link:label id="lab_dmtk_EVERSANALifeScienceServicesLLCMember_documentation_en-US" xlink:label="lab_dmtk_EVERSANALifeScienceServicesLLCMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">EVERSANA Life Science Services, LLC.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dmtk_EVERSANALifeScienceServicesLLCMember" xlink:href="dmtk-20220630.xsd#dmtk_EVERSANALifeScienceServicesLLCMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dmtk_EVERSANALifeScienceServicesLLCMember" xlink:to="lab_dmtk_EVERSANALifeScienceServicesLLCMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_SaleOfStockNumberOfSharesIssuedInTransaction_0773fd50-6974-4f9b-aabb-477c8b0c7204_terseLabel_en-US" xlink:label="lab_us-gaap_SaleOfStockNumberOfSharesIssuedInTransaction" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Sale of stock, number of shares issued in transaction (in shares)</link:label>
    <link:label id="lab_us-gaap_SaleOfStockNumberOfSharesIssuedInTransaction_label_en-US" xlink:label="lab_us-gaap_SaleOfStockNumberOfSharesIssuedInTransaction" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Sale of Stock, Number of Shares Issued in Transaction</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SaleOfStockNumberOfSharesIssuedInTransaction" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SaleOfStockNumberOfSharesIssuedInTransaction"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SaleOfStockNumberOfSharesIssuedInTransaction" xlink:to="lab_us-gaap_SaleOfStockNumberOfSharesIssuedInTransaction" xlink:type="arc" order="1"/>
    <link:label id="lab_dmtk_OperatingLeaseCostAbstract_57ff3477-2ec1-4025-b428-be7afd33c373_terseLabel_en-US" xlink:label="lab_dmtk_OperatingLeaseCostAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Operating lease cost</link:label>
    <link:label id="lab_dmtk_OperatingLeaseCostAbstract_label_en-US" xlink:label="lab_dmtk_OperatingLeaseCostAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Operating Lease Cost [Abstract]</link:label>
    <link:label id="lab_dmtk_OperatingLeaseCostAbstract_documentation_en-US" xlink:label="lab_dmtk_OperatingLeaseCostAbstract" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Operating lease cost.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dmtk_OperatingLeaseCostAbstract" xlink:href="dmtk-20220630.xsd#dmtk_OperatingLeaseCostAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dmtk_OperatingLeaseCostAbstract" xlink:to="lab_dmtk_OperatingLeaseCostAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_dmtk_AssayRevenuePayorBMember_9ba45964-3c4e-45ba-92a8-1979b2b1a54b_terseLabel_en-US" xlink:label="lab_dmtk_AssayRevenuePayorBMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Payor B</link:label>
    <link:label id="lab_dmtk_AssayRevenuePayorBMember_label_en-US" xlink:label="lab_dmtk_AssayRevenuePayorBMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Assay Revenue Payor B [Member]</link:label>
    <link:label id="lab_dmtk_AssayRevenuePayorBMember_documentation_en-US" xlink:label="lab_dmtk_AssayRevenuePayorBMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Assay Revenue Payor B.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dmtk_AssayRevenuePayorBMember" xlink:href="dmtk-20220630.xsd#dmtk_AssayRevenuePayorBMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dmtk_AssayRevenuePayorBMember" xlink:to="lab_dmtk_AssayRevenuePayorBMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncreaseDecreaseInOperatingCapitalAbstract_a88a5d49-d34c-4245-a7ab-69e5dac56101_terseLabel_en-US" xlink:label="lab_us-gaap_IncreaseDecreaseInOperatingCapitalAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Changes in operating assets and liabilities:</link:label>
    <link:label id="lab_us-gaap_IncreaseDecreaseInOperatingCapitalAbstract_label_en-US" xlink:label="lab_us-gaap_IncreaseDecreaseInOperatingCapitalAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Increase (Decrease) in Operating Capital [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInOperatingCapitalAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncreaseDecreaseInOperatingCapitalAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncreaseDecreaseInOperatingCapitalAbstract" xlink:to="lab_us-gaap_IncreaseDecreaseInOperatingCapitalAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationTextBlock_4e94dd43-cd28-4093-9055-909696b53a0f_terseLabel_en-US" xlink:label="lab_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Summary of Changes in Fair Value of Level 3 Liabilities</link:label>
    <link:label id="lab_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationTextBlock_label_en-US" xlink:label="lab_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Value, Liabilities Measured on Recurring Basis, Unobservable Input Reconciliation [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationTextBlock" xlink:to="lab_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_dmtk_SecondAmendmentMember_50a2309c-6e3e-429a-846a-3f488126fd8a_terseLabel_en-US" xlink:label="lab_dmtk_SecondAmendmentMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Second Amendment</link:label>
    <link:label id="lab_dmtk_SecondAmendmentMember_label_en-US" xlink:label="lab_dmtk_SecondAmendmentMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Second Amendment [Member]</link:label>
    <link:label id="lab_dmtk_SecondAmendmentMember_documentation_en-US" xlink:label="lab_dmtk_SecondAmendmentMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Second Amendment</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dmtk_SecondAmendmentMember" xlink:href="dmtk-20220630.xsd#dmtk_SecondAmendmentMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dmtk_SecondAmendmentMember" xlink:to="lab_dmtk_SecondAmendmentMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_RetainedEarningsMember_282336ce-9fed-41dc-8dd6-7cc38b2b3c99_terseLabel_en-US" xlink:label="lab_us-gaap_RetainedEarningsMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accumulated deficit</link:label>
    <link:label id="lab_us-gaap_RetainedEarningsMember_label_en-US" xlink:label="lab_us-gaap_RetainedEarningsMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Retained Earnings [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RetainedEarningsMember" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RetainedEarningsMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_RetainedEarningsMember" xlink:to="lab_us-gaap_RetainedEarningsMember" xlink:type="arc" order="1"/>
    <link:label id="lab_dmtk_PrepaidSoftwareFees_0cac8860-5bde-40bc-aba2-d824d8bc8193_terseLabel_en-US" xlink:label="lab_dmtk_PrepaidSoftwareFees" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Prepaid software fees</link:label>
    <link:label id="lab_dmtk_PrepaidSoftwareFees_label_en-US" xlink:label="lab_dmtk_PrepaidSoftwareFees" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Prepaid Software Fees</link:label>
    <link:label id="lab_dmtk_PrepaidSoftwareFees_documentation_en-US" xlink:label="lab_dmtk_PrepaidSoftwareFees" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Prepaid software fees.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dmtk_PrepaidSoftwareFees" xlink:href="dmtk-20220630.xsd#dmtk_PrepaidSoftwareFees"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dmtk_PrepaidSoftwareFees" xlink:to="lab_dmtk_PrepaidSoftwareFees" xlink:type="arc" order="1"/>
    <link:label id="lab_dmtk_ScheduleOfPrepaidExpensesAndPropertyAndEquipmentTableTextBlock_5775ccd0-675a-437c-966c-12fe89561524_terseLabel_en-US" xlink:label="lab_dmtk_ScheduleOfPrepaidExpensesAndPropertyAndEquipmentTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Prepaid Expenses and PP&amp;E</link:label>
    <link:label id="lab_dmtk_ScheduleOfPrepaidExpensesAndPropertyAndEquipmentTableTextBlock_label_en-US" xlink:label="lab_dmtk_ScheduleOfPrepaidExpensesAndPropertyAndEquipmentTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule Of Prepaid Expenses And Property And Equipment Table [Text Block]</link:label>
    <link:label id="lab_dmtk_ScheduleOfPrepaidExpensesAndPropertyAndEquipmentTableTextBlock_documentation_en-US" xlink:label="lab_dmtk_ScheduleOfPrepaidExpensesAndPropertyAndEquipmentTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of prepaid expenses and PP&amp;E.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dmtk_ScheduleOfPrepaidExpensesAndPropertyAndEquipmentTableTextBlock" xlink:href="dmtk-20220630.xsd#dmtk_ScheduleOfPrepaidExpensesAndPropertyAndEquipmentTableTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dmtk_ScheduleOfPrepaidExpensesAndPropertyAndEquipmentTableTextBlock" xlink:to="lab_dmtk_ScheduleOfPrepaidExpensesAndPropertyAndEquipmentTableTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CashFDICInsuredAmount_9bae311b-5e7a-4413-a40d-67527133b9fd_terseLabel_en-US" xlink:label="lab_us-gaap_CashFDICInsuredAmount" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Insured amount by FDIC</link:label>
    <link:label id="lab_us-gaap_CashFDICInsuredAmount_label_en-US" xlink:label="lab_us-gaap_CashFDICInsuredAmount" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cash, FDIC Insured Amount</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashFDICInsuredAmount" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CashFDICInsuredAmount"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CashFDICInsuredAmount" xlink:to="lab_us-gaap_CashFDICInsuredAmount" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CommonStockMember_c5527c17-8196-4005-ae6a-6e40c5ef2900_verboseLabel_en-US" xlink:label="lab_us-gaap_CommonStockMember" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Common stock</link:label>
    <link:label id="lab_us-gaap_CommonStockMember_52ffca7b-6748-460d-8f59-7717d86e12e5_terseLabel_en-US" xlink:label="lab_us-gaap_CommonStockMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Common stock</link:label>
    <link:label id="lab_us-gaap_CommonStockMember_label_en-US" xlink:label="lab_us-gaap_CommonStockMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Common Stock [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockMember" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CommonStockMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CommonStockMember" xlink:to="lab_us-gaap_CommonStockMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LeaseCostTableTextBlock_1a9c6fff-aac2-40ad-ae93-ed2221c8c298_terseLabel_en-US" xlink:label="lab_us-gaap_LeaseCostTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Components of Lease Expense</link:label>
    <link:label id="lab_us-gaap_LeaseCostTableTextBlock_label_en-US" xlink:label="lab_us-gaap_LeaseCostTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Lease, Cost [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LeaseCostTableTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LeaseCostTableTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LeaseCostTableTextBlock" xlink:to="lab_us-gaap_LeaseCostTableTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant_5c56df34-21c5-4f87-a3af-7e913444d6e7_terseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Options remain available for issuance pursuant to future grants (in shares)</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-Based Compensation Arrangement by Share-Based Payment Award, Number of Shares Available for Grant</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_RevenueRecognitionPolicyTextBlock_c4438ef0-e543-44d3-9163-c9e98863c8f4_terseLabel_en-US" xlink:label="lab_us-gaap_RevenueRecognitionPolicyTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Revenue Recognition</link:label>
    <link:label id="lab_us-gaap_RevenueRecognitionPolicyTextBlock_label_en-US" xlink:label="lab_us-gaap_RevenueRecognitionPolicyTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Revenue [Policy Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevenueRecognitionPolicyTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RevenueRecognitionPolicyTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_RevenueRecognitionPolicyTextBlock" xlink:to="lab_us-gaap_RevenueRecognitionPolicyTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_StatementTable_355e0f80-25c7-463c-8ed0-22a048432ea9_terseLabel_en-US" xlink:label="lab_us-gaap_StatementTable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Statement [Table]</link:label>
    <link:label id="lab_us-gaap_StatementTable_label_en-US" xlink:label="lab_us-gaap_StatementTable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Statement [Table]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementTable" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StatementTable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StatementTable" xlink:to="lab_us-gaap_StatementTable" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LesseeOperatingLeaseRenewalTerm_078b506a-d454-4180-9e28-36dd72867a1d_terseLabel_en-US" xlink:label="lab_us-gaap_LesseeOperatingLeaseRenewalTerm" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Renewal term</link:label>
    <link:label id="lab_us-gaap_LesseeOperatingLeaseRenewalTerm_label_en-US" xlink:label="lab_us-gaap_LesseeOperatingLeaseRenewalTerm" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Lessee, Operating Lease, Renewal Term</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeOperatingLeaseRenewalTerm" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LesseeOperatingLeaseRenewalTerm"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LesseeOperatingLeaseRenewalTerm" xlink:to="lab_us-gaap_LesseeOperatingLeaseRenewalTerm" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_DocumentQuarterlyReport_29b9159d-e4fe-4f0c-9340-41296e387fc6_terseLabel_en-US" xlink:label="lab_dei_DocumentQuarterlyReport" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Document Quarterly Report</link:label>
    <link:label id="lab_dei_DocumentQuarterlyReport_label_en-US" xlink:label="lab_dei_DocumentQuarterlyReport" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Document Quarterly Report</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_DocumentQuarterlyReport" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_DocumentQuarterlyReport"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_DocumentQuarterlyReport" xlink:to="lab_dei_DocumentQuarterlyReport" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LetterOfCreditMember_5c8bee32-08ce-431f-a7ae-d16f5f69b96f_terseLabel_en-US" xlink:label="lab_us-gaap_LetterOfCreditMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Letter of Credit</link:label>
    <link:label id="lab_us-gaap_LetterOfCreditMember_label_en-US" xlink:label="lab_us-gaap_LetterOfCreditMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Letter of Credit [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LetterOfCreditMember" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LetterOfCreditMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LetterOfCreditMember" xlink:to="lab_us-gaap_LetterOfCreditMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AssetsCurrentAbstract_643a4d9c-2174-42d3-90a0-6c3bea693e38_terseLabel_en-US" xlink:label="lab_us-gaap_AssetsCurrentAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Current assets:</link:label>
    <link:label id="lab_us-gaap_AssetsCurrentAbstract_label_en-US" xlink:label="lab_us-gaap_AssetsCurrentAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Assets, Current [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AssetsCurrentAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AssetsCurrentAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AssetsCurrentAbstract" xlink:to="lab_us-gaap_AssetsCurrentAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OperatingLeaseLiabilityNoncurrent_9390d422-1b7c-4f35-bfa2-117137ac648f_terseLabel_en-US" xlink:label="lab_us-gaap_OperatingLeaseLiabilityNoncurrent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Operating lease liabilities, long-term</link:label>
    <link:label id="lab_us-gaap_OperatingLeaseLiabilityNoncurrent_label_en-US" xlink:label="lab_us-gaap_OperatingLeaseLiabilityNoncurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Operating Lease, Liability, Noncurrent</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeaseLiabilityNoncurrent" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OperatingLeaseLiabilityNoncurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OperatingLeaseLiabilityNoncurrent" xlink:to="lab_us-gaap_OperatingLeaseLiabilityNoncurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_UnbilledReceivablesCurrent_316f127a-cda8-4246-836c-69a69a68a093_terseLabel_en-US" xlink:label="lab_us-gaap_UnbilledReceivablesCurrent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Unbilled receivables</link:label>
    <link:label id="lab_us-gaap_UnbilledReceivablesCurrent_label_en-US" xlink:label="lab_us-gaap_UnbilledReceivablesCurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Unbilled Receivables, Current</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_UnbilledReceivablesCurrent" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_UnbilledReceivablesCurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_UnbilledReceivablesCurrent" xlink:to="lab_us-gaap_UnbilledReceivablesCurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_srt_RangeAxis_0e26bcb8-f674-442d-8afc-a081585062d6_terseLabel_en-US" xlink:label="lab_srt_RangeAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Statistical Measurement</link:label>
    <link:label id="lab_srt_RangeAxis_label_en-US" xlink:label="lab_srt_RangeAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Statistical Measurement [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeAxis" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_RangeAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_srt_RangeAxis" xlink:to="lab_srt_RangeAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_dmtk_TheCompanyAndSummaryOfItsSignificantAccountingPoliciesTable_6a8d5e74-6906-48a8-915f-a2492f4de123_terseLabel_en-US" xlink:label="lab_dmtk_TheCompanyAndSummaryOfItsSignificantAccountingPoliciesTable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accounting Policies</link:label>
    <link:label id="lab_dmtk_TheCompanyAndSummaryOfItsSignificantAccountingPoliciesTable_label_en-US" xlink:label="lab_dmtk_TheCompanyAndSummaryOfItsSignificantAccountingPoliciesTable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">The Company And Summary Of Its Significant Accounting Policies [Table]</link:label>
    <link:label id="lab_dmtk_TheCompanyAndSummaryOfItsSignificantAccountingPoliciesTable_documentation_en-US" xlink:label="lab_dmtk_TheCompanyAndSummaryOfItsSignificantAccountingPoliciesTable" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">The company and summary of its significant accounting policies.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dmtk_TheCompanyAndSummaryOfItsSignificantAccountingPoliciesTable" xlink:href="dmtk-20220630.xsd#dmtk_TheCompanyAndSummaryOfItsSignificantAccountingPoliciesTable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dmtk_TheCompanyAndSummaryOfItsSignificantAccountingPoliciesTable" xlink:to="lab_dmtk_TheCompanyAndSummaryOfItsSignificantAccountingPoliciesTable" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_RelatedPartyTransactionAxis_7034d71a-0b5a-4f83-bc18-f0fe14f1808d_terseLabel_en-US" xlink:label="lab_us-gaap_RelatedPartyTransactionAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Related Party Transaction</link:label>
    <link:label id="lab_us-gaap_RelatedPartyTransactionAxis_label_en-US" xlink:label="lab_us-gaap_RelatedPartyTransactionAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Related Party Transaction [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RelatedPartyTransactionAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RelatedPartyTransactionAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_RelatedPartyTransactionAxis" xlink:to="lab_us-gaap_RelatedPartyTransactionAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_RetainedEarningsAccumulatedDeficit_bb614d4f-d699-4d43-9fea-329b228e7925_terseLabel_en-US" xlink:label="lab_us-gaap_RetainedEarningsAccumulatedDeficit" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accumulated deficit</link:label>
    <link:label id="lab_us-gaap_RetainedEarningsAccumulatedDeficit_label_en-US" xlink:label="lab_us-gaap_RetainedEarningsAccumulatedDeficit" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Retained Earnings (Accumulated Deficit)</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RetainedEarningsAccumulatedDeficit" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RetainedEarningsAccumulatedDeficit"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_RetainedEarningsAccumulatedDeficit" xlink:to="lab_us-gaap_RetainedEarningsAccumulatedDeficit" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CashEquivalentsAtCarryingValue_f7104de5-9b86-4cd4-affc-70b44ff1fb9b_terseLabel_en-US" xlink:label="lab_us-gaap_CashEquivalentsAtCarryingValue" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cash equivalents</link:label>
    <link:label id="lab_us-gaap_CashEquivalentsAtCarryingValue_label_en-US" xlink:label="lab_us-gaap_CashEquivalentsAtCarryingValue" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cash Equivalents, at Carrying Value</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashEquivalentsAtCarryingValue" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CashEquivalentsAtCarryingValue"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CashEquivalentsAtCarryingValue" xlink:to="lab_us-gaap_CashEquivalentsAtCarryingValue" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AccountsReceivableNetCurrent_8ce58ed4-4fe6-46de-87ad-816385eb2857_terseLabel_en-US" xlink:label="lab_us-gaap_AccountsReceivableNetCurrent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accounts receivable</link:label>
    <link:label id="lab_us-gaap_AccountsReceivableNetCurrent_label_en-US" xlink:label="lab_us-gaap_AccountsReceivableNetCurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accounts Receivable, after Allowance for Credit Loss, Current</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccountsReceivableNetCurrent" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AccountsReceivableNetCurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AccountsReceivableNetCurrent" xlink:to="lab_us-gaap_AccountsReceivableNetCurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PaymentsToAcquireMarketableSecurities_0cac76b5-eca6-42af-92ce-090c7f0b7734_negatedLabel_en-US" xlink:label="lab_us-gaap_PaymentsToAcquireMarketableSecurities" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Purchases of marketable securities</link:label>
    <link:label id="lab_us-gaap_PaymentsToAcquireMarketableSecurities_label_en-US" xlink:label="lab_us-gaap_PaymentsToAcquireMarketableSecurities" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Payments to Acquire Marketable Securities</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsToAcquireMarketableSecurities" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PaymentsToAcquireMarketableSecurities"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PaymentsToAcquireMarketableSecurities" xlink:to="lab_us-gaap_PaymentsToAcquireMarketableSecurities" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_StatementEquityComponentsAxis_6ddb08be-e74d-4b41-86ab-93745164c457_terseLabel_en-US" xlink:label="lab_us-gaap_StatementEquityComponentsAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Equity Components</link:label>
    <link:label id="lab_us-gaap_StatementEquityComponentsAxis_label_en-US" xlink:label="lab_us-gaap_StatementEquityComponentsAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Equity Components [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementEquityComponentsAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StatementEquityComponentsAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StatementEquityComponentsAxis" xlink:to="lab_us-gaap_StatementEquityComponentsAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FairValueMeasurementsRecurringMember_88b708fc-785c-4f02-8acd-02bba3757c87_terseLabel_en-US" xlink:label="lab_us-gaap_FairValueMeasurementsRecurringMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Value, Recurring</link:label>
    <link:label id="lab_us-gaap_FairValueMeasurementsRecurringMember_label_en-US" xlink:label="lab_us-gaap_FairValueMeasurementsRecurringMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Value, Recurring [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueMeasurementsRecurringMember" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueMeasurementsRecurringMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FairValueMeasurementsRecurringMember" xlink:to="lab_us-gaap_FairValueMeasurementsRecurringMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_RelatedPartyTransactionsDisclosureTextBlock_d6049b62-f2f2-4a04-ae9a-32541bec2a0d_terseLabel_en-US" xlink:label="lab_us-gaap_RelatedPartyTransactionsDisclosureTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Related Party Transactions</link:label>
    <link:label id="lab_us-gaap_RelatedPartyTransactionsDisclosureTextBlock_label_en-US" xlink:label="lab_us-gaap_RelatedPartyTransactionsDisclosureTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Related Party Transactions Disclosure [Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RelatedPartyTransactionsDisclosureTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RelatedPartyTransactionsDisclosureTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_RelatedPartyTransactionsDisclosureTextBlock" xlink:to="lab_us-gaap_RelatedPartyTransactionsDisclosureTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_dmtk_OperatingAndFinanceLeaseLiabilityPaymentsRemainderOfFiscalYear_b4fdcb03-7a3e-4eca-934e-9b9f14996ebf_terseLabel_en-US" xlink:label="lab_dmtk_OperatingAndFinanceLeaseLiabilityPaymentsRemainderOfFiscalYear" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Total future minimum lease payments due in 2022</link:label>
    <link:label id="lab_dmtk_OperatingAndFinanceLeaseLiabilityPaymentsRemainderOfFiscalYear_label_en-US" xlink:label="lab_dmtk_OperatingAndFinanceLeaseLiabilityPaymentsRemainderOfFiscalYear" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Operating And Finance Lease Liability Payments Remainder Of Fiscal Year</link:label>
    <link:label id="lab_dmtk_OperatingAndFinanceLeaseLiabilityPaymentsRemainderOfFiscalYear_documentation_en-US" xlink:label="lab_dmtk_OperatingAndFinanceLeaseLiabilityPaymentsRemainderOfFiscalYear" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Operating and capital lease liability payments remainder of fiscal year.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dmtk_OperatingAndFinanceLeaseLiabilityPaymentsRemainderOfFiscalYear" xlink:href="dmtk-20220630.xsd#dmtk_OperatingAndFinanceLeaseLiabilityPaymentsRemainderOfFiscalYear"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dmtk_OperatingAndFinanceLeaseLiabilityPaymentsRemainderOfFiscalYear" xlink:to="lab_dmtk_OperatingAndFinanceLeaseLiabilityPaymentsRemainderOfFiscalYear" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_InterestIncomeExpenseNonoperatingNet_15dea60b-7c91-4d8c-82fe-01950df58aad_terseLabel_en-US" xlink:label="lab_us-gaap_InterestIncomeExpenseNonoperatingNet" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Interest income, net</link:label>
    <link:label id="lab_us-gaap_InterestIncomeExpenseNonoperatingNet_label_en-US" xlink:label="lab_us-gaap_InterestIncomeExpenseNonoperatingNet" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Interest Income (Expense), Nonoperating, Net</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InterestIncomeExpenseNonoperatingNet" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_InterestIncomeExpenseNonoperatingNet"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_InterestIncomeExpenseNonoperatingNet" xlink:to="lab_us-gaap_InterestIncomeExpenseNonoperatingNet" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_DocumentFiscalYearFocus_ed62c582-db3c-4b9f-a3a6-96988b3632f2_terseLabel_en-US" xlink:label="lab_dei_DocumentFiscalYearFocus" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Document Fiscal Year Focus</link:label>
    <link:label id="lab_dei_DocumentFiscalYearFocus_label_en-US" xlink:label="lab_dei_DocumentFiscalYearFocus" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Document Fiscal Year Focus</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_DocumentFiscalYearFocus" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_DocumentFiscalYearFocus"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_DocumentFiscalYearFocus" xlink:to="lab_dei_DocumentFiscalYearFocus" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract_cea212d4-639f-4ab6-8d4c-9cf757e92ea9_terseLabel_en-US" xlink:label="lab_us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cash flows from operating activities:</link:label>
    <link:label id="lab_us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract_label_en-US" xlink:label="lab_us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net Cash Provided by (Used in) Operating Activities [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract" xlink:to="lab_us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_StatementLineItems_accfd0d1-1a59-49a7-bca7-688ca54433d3_terseLabel_en-US" xlink:label="lab_us-gaap_StatementLineItems" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Statement [Line Items]</link:label>
    <link:label id="lab_us-gaap_StatementLineItems_label_en-US" xlink:label="lab_us-gaap_StatementLineItems" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Statement [Line Items]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementLineItems" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StatementLineItems"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StatementLineItems" xlink:to="lab_us-gaap_StatementLineItems" xlink:type="arc" order="1"/>
    <link:label id="lab_dmtk_OperatingAndFinanceLeaseLiabilityPaymentsDueNextTwelveMonths_e220d468-0cd4-47e7-9a1e-b60875e85649_terseLabel_en-US" xlink:label="lab_dmtk_OperatingAndFinanceLeaseLiabilityPaymentsDueNextTwelveMonths" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Total future minimum lease payments due in 2023</link:label>
    <link:label id="lab_dmtk_OperatingAndFinanceLeaseLiabilityPaymentsDueNextTwelveMonths_label_en-US" xlink:label="lab_dmtk_OperatingAndFinanceLeaseLiabilityPaymentsDueNextTwelveMonths" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Operating And Finance Lease Liability Payments Due Next Twelve Months</link:label>
    <link:label id="lab_dmtk_OperatingAndFinanceLeaseLiabilityPaymentsDueNextTwelveMonths_documentation_en-US" xlink:label="lab_dmtk_OperatingAndFinanceLeaseLiabilityPaymentsDueNextTwelveMonths" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Operating and capital lease liability payments due next twelve months.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dmtk_OperatingAndFinanceLeaseLiabilityPaymentsDueNextTwelveMonths" xlink:href="dmtk-20220630.xsd#dmtk_OperatingAndFinanceLeaseLiabilityPaymentsDueNextTwelveMonths"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dmtk_OperatingAndFinanceLeaseLiabilityPaymentsDueNextTwelveMonths" xlink:to="lab_dmtk_OperatingAndFinanceLeaseLiabilityPaymentsDueNextTwelveMonths" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FinanceLeasePrincipalPayments_33be8d5c-e7f3-406c-8b2a-699fe325536d_terseLabel_en-US" xlink:label="lab_us-gaap_FinanceLeasePrincipalPayments" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Financing cash flows from finance leases</link:label>
    <link:label id="lab_us-gaap_FinanceLeasePrincipalPayments_label_en-US" xlink:label="lab_us-gaap_FinanceLeasePrincipalPayments" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Finance Lease, Principal Payments</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FinanceLeasePrincipalPayments" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FinanceLeasePrincipalPayments"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FinanceLeasePrincipalPayments" xlink:to="lab_us-gaap_FinanceLeasePrincipalPayments" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_WarrantsAndRightsOutstandingTerm_472731c8-7094-4b03-b0c9-4b4df81308ed_terseLabel_en-US" xlink:label="lab_us-gaap_WarrantsAndRightsOutstandingTerm" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Warrants expiration period</link:label>
    <link:label id="lab_us-gaap_WarrantsAndRightsOutstandingTerm_label_en-US" xlink:label="lab_us-gaap_WarrantsAndRightsOutstandingTerm" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Warrants and Rights Outstanding, Term</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_WarrantsAndRightsOutstandingTerm" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_WarrantsAndRightsOutstandingTerm"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_WarrantsAndRightsOutstandingTerm" xlink:to="lab_us-gaap_WarrantsAndRightsOutstandingTerm" xlink:type="arc" order="1"/>
    <link:label id="lab_dmtk_RestrictedCashAndCashEquivalentsIncreaseDecrease_53ede2a6-c5c9-4e14-a5cc-42c99697e892_terseLabel_en-US" xlink:label="lab_dmtk_RestrictedCashAndCashEquivalentsIncreaseDecrease" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Increase (decrease) to restricted cash and cash equivalents</link:label>
    <link:label id="lab_dmtk_RestrictedCashAndCashEquivalentsIncreaseDecrease_label_en-US" xlink:label="lab_dmtk_RestrictedCashAndCashEquivalentsIncreaseDecrease" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Restricted Cash and Cash Equivalents, Increase (Decrease)</link:label>
    <link:label id="lab_dmtk_RestrictedCashAndCashEquivalentsIncreaseDecrease_documentation_en-US" xlink:label="lab_dmtk_RestrictedCashAndCashEquivalentsIncreaseDecrease" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Restricted Cash and Cash Equivalents, Increase (Decrease)</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dmtk_RestrictedCashAndCashEquivalentsIncreaseDecrease" xlink:href="dmtk-20220630.xsd#dmtk_RestrictedCashAndCashEquivalentsIncreaseDecrease"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dmtk_RestrictedCashAndCashEquivalentsIncreaseDecrease" xlink:to="lab_dmtk_RestrictedCashAndCashEquivalentsIncreaseDecrease" xlink:type="arc" order="1"/>
    <link:label id="lab_dmtk_EstimatedMarketValueOfDebtSecuritiesWithContractualMaturitiesOfLessThan12Months_97cd02de-f7f3-4e92-9eab-778bc9827808_terseLabel_en-US" xlink:label="lab_dmtk_EstimatedMarketValueOfDebtSecuritiesWithContractualMaturitiesOfLessThan12Months" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Estimated market value of debt securities with contractual maturities of less than 12 months</link:label>
    <link:label id="lab_dmtk_EstimatedMarketValueOfDebtSecuritiesWithContractualMaturitiesOfLessThan12Months_label_en-US" xlink:label="lab_dmtk_EstimatedMarketValueOfDebtSecuritiesWithContractualMaturitiesOfLessThan12Months" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Estimated Market Value Of Debt Securities With Contractual Maturities Of Less Than12 Months</link:label>
    <link:label id="lab_dmtk_EstimatedMarketValueOfDebtSecuritiesWithContractualMaturitiesOfLessThan12Months_documentation_en-US" xlink:label="lab_dmtk_EstimatedMarketValueOfDebtSecuritiesWithContractualMaturitiesOfLessThan12Months" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Estimated market value of debt securities with contractual maturities of less than 12 months.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dmtk_EstimatedMarketValueOfDebtSecuritiesWithContractualMaturitiesOfLessThan12Months" xlink:href="dmtk-20220630.xsd#dmtk_EstimatedMarketValueOfDebtSecuritiesWithContractualMaturitiesOfLessThan12Months"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dmtk_EstimatedMarketValueOfDebtSecuritiesWithContractualMaturitiesOfLessThan12Months" xlink:to="lab_dmtk_EstimatedMarketValueOfDebtSecuritiesWithContractualMaturitiesOfLessThan12Months" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_NonoperatingIncomeExpense_ea7741b5-6934-432a-b01b-54df61472433_totalLabel_en-US" xlink:label="lab_us-gaap_NonoperatingIncomeExpense" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Total other income/(expense)</link:label>
    <link:label id="lab_us-gaap_NonoperatingIncomeExpense_label_en-US" xlink:label="lab_us-gaap_NonoperatingIncomeExpense" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Nonoperating Income (Expense)</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NonoperatingIncomeExpense" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NonoperatingIncomeExpense"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_NonoperatingIncomeExpense" xlink:to="lab_us-gaap_NonoperatingIncomeExpense" xlink:type="arc" order="1"/>
    <link:label id="lab_dmtk_PrepaidTradeShowsCurrent_121456e6-90de-4dba-acf7-b409b0edbbe7_terseLabel_en-US" xlink:label="lab_dmtk_PrepaidTradeShowsCurrent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Prepaid trade shows</link:label>
    <link:label id="lab_dmtk_PrepaidTradeShowsCurrent_label_en-US" xlink:label="lab_dmtk_PrepaidTradeShowsCurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Prepaid Trade Shows Current</link:label>
    <link:label id="lab_dmtk_PrepaidTradeShowsCurrent_documentation_en-US" xlink:label="lab_dmtk_PrepaidTradeShowsCurrent" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Prepaid trade shows, current.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dmtk_PrepaidTradeShowsCurrent" xlink:href="dmtk-20220630.xsd#dmtk_PrepaidTradeShowsCurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dmtk_PrepaidTradeShowsCurrent" xlink:to="lab_dmtk_PrepaidTradeShowsCurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FairValueByFairValueHierarchyLevelAxis_ee12b659-9b1a-41ac-b8bc-53c71e163140_terseLabel_en-US" xlink:label="lab_us-gaap_FairValueByFairValueHierarchyLevelAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Value Hierarchy and NAV</link:label>
    <link:label id="lab_us-gaap_FairValueByFairValueHierarchyLevelAxis_label_en-US" xlink:label="lab_us-gaap_FairValueByFairValueHierarchyLevelAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Value Hierarchy and NAV [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueByFairValueHierarchyLevelAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueByFairValueHierarchyLevelAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FairValueByFairValueHierarchyLevelAxis" xlink:to="lab_us-gaap_FairValueByFairValueHierarchyLevelAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax_cd59c522-24f4-4714-8951-ef3575b0f005_negatedLabel_en-US" xlink:label="lab_us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Gross Unrealized Losses</link:label>
    <link:label id="lab_us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax_label_en-US" xlink:label="lab_us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Securities, Available-for-Sale, Accumulated Gross Unrealized Loss, before Tax</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax" xlink:to="lab_us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OperatingLeaseRightOfUseAsset_17e1eb17-8109-4930-8f5c-f7ef0e8c23a4_terseLabel_en-US" xlink:label="lab_us-gaap_OperatingLeaseRightOfUseAsset" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Operating lease right-of-use assets</link:label>
    <link:label id="lab_us-gaap_OperatingLeaseRightOfUseAsset_label_en-US" xlink:label="lab_us-gaap_OperatingLeaseRightOfUseAsset" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Operating Lease, Right-of-Use Asset</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeaseRightOfUseAsset" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OperatingLeaseRightOfUseAsset"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OperatingLeaseRightOfUseAsset" xlink:to="lab_us-gaap_OperatingLeaseRightOfUseAsset" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ClassOfWarrantOrRightNumberOfSecuritiesCalledByEachWarrantOrRight_f664b6e1-f8b5-48cb-aee4-256a97746f63_terseLabel_en-US" xlink:label="lab_us-gaap_ClassOfWarrantOrRightNumberOfSecuritiesCalledByEachWarrantOrRight" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Number of shares issued for each warrant (in shares)</link:label>
    <link:label id="lab_us-gaap_ClassOfWarrantOrRightNumberOfSecuritiesCalledByEachWarrantOrRight_label_en-US" xlink:label="lab_us-gaap_ClassOfWarrantOrRightNumberOfSecuritiesCalledByEachWarrantOrRight" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Class of Warrant or Right, Number of Securities Called by Each Warrant or Right</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ClassOfWarrantOrRightNumberOfSecuritiesCalledByEachWarrantOrRight" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ClassOfWarrantOrRightNumberOfSecuritiesCalledByEachWarrantOrRight"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ClassOfWarrantOrRightNumberOfSecuritiesCalledByEachWarrantOrRight" xlink:to="lab_us-gaap_ClassOfWarrantOrRightNumberOfSecuritiesCalledByEachWarrantOrRight" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ProductInformationLineItems_071d7811-451f-4caf-b768-57c8b7b2f238_terseLabel_en-US" xlink:label="lab_us-gaap_ProductInformationLineItems" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Product Information [Line Items]</link:label>
    <link:label id="lab_us-gaap_ProductInformationLineItems_label_en-US" xlink:label="lab_us-gaap_ProductInformationLineItems" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Product Information [Line Items]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProductInformationLineItems" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ProductInformationLineItems"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ProductInformationLineItems" xlink:to="lab_us-gaap_ProductInformationLineItems" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_DocumentTransitionReport_6f6fc1bd-a90a-42c9-87e8-60d24a62157e_terseLabel_en-US" xlink:label="lab_dei_DocumentTransitionReport" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Document Transition Report</link:label>
    <link:label id="lab_dei_DocumentTransitionReport_label_en-US" xlink:label="lab_dei_DocumentTransitionReport" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Document Transition Report</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_DocumentTransitionReport" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_DocumentTransitionReport"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_DocumentTransitionReport" xlink:to="lab_dei_DocumentTransitionReport" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_LocalPhoneNumber_b00a30a4-0862-44b5-8081-b21f5c8b8a21_terseLabel_en-US" xlink:label="lab_dei_LocalPhoneNumber" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Local Phone Number</link:label>
    <link:label id="lab_dei_LocalPhoneNumber_label_en-US" xlink:label="lab_dei_LocalPhoneNumber" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Local Phone Number</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_LocalPhoneNumber" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_LocalPhoneNumber"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_LocalPhoneNumber" xlink:to="lab_dei_LocalPhoneNumber" xlink:type="arc" order="1"/>
    <link:label id="lab_dmtk_CowenLimitedLiabilityCompanyMember_9a2b0254-2941-4ab4-afef-b60de9a7169e_terseLabel_en-US" xlink:label="lab_dmtk_CowenLimitedLiabilityCompanyMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cowen and Company LLC</link:label>
    <link:label id="lab_dmtk_CowenLimitedLiabilityCompanyMember_label_en-US" xlink:label="lab_dmtk_CowenLimitedLiabilityCompanyMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cowen Limited Liability Company [Member]</link:label>
    <link:label id="lab_dmtk_CowenLimitedLiabilityCompanyMember_documentation_en-US" xlink:label="lab_dmtk_CowenLimitedLiabilityCompanyMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cowen Limited Liability Company.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dmtk_CowenLimitedLiabilityCompanyMember" xlink:href="dmtk-20220630.xsd#dmtk_CowenLimitedLiabilityCompanyMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dmtk_CowenLimitedLiabilityCompanyMember" xlink:to="lab_dmtk_CowenLimitedLiabilityCompanyMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OperatingIncomeLoss_0aa30722-177e-4124-adec-3268143a7bdf_totalLabel_en-US" xlink:label="lab_us-gaap_OperatingIncomeLoss" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Loss from operations</link:label>
    <link:label id="lab_us-gaap_OperatingIncomeLoss_label_en-US" xlink:label="lab_us-gaap_OperatingIncomeLoss" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Operating Income (Loss)</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingIncomeLoss" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OperatingIncomeLoss"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OperatingIncomeLoss" xlink:to="lab_us-gaap_OperatingIncomeLoss" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncreaseDecreaseInInventories_63e6e5fe-d642-4a0b-aedf-6c20cdb8f327_negatedLabel_en-US" xlink:label="lab_us-gaap_IncreaseDecreaseInInventories" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Inventory</link:label>
    <link:label id="lab_us-gaap_IncreaseDecreaseInInventories_label_en-US" xlink:label="lab_us-gaap_IncreaseDecreaseInInventories" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Increase (Decrease) in Inventories</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInInventories" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncreaseDecreaseInInventories"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncreaseDecreaseInInventories" xlink:to="lab_us-gaap_IncreaseDecreaseInInventories" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock_45c8d2c6-5ffb-4f55-8d81-e82561418f8c_terseLabel_en-US" xlink:label="lab_us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accounting Pronouncements Issued But Not Yet Effective and Adoption of ASC 842</link:label>
    <link:label id="lab_us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock_label_en-US" xlink:label="lab_us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">New Accounting Pronouncements, Policy [Policy Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock" xlink:to="lab_us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets_fdc97e0a-01cf-4869-9709-45a35da62c32_negatedLabel_en-US" xlink:label="lab_us-gaap_IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Prepaid expenses and other current assets</link:label>
    <link:label id="lab_us-gaap_IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets_label_en-US" xlink:label="lab_us-gaap_IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Increase (Decrease) in Prepaid Expense and Other Assets</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets" xlink:to="lab_us-gaap_IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CommonStockSharesOutstanding_4f5e323e-2bb6-46c4-b42e-4a1053976317_terseLabel_en-US" xlink:label="lab_us-gaap_CommonStockSharesOutstanding" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Common stock, shares outstanding (in shares)</link:label>
    <link:label id="lab_us-gaap_CommonStockSharesOutstanding_label_en-US" xlink:label="lab_us-gaap_CommonStockSharesOutstanding" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Common Stock, Shares, Outstanding</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockSharesOutstanding" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CommonStockSharesOutstanding"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CommonStockSharesOutstanding" xlink:to="lab_us-gaap_CommonStockSharesOutstanding" xlink:type="arc" order="1"/>
    <link:label id="lab_dmtk_AssayRevenuePayorAMember_d84ed355-962c-4b97-a061-f394e6aef982_terseLabel_en-US" xlink:label="lab_dmtk_AssayRevenuePayorAMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Payor A</link:label>
    <link:label id="lab_dmtk_AssayRevenuePayorAMember_label_en-US" xlink:label="lab_dmtk_AssayRevenuePayorAMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Assay Revenue Payor A [Member]</link:label>
    <link:label id="lab_dmtk_AssayRevenuePayorAMember_documentation_en-US" xlink:label="lab_dmtk_AssayRevenuePayorAMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Assay Revenue Payor A.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dmtk_AssayRevenuePayorAMember" xlink:href="dmtk-20220630.xsd#dmtk_AssayRevenuePayorAMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dmtk_AssayRevenuePayorAMember" xlink:to="lab_dmtk_AssayRevenuePayorAMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LiabilitiesFairValueDisclosure_babc45ad-138c-4917-a541-5f14ffa72357_totalLabel_en-US" xlink:label="lab_us-gaap_LiabilitiesFairValueDisclosure" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Total liabilities measured at fair value on a recurring basis</link:label>
    <link:label id="lab_us-gaap_LiabilitiesFairValueDisclosure_label_en-US" xlink:label="lab_us-gaap_LiabilitiesFairValueDisclosure" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Liabilities, Fair Value Disclosure</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilitiesFairValueDisclosure" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LiabilitiesFairValueDisclosure"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LiabilitiesFairValueDisclosure" xlink:to="lab_us-gaap_LiabilitiesFairValueDisclosure" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PropertyPlantAndEquipmentByTypeAxis_54215618-9580-488e-b297-4363b7ef2a13_terseLabel_en-US" xlink:label="lab_us-gaap_PropertyPlantAndEquipmentByTypeAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Long-Lived Tangible Asset</link:label>
    <link:label id="lab_us-gaap_PropertyPlantAndEquipmentByTypeAxis_label_en-US" xlink:label="lab_us-gaap_PropertyPlantAndEquipmentByTypeAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Long-Lived Tangible Asset [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentByTypeAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PropertyPlantAndEquipmentByTypeAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentByTypeAxis" xlink:to="lab_us-gaap_PropertyPlantAndEquipmentByTypeAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_RelatedPartyTransactionSellingGeneralAndAdministrativeExpensesFromTransactionsWithRelatedParty_43a79865-12f9-4658-8eba-edd7c50b4a0f_terseLabel_en-US" xlink:label="lab_us-gaap_RelatedPartyTransactionSellingGeneralAndAdministrativeExpensesFromTransactionsWithRelatedParty" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Related party certain marketing cost</link:label>
    <link:label id="lab_us-gaap_RelatedPartyTransactionSellingGeneralAndAdministrativeExpensesFromTransactionsWithRelatedParty_label_en-US" xlink:label="lab_us-gaap_RelatedPartyTransactionSellingGeneralAndAdministrativeExpensesFromTransactionsWithRelatedParty" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Related Party Transaction, Selling, General and Administrative Expenses from Transactions with Related Party</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RelatedPartyTransactionSellingGeneralAndAdministrativeExpensesFromTransactionsWithRelatedParty" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RelatedPartyTransactionSellingGeneralAndAdministrativeExpensesFromTransactionsWithRelatedParty"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_RelatedPartyTransactionSellingGeneralAndAdministrativeExpensesFromTransactionsWithRelatedParty" xlink:to="lab_us-gaap_RelatedPartyTransactionSellingGeneralAndAdministrativeExpensesFromTransactionsWithRelatedParty" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationLineItems_795382df-105d-42b2-b1ba-6b4a03632d9d_terseLabel_en-US" xlink:label="lab_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationLineItems" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Value Liabilities Measured On Recurring Basis Unobservable Input Reconciliation [Line Items]</link:label>
    <link:label id="lab_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationLineItems_label_en-US" xlink:label="lab_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationLineItems" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Value, Liabilities Measured on Recurring Basis, Unobservable Input Reconciliation [Line Items]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationLineItems" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationLineItems"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationLineItems" xlink:to="lab_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationLineItems" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract_5a18a587-c607-432a-af5c-c06fc3fb08fb_terseLabel_en-US" xlink:label="lab_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Adjustments to reconcile net loss to net cash used in operating activities:</link:label>
    <link:label id="lab_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract_437b0e2b-af50-4ca1-8f04-01394421a4f9_verboseLabel_en-US" xlink:label="lab_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Adjustments to reconcile net loss to net cash used in operating activities:</link:label>
    <link:label id="lab_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract_label_en-US" xlink:label="lab_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Adjustments to Reconcile Net Income (Loss) to Cash Provided by (Used in) Operating Activities [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract" xlink:to="lab_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_dmtk_EstimatedMarketValueOfRemainingDebtSecuritiesWithContractualMaturitiesOfUpTo23Months_c4a24968-b793-4385-982d-3098c86613e1_terseLabel_en-US" xlink:label="lab_dmtk_EstimatedMarketValueOfRemainingDebtSecuritiesWithContractualMaturitiesOfUpTo23Months" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Estimated market value of remaining debt securities with contractual maturities of up to 23 months</link:label>
    <link:label id="lab_dmtk_EstimatedMarketValueOfRemainingDebtSecuritiesWithContractualMaturitiesOfUpTo23Months_label_en-US" xlink:label="lab_dmtk_EstimatedMarketValueOfRemainingDebtSecuritiesWithContractualMaturitiesOfUpTo23Months" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Estimated Market Value Of Remaining Debt Securities With Contractual Maturities Of Up To23 Months</link:label>
    <link:label id="lab_dmtk_EstimatedMarketValueOfRemainingDebtSecuritiesWithContractualMaturitiesOfUpTo23Months_documentation_en-US" xlink:label="lab_dmtk_EstimatedMarketValueOfRemainingDebtSecuritiesWithContractualMaturitiesOfUpTo23Months" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Estimated market value of remaining debt securities with contractual maturities of up to 23 months.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dmtk_EstimatedMarketValueOfRemainingDebtSecuritiesWithContractualMaturitiesOfUpTo23Months" xlink:href="dmtk-20220630.xsd#dmtk_EstimatedMarketValueOfRemainingDebtSecuritiesWithContractualMaturitiesOfUpTo23Months"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dmtk_EstimatedMarketValueOfRemainingDebtSecuritiesWithContractualMaturitiesOfUpTo23Months" xlink:to="lab_dmtk_EstimatedMarketValueOfRemainingDebtSecuritiesWithContractualMaturitiesOfUpTo23Months" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PropertyPlantAndEquipmentPolicyTextBlock_ff11995b-37fd-4288-a114-acff869e5097_terseLabel_en-US" xlink:label="lab_us-gaap_PropertyPlantAndEquipmentPolicyTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Property and Equipment, Net</link:label>
    <link:label id="lab_us-gaap_PropertyPlantAndEquipmentPolicyTextBlock_label_en-US" xlink:label="lab_us-gaap_PropertyPlantAndEquipmentPolicyTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Property, Plant and Equipment, Policy [Policy Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentPolicyTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PropertyPlantAndEquipmentPolicyTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentPolicyTextBlock" xlink:to="lab_us-gaap_PropertyPlantAndEquipmentPolicyTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PreferredStockParOrStatedValuePerShare_40dc2946-754b-4b05-addf-a5ec02814775_verboseLabel_en-US" xlink:label="lab_us-gaap_PreferredStockParOrStatedValuePerShare" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Preferred stock, par value per share (in usd per share)</link:label>
    <link:label id="lab_us-gaap_PreferredStockParOrStatedValuePerShare_label_en-US" xlink:label="lab_us-gaap_PreferredStockParOrStatedValuePerShare" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Preferred Stock, Par or Stated Value Per Share</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PreferredStockParOrStatedValuePerShare" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PreferredStockParOrStatedValuePerShare"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PreferredStockParOrStatedValuePerShare" xlink:to="lab_us-gaap_PreferredStockParOrStatedValuePerShare" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFour_c893eae3-34a9-4d25-bc49-02f0614de544_terseLabel_en-US" xlink:label="lab_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFour" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">2026</link:label>
    <link:label id="lab_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFour_label_en-US" xlink:label="lab_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFour" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Lessee, Operating Lease, Liability, to be Paid, Year Four</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFour" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFour"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFour" xlink:to="lab_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFour" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncomeStatementAbstract_45dfb8f6-c34b-4612-93d3-4a250a34f822_terseLabel_en-US" xlink:label="lab_us-gaap_IncomeStatementAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Income Statement [Abstract]</link:label>
    <link:label id="lab_us-gaap_IncomeStatementAbstract_label_en-US" xlink:label="lab_us-gaap_IncomeStatementAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Income Statement [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeStatementAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeStatementAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncomeStatementAbstract" xlink:to="lab_us-gaap_IncomeStatementAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AdditionalPaidInCapitalMember_4d6e12b4-3793-46df-843c-eb1187561a3d_terseLabel_en-US" xlink:label="lab_us-gaap_AdditionalPaidInCapitalMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Additional paid-in capital</link:label>
    <link:label id="lab_us-gaap_AdditionalPaidInCapitalMember_label_en-US" xlink:label="lab_us-gaap_AdditionalPaidInCapitalMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Additional Paid-in Capital [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AdditionalPaidInCapitalMember" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AdditionalPaidInCapitalMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AdditionalPaidInCapitalMember" xlink:to="lab_us-gaap_AdditionalPaidInCapitalMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_BalanceSheetLocationDomain_4d235ae8-0f64-437a-a5f1-0b7b5619c30d_terseLabel_en-US" xlink:label="lab_us-gaap_BalanceSheetLocationDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Balance Sheet Location</link:label>
    <link:label id="lab_us-gaap_BalanceSheetLocationDomain_label_en-US" xlink:label="lab_us-gaap_BalanceSheetLocationDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Balance Sheet Location [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BalanceSheetLocationDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BalanceSheetLocationDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_BalanceSheetLocationDomain" xlink:to="lab_us-gaap_BalanceSheetLocationDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_DocumentFiscalPeriodFocus_e0194e4f-195b-418e-91b0-4a5541e8a31b_terseLabel_en-US" xlink:label="lab_dei_DocumentFiscalPeriodFocus" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Document Fiscal Period Focus</link:label>
    <link:label id="lab_dei_DocumentFiscalPeriodFocus_label_en-US" xlink:label="lab_dei_DocumentFiscalPeriodFocus" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Document Fiscal Period Focus</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_DocumentFiscalPeriodFocus" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_DocumentFiscalPeriodFocus"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_DocumentFiscalPeriodFocus" xlink:to="lab_dei_DocumentFiscalPeriodFocus" xlink:type="arc" order="1"/>
    <link:label id="lab_srt_CumulativeEffectPeriodOfAdoptionAdjustedBalanceMember_0d589680-c8a0-451d-bf94-7dce3ea87689_terseLabel_en-US" xlink:label="lab_srt_CumulativeEffectPeriodOfAdoptionAdjustedBalanceMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">After Adoption of ASC 842</link:label>
    <link:label id="lab_srt_CumulativeEffectPeriodOfAdoptionAdjustedBalanceMember_label_en-US" xlink:label="lab_srt_CumulativeEffectPeriodOfAdoptionAdjustedBalanceMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cumulative Effect, Period of Adoption, Adjusted Balance [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_srt_CumulativeEffectPeriodOfAdoptionAdjustedBalanceMember" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_CumulativeEffectPeriodOfAdoptionAdjustedBalanceMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_srt_CumulativeEffectPeriodOfAdoptionAdjustedBalanceMember" xlink:to="lab_srt_CumulativeEffectPeriodOfAdoptionAdjustedBalanceMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_RestrictedCashNoncurrent_e5511544-6386-446d-b67c-566ffa3e892b_terseLabel_en-US" xlink:label="lab_us-gaap_RestrictedCashNoncurrent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Restricted cash</link:label>
    <link:label id="lab_us-gaap_RestrictedCashNoncurrent_67abea6a-1c0c-4eb5-b930-41f381ff2314_verboseLabel_en-US" xlink:label="lab_us-gaap_RestrictedCashNoncurrent" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Restricted cash</link:label>
    <link:label id="lab_us-gaap_RestrictedCashNoncurrent_label_en-US" xlink:label="lab_us-gaap_RestrictedCashNoncurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Restricted Cash, Noncurrent</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestrictedCashNoncurrent" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RestrictedCashNoncurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_RestrictedCashNoncurrent" xlink:to="lab_us-gaap_RestrictedCashNoncurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding_ef462d27-7819-4bca-acc6-a5aec9d26049_terseLabel_en-US" xlink:label="lab_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Weighted average shares outstanding used in computing net loss per share, diluted (in shares)</link:label>
    <link:label id="lab_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding_label_en-US" xlink:label="lab_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Weighted Average Number of Shares Outstanding, Diluted</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding" xlink:to="lab_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment_2b6fea56-b06f-43cd-a7d4-8f8c2cd6ed90_negatedLabel_en-US" xlink:label="lab_us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Less accumulated depreciation</link:label>
    <link:label id="lab_us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment_label_en-US" xlink:label="lab_us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accumulated Depreciation, Depletion and Amortization, Property, Plant, and Equipment</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment" xlink:to="lab_us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRateMinimum_c652fac9-beba-4742-bb28-232d1dee5c80_terseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRateMinimum" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Assumed volatility, minimum</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRateMinimum_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRateMinimum" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-Based Compensation Arrangement by Share-Based Payment Award, Fair Value Assumptions, Expected Volatility Rate, Minimum</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRateMinimum" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRateMinimum"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRateMinimum" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRateMinimum" xlink:type="arc" order="1"/>
    <link:label id="lab_dmtk_LesseeOperatingAndFinanceLeaseLiabilityToBePaidAbstract_bc913dd1-9e9a-4845-9fe9-c7383686cc4f_terseLabel_en-US" xlink:label="lab_dmtk_LesseeOperatingAndFinanceLeaseLiabilityToBePaidAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Total future minimum lease payments</link:label>
    <link:label id="lab_dmtk_LesseeOperatingAndFinanceLeaseLiabilityToBePaidAbstract_label_en-US" xlink:label="lab_dmtk_LesseeOperatingAndFinanceLeaseLiabilityToBePaidAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Lessee, Operating and Finance Lease, Liability, To Be Paid [Abstract]</link:label>
    <link:label id="lab_dmtk_LesseeOperatingAndFinanceLeaseLiabilityToBePaidAbstract_documentation_en-US" xlink:label="lab_dmtk_LesseeOperatingAndFinanceLeaseLiabilityToBePaidAbstract" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Lessee, Operating and Finance Lease, Liability, To Be Paid</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dmtk_LesseeOperatingAndFinanceLeaseLiabilityToBePaidAbstract" xlink:href="dmtk-20220630.xsd#dmtk_LesseeOperatingAndFinanceLeaseLiabilityToBePaidAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dmtk_LesseeOperatingAndFinanceLeaseLiabilityToBePaidAbstract" xlink:to="lab_dmtk_LesseeOperatingAndFinanceLeaseLiabilityToBePaidAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1_768bb17d-902e-4e48-953c-e7a4a3f54c47_terseLabel_en-US" xlink:label="lab_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Expected term</link:label>
    <link:label id="lab_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1_label_en-US" xlink:label="lab_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-Based Compensation Arrangement by Share-Based Payment Award, Fair Value Assumptions, Expected Term</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1" xlink:to="lab_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfNewAccountingPronouncementsAndChangesInAccountingPrinciplesTextBlock_836dbbac-9bf5-427f-b430-b19d6a8d666a_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfNewAccountingPronouncementsAndChangesInAccountingPrinciplesTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Adoption of ASC 842</link:label>
    <link:label id="lab_us-gaap_ScheduleOfNewAccountingPronouncementsAndChangesInAccountingPrinciplesTextBlock_label_en-US" xlink:label="lab_us-gaap_ScheduleOfNewAccountingPronouncementsAndChangesInAccountingPrinciplesTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accounting Standards Update and Change in Accounting Principle [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfNewAccountingPronouncementsAndChangesInAccountingPrinciplesTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfNewAccountingPronouncementsAndChangesInAccountingPrinciplesTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfNewAccountingPronouncementsAndChangesInAccountingPrinciplesTextBlock" xlink:to="lab_us-gaap_ScheduleOfNewAccountingPronouncementsAndChangesInAccountingPrinciplesTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_dmtk_OperatingLeaseCosts_954bd65f-a567-455d-9451-3a7ab03baa86_totalLabel_en-US" xlink:label="lab_dmtk_OperatingLeaseCosts" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Total operating lease cost</link:label>
    <link:label id="lab_dmtk_OperatingLeaseCosts_label_en-US" xlink:label="lab_dmtk_OperatingLeaseCosts" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Operating Lease Costs</link:label>
    <link:label id="lab_dmtk_OperatingLeaseCosts_documentation_en-US" xlink:label="lab_dmtk_OperatingLeaseCosts" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Operating lease cost.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dmtk_OperatingLeaseCosts" xlink:href="dmtk-20220630.xsd#dmtk_OperatingLeaseCosts"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dmtk_OperatingLeaseCosts" xlink:to="lab_dmtk_OperatingLeaseCosts" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AccountsReceivableMember_7ae9549d-cc2c-4e77-88d1-15a4f4dad521_terseLabel_en-US" xlink:label="lab_us-gaap_AccountsReceivableMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accounts Receivable</link:label>
    <link:label id="lab_us-gaap_AccountsReceivableMember_label_en-US" xlink:label="lab_us-gaap_AccountsReceivableMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accounts Receivable [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccountsReceivableMember" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AccountsReceivableMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AccountsReceivableMember" xlink:to="lab_us-gaap_AccountsReceivableMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CommonStockValue_36ce03aa-bd79-4f90-8af8-d81d2d4a0437_terseLabel_en-US" xlink:label="lab_us-gaap_CommonStockValue" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Common stock, $0.0001 par value per share; 50,000,000 shares authorized as of June&#160;30, 2022 and December&#160;31, 2021; 30,038,447 and 29,772,922 shares issued and outstanding at June&#160;30, 2022 and December&#160;31, 2021, respectively</link:label>
    <link:label id="lab_us-gaap_CommonStockValue_label_en-US" xlink:label="lab_us-gaap_CommonStockValue" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Common Stock, Value, Issued</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockValue" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CommonStockValue"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CommonStockValue" xlink:to="lab_us-gaap_CommonStockValue" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DebtInstrumentNameDomain_533f98dd-b441-4671-a5a8-67090a402d1d_terseLabel_en-US" xlink:label="lab_us-gaap_DebtInstrumentNameDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Instrument, Name</link:label>
    <link:label id="lab_us-gaap_DebtInstrumentNameDomain_label_en-US" xlink:label="lab_us-gaap_DebtInstrumentNameDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Instrument, Name [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentNameDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtInstrumentNameDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DebtInstrumentNameDomain" xlink:to="lab_us-gaap_DebtInstrumentNameDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfFairValueAssetsAndLiabilitiesMeasuredOnRecurringBasisTableTextBlock_b04bc85e-91c9-4a69-80a7-7581035cc619_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfFairValueAssetsAndLiabilitiesMeasuredOnRecurringBasisTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Summary of Assets and Liabilities Measured at Fair Value on Recurring Basis</link:label>
    <link:label id="lab_us-gaap_ScheduleOfFairValueAssetsAndLiabilitiesMeasuredOnRecurringBasisTableTextBlock_label_en-US" xlink:label="lab_us-gaap_ScheduleOfFairValueAssetsAndLiabilitiesMeasuredOnRecurringBasisTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Fair Value, Assets and Liabilities Measured on Recurring Basis [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfFairValueAssetsAndLiabilitiesMeasuredOnRecurringBasisTableTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfFairValueAssetsAndLiabilitiesMeasuredOnRecurringBasisTableTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfFairValueAssetsAndLiabilitiesMeasuredOnRecurringBasisTableTextBlock" xlink:to="lab_us-gaap_ScheduleOfFairValueAssetsAndLiabilitiesMeasuredOnRecurringBasisTableTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_dmtk_WarrantLiabilityFairValueDisclosure_5f0b52e6-db96-4228-ab6d-35122ebde06a_terseLabel_en-US" xlink:label="lab_dmtk_WarrantLiabilityFairValueDisclosure" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Warrant liability</link:label>
    <link:label id="lab_dmtk_WarrantLiabilityFairValueDisclosure_label_en-US" xlink:label="lab_dmtk_WarrantLiabilityFairValueDisclosure" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Warrant Liability Fair Value Disclosure</link:label>
    <link:label id="lab_dmtk_WarrantLiabilityFairValueDisclosure_documentation_en-US" xlink:label="lab_dmtk_WarrantLiabilityFairValueDisclosure" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Warrant liability fair value disclosure.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dmtk_WarrantLiabilityFairValueDisclosure" xlink:href="dmtk-20220630.xsd#dmtk_WarrantLiabilityFairValueDisclosure"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dmtk_WarrantLiabilityFairValueDisclosure" xlink:to="lab_dmtk_WarrantLiabilityFairValueDisclosure" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PreferredStockSharesAuthorized_c77ca4b9-6b47-415e-bcfb-0a909aadf9f5_verboseLabel_en-US" xlink:label="lab_us-gaap_PreferredStockSharesAuthorized" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Preferred stock, shares authorized (in shares)</link:label>
    <link:label id="lab_us-gaap_PreferredStockSharesAuthorized_label_en-US" xlink:label="lab_us-gaap_PreferredStockSharesAuthorized" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Preferred Stock, Shares Authorized</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PreferredStockSharesAuthorized" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PreferredStockSharesAuthorized"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PreferredStockSharesAuthorized" xlink:to="lab_us-gaap_PreferredStockSharesAuthorized" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationTable_43307388-a392-45f2-b699-753b7ee2756a_terseLabel_en-US" xlink:label="lab_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationTable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Value Liabilities Measured On Recurring Basis Unobservable Input Reconciliation [Table]</link:label>
    <link:label id="lab_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationTable_label_en-US" xlink:label="lab_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationTable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Value, Liabilities Measured on Recurring Basis, Unobservable Input Reconciliation [Table]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationTable" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationTable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationTable" xlink:to="lab_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationTable" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_fea361a3-30a9-4127-be46-c4782761bf8d_totalLabel_en-US" xlink:label="lab_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Total cash, cash equivalents and restricted cash</link:label>
    <link:label id="lab_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_label_en-US" xlink:label="lab_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cash, Cash Equivalents, Restricted Cash, and Restricted Cash Equivalents</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" xlink:to="lab_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" xlink:type="arc" order="1"/>
    <link:label id="lab_dmtk_OperatingAndFinanceLeaseLiabilityPaymentsDueYearTwo_d90638b1-46a3-4c77-953d-7a09b1cc7264_terseLabel_en-US" xlink:label="lab_dmtk_OperatingAndFinanceLeaseLiabilityPaymentsDueYearTwo" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Total future minimum lease payments due in 2024</link:label>
    <link:label id="lab_dmtk_OperatingAndFinanceLeaseLiabilityPaymentsDueYearTwo_label_en-US" xlink:label="lab_dmtk_OperatingAndFinanceLeaseLiabilityPaymentsDueYearTwo" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Operating And Finance Lease Liability Payments Due Year Two</link:label>
    <link:label id="lab_dmtk_OperatingAndFinanceLeaseLiabilityPaymentsDueYearTwo_documentation_en-US" xlink:label="lab_dmtk_OperatingAndFinanceLeaseLiabilityPaymentsDueYearTwo" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Operating and capital lease liability payments due year two.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dmtk_OperatingAndFinanceLeaseLiabilityPaymentsDueYearTwo" xlink:href="dmtk-20220630.xsd#dmtk_OperatingAndFinanceLeaseLiabilityPaymentsDueYearTwo"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dmtk_OperatingAndFinanceLeaseLiabilityPaymentsDueYearTwo" xlink:to="lab_dmtk_OperatingAndFinanceLeaseLiabilityPaymentsDueYearTwo" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AdjustmentsToAdditionalPaidInCapitalWarrantIssued_ef47e6b3-6681-484a-a19e-60a417dac3a7_terseLabel_en-US" xlink:label="lab_us-gaap_AdjustmentsToAdditionalPaidInCapitalWarrantIssued" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Issuance of common stock from warrant exercises</link:label>
    <link:label id="lab_us-gaap_AdjustmentsToAdditionalPaidInCapitalWarrantIssued_label_en-US" xlink:label="lab_us-gaap_AdjustmentsToAdditionalPaidInCapitalWarrantIssued" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Adjustments to Additional Paid in Capital, Warrant Issued</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AdjustmentsToAdditionalPaidInCapitalWarrantIssued" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AdjustmentsToAdditionalPaidInCapitalWarrantIssued"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AdjustmentsToAdditionalPaidInCapitalWarrantIssued" xlink:to="lab_us-gaap_AdjustmentsToAdditionalPaidInCapitalWarrantIssued" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LiabilitiesCurrentAbstract_1dc775db-7e79-416d-9588-b1da110f9afb_terseLabel_en-US" xlink:label="lab_us-gaap_LiabilitiesCurrentAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Current liabilities:</link:label>
    <link:label id="lab_us-gaap_LiabilitiesCurrentAbstract_label_en-US" xlink:label="lab_us-gaap_LiabilitiesCurrentAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Liabilities, Current [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilitiesCurrentAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LiabilitiesCurrentAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LiabilitiesCurrentAbstract" xlink:to="lab_us-gaap_LiabilitiesCurrentAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CommonStockSharesIssued_9b45dae5-e95b-479a-8319-9cd569489ce5_terseLabel_en-US" xlink:label="lab_us-gaap_CommonStockSharesIssued" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Common stock, shares issued (in shares)</link:label>
    <link:label id="lab_us-gaap_CommonStockSharesIssued_label_en-US" xlink:label="lab_us-gaap_CommonStockSharesIssued" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Common Stock, Shares, Issued</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockSharesIssued" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CommonStockSharesIssued"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CommonStockSharesIssued" xlink:to="lab_us-gaap_CommonStockSharesIssued" xlink:type="arc" order="1"/>
    <link:label id="lab_dmtk_OperatingAndFinanceLeaseLiabilityPaymentsDue_6c0671b9-9bbf-4499-b6b0-6bccb6b68e73_terseLabel_en-US" xlink:label="lab_dmtk_OperatingAndFinanceLeaseLiabilityPaymentsDue" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Operating And Capital Lease Liability Payments Due</link:label>
    <link:label id="lab_dmtk_OperatingAndFinanceLeaseLiabilityPaymentsDue_label_en-US" xlink:label="lab_dmtk_OperatingAndFinanceLeaseLiabilityPaymentsDue" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Operating And Finance Lease Liability Payments Due</link:label>
    <link:label id="lab_dmtk_OperatingAndFinanceLeaseLiabilityPaymentsDue_documentation_en-US" xlink:label="lab_dmtk_OperatingAndFinanceLeaseLiabilityPaymentsDue" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Operating and capital lease liability payments due.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dmtk_OperatingAndFinanceLeaseLiabilityPaymentsDue" xlink:href="dmtk-20220630.xsd#dmtk_OperatingAndFinanceLeaseLiabilityPaymentsDue"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dmtk_OperatingAndFinanceLeaseLiabilityPaymentsDue" xlink:to="lab_dmtk_OperatingAndFinanceLeaseLiabilityPaymentsDue" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AccountingStandardsUpdate201602Member_be7a81bb-b9a6-439b-a3d7-20925d820d19_terseLabel_en-US" xlink:label="lab_us-gaap_AccountingStandardsUpdate201602Member" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accounting Standards Update 2016-02</link:label>
    <link:label id="lab_us-gaap_AccountingStandardsUpdate201602Member_label_en-US" xlink:label="lab_us-gaap_AccountingStandardsUpdate201602Member" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accounting Standards Update 2016-02 [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccountingStandardsUpdate201602Member" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AccountingStandardsUpdate201602Member"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AccountingStandardsUpdate201602Member" xlink:to="lab_us-gaap_AccountingStandardsUpdate201602Member" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FinanceLeaseInterestExpense_c4ae7f7f-c4b5-4d49-9052-5f9a111ef03b_terseLabel_en-US" xlink:label="lab_us-gaap_FinanceLeaseInterestExpense" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Interest on lease liabilities</link:label>
    <link:label id="lab_us-gaap_FinanceLeaseInterestExpense_93e1b032-0588-4e69-b448-485b197afac3_verboseLabel_en-US" xlink:label="lab_us-gaap_FinanceLeaseInterestExpense" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Operating cash flows from finance leases</link:label>
    <link:label id="lab_us-gaap_FinanceLeaseInterestExpense_label_en-US" xlink:label="lab_us-gaap_FinanceLeaseInterestExpense" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Finance Lease, Interest Expense</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FinanceLeaseInterestExpense" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FinanceLeaseInterestExpense"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FinanceLeaseInterestExpense" xlink:to="lab_us-gaap_FinanceLeaseInterestExpense" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CapitalExpendituresIncurredButNotYetPaid_3070779f-3314-4d66-a787-9840a8cbdbdd_terseLabel_en-US" xlink:label="lab_us-gaap_CapitalExpendituresIncurredButNotYetPaid" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Purchases of property and equipment recorded in accounts payable</link:label>
    <link:label id="lab_us-gaap_CapitalExpendituresIncurredButNotYetPaid_label_en-US" xlink:label="lab_us-gaap_CapitalExpendituresIncurredButNotYetPaid" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Capital Expenditures Incurred but Not yet Paid</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CapitalExpendituresIncurredButNotYetPaid" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CapitalExpendituresIncurredButNotYetPaid"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CapitalExpendituresIncurredButNotYetPaid" xlink:to="lab_us-gaap_CapitalExpendituresIncurredButNotYetPaid" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_WarrantsAndRightsOutstanding_a53481f6-23f9-4e5d-b3bb-45cd8c3b8e5b_terseLabel_en-US" xlink:label="lab_us-gaap_WarrantsAndRightsOutstanding" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Warrant liability</link:label>
    <link:label id="lab_us-gaap_WarrantsAndRightsOutstanding_label_en-US" xlink:label="lab_us-gaap_WarrantsAndRightsOutstanding" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Warrants and Rights Outstanding</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_WarrantsAndRightsOutstanding" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_WarrantsAndRightsOutstanding"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_WarrantsAndRightsOutstanding" xlink:to="lab_us-gaap_WarrantsAndRightsOutstanding" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncomeStatementLocationDomain_f74c8e5b-5a6d-41e3-8660-d560953d5e89_terseLabel_en-US" xlink:label="lab_us-gaap_IncomeStatementLocationDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Income Statement Location</link:label>
    <link:label id="lab_us-gaap_IncomeStatementLocationDomain_label_en-US" xlink:label="lab_us-gaap_IncomeStatementLocationDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Income Statement Location [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeStatementLocationDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeStatementLocationDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncomeStatementLocationDomain" xlink:to="lab_us-gaap_IncomeStatementLocationDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FinanceLeaseLiabilityCurrent_ac9ede52-efd8-4807-9fc3-caef272d9701_terseLabel_en-US" xlink:label="lab_us-gaap_FinanceLeaseLiabilityCurrent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Current portion of finance lease obligations</link:label>
    <link:label id="lab_us-gaap_FinanceLeaseLiabilityCurrent_45e0ea9f-45f4-4d2a-bd7b-fdacd042034f_negatedLabel_en-US" xlink:label="lab_us-gaap_FinanceLeaseLiabilityCurrent" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Less current portion of finance lease obligations</link:label>
    <link:label id="lab_us-gaap_FinanceLeaseLiabilityCurrent_label_en-US" xlink:label="lab_us-gaap_FinanceLeaseLiabilityCurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Finance Lease, Liability, Current</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FinanceLeaseLiabilityCurrent" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FinanceLeaseLiabilityCurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FinanceLeaseLiabilityCurrent" xlink:to="lab_us-gaap_FinanceLeaseLiabilityCurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems_77e60ba4-3332-4974-af5d-496bd6d79da3_terseLabel_en-US" xlink:label="lab_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Value Assets And Liabilities Measured On Recurring And Nonrecurring Basis [Line Items]</link:label>
    <link:label id="lab_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems_label_en-US" xlink:label="lab_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems" xlink:to="lab_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_AmendmentFlag_967956cd-b7fc-498f-a968-0d5e290b9b13_terseLabel_en-US" xlink:label="lab_dei_AmendmentFlag" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Amendment Flag</link:label>
    <link:label id="lab_dei_AmendmentFlag_label_en-US" xlink:label="lab_dei_AmendmentFlag" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Amendment Flag</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_AmendmentFlag" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_AmendmentFlag"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_AmendmentFlag" xlink:to="lab_dei_AmendmentFlag" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LesseeOperatingLeaseRemainingLeaseTerm_d38ae736-7de3-4dff-b796-3650487a962a_terseLabel_en-US" xlink:label="lab_us-gaap_LesseeOperatingLeaseRemainingLeaseTerm" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Remaining lease term</link:label>
    <link:label id="lab_us-gaap_LesseeOperatingLeaseRemainingLeaseTerm_label_en-US" xlink:label="lab_us-gaap_LesseeOperatingLeaseRemainingLeaseTerm" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Lessee, Operating Lease, Remaining Lease Term</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeOperatingLeaseRemainingLeaseTerm" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LesseeOperatingLeaseRemainingLeaseTerm"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LesseeOperatingLeaseRemainingLeaseTerm" xlink:to="lab_us-gaap_LesseeOperatingLeaseRemainingLeaseTerm" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_NetCashProvidedByUsedInInvestingActivities_ccc5efb4-1921-49d0-a17b-b0e0e6ed5007_totalLabel_en-US" xlink:label="lab_us-gaap_NetCashProvidedByUsedInInvestingActivities" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net cash used in investing activities</link:label>
    <link:label id="lab_us-gaap_NetCashProvidedByUsedInInvestingActivities_label_en-US" xlink:label="lab_us-gaap_NetCashProvidedByUsedInInvestingActivities" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net Cash Provided by (Used in) Investing Activities</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInInvestingActivities" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NetCashProvidedByUsedInInvestingActivities"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_NetCashProvidedByUsedInInvestingActivities" xlink:to="lab_us-gaap_NetCashProvidedByUsedInInvestingActivities" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OperatingLeaseCost_10ba1ae7-ba70-458d-824c-d6b2931fdf57_terseLabel_en-US" xlink:label="lab_us-gaap_OperatingLeaseCost" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Operating lease cost</link:label>
    <link:label id="lab_us-gaap_OperatingLeaseCost_label_en-US" xlink:label="lab_us-gaap_OperatingLeaseCost" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Operating Lease, Cost</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeaseCost" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OperatingLeaseCost"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OperatingLeaseCost" xlink:to="lab_us-gaap_OperatingLeaseCost" xlink:type="arc" order="1"/>
    <link:label id="lab_dmtk_PrivateSpecialPurposeAcquisitionCompaniesWarrantsMember_66619a86-e383-4667-bbd1-ba412eda9cd2_terseLabel_en-US" xlink:label="lab_dmtk_PrivateSpecialPurposeAcquisitionCompaniesWarrantsMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Private SPAC Warrants</link:label>
    <link:label id="lab_dmtk_PrivateSpecialPurposeAcquisitionCompaniesWarrantsMember_label_en-US" xlink:label="lab_dmtk_PrivateSpecialPurposeAcquisitionCompaniesWarrantsMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Private Special Purpose Acquisition Companies Warrants [Member]</link:label>
    <link:label id="lab_dmtk_PrivateSpecialPurposeAcquisitionCompaniesWarrantsMember_documentation_en-US" xlink:label="lab_dmtk_PrivateSpecialPurposeAcquisitionCompaniesWarrantsMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Private special purpose acquisition companies warrants.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dmtk_PrivateSpecialPurposeAcquisitionCompaniesWarrantsMember" xlink:href="dmtk-20220630.xsd#dmtk_PrivateSpecialPurposeAcquisitionCompaniesWarrantsMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dmtk_PrivateSpecialPurposeAcquisitionCompaniesWarrantsMember" xlink:to="lab_dmtk_PrivateSpecialPurposeAcquisitionCompaniesWarrantsMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_InvestmentHoldingsTable_08ae0da5-d3ef-4b40-9efe-192ca535a6cd_terseLabel_en-US" xlink:label="lab_us-gaap_InvestmentHoldingsTable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Investment Holdings [Table]</link:label>
    <link:label id="lab_us-gaap_InvestmentHoldingsTable_label_en-US" xlink:label="lab_us-gaap_InvestmentHoldingsTable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Investment Holdings [Table]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InvestmentHoldingsTable" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_InvestmentHoldingsTable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_InvestmentHoldingsTable" xlink:to="lab_us-gaap_InvestmentHoldingsTable" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_StockIssuedDuringPeriodValueEmployeeStockPurchasePlan_1122bd2c-f8d5-4d60-b4c2-8036743f2007_terseLabel_en-US" xlink:label="lab_us-gaap_StockIssuedDuringPeriodValueEmployeeStockPurchasePlan" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Issuance of common stock from Employee Stock Purchase Plan</link:label>
    <link:label id="lab_us-gaap_StockIssuedDuringPeriodValueEmployeeStockPurchasePlan_label_en-US" xlink:label="lab_us-gaap_StockIssuedDuringPeriodValueEmployeeStockPurchasePlan" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Stock Issued During Period, Value, Employee Stock Purchase Plan</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockIssuedDuringPeriodValueEmployeeStockPurchasePlan" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StockIssuedDuringPeriodValueEmployeeStockPurchasePlan"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StockIssuedDuringPeriodValueEmployeeStockPurchasePlan" xlink:to="lab_us-gaap_StockIssuedDuringPeriodValueEmployeeStockPurchasePlan" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ComprehensiveIncomeNetOfTax_5f68aaa6-cd1e-442c-a03e-c9ee7e017953_totalLabel_en-US" xlink:label="lab_us-gaap_ComprehensiveIncomeNetOfTax" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Comprehensive loss</link:label>
    <link:label id="lab_us-gaap_ComprehensiveIncomeNetOfTax_label_en-US" xlink:label="lab_us-gaap_ComprehensiveIncomeNetOfTax" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Comprehensive Income (Loss), Net of Tax, Attributable to Parent</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ComprehensiveIncomeNetOfTax" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ComprehensiveIncomeNetOfTax"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ComprehensiveIncomeNetOfTax" xlink:to="lab_us-gaap_ComprehensiveIncomeNetOfTax" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax_5548312b-9d31-47a4-83f4-f9464ba249b9_terseLabel_en-US" xlink:label="lab_us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Gross Unrealized Gains</link:label>
    <link:label id="lab_us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax_label_en-US" xlink:label="lab_us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Securities, Available-for-Sale, Accumulated Gross Unrealized Gain, before Tax</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax" xlink:to="lab_us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ImpairmentOfLongLivedAssetsToBeDisposedOf_c983d98f-a0a0-462b-b4bf-cba961937e07_terseLabel_en-US" xlink:label="lab_us-gaap_ImpairmentOfLongLivedAssetsToBeDisposedOf" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Impairment losses</link:label>
    <link:label id="lab_us-gaap_ImpairmentOfLongLivedAssetsToBeDisposedOf_label_en-US" xlink:label="lab_us-gaap_ImpairmentOfLongLivedAssetsToBeDisposedOf" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Impairment of Long-Lived Assets to be Disposed of</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ImpairmentOfLongLivedAssetsToBeDisposedOf" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ImpairmentOfLongLivedAssetsToBeDisposedOf"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ImpairmentOfLongLivedAssetsToBeDisposedOf" xlink:to="lab_us-gaap_ImpairmentOfLongLivedAssetsToBeDisposedOf" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityCurrentReportingStatus_5b5d5f7b-06f0-4347-8236-2fedf771e6b5_terseLabel_en-US" xlink:label="lab_dei_EntityCurrentReportingStatus" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Current Reporting Status</link:label>
    <link:label id="lab_dei_EntityCurrentReportingStatus_label_en-US" xlink:label="lab_dei_EntityCurrentReportingStatus" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Current Reporting Status</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityCurrentReportingStatus" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityCurrentReportingStatus"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityCurrentReportingStatus" xlink:to="lab_dei_EntityCurrentReportingStatus" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OtherAssetsNoncurrent_d241cb54-140c-45f9-a231-b67e29fcd919_terseLabel_en-US" xlink:label="lab_us-gaap_OtherAssetsNoncurrent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other assets</link:label>
    <link:label id="lab_us-gaap_OtherAssetsNoncurrent_label_en-US" xlink:label="lab_us-gaap_OtherAssetsNoncurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Assets, Noncurrent</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherAssetsNoncurrent" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherAssetsNoncurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OtherAssetsNoncurrent" xlink:to="lab_us-gaap_OtherAssetsNoncurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncreaseDecreaseInEmployeeRelatedLiabilities_680bc5f8-ec0d-4fd1-b476-88118da65df4_terseLabel_en-US" xlink:label="lab_us-gaap_IncreaseDecreaseInEmployeeRelatedLiabilities" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accrued compensation</link:label>
    <link:label id="lab_us-gaap_IncreaseDecreaseInEmployeeRelatedLiabilities_label_en-US" xlink:label="lab_us-gaap_IncreaseDecreaseInEmployeeRelatedLiabilities" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Increase (Decrease) in Employee Related Liabilities</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInEmployeeRelatedLiabilities" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncreaseDecreaseInEmployeeRelatedLiabilities"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncreaseDecreaseInEmployeeRelatedLiabilities" xlink:to="lab_us-gaap_IncreaseDecreaseInEmployeeRelatedLiabilities" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FinanceLeaseLiabilityPaymentsDueNextTwelveMonths_d627fb6e-865a-47f5-9cdc-2ebc0c1d594b_terseLabel_en-US" xlink:label="lab_us-gaap_FinanceLeaseLiabilityPaymentsDueNextTwelveMonths" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">2023</link:label>
    <link:label id="lab_us-gaap_FinanceLeaseLiabilityPaymentsDueNextTwelveMonths_label_en-US" xlink:label="lab_us-gaap_FinanceLeaseLiabilityPaymentsDueNextTwelveMonths" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Finance Lease, Liability, to be Paid, Year One</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FinanceLeaseLiabilityPaymentsDueNextTwelveMonths" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FinanceLeaseLiabilityPaymentsDueNextTwelveMonths"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FinanceLeaseLiabilityPaymentsDueNextTwelveMonths" xlink:to="lab_us-gaap_FinanceLeaseLiabilityPaymentsDueNextTwelveMonths" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardPurchasePriceOfCommonStockPercent_a123a795-cc73-4ce7-8307-a24e7e9ddaf8_terseLabel_en-US" xlink:label="lab_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardPurchasePriceOfCommonStockPercent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Options granted, exercise price expressed as a percentage of fair market value</link:label>
    <link:label id="lab_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardPurchasePriceOfCommonStockPercent_label_en-US" xlink:label="lab_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardPurchasePriceOfCommonStockPercent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-Based Compensation Arrangement by Share-Based Payment Award, Purchase Price of Common Stock, Percent</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardPurchasePriceOfCommonStockPercent" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardPurchasePriceOfCommonStockPercent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardPurchasePriceOfCommonStockPercent" xlink:to="lab_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardPurchasePriceOfCommonStockPercent" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DisaggregationOfRevenueTable_445cdb19-ee72-44ce-b8f9-c24aafabb6da_terseLabel_en-US" xlink:label="lab_us-gaap_DisaggregationOfRevenueTable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Disaggregation Of Revenue [Table]</link:label>
    <link:label id="lab_us-gaap_DisaggregationOfRevenueTable_label_en-US" xlink:label="lab_us-gaap_DisaggregationOfRevenueTable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Disaggregation of Revenue [Table]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisaggregationOfRevenueTable" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DisaggregationOfRevenueTable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DisaggregationOfRevenueTable" xlink:to="lab_us-gaap_DisaggregationOfRevenueTable" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_StockIssuedDuringPeriodSharesEmployeeStockPurchasePlans_652f8e05-b04a-4cf4-9648-2eda211daaf5_terseLabel_en-US" xlink:label="lab_us-gaap_StockIssuedDuringPeriodSharesEmployeeStockPurchasePlans" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Issuance of common stock from Employee Stock Purchase Plan (in shares)</link:label>
    <link:label id="lab_us-gaap_StockIssuedDuringPeriodSharesEmployeeStockPurchasePlans_label_en-US" xlink:label="lab_us-gaap_StockIssuedDuringPeriodSharesEmployeeStockPurchasePlans" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Stock Issued During Period, Shares, Employee Stock Purchase Plans</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockIssuedDuringPeriodSharesEmployeeStockPurchasePlans" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StockIssuedDuringPeriodSharesEmployeeStockPurchasePlans"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StockIssuedDuringPeriodSharesEmployeeStockPurchasePlans" xlink:to="lab_us-gaap_StockIssuedDuringPeriodSharesEmployeeStockPurchasePlans" xlink:type="arc" order="1"/>
    <link:label id="lab_srt_CounterpartyNameAxis_3bc7ebac-c5f1-4295-b60e-cdd532aa0fc2_terseLabel_en-US" xlink:label="lab_srt_CounterpartyNameAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Counterparty Name</link:label>
    <link:label id="lab_srt_CounterpartyNameAxis_label_en-US" xlink:label="lab_srt_CounterpartyNameAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Counterparty Name [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_srt_CounterpartyNameAxis" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_CounterpartyNameAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_srt_CounterpartyNameAxis" xlink:to="lab_srt_CounterpartyNameAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_dmtk_TwoThousandTenStockPlanMember_7e9ac5fb-b32b-4dd9-8c21-57ce193ced64_terseLabel_en-US" xlink:label="lab_dmtk_TwoThousandTenStockPlanMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">2010 Stock Plan</link:label>
    <link:label id="lab_dmtk_TwoThousandTenStockPlanMember_label_en-US" xlink:label="lab_dmtk_TwoThousandTenStockPlanMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Two Thousand Ten Stock Plan [Member]</link:label>
    <link:label id="lab_dmtk_TwoThousandTenStockPlanMember_documentation_en-US" xlink:label="lab_dmtk_TwoThousandTenStockPlanMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Two thousand ten stock plan.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dmtk_TwoThousandTenStockPlanMember" xlink:href="dmtk-20220630.xsd#dmtk_TwoThousandTenStockPlanMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dmtk_TwoThousandTenStockPlanMember" xlink:to="lab_dmtk_TwoThousandTenStockPlanMember" xlink:type="arc" order="1"/>
    <link:label id="lab_dmtk_TheCompanyAndSummaryOfItsSignificantAccountingPoliciesLineItems_86ffdd0b-43f8-464f-bf5f-25839ed0ad48_terseLabel_en-US" xlink:label="lab_dmtk_TheCompanyAndSummaryOfItsSignificantAccountingPoliciesLineItems" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">The Company and Summary of its Significant Accounting Policies [Line Items]</link:label>
    <link:label id="lab_dmtk_TheCompanyAndSummaryOfItsSignificantAccountingPoliciesLineItems_label_en-US" xlink:label="lab_dmtk_TheCompanyAndSummaryOfItsSignificantAccountingPoliciesLineItems" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">The Company And Summary Of Its Significant Accounting Policies [Line Items]</link:label>
    <link:label id="lab_dmtk_TheCompanyAndSummaryOfItsSignificantAccountingPoliciesLineItems_documentation_en-US" xlink:label="lab_dmtk_TheCompanyAndSummaryOfItsSignificantAccountingPoliciesLineItems" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">The company and summary of its significant accounting policies.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dmtk_TheCompanyAndSummaryOfItsSignificantAccountingPoliciesLineItems" xlink:href="dmtk-20220630.xsd#dmtk_TheCompanyAndSummaryOfItsSignificantAccountingPoliciesLineItems"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dmtk_TheCompanyAndSummaryOfItsSignificantAccountingPoliciesLineItems" xlink:to="lab_dmtk_TheCompanyAndSummaryOfItsSignificantAccountingPoliciesLineItems" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfStockByClassTable_35a3ade3-d512-46ca-b08d-1ba33c0ff5ab_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfStockByClassTable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule Of Stock By Class [Table]</link:label>
    <link:label id="lab_us-gaap_ScheduleOfStockByClassTable_label_en-US" xlink:label="lab_us-gaap_ScheduleOfStockByClassTable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Stock by Class [Table]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfStockByClassTable" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfStockByClassTable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfStockByClassTable" xlink:to="lab_us-gaap_ScheduleOfStockByClassTable" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityIncorporationStateCountryCode_365bbff0-e900-43f1-b9d2-02252eda2985_terseLabel_en-US" xlink:label="lab_dei_EntityIncorporationStateCountryCode" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Incorporation, State or Country Code</link:label>
    <link:label id="lab_dei_EntityIncorporationStateCountryCode_label_en-US" xlink:label="lab_dei_EntityIncorporationStateCountryCode" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Incorporation, State or Country Code</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityIncorporationStateCountryCode" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityIncorporationStateCountryCode"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityIncorporationStateCountryCode" xlink:to="lab_dei_EntityIncorporationStateCountryCode" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FinanceLeaseLiabilityPaymentsDueYearTwo_517622d8-58cf-4ee7-b3ff-417fb25177b9_terseLabel_en-US" xlink:label="lab_us-gaap_FinanceLeaseLiabilityPaymentsDueYearTwo" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">2024</link:label>
    <link:label id="lab_us-gaap_FinanceLeaseLiabilityPaymentsDueYearTwo_label_en-US" xlink:label="lab_us-gaap_FinanceLeaseLiabilityPaymentsDueYearTwo" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Finance Lease, Liability, to be Paid, Year Two</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FinanceLeaseLiabilityPaymentsDueYearTwo" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FinanceLeaseLiabilityPaymentsDueYearTwo"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FinanceLeaseLiabilityPaymentsDueYearTwo" xlink:to="lab_us-gaap_FinanceLeaseLiabilityPaymentsDueYearTwo" xlink:type="arc" order="1"/>
    <link:label id="lab_dmtk_ScheduleOfLongTermFinanceLeaseObligationsTableTextBlock_7e3b9d90-0f4c-42a2-8534-528e740b6270_terseLabel_en-US" xlink:label="lab_dmtk_ScheduleOfLongTermFinanceLeaseObligationsTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Long Term Finance Lease Obligations</link:label>
    <link:label id="lab_dmtk_ScheduleOfLongTermFinanceLeaseObligationsTableTextBlock_label_en-US" xlink:label="lab_dmtk_ScheduleOfLongTermFinanceLeaseObligationsTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule Of Long Term Finance Lease Obligations Table [Text Block]</link:label>
    <link:label id="lab_dmtk_ScheduleOfLongTermFinanceLeaseObligationsTableTextBlock_documentation_en-US" xlink:label="lab_dmtk_ScheduleOfLongTermFinanceLeaseObligationsTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of long term finance lease obligations.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dmtk_ScheduleOfLongTermFinanceLeaseObligationsTableTextBlock" xlink:href="dmtk-20220630.xsd#dmtk_ScheduleOfLongTermFinanceLeaseObligationsTableTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dmtk_ScheduleOfLongTermFinanceLeaseObligationsTableTextBlock" xlink:to="lab_dmtk_ScheduleOfLongTermFinanceLeaseObligationsTableTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_BasisOfAccountingPolicyPolicyTextBlock_4762d82a-5613-447f-8bb5-b612b61937eb_terseLabel_en-US" xlink:label="lab_us-gaap_BasisOfAccountingPolicyPolicyTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Basis of Presentation</link:label>
    <link:label id="lab_us-gaap_BasisOfAccountingPolicyPolicyTextBlock_label_en-US" xlink:label="lab_us-gaap_BasisOfAccountingPolicyPolicyTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Basis of Accounting, Policy [Policy Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BasisOfAccountingPolicyPolicyTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BasisOfAccountingPolicyPolicyTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_BasisOfAccountingPolicyPolicyTextBlock" xlink:to="lab_us-gaap_BasisOfAccountingPolicyPolicyTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PropertyPlantAndEquipmentNet_9bf8b274-a9e4-49a4-a6ed-921384dfe4cb_terseLabel_en-US" xlink:label="lab_us-gaap_PropertyPlantAndEquipmentNet" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Property and equipment, net</link:label>
    <link:label id="lab_us-gaap_PropertyPlantAndEquipmentNet_5f879c8f-117d-4194-bd6e-474c95cc606f_totalLabel_en-US" xlink:label="lab_us-gaap_PropertyPlantAndEquipmentNet" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Total property and equipment, net</link:label>
    <link:label id="lab_us-gaap_PropertyPlantAndEquipmentNet_label_en-US" xlink:label="lab_us-gaap_PropertyPlantAndEquipmentNet" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Property, Plant and Equipment, Net</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentNet" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PropertyPlantAndEquipmentNet"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentNet" xlink:to="lab_us-gaap_PropertyPlantAndEquipmentNet" xlink:type="arc" order="1"/>
    <link:label id="lab_dmtk_LeaseAmendmentsDomain_3c448576-3a29-41ec-9bb1-cd889cbbe321_terseLabel_en-US" xlink:label="lab_dmtk_LeaseAmendmentsDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Lease Amendments [Domain]</link:label>
    <link:label id="lab_dmtk_LeaseAmendmentsDomain_label_en-US" xlink:label="lab_dmtk_LeaseAmendmentsDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Lease Amendments [Domain]</link:label>
    <link:label id="lab_dmtk_LeaseAmendmentsDomain_documentation_en-US" xlink:label="lab_dmtk_LeaseAmendmentsDomain" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Lease Amendments [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dmtk_LeaseAmendmentsDomain" xlink:href="dmtk-20220630.xsd#dmtk_LeaseAmendmentsDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dmtk_LeaseAmendmentsDomain" xlink:to="lab_dmtk_LeaseAmendmentsDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OperatingLeasePayments_aac5a88d-e50b-4fea-862a-9d2e2e1473f0_terseLabel_en-US" xlink:label="lab_us-gaap_OperatingLeasePayments" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Operating cash flows from operating leases</link:label>
    <link:label id="lab_us-gaap_OperatingLeasePayments_label_en-US" xlink:label="lab_us-gaap_OperatingLeasePayments" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Operating Lease, Payments</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeasePayments" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OperatingLeasePayments"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OperatingLeasePayments" xlink:to="lab_us-gaap_OperatingLeasePayments" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityGainLossIncludedInEarnings_2468086a-d521-48e1-a412-127a8d18936f_terseLabel_en-US" xlink:label="lab_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityGainLossIncludedInEarnings" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Change in fair value of warrant liability</link:label>
    <link:label id="lab_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityGainLossIncludedInEarnings_label_en-US" xlink:label="lab_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityGainLossIncludedInEarnings" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Value, Measurement with Unobservable Inputs Reconciliation, Recurring Basis, Liability, Gain (Loss) Included in Earnings</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityGainLossIncludedInEarnings" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityGainLossIncludedInEarnings"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityGainLossIncludedInEarnings" xlink:to="lab_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityGainLossIncludedInEarnings" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_EmployeeStockOptionMember_fe21556e-9e4a-406a-b05d-ae4a0d8280df_terseLabel_en-US" xlink:label="lab_us-gaap_EmployeeStockOptionMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Stock options issued and outstanding</link:label>
    <link:label id="lab_us-gaap_EmployeeStockOptionMember_label_en-US" xlink:label="lab_us-gaap_EmployeeStockOptionMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-Based Payment Arrangement, Option [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EmployeeStockOptionMember" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EmployeeStockOptionMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_EmployeeStockOptionMember" xlink:to="lab_us-gaap_EmployeeStockOptionMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_SellingAndMarketingExpenseMember_9509a25c-48e5-45d5-876d-27c5181c8dd1_terseLabel_en-US" xlink:label="lab_us-gaap_SellingAndMarketingExpenseMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Sales and marketing</link:label>
    <link:label id="lab_us-gaap_SellingAndMarketingExpenseMember_label_en-US" xlink:label="lab_us-gaap_SellingAndMarketingExpenseMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Selling and Marketing Expense [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SellingAndMarketingExpenseMember" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SellingAndMarketingExpenseMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SellingAndMarketingExpenseMember" xlink:to="lab_us-gaap_SellingAndMarketingExpenseMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate_57435944-4d47-4536-8e3f-e735da650b98_terseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Assumed volatility</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-Based Compensation Arrangement by Share-Based Payment Award, Fair Value Assumptions, Expected Volatility Rate</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PropertyPlantAndEquipmentDisposals_5ebef6c5-448c-44c3-9e48-ac9e3bdc8734_terseLabel_en-US" xlink:label="lab_us-gaap_PropertyPlantAndEquipmentDisposals" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Disposal of plant or equipment</link:label>
    <link:label id="lab_us-gaap_PropertyPlantAndEquipmentDisposals_label_en-US" xlink:label="lab_us-gaap_PropertyPlantAndEquipmentDisposals" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Property, Plant and Equipment, Disposals</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentDisposals" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PropertyPlantAndEquipmentDisposals"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentDisposals" xlink:to="lab_us-gaap_PropertyPlantAndEquipmentDisposals" xlink:type="arc" order="1"/>
    <link:label id="lab_dmtk_GrossProceedsFromOfferingBeforeDeductingUnderwritingDiscountsAndCommissionsAndOtherOfferingExpenses_324d63ef-f7e0-46b7-bb64-bf3c427d5302_terseLabel_en-US" xlink:label="lab_dmtk_GrossProceedsFromOfferingBeforeDeductingUnderwritingDiscountsAndCommissionsAndOtherOfferingExpenses" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Gross proceeds from offering, before deducting underwriting discounts and commissions and other offering expenses</link:label>
    <link:label id="lab_dmtk_GrossProceedsFromOfferingBeforeDeductingUnderwritingDiscountsAndCommissionsAndOtherOfferingExpenses_label_en-US" xlink:label="lab_dmtk_GrossProceedsFromOfferingBeforeDeductingUnderwritingDiscountsAndCommissionsAndOtherOfferingExpenses" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Gross Proceeds From Offering Before Deducting Underwriting Discounts And Commissions And Other Offering Expenses</link:label>
    <link:label id="lab_dmtk_GrossProceedsFromOfferingBeforeDeductingUnderwritingDiscountsAndCommissionsAndOtherOfferingExpenses_documentation_en-US" xlink:label="lab_dmtk_GrossProceedsFromOfferingBeforeDeductingUnderwritingDiscountsAndCommissionsAndOtherOfferingExpenses" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Gross proceeds from offering, before deducting underwriting discounts and commissions and other offering expenses.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dmtk_GrossProceedsFromOfferingBeforeDeductingUnderwritingDiscountsAndCommissionsAndOtherOfferingExpenses" xlink:href="dmtk-20220630.xsd#dmtk_GrossProceedsFromOfferingBeforeDeductingUnderwritingDiscountsAndCommissionsAndOtherOfferingExpenses"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dmtk_GrossProceedsFromOfferingBeforeDeductingUnderwritingDiscountsAndCommissionsAndOtherOfferingExpenses" xlink:to="lab_dmtk_GrossProceedsFromOfferingBeforeDeductingUnderwritingDiscountsAndCommissionsAndOtherOfferingExpenses" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_BalanceSheetLocationAxis_81204217-ee51-42f2-958d-a0e43c9092c9_terseLabel_en-US" xlink:label="lab_us-gaap_BalanceSheetLocationAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Balance Sheet Location</link:label>
    <link:label id="lab_us-gaap_BalanceSheetLocationAxis_label_en-US" xlink:label="lab_us-gaap_BalanceSheetLocationAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Balance Sheet Location [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BalanceSheetLocationAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BalanceSheetLocationAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_BalanceSheetLocationAxis" xlink:to="lab_us-gaap_BalanceSheetLocationAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_SaleOfStockPricePerShare_50f24e64-76a6-4040-9759-31464d704a62_terseLabel_en-US" xlink:label="lab_us-gaap_SaleOfStockPricePerShare" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Public offering price (in usd per share)</link:label>
    <link:label id="lab_us-gaap_SaleOfStockPricePerShare_label_en-US" xlink:label="lab_us-gaap_SaleOfStockPricePerShare" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Sale of Stock, Price Per Share</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SaleOfStockPricePerShare" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SaleOfStockPricePerShare"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SaleOfStockPricePerShare" xlink:to="lab_us-gaap_SaleOfStockPricePerShare" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CommonStockSharesAuthorized_0b63e3bc-8182-41ed-9db6-7291f9670baa_terseLabel_en-US" xlink:label="lab_us-gaap_CommonStockSharesAuthorized" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Common stock, shares authorized (in shares)</link:label>
    <link:label id="lab_us-gaap_CommonStockSharesAuthorized_label_en-US" xlink:label="lab_us-gaap_CommonStockSharesAuthorized" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Common Stock, Shares Authorized</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockSharesAuthorized" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CommonStockSharesAuthorized"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CommonStockSharesAuthorized" xlink:to="lab_us-gaap_CommonStockSharesAuthorized" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfRelatedPartyTransactionsByRelatedPartyTable_ebe56aee-3697-4f78-b70c-375b5d3827ca_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfRelatedPartyTransactionsByRelatedPartyTable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule Of Related Party Transactions By Related Party [Table]</link:label>
    <link:label id="lab_us-gaap_ScheduleOfRelatedPartyTransactionsByRelatedPartyTable_label_en-US" xlink:label="lab_us-gaap_ScheduleOfRelatedPartyTransactionsByRelatedPartyTable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Related Party Transactions, by Related Party [Table]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfRelatedPartyTransactionsByRelatedPartyTable" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfRelatedPartyTransactionsByRelatedPartyTable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfRelatedPartyTransactionsByRelatedPartyTable" xlink:to="lab_us-gaap_ScheduleOfRelatedPartyTransactionsByRelatedPartyTable" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_StatementOfIncomeAndComprehensiveIncomeAbstract_label_en-US" xlink:label="lab_us-gaap_StatementOfIncomeAndComprehensiveIncomeAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Statement of Comprehensive Income [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementOfIncomeAndComprehensiveIncomeAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StatementOfIncomeAndComprehensiveIncomeAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StatementOfIncomeAndComprehensiveIncomeAbstract" xlink:to="lab_us-gaap_StatementOfIncomeAndComprehensiveIncomeAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ClassOfWarrantOrRightAxis_5cbdecc5-8f50-4356-9a58-6708135ea76b_terseLabel_en-US" xlink:label="lab_us-gaap_ClassOfWarrantOrRightAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Class of Warrant or Right</link:label>
    <link:label id="lab_us-gaap_ClassOfWarrantOrRightAxis_label_en-US" xlink:label="lab_us-gaap_ClassOfWarrantOrRightAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Class of Warrant or Right [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ClassOfWarrantOrRightAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ClassOfWarrantOrRightAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ClassOfWarrantOrRightAxis" xlink:to="lab_us-gaap_ClassOfWarrantOrRightAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OperatingExpenses_3cf46515-95de-4da4-9fb4-3df8538ba74f_totalLabel_en-US" xlink:label="lab_us-gaap_OperatingExpenses" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Total operating expenses</link:label>
    <link:label id="lab_us-gaap_OperatingExpenses_label_en-US" xlink:label="lab_us-gaap_OperatingExpenses" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Operating Expenses</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingExpenses" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OperatingExpenses"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OperatingExpenses" xlink:to="lab_us-gaap_OperatingExpenses" xlink:type="arc" order="1"/>
    <link:label id="lab_srt_MaximumMember_27c1024e-803b-46dd-ae3f-9eb7f00e57e3_terseLabel_en-US" xlink:label="lab_srt_MaximumMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Maximum</link:label>
    <link:label id="lab_srt_MaximumMember_label_en-US" xlink:label="lab_srt_MaximumMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Maximum [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_srt_MaximumMember" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_MaximumMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_srt_MaximumMember" xlink:to="lab_srt_MaximumMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax_e6420177-8d2d-47b4-9b86-9fc2fcdef492_terseLabel_en-US" xlink:label="lab_us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accumulated other comprehensive loss</link:label>
    <link:label id="lab_us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax_label_en-US" xlink:label="lab_us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accumulated Other Comprehensive Income (Loss), Net of Tax</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax" xlink:to="lab_us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax" xlink:type="arc" order="1"/>
    <link:label id="lab_dmtk_StockIssuedDuringPeriodValueStockOptionsExercisedAndRSURelease_d9e51edc-935a-4441-8061-60f90ffa6349_terseLabel_en-US" xlink:label="lab_dmtk_StockIssuedDuringPeriodValueStockOptionsExercisedAndRSURelease" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Issuance of common stock from option exercises and RSU releases</link:label>
    <link:label id="lab_dmtk_StockIssuedDuringPeriodValueStockOptionsExercisedAndRSURelease_label_en-US" xlink:label="lab_dmtk_StockIssuedDuringPeriodValueStockOptionsExercisedAndRSURelease" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Stock Issued During Period, Value, Stock Options Exercised And RSU Release</link:label>
    <link:label id="lab_dmtk_StockIssuedDuringPeriodValueStockOptionsExercisedAndRSURelease_documentation_en-US" xlink:label="lab_dmtk_StockIssuedDuringPeriodValueStockOptionsExercisedAndRSURelease" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Stock issued during period value stock options exercised and RSU release.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dmtk_StockIssuedDuringPeriodValueStockOptionsExercisedAndRSURelease" xlink:href="dmtk-20220630.xsd#dmtk_StockIssuedDuringPeriodValueStockOptionsExercisedAndRSURelease"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dmtk_StockIssuedDuringPeriodValueStockOptionsExercisedAndRSURelease" xlink:to="lab_dmtk_StockIssuedDuringPeriodValueStockOptionsExercisedAndRSURelease" xlink:type="arc" order="1"/>
    <link:label id="lab_dmtk_CreditLosses_61718382-6d55-49be-b6f6-b5195d97b691_terseLabel_en-US" xlink:label="lab_dmtk_CreditLosses" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Credit losses</link:label>
    <link:label id="lab_dmtk_CreditLosses_label_en-US" xlink:label="lab_dmtk_CreditLosses" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Credit Losses</link:label>
    <link:label id="lab_dmtk_CreditLosses_documentation_en-US" xlink:label="lab_dmtk_CreditLosses" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Credit Losses</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dmtk_CreditLosses" xlink:href="dmtk-20220630.xsd#dmtk_CreditLosses"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dmtk_CreditLosses" xlink:to="lab_dmtk_CreditLosses" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CashAndCashEquivalentsRestrictedCashAndCashEquivalentsPolicy_77edde68-e8b7-4b20-ba05-c0e070417b8d_terseLabel_en-US" xlink:label="lab_us-gaap_CashAndCashEquivalentsRestrictedCashAndCashEquivalentsPolicy" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cash, Cash Equivalents and Restricted Cash</link:label>
    <link:label id="lab_us-gaap_CashAndCashEquivalentsRestrictedCashAndCashEquivalentsPolicy_label_en-US" xlink:label="lab_us-gaap_CashAndCashEquivalentsRestrictedCashAndCashEquivalentsPolicy" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cash and Cash Equivalents, Restricted Cash and Cash Equivalents, Policy [Policy Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashAndCashEquivalentsRestrictedCashAndCashEquivalentsPolicy" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CashAndCashEquivalentsRestrictedCashAndCashEquivalentsPolicy"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CashAndCashEquivalentsRestrictedCashAndCashEquivalentsPolicy" xlink:to="lab_us-gaap_CashAndCashEquivalentsRestrictedCashAndCashEquivalentsPolicy" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CashAndCashEquivalentsAtCarryingValue_25553674-3bbb-4adc-9ce4-5ccecfb0c78e_terseLabel_en-US" xlink:label="lab_us-gaap_CashAndCashEquivalentsAtCarryingValue" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cash and cash equivalents</link:label>
    <link:label id="lab_us-gaap_CashAndCashEquivalentsAtCarryingValue_label_en-US" xlink:label="lab_us-gaap_CashAndCashEquivalentsAtCarryingValue" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cash and Cash Equivalents, at Carrying Value</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashAndCashEquivalentsAtCarryingValue" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CashAndCashEquivalentsAtCarryingValue"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CashAndCashEquivalentsAtCarryingValue" xlink:to="lab_us-gaap_CashAndCashEquivalentsAtCarryingValue" xlink:type="arc" order="1"/>
    <link:label id="lab_dmtk_PlacementAgentWarrantsMember_b3e71bfb-e90b-4545-9741-c8cf7dd60d37_terseLabel_en-US" xlink:label="lab_dmtk_PlacementAgentWarrantsMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Placement Agent Warrants</link:label>
    <link:label id="lab_dmtk_PlacementAgentWarrantsMember_label_en-US" xlink:label="lab_dmtk_PlacementAgentWarrantsMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Placement Agent Warrants [Member]</link:label>
    <link:label id="lab_dmtk_PlacementAgentWarrantsMember_documentation_en-US" xlink:label="lab_dmtk_PlacementAgentWarrantsMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Placement agent warrants.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dmtk_PlacementAgentWarrantsMember" xlink:href="dmtk-20220630.xsd#dmtk_PlacementAgentWarrantsMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dmtk_PlacementAgentWarrantsMember" xlink:to="lab_dmtk_PlacementAgentWarrantsMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AssetsCurrent_016f543b-6de8-4089-80ea-addd5c3aec0d_totalLabel_en-US" xlink:label="lab_us-gaap_AssetsCurrent" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Total current assets</link:label>
    <link:label id="lab_us-gaap_AssetsCurrent_label_en-US" xlink:label="lab_us-gaap_AssetsCurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Assets, Current</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AssetsCurrent" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AssetsCurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AssetsCurrent" xlink:to="lab_us-gaap_AssetsCurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_dmtk_TwoThousandEighteenConvertibleBridgeNotesMember_16d62d20-49b2-4e81-a544-481c66e23528_terseLabel_en-US" xlink:label="lab_dmtk_TwoThousandEighteenConvertibleBridgeNotesMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">2018 Convertible Bridge Notes</link:label>
    <link:label id="lab_dmtk_TwoThousandEighteenConvertibleBridgeNotesMember_label_en-US" xlink:label="lab_dmtk_TwoThousandEighteenConvertibleBridgeNotesMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Two Thousand Eighteen Convertible Bridge Notes [Member]</link:label>
    <link:label id="lab_dmtk_TwoThousandEighteenConvertibleBridgeNotesMember_documentation_en-US" xlink:label="lab_dmtk_TwoThousandEighteenConvertibleBridgeNotesMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Two thousand eighteen convertible bridge notes.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dmtk_TwoThousandEighteenConvertibleBridgeNotesMember" xlink:href="dmtk-20220630.xsd#dmtk_TwoThousandEighteenConvertibleBridgeNotesMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dmtk_TwoThousandEighteenConvertibleBridgeNotesMember" xlink:to="lab_dmtk_TwoThousandEighteenConvertibleBridgeNotesMember" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntitySmallBusiness_3da99ace-2ba4-46b1-970b-76293817b87f_terseLabel_en-US" xlink:label="lab_dei_EntitySmallBusiness" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Small Business</link:label>
    <link:label id="lab_dei_EntitySmallBusiness_label_en-US" xlink:label="lab_dei_EntitySmallBusiness" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Small Business</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntitySmallBusiness" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntitySmallBusiness"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntitySmallBusiness" xlink:to="lab_dei_EntitySmallBusiness" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_SharesOutstanding_2e71e91c-c16f-4dc4-9d1c-baa2de58218c_periodStartLabel_en-US" xlink:label="lab_us-gaap_SharesOutstanding" xlink:role="http://www.xbrl.org/2003/role/periodStartLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Beginning balance (in shares)</link:label>
    <link:label id="lab_us-gaap_SharesOutstanding_c4112d20-eb2c-4129-b60c-6275321b25a4_periodEndLabel_en-US" xlink:label="lab_us-gaap_SharesOutstanding" xlink:role="http://www.xbrl.org/2003/role/periodEndLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Ending balance (in shares)</link:label>
    <link:label id="lab_us-gaap_SharesOutstanding_label_en-US" xlink:label="lab_us-gaap_SharesOutstanding" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Shares, Outstanding</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SharesOutstanding" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SharesOutstanding"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SharesOutstanding" xlink:to="lab_us-gaap_SharesOutstanding" xlink:type="arc" order="1"/>
    <link:label id="lab_dmtk_IncentiveAndNonQualifiedStockOptionsMember_bda98f18-aba2-41dd-b861-cb2c63e76982_terseLabel_en-US" xlink:label="lab_dmtk_IncentiveAndNonQualifiedStockOptionsMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Incentive and Non-qualified Stock Options</link:label>
    <link:label id="lab_dmtk_IncentiveAndNonQualifiedStockOptionsMember_label_en-US" xlink:label="lab_dmtk_IncentiveAndNonQualifiedStockOptionsMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Incentive And Non Qualified Stock Options [Member]</link:label>
    <link:label id="lab_dmtk_IncentiveAndNonQualifiedStockOptionsMember_documentation_en-US" xlink:label="lab_dmtk_IncentiveAndNonQualifiedStockOptionsMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Incentive and non-qualified stock options.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dmtk_IncentiveAndNonQualifiedStockOptionsMember" xlink:href="dmtk-20220630.xsd#dmtk_IncentiveAndNonQualifiedStockOptionsMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dmtk_IncentiveAndNonQualifiedStockOptionsMember" xlink:to="lab_dmtk_IncentiveAndNonQualifiedStockOptionsMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_StockholdersEquityNoteDisclosureTextBlock_d934ee54-09aa-4df4-bd4a-a3dc59b758b9_terseLabel_en-US" xlink:label="lab_us-gaap_StockholdersEquityNoteDisclosureTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Stockholders' Equity</link:label>
    <link:label id="lab_us-gaap_StockholdersEquityNoteDisclosureTextBlock_label_en-US" xlink:label="lab_us-gaap_StockholdersEquityNoteDisclosureTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Stockholders' Equity Note Disclosure [Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockholdersEquityNoteDisclosureTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StockholdersEquityNoteDisclosureTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StockholdersEquityNoteDisclosureTextBlock" xlink:to="lab_us-gaap_StockholdersEquityNoteDisclosureTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FairValueMeasurementFrequencyDomain_8f148101-533e-406a-80a9-970a324dae04_terseLabel_en-US" xlink:label="lab_us-gaap_FairValueMeasurementFrequencyDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Measurement Frequency</link:label>
    <link:label id="lab_us-gaap_FairValueMeasurementFrequencyDomain_label_en-US" xlink:label="lab_us-gaap_FairValueMeasurementFrequencyDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Measurement Frequency [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueMeasurementFrequencyDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueMeasurementFrequencyDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FairValueMeasurementFrequencyDomain" xlink:to="lab_us-gaap_FairValueMeasurementFrequencyDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OperatingLeaseRightOfUseAssetAmortizationExpense_6b20cc4e-baa1-4b5c-8eb4-b4f2b1570722_terseLabel_en-US" xlink:label="lab_us-gaap_OperatingLeaseRightOfUseAssetAmortizationExpense" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Amortization of operating lease right-of-use assets</link:label>
    <link:label id="lab_us-gaap_OperatingLeaseRightOfUseAssetAmortizationExpense_label_en-US" xlink:label="lab_us-gaap_OperatingLeaseRightOfUseAssetAmortizationExpense" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Operating Lease, Right-of-Use Asset, Amortization Expense</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeaseRightOfUseAssetAmortizationExpense" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OperatingLeaseRightOfUseAssetAmortizationExpense"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OperatingLeaseRightOfUseAssetAmortizationExpense" xlink:to="lab_us-gaap_OperatingLeaseRightOfUseAssetAmortizationExpense" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_RevenuesAbstract_12441129-3938-4f25-8883-ad059b3b8f79_terseLabel_en-US" xlink:label="lab_us-gaap_RevenuesAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Revenues:</link:label>
    <link:label id="lab_us-gaap_RevenuesAbstract_label_en-US" xlink:label="lab_us-gaap_RevenuesAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Revenues [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevenuesAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RevenuesAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_RevenuesAbstract" xlink:to="lab_us-gaap_RevenuesAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_dmtk_WarrantsToPurchaseCommonStockMember_7414319f-46fe-4068-acbf-a7faa0a33b8b_terseLabel_en-US" xlink:label="lab_dmtk_WarrantsToPurchaseCommonStockMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Warrants to purchase common stock</link:label>
    <link:label id="lab_dmtk_WarrantsToPurchaseCommonStockMember_label_en-US" xlink:label="lab_dmtk_WarrantsToPurchaseCommonStockMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Warrants To Purchase Common Stock [Member]</link:label>
    <link:label id="lab_dmtk_WarrantsToPurchaseCommonStockMember_documentation_en-US" xlink:label="lab_dmtk_WarrantsToPurchaseCommonStockMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Warrants to purchase common stock.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dmtk_WarrantsToPurchaseCommonStockMember" xlink:href="dmtk-20220630.xsd#dmtk_WarrantsToPurchaseCommonStockMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dmtk_WarrantsToPurchaseCommonStockMember" xlink:to="lab_dmtk_WarrantsToPurchaseCommonStockMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_RestrictedCash_f40f9d58-7cd2-4705-9c34-4c33a98e685b_terseLabel_en-US" xlink:label="lab_us-gaap_RestrictedCash" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Restricted cash</link:label>
    <link:label id="lab_us-gaap_RestrictedCash_label_en-US" xlink:label="lab_us-gaap_RestrictedCash" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Restricted Cash</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestrictedCash" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RestrictedCash"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_RestrictedCash" xlink:to="lab_us-gaap_RestrictedCash" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionPeriod1_a5505967-98b2-4887-bf33-ee2403a91a1c_terseLabel_en-US" xlink:label="lab_us-gaap_RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionPeriod1" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Revenue, remaining performance obligation, expected timing of satisfaction, period</link:label>
    <link:label id="lab_us-gaap_RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionPeriod1_label_en-US" xlink:label="lab_us-gaap_RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionPeriod1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Revenue, Remaining Performance Obligation, Expected Timing of Satisfaction, Period</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionPeriod1" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionPeriod1"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionPeriod1" xlink:to="lab_us-gaap_RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionPeriod1" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized_4edfb255-0fa7-46a9-a6d5-846b7b23d0a8_terseLabel_en-US" xlink:label="lab_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Compensation cost related to non-vested awards not yet recognized</link:label>
    <link:label id="lab_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized_label_en-US" xlink:label="lab_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-Based Payment Arrangement, Nonvested Award, Cost Not yet Recognized, Amount</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized" xlink:to="lab_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_InterestIncomeMember_6f43fb4d-5b79-4b3c-86ef-ec74695df8c3_terseLabel_en-US" xlink:label="lab_us-gaap_InterestIncomeMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Interest Income, Net</link:label>
    <link:label id="lab_us-gaap_InterestIncomeMember_label_en-US" xlink:label="lab_us-gaap_InterestIncomeMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Interest Income [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InterestIncomeMember" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_InterestIncomeMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_InterestIncomeMember" xlink:to="lab_us-gaap_InterestIncomeMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PropertyPlantAndEquipmentTypeDomain_3dbbdaa9-0465-45f5-9a69-f031f8e067ee_terseLabel_en-US" xlink:label="lab_us-gaap_PropertyPlantAndEquipmentTypeDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Long-Lived Tangible Asset</link:label>
    <link:label id="lab_us-gaap_PropertyPlantAndEquipmentTypeDomain_label_en-US" xlink:label="lab_us-gaap_PropertyPlantAndEquipmentTypeDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Long-Lived Tangible Asset [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentTypeDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PropertyPlantAndEquipmentTypeDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentTypeDomain" xlink:to="lab_us-gaap_PropertyPlantAndEquipmentTypeDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncreaseDecreaseInAccountsReceivable_73e506c6-2a99-4260-8bb8-4972c8df522c_negatedLabel_en-US" xlink:label="lab_us-gaap_IncreaseDecreaseInAccountsReceivable" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accounts receivable</link:label>
    <link:label id="lab_us-gaap_IncreaseDecreaseInAccountsReceivable_label_en-US" xlink:label="lab_us-gaap_IncreaseDecreaseInAccountsReceivable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Increase (Decrease) in Accounts Receivable</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInAccountsReceivable" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncreaseDecreaseInAccountsReceivable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncreaseDecreaseInAccountsReceivable" xlink:to="lab_us-gaap_IncreaseDecreaseInAccountsReceivable" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_Security12bTitle_e9901c98-e0b9-4698-8c1b-b76ba03b5124_verboseLabel_en-US" xlink:label="lab_dei_Security12bTitle" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Title of 12(b) Security</link:label>
    <link:label id="lab_dei_Security12bTitle_label_en-US" xlink:label="lab_dei_Security12bTitle" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Title of 12(b) Security</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_Security12bTitle" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_Security12bTitle"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_Security12bTitle" xlink:to="lab_dei_Security12bTitle" xlink:type="arc" order="1"/>
    <link:label id="lab_dmtk_RentableAndUsableSquareFeet_3ead0508-5d14-4a29-b317-53cd0feb67ae_terseLabel_en-US" xlink:label="lab_dmtk_RentableAndUsableSquareFeet" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Expansion premise (in square feet)</link:label>
    <link:label id="lab_dmtk_RentableAndUsableSquareFeet_label_en-US" xlink:label="lab_dmtk_RentableAndUsableSquareFeet" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Rentable And Usable Square Feet</link:label>
    <link:label id="lab_dmtk_RentableAndUsableSquareFeet_documentation_en-US" xlink:label="lab_dmtk_RentableAndUsableSquareFeet" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Rentable And Usable Square Feet</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dmtk_RentableAndUsableSquareFeet" xlink:href="dmtk-20220630.xsd#dmtk_RentableAndUsableSquareFeet"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dmtk_RentableAndUsableSquareFeet" xlink:to="lab_dmtk_RentableAndUsableSquareFeet" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ClassOfStockLineItems_a66a3b37-1793-4575-aea5-01d686797a0a_terseLabel_en-US" xlink:label="lab_us-gaap_ClassOfStockLineItems" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Class of Stock [Line Items]</link:label>
    <link:label id="lab_us-gaap_ClassOfStockLineItems_label_en-US" xlink:label="lab_us-gaap_ClassOfStockLineItems" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Class of Stock [Line Items]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ClassOfStockLineItems" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ClassOfStockLineItems"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ClassOfStockLineItems" xlink:to="lab_us-gaap_ClassOfStockLineItems" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OperatingLeaseLiability_abbb43e2-eb42-41f4-ae65-b07699501796_terseLabel_en-US" xlink:label="lab_us-gaap_OperatingLeaseLiability" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Operating lease liabilities, net</link:label>
    <link:label id="lab_us-gaap_OperatingLeaseLiability_label_en-US" xlink:label="lab_us-gaap_OperatingLeaseLiability" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Operating Lease, Liability</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeaseLiability" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OperatingLeaseLiability"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OperatingLeaseLiability" xlink:to="lab_us-gaap_OperatingLeaseLiability" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AccretionAmortizationOfDiscountsAndPremiumsInvestments_307365c2-2439-43da-a7be-c7aa7fd3659a_negatedLabel_en-US" xlink:label="lab_us-gaap_AccretionAmortizationOfDiscountsAndPremiumsInvestments" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Amortization of premiums, net of accretion of discounts on marketable securities</link:label>
    <link:label id="lab_us-gaap_AccretionAmortizationOfDiscountsAndPremiumsInvestments_label_en-US" xlink:label="lab_us-gaap_AccretionAmortizationOfDiscountsAndPremiumsInvestments" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accretion (Amortization) of Discounts and Premiums, Investments</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccretionAmortizationOfDiscountsAndPremiumsInvestments" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AccretionAmortizationOfDiscountsAndPremiumsInvestments"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AccretionAmortizationOfDiscountsAndPremiumsInvestments" xlink:to="lab_us-gaap_AccretionAmortizationOfDiscountsAndPremiumsInvestments" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FinanceLeaseLiabilityPaymentsDue_cc77ee1b-7426-45a5-8133-1f11b099bf2b_totalLabel_en-US" xlink:label="lab_us-gaap_FinanceLeaseLiabilityPaymentsDue" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Gross finance lease obligations</link:label>
    <link:label id="lab_us-gaap_FinanceLeaseLiabilityPaymentsDue_56aee6db-13fc-4764-a70a-2ff7049b2fff_terseLabel_en-US" xlink:label="lab_us-gaap_FinanceLeaseLiabilityPaymentsDue" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Gross finance lease obligations</link:label>
    <link:label id="lab_us-gaap_FinanceLeaseLiabilityPaymentsDue_label_en-US" xlink:label="lab_us-gaap_FinanceLeaseLiabilityPaymentsDue" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Finance Lease, Liability, to be Paid</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FinanceLeaseLiabilityPaymentsDue" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FinanceLeaseLiabilityPaymentsDue"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FinanceLeaseLiabilityPaymentsDue" xlink:to="lab_us-gaap_FinanceLeaseLiabilityPaymentsDue" xlink:type="arc" order="1"/>
    <link:label id="lab_dmtk_ContractRevenueAdhesivePatchKitsMember_59b6a803-bfd8-45d4-a948-6d5c812544a4_terseLabel_en-US" xlink:label="lab_dmtk_ContractRevenueAdhesivePatchKitsMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Adhesive patch kits</link:label>
    <link:label id="lab_dmtk_ContractRevenueAdhesivePatchKitsMember_label_en-US" xlink:label="lab_dmtk_ContractRevenueAdhesivePatchKitsMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Contract Revenue Adhesive Patch Kits [Member]</link:label>
    <link:label id="lab_dmtk_ContractRevenueAdhesivePatchKitsMember_documentation_en-US" xlink:label="lab_dmtk_ContractRevenueAdhesivePatchKitsMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Contract revenue, adhesive patch kits.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dmtk_ContractRevenueAdhesivePatchKitsMember" xlink:href="dmtk-20220630.xsd#dmtk_ContractRevenueAdhesivePatchKitsMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dmtk_ContractRevenueAdhesivePatchKitsMember" xlink:to="lab_dmtk_ContractRevenueAdhesivePatchKitsMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CashUninsuredAmount_fefcf020-3271-4919-ab34-17bbaa7cb757_terseLabel_en-US" xlink:label="lab_us-gaap_CashUninsuredAmount" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cash held in excess of FDIC limit</link:label>
    <link:label id="lab_us-gaap_CashUninsuredAmount_label_en-US" xlink:label="lab_us-gaap_CashUninsuredAmount" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cash, Uninsured Amount</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashUninsuredAmount" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CashUninsuredAmount"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CashUninsuredAmount" xlink:to="lab_us-gaap_CashUninsuredAmount" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LiabilitiesAndStockholdersEquityAbstract_bbd47bb9-803e-4273-bd43-854b4691b3bd_terseLabel_en-US" xlink:label="lab_us-gaap_LiabilitiesAndStockholdersEquityAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Liabilities and Stockholders&#8217; Equity</link:label>
    <link:label id="lab_us-gaap_LiabilitiesAndStockholdersEquityAbstract_label_en-US" xlink:label="lab_us-gaap_LiabilitiesAndStockholdersEquityAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Liabilities and Equity [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilitiesAndStockholdersEquityAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LiabilitiesAndStockholdersEquityAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LiabilitiesAndStockholdersEquityAbstract" xlink:to="lab_us-gaap_LiabilitiesAndStockholdersEquityAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AvailableForSaleDebtSecuritiesAmortizedCostBasis_3d167b5d-e708-4707-8b66-079560b68dab_totalLabel_en-US" xlink:label="lab_us-gaap_AvailableForSaleDebtSecuritiesAmortizedCostBasis" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Amortized Cost</link:label>
    <link:label id="lab_us-gaap_AvailableForSaleDebtSecuritiesAmortizedCostBasis_label_en-US" xlink:label="lab_us-gaap_AvailableForSaleDebtSecuritiesAmortizedCostBasis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Securities, Available-for-Sale, Amortized Cost</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AvailableForSaleDebtSecuritiesAmortizedCostBasis" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AvailableForSaleDebtSecuritiesAmortizedCostBasis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AvailableForSaleDebtSecuritiesAmortizedCostBasis" xlink:to="lab_us-gaap_AvailableForSaleDebtSecuritiesAmortizedCostBasis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable_1b63e65b-6d7c-4728-a7f0-3ad169d3f11a_terseLabel_en-US" xlink:label="lab_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Value Assets And Liabilities Measured On Recurring And Nonrecurring Basis [Table]</link:label>
    <link:label id="lab_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable_label_en-US" xlink:label="lab_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Value, Recurring and Nonrecurring [Table]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable" xlink:to="lab_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable" xlink:type="arc" order="1"/>
    <link:label id="lab_dmtk_FinanceLeaseCostsAbstract_0ad561b2-1733-4908-9445-0d7c3bb2effb_terseLabel_en-US" xlink:label="lab_dmtk_FinanceLeaseCostsAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Finance lease cost</link:label>
    <link:label id="lab_dmtk_FinanceLeaseCostsAbstract_label_en-US" xlink:label="lab_dmtk_FinanceLeaseCostsAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Finance Lease Costs [Abstract]</link:label>
    <link:label id="lab_dmtk_FinanceLeaseCostsAbstract_documentation_en-US" xlink:label="lab_dmtk_FinanceLeaseCostsAbstract" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Finance lease cost.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dmtk_FinanceLeaseCostsAbstract" xlink:href="dmtk-20220630.xsd#dmtk_FinanceLeaseCostsAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dmtk_FinanceLeaseCostsAbstract" xlink:to="lab_dmtk_FinanceLeaseCostsAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_InventoryNet_768a7844-6abf-4b06-8c93-c15170aa8ebf_terseLabel_en-US" xlink:label="lab_us-gaap_InventoryNet" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Inventory</link:label>
    <link:label id="lab_us-gaap_InventoryNet_label_en-US" xlink:label="lab_us-gaap_InventoryNet" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Inventory, Net</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InventoryNet" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_InventoryNet"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_InventoryNet" xlink:to="lab_us-gaap_InventoryNet" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AccountsPayableCurrent_704b2377-1c3d-45ec-84cb-222644ac7d58_terseLabel_en-US" xlink:label="lab_us-gaap_AccountsPayableCurrent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accounts payable</link:label>
    <link:label id="lab_us-gaap_AccountsPayableCurrent_label_en-US" xlink:label="lab_us-gaap_AccountsPayableCurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accounts Payable, Current</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccountsPayableCurrent" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AccountsPayableCurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AccountsPayableCurrent" xlink:to="lab_us-gaap_AccountsPayableCurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_dmtk_ChangeInUnrealizedGainLossOnAvailableForSaleMarketableSecurities_1638b9a8-96e0-48f0-9215-f27c5e3537ce_terseLabel_en-US" xlink:label="lab_dmtk_ChangeInUnrealizedGainLossOnAvailableForSaleMarketableSecurities" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Change in net unrealized (losses)/gains on available-for-sale marketable securities</link:label>
    <link:label id="lab_dmtk_ChangeInUnrealizedGainLossOnAvailableForSaleMarketableSecurities_label_en-US" xlink:label="lab_dmtk_ChangeInUnrealizedGainLossOnAvailableForSaleMarketableSecurities" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Change In Unrealized Gain (Loss) On Available For Sale Marketable Securities</link:label>
    <link:label id="lab_dmtk_ChangeInUnrealizedGainLossOnAvailableForSaleMarketableSecurities_documentation_en-US" xlink:label="lab_dmtk_ChangeInUnrealizedGainLossOnAvailableForSaleMarketableSecurities" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Change in unrealized gain loss on available-for-sale marketable securities.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dmtk_ChangeInUnrealizedGainLossOnAvailableForSaleMarketableSecurities" xlink:href="dmtk-20220630.xsd#dmtk_ChangeInUnrealizedGainLossOnAvailableForSaleMarketableSecurities"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dmtk_ChangeInUnrealizedGainLossOnAvailableForSaleMarketableSecurities" xlink:to="lab_dmtk_ChangeInUnrealizedGainLossOnAvailableForSaleMarketableSecurities" xlink:type="arc" order="1"/>
    <link:label id="lab_dmtk_LesseeOperatingLeaseLiabilityToBePaidAfterYearFour_16d85de8-e342-49ac-96d2-8ad725f982d3_terseLabel_en-US" xlink:label="lab_dmtk_LesseeOperatingLeaseLiabilityToBePaidAfterYearFour" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Thereafter</link:label>
    <link:label id="lab_dmtk_LesseeOperatingLeaseLiabilityToBePaidAfterYearFour_label_en-US" xlink:label="lab_dmtk_LesseeOperatingLeaseLiabilityToBePaidAfterYearFour" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Lessee, Operating Lease, Liability, to be Paid, after Year Four</link:label>
    <link:label id="lab_dmtk_LesseeOperatingLeaseLiabilityToBePaidAfterYearFour_documentation_en-US" xlink:label="lab_dmtk_LesseeOperatingLeaseLiabilityToBePaidAfterYearFour" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Lessee, Operating Lease, Liability, to be Paid, after Year Four</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dmtk_LesseeOperatingLeaseLiabilityToBePaidAfterYearFour" xlink:href="dmtk-20220630.xsd#dmtk_LesseeOperatingLeaseLiabilityToBePaidAfterYearFour"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dmtk_LesseeOperatingLeaseLiabilityToBePaidAfterYearFour" xlink:to="lab_dmtk_LesseeOperatingLeaseLiabilityToBePaidAfterYearFour" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfProductInformationTable_090ca679-ee88-4957-ae79-fa77f55c7520_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfProductInformationTable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule Of Product Information [Table]</link:label>
    <link:label id="lab_us-gaap_ScheduleOfProductInformationTable_label_en-US" xlink:label="lab_us-gaap_ScheduleOfProductInformationTable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Product Information [Table]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfProductInformationTable" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfProductInformationTable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfProductInformationTable" xlink:to="lab_us-gaap_ScheduleOfProductInformationTable" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_NatureOfOperations_bf419c6b-9e42-4332-abc1-5c9841453c51_terseLabel_en-US" xlink:label="lab_us-gaap_NatureOfOperations" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Nature of Operations</link:label>
    <link:label id="lab_us-gaap_NatureOfOperations_label_en-US" xlink:label="lab_us-gaap_NatureOfOperations" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Nature of Operations [Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NatureOfOperations" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NatureOfOperations"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_NatureOfOperations" xlink:to="lab_us-gaap_NatureOfOperations" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_WarrantMember_8e0db5d0-2ca0-4f69-8e23-3198ebc8063b_verboseLabel_en-US" xlink:label="lab_us-gaap_WarrantMember" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Common Stock Warrants</link:label>
    <link:label id="lab_us-gaap_WarrantMember_label_en-US" xlink:label="lab_us-gaap_WarrantMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Warrant [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_WarrantMember" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_WarrantMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_WarrantMember" xlink:to="lab_us-gaap_WarrantMember" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityFilerCategory_8243c0dc-7b87-4009-84b6-88f589ccbf6a_terseLabel_en-US" xlink:label="lab_dei_EntityFilerCategory" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Filer Category</link:label>
    <link:label id="lab_dei_EntityFilerCategory_label_en-US" xlink:label="lab_dei_EntityFilerCategory" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Filer Category</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityFilerCategory" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityFilerCategory"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityFilerCategory" xlink:to="lab_dei_EntityFilerCategory" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ProceedsFromIssuanceOfCommonStock_75beda6c-d8ab-41a0-a386-5cf9d35af1a3_terseLabel_en-US" xlink:label="lab_us-gaap_ProceedsFromIssuanceOfCommonStock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Proceeds from issuance of common stock</link:label>
    <link:label id="lab_us-gaap_ProceedsFromIssuanceOfCommonStock_label_en-US" xlink:label="lab_us-gaap_ProceedsFromIssuanceOfCommonStock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Proceeds from Issuance of Common Stock</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProceedsFromIssuanceOfCommonStock" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ProceedsFromIssuanceOfCommonStock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ProceedsFromIssuanceOfCommonStock" xlink:to="lab_us-gaap_ProceedsFromIssuanceOfCommonStock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic_b2d81e29-7bdf-4241-814e-ce00fff7e01f_terseLabel_en-US" xlink:label="lab_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Weighted average shares outstanding used in computing net loss per share, basic (in shares)</link:label>
    <link:label id="lab_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic_label_en-US" xlink:label="lab_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Weighted Average Number of Shares Outstanding, Basic</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_WeightedAverageNumberOfSharesOutstandingBasic"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic" xlink:to="lab_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_RestrictedCashAndCashEquivalentsCashAndCashEquivalentsAxis_864765b1-efb4-43de-b328-a7ecf39190ae_terseLabel_en-US" xlink:label="lab_us-gaap_RestrictedCashAndCashEquivalentsCashAndCashEquivalentsAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Restricted Cash and Cash Equivalents [Axis]</link:label>
    <link:label id="lab_us-gaap_RestrictedCashAndCashEquivalentsCashAndCashEquivalentsAxis_label_en-US" xlink:label="lab_us-gaap_RestrictedCashAndCashEquivalentsCashAndCashEquivalentsAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Restricted Cash and Cash Equivalents [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestrictedCashAndCashEquivalentsCashAndCashEquivalentsAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RestrictedCashAndCashEquivalentsCashAndCashEquivalentsAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_RestrictedCashAndCashEquivalentsCashAndCashEquivalentsAxis" xlink:to="lab_us-gaap_RestrictedCashAndCashEquivalentsCashAndCashEquivalentsAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_dmtk_ManagementWarrantsMember_a57e83e9-6c5c-4727-a9a9-5791e2e84833_terseLabel_en-US" xlink:label="lab_dmtk_ManagementWarrantsMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Management Warrants</link:label>
    <link:label id="lab_dmtk_ManagementWarrantsMember_label_en-US" xlink:label="lab_dmtk_ManagementWarrantsMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Management Warrants [Member]</link:label>
    <link:label id="lab_dmtk_ManagementWarrantsMember_documentation_en-US" xlink:label="lab_dmtk_ManagementWarrantsMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Management warrants.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dmtk_ManagementWarrantsMember" xlink:href="dmtk-20220630.xsd#dmtk_ManagementWarrantsMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dmtk_ManagementWarrantsMember" xlink:to="lab_dmtk_ManagementWarrantsMember" xlink:type="arc" order="1"/>
    <link:label id="lab_dmtk_TenantImprovementAllowancePerRentableSquareFoot_0ff17e55-9d42-4a47-a8ae-7655045bf448_terseLabel_en-US" xlink:label="lab_dmtk_TenantImprovementAllowancePerRentableSquareFoot" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Tenant improvement allowance per rentable square foot (in usd per square foot)</link:label>
    <link:label id="lab_dmtk_TenantImprovementAllowancePerRentableSquareFoot_label_en-US" xlink:label="lab_dmtk_TenantImprovementAllowancePerRentableSquareFoot" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Tenant Improvement Allowance Per Rentable Square Foot</link:label>
    <link:label id="lab_dmtk_TenantImprovementAllowancePerRentableSquareFoot_documentation_en-US" xlink:label="lab_dmtk_TenantImprovementAllowancePerRentableSquareFoot" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Tenant improvement allowance per rentable square foot.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dmtk_TenantImprovementAllowancePerRentableSquareFoot" xlink:href="dmtk-20220630.xsd#dmtk_TenantImprovementAllowancePerRentableSquareFoot"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dmtk_TenantImprovementAllowancePerRentableSquareFoot" xlink:to="lab_dmtk_TenantImprovementAllowancePerRentableSquareFoot" xlink:type="arc" order="1"/>
    <link:label id="lab_dmtk_TwoThousandTwentyEquityIncentivePlanMember_b700382c-e374-4d0d-a545-544902fb9164_terseLabel_en-US" xlink:label="lab_dmtk_TwoThousandTwentyEquityIncentivePlanMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">2020 Equity Incentive Plan</link:label>
    <link:label id="lab_dmtk_TwoThousandTwentyEquityIncentivePlanMember_label_en-US" xlink:label="lab_dmtk_TwoThousandTwentyEquityIncentivePlanMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Two Thousand Twenty Equity Incentive Plan [Member]</link:label>
    <link:label id="lab_dmtk_TwoThousandTwentyEquityIncentivePlanMember_documentation_en-US" xlink:label="lab_dmtk_TwoThousandTwentyEquityIncentivePlanMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Two thousand twenty equity incentive plan.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dmtk_TwoThousandTwentyEquityIncentivePlanMember" xlink:href="dmtk-20220630.xsd#dmtk_TwoThousandTwentyEquityIncentivePlanMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dmtk_TwoThousandTwentyEquityIncentivePlanMember" xlink:to="lab_dmtk_TwoThousandTwentyEquityIncentivePlanMember" xlink:type="arc" order="1"/>
    <link:label id="lab_dmtk_LesseeOperatingLeaseNumberOfRenewalTerms_7f6cab99-2800-4376-9ba1-25c704e34057_terseLabel_en-US" xlink:label="lab_dmtk_LesseeOperatingLeaseNumberOfRenewalTerms" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Number of renewal terms</link:label>
    <link:label id="lab_dmtk_LesseeOperatingLeaseNumberOfRenewalTerms_label_en-US" xlink:label="lab_dmtk_LesseeOperatingLeaseNumberOfRenewalTerms" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Lessee, Operating Lease, Number Of Renewal Terms</link:label>
    <link:label id="lab_dmtk_LesseeOperatingLeaseNumberOfRenewalTerms_documentation_en-US" xlink:label="lab_dmtk_LesseeOperatingLeaseNumberOfRenewalTerms" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Lessee, Operating Lease, Number Of Renewal Terms</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dmtk_LesseeOperatingLeaseNumberOfRenewalTerms" xlink:href="dmtk-20220630.xsd#dmtk_LesseeOperatingLeaseNumberOfRenewalTerms"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dmtk_LesseeOperatingLeaseNumberOfRenewalTerms" xlink:to="lab_dmtk_LesseeOperatingLeaseNumberOfRenewalTerms" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AccruedLiabilitiesCurrentAbstract_df464a6e-e98b-4618-809c-8f6d6800c384_terseLabel_en-US" xlink:label="lab_us-gaap_AccruedLiabilitiesCurrentAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accrued liabilities:</link:label>
    <link:label id="lab_us-gaap_AccruedLiabilitiesCurrentAbstract_label_en-US" xlink:label="lab_us-gaap_AccruedLiabilitiesCurrentAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accrued Liabilities, Current [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccruedLiabilitiesCurrentAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AccruedLiabilitiesCurrentAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AccruedLiabilitiesCurrentAbstract" xlink:to="lab_us-gaap_AccruedLiabilitiesCurrentAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LiabilitiesFairValueDisclosureAbstract_018231f5-f1f1-462e-bf18-9a5d8c54f387_terseLabel_en-US" xlink:label="lab_us-gaap_LiabilitiesFairValueDisclosureAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Liabilities:</link:label>
    <link:label id="lab_us-gaap_LiabilitiesFairValueDisclosureAbstract_label_en-US" xlink:label="lab_us-gaap_LiabilitiesFairValueDisclosureAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Liabilities, Fair Value Disclosure [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilitiesFairValueDisclosureAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LiabilitiesFairValueDisclosureAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LiabilitiesFairValueDisclosureAbstract" xlink:to="lab_us-gaap_LiabilitiesFairValueDisclosureAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AllocatedShareBasedCompensationExpense_4cd96b0f-7641-48b6-be37-76b93dfe2b7c_terseLabel_en-US" xlink:label="lab_us-gaap_AllocatedShareBasedCompensationExpense" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Total stock-based compensation</link:label>
    <link:label id="lab_us-gaap_AllocatedShareBasedCompensationExpense_label_en-US" xlink:label="lab_us-gaap_AllocatedShareBasedCompensationExpense" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-Based Payment Arrangement, Expense</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AllocatedShareBasedCompensationExpense" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AllocatedShareBasedCompensationExpense"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AllocatedShareBasedCompensationExpense" xlink:to="lab_us-gaap_AllocatedShareBasedCompensationExpense" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_NoncashInvestingAndFinancingItemsAbstract_36d59964-1093-4873-81f4-2bf4ad8488ca_terseLabel_en-US" xlink:label="lab_us-gaap_NoncashInvestingAndFinancingItemsAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Supplemental disclosure of noncash investing and financing activities:</link:label>
    <link:label id="lab_us-gaap_NoncashInvestingAndFinancingItemsAbstract_label_en-US" xlink:label="lab_us-gaap_NoncashInvestingAndFinancingItemsAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Noncash Investing and Financing Items [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NoncashInvestingAndFinancingItemsAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NoncashInvestingAndFinancingItemsAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_NoncashInvestingAndFinancingItemsAbstract" xlink:to="lab_us-gaap_NoncashInvestingAndFinancingItemsAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_SecurityExchangeName_89ba2782-2b79-4a14-a841-d11d23a21302_terseLabel_en-US" xlink:label="lab_dei_SecurityExchangeName" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Security Exchange Name</link:label>
    <link:label id="lab_dei_SecurityExchangeName_label_en-US" xlink:label="lab_dei_SecurityExchangeName" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Security Exchange Name</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_SecurityExchangeName" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_SecurityExchangeName"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_SecurityExchangeName" xlink:to="lab_dei_SecurityExchangeName" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ClassOfWarrantOrRightDomain_bd22f48a-5ac5-47d5-b857-562e391a576b_terseLabel_en-US" xlink:label="lab_us-gaap_ClassOfWarrantOrRightDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Class of Warrant or Right</link:label>
    <link:label id="lab_us-gaap_ClassOfWarrantOrRightDomain_label_en-US" xlink:label="lab_us-gaap_ClassOfWarrantOrRightDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Class of Warrant or Right [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ClassOfWarrantOrRightDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ClassOfWarrantOrRightDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ClassOfWarrantOrRightDomain" xlink:to="lab_us-gaap_ClassOfWarrantOrRightDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_GainLossOnDispositionOfAssets1_3bee0304-191a-4b81-a027-59501790f67f_negatedLabel_en-US" xlink:label="lab_us-gaap_GainLossOnDispositionOfAssets1" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Loss on disposal of equipment</link:label>
    <link:label id="lab_us-gaap_GainLossOnDispositionOfAssets1_label_en-US" xlink:label="lab_us-gaap_GainLossOnDispositionOfAssets1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Gain (Loss) on Disposition of Assets</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GainLossOnDispositionOfAssets1" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_GainLossOnDispositionOfAssets1"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_GainLossOnDispositionOfAssets1" xlink:to="lab_us-gaap_GainLossOnDispositionOfAssets1" xlink:type="arc" order="1"/>
    <link:label id="lab_dmtk_IncreaseInTenantImprovementAllowancePerRentableSquareFoot_6c06f2f6-27cb-4cd5-9a79-a1b9a21f7d2b_terseLabel_en-US" xlink:label="lab_dmtk_IncreaseInTenantImprovementAllowancePerRentableSquareFoot" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Increase in improvement allowance per rentable square foot (in usd per square foot)</link:label>
    <link:label id="lab_dmtk_IncreaseInTenantImprovementAllowancePerRentableSquareFoot_label_en-US" xlink:label="lab_dmtk_IncreaseInTenantImprovementAllowancePerRentableSquareFoot" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Increase In Tenant Improvement Allowance Per Rentable Square Foot</link:label>
    <link:label id="lab_dmtk_IncreaseInTenantImprovementAllowancePerRentableSquareFoot_documentation_en-US" xlink:label="lab_dmtk_IncreaseInTenantImprovementAllowancePerRentableSquareFoot" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Increase In Tenant Improvement Allowance Per Rentable Square Foot</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dmtk_IncreaseInTenantImprovementAllowancePerRentableSquareFoot" xlink:href="dmtk-20220630.xsd#dmtk_IncreaseInTenantImprovementAllowancePerRentableSquareFoot"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dmtk_IncreaseInTenantImprovementAllowancePerRentableSquareFoot" xlink:to="lab_dmtk_IncreaseInTenantImprovementAllowancePerRentableSquareFoot" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LettersOfCreditOutstandingAmount_9fe0f010-3313-438e-ab03-e3268a155b3c_terseLabel_en-US" xlink:label="lab_us-gaap_LettersOfCreditOutstandingAmount" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Letters of credit</link:label>
    <link:label id="lab_us-gaap_LettersOfCreditOutstandingAmount_label_en-US" xlink:label="lab_us-gaap_LettersOfCreditOutstandingAmount" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Letters of Credit Outstanding, Amount</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LettersOfCreditOutstandingAmount" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LettersOfCreditOutstandingAmount"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LettersOfCreditOutstandingAmount" xlink:to="lab_us-gaap_LettersOfCreditOutstandingAmount" xlink:type="arc" order="1"/>
    <link:label id="lab_dmtk_StockOptionsAndRestrictedStockUnitsMember_19a479d8-62bb-4e79-8501-cd97dabea1a2_terseLabel_en-US" xlink:label="lab_dmtk_StockOptionsAndRestrictedStockUnitsMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Stock Options and RSUs</link:label>
    <link:label id="lab_dmtk_StockOptionsAndRestrictedStockUnitsMember_label_en-US" xlink:label="lab_dmtk_StockOptionsAndRestrictedStockUnitsMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Stock Options And Restricted Stock Units [Member]</link:label>
    <link:label id="lab_dmtk_StockOptionsAndRestrictedStockUnitsMember_documentation_en-US" xlink:label="lab_dmtk_StockOptionsAndRestrictedStockUnitsMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Stock options and restricted stock units.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dmtk_StockOptionsAndRestrictedStockUnitsMember" xlink:href="dmtk-20220630.xsd#dmtk_StockOptionsAndRestrictedStockUnitsMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dmtk_StockOptionsAndRestrictedStockUnitsMember" xlink:to="lab_dmtk_StockOptionsAndRestrictedStockUnitsMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_GeneralAndAdministrativeExpenseMember_cc04472e-17a4-4343-a9b3-821908c801df_terseLabel_en-US" xlink:label="lab_us-gaap_GeneralAndAdministrativeExpenseMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">General and administrative</link:label>
    <link:label id="lab_us-gaap_GeneralAndAdministrativeExpenseMember_label_en-US" xlink:label="lab_us-gaap_GeneralAndAdministrativeExpenseMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">General and Administrative Expense [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GeneralAndAdministrativeExpenseMember" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_GeneralAndAdministrativeExpenseMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_GeneralAndAdministrativeExpenseMember" xlink:to="lab_us-gaap_GeneralAndAdministrativeExpenseMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax_0828e9b3-ed4d-49a1-91f1-fbb272b78306_terseLabel_en-US" xlink:label="lab_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Total revenues</link:label>
    <link:label id="lab_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax_label_en-US" xlink:label="lab_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Revenue from Contract with Customer, Excluding Assessed Tax</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax" xlink:to="lab_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CommonStockCapitalSharesReservedForFutureIssuance_455bd696-4e9f-4e17-b4be-91e3172b4cd5_verboseLabel_en-US" xlink:label="lab_us-gaap_CommonStockCapitalSharesReservedForFutureIssuance" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Common stock available for issuance (in shares)</link:label>
    <link:label id="lab_us-gaap_CommonStockCapitalSharesReservedForFutureIssuance_935da320-7967-480b-9720-ff28a5e48de8_terseLabel_en-US" xlink:label="lab_us-gaap_CommonStockCapitalSharesReservedForFutureIssuance" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Total common stock reserved for future issuance</link:label>
    <link:label id="lab_us-gaap_CommonStockCapitalSharesReservedForFutureIssuance_label_en-US" xlink:label="lab_us-gaap_CommonStockCapitalSharesReservedForFutureIssuance" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Common Stock, Capital Shares Reserved for Future Issuance</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockCapitalSharesReservedForFutureIssuance" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CommonStockCapitalSharesReservedForFutureIssuance"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CommonStockCapitalSharesReservedForFutureIssuance" xlink:to="lab_us-gaap_CommonStockCapitalSharesReservedForFutureIssuance" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_CoverAbstract_bc1cfd6a-c155-40ac-ad75-4b65e47f18a6_terseLabel_en-US" xlink:label="lab_dei_CoverAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cover [Abstract]</link:label>
    <link:label id="lab_dei_CoverAbstract_label_en-US" xlink:label="lab_dei_CoverAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cover [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_CoverAbstract" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_CoverAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_CoverAbstract" xlink:to="lab_dei_CoverAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PropertyPlantAndEquipmentGrossAbstract_ca601737-0477-4ab9-a3a5-07fe7ce386a4_terseLabel_en-US" xlink:label="lab_us-gaap_PropertyPlantAndEquipmentGrossAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Property and equipment, gross:</link:label>
    <link:label id="lab_us-gaap_PropertyPlantAndEquipmentGrossAbstract_label_en-US" xlink:label="lab_us-gaap_PropertyPlantAndEquipmentGrossAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Property, Plant and Equipment, Gross [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentGrossAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PropertyPlantAndEquipmentGrossAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentGrossAbstract" xlink:to="lab_us-gaap_PropertyPlantAndEquipmentGrossAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FairValueInputsLevel3Member_abb869f8-3259-466b-890c-6788d65de5fd_terseLabel_en-US" xlink:label="lab_us-gaap_FairValueInputsLevel3Member" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Level 3</link:label>
    <link:label id="lab_us-gaap_FairValueInputsLevel3Member_label_en-US" xlink:label="lab_us-gaap_FairValueInputsLevel3Member" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Value, Inputs, Level 3 [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueInputsLevel3Member" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueInputsLevel3Member"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FairValueInputsLevel3Member" xlink:to="lab_us-gaap_FairValueInputsLevel3Member" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DepreciationAndAmortization_bad75e3a-50b8-4bfd-ad7c-93b52afdd817_verboseLabel_en-US" xlink:label="lab_us-gaap_DepreciationAndAmortization" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accumulated amortization</link:label>
    <link:label id="lab_us-gaap_DepreciationAndAmortization_9910521a-60fa-4398-90cd-31ddb66ee510_terseLabel_en-US" xlink:label="lab_us-gaap_DepreciationAndAmortization" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accumulated amortization</link:label>
    <link:label id="lab_us-gaap_DepreciationAndAmortization_label_en-US" xlink:label="lab_us-gaap_DepreciationAndAmortization" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Depreciation, Depletion and Amortization, Nonproduction</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DepreciationAndAmortization" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DepreciationAndAmortization"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DepreciationAndAmortization" xlink:to="lab_us-gaap_DepreciationAndAmortization" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FinanceLeaseWeightedAverageDiscountRatePercent_eb42568a-80a0-4a58-9242-9971843e5018_terseLabel_en-US" xlink:label="lab_us-gaap_FinanceLeaseWeightedAverageDiscountRatePercent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Weighted-average discount rate for finance leases (in percent)</link:label>
    <link:label id="lab_us-gaap_FinanceLeaseWeightedAverageDiscountRatePercent_label_en-US" xlink:label="lab_us-gaap_FinanceLeaseWeightedAverageDiscountRatePercent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Finance Lease, Weighted Average Discount Rate, Percent</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FinanceLeaseWeightedAverageDiscountRatePercent" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FinanceLeaseWeightedAverageDiscountRatePercent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FinanceLeaseWeightedAverageDiscountRatePercent" xlink:to="lab_us-gaap_FinanceLeaseWeightedAverageDiscountRatePercent" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate_6736f14a-d7ef-43bf-820c-b529017d915b_terseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Assumed risk-free interest rate</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-Based Compensation Arrangement by Share-Based Payment Award, Fair Value Assumptions, Risk Free Interest Rate</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LiabilitiesAndStockholdersEquity_be3d711a-96ea-430a-9b83-1458c11cd627_totalLabel_en-US" xlink:label="lab_us-gaap_LiabilitiesAndStockholdersEquity" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Total liabilities and stockholders&#8217; equity</link:label>
    <link:label id="lab_us-gaap_LiabilitiesAndStockholdersEquity_label_en-US" xlink:label="lab_us-gaap_LiabilitiesAndStockholdersEquity" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Liabilities and Equity</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilitiesAndStockholdersEquity" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LiabilitiesAndStockholdersEquity"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LiabilitiesAndStockholdersEquity" xlink:to="lab_us-gaap_LiabilitiesAndStockholdersEquity" xlink:type="arc" order="1"/>
    <link:label id="lab_dmtk_RevenuePerformanceObligationSatisfiedVariableConsiderationUpdateIncreaseDecreaseInRevenue_d13c21a4-3388-4f23-986b-b9f686d3aca7_terseLabel_en-US" xlink:label="lab_dmtk_RevenuePerformanceObligationSatisfiedVariableConsiderationUpdateIncreaseDecreaseInRevenue" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Increase (decrease) in revenue</link:label>
    <link:label id="lab_dmtk_RevenuePerformanceObligationSatisfiedVariableConsiderationUpdateIncreaseDecreaseInRevenue_label_en-US" xlink:label="lab_dmtk_RevenuePerformanceObligationSatisfiedVariableConsiderationUpdateIncreaseDecreaseInRevenue" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Revenue, Performance Obligation Satisfied, Variable Consideration Update, Increase (Decrease) In Revenue</link:label>
    <link:label id="lab_dmtk_RevenuePerformanceObligationSatisfiedVariableConsiderationUpdateIncreaseDecreaseInRevenue_documentation_en-US" xlink:label="lab_dmtk_RevenuePerformanceObligationSatisfiedVariableConsiderationUpdateIncreaseDecreaseInRevenue" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Revenue, Performance Obligation Satisfied, Variable Consideration Update, Increase (Decrease) In Revenue</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dmtk_RevenuePerformanceObligationSatisfiedVariableConsiderationUpdateIncreaseDecreaseInRevenue" xlink:href="dmtk-20220630.xsd#dmtk_RevenuePerformanceObligationSatisfiedVariableConsiderationUpdateIncreaseDecreaseInRevenue"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dmtk_RevenuePerformanceObligationSatisfiedVariableConsiderationUpdateIncreaseDecreaseInRevenue" xlink:to="lab_dmtk_RevenuePerformanceObligationSatisfiedVariableConsiderationUpdateIncreaseDecreaseInRevenue" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_RelatedPartyTransactionsByRelatedPartyAxis_e0f25faf-f535-4afc-8d8d-b550c179aaef_terseLabel_en-US" xlink:label="lab_us-gaap_RelatedPartyTransactionsByRelatedPartyAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Related Party</link:label>
    <link:label id="lab_us-gaap_RelatedPartyTransactionsByRelatedPartyAxis_label_en-US" xlink:label="lab_us-gaap_RelatedPartyTransactionsByRelatedPartyAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Related Party [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RelatedPartyTransactionsByRelatedPartyAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RelatedPartyTransactionsByRelatedPartyAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_RelatedPartyTransactionsByRelatedPartyAxis" xlink:to="lab_us-gaap_RelatedPartyTransactionsByRelatedPartyAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AccruedVacationCurrent_edc7ff01-c176-4fb3-a0b5-ed89c75780f1_terseLabel_en-US" xlink:label="lab_us-gaap_AccruedVacationCurrent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accrued paid time off</link:label>
    <link:label id="lab_us-gaap_AccruedVacationCurrent_label_en-US" xlink:label="lab_us-gaap_AccruedVacationCurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accrued Vacation, Current</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccruedVacationCurrent" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AccruedVacationCurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AccruedVacationCurrent" xlink:to="lab_us-gaap_AccruedVacationCurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract_a43a1279-4481-403a-99d6-9b96a3bba33c_terseLabel_en-US" xlink:label="lab_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Organization, Consolidation and Presentation of Financial Statements [Abstract]</link:label>
    <link:label id="lab_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract_label_en-US" xlink:label="lab_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Organization, Consolidation and Presentation of Financial Statements [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract" xlink:to="lab_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_dmtk_TwoThousandTwentyEmployeeStockPurchasePlanMember_0c99c45e-8eed-44ce-a1f2-d16eb7bafff3_terseLabel_en-US" xlink:label="lab_dmtk_TwoThousandTwentyEmployeeStockPurchasePlanMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">2020 Employee Stock Purchase Plan</link:label>
    <link:label id="lab_dmtk_TwoThousandTwentyEmployeeStockPurchasePlanMember_label_en-US" xlink:label="lab_dmtk_TwoThousandTwentyEmployeeStockPurchasePlanMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Two Thousand Twenty Employee Stock Purchase Plan [Member]</link:label>
    <link:label id="lab_dmtk_TwoThousandTwentyEmployeeStockPurchasePlanMember_documentation_en-US" xlink:label="lab_dmtk_TwoThousandTwentyEmployeeStockPurchasePlanMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Two thousand twenty employee stock purchase plan.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dmtk_TwoThousandTwentyEmployeeStockPurchasePlanMember" xlink:href="dmtk-20220630.xsd#dmtk_TwoThousandTwentyEmployeeStockPurchasePlanMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dmtk_TwoThousandTwentyEmployeeStockPurchasePlanMember" xlink:to="lab_dmtk_TwoThousandTwentyEmployeeStockPurchasePlanMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FairValueInputsLevel2Member_9af1955b-8467-45e0-8d61-afa6145d13a8_terseLabel_en-US" xlink:label="lab_us-gaap_FairValueInputsLevel2Member" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Level 2</link:label>
    <link:label id="lab_us-gaap_FairValueInputsLevel2Member_label_en-US" xlink:label="lab_us-gaap_FairValueInputsLevel2Member" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Value, Inputs, Level 2 [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueInputsLevel2Member" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueInputsLevel2Member"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FairValueInputsLevel2Member" xlink:to="lab_us-gaap_FairValueInputsLevel2Member" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DemandDepositsMember_9ed49f1b-fb08-4517-ab9e-5287d0aa6a24_terseLabel_en-US" xlink:label="lab_us-gaap_DemandDepositsMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Demand Deposits</link:label>
    <link:label id="lab_us-gaap_DemandDepositsMember_label_en-US" xlink:label="lab_us-gaap_DemandDepositsMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Demand Deposits [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DemandDepositsMember" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DemandDepositsMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DemandDepositsMember" xlink:to="lab_us-gaap_DemandDepositsMember" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_CurrentFiscalYearEndDate_99afbfab-592a-4750-a269-d7a6fa4fc0a4_terseLabel_en-US" xlink:label="lab_dei_CurrentFiscalYearEndDate" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Current Fiscal Year End Date</link:label>
    <link:label id="lab_dei_CurrentFiscalYearEndDate_label_en-US" xlink:label="lab_dei_CurrentFiscalYearEndDate" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Current Fiscal Year End Date</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_CurrentFiscalYearEndDate" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_CurrentFiscalYearEndDate"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_CurrentFiscalYearEndDate" xlink:to="lab_dei_CurrentFiscalYearEndDate" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_MarketableSecuritiesCurrent_e1cbace5-d340-4261-907a-fe74420baaae_terseLabel_en-US" xlink:label="lab_us-gaap_MarketableSecuritiesCurrent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Short-term marketable securities</link:label>
    <link:label id="lab_us-gaap_MarketableSecuritiesCurrent_label_en-US" xlink:label="lab_us-gaap_MarketableSecuritiesCurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Marketable Securities, Current</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_MarketableSecuritiesCurrent" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_MarketableSecuritiesCurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_MarketableSecuritiesCurrent" xlink:to="lab_us-gaap_MarketableSecuritiesCurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_RestrictedCashAndCashEquivalentsAbstract_450f9ca5-33df-42c1-917f-4535369e58d4_terseLabel_en-US" xlink:label="lab_us-gaap_RestrictedCashAndCashEquivalentsAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Reconciliation of cash, cash equivalents and restricted cash, end of period:</link:label>
    <link:label id="lab_us-gaap_RestrictedCashAndCashEquivalentsAbstract_label_en-US" xlink:label="lab_us-gaap_RestrictedCashAndCashEquivalentsAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Restricted Cash and Cash Equivalents [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestrictedCashAndCashEquivalentsAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RestrictedCashAndCashEquivalentsAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_RestrictedCashAndCashEquivalentsAbstract" xlink:to="lab_us-gaap_RestrictedCashAndCashEquivalentsAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_EarningsPerShareDiluted_bb180764-0b32-4875-a24f-ebc8ba7a5966_terseLabel_en-US" xlink:label="lab_us-gaap_EarningsPerShareDiluted" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net loss per share of common stock outstanding, diluted (in usd per share)</link:label>
    <link:label id="lab_us-gaap_EarningsPerShareDiluted_label_en-US" xlink:label="lab_us-gaap_EarningsPerShareDiluted" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Earnings Per Share, Diluted</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EarningsPerShareDiluted" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EarningsPerShareDiluted"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_EarningsPerShareDiluted" xlink:to="lab_us-gaap_EarningsPerShareDiluted" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_SaleOfStockNameOfTransactionDomain_6bbd733e-78f7-4d3a-a249-21873f0d7561_terseLabel_en-US" xlink:label="lab_us-gaap_SaleOfStockNameOfTransactionDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Sale of Stock</link:label>
    <link:label id="lab_us-gaap_SaleOfStockNameOfTransactionDomain_label_en-US" xlink:label="lab_us-gaap_SaleOfStockNameOfTransactionDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Sale of Stock [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SaleOfStockNameOfTransactionDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SaleOfStockNameOfTransactionDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SaleOfStockNameOfTransactionDomain" xlink:to="lab_us-gaap_SaleOfStockNameOfTransactionDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_StockholdersEquityNoteStockSplitConversionRatio1_07a1c9e6-f7de-4e5e-8fb6-5067d2aac464_terseLabel_en-US" xlink:label="lab_us-gaap_StockholdersEquityNoteStockSplitConversionRatio1" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Conversion ratio of reverse stock split</link:label>
    <link:label id="lab_us-gaap_StockholdersEquityNoteStockSplitConversionRatio1_label_en-US" xlink:label="lab_us-gaap_StockholdersEquityNoteStockSplitConversionRatio1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Stockholders' Equity Note, Stock Split, Conversion Ratio</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockholdersEquityNoteStockSplitConversionRatio1" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StockholdersEquityNoteStockSplitConversionRatio1"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StockholdersEquityNoteStockSplitConversionRatio1" xlink:to="lab_us-gaap_StockholdersEquityNoteStockSplitConversionRatio1" xlink:type="arc" order="1"/>
    <link:label id="lab_dmtk_AssayMember_33943d72-b578-45e9-9ed0-ffd6b96248ab_terseLabel_en-US" xlink:label="lab_dmtk_AssayMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Assay revenue</link:label>
    <link:label id="lab_dmtk_AssayMember_c3f69425-c3bb-4bb5-98f5-356031a3ebac_verboseLabel_en-US" xlink:label="lab_dmtk_AssayMember" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">DermTech Melanoma Test</link:label>
    <link:label id="lab_dmtk_AssayMember_label_en-US" xlink:label="lab_dmtk_AssayMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Assay [Member]</link:label>
    <link:label id="lab_dmtk_AssayMember_documentation_en-US" xlink:label="lab_dmtk_AssayMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Assay.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dmtk_AssayMember" xlink:href="dmtk-20220630.xsd#dmtk_AssayMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dmtk_AssayMember" xlink:to="lab_dmtk_AssayMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfStockByClassTextBlock_1404349e-ecd5-4562-803c-5d31511203ec_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfStockByClassTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Summary of Common Stock Reserved for Future Issuance</link:label>
    <link:label id="lab_us-gaap_ScheduleOfStockByClassTextBlock_label_en-US" xlink:label="lab_us-gaap_ScheduleOfStockByClassTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Stock by Class [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfStockByClassTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfStockByClassTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfStockByClassTextBlock" xlink:to="lab_us-gaap_ScheduleOfStockByClassTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue_7ffa6803-63dd-462d-8099-4e20c8e52454_terseLabel_en-US" xlink:label="lab_us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Stock-based compensation</link:label>
    <link:label id="lab_us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue_label_en-US" xlink:label="lab_us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">APIC, Share-Based Payment Arrangement, Increase for Cost Recognition</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue" xlink:to="lab_us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue" xlink:type="arc" order="1"/>
    <link:label id="lab_dmtk_ContractualActivitiesMember_269fe500-a82e-4745-9fa1-8acf654891bb_terseLabel_en-US" xlink:label="lab_dmtk_ContractualActivitiesMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Contract revenue</link:label>
    <link:label id="lab_dmtk_ContractualActivitiesMember_label_en-US" xlink:label="lab_dmtk_ContractualActivitiesMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Contractual Activities [Member]</link:label>
    <link:label id="lab_dmtk_ContractualActivitiesMember_documentation_en-US" xlink:label="lab_dmtk_ContractualActivitiesMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Contract activities.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dmtk_ContractualActivitiesMember" xlink:href="dmtk-20220630.xsd#dmtk_ContractualActivitiesMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dmtk_ContractualActivitiesMember" xlink:to="lab_dmtk_ContractualActivitiesMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FairValueAdjustmentOfWarrants_0d72e68f-f862-4511-9bbd-ce40f3513cca_negatedLabel_en-US" xlink:label="lab_us-gaap_FairValueAdjustmentOfWarrants" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Change in fair value of warrant liability</link:label>
    <link:label id="lab_us-gaap_FairValueAdjustmentOfWarrants_8711b051-5b13-4e2e-b9e7-5471b0cb02ea_terseLabel_en-US" xlink:label="lab_us-gaap_FairValueAdjustmentOfWarrants" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Change in fair value of warrant liability</link:label>
    <link:label id="lab_us-gaap_FairValueAdjustmentOfWarrants_label_en-US" xlink:label="lab_us-gaap_FairValueAdjustmentOfWarrants" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Value Adjustment of Warrants</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueAdjustmentOfWarrants" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueAdjustmentOfWarrants"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FairValueAdjustmentOfWarrants" xlink:to="lab_us-gaap_FairValueAdjustmentOfWarrants" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ConcentrationRiskByTypeAxis_a0b4020f-b403-4be2-a630-17058cacb0d6_terseLabel_en-US" xlink:label="lab_us-gaap_ConcentrationRiskByTypeAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Concentration Risk Type</link:label>
    <link:label id="lab_us-gaap_ConcentrationRiskByTypeAxis_label_en-US" xlink:label="lab_us-gaap_ConcentrationRiskByTypeAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Concentration Risk Type [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ConcentrationRiskByTypeAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ConcentrationRiskByTypeAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ConcentrationRiskByTypeAxis" xlink:to="lab_us-gaap_ConcentrationRiskByTypeAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LiabilitiesCurrent_a5c2428d-a8f0-4efd-a53d-cb41a987c4db_totalLabel_en-US" xlink:label="lab_us-gaap_LiabilitiesCurrent" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Total current liabilities</link:label>
    <link:label id="lab_us-gaap_LiabilitiesCurrent_label_en-US" xlink:label="lab_us-gaap_LiabilitiesCurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Liabilities, Current</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilitiesCurrent" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LiabilitiesCurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LiabilitiesCurrent" xlink:to="lab_us-gaap_LiabilitiesCurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMinimum_5fb31b0d-9bc7-4bea-9d52-ceaf06c27639_terseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMinimum" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Assumed risk-free interest rate, minimum</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMinimum_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMinimum" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-Based Compensation Arrangement by Share-Based Payment Award, Fair Value Assumptions, Risk Free Interest Rate, Minimum</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMinimum" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMinimum"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMinimum" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMinimum" xlink:type="arc" order="1"/>
    <link:label id="lab_dmtk_FirstAmendmentMember_65190eb6-4291-49c6-9eec-51b753359d75_terseLabel_en-US" xlink:label="lab_dmtk_FirstAmendmentMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">First Amendment</link:label>
    <link:label id="lab_dmtk_FirstAmendmentMember_label_en-US" xlink:label="lab_dmtk_FirstAmendmentMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">First Amendment [Member]</link:label>
    <link:label id="lab_dmtk_FirstAmendmentMember_documentation_en-US" xlink:label="lab_dmtk_FirstAmendmentMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">First Amendment</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dmtk_FirstAmendmentMember" xlink:href="dmtk-20220630.xsd#dmtk_FirstAmendmentMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dmtk_FirstAmendmentMember" xlink:to="lab_dmtk_FirstAmendmentMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearTwo_10bcd694-54e1-40c0-adf2-faceb72c9f4e_terseLabel_en-US" xlink:label="lab_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearTwo" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">2024</link:label>
    <link:label id="lab_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearTwo_label_en-US" xlink:label="lab_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearTwo" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Lessee, Operating Lease, Liability, to be Paid, Year Two</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearTwo" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearTwo"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearTwo" xlink:to="lab_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearTwo" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OtherAssetsCurrent_e66a4b39-6a50-456e-bd78-b4ebd4ce4831_terseLabel_en-US" xlink:label="lab_us-gaap_OtherAssetsCurrent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other current assets</link:label>
    <link:label id="lab_us-gaap_OtherAssetsCurrent_label_en-US" xlink:label="lab_us-gaap_OtherAssetsCurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Assets, Current</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherAssetsCurrent" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherAssetsCurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OtherAssetsCurrent" xlink:to="lab_us-gaap_OtherAssetsCurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CustomerConcentrationRiskMember_1486afe4-fbf4-49ec-bd09-ae52921f9ab8_terseLabel_en-US" xlink:label="lab_us-gaap_CustomerConcentrationRiskMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Customer Concentration Risk</link:label>
    <link:label id="lab_us-gaap_CustomerConcentrationRiskMember_label_en-US" xlink:label="lab_us-gaap_CustomerConcentrationRiskMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Customer Concentration Risk [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CustomerConcentrationRiskMember" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CustomerConcentrationRiskMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CustomerConcentrationRiskMember" xlink:to="lab_us-gaap_CustomerConcentrationRiskMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_RevenueRemainingPerformanceObligation_c60ee745-af9a-4448-a272-2c78200b5b08_terseLabel_en-US" xlink:label="lab_us-gaap_RevenueRemainingPerformanceObligation" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Remaining performance obligation, estimated revenue expected to be recognized</link:label>
    <link:label id="lab_us-gaap_RevenueRemainingPerformanceObligation_label_en-US" xlink:label="lab_us-gaap_RevenueRemainingPerformanceObligation" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Revenue, Remaining Performance Obligation, Amount</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevenueRemainingPerformanceObligation" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RevenueRemainingPerformanceObligation"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_RevenueRemainingPerformanceObligation" xlink:to="lab_us-gaap_RevenueRemainingPerformanceObligation" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardExpirationPeriod_b9538d20-ce1d-45a3-bf7c-83d03ac98b0c_terseLabel_en-US" xlink:label="lab_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardExpirationPeriod" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Contractual term of options granted</link:label>
    <link:label id="lab_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardExpirationPeriod_label_en-US" xlink:label="lab_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardExpirationPeriod" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-Based Compensation Arrangement by Share-Based Payment Award, Expiration Period</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardExpirationPeriod" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardExpirationPeriod"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardExpirationPeriod" xlink:to="lab_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardExpirationPeriod" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CorporateDebtSecuritiesMember_6e8fea57-dc3f-4c48-898d-9174fa560a8e_terseLabel_en-US" xlink:label="lab_us-gaap_CorporateDebtSecuritiesMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Corporate debt securities</link:label>
    <link:label id="lab_us-gaap_CorporateDebtSecuritiesMember_label_en-US" xlink:label="lab_us-gaap_CorporateDebtSecuritiesMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Corporate Debt Securities [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CorporateDebtSecuritiesMember" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CorporateDebtSecuritiesMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CorporateDebtSecuritiesMember" xlink:to="lab_us-gaap_CorporateDebtSecuritiesMember" xlink:type="arc" order="1"/>
    <link:label id="lab_srt_CumulativeEffectPeriodOfAdoptionAdjustmentMember_a19c771c-26b4-4097-a11c-61edfe0d3c83_terseLabel_en-US" xlink:label="lab_srt_CumulativeEffectPeriodOfAdoptionAdjustmentMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Effect of Adoption</link:label>
    <link:label id="lab_srt_CumulativeEffectPeriodOfAdoptionAdjustmentMember_label_en-US" xlink:label="lab_srt_CumulativeEffectPeriodOfAdoptionAdjustmentMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cumulative Effect, Period of Adoption, Adjustment [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_srt_CumulativeEffectPeriodOfAdoptionAdjustmentMember" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_CumulativeEffectPeriodOfAdoptionAdjustmentMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_srt_CumulativeEffectPeriodOfAdoptionAdjustmentMember" xlink:to="lab_srt_CumulativeEffectPeriodOfAdoptionAdjustmentMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_NonoperatingIncomeExpenseAbstract_f30aa652-ac85-4ca6-bf6f-c898348c6b83_terseLabel_en-US" xlink:label="lab_us-gaap_NonoperatingIncomeExpenseAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other income/(expense):</link:label>
    <link:label id="lab_us-gaap_NonoperatingIncomeExpenseAbstract_label_en-US" xlink:label="lab_us-gaap_NonoperatingIncomeExpenseAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Nonoperating Income (Expense) [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NonoperatingIncomeExpenseAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NonoperatingIncomeExpenseAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_NonoperatingIncomeExpenseAbstract" xlink:to="lab_us-gaap_NonoperatingIncomeExpenseAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_dmtk_EquityIncentivePlanOptionTerm_836397d9-d72b-458f-8496-5c19d57b771e_terseLabel_en-US" xlink:label="lab_dmtk_EquityIncentivePlanOptionTerm" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Term of the option</link:label>
    <link:label id="lab_dmtk_EquityIncentivePlanOptionTerm_label_en-US" xlink:label="lab_dmtk_EquityIncentivePlanOptionTerm" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Equity Incentive Plan Option Term</link:label>
    <link:label id="lab_dmtk_EquityIncentivePlanOptionTerm_documentation_en-US" xlink:label="lab_dmtk_EquityIncentivePlanOptionTerm" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Equity incentive plan option term.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dmtk_EquityIncentivePlanOptionTerm" xlink:href="dmtk-20220630.xsd#dmtk_EquityIncentivePlanOptionTerm"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dmtk_EquityIncentivePlanOptionTerm" xlink:to="lab_dmtk_EquityIncentivePlanOptionTerm" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMaximum_499e172e-6de2-4538-acef-502471169b3c_terseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMaximum" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Assumed risk-free interest rate, maximum</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMaximum_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMaximum" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-Based Compensation Arrangement by Share-Based Payment Award, Fair Value Assumptions, Risk Free Interest Rate, Maximum</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMaximum" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMaximum"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMaximum" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMaximum" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityAddressAddressLine2_6fd71e2f-e18c-4df7-b989-be34fd369ab2_terseLabel_en-US" xlink:label="lab_dei_EntityAddressAddressLine2" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Address, Address Line Two</link:label>
    <link:label id="lab_dei_EntityAddressAddressLine2_label_en-US" xlink:label="lab_dei_EntityAddressAddressLine2" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Address, Address Line Two</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityAddressAddressLine2" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityAddressAddressLine2"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityAddressAddressLine2" xlink:to="lab_dei_EntityAddressAddressLine2" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityAddressAddressLine1_a0215f16-3271-4262-a182-b2143adc6468_terseLabel_en-US" xlink:label="lab_dei_EntityAddressAddressLine1" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Address, Address Line One</link:label>
    <link:label id="lab_dei_EntityAddressAddressLine1_label_en-US" xlink:label="lab_dei_EntityAddressAddressLine1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Address, Address Line One</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityAddressAddressLine1" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityAddressAddressLine1"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityAddressAddressLine1" xlink:to="lab_dei_EntityAddressAddressLine1" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CostOfRevenue_ea3dc5e4-1c36-44fa-89b1-c7ab63444c66_terseLabel_en-US" xlink:label="lab_us-gaap_CostOfRevenue" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Total cost of revenues</link:label>
    <link:label id="lab_us-gaap_CostOfRevenue_label_en-US" xlink:label="lab_us-gaap_CostOfRevenue" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cost of Revenue</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CostOfRevenue" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CostOfRevenue"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CostOfRevenue" xlink:to="lab_us-gaap_CostOfRevenue" xlink:type="arc" order="1"/>
    <link:label id="lab_dmtk_AccruedBonusAndDeferredCompensationCurrent_33442ce3-604c-4b2d-b5c3-5f58e10307aa_terseLabel_en-US" xlink:label="lab_dmtk_AccruedBonusAndDeferredCompensationCurrent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accrued wages, bonus and other</link:label>
    <link:label id="lab_dmtk_AccruedBonusAndDeferredCompensationCurrent_label_en-US" xlink:label="lab_dmtk_AccruedBonusAndDeferredCompensationCurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accrued Bonus And Deferred Compensation Current</link:label>
    <link:label id="lab_dmtk_AccruedBonusAndDeferredCompensationCurrent_documentation_en-US" xlink:label="lab_dmtk_AccruedBonusAndDeferredCompensationCurrent" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accrued bonus and deferred compensation, current.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dmtk_AccruedBonusAndDeferredCompensationCurrent" xlink:href="dmtk-20220630.xsd#dmtk_AccruedBonusAndDeferredCompensationCurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dmtk_AccruedBonusAndDeferredCompensationCurrent" xlink:to="lab_dmtk_AccruedBonusAndDeferredCompensationCurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_srt_ProductOrServiceAxis_408a16b9-60e3-41c7-b0d9-63ecf69efc0f_terseLabel_en-US" xlink:label="lab_srt_ProductOrServiceAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Product and Service</link:label>
    <link:label id="lab_srt_ProductOrServiceAxis_label_en-US" xlink:label="lab_srt_ProductOrServiceAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Product and Service [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ProductOrServiceAxis" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_ProductOrServiceAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_srt_ProductOrServiceAxis" xlink:to="lab_srt_ProductOrServiceAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FinanceLeaseWeightedAverageRemainingLeaseTerm1_2b8dd5e1-c3fb-407e-963d-fa1e53675fb2_terseLabel_en-US" xlink:label="lab_us-gaap_FinanceLeaseWeightedAverageRemainingLeaseTerm1" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Weighted-average remaining lease term of finance leases (in years)</link:label>
    <link:label id="lab_us-gaap_FinanceLeaseWeightedAverageRemainingLeaseTerm1_label_en-US" xlink:label="lab_us-gaap_FinanceLeaseWeightedAverageRemainingLeaseTerm1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Finance Lease, Weighted Average Remaining Lease Term</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FinanceLeaseWeightedAverageRemainingLeaseTerm1" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FinanceLeaseWeightedAverageRemainingLeaseTerm1"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FinanceLeaseWeightedAverageRemainingLeaseTerm1" xlink:to="lab_us-gaap_FinanceLeaseWeightedAverageRemainingLeaseTerm1" xlink:type="arc" order="1"/>
    <link:label id="lab_dmtk_SpecialPurposeAcquisitionCompanyWarrantsToPurchaseCommonStockMember_f72f8c12-b170-4f91-8862-67fa85db7b89_terseLabel_en-US" xlink:label="lab_dmtk_SpecialPurposeAcquisitionCompanyWarrantsToPurchaseCommonStockMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">SPAC Warrants to purchase common stock*</link:label>
    <link:label id="lab_dmtk_SpecialPurposeAcquisitionCompanyWarrantsToPurchaseCommonStockMember_label_en-US" xlink:label="lab_dmtk_SpecialPurposeAcquisitionCompanyWarrantsToPurchaseCommonStockMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Special Purpose Acquisition Company Warrants To Purchase Common Stock [Member]</link:label>
    <link:label id="lab_dmtk_SpecialPurposeAcquisitionCompanyWarrantsToPurchaseCommonStockMember_documentation_en-US" xlink:label="lab_dmtk_SpecialPurposeAcquisitionCompanyWarrantsToPurchaseCommonStockMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">SPAC warrants to purchase common stock.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dmtk_SpecialPurposeAcquisitionCompanyWarrantsToPurchaseCommonStockMember" xlink:href="dmtk-20220630.xsd#dmtk_SpecialPurposeAcquisitionCompanyWarrantsToPurchaseCommonStockMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dmtk_SpecialPurposeAcquisitionCompanyWarrantsToPurchaseCommonStockMember" xlink:to="lab_dmtk_SpecialPurposeAcquisitionCompanyWarrantsToPurchaseCommonStockMember" xlink:type="arc" order="1"/>
    <link:label id="lab_dmtk_PrepaidEmployeeCompensation_6dc1b29a-4821-429e-8f35-147b271fedb1_terseLabel_en-US" xlink:label="lab_dmtk_PrepaidEmployeeCompensation" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Prepaid employee compensation</link:label>
    <link:label id="lab_dmtk_PrepaidEmployeeCompensation_label_en-US" xlink:label="lab_dmtk_PrepaidEmployeeCompensation" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Prepaid Employee Compensation</link:label>
    <link:label id="lab_dmtk_PrepaidEmployeeCompensation_documentation_en-US" xlink:label="lab_dmtk_PrepaidEmployeeCompensation" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Prepaid employee compensation.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dmtk_PrepaidEmployeeCompensation" xlink:href="dmtk-20220630.xsd#dmtk_PrepaidEmployeeCompensation"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dmtk_PrepaidEmployeeCompensation" xlink:to="lab_dmtk_PrepaidEmployeeCompensation" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CreditFacilityAxis_e2b42880-2aba-4734-99eb-647036b1ff9c_terseLabel_en-US" xlink:label="lab_us-gaap_CreditFacilityAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Credit Facility</link:label>
    <link:label id="lab_us-gaap_CreditFacilityAxis_label_en-US" xlink:label="lab_us-gaap_CreditFacilityAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Credit Facility [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CreditFacilityAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CreditFacilityAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CreditFacilityAxis" xlink:to="lab_us-gaap_CreditFacilityAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax_10a82a5b-99c6-4535-baa2-c554295f2fed_terseLabel_en-US" xlink:label="lab_us-gaap_OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Unrealized net (loss)/gain on available-for-sale marketable securities</link:label>
    <link:label id="lab_us-gaap_OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax_label_en-US" xlink:label="lab_us-gaap_OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">OCI, Debt Securities, Available-for-Sale, Unrealized Holding Gain (Loss), before Adjustment, after Tax</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax" xlink:to="lab_us-gaap_OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_RestrictedCashAndCashEquivalentsCashAndCashEquivalentsMember_5516bbe7-6c97-4647-a119-7e6c4edc212d_terseLabel_en-US" xlink:label="lab_us-gaap_RestrictedCashAndCashEquivalentsCashAndCashEquivalentsMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cash and Cash Equivalents [Domain]</link:label>
    <link:label id="lab_us-gaap_RestrictedCashAndCashEquivalentsCashAndCashEquivalentsMember_label_en-US" xlink:label="lab_us-gaap_RestrictedCashAndCashEquivalentsCashAndCashEquivalentsMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cash and Cash Equivalents [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestrictedCashAndCashEquivalentsCashAndCashEquivalentsMember" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RestrictedCashAndCashEquivalentsCashAndCashEquivalentsMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_RestrictedCashAndCashEquivalentsCashAndCashEquivalentsMember" xlink:to="lab_us-gaap_RestrictedCashAndCashEquivalentsCashAndCashEquivalentsMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_EquityAbstract_label_en-US" xlink:label="lab_us-gaap_EquityAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Equity [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquityAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EquityAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_EquityAbstract" xlink:to="lab_us-gaap_EquityAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityTaxIdentificationNumber_01b4368f-e346-4b71-80df-03b904b526f1_terseLabel_en-US" xlink:label="lab_dei_EntityTaxIdentificationNumber" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Tax Identification Number</link:label>
    <link:label id="lab_dei_EntityTaxIdentificationNumber_label_en-US" xlink:label="lab_dei_EntityTaxIdentificationNumber" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Tax Identification Number</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityTaxIdentificationNumber" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityTaxIdentificationNumber"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityTaxIdentificationNumber" xlink:to="lab_dei_EntityTaxIdentificationNumber" xlink:type="arc" order="1"/>
    <link:label id="lab_dmtk_WeightedAveragePurchasePricePerShareInOffering_733bfe50-d1c0-4019-abe7-fa300136cbae_terseLabel_en-US" xlink:label="lab_dmtk_WeightedAveragePurchasePricePerShareInOffering" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Weighted average purchase price per share (in usd per share)</link:label>
    <link:label id="lab_dmtk_WeightedAveragePurchasePricePerShareInOffering_label_en-US" xlink:label="lab_dmtk_WeightedAveragePurchasePricePerShareInOffering" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Weighted Average Purchase Price Per Share In Offering</link:label>
    <link:label id="lab_dmtk_WeightedAveragePurchasePricePerShareInOffering_documentation_en-US" xlink:label="lab_dmtk_WeightedAveragePurchasePricePerShareInOffering" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Weighted average purchase price per share in offering.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dmtk_WeightedAveragePurchasePricePerShareInOffering" xlink:href="dmtk-20220630.xsd#dmtk_WeightedAveragePurchasePricePerShareInOffering"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dmtk_WeightedAveragePurchasePricePerShareInOffering" xlink:to="lab_dmtk_WeightedAveragePurchasePricePerShareInOffering" xlink:type="arc" order="1"/>
    <link:label id="lab_dmtk_FinanceLeaseCost_f18b81c1-5028-41b9-ab68-b30967287788_totalLabel_en-US" xlink:label="lab_dmtk_FinanceLeaseCost" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Total finance lease cost</link:label>
    <link:label id="lab_dmtk_FinanceLeaseCost_label_en-US" xlink:label="lab_dmtk_FinanceLeaseCost" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Finance Lease Cost</link:label>
    <link:label id="lab_dmtk_FinanceLeaseCost_documentation_en-US" xlink:label="lab_dmtk_FinanceLeaseCost" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Finance lease cost.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dmtk_FinanceLeaseCost" xlink:href="dmtk-20220630.xsd#dmtk_FinanceLeaseCost"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dmtk_FinanceLeaseCost" xlink:to="lab_dmtk_FinanceLeaseCost" xlink:type="arc" order="1"/>
    <link:label id="lab_dmtk_ReclassificationOfWarrantLiabilityDueToPrivateSPACWarrantsNotHeldByOriginalHolder_faf5f94d-ed08-41ea-a3ac-6cc49715942c_verboseLabel_en-US" xlink:label="lab_dmtk_ReclassificationOfWarrantLiabilityDueToPrivateSPACWarrantsNotHeldByOriginalHolder" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Reclassification of warrant liability due to Private SPAC Warrants not held by original holder</link:label>
    <link:label id="lab_dmtk_ReclassificationOfWarrantLiabilityDueToPrivateSPACWarrantsNotHeldByOriginalHolder_cd64cdaf-3b80-4807-9f43-b8266a9e5682_terseLabel_en-US" xlink:label="lab_dmtk_ReclassificationOfWarrantLiabilityDueToPrivateSPACWarrantsNotHeldByOriginalHolder" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Reclassification of warrant liability due to Private SPAC Warrants not held by original holder</link:label>
    <link:label id="lab_dmtk_ReclassificationOfWarrantLiabilityDueToPrivateSPACWarrantsNotHeldByOriginalHolder_label_en-US" xlink:label="lab_dmtk_ReclassificationOfWarrantLiabilityDueToPrivateSPACWarrantsNotHeldByOriginalHolder" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Reclassification Of Warrant Liability Due To Private SPAC Warrants Not Held By Original Holder</link:label>
    <link:label id="lab_dmtk_ReclassificationOfWarrantLiabilityDueToPrivateSPACWarrantsNotHeldByOriginalHolder_documentation_en-US" xlink:label="lab_dmtk_ReclassificationOfWarrantLiabilityDueToPrivateSPACWarrantsNotHeldByOriginalHolder" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Reclassification of warrant liability due to private SPAC warrants not held by original holder.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dmtk_ReclassificationOfWarrantLiabilityDueToPrivateSPACWarrantsNotHeldByOriginalHolder" xlink:href="dmtk-20220630.xsd#dmtk_ReclassificationOfWarrantLiabilityDueToPrivateSPACWarrantsNotHeldByOriginalHolder"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dmtk_ReclassificationOfWarrantLiabilityDueToPrivateSPACWarrantsNotHeldByOriginalHolder" xlink:to="lab_dmtk_ReclassificationOfWarrantLiabilityDueToPrivateSPACWarrantsNotHeldByOriginalHolder" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PriorPeriodReclassificationAdjustmentDescription_8d7300c2-a66f-4458-8072-d7a79f968626_terseLabel_en-US" xlink:label="lab_us-gaap_PriorPeriodReclassificationAdjustmentDescription" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Reclassifications</link:label>
    <link:label id="lab_us-gaap_PriorPeriodReclassificationAdjustmentDescription_label_en-US" xlink:label="lab_us-gaap_PriorPeriodReclassificationAdjustmentDescription" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Reclassification, Comparability Adjustment [Policy Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PriorPeriodReclassificationAdjustmentDescription" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PriorPeriodReclassificationAdjustmentDescription"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PriorPeriodReclassificationAdjustmentDescription" xlink:to="lab_us-gaap_PriorPeriodReclassificationAdjustmentDescription" xlink:type="arc" order="1"/>
    <link:label id="lab_dmtk_StockIssuedDuringPeriodSharesStockOptionsExercisedAndRSURelease_32c05faf-7524-45cc-a7f4-b84f014cf216_terseLabel_en-US" xlink:label="lab_dmtk_StockIssuedDuringPeriodSharesStockOptionsExercisedAndRSURelease" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Issuance of common stock from option exercises and RSU releases (in shares)</link:label>
    <link:label id="lab_dmtk_StockIssuedDuringPeriodSharesStockOptionsExercisedAndRSURelease_label_en-US" xlink:label="lab_dmtk_StockIssuedDuringPeriodSharesStockOptionsExercisedAndRSURelease" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Stock Issued During Period, Shares, Stock Options Exercised And RSU Release</link:label>
    <link:label id="lab_dmtk_StockIssuedDuringPeriodSharesStockOptionsExercisedAndRSURelease_documentation_en-US" xlink:label="lab_dmtk_StockIssuedDuringPeriodSharesStockOptionsExercisedAndRSURelease" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Stock issued during period shares stock options exercised and RSU release.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dmtk_StockIssuedDuringPeriodSharesStockOptionsExercisedAndRSURelease" xlink:href="dmtk-20220630.xsd#dmtk_StockIssuedDuringPeriodSharesStockOptionsExercisedAndRSURelease"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dmtk_StockIssuedDuringPeriodSharesStockOptionsExercisedAndRSURelease" xlink:to="lab_dmtk_StockIssuedDuringPeriodSharesStockOptionsExercisedAndRSURelease" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DisaggregationOfRevenueTableTextBlock_3b88be65-7017-4fa6-9170-e5b8715370f7_terseLabel_en-US" xlink:label="lab_us-gaap_DisaggregationOfRevenueTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Revenues Disaggregated by Revenue Source</link:label>
    <link:label id="lab_us-gaap_DisaggregationOfRevenueTableTextBlock_label_en-US" xlink:label="lab_us-gaap_DisaggregationOfRevenueTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Disaggregation of Revenue [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisaggregationOfRevenueTableTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DisaggregationOfRevenueTableTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DisaggregationOfRevenueTableTextBlock" xlink:to="lab_us-gaap_DisaggregationOfRevenueTableTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_dmtk_NumberOfRevenueStreams_c9766307-9a42-4c4d-8f33-1a3a32bb421b_terseLabel_en-US" xlink:label="lab_dmtk_NumberOfRevenueStreams" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Number of revenue streams (in number of streams)</link:label>
    <link:label id="lab_dmtk_NumberOfRevenueStreams_label_en-US" xlink:label="lab_dmtk_NumberOfRevenueStreams" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Number Of Revenue Streams</link:label>
    <link:label id="lab_dmtk_NumberOfRevenueStreams_documentation_en-US" xlink:label="lab_dmtk_NumberOfRevenueStreams" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Number of revenue streams.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dmtk_NumberOfRevenueStreams" xlink:href="dmtk-20220630.xsd#dmtk_NumberOfRevenueStreams"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dmtk_NumberOfRevenueStreams" xlink:to="lab_dmtk_NumberOfRevenueStreams" xlink:type="arc" order="1"/>
    <link:label id="lab_dmtk_DermTechOperationsIncMember_f4e0f2a1-faa2-49de-9eff-3933d95ad6df_terseLabel_en-US" xlink:label="lab_dmtk_DermTechOperationsIncMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">DermTech Operations</link:label>
    <link:label id="lab_dmtk_DermTechOperationsIncMember_label_en-US" xlink:label="lab_dmtk_DermTechOperationsIncMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Derm Tech Operations Inc [Member]</link:label>
    <link:label id="lab_dmtk_DermTechOperationsIncMember_documentation_en-US" xlink:label="lab_dmtk_DermTechOperationsIncMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">DermTech Operations, Inc.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dmtk_DermTechOperationsIncMember" xlink:href="dmtk-20220630.xsd#dmtk_DermTechOperationsIncMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dmtk_DermTechOperationsIncMember" xlink:to="lab_dmtk_DermTechOperationsIncMember" xlink:type="arc" order="1"/>
    <link:label id="lab_dmtk_SpouseOfChiefCommercialOfficerMember_d47650eb-ba1a-4d1b-a869-0362a70c002b_terseLabel_en-US" xlink:label="lab_dmtk_SpouseOfChiefCommercialOfficerMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Leana Wood</link:label>
    <link:label id="lab_dmtk_SpouseOfChiefCommercialOfficerMember_label_en-US" xlink:label="lab_dmtk_SpouseOfChiefCommercialOfficerMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Spouse Of Chief Commercial Officer [Member]</link:label>
    <link:label id="lab_dmtk_SpouseOfChiefCommercialOfficerMember_documentation_en-US" xlink:label="lab_dmtk_SpouseOfChiefCommercialOfficerMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Spouse of chief commercial officer.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dmtk_SpouseOfChiefCommercialOfficerMember" xlink:href="dmtk-20220630.xsd#dmtk_SpouseOfChiefCommercialOfficerMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dmtk_SpouseOfChiefCommercialOfficerMember" xlink:to="lab_dmtk_SpouseOfChiefCommercialOfficerMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationCalculationRollForward_27114cc1-ef7f-4a81-a391-b54db2e38a59_terseLabel_en-US" xlink:label="lab_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationCalculationRollForward" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Value, Liabilities Measured on Recurring Basis, Unobservable Input Reconciliation, Calculation [Roll Forward]</link:label>
    <link:label id="lab_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationCalculationRollForward_label_en-US" xlink:label="lab_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationCalculationRollForward" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Value, Liabilities Measured on Recurring Basis, Unobservable Input Reconciliation, Calculation [Roll Forward]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationCalculationRollForward" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationCalculationRollForward"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationCalculationRollForward" xlink:to="lab_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationCalculationRollForward" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect_1b0ec10e-1864-419c-8d32-d3731ead1297_totalLabel_en-US" xlink:label="lab_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net (decrease)/increase in cash, cash equivalents and restricted cash</link:label>
    <link:label id="lab_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect_label_en-US" xlink:label="lab_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cash, Cash Equivalents, Restricted Cash, and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect" xlink:to="lab_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect" xlink:type="arc" order="1"/>
    <link:label id="lab_dmtk_PercentageOfPriceAtSharesPurchased_b2572b56-0112-4733-8c33-466d1500b28c_terseLabel_en-US" xlink:label="lab_dmtk_PercentageOfPriceAtSharesPurchased" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Percentage of price at shares purchased</link:label>
    <link:label id="lab_dmtk_PercentageOfPriceAtSharesPurchased_label_en-US" xlink:label="lab_dmtk_PercentageOfPriceAtSharesPurchased" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Percentage Of Price At Shares Purchased</link:label>
    <link:label id="lab_dmtk_PercentageOfPriceAtSharesPurchased_documentation_en-US" xlink:label="lab_dmtk_PercentageOfPriceAtSharesPurchased" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Percentage of price at shares purchased</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dmtk_PercentageOfPriceAtSharesPurchased" xlink:href="dmtk-20220630.xsd#dmtk_PercentageOfPriceAtSharesPurchased"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dmtk_PercentageOfPriceAtSharesPurchased" xlink:to="lab_dmtk_PercentageOfPriceAtSharesPurchased" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityCentralIndexKey_3d5a947a-d119-41a5-b222-8a54d1865f3b_terseLabel_en-US" xlink:label="lab_dei_EntityCentralIndexKey" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Central Index Key</link:label>
    <link:label id="lab_dei_EntityCentralIndexKey_label_en-US" xlink:label="lab_dei_EntityCentralIndexKey" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Central Index Key</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityCentralIndexKey" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityCentralIndexKey"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityCentralIndexKey" xlink:to="lab_dei_EntityCentralIndexKey" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AntidilutiveSecuritiesNameDomain_2eec49db-015b-43a7-ab0d-8a7c7bd2211e_terseLabel_en-US" xlink:label="lab_us-gaap_AntidilutiveSecuritiesNameDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Antidilutive Securities, Name</link:label>
    <link:label id="lab_us-gaap_AntidilutiveSecuritiesNameDomain_label_en-US" xlink:label="lab_us-gaap_AntidilutiveSecuritiesNameDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Antidilutive Securities, Name [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AntidilutiveSecuritiesNameDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AntidilutiveSecuritiesNameDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AntidilutiveSecuritiesNameDomain" xlink:to="lab_us-gaap_AntidilutiveSecuritiesNameDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_NoncashOrPartNoncashAcquisitionFixedAssetsAcquired1_e045ea54-b2d3-4f2e-86f5-4caa286e4338_terseLabel_en-US" xlink:label="lab_us-gaap_NoncashOrPartNoncashAcquisitionFixedAssetsAcquired1" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Property and equipment acquired under finance leases</link:label>
    <link:label id="lab_us-gaap_NoncashOrPartNoncashAcquisitionFixedAssetsAcquired1_label_en-US" xlink:label="lab_us-gaap_NoncashOrPartNoncashAcquisitionFixedAssetsAcquired1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Noncash or Part Noncash Acquisition, Fixed Assets Acquired</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NoncashOrPartNoncashAcquisitionFixedAssetsAcquired1" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NoncashOrPartNoncashAcquisitionFixedAssetsAcquired1"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_NoncashOrPartNoncashAcquisitionFixedAssetsAcquired1" xlink:to="lab_us-gaap_NoncashOrPartNoncashAcquisitionFixedAssetsAcquired1" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FairValueByMeasurementFrequencyAxis_3d57f0a0-1ce5-4d47-8427-ffbce315ed86_terseLabel_en-US" xlink:label="lab_us-gaap_FairValueByMeasurementFrequencyAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Measurement Frequency</link:label>
    <link:label id="lab_us-gaap_FairValueByMeasurementFrequencyAxis_label_en-US" xlink:label="lab_us-gaap_FairValueByMeasurementFrequencyAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Measurement Frequency [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueByMeasurementFrequencyAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueByMeasurementFrequencyAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FairValueByMeasurementFrequencyAxis" xlink:to="lab_us-gaap_FairValueByMeasurementFrequencyAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_dmtk_CommitmentsAndContingenciesLineItems_a586705e-1654-49ea-9f2d-e0e0e32f7587_terseLabel_en-US" xlink:label="lab_dmtk_CommitmentsAndContingenciesLineItems" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Commitments And Contingencies [Line Items]</link:label>
    <link:label id="lab_dmtk_CommitmentsAndContingenciesLineItems_label_en-US" xlink:label="lab_dmtk_CommitmentsAndContingenciesLineItems" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Commitments And Contingencies [Line Items]</link:label>
    <link:label id="lab_dmtk_CommitmentsAndContingenciesLineItems_documentation_en-US" xlink:label="lab_dmtk_CommitmentsAndContingenciesLineItems" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Commitments and contingencies.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dmtk_CommitmentsAndContingenciesLineItems" xlink:href="dmtk-20220630.xsd#dmtk_CommitmentsAndContingenciesLineItems"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dmtk_CommitmentsAndContingenciesLineItems" xlink:to="lab_dmtk_CommitmentsAndContingenciesLineItems" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_bf658d17-aa22-4161-a3ac-6240863ba693_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule Of Share Based Compensation Arrangements By Share Based Payment Award [Table]</link:label>
    <link:label id="lab_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_label_en-US" xlink:label="lab_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Share-Based Compensation Arrangements by Share-Based Payment Award [Table]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable" xlink:to="lab_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ConcentrationRiskCreditRisk_e70655df-7f81-4de5-9cb5-d732a239a60d_terseLabel_en-US" xlink:label="lab_us-gaap_ConcentrationRiskCreditRisk" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Concentration of Credit Risk</link:label>
    <link:label id="lab_us-gaap_ConcentrationRiskCreditRisk_label_en-US" xlink:label="lab_us-gaap_ConcentrationRiskCreditRisk" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Concentration Risk, Credit Risk, Policy [Policy Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ConcentrationRiskCreditRisk" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ConcentrationRiskCreditRisk"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ConcentrationRiskCreditRisk" xlink:to="lab_us-gaap_ConcentrationRiskCreditRisk" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OtherAccruedLiabilitiesCurrent_f205463c-1d58-4b23-9d41-165a88275579_terseLabel_en-US" xlink:label="lab_us-gaap_OtherAccruedLiabilitiesCurrent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other accrued expenses</link:label>
    <link:label id="lab_us-gaap_OtherAccruedLiabilitiesCurrent_label_en-US" xlink:label="lab_us-gaap_OtherAccruedLiabilitiesCurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Accrued Liabilities, Current</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherAccruedLiabilitiesCurrent" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherAccruedLiabilitiesCurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OtherAccruedLiabilitiesCurrent" xlink:to="lab_us-gaap_OtherAccruedLiabilitiesCurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_dmtk_OperatingLeaseIncrementalBorrowingRateAtEffectiveDate_c699bd1e-50fe-474a-8e90-75472e57a50e_terseLabel_en-US" xlink:label="lab_dmtk_OperatingLeaseIncrementalBorrowingRateAtEffectiveDate" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Incremental borrowing rate</link:label>
    <link:label id="lab_dmtk_OperatingLeaseIncrementalBorrowingRateAtEffectiveDate_label_en-US" xlink:label="lab_dmtk_OperatingLeaseIncrementalBorrowingRateAtEffectiveDate" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Operating Lease, Incremental Borrowing Rate At Effective Date</link:label>
    <link:label id="lab_dmtk_OperatingLeaseIncrementalBorrowingRateAtEffectiveDate_documentation_en-US" xlink:label="lab_dmtk_OperatingLeaseIncrementalBorrowingRateAtEffectiveDate" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Operating Lease, Incremental Borrowing Rate At Effective Date</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dmtk_OperatingLeaseIncrementalBorrowingRateAtEffectiveDate" xlink:href="dmtk-20220630.xsd#dmtk_OperatingLeaseIncrementalBorrowingRateAtEffectiveDate"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dmtk_OperatingLeaseIncrementalBorrowingRateAtEffectiveDate" xlink:to="lab_dmtk_OperatingLeaseIncrementalBorrowingRateAtEffectiveDate" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_TypeOfAdoptionMember_5c2452d8-ea02-4dc9-85a7-c54f7c8e4aa1_terseLabel_en-US" xlink:label="lab_us-gaap_TypeOfAdoptionMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accounting Standards Update [Domain]</link:label>
    <link:label id="lab_us-gaap_TypeOfAdoptionMember_label_en-US" xlink:label="lab_us-gaap_TypeOfAdoptionMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accounting Standards Update [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TypeOfAdoptionMember" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_TypeOfAdoptionMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_TypeOfAdoptionMember" xlink:to="lab_us-gaap_TypeOfAdoptionMember" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_CityAreaCode_8e85f79b-9906-4416-b8e3-22de78e2cb0a_terseLabel_en-US" xlink:label="lab_dei_CityAreaCode" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">City Area Code</link:label>
    <link:label id="lab_dei_CityAreaCode_label_en-US" xlink:label="lab_dei_CityAreaCode" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">City Area Code</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_CityAreaCode" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_CityAreaCode"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_CityAreaCode" xlink:to="lab_dei_CityAreaCode" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_GeneralAndAdministrativeExpense_96231af6-01f6-4aa4-b4b0-b0ae9abce1fd_terseLabel_en-US" xlink:label="lab_us-gaap_GeneralAndAdministrativeExpense" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">General and administrative</link:label>
    <link:label id="lab_us-gaap_GeneralAndAdministrativeExpense_label_en-US" xlink:label="lab_us-gaap_GeneralAndAdministrativeExpense" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">General and Administrative Expense</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GeneralAndAdministrativeExpense" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_GeneralAndAdministrativeExpense"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_GeneralAndAdministrativeExpense" xlink:to="lab_us-gaap_GeneralAndAdministrativeExpense" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AssetsAbstract_2bc059b9-d649-49db-83ad-aa1473f7f27a_terseLabel_en-US" xlink:label="lab_us-gaap_AssetsAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Assets</link:label>
    <link:label id="lab_us-gaap_AssetsAbstract_label_en-US" xlink:label="lab_us-gaap_AssetsAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Assets [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AssetsAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AssetsAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AssetsAbstract" xlink:to="lab_us-gaap_AssetsAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CommitmentsDisclosureTextBlock_36d3d9c6-41d5-436b-a6c2-bf3110a184ce_terseLabel_en-US" xlink:label="lab_us-gaap_CommitmentsDisclosureTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Leases, Commitments and Contingencies</link:label>
    <link:label id="lab_us-gaap_CommitmentsDisclosureTextBlock_label_en-US" xlink:label="lab_us-gaap_CommitmentsDisclosureTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Commitments Disclosure [Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommitmentsDisclosureTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CommitmentsDisclosureTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CommitmentsDisclosureTextBlock" xlink:to="lab_us-gaap_CommitmentsDisclosureTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_StatementOfStockholdersEquityAbstract_d0b9e000-dff6-4d21-b192-f824c5d87e8d_terseLabel_en-US" xlink:label="lab_us-gaap_StatementOfStockholdersEquityAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Statement of Stockholders' Equity [Abstract]</link:label>
    <link:label id="lab_us-gaap_StatementOfStockholdersEquityAbstract_label_en-US" xlink:label="lab_us-gaap_StatementOfStockholdersEquityAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Statement of Stockholders' Equity [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementOfStockholdersEquityAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StatementOfStockholdersEquityAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StatementOfStockholdersEquityAbstract" xlink:to="lab_us-gaap_StatementOfStockholdersEquityAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_SubsidiarySaleOfStockAxis_7ed661a6-1a81-46d8-a19e-697a2c4d6fbe_terseLabel_en-US" xlink:label="lab_us-gaap_SubsidiarySaleOfStockAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Sale of Stock</link:label>
    <link:label id="lab_us-gaap_SubsidiarySaleOfStockAxis_label_en-US" xlink:label="lab_us-gaap_SubsidiarySaleOfStockAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Sale of Stock [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SubsidiarySaleOfStockAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SubsidiarySaleOfStockAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SubsidiarySaleOfStockAxis" xlink:to="lab_us-gaap_SubsidiarySaleOfStockAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract_ddd76e7b-be6b-4235-852b-43c106eccdd7_terseLabel_en-US" xlink:label="lab_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cash flows from financing activities:</link:label>
    <link:label id="lab_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract_label_en-US" xlink:label="lab_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net Cash Provided by (Used in) Financing Activities [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract" xlink:to="lab_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_dmtk_AdjustmentsToAdditionalPaidInCapitalWarrantIssuedShares_5f797424-c1c0-4392-9cdb-0cfec288147d_terseLabel_en-US" xlink:label="lab_dmtk_AdjustmentsToAdditionalPaidInCapitalWarrantIssuedShares" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Issuance of common stock from warrant exercises (in shares)</link:label>
    <link:label id="lab_dmtk_AdjustmentsToAdditionalPaidInCapitalWarrantIssuedShares_label_en-US" xlink:label="lab_dmtk_AdjustmentsToAdditionalPaidInCapitalWarrantIssuedShares" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Adjustments to Additional Paid in Capital, Warrant Issued, Shares</link:label>
    <link:label id="lab_dmtk_AdjustmentsToAdditionalPaidInCapitalWarrantIssuedShares_documentation_en-US" xlink:label="lab_dmtk_AdjustmentsToAdditionalPaidInCapitalWarrantIssuedShares" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Adjustments to Additional Paid in Capital, Warrant Issued, Shares</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dmtk_AdjustmentsToAdditionalPaidInCapitalWarrantIssuedShares" xlink:href="dmtk-20220630.xsd#dmtk_AdjustmentsToAdditionalPaidInCapitalWarrantIssuedShares"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dmtk_AdjustmentsToAdditionalPaidInCapitalWarrantIssuedShares" xlink:to="lab_dmtk_AdjustmentsToAdditionalPaidInCapitalWarrantIssuedShares" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_EarningsPerSharePolicyTextBlock_c25cb0ce-03e5-4805-bb8a-3c8e652d504c_terseLabel_en-US" xlink:label="lab_us-gaap_EarningsPerSharePolicyTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net Loss Per Share</link:label>
    <link:label id="lab_us-gaap_EarningsPerSharePolicyTextBlock_label_en-US" xlink:label="lab_us-gaap_EarningsPerSharePolicyTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Earnings Per Share, Policy [Policy Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EarningsPerSharePolicyTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EarningsPerSharePolicyTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_EarningsPerSharePolicyTextBlock" xlink:to="lab_us-gaap_EarningsPerSharePolicyTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensation_e902bbce-09f8-4f4a-8fcf-a4de06728bb6_terseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensation" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Stock-based compensation</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensation_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensation" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-Based Payment Arrangement, Noncash Expense</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensation" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensation"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensation" xlink:to="lab_us-gaap_ShareBasedCompensation" xlink:type="arc" order="1"/>
    <link:label id="lab_dmtk_NumberOfWarrantsEntitleHolderToPurchaseOneShare_e80726dd-b7b1-4302-b60b-f45587d86421_terseLabel_en-US" xlink:label="lab_dmtk_NumberOfWarrantsEntitleHolderToPurchaseOneShare" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Number of warrants entitle holder to purchase one share</link:label>
    <link:label id="lab_dmtk_NumberOfWarrantsEntitleHolderToPurchaseOneShare_label_en-US" xlink:label="lab_dmtk_NumberOfWarrantsEntitleHolderToPurchaseOneShare" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Number Of Warrants Entitle Holder To Purchase One Share</link:label>
    <link:label id="lab_dmtk_NumberOfWarrantsEntitleHolderToPurchaseOneShare_documentation_en-US" xlink:label="lab_dmtk_NumberOfWarrantsEntitleHolderToPurchaseOneShare" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Number of warrants entitle holder to purchase one share.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dmtk_NumberOfWarrantsEntitleHolderToPurchaseOneShare" xlink:href="dmtk-20220630.xsd#dmtk_NumberOfWarrantsEntitleHolderToPurchaseOneShare"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dmtk_NumberOfWarrantsEntitleHolderToPurchaseOneShare" xlink:to="lab_dmtk_NumberOfWarrantsEntitleHolderToPurchaseOneShare" xlink:type="arc" order="1"/>
    <link:label id="lab_dmtk_ContractRevenueRNAExtractionsMember_52329510-48c1-41d0-986d-823145008383_terseLabel_en-US" xlink:label="lab_dmtk_ContractRevenueRNAExtractionsMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">RNA extractions</link:label>
    <link:label id="lab_dmtk_ContractRevenueRNAExtractionsMember_label_en-US" xlink:label="lab_dmtk_ContractRevenueRNAExtractionsMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Contract Revenue R N A Extractions [Member]</link:label>
    <link:label id="lab_dmtk_ContractRevenueRNAExtractionsMember_documentation_en-US" xlink:label="lab_dmtk_ContractRevenueRNAExtractionsMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Contract revenue, RNA extractions.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dmtk_ContractRevenueRNAExtractionsMember" xlink:href="dmtk-20220630.xsd#dmtk_ContractRevenueRNAExtractionsMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dmtk_ContractRevenueRNAExtractionsMember" xlink:to="lab_dmtk_ContractRevenueRNAExtractionsMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FinanceLeaseLiabilityUndiscountedExcessAmount_446e094d-d5e6-4136-873c-22f7ef518f8b_negatedLabel_en-US" xlink:label="lab_us-gaap_FinanceLeaseLiabilityUndiscountedExcessAmount" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Less imputed interest</link:label>
    <link:label id="lab_us-gaap_FinanceLeaseLiabilityUndiscountedExcessAmount_label_en-US" xlink:label="lab_us-gaap_FinanceLeaseLiabilityUndiscountedExcessAmount" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Finance Lease, Liability, Undiscounted Excess Amount</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FinanceLeaseLiabilityUndiscountedExcessAmount" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FinanceLeaseLiabilityUndiscountedExcessAmount"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FinanceLeaseLiabilityUndiscountedExcessAmount" xlink:to="lab_us-gaap_FinanceLeaseLiabilityUndiscountedExcessAmount" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ClassOfWarrantOrRightOutstanding_b4ff1a8b-32a1-4d3b-baa1-f976bd6dd35a_terseLabel_en-US" xlink:label="lab_us-gaap_ClassOfWarrantOrRightOutstanding" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Warrants outstanding (in shares)</link:label>
    <link:label id="lab_us-gaap_ClassOfWarrantOrRightOutstanding_label_en-US" xlink:label="lab_us-gaap_ClassOfWarrantOrRightOutstanding" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Class of Warrant or Right, Outstanding</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ClassOfWarrantOrRightOutstanding" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ClassOfWarrantOrRightOutstanding"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ClassOfWarrantOrRightOutstanding" xlink:to="lab_us-gaap_ClassOfWarrantOrRightOutstanding" xlink:type="arc" order="1"/>
    <link:label id="lab_dmtk_IncreaseInTenantImprovementAllowance_added89c-590d-4aa5-a2ad-7b098c857933_terseLabel_en-US" xlink:label="lab_dmtk_IncreaseInTenantImprovementAllowance" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Increase in tenant improvement allowance</link:label>
    <link:label id="lab_dmtk_IncreaseInTenantImprovementAllowance_label_en-US" xlink:label="lab_dmtk_IncreaseInTenantImprovementAllowance" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Increase In Tenant Improvement Allowance</link:label>
    <link:label id="lab_dmtk_IncreaseInTenantImprovementAllowance_documentation_en-US" xlink:label="lab_dmtk_IncreaseInTenantImprovementAllowance" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Increase in tenant improvement allowance.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dmtk_IncreaseInTenantImprovementAllowance" xlink:href="dmtk-20220630.xsd#dmtk_IncreaseInTenantImprovementAllowance"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dmtk_IncreaseInTenantImprovementAllowance" xlink:to="lab_dmtk_IncreaseInTenantImprovementAllowance" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PaymentsToAcquirePropertyPlantAndEquipment_827e3440-a820-46bb-90d9-b1a7b7472e79_negatedLabel_en-US" xlink:label="lab_us-gaap_PaymentsToAcquirePropertyPlantAndEquipment" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Purchases of property and equipment</link:label>
    <link:label id="lab_us-gaap_PaymentsToAcquirePropertyPlantAndEquipment_label_en-US" xlink:label="lab_us-gaap_PaymentsToAcquirePropertyPlantAndEquipment" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Payments to Acquire Property, Plant, and Equipment</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsToAcquirePropertyPlantAndEquipment" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PaymentsToAcquirePropertyPlantAndEquipment"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PaymentsToAcquirePropertyPlantAndEquipment" xlink:to="lab_us-gaap_PaymentsToAcquirePropertyPlantAndEquipment" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_MachineryAndEquipmentGross_d051324e-a4f4-4a6e-a4c1-10ccc1b09900_terseLabel_en-US" xlink:label="lab_us-gaap_MachineryAndEquipmentGross" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Laboratory equipment</link:label>
    <link:label id="lab_us-gaap_MachineryAndEquipmentGross_label_en-US" xlink:label="lab_us-gaap_MachineryAndEquipmentGross" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Machinery and Equipment, Gross</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_MachineryAndEquipmentGross" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_MachineryAndEquipmentGross"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_MachineryAndEquipmentGross" xlink:to="lab_us-gaap_MachineryAndEquipmentGross" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ResearchAndDevelopmentExpenseMember_66bf0df4-15c8-45a6-96aa-8674af18ece9_terseLabel_en-US" xlink:label="lab_us-gaap_ResearchAndDevelopmentExpenseMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Research and development</link:label>
    <link:label id="lab_us-gaap_ResearchAndDevelopmentExpenseMember_label_en-US" xlink:label="lab_us-gaap_ResearchAndDevelopmentExpenseMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Research and Development Expense [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ResearchAndDevelopmentExpenseMember" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ResearchAndDevelopmentExpenseMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ResearchAndDevelopmentExpenseMember" xlink:to="lab_us-gaap_ResearchAndDevelopmentExpenseMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DisaggregationOfRevenueLineItems_28298bfc-71e6-4ce9-8992-9de86065d366_terseLabel_en-US" xlink:label="lab_us-gaap_DisaggregationOfRevenueLineItems" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Disaggregation Of Revenue [Line Items]</link:label>
    <link:label id="lab_us-gaap_DisaggregationOfRevenueLineItems_label_en-US" xlink:label="lab_us-gaap_DisaggregationOfRevenueLineItems" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Disaggregation of Revenue [Line Items]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisaggregationOfRevenueLineItems" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DisaggregationOfRevenueLineItems"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DisaggregationOfRevenueLineItems" xlink:to="lab_us-gaap_DisaggregationOfRevenueLineItems" xlink:type="arc" order="1"/>
    <link:label id="lab_dmtk_AtTheMarketOfferingMember_4818958c-d814-452e-930d-e3722a2b1c85_terseLabel_en-US" xlink:label="lab_dmtk_AtTheMarketOfferingMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">At-The Market Offering</link:label>
    <link:label id="lab_dmtk_AtTheMarketOfferingMember_label_en-US" xlink:label="lab_dmtk_AtTheMarketOfferingMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">At The Market Offering [Member]</link:label>
    <link:label id="lab_dmtk_AtTheMarketOfferingMember_documentation_en-US" xlink:label="lab_dmtk_AtTheMarketOfferingMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">At the market offering.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dmtk_AtTheMarketOfferingMember" xlink:href="dmtk-20220630.xsd#dmtk_AtTheMarketOfferingMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dmtk_AtTheMarketOfferingMember" xlink:to="lab_dmtk_AtTheMarketOfferingMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability_e1489e2d-37a4-4e8a-ba15-bce85c022dc9_terseLabel_en-US" xlink:label="lab_us-gaap_RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Right-of-use assets obtained in exchange for lease obligations</link:label>
    <link:label id="lab_us-gaap_RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability_528e5ea7-9aea-427b-95e7-b7c2d7a83876_verboseLabel_en-US" xlink:label="lab_us-gaap_RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Right-of-use assets obtained in exchange for operating lease obligations</link:label>
    <link:label id="lab_us-gaap_RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability_label_en-US" xlink:label="lab_us-gaap_RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Right-of-Use Asset Obtained in Exchange for Operating Lease Liability</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability" xlink:to="lab_us-gaap_RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CostOfSalesMember_20d831e9-478e-4670-b1d1-259ac77f5b05_terseLabel_en-US" xlink:label="lab_us-gaap_CostOfSalesMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cost of revenue</link:label>
    <link:label id="lab_us-gaap_CostOfSalesMember_label_en-US" xlink:label="lab_us-gaap_CostOfSalesMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cost of Sales [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CostOfSalesMember" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CostOfSalesMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CostOfSalesMember" xlink:to="lab_us-gaap_CostOfSalesMember" xlink:type="arc" order="1"/>
  </link:labelLink>
</link:linkbase>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-101.PRE
<SEQUENCE>12
<FILENAME>dmtk-20220630_pre.xml
<DESCRIPTION>XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT
<TEXT>
<XBRL>
<?xml version="1.0" encoding="UTF-8"?>

<!--XBRL Document Created with Wdesk from Workiva-->
<!--Copyright 2022 Workiva-->
<!--r:00c1bec6-bc29-44ad-a3fa-8dd942e770ac,g:dd828811-c245-4da7-9eef-30b71a6b7e18-->
<link:linkbase xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xsi:schemaLocation="http://www.xbrl.org/2003/linkbase http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd">
  <link:roleRef roleURI="http://dermtech.com/role/CoverPage" xlink:type="simple" xlink:href="dmtk-20220630.xsd#CoverPage"/>
  <link:presentationLink xlink:role="http://dermtech.com/role/CoverPage" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_dei_CoverAbstract_a39e8c06-4093-4318-a7d8-1d5a73d8fabb" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_CoverAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_DocumentType_f2c5b7a5-1c2d-4161-b8a4-bad1d0fb7edc" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_DocumentType"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_a39e8c06-4093-4318-a7d8-1d5a73d8fabb" xlink:to="loc_dei_DocumentType_f2c5b7a5-1c2d-4161-b8a4-bad1d0fb7edc" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_DocumentQuarterlyReport_a2aaa559-3e00-4b10-bd3f-ac8dd3cd724f" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_DocumentQuarterlyReport"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_a39e8c06-4093-4318-a7d8-1d5a73d8fabb" xlink:to="loc_dei_DocumentQuarterlyReport_a2aaa559-3e00-4b10-bd3f-ac8dd3cd724f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_DocumentPeriodEndDate_2edce89e-a417-4a3c-9457-3c868899cfa5" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_DocumentPeriodEndDate"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_a39e8c06-4093-4318-a7d8-1d5a73d8fabb" xlink:to="loc_dei_DocumentPeriodEndDate_2edce89e-a417-4a3c-9457-3c868899cfa5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_DocumentTransitionReport_32d4587a-a8e4-4f27-9ef9-e35269f7bc59" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_DocumentTransitionReport"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_a39e8c06-4093-4318-a7d8-1d5a73d8fabb" xlink:to="loc_dei_DocumentTransitionReport_32d4587a-a8e4-4f27-9ef9-e35269f7bc59" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityFileNumber_b2dd68f7-a86a-4a73-815a-b64117f1e4d1" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityFileNumber"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_a39e8c06-4093-4318-a7d8-1d5a73d8fabb" xlink:to="loc_dei_EntityFileNumber_b2dd68f7-a86a-4a73-815a-b64117f1e4d1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityRegistrantName_949e7133-5917-4079-af89-e64fa1c4accf" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityRegistrantName"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_a39e8c06-4093-4318-a7d8-1d5a73d8fabb" xlink:to="loc_dei_EntityRegistrantName_949e7133-5917-4079-af89-e64fa1c4accf" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityIncorporationStateCountryCode_31460ec4-c04f-496f-95e1-eb4c7686cd29" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityIncorporationStateCountryCode"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_a39e8c06-4093-4318-a7d8-1d5a73d8fabb" xlink:to="loc_dei_EntityIncorporationStateCountryCode_31460ec4-c04f-496f-95e1-eb4c7686cd29" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityTaxIdentificationNumber_7c8bde54-7d52-4033-b5e1-3a8abee784b8" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityTaxIdentificationNumber"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_a39e8c06-4093-4318-a7d8-1d5a73d8fabb" xlink:to="loc_dei_EntityTaxIdentificationNumber_7c8bde54-7d52-4033-b5e1-3a8abee784b8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityAddressAddressLine1_22bb0886-20f9-4057-9232-adfd4fbe77c7" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityAddressAddressLine1"/>
    <link:presentationArc order="9" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_a39e8c06-4093-4318-a7d8-1d5a73d8fabb" xlink:to="loc_dei_EntityAddressAddressLine1_22bb0886-20f9-4057-9232-adfd4fbe77c7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityAddressAddressLine2_fe1836dd-50a3-4da6-bd15-59af0170e94f" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityAddressAddressLine2"/>
    <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_a39e8c06-4093-4318-a7d8-1d5a73d8fabb" xlink:to="loc_dei_EntityAddressAddressLine2_fe1836dd-50a3-4da6-bd15-59af0170e94f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityAddressCityOrTown_783c539a-4de6-4ae4-b356-bb62e48d5a41" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityAddressCityOrTown"/>
    <link:presentationArc order="11" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_a39e8c06-4093-4318-a7d8-1d5a73d8fabb" xlink:to="loc_dei_EntityAddressCityOrTown_783c539a-4de6-4ae4-b356-bb62e48d5a41" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityAddressStateOrProvince_b802531c-8d00-4452-b10f-3ffe70b8a32d" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityAddressStateOrProvince"/>
    <link:presentationArc order="12" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_a39e8c06-4093-4318-a7d8-1d5a73d8fabb" xlink:to="loc_dei_EntityAddressStateOrProvince_b802531c-8d00-4452-b10f-3ffe70b8a32d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityAddressPostalZipCode_5f7c6600-0c02-4675-a87e-42249fd6764f" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityAddressPostalZipCode"/>
    <link:presentationArc order="13" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_a39e8c06-4093-4318-a7d8-1d5a73d8fabb" xlink:to="loc_dei_EntityAddressPostalZipCode_5f7c6600-0c02-4675-a87e-42249fd6764f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_CityAreaCode_75650289-35f5-450c-b5a8-5bfbbb3bd4e7" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_CityAreaCode"/>
    <link:presentationArc order="14" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_a39e8c06-4093-4318-a7d8-1d5a73d8fabb" xlink:to="loc_dei_CityAreaCode_75650289-35f5-450c-b5a8-5bfbbb3bd4e7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_LocalPhoneNumber_93da9625-5e42-48a3-84c0-b8f43bb525b1" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_LocalPhoneNumber"/>
    <link:presentationArc order="15" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_a39e8c06-4093-4318-a7d8-1d5a73d8fabb" xlink:to="loc_dei_LocalPhoneNumber_93da9625-5e42-48a3-84c0-b8f43bb525b1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_Security12bTitle_10acaf7c-9c44-4a74-8dfd-6390ac76fe2c" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_Security12bTitle"/>
    <link:presentationArc order="16" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_a39e8c06-4093-4318-a7d8-1d5a73d8fabb" xlink:to="loc_dei_Security12bTitle_10acaf7c-9c44-4a74-8dfd-6390ac76fe2c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_TradingSymbol_7b439980-6532-4238-ae48-9e6b760a646a" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_TradingSymbol"/>
    <link:presentationArc order="17" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_a39e8c06-4093-4318-a7d8-1d5a73d8fabb" xlink:to="loc_dei_TradingSymbol_7b439980-6532-4238-ae48-9e6b760a646a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_SecurityExchangeName_b25fd3f6-1e33-436c-a051-112c4f6867f4" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_SecurityExchangeName"/>
    <link:presentationArc order="18" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_a39e8c06-4093-4318-a7d8-1d5a73d8fabb" xlink:to="loc_dei_SecurityExchangeName_b25fd3f6-1e33-436c-a051-112c4f6867f4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityCurrentReportingStatus_6a64b5e2-7949-46fe-863d-571f585eb9d5" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityCurrentReportingStatus"/>
    <link:presentationArc order="19" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_a39e8c06-4093-4318-a7d8-1d5a73d8fabb" xlink:to="loc_dei_EntityCurrentReportingStatus_6a64b5e2-7949-46fe-863d-571f585eb9d5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityInteractiveDataCurrent_662a521c-2b52-4eb1-85b3-203c9b4aed62" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityInteractiveDataCurrent"/>
    <link:presentationArc order="20" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_a39e8c06-4093-4318-a7d8-1d5a73d8fabb" xlink:to="loc_dei_EntityInteractiveDataCurrent_662a521c-2b52-4eb1-85b3-203c9b4aed62" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityFilerCategory_ffcc8ea3-eda5-47bc-bb94-0ce319c5bf6d" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityFilerCategory"/>
    <link:presentationArc order="21" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_a39e8c06-4093-4318-a7d8-1d5a73d8fabb" xlink:to="loc_dei_EntityFilerCategory_ffcc8ea3-eda5-47bc-bb94-0ce319c5bf6d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntitySmallBusiness_5163303f-693a-498d-be8a-e1470122dcb7" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntitySmallBusiness"/>
    <link:presentationArc order="22" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_a39e8c06-4093-4318-a7d8-1d5a73d8fabb" xlink:to="loc_dei_EntitySmallBusiness_5163303f-693a-498d-be8a-e1470122dcb7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityEmergingGrowthCompany_5c033e00-e116-4a18-9d69-121050bc4229" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityEmergingGrowthCompany"/>
    <link:presentationArc order="23" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_a39e8c06-4093-4318-a7d8-1d5a73d8fabb" xlink:to="loc_dei_EntityEmergingGrowthCompany_5c033e00-e116-4a18-9d69-121050bc4229" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityShellCompany_f4158970-0690-42c6-86a0-a1303bff5cd1" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityShellCompany"/>
    <link:presentationArc order="24" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_a39e8c06-4093-4318-a7d8-1d5a73d8fabb" xlink:to="loc_dei_EntityShellCompany_f4158970-0690-42c6-86a0-a1303bff5cd1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityCommonStockSharesOutstanding_cd65365e-9791-4450-a9a5-6baceb074e29" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityCommonStockSharesOutstanding"/>
    <link:presentationArc order="25" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_a39e8c06-4093-4318-a7d8-1d5a73d8fabb" xlink:to="loc_dei_EntityCommonStockSharesOutstanding_cd65365e-9791-4450-a9a5-6baceb074e29" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityCentralIndexKey_527fb979-5cd1-4795-9668-d4bfde7c33b9" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityCentralIndexKey"/>
    <link:presentationArc order="26" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_a39e8c06-4093-4318-a7d8-1d5a73d8fabb" xlink:to="loc_dei_EntityCentralIndexKey_527fb979-5cd1-4795-9668-d4bfde7c33b9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_CurrentFiscalYearEndDate_da444523-c72f-41df-8318-366c5198316b" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_CurrentFiscalYearEndDate"/>
    <link:presentationArc order="27" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_a39e8c06-4093-4318-a7d8-1d5a73d8fabb" xlink:to="loc_dei_CurrentFiscalYearEndDate_da444523-c72f-41df-8318-366c5198316b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_DocumentFiscalYearFocus_437b3d41-b62a-4922-bfb1-54df228d516a" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_DocumentFiscalYearFocus"/>
    <link:presentationArc order="28" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_a39e8c06-4093-4318-a7d8-1d5a73d8fabb" xlink:to="loc_dei_DocumentFiscalYearFocus_437b3d41-b62a-4922-bfb1-54df228d516a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_DocumentFiscalPeriodFocus_ca328cf1-ae78-4237-98e6-89e6406e0ad2" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_DocumentFiscalPeriodFocus"/>
    <link:presentationArc order="29" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_a39e8c06-4093-4318-a7d8-1d5a73d8fabb" xlink:to="loc_dei_DocumentFiscalPeriodFocus_ca328cf1-ae78-4237-98e6-89e6406e0ad2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_AmendmentFlag_830166f7-8754-4fc3-ae58-03a4cada8f38" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_AmendmentFlag"/>
    <link:presentationArc order="30" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_a39e8c06-4093-4318-a7d8-1d5a73d8fabb" xlink:to="loc_dei_AmendmentFlag_830166f7-8754-4fc3-ae58-03a4cada8f38" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://dermtech.com/role/CondensedConsolidatedBalanceSheets" xlink:type="simple" xlink:href="dmtk-20220630.xsd#CondensedConsolidatedBalanceSheets"/>
  <link:presentationLink xlink:role="http://dermtech.com/role/CondensedConsolidatedBalanceSheets" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementOfFinancialPositionAbstract_5c316d62-1f46-4163-be8b-5f1d35b7be93" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StatementOfFinancialPositionAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AssetsAbstract_40bd693a-6253-407c-94b2-6993023879f9" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AssetsAbstract"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfFinancialPositionAbstract_5c316d62-1f46-4163-be8b-5f1d35b7be93" xlink:to="loc_us-gaap_AssetsAbstract_40bd693a-6253-407c-94b2-6993023879f9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AssetsCurrentAbstract_55139aa9-6354-4cf6-af26-723e011579b3" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AssetsCurrentAbstract"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AssetsAbstract_40bd693a-6253-407c-94b2-6993023879f9" xlink:to="loc_us-gaap_AssetsCurrentAbstract_55139aa9-6354-4cf6-af26-723e011579b3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashAndCashEquivalentsAtCarryingValue_d0858d9a-853c-4838-ab05-5e3d945d7fb2" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CashAndCashEquivalentsAtCarryingValue"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AssetsCurrentAbstract_55139aa9-6354-4cf6-af26-723e011579b3" xlink:to="loc_us-gaap_CashAndCashEquivalentsAtCarryingValue_d0858d9a-853c-4838-ab05-5e3d945d7fb2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_MarketableSecuritiesCurrent_62749b79-aeaa-4088-b2e5-1e0820f07e04" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_MarketableSecuritiesCurrent"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AssetsCurrentAbstract_55139aa9-6354-4cf6-af26-723e011579b3" xlink:to="loc_us-gaap_MarketableSecuritiesCurrent_62749b79-aeaa-4088-b2e5-1e0820f07e04" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccountsReceivableNetCurrent_81d0eadc-f69c-4c1d-bce0-659cd914b69e" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AccountsReceivableNetCurrent"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AssetsCurrentAbstract_55139aa9-6354-4cf6-af26-723e011579b3" xlink:to="loc_us-gaap_AccountsReceivableNetCurrent_81d0eadc-f69c-4c1d-bce0-659cd914b69e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InventoryNet_77a9854d-0e19-4aac-9593-4bf59cb1a7b3" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_InventoryNet"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AssetsCurrentAbstract_55139aa9-6354-4cf6-af26-723e011579b3" xlink:to="loc_us-gaap_InventoryNet_77a9854d-0e19-4aac-9593-4bf59cb1a7b3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PrepaidExpenseAndOtherAssetsCurrent_adefb463-269e-457a-b964-33cce857e8ec" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PrepaidExpenseAndOtherAssetsCurrent"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AssetsCurrentAbstract_55139aa9-6354-4cf6-af26-723e011579b3" xlink:to="loc_us-gaap_PrepaidExpenseAndOtherAssetsCurrent_adefb463-269e-457a-b964-33cce857e8ec" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AssetsCurrent_9f949a59-5ef1-4abf-ba5d-cd0dc3ef9210" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AssetsCurrent"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AssetsCurrentAbstract_55139aa9-6354-4cf6-af26-723e011579b3" xlink:to="loc_us-gaap_AssetsCurrent_9f949a59-5ef1-4abf-ba5d-cd0dc3ef9210" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentNet_46edf4a0-3d47-46cd-be96-9f9e9a2270a9" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PropertyPlantAndEquipmentNet"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AssetsAbstract_40bd693a-6253-407c-94b2-6993023879f9" xlink:to="loc_us-gaap_PropertyPlantAndEquipmentNet_46edf4a0-3d47-46cd-be96-9f9e9a2270a9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeaseRightOfUseAsset_119494f2-d9b5-4541-a938-585602ddd211" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OperatingLeaseRightOfUseAsset"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AssetsAbstract_40bd693a-6253-407c-94b2-6993023879f9" xlink:to="loc_us-gaap_OperatingLeaseRightOfUseAsset_119494f2-d9b5-4541-a938-585602ddd211" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestrictedCashNoncurrent_1d0f0693-4f17-4fac-8e7e-1999d7882888" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RestrictedCashNoncurrent"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AssetsAbstract_40bd693a-6253-407c-94b2-6993023879f9" xlink:to="loc_us-gaap_RestrictedCashNoncurrent_1d0f0693-4f17-4fac-8e7e-1999d7882888" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherAssetsNoncurrent_5145029d-43bf-4372-b9c1-bd6084d069a3" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherAssetsNoncurrent"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AssetsAbstract_40bd693a-6253-407c-94b2-6993023879f9" xlink:to="loc_us-gaap_OtherAssetsNoncurrent_5145029d-43bf-4372-b9c1-bd6084d069a3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Assets_47f7a19a-8825-46ff-b103-7569c4dba9cc" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_Assets"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AssetsAbstract_40bd693a-6253-407c-94b2-6993023879f9" xlink:to="loc_us-gaap_Assets_47f7a19a-8825-46ff-b103-7569c4dba9cc" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilitiesAndStockholdersEquityAbstract_cc63a337-9585-4940-ac14-7bbd232b126b" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LiabilitiesAndStockholdersEquityAbstract"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfFinancialPositionAbstract_5c316d62-1f46-4163-be8b-5f1d35b7be93" xlink:to="loc_us-gaap_LiabilitiesAndStockholdersEquityAbstract_cc63a337-9585-4940-ac14-7bbd232b126b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilitiesCurrentAbstract_d0d3d4a9-665c-4d3c-92ec-283299a8df78" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LiabilitiesCurrentAbstract"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilitiesAndStockholdersEquityAbstract_cc63a337-9585-4940-ac14-7bbd232b126b" xlink:to="loc_us-gaap_LiabilitiesCurrentAbstract_d0d3d4a9-665c-4d3c-92ec-283299a8df78" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccountsPayableCurrent_73b7f8eb-18d6-4baa-8de6-b0b770392773" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AccountsPayableCurrent"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilitiesCurrentAbstract_d0d3d4a9-665c-4d3c-92ec-283299a8df78" xlink:to="loc_us-gaap_AccountsPayableCurrent_73b7f8eb-18d6-4baa-8de6-b0b770392773" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EmployeeRelatedLiabilitiesCurrent_f6ad7fd0-82fb-4920-98a2-d4e51365ea74" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EmployeeRelatedLiabilitiesCurrent"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilitiesCurrentAbstract_d0d3d4a9-665c-4d3c-92ec-283299a8df78" xlink:to="loc_us-gaap_EmployeeRelatedLiabilitiesCurrent_f6ad7fd0-82fb-4920-98a2-d4e51365ea74" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccruedLiabilitiesCurrent_23e23c36-d3a9-46a7-8fd7-d0bdee673100" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AccruedLiabilitiesCurrent"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilitiesCurrentAbstract_d0d3d4a9-665c-4d3c-92ec-283299a8df78" xlink:to="loc_us-gaap_AccruedLiabilitiesCurrent_23e23c36-d3a9-46a7-8fd7-d0bdee673100" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredRevenueCurrent_0a017323-9bf9-4806-a612-8b5b6ddadfad" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DeferredRevenueCurrent"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilitiesCurrentAbstract_d0d3d4a9-665c-4d3c-92ec-283299a8df78" xlink:to="loc_us-gaap_DeferredRevenueCurrent_0a017323-9bf9-4806-a612-8b5b6ddadfad" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeaseLiabilityCurrent_310d95cd-578d-4ccf-b54e-8ac9cd96048f" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OperatingLeaseLiabilityCurrent"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilitiesCurrentAbstract_d0d3d4a9-665c-4d3c-92ec-283299a8df78" xlink:to="loc_us-gaap_OperatingLeaseLiabilityCurrent_310d95cd-578d-4ccf-b54e-8ac9cd96048f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FinanceLeaseLiabilityCurrent_649f9b53-44e7-4f34-a055-c5d16ad3f6c6" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FinanceLeaseLiabilityCurrent"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilitiesCurrentAbstract_d0d3d4a9-665c-4d3c-92ec-283299a8df78" xlink:to="loc_us-gaap_FinanceLeaseLiabilityCurrent_649f9b53-44e7-4f34-a055-c5d16ad3f6c6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilitiesCurrent_d5683696-c8e0-4410-b645-55cad79eba53" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LiabilitiesCurrent"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilitiesCurrentAbstract_d0d3d4a9-665c-4d3c-92ec-283299a8df78" xlink:to="loc_us-gaap_LiabilitiesCurrent_d5683696-c8e0-4410-b645-55cad79eba53" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_WarrantsAndRightsOutstanding_25a12988-9b30-4843-80cd-bd0deee04b98" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_WarrantsAndRightsOutstanding"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilitiesAndStockholdersEquityAbstract_cc63a337-9585-4940-ac14-7bbd232b126b" xlink:to="loc_us-gaap_WarrantsAndRightsOutstanding_25a12988-9b30-4843-80cd-bd0deee04b98" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FinanceLeaseLiabilityNoncurrent_515365e9-d07d-4bfa-9b37-16d375222ae7" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FinanceLeaseLiabilityNoncurrent"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilitiesAndStockholdersEquityAbstract_cc63a337-9585-4940-ac14-7bbd232b126b" xlink:to="loc_us-gaap_FinanceLeaseLiabilityNoncurrent_515365e9-d07d-4bfa-9b37-16d375222ae7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeaseLiabilityNoncurrent_2ca553f0-fea1-4e95-923a-4022a3a93cb4" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OperatingLeaseLiabilityNoncurrent"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilitiesAndStockholdersEquityAbstract_cc63a337-9585-4940-ac14-7bbd232b126b" xlink:to="loc_us-gaap_OperatingLeaseLiabilityNoncurrent_2ca553f0-fea1-4e95-923a-4022a3a93cb4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Liabilities_f06c1fab-bb96-4cd2-b18a-0edf3370ec71" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_Liabilities"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilitiesAndStockholdersEquityAbstract_cc63a337-9585-4940-ac14-7bbd232b126b" xlink:to="loc_us-gaap_Liabilities_f06c1fab-bb96-4cd2-b18a-0edf3370ec71" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockholdersEquityAbstract_14aafef4-de6d-4d81-863b-1074f80cfdc4" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StockholdersEquityAbstract"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfFinancialPositionAbstract_5c316d62-1f46-4163-be8b-5f1d35b7be93" xlink:to="loc_us-gaap_StockholdersEquityAbstract_14aafef4-de6d-4d81-863b-1074f80cfdc4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockValue_c2a60a5c-3ed5-4fa1-8291-027b1fedcb13" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CommonStockValue"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StockholdersEquityAbstract_14aafef4-de6d-4d81-863b-1074f80cfdc4" xlink:to="loc_us-gaap_CommonStockValue_c2a60a5c-3ed5-4fa1-8291-027b1fedcb13" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AdditionalPaidInCapitalCommonStock_80fc1477-8052-4233-a0b1-dd33d4ca4e7e" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AdditionalPaidInCapitalCommonStock"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StockholdersEquityAbstract_14aafef4-de6d-4d81-863b-1074f80cfdc4" xlink:to="loc_us-gaap_AdditionalPaidInCapitalCommonStock_80fc1477-8052-4233-a0b1-dd33d4ca4e7e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax_c708e334-5ca9-47b3-a8ce-44c452eccd37" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StockholdersEquityAbstract_14aafef4-de6d-4d81-863b-1074f80cfdc4" xlink:to="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax_c708e334-5ca9-47b3-a8ce-44c452eccd37" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RetainedEarningsAccumulatedDeficit_2391c984-a109-4d00-a583-f01c256cfa55" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RetainedEarningsAccumulatedDeficit"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StockholdersEquityAbstract_14aafef4-de6d-4d81-863b-1074f80cfdc4" xlink:to="loc_us-gaap_RetainedEarningsAccumulatedDeficit_2391c984-a109-4d00-a583-f01c256cfa55" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockholdersEquity_c0c9e057-a185-42c3-9ca9-aa4dc5ac3309" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StockholdersEquity"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StockholdersEquityAbstract_14aafef4-de6d-4d81-863b-1074f80cfdc4" xlink:to="loc_us-gaap_StockholdersEquity_c0c9e057-a185-42c3-9ca9-aa4dc5ac3309" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilitiesAndStockholdersEquity_653a5e36-e646-41a4-9d5f-c4f04404fcd9" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LiabilitiesAndStockholdersEquity"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfFinancialPositionAbstract_5c316d62-1f46-4163-be8b-5f1d35b7be93" xlink:to="loc_us-gaap_LiabilitiesAndStockholdersEquity_653a5e36-e646-41a4-9d5f-c4f04404fcd9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://dermtech.com/role/CondensedConsolidatedBalanceSheetsParenthetical" xlink:type="simple" xlink:href="dmtk-20220630.xsd#CondensedConsolidatedBalanceSheetsParenthetical"/>
  <link:presentationLink xlink:role="http://dermtech.com/role/CondensedConsolidatedBalanceSheetsParenthetical" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementOfFinancialPositionAbstract_cd81a426-85c6-4149-96b2-14db12c4fc0d" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StatementOfFinancialPositionAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockParOrStatedValuePerShare_688e7e92-c903-4fc1-b3dc-93b86225dd5d" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CommonStockParOrStatedValuePerShare"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfFinancialPositionAbstract_cd81a426-85c6-4149-96b2-14db12c4fc0d" xlink:to="loc_us-gaap_CommonStockParOrStatedValuePerShare_688e7e92-c903-4fc1-b3dc-93b86225dd5d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockSharesAuthorized_03bfc520-c6e1-4d72-99e3-11c10c7ef39e" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CommonStockSharesAuthorized"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfFinancialPositionAbstract_cd81a426-85c6-4149-96b2-14db12c4fc0d" xlink:to="loc_us-gaap_CommonStockSharesAuthorized_03bfc520-c6e1-4d72-99e3-11c10c7ef39e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockSharesIssued_6046832f-dd8d-4283-a261-fa07545692d3" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CommonStockSharesIssued"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfFinancialPositionAbstract_cd81a426-85c6-4149-96b2-14db12c4fc0d" xlink:to="loc_us-gaap_CommonStockSharesIssued_6046832f-dd8d-4283-a261-fa07545692d3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockSharesOutstanding_6f3f3f8e-6fc4-455b-963f-4d3e79513c46" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CommonStockSharesOutstanding"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfFinancialPositionAbstract_cd81a426-85c6-4149-96b2-14db12c4fc0d" xlink:to="loc_us-gaap_CommonStockSharesOutstanding_6f3f3f8e-6fc4-455b-963f-4d3e79513c46" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://dermtech.com/role/CondensedConsolidatedStatementsofOperations" xlink:type="simple" xlink:href="dmtk-20220630.xsd#CondensedConsolidatedStatementsofOperations"/>
  <link:presentationLink xlink:role="http://dermtech.com/role/CondensedConsolidatedStatementsofOperations" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeStatementAbstract_5ec073d3-d27c-410f-abaa-97385fa788ab" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeStatementAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementTable_de9271b0-469c-409f-9e91-5dc0b37f57c9" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StatementTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementAbstract_5ec073d3-d27c-410f-abaa-97385fa788ab" xlink:to="loc_us-gaap_StatementTable_de9271b0-469c-409f-9e91-5dc0b37f57c9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ProductOrServiceAxis_0889972a-d70c-449b-b7b2-1c703ad07d55" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_ProductOrServiceAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementTable_de9271b0-469c-409f-9e91-5dc0b37f57c9" xlink:to="loc_srt_ProductOrServiceAxis_0889972a-d70c-449b-b7b2-1c703ad07d55" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ProductsAndServicesDomain_c4f0baee-2d4c-4df2-8971-58e87ed49022" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_ProductsAndServicesDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_ProductOrServiceAxis_0889972a-d70c-449b-b7b2-1c703ad07d55" xlink:to="loc_srt_ProductsAndServicesDomain_c4f0baee-2d4c-4df2-8971-58e87ed49022" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dmtk_AssayMember_9b8effeb-2e3d-49bb-839f-06f64efd0c0f" xlink:href="dmtk-20220630.xsd#dmtk_AssayMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_ProductsAndServicesDomain_c4f0baee-2d4c-4df2-8971-58e87ed49022" xlink:to="loc_dmtk_AssayMember_9b8effeb-2e3d-49bb-839f-06f64efd0c0f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dmtk_ContractualActivitiesMember_ce9ce47e-5841-4155-80ad-1c34febf9186" xlink:href="dmtk-20220630.xsd#dmtk_ContractualActivitiesMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_ProductsAndServicesDomain_c4f0baee-2d4c-4df2-8971-58e87ed49022" xlink:to="loc_dmtk_ContractualActivitiesMember_ce9ce47e-5841-4155-80ad-1c34febf9186" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementLineItems_2af1aebd-be4e-4c85-a656-882c109b648f" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StatementLineItems"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementTable_de9271b0-469c-409f-9e91-5dc0b37f57c9" xlink:to="loc_us-gaap_StatementLineItems_2af1aebd-be4e-4c85-a656-882c109b648f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevenuesAbstract_9b4efb19-04c6-4281-af01-c6759460fabd" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RevenuesAbstract"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementLineItems_2af1aebd-be4e-4c85-a656-882c109b648f" xlink:to="loc_us-gaap_RevenuesAbstract_9b4efb19-04c6-4281-af01-c6759460fabd" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevenueFromContractWithCustomerIncludingAssessedTax_c8cee43e-6a02-4e31-988c-0910b282a838" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RevenueFromContractWithCustomerIncludingAssessedTax"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RevenuesAbstract_9b4efb19-04c6-4281-af01-c6759460fabd" xlink:to="loc_us-gaap_RevenueFromContractWithCustomerIncludingAssessedTax_c8cee43e-6a02-4e31-988c-0910b282a838" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CostOfRevenueAbstract_751f74ef-4318-41c6-947a-93d860bb37d3" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CostOfRevenueAbstract"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementLineItems_2af1aebd-be4e-4c85-a656-882c109b648f" xlink:to="loc_us-gaap_CostOfRevenueAbstract_751f74ef-4318-41c6-947a-93d860bb37d3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CostOfRevenue_13f33b09-217e-4eea-b1e0-63de35b616ed" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CostOfRevenue"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_CostOfRevenueAbstract_751f74ef-4318-41c6-947a-93d860bb37d3" xlink:to="loc_us-gaap_CostOfRevenue_13f33b09-217e-4eea-b1e0-63de35b616ed" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GrossProfit_141d12c7-0072-4da2-8778-457944f5ba2c" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_GrossProfit"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_CostOfRevenueAbstract_751f74ef-4318-41c6-947a-93d860bb37d3" xlink:to="loc_us-gaap_GrossProfit_141d12c7-0072-4da2-8778-457944f5ba2c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingExpensesAbstract_a4334561-cd47-4a61-b1af-59941960d883" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OperatingExpensesAbstract"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementLineItems_2af1aebd-be4e-4c85-a656-882c109b648f" xlink:to="loc_us-gaap_OperatingExpensesAbstract_a4334561-cd47-4a61-b1af-59941960d883" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SellingAndMarketingExpense_fafb1220-9ddc-4e9e-9962-cd97cbae8bc1" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SellingAndMarketingExpense"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OperatingExpensesAbstract_a4334561-cd47-4a61-b1af-59941960d883" xlink:to="loc_us-gaap_SellingAndMarketingExpense_fafb1220-9ddc-4e9e-9962-cd97cbae8bc1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ResearchAndDevelopmentExpense_894fbfdb-d9a3-4aed-abfe-fe342ffada73" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ResearchAndDevelopmentExpense"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OperatingExpensesAbstract_a4334561-cd47-4a61-b1af-59941960d883" xlink:to="loc_us-gaap_ResearchAndDevelopmentExpense_894fbfdb-d9a3-4aed-abfe-fe342ffada73" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GeneralAndAdministrativeExpense_ed3192de-dca1-458c-bc9e-1abb45dbb941" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_GeneralAndAdministrativeExpense"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OperatingExpensesAbstract_a4334561-cd47-4a61-b1af-59941960d883" xlink:to="loc_us-gaap_GeneralAndAdministrativeExpense_ed3192de-dca1-458c-bc9e-1abb45dbb941" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingExpenses_8a3cf02e-3e8b-473a-aa26-e462fc6af8e1" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OperatingExpenses"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OperatingExpensesAbstract_a4334561-cd47-4a61-b1af-59941960d883" xlink:to="loc_us-gaap_OperatingExpenses_8a3cf02e-3e8b-473a-aa26-e462fc6af8e1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingIncomeLoss_17012ba1-8c13-492f-a052-4a2ebcb9e379" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OperatingIncomeLoss"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementLineItems_2af1aebd-be4e-4c85-a656-882c109b648f" xlink:to="loc_us-gaap_OperatingIncomeLoss_17012ba1-8c13-492f-a052-4a2ebcb9e379" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NonoperatingIncomeExpenseAbstract_33e5a4f1-80fc-42be-a4ac-772b90369c13" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NonoperatingIncomeExpenseAbstract"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementLineItems_2af1aebd-be4e-4c85-a656-882c109b648f" xlink:to="loc_us-gaap_NonoperatingIncomeExpenseAbstract_33e5a4f1-80fc-42be-a4ac-772b90369c13" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InterestIncomeExpenseNonoperatingNet_7d54e0d5-5efe-4642-a2c0-103af807eb68" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_InterestIncomeExpenseNonoperatingNet"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NonoperatingIncomeExpenseAbstract_33e5a4f1-80fc-42be-a4ac-772b90369c13" xlink:to="loc_us-gaap_InterestIncomeExpenseNonoperatingNet_7d54e0d5-5efe-4642-a2c0-103af807eb68" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueAdjustmentOfWarrants_949374e8-0a06-478f-94ff-b3f541e63531" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueAdjustmentOfWarrants"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NonoperatingIncomeExpenseAbstract_33e5a4f1-80fc-42be-a4ac-772b90369c13" xlink:to="loc_us-gaap_FairValueAdjustmentOfWarrants_949374e8-0a06-478f-94ff-b3f541e63531" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NonoperatingIncomeExpense_992da3fe-7d0f-46eb-80f8-f2d25c252d77" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NonoperatingIncomeExpense"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NonoperatingIncomeExpenseAbstract_33e5a4f1-80fc-42be-a4ac-772b90369c13" xlink:to="loc_us-gaap_NonoperatingIncomeExpense_992da3fe-7d0f-46eb-80f8-f2d25c252d77" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetIncomeLoss_68a6c3f7-33a2-4edb-bb53-1bf71ae13160" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NetIncomeLoss"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementLineItems_2af1aebd-be4e-4c85-a656-882c109b648f" xlink:to="loc_us-gaap_NetIncomeLoss_68a6c3f7-33a2-4edb-bb53-1bf71ae13160" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic_94ab4263-c080-4a73-96a9-b11556982b00" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_WeightedAverageNumberOfSharesOutstandingBasic"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementLineItems_2af1aebd-be4e-4c85-a656-882c109b648f" xlink:to="loc_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic_94ab4263-c080-4a73-96a9-b11556982b00" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding_08e3fd73-fbb7-4546-80bc-106a69c6ed30" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementLineItems_2af1aebd-be4e-4c85-a656-882c109b648f" xlink:to="loc_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding_08e3fd73-fbb7-4546-80bc-106a69c6ed30" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EarningsPerShareBasic_4a3e3124-eee0-4a73-994c-2ddddec0010a" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EarningsPerShareBasic"/>
    <link:presentationArc order="9" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementLineItems_2af1aebd-be4e-4c85-a656-882c109b648f" xlink:to="loc_us-gaap_EarningsPerShareBasic_4a3e3124-eee0-4a73-994c-2ddddec0010a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EarningsPerShareDiluted_bcd718c1-3b5b-43c7-9ba2-a186ecfbd0bf" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EarningsPerShareDiluted"/>
    <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementLineItems_2af1aebd-be4e-4c85-a656-882c109b648f" xlink:to="loc_us-gaap_EarningsPerShareDiluted_bcd718c1-3b5b-43c7-9ba2-a186ecfbd0bf" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://dermtech.com/role/CondensedConsolidatedStatementsofComprehensiveLoss" xlink:type="simple" xlink:href="dmtk-20220630.xsd#CondensedConsolidatedStatementsofComprehensiveLoss"/>
  <link:presentationLink xlink:role="http://dermtech.com/role/CondensedConsolidatedStatementsofComprehensiveLoss" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementOfIncomeAndComprehensiveIncomeAbstract_28ec83f7-2740-4b61-9ac8-25543d10d21a" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StatementOfIncomeAndComprehensiveIncomeAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetIncomeLoss_e89efb1c-324c-4523-8a40-84ec4c943443" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NetIncomeLoss"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfIncomeAndComprehensiveIncomeAbstract_28ec83f7-2740-4b61-9ac8-25543d10d21a" xlink:to="loc_us-gaap_NetIncomeLoss_e89efb1c-324c-4523-8a40-84ec4c943443" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax_54c55ccf-666b-47f2-859c-74933d98125e" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfIncomeAndComprehensiveIncomeAbstract_28ec83f7-2740-4b61-9ac8-25543d10d21a" xlink:to="loc_us-gaap_OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax_54c55ccf-666b-47f2-859c-74933d98125e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ComprehensiveIncomeNetOfTax_e889946f-b880-47e9-b0dd-0e5a9f3f1b54" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ComprehensiveIncomeNetOfTax"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfIncomeAndComprehensiveIncomeAbstract_28ec83f7-2740-4b61-9ac8-25543d10d21a" xlink:to="loc_us-gaap_ComprehensiveIncomeNetOfTax_e889946f-b880-47e9-b0dd-0e5a9f3f1b54" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://dermtech.com/role/CondensedConsolidatedStatementsofStockholdersEquity" xlink:type="simple" xlink:href="dmtk-20220630.xsd#CondensedConsolidatedStatementsofStockholdersEquity"/>
  <link:presentationLink xlink:role="http://dermtech.com/role/CondensedConsolidatedStatementsofStockholdersEquity" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementOfStockholdersEquityAbstract_be1596f7-7e23-4721-ba18-e47eed8b1d18" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StatementOfStockholdersEquityAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementTable_10b6eb0c-8506-4921-b45f-f26b77cb681c" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StatementTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfStockholdersEquityAbstract_be1596f7-7e23-4721-ba18-e47eed8b1d18" xlink:to="loc_us-gaap_StatementTable_10b6eb0c-8506-4921-b45f-f26b77cb681c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementEquityComponentsAxis_98339414-d941-4fe6-a355-fb9abc08d8f1" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StatementEquityComponentsAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementTable_10b6eb0c-8506-4921-b45f-f26b77cb681c" xlink:to="loc_us-gaap_StatementEquityComponentsAxis_98339414-d941-4fe6-a355-fb9abc08d8f1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquityComponentDomain_3bf10d11-ae95-4561-a98c-f63eac81761f" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EquityComponentDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementEquityComponentsAxis_98339414-d941-4fe6-a355-fb9abc08d8f1" xlink:to="loc_us-gaap_EquityComponentDomain_3bf10d11-ae95-4561-a98c-f63eac81761f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockMember_5684db57-17a2-4af2-ae24-872570abc264" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CommonStockMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EquityComponentDomain_3bf10d11-ae95-4561-a98c-f63eac81761f" xlink:to="loc_us-gaap_CommonStockMember_5684db57-17a2-4af2-ae24-872570abc264" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AdditionalPaidInCapitalMember_ef76cc4c-9879-4811-8de3-c850ecd3ae69" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AdditionalPaidInCapitalMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EquityComponentDomain_3bf10d11-ae95-4561-a98c-f63eac81761f" xlink:to="loc_us-gaap_AdditionalPaidInCapitalMember_ef76cc4c-9879-4811-8de3-c850ecd3ae69" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccumulatedNetUnrealizedInvestmentGainLossMember_fe2a588a-7a8b-4886-a541-366453a3bffe" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AccumulatedNetUnrealizedInvestmentGainLossMember"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EquityComponentDomain_3bf10d11-ae95-4561-a98c-f63eac81761f" xlink:to="loc_us-gaap_AccumulatedNetUnrealizedInvestmentGainLossMember_fe2a588a-7a8b-4886-a541-366453a3bffe" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RetainedEarningsMember_b7fbe20d-d4da-4733-bafe-09e363a0c33d" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RetainedEarningsMember"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EquityComponentDomain_3bf10d11-ae95-4561-a98c-f63eac81761f" xlink:to="loc_us-gaap_RetainedEarningsMember_b7fbe20d-d4da-4733-bafe-09e363a0c33d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementLineItems_9c451478-d5f5-4a5c-b620-b3e5208d0027" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StatementLineItems"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementTable_10b6eb0c-8506-4921-b45f-f26b77cb681c" xlink:to="loc_us-gaap_StatementLineItems_9c451478-d5f5-4a5c-b620-b3e5208d0027" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SharesOutstanding_6853c7de-e48d-453a-aa0e-446456e4ae22" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SharesOutstanding"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementLineItems_9c451478-d5f5-4a5c-b620-b3e5208d0027" xlink:to="loc_us-gaap_SharesOutstanding_6853c7de-e48d-453a-aa0e-446456e4ae22" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodStartLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockholdersEquity_d53dc868-6db2-4338-95f5-5f5be1716f14" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StockholdersEquity"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementLineItems_9c451478-d5f5-4a5c-b620-b3e5208d0027" xlink:to="loc_us-gaap_StockholdersEquity_d53dc868-6db2-4338-95f5-5f5be1716f14" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodStartLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockIssuedDuringPeriodSharesNewIssues_d9762a31-08de-41c3-99f9-d7c93787e08d" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StockIssuedDuringPeriodSharesNewIssues"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementLineItems_9c451478-d5f5-4a5c-b620-b3e5208d0027" xlink:to="loc_us-gaap_StockIssuedDuringPeriodSharesNewIssues_d9762a31-08de-41c3-99f9-d7c93787e08d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockIssuedDuringPeriodValueNewIssues_5c7d8e21-52f0-4362-b97b-b39b0fdf1e8d" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StockIssuedDuringPeriodValueNewIssues"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementLineItems_9c451478-d5f5-4a5c-b620-b3e5208d0027" xlink:to="loc_us-gaap_StockIssuedDuringPeriodValueNewIssues_5c7d8e21-52f0-4362-b97b-b39b0fdf1e8d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dmtk_StockIssuedDuringPeriodSharesStockOptionsExercisedAndRSURelease_6b458a48-9114-437e-9107-ff3ebc588911" xlink:href="dmtk-20220630.xsd#dmtk_StockIssuedDuringPeriodSharesStockOptionsExercisedAndRSURelease"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementLineItems_9c451478-d5f5-4a5c-b620-b3e5208d0027" xlink:to="loc_dmtk_StockIssuedDuringPeriodSharesStockOptionsExercisedAndRSURelease_6b458a48-9114-437e-9107-ff3ebc588911" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dmtk_StockIssuedDuringPeriodValueStockOptionsExercisedAndRSURelease_7845e567-4658-4e99-b43a-67307be83ae6" xlink:href="dmtk-20220630.xsd#dmtk_StockIssuedDuringPeriodValueStockOptionsExercisedAndRSURelease"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementLineItems_9c451478-d5f5-4a5c-b620-b3e5208d0027" xlink:to="loc_dmtk_StockIssuedDuringPeriodValueStockOptionsExercisedAndRSURelease_7845e567-4658-4e99-b43a-67307be83ae6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dmtk_AdjustmentsToAdditionalPaidInCapitalWarrantIssuedShares_a009c208-8ca3-43f9-8fff-12aa4ac54d01" xlink:href="dmtk-20220630.xsd#dmtk_AdjustmentsToAdditionalPaidInCapitalWarrantIssuedShares"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementLineItems_9c451478-d5f5-4a5c-b620-b3e5208d0027" xlink:to="loc_dmtk_AdjustmentsToAdditionalPaidInCapitalWarrantIssuedShares_a009c208-8ca3-43f9-8fff-12aa4ac54d01" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AdjustmentsToAdditionalPaidInCapitalWarrantIssued_31d7cfb0-f5d8-43d2-8f67-4238d7f9a46c" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AdjustmentsToAdditionalPaidInCapitalWarrantIssued"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementLineItems_9c451478-d5f5-4a5c-b620-b3e5208d0027" xlink:to="loc_us-gaap_AdjustmentsToAdditionalPaidInCapitalWarrantIssued_31d7cfb0-f5d8-43d2-8f67-4238d7f9a46c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockIssuedDuringPeriodSharesEmployeeStockPurchasePlans_61803863-f049-4670-b1a9-679796cac7e4" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StockIssuedDuringPeriodSharesEmployeeStockPurchasePlans"/>
    <link:presentationArc order="9" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementLineItems_9c451478-d5f5-4a5c-b620-b3e5208d0027" xlink:to="loc_us-gaap_StockIssuedDuringPeriodSharesEmployeeStockPurchasePlans_61803863-f049-4670-b1a9-679796cac7e4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockIssuedDuringPeriodValueEmployeeStockPurchasePlan_59a2c992-76b1-4dfa-9b09-0b08bc766f54" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StockIssuedDuringPeriodValueEmployeeStockPurchasePlan"/>
    <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementLineItems_9c451478-d5f5-4a5c-b620-b3e5208d0027" xlink:to="loc_us-gaap_StockIssuedDuringPeriodValueEmployeeStockPurchasePlan_59a2c992-76b1-4dfa-9b09-0b08bc766f54" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax_7036b9be-782b-4830-a22d-e492a2e27cf4" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax"/>
    <link:presentationArc order="11" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementLineItems_9c451478-d5f5-4a5c-b620-b3e5208d0027" xlink:to="loc_us-gaap_OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax_7036b9be-782b-4830-a22d-e492a2e27cf4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue_bd5b8989-a4cf-4bb2-af25-f3b7ad9c5e67" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue"/>
    <link:presentationArc order="12" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementLineItems_9c451478-d5f5-4a5c-b620-b3e5208d0027" xlink:to="loc_us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue_bd5b8989-a4cf-4bb2-af25-f3b7ad9c5e67" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dmtk_ReclassificationOfWarrantLiabilityDueToPrivateSPACWarrantsNotHeldByOriginalHolder_d655bc4a-c2ab-46b1-ae2e-0ce2743b0cac" xlink:href="dmtk-20220630.xsd#dmtk_ReclassificationOfWarrantLiabilityDueToPrivateSPACWarrantsNotHeldByOriginalHolder"/>
    <link:presentationArc order="13" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementLineItems_9c451478-d5f5-4a5c-b620-b3e5208d0027" xlink:to="loc_dmtk_ReclassificationOfWarrantLiabilityDueToPrivateSPACWarrantsNotHeldByOriginalHolder_d655bc4a-c2ab-46b1-ae2e-0ce2743b0cac" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetIncomeLoss_0c3435fa-61b5-4c38-ac8e-e34deee7331c" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NetIncomeLoss"/>
    <link:presentationArc order="14" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementLineItems_9c451478-d5f5-4a5c-b620-b3e5208d0027" xlink:to="loc_us-gaap_NetIncomeLoss_0c3435fa-61b5-4c38-ac8e-e34deee7331c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SharesOutstanding_a51cb3a4-b210-47f7-8475-25a5f1e1a8a5" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SharesOutstanding"/>
    <link:presentationArc order="15" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementLineItems_9c451478-d5f5-4a5c-b620-b3e5208d0027" xlink:to="loc_us-gaap_SharesOutstanding_a51cb3a4-b210-47f7-8475-25a5f1e1a8a5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodEndLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockholdersEquity_cd67a1d7-3730-4ba6-ba07-c1f2707ad3c6" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StockholdersEquity"/>
    <link:presentationArc order="16" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementLineItems_9c451478-d5f5-4a5c-b620-b3e5208d0027" xlink:to="loc_us-gaap_StockholdersEquity_cd67a1d7-3730-4ba6-ba07-c1f2707ad3c6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodEndLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://dermtech.com/role/CondensedConsolidatedStatementsofStockholdersEquityParenthetical" xlink:type="simple" xlink:href="dmtk-20220630.xsd#CondensedConsolidatedStatementsofStockholdersEquityParenthetical"/>
  <link:presentationLink xlink:role="http://dermtech.com/role/CondensedConsolidatedStatementsofStockholdersEquityParenthetical" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementOfStockholdersEquityAbstract_4583e81b-0008-495a-9339-5628ff052327" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StatementOfStockholdersEquityAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementTable_e93f72ce-8e6b-4394-9a1f-bdaf17d6c330" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StatementTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfStockholdersEquityAbstract_4583e81b-0008-495a-9339-5628ff052327" xlink:to="loc_us-gaap_StatementTable_e93f72ce-8e6b-4394-9a1f-bdaf17d6c330" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementEquityComponentsAxis_36b5daf5-b862-4a6b-9d27-2086c33e8cbd" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StatementEquityComponentsAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementTable_e93f72ce-8e6b-4394-9a1f-bdaf17d6c330" xlink:to="loc_us-gaap_StatementEquityComponentsAxis_36b5daf5-b862-4a6b-9d27-2086c33e8cbd" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquityComponentDomain_cc371fb8-d8ad-460e-8f9e-4a8ed8a8bff3" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EquityComponentDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementEquityComponentsAxis_36b5daf5-b862-4a6b-9d27-2086c33e8cbd" xlink:to="loc_us-gaap_EquityComponentDomain_cc371fb8-d8ad-460e-8f9e-4a8ed8a8bff3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockMember_16ef982a-d349-456f-9fbf-47cf6a700e9e" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CommonStockMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EquityComponentDomain_cc371fb8-d8ad-460e-8f9e-4a8ed8a8bff3" xlink:to="loc_us-gaap_CommonStockMember_16ef982a-d349-456f-9fbf-47cf6a700e9e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SubsidiarySaleOfStockAxis_6380f9e8-fecd-4656-9627-ff0bd2061f06" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SubsidiarySaleOfStockAxis"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementTable_e93f72ce-8e6b-4394-9a1f-bdaf17d6c330" xlink:to="loc_us-gaap_SubsidiarySaleOfStockAxis_6380f9e8-fecd-4656-9627-ff0bd2061f06" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SaleOfStockNameOfTransactionDomain_2ec7b192-b364-4655-8d54-bc59312b85b3" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SaleOfStockNameOfTransactionDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SubsidiarySaleOfStockAxis_6380f9e8-fecd-4656-9627-ff0bd2061f06" xlink:to="loc_us-gaap_SaleOfStockNameOfTransactionDomain_2ec7b192-b364-4655-8d54-bc59312b85b3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dmtk_AtTheMarketOfferingMember_f44321ac-ef57-4436-999c-15f15c9d40ee" xlink:href="dmtk-20220630.xsd#dmtk_AtTheMarketOfferingMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SaleOfStockNameOfTransactionDomain_2ec7b192-b364-4655-8d54-bc59312b85b3" xlink:to="loc_dmtk_AtTheMarketOfferingMember_f44321ac-ef57-4436-999c-15f15c9d40ee" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementLineItems_fe4dd4af-81df-4a39-a3a1-fbcb0ed24dcb" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StatementLineItems"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementTable_e93f72ce-8e6b-4394-9a1f-bdaf17d6c330" xlink:to="loc_us-gaap_StatementLineItems_fe4dd4af-81df-4a39-a3a1-fbcb0ed24dcb" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SharesIssuedPricePerShare_975523e8-87ec-4b81-8740-eb8e4e7d4e24" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SharesIssuedPricePerShare"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementLineItems_fe4dd4af-81df-4a39-a3a1-fbcb0ed24dcb" xlink:to="loc_us-gaap_SharesIssuedPricePerShare_975523e8-87ec-4b81-8740-eb8e4e7d4e24" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AdjustmentsToAdditionalPaidInCapitalStockIssuedIssuanceCosts_afe3c55f-0766-456c-9cbb-72c5c51b7b7d" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AdjustmentsToAdditionalPaidInCapitalStockIssuedIssuanceCosts"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementLineItems_fe4dd4af-81df-4a39-a3a1-fbcb0ed24dcb" xlink:to="loc_us-gaap_AdjustmentsToAdditionalPaidInCapitalStockIssuedIssuanceCosts_afe3c55f-0766-456c-9cbb-72c5c51b7b7d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://dermtech.com/role/CondensedConsolidatedStatementsofCashFlows" xlink:type="simple" xlink:href="dmtk-20220630.xsd#CondensedConsolidatedStatementsofCashFlows"/>
  <link:presentationLink xlink:role="http://dermtech.com/role/CondensedConsolidatedStatementsofCashFlows" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementOfCashFlowsAbstract_2c6a0077-b19e-4aaf-af3c-248f3c7c79a6" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StatementOfCashFlowsAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementTable_eb71ec79-822e-477e-83da-9daeba64c09f" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StatementTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfCashFlowsAbstract_2c6a0077-b19e-4aaf-af3c-248f3c7c79a6" xlink:to="loc_us-gaap_StatementTable_eb71ec79-822e-477e-83da-9daeba64c09f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SubsidiarySaleOfStockAxis_5c667b1d-6dce-4ba7-ba0c-8bcbf422f769" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SubsidiarySaleOfStockAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementTable_eb71ec79-822e-477e-83da-9daeba64c09f" xlink:to="loc_us-gaap_SubsidiarySaleOfStockAxis_5c667b1d-6dce-4ba7-ba0c-8bcbf422f769" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SaleOfStockNameOfTransactionDomain_375a757e-8bea-4c0d-8d6d-bdd4d4688188" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SaleOfStockNameOfTransactionDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SubsidiarySaleOfStockAxis_5c667b1d-6dce-4ba7-ba0c-8bcbf422f769" xlink:to="loc_us-gaap_SaleOfStockNameOfTransactionDomain_375a757e-8bea-4c0d-8d6d-bdd4d4688188" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dmtk_PublicFollowOnOfferingMember_69bed3c5-15f4-4c15-b938-580b6dc5f7c4" xlink:href="dmtk-20220630.xsd#dmtk_PublicFollowOnOfferingMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SaleOfStockNameOfTransactionDomain_375a757e-8bea-4c0d-8d6d-bdd4d4688188" xlink:to="loc_dmtk_PublicFollowOnOfferingMember_69bed3c5-15f4-4c15-b938-580b6dc5f7c4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dmtk_AtTheMarketOfferingMember_4906c63b-a728-4e4d-b808-3b6c7b396a88" xlink:href="dmtk-20220630.xsd#dmtk_AtTheMarketOfferingMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SaleOfStockNameOfTransactionDomain_375a757e-8bea-4c0d-8d6d-bdd4d4688188" xlink:to="loc_dmtk_AtTheMarketOfferingMember_4906c63b-a728-4e4d-b808-3b6c7b396a88" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementLineItems_7dcde0ba-6240-4f9b-9270-45c944ca5c64" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StatementLineItems"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementTable_eb71ec79-822e-477e-83da-9daeba64c09f" xlink:to="loc_us-gaap_StatementLineItems_7dcde0ba-6240-4f9b-9270-45c944ca5c64" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract_dbac9c29-6cc5-40ff-a7dc-4886c9a80ae9" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementLineItems_7dcde0ba-6240-4f9b-9270-45c944ca5c64" xlink:to="loc_us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract_dbac9c29-6cc5-40ff-a7dc-4886c9a80ae9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProfitLoss_a0f50877-5984-4b3e-96ae-c641130881ad" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ProfitLoss"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract_dbac9c29-6cc5-40ff-a7dc-4886c9a80ae9" xlink:to="loc_us-gaap_ProfitLoss_a0f50877-5984-4b3e-96ae-c641130881ad" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract_1bec0f85-f7d3-4b74-96f3-b63046131ae8" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract_dbac9c29-6cc5-40ff-a7dc-4886c9a80ae9" xlink:to="loc_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract_1bec0f85-f7d3-4b74-96f3-b63046131ae8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Depreciation_3b4ad905-fe5e-4473-9bee-3ddefaed2498" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_Depreciation"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract_1bec0f85-f7d3-4b74-96f3-b63046131ae8" xlink:to="loc_us-gaap_Depreciation_3b4ad905-fe5e-4473-9bee-3ddefaed2498" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueAdjustmentOfWarrants_fd4544cf-f2d5-4dc3-afab-57d618088513" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueAdjustmentOfWarrants"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract_1bec0f85-f7d3-4b74-96f3-b63046131ae8" xlink:to="loc_us-gaap_FairValueAdjustmentOfWarrants_fd4544cf-f2d5-4dc3-afab-57d618088513" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeaseRightOfUseAssetAmortizationExpense_7e710cd7-9ea6-4277-9bc3-3292d64afdfe" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OperatingLeaseRightOfUseAssetAmortizationExpense"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract_1bec0f85-f7d3-4b74-96f3-b63046131ae8" xlink:to="loc_us-gaap_OperatingLeaseRightOfUseAssetAmortizationExpense_7e710cd7-9ea6-4277-9bc3-3292d64afdfe" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensation_d0ea38cf-8c87-40a6-a5f2-415ba2784366" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensation"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract_1bec0f85-f7d3-4b74-96f3-b63046131ae8" xlink:to="loc_us-gaap_ShareBasedCompensation_d0ea38cf-8c87-40a6-a5f2-415ba2784366" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccretionAmortizationOfDiscountsAndPremiumsInvestments_959cb319-fb1a-4758-bc28-2366389e6b34" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AccretionAmortizationOfDiscountsAndPremiumsInvestments"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract_1bec0f85-f7d3-4b74-96f3-b63046131ae8" xlink:to="loc_us-gaap_AccretionAmortizationOfDiscountsAndPremiumsInvestments_959cb319-fb1a-4758-bc28-2366389e6b34" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GainLossOnDispositionOfAssets1_04ac0706-8c66-40d8-98c2-a1d28c20745d" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_GainLossOnDispositionOfAssets1"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract_1bec0f85-f7d3-4b74-96f3-b63046131ae8" xlink:to="loc_us-gaap_GainLossOnDispositionOfAssets1_04ac0706-8c66-40d8-98c2-a1d28c20745d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInOperatingCapitalAbstract_d49cbba7-8307-4e2e-ba19-cb3c18ba92fc" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncreaseDecreaseInOperatingCapitalAbstract"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract_1bec0f85-f7d3-4b74-96f3-b63046131ae8" xlink:to="loc_us-gaap_IncreaseDecreaseInOperatingCapitalAbstract_d49cbba7-8307-4e2e-ba19-cb3c18ba92fc" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInAccountsReceivable_7e16bb8c-eca7-486d-b1a9-5e9d90584552" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncreaseDecreaseInAccountsReceivable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInOperatingCapitalAbstract_d49cbba7-8307-4e2e-ba19-cb3c18ba92fc" xlink:to="loc_us-gaap_IncreaseDecreaseInAccountsReceivable_7e16bb8c-eca7-486d-b1a9-5e9d90584552" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInInventories_7a189b64-f791-4fd8-b02a-a21bee33042d" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncreaseDecreaseInInventories"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInOperatingCapitalAbstract_d49cbba7-8307-4e2e-ba19-cb3c18ba92fc" xlink:to="loc_us-gaap_IncreaseDecreaseInInventories_7a189b64-f791-4fd8-b02a-a21bee33042d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets_615cb9dc-c75b-4167-b5eb-e8e07c806992" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInOperatingCapitalAbstract_d49cbba7-8307-4e2e-ba19-cb3c18ba92fc" xlink:to="loc_us-gaap_IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets_615cb9dc-c75b-4167-b5eb-e8e07c806992" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInOperatingLeaseLiability_5e300b1c-d85f-4f0e-a537-29f374a87daa" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncreaseDecreaseInOperatingLeaseLiability"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInOperatingCapitalAbstract_d49cbba7-8307-4e2e-ba19-cb3c18ba92fc" xlink:to="loc_us-gaap_IncreaseDecreaseInOperatingLeaseLiability_5e300b1c-d85f-4f0e-a537-29f374a87daa" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInAccountsPayableAndAccruedLiabilities_636b54fb-55b9-4cbd-a20f-e83d68d69bf7" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncreaseDecreaseInAccountsPayableAndAccruedLiabilities"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInOperatingCapitalAbstract_d49cbba7-8307-4e2e-ba19-cb3c18ba92fc" xlink:to="loc_us-gaap_IncreaseDecreaseInAccountsPayableAndAccruedLiabilities_636b54fb-55b9-4cbd-a20f-e83d68d69bf7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInEmployeeRelatedLiabilities_aa798780-7b0f-4886-ba71-f8523ef506ab" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncreaseDecreaseInEmployeeRelatedLiabilities"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInOperatingCapitalAbstract_d49cbba7-8307-4e2e-ba19-cb3c18ba92fc" xlink:to="loc_us-gaap_IncreaseDecreaseInEmployeeRelatedLiabilities_aa798780-7b0f-4886-ba71-f8523ef506ab" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_e452a2d2-5ae0-44d4-81e3-1ce7fadd358a" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NetCashProvidedByUsedInOperatingActivities"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract_dbac9c29-6cc5-40ff-a7dc-4886c9a80ae9" xlink:to="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_e452a2d2-5ae0-44d4-81e3-1ce7fadd358a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract_ffba9c8e-842e-4bc8-8ac0-27dd09c9e3d4" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementLineItems_7dcde0ba-6240-4f9b-9270-45c944ca5c64" xlink:to="loc_us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract_ffba9c8e-842e-4bc8-8ac0-27dd09c9e3d4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsToAcquireMarketableSecurities_f545555c-d958-42c2-a99a-89dc038454e6" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PaymentsToAcquireMarketableSecurities"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract_ffba9c8e-842e-4bc8-8ac0-27dd09c9e3d4" xlink:to="loc_us-gaap_PaymentsToAcquireMarketableSecurities_f545555c-d958-42c2-a99a-89dc038454e6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dmtk_ProceedsFromMaturityOfMarketableSecurities_d39933b0-55c3-4309-be65-0e65e301f299" xlink:href="dmtk-20220630.xsd#dmtk_ProceedsFromMaturityOfMarketableSecurities"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract_ffba9c8e-842e-4bc8-8ac0-27dd09c9e3d4" xlink:to="loc_dmtk_ProceedsFromMaturityOfMarketableSecurities_d39933b0-55c3-4309-be65-0e65e301f299" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsToAcquirePropertyPlantAndEquipment_473eccf4-27a0-40fb-9dc3-4ef0b5c366f8" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PaymentsToAcquirePropertyPlantAndEquipment"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract_ffba9c8e-842e-4bc8-8ac0-27dd09c9e3d4" xlink:to="loc_us-gaap_PaymentsToAcquirePropertyPlantAndEquipment_473eccf4-27a0-40fb-9dc3-4ef0b5c366f8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInInvestingActivities_15a54604-40e0-4448-b36e-222e07414161" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NetCashProvidedByUsedInInvestingActivities"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract_ffba9c8e-842e-4bc8-8ac0-27dd09c9e3d4" xlink:to="loc_us-gaap_NetCashProvidedByUsedInInvestingActivities_15a54604-40e0-4448-b36e-222e07414161" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract_51e468ee-474f-4b99-bd8b-74f538a0699b" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementLineItems_7dcde0ba-6240-4f9b-9270-45c944ca5c64" xlink:to="loc_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract_51e468ee-474f-4b99-bd8b-74f538a0699b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProceedsFromIssuanceOfCommonStock_1ccfa8da-5f5a-402b-92b8-67c3f71c974d" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ProceedsFromIssuanceOfCommonStock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract_51e468ee-474f-4b99-bd8b-74f538a0699b" xlink:to="loc_us-gaap_ProceedsFromIssuanceOfCommonStock_1ccfa8da-5f5a-402b-92b8-67c3f71c974d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProceedsFromWarrantExercises_79e1d724-416f-4339-be0e-e5968f3b02a6" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ProceedsFromWarrantExercises"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract_51e468ee-474f-4b99-bd8b-74f538a0699b" xlink:to="loc_us-gaap_ProceedsFromWarrantExercises_79e1d724-416f-4339-be0e-e5968f3b02a6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dmtk_ProceedsFromReleaseOfRSUsAndStockOptionsExercised_6ef95f43-7d00-499b-9f17-238231fec521" xlink:href="dmtk-20220630.xsd#dmtk_ProceedsFromReleaseOfRSUsAndStockOptionsExercised"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract_51e468ee-474f-4b99-bd8b-74f538a0699b" xlink:to="loc_dmtk_ProceedsFromReleaseOfRSUsAndStockOptionsExercised_6ef95f43-7d00-499b-9f17-238231fec521" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProceedsFromStockPlans_5cb99dae-a28c-4959-95c3-2be68db871c1" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ProceedsFromStockPlans"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract_51e468ee-474f-4b99-bd8b-74f538a0699b" xlink:to="loc_us-gaap_ProceedsFromStockPlans_5cb99dae-a28c-4959-95c3-2be68db871c1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RepaymentsOfDebtAndCapitalLeaseObligations_0c06f478-3a79-47fc-8b66-da0e597072e1" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RepaymentsOfDebtAndCapitalLeaseObligations"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract_51e468ee-474f-4b99-bd8b-74f538a0699b" xlink:to="loc_us-gaap_RepaymentsOfDebtAndCapitalLeaseObligations_0c06f478-3a79-47fc-8b66-da0e597072e1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInFinancingActivities_e1c8345f-0fbc-4155-9680-3259bf497e9c" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NetCashProvidedByUsedInFinancingActivities"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract_51e468ee-474f-4b99-bd8b-74f538a0699b" xlink:to="loc_us-gaap_NetCashProvidedByUsedInFinancingActivities_e1c8345f-0fbc-4155-9680-3259bf497e9c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect_28d29721-17ac-4f50-a100-cc3bc67975a6" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementLineItems_7dcde0ba-6240-4f9b-9270-45c944ca5c64" xlink:to="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect_28d29721-17ac-4f50-a100-cc3bc67975a6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations_ac214eb7-5599-4226-9841-cc4dfa64aad4" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementLineItems_7dcde0ba-6240-4f9b-9270-45c944ca5c64" xlink:to="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations_ac214eb7-5599-4226-9841-cc4dfa64aad4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodStartLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations_f1b5ee54-2030-44a6-91b0-10b0f03e0948" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementLineItems_7dcde0ba-6240-4f9b-9270-45c944ca5c64" xlink:to="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations_f1b5ee54-2030-44a6-91b0-10b0f03e0948" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodEndLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestrictedCashAndCashEquivalentsAbstract_4d8a4444-5f1f-4829-afe7-793e04bfabfa" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RestrictedCashAndCashEquivalentsAbstract"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementLineItems_7dcde0ba-6240-4f9b-9270-45c944ca5c64" xlink:to="loc_us-gaap_RestrictedCashAndCashEquivalentsAbstract_4d8a4444-5f1f-4829-afe7-793e04bfabfa" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashAndCashEquivalentsAtCarryingValue_de5a7d63-45ad-4442-943a-cfda7dd7d2d5" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CashAndCashEquivalentsAtCarryingValue"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RestrictedCashAndCashEquivalentsAbstract_4d8a4444-5f1f-4829-afe7-793e04bfabfa" xlink:to="loc_us-gaap_CashAndCashEquivalentsAtCarryingValue_de5a7d63-45ad-4442-943a-cfda7dd7d2d5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestrictedCash_13c14ce0-cea0-4afc-897e-e11334349f44" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RestrictedCash"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RestrictedCashAndCashEquivalentsAbstract_4d8a4444-5f1f-4829-afe7-793e04bfabfa" xlink:to="loc_us-gaap_RestrictedCash_13c14ce0-cea0-4afc-897e-e11334349f44" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_0e55e36f-c2b5-459b-a2b6-fd8734b572d3" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RestrictedCashAndCashEquivalentsAbstract_4d8a4444-5f1f-4829-afe7-793e04bfabfa" xlink:to="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_0e55e36f-c2b5-459b-a2b6-fd8734b572d3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SupplementalCashFlowInformationAbstract_698e33fa-342e-44b1-b388-370f38648f44" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SupplementalCashFlowInformationAbstract"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementLineItems_7dcde0ba-6240-4f9b-9270-45c944ca5c64" xlink:to="loc_us-gaap_SupplementalCashFlowInformationAbstract_698e33fa-342e-44b1-b388-370f38648f44" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InterestPaidNet_87d3888c-f622-4890-9d5b-4f09ec257a66" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_InterestPaidNet"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SupplementalCashFlowInformationAbstract_698e33fa-342e-44b1-b388-370f38648f44" xlink:to="loc_us-gaap_InterestPaidNet_87d3888c-f622-4890-9d5b-4f09ec257a66" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NoncashInvestingAndFinancingItemsAbstract_4c5587da-77c1-4932-a96a-78fd7ad547ad" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NoncashInvestingAndFinancingItemsAbstract"/>
    <link:presentationArc order="9" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementLineItems_7dcde0ba-6240-4f9b-9270-45c944ca5c64" xlink:to="loc_us-gaap_NoncashInvestingAndFinancingItemsAbstract_4c5587da-77c1-4932-a96a-78fd7ad547ad" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CapitalExpendituresIncurredButNotYetPaid_f271cc57-61d5-4d4d-bfca-2333c82c7558" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CapitalExpendituresIncurredButNotYetPaid"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NoncashInvestingAndFinancingItemsAbstract_4c5587da-77c1-4932-a96a-78fd7ad547ad" xlink:to="loc_us-gaap_CapitalExpendituresIncurredButNotYetPaid_f271cc57-61d5-4d4d-bfca-2333c82c7558" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dmtk_ReclassificationOfWarrantLiabilityDueToPrivateSPACWarrantsNotHeldByOriginalHolder_bb7c6508-12b5-4875-828d-ea66fc1c3775" xlink:href="dmtk-20220630.xsd#dmtk_ReclassificationOfWarrantLiabilityDueToPrivateSPACWarrantsNotHeldByOriginalHolder"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NoncashInvestingAndFinancingItemsAbstract_4c5587da-77c1-4932-a96a-78fd7ad547ad" xlink:to="loc_dmtk_ReclassificationOfWarrantLiabilityDueToPrivateSPACWarrantsNotHeldByOriginalHolder_bb7c6508-12b5-4875-828d-ea66fc1c3775" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dmtk_CashlessExerciseOfCommonStockWarrants_55998ebb-57b9-4bde-bb1a-3a6c5f57a6d0" xlink:href="dmtk-20220630.xsd#dmtk_CashlessExerciseOfCommonStockWarrants"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NoncashInvestingAndFinancingItemsAbstract_4c5587da-77c1-4932-a96a-78fd7ad547ad" xlink:to="loc_dmtk_CashlessExerciseOfCommonStockWarrants_55998ebb-57b9-4bde-bb1a-3a6c5f57a6d0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability_f17d4611-45a6-465a-81da-60b53fa98f4c" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NoncashInvestingAndFinancingItemsAbstract_4c5587da-77c1-4932-a96a-78fd7ad547ad" xlink:to="loc_us-gaap_RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability_f17d4611-45a6-465a-81da-60b53fa98f4c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NoncashOrPartNoncashAcquisitionFixedAssetsAcquired1_e37a7148-9d57-4be2-b753-894415a5fa95" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NoncashOrPartNoncashAcquisitionFixedAssetsAcquired1"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NoncashInvestingAndFinancingItemsAbstract_4c5587da-77c1-4932-a96a-78fd7ad547ad" xlink:to="loc_us-gaap_NoncashOrPartNoncashAcquisitionFixedAssetsAcquired1_e37a7148-9d57-4be2-b753-894415a5fa95" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dmtk_ChangeInUnrealizedGainLossOnAvailableForSaleMarketableSecurities_7318b641-94b5-4fa4-8550-704a72813af2" xlink:href="dmtk-20220630.xsd#dmtk_ChangeInUnrealizedGainLossOnAvailableForSaleMarketableSecurities"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NoncashInvestingAndFinancingItemsAbstract_4c5587da-77c1-4932-a96a-78fd7ad547ad" xlink:to="loc_dmtk_ChangeInUnrealizedGainLossOnAvailableForSaleMarketableSecurities_7318b641-94b5-4fa4-8550-704a72813af2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://dermtech.com/role/TheCompanyandaSummaryofitsSignificantAccountingPolicies" xlink:type="simple" xlink:href="dmtk-20220630.xsd#TheCompanyandaSummaryofitsSignificantAccountingPolicies"/>
  <link:presentationLink xlink:role="http://dermtech.com/role/TheCompanyandaSummaryofitsSignificantAccountingPolicies" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccountingPoliciesAbstract_6d7c4c09-9341-4174-a401-b9ccce0fdbf9" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AccountingPoliciesAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureAndSignificantAccountingPoliciesTextBlock_064ed795-2b7f-42a0-94fb-af37730ebe08" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureAndSignificantAccountingPoliciesTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountingPoliciesAbstract_6d7c4c09-9341-4174-a401-b9ccce0fdbf9" xlink:to="loc_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureAndSignificantAccountingPoliciesTextBlock_064ed795-2b7f-42a0-94fb-af37730ebe08" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://dermtech.com/role/TheCompanyandaSummaryofitsSignificantAccountingPoliciesPolicies" xlink:type="simple" xlink:href="dmtk-20220630.xsd#TheCompanyandaSummaryofitsSignificantAccountingPoliciesPolicies"/>
  <link:presentationLink xlink:role="http://dermtech.com/role/TheCompanyandaSummaryofitsSignificantAccountingPoliciesPolicies" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccountingPoliciesAbstract_9848fb57-5553-4355-ab3f-196ecbd8dd7e" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AccountingPoliciesAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NatureOfOperations_7c91868a-8420-4b9a-9d67-bf38dd7992b5" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NatureOfOperations"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountingPoliciesAbstract_9848fb57-5553-4355-ab3f-196ecbd8dd7e" xlink:to="loc_us-gaap_NatureOfOperations_7c91868a-8420-4b9a-9d67-bf38dd7992b5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BasisOfAccountingPolicyPolicyTextBlock_9f93a83f-1069-44f5-8baf-3fb997a77ddc" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BasisOfAccountingPolicyPolicyTextBlock"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountingPoliciesAbstract_9848fb57-5553-4355-ab3f-196ecbd8dd7e" xlink:to="loc_us-gaap_BasisOfAccountingPolicyPolicyTextBlock_9f93a83f-1069-44f5-8baf-3fb997a77ddc" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PriorPeriodReclassificationAdjustmentDescription_e16cbaba-6099-4be9-b69a-451ab71af760" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PriorPeriodReclassificationAdjustmentDescription"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountingPoliciesAbstract_9848fb57-5553-4355-ab3f-196ecbd8dd7e" xlink:to="loc_us-gaap_PriorPeriodReclassificationAdjustmentDescription_e16cbaba-6099-4be9-b69a-451ab71af760" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_UseOfEstimates_9f36ef97-bcbe-4ac9-8443-4b13b02df647" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_UseOfEstimates"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountingPoliciesAbstract_9848fb57-5553-4355-ab3f-196ecbd8dd7e" xlink:to="loc_us-gaap_UseOfEstimates_9f36ef97-bcbe-4ac9-8443-4b13b02df647" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashAndCashEquivalentsRestrictedCashAndCashEquivalentsPolicy_5747c1ec-03fc-4f80-b47b-d225af316a8f" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CashAndCashEquivalentsRestrictedCashAndCashEquivalentsPolicy"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountingPoliciesAbstract_9848fb57-5553-4355-ab3f-196ecbd8dd7e" xlink:to="loc_us-gaap_CashAndCashEquivalentsRestrictedCashAndCashEquivalentsPolicy_5747c1ec-03fc-4f80-b47b-d225af316a8f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentPolicyTextBlock_af185b52-a6b6-422a-972e-4890af0fd685" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PropertyPlantAndEquipmentPolicyTextBlock"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountingPoliciesAbstract_9848fb57-5553-4355-ab3f-196ecbd8dd7e" xlink:to="loc_us-gaap_PropertyPlantAndEquipmentPolicyTextBlock_af185b52-a6b6-422a-972e-4890af0fd685" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ConcentrationRiskCreditRisk_4dee0d6f-c6ad-4647-97a3-aada03e4bc29" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ConcentrationRiskCreditRisk"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountingPoliciesAbstract_9848fb57-5553-4355-ab3f-196ecbd8dd7e" xlink:to="loc_us-gaap_ConcentrationRiskCreditRisk_4dee0d6f-c6ad-4647-97a3-aada03e4bc29" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevenueRecognitionPolicyTextBlock_f358acfa-e9ed-47ce-b7ce-9c5f1271def4" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RevenueRecognitionPolicyTextBlock"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountingPoliciesAbstract_9848fb57-5553-4355-ab3f-196ecbd8dd7e" xlink:to="loc_us-gaap_RevenueRecognitionPolicyTextBlock_f358acfa-e9ed-47ce-b7ce-9c5f1271def4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ReceivablesPolicyTextBlock_6abd91ed-7538-4f0c-8167-9e33b953ccbf" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ReceivablesPolicyTextBlock"/>
    <link:presentationArc order="9" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountingPoliciesAbstract_9848fb57-5553-4355-ab3f-196ecbd8dd7e" xlink:to="loc_us-gaap_ReceivablesPolicyTextBlock_6abd91ed-7538-4f0c-8167-9e33b953ccbf" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EarningsPerSharePolicyTextBlock_35689709-564b-407e-a462-6f92034b9a92" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EarningsPerSharePolicyTextBlock"/>
    <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountingPoliciesAbstract_9848fb57-5553-4355-ab3f-196ecbd8dd7e" xlink:to="loc_us-gaap_EarningsPerSharePolicyTextBlock_35689709-564b-407e-a462-6f92034b9a92" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueMeasurementPolicyPolicyTextBlock_3291f91e-af9a-4cda-8cd4-aa703e65c1e8" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueMeasurementPolicyPolicyTextBlock"/>
    <link:presentationArc order="11" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountingPoliciesAbstract_9848fb57-5553-4355-ab3f-196ecbd8dd7e" xlink:to="loc_us-gaap_FairValueMeasurementPolicyPolicyTextBlock_3291f91e-af9a-4cda-8cd4-aa703e65c1e8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock_bf0b2355-1cdc-4ae6-a56e-02fbcdda7aea" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock"/>
    <link:presentationArc order="12" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountingPoliciesAbstract_9848fb57-5553-4355-ab3f-196ecbd8dd7e" xlink:to="loc_us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock_bf0b2355-1cdc-4ae6-a56e-02fbcdda7aea" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://dermtech.com/role/TheCompanyandaSummaryofitsSignificantAccountingPoliciesTables" xlink:type="simple" xlink:href="dmtk-20220630.xsd#TheCompanyandaSummaryofitsSignificantAccountingPoliciesTables"/>
  <link:presentationLink xlink:role="http://dermtech.com/role/TheCompanyandaSummaryofitsSignificantAccountingPoliciesTables" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccountingPoliciesAbstract_ecd5aa9d-f83a-471b-ae57-76cea80da1eb" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AccountingPoliciesAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisaggregationOfRevenueTableTextBlock_a1e60537-3117-46d7-a25f-d0c9d385b1da" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DisaggregationOfRevenueTableTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountingPoliciesAbstract_ecd5aa9d-f83a-471b-ae57-76cea80da1eb" xlink:to="loc_us-gaap_DisaggregationOfRevenueTableTextBlock_a1e60537-3117-46d7-a25f-d0c9d385b1da" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfProductInformationTableTextBlock_22a20543-8106-497b-acd5-3d802331203e" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfProductInformationTableTextBlock"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountingPoliciesAbstract_ecd5aa9d-f83a-471b-ae57-76cea80da1eb" xlink:to="loc_us-gaap_ScheduleOfProductInformationTableTextBlock_22a20543-8106-497b-acd5-3d802331203e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfFairValueAssetsAndLiabilitiesMeasuredOnRecurringBasisTableTextBlock_3407da3b-64b5-44a1-9647-87053ee7d193" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfFairValueAssetsAndLiabilitiesMeasuredOnRecurringBasisTableTextBlock"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountingPoliciesAbstract_ecd5aa9d-f83a-471b-ae57-76cea80da1eb" xlink:to="loc_us-gaap_ScheduleOfFairValueAssetsAndLiabilitiesMeasuredOnRecurringBasisTableTextBlock_3407da3b-64b5-44a1-9647-87053ee7d193" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfShareBasedPaymentAwardEmployeeStockPurchasePlanValuationAssumptionsTableTextBlock_5607f784-c98d-4358-9959-73ba692e6168" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfShareBasedPaymentAwardEmployeeStockPurchasePlanValuationAssumptionsTableTextBlock"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountingPoliciesAbstract_ecd5aa9d-f83a-471b-ae57-76cea80da1eb" xlink:to="loc_us-gaap_ScheduleOfShareBasedPaymentAwardEmployeeStockPurchasePlanValuationAssumptionsTableTextBlock_5607f784-c98d-4358-9959-73ba692e6168" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationTextBlock_618487a7-3dc9-44c5-abe8-69b61166b3c7" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationTextBlock"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountingPoliciesAbstract_ecd5aa9d-f83a-471b-ae57-76cea80da1eb" xlink:to="loc_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationTextBlock_618487a7-3dc9-44c5-abe8-69b61166b3c7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://dermtech.com/role/TheCompanyandaSummaryofitsSignificantAccountingPoliciesAdditionalInformationDetails" xlink:type="simple" xlink:href="dmtk-20220630.xsd#TheCompanyandaSummaryofitsSignificantAccountingPoliciesAdditionalInformationDetails"/>
  <link:presentationLink xlink:role="http://dermtech.com/role/TheCompanyandaSummaryofitsSignificantAccountingPoliciesAdditionalInformationDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccountingPoliciesAbstract_53e030a2-1e17-489d-9075-d65d33b16494" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AccountingPoliciesAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_dmtk_TheCompanyAndSummaryOfItsSignificantAccountingPoliciesTable_95d7a53f-335f-4229-be81-79cd256ffc74" xlink:href="dmtk-20220630.xsd#dmtk_TheCompanyAndSummaryOfItsSignificantAccountingPoliciesTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountingPoliciesAbstract_53e030a2-1e17-489d-9075-d65d33b16494" xlink:to="loc_dmtk_TheCompanyAndSummaryOfItsSignificantAccountingPoliciesTable_95d7a53f-335f-4229-be81-79cd256ffc74" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentByTypeAxis_8c96c3c0-7d09-4310-8d4c-c39c32653a90" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PropertyPlantAndEquipmentByTypeAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dmtk_TheCompanyAndSummaryOfItsSignificantAccountingPoliciesTable_95d7a53f-335f-4229-be81-79cd256ffc74" xlink:to="loc_us-gaap_PropertyPlantAndEquipmentByTypeAxis_8c96c3c0-7d09-4310-8d4c-c39c32653a90" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentTypeDomain_84c1d513-450f-4b3a-b842-8429d41742b9" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PropertyPlantAndEquipmentTypeDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentByTypeAxis_8c96c3c0-7d09-4310-8d4c-c39c32653a90" xlink:to="loc_us-gaap_PropertyPlantAndEquipmentTypeDomain_84c1d513-450f-4b3a-b842-8429d41742b9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dmtk_AmortizationOfLaboratoryEquipmentAcquiredUnderFinanceLeasesMember_7a02c9e8-41dd-4f90-8fb8-4476a663494b" xlink:href="dmtk-20220630.xsd#dmtk_AmortizationOfLaboratoryEquipmentAcquiredUnderFinanceLeasesMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentTypeDomain_84c1d513-450f-4b3a-b842-8429d41742b9" xlink:to="loc_dmtk_AmortizationOfLaboratoryEquipmentAcquiredUnderFinanceLeasesMember_7a02c9e8-41dd-4f90-8fb8-4476a663494b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dmtk_AssetsHeldUnderFinanceLeasesMember_680df41e-de64-4a58-bef6-acd51f7f242f" xlink:href="dmtk-20220630.xsd#dmtk_AssetsHeldUnderFinanceLeasesMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentTypeDomain_84c1d513-450f-4b3a-b842-8429d41742b9" xlink:to="loc_dmtk_AssetsHeldUnderFinanceLeasesMember_680df41e-de64-4a58-bef6-acd51f7f242f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeAxis_7ef1799a-aa46-4d9a-aa2a-f20a8d51ba8c" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_RangeAxis"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dmtk_TheCompanyAndSummaryOfItsSignificantAccountingPoliciesTable_95d7a53f-335f-4229-be81-79cd256ffc74" xlink:to="loc_srt_RangeAxis_7ef1799a-aa46-4d9a-aa2a-f20a8d51ba8c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeMember_ae02ff38-145b-456e-b2a5-700d276bd325" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_RangeMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_RangeAxis_7ef1799a-aa46-4d9a-aa2a-f20a8d51ba8c" xlink:to="loc_srt_RangeMember_ae02ff38-145b-456e-b2a5-700d276bd325" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_MinimumMember_e565133e-8985-41ab-b07b-e477471102ec" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_MinimumMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_RangeMember_ae02ff38-145b-456e-b2a5-700d276bd325" xlink:to="loc_srt_MinimumMember_e565133e-8985-41ab-b07b-e477471102ec" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_MaximumMember_8df31568-0415-4ac5-b268-5e521a00d9c5" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_MaximumMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_RangeMember_ae02ff38-145b-456e-b2a5-700d276bd325" xlink:to="loc_srt_MaximumMember_8df31568-0415-4ac5-b268-5e521a00d9c5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ProductOrServiceAxis_5557e068-9580-46a3-83df-b0251499fe39" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_ProductOrServiceAxis"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dmtk_TheCompanyAndSummaryOfItsSignificantAccountingPoliciesTable_95d7a53f-335f-4229-be81-79cd256ffc74" xlink:to="loc_srt_ProductOrServiceAxis_5557e068-9580-46a3-83df-b0251499fe39" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ProductsAndServicesDomain_b45adba5-cd55-4e3e-9f8c-1a8d74e38982" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_ProductsAndServicesDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_ProductOrServiceAxis_5557e068-9580-46a3-83df-b0251499fe39" xlink:to="loc_srt_ProductsAndServicesDomain_b45adba5-cd55-4e3e-9f8c-1a8d74e38982" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dmtk_AssayMember_089982e5-b150-4147-99b0-43e09d29ddce" xlink:href="dmtk-20220630.xsd#dmtk_AssayMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_ProductsAndServicesDomain_b45adba5-cd55-4e3e-9f8c-1a8d74e38982" xlink:to="loc_dmtk_AssayMember_089982e5-b150-4147-99b0-43e09d29ddce" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dmtk_ContractualActivitiesMember_fb8f2698-dd9e-4b1b-8aa5-e74acc21570e" xlink:href="dmtk-20220630.xsd#dmtk_ContractualActivitiesMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_ProductsAndServicesDomain_b45adba5-cd55-4e3e-9f8c-1a8d74e38982" xlink:to="loc_dmtk_ContractualActivitiesMember_fb8f2698-dd9e-4b1b-8aa5-e74acc21570e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis_9b22764a-34fe-4cfb-b1bf-a63aaf5a3e42" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dmtk_TheCompanyAndSummaryOfItsSignificantAccountingPoliciesTable_95d7a53f-335f-4229-be81-79cd256ffc74" xlink:to="loc_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis_9b22764a-34fe-4cfb-b1bf-a63aaf5a3e42" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AntidilutiveSecuritiesNameDomain_cf3f621c-6a3c-4264-a64e-c8dad588553f" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AntidilutiveSecuritiesNameDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis_9b22764a-34fe-4cfb-b1bf-a63aaf5a3e42" xlink:to="loc_us-gaap_AntidilutiveSecuritiesNameDomain_cf3f621c-6a3c-4264-a64e-c8dad588553f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_WarrantMember_6fabcf63-2dfc-4292-bfd3-ea7e9623df52" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_WarrantMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AntidilutiveSecuritiesNameDomain_cf3f621c-6a3c-4264-a64e-c8dad588553f" xlink:to="loc_us-gaap_WarrantMember_6fabcf63-2dfc-4292-bfd3-ea7e9623df52" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dmtk_StockOptionsAndRestrictedStockUnitsMember_fbdbc0be-ccc8-4d54-814b-4d1e7b1c5c12" xlink:href="dmtk-20220630.xsd#dmtk_StockOptionsAndRestrictedStockUnitsMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AntidilutiveSecuritiesNameDomain_cf3f621c-6a3c-4264-a64e-c8dad588553f" xlink:to="loc_dmtk_StockOptionsAndRestrictedStockUnitsMember_fbdbc0be-ccc8-4d54-814b-4d1e7b1c5c12" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueByFairValueHierarchyLevelAxis_1726d8fb-c4c1-45c0-ab8b-c2bbcb5c3fa6" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueByFairValueHierarchyLevelAxis"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dmtk_TheCompanyAndSummaryOfItsSignificantAccountingPoliciesTable_95d7a53f-335f-4229-be81-79cd256ffc74" xlink:to="loc_us-gaap_FairValueByFairValueHierarchyLevelAxis_1726d8fb-c4c1-45c0-ab8b-c2bbcb5c3fa6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_37c774ab-38e2-4021-9462-8afa8c1758fc" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueMeasurementsFairValueHierarchyDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueByFairValueHierarchyLevelAxis_1726d8fb-c4c1-45c0-ab8b-c2bbcb5c3fa6" xlink:to="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_37c774ab-38e2-4021-9462-8afa8c1758fc" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueInputsLevel1Member_7ad0da8b-0851-460c-b3d5-d7336b987b40" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueInputsLevel1Member"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_37c774ab-38e2-4021-9462-8afa8c1758fc" xlink:to="loc_us-gaap_FairValueInputsLevel1Member_7ad0da8b-0851-460c-b3d5-d7336b987b40" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BalanceSheetLocationAxis_36d9a5df-0262-48c1-bfcf-53daf46921c3" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BalanceSheetLocationAxis"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dmtk_TheCompanyAndSummaryOfItsSignificantAccountingPoliciesTable_95d7a53f-335f-4229-be81-79cd256ffc74" xlink:to="loc_us-gaap_BalanceSheetLocationAxis_36d9a5df-0262-48c1-bfcf-53daf46921c3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BalanceSheetLocationDomain_2d19ac3a-bdd9-47b0-87de-0ad4e9bca9a5" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BalanceSheetLocationDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BalanceSheetLocationAxis_36d9a5df-0262-48c1-bfcf-53daf46921c3" xlink:to="loc_us-gaap_BalanceSheetLocationDomain_2d19ac3a-bdd9-47b0-87de-0ad4e9bca9a5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dmtk_RestrictedCashMember_0e714c6c-a9e4-443d-b89c-c08750d80f1a" xlink:href="dmtk-20220630.xsd#dmtk_RestrictedCashMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BalanceSheetLocationDomain_2d19ac3a-bdd9-47b0-87de-0ad4e9bca9a5" xlink:to="loc_dmtk_RestrictedCashMember_0e714c6c-a9e4-443d-b89c-c08750d80f1a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dmtk_TheCompanyAndSummaryOfItsSignificantAccountingPoliciesLineItems_a00eadb6-3359-4607-b904-74e98db98f18" xlink:href="dmtk-20220630.xsd#dmtk_TheCompanyAndSummaryOfItsSignificantAccountingPoliciesLineItems"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dmtk_TheCompanyAndSummaryOfItsSignificantAccountingPoliciesTable_95d7a53f-335f-4229-be81-79cd256ffc74" xlink:to="loc_dmtk_TheCompanyAndSummaryOfItsSignificantAccountingPoliciesLineItems_a00eadb6-3359-4607-b904-74e98db98f18" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockholdersEquityNoteStockSplitConversionRatio1_7438cb9d-ced0-44b1-9573-579739c9ce53" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StockholdersEquityNoteStockSplitConversionRatio1"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dmtk_TheCompanyAndSummaryOfItsSignificantAccountingPoliciesLineItems_a00eadb6-3359-4607-b904-74e98db98f18" xlink:to="loc_us-gaap_StockholdersEquityNoteStockSplitConversionRatio1_7438cb9d-ced0-44b1-9573-579739c9ce53" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentUsefulLife_f1d4d914-0611-4a87-9a17-15358337dfc1" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PropertyPlantAndEquipmentUsefulLife"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dmtk_TheCompanyAndSummaryOfItsSignificantAccountingPoliciesLineItems_a00eadb6-3359-4607-b904-74e98db98f18" xlink:to="loc_us-gaap_PropertyPlantAndEquipmentUsefulLife_f1d4d914-0611-4a87-9a17-15358337dfc1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Depreciation_56323265-4b63-4235-868e-3e330d591c33" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_Depreciation"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dmtk_TheCompanyAndSummaryOfItsSignificantAccountingPoliciesLineItems_a00eadb6-3359-4607-b904-74e98db98f18" xlink:to="loc_us-gaap_Depreciation_56323265-4b63-4235-868e-3e330d591c33" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentGross_49dbbd97-e141-4615-b78c-38dd6403d69b" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PropertyPlantAndEquipmentGross"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dmtk_TheCompanyAndSummaryOfItsSignificantAccountingPoliciesLineItems_a00eadb6-3359-4607-b904-74e98db98f18" xlink:to="loc_us-gaap_PropertyPlantAndEquipmentGross_49dbbd97-e141-4615-b78c-38dd6403d69b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DepreciationAndAmortization_1e7a291b-2f38-4574-8d5c-b3dd0d2ca82e" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DepreciationAndAmortization"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dmtk_TheCompanyAndSummaryOfItsSignificantAccountingPoliciesLineItems_a00eadb6-3359-4607-b904-74e98db98f18" xlink:to="loc_us-gaap_DepreciationAndAmortization_1e7a291b-2f38-4574-8d5c-b3dd0d2ca82e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentDisposals_80859500-9254-46b0-be9d-d94fd56feba5" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PropertyPlantAndEquipmentDisposals"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dmtk_TheCompanyAndSummaryOfItsSignificantAccountingPoliciesLineItems_a00eadb6-3359-4607-b904-74e98db98f18" xlink:to="loc_us-gaap_PropertyPlantAndEquipmentDisposals_80859500-9254-46b0-be9d-d94fd56feba5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ImpairmentOfLongLivedAssetsToBeDisposedOf_7003c279-aa48-4f09-bf54-f4893311cb7f" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ImpairmentOfLongLivedAssetsToBeDisposedOf"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dmtk_TheCompanyAndSummaryOfItsSignificantAccountingPoliciesLineItems_a00eadb6-3359-4607-b904-74e98db98f18" xlink:to="loc_us-gaap_ImpairmentOfLongLivedAssetsToBeDisposedOf_7003c279-aa48-4f09-bf54-f4893311cb7f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DepositsMoneyMarketDeposits_a242539c-0f60-4b6f-af15-e3b60e3aa6d6" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DepositsMoneyMarketDeposits"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dmtk_TheCompanyAndSummaryOfItsSignificantAccountingPoliciesLineItems_a00eadb6-3359-4607-b904-74e98db98f18" xlink:to="loc_us-gaap_DepositsMoneyMarketDeposits_a242539c-0f60-4b6f-af15-e3b60e3aa6d6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashFDICInsuredAmount_2883975a-46ca-4472-936d-654ce67a3612" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CashFDICInsuredAmount"/>
    <link:presentationArc order="9" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dmtk_TheCompanyAndSummaryOfItsSignificantAccountingPoliciesLineItems_a00eadb6-3359-4607-b904-74e98db98f18" xlink:to="loc_us-gaap_CashFDICInsuredAmount_2883975a-46ca-4472-936d-654ce67a3612" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashUninsuredAmount_5c7b9029-f1e9-4e9b-a12e-0823dd6993f9" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CashUninsuredAmount"/>
    <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dmtk_TheCompanyAndSummaryOfItsSignificantAccountingPoliciesLineItems_a00eadb6-3359-4607-b904-74e98db98f18" xlink:to="loc_us-gaap_CashUninsuredAmount_5c7b9029-f1e9-4e9b-a12e-0823dd6993f9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dmtk_NumberOfRevenueStreams_2f3e5c50-2bff-47d2-aa7b-eee52a1d7095" xlink:href="dmtk-20220630.xsd#dmtk_NumberOfRevenueStreams"/>
    <link:presentationArc order="11" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dmtk_TheCompanyAndSummaryOfItsSignificantAccountingPoliciesLineItems_a00eadb6-3359-4607-b904-74e98db98f18" xlink:to="loc_dmtk_NumberOfRevenueStreams_2f3e5c50-2bff-47d2-aa7b-eee52a1d7095" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dmtk_RevenuePerformanceObligationSatisfiedVariableConsiderationUpdateIncreaseDecreaseInRevenue_6a729a6a-5c5b-4412-9026-ccd15c5cd9f6" xlink:href="dmtk-20220630.xsd#dmtk_RevenuePerformanceObligationSatisfiedVariableConsiderationUpdateIncreaseDecreaseInRevenue"/>
    <link:presentationArc order="12" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dmtk_TheCompanyAndSummaryOfItsSignificantAccountingPoliciesLineItems_a00eadb6-3359-4607-b904-74e98db98f18" xlink:to="loc_dmtk_RevenuePerformanceObligationSatisfiedVariableConsiderationUpdateIncreaseDecreaseInRevenue_6a729a6a-5c5b-4412-9026-ccd15c5cd9f6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredRevenueCurrent_6f2e072b-ab53-4f55-a1da-295ef6f3078e" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DeferredRevenueCurrent"/>
    <link:presentationArc order="13" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dmtk_TheCompanyAndSummaryOfItsSignificantAccountingPoliciesLineItems_a00eadb6-3359-4607-b904-74e98db98f18" xlink:to="loc_us-gaap_DeferredRevenueCurrent_6f2e072b-ab53-4f55-a1da-295ef6f3078e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevenueRemainingPerformanceObligation_7281bf3b-19ef-4ced-94c3-ee27e9e5ef8e" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RevenueRemainingPerformanceObligation"/>
    <link:presentationArc order="14" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dmtk_TheCompanyAndSummaryOfItsSignificantAccountingPoliciesLineItems_a00eadb6-3359-4607-b904-74e98db98f18" xlink:to="loc_us-gaap_RevenueRemainingPerformanceObligation_7281bf3b-19ef-4ced-94c3-ee27e9e5ef8e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionPeriod1_ab8cdf48-0284-4d95-a3f2-87beb1954e08" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionPeriod1"/>
    <link:presentationArc order="15" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dmtk_TheCompanyAndSummaryOfItsSignificantAccountingPoliciesLineItems_a00eadb6-3359-4607-b904-74e98db98f18" xlink:to="loc_us-gaap_RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionPeriod1_ab8cdf48-0284-4d95-a3f2-87beb1954e08" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccountsReceivableGrossCurrent_22a47f88-76a7-4b34-a8d4-2b720799d4e0" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AccountsReceivableGrossCurrent"/>
    <link:presentationArc order="16" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dmtk_TheCompanyAndSummaryOfItsSignificantAccountingPoliciesLineItems_a00eadb6-3359-4607-b904-74e98db98f18" xlink:to="loc_us-gaap_AccountsReceivableGrossCurrent_22a47f88-76a7-4b34-a8d4-2b720799d4e0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_UnbilledReceivablesCurrent_9ac7ae56-5aa1-48e5-9ab2-5a8d57c81151" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_UnbilledReceivablesCurrent"/>
    <link:presentationArc order="17" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dmtk_TheCompanyAndSummaryOfItsSignificantAccountingPoliciesLineItems_a00eadb6-3359-4607-b904-74e98db98f18" xlink:to="loc_us-gaap_UnbilledReceivablesCurrent_9ac7ae56-5aa1-48e5-9ab2-5a8d57c81151" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccountsReceivableNetCurrent_faff052e-6596-451c-b512-6f4513871c09" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AccountsReceivableNetCurrent"/>
    <link:presentationArc order="18" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dmtk_TheCompanyAndSummaryOfItsSignificantAccountingPoliciesLineItems_a00eadb6-3359-4607-b904-74e98db98f18" xlink:to="loc_us-gaap_AccountsReceivableNetCurrent_faff052e-6596-451c-b512-6f4513871c09" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount_e788b369-27c3-4137-ae3d-253d182f6ff2" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount"/>
    <link:presentationArc order="19" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dmtk_TheCompanyAndSummaryOfItsSignificantAccountingPoliciesLineItems_a00eadb6-3359-4607-b904-74e98db98f18" xlink:to="loc_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount_e788b369-27c3-4137-ae3d-253d182f6ff2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LettersOfCreditOutstandingAmount_237869d0-d9ef-4c28-a30c-0b5a46acdf0b" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LettersOfCreditOutstandingAmount"/>
    <link:presentationArc order="20" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dmtk_TheCompanyAndSummaryOfItsSignificantAccountingPoliciesLineItems_a00eadb6-3359-4607-b904-74e98db98f18" xlink:to="loc_us-gaap_LettersOfCreditOutstandingAmount_237869d0-d9ef-4c28-a30c-0b5a46acdf0b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://dermtech.com/role/TheCompanyandaSummaryofitsSignificantAccountingPoliciesScheduleofRevenuesDisaggregatedbyRevenueSourceDetails" xlink:type="simple" xlink:href="dmtk-20220630.xsd#TheCompanyandaSummaryofitsSignificantAccountingPoliciesScheduleofRevenuesDisaggregatedbyRevenueSourceDetails"/>
  <link:presentationLink xlink:role="http://dermtech.com/role/TheCompanyandaSummaryofitsSignificantAccountingPoliciesScheduleofRevenuesDisaggregatedbyRevenueSourceDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccountingPoliciesAbstract_1610db71-42e4-4c33-95a9-0a9bb4df9ac4" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AccountingPoliciesAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisaggregationOfRevenueTable_31907cb3-c412-4a6a-9de6-e6eec1ed7e97" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DisaggregationOfRevenueTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountingPoliciesAbstract_1610db71-42e4-4c33-95a9-0a9bb4df9ac4" xlink:to="loc_us-gaap_DisaggregationOfRevenueTable_31907cb3-c412-4a6a-9de6-e6eec1ed7e97" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ProductOrServiceAxis_8fb942e0-b7d4-48d6-8a78-c108cc5a1358" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_ProductOrServiceAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DisaggregationOfRevenueTable_31907cb3-c412-4a6a-9de6-e6eec1ed7e97" xlink:to="loc_srt_ProductOrServiceAxis_8fb942e0-b7d4-48d6-8a78-c108cc5a1358" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ProductsAndServicesDomain_0b5a9965-3348-424e-8e70-11910f018739" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_ProductsAndServicesDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_ProductOrServiceAxis_8fb942e0-b7d4-48d6-8a78-c108cc5a1358" xlink:to="loc_srt_ProductsAndServicesDomain_0b5a9965-3348-424e-8e70-11910f018739" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dmtk_AssayMember_4bdc7221-fa00-48e8-a83d-ac0071e6e7e0" xlink:href="dmtk-20220630.xsd#dmtk_AssayMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_ProductsAndServicesDomain_0b5a9965-3348-424e-8e70-11910f018739" xlink:to="loc_dmtk_AssayMember_4bdc7221-fa00-48e8-a83d-ac0071e6e7e0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dmtk_ContractRevenueAdhesivePatchKitsMember_d85e3ad1-aeb4-4611-b299-37c9a5f0b2ab" xlink:href="dmtk-20220630.xsd#dmtk_ContractRevenueAdhesivePatchKitsMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_ProductsAndServicesDomain_0b5a9965-3348-424e-8e70-11910f018739" xlink:to="loc_dmtk_ContractRevenueAdhesivePatchKitsMember_d85e3ad1-aeb4-4611-b299-37c9a5f0b2ab" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dmtk_ContractRevenueRNAExtractionsMember_2c51686f-7537-4660-a298-25a295d128c6" xlink:href="dmtk-20220630.xsd#dmtk_ContractRevenueRNAExtractionsMember"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_ProductsAndServicesDomain_0b5a9965-3348-424e-8e70-11910f018739" xlink:to="loc_dmtk_ContractRevenueRNAExtractionsMember_2c51686f-7537-4660-a298-25a295d128c6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dmtk_ContractRevenueProjectManagementFeesMember_ff422d0b-9e30-4645-89fb-ca63b862cf40" xlink:href="dmtk-20220630.xsd#dmtk_ContractRevenueProjectManagementFeesMember"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_ProductsAndServicesDomain_0b5a9965-3348-424e-8e70-11910f018739" xlink:to="loc_dmtk_ContractRevenueProjectManagementFeesMember_ff422d0b-9e30-4645-89fb-ca63b862cf40" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisaggregationOfRevenueLineItems_5ef8eee2-8398-4fd5-ad8f-5e61c66ce689" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DisaggregationOfRevenueLineItems"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DisaggregationOfRevenueTable_31907cb3-c412-4a6a-9de6-e6eec1ed7e97" xlink:to="loc_us-gaap_DisaggregationOfRevenueLineItems_5ef8eee2-8398-4fd5-ad8f-5e61c66ce689" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax_0952b5c2-a505-4af0-a8d2-ba22175ee89c" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DisaggregationOfRevenueLineItems_5ef8eee2-8398-4fd5-ad8f-5e61c66ce689" xlink:to="loc_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax_0952b5c2-a505-4af0-a8d2-ba22175ee89c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://dermtech.com/role/TheCompanyandaSummaryofitsSignificantAccountingPoliciesSummaryofPercentagesofTotalRevenueorAccountsReceivableforThirdPartyPayersandPharmaceuticalCustomersDetails" xlink:type="simple" xlink:href="dmtk-20220630.xsd#TheCompanyandaSummaryofitsSignificantAccountingPoliciesSummaryofPercentagesofTotalRevenueorAccountsReceivableforThirdPartyPayersandPharmaceuticalCustomersDetails"/>
  <link:presentationLink xlink:role="http://dermtech.com/role/TheCompanyandaSummaryofitsSignificantAccountingPoliciesSummaryofPercentagesofTotalRevenueorAccountsReceivableforThirdPartyPayersandPharmaceuticalCustomersDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccountingPoliciesAbstract_6795bee8-411d-42ad-9283-7dd3b12eb0a9" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AccountingPoliciesAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfProductInformationTable_cd66229b-81e0-4515-952e-56bbf18b0068" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfProductInformationTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountingPoliciesAbstract_6795bee8-411d-42ad-9283-7dd3b12eb0a9" xlink:to="loc_us-gaap_ScheduleOfProductInformationTable_cd66229b-81e0-4515-952e-56bbf18b0068" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ConcentrationRiskByBenchmarkAxis_f12ef6c8-0fe9-4160-baed-3941f0de8455" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ConcentrationRiskByBenchmarkAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfProductInformationTable_cd66229b-81e0-4515-952e-56bbf18b0068" xlink:to="loc_us-gaap_ConcentrationRiskByBenchmarkAxis_f12ef6c8-0fe9-4160-baed-3941f0de8455" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ConcentrationRiskBenchmarkDomain_4b40fa93-04cf-45d6-8c22-ba96151cfac3" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ConcentrationRiskBenchmarkDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ConcentrationRiskByBenchmarkAxis_f12ef6c8-0fe9-4160-baed-3941f0de8455" xlink:to="loc_us-gaap_ConcentrationRiskBenchmarkDomain_4b40fa93-04cf-45d6-8c22-ba96151cfac3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SalesRevenueNetMember_4881dee4-f86d-4a1f-a83c-b96e654cb4f2" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SalesRevenueNetMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ConcentrationRiskBenchmarkDomain_4b40fa93-04cf-45d6-8c22-ba96151cfac3" xlink:to="loc_us-gaap_SalesRevenueNetMember_4881dee4-f86d-4a1f-a83c-b96e654cb4f2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccountsReceivableMember_f48674ef-23c9-4b40-ab01-f263499ea8f9" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AccountsReceivableMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ConcentrationRiskBenchmarkDomain_4b40fa93-04cf-45d6-8c22-ba96151cfac3" xlink:to="loc_us-gaap_AccountsReceivableMember_f48674ef-23c9-4b40-ab01-f263499ea8f9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ProductOrServiceAxis_1131902d-5360-495f-956f-1f0f9bbac197" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_ProductOrServiceAxis"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfProductInformationTable_cd66229b-81e0-4515-952e-56bbf18b0068" xlink:to="loc_srt_ProductOrServiceAxis_1131902d-5360-495f-956f-1f0f9bbac197" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ProductsAndServicesDomain_41cc4632-ef30-4e47-9cc1-79c42e9f8da9" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_ProductsAndServicesDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_ProductOrServiceAxis_1131902d-5360-495f-956f-1f0f9bbac197" xlink:to="loc_srt_ProductsAndServicesDomain_41cc4632-ef30-4e47-9cc1-79c42e9f8da9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dmtk_AssayRevenuePayorAMember_65271da8-fdc8-4091-b8cf-d0f8a6365414" xlink:href="dmtk-20220630.xsd#dmtk_AssayRevenuePayorAMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_ProductsAndServicesDomain_41cc4632-ef30-4e47-9cc1-79c42e9f8da9" xlink:to="loc_dmtk_AssayRevenuePayorAMember_65271da8-fdc8-4091-b8cf-d0f8a6365414" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dmtk_AssayRevenuePayorBMember_fb670133-f9a6-421c-8a93-e588dd2b6ea6" xlink:href="dmtk-20220630.xsd#dmtk_AssayRevenuePayorBMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_ProductsAndServicesDomain_41cc4632-ef30-4e47-9cc1-79c42e9f8da9" xlink:to="loc_dmtk_AssayRevenuePayorBMember_fb670133-f9a6-421c-8a93-e588dd2b6ea6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ConcentrationRiskByTypeAxis_cfd11759-d744-40c6-be16-7f93eea3a1d4" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ConcentrationRiskByTypeAxis"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfProductInformationTable_cd66229b-81e0-4515-952e-56bbf18b0068" xlink:to="loc_us-gaap_ConcentrationRiskByTypeAxis_cfd11759-d744-40c6-be16-7f93eea3a1d4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ConcentrationRiskTypeDomain_43f9c02f-7401-42a7-828b-8f9ee4d0ee64" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ConcentrationRiskTypeDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ConcentrationRiskByTypeAxis_cfd11759-d744-40c6-be16-7f93eea3a1d4" xlink:to="loc_us-gaap_ConcentrationRiskTypeDomain_43f9c02f-7401-42a7-828b-8f9ee4d0ee64" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CustomerConcentrationRiskMember_ea7a3d48-2cb7-4970-afa4-b9fcccb60599" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CustomerConcentrationRiskMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ConcentrationRiskTypeDomain_43f9c02f-7401-42a7-828b-8f9ee4d0ee64" xlink:to="loc_us-gaap_CustomerConcentrationRiskMember_ea7a3d48-2cb7-4970-afa4-b9fcccb60599" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProductInformationLineItems_2d59d880-d4b4-4cfa-a22b-96ce99ff3b56" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ProductInformationLineItems"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfProductInformationTable_cd66229b-81e0-4515-952e-56bbf18b0068" xlink:to="loc_us-gaap_ProductInformationLineItems_2d59d880-d4b4-4cfa-a22b-96ce99ff3b56" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ConcentrationRiskPercentage1_bf6212de-8734-4d98-ba05-821acd5b8ca0" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ConcentrationRiskPercentage1"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ProductInformationLineItems_2d59d880-d4b4-4cfa-a22b-96ce99ff3b56" xlink:to="loc_us-gaap_ConcentrationRiskPercentage1_bf6212de-8734-4d98-ba05-821acd5b8ca0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://dermtech.com/role/TheCompanyandaSummaryofitsSignificantAccountingPoliciesSummaryofAssetsandLiabilitiesMeasuredatFairValueonRecurringBasisDetails" xlink:type="simple" xlink:href="dmtk-20220630.xsd#TheCompanyandaSummaryofitsSignificantAccountingPoliciesSummaryofAssetsandLiabilitiesMeasuredatFairValueonRecurringBasisDetails"/>
  <link:presentationLink xlink:role="http://dermtech.com/role/TheCompanyandaSummaryofitsSignificantAccountingPoliciesSummaryofAssetsandLiabilitiesMeasuredatFairValueonRecurringBasisDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccountingPoliciesAbstract_13314fee-0736-4a17-b0e6-d2e62c335829" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AccountingPoliciesAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable_7384285f-1ae4-404b-a97f-bebef0062cb7" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountingPoliciesAbstract_13314fee-0736-4a17-b0e6-d2e62c335829" xlink:to="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable_7384285f-1ae4-404b-a97f-bebef0062cb7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FinancialInstrumentAxis_a684fd69-feb9-462f-b238-5a63a0e588a7" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FinancialInstrumentAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable_7384285f-1ae4-404b-a97f-bebef0062cb7" xlink:to="loc_us-gaap_FinancialInstrumentAxis_a684fd69-feb9-462f-b238-5a63a0e588a7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_e9c8d67f-49d8-4b83-994c-18f009a2ef44" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FinancialInstrumentAxis_a684fd69-feb9-462f-b238-5a63a0e588a7" xlink:to="loc_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_e9c8d67f-49d8-4b83-994c-18f009a2ef44" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CorporateDebtSecuritiesMember_5a59a329-db41-4eb2-a504-06b48050e83f" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CorporateDebtSecuritiesMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_e9c8d67f-49d8-4b83-994c-18f009a2ef44" xlink:to="loc_us-gaap_CorporateDebtSecuritiesMember_5a59a329-db41-4eb2-a504-06b48050e83f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_MunicipalNotesMember_d9ec53c8-a8bf-4694-aae4-50ef3becdbaa" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_MunicipalNotesMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_e9c8d67f-49d8-4b83-994c-18f009a2ef44" xlink:to="loc_us-gaap_MunicipalNotesMember_d9ec53c8-a8bf-4694-aae4-50ef3becdbaa" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_USGovernmentAgenciesShorttermDebtSecuritiesMember_91ee0851-c057-4cfb-b8fc-8b1f5f066d62" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_USGovernmentAgenciesShorttermDebtSecuritiesMember"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_e9c8d67f-49d8-4b83-994c-18f009a2ef44" xlink:to="loc_us-gaap_USGovernmentAgenciesShorttermDebtSecuritiesMember_91ee0851-c057-4cfb-b8fc-8b1f5f066d62" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueByMeasurementFrequencyAxis_5267ab25-acb5-4af8-b960-605140ebe4e0" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueByMeasurementFrequencyAxis"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable_7384285f-1ae4-404b-a97f-bebef0062cb7" xlink:to="loc_us-gaap_FairValueByMeasurementFrequencyAxis_5267ab25-acb5-4af8-b960-605140ebe4e0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueMeasurementFrequencyDomain_1c51a0a1-1c79-465e-a528-2cd9e5a79d90" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueMeasurementFrequencyDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueByMeasurementFrequencyAxis_5267ab25-acb5-4af8-b960-605140ebe4e0" xlink:to="loc_us-gaap_FairValueMeasurementFrequencyDomain_1c51a0a1-1c79-465e-a528-2cd9e5a79d90" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueMeasurementsRecurringMember_0c2e8a74-0641-4fcd-813c-eae4115b0cc7" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueMeasurementsRecurringMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueMeasurementFrequencyDomain_1c51a0a1-1c79-465e-a528-2cd9e5a79d90" xlink:to="loc_us-gaap_FairValueMeasurementsRecurringMember_0c2e8a74-0641-4fcd-813c-eae4115b0cc7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueByFairValueHierarchyLevelAxis_c076d943-ad67-4fd5-8026-50cacfb2c3ce" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueByFairValueHierarchyLevelAxis"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable_7384285f-1ae4-404b-a97f-bebef0062cb7" xlink:to="loc_us-gaap_FairValueByFairValueHierarchyLevelAxis_c076d943-ad67-4fd5-8026-50cacfb2c3ce" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_8ac27ac8-6dbc-4697-a7cb-919fa71b7055" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueMeasurementsFairValueHierarchyDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueByFairValueHierarchyLevelAxis_c076d943-ad67-4fd5-8026-50cacfb2c3ce" xlink:to="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_8ac27ac8-6dbc-4697-a7cb-919fa71b7055" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueInputsLevel1Member_268b586d-152c-4f6e-9fc2-e8dad47864ad" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueInputsLevel1Member"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_8ac27ac8-6dbc-4697-a7cb-919fa71b7055" xlink:to="loc_us-gaap_FairValueInputsLevel1Member_268b586d-152c-4f6e-9fc2-e8dad47864ad" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueInputsLevel2Member_e2295045-c8e3-4e56-bb6e-be7b79f9f7df" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueInputsLevel2Member"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_8ac27ac8-6dbc-4697-a7cb-919fa71b7055" xlink:to="loc_us-gaap_FairValueInputsLevel2Member_e2295045-c8e3-4e56-bb6e-be7b79f9f7df" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueInputsLevel3Member_af6c5e99-a2a1-4257-b830-efc58d40d128" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueInputsLevel3Member"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_8ac27ac8-6dbc-4697-a7cb-919fa71b7055" xlink:to="loc_us-gaap_FairValueInputsLevel3Member_af6c5e99-a2a1-4257-b830-efc58d40d128" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems_d9a598e3-7abb-4128-9854-0d6a3d85e0ea" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable_7384285f-1ae4-404b-a97f-bebef0062cb7" xlink:to="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems_d9a598e3-7abb-4128-9854-0d6a3d85e0ea" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AssetsFairValueDisclosureAbstract_73afe5f2-1dd8-4248-b4e8-ffc91751cca5" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AssetsFairValueDisclosureAbstract"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems_d9a598e3-7abb-4128-9854-0d6a3d85e0ea" xlink:to="loc_us-gaap_AssetsFairValueDisclosureAbstract_73afe5f2-1dd8-4248-b4e8-ffc91751cca5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashEquivalentsAtCarryingValue_b7be46ed-3b5a-4d61-bbfa-db3193d75efb" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CashEquivalentsAtCarryingValue"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AssetsFairValueDisclosureAbstract_73afe5f2-1dd8-4248-b4e8-ffc91751cca5" xlink:to="loc_us-gaap_CashEquivalentsAtCarryingValue_b7be46ed-3b5a-4d61-bbfa-db3193d75efb" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestrictedCashNoncurrent_81ddaa82-ce5e-49e6-9cb8-7ada8ac78a04" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RestrictedCashNoncurrent"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AssetsFairValueDisclosureAbstract_73afe5f2-1dd8-4248-b4e8-ffc91751cca5" xlink:to="loc_us-gaap_RestrictedCashNoncurrent_81ddaa82-ce5e-49e6-9cb8-7ada8ac78a04" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InvestmentsFairValueDisclosureAbstract_3d4756fb-8fe6-4f6f-98aa-373132f045e2" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_InvestmentsFairValueDisclosureAbstract"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AssetsFairValueDisclosureAbstract_73afe5f2-1dd8-4248-b4e8-ffc91751cca5" xlink:to="loc_us-gaap_InvestmentsFairValueDisclosureAbstract_3d4756fb-8fe6-4f6f-98aa-373132f045e2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AvailableForSaleSecuritiesDebtSecurities_47d82b68-9cbd-4438-866f-4564d9ba361c" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AvailableForSaleSecuritiesDebtSecurities"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_InvestmentsFairValueDisclosureAbstract_3d4756fb-8fe6-4f6f-98aa-373132f045e2" xlink:to="loc_us-gaap_AvailableForSaleSecuritiesDebtSecurities_47d82b68-9cbd-4438-866f-4564d9ba361c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AssetsFairValueDisclosure_1e4710de-54d1-4801-961b-1886c4227f41" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AssetsFairValueDisclosure"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AssetsFairValueDisclosureAbstract_73afe5f2-1dd8-4248-b4e8-ffc91751cca5" xlink:to="loc_us-gaap_AssetsFairValueDisclosure_1e4710de-54d1-4801-961b-1886c4227f41" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilitiesFairValueDisclosureAbstract_18f6f9e6-cc8c-41bf-aa25-3849e43f827c" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LiabilitiesFairValueDisclosureAbstract"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems_d9a598e3-7abb-4128-9854-0d6a3d85e0ea" xlink:to="loc_us-gaap_LiabilitiesFairValueDisclosureAbstract_18f6f9e6-cc8c-41bf-aa25-3849e43f827c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dmtk_WarrantLiabilityFairValueDisclosure_3ad25e3a-b56e-42a7-8865-cf67b6f83a49" xlink:href="dmtk-20220630.xsd#dmtk_WarrantLiabilityFairValueDisclosure"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilitiesFairValueDisclosureAbstract_18f6f9e6-cc8c-41bf-aa25-3849e43f827c" xlink:to="loc_dmtk_WarrantLiabilityFairValueDisclosure_3ad25e3a-b56e-42a7-8865-cf67b6f83a49" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilitiesFairValueDisclosure_ab9eb4ce-43a7-4121-9869-a4e81e2be85c" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LiabilitiesFairValueDisclosure"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilitiesFairValueDisclosureAbstract_18f6f9e6-cc8c-41bf-aa25-3849e43f827c" xlink:to="loc_us-gaap_LiabilitiesFairValueDisclosure_ab9eb4ce-43a7-4121-9869-a4e81e2be85c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://dermtech.com/role/TheCompanyandaSummaryofitsSignificantAccountingPoliciesAssumptionsUsedtoDetermineFairValueofEachOptiononDateofGrantIssuedDetails" xlink:type="simple" xlink:href="dmtk-20220630.xsd#TheCompanyandaSummaryofitsSignificantAccountingPoliciesAssumptionsUsedtoDetermineFairValueofEachOptiononDateofGrantIssuedDetails"/>
  <link:presentationLink xlink:role="http://dermtech.com/role/TheCompanyandaSummaryofitsSignificantAccountingPoliciesAssumptionsUsedtoDetermineFairValueofEachOptiononDateofGrantIssuedDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccountingPoliciesAbstract_202783da-19bb-428f-8ed4-f1cba0a528e2" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AccountingPoliciesAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_9c52e45c-8fde-432b-bc2d-d6e85dbbba5c" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountingPoliciesAbstract_202783da-19bb-428f-8ed4-f1cba0a528e2" xlink:to="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_9c52e45c-8fde-432b-bc2d-d6e85dbbba5c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeAxis_d8899e4e-7499-4950-8b83-911afcddac6f" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_RangeAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_9c52e45c-8fde-432b-bc2d-d6e85dbbba5c" xlink:to="loc_srt_RangeAxis_d8899e4e-7499-4950-8b83-911afcddac6f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeMember_1815cf0a-5ca8-4b37-a859-24fa074f0dca" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_RangeMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_RangeAxis_d8899e4e-7499-4950-8b83-911afcddac6f" xlink:to="loc_srt_RangeMember_1815cf0a-5ca8-4b37-a859-24fa074f0dca" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_MinimumMember_cd0cd1d7-cebd-44b3-bbcd-9348d4f95ddf" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_MinimumMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_RangeMember_1815cf0a-5ca8-4b37-a859-24fa074f0dca" xlink:to="loc_srt_MinimumMember_cd0cd1d7-cebd-44b3-bbcd-9348d4f95ddf" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_MaximumMember_7dcc3e5f-0829-473a-80eb-9c69d2ebe00f" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_MaximumMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_RangeMember_1815cf0a-5ca8-4b37-a859-24fa074f0dca" xlink:to="loc_srt_MaximumMember_7dcc3e5f-0829-473a-80eb-9c69d2ebe00f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FinancialInstrumentAxis_9e670f38-4423-4f5c-b600-15ecd68dcd3a" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FinancialInstrumentAxis"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_9c52e45c-8fde-432b-bc2d-d6e85dbbba5c" xlink:to="loc_us-gaap_FinancialInstrumentAxis_9e670f38-4423-4f5c-b600-15ecd68dcd3a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_7ba25e10-fa45-4718-9850-c0f302a5f5d1" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FinancialInstrumentAxis_9e670f38-4423-4f5c-b600-15ecd68dcd3a" xlink:to="loc_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_7ba25e10-fa45-4718-9850-c0f302a5f5d1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_WarrantyRightsAndObligationsFairValueOptionMember_9e362d40-8421-43d7-9de5-1a3c9fbfcbd7" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_WarrantyRightsAndObligationsFairValueOptionMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_7ba25e10-fa45-4718-9850-c0f302a5f5d1" xlink:to="loc_us-gaap_WarrantyRightsAndObligationsFairValueOptionMember_9e362d40-8421-43d7-9de5-1a3c9fbfcbd7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_2f43c406-f7ac-4b4a-b065-b91ea6487ecf" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_9c52e45c-8fde-432b-bc2d-d6e85dbbba5c" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_2f43c406-f7ac-4b4a-b065-b91ea6487ecf" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate_80dbe40d-66f9-48c4-b01e-ad7b51ecedeb" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_2f43c406-f7ac-4b4a-b065-b91ea6487ecf" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate_80dbe40d-66f9-48c4-b01e-ad7b51ecedeb" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMinimum_6f97c29a-2fce-428c-b330-026005dc4e55" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMinimum"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_2f43c406-f7ac-4b4a-b065-b91ea6487ecf" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMinimum_6f97c29a-2fce-428c-b330-026005dc4e55" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMaximum_3bbb8b0d-487a-4dcc-8419-8e9c67eb8d92" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMaximum"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_2f43c406-f7ac-4b4a-b065-b91ea6487ecf" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMaximum_3bbb8b0d-487a-4dcc-8419-8e9c67eb8d92" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate_f6f9f7ef-5276-41ba-bedf-bfd68df93245" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_2f43c406-f7ac-4b4a-b065-b91ea6487ecf" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate_f6f9f7ef-5276-41ba-bedf-bfd68df93245" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRateMinimum_f6c1e952-ff05-48b6-a6ba-de7e9d6e19c1" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRateMinimum"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_2f43c406-f7ac-4b4a-b065-b91ea6487ecf" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRateMinimum_f6c1e952-ff05-48b6-a6ba-de7e9d6e19c1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRateMaximum_f02764ef-9a04-4f62-a0dd-d736cecc9ab0" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRateMaximum"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_2f43c406-f7ac-4b4a-b065-b91ea6487ecf" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRateMaximum_f02764ef-9a04-4f62-a0dd-d736cecc9ab0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1_83540962-79f0-4737-b9ae-661cd852521a" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_2f43c406-f7ac-4b4a-b065-b91ea6487ecf" xlink:to="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1_83540962-79f0-4737-b9ae-661cd852521a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate_31d33db1-225f-47f6-b5f2-98cd3112389c" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_2f43c406-f7ac-4b4a-b065-b91ea6487ecf" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate_31d33db1-225f-47f6-b5f2-98cd3112389c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://dermtech.com/role/TheCompanyandaSummaryofitsSignificantAccountingPoliciesSummaryofChangesinFairValueofLevel3LiabilitiesDetails" xlink:type="simple" xlink:href="dmtk-20220630.xsd#TheCompanyandaSummaryofitsSignificantAccountingPoliciesSummaryofChangesinFairValueofLevel3LiabilitiesDetails"/>
  <link:presentationLink xlink:role="http://dermtech.com/role/TheCompanyandaSummaryofitsSignificantAccountingPoliciesSummaryofChangesinFairValueofLevel3LiabilitiesDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccountingPoliciesAbstract_0c2e0717-3a9d-4cc2-baa5-e397ea8d2cec" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AccountingPoliciesAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationTable_a38b2232-cf07-4f25-8ce3-e0f1d1d12a79" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountingPoliciesAbstract_0c2e0717-3a9d-4cc2-baa5-e397ea8d2cec" xlink:to="loc_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationTable_a38b2232-cf07-4f25-8ce3-e0f1d1d12a79" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueByFairValueHierarchyLevelAxis_87445397-af94-4889-b8e9-64296983a1ce" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueByFairValueHierarchyLevelAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationTable_a38b2232-cf07-4f25-8ce3-e0f1d1d12a79" xlink:to="loc_us-gaap_FairValueByFairValueHierarchyLevelAxis_87445397-af94-4889-b8e9-64296983a1ce" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_43f5fc5a-b4fc-49c6-baa2-75ea5a30a846" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueMeasurementsFairValueHierarchyDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueByFairValueHierarchyLevelAxis_87445397-af94-4889-b8e9-64296983a1ce" xlink:to="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_43f5fc5a-b4fc-49c6-baa2-75ea5a30a846" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueInputsLevel3Member_f00931fe-5fbd-480a-a710-1d19ad17c647" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueInputsLevel3Member"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_43f5fc5a-b4fc-49c6-baa2-75ea5a30a846" xlink:to="loc_us-gaap_FairValueInputsLevel3Member_f00931fe-5fbd-480a-a710-1d19ad17c647" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueByLiabilityClassAxis_a4f1c219-bfe1-4bdf-b272-c1c6777c3469" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueByLiabilityClassAxis"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationTable_a38b2232-cf07-4f25-8ce3-e0f1d1d12a79" xlink:to="loc_us-gaap_FairValueByLiabilityClassAxis_a4f1c219-bfe1-4bdf-b272-c1c6777c3469" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationByLiabilityClassDomain_3a8ef555-77a1-4cca-8e11-5f6386ba2978" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationByLiabilityClassDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueByLiabilityClassAxis_a4f1c219-bfe1-4bdf-b272-c1c6777c3469" xlink:to="loc_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationByLiabilityClassDomain_3a8ef555-77a1-4cca-8e11-5f6386ba2978" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dmtk_WarrantLiabilityMember_33e13ba0-a31c-49ce-bfc8-8da735682c69" xlink:href="dmtk-20220630.xsd#dmtk_WarrantLiabilityMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationByLiabilityClassDomain_3a8ef555-77a1-4cca-8e11-5f6386ba2978" xlink:to="loc_dmtk_WarrantLiabilityMember_33e13ba0-a31c-49ce-bfc8-8da735682c69" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationLineItems_7cecc0fe-76d0-4f65-8e97-61ebbae2f340" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationLineItems"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationTable_a38b2232-cf07-4f25-8ce3-e0f1d1d12a79" xlink:to="loc_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationLineItems_7cecc0fe-76d0-4f65-8e97-61ebbae2f340" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationCalculationRollForward_208c6ecd-8623-4c08-b61d-2c4ebdf58626" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationCalculationRollForward"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationLineItems_7cecc0fe-76d0-4f65-8e97-61ebbae2f340" xlink:to="loc_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationCalculationRollForward_208c6ecd-8623-4c08-b61d-2c4ebdf58626" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue_771ffc77-1294-440b-b834-8bed1e7207ac" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationCalculationRollForward_208c6ecd-8623-4c08-b61d-2c4ebdf58626" xlink:to="loc_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue_771ffc77-1294-440b-b834-8bed1e7207ac" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodStartLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityGainLossIncludedInEarnings_b2dddcb0-9948-4376-89ff-410e6d166d62" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityGainLossIncludedInEarnings"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationCalculationRollForward_208c6ecd-8623-4c08-b61d-2c4ebdf58626" xlink:to="loc_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityGainLossIncludedInEarnings_b2dddcb0-9948-4376-89ff-410e6d166d62" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue_1f424ea3-850b-4b87-a00e-4bf2f86ee70b" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationCalculationRollForward_208c6ecd-8623-4c08-b61d-2c4ebdf58626" xlink:to="loc_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue_1f424ea3-850b-4b87-a00e-4bf2f86ee70b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodEndLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://dermtech.com/role/BalanceSheetDetails" xlink:type="simple" xlink:href="dmtk-20220630.xsd#BalanceSheetDetails"/>
  <link:presentationLink xlink:role="http://dermtech.com/role/BalanceSheetDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract_f796448d-656f-4483-be1e-f76f7d20a009" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SupplementalBalanceSheetDisclosuresTextBlock_9834cfb5-a235-4a77-b3d9-a34da8da4da7" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SupplementalBalanceSheetDisclosuresTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract_f796448d-656f-4483-be1e-f76f7d20a009" xlink:to="loc_us-gaap_SupplementalBalanceSheetDisclosuresTextBlock_9834cfb5-a235-4a77-b3d9-a34da8da4da7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://dermtech.com/role/BalanceSheetDetailsTables" xlink:type="simple" xlink:href="dmtk-20220630.xsd#BalanceSheetDetailsTables"/>
  <link:presentationLink xlink:role="http://dermtech.com/role/BalanceSheetDetailsTables" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract_0d54f051-1469-4522-9343-22316a877df3" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtSecuritiesAvailableForSaleTableTextBlock_a3558656-0316-4219-8d9a-2642c4098f8f" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtSecuritiesAvailableForSaleTableTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract_0d54f051-1469-4522-9343-22316a877df3" xlink:to="loc_us-gaap_DebtSecuritiesAvailableForSaleTableTextBlock_a3558656-0316-4219-8d9a-2642c4098f8f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dmtk_ScheduleOfPrepaidExpensesAndPropertyAndEquipmentTableTextBlock_da058665-e517-456c-8c9c-955eeddb16e1" xlink:href="dmtk-20220630.xsd#dmtk_ScheduleOfPrepaidExpensesAndPropertyAndEquipmentTableTextBlock"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract_0d54f051-1469-4522-9343-22316a877df3" xlink:to="loc_dmtk_ScheduleOfPrepaidExpensesAndPropertyAndEquipmentTableTextBlock_da058665-e517-456c-8c9c-955eeddb16e1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfAccountsPayableAndAccruedLiabilitiesTableTextBlock_cd9400b2-2fc2-4b05-863b-b4f63bd4b4e8" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfAccountsPayableAndAccruedLiabilitiesTableTextBlock"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract_0d54f051-1469-4522-9343-22316a877df3" xlink:to="loc_us-gaap_ScheduleOfAccountsPayableAndAccruedLiabilitiesTableTextBlock_cd9400b2-2fc2-4b05-863b-b4f63bd4b4e8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://dermtech.com/role/BalanceSheetDetailsScheduleofShortTermMarketableSecuritiesDetails" xlink:type="simple" xlink:href="dmtk-20220630.xsd#BalanceSheetDetailsScheduleofShortTermMarketableSecuritiesDetails"/>
  <link:presentationLink xlink:role="http://dermtech.com/role/BalanceSheetDetailsScheduleofShortTermMarketableSecuritiesDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract_69582308-2035-4e6d-923b-20c473e607e2" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InvestmentHoldingsTable_e86812f8-3125-487c-954d-0c0afa5b0766" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_InvestmentHoldingsTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract_69582308-2035-4e6d-923b-20c473e607e2" xlink:to="loc_us-gaap_InvestmentHoldingsTable_e86812f8-3125-487c-954d-0c0afa5b0766" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FinancialInstrumentAxis_2450a858-cf51-43df-9bef-fd71f15a85f7" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FinancialInstrumentAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_InvestmentHoldingsTable_e86812f8-3125-487c-954d-0c0afa5b0766" xlink:to="loc_us-gaap_FinancialInstrumentAxis_2450a858-cf51-43df-9bef-fd71f15a85f7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_9eb0a980-473b-4736-83b8-eb1d0b27ffc8" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FinancialInstrumentAxis_2450a858-cf51-43df-9bef-fd71f15a85f7" xlink:to="loc_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_9eb0a980-473b-4736-83b8-eb1d0b27ffc8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CorporateDebtSecuritiesMember_5b028946-ceb3-46d9-a46f-f769441fbda4" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CorporateDebtSecuritiesMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_9eb0a980-473b-4736-83b8-eb1d0b27ffc8" xlink:to="loc_us-gaap_CorporateDebtSecuritiesMember_5b028946-ceb3-46d9-a46f-f769441fbda4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_MunicipalNotesMember_4d916c72-e579-4a7c-bd55-a4d1debd7a27" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_MunicipalNotesMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_9eb0a980-473b-4736-83b8-eb1d0b27ffc8" xlink:to="loc_us-gaap_MunicipalNotesMember_4d916c72-e579-4a7c-bd55-a4d1debd7a27" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_USGovernmentAgenciesShorttermDebtSecuritiesMember_adf95cd4-4767-48ee-bd2b-fadc21608239" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_USGovernmentAgenciesShorttermDebtSecuritiesMember"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_9eb0a980-473b-4736-83b8-eb1d0b27ffc8" xlink:to="loc_us-gaap_USGovernmentAgenciesShorttermDebtSecuritiesMember_adf95cd4-4767-48ee-bd2b-fadc21608239" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InvestmentHoldingsLineItems_18800c31-6235-4f71-9c5f-cf460bf618e6" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_InvestmentHoldingsLineItems"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_InvestmentHoldingsTable_e86812f8-3125-487c-954d-0c0afa5b0766" xlink:to="loc_us-gaap_InvestmentHoldingsLineItems_18800c31-6235-4f71-9c5f-cf460bf618e6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AvailableForSaleDebtSecuritiesAmortizedCostBasis_b2c5abed-7932-45fa-92cb-808ba169abda" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AvailableForSaleDebtSecuritiesAmortizedCostBasis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_InvestmentHoldingsLineItems_18800c31-6235-4f71-9c5f-cf460bf618e6" xlink:to="loc_us-gaap_AvailableForSaleDebtSecuritiesAmortizedCostBasis_b2c5abed-7932-45fa-92cb-808ba169abda" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax_95be59cd-5db4-46ab-87c0-b2236631aac8" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_InvestmentHoldingsLineItems_18800c31-6235-4f71-9c5f-cf460bf618e6" xlink:to="loc_us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax_95be59cd-5db4-46ab-87c0-b2236631aac8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax_4b2aae84-e2e4-4ffb-a62d-4fad59e969d1" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_InvestmentHoldingsLineItems_18800c31-6235-4f71-9c5f-cf460bf618e6" xlink:to="loc_us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax_4b2aae84-e2e4-4ffb-a62d-4fad59e969d1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AvailableForSaleSecuritiesDebtSecurities_ec6bae7d-f84e-431b-b960-f81128f9a5dc" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AvailableForSaleSecuritiesDebtSecurities"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_InvestmentHoldingsLineItems_18800c31-6235-4f71-9c5f-cf460bf618e6" xlink:to="loc_us-gaap_AvailableForSaleSecuritiesDebtSecurities_ec6bae7d-f84e-431b-b960-f81128f9a5dc" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://dermtech.com/role/BalanceSheetDetailsAdditionalInformationDetails" xlink:type="simple" xlink:href="dmtk-20220630.xsd#BalanceSheetDetailsAdditionalInformationDetails"/>
  <link:presentationLink xlink:role="http://dermtech.com/role/BalanceSheetDetailsAdditionalInformationDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract_8703143c-b01e-4a2a-b2b6-70925e6ca4c2" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_dmtk_EstimatedMarketValueOfDebtSecuritiesWithContractualMaturitiesOfLessThan12Months_af434527-ac49-453b-bffc-c8aa127b18db" xlink:href="dmtk-20220630.xsd#dmtk_EstimatedMarketValueOfDebtSecuritiesWithContractualMaturitiesOfLessThan12Months"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract_8703143c-b01e-4a2a-b2b6-70925e6ca4c2" xlink:to="loc_dmtk_EstimatedMarketValueOfDebtSecuritiesWithContractualMaturitiesOfLessThan12Months_af434527-ac49-453b-bffc-c8aa127b18db" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dmtk_EstimatedMarketValueOfRemainingDebtSecuritiesWithContractualMaturitiesOfUpTo23Months_ea989277-18ef-44ca-984a-363d8c8e41ae" xlink:href="dmtk-20220630.xsd#dmtk_EstimatedMarketValueOfRemainingDebtSecuritiesWithContractualMaturitiesOfUpTo23Months"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract_8703143c-b01e-4a2a-b2b6-70925e6ca4c2" xlink:to="loc_dmtk_EstimatedMarketValueOfRemainingDebtSecuritiesWithContractualMaturitiesOfUpTo23Months_ea989277-18ef-44ca-984a-363d8c8e41ae" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dmtk_CreditLosses_0f090e64-0b23-441f-b126-088f860a2572" xlink:href="dmtk-20220630.xsd#dmtk_CreditLosses"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract_8703143c-b01e-4a2a-b2b6-70925e6ca4c2" xlink:to="loc_dmtk_CreditLosses_0f090e64-0b23-441f-b126-088f860a2572" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://dermtech.com/role/BalanceSheetDetailsScheduleofPrepaidExpensesandPPEDetails" xlink:type="simple" xlink:href="dmtk-20220630.xsd#BalanceSheetDetailsScheduleofPrepaidExpensesandPPEDetails"/>
  <link:presentationLink xlink:role="http://dermtech.com/role/BalanceSheetDetailsScheduleofPrepaidExpensesandPPEDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract_e4695bc6-ab10-4997-aad9-eb391b5404a1" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PrepaidExpenseAndOtherAssetsCurrentAbstract_839cd205-f109-44f5-90ca-e30730e70140" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PrepaidExpenseAndOtherAssetsCurrentAbstract"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract_e4695bc6-ab10-4997-aad9-eb391b5404a1" xlink:to="loc_us-gaap_PrepaidExpenseAndOtherAssetsCurrentAbstract_839cd205-f109-44f5-90ca-e30730e70140" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PrepaidInsurance_f87e6c2d-7656-4d40-81e3-72ed2365fd1c" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PrepaidInsurance"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PrepaidExpenseAndOtherAssetsCurrentAbstract_839cd205-f109-44f5-90ca-e30730e70140" xlink:to="loc_us-gaap_PrepaidInsurance_f87e6c2d-7656-4d40-81e3-72ed2365fd1c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dmtk_PrepaidTradeShowsCurrent_42b9ce3b-f651-45ff-83ba-1523f8f4b401" xlink:href="dmtk-20220630.xsd#dmtk_PrepaidTradeShowsCurrent"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PrepaidExpenseAndOtherAssetsCurrentAbstract_839cd205-f109-44f5-90ca-e30730e70140" xlink:to="loc_dmtk_PrepaidTradeShowsCurrent_42b9ce3b-f651-45ff-83ba-1523f8f4b401" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dmtk_PrepaidSoftwareFees_03a20fc5-948b-405c-aec4-8e5685747d66" xlink:href="dmtk-20220630.xsd#dmtk_PrepaidSoftwareFees"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PrepaidExpenseAndOtherAssetsCurrentAbstract_839cd205-f109-44f5-90ca-e30730e70140" xlink:to="loc_dmtk_PrepaidSoftwareFees_03a20fc5-948b-405c-aec4-8e5685747d66" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dmtk_PrepaidEmployeeCompensation_b5ddcbbd-70fc-4f41-b732-8c5a6ea42210" xlink:href="dmtk-20220630.xsd#dmtk_PrepaidEmployeeCompensation"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PrepaidExpenseAndOtherAssetsCurrentAbstract_839cd205-f109-44f5-90ca-e30730e70140" xlink:to="loc_dmtk_PrepaidEmployeeCompensation_b5ddcbbd-70fc-4f41-b732-8c5a6ea42210" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherAssetsCurrent_74efdf65-5f74-4a74-b4e8-ee0824c87ac0" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherAssetsCurrent"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PrepaidExpenseAndOtherAssetsCurrentAbstract_839cd205-f109-44f5-90ca-e30730e70140" xlink:to="loc_us-gaap_OtherAssetsCurrent_74efdf65-5f74-4a74-b4e8-ee0824c87ac0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PrepaidExpenseAndOtherAssetsCurrent_c02fdc95-08ef-4c2a-8666-cdd018ec7ea4" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PrepaidExpenseAndOtherAssetsCurrent"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PrepaidExpenseAndOtherAssetsCurrentAbstract_839cd205-f109-44f5-90ca-e30730e70140" xlink:to="loc_us-gaap_PrepaidExpenseAndOtherAssetsCurrent_c02fdc95-08ef-4c2a-8666-cdd018ec7ea4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentGrossAbstract_e5afb0f5-6a27-4c32-9a88-26d4101ddfeb" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PropertyPlantAndEquipmentGrossAbstract"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract_e4695bc6-ab10-4997-aad9-eb391b5404a1" xlink:to="loc_us-gaap_PropertyPlantAndEquipmentGrossAbstract_e5afb0f5-6a27-4c32-9a88-26d4101ddfeb" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_MachineryAndEquipmentGross_93f233f3-6047-48b8-85a2-c6acb245db4f" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_MachineryAndEquipmentGross"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentGrossAbstract_e5afb0f5-6a27-4c32-9a88-26d4101ddfeb" xlink:to="loc_us-gaap_MachineryAndEquipmentGross_93f233f3-6047-48b8-85a2-c6acb245db4f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dmtk_ComputerEquipmentGross_8b79bb20-5399-4691-84f8-ef6b56d6420c" xlink:href="dmtk-20220630.xsd#dmtk_ComputerEquipmentGross"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentGrossAbstract_e5afb0f5-6a27-4c32-9a88-26d4101ddfeb" xlink:to="loc_dmtk_ComputerEquipmentGross_8b79bb20-5399-4691-84f8-ef6b56d6420c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FurnitureAndFixturesGross_9a621b85-634b-427f-821a-abce9ecd7b19" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FurnitureAndFixturesGross"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentGrossAbstract_e5afb0f5-6a27-4c32-9a88-26d4101ddfeb" xlink:to="loc_us-gaap_FurnitureAndFixturesGross_9a621b85-634b-427f-821a-abce9ecd7b19" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LeaseholdImprovementsGross_2c0de40b-28d2-43f5-b5d4-829791a69118" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LeaseholdImprovementsGross"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentGrossAbstract_e5afb0f5-6a27-4c32-9a88-26d4101ddfeb" xlink:to="loc_us-gaap_LeaseholdImprovementsGross_2c0de40b-28d2-43f5-b5d4-829791a69118" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ConstructionInProgressGross_1b019c94-ef7e-4527-88f1-294ccd82dd69" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ConstructionInProgressGross"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentGrossAbstract_e5afb0f5-6a27-4c32-9a88-26d4101ddfeb" xlink:to="loc_us-gaap_ConstructionInProgressGross_1b019c94-ef7e-4527-88f1-294ccd82dd69" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentGross_f50b2513-19f8-4d95-a913-5cb1eee037a0" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PropertyPlantAndEquipmentGross"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentGrossAbstract_e5afb0f5-6a27-4c32-9a88-26d4101ddfeb" xlink:to="loc_us-gaap_PropertyPlantAndEquipmentGross_f50b2513-19f8-4d95-a913-5cb1eee037a0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment_640eb5e1-ad58-4951-a116-09dc35903db1" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract_e4695bc6-ab10-4997-aad9-eb391b5404a1" xlink:to="loc_us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment_640eb5e1-ad58-4951-a116-09dc35903db1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentNet_c99fabca-498f-4d07-ab74-b3c49b13c354" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PropertyPlantAndEquipmentNet"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract_e4695bc6-ab10-4997-aad9-eb391b5404a1" xlink:to="loc_us-gaap_PropertyPlantAndEquipmentNet_c99fabca-498f-4d07-ab74-b3c49b13c354" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://dermtech.com/role/BalanceSheetDetailsScheduleofAccruedCompensationandAccruedLiabilitiesDetails" xlink:type="simple" xlink:href="dmtk-20220630.xsd#BalanceSheetDetailsScheduleofAccruedCompensationandAccruedLiabilitiesDetails"/>
  <link:presentationLink xlink:role="http://dermtech.com/role/BalanceSheetDetailsScheduleofAccruedCompensationandAccruedLiabilitiesDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract_b5e46103-d879-4517-84b5-f3ccb1ef63ed" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EmployeeRelatedLiabilitiesCurrentAbstract_3d1960ce-a190-44f1-903c-1d6b83088cd8" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EmployeeRelatedLiabilitiesCurrentAbstract"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract_b5e46103-d879-4517-84b5-f3ccb1ef63ed" xlink:to="loc_us-gaap_EmployeeRelatedLiabilitiesCurrentAbstract_3d1960ce-a190-44f1-903c-1d6b83088cd8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccruedVacationCurrent_1b44f75a-e9be-4207-8835-9276a02c72fb" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AccruedVacationCurrent"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EmployeeRelatedLiabilitiesCurrentAbstract_3d1960ce-a190-44f1-903c-1d6b83088cd8" xlink:to="loc_us-gaap_AccruedVacationCurrent_1b44f75a-e9be-4207-8835-9276a02c72fb" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dmtk_AccruedBonusAndDeferredCompensationCurrent_1e27616f-2eb1-4176-bc02-9ad72793dbb2" xlink:href="dmtk-20220630.xsd#dmtk_AccruedBonusAndDeferredCompensationCurrent"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EmployeeRelatedLiabilitiesCurrentAbstract_3d1960ce-a190-44f1-903c-1d6b83088cd8" xlink:to="loc_dmtk_AccruedBonusAndDeferredCompensationCurrent_1e27616f-2eb1-4176-bc02-9ad72793dbb2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EmployeeRelatedLiabilitiesCurrent_5823fe3f-7992-4cef-b9a3-1c951fc8d191" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EmployeeRelatedLiabilitiesCurrent"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EmployeeRelatedLiabilitiesCurrentAbstract_3d1960ce-a190-44f1-903c-1d6b83088cd8" xlink:to="loc_us-gaap_EmployeeRelatedLiabilitiesCurrent_5823fe3f-7992-4cef-b9a3-1c951fc8d191" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccruedLiabilitiesCurrentAbstract_406c4e65-c578-4b04-bb0c-c596c9f313a5" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AccruedLiabilitiesCurrentAbstract"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract_b5e46103-d879-4517-84b5-f3ccb1ef63ed" xlink:to="loc_us-gaap_AccruedLiabilitiesCurrentAbstract_406c4e65-c578-4b04-bb0c-c596c9f313a5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dmtk_AccruedConsultingServicesCurrent_819222c6-cc7c-4590-927a-8f8d5e401985" xlink:href="dmtk-20220630.xsd#dmtk_AccruedConsultingServicesCurrent"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccruedLiabilitiesCurrentAbstract_406c4e65-c578-4b04-bb0c-c596c9f313a5" xlink:to="loc_dmtk_AccruedConsultingServicesCurrent_819222c6-cc7c-4590-927a-8f8d5e401985" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherAccruedLiabilitiesCurrent_726df1fd-6f0e-4909-9b2d-4579f652c73b" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherAccruedLiabilitiesCurrent"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccruedLiabilitiesCurrentAbstract_406c4e65-c578-4b04-bb0c-c596c9f313a5" xlink:to="loc_us-gaap_OtherAccruedLiabilitiesCurrent_726df1fd-6f0e-4909-9b2d-4579f652c73b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccruedLiabilitiesCurrent_dced720b-2bce-4ab9-910f-8924e8a4eaee" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AccruedLiabilitiesCurrent"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccruedLiabilitiesCurrentAbstract_406c4e65-c578-4b04-bb0c-c596c9f313a5" xlink:to="loc_us-gaap_AccruedLiabilitiesCurrent_dced720b-2bce-4ab9-910f-8924e8a4eaee" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://dermtech.com/role/StockholdersEquity" xlink:type="simple" xlink:href="dmtk-20220630.xsd#StockholdersEquity"/>
  <link:presentationLink xlink:role="http://dermtech.com/role/StockholdersEquity" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockholdersEquityNoteAbstract_7156740e-b325-4d22-bdf2-3d708a43c4a6" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StockholdersEquityNoteAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockholdersEquityNoteDisclosureTextBlock_7fd8a274-c25e-4967-97ff-76456f493288" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StockholdersEquityNoteDisclosureTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StockholdersEquityNoteAbstract_7156740e-b325-4d22-bdf2-3d708a43c4a6" xlink:to="loc_us-gaap_StockholdersEquityNoteDisclosureTextBlock_7fd8a274-c25e-4967-97ff-76456f493288" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://dermtech.com/role/StockholdersEquityTables" xlink:type="simple" xlink:href="dmtk-20220630.xsd#StockholdersEquityTables"/>
  <link:presentationLink xlink:role="http://dermtech.com/role/StockholdersEquityTables" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockholdersEquityNoteAbstract_5f3e0743-4af3-4864-afba-13a6430e8e24" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StockholdersEquityNoteAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfStockByClassTextBlock_91e0a248-b100-44e9-9a78-bb6c52ad5628" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfStockByClassTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StockholdersEquityNoteAbstract_5f3e0743-4af3-4864-afba-13a6430e8e24" xlink:to="loc_us-gaap_ScheduleOfStockByClassTextBlock_91e0a248-b100-44e9-9a78-bb6c52ad5628" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfShareBasedPaymentAwardEmployeeStockPurchasePlanValuationAssumptionsTableTextBlock_80073d9c-58ef-4cb1-9022-f221f8294147" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfShareBasedPaymentAwardEmployeeStockPurchasePlanValuationAssumptionsTableTextBlock"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StockholdersEquityNoteAbstract_5f3e0743-4af3-4864-afba-13a6430e8e24" xlink:to="loc_us-gaap_ScheduleOfShareBasedPaymentAwardEmployeeStockPurchasePlanValuationAssumptionsTableTextBlock_80073d9c-58ef-4cb1-9022-f221f8294147" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisclosureOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTextBlock_fda1b84b-09dd-4658-80e7-228420629f34" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DisclosureOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTextBlock"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StockholdersEquityNoteAbstract_5f3e0743-4af3-4864-afba-13a6430e8e24" xlink:to="loc_us-gaap_DisclosureOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTextBlock_fda1b84b-09dd-4658-80e7-228420629f34" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://dermtech.com/role/StockholdersEquityAdditionalInformationDetails" xlink:type="simple" xlink:href="dmtk-20220630.xsd#StockholdersEquityAdditionalInformationDetails"/>
  <link:presentationLink xlink:role="http://dermtech.com/role/StockholdersEquityAdditionalInformationDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockholdersEquityNoteAbstract_4910ef13-858d-4a35-a581-68e0371f9d5f" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StockholdersEquityNoteAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfStockByClassTable_f8f23445-e5f5-451f-b8f7-1b42f26c0490" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfStockByClassTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StockholdersEquityNoteAbstract_4910ef13-858d-4a35-a581-68e0371f9d5f" xlink:to="loc_us-gaap_ScheduleOfStockByClassTable_f8f23445-e5f5-451f-b8f7-1b42f26c0490" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeAxis_3fb656a8-b3c8-40e6-b71d-d800683817a3" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_RangeAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfStockByClassTable_f8f23445-e5f5-451f-b8f7-1b42f26c0490" xlink:to="loc_srt_RangeAxis_3fb656a8-b3c8-40e6-b71d-d800683817a3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeMember_3cc7ecf5-d437-4f1f-8b59-4a8acb75d058" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_RangeMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_RangeAxis_3fb656a8-b3c8-40e6-b71d-d800683817a3" xlink:to="loc_srt_RangeMember_3cc7ecf5-d437-4f1f-8b59-4a8acb75d058" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_MinimumMember_45ea3b6b-6a9a-4a9f-a2c5-878e56d00cd4" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_MinimumMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_RangeMember_3cc7ecf5-d437-4f1f-8b59-4a8acb75d058" xlink:to="loc_srt_MinimumMember_45ea3b6b-6a9a-4a9f-a2c5-878e56d00cd4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_MaximumMember_4aad9716-835d-41bb-b980-748352d4fc7d" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_MaximumMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_RangeMember_3cc7ecf5-d437-4f1f-8b59-4a8acb75d058" xlink:to="loc_srt_MaximumMember_4aad9716-835d-41bb-b980-748352d4fc7d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementEquityComponentsAxis_5892d6ca-1e7b-446d-851e-682f8acb75ac" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StatementEquityComponentsAxis"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfStockByClassTable_f8f23445-e5f5-451f-b8f7-1b42f26c0490" xlink:to="loc_us-gaap_StatementEquityComponentsAxis_5892d6ca-1e7b-446d-851e-682f8acb75ac" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquityComponentDomain_f749b762-f0d8-45bf-ad21-0f593e81809a" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EquityComponentDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementEquityComponentsAxis_5892d6ca-1e7b-446d-851e-682f8acb75ac" xlink:to="loc_us-gaap_EquityComponentDomain_f749b762-f0d8-45bf-ad21-0f593e81809a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockMember_6de37144-2758-42d5-af7b-8e507d887365" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CommonStockMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EquityComponentDomain_f749b762-f0d8-45bf-ad21-0f593e81809a" xlink:to="loc_us-gaap_CommonStockMember_6de37144-2758-42d5-af7b-8e507d887365" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RelatedPartyTransactionsByRelatedPartyAxis_4c3e7e09-e9df-408a-bd40-84961e41669c" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RelatedPartyTransactionsByRelatedPartyAxis"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfStockByClassTable_f8f23445-e5f5-451f-b8f7-1b42f26c0490" xlink:to="loc_us-gaap_RelatedPartyTransactionsByRelatedPartyAxis_4c3e7e09-e9df-408a-bd40-84961e41669c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RelatedPartyDomain_9a744bdb-e931-4450-aa65-8535ac80af56" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RelatedPartyDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RelatedPartyTransactionsByRelatedPartyAxis_4c3e7e09-e9df-408a-bd40-84961e41669c" xlink:to="loc_us-gaap_RelatedPartyDomain_9a744bdb-e931-4450-aa65-8535ac80af56" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dmtk_CowenLimitedLiabilityCompanyMember_48bf2a53-3d9f-4dce-aefa-a6b9fe9734a9" xlink:href="dmtk-20220630.xsd#dmtk_CowenLimitedLiabilityCompanyMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RelatedPartyDomain_9a744bdb-e931-4450-aa65-8535ac80af56" xlink:to="loc_dmtk_CowenLimitedLiabilityCompanyMember_48bf2a53-3d9f-4dce-aefa-a6b9fe9734a9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ClassOfWarrantOrRightAxis_b5d87b7b-0e91-4e62-9cb1-d4254ccded05" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ClassOfWarrantOrRightAxis"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfStockByClassTable_f8f23445-e5f5-451f-b8f7-1b42f26c0490" xlink:to="loc_us-gaap_ClassOfWarrantOrRightAxis_b5d87b7b-0e91-4e62-9cb1-d4254ccded05" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ClassOfWarrantOrRightDomain_dadeb2b1-188b-46d9-83a7-9ce3d4c75eff" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ClassOfWarrantOrRightDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ClassOfWarrantOrRightAxis_b5d87b7b-0e91-4e62-9cb1-d4254ccded05" xlink:to="loc_us-gaap_ClassOfWarrantOrRightDomain_dadeb2b1-188b-46d9-83a7-9ce3d4c75eff" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dmtk_SpecialPurposeAcquisitionCompaniesWarrantsMember_c86444f3-f998-43ca-9634-69578f79c176" xlink:href="dmtk-20220630.xsd#dmtk_SpecialPurposeAcquisitionCompaniesWarrantsMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ClassOfWarrantOrRightDomain_dadeb2b1-188b-46d9-83a7-9ce3d4c75eff" xlink:to="loc_dmtk_SpecialPurposeAcquisitionCompaniesWarrantsMember_c86444f3-f998-43ca-9634-69578f79c176" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dmtk_PublicSpecialPurposeAcquisitionCompaniesWarrantsMember_808327ba-d110-4204-a8d1-7a8a17d18799" xlink:href="dmtk-20220630.xsd#dmtk_PublicSpecialPurposeAcquisitionCompaniesWarrantsMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ClassOfWarrantOrRightDomain_dadeb2b1-188b-46d9-83a7-9ce3d4c75eff" xlink:to="loc_dmtk_PublicSpecialPurposeAcquisitionCompaniesWarrantsMember_808327ba-d110-4204-a8d1-7a8a17d18799" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dmtk_PrivateSpecialPurposeAcquisitionCompaniesWarrantsMember_76f9af35-2cfa-4d37-a0af-0958ef995b28" xlink:href="dmtk-20220630.xsd#dmtk_PrivateSpecialPurposeAcquisitionCompaniesWarrantsMember"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ClassOfWarrantOrRightDomain_dadeb2b1-188b-46d9-83a7-9ce3d4c75eff" xlink:to="loc_dmtk_PrivateSpecialPurposeAcquisitionCompaniesWarrantsMember_76f9af35-2cfa-4d37-a0af-0958ef995b28" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dmtk_PlacementAgentWarrantsMember_33908ec1-afba-43c4-9c51-6019c7ef1a4f" xlink:href="dmtk-20220630.xsd#dmtk_PlacementAgentWarrantsMember"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ClassOfWarrantOrRightDomain_dadeb2b1-188b-46d9-83a7-9ce3d4c75eff" xlink:to="loc_dmtk_PlacementAgentWarrantsMember_33908ec1-afba-43c4-9c51-6019c7ef1a4f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dmtk_ManagementWarrantsMember_3bb8094c-4170-4531-a651-cec515511135" xlink:href="dmtk-20220630.xsd#dmtk_ManagementWarrantsMember"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ClassOfWarrantOrRightDomain_dadeb2b1-188b-46d9-83a7-9ce3d4c75eff" xlink:to="loc_dmtk_ManagementWarrantsMember_3bb8094c-4170-4531-a651-cec515511135" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentAxis_615a46e4-9e5a-498b-b99e-0869f8fb1e95" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtInstrumentAxis"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfStockByClassTable_f8f23445-e5f5-451f-b8f7-1b42f26c0490" xlink:to="loc_us-gaap_DebtInstrumentAxis_615a46e4-9e5a-498b-b99e-0869f8fb1e95" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentNameDomain_2933b503-692e-41c8-a34a-07a418b29c6f" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtInstrumentNameDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentAxis_615a46e4-9e5a-498b-b99e-0869f8fb1e95" xlink:to="loc_us-gaap_DebtInstrumentNameDomain_2933b503-692e-41c8-a34a-07a418b29c6f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dmtk_TwoThousandEighteenConvertibleBridgeNotesMember_fe3c8d11-20db-4c2e-bbe6-37f39c10d3ad" xlink:href="dmtk-20220630.xsd#dmtk_TwoThousandEighteenConvertibleBridgeNotesMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_2933b503-692e-41c8-a34a-07a418b29c6f" xlink:to="loc_dmtk_TwoThousandEighteenConvertibleBridgeNotesMember_fe3c8d11-20db-4c2e-bbe6-37f39c10d3ad" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PlanNameAxis_3647d14d-387a-46b9-bc79-960aa66ff3ee" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PlanNameAxis"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfStockByClassTable_f8f23445-e5f5-451f-b8f7-1b42f26c0490" xlink:to="loc_us-gaap_PlanNameAxis_3647d14d-387a-46b9-bc79-960aa66ff3ee" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PlanNameDomain_7b62e359-94e6-43c0-b92e-0b5e05bd71e8" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PlanNameDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PlanNameAxis_3647d14d-387a-46b9-bc79-960aa66ff3ee" xlink:to="loc_us-gaap_PlanNameDomain_7b62e359-94e6-43c0-b92e-0b5e05bd71e8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dmtk_TwoThousandTenStockPlanMember_7e5f5726-8354-4ff9-a761-33df2aef9f45" xlink:href="dmtk-20220630.xsd#dmtk_TwoThousandTenStockPlanMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PlanNameDomain_7b62e359-94e6-43c0-b92e-0b5e05bd71e8" xlink:to="loc_dmtk_TwoThousandTenStockPlanMember_7e5f5726-8354-4ff9-a761-33df2aef9f45" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dmtk_TwoThousandTwentyEquityIncentivePlanMember_fb5500c3-8c52-44ed-b447-cb9bae78f443" xlink:href="dmtk-20220630.xsd#dmtk_TwoThousandTwentyEquityIncentivePlanMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PlanNameDomain_7b62e359-94e6-43c0-b92e-0b5e05bd71e8" xlink:to="loc_dmtk_TwoThousandTwentyEquityIncentivePlanMember_fb5500c3-8c52-44ed-b447-cb9bae78f443" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dmtk_TwoThousandTwentyEmployeeStockPurchasePlanMember_8b180053-ecc4-42ab-ba58-8cd3b0e60709" xlink:href="dmtk-20220630.xsd#dmtk_TwoThousandTwentyEmployeeStockPurchasePlanMember"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PlanNameDomain_7b62e359-94e6-43c0-b92e-0b5e05bd71e8" xlink:to="loc_dmtk_TwoThousandTwentyEmployeeStockPurchasePlanMember_8b180053-ecc4-42ab-ba58-8cd3b0e60709" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AwardTypeAxis_36b07ae7-0ab9-4973-abef-539ffeffe724" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AwardTypeAxis"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfStockByClassTable_f8f23445-e5f5-451f-b8f7-1b42f26c0490" xlink:to="loc_us-gaap_AwardTypeAxis_36b07ae7-0ab9-4973-abef-539ffeffe724" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_c87e4271-1737-415c-91d4-49d9882e1d76" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AwardTypeAxis_36b07ae7-0ab9-4973-abef-539ffeffe724" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_c87e4271-1737-415c-91d4-49d9882e1d76" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dmtk_IncentiveStockOptionsMember_6fc10cf5-c1f5-4f11-86ee-23110810f14c" xlink:href="dmtk-20220630.xsd#dmtk_IncentiveStockOptionsMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_c87e4271-1737-415c-91d4-49d9882e1d76" xlink:to="loc_dmtk_IncentiveStockOptionsMember_6fc10cf5-c1f5-4f11-86ee-23110810f14c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dmtk_IncentiveAndNonQualifiedStockOptionsMember_02340a0c-6eaf-4776-a94c-cf022c71da7d" xlink:href="dmtk-20220630.xsd#dmtk_IncentiveAndNonQualifiedStockOptionsMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_c87e4271-1737-415c-91d4-49d9882e1d76" xlink:to="loc_dmtk_IncentiveAndNonQualifiedStockOptionsMember_02340a0c-6eaf-4776-a94c-cf022c71da7d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ClassOfStockLineItems_928bff83-ef8c-46ce-ba61-3f33fb764019" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ClassOfStockLineItems"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfStockByClassTable_f8f23445-e5f5-451f-b8f7-1b42f26c0490" xlink:to="loc_us-gaap_ClassOfStockLineItems_928bff83-ef8c-46ce-ba61-3f33fb764019" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockSharesAuthorized_9deb75b7-97e5-436b-8b34-cc69be72177c" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CommonStockSharesAuthorized"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ClassOfStockLineItems_928bff83-ef8c-46ce-ba61-3f33fb764019" xlink:to="loc_us-gaap_CommonStockSharesAuthorized_9deb75b7-97e5-436b-8b34-cc69be72177c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PreferredStockSharesAuthorized_63ec129e-ead1-4de4-8741-d6c149e27f88" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PreferredStockSharesAuthorized"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ClassOfStockLineItems_928bff83-ef8c-46ce-ba61-3f33fb764019" xlink:to="loc_us-gaap_PreferredStockSharesAuthorized_63ec129e-ead1-4de4-8741-d6c149e27f88" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockParOrStatedValuePerShare_df563dac-fdb1-4783-be52-04f9154585e4" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CommonStockParOrStatedValuePerShare"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ClassOfStockLineItems_928bff83-ef8c-46ce-ba61-3f33fb764019" xlink:to="loc_us-gaap_CommonStockParOrStatedValuePerShare_df563dac-fdb1-4783-be52-04f9154585e4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PreferredStockParOrStatedValuePerShare_293ad831-7320-4be7-9866-d768cdbe5f0d" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PreferredStockParOrStatedValuePerShare"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ClassOfStockLineItems_928bff83-ef8c-46ce-ba61-3f33fb764019" xlink:to="loc_us-gaap_PreferredStockParOrStatedValuePerShare_293ad831-7320-4be7-9866-d768cdbe5f0d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockIssuedDuringPeriodValueNewIssues_db645b36-ef4d-4217-afcc-0c79a0171af6" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StockIssuedDuringPeriodValueNewIssues"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ClassOfStockLineItems_928bff83-ef8c-46ce-ba61-3f33fb764019" xlink:to="loc_us-gaap_StockIssuedDuringPeriodValueNewIssues_db645b36-ef4d-4217-afcc-0c79a0171af6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockIssuedDuringPeriodSharesNewIssues_48808a21-5a82-4a9f-8516-7ac22e3c37c7" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StockIssuedDuringPeriodSharesNewIssues"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ClassOfStockLineItems_928bff83-ef8c-46ce-ba61-3f33fb764019" xlink:to="loc_us-gaap_StockIssuedDuringPeriodSharesNewIssues_48808a21-5a82-4a9f-8516-7ac22e3c37c7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dmtk_WeightedAveragePurchasePricePerShareInOffering_eb4a4b97-2d59-4915-a5de-56e385d017f7" xlink:href="dmtk-20220630.xsd#dmtk_WeightedAveragePurchasePricePerShareInOffering"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ClassOfStockLineItems_928bff83-ef8c-46ce-ba61-3f33fb764019" xlink:to="loc_dmtk_WeightedAveragePurchasePricePerShareInOffering_eb4a4b97-2d59-4915-a5de-56e385d017f7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dmtk_GrossProceedsFromIssuanceOfCommonStock_f690d0b4-db2a-4b22-b8cd-d74b46f19475" xlink:href="dmtk-20220630.xsd#dmtk_GrossProceedsFromIssuanceOfCommonStock"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ClassOfStockLineItems_928bff83-ef8c-46ce-ba61-3f33fb764019" xlink:to="loc_dmtk_GrossProceedsFromIssuanceOfCommonStock_f690d0b4-db2a-4b22-b8cd-d74b46f19475" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dmtk_IncreaseDecreaseInStockIssuanceCosts_3dfd266f-0b8d-446c-9344-66e5a31cfe91" xlink:href="dmtk-20220630.xsd#dmtk_IncreaseDecreaseInStockIssuanceCosts"/>
    <link:presentationArc order="9" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ClassOfStockLineItems_928bff83-ef8c-46ce-ba61-3f33fb764019" xlink:to="loc_dmtk_IncreaseDecreaseInStockIssuanceCosts_3dfd266f-0b8d-446c-9344-66e5a31cfe91" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProceedsFromIssuanceOfCommonStock_716a0cdb-12ba-483b-a798-073b25725e2d" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ProceedsFromIssuanceOfCommonStock"/>
    <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ClassOfStockLineItems_928bff83-ef8c-46ce-ba61-3f33fb764019" xlink:to="loc_us-gaap_ProceedsFromIssuanceOfCommonStock_716a0cdb-12ba-483b-a798-073b25725e2d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dmtk_StockPurchasedByUnderwritersPursuantToOptionGranted_6900af65-3b17-4f1b-b514-d8b60e0f65de" xlink:href="dmtk-20220630.xsd#dmtk_StockPurchasedByUnderwritersPursuantToOptionGranted"/>
    <link:presentationArc order="11" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ClassOfStockLineItems_928bff83-ef8c-46ce-ba61-3f33fb764019" xlink:to="loc_dmtk_StockPurchasedByUnderwritersPursuantToOptionGranted_6900af65-3b17-4f1b-b514-d8b60e0f65de" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dmtk_UnderwritersGrantPeriodOption_5d9c6659-4e5b-4110-b9ab-0f0bdcf239d2" xlink:href="dmtk-20220630.xsd#dmtk_UnderwritersGrantPeriodOption"/>
    <link:presentationArc order="12" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ClassOfStockLineItems_928bff83-ef8c-46ce-ba61-3f33fb764019" xlink:to="loc_dmtk_UnderwritersGrantPeriodOption_5d9c6659-4e5b-4110-b9ab-0f0bdcf239d2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SaleOfStockNumberOfSharesIssuedInTransaction_f7f48cc3-ac59-4c58-a5f5-a4898aa73bad" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SaleOfStockNumberOfSharesIssuedInTransaction"/>
    <link:presentationArc order="13" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ClassOfStockLineItems_928bff83-ef8c-46ce-ba61-3f33fb764019" xlink:to="loc_us-gaap_SaleOfStockNumberOfSharesIssuedInTransaction_f7f48cc3-ac59-4c58-a5f5-a4898aa73bad" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SaleOfStockPricePerShare_9c9024d1-cd51-4043-8cad-d7a98551c6c4" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SaleOfStockPricePerShare"/>
    <link:presentationArc order="14" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ClassOfStockLineItems_928bff83-ef8c-46ce-ba61-3f33fb764019" xlink:to="loc_us-gaap_SaleOfStockPricePerShare_9c9024d1-cd51-4043-8cad-d7a98551c6c4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dmtk_GrossProceedsFromOfferingBeforeDeductingUnderwritingDiscountsAndCommissionsAndOtherOfferingExpenses_170a1b06-4246-49a8-a4a6-7337db9485a5" xlink:href="dmtk-20220630.xsd#dmtk_GrossProceedsFromOfferingBeforeDeductingUnderwritingDiscountsAndCommissionsAndOtherOfferingExpenses"/>
    <link:presentationArc order="15" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ClassOfStockLineItems_928bff83-ef8c-46ce-ba61-3f33fb764019" xlink:to="loc_dmtk_GrossProceedsFromOfferingBeforeDeductingUnderwritingDiscountsAndCommissionsAndOtherOfferingExpenses_170a1b06-4246-49a8-a4a6-7337db9485a5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dmtk_ClassOfWarrantOrRightWarrantsOrRightsIssuedToPurchaseCommonStock_894a6f61-793b-4561-9dfa-67d3e81df015" xlink:href="dmtk-20220630.xsd#dmtk_ClassOfWarrantOrRightWarrantsOrRightsIssuedToPurchaseCommonStock"/>
    <link:presentationArc order="16" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ClassOfStockLineItems_928bff83-ef8c-46ce-ba61-3f33fb764019" xlink:to="loc_dmtk_ClassOfWarrantOrRightWarrantsOrRightsIssuedToPurchaseCommonStock_894a6f61-793b-4561-9dfa-67d3e81df015" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_WarrantsAndRightsOutstandingTerm_1bc3f260-8017-401e-b3a7-0f3ccc47d1c2" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_WarrantsAndRightsOutstandingTerm"/>
    <link:presentationArc order="17" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ClassOfStockLineItems_928bff83-ef8c-46ce-ba61-3f33fb764019" xlink:to="loc_us-gaap_WarrantsAndRightsOutstandingTerm_1bc3f260-8017-401e-b3a7-0f3ccc47d1c2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dmtk_NumberOfWarrantsEntitleHolderToPurchaseOneShare_ccb9da78-4a04-490b-a26d-e15f297889bd" xlink:href="dmtk-20220630.xsd#dmtk_NumberOfWarrantsEntitleHolderToPurchaseOneShare"/>
    <link:presentationArc order="18" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ClassOfStockLineItems_928bff83-ef8c-46ce-ba61-3f33fb764019" xlink:to="loc_dmtk_NumberOfWarrantsEntitleHolderToPurchaseOneShare_ccb9da78-4a04-490b-a26d-e15f297889bd" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1_c47c69c3-b4e7-45f0-b198-ae64358a2f44" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1"/>
    <link:presentationArc order="19" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ClassOfStockLineItems_928bff83-ef8c-46ce-ba61-3f33fb764019" xlink:to="loc_us-gaap_ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1_c47c69c3-b4e7-45f0-b198-ae64358a2f44" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights_84b4b4e6-8a27-496a-8340-d9eb9f211563" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights"/>
    <link:presentationArc order="20" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ClassOfStockLineItems_928bff83-ef8c-46ce-ba61-3f33fb764019" xlink:to="loc_us-gaap_ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights_84b4b4e6-8a27-496a-8340-d9eb9f211563" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dmtk_CommonSharesIssuedUponExerciseOfWarrants_381d624f-02e9-4564-9b40-bc6789c1f3b3" xlink:href="dmtk-20220630.xsd#dmtk_CommonSharesIssuedUponExerciseOfWarrants"/>
    <link:presentationArc order="21" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ClassOfStockLineItems_928bff83-ef8c-46ce-ba61-3f33fb764019" xlink:to="loc_dmtk_CommonSharesIssuedUponExerciseOfWarrants_381d624f-02e9-4564-9b40-bc6789c1f3b3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProceedsFromWarrantExercises_ee9ddc30-1d16-43dc-bfcf-11bb2cfc9653" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ProceedsFromWarrantExercises"/>
    <link:presentationArc order="22" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ClassOfStockLineItems_928bff83-ef8c-46ce-ba61-3f33fb764019" xlink:to="loc_us-gaap_ProceedsFromWarrantExercises_ee9ddc30-1d16-43dc-bfcf-11bb2cfc9653" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ClassOfWarrantOrRightOutstanding_5801145f-1f10-4e13-8f70-aced4ba96df6" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ClassOfWarrantOrRightOutstanding"/>
    <link:presentationArc order="23" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ClassOfStockLineItems_928bff83-ef8c-46ce-ba61-3f33fb764019" xlink:to="loc_us-gaap_ClassOfWarrantOrRightOutstanding_5801145f-1f10-4e13-8f70-aced4ba96df6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ClassOfWarrantOrRightNumberOfSecuritiesCalledByEachWarrantOrRight_6ab1c18b-db9c-49a7-aac3-557d05147363" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ClassOfWarrantOrRightNumberOfSecuritiesCalledByEachWarrantOrRight"/>
    <link:presentationArc order="24" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ClassOfStockLineItems_928bff83-ef8c-46ce-ba61-3f33fb764019" xlink:to="loc_us-gaap_ClassOfWarrantOrRightNumberOfSecuritiesCalledByEachWarrantOrRight_6ab1c18b-db9c-49a7-aac3-557d05147363" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized_74e7e75b-c8a3-4df3-9fa6-22c888e60764" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized"/>
    <link:presentationArc order="25" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ClassOfStockLineItems_928bff83-ef8c-46ce-ba61-3f33fb764019" xlink:to="loc_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized_74e7e75b-c8a3-4df3-9fa6-22c888e60764" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1_dcee10a5-48f2-4a0a-a644-ca3637c00236" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1"/>
    <link:presentationArc order="26" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ClassOfStockLineItems_928bff83-ef8c-46ce-ba61-3f33fb764019" xlink:to="loc_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1_dcee10a5-48f2-4a0a-a644-ca3637c00236" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardPurchasePriceOfCommonStockPercent_73916c31-d5e8-4ee1-96f2-b4aae5ce7b96" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardPurchasePriceOfCommonStockPercent"/>
    <link:presentationArc order="27" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ClassOfStockLineItems_928bff83-ef8c-46ce-ba61-3f33fb764019" xlink:to="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardPurchasePriceOfCommonStockPercent_73916c31-d5e8-4ee1-96f2-b4aae5ce7b96" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardExpirationPeriod_38522995-d266-4bb6-a53c-71ad90e92484" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardExpirationPeriod"/>
    <link:presentationArc order="28" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ClassOfStockLineItems_928bff83-ef8c-46ce-ba61-3f33fb764019" xlink:to="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardExpirationPeriod_38522995-d266-4bb6-a53c-71ad90e92484" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant_b43a2f63-f160-4f06-b93b-fd14627cf829" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant"/>
    <link:presentationArc order="29" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ClassOfStockLineItems_928bff83-ef8c-46ce-ba61-3f33fb764019" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant_b43a2f63-f160-4f06-b93b-fd14627cf829" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dmtk_EquityIncentivePlanOptionTerm_d302a45d-32a2-4a4f-915a-563d495300e1" xlink:href="dmtk-20220630.xsd#dmtk_EquityIncentivePlanOptionTerm"/>
    <link:presentationArc order="30" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ClassOfStockLineItems_928bff83-ef8c-46ce-ba61-3f33fb764019" xlink:to="loc_dmtk_EquityIncentivePlanOptionTerm_d302a45d-32a2-4a4f-915a-563d495300e1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SharesIssued_60e3a557-2e9b-48bb-af2b-a61434b16246" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SharesIssued"/>
    <link:presentationArc order="31" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ClassOfStockLineItems_928bff83-ef8c-46ce-ba61-3f33fb764019" xlink:to="loc_us-gaap_SharesIssued_60e3a557-2e9b-48bb-af2b-a61434b16246" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dmtk_CommonStockOutstandingPercentage_84c454ed-edc7-42f6-8352-937abbeafe06" xlink:href="dmtk-20220630.xsd#dmtk_CommonStockOutstandingPercentage"/>
    <link:presentationArc order="32" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ClassOfStockLineItems_928bff83-ef8c-46ce-ba61-3f33fb764019" xlink:to="loc_dmtk_CommonStockOutstandingPercentage_84c454ed-edc7-42f6-8352-937abbeafe06" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dmtk_PercentageOfPriceAtSharesPurchased_8be98cbf-2327-4b23-911a-80ce6dffab5f" xlink:href="dmtk-20220630.xsd#dmtk_PercentageOfPriceAtSharesPurchased"/>
    <link:presentationArc order="33" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ClassOfStockLineItems_928bff83-ef8c-46ce-ba61-3f33fb764019" xlink:to="loc_dmtk_PercentageOfPriceAtSharesPurchased_8be98cbf-2327-4b23-911a-80ce6dffab5f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockCapitalSharesReservedForFutureIssuance_329df056-fb7f-478f-b831-40a744df5302" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CommonStockCapitalSharesReservedForFutureIssuance"/>
    <link:presentationArc order="34" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ClassOfStockLineItems_928bff83-ef8c-46ce-ba61-3f33fb764019" xlink:to="loc_us-gaap_CommonStockCapitalSharesReservedForFutureIssuance_329df056-fb7f-478f-b831-40a744df5302" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockSharesIssued_892377de-3e44-4e6e-be51-ee34668e0f5c" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CommonStockSharesIssued"/>
    <link:presentationArc order="35" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ClassOfStockLineItems_928bff83-ef8c-46ce-ba61-3f33fb764019" xlink:to="loc_us-gaap_CommonStockSharesIssued_892377de-3e44-4e6e-be51-ee34668e0f5c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dmtk_WarrantsVestingPeriod_0f45e51a-cb08-4c35-b7bc-a960b4fc25c0" xlink:href="dmtk-20220630.xsd#dmtk_WarrantsVestingPeriod"/>
    <link:presentationArc order="36" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ClassOfStockLineItems_928bff83-ef8c-46ce-ba61-3f33fb764019" xlink:to="loc_dmtk_WarrantsVestingPeriod_0f45e51a-cb08-4c35-b7bc-a960b4fc25c0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://dermtech.com/role/StockholdersEquityESPPValuationMethodDetails" xlink:type="simple" xlink:href="dmtk-20220630.xsd#StockholdersEquityESPPValuationMethodDetails"/>
  <link:presentationLink xlink:role="http://dermtech.com/role/StockholdersEquityESPPValuationMethodDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockholdersEquityNoteAbstract_77e7b28f-5fd0-451a-98af-4f72c2ce3af3" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StockholdersEquityNoteAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfStockByClassTable_ce3207fe-271e-4b73-867f-992c8751afab" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfStockByClassTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StockholdersEquityNoteAbstract_77e7b28f-5fd0-451a-98af-4f72c2ce3af3" xlink:to="loc_us-gaap_ScheduleOfStockByClassTable_ce3207fe-271e-4b73-867f-992c8751afab" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PlanNameAxis_2ee11628-2ee2-4361-a92c-6ee12302517a" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PlanNameAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfStockByClassTable_ce3207fe-271e-4b73-867f-992c8751afab" xlink:to="loc_us-gaap_PlanNameAxis_2ee11628-2ee2-4361-a92c-6ee12302517a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PlanNameDomain_6bc8bd4c-af9f-4dd7-a494-d3606b0d38b6" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PlanNameDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PlanNameAxis_2ee11628-2ee2-4361-a92c-6ee12302517a" xlink:to="loc_us-gaap_PlanNameDomain_6bc8bd4c-af9f-4dd7-a494-d3606b0d38b6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dmtk_TwoThousandTwentyEquityIncentivePlanMember_e3f30022-84f1-4245-8ceb-d5722e341d96" xlink:href="dmtk-20220630.xsd#dmtk_TwoThousandTwentyEquityIncentivePlanMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PlanNameDomain_6bc8bd4c-af9f-4dd7-a494-d3606b0d38b6" xlink:to="loc_dmtk_TwoThousandTwentyEquityIncentivePlanMember_e3f30022-84f1-4245-8ceb-d5722e341d96" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dmtk_TwoThousandTwentyEmployeeStockPurchasePlanMember_cfd196d6-9b88-4eed-8107-53eec53d0d5f" xlink:href="dmtk-20220630.xsd#dmtk_TwoThousandTwentyEmployeeStockPurchasePlanMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PlanNameDomain_6bc8bd4c-af9f-4dd7-a494-d3606b0d38b6" xlink:to="loc_dmtk_TwoThousandTwentyEmployeeStockPurchasePlanMember_cfd196d6-9b88-4eed-8107-53eec53d0d5f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeAxis_18456c7d-238d-429f-98c3-1287ce6f2ab5" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_RangeAxis"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfStockByClassTable_ce3207fe-271e-4b73-867f-992c8751afab" xlink:to="loc_srt_RangeAxis_18456c7d-238d-429f-98c3-1287ce6f2ab5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeMember_16a2eaf8-57ca-482b-84f7-d45327c848da" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_RangeMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_RangeAxis_18456c7d-238d-429f-98c3-1287ce6f2ab5" xlink:to="loc_srt_RangeMember_16a2eaf8-57ca-482b-84f7-d45327c848da" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_MinimumMember_51b3eeb0-5c98-4fd2-86be-c83e601a8695" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_MinimumMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_RangeMember_16a2eaf8-57ca-482b-84f7-d45327c848da" xlink:to="loc_srt_MinimumMember_51b3eeb0-5c98-4fd2-86be-c83e601a8695" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_MaximumMember_2285574b-d8d6-4101-876a-3d8507765c96" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_MaximumMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_RangeMember_16a2eaf8-57ca-482b-84f7-d45327c848da" xlink:to="loc_srt_MaximumMember_2285574b-d8d6-4101-876a-3d8507765c96" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ClassOfStockLineItems_430b0622-ec0c-4636-9f52-50f291627349" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ClassOfStockLineItems"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfStockByClassTable_ce3207fe-271e-4b73-867f-992c8751afab" xlink:to="loc_us-gaap_ClassOfStockLineItems_430b0622-ec0c-4636-9f52-50f291627349" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate_2c29acdd-c225-4e08-88df-94ef01d88c0c" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ClassOfStockLineItems_430b0622-ec0c-4636-9f52-50f291627349" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate_2c29acdd-c225-4e08-88df-94ef01d88c0c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMinimum_909dcc05-aaa4-4bb4-8809-6388ecd0e297" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMinimum"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ClassOfStockLineItems_430b0622-ec0c-4636-9f52-50f291627349" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMinimum_909dcc05-aaa4-4bb4-8809-6388ecd0e297" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMaximum_54af929b-4376-4f6f-acbb-0b7278d2f5f9" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMaximum"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ClassOfStockLineItems_430b0622-ec0c-4636-9f52-50f291627349" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMaximum_54af929b-4376-4f6f-acbb-0b7278d2f5f9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate_f380decb-4ff9-42c7-bc8b-fe190cfa5d7e" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ClassOfStockLineItems_430b0622-ec0c-4636-9f52-50f291627349" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate_f380decb-4ff9-42c7-bc8b-fe190cfa5d7e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRateMinimum_5b192792-9bbb-489b-afee-82c50060647e" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRateMinimum"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ClassOfStockLineItems_430b0622-ec0c-4636-9f52-50f291627349" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRateMinimum_5b192792-9bbb-489b-afee-82c50060647e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRateMaximum_50e91673-98eb-48f6-982e-52b655c1db40" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRateMaximum"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ClassOfStockLineItems_430b0622-ec0c-4636-9f52-50f291627349" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRateMaximum_50e91673-98eb-48f6-982e-52b655c1db40" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1_3cf07258-11a1-4b6b-9895-bae91e6379f3" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ClassOfStockLineItems_430b0622-ec0c-4636-9f52-50f291627349" xlink:to="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1_3cf07258-11a1-4b6b-9895-bae91e6379f3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate_6ef8c1d8-c720-418b-939a-e9d562fd6530" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ClassOfStockLineItems_430b0622-ec0c-4636-9f52-50f291627349" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate_6ef8c1d8-c720-418b-939a-e9d562fd6530" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://dermtech.com/role/StockholdersEquityShareBasedCompensationExpenseDetails" xlink:type="simple" xlink:href="dmtk-20220630.xsd#StockholdersEquityShareBasedCompensationExpenseDetails"/>
  <link:presentationLink xlink:role="http://dermtech.com/role/StockholdersEquityShareBasedCompensationExpenseDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquityAbstract_11710341-b5b0-4522-b017-47ba19bea333" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EquityAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_b2fb6620-f905-4f42-983f-9359fedf3176" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EquityAbstract_11710341-b5b0-4522-b017-47ba19bea333" xlink:to="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_b2fb6620-f905-4f42-983f-9359fedf3176" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeStatementLocationAxis_8d4902f1-e23d-4897-bd55-a579f3daf15b" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeStatementLocationAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_b2fb6620-f905-4f42-983f-9359fedf3176" xlink:to="loc_us-gaap_IncomeStatementLocationAxis_8d4902f1-e23d-4897-bd55-a579f3daf15b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeStatementLocationDomain_52d82877-dd85-4495-ac3b-8f8e6fd05a23" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeStatementLocationDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementLocationAxis_8d4902f1-e23d-4897-bd55-a579f3daf15b" xlink:to="loc_us-gaap_IncomeStatementLocationDomain_52d82877-dd85-4495-ac3b-8f8e6fd05a23" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CostOfSalesMember_6cb53a98-6bb3-4853-a487-a91930841084" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CostOfSalesMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementLocationDomain_52d82877-dd85-4495-ac3b-8f8e6fd05a23" xlink:to="loc_us-gaap_CostOfSalesMember_6cb53a98-6bb3-4853-a487-a91930841084" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SellingAndMarketingExpenseMember_1e210148-77bf-4d85-92eb-b06e14d22c93" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SellingAndMarketingExpenseMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementLocationDomain_52d82877-dd85-4495-ac3b-8f8e6fd05a23" xlink:to="loc_us-gaap_SellingAndMarketingExpenseMember_1e210148-77bf-4d85-92eb-b06e14d22c93" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ResearchAndDevelopmentExpenseMember_5ff43d1b-9d51-4550-9981-648d613dab3b" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ResearchAndDevelopmentExpenseMember"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementLocationDomain_52d82877-dd85-4495-ac3b-8f8e6fd05a23" xlink:to="loc_us-gaap_ResearchAndDevelopmentExpenseMember_5ff43d1b-9d51-4550-9981-648d613dab3b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GeneralAndAdministrativeExpenseMember_0fdbc97b-429f-42d0-8ef8-202878f6cd62" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_GeneralAndAdministrativeExpenseMember"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementLocationDomain_52d82877-dd85-4495-ac3b-8f8e6fd05a23" xlink:to="loc_us-gaap_GeneralAndAdministrativeExpenseMember_0fdbc97b-429f-42d0-8ef8-202878f6cd62" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_17f3dbe2-cb04-454d-a615-fb9c94b1dd01" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_b2fb6620-f905-4f42-983f-9359fedf3176" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_17f3dbe2-cb04-454d-a615-fb9c94b1dd01" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AllocatedShareBasedCompensationExpense_f15c4bca-ceab-4ab7-a9e3-78181a8729da" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AllocatedShareBasedCompensationExpense"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_17f3dbe2-cb04-454d-a615-fb9c94b1dd01" xlink:to="loc_us-gaap_AllocatedShareBasedCompensationExpense_f15c4bca-ceab-4ab7-a9e3-78181a8729da" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://dermtech.com/role/StockholdersEquitySummaryofCommonStockReservedforFutureIssuanceDetail" xlink:type="simple" xlink:href="dmtk-20220630.xsd#StockholdersEquitySummaryofCommonStockReservedforFutureIssuanceDetail"/>
  <link:presentationLink xlink:role="http://dermtech.com/role/StockholdersEquitySummaryofCommonStockReservedforFutureIssuanceDetail" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockholdersEquityNoteAbstract_7283d720-f9cd-4f80-b187-9160f3d35bfe" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StockholdersEquityNoteAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfStockByClassTable_69a5128d-d5ac-478d-a295-ea48e61b25a3" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfStockByClassTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StockholdersEquityNoteAbstract_7283d720-f9cd-4f80-b187-9160f3d35bfe" xlink:to="loc_us-gaap_ScheduleOfStockByClassTable_69a5128d-d5ac-478d-a295-ea48e61b25a3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AwardTypeAxis_ee3da456-8707-47b8-be7f-5fb6df4e6849" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AwardTypeAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfStockByClassTable_69a5128d-d5ac-478d-a295-ea48e61b25a3" xlink:to="loc_us-gaap_AwardTypeAxis_ee3da456-8707-47b8-be7f-5fb6df4e6849" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_4b4fcc2b-7620-42f9-996a-b7a8d48fd2b6" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AwardTypeAxis_ee3da456-8707-47b8-be7f-5fb6df4e6849" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_4b4fcc2b-7620-42f9-996a-b7a8d48fd2b6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dmtk_WarrantsToPurchaseCommonStockMember_cf534fd4-1399-4817-b8cf-9bc631533d88" xlink:href="dmtk-20220630.xsd#dmtk_WarrantsToPurchaseCommonStockMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_4b4fcc2b-7620-42f9-996a-b7a8d48fd2b6" xlink:to="loc_dmtk_WarrantsToPurchaseCommonStockMember_cf534fd4-1399-4817-b8cf-9bc631533d88" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dmtk_SpecialPurposeAcquisitionCompanyWarrantsToPurchaseCommonStockMember_9fece722-c122-443d-bc49-04081f8d81ce" xlink:href="dmtk-20220630.xsd#dmtk_SpecialPurposeAcquisitionCompanyWarrantsToPurchaseCommonStockMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_4b4fcc2b-7620-42f9-996a-b7a8d48fd2b6" xlink:to="loc_dmtk_SpecialPurposeAcquisitionCompanyWarrantsToPurchaseCommonStockMember_9fece722-c122-443d-bc49-04081f8d81ce" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EmployeeStockOptionMember_23e8708c-326d-46d7-a9df-4daacbfbb3d5" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EmployeeStockOptionMember"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_4b4fcc2b-7620-42f9-996a-b7a8d48fd2b6" xlink:to="loc_us-gaap_EmployeeStockOptionMember_23e8708c-326d-46d7-a9df-4daacbfbb3d5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestrictedStockUnitsRSUMember_d6ec5fa4-eb79-4ff1-b80d-7f8123b856ce" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RestrictedStockUnitsRSUMember"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_4b4fcc2b-7620-42f9-996a-b7a8d48fd2b6" xlink:to="loc_us-gaap_RestrictedStockUnitsRSUMember_d6ec5fa4-eb79-4ff1-b80d-7f8123b856ce" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dmtk_AuthorizedForFutureEquityGrantsMember_d5768727-3f6c-4e77-9d24-627a51302665" xlink:href="dmtk-20220630.xsd#dmtk_AuthorizedForFutureEquityGrantsMember"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_4b4fcc2b-7620-42f9-996a-b7a8d48fd2b6" xlink:to="loc_dmtk_AuthorizedForFutureEquityGrantsMember_d5768727-3f6c-4e77-9d24-627a51302665" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dmtk_AuthorizedForFutureESPPPurchasesMember_6da9e3ff-6398-48f3-b740-7fdfb7831c89" xlink:href="dmtk-20220630.xsd#dmtk_AuthorizedForFutureESPPPurchasesMember"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_4b4fcc2b-7620-42f9-996a-b7a8d48fd2b6" xlink:to="loc_dmtk_AuthorizedForFutureESPPPurchasesMember_6da9e3ff-6398-48f3-b740-7fdfb7831c89" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ClassOfWarrantOrRightAxis_dd043450-805c-4039-ad80-a1f79dfdaa28" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ClassOfWarrantOrRightAxis"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfStockByClassTable_69a5128d-d5ac-478d-a295-ea48e61b25a3" xlink:to="loc_us-gaap_ClassOfWarrantOrRightAxis_dd043450-805c-4039-ad80-a1f79dfdaa28" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ClassOfWarrantOrRightDomain_15a498ec-6cc6-4f12-9ff7-4be31f4ade6c" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ClassOfWarrantOrRightDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ClassOfWarrantOrRightAxis_dd043450-805c-4039-ad80-a1f79dfdaa28" xlink:to="loc_us-gaap_ClassOfWarrantOrRightDomain_15a498ec-6cc6-4f12-9ff7-4be31f4ade6c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dmtk_SpecialPurposeAcquisitionCompaniesWarrantsMember_1141927c-c70b-47d6-83eb-74e5ab8e7a6c" xlink:href="dmtk-20220630.xsd#dmtk_SpecialPurposeAcquisitionCompaniesWarrantsMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ClassOfWarrantOrRightDomain_15a498ec-6cc6-4f12-9ff7-4be31f4ade6c" xlink:to="loc_dmtk_SpecialPurposeAcquisitionCompaniesWarrantsMember_1141927c-c70b-47d6-83eb-74e5ab8e7a6c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ClassOfStockLineItems_e233692e-d83d-4833-818e-316f2f34c328" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ClassOfStockLineItems"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfStockByClassTable_69a5128d-d5ac-478d-a295-ea48e61b25a3" xlink:to="loc_us-gaap_ClassOfStockLineItems_e233692e-d83d-4833-818e-316f2f34c328" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockCapitalSharesReservedForFutureIssuance_f7f70e83-c049-41c2-9529-3ff86630fb58" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CommonStockCapitalSharesReservedForFutureIssuance"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ClassOfStockLineItems_e233692e-d83d-4833-818e-316f2f34c328" xlink:to="loc_us-gaap_CommonStockCapitalSharesReservedForFutureIssuance_f7f70e83-c049-41c2-9529-3ff86630fb58" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dmtk_NumberOfWarrantsEntitleHolderToPurchaseOneShare_32784726-9e64-4bfe-9877-9ebf932ef7f8" xlink:href="dmtk-20220630.xsd#dmtk_NumberOfWarrantsEntitleHolderToPurchaseOneShare"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ClassOfStockLineItems_e233692e-d83d-4833-818e-316f2f34c328" xlink:to="loc_dmtk_NumberOfWarrantsEntitleHolderToPurchaseOneShare_32784726-9e64-4bfe-9877-9ebf932ef7f8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://dermtech.com/role/LeasesCommitmentsandContingencies" xlink:type="simple" xlink:href="dmtk-20220630.xsd#LeasesCommitmentsandContingencies"/>
  <link:presentationLink xlink:role="http://dermtech.com/role/LeasesCommitmentsandContingencies" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommitmentsAndContingenciesDisclosureAbstract_01c749e7-7a3e-4451-a5ed-41a108f4303b" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CommitmentsAndContingenciesDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommitmentsDisclosureTextBlock_1015371a-caea-432e-83fe-a97dc46c4ee5" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CommitmentsDisclosureTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_CommitmentsAndContingenciesDisclosureAbstract_01c749e7-7a3e-4451-a5ed-41a108f4303b" xlink:to="loc_us-gaap_CommitmentsDisclosureTextBlock_1015371a-caea-432e-83fe-a97dc46c4ee5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://dermtech.com/role/LeasesCommitmentsandContingenciesTables" xlink:type="simple" xlink:href="dmtk-20220630.xsd#LeasesCommitmentsandContingenciesTables"/>
  <link:presentationLink xlink:role="http://dermtech.com/role/LeasesCommitmentsandContingenciesTables" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommitmentsAndContingenciesDisclosureAbstract_4d6bf09e-6f4a-486e-ad93-2344a7017db6" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CommitmentsAndContingenciesDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfNewAccountingPronouncementsAndChangesInAccountingPrinciplesTextBlock_9854febb-7be2-45e4-86f4-d2e7fab3aa87" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfNewAccountingPronouncementsAndChangesInAccountingPrinciplesTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_CommitmentsAndContingenciesDisclosureAbstract_4d6bf09e-6f4a-486e-ad93-2344a7017db6" xlink:to="loc_us-gaap_ScheduleOfNewAccountingPronouncementsAndChangesInAccountingPrinciplesTextBlock_9854febb-7be2-45e4-86f4-d2e7fab3aa87" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dmtk_ScheduleOfLongTermFinanceLeaseObligationsTableTextBlock_2ea7e66e-c8e6-4f0e-b386-d7fb2d5f24d9" xlink:href="dmtk-20220630.xsd#dmtk_ScheduleOfLongTermFinanceLeaseObligationsTableTextBlock"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_CommitmentsAndContingenciesDisclosureAbstract_4d6bf09e-6f4a-486e-ad93-2344a7017db6" xlink:to="loc_dmtk_ScheduleOfLongTermFinanceLeaseObligationsTableTextBlock_2ea7e66e-c8e6-4f0e-b386-d7fb2d5f24d9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LeaseCostTableTextBlock_baef7549-3571-4d2d-845a-a452ca6bdb60" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LeaseCostTableTextBlock"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_CommitmentsAndContingenciesDisclosureAbstract_4d6bf09e-6f4a-486e-ad93-2344a7017db6" xlink:to="loc_us-gaap_LeaseCostTableTextBlock_baef7549-3571-4d2d-845a-a452ca6bdb60" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dmtk_ScheduleOfFutureMinimumRentalPaymentsForOperatingAndCapitalLeasesTableTextBlock_05d430c8-8467-4703-aeb1-965595cdc8b3" xlink:href="dmtk-20220630.xsd#dmtk_ScheduleOfFutureMinimumRentalPaymentsForOperatingAndCapitalLeasesTableTextBlock"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_CommitmentsAndContingenciesDisclosureAbstract_4d6bf09e-6f4a-486e-ad93-2344a7017db6" xlink:to="loc_dmtk_ScheduleOfFutureMinimumRentalPaymentsForOperatingAndCapitalLeasesTableTextBlock_05d430c8-8467-4703-aeb1-965595cdc8b3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://dermtech.com/role/LeasesCommitmentsandContingenciesAdoptionofASC842Details" xlink:type="simple" xlink:href="dmtk-20220630.xsd#LeasesCommitmentsandContingenciesAdoptionofASC842Details"/>
  <link:presentationLink xlink:role="http://dermtech.com/role/LeasesCommitmentsandContingenciesAdoptionofASC842Details" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommitmentsAndContingenciesDisclosureAbstract_2b35546a-c0a2-4399-a3f3-4768fa0934a8" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CommitmentsAndContingenciesDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NewAccountingPronouncementsOrChangeInAccountingPrincipleTable_9cde0d43-432a-4821-8656-c7beb3b10889" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NewAccountingPronouncementsOrChangeInAccountingPrincipleTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_CommitmentsAndContingenciesDisclosureAbstract_2b35546a-c0a2-4399-a3f3-4768fa0934a8" xlink:to="loc_us-gaap_NewAccountingPronouncementsOrChangeInAccountingPrincipleTable_9cde0d43-432a-4821-8656-c7beb3b10889" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AdjustmentsForNewAccountingPronouncementsAxis_08277cd0-78ae-46ad-af14-d327afeb7e3a" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AdjustmentsForNewAccountingPronouncementsAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NewAccountingPronouncementsOrChangeInAccountingPrincipleTable_9cde0d43-432a-4821-8656-c7beb3b10889" xlink:to="loc_us-gaap_AdjustmentsForNewAccountingPronouncementsAxis_08277cd0-78ae-46ad-af14-d327afeb7e3a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TypeOfAdoptionMember_727d312e-b0dc-4f55-9d9e-351c365b09eb" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_TypeOfAdoptionMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AdjustmentsForNewAccountingPronouncementsAxis_08277cd0-78ae-46ad-af14-d327afeb7e3a" xlink:to="loc_us-gaap_TypeOfAdoptionMember_727d312e-b0dc-4f55-9d9e-351c365b09eb" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccountingStandardsUpdate201602Member_abd50a96-9760-49c3-92d9-105aa33a5e21" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AccountingStandardsUpdate201602Member"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_TypeOfAdoptionMember_727d312e-b0dc-4f55-9d9e-351c365b09eb" xlink:to="loc_us-gaap_AccountingStandardsUpdate201602Member_abd50a96-9760-49c3-92d9-105aa33a5e21" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_CumulativeEffectPeriodOfAdoptionAxis_a0084a94-3b5f-4e43-b07d-35816cfd43c1" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_CumulativeEffectPeriodOfAdoptionAxis"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NewAccountingPronouncementsOrChangeInAccountingPrincipleTable_9cde0d43-432a-4821-8656-c7beb3b10889" xlink:to="loc_srt_CumulativeEffectPeriodOfAdoptionAxis_a0084a94-3b5f-4e43-b07d-35816cfd43c1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_CumulativeEffectPeriodOfAdoptionDomain_1d0cd232-ac22-42bf-97df-4bb0d94545be" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_CumulativeEffectPeriodOfAdoptionDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_CumulativeEffectPeriodOfAdoptionAxis_a0084a94-3b5f-4e43-b07d-35816cfd43c1" xlink:to="loc_srt_CumulativeEffectPeriodOfAdoptionDomain_1d0cd232-ac22-42bf-97df-4bb0d94545be" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_CumulativeEffectPeriodOfAdoptionAdjustmentMember_af48c331-7859-45a0-ab9e-f159362a5dad" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_CumulativeEffectPeriodOfAdoptionAdjustmentMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_CumulativeEffectPeriodOfAdoptionDomain_1d0cd232-ac22-42bf-97df-4bb0d94545be" xlink:to="loc_srt_CumulativeEffectPeriodOfAdoptionAdjustmentMember_af48c331-7859-45a0-ab9e-f159362a5dad" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_CumulativeEffectPeriodOfAdoptionAdjustedBalanceMember_dce0eaea-a7fd-4f40-babc-a12aff704242" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_CumulativeEffectPeriodOfAdoptionAdjustedBalanceMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_CumulativeEffectPeriodOfAdoptionDomain_1d0cd232-ac22-42bf-97df-4bb0d94545be" xlink:to="loc_srt_CumulativeEffectPeriodOfAdoptionAdjustedBalanceMember_dce0eaea-a7fd-4f40-babc-a12aff704242" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NewAccountingPronouncementsOrChangeInAccountingPrincipleLineItems_3c5d8cdb-cda1-4b52-bf73-92730a1daa7d" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NewAccountingPronouncementsOrChangeInAccountingPrincipleLineItems"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NewAccountingPronouncementsOrChangeInAccountingPrincipleTable_9cde0d43-432a-4821-8656-c7beb3b10889" xlink:to="loc_us-gaap_NewAccountingPronouncementsOrChangeInAccountingPrincipleLineItems_3c5d8cdb-cda1-4b52-bf73-92730a1daa7d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract_84f28044-03ff-4187-8529-c22a66687c3d" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NewAccountingPronouncementsOrChangeInAccountingPrincipleLineItems_3c5d8cdb-cda1-4b52-bf73-92730a1daa7d" xlink:to="loc_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract_84f28044-03ff-4187-8529-c22a66687c3d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeaseRightOfUseAssetAmortizationExpense_1c9c2025-d18f-4bfc-aec2-ebe66f19cd88" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OperatingLeaseRightOfUseAssetAmortizationExpense"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract_84f28044-03ff-4187-8529-c22a66687c3d" xlink:to="loc_us-gaap_OperatingLeaseRightOfUseAssetAmortizationExpense_1c9c2025-d18f-4bfc-aec2-ebe66f19cd88" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInOtherOperatingAssetsAndLiabilitiesNetAbstract_7e508833-db5b-46de-85f0-de7cab7efff0" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncreaseDecreaseInOtherOperatingAssetsAndLiabilitiesNetAbstract"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NewAccountingPronouncementsOrChangeInAccountingPrincipleLineItems_3c5d8cdb-cda1-4b52-bf73-92730a1daa7d" xlink:to="loc_us-gaap_IncreaseDecreaseInOtherOperatingAssetsAndLiabilitiesNetAbstract_7e508833-db5b-46de-85f0-de7cab7efff0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeaseLiability_457b44a0-6a47-4404-bd18-097d1686edf1" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OperatingLeaseLiability"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInOtherOperatingAssetsAndLiabilitiesNetAbstract_7e508833-db5b-46de-85f0-de7cab7efff0" xlink:to="loc_us-gaap_OperatingLeaseLiability_457b44a0-6a47-4404-bd18-097d1686edf1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherLiabilities_407064a1-c96c-4444-b548-fa6fdd03575b" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherLiabilities"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInOtherOperatingAssetsAndLiabilitiesNetAbstract_7e508833-db5b-46de-85f0-de7cab7efff0" xlink:to="loc_us-gaap_OtherLiabilities_407064a1-c96c-4444-b548-fa6fdd03575b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://dermtech.com/role/LeasesCommitmentsandContingenciesAdditionalInformationDetails" xlink:type="simple" xlink:href="dmtk-20220630.xsd#LeasesCommitmentsandContingenciesAdditionalInformationDetails"/>
  <link:presentationLink xlink:role="http://dermtech.com/role/LeasesCommitmentsandContingenciesAdditionalInformationDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommitmentsAndContingenciesDisclosureAbstract_000d4dc7-4084-4d19-a124-2d93d4f7bf79" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CommitmentsAndContingenciesDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_dmtk_CommitmentsAndContingenciesTable_2c2294c8-849b-4277-b8fd-f55918436fd9" xlink:href="dmtk-20220630.xsd#dmtk_CommitmentsAndContingenciesTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_CommitmentsAndContingenciesDisclosureAbstract_000d4dc7-4084-4d19-a124-2d93d4f7bf79" xlink:to="loc_dmtk_CommitmentsAndContingenciesTable_2c2294c8-849b-4277-b8fd-f55918436fd9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentByTypeAxis_a4c11451-65b3-4831-9574-7a95d1b762e8" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PropertyPlantAndEquipmentByTypeAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dmtk_CommitmentsAndContingenciesTable_2c2294c8-849b-4277-b8fd-f55918436fd9" xlink:to="loc_us-gaap_PropertyPlantAndEquipmentByTypeAxis_a4c11451-65b3-4831-9574-7a95d1b762e8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentTypeDomain_e7610053-6abd-42c7-b480-c007f03673d6" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PropertyPlantAndEquipmentTypeDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentByTypeAxis_a4c11451-65b3-4831-9574-7a95d1b762e8" xlink:to="loc_us-gaap_PropertyPlantAndEquipmentTypeDomain_e7610053-6abd-42c7-b480-c007f03673d6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dmtk_AssetsHeldUnderFinanceLeasesMember_53df728d-59ae-4d73-8ec9-2adbaa457202" xlink:href="dmtk-20220630.xsd#dmtk_AssetsHeldUnderFinanceLeasesMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentTypeDomain_e7610053-6abd-42c7-b480-c007f03673d6" xlink:to="loc_dmtk_AssetsHeldUnderFinanceLeasesMember_53df728d-59ae-4d73-8ec9-2adbaa457202" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeStatementLocationAxis_65855f13-b6a1-4562-b341-f3f2d3594036" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeStatementLocationAxis"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dmtk_CommitmentsAndContingenciesTable_2c2294c8-849b-4277-b8fd-f55918436fd9" xlink:to="loc_us-gaap_IncomeStatementLocationAxis_65855f13-b6a1-4562-b341-f3f2d3594036" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeStatementLocationDomain_7252fd6e-dab7-4d1a-9355-5e6032ab46ed" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeStatementLocationDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementLocationAxis_65855f13-b6a1-4562-b341-f3f2d3594036" xlink:to="loc_us-gaap_IncomeStatementLocationDomain_7252fd6e-dab7-4d1a-9355-5e6032ab46ed" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InterestIncomeMember_4b457eb8-7ea5-40f2-8cfd-90339c1aef2f" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_InterestIncomeMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementLocationDomain_7252fd6e-dab7-4d1a-9355-5e6032ab46ed" xlink:to="loc_us-gaap_InterestIncomeMember_4b457eb8-7ea5-40f2-8cfd-90339c1aef2f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_CounterpartyNameAxis_ae208273-23c2-4d85-a96a-400e7a878ed5" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_CounterpartyNameAxis"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dmtk_CommitmentsAndContingenciesTable_2c2294c8-849b-4277-b8fd-f55918436fd9" xlink:to="loc_srt_CounterpartyNameAxis_ae208273-23c2-4d85-a96a-400e7a878ed5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RepurchaseAgreementCounterpartyNameDomain_4483823c-0592-4742-bde4-7b21b9899455" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_RepurchaseAgreementCounterpartyNameDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_CounterpartyNameAxis_ae208273-23c2-4d85-a96a-400e7a878ed5" xlink:to="loc_srt_RepurchaseAgreementCounterpartyNameDomain_4483823c-0592-4742-bde4-7b21b9899455" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dmtk_KilroyRealtyLPMember_b3cb872a-b916-417a-98c2-5358798c6ae1" xlink:href="dmtk-20220630.xsd#dmtk_KilroyRealtyLPMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_RepurchaseAgreementCounterpartyNameDomain_4483823c-0592-4742-bde4-7b21b9899455" xlink:to="loc_dmtk_KilroyRealtyLPMember_b3cb872a-b916-417a-98c2-5358798c6ae1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CreditFacilityAxis_b964033e-cd1d-4d17-af00-143c0813b7ce" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CreditFacilityAxis"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dmtk_CommitmentsAndContingenciesTable_2c2294c8-849b-4277-b8fd-f55918436fd9" xlink:to="loc_us-gaap_CreditFacilityAxis_b964033e-cd1d-4d17-af00-143c0813b7ce" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CreditFacilityDomain_f3a5c358-cb34-4c88-ba83-02b9d121f472" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CreditFacilityDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_CreditFacilityAxis_b964033e-cd1d-4d17-af00-143c0813b7ce" xlink:to="loc_us-gaap_CreditFacilityDomain_f3a5c358-cb34-4c88-ba83-02b9d121f472" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LetterOfCreditMember_bed0724c-62ae-4016-b157-b00c7d9c9fc9" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LetterOfCreditMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_CreditFacilityDomain_f3a5c358-cb34-4c88-ba83-02b9d121f472" xlink:to="loc_us-gaap_LetterOfCreditMember_bed0724c-62ae-4016-b157-b00c7d9c9fc9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StandbyLettersOfCreditMember_b76d0bba-9e26-42ce-90a4-5669fc8f0459" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StandbyLettersOfCreditMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_CreditFacilityDomain_f3a5c358-cb34-4c88-ba83-02b9d121f472" xlink:to="loc_us-gaap_StandbyLettersOfCreditMember_b76d0bba-9e26-42ce-90a4-5669fc8f0459" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeAxis_8d5057e0-648e-47b6-8e30-9a724228d866" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_RangeAxis"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dmtk_CommitmentsAndContingenciesTable_2c2294c8-849b-4277-b8fd-f55918436fd9" xlink:to="loc_srt_RangeAxis_8d5057e0-648e-47b6-8e30-9a724228d866" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeMember_357a7450-c1e0-4030-8660-fa80b291cee1" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_RangeMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_RangeAxis_8d5057e0-648e-47b6-8e30-9a724228d866" xlink:to="loc_srt_RangeMember_357a7450-c1e0-4030-8660-fa80b291cee1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_MaximumMember_e6bddf5b-1015-43db-8bc1-69ce5eac7063" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_MaximumMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_RangeMember_357a7450-c1e0-4030-8660-fa80b291cee1" xlink:to="loc_srt_MaximumMember_e6bddf5b-1015-43db-8bc1-69ce5eac7063" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestrictedCashAndCashEquivalentsCashAndCashEquivalentsAxis_992317c1-7272-418b-8938-c23b8b16f1f0" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RestrictedCashAndCashEquivalentsCashAndCashEquivalentsAxis"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dmtk_CommitmentsAndContingenciesTable_2c2294c8-849b-4277-b8fd-f55918436fd9" xlink:to="loc_us-gaap_RestrictedCashAndCashEquivalentsCashAndCashEquivalentsAxis_992317c1-7272-418b-8938-c23b8b16f1f0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestrictedCashAndCashEquivalentsCashAndCashEquivalentsMember_67047a88-67f1-4fac-9160-61bf3edde121" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RestrictedCashAndCashEquivalentsCashAndCashEquivalentsMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RestrictedCashAndCashEquivalentsCashAndCashEquivalentsAxis_992317c1-7272-418b-8938-c23b8b16f1f0" xlink:to="loc_us-gaap_RestrictedCashAndCashEquivalentsCashAndCashEquivalentsMember_67047a88-67f1-4fac-9160-61bf3edde121" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DemandDepositsMember_59d689e5-2a99-4cfa-b3aa-361d97a8ebe2" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DemandDepositsMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RestrictedCashAndCashEquivalentsCashAndCashEquivalentsMember_67047a88-67f1-4fac-9160-61bf3edde121" xlink:to="loc_us-gaap_DemandDepositsMember_59d689e5-2a99-4cfa-b3aa-361d97a8ebe2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dmtk_LeaseAmendmentsAxis_87b4f953-3f94-4a47-af01-ef85afa3c16c" xlink:href="dmtk-20220630.xsd#dmtk_LeaseAmendmentsAxis"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dmtk_CommitmentsAndContingenciesTable_2c2294c8-849b-4277-b8fd-f55918436fd9" xlink:to="loc_dmtk_LeaseAmendmentsAxis_87b4f953-3f94-4a47-af01-ef85afa3c16c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dmtk_LeaseAmendmentsDomain_0ad00eab-cda2-40a8-bc0f-7446368ebdc8" xlink:href="dmtk-20220630.xsd#dmtk_LeaseAmendmentsDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dmtk_LeaseAmendmentsAxis_87b4f953-3f94-4a47-af01-ef85afa3c16c" xlink:to="loc_dmtk_LeaseAmendmentsDomain_0ad00eab-cda2-40a8-bc0f-7446368ebdc8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dmtk_FirstAmendmentMember_ee895a40-0837-42e2-a5ab-38cf88555fa2" xlink:href="dmtk-20220630.xsd#dmtk_FirstAmendmentMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dmtk_LeaseAmendmentsDomain_0ad00eab-cda2-40a8-bc0f-7446368ebdc8" xlink:to="loc_dmtk_FirstAmendmentMember_ee895a40-0837-42e2-a5ab-38cf88555fa2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dmtk_SecondAmendmentMember_2f8c14d7-2cd0-43c8-8e51-ed577c43f6d4" xlink:href="dmtk-20220630.xsd#dmtk_SecondAmendmentMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dmtk_LeaseAmendmentsDomain_0ad00eab-cda2-40a8-bc0f-7446368ebdc8" xlink:to="loc_dmtk_SecondAmendmentMember_2f8c14d7-2cd0-43c8-8e51-ed577c43f6d4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dmtk_CommitmentsAndContingenciesLineItems_d24de695-d90c-4388-96d5-68f91264e2aa" xlink:href="dmtk-20220630.xsd#dmtk_CommitmentsAndContingenciesLineItems"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dmtk_CommitmentsAndContingenciesTable_2c2294c8-849b-4277-b8fd-f55918436fd9" xlink:to="loc_dmtk_CommitmentsAndContingenciesLineItems_d24de695-d90c-4388-96d5-68f91264e2aa" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dmtk_PercentageOfUsefulLivesOfAssets_19c0a6eb-0982-45a7-86ee-4117f3852387" xlink:href="dmtk-20220630.xsd#dmtk_PercentageOfUsefulLivesOfAssets"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dmtk_CommitmentsAndContingenciesLineItems_d24de695-d90c-4388-96d5-68f91264e2aa" xlink:to="loc_dmtk_PercentageOfUsefulLivesOfAssets_19c0a6eb-0982-45a7-86ee-4117f3852387" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentGross_ce623fd2-a345-4796-93cc-e69c010304e3" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PropertyPlantAndEquipmentGross"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dmtk_CommitmentsAndContingenciesLineItems_d24de695-d90c-4388-96d5-68f91264e2aa" xlink:to="loc_us-gaap_PropertyPlantAndEquipmentGross_ce623fd2-a345-4796-93cc-e69c010304e3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DepreciationAndAmortization_52f2215d-c827-4709-9624-6170658d03ca" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DepreciationAndAmortization"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dmtk_CommitmentsAndContingenciesLineItems_d24de695-d90c-4388-96d5-68f91264e2aa" xlink:to="loc_us-gaap_DepreciationAndAmortization_52f2215d-c827-4709-9624-6170658d03ca" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FinanceLeaseInterestExpense_ea558448-4967-45bc-a35c-830f669591b0" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FinanceLeaseInterestExpense"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dmtk_CommitmentsAndContingenciesLineItems_d24de695-d90c-4388-96d5-68f91264e2aa" xlink:to="loc_us-gaap_FinanceLeaseInterestExpense_ea558448-4967-45bc-a35c-830f669591b0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dmtk_AreaOfBuilding_a166278b-bd91-4a6e-93fa-d1630f6119dc" xlink:href="dmtk-20220630.xsd#dmtk_AreaOfBuilding"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dmtk_CommitmentsAndContingenciesLineItems_d24de695-d90c-4388-96d5-68f91264e2aa" xlink:to="loc_dmtk_AreaOfBuilding_a166278b-bd91-4a6e-93fa-d1630f6119dc" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dmtk_TenantImprovementAllowancePerRentableSquareFoot_58155933-8326-4440-96ce-8975280baaf0" xlink:href="dmtk-20220630.xsd#dmtk_TenantImprovementAllowancePerRentableSquareFoot"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dmtk_CommitmentsAndContingenciesLineItems_d24de695-d90c-4388-96d5-68f91264e2aa" xlink:to="loc_dmtk_TenantImprovementAllowancePerRentableSquareFoot_58155933-8326-4440-96ce-8975280baaf0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TenantImprovements_ffd7f28e-c45f-4069-8089-145f99c4fbec" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_TenantImprovements"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dmtk_CommitmentsAndContingenciesLineItems_d24de695-d90c-4388-96d5-68f91264e2aa" xlink:to="loc_us-gaap_TenantImprovements_ffd7f28e-c45f-4069-8089-145f99c4fbec" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dmtk_NumberOfImprovementPhases_d7c4ce40-dc8f-4343-a5f3-e8b805909f85" xlink:href="dmtk-20220630.xsd#dmtk_NumberOfImprovementPhases"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dmtk_CommitmentsAndContingenciesLineItems_d24de695-d90c-4388-96d5-68f91264e2aa" xlink:to="loc_dmtk_NumberOfImprovementPhases_d7c4ce40-dc8f-4343-a5f3-e8b805909f85" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dmtk_LesseeOperatingLeaseNumberOfRenewalTerms_39be3d11-faf8-4719-ac2c-9faffb5b95d7" xlink:href="dmtk-20220630.xsd#dmtk_LesseeOperatingLeaseNumberOfRenewalTerms"/>
    <link:presentationArc order="9" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dmtk_CommitmentsAndContingenciesLineItems_d24de695-d90c-4388-96d5-68f91264e2aa" xlink:to="loc_dmtk_LesseeOperatingLeaseNumberOfRenewalTerms_39be3d11-faf8-4719-ac2c-9faffb5b95d7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeOperatingLeaseRenewalTerm_56329a62-f121-4544-96b3-325d5aef48a2" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LesseeOperatingLeaseRenewalTerm"/>
    <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dmtk_CommitmentsAndContingenciesLineItems_d24de695-d90c-4388-96d5-68f91264e2aa" xlink:to="loc_us-gaap_LesseeOperatingLeaseRenewalTerm_56329a62-f121-4544-96b3-325d5aef48a2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeaseRightOfUseAsset_5b1a2e88-aff4-440d-895f-828b5c2d4e27" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OperatingLeaseRightOfUseAsset"/>
    <link:presentationArc order="11" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dmtk_CommitmentsAndContingenciesLineItems_d24de695-d90c-4388-96d5-68f91264e2aa" xlink:to="loc_us-gaap_OperatingLeaseRightOfUseAsset_5b1a2e88-aff4-440d-895f-828b5c2d4e27" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dmtk_IncreaseInTenantImprovementAllowancePerRentableSquareFoot_1a845905-b90e-4aee-b336-770cdc0fd2b8" xlink:href="dmtk-20220630.xsd#dmtk_IncreaseInTenantImprovementAllowancePerRentableSquareFoot"/>
    <link:presentationArc order="12" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dmtk_CommitmentsAndContingenciesLineItems_d24de695-d90c-4388-96d5-68f91264e2aa" xlink:to="loc_dmtk_IncreaseInTenantImprovementAllowancePerRentableSquareFoot_1a845905-b90e-4aee-b336-770cdc0fd2b8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dmtk_IncreaseInTenantImprovementAllowance_4d5f9c79-9272-4c00-be4e-22228a16f69a" xlink:href="dmtk-20220630.xsd#dmtk_IncreaseInTenantImprovementAllowance"/>
    <link:presentationArc order="13" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dmtk_CommitmentsAndContingenciesLineItems_d24de695-d90c-4388-96d5-68f91264e2aa" xlink:to="loc_dmtk_IncreaseInTenantImprovementAllowance_4d5f9c79-9272-4c00-be4e-22228a16f69a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dmtk_RentableAndUsableSquareFeet_57eae4a1-8acf-4da7-a593-48acc4eec80e" xlink:href="dmtk-20220630.xsd#dmtk_RentableAndUsableSquareFeet"/>
    <link:presentationArc order="14" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dmtk_CommitmentsAndContingenciesLineItems_d24de695-d90c-4388-96d5-68f91264e2aa" xlink:to="loc_dmtk_RentableAndUsableSquareFeet_57eae4a1-8acf-4da7-a593-48acc4eec80e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeaseLiability_e3bf3edc-09e9-40e2-a1b2-b9c4c5f35c31" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OperatingLeaseLiability"/>
    <link:presentationArc order="15" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dmtk_CommitmentsAndContingenciesLineItems_d24de695-d90c-4388-96d5-68f91264e2aa" xlink:to="loc_us-gaap_OperatingLeaseLiability_e3bf3edc-09e9-40e2-a1b2-b9c4c5f35c31" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dmtk_OperatingLeaseIncrementalBorrowingRateAtEffectiveDate_c79db5ce-e215-46d2-a09e-3b484e3b0e1c" xlink:href="dmtk-20220630.xsd#dmtk_OperatingLeaseIncrementalBorrowingRateAtEffectiveDate"/>
    <link:presentationArc order="16" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dmtk_CommitmentsAndContingenciesLineItems_d24de695-d90c-4388-96d5-68f91264e2aa" xlink:to="loc_dmtk_OperatingLeaseIncrementalBorrowingRateAtEffectiveDate_c79db5ce-e215-46d2-a09e-3b484e3b0e1c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInOperatingLeaseLiability_da8be4d5-8fc4-401c-9442-d9534a103a64" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncreaseDecreaseInOperatingLeaseLiability"/>
    <link:presentationArc order="17" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dmtk_CommitmentsAndContingenciesLineItems_d24de695-d90c-4388-96d5-68f91264e2aa" xlink:to="loc_us-gaap_IncreaseDecreaseInOperatingLeaseLiability_da8be4d5-8fc4-401c-9442-d9534a103a64" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dmtk_IncreaseDecreaseInOperatingLeaseRightOfUseAsset_5cecf4b6-8aaf-47ed-8241-7aaf58b70afa" xlink:href="dmtk-20220630.xsd#dmtk_IncreaseDecreaseInOperatingLeaseRightOfUseAsset"/>
    <link:presentationArc order="18" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dmtk_CommitmentsAndContingenciesLineItems_d24de695-d90c-4388-96d5-68f91264e2aa" xlink:to="loc_dmtk_IncreaseDecreaseInOperatingLeaseRightOfUseAsset_5cecf4b6-8aaf-47ed-8241-7aaf58b70afa" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue_a578da29-d2e2-4229-9bb6-b3100df23470" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue"/>
    <link:presentationArc order="19" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dmtk_CommitmentsAndContingenciesLineItems_d24de695-d90c-4388-96d5-68f91264e2aa" xlink:to="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue_a578da29-d2e2-4229-9bb6-b3100df23470" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestrictedCashAndCashEquivalents_7dcd93a6-f4c7-493c-8e82-42780dc02ee7" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RestrictedCashAndCashEquivalents"/>
    <link:presentationArc order="20" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dmtk_CommitmentsAndContingenciesLineItems_d24de695-d90c-4388-96d5-68f91264e2aa" xlink:to="loc_us-gaap_RestrictedCashAndCashEquivalents_7dcd93a6-f4c7-493c-8e82-42780dc02ee7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dmtk_RestrictedCashAndCashEquivalentsIncreaseDecrease_40d328f8-56c6-4253-a877-1dee8f2a3f25" xlink:href="dmtk-20220630.xsd#dmtk_RestrictedCashAndCashEquivalentsIncreaseDecrease"/>
    <link:presentationArc order="21" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dmtk_CommitmentsAndContingenciesLineItems_d24de695-d90c-4388-96d5-68f91264e2aa" xlink:to="loc_dmtk_RestrictedCashAndCashEquivalentsIncreaseDecrease_40d328f8-56c6-4253-a877-1dee8f2a3f25" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dmtk_TenantImprovementAllowance_455eff75-1896-48a5-bf8c-8ed6f2a8be8a" xlink:href="dmtk-20220630.xsd#dmtk_TenantImprovementAllowance"/>
    <link:presentationArc order="22" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dmtk_CommitmentsAndContingenciesLineItems_d24de695-d90c-4388-96d5-68f91264e2aa" xlink:to="loc_dmtk_TenantImprovementAllowance_455eff75-1896-48a5-bf8c-8ed6f2a8be8a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeOperatingLeaseRemainingLeaseTerm_7d772107-f704-4903-90bd-982269764357" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LesseeOperatingLeaseRemainingLeaseTerm"/>
    <link:presentationArc order="23" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dmtk_CommitmentsAndContingenciesLineItems_d24de695-d90c-4388-96d5-68f91264e2aa" xlink:to="loc_us-gaap_LesseeOperatingLeaseRemainingLeaseTerm_7d772107-f704-4903-90bd-982269764357" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeOperatingLeaseDiscountRate_27a1d10e-c583-4bcf-8427-168192d8c385" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LesseeOperatingLeaseDiscountRate"/>
    <link:presentationArc order="24" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dmtk_CommitmentsAndContingenciesLineItems_d24de695-d90c-4388-96d5-68f91264e2aa" xlink:to="loc_us-gaap_LesseeOperatingLeaseDiscountRate_27a1d10e-c583-4bcf-8427-168192d8c385" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://dermtech.com/role/LeasesCommitmentsandContingenciesScheduleofLongTermFinanceLeaseObligationsDetails" xlink:type="simple" xlink:href="dmtk-20220630.xsd#LeasesCommitmentsandContingenciesScheduleofLongTermFinanceLeaseObligationsDetails"/>
  <link:presentationLink xlink:role="http://dermtech.com/role/LeasesCommitmentsandContingenciesScheduleofLongTermFinanceLeaseObligationsDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommitmentsAndContingenciesDisclosureAbstract_3a9836ae-e488-4d7f-9cb0-4b1b6377df4b" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CommitmentsAndContingenciesDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FinanceLeaseLiabilityPaymentsDue_4c69a6d5-fb1d-4829-be83-7cdc1ce128c0" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FinanceLeaseLiabilityPaymentsDue"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_CommitmentsAndContingenciesDisclosureAbstract_3a9836ae-e488-4d7f-9cb0-4b1b6377df4b" xlink:to="loc_us-gaap_FinanceLeaseLiabilityPaymentsDue_4c69a6d5-fb1d-4829-be83-7cdc1ce128c0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FinanceLeaseLiabilityUndiscountedExcessAmount_13994ac2-0c07-4a6c-b657-219c0c921371" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FinanceLeaseLiabilityUndiscountedExcessAmount"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_CommitmentsAndContingenciesDisclosureAbstract_3a9836ae-e488-4d7f-9cb0-4b1b6377df4b" xlink:to="loc_us-gaap_FinanceLeaseLiabilityUndiscountedExcessAmount_13994ac2-0c07-4a6c-b657-219c0c921371" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FinanceLeaseLiability_caa8616d-2305-4596-894c-a8dbab2a3ca3" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FinanceLeaseLiability"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_CommitmentsAndContingenciesDisclosureAbstract_3a9836ae-e488-4d7f-9cb0-4b1b6377df4b" xlink:to="loc_us-gaap_FinanceLeaseLiability_caa8616d-2305-4596-894c-a8dbab2a3ca3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FinanceLeaseLiabilityCurrent_1dbd516a-8c76-4356-9f79-9e39ff8aea39" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FinanceLeaseLiabilityCurrent"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_CommitmentsAndContingenciesDisclosureAbstract_3a9836ae-e488-4d7f-9cb0-4b1b6377df4b" xlink:to="loc_us-gaap_FinanceLeaseLiabilityCurrent_1dbd516a-8c76-4356-9f79-9e39ff8aea39" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FinanceLeaseLiabilityNoncurrent_c08e6d5d-adf7-41b7-a9b9-c227f4610a07" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FinanceLeaseLiabilityNoncurrent"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_CommitmentsAndContingenciesDisclosureAbstract_3a9836ae-e488-4d7f-9cb0-4b1b6377df4b" xlink:to="loc_us-gaap_FinanceLeaseLiabilityNoncurrent_c08e6d5d-adf7-41b7-a9b9-c227f4610a07" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://dermtech.com/role/LeasesCommitmentsandContingenciesComponentsofLeaseExpenseDetails" xlink:type="simple" xlink:href="dmtk-20220630.xsd#LeasesCommitmentsandContingenciesComponentsofLeaseExpenseDetails"/>
  <link:presentationLink xlink:role="http://dermtech.com/role/LeasesCommitmentsandContingenciesComponentsofLeaseExpenseDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommitmentsAndContingenciesDisclosureAbstract_6914bec5-ac2f-4eeb-962a-fa6a262364f0" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CommitmentsAndContingenciesDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_dmtk_OperatingLeaseCostAbstract_bb3136cf-4ced-4900-bc53-9bd1e456f82a" xlink:href="dmtk-20220630.xsd#dmtk_OperatingLeaseCostAbstract"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_CommitmentsAndContingenciesDisclosureAbstract_6914bec5-ac2f-4eeb-962a-fa6a262364f0" xlink:to="loc_dmtk_OperatingLeaseCostAbstract_bb3136cf-4ced-4900-bc53-9bd1e456f82a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeaseCost_3f690019-cb8c-49be-9582-cf7eef7f8c22" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OperatingLeaseCost"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dmtk_OperatingLeaseCostAbstract_bb3136cf-4ced-4900-bc53-9bd1e456f82a" xlink:to="loc_us-gaap_OperatingLeaseCost_3f690019-cb8c-49be-9582-cf7eef7f8c22" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_VariableLeaseCost_3087d6c0-8bdb-4c54-844f-e665d3e55e4e" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_VariableLeaseCost"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dmtk_OperatingLeaseCostAbstract_bb3136cf-4ced-4900-bc53-9bd1e456f82a" xlink:to="loc_us-gaap_VariableLeaseCost_3087d6c0-8bdb-4c54-844f-e665d3e55e4e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dmtk_OperatingLeaseCosts_5999a1b5-1a25-450b-a8e5-b30455c2bdf2" xlink:href="dmtk-20220630.xsd#dmtk_OperatingLeaseCosts"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dmtk_OperatingLeaseCostAbstract_bb3136cf-4ced-4900-bc53-9bd1e456f82a" xlink:to="loc_dmtk_OperatingLeaseCosts_5999a1b5-1a25-450b-a8e5-b30455c2bdf2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dmtk_FinanceLeaseCostsAbstract_1f6bb445-35ab-4371-934c-fa205d08b9f7" xlink:href="dmtk-20220630.xsd#dmtk_FinanceLeaseCostsAbstract"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_CommitmentsAndContingenciesDisclosureAbstract_6914bec5-ac2f-4eeb-962a-fa6a262364f0" xlink:to="loc_dmtk_FinanceLeaseCostsAbstract_1f6bb445-35ab-4371-934c-fa205d08b9f7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FinanceLeaseRightOfUseAssetAmortization_4b951dfd-3a93-427d-8f0f-2676e8064d88" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FinanceLeaseRightOfUseAssetAmortization"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dmtk_FinanceLeaseCostsAbstract_1f6bb445-35ab-4371-934c-fa205d08b9f7" xlink:to="loc_us-gaap_FinanceLeaseRightOfUseAssetAmortization_4b951dfd-3a93-427d-8f0f-2676e8064d88" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FinanceLeaseInterestExpense_f448ace9-bc6a-4f08-8a22-c4e801964221" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FinanceLeaseInterestExpense"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dmtk_FinanceLeaseCostsAbstract_1f6bb445-35ab-4371-934c-fa205d08b9f7" xlink:to="loc_us-gaap_FinanceLeaseInterestExpense_f448ace9-bc6a-4f08-8a22-c4e801964221" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dmtk_FinanceLeaseCost_4231bdcd-be99-4f0e-8b8a-646e0e6062e8" xlink:href="dmtk-20220630.xsd#dmtk_FinanceLeaseCost"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dmtk_FinanceLeaseCostsAbstract_1f6bb445-35ab-4371-934c-fa205d08b9f7" xlink:to="loc_dmtk_FinanceLeaseCost_4231bdcd-be99-4f0e-8b8a-646e0e6062e8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dmtk_CashPaidForAmountsIncludedInMeasurementOfLeaseLiabilitiesAbstract_5a136be1-a64e-4de7-8022-3cf87da57ca1" xlink:href="dmtk-20220630.xsd#dmtk_CashPaidForAmountsIncludedInMeasurementOfLeaseLiabilitiesAbstract"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_CommitmentsAndContingenciesDisclosureAbstract_6914bec5-ac2f-4eeb-962a-fa6a262364f0" xlink:to="loc_dmtk_CashPaidForAmountsIncludedInMeasurementOfLeaseLiabilitiesAbstract_5a136be1-a64e-4de7-8022-3cf87da57ca1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeasePayments_eea285c9-ec26-4b6a-84c7-734e3380a616" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OperatingLeasePayments"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dmtk_CashPaidForAmountsIncludedInMeasurementOfLeaseLiabilitiesAbstract_5a136be1-a64e-4de7-8022-3cf87da57ca1" xlink:to="loc_us-gaap_OperatingLeasePayments_eea285c9-ec26-4b6a-84c7-734e3380a616" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FinanceLeaseInterestExpense_a6e02bde-a164-4673-9e8f-0e2e3b31a598" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FinanceLeaseInterestExpense"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dmtk_CashPaidForAmountsIncludedInMeasurementOfLeaseLiabilitiesAbstract_5a136be1-a64e-4de7-8022-3cf87da57ca1" xlink:to="loc_us-gaap_FinanceLeaseInterestExpense_a6e02bde-a164-4673-9e8f-0e2e3b31a598" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FinanceLeasePrincipalPayments_ebf1c1e4-204e-45fb-8ec8-ccbfb4c82c85" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FinanceLeasePrincipalPayments"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dmtk_CashPaidForAmountsIncludedInMeasurementOfLeaseLiabilitiesAbstract_5a136be1-a64e-4de7-8022-3cf87da57ca1" xlink:to="loc_us-gaap_FinanceLeasePrincipalPayments_ebf1c1e4-204e-45fb-8ec8-ccbfb4c82c85" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability_82859983-337c-4020-afe9-6274cfe2f295" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_CommitmentsAndContingenciesDisclosureAbstract_6914bec5-ac2f-4eeb-962a-fa6a262364f0" xlink:to="loc_us-gaap_RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability_82859983-337c-4020-afe9-6274cfe2f295" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RightOfUseAssetObtainedInExchangeForFinanceLeaseLiability_3eec6b79-0e86-451b-b720-119a2409c6d9" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RightOfUseAssetObtainedInExchangeForFinanceLeaseLiability"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_CommitmentsAndContingenciesDisclosureAbstract_6914bec5-ac2f-4eeb-962a-fa6a262364f0" xlink:to="loc_us-gaap_RightOfUseAssetObtainedInExchangeForFinanceLeaseLiability_3eec6b79-0e86-451b-b720-119a2409c6d9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeaseWeightedAverageRemainingLeaseTerm1_aa6a02bc-9e66-4f4a-8c6c-0adbeb8725d4" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OperatingLeaseWeightedAverageRemainingLeaseTerm1"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_CommitmentsAndContingenciesDisclosureAbstract_6914bec5-ac2f-4eeb-962a-fa6a262364f0" xlink:to="loc_us-gaap_OperatingLeaseWeightedAverageRemainingLeaseTerm1_aa6a02bc-9e66-4f4a-8c6c-0adbeb8725d4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FinanceLeaseWeightedAverageRemainingLeaseTerm1_79fe82e2-081c-4311-9a42-23cdbe2557c4" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FinanceLeaseWeightedAverageRemainingLeaseTerm1"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_CommitmentsAndContingenciesDisclosureAbstract_6914bec5-ac2f-4eeb-962a-fa6a262364f0" xlink:to="loc_us-gaap_FinanceLeaseWeightedAverageRemainingLeaseTerm1_79fe82e2-081c-4311-9a42-23cdbe2557c4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeaseWeightedAverageDiscountRatePercent_1df16bad-65e2-4236-9358-85866e08f28d" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OperatingLeaseWeightedAverageDiscountRatePercent"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_CommitmentsAndContingenciesDisclosureAbstract_6914bec5-ac2f-4eeb-962a-fa6a262364f0" xlink:to="loc_us-gaap_OperatingLeaseWeightedAverageDiscountRatePercent_1df16bad-65e2-4236-9358-85866e08f28d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FinanceLeaseWeightedAverageDiscountRatePercent_5b57b685-bf79-4c4e-ba4e-8018cd15b10e" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FinanceLeaseWeightedAverageDiscountRatePercent"/>
    <link:presentationArc order="9" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_CommitmentsAndContingenciesDisclosureAbstract_6914bec5-ac2f-4eeb-962a-fa6a262364f0" xlink:to="loc_us-gaap_FinanceLeaseWeightedAverageDiscountRatePercent_5b57b685-bf79-4c4e-ba4e-8018cd15b10e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://dermtech.com/role/LeasesCommitmentsandContingenciesFutureMinimumPaymentsDetails" xlink:type="simple" xlink:href="dmtk-20220630.xsd#LeasesCommitmentsandContingenciesFutureMinimumPaymentsDetails"/>
  <link:presentationLink xlink:role="http://dermtech.com/role/LeasesCommitmentsandContingenciesFutureMinimumPaymentsDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommitmentsAndContingenciesDisclosureAbstract_2b5563ba-91fc-41ad-98e3-7a77bd802d32" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CommitmentsAndContingenciesDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeaseLiabilitiesPaymentsDueAbstract_5564639b-d9eb-429e-9869-fc4a6757eda1" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OperatingLeaseLiabilitiesPaymentsDueAbstract"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_CommitmentsAndContingenciesDisclosureAbstract_2b5563ba-91fc-41ad-98e3-7a77bd802d32" xlink:to="loc_us-gaap_OperatingLeaseLiabilitiesPaymentsDueAbstract_5564639b-d9eb-429e-9869-fc4a6757eda1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsRemainderOfFiscalYear_6e6e0d37-00b2-4b54-86c3-6ae98c392f46" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LesseeOperatingLeaseLiabilityPaymentsRemainderOfFiscalYear"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OperatingLeaseLiabilitiesPaymentsDueAbstract_5564639b-d9eb-429e-9869-fc4a6757eda1" xlink:to="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsRemainderOfFiscalYear_6e6e0d37-00b2-4b54-86c3-6ae98c392f46" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths_a02ae594-11a3-4b8a-b290-f5540bfcc215" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OperatingLeaseLiabilitiesPaymentsDueAbstract_5564639b-d9eb-429e-9869-fc4a6757eda1" xlink:to="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths_a02ae594-11a3-4b8a-b290-f5540bfcc215" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearTwo_7fe266f3-7815-488c-ba13-a7e1ad901b4b" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearTwo"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OperatingLeaseLiabilitiesPaymentsDueAbstract_5564639b-d9eb-429e-9869-fc4a6757eda1" xlink:to="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearTwo_7fe266f3-7815-488c-ba13-a7e1ad901b4b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearThree_34bfc92a-ac19-4393-9ef4-72871549562d" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearThree"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OperatingLeaseLiabilitiesPaymentsDueAbstract_5564639b-d9eb-429e-9869-fc4a6757eda1" xlink:to="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearThree_34bfc92a-ac19-4393-9ef4-72871549562d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFour_97fe8bf2-b325-44a4-b6e8-a9bd12619d61" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFour"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OperatingLeaseLiabilitiesPaymentsDueAbstract_5564639b-d9eb-429e-9869-fc4a6757eda1" xlink:to="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFour_97fe8bf2-b325-44a4-b6e8-a9bd12619d61" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dmtk_LesseeOperatingLeaseLiabilityToBePaidAfterYearFour_72757e00-a8b6-4dbc-b64b-e4eff2cc06c2" xlink:href="dmtk-20220630.xsd#dmtk_LesseeOperatingLeaseLiabilityToBePaidAfterYearFour"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OperatingLeaseLiabilitiesPaymentsDueAbstract_5564639b-d9eb-429e-9869-fc4a6757eda1" xlink:to="loc_dmtk_LesseeOperatingLeaseLiabilityToBePaidAfterYearFour_72757e00-a8b6-4dbc-b64b-e4eff2cc06c2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue_c0b0d680-b7f8-4209-bbc0-13c47fe035a2" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OperatingLeaseLiabilitiesPaymentsDueAbstract_5564639b-d9eb-429e-9869-fc4a6757eda1" xlink:to="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue_c0b0d680-b7f8-4209-bbc0-13c47fe035a2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FinanceLeaseLiabilitiesPaymentsDueAbstract_10b57164-2096-42ad-b0a6-f09839a384bb" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FinanceLeaseLiabilitiesPaymentsDueAbstract"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_CommitmentsAndContingenciesDisclosureAbstract_2b5563ba-91fc-41ad-98e3-7a77bd802d32" xlink:to="loc_us-gaap_FinanceLeaseLiabilitiesPaymentsDueAbstract_10b57164-2096-42ad-b0a6-f09839a384bb" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FinanceLeaseLiabilityPaymentsRemainderOfFiscalYear_9a0d8287-afca-4f9a-9020-25e7127a4771" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FinanceLeaseLiabilityPaymentsRemainderOfFiscalYear"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FinanceLeaseLiabilitiesPaymentsDueAbstract_10b57164-2096-42ad-b0a6-f09839a384bb" xlink:to="loc_us-gaap_FinanceLeaseLiabilityPaymentsRemainderOfFiscalYear_9a0d8287-afca-4f9a-9020-25e7127a4771" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FinanceLeaseLiabilityPaymentsDueNextTwelveMonths_a3f4136c-1853-48ba-937f-d562e772f986" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FinanceLeaseLiabilityPaymentsDueNextTwelveMonths"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FinanceLeaseLiabilitiesPaymentsDueAbstract_10b57164-2096-42ad-b0a6-f09839a384bb" xlink:to="loc_us-gaap_FinanceLeaseLiabilityPaymentsDueNextTwelveMonths_a3f4136c-1853-48ba-937f-d562e772f986" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FinanceLeaseLiabilityPaymentsDueYearTwo_84f56f7d-401f-4863-9175-9ce583a28df9" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FinanceLeaseLiabilityPaymentsDueYearTwo"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FinanceLeaseLiabilitiesPaymentsDueAbstract_10b57164-2096-42ad-b0a6-f09839a384bb" xlink:to="loc_us-gaap_FinanceLeaseLiabilityPaymentsDueYearTwo_84f56f7d-401f-4863-9175-9ce583a28df9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FinanceLeaseLiabilityPaymentsDueYearThree_95be8b7f-f4c0-4087-b65c-b940a552d47f" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FinanceLeaseLiabilityPaymentsDueYearThree"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FinanceLeaseLiabilitiesPaymentsDueAbstract_10b57164-2096-42ad-b0a6-f09839a384bb" xlink:to="loc_us-gaap_FinanceLeaseLiabilityPaymentsDueYearThree_95be8b7f-f4c0-4087-b65c-b940a552d47f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FinanceLeaseLiabilityPaymentsDueYearFour_3a752291-ea8b-4d8e-b17f-ada3f66c7d98" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FinanceLeaseLiabilityPaymentsDueYearFour"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FinanceLeaseLiabilitiesPaymentsDueAbstract_10b57164-2096-42ad-b0a6-f09839a384bb" xlink:to="loc_us-gaap_FinanceLeaseLiabilityPaymentsDueYearFour_3a752291-ea8b-4d8e-b17f-ada3f66c7d98" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dmtk_FinanceLeaseLiabilityPaymentsDueAfterYearFour_81d523aa-9e65-4181-a52f-51c23b005fbf" xlink:href="dmtk-20220630.xsd#dmtk_FinanceLeaseLiabilityPaymentsDueAfterYearFour"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FinanceLeaseLiabilitiesPaymentsDueAbstract_10b57164-2096-42ad-b0a6-f09839a384bb" xlink:to="loc_dmtk_FinanceLeaseLiabilityPaymentsDueAfterYearFour_81d523aa-9e65-4181-a52f-51c23b005fbf" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FinanceLeaseLiabilityPaymentsDue_c8af02b7-d544-4b8b-83ae-23d974c0da57" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FinanceLeaseLiabilityPaymentsDue"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FinanceLeaseLiabilitiesPaymentsDueAbstract_10b57164-2096-42ad-b0a6-f09839a384bb" xlink:to="loc_us-gaap_FinanceLeaseLiabilityPaymentsDue_c8af02b7-d544-4b8b-83ae-23d974c0da57" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dmtk_LesseeOperatingAndFinanceLeaseLiabilityToBePaidAbstract_762d73b9-8ca9-455b-9427-8e6080522f34" xlink:href="dmtk-20220630.xsd#dmtk_LesseeOperatingAndFinanceLeaseLiabilityToBePaidAbstract"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_CommitmentsAndContingenciesDisclosureAbstract_2b5563ba-91fc-41ad-98e3-7a77bd802d32" xlink:to="loc_dmtk_LesseeOperatingAndFinanceLeaseLiabilityToBePaidAbstract_762d73b9-8ca9-455b-9427-8e6080522f34" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dmtk_OperatingAndFinanceLeaseLiabilityPaymentsRemainderOfFiscalYear_83ea8e62-68fa-471d-a6d3-e755c4fcb0a7" xlink:href="dmtk-20220630.xsd#dmtk_OperatingAndFinanceLeaseLiabilityPaymentsRemainderOfFiscalYear"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dmtk_LesseeOperatingAndFinanceLeaseLiabilityToBePaidAbstract_762d73b9-8ca9-455b-9427-8e6080522f34" xlink:to="loc_dmtk_OperatingAndFinanceLeaseLiabilityPaymentsRemainderOfFiscalYear_83ea8e62-68fa-471d-a6d3-e755c4fcb0a7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dmtk_OperatingAndFinanceLeaseLiabilityPaymentsDueNextTwelveMonths_d3125b51-40ee-4adc-8ca5-8faf9d459b1f" xlink:href="dmtk-20220630.xsd#dmtk_OperatingAndFinanceLeaseLiabilityPaymentsDueNextTwelveMonths"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dmtk_LesseeOperatingAndFinanceLeaseLiabilityToBePaidAbstract_762d73b9-8ca9-455b-9427-8e6080522f34" xlink:to="loc_dmtk_OperatingAndFinanceLeaseLiabilityPaymentsDueNextTwelveMonths_d3125b51-40ee-4adc-8ca5-8faf9d459b1f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dmtk_OperatingAndFinanceLeaseLiabilityPaymentsDueYearTwo_8b515469-2b31-4c94-bf0d-6a0b633ba38c" xlink:href="dmtk-20220630.xsd#dmtk_OperatingAndFinanceLeaseLiabilityPaymentsDueYearTwo"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dmtk_LesseeOperatingAndFinanceLeaseLiabilityToBePaidAbstract_762d73b9-8ca9-455b-9427-8e6080522f34" xlink:to="loc_dmtk_OperatingAndFinanceLeaseLiabilityPaymentsDueYearTwo_8b515469-2b31-4c94-bf0d-6a0b633ba38c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dmtk_OperatingAndFinanceLeaseLiabilityPaymentsDueYearThree_3b40dff0-d1bc-43ac-b86d-c1ae916d7995" xlink:href="dmtk-20220630.xsd#dmtk_OperatingAndFinanceLeaseLiabilityPaymentsDueYearThree"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dmtk_LesseeOperatingAndFinanceLeaseLiabilityToBePaidAbstract_762d73b9-8ca9-455b-9427-8e6080522f34" xlink:to="loc_dmtk_OperatingAndFinanceLeaseLiabilityPaymentsDueYearThree_3b40dff0-d1bc-43ac-b86d-c1ae916d7995" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dmtk_OperatingAndFinanceLeaseLiabilityPaymentsDueYearFour_9aa4e87d-569e-4f41-8645-34ed1ffc6767" xlink:href="dmtk-20220630.xsd#dmtk_OperatingAndFinanceLeaseLiabilityPaymentsDueYearFour"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dmtk_LesseeOperatingAndFinanceLeaseLiabilityToBePaidAbstract_762d73b9-8ca9-455b-9427-8e6080522f34" xlink:to="loc_dmtk_OperatingAndFinanceLeaseLiabilityPaymentsDueYearFour_9aa4e87d-569e-4f41-8645-34ed1ffc6767" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dmtk_OperatingAndFinanceLeaseLiabilityPaymentsDueThereafter_d3506572-429a-43c7-b102-0822e50a567c" xlink:href="dmtk-20220630.xsd#dmtk_OperatingAndFinanceLeaseLiabilityPaymentsDueThereafter"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dmtk_LesseeOperatingAndFinanceLeaseLiabilityToBePaidAbstract_762d73b9-8ca9-455b-9427-8e6080522f34" xlink:to="loc_dmtk_OperatingAndFinanceLeaseLiabilityPaymentsDueThereafter_d3506572-429a-43c7-b102-0822e50a567c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dmtk_OperatingAndFinanceLeaseLiabilityPaymentsDue_f0b51432-9b68-4ded-945e-577aa5e4a315" xlink:href="dmtk-20220630.xsd#dmtk_OperatingAndFinanceLeaseLiabilityPaymentsDue"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dmtk_LesseeOperatingAndFinanceLeaseLiabilityToBePaidAbstract_762d73b9-8ca9-455b-9427-8e6080522f34" xlink:to="loc_dmtk_OperatingAndFinanceLeaseLiabilityPaymentsDue_f0b51432-9b68-4ded-945e-577aa5e4a315" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://dermtech.com/role/RelatedPartyTransactions" xlink:type="simple" xlink:href="dmtk-20220630.xsd#RelatedPartyTransactions"/>
  <link:presentationLink xlink:role="http://dermtech.com/role/RelatedPartyTransactions" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RelatedPartyTransactionsAbstract_19ba6ac5-9c20-4339-950e-c0fe2efcb21b" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RelatedPartyTransactionsAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RelatedPartyTransactionsDisclosureTextBlock_7ed991b0-afdc-4865-82aa-464786f610e4" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RelatedPartyTransactionsDisclosureTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RelatedPartyTransactionsAbstract_19ba6ac5-9c20-4339-950e-c0fe2efcb21b" xlink:to="loc_us-gaap_RelatedPartyTransactionsDisclosureTextBlock_7ed991b0-afdc-4865-82aa-464786f610e4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://dermtech.com/role/RelatedPartyTransactionsAdditionalInformationDetails" xlink:type="simple" xlink:href="dmtk-20220630.xsd#RelatedPartyTransactionsAdditionalInformationDetails"/>
  <link:presentationLink xlink:role="http://dermtech.com/role/RelatedPartyTransactionsAdditionalInformationDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RelatedPartyTransactionsAbstract_d4dd38c8-3e3e-4fb8-bf62-dad873a6ab08" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RelatedPartyTransactionsAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfRelatedPartyTransactionsByRelatedPartyTable_7f938250-c13c-4013-98bc-28ebdd02fc95" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfRelatedPartyTransactionsByRelatedPartyTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RelatedPartyTransactionsAbstract_d4dd38c8-3e3e-4fb8-bf62-dad873a6ab08" xlink:to="loc_us-gaap_ScheduleOfRelatedPartyTransactionsByRelatedPartyTable_7f938250-c13c-4013-98bc-28ebdd02fc95" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RelatedPartyTransactionAxis_70c11db8-c73d-40bb-bf31-a09f0ffb5952" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RelatedPartyTransactionAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfRelatedPartyTransactionsByRelatedPartyTable_7f938250-c13c-4013-98bc-28ebdd02fc95" xlink:to="loc_us-gaap_RelatedPartyTransactionAxis_70c11db8-c73d-40bb-bf31-a09f0ffb5952" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RelatedPartyTransactionDomain_3c78c66c-259b-4549-92d0-f3c9a6714568" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RelatedPartyTransactionDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RelatedPartyTransactionAxis_70c11db8-c73d-40bb-bf31-a09f0ffb5952" xlink:to="loc_us-gaap_RelatedPartyTransactionDomain_3c78c66c-259b-4549-92d0-f3c9a6714568" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dmtk_EVERSANALifeScienceServicesLLCMember_ad0ffbdb-d7d3-46f7-8096-3adbbccab0d1" xlink:href="dmtk-20220630.xsd#dmtk_EVERSANALifeScienceServicesLLCMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RelatedPartyTransactionDomain_3c78c66c-259b-4549-92d0-f3c9a6714568" xlink:to="loc_dmtk_EVERSANALifeScienceServicesLLCMember_ad0ffbdb-d7d3-46f7-8096-3adbbccab0d1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dmtk_DermTechOperationsIncMember_d56eae0d-299a-411d-9eb0-fcb7a7cbbf4f" xlink:href="dmtk-20220630.xsd#dmtk_DermTechOperationsIncMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RelatedPartyTransactionDomain_3c78c66c-259b-4549-92d0-f3c9a6714568" xlink:to="loc_dmtk_DermTechOperationsIncMember_d56eae0d-299a-411d-9eb0-fcb7a7cbbf4f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RelatedPartyTransactionsByRelatedPartyAxis_48551bbe-a426-492c-affa-fa37aab42e91" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RelatedPartyTransactionsByRelatedPartyAxis"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfRelatedPartyTransactionsByRelatedPartyTable_7f938250-c13c-4013-98bc-28ebdd02fc95" xlink:to="loc_us-gaap_RelatedPartyTransactionsByRelatedPartyAxis_48551bbe-a426-492c-affa-fa37aab42e91" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RelatedPartyDomain_4d915b0a-fe7c-42a5-a0aa-055c22554d67" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RelatedPartyDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RelatedPartyTransactionsByRelatedPartyAxis_48551bbe-a426-492c-affa-fa37aab42e91" xlink:to="loc_us-gaap_RelatedPartyDomain_4d915b0a-fe7c-42a5-a0aa-055c22554d67" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dmtk_SpouseOfChiefCommercialOfficerMember_06924935-619c-4631-9b2e-d5699392424f" xlink:href="dmtk-20220630.xsd#dmtk_SpouseOfChiefCommercialOfficerMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RelatedPartyDomain_4d915b0a-fe7c-42a5-a0aa-055c22554d67" xlink:to="loc_dmtk_SpouseOfChiefCommercialOfficerMember_06924935-619c-4631-9b2e-d5699392424f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dmtk_BrotherOfChiefExecutiveOfficerMember_0a0343ce-5e85-44f3-b47b-df542695dbea" xlink:href="dmtk-20220630.xsd#dmtk_BrotherOfChiefExecutiveOfficerMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RelatedPartyDomain_4d915b0a-fe7c-42a5-a0aa-055c22554d67" xlink:to="loc_dmtk_BrotherOfChiefExecutiveOfficerMember_0a0343ce-5e85-44f3-b47b-df542695dbea" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeAxis_611ab9bc-5568-4c0e-ab98-c5006cbab4d1" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_RangeAxis"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfRelatedPartyTransactionsByRelatedPartyTable_7f938250-c13c-4013-98bc-28ebdd02fc95" xlink:to="loc_srt_RangeAxis_611ab9bc-5568-4c0e-ab98-c5006cbab4d1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeMember_d0ff829b-39bd-49c2-b539-7a9c0f0068ca" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_RangeMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_RangeAxis_611ab9bc-5568-4c0e-ab98-c5006cbab4d1" xlink:to="loc_srt_RangeMember_d0ff829b-39bd-49c2-b539-7a9c0f0068ca" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_MaximumMember_855ccdb9-b5c1-41dc-bf6f-430027c95931" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_MaximumMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_RangeMember_d0ff829b-39bd-49c2-b539-7a9c0f0068ca" xlink:to="loc_srt_MaximumMember_855ccdb9-b5c1-41dc-bf6f-430027c95931" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RelatedPartyTransactionLineItems_a45f0ba5-689c-41c9-b0fc-7f94dc2e3e4c" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RelatedPartyTransactionLineItems"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfRelatedPartyTransactionsByRelatedPartyTable_7f938250-c13c-4013-98bc-28ebdd02fc95" xlink:to="loc_us-gaap_RelatedPartyTransactionLineItems_a45f0ba5-689c-41c9-b0fc-7f94dc2e3e4c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RelatedPartyTransactionSellingGeneralAndAdministrativeExpensesFromTransactionsWithRelatedParty_a744e7f5-0208-4c77-99b4-065d18ab3988" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RelatedPartyTransactionSellingGeneralAndAdministrativeExpensesFromTransactionsWithRelatedParty"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RelatedPartyTransactionLineItems_a45f0ba5-689c-41c9-b0fc-7f94dc2e3e4c" xlink:to="loc_us-gaap_RelatedPartyTransactionSellingGeneralAndAdministrativeExpensesFromTransactionsWithRelatedParty_a744e7f5-0208-4c77-99b4-065d18ab3988" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockSharesIssued_eb0ac3de-a229-4203-a2d9-492bc43f549c" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CommonStockSharesIssued"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RelatedPartyTransactionLineItems_a45f0ba5-689c-41c9-b0fc-7f94dc2e3e4c" xlink:to="loc_us-gaap_CommonStockSharesIssued_eb0ac3de-a229-4203-a2d9-492bc43f549c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RelatedPartyTransactionExpensesFromTransactionsWithRelatedParty_1dc9c27c-4f4b-4cc5-b136-13e4b305e372" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RelatedPartyTransactionExpensesFromTransactionsWithRelatedParty"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RelatedPartyTransactionLineItems_a45f0ba5-689c-41c9-b0fc-7f94dc2e3e4c" xlink:to="loc_us-gaap_RelatedPartyTransactionExpensesFromTransactionsWithRelatedParty_1dc9c27c-4f4b-4cc5-b136-13e4b305e372" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://dermtech.com/role/SubsequentEvents" xlink:type="simple" xlink:href="dmtk-20220630.xsd#SubsequentEvents"/>
  <link:presentationLink xlink:role="http://dermtech.com/role/SubsequentEvents" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SubsequentEventsAbstract_df72ae88-cfa1-49ee-91ff-51decf0a09cc" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SubsequentEventsAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SubsequentEventsTextBlock_e4f5b7c4-3895-4cd3-a83b-4b3421605e0b" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SubsequentEventsTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SubsequentEventsAbstract_df72ae88-cfa1-49ee-91ff-51decf0a09cc" xlink:to="loc_us-gaap_SubsequentEventsTextBlock_e4f5b7c4-3895-4cd3-a83b-4b3421605e0b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
</link:linkbase>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>13
<FILENAME>image_0a.jpg
<TEXT>
begin 644 image_0a.jpg
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MU]75>?]15E8V:=*DKEV[8FF+GCU[/O'$$[B''>;M.O >)VIOMM-H6"**#_^
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MW+AQ\H]&WHY__O.?L8N=S.(U38\>/61]DO=W\MQSSV%U^\"]-1A0?>][W\.
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MV/<\I@$WUF @$^)PPXEB#OYI&-9%,5&GXI]R"PRH*BHJ,* :-&@09@2LUF!
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M'4-JUVX)6"1TZ]9MVK1I2Y<NW;AQX]Z]>^M;5%96KEV[MK2T=/CPX1AH,6#
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!@@$!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>14
<FILENAME>image_10a.jpg
<TEXT>
begin 644 image_10a.jpg
MB5!.1PT*&@H    -24A$4@   JH   )*" (   !KH_"_  "  $E$051X7NR=
M#7@35=KW _AM4*N(1#Y$LU56JX@5GX5'W:!K5[<NL"(BJ!'[ZA:6=:NHP;JB
MKGRHQ <MBQ98HU!1*Q!Q*2RU$-&"E$J (G1K$ J4$F@++3&44B:9ON=K)I-)
M4EKDL_G_KG/U2F;.G#DSG9S_.?<Y<]^&)@    #$&0;]!@    "T=2#_
M0-P!^0<   #B#L@_    $'= _@$  ("X _(/    Q!V0?P   "#N@/P#
M<0?D'P   (@[(/\   ! W!%%_H,SWR,I\/#0P/ 'Z=^''Z0?AC\4&#&4_J4?
M'@H\^G#@L1$T64<$'G\T\(25II&/!M+(A\?$5Y+H5Y(>#Z0]3C_3ORS]OY$T
MI;&_)#W)TQ.!I]0/)*4%_OS_E*3YG/ZD2*.>"HSZ<^ OZ33]=70@X^G ,R3]
M3?Q]5I<R F-9(A_H7N7S<\\$QCY#_]+TK/+WV<#S)(VE?U\82Y/M.9I>8'_'
M/<\2^_#B"X%,6S!S'/W[<F9P_-^#K[P<?/FEX"M_IVG*6W)5E?[^ @   *<:
MR#_D'YP2 G[/-PN=G,6N-67>AF#$]H5Y+O>6F@8Y=%2PP;OQZT5SL^UV>Y;#
M^?5&Y2B&Y'4O7NA<[/9*<I-\P//UOT4QK*@E)=6B'+G>NW'%HAQ21O;<I6NV
MU>XM_4HY88BE;N_A4,EAI9':EE;X)66?ML(,<J;:TJ^T6SB\8JRXAO*5])"%
MWWC\ :6<PU[W4N6\VL\1:"NS,'_EYEU^46S$43RG.(ONQI)K\*G7(++3F_OO
MG.RIY,[D+/K:75[+,AS#!0)P!A!%_@-_'DF2=*X!Z9>F'EWELBWZ^PL I<9E
M2S9H,%IL"SS^R.T&\Y#)A7N8JASVNMX::#9J=QH'3%BNJIW/93,9#*9,ER\H
M/FLR)DU<74_R2+M<DX:8M3N&C'GZ[K"LC&2;JR9467UIM%:37+N8.D94.&GR
MJO7_2@G;Q. 5(\A5KG']V::D47F5BF#R<OAYM9\CT%?&F#ARKH?VD2*."I8Y
M4DC6H0Y/0Y1Z&GH-G+1<$>R ?_/<47W#+](X.*O$%^7 HUX@ &<"T>2?#,&?
M&JE7,J1C2%=UE7^$_(.H:+1*VE?B>"J1R-@S2ZMES7;YX,Z%S_4B,C0\=Z<L
M']F6^T2BT9#XE*-DGT2'JKL*[4.,XBA69*3\ZP7IB#?OV412X,"IA=YZN4GR
M[UP]=_I23VV5U[M[J_-9>D2&<ZN7L$\94C,TI<D-^\M7SQQ):F(<9%^[7XX4
MW29:N;H]I)!29T8?@Z%/AK.4%EDC+ ;R_N7C>B7T&C+D7J,A851>E3A/*^5?
M5.;'N2/)';),+*J+<E04^><WMJ&V?.6,D:1NW>^QK_')I$.R]-E>Y(KN&[^H
MK(Y>>+"AQK-ZP4<+2P]&*;;I*!<(P!E!-/EO9O1_3L06OE%-D7OC.1'Y]_RD
MO[\ 4,)$)>AQT-%DBL,3C+6]WN,8833T'.0H/:(4P7242&A&7A73G:/*?W!+
MSN">BECJ"/I<F?0(F\NGWQ5>,H5W(XR]QBW?K^VOZ(FZ*[#?]7(O0_]QRU9]
M-MQL,*;E[FR,R!SU0(6PRO"<J5DEJN&D!?+/D+V+1I-.3*^77?M][-YVOR=K
M'360Z-$?V+)= )SNM$S^+[\D^-EG\N)%) 7?SY(ZGBNV7]DI.'V:G/>EO.A+
M\C?X]A2IZ^5Z"8SGU+,;Y!_$0*L<D6K:RYJ]S+UVQ6?CR BYS\B<TH:H2A,F
M;]'DWS@@?<(4.^4S=VT@0L6UM$K^(_LKW2WIK[(3O3O7O2^:/5^!6_ZIZ-;O
MS$TS&LS#<\M9_E;*?\*PB9_.RWEWC,78:^#D;YC](^*H9N5?LW=KWJ@DI0]Q
MN,:SP2W85$$7#;3R @$X0X@F_T]:20J3L2NOD&MJ^5[YAQ(IX0*Z\?*+Y?\L
M:9+%6AYYZU8IZ3J]_L5YHJ-_&/]!5+ARF))31U@?34TV&@R)Z3E1YOZ3ALU8
M[X^J;4TMD?_DU$>ME)%V5[4D[\P=;CQ!\L\NA)(^R>5M1AWEZJ7/)":PCDX3
MKP^;VM!ECG)@".VE#;68R<>^3^=L/A!E&J*%\E^V/B(;1UN9EEX@ &<*T>3_
M_UE)"I.Q*SO+^XC\TV=>WKA!NH3*?_"U5Q7M;VHZY ^D#-"+GS89SY&Z)$A7
M7")UOE@ZKYU^KYHZGDO[%B1=>)9^5]34\1SIHO.DB\ZEB7P^M_43$%=V"MS9
M+_![BW1M3^F"#OJ]L5(SEZ!-5V'T#V*A'5-.S9[[54DU7\''M]/IY(J2G/1$
MHW' E-6UZAA4NU:NJ:EQ0U;_A)#]/%+^=4HOA%.UMVMIE?S+C273^HM%"<U(
M8.0NJ2HO@]0X<>@+U"@Q\>E4LU&I3ROE7U0FX"MZJU^LFC0O_Z&[5\EV]1_G
M4M8AM+0RS>P"X'0GFORG/492F(P1^5='_YLW4'D>?+_L4UJ)AH9 QAB]\H6G
MP) _-=76RG6U\LX=4J>.D1EX"KXS5:ZIEBMW!4<\%+E7GSJ>*Q>MD?=6R54L
M[=TK;_E17O5-<.*KTN47Z3/K4J>+ YGCY%7?R?OW-TE24T"2#QZ4MVX)SGI?
MZG6U/K.:S%?)JU;*V\OE'>7!O"^EA OIQLLN"K[UENSQR.7;Y.^+I:NO#.7'
MW#^(22SET&[WE60-5N;[&YFIG$\0\)P!W]IW[J$K\!R>(VS34>5?+L\=3D;+
MV@4$P09_/5LXT!KYEW;F/=-/*2?6A31%N4:YDIK959N$E1L^(LN).%!+>&4T
M=@A_25:J]NK$VHBDR47U<D29AW?GO4"75=*[)U7GV^C2RR=RM_$[V=+*-+,+
M@-.=:/(?.?KO>H6\3ZP5DG]8'[C[3KEJ+_LB-QWT!Y]_YJBCX<###U'; 7T;
M^8#4*:8V!S_X@!;;T! <&5Z!J(G(_Y:MS"31)/L/RC_[A35"EH,+<IL;RO?L
M*J]>'3)=D _J9_)MCU>ZY[?Z0Y04&/A'N;&!78D<G/Z.U/&<8%964U"F&PX=
M"CSTI[#\,/Z#F,12#NUV^8C',<AH,/1[VUTOR[4K)PWH;C#T'C;QHP5.YX(Y
M$X;1Y?>IDU;7R/4E.9/?GV,?25?U<UMZ:()\ 7LG?2%]*;TI4+MZR@!2H+'_
MR"FS%SCGSYF2UO?V:26-<HODGY6V(&?Z>&M_^L;!R-F;0U/CB4,GSHEX_5U_
MC7)5WJ@$U=I/-_ +9!I<':&X4:?;PR]MP>PI(TEE>@[,WMB@WJ[$$1/G+,S+
MRWT_XQZZH(^M[0^KYX*<]\=;^]*<3SGHK %I<TISZ(L QL2AXS_()<7.M-%;
MK:U,BRX0@#.(:/)/_?/HY+^+O)_+ORQ7[I0]/_*<9.@<>'!P2PSU@6$/B4-\
M!YH9FH?D__%'(_?JTT7GR5NW\6(#MK%2CRN#"Q?QKTVDD]&ULSX_3^>U"W[T
M(9-\>C5R20EU3/3@D. 7_VXZ(D9$\J:-TC5=]0>JA[^?W11D8Z C1X*37V^J
M/\2.D8,SW]=W@WIVHQT4 *)05S31$FT1?OAVN2)O=++R59:\JV9DW*N\M6]*
M'OK*7/=>.G:O7Y=U#Y$K@['O4]EKF5(J6Q24]_Z;#GN+9MM2>XFMR</'?[Z)
MK2V0ZXLF)X6RA1-66J)E6,;$.2O*A<<>;J+0($;;3?IK$99_=:T?XTBI8U!/
M9H&OTF36E6E*<92%C!CZRCQK7[2I5O7\L_I?&0,2Q4[SO1DS5BE2K2W3:+8,
M)]?P=3GK&#!D_]:O'>/H9(3(DCPPX_UOJ4^%EE\@ &<2T>2?NNT+-_[ST7_H
M)RL(OOV&7AUCI,!P)O]$<^L.2)?%-OY_Z&B2 ZV1?R:N<E,@XR]'R%G^^M<F
MF;020?F@3^IATN?GB8S(:P_0FOS\<_#-B5+G2\A&<JQT?H? _7^0RSST,H-2
M\.,/I0MB=&NZ=@Y^DBL?8193Q6P@;U@O]>BBSTE7_HNN$@#'"5GR[_-ZO7OJ
MM-X B;;Z:W0OZS<'R;TGHH@V [NZ5MP-#>*%_F,Z%H SBFCR'SGW'QK]-\D'
MZN1]^\3GVOW!YS.D2]D4>+.)RC]32KFN[BCRW]0J^1>C_^ 7GP?_,5[>)K[*
M7Q?0Q8:1AY":W',/[\<$_^W43A <82DP>@R?I&C:NU?Z58_(PT6Z^/S@/Z<+
M[0\&Y1]^D&Z]29_G7&[\+^55 @   $X?6BS_ZMS_^K6!]*?H<CGVC8A?</)K
M>J-W1 H,'\;?&Z#RW\S2OP\_9/)?'QP97H&H22/_O"X4(L;;MTNWW:S/K*3
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MU4/H!R+_-]W2JQT;_1>OI_+?['6J9@.:9LQ\I_UY'8C\/_?2*^S^-'LH
M<$J)*O^9)-&1NL%@O/BBU<4E[[V7==;9'>CW=H9N5_?\IG"5T@/@AO?H'#G2
M^/QSH]JSH?_()T=)4D!BR*IC?X%>+'>4;[GYEE[\P+//.?N*+IV[7'G%^1?0
MW@!) X<\5-]P..+4="&>^F7CAC7G=Z3R3XW_4>0_)-O:K?NJ*H7\=Q+RWRQA
MA7PT^_T.YU/YSWQU K0?M EDJ6:+FZ-U'G!,R/Z*C:(LSJ8*'O,W)M6%]E$C
M,_-V_J+3 @!B$D7^7_M')DE\]-\QX>+OUVVJK_??:>G'.P3D[_6];ZS9OY_E
M;4[GB/P_]UPZ&:^3T?^=EKOF?O+QW$]SYGZ2\]^R_X9GU,OPOV9..^O<L_AT
M YM09^L/^#2$P7#)99U<WZZ.E']M(3^4%%_0\3RZ;+!#NW]FSRA8EO]5P=+2
MLC+-::+(__X:.OHG9[FDT^7%ZS9I=\5 )_]GM3NK7>9K$R+J!L"9"'>LJY#X
MB/W;2OT*G982]+DR61@?%<4K7TPJG%:SWL<P .#X$57^7R2)S_T;$RXN7OL#
MV?C==]]VO/A"\<MM9WC\R2</48<VS?7?CQPY_.PS3]*)?WY0![H(@*0I__=N
M>$;5%$\YTGC8\MO?\,['=3<DS?GXXT\^^XRDCS_]Q#* OIU/TAUWW_NS_G5\
M62NZ&]S?G7?AN;3+P.8+J-_BL]N/RAC;_+1%354E7?I'Y/^RR]>T:.X_A./#
MZ=SXG_GJZY!_T"9@\M]S?/XN;T5IOGUHHB%AM'/W$>K9MWR5T_%>]MRO2JH/
M-S4=]KKSEZS=4/SY[$_<.W>3SR5;MQ;.=SC^[?;ZJDN6.++G+"ZIDJ@GOETE
MCD<-AO[C\[=ZF5<^V;]MI=,Q+?N3?)*!GI&7/-/A7%7NWT[EO^=S.:YY,V;,
M*RSW-??3!0"TGBCR/VWZVR29KS7W-%]]_<TWE?SP(]E(A/.==Z=<DWA-SVNN
MONKJJWI>>\WTF3,5-66=@(A?IW2D<<*$%WM<<U6/GCVZ]NC6[:INW=C?&?_Z
M2.DW:&52=/(WK%MSS;57F;J;NG3K,L,Q6RO8RPJ67-'UBLN[=.[<]8HO_Y.O
M6;6G(KHCFS>N[7I5U\LZ=R+ITLLO3>ATZ:6=+AW[XM^CR7^HD-I]>_K_]K:+
M+KVDF]GLWJ@S432/G//QC(Z77VQ,Z/CJ&U/8EK ^#0!G($S^Q?A;/ECX:G?J
M8[_RR+;<)Q*[][4^\W1J+^. *:MKRZE.,\SVW%SELX&ZUT^F408)HM_ H_HJ
MX_XC6W*?Z&/L^^@+3P\T&U,GK:YNI"4;C<DI]R4G69W?JL52^KWMKL</"H#C
M213Y/\SP^7[V47YFZ_PIDB21[P=(HM3Y#_HB9O'#(%I[Z-"AVKHZDO;7UM(/
MC(;#:ABQH))"/VQRZII]^W@Z<H2_7B@(!*2JZFJ:JJH/'JQGV[AR<PM\J!#I
MR)$]>_=Z]^SA:;?72U*=SZ=F"(<?&PP& WOV[JFHK*ST>F/Y^HW%SW[_MAT[
MMNW8OK^N#L(/V@1:^>>.>\U6YW]IK)V$)[*_^9Y%W^TWOG ]U6G3T\[*@PT-
MK"O0_277@0,E6:D&P[ 9I3[6;^"2'R;_+#IP+VOV,C<KJ/OX)2M)R:87\O<'
MY(:J7?NV*$75E^<\$@HJ"  X3D21_VCH]$R5VU;I7$1FL4*^5>4T4Y-6%A+*
M'J.0HY373$V:ZQ4!<(:@E?_ _OP73#2>W@\N6[+!F)SZJ)4QUE'R@V:27IVP
MYTI/-5L3?T\K_WPU@"DY=00K9^1HQY>?IO?23/9'*4I;.0# +^38Y/\8.%ZB
M>%P*^>67TW2<"@'@M(7)?_>,G#5KB_)G95BZ&_I.**S]N31[D"'AJ9Q-N[S>
MRO*-FRL:=AZ3_//XO+U&YFR@<?C*-VVLJ*8E&X?8O_UQZ]J%L[]>N2"B*'T%
M 0"_@"CR'_S'JR0%TJR:]%CXUV-+CT9L.89T1M7D+^GR?R-?.P3@C. @M?,+
M3,G#)BWT'*#6K>IO)@]4HG\EON2J96OT^F25T$E")O_T<U3Y#U3G/6U4Y_[E
M/863ARC3^_ULKBJY>L6K [JSK\FC\[ZE\A]>E*Y^ (!?0A3Y#_1+)DDZUX#T
M2]-E'>6O7?K["\ 9@MQ0MX>.S;U[ZAK"C%V2KZ)TO;MT>[6?2'*PH:Y*R1#Z
M3(_EG^B:?[K.GQVH^<R_5Y2ZW:7EK* F>E3UEI*-'B_Y&JTH ,#Q(XK\RVN*
M:"HH"$]+E0__D0N^8FFILE'===3$#R0?\I4#\UGBI?%=1TW\6/[A*Z4$-47F
MCYKXL05*E=1CU?JH.=7/:N6;+T13VM<N>=\^_?T%    3C51Y#\&:M];^X%_
M;GFW7'<(_ZJF%J*KP'$L1/W:0G1''5M- #@=$5;YTPE]%0$ OP#\H@   ("X
M(ZK\J^/7EB^SYSEEYG@G<DS<0M3,M#3%J0!_K;_E ?34:O,#U8JU]G*TEZ >
MJ&YO":TZ(P   '#RB"K_%$EJ7+5ZQ8Q_O3?+,7/)TL4'PGWF2-*1U44K/_AP
M9O:L]_^=]^7^VK 9[D! 6KG2M31_"4N+5WZWTKMGC];C7L.A^N]6%RYS%10L
M^VK9\H(?-F^J/W2(Z7TH#RFDI,3]:>[<3W,_7?G=MW4'#JB[",% H+AX=>'*
M;[XM)&G%NO7N??OVL5,$=:);6;ECW?IU$G5>)+;OWU==M&8U26N*BW@J+B[:
M[?7RO:20'WY87ZV?LY?]?M]WJ[[]\M\+UJ[]WN_WZQP(>G=7_/33%G4C^;#%
M4]K0T*#- P   )PF1)%_HKLD/6?[:^>NG7]WW^_^^*=!YNNN[F?YW]HZ(<!$
M^__ZMR<[=[OB]_?_X8\/#+XNZ=KK>R=MV[Y#+:&^_N<;>_?J>DV/:Y-^;;X^
M\>KKKKZ\Z^4OCG]5==2_<^>V&V[ZU46=$LR]?G7U===T,EWVZYN25JY>HY80
M#$@OO_P<V=[/<OMM_6]+N/SBWK?V"3O%P9][7'WEY5=V[MJS6]=KNG6[IINI
MAREO:;Z:@4.Z%",>&7Q)Y\M*/5OY!I+^LWA!CU_U,%UUY4677G3NA>==WO6*
MSMV[3'U_AC@D&# G735C[N=J(0'IB*L@KV^_F\D5)27??)GILI[7FC]?\(6V
M!V"SC>G4O<L/I=1!<A/KG23=FKA.^0H   "<5D21_\5+G"1=T\N\ZKLU@4 @
M& SNWKWKC@']W__7!TSPY/GS/S;WNO:[-6OYWIJ:ZA&//73_ P\<D<2+N?7U
M_CZWWN0J_*ZAX?"AAD-DK/S,LZ,ON-BXY*ME/$/%SFW7WV >_;=GR:"_OO[0
M^G7%5W:__$_#'N;R?*C^X*0)F=VN[I&_W'7DR)'&QL:RLM+A(QZ\_T\/2)+P
M0$SDOWM/TY?_6>;S_7S ]W-M;>W?,D;=]?O[F+->;K&G0_#U:PL3KS=?]^MK
MWYJ:I6R728&D*U-34_/R2QG7]>F]8]?N??MK#RDC=2+_U_RZ1_:<SW@AA(4+
M/[VLVZ76]%&5WKVT,C^6C?G;G[N:>VS<7,8S$)ZW_85T,O[XX$/\)I#NR[6]
M>[HW_U<M!    #A]B"+_UI$/D31F[',A:[PL[]M/G?"3C\&@=/_ W[W^QA3M
MV'?GSI\Z7M;QIVUB='ZHWG]+WYN^+OR.10]H\/M_)O+?Z<HNI,<@\N^@\C_F
MV><D22+ZOL6SN5N/S@,?',;E^?OBE9=>?M$++[^J5("DP-:?RCI?>?GF'W\2
MISCH[]'SRGQ7X1$&Z45D9CY[WV#>!1'R7[5W]UTI_8991\Z=Z[CQUF3_06Y[
M$-4F"OW&Y!=OZ'O+SR)\@(#*__4]LG-R^60!J5_JX-_U'3!@]]YJ30?B\ CK
M QDOOJ3>!"+_8UZPW3[@-U/?RPX&21D!(O_K2LO44$8 G"2DVO*2=1LK_/RG
M*]5M+RG,7YB_VE/#8VT<J2MWN_+^G;_RQYK0^_>':SP;W.Y-%7[>O>9YEGR]
MT:MYVUZ6:K:X53PU4FVA?>23F7G;-9-M_'1?+7:YM]2TZD5]N<&S9)I];E%U
MJWXOO-J4DBW5+3M?H+;PG9$C7\_;J48> 2!.B2+_M_\VF:3_F_;/R'ET0D-#
M_0V]$^=]\:5V8WW]P:Y7=5[^S7?L&QF^'[BQ=Z\;>M_PFSMN(^FZI,3S.UXX
M;<:'1Y0X.CMW;/WU]==<<ZUYT) __N[W [KV[')5HGGILJ_9SN"7"S\[YX*S
M/OSX$^7L5/Y]!_:;$[L7?%W(2V"C_RZ]DV^^Z_<6DOK^IL\%%UV0O_P;OI<?
M.']>SCD=S_DB;ZEW]\[NUW3]9N5WO"B1(R!->3,SZ7](MT O_U>3T?_'G_&<
M!_V^I.3KTO[ZM!*IB-X3TB^9./FE(8\_'@B*^_.<;?3+;TTI+%S6M=?5A45K
M P$I\:8>;FH>"(M:!,")1):\J[+3;S?2X'O,"6_M<ELB#[IG,"0^F^=MJ'6]
ME"B^&Q-'+_+R/L)NYQ,)9(O9ZJP@W8?J;R<-$ ?U&9E3JBQ@83Z %8SI>=5>
MIU4]$27@WSQ[9.AT+[EJFPL('@YS"&@<YO"T9KD,<RBHT'W JRNJC]X#"(\Z
M"$ <$T7^APX?2-*+K[S"!M_T!TS&N&O7%2U;X2(? M(1R]W]I_YSNO:0ZJK*
MBSH9-_UW"QOL$OG_^>;DI'??>[_ M7R9:]F\!9_?>MO-M]UQ>T6E6%Y'Y?^&
M:U+NO_^S>9^3M.SKKRN]>P(!+J7!%:XE%UYTWIO47,_['U2S]^[99>K>^?L-
MFW@)W/C_C\E3%B[Z]Y=YBSZ<\]'-MR2]-NE-=>U=0&I\\*'4<RX\?_AC(YY,
M3[O"U.GIYVS*VD!V&C+ZGS0NZ7]N]=<?XEO$D73T?Y4R^I=)=^=_[KQE\(A'
M?J;& V&-" 8#8U\8]=BHT4'E?,\\GS[^+7M DIX:\_AUR;V_7U=RS?7=(/_@
MY'*P)&OXL(PG[E15V;]QX>>%GIUE^:_<P]1]9T/Y]RM+JQKJ-\X8V-U@RG3Y
M@DURE6M<_X3DY-Y<_H-ECA23<=C<;0T5>1E]1!X*D_^>X_-W43> -7ZI22?_
M]=_;^R48^K[HW+S3Z_VI:-[B$O_A.L_*13DSICGF?552)='>B7OQDG7E6U?F
M.N8L=.^NKRY9[)CI6%Q2+9%=*S^:^1^/O][KSE]2LG5KX;P9,^85EOOH#TRF
M&^=FO^?XO*"D6C-J9_+/:E3J?"99. :6?>4K%SJFS9B;O[&:FC>.A-<!\@^
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M0/O:*DV&7@,G?U,M\_Z$=A8@X-\\=U1?DSBHW_^0TX4,_CZ7C=H;\O<KN0$
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MSDI^[WTNFVFHP].@[*QQV?JG.,J"30T>1UJ:<T<+_T,GE%CR3X769'/Y>#_
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MF>4C(@_343K,TUW+B: BM@SI:UM0.B\MA=S)*BK_I%H5SC232<QB4Y$J8\:
M?Q;,RTBA3X7:_Q'V'MW7DT8,^1=7J/8+-?U$=8*'S2I)XG^OS' P4P%=4:+Y
MRF:8#*I]AEXJ?Z;ID\%6 +"^$LE-IUE"O<LZS<-'>P^LUS7"2F>#^'R5J GK
M+]/?@ZBALIY J3P  )Q,@DQ013-9X-$TB7S)%-4_JB7*6%9=QL3FN24Z$V\P
M#,UVC&?&]B9NE@^UD*&Y\R2K8Y.?S=R3_([B/*;3?F4OG\+W"=F.7&<=6G!@
MM1=X_+I*LG5=]/PAP:.*2YMG,06@J&.4*L6XP&@"P8P.D06&BXBFD\&N1;GD
MY3DGJK47H_QH,J2O;99S)E_-%_J_&VC_J29TA\EUC'WSC=0,MDJ BU1($_5?
M3Q8QY+^E1,X> 0   " 606K%X8O?HWP]>?P2^>?K\,.6D@(    @!FRF7QBM
M@Q%?3RJ_1/X!    <$8"^0<   #B#L@_    $'= _@$  ("X _(/    Q!V0
M?P   "#NB"7_D1'_N)<#U8_O,1#T>UP.&XM;H=\59[ ;(;P4*:$[^(L?8:XS
MPIUCZ'+&N)_</8CRCZ,>IL2+)8P4F[-,XXFTT5O,HC=%+5]_.@   &V'6/(?
M$?&/N6!DP8_XB_[,F253%.J 3QNNJLP7'JF)%TC*&9\R=JS5I(T%$)?X7+:4
M,39RNZ@;3GY[QSA+ES!W77M8^$3FI-/,/6YS_Z!FL[UX?UA.7XS[R2."U(@.
M'.T:4-=,K(O .A/:D!(B>E-Q ?5>&5F^]FMKXCD#   X[8DE__J(?TKD(EW,
M*!'M=S]U6:SZ*Z;>F#61FC3N&%FH'F@)CZC$))E'AG#YA%=MOW"D*$;_W'DX
MC7#I*-L:D3/:_0P%:ZASVU.5Z)Q*O*6P_$K'SD?]5)OM>?EAY9='.1T  ("V
M0BSYUT?\T[M<]GL*[,*G->TE:,-5U16'16K2* <+;* -)1"OJ)&UE ]*("76
M50J/^LSN/ \KJ<^IW$\6!H/>_4Q7V3SJ.YJAV/!):2G\O\".39OI&,LRI]G&
M]J,].1Z<-'O6&]KR:8@._>D   "T&6+(OS[B'QLIAN(L\5C./-Q?LJW@F[!P
M5;KH?Z%98]4<K6Z)5]0AM8C05<)&ZO-*::SH3%<=#W7U30$;?]=Q :9W5<U)
MQO1-4>\G_;_1>TZ'_O0?).(JL7\EFZ#1!$5D9@;K? ^-(::&Y5;*IR%)=*<#
M  #0=H@A__J(?U0JM#&C1! _,;[?'Q:N*CQ2DZ90KC<G-$+SF0$;4O/;J]PK
MRVLN;Z,:'HK'_%:"1X4O ^0Y*9'WD\>-9ENHZK.04SR6%/_OV'+<XEB*LD2#
MK=[0EQ]Y.@   &V'&/(/    @+8+Y!\   "(.R#_    0-P!^0<   #B#L@_
M    $'= _@$  ("X _(/    Q!VQY/\$A/S1>@:,\Q RITO('PISX< \!"#D
M#P  Q VQY/]$A/QAY5!'@?'M0_[T"?E#\!?;Z7]JJ,-3'UX3A/P! ("V3"SY
M/S$A?X0"C7%6QKDCN=,AY$\3S\,Z;2+P#T+^  ! G!!+_D]$R!]NRN8N9N.;
MTR+DSPM?%-@MEDR'?00-S4 #-B#D#P  Q LQY/_XA_P)^MU3H?V"TR+DCZ:'
M1SH#8]]\ R%_   @;H@A_\<]Y \W8G/B/NK/:1+RAZ&NZ$3('P  B"-BR#\
M    VBZ0?P   "#N@/P#    <0?D'P   (@[(/\   ! W 'Y!P   .(.R#\
M   0=\22_Q,0\B=8Z<I$R!_&Z1/R)W9-]%\!  "T(6+)_W$/^<,<TE&OM//U
M;NKCC=,GY$]S-4'('P  :,O$DO\3$O*'>;O#:++IM GYTQ2[)@CY P  ;9E8
M\G\B0OXT">?!\"%_6H3\86: 6#5!R!\  &C3Q)#_XQ[R1[B@KZ!#VU <H'CE
MM CYPXA>$X3\ 0" -DX,^3_N(7_4M0)A&^.4TR?D3\R:Z+\"  !H4\20?P
M  "T72#_    0-P!^0<   #B#L@_    $'= _@$  ("X _(/    Q!V0?P
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M(J%N*8]4"P  X'0G8L5 O,+'^L)2SNS!PO)Q4H6TZ9?)/P    #.2"#_
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M&09,PE+!XP(?/5Y39'P_-XL-Q:S9],)8S,J4,RZ^7PR4(3L-L\$C_FDV*OT
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M!" EY(^XY_PVLF-"\>%TH>!:-?4/^0<   !.-Q#R!P    #''<@_    $'=
M_@$  ("X _(/    Q!V0?P   "#N@/P#    <0?D'P   (@[(/\   ! W 'Y
M!P   .(.R#\    0=T#^ 0  @+@#\@\   #$'9!_    (.[0R[\2.A
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M<\"[_J0)DD[2-@$&_P$@!XA_  " @H/X!P  *#B(?P  @(*#^ <  "@XB'\
M (""@_@'   H.(A_  " @H/X!P  *#B(?P  @(*#^ <  "@XB'\  (""@_@'
M   H.(A_  " @H/X!P  *#B(?P  @(*#^ <  "@X]O@7    H/NSY;N-2S$
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M?^#&?0?&59!VP/T_&%1E^ENG R.])"-Y+]^P:\<RVI[HZU^Q8Y<VG'!7Y<C
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MLR(]$>$!X>[[!CS_J3XH,C,PDHY/W/F+!3MVL_$,[90(0R<[4> GW^YI'FD
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MOMO8B^VU 0  H!NRY;N-2S$   #<?A#_    !0?Q#P  4' 0_P    4'\0\
M %!P$/\    %!_$/  !0<!#_    !0?Q#P  4' 0_P    4'\0\  %!P$/\
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MS[FFN;W8M0(   #D.=<TMQ>[5@   ( \YYKF]F+7"@   )#G7-/<7NQ: 0
M /*<:YK;BUTK    0)YS37-[L6L%    R'.N:6XO=JT     ><XUS>W%KA7@
M.CM[9,/*]<M6KO]HUBN>OL_=G9FJALY:N^% TK1H<O_*/_9_Z)6I*_?&XYNG
MKCQN*@(  ,AP37-[L6L%N'[2B2U_O'_DHG66C.<NQG=MI0V"A_ZXX9LTFY/<
MMVBRYZ')[^Y/LHKJ@@,7;'4  /(>[<8,'+/^&/]BTZ23^S\9.F9]G/SW[*%E
MKXP?OE(O3Y\*KUZ_;/'R=Y<M'/J+Y?O-M<[N?W?DM&4G+IEF089KFMN+72O
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MHUFOW#]R4=V6M>9E.M,G-[S^-CL,:I9.'MC^T:S \%F?[C>6[$SNW[)VZIC
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M#P.P0O-*6$[K/7M=>SPXT13>EXE_VY)<UIFW"=<TMQ>[5H!<O?51B$SVN0
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M7-/<7NQ: 7)E7//?.'(!T.W8W]8 5\#^-KHI[#M1J%Q?"GNQ:P7(%>[X!P
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M.=<TMQ>[5@   ( \YYKF]F+7"@   )#G7-/<7NQ: 0   /*<:YK;BUTK
M0)YS37-[L6L%    R'.N:6XO=JT     ><XUS>W%KA4    @S[FFN;W8M0(
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MFHZIE6*)+WB<QJU0KD1;Z5 !S5VCIYX,D_@7J]58NU[[=-!7(GB5:(HV+*1
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M%\0_  ! P;''/Q\I!X"K9OM, 0#D(7Q5 0  %!S$/P  0,%!_ ,  !0<Q#\
M $#!0?P#   4',0_  ! P4'\ P  %!S$/P  0,%!_ ,  !0<Q#\  $#!0?P#
M   4',1_+@3A6B<  ( \@$#*A3/.<YT   #R  (I%\XXSW6ZX=KCX6 XWFZ?
M;8BKLJS&[7,! *"PW(1 NHTXXSS7Z89K5N6R0#AIGVU _ ,  .(_-\XXSW4R
M284#'GIW>-$[IWY;C2S2_U8JD41G.A;T>\D#2:Z0/(%P&UFN2HVG6 7RGW/Q
MT"RV=+&L[$F2[GYPHL36(_GKFT-\G55JK#G4U3H1_P  !0_QGPMGG.<ZF= T
M%_W!1"H1]'OD^9%D*AF9+Y?-"=7[1:DFG&R-*)6B,_XC:WT>ENC)/8I<J42C
MJEQ,@C^>YFOEO?^$<YWL85M,K181_P  !0_QGPMGG.<ZF= TITF<BJM5M,>N
M^>6;;_Z2A'ZJLS,=5;S.^-]>*V<6)BLXG(RJ/HGU\VG 'V;QWWJY=2+^ 0 *
M'N(_%\XXSW4RT>,_K??4>?^=/F2]?]93)Z'='E&\I;[@Z71,K11-O7\;NCHI
M$&ZR]OZSK1/Q#P!0\!#_N7#&>:Z3B1[_))WCVG%ZH5BN:8BG^$/]V'\J08\"
MD,Y]A5PAFH_]D^[^K%#\%"^EQ_5]:C1Y+JJ46X[]:^O$L7\  ,A _.?"&>>Y
M3CF)JS(?L@<  +BN<@RD N>,\URGG"#^ 0#@QL@QD K<)N%:)P  @#R 0,J%
M,\YSG0   /(  BD7SCC/=0(  ,@#"*1<..,\U\E%LRJ/4N.I=#R\,AQO-WX:
M<%W@<K\  *!S#20P<<9YKM,5H1<"TJ[W<QT#&_$/  "Z*PPD8)QQGNN4D0P'
MO%XEDHHJ7D'BU^D3?;/GD-Y_<R.[<+^G7"[W2!4RO:)?<:5Z1+NJ;V=;5"D7
M?<&$_I\S\88:N9A=!F!^))D@JRV52D7ZN%J-M=NO]J\]I$O7A.)I_<8#@E>)
MZAL  (#;'N(_%\XXSW7*8%?BDY=&@A,D22I3-M;[2KW*JB5T\+\MT_NG$=[&
MELQTW&ED9ZX&V!3T>=F]?Q(1I:I,^3P4D,1*-98^'?21N#^L7_Z/7^]O242[
M_%\J&:Z11'^P)13PE/B"ITT[!@  MS_$?RZ<<9[K9$(OOR]6^L963%$"96.G
M3/%ZV25[K?'/4C]S?4 N$?2)Y4IH)?V7WO*']]\965$#9;+:S$87R'\.\57I
M5_NOW:X_U.X@0$<:V T%  "@D"#^<^&,\UPG,S[PKG7!V7\2AZ\H_CM)S[Z4
MCO#3$?O3>N^?XZEOQ#_M_9NN]I^U]X_X!P H.(C_7#CC/-?)@B1W"3OH;OQ'
M/_.?GA# COUGCW]VX$ @Z1])TSL&:,?^V>'\:,@2_\U7<.P?\0\ 4' 0_[EP
MQGFN$P  0!Y (.7"&>>Y3@   'D @903X9HG  " 6P^!E!-GG.<Z 0  W'H(
MI)PXXSS7R23K9?CX]7ZO^@H\-_M4OE1<'<7.- 0 @.[$&DC@PAGGN4YN2)M
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MK:<"G+%N*\6&#<S'_LEBLT+Q)([] P#<WA#_.7#&>:Z3?8WNVK3#__;Y
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MGNO4G="<+U>B;;G?]R\O?U     FW2N1;C%GG.<Z=2O:K0AIY]Y\?V%WB'\
M@'S7S1+IUG+&>:X3  ! /D B 0  %!S$/P  0,%!_ ,  !0<Q#\  $#!0?P#
M   4',0_  ! P4'\ P  %!S$/P  0,%!_ ,  !0<Q#\  $#!^?\!#'!H=7(&
..JYH     245.1*Y"8((!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>15
<FILENAME>image_1a.jpg
<TEXT>
begin 644 image_1a.jpg
MB5!.1PT*&@H    -24A$4@  !0L   )Q" (   !JOW.]  "  $E$051X7NR=
M76Q=UYF>B0)%T^JJZ$UU5Q1$?5'D3A(*M!@T<HVV"#1$ 6M4%)E4Z5!3*YT,
MK 3$U(!_-#$H60,U3DRJ4NPX-FW]V HYD_A',0>&U234V#$M,TYFE&%*N68X
M5L:163#-D$"( +N?]SOGR\>UUMD\_#D2%3_/Q<'>WU[[7>NL_7/V>];::_54
M         %!5/6D         X$,)#AD       #@ W#(         !^ 0P8
M      #X !PR        P ?@D $        ^ (<,        \ $X9
M ( /P"$#        ?  .&0       . #<,@         'X!#!@       /@
M'#(       # !^"0 0       #X APP       #P 3AD        @ ]HZY![
M>MINBBPM+:4A:+'5*F=^?CX-W6RV5!5MM?K94I5343^-+-6DT9O'EBI,Q<FS
M&M1/,Y2GF2U5'FZ&S7"Q-[/5ZN?==]]-0YN-'8)IN!FD1V(E;6UP#P
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MQN!D-BBT!Z.@3&9LT57P[-8;RSH7-/[T3_\T6F)+.30TY*NKTF2)<<@
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M4A14"8NY1+N^W'JY.GG3.-]7DU19[@HFEGAJ:FI@8,!7.Z')$N.0 0
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M<M>CV4S%VMV+W;F@%SO))2FV!&6;K>H4K.IWDOO[^WUU33198APR      !
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M)*B.V2;B$94P$9RM6Y[=U0MUS"[F$GMZJX1)+@H^]MAC'AFK\=6UTF2)<<@
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M&.PVM6I-SI0(*I?BY$Q1T'+)!8O%UO1147!L;&QD9,17DW>2-TC9(3/;$P
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MH((RL1Z,N10%%4R*7124,5;*)'CLV#&M5O4P78:O;@HK3%3BJ;!8MQPX9
M  " 6PY_=.]IS?:TN+CH$3.6(R,C,5BU&HHO7KSHD:HU#Y,[4I%/F[1<S\.4
M"-KRV7JV)X]4K5P2P<2$BSR7HJ#FE$J*7114/<2@%?O,F3/GSY_W2/).\J;0
M9(FQ6        -VFH0VYM[?7EH>'AV,PMNZZ?96;39I\M=?,S(PWQJHA-\FE
MV.3;>1MRNUR*@I8L!ML))FW($OSB%[\X/3VM-%5=;_Y.\F;19(EQR
M -UFSYX]UZY=F\S>0UY<7%3_:HW@I:#>0Y9E]9[5LL<Q:,O1 \N(VKZRQTDN
M;EG=V;I(%)2(+*LOM\NE0="#[00]J&47C!9U;FYNY\Z=OKI9-%EB'#(
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MU6JVM91Y+AL1C&W($AQ=.197L0U9@O:5K1[>??==!9-WDC>7@B5.5G'(
M    W4,^:Z$UVY-LH6RGOX<L>ZR@^^%HC+6L]Y 5=,_I"\I%XC$7F=B%,--2
M,9<-"OJR6^BBH"^[WYZ;F[OSSCOU-:MZF*Z!@0$M;SH%2YRL]JPD)@
M ( -XCY+?MA]IC;).2>]E&4RW1Y[T)+%H-RF?*8GD_.,N50M^RKCZL$\EPT*
MSM8^/P:+@@J>;8W+/3$Q,3@XZ%O'QL:L0GQU<RE8XF0U!G'(        FTNS
M0W97V>R0W6H6@^LSM VY;$0P!IL%%30_;*[8MPX,#)AG]M7-I6")DU4<,@
M    0/>0SU);\>S*[LK[]^\W>VR?,3C9IO]S,3BYWD[1[7+9B& 2;!",P?[^
M_C@NU\Z=.^?GYWUU<RE8XG:K        L.EHNN/1;*2NR=80T&ZA1^MAJ^17
ME5+V5>1!><YJ[0-K;?I(74J9!-L))L'#AP\O+2TI8M[8'+*6NT&3)<8A P
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M8I\Z=>K>>^]M54\U,3$Q.#CHJUTE=<@-JP       +#IF'LTC_KUKW_=K.-
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M:O?FY^=W[MQIGU7M5&UYU2F75M5LP!SX;;?=EEABL^@C(R,A5==)'3*S/0$
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M.\32VUZVKRGT]?69VKHMI _3-3T][<&>>JZED.I&D#KD^$[VNK\>
M;&7,BTY-3<71JC>"64A3:^Z>W8"&Z8J6V*3,=:],=2-('7(<F@R'#
M %U%PW298X^66*W3(=4-(G7(T?3CD $      *"KC(^/[]JURS[CW,.V?..'
MZ:IRA]RP"@       +"Y# P,'#APP"RQF60/]O?WQW>2;QAM+?'$Q 0.&0
M     +K*'7?<<?+DR;Z^OF28KI#DQE%VR,SV!        #> [=NW?^<[WXGV
MTZQR?W]_2'+C*#AD9GL"      " &X /TS4P,.#!L;&Q^$[RC21UR,SV!
M     #<&#=-EEGAD9,2#FI\YI+IQI Z9V9X       #@QJ!ANNPS6N*^OKYU
M3ZV\05*'S&Q/        <&/0,%T[=^Z<GY]79&EIZ29:T=0A-ZP"
M;"+;MV]_^>67S2%[9&IJ*KZ3?(,I6V)S[?W]_3AD        Z!(:IFMB8B(9
MIBN^DWR#*3MD*Q\.&0       +J'ANDR/VRNV(/F1J>FID*J&TK!(0\-#9D]
MOKF=OP$      .#7&Q^F:WIZVH/QG>0;3^J0W1YK-6X%        V"PT3)<9
M3SE08VYN+KZ3?.-)';+;8ZW&K0        ";Q?;MVU]XX86^OCZ/3$Q,# X.
MAB0WFM0ANSW6:M@(        L#EHF*[Q\?%HB9-WDF\\J4/V9=Y#!@
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M47#(LL<3$Q,X9        -A<-$R7^6%SQ1Y,WDF^6:0.V>VQ5N-6
M@ VB8;H&!@:FIJ8\&-])OHFD#MGML5;C5@       ( -,E!C?G-I:4F1^?GY
M^$[R321UR+%=&X<,        F\NN7;M.G#C1U]?GD:FIJ:TP3%>5.^2&50
M     ( -LFW;MB>??')P<- CR3O)-Y&VEIB1N@       &!SF9F9,8<\-#0T
M/C[NP>2=Y)M(V2&;/6:V)P       -A<-$Q7?W__]/2T!^,[R3>7@D.6/9Z;
MF\,A P      P"8R,#!PZ-"A:#;->\9WDF\NJ4-V>ZS5N!4       !@(^S:
MM>OAAQ_N[^_WB)G0^$[RS25UR'$2*APR        ;"+;MFT[<>+$R,B(1X:&
MAK;(,%U5[I#C',TX9        -@L-$S7X.!@G&8X>2?YYI(ZY(95
M@'6C8;IBS^5JBQG/MI9X9&1D2Q44        ;FD&!@8^\YG/F$/VR/3T='PG
M^:93=LA#0T-62APR        ;!:[=NUZZ*&'S"=[9&QLS.QG2'*3*3ADV>.E
MI24<,@       &P6&J8KCLLU.#@X/CX>DMQD4H?L]EBK<2L       # ^M P
M70,# U-34Q[LZ^N+[R3?=%*'[/98JW$K        P/K0,%UF,^?GYQ79@CV7
M4X?L]EBK82,       # .AD8&#AX\&!?7Y]'IJ:FXCO)6X'4(?OR%G3S
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M=GNLU;@5        8*V8M?S,9SXS-37ED?[^_BTX3%>5.^0XMA@.&0
M #;"ZZ^_OGW[=G.7\_/SBBPM+6U9LYDZY(95        @#5Q\N3)W_B-WXCC
M<DU/3_?W]X<D6XBVEGAN;@Z'#        !OAP($#_^D__:?!P4&/C(V-C8R,
MA"1;B+)#9K8G        V#B[=NWZ]*<_'8?I,K<<7^_=4A0<,K,] 0
MP*9@OO*W?_NWX[A<YC?-=88D6XC4(3/;$P       &P*/DR71^;GY\URAB1;
MB]0A,]L3        ; HG3Y[\E__R7\9QN::FI@8&!D*2K47JD)GM"0
M #:% P<.]/7U#0T->62L)B396J0.N6$5        H'-V[=JU?__^V! [,# P
M-345DFPMVEKBD9$1'#(       "L&S.5__[?__LX+I=%YN?G0Y*M1=DA#PT-
M]??WXY !      !@?;S^^NO_^!__X^@KS2KW]?6%)%N.@D.6/5Y:6L(A P
M    P/HX>?+DO_@7_R*.RS4Q,3$X.!B2;#E2A^SV6*MQ*P       $"':)BN
MD9$1CYC?W,K#=%6Y0W9[K-6X%0       ""RO+R\L+"@Y<4:#^[:M>O@P8-Q
M7"[SF]/3T[ZZ!4D=LMMCK8:-         '_+T:-'/_G)3PX/#]]SSST]-?OV
M[1L9&?GXQS_NP4<???3==]_U7;:^QTP=<L,J     &P%7G_]=7M.Z^WM'1H:
MNN^^^_1@*IYYYIDT-0! =_C=W_W=LV?//OSPP_$N9,$S9\X\]-!#6CUX\*"G
MGYZ>[N_O#P);D;:6V&ZX<14  &"KH9_>/7OV//#  P,U1XX<>?#!!VWAV+%C
M'CQ^_'BR<,\]]]C/N2W<>^^]MHL';2];,(6BX&_^YF\>.'! 0=M10=NK$T$/
MFK*"ON] $#01#UII%8S%+@JJA$FQBX+)@B];8@\6!3W8><7FQ8Z54SQ2><4:
M9@73 W]3,?]IY1P?'T\WW%BL !_[V,?L\\*%"Z.CH[.SLXI;!5K5K4P+ - M
MCAX]:K=],\E^%UI>7K9;TRNOO&*WIH6%!5N.XW+9JME,7]V:E!TRLST! ,#6
M1[]3^_;M>_KII^4\M6"VZI%''M'RB1,GOOK5K\IKV8*MFG_0PD#MV2R9_)@%
M;2_YM*+@__R?_W/7KET*RLA9T/:RY69!4U#0%WQ?N4<75&DMZ M)L8N"LIU)
ML8N"']1"2]"W#M0F5L&B8 QZG>2"$DD$8[&]<@Q[G$H$\XJU?0\?/FSQ],#?
M5';5_-9O_=;P\+ M?.YSG[.GPQMOF%]ZZ:63)T]:OGK33R;9%D9&1O;LV9.F
M!H";A/[)%68F>WM[[<ZV?_]^16SAGKH?LGWNWKW;@X:EM/0>_,(7OK"[1NF%
M!%W$L 2>2[.@BF'!2Y<N>6EMV6XILS6*V%WEK;?>L@6)>"ZV>Q2\=NV:[D*R
MQY.3D[:+K5I0=RK/PMSRC;]AKI6"0V:V)P  N"70[Y1]VL_P^?/GO_:UK_E(
M(8;]0C_SS#,7+ERP'VQ%;,%\Q=C8F'Z\A=S%<\\]%X/M!&U?_2GNP>]^][N6
MTCX]4A2TH*E92G_LJ&I!2Y8(*A<KYZK%S@4;BIT(V@/*"R^\('_EP1=??-%J
M+!'\6DT2;%>QB6"QV%;"V-I0-1;;//-==]TU7L+*?[T+3$Q,I#FMY+;;;ANO
M'^]T@MEW,9.\??MV.P]MT]Z]>\TYO_;::_Y%NH35__'CQ[VV_7RPI\]MV[8-
MA(E5-I>[[[Y;W0P=>SX>JN&Y$2 G7A?YCXA^+Y*[L?^(Q*#MF]^-]2.2M]\F
M]_SBKY+M8CL^]MAC,9C_*DGPE5=>&1D9L8O=@_'VKN_8+A>[C?NX7+;Z\LLO
MS\S,_.(7O_ T6Y#4(3/;$P  W"KH=ZJGO4-.GD7THVXIX^^W!<ULY,XP%Y0S
M-!L93>!XR6KF@NT,;2)8M3&T1:M9%,R+G0M6:S'VYVL2P?P12A4;!8O%UC-9
MA\66__S8QSZF9EM;.'GRI#W/'3ERQ%;/=@U[$'SJJ:=^[_=^3_D:=]YYIP5M
MDX+V>.??Q:I"%3L_/V^GP8D3)VQ?^^SM[;64!PX<L#)WHZ/X-[_Y37/FONKG
MP[%CQS[YR4^:2;9\0_)-PV23\\&6[4A9T)^> <!)'')^SY^8F#AW[EQR\[0?
M$0M>O7K5@WZA);]*\2XD='M/?D3R7R4+VNWT;/9_95["M]]^VPJCEXH526[O
MBA=S>>^]]V*?ZJFIJ3?>>.,O__(OIVHL8E;9OM$O?_E+3[,52!TRLST! ,"M
M@GZG]N_?+[<V6W?HTM.#_6S+M?K"<NUFAX>'=^S889^'#Q_NJ0<ZTK(]W)L%
M4A<RT]&?Y;:JA9ZZEYJ6+;'MTEOC.GDP"OIR#.:"42<7C-D5!?WK>_F+@AZ,
M]> ZQ5QB/;B.![5+(E@LMNUB3V/%>L@/GY:3PV>K"[63MP7SGWH%UX-Z+',=
M%RD*^DFRN+@X7J/'.RM,(NC+>ACU7+3<3M >,>T)\IY[[CEUZI196?NF'__X
MQ^^]]][-,LPOU;VL]7CJ);QV[9J5RDRR%< JV9NRK7B:?"4^6VM&EN4P1XN"
MJFVE%]>O7Z_J?2T>SS0%E;65Y M?^(+O @#";HRZFNPVV.Z>;S<'VQ1OGA[4
M?=+OF2X2[ZBYH.[&"OI-.-YX/2B1_.;IMS4%WW__?;^3%V_OR2W:;Y[//ONL
M)5!5F!DV>_SJJZ_^JG;J--/3TQ;_P0]^\,X[[_STIS^-6V\6J4-FMB<  +A5
M,/OQPQ_^4/Y*$?V6JZ.L?MVKVK>\5&-!^T6O6FV_W_WN=_6+KF3Z7;___OOM
M<<'?Y)2@Y>*6( KZOL6@!+6O'A<\:$\#B:"7)R^V"ZK8]NUR02MV%-Q?_VN0
MUT.22U&P&"Q6K(+F*A/!I&(5?.655V)C1:R'W:VV1\\EJ9QBQ1X_?OS<N7-)
M,*_8HF"Q'LS3FN"1(T>B8'+X9FMC;+G$[]).4,56<'Y^_IO?_.;33S]]WWWW
MV1EKCUAJ87[FF6?4(KU6QELC=>G;7;ERI:=&#\$:.$>/T1Z\^^Z[E;4X>/"@
MK9J!CZ\U6O!$C2UX4(+V:8_=BN@$^ZN_^JM8.1:/5P0 &'8IZ2X4?ZKRFX9N
M.(HDP>0NI-N:!3N_"R7WR:M7KXZW;M$# P-F675;R^^3;[_]M@?MU].SB+=W
M,\D//OA@#,9BGS]_WKZXXG8;M#3?_O:WM9KP\Y__W.RQF60STK_\Y2_--L_-
MS=DN-Z4_=NJ0?=D*%%<!  "V&G*SG_C$)V+0G)CYG/???]\C]A,^-C9FO].+
MBXO^TV;+%GGAA1<\F:%G#GM0B+^ LD-F!CPB0<.]8KN@[25!CU2M7.PS!JTD
M*J%'BH+VO>S;V7?T2%42M/+G]5"5<BD*%H.YH!7LN>>>2X+%BK7'+"MANV+'
MVI:1]MHVOVJ/94\\\<233SZI%A)A!_UL_0:=[UB5ZJ&JO_*^??MNO_WV)%BL
MA_[^_H]\Y"-)+G::><3069<$O_SE+YO[=0-IV+)%SIPY$V<!]?/!7+%Y8WLV
M-9_\J4]]ZFS=?]M6.S?,]CQJ^]I7L&*KMGM:U:AZ2&J[W6EL.?HSL0>3LTZ"
M]HCO$<LK'C[''H5/GS[MSERH+2M&+('5C-JRFH-_]$=_]/CCC\=#7PS:\E-/
M/645&%*E@EYX@!N)G7MVA9[-?JK:W84Z^1'1?3*_UR6"NALW_XC85:,FW%PP
MN>?;%RG>WG6OLWM@N/A^=?,\>O2H6V)SOY;19-W.O&JW:C/,/_G)3ZQLZH]M
MSM2"2TM+J^ZX*90=LEGVG3MW<C<! ("M3-Z&K+^]KUZ]FO\7KG^^&]J0U3QX
M]]UWV[[V5.U!_R]<@MIWLB;YMSX)%O_^EV#2^!9+N*J@N<VDV!:TQY$H>/CP
MX>9Z:! L!K5O%%0)B\%BQ1:+K7KPVIYLM8VXH(;"+M;#-[[Q#3OTQX\?SP63
MQA;3_Z?_])^N6@]_\ =_8/9X:&BH^?#I:?7L:JTW5CQS]2=/GC1S:$='1K2=
MX,LOOWRV[AUMIG?;MFW_\3_^Q]_^[=]N-LSCK39DKVT]MOEI/-+JM-G3ZLJN
MH.RK=X^,G39C4/TS?5_["BYHN5CZT:P+@->#'SX%BZU823T4@WG%%H,ZZXI]
M*UR09UJX6738AJS3V-\<4;+B=:%KW.=2:A9,&J7SB\7N>!I70O]YQ5Q4;-^W
MN0W9NUOWK.RT\L033[C'_L$/?O!&S9MOOFF?:BM^[[WW8A?F(FZ,O3^V*?SU
M7_]UFF[S*#ADV6.K$>XF  "PE='OE#I\+I1>G4J"MFR_XHOU:Z+Z@=?C@BWK
MF4-/T@OUE#FS-?X(HF7[I;?T/C>&Q*.@!RVE/X+H*2<1]&!2PDX$8[$EJ&*[
MH'W-YGIH)^@B,1CWC?50#*K8><46BZUZ4&U/AM>&75!31N7UH%STT&DFN5W%
M*GC;;;?]PW_X#YOKX;__]_]NUO355U_5]VIW^/R[^'(NJ,.GX'++*N_=N]>*
M:H;?K7([P=EZW#)+=N# @<]][G-V*.VI[)YZWB_35$-*M?(]9%6L/9Y*Q*X(
M^RZWWW[[TT\_/38VIG9^=8;7\HLOOJB6)973%HI!6[7":U\KOYYZ+1<_9"JV
MGOLGZ[-.IMI=MSMM]][Q34A?+@:C2_?E/%A\G3X*JK;W[=NG>@.XP<3WD-O=
MA>)-0V?L9/9";W[3\%M<.\%X?TB"+OB__M?_>NJII_S&ZW<A*4=!N]"BH"W[
M0@S&8INA_=*7OJ1Z,*Y>O6IY5;7CE2O^V<]^)L]\^?)EO8?<21.QW9_?J(?[
M2C=L'JE#=GNLU;@5  !@2Z'?J9YZZ"!S%,6AI^.D1,:##SYX/AMR.<Z6(4U[
MPCY?$P7MUUUN(0I^-QL4NFJ-3?KVVV][9*$T*/1"/39I<1C25055;.\BJV*[
MH)K*1;$>BH+Y;$_+I3ZWQ7I0,';$32HV!I.>O5;;SV1CM$KPU*E3<>(B%3M6
MCD74F3FO6!<TN]A3OR+;KA[^X _^P-)H "W50_'P)=]%3Y/%P_?2RE%D)6CV
M^\B1(]NW;[>\[KKKKK,UN6!2#R9H^]IW-,.\:]<N^R*F\)N_^9OVW'G__?=[
MLN4P+*VE,2-M>?W;?_MO;4<+YA4;CU35RB4)JH_EYS__>2OP;;?=9H;<=.P!
MUZK1F_VK^B\J56P\Z_+:+IY@"Z4AV8O7Q63'0[)'0;\N/H1S1/<TDJ:&KN&U
MW=/F+I3?-'0:YQ=+?A=J$$Q^YE[*IAN0H''GG7>: 52PW5W((O;KZ1$)CM5C
M6?L7]&O<[P]V2XDW<+L'/OKHH[[JF%N^=NV:.E2_]]Y[O_C%+\PM_^A'/[)@
ML7G9C/2;;[[9U3&]4H?L]EBK<2L  ,"60K]3>NPX'Z8+4GRR-2F1]P)=KON#
M)9,SN<_1'^%Z?+0?>#-=<>;)Y?H/<@GZHX."Q:DLS5TDN=0S6:936:I/79)+
MAX(6M,<1+W84C ;&Z\&+7114T.O!]TVZR!J7+ETJUD/2ZR^I6 _&8HO#AP\G
ME>."9O >>. !!57"_/#9 YG9-N]N7=7%=L&9F1DS>.8JS3&.E68B_?2G/_V1
MCWS$AU?U>LA/DL3(J6+C ZN*G1BY7-"L^!_^X1_:CO;M;,&'MIZM6X]7%7SM
MM==LQZ]\Y2NG3Y\NUK8_OUG03F.K'*MA>TXUVUP\4G[6Q: ]$]N.#SWTT*E3
MIRQW!1=JAVR%/-P:G+:J#U]RH54M0YO7=G(^+)0<<GY=*)C40[N+)0JJ*FPY
M7A$?$AH>XQLVP:;CM:V?JN2Z*%[C?AHG-\_B7:@HF%P7RZ4IZV=;OTKGZWG4
M/5B\"YF@=TV*@O&&X]>XWQ]&1D8LC6^UN\K%BQ>UVHQY8'7)OGSYLGW^^,<_
MKFJ%A?H%9MMD\9___.?I;IM'ZI#CWX=</P  L)71[Y3>\EH(TP7I042/ K.M
M7J#ZF=<O=]RJ1P%MU>/(;&VZ;K_]]D<??52/Z=KJNRB7N(L+ZA%!SQ8Q%^U2
MW.K!=0CZ+O$K+X1.L/DN1<'F,A2#>1E4=7XLBA6;[V*?.D#%,AP[=LS<H&]M
M5P;O;JVM\9N:!=V[=^\G/_G)W_B-WUBN9_^*6]6YVO8MUH/GHN_B6Y,RQ&^J
M8+N*3791 _CO_,[OF(&W<JIIO5E00:^'6-MF K55)[E7CG'NW#FKG-[>7CNE
M7W[YY89C,5X/?OO9SW[6ZN2NN^Z:F9E)OHOELE"?8+Z+GIMG6Q=:K)RDMOU+
M:5\/^D+<MQAL5P_)+K[0TYJ;*KKW#PD-C_$-FV#3V;-GS[5KUZK6\!#QNM!I
MG)S;R6FLD]QO"^VNBW:7<[Q88G;Q_F +_^V__;?IZ6D/>G91T,N?".J&$Z]Q
M[X_]P ,/7+ER1?5P]>I5=:@V_N(O_D(C5*\Z3O72TM)?__5?_^QG/[/E'_WH
M1WJ!6:1)-Y74(3>L @  ;"F.'CWZRBNOC+3&&>IIC2KTT$,/^<N*'CQUZI1>
M5M2^]ONM\47UJ%%E#:&OO_ZZ>2>9Y+Q%<;2>Y4@/ 2[XXHLO^K.+!S?2?MN)
MH(K]Y2]_.0KNK@=2RIN=DZ;:JI2+!/,FB#Q8K(?9-DT0#>V6[E[R>A@8&#"3
MK&(GE9/4@TSRXX\_GM2V!?_D3_[DR2>?[*G['FM?"<H>JPFW73TDK<3%PZ>G
MR>0D69/@'__Q'S_UU%.WWWZ[6>4#!PY\][O?+0KF[?F3=>\)">K<7JX?3Y/:
M5BZ6\DM?^I)]Y5V[=IER?OA.GCSYX(,//O;88^;;VYTDRD4GF,X'[UR]O\T<
M8\E9IWJ8* VL5;PNDF"[>DAJ6_OZ+&@?PF=:?>7DBQ>#T%7\;AS;8"=K3WLA
M3)6G8/$T?J4T55YR7;SUUEO)Y5R5+A:_"^FZ4'"A?J_AC_[HCV+0;VN^;T_]
M/VPN:-_+?G-'6F_^]]1C_NF>;T$?.N'/__S/S=:^__[[/_[QC\TV__*7OWSW
MW7??:+V!;,&?__SGJ[Z$;&FN7[_^SCOO%'M?;R*%RT;,S<UQ_0  P%;&O,2Y
M<^?LMSD&[5?YS)DS[X?YA^S7^KGLW5<]$SRW\EW'M]]^.[Z-:=[IG_VS?W;Z
M]&D+7KUZU9,MEUZF+0K.ULW1]M 3@WKW-1&T)YO\K;,.!<U0F:6)+YCUU)W"
MDEP6-O8N=!XLUH.>JY)<DHH5WVV]^^K/&WD]F$-^X($'SM<C5R6YY/7PC6]\
MP[*. \,<.7+$#+;JX8X[[M ;<?K*O_,[O_,/_L$_\![.Q7K0)%5),*]8U8.E
M3&J[0T&?-LF6;9>]>_?:6?>5KWS%@M[WNZISJ5\)7_%.>*QMKT9=%[&VO6+M
MN=8>6*T>S(I_]*,?M7-;M:W(;;?=]OCCC^<5&[^+6RS5@QU$S[>G-,>8]DW.
MA_=+TXGE%5L,%NNA6-NQ8C^$S[1^I%8-0E?QB^5W?_=W/:C3N'BQ%$_C52\6
MW862^V3Q8M'=.+G&E8O]F+KSE&!TYO9%BH(?__C'D\O94BJ7^/*+F>$_^[,_
M\U41WT"V!#_YR4\L:&ZYW1O(QM_\S=]8@E6]] 8I7#85LST! ,"MP/[]^^WQ
MPCMT5?5?YN/CX_8@XO^%+[=Z?,VV^H]5K?_@9U<.1*P$R8#,]BA@NS_VV&/^
MO_YRJX-9AX(+I8%&XU#)+N@BZQ#<L6.'%[MJ=8=K-R!S<[&U7!Q/.Q\?-:F'
MV5;?O"0XNK)B)>A!==(KUH/98S/_>2[%>K#@Q8L7O;NUN5]3MB.H>K"GO6W;
MMGWA"U\8K3M7__V___?M<;"A'O1=-$E54CGYX1NO9[WRI\G.!?5=XB15$K24
M]]Y[KWW^U__Z7\WGVQ/D>%TYN:!R&6TUQ<_6O9V3TU@YJM@>M(K]_.<__ZE/
M?<K2WWGGG>.M5N6D8I/OHA;C>(+Y.X<*7@VS?\5]DV!Q.K%8L<6@GR0-)8P5
MZ[.@?0B?:=T,)_@FN#$</'A0I_%(Z^47OR2_&Z9&:W<:ZU^>T3 %5,-UX9=P
M#.;7A>X/2=#N0F?.G+&KV <LD*#?UM0RG%]]]KV2RUG=2<PSNT,VNVL&^*76
MB 9%W/1>N7)%KQ^_44_L]'[X$\&8F9EY\\TWN_H2<E5TR,SV!   MP3ZG2K^
M;,?G /_9]N< ?["H6D\;]@.?/%A\MS6-Y&NOO>;=K>WI?QV"'I1F?*Q/!!4L
MS@K;+-A3_[LOJ<DPVU-1L*'8L83%!ZQ8.4D]%*?35-;Y$YL'S77; U8BZ,4V
M%^>S/>6"52BV!]7=^MBQ8_:H9[O'>O@?_^-__+V_]_?^\W_^S^I<K6(4ZT&-
MO0JJV$GEQ,/GP=GP.-N)8#RF1<&_^(N_L+T&!@;L@)I//GGRI#V\YH+*Q;ZU
MLI953D[CI-CGSY^W*K)ZV+MWK]XZ-K<<6WJ52VY9K22F&4^PD?J=9&WR>BA6
M;!(LGF JX>Q*GQ K9[*]3_"@5VS/AWBVIZ(9+@:AJWAMJ[MU<HWGUX6".HV3
M/]V*%TOQ5RGY[4NNBZK]7>AL/9NZ\G+!LW4'F?S/:%U]&@;/+^?9UI $(V&8
M+G/(=LM]HWX#^<<__O&JKQ]7]2O*[[WWGOGA__-__D]5V^:IJ2G;_7O?^]X;
M]5S*Z0Z;2GK9,-L3 $!._<][6]+4<*-0Y?>TZ?IUM32K3>QXZ>1=0\VVG:_G
MAI6@WDE^[+''\JZA'0H:+[SP@FEJ8DSQ?JFOJ3TJF6 R#,FJ@JH*KX<X[TY1
ML%CLO(3%BE7E6&*/5'4/NEQ002N 1R28= 54)[U$4,7^RE>^$B<+R06KNMA)
MY=A!/WWZM#V?Q6)+L+^__^_\G;_CG:LM95YLO?7W]LJIL,;J^8'SPU?L$ID?
MOESPN7IJXECLHJ":INW1TV\X=]QQA^9PBH+&PP\_K,KQFU)R&@L[C<^<.?/%
M+WY1HULK^/+++]N^G_C$)_2*LH+JR9GD\N4O?]DT=^S8X1%-UI6<=<43+*_M
MX@FV4.IK6KQ8BB6,%XNJ8N'#.MN3?S8'H:MX;=M"\1K/KXNJ=-/0=9%<+,7K
MHOC;E_^(--R%'GGDD<'!07.D"NHN9'<83U:5KCX)^NW=[C#3T].^]4_^Y$^^
M__WOZVWDO_F;OS'/;%[7OO5/?O*33MY MO1FE37 M>V8;MYLTLN&V9X  '(:
M[H<-FZ#;^-/>9&GXD/%L="C]XVZ_KS&H?]PGPO!"VC<1?.VUUX:'AY]ZZJGX
M3W^'@E7[%MJ)TGA%22-D)X*J"J\'[_A:%"P6.R]A%$PJ-F]#EBW,ZT%9QUQ&
M5\[VM%QW@U<]>% EG*B'>CYV[-BJ@GGE:+J@7#"OA^0DT7=YI<WH4,GA2R8E
M\HH]N[(M/1?4=[%Z:!944,_*&@7'/.WCCS^NI]53ITY%P9&1$7W!V(;LAT^O
M'W_THQ\]<>)$<AI[Q7[M:U][X($'MM>HTT1>#TD;<E5WKE:QD[,N.1^*M9V?
M8 H6ZZ'=X<LKUL\'ORX.'3JD!!\>&GZ;&C;!IN.UK>Y.Q9M&AW>AY+96O"[\
MII$(QNLB!O.[D 3-Z_;U]9DQM!O+^?/GGW_^^7A;:[CZ_/9N7]S?);9-W_K6
MM[0LS!+_[__]O]4@K)>0WWWWW:H>BZO=&\A5O=52VH[IALWF5U=(3XF0$@#@
MPXONA\E=L1B$&XDY ?MM;C<%A7ZD]9N]4../$1[TA:IE$;5O4?"%%U[P[M:S
M*V?=:!;T!0_&%WI=1PMOO?56#'8H:,]>'EQNO7H=2YCDDA0[%XRY)/6@8OOR
M;'A1K5@/,1<M)()QLA OMG+1>\A)/>2"Q6(7!8OUX#KQN^2"*NUXZ_#%7!)!
MURD*>OF;!6-M2\=,L@O.S,SXF2]!&>/)NKOU^^$]P^GI:3MI+?''/O:Q\ZT9
M5CT7+TRL6$MO(I_ZU*?,5'_G.]^1CLH?WT-64&YYH=7=.JD'"19K.ZE8%2PY
M?$D]%&L[KU@/^G41V[<_)#3\-C5L@DW'+EN[JR_7M^7DW"Y>%[.EFT9R74RN
MO!L7+Q:_'/+K(EXLVF6\S:_2.^^\<^[<N2>>>**_O]^^B K6?/5)\$__]$_-
M8'LEO%$:IDO\XA>_L+W4DFRKYIDUI=.?__F?7[UZ-7G?6,-?__2G/XW!;I Z
MY+")ZP< X&\IFN%B$&XD1X\>'1L;.W'BQ'+K/VQ;>.FEERRHGWDQ6YKE:+:>
ME,B">FX0MI?M:PKM!-7=^O.?_[SM:+NO0[ J#0IMNT@P%GNA-/1T4=""3S[Y
M9 R:'WCQQ1<U3+$G\UR28ENR"Q<N)(+-]>#!9+#3JDT]*)<8C()^$:F$&G)9
M$1_+.JF'7+ J%3L7]&!2#Y-AVJ08+-:#I<QSR2OV;$TB^%PV65=1<#2;_4N/
MIU&PI^X]X8)>C0\^^* ]U-HQ-<T[[KC#XI_XQ">^_O6O)X>O>(+-AHO%'G-M
M=SOACQ\_[B7T^YY7CIM/L^BJ[:0>7-"#MF]RUBVW_H32T[:"Q7HHUG9>L0KZ
M=?$AO%'KP;X=:6KH&GK]>*P>]+'YIM'A74C717XYYQ?+;.ENG%\L?A=*?I6*
M@F?KP?.;KSX3M#3V?;6JAE_[]9R?GU_U_>&EI273F9N;^\N__,NWWGI+/;TM
MNQ_^\(=_]5=_]7X]6=2J7;(W#@X9 &!U=#\LWB2Y5=Y$[KWW7OL97M4AMW,"
MQ4>'HB-R0?N!_^?__)__NW_W[_*'F\X%BTZ@<VM1=,A///%$#.J9;"/6(B]V
ML6+S7-K50Q*,@GX1>3VX8)P/.7^4S'/)'R4300_FAT]/?LV"_BB9YU(4S/\^
M>&;E7$I%P>5LUJNJC4..@JK&Y;JIZLR9,R,C([???KM>-BX>ON()EE\L,S,S
MYI#M!/ORE[]L(G[?\\I)'/+YCO_H2<ZZ_)^C8CVTJ^VD8JN5U\6'^48=O_N'
MN1YN%G:!V&E\[MRY!Q]\T(/M3N,.[T(^>9LG*UXLLZ6[<7ZQ^/TA_BH5!74Y
MKWI;,[[RE:_8!:[EG_[TIU;4-VHN7[[\LY_]S((_^M&/?O*3GYA@)W;W__[?
M_VL.V79_\\TW_]__^W_IYBZ 0P8 6!U_*$SP37!3,,^PN+CH7=>62YV!%UK]
MP69+O4EC<#+KSY8(FJW=OGW[77?=)5/ARNL0C%NE,]E9]]1$T(.QE_5"W=]U
M=F/=4XO%+@K&8+MZ2(*)8$,O:[/'3S_]=%X/Q5R28A<%72<*SK:Z-;IR45"E
M'6_3*;HHZ NQ<IH%%?1B1\'8R[IJ3:GB@G8.V+[?^,8W[(JP9:M5.PW,M=JR
M16S5%^RN9?MJJV$+>LG9EWVK!2V]"VJA:M_+VNLAJ6W_[DG%)L'B=&*Q'MK5
M=E*Q+OAA[F7MQ!\I?K!N/(<.'1IOS?:47!?Y-3[;V5W(KXN&B\6OBWCUY1>+
M[ZN%8B[)U>=%+0JJV.:0KURYHAJ8F9DQ<WOUZE4SPQJ4ZQ>_^,5;;[WE;R#;
MLL9?;';+MM42NVQ7P2$# *Q.T0P7@W C4>7WUL.?O%2CQX6J]<20#&&BW_)D
MJ"<%\Z&>HN#KK[_^B4]\PIS XX\_'@7UQ/!&:82J9D$/GCIURAZ;9%IZ6A;E
M_OOO=W_BP8<??EC^1$'9E0<??-"#$GSQQ1='Z^DWE$RFZ*&''G(7U$Y0ILA2
M)KET4K$*MAL;)@]>N' A"@ZW&:G+!,T>/_#  TDP%\QK6_60"!:'>GICY<!:
MDVV&_E(]>%!?6;DT"^II,CE)V@DFM1T%=?BBX$@]I8H+GCAQPO:U(KWVVFL>
MS&L[/U+*I</QX=3,*U>LH)TD?M9%P>+5EPLF096PW>Q?Q=I.*M9W7_YPC]3E
MJ!+R9;@Q>)VK:\_&[T+)=5&\6(J_2ODPAXE@PUTHOS\4;VM^]<7_I+[__>^/
MMT;(C_@;R":N*9W44&P>N-B\_+.?_<RVOO/..S'8)7#(  "KH_MA\2;)K?(F
MXH>@.*M-<1H,/8@DTP6]4IH&PR*6\IY[[KGMMMNV;=MVX,"!;W_[V[G@#TNS
MVA0%QVIB">T)X/3ITTFP*#A1SZMQ]>K5&,PG9UI8XS0YB6!>;'O*R8M=%'S[
M[;?/E>8726I[>>5T(*(XVY/JX=2I4W&VIXDVTZ(DQ58]),76;$_%P_?&RLF9
M\NFC=/B2VBY.W%(4U%D7BUT4+)[&+AB?TR1X]]UW>S+;Y8DGGI"@4O;4_X]8
MT,ZQ'3MV>-#.9-OWH8<>\DA/_:*R!>^___X8?/CAA\^<.6-')P;;S?9D]1"?
MB8NUG1^IJE3;JH?B[%])Q18OEN(L:+' 'S94"?DRW!B\SFVA>%T4;QKY=5'\
M$=%=J'CS3*Z+_+>O*%B\"Q6OOORV5K6NOA_\X ?]_?T>G)J:^L8WOI&,N57$
M;MT^I9/MI7$KEY:6?OK3G]KGW-S<Y<N7S3RGNW4!'#( P.HTW \;-D&W4>6K
M#5G_6_L_[OK;VVQ;_'.]W?_HEL:\HH(]K7;7!Q]\\,B1(U_]ZE?-I#4+VM-#
M_',]$:Q:?\Q/UB0E/'SX< RV$RP&_5M'P=FZDUYS/2B!/5KE@DFQA^LQL5<5
M5+'?K\=/CKF,KJQMKX<K5ZYX<*'NG9M/'Z6O_/333Y\X<2(*%NLA%ELE+!9;
MA8FYZ DO%[3R),56L%@/'BP*^EEWMM5&5!14,#F-HV!L0RX*#M?S,(VW6F^\
MMF,]2# Y?+%R&BI60>7B;<@Z?+/U61>#>6VW$]2W3FJ[V"Q6K-CB^1#;D"5X
M\.!!)?@0@D.^N7B=JPUY(W>AY')6,.F 4[PN_*;1B6#QQ[1X]<6[4!6*?3X,
MTU75_VR^4;]";/Y6PU WS.<DU!];$[;;_<IVU #7]MF)T]XX.&0 @-71';(=
M:6JX49AG,%<F%U<%XQ&]GS\'Z!==#P>^'!\.%/SXQS\^WGHSMBJ9R:*@GB%F
M5[I3)<A]HPM.UH-4];2Z3!\X<, [5_L;H8=;;Y,F0>\+K64K=GQ\\:!WKI;M
M/USC^Q8%U=W:]E7Z_\_>MP=955WIWV0FDTQ(*O-(9H94)L8J"F(9G1J#5!XS
M-0.&Z(C$)"5#)F+95@!%T1$=$AD-:4$!8P\DX=%--]C=T W2TCZ01CJ).HDD
MT;XBHA&#(MHAR*AAJC,F5-EEU?E]V=_OK%EW[7W.O2ATPYR]_KAU[CK[?'N=
MM?=:>Z^S7[[8.7K0O2ZC;5\/F]-N'',) O*T)P.8HVT"ZER,V'R6N4C?+@C(
M'"FV9@;U $(WS@?4[\(<$2+Z@/[Z6Q^0):4!Z]S>70+(P+CL(M4KKKCBCCON
M6+ERY5Q'N,#?VV^_'>EON^TV<.;-F\<$U#"9<LWT2,.=TCC7'<SN[F[F4N_6
M(5,/,KE:,XVV_9(RUJ>UK?50SEX)*7K(*CY<CQT[EB!%=M3ZW8NLA^&B6;-F
MT2[X+2EYJUZ(=@&BO?N',Q'0MPO-Y+7OC0V@>"'?G'U OH(6&]YCV[9M!#]T
MZ)!$M@<.'/CM;W\+)L/=W;MW[]NW[[777JNZP37G8^]T5#6Z/B84(^1(D2)%
MBG2RTLR9,S=NW+ADR1+AH'GNZ>D!$]&%9OHS>_M#IQPAV.CL[-RQ8X=N 3DA
MN2K@0&B&,P#]N<<$?$SMV9N$)J 2T.QK&LP%@!!;2PCY@V+[<^J"@#EB5]4#
M<S',+$!TK;2V?4"&;7<ZJJH'#FCXN1BQ!T+;L08!448;W;%)1MM!/7!L5IC,
MQ10?](!D?BY=WA[./N"$"1,0J6I Z$T#BAH7+ER(E(B'&1Z3UJQ9@Y2:B0"X
MM;45-8?A,0G:YC[8#(])2-#1T='4U 0F<]$53/(-UCHJUM2ZH/51V[KX!ITY
MWQG:3;<6NP @]$#%%KE/J]^]R'H8+A*[F#%CAC"/U@L9N]@>.IP)'-]/^L82
M],9!+^0WID% !LE:[.G3I^_=NY?7<,L(GLW4Z#???/.___N_7WKI)4ZH9F*D
M >?PX<-9H\0'#Q[4PAQ7BA%RI$B1(D4Z66GQXL4(+/5^10/N(S>::OF8G:1?
MS='8RR?SQ'TUW^(=X8BGEBU;!B:B$3()B%QJ 42/7SZW)RG@0Z%=D<QI3P3<
MX>W+XA_&X^="0(BMG^5T/B-VV=N7A<S:Q:Y1#X:9 P@];%;:]@'GNO%/ZB%?
M;)'0S\47>X,[4B4?D&)W5QY*E /HUSI3? 1DZ&N8?GWP >OJZM:M6Z<!N;Y
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M0NBTI]YTF2C;<C++Z0(MLPY9NS4V^7B6Z>79WM#J5@)*;T.N?69P';*6D,&
M.$_&/+Q>M6J5/$OGR?!5 _+U]8)>^'G&2Y,F34+Z*ZZXXE.?^A1[.?V.M(2B
M!S)+Z3IDK0<C=HX>)!<!U,KQ]1!<ARP@8,Z;-P]!,G.1^"T+4,0F,PC(:P.8
MI1P#*&+K^E [H"]A$%!JW?[]^S4@ZX9^ESJW=U=_6HW9:6;1Z].>0&CK49<
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M6G0D)F?0G3\$5RG>F,QN1_K9_M!I3Q ;SYH65MR[. &1D%TE\JF'KLJ]B[,
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MM&3)$C3S"Q<N%(XP9\Z<*9P)Z?H?L9R26^< )AHY3K<F^8"XBSX'4HHIEE)
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M4.^7*RZ.@,9Y]GN3T^"<\P&UA/*L#UA*=W@>J-QHM-YM^1O<D#GHC74N<BV
M);>P;7.Z<ZD1.T>Q1@_B\Y-T:-%HF]=0#GXY8Y" O96[=E]TT47HWHD>$.UD
M[:?-!/YVQP@ID0NZDL($!SFRN!D/RRMHL;, 10\YVA9 @I@RU6)KQ1+0, DX
MX&9"0F:1,%B-DW3BY?GGGT]1F4M#0\.J5:OVNXW*"9A?Z\#GI/3#AP^+'NYP
M)+F(A"RIP702J;Q[UBM+CD8/S(7UH90.=N%Z0KJ[M6;JXA/+7>'(-^=RL4][
MXKOKWTA#27/FS#%V4=7ZC+%H+Y2$G$95P':W9KAT[ CA+H7IZ^O#W_>][WU<
M"+.WVH3J(T>.(,"&5[_4;7!]X847SIPY\].?_O3TZ=._]*4OG7KJJ11UV"E&
MR/]WB.>MZ2,Q2^FBM<<J#S>F16D+)-,_CU&8;(38_O5ZIR5O3H_3%.O5@-JD
MM83%K&#^6Y.C?W.H:H)(D0I%M(A1;IIQT#7Q,![Q0NRC//[XX])32=+>!H('
M!I^)"H0T()F<K2K/$M X3_91D)+/TGEF 1KGR6?-6<1D\K!*&0J@V'B<8DLN
MM7AC NIC9@5PX<*%^7K(46Q6(\(H3N=B]"#M%)FE]'!!'OBY9<L6R65S>B;S
M@P\^J $9^VFQ"2B[3!FFZ_+\_R *BC7UP2A'/RMBY[1]IH(%R]370]76F2$B
MG]6*Y;LP,$;Q,41$<&N*;_SX\1,G3LPJ/B/AHD6+ -C3TZ,5R^VR6%@KTL_E
M+"D"\DL' 8/UH;>RI(3YF#ISE3$P7\0H-BBV7U(Z%[&+(I_VQ&JC?R,-)8G.
M^4DK6(V#_L%W:T'_4$LC,GGRY.2XE?[*E2MA7V><<4;)C0S#P>+WZJNOQ@6"
MX?PMNPX<.("V$O:.\)BNK+6UU28:#OI?35$L=>MXZ3'2<2*4%]M+_ H'OZM7
MK^[JZN)1;*0!-^6IN_+0$=@2.X["2=(#*G!+J@>:KFYWZIH&_+4[\6+KUJW_
M^V0*" 3-A!F(A,6L8/Y;DZ-_<ZAJ@DB1"D5B.(/N+*6@:S)>:/[\^4%?AY23
M)DT23NV =+Q!P%^[8Y,H9! 0U^ 8YVD\.8E!%[VQ,/&@B$U^$##HC050,_%@
M9V?GL=4#W\6(;0#'CAW;Y19LLU5BXFG3IN'96VZY!9T_24FQT862\Y^22FV3
MJ =T$-%IDSE[HAP NC;M][D$M2UMGW#XK&DW@VU?4 _!7'P] #"G=1:9$Z58
M289;:.[7KU\/9>(:$7)267Q<5#QERI2<XB,@ERY#O4:Q<]WVT6UM;5UN6%Z>
M184AH"[EH![\DDK2:BQ,@  <+X+7T<F"8OO5>+#RT#**!&:13WO2Y:*O(PT-
MB<Y+[K0GWQL'_8-O+#3GVKV0\0_R>_R(RX\A(<+CTT\__=133QWG3@V8/7LV
MSW/*6H%,^M"'/H3$W+1HV*G"9HSBCK<>(QU;FN"VS4#G3SXXE=(Q9#:0LJH!
M?S=MVK31'11.#E=5W7OOO1O3D\1[W:87^ NTC6X! ^M#?7T]H/"X &YW!Y$S
MF0$D4P#)7+9LV5UWW<4ON_8="D#^6VNWY=\U5#5!I$B%(C&<<GJ64F\-0[[!
M(3ZDE&&QQ'W"-X#\6K]___[>:F.&_,:/GA"],87T 2EAUB"D>/(D>PQ9BUW*
M'4/V]; Y-(:,OTN6+,G70U"Q03U0VP^YK;/\H6\-B!R9"\4N98\AL_@ >/WU
MU_/T*2D^(R&ZC(CT&AH:^*Q63G<ZAIRC;;Z@'KW1$@J3R?3H#3NF0>7H7()Z
MZ$V/CS+%1T 90]:*]0%E#)E,77Q0U^C1HQ'B9A4?7QSA,=+[BN4^/2  2B5A
M\1%09@IDU0<#F*AJ+,S@&'*PU@6K,9ER:)E8WYPY<YB@@*1[#K$7,?0D.N=T
M)W[>"EJ?[X6,L=3BA8* LKT"_PX-P>% -OAP!,PE]]GNM--.P\7TZ=-;6EH0
M2YOTN/7>][[7,(>+*FS&*&Z(]1CI;1):IGXW=9EV!:O@,B&VE(L6+4)?8?SX
M\7+!K?#PEQ?<-T^N0>WIOGE(TZ[6(8]WU.CH_///QR_WS3. F@DTN8"$#)YK
MV3;@_Q[Y9D6._LVAJ@DB12H43:@\[8G=A=[<9</LQ#_SS#.X_K=_^[=;;KF%
MW^P2=78.@PT-^.O0^EM!3M*@I3^TA Q"RC)1]OY7J/6WI8SUEIP #(Y<T+VW
MI^N0I?=#L7, R11P#2C7]>D1.R4W7S=+#T'%!O4@%XGKV(G8HAQ>$Y#AEBAV
M0GI485*Y#ED J=@KKKCB\LLO%SUH0-"T:=/0!A%0D%E\76X=,G/1@ /N<"8-
MN+ER/;;@:$"^?CEC_:U1#L&S]$"F .IG!])UR#H72F@ 6=EXVI,6F[ET=W<C
M ??+]"7DN5;-S<U&#\1!;,QUR(/IDBN*7>\F5U-"_Y6E/OB (K_6@Z[&[&"P
MRV$Z%;J7(M=R(;T4@!!Y5"$/F"3IGD/L10P]<1TRK89.0^PBZ!^RC$6;,P%Y
MD2@OE 4(NR@=)56\P[$@3JA&;,P)U3#))4N60$+H!_S6UM92.OGE1" ;(1M2
M*2.=Z,3RXF^_VR6RJ:EI,/V FC@SZZX\= 1F@ZYA<+-3F"Z-DX3FJJ.C8]NV
M;=+&#+H-0KN\_5T)2(O5S*[T6!3*@P1+ERZ5-,4AWZPJ3,Z[:ZAJ@DB1"D7S
MYLWKKCSM*<LUT:WUN\^(AP\?_K,_^[/++KML0[IWL9Q%Y_M)7/3T]"!(V[]_
MOP"2&=R[V-^S%\X3WGA4>A  +B P\JUZ$ "ND8Q'+I&3I'M92U2?.+'QLEF
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M RX>+J<S,=":2DPK3+E@1Z0_G>-!BV(S+TS:;=E-KA[EIBHQZF9+5D[G>&C
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M<\XYW)TK7VP CG,!) &U<D //_PPQ0[J09@BH7XV1P]L3(W81]4ZU[M-UX*
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M?BP2%G/;C"RSRN(;JC%9I$@%(7\,60;??%_'C^L<0Q8_R0]Y]'7!L5/M)X.
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M)*:79T'<Q($='?&H_6H=LH#[@&3*I&)>CQT[UN2":\971@_]U9:):CV0:?3
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MK) ZOS$59_S*5[XB?]>L6;,T%?F"_"L,4:7G9H+%7SU2U]7YA?DR7^9408W
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MF':]4D 8 0@C%=9FG6LTG X1T F[+LW?HTE2R#JY[E_7OC+=J78];0JHQDI
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MQQAZ!TC#!X:#BE8(7Q!AMZ;JK SE>"JLG[PN71,B9$T[<R0'J+3UM\1Z074
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MM!6B.NA!KYW@!R\6<,^>/3)(=CKT*]*XDS8 :VCC7#VN!)P.X7.TJ9><#C6
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MXK? *+^H(([E0(5U'"AM"DAICPH(M7$*C#E =TH]H-)68A30TM93*@'I+Z6
M^-2=4@.84YL"ZJ?VE/*G:J2_E)Z2HTT!58?]:?<1_;27;C\I8"$6:BQ_ZL)7
M^'0DVK/7@1K+G[KP%3Y5Z>RG9=IZ0&DKH-/!A@^O./9#&CLOED-_.'QHC5>U
M&^DIAQI Q<&!$T>.O_WM;S_TT$.28&O6K)'A1$YM]TO5"PXP3U5P%J4ERMPI
M#E!I6T YON666]:EE3[.I,<=D;;^4JN#,T;:3@=;E:P.8I%QE(S2.P%CQ'.
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M)=H*= (.PFY/2*/8948=8E[": '/GS]_\\TW]]/ ?L8CY$@;.M@1<L/>KJ&
M4)OJ0,-'\R&&3]]S )\!&R%3M:.PU#B5WL2@M"U@T[[O06G7 +IZT; T!N#1
MX87XH0--8P=X)>UPX'2(:3S-7E.A^1 !&_:26$X'&SZ47#XXP(:IC:R+7J+:
MJ!<T?%;8@MHQ?!&PD,91APB8"Y\3-E[L(GQ1V+'03D; 9M:T:W1HF-H(WUAH
M-(Z%]Z#0"MEZT60 QT*]H+0I8*1-ZX4,%Q50FT2:QC'K5%@-GXZ0G=KU@+0Z
M'TKEB2>>4"/5@6:=:X6D-__TIS\M@T_YIJM]46T .B^HSJ M: L6+!# IYYZ
MRM$&H$OC'&V:==(1Y-)81\@YP)P.$9!F700<"[6O/NNN;>U#DM!KH1D#1H;4
M2'6@7F+S3@&G6/-^[MPY"1^E;4?(-'S3F<8SYD/L^Q30T8Z-!FB?''[G$PP[
MNWL*2"M:9-BPSI0"3K'.%)&*:1S#%Y.$ N:R+JH= 7/Y0 $CP]CW*6#L3*,X
MT4M.;4>[:5<BZ&PT*@%IDE# 2F&IL5YM2AM&^>$?__C'Y=^E2Y<*E'XJ_TZV
M"UO,D?+_1LCH G69LNGTR+[?/KX7R_///S\YO)K?=!HK]MM)T0B)'B/,, [,
M]!*]:0'P.%VY/SR#(@>(XP@X'29$J1<':&E30#V.@-&+TT'/I48K[".//'(T
MS3**@'K0R\^RCK051V=9.[4+.NBQ!;2TG9>XY*/J8+WTAU<NQ;&;96V]%(2E
M1CVV#".@TJY/8P<(M2.@36, JA<'J" Y0-!^QRQUJ(!4;0H($*N#!01M-7;J
M "]46#5&0!7'JJV T0MT<("%\.'<3K4I;0=(A:4,'6 Y? Y0#ZR1,HQ&*NR,
M:=?HH$8J+/42 :=-.UD&')@TIK0+@%0'!X@WAP&(=Y(5O%_,.B<LO* UE@;6
MZC 2(*4M@.O7KZ?B**#^KIP.SDNL?0",C4:D;1N-?_[G?]ZZ=>N^??MB)P*U
M]=P<;:>#TEZR9(D".K4?>. !&2'G ,LZ6$#5 3\Y!XAC:U3P&B]*N\9+): >
M7"M RY :J0X%+S;!** >]T."44"AO365Z50F4XEM?C\TGC$?\ 6;Q@[0T580
MI=U/10&580XP,HP5S=%V#%4<V^930&5(PP>0&K75"P748T<[JAT!E78-8&0(
M(]5!J9;%H5ZBVHZV&K$2V.P!:9+D &N$I<91U7:TU2A_L<.37*M?O7H5[N*_
M<Z'\_R-D-SRV!6&X$#;L@D6C!>-KPSNA(=AT#0R[> #B>O;LV5-F;@",;C4"
M!=2LI8!-HGTV%>?% 8(V!<1O4=H1T!J=#@!\^^VWG=$!0MCCQX^O6+'B)S_Y
M"04$[=Q*79&VU:&7WN^2GL:&KZ!##!_5P7D!(,T'>%$C ->N70M ?9A,O5!A
M+[.]M1QM,(R 2G+4-%9 JW8$U#2V24(!!RR- 7@E;,S@ *G:%# *BW-QNC,6
M='#AB\*.MX&V@/U4G XN'Z@X$1!&)6D!D0_.&-6FM!U@IPX1L"9\#I : ?CR
MRR];AI$V%98"EFG7Z."\4$!JC(#42,\=I#2.QG'6O%/:45@%U.U5!^F=Y*@#
MO#@C;87.IY6Z^NU^=3#&YOW8L6/2;A\X<" "YFA+%RR8NW;MHN+ &+,NZD!;
MH9K.-.H 0,Q(.GCPH/5"FW>W;9+2=N)8VKVTYT(,GWQ?/&)EQPA8HP,L3H><
ML)8AC#/+NGHOE8!6[6L""(:T,Z57:YU><"[U$MN'<5;1'."B18ODNH6FL:-=
MR(?8&E/ 0J.AQLBP !@9QHH6A04@O#AC#4,:ODJU;8*5PU=0.P+6Y$/400%C
M^"A@09R"%ZNVH]U/18VS!X1%C64=:H1U# OBY+Q$VE9MZ=V.'CTJ_W[ZTY_&
MB5+D.PL7+M1_YTCY:0=?&!ZCG#Y]>FQL[-UWWU7+.VFM^=/MWH\HTC6B(;!&
MM NOA7T4C@XO0"_@XL+-9H&7YX97<@>@\Q(!I].*]I2V T124MKRB]1" 6%T
MM"D@C$X'$1"T)2,_][G/R2"9 KZ3W^VIK ,NX';NW%FC0R%\5H?&T%8+PD?S
MP1DMH,YUC%YR.E32QO282)OJ0&E3P!@^!P@=G)$"5J8Q!:1J4\"<L-0+U8'6
MOB@L]>+"1_.!BA,!8:3A<Y.1*&".=HVP!<#*9LT!4B,%C+2IL!2P0+M3!^J%
M E)C!*1&>FY-LX82 :D."JBMC91[[KF'ZE"C-FA+H]J8%BPV[]*K8H;S+;?<
M8F=FG0R=B*.-0?+CCS\>=:!)DM.!JDVK<PR?T^&[W_VNC%2E#XJUCZK=F<;-
M,&W(2,-W__WW1X8CZ4##1P$=P]ED7;V72D#:]UUSP)F%#X7F ]4A)AB,%E!2
M8LF2)3&-*6V:#S%\M%Y0VM#!>9'O'#MVK!*0,NS,A_K>F3*DX:M1N\GH0,-'
MU8Z E'8!L+/V44!*FW8BT0MMC6F;/QM T*YOA3J%I0RI. 4OCK9<1%FU[[KK
M+FGSY6N;-V_6KVW<N''ERI7Z[QPIO<[A<>XVQBQO.%V^?-G=QJ W6JY<N6+O
MB^!V#F+<">AH%P!SM,N ,-;?</K1\,WU_O##V$<???2..^YXYIEG'"!HKUZ]
M>NO6K67:40?Z#)GJ4 Z? JJ7"UVW.0%('S)T/D.FPMJL4X8%VM?VOND1MIT8
M!:0WE2F@2V.E70:D:A< 8_C&A_?5H( V?#6 46W0IH!EM7. 5.TS;(.*J#:E
M30&I#A$0:EO 7/@<(#4JPYKP.6$I8(XV!70ZP$C#YP"I,0?HC/1<&#N;=PI8
MT & HSY#!F _%4?[_/ S9 AKFW?I5=>M6W?@P('SZ2U-;"D)P!K:NW;MP@I;
M5AR:=3D=7*-AU58O"NC4=CJ\^.*+TH/("#D"YM2V#&NR;M1GR*/JX!C6UXO9
M9%V]ETK >.DR8T 8:?/NKE)&\G(-FW?Z##E'.^8#:,?6N #H:..>N*4-ANJE
M$U#/??OMMV-%RPD[7MT[.X8T?)5J Y!ZB6D<U8Z !=H1,.J0"U\AC9V72K5=
M^*SQF@#:).G4H498&!T@%2?G)=)^Z:67QH>S#N\0_?W?__V##SZ([TA9MFR9
M#)+UWSE2>C7#8ZB&XW>OW4L+^,([X1V#R5'>Z,@!.MJ=@#G:.4"K@QJE#RL#
MJK&?6BX8%5"N!C9OWOSZZZ]'VG(-(7U&@7;403Z*[R%3'6K"AV/K!3\AAD\!
M8=1C!>D5WT.V@%8<-2K#3MHJLJ-- 0LZJ-J=@##2-*: >CP8IIT#M+1I&E-
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M):IMQ7&T:P C0_M;"H!.''RJ./9'Y<1QM-5H)T67:9<!<4HE8(VP+GPX*.M
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M[\477XRM$-6A/NMB@CFU[8T&![AY\^98^V*2C*1#9!@!FPK:*+/Q,DO > U
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M5A.^2+O)J!VSCJI-\Z$RZRC#^O!%0*CM:%-Q(NV"VC0?.@&;O+"4]HS3..I
MO=#>^<$''Q3C^O7K[;I<*U>NE$&R^=8<*CWYY1_]Z$>E,?K !S[P6[_U6[JB
MMTCY_///VQL,4^FNPW/A)>]Q]BHY7=CC/'NE/KZCC[!98[]]-]UY<2^L*^ 1
M\]SU[;??CH"1-AC6O %/&4; IKU%%[U0'5X+MW..A)4 <-/(WN:$D>KPVO S
MY)S:E':-#N5\B,:)=H.*7CNY>M.F3>/FCB:,#G DVF>&]YL9B395&X".H?-2
M#^ATR &J#C:-RX UX7. .=I46$<;QAH=J+$,6!:' N9H4V%I/L0$*ZCM&#I
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M97TK$'6@V4^%C5YB_:3&J,//;H0<[T=$P)@D ,2"KDT[0LXE"6JL XQ>*&T
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M[<I6R#',T09.%)8".AV 4P9TM &HX!8P1[O&RS6G30&ID0+J\6QTL,9^FP9
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M &/TLK]=J2OF@WK!N<Z+)EBL%Y&V [1>RK3+PM8 QC0NU LU%@#!,.K@A*6
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M$):&CPI+O>"XL_;ELBX"_HQH4T!*VP)2(Z5= *0Z]$V".=JH%ZM6K5+:\ )
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M$/.! @K4X<.'8=2W 2?8 O0QZV@^4"]1G/JL0QH[+_6 40<*>(&M6TB7G8R
M-'P4$/4B>HG"'@G++5*U:3[0\,5Z00&C.#G F ^%\,TX'Z+:-,&HVE%8"IC3
M(0)&':@7F@_1B^:#:]:B%RIL!&R8L/6 U#A2^**P,8TU?#JSNFG;R<[P%0!W
M[-@Q;69KCT0[9EU.!Z<V:-N514&; E+:-'PQZRAM*@ZE;76@@)0V33!:^Z*P
M-'Q46.JELO;ELBX"7G/:%)#2CH#42&E30*I#3#!+6U\'B%DWG5D$.-8+6OMH
MO<C1CFF<$W;&@+EZ06G3>A%UB D6 6/XJ+"Y\$6UJ3A4[<HTIK3KTSA'NU.'
M)@T.3X:EIW. CC;5@29)3@<J; WM6>H0U:8,8QJ#]J%#A]YZZZVE2Y=.MCOM
M25F\>+']=PZ6GDA0'B1#^A,G3N#&AAI/I**1FTZW(DZ?/JWW,)H4R_&P"YG&
MT@+*L:2+WMA0XZGAW9X Z"9EP2C?=%[$*-G@O+@,!NWGPE(31]*+"C6 5 <'
M"(84\'Q8"8#JX(P4<"HM1F>-TD4-TK(9D7:-#KGP11UR^>  8=RY<R>,Z$<U
M?!0PTHZ E'94&UE7%A: )]G6A3E 2KL,"&,4]DC8NC "-OGP.4#0/AEVGHSA
MZV?V0J2UCWIQM/NA7L!(PT?5SNG@O-#PT58H%S[+,*I-$XRJ386-@$U>AQIA
MJ9>8#VJ,.KAVDGJ)PL)( 6,K5 \XF_!185T:V_#I?LA3J9VL"5\.4'X=9I#J
M/;YZVK'1B#K\]W__MUS$'$EE/%5AU!%QNF7+%KL?,@"CVC2-:?AR64?5=EY<
MUA5TB("4-JT7E<T[#1_-.NHEIX,%S&4=!;R&M"D@I4T!J3%'NT:'?D@P&)4V
MZ@6FL$4O9\-&LLB'V)G2VE?3F=*LRPD;&58":CXX<2AM6B^B#E38FMZ9"DO#
MIVKGP@<+5;L^C7/AJTGC'&TJCM,!1C="+@.Z\%$=G)><#K19JZ$]>QV<VI1A
M+HV/'S^^9\^>?IK7>?7J5=B;-(*P__Y_[)W/CQSG<?[W8" '70+D1"! +@+X
M#]C,-2'"DX#( <)<(B \B+8!!4AB@TZ$!!8!P;0$$+$AT:9^)1))<4DN=PV;
M(E=:)9%L@X9-MA%;-F)9-DEXH"2 (1%8&Y .>^GOZRY/N::>IZIK9E;Y'K1]
M6,S63'_JF:?J?7NZIZ?[0[C\^OTG.\E2\LGT"N92)QD/V\,BG235E6>[Z1?]
M=I5N>CH!!;:_+[WTTHZY'+E;Q:5+-+A5G#"GP3ZKJ^BS5$/R3B.@E8U &]0'
M=!4-)L\>.7)D9;B'9/L4U;9/<IJ3WI)D+A\$B*N@#_A.Z;,:7!DN RO"\E66
MT4#?*7W6:9"@*"P"(PT4:&4C<($W18$JS&I0H%M%@@JD;MMW&EGG@)%LJT&"
MN$KBPZYHP'YP62(-U&WZ+ )'5\G?5+Z*OBF:Q0&3+*@A!])5ZL!HE21+I$&"
MZH.S3O9I914YXQJ!5(,#RBK1U$J%:1:<--"'MGO\E:]\12;PIK/)/C@L[8%.
M[PZ8:["RG761AOHJ"VO 55PZ^ZS3, %C<15\4PNLLJ2&!58I:J"KT&=I,%\E
MU]!!<7&5UJ@[PR__HRSR0)_%<:&KZ+-V%=50D:VK),^BPE&@KF)EJS GFUJ'
M/E!C'3 OGP4ZV6HL;OOR=^ID1SZX+(D/=)5(@UN%RM9G;7 NH%RN.5K%98DT
MX#M%ZZCLY7V0H&J@Z1S0:MC<W&RCM>UC_^,__F,_7=H+VKZA_OOA7'Y]J(_N
M)#<W7WWU51V3$EF'*_M+,#IJXH)79@\YR[KTT!H>F\&C)AB4PE>.S4@GX;&9
MXK$Z :)L!*)L!$J0'O3"(T"7X8[DG;G;DY[U)UGH%QT5'T0VE@]]J/2##D()
MBI[V^.S9LU@^"D39%JC!R&WL.C169-M@%Q_\HT"4C4"4C<#$!QP76+YNV@\:
MS,>%#0H0L]!^T*Z3" 5&LL6'W.W$A\JA5@1*D)8O.BW% FG7"1"-I;(C'RK&
M.J"ZC?V 6:BQ- LU=A38Q[(K0.IV4CYJK V*#P[8/K4+L)M>O+!G0)5-@2I;
M3\_!\D6RL>O0G#:W/_?<<[)[_+6O?>VMM]YJ6^%+ERY=O'CQX8<?7IDN"*2R
MU5A:ODK74;=IUXV6CP)IDTS8N(BZK@*D74>S1#XL/)R7E[V+LQ#-$@&I#[3!
M<#BW<='TN),=7!;M!QP7T7"V6;I@8TIETP]7."[JP&A<4-D.*/V /B"0^C#:
M=0*DLE]C-R[%\J$Y*COW0;.@[&(;1[*I.>@#GI*Y,)#Z,(F'<W$VIK*7] '=
M3O81).+*]^233[9_'WOLL;:5T;5.G#@1?77ZX5E^\T$!=Y*;:]+66LM^^AM@
M]VN*5ET\4?[BL&C9>C-.+/#Z<*L ^G.=V^9V(-OLS'L:O#/<X:!U@\U"S^]W
M/=V;WG*RVQM!(/ZJA/J "BFP@SWD/O#A,NPAB]MBK'[RDRSZ8SE9BCX</'CP
MW+ES+[[X8GN@Z[;/ERW2@.VCFP:/'CUZ_OSY-JXTTIYMKVFOE*\[-/CLL\]:
M8#_(;A%:/MH/__F?_ZD1D8T_(*%NTZYSQDKYT&WZ Q($1N,"LVR8NU[)0H&)
M#PZ(Y1/9&[-W.(C&!6:1C2B./G1;NTZ#%!C)OL!^@5_O!]?&=/2U70L$HMOT
MT@8(I%U'AW,B&WVH&$N!.)S[N'S.AW?9[1\H$&53()5=!%*W:3]0MZ\/&Y$?
M_O"'&J'CHDT^VL8R!?4!$-M8@2I[);C$0R0;NP[;^.<___G33S_=9M3V,:7M
M8[0AW$^!;:H\??JTSJ@42&7C+"3EH[)IUZ';./K0;>H#!6*3"! 58M=%Y2MV
M'<T2^;#P<%Y8MI3OXJ[.0C0+ JD/V&!]X$/[#-""G_C$)VP0LR2S<3[Z)(@;
MTTAV>\ON5ZDX+JA""J1M++,0E8WC GV(@':KU+/IG<JFT[NX_=KL38EH^= <
MD5T9SMAUU <J.W%[M.OZ\F5]BL#(!SJ<L8WK@V4N'UY]]=6\240A[3H*E/+=
M?__];[WUUJ%#A]I>L;Z@_=LV.OKOAW/Y[<5+9"=9KP*R,WPIWTV_H.^'/EB?
M7D=:#GCL#,<A.G:QM6Y8]-B&]-"$72O/W5-*7F OMJ9P$2! &I3']*)S]!IQ
MJJH%WWGG'7F,0.>#R+97Y$M\* +E,0:I#S2+75>SZ/EX*]-S\T9]V!X. ./E
MKU&V!$=]L%D4*"]H>]%BILUB@=2'!#@9%@ND74>!+FB-S8&2$<<%S=(-2P4X
MEP^V?"(C FI09- L;09'H$"<VS9+ D39DH4"G3EW9N^C8($2I%V7](, 5;:\
M "^/[X"TZ_1QY#:5G0"IL0G0#F<-8OF<#Q)T/B1 *SL!.ME%('7; C6+9G19
MUMGHZV!<M&E-@NO3WR0G0.NV[5@%TML$1+)QC%L?)(N>7/VI3WVJ!=>&FZ8*
M\)EGGOG2E[XDLE>&@Y44&,G&\JD/*%N!\@(!)K(CMZD/$3#:*J%"&]3':&R]
MZVB6R(>%@0O(5J!"HBP4F,BF6:ALIS "H@_)1=>M['PVM@JW9D>? D55+GMK
M^I8EJ$"47?'!&FNS4-D"Q(VIE3T*E'7UO5 ?4#8:FV],+= %K0^Y;!M,?$AD
M2Y8$2&5K,/I0,2\P]\'*UO=ELXA1Q2SS^N"RV":Q"NEL3($OO_RR7'S^S_[L
MSV[>O"EJV[)OWS[[[X=S^>T><C_L).M1:@V*K7?@ID0WV V[?OK3GZ[/[NZN
MP^W1!'C#W&]-UNV&14LH07H'L-%[C6I_BT@!2M#)EDZB6? ^8VW%'_WH1RX+
M]:$.M IID )I$"NU,IR/MS7<>5A/>:*RK0_M8Y\T0"+;9J% 4=@F+)=EW91/
MLG33)G% V@\YT :CKJ- %T1C(V T+F@6E5T$SN6#EL]FH< M=K=#EX4"J=NR
MUBB0NAT!G3D)D'9=-/H<<(N5SQE+@PK4=?O8;2J; M&'"I &;?F<#W@L8(O-
MDU3V*+!G RT!4K>CT:<^V"P:I/U@?="[/4V&LZ-'@2+;#6<!-MER=V4[3Z(/
M(AO'.,Y"__$?_R&[QX</'W[__?>WAQ.XVDYR>ZJ]\F,?^U@+MG6;[+_]V[^E
MP%RV-=::0V5OL:ZCLA.WT8<<:&7G"B48E<\!NV%QLG=Q]-6!<\FFTQK-0H&C
MLFD6*EL5YD"K<&OVQMV1[,IL'(T^"^Q@/T&"6\Q8N3NN!A-C*1"-E2Q4M@7B
MQE1D1^/" 2>P>X,^H&QK;&5CZK;.$JP/9S2'^C J6[)0()6-YBP)K/@@6:+I
MO9ZE6\@'ER522&=C!+8]Y'_]UW_]YC>_V;8O\K*VW+IUR^X&?F@7;X&8XJS!
MLQ?>'<[BN'KUJGG5;X+N+ XY+>3-V7-%VHKT= AW:FAKE]7A]O$:Z=DID6V1
M.Z&WUVMD9S@)IWW(>.^]]S38'K>(DRU EP6!/?.! JEL"FPK.H4T2($TZ!3*
MP8ZGGW[ZW+ES'_WH1_5E5+;X\&__]F^REBR?^]SG6O"!!QZPP2]^\8OGSY^_
M[[[[--+@+45+9%ZUTE[07M9>;(/R":_]E7\EM30)EL_U VVPI!^PZYRQ G0G
MGT3&(A#[08 5V47@O#Y@%@JD09>% JG;.)PID+I-@6A. JR//@>\ F=Z4V-I
MD [GR&TJNV)L$4B# AR=/&5=-RXHD!J+P)X-- JD/M LT@\X>=+RT6FM$72V
M:8M,:Z- F2>=[-O#=SAM6NO-AI+Z@&W<,W-:QC9//O_\\[)[+,'+ER^O#K-Q
MVSU^^^VW)=B2K@Z3IZ[;EV6+L<MT'<J.W!XM'P4F6R6GD(X^-+;>=31+Y,/"
MP*)LZ@/-0H%%V30+E8T-1H&B4*9W&1?M;R+;9MF)9V.714:? ^*YIGUL+&WC
M2ODB8ZEL:JS+$HT+!Y3/QFZ[27U V6+L*MRX-"^?!HNS,2T?;;"B[#YVV\FF
MYBP#K/N ;=S/.5B6\<$%J4(!8OG<NHW6-D#ME7_YEW^IP>;J@0,']-\/[?*;
M#?QO]V"FB[Y"CFU<-[^ WQD.8[3(NCDD9H/N,,9KLS\E[X:C4!8HP<WA&NL*
MI,=%)/B]V<OJZ.$<E\4=+Q2%].BL]#H>'\(LZ ,%.MD4J ><G \N2($TB HM
M,/\.68 R]SW^^.,6N)@/M!^2\LDKL7R+ 65><$!GK "EZT:-Q3:.?'!M3&47
M@?V</DCY1OMA?;@Q0YZ% JG; L0L5#9UFY8/)PT*=+-04C[,XGR@QM*@K#LZ
M+OHQV:,^5( TJ,!*^63=/ LU-@)NL6G- 1,?L'SB@\OBS$GZ0=KXR)$C"J3?
M(5,@E:WC0C:4U ?I.FQC9XX GWKJ*?EM2P,>.W;LY,F39\^>;0]:<&MZ.TH!
MMIWD,\/U%Q58D2T*J=LHVP%[UB2)VZ[KHO)1(-TJ4858/F>L!&GYEO=A8>"H
M;.H#S4*!<\FNN(T-E@!U>I=Q(;]$0-GUV9AN3.E6J3C01+8+ULN'/E#9=%Q$
M6V<GVP$EZ+:;B0\H>Y5=Y"POGP569N.H?+2-B[(E2RY;@E3V8D!1^/KKKR,0
M?< VEO(5L^QBUU&%"J1=9X%?_O*7+PX7+=)/_FTY>O1HVP#IOQ_:Y;=[R#-1
M<R$3+5@W3#KOF1^Q2 VZZ27F;7 R+%H;*>KV\%,9!]R!R[)WP6_2;%"%687Z
M6($BS,E6M0XH:BG0!M$'"K0^(% 54A\T^"[[%<1H%@I,?H<L$ E^YSO?6=X'
MV@]6=@1TYBP&U*[3(!HKLB5(@?K8 E6ADTV!D>PBT):OXH,$%1X!)2B<* L%
M6G,4KL"*; DZV0Y(S8F U@>5+>OJ8PNT69P/.*U-9N^R8('ZEA%8\<$!(Q\J
M0/NL!ATP+Y]=-\I"C<V!N6Q]$ 'UL?-!LSASL'PJ6X+J@P#Q=\@4F,B6'P.W
MO]0'3>=D.W,T2]N7:)](VLO:]/N#'_S@PH4+[=^V%9:KBXEL2;<R7%%B+MG6
M!^JVE>V 6#[-0MU6()V%VN.V;@YTLA.%^AB-1=E=H>MHEET')K*I#S0+!2X@
M6Q]3V1TT6 *4H'#T;D\HNSX;6Z"3K1PK6]6J0F>L!%T6IY#Z$!E+95N@&NMD
M.Z#*=D#)(@]4V*@/5K8\2X'*L<]2'_0QE:U!ZH/+4I1MLT2R[;-4]KQ 2Z9
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M:!__^,=5=ML'?O+))_MA-O[S/__S2Y<N"7!ENB0^T/*-NEWO.CI8</2I.0L
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MA>A#!:CO96'9J\/U_"*@K*OF5&8A5&B#3J'U82[9F$5DTTU543:Z[8!4]EQ
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M6VU/4/_=6V19B7:/6\O>N'%#>[$W!SFT=?IIP?#G["VXN;DI%=)@*XD6M3=
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M>-ZZ=4OB_7!EQ+MW[^J_>XLL(WO(_5"2T6_M9;D-MTWJV6D _?2DBSNSMW]
MX+OLI(L(B*=#H&P!5DZ'D)-/6GMI9(>=:RI!)UN C: 1#59D([ NFP*OP)E[
M%'A[.,CG@G):B*U4'V1!V108R7;]0(&T'^K J!\<D+8QGHS4,Q^DC1&(/D@;
MCYX[)$ Z^NBX0"#ZL!&<2T9ETRS6!S'69:'#F?I RX==EY0/VQC+)SZXX8Q
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M@%NU60AE2S#Q0=;5H 5&LAW0R1:%&J3;OE'9D0_=HL/99DED4W/R+ BDE:)
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MFKV/ JV49$F&,_I ^\%E$:#-XF13('6;&BO!9<KG9(\":=#Y@%F<#[@N#29
MD>V H]/:J \*C'QP004J1($NBSYVLBO N637V]@%J=L"=%DLT,K>8L/9 2/9
MS@?-8H&C/EC9"AR5+4"4C4 LWU:AZP28R!9@V[]JC\^<.=/6/34L*!M]H+)5
M8>(#;I6<0AJD/M@L%KA5*)^^!0OL8%PD/D@69VP]"\[&-$LW+"Z+ N77X\>/
M'X]\&'5[M'S6!Y7M%"HD\4&!F@5]D.!64+[$!Y6MLY#-LL6,E2RC0)2-YEAC
M*[*3K;.L2WVPP0H0R[?%?'"RK0^:A0)I$!4NWW5.-E68 +'!-.A\4(@"B[+M
MMJ_]_<(7OO#""R]\[G.?DXS]<'ODHT>/ZK]["RXK=^_>I3O);0K[R4]^@IV'
M R:JJZV6UG5K6+!1'% .L=A@6ZL5V_7$C<)]YQ2HZRI05I=U$]F5&Y=)$&]<
MYK)8V=;85;@/(0)[YH-D<4#)TJ8#EP5E1T J&X$H6X!VXM @NNW*1Q6J#WD_
M4& DNPZD_4"!;KY+RE?<.Y5U%=C%XP*!B6P-"C#J![I!I4#[EFD_N"S:8-%P
M=D#,(C[HNI+% >>237UP61(@#=+A3'W @>;ZH0CLXX%&%19]V(J-=4$Z"[DV
M3LIGVS@!SB6[WL8N2-V.1I^N*Y_[<5K#<9'+=CXXV0(L^N#<3KJ.CCXZG*/R
M*9#*3OH!9;>U'GWT4;G3I *I;/2!RMYBQE+9Z,,Z?#[6?D ?, OM!Y0M0-I@
M#DB-=6ULC9TWB^T'FD6!'4SO$CQUZE1;O94O\2%Q&X%;S%CQP<EV"I.NB\:%
M TH6E4W+%_D@LMTLI.\:C;59$B#*QB :6Y%-@:+PQS_^,?HP@8\N%: MGZY+
MRR=9<#BOL_)UP2$M5$B'<]%M*ILJ' 7:!G/!>AM'65S7/?_\\Q<N7'C\\<?M
M=;D.'3IT^O1I_7=OP>77)\/0G>2VL5];6[MZ]:H-RMSZYNQ)%_3<@(UAD1Z2
M97LX#< %*5#.XL @/8O# 5N[K [W8==(/P6VIVRPO;7V!MO;U B538%4MMQ:
MW681H,LBLJFQ+@L">^8#K91D<><64MD(3&13H),M)Y_<,9>Y[YG;(KO2#^+#
MJ&P*I+*+0-H/%"BRW3DSM'S-!Y=%Q@4]"<=EH>,B E+9>)87 B6++=^\/F _
MN"P[[%PR.BYN#\>J:?E&Q\6\LJD/.)P=D+I=G#1TH"'05:H([-E H[+G\H$:
MZ\[RHK.0R*Z4#]N8 N>276_CBMMTTD"WZ2Q$QT4DF[KM@'1<1$#:QG1ZKVR5
M$-@S'ZALV@]4=@.>/W_^OOON6YDN]]Y[[PLOO'#NW+F/?O2C&FPO:"_[XA>_
M*/]:(,JFQM+RX2QT <ZQI&V,66@_T/)%#49E5]I8?*"R1[,(D&9QLG%Z;\O3
M3S_=7MFJHQ'J W6;]@,:*S[04X6=0MIU6#X!NBQT>J?EHSY$LQ =?;1\"$0?
M<&-*C2W*ID#J@^R^CLJFP*2-Z?R PQG+AZ=,TRQT.*/L/G ;@71[@<;V#"C&
M+MS&D6S7=:T?7GSQQ:]^]:O[]NV[>?.FQN^YYYY;MV[IOWL++K_9J.!.<O/T
MK;?>PL,8WV-W.7IM]O?E;957AD77E>#F</N''"BCS@'E8,EUN!( !;[)CM9?
M'RXA9A5N#;]B5Z $G6P*C&3K*]$')UO$H ^KYL@N!48^N..%-DM%M@7V8[(1
M:&5K/SB@BK1 ZC8JE-DGETV!5'81V+-^H$!]RPC$?J!9I(T1Z/H!QT4.=+*C
M+$ZV9%G8AZ@?T)QKUZ[1!G-9T(=U,';Y\D7]8(,(E&!E%J)9<J!;MPC<FAUH
M$ES>!P=<9S=N<;.0 ''TZ7NQLET6"IQ+=KV-*VX+<-1M ;HLJA#'!<IV/O2Q
M;#<N<J"3+4 GVXT^*CL".A\D2'VHE,_V0]LQEKW?X\>/?WE83ITZ)<'VMSU^
M[+''SIPY<^3($=E#SF53A<X'VG5T!AN=A6@_T/)%#9;(KK0QRJYDL4"7A98/
MMTJM(NV5>F)\X@.=-*(V=CZLLUF(*G1!6CX%NBS4!SKZJ-O1+$3=SL<%]4&"
MN#&-VK@BN^*#!*^PRX]1V0BD_4#+%PUGFL4II%G<6TYD8]<YH*Q+M\[46 2Z
MRVXE/M @RG9=)\!''WWTZU__^L,//RPO:TO;-VY[R/KOWD*7WU['3':2W5GI
M8FXW>RJ\5'I[6#383<\3Z*9G(.BZ\JP$994(*-5U0'U6.>_!U>0=4!^[=:E"
M>8RR*3"2K5GT,681V6((E:UOGP+=>W% E:T/YI*M:BNR$2BR;1"!3K;-@CZH
M0NV'1#8%4A^*0/0A LH#"5*@/N[,B328)0)J/^"XJ !5-LWB@"[+ C[(NLJ)
MLL@#%88-YK)8'_0MZV,;7%(V!<IC!-IT*ML"\RP5H%N7!A'X ?F@0 E2H#Y6
M0VP6"[2R79;EI[5Z&TN0 JULG#04Z&2[+$XAC@LKV_F0R!8?Y@(ZV?KVZ>BC
MLG-@+EO)H^53<@)$V9<N77K\\<<KLBM E:T/(F-I4."T'QP0IW?E5'Q0H 2=
ML2B[DH5^N+*R718!*D<>R+GQQX\?=T#J@SZV0"N;^B!!"J0^:- "T0?KIZ:C
M/JB?U =]-BG?%G/; 7,?-.B SMBY9%=\<!H0B+(ID"J,?&A9WGGG'><#S>(4
MTBRZ2BX[*5]7V-RC0@>T&G(?:!!ENZZ3?GCUU5<??/#!BQ<O_O5?_W4_74Z?
M/GW@P ']=V^AR\R5ON7:W_:$I7X89M>N7;LX>SFU27#7BO:RS<W-G>D!$JGW
M5;C]0UL1@6OLCN1K<+_O&^R.Y C<9E<-C11NS-Z9G;YER;+&;J3N%$Z&BUNZ
M+*_ ]1NI;&EQ)YMF$1\L4+*T]R)C29:Z[+86^A#)1J#(=N5SP)Z5C[I-^X'*
MID#J0Q&(LB.@^&"#%"C],)HE JX.BS.V"&SSYL;L?35H^62@89:Y?*CT@S,G
M:C"1C3ZL%<;%DK(I$(=S<5J+LM2!;ET:1&#_P?BP,7O?'0K<F0YGEV5M6%SY
ML(V7G];J;5QQ&X'4;3H+T6D-QT7B-I5-QT4%B%U'1Q^VL6;)@1)$V;0?T&TQ
M%F4C$&6WMJ0^4-D58.0V&DN#M!\H$*?WN7R(VAAE5[*@[&TV&]/R23\(4#Y
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MLQP]>M3_>;!,+A-'R,-.P?C'XM>N7;/"6%#^@ES^^OSZ]>L&',;"2V!8%QW
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M/99% A%LXPH",J#Y(&5['R10CD#>%IE%RIZ/$ZC,(GV0Y<M\\%DRX.WQ!&<
M9CX$(,]$ >B#!I2R)=#+[F3QP"![7C[)LCN@EQV"DVYG0.X'+SL ?3]8@T$
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M!U2$+!*(X N+CT7YO=_[O8JQ@S)'9NG(#ED86"^?!+)L"90^%(&#Z@=D"3Y
M=L@"X&3Y!I5% J7L]ID*L%,^Z0/+EN6K *5L]D$".SZPPKH/$K@7'T*6I7S8
MXRQ4!,KA''SH#&?V(;B][T#9#_4LLGR9#[+KI.Q)MV4_2* L7R:[TL82F+DM
M95=\D H9."C9G>',QH9^&/+R21^D; :VKQ\-:+]HE3[(+-)8SB+[079=QX=B
M/U3<+I9/ CL^R#8N^A" 3S[Y9 4XJ":1Y4,_2-EL;*6-I>SZ8,F 4G9E.+,Y
M'87%?I#&!MDR*&6SPJ'L0]U8SB(52A_VTL928=T'=EN6K][&#)3C0OH@9<MQ
M\<033[3@W_@;?\,B:VMK1X\>=1\Y6*I+>H1\__WWXR1N_S1&=O8EG-;"NNUX
M.)P?VE#/VFY_WKIU*P##^2$)] H]4"H,9U^VI\X7!MF_OWA^"$%_WE0"?= #
M,988*&5[<V06*1M!3 3A+!0#C=EQNRA; O?%!P;.QB7(EEF^06>I*UDZP" ;
M0#Z/+F7+DXCL@Y2]J<HG?0A V0]PF]LX !&LG#=EX)#[4#'6^J'?Q@C*6:CB
M0P8,LK%N9Q8J BTH??# OMLS:N,.D$__UX&S<>F7+Y.=M3'[(,=%919BMP$T
MD<N6K]-UDVW< ;+;4G9P6\KN*,RZ+@"E;!X7MBT,#+(ED/LA S[XX(,M>.S8
M,0,&'V06:2QGD?W@@1;,&@Q =IN!<A;ZW=_]W2 [&Q?<#P$H?9#EVX4/'MB.
M#<Z<.=,W=E!-(LL'A9B%\*P! _*XP"=M702+LC?48,G<9J"<A2K#F<V1"A'D
MG2DK!)#WSD'V,&Z+[#HIF\LG?0CC(C,6P'[7(8MLX^R:@ET I<*Z#YG;LL$R
MV17@;%PJ/LA9*(R+7__U7__"%[ZPLK+RZ4]_&I&VG#IU"G>5.EB67=(C9/P.
MV4J("J$V]AHE1['MM14;ZVXN_@K"@'Y=V2@,''9&KP2R0@ ["@'<4+\Q"%D,
MZ&5+'SK -^B7+0#:X)= *1M!F47*]N98Q@QH07Q NEV4+8'[Z ,#@^Q.%@^L
M9,F MJ[)]D![S4#(1M" OE+>!RG;@ CZ?@BR ]!G,;B13;8$>K?!R7Q@8,<'
M &6E)- ^P#[X+  NY4,?:++EN/! >YT!VPN<\,9K[W8'"'/,!Y_%@OA !XB@
M-+8(-!]D^3+9_3;V/B H@1;TP([;'FBRZ^4SJ0!RDV0^O/322[+K/'!2=G!;
MRIY4:!]@V0!ZV<$'#_19)##(ED#?#QT@?H>\NKHJ?6"W U"ZC=>R'QC8EO;U
MNGW^>]_[G@<&']AM#T30@%GY^N."91N090>W#;YK'SRP?2=\YIEG,F,A6V8!
MT++XKI.5DFZ;)YG;F6P?G$^Y[8$(2F!?M@_BM1P7]L+6S11Z(#R1Y?/F +Z9
M[/M88<<'+SL O;$>F'6=SV) ^:7"N[TL4"KTP+X//NC=]CX8L"^[ D2PXH.]
M!L2 V/SVXM*E2V?/GCUZ]*B_+U?[<VUMS?X\6.K+Q!'R,';#-7HXTU9^%[CK
MBT\Q:>NVFK4]C7UL6]VO;UM=;,# 8>?&=P$H%:Z-2U_AD-STE65CDP-0^B"!
M7U9WB2S>KT_*OG7K%F>1LN5=(B_2_1L!K+A=E"V!K]!M!NM Z0,#A_+=$0&4
M-SN5/C"0^V&-[ELXHZ?[#,E=(F4;KZN[1#*0^V%0Y4,_K-/M-R_2W3*YC1$,
M;D,A^\#EZ_C QA;[@=N8S8&Q=1\F@8,R-BO?&MUV4G8=NYT!I=O<==P/!K2]
M\I 86P0.2?DRV94VA@]<O@#,FH3=EK-0O7QLCFR2S ?N.@9V9$\.9_@0^D$J
ME&[+:8U] )!]8.!>VC@ \57DP0<?9!^DV^R#=%OV0P:\M'@%HQP7TFT >7J7
MY:N,"Y:]G7RI8+=E^1@X)#YXX)T[=^ZYYY[?^9W?86,A.TQKG3;V662EI-NS
MVBW9I0]UM[/RR39FV1QD'U"^*^IFR*QPG6X*C8$69+,YD%V9A3H^L+&RC7DX
M<]=Q%O@0LFSEWUHK0*FP6+Z.VW):X_*Q[ S89%L$P8H/6]UQ\?###S>=APX=
MNGGSIKW;YM(V<NW/@Z6^3!\A;XTG+:[2PYDNCXNOW"QYQM=5>L1K"[;V\L 9
M_6 =00E\<?'Q;E)A>PV%?>#V>#;HA>3!H4$V ]D'"<0L<&5?'UVX23<YD[(Q
MQMIPL@N9AAV@GX@!K+A=E"V!9LXN@$/N0P!"=B7+C)Y]AZ#T@8$;JHVE["OJ
M$8YA9V;E"SY@KU#Q0?8##Q;T@P?.DR=P<ANSVU:I2OFD#PSD2F7 T,869!^R
M<<'K%H%L+)>OO6Y[P8V=$\ 6#%TGW99 Z?:,NJ[3#^$[669L!2C+E\E&&P?9
MLHU#DW2 DVX#N.OR9>:$)NG[( =+ $K9LGP\&V^H6:C>QIGL  SS X*R?'MI
M8P]L7T(:\.S9L\59B'U@MV4_]($^.*-Q@:#LAVQZ#UED&TN%'.0O%9G;<GIG
M(/O P&]]ZUL?_>A'\9B]X(.<UF0;L]O26!GD@\"*[&%)M[/R]1M,!J4/5CY6
M&.9)E.\R&1OFR4&9DW4=R\Y\R(P-P TU^HJ3AFSCR_0 UR)0*ERJ?-)M.:WM
M8_DRM]F'67=<_.S/_FR#^/MR->#==]]M?QXL2RT31\CH@WGR<"9[=Q@KA-+R
MNU@WO.N!MJX,,M"_*Q7.=JY P+L9L+-*)ML#69@$6C  ,=3]*@R<E,VK^"P6
MS(!>0\A26:6B0<I>%CCI@[V+52I99CL%,J#,D@&EAHYL>]>;$V2S#Y M@5)#
MWSH+^G=ME;Y+TFWI4E_#)) U](&V2D>8 3L^+ N4QLJ-"JN 8T#IM@0&#;M;
MI?-N4-@']K<TK.+;.*P2@ A.:N FR32$+/9N9Y6^.0;\_X,&;QT;.]G&?=GV
M+E;I ^4J$MC78.\>/GRX1?"$(0-F6\KOLG5XM[-*!D20-TJZ'5;!BTQ#IX6D
M!I;MWPU9@@]2(0,G^V$^_J_=AS[TH==>>\W[8%D8:$$ LRVU=+*%_"KV8BG9
MR[H]"62%')2K6% JQ+IAE4PA@M*<H %!5MCQH6]L9Q4ONS)I>*!ER7SH *7"
M$*R4CQ4BG5_%9!MPU^4+63H^! W!AZ]][6MGSYY]_/''CQ\_/NPL#SWTT(D3
M)^S/@V6I)3U"?N"!!YYZZBFKP9"<"4.=^,1V.,F!=?GLT2:=-9%!!@YC6UR[
M=HT5RI,]#&S!Z]>OH^VPS.C<C)1MF\Q!/CT9LAC0!KD%)9"-9=EL#H#!G QX
M<3RK6G&[+IN!+'LI(,N60&QR)4MH$@!?7KSG@?G 0+^N!$K9U@\A*-OXQ?&V
MAY/E8Q^R\LE^X)M)H!_")G,6]L$4RJ#T@8%<J0H0LCFXQW'!P8JQU@]^76F.
M+-\LF86D#[+KLC/E%NP 99"!4K;T0;9Q-AN')LE\X":1;O,L%(!#5S;[P/T@
M!XL$9H-%RI;E"[*S68@5LFP *[)YGI1 V0]!=L=8EMV"[7M>@^ +"8 RB_1!
M9H&QD[(E4%[7P#[PSC0S5LYUTH<P+E@VUI59>,)AA0P<<MD&;/O*>^ZYYZ67
M7H(/(0L#YTG79>-"!H.Q\JK#3/;NW.X 66'8F?JN0V10YDB%TH=,X09]=<ED
M9VY+'RK&RL'"LBN3!M;-]LX5H)QPI.Q*^5CAX*:U_2T?9Y$^_,9O_ ;+]CY\
MZUO?>NRQQ[[PA2^</GW::.WPN!TDVY\'RU)+>H1\__WW7[APX>KBKVMNJX<S
MX5<EMV[=LLB6NKX?Z[;">R!?>2^#$KBE?K[%/Q@8U.]>MM4/)P"LR,;-^L+/
M$EJ7AQ\,;(\_K@Y9&A![J5T8F\EF<UX?[Q<?LF3 IF>R?)B5)F7#!YE%_DQE
M$CCDLMF'%KE"/V7G++))7J3G:L 'EMTBW,8,E+*;/,[";8PF>7'Q*042*'W@
M\LDL:.-7W0,)K!\FVUCZP.-B2&1+(%>JV _#SG,4)MNX."Z&,E :RS/8,&:1
M;G/YUI)9B'VHS$*0';)T@$$A SNRN7Q9&_-L+,<%^\! =ANR0TWKY<O,X3;F
MP=(!AL$B@>RVE"U''_LPY&U<*9^<UAC8Z0<N'P.S?CA__GQ;UXZ0MY-)@WW@
M+-)8*5L"X4.E?.B'X#8;*[\#</D #.-"RI;3FO2!%4I@)ML#7WOMM7OOO??Q
MQQ_G24,"N>NDVSP+(<AN7QD7OVXFNSAIL-L9D-M8[DR+72<5\LY4*AS4(W\Z
MLMEM-I85UH'2G.*D(=N8?1@4$ T6)AP)E IE^5@A?-C'\FVK:4VZ71D7#;6Z
MNKJRLO*">U+4W7??W0ZA[<^#9:DE/4(^??KT P\\,-OY[_MAYQ2(O /;Z[5[
MY6%= V)=?_<V&91 "WJ%.!_348C@]GC69Y;<^A*0CFP$<6?_ #2(#P9@Z_+;
MXPWH [ C.P"E; Z&+!EP<WR>Q,6=[WD2"-ES=7]4+]N G"7(+@([LJ4/<-L#
M.<LL;Y);[KD:!@RR\;H(9-F;X],"0A;VP9ID$A@4RO)E6386'U#A@=8/%L1F
M=GSPP(KL .1* 3AIK 4GVQC!R7&Q+##(QFN>ULP< /OE"^9('PR(H $-8L"0
M91(8%'J@!;_][6]+V>;#?*J-O6RX+8%>=@:<O.%JO7R9.0$H!\LDT((=()<O
MR+;7/@O[8$%N8\CN^S#+IS4/W'L;FP\(&O#DR9,;ZFE/?1\XBS16RI9 9"R6
M;U.Y'8R=J^\ ^(!L8S\NI&QDF?Q2(15V@"P[ "&[H?[A/_R'SSSS3/M"WXZ9
M__ /_S #UMWFISUM*K=GXV+K9K*7FC2R6:CO X+UR3/XP H]L*-PV-F6RI<*
MDVU!?$ :ZQ76@=(<K%7L.MG&\DN%'&A%8+U\#)R-BP7G>RB?9?% Z38^,#DN
MVE';O_MW_^[LV;-M&.(S=^[<L9.,!\LNEN@=WZD+9;@]/O: ZVHE1%U?G7K.
MF#7**_2\M0!$\.7:0SL!K"A$WIEJ90_,9'L?)!#!-@Q\T(!AC@C CNP E+(Y
M*-WV0 O.QW&>E<]D#WD_((7,$F07@<OZX-T&D+-,-HD$FFQ;MPZ4;L_R^<[+
MG@0&A9/]X+.8[ S89/S7__I??1"RI0\,K,@V(%>JV ]SVFUG;5P<%[L##JX?
M;%TO.YC#;DL@S)$^!*"<A;!NR%($!H4RB+58]F:YC<.DT?>A#T10SD+U\A6[
MCLO'39(!360'V)$M1U_6=1;T"KWLS(?):0U ]D$"@VP)Y#9N7T(:1#[M*?.!
MW9;C0LJ60/;!F%P^"_;[@;\#</GDN"A^K4<6Z8,'ULLG@2B?!;_^]:^?.W>N
M?4%_[+''SIPY@Z^.'KBLVS!VOC@;R_+A _XXP8+L-F0;,#-G*1_P>2];#F?I
MMIS6&"@5;I5/+K#LS;R-@\(ZD(/![7FMZR00"B50SI.3P([;'846A-M[*9^<
MUJ3;]7&QLK)RZ=*EHT>/8O6VK*VM^3\/EF67Z2/D05V NJTN<6G5O3@^Y=PB
M;<'#OMM;%L&ZZ^OK;XS/ O7! 'Q]O$9"7KWPZN+%!GR=20?HKT 8$B"NX@BR
M^1H)"92R ?19)+ CN^(#!Z7; ,JK663YV)P@N\%;BHKL(G!9'^1%.+?=[?Z'
M<I-((+?Q4 9*M^4U,RR[ Y0^3/;#H-R6P%OT@(I!C0L$ W!KO$RH(IO'!8(5
M8Y&ETL;L@QP7>P$.8S_(:4U>2U8I'[O= 899"+.Q''U%8%A7!O?>QB'8\8'+
M%]:5LY#<*V59*ETG?9!-D@'E;!R 4C:7;\B[3AHK97,;2]D!>&O\/YP*,&MC
M::RU,;Z*?.0C']GU+(1^J.R=O_K5KS(P\T&6KS)I9.,B &4;R]F8W=Y67RHR
M8+U\T@=,&M_][G<_][G/W7///;_P"[_0UFW!;WWK6_9H&0!WMS.5L[$L'ZXU
M#;O[S.W@@S2G[@-?B"L5RB!_%^H @\(Y/>5HR&=CELU=)Q4NY0,'V>UBUTF@
M_%(A!UH1V'%;*I2S$&>10/;A$@UG6;ZEQL6__;?_]O3IT_Z^7.T@[M2I4_;G
MP;+L,GV$C!,>+].= ,)M$G :XU5U.@=!:QI;MP*\O7CU H+?6/Q)/<Z^3"K<
M'L_QX#^E^T#;9 Y><X]_D$ ?]#Y@7N@#ARG9!I2R99#=!O#ZXO-%;-V+[G_S
M(#LS)P KLHO 84D?V%BX'8"5+!EP0[5Q!=AQF[-(V1(H?:CT [LM@0BR0JPK
M@T$V-KDOVS:9?6!@\ %!:6QH8^F# :5L7K<"W%P\,8_@QN)C,*0/$BC=[@,M
M"""[O9&T<08,_2!ER_(5VS@T2>8#-TD&#$$ PUXIR[*AVEAFD3Z$)ND#+=@!
M%G>FLNND#_A*Q[(#L",[^% !F@\ABP3Z-KYKYVE/W& ,9+<!#/^'+-V6P+X/
M(4METIAWQT4 2G."#QVW^5M*!JR7+\C>&.^O=O[\^79LO+JZBHNK91O+\G$;
MRRS!6%D^R^+7[;L=? C!N@_F=K_!9! *918&AGER&+?E:G+;+0:RL=CDT"32
M6*DP\T%FV777,3#;7^P.F+DM?6!C>:^4 >5W(3F<>3>W06Z;#Z'!+E^^W,;C
MS__\SZ^LK"#>EJ-'C[;#:?OS8%EVF3A"1LE1L-G.?^O;"Q1FMJN?3F'="E &
M/;"BT%Z8P@P8-CD$3;;_$8L!.0M\L '< 19ESY-']<A@ )IL!#,@U'K9!K07
MYK8']F47@<OZ@* '>K<-6,F2 6U=^^UE$8@7"$JWC9/)ED#I0S!6!MEM;N-Y
M\E"$L*X,!MD 9K+#)B_E@W\W\P$<Z4, 2MF\;@489.-=DRU]P(O66I-N5X"S
MQ3:V+![H94\"YXO]$&3#!^.82_WRX85WVV0'8P/09'> %O1 *=MG,7,F97=\
M,+45X&8R^J1L#[37!NQD,1^0Q11*'\QA )]__GF?1?K0!P8?@FP)-+7^:4]]
M8 @&8SM91E\%,/@@C;4L"!HP^, [TR)0RC:U(4OP82E@O7S@P)S77GOM_>]_
M_]-//_U;O_5;'AA\"+(]T%[WW39@)TLPUC9* H,/(5CWP8(!&!3*H%?(6:1"
M[R=K"#YT9 <?-@NS$"N4&KS:S&UDL<WO9Y% \R&LNRPP!+/R6;H Y+U2!@RR
M@P]8Q<LVH+V0Y;-5+,OJZFJ+M']?=O\U?>C0H9LW;]J?!\NR2WJ$_."##\)Q
M5 C+C)Y(WEY<NW9MK7S[37]9"$I; <H@@)?=D[B'1.&7Z<GL6^.3N!FXOOAH
M[V$$AB" ZW2W[0UZ@#A\L+&$10*E#YGLMGJ0'6YSCR"[#=D^2P:\."Z3YKPR
MWA"R(IM]D,"ERK>NGLS.;E]9?%"'!677,9 5+M5UF,X0E&ZC'Z1L"90^5/J!
MMP7EXS:^2@^HX'6YC1$,L@%DV7*399!]V*0'=60^-!H'>5SPZ-L+<%!=UR]?
MQ>W0=1U@:&.XO:YFXPJ0^T&:4R]?-B[D;,Q +A\#M]7^0LK.W,YD3_I@35(!
MKM/H8V"G?++K0A8YK65MS#YD;E> TM@*$%WWI2]]:>:>]I0!.<C36I:%C85"
MSL+&HGP^*,L'<[B-*T I>UZ;WI<"ULMW99S6VN'Q/??<T[Z(2Z#Y$+(P,.NZ
M8 [ZH3@+7:7;RS/09$].&E(VLE2F=RE[G:8USB(5 ACV?;(?9FI<9#ZL%V8A
M5C@D/O#.5)I3[#H)A$*N5!W(LEFA^<!MS W&6;+RL0^R?$N-"V3YY"<_^1N_
M\1OMD-A6N7'CQMUWWVU_'BR[6-(CY <>>.#"A0O7%N_DWBE2I>JA+P=UB"6!
M,LA]B6!E?':Z/P#G-(G+[M_>N;-_ ,I!R]W//O1E>^!6LJ>7LP"[S4#(KDSB
M/'E)V9D/[/92Y<NFR !<H^=)<!8T&,N6"KE\##2W*_L>*5L"I0^5?N!M0?G"
M[G9;/:""UT6PZ$-]7%1\&-0WX(X/O#,KSD)[ 7+7=<I7<9N[K@\,;E\>ER";
M^X&!LA^D.<7R]<>%;!(&RFEM\D1/)ENZ+65+MR60FR0#\ID"!LKRR:ZK3&M;
M21MG/K#;%6#'V$D@NN[\^?.SJ2/D.<U"V\FTQEDR8XO3&KHNN"W+QSO3(E#*
MAMOKA>E]*6"Q?,V<YYY[[OWO?S_^GRH#7BY/:S+(YBPU"UU=_(FF!,*<R4E#
MRD;734[O4C84LNRL?%[AH!Z-EO5#O8VOU&:AB@^#VIE*<^I=QT!3N#O@;7I(
M5:90MC'OE=AM63[K!Y8=@!AHE?)==P\U;%/E,\\\X^_+M;*R<OSX<?OS8-G%
MDAXAGSY]^O[[[Y_M_)_^,%8(K^W%UCBGS)/+,NU=OZZ]:T%YJ9('RN",KFV0
M"FT5"<2+(-L#[;6E"\"0)0 Q7+T/#)0^5&0#:*^E#Q8TM=+MH!"R[84TQV]^
MWVWC2!^D[#[03,YD>R!>&U!F,6"0+14:<%+V9NWZ)<BN (-"";377C9OB^=P
MEJ"0?;#71=D (IUM\BY\L."DL=X':V/C^&WQ0+R[=Z"9$WRP%P8T<P T3@;$
MBPH00>/X+,:Q=R4PE"_X$&17R@?@9K=\)EL.9P-ZV1F0S6'9P8>.[&#.))";
M) ,BV ?ZH''ZLK%*)CLH[/N 8-\'#S3.+H#V^MBQ8^UCG:NL[34#?3J9Q=8U
M_=X'>R&-!6>S,&F8)]Z<(E#*]FZS#_9B=\#)\N'UK_S*K[0OY7W@;)EI+02A
M-I@3@/8Z9+%9".MV@)N%24/*MM>LT*\K99O"OCE2H6W+Z^[1:,;)%%HP\\%D
M(Y@96_'!LNQOUP5@4+@L$*]?=P^IZBC,RL= ^( 7YJ<OG\$SV7Z3 [!3OLV=
M?OC:U[YV[[WWGCIURNZOW)83)T[X/P^672SI$;+=J0LE>87N!7+MVC5KG6&G
M [)?G_MUT0W^U^=85P+E/0]>>.$%GX6!PZCPR^."7LR II"!\F82UZ]?#\"0
MQ8 V4"T8;AX (/M0ERUOY2)OHM!D]]TVA5[V?)P1Y#T//'#(W:[X(&5G0/@0
MW&;9 /HL_39FV5)A '9D![=E^8+L/E#Z4.F'T,96/@,.*DNG4G)<9+(W=QY5
M#V#6#Q4?0OF6\N$BW;6%NPY .2Z6 @9S.N6KN,W #34+26 V&W,6!L+J ,QN
M>54IG_7#9/E"DW"E (3L/E &^VY+V=+M22 W20:471> 9H[LNI!%3FM!MBFL
M^+"AFD0"V8<ZT'==^Q+2(*NKJU*AG(4FIS5DJ8P+ %FV;..L?+PSS?HA *5L
M=IM]0)#'11'8%/[N[_XN _%)E..^^^[+C,7'+"C;. !#4)H3@,59R-J)@<$<
M.6D4NT[Z("?/H+!C#I=O-BX6Q+I</JD0GY0^!-E9&[-"SA+<7K;K9!8O.U.X
M%-#+GE38+Q\#!S<+!=FR'UBV!8OE\_UPZ=*EIYYZ"D][PL?:<N3(D<V=+V '
MR^Z6Z2/D03U/8DO=<!Q7+[Q,=S"WRP!L>9'N%X^;E0>@O/%ZZS;.PL!M=:]Y
M"7Q5W<D=XX$?4+&V>"?W-_)'!<@LKT[=R=V [E-:MGP<B/3A*MWF7KH-A0$(
M'[QL"91NXVF$%1^D; 9"=GAZAY3]HGH<2-;&+%LVF 1*V2&++)^4G0&E#Y5^
MD&U\E1Y((+/(2DG@<\\])V4''SKC8M('!"O&2A]0OMW-0DL!V1PVMM/&/"XD
M,)2O ^39.&21_8!9* "E#\7RR7Z0Y9--PI4"4)8OK"N#F=LRBRQ?$1B:I .4
MLW$ %G>F<EJ3LJ&094L?9-<%(.\OAC(P=!V^BGS\XQ_G-I:S$ .EVW)ZYW$Q
M+-G&LGR3DX8$RB\5';=Y>@^R]P(<W"QTY\Z=5I3VKS060#D+<3_(+-+MD&6I
M62@8*]V6/L@F87.D0CEY2H5LCBR?S (?*N7+VC@ .VT<RI=EV6,;<Y,$V5)A
M'<BR.PHKY6,@C)6C3^Y,Y6S,QF;E\VX__OCC;=W/?O:S]J UC%;[P,&RNR4Z
M>-?.TOD_9)P"F2]>S8)3(*_34[ WDX>YM_V$G2P!$ ]V"EG"TYYP3D5F\<#M
M_,1; $+V[T\]U-X#0Q#.6!:<P<*Z,DOPX17W-' /M'6E; 21I6,L@"$HW?:R
M^3S9Q9V39Q(HW0:PX_:D[ "$[&".E#T;:^3+9UFXC5EV"_[!'_P!WJH @VR9
MA7V0LB50^E#I!RL? _%6)XNL5 :4LA'T0#DN*C[XX"Y\P+IX$B,'+8L'ABQ%
MH#0G& L@M_$&N=T'!MD=H 6QEL_2Z0<Y"W&#5<HG^T&63S8)@#P_A"P2*(.9
MVS(+W)Z4W0&&R;,#M& '6-R9=K*8[-E.@_7'1:?KI ^[ W+7M2\A#;*ZNKJ7
MO3."P5AX:$"L)=U>JHU]EFQ<<#\$H/=!9IGT 5FDL<L"A\59Z/KUZY_[W.>D
ML0!V9B'O@\PB9<LL2\U"MJYTN^-#^)+)YDB%WFV_+BMD<V3YAG%;PG]U>A\Z
M"K$N]/1E9VT<%$YFD3[(+"R[/VE(A74@R^XHK)>/@6#*+/WRS?)QP<!0OO;O
M$T\\L;:V]HN_^(M8L2WMW2-'CMB?!\ONEO_O"-D.C&TY?/@P?E-N9<!KN8=N
M/=HO(7IBK@ZJY1SALWA@/PN \OA9 O%Y/P)#, .&H,F^/?ZO*;)(H/0A \X6
M?P4A@Q+H98>@=)MES\?%^W!Q//G-0#8G #MN=V0'(,H7S(&J(!MF^O)MJ9_*
M>*"7'13.QF42:+)E%O9!RI; H% "93^85),=@#*8^= !2MD^"* <%Q4?V.VE
M?/#K6L80W$C&A<\R"93F!&,!1-#W@ZWKLTP"3?8D<#8N(8CA;$#.TC?6MCW(
M-G.04?:#+!\#(=N[+8'F0P!ZV1US@FSV85+V)- FSTG@9C+Z/% &(8//B<@L
M_]O6Q0;+Q@7[8%DZ/BP+E%UW\N3)]M:Q8\>&Q4G#9ZD $93&_F\7:%P$V1[H
M@YO*6&3ICPN8$W:F^, ;],-%F:7C@\\2?%@6N+7X2\@6?.:99_[3?_I/!@P^
M^"P!Z'V063JR0Y9@[)PF#60QH#<V!"=]D,&.0BX?UF6%'HB@_'+ES3&@06Q=
MJ3 8.\O'!?NPJ09+D)UEV50^R"PL.YLT>,)9"LBR.^-BV?)YH,EFM_OEP^?[
MQ@8@@INCV[_V:[]VYLR9AQYZZ,2)$WBK+9_\Y"=/G3IE?QXLNUO^SQ'R0O2N
MN_[R7_[+?!TUKO)J@\=]5EP.L:VNXMA2%V;C3,^KB]>97+MV+60!L'(-59MH
M^/(8EKVMKBW<&F\K%X(2^ I=Z0W@Q?%_32TH@=('";Q&SQZ000F$[.N+CP.1
M;F>RUQ=OKX>3WS*+O""YXG8F6Y;OE<6[ D(V^Q!DS]5C41@XJ#8&,,B60)1/
M9F$?I.S)?A@2H.P'63X&RJ#T(0-6?.!^ +#BPXP>#S,LXP,#Y^,.;W>S4 <H
MS9'EXS:6XZ((O+AX 6H'&(*OJXO3.$MF;+%\LA]D^;)Q(:=W!LKR!=D=<^JS
M$,LN B_2-749D$<? V40;5R1C?VFERW'1>8#N\T^U($\UP%X_OSY!K1O)NBZ
MD*4('))IC<>%-';9-IZ<-.3.]!6Z1?^VFH6DVW)<L#EU('9S_FZZW_WN=S_^
M\8^SL?!A=].:W)FR[$&YC7Z0DX8T]LON)L"# DK9,B@5RO*A'WCR##Y@-@ZR
MV1R4;TW-QK)\<N\\:2QD\V!AV5D6]J'>=3PNBGOG#C#(YO(9<'?EDZ./W<[*
MMS8N%6.Y?'"['2>WX^%V>-P.DNVMX\>/KZRLN,\>++M9TB/D8\>.O?322W:V
M8QAKN5&^4TBX+ 3!5G(&?D/=C^3JSC.^;-T6;.T5@"'+]GB>YL7D/APL.P#G
M.X]_Z ,1?('N%H:Q';($X*!\D$#SP:\K@QGPZN+C0*3;?=D,]/.%- ? BMN9
M;%F^%^@9@) =@$$V@M('!FZH-I;E"T#(OK+X%).LZZ1LZ8/LAP"4_9"53[8Q
MEX]]R( 5'[)^P'ZK[P."%6.E#QDPM#'6+<Y"$KB^^$5-&@N@[#H>%]+M#!C<
M[@ M".#+A?O32&.M?,$'V<:5\@&8E2_(EL.Y*%N:(V5+(,M>"LA=EP$K72=W
MIA79,]IO(EB9WF66S(<*$$'9QH\__OAL\6E/LHWKP.+T+LNW5!OWRV=MS.:$
M^<':6#9)\$'.QK)\D\!A9UJ[[(Z0?_NW?_N+7_RB!.YN6D.P+ENZ79^%_!%R
M!F39')0*9?FL'P(P^(!UY1B7<UT&#&Y+8RM?*FR30[!>OMVU\: F#:Q;V3M+
MX)R>O2?+!^"5Q:=>+56^S ?.$H"S9!;J $VA!=N1\^KJZMUWW[WI[LMUZ-"A
M&S=NV)\'R^Z6] @9$11UOGCS]]G.__ZC*5%%"]H+U ^%MZ $&L>"6-> >%<"
M+>C?9:"4W5DE P8-"&(L!=D,E#Y(H'Q7!C.@U!#<KLCF=_TJP1Q[=]+M3'96
MBP!D#6R=U) !\:X/!F"VBC=G4H.4W?&A#Y2KA"W-WI5!Z4,&#.]*'VR3I0\
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MV2$89$N@]\&FFPXPN)W)ECYTW/9 DQW,81\8*!7*H &#V[?H@010."F[[D,
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M#$*V;^-.EB ;"B60?0A9.D >+!GPXQ__^,;.TYXD4+9Q!^C'!8+2V-!UTE@
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M.,M92+HM@5R^#=K=<U#Z((-281$XC-M2E\UN2V/E])XIE$%OCF4)VY*U\2Z
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MY=YY+[)E&V? 2;<E,)3OKIWG(1>!,-8'9S0N$"QV'8P-67;=QB9[LGQLSE+
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M<;S\O@[LFV,^<)"-W36P"6[?'EOA'G[XX9_ZJ9\Z?OSXJ5.GSI\_WXKB=Z8
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M 3/9WAP)]#Y8, -"845V $K9"/),M+GH-H!SVC-='$]^,U!^?9'S/C:SGR4
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M9,"@4 (KY3.W0Q:Y$Y% EET'UO=*7#[9==('G(UB<R10#I;@]C[*[G0=-QB
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M3!X:]B(]0+4%6WOY+//DT60O%IX#;(T>@)R%MZ4CF\W!-[\*\,H>'J J?0A
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M[<6/_,B///C@@^V ^>FGG[9G2EF!O#F9V_U:5(#V;A;L9 GEPRI67 _T_6!
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MQDY%"/6$9),0;HMHI^) N8@RU=$&H79;O$R;)0C-:)-[(A?30S,X*4(=A\Z
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MI!5CR!A(%(3:;9/0# X(]>I0QT-@BQ"*D4F^9!&' P<.;-Z\>>O6K0T-#:4
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MFNXWL'(U9#DAY8_#X7 X' Z'P^&X;/B#0HX'OD@8;-RX<?OV[21.YLV;!ZE
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MTWUC0C[F Y,0QDKM+&LFY.QB0C;F$\87Q=[&A.):8*Q4IRO'UP*>D8;I;@
M#%=)1$%4XK/-A0\FX4]^\I.?_O2GI(?W[]^_,JRN3**7%.-==]VU8<,&7A.+
M["TM+8L6+6IN;DZMB47'>/47M8A$._S,+)"]5%7(\9I8E"EIX.+SHNN",HK]
M&41FA\/A<#@<#H?#\<>!I$+>N''CUJU;64&1!=)+KQU5KEV,"L;7 ]@(A68N
M1J77P8(QGQ#&KJXN38BUE 6A6*$*1FP4I'.!DLRJ;@M",PXPOOKJJ_F$,,)M
M-B*M6/J+KT6[K=<#,PF%AW0F:>!CQXX=/7ITS9HULV;-^IN_^9LE2Y8<.'"
MY"Z5]><^][G&L$STNG7K5H8UL9Y]]EFJ!M___O=7JC6Q2 S':V(UAB'B>$TL
M;"9,R9%[/N@2*%]2X_('A\/A<#@<#H?#X;B,2"KDMK8VDH7_^J__RI8LL;N/
MWH>I=V"['!7<-JG'VN4('@K"MZQ=CBBAF<N)VDV)+EZ\J EU'"@)Z6TBO'#A
M0FS4A'!;&/4N1UG8]4I'6P='[,-T[MPY*LK]^_=36BI$R%?,*&YH:'C^^>=G
MSYZ]<.'"FVZZB0ZP)M:^??LPN(J3![(F%K\/_+=_^[>C1HUZZ:67_N!Z+N"
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?A\/A<#@<#L?[^']0T'GDR4>B?@    !)14Y$KD)@@@$!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>16
<FILENAME>image_2a.jpg
<TEXT>
begin 644 image_2a.jpg
MB5!.1PT*&@H    -24A$4@  !+X   -S" (    H44:_  "  $E$051X7NR]
M#W03UYGW3]-NS^Z>;E>[9]--=[OK?9OV>),WIR]OTZ79_L*2J-E0$TS@-:ZP
M:SS%&&*!'<1B8V'C?\$R!DTPR/Q1,$,P8!!@CP,Q 0>L$!QP7"L%AS^Q"!#B
M@,"Q75LKL[(C2_K-O3,CS8QF1B,A8P/W<TZ(=>?.G7OO7,W<K^YSGV>2!X%
M(! (! *!0" 0"%DF"1,0" 0"@4 @$ @$ H'@@Z0C H% (! (! *!0"#"@*0C
M H% (! (! *!0"#",*D#@4 @$ @$ H% (! (62;Y_?Y)" 0"@4 @$ @$ H'@
MX)=%F/L!1]@\,1CI*$Q&(*("C24$ A$3T,,$@4 @$.-+V#=1V P/$ K;@J0C
M(I:@L81 (&(">I@@$ @$8GP)^R8*F^$!0F%;D'1$Q!(TEA (1$Q #Q,$ H%
MC"]AWT1A,SQ *&P+DHZ(6(+&$@*!B GH88) (!"(Z'&V;9HS];DY&YH_VJZ=
M/5>[QE@,/KYY9'^NVGSN*]),.CS"4T((^R8*F^$!0F%;D'1$Q!(TEA (1$Q
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MT/!2JY[']>L#*@;>B+1-G98@JF#AC:0Q7T\TV1QWH3V>N4"CGALTF,2-=%<
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ME6TH@D(BZ =(E+?&ZW+=I?]R=9'<Z*QR7R4^HK$6>; .<JA^ -Y=E?L*XEK
M<B4HDHXT'E?WV=U%NN+&*UP_- I?5<<AM$3\Z4]_NG+ERGW[]IT\>?+$B1.U
MM;6OO_[ZCW[THTEP[;&[6_CM$"5DC='G&1QTN;H[[;U1WQ^%;8E*.CI;H?.;
M3=-5\RQ<+R]@9B;JQT5?NKZT!#BD>:,XEU(1]41^%HA37U!3;S*:S<9JRUO<
MZ/:L0Q?#MF;X0R9SN6V%=<V'P&S/ZVRM!M/$ZK5UUZZ0:_-T:DR7MQ1(1_P@
MF%,"Z3A7I]-H=7GZ\G4&\Q9#=:V9R59.M%T%9;)><QAA";6-U=Y/J[M>*\[Z
MO"G5$XVD,9_ZMXEX R::=I0EZ8XVFZ<M)3L:J4OB]2<LJ=/4<_)-AZKS"X[=
MH=I>^49%864MU:ZV/M@5C9U,@7NZ1KYQ (= Y@*->B[M2<AU@]%1IJJUQ6\4
M4@TO7[EL*70F5/U6E6&+V;"1J"XSU)K+YLU) ]V2G3RO@-.'NT]UP!9-#+AC
MB;>3T]$SX/:"K9A?WW+T_0\GMB< S=T1HL"!(=A./!JR=9D;Y540KY79/#P0
M&&]L.%8_9S<U&GX3DXA?3 \-RJ4C?PF#9^.GO!!1Q$_WNNS-_+CJ<6H]*>&2
M040Z<BL,:AO4 ^P\?LREHWR9(HS!7D?9.HCWO#R2LD>V6V@DSPTBYV:&+RJB
M=Y,C8ZU*H\QFE0?8J$F2-7HIH27IU2FT>F,#;Z$UG!YF$.QOI(UO0_9Y B'J
MX2W5AN\QK\M6%5BPY<6*1-*1QG?GM#'GM95KHC-8?0[RQ!-/'#QXT.L5N1G?
M?/.-V6RFI./RY<N%Q\00KC&.7MBN6[M!I]^(;VA4]-P006%;HI*. ><W@RZ>
MEY?@H5 _+A[HD&:441$#_#CU0:\Y7(<NP\S<+NAK9X1.89S- -<UH^ DUY#;
M?7<(^-RAG?2XJ7FDVST$4CS?T-=EL]UJ;>H O\;PIIX<;<.XL6%]WH#Z]+E<
M\%]0>3IQ:(CZ&_CL@==BRJ&RTOYP8=M9;SWL#)4I$%R9+C/@N\;G97WD!/WB
ML,Y^ I-FNO?HC\/\/H0SZ>"]&6<B'DL0SMP=OC_  _T&?(X__A2VZU-[<]GL
M9QY_+F?WL;<PVDT?5F[$YF$8_2*9@F&SZ.=9ZOHM3,[S[P??]IK *72!VX\Q
M;J8#KX? 8S$>,Y9GJ VG.RT85M=QVI3QW(_C9Z^U=M2!TS/FEIYN;\"T1N,"
MMF@:<!9\V?\"(QH)D&&1NO3]S@8==NC,Z3<SGWO\F=EE)]FW+G.MQU\J;^G8
MRTP1YN2NR9SZ>/S<BE:J?-VACA-O9H"/9=:/#C$7U2F;0#QLW!]1)[B*UW&2
M&46?7K26S8U_?)IV]R=VZJ[]I*+MBB6%FCN2!*::9F@[9TGY23R&!>8[C],C
M1X,Q,Y#X F)W#G7W$RM.]4Z<K^B#0W0/DX<!Y>)!9BE&>2&BR)S.-6F#A-C^
MT8A*.XX B,?;V@+/:=9 42YHNP#1\D6Y)U4@'9="#%#_!. 17;C4H[@.,CTO
MB:3\D^T6&L45$R=&TC'\2IJ ")=_P?I;J(:4"D,:4KVQ@A_;)KRZ$XQ&[KY3
M@:2,4^M-G%]YE.A2SE9DA<C=[H<'SIMHU$/;J;+_#\D@QX\@87WA?/311__K
M?_TOGR_<I,'G^NK*35I6,'BO'M"^,NN-MVM+MYZ--I*"PK9$)1T1" FHL902
M%<SYOB_)C*E3IB3BM@LDEJ0GS'IU$H8E+&GJ=ETZML^R/E6M)PB]&NA ';#7
MQ3'<-N @LV&8EGTXIF9RMCF\'AL^!;=1KX.@VJ0+S#0:,V'^P*O=PY;PGHU2
MB:HGIFH7)5$"X)D<\LL;IRNR*RR;&>4Y-4.;M)@]_3!IQ()G!2M&:TNU5JO1
M8)IGM.27C@\JTG!V'S-U+1U&?M'?G#^94AT@\!0H*'7*DDUF<]WY<PU $B=H
M2;OC-)Y6L:N&N>CKRB80#QO"43)F<*Y)O3Z3Z%%4:TC_\9*FGN%SIJD+X3V=
ML;IDX1.,='QBVNK52Y]0 >D8N(GTR*'&&SWV/-3@2]!NVE9==PYX:49$R*/[
M8E(L'O@+8O<OKB//$R9 X#J%1E3:<96&&L/8J6I@_8?7)/D9O&CYHMR;*N '
MT!-;$ L@$VE3<1UD>UZ"!UTZ"OI-$;(W0HH1A[6,(X^BND&QA-][H6:Z0F3S
M\R)J"%"BM)%T%"?X)O*<;WCWPE5[SXCMW7<Y7TR%KRH31)@JQOSY\_OZ^H2I
M GRN+S^N-[Z6_/OR(WR[#[ZNC1"%;4'2$1%+Y,<2?XX>))C>WZS[\0QL_K1I
MYB,'L3FOZ^=/7K+WB%&CMWX]8G]_3WCI.)W)*2X=Z0(;SS6P0E%4.DZ;F?C,
MXRI*.DXN;#ZU7:-^#BPJ@M.G)R;^7*5:("$=E^BQZ4N:SL!ER<QIB0G/J.(I
MZ3A9WWB*6*2.7\+. &CI^.5P6\4O6-7QCO7DD3T[=Y2D3-:9M@#IF*AO;B8T
M+\8'+ZIP O&P(35@_-*'(DWW"P]1KT]FO!&&]'AJ=@)LBL#/#5/54^-44]3J
M1" =IZK5<7%4"D__TR,G*!V=]J-UQ(X2S>3\YOXH?P)\E)%_F#S,*!4/_'4&
MP3Q2:2$2A#D]Q$!.)/ZXN+03"=VNXJRW3$#I*#"5%&DIBV#N'IT]9)B>%^5!
MEXZ"'E8&MWMYG29PL<.'-\#&7#IZ';;#)$D2=/C34&MG_JICI-(QI+>]CA.%
MPI55@#*9C:2C.,$WT6@K-HG!W!-\IRM\51V#"%/%*"HJ^N*++X2I KPW6]Y8
M\,JB]0T?WW!%+Q6%*&P+DHZ(6"(_EJ2F[VPZ^.GQ*=V>]F8\,6%9?JJ.O-%A
MFCJ[<K=I_DLS9KZTA. 9K'*EXY)X=3*&+<PM+V1R7AP$;PAJ^G[WLSWS9\R<
M.6/^GJ-U&%W@]*RLV3!_9LE;6XJ+F^^ QS%=0F:)N1+#ZD[O27\<>_NDY?67
M7IJ3J$[%+=7T%>M/$TF/4](Q V9.2YSR8\Y9#3<ZJZ=.79 U)\MHU&+US7N2
M?H'5O6?)G/%2<J)Z]KJ#>]<4-]^"CW[J6G,ULU\'S8E74Q)U_KS4.8DS-)J$
MZ89=-=BRNI.UF2\E)"=.GXW7FIF+*IQ /&Q(#1B_]*%(T_W"0[X1^QYF%'UR
MEAH\B<DS$FGS8]R Q>NI?X!TQ PXEFC ]5,HZ0AO8GKBE,>9D1.0CG=.ER:_
MI)G[TO3U =_9".7(/TP>9A2)!][&)%7H[%!1(=*$/3TT KO0SX>$M.,OX@F/
M3D3I&")WU656$;\CSBZ"NQ8KXX5%M@YA>S[&**Z8.&'$# ?I"XD-"05PA)]@
M- J'8@#!MX:[%B==O7M!?LE:8*8;WF"5W]LB^;VNKEJA?R"EX3J0=!2']R;R
M]-B([!=_MSN*O8XZB# U!)_/]Q__\1]#0T/" T(\;K<GYM':%;8%24=$+)$?
M2U+3]T"ZS^T<=%//0H]KP.D:=+I]/H^K?\#-;@'UN0<'J33JW[MNYN@@NR75
M 7>KLCD!5"%#'L8Q"MQ3&B@0;!.%^0<[MF\\ZV0VH-(EW 67H$H!&U?!-E3V
MNO05J0.#](Y<=KLIYRSJBGU4X4XW:,4HK+D7%@WVJ0Y_4KL1QK&$UX*>6MBK
M@MKQ*@F/@!ST1WC1V/VJ]  A-6#\TH<B3?>+' KL,0:#J!?N888C<WC(Y89#
M#HQ#S] 0]=\ W D-;^+ 0'#D,&,/WDBPB9I?/D(1\@^3AYEPX@$L93#K& %"
MEL+"%1*&\*<+M:NL6.)*N] E,HX&F)#24;C 2P$\QYQB[<2\+KN5X'K+!!D$
M\W7%=0C?\[%%<<7$N7?IR+=6E5]YDU1B_.4[%0P8 ]P0!HL2^=;PI)=4]>X1
MP8+J9 QOIFL5$F!#R79$P:\8(=]ZD6(I9'Q9*81_EV6_; \?P3>1KZ>-*%WV
M^]^_MJHA"NGX/8C%8A$>X$#IQI*2DF>??59X0 SO]?I5Y42MD6B-=F=C* K;
M@J0C(I9PQI)OI'/'ZB-M1U;OZ&2_8\P<G9H<9-39VV"\/FXZ L$G)66>T[JM
MYE2]3EU]ZNC&@OPL&*]U"6YS48?H4*NIV;L[/@%_8!767A\<2TS@UL7%Q8O9
M2+#L&*-=0#..H -70<-O(O+HOIAXXD$)8EL-(RY$Q1,JB@1,J*#BZB4I:1<R
MR^>6/^;242$AEX[,CTMH;#W%RD11S\<0Q143YYZE(]_*5[@N)X2OQ+@Z,[(;
MI JQ:XW%(!$A]!<6"2172OD(C:(Q_ 0;4E4^)(E:7RON(U<)2#K2W).;G#0(
ME7G>O'F=G9T"1SC4Q[-GSTZ?/IW*L'GS9NXA*7R.^JP7?ZN9-&M+]S?"8]&B
ML"WAI*/WZL'LE.3L0]?Y(V[TDEFM>^]+.'7+*-OWWO8\$,+>>L='QW7$C!9S
MMEJ3OK $7Z?#L-2\/2?K8# ,.E*B!Y[>W,]D3D_6O>/PNSJK\2.?OK.Z^I/>
MMHVI&HW6;#U+4,6FSWMI>0,=0@-$7\S,TLQ0)\^94[&K!J=C0N)P+M@(8G\O
MS-3,F)X\.ZVBK1^D+#ERXUSUC 49"\"A*DM-#E6E=$WR+/7SZI_])''M6MVJ
M8YT-FXEC.^ $U+BE;*%F3H[YXB"OJ8A(X(TE7U]KZ?S2UK[ ]R,@'3>F9Q9G
M9%<AZ8B0A1H8ONZ& O"U7:1)-UKV9L%XK=.A=$RV;3*?N=RP8L[KR_/>@F%C
M>UP"B>B'05/9HH+I2#H^",B]F!YN(E1]X@Y.(RP$$JET%)FO<Z;^$E)!( ]5
M_,6?"2L=Q==S1)F,$1>$2EZZ-X0H[/F8H;ABXMRK= R[C,9'QA&1F*VF)*&_
MML1FD(@AL&06(RZ3Z)*5S!RD-C0J(&SW2H&D(^3>W.1<AWS_^]^?!'GRR2>3
MDI*6+%FBU6I???55.J@CQ=-//ST\/"P\682A2\3OGWWRGR9]+[?Y3Q-NU='C
M=EVVK&G@2T>G#5^"80NQQ=M I'O+%%56&PAA[W !P?9BPO2,;<<(2J=E9&,+
M*\_8R!58B7DS1SKVP],+R(X#,//K.?K#U./&YSQ=JBYO=7[C[-BV<$YR)K&M
MTD2-SX$.8XI:,U>MK8#2,=]8C(--;J9EF"%$.N:6%U<V.3PV$W4B]?Q]8F')
MZAGQ&)2.N9;3AY935<HEZ5CAC;AQK2YQD0[38HNKX01TH6YEYIQDW>Y+82V,
M$9+PQY('QLD,?L$"TM%D:F[#M8$MXVCNCA %# QJ*OE,WM%3U=,P2P>Y'L9K
M+3#!54<8?[6V.K^4>-L(P\;64X^I<-+QL%Y?<YC<D$O]R_X$BX;?Q$3VQ?10
M$X'J2]#7MHLO)4102(#(I:/(HDI@>BHN%0"29H>R9PFYW](1X'78:@6FPGRX
MJT \%+=+:<_'"L45$^<>I6/$T2F$&R/YIRB3]PEZLBOD'L5ND(C@M).%DL-&
M74C:E>I&FO#-!..PR\&+PII0:.5$:HP,)!TAHU??75=:7+1F77GMQQP;T8A>
M51]\\,%?_=5?T2HQE+__^[_OZNH2GB/!Z-4#A16U#0T?W)LU,H])RMH23CIZ
M;[84IB_9<K2EG1-WWME:66II;]F4],S+N29SZ8K2]45K0 C[@U>]U(RMX4Q3
MKF%/3;&>J&_8:\S65Q^J+BS875<-HMMOL9B+].OFJ6;O:F_95EA:6@DR:Q+G
M%Q)@'D?/\X:O'ZPPU)H-)LN!M>7FVK+IJK1#]*JCOH0@ZXG\+#U1O:*@IMYD
M-)N-U9:M@;D@26[/7U!(F L+FF[Y'$UK=5JU5I>7E:D#ATZT$*!*I/62G9&.
M.%Y_PI*6;2(JP 1TQ;3X&66U5(%MX5SB(J01C"4V3B8#.T<'NWMA6$Z^(2L"
MP0<.#"^,H3KL&O+ T*]TO%8?<VB@%^XD9 *?LJ< <^E@@-E@4?3FPSN]8(,B
MW$S*/8288,B]F!YNPJN^..C;F;>52TCX0D*)0CKZ1;RM,J9WHE(!PG-J(F,W
M*#\U'P_I2 ."!-;S-S?".Q+X.4H$Q>V*H.=C@N**B7-OTI$W$A1M]A/:K(J$
MG?"Z[*>@Q_7)G&PJH!BI&:#D/8KU( D!>EOEQI:$8\8J^D.#$D8<MO=(H87J
M9 S?QV^CTVZUX)CF'G2C7WB79;]L#Q^<-Y'7W=<_Y!OJZ[O+-3:-]%7UZ:>?
M/OOLLUS%2//K7__ZQHT;PMPR])]<^<PO7]14G979'APADY2U)9QTA&XB'+W.
M(6[<>69:1@F $2;2/1/"GCD$9WALQ'OJ#^AF@O8\ 3V#W.H=&H6GWX69[PX.
M]#B@4Q!VGL=.!.EB@?SPPB)[6-\DG*/!N2!UO?X!IBA8$_==%YAFTH<&@E4"
M!5)'W715J<*9"6B@%8AHD1U+DG-TJ73$(X[,P) Z%&FZ7_808AR1?Y@@$ @$
M C'6!-]$GG-[=W_F\0_?.;;OO=L1&ZQR\7J][[__ODZG>_755V?/GKURY<HS
M9\X(=C^&Q7N]H2A]>?[JJJ.<RMPC"ML25CHB$!% C:7@3U,A4'-T81)$*AWQ
MB",S,*0.19JNDCV$&%^$SQ<$ H% (.XC08GD^[)AP;^"]<%?XK;_B=C#:LSQ
M]5K+7WGAA5?QUHFWZHA 1(#\6)):WI%*1SSBR P,J4.1IOME#R'&$?F'"0*!
M0" 08PWG3>1Q=9_=7:0K;KS"C9>F\%75"IG#8C 8N$=GS9KU#,1D,G'39? Z
M+OQ1),#L/:&P+4@Z(F*)_%B2FJ-+I2,><60&AM2A2-/]LH<0XXC\PP2!0" 0
MB+&&L^IXJ\6P]+65:XSK&B]QW'@H?%6=@8!%RTF3_N$?_N&MM][B'MVW;]^O
M?O4KZM!?__5?#PXJ"O3@O5 Z:=)OTA=L;D.KCH@'&NY8\O6\M[J"J,DCA'$=
M0^"DW[UDQG3-[:0V49.R&#_>3.BP=,RPTV0B'==)[+G4XC79ZN?5V6N*,Q,U
M6%;)Q@H0T.^-3::E"5/4DU6)!Z'3W0I>A!A36]!9/(X;=09KY]Y$U600\<]8
MG,G&= &7L[R%$R2X8D:9>?TBM285P\]$Y\H:$1/8@>'I:5I?L7M+GOE\X!<V
M!6.)AU2Z7_808AQ!+R8$ H% C"_!-]&]!><H@_S9G_W9VK5K1<-O^'R^QL9&
M2CINV[9->$R4_I,KG_[AD__Y)I*.B <;_EBB=>"=P&>I.7HP?;@#S\"PG(KU
M63-F3M=6;UUKLKG\KEL=(-;+7'7\,Q@(\6(&,A)$:LG"--5,0#\0C.$T\-!+
M2T=.A)A<\MI([Y5/[+VL=$S1ZA;KF<QL3)=,<#GSL5T&;!FXHJ,14SWUXLS$
M#//Y:+V?(6) <&",7C2K]<W]07?8X<<2'ZETO^PAQ#@R$5Y,]"_$" 0"@1AW
MA _H^T+PNO<6G.-_0XX>/2H\P*>EI67Z].G"5#&\U^M7E1.U1J*54YE[1&%;
MHI*.WJL'LU.2LP]=]PX[K$:]I'OB7NOZ7:>.ZM7FYJ.5J_,KV6D]O<XSM\S:
M27(#<R,> CACR>>AAG55W4Y]=9N3&=92<W0VW>MLK2ZUG&ZIGJV:N?=<TYK2
M W5K2[;6&DHK0#!/L.H8E(XP4LM>O( )Z'>3DHZ?M%73\5K>XD:((:WV :YT
MQ ^V6E[7,M(11/D#,5WTA\#E]FPWFK:5Z3?5ENKU>6L;SC7FEIZ.+-P2(J:P
M \-]W5)155^C7W_&R1J)A!M+0J32_;*'$.-(Q"\F! *!0"!B2O!-Y.MIV[UY
MD]%HW-!DYP2=4/BJ2H$(4\5XY957O-[P"XF^7JLA/2TMO>H!D8Y^C]MUV;*F
M@9*.?;8=Y9+R[YMNRVI->KIF17JZ<<]>;:)&DZBEI6-N>7$VO?@C=2[B@80[
MEGSNH2&/C_Z73I'ZV@32F3B0GKN#KF$?"/0RRL1T80*TN#CQ5&"D%O<P$\>%
M#AC#Q&L)B1##7 >&>'&/P)(](!(,C!7CN-,_2"?2\5K<@Z!$YHJ<QP/BOA/X
M30&$=F3^%1P2$FFZ7_808AR)_,6$0" 0"$0LX;V)/#TV(OO%W^V.0CINA@A3
MQ5B\>'%/3X\P58C/,SCH<G5WVGMC%II#<5NBDH[>FRV%Z4NV'&UIOPH,!8D3
M-KOXVHS'AC^CJS]E3L6"QH25[#K/?KCX@Z3C0X7\6)*:HTNE(QYQ9 :&U*%(
MT_VRAQ#CB/S#!(% (!"(L8:WZDB4+OO][U];U1"%=,0APE0Q7GGEE:^^^DJ8
M*F#TPG;=V@TZ_49\0R-GX^4]HK M44E'L+ASQ]'K'.*LU0BST/B&74,>N.XT
M"A=YJ,QW>>L\4B<B'DPF0<]1",1$@]*'PB06F4.(\47X?$$@$ @$XC["DX[W
M8+#Z'Q!A:@C7KEW[B[_XBZ&A(>$! =ZK![2OS'KC[=K2K6<?#(/5P%Y'3V#3
MHS +1':O(^/3<C/\N"6&#H(0XXC\6)):WI%*1SSBR P,J4.1IOME#R'&$?F'
M"0*!0" 08PWO370/!JO?@I25E?E\DANA>GM[?_[SGS_]]-/" Y)\,W#IG-T5
M,P&EL"U12<?@7L? '\(<$-F]CHQ/RQKXD90H ?& (3^6I.;H4NF(1QR9@2%U
M*-)TO^PAQ#@B_S!!(! (!&*LX:TZWH/!ZO,0*O/,F3,[.SL%1]UN=VUM[3_^
MXS]2&2AY*3@J@O>+8Z4YOT]/2WY!U_!@&*P&]CJVM9#4'V]L)S^+8J\C[=-R
M&_QX*H:B&3&.\'^>Z?NB^U;W%WT1N#9Q-&J7'+EQKGK&@HP%8#FZ>.,Z76KZ
MXHJ=U4;:M^I7YT"0A@OUNE7'.AM,1F-!3GX.R&"]=A$$ KD)_:]Z@#-5$+TC
MVV39!G.6@FQ8>O:>ICHFM*,%4ST%HS[NJ0$Y,[,T,V @QUUF[&=3P"F;B6,[
M=*GS4[/KNI"OG'%":L#X X=\MYI6K]]=4V[N9**H2)TBE>Z7/8081R)^,2$0
M" 0"$5,X;R*OV_&9S?;'2XZ[W$FAPE?5*<ACCSTV"?+TTT^GI:7I=+HE2Y8D
M)"1\__O?I]-_\(,?]/?W"T\68=35>>KCK]VWC^T^=ON!D([!O8Y#X(^O^UU2
M6Q;#[G5D/@:=8"(>:'ACB9K6+U$O:;H5N+=2<W2.="2Q)Q:6K)X1CT'IF(UI
M-M@\?I>CXVVM>JY&K:LC\0PL(\=8L2QQD0[3&\OC55EM(,,7+3 @Y,&.!JYT
M+"9/[]-1.34J%=9\F2R84[)Y"Q/:,5T-I&-&+GGR$,B9;RQ>" ,Y-A"4= 2%
M:['%U6<N-ZR8LX8;3A!Q/Y$:,'[.H=%+9K6N.?"@E3I%*MTO>P@QCD3^8GJ4
M\-CP>%7DJ'$;_2-+-XE%>'X\;@O.3UPV7,TYIB'L[L Q/KP+\<H(Q=M%),1Q
MBE7)E@P1]$,"89>8C("72S ?VP_WVHU2>!RDEI-?"]]*HH=HXC$IEX&\:K-@
MI".80\FMC%/K:\C#-H=(YR@Y'1"'X?7D8:N$3T0^7I?]%$GNP[')O"+4>H*4
MJ(6_UZJ?PLD:[KY+Y1?M+EDX8W)<;@V?6'[+!*<K)<R7]-$C^";RG-M+?.QP
MW/S\2-U['+46T:NJIJ;F.]_Y#JT20_GS/__SDR=/"L^1@_JNG8_AVMLD96V)
M3CHB$.+PQI+'7J=-U-;9(UEU;%JKTZJUNKRL3!WUJFNHQ5>4FFLK"RO>J 2K
MC@6)J6LL[<W5TU4S+2<L:=G&]4O4*<7FVO(%+\\M @$A2TN+\O1$D\WQ.0S\
M>-C:4HO7G["D3E//R3<=JLXOJ,*9T(Z+XU738=3'XP0,$4GDE\% CD0-]AQ6
M#PHW$15Z4VUU?L6Q.^A!.CY(#1A_X)#G<\NJC?4[UZQOZZ-_H9 Z12K=+WL(
M,8Z@%Y,<]ZIY8CNI5<5EDK?$9R^BDUIQO'8B@5,F)"Z!Z!(OF$;8#Y,SR1OB
M^2>T=%3%Z:UBFLSKM!8*Q#0@:GVB+B2%VB^2TP&3L:HSHN(/0DUDFX6*,12U
MOE8H( 4M#7??G58]-W=@^(G*.5G"2<?[=6MH8ODM$YZN$/DOZ2-(\$WD^]/Y
M R8CA=G:S<:<XV50Q@<??/#44T]Q%2/-TT\_W=;6)LPMQ0-HL!IPDW.E+G-.
M.GYF0)B#QL-$;\=W'2/R4M,7E^VOJ:AI/JK#S*<:*W==<EZLU:7.SRAKZCBT
M7*U)TVAFJ:<D9!N+,VD_.G/+K)TD+O5[#V)"PAM+8,WY[I +1&JDD9JC!]/A
M0K1KR.UVNYCE:%ZHQKM@L=KO\[B=+B9RHWN8SL $A!R&Y_6Y/*-LX$<8JA$<
M=0^ Q6U.:,?!?GB%NTS.P;LPD".X-"=Z9.^ 6_Q1C;@/2 T8?^ 0M&M@_N6F
MAR"5[I<]A!A'(GXQ/5+<J^:)\:16I4K$;:(3 =%)K2AN.Z'A%,BBKK+)_*8>
MV@]2^2>V=%3%%5I%G 4*UM98[D6?Q&63MT:"9T=Z.F R1EP0:_^(PUJF6*R$
M%,)7@W(+R$+9-D5O[66.C(%TO'^W1A7;;UGHZ8J0_9(^BG#>1%YW7_^0;ZBO
M+QJ#52ZCHZ,G3Y[4Z_6__>UODY.35ZY<>?SX<2I1F$^.T3]9MQJ/G'E_2S5W
M"?0>4=B6J*1CT$V.WWO=DKZ\J4?<W)3Z'E*:<*YZ04:6B1J+W:1Q;7E!.L4*
MS6)CVTV;B;!YJ#R4B%^BUJPFKU^!^R$;&3\ZV2E:W6(]DHX/%/)C26J.+I6.
M>,21&1A2AR)-]\L>0HPC\@^31YU[U3PQG]1*S?5%)[5BB%BKTG"$02@B_2"Q
M8#7!I:-HF5+5NS=]PE^\BOAT@%!_^L%ZHZTJ9$S($Z?&VSEMEK!!%8&?DROM
MQD(ZWL=;$]-OF=CI"I#[DCZ2!-]$GG-[=W_F\0_?.;8O:H-5&8J*BN9#J#^$
MQT+QG-N\<L?13?IE><:F!T,Z!MWD-%85&BKG:\V7Q=;S ZN.QFJBK-A4:\C=
MV78&GZL[VFR>MI1TN'NMN-YD+LTE3M9M8_:G >EXF/6CL[_5\KH62<<'"OFQ
M)#5'ETI'/.+(# RI0Y&F^V4/(<81^8<)0@11=20.=ZXIO9M+$M%9J:BQJ.BD
M-A2^\$@HP7.#VD#"8A B.H,7$3:1=([RG))$(1U%%*^8!2]$4I^(W$JOPT;B
M&%^4<U59F-,A([",R9P2A#F]M\A,@? 'FR.Y'A"==JLEQ):5.V84VZP*K%6Y
MPX-W[[C=KH3[?6O"$?-OF3^2G B&X)LH1@:K4CS[[+.3(-0?PF.A>+N/S*;R
M_G#2#W-;'HRXCD$W.2,^MW,0V@0*LT!HJS_H(,<]T.>BQBCM,L?MN@O'J]<]
MT._R^& V\)')R?6C(U$R8F)"C25A5&\$8@) Z4-A$HO,(<3X(GR^(.2)0/.,
MQ:16U+1/X525NXXT16_MX:D(D6)91*6CJ-I4WCG*<TJB7#I.P;!$YD_A@A+'
M@E>#\9:O(M8G F-@[D*NDM,! G'(OY4#-IQM!20.J^T2-1OV.[L(OL;D&A@K
MLEF5ME;UQU8ZWI];(T/,OV7^2'(B&,)*I+ 9%'+QXL5VR-RY<X7'0O&<VYRW
M>E5JT8ZJ#8V1C7,Y%+8E*ND8V.L(#58S39](U)HV1LU?9?VX 6]R^*'3RY0T
M+'D&"(J0E3)#/3<%>_.]=_%4C49;L0W78>D9E<T=%AA-P4PZ^C[>NOO\<'=3
M1KSJ1;C[<<9T3<IB_#T23TV>HUV6HS\,HGW4U,*/Q$77GR["'945C4T$**K,
MO'X%O#1NI*Z[L,I2D\.YKM%BSH8?4^=R(C%@%693%@SJT/:U"V[%Q"JL=RZ:
MU;JF"V %U0W744><;1M!G<WGHWBE/-S(CR6IY1VI=,0CCLS D#H4:;I?]A!B
M')%_F"!$B$#SC,VD5FB"Z%<Z5>5J!GIFS%,1TC:K$M)19%>8\LY1GE,2Y=)1
M74G@S/J54!($NBXNP5Q3>8_ZA-<H;C9EI_N%7<V[E0+))[7=E,9[@\R<S,G-
MO;E*;%;Y>037BJ5TO%^W1I)8?\L RG,B&#AOHE$/O=C(_C\D0VR8/W^^,"D4
MW^V6]83UIKT%-Y\5_I00/0K;$I5T#.QU'+W5I)OZBXJV86$&&EHZZA*UV1@E
M\WC2,2/76)SY8L+TC+<^:JE>."<Y;69R)?6 !H$?UX)H"E@)4&BM5<5XN:ZX
M #C.R2TOSIPQ<[K6_-&QZH7)R9DKEY6]"Z5C'?RX^]+=#A/84>GJ)G$3**H1
M4TV!EZX$TC'7<AHXXPE<=]LQ(@=^+,FF(S%DF6T>K\O13M!!':[WP:V85,H5
M*[X$PU88UV\*2L>.;52=,W=?#+&)>=21'TM2<W2I=,0CCLS D#H4:;I?]A!B
M')%_F"!$B$#SC-&D5A5B+*IDJLI;1V(7#'D*0605D492.H:XHU3>.<IS2A*!
M=,1/D*SNXBODH!Z;HF]NXC4S<GW"-[",1CKR2^#:<"HV-&416'MR;JY@PZ18
M43R9&I(AIM+Q_MP::6+[+:-1GA/!$'P3><XWO'OAJKUGQ/;NNYRA%?-7E2+I
M.#8H;$M4TC&XU_&4E<0S9Q76?R;Z5*>EHZF^=7>:MA%(1[#V2"66@: (1(F^
MX4Q3;JEYVQN&6G/Y\IQ,_:;:TI*=)^M -(6T7/"='^[ ?[&4[#C$[GX\=*YI
M39'95&BH,1N*BE95F,W&*F(3_%C3-G#+NK;<7%M9\.:&8E"47I^W%EZZPBAR
M7<.>FF+F(Q.)P5ABKC$4OE&<"X,ZV/M[K9M RH(9TXLL[2V;IJLFYQ*-I#%?
M3QS<4[&:JK.A^JRHKZM'&=Y8\O1]T7VK^XN^P#=,:HX>3 =.DN:FI,Y/SH._
M-8"]KTVXL4*[Y,B-<]4S%F0L4">EY)06K<6-.@-PP$N0A [#4O/V= U"GTS"
M9>34[%TGZQ:KII2 S%0YM//>&=/!PK)E*[@6EIZL6QM2VA"O?HAQ0FK ^ .'
M?+>:5J_?75-N[F2F=U*G2*7[90\AQI&(7TR("#1/3">UZC1,S9G.\V2>DJFJ
MP%J5GJ/S!8EPKLS"DXYQ:BR-4RT94T;9SE&>4Q+ETE$+_$&P7<054<'FQQ5:
M!R[Q? A%K$\$!J61&JR..&Q[])Q;S"]!H'!$EPKY"%PB<8>%X)#04E0@4T.N
M%4OI>']NC0RQ_9;1*,^)8 B^B4:OOKNNM+AHS;KRVH\YVPL5OJH:(,)4,1Y2
MZ<C=Z^CWN-UWI78D,N$3Z.V.]%9&L-V1#KO@9$,@4*7U@1V/[D&P'9()P\#L
M?@2[(H6['T<]KKY>*B<=E<'O8S[Z_W_VWC^NJ2O/_W=W?NSLS.SCD?UCOMO=
MQWZ7[\YW'A^_\_AV9]V=&:;[>=3UVTQW'!QI996),,BM2"U1T+A"C8! 1'Y(
M;D63JE&,6U3:J'"MFFI9-:U22ZFI2BN5.)92?T0H4*"126A,\KWGW-^_DIL
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MQ0D'_6/0H0[PF@,6+W*.<$+^X2%?T$\O.1OT@96#_KMW_6,C8)4CF3$ G-2
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MT^G8,LO)$SARMZ,$.98T" 0",1F(GR\(! *!0-Q'8DJDF FD! (!4CHN6+"
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M*> ]MF*A85TF/;%I?C2OXEQ'"V8@+C@P\'%^Q9G/OG#5+)CYXZ?T^Z]X#H-
MS2\P^_D+CH*G?O1D:O6[ ^27>JBUL)B<$<D'O0$S;\K15IWK=&#8?Y^FTE24
MZG\""Y^)=W394\ DX2;(2X")Y ;O#Z8.L!X_Q?[[HPL'<I_Z\<Q4<]N =,I!
M3#*3J/>XHD*W7*9%,W\T1[_OXU'O:=.")W_T5,&^*Q^3]_HG5>]><RS3S-1A
M.L'?S/VGQZ&#J**#GEF4Q0V&>T.ME<7DJP97_@4/;Y32(U"'T6-J9KG=IH-O
M=7XOG<RRT_@T5:[)O@,-L\0>)HA'DI"WHQZCM9%(.E(2* G#3S%6*5\W 0U6
M2;D$)0U#MPD@!+7&1MKH-.HA2H!HD#<<A7SN>EI2"*0C;6=+PNI/4=8\IE8*
MXHI"K*:4250Z^CIPH!N%IM00-+*"+N.+)1:J+;,+C63'R$H@JC+)6NU,>6T)
MNCUIMG9VDBKIJ)$3V'(JBVX+N)_-G)F19S&6-V"RB"O 079((S07<\U13AP%
M.-YF%AH-2;+W7:Y1B&D--Q.%^]OM%:M?>.&E]2T)2,>?0/BB\=O?_G9V=G97
M5Y<XJ0J.'S_N=#K3T],O7[XLCN.Q>?/FHJ(BM& 5\5"3V%CB7NN'6@U:Z[MO
M&;6V8X>PA49[,W'4828UY.P<_<)50#J2;Q5#K6O(J><)@[-_N-.B(V4A1LZH
M=J,6VV3&4O3;=EJ;+HV&R2FM?B%8J$-+1TSSQ&S]BPOY:<A)+QF'V^?R?Y'\
MBV3<T20C'=DZD'_8C-I<LWE9LAZW60]?ACOH$%/*5$A'\K8_N<+9[^MROMY*
MU"Y<X;P5Z+3.!@-CIF;.VO*5_TK+1>YOR3CT!N'8:;]!K.0-!O(UQ6#W^+GR
M&ZNP'_-&*3T"R=S4P/N"R)F=G)R*MY_&GR23#78YC[1[A]PX1KZ!>04E/Z8D
M]C!!/&J0LF&_D9)&A85 "PFE(Q0GDE67H6Y[2A(C$JB5F2*!1-F.9'0:U)E)
M6OQU._F5%TA'2FGHR&\Q+SDL1U9<T:C7)XE)1[B(5]ZZR&A@J=RBS*=DM6^<
M L);1D)3E<EML!?*:4M*>>IL]O*9L:5CDA;+DJN&5&5%:4N$,07+&C!9Q!40
M0MUT]@Y&3RS+^&TB'W9(E[ H%FFC$-,<WDP4\GNONMT7N[QC?#^9*J>J[T,H
MT?B][WTO+R_O\\\_%R>"E):6BH,D7+]^W6@TKEV[=G!P4!S'8\N6+1LW;MR[
M=Z\X0@&5;8DM'4,]CES+1\)'W0UP<.*RLJV;#9G9RTVM;8?UP,DA[GA5O^)8
M[R7K//S=3AMF:.U@-AJ-7+$7D2FK]UK-<(?2H;<M6D/KD/=-P_J3G2T5!>L*
M,K'L_/W.)N!/):^T;$VF3J>W7?:!(QEK8!H;X;W;0Q1IDV?_3+/D,'6N!N6W
ML_W+4=?.AG>;H>0H7XR]R*M2-I9N=%QX:VL3.H/Q/D&.I8R$8 H@YS.M5IN*
MN[MXLFUN:NJ_@AF7DHZ!]JJ?4+\LCGGL&)2.*XS8W!7'NSQO-=GWE.MFK6L=
M\M]P&*O:1^"#'DK'.?-3G_R1)GOW&39-?P=\@^]K-<Q)Q73)<_)69T21CFFK
MC$MFK7CS,T_K?OO.<MU<0VL?O^&(J4 \2B8&52;YKC/+Z!H=O]:Z_VVB5D>^
M,X&=+4 Z:L$/\+.UVEFD7.3_+1F'M'3L&.8/AO#G#@QO#X2Y\NV;L)F\44J-
M0%8Z]K<:?CP/6S)GCF5'S2PRF<_3RDK'$1\:9K$F)L1T ;[?4P9#RH8E7K J
MBZ(R9%!( *U>T%P)M1-?.E)R5+S[D9(*4G'%HEZ?)"0=*:.KC/:C&'#A57;B
MA&CG)]RM1VDP2JU)38),9;I;C3+F-=![9"_U=H ;$DLZDCJJ$UY%I/HD*BM&
M6T2_",@BKH"0"4M'J@)  P>A+)?J6$FC$-,=;B8*7CI@_\#KO?7'8TTG[G#?
M8I53%2L=GWGFF6/'CKF56;1HD3BSA*ZNKDV;-F$8=O/F37$<CY=>>NGYYY\_
M?ORX.$(!E6V))1W#MYV&V;^H;A>>,P*E8SZFVT(^4&Y %0>=')[<A3VQK+QT
MWLP*<W4.AA54UYFA=*1]:?J\%_Y;KUVDTZ9C2\GH8N+"(4/JBP8=.56T?DH4
MIY6_NAVHP>*&??BRM/3<?5?&*>E(IL'*Z5=Y<"3C&JUND59?#:5C&=$3"-]H
M*=9E9Y$FCB4  (  241!5.M>U*7_1%-]@5>EI8:"N9HG3? X1\3](-I84C8B
M\<+)Y_**'_TK[@Y\06!/:7796'9J\H_TS>?L"W\$I>-,K4Z7KK>?O[!_Q;.I
M:<^F5L-EJ"V]G=;93^=O*EKTK&[1LW/KVD?[748C'#.,=,2:SNW/_E'V*_LJ
MTNDT0U Z#KF,/S7L[W@+3'R:'Y%7S"ZWX/#2[!]4'8C>"Y;9<PV;UJ0^NTCW
M[*(JYF01Q-2A-& BRE&QP\>O[E\R;_[\^3GVSB'/_B7/IJ8_FPY7HNIQ')M9
MA5<EDW*1_[=D'#)6QSOGJKG!0+X5Y<)77JY\T2B%(Y"6CK6G6DO N&O%4U->
M:7EMQ;/SYSV;\]H5WRAE=1S@E_RX$OUA@I@NC'LO?4+[-E$O':E7?"410J]=
ME+SWAVZ[2E(T6I,+""V)=%2X.J..E*2">GV2@'2DK'\2HVL,*#,LK: HIR\2
M<<A69@"H/I%: QH/J&6J2U1(QQO,2E2^1A6I+#5MF8!09_T;<<9/Y<0*4)*;
MKJ&\CD72\;&#FXG"7UT^:#&3V%PW>.?SJ9RJ_@UB4<'O?O<[<68)I&+,R<G9
MO7OWG_[T)W$<C__YG_\A"**WMU<<H8#*ML22CG ]?:Y^]ZF.Z[POWPU@3@SW
MN4QEEL:JPKW'FR@GA_MWUQCT6GU^AN:GQ8YS9ZP+-#]98S_J]M[K<]5LLC76
MEE1OK"5ZO T:S8+]'6=VEE14U#:?<F3.T::MLQRVKBNNQX$KSC<L:PJJ&FU5
MUO>'@73$<3)-5B%/.E)N%7$S]-L)EOZ33Z\GB]YZUSHG&[<+JK1A0>IZ1T=S
M:=WY470*XWTAVEA2\UI/$O0-#OOAJ9[]7I*^H>'A47"6YN"(GSI:D_:O$_0-
M -<[D;!_A(P!V:@$,)#,[ANC9CMX!ND82$.5S*4)^H;O!NGL9.17 P-]X(+#
M8]2EV3^8.I!IAH;]03(0G.[)U1@Q52@-F(ARE*IPYKQ6R@</O)LA_\BH/SCF
M\P=\PZ,^_M\RXY LX>XP[;F'&0SA@.\N\W[%E2\<I?38A@,/#$MF$++GWX+Z
MC, _>"4_KD1_F""F(0KB30*UJE!NCQ_UN@](,39V"%VC4KE8;2.1CI1-3')U
M:DVFLN"A](DBO"LD(!UC2BDY1,8]6@+QO0I%^)6!>HE_":CQH&2*0SK*K)X5
MJ2SJ8PPA)Q!O,L3H;:%OI!B)Q09FL=&24N"B88:DXV,';R8*^0>'[H;O#@XF
MLF!U"40<*D=V=K8X2,*M6[?>A P/1W'B%7G__?=)]6@RF<01"JAL2RSI" CZ
M_>.LHT((X[>0? LG7WBHC^%Q/V#,=]?O'_$%P-O5V##Y+DZ]0E'O4K0C1/J=
MB4S,N$DDW^;)MR1*+9!O6@'Z18HJDT[#7%?BMY/6"=2KFZA*(V-D8E9%(*8:
MWE@*CW?N*3W6?JQT3R<S=IC7]QN$ 9SJCC,/7Z77?<1C#A@8ODZ[ <,RB_9?
M>(_\(QO#7=!S#(@*?4;DIR0__81&\Z_)VB*B!ZR-H,>2UPE&%_4O6Q3BD2+6
MQ(28=JB2CB%?=R.6Q/G($4"50).D+3G%J$=*V/!E@$0Z>@E,(W-UB7P2H5Z?
M)"P=8\@M(5+CGNPI';S*0&W),TO"U:KPHZ3M4:1CA-G*R!I[12J+JD:LML"[
MD%!O2T\KB9(8(+Z*9#VMW"D=2#H^=G S4?#2@7U7@Y% W\G7$UBP.@X1A\JA
M)EE75U<-Y,Z=.^(X'A:+9<.&#4>.'!%'**"R+6JD(P*A%L%8"@^V52RI:!MD
M?W3@2<<,>*H[>JU'1(,<&$'W'OR\FUB+&=<46\AW#E^_%_ZD'4,B*H4C'AW0
MQ/38$5LZ,KH1:^R.YH<SPCA'I64,=;B%4&U*I..$K(ZQ%!$@8>D8C]51_GP1
MB,"-#;\R4-2Q*S.9U:J1N*5C1+AL=>JLCKQ"V,7)QOV2HSXEB:-!&:5EB;(*
M%S']X6:BB2U8G5RN7+FR:M6J39LVW;@1;2@ZG<Z&A@:'PR&.4$!E6Y!T1$PF
MPK$4A(>V<],D)QWQ0_!4=_1:CX@&.3#" V=,1NMA:\EZ>T--^8[&JNI#:JR+
MWJ-&8\-18DLA<T@T&F./'&AB>NR((1WI QYCZT8*SNT-];JO#'5%A:N+U9$8
M]?HD >D84[@"Z>2DCR2!'RE#F3Q\"2JH#&_-*K=:-9* =!0L6QV/?Z\CE2:*
M5!97 $*K/LG D$VL +?460:>219)Q\<.Z4P4O/SVV_%;'2>7-]YXXX477B#5
M8U]?-%]Z__5?_[5MV[:ZNCIQA (JVX*D(V(R$8TE9J4Q#?/ZSAWC+@Q'( 10
M X->SP[W)=);"-DQ0XTBZ5@">?H&?#[X+\B"QM@C!YJ8'CL4Q!N /LLQ26LD
M/&IT(X"U*ZJ3CO*N=Q(3,[(D(AVEJRB%B!:C4DM&96HK67LIK RW9I5;K1I)
M1#I&>,M6SWM$*BM&6YA;(/9,PT=< 1K:UBIRC*206 9:\4J<";&2DMT B:3C
M8P?/ZMC?;M]2M^'%IV?\?[O[N7.S'LA4Y?%X[MRYT]W='7W!JL_G>_OMMTF=
M*8Y00&5;D'1$3";1QY+2Z[M2..(Q)\K 4(J*-QSQT!+]88*8ABA(1VJY*?!\
M0W3+B0!*(4B.X(LA5"0+5N7+43CD@T.]/DE(.D8]"Q&>4:GA7.!$:;)8 HDJ
MPZQ9!>= <LHS(>D889:M:C%,*U19C*KD]J#RF="YCG17"!:7*B:6('*0PT<D
MSI%T?.S@2<>^LV4+?_O2FNWGAA)PDS.YD&JPN+BXKJ[.[7:+XW@L6+!@SIPY
M'W[XH3A" 95M0=(1,9F08TGT>RX?\O5=' 11"D<\YD09&$I1\88C'F;$SQ?$
M]$96.M(&);[G3!&,R0C;WL'L=@MY.QJ!E5+."RN-5#I2!D:RG/I3E+<5>A^=
M@ABC4:]/$I..K!)+TC++[P'0^ST&Q!+;QN@K0IG6T88U<66@67)A+9[/KE:-
M)"P=V66K &$LW1:RD_%FEX?ILG'8F%D@.7UTBA+B"O!@-BLF<#A'%,D=86+I
M;D'2\;&#+Y'"_B\]KB8</^[A>0Y](!K*X_$</7KTX,&#T:V.7J^WM[=W__[]
MX@@%5+8E0>D8ZG'D6CX*1@)>EYEU=B+#O2LVK;%UZ'-"GYJ^8.'B]'G:]+2T
MZM<:P)&,N7FZS/6N#UK &8QD;%9U^\TN&T8=@7VORZ8U.#\ARH0)AB+>(WKM
MPHR"B@TU3B]U= >[TPE$I6/9&;KGM,G: G-9M=F\#F0ORL8RT]/T]BM@Y7U)
M.I:E2RNPO>?$0>#J N-16$XUR+LL5S=OKN!"2Y<N7O?FQ\=P:^=@#U&D39[]
M,\V2P]31(* )^18R):^-NHP<8_TF0^82K-IF,=,UK"VKS-<^K?V91O,T>0E+
MZWM[08*-VRPK4UBWD-.&Z&-)R?*C%(YXS(DR,)2BX@U'/+1$?Y@@IB$RTI$6
M/ JPJH R9XE0LFY12*4C:YH3P3=D2:'T2118F4&I-7G$WCX%A'P>P@@5EX19
M6/UYNHTQ5WM2LHU.():.3-L%1K]$I6.$=T?$L2'O^7I*)4K@BW\%Q!40P"Q;
M9<2SREM#V15E5ODR\)<!1UW\'/4N(AY1>%;'_O9]KVXSF\U;G E(QQ$>H9#,
MEW3KUJU%$/(/<9R$-]YXP^%PO/GFF]&MCENV;-FQ8T=]?;TX0@&5;4E(.H9O
M.PVS?U'='H@$!MU[-LD\-2C" ;<U!\LI(,ZVX$YOL#U/D^SP#KLMJ[&EI.Y:
M9RY;D:K/QXRU9A#KMM28JW,PK."(-SSJQE=@V%ISW6I! HL["!1=6NK"%_-,
MQ^6E8R'1<XO\V.,E+&:S 61?@NF7I:?G[NL:)[_SI=GZG+1TP[[SIZT@\.75
M=#E0.A9N*JL57<CR[JE*;<4Y>"PD=:KD&JUND59?#:5C&='CY]JHGS=_[G-/
MS:EQ!T,^;X>=3*!+U8,:]@!O,1<.P4O8]V^QPP3]/IYOCVE#]+&D]/JN%(YX
MS(DR,)2BX@U'/+1$?Y@@IB$RTC'ZVS]?0HQZ7 [:<B4V:LDB)QVA,>\H=;(\
M4P[!<T(C1_0::B9#.D)\'A?1P!.0LS#\=<X(29L-Y7;K<?#77DJD(QTK6+0Y
M >G(&AAE8\F;1=B!69@"&%2)&/>+0EP!(8RUDU[!J^[6Q)3<3-]"LR22CH\=
M@IDHV.^VYS_SAWT)2,?O0V9 AH:&Q-&1R,]__G,JEOQ#'"?AXL6+)24EI:6E
M-V_>%,?QL-OM=75U!$&((Q10V9:$I"-<*9&KWWVJXSK0/_93;L%9.BR#;;5U
MCHY6:TG9AL)RNZWP-S-3U]FM:XM?J5]7;B>:[>M,S6W[LD@99B1CUV&+7ZQP
MG#MCK6FZV%I;X>@XLVVN9K&#2U!2[+P=!HX3;?;BE7DO5]ML9JMC!^='$?Y+
M$.]Z/$<9Z6@ARR>?A7.K&FQ5#>W# >_A+,U<4Z/-7&_?5@("-VQ8SY5#$+O7
M+2T17@AO_>1-1N!1TM%&4%9'LDK$49?G,ZZ-M<0EYX9,_9IR6T-5R4:@0FEQ
M2TG'9GB)4VU'7H$)FJ'$E3Y2'VWX8RG<?Z*TVMY09)><ZRB&"X?Z?UG>TB+Z
M#J[0ZC(Q_#4;=0XD9\+]2>IA80+6"(R81B@-F @;%;[M+*W;U[#)UDF_22AE
M40I'/+3$/3$A$ @$ C&I<#,1<)-3L?J%%UY:WY* =/P_(?\;,CHJ(YK.G#G3
M GG^^>?%<1*N7+EB,IE^^]O?1I>."Q<N7+QX\<-SKF/0[Q^G_622,.X-A4!'
MFI%PT#_F&^[W#OB"_N$^[Z O>,]/?O3V#X^,!<)D&C_X2,92WCC)_X"_P)IR
M_XA/D"#".DX,1H*^ ?(_ C^*Y+]>+W#%"-PMAD$V/\P>8!TS H>?5$;66R-7
M#IEW:%AZ(<YY(VP.J"13);()H*YT&^_27D,#O@'01G[GP%S4)<CJ!6&",-\M
MY+1!.);&V!7(%$JO[T+IF%%HKJQEI.,S\U-S;"UVZAQ(3H<?87X=8!+01N!I
MM?H7H31@(KPHN+B]E?W-0"F+4CCBH26AB0F!0" 0B$DCYDP4,P%%%H3]>/+D
MR5T\2-W(1BU9LH3]6PF/QY.2DK)]^_:1D1%Q'(^WWW[[#W_XPYX]>\01"JAL
M2\+2$8&0@3>6PL&>YO7U37N-UO91VHNQTNL[3SI"2^SP^]:J[;:J[0Z;M>72
MD<(*>P-U#B0K';O.BA/01F"9'W(0CRY* R;"1@7_Z%B_M7EO95W[(/4;H%(6
MI7#$0PN:F! (! +Q8(DY$\5,0"&2CO/GSY_!@Q1X;)0:Z>CU>D] ^-(Q' Z/
MCH[^Z4]_8D-V[-B!X_C#8G6DW>2$KA_*STC//]PC;SP+^:XT"GS&$-W0#-5!
M4.L/[83=@&&91?M/-T(O-=O;1[^Z8B_*S%YNLM7F:A=E8&:'+5_H66<>7*!X
M?CAR [JE68X[7H5YR[9N-L",K[ &*ZTN>UGIAB+@#L?:;#=HD[7/I:>EZW1Z
MVV6PSK:A$7K*,=4;,> XY^1K4);D:69JP=)'QPZ]-FU!&MX^V@M\_&2L:W1L
M+3W6?JQT3Z?_.I&?DJR=I4D]Q'.QPU6^^HB3;%=VCLE6MQ;XZ:FM-(/T!>:R
M953E!X&=Y,075.?0_G)T!7G+0?U;VPY3[6H?%'?GHP!_+(7]=^\&P]2_5(C2
MZSL73EMB:9LP9^,5FW E"6@CL/Q 1#RB* V8"!L5#OCN!NE_^>$2E,(1#RT)
M3$P(! *!0$PBO)GH7I!ZFV7^*TD0#9%T'!H:NGW[]K9MV_;MVT?^\=577[%1
M:J3CM6O7K)#^_GXJA%2,]?7UJU:M4N\41XK*MB0D'3DW.4&_[U-'98N"=/2Y
M+91+&,9G3),#!XYPJNM6@_6'!JP /^\FUF+EMGK:P\TX=%$#-G _.?.9E+DY
M.T_:7R4$GG66P06*EWU .LZ;/U=O.]D \N9CNBU4QJ<P3CKF%#;LK:=]Y'Q!
MX$>[+^Q<ED9^NC(.I&,3])13NW.S'CC.>;N))QW+B'.'<.)&T&VWN+N =$S%
MK)<_;ZM84M$&C1M !I\#VA4XPJ%<[+"5]]T@<(O;%_$>P33)T,T/=.(*"E\#
M*_^N"S@!6H8MW\GYRW$XZ(8#WZVP75>BV: ?6J*/):77=Z5PQ&-.E(&A%!5O
M..*A)?K#!(% (!"(J8:;B8*76XY_<MW3/^X^?IQWQ([*J4HD'2D:&QN=3J<H
M4(UT_.BCCUI:6O[]W__]ZM6K5,@WWWRS9LV:TM+2X\>/L\D(@MB]>[<:EZT4
M*MN2D'1DW>2TGR%*LE=LW$U<E5TH&!QP;>/YC#E:E+H4.L)9H)G_6IMC59YE
MI\EH/6PM*=Z!0Q<R[WI\MUVF,DMC5:'1:&HY[RRLVM]09A1ZUH$+%,^- I5%
M7')65NS?"?*V-.+YJ_2YLV=EK"JEES)N,-J;#UN*<FD?.9\3^*%SAZJK&FU5
MUO>'O<[:LHW 4XYIZ7-9E8TVL_4X == YJ<O+@9+'\_8C<8=MK6;G/T]A+'<
M;J^L:KT%EDI2PX62CCCE"*>6JWS-)EMC;?$K6\J,VQHKC,:B&N@'Z @C'6V@
M\GFK#= )T,(G4TM8?SDM'] -WWN\B6I7VR-O=92B]/JN%(YXS(DR,)2BX@U'
M/+1$?Y@@$ @$ C'5<#/1O6N./SS]'R]MV)BWR?DEO0]+D" J_PGY7,@KK[QB
MM]M%@8L7+Q9GEG#V[%F3R5104'#]^G4J)! (5%96;MBPX=2I4VRREU]^^>#!
M@Q45%6Q(=%2V)2'I"*#<Y-SU#?1YOQSR*;I[H5S",#YC@%\<,FP,N+^AG-GX
MAX'C&,Z%#/1/ YS(L*YN9#WKC(<IIS5@$>,8DQ<XMKGI'?)32QF9(AD?.50N
MOHN:>P)/.?0BR0"S]'&,=I,3";%.>N#R2-@LD!TZR!%4 #:72ND? 9>AEU-2
M[G.HE9;D1Q_M!,CO%_C+H1K.MDNQ2Q]JR+'T=P@$ C$9B)\O" 0"@4#<1WA6
MQTL'[(?M+Z_;[NSVQ;]@E7\X1W34',[QV6>?;=FR9=NV;0,#]'FDH5"(5*$U
M-37\M:_OO/-.5575Q8L7V9#HS%#7E@2E([/7\5I3;EHVV'DHR]3M=22.X[E@
M@^*502_Q:H.C+E.GTU=N-H*]BZL+J 6B]!;$7-V\N>D+LJK;AZ#WSH492Y<N
M7O?FQ\=P:^=@#U&D34[)Y_GS!-LC+>VCODZP61&K/7)Z#UG_').U+A]4F#X9
M(K^R+!=N1VP[8],:6X>&J#IOM.(KR=B%R_/RL>R<VM8+;^A!$[:U#W,_3DQ[
M$AA+" 0"(04]3! (! +Q8.%FHGO7CV^N*-M06;?%F<#A'),K'>_>O5M75X?C
MN-]/'\0:" 0LD(Z.#C;9L6/'YLZ=ZW XV)#HS%#7EH2D([?7$6C([#7.?I[^
MYC%U>QU/G;&N !L4NT: =&S9!G8P;K%N!GL77UYM.LY)Q\)-8*UL$!8+I&-:
MZD++NZ<JM17G1D&=;\!%IV3X(IUV!;T]DOAL'&QQ]$5\UXGRW>Y@$&R 3%X
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MA\D,?NB$AG(YX_<-^Z"C'?KC\,"P/P0SDLGNDH7[* <Y_D TCSN@A'O0MTV
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MC*(3,0NS?P(%F7C]H01*2- )%+0?FTRC0CHJ(3S% : @':.A)[P\">/K)HS
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MO7NMK:T+%BSX]K>_S=.,@%_^\I?_\1__(<X@X9UWWKETZ=(''WS@\7C$<1-
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M80+2,0@[@3):LALIX5Y'*B7M$4<KD(Y)P$@(Q6$2W+') *(8(R<M'?V\O8[
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MVBF:4A%$8D[MS2'0[/BX.-T%9Y=)KOKBM)$\<O7+@J*R$M \ZKK['M-6,]N
M_T)#E%[ZZ4=R(8M/*$-4>OCP85M_>.U8"FQIS&';MCSJ5_.4M===]VTE*Z/>
M7J@\<-7E.%VR?,[;\S(/7!]">CY><N(S@J!A&D]/-Z60O9-O>]IE3EOP=M1*
M7>N=F^;,>6_/B=55&Y*5>OT:F)UXC5ZO)!J^\1?>32V11:MM/792SF4P7M70
M<8*K\2J=LE)SOKV)4-$"8N70(>@=C'1-4-??\< _O7#2DS+KOZH'T; M.?&K
M(0-3$T6\'[WE1"<XM+P>V%Y!80XP@[W?G"19BB:^= P,# %>^H<)X]5C%BSO
M,,(&V%HP0L<LL!;.=2S'#*O@_Z&I^L'3Y(QQ'U[D.OIY:"PD?8VCJ-D(B&?4
M97IFD>VU&[8A9AI=>?K293%*R)6*F&.<S')\T;+8%&;]#5S'O.H#)"BM4)7$
MN(YQOY(5M NH=]:IJ^L@H<[FC4F0@:9G%*SOP3J^F9#)?K&AH&#A? *XCBG9
M='L[(M?IZK-7FMI&__O*;K*N_7*WH]=N_-1,FPQM-H/![NUMRD.L-O'ORG0=
M;%V "(=IY&>$;&%QZR6^=A6125ZPTUE$L?4A#*UTV@W;21W3W[RF&Z<U\M+6
M!Q=9OI^Q^S3Y>1/; !<W1)WW UA\0AJB2C.E U&7802_+7GMY!R5Y8FSTZ!0
M$(HYZRU/W%V60U:Z;,5Z2Z^[Z\2A-@>T&K>=Y"3F\D3D.H[?IU,61$?'DG0U
M$;V^TF2JNW*YB5BBK*PRUC56 ]<Q3:ZNIEO:.AI4@L+/=S1D_#;ZM]%DQR@H
MEB#M732QBB"6K+<\'.TT+B!*]424;$&*<L7'9EH;3=I?UGT,=AUC"6/G0'_W
MU>[^8>@Z+E]A;*Q#KF/R.CBM1^H8US%VK8I0(ZJD[.I]%< ,?G_AFSWLK2&L
M  ,#@\-+_S!AO'K,@N4=1M@ 6PM&Z)@MUC+N>=K]]1^^$Z2<CR1S"K$OTW(=
M>9J<"T<_8SZL5IHFI\D9[:G7\3PT9#7%4=2L,K<>2%+J %6,*9=8M58#F&F6
MRY8=O&S9JJFMXIAC +%-T^7F; U5#4AE#ALV98+2E,DJQE\:[[,%4.]\G%;T
M"2348?EU;-TN@>NX4J52*%59Z40&H*LYU?(9(M=INVNOJ+ -ME<4'[O-.@"F
MAO.'\W-S\^MO^X#S UEMDDD!S0\-&[F7-'_=7) 2G[U-#VM/-U25J(T-QOR\
M$_<@EX\QBTA< _I;E5]G;2 M#WL:6;X?YUVZ[!,=VX"'W!"UW@Q@\0EIB%K.
M4OGA[#K.S;>Y1KHI@O'NYJIMKK%;UMJ3=)E";7LZUOU5K=]UY"2\ZSAH5?UJ
M*;%ZX0)MW9':?9\7)\S=>.C"L3KJ\V+%W-]&STT-<AVYPNM-&0MC"47T0E/7
M<Z'K&*NV]?NZJ27 =8R)C?U7F4PY [N.@"1IJ]9ZGW,=2P _D[:FQ:@WF8I7
M?9@*I[7&1,PC&D^9DS(055*#(2<-F,%.REC"WAK""C P,#B\] \3QJO']U[>
M>1WTKFKF4:]0*+=N5Z.#0NH6P%NNURGE\43J[NFEJL+6$H; UH(1.KZWM?1R
M!_J46RO4[+$OU@5XCTNA-QWXK66\[US1BO_\:-/N\X-^QS&RS"G$ODS+=0R9
M)@>2V/ \-$C-"ZEH?) [!M+,0 Z;">\($$.Z&IXYAJ.H@9J 5&84EL82V$P$
M4^\@0AV>@08PV7"\-2,>SS @S7%SE#8<N<[8S99#EP8]'M:10#5ZAEP>8!<^
MCM7&&UP7[ O3]P'W,P]'_ ,8>@!9#M!EJ7I0?SUCX"J.R(=M%=L _Q %L/B$
M-$3/'-;Z,#ZP.MQ=NWYQ;-SB6-WY1U=K5R]=MFQ9"M4YV%V[>O'298O74]:Z
MHB)K'S,%O.3$9P3(R$*DK9*_IZIMMY++9+]X+V:I0K$DIM3<HHE?K%BY.&9E
M_((T<$Z5Y;]5$77'V,++-&O 9<?(V-54=S_G.FZL.TVM7AP;OS@>'55M/$^M
M>%MI/EI%4)TO.W:"WG$D2=S?W*2/<[Q-:%J?CWK<0710G!EPMP8&!L9DF,8/
M$\:,PV0R)24EU=75H3^_]_(..@--E>#,Q0[C=G10J.2HWQG(IE]PB$D"V%K"
M 965E6O6K&EM;45_8FO!>!&>/7NV9<L6QEINW[Z-)-_;6GJY WT9.ZJT[+$O
MO^N(4NA-!T)K 5N.MCJ2/-J-=QU#5,7 D$2@+3'>$?+AX4?6T>)<Z''/T!#T
MT 42X%TQ;K_3.02N\KJ=PX# UN^1,Z5Y@6,/7EB 8N&;"Q];.%L@4]H0\P?\
M]SE\"P#*1Q2X\$_FKR&/=]CY\L2V^$[!P'AMF)G;S761C8$/V*Q(4RR-41"K
M%8H/03P\LZ3PQR=_=1*\MUZKRM30CAX8I!"K(-+2%4M1!+MK8N@ZE0-"WTW;
M,T 8,\K\)(QO;_Z6#;,O2F,W1N[!T :MK=,,%C% <W\UN?\$+$=GNW/=1*B.
MM]* $2!37Y0*7I"G)RQE8_Z9!UV_K7S_V6-JN<EZ+%$V/V]KAGR^_/UW8QOX
MO%.Y,)A_[98].U6)JU-*+!T-J#W[JXDY4?+X5$/M"ZJ;*XO=C>0BU@#JNMO'
MK.U^_O.?O_766__K?_TOK58[,0/+.\89((MT&FV-J6157!(X@E%8N$5G,NF-
MYCUJ=35-G^UV3V>!-Q/6PK$S!&]6U%8#&^"MY>;#X*TPTPEJ%[ 6.-K(NB!)
MP>"$NY-2$<DI9=8.LRK86JP7 (7!/4C*L.!]F6P^VA@!5KH-*J,\U8'6<NID
ME5QM[>]FIT\V+] X&8/_NKS:>DQ%F,XVE^45E!:%;"VKDG+@W0'ZJU;E,LTF
M2%O?99-<??S;+T A&5N+RMAF<,;/C0,,VO_HHX]^]K.?(6LY=>K4Q _$6E0;
MU7Q2<?;.C2>2$X"QR'/HGF&IC5.QM928RK,@VX7%@4)C>,*+H*?$I-;"S".D
MWIAD^M*"'F5":ZE/E"W,TV?"!]?6,C:G70^MW&*YUVY82MHNUT!K,9:GP?:8
MJU'[4]/7O+"Z;&A%?N,/L);Y\^<SSY:?_O2G,IGL^O7K$S-@+;W<@3[^V!=]
M%)P"*U7&K^92Z$T'?FL9=_=VVB%N]0O>^\^$.84+0NP+=ATQ9A*1;4N1W3L,
MC+#"S-QNKG9_#+PB5LEN5I3"5501W7,+!#4P:O[XY+/?@/?6RL*-.H'KF*LO
M(F$$.V7WV$$D/+-,8<.8B]FDP8+X=MIQ!\5*<!LC?$Q^LER6#C4W$L7*=%".
MVW'W# E"V9O!:A*LV#:!%^1@]89B_IG5SO_TF@M W'U6<G+R&@U:U774*^4K
M%?)-L'8E#.;_.UD4:?=ZX2K6P-:B8)R9A&SZ=(-VTNK.TZQ<S!IPH&ML_-UW
MW_WQCW_,3,1/?O(3YO/$#"SOT-$>]LP%^]*0>_?'Y[F:!F;"6GAVAB-US*0K
MY%'L9L5I0(_GMQ;Q5AAULJ[*[SHRUE4&20H,C+' &43K^R!KV;;H[00X$>/,
MX#=WH'D';S%X9;5_'CEKN4MK4HB43/K^.)J^(./T,N-[UYS'V$EREF*=WKP?
M6E1HUI(NDY4R=P>PECJ9+)UIMKOOKJT"5G>'=21X:V&-/Y\=!QBTS_@ ?_57
M?\5,Q-_^[=_^QW_\Q\0/Q%H@^X9"OIZE,T OC)B[_B%* "ZVEJ"-4[&U-!.R
M:,AVT0)<QP#"B\"GQ*36PLRC8B,H1SQ]4UD+\WQ!+\O0@PM9"V/2"S<49RV,
M4I,D!:TE748T@_:D*[6@_0G,DZJ$F+PZ,[(B?PN#K>4O_N(OF(EXZZVWTM+2
M)F; 6H0'^KA37>C/[V4L0FMABKM40YU^\#B@K)DPIW!!B'W!KB/&3"*R;2FR
M>X>!$5:8D=O-QP:99\2KOH3+M3*X6;$W=TT^#(F_RKF.];&R#\&+ZHK/C."]
MM6Y+8:'6M!N$*X-(^T8J-QU$L.<=>\*'V:O5)2",.1LNQR>);W<X6KB-$;CK
M"*+BUT7)8F YGU:4&ZEMI:::TC4?K"P$H>S;ZL[5PT5A"7A!3N6O 0'MFH-G
M[=UN&'>O:CQK2B3T).<,-+,?0.WE*)A?I=ZB-I@TV=3I.@U;2_(\>+:_E]9/
M6MUY()^<-:"ZS?E\WKQYS,(.+>^8SQ,SL+Q[59@):^'9&6I,[*YC#-RL.$D!
M&^"M1;P55G7T:!6P%F7"*MZZ3/EYED?C_6=*U)4UFN)]I^O( &NI4# K?#01
M=VY!UQ'.NZW;#:R4A,HH0EYH+>MDL@_JVJW&?/,=X)F<!R'W?N,\<+;CMAO0
M!ZQ4';.:%F[P&TDHUO+!_+7E)/1V>IN4'R84[ZG1IGT04V0&U=6>:X"^!V\M
MK/&O1>. @O;????=G_SD)\Q$_/2G/_WHHX\F?B#6 M@WT*XCH#. =RZ\Z[M;
M.-=QZHU3L;6HU3G;&@';13-P'0,(+P*?$I-:RP?STRI-VR:=OJFL)15ZGLAU
M1-XIO&1;CDI.J')V6:PDM);<G(PBT%I#A1X\BWH9SU!OF+RZ)F5L7(#Q!UC+
MSW[VL[_^Z[_^R[_\2^9#24G)Q*RPEG&'5;LI9^/O_O?RSZ[C ZLAJF)@2"*R
M;4G0.W",1)&:IL@I YL2">O(XS0XY96V-G,%?TQEDUR1FJ[(IQUC[NOHL,>A
MXWNYLV'HJK8!P1F5M7+%!H-Y3^ A$.T^ SP&8VASC=TX?*BI#B0%V:C5_WY&
MPUQ'>\Q%X,7AH%7USI(2:E=6[((EQ64%($M-WSA[Y _FE0&]GB8S 0;&2V&&
M'B9HLV*4"U,?@>^?!YUL2#R,V =:8YY1%$L?'*[,!L\[!]E@9J ,0]]1B#L,
M1)\\OMV_,0(#U]G >U3.<_\+<C:4?12T!<7,@XN<,*!]U-5FO>!\/@%#[L<]
MP\-(APN,9VL'I<-@?M#:01 YS[:'C;4.>!\?4!WL_N2L >#Q<NW:M7_XAW]@
MUG:__.4OO_ONNPFXO M/S)"UL)/.L20,PKD8X0@46&N99"N,O1!-'K0N-D #
M1&: T15;RS _$; ZWEAX,@4V0EYH+:YAQ)O S!PHT!MHG -ME@XGJ)&QD^>0
MJ8&O-!1K@4;*6LNH_ZY!U8%KD84$&3^WO3,QT='1\?=___<RF>S7O_[ULV?/
M)GXHUL+>DAR=@9.;2$1=,9FU!&R<3F(M\!(XVCRK0L!MRS\E)K6649[X(VCZ
M)*S%/\7\Y,('%V.I3 F@)8/L\Q TGJ,O\3\Q@JN#5AUD_'YK(4GRYS__.6,M
M2Y8L0:,9/$EA [^U>*]\T=1^GJK[VDQ]*:!:G"%S"@N$V!?L.F+,)"+;EH)=
M1W#4A,O7\LT)]I37O:/<NT;&=<P1' [Q.LS1LO2V@"POUX?8,VEL7$T!?;XN
M\!#(HPXJ$QU-&;-_3K9=14E!##0U@WE9QI]85'.6Z-J&?+>.5.PMSZF^<&GW
M'NNIO6R6&O;('\PK WH]368"#(R70F0_3&8IYHIV!B0ED@IBB:2"6(*M)0PA
M.6MBB:2"6#(-!6PM80CQ-$G.HZ1$4D$L$2OXK<7WX(RAPMPY\/2;UBZ\ZSB5
MJN\.G147O93J#E@L#K:)B 3B$[*K/M^:J%"DK5F[ L;(YL6\^SX;6@UVP,OX
M<.V]<#O%'SN;'T\D*>(R35R.>(S9"X$M#7>;,^>]/2=6=_;)H],ER^>\/2_S
MP-7KMI*546\O5!ZXU$TK9;*WHV+UK8 Z @)FY@!9-&31:MMC!U"0R=Y;"YA7
M687:,Y1"]@[(^=%CSB?/MIG3%KP=M5)+Z3=H8<SW*T: ZXA"V,$Y-)"OI=!D
M8$]Y=7W)N8[H=%")FFJV4)^ PQY9FO+<PH L+ZT#PC,J(&4(."LB/ 2BT17E
MH*,I3KNIV&9'24%*M)H9S,OB<]AI,D-)6=MH0WX967YHO[[8YNQI1%EJO.R1
M/VV5]01@CYAP==MO3R_<' ,C=$SUPX3QAB!>5TE*)!7$$DD%L01;2QA"<M;$
M$DD%L60:"MA:PA#B:9*<1TF)I()8(E:0M!9)A5F$$/LBY3I.C(]>V5=NZP\4
M#G:(B 3B8Q,+*TMA".R5>^B0-#B^CSX(#D]W-&O1=HH_=G9ULC(E+EYUH&LX
ML!:,V8< YXI8HJRL,M:=.ZU?L=[2Z^XZ4:--_M5ZRY/1RX8%J7K]VEBRH5:E
M(&F*D*LIFFZQ.WS X\KX;?1OH\FVNW2&7&VBU"L(?2FKT'&Q(65!='0LV?X'
M:DD&W6$FHM=7FDQU'2?T<_.MI\JB21#X_>H@Z!U[F,1_#HT_Y15P3(4_R<8>
M#0K.\H(T_6=4T,$YX2$0 1T .+!Z:0@<%W'>G_&\+-Y1SV"'Y<(31$(+T]7P
M66KX(W^PLVS?,3!>+:;\8<)X,Q"OJR0ED@IBB:2"6(*M)0PA.6MBB:2"6#(-
M!6PM80CQ-$G.HZ1$4D$L$2M(6HNDPBQ"B'V1=!W=]HH*F\L9L,_@NUTO)A*@
M<N5SDF ([+FN ->QKPW0X^J-;7W(==0;J@("QQ4R64Q)#5 8$-2+,2OAMZ5Q
M5_>Q.NKS8L5<0I6Y7&U[.M;]%:5-CE+;7+Z;U)(TO3XUFB@RU+4Y[C<)7,<^
MJVIA+*&(7F@X69\A_SB+F+O)<MG,*IPP9?QJ*;%ZX4+#GFW19(?SYK':?9\7
M)\Q5&783*K!E]XHQY9V"@8$QD\"W6QA"O*Z2E$@JB"62"F()MI8PA.2LB262
M"F+)-!2PM80AQ-,D.8^2$DD%L42L(%C6#M[J>B)>:$:2.878%TG7$<:\BO<9
MQ$0" CY<?XPO&]K+YO3SAVL'Q<YR"ABS'8)[K.^\)GZQ8N7BF.U?M^]?O7CI
MLL7KJ4L7:U<OC8U?&JOYJK-)!:G_)B8<-!$E5Q!$<K&USV53OZ>J;3]&QJ[,
MS5U#T%V=AK@%Z6OC@$+BO\MD,N9+*QDK3R(^V'+RYFE-[%*%8DF,AOQD<9'U
M[&<$U?E*K4API\P<30XZH3HQ K(V6=M!*&."NOZ.9^QFRZ%F2BE?D9#QB?[S
M\_VO=)L/LN-HVP9]=PZEQ:22YR[;-%OI^_? OXQ#CFER,-X$IOQAPG@=>/;L
MV:Y=NW)S<YE_>>*3(!U)B:2"6"*I()9@:WGC8"Q$I],QUD+3-))(SII8(JD@
MEDQ# 5O+&\>#!P_$UN)SV%MH")B#47(>)262"F*)6$%@+;Z1*WLWJ$KU.RS=
M.-8Q1%4,#$D$V!(X:OG$Z?%Q)QZA6^=U]\/T.N,>UQ#X"JDY'"Q=F&=H"'SI
M=0^YW4- @;D2498Y'(\?H]*\;N?33E,F:7>!2YG+'M%IFZR#WF'G*W[_$.PZ
MS@1-#NLZCG; 9&NZ\G3 @F/L?&RO-+7U-"OE<;$K=M#[C:]T3Y5CQ[G^'%"M
M9FVB+W48/Z7O/[(S_P+7$=/D8+P!S,P/$_OB8Y(TW((D[W=\CI:<^-4P7?57
M)T61_(%YM(>N!V1%1R'-*,G[!6>72:YJ_A8D>5^2@3*\@5<M,#F'2FL#<=WO
M!2=YM]VY+D[V#1*+QRV/(^%K&N9A4@12A*-$[2EE5L?8A*-9N?[(O<O&I5L,
M)IZBF2T9MCFUPEQ=F)F;.5D5VZD3G[,)OC.85M%D=0WW>BC@WF8\1IE,QO\[
M,=FZ2E(BJ2"62"J()3-A+5R2=U,3".IFJ<N24PVUU< &>&NY^3 XR;OI!+4+
M)L&#>1TG2?+.,SL(K<5Z ;PNO-<#K&7!^S+9_!<E>1=:RZF357*UM;\;3N5<
MF6Q><))WYO<%6!I-(HYN8"TC#CIWO:7KLF$]:6OU$WH'6$N:(H=Z@4%F(RL"
M;SQ1R2^P%L83F#=O'K/L9ZS%:K5.B.8H%(FD@E@R#869M!;51C6;G -RH8,[
M-YY(3@#&PKY$#K*629Y%@=;"S$X6N-\1GX(R%G[[ +Q<#GI*3&HMJY(X>G;2
MUG?9)%<?__8+P#.2L14FLPW=6M9NV;,3/B4L'0W08IF289O!'?$B@XS=C>3<
MXY'KN^E*$#]"7%P<8RV,S3#6<N'"A0DT3=X'UC*J]1&;@U%R'B4ED@IBB5A!
ML"/RY _'OGV">+8%F ES"A>$V!?L.F+,)%Z?+7E'W,CS#/K\*A'@.LX03<X$
M2/YFVE>LA,G6ELO>W4116[76[\!!\3_1S%=4GD;["630>67P=1\"[#C51R\"
MFIS2G.K+#]C&,_]ZN<QXF"8'X[5B9AXF[(N/S1N3EBD4L4H^#3=81?%)WB>8
MVS G>1V,U3_[C2B2/R"/M@<D[Q9D11<D>3=L)W7K"2*/=MSA,FO#Y. ^^*!0
M)2A5R7)9>E"2=\?=,_"U46"R;_W6,KJ7I5\&#Q-UK#)#P:?8!DQ:-/&+U.*"
MI3*9G&0IFKF2M;#-V>;S=>A=E;@*+9%N8A-\1R]7JM:IJ^NXUT,!JR*TWS@!
M?4CF\\1DZRI)B:2"6"*I();,A+5P2=X/'*EC!E ACP*N8THV?1H<$O%;BSC)
M.W6RKLKO.DZ2Y)UG=A!8R[9%;R? 21GOA=$]+T[R+K"6N[0&9EV_/PZF\OPD
M2=Z!,\!8VCH53RH!9ESYBPT%!0MCM"3)$7H'64MI4<D+#%+XQA.6_")KX7V
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MIU4B>O:T#V**S,!::L\U0-?QY:PE2Z7> I\2U.DZ#2IY;3D).\5;B\@@&7G
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M@5F)T"%ARP.00LUR#1TJ9H_R9I23^VW]+[WM%B+\O6,C.169Z>O L>$39QK
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M_LDF./5ZG/TH12>;P)/["OSI=?<+*(*XM)^0 0@E]X2EB;* LKD]/9X1)/$
M;B''8W2JPSOJ0:Q"_L:]))A6.?KZW2!CZH3+;KGPQ#/D\J ,I>Q7H%&(ZPA4
M#NOBTI-B8+P21/;#9)9"O*Z2E$@JB"62"F()MI8PA.2LB262"F+)-!0X:_&Y
M;/GOO)-O<_DFO'8RBB-VDU?8W5YW-ZV6OR.3O2///^48LY/1I!W\TKOM)$':
MG0Y:I2 4_!6R*#6IE?/7DW:7\/+>=G_94),I 2RHO:!46QO)7QC+E!S0*K:Z
M:;\6GDT03%.X)N=@EFH#@\/CPP,#(\*U3R0]?$+LBY3K"%:QKB$/S$'OEZ%Y
M1?^.>V&*>LARZ?&XAYG5+:#0]#-A\CR9O+[+[?^3(]@<9DI 6>]'N57R&'>M
M%W%O(II-(.36WQCAAJEM:;8CLGN'@1%6P+=;&$*\KI*42"J()9(*8@FVEC"$
MY*R))9(*8LDT%#AKZ;>I8^5RN=K6C]PXOW/8_BVU9 5PY'SWZ+0E:JM%[#H2
M8$>$=^T"?3S?S8#+F?(GT^1<1^&?3"6"5OW 7,>PI\FY?/# G[P3HWTG#AU_
MC&ER0E/%P)!$9-M29/<. R.L@&^W,(1X724ID5002R05Q!)L+6$(R5D32R05
MQ))I*+#6XF)\M.KV4_E1:IM+L.OX#E%SL[N!6$)U\P$9PCU)L*DXJ>O(;QXJ
MZ0YSP.4 4[B.W(7OI%$W70&M^H&YCN%.DS/>WVK(_Z1P[?\AZNX(LG-$TL,G
MQ+Y@UQ%C)A'9MA39O</ ""O@VRT,(5Y724HD%<02206Q!%M+&$)RUL02206Q
M9!H*T%K@N5#69\NW#;;#+3^GG4Q*H^_Y@/\6Z#J^U*YCT.4 DV@*=AU=;GO%
MDC3ZD2^P52[7#\IU#/M=QRM?-+6?I^J^-E-?XN0<(:IB8$@BLFTILGN'@1%6
MP+=;&$*\KI*42"J()9(*8@FVEC"$Y*R))9(*8LDT%*"U]-O42JK;@XZM^H^D
M,EY?5+[-V44MB<VW,:[<(UM^TK0.K HN#SAZZG70&7*RW3W!N*DKEE#?MK-R
MV S;C8!6V7I^4*YCN.\Z^AZ<,528.P>>?M/:A6ER0E3%P)!$9-M29/<. R.L
M@&^W,(1X724ID5002R05Q!)L+6$(R5D32R05Q))I* !K\6\,@HV^*)4ZFW4.
MD4?7Y9*BR1&YCOR!U2B"OA? L@-J$?B6[FL4,1=L*Q*[VQV#G-SGME> (F($
MK5(WG^*+)6B'H N1!_$T2<ZCI$1202P1*_B?+>-/VJ@=>@:8817\/S15# Q)
M1+8M"7HWV :2BZY59:Z0*Y)3B\GM*B*9*&L^#7*3II08RS.TMDX:)&:4QRV/
M(]M<8S#'XP:#N1JP#;L[*48_I;3^N(G53XM5)*PCVP:XK\JL'8>5\OC4](2E
MS+^&VFIR_PDJ)S$Y>=7B^8N8&@UMKHGAFX>WIB0NBT]0?W'VZ'Y;WW3I3I\/
M6G/>F5_&-++?IHV-W6+X=&-\_.:#YX]HU"T.Y@>L;6>B0J$T77$#NN-X6#4&
MQBM'9#],9BG$ZRI)B:2"6"*I()9@:PE#2,Z:6"*I()9,0P%;2QA"/$V2\R@I
MD5002\0*0FL9]SR]U?FGWD":SD@RIQ#[,CW7<:"-3$T@+S@G1ATVO1J\>ID4
M*"5Z0N+_S][[AS5QY?OC?9[]YS[]@=%JJ]Q];N^VO>OMWGVZ=MOUX;F/7I_-
M[;.NKKBPR)/"%YDKH)<HU'B%$D$A" $D4Y&D2"J.+57:E!]#4=HNM6:M5E-*
MNFK5KE&TEM94"A3X1 TT!+YSSLSDUT%/B%"']+R>I]2\\IHSY^2<F;S?F7->
MAZZM ?M IJ@KBF&@_+[M3"WW#ZK$J$^/5E#I6_,W@=BT:(<Z,3Y6R9PCF\5-
M6TQ\+$TG^*:.'6!S4>6VC8ER14H&M7:GU3'FZ&0+]L ]2--E"V.4JG5J'<TE
MBBXKHP<_4G+7PE;V6+W(.,:\>Y:FR^8O6;%4:3PW(+[5"M/.A"Q=?AKWE_VP
M0:M,UUM=8_T=N@3NC%GL9;?+6DGO/Z",CH^F#*<_-Y4<#/4G2>?%9N,>G:;F
M?+=5SU@L#'W\:YNI\L G1PW%!T'JV%&=&AN?]L:Y89 Z)H!3!Y9 0##Y".^;
MR30%&E=A&:P 9; "E"&C18+ ]AK*8 4H$X* C!8) NTF;#]B&:P 95"!=[2X
M3K^F:[WP5>>G!TS'^T?&$4Q_!-F6D%+'T6NMFY8NVM3:/3K4:]U;'%3JN'S%
MTI512TIAH*RETHU6E]MA;V>XE)+*K7F#!K'I3L..U'@N1/6=0TPPO3#AL32M
MX&V=N[,>;"Y:K(Q?K68:FP[0FPMVUVHU+^LU< _2G.S"MX^;7E3JRM3JW<;-
MQ:W=3CMK9.VN,7N+6EWS3BN3KZZLU:@UY7FBONE4:Y'F>.]HSY%"\%;!O@_K
MP/-)84_4+E9G8$J+C;6%2V4+LYA&L(C<9:TH,.Y1%S!,D?:](TQ>2\BIHZU6
M6[9K9\U!\Z%7-3DYN=K*G+CU>SKLE^#.JT-7ZDNTM4:MYM6VCT'>.S8V:+/Z
M[O)*0# E".^;R30%&E=A&:P 9; "E"&C18+ ]AK*8 4H$X+@/@*"B4 8-R.=
MAW:4Z'2Z\N+:3TCJ&*34BY%S-=G%9=FTJ;W3P86VS&&K;=PI;"XA7.8"7YH]
MU;HM49D! V7FH_=V%1AKM'G;\[,*&/8M_:9,+C8M?"$V25MCU-98?+J$8'IA
MPF-I6L&O=?SFHF!74K"DV^7HA5N-NN$>I"/"EJ3.F_W7K_-;D,)=2?EM3 $S
MZASH1?5@1],QX2W^I>^>J/YG' 435NL_OG[=SI'V(W<Q816><N#F@*7M1/^-
M@0'0%KN]5Z@5>%O<<)6#SXZL! 13BO"^F4Q3H%$XEL$*4 8K0!DR6B0(;*^A
M#%: ,B$((B,C YB0,8E%_<3!=5-?7]^2)4L>>>21/_WI3[=NW<+V(Y;!"E &
M%6"[.)QN/D&V):34$82:@UR$*<;'?$ Y#H1PF8\U01#L@H'RJ!B,CCC[N^WV
M[G[G$'PY*L;?!-,5(8RE:02?UDW96D?A,>/-\T9*U=;.*J/C$]3UEYUCPU^\
M5:A,E,<E9&S7[3W6,YFI&S_M_*(P^=S=69^1$)^>LR4],;FDJ5X5M4A[8E!H
M;Z;Q7*_0$$M?8#$$!).*\+Z93%.@<166P0I0!BM &3):) ALKZ$,5H R(0A@
M,G"]3449SP_:6W-71&\R,$6W7WMU)T1&SK-4)D5%Q:U3*!3KXJ*BDBK!M_P5
M^$4)EY;TGZ"I!$5:HF*GU6EE].QK2GD\E56<SWWI4XF*^.7@$/)]"KN)RQMG
MS)CQ3__T3]S?I*0D;#]B&:P 95"!-W4<[;MXOAM-4<+IYA-D6T),'0D(QD5X
MCR7?U'&*UCH*J>-0!YU"49DEY>EP*>,9A\NZES;5<(EH=-Q.]G4#?)@_6>"G
MG5\2)Y^[G(XO3 49:2I-87(^_;)!EUU[?H1OK^J-\P-"0ZX,!19#0#"I".^;
MR30%&E=A&:P 9; "E"&C18+ ]AK*8 4H$X( ) -];=FQL93Q9#M8X6_81)??
M?NW5G0"*<EGU>DL7:V2[+'J]U06^Q/G4$?[&^CV7.JY2Y.:D_SYZ=;2"AJDC
ML+Y31BM2JRQ][>"0P%)_BN"ZZ1>_^,7]]]_/7<L///# [W[W.VP_8AFL &50
M@<]31_?-TWLVJ(J)PVIHJ:-HD\,_H,AHN#+^0T>/-V,30[?:[<V4["EY?%)F
M_0?URBVM5]OURY,2Y4\^+5\D3\_+3U^V4)[-7NHPRM5M9]^!#U[&QH M!WQH
MTW^&X]_[].T,3ORT3+8HGN(NN<'QSTIP#S'QL32=X&W=E*UUA +CO@+E-M.Q
M(X88V9.;P%+&MNLNJ[& J>+>8G(UVNVEDYHZC@GY*OC[N:W]")N7O)ZK%960
MO%E/YY;L*G_G\@]\>TLUU:U'F%=8^[##=L9&[*P(IA+A?3.9ID#C*BR#%: ,
M5H R9+1($-A>0QFL &5"$'#)P*"9SC.]H\\RLC7J%U]4[SORMA!V3A#CI8[<
MEWC53BHVBVELL=I_N,P6T35TYC+YR_Q3QUHN!F!;3#JP7.L]:]<)DCKRX+HI
M/CY^]NS97-XX9\Z<O+P\;#]B&:P 95"!SU/'[D_>_;0;3)ST0SC=?()L2TBI
MH]<F!SZ@*&JZ;>HH>#,>K/.FCC%QAL8Z:LF&@LU+YBLH;7.'$%)S8>M70U9#
M"I62J=/IA-011+0N*U-*:P#/7@;Q=T<]?-S/WN:D!/<2$QY+TPI^K9NBM8Y0
M\%VO XA=-_M[X%)&[OCA+]ZJLUP'QUYI>WUR)ZR.^:RK_,[2>N)K>%*GHZ_?
MZ893T^&5QK>77_ XZIF+3D P50COF\DT!1I781FL &6P I0AHT6"P/8:RF %
M*!."@$L&X%<8%\(.@2_C :?':V"B@'F%R^ETP0+!/X0O\9[OKMOY;W_N6[ZG
MWSD,WN*^0?F@H6?0 99K<5$ /(0 =M.M6[>V;-GR[+//EI>7\TR P/=E, Q6
M@#*HP"=U='2=L4)<[/%)(,/IYA-D6T)*'3TV.2?A XKM>]A_C&N3(WHS&MA#
M!IU1>$1CS-6^4E6:K9)3JNP-_JGC9\?+RDWM;8:ELB>S:EJL=C?X\6:W<7/*
M"VN* )^W_Z,&+G5L!+_9L$?)0P\)8L)C:5HAO%M'0" ID,M-@D#C*BR#%: ,
M5H R9+1($-A>0QFL &5"$$022!5SY\Z=/7OVO'GS M^XIQ 'CLO1=?*-;:K\
MYHM.GY_.P^GF$V1;0DH=O38Y-QP]U^W?]3EN^VL-;X<SZO.(AG=N=#H=-YS.
MFS><P^+3&&"B YT;1UW.@1[^68WPB&9(Y(%B")""Q22!U!#"6)I&\&G=E-GD
M#)ZDP>ZFAD9&)5\HC\O<D.$G^ K:Y]@=Y\#.J(D9N=E)*Q14AM[2.WRAY<TC
M[\)CF7..$9?]0XVZH:.MWMR#_45S%(K?^J@N<VFREC%LBH_/J2=+&0GN-<+[
M9C)-@4;A6 8K0!FL &7(:)$@L+V&,E@!RH0@@,D :I/S95^;6FX\-R&+?ZXH
M\.4>GY19LC55'I>0:3I]AE'&K%(:3SM<5GUZRAHP2^[5QJK,F!AET:[<V*C%
ML9660; :BQ._U?XN=\8S_18]Y!O> E6Z&7B.GP:X;M+I=#-GSIPQ8\:L6;,.
M'CR([4<L@Q6@#"KPIHZCUX_I,O_WI2*RUC&TU-&SUO%B75IL,O>/0(&(D7-@
M[6+?EZR*BZ0/1,L6R!<NR] 5E3$L")TI[3X])9LO5R2DT9:O04S\WG$V8]E"
M^0*9+$I!I:4KELOC8V-+3@RZ+T,^4Y=/L_8K+$WKE%PDG4S%O[#%_$D3V'U.
M/-?91J5\50+U\E\_8F!0WMK18 2'4$\OW/+^F2:]3K=>*#.PK@23@(F/I>D$
MW]1QJFQR!ML-PNZF7['T 5;/^ FL;= ^Y[6F7<837S1MCET>M>0/"BJ?O=)K
MK31:OH/')A:;3MKLWWYB*#YH[V)+\.LW1EV][4#L[C0EYS9_U6,SZ4GJ2'#/
M$=XWDVD*-*[",E@!RF %*$-&BP2![364P0I0)@0!2 ;&L<EI;\M61%-[ST\D
M=Q13Q\2,DFUI4<L3-/5-.[EO;8>5^^YV"JEC*JW=JK>ZW'WV[C[ N_C56%?L
M[.:%BZ/A&:&^FZ_2Q'+7L '734\\\<0##SS 7<L//?30PH4+L?V(9; "E$$%
M/D\= 4:=W]G^]LDEDCH&*?7"N]9QS'W%E S_,1Y&A;6+[$=-J@002;/'P";C
M]E8MM1&$SHYK'4RJD#J:WX4Q<;,=7%''6"XSI')@HMCO?Z7!/!"DCLM7+%VC
MRDR,5F90&ZN.?&;[QJ*'ZR2UZ;]?MC1%MUL(XKE<42^DCM%K590:OA3+))AL
M3'@L32MX6S=E-CGN*XUYPNZF7[)T\QDS[2/0I*NR-, ^1U-:R9VHUI"S\K=_
M4#-LB]EVS5I1<?CO;X-C\[=6?_"/'A>7>;9^8]N?AT\=Q^#.JV\?J=66E;VT
MN7ASW/H]'?;A0 D!P8^+\+Z93%.@<166P0I0!BM &3):) ALKZ$,5H R(0@B
MQ[7)V6,LS*O[0%^XS^8,T-\!,'445UTU'F4+:H\?KBRH-A1L+]JJ6IN1L5ZE
MKF'?:6:*BG?K"U^V7!4#6BX2T-,OR&0O\F?LL>KW'&[CJ[3?=KMI?&$-KIM^
M]:M?/?C@@]RU'!$1\8<__ ';CU@&*T 95.#[U/&C_+@__N^FJF-]ODE/.-U\
M@FQ+2*FC=ZUC<T6>MFRUTOC%N,_P>H6UBWGYV\KJ020MIHXZO;$4AMHE^2_(
MJ&;[F'OPN '&Q*5U']6#U%%=P+"-3$ZZFC%LSGT7I*8@=?RRWU*C-59I#;5&
MFCW5NBTF.K?Q^!M)E.'(9R?>UNS@UTFNJ#_1FJ5]NW$'C+E?._FW/> 09;*J
M\; I*4.GR_.623#9F/!8FE;@6W<?P001^#D2$ 0!,G(D"#2NPC)8 <I@!2A#
M1HL$@>TUE,$*4"8$0>2X-CG\%N7 R68"T:%8%+_J:@04*"[4<CD&!">]'H?+
MY>@%JZS@&<=XP[SN?I\SB@NR1,%/#UPW'3Y\^-%''YTS9\Z__,N_7+IT"=N/
M6 8K0!E4X/O4$3QR--?1]"$R8358J2_$M8[#\!]P](\#M[A&$:YI]*QFY"\P
MZ$@Y.G1S &A$PT9P"7'_XJZV;KN]N[^_#ZZ-A#TD^%_QUZ3H2#EP<VB4/XOG
M7(..(3<LC?>N!(7"0S@*\$YAO>4$;@T$P2.$L32-X&V=,(-:D9F^+C%Y7>'[
M1QK R^QZEI:K6L_ROT&.\0^]<\0YU?SR2&7)Z[0J<355TO@ADPV.-9:ER5<E
M)):;:C+!LDF]9=#59^_],>>+#EVISXF/5Y;H"\">R*/7S9K$Y]/*]Y:E)M"F
M ZJH1=H3@T+E,XWG>KW;51$03"7"^V8R38'&55@&*T 9K !ER&B1(+"]AC)8
M <J$(."]3P@DB'GSYLV=.S>0O=<(&#\!"*>;3Y!M"3%U)" 8%^$]EOQ:9V^E
M32:X(U,7_RR=9L]:Z?44M5E77NF3.JK G&IUBUU8'OG""CEM=;D=72T%_+'4
MK^=[4\>4+/:R^\=.'4==SGZ;J73G_DJP)[++^G+TJM4;BK692Q=E:BIW&G39
MM>='^,JKWC@_("S:)(LA":88X7TSF:9 HW L@Q6@#%: ,F2T2!#87D,9K !E
M0A!@DX'@,8E%_<3!==/9LV>YSW/FS)F//_[XK5NWL/V(9; "E$$%V"X.IYM/
MD&TAJ2/!9"*\QU)@ZMCTB;DP7U^KS=IW?IA[6<.4:4SM1RJ7RA9D,:U6^TU^
MJ2V84ZULMHO+(S=M5!48:[2Y.GT^/%:M+@3+$;D\LU#--+)FF\/1:;6-.P-\
MBC!L/U($UC=V--+LY[;V0Z]NU>1O3(C;6%RF6I/T4LFN\G<N_\!7OE13W7J$
M>04DQC]V)0E^<@COF\DT!1I781FL &6P I0AHT6"P/8:RF %*!." "8#/@ZK
M2Q?\_.F5\1D-(>P6SA7%&YY3)49]>K2"2J=6;MAO.Z;7FTR"9T<J\%^M_^A=
M<+H+X(=F[C"7E4ZILUD8O?F84;DJ1EFX*U\1%16W3K$<_()L-)91"8J0ZC-]
MP773,\\\\]!##W'7\HP9,Y8M6X;M1RR#%: ,*O!)'4=<8,;BZ/"%S__AL[%U
M.-U\@FP+21T))A/A/9;\6L?/H!YU]O>"37_!2V'FMLO9W\-/BH83I,'<:3B;
M&DZ=!GO.B#O6\,>*.Q%[-YT)=6_B4#'J<O3"O8F'G$/?65H[^L$L=#><BR[\
M!2J^\D*+/!/("0BF"N%],YFF0.,J+(,5H Q6@#)DM$@0V%Y#&:P 94(0@&3
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MZD@PF0COL13>K2,@D!3(Y29!H%$XEL$*4 8K0!DR6B0(;*^A#%: ,B$(8#*
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M4MF3634MK+[,]+?FK0;+X B,\J^(Y]I_81C.!V",N0KY*K_3@:B]Z51SEN9
M8R$(]+/VG3A!QZ6PET%R*^>.R,O5TSG@D#TY:_+ R]9KH_86&,K3PM-.?K(!
M2!Y>KL@!$?_A0T88<V>L>OX/L6I#@R$O=W<%W7C8E)3EDSIRAS3456[+,QT[
M8M!HMN6K5 JE*A?DR=,*$QY+TPI^K0,_$,+]3L'OB!!#[E'X0^)U\#/AJ+C]
M*?SAL(<CG/T<#7Y0' #_A[\OPA\^Q\#]J+]/V!^5$T 2_A7V384_/7;W.T?
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MM4A[HO^**4W_V3#\ZQ(JGVD\UPN?QF\ 4Z8)"*82X7TSF:9 HW L@Q6@#%:
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M*(,5H P9+1($MM=0!BM F1 $D8$.JS+9S[?LVK3L/U\*Q6%5=.R'ANKMC5Q
M9O(ZH/*IH^<'XJHJ];H\8(C:]L41/V?46ML GSJ.@H#04%V@.W! 5["[(I<V
M<>'E;GW6RIA,^O6*HH8/ZD$,V6,NU)H^J,IX/FFGZ,ZZ6U_X,GC""<\U:"X$
MEJH9ST=7F"T5T;3)I"ZHH355I_OYH!3^3JVOH]6;TTM G6O?:_ Q=-V8FEE
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M^PR8ON)VV,[8'"1]))A"A/?-9)H"C<*Q#%: ,E@!RI#1(D%@>PUEL *4"4$
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M6:#GSL#HV=>@_JWV=WV<;PHJ#= ^9^_VXD:+25UU:IAOX)FC=$J=S5*=3B5
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MK2,@D!3(Y29!H'$5EL$*4 8K0!DR6B0(;*^A#%: ,B$((L>QR1F#3$@V.>!
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MW+\=W%_>=K6OWPGV*Q J#$@'/+6P-8"C=\ )WX"G<XKGO>D]B]!,OP9^U^N
M'^R$G5KY;F(81J52'3Y\V,,$"";$8 4H@PJ\J>-(YZ$=FOQM161S#I(Z$DPF
MPGLLW47K_%-'"DP5"2UUY/*C07,>3(=\=YU1T=HXF(_QRAXN:Q(W*1T7P]=8
MU3(J:1F?)7H@I)3"H@NWO;,3;%+J1XHO;>-5Z0XIEC=UG*\NT_*I[.U2Q_'/
MZ+A-ZKA0+E\LIKB47+Y0T/!'M;>JY^>9!\4VCI,ZVOP_*Y!P@I?C?*KCMHM@
MJG 7EQO!5 &-J[ ,5H R6 '*D-$B06![#66P I0)01!)(%7,F3-GUJQ9W-_
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MN7/G/OKHH_/FS0M\XYXB8/RX3O_UK]]Z?^L.IYM/D&TAJ2/!9"*\QU)XMXZ
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MC;VM"UT.K$3AR(X/P=$9_.4A:#I"O[H@/\ HGE5&A44()W*)Z?CB*E6"K=0
M@@HZ^$QU>%YQL2XG%Y4H1;YX/(9>%[N.8;)Y=W]OR\[$\*C855%%0K.>KUJX
M5*4Z4JDQ0],Q2RRP RODC#$=A79 H1O8%S(U_2VG6XI+)::C>',LYC15LHXQ
M0*L/-(C""48\S19]$30=$XV%F? V7AT&40>GP-3\P^!<7G3W-+EI9K_IJ%)K
M4EZ>MW[SYJ6+&<:$&T?W_PLGO+W5+770=(233=K7-N"[[6G1&MU:/9P7O.>
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MOHO"#[+5RDC,&$2Q'2>SEZ8?@GMV,F0$%.2/6P""/(53)50%4D)5("7R;@E
M4%>-E% 52,D4%/S&P'?&]]C47SF$9;ITZ=+/?_[SQQ]__/GGG__FFV^HZTB5
M4!5(":D@66*OI^/C?;FZO .?2RNX!-/#9X)SF:SIB+WY$J^TZ/''+F[1!3_*
ML0[I8:"_&SC-_;0BB#/&1_OQ+;X6>+T!\TV?YR[TQ?N8/Q!G3+_(LN,CF\&T
M-(A_!8\$$=N,HN3!3#GX+1_3";C*1W4SC/E=A#?\K1'D.G@67A@2 &<J$M(
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M7P%54E  N+0\C*@) J/%:C$@<-H7X7P79T6BD<* ZKZ>;DFU%5CH14Z E!'
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M RR^?*N5LQCLY:;XE<MS$7?.P@RNWN6^"^H4"_)LBS4/]9BAU>^PI^=92W)
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MTY-5\'NVYO)@!TBM @QVVWEW5QLF4[V*7X"@.:2&FKPO!:M?&47AQ:::\[>
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M?/* =@5@,1695 ?PMS,@/NT36551FI*8<M6'V>DD:42#Z!L<X7X4K!)E?'B
MW^:WNCQP.G<@J:J$H'7Z0%BFZ]>O+UVZ=.[<N?_S/__SS3??4->1*J$JD!)2
MX7O)=9PNF.!<)FLZ>J'WH\*6]?(O7](CWO][E %(2=-A6I?-D$>GXR;RJ&1;
MK'EYV%\!?"8;-#X*&> D6:_3F1W-#=:(T&4Y.RI,YNHKGP-+IO-X/JX<L 7Z
M6T[U(AX7D;<&>& L-D 2([2LU^>#IM@FD'8%U?#EACT7NJ]4FTT5=M.FG$VF
M,KNIS&'/A:0[*U)TF)8F/^]5X#+*CW\YMJ#"7JB)VFCES#YO#YSI[N.N2^#W
M'&1-8=I2X+$9G[;'T0(J?T"RF09.OR#S\ G;4H87C#JOBUV@JSUACV% Q*#/
M[0.8AX90&"$@Q=%:.0NX>\OGA&24'VQXJ\0_>&D=A6[,(:19]PI00%XO9#K6
MB^V@N51>\#/6$K1#PCH>=%B*!+L541;Y*(Y.08^9E UH[.88F=Q>FGX([MG)
MD!%0D#]N 0CR7$654!5("56!E,B[)0!!73520E4@)5-0F"\C4#%OWKS''GOL
MB2>>&/O&CPJ\;^1<1Q&3-1U'H/>CLP?\G"+E_1]3!L CTKKX>'201P7^D +]
M%5(B%I%"!CHZ@/\$_ XD8;(1*P?X.69$^2@/#&S9WR88JO1R.'@\#.0\$7_4
M$1KPT=(,CN+[P9XBPMLS@JAK(+$-]MC<C[9'XO^Y"[ES()</: 2^"SAUP!BD
M;A_0/O WH;F@82-/$685(NLHB!*IU\LW5,S0@^9R']HAZ$?JA;ZN,11'XHI+
MV(!(3'(O33/X9Q>0-#E#5^IP+X5BC+&J&OB0<4CS5X /("JK^F*;(ZD,.(UQ
M?='N-A#LG;"Q,"\-#,!N31'T4S;G;031W?8/WF>38/#V2Z":*$C]WP\Z!6-#
M0='+F91$_2'GH<V[6P>ZG$ Y+CY5[9M[0_<7/"HT"FOVA(6S3:>WPVAV4/TE
MFHF+6O82X-IY[X!8WW4J/_W*"#X$]\-DFH(\A5,E5 520E4@)?)N"4!05XV4
M4!5(R104H#% TN2<O-;QY_;._C'*]\=D:'*2U)D'W2.W)T:3DZ!E(M=4NIS6
M-/#S_<A@=X->:3][#2495;>TPA0M\YZM*8C(( GV>-D#KUUO=90#]X#GG%T3
M&:;9]?''NR#73AV'!G:Y;Q15'F[\XV9V4V7[*:L^W\1$J[4U#YB\0%@FN]V.
MZCH*ZW'HT"'J.E(E5 520BKX3<>102\Z^HK_19C(PT<27S;\[>7W]S9>NU?<
MWH^/B<QE9/*F8S],(%1&I*[7@H-LP]6;-[K&L2)D_!5B,GMI^D$RNT"DR1F&
M?G@<J.SSBF/34>@4_-[3[F MIK4+?E7D[!=KM#H<I2#8^VL^A84#:.: ?G;Y
M/A9$=^\[\9%M'0S>?AF8CBK&]NX>T704^QKN:C*N,39U#8]TMP!EW;[SGTGF
M_L<Z%)T.0[*]KM="YH3!:/:W89CZAE3]0<"UL[F(Q?=-?I[(  CNA\DT!7FN
MHDJH"J2$JD!*Y-T2@*"N&BFA*I"2*2@ 8X"DR4G-S8U> JJ[C=&^+T!3$Z7)
M*<PK@L1R$Z+)6<^:]'&QNH2D)&@ZWFC(5*N8'>]7ZQ:MBC/65V^UOM=D35Z3
MI4M41B5:*\O]!=4V@A/%J6KX;0O2M;PN-@1P['A@?A,<F'L F8YJK1$,"3=>
M;&<UL7F:I/1\,Q.I-AZ_]6"_BH5E>O;99Q]^^&'AL_S((X^$AH92UY$JH2J0
M$E+!;SIZS]6]^^FE]IL#KG??E91GG,##9_C.*>._OJBQ'&K]ZO)[>2_^TS/Q
MCLO?/MC[.S%,8"X DS4=1V 4Z'X>'WQW.EJORZ:C#!\FN9>F&21>QX"DR<%Y
M\Q+3$84?9Z!.;[F/%T2L*ZWEJ]@D/?^5&]<1S3:7%A3:*_(C7@C/$0:0\VH>
MT'_+NC$51'>7O&'+*8+!VXM -5&NP&3?"HNF"F/;*N;3BOGZ0Y>J@;+%YCPC
MF7O9SF(8G0Y"LG?8U0J%NA(7*06QY<+7;0YGSWG%9,[&]VWR3 4R@A'!_3"9
MIB#/550)58&44!5(B;Q; A#452,E5 52,@6%^?>DR4F+5BD7A294=TSF2.LW
M'>DT.1W@&_F= UP!)+RY'TU.OIZKK66SMC8>956QC,[ <9O"LZH^L.;HLX2F
M:PU[CQW-S[-6L;ITK4Y?SL-O^7+66':N1\*=4_Y./5=@L.TT6/;OMP"NG2UV
MJP4.K+U/I-6 0\*-:Y>I2AJ=)2^M8G+9<G9*I$'?!<(R_?SG/Y\Q8X;P69XY
M<^9O?O,;ZCI2)50%4D(JC Y8->;E%KSZT$,IG_F]T_=^^'@]G5_["""&^RX?
ML?SN!3"WAV8\\[N];9X'>W,GC'O/A<#43,<#K?@@N[?EDW,RK:(,'R:YEZ89
M)+,+5)H<7U"W+\:XL]>#.P7!V( /P(N443PS?(W+J*(!^$*@^T=EY_NJB8).
M8=#R'5\ N208 S<EG?LW..89AV3?$:/9QQ0I]=TW&3( @OMA,DU!GJNH$JH"
M*:$JD!)YMP0@J*M&2J@*I&0*"O/O39/C[;M]VR.AJYD(H%TQ09H<D5@.?TN*
M7Y<2YAL$F$ETH[/'TP>^K.^";_!;W1Y0G;N_#WSM@NY$3CR8;02_Y1%1G90[
M1U(U'7^Y@V$@$AV<M02'A!OO\T".'6'P,"OM01_LA66JKZ]_[+''A%OZ^../
M7[QXD;J.5 E5@920"G[3<?BFD]LZ@5S'04_;_I1?/P&L1'7)23<R,OMO?5SR
M,K(=7RS^^"]_=::C[S,PYN K0\9D]](T0W#/3H:,@(+\<0M D.<JJH2J0$JH
M"J1$WBT!".JJD1*J BF9@@+B/I$1@'CBB2?FSIT;H#0Y$,-]M]H__.-%26;-
MV(?/P-G2%YYZ,:OJY)\^?"OKOYZ(WG]IH.>\(_,_9OS]BUFU;5^>M/SG/_TL
M]^0]Z]O]Z!@[EW$P!=-1AHQQ$=Q[*;AG)T-&0$'^N 4@R%,X54)5("54!5(B
M[Y8 !'752 E5@91,06&,,?!=\#TV]5<.89D^_?33O_N[OWOTT4?_^9__.1"+
M<PS?.)D7\5^_WUAVJEOJ,AO[\''7Q3T4[^CX%KS^]CSW__[[?T>]]-2,Q2D5
M__L7D-\W?-=I7O#$IN.@#$3 8>Q<QH%L.LKX/A'<>RFX9R=#1D!!_K@%(,AS
M%55"52 E5 52(N^6  1UU4@)58&43$$!&@,2AM6HK+>=[YFYLY,*5440FH+,
M-(DIZ@Q8*CPVM?IT$[M6K0X/BUJY:%%LJ?.FA/7T2T\;!\E.SWR-7TA83Q$
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M-+[B11UE*[=H-ST+J2-*_&@\LC]%R+'16DO)-2RKD0.*:+?2ZY*;K@^VE:\
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MO@ WS)!P+'/.;OM O?5P6\,;[.&WU='KXPL^.%&7(0]<D\)=N [&?31%O\>
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M'J%\1A.>;?JX(F5US';S)[1BQWVFCF^^^>;<N7,??OAA?D;4W-Q,[$>BA>B
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M(-UN?@A\7D6T$!UP"]$!MTBCQ0]![#7<0G3 +3XX+,1E<D3)QLE"+ KH'?"
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M:6UM0SRS"!&_.0SPQ23B?@)_"B=:B ZXA>B 6\39$H(@CAIN(3K@EB < LC
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M@_14BTREB3,6QFB,&W.H9+W#!8)!S._)D2).K]=G"T\=5^OW[<I5J]7;K0>
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MGOBH!4 <I;R45ZSAE74$E?0JK/3?.H%*3:!L3+QDNMHGS^.3C>GPOT96ZRK
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M=T)RT]NO;L)KY-;@(BN8KH]?W?AK1R@\ ]=[O4H\Z,+QF^1"X1ENR<:O#LC
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M?,.E/@<1F*">()JQNQ$D(C\.2XNC0<V]$96QRJ(\>-[W389=IWI:+!LK]I=
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M%E/H 2Z?OQ=\K>N]4)D8%;EZ@SXK>F[<^[]BMA,1(GZK$+^80A#X<Q710G3
M+40'W"+.EA $<=1P"]$!MP3A@+1/1(0@GGSRR<<??SS4E')\4\?3ZF 2Y_SO
MKN%3QV%AH+R.SZS:?\7?L]?M_-NAW24LG]655!QR7![6RQX<HX;6EN%21TZ-
M)C9^R1*C]8"",AZI+<A(ATHYO%I,?-0"("I3;.^X?>?V&:!5\TVUPNL0&1&1
M?XR7M[%\ Z(!HREZWV= ="?FC;EK:E!6C()<7>+\Z=(DG6JY3YF&TACT22#'
MO?GL97!@5#0E@^?2F8R;F8,[_#5XKO<VUT#=%V/U=JCH8_T1))GT"<FLI ]9
M.:6<IN/@%TK[KM[;!$XI!PKGE-*Z]; )FJ3TI&@J)K'\V]_$!H+A0S"76.JX
M2%E:0,TU-OZ(J*/+02]*L%SN.6V8):.HJ0I+Z_5&2Z5)MX2EA7]:9^OL8QWD
MZ>G+ '4$.YE9AX[3>AD%<GC2TVD810#^$Y[P[PI!ZSQNU[>F[)CP>8N7!A5;
M+T*$B,$QG"\F$7\GX$_A1 O1 ;<0'7"+.%M"$,11PRU$!]P2A(,?&;@[W,.B
M?N-@A^GGGW^.CHY^[KGGDI.3D27 0?CG4"Q$!]R"._B&N*_5SFB2WWQSU;J:
M7YDZ#B6O8Y^G[=R))N]NU7N#(;9EN-01R>1XG#6QDE<B8V)B4F0K=:8="J"4
MH^348G2J." JPYQQW>YQ&(!6C2X_F7/0\WHV7ND7.5".,11#T9V.!EV45+98
M*L\'2C!<-L(U/F4:5ZO3]0,4T4$*-) Z<@(V.52\,4"#APO>:[$#11DNPZ&7
M.LYE?0S;UB.E'"V5#.5\KC1 (1S0!*244P %:>+E6I8ZLDV02224]5MS1H3Z
MDZ"E;T<V JDC8U3.6V?]II*GCC*EK:VWB9G/4L=IF;8N5Y.5I8XQ,U:LB/QS
M3GW711.E->U.YJ@C<.AN8B@?=12>Z7[ U[K>RW69,0G%[^0K-:JTLD;?IG<1
M(D3<&PSGBTG$WPGX<Q710G3 +40'W"+.EA $<=1P"]$!MP3A ,D 4EB]T5R9
M'AFC>7=WGA)L=QHV)OH45J$@ZBRP$CXC0F___B,HIHKT%%ON=!RCJ2B9N- \
M,-AA^NM?_SIFS)B''WYXW+AQJU>O)HXCT4)TP"VX@Y Z?J&7SYG\'Y'KS+\R
M=1P*6"*V:E1,#1 Z<9TRT56GAJ-+,A"&V);A4D</+_JBWY&S2'' :IR]VMQ0
M2P.EG$1.XH51*X&H#%W?=:V^H!!HU<R3+#1Y'0PI&0=:!=(OE4 Y9G?U^CQC
M6<X\R9(J]-;11QUSH#(-G8+D=IK/\=01*KOX!&PVZ9G\0 T>SNU'6PY4]'FW
M\9:?D$RNYH,*I)3#?/;A>E"^)E^5!IN0N0PIY2Q#PCE%.O;B9]L8/5L:D:ZO
M,J1G[+8Y+@2?='/DPI\ZSI#*%L^=5V@_6T5-D<JHY:EYF4OGAD7.C=0<O7BV
M/&'NP@5S8[>##:OFQM/ZR$6;Z-0X4X,Y80K+VV-2\C2Q<\,BYH;E'VWC7S=Z
M3C,4<_K^,4CA6T<7"HUP=W6"G)PB1(BXQQC.%Y.(OQ/PYRJBA>B 6X@.N$6<
M+2$(XJCA%J(#;@G" 9 !3F'U^->EFMR<N$2Z,"]XZHCT!4'B--GRK?6'M^L=
MG>U6)*:ZAZ..-UCJN%BFJ;MV=_L)1S#889HT:=(__N,_LM<RRQY?>.$%XC@2
M+40'W(([^*BCY]1[.LO92Q>^VFVJ'[9,SCV'@#HZ:V)&K:H1B+X&C2&V9;C4
M\8Y/] 4HN]R&T;T!*C)=?L(Y0*NFR^5S0!([ =(OO!P.=Q0+/I%]@ (-TH#Q
M*KOX3@T.Q#1XO&Y0T0?\'2 DT\LIY7C#FKG3=2"EG Y...<6/ %J%.L!PII1
M-40$0#"7H R/L[6#95:H6\'OM]E^YI5W..FC/L2^/#<[7"Z@EH1\@1/K  \'
MONRG4 FIX^8]N#B"Q3"O%!$B1 0/\7(+0>#/540+T0&W$!UPBSA;0A#$4<,M
M1 ?<$H3#1)_"JG%?F2(R)JL*9 $(FCI"H=2MU150$-5NWJ)W--MR>#%5*%9?
MLTNGH5DG<8_2@&"'Z9577ADS9LQ##SWT^../O_GFF\1Q)%J(#K@%=_!11Z"P
MFJ_3Z0J#45B]YWC J*,($0-B9,^ED=TZ$2)""N+E%H+ GZN(%J(#;B$ZX!9Q
MMH0@B*.&6X@.N"4(AXG^"JO7?7+]PP8HRBN4B@11W6XW>H>!Q%2!6/W5-E</
M$OD//%X$#W:8VMO;7WWUU:>??CHR,O+GGW\FCB/10G3 +;@#,9SUU[SY"-[!
M!$*DCB)&"D;V7!K9K1,A(J0@7FXA"/RYBF@A.N 6H@-N$6=+"((X:KB%Z(!;
M@G"8*")4\<033XP=._9WO_M=X ?W%0'S)P"!-Y_;S8>*@.+I8"@ZU$QX_WS;
MU631O?GRZ%$0HU]^4V=I<@F/@=2Q/XQ>M?^:P&]8&#6T&ZE('47<2XSLN32R
M6R="1$A!O-Q"$/A3.-%"=, M1 ?<(LZ6$ 1QU' +T0&W!.$ R8! )B=J_LQ9
MX9%!:=A,%&5R[A&F^>=UW+U[-W$<B1:B V[!'7S4L<_5<AHIG9YK$^1.#+SY
M@%2, B;7+P9,U8C0YV[:_>8SKR3O..AHNN1T7FX^9=V1_,HS;^YN\B7?  JK
M_OJK/.Y"=G74T&ZD(G44<2_!SJ5I(Q<CNW4B1(0: N\O(NXW\$$A6H@.N(7H
M@%O$QY@0!''4< O1 ;<$X0#(@)],3H*F[DM3;DT0O Y21U$FYQZ ':8I4Z8\
M_/##[+7\R".///?<<\1Q)%J(#K@%=Q"\=?2X6K[8E:U0U9X3ID\DW'P D_PO
MG6-8PII7#R6_-*?X;VZAS?VWXCDO)1^ZZC7TN3M^<O:#GS@]D6! : L/D3J*
MN)<8V7-I9+=.A(B0@GBYA2#PYRJBA>B 6X@.N$6<+2$(XJCA%J(#;@G"86*
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M3O2S^YRU^G2'J[W#W7.3'1UV2G1V81IG?7"&],"I ;YVAG +^DWCM_G%%.+
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MN3[HP;WNMN\^VZ.+GS-Y]'U56!4A8M@8V7-I9+=.A(B0@GBYA2#PIW"BA>B
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MDDC&*ZQ^VXG0,AFW(K-:;]K&7I++]>6E2D4Z6#[3OJN'JVQZNSAP""/[9O*
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M/[*;M^@=S;8<K>GCK:G*K )=@5)96K-+IZ%9IV!.\1L!.TQ//?74@Q2L[0
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MI<_,T)5HM22HH]=KYTBKY>H#_:00H@BD+TT_A';M1(@0%,3'38! QU58!BM
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MIN.M5CO7-P FZ$LA@M"NG0@1@H+XN D0Z+@*RV %*(,5H(S86P0(;*NA#%:
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M+K?Y$8/?!^X'HU9JF>2%6,-5_E,D[NL8*$+[93)-@8ZKL Q6@#)8 <J(O46
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M!]V20\CF'.*^CH$AM%\FTQ3HN K+8 4H@Q6@C-A;! ALJZ$,5H R00C$WB)
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MF3FK7&"Z0\2L9QUWFFM!+7*]$U\:?5/'ISQOI  02%^:?@CMVHD0(2B(CYL
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MDUNSLI8L)IB5=:;+7S,;)]+GE(6O)U)T='O8Z@E)(CS)6UIR2V24HNJ2@UL
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M5H R6 '*B+U%@,"V&LI@!2@3A  $ WR'U:4O_/SYE5%;W](D!^VP&I-4D)T
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M2H%J@U2VE00;>#A&^VPW.AF/' V1J >&JZ3TWZ+@4:$;.O[RE[]D'%;I_[X
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M[P>!]*7IA]"NG0@1@H+XN D0Z+@*RV %*(,5H(S86P0(;*NA#%: ,D$(8##
M=UAU./I[X7JN!W%8999Q,19ZMQRN[^!RO%'GD)TU7_4NN+O+.:F.\);FP=,
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MC/M[D8JAHXBI1&CWI="NG0@1@H+XN D0Z+@*RV %*(,5H(S86P0(;*NA#%:
M,D$(0## =UA-S2E(BH[:^I8F6718_<% -].___N_SYP)3$,?>>21UU]_'=N.
M6 8K0!E4P)MU_,+PE\5_W)S]5F*^^>;W.NO8VY2RX(_E%[YS?]V0./\UZG.X
MBGJ@+7OQXO(+W(4GV)RCXX.:QL^_Y9TK(/C790),%CJ.VEIS(^9)GMU(-1[B
M[9WHM%)R9>LW-I-J9VNO&^06GSF=N^I)R;^]FGGR;*U< A"I!]F]]VRGBR*>
ME#P9473Z;#4!^-_&'CY93<R32)Y<M//$64,B*VZJY+X]^X_#&Y^5/!NM[W($
M\O2*$ @FZDNA 5[MP-M?1B0DQV\IJ-J;EI*26U%)QD1%)FQ,7B5=*$W6J@JT
MVO2=K9\8R4.-5%H,$9=T^+-[]H]YFC33E;-ZJ;+Y0IUB9^-Y(_T'8XLT*C*R
MX,S@);U48;Y@VB:5Q1#D(3W]9R8BMJ!C8,Q6+Y>NCHYYI_W,'A\!67.V>9\Z
M13W.%9E#"*U!GR25Q6U(C%Z^Y<3U<V7+=^KT"B(NOO"8H;R\:\!F3I)(EM#5
M290M9\H@[H(Z]1B_]8^!5ROCK, (Y-1%L%FNB!!_F4Q3H.,J+(,5H Q6@#)B
M;Q$@L*V&,E@!R@0A ,& C\.JL=OQF2$[3K9;=%C]P4 WT]RY<W_RDY_0S_)#
M#SWTN]_]#MN.6 8K0!E4P)MU/'>$JJ5VI.\U7^9'*/XO'Q :SL  $SK>:-@\
M_XVJ*^ZQX9X6ZMVV&^!J[F^:% MXH:,?1IW]GW]T5)L8-O>'G75T6-[6F/M<
M8R[;.?,[J<H*DZE"J3QN&[U\,'WKUKSFSTT9X3%D^^7CA2FI*O,-M_/F^;IC
MYFJUDJHSF4Y;Z='/R,7]JI-][C%WWTG5]NT9Y$G+V>.:G45:\/RX^LPY\402
M*[;6Y[#?:G4[553+Q^T??FH3AT_3$!/TI1 !KW9,Z*CR!@ 5U64;HJ(2JBY=
M;R!-W3;PVZ$B7)Y$*!(VD:V?F3(B<SX<L'?R-%\.6\KBB?AD;4%*^$8%H81_
M, 8MNEUDP1:"V*XMEH>M"(_7&RGZ>6'^,K&A8T;^CHT^ N+9YW):+H][1?J0
ML&5+X\L;J62I+#Y5FQ7SY(:<K.42B92T.$#$4D'EJHJ+%9G9"71UTK4J$I8A
ML+^=(CP8M7V0N715ON' MH4+8PU7?=YAX[>^5NL-'3D!S_7[QXS0?IE,4Z#C
M*BR#%: ,5H R8F\1(+"MAC)8 <H$(7C*SV&U:#>5&;=%MT>9*#JL_F"@FRDG
M)^?11Q]]^.&'Z?\V-#1@VQ'+8 4H@PIXLXY7&W:I5=EYQ;O-DVW.,=+=5*+%
MH*2I>X(0$ (N6)W[QLZF+]G../IET\XWYLSE+UCEX+I][6.C3K%RSHS9"^+R
M*IN[>N"V]L'!ORX38-+0L:2DU3X*0\?23#JTLYPD<TY\;:6622229U*I_7N,
MYXYE;4W.)!)S6GL'+=4Y]'!6FT<V=UH^_:+?Y:8?IY*<5C!]86_-24A0*/?I
MMRD/7[/"J<M1>^NN!&('*_[RF)+Y]LJU3__;<J'=6)!\\-)DMU6$0#%!7PH1
M^(2.RAS*5*U+22ZIJU"NC4W)?BM34Z'75'1<.L:%CKJZ]JK8Q-UT<*:K+4O/
M:+S17<?3?-I>5&SH;"Y;*EEA^- 0FP3^8%!EVXF8]6I#9TOI4LF:FG/UJ6JJ
M@KZ0/C/#? /,\(, H[W(3T#6=-;GKHW:7HQ<L9<^Q'C&G*HY7*$"/]-0.=L5
M<JE<D:I(SU265JIS#EZV6<A5\::/C* Z=51Z(BA#QDFX'$ $"WX?P,#QF4&Q
M?%GXJS^7/+.,NLP?@8Q.T/J_2JTX;MH-?IL[O"N=$0R*[SZ T'Z93%.@XRHL
M@Q6@#%: ,F)O$2"PK88R6 '*!"%@S4]FSY[M_1< ^ ?+3 F\%^!=@OFGA_$(
M&)57Z?_5CP,_^]G/'G_\<:$YY7 =9]1Y:\#A^/J*[2[_]]WOY^4S;#M[HN'\
M(/=QL,M8T]IMYUW7[;K99:;>BEOP])PPN?;([LU/\U?)!HG[K,LDH:/[GK5Z
M8WQZWM9TO7?!ZGLM!TF3[;MA2]EJJ=)DNW/M\*;XZI.'X]8JBK/B91J#/HW(
M*29)?7.W<VS,V6W8)E/D***3#Y^JIL_@[GL_J^C0_A1Y#JG:HCC02.U@Q6WO
ML=\6&HZID[<5J^1)-=V!_/ C0B"8H"^%"'BU _[:-IOM&\9KVS'H&!YQ.6Z!
M3XS']["3QK";<>MV<C;;P*R;T[C 5S3CM#M8/;3DIFE@[>UR#CG@X4YP(7 ,
M>"+!5ZSW-T\ +C'LN.48YXK>PM GM_4.VIW.NPY@_^UR.X=N,6=UWKGC&H'5
MZ1L<'(!E$&>]@L3(M9KDZ-C$Q+CP\/#5^HN^(>"XK3_4W]O;#XS8H4L[(Q !
M$=HODVD*=!2.9; "E,$*4$;L+0($MM50!BM F2 $O&#@03&%I_J1@VZF;[_]
M-B4E9?[\^2J5BF'\!/R/]\-@!2B#"KQ-[#IWI.KSX>Z.ALJJ][^9V";'%_1P
M[!MZL$B/KP+:]\5M[VZK*=?J*'/7379(-MAE*#=T>8))QB;GN:B"]ZUV%Y)@
M&20FKXL'DX2.8\Q8!PQ!O3O5#(,M:, W]YQ#=X>YL2FX-[U@Q EWJJ'A&7UR
M.^=P9W Z'&!S&RC@B9GA,OWM71=W*M^2B)@>F+@OA0)"NW8BI@*CSB&[T\W\
MU_\[$0%!?-P$"'1<A66P I3!"E!&["T"!+;54 8K0)D@!" 8\+')R5(G1,9I
M*P]N$VUR?C#0S?3G/_]9(I'\]*<_?>RQQ[*RLK#MB&6P I1!!=[0T7V[ZSU=
M<?;&/\SXSP]X>RB.__)Q#5A;J.RX,%[:X]RPS9K*UJOWX>3BZFM*_\V<E2GY
MZI0_S7]%8;CD&$'M=MQ.V_F6OVH37YLS\_=Q.?\9-5L8H:/_LJW_<_@72(3@
M,5%?"@V$=NU$B! 4Q,=-@$#'55@&*T 9K !EQ-XB0&!;#66P I0)0@"" 1^;
MG!-?=QOBMFQ)+A5M<GXPT,WTRU_^DK')H:-'(=KDN'L_4JUZ??.VO6T#F 6K
MKJ].J9;-G#%[?M1_:LJKZHPTCE+O9&\.FSMCQM-AJ@]LF.DQCTW.F-MQGEKW
M>WC(EWZA(P>7XTN+69\1-7_VS/G16?H3GWQY'\'I!!BG+N-ALM!1A(A $=I]
M*;1K)T*$H" ^;@($.J[",E@!RF %*"/V%@$"VVHH@Q6@3!""I_QM<K(R,S5%
MBO5K-HDV.3\8Z&9:LF3)PP\_3$>/CS_^^+IUZ[#MB&6P I1!!?PUR6[G36MK
M-4DV3&:3,_;=#:-\ULQEJJ9_^B\^<M_YLNFML)F_3V_IFS2Z YMS<'MR,-'C
MXI6Z]P[$CALZ<O#XY<09X8\4P0"IR_@00T<14XG0[DNA73L1(@0%\7$3(-!Q
M%9;!"E &*T 9L;<($-A60QFL &6"$,!@@$NG JE8]]Q.^Y!SE/FOGWARP%.Y
MG$X7>QYO>M<]D/$UZ'0/.X?=;I?S+LC58LP1!OM (AC(V((I[LYA%W.4:]@)
MG B@ZX&#<TCXT8!NIH&! 3IZG#U[]LJ5*[_]]EML.V(9K !E4 $VG15Y^=QH
MV/PBV)71E^4P9-&^/BNE:<"?YV-DH"7K-W-6*JJZX I4M\OV@2KLZ1DSYDP6
M.K* ?<^?O%\@=1D?8N@H8BH1VGV)5SNX.4?T)M*P1RZ-(E;-^[=<R["M\6UM
M?FK4VAB93*Z0KZ3Y#26&BF1VM\9N8Y)TL31)7[<_+29NDXK4)(*/QBO_8'9Q
MU)ML+I#W#'9KC(XA/SBC)Q3-7\./,001JS"T-;]3W51=RF[>J%2D*P@B)NWP
MY3O<?H]KHY8O!45J:J; GHUO;DUZMVNXQ_QV<7[<<_.DD1&1&E 89G='\)'L
ML ?V-U+$9!C]NB4S<G'8J[]]]B79CFVR9U]::[CB8Y,C[NL8($+[93)-@8ZK
ML Q6@#)8 <J(O46 P+8:RF %*!.$ )AFBA DZ+CQ9S_[F=#L9?WZCQ_\7S[
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MCR@8'A*_U0B_%2\Y7UV^3S<!5D+@L\^XU#S)S,I?'!84?H0=D=KL^^KLZVQ
M,_AVBH<>%;\.\5T,_*8D7/ZP3O%3C_#91_J@)%4(OAH%%)\.^E(4T"JA/=)7
M(^D<>B=][0FXN8B5PXZ ^Y9[U MO7L%%?&<25.>[R\ B$B,UTN7OE*29YF]:
M?%7N,<$!3*J?5[FD@N+I$S#[7(H&1'?O" AD!7*YR1#H<Q66P0I0!BM &3);
M9 CLJ*$,5H R$0B@]0F!'/'PPP\_^."#_)^AO_A.(<X;[^6C;_R&T=<Y3AP]
M#C_Q"0B]^4SVG*DT85!YI@>[IG3LPZK_Y[_9;D\H+P%NVO%_@T#T[O_7^/[
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MADX5X48J". +KZ""WU=$]\UDB0)]"L<R6 '*8 4H0V:+#($=-93!"E F D%
M,'"G6,2JON?@A^GJU:L_^<E/[K___I___.=#0T/8<<0R6 '*H +_$'LO'SW\
M!^_,>-_IW[SSM?_1^$YN/FC9.>*ZL,SB"E!Q6 #1+-()Y_GB-9NJSYUO#]CF
M?K"UO,+:;K/$*A[/J3G.[<G1UAQW."<'[&7Z_;5&0RF(<#ZM42CBK1?/6PR&
M'71CZ^'DY2\D:"T-EH+\_;166\-Q%[K=M^Q%.G.M,>?@R3J:N]RR(SXN5<M:
MMN7OKLS3LUPCFU?4=+DYQW 1?&0#@F+#D6I0MJF6SGI%G?'<T]OK3EE,#&.R
M6/<#OL&\-:.DEO^Q[4,^(/RJI[' 6,,8:]J^^&VYP=I^OBI6\7(]J)"MT?+U
M'[=WNX30T3EPODA;56O0'[P^ G=H9?)5RK5B(V\&'9IG!MOI7VSF.JR4(E;+
M-G)VAYU>JSEE8U:L-YD* ,,6I&GW,]M*6OK[?"=JM?6L-24+"O@.GNIWM?J:
MU !62_M7M\,N'VT4S\RE2_2:=.Z])M!@_H1DBL6GX7)YMMC(/_V#@C/^T%&,
MI<N1D]QVR=].,S\B*>I2DUBM=)X#6F7U"9B"_)9;"UKQ,,M<BA($]0X\[G?!
M8!Z>_XYFFOLBZ,4*T#2KGU\9FUY]&KQ2"7JS,.,\JE!L<7BGW,Y/["!HS^><
M-^ (PF O,)]^O(-.IZ@-Z1NK^##>S4^7@-<TZ3DU!RO!6Y+RZEUJ\.KDS)LP
M=(Q?HWZER!<Z@O<@7C%T-.Q\%;S6*:W(%%Z+O$XI5NA;/P3O8C1):LU&#95-
M"R]Z0B(?@GECJOM(%I6\EKGF7]'"P_<^Z^;)T*DBAHZ^%UX+NN:B%M%],UFB
M0)^KL Q6@#)8 <J0V2)#8$<-9; "E(E  (*!0(?5Q+QC;>^4LEQS) ZKC\+_
MMV[4[RU2QZ]5P[?_'L'\!OBF5K%TH/\J?)L_J]LJ QX5@+?JIY,^V:I88-9Z
MXZ9HG1KJMOJZ?O]>X1WTP+2P)$U3NH,&V8]#-HV2Z6PWIQ]Q+-3[YSL!/TS_
M^J__>L\]]_#7\GWWW1<?'X\=1RR#%: ,*O"'CM-?GK>4FTP5)?JZ*]_Z9\F=
MW'S0LG/$=6&9Q16@XK  HEFD8!TV6 (^"A=2BQ"68H-5V -]?0-N]S#XTRN(
M^7_ 5==3GA$76(+M'0=;ED[#(L*R;&'+5'&!MF=X4-K_='K",S($=T>=!&O!
MG?W#(V-B09_ ,R:5!4NZOW0.B>O%?74&;J@:M(A\"JQ$!ZO&I\ :=*%^_^IS
MOB$CH"'"6G'0!E\CT4-/>=QC7K&U0EM&1_DV\Z18:%@Z(;X3!39RG88'AI5/
M!S?)=TJ%!>O"$84S,R-6+C1X6#@_T^)FK_Z>PJ'REPULK>\D2U7Q[125TGGP
MG>>P)PKV9$&892Y%"8)Z![]4#]AIK9DQY!RY#N*!#X->K#B<4[RFZ5)+CO%(
MC4YZLU#S=@NK V\KM(8*@YZI,::MBMW!!^W5!74VN ;[.(S\#^2E%<#0O=?5
M:C%8+YXWISSY@I:I+<_?75DLOJ;)Y>ML,.=F&&N8HK274HK!JQ.K!;[7$-^
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MZCL!/TQ___=_+]CDW'WWW4]#A @"?YP/@Q6@#"H(^+#LZ3VS)W?+5MVQ+G?
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MA)[%Z,5"YM+20W3WCH! 5B"7FPR!/E=A&:P 9; "E"&S18; CAK*8 4H$X$
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M1Z?Y<<G%@<F*L+9:2]Y+S[RH%;(E VN#&8,PD9(IR#?3><*:0VT#6!/8TN8
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M7!@F;UC7/?&+=<$.JV3,7_[A  "  $E$051SCH4BNF\F2Q3H<Q66P0I0!BM
M&3);9 CLJ*$,5H R$0@>#;7)4;T86[BW-"]S8X0V.8WMC;J=NXJ!U4W5^8]M
M99+G#4R,$@P[8+I6XP4NXYFG\NK>-6>]$+=9HU9I-,4@=,S<9V^KC#,UVXIT
MYCI:<Z#3*^9V"9NQ;4\0BU0"&;!IC4(\';PYQZ]^]2OL.&(9K !E4 $)'5$
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MK !ER&R1(;"CAC)8 <I$(""S189 APD[CE@&*T 95! P6Z;&KAS8K"DAFW,
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MZ,C'@4JE,@;4 $)'/L*DV]T!H>-7?+4PGIRZQ64 F==EURN5S\6 :).$CJ%
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MWS47:/-RM.)NX?Z]T/E*=%IS':W=EIG-_]A(Y^VQGZ7C=G'6(FT-G;OSZ.]
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M 38=TF;="P&(0OE*1D>!BP7PX.@;</_1ZQX:]DQX/%YPE%&^VFDO.!;\$9B
M3$(!<.( #-A6'.X6[M\+7=ID>]@#R;Z!8;XTW% =;-H][!EQM%P:@+4)NZS[
M-C/GF4EH0<+_*)07^A78 )X7#$K@%N#"=N;C<*-TX82$;'X.?$SZG0,N]_"
M4.I/!&&8KEZ]6EE9^=577_F8$,&"&*P 95!!0#HK?T:^=CJ_^O1$W3M?^Y^5
M[N3F \M.NKO>/?.>C:5K+SK'YXCKPC*+*T#%84%"1X+%!)E+?U[,$3KR_YKP
M^<1,W>(R8H1<1U_6XG WJWI,:W>Y[%KPHSM,5?Y<1SZ..UN@7,-'F/ 7:-07
MG.O8OH^*"9_K"%LB? ,,4TE KB-,F%16.@07XJ!<1Y"X*.0ZPD Q--<QX!
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M).)EG!L8U,_CAF'[D@ ! @2,!L)@XH,@YU74")5 1J@$,B+T%A\$M=7(")5
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M:_G'DKQMS.)4G38U94NY6EFD5<:&+$R!.^0D@I/6F"RV06M%H.@5S@T(+A@
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M!-]E(""G39M&;4=JA$H@(R3!XZGC@..ZY</#GXWGYAPC1>XQ@21[!23=(56
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M-OBD&6#>O'EM;6UJM5JCT>#()Y]\ G0C^.H"509D&)"1V$3GE5=> 0>:S>:
M@  PLN@1WG[[[9=>>LE9>%-34UI:&GX,6%!0\,477P ))Y?+02&IJ:E _GWX
MX8>8";[,O_C%+T#YI:6EX%,@'7&!K[[Z*K9[!0)RQHP90.D![1<3$U-34X.7
MRX(2 !D$@?Q;O'CQU:LPD0THTI24%' AX#4X47=W-W@-E"<H.3\_'Q2[<.%"
M\'K]^O5__>M??__[W^_;MX^OLH#1HLW(5C37;5+$*U0JM='JX)>:[_I(EQ06
ML21Y=;Q\5^.N-6^V]%Z S^U#E[+ZC7"90%31QP<WHA7C6J.UN]68)/:?P\1$
M\>0;)^#A2W.J:]&:^4QM_A+7"O901EZ0PR^AQZ<[V &7BU=_ LMY<9IHX6:T
MM!L1TE>;#AO0DO(Q :6[2$+#&$D MPQ^O4H5OZSVY!'U,K;I$+\^'WR4KDK)
MW75LYQK-D5Z\U)_)J]Z'JZ')CU6:6HQYZ5EX ?QGQUR+VYFUA>KE<_W%,9IZ
M_*LI6N  ;M3[=:YKA_DV'U2XEKN',7E:;2PX*LG8>HV[5ULTJB%) 57<.OG%
MD8O=TP'TFU!M$])D$9*@..V)&YY7/#Q&'DP$W!>0\RIJA$H@(U0"&1%ZBP^"
MVFIDA$H@(V,@..U/!/@:GGSRR<<??]PS>K_AT7\\\'4&'_+8$72=U\CX$DBR
M5XPL'4FT#TF*RV5I.81JE2J9GTOAI^UH#:<,SFQ8O!PTJJCQXCX^'[(Z+V7%
M'-%TL?_<6%56'IZ:<%,],$5;5(D/QWF C=?M7*;?VWK--I2=Z">:Q24BPLE0
MXP64(=F$D@/;<(K@X*#'-#&OKEDO@[E_J2%,.)C<%%5I40ZG2#0#3]TTJ,Y;
M]Z"CUFK8Y3C#<[-QZ.&@GM<:V6@X/3KT(9K)269+J^'#.NXR^?3(VAW.Y[3\
MW!<EA0Z]T=]0C*8O"1 P6K09F6>G9NP_X_;U@2O -849:K@)KU'U1IEBD:*A
M8P JHH!Y<Z3:/7B%>4G9.KQBO)![J@]&@X&.!DS&*\\'[2"*ULQ7,Z)G72O8
M0^>*1)G\$GJ\+/^ "2X73X$[<[#5S=QR<4R0!4IC&7G-.$A';AG\!I5J\1/+
MUZR9^;*"5:#E]\H8^)'N^.4/%>+L!MMM;JF__9PQ8S.J1HS(?[Y4MI3+][9V
MNBUNQVO:P8C]68>UDY>.\$9I-N4ZKUT<,C]84U7.+W='EWP4'=4VR-\K:_-;
M*%7!F120%8'7R3- .KJE ]27H_7\F46*)4$ALFTGX:8X=PAA,/%!D+-P:H1*
M("-4 AD1>HL/@MIJ9(1*("-C(%#%P)UC'(OZC@,TD]%H_/&/?PQNZ5-//?79
M9Y]1VY$:H1+("$F@-O'0P:?'VEAE.-HU8#_^3OKRUY)+ZJW<7N5>00Y<(^@Z
MKY'Q)9!DKQBM=/S*+2ENL0(N;APYAY"?2\47[?_T5(N^F)>.H7!F@S55HK'U
MMC,?<JE*OY4UUL.)';*?D8A7\E,],$5#B8[2'"0=0?D=9K4.394V@HDARDY,
MX;(HH]&LT5S'P@S)G'R5FW3TG"8":9<K@[E_BR*DD6AR<X/+X>2F;AMAG972
M&#QALJ)M6)NK<:*SV^$90#HV:Y:!$G1:5+*]2?7*')@BR%TFGQZ9_?HZ3^F(
MDD(][O0W$Z/I2P($C!;PJ6-3=>:BD(1\N/J]VJC:@)::;Z_*3%>7*A.WM'SA
MS!9FC4=JLQ1EQ7"%>4GLC.7E:,7X]$285?(9&@WXU)&!JZ;<;&UI7LKZ#7C-
MO#PIEUO!CFCM)I9?0E\,XS'Q,KA<O#BUO*X2CDMJM/:;(U0U; N'V<AC@S.;
MQ;D,'DC'+)E,(I4M$(E6X>7W\RK 1VR#[0L\I@VTFW(SX(+V]6H%JD9R4N8[
M#?H54BP=SYCXQ>V!J?R:=M9XS&(^AY)C^!OU3GDF=^TKY#IMBG)C$;?</1/=
MBGH;'N?Y>Y4*K1J&) 7,CD7KY&.B9>[I /M+X87$SWUY<7:I5J5I[/"\XN$A
M#"8^"')>18U0"62$2B C0F_Q05!;C8Q0"61D#(2?N#FL2HO4T%OUHZ,F11;Z
MMV-T&&>'54E4C"01E@.7?AQL8)=*)$'S0P)>>"&\D#-T7*[6ER!?R:.HD,V'
M#FV6SE\@13]TAH3**\[?:#6ND8CG9=36(0*[:752F:5>K=;KE=+%L YO9&QZ
MG7-5'("K3D)"93DP%ZQOL+-.)M:V-*DCR\R-<';M>;%W%:"9IDR9\M!##X'O
M\B.///+'/_Z1VH[4")5 1DB"NW0<<%P_VW*Z;>C^GVZ#ST#OB3>"I5N/7+]F
M5OTMI/A0:[,V--)P>?C5Q.3 -8*N\QH97P))]HK12D>\L3:?%(=2 4?,(80"
M"<ZE& V2C@JYCF683!5; 6<V7";A 8O=QN=#+D?)DU@ZUJ*G<\Z)()BB\0\M
M<4:BI9.?TI6=^6<SRDZLY!(1Y95':A4QLD0%S)"<+YJR4E>C5R6B],+;'M/$
MC"W[RMFJO7J)2#0G$TUNKG(YG'#JEEO]GA:F+*KU[^ )4P4RFVFN5JF+T4R+
M/SP\T7CI3$5J'BA!;2Q',[E71($5Z*DCODP^/?*=76IED599I->FH;EO,DQ$
MK :7\VUX[CBJOB1 P"B!5VOWV#OL:'UXAYU;P0Z"CBZTV)U/"^'7=>,UYU?@
MNG2XP+NK'665H#78+C):[HW6G^,U\ZX5[(CFL80>+_G&R\5A.=S:;W>"6QK$
M*,%GL[@2 1"ZNQTWX6IWN'S=9N<7G/,GXE)B^'JZ5I@CFG-QN\.UIATNC><N
MS47&UXYO+%YI;[W6=>/FT$7R_+WBRG<F!=CLW#IYG!?@3 > ^3RP&OP=OG,(
M@XD/@IQ742-4 AFA$LB(T%M\$-16(R-4 AD9 P%)1\YA-4R>G:?)3=KX09-F
M_5BEXW@YK )EF*1*SU&II-!JM>[3C]DE\R6Y)FLC>N"!"6N,]15.7TEX%7ZL
MN<]N5L<SB^?,"\VIL_8.VINUK.E*,T]X^I7P=&ET 92.2V =@B?[K=O7H E;
MM.7D;20=)?'(1Z.GLRXC*%"JUN9$A,LBR>T5[C*F(^GXX(,/@N_RPP\__)O?
M_(;:CM0(E4!&2()+.O8=?4M5>^;"N4^VZQNZ7(9*;H-/G]40'V%H&[Q]O'A&
MQ+;6'JK5*CEPC:#KO$;&ET"2O6+4TG%(4AR<EE%R"%'*'#?%09.2:QWV6W!"
MYIY).."6#^F<UKBF/H/<_,8YG^/+=T[IX NW1$241=GK@),>T)0WX72QW69W
M9B<.G28Z9VG.R8USOH5>\#F$Y*<>A^-\0W0CT$RN9\CDU94>R:<^XRD:LO&_
MVF6[DTQ"W\?H^I(  0($# -A,/%!D/,J:H1*("-4 AD1>HL/@MIJ9(1*("-C
M("#IZ.ZPRN97G>:?_HT.X^NPBE:BH2<N3549.J,^Z_5R5E'2<H"7CGA-"N<K
MF87\5[=O5V44:S)RM6I559.QH-1RQ<Q&2M65^QNJ<B$A72XK,C46!+)0.L:H
M01T62^6KY6H=*].U].'E>*#D3+E.*P]*U7]0%#L[?(-I+QM8,(+@N1L S?3&
M&V\\]MAC$R9,>/311^OJZJCM2(U0"62$)+BDX^U_J/[[ 80EU=>]2L>!WJ/J
MN?&E#8:TW\W?=KZWTV)8_2?9GNO#_Y9,#EPCZ#JOD?$ED&2O&+UT%"!@> A]
M28   >,"83#Q09#S*FJ$2B C5 (9$7J+#X+::F2$2B C8R#P[B=//CGT_V,'
M5\*3".C_KH^&,/B@.X$[R!N\?^ Z"_K4\W!G@<0';B\]"G8>XUG3>XS''W]\
MXL2)3SSQA.<']Q5\Q^FSMQW:EB9+KS[K;L8[9/ 9L+6:R@L+=S1:>VY;*E.4
M[YBO"[F. @2,"&]]J<]:JY"$QBI5JR1S8K><N7QFRYJ"YDOP+]R)J+.1C0Z5
M1*2^4_V&5"()B5A3UU I#91$+(K+61,E#HD(E5=\5 Z31:%CAVRUZ6RS.E/)
M1HG]9X=EL'G<(1?[>YHV%1_IL>Y9;SQV5!V^K/8+_@<\_"M=-2I!NF)E8=V%
MXQ5KMIUP.7"^ =,&G(>KUL:(%TA"L^"J#_A<^ER%/#0H8\\79TJ7L:7EL6&2
ML'QCU=H0>"%.PP_>VH0M+8%E1C A*T?OBLF9<U8$3IDVK"MFHO[P%QWP&3OZ
MI=#EP(3M0^O:6PW(X6E*8"5.IET&'9AB0I%79V%C5X_5F(QJ%;D8;C'L_$BI
MT\8C8RJTX6J4/#V)&:T9YKU"S_GRN#D1[+OOLJ&A!1^=?%\AWWG!ND\AK[&Z
M.L#)$Y[F6'B7U&#_)V*'WGSE%C6^16$+H-,5FZZ*0W9<HAE.>U7.[FNE."0H
M*&<K:E_09[2*A0G%1SNMM;$BT4S$Z?2LZ1CAM,F)2(++]8OU+9=0BP_TGJEY
M^X-:-C2*K7D+9N:\:P2W(")F@ZD=):A,GINI*XP-"8V1RY@Y46QC1W]K)7R[
M.CDF)#1V^_Z]BJS*>GU"X(L!NC/?E.4-W@83 ?<9Y"R<&J$2R B50$:$WN*#
MH+8:&:$2R,@8"&YBX.MB'(OZC@,TTZU;MQ(2$L"+]/1T'/$@N+^]DPB50$9(
M@JN)!Z[6J^)>6Y6EVE!K&69SCM&"/'8$7><U,KX$DNP5@G04,)[PWI?ZSQNB
M V?/79Y?(%MN.'FQFBULO@+_(NG8K%DND2Q5I">K&F\,#GRNS\E720," T-3
MM7G1L^8%!F76->]  JE 7Y(<(DU=+=.:T2J+-O.;+'?(+NM@1T.F@LU7E)UJ
M0-Y(%<W0\W:H=(PJ:FP_I@M9HH.J#\D)2?!*=8$*;ZV)#_\(9A'PSD_]ML:\
M%Y]]]OGP[2T7=F44-MKMYW=KBC=E;#:WN>]RZ2X= ^;-62R+2QF]*Z;3G+,*
MY?1Z=<6\T-=QE9..L/).!R9L'YK"76]S!?*76L:E[ -!B$Y]PMYK-4I1K68P
M4#JZ?X0,5_!=2BS:5@#=GD9EAGGOT'].'Y&X:9-LQHQDXXF/-=F[+G0T@;]$
M!W WQ\+2,=WPC[JA-_]RLRX.W8>,6,[IJA7;<;GL53F[+] B72B9!+NV;F5+
M=)GI^?FRU+1HS!GI9\71P,UA%?F7\M+1;B[4-EZH73EC3IR"W; Y/W%U<NR,
M.3(V3VELZS^[JV!S?E)1\PU+55;%B<_T"?%O?SS8Y["#M^7'87![ TKCZ3I:
MM,ED^Z8HQV$&$P'W%>2\BAJA$L@(E4!&A-[B@Z"V&AFA$LC(& @_(6QR\$]O
ML17G1CL^_F3<;')N=S46,I*PV)PT9/?X1E51W/SY<=I#)D^W&\X.Q\[;ZJ0:
MK;WV$SIDEF,ZI$5'G3B&_&^&=\V)D68P#++#V6PZ@GZAOM^N.:"9_O:WOTV<
M./&'/_SA8X\]MF;-&FH[4B-4 ADA"1Z_#@PXKEL^//R9(!WOD"I  !7>^E+/
M^7*%0IT5L6 A$Q2I.6KGT[O1]+W_7$52IN[MU]=N*%PK+]BARTHJWUW.UEC,
M12O3,[*-+686R+ERY#-4 ^TTS^Q7O,ABZ6AM/Y#+'7*Z=W"@Q\P^'UEY:C^;
MJJ_?S^4/Z'7),7*=T;1?ATIXSPPD&3<"MAGE&;JJ]4F)*Q/ 1R9+!SS<:(59
M!)MWY"HV5'ULL??93.G3_69)BQJMO6;UALKW4R.6J7<:-ZS)+LS5N!XT\1D(
MG%EEVOS A-&[8CK-.2N@=/3NBOF%W=)BL?>[/75$#DR<?6AQ:ODI[.'$[_X"
M\RZ,N@PY-'P"IP;2,1_5*B&&B1WZ$9:.,(/"6*E>&3UJ,\Q[!8>E5)F7%Q\<
M')^7IR@Y><;MT2+7 4[7:PAS+/07&FL=\[CY.>E)W'W 3E><=-1R]JJ\'1?*
M ]$DI*PO4&'7ULVL\;B9#8XT?F3@../E<>7FL H;<:-NOQFUN-U<4/#!05U2
M7K8L/')5'JN,C8F'KQ>M M+1\G9J'IN3F[\J.$[]9F9R7G9"P>Y^ZP>IX&W5
M&\G!<47-;;!CM#469)C&JZ+W -X&$P'W&>2\BAJA$L@(E4!&A-[B@Z"V&AFA
M$LC(& A(.@ZUR>%^>AN;=!P7FYS;7S:JF?F+%#HV1AP2Q2K7J,U]_9UM-1L]
MW6Y<+I+85H=%OVSJH%D.*X:F.7 ? : P1W3-B0;2,1K9X:QEV1)?<,T!S?3,
M,\]@FQR@'G_UJU]1VY$:H1+("$EP?^KX47KPGU];653?Z0FG[Y   (  241!
M5)Z]Z#[X]+>9=/LO] ]VMS8<;G4,#'Y9KU+5?^E&]@ Y<(V@Z[Q&QI= DKU"
MD(X"QA/>^Q)VO^RS=T!')# ][G% VR'T%[ZUMW-625W(;0F;*O5UVY%U4-]-
M._89XNPT!_H</3S'>0@^"S)PXOR*>J#1H_5:5U<G_.LLH0\?/H@,EJXABR;H
M5@3_CP['5DY7NV[>:*P[V'4;E@-/"FN)#"HQE3/S=&*(F1/R9QJ]*Z:;.>>P
MKIA#7:.<#DQ.^U 'OGRG.:?+@0D?B(+=G OFD(]P@=P!CM&;8=X[##ANW "-
MA?YRW8"_I4,Z@+LY%OH+NX'35M3=JHJX#]P+EQV7TW24O^W(-10[>[DLN\8'
M7/U=C8A;'"U8_;3+<</F&.CG_W:<?[\"+E@=1!'0:E;D4@8_15\K\+:K"P7Q
M;8$]Q/-\/@SO@XF ^PIR7D6-4 EDA$H@(T)O\4%06XV,4 ED9 P$)!V'V.3@
MG]Z*FJVC'<JA=!P?FQS;^4J6+6>YG[-W5NNRLC>I,UGCVYYN-_*,$E91=!1M
M% >7&F7*==6UNEQHEI/SUO:<[.+B[%RXF_J(KCD,D([Q:FB'LZZVCO4%UQS0
M3&*Q>,*$"=___O<G3ISXZJNO4MN1&J$2R A)<'_J"!\YFLI9]MWA%JSRCJIM
MAHAX _P5V! 181AALRYRX!I!UWF-C"^!)'N%(!T%C">$OB1 @(!Q@3"8^"#(
M>14U0B60$2J!C B]Q0=!;34R0B60D3$0H!B >P1TV^&/<WUN/[V-6AY!%<K_
M)(M^K@6%?-5G[^QR],*?ZKA?GP?ZX+G06_!?SVU$@#]!\C]SXQ^(P?'<S]G0
MC9_[M1W_T/D5^M4;[@CEZ+J&?FSG?F?D?]G\:NA> .AG4'@ZY^^;MX>6<]/1
M?=/!_9C>[^AJQWL6N'Z4A[LA@.+['/9NGG9W 9JIL[-SYLR9CS_^^-_^]K=;
MMVY1VY$:H1+("$F@IK-^=Z6C  'C!<\N)D"   &CAS"8^"#(>14U0B60$2J!
MC B]Q0=!;34R0B60D3$0L&VF  %W"(_^XP'WP0=(QZD1JDK#YE5_^,LJ7:5!
MM^H/WV+IZ!D6(&!,\-:7^FV-KX>%2D)3]WS^#\VL9;77K#MEJ_=9T<I[9&"S
M0!*:ILW/PXZ@,#O\C15!DA")8F_K\:W2H)"0T&SL=SJ(C#&9L*2R,U=;H(WJ
MY8'!7FM=EF3.(FE\I$02S1XZ#XU;FXY40"M4=L_A+<ON^B*+P2$V.3 )X=UL
M3=/PKIA1JAW;MYJN#G0=!*_S=!IH>KEV;2SX%"9/]EA-*KGAL$DA"5Q3H%X9
MY#]W-;LF;';TV^='NXSFVPG4ER02J2Q>SN5SYKC9HD9$J1N[SK\=/2=*9=RN
M")1D;-^2$2A1@+OM68[/ O<E9'Z[;-<71S0![($6:!A[R6J,$3'5UL&>#FLG
M[-(#=NNI,Q>O7SQ]JC8_H^IL^TU[VVG+]0[KJ1.6UG.G6_>_GE%UVMK]5?OY
MLS!XYN*5SX]9KGYY=-/\2:))8N7^6JVZ\=3[JDU:EC6TG+G8==5R[+//K9U?
MV<^;#Y]H;3U[MKUGP-YV[&2M*K?@]:QW3H'RKUZS#]RTGC[?WM?3;CEQTG*R
MQ7+^_.F+]KMV<[T-)@+N,\A9.#5")9 1*H&,"+W%!T%M-3)")9"1,1! ;W'9
MY'!N<YPMC693KMIL-:O?V%,K%VM/])BQ24P\H]RZAW.@.0-M;[A,^\%!\$\Y
M$RJ)#I-L,$-3'.-;J+3L=.B@%B8)"7CAA?#"QNL>-C;\65@V9W69Y<,U(K\Y
M+[P85/CA>3"\]Y\#$Y@(:%KC4>MO.<AFHK8C-4(ED!&2X#:V]#NNM%D[+Y_]
M_$OWB:7[X#/0?G2WP0U5V]ZH/GG+C>P!<N :0==YC8PO@21[!23=(56  "J\
M]:5^6W-QE"0T,K=Z%W0-33$V5R:%+,]<O1HZK&(O4VLU(V*XS21892I[\'JC
M)FP1JV6UC3T# VW&'&1GRCOK=%HO?(Q<-*NM S=/EBCR"^*CRHY=V%VR]?@E
M9-S:Y8!6J-L/G:K.*+RWTA$:G\YC..GHW15SY;L?04O8:S"^LO;TD:)-^SZI
M+MB<GU"P&TC'#O.;V7J]6FUJ5.L^;MZ27U>[/G#!HMC*5D$Z0J"^%!02G9:<
MR4E'M=,6%5K;&8'$[FG5)RR3)A8VFE@_,=MH0ILI?U. ^U)DHFI-V!-1&6L"
M_!2J',XQ>*AT[#._+G^S/"6Q4+=\RJ*LW-35\K 7GP]EELAS<V59K,Q_LE1=
M(IOIY_?$)#^_Z;*W=BH#1! SY.KLY;+$-"9\ULR5JU-R6:7X:9FN8JU"5[5:
M))J9D2P2/1\:)A)-\E=NTT;[3Q&)%F9D)20GK5R3GEISH5DC+2RK5BOD.C4H
M*S(7'*]X'?HDWQ5X&TP$W&>0\RIJA$H@(U0"&1%ZBP^"VFIDA$H@(V,@/ "E
M(V>3PR#IZ&9+HQ0'2@+%,;(X22#S9DM3$3*)B68RI#&(8#U5 VUOM+LJL'3\
M$DC'!9*4Y)A9R!0'2<<H=1F<#$05-78VH7^ [,C&IO=:VWL;U-#&!O[;A*5C
MOA29W\!_\<U]:'B_?:(D29'):+Y!_VZ-"\AFHK8C-4(ED!&2X!I;^HYL?_-M
M;4:Y>=?V&NAL1!!(?+L7K'J&!0@8$[SUI9[6BLP,W59VV>S?K=(W[2]*E*_)
M,WS:H(A@H73$CJ;I*4D*SA%TY\YM:^4Y93JE=%/=_D(Y6ZI3I&D,'UOL_0/M
M^S/EFDI-^JKX.&2CFKG%<N.\(9T)6A"3%A>\3+//8H/RLNGT?FB%^H&E"X_:
M=QON#JO(IS39.((K9I*V_(W4FHLG2T$\J6B3*L/4A1PR\][:"PL#6KIR;T5J
M<G+JFV5L@>E+2\4:17I2Z<G;GF?]3@+TI1QEJ5:Y.G6ULDBK+-)K-;QTS(2=
MQV2QP9N9+8M>OBHY.7GU:O G=?2F>?</V)\ FKXFR*1B:6RHZ-D4:!BK4*0M
M%(GENIJ]^YO.0:T&/?0.M)0HLK(#1&O*];FKX@->\ \-90KU>K;,R(HG!28I
ME6FKF+DHV& I7_+LTU ZQLE"7YB]E%6MB9,NGNHO!]+1CVVP5+)L87Y!L2(@
ME%G*;BU;,M<_4O=N<9B_GT@DR5H76[9W<V2D[H/#>C8IBWU#J\EB4T2BI[5Z
MK=ZHA;_FW!UX&TP$W&>0\RIJA$H@(U0"&1%ZBP^"VFIDA$H@(V,@/ "E(V>3
MDXN-RGE;FMSL3/@\,'62*+'\ W6F5J=&7C+A3+9&EPL(>/JQ4YV8G SMN\T7
M/S-FL25LW%SQ>OS4L126QMEZOV=N.X@F(7WMIL*,304IK+XJ%]K8K"UDU[):
M-DNW;7T),K_!TM%F,9^S]Y\MCPZ-2*SZKOU>3#83M1VI$2J!C) $U]AR^]R[
MZQ3I:5GKLDL/=[GF9",-/H)T%"" BF'Z4I^]_1J7%([SLW%V.)<7CEQ+>4=0
MF!T.^2CA&_F@MMM[;-CO%&=O(S)GHXJ2PCN@)V@'9W0)@U_Q5JCWR%+2T_CT
MQLWA73%MCLO[X8)5[(K)U1"_QF4A:TV'[8;C-DY,1Z^_8_^&C 2N;W 6J4Y;
M5-X=EK^Q[G\]B_!EN$Q?'3?MW0X'LNA%7@O=-Y!;;#=G$HMZ#G2:M3L<O?#;
M U]UV^'K'FC)8+?9H3<LZ#S8K0%\36Y<KLN8/4LLGK%4VWS5T==CAU; R+P!
MF@9W6/1K%*:+T*<7=3GXUV[KLO<X;"UEL7FFZS<Y/XD!Z G<94=V#TZ?Y+N
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MF4."@A8N"!"',%%%C5TMJ#Y5LM5[6@R@/R>OACN&U5X\"7IX7:>3G[,5YO;
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MU B50$9( N@M\Q"@PZKNL-5ZZ;-=Y>]=\>ZP"J3CSY_["]9]&*^JZK]T?DR
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MX:O%"T%L-9PA"G#&#0%?+5X(O)F([4ADB *<P06.:H&#<ZP%?JXHM_QKF)N
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M5'IFWBKYQN+T@IQ,YJYC/%"B-8)EKONDG*(^+L[9]<5.F5RS-EJ87*:K^KA
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MJ#2T85HMS,(!*VHS%&UKZCQ8F+XR&BHUVU:GC4C-87:=(JN@QCS$6HC[/7I
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M^Z#!U,W@]Z<^!;^,2J7:T.K4NVTB!Q]\7L186RHS4S=\<J#QA@N!RTF<&9<
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MAW9$L'4:BN3ZEO.[MN\_>=I\O\,_(8 S!+;6W]__=[_[75)2TO[]^R?1*[+
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M!\;R[;??_N___F][\,R U?)]F^GK'?GE-5I*7O!117JAOO/LK@_K7(Y),@$
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M89%9WBR!(/$GF" O"4* FD$EB*1B5(JT*2]!E-92-56H122N1<4:>;%%3+%
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M6/SO__XOZD$!;-NVS6D&G<D">(Q^?GY.AZJ"7;_][6^=7GVF\:<__<GV8!$
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M??-U=;HH7;N;X$HU.EV%3AD -C12+I5!_@4J3\./ 6QCXH9 >^%8!BM &:P
M95AK<4-@:PUEL *4F8+@J:>>8C!3QC2>ZD<.NIIV[=KUUEMOT2$B;#UB&:P
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M"LM@!2B#%: ,:RUN"&RMH0Q6@#)3$ !G@'HUU]%I[J?>&])O#X>'^BV3_84
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M$<R/"N?:#9KIR:+I^H[+:JZXJMM4;IO,&1S,YZR@4HG:)HNF5-T8I-*-4E-
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M;VFUVNKJ:J<>( !P'<?;!0!<.Z=S$<O+RY.3D\'&V;-G1_S&"<:^.L6Y<^=
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M*OFN.B>5S)(M6"0%8JUVVEUT9XT)BUD&^K.+9; "E,$*4(:U%C<$MM90!BM
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M( .YO__][VRU/TR?/OWBQ8LL42@45E96LD22=>O6I:>GL]4^0,:-FS=O)K_
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M%@='@S]Y@Q]_X2^_YHPY\-=P\[Y&ZC=BD_F7Z"&;;?YQ0*L)6X]8!6M %=3
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M'!"TFK#UB%6P!E1!#=VMQ5BV7W%$L29B:_XUN P V]!W]"52WSW(H@!6D^7
M:) UD!5F6$5'M]HM=.RXD;TV?G=.]I9UQ 4T,^C A(Z=.LT!0LCWY'FF,T/'
MM6O7/D[O'R0K*TLH%+)5BD<,3'V<T''OWKWV#<SL#AE.3Y\^/3L[F_V!K< Q
MJZR.1[2=Y.3D,$>KFJQYP$\F:7+U[?S54V8'2XB4G<EAD1%!4V8+B:1XD&$U
MS=5]:=#A'R]MW5;4^J!&&1IRX$+7O7SAN+GQV9GTZP:Y(G5G,EBK]U[^RK>$
M8/JXT:#79J_S\$]1%\EDA:5;MYVNN0;GH\/<K>RS&$ 8H:/ E<>;S^="1PZ.
MQ\;:S81CD$&?J[ *UH J6 .J<*W% <'6&JI@#:AB@X%K+0X(6DW8>L0J6 .J
MH(;NUM)1?2R*-V;8F,61JL<;L&I9DX.MT\ER(@L9H5/GW1S?D:QX$@:9[HRI
MDA"[A8Z=NF^_GOSQIUZ+9ZTK0H=;#DSHV&&DGISU,,$4S<<??_SX&4%Y/%YN
M;BY;I;A[]^X77WS!5BD>)W2\>/'B)Y]\PE8=##+,<W)R0K/.VLR%"Q=8PU99
M[00UF! /A5Z3FGKJ.T5X4IS0RW=-$A$?%! "MI>N4=5VW,B.CHT.W[I-*BYJ
MUAZ(2HH+3?VF4Z=1$4'^T@-'Z-<(4402D9Q=U7[CH&!*<-8-0Z?N5-3B8%GF
MQHB(B*BL3$)<U-1PO:NA<+TH+5,B_O>U-O99#"!P-0XC-<$]7Z?+$T6HJ/GN
M'!P<MF/M9L(QR*#/55@%:T 5K %5N-;B@&!K#56P!E2QP<"U%@<$K29L/6(5
MK %54$-W:S'^M%N:?^UV]<7]RO.,I5/ZW9ST)=)9ZYC!(0-SLISITA+&U,9F
MC?33'LE7J74@1_HRITI"[!8Z#D*:G(X;JO"OOOQ\T:<SW+?1';)U=75__O.?
M>_CZCU:K'3MV+%ME,'[\>+9$0<9^9&#)5OO,FV^^:76(K$.A5"K_\8]_V''2
M(PP.<W)R8)ET.R&_BO3T=#1N-%EO2]2 U4O-AI960U>GY;7QQLG#10U40E&@
M@&GBEFUJ)VH&.>.U W[496AK,[3I#9U@PCF8B=[.V)TZ&%DTR%/Z1.DYP=V2
M1I6#@^,QL'8SX1ADT.<JK((UH K6@"I<:W% L+6&*E@#JMA@X%J+ X)6$[8>
ML0K6@"JHH;NU=%0?WY@@E4J3XS)_L#ET[+Q;&#EKV/04C?4.!BI*!,Q:DW.U
M.WHDH\WIHZ>OR0'=$N82)(569F;!W5F19S_H#AU_2GI^Q:G&)Y@FQ_JBCAD9
M&7Y^?@R;+82&AN[=NY>M,NBM=S$Z.OIQ>N22DY/M.!QTX/#U]26_9[;Z&)"Q
M>GAX.!DEQL?'D^TD,S.3?$MND*&CU1C5WFV)@X/C&86[F3@@Z',55L$:4 5K
M0!6NM3@@V%I#%:P!56PP<*W% 4&K"5N/6 5K0!74@&TM6$,W<$4-,TC?H#GU
M#0-F E6]]I34>R10QWE+3Z)#VY"]V4E9^\(PR[5TZ:O/2!<-&S9GC?(*6LI
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C.NK_&  1>-7_$3S^WO]/JNR5,[/CGW4     245.1*Y"8((!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>17
<FILENAME>image_3a.jpg
<TEXT>
begin 644 image_3a.jpg
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MK!VM2)C#I)+"/&(^J6-"M)GW#@\/6UE9:6YS/+\,# P 1UI7S271_.30R+J
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M#8&LK"P3$Q-=HU+ .3T]/0UGY!-TZT U=2W@!-<)4(N,C SDB6WLT1R\O+Q
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M#5]?7Y 'O_+**T#++2TM4U)2^'SD/D(&"ZAE%145X!*Z??LV:*A!%5O?\]?
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MX^,3$A*2DI* T9TY<R8Z.CHQ,1%$0-S7US<@( #M[HF($O/PQI%+[F53ZV+
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M@"8:--3(*&0K#@X.!OX,:9"4]_7U(:./@F:=PY)@BER6DEDQNK"V.>H:F.8
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MGKGDD-&W-DU*.E 0[9]65%?<Q(#K'!X+T!PP@>: "30'=* Y8 +- 1UH#IA
M<T 'FH,^&*8YE):6.CDY(:.[1;W.@3U$+L_&%S?DYS0\PO,<)!*)>ANE'0&-
MH9>7%]J30R63V7ZFU^_Y5XWIM9Q:%] <= +- 1-H#IA <T 'F@,FT!S0@>:
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MU$U1V8+5]^X:: XZX7*Y<+](= @$0DM+"S(*T<+9V1F: PID,AE.>$,G("
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M)4/FLKLS!PJ%0J?3D5&(%J !18:>-CN9 [?4Y>+IVQXYA,Q0.V.K1"*I)"W
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M''=M,OKE+W^Y5(!H?C$7SMUZZZWFT $#!I1]<JX,&C*'V5!D#F:U'7?<<=<
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M;$0M=ZP+J*"%1U]) V\KO.O:M6MU=;7ZIBN)06J"FV(R,J4A.*\)[R]I29Y
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M35"+2*S&,=,2/.K[-4,HA0?-&*)W)/G-%Z_8F-] Q?9//OD$8>X@-8W.I>'
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MTM&  .Q""6]3%.6TSD%!B'Z^NBCB*%"(##28X$JWKW O\AF9F-$5-PG.D"F
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M+NDE!PB,5ZF&=%)]7=/G3 ,FQ;8$4R\EIV#8I8M&C1HQA-S#0QQ&IVNC$"5
M2PI/!,#@TB]I4@SZ!FWJK9K0XBWYYAL;S:D<M :()P1'Q+OOOCL-01*3<9,2
M:H5LTS8%PY_<"(0)2C74!1.#ED] +9J?K_U.[;NQ$D\3V'#[A=C#HPG>4IY"
MU=&#F*7B.X#E+K(!EA!\-S('IKK**JO0(LZ<MZF,M\3= Y@ /<P-8Q2L<^?.
M&>F*U6AO$:]\$OMJ.+I<.\&NBT5*XAZ^I7=L]X=9%\7ZGYJ2M$$8JJ@T;>#3
MA@><<<89DH3JV"F;?HQUH$%#:,5Y_C/\0P\]5*PF7M0[ZU.4SR *A)#K(M.&
M?'A1%#$Q]_D6_E/F(%$I'O3F.^2)\0Y<0V04;QL^B1U66*2C?$#S3NW>ADP;
MAL0SKW[Q,K](&T2*+!<E^7Q*&%WZM@&WW803&S'3>(LBOFM ["?N&\ ;%$&G
M&:0B%I45:#<  (  241!5/]4QJ,T_"F-K?,!A]'!.;]W#IMMMAD)%CM2#)^K
M249E,EE(+5^T(CL%C=32/)#_U!TI;+KIIEQ9:=I <(9&6/G4[+F2%42<6/]8
M@S0@WF65OB+@Z#(ERV?G1ET4X;9!E:8-Q:C%>X93$PF5N%D"7'?H7 J&(TI$
M1NG^G 02-]XCCC@BI?FGVN\Y?/;6$U/&5/4?,.2F)^;TLL#,86&@CKRB)K8
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MSZ3X#H;HW!^EI/Q>?!'ENO@N ;6?%2<.3XV-0)/B@Q6Y3)/!&@X:=(U[F>=
M.RA6WXV)<XV?CS-,TX05W1^?=$!MYB>Z@!G:"7$^;.K )IMLXF;!6T6&G ^T
M,B*!$V9"3YXHPF0C18RA$1G>$ADF8."G<<2J+C D$Q*$/1 ?D&G>O+FI5'1B
M.&14I$]Z,?G1F2>??%+FR<#AT="0U;PESMSX),XUQEN3.LQ*"1T]U\=78I+:
M9/73L9\>>8_$V;AXWI Y?*7PW<@<^L;92B:L"R^\,-\V,"*:><$%%_PCSF,0
MIN>&:1-9Z2L%*C<T%DRJDQZL*,JTH4\<;L8*BK<--?$<--.&_O&UK]*]#1F
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ML27?[U.4KZ3R;8-6Q8X.GIQ$5EII)8&U7%3#YTI.4N(J*^*@JM[Q2J'T<;M
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M=8_>D4B=QQUW'+"_ES"LLW.]!#SFR$\36B?C]$+_]"4TUMRXO%^:.[[0!0.
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MX6>EE,'?##\1/2WN2:<GP$G#;,#+OA.,,[.% 9\[[;13R0>B#VM/CL=C;0I
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MY))T#& FEN]MB9'E9]&/^G7J52XK"I4WMPL&>W+M!!*(USHE ZV?D%8+4EF
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MFMP2YWL5*$^G)'O#<!*[XO_J1?O?3WQ/W>%G?1$9BY,(PI_8#V,#HXXR&-;
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M[II$CZP$TQ//MS.WX6LK#N2P@68N2/Z[6E^M 890LZ9F_1Q*KC1:0FTN#J?
MLVDM8$S'Q;GM4_MY(%F66P'M<;0=S$VX_EQ-GIGT!9>-YQ:L9;4_T7[A&<U
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M$>'KG_WL9\.)4PP2O(R,-3B4R^O(&-UJ4&M7)C%?7VZ4CN2&M'?5K D%JC4
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M>!A0RT;123D#U/%T6W(;D5R#N4FL'6WNN>>>[=&DP?#C)*8I.C%8ZV*1L8*
MK2NSDK[ J/V/<52;$7<X$XT^S\@E>T.H;-8U9=H9RTVAXI22^Z9L6@*/@!;9
M6,A;DST0 %_YRE?*,P$8,(]LBCUU=&6"1Q4\QR<%.PS/B";M%? 4@;4D]_9E
MR<%D25YMM=5,67G9P8"668"6A_[$%3&6IU)4!BT.\HB25#P(/&0_)3:2%^L$
MLBPW_\ )NNV-)ZXZ=54&2W;$3M:C=CI2O&N.*%6UWIN=NC!74@LSCF5OR:.I
MV=<8&X\9#09=0%%__ P[<W:AV7IJ'G6WZLQA57G+@O+777?=SFP#_33%>H&
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MPP)YDGL*(/6WE1<KJ5GC3R@?V8BXAO8^ZU_TU1KLN5 N%4F=A&#D\_G92.7
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M%P*;#2 DL(A0W[U;Q.R$CY9)J4". ,")^ IT;C"#3I*K3$HAE<(,1GTP%=O
MN'*U_QMD#>*1+EVZ)*5M\_W8]0J.VC!RD.%TZS#%8^OH1VUIEL/A]_:__<9;
M[Z4[3!W7<F#B OS8"X!UZIY[[F%I^/:WOWW""2><>^ZY3-FG'_I48VFP8FGJ
M8B(@8V@>S<>6 TJ=?4,"OZ^CMB]J.3"C6.=(-Y0D%BW4IB-O^3JWP')@&D#]
M?4J1AIIHWX,B.3/ 3K6J%@RB^_7KATCB9A9IYLD["C%EB*^00P@D!3=R X(/
M*Q\L(\6LV"5EU57*U01IFU!LJ 4K?UIKMYU ;_0Y35%0>7+Y  9D-#=P%?:
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MC!91!2HX,"Y7WJC  'Z0X#9%/(-V;?*><5)&.<" I=4J-P'P,86J>\/)9B1
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MWL!_7!O;S!VH #E\@D.T>=M+I4I;;OMJIB(3UBDU+8^#9! (?NB6Z2B3_P\
M0[?/*\ 7_&Q0==@M2D/,/?3,@T +2#9[F!$F?<2($1B<XY7[CU??>NNMV**,
M&K4;XP23LE>O7O>JH*&]VC .^8FT<HX1S"J[=8T=._;FFV^&*IY4ZB&^\!8@
M!P#(DAD!)TP]!,]/P(",$W*$ V]PXCKEC66%8P5B3B%1D&P5G.6_5!7NF&+K
M/6'%P+!.U,DK+Z:ZT7&='/KXQ;H.P".OR^46S%L@#+#-G8X1\I3!PCQ"/Q 8
M% X:'U;5"\!C7NP"08?,:5R10KR:3DRQ"U5MG7]X7;=NW<X]]UQP"V'0&SU
MSWQ!U' /5CKOI1,GA&4Z&"-""6SP+( EE+!OG1(E.] 3$;=*%6:,&2;T(<4O
M/:Y:$/1CH^Z$5(1T0VNP'#ZOL0RA-[ 0L!3"U#"4\T?#DLAYD :O(0<0R^CH
MP>8ELM%6*V16DBC=5A_V</C#0Q^\=^B#9[8]6YJH*$\DT"4+8[$G5SSZYIM[
MWWK[W4.'#K[\RLO16+0D455:$GM@XCVQXO(#[[R][^UW#M<GWGEGQHR/HY7@
M69C:[CH0><N6+>&U4D58%:CH$(#M5H,Q$4W()?LL(6>00EVZ=('C$%RL."-4
M6YJKX\:-@^7YLUV[=BRI"-X<.2-HWRWT4&A$MVO;CYJ<,>B&&Z[I,V5 [XZ#
MIH9&WS%RX+CHFM)A_WG.:6>TN>/^47TN;]6S<_OF9YW\LR:-+VQYPW577''M
MU*K*Z7>%XU/NFCBSXOI&Y__JMTT[W=SK^K[C9L\I+>W?8^B=P\>654P<=%>G
M:Z_^Y=F_ZS_VKC$].]S4M^_HV+(W]M7K=DB <F68*%#P&+(Z4!Q1LI%IH+=,
MM?-H;Z>*&R13IPTQG5%X]R>XM$G!;'E*&5>@XY?@$J@[JN70I$F3A8KJC*9"
MHM//6* $[T2$4E6B@TN.S?#K\E5]/%#*&0B"%/F6H;14S&QPVN"#H%SY#L24
M22D])/J15"8EKB)UTP/!O4^$>&_6K)E?@>1,-YF.: =3J12A"M"(:1380G]Y
M"[*ROK9^85'^U/QHV8H7/DE^>ES+H77KUM_\YC>OO?;:4B6W^ J H3G,DJ>N
M#1A05RA78303]\::<LLMM\Q/JYAQU-9@.=0W;_$FE524A1.I 6;+E&AED?)=
MQ%42+JJJ#F5*+A33UB!XM[=2L=R!DMINR=9.OT_?6.\+%.+CQ!&P'_0-F]$G
M,LMF"1H;?<(D$#>"V,<+](8BA:V"1L5$PD6W*T=;@7+8P:66;N5J\/9(E?&"
MX9GO$NULP'OH3\!@ QU>13G8H2QX#(170"BK518GHEBHI+RT4;.\1XNV4:JH
M,J!%\_:=&2KQ"T<Q.ONZY,L=8KG2@.8K?[-C#P )I?91)8ZP$I:ORG1)Y5;B
MC0CNJ%(;S5)E:\@7G<\5<(L4P>, ((8/BN@-;15A09_\C"F#$'>.&C6*U1T,
M !(F%M]9!JP4 AZB']SR.G [=>I4WLA8WGOO/7LK%<DO,ZF]EBS%J<]5D6Q&
MFB\?2A36@XHNB&A7WC%PA<K]#WXNOOCB'__XQY,F32HKB=\W9EB'$='R1S:7
ME-2GXG$";'@$8+B_M*)T[Y8'HW?VO2NCL#!65%A0\*UO?0OMV81$M\@RAN-1
M@P%^\G^Q&F(+T9^7RAG%)331B!JR$JB@ ?N^6^ME1+R=?\I5ZX.IM[,O4#G/
M.C]]L, 06!<Q<NB$V9^BFD2TQ:H&\)CR?(?D1Y?4)HWI9+5*@98J9PC3!_$[
MLP<_BY5;B16%43 OO,ZK&GWR,T\Y+LKD\ 8 W#Q?(2C SQ0#'LAG!AG(!*4?
MF*L,R! Y PD\:OR6I+P"HHI=KE323"C0.U[@Y/#APRM4&H4W<AOV/Y?H!S"J
M%'P/23!J)M%'_.8R* ?6XRE'0_+(/-5? [S;E)"1=]D!CYEE*6+MG*?BC[P%
M.QPDE*LX(QA&DC!E\%&1BA(Z7(0.N7FY4HKQ:B:(+[S.RKK!*Y:_G*>,&U!]
M(#"8NEQ.4]"M8RA!#ICYQ2]^P4_HEF[G*M'*.J6 8\H<D?F@(KQSE4<K*6\E
M(Q!Z0T0D%!S%/S"=/<&*Y>((/"<T>"NEVM$LA\/[GE_WT)(GGWMI^^-+EFU]
MY?5=K^U]YX/WWGQAUWO)P_M?WK9BX?+-+[RX:<6296N>V;9Q^;R%#RW;_-Q+
MFU<O6KIQS[Y];[[TXH[7]NY[YUAN %^+!D$V;=H4OH90^>RKUJ]?/V<.=:Y/
ML,>EZZZ[SI;#\\\_#UUY.SQ16KKFL47;-VW<^LS6-4N7/O30JIR<J7>-G9 1
MBDR?<-L]D_*>V_'B2Z^\]N;K[^S9]?R$N\8]D%D0RID\9,CMH=+*/9L?6[Q\
MTZY7]VQ>M34_IS O5!2)U7OLE*1EH,=<<>CS2#4X%Q8#0O[LT:,'Z^D=RD/*
M#=@V2,)R900)/&!IF4H5];""OM"E>O?NS7?OJ57)D6;+TZM71>\O7;6V)KM@
MTI2<+M??U.]/K3O>.G+HP.ZWW5>RX^')C9O\JG'O$4-NR1@U>6K.E-LZ]1T]
MOM<5C2[NDI@];W;9?0-N['[%>1=?W:YYHU^<?]/P^W*F#+^NRVV//;[@@?9M
M6[:YX/P_]6G=XO*?-VXU\*ZQ4^\;?UW3QNTZ7M-\0.X3&U]^]>W]5=I6+]*>
M(Y '9@,BPF9#N1RBJE,YA9+:6G9L0UPAT=84?2F9$J>((SH$DRR[P2762D33
M42.D+[C@ K 4DRMOR:<S*?D ,Z3FTX;@$B !F$43EY:DE7MC(*S47,J1\S"D
M$ESZ,"TDND!^"H'9P&KU:"J34JY"HH- <$8-5"4*>["AF)1O%?<'I)+>WGGG
M'18^H.+F"L4W'GG'7]R",X<#K[_Q]KYWCE#\CVLYH$&!\.#HYBLTB!P-@3FU
MG<"0K;D%%B96$ZLD4W;LX3=8#O6M.&4YP#GGGW_^P($#[[OO/C17M#2K.'7R
M+P3I]O*_^>:;D8/\/UMQ"UZ;H]JA+U,H)V1=IKK1[AD-GI_(H$*%'M(/5/Z
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ML\]:9G)I[.?4<V %!&F@*%!DZ=Q*?$BQ#:SC@?8)M( =5O8(WH@"$%RB-PO
M'#F#U:7ECT)2V6S@$ABN2<L?Q4K]B$*B*U*9E-)#HA'%Y7+9BBKO-E/9MFU;
M3 Z[-CVCNB(LIEQEP:('2\7@\?^^%E@.;VQ_>MWZ=<_NV/G&NY_X+A[7<OC_
MIS58#O4ML!P@[O_ZK_\:/WZ\O970";R*LQY#<RRN:#.H^SUZ]'CNN>?0I:#I
M#)5%2\H#WO8T<\_-5H_H&9YG;?:&?:'< ) ^^3HPS5<!EP>5"0<F1!Q XO"
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M:L5GQY1]CTE):!LF5V<LJ%89<CLI5)W@!:HQ&9=W$Z/CYAQETT.'!C^/J&@
M;^%F9I";K7#S)R]%1S2$2"YFD/^KY7?.B@*TW DJ4+G:MV\/G^?K/ J!>,DE
ME[1JU<H+$MHA1D7KUJU!%(^SC)UYYIF,ER$ "6*+![F$\"I7B3$6'CJL4>@8
M,\C/+ 4_)%1^ 1CBVG&9K= 4YA1X>'"^$F%AH7%SH4Y+'E(B74 UBN;)"QDB
M82ZX/T<'OEP%2X!A$Z)(54?HF>^3E?^7>0=%7/6DS%>-ME)5(:43'MRL9.U5
M.A8'5P:>&3>>F8A<)9P%-B_>(,>*.WUR#Y=8OX'34QG765RYPDA,>,##;5$5
M;8#R@0W" $LSU$I4L76!:GO7R$;:HB2M?#&*T-=1H,NUYP2NP#8 Y*G-4!5P
M[\\5RC^J5L[9(! 483D8=1$UX"F2&U54C?$"S]VJ!,= K%C88&-24-^M=O,N
M__2JS$#XSB06*SX'L&&*#%6'8)B\RZLCT/*]6)$2,96-YW$LS"NNN");1;(!
MX!(U/P(D5UUUU0JE8S9]8F="U?3#T, &9#Q+S8:0*X4S7F"@-Q#(ERK%G1NW
ME0ID*E<*A.]][WN1AC@'M2]A.7ST[DMKY\Y>LF9)86S>EO5+2Q:_^/[?;B/S
M;]^@SU-//=6ZN.4JA KUHHM#EBBF2 8NY:H*4+%B(8)G46$#LX%G [5[PH0)
MW%__[8.W-]06E-;-O+/_\()9,PLFWQW?5&\AT"%,4:Z$I$>8#;!D0KZU],!G
M]^[=80>H&FNY5+$-0,B"FZ44(-!_L4(!47^9XHD3)R+W6#UA#2"'=_BTV<#]
MO)1G>_3H$;C7LPKDJO)FL5QEGOATE6BDF=;E^I A&^VT SO6S9]9??N]]X^Y
MM?^P,=/BT:R[AXU<L&[;CHU/;MOY\KHERR()Y&3]<:@U@?=3$;K[E<#4>Q]5
M:H'9X-B&'!643"@D.G!2.G3HT&K5G8CK>!R,I=L&&Y5^/:)R=;PQ_;1AF\J,
MEJCQE,^('OC\>@Z;5 G.V>=#:F%Y+P?)?[RO%)&/0.AH(=&%2H+G536X%)@-
M",FP4E0'T;I!2#3CRI6;1A 2S4L1MH8\HK+E0; 'RALF(O] /T%P\-^E?9);
M:=N*DMC]0P>,23R^)[C:8#E\S1K+*AH/'()P@1_L^N*$,) U5#AUZE3$AS]9
M^'OW[OW\\\\CK;SDKU*5UK#2/$.=J."PEE4E?L+\=G2& <+:Y$8V\=."*:'3
MWGQ%_Y@9D!215-4G'L^4APRR#ZZ#D[/DG@&$C\E;B?M+="IWYYUWHOT@668J
MOV=2WDK6@.U'@195I1@U-"VDSVQEN&=T3@,**_*3T:&L%\H3L4J^FV@DWIRV
MFCM3D="\O5B-D?(N:_",#IW2PI1[P&2?/GT0-S.5&Q2AP(+!,&U"P.U-FS;E
M6827CV5Y4;$JE#^J[#& 5ZZRH+!Z6#M,<?D.H<\M7[X<U)7(+=*I!C)4(A03
MJTRN]EE*51F6VP]*I$4Y]R#B62<J=)S-BL);*A34&T\=HR/:;" !*E*83KQE
M#O#<4*0L>%&%1M#5P($#>>D\E9UF+FPO@5OG5FK>O'FG3ITNOOAB1'9)?5G0
M)2Q@?$>F,YNN>(W8?>ZYYWC=+)7R2:K.M!$X(U72FQ'QSTK5T&$L$!CC0M:[
M .<]]]R#OAM6 ME,E1,&\WR"A&PYFQ7K(()[&#[O!:5,&7V".F:'P2*G(LK7
MF:,B;MS)B!@+2.,5NW;M FQ^TCD 0,9Y<N\!#X@_+S- "Z4=4D9MWC)Z]&BC
M.J38@ *U1U7-K41>-(P%@'G1=!7\MJF6IYA%W@)X=7(K\FY3ERY=UBJN$0B9
M,B;"^CK]6,)Z\2A12A"66]XR7\FR]N[="X<RM&'#AC'P^6H\%56LCB<K+ <J
ML%&D"LJ3U9@I7L2#L#\(86:A,4844?;TKEV[_O"'/P3R.<K]Q0KDHSEZ8VJ2
M2H=5JKTZ!I743D2UPDZ8:Z^44"#=,D=,F8UMR'74J%%@;[JJ[,45J ,21HX<
MV;ESYT>4!@0$SE4F@T=4 Y57T _OM=9B0QKPX&4X*Z%X>H:6U YB7!L9@)24
MBT5$^6'H_R-5N*>3DE1&1=NB/_WI3PL;<BNI?0G+X7]9@Y4:-VX,7TQ2U52;
M#1 Y7,FG_0_A(%@/C<W"UNVEEUXJ4ZF!(IU@P]V!EOF)Y7!PW_9'"S.JZV*C
M)E76S0CG%\[;4K^OA\SLT*%#D2)]CPB)+I=3N]5H>!\!&SC!9RNVP4Y*_&G;
MP N*4S7P7J<8X1*@;M#YO-?ZL,J\P+8HRG:C1^W.E[>PW^BEWPVSP=I"Q?]C
M[SZ@/*^J?-'?N]Z:]2YKEG?>S+IKQ%%4&+TF,*(21@QD&((@ B(Y-!F!%B0(
MB&0:Z%3573EV5755YVZ:V&0) I(4%!!$,B(B8D#4>I_^[JD_?T&]RGIOD+'/
M6EW]_Z5S]MGG['WV/F>'!%8A)C7,=2Z?MM\:;_A_/K+I%MONO,>V7]C]D ,F
M3_GJ&5\[X>0C=OGPACM^8<N/;W/<U(ZQE;K&2D.I9K5A*($*![/IAL,T>NU'
MJ0U#*0N;(BG]-@%8V^,27:MV\VG#[1-):6N[L-FWH2(I@7\D&Q"E%8S_2<W!
MBF^A+-VFU(:;FERB*Y)2W6]+'JK&HSHMZ8HAI;\6G<9IPZ_B$MV6J$T=.15O
MZ&SX[=5)4E0M8FO-N;%OB-=9B1_>J=BL$(4YD\@//_QPT_+::Z]M5F+_\TM#
M<_CI?7=>?<7BT>'!Q3<_V7BZ2G-XG94GGGCBG_[IG][UKG?A,MMLLXUIAVL,
M)L6)B4MTZ$L@^1+R!A*UO19XE%!KL_DZ% ]I:[/I[IVR&2 +-EBDIXMRVHB_
MH%(R5EE[JP<](#G$0.@T[_$CGW?D(/CDDU>&PU^:[#E%$K?&GWA6[,C!X^7I
M"3FJ8%Z_BH<TZ<K[#S[XH$O\I?9XD!GAM60%W)"T!ZHYR9]0HFK9\V":9&*4
M=LHII\  :(\\\LC)DR=7D%.8^?SG/^_.><G9[.]11QUUZ*&'EAB$"Q]]]-%Z
MX65@E_QT64)&J@IW'H^UDA9]A:> 84$R,WAJ%+ _' VH:@,Y^'6_]FAQ0Y_K
ME(4*=[L].;S5X YI<M*D20#S"$X,&>ZO!JL"'!*COYEX_VVQQ"7 P5)M4'5$
MD;LUN9!=+HV'-"G*B/0GN-.ODWUF3@Y\#)D1+$QZ><,--_R'?_@'W9^[<OMV
MWE-//0G:8M:DU3766&/;;;>%1G<&!U=Z\5YU]37]?3UC213Z]W__]X<<<DAW
M///(RD!:E P>P".L6S#TMSB[(2,.ML=5=T&\XNZ,*9=*KDQN8_AIB?VN28B/
M>\V\FA5#LMMNNVTP?K> 7#IQHM65TP#:5QW<=Z7 [>SX.1!J+:Z_3CZ'@9Q7
M>',\$G#I,+52%FS*???=9T$=R^G$0+QU:7JUBLR(]3SLT2$O2$"JLI:I5;ST
MTJ'D:0+_\L1Q<K\[2216)* P""%P.&[BE*4Y.8/6(^!9OP?B^ XGXS'G+=(P
MUDC2\E!+((30W[J3CF-&++!->+*.6>I]KV%E,V/?3),Y]=13QR;2F@YD^W]V
MX@!VQ$E S;#MM3777//&&V^L;<Y"KR&KI!9S$^3 D%FT#.7<1!DV9(T\#)")
M-*;'J*,M_A@TTNZX3Y0*!&,@UW$ EX<T.BHEI_)"#&;K$<#O?__[X616#MR6
M)I\#]/;%KE>G?IM KNIOGTCOH)4:(P*!EX?C'>XOBL,35LHLP\,CL:Y>9:W4
M*'^.YF"26 UW^"/%(.(#Y9/S7ZGH]<<__O$+$O1Y6GSP&F(W*IN9(S7\I P.
M&_)BJ0VCB?]1:V)#;7C^^>=I!<60QW_WVU_]\JF'?_3C'][S_4=_<-=5-]WU
MY,]7BN X/&2:[<UJ0VTEJ+ ]IJJU[XX+65+QO5DII3:X@V\4D#/BTH 8*388
M G)#>G>F6%:FQ?<,R>AF1W(.6%^>>>89B_OL.!3-BWO&K4V)SPQQK8 C.>UL
M=@Y^[,D'OCYI_UVVVWB3'3Z[U;9?//2X(\XYJ[6O_=SC3SKMT)TV7FNMMWUL
MB]W.ZQT=GO-[+M'/);>L9;$WYD:ZV>AUG3;,RJ;A:,P'F@7HVK5IJ W-O@UE
MN#4[%CZ#OQ^ ]=XDK=)97*B6DL:C<_YD)KB%B>G4'B.E9K4!O_*H+=MVK<D2
MW7CD\^+_;=DP+1/3QB,LJ".[?MTQOFBH#66D5-I@>URB&T9*XW&)+B96C.Z9
M)-5Q>?#!!YN!6VVU504+PL:;CU_^\TM#<_C=3W]XXXIEBR^^^<E?_@4YI/]Z
MRBK-X3_*/__S/W_P@Q\T4_&OVG(PR1;$+)OT8Y9?F9A(O7$8M:+<GH \9% \
MP@ND!X\(>64HB0Y]:/HN3I8#BS<:(T^4EJ]F=PCZ>%9W8N"0J"Y.!%($,)3H
M[&B[) :LF8*A-L#XL#.9FTM<(!WZA #4'B-U\A 1JO(Z@611O"]JCQEXFJ#D
MD B]3\9UZ4V-8G\F*P9$+M'$PL2:Q%B'<LA;5BLML:1$S%:%WF1^P)B0/7AF
MQWK>7Y  NW9!K!S@UV7=U_18+-0!H_(GDY$>!]]IIYW\  -(P.-E+Y!$M?A$
M<AC[C<L?<<01=<Q2)D9*'<5 H+_@GQ<+%JH+1$%F#9G!\MM$G1L;DC+PP))(
MQA""P8%<TS[$1W3*^S](U"F"U(4QH+\K<09++'[@@0>TCO=!T9Q$;M6T-6SS
MS3>GA#WRP'<6=I]Y2LNR]I%+KKWF*E."YO"1CWR$?K7''GN8)\,C0]^_XYKN
M<T\]>?"*F[]SW]0+SJ>CGI]XX;!DMJ@6_B$*YC6MXR"I$:2N8/<@P?A<@KE.
M7?2":$NLM/(9""_T)-&87NN.+@_G] :<WJ\SHI:XKVC.RG=)8OAZ6D=,_K8E
M30?I&:YJK\B\-2(P# D^AP13'0YA#-C@496YI+_F@YO&T4)5L5_K&$VU\V,+
M5ZT8CIJWM9QW9+<)M-XQ3'[,BO/<W)@AS4D@% MV6=?<$K^.:MIL\=N(U%&>
MI1&08+.NSTN$C3*INC%IOW???7=#/S?*WJ)D[&Z/9XX>790(6MTY3- T9-;"
MZ9V>V!/"S[)DM_#.\O@ZT_?>]*8WU32&9) L3[3E<A\"B<Z:.? &3I?>A"A$
M!UJ( G;EBNG*J0)2@L 238J6O:;16;%?VFVWW=[SGO> W/0H-F(NP1XIP3O;
M;;==>9Y PFBBJ8 $ENY,3G27;A:]&VM3RR?DMJOCO0-:3P%FK)&8:O51*T80
M+=,<:$=KK[WV^_ZVRSKKK+/::JO]'Y4HZ\7LY!PTZ-_ZUFW?PD_]YW]_;KO-
MH&^QQ1:7QUGHOU+195*.OR8S2C$Y[TKQNX[.ZCC"=-U[[[U+5#+!2FVH-;39
M-P#-FGO$_;>][6WKK[_^>NNMM_X&&_[;AO[]V_KK;;#A^NO34MQ_\YO??/SQ
MQS>DS(KS@3^7[8T9WC#7V7???;M6>E>?BPO1$*8G9H,Q N&=\5\Z.\E_: Z3
M)T\>27@W5(P0%B:H?\4P\ .1(CW4@1$A)2M1?[)/ZL)M39&4<.S66'[6[H8W
M&QI1!(/NZ>=-'1KJN6#ZS(7#0]]_[,<O_/JY1^Z_]];O?O_\L\Z:>MZYTV>U
M]<X9ON22WU,;!K)3V9&P5'C+RURB6R<B*>$/S3&%;DJ,#>"5VF E;3RZ?<)-
M'-)Z7Y'NK2MFF0MB6=0LO(+_:U_[VA_4' B.)?K7J<++7*+'DKNC(V&1KFER
MB39J8(,H@U*R1*/7+R2287L"3O1EE[;A_CX>&XJ!&"FU)X9LLTMTV6#/R1[H
M0 *W^&WB8<)X/E"__O6O__SG/Z=GCC69>[TFY27-X87GGWCDA]__WG47W[S*
M6NGU7$IS,(\WWGAC](# 4(++:?&L,AWU&ET5&SKLL,.^G2 P'3D6\,AT+!+J
MBB>BU;UD:P2 ]LJJIYXBAEN2I9@JKY6^Y :N;?61A%S$7FMK?WDRM<V,$38N
M=F'<E.MH6+ND$'( (6-&S%2(?1@E.$N(+R+TJ"/G?2C9ZJ4CWB>)DGOTI3:&
M<0V7N ;X-;KGGGLBN?H0>]TSR3BK1<K)+KOL4N8?X/_J5[]*^G>S2!T+WG77
M77$9;X*Y8E;H6K5"(H<$XC(,X!>FW59;;=610TS@$54+)QK2KSJ*[4PAJ]4V
MS\R$\5D:[_/&Y75))@!LPC&H^N.> 5<M<7B +N]/B_^#82(G@5F=X+%.:&4X
MQP[JMPS@1#6"D&DE &%/;/'5"3QLMW:CU5.&7B>??++:EI+2'O[.TK83I\YL
MF]G2ZC5B&500%V!CTTTW+7.@KLZ.<\\ZZ_2YUWWOAT_.G#']*U_YBMH@!"JF
M)\30@@2.T/?V&.5C?/C+\ACE%U,&'C%Q5B)*&;(*FVW$S0UWB)YPVYHP/MCT
MBKCSZB;@H>CK23T&/U8U>#9)8*\E@4%I0<"K275.8BL18=M2B.E$S_XX'GC!
ME+;T0B9XL._"B7J 9&6E)(-A1MQRO$. :$V9F=BX=9Y6&^UE3D89!I)OKX\K
ML]9;$T\,/-Z?EJ)=>@B /?*"'UHI==I30U:',UZ#3&J#.58SJE1E4D)G8BO!
MS(*XD50W#:NJ8$]S+=&F>N(<HOM ,G]@S(>M"4 ,6OBLXRR5E^8P+>&)3%%(
MJ...60E4A>CTI;"'^@SHDD25,:9:!-ZBI*PV$ "^(A9EK;$4UR+RG!IC\1(7
MS%NC9IX8=-VL$T@PF,-: 3#B4JT/RX&R+184)@8%S_AZY YTW9V88)W)M>)-
M2)N1:%VE7= B3!Z-XF FV-+8.&VXX88Z^.*++S[[-U]@OB'Q_+&RQQY[E G9
MT]^[]>*AA:-33CCHI+'[[KWX_)'_V+7=9Y]]_AS-@6!-XB'J$00K;1G6\<@C
MCX"A+@VNH7?SWHE2%H,/I/CA*<;EOO=_EH!^];)+?:''-BX-/7+V@_C8J.W>
MM(A]F;?5HH(#$.P:C:I?HZ Z]=1323EX(,9[10HR,5<1$7[B)MI!>B8\!=A<
M0H_-:D-9QU4Q2X?C-V7>%H\"GE[KPJ.//-(10]EB;FIN"-!UZ.?#OIPNHHAG
M)T1)0W;""2><E:)"8"R,F1\@T8O%$0E8+DURJY4%[G.?^QQ-PP_<YJ24HX\^
MVE=''GFD^X;/$/NK:\,Y=YV3@'4-^(W+K 3_&8R%?<.W83Q12KM69K99><9X
M[I1S,:KO/_#@#Q]^& )A=,J4<\\[;PI(L#<+2D,CTO?:.^^(B?](4Y9H8[$@
MT:N'8_&E-+;DQ_]D)*7RT$/=2W/X_,,?_K#QJ%RB!R<RIMW;=#X&3O ?=]QQ
M?S"VTD<_^M'6> ]V_KY+=!W ]B8LI-*L-NA([?2534?QS'KT0GP;ZI/>.&4U
M-(HZ0>UO<HENC#5=Y89$G(<0<P!WK= LM4*1Q#1'ZVM/L#@(&4@RN->P-#2'
MWSQZ_==V_;</;'30_+M?<M1>I3F\_DII#@@5L\ !<9R2>RY,A):2R68E:$Q_
MC,*[DLUD/(17*L&<A)8GP=3:3'K#,0E&7FN)*_!XS/=+^L2"<;=R;W6'#E"B
M<T\,]&^]]59LKB,B..[L30)-RT3FAXKFU!:;D&5)M:;%<O&T6J# WA@RXMU&
M%]%JKCLN93@RXID5!U;DA^IN2PRB]F2'&(^5MJI0];R8[-<YPXR8>0"I=I(P
M<9R4S*'^P@D H&AJHH)Z!U<E2A)J@8W@QV.OWQ9+H4L3'W8DWE1>*//]L7A?
MX A(O6)*=B6)=1G66Z)*",8%2MB"EK&X,I?R P 2-F91-AYM":D$16TY)VV/
M5Q;@V[([HEAR#%EG_,MGQQ8<$J8F:NKBA$;U<DF]-R9S<^V"@,$*,9X8->W9
M\]A@@PW^\1__T>+4U[=RIX-<:'5L2[)MRM4;W_C&;;;9ANK5'BM5'UY]S36S
MX_*%.Z^VVFH 'DA0O!(Q%\2!!'K+[:3D9LB$$PO)C!AHF7O>!/RL;-A;"_7W
MA*0]!M[ 1$KOF2EP<D=2^VE";4:V,Q)VB:KZ:&;6>MP1LX'9B2]TRBFG&&MS
MQH#.CK/!M0F2NR0N.NT)^3J>? Z%6SAIG*J[8T"IG6W1 (%$TS#BY@EX (8$
M4)/[TY( $6QP-7-"239DI<_X6X<59DBY5Y(M3.R.1%_M2SX'>GM'BB5J/$OF
MS*2M+:\ \L'L^#VKD_[6%0,MG?44#."I\84!'VI]6MPSB!%CR8#1FACM.#@@
MX58]6@'2^4G9OM9::YD8J*S68#67H#.8_!AJLZI9._UP.3?Q$RW I7A81"MK
M]8P4]&7(>N(+KBQ.R#5HF9+L\MMMM]V;W_QF&*B=PA<2U[@C!S6>KKGFFJHM
MHL,$/-6UUL2),G;C,1%L2][&6M1K]/W5!!3U)7B 2W)J&5/U)"N\KU99*_U%
MI:$Y//?H@S>-#"^X9N[9LZ]XZ+'KN^?^AP3V9VH.:ZRQQ@<^\('*Y.@'_8UD
M=M111_G6)6ZSV6:;$>O777?=#5,(&>2_3WSB$V:";]=??WW<<N.--_;(^T Z
M[+##U%"7BQ*GX2,?^8A+RUQ1Q(<__&&,J&JKLMYZZ^VRRRY8JW=<:G3++;=$
MX_6ALM%&&VG4CW>\XQV?_.0G,9_)DR=_Z4M?.O300XF2FL#Z3DW!3$C>1QQQ
MA#6NS.%*,.WX?;4!PQ]-&4@B-GRF8>5?KESSDR"L>$5C!]H[RY-&<RAN *IM
MB)+$31S,:DC>!0\>@J=]*84$"<[2#8X__GA_,:M--MG$S3I:MX">>>:9^ -6
M@-B'4S !,.C1X,IT"BM-@)I]&TKL1CM#23K6K#98#FJ]WFNOO=[][G=;#K;:
M<O.--OCPN]_]O]^ZQEO?_=[WK/FO[_KHIS9W'TM!N?657M>V>E^B8FBNL4=>
MD8A:DH!5<Z!JG#:4D6U'TVD#HJY'XQ.1E+H2$\*/9K6!'-(>*Z\Z+6F.'Z6&
MGFRI0..?T!RZDKBF\:@V=WH3N:06J8:1DN'#XM2I"]"RZ/<C*5DIU%9K].(D
MJ*E'WKEJ(I+2K)AT-CN"WYR(B'!E[';??7=SWILU3\IZ$S!;;+&%>34>V:R6
ML]>P-/(Y_.C;-U]YQ8H;;EBVX/K'&D^1\XP$@UGTUUV6Q.KXXQ__^$L=^R/E
M;T5SL 9ON^VV TE*@$&005N3F D-E'E21[:H\41,' :OB-LQ2<4D1A+$BT6)
MU8A^3.BK$MZA-I/0N5GK'8R J KU"!*'(DE@<T6WN*VV7")^,+CT%,^JG1CW
M<6& +8C/\7GGG8?-S4[$&,QNM]UV\_32I.["X\!#"%@<0QT3$?5ZA#_J(+GG
MN80!)5)K%SF5.0KZ;T_RAXZ<, (8_7O95SU)IP*&N?% (&9YW\W;XVXU%.MS
M>+@E84!KA0 VX9C JM=8/X$8QGSBTK=///&$*01X7%[]2!T.P>EW[:K"CQ_P
M;^TY_/##=;"X'B00QRU[A80SSCC#'<P+2!:)8X\]UE\@ 7Y*BA<*I$(=A,//
M_,2R?#'11<$SFFB8)#SU8_UE#_/  P_H49E(X>9>P+7+ML0(WG333?OOO[^%
MQU/UP"3(O> ^OG;,,<=88K_PA2]LNNFFZH&?,L*QM,,#,+;>>FOR**W (MV9
M8%F+PD:]!@D@!)(1K/'R5_T:M5C"B>$NOS0CJ(/PW!D#MK:<WD U9@JK^N(%
M36.@,&9$9N90RRHRF/AWHRO=,\9*5 6YH5?5B2>>: +4N;!Y^]!##WE-Y9Y:
MF\N%KF:U98SZ 5>&&%08O0][$TF])>=U;0FZ98(M2W!T\.B::J]+?N7:MN^,
M::P/!Q+)VWRX,S'4Y\3GW@L67?+]LN2$]J/\ZA!=]0M.#(=!T1'R#7SJ&AI<
MD #$]!;@D;W,%IA9DCCHM71!PMR4VNDL9?6<9,8 S.T)KGIALFWH+ AGQR_<
M)2EP]=57]PD80/6SI/( >8U@>;$K%R4+6VD7?H#'?,,3C" ,&[6BK)ZX4:E<
M$X88-@!9P*B-K+/CCCO6Q+@D!?!&5BO>@1DOPS,81I-_'6;H(67092)!,H08
M,H-^;1P_?IV,-,.)(K X09GU3B\T85 \]4/'=;![56RE/[L@<WQ@ZK2I9YQT
MPA&[?6ZG/7?\U)9['W?*$3OO?-2Y4Z8@NO>^][T0_O+/7E%>"M?X%Q:\$?=[
M^=T_K[SSG>]LV-7\1<5<_5__ZW]9PMISNH5@,1F\M_R%Z ^X7&N.N*]+3JZY
M$R[1F$;#IL4J8*Z:D(,)=V%.-G0#*Y3Y/)+4SIW)E=GLV[ L@?6&$^EA*$;M
M]>B7"8->^QHX/\4&9EI2NN*ZYJ9%\YQD=B/[TI0..>20 U. [:9EXN1XUM$W
M?(M:Z17NT#10$'@J)D$58O?LN$27J4RS5$HZ=Q]FT)09,J$8O/CH]Y:<-V7Z
M:4>?-+3BPIE?.6G^ ROEX[*/&D^OZ_QP3CQ]\8W&:8/NUY(W/!%)J>';\)N)
M2$JUTKU,;<!1>[*M,YIL:\U&2IA#3_9B2NUIN$0K#R<#57>\O:'ECVD.NH^S
M-8X4,!R =>3@M_T5D92,;V=.]6LM:'9[N*3)J:SX:CUZ(2[1 S%2FIV3^4:O
MS:+:S;3:?O&+7ZR<H0TMZ]8$7)F?H"_(LY0]7)&F5R^\5N4E,O_EH]^X^K*+
M+[KZGJ?^0T=2+%5FRQZOAT+@)((V(/]CY6](<]ANN^T0&(YO5;XPP9$6QBO:
M7"S- 55,GCR9I((IU.;H-8GOWA?C^\5))D! ]#)68G5'JZ1S/X@^<Q)+#IV[
M]!K=@!!)1)B3($B8VM08WHS$\A)3 PQA%U\CD!FGTT\_W=R:GSRX>(TWBZNJ
M ?=1)PJ\+JY"J+%T!L*!]U'4I2D7)CO!L_%>\B:"!%N=%Z,N5*V&TON]0+XI
M8Y(BW:$4!(R?#F:;F9#:&Y^PX1PWN_2F'X/)3$=S  .<E*J S_;'[7@PMNDT
MM-J%71J/MVL3C%_K)8:"N4PXCC[ZZ.VWWQ[OGI=<%G4&#0FU/6PE@!8+5;%^
M[*/A.@(_?I?F #PU;++))A8V0P91%@!<J?0EEP87UQN)M9AAO3>V 7Z JKB5
M%Y;DX%C39%8DL//..^^RRR[0 MHKDQE S6HCTYL>ZZ^_OJ=;;+&%J@K)ZBG#
M,&!OMMEF5B]<3/T@;(F3]R^21<$8J0V_QE]@OD9-P7DAQZ/:F082>$R8XXX[
MSB)W_OGG6^<JD?:4!"#'3PF7[GO'"EI>['5D9%&G]KB\(/%#8,FEI?'$%%(.
MJ.8EO8:I"Y,Z!:5:O",A#O7=36N\"0,&2S7P:H)!M6J_GD2*.KC[[KL;/HU.
MCP>_2XN0WR8SE=B0@;;.'(K[E^8,/+IBN;SK@M9U'&'Z\8L8JAHC*#4BIG%'
M@@":JV7: 6^FC<ECY;L]Z12T4M*,:FFA>^ZYYP5QEU3T&HGY 4A/00ZPV3'=
M!CSF"+=U&@"W/IR2H%AO>M.;AA-OT>@ P _@K8AOB3&B,Q@CXTA)>"%)%3PR
ML2'-!/.)GD(RD P$&K%.&+ZRKX,32*CY#"V0@$;TQ4Q0#\)!RY<F;2(* L_%
M2:\!AF)!D$ 4H/26EC44IYWR_;@A^1SQA+ONNJL4X"4)=%@5 M4=T)KPR!DG
M7*4Y_/G%?"LZ,I%F$I5;9K7-;IGA9^M,,W]J+- :<6_^1%F:\ POO_MG%(-^
M9U.JA+^H:+0AQ_]%!=VMN>::Y.SB/Z8TJCDM93 ^N'KM/DZ(Z&HOJ2-GFPTI
MLRQF2P$H!MB0DO&6><E6-">A*9!\L]K@S;G969N5 *R-'>B&VH!+XV9(WKC,
M2G91!8UC+Q901.<':'$D1(2BP6RDO-P5.P+DC,&6:19FB$[+(Z(KD22JK?$)
MEVA+TMQ$4JKS\WJ$;?8DL@@VM2#QNR<TA]\\^H-+SSEE9O?)4^>,=+6<>7+[
MC2OCZFBZA+#:-1A(C,'%32[1I3;,2F;/D82%:(ZD5$9*_0DY-9(40/5H/"[1
MI;"-)33\#YI<HG&&OD1Y*?.ABBY8I4X;2MG -_[8F<.'/O0AO*[1:U+$PKA$
M%QJO;G*)K@5=A1TQ;<*X&DKRK^(27?JG1QC=RR(I#2021ELB*3V=<$E55L1G
MS)JRXXX[&M/F^%%8Y4AT.<!CW5XKG,!JLW'7:U)>BJWTR -W7+ETR76W/O*S
M5[-?\'HI?RN:@P65L&*!1\DMB<=B6M^1-+&( ?TOC+52G<2YQ';O3RRVMEA7
MCT^DEO3"Y<G26I9.JKHU<1@6Q,#&<E*\WFO8ZXP$HT1XI9&C9[^__>UO3TLL
M%X7(>]!!!Y724I*$)7]F3,R)33_\X0_)A3TY!,2S/"UF<4&LE4!89R8H$.&1
MJ.I,<"QA0&]-6*'BSBYU=FJ"S^(F )@3+]7I\1"X-8EUST^AQ%\;:R4P> &A
M7I\<QGY[QYO>)WLA6C_&)ZR5O'QIK)7F)C8"?M25X(]SDQI,7\I:J8#7]_'8
MTF'K9R1:* FI[.R]"4[,],IDH],7R(&B.G8  ZT /^I*B@-/RZ[7)0':I4>6
MA'HT.]9*QG=J;.X7QUJI3%]@J<XE+"0>:5<]OO6A5GS[X0]_^,UO?K,5:"#F
MN3OMM!-)5#U#B9B)U1+[/(40P/N-?_7$%,U@K;;::CAO1Z(>Z04]JG "MS!@
M!:TATXI+'9\:TY=:04VPUMC.08)^^5W;8[5IIT=E!5<'M6X"!AB[[KHK#FLU
M]=22J2K3%6"66-/OLY_]K&GOOD$Q9'H-AZTI5R=([J(DDH.'FL:#L<P! ^4'
M2+7)YQ*T8% )#0&6   Y)5BH:EX"DG@*/+KNYIMO3E;VU)W2SV&C#)2U946W
M'GC4'S^31V+QW!4GF?%LI-6\G1,3P?+_T01DFO#$:*":M]0) )^<;-_Z[F5K
M(6R !WA&:BQYN$'K'5IZ^=+!B5E4&_!@\%2[H#KLL,.@:*VUUB) F F+$B%7
M*X;/@M27Q!2(HJR5SI](E^ZW%Z8G;:TEDV1O/JOVQ#@JJ,1D\QMX/?%0U+31
M).+ CUD$'NA5+:7"",Y(^A?S 1B60_?A87',A4UCWT)"62O5-IYV;TR>5WWI
MBJ,.J>@WR4)="SG<JJ>>0C4(5UDKO2;%W&M(6G]1J8VME]_]\XI&7YVZTI%,
M<'3..AOL3>HA,]G\P:6Q2IQA43R+T+C9A5U4=,'Z'..:EQ20)+R9<85J6*?@
M?D/)'E,$-:_).=@[WJPMI,[$4FNH#5!7A^TC29J&G)<F\K+5N<P.BT%I:UJ\
ML#3A_9UWWKD8#KKNCKL7IEI>U(K>E=I0//9E:D-+7)+J!(#:T-"(2NR>G5/*
M@21[0>^UG(VOM+WYV:,//OSP_0\]\M#]W_O^@T_^?"7RIR5$WJ*$K/"M)9X<
MTJPL+4S\HL$<[,]O,E(:GW")[H_?MD(?:SRZ[;;;P%;KVF!B@30>60&+ U2C
M+AN/B."=,:DMS<UH8I5_T$.Z.1,<+@>P8M&M<8EN5AM*TVN-I\K%3?&C<*V+
MXBS:FEQ#S<I2^38,-$52:ABDZ2.0-MUT4PP9(_5A,T)N30;5_@3:5BS-7_[R
ME\>C??TU;(@TK)5^\MWK>L\^]LM?G[[B@?_H\G_)\K>B.= 9R*"F<@F@ER97
MP*R$/JS-Z94;2S-G'G+((=]).JH2'2 $XRC>Y*]'9OE G)5[$W )\^J)NRV:
MQ ANO_UVC[Q)A$*!I*A:U$EI=(;+$_ZE(^Z8AR3]W)DIOD*?)2LC::R9SM"5
M0M;!'/'KKN15&4I\V$LF/*3]J'UQG?(YGDA<0*7@ ;Q*GGKJJ<X4!(FP.R8R
M^W0E"$^]IBH$B7-Y2MB:EKBT94HX/9;K7B.C#,;_#(HJ/.NBA'/V@A8Q<8RX
MN%*YVV+*LY,V6*^_F<"I&J44_3+>;X4$ C>92?>[$OQ!BT\E765'4DOZO6+%
M"I*6%[3H1VD7W4ES8Q1*G/(A%!UZZ*'$Z,ZX$UC&?I%,NEH!0\/TI2WI]HAW
MI+U:NEQ"^YU)J.?EXCY&G$!I.5FV;)FE@K0-SF.//18&'GC@ 8Q^L\TV(XX;
MD5+5#C_\<$C#9^E"%BIOUL3P0C6*[>IUV075?#.CRD.Z/8$UP0 GA2+3R;>C
M<3=T26.A,1(B=0W'!+E&#0%0(<3]$Q)Y$(H,+H9N&FMQ=ORJ79;T#'LZ" GS
MD^7#"U9E<ZRT'2/XW'//62^GQB%$#3]):N025<U;3R&A,]G-)DV:5'IF>W:2
MK+BD@=IT-.+F?.W\38F?/89.1^V,SJPJBXJU5BNUFC[__/-0W9)BR"!A6=*6
M>VK(/)T9-Z&NN)L;[FK1<O[$$T_<D]P%AMB@^W%+(L^V)WES&9C-2 Q?*-*<
MU06BX*%T^)KG[D.LR^GQ8H=&<_AC'_M80U[7HA$OR%T:LI+758N*]65Q4NRI
MRM#743X\^'SRY,D)NK(RWX5+Y&#*U;RE*N@L]1*B*AQS!4$ZYIACCCSRR L3
M3D!_*1L=B9YNR)!#\1-O5@2;MI32,[W6GOT(Z )&D2HT KZ\S^'0>'FZ*#DE
M-]QPP_8X%*XJ_YGE]66M9%*1)LU>+-TTKETD_*K$;A2-C7OD)M@Z7A%):23V
M2T.)PK>HR=[=C'5S2;RJNF,JT^S;8-*.)D>D1_XVY,4RS1W(P7A;U)A]]MD'
M4_(Y'E4[UBW9!P22-[^33'!(=:^]]D+4E';LT2/L$? 8BZ661'M.$@_[ZY%E
MNK%=C0FT3D124ODWFO(VE$MT6W;B!F+3.!ZE':X^D/+^]W_@PQ_Y\ <^^(&5
M">$_]K%UUG[OVFNO_;:WO6W777=%[+@BPB\'C ,.. !C+^\10%+ K!I^@[D>
M><=-Z/74MZ2("O=DB:$1X3#NEX\'EN(3556%A(K:@/"HC(KW3]EWWWW)XNY@
M-:KUE/R#54[YX_D<RL#IN:2K4V$M7M=>>VUC4N%.HPGAC>W V+)X9-4C@UY;
MBJV)I+0@,4+J$7Q>&9?HT0DCI9H&6!]D;K_]]GI771B<R-M0Y8YDUZG3!E.H
M',S*$@Q:+DE0^->VO!1;Z9<_?O"!>^^YZ[N/_?2EM'0P\*/73VD<$OZ)\C>D
M.6R]]=:M\2) ]J3/MF1B;TM,&)-R:OP0T# YQ@I-1"/R^NH'"1!I$B,;0@,&
MBM)05#FJ7G_]]2B!"*(J?*>L%WR(G5V6D*\]*9B.;TO\ZHQSU>4)J4FLZ<B!
MHP\),7.2\@9[)9?,C/LF\L U-$&2>"S9NP V%C=BBH%+(B"IA5 +&)40/?%K
MHB&QFU1:[+5\,PB.LQ*7FD@T$.MS3<^+Y97+WB2N(L&HI#U6X%V)$K,TWJ*@
MQ0)T327D'FQ(_:I%^1!B\2B<#">T/]8#\A*G[KOO/A5^.YG1O$.* C,QZ.Z[
M[\9)2\(;C F9;\M9?&Y2_,# PAA66BH@ZI*D%IZ50^26A&D:3,3]WKB,^]"P
MJI9L6KN_?3G>L<: 7-,J!U[A!";==%G &R88 *V:'TX@5W7BW;2C=[SC'7@]
M9EV>@E@#AFXN[;333OKXZ4]_&N/&K/W=<LLM=]AA!PS]G_[IGS!H:L,UUUQC
M;J@6AFN7SI 1_K0"3FAT$Q(PW,*,E0EZ?67(7*H!)X6$94G$46=$%R95<TLR
M)6.[<&)=[(H'OS%:D?!-W=EOU@5C-RN'_MY4B<FY++%HS5O2I"E:Q\?0"(RR
M'R.4J\J;ER7'-CB]8VHM2B#7"^,5<T5B*PW&;@$8L%UC9R@7QJ<"2'ZX7)Y,
M#K.SHP;FVCCLB#.T0==?HT::-P0ZHA4ONPD2':F=,^!Y!(UPHD["A^:L_5Z
M*'115-:?X&9]"3!R98+VUJSPP]..)&WHFDA #MK2@>'VXH0-F),P@EI<=]UU
MW<$W"UW@UY8A,X(6JI'DVD-??H#633K>K<E72(CW<JGW)M729&C17"'!6)<X
MXB]XX.ISG_O<>]_[7JOXN][U+E1 .*"=FF_KK[^^*;3IIIM6N%X@S4LL6ITR
M-[2EX^;MO"2)AP&U_2B!7$UX[T 4%@$ X,$MJ.#-#^-8AT*KSAQ>D_+ZTAS0
M9J5,1<A3$DW$5$3^N$2I#5Z(H]G*3'#-+M$6G>&)2$K>004-41(ANU_\O#<N
MT<VG#6AD* E),#',H=FFY?*D>Q]-'E4?FNV3)DVZ,OE,:CDK]=C:?6GR3E2@
M(6VAJ;)(M*:7VO#MI+'K3#**V;&Y0O5 (EB7HE(F!@6>M>::5[A$8S*UQ;XB
M+DGUJ/;F.G*,#*JR%224DZ/V2RX7S=5.RI2DLKYJHGA4ME46E]-//QV0=5^[
ML%$*3_956@XZZ" \1\<WVVPS=5:G .-S\%OC(.3J))2T]-1A+]XR%E^^*V-M
MBW5/26R&.H'':BQ8VVRS#2R]_>UO_X.: ]91ND%O7*+;$MFO<?Q"W%^0O+1P
M.)A(2HV#B!<FLD378K2@*9+2B\G;T!^7Z/;$@+'BF%=^&P5@=Z],T;TR?6=M
M0=97XU$;@#&6T/EX;!T%GWCBB8MC2F!!O_TUS0%7I7'F\-1=-\Z_X+36)7W]
ME[]T%D1:@.IHF'_M9:VUUMI@@PU>ZM@?*7\KF@/*7&>==:S0J&XH::IP%N(@
MBAJ./]:74WKB?NJO%;KL!2VZ7C#I3=^N))B\.*=R" F+Z4O*6!2%D=5V)I)#
MD&><<4;MT&N%G&T-0 ^DV\,//]R=UL2IQ"]VW777DT\^N30*9%][Y]TI6  *
M_]K7OE;QR(@1M96^(&:1+D&(Y*K=<E,>3$@*W 1XU ._BY53]&N+5*-X 9%K
M.$%+?4ZP($3J[\R<]A9?GIYXS&W)"HPEM>8LLB?.#W@0!()Y10),886C"8
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M");NI)L4,$T/)G/S;W_[6XV:/]K2$'BZXNK7'N/^NQ,D5^L=<6C6=**8KRS
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MT.AJJZU&):MC*S/-PFR5Q=T\*K<38^2RAJP6(43G'2N])6$HWB!P"#/')_E
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MS_0"--8$FQV[6V-4F@,8X,?GX%&A2DIMJ!9=FAC=\:Y9&'\& PH#1G9I_%N
M#5%^^.N^Z5'P3$\T0UVH>6LXYL<72-'EUI1ZI'+(L2YJ?32'SH-Q6S=D5O%2
M.,T$O=;*4))8:ZM&L#.F5B!1N7=\[FFAR O+XW<Q,^<2G8F'N""N"&4"X;(
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M3BC&%I[:43-O5\27H.S-H-IO<Q).#*AZ  ]R'-_$L("9SZ5K[;WWWNH'@[]
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M]/;.CL>36'=N$HU!$7D.BSP_L96&L[>TR2:;%#P@*6LEO[5;)^#Z#A[H.O#
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M4S[9WLY![( [\,Z@08,06T_*0QI1 U9H#VFK&7R+(,B=?.6'AAM"EOQ ?'1
MFXA$A[>5R'EA;>*;R)SYLU(&/GW/]?_294KAVK*IO5\;,7;:]/X]7WCIV<=N
M;=ZI4Z<N/3H]_"__^L>GGGHC/G9XRR?;=&U_^R]O:;[DPT-;MU8#'ES8XA3
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M*\,MOHU6EO8HA&".CLH+% LD>&2UP1S^C3?>&#Y\>/?NW:D?"+V#D"F/<^Z
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M#S$/=-F]>W>&]D?RY'H>[=$!&_>Y!RO"BR^^V+5K5QJUYF:+  LJ +QLV;+
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MZW Q+O,5<I1*YL^?#[3T!63.DD$7L($H<WP  P"4!# &HJ@6G&Q0G%->YBE
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MRR,? 9D#P&U0&QY[[+'YBK+ MSX"HON5R@]MMT7/"N[03?0BGD(:,"CNH,!
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M+\*(#PH:>&SB1HB1:,"-E&%D$:5[[[V7#[ 0H\]/.*_P/%71:YJ@USIU X=
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M#'DV3."OJ6Y&AV$%3SD/%2I4>"-'#H)\H%9.11F:TW8O*E#+XG2TN@L<9@
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M,S'QW/DT/;-[=UI )3#A_-BTL"<-3 "9$9=VT8JXD7?!7,3@=8&,1..L911
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MQC]3?LZ_"3'5]G@0S- *H\GH*U*2T>7%#!DR3+=+730]J; AU3_%JU 'H8
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MW@$XB.%3$M$1*;WWWGLT+=L&JN/]3$K?V"E>J;GS=I&GUKYI98T=B=9<UZ[
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M(49ZAIHA1L.D&0$7W4'A/,OXY!G33O'O^X-FA%=6'V(08>U93Z-_]VX'YK'
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MA3C/;9"E+FH\:H=#!,Q%"\"ZPH+_/'"/_8A/D8W@7ZQQP6Z)]C83"IDR87D
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M>"BM '>%79.=CT0F4F**>[Y9&E3 W+2M+![-TU_OH,5^BS/[,#+A]]EVD[&
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M(SC&I]YJ%2-+;1[\M")VOF^39?/=G8T"1D)#*SSB4P'C"6H(?KI[/CO"KDH
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M /,*.\4K 4ISR%P!0V:$)A(<>!"C2$8M:R"8 '[0H$%DYIF_L#?9D*&P$)"
MWI(E2V+6ITZ=NG___K 'V<B@"*2@&J%&<<PFV)Y2O*=R+&9$ #)"TV#T#M4R
M8,  3#W0@C#E?<6*%1$]+[WT4KERY?"7>'[^^><+%"B (_2/?_R#G^G2I6O?
MOCVF ]R+[.[:M:M@1J:COU$A1RVAB@ ,JP( 4 8 0V84!CA!A:.!))A0#% =
M\/.3;'03444V_E(<LN>]9I$9#M!%%^9%A=@?27-\0EXC2B GBJ!BD8-H'=Z3
M;8HE= \_(09:H6FR02&T0I=Y!CQ:0>Z#?X !?KQ07O(3TD6P0CED@\P&#QY,
M-I[))F!H@IHA&) &A'R",FGE*PNMO<O"]8 9\H"<X<.'4XJR8 -@P 8"FFR
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M)_"@U2J>>0-A(X[(?]ABH2(H>$DKU$G-DL#0)!)LJ=U "F)IQ=_V+!VR^S2
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MT]812R#J.TMZIJI3EA@O (;!>>:!]^2!?IYYYAEZK3Q4 OV Y-T6/ :RAUE
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M'52B1(FR9<O6K5L7P&@('JQ=NW:Y<N7X1,W0(3\M3- G<"ZFH8(@4027C[+
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MA+D1ZQ#BX%^G&U%.2) //OA@L%W:^ANE W;AQG///8=<YB]L',/.I3B_SG/
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M\Q87"VH$8-X$6HPCC%V*K+-[167<[['H3W(;J!GXH2X)>6ALZ-"A4!T2FS?
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M$^$##H$?J46OJ42>&-8(J"8S1$*%4)$< TJ!-.0>1 B!?6TG[.6?@%YR+K;
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M,_W]UZV+NB+J]NU;*Y>'+P@-/6@J<\NF+>/]QH>&+KAQX_IM"XVMY0O'G5#
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M!/-@#)^!S$""[3'7/0Y!*>!A( 2,#EZB[F/8#3"4\O8)A]@5A%KP7VW'"S%
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M"<K< E!8J?:?_.0G%'7BQ$M?>OF5/[ST_!577-Z^?7L\H7B9Q]1Y]) NL7-
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M>%#XRBNO3%!;Q/@\W2=Z ?)4*?J2D'ZAA1;*FQ'-J2<>N=Y1"_3[\I>_+,Q
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M_Q-_^-,&O$\CAW^^U';. 0A"MW<J@0"H1ZS%TW2;XQB88#OI>4P(T!];^['
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MTR;)8<_W_$F_=/T3F-+)5X "AM!36$&=,)R>YLDA(KH&*WA+YZ'7R+%F/!N
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MR!YC5"IWS.E!:BQ"NASXUEDAGN1?.$/-_*2^-0]@;JB0AA3WU#NGN53)J<^
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MVK5K1PB!\BO.P@0L:Y;<BV00T(^3;- &@3D<."4&E!P]>C0M4C_@B_% ;WF
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M /C@75$_'^+D3C1>3).B4QO:3157:, + 2N 97B%N>5/&()'2-,\#"XMEQ/
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ME- @@4Y!,' *?%$;C_$EV+)6;BE.E6.1O!XCZ0'RY1)K @!J "+HOM&YS,@
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M2YU((,#B+@?T:0(NH1V,*:Q ?;#L&&A'.>0 /5 +5Q5&D/!H*3@JR!4R $I
M# (/VY%PF QZP#T\* B#STB+;DK48(^^X%1HS(-6HHS43/<ADB&[8=J&A R
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M.>A"F9;*D<//%H8>IX?!90@.'3Z,> !D>7GY?/#T]  0\8RK5JWZA!3&#A5
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M)A^>I&L\"?%P#PH9WXO$=5>.!-OT;M"VS_Q)W3][_[TOOF[=K$J-+QI\,S[
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MNFVX?#!C9D#>NECGR3.<7,>/[C\Q_- EH]N-H0%(!PT:],@CC\!87N$SLL$
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M<F#(SYT[ISL-C&IA,*#>8*Z^HF<;S$>BS9N43DDZ=E!#'9WEDD\=JJA3YQ(
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M ,/23#NF&#X&A5809FK#_45R*F>"*I)46CQ,<-*O7S\X;-!RNR+?.W)%:7;
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M?0&L8 N?Z0X>(5V#5SJY#DA"&]WA,8 =(G7CBNX0H]HD*:ODNCIJH'6@C!H
M6\B#,*@"-GD 3:?"(U(2C1EIC?!._1ODVEV"(E0>;86&5+G]#:L!;&9)%E?
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M,E#CJ:>>TN1K&C;P%H8'X"!RP$VAFXI9O*BNP&W)Z+Q$5AMT+Q,U8Q4T.@*
M\"D!%W3>3RZ1F2V7L (H_I)+T5&*MR0)F2O)FW5>2MT.9SGMP)\8#]TFP3.>
M<A935\D]9?,#A4KX\C_-ROJ3,GGRY*Y=NQKG4&=,Z-NF6P_+YA_6:=RR0:V:
MG[0;[^@1N#  !:9'=[]VW^6NR(&HC-$$ZS74U"E5\\-_V,@!@*8V[!P\GSAQ
M(MY#Y5\)%\'''J:"28.E>LO'704=(7!:*SL*?K8@SU@+.SO;[I8]0H*#$=2!
M@P;W[_GMH2.5%X$?6E&#>E>Y?OW:V3-G]A\XN&-'669Z>FQ"7%)B0D)L3&Q<
M;&145("O_\R9,VSM[*.B(Y=F96& \4O @5_?:'O_I<*4E14Y9]30+YP,X )3
M"M3 .CP50HOYDIJ,?]$+C<GA%5"0+9E;==T !,".\OGCZM5/["XI#'.TZ#=^
MHMT<UWFV';^QF!*S<[+]9!MK:^C7656P"R3!2.,+ZMPD[VI@3Z,9<@&<LVQ>
M4C5,E4.NM*ZDXB5  S9;?:_Y<I26YW6:&<!$BQ&,._V\>KS\_/GR#24[MNP\
M<OY.!,8SS9LW!]_P .##2KF8'%!%1_@&!--5(VI;*-?,TW=H TYA!:T$2()+
M.@*%D*V3H  1THM' GQ1"33S&"C'3[Q"A2F2>Q3M /?@&)5C"/G37\[[NLF9
M*[@*YWE>?X(D*F>,0%%>Q[/DWUUR<1N_ZJ('G.1?Z,^0A7$0 #-!/?HD].3)
M5=E;I4 53,,Q)<:8/GTZ[AW\1[1H"$Y"/P,$P>:%/CJB65_Y4\%<W67HI_N0
MJK-4-$TE-,1/;G+E LBY4-+4TCN"$QZF?MZ"0A4S[0)LH7<Q<E$ E)R22^YP
M'-6EALD\LU8V&D$&WS!25 *U! E9DMLT78YE$RKH;J4Z=>I@4W3FFT*/\-35
M@L -Y):P$!BI4:,&[F;CQHU??/'%;MVZ84W4E33([I=HTRE>ND9MO.(E&USY
M'H[Q_6VYXR+=E$F) <4@$GZH6B$_=.JV,77FC0PY$:Z/%4G*49UZWR5W%S B
M]&NAW$^LAT]HR\K*"C'3 Q6( 9[Q(X\\@GD%$KM96,R7&] 02,@F:@4D'WOL
ML8$#!])EM=K VM"A0ZG38-JTK# (;D )GC>A"-86L:%1ZB<V@')T4,,>R,,<
MJPO!EU1%WW4+-"01;>*&#1@P /Y$F3(IT;MXR>:L*+=,,BLJ,3 3T\E(,2X,
M+OJB:5TNR]5/",F''WZ(8P S80A\8T#-X, '1A^M)SP@-&K2I E=5AL-\FL,
M@\HT;-CPE5=>P7K:V4\=V+?'SM71]K-GVO7N-SFA+"-[^;OOODL3C!TJGR;7
MA\,9%6/^5#&F(1 /RP*=\&K-SY7*D0.O\"=?_A_V[@3^ZRG['_@,PV_L^[YO
MOT2&F3(&/[(4TE#*\K=O,UDCD91*EBQ94Y862=H044DE$5FRC#6#5$*V[&-M
MZ/-_?L_Q>??U;5&2T3Q<CT<^W_?[ON_[W'//>9USWO?><XFQH3_UU%./..((
MG'&="?[.1_]YRSQ&#C,^?_?%9Y]Z=/3=#[Y<L0P^RZ^1PR)6BLB!=YXGP=$3
M:O_99Y_10XZF?W-+='YV2I7[-B;I8%9J)L#U>'XD P<P);_$9-@PHKP?BV!1
M5&I,,V$]H'1W=$5:CP'""/\FZ L;0'8"*%#K&SOD2C$/T*M\O(N[ )1)R#6C
M$).^??SQQ\,C":!JV:F<E'PL/G4PTLLMMQQ//;W5M,VY#G7OO?=&2<Z0YL+*
M_/ZGYJ X1"(S*5%4RI\^HK !&!U[[+%),R\?)2^]]%(NZ_(6O092J (Q&.(6
M,C)@Z!R'.=P69]'GM\"[(R,3ESV7"JB@(\()6,8=T:!>_-B3X+Y7($OO2'_Y
MQ4>31MYP]^2/QP^X;=BC3SYV9[<[)W]3\8VP7;MV^=GRQY59(X?--MN,-<TU
M;PM[M5+ER&%!5BN-C=TXS$-QM#-[6=QE\W1S6+D8N]_^]K>Y^V76PCUZ-+;V
MSJ6D_T$>N!'>M<&&&S5MVI0EX+LP*L2&;(B0V5220-Y..NDD=IVS6+6A^2Q?
M?O#"+9VO;G?\H2>>?^5E)QQ[\#&7C1Y[9XN]#CKV[VVN'O;8Q'<_?ONMJ9GN
M"3/OBW-:R+P1-*"''WYXHT:-F'-$LE6L(%U+-9^ODI$#3- I@I=JBR$<&CR!
M,^2?W>5LD5OV$A/H&@T%Q1@[)LY$RUDRLG%3Q4%=W?ZPS3;3WWOSP9O//^2P
MIF>U.^^*JRXX+?[GV   @ !)1$%4M=WEEW1_H,Y>=6^(;3:44?O#XT2G;R/M
M 0ZCH5,L._2B7+FAXQ?%(<27Q$EP\*=39,OM%B?!71E;#C#$;\B3ZY5OOOEF
M[B/T\"+JS!\2.M:I4Z?N'GO6VW.OO>KMN<=>]>K7\[\]ZM;=X__^;\=55UUM
MRRVW!"GUZM7CUG BX4:Z/L"V<YQ9-B[.FH!I_2(5M?:Y=%?&^;74)Q>RGU\^
M":YC% !;"HSJ&'NEDJL,<Y<XR:X4*^/39\JY4[:0]W-I+.\!5AC;J7P2G/9A
ME,KI=U(- I#^)5341VT6"603S?AV.L(K(AX)W8R"=S$9N;J5E\#M&Q*Y[W(.
MI&\LX]$X&KQ:-&6(NT4JU;0%N?*$X.5'='8G)U72Z! #H<+(R(WK%0:T8VQ;
MQRCMY)_=XR2X"RZX0,W<D#HMCMP>6LZE0:FK5Z].&HT%=?YCE-H[[UQ_[[VW
MV68;P)A359_%'C]O+R(!3,NO:8C)R $&$IA2./?Y@3]9A#-$-%?P8Q>E1H^^
M&VCPCB$9D.?'LOP^]=9;;Q$J+;,= @Q\\X./"&#1<&]LA<]'A&'5JE5;=MEE
M/XS]S1DV$(F,>--IRZ@R9TW32V9EB(>N85>ZX(1*!P6]4 B?.= #XV!UT$3K
M$?E&;&!P"RJD)-!*?I'QRK>PVA@.WH&8=Z$S_0%W23*XP&=]J9Q)J4&#!FW:
MM$E/ _VZG"U[A.1ST(=%;E/$^&& <M-V[_(B)8(TH-*6Z PL<UB3F=K$^4TV
MV23#AJ0_/ST8.]<!?E("'$ KX$WN&1WT4Q-]?"A.2$SE*D5PHLNI05A'#'*9
M0_V]ZI[;IL7$*>]]\,Z4L<^_NNV?M^/> (1LG_QCSIA(_8="]!"5+R/[EM$T
MOA!COUF*X=AGGWV(*W. @2BAR/1+RYP0+;B8&V\TB[V[[+)+G0K<J5O^I^)_
M4>+W0BB:-B+8F,R9M<R<<_CP^5Z=.K;O,>J=SV9:_U\CAT6L%)$#A!4YT'!7
M\H,$0\@52Y %EP,C9UDIT# #^I0#C]# (B7"=>5,2@D3Y#NK/5[I>!?0"1K2
M"_0@_,I)ZGSDKO(A#&""MN=W%__2O426SV./73ID%(9&B71%_.NLLP[!!:PI
M@CEYG6&#0K&766:9]/L?BW,;DF;]HJOYEMP15<#<H$@:G<3059Q!YTX[[?1&
M'"3'1@IR[KSS3EWV+Y<"#(V.+(K004<  <OJ18@$?[=&%DBH<7WLN?0O%%8S
MG8P,HG)) &@;%-ECT _0\<KK?I(YAY8M6[+T</:=R?\<U;U[[YNO:7=^YYLN
M;]7BXMY/O?[^-_^>SB5-[^K'E2J1 U #^OK%WC-(;\1&TJ+R3QLY_+0[I*M$
M#G"M%))?"K(KN\@N+K'$$@L2.13%T&^WW79PGP"D/ZH7C %]))\$TA6:2+!Q
MDHVI^OQ\EFE/WWC:Y=TO/V*_)A>T/'CK77;;Z[0^ R[<]C<;'GQ"AW,&W/_J
M+%NT]1IC^4 0@T/#LV3=R?:@R%#9OGW[^O7K4T8*F+)-RZ@PWY'WH!=<G%E#
MBV+.@0=S?Q0=Y]QP2B@4=<L=TM?&:>O@U[O2FZ=0AI66/18','DJUV.XPG_Z
M^*-IGWTT#:/>?NN=3[_X_),//YKV\>?''',,(O,+"'><:H\?/SX=.XWPWK2<
M2VMX)/FN:^.L!K>XFZ.CZ!<5]F"J.0^>6YP?*>^(-&NN<#5P9D L,>\?A8)?
M5Y%2YA]]^_6K7;LVJ7CQN:=?FC#IC2F37WEUTN2)K[XR86+'2R\EX3K.&<IO
ML6A J@A'?Z^-TC4.,(8):-,@KP5871/9'G7!G]?$=HC\8@HW^$RZ@SRC@#QD
M0]=L'[O2JW8+^%P51Z=UC"E33K8W=HWE3UZ*U1P=[<-M0V.PO#UCF$0P=W':
M[P0N-6O4J#$RYF<4#E,RIW7KUJ+-%BU:Z(*N(<#HWQV;^&$C Z$=;]2(-W*I
M^?T@%,'HY_]UBQ.UAT8J6'7\'A&%5WU;[)=@L(P%AKB8D55.^1J%ZZ/DAWR#
M:,0]I5GM:P>2<_<]PH.\>_"=KTZ<-&GRJZ\8GLF3)KX\X=''GX1I0V,%/&NH
MM7P*8S$!XCT56;]%!3B3D0.X8(PRU^<=D>%WK;76XO]QCL\XXPQ-U:Q94P<Y
MXH3!H/#1F9(--MB &.? )=#E3#@'L6W;MAIITJ0)N:)'.5=)BG+)V3-Q.H'V
M?Q,[>8QIQE?4#6'D)V$V9QO2!/,R5</)C&2NBV.\H4U^,22N7%6(^FCLS9@2
MQ< ==]QQ7.3/(ND08Z1Q=&J<K%*NG&'(Y5X&=,455T0S*3(<9 !NJ(\;K ^(
MVWWWW8D9!LZ(7?BM6K7:=]]]$:RF=D@"K*.J=\<!+SJ%3H!S8^R:R(]]W)7<
M,)/!<TYK\_6)7.%"B&$*9F*U4<C(64]=SP\$Q3X'4$8JC X-TCO@H_LZDK-G
M7@1;<AM20A^.@1%]U_[HF+G*3ZLC1][[QS_]Z<]_WK;6MMMN56-+<0X=&1F;
MIG!/[P;%,:\P/"<5#1!*^L?1'\BN0*WO%VJBVJ&''@IS/$BD3SSQ1*-/!G ;
MS1G5%T7,F4/V\Y?TJ69;9D8.,[Z<^O(C_;K>-&;2S(USOT8.BU@I(@=@2IFA
M1OX)(G/RM!3K@OQ(S:3;(R.E28(1K>L7";-+Y;T-.</X=22YHX19C4I0U,\B
M 3/,ZED^8HG*T?G\NO!5[(^DC1DW X4;RT=6 TJ/9-@ @%*9(8[&:7N[=NUV
MW7578$3X6-#\R@4-,T!/8F ]$!<YL 'C(]]_THR,DTXZ*?<Y9$Z)#'N*;P!D
M?4;L^@!SB %2[ '#EI]G@.GYYY_/L;@[EBA0:<X'C(,4FDI'Y)[8A7E9[+?+
M+V'ZY5_VP"OTUV\6#@K '=7\OCH2.&B6\;LZ=D'H/M3.X5B0XBU;;[WUCN6R
MPW=E^QW*5_@N]U8Z?7E^RZR1 [PS^A==W/&&FV[J>OVU-_6ZJ:C\TT8.^^^_
MOP#RI\K*6B5R^$UL/<SP<N%%#F1LFVVV67?==3.0GDLAEN2AZM7Y+._]H^?Q
M'0:,&C#ZO<]?NNFNT?==W[G/W7W;-[_BKENN/:/KT'^^.W_KD=ALHTD]F7:.
M2X;0W% V'C-Y@3TB&3GIPEXBP7]E.RDU@:$[\*$46Y6H;7Z0^[C227#DBDGV
M^[HX@VE('';!04D8X?EI'WKD]U?B-_-<WJ^GO_ON>U]]^:4W<F<%QM0JV<O+
MS%5/L *F718%@E'/3I'/H&,L(*3:&>J/B#VO/)L;XR2X_.+;(8YW]"#"*%?6
M5##AM<@!6BPFN3,RL^GU&6>TZ-KMXC'=+CSSG.MNN.;"\RZ_YHISFAW69F"/
MVP;OOMMNM*9WG".9 $62.:/P!&^UXQ6 !1I T=YQB.2=<0"V.J &&3?&4D,V
MV)]((B=D%9TZDKU&/R(+=TIK%\<Y5ORM7"&)_\ M(['<'.Q=7T>N)TB5W\MY
MM\ M5^23?RSR8&9!8#A$"+OMMEN.A9$]]]QS><F<9M=Q!F%%US+@*<587Q_;
MT!4L]2*L\Q2GG%SUB#,Q\[L5!J:;6PJ49K8T M*GQYX''$#5YY%/O&-D94U9
MRNF+B\HGP8V*0Z:'QM&!K!LF@-DGGGARK_J[O__\L'//Z-"CY]5MSCK_VNY7
MGM+XS"ON>7Z'[6IQT5A&C0PLGRQ$ I-7I3!DW>,DNV*? YZ@"M/R<X.XHIB[
M5KGX/J4I(YCN[%_^\A=.9#$T6)V&$IV4J%NDXBF%"<YHC>4B#ZSGM7%"'&]R
MI956.O744ZM,^&-@3GT480-BO"6_">9W*]K:H$$#C\-)$90*4*YAPX89#RR_
M_/*B&B,(S=AWQ'CU"2><L-YZZXFUU,=V70:28% (M,466_CMEA'DWW.S7-%4
M1DTM6[8D'AY?:JFECCKJ*,0+4>AL'L=&8-Q:;KGEV-E##CD$_:)]D+C33CMI
MRBTM;[GEEBSO.>><@_GHY*@@-;L#]@>5]S80R%[E\]KXWT2(!2F5=[;<%6E=
M2I%0?M---RU.@LN9)1SH$L<HY9!1$,*3O@$KH!JVI#G _T*N>#C71$E?Y9G8
M+I7QB<J)&P_$F7$3(Y/8H-B^GY,\V#LGUQF<8A'NZ;4!\FI:\)T7ONB4F9%#
MEG_'(H=R^35R6,1*$3EP5??;;[]$EJF1O(@^P* OXR#&Q"S&(+\SD?49D4E)
M:)Z/XR;HS$\=1=B0T^YL0[_R*?$TBG[F="=\'!!+2TL!<X-B75"",IU'0+&=
MP"-I]JAQ$I-H."HRHN;7!6)'2_FII?(IU\4\9JZFX#&#*BX%+R1IIKW>*/"H
M5Z^>"@/+!_>@X>XXWB7#!H,.7G/_'%@!6P4QS9HU8P- 3"YQ!C0:R=^7Q/XG
MT,^PP;BK(EVZ"K C5]_V[]_?;[CIEDY=&2<\^(UR?6>B;HCSXRZ/XL^F39LN
M^)S#PBZSC1S&CGWX^6<?>O7A,?WO&'/Q>6W'W#'\T9??>/OYIZMOO.&_ICX_
M[(ZACS[SPD/W#[M]^-BGGQG_^@=3GQLW=N2 _O>]\-97_YKZT!UWCAS[U"-C
MA@\?^^(FF_^A5^^;1XQYY/X1@X<_-J'BC)1*)5<K[;GGGOQ(PYH>0Y8%CQQ6
M6&$%ZI"S_ LO<C#N^;JSSSX['8XYE9\D<OCR\[>?>."U65\SX]U7GI[\^L?S
M$=/]0*&M.$:1*0YDX/+R;S(Y.M6N5JT:7X0_ 5AXP!Q-<DZ%Z9HKA'^CC39R
MA4_@7\.JJ9R\HAUL,S7D]VN3S\$MIJ>>NB<2',$<6DRA@%N&_??$JC#C2SB!
ME5LW1KDVLOY37G:=YY>S!'TBX<' .,#ALCCDD7_V4AQOC'*JZE\TW!%G":,V
M=UAIDQN=]55PA=?R2>1Q1X97-VER_ 7G-[FQTZ!A5Y[7YI+.-_>YZ+"##SNB
M_5U7]^RS\\X[ U*NAI?RSF&7^EZA30[0Q$@[.SS2ZP$WTH).;]=?+EK7R#*$
M;%V#I1@+541'.CXLLDV 0<C,G1T8YUAI ;O41&1^! 5'0@7ONB(.J(%(^@6I
M-&+L<JV: $S[QN*FR"*%*NU[5@O:-Q;0'OKQ Q@1E5NU:L4G,]SZE9F".',T
M%$-X;!HT=GZ#WWZ1<3*_O&04E_N #0?^JVEHM&]84:+7F;SRMEA=IBEC+8)"
MLS]=S]@/TF*"6VR3\?)JPT%W^'FWQS%!Z!<7X88_[[CCSCIUMAT[^MZ[KNC<
M_LP+^HZXX?SV%[3OU*][OP?_O,-V3__C'X0M/[0CR9CJ,DKTVC#EW@\RF9%#
MK5JUB/<IIYQ">DD@!G+[R/9-L;0/)9Q=D1(RV"_<S@@31AGKXLN=CN0B3U8)
MG'+6TZ+E4IQ2G,7$32<,DV)O@,Y"+4:\%$MQ[HDI.",^HYQ)*9<29"*0G*PP
M=CBF7WX<<<018H_A<5)>*7)I&+4F39IH$Z@V;]X</TL1:!$G=PW!T4<?31TR
M $,DV+\A-AD?>>21=>O695C3GI9B"71Q2*L8C!@PHP(#YMA(&=\UUECCG7?>
MP</<"+?KKKOVCZ/TTFTPZ 2I8YPFWKAQ8]S(6(OI-Z"8+ZX@5!R#.\J9E+RE
M6,Q&>@D &CA\&,(<#"Z?/:4:2RU*(:4&-R<<4LP0:;Q23;#%GX;2+9J.@5XD
MNL@E6P0)/0D.'LDOFR0$;=2'U.F4?XTXY=*^3AD1+2 #;?[4(('/H:]2@">H
M%S-XUMC-.FV[J)0B<OABVOO3WGCIV>>??&9*1526Y=?(81$K1>10['. 6?UC
M&3$P!=R4^>%8Q/E59%)B#M-3!PIICTOE+=%%V$#]AD4JNAEQ7J9J&9 D9DV)
M[014FB8DLF1P<DOYW ;*[%8&]&_&(1*)F)]'GN8,&TJQ67EP>2TC.CT.0=9=
M=UVOT!<X"&II(XWE4!Y__/$;;+#!2BNM!'V*S6&J^;=UZ]:_^]WO3CCAA!?+
MA\B@7T\367*14GYIR^71N=Z)M<,9GG'N4M!]MM8/?006T#QG:=GO_ ;)QN2$
M>TZ@ZY17: USM,.YS)@!Y[VQ3Q26";CH M,.^.#X@N]S6-AEULB!>1CW^#]>
M&7=#\VK5UJK9Y."Z?ZKVFW6/.O^Z-H?MO?%J*SQ\\SDG'M?TS&8G;E-]U=_\
MY;#3#MO]KZW:7=RQX\D''G;AH']^-GG0?AMON]_^A]6N77V=.JU6V6#KWRRQ
M](8-_G[4;M6W.^G:Y]^O$(.B9%96IF54',C]8"1.R;+@D</,=.8_2^2PY))+
M5IF KE)^,') %1=<M'G*[(KK[K9JW:9MN[,K_FUS=NO69Y_3MDV;=NW//:_=
MV6=7?!^^X/SS!,95G_Q1A>AJBO/!T0$R@H2V;=NBX9ACC@&G=!:W]]UW7V/'
MNZ(R_LT'*8AAQ7"ZS+GG]8Z*/*$\5UY1+&ZZGWOA8OK$Z5-"&'^*,;A63#Y4
M8>/3PZ;O.),?*83Q-\8BHDYQ:$!^,L_E!W &LL&HG-RX,LYGA _YJ5+]W!B@
MIL$E#'QZ5*G,U2/VW AU8 )'RICR8 ;$NG-4P=)==]WMBBLN>O&^T:-'/O3H
M0_>,>OBAA\8]\M#CD\:.>W*++;;0KX^B: T0\3D>CD1 :$Z\U;[6$ Q&=(W/
MC3,77G@A9\Z?+KH%1K@X@"[A)1U04'QW%)Y*KB!"6T8"B >,ET8&4E@].M*;
MXAA([Q1[.5#"'2=U(R)5)=J\"]9I''\F1()7#!\0Z\<\N_[ZZQM3ZH]R+A20
M1)4NL#6 '7G>F/:"'Z9!T*=KW"F>]Z#8,'U19)AP_;K8\YU<-5X9_V1TIW<&
MG::@RJO]BZ1>4?+SS46Q;0,]5T4:W\FQ!\^KO>C?<5Y$KSB;?-JT:5]6Y-BY
ML=:V?WIBU-T/W3UFW-A1(^ZK^&0Q8O034Z9]W7C_QOB +=XE(M)KA$V*H_?
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MF,1P&JZ/TR(! ;<8 ?FI T1>%<N+8=]EL4C:GS?&*4LC([4(\P936'<7<P$
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M$J91A%D4:6HYDQ(P*B8E<P*]F&THPH:IL3\[Q0@Q%#X7*7W[_81K-!:V)O'
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M.'D-@(.LAR,#C_H<K_LB6R@.J^DNAB #$AH.KZ:/&')-[/),)GN6:4!G;N3
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MI Z(?*R@1L1"!JZ*PPVX[#RY#!@@#S7TU-61#HX? ^HUB,,XS[$^Z*"#1*K
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M5]6K/U<Q.IAC1/ M-Y6Q: ;7#UPUW"_'@8/8?F><^06<FS1IPG,Z[[SS7(?
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MI&.9E4)-]0=7VA+=-_*LEV(1<[?O9U(:4<Y0\6ALM$"SUP$ONB=$48<>(A(
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M+;_6&%/+ B9HIEN)682F1^P%+)43L!9;HN'LZ$J9E'J7CWMC[3Q2 &B&#:4
ME.&QT2KC 088MB9,:/^:\I9HU8;$5&\2D[,-&38813I)< =$4E>HK36OA@(@
M.\TP) *%M'?YY9??=MMMH8,_T^G4=[#XN]_];F!L(0"@$+# K((Y$"=73 ("
M0O-0)/Q&#(C)SXI<"C\8&/1S0;@:N1M,(]BH[[KLNG]%"!=%?D9&!6&Y3@EG
M6 +]%3.0,:BJ+YE# ZE0B>/"_,_)U/UR2I7(X=C(RJKC:7I_PL@A3QY]\<47
M\S-S*4Z"*^[.MC"T^:TNP]JY%-0NO?323,7_SEM99YUUF(&JK429;>0@S$!_
M5?JB=.C005.S[N'^F2.']Q\9>,NCK[X]<>P-UPT=?NNE38ZX<-@+;W_U^<2[
M.@]^J_3Y,X.N:=UEZ/@'AMS^P-!K+NYZ6=<+^SXW3R'9_)8B<F"2$ST@"?^)
MMN8@4JZKXC254GQ<O#E.1TG[Q*C3K-R>3A03#6 +KX) $H81D:TEO^EROM.A
MH>D](E-DWDK5H[/4$!2 ET%QD' IDAJCI$@@D3,;>6ML'$+':2O%BDKZ+N9/
M)$%JID] O_9A6N&E<;\ KZXE_N2M[#4WQ:OYXL5W$_077XY[]NRIXR>??'(1
M.<R(:1G.JV@9D;!NH7[7GQ%3M?J.&-V$C0)@? :G,%#?FS=O+C#F4>F[ZS@/
M&/47%+L%1><+!WZ2PDO&S]GNY/E)(H?<.D^6<K8A=_&6O<,/NG8X9]^_[KOB
MZJLNM_32RZRZVIKKKKO&BBLNL^S2K5N??'R[#C=U^-O>FZRQ4\M;>PX<^LC8
MAT@C(Y6CG )&*G*!+CMBH/M&[J#CCS]^R267!+R%"-T?F932GF:^$Z).@VA*
M[S@L"!XB3%-:U@*)&C5J%)-$2@G,2Y$-UFB^&H4B](\D4?#VP3A0@MSBDLIM
MV[:E;E[J-X>2_!/1W>K6_>K-QWM>U*'KH-N[=1T#HZ^]YAHU9\22O"NOO/+)
M)Y^<-&F2-U(6BL;OYV"DIX[SWH)^*HP,;Q&I(D: \4$4??$4@FE$=A/]:!9=
MT!HM4TSV.C<*_JW)T5<W/?SLL\\[OUWK9E>//+;)L8RI6_E-$[58M\,.._!<
M1?Z''WXXRYOY>1^-\UNI*H:[XHW;;;>=@<"$(FSX/)9'YN>&+;;8 C%JWA(;
MP?%'9>V@O&G3ID((S"R%['F$)REL]ENOM98S)(M0P?D)$R8 O=PA1NHFQY$:
M5>N5R_\6.Z1G5WXH<O@%E5\CAXI2.,<&OG;MVC2$^PZ/:'+N;2B%#>80%YA5
M3'T"(-?3;'\9F93N+1_W1H%[E;=$BP'XBPF@G\81C^E+,9SJ#RXG8'ZFTI9H
M,%>$#024?S \,BE5GB$MQ7<7J JJM-\W=BOF%T'ZGU?0Q@G31Y+-G5UVV67U
M$604"5CA N-*#M1D(;26P0DF>+Q8,=6WG$K/%3X<8I@ZA,$(;X<+J(* S+E&
M] AR :R1D<P;** *YFJ3K1(;\"2@3(9)N0#@E3B4NDN7+C@ @\;'N:0#8_TT
MQRC3IYQRRBE]([/$+[G,5^2PR2:;&/0T##.;F'.I'#G,J2R^^.);S%)JU*@A
M:#30V(C/F$]TYQX_&-_I\U/FY-;/-G+8<,,-5UEEE6VVV0:CUE]_?1*UY99;
M)IVKK[ZZ7J2R5"X_<^3PKR=OO_&AQ^[L>-HQ+:[I>E&3(]M>,^+1\:]->?GN
M+K=,Y*T^>T?;JZZXLLTE%[;]^Q%M![XR[=V//I_]DO<%+$7DP+^DJO2"*M'$
M!QYX(/=/WW[[[:]'NDSZ2UG\ZR*_G'(QW@P;4^TB31PW;IR+=)]:T3(<!CZY
MJ]4CV3)7XZY(QYEK%RFU%\$*BLG]U;X65*;4_!(O5;E=NW;0B19?'_ES<D6'
M*Z]'UF8O14"N,E=?4]PU5/G-E! ,-/PSLK+FI@CT>-9+Q\5Y=BRQ0 6"42M4
M08:<-H',Z!\4J45= 96>/?744XO@!V$$#]D\L)]3;+(8*5$]SI0BJ*!HB9:(
MX45Q.G/IOU!'@ $N6K5J-=OE#0NU3(Z-O[FQK4J94^0P_5_37IL\9>K4*1.>
M>V[B.Q]^^/J$%R:\]=&'[TP8_\K4#[\HT"0CA[Y1<IT]:V6 <K9A^O1_WSOZ
MWILO.NN<EB?ON-,.)Q[=^/!33C_LJ),>?>[Y QK5/[[IP4V;G7E!BU9GMVE]
M[-F7#KFG8N*"/#1NW)B7J1'\G!QI>32^]]Y[Y[Z4)(]3?N"!!_*)IT>.+$\!
MVQ0)]AH@+[WTTLLMMQP';O/--^<!\]6VW79;?_JW9LV:\&?%%5?T)Q_Z_R+#
MF]'):H!WM=56 TW_%TDC8)'Z?NRXXX[5JE7;>..-UUMOO00T".9QU[5S]-''
M&/_GAO0=<._@ZZX<)D0;.F2(FEZTU59;:7GGG7?6U*:;;JK]6K5JN>)//XH6
M& @O==U;"F)@9M*\P@HK( .6NH(8M_1+4WYK8>655UYWW76U]N?MMNO2I?,W
M'XWO=U7?08.Z7=+UR0>?>;+:__YO#CT7A6_0HD6+C3;:Z-'(HK[__OM[%O+0
M+]HZ/9Q=6MFF39NI4Z?J('O-CB>J"V_Z15Z!4GS0%'5TZ];-Z+1NW?KU2*J&
M\WP&HMZD21.=RH5>_H4G=>K4H:&E\*/@0[YH42PSHE2].DLI(H=OOOK7>U->
MG3#YS0\JG>OV:^2PB)4B<@! F6*(*1)S,TXI$#2$;F388&C5S^4K[\99,[F#
M'L@.CAQG*4#YO;_8$LU.YY>S3R.34NYMH#^L)ES.L(&O7U R9<J48I'2E^4M
MT0S/C,BDI(6LQ@!3T8Q>+K[X8OJ?O@6OG6+S#N$I2C@*G'7^ ;2"-7YGV( 8
MT# N4C,U;-C0*\!$?M+S(*N?LR6O1UZV7-?T=21=+M:EZ#LXZ-"A0\85;K$9
MR$# T"@]>O3X_^R=!UR65?O'+:W>LF'+TH:FE2M?*^W-D2,WEGO@Q TBBH"(
M@Z& XD84MXBH@" H0T0VHH)[H[@5]\8]0'G^W^=</K>/.*)2L_J?CY_'F_L^
M][G/N*[?];O.Q <#3R$*$ X/#P]9@S%:[>@,R>!/\@S$\R<WJ0'2E!72/(55
M@VZ0W4EJFT@K*RL9&'F1PR,]!T1(")!0*"TR)@<96*I6@\CV7$\.6(6&#1NV
M?%3 9&*3"CQFG0,!'N/HZ$C3DQE9,IM/=^7/!(0?,X8 Y[F/1:1980"(.M)K
M/!\,&T8I5JI]@;6 ?<*^Y@>=GUHXO6/5WGT[UZ4$SPJ*7N:_>,WZW?M.7+A\
M>7_*^K-W+NU8&^V_T&].^,IM:Y+"%JT^]\SR)9X#K&6*.@<*W1&##16;I\Y5
MD"X,H!P'/L:P&[VOVD93ZZW'"?=7"QM.GCPI:S_$,3NE3H+CD4@"4 !?E+GO
M@)*L1))EQ+YJG4.<VIP1X[= '>&"1G_RR2?-FC5#+.$T,'534U-$&FG4>DR0
M-/*\7YTP R)1"NEG@<_)QE#219><G#Q:;? JCWS5#IXR]0*M&3Y\N-;5 J20
M,>&C),M;J ^4A63EF#/>I11D[SGLJ/NX %I2,Q%//'M.IRP(M4H]H/O/?\RA
M3ITZ" ^M__#DBL=Y#D>B7"O_4*.[\Y#V/S>TFSAMC,O 7C;.3N;MRA2L,"!P
MN];7*IX#BBRS>6E'FGZMFII+,<70W+JMMWK[#AZ,CEY^XY:>3F&/YOO-SU C
MX;=O7D^.CUV5NB[GCKZS#$D#0]JV;4NR4%@\!"QUMV[=9!\PD2ARB[AV[-@1
M)HV=$J05$P:\4 IK:^M*E2HU;=H4J=,F &.+8]4B1EY'%^ V,D8GPW<RGD8@
M98J#LZ=3QAU+)W)+PR'88#AI]NG31UQW>866;=381'<E(V!^8.*N_9L3=F!9
M9\V<V;MW[VAUZK9.J1(:(=M>H=&(\0JU5$FG1"A,G:J$\,N0@IPA()U]Y)EW
M90Z>YAW)/K.R6)R6Q>Z0-U*+B8G]N5XMWR&]?9:$+IRW)#AH93>; >W:MJ5Q
M>1&#!<N'Q./&H'186"H0_PJ#@D,K0U*T/O(@5*=QX\:8$FV2$A2(_$AO(VUA
M86$!8M#BT]2:>+*$Q?'T]*34U"U 0;G =JP/'VW5JM4:M<ADO3H:2^KM'QR4
MYZ"OJ/-;DD*6A"R/F!^8SW4.+UCX?\]!'R!M8AWAQX,'#^8"A0$(= 9D ?5$
M?_:J'4)D8/VLVH!5D.6&.NY-6]^S59W=)I@EJ_UD7A")B-L@0P?W -2P)!H-
MU-P&61*M4_9;W ;!J;5J)R49!R!-%%56%Z'\Y!F#BH:#+U *"H5UEXF8N/6
M(.J*]N(Y * ZPS[98JK!XKIUZW(MWA'Y1XW%G BQ$[>![%%,,+1&C1HZ-<N3
MKP"7(-<DM6>B^$[D%C2D:!2*:\H"DZ8^>835GSA1OW,\B.^IMA67@1'B0VC(
M)+GE#O?Y$"^2IL0D#]S!6DC?QHL<J(0J5:I4KER9FD$P^O;M6Z]>O1"U8A6T
MQ;08;]\$E(C1XJFX<T\.(*]PLD>&)ZR0)N V4+$Z1;^HQD2UE_^S#L@D69(1
M:N. YX#,("&(JZ_AD $)\+^77WX9UPO[-%P%J"=6L&C1HD8)_%N"> Z4G4J
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M9-L/Z#),]V'/06\P<N_FYLK$;MV].RI@3>ZJOF>=P7/ 7FA]ZI@SQ)5DQ6T
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M)'$*CLL',DH?C& N9%3RS_4RPQ&5(&F5*E4$<\D&< R0^:DCL4D'+K)X\6)
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MHK9"&WB%E/&+BA<O#O-IT*"!BXL+G@PQH?74AHS#D#<R(_FG=!'J3#>A$-
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MV9,GN4T9W;-C5W=7>_/!\R9XCS=KU<%UG-.H^5N.9V4M#@X60R,SOJ330:=
M &B"0\(296T#O\%J"]=_?- \!]WMK ,9.]>MW[#WU/VE4 ]X#B=B.]<RZ3)B
M?ES8;)OV%E,CD@+<S2K6ZSDK[?#^Y:,;?&\6M/\?-UOI8<_A3M;1E?[3)B_
MQ_*9Y3-SVJQIPYK5Z3G,V;Y;IT:_#)TRNFM)$VO/L:/&N7O.GC[++\#+M')C
MB]'1QXYDK%_IU[]%NU_:.,Y?DG3":'3FZ7H.-)B'AP<&#*1#>< LM%WF,LHJ
M9 VS%AGMI"0.O;@-V]2Y!T+I9&*E2(!@EBPG(";Q-;>!6M)&&V@&6=N@,W(;
M!&>-ET23IN8VD%LM,[P"M8*$@3O2Q2@S$\ [ !>L'#9LV,B1(S'2^ Q (09
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M[AV^:?7:#8F^SD/=!IDY3_?U76=D;)^NYX!"8FYU:H$_R<)FH,OHMC!U64X
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MN[?N/G[^Y-'3ER^=.)UU?&?*VE5KM^W/V+(Z(CC%F"X]=<]!%B2@GY@ZX;X
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M38@ZM8.&0R4!GW+ERL&M,90R#BDF3+I(=&IN/0E"@/!,RI8M2U+B*O-=<1N
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M\P  45(7%Y>&C1J=.GXLY^K9S,,']F>>M[(=V+>O)14"3I$.6 _B [@8$O*
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M%5!S"_OTZ0-%H1YT:AU\3$P,A($Z =-(65X!T !8F9 ):."/:3X,M &S*]%
M1<HB*0.>_?OWKUNW+M<8=^)K"R\GJB#R?U*=MB1NPW6UB;P8(Y0%WX_*%(<*
MK4&GN.87FX7]76<X>T[<!N$PQMNZ9&9FTOHBM'@U_H8CJ_-4)H0*#16W 7'R
M5F?(Z-0P#KH/1"]6)[HB !&&(ZO_#4%;YW!^7WI*X-1)@<OW9MTO^_][#@]Y
M#KKKVX)\Y@;&KX^(3$[?$3_-PV5JV(ZCFWQ\PC;M3-^8$KP@)&&\3=/R-=J-
M7;QP_" ;BWZ#!YN;6GG.7>$?LBPEV*5G-RN7<./%Y+_I.>@42"&OL$"AXT\(
M-)BSLS/*!N?#Q@\9,D1;$AVN5B&+9J:GIVMK&T !'Q\?(3JH&3 G;D..X91U
M40;XJ[_AN#<P$?P2G,6^BML@!$XF*0F RMH&L;L !RHMC%/Z70 =;;2!#$A7
M.N NRPS(!JT#ID/W*0*X0%)$ X)!+JR[K)"FR8$_:N;,F3-#5#ASYBS?6KX\
MJE6KEJ0#=Y=N %G"(1TJ& "@ 7/8M&E38,[6UA:&(9_#J$,/8M6<;[XX01W<
M1@Y!!S)&9G[^^6=J#XL%YLK(3*E2I2+#0^_>R;U])^?ZU1NWLF]<NW'W^(D3
M +2EI24E!6Z6J3UJR3:)\!5P'] D#T#M/<\AY\;%L\>/G3AU]-#^?9G'3Y^Y
M).Z\> XBW-3;.2V<U0<9[R8/'WSPP;OOO@LQ?=<0WGOOO<*%"Q<J5 BB!A/Z
M^O<'WB+96K5J:9X#6 QWA"S**KT[ZHA6E4U]^/K9>PZGHFQK6TY8E7%?"_Z\
MYX!.44M4'1096@\@T$98!:$CR ]RWKIUZ]$>^CT0[ZI#$1 DA(<&[=6K5\&"
M!6E$.4261\2WM[<G$8QTE2I5$$AD@.:2]8[D 0I.N7B7:*:FIL>.'97LHX 8
M5&@-B2,8R#!OP5?,S,Q@%3@GI,,O9 (&3]/@,[_RRBNOO?8:IEW:ET?<(0XB
M31QD($^$1P8>46I9CR$C6LB5"!@_,K."#!,'B3*6+FH,!<1YT#WH.=R^>>'@
M_J.GSYZB#H\=.WY1=40][#G(!O @R7&]GW_LT*$#>]-W[DS?<_CH<<J.IM2I
MH_?&868R3!>LMFM$\- FI)&F6;-FS<J5*\^H0YJ!K*5+ER(M:]09<+BXQ#RK
MEE +(M&(\CJOH+SP=6A*JCJ%#8<_(R.#&J#XU#Q,"UTC3:2=R'OW[UL2N&CS
M]M4C!MD.[><Z(RHM)2F!7"&QT X 1'\ZM^?X[=LW1BR:XS+2.S8U=5EDI,Q6
M!SR!()"$C)'_C>HT<?@*]#%6G3+)U^'E9(],(IQ<4XU1:L()/%+(UE\>\N,Y
M /6P*^,);,\ZB.<@D[XP80O5RF,,'!=0:J& ,A5'XW/@=J!AGBVR(>8 &:/.
M\2ZT78ED^ (HH_[!.BLK*T"F:-&BX ,J#!R!BA]^^"%:#^OE@C^K5JV*RA.!
M/]$IY)Q?KKF#A. /R"N\SENH)W^B BU:M$ 74%(2IX:!6=G_#1-3O7IU-.ZM
MM]Z"WVMK&V CF%VQIS+8(AM WU8GE!$D&O),D5%)G"BT ^\438024%+>XJ,H
M[RJU QA6#QT$ &EBF96$X48C\=6)@"(,'3H4C,(-X%WD%G6 =G.?:VH&)25E
MJ(5L.P9L@I,F)B8D)2/A6 <4$S,*@O$)(,Y?]=:CP@@,%IR24C_H'7J*@E 0
M6@=]P:$20B]K&X2IWU 3K5%\$0"H#A@K'$;H@>@+"$"&R1Z?P#X&JK4-PC1D
MI9/8+-)'?Z5/4R96:6Z#<662?RB!K&T@VX"8],,B6E0%E5R^?'EQ*I 9(4[_
MDO"UP7/(RE@S?Y*;QY3IT>GW)]4_[#GD9M^X<NGRC6S]A)MK)W;%!/O-]@U:
MF7[R5KZL]S,,S\ESR,DZOB; >\'J'<=V)_D%+5HP)R(E)7BZ;_"B6?,6+_&=
M%1(6,M?7:[)/S+;S=X^M7IR8%N'GVG=48.2J%6E):S=NCI[MMR1BZ<J3]T=U
M\N4YZ!2BP34]/#Q$H!\70!PA>< -N(.>Z!ZU))K[PM31>4R@N VRG@F]E7'8
MN,?LI 1JH$OB-I#R<G7<&SB;JY9$AQC.;1"W0=8VH-X!A@U89>@#F,A66T""
M4"BP]"Z@@=CO8<.&^?GYH<E\A6BRMH'7B48*_ DJ 6U=NW:%N("_&(\PM;TI
MB";=I0 ]F [II[K:M6M'L@@'1=9\&$ 3(*M1HP:T&^S&(<']()UQX\;!*C"!
M."=\'6\-L$ !("Z@*C5#,640 X-$%?%T].@QWU6N=&!#^/A!([R\O88/'=*G
M<R>3;I[+=I_^U:015H<*I&9(?\2($3*UFDKF6W!-PYB#?N;/H963ZU<N\=TO
MO_ZW>JT?RC88,7U)NK+"FN<@N\<^'"#<8"56)^\#=<(.1.V1=#F?(<]L)=H7
M&S!\^' !!9K5QVB7]]*E2R,G9#6?!.(/> Z'9U=\\]6BC5J$:?,KGXKG(+L>
MN;JZ(AA]^O01"X2D81I%-9 63!%BMGGS)F0#MBU$&?J+C"TQ[-I.V6E?&5_"
M!O,YS(DH+%4G75,X&WA?I(PP()Q]^EANVK09(,)]Q5Y")3&-XH!Q$YTE/KGB
M*?:83)(]R3:4';[R\<<?HR\Z-;  E4<X^97E'"5+ED0[BA4K1L'EE<<%1T='
ME*MV[=J/W(R!//!=XVEI6L#*8C]TQI[#M:,+^M<N\&JQZET=;5O6KVUAYY.L
M3]/8<R#GT 6:%;94K5JULF7+?5.A II8OWZ#;[ZI@(^#R$$I4$8H-;!#RI \
MM( &TG9BP,4"(F3^ ]6.ALH8 I#"*RBO@!7, $<]5.T=3$/0'%"<L>IL!R+
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MS2XN+F0#IT+F/.C4)"LP N22":G8'F#B^/'C?GY^P &8A>6024T>'AX\ B^
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M"($)H!98 <*^_/)+4H/6R/)E,,O+RPNT(H?\2>DVJ;.KN4F6@!X\A[GJN D
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M)?6#YU"B1(EPM9L[GR/_F&U*1V$A_<)@  XR2;+X79 ; (N4J49P#?P" :E
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M05@XG84D.7/FI'*]@,60:&] 0(#>7=^SG92X2]G1MFW;0%V]5.%!D%=Z' '
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M2.CQ]?6%@A->RY4K5[ER97J3GZ#FW$MDQ +Q+[!EB+T0T!@$60?Y"<%7TY^
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M.G?NW%P["-9E,U-Q:;!2:+C6?%OC+EH>*C2G?H=U\5R^7^+928D0[HSO$M6
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MY-X_,'X^:<-]-^W&./%'!9K+=I:PF/I#V]4#]Z2OE6"C ;[D6? ,C(HL6N\
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MY'S/=C%HC%CN;!G)XP1&&N 74]>0:I0=)N_R;,"J*(B$N%F*54<NRV?P85#
MH>!<)F%P3@U.N#Q[8@@-7389%'(FH@8KXBF(@;25*U?6"*7+@[GS/;MDKK:]
M7)0VP"3 +-DWH85H36Y';="O_C;946D#_(RG2'XN@"A(F1+&>=>_P7:PE<Q
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MC?3Y6TP?-R5LFR=M0&PB/H*E2I4*!\%K!!IT!+XIT,9AL7 YX!U;=A7M6=L
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M0UIJYEG41LT(_,X[[Y!.DX?3WI(E2ZJ;J)]FTD'<A4K1!J;"!VK 8+B>AF
M^?+E<WO7F:5^M=I.6.U^:T%PQ?8 $+Q)X5QI V"-<Q%R((+08IKYV%[$$8/%
M ,@A(SSK!(C-Q"'\@AX7A8WWK [<N"ZAZ==5!T^:'C<KND5%WZ^*E:J2_ZW4
M!>L'#@W\_*_/Y&S<>5*+!A7*E<M3HDKE\KY=.W3OV;UOW0)O//]NGI E[O1,
M.:32AINV)'J1G96AM(&P)W*OM,%9$@WQ4CA_8$NBN4R@X3WGF' >X;4DFA"E
MM.&!K6UP7M>( 3M#DE2E%XF0\O3ITRL_Q_O0,*QEU*A1=''=NG7!*V4.\$+
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M#1N=V[$DNG_'NKZU6O<8,7G]T=(EBD$1$)X+7GGEE8\^^HBG<Y=EIU60BDR
MWH>VOO;::_Q+T^ <",,U$VT;?K@"RD'S?(_.$8:[Z%DDR9,G+X9]:]?\0:V;
M#EUQU.4>4-^(KKC&F:04X5FJB&N@-+J;U 4O6V:+W9VT89KG$(\;=J0)T13C
M).3#DA,\NP40PR+#ATST\P]?%M\O<%C#NC4;-&D;6+]YX,B>9:LW[>!;IF5$
MU/CF34J4J%2C;>.NK7J&3QG9KGG+K_,5]!O8<\KFZ]<NNS=@56S3VP8JOV\;
M(WJG#20,V*IR %KA+(E^8!.XP1,Q5RVU%!V! 4SV'-QQW?8FUD1**B?\HP'5
MK.UBQ"WX9H(M-N 1"$#70XLU2VVK'=JJ3 FB@YP\!6V3SRAM$&H)\12\:10,
M!IP!RK 9S"G2#AFDF0B/U=$I=!D&@A&2?F/S^#6?,V3(P$_*3V@R*0%6O<H.
MFQ.%@J,X:8.XD=*><W:BA=[#P%&P(FSCX,%#Z&GMU"Y5&G18N-F=7= ZP 3Y
ML5[<$SY*;<6*%8/!\$3\%"-$G\B/I5$/0I)>\A/@@(/@!2 &R3;>30W8X7]+
MYH -.&^&?\GBK'.@N#Q3<7 W-(_Q8#/.BEY<##.3,N&@R;;YILOL',GA #(
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M//C?>_S/57YJYD"@PD^R9@4ELF=S_T/1OU;<7_TLA;K3I$D#W?<6['N+7B!
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M=I)F"F4B/-[][+//@I#X-7+B OP)LP1.I1.];="( %Z,,+@JX=)E>2G7DVF
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MY"?,*&A=M/VF%GEVW=9@L]*&'7:(A'I6[Y%$U)Y6ID.(C]INJDK5J)D8HP"
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MR1Q<I]=M7+T\,6;LX/!%*Z(GCPQ;\NU4^!PY<F!^& \8XO+D (F>/4\!#1!
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MD2LW+9W4L<_PB%D+=QS=N7+^CHMWW2Y)>6S__6^*,@=GG0.(!^J"-A@240P
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M286:LJ/0!![[YIMO"+EI-78(]U&I@5%#_(,*MJ68YO O1DC;'Y$-JLV>/3N
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M?>RU W8T]:&E1&[8X,M,B''W9R/2[CS,53O9&E;KL:66Z=O=*>2NF$(=:(L
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M)X:&]N[:M%:!$I6;-ZA:L'SM)FT'S9@W>^&"!9@W.#/!CD"F'LS543N6 5S
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M%F.).C -[J+?V78L([U\U\FD) Y3)\+LQHUC[7QECRWZA9(9SI9H/H$\*[J
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M^@U+)E0O7+A@@[#H31O7T1FK5T5OW'HXWBMU/Z.<6]4[=?)TA6OT6GE@QXR
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M;.[BU+Q*E<HTAEL !+D+QHB5R0)N%"-8'16O*6P48CX*][[*,BEO&9ZH,ZT
MFH)'P1DT ,@"R'!R<JI2N3(^%G0E,R3+S*O)Y66S#M3PY\8MT?HKU84JDY)
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M>$((L( _,6]*BO=IW+@QS9BLLB?A3&D#):D*S\)/##T-H)Y%:J&+3!#K4ZX
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MO$WTHT>/36X)Q_3$]'7THQC36_XG^.-5X:M!\(1,@FAB->,;[ MM1^TMIF*
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MX!?:('L;] 2LNU4V6%FDA%/"(8COXE<<@DX;-JM$.O*"&0<^S7Q(\'5UX*;
M*=I M;/,6Z*!+"'F7;P4UH$:?HEB8)0G2G!--*Q>O7I);E+"Q4TQGRR6:H+C
MPO\/'SY<_P8$#(0U%'D+(LP!P(=;ELEDS9P_-&?.G/+GGJ>W1-/_@F; O@Q?
M[MRY42%* BBA$U!*F6&0?/]\(+[ XGAPF"I(FGB!WGIX>(Q7603 E[UZ]:(!
M#%___OT)LKERY2+8P7N=G9TI#\4E+G3NW!G4RY"M57OP!$\+[);H++2!-LC<
MEVR(%P4&U*(G8B:0$WUOPQV520G8+<701IY:UAI(6B=9X@\[G6'>VW!?95):
MJ_8VQ*E=R- &61>$-NJF0<U$82P"*R-&RUWT14I)=J;$;D"\;%2@WW2=EZD/
MX3 W50)6:;\L4A+8((VAHXQVJJ_RHF;ZG%_WJP2LD(<=2N@N^)7L0G1Q<4EP
M[*H'X G&V7@>IW[]^GQ#M=R75G%'_J2?>2ATP,W-C1'T\_-C+&@Y1 6+YD)P
M%&,J3(F[R\3C.Q%)R,IZY\RVO<?O1%R]9#@*^FGF\/C(;#>;$D6MRU>J7/;7
M7'EM^X;L39B>2$Z>W#V_?_[X 6U=VCC7^>V;-)4]Y^V\%F6(6S%WCZR>VL:A
M\A_U.L_8>^WE EJJ,0>C*.P=9]K88/I#_M(2;7%X2BQG]%\O<]#46ZLA0X8T
M;-B0P9/%?V;F\&C_S)&=_FP[?/*DX:XN708O.G#&9!*%$S&'N"<W]F__Z_BA
M\_KH/L4<(LX>O'!;AUO/8@Z8^G???9<A0X8<.7)X>7D9)[LUM5I)(KV<N!RB
M$B+A!S%R?#K!&]_'GQ@PWE86'/,G'X %%"!"R\(#/F/2<2KEMLPJA*I]KOA?
MV2;!7? CY<N7Y^EP]-2#^^C=NS?QID^?/A$1$3R[T!*<U%UUVAI!<;9*Y$<<
M.JK2<G,7[LLEL!'J-^Z0YHXX1^KD$@(&O\H[3OR@7$6;-35CRP=9[BRKE?[)
MS"'VRI[URY<MVW+\U('P96O_.G/MS.Y%NXY?.KHE;/V.'9LVK%JV.'SSQI7+
MEX>O/7#ZTLE#9Q]H$>?V;ETV8^W:5<M7A2_?N&?KUK^.[PN?O^_BG9NG=A]/
MR,+]ZA+W^/"<P5T&CJM<HV5RS.'-2^HRAV=(7-R>W3L]/+TG39JT.GSES9MO
M?Y'N#S_\@$_ P 4/@<O!*,3^QHT;8^!@#F 69=JV;<LWX ,@.\9._(;\RR60
MA(X=.X+/-/->9UPTI@??6*42K\FZ($'J@HV 4/*B03/O;=BHSFV(49F4X/:"
MP/88,BGA&? >0AN>J"W1>#F)E)O4N;PRVW!,K2;7,RGQ6<^D-%=MB98%&\8M
MT6 C]% : YX#J-$8X2VR/UM3^QR2W#P6IXXH7F1(0)P*0H<00637EJ96N2Q2
M\G2IU!9]GP.@4(8,5DF' PIM;&R(/O2Y1 I-/8*.U&4I$8]3L&!!F8(&2J)=
M9U3>L+4JITB7+EU040(*F@.LM%)YA(DC:,[(D2-13GZE&-J"]@X:- CJ2YFZ
M=>L28DJ5*I4^??K,F3-#_R /F3)E@DY C,&CK5NWEO7ZA FAFJ@'C01M"VV@
M3EHBVBBI_(0/T#:=-J!X0>K<!BDF6Z)EMD$R*4G-LH5&WYN! @MMT!05U&F#
M<!AYP7]'95*2@>9>O_SR"Y_U+=%)=J9L6EBF#F'@$:3-TA@H/1TH]/Z6.GM.
MD#>-(62CZFI.*'Y+M&ZGP>:,9Q0C!$^8,($P38.Y!4\'G>;N&""7,\38.&:"
M A@GZ C-N [C]GVB=JM6K4 (]"V=@XGQ=)@S#T6#Z:)APX:!EU >^H<& Q6$
M_-O9V4E6-YZ(Q]23D;P3S;A#6LFC.Y$Q!N3[%'.(VM^S4M4_?19=C'S\Y.'E
M11Y__N+08_/U9&&R2-R5Z>W*9BQ4O<?$=1<.S*[V^X#U5Y_:_7Q[VZB"&3ZR
M^O"S'+]4JNE@;V=K4ZEJC193_QY961T<'"R_?:T"1:Y2I8KEMZ\@23"'GW_F
MWXC=DYOD_<3**GW==B-7+!W=[D_/);M-+P.*)&(.B>4E]CG@C !MGWWV6;IT
MZ0!M%LQ!#J;%&<U2FPH.'CP8K 2?CL?!FQ!H\3O\>TV=; KT(=SB2HB[N(9
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MP'2:^>PY%"!4'7,N'  U0SEI:M.F3>E8'!&Z0:LF3IP(HI6D3^@;.@^ZA>?
M%F29OM"&8X9,2G27OD@))92]#9)\2;9$"]4Q;M"G>3JCCE:G1,M.&VYA;6U-
MVX1I8"#3S6FI4( @\Y9H33%J?C).?>BFC<GH6Z(7JP2L\LJ&!X0XZ9F4N$0
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M39MCU9;HK8:3$$^HLXQT$AZBLIY(GR]4AR=J:DR-'.:2(5$R;=:W_<2I4_D
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M,W;HT&'QXL5@<6 $P7ZRRIJ*UL$0(.WT-C8(4&!8@0A@A2)%BH A*"F7X)1
M;$V;-J5S_/W]1XP8 =P!N/ K: P\D2-'#J )J)T1QWT!]S%G[D[-ER]?!M:
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MLYLFC%YV[FY,U,,H6?]#DWB<*5.F@$<]/3T9'1@%Q(/'!%P.&#  AX.'E'F
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M9 Z@2?X$=Q*2@3YCQHR1,T_T\@PTQ<"7^B56.G.XL6?LLA#_MOW'!T^:,&E
MPS]:CYHXK,>?=<O]TBYX>5#/*?' [FTQ!_P H)E':]&B1>O6K<$']#S("0)
M>? -%X+JA@X="M3HVK4K7=&N73L4OE^_?DV:- '2@5I0)CED>J02+N$G@CU@
MBU'&M-NW;\]8HV_<!63 73 $!@LT/VS8L(DJ23S%0*N L.[=N], _D1IP>[<
M#I4 ^=$&/L,3T&J *40%,,&?&3)D^.233^A\V@92Y(GD$F"?O[\_] -VQR7
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M4Z-FT[:3#M])V4OJ=\PA7MXZ<\#V\+] O?OW31/]FO)W%2M6E#?N?Q-)DCE
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M -!UZ];)FU2X_8D3)U!F 6IR%R :Y64YC:QZAXZ"3F0UMJ;>O/(9C(49HN3
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M8_OA  1U.=?S64+$(@"?-PCHL&;-FL1"N%^5*E4" @+Z]^^?)T\>GJM1HT8
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MUJV;>)\#@.#77W^U+)VL&)D#M?WPPP_&UB(#!PX$=C,04N:YS('@#4*5;">
MX,0[I%^9.6BQ4>>/7[UZ8,W*;?L.[M^_\^ -DT==9V8.%2M6M%+3%'J=(A3@
M02R^U%Z9.?!$@C!XZJ^^^BKQP2/(J%&C,#J0NJP3 &< Q0 *>':<R:E3IV;-
MFB782/+M"!Q!A;@$G><G0?-T.\]U^?)E@%'/GCWGS9M'56 ++@%2Q*F7G=B[
M_J: #T ]V89!G2@;,!3;U]]/:PK<TRV@-'M[>V@#V [&+I,2 !%N 7#$I:!:
M0$^:P2UDQ11_"G%%A?3M$#P1^B^T@1MA.W"8:'6.&&,J^QR 0?C,.2JIZ-L5
M(W, WAG?L*2:@ X995"=<7/VVK5K41O0,*.)Y@-YA8-)9VIJMH&>E)TJ-V_>
MI :A#11CR/"0.W;L0.&)5B!+QI%Q1TN!IV!3'""P$HL&[G,7"C B7*5OB4:[
M=-I S2=/G@1_4]L<E4DI3JW@7ZI$7XJS6&W]IP: -=B4JRB)WN+N7%Q<:#;?
MPP'D34JO7KTD\5=Q=2 &/T&A<6@T'@X@^R*X"_0;5>02G9&B9F@@/A;$C]K+
M(GZ9D(0,8)AT([8&%5EO%DQ#WJSS1%S>HD4+])/"F /X6Q28J[@1]@@MP9?2
M,W9V=G@A@DO-FC6);K0-$Z##_?W]-ZOD!S2)R\5,HM5N=3VLH$6T7SX?/GQX
MJ?F(1H8) VS7KAU#PT!0GJKHHK4JK2H.1+(JG53"ER <? M60^7\)'_R$Y4S
M''0OU(7/= B,BPKI'U2%?[&^^O7K<Z&1.6B*ZO L$]56:6Y$'QI_?2>Z).R0
MCKJQ=^6X]HTZSSX8_Z9/>QYS>%&)N[U^3,\_&]:OW_#/9LT=F_*I;KVF;;U7
MG8UG!S>W![::M#,ZYO+Z&9/&!:\X<<LRG+V(O&,.\?)W8 Z:>G. 81-I9/&Q
M*-G?1Q+G5L+'.3HZRBN05Y%=NW;AF]8^+?@I>4,CZ:@MKTFA6# '=!A.TM L
M(&9\WS^(.4 2Z'F]_0A_ I3U+-HOS1S NZ^=.2#ITZ>7?M8;W+1ITZ)%BW;J
MU$D*/(LY$!VIJG7KUC ]4(B\/M>2RJWT$LQ!UG)\]]UW<%=@;@T'XKE]C>HU
M[-$&AYJU'.P)[Y T^E9+=>: !P"% T2\O+P^^N@C/#78:Z%9J!FP@E8 =&1O
M@[RXE=7DX :Z@F(8#B L+"P,2 VV>*!DRI0I #Y^A4Z MP TF3)E H[3%1@%
MO!T8@9J!P$ V%-:4I?-3GSY]]NS90U>C%6+UA#H:27E^DKRN\GX76P,.5J]>
M'0R'K0$UN+O,-O OC02\PL= 8#2#^\HZ;]D2+;,-LNA<AAO'"!R1+=$\SG(E
MT@ :@QU);B6J\O#PD :_7>&YTJ1)@R?75&II&:#4%# WR#AQ*MBUBCDX.3E)
MNA[IS!6&3$KCS,>$@T>#@H*$!*(;* !D R^*OLF^6X:>:QENE!8K[M>O'TK5
MM6M7$*1D946?A9 \4:>5&3,IT3/RMA[-E(5MFGI[S>CKDUHT!A62=4$@%2ZG
M,5@]^L,0H[<0_J%#AZ+8W'W#A@W[5#98(/@NE6@(9:"I8K/P!UR'^$9?7U\N
M1,F%4:-:^I9H.H<8IT_$K5=[&/![7(*2PZB+%"D"],<K\FBX+[KE]NW;D'.\
MUL"! [DOOH+.E$D)C(*:I3-Y"MI/OZ'#-!YUI=F8Q@<??%"F3!FNQ8= X+$1
M[F7R/0X.>"0:GS]__FK5JM6N79M_\^7+!T,F<, Z2I0H4:5*%7 \Q<J7+T\Q
M:N-+'!$4'>9639T16:E2);[D,T]A:VN+#^0;W#(XAP?!*K%0BNG' 7&A+"_D
M7SYS+??B$LI3DB\+%RX,)8:5R8XX$=G.)/.?#.B[TZ.?)0ES#M?W#&]M6[)&
M^_E'$G8<O![FH,7%QIB.G[>0)^95(!>6]/RQW8)H[=YJG\'^@S;&IQ-)H;QC
M#O&B,P>L$>-D@/.\#2E4J!"NI[ 20)5DF7P5X4%2M-8\>4G,'#25]4A_$?+:
M13_/X=5%-UJPA94Z:-F(($6,^VO_YLSAO??>LVR]$EE!J_W]F,.WWWYKV58E
MDMU/2XHY,%[@0O"HCX\/45]?B"42\S1SP"]ER) AS_.8 _ BX=Y65O?NW0/9
M'#IT:)_*="["..K_BH@FI#)S,*Y68K@)_PE%E: /Q'A9F0WRDV4A@J<!,41W
M'ADLPF>4 8S%X_,!BHZ7 ]-P+\(\( 8,],TWWX!I^$R;2Y8L"8R@/!"'X4#Q
MZ%NX4\:,&5>K8Z<" @)PDC@HXASP5+ 1(!742%4;-VZ4U>2H-P,$VB!>H G9
MLF4#/]&3W!?$ Q5D3*$0/*8H&WVU2!V%JSV=28GZ]2W1@,LP)3(*PF&X7':I
M A:]O;UE9]3;%3 K9$]2%,"^DMP&\^:$L4B2-FAFYC!*)?LV;4-?L9S_8A1M
MV[%SY\R9,Z[?,/4YMA82$BSSR8\>F8X:6+]^773T(P8=<UBX:.'%"Q?0"N@'
MPT=0 %@#W]&?08,&P75A$59J9B-.B>Q"EMD&<#\*($H;$1%!%\G(8LY&VK!#
MG1@HM &F ="7J8_(R$@>#9Z MH!9N1'\%@V!;6*&C#ZJ19R"$G-'5!'X3E7]
M^_?G>P'6B*NKJYZD"PXCVPD@WHP:P!V=APZAZE@?2@40I[OX'@,$Y=-"[ [-
MQRJA[K2Y0X<.+BXNW!$E!$X)<SY]^C0,RLC!Y/L8=58&[8==\%P\"^VG#2@M
MYD^0*E"@ %WGYN9&[ ."TYFX)GH5$\"0/_[X8YX"C8*76JG#'V%!DDP/\R06
MBX_Z_/// ?K8\H<??DBDHTX,4PY/E&)$-SY_^>67<!(Y%$C.6Z1+(3/\F35K
MUB9-FM >/G_]]=>XD;9MV\(,\0;T#V/=7@F?Z02H!?7+>P$<BS#\=Y)8]!W2
MM_9O6#@?#SEK[HX$C/&:F,-SY&)8WVQ=EC[1(L)</?KW66W*69%R><<<XD5G
M#K@)W"61[^X_7T!%&+/Q/?HKBI.3$WX!Y'K.+-0_8L2(T6J/W9N0-\$<8M1B
M;D@";AV8)<NK<,<'5.8-O?P;8@Y$"X$1#1HT>#GF(#"+B"O$0-I/F)2M(/K>
M]+\;<Z!"HJR#@X.F5CZ "8A)A!R]@#"'5JU::6H!0'AX.&')T]/SR)$C24Z^
M63 '(I^5RJY[_?IU>IA_@:H XLN7+_,G%?[RRR]Z,5WNQF=E?2%)9>:P7B5)
MY .(!"A@I?"$_JNF#AZ1!8U"&Q"!W> Y<#_EZ6UP'A8$($#_&4%,F-I #P!Z
MU .H#88#%<$$0# 818X<.2 &&#6(D)+8!9 +7(A*X$EX3/ <R  G:6MK"QX2
MN,#839TZ%91#MV.S0#<:QE6@%GV? X*CX*9 D-FS9P.G9 &WIO9G@SY1#QEH
MV=M@I WRMI@1AS,L-9_+*[1!EN+P"&-4;B7<>(KZ_ T)P!&@)B]? 6?ZN0JI
M(_3#-K6)/+$(<Y@6',SGT%DS)TP)N7OGYLW+U]:L7S]R\, C)_^/O7.!J_G^
M_WB;&?O;,&/#;.YCF"&6F,OFKA&YRZ6DHJM"E%9NY5I4[B)WDGM%;KE?:VYS
M3^4ZUS#*7>?_/-^WOH[391G#;^N]Q\-.YWR^G^_G\_Z\+Z_7]_NY7+R7<O/$
MB5-3IP1&1D;=2+I^-CX^9,ZBL&5AE\^?_R/I[C<5*RY8LO3XX:-KPL-/GC@A
M"#XN+H[1'S)D" ;)2.&P!"N#M/,<MNCLI,1H!L^:??Z"%D\GIZ0P?%Y>OS+Z
M3QX_WKAI$P2#3_QTY/"AQ8L6RDY<."\,1!Z($#0(=#*^]!%K!+7+Y+33R@EK
M, %L@_: R&?.G(GF6[9L.7[\>, ZN(760H:)HD)(:(SZMD&F^8DUXG=@XK%C
MQY+IL"ON@@?!$ZI4J8)[,J9GE27X6#YXVM[>WMK:&M/%>1V5XQ<!XL.'#Z<!
MZOKR!6D[*1'W*(FIJP9,A?)6C;;!3$@BF'&^?/G<W=WE/16Z(;R0*7 -/N.D
MLY3%;'R&%!'DY6T\3:6_> ??TQ=<+S0T]+OOOB/=H!G91X$(3#%T+J^;@ ?H
M4/9K(HEP%RY_H)S0EYB8R"4X8/WZ]=$;2E;]E+"\4CE+6Z,LM.!&N#Q*0,G2
M*<9:!BY'THL*0I(38Y;/GSY]YLS5AYZ]0M>\,>80Z5&BPYBM,5'CNEKT[.$?
MM6__KEV[#YR]]1(K4W.8@RKOR&REURX$D=?('(BG*N32E>+%B^L7?4WR3S '
M$:*J0!.1NG7KZCGM/\$<"+AY\^9%8T1\@/[?8PXBX\:-&S9LF/HGR4DPMRI_
MFSET[MSYGV .&F5AC+I>A22*'G0W'68X^(8"J,73TY,.RGR&S$2/.?P]>9>9
M PA,'OK:VMI^_/''W!IP]KRT<@KXZ-&C-<K.;&!Q,6^,$&-@O/[O__ZO:M6J
M>- .Y<190)6'AP>#"Z'Z\LLOJ0H0(W.$-F_>[.WMC<%CG')XLU@RV +OPZY*
MERX-=0'-@/5!7302*@). D-HE$6TNM@(_ $B :N!L0P-#4DP0"+<K6'#AJ Q
MV4E&UGVJ.RG1 !HC'/C0H4/0!G$]L!TV+R!8-J*!-J0JL^%!J.I""XJA:I 3
M]X518V;/%/3V!%2'O] \4!2@ZDUB*?(7L$_O!9TJPAR"9X7LBIK^4X$O#-MY
M!8]S*F50X(<F9LZ]NKE-7!$TN(G!QU^9F-2M8UBGM76?6J6_,C1N8=6G;_?N
M5JU[>A?^NG03\X%#!XS?>>+XSNW; <' ?5=7U^[=NV,YO7KUXC,1(S PD+ML
M5M;7,B[2&#@ >#KA])&SA_9NW7=L1M"$_@[.;FX>U#!MSOS)4P+V[(R)OWQY
MW<J5;NX^"=>T&@/"@J2%-E )3!6'>JH(EL!/EI:6^ C:QFAE3;\LT%>M44PQ
M*2D)U@UN@=!2&[X X ;URFX!?RI+HL4:96U#F+)C6)\^?6"Y P8,P,'Q00@P
MM<G:!BZ9/W\^,1POH %X%DY!1WKTZ$$> =]O4DXV@!6@#=F73&C#^K13HJ$*
M4&*A#32#<%VS9DW<"EI..Z.5?0OIIKSEDQ>)N 8WDC;3!951TQCZ(MOI"M.P
ML+"@_GKUZO$E'2=* /5@,I@B28&K4E)2Y'4''<>_Z#NA'E:V5MF)%<42-^@"
M-@PNXJ8:)=YB/+B\&F=D,B&.2?:4%WW8'A'CU6<O_UM%#X3HR0O,X<'M\_$G
M?C]Z])A6CI\X<?+DB>/*YV/'CA[]_53\U;0#&C*2U/O73T8MGC%NM*]?T(+H
M(Y=T;YFT:\J/1C6^_[Z:=EJ+8?5JWW]?I?H/;0)WZV>U+"6'.6B%T<+92#FD
MG_\@<Y"I!80>V:B!T$ ^(&1CHG*D"_F/N  .($QGN$RS0($"@)B C(10I4Y,
MSU!  Y31O03(.$81@JGL)Z-_S=^2=X$Y$*QEEA$0BE3T#C(',A\(KW#APEQ.
M9FK6K!F#3C(8/'@P>4B_=);RLLR!!,9]Z]>O#]3(SNP.1O.SSSZSLK)R=G:6
M5^<(G\GW9'3U2S[8*J);#(Q.O_+GS_]2A_V]8>: ^<D*3NZ;+U\^@W3,8<J4
M*5 L@!'^*ZTZK&P\=4,1Z!^JD)F$N+ X6J-&C>SL[# ,P*4@>.(YZ$&ZAH]
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MN[3QO:SZT"@OJ<:,&<,0TUH4B])P;6J#=3 T@ =ZBFEIE$4=1"$UN>=(>E%
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M9[@\E,9,4T0MAEU!=U]J"I;*'+(IV;1,C;)H>.7*E6C#UM:6#R1UF@<<05=
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MJE0! N)*\I)07%N= "T/".02OMRX<:.$+\8Q(B)"N#UH0UY0:!1L@7>##_B
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M/7GBD"X]W(-&C_*>,=[=+VK_XB&.XZ<&S=MX]/B!V?U[# PYDMEKJM<BPAP
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M/  H )V2J MD3'N"%(&.TF8^$'RLK*S@)V!6>#+>!W,@1A&ZJ8%!!^@#:OF
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M!0KDS9NW=NW::C;BCK*Z5*/H&> EV$*@(78(!J(\P!1L+0A@C[*AOCQ2Q;D
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M<^?&T31*I*).QD)H Z[!( KL%@X@^0P/!6-MW[Y=:,..'3N 4(+4X0- $YG
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M5,<A9._=>^=F6=:OTW[ E*F^W3HZS5J]R/%[P\8V,TZ_SO=.^J+'' C'Y!Y
MZMBQ8T'J!O\\<UBD[(-!0"]5JI1@M<P$:$6,P]GDT4[6\E:8 UPK+BXN_D6A
M6F]O;X,WN,XA.3F9-#E@P !/3T\B?A8OE^6= R0!3$ [;6UMR<WD2)J=H)S5
MK7]!YO+O8PY067#,L6/'P.C8)]%3!A1X+=!<3UZ1.90K5T[ =.7*E6$.1&H,
M1D #EB:X4),V-5GP-+^&AX<3HDGPD&V .[E9LA= !- @H(=Q!&_)@DCP#4Q#
M,)-&>2D!:I?$3&%@0;P"=' Q8(J<<8N@![HFB(%&SIX]6QK#OWQ6'8$L7J-&
M#9@#L(,60@G$5;&E)6DG3]V\>9,[RD--4 L0BO9(,8 :M4EC, ^Z*>\TZ!$(
M@YI=7%S 9. ,U"4[XJO,X0VL<P!PJ K1$YI'^)+GLNF%;NKZ\C\DV!+#,63(
M$!J#/F6WJW>$.>@*XT5D9DRQ!X(P1BZKI6DJ5HJB)DV:Q)]0 M Y484$C9'C
M=%N4O8.!X,2H<<JYU]@;EX .^1*3HP88B*NKJYN;&_@;M@^1D'=6Y"E9X< =
M^8;Z"8QD$WI$Y&S>O#G^@M(P14R+\2)> 9?5MPTHEGN)!Q%.L4SX-B$(Q*Q+
M[P6IRQLVV4%$7GUP.:;[Y9=?YL^?7PZKIIBZ[(?:A%&C$Y@&+L!]Q=K5E"%/
M!(1=3YX\&=R"[]^^>2-^XY1? R8,&C9JU""G'NV&1)[Z ]W2(Y(%CKP@;7TV
M3:7O$'XZ6*5*%>)\V[9M!;6C!+0J' :%DQEEJA7#Q+]X&42%$9%7A7BQ^)VN
M,#3Z+#8CH0:Y"V8)19%O)#<]55;+9"84EIE"=)]+Y,M+:3M6TT'U2SV1)>]2
M3'VF0&%18]8W%>$J- _AU$$+#^,VS[1N;]JQ=4O'9<\/K>=>, >I615U5]:K
MOQ_^_?2YV]<.K-O['/GH,X>?["9&Q_UY+^7AS5.3;6TZVH>=2[EW]^Z=JR<C
M'+LV^W5'!M,@T^1)RHVS>];,'FA>_ZL21MT&35RY_=BM1YD^8TZ,\JEFYN0_
M>_G);*?W'.;P3-X2<WB<N&>.=9<!GGWM1RY8NWF.KZN+A>%/+=U"5LU8MOZW
MV(/1$;/<3,T]AKGT]IP0ONO4I9,KNE5I835PZM$7K/$U2WKF(,@#R 7:-OCG
MF8.$MC/*WDJ??/()_X*_N745'0%+\3W0D*!/"\D3L@MU%O)6F,/;W5L)T$#D
MDFWCR9WD.;V'0^DEB]E*+RO_2N9 ITCV7-BK5R\96?X%B.S;MV^OCI!-,4BZ
M#W[5KR5ST64.0/.B18L"J3%+/N3*E0O\3>.Y%[C$V=F9!,]G<O_PX</Q GX"
M*$^9,H5Q!\20WDJ6+#EZ]&C"-<7 6$0VL#ZT!X0$<5VB'$0%!<(4J8'V\].Z
M=>LP*H:)S_2"SS ',#TU \N GM( H,S8L6/!$Q2+B(C M" >?.9>'AX>("K*
M4'*V<D1N]>K5FS9M"F[C$D 5Q= )-7.A- ;D-&?.'"[!?<! 0FYE<38V#YKA
M)RZDD4N7+N6S;"0%EFK4J)&3DY., M?*^Y-WA#G00HQ$'B>GES?&'  ZZJ0=
MT/:[\\[A+P74#O;"W<#'= 1K <5B@<2]4:-&$?/I"%9-&>(&?!+;D\?V$ Q,
M&F/C7Y2,W?(OE'75JE7\!%P>-.C_V?L.@"JN_&N3;=]N_MEDTY.--7&3J)O$
M-$MBC;J6V'OOJ @(B"!-J0+200%I(DUZD0X"4D2J]"*]2^^]O>^\N3 \!AZ"
M8I^S&YPW<^?.G5M^OW/F-BE!04'8_S5KUFS:M GM0EA8&*88K0;UT-[>'G^G
M3Y\.:XDFAI]D,@ :!>@RX9T@J:C;Y-W!?5%1HZGY#T@MO 92170O(J2G1".=
M> O"MHEN/WKT*+P;' 222B]=@(?B%8JI:4MP3S@F=1@Z!.H(K0F/0!I@7E":
MA)7B]144%* K%BU:!$_Z]5=?S5\P_]???OOIIY]FSOS/O'GSX-IP'O()^4,2
M@]=!K4!;@Q'&<^$=D$O(6!@-M!J\/DD,THR[X [P(J1S XT1>8*ZC7<AT@B9
M,RXO^0H K095B,=W][96EZ2GQ'D9REV-Y':Z$J" 4"Z,H:V#,Z3K"T*\':UM
M7>[F#K;!(<JA)'COREG_>/O=#_KQ_OOO#QR]\W__FKM*-Y;?:(O&*#.))3_,
M_7F3M)V5ZI*%%X+*AO1[#$=O5W--8UM/3_?89TJSRJ$?STLY/,R+<@LOXS1G
MN]E=T]*T]78SU;KF&'HGRC<ZI;"DBKO9^/6 \M[6!_=\S=1U7$.]KWM&)WB[
M)X]9&CX&&,HAF)J)Q:$&)Y EY)ZV<H!])VLKP:K"LD_B,\\!Y\E(8H0$0Z)W
M@.*'UTTY( !H.ID\2K[4C@6L<A@%1#F0[9P!>$T.E6PP )C$-3Q8OW[]-]]\
M@S!1U':V8P2O<H 7?_/--\'^/_[X8U3=&3-F0"WCC7#\]==?@RB@?GY+ =2<
M/OZ> @X0&#?^^../Y#PP_):O*""=R#0T!T8PG,$QB0W'<RF08YS$I?YXA]Y"
M5CHBZ?R&PKIUZU"I< :7R!.!;ZFDTC'3QS@@:<,Q_C+2S B& ]1/T!JPJU0*
MO/,<GJ-R0,U$ZWOGG7>@=H;/BN$\0^504E)B;6T--P^GEI>7!T,**DRNON#*
M@1<H4-CJ5&H3.@@ O!=4!/["LNGHZ*#$\8ZXA.(N*"C(S,Q$(PVC%O*"\(8W
M 34',P;O)[.-08)Q'O37V-@8)G3OWKUH)B!MNW;M.GSX, S4L6/'T.X@-I!=
M,.G(,2AJ%1458JY!Z\'[R8>J1FJ1,;*2$H=2K?1\)Z2!_L"/5"&W26\#SB !
MB &Y!WNU9\\>R ;2JT9Z&WBG_212:Q.WM+2@,D/M3)X\&:8&% 4/(CH9?A.Z
MA1YSB'22'H!>:OFR@(  TD4)UX;7(;TE2#]R#R^+#$0]=* V=B3:#)F)AQ+9
M@)+%BQ\Z=.C(D2/(/;PF9 ,D*.Y%MI-:5$R-B'O"6O0R GS#W-Q\X%='3N@-
MR6,'SQD%5_&T=0D)";+>%R]H$M+;T5Q97I@29J#M,=B">)5#7U-I7+B_ES=W
MV!L3/MY>01%9%7ST0&^%\[GUW_^^7\'4,RG,<LTR]8AA(?NZZQ+][=0ORDC*
M7M2S"\IM'/=D658Y].,Y*8?' 6S4HSX</Q$8RB$I*8GT#,+>$<[TM)7#=3YK
M*W5W-):55393C9,H![(3'%P%##&_14YHO#[* 44&O[ASYTXXF]+2TD?V,_""
M50ZC@*$<EB]?3L8 @. R@U*==9.>0#D4%17!%L%AQ\?'@_K TY-1];$44+ZZ
M%.#LR0'O3ST]/7!6L':0JN'!R*12Q!!' ;$A6A,3$W*>-]B(QPS0EW2H79Q)
MG"1:  <Q,3'(!'),</_^?4='1]"1H3&-#ZC_($8H]-M#@?=Z[LH!+TM&F  C
M!G@VR@$L&3Q;3DZ.GC8M*2EI,[!IUTND'!@@@UO JN%K(B(BR$QK,'M]?7U4
M8RLK*[04* <T'%0 U&W\18D$!P?;V=FAYH#VJ:JJHJ[B]9N:FN!H8#!16W!&
M1$0$'F?APH7P+-#_"@H*,*JPHFB5.(]Z5596!GM(/ 48-F@T660,0/P7+UXD
M\QSP. 2C90.$#<DH/!&&&LT!SA26"BY#6UN;# &%%[,=V$"=Z %ZM0!P>M!%
M)&/1HD4'#AS 0_%32DH*X<%?B7-$)"AKY 9G8*%DT%8R6( T-[+   @?2#\R
M!,]%JCP]/1$;<@SB! =X**D22"WR"HG9NG4K3L)/X2=,"EX0%@^Y1S9P0.M#
M)*-LF?RJ C8?\G*480ZP#,>/'R<+T_%B4#F41JI+"FS9M<<D?I!CC+B']/C1
MUU93&.EB*'[\R-'=*SY\;Y&HB>^#RN9!<=!5$:Q[>NO6W3OW'Q$XNG_[KAW[
MCEY)KAFD1F,!JQSZ\=R5 ZS>IDT;!^85X>\V NZ/;=NV4@>EU-C'IPV&<@ A
M(),@T]+2OOWVVTF/4@Z^U\Z=/7-&P2S(RTYAP\%+_C&1YBINR85I-O(BHMJN
M44$V,@+[S^H;W; (28IQN:)Q\=@NM0\^F%Y3PQWQ3,!/.=07!4KNV"9K>:>^
MNW\_!T),08_ 3NC;^>&55PZ"U*9(IT^?1I'!C<&UP-;3 <8(>+X]>_9,G3J5
M50[#P5 .!(CPQQ]_9 9]8N7 H58'(O/P-#0T#AX\R.NH$#F9)#HB$!Y\\>NO
MOT9-8%ZC@'NA+NC8.-3G4AA 9KCQ '&"M?/&.0I0/U%[F5&,![A]1,_]W$<K
M@769F9F1*1PPE2!M9/ )+YZ9<H!%RN(!Z"D90,]YF94##10TB'4UM4<UW!/:
M)L0DQ .4-OZB*8$3XS5!J5$9P%L0("<G)S\_W\_/CW08\@+V!&T99!I- ZX-
MQA.6$%1GU:I5FS=O?N^]]\AL 31)V,:.C@XG)R?B=WJIU53Q"%S"+<AG7**G
M1*.@23V$2@'/]O?WQ[U(&(P&GD)Z&% NH.:DGI M38AL@ ;PX&[(P+4#*U:L
M0#+P@F#Y>")9FO;GGW_&>7EY>3A!,K\9" D)P0O2L@$&G#BR FI9)SP1#>?(
MD2.0 7!#4)*P+>[N[O18+.0/TDGF$IPX<0)U&(]#@T6<H:&AT)]HZ:27 XG!
MZY /BZ\;(,"0AV0<( ,HN\.'#]\>:9PJSPSIFONA;E>N.J?R= @,40[5<4J*
MUV_SC&4:+_HZ6XK2PNV,U,6/[]^V^[1[;O\,Z=I[5WY;)^&36TN*K:,VTUQP
M^Z9K"2/0%/Y@E4,_:.6 OV2DP7]' NED'P[2APZ N'P]#"0VA $99=[Y_???
M47CKK;<@^E'GX@'RS2XN+CZ!>X@3,$:P7Y,G3Z8?-$;@T6O6K&&^[:A@* <8
M%#)J$VG#VTUZE'+P5%K[]:_+#LI::8O.G_3%QDNZ<EN6K#@F>>Z<UA4M?9TK
M"D>_?__C]>+B.R;//R"AZNAD96#A\:]IWU97<;^($,"JTLH!-6W2@')H*0H0
M6C3[#YF;I6@"O5SE@#Q)3T]'^+&XP%=;.5A:6LZ9,P<N$VZ#.(#A:RN-#I+.
M0X<.(6$H4')RPI7#UJU;.923ALN?])(K!Z@@_"PK*YL[=RXSZ 0I![+H!XI5
M3$P,SIN^A,@A#R[S >H&V4\ =8!YC0+N':X<0,>9X<8#Q#DNY:"LK,R,8CP
ML7L1E .,,VJRM+0TZH:WMS<<*L@9F5-.@#,@9XSA@L]&.5R[=HUYB@>O@')@
M@%@5^ ZH(W#Q.W?ND&5;\:;@Y6055[0O:#F<@5GC=0<$,/@H1#)- K? ]^'8
MEMJB3E55%31:0$  !FKY\N4[=NQ &!!'/)$,(>%0*XQ!#^"8]#:4EI8:&QL3
M;=G<W'S]^G5?:B=$^)WSY\]_^NFGI'["[^!91-&1M96);,#KN+FYH:7@EO;V
M=EA[/!V/X%"*%%&!J(#TPPI!KNS;MP]L%8H%MR#9>#M0?_![))ZX.=1#Z $R
MI1O/Q2UR<G*HM)]\\@G>"'8>&H SL T+T3"PJ+ 2>$$(&"B0^OIZ"!@8(A@?
M,L7"Q<6%+,SP&@)&!ID,?@*SB;Q%&:%1HRA!(.'C^"V,09.0GMJ\,*\;!EH&
M/AF#0\^'*(<"MY6_"5Z+&?RB.@[T=3=4E994<LNHISCVEE_(W9CH[&HRE*HW
MV>+  NTA7JDF7&O^AAN#HS[& %8Y](,H![0*24E)-,ZFIJ;:84#+@4N /:*'
MU1* +Y:7E^,6W BN +(R,*F%"_S$29B#JJHJ,"<R=Y#W7AA?U#ED:6(B92\>
M9H0&.+LYVZN<$9<2$10^;T\FW<!4P1>.F#!^@/V"^8!X&/JNCP!#.>CKZY,^
M!R05W'32,.4 T_;NN^_25,Q#_:15L(^)G*65Q051)15Q886KEGJBFP^>$#I]
MZJ+T977-RTH*>C=TI15UKREI1\3=#4_-^/2;GZJHOE0"NL,4L4%03:+G.?3U
M=+:WM7=V]U%6]<TWWX2.@C_@MZ0Z Z^><E!04(#!"@H*DI657;UZ-:P_3_"Q
M*@?D"72I&[40X=Z]>Y&E[[__/C@WN3JQR@$-A$0.O//..Y.H\6;PJ63-"C2-
M24^@'.#R/_[XX]FS9],!ABN'O_[UKU!6]"V3QJ\<X$$___QSM&O4>5 !#N7%
MGY)R:*. @Q]^^ %E[49-4N10+.3JU:NP)Y5\  T&VX(JC9#,:Q1P+VH@\KR>
M H*!&X&[,,.-![ ;4 X-#0TDSE& E\*[W+MW#S:*&<O8@$@0 Y@-4LX;,YX.
MKE9+K;:$^C"\/4XLH!R0SY! 4-JHBC-FS)"1D2$#3GB!,."L:.RPWN0#[?-5
M#FCRR)\G'Z'^HBD'!GJH+9E1*R#;4%)@Y\@0D%UG9V<M+2T0/EA(5'LRGZ&>
M:@6HF3#7#@X.:!UH8E =9&$ M$H<X'9'"K@$PR@E)77HT"&T,C!X,S,SN"$8
M!%@\(AM02Y'#9%M#Y/-U:B,VTI$+_KUHT:)9LV;A<<A &VK_:0XE&W!,W!E9
MRHS^6 "= *Z/2$Z=.@6RC@28FYM/G3H57!/)V[!A ZPWGHM'0"I .4R9,F7%
MBA5P&;"!!PX<@,@1$1'Q\O(Z<^8,&BG\Q<6+%^$Z8>U!<W&5[%@'.HAHR2)%
MJ*O@0GAEI!DQ>U-;H4.N(P8\D:06 HSTF;RV@ E%?F[9LF7-FC6@<#MW[K2R
MLJH=MG4TC4$2TMM>GNPJL5W(-GDP,&-MI94K):P2'S$&>R3T5<=;;E[YAX@C
M-ZKZ:),U_UUTTB",NX@5A1SG,W-%77@69NK-N"GYRTEW?A.N1P2K'+B 'P5Y
M(KV3*'NBRT<$K PO[:!!]#H\!+@%\QX.!V0(Y@;&!627>>>D263O&%0^,AV*
M4U<8?3<HOK X[*;L^N_WR"@YD][E[=NW#^\9?R1@#9]0.<!DD+H.RO7IIY\B
MP>[N[A$1$>"%!P\>9+[,I$EW;G/W3>SIZ.!P5?@@:X;)),<PZ&3@?2^7_'']
MZ'???U_!,\\!9KJ6FB']Y9=?PB9.XC-#^D]_^M.T:=/HT9R/Q"NF'.#)X!+4
MU-3DY.1@ZR%-AZ^M]$CE +*.8/OW[T?E!P]#/(RNYXE5#KR8/GWZ)Y]\0NH,
MY 2]#?EC*P<"L+>8F!CX9KS.Y,F3P>]AK_ 3;0<%R@@\:?S* 7[]].G30D)"
M_:V5<AY/23F@E9%90X@*])16#BAKE+X-?Q#V@!KNY.3$O#8 LN2E]0#(SR<$
M(J$C'!VV%)CWCP?D=F:\UM;(&6LJ?M"^I_U!%*4#;D?ZLO[QCW] 3X*5,@-1
M@*2![P#3"@T-S:$P]OZ9QP8_Y4"^)2.+R">AQ\8+KAR&H[.S$R8N/CX>[AB-
M"%X;A4)V)]#6UD:)X.3MV[=!J>$+H#<@;A$&8@,U"AH##!LM$:P=J@.F&.=Q
M.P*#A<,(BXF)P<5 Y",DXA$6%L9?F!<X$01#58$CZ*-VU,&SEBQ9<NS8L?3T
M=#)\B$.1$#0?8E6@ZSP]/4EO PPR+!BJ^JI5JU"EH4L1FZ*B(HSGVV^_C:=
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M_A!DOH"  )+GY.0$.W/X\&&B =JHK4Z@%I 8"0D)<7%QA"?#YQJIE:#@."
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M)BNX8]XO?XCIA-0-TI">A_=]+:ZZ%U0^N"RZ#3SGM[V&:<WCDP^L<N""5SE
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M4]I#>OKTZ9:6EM840.Y!Z,W-S9%:7U_?&S=NS)T[%XQ!65G9S<W-T],S("
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M#S^</'GRU*E3MV[=>I@"I(N @ #X$Z0"_B*\N[M[4%!02DJ*I:6EKZ\O[^-
MK$$I<  A86IJ"IK+>Y6<AUJ@?^KHZ(#@\EP? 0SE #9/YCEX>WN#Q#^V<D#.
M0(%45565E)00_NWEY06U8V5EA;=X__WWH8NF3Y\^8\:,9<N6+5JT:.G2I:=/
MGSYSYLR5*U=L;6W!7Q$SO#L4 H[!VI$54%"X=/WZ=0T-#10<["]R&(987U\?
M=^'%=^S8L67+%B$A(7"1@(  9"-BP'/Q+F3F0UU='9)$UB!'3D+1N;JZ0@S@
M@"RQBO#@\7@02B$J*@JY!_U Y &\RR-ZKA\7K')@P< PY4 -?>A?$*.;ZFON
MZ^GMZNKC]'5UH:WU]7:2E3BXPR9&0&][!]-3O#C* :T,EN3@P8.'GBWP1+2[
MVEI^+IG%:*!&*\5P.$U)$4'.5H$9A26=G):4@+#["?<2'V0D9157MG34MG2W
M%<;>IX9V]U86%^;%^86&A,5F9,0$NWIX>GBX^20^;*G+\ ])2 RY$Y]7V @>
M]+Q&*W'['-K2XWRM'%U\HPJJ$R-C,V.]O;U<K5W\8W*::[."[\3&1MT)C\^M
MKFCEM#4TM#?E1B937X7[RM(+<^X&WKX;Y.GFXAL:DYH4'>COXX__WXDKJ2I/
MC/1Q=;"Z&55,EI]EE</K@\']'&JR CQ=W#P]P[/YS) N\EZS8/4VL4M734Q,
M#2_M7O+;W.4G-8U-C(V,])1/+UVZZ$+DX 2)(>@NN2&R1CJBI37&1EKW>B9J
M9&?US0L;1'W[.S=J8\S7K5VS=MWJ52N6+UO^^ZK_K5FY\O=-E\-'6-&%/UCE
MP 6M',#80#=!K_4&8&!@ .Y>7,S]-L  &&1N;JZ2DI*BHN*E2Y?4U-1D9&3@
M>^;-F_?!!Q^ !$,/F)B8@->"'(.,@O+*RLHBI*&A(:(%N\49,%0[.SNX*][A
M.N"L$ G#/XJ#N?(./0(V;=H4%A;&H48Z(9UD(P)>@!DO6+" _NGDY,30'L/!
M4 Z@^$0Y@+C_\Y__I)7#B$-N#APXX.CH"+V4GIZ>D)  ?N_L[(PL%145!;,G
M_%Y%14586%A04!!OO7W[=B@EL'SD"4H!0N+JU:O(2;#5LK*RIJ8F6'"R:AB)
M'P>>GIX*"@J("M86?_'6L+P6%A:XQ<?'!Y4S.3G9WMX>2DQ>7A[G0?VY>_3D
MYZ.N(U7W[]]W<W,S-S>'D @-#84V %N-B(A WN( .4]BP"UX38B*CHX.^NG/
M#*QR8,' ",IAHO'B* <6+R,8\QPJXS+S2^JZ6C)=K)WO).9GQ_E:6KMYN=A9
MV_C?3TI(*2J(\79VMK\9D5=3D>9W.Z6H/#4I+2/!\YJ1T<W;D8$N;D$)%93=
M?;[S'"@TE58U]W:UYT=X> 3=C4G,*:]J[VE(][!W"HI,B?&_Z1@:=<_/U>ZZ
M5WQJ<GIQ8;2GHY.];7!.;HK+O:*:JL+["2GI<9[FYM?,+,SMG/RC<ZG)#X-Z
MGE4.KP]HY=!47IP>&1@8E_:P99!=#%$.Y?<4A#;_\O,O\^?/GS=_P>)ERY8O
M^VW!O'G<S65^^>6W7<)V1*4.1U^]O]KN=1)V666590^KVKJ;4ERU=F\\;O=@
M@$]VM[>VMK5U=/;T]G8VEB<$VIP_L'&O?A2[MM*XP:L<Q,7%>?>0)K05A0T^
MC<P"Q0P*"H(80&O_ZJNO9LR8 2;]QAMOO/ONNQ]]]!&J!:BSE)04(>@(B:A
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M;$#[,C<W9SQOL#FPH<R MLK=W1UM,#I6FU?8N2 Y  !V%FLSP7T'MDMR^-Y
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M*!0*6A,]%AT9=)"-UWU]XUH?;8F'AP>JQ5'00EMBV;S]L-GLW_SF-^@#EO#
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M#3% 60)%A:BH*+0FD4A$C^WO[T=EO7% 4IVA[P%ZW>7EY>GI:90-4"1 V8!
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M'=9//$!RV!DR,S.CHJ(LEVY[*![P>+S>WEY'1T=[>WLRF2R5FJZN P
MWQ\L.6C9G7<///_"Y]Z]+!G6:DH.&K5<)D%0G2;C,6O2W7%]D!QV,BJ5&A(2
M,C=GBHG;'X/!*"LK<W9V]O+R&A@8@),,       _)"PYJ+FTUIJBLO8QOL)4
MCV')02U<ZJ\O3,_.+<C/RTE+"/9WSQFS_E,O)(<=(SP\/#\_WW+IMD2GT]%'
M)\2 0J%8-@,     @.^?:28X:TSG')2<CLR0RR?..!&*>X8H8U-S7)GU4?(A
M.>P8@X.#*#RPV6S+ANUD;&S,W]\_,# 0C\?OZ(X9       [G5ERD/,E"J5:
M*9'I!VDU,IUS6![,C E,S,D,NTT8X)HFF=X,DL-.XN+BTM#08+ET>T#!QMW=
MW=75M:*B8GY^'JY- @    #X<6'S.7"F1]MR";B\FBF>E5%91>.UJ:E)8RIM
MJY-7&96/K; 9)(>=I+>W-S P<%MU,A:)1&0R^<Z=.]>N7>OIZ9%()) 9
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M/-U]PR-CHDJGK<\[#,EA!PL(""@J*K)<^C6A!'+SYDT?'Y^2DA+T48!KDP
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MR'2U$F^FH2P[.:60M"C!6DW)02L:;RLC=O<WQKA?N6KK$5FQ",D!      "
MA\<#CJTDGF@(#PRI7V"U>/L6]P^5QWM$D4R#MYJ#Y        , N9)X<5$(>
MF[?A,B0L.2QU$=/PV0R=CC,VR9%PNZM"'2OF3>N9@>0       # +H0E!SZ5
MTDLBC8UT=4SRL%8L.6C9PXGA0<EUDQ*E;(E<$^X<5+=D?6A62 X       #L
M0E@/:<%$:WI\) X7D=6SC+6:]9!6L^FD?$+0G9LW/4+36RE;Y 9(#@
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MV$KU:1DI9+%AJ9S7F>,>,V"\8PDEA]F1\J1 7%1DX:MO'"@HR,>:(#D
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MX%O? T@.X&' KF\@S<SRI@ISBJKCW$/3LD)]7&)+6ZNCWGKCY>>???.\4ZU
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MM&S<R'3.0<8>K"1<^?M7A.YEK!5+#BM]E>F$3..^Z=3"]K+@VU6FCM3F(#F
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MJW5V=C9?1RZ77[]^W7R)5>@3'!T=;;GTFY)()+:VMI9+MX>FIJ;$Q$3+I0
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MJT3CUX\J>JS^>=%VZC\ZZ"YZ==/KZ#\52>C(QZ(C@!X>8;8CJ#7:]#G; BH
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M>&QL++J-DL/UZ]>Q"ML\.3"9S*M7KY:6EF(/Q)B2 X^2&.1JXYXQ2ZX_\@
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MD;!'N^NK:VKKZNNKB]/]/4/+9JQ?*[5%<M#'C!N7'<+"U^:F@.0       #
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M\?(#A61K90:];_/H70B ?&=C?GIR>IE8ZZ>2[<ID4@4ZXKI,J3H\W)=HWOM
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M[.P@$?)@VQC'$ \0%T0@!JH-51C6$$O !')!D3'T@7DO+"S ULK*"K@^1KS
MP$#X&1(20KR5" ,C$1I!F,%@P(?@X& (@&)B\$Q*2H(86H-*I8*"!P4%@<>C
M$8B( MM\+<+#P\'[P=1A"T60#J] UJ$$N:@+*H[*CHR,$ $#S*$9435(PC'\
MHFT1":#%,#A#& Z Z*-9$!4@%R$!<M&&&-O1O,A"!8E&@_/P$W5'U1!1Q,;&
MPAS2B3762$1K=W=WXSBZNKI"%4(.]5>\U/4/XR1RD(C&AP7"J579X<FS3R]'
M#FJY2#BX_ =N^[VTSH$NZ6/8&)MYIS#./;+]SJ^0UD$''73X'B$L+ QS*F90
MS$:8/#!=87+"Q(/9"-,5)BU,S]C%Q(/=&S=NG"W_"LC[BR-,K3T#C*Y>OV84
M&.-U\YQI1*BOP3-/]O@R/]OIIKVSK4<$L[J*D5E>QXP-R>D8[*V-L3!Q]WCN
M&!2:7CX\V5E"K^QLH:87#77EA$7&1B7E%\4]_^SZC5M&YG;A!;SBDHKN[OID
MLX=.GL:>I=-K@B*?WY_[S#P@F=?<49J8P6JNB7-[\+.??V@;XFUV[?Y#TPS-
M5VQT^)8X7![BE\<$&YK<N.&32 ZV]$BLJ"\JJ./7)407#"YO37/I7$$WR<DR
MO(!)#[C['[_]U,(UG99H^:EA:(=(Q'-_>%O/*C8N/LPK,2N_@A%H>N.660:G
MKB Y/#*7$6EIZA;E;77Q471ZFH]_"&]\LLS'^-K#<$Y366),-KLHSN*Y<T!0
MA,^C#RX^LDPNI'L_N.F:U[VO5J]UI=]^]_>WGX57"M<V&L,N?'[UKKE]> RS
MN3C5R]K"D<QFQ7@'%)87%597%Z0X/?WXXRLWG&+"S2X_""D>58I;O?6-O0HX
M%!=S!Q][2^MH;EE!3LUP4X+^[PQM?6+*!B=&*KP>W[YO%L6@Q887-C%3W<S-
M7"B<\AAO__SRDB)>52[)[M'Y<Y?OQG4L3'?Q.]M;V&6\AKIJ:I#M@ZL7[MV\
M^>GUBY_X9G,S(QU2JI85:K5B.,+@SH4/##WL[_Q.WSF)DNQT_[9=8FJ$6WQ!
M7N!G/[OB[AM.9E77U&3]ZH.GW+;&@O#G/S=]]OC\M9"<+)<O;MK$ML@/1Q)M
MS:R#_6P?NR62_#V3\_*S<FDUPH$\7WW78$^SZY]>O>X9%!00'N1A8.,1F\9I
MZTIW?W)-[^'#^[9^KDZQC&P7"VMW\\?W;EFG5Q3'!Z8R\\+N?_(LMVOYVS_)
MKE9CT !'6EM;P_C0U=4%)@V&"LI+)I/!]>/BXC"D@/B"R()/@\J#H1)/&8$$
M@[$A$3PO,S,3I!E$'+0>/+B^OAY,%VH1$H#@8O !!<>X!)V0@38$'C"$8(/@
MZ-#9U]<'0H\  *H@ ^Z+XL331\2J!C!LQ!+$>XK K<&&(8\  _I!CA$G@'S#
M80R#Q/IF& 5?!/$EG,=("+4P!S$P?A272J5@_ $! ="/L 2A#@@ZTI&+LL1K
MD; !BZ@1_$E+2T-U(#PT-(3V@4M@[:@%4HB0IJ&A 3ZC+FA&,'M4UL/# [D$
MF\<@# H[,#  *Y"'%6)1!_$&6SA&! 8HPN%P.CL[$2_!<XSDR((#<!YU1*M&
M1T<CAD'[PQ QYA/W+M!N.(*$.3@&BXA8B&,'NZ>Y]3?'R3J'5^$5D</7X6SD
MD)\G*O>]XT[B-?7<>6P5]Q<2.>P)\[)YDUO'9YUTH,#&T<(Z-C/)WM M)HV1
MG1K@&E$YNB1DT)+);D^< V/" WT]HU,2O?1,?*I&IYIS8ZP,3#QI?/'.##/8
MP=[&]IF]I96+C8F>F:63?VQ:<6L[DTI/#PECMQ1'.7N[VH2F=RXIU(N5=A'E
MM73W.RZ!,9&A/E:FEL\,[EL[1U)+Z21_=P?WY+JAZ18VN[6QR#N>T34PN:)4
MBUK\#?6,;%U<W7TH54-[6WV%=>,3G%0W;T=+%Q?':SZ%S7-S]=E!8=Z>WCZA
M_OZVIM$MLT/Y7N:&)L$%M;45E5R*IYF-6Q"G=X2=XOS4SL$MCIP5F9:5&N(3
M'AX=$N1@:FME8FAEXQ*?&F>K;V1+RL^.B_#WCBMK9"5'EW<-U+.X?;-#U=E5
M+37)Z8S4",.+UXRBR6D^MDX>?LGI\99WG'.:AB<:<_U\?!+(,=://6FEG-R4
M(-?8*M'>9E]S/I6>%Q,528KQ<2-5=/>R,AH7M]K3[?R2!!N'F\)BU^B2PC2'
M1WX)J<%N3LX>%%9E80"%Q<ZP-P^MG_S21]3^U\/'Q^?O_N[O7M?B7_[E7_#[
MVFNOO?'&&_C%285=_&(76?@]3CF="$FB%'Y_\(,??(N/]>B@P]<B(B("LZ9(
M)(J-C<4,1#S<B D&<S,QC&*\QM2"&65F9N8;10[;8^QR!C7>\</'$<R<$)^4
MM!C_ $N?"$I6<GQIWS@K)3 ]P=$NC)X7'Y;=OC#=4,)?6QZJ)P4F%J:Y.T>'
MA$9D%Q32R/%9^93XZ.R,R'A*9EA$1G:8DUM42EIJD'-8)B,UOV6TOYX2F$1+
M>QY8,3+?4QSM'>CKZ!E)34U/BP^-I-+\G+T3\OD[6_SXT,3,W/KY_3^%(.F@
MEH_5IZ;%Q"5%NL<DI8>1: 49J>E)CI9NY )>*Y<23J:$N@6D4E-C0QR?V<?F
MYY;0*8&NL47]\W.U<1&):2G)(7ZAZ5GQ<<GQO@&DN!AZ\_A$![NT@9<4F%I5
M$G+-U"DF+#8\G5;3UDJGI$0&45IFIUJR&"55^9D)]K^]YQ :DL6N2@TFY>8$
M^02G%@O7I&O#3#]?4FQH1$)*<7U^M&=:=A&3%N!G%QZ3PRS-C DN:*IDL'OY
M96FDQ*STL,"LFO(8>W=?+\]X9F-W5PDCMY06ZA6:G)(12[*Y:Q-5F)C$Z)KL
MRP_VAN=IF?2<E"!'[^2\TL;FLF _Q^@86G%95FQ0?G--(9O?49:>2,H@AP=F
M5K*2$AOG%KMK\U)(<<'Q5"8M,B0VUL_-]9FQB:VS4W3EQ#"+7#FSLRW:6NPO
MK."5! 7X^KKX9!?F4;/2 OR2&YLYE)JA25Y*;!X[+S&"7,C,"-<SL8BA%N=&
MACBY&.H;F8=GIOMZQ^44U_8T5!459D4\_M6#>'IIA*U?1D%6> *]=6B"FY-1
MDF5[Y8E+:%Q%+R_QNFL6NR#J:53[6'])5IB7DZ5S<G5_:8Q+1')F>L!G#]P8
MG<M2Z5(SO;*IF>[C'%<EF/]*<O=U4"@48+2'6A!/,X(<8QB12"2()<#:L2O6
M KO$0@(0[J6E)0A@ _(H3O![J-K=W<4VL:H!] Z[$$ 6L=IA0POBN7RU]LM:
M4([ME945;*,4\8P^<:<"(0JRH!->$;:P@5^HA0 DL2O7 I)0B]UU+6"(6'5
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MI24*A8)\YVIJ:H)^+2\OKZ^O#[JVLK(R)I,)O1OT=% $7AH2[0">&6B SI%
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M->2F[O[JW!Q*5WM>PI,45%)^2G1N55-.+I$UKSH= N3"&X#7S1Q<$=(NO!Y
M%WOSYLWL[.S*RDK@#*>+7P%?SAP.U]@5^;&)M1TT?&EF&LKSWIDS=\+SV\=6
M>FG=DTWI63FI3]-3?(+22(2,\(PNGF"P(B<%%7@W(*Z63,;G9)9UT2O3D]'Q
MZ+Q4=%Q2;(C/@T?AF>69J$_NW;WS,#"U-#\]C])(S P/*QT5KW;GIF3DYN-R
M,W-0,5$EU"DJM7]-]V7]CPLNO'G8W;:9-C=TVR<_YVBY[51"<DK=A,@>1NS
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M=JRKHHUB>/KD3@A?+Y"SE>!C#IQUX':[H2$";<!BL< $0!<@Y[0B450J%:)
MZ8!& .: W"V- (RSFS=OAH>'!T)"".$SHZJJZF<_^]FA0X>N7[\.G=9KK[WV
MFR" %SJPS,S,UU]_/3@<H% H$ ?(4"B4:]>NO?'&&Y 5].+!^>^I>6.-I05-
M'<TU5:4UE65%Y0T%2<F1<:=^>;2HO_[Z?QZ[6UE>UM)2%9=259=;,2[<G"[^
MS;\<S\Q,_C"JI'>@XL:9&]D-5871Q>@E*F]YI*JB+"WQVJ'_.EH\QM<0JPX?
M/7(F,B8E[GYF9DKTA7._^5U,3?[EGYTX?S/JYH<?A,5'7_[@R.5.]L[64F?,
MR5_\Z&<_^8^WTG#$X;3W;Q0,8]!M(WW%D8>.OG\J\F[]BFG?JYQ?FNRIKJVH
MJI_CJRCH]%]^]V3=$GDD^>S1,]%8CFBD(/IFWHA*QQX:9[_$8^@.%B;SC4.W
MA[AJ;O_ LHP^6)R7V]397I@8=OS(>[\[=.Q\;FM]?FI).:HT]<R;[YZ*[A7M
M;"FTGWUSNE6^6%XTM#0YT-RVKE7ADR_?STQ)2,XI+FH<&)T7VZ1#ET^<S)CF
MLS%9;QZ.G]E\REVE+@NEJ7'CP3(IFV2X)NU&1&3T[;NQEZ_>R>UF*X,O$'1O
M$8=KFZ;E#J];1T7%1T0DYR3%5A'DCXUD SR.G97F7J[?JK$(YROB$[O9OG-"
M/0;A2&O[.&7+%^/:G6O,N1=YY\J9L)(IP2=TS!XUOKAX2ATDY5%A\^_%--*"
MVII+LC%6UT0\<.6A>VNIKG>4JW[<QC+3*W,'Q-;@Y6$[BR7%8\K'+W/<VR&,
MUK83#S[@BP/H!)&Q=C#C1D='#PQ/();Q[.PL(D,D$A$K'(%8+ ;3']D;;3 8
M(*L#4Q8?#Z <4.+!T,?A?;C*"&A)8V,CD V@-V"20CCT]1#H<#B@4*@>:-$#
M=0-6@,%@D!LJ]OW4 HQ,EA_@!6LA>+H#_D(L< ,@&Z"32202<IC[OO\FV>+B
M8B03!(@,%/<9[N[\,O"0.7@M>K/# NW7KO*O2T408 XV.74&-RNSZJD;XJ?0
M]2"\M,P!] USH'2$*N20B%S)MLKL4$QU=6#FF8R%P3[<,FEYNJNA%[](Y.VJ
M*+B)L=[V*1:3A%Z1ZK5B(DD@IHVV--6T3'%E;*K"9E&QQSOZB1(Y;:1CG,,C
MM%>UCQ-W;)IE3#]FGJN0TB;7A3PBMAF-G>IOJ:II07=U=N$6R03\2%?G_*;>
MH1=-=7:-34ST#_?C6&JS;+VO9VP!/SN%PTWW#<QR- ZC=*:K:VII96YLM*<#
MQ^(1>MO[)O'+,YC^T:E1=!]ZFJ8RJ9F#==4M[5UM[5TS0KW'JE[']G1TM]=6
M57?/$18'N@<PDY/3O8TC&ZHM1M^\4"U>Z6P=(:PLC8SV=L]QK7:CD#I'$XL6
M)KK;L%/HIM[1&;* RV,OD<C+4UW]BUL&BT[*Y]+8'!*;L3+6W3Y!9BQV=?9A
MQ\=&^KI'QD9ZT>B1B<F^KF$B@XK']G5BYQ<Q'7W] Q-DZL8"0ZXU?EPS_/)Q
M\>)%:- !M06.E965P<'!H:&AMK8VT&Z!)@M18(<!;1@>'N[L[/0=-1#4?!D,
M!NBRNW>CKUP]9U+)%S&=:/0 GDIERVUV!6VBKZ.KIZ,.5=W6.SHZU%*#GL!C
M^]']?0M<)9]%6N*J9.L3G2T=4ROX_KKN*2*=QY)J)>M=LSPE>QDW-S\^THVJ
MKFW",O16+8>ETFUOR16[)O%26TOC )[+Y9&7Z)N4:4Q]]?"FT6Z0K'75839(
MA $\:UN_O3K0T8L>QF(Z*JNZIJ<&&]M:>L;G9_N:.G$DE=4BP \-39'HQ(G^
MWL'^[@$\6_4I]'<(7R;H=#HT-F0V'+H]-!J-G!&, +P2B61M;:V_OS\X'(!T
M>QB_#-)?0GN&K (C80BL0LHD=F!DHB\_JW%F=:@H,ROY[+OO_>K4D3-'SKY[
M[(V?__9.8]_0>'=!7&9Q\L6$8::(V)N;TU"16U"0DE@PN333/$%8[4Z\D-R.
M)]&PG=UX7.F]BT=O-[!T>X:5FNMQB6FI"5EE-:CLV[=2<N/"LQM*HBXE9V5E
M)]VY?O/:U9MWHN+:Z*9]M8R!;\ZOKXFY&%^:DYQ05I22$!>55#;>5GP[-3FC
M("6CC600$(=6!BK*!E=6<=,+J]/]#?D%@VLL4G?2G?BLJCFNA+Y&I:ZRU YQ
M3V+-1M#!("\9[&Q<Q?%WDH8)^-;6>8F2UE_9/K+87Y9>"=H>E5'0.TF8K$Y+
M:>@='JR\<2XBLW'IP7#(9X73Q.NKZ&PO2;Z3T$7A$-H3;WYT,JJRHZ*X<X:P
MNJFE]B<EWLELQ^$QC46U4QREP?6$9K'0NU +OKVD/KBTA,Z:S)B(J-24.T=/
M1E2,,!XC&WN\H;+;T0TLL\=K4*[CAI>H2ZVEG>3M@X3$820W5*\@%OR>AM):
MCIH2^LQ3MYI4D9A8/<WW&>QN,PM3>??LR5-GPLOF-S]AAX?7QNEM>(PY>'?P
MS:BL8ER04>]5"]<QW:L'&Y^)A1Z;%Z@>YR9>Q6 55FH++M;!1S>,;S_..SQF
MSAJF;_5S_DK//+,H,&"/C,$C;J0?1$("@8@)_F0^@3D'F\W&Y_-I-!J52@4K
M&>RQP Y@,+(1-VBJX+/=P#I?6EI"1KO!Y@8=%3RK_XD M?;D B>DG@="X&]A
M82'P%F +4*)0*-SWEXY,DCB=SIF9F=K:6F3#!I(*G@L8PO3T-/3O"PL+4'\<
M#@>5A =$!@K!3@7=Z_8#\9+)9)?+!<0)#&7$C60%S %*AQ#$BT"OUX/=#-KX
MP/O\6A!8K:1GS12FY]:AFSMG?4O($ 28@YDSW=K2S-=0$Z*Z-XT?]\6\+,QA
M>[&U<7DSN+EYMB;C/KH<6Y1_YTA4W>0*:6I\=':BI>3LF?PQ"KZON7L -T/
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M3L%@*@P6LU9E=FPKU5J5A+DI4PCE.Y9=K7)GUV2T&F04,FF-PE-N^[K_/;6
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MM4''>H3P_  KA$ZGTV@TY.\!/!;XR/W0]2":[L?#R$\#.H/)8#">3/QDR"<
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M=%SX>.>S7R=ZO9[!8( V;GAX6"02^0Q-GYR@T^G [@>: 5A^OFD,Q_@R &/
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M'JUL_8 #_3P<.J0XO;=+-T]MZY[[>&V*;PB+Q0+L*S:;K=/I@'$&3+KC=2&
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MV'AJE$-(2,C-FS>!5)B;FZ-2J2! (!"D4BF-1@.J8&UM#8_'@X<2C4;O[.R
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M5=L[3!M?H&$J$"W-&9E5'>0Q4LW=WP>$!X9>3^Q9WJ;W,A0.B\$[FM./GZ>
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MS8 /[W<Q1EO3NLB$_DY(;5$=D=(**RR)/A\8<#N^K+,1U8C(N70AO(V]M42
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ME569E6-D9$1F1L8\SQ'&:(2&\SR/.( (B@,**J!,,HDC"@HBJ#@ HH),(I.
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MV5WHXI2T]"8$#$[JJ"QMH'&YI))?'SF?":V$0.O2GE;WH[$C6T[7]BH=T4;
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MN,,]K9",>_<?YT+[>F&U#9#\*@*+VE;3QF A"@OR2VKA50F9A1EY]=U86"E
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M?/0__ELZT:07UEQ.(H.)MR>0T#Z1?E- S+E%?Z<UNN?,P0,(%MG$%Z>EP[G
M=^!5,/(N9K&^<S\",H>.Y5=YXF9F3G(%;54[V9V2@Q [HVO=CU]C#J#?6P>W
MLP+#!WO -5YUJIYA_W%8X;\)+YG#CDYOMCICNUL+JXZ7L6]J2+]\(EZ>&?O!
M.*@A#=J^!XK8?7[,_X6]^GT+]P<>N;<NWW@<W[C],9G#KM=A<?L\VQL+Z]L>
MYZ92J5I;T;G#L9#+LFDP;!D,&NV6W:3?T.@VEB5KZDV3>4NK,9@-&J5&:W9X
M_1YG ) N[MUV!D,>LVI#;_,$?3:33JO1;QET&IUAVV'5;FRHM5K5FE*M-MHM
M)KO3:=QV.$Q:C<ZTO>,)>,Q;VSZ7V;"O2J/9W-IV1O9"=IU6K3,[=DP:Y:;9
MN>/V^@&!@%(-#K_;L>UVF2W.\+M.BAWBCXFHRSC9405KJ2EJ0%8A"40$1?O.
M7T=4TXMJAL.[R.UP:&M[ ZJKN; (!BVKH2WK)B@#<DEG62,=5W.GN:.G!M;4
MUM;>.2H<IZ!J801*<SF,/,0B-Q>7=DV*QUJSTEN98ZAZ*)8RRF)2Y]=6!GM0
M?0Q\>7YY=5T-@C*]LAV-V[A]?*U*3.U$MR)[!1MR-K*+RFZI;,1TU-01:.C2
M1XG'+I^[\,7IQK;NIJ(*'(<$[^SO*7K6(=A\PYOI(7Y^L%@L<_/SXMG9^?GY
MI:5%O?[ Y.8'P4*MS+AQ(R&OHN#J[T_>?5I9G'GARUR"6CV>^LWEQ*RFIG9$
M'7UQG=W3CJG(+"Y..O/DV8-L.+:MX,FUHX^P,AFQK 9>EY-U^]*-&U=N)J?>
M?)CZ[.*1ITV-53=O?76Q8D@U3^GF* S2D;KTQ*1.:L>#4Z>^NI:5FOZP,.5:
M1FG1G1-7'^0@"=1>W.0[W]^'^$/AW5 M"[G<T2%:-QS.6I3WDX?F1E#9E;"2
M[!+\\*K>*F,@:S -:<_*@<$)!2E.STY(;2#0&^#PTO+J*@B"V5/70NBJK.M!
M-<()R,IVD?_P)03 )6\OJ"(L'=B!B6WUUS<@FSFOGMM=__(0JKQEQ/*ZTUNG
ME-U8W2XTO*8S$-2-EE<T\P^<"0&5Y]B$L3<R[P8TTA'&[+_*._=;",PBOVGB
MF%99:9]<I^O4^&?-_9Q1Z*G'Q.<O.?-(0AJTJ[O\3"H!W!2(J=J?IL/[%Y?H
ME4C1 5?9NQ9:VOU>4,]A;P5;">^;!-E/P$1L*BO'XE.>UC)DX.0^I)V!YJ51
M0;=XQK9K'__J>N?^0OT6YNZ%7__/7WSPT0>_?O_;S);9E1'(R??_X;WW/_CD
MJ]O=+SR"AZ8K+[WWWGN__<U'7YTM')#:@!*Z3^8/JVV:\9:[5[Y^[]<?GGU2
M,_Z\ZRSB@B8X=2T T**1FNN/Z<]W _3-ES(Q$X*^C*=T<#CTLO-/_3J+X([$
M#=S6.V<^_L4_';V3C=OP1^T2[,D_^[M???S11Q^^_\'7]8O>5\>5_&+$<03'
MMQ\0-$HQ.;>._/[]#ZX5TH3&ES\(ZUCI?__']W[_^]]_^)OW/LUI%XVWG$_J
MU $MWC7TYF9#>D1SN)1L-KCQLJ<?3VILXX)Z#G'C=-?3VZ=^^>O??7NWB+6V
M\U/X>;W:<S#*F$1,6QMV;.T56068P\K*"G 1C8$*MOL?H!+S/O8O7@:^BMO_
M\SJ $HA$XNW;M\&B]K-'7R_M0)DO\*J"EY<ODQ_X\QP ZU"KU3\:<P 1#P4/
M3,)W(X$=V_8.J""^&X\&W!Z7TQ>*Q\"3X-%XV._S>H& 2#3L]$?BD6 P$@WY
M7"Z7%[B+QWP.@$P$ SZO"]1O#H/ZT<%0P._9<7E]'I?+X_4#-TZWU^MQN[V!
M<-#G\O@"P7 L%O&!I?D];J\K""H[1Y^KB(?<+K?' Z1V>H+1>"04"(:B<:">
M") D'(L$_7Z_+Q")A+U ,K<_$@L%0M%("*C&[]PV;9FL.SLNG\]CM]C<^\7;
M;5:;<\=N<WCV]:[#8)8XJ+@>CH8#7J?=8O&$8O&(U^UV.IPNMV__Q/M>U.>T
M@0T) ,T ]:B] :"L@ \,]05\3KL-^ L4$(Y$@S[W#D"%@*)<H$!.ISL8"0=<
MCFTKT"VA**@K'7#YPZ J-]""4'07(&@.N]/G\_JBL; /K-;M"\=C(8_+#;3;
M9;>[_8!D3KO=Y7$!LKM\?X"G\3\.XD#C@$[UNG8<7N!K_#X+EU'OSK;9:+;:
M=OS1D',':*+;:7> *N' =P9\7VY?-!+P^(.1H->^[0 >M4C O6TV;SMWK$:3
MU>'<L9C,._ZPS^4,A0+ LQ4!OGN?+P3VFG/;;'/XPI%PT!\(A*/QO5C %]K=
M!6L$NAEX/$#=^5C0M;-CMYB!)\#C=0'?D&O;$8J&_2ZW-^3WA6(1X GUA=ZA
MVWV(GP^\8GS5C0=-*XX=/N3)HTS(Y(9QIK?V60E>8?_!G#%JG!+.*60B(KZ]
M&<\9K*YK[D8V,R7633X"BL%AVAM*&[HF!-))'E_"0'5TMK>1\/D%T%Y\,Z0P
M*Z>VB]#6AFNOJVE!02M2BG!+4D9]/0(.ITY0*(,"8DV[4*?DHA$MU9GY=5T4
M;%L+K*RRL;8T_68Y<1"7#VVI*ZS"#XU,S"S-3X$[NX?XMR,>!0UAQ",^F]7N
M!5XS 9\_' KY@WZW;<MH]0 C!_"^BOAWK&:SU>GSVG1ZG67;"0PF'F# \/H"
M<6#L\NQ8+,"H#Z9XW73)GRZB7I-^R^$_N"T6"P O"O]!5Z%QG]UDL+PPT?,2
M$=^.<<OJ??T 03RP8S!8/*^?!8\'_<$W%ZIV@3="(/1FZ+\.5O/6RKI*J]6H
M5M<U.JUJ7:G:4*W)U]5:'0"]5KVVNKZ^KEA1:O1Z'?!O8VUM70FD6%&H-&"*
M%]!NK*^I-%H@@4:E!(H <NMUN@T@X=JZ LB@V2].JUY?7U6IP63JM17YFAI(
MI <J75M97@ A65B4 >6JE?+E1?!^4;JZH=7O5Z!6KDH7%R22A67Y.B"*7@\*
M#%0#5+@J7P;#%:K].O=K48(U B5OK"F4W[5D8W45;-OZV@8@N%X/U+H*-!QL
MDUHA6Y1(EA1@&_5 3ZPL+^V+ PBPHMK/_0* $$JP:4#^S4V]9GT%2+<H6]<"
M-\^EW*]<]EQX0";9JDJYMJ)4/^\ZH/%KZT"7K(-R ]!L '*J03F!2.WZBA1L
MQ<HZV*:WH-5JK=9_UU."+YD#,'8 LXY@Q._UO_KAGSMW[L_^[,_^^L? 7_W5
M7_WYG__YW_S-W[P9\2,!*/S$B1.O&O8]^(',(;B$J43QGVNX@/ JF<^NW"EH
MJH="J718UL6$"Z>*J>I5=OX]5 <3EIB5DWKA0B4%7W\YJXG6"TE'T<C0!_>O
MW6O@&I5CL)+*=EQ'R?V$JWE4S0KIYL=7<BO:N]O*[]U+O'GJRPO7'E?6%U\]
M<CLK,_':A7L(9E_>N6OY+;1!X4A3XN,&-+0@.?/Q%XU+:[)IR=+V[EY$2[O]
M^?D;=Q_<.?=M;I](-8B#-W?PUG7+,Y-+PBF><H[<V C-SD1UHNY?>)*548#M
M0R*H/')]:@T:6Y)T^A__[H.3Y^[#L(U)ES*:*$*M<B3CVM4[3U**BVJP;%EX
MSTI\6H"=UEFU/,:,>A)=<O[C7WV8WKDT2ZXJR;GV^?4GR9V+:OO>GFVLM;84
M@6J'%3\ZETB2K@R4EG90VVNK$+!2")9"KGUTZPET8$[!YRVN4LJ2SGQ;1.VO
MOW+U>G)VYO733_'B%1$FY\+5PG84K*IG9(K8\JBHC8(I26XG#]!FU(J)IJJR
MRHK4^TEMC-;R!TF7CB0U+]E,P[F7S]U\6EA=48'J[.OI@-945)>5)5V[5=$O
M?Y<UAT,<XA!OPS7=!TVKI*EW#/3LNT_RX(/CP@DV6R13:4WV'ZPEM>^]81<T
MUQ:+ ?.42,#O!IAS%%3D=SJ<GD!T%US;"4=CN\_7A/83A_8Y[2YH-2\.>D('
M)C>A"*C4'XN$ VZ 2/M#0,+]U/%(T =JRX&Z^!%@ NL!+:-$ 0(<B\>C?G#U
M(1")'SJ .,0A_M@H*"S\_>\_/'+DR!< ]C]?7N]C_Q+\>!'PXNI BM?"WXS9
MS_E&P(&(UQ)]A]=#7N5[(^CEU1OAST->7;U^^7JN U&O;K^[.Q!T(-WK=V\G
M>A6Z'W$@_L75JX C[RSM5= !?/CAAWEY>6]^>7],_/5W&M+;*V)&;_^D=)0V
M\2X5EY\+?AAS""G1#V^F=0NMKU117%SL^+J<E':SL#;EZ=W,Y$SLM%7)?/S;
M<U]F)";GE%6FI12E9&>79C]..'?G6E95=E9J[K/D1LZ&A-K9SYN@-Z2F0;"C
MRATEY='5;&A]!X6&@61=_\6G5_.STHK@U4GW\BN+"U*?I,+PZ)R$E/HN[AP'
ME9KY(/7K>[7(NMN_R&",LGO[&<OV:$C'>'PVX>JYT^=O)G=.KFL'L)#ZNNYA
M+I.$9P_0B:/4)FACQ?T3%XY?/GXU*2,_ORKWQLVL@IQGE5T=77WS GQ>=GYN
M)7ZHKZV%/CPZI@SY!=T#PSVME$G!V !'OC#>5)>3WC"ZOC+03A@A(XL?/6GH
M0U8\RJVCL%L?W\JK*&QECR\[@NO$)AI_;J NJZ"F@;CF-C J<O/3K]TO0 T/
ML@CC"PHF<7+;I9*P\!1V>UE.<D;'$+D^,2GQ\=/$![?S23.&L%>$8<GG\+E7
M,@O2DK.K2[(>G+EQ,Z>@I)TS,STYP1G!YEX\G9!9<NWAT]S$!S"FSF,>JBJI
M;D<T8UECHYWY><V3<V.=S4.2L;[1=8->O_V#)SU_!.P&-Y>GIV:ELMFIB1F)
MA"^0&M_)96+6%='(P/"BR1?V;(G8K*EEK1^@@A;9 )4V/#X]/35 &5VP^F->
MW=P AS?%GQ9,#/.D"OG4*'MP6*S9LEJ<IDW%PH)DDL8>XRZHU;)QYKA4[PC[
M]!,,UH1@4;DJ8C&G-5LJ(6=X8$RTJC&:':8U(7]R8DRD-&TIY]8V33J3T;C"
M)3*()-:4UN'9MEH<7K]A;H+%&EVUN?4:Y:K>J!",,QE":SCFLZBFAKBS,XNJ
M+<4$>V1B8DZN5:HU%J?7LLY;LGB]>@DP7LQ(Q,(I[MC,ABWH5(N 2M1ZO<,9
M"'L4O"$.7Z)2K_#H--ZB9&[)[-M12U=7!,.3\[/3H[SQ48%$+E^5B4<')@6S
M:KM];9K.9H^+E=O;%KUV7<(9G^ MV<*A[8U%#G-"+)1H/*&0Q[HVO>YR&^<F
M!H86% K!V"A?K+2%@.XUR]?-+K.,/SG.&I>L;RC%BDVS52V>&)T2KCZWJG&(
MN%>G5VW8(BZ+FM]/&Y\6+<Z*^0(V@3@DD*C]W^O$[1 _7^R&MZ1<(IN_JEB8
M&.((9R=IM"')VL:R7J/=T!B]P;U8R"";&N(+^%P>9V))M<@;')V2FLQ6G4&Y
M))F;GZ(/CTR)9R='^--\SM# A,KQ$SB%_5. 3\<=YDA>/W$4"CDTFP<4%7;#
MAD4>9V;]=:N(N^Y-V<3PC-[UVG9ZT"3GC/ WG ??=2&35&9X;5L#W(:PZ!6J
M[?_PK?A#_)SQDCFX%:/E*<DEF/ZYK7=.>WXF^&',(1*TZY:$:VJSX^7^2\2X
M;@X /TFSW[$NXL[-R[0[4:]VFC_.$"[(Q-)UQ=PPF:^S;BYQ^_@RM6*2)UZ5
M+2MM :]!/"%:6UV663S^R%XTH)GB+6JU*MGJ\IR(RYI<W[$N"9;DR_,+,_R9
M1<FB0BF;$2VOJ\T>JU*VI9(-S^FW5D>[!D2S<]/3(M5.,!HRS,TL3$\,L3@S
M2KO/KU<N2V<$HMEI/G]A965A02Q<6ED4"J>H Z/B:9%TTVV:'QK@R;5FDT8J
MMVRK9Q>DBC6-3C[.FEI1F8$AQ[BR:3=+><+%=:W=KM,:K$:U5+/M6)_BSLPM
M2"3S2HM1RA)M>=SJN=D5Q=R,<&;%%8[9I$+>O$B\ LP%0Z":S_J662^:6I*+
M1Z=6K>Z 46O9C>Q85OF30K%D22[7Z%72)=FB:&I*.+^RN>V-1:UK>F_(9MRV
MZ6>%LWK#VDC7N,JL7URUA^WZ1>$$?W%I16_13DP(YD7S*DLP$C(HS-& 3RT<
M'5V4K2TNB86<J16S0[.J=?I\OK<V;/\=$7.;I]"U-?75%?7PRHP[)[X\EDG3
MO)EH#_15.<CLJ4Y+2.^5F);H+=TT[KS*'=F+F!8Z"Y,RFSI:6_%]Z*XQI7&5
MDO;/Q\Y<O';[\E<?7;R?5-F"[Z?UU$-:>IM:\)3&\IK*W#PT@]A>F9?Z[2\O
M(SCRM5$RCDI"0LKN/FM@C$R-].((3#H!A^\B<R:7>:T/KET\\?EM!+8^.;$.
M16AJ@12GIN?#TQ]5,K9L>O[,S/*\D$PB$BE]N$YR<VE&50<6T8;'MW=0%BRF
MF:X[1R]GIQ46E-<AVNK3SB4\*\Q)ST'S!(3\6XF50^/]#;"\@HR[URZ<.WVR
MB+FZK>A+>UI4G5J &%^VK$^@"?3Q(1:5C.\F4= %UTY=SL%VP:%MR'O';Q1F
M/SYZ]NO/KR9G%)<T=U&'A_'U1&HWO)M.Z\[*+8"PIX?IG<6G3YV]7BUUNV8P
MA5_^_?%'=[,I:I=5@GV2D(-BC;'P)):(UY%P[)O;&50%\! &!8CR"A0DX^K%
M;]\[5]K8"LU*S\,/=#TX_NF9>]C%'^?4[\\&W_FGB8!D ;2S"_YY,]$A_B00
M48[@*B&UK7TT*AX-J6JLRBPGCY*R,@M;$.@1@VLO[&!"+OWVRM7KQT]_<_%A
M;FT'D=H%:\;WUJ Z8545E?D%Z.;,\Q^]_^V]M&Q(9TM]&V_S\$D"X=6PN^L@
M _L&?YXC[N'C\I+Z#OK6#6MY)%0+3OKZI,MKFFLK:>6M'E 5 )F#E%1;25P[
MJ"'M$")@;VM(SPRUXWXD#>E#'.*=>,D<["LB>@L$3AI6;/^<EPQ^&'/8<\_U
MHQM@O2+YTC@21YV:FV:-#C*0J>6EU;AQF5RGGB+6%960EK>]QG5NQ[!TD5G\
MM)"ZM#+17):5USHZ,R=12 <09=7UC:.*31&^,AU&G>>2>X5\_M"2T:Z;&QSG
MTHFXKD[\DDS,Y(SVU1<T4]?MQDDLHJJ!-B\<%VPH1]M@T,I*W# 57MR 'Q@;
MX=(%?$Y;?36:@J]-J\ RI<&]P%PK53 Y",W)KB'*]F+Z7L8$;V!DR>8T+0K6
M 4Y@76JORKCU;4$/N9L\)YONKLHN+BOK&1S'-U1#>^:TRH'6PJM?9M"7U\4#
MC.[:W'H"9\MI'$0UEM=W4%AB]<8$O@>'8R\[+%)T445]36=C4WT=(,KL#*,)
M"D7TR=VA33&]!GCG%!94U390>:(I+%=O6.ANJ&FG$J"9E>TDH58C[JFIJ*DN
MRJZ&0*I+"PKJ&AKZ) ;]TOA@#ZRPL@I25I2>BF1N[+B6\'6E)?4]/12F1+&A
MD%+JBS+JNX<GE]0;XTVED/("S(+MNV7CY^^EG\S;*>K<FNRH;D!5%S:V5E[\
MZD125A5&\HZCOD$-C4#H;BY-:R!R!WM;V_H&)X:%ZSNQ2,S,(S$7YP:ZNKK;
M>GFK1LU09]>L='ILF(* 5-06Y=42AH=ZNW #K5 (DM*/PS465Y,GB,@J!+PX
MNWE\Q:#E$MK[!_&UN4^*D7U$-AT-:V(,$9&P>C@<Q2:W5'?SA**9H>8R**:]
MJ!A&:"V\T\)?&.B> B;3U@DVN;NEN;J9,,S&% 'TH*81U0*P!_QP=QMEV:2:
MQA>D5S04EY;65-5TXYM2$G.K897Y=25/<N'DCO+\2F1C$Q)>]?#FPR)H(VU.
MOZT@E]2VMI44(_NGS#H^HH4VR<; T00*A=A<\32Y%DLH2RII15=D5\ *BQH&
MIR6RZ=;BBC9L#[$?6]W-)$/1M%%:;6YQ-;H%@:C,2"V#5C7-F+<7^$PB6[K*
M:JLG8"MNY4)[6DLSJ_$T8A>=UIZ5"<7@1B1J;]0S0^RG87._OG4O.P>&+*N!
M-L(K:^LKBV!=^,:.:=N;7\<A#G&(?7@W-J3"<<[PR$!O$YPFD?63A^>&&E-+
MZHJSRH@<Y:9YGM;)F./W]G;5YY665R!(@T0RN;\8"NW$]G0TEE836])O7DNN
M;&V"MI-::UNG7YWR_9.&>[6['(*3'+"S%S.SD#G/&F9>O1UV _(Q='7KT!LV
M5%VKHTTU[=.;KUE<"FYR:ZN;)C4'2494Q^P9,;^A(>W?6!JDB0_72@[Q1\0^
M<P"WOW:]-HU&(9F>T[@.F8-10!@5KLFD$[W5]Q\^3DS.2KWPK+RDO)W/;RW*
M18Y())3JNV=O8^>-VI&Z&T^KA\1\ H6S;O)9951$YW ?[/YG#[*S$BY>NY4^
MH'5JYG@L&IN*+DMXF%U9QU*IAK(3;I0C<5AHROGTE!O):37PMJI:*$T\1RQY
M?/E:'9/10Q3R6Y_=O'S\7"FZ[L&9^WF(AIR$*S=R6J>7%(MC+5<_NE;6M1#R
M2INR'R6B1@5=J %CV*\8+4]\G)U12I1OKC![>*"!+/MH-YD$*<^K3'CO;G+6
M\8\_.WWN1B.95?_L\IU"GMDE'1ON+<^ZDW'O](.<K"M?)];TF]Q*9.*=HT>O
M9]92Y^=Z2HJ*BE%<PQJGN7MJ%E?\P;$O?WO^9OJ3I(KNOJ;,5+S4NL:$WCQ_
M[?JYT]>NW\[-2WN0D5/<SIZ=69)/8V]_<CF_94J[-IA_Z^J]&^>/7K[Q../A
MUY]<+ZYL1'=69[43FQ).7[V67-/>1< /SFF7R1E7KEQ-**UK;X&/V?;BFOXV
MC& "]>#"H[S$^U?O7KE4._N2.?S4L!OUV,WF;;O=:C9N&4UFL]WSSI]0S.NP
M;AFV3':'TV$WZO5&J\7F"L9BT2"H[.ZSZE1*M=$3"OOL-D\L'G"[7$ZGW>DP
MJ=<5ZWIGP&>Q;-M<7H_3K%I9W= :MVU&C5)M<GB#/H=.M:[6&LQ&O49G\7AW
M]#K]EMD"1*L,0!ZGWQ\*.BUFI]MA-)AW'%:CS>G<MH+&PJ-.DT:^HK8:=<HU
MI=YJW7$X+2:]6@E [_3Y?2Z[P;!E,5H<GAVC5K>O7N\$A-_2&5U^C\-HM=M-
M!J/9M+6I56O-3G_0;=4;K$Z;W>'V!@,>DUJE,5J=#IM!LZ$QZ+= \U^;1HM%
M!VI]F3S16#P>LILLVUO:#8U::_$&' :%0KEE<=B,>H/9;+:8@9J#D9!KQ^X*
M[.ZYMQ1RZ<J:V>VTFS?U^DW]IMEFT8'N*$PVES\4]KB\ 9]#OZ59E2E6%!M6
MI\^WLVVQ>\-AC^/U??]#_!L!.A'T^P.!8"@4CH#>#6/Q6#P*O$GBNZ"*0S@8
MW#?-'0?]P>_&P13[AARBH")#!+B-QH$2 @$_$!@&R@@% W[_?I9X!+@)!D$-
MB$@X% P!:8) (:#!AC!8"^B\,!0&K6+$09T(X!/( 3Q'0&+0T;W7$P!% &N-
M[6O][L9 W8H8:+S!ZW%[08'WL5\'(!%H9F/?O$0P#+JF!RJ([\7#@#C[GNI!
MW_51X#,*% \T%#29 =0'B!A^[L$^'@/=V0.- SHC' -D \)!,8";_\!-T#\8
M\7#([_.' \XM4*,W%'3MN (^SXY[QV+84&_M^"-AGS>\%_6%0UZ[RP4,75NV
M0-AO<^ZX=CQ.NT&M-YBVS0:]$1@'@('''3XTE;N/B%.CV+!X#QXNBH6 8=-Q
MP/34;M1E5BOUCO#K9"ODLJ@W-IVO*T/'O&9@D':^OK\>\[H\;UK!WXV$O9XW
MCC =XA _*E[N.5C7UF3CC($9)GGRI>7<O0L7+CQ7:_[IXR_^XB].GCSYJF'?
M@Q_&',(Z1A\%UU"2EH=A4Z&%59DM=1@< E+;UP.M;<5AL=B.SFX"F;^J$A-Z
M2"-<P<C0X()RVQT+;HOIPW+5XCB;Q^V!U.-H[$63UZ972^C4_DGN,*[H^+FR
M'N8@JY>(;:BIA;0P^/V%91T4;%-C%T,DX/:12=THPO H 8$CH#N&9@>PG2Q"
MW^C:^@R=3"/D9N37M;4UH9'U]<1IJ7)]AC_&8>+0;.$H<]GK6Q%/CC IQ9=O
MEC;W]:/A:([,M1N2<^<D3$(G&EY2GEZ05UH"0Y-YXU14.Z&WEV_T&*1R,8DX
MH9,/8+ =#4B:4.YP**FXOLZJBBIH,X&"[:)TP>JZZ&PJO %/@4%2ZNM+FMO0
MY-:&AAY*3SMC22?CTUL:ZW*KR4K;EJ@71^4,8NN0O<3VIDYD;6WOU)QT>1Y(
M@83DYT$P1"JMLZV',S<Y3"YO98HD(RUM1"*ALQE2UCP@-^BFT"T]E([.@=EE
MT08PYKE$PQRU:H8V(5GLKZU!]_:.JYSOG([_YT%\ UW3.]0'O8GJ)\.RD%3Q
MBK"KL+:?1^LDK=I5H\@KG]VJJ*Z%P6H+J\L;6CI*;EU^VL31*281)7FY&:6Y
MC\_]_GP6:<[JFFLY=_/&PWP$"E+5VMO6VD^"WK]_\]:CE*2$RW?+QM2^F(I\
M*ZMW97VB(;<0A2.1NIO*<TJK<FY_<?UI255M0>*UE"84Y,&]A"24RN>8Q$&?
MW,ZO1<*+,G,+BNIJZBLSDTI[Z%V9YZ^=.7D]+0L)[<8T-6*&EH;JKQ>2EI8G
M^ZBX(:%R7=B%AA7E$28%;*%:PYOC]N1#^P7]D </$J_GMG5UHGO[6LK*JFN:
MR21<8RE^;H&5=?5:8MJ],U]>3WN:DU68="^_0V)VK5$R/[YP+Z<<5E>5DUH*
M0<#*4G)+&AO;810LNJ&ZDZL(@YNA@Y#TU(*R*CBDO+P(2N<.((L+RS+*\4*I
MA,HD89(_//,0TH I;VBC<5GUM?VCE))__/V%ZXFU H/_S:_@$#\.W OLSK*\
ME*O'CE]/2&G&HZK:!F8'QWJ;LE,(-#RL&56;=KN@>69S<[RBM'N8 ;_;@",C
M"HI+4LLHZZK!ZBIH;2&6TEMU^^;]K*J"AR>N7+MU/^':C5STR-:6J/C2C9MW
ML\O*ZVHK*ZOAI3<NW84,2J6TT@N/,ZJ:^\@MD-ST^W?3T_-R,.-B[AB3-]29
M=1;9W5E=55==D/KXJ[_[IJA_$(?AJC=&X:>/I/<1.Q^7$^8E[+Q3QS[_W6\_
M?9*9EWK_]HV;]Z^>/'+C;DHUEM322EK:4-"*ODQ(AO;@6UI;)J:Y[37%^4A,
M!ZRINQG1,\X=H/35/SAQ\6X:3;N[YUJ$Y23<>/@HKVEXAMZ%Q> Q=?"*HI*T
M^]7MC4^//LPLA]26)]XMH2Z!+M\/<8C_[(@';#O^<,AC=P<\/N^.8\?E<YA,
M)HMMQ^7V>]PVL\,7]KCM#IO3'_3[W#Z?RZ!5ZTTFH]YH<WI\+J_/9G='8Q&O
M9755;]FVVD'CC:#A*>.&1K-I=NS8K2:C85.WH=99G%Z_S[ZSXPT%/"Z?WV'0
M&PQFJ]6X:7&& NXMK59OLMLMFWJK*[(7]]M,6X8ML]ELW;%9328@=D.MT1F,
MVSO^?S-KWP77+-P[#J_?N[VU9??X0&N1%IW&[ T'[(9-LS,8#7FVC4:3>6O3
M:-S:VMK<--NV'3N.;5L@Z-UQ>CQ^W\ZVW1.*^'>VP'@#D,!NLYG,QJUMAVT+
MD-,2B$4]-LN6R6IS@&M;5H/59O5%0BZ]7J/==KEL#K?+Y057_$Q;6Q:WS^O_
MCU3E? =>[CF$MA9I@]-Z@V+Y=1_2,IDL'H^'?]J(Q6(JE>J%5=:85RN;Y?#$
MJR;OV[NF/XPY@(@$7]<7!%>8PA%PT0DTZA'U@R937R8 %Z#> O#\O;G2N1L/
M^E[:KOHNTVYL+_[BL=@/ 8H/OYGQ.<+!&%!]P./Q!L"%G?W#R7'0T,EW1Y7W
M0"NNOE HZ/.!-E;WU\4 @(EV=^,AO]?M"\5WHX']UQJ89]] "? 1"7@]7B +
M$ <V+!Z/!O<+B 3\O@!8')CCN<!@I2%O:%_V> 1<2 1_J;O?=48L& 17\8)>
M#V@1!4@:BH(&9KUN;RBZ7\)N;+^8:- 'M ,H/;AO"#0&"!>([M?QO&10L%W0
M;P@@2L #&F9]1Q?_IX*F\U'ZI7/'?W7^8GIR44UN WVXLP("KWSZI'/1O#Z&
MO'4ZJXM!;DXJ@:/@;2-K*[*I2670RJ$R9J6+M/K+OSIRX5D5163>$2*O):56
MHVD=B+IJ#*Z+B"Y\D)21#6,OR06T2:5^'E]?69R9685JPO%6M4(2LF],)I_M
MSKY].JT4UH@L3WF045=;F)B4GMNZ8C=-\3A3(^137S_%BV1#[87?)*!6U@2$
MKMJDA,SLA/3<_,RGF?F/4DJ;D5699470/OX(K;N-K-H++[0V5F4]S*NJK.>K
MU6/"$711157ED_,)Z3TT/I?57/@LJZ);H%H:K'F6]* 8Q5O7"\A3*AGI\;GD
MB@)H%WM@F$(;5QH4Y))K*8^O)9:1N"M+E/N?/6Q;6I6--!1>S4WXYNC)4ORT
M,Q34B"A](L5$UNW[!1URY>(HN:.;IY QNMHI3"JJC]R1^Z *T5#?6)F17H>&
MYF94U!9F(88EHA'9.PZ,'>)UO'/8^I?AV1CEC$V+V:FG+B7EU/8Q6O-KNBB-
M':BJM(2"U+,/,N#(5DAU93.)WI)ZZ?JYFV>/Y6-'AJ='T&<3:QACW56U%<_.
M/X-C2%3:K$9*2;G^)#FOKK,+#S!2U=)(P=WDP@IT:SLB-QM&FY^D8"<MGIW%
MOJ(;&4554$A^(8+14WK^V$=G+J5"FP<U4L;=1T\>9%RZ64N9IC"'95/8PK+R
M[(12]IJ*VW+]L[-7;B:D9^2V3:E4')I L;&T-$Y"E*<_R:K(N'<AO01'8<)Z
M*")=P#10],V=JQ>NWTY)J:C/K^U?DHI'\3F/KF?7MY-&R6UH3$UR8@6R4Z#W
M1XUB9-&3VX]N7;^:470O.:^Z^%GRC=LUY#E*2TGYXTN%-?!6^O18'[)OUGVX
MZ'N(GP&\PMQ;2 *A[''[$*ZQ!HK!8Q'U576EF5D554^A!=5WKM:-;M"QI;7)
MM^O0W0@D7R8H?_"XM*'PPJ]/ID-[J4@X)*\8-CP[!'WT=__CDR>Y>?6T&:UM
M=]<TG/,@_>&#)TF)!2FW+R5DI]ZYEHH>9*$@F:7%"%Q;97EM,[(6T8E 9B>?
M_2P5LZJ::WIZZU%=1UMC326*OFXS#A=<.W<YH;0<4E-65@IKJKF?<"?IT=D3
MY],;N:][U?O#$;//S8M%@UU0:G]G:5$5K(,P0L"A88\2FR46W2"\JK9=H%^A
M95RZ>.?6Z0^_/?[E\:,??GB]J*"A!9I^OZ4#6EQ175Z&;$ 0^ H-K^&;B^>N
MW#S_V0?72XL*;R6</U_5VI+^- _:QE]1D H??_G5W<Q*NDI#3?[J24'&H&Z1
MDE.1FU996YI7W%B97]>*@E4!XUDBG#$T-KWUIIS_H7C)'$!$ KZ#3@S>]@3W
M$X;NI2>XL'FD->V]O_G=@ZZEMR<//XPY1"TSHHWMK24*@T[##2XN+0S-JLR6
M#:%8MZV63 I&^L<6;#ZW8IQ!8XQ/3K& EY+;9Q&R6"PF5\!ED,?Y\\*I$1J-
MOR :)-#9@R.#3.;8^!AS@,%9,@>\1C&+U-<_OFKV15UK+"*-.R.;'^^G"^87
M)@;[2:.+,IG2;%SF# S0*(S^T2G^4"^=3B7A.]K9JY:?L_;ZSQQQMWJ)TTYA
MD"!PL=J@F!@6+B](MG;,X@FYW6_3+T].+\NG)\7*I0DF4ZRQVZQZ[0YX!GEZ
M6L@?&9];6I0J]3K-3F!S<4JRO"R1B"=GEE>F>0(AER>:%XI6K7;#NBD<TDV)
MUJU&.8<KG!GCS2V+N5P!?V28U<_D+<KF9V9F^%PN=Y0]/BM;D&U'_"JY:)3&
MD4B%'"Y?,#XN$$\.,3F+\ODE@\^[-#D@%$TNKD_-SW*&I]<-&KE0JG7:+,;@
MWIX-E&#5N+DDW/2Y5;KUQ?G-'=TDFLX>9W$E$L&,8F5F8F9RJ!?1SI'+%$J-
M0:<R^YP*#F=!)5L4SW"')I:MGJ!'O:)V6A9')H3BR3&>1#XSR17-"'G2%=$@
M:Y QOK!A"\<\YC4N:W!\=IHSP9_FC(E6I5.#'-"*R_C$^*1B2[%LV MO&=:E
MDD4^;X@CT6H$K,G539W2=#AQ^U^ S68W-365EI;V]?6]&?<O(Z"1S8W3L>7U
MQ,E9B50V,SPXQL!2QP;'E[5+-/KD[-00FR-<5JR)I\<9*"*7+YQ=GJ PN.()
M#G=\5*"0S/"75N86EN1ZNTDZ.B*8GII@]?:QY]<<3AUO=&J*.SI(G^"R:&/+
MZ_(%M3O@-2QQ1V9$DY-S"^.CXP+. !$_*%R6S:QX/2K<V*)<2.U?U&S*Y.O&
M=1%_P^O:6%39;9M23A\:T4.>5RQ-2OY_]MX#.K$KS__LW;-G]^SN.;O_F?V?
M_\[.3._.3/>_W6YWV^ZVN^UR3MWE6';EG*12SCDBH0B2 )$S"!!10B"!0$0E
M4!8" <H9Y8Q 2("0M.^I;%=TNVSW=+MF]"E$O7?3N_?Q[GOW^^Z]OSN]/&*=
M6%R>FQNU='2T&=LZM<V]4^-6R\CH[,+&]KY[N$4JJZW$T3H&!GO;5#*MMJY>
MW]'9;^M6B!4-#8:NCO:)/8][<;A_=';:W-.LEM=H!U<<78JJ)LM0<V5Y146M
M6-_;J6[H[N]M,S;)JAKL\P^.-#GFF*>3?1OJ9OSE^)"P,G8-NA1:4H+*0%>R
M,<4%\(0O;I]-C,C U+9R^512^B=!-W/@E2.!0YO<LK:@+<@IQT#*J&Q,(8F%
MAZ7GH!G4K'1&M8 MU70,;_O=W6R1CED<]?EE&*XHE]%K:ZOJG!B5(XN*(V-3
M\_,2T_.*F T#$TU5)449V?S.=<^AOU>NGAIIE2@4^H[)F96V\CPXEBKD5+)@
M)<CZONE&G6%(5YI:0!6TNQXNPW?$/='2UVF?Z:]J5+ 0(@U'H!CL;5<V=T[/
M.K?6!_35$M7(O+69E).>%IE8Q)=4\5%)*=A*)(E-0^212T-3865%V4@<D2G7
M=];BDXI+L922M%0\#PG/0167*QH55)'>U&+H&ZYGXY)O1R<75K1T"O-",C+"
MF>T::4UW&Q]7FHO 4DLS\O)3"RKJZ_%06*U!+^S[437^OE8.VPM30P/6D1';
MP'UFQ/XBRF%WWL2C5]2VV.9'1BR.29.<C2A#L,75C-P2+)947 S)$7:!*W;_
M,.XI!^]2LPAQX[./@LE=CW;P/)ER\)ES3^<A\J^_\,69,V\%%1<7A4?G"'6\
MA&O9V.*"[)RP3Z,)9I.6)U<K&? OGOW]U5+9RH8E_\*%4Y>#DHK0A660U,2P
MR^^?@E)+KK]U+CP^(S;H2G1JTJV+9\/HW6MS'64W/OK@5*S(-#O6():JQ<CB
MD 2"JEO-HPKJ] J=4LBNZ>V@1E^^^-G[ISX,3<N\^=;9"\&9)0P45=0S]<.[
MXH[YV^!?[!MVK+O7.GFD<HJP?WX.:-P#+2LL%4.1#[F=8V)D5CJAML\@Q>+*
M.?KQ=4>O"%4FT"AYY7@*JV%L86-IL%&LMT[9VKA49%HIOEK9-S;45,UGX<G*
MX?EQ0T5]CZD!E5N$1B!*")0*7A4'DX^I;EWP':Z::C$X%)I>UVXTM-NG5Y9W
MYIJX6 *YJKES=&#89%*Q*30B1=%OMTXXYJ<GI[?7^[ET J%*8]#J&ZIQI9R:
M>J%Z:&72W#%LZFI6]\\,Z02$<KQ8+:,5$T1JL_-PQ\2JL\POVVO):);4OG7H
MLNL8^-+B<I*T>1RLA.N#U5PBGF\TZ9F%1=#TC$0(@MTVN>%9ZB;D8'@\8067
M7([&HE$%.:65W8.#'1U*C6%LLJW1#%KN.MR9M7?V]UF,]M'!1EK]T,*(AL2H
MGUR8T/ J!!UW5P ]YKL1$1'Q3__T3[_ZU:_H=/K#?M^%@\#C!!K8+?FPVY_C
MKWM/^Y[K0 3VO.ZMQ_<%W^.H4_;@NY7^F&-^M""*,U_XU;_^MY\]\ZMGGW_]
M]==__H__]\]>>.Z9?_F79Y]__A>__,7_^XM?__:Y%UY\[J43+SW_++#W\EL?
MGSO[P6OO?O31VZ^\_<&K/__9\Z^^]MH?7G_UUS_]V1OOO/G"2V^__^9++[[X
MN]?^=/JSMY_[Q7,_^]D__^,SSY_XW8LOO_?N&R^]_M[;?WCUC3_\]-]^]=O?
M_N:Y5UY^_IG?O/#,?W_VQ=^]\O;)S\^>_>R=U][Z\.0;0*277OOP\\_??>GE
M5T_\X<5?/?/<"\_^[+E7__CF&V^\\X?G7GCE]=??.77A\J6+WY=+ERZ?^>2M
M=]_Y\).3K[WSSBN_?/;YW[WQ_L<?G'CQQ!\__O#D!V^_]//_[X5W/CKYWENO
M_?;Y7_[;K]\[<_G2N3^=>.6=MY[_S6]_^]*;[[_V;[_XW>LGWGCU-__ZT__^
M_.]?_,T+K[[^VFLOO73BO;=_\ZOG3YQXX]UW_O#L,[_^W6_?^NB3MUY[[?>_
M>O:97_[JQ9=>^,TSO_S7_^>9EW[[_*]>?.[GS_[V=R_^_HU7?O_2:\__\I>_
M>_6EW_S\M[]/B,YX^+?YF_+U/(<-6V,ED\2@X3AMX#+B=_F+*(<-(^:UW_[\
MU<BLN)///1.571KTZG_[NW\X%W;S-S_Y^P]NYZ;<",T2=?_P$<GW]3DX1$5I
M&> P_,U''Q%/IAQVAU@Y*9\%!P6'1N=#BI*@Q1@B 4,J@V%8Q)#8?%QQ)E8V
M9&^FT*JJ2G/2LPD=J_N'NQ9,,8Y$Q)45(-!,=#:$4D>#(WAX2":6A$?#LG-3
M8N+2B@K+>*;E,4W!M0_#LDE:ZXRCE8<3\$K3TQ#DBDH^H1@MJ*^@,=@$)(>#
MAC&;NOK[)?021 Z42$3@L;A"/%_>-+[]:*&.>1K8':[1]4YVR.@-'=T=C<)R
M+#0I+B,MAZ S-E55]6YM=M542Y1UE1QE=U=/L[1*U5R=_LD;MW+2@CZ\%!1)
M,DU,6[44: $"EA0?%IQ);^Q4D^')Z?G$>N.@;;2_"7_[#J3:T,(32J6XK$\O
M7[B12^ R^+6*9LM0CX2G,IL[*7DW3URY$X\4#\VN]-&2+UVZD5E1W=FJSPK-
M+9=TCYI-4EK\)^=3*=56YUQ#W,V+US/AN= \.I.1EY42?/MV$K((AA:SLV)S
MX.54E:H2%G,K+O3\JQ>@=*-SO:<T.C15T"B%7#L;B^C:6&LN3KCP82R1B4I*
MDX)6C>:;(>&7KV;P9-3(=T]__N&?WOOCR42I?65S6DWB-LH*8M][_L1GR62M
MAEDFZ!YL%R3<"4_*X356DN6S8,^S;Z)=*L%GX1M4J-3@\#R!B@,GUO=9QRW2
MO&!R^Z.O!X[Y5J*CHP'9\.:;;V*QN(?]OIW=D48^#%+&H7/UT],6N4:L458)
M>;"2E 0"GYT3#2%6=1AD?)U,1A*UFU54&"P^/%=JF^IK4O!0-$._FEQ6EG*G
MD$VCX$BE647HNK9N33V_J;,1D1)^YLUW@C-SBA$EF2EPN65IPU29F%?"E6GD
MI(:1D59"$93 I^>%9F"YAIFI;D8)%%5!RHV&D#1#L^,C _8QBQ2?DYZ4D! 3
M'9T.+\I/NOC!>U?O9$ KA)S\D (T%9V;6$QO5<GJ='QH<E%%PQ"@!/8FM860
MM$(,GLD7$7-R2@L*<&#/<>_"0GMY;"R,S*:@X(7D9N?NBI1<F(X3-72T5J%+
M"G-)=2J==6S"/MRET[35%B9#<O*!L)EW"J0]CN-K\IC_&(R,CO?TFJP6LQE<
MH=ED[N\W@UC,?7W =S_P/[@%KNYL-O=;3*:>KNY>4T\/$ <,;0%72C:!:Q];
MP%US;Z\)7#ZYMZ>[NQ>,#R0'! %=  _3T1<0%#B4&5QF&4@6/"SHV],-I@LD
M#+H _X/QCR*"_L!?;P^0?J_I*).]W5T_C.Z>7N"(P+%ZCU+L \L#9J\'+-?=
MH_4<>0$% +/2?93YHYP">;" A0;+;@%/2Y\9/ -'/F#.CPIYMTS@.0*\P6!@
M.2S V3PZC^"I/%IC&OP[.NV 6W?WQ.3$P[_-WY2O^QSV-AU];7J-MOG^9:S^
M(LIA5@F_%A-^,QB"*\I.8+'P8;?#$U/SBM*N_2F<JC-J<;7FV;4?_H[FGG)8
M,DGT(KQ@X+&OEIY,.1SNKCJFIA;7MS9606LX*YL>CW-N;GIV>7,3G!;CF)R9
M6UQ97EB8!_XMK:QN>?V[KN7)D;$IQ\+BTO+2XL+<$CA?9G-K=7)H:&3"L;2\
MNK*^N3H/FJ39=6]OK8 SC+;] >_6\O3$U-+JVNSX^.SJYL:B8VIZ<<NU.CTV
M/C$^-;>RYEQ=75P8MX^.C8U-S,PLK#NW-M?=_D# [_4!/UM@S[N][0MX/3M[
M^SZ/<VUCR^/> M@!?3S.C8WU#=>NQ^7:=JTO+P'Y6MMT;FYN.)U;[IV='=#^
M!Y#M7?_>GF_'%PCL'5DU\8'S''R BVO#XS\R@^+W[0*^7K<'-&JR"TY?<+NW
M_?M[WEV?W^?>=F]MK*QM;FTYG<[-C;65Y0W7T0P,GW/;O[?K6EE9!S)XX-]V
M ]G=\0&I^7V 3MW?!<[LZH8+R-KNKM_O];B<0+:<KBWGYM;V+BAD?4XP%YX=
M_YYO>V-C=<6Y\]1/<]B;DO*%_ I*&899787+03)JJ_FIY\^EE5-9-/7286"J
MMW]@<-0BY56(N&R6MM]J%.%@<&QA-H0DK6\='9\9;*ZD-W4VH"'I"6DPCD2(
MKY0(<&65@@H,IJ2PO+)>I:Z6-=A&[(I*-)<OJ*IBH%&$:I5U=ME:S6:).?!\
M-(=542R0=#@<!A*!SB66T[A\#)5!*"UAB;AH5JU<K&@";HGV:7,MD45%H7"8
M<CR'0\:4E6045[9HRB]!47R&@"\@%>:311Q4*B2[&%[9;+:;Y/(ZE9A45%12
M!">(I%TS2^;::BH\)32NE,6LZ9M?6;2JF1P2%B-12W 8!CFW**^$4FMV.)W3
M.G09AUN6DU4&'+['X3#6Z(;M+:)*+NI*>*F(2<!*5+:EO4/WA)J%+*L1XK 2
M?2TA,R.GH)PM$_.(5!*6I1T<7SQNJ'U7,C,SWWKK[3]^\+Y8Q-L-[(.3H_8>
M&*CZYW".Z9HT1F-=\JLQ%1U=HF($+",F+CR%V&24HC.OG_\T)#4?0T;$A2<F
MA03%9\8C*IN-2OF0?[M-P"B.NI&8'AI7QE))-(RLW__S%:QM:K1%1HV_GB9L
MZ6G@U<NP$1\&1V460D+.QK",LXLMJ,L1V01D=DAZ)H0@,YGLME;&K?=O%E>H
M&KO:C<9N&?3,RQ_>(K<[');NUI9.'3$UZ$8<L\E0RVYR#'9JY9CPJW="X\A\
M7,C[84EYJ2%GOO@\]')D7#JRH@)76"R=.SST#E9'W[AT*S(\+1=)IR##WG[W
MD^#P<*C"%5AJ,R@J,=7-IMZN&F&;8Y*>>_&Y3Z\F1D84";NF^GOJ>5Q]5Z^A
MHY[#KF44L#OZQ1D7+YW[-%7<._^X1\^/E@/O]N;*VMHF.+\-N$GONMUNX#[L
M<FZNKVZ :W4'=H%'B=/M\1\<^%P;0#C@<;"UON'>]@ !G3L/F04ZYIAC_N-S
M;Y[#GM/:0,DHK!S<O-<C^Q=1#OO^;:!%N;:QO>O9\>SN;BTO+BPN+*VM+CKF
M5[?<VTZW][$]WM^1>\IAW8R!I=Z\%5-:._B]YSF,D&Z&Y=6,?'U/]/0R+]VX
M&(JNEN*1184P!*XP^'IHL:Q_6 D[&QI? ($5)(?'AB9@>-3<)+I"A$Y.";Z<
M*W;,=\-OGO\\.(M,P%-UK8KRI$2&5%75XYP=:NOL63KTJ#*O7;^=0J*777@S
MC-W6IQ&QRQ/3F77,XE1HPID3OW[CW=/72AG8\#>OAZ5#L7Q*&5K AIU)K^SI
M;U>T][29!H;Z%"RQ@,_2CDX;^>50&#SVQNG/OKC#'UBPUR+.OG<M,;4(AL0(
M9<*<"Q^\\?ZK;YRZ?>O<)U^<OEG$).4G4#1M8EPRC*YI47":1V=&VE3&3D.3
M (<3#TPU,9-.EAN'3&:KU:H7MDR.RR P6GD&(0\5%YJ>F1Q+5_#HE6(^-KV<
M"$^_G9:7$WKV62MT1   5#5)1$%4XJ6;H:$WKF626B>VW):*:YE5?<V,D&O)
MU4/+ Z+L.$JU4M R,&1K;QP^.-SMIJ:<NY;'@&5%$C'H<C@DZ/,WSUT-R\@(
M/7,37F4_.'14!&62I9R\)+J8!(V"Q 7G\D>>>L.:!UX/:'XUX/-LN;UW)[;O
M^W:<ZYN>([-ZP",:=#K<\SA=X-3R@,_E!$2@?\>UN0'J,=  )6B+<A]0;9[-
M39=W#YQ-#FQ[O*"]2G Z^3YH8O+ []W:V-AT;;M=3M?.W48UD"9XR*/9_?M'
M$^M];M<.$![0B=Z]P\"NVP-:L P$C@( $4!O<*+\?@ T7ND[2A^T/PG\OQ\
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M^P<^]Y9S=67=L^-:__*:\>T"5]'>CLOI\@: *VQOU[,-KBSO=:VNK&QN^X$
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MVJ>#K_L< JN#ZI;>F>GQB95[5_%3J1R\\QH>!5Y2RFR9?K1U^63*X?$<>/<
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MI2@*^>FA7UR95 ?N^TL&DU[\ZG=":B@'TBSXE)B<P]_ZP>EJQJY")P757=N
M-[O]D]A7EK7CF<>^]O6?)XYN9YW?2T YF"FU-66%G8BA+L)!/Y@OBG(   "
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M;-ZP=SOM=I=['2IP0?$9H8B'/K=K<T?0_]#_\^$&GF_5ONKSMW<LVYP>KT5
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MO%ZOP6#0  !_/G:[_9577L%BL7J]?G\= /"AF$PF.!S^YIMO.AR._74 P$?
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MT^F<FIK:7PH /"4 Y0            #^-$ Y            @#_-H?DY'#C
G 0YP@ ,<X  '., !#G!\^/'_ 1UFT;*&E>MU     $E%3D2N0F""

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>18
<FILENAME>image_4a.jpg
<TEXT>
begin 644 image_4a.jpg
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M(2T-C\U)JD8\>D2L/20>.\:$#HHY<H1_?HPVH]> M$[.M\>E=:[I W.3 0
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M[M*Y\X6=.EW@#A=TZ:R[5'?+WVY)FC;UZ-&CVCSG!,I=F#7X/N*'D\ET,GD
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M9/C(QSI>@"M%6J?*<4"=Q0^X]L-U-1'WW='Q0BQW:.@;$E*PM41HC[VA 0
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M(G?F^(F6+717,0  SA5\:IV9;R3):\[U_?I5[3W0V-@P\>6QG2_L)$]8OGO
M?15L;YNV'Q/?YF1CL8)GUV Z=NZ(PP4=9[__H3:I8KTW9?.F]9V)PD"5WGI[
M_U=-4Z9,G?K:M&FFJ4F#'OI'IPO8H?]FK5#FDE#-AMEJVWAI#QVU#Z'V8)]?
M)%P3<J-]1[DRI2=(ZPP?^2B>KX.T3H^>>TY ZS":FXX-?B22CF%=<=55H'4
MH WXDO0!0?3W#/9=-7#<7.8SZZ]0LSXY4BJ3$6RVM5VLRV8.YCBCU:$]  #
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M/;A^0Z$L65""DI+B(8\_&M3[LAO_=F/(K<&7]^X1^_3358X#9 "+):LYM'^
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MW)^)OJFT&H.Q,]'BH]H<?PG>:5\U?4BH5-WP-%LMCA;+LX@7"MV(+-E]%P
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M,FLXQ_5-7J]8MNY23&'&:\[?2W]]@')RCUB5DQ#&<4/32Q6F'P  SAR@=0
M..,(C;6[2VU;2G?52"N]A<:#.XIMI97.!N?!_61W/KP^G*T$Q\O15<O.?>PE
M2#;WDU>/BXVUNTIMMFWV/;6-(I5'(RSVAE;7GIS$_FRYEK8E9'55T)C,'5K5
M(C;6["K=8BO=78N:H6T/W510V1(  ,XDH'4  #@/X6LWSAXHV7DX+G2(>6.M
MIS+!JZLBQV3]T:(]  # N01H'0  SD^$1D>9K6!M;GY!<7DMN'4 @  &M X
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MS!ASX?_A! 9#%/Y(OO=.>YZ9-DUO2,IS-..<^I'&D:@2TW]7(%UU/,8G  "
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MG*K 9B)&$<$&0SC)6Z^.041)JD[229*"E.9@G2:C3JM?K7-BT*\L$=\
M   $@1KVY'GE3">=-J-.:SMI'5FRP>1?       DZ*QS]^Y';#R++K+3)CYE
MM(O6 0      .$L!K0,     0" #6@<     @$ &M X      ($,:!T
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M<A!(B)0M9V[JB+MXXJE$[6R/EC#IG52699(E(XY*5>84UI*FJLM@B/2L&@
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MV:N($TKT2[VR#EL1W 8>9@:PKL.>F[#HH2,==<P#954C\1.IT3222<"7<U!
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M]?9<":6P$KE11U+E9$K/,+J'M?1&L]7F,>&*C9=1D02+L    ("S#C]:!P
M    X)P'M X      ($,:!T       (9T#H       0RH'4       AD0.L
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M<2$D+;7E() 0*5O.'+LRE^G6*G:7)5L1+6'2.ZER%JQ=?+?-8(CTK!H
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MN82/NL#/.0   '#F\:MU3J&?<]*5HOC"+R6G$X _?/H2/PO\G/NLBZ"M&@
M  !.+WZUSJGS<TXZ;"_Q@'=\^Q(_\W[.?=<%?LX!  " LP!_6N<4^CEG4'_:
M:O>B@!=\^Q(_DW[.2:O\U 5^S@$  ("S #]:YY3Z.:>0D1<8VF@;/[[$SZ2?
M\[;J\JP:     $XW?K0.      # .0]H'0       AG0.@      !#*@=0
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M     (!A ZT#    @#0#K0,   " - .M P   ( T ZT#    @#0#K0,   "
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MC+I)=W+043L! .!@<,>OFYMD*D3B,-H(\@=(*D.=871@176(B ]5B2G5VIQ
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MQ4J.',:N4<?9OLL3!+FQ6:]8?JYBC3HZ[YK@WBB9?(27LN>7JG3?+#&)#0
MAX#8@&*< WI0"%Q(-!)5G_VR]BI8,XQ6/]]9URM-W16HM-*T'2KAJY5GS[I#
M7GC12608K6S9UTVXM&*YT;+GM=75SK74J9_04-4(OUUUNMK<"AP.>FFO&OV?
M;BAETUQ;9)<6NR.W$G_B/=A#ZP      W#Q(DO;GEMH7T#H     & '(YW<@
M[\1 ZP     @S4#K     "#-0.L     (,U ZP     @S4#K     "#-0.L
M    (,U ZP   $@?D400XU[ITD YQ*6<@3.0AY)Z!J%^@U"$$D-O1R+Q.O0;
M)>^P87(M:"8*E<M..,&5>I#\P(89=--N[%",P7&.H!O<PWS!K^_]\T#K
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M ZT#    @#0#K0,   " - .M P   ( T ZT#    @#0#K0,   " - .M P
M ( T ZT#    @#0#K0,   " -).L=3(      (>3J*J)_!L     ($U ZP
M   @S4#K     "#-0.L     (,U ZP     @S4#K     "#-0.L     (,U
MZP     @S4#K     "#-0.L     (,U ZP     @S4#K     "#-0.L
M(,U ZP     @S4#K     "#-[$_K-&)$]^B;JU>OOOKJJ]&M^^%5)KHUC-I!
M55*=*_K%0*BB7G_]]>C6_KCQZP4   #  /2O=78^^\"='\B$><N='_G49]O1
M/7OSXO/_[]3/OR/SOGO^^D<##O^JA.F)=__#(P^\TEW'K'WK[-21]V4R$_=\
M]D3TN_WSU3_YW%UO>=^1!_Y5](L^>/%[J_??3K6M0^X     -Y=^M<Z+SW_C
M^"^\-9.Y[_[?^?U&H_&UKY4^,W5[5LF=\0>?J>_;NO/DEX^/9\9_\8'/_&1
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M>@_=EM]<6/KJJZ^^^N17'ILM?/$*.<J"VFI'&&L=)1E?_='SA=D"WT,
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M      !O%- Z     $@ST#H     2#/0.@    !(,] Z     $@ST#H
M2#/0.@    !(,] Z     $@ST#H     2#/0.@    !(,] Z     $@ST#H
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ML7:,;0]D8*"O7 T$NI%TM]N;_DR>%^4(Y*]2=_(UM@"QS8:4#>XV&"V@=0
MAXB=9N5DCFP(LNB5<-;)"NU6PR_D>+UL;MYO;-%1U=.>+*#E+>2%L5()="5^
MM[<;I9D9_Y7@Q@7+P(VRP=T&HP>T#@#@4-&NEZ86L<SU)H&[#5(!M X
MT@RT#@    #2#+0.     -(,M X     T@RT#@    #2#+0.     -(,M X
M    T@RT#@    #2#+0.     -(,M X     T@RT#@    #2#+0.     -(,
MM X     T@RT#@    #2#+0.     -(,M X     T@RT#@    #2#+0.
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M=0    "09J!U     )!FH'4     D&:@=0    "09J!U     )!FH'4
MD&:@=0   (!#RTC'$AP5H'5&'<HQ18&P+?F"7T\(S;1GVD[&9G(8"O'2XEL
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M-AA]2$3K\!:2*6J6,^X5S_KZ$=IJ5"[X_G*!7*1CK'7"I>DM-6IY+JI8YW(
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M%UUN#L]>S!HFLAR,WZ)FKQ' U3KZY=]L?NF))5ZLX[Z"SHB9I_<*96@=
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M772Y.9T=-0TS:YC(<C#>?=X%#A97ZXB;0FF=I2>6>+&.^PHZ(V:>WBN4H74
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MR_-Y#;YUY:@/D]K;Q9@1W9:9S"&]R>[5A41>Z.;05Y[I9+K<0%/BJ)+P,O8
MA+1.].5P6FUI+$;N.^?KFZ1C' +!D:1U$HL-8"M1]%UWT3J/K*X^$CO1OE^V
MA]8! !Q2KE06S_6<SX$; S=YY.G7'3DHK6IQ9F70\M5LLS *YC%H'0     D
MLMU868BMDND7>L]K-,QCT#H     2#/0.@    !(,] Z     $@ST#H
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M\"@   !O(.W&V7E^ ?8-!UIG=)&!'0    #[(CJ>1OX-     ) FH'4
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MGG,     @)L!M X     T@RT#@    #2#+0.     -(,M X     T@RT#@
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M10\9Q!($ (!##OFP>B]8&1PU=YU9&;3\Z[5B810BJ$'K#)^X9!GX+UHT
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MO<].L_:4J5;6S=ZES2KQQ.^Z4P@(KB)DK(K?#?L#!94TOU12M5>_'O]E31T
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M=0    "09J!U     )!FH'4     D&:@=0    "09J!U     )!FH'4
MD&:@=0    "09J!U     )!FH'4     D&:@=0    "09J!U     )!FH'4
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MPN^<NW8=QZ%&;X?L.KVT?4O<>><\O"7V3KOK3Z S!5HG> TELK*G*] Z
MP*&%?%@':<-N58LS*X.6?[U6+(167+Q!0.L     ()'MQLH"+VD8!'JKJW2I
M'[O+00.M P   ( T ZT#    @#0#K0,   " - .M P   ( T ZT#    @#0#
MK0,   " - .M P   ( T ZT#    @#0#K0,   " - .M P   ( T ZT#
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M (B9K , Q$S6 0!B)NL  #&3=0" F,DZ $#,9!T (&:R#@ 0,UD' (B9K ,
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M "!FL@X $#-9!P"(F:P# ,1,U@$ 8B;K   QDW4 @)C).@! S&0= "!FL@X
M$#-9!P"(F:P# ,1,U@$ 8B;K   QDW4 @)C).@! S&0= "!FL@X $#-9!P"(
;F:P# ,3L_\J=-.5^Q*@5     $E%3D2N0F""

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>19
<FILENAME>image_5a.jpg
<TEXT>
begin 644 image_5a.jpg
MB5!.1PT*&@H    -24A$4@   J0   -#" (   #T$IIP  "  $E$051X7NR=
M"7@39?[' W@;T,HAD4,@6^U*!;'""HL8/+IH76!%1(I&K+H%$3F48EU15RXA
M_M'B46"-0L45@8A26$HAHN4HE0!%J#4(A982:$M;2BBE))G\WV-F,IDDI2!G
M^OT\[]-G,O/..^],TOF^Q\SOJ_$"    (*S1J%<     (+R V ,   !A#L0>
M    "',@]@   $"8 [$'    PAR(/0   !#F0.P!  " , =B#P   (0Y$'L
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M;"KVK(E@VY&GR,_QR^_QN.*-@]IWNO66MK=<>=45]/P:-V[1ZN9;VK6]U_"
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M63F!=9;VY0>6"N29M^45E)RF#@ T)"#V    0)@#L0<   #"'(@]    $.9
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MO.D!J!<0>P# !4#YQKRN^XB%NQ2O\(EX]EA>?7N1/(8/ #AW0.P! !<(<2!
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M1#W(Q_/%'Q%[_FR\W^.=      @!FZ$7!Z0] 1_/(W]$[ $   !P&0"Q!P
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MPKE$C' 8\G.7,,(! ("P)838 P   "!<@-@#    80[$'@    AS(/8   !
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M1QQ4"%X^C'   "",""'VY]X(AZ$NMH$2TG[F@AKA>.HL/_!P    +E="B#T
M    P@6(/0   !#F0.P!  " , =B#P   (0Y$'L    @S('8 P   &$.Q!X
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M/Z+T+()?-UI]RY*?9-09/\YQL+EY6HI"+\5ZT@%=J9Z\^TM*%36%C4/4T(<
M-#KVZ "[DP=7''E XKS-U8I2PJ8>?#WXFF"GEF*9RY^YD]W%-**YJ_SP!*G^
M^/>FQXWA/PGIVY?:3_RK/\]J%4+LZXO<Y%1O./^PZ32_WQ\  (!+%74?L@'C
MI$,@DG3R1T/HW,IY%;,_(O9LGD9\0/$"XFMR<F]6    ESH!,_T-%=Z/%T?!
MV5BO.*IQ?H7TCX@]     "X#(/8   ! F .Q!P   ,(<B#T    0YD#L 0
M@# GE-@'&N$HW@KEGA!^[XFR2+KRWF+T>YZ91ZX]"P*/&![42J&>Q1 *'FJ?
M,#=S<;)!(SVB*;^=*5X][IV0FV]1Y)%> N9!LIQV"XW2++^AX+1;S4F^*)T
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M;[S>VG WPE$9U"I]<20C'/&:\\O(]O&YIJD,TNJ8LH?8 P   )<:,,(!
MP!D!L0<   #"'(@]    $.9 [ $  ( P!V(/    A#D0>P   "#,@=@#
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M   0-M0E]N>.LD>[M-"T3!QMFKUZ]<J7AOSU'O9B'IYR!P   "X %T;L 0
M '#1@-@#    80[$'@    AS(/8   ! F .Q!P   ,(<B#T    0YD#L 0
M@# '8@\   "$.1![    (,R!V ,   !A#L0>    "',@]@   $"8HQ9[A74L
M    \(=0&)1>(%2B!CAJL?<JW&8!  " RPNUI $&Q!X  $#XH)8TP(#8 P
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M&W8)\Z]F4UX_H*<U!6*_=W86>P   .#@^1->O>LO$'L   #IP94TP$#L 0
MI =7T@"3(/8     2!,0>P   "#E0.P!  " E .Q!P   %(.Q!X   !(.1![
M    (.5 [ $  ("4 [$'    4@[$'@   $@Y$'L    @Y4#L 0  @)0#L0<
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M0.P!  " E .Q[S=R*OVHX_XJ    0PQZ;0   "#E0.Q[X.>WIO:YN#4"
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M1@F(?0_$Q;O7Q:T1    .'SV)?:C1ER\>UW<&@$  (##!V(/    I!R(/0
M )!R(/;]9[-1>5/&&^CEU8.UP#_9^64Y&?"KNYH<G">6&W8,G^[9:@0G_> .
M_^WF.<'U<N%'SSWW5WP0)-$XI@IQK,H5A"0# (#]T4'L18\?]L(F%.[^W\QV
MTDZ,(ASUEM]45&_LR/=Z=^5(B'U<K3O0+!<F*7S0;KO:Q^\"(XV;X8;2>E%O
MIEZBBQ FR'$SW-#=*M<YY83>P*VM0S$ AHC.8J^[894BP@1?VP].VHG]578T
MT7&(H]^2X,J^X[F7.7M')LR"(]_HI1P$E+]+I^&2Z09,-8XH.GD'**<1A011
M'^J1_^XB]M$7D=U\!VW]AK'G^Y/&L@\#,&0X?+)*?)"E5#VR#ZV5IHHWUB+Q
MQ@EG0XK21+OZON_+4.24>2%+;TS9<9\ B)&0X89'U0E9(>P$.4Z&&[I;.:C.
MN@Z;P^C*=6VMY&( #!.[BCVGB%!B;R6Y"=/8T'JI^LU.26[<VG7:B5'LJ<T+
M\6&4>W5T339A0J>NN:<R"+#I(+J5N^5"G@^IZ*'FK%A=4;%W\@[4UBM%.H>;
MHN,3>UE;COQ7ADOJ)/;4G9E@O3QB"+_WBI4[JCW*-K+$GH,GTJ_P+U4IT1]E
M0B)[B"I_P"''[\:#F$8W#!KJ=]VE8,#\5C3UW72@OH[$?0(@&=W5W"\7QN15
M[0R+G00Y3H8;L3J=D BGZ=1V)[D8 ,-$9[$/>V'CQD]*<L.W1ZYX\>(.26XH
M8X3!2CLQBEVU8]FKWB%,4N>DKC%9<,B8$);]';$>GIDPR$&T"XN</E'QEVP'
M4PY#LH;KT?]>O+B3V(>K<ICR<33?@4D+)DTB2^RY;?R!0O2K.E1M,A;I9KQG
MC&YHB[T.&<3.B5/%T_G,=/2Z L#!ZFK<=';J3G$3Y+@9;FK)6>_"FV+GY'@
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MKC'!W],+W*LF/O4)0 \@$0X8-2#V    0,J!V ,    I!V(/    I!R(/0
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M>S\HWO7%GZI!(AQP!.D@]@  D%Z0" >,&A![    (.5 [ $  ("4 [$'
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MD0V_B";PN+'6U59JF**;O>.^Z%?DI+KWDB\GW(I_KQ#^&0[A)XTJ.>#0IAL
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M),(!1X\.8@]2!CU=S).1/;&WK?:8+V=O6P&P%Y (!XP:$'L    @Y4#L 0
M@)0#L0<   !2#L0>    2#D0>P   "#E0.S["[V8.ZZ?.>=WRF603OLM7F*K
M$9S<_>U$]9(>    L!,0^SY#265TR'<*L&/"OP, !HX;/\=E+?!/=LX'UMT8
M'8!! +'O-V$\.++RIRD.%QOH=1VX1J=VI5[#B69#/=&$QU]P^!IIV=.WXYY'
M4755CB(9&,2;\=TPX " G8#8@[0"L>\[.M9FJ/JDV1=O!G-6,FS9:U0HMBZE
MSMRH%">SA?(]T1-1B*X'*J9L*/96CJ+J51FKF'-L(P$! $X23@I33;=5:Z68
M/QG46W9*>YFH@G).1D+FV0/H^4",Q:-9/?6@W//]T8T-"H8<B'W_D9[\CZK&
MGR\UNU4-9!A=2AE\C\7^=R9#C.QTW#XH%'LKDO'-BYVSR0$P>L23<')2.]^?
MTC&A*3^>3+QT=9D2-[LWFJZ!!]#A>%I7N*826% VG0F(/1A.(/8#@&QZ,A%D
MJE;G.;M6I>AQMMD.EOVN8@_+'@";AIVPFZ1<Y6608^)H'I".HVI9AMQR\S2>
MCE1H!N6B6A]B#X83B/T@D)EC3"8WTNQ+M>H;,G40YXF1EGW2G/VN8M_X%G/V
M (08RU[#1OR4/^/IR2^R[-G<G[\8O"#NK+J3B%*7<2U[!:>R%(-R6/9@B('8
MIPZ2?'KN3W5,'1\F F!$,'/V/&BNUX)9DODMDOQY:\Z>)N WY##:2439<<Y>
M9X_$G#T8>B#VZ:-95>F&U=-#    1AR(/0   )!R(/8   ! RH'8 P   "D'
M8@\   "D'(C](*!7=,:RA7+X,M"!P&_BF5>$-1S@<^T&OY5WAX-]?MNHE"LJ
M5%^<9BU8H >/]9/&[O\!   <-2#V X""ZDQX7FZAW#SX)#CF7?S8M^8UO!TC
MZ]%+R?-!?5,^U9\[\!$) $-,\NT3@MCXX*@"L>\_,ESN^\N%297KMMU86>2W
M=CDV?KMQ?9'>\<UZ"\N-MA/66[_O*_^[52\O<(1=#NLM\^*09:^2Y?"7,<N>
MPH;0)G_UW',4E:]I,NW*@0>)O;^XT@B'(4[0'JJ*]TGO'$_03Z 80>)#W6YJ
M4X4E:8?Y?@ 8>B#V(*U [/N.2H3SK9!8:3=3_^(M5EH4KBM7>'NYF-?1N/*%
MI;>B4;AK@3_&@P"NBN* 2D77JU+L.5E.J[+HD82[8L]_R;(G!P/I\=?13+OM
M5NW]8*DH9#OK+R[7FDEB/\[#%!G9M[(IZUE;CC2U^A&/ +Z.C"0 & !(A ,
MQ+[OD,2R8<P(D[?5".:LX-Q1'[L;UOO+5BTHJ "Z;U1;]_7\.G<ZSIR]$FD6
M^"2QEQ;YJ>+I/#4C;GFWU7"!^C]'[.6,@'0)G%]99CFO.TVMU4K3V5-GS^9S
MUD@"@+Z#1#@ 0.S[#H71UN(G/Z_>%Y))EOT6B:O_<BE,?C/MOW;.">NM8&^
M&1/0FA@OK/5FV0N+AT)_"VD.+6_6;Y5I5XO]EO32KZN>+A1[[D:SXYXW1K\H
M,0(YU9XXD@"@7[@C9B3" :,(Q+Z_1":P]63YEIZSI^2V33UG+VWW!]$HW-_H
M4+A9KQ#4[M[B"-Z"?"&HAI8].1O9"T]3[W&Q;U%/EV'!9K56CPY(VHW*&P5/
M]F.4DJ=IXN]F9_P91^QIO#*NY3P:@9R&"_3?@W_I (">2!R&(A$.&#$@]B.-
MGK8_'&&Y4$,  &D/241!5"^[>G#/&DD , "0" < B/T(PT\/'%JR'$[CR\Z)
MPQE)    Z!J(/0   )!R(/8   ! RH'8 P   "D'8@\   "D'(@]    D'(@
M]GUFJQ',R9?8&1GB8V=V#L?=&^U&Y4K%BGN_3_C-_D9W+=2[[JHP  ,!L?%!
M6H'8]QD2>RM@5Y\YZ+TKL>^&@]XU (< Q!ZD%8A]GTG2O+9,7I?U_!DO5[QQ
MPTG"84+@>;[OZ6QXK4HQ3^4IK,?9\P7>/)XECZH8]SS*4I>=#3C+1\2=$,VP
M9_)Y.*%"U"I51MZ(;/ZUJ\NFP9$66OLR80%I\S>J&RMZU[_C[O);G;YOS%^\
MWJ"&6=L>F.<!@&TDP@%@&V+?=QPWOE>L-#D<_6*EM4%1:7<2^S&*[LDY/(J5
MNY6BQYI:+>7'=3BP6.JYU6MJ*XKW.1<T'D2'&CQB,!GVRJLJZB?UAI/9PEM+
MD=7R/=$>"K>W1?GZ.)2O"B;JM%#M2^^$5L7/W-"[YL+5JU:,THG"U2O)VP*P
M?Y (!P"(?=^)6_;A-Q32;B>QERHH%%I8#ZO\=RW,DD>EY]P4'1<O1A+6N6(?
MS;!GK?*N_^%GD573 T8;'&^AVM>]6OER4))A]F-B+]JIVL$_QVTGQ!X<'$B$
M P#$ON_$Q5XFFE/Y[(5EO[(:3<*18-G/E&KKR6+OI.@PVIDL]CJ!A\RP%U1V
MM^RI/=$&=Q)[T2'*Y'O5-_RN+'N(/3@<D @' (A]WW'<^&Q=M.7TMIJSKVPX
M23B<&7&>Y*8Y^R2Q=U)TK%UW1)3CX4OCAHAFV&OO/F?/YD[D(8-.8E^_'<S*
MFD^=\CA#KMIUISE[B#TX)) (!P"(_5 1]2A&@ H"  #8*Q#[80)B#P  X!"
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M$2J,#     J(/0   )!R(/8]\/-;4_M<W!H!  " PP=BWP-Q\>YU<6L$
M#A^(?0_$Q;O7Q:T1    .'P@]CT0%^]>%U51&"A7TC3OVMGA-CD)1](3]<UR
M8;)4V^"_D2?P-BK%:3MD=Q+6>U,J_.UFHU*N=/\"5;M1N5+1L<9V1[^M!
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M?^0>T M!(APP:D#L 0  @)0#L>\?TL\'  "C@]L/@@&!,P$   "D'(@]
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M25<(#@R(/0   )!R(/8   ! RH'8 P   "D'8@\   "D'(@]    D'(@]@
M $#*@=@#    *0=B#P   *0<B#T   "0<B#V    0,J!V ,    I!V(/
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M2(03%?NUY6CJ&G.%L"5#<':H^]UEN$$B'' $Z23V46<OO;&]R?Y5(<-?U4T
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M0%R\>UW<&D&_,<^!)KY-<$"H5PH=KP,   P,B'T/Q,6[U\6M$0   #A\(/8
M  ! RH'8 P   "D'8@\   "D'(@]    D'(@]@   $#*@=@#    *0=B#P
M *0<B#T   "0<B#V    0,J!V ,    I!V(/    I!R(/0   )!R(/8   !
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MP)0?2#'Z^79S^Q\&ZN8RO81^_E\^Z*,M]2VZKS5T<^IB<@)NN]VJOL%-Y=%
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M)L.TN"<>   &#<2^?\15 4LJ%_?$ P# H('8 P   "D'8@\   "D'(@]
MD'(@]H.@W:B\4?#X ;2L_^I*8Y.^;-66BWXV\N5ZN3">\8.&V*(>S&;%]V]4
M6VVW-@   &!'(/;]YT&M-)W)SI:JS>W62M'+9@OE9ONK8'9,:7GKDY(_EIT-
MZEO54CZ;*U:V9#$H/0  @#T!L>\[S7(AF\V7JI9NMYOEA6QFNE1[$'XGV*H4
M<]E\\<WSOAX'     +T#L>\W[5HIG_&*E9;U7:M2]#+Y4JW-'XCQ0GE]NQ'X
M\F7S3(8,?6@]  " /0&Q[S=DKG<4>UHQHP'^D,EXIX/@!2\S6:QL6)L
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M54_T81<  & !L>^!N'CWNK@U G 4D"YJL#?<HPG (,"%V -Q\>YU<6L$
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M    X.R!V ,    9!V(/    9!R(/0   )!Q(/8   ! QH'8 P   !D'8@\
M  !D'(@]    D'$@]@   $#&@=@#    &0=B#P   &0<B#T   "0<2#V
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M    &0=B#P   &0<B#T   "0<2#V    0,:!V ,    9!V(/    9!R(/0
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MOW@  !@W$/LA^(\'EYYS2PH#MNQM\=\-  ",&XC]$"3%>]@M*0S8LK?%?S<
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MSF$ 3!(#Q#YE+9[)/"9?L-[0H+A!NZ)K%\,#F8Q<)D\K_U*F= N2E\C$)UC
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MF @'@&D'8@\ &)YSG@@'@&D#8@\   !D'(C]Z#!KZ $ 8$J(]X-@3.";
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MQ7E93W!6[+#8+IA0(/8  #!*=BONTAC=W?W6_777@S!/&Q![    (.- [ $
M (", [$'    ,@[$'@   ,@X$'L    @XT#L 0  @(P#L0<    RSO\#1QI"
1#;=KG2L     245.1*Y"8((!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>20
<FILENAME>image_6a.jpg
<TEXT>
begin 644 image_6a.jpg
MB5!.1PT*&@H    -24A$4@   J<   *L" (   !>0(.0  "  $E$051X7NR=
M"W@35?K_ W@WJ/4"1"ZBV2JK5<2*N_#S$G2MNG41Q8J@1NQ?M["L6T0MUA5U
MY:;$1<NB!=8H5EPK$'$I++40+^52*@&*T"U!*%!*H"VTQ%!*F63Z/Y>9R5S2
MTK)02O/]/.?),YDY<^;,9'*^YSUGYGU-#0    "(#DSZ%0    !HIT#U 0
M@&@!J@\   !$"U!]    (%J Z@,   #1 E0?    B!:@^@   $"T -4'
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M6;CM1LVFB\\+?3:/%1<2UZV5W!(TEL[O1)_/%QO$'3N$2\WZK3Q1C[Q0?0
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M;-GB3S[Y:.XGSD\__;AL3SDO]N"!BNSY\[*RYGZ6-7=QSF+6/0(@JM$^Y0<
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MJ>KWZT,J&7-%E\+US55]410J*LKON.>VCF>3ZG:X^OI?;]JZC75-&ALD
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MZ@6^W/Q.N&X7_E5)S417@9-8B/*UF>CV.K&: - 6D8;>VQ+Z*@( 3A3\G0
M (!H0:?ZBK7:_ ?F>4Z1^<DQ6L#-1,E,2Y.= ?#7\9L?PDZI-M]1J5A+3T=]
M"LJ.ROKFT*(C @   *U$!%M?$.I7K?ENUC\_F..<O739DD-:%S>"<&Q-P<J/
M/IZ=.>?#?^=\?;!:,WL=# HK5[J7Y2YE:<G*U2M]^_:I_>+5':E=O29_N3LO
M;_DWRU?D_;1E<^V1(TSFPWE((45%GG]ES_M7]K]6KOZAYM A91,A% P6%J[)
M7_G]#_DD?;=^@^? @0/L$"&=UI:7[UJ_8;U ?0U)ZP\>J"Q8NX:DM84%/!46
M%NSU^?A64LA//VVHU,_'BX& ?_6J'[[^]\)UZWX,! (Z-W^^O64__[Q-64D6
MMGF+Z^KJU'D   " MH#V&?X@D4CAQ;0_=^G>Y7</_.X/#S]DO>[J ;;_JZZ1
M=)=(_I__\FR7'EWO>_#W?WADR'5QUU[?-V['SEU*";6UO]S8MT_W:WI=&_=K
MZ_6Q5U]W]17=KWAEPAN*\_S=NW?<<-.O+KH\QMKG5U=?=\WEELM^?5/<RC5K
ME1)"0>&UUUXDZP?8;K]MX&TQ5US<]]9^FD,<_J77U5=><667[KU[=+^F1X]K
M>EAZ67*6Y2H9.*0G,>*)(9=TN:S8NYVO(.D_2Q;V^E4ORU577G3I1>=>>-X5
MW;MVZ=EM^H>SI%U"06O<5;/F?:D4$A2.N?-R^@^XF9Q17/S-EUDNZWVM]<N%
M7ZF%/RUMS.4]N_U43+T7-[!.2=RML>OEKP   $#;0:/Z2Y:Z2+JFCW75ZK7!
M8# 4"NW=N^>.00,__.='3.?$!0L^L_:Y=O7:=7QK557EB*<>>_"11XX)T@NU
MM;6!?K?>Y,Y?75=W]$C=$6(9CWUA] 47FY=^LYQG*-N]X_H;K*/_\@(Q\6MK
MCVQ87WAESRL>'O8X5^4CM8<G3TSO<76OW!7N8\>.U=?7EY04#Q_QZ(,//R((
MDGM@HOH]>UN^_L]RO_^70_Y?JJNK_Y(ZZN[['F">=/FP/#6X-ZS+C[W>>MVO
MKWUG>H:\7B0%DAY,5575:Z^F7M>O[ZX]>P\<K#XBV^5$]:_Y=:_,3[_@A1 6
M+?K793TNM:>,*O?MIY796C+F+W_L;NVU:4L)ST!X*>U/I&_QAT<?XQ>!]%JN
M[=O;L^6_2B$   ! &T&C^O:1CY$T9MR+X2%W43QPD#K&)XNAD/#@X-^]-76:
MVM+=O?OGSI=U_GF'9(L?J0W<TO^F;_-7,X_^=8' +T3U+[^R&^DH2/EW4=4?
M\\*+@B 06=_FW=*C5Y?!CP[CJOQCX<I+K[CHY=?>D"M 4G#[SR5=KKQBR]:?
MI4,<#O3J?66N._\8@W0>TM-?>& ([WE(JE^Q?^_="0.&V4?.F^>\\=;XP&$^
MTB!5FPCSU"FOW-#_EE\DE_X25/6O[Y69E<UG!$C]$H?\KO^@07OW5ZKZ#4='
MV!])?>55Y2(0U1_S<MKM@WX[_8/,4(B4$22JO[ZX1(DJ!$ K(527%JW?5!;@
M?UVA9F=1?NZBW#7>*A[_XEA-J<>=\^_<E5NKPN_-'ZWR;E3%O.=YEGZ[R:=Z
M2UX4JK9Y%+Q50G6^8^2SZ3D[53-J_'#?+'%[ME6UZ 5[L<Z[=(9C7D%EB_XO
MO-J4HFV5S3M>L#K_O9$CW\K9K40# 2 :T:C^[7?%D_3W&?\PSI$3ZNIJ;^@;
M._^KK]4K:VL/=[^JRXKO5[-OQ%@_=&/?/C?TO>&W=]Q&TG5QL>=WOG#&K(^/
MR2%M=N_:_NOKK[GF6NM#0__PN_L&=>_=[:I8Z[+EW[*-H:\7?7'.!6=]_-GG
M\M&IZOL/';3&]LS[-I^7P&S];GWC;[[[/AM)_7_;[X*++LA=\3W?RG=<,#_K
MG,[G?)6SS+=W=\]KNG^_<C4O2LH1%*:]G1[W&](;T*O^U<36_^P+GO-PP!\7
M?UWRGY^7@P;1:T*Z(Y.FO#KTZ:>#(>GZO)@V^K5WIN7G+^_>Y^K\@G7!H!![
M4R\/'0S0!! "X%0B"KY5F2FWFVGX.^8AMWI%6BP/>V<RQ;Z0XZNK=K\:*WTW
MQXY>[.-=@[VN9V+(&JO=549Z#94_3!XD[=1O9%:Q_' *<] K8T[)J?2Y[,J!
M*,' EKDCPX=[U5W=5"1N+<QMGWF8T]N21V&8VS^9GH/>^*[R^,*OC?L'0+2B
M4?VDX8-)>N7UUYFI3?^WQ*)=M[Y@^7=NLA 4CMGN&3C]'S/5NU16E%]TN7GS
M?[<QTY:H_B\WQ\>]_\&'>>X5R]W+YR_\\M;;;K[MCMO+RJ4GYJCJWW!-PH,/
M?C'_2Y*6?_MMN6]?,,@5-/2=>^F%%YWW-AV3Y]T.*M7[]^VQ].SRX\;-O 0^
MPO^W*=,6+?[WUSF+/_[TDYMOB7MS\MO*XW1!H?[1QQ+/N?#\X4^->#8EN:OE
M\N=?3),?]V.'(;;^Y/%QO[DU4'N$KY'VI+;^5;*M+Y)>SF_NO&7(B"=^H4,%
MTMA#*!0<]_*HIT:-#LG'&_M2RH1W'$%!>&[,T]?%]_UQ?=$UU_> ZH/6Y7!1
MQO!AJ<_<J8AQ8-.B+_.]NTMR7[^7B?KNNM(?5Q97U-5NFC6XI\F2[O:'&L0*
M]_B!,?'Q?;GJATJ<"1;SL'D[ZLIR4OM)>2A,]7M/R-U#G?55!80&G>K7_N@8
M$&/J_XIKRVZ?[^>"^4N* D=KO"L79\V:X9S_35&%0#LEGB5+UY=N7YGM_'21
M9V]M9=$2YVSGDJ)*@6Q:^<GL_W@#M3Y/[M*B[=OSY\^:-3^_U$__8")=.2_S
M ^>7>465*AN=J3ZK4;%K;+SDM5?TEZY<Y)PQ:U[NIDHZF'%,6P>H/@ 4C>K/
M_70.27WZWK!SUVZ145FY[[>WQ\^<]4\^KY^9F7%3_UNV[RCEX]M'CQ[YZVLO
MW7;'G75U];P$/L*_:NUZI<R9,QTQ72]?7:B,\!/5MSX_[B5MUYP6WD"?L:](
M2GKPQEOZE<H5.'SXE[?>2N][6__:(Y(I4!OXI<=5W5;D%R@[O__^VW]X]%$6
M%Y@6LFECX36__M7'G_UKY>K5JPL*/OHHL]M5W?^[;:<R)D]4_^TI1/7C(XSP
MWW#5G'GSI:^B^.:D](NZ73;ORP4A9MD3:5^=OSSVQJN_6)2C[/7"2RE_G?H.
M6:BNKAKYW..WWC&@6\\KF.H#T+KH37!"3<$D&Y&Z204U#6*@;).G8'EF2I\8
M9NN+M44S[HT9X5PQU\Y5OS(GQ<QW/\I"W#Z15<J%EJF^Q>Y8X'*YOBFJTJL^
MBYP;<WOFYK"!3XN*M24]D62+-9F?S-IQF"FNC#DNOI^%+?5YQK5]KR3&Q=23
MO\* =SVUAW=DCXXUD7(>L5G-YD'3UBA#"(KJEZW/2NG+1A<"-+-YH/WET8G6
MWH,FKZRNB%@'J#Z(=C2J?_AP@*0'_G#O3?W[3ISZUMN.B7?>,_".>^ZN.?2+
ME"'P2^)#]U_?+V[*.Y,S9KXW]+'!EMX]5A7\J,AV;>TOM_[VYH)U&UEVNF;N
MI[,NOOR29<M7\!*(ZM]PH_4O+[VL5GTBM[P$0O7!ROON']3WUG[O_^/]]]Z?
M9KM[0-<>79?D2;LW,%O_*FOW;U<5*FOFSLV\_>Z[Z^OK^1$G3DI_^/''V<-]
ME("_YOJ;?O5TRI_KCDI=$Z+Z[TQYI>_ VXRV_J]NO)K9^A+[]I4_.ORA;KV[
M_VW2I-QE2UYX8?3EW6-^]] 0I2C"N)='3WAG&E\^5'/P@8?N.:?S^>NA^J#U
MT:N^>&S[O.$QYMA1KMW$]J7BS ?A8Y,<^;[:K5G#XP9,7N.G>S'5#^^N,XO5
M(_PT6([N0$R"^1R!C'BX:L^>TN(-:[-2>])R:EB!_<>[*XX6S1AHZCEXUJ:Z
MP_D3>I)""LK4JM_S5?>A6M;G2'&5K2,5CAF54T%Z__EO]*31?O=+Y:M'^,U#
M)O]0+K"SB[%G?N_)STJ--_5\(_]P(%(=H/H@VH'JAX'J@S,;C1B+@B_O]4$]
M-28R61G8QH;$;6]D3+B=![E/LEE-9NN@])P?YVMM?278'5-]]1A")%M_8,9&
MY5\AQ="SVH8FQK-0>RK%53H9O+.@4WUU@-V-7\GUX<%Y51T+R=9?7+S",=C<
M\]Z,];5^=YK%9(Y/?-+.&/W)QIWN1NL 0!03P4L/ .!,@SUFG^M(-)EZIF:M
MW506.+AR,M$\\P,3%J[T>#R;R@[LSE^<Z_&6\2%QT[WO+/[/)P[&!'N\*2;>
M_JY[IR?S]AC3($?^CD*GO8]IX(RB>MXY9ZI/RY6?X8\XKQ_[3,:R-9YUWRU\
M=_;"3_\28[I]4D'5@=Q7]'9V\U5_ST92'_/@&6MV[]SH3(XQ)684R8(M[>L1
MQ-VN9_J8^KSFKBPBF6-&9FVFD0)W;-JTJSSWQ4;K $ 4 ]4'H!UPN"CC?GG(
MFPKR6@^QO\.84[)_R!HI#XKW&3QYA4]Y>4^18?4S_-:A4_+WR3FTA=M=/KJ+
MN5]&D3R&$ QLF3>J/Y^J-YD'3?]Q^PIJ9Y/E?O']S(KBWI]1=+@1U2>;_DM5
MGQ8JJ[ZOKC+?,=C**]1G\)3OPP_J*ZK?$#SH?JV/*6Y4SLZ*<&9S;-J*@WR\
M(6(= (ABH/H M =H*'IJYC*J H+F.WOPOD$(^+85>7@,>]V>%35UTGLT=57;
MBSS%.ZLU[\"K"Z/Q[C6[*'FJ]W@W%='2Z6R=$-A3O+ZX+% ;J#I UM ]Z)[J
MPPF!JOU23>FF4%U-13@+7^+E&.LL[\L/+!?(,V\H+JTX3AT B&*@^@   $"T
M -4'    H@6H/@   ! M0/4!  " : &J#P   $0+4'T    @6H#J P   -$"
M5!^ Z$6L\Q6OS%V4NZK85]NR]]B%*B^/;Q]^N5^L\RZ=X9A74*E]M?[$$86:
MG47YWRQQ>[95\4,$ V6;/9Z-WBI5_#T 0$N Z@,0K=059XV4/?C1L'7AF'G'
M11/@WM1WF.,[GR!4YCQO-@]S>J7PF/\;P<"6N2-CN:\]N7IB:?9P>EA+FMNO
MSP\ :!90?0"B%![")BEKFR <]*[=[!.(;>W-7SPO<X;SRV]8B'K!YUF25U2Z
M-3_[G[.R5Y8&PMT"MN_ ";G;?66;ESN&Q]"8N;OJ?2L_F?T?+\FF#W4?JBLK
M7.+B_/M;[R%1K/5Y<N=E?N#\,J^H,I+ASGW[]W_%M66WS_=SP?PE18&0N#M[
MN#G&:NUILJ2[_1K/@ " 9@+5!R!*">W(&F(VF6UC,Y>L]U&/MGMS4N*LMJ$L
M"E_O(5G;0BS*CDS, ,>/M?*^3/7E2#8L9JXYY:N-4GB;"EVH^X,'5XSOT]N6
MDI::V,=D[O_$%QNVD0RF6%O2(S:K61L54(+'\;L]<[-J0YW7F62RC/]ZZ<0X
M4WR:NRJ\!0#0;*#Z $0M1WWN=UC$&G/LR+E; O6'J_;N+2WVL(CT-+8-4_V>
MX]V'0C]G/=23QMV1]]2H/A_NMV>OXZJ_]@==J'OW=^]834]DE0;*LI^AY1XM
MHAE&Y52(XN'\-WJ:^J;F[@]7*ER^*K0N(53B3+#0L?W:-9/B^.[AC0" 9@+5
M!R":$87 KC4SGH@Q]4E9O.Z'-QXP$Q-\Z /Q/+!].*)N&0V(UXCJBP=SQUI,
M,:DYF[GJYWVE"W5?M&=9:@P?,.A)3/_JBIP47CZQZ8LS;]>I.X/;^@,S-M;+
M:T)>9T)XX,%$CU=QLAX;!""*@.H#$)V$ I[L&0O7>'=OW^ <92$&]Z>SB3;W
MGK3F\(%OTE2V?N.J'Y^:E>\I^,]'J?>:38->S_=) >S7KHD0ZMX\*&7B-,>L
MK]?M]@O!S22#>?",-;MW;G0FQY@2,XH"8N6J&>.GNKQL\*!!GM>/?29CV1K/
MNN\6OOMWQU\333'#)OUKH<OE6N"P6VATW7)8^P"T%*@^ -%)*+!N^B#I&?F>
M@U[/\]7O8[:^R62.B^]GD57?3$/>&U2?V>(2YO@G)BTJ"8B"',#^4*4VU'V%
MU_F0_#"^R3S8L:Y"E:'/X"G?5XJ\&Z$>Z@\&MLP;U=\B[33@-^1PX5%]OSN-
MCB[D'I1S P":"50?@*A%% (^;]'&XIT'I:CS@K^LN*BX[%!=X "-7A\.71^J
MJZG0Q*:GFZ@M[U.M506P5X>Z/UR4<;_)\H)K^UZ?)W.P-)[/,VSR^@)LF#Y0
ME)%HOO>]=7[-8WUB7?4>[Z8BFNE8H&H_K9*$$*B2#P4 : E0?0# *47]YKVE
M_ZAY6U1O $J$MKM>?"-;&=X' )PRH/H @%..-#2@LM8! *<%J#X    0+4#U
M 0  @&@!J@\   !$"U!]    (%J Z@,   #1 E0?    B!:@^@   $"T -4'
M    H@6H/@   ! M0/4!  " : &J#P   $0+4'T    @6H#J P   -$"5!\
M  "(%J#Z    0+0 U0<   "B!:@^    $"V$5=\$    @#,?E<KK:6H;
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M+8=OTC[9QW-2C->3QVEF:ZC8LZ!//)H3_W72LCS2OA3Y\0OV9(:^?./A
MM!,,J@\   " =@I4'P   (@6H/H   ! M #5!P   *(%J#X    0+4#U 0
M@&@!J@\   !$"T;5/P71=]3^^Z(\FDM;B;Y#8:X7V)O]B+X#  #1@5'U3T7T
M'58.=><7W7[=VT[T'4*@T$%_J22GMU9;$T3? 0" =HM1]4]-]!U)>,:XRJ/<
MW5M;B+[3P/.POIH4@P?1=P  (!HPJOZIB+[#QZNY_]?HIDU$WWGYJSR'S9;N
M=(R@X1)H$ 5$WP$ @*C H/HG/_I.*."9#LF7:!/1=U0=.]('&/?V5$3? 0"
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MH^]03WY-E(_H.P  T#XQJOXIB+X3*'30KH!)[Q0V&FDLYDVK1]]IM'Q$WP$
M@':+4?5/>O0=(D)#;.DS'2/B6&<BNFDLYDWK1]]IK'Q$WP$ @/:+0?5/>O2=
ML#=X O,/'\U$CGG3RM%WI&&&R.4C^@X  +1?#*I_\J/O,/3%1BF-QKQIU>@[
MH2;+-QX.  ! .\&@^@    !HIT#U 0  @&@!J@\   !$"U!]    (%J Z@,
M  #1 E0?    B!:@^@   $"T8%1]8_0=?8XP :_;[6V!RU;N!9:^Z,^<O9,C
M:%XZ;_<8 ^302#=SF7-#D\4^O;"IBPT .%50+Q?R7]/$?%-*(45(<Y7N\OJY
M.\PP]NQU-&3&!&=F$MW!X1&D$A2O)-S!MN2B5+NWU3X[4WNXTN,'RJ)>-UQ>
M8S2LD^D*I=[GR75[=6[3F2\0E4^PD]1D*;[)(Q'R>;[^+L+)ME5"7F>BXM-,
M<8\FP1W<E83H+9&LN%X]C1A5WQ!]A[GAL]FLEN3/"]?,E+R[3%_E"TFN^*NU
M$7="OE73N<.99%<947F3S6[GCOV5OY;D[)W>[_17UX;SH7GB1MB'1 [V(X6#
ML]!H0 E.KU#N3F?W'W4I4T<K/-!FHU$#3O^5C80A0$[]+E=R/'=P1&,2-OHG
M  "<0JC[+,V_CS9NS":1XV70E719SL5;O\\62.T8"V$EMVBTP')7,HU9%A<.
MD:4*;&$X7-.!LI@/;]G[EKROI"7,+RJ#^T93AT,K+B!9;?81MH2I"V8WVL8*
MU'48:Z6GOCV.'J)"]N+%FW2IG9?Z B%#DU4OA>B4.P'LBMEL VDW95(:D0;+
M&%=Y?;C?P^LI!0 KE_LTI&+;J5-7VPB[+6FJ@P=HK?,5JA6'E3S"/H+&#SFE
M;D.Y]K&0<[9Q#MK%X9H2^=38C9&8EK>!B9&%7G!>><G=&3DCZN"._H+6EQ<L
M>)GYNF7N[Y(SYHQC'0*M+_93C5'U]=%W2JARA^^59%>IGP;0(WT9K\L>Q]S'
MJB/NE-'K(NN]PU,EN?9C1<L_O&VJTY% KZGJ+R&'\_'3KFMCP7[RRG@XN#*O
M*SE.^FJ;[O%S1[;,$[#D4:Z,U:V-N?TW!,AA5PF^[@$XO:@'.+ER\S"A<79'
M=MCVE;QH\R:+M3"9<Z:R%LTZ=4YF0IS-%B\W62SXB"//[9"B:M.]PWXYC8=K
M(E 6][%M=RS@MJ]BE7$38A\UQ*4VD$HPC=89#H?&8VTH?8C&VEC) 6NU-O0&
M;:[HOCO5;:DA/(<<.[2\@M:3ZADUXBW)V84+4J@HTC ?Y'1J=/44:!V2G(4Y
M:1926Q\=%Z%6'/< 6R9]E0*_J17'*C>;[$KR0DY^^\F&-TCE"S]G%VISH?0[
M1CRU +TF";,+J5=U29M4E?>6D;X1K62-USF"7$;:QR)EU9 BI3,E7<8:<H*M
M&(;>J/KZZ#NR@W<EXHO ?GB;H\!-.VNY.9J(.W2E.@*LZF[F0UY)=KO52OX>
MEM2T<>R2-6C#^="N:Z/!?IBN2QUPTD7ZD5PYY=A6A[M ZJ^T550A"7B '-:/
MAWT/P.E%]CNN71OR>5RT\9%%5!V%DIFJXQP3$DR)=CNS_RS):>,&\G\S,_2)
M$/I5GK/5L3,,A],'RM*-V->SBL11U0SX):M,,B&J/"I!H@OJ<&@!@1Z45*#I
M-E9JI7=*@[O^:F\>-]Y9;'2:.QP_Q=!D*8,BK'F7^AV2O4?72\/=^GK27);T
MW#S>:V*0M0=)9G+N^_CX"@OH:E </MIQ:C62GA2I3KWT6_BD(7IZ\L93V^=Q
MV-/<Q73T.CPXQ"Q2)4 :J6WY&D?"!%IGJ@+)<YSCV*6N9Y[4,YSA\:36P*#Z
M87M4^BYW+95>GD^*[T)'_@T1=]@-E>!<5<C[?;2_HY3&I'I.]APZM9_H<&6R
MZ:@ZUJN2P_GPKFM8U[7!?N0^8$F9*UG]5;*8O?+X>1M%[C^% ^2P2\K:%#HN
M%\]G^@$ K8LR\RH1MFB5J!8Z/:9M]T-T(#HAPS4GB8[K.CXG?V%FX; _N%K,
M9*67>P#ZPS4>*(OM11L->;ZUNIB--^RB0Q&2(6XE^6MH>!1#.#0Z\FIL175M
M; D;Q.7&**LA/;5X+F/RP$!8$0Q-UG<>7D,_#:<NY^=*26=#J' :Z\GKH#3=
MDH@45[M9I#<I )@2]E-6'!I65-91);K;*8%T3<A/N4N>AY5BT,B/4&A.+:]X
M?G("Z8U54-67M,DBG0L]M1)F^O\C;WYJ F_>I1%OZ;DN>?P[/#S3"AA47_]L
MB-3KH=]#\B0ZF[^A(Q7TYY1G+Z2(.YH /%*H'OX+21,Y'CJ60*Y*(>]OAK3A
M?.09@<C!?@*JK_1&E)^X85%DI(X8O9+\ECJ5M\4)$"E 3OBIA3B[(_<,>GH%
M@':$:H"3-%VT_9'GJL//T*F-=:[!Q+@?8$G++:$/XO$0U<P2E0Q]&KE*996J
MGPDP'*[10%GAQZ3DI_QH.2;EP28J[S:[W49W5,<_XU^%751R3$FS\[*.W\8F
M3'",8S6D,_?\B/+S"AK#6M]D*8\]6NPS"WUL_IZ6HA).J9YTB%>N)S>(2:F2
MIK"1B3KZH(#)PAXO8"UY9,51ABA.V32N)"5L5B)LT]=%.K4,UVS^@)X2TLPD
MA995'K @U1_W]M3$5'Y+R+^^W)'B/WWKJI5!]9N+T@G5;SCUL"DWS8T(  "@
MK:(W)J.8 !T4D:63/SY"IUU:4\Q.3/797([T6&,K$NZ$\A"Q    VCJ&IP&B
M%6[92^/B;/17&N=H52$],=4'    P)D'5!\   "(%J#Z    0+0 U0<   "B
M!:@^    $"T85=\8?4?U=BD/1*%YWY0YZU7VECSM\\S<.>X)8#QB^Z!>=BLM
M^60(T9@-L_/FI]M,\H.=REN>TM7C 1N*2ERJ//++Q-S]5L#KHAZAE?<: EZW
M,RWL"!0 <)+11-9IH&_5:P/2R+Y7).P3ITD.?+0N<GDT,K4/@ CO0B/ZSAD
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M((UDNB@VL6Q_RQ%T9$.?-GCRF#_WU<I1&4*(OL/.!M%W3B8&U6\-5-'G
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MH:I'W/AEU#W9Q\U%-@G>0@RJ#P   (#3!>T!C&G1 WHM JH/    1 M0?0
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M\Z?UH?H   ! VP'1=P    !P4H#J P   -$"5!\   "(%J#Z    0+0 U0<
M  "B!:@^    $"U ]0$  (!H :H/    1 M0?0   "!:@.H#    T0)4'P
M (@6H/H   ! M #5!P   **%L.K+,?L     < :C4GD]36T#)XOM/C]2-"3]
M#P\  &T,J'YK8)0'I':9]#\\  "T,:#ZK8%1'I#:9=+_\   T,: ZK<&1GE
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MX'!1AN%ZEEDQW+L9'M9C@Q!WS5P>?K306#'691D^;[641Y7!<+BH3?H?'@
MVAA0_=9 4H6(ZECN=;WY.+.JKW]XPE?+?SY(U5028,4$9RM95T"6?Z;QO!_P
M\[?C!W0SD:TE)7)1W7XS9MYRS<![^?*/7F13\L0NGY@QX;DDC:UO'(0P5JPF
M/(O?]?'QV>M_"F<P'BY*D_Z'!P" -@94OS4PR@-2NTSZ'QX  -H84/W6P"@/
M2.TRZ7]X  !H8T#UF\6,HB'_8S(J!%+[2_K[!@  VAA0_69A5/&6)GV)
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MA,S3ZS.B5&$OG&X=M2JR<;DGE%L&/#XN9/NX)4I;]U,K7S1@L%RO_-X;I4U
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M0,)I:]67DW1L9_1)$%7Q]9J=X\;E$53?^,4F  " )T!;JW[SB*KX>LW.$0
M &@Z4/TU$57Q]9J=(P   -!TH/IK(JKBZS4[1P   *#I0/771%3%UVMVC@
M $#3B:K^D]Q])_B-G]X)(W:+"_5;K]6FZ35QAYZHBJ_7]-Q##?_PZ1$FO@7H
M'[ %BQGH7Q/QS^*#=.*N[ESA2WR$PD06$EB9^%7WY2\ &ZS$#%J"]MQ]Q]I6
MQR2H%$:[%SR<X47X'P3K0\LZS#_PHV4JVNJ&@*035?UF[;[# L,+Q?2>\4[V
M!!HO%_,QZUXL3=VA)ZKBZS6I^OHS4>%#R]@]/'HY$?K)NUPL3*XK<GM>+ONO
MDLG^UDI=MZ>M^B*3WO6NF0B:2QONOD.+.YG;ZIC+<YF50M2:;.@9KE?&:3WK
M^"JS7/4&!KPJ+PG*:Q3BZ05M0U3UF[3[COQ--O<#*%VPZ)Z_(,_*"A0L+!/!
MWJ%']@_D6C[AXIF[VJRX0T]4Q==K8=47/@0M;4:JKS:JX<4-@P5PN& Z$&)O
M8Q-[5X-&C;?YR1X_X_;J#0NX(Y7.Y=T>LPGC5>R";7+H6\YZ5:L,E(B7/%)?
MO3[9+PP%+>X),4AG#Z0I$;>P=E'#NYV2ZA\O?OQF-EAKSP^$I(][[QI[ZM!3
M:&85/&EMLTK,1H)74VC+W7=DPV*JOE4IY+J9_-C+D$"]4BR6BK'=66IA^ORZ
M!M4'[454]9_P[CM\CEJ33@?'#(7F,&^JSSVTTSXQ3./U>:([]/ G\E?M#:[E
MA_$YP8H[]$15?+W6,,+/J]72%:WU=#OEJOC^4(74<B&$O/3AGG D@P./>M<O
M+;$Z0U+*G@'>RB_4A/E7E]ODW+AA^OJZ#-0QX9L9K&RJSZ6O^+[XOCIYFP/N
M$\SQ J5_MHM*'8KPCCO4"9,KF_J(KR.;+]T)[ZES^\M05J]??7L >O]4:<?=
M=QY$=MF)5(J@3R">X0'=.8@-8E%W(=CBDNJ%K-&B.L3X( "T&A'5?[*[[Q"\
M.*[0EP]I27Q156HW\ND=67>P1S3NU7'VX-\=S789?ORC[=##XL:Y<7>DYXU2
M611?K;])?0O.:^4=>J(JOEX+^_I&T?R1#O%"N!?>J"H;)?5C*N(3?5 Q.PTQ
MDQZHP]3)PQQ[Q)VDN[KGD'N@T[U2#IT8W+0@I$^O!LY[1V/*0*K/U^(T^J+6
M9_$;1_GB3JA_(XIZ\[R]XPX=M_9=E*K/>R3Z9,_?M+*J?+Q2& DT@:6VVWW'
MVF7G@=T%M^?T^%Y[K.J;Z_F+)G& 7XL,!^-#CP"T&!'5CYFX]YAVW]'JJY(%
MH^_L<SNI='XR+&PLR58F/FO>H8<EG%(N4&]#O+CPC@Q%J!Y&F0+.J^W0$U7Q
M]5I$*8FPZI/"R0$4ZKL82>G=SN/C5Z37:S4LTKU6TY$ZW?%9VG>'W [NS)A?
MI=V$A7S]GL+MJ;@RQ*N^W-U'7&6)SLT6O)#J^[Z^+JJ_2Y"_XPY_'%E.71S+
MUY?X$0[K4],S8]U,\.1IP]UW[&UU+'2E"&W2LZ*O'QHI\'L ,;4;@-8DHOI/
M;O<=<S)ML&F;2G?\>%^/K]94 Z-^O,4:=^B1<0(],DV5GX+2E(X&[TD461U7
MV:$GJN+KM=AVP?+UJZH 75EW,"T*4/U0C8#(?6Z"7RB$9B/[MU'_D$'/!DAE
M\^?SQO:[=A-&%S6VR5'C^E89:*OBJ.K358WA=G_L0%_"+JK_9>D==^@QHNW[
M#'=?JGX]O*=.+9C-0%G]<^6V>K3:+<*\,6B_W7?TS"$)-0M!B(OP*T6PK0[O
M*66]:P3&PG-1[=H'0,L34?V-AOF3A(<GJN+K-3O'%B#<_ &P-BC"W\:/#7;?
M 0EGPZN^_1N\AR.JXNLU.\<6 *H/  !)8\.K_N,AJN+K-3M'    H.E ]==$
M5,77:W:.    0-.!ZJ^)J(JOU^P< 0  @*8#U5\3415?K]DY @   $TGJOI/
M<O>=QKOCZ!_ A!?8(2(;]C0BNAE/\.L^^T?\J\#K;9FKT+S\GS<Y_\,W7IZV
MM7SM)G^YY]_7Q[K[3NQOA^S?Z=G4/%IVW"H 'ZS1%,B7(JL /2'DM;ZJE8JE
MF!\^A5>*%%\B_;XPND+1>@FO$&R_J[%^K+@>UO?-QF],T(*TQ>X[UI<K=W72
MSX]59&-+*KL)\A?="ZWA8^_ETZ#V ="Z1%6_6;OOA';'X85Z>DYZ9WJM^?;1
M#7L:$+,9SP+_@C\E%ZX)K[JS3F;_C[W_SMG;?32BY6NW\._U'^/N.[QP"OWJ
M?;Z4SQBK@ZVF^HPM3DKUFX]0]SUQ#YAQ7&XO=*/XT$H<0%G1>L#T=*T@MU!]
MFWH;[+YC?;FT+ 2O_1Q>4IHQ=]_1B_/(A:1J2W1Z]!NT]_*9;5#[ &A=HJHO
M!?B)[[X35GW6;/]T(ZW"V+ GGA4VXU&=_4#UN2<A/X[L_ML?1ZW;,_ZAOQG/
M__COG4W_.?U:1,O7;F'5?P*[[ZBM]DS5[Y$[#ND-<L(+Z9B^OKI0BG;0\7W]
MV1OA?7>TET,%EIO[,72STMEL6M_,\((\\G$B1%9=<H>>%.T,Q)>C]'0M6@R8
MTD0EUE!]:F>EZLO+Z5+YBS71;?E"NV*QA;'@_5>,YY _2K =$3\' UYU5@>H
M^/&8GXK?CBCL8E*5,;[9R'>WZG9$K4D;[;ZCO]POBZY:.MCJ689WWQ'?=5<F
M>Z!+/RI!R#/>B;?W\K%J'P"M2U3UG_#N.S&[X] JV;)%C*\V?!EKL3R+QIOQ
MJ,R-!EI&VD7]_]SJ#>B/,\\)_M/Q_*"_&<]_Y_R[[I^^$-7RM5O#"/]CV7WG
M 7?1LD>-Y=)(;OE32R_D7Z<:JCXML<PY\ZJ%(=4W]MTI7W%9DW@%0^-6TV?@
M9%*5Q]^1R7AKI;Y"98Z*0<^ +L^26I)O2>[$L_!GCO#?:>SK1R/\,;L!R:>N
M,W_^?+8K".229V86Q@SVR*\CM,JA_W7([8B"U8@E<LE(ZG;$%8!.#G88NC)^
MW/AF_3N\KNV(6I.VV'W'^'*K?APEI/KV[CL4SN1%HY6<SVL5%]_S#_?8[5+<
M7CZAV@= ZQ)1_2>[^T[<[CBD%IVB-:V)IC9UP#W4&W7+](8],EZ]]LUXM.2'
MQB#]8(;,I[=0^C#\<19XX]T^]]!?^IOQ_$_.?_^_GOG?HEJ^=@O[^@H_#JQ>
M//3N.T+5^EX*NXG68J+64OFFZM/:^[)@.JKIJ[ZQ%F^P@T[89Y+O4F$XYQ\?
MX9UU).(SW;9C#/[IZL0[JZE^^+A_.?5BL5[YO>>=D8/-G?FI>7/@N?)VN#"1
M\0Z*(061:O_K4)FK.W"O4KS@J2=$JKY9 /TMA*/TX6\VLH?0FK8C:E66VF3W
M'?GECO[*58M2F\]29/<=T5M5GZ<N5X;VLQ$?MRODND3V\HFI?0"T+A'5CYFX
M]YAVWY$AM>B<&C\XS]+-7KCV>.B(N6%/XW%$SB2\&8_<ZR5E+Q@NE^OW-]ZE
M^OZR^7$J%'/N='KRA>-I8S.>KQ_X__[WJ):OW=:@^I&=;TP):;C[#O=L8B+#
MEJ__0;G0RW,=]/2EL*_/&^%$?7U#WM;DZQ\H3%U2[G50C">J^N+$G7QUVK4Y
MN&?T+C?E,7=&/BU2L,W]T^3C%FQ'Q!XY*[0\2#W(QJI/>?I/W:#:P%!]L[ZO
MK[^[<.(&VQ&U(.VP^X[UY5)SQ*%X.S@DT8^EG@V@??U98U,KT]>W]O)I5/L
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M    ) 6H/@   ) 4H/H   ! 4H#J P   $D!J@\    D!:@^    D!2@^@
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MLU"IB@)#[]N4D(P)+4P=< [TQ2I<JY@09DGV!+GI]9*33CMY-ZSZ0NR[5"1
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M    D@)4'P   $@*4'T    @*4#U 0  @*0 U0<   "2 E0?    2 I0?0
M " I0/4!  " I #5!P   )("5!\   !("E!]    ("E ]0$  ("D -4'
MD@)4'P   $@*4'T    @*02J[P    "@_3%4WB;TWON5!1@,!H/!8&UMIK);
M0/5A,!@,!MM09BJ[!52_V79]<NR[F:T<@]FZVWWG_,Q\-(U*.7:ZV]EV<.1.
M^'CU_-F14[_[(II>V<ST:Z]>>KL<.2ZL?#.WZYGNH9O7C8-K+\_[,S=RE'(S
MYQ!;C.KYD=,'NS=39AW[!\].7XUFLI+%Y@F#P6 /9[6"NW_0JT6.;WPSE=T"
MJM]<,W5WYKW!;EN##?OB_%#&Z3A\:MJ4X?GQD<.;[(.FW3G5OVU3_Z5Q^SC;
M]*6#'9G<F"&KZRB/[(7(TV.+47UKZ%N;N@\?&ZN*!%<OO[Z[(]IE6<%B\X3!
M8+"'LO(?3PT\K_R9H1OK]$#68G,71W+;9?ZYL8OL:%V?.+>W8Y?J9WQR;7 +
M7]]QONY>FU!GR;;1*%6Y\O/<_DWB0'?NU.2<=JZ<39G7WS)\L GOR-=59IQ_
M?.:!F<IN =5OKI'N;M[>?\YVJ0,]]F6;7C@=>W?OW:J?#]9%];V?/E^NGA\^
MS,^<R/"-@GA<Y"E\1(CWA._$=^S_[FCE>JRL-BK/S,UC_;+"/'_PU?<NEOV<
MG4W]%_XI5 QU"C_NL3(?+:>9OZPPX8\V;;UK90B#P6"K&,ODMNW=+SPI7Y]<
MILVZ/:366\=-E>JSF_3BL<E[#<^BUO@>-\O]QZZ]S\=_^W/I[%V[<##4G+(3
MF#EW4><3G[EAIK);0/6;;+,%]P6E9^XY)8&F'OO.-^FQLVG?N0OEN0O#_?*I
M,OH$?+#C6[G+U??+MX[MVZK\>SI+/BN<DDYGP29YYN?&T.F&Y9$9<D\ST'+U
ML,HH0C2B$!N9$!9;3C_QO:O>L>W=QPK4Y_#SC'W7S!,&@\%6,>T<:\_[L5M(
MO_N/3<P<R^P]Z/[==G5%;L<DTHF79U$3_<SNX=OO3Y[;32G_5'!W&<TR-]>D
M[K>/99X)G'B^%N>U>?O A8NR,8]F;IBI[!90_>:;,?AM"U[@]!N#^M(/YM?L
MFE.?(*+!_-S(E+)_(*[RUE&7 T?DH,O@P7-Q 7R[/*'Y!/X5_1?FP2"3V"Z%
M7S%BR\EC_R??56&&(,^X=V$P&&Q=YD?.GU2$/XA0!BZ0TG*CGQ%J V6"B.I+
MR#NZ(<0^1O6UV9.]K,P-,Y7= JK_M(Q'P:5"!PZZ[_1_QETY>Q ]&%D/Z6[8
M2_9E59B_=X,  #5$241!5,ZG"\EV; 3>*L]G1M?!#QY\:AXT!OC]TRW5UW_>
MC"WG @UNC;U[[.01&M_BL\)YVN]&2@N#P6"K6JW@OK"]>UM<&/*1336M4^/>
ML>U^VQ55?2K#KB XKWU];O&TZ@MW:_J_'=NWU<G\*"=]?9;SJ.KS<#YW&F(S
M-\Q4=@NH?A,MU"_CT'<@>*3'UR<O9+LY@8KG;-T[?.LZ3;*39YFNO!_ GZ<P
MN//"H#=K.--^D/P+GF_"F4>END%Y^+GD2\OX/P4 N!>B:HY9C.#3<?[/9T?^
M>%U-5Y$Y1,MYET^7!0YW4X(^A_5NY$["8##82J9"I$+RFZ+Z6ND#U>?6F.1\
M*N2.QX_K'SYU4ZK^&Z=D2VN-Z_.UMKOOC2NQ^-?XS TSE=T"JM],$R[L.X/J
M9W+.ILQ/?JZFMLE)FUMWNS\Z*&?1LX>]?VB$YX8$L^UXE-V13W#PB[O@-W)R
M!@"%FZYP!X+R[.]GU6=GW5;0!N6IS%T<_0G/,A4'C[U&<_)# _EF,8S<@K.<
M[N_]P*O(^'],.<N5PJO?X_E]?OY&GC?+T7=A,!AL?>;/X5?3F2,)'M6,><HT
MULX'#5_?;_JX:?WLXO"+SI8CA4^B<_AU.>4/H*PY_"K#N[IU51.<PYEC7!\&
M@\%@L!;ZO?X7YX=Z@\[!DS=3V2V@^C 8# :#;2@SE=T"J@^#P6 PV(8R4]DM
MH/HP& P&@VTH,Y7=8J7]^     "PD8#J P   $D!J@\    D!:@^    D!2@
M^@   $!2@.H#    20&J#P   "0%J#X   "0%*#Z    0%* Z@,   !) :H/
M    ) 6H/@   ) 4H/K-X-/: BP)9G_Q  #08D#UFT%4'F ;TNPO'@  6@RH
M?C.(R@-L0YK]Q0, 0(L!U6\&47F ;4BSOW@  &@QH/K-(!"&RJ7O?,T)^,O<
MKSZ<BXH')]O\'WYZ\T_1MWRKWCS^'Y]9)<UZ+2;/^0]'#W=\[?"O*O-V8EC$
M["\>  !:#*A^,_!5X4^3I_^#DSD^^07_>>=7@]LZ!B]]&!&/-1GU#+9]9_2.
M??Q1+";/+W[WTXSS'T__KAI)#(N8_<4# $"+ =5O!EH50G[SGSZ\\+=_R8YU
MM7+AM>\]1[[_UK_ZZ8V/9#+J',R2XG[MN>?^E\V.L_FY_WMDY)7]'8[3\3?G
MWJ]*A7Z^;["W(X@9D$)S-X)S(*GF(_O^R]#@\T*YQZ;'?K!O*P<9GO_;T3_^
MJ5;]W2\.\W6=CGVOC__;?%R>?M=D[L:5-[[SEYN#Q!'-@]E?/   M!A0_6:@
M58']YH#-SPV>^]V_??[^+_H[_O+8A7^;UY$ *?:B<_ 9O2#UK?*1_G_\@%^P
MY\V)6;RKM_[Q;[:2, ?Q>5_^2;.=KWWK^$15Z7>L8&L7?X4\__C!N=ZOO?#]
M*[-QHP P9?87#P  +094OQEH50C\9E_IY4&C*R!4_Q,Z0M(NWGJ.]=4_T7_A
M>_-&MB3><OA GQA2Z/F/)M_Y/OOZ'?M^X@D__M^F?_53&6-PN)-QKT&>HD/P
M*8<??%:;<Y!4L[]X  !H,:#ZS4"I@JG!]'I;[R]N*4670?L@V>:0[QZ<Z*L^
MAPUXL.!/Y(7[PBQ4_[./)E[_*SD\3R<^Q^/T<G"A_Q\_F-.>_2<<2! ]CR^H
M"Z*' \)Y2N^?\@Q.CT@=S#?[BP< @!8#JM\,E"J$9N:SNR]C]1_JX?:O[?_^
M^>F/_&3^W#K_14C^GWMN\(<\T/[\=WYQ\R.1Y[^]]WWY9_Z__)5T^@/O7W0F
M*AY/"] C"_>X<R NVON= 1KUEZ&%<)[&1(3@]*U_]<-W?A<=)H!!]0$ +0]4
MOQE$Y0&V(<W^X@$ H,6 ZC>#J#S -J397SP  +084/UF$)4'V(8T^XL' ( 6
M ZH/    ) 6H/@   ) 4H/K-9?FNU]>5<HLR%KQ4RG=FO5G^MV:E!    !XW
M4/VFLEPI].Q,ISMSQ87E!U!] !+$0L7+I>FWKUW9PL=U^]W'Q')MZD0V)2Z2
M?J586Y1N!J^LU9,K5JG1D:FJ7A\E:I"LP5EK309:&ZA^,[E?*1SH*?Q^W-WC
M%N<>6*J_7"WF>J@&I;(GIFJ+XF!/H;)4+O2D.O.EI9J73>7&R_]\(BNK&34<
M\R*-Z$-0[>WJ\^XN/UBL39WF&B_KI*[_J;Y"&1/- 'BJ4&WO?;UPM._XT3[=
M[W_LD%^1/E&J?U4I](IV8U']N;10S*4"UX(:HG1^JOY@KNBF10NDSU+)JO%G
M^9FOD@RT.%#])K(L)/Q H?*5J"2='.0W5/_MLJ@Y7(7JI1/I5*XX.^ZF!KSR
M%3>=3N\Y,S6>2XE.@&HHEJF:=>9OW,AWI@:]ZGU5ZRB[/?G2/'7D.U\>'7VY
M,_MF6618?C.[QS\7 / TH.J_XT#V0)\W:[_U^!$>0::G</O+8JY+^ SB@' ;
MR'N0[PJQ[\V7ZJ(%JGD#G?FI>Z%DQ\>OQ)Y%S<X:DH%6!ZK?/*BGS'XZTUNH
MW#=4__Q-JGY<<>CH@%?]N-"S\R5W8,?Q,Z_O>2E_/$/OUBM%;[3@<C92];F+
M+?.IA>H>U>?@:LZ Z!2$2@, :#+URG@^FW)2:=>KU)]<-WQ6- 0<,IRM^JU*
MJ'$0"?88JG]C-I3LJ'<^]BR9>-5DH-6!ZC<-T;_>V5,H<UU7KRF,W\C77U@H
MY=..L\,MWM$O/A.U+M7G59<7RH4^Y>N;JK]0=%/DZS^H3^73WWFC<(A]_2?7
MN   UL=2Z>3 Z.^]O@R+[A,D"/C)N<.VKR\'&0-?WTA&3GS<6>3KKR$9:'6@
M^LV"))G\>_Z#0_0]A=M3#<?UEV4:"@G0B "_N*_GX'1EW4'1,[@R?CRD^L&X
M/D\7\L?UQ9\G)FM0?P">(J(%Z!P\/WI\H/#K?+KGR:@^-QIRB)TNEQN?>J.'
M1@:-XX2<8"0\$&-<WTA& _8Q9W&T<@W)0(L#U0< @";@S^%/I7/C3ZH7;CD/
M-)E 3M:7$W[KI?P>)?-\U*&)08L\Y\!(UN"LU9*!]@"J#P  38(B_,V8S=<(
MX>4/R!\0@<0"U0<   "2 E0?    2 I0?0   " I0/4!  " I #5!P   )("
M5+]IA!;+2V5/3]46[22KLEPK72HU^LV/_M7^8V2Q5BJ6:E_5O)?H=SL @(<'
MN^^ E@"JWS2,]2SY-[7^?KOK8,4UL)Z ZOLK=P( '@WLO@-: ZA^TS!4_X%:
M.:NX<#^TFAZMAM&3SAY(JS[X/;4XAEHEXS8OS>LX?W/HY9Z=_*-;<Y5?K?KT
MWXYTNM.AS?:\ZI)>M8/[X[0&</I EO;ID]WS\')^X5W[*#&=^.T?_WB U^B(
M[ IH[OCGOXN./P!1L/L.: V@^DTCK/IRBYWR%;>3M\&M?US(]A4J<T+7>:5]
M46GW=.:+-T*J/ZMKE^BJ]U*H(+3*KZGZ+,/T[H!W\WS6D&%ZD[?IH]7^15;W
MBJ$"W)XP=NT3G9(_LZ\_SQ'^/U./WM@I@-8#-G?\$V6#W@.P MA]![0 4/VF
M$>?KE]_.LG?,=+(W+V5>2GC!BU=]#K6E!O/',TZP_:ZI^KS#GGIQSQQ-G/='
M >2[U"<P"O#C(^':*UL'J?IW@O+SN>>]H^%= )HR; E .X/==\!3!ZK?-,QQ
M?9IQ0Q6&M)]=;47=\/4S/84/RM*GIUDS.TW5U]-J4GYXGRX0K_JZHR[^DMOT
M^;Z^Z#%\&2Y :->^0:]V9Q5?/Z3Z1C'0! !@@=UW0&L U6\:YAS^5-K]98GF
M\/OCZ')6_[U2OF=G>F=*_7F_7GZ3WDUEL@=8]>5V%U3!N*;1AKQ!G#!>]2L?
M%+)JGJWKE<G7EX/Q:F<_JP#U\# _#26L-*YOJCZ-$007>A)-&@#M#';? 2T!
M5+^ET+5K=?30OGU\%2R_' #03+#[#GCJ0/5;BC6J/KO@*7-H8*U ]0$ (,E
M]0$  ("D -4'    D@)4'P   $@*4'T    @*4#U 0"@"6 9*] 20/4! .#)
M0[^?>>*[[P"P*E!]  !X\C1U]QT &@+5!P" IM"DW7< 6 FH?M/@C; $6"0'
M@*32M-UW'A]HN#8:4'T  'CR-&/W'0!6!ZH/  !-H"F[[P"P&E!]  !H$D][
M]QT H/H   ! 8H#J P   $D!J@\    D!:@^    D!2@^@   $!2@.H#
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ML7,'NS?3!3OV?W>T0A)>KOP\MW^3+$-NC)Y:6=J]^[\97,[(,*;,LJAKB$_
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M& P&VU!F*KO%2COS     & C =4'    D@)4'P   $@*4'T    @*4#U 0
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M P   $D!J@\    D!:@^    D!2@^@   $!2@.H#    20&J#P   "0%J#X
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MBOO 6DXWA%[H_"NE_!Y1MK?'A^%/ -!<= "26R&I^M0=U_5=!_;])@A!_O8
MJM]$HK/NU7SX5#I[(*W%GNO//5([ZD&/5\MORCA^*GMBG 8%)'HDWM&#!6I"
M@*AZ51)O)\6^M?;"N9>N?/HO[\B+<@*:4;A<&\_Y\P"$!B\OUV,N.D]%HG?E
M]:4\WZ$\Z:!H(+IXJ,(O6%?VQ&1M6?GI5# YT)"?JHM. _4)''_F <<#.$)
M:5C=EVM3)[@(H@13(IN%<H'/"$]E   \,;3JJSF\HA69NB=CD-1-#_Q[/:,(
MG?+V *J_45E_![Q17 $  ,!& :J_P9"_"93TY(K5U35?__Z>H/ETBW8"
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M%'I4)V"A7.A+Q7^HA8IWQA,-1 ,XDZYLX>/Z@_E2?D_<G6&-[RE4@L-KO$L
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M&-:D 0# 6M&J+UHJZO2+>C9U3_2MU2A;X-^K&38(\K<)4/U6QQHR!VO%#J4
M  " ZK<Z]N_EP"KHX 1!$QX7[00  )!@H/H   ! 4H#J P   $D!J@\    D
M!:@^    D!2@^@   $!2@.H#    20&J#P   "0%J#X   "0%*#Z    0%*
MZ@,   !) :H/    ) 6H/@   ) 4H/H   ! 4H#J P   $DA4'VU.2D
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M    ) 6H/@   ) 4H/H   ! 4H#J P   $D!J@\    D!:@^    D!2@^@
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M.0.-"*D^     #8P4'T    @*4#U 0  @*0 U0<   "2 E0?    2 I0?0
M " I0/4!  " I #5!P   )("5!\   !("E!]    ("E ]0$  ("D -4'
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M\/8_+F2[N#IF\^,5C.L# -:)5/W2$D]#EJJ_*#Q[:HX^I_"^:LW@8[094'T
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M    2 I0?0   " I0/4!  " I #5!P   )("5!\   !("E!]    ("E ]0$
A ("D -4'    DL+_#QOF5,FVH/D.     $E%3D2N0F""

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>21
<FILENAME>image_7a.jpg
<TEXT>
begin 644 image_7a.jpg
MB5!.1PT*&@H    -24A$4@   J,   -8" (   !_WW-1  "  $E$051X7NR=
M"W@35?[^ W@WJ/4"1"ZBV2JK5<3*NO!3-^A:=>LB+E8$-6+_:F%9MXA:K"OJ
M*A<E+EH6+;!&H>):@8A+8:F%H!:D5 (4L%N#4*"60%MHB:&4,LGT?RXSD\G,
MI+1(N:3OYSE/G\G,F3-GILEYSSDS\WU-30    "(74S:%0    "((:#T
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MM$KIQ<:2Z0.E!PB:43O])J$J+YW4.#[E!3K5,/&99*M9KD\KE5ZJ3-!?]-:
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ME"U0>M#NT2K],6'TH$MK;^'1!_AE&XO6[JO XMYK5QJB/H1F65W(,=>$OQ4
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MSOYPCC:'%JDFFS>N/>?\L\B.'3IU7%?R?60>+:&@<&?2_]',K'.CYLKX/OY
MU%L5RY<OO?#2SOR\!B7=4W? +QQI?/2Q/W4XIU.'CAW../?LCW+GAV1O7P#:
M+6+-ND^RWIF9OPW=7@!.%EJE#\_>=S"=?^&%:XI+R$^U\7!]XLW72P+8P31Q
MJH/):G,R1I3^Q?%CN-)?=''<]?T2;KCIAAMNZNN<FR-GX0/QJ&/ZES*?5:OO
M[;]/8L(9,:5H6,BF#454Z5G_P+.I5)6?$Y$_%!)&V(?VNNJ*RWM<?N999]#S
MZ]CQTBY=+^_9X[>V.P('#T7NJR 27GEM?,>S.Y+N"Y'VB6^^/6].=B<F\Z:.
M'1Y]>K00Q U!    )Q^MTDMC>B:Q9Y]W[AN3W\J9]^'_>^JQ,\_JQ(?79YQS
MION;U2JE-]9IM=(_\GAJ?7V@_E!]??VA(X(R?.<E:'6:\_.!VH2$^ YTJ$UU
ME!1R7N?./_SX8V3W0C0L8?/&XG/-=$S?\0S#,;UR7 H1[ /^NNJ:FA_*MOSZ
M^E^1OL4%%U^R;,6JJNKJ?;6US=[L%VOW5]]^YX".9W4DTG[A11=UZW8IO6X=
M3=;KKJOP[=7N 0   )P,C)6>#J;9O#19X$++A?.2KI=->'VB(+"059+H&H_L
MB=*_\,)HHO2DA.MNN.&%\<]GO$C3_W[8&KDC%VGM[/TG'W]P!E50T]"'1R3=
M=1NOS[/C,T51&2ASP58*"2D!?#8IL_=G&H[IFU1*KW04FO95[[[^IFO($2^Z
MK,MW&_7] SWTH-NV_3#H[O\[\[PSI1Y)IP[7W-BO:/UZ;5X   #@)*%5^M??
M^!M)BM)+>L_^CGYF[-8?O4$Z*1UDVBR]6J,I@4.4?OSX/W<B2M^)=11X@1U-
M_UE:H-HQ*&MM1"%D)/V'Y$%$.#N=T6G1DOS\_RZZ*(Z^9W.%]>J#]=Q_4[VC
M(OE2(9M+R)C^;'*LCF=VBJ[T/#\OA"Y3I>_7AU0R[K(NQ>M;JO2B*%155=YV
MYV\ZGDFJV^'*:W^]Z8>MK#L2;3(     .*%HE?[OK[]$$I^]/^>\\YY\<M3%
M%U_$[Y0/2KIK^XZ=T2>T(Q".-&9D\#%]A\X77G#5U5:2K-=8V<Q_<XBA4.%7
M2\^_X!PBNETO[UZ^LV+OGMVWW7X+GU18^N4*GDLGI>$UFS84$:7O0)6^X_K-
M>J57!O3*+G2!*/T--_7IP,;TQ1NHTC=[GLID $TS9[W3\9Q.1.F?>^D5=GV:
MW14    X@>B5/I,D.OXVF<P77K"FN.2]][+..+,3_=S!U./*WE\7KI;%GL^<
M&W/D2./SSXWJR ;T(Y\<)0A!@2$JP>TEM+JXLWSKC3?UX3N>>=:97;MUZ79Y
MUW//H\)/TN"A#]4W'-8=FCX?IWS8M''MN9VITM/9>P.E#RNT>NV^JDI)Z2^5
ME+Y9(@KY:,[[G<ZE2I_YZAN0>1 3B$+-5@]'_5+^,2$&*C9)97&V5'#CVJA4
M%SI&C<S,V_6+#@L D- J_6M_SR2)C^D[QUWXW?HM]?6!VVT#N/:3O]?VO;YF
M_WZ6MSE)(TK_W'-I9!1.QO2WV^Z8]\G'\_Z=,^^3G/^5_2\RHU9Q_S5K^AEG
MG\'O%[";W^Q9 7X?P62ZZ))+W=^LT2N]NI#-)<7G=3Z'/LW7J<,_LV<6+,__
MLF!9:5F9ZC &2K^_AH[IR5$NNO2RXO5;U)NBH%'Z,SJ<T2'SM3=T=0/@=(1'
MG)6)?\3Q3:7V:9J6$O*[,YEKC8(<PRXJ%2Z[51M\%P!PK.B5_D62^'UZ<]R%
MQ>LVDY7??OM-YPO/EWZD'4R//_GD(1H3IKE>^9$CAY\=^R2]2<]WZD1OV),T
M]1_O1F94YM(I1QH/VW[W6][/N.:ZA+D??_S)IY^2]/&_/[$-HF^]DW3;G??\
MK'W-753KZT;/M^><?S;M'; )?QK0]\R.H]+'-7_?H::JDCZ11Y3^DLO6MN@^
M?1CGAS/X['WFJZ]#Z4%,P)2^]X3\GWP5I?F.E'A3W&C7[B,TY&WY:I?SO>QY
M7Y94'VYJ.NSSY"]=M['XLSF?>';M)LLEV[85+G Z_^/Q^:M+ECJSYRXIJ1)H
MW+J?2IR/FDP#)^1O\[$8=F)@^RJ7<WKV)_DD STB+WF6T[6Z/+"#*GWOYW+<
M\V?.G%]8[F_NIPL .!I:I9\^XVV2K%=;>UNOO/;&&THV_T!6$HU\Y]VI5\5?
MU?NJ*Z^X\HK>5U\U8]8L63B9WNM^B,*1QC?>>+'755?TZMVK>Z\>/:[HT8/]
MG?FOC^0N@EH1I:[[QO5KK[KZ"DM/2[<>W68ZYZBU>7G!TJ[=NU[6K4N7[EV_
M^&^^ZF$Z!:GG\?VF==VOZ'Y)ETM)NOBRB^,NO?CB2R\>]^+?C)0^7$CMOCT#
M?_>;"RZ^J(?5ZMFDF7AH'C'GXYF=+[O0'-?YU2E3V9J([@L IR%,Z:51M7BP
M\-6>-,Y\Y9'MN4_$]^QO'_M,<A_SH*EK:LNI)#.LCMQ<>=E$0\PG4O\\@M1%
MX-:T\FC^R-;<)_J9^S_ZPC.#K>;D26NJ&VG)9G-BTKV)"7;7-TJQE %O>^KQ
M@P+@V-$J_6&&W_^SG_(S>]*>(@@"^7R )$I=X*!?=\<] B*KAPX=JJVK(VE_
M;2U=8#0<5@RR0G(*_X;)H6OV[>/IR!'^+I]$,"A455?35%5]\& ]6\=%FD^A
MAPL1CAS9LW>O;\\>GG;[?"35^?U*ADCXOJ%0*+AG[YZ*RLI*GR]:$-QH_!P(
M;-^Y<_O.'?OKZJ#Q("90*SV/:&NUN_Y'K67BGLC^^CMF(3M@0N$&*LF69UR5
M!QL:F.KW?,E]X$!)5K+)-&QFJ9]U$;BZ1R@]L[CM8\]>[F$%]9RP=!4IV?)"
M_OZ@V%#UT[ZM<E'UY3F/A.WR  #'A%;IC=!(EZ*LK9(T76;I&?56E=-,35I9
M2#A[E$*.4EXS-6FN P3 :8):Z8/[\U^P4*>XS>Z,1&8";V>,<Y9L5MU05VZN
M<U&G\JQREE,K/;]S;TE,'L'*&3G:^<6_T_JH;LP;%*6N' "@51R#TA\#QTO_
MCDLAO_QTFHY3(0"<LC"E[YF>LW9=4?[L=%M/4_\W"FM_+LV^WQ3W5,Z6GWR^
MRO)-WU<T[#HFI><FLWU&YFRD#G/E6S955-.2S4,=W_RP;=VB.2M7+=05I:T@
M *#%:)4^]/=720JFVE7IL<B/QY8>U:TYAG1:U>3/:>+_]._X 7!:P#W@.9;$
M89,6>0_0.:OJKR</ELVNXE]RU[)'YR37=Z;T=-E0Z8/5><^8E?OTXI["R4/E
M6_$#,MQ58O57KP[JR3XFCL[[ABI]9%&:^@$ 6HY6Z8,#$DD2SC8A_=)T26=Q
MI5MS>0$X76 >\!2M+;W@KRC=X"G=44U-Y:E%O9PAO$SWY4MJM_@(YWCVF1G/
ME[."FNA>U5M+-GFI6;U140" 8T6K].+:(IH*"B+3,GGAOV+!ERPMDU<JFXZ:
M^(YD(5_>,9\E7AK?=-3$]^4+7\HE*$F?WS#Q?0OD*BG[*O51<BK+2N6;+T15
MVDJWN&^?YO("    )QBMTD=!Z5&K%_ARRSO;FEWX1R6U$$T%CF,ARL<6HMGK
MV&H"P*F(-*U^*J&M(@"@Q>#W P   ,0R>J571J4M?]"=YQ19[!K]2+>%*)EI
M:?++^OQU^99;PRG5YCLJ%6OMZ:A/0=E16=\26G5$    H*W0*SU%$!I7K_EJ
MYK_>F^V<M739D@.186<$X<B:HE4??#@K>_;[_\G[8G]MQ-WH8%!8M<J]+'\I
M2TM6?;O*MV>/.CY=PZ'Z;]<4+G<7%"S_<OF*@LW?;ZD_=(A)>S@/*:2DQ//O
MW'G_SOWWJF^_J3MP0-E$" 6#Q<5K"E=]_4TA25^MW^#9MV\?.T1(HZ^5E3O7
M;U@OT/@_TOK]^ZJ+UJXA:6UQ$4_%Q46[?3Z^E12R>?.&:NW]=3$0\'^[^ILO
M_K-PW;KO H& )MR>;W?%CS]N55:2A:W>TH:&!G4>    X*2@57HBL20]E_&7
M+MV[_/[>W__Q@?NMUUPYP/9_M762UA*9_\M?G^S2H^O=]_WACW\:<DW"U=?V
M3=B^8Z=20GW]S]?W[=/]JEY7)_S:>FW\E==<>5GWRUZ<\*H2K'[7KNW7W?"K
M"RZ-L_;YU9777'6IY9)?WY"P:LU:I8104'CYY>?(^@&V6W\S\#=QEUW8]^9^
M$8<X^'.O*R^_[/(NW7OWZ'Y5CQY7];#TLN0MRU<R<$CO8<0C0R[J<DFI=QM?
M0=)_ERSL]:M>EBLNO^#B"\X^_YS+NG?MTK/;M/=G2KN$@M:$*V;.^TPI)"@<
M<1?D]1]P(SFCA,0;+[%<TOMJZV<+/U>+?4;&F$M[=MM<2B,'-[&.2,+-\>OE
MCP   ,!)1*OT2Y:Z2+JJCW7UMVN#P6 H%-J]^Z?;!@U\_U\?,&T3%RSXV-KG
MZF_7KN-;:VJJ1SSVT'U_^M,107KAM;X^T._F&]R%WS8T'#[4<(B,@,<^._J\
M"\U+OUS.,U3LVG[M==;1?WV6#.7KZP]M6%]\><_+'ACV,%?B0_4')[V1V>/*
M7ODKW$>.'&EL;"PK*QT^XL'['OB3($BA>8G2]^QM^>*_R_W^GP_X?ZZMK?UK
M^J@[[KZ71;'E4^YT8+UA76'\M=9K?GWU6].RY/4B*9#T6FIJ:EY^*?V:?GUW
M_K1[W_[:0_+XFRC]5;_NE3WW4UX(8=&B?U_2XV)[VJA*WUY:F1_*QOSUZ>[6
M7IN^+^,9",]G_)GT)_[XX$/\(I">RM5]>WN^_Y]2"    '"RT"J]?>1#)(T9
M]UQX.ET4]^VG@>C)8B@DW#?X]Z]/F:H>T>[:]6/G2SK_N%T:<Q^J#]S4_X:5
MA=^R"/H-@<#/1.DOO;P;Z1Q(^7=2I1_S['."(! IW^K]OD>O+H,?',:5^+OB
M51=?=L$++[\J5X"DX+8?R[I<?MGW/_PH'>)@H%?OR_/=A4<8I,.0F?GLO4-X
M;T-2^JJ]N^](&C#,/G+>/.?U-R<&#O(9!:G:1(RG3'[QNOXW_2R%T)>@2G]M
MK^R<7#[;3^J7/.3W_0<-VKVW6M57.#S"_J?T%U]2+@)1^C$O9-PZZ+?3WLL.
MA4@90:+TZTO+%.<> $X00FUYR?I-%0'^TQ7J=I04YB_*7^.MX7X31^K*/>Z\
M_^2O^J$F_%[[X1KO1I5G/,^S=.4FG^HM=I5=/<%;(]06.D8^F9FW0W6WC!_N
MRR5NS]::5KT +S9XETYWS"NJ;M7OA5>;4K*UNF7'"]86OC-RY.MYNQ3W#0#:
M!5JEO_5WB23]8_H_]?>\"0T-]=?UC9__^1?JE?7U![M?T67%U]^R3V10?N#Z
MOGVNZWO=;V_[#4G7),2?V_G\Z3,_/"+;QNS:N>W7UUYUU=76^X?^\?=W#^K>
MN]L5\=9ERU>RC:$O%GUZUGEG?/CQ)_+1J=+[#^RWQO<L6%G(2V!C^FY]$V^\
MXVX;2?U_V^^\"\[+7_$UW\IW7# _YZS.9WV>M\RW>U?/J[I_O>I;7I24(RA,
M?3,SX1;2 ] J_95D3/_QISSGP8 _(?&:U+\\(QOST&M"NB 3)[\T]/''@R'I
M^CR7,?KEMZ86%B[OWN?*PJ)UP: 0?T,O#QWT1YCT -"6B()O=7;:K69J*\>B
MT]:NR(CG=G(F4_RS>;Z&6O=+\=)G<_SHQ3[>'=CM>B*.K+':716DIU#]S:1!
MTD[]1N:4R@^;1-C5F]/RJGTNNW(@2C#P_9R1X<.]Y*YMSM4Z$A8^SSS,Z6W-
MHRTL_)Y,ST&O?E5]=+&/]-,#H-V@5?J4X8-)>O&55]B0FOY6R<AUW?JBY5^Y
MR4)0.&*[<^"T?\Y0[U)=57G!I>8M_]O*AK!$Z7^^,3'AW??>+W"O6.Y>/G_A
M9S?_YL;?W'9K1:7TU!M5^NNN2KKOOD_G?T;2\I4K*WU[@D&NFJ&OW$O/O^"<
M-^E\.^]J4'G>N^<G2\\NWVW<PDO@L_=_GSQUT>+_?)&W^,.Y']UX4\)KD]Y4
M'HD+"HT//I1\UOGG#G]LQ)-IJ5TMES[S7(;\R!X[#!G33QJ?<,O-@?I#?(VT
M)QW37R&/Z472L[GE]IN&C'CD9SHE(,TQA$+!<2^,>FS4Z)!\O+'/ITUXRQ$4
MA*?&/'Y-8M_OUI=<=6T/*#TXL1PLR1H^+/V)VQ4!#FQ:]%FA=U=9_BMW,2'?
MU5#^W:K2JH;Z33,']S19,MW^4)-8Y1X_,"XQL2]7^E"9,\EB'C9O>T-%7GH_
M*0\E;%?O\^VI"0A-&J6O_\XQ(,[4_T77][M\OA^+YB\I"1RN\ZY:G#-SNG/^
ME]2!GG1$/$N6KB_?MBK7.7>19W=]=<D2YRSGDI)J@6Q:]=&L_WH#]=3MGCK<
MJVSI1;IR7O9[SL\*2JI58W&F]*Q&I:ZQB5+$7-%?OFJ1<_K,>?F;JNFDQ9'(
M.D#I03M%J_1SYLXFJ4_?ZW;LW"4RJJOW_/;6Q!DS_\7OTV=G9]W0_Z9MV\OY
MW/7APX?^]O+SO[GM]H:&1EX"G[U?O7:]4N:,&8ZXKI=^6ZS,WA.EMSXS[OG(
M+C@MO(D^&U^5DG+?]3?U*Y<K</#@SZ^_GMGW-_WK#TE=_OK SSVNZ+:BL$C9
M^=UWW_SC@P\RCUU:R*:-Q5?]^E<??OSO5=]^^VU1T0<?9'>[HOO_MNY0YMN)
MTK\YF2A]HL'L_757S)XW7_HHBJ]-S+R@VR7S/EL08B-X(N??%BZ/O_[*3Q?E
M*7L]^WS:WZ:\119J:VM&/O7PS;<-Z-;S,J;T )Q8M$-M0EW11!N1MXE%=4UB
MH&*3IVAY=EJ?.#:F%^M+IM\5-\*Y8HZ=*WUU7IJ9[WZ8V<4^DE/.Q94IO<7N
M6.!RN;XLJ=$J/7.AC;LU>TMX($^+BK>E/))BBS>9'\W9?I"IK(PY(;&?A2WU
M><*U;;<DP*4Z6_J#VW-'QYM(.7^R6<WF05/7*%,%BM)7K,])Z\MF$0(TLWF@
M_871R=;>@R:MJJTRK .4'K0[M$I_\&" I'O_>-<-_?N^,>7U-QUOW'[GP-ON
MO*/NP,]2AL#/R???<VV_A,EO3<J:\<[0AP9;>O=87?2=(M7U]3_?_-L;B]9M
M9-GIFCES9UYXZ47+EJ_@)1"EO^YZZU^??T&M]$1B>0F$VOW5=]\SJ._-_=[]
MY[OOO#O5=L> KCVZ+BF0=F]B8_HKK-U7KBY6ULR9DWWK'7<T-C;R([XQ,?.!
MAQ]6;.8#_KIK;_C5XVE_:3@L=4>(TK\U^<6^ W^C']/_ZOHKV9A>8L^>R@>'
MW]^M=_>_3YR8OVS)L\^.OK1[W._O'Z(411CWPN@);TWERP?J]M][_YUG=3YW
M/90>G'BT2B\>V39O>)PY?I1K%QGC4D'F$^SQ*8Y"7_T/.<,3!DQ:XZ=[,:4/
M[ZX9_JIG[ZDAC>9 LH%]A718>N2#-3_]5%ZZ@1G0DW+J6(']Q[NK#I=,'VCJ
M.7CFIH:#A1-ZDD***M1*K[:EKUA'*APW*J^*]/BIU7W?]/R]4OGJV7OSD$G?
M5 KL[.+LV5]["G/2$TT]7RT\&#"J Y0>M#N@]%!Z$$-$"+ H^ I>&=0S8BA,
M5@:VLNENVZM9$V[E)O$I-JO);!V4F??=_,@QO6(BI[:K9QB-Z0=F;51^%9(W
MG=4V-#F16=BI5%;I6/ .@D;IU6:U&S^7Z\.-;E6="6E,O[ATA6.PN>==6>OK
M_>X,B\F<F/PH,[VWC_YHXPYWU#H T)[0*CT X/2$/1Z?[T@V,5OY316!_:LF
M$9TSWSMAX2J/Q[.I8M^NPL7Y'F\%G^XVW?76XO]^Y&!,L">:XA+M;[MW>+)O
MC3,-<A1N+W;:^Y@&3B]IY!URQ:Y>?O;>\#Y]_!-9R]9XUGVU\.U9"^?^-<YT
MZ\2BFGWY+VK'TRU7^I\VDOJ8!T]?LVO'1F=JG"DYJT06:6E?CR#N<CW1Q]3G
M97=U"<D<-S)G"W7@V[YIT\[*_.>BU@& ]@24'H#80.TH3T5XK8>,L\.8TW*_
MR1DI3WCW&3QIA4]YT4Z17O6S]]:ADPOWR#DB"[>[?'07LV1,3PD&OI\WJC^_
M]6XR#YKVW;85W&_>W"^QGUE1V7NR2@Y&47JRZ7\ZA_N&ZD+'8"NO4)_!D[\.
M/V"O*'U3<+_[Y3ZFA%%Y.ZK"F<WQ&2OVRY[W!G4 H#T!I0<@1E <Y2DU 2'B
M,WM@ODD(^+:6>+@'O&;/JKH&Z?V7AIIM)9[2';41[ZBK"Z-^\1&[*'EJ?_)N
M*J&ETSMQ0N"GTO6E%8'Z0 VUI0\[S8?W%0(U>Z6:TDV&MO2L''V=Y7WY@>4"
M>>8-I>551ZD# .T)*#T    0RT#I 0  @%@&2@\   #$,E!Z    ():!T@,
M  "Q#)0>    B&6@]    $ L Z4'H%TC-OA*5^4ORE]=ZJMOW7OF0HU7\JM7
M7KX_-J?Y9M![W@<#%5L\GHW>&GC, ]!2H/0 M&,:2G-&RI'T6F<J'VD0;^H[
MS/&53Q".Q6D^*D:>]V)Y[G!Z6$N&VZ_-#P P!DH/0/N%V\2DY&P5A/W>M5M\
M AE#>PL7S\N>[OSL2V;Q3EWE"TK*?RC,_=?,W%7E@7!7@.T[<$+^-E_%EN6.
MX7'4?W9GH^0T']19Q8<:*HJ7N#C_6>D]($8SGE<P\+P/B;MRAYOCK-:>)DNF
MVQ\1H0\ $ TH/0#ME]#VG"%FD]DV-GO)>A^-)KL[+RW!:AO*W.UZ#\G9&F).
M-C)Q QS?U<O[,J67W6*8_ZPY[?.-DH5,E<8J?O_^%>/[]+:E9:0G]S&9^S_R
MZ8:MT8SG90P\[YL:O,X4DV7\%TO?2# E9KAKPEL  -&!T@/0GCGL<[_%7&',
M\2/G?!]H/%BS>W=YJ8<YNE/_&*;T/<>[#X1^S+F_)_6VD?>,4'H^E6_/7<>5
M?NTW&JMX]U=O64V/Y)0'*G*?H.4>9E[RAL;S$>5'>MZ'RIQ)%CIO7[]F8@+?
M/;P1 ! -*#T [1Q1".Q<,_V1.%.?M,7KOGGU7C,9:@^]-Y$;PX?=:2NHT5P4
MI1?WYX^UF.+2\[9PI2_X7&,57_+3LO0X/C'0DPSQ:ZORHAK/R^@][T->9U)X
M@L%$CU=UO![] R"6@=(#T&X)!3RYTQ>N\>[:ML$YRD(&UG-G$3WN/7'-P7U?
M9JC&]-&5/C$]I]!3]-\/TN\RFP:]4NB3#.#7KC&PBC</2GMCJF/F%^MV^87@
M%KWQO%B]>OKX*2ZO;!ZO];S_A^-OR::X81/_O=#E<BUPV"W4J;82HWH C@J4
M'H!V2RBP;IKD1D^&VJ\4^!KWL#&]R61.2.QGD96>^]!KE9Z-N27,B8],7%06
M$+FO_#U9)0=4OO+4*K[*Z[Q??HC>9![L6%>E-YYG70?U-'ZDY_V 6\CAPC/V
M?G<&G47(WR_G!@!$ TH/0'M&% (^;\G&TAW[)==VP5]16E):<: AL(^ZOX>M
MW\/F\?*NLF6]:JW.5YY;Q1\LR;K'9'G6M6VWSY,]6)JKUQC/!TJRDLUWO;/.
M'_%HGLKS_DC8D)XB!&K@-0] BX#2 P#:&O6;\9;^H^9]KWI;3R*TS?7<J[G*
MU#T X/@!I0< G BD*0#5J!P <&* T@,   "Q#)0>    B&6@]    $ L Z4'
M    8ADH/0   !#+0.D!  " 6 9*#P   ,0R4'H    @EH'2 P   +$,E!X
M  "(9:#T    0"P#I0<   !B&2@]    $,M Z0$  (!8!DH/    Q#)0>@
M ""6@=(#    L4R$TIL     </H3(>[J#P    "(,:#T    0"P#I0<   !B
M&4.E#_G=F19IJM]BRRSPA;0YP@2\;K<WH%W;#(+/E6:RC'%5-C:%RIQ) S/<
M-=HLQK =[2Z?=CT  )Q*A'R>.1DVVGXFV*>M;J[]/+Z0XW[QE3?0PN,U^CPY
M&3;:TEOL,XI]C=KMH#6$O,[D5%<EO_9^=X8EQ>EMD#?6N#,&)CG+0DT-7F=J
MJFMG"_]#QQ%#I:>::LEP^[GD6S+=%049ED2;S6I)_:1XS0P[_6[P;W# X["1
MG+6^@DSZC9&Z!2'?ZFGV!/H%2G55$#4WV>SV)':>!+H+V4(_^EQV$[T<Y!HE
M61T>@5^.TEIZT(&V@1:3;9PC(XD<BUT:OB/K?=CGE 4:?.[7V.>D3'=EB%Y9
M7D/Y6@, P$F@L=(UQF)[S>UK#%6Z4BTVAR<0;A*IIC:P=G6(?42"-.8);'&R
MK:3%=)86D=;09A]A2YK@&#>0MH.6,?,+_JEJ(<M"(5_Q--8,D]TK2N3\LXH+
M6'-=6REOM4\K]K&V,6&$?8A%:D@E6-U8XQG:Z4I-(,4W1E2RD<F5U69+)&UL
MAF,<;;5IZTKJD&BQV0:2UCYC(NTH2,.V2G=F$CT%>N+:$U0K0B45"+5>&!=H
MD&>$?82%E2"4R:?L]+95:\^U3R]#QK5E6IZ<4;"!700+K1OY1_AED;*-L-O8
MF)9<4NN0QT<DLG\B.8O$5-=W!=+_E']LJTZ H=(33>7"["]SIE)-IFJM""HY
MX7*_9YJ-BK3794](<GY-ZFIS%/N)8-.5%?1:R!KO\-1XG2FLW\"I<-FM]$K9
M' 6N#/J]]#?*'0NRR9;AWB,-^HL_L=.+NZ788:-?<KHU03X*V?GS#$NRP^,C
MA9O4->1#_S;\!@  0'1HDVV5!S8<)@]$HORT,4MR;JGD31P5Z02[JT+P.*PF
MTIK52060)HX*=BG5,ZISRM"+MY!53(3X[A:JT#R_OYXUAESOB?Q4>1S)M"6L
M=+&&E+21*:HYT0;><JK:24TE^4B,[/C5 CL=0>TL=EAI0\P:\-3<X@7L%':N
M=EA)(^^G5;)-\_AIG74GZ(E4A')WA%YXC0HTS,-+2'/Y!.D2,>UHF]9>GGLV
MD"%];0.T/LJ5K_"2GA.M52V72V\%Z?G1LZCS.D<D.3>0?X3545Q'-%3^KZD^
M'O\SX1@J/3T9VCOC?<PR/_TBLJO)OI'RA2;_LR*WPYJ8D9_GD+.;I)56\O65
M2R-?(%OX(RW":E^PE'P#:&^1%BMW+.@F<CEJ/.R:TJ\O/99/ZL;2K?2:-M'O
MGVVB(R-\3*NCJ$BJ(0  G$R4EBIB#6L2:2> :+.[B$V%^I7;EX$R%QTU\ME*
M@:HFD62I/6P(#[U4+:1*L]GHDWYD4IWQ>8&TE6DY;QME15&-N.@4*9,N&6TE
M/0UT!6F(RYA:[Z1'(6UL(S\[.GZC1Y&FJ5F5PNUQY E2@5 I E,1&:X7N@)+
M"W5Y$LF%D@5>OD1*Y8\_TO6)(D.:T]_C<=@SW*7D^K,KS_\1!17T)CC9MU&:
M&J]<XTB:(/5.[%E.FH?\._A=:>5C6V&D].%OF/19[E&RSB;MF_AH;U&:U4]Q
MEFU@_3C:5:'*3;\*Y"NQNICW*&F_1E6:-&-?SQ\%D+\-])L4D#HU.USV1.F+
M)7W/V(^![DC^V95T9LR265 \B]9$.C3M0K;I90( @!;!QO1D/!K@<Z+AD6XI
MFPHEC9B'-7$5TMU<J1$KHPVG-"?*1(6T>'R0IVTA_516DV9[BOG$JIQ?RN:5
M!NMT:&ZQ9.2728\W*;>*.:P?0.H6$ )E<^R69$?QMY&59'.KDIBIIF9I.\R5
M+U$WG<#G5OD07'6"5+95BL#FWL-Z0:<<= 6R^0Q='B:9=$2G.9>VH"*Z#&EK
M6U Z/S6)7,DJJO2D6A6N5(M%N@U-1:J,#?'_63 _/8E^*Y2NCC2+H_G81A@I
MO70R2F]/U?M3;L:P.T""]&^6[T:P"0#ZH(?J([L;9%(F6.A9\:\O_1*PN_6L
M!T1RTULBX3YCG>I[1CL*K"\UPD[OW/![2U)-6"^8?O6E&LKW_N7* P# B23$
MM%-J)@N\JB:1/]Y$I8[*ACQ"51XY8O>D!7K7W&1*R79.8+/E37Q>/=Q"AN]S
M)]B=6P+L+CO)[RS.8Y(<D+?RV^U^2:'UCS^''PZP.PJ\ 4TEV3-8]/AA;:/B
M2IMG:0Y?%D*#*D4Y02.!8%,)^@(C1435GV#G(I_RBIRV:NVEL;N1#&EKF^6:
MQ1^R"__?3;2K5!.^PN0\QKTY)3F=W='G(A761.W'ML%(Z5N*_DX/     *(1
MHG,S_)ET@X]MQ3$K/7\2/N)A3@    !$@=V5EZ:B0[J/;<@Q*ST     3@.@
M]    $ L Z4'    8ADH/0   !#+0.D!  " 6 9*#P   ,0RADJO][+C@0*4
M +?'0"C@=3LSF$V#=E,[@UT(*="/[%3!W[*(B#X1&5]"DS/*]>01-N1_'(W'
M)+W%P4C*<)6I0G0V^HJ969%A^=K# 0  .%TQ5'J=EQV+3<AL??@+]"S*(Q,/
M&JY.;<14YH_T(.(%DG(F)(T;9[>HX^&W2_SNC*0Q&>1RT?B4_/*.<94N9<&M
M]C!C0!:]TLJC3O/ F5:KHWA_1$Y_E.O)#3!JI+X:[070Z$:L-\#Z#6H'!<FL
MJ+B AG74EZ_^V!I38@   *<8ADJO];*3/7DT;DB29>U^&K97B=E+(Q*K/(A4
M<0J9,PUD@QL(,?7E1@ANOQ19.B"%'93&]#R -K5I=)9MT^4TNIYAPX(ZCR-9
MMIB4[84B\LM].#^-U6QUY.5'E%]N<#@   "G)X9*K_6RTX8=#G@+'%)<9]HA
M4!LQU15'>!"I1(+%\5>'TV^O*)Y1\H+L&\1Z19$NQ>S*<V]$;4[Y>C+7!WKU
M,]UE\VG\9(8\"4]*2^+_!;9OZBSG.)8Y-6/< -IIXPZ;V;.GJ,NGCA3:PP$
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M\KF!PPT  ,0DADK?%@XW?"Z:QUYMWYP2#C<O?%[@L-DRG8X1U)Z FA; X08
M &(3(Z4__@XWH8!G&F1>XI1PN%%UYHCNCWMS"AQN   @1C%2^N/N<,-GH3GM
MWN3F%'&X82@/6L+A!@  8A8CI0<   ! K "E!P   &(9*#T    0RT#I 0
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M32<8EP^'&P  B"&,E/[X.]PPM,6V4Z+ZRIQ0AYM0L^7K#P<  .!TQ4CI 0
M ! K0.D!  " 6 9*#P   ,0R4'H    @EH'2 P   +$,E!X   "(9:#T
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M,3MFI6?W9J3'$4\@X<XFMUL%  !PJJ.[N]]>X2-X:?Z;S?)*\QEM*Z3'K/0
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M7$>-GJ1>#"V%?SP-G>N,D(WF NPY.VEV7>4^IWK@HK+$V6HO.V]DSEBYGP4
M.$%H_$A5'B410N"7UH>-7!4#7/6C79$.>Q'W[#6/^RG'5<:I#?)C7M*3VIK)
MX--4 E1$/%ZGNKPSBIF&JAY9XY=1\W0>'R*R&]Q'PTCI 0   '"RH*H_IOF'
M[%H%E!X   "(9:#T    0"P#I0<   !B&2@]    $,M Z0$  (!8!DH/
MQ#)0>@   "KH6]KL+7;M*^\MXY@=;L*A7&@$$74HEQAUN%$'2J%!A 3?ZFG\
M[7E5=-N0M%*.&QCAD=92/S,H/0   !4GR>&&QH,+.]S0.#PLQ%X,.]QPV-6@
MGK%5+%C>@M("=8!;%K^.K[0R S.U1YH4.>?H?F90>@   &%.DL.-$A:=!_QF
M\>UCW.&&0L.B<R>Z\%2*RN%&TO(J>G$D,0][I$DEM,#/#$H/  ! 0>LT<Z(<
M;N09^R8N;W*8VUAVN&F*"%Q/;UZ0GE-Q >G-2+;F<MQ[&CU==GL)VZ%16NAG
M!J4'  "@<!(=;FSL0,SH)&QI%KL.-TV1@>NITI/^S!97:H+B"R-9HGA72S:^
MTBZRE6N+_<R@]    !1.EL--*.!U94CKJ9]-4U-CK#O<:#QGU88WLL.-=,WY
M963[A.W0-,YGS=RFA](#    IQ1PN $   ! RX'2 P   +$,E!X   "(9:#T
M    0"P#I0<   !B&2@]    $,M Z0$  (!8!DH/    Q#)0>@   ""6@=(#
M    L0R4'@   (AEH/0   ! + .E!P   &*9"*67_>\     <!H3(>[J#P
M  "(,:#T    0"P#I0<   !B&2@]    $,M Z0$  (!8!DH/    Q#)0>@
M ""6@=(#    L0R4'@   (AEH/0   ! + .E!P   &(9*#T    0RT#I 0
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M    H.V!TK<4O7*W-DD%A7R>.5+0(8M]1K&OD;W6J)!@=VZA[@)L9?M[&Q$
M ,!Q!DK?4O3*W=K$BF&!@[@70*#88:/QA6IIN"'N'L0#"-*P0BQF\/$R#P0
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M#)0>    *#-0>@   *#,0.D!  " ,@.ESYCD77:G\982;L91*&\-8HIT8S0
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M/L702=AJ>Q3)-!MJ5$PS&L=GR;CZM>OMJZST0MI7><613L%!30_>*OE-N $
MS -*#P!8G/PFW   Y@&E!P"<D8(GW !PT8#2 P   &4&2@\   "4&2@]
M4&:@]    $"9@=(#    909*#P   )09*#T ;XG9M+\3T(WGE6"K,X:?$0#@
MG(#2 _"6F/9;:\WV]1;\4P$ YPJ4'H"WA+23JP;-=A=), " \P-*GR644$>C
MN0BAN3B,[VZWWMNJ7U6Q!>?,E#*0< 0"<,& T@/PEA =NX!&[]L?M8+-:(PL
M& # ^0"E!^ M,9L.;E*.^])RN',?5^0! ,X+*#T ;Y/Q75R1!P X7Z#T
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M[^[6]&9VWYJGYR,9\_0@OT#I,X2TO*IUUUP0]T)=RLO3]"1INA!_KB_1#\.
M>P \L\Z5;]",AM,C%G*N@T=?M6457@E;G>%4JC@M%]2<Z6T=FROAT5=]Y3#/
MZ%-#F?@6%=-"U]=WK-':N/1?JC=ORBOO)WK*7UZ]S+T94@.>-:"^R#,:2!";
M:EY_G^8=J%E,[("YR$!NA,<>:!6(?1ZP+\7(UZ7FBRN]7M)<;$^S2-RU-=#0
ME+Y@19X(,[T6']4,353-Y*6I\K4]LP9 CH#2YPYN.,YX!3X 64*C][FZ(N]L
MB%-L%1U'<)& TN<*6>@OR5%Q_T,   #@[$#I 0  @#(#I0<   #*#)0>
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MQ,R](H\S:J^WKUK:#J4'  !P"E!Z    H,Q Z0$  ( R Z4'    R@R4'@
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M&2XO+2TWHL?/NUMJ\\V/.Z)WL!ZN5RI!\WI;K;4<MA]-2=>W O,RWJ43>B<
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M#)0>    *#-0>@   *#,0.D!  " ,@.E!P   ,H,E!X    H,U!Z    H,Q
MZ0$  ( R Z4'    R@R4'@   "@S4'H   "@S$#I 0  @#(#I<^(K\<3//#
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M]]_[._DW_\T__\VUZQ\-G]'?_/M_^N'PP-_:V/OW$IL5BWW]AO<9C_(^_(8
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MY3[K0VQ$U^XGX7\Q    \!I 5Q8EJ=QG??A;!    -X^4/I%22KW61_^%@$
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MV'?9O4["S6S2O;JJ+/.<;;H!'@"\<7*9<$.P>8.Z<=3<'2HM%_GF57E^. X
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M((^\O"7<>$K/4,*"/<4@3K&UM!D'^?Y(C695:D%MOM+[N3B/=79.XDP$(#=
MZ;/$GJ?7"3=4<)]<TWM*[]8ER?;%*+V70S-/Z0?WW!@;>SNXO@]XY#+AAHF5
M/@Z;X0B[VQ]:+ZUSQUF,:WHY 2].D,8UUO+C%*7W<W%HGIX3I3%/#_(+E#Y+
M[)%VG7 3SXO/FZ=/E!2K[6%<:<]7>I6,IW-HNH_3E7[\PHVQ^>V@+2\E%GL8
M#5'3 X<<)MPHK)K>.Z?,2W51O5[2>S]^R5?L2V*EUVOYD38<^R1?;])U? #D
M#R@] .",T.A]KJ[(.QM(N $7#2@]    4&:@]    $"9@=(#    909*#P
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MI.%*M&% D=.$FQ@JY1-9-?'982UF)=R\_^F=K?I&>S#RK20]"?>[$4BX 04
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M1APAX0: (@&E!P4'2@\  "<"I0<   #*#)0>    *#-0>@   *#,0.D!  "
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M#J&A.]VM<VPVBC8V[!B(9! .6^*()ZN7H]%$1=?$762YDIMP,WJ4'I\#0)Z
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M[CQ]YQ''_%C?!?) (1)N$H=E/.1.. =VLJ:75^S3\2L/2#5ZK]?R$F[\P!L
M<@B4'N0$OJB[/9A135]#^F>NH='[_%^1-Q<DW("+!I0>Y(097;@GJWA,S ,
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M(77'TT'4C*^]1Y8=*"Y0>@# &4&6'0"% DH/    E!DH/0   %!FH/0   !
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ME,<#<BPG%Q/RR,M=PHW/J4KO)=ST?ME>O:H[QR'WAF/B8]5+N/%S<:#T((]
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MR\6QE%X_\1)N_, ; '((E!Z<A?FM)[A T.A]GJ_(.X7$]2@ E!PH/3@+4'H
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M5ZX$M6;W,90>O 5RF'"CL97>N8@UCJZ1Z?5SLFH2T36JIE?7V,]9"PDWH !
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M7)$W!R3<@(L&E+Y\T-"E"L!M/T)%#P  %QPH/0   %!FH/0   ! F8'2 P
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MWE->')0.M-WJC@Y9Z7TKJMFHNU6GC-IP/9!^.VH5=1?K;-S9HBT&87AZ9P*
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M0@"\$C1Z7^ #26CS*A(:P44"2G\!4'G;5(,@F X  "X:4'H   "@S$#I 0
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M4'H   "@S$#I 0  @#(#I0<   #*#)0^2UXYX29[^/:_-[]CA^-^MY_36[/
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MP\'OSDO'RTZ6%TU;.1)!(_JMEKQUC?G-2DP/AQM0-J#TN>*.T]-,-"NF-PT
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M04_LN2S@< - F8#2 [ *E!X 4!V@]    $"5@=(#    509*#P   %09*#T
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M7-UKASTXP0  -@>4/D_(H8YZ<V%"<WN8O'H4/.XTOU6V!1MF1AY(N ,!N&5
MZ0&X(43#SJ/>^_"'P+L;3> % P#8#%!Z &Z(Y6SPC'S<M[;]PU\Q(P\ L"F@
M] #<))-7F)$' -@L4'H   "@RD#I<X*F00$ ;AGIB@" 38 ;$0   *@R4'H
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M2E\XN.*XY Q\ /*$>N\W.B-/(QZ6W<LW :^V%0#E!4I?*&2@OR5[Q=,? @
M )<'2@\   !4&2@]    4&6@]    $"5@=(#    509*#P   %29?P-F5\[G
0U]>W&P    !)14Y$KD)@@@$!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>22
<FILENAME>image_8a.jpg
<TEXT>
begin 644 image_8a.jpg
MB5!.1PT*&@H    -24A$4@   JL   -"" (   #.11)8  "  $E$051X7NR=
M"W@35?K_ W@WJ/4>N8AFJUVMLECQM_!3-^C:U:T+K%B1JA'[URTLZU91@G5%
M7;DI\8>610NL4:RX5B#B4EAJ(5X*4BH!BM"M02A02J M;0FAE#+)Y'\N,Y/)
MY&*+4$KS_3SGZ9/,G#ES9CHY[_=<YGUU 0    #$'SKM!@    #$ 5
M0#P"!0    #$(U      0#P250'XY[Y#DN_A=-^H!^G?AQ^D'T8]Y,M(IW_I
MAX=\CS[L>RR#)G.&[_%'?4^8:1K]J"^3?'A,^DH2_4K2X[[,Q^EG^I>E_S>:
MIDSVEZ0G>7K"]Y3R@:1,WY_^GYQ4G[.>E-*8IWQC_N3[<Q9-?QGKRW[:]PQ)
M?Y7^/JM)V;[Q+)$/=*_\^;EG?..?H7]I>E;^^ZSO>9+&T[\3QM-D>8ZF">SO
MQ.=98A]>F.#+L?AS)M*_+^7X)_W-__)+_I=>]+_\-YIFO"'6UFKO+P   '!*
M@0*  @"G$)_7]?42.V>98UVEN\4?MGU)H<.YK;Y%#![E;W%O_G+I@CRKU9IK
MLW^Y63Z*(;B=RY;8ESG=@A@0#[J^_+=4#"MJ>7F=5([8[-[\U=)\4D;>@A7K
M=C3NK_A"/F&0%4[WT6#)(:61VE94>P5YG[K"#'*FQHHOU%LXO&*LN):JU?20
M)5^[O#ZYG*-NYPKYO.K/8:@KLZ1H]=8]7JG8L*-X3NDLFAM+KL&C7(.4G=[<
M?^?GS21W)G_IE\ZJ1I;A."X0@,Y.5 7@^]-HDH2S=4@_-_7M)59NT]Y? "CU
M#DN*3H7>9%GL\H9OUQE'3"O9QPS+4;?CC:%&O7JG?LCD58K!\S@L!IW.D./P
M^*7/JHS)4]8VDSS"'L?4$4;UCA'CGKX[)"LCQ>*H#U966QJMU53''F8@PRJ<
M/&W-QG^FAFQB\(H1Q%K'Q,%L4_*8PAK99O)R^'G5G\/05D:?.'J!B\JDL*/\
ME;94DC7=YFJ)4$]=TM"IJV2;[?-N73!F8.A%ZH?GEGLB'/B3%PA IR>Z B =
M\:=&:XT9TG&DJWN)/T !@(BHS)5PH-SV5"*Q9,^LJ!-5V\7#NY<\ET0LT:B"
MW:)X;$?!$XEZ7>)3MO(# NVP[BFQCM!+1[$BPQ6 UB8=<Q<^FT@*'#JSQ-TL
M!@3O[K4+9J]P-=:ZW7NWVY^E1V3;M[L)!^2.-4-5FMC24+5V[FA2$_TPZ_H&
M,=SN!FCEFO:10BKLV0-TN@'9]@I:9+TT;B VK)J8E) T8L2]>EW"F,):Z3SM
M5 !297Y8,)K<(=.4TJ8(1T50 /S&MC16K9XSFM2MSSW6=1Z1:)(5SR:1*[IO
MTM+*)GKA_I9ZU]K%'RRI.!RAV,!/7"  G9_H"B#&&,!985OX1B6%[XWG1!2
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ML0FQ<)$4@'Y(UN095LHGSD9?F"%7TRX%$"Y9^IBR7F$G>GN!\T"D@7T9/@5
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MX9JK@OFQ#@!$)9KQ4&_WE.<.E^?^6]F8.9\IX#E]GO5OW4,7Y-E<Q]BFGU0
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M25M31DWZ= M;9R VETY+#F8+):2T1-/(["D??E4E.?/A Q4JI#YW0'LMTA2
MLO2/<:S"-JP?&XJO5676E&E(M54&AS*TE7G6NG1+H^(4:.T_LX<D2CN-]V;/
M62-;:W69>J-I%+F&+ZN8-F"(WNU?VB;260DI2\K0['>_H;X6VGZ! )PV1%<
MU*E?Z"P 'P,(_FHE_&].UQK(*,DWBBD 8G:;#@J71)\%>-\6$'WM40#,OHH!
M7_:?CY&S_.4O 9$T%'[QL$?H:]#FYXGTRQL/TIH<.N1_?8IP^45D(SE6.+>'
M[_[?BY4N>IE^P?_1^\)Y491-K\O]'Q>(Q]C0J3QX(&[:*/2]4IN3O@L@J24
M3A"BX#W@=KOW-:E]!1+SZJW7O,0?"Y)[7U@1709V=>VX&RJD%_V/ZU@ 3A^B
M*X#P=0#!,8" >+!)/'! ^MS8X'\^6[B838?'3%0!,&,I-C7]A ((M$L!2&,
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M=EH"-_36?SJJ5;U\K@"X$3U<,HDZY4NW5?Y0].K3S[RW<NV"ET:/?JUP]]&
M4%N^9-;$K-%F<V;VE 6KJP^3D_BK5[PZ9N)[WZPKRGUN-#G1RXLJN#_!2)D#
MXD%7X5O/D&WFL9,^^*Y>%(6Z34MFY631, *9V5.7L&/#%<#1W86OCC0E4B^!
MZ8^DLP]#QB_=?:#$^NQ;2U?,2H<" $!%= 7PR$B2M,8,Z3A2WZN@ $!'(W76
MGRMJ4 ]YRP,#1E.Z>82)^KX=\G))'8O5J]>;LB;/>"EKR-!I[UGO5?S?ZD=*
M08<Y$13 (_FNU73$0,)D75^U=FJ:GOK<'<'C]NH&3BYI]/%Q!17ZQ+%+W?[Z
M2)F/LB ]-"( ';U((:=CQIY6FX<1TB=-^L8300$(=:6V9]*,3+R\:$Y)H!]F
M.:KY.\OJR@, 8B@ ?]XLDGR/C_*927J8_572PS0])B?-UT='^AX;2?]*Z:&0
M] A)Z;Y1(WP//^#+>-#W\ C?0W]D:;@O?9COP:%R^H/T=P1/]_L>N)]^('__
M^'O?<%4:=A]-],.]],/0>UGZG>\/J=)?)=U/TCTTI9'T6]_]O_7];HCO=R;?
M?7?Y4G]#TSUW^.Z^P_=;ENZ^W3?D?VFZBWTPL40_#/;]9I!@&BS0#_0S3P+_
M<.>OA3M_3?_^AOZ5O@Z_7]RU2WM_ 3B92.968^W$W78:-BAU:FF#&/!Y2EY+
M)G8XJW!?1=[M.IUA]+RRW1Y!.-HBB&V8!9C^$H\,1*SX,7ZR0<\LV>[U'O3N
M7CR:QC%ZH]3C"X@'2EZ^4Z=+RBK<*U5IR)NEC<?$AJ)G:(3BIY=N_#12YFT5
M><-TNN31<];N]AX36HX* 5&HW[6SB<7L:"C*3N"5"U< A+V%64DT2*!O9\'(
M?CJSW:WL@0( ()2H"N"XB+3 IKU3A/2% CG\1WN/56!Q ;0;(Z(^A>:SNI#C
MK@E_2P& CD6*EJN)"RP9838U'E!9Q",_+AY[.^OV)Z5-7%CAE?KK$6PE/X2C
M'Y@^B8WDAQ8K?9-,K\ FXVE1+>KMXH_YP_J00PKL4R)E7G]DQ^*Q PWT+,9A
M$VG4(E%P?SUK3&IP%"&B A#WEW[P"NWZIY@GO<%F,E*>G%6Z7_H%0@$ $$H,
M!<!-%YV_BVY--;9-.83##_2K"FF++51.RE$.Y!M_PJ#*^]2%*+72I%"D#>KM
MH870EP;#4PC:[Q1^8+0;",#)H7GME&1BTP=/=-1*CZ7@J3^P+G> GH[;5]&I
M?4DEC"RH)CF$QAUK%UMIC-V$V_.V'(VM /I-*JI1Q1,*50"^\ERZZ&Y8/HO]
MU^*RI9,#1A;LE'+QTQU=;^U/:I+UZ5)KQ,SD9R,T;:<UHCI@6-[WF^BR!OVP
MEQ=_O7Y=?G:?* K O[/PA0?H)$%*VJ-T3D%O-&7D%.Z4?GY0  "$$E4!N/?5
MD.3<\)USPWKGQN^<&\G?]>6;-^W:O>O(D2.B\KZ^%K5=5)M)]>>V$'Z@.H7D
M"R'D>WL40%1""J%N!L(+40J+6BH4 .A@O%OS1M)NO7'H,[D?+LY_VY(^,-%:
M5$+CV/898IF_JJ3(EGTG,;?#\[<)N_\S<]:2DO7KU]C&&'3Z ;GE1[D5-UEL
M!8M+HJT$5- ,+7#QH;_7\N$7):O>RQZ8H-,_FK_CJ)1+?WO6VPL^L=+9"/WP
M_!W>B)D]NY>].VOI-^N=7]FR^NMT]^8Z5U/M8AB;O[FRW/XR6\H020$$> W[
M#,O_T5>5/TS9);B=RY;8;1:26V<P6Q<M65Y>%_7'"D#<$%4!3)T^B:0SSCZC
MQUD]NI_9HP=)9_0XXZP>^@OUIKM-[WWP_N'#["W;SDQ$F1)I6VS:=T3[<@-P
MTA!JOLE]DKZQQS&.F%:RS^_=;%/>B],E#9VZRBV(_MV+,^6W_/5#)J]R'U6]
M/B>_3\_A"D#S2CWM]1,K_G1A'=_J\VZ=/SKH-F#$5,<>(;@T84 *78&HTR4^
M9=MZ4(R<^>AN^U\2I4U]AKQ<[!::=RQ^5KJ6Q-M- Q)8'0Z7Y][+%QD$ZT+7
M-/3/+MK/3F>R.ID+!+YT( A5.9'F+ &(+Z(J@,E37R))UYW^7+IU[T90_X"(
M(!CQ\,/-1UKD4?HV(JJZU.H#?WIX/Y2(!X;VRV6B#U=H:L*S\0]MN"*I5$U-
M^-<V%P+ R<7?TKBKPNET5NQJ;)$?2+&E?AOU]^-R*XX"1<'K=I6'9!-;ZK:5
M;RC?5A<<[6=;F_:Y]ZEF !C^EJ9:C=M!=KC36;Y-.8F\/F!15?WV<F=%M2I[
M>&:2W>LFVS96[&R03R9XJ\FED ./DM/Q.K#J'/ *JNH(WGJ^1?D@;=WG#E+;
MI-P- .*8J K@M2DODL05P)EGG_7(8YE_'C?NUH$IBA+HUJ-;P>+/6-Y8OR6_
MW^?X<L64::]-F3:9I*DD39\R;?J4;TM+E2SL;P3CS1&$8PL6S'_S_V:\.7/&
MK-FYC4T'0\XH3<]'*.1 W;YW\OZ1.^OM6>_DUM8?4+;+A%1;]/N7%BZ>,_?=
M.7/>F3OWG7GSWIT[]]UY\^;,F_ON)P4%K<<BSQR*HK!BQ=(//GAO_@>V#S]\
MOWI/#2^VX4!MP<(%^?GS/\J?O[1P*9-* ,0UH2L$ 0"GGJ@*X.^37R1)Q^S]
M^1?T7+-V([&M'L_!Y)NXDU%*SJ175$=$U@&"T)J3\W3W,[K1HH*IV[09;VJS
M4B(8V@W.TIX7G,=KTKU']WGOS]?FT"+5Y/M-Z\XY_RQR8+<>W=>7;PW-H\7O
M$^Y._5^:F8D>-=<D)GF\4:<\5JY<?N&E/?EU#4F]M^F@1SC6^NAC#W0[IT>W
M[MW../?L#PH6^N48R@#$+6+]^H]SWYI3M!UR&(!.0E0%$)P%Z*8[_\(+UY:5
MDY]PZ]'FE%MOD@QC-]V4&59F;F.9-Z( 7I@XCBN BRY.N&E \LVWW'SS+?UM
M'^;+67C'/>H8P(LYSZJM\IV_364&-61H,F(AFS>64@7 =(-S<X4J/R<DO]\O
M9)A']+WVZJMZ7W7F66?0Z^O>_=++K[BJ3^]?F^[R'CX2>JR"2'CYU8G=S^Y.
M9 TQ^5->?W/!_+P>S/SKNG=[]$]C!1\F' $  '0ZHBH :0R F=ZSSSMW\K0W
M\A>\__^>>NS,LWKP[O@9YYSI^&:-2@%$MM]J!?#(XYG-S=[F(\W-S4>."4IW
MGY>@M=^<0P<;DY,3N]&N.;6OI)#S>O;\X<<?0V6'&+&$[S>5G:NG8P#=SX@X
M!J"<ET(,^4%/4UU]_0^56WYYTR^(YKC@XDM6K%I=6U=WH+$QYF("L;&A[LZ[
M!W4_JSLQ^1=>=-&55UY*[UMWG?'&&ZO=^[5'     )V GU  M//-QK?)!VZ
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M50 #DD@E$RZ[O&Q#6Q6 * JUM35WW'U;]S-)=;M=<\,O-_^PC<F4:(,'
MP*DDJ@+X^VLODL1G <XY[[PGGQQS\<47\9GX(:GW[-BY*_K > C"L5:+A8\!
M=.MYX0777F<DR7B]D<T@Q$+T^TN^6G[^!><08WS%5;VJ=E7OW[?WCCO_AP]"
M+/]B%<\59F*#6S9O+"4*H!M5 -TW?!^N )0! .40^H$H@)MO2>K&Q@#*-E(%
M$/,ZE<$#FN;,?:O[.3V( GCNQ9?9_8EY*    '#JB*$ <DBB_76=3G_A!6O+
MRM]Y)_>,,WO0[]UTO:_I]W7)&ED$\!'XR!P[UOK\<V.ZLP& T4^.$02?P! 5
MY_\26GNYJVK;KVY)X@>>>=:95UQY^95777'N>500D#1TQ$/-+4?#3DW7Y2E?
M-F]:=VY/J@#H+$ $!1"TW.JM!VIK) 5PJ:0 8A)2R ?SW^UQ+E4 .:],AOD'
M70)1J-_FY*B="AP7HK=ZLU069TLU#Q <E;H2ZYC1.86[?]9I 0"1B:H 7OU[
M#DE\#*!GPH7?;=C2W.R]TS2(:P+R]X;^-]4W-+"\L4P=40#//9=%>NW=NG>[
MTW37@H\_6O"O_ 4?Y_^W\K^A&;66^)]S9YUQ]AE\WH%-KK.U"'P^0J>[Z))+
M'=^L#5< ZD*^+R\[K^<Y=!5ACV[_R)M3O++HB^(5%965JM-$4  -]70,@)SE
MHDLO*]NP1;TK"AH%<$:W,[KEO#HYK&X G(YPS[LRB8]8OZG1KM9I*WZ/(X=%
M^U&0??9%I=IN-FJ=$ , 3A Q%, +)/%U /J$"\O6?T\V?OOM-STO/%_Z\7;3
M/?[DDT>HKYM8*O[8L:///O,D703 #^I!%P20-./_W@[-J(S)4XZU'C7]YM=<
M?UQ_8_*''WWT\2>?D/31OSXV#:%O[9-TQ]WW'M*^IB^J[>XFY[?GG'\V50UL
MXH Z-CZS^YCL\;'G+^IK:^A*0*( +KEL79O6 02QO3^;SP+DO/(:% #H$C %
MT&]2T1YW=461-3U1ES#6OO<8=?U;M<9N>R=OP1?E=4<#@:-N9]'R]9O*/IW_
ML7/W7O*Y?/OVDD4VV[^=;D]=^7);WH?+RFL%ZJ=O3[GM49UN\*2B[6[FLT_T
M[EAMM\W*^[B(9*!GY"7/M=G75'EW4@70[[E\Q\(Y<Q:65'EB_70! .TDJ@*8
M-?M-DHS7&?L9K[GA5S>7?_\#V4ALYUMOS[@V\=I^UUYS]357][ONVMESY\H&
ME>F L!^H<*QU\N07^EY[==]^?7OU[=W[ZMZ]V=\Y__Q E@YJ2RE)_4T;UEU[
MW=6&/H8K>U\YQS9?;;-7%B^_HM<5EUUY^>6]KOC\/T6J17P*DB+9NGE]KZM[
M77+YI21=?-G%"9=>?/&E%X]_X6^1%$"PD,8#^P;_YK8++KZHM]'HW*P9J(B-
MF/_1G)Z77:A/Z/G*]!EL2XBL > TA"D J1<N'BYYI0_UPU]S;$?!$XE]!IJ?
M>3HM23]DQMK&*FJJ&49K08'\64==\*?0>(0$23KP$,!R[__8MH(G!N@'/CKA
MZ:%&?=K4M76MM&2]/B7UOI1DL_T;I5C*H#>=S?A! 7#"B*H CC(\GD,>RB&V
M\I\B" +Y?I D2I/WL"=L1C\$8FZ/'#G2V-1$4D-C(_W :#FJ!!SSRRGXVR:G
MKC]P@*=CQ_@[AQ(^GU!;5T=3;=WAP\UL&S?>?"@^6(AP[-B^_?O=^_;QM-?M
M)JG)XU$RA,*/]?O]OGW[]U77U-2XW=&< 4?CD->[8]>N';MV-C0UP?:#+H%:
M 7#/OD:S_;\T)$_"$WE??\="]0Z:5+*1FFK#T_::PRTM3 WT>=%Q\&!Y;II.
M-W).A8=)!V[U0Q0 "R6<9,Y;Z60%]9FT?#4IV3"AJ,$GMM3N.;!-+JJY*O^1
M8/A! ,")(*H"B(3&I"D6MUVF+BRSM&:^7>7$J$D["PEFCU+(3Y07HR:QA!$
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MM//WHM?K^7;--Y__>_'Z]=]YO5Z->T'WWNH??]RF;"0?MKDJ6EI:U'D   "
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M[Z>5^:%RW%__U,O8=_/62IZ!\+SEST1G_.'!A_A-( KFNO[]G%O_JQ0"
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M]NOU]RE3BE8L>_;9L9?V2OCML.%*483Q$\9.>F,&_WRPJ>&^87>?U?/<#5
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M !#'0 $     \0@4     !"/0 $     \0@4     !"/0 $     \0@4
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M/MFXC630)9K2'S 9]:'1"R5XO,';\[:H=K2X;.DZP\3/ET].UJ58'/7!/0"
M-@,%   @''4[WF#1=/2)H^=O];8>KM^[MZK"N2X_NP^+N\,40)^)CH/^'_.'
M]:$Q@>0C0Q0 GQ(P%ZSG"F#=-[D#] GFO*^=)?G9*;H^KSB^>L.H>R2_REM=
M\ 0M]V@YS3"FL%84#Y>\TD?7/[MH?[!2P?)5X8 )_DI;JH&._S>OG9+,#P_N
M! "T$2@   !'%+R[ULYZ)$&7E+5T_3>OW*<G7?,1]Z7H@PJ A>"KIH'[HB@
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MO7@ P"D!"@    "(1Z      @'@$"@    "(1Z      @'@$"@    "(1Z
M    @'@$"@    "(1Z      @'@$"@    "(1Z      @'@$"@    "(1Z
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M[#)9'/ND08*RC\WTIF\ILYKHPT_W)LMG(0=_9C&D69UN4KA.74,^5' 2GPP
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M;&2@F.5K3P<  *"+$%L!G/C(0-1B.6=2>Q/G/@%CQ>/IV,A U(-@C/(1&0@
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M<C8J+(U_=*@A_?D*      "G'U      0#P"!0    #$(U      0#P"!0
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M'-Q9IJ-RD>0;G :34)QY\3S<1\<X>\5RYJ.4QEB2G% :F5O-U'$6HB&"(14
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M]>4LG@3S-TY-.]-)5.0235-:PSOTY"GAP234>9A_3973[!;)=Z8RYZ)T&@
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M+..8+A$9Z&>BBC@,  "@2Q.V>B!>X3U^1 8"    0,<#!0    #$(U
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M3O2K=#4\$N!"EZN(!L*BR/W@TR\28!28<RSFP+])B0VHVJAV+IUE=ZTYCMB
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M>[*[WZX<&2@0XMB?3H(015563%2.%#Y>C@M O<C+T7""8>0HQQ<'#@H   !
M.*<P,I")G8@%@@F&@NNZD8$"H8[]J0(@.F>+/3-9B9LCA8QQK9'")4N'R*%Q
MCS<.'!0   " <$Y59""_UV6W2-MI'*! H+6K1P;2Q/95!PJ2(P-)]YS?1G9,
M,(R<)F)<VY<!0 $     G1-$!@(   # "0<*     (A'H     " > 0*
M (A'H     " > 0*     (A'H     " > 0*     (A'H     " > 0*
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MQ;OMXY@O6_(AVVS_ACP]3$"0S-FR0UP 0-<$"N"D$TD!J&<!Y(4"TAB M""
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M2D ='5[2U@< T*6  @"@0W 7'O=*P#9!#'D:EGP" -H!%      0CT !
M /$(%      0CT !     /$(%$"7P+O=V7Y7,^#_L_>^KY%DZ;VG_HJQ\^62
M[P:],"N68<1>;C!PTR]T66I@M-B"&X8$CS#EW3)E=QKMI:# A<5.7HL[2YFB
M&P>49]R+Z":&AF*@+$]Z[-ZRBYQ.-[U35^3-<5-3*Y)LRJ*J2))&")'4GN?\
MB)\IE4HE*2(5GP])569DG,A(9<0YW_.<<YXO $"500%<)--A9T/68BW4_*UN
M<A58G+P]6JD5OSF#_4YK2;(!]G0FM^FHJ]T&%A8:K; _L;E<3IQG[A(, 0
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M-@:0*:['FW & J@P* " 2P%G(  H&2@   " *H("    J"(H    @"J" @
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M@4R>/IVA3_[@7VGS'J4$^L&*=GM:M#E\<G_D@T&P%E]R$Z7E?MB;J#UO:;.
M%#@# 506%,!%HQKO>BZD?TP,(*4 QE\.GKLBAZ/>CTS7O!4^&:0<@![O916
MC@>DQA?NA-O1/M&H@3V' ^L88&+^NXGTP_E1@/%D\/,P:'ERT+0"R%@9N8-B
M1Z!Y-V<@Z=B'3<GVHQKI=9%WQB_XLVW?&$[:E'\1.AEP[ ZLU,"Z-.IQDDH3
M43#@"P!075  EX'4X*G._3$*X+A1 -7G:X@#D+3OC?>[.TD'H/0\@$@!V!B
MF7S@S(2.GH5-;^WWKF5B  D%X&( <L+-ULW?32N 7<EOWWFN8]%OB@&@ #*<
MU1E(#((;Z[HY=Z, M65O^00%((6<IY26E8VM7FK")LY  ""@ "X.G8;=5,W9
M\/YQ"D!5]X^V]"!].FR0G@=@!_7-6.]+:PMD_&'C'/(N:;SI\)TX#R"A ,8G
MS@.P@_TU_^9-;RT8[,DXM!TLR,T#0 '$G-D9Z'#4O>LW-L),Y$ "]QO)48!Z
ME,/?1>^=79!<A"Z<;^+\DTSKGA@%P!D(H%J@ "Z2>%K6*2?VPY7DK,Y $OLQ
MD_06]+#+URDA&,\$7)(VVZK)M%V01/Y]%R+*S"O$&0B@ZJ   "X%G($ H&2@
M     *H("@   *"*H     "J" H   "@BJ      J@@*    H(J@     *H(
M"@   *"*H     "J" H   "@BJ      J@@*    H(J@     *H("@   *"*
MH     "J" H   "@BJ      J@@*    H(J@     *H("@#@HIE.>EO>@J+F
M;>R,IMFW 0 * 04 <-%,>NW55G"O'>YEWP$ * X4 ,!%,YT,PI97]UI!9S#.
MO@D 4! H@"(XZK7K"PL+=9].8748/=ALW]UHW.J,RS ,,.FU];B$'XZR;P%
M54 ! %PT>Z'OR2A \&';NQZ.CK+O P 4 0H X**93OKW_9KJ<2_Z6X^8"0@
M)0$% ' IC!XP$Q  2@4*    H(J@     *H("@   *"*H     "J" H   "@
MBJ      J@@*H!!<1C9AT0^>3%Z_GHX>;?F+VCZF&?0E=VR\9:'1"ON3Y '&
MG59M?3N\4V\$@_&3P.SFW>Z,#I-[ 5P8)M6Q9#FH^??[DQ)G.9@^"YO+.O_F
MX:A[5R=FR-Q0B80-^F84)MTX?=/$WF+I;WHX#*]+(6?X-!V&3?V:.Q'F!11
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MFE9>3\=QVQ/FC8E1 #W*9E8]W.V.#EVI6'SK&;NOIX.@85]?3TPS!"@O*
M."LR"E#FF8!O0+79JG=?QBD, )<""@   *"*H     "J" H   "@BJ
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M7*'(&0!</*=7 "9PG>S+ZG'N.-((    <\/I%0    !<'5      500%
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MY=;C>OFI607P5KQQ+0  5!T4 ,#50R:+U&K7PZ&X<@, S 0%    4$50
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M3H?$'5>T%(#J@@(   "H(B@   " *H("    J"(H    @"J" @   *@B*
M ( J@@(   "H(B@   " *H("    J"(H    @"J" @   *@B*    ( J@@(
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M_9_?_[9J"W_ZUZJCK*K+/57M_N8WOOT__X_2:_KM/_FK__L_2[?^FU(1Q\V
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M.^-7<^?\&[_S)__'[Z3_JOEK,O&7SU^9\07@_H9:@K@;Y-S$XN4\LA4!0 E
M 5PVKD;0_:&(;__1#QX.=-<J:NUTP^\ZQ]*N&"GPNW_S3_)$UX##__:7O_M;
MW[KU][_,]ZYF!Q5T%:R/'_6]]!-=Y\:]\*BF-F';3.,:U=K/I'%5YS.,/CU?
MQ<]X1 I#\YWO_]>_5ZVIWJ@_*!\,L-_E2_VY2:&S_T]_]?O?T.W6,5U)/=SP
MYGYP[J\7/Z(O^Y7LHYOA7$#%[),\,7W DW:>\=?[VY[:4S>BT5] MZ_'*!OW
M*?;;Q;^L>_>$WR)ZRYSG'__EHZ'[ WZE3^_W__)S<^:_F6MH7_WRTWNJ@==G
M;GZU],6CSUGDJ5R<W\R%$+3^L"0C-/DKTYR)_JNF#A[)H_SW*O4C6Q$ E  4
MP&7C:H09%72J&9/*3M>_4<0U:M133Q(UZAL50++S+9\5-:NZ%8G>E0I7]\M3
M3:/J03[8M+VT8T9PXX+)3U2[)QN261WNY,;HL/_Z+S_^"]._7[#M7+;3G)Y/
M,$,!J'[VW_]IJK\8#45GH].9OFGVR\IG?<L>)__%9YV8/:"3+]D#9@^2&2,W
M?['AWVW_^?'C[OKKQ[^.G?/QC>_]E_"+_1F_A3K:QW=M#,".':2EGOR1O\R=
M>?((KOFW;7#^5TM<3ODK?,8!W3XSKLQ?Q,6=&I:(U,Q?>1X>V8H H 2@ "X;
M6R/D>[KI@5M7#SY-=];S4L .!^1J'&FQ;+!:QU==\$"/XXZ&.W_QGW3O67=M
M=2N2/KZI9Q--HPE%W/K[7^K @Y,F^@PEDG_ZX>&9'>YXHSL-W3N4,_PWZ>BK
MM_K1EXV:%OU$=T8SGQ+_T:0C:Z+3V7T2CUQ;E?^R44C&!!Z2"B;^%9+MF>DE
MNYUE?.?DO][_^[GK?*?.2@XR4S/%[:)KOW79U+61^BWTWT2/\LC?1+\57X3I
M*$YTYNGF5A=,=L'SO]I)(809<9KH!.3)C"O3?'TM.]SX5/[O,">/;$4 4 )0
M )>-K1%F](=T/>ZZ=+I'&%6IJM9[$34#B9HT'B?^QO?^_*\?)><!I :&O_\7
M#V08-3$2[/;/]P)?Z7[S;^IN]Y=QQ]=4S5+P#YNV5YV;&1X7/*&.SC6WJ8W1
M:;PPW<T%,YHN?Y;DH+@$KE/?\3=^YT^W_R41+8^&D$^Q""(3G99/__^R7U9^
MK^]\_]8?RC'=I[M']L3T#Y39^11_O7@RP3>_>^LGZO=*_8+Y;R&GY)K8Y$0$
M.^T@]UO\Z^--/8/DN]=_/S&*GPT&V#_[PG>:UU?3LB,U;A4KL.S%8S[E-[^U
M_H??S8!IM[\  $9F241!5 <Y,M=&? +Y*S,Q%</^N,D;9/X>V8H H 2@ "Z;
M?-7 XVH]9C5U/"K_R%8$ "4 !7#9Y*L&'E?KD9]5P(,'"@#*" K@LLE7#3QX
M\+CRCVQ% % "4     !5! 4   !015      500%4!S34>]^R]-KJVK^W>[H
M4&WI;ODUV=#8Z RGV0(   #G!@J@* X&P>I"K1GTQZ\GW;97J[4Z+P=!8V&I
MU=GMM)86&L$ "0   !<&"J @QIU6K=8(^C-:^>FSL+F( @  @ L%!5 ,4^GN
M>^W>)/O&ZW$_:-86%IOA,P0   !<'"B 8CCJM>LS%(!M_OW@25X:    G",H
M@(+0HP!>NSMY?3CJW/865MJ]%Y/>EK=0\S9V1G3_ 0#@@D$!%,7AJ'O7S/M?
M\%KW>Z/IM!\TS&O9E L/    G"<H    @"J" B@&U]<_B6P9  " \X-F!@
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MBD'F-,AF54Z&R3)3;=0=TP]E(HZ=!W!,*3T/T;YFG@W,!R@  #@K,@I0PIF
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MYAP%+:K'?R-U"^ -"/,/"J!PK)/I85X!F'RE\GH]_&P[[?03^09E@K&_CA5
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M_B3GYI>ZRY(*(+M&)A4S<*6R1\,;$.8.%$!)00' '""C '-\E>(-"!4'!0
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M<^2^D3$0RKQ\[6( =LX_SD!P94 ! ,!9P1D(8)Y! 0   %01%    $ 500$
M  !4$10   ! %4$!    5!$40"%D\@$T-CHZA?F)6-\1ZPA0AM774&5*Z0R4
MY7#4O:OS:9AU?<<Y V4\?C*E< :"*PL*H!"26<-T!E-M9W(RDLN<E4M0%LKH
M#)0E2MJCGJS<"(?#V;X &8^?X9-TJ3'.0'!500$4PDP%D$U7XO*0J#[6W>YG
M'_JZ=U%O;V_[-[1!P)+GB5&@S49B=_9\WRM)@C:XTI30&2A'-G6_,^_)*(",
MQT\8G"KA/\Y ,/^@  HA/0I0\[>ZHZGT))))_G<[K67=I1 _DEJK\Z+77I)J
M1><#%@6P*-T1V__XJM-J2&!3S 46J7W@4BB=,U 6Z<1K(P"YIQKMWGBV,U!&
M*$3V ;;4/LY <%5! 11"5$>(>;FV DI6*":)Z3]&J<M-%M*]K +0J<NM5]!3
M:A\H@+(Y V5Q<;7:LK?<.-89*.L7\")5JC?!&0BN*BB 0DC4$=H2T/7FWRH&
MD%0 Q #@DBFC,U"6:*A>W37-VYV]G=G.0!F/'YD'D"@U_AIG(+BJH  *(=5+
MD"G$]>OA<'+2/(#1X=%)"N"(>0!PN932&2A+[/&CE]MDI]H<X_&3*84S$%Q9
M4 !7 STQ6_4_) :P3/\#+@F<@0#F&13 U2!:Z%SFQ=D  % B4     !5! 4
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M"?, 4 !7CR*=@6(/'OWQJH-N;RCS]G$*(+>"P)7*;(^=@>1>4$>8],-6O!;
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M:E)" 40Q@,;[W9VT.9",-49V.]=UI%U:6=V#%Y>4? P@,0_ !/^OM7N_RL4
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M>_L9+Y_LG1*- B2=@>(8@)WS[TKA# 1S#PK@ZB(5U:KJHS@SWQ)TTN"*(:,
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M,DU^3@'@#0CS#PH  ,Y *;T!-8D80,;T+^L!&.\Y8^',L0K E<(;$.8>%
MG!49!2C53,"W V] J#@H    @"J" @   *@B*    ( J@@(   "H(BB 0C!K
MCE?=ZJ/]3FO)I 8\B;==DG<*LY\9*Z<! * :H  *P2B FEX];%8MV^3 )_&V
M"N 4H #@K!3K#)2Q_$EL-^O]:HDL6.*@<5W?.-G5@):<,Y!+K1%9::0S;5AP
M!H*Y!P50"*( :IZW++G*)5-I73T7!1#5:S-<?$:'JKGV?-^3*D?6'T<[F_IN
MV&LWEKUE75'IY<@F!C ==77F5ETK3=)%QB@ ."N%.@-E+7_<=B6F5^2><O:
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MP1D(*@X*H.3H.7TR*'!Q'644  ! %4$!    5!$4    0!5! 0   %01%
M $ 500$4PHR<@-E=(DZU%N!-CCNCT+?KH\SJYR67]D2G'V@$@V&8R#CDTJJ_
M-7NA?^--IPI7@Y(Y TVZ[>;]09S0UWCZ9);_95<#9H_@78^OWL3+9 ;N1*F3
MG8$.)KT?-LOBQP$P&Q1 (23S 5R$,U".I +03B?.*T@R"\GS.,4IP&DHE3.0
MNJ37Y1PD2T^B%9>T?7IIOC3G:Y+J)_DRS@FHU,S#MK3Q1FIG7CIG()L]T]UE
M;W0&4CO8%(0 )04%4 A)!7">SD ???;SI#&/2RY4\_PUYY<J2.H2U>^?FGC
MJE2%QRJ J-MD.CHNCY!L: :[CX/&LJMYE[4]P0V=QGC)\^2,;*:4T<Z&=!8]
MW_?J[4=[J0-F/P_FA#(Y T5MK5S/YN+4]TYR!YOJ?]9+:?(_[>SNN&!;YJ4C
MHQO>[ R4E-H 900%4 @S1@&DH7]79Z"G:6.>W9<VE>^!A"N3@7U7 \928)0:
M!4B(@;UC7'PDW%IO=QZW5:/>.U3'D9/_M5, X@0XC2U9]5G)J2[6V]O;LP\(
M<T=IG('4U:LOXY2T7=%/!*5B[_CQ)9=YZ<@,MV5>ZAO$I..,M]C[Q"B &<Y
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MIQ_MCQ4I@%,X Q$#@)*# BB$$Q3 ZW=Q!HKF =BRQ\P#$*3^JBV8D.GK["A
M8AA *LV$BX\6$_)JK76S(5Z">CA@84%/)IBM ([2\P!VGJ0..*LNACF@3,Y
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MOD]R]20R<*FF>GU=<OBXURZ[GZS@OQ$.#V9[ R:2_;E2)WH# I0>%$ Q)!1
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M , 9*,(9" #.%10  )R5TC@# < 90 $   !4$10   ! %4$!    5!$4
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M7NC7\66I%C@# 4#)0 $ 7#0X P% &4$! %PT. ,!0!E! 0!<"C@# 4#)0 $
M  !4$10   ! %4$!    5!$4    0!5! 0   %01%    $ 500$   !4$10
MP$6#-R  E!$4 ,!%@S<@ )01% # 18,W( "4$11 (> -6#WP!@2 DH$" +AH
M\ 8$@#*" @"X:/ &!( R@@( N!3P!@2 DH$"    J"(H@,M&IE\!0,7(5@0
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MT70P64[,3$>(3V @,5OUB3M#.7EUM"?R=YEQ E <Z@I;_[ ;7K>=X8OF30I
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M G!/M*[5R)07/?U0?_9">HX.0'E! 903$QA8,-'U[)L )4%& 2YG)N ;<#,
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M .<*"@  SDIIG($ X R@     *H("@   *"*H     "J" H   "@BJ
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M!@* DH$" +AH< 8"@#*" @"X:' & H R@@( N!1P!@* DH$"    J"(H
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MH * N0$%  !G(%X+P"(4@#D%!0  9T5& 9@)"#"OH     "J" H   "@BJ
M    J@@*    H(J@     *H("@   *"*H   +IKII+?EZ61/I&X$@/*  @"X
M:":]]FHKN-<F8R, E D40%5P;@+62Q N$9,^K^ZU@@X..@!0&E   )?"Z,%F
M^^Y&XU9G7(9A .=.F3:G (!*@0( N&CV0M^348#@P[9WG1@, )0$% # 13/5
M_LZJQ[WH;SUB)B  E 04 ,"E,'K 3$  *!4H    @"J" @   *@B* #X_]N[
M8]?&S3".X_XW-'OUELW3.WG)G.4&#UYNR%:HP-L-!QD,G@X*!X(LA>- 1Z%+
M"8@N+4'%9#F*,91K"<;E"$TPX@@FB/1]7KV292EN3.\2Z:+O9XH2^94@/._[
M>U])%@"@B4@    T$0D  ( F(@$  -!$) #@H?%F( !U1 ( 'AIO!@)01R2
MIN#-0-7AS4  ZH@$ #P*W@P$H&9( ,!#X\U  .J(!  \--X,!*".2 # H^#-
M0 !JA@0  $ 3D0 >F]Q^!0!-4NP'40_\8P  :"(2    340" ( *W$Q&>Z,)
MSX:B0B2 BL13KR?/AZ6<GC?=]3$Q^7J_=C]_8WF\F!R[*FFH_RI<K-9_ E [
MJT7P(BW8XVFT0^G'?_F#3GN=&%9S_]#);><>.K6OGTB_!C3QW)^=>?V._*A>
M!+DN(EZ<#)4CGW+]F3V38N/QW!\XFWW.[7+J#<S1!MYT6=K$UX$$4*&;A?^\
MY0RW?TG<<N:_]F?7I5\'KJ-&DRC=OIYY![;PHG"D',<-=BK!:.J/?YAM._C=
MMIP2@-W)X.QT5;>SXQI O C',KBG@_)J$;[*;YM]9%(AM2_]PYX;7-C?2Y_0
M5J.?)])+Z-[F8^#NY;J("[W94N-P\KK72CY5;OQJ,MK7V_D$$,\\L__O26N7
MFYL[]3^H 1) A<PWLV9EIL=CMV?2>L_UIY&4L=EROGT7OG4EI-M\;6HO]_7^
MLF=I":'06G(L=>C*)* S\#]<!D/;O/ON1*>&9_UGCIX$?.?93W7ZWOM(QONA
MRC;7I_0?J07 ?=+I^<8<?BL]53A4[DO="=C]%WY??3/2I5I.  -_?B5UFF4%
MF<U+P7XR\X1#?SZ7(;]TX'1$OR@W;OXD)YM+ /%2.A#="UW+-*9]=/)3?K/8
M.&J+!%"A<[_?3K^8W:1LJ<\HK=B5U%+^:]M-K]$>A?_HVLLOT$E]YI<$;N]J
M[4\YEJS^_9$>5!]]SY1T,@G(+PPFT>0H.!TK$Q>NI-H/O%E4/"4 _T<ZS][]
M*H#I+G)U;U80[[X*D,L6$@O:=GH0O;=7 <K1(PGW:CRQ9Y)K7*X^J,&;[X\V
MKCR:'=9#_DO_37Z3!/#5( %4QV1V6RQV=-<_9^'Z[\#MFM)=S@+/K@%(2#^7
M+-_SLM5[\]'-!%!N[?QTU#;K!-E!I>;UH'YM3J-K5O_B2(Z4K &T'/?'T"X;
M9MW317I* #Z7+M..4EV[]GZO>Q- *M>QF.F!*?,U<]&P_,'L(H)L9(W'T62L
M=#*X"C?O/<JZJ<BTEJT!))NEQE%7)(#JY%?OLQ6\&[G?1P;XE1[%3==@=E.C
MT[F=B)\7K[39'<+(WEZT/PI_+;9VJ?<Q!2P[RP_F0J09W>6GI(^P5P0G\Q-S
M8F?3) ',3^7> MU:=DH /H>IV:[JMK]D C#UJSN4:;J>OW&G43)F'WC3L]Q(
M?VM7(G47L<S?0I0UGKY#TEK/-+@/X&D@ 51GX??7E]:25\B;>VF3F_G-/7TR
MZ3_Y34;QEO07)F5_\/N=S8GX>D6QI=SCR2(NM;:^4B 'U87Z4:*]_'D83-_V
M[5T%YI*A_F57*9,2XL4O8[-L6#REG3HL -MDSP+L_K*H[0E BEI7][+T JK"
MG4;V*D#ZN%#28'A5Z'D*C=NC9<\?9:?!LP!/ 0D  "KPI;X/0/+]Y@-^.Y%U
MQ_UA,-\I?N")(@$  -!$)    )J(!   0!.1    :"(2    340"  "@B4@
M   T$0D  ( F(@$  -!$)    )J(!   0!.1    :*)_ 2[(Q-34/_M-
) $E%3D2N0F""

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>23
<FILENAME>image_9a.jpg
<TEXT>
begin 644 image_9a.jpg
MB5!.1PT*&@H    -24A$4@   J<   -N" (   "D%S>;  "  $E$051X7NR=
M"W@35?K_ W@WJ/4"1"ZBV2JK5<3*NO#S$G2MNKB(8N6B1NQ?+2RZ1=1B75%7
M;DI<M"Q:8(UBQ;4"$9?"4@OQ4I!2"5 NW1HN!6H)M*4M,912)IG^SV5F,I>T
MM"S4TGP_SWGZ)#-GSIR93,_WO.><>5^3     (#HP*3?     (!V"E0?
MB!9,ZP$    0'9@:     ! =0/4!  " : &J#P   $0+4'T    @6H#J P
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M+ 7'CN,S$0T'#@B_Z64\7$H7GAOZQVQ)\D,A<<L6X>8;]'G.YB/\1;Q*
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M]DB=/ +?3$25Z:P^\/A#]UHB'JBUOV4:'Y;0U81GXQ^:<452J;J:\*_-+@2
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M ."4 =4' )QRI*$!E;4. /A5@.H#    T0)4'P   (@6H/H   ! M #5!P
M *(%J#X    0+4#U 0  @&@!J@\   !$"U!]    (%J Z@,   #1 E0?
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MKMPT5UT@E7"5(K#Q^;!>T*$(0X%LG,.0A\DGM>YTUW(J*&U<AO2US2U:F)1
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MG)CJ\Q7UFD6A     &@$-HLO#5&'#%];CQ-3?0    "<?D#U 0  @&@!J@\
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ME>CTUFIK@N@[  #0;C&J_JF)OB,)SSA7692[>VL+T7<:>![65Y-B\"#Z#@
M1 -&U3\5T7?X>#7W_QK=M(GH.R]]F>NPV=*<CE$T7 (-HH#H.P  $!485/_D
M1]\)!3PS(?D2;2+ZCJIC1_H $]Z:CN@[   0'1A4_Z1'W^$CU9RH#\#31J+O
M,)1%FHB^ P  T8)!]0$   #03H'J P   -$"5!\   "(%J#Z    0+0 U0<
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MI'I&C7A+4E;!HF0JBC3,![F<&ET]!5J'1&=!=JJ%U-9'QT6H%<<]P)9*7Z7
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M8G9BJL_F<J1EC:U(N!/*0\0"  !HZQA6 T0KW+*7QL79Z*\TSM&J0GIBJ@\
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MKC&L!HA6N&6/Z#L     :!V@^@   $"T -4'    H@6H/@   ! M0/4!  "
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MU?<4<#\\DI(5%:A#__&@8I'%PG!>[KV.-5_,C1T--^CVLLS<&S$G[,S_=),
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MQ7ZMDY>%2:N\=8/$IZD$J- LS5/=WMD%3$-52]SX;=2M[./F(IL$;R$&U0<
M  # KP7M 8QKT0*]%@'5!P   *(%J#X    0+4#U 0  @&@!J@\   !$"U!]
M    (%J Z@,   #1 E0?  " #'T+G+TEKW^EOGF<</2=L*L8ZJ%$[2JFG4;?
M43MBH0Z+!-^:F?SM?)6'W9"T4?97J(G?=H*QUJ#Z    9'ZEZ#O4#UTX^@[U
M^<-<^[7CZ#L<=C=H;-MRYJ1O45&NVLDN\Y7'-UI9<#5U_#;)2T^+8ZU!]0$
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MV:WL,]LH$6>?N<;'"PUX<QW\1/*I&P(>ATW.23<GS/UB;@+/(F]Q%C=>)0
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M<Z<E,%T/^>E@?K++)_") )-MIB<@T(U\/8&T>)!F8!T%EE-_(N.P/P  @/8
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M+RCV<]51?0=8>J0^@(N@^@ZPS$A]  #J@M0' * N2'T  .J"U < H"Y(?0
MZH+4+U,RO>ZYIS:+J]^<S_&H%_;.\WVJN9/W 9^!ZCO TB/URR/??3>3[9^.
MY:OM37_PF8?-43*AWGGLQ_/K?192'Z^#ZCO TB/U2Y.?D7?Z?/#QN#AS3K&>
MS8NHULZ&ZTH5',MJ_L<?_^=XM$ W(*:C1SLR[8\4O-GOZEHYUE8P?!:VFWH9
M/16@9+Q9/6YGF-27V7_SE7ZRY7.*T_@<OJKPSYJC>X!Z8O]D@B ]D4N\A_0.
MKP"J[P!+C]0O37[:6J,P2VZQGLU^U->7Z797\UTK4W0G?-QIQM/HJKY73_?U
MQ^.P;3L[O<G)I+?CV.WP1;>X>IKZV0(\3W/E<PIS ^O4/[/PC[11CN1YU4ZK
MN_+L1\-@N^']U0>FJ(\,;VRMSY8<Q)*A^@ZPW$C]TA3Z^J/>_1_T/KS[RGHV
MV=0W _*%HCOW[N6&],T(_V$\>7XVW?/C^87'HUP_SIVU/>S.I/YG%/Z1!=U[
M'R;/'NV2&6?0LG,&8TG)W'Q4WP&6%:E?GLQY?3V6KCK$P]V9OOZK4[]0=.?!
M0U,RYU1%\H:>+?^LOOYY4C]>0.ZJK?Z#WU2[="!%@V0D($G],PO_Z-1_OY]]
M=O<[?M37QQ5 ]1U@Z9'Z99J]AG_VO'X^]:5FKJW/ZYM4+A;=>9D[:_[IP-\X
MX[S^>5+_1;Y\SDMS5\[CYE*_N ])X1^=^L$H.:^?N_(@WIET)[!TJ+X#+#U2
M'\!%R @_9VJ 947J P!0%Z0^  !U0>H# % 7I#X  '5!Z@, 4!>D?IEFO[GW
M6194?2>:=23"%Z]Q/I6LOI.? 7KFV[!3F;YBSAL]_@*JF7]Z6KA[JJ>IT&OE
MOJ-XSL6 ZB+URU.AZCL7VRQ@5+'ZCGRL9%8HF:Q"WM3CT&ML!\-C/?/5IC\X
M'/CNG#GU9":,:S)!EIF.>O@D=W<T&?B;>OZK>&[LN6N=M1A08:1^::I4?6<F
M]0LU<BB9@WFJ7'WGL->YEGZ^3DU"J]3?#[U5_>XW'['XMRJVHRF%=5MY]_NY
MN[VGH;>A&] GZ?S6LVN=M1A08:1^::I4?2<[PB_'*IEI-5,CY^]V*9F#^:I9
M?4>7>\A-_JC:T^^X[=W1B<G^(_V1V=(_:&G#5^=WX.?N]O;B8;-\G!?6.FLQ
MH,)(_=)4J?I.L:]?J)'S1W]*R1R<I:K5=^04>Z,=CJ?R,>G?:;4*PU3J,[61
MMGWE1(!9..[K9^]*)WY=+SS3US_/8D"%D?KEJ5#UG6+J)WW]N7<!HX+5=_3%
M>J9A&D6RU(]H)&>FHA/P)\6^?C3^?Y0YKY^YJT_8ZS;Z['G]<RP&5!BI7Z;9
M:_AGS^N74GVGF/KI>7VSR@DE<S!'):OO3(?9=_N):EO+'</I]%[$'[&F%_1E
M+#XJ%B77*)B%]#FUPEW=1H_NR[6!9ZQ57*RX;T#UD/H +F+)J^^HG%[WPNI<
MD@"4C-0' * N2'T  .J"U"^#.?$'H%:*!P*@ GA? @!0%Z0^  !U0>J7*3<9
MSN>;[';>IN0[Q+D*(WHJ7N=<,_,# &J U"^1_O)]E,J2T(W7G];C7)N2^<+D
MZ_O9;^H#KX^:>^=<#*@N4K]$TO6V]4Q>,F.H:Z]ZX?-TVA,S;5\RY4AT6#GC
M.#MG4P>Z9Z]^&,9S :TZ3H,RNK@\U-RCYAZ6'JE?HGQ5^[0"WFDT%J^.6<<R
MU=>*S+EK'I>#BRV'%?DA4T%GSJ9,SW[#[S[(K,(L^KA$U-RCYAZ6'JE?GLQ9
M]JG,D*\2>O!\$/I17U^ZZ0?I<*75;(?#X[A&KI8.X\_;U(&4Y;7;#W=O1K_2
M9P%LIB'#9:+FWCD6 RJ,U"^-.;^8G4X_Z9<_'LJO-OS^1Y+3K6 HARH)[)?2
M]2_4V#UC4X.!'/B:_E[7C/,_UZT!<Q8 N#S4W/O,Q8 *(_5+8T;@$[H6R/19
MT%JQ+'O-6=,I?JQ/TNO?1WVI<=\W5PNMN)V'@^@H-F]3NOLO/?MHFY;M.&MS
M6@S :Z/F'C7WL/1(?0#G1,V]SUBLN&] ]9#Z "Z"FGO ,B/U 0"H"U(? ("Z
M(/4! *@+4A\ @+H@]9?7\:A[NW.?+PL! ,Z+U"_7W/GR9'K=;&4\F6BL\&5H
M_06AZ,OW^IOY6\'H:>"N\A5AE.B,JA  E@>I7R8]H\B:XT33>T4S\.CI=%3J
MCZ,I>O2</?G4/PB]-?5H0S<73.K?"][1D_4ZG6X_^KYR=;Y"C:NIBM5W %P(
MJ5^F SU_YUXTBZ=,[[72"IX>RO2ZCI[=<U6F_CB4JCFYU#>3CNWOFME BWU]
M&2IHML./=KW5:DR7AJNJRM5W )P+J5^B:,;0$]7CEUY[,K ?_; 7#^P71OAE
MA$#W\DVCP534S:1^OF /HZY8I&I6WP%P7J1^:4S)G)BM^^[GZNL?Q*5"]7I>
M^"*?^OJ4?UQSC[JZ6+2J5M]9H*BP=5KT$EA>I'YIHIYZ_/-:T__YOI3+,Z33
M+T7#XOOSRGR94B(;M_SK.O55S*_K%8=QA1[Z^EBH"E;? 7 QI#Z <ZID]1T
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M PM#]1T %4/J P!0%Z0^  !U0>H# % 7I#X  '5!Z@, 4!>D/@  =4'J XM
M]1T 543J XM ]1T 543J XM ]1T 543JEX;J._5#]1T %4/J XM ]1T 543J
M XM ]1T 543J PM#]1T %4/J P!0%Z0^  !U0>J702Z<!E SQ0,!4 &\+P$
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MO)I/U]6]Y5_/Y#RICY)5L.8>@(LA]0&<4R5K[@&X"%(?P$4L><T]H.9(?0
MZH+4!P"@+DA]  #J@M0' * N2'T  .J"U < H"Y(?6 1II/>CJ,G8-+3+Q9_
M#0!O!*D/+,*DU]GP_%L=YG %4"6D_E46S]YOYNU'F<PT=@W'\T.JU "H#%(?
M6)C1@YN==]O-Z^&X"D/\<=7'?#$( +5"Z@.+L!^XCHSP^W<[SC9C+0 J@M0'
M%F&J:R6KGO6*N_.(J_D 5 2I#RS,Z %7\P&H%%(? ("Z(/4! *@+4A\ @+H@
M]0$ J M2'P" NB#U 0"H"U(?6 2J[P"H(E(?6 2J[P"H(E+_*J/ZSIM#]1T
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M!%A2I#Z BY 1?J[F Y85J0\ 0%V0^@  U 6I#P! 79#Z  #4!:D/ $!=D/H
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M!Q:&ZCL *H;4!P"@+DA]  #J@M0O@UPX#0!U4CP.HAIX80!@$:S:WU!%O#
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M ("Z(/4! *@+4A\ @+H@]0$ J M2'P" NB#U 0"H"U(? ("Z(/4! *@+4A\
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M]@5-7Y3< $;NSZ[').)W2.Y9?O339(=S#1?YM^B_4J&1-V<'N%W6K7@@ "J
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MXIO*Y-9.N^,U7Y7ZU-S#\B/U2S,SI_>IF21<3Y@O1;[7S$S[>J9/TW784XT
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M'D<C_-''L/AX<3&J[^"J(O4!7(2,\"_Q.2.J[Z#F2'T  .J"U < H"Y(?0
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M % 7I#X  '5!Z@, 4!>D/@  =4'J P!0%Z0^  !U0>H# % 7I#X  '5!Z@,
M4!>D/@  =4'J P!0%Z0^  !U0>H# % 7I#X  '5!Z@.+,)WT=AQ+L9WV[FA:
M_#4 O!&D/K (DUYGP_-O=8+]XF\ X,TA]8%%F$X&@><T',\/!^/B+P'@#2'U
M2[,?N T9\76#4?%7N*)&#VYVWFTWKX?C*@SQ3WH=?<Z!=R!08Z0^L BJD>?(
M"+]_M^-L!Z.3XN\!X$T@]8%%F$[Z=UQ;]:Q7W)U'7,T'H")(?6!A1@^XF@]
MI9#Z  #4!:D/ $!=D/H  -0%J0\ 0%V0^@  U 6I#P! 79#ZP")0?0= %9'Z
MP")0?0= %9'ZP")0?0= %9'ZI:'Z3OU0?0= Q9#ZP")0?0= %9'ZP")0?0=
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M:692/W<U7U0:_,RK^71=W5O^]4S.D_HH626K[P"X"%(?P$4L>?4=H.9(?0
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ME%[#SY='@"5%Z@.X"!GAYVH^8%F1^@  U 6I#P! 79#Z  #4!:D/ $!=D/H
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M GXQ\17FK[,N4"FS*5BW&ZJ(%P8 %F$V!>MV0Q7QP@# (LRF8-UNJ")>&
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M"/XG?Z^O<I5KWI_PM<#V:K5/6]D]0/5!$ 1!L*-H*[L'J#X(@B (=A1M9?<
MU0=!$ 3!CJ*M[!Z:_6<>       Z"5!]     .@60/4!    H%L U0<   "
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71/LO?:ZD44ASK-4     245.1*Y"8((!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>24
<FILENAME>R1.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.2</span><table class="report" border="0" cellspacing="2" id="idm139763872751760">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Cover Page - shares<br></strong></div></th>
<th class="th" colspan="1">6 Months Ended</th>
<th class="th" colspan="1"></th>
</tr>
<tr>
<th class="th"><div>Jun. 30, 2022</div></th>
<th class="th"><div>Aug. 05, 2022</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_CoverAbstract', window );"><strong>Cover [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_DocumentType', window );">Document Type</a></td>
<td class="text">10-Q<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_DocumentQuarterlyReport', window );">Document Quarterly Report</a></td>
<td class="text">true<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_DocumentPeriodEndDate', window );">Document Period End Date</a></td>
<td class="text">Jun. 30,  2022<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_DocumentTransitionReport', window );">Document Transition Report</a></td>
<td class="text">false<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityFileNumber', window );">Entity File Number</a></td>
<td class="text">001-38118<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityRegistrantName', window );">Entity Registrant Name</a></td>
<td class="text">DERMTECH, INC.<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityIncorporationStateCountryCode', window );">Entity Incorporation, State or Country Code</a></td>
<td class="text">DE<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityTaxIdentificationNumber', window );">Entity Tax Identification Number</a></td>
<td class="text">84-2870849<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityAddressAddressLine1', window );">Entity Address, Address Line One</a></td>
<td class="text">11099 N. Torrey Pines Road<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityAddressAddressLine2', window );">Entity Address, Address Line Two</a></td>
<td class="text">Suite 100<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityAddressCityOrTown', window );">Entity Address, City or Town</a></td>
<td class="text">La Jolla<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityAddressStateOrProvince', window );">Entity Address, State or Province</a></td>
<td class="text">CA<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityAddressPostalZipCode', window );">Entity Address, Postal Zip Code</a></td>
<td class="text">92037<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_CityAreaCode', window );">City Area Code</a></td>
<td class="text">858<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_LocalPhoneNumber', window );">Local Phone Number</a></td>
<td class="text">450-4222<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_Security12bTitle', window );">Title of 12(b) Security</a></td>
<td class="text">Common Stock, par value $0.0001 per share<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_TradingSymbol', window );">Trading Symbol</a></td>
<td class="text">DMTK<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_SecurityExchangeName', window );">Security Exchange Name</a></td>
<td class="text">NASDAQ<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityCurrentReportingStatus', window );">Entity Current Reporting Status</a></td>
<td class="text">Yes<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityInteractiveDataCurrent', window );">Entity Interactive Data Current</a></td>
<td class="text">Yes<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityFilerCategory', window );">Entity Filer Category</a></td>
<td class="text">Large Accelerated Filer<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntitySmallBusiness', window );">Entity Small Business</a></td>
<td class="text">true<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityEmergingGrowthCompany', window );">Entity Emerging Growth Company</a></td>
<td class="text">false<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityShellCompany', window );">Entity Shell Company</a></td>
<td class="text">false<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityCommonStockSharesOutstanding', window );">Entity Common Stock, Shares Outstanding</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">30,039,946<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityCentralIndexKey', window );">Entity Central Index Key</a></td>
<td class="text">0001651944<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_CurrentFiscalYearEndDate', window );">Current Fiscal Year End Date</a></td>
<td class="text">--12-31<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_DocumentFiscalYearFocus', window );">Document Fiscal Year Focus</a></td>
<td class="text">2022<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_DocumentFiscalPeriodFocus', window );">Document Fiscal Period Focus</a></td>
<td class="text">Q2<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_AmendmentFlag', window );">Amendment Flag</a></td>
<td class="text">false<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_AmendmentFlag">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true when the XBRL content amends previously-filed or accepted submission.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_AmendmentFlag</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_CityAreaCode">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Area code of city</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_CityAreaCode</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_CoverAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Cover page.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_CoverAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_CurrentFiscalYearEndDate">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>End date of current fiscal year in the format --MM-DD.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_CurrentFiscalYearEndDate</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:gMonthDayItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_DocumentFiscalPeriodFocus">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Fiscal period values are FY, Q1, Q2, and Q3.  1st, 2nd and 3rd quarter 10-Q or 10-QT statements have value Q1, Q2, and Q3 respectively, with 10-K, 10-KT or other fiscal year statements having FY.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_DocumentFiscalPeriodFocus</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:fiscalPeriodItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_DocumentFiscalYearFocus">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>This is focus fiscal year of the document report in YYYY format. For a 2006 annual report, which may also provide financial information from prior periods, fiscal 2006 should be given as the fiscal year focus. Example: 2006.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_DocumentFiscalYearFocus</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:gYearItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_DocumentPeriodEndDate">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>For the EDGAR submission types of Form 8-K: the date of the report, the date of the earliest event reported; for the EDGAR submission types of Form N-1A: the filing date; for all other submission types: the end of the reporting or transition period.  The format of the date is YYYY-MM-DD.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_DocumentPeriodEndDate</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:dateItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_DocumentQuarterlyReport">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true only for a form used as an quarterly report.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Form 10-Q<br> -Number 240<br> -Section 308<br> -Subsection a<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_DocumentQuarterlyReport</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_DocumentTransitionReport">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true only for a form used as a transition report.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Forms 10-K, 10-Q, 20-F<br> -Number 240<br> -Section 13<br> -Subsection a-1<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_DocumentTransitionReport</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_DocumentType">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The type of document being provided (such as 10-K, 10-Q, 485BPOS, etc). The document type is limited to the same value as the supporting SEC submission type, or the word 'Other'.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_DocumentType</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:submissionTypeItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityAddressAddressLine1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Address Line 1 such as Attn, Building Name, Street Name</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityAddressAddressLine1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityAddressAddressLine2">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Address Line 2 such as Street or Suite number</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityAddressAddressLine2</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityAddressCityOrTown">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Name of the City or Town</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityAddressCityOrTown</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityAddressPostalZipCode">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Code for the postal or zip code</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityAddressPostalZipCode</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityAddressStateOrProvince">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Name of the state or province.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityAddressStateOrProvince</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:stateOrProvinceItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityCentralIndexKey">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>A unique 10-digit SEC-issued value to identify entities that have filed disclosures with the SEC. It is commonly abbreviated as CIK.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityCentralIndexKey</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:centralIndexKeyItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityCommonStockSharesOutstanding">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Indicate number of shares or other units outstanding of each of registrant's classes of capital or common stock or other ownership interests, if and as stated on cover of related periodic report. Where multiple classes or units exist define each class/interest by adding class of stock items such as Common Class A [Member], Common Class B [Member] or Partnership Interest [Member] onto the Instrument [Domain] of the Entity Listings, Instrument.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityCommonStockSharesOutstanding</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityCurrentReportingStatus">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Indicate 'Yes' or 'No' whether registrants (1) have filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that registrants were required to file such reports), and (2) have been subject to such filing requirements for the past 90 days. This information should be based on the registrant's current or most recent filing containing the related disclosure.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityCurrentReportingStatus</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:yesNoItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityEmergingGrowthCompany">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Indicate if registrant meets the emerging growth company criteria.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityEmergingGrowthCompany</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityFileNumber">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Commission file number. The field allows up to 17 characters. The prefix may contain 1-3 digits, the sequence number may contain 1-8 digits, the optional suffix may contain 1-4 characters, and the fields are separated with a hyphen.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityFileNumber</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:fileNumberItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityFilerCategory">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Indicate whether the registrant is one of the following: Large Accelerated Filer, Accelerated Filer, Non-accelerated Filer. Definitions of these categories are stated in Rule 12b-2 of the Exchange Act. This information should be based on the registrant's current or most recent filing containing the related disclosure.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityFilerCategory</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:filerCategoryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityIncorporationStateCountryCode">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Two-character EDGAR code representing the state or country of incorporation.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityIncorporationStateCountryCode</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:edgarStateCountryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityInteractiveDataCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true when the registrant has submitted electronically every Interactive Data File required to be submitted pursuant to Rule 405 of Regulation S-T during the preceding 12 months (or for such shorter period that the registrant was required to submit such files).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Regulation S-T<br> -Number 232<br> -Section 405<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityInteractiveDataCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:yesNoItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityRegistrantName">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The exact name of the entity filing the report as specified in its charter, which is required by forms filed with the SEC.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityRegistrantName</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityShellCompany">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true when the registrant is a shell company as defined in Rule 12b-2 of the Exchange Act.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityShellCompany</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntitySmallBusiness">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Indicates that the company is a Smaller Reporting Company (SRC).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntitySmallBusiness</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityTaxIdentificationNumber">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The Tax Identification Number (TIN), also known as an Employer Identification Number (EIN), is a unique 9-digit value assigned by the IRS.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityTaxIdentificationNumber</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:employerIdItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_LocalPhoneNumber">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Local phone number for entity.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_LocalPhoneNumber</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_Security12bTitle">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Title of a 12(b) registered security.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_Security12bTitle</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:securityTitleItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_SecurityExchangeName">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Name of the Exchange on which a security is registered.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection d1-1<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_SecurityExchangeName</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:edgarExchangeCodeItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_TradingSymbol">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Trading symbol of an instrument as listed on an exchange.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_TradingSymbol</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:tradingSymbolItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>25
<FILENAME>R2.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.2</span><table class="report" border="0" cellspacing="2" id="idm139763871952656">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Condensed Consolidated Balance Sheets - USD ($)<br> $ in Thousands</strong></div></th>
<th class="th"><div>Jun. 30, 2022</div></th>
<th class="th"><div>Dec. 31, 2021</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AssetsCurrentAbstract', window );"><strong>Current assets:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CashAndCashEquivalentsAtCarryingValue', window );">Cash and cash equivalents</a></td>
<td class="nump">$ 120,333<span></span>
</td>
<td class="nump">$ 176,882<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_MarketableSecuritiesCurrent', window );">Short-term marketable securities</a></td>
<td class="nump">53,457<span></span>
</td>
<td class="nump">48,449<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AccountsReceivableNetCurrent', window );">Accounts receivable</a></td>
<td class="nump">5,962<span></span>
</td>
<td class="nump">3,847<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_InventoryNet', window );">Inventory</a></td>
<td class="nump">1,432<span></span>
</td>
<td class="nump">480<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PrepaidExpenseAndOtherAssetsCurrent', window );">Prepaid expenses and other current assets</a></td>
<td class="nump">2,681<span></span>
</td>
<td class="nump">3,166<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AssetsCurrent', window );">Total current assets</a></td>
<td class="nump">183,865<span></span>
</td>
<td class="nump">232,824<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentNet', window );">Property and equipment, net</a></td>
<td class="nump">4,916<span></span>
</td>
<td class="nump">4,549<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OperatingLeaseRightOfUseAsset', window );">Operating lease right-of-use assets</a></td>
<td class="nump">23,694<span></span>
</td>
<td class="nump">7,744<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RestrictedCashNoncurrent', window );">Restricted cash</a></td>
<td class="nump">3,470<span></span>
</td>
<td class="nump">3,025<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OtherAssetsNoncurrent', window );">Other assets</a></td>
<td class="nump">167<span></span>
</td>
<td class="nump">167<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_Assets', window );">Total assets</a></td>
<td class="nump">216,112<span></span>
</td>
<td class="nump">248,309<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LiabilitiesCurrentAbstract', window );"><strong>Current liabilities:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AccountsPayableCurrent', window );">Accounts payable</a></td>
<td class="nump">861<span></span>
</td>
<td class="nump">2,880<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EmployeeRelatedLiabilitiesCurrent', window );">Accrued compensation</a></td>
<td class="nump">7,818<span></span>
</td>
<td class="nump">5,120<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AccruedLiabilitiesCurrent', window );">Accrued liabilities</a></td>
<td class="nump">3,272<span></span>
</td>
<td class="nump">1,227<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DeferredRevenueCurrent', window );">Short-term deferred revenue</a></td>
<td class="nump">1,310<span></span>
</td>
<td class="nump">1,380<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OperatingLeaseLiabilityCurrent', window );">Current portion of operating lease liabilities</a></td>
<td class="nump">1,693<span></span>
</td>
<td class="nump">1,453<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FinanceLeaseLiabilityCurrent', window );">Current portion of finance lease obligations</a></td>
<td class="nump">134<span></span>
</td>
<td class="nump">121<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LiabilitiesCurrent', window );">Total current liabilities</a></td>
<td class="nump">15,088<span></span>
</td>
<td class="nump">12,181<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_WarrantsAndRightsOutstanding', window );">Warrant liability</a></td>
<td class="nump">24<span></span>
</td>
<td class="nump">146<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FinanceLeaseLiabilityNoncurrent', window );">Long-term finance lease obligations, less current portion</a></td>
<td class="nump">111<span></span>
</td>
<td class="nump">136<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OperatingLeaseLiabilityNoncurrent', window );">Operating lease liabilities, long-term</a></td>
<td class="nump">22,312<span></span>
</td>
<td class="nump">6,148<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_Liabilities', window );">Total liabilities</a></td>
<td class="nump">37,535<span></span>
</td>
<td class="nump">18,611<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockholdersEquityAbstract', window );"><strong>Stockholders&#8217; equity:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CommonStockValue', window );">Common stock, $0.0001 par value per share; 50,000,000 shares authorized as of June&#160;30, 2022 and December&#160;31, 2021; 30,038,447 and 29,772,922 shares issued and outstanding at June&#160;30, 2022 and December&#160;31, 2021, respectively</a></td>
<td class="nump">3<span></span>
</td>
<td class="nump">3<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AdditionalPaidInCapitalCommonStock', window );">Additional paid-in capital</a></td>
<td class="nump">445,491<span></span>
</td>
<td class="nump">436,183<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax', window );">Accumulated other comprehensive loss</a></td>
<td class="num">(865)<span></span>
</td>
<td class="num">(124)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RetainedEarningsAccumulatedDeficit', window );">Accumulated deficit</a></td>
<td class="num">(266,052)<span></span>
</td>
<td class="num">(206,364)<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockholdersEquity', window );">Total stockholders&#8217; equity</a></td>
<td class="nump">178,577<span></span>
</td>
<td class="nump">229,698<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LiabilitiesAndStockholdersEquity', window );">Total liabilities and stockholders&#8217; equity</a></td>
<td class="nump">$ 216,112<span></span>
</td>
<td class="nump">$ 248,309<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AccountsPayableCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Carrying value as of the balance sheet date of liabilities incurred (and for which invoices have typically been received) and payable to vendors for goods and services received that are used in an entity's business. Used to reflect the current portion of the liabilities (due within one year or within the normal operating cycle if longer).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.19(a))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 852<br> -SubTopic 10<br> -Section 55<br> -Paragraph 10<br> -URI https://asc.fasb.org/extlink&amp;oid=84165509&amp;loc=d3e56426-112766<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AccountsPayableCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AccountsReceivableNetCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount, after allowance for credit loss, of right to consideration from customer for product sold and service rendered in normal course of business, classified as current.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 310<br> -SubTopic 10<br> -Section 45<br> -Paragraph 2<br> -URI https://asc.fasb.org/extlink&amp;oid=124259787&amp;loc=d3e4428-111522<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 310<br> -SubTopic 10<br> -Section 45<br> -Paragraph 9<br> -URI https://asc.fasb.org/extlink&amp;oid=124259787&amp;loc=d3e4531-111522<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AccountsReceivableNetCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AccruedLiabilitiesCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Carrying value as of the balance sheet date of obligations incurred and payable, pertaining to costs that are statutory in nature, are incurred on contractual obligations, or accumulate over time and for which invoices have not yet been received or will not be rendered. Examples include taxes, interest, rent and utilities. Used to reflect the current portion of the liabilities (due within one year or within the normal operating cycle if longer).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.20)<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AccruedLiabilitiesCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Accumulated change in equity from transactions and other events and circumstances from non-owner sources, net of tax effect, at period end. Excludes Net Income (Loss), and accumulated changes in equity from transactions resulting from investments by owners and distributions to owners. Includes foreign currency translation items, certain pension adjustments, unrealized gains and losses on certain investments in debt and equity securities, other than temporary impairment (OTTI) losses related to factors other than credit losses on available-for-sale and held-to-maturity debt securities that an entity does not intend to sell and it is not more likely than not that the entity will be required to sell before recovery of the amortized cost basis, as well as changes in the fair value of derivatives related to the effective portion of a designated cash flow hedge.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(30)(a)(4))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 11<br> -URI https://asc.fasb.org/extlink&amp;oid=126968391&amp;loc=d3e637-108580<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(a)(23)(a)(3))<br> -URI https://asc.fasb.org/extlink&amp;oid=126734703&amp;loc=d3e572229-122910<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 14A<br> -URI https://asc.fasb.org/extlink&amp;oid=126968391&amp;loc=SL7669686-108580<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 40<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (h)(2)<br> -URI https://asc.fasb.org/extlink&amp;oid=124501264&amp;loc=SL117420844-207641<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 40<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (g)(2)(ii)<br> -URI https://asc.fasb.org/extlink&amp;oid=124501264&amp;loc=SL117420844-207641<br><br>Reference 7: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 14<br> -URI https://asc.fasb.org/extlink&amp;oid=126968391&amp;loc=d3e681-108580<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AdditionalPaidInCapitalCommonStock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Value received from shareholders in common stock-related transactions that are in excess of par value or stated value and amounts received from other stock-related transactions. Includes only common stock transactions (excludes preferred stock transactions). May be called contributed capital, capital in excess of par, capital surplus, or paid-in capital.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(30)(a)(1))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AdditionalPaidInCapitalCommonStock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_Assets">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Sum of the carrying amounts as of the balance sheet date of all assets that are recognized. Assets are probable future economic benefits obtained or controlled by an entity as a result of past transactions or events.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-03(11))<br> -URI https://asc.fasb.org/extlink&amp;oid=126897435&amp;loc=d3e534808-122878<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 852<br> -SubTopic 10<br> -Section 55<br> -Paragraph 10<br> -URI https://asc.fasb.org/extlink&amp;oid=84165509&amp;loc=d3e56426-112766<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(A))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8736-108599<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iv))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 6: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(a)(12))<br> -URI https://asc.fasb.org/extlink&amp;oid=126734703&amp;loc=d3e572229-122910<br><br>Reference 7: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 852<br> -SubTopic 10<br> -Section 50<br> -Paragraph 7<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=124433192&amp;loc=SL2890621-112765<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(i))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 9: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(ii))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(5))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iii)(A))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(i))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -URI https://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 14: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iii))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -URI https://asc.fasb.org/extlink&amp;oid=123596393&amp;loc=d3e14064-108612<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(B))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 17: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (bb)<br> -URI https://asc.fasb.org/extlink&amp;oid=123419778&amp;loc=d3e5710-111685<br><br>Reference 18: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(5))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 19: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (d)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8933-108599<br><br>Reference 20: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 45<br> -Paragraph 25<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=116870748&amp;loc=SL6758485-165988<br><br>Reference 21: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iv))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 22: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(18))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 23: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=114001798&amp;loc=d3e33918-111571<br><br>Reference 24: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8906-108599<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_Assets</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AssetsCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Sum of the carrying amounts as of the balance sheet date of all assets that are expected to be realized in cash, sold, or consumed within one year (or the normal operating cycle, if longer). Assets are probable future economic benefits obtained or controlled by an entity as a result of past transactions or events.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1<br> -URI https://asc.fasb.org/extlink&amp;oid=124098289&amp;loc=d3e6676-107765<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 852<br> -SubTopic 10<br> -Section 55<br> -Paragraph 10<br> -URI https://asc.fasb.org/extlink&amp;oid=84165509&amp;loc=d3e56426-112766<br><br>Reference 3: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 852<br> -SubTopic 10<br> -Section 50<br> -Paragraph 7<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=124433192&amp;loc=SL2890621-112765<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(i))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(A))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iii)(A))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 7: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iii))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -URI https://asc.fasb.org/extlink&amp;oid=123596393&amp;loc=d3e14064-108612<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(5))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iv))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 45<br> -Paragraph 25<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=116870748&amp;loc=SL6758485-165988<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(B))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=114001798&amp;loc=d3e33918-111571<br><br>Reference 14: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(ii))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(5))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (bb)<br> -URI https://asc.fasb.org/extlink&amp;oid=123419778&amp;loc=d3e5710-111685<br><br>Reference 17: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iv))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 18: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(9))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 19: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -URI https://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 20: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(i))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AssetsCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AssetsCurrentAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AssetsCurrentAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CashAndCashEquivalentsAtCarryingValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of currency on hand as well as demand deposits with banks or financial institutions. Includes other kinds of accounts that have the general characteristics of demand deposits. Also includes short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates. Excludes cash and cash equivalents within disposal group and discontinued operation.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 4<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3044-108585<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=124098289&amp;loc=d3e6676-107765<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(1))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CashAndCashEquivalentsAtCarryingValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CommonStockValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Aggregate par or stated value of issued nonredeemable common stock (or common stock redeemable solely at the option of the issuer). This item includes treasury stock repurchased by the entity. Note: elements for number of nonredeemable common shares, par value and other disclosure concepts are in another section within stockholders' equity.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 852<br> -SubTopic 10<br> -Section 55<br> -Paragraph 10<br> -URI https://asc.fasb.org/extlink&amp;oid=84165509&amp;loc=d3e56426-112766<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CommonStockValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DeferredRevenueCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of deferred income and obligation to transfer product and service to customer for which consideration has been received or is receivable, classified as current.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(20))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DeferredRevenueCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EmployeeRelatedLiabilitiesCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Total of the carrying values as of the balance sheet date of obligations incurred through that date and payable for obligations related to services received from employees, such as accrued salaries and bonuses, payroll taxes and fringe benefits. Used to reflect the current portion of the liabilities (due within one year or within the normal operating cycle if longer).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.20)<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EmployeeRelatedLiabilitiesCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FinanceLeaseLiabilityCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Present value of lessee's discounted obligation for lease payments from finance lease, classified as current.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 45<br> -Paragraph 1<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=123391704&amp;loc=SL77918627-209977<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FinanceLeaseLiabilityCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FinanceLeaseLiabilityNoncurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Present value of lessee's discounted obligation for lease payments from finance lease, classified as noncurrent.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 45<br> -Paragraph 1<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=123391704&amp;loc=SL77918627-209977<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FinanceLeaseLiabilityNoncurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InventoryNet">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount after valuation and LIFO reserves of inventory expected to be sold, or consumed within one year or operating cycle, if longer.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(6))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=124098289&amp;loc=d3e6676-107765<br><br>Reference 3: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 852<br> -SubTopic 10<br> -Section 55<br> -Paragraph 10<br> -URI https://asc.fasb.org/extlink&amp;oid=84165509&amp;loc=d3e56426-112766<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InventoryNet</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_Liabilities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Sum of the carrying amounts as of the balance sheet date of all liabilities that are recognized. Liabilities are probable future sacrifices of economic benefits arising from present obligations of an entity to transfer assets or provide services to other entities in the future.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.19-26)<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 852<br> -SubTopic 10<br> -Section 50<br> -Paragraph 7<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=124433192&amp;loc=SL2890621-112765<br><br>Reference 3: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (d)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8906-108599<br><br>Reference 4: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 852<br> -SubTopic 10<br> -Section 50<br> -Paragraph 7<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=124433192&amp;loc=SL2890621-112765<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 45<br> -Paragraph 25<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=116870748&amp;loc=SL6758485-165988<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(5))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -URI https://asc.fasb.org/extlink&amp;oid=123596393&amp;loc=d3e14064-108612<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iv))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (bb)<br> -URI https://asc.fasb.org/extlink&amp;oid=123419778&amp;loc=d3e5710-111685<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(B))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iv))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=123419778&amp;loc=d3e5710-111685<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=114001798&amp;loc=d3e33918-111571<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(5))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iii)(A))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(i))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 17: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(i))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 18: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -URI https://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 19: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(A))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 20: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(ii))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_Liabilities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LiabilitiesAndStockholdersEquity">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of liabilities and equity items, including the portion of equity attributable to noncontrolling interests, if any.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=114001798&amp;loc=d3e33918-111571<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 852<br> -SubTopic 10<br> -Section 55<br> -Paragraph 10<br> -URI https://asc.fasb.org/extlink&amp;oid=84165509&amp;loc=d3e56426-112766<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-03(23))<br> -URI https://asc.fasb.org/extlink&amp;oid=126897435&amp;loc=d3e534808-122878<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(a)(25))<br> -URI https://asc.fasb.org/extlink&amp;oid=126734703&amp;loc=d3e572229-122910<br><br>Reference 5: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -URI https://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 6: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(32))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 7: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -URI https://asc.fasb.org/extlink&amp;oid=123596393&amp;loc=d3e14064-108612<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LiabilitiesAndStockholdersEquity</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LiabilitiesCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Total obligations incurred as part of normal operations that are expected to be paid during the following twelve months or within one business cycle, if longer.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 852<br> -SubTopic 10<br> -Section 55<br> -Paragraph 10<br> -URI https://asc.fasb.org/extlink&amp;oid=84165509&amp;loc=d3e56426-112766<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 852<br> -SubTopic 10<br> -Section 50<br> -Paragraph 7<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=124433192&amp;loc=SL2890621-112765<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(A))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 4: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 852<br> -SubTopic 10<br> -Section 50<br> -Paragraph 7<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=124433192&amp;loc=SL2890621-112765<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 45<br> -Paragraph 25<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=116870748&amp;loc=SL6758485-165988<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -URI https://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 7: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(ii))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iv))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(i))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=123419778&amp;loc=d3e5710-111685<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=114001798&amp;loc=d3e33918-111571<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(B))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(5))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (bb)<br> -URI https://asc.fasb.org/extlink&amp;oid=123419778&amp;loc=d3e5710-111685<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(5))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iii)(A))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 17: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(i))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 18: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iv))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 19: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -URI https://asc.fasb.org/extlink&amp;oid=123596393&amp;loc=d3e14064-108612<br><br>Reference 20: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section 45<br> -Paragraph 5<br> -URI https://asc.fasb.org/extlink&amp;oid=124098289&amp;loc=d3e6904-107765<br><br>Reference 21: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.21)<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LiabilitiesCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LiabilitiesCurrentAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LiabilitiesCurrentAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_MarketableSecuritiesCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of investment in marketable security, classified as current.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_MarketableSecuritiesCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OperatingLeaseLiabilityCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Present value of lessee's discounted obligation for lease payments from operating lease, classified as current.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 45<br> -Paragraph 1<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=123391704&amp;loc=SL77918627-209977<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OperatingLeaseLiabilityCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OperatingLeaseLiabilityNoncurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Present value of lessee's discounted obligation for lease payments from operating lease, classified as noncurrent.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 45<br> -Paragraph 1<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=123391704&amp;loc=SL77918627-209977<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OperatingLeaseLiabilityNoncurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OperatingLeaseRightOfUseAsset">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of lessee's right to use underlying asset under operating lease.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 45<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=123391704&amp;loc=SL77918627-209977<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OperatingLeaseRightOfUseAsset</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherAssetsNoncurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of noncurrent assets classified as other.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(17))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherAssetsNoncurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PrepaidExpenseAndOtherAssetsCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of asset related to consideration paid in advance for costs that provide economic benefits in future periods, and amount of other assets that are expected to be realized or consumed within one year or the normal operating cycle, if longer.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(9))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PrepaidExpenseAndOtherAssetsCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PropertyPlantAndEquipmentNet">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount after accumulated depreciation, depletion and amortization of physical assets used in the normal conduct of business to produce goods and services and not intended for resale. Examples include, but are not limited to, land, buildings, machinery and equipment, office equipment, and furniture and fixtures.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 360<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -URI https://asc.fasb.org/extlink&amp;oid=6391035&amp;loc=d3e2868-110229<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(a)(8))<br> -URI https://asc.fasb.org/extlink&amp;oid=126734703&amp;loc=d3e572229-122910<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 360<br> -Section 50<br> -Paragraph 1<br> -URI https://asc.fasb.org/extlink&amp;oid=124429447&amp;loc=SL124453093-239630<br><br>Reference 4: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 852<br> -SubTopic 10<br> -Section 55<br> -Paragraph 10<br> -URI https://asc.fasb.org/extlink&amp;oid=84165509&amp;loc=d3e56426-112766<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PropertyPlantAndEquipmentNet</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RestrictedCashNoncurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of cash restricted as to withdrawal or usage, classified as noncurrent. Cash includes, but is not limited to, currency on hand, demand deposits with banks or financial institutions, and other accounts with general characteristics of demand deposits.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(17))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 50<br> -Paragraph 8<br> -URI https://asc.fasb.org/extlink&amp;oid=126999549&amp;loc=SL98516268-108586<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 954<br> -SubTopic 210<br> -Section 45<br> -Paragraph 5<br> -URI https://asc.fasb.org/extlink&amp;oid=120413173&amp;loc=SL116631458-115580<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RestrictedCashNoncurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RetainedEarningsAccumulatedDeficit">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The cumulative amount of the reporting entity's undistributed earnings or deficit.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(30)(a)(3))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 852<br> -SubTopic 10<br> -Section 55<br> -Paragraph 10<br> -URI https://asc.fasb.org/extlink&amp;oid=84165509&amp;loc=d3e56426-112766<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(a)(23)(a)(4))<br> -URI https://asc.fasb.org/extlink&amp;oid=126734703&amp;loc=d3e572229-122910<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 40<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (h)(2)<br> -URI https://asc.fasb.org/extlink&amp;oid=124501264&amp;loc=SL117420844-207641<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.3-04)<br> -URI https://asc.fasb.org/extlink&amp;oid=120397183&amp;loc=d3e187085-122770<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 40<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (g)(2)(i)<br> -URI https://asc.fasb.org/extlink&amp;oid=124501264&amp;loc=SL117420844-207641<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RetainedEarningsAccumulatedDeficit</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockholdersEquity">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Total of all stockholders' equity (deficit) items, net of receivables from officers, directors, owners, and affiliates of the entity which are attributable to the parent. The amount of the economic entity's stockholders' equity attributable to the parent excludes the amount of stockholders' equity which is allocable to that ownership interest in subsidiary equity which is not attributable to the parent (noncontrolling interest, minority interest). This excludes temporary equity and is sometimes called permanent equity.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -URI https://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 852<br> -SubTopic 10<br> -Section 55<br> -Paragraph 10<br> -URI https://asc.fasb.org/extlink&amp;oid=84165509&amp;loc=d3e56426-112766<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 310<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SAB Topic 4.E)<br> -URI https://asc.fasb.org/extlink&amp;oid=122038336&amp;loc=d3e74512-122707<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(31))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 6: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(30))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 7: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -URI https://asc.fasb.org/extlink&amp;oid=123596393&amp;loc=d3e14064-108612<br><br>Reference 8: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=114001798&amp;loc=d3e33918-111571<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockholdersEquity</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockholdersEquityAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockholdersEquityAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_WarrantsAndRightsOutstanding">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Value of outstanding derivative securities that permit the holder the right to purchase securities (usually equity) from the issuer at a specified price.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_WarrantsAndRightsOutstanding</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>26
<FILENAME>R3.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.2</span><table class="report" border="0" cellspacing="2" id="idm139763871892704">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Condensed Consolidated Balance Sheets (Parenthetical) - $ / shares<br></strong></div></th>
<th class="th"><div>Jun. 30, 2022</div></th>
<th class="th"><div>Dec. 31, 2021</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StatementOfFinancialPositionAbstract', window );"><strong>Statement of Financial Position [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CommonStockParOrStatedValuePerShare', window );">Common stock, par value per share (in usd per share)</a></td>
<td class="nump">$ 0.0001<span></span>
</td>
<td class="nump">$ 0.0001<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CommonStockSharesAuthorized', window );">Common stock, shares authorized (in shares)</a></td>
<td class="nump">50,000,000<span></span>
</td>
<td class="nump">50,000,000<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CommonStockSharesIssued', window );">Common stock, shares issued (in shares)</a></td>
<td class="nump">30,038,447<span></span>
</td>
<td class="nump">29,772,922<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CommonStockSharesOutstanding', window );">Common stock, shares outstanding (in shares)</a></td>
<td class="nump">30,038,447<span></span>
</td>
<td class="nump">29,772,922<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CommonStockParOrStatedValuePerShare">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Face amount or stated value per share of common stock.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CommonStockParOrStatedValuePerShare</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CommonStockSharesAuthorized">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The maximum number of common shares permitted to be issued by an entity's charter and bylaws.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CommonStockSharesAuthorized</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CommonStockSharesIssued">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Total number of common shares of an entity that have been sold or granted to shareholders (includes common shares that were issued, repurchased and remain in the treasury). These shares represent capital invested by the firm's shareholders and owners, and may be all or only a portion of the number of shares authorized. Shares issued include shares outstanding and shares held in the treasury.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CommonStockSharesIssued</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CommonStockSharesOutstanding">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Number of shares of common stock outstanding. Common stock represent the ownership interest in a corporation.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI https://asc.fasb.org/extlink&amp;oid=126973232&amp;loc=d3e21463-112644<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CommonStockSharesOutstanding</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementOfFinancialPositionAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementOfFinancialPositionAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>27
<FILENAME>R4.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.2</span><table class="report" border="0" cellspacing="2" id="idm139763870706288">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Condensed Consolidated Statements of Operations - USD ($)<br> $ in Thousands</strong></div></th>
<th class="th" colspan="2">3 Months Ended</th>
<th class="th" colspan="2">6 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Jun. 30, 2022</div></th>
<th class="th"><div>Jun. 30, 2021</div></th>
<th class="th"><div>Jun. 30, 2022</div></th>
<th class="th"><div>Jun. 30, 2021</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RevenuesAbstract', window );"><strong>Revenues:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RevenueFromContractWithCustomerIncludingAssessedTax', window );">Total revenues</a></td>
<td class="nump">$ 4,233<span></span>
</td>
<td class="nump">$ 3,119<span></span>
</td>
<td class="nump">$ 7,951<span></span>
</td>
<td class="nump">$ 5,643<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CostOfRevenueAbstract', window );"><strong>Cost of revenues:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CostOfRevenue', window );">Total cost of revenues</a></td>
<td class="nump">3,273<span></span>
</td>
<td class="nump">2,624<span></span>
</td>
<td class="nump">6,827<span></span>
</td>
<td class="nump">4,626<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_GrossProfit', window );">Gross profit</a></td>
<td class="nump">960<span></span>
</td>
<td class="nump">495<span></span>
</td>
<td class="nump">1,124<span></span>
</td>
<td class="nump">1,017<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OperatingExpensesAbstract', window );"><strong>Operating expenses:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SellingAndMarketingExpense', window );">Sales and marketing</a></td>
<td class="nump">15,001<span></span>
</td>
<td class="nump">7,907<span></span>
</td>
<td class="nump">30,444<span></span>
</td>
<td class="nump">14,419<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ResearchAndDevelopmentExpense', window );">Research and development</a></td>
<td class="nump">6,915<span></span>
</td>
<td class="nump">3,594<span></span>
</td>
<td class="nump">13,253<span></span>
</td>
<td class="nump">5,845<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_GeneralAndAdministrativeExpense', window );">General and administrative</a></td>
<td class="nump">8,878<span></span>
</td>
<td class="nump">6,301<span></span>
</td>
<td class="nump">17,452<span></span>
</td>
<td class="nump">11,473<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OperatingExpenses', window );">Total operating expenses</a></td>
<td class="nump">30,794<span></span>
</td>
<td class="nump">17,802<span></span>
</td>
<td class="nump">61,149<span></span>
</td>
<td class="nump">31,737<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OperatingIncomeLoss', window );">Loss from operations</a></td>
<td class="num">(29,834)<span></span>
</td>
<td class="num">(17,307)<span></span>
</td>
<td class="num">(60,025)<span></span>
</td>
<td class="num">(30,720)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NonoperatingIncomeExpenseAbstract', window );"><strong>Other income/(expense):</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_InterestIncomeExpenseNonoperatingNet', window );">Interest income, net</a></td>
<td class="nump">149<span></span>
</td>
<td class="nump">35<span></span>
</td>
<td class="nump">215<span></span>
</td>
<td class="nump">69<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueAdjustmentOfWarrants', window );">Change in fair value of warrant liability</a></td>
<td class="nump">105<span></span>
</td>
<td class="nump">170<span></span>
</td>
<td class="nump">122<span></span>
</td>
<td class="num">(1,519)<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NonoperatingIncomeExpense', window );">Total other income/(expense)</a></td>
<td class="nump">254<span></span>
</td>
<td class="nump">205<span></span>
</td>
<td class="nump">337<span></span>
</td>
<td class="num">(1,450)<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NetIncomeLoss', window );">Net loss</a></td>
<td class="num">$ (29,580)<span></span>
</td>
<td class="num">$ (17,102)<span></span>
</td>
<td class="num">$ (59,688)<span></span>
</td>
<td class="num">$ (32,170)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic', window );">Weighted average shares outstanding used in computing net loss per share, basic (in shares)</a></td>
<td class="nump">29,964,849<span></span>
</td>
<td class="nump">28,979,148<span></span>
</td>
<td class="nump">29,904,972<span></span>
</td>
<td class="nump">28,070,539<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding', window );">Weighted average shares outstanding used in computing net loss per share, diluted (in shares)</a></td>
<td class="nump">29,964,849<span></span>
</td>
<td class="nump">28,979,148<span></span>
</td>
<td class="nump">29,904,972<span></span>
</td>
<td class="nump">28,070,539<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EarningsPerShareBasic', window );">Net loss per share of common stock outstanding, basic (in usd per share)</a></td>
<td class="num">$ (0.99)<span></span>
</td>
<td class="num">$ (0.59)<span></span>
</td>
<td class="num">$ (2.00)<span></span>
</td>
<td class="num">$ (1.15)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EarningsPerShareDiluted', window );">Net loss per share of common stock outstanding, diluted (in usd per share)</a></td>
<td class="num">$ (0.99)<span></span>
</td>
<td class="num">$ (0.59)<span></span>
</td>
<td class="num">$ (2.00)<span></span>
</td>
<td class="num">$ (1.15)<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_ProductOrServiceAxis=dmtk_AssayMember', window );">Assay revenue</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RevenuesAbstract', window );"><strong>Revenues:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RevenueFromContractWithCustomerIncludingAssessedTax', window );">Total revenues</a></td>
<td class="nump">$ 4,147<span></span>
</td>
<td class="nump">$ 2,910<span></span>
</td>
<td class="nump">$ 7,665<span></span>
</td>
<td class="nump">$ 5,100<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CostOfRevenueAbstract', window );"><strong>Cost of revenues:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CostOfRevenue', window );">Total cost of revenues</a></td>
<td class="nump">3,236<span></span>
</td>
<td class="nump">2,604<span></span>
</td>
<td class="nump">6,766<span></span>
</td>
<td class="nump">4,575<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_ProductOrServiceAxis=dmtk_ContractualActivitiesMember', window );">Contract revenue</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RevenuesAbstract', window );"><strong>Revenues:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RevenueFromContractWithCustomerIncludingAssessedTax', window );">Total revenues</a></td>
<td class="nump">86<span></span>
</td>
<td class="nump">209<span></span>
</td>
<td class="nump">286<span></span>
</td>
<td class="nump">543<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CostOfRevenueAbstract', window );"><strong>Cost of revenues:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CostOfRevenue', window );">Total cost of revenues</a></td>
<td class="nump">$ 37<span></span>
</td>
<td class="nump">$ 20<span></span>
</td>
<td class="nump">$ 61<span></span>
</td>
<td class="nump">$ 51<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CostOfRevenue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The aggregate cost of goods produced and sold and services rendered during the reporting period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(5))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -URI https://asc.fasb.org/extlink&amp;oid=123596393&amp;loc=d3e14064-108612<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -URI https://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iv))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03.2)<br> -URI https://asc.fasb.org/extlink&amp;oid=126953954&amp;loc=SL114868664-224227<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=114001798&amp;loc=d3e33918-111571<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(5))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(i))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(B))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(A))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(i))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iii)(A))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 13: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(ii))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iv))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CostOfRevenue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CostOfRevenueAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CostOfRevenueAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EarningsPerShareBasic">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The amount of net income (loss) for the period per each share of common stock or unit outstanding during the reporting period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 40<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (e)(4)<br> -URI https://asc.fasb.org/extlink&amp;oid=126732423&amp;loc=SL123482106-238011<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22583-107794<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22694-107794<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 10<br> -URI https://asc.fasb.org/extlink&amp;oid=126958026&amp;loc=d3e1448-109256<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22595-107794<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22694-107794<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 7<br> -URI https://asc.fasb.org/extlink&amp;oid=126958026&amp;loc=d3e1337-109256<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 40<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (f)<br> -URI https://asc.fasb.org/extlink&amp;oid=126732423&amp;loc=SL123482106-238011<br><br>Reference 9: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 55<br> -Paragraph 52<br> -URI https://asc.fasb.org/extlink&amp;oid=128363288&amp;loc=d3e4984-109258<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(23))<br> -URI https://asc.fasb.org/extlink&amp;oid=120400993&amp;loc=SL114874131-224263<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 55<br> -Paragraph 15<br> -URI https://asc.fasb.org/extlink&amp;oid=128363288&amp;loc=d3e3842-109258<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 7<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22644-107794<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=124432515&amp;loc=d3e3550-109257<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(25))<br> -URI https://asc.fasb.org/extlink&amp;oid=126953954&amp;loc=SL114868664-224227<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 2<br> -URI https://asc.fasb.org/extlink&amp;oid=126958026&amp;loc=d3e1252-109256<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 60B<br> -Subparagraph (d)<br> -URI https://asc.fasb.org/extlink&amp;oid=126958026&amp;loc=SL5780133-109256<br><br>Reference 17: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04(27))<br> -URI https://asc.fasb.org/extlink&amp;oid=120399700&amp;loc=SL114874048-224260<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EarningsPerShareBasic</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EarningsPerShareDiluted">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The amount of net income (loss) for the period available to each share of common stock or common unit outstanding during the reporting period and to each share or unit that would have been outstanding assuming the issuance of common shares or units for all dilutive potential common shares or units outstanding during the reporting period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 55<br> -Paragraph 52<br> -URI https://asc.fasb.org/extlink&amp;oid=128363288&amp;loc=d3e4984-109258<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 7<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22644-107794<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 55<br> -Paragraph 15<br> -URI https://asc.fasb.org/extlink&amp;oid=128363288&amp;loc=d3e3842-109258<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 2<br> -URI https://asc.fasb.org/extlink&amp;oid=126958026&amp;loc=d3e1252-109256<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22694-107794<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22595-107794<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22583-107794<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 60B<br> -Subparagraph (d)<br> -URI https://asc.fasb.org/extlink&amp;oid=126958026&amp;loc=SL5780133-109256<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 40<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (f)<br> -URI https://asc.fasb.org/extlink&amp;oid=126732423&amp;loc=SL123482106-238011<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04(27))<br> -URI https://asc.fasb.org/extlink&amp;oid=120399700&amp;loc=SL114874048-224260<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=124432515&amp;loc=d3e3550-109257<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(23))<br> -URI https://asc.fasb.org/extlink&amp;oid=120400993&amp;loc=SL114874131-224263<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22694-107794<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 7<br> -URI https://asc.fasb.org/extlink&amp;oid=126958026&amp;loc=d3e1337-109256<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 40<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (e)(4)<br> -URI https://asc.fasb.org/extlink&amp;oid=126732423&amp;loc=SL123482106-238011<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(25))<br> -URI https://asc.fasb.org/extlink&amp;oid=126953954&amp;loc=SL114868664-224227<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EarningsPerShareDiluted</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FairValueAdjustmentOfWarrants">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of expense (income) related to adjustment to fair value of warrant liability.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3602-108585<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 480<br> -SubTopic 10<br> -Section 25<br> -Paragraph 13<br> -URI https://asc.fasb.org/extlink&amp;oid=109262497&amp;loc=d3e20148-110875<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FairValueAdjustmentOfWarrants</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_GeneralAndAdministrativeExpense">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The aggregate total of expenses of managing and administering the affairs of an entity, including affiliates of the reporting entity, which are not directly or indirectly associated with the manufacture, sale or creation of a product or product line.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03.4)<br> -URI https://asc.fasb.org/extlink&amp;oid=126953954&amp;loc=SL114868664-224227<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_GeneralAndAdministrativeExpense</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_GrossProfit">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Aggregate revenue less cost of goods and services sold or operating expenses directly attributable to the revenue generation activity.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 31<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8924-108599<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8906-108599<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8736-108599<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (f)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8933-108599<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iv))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=114001798&amp;loc=d3e33918-111571<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(A))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(B))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 9: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(ii))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -URI https://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(i))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(i))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iii)(A))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -URI https://asc.fasb.org/extlink&amp;oid=123596393&amp;loc=d3e14064-108612<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(5))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iv))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 17: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(5))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 18: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03.1,2)<br> -URI https://asc.fasb.org/extlink&amp;oid=126953954&amp;loc=SL114868664-224227<br><br>Reference 19: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8933-108599<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_GrossProfit</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InterestIncomeExpenseNonoperatingNet">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The net amount of nonoperating interest income (expense).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InterestIncomeExpenseNonoperatingNet</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetIncomeLoss">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The portion of profit or loss for the period, net of income taxes, which is attributable to the parent.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04(22))<br> -URI https://asc.fasb.org/extlink&amp;oid=120399700&amp;loc=SL114874048-224260<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (f)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8933-108599<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22595-107794<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(18))<br> -URI https://asc.fasb.org/extlink&amp;oid=120400993&amp;loc=SL114874131-224263<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 40<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (f)<br> -URI https://asc.fasb.org/extlink&amp;oid=126732423&amp;loc=SL123482106-238011<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 50<br> -Paragraph 6<br> -URI https://asc.fasb.org/extlink&amp;oid=124431353&amp;loc=SL124452729-227067<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(5))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 8: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(20))<br> -URI https://asc.fasb.org/extlink&amp;oid=126953954&amp;loc=SL114868664-224227<br><br>Reference 9: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3602-108585<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)(2)<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22499-107794<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iv))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iii)(A))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(i))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(i))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 9<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22663-107794<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iv))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 17: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(ii))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 18: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -URI https://asc.fasb.org/extlink&amp;oid=123596393&amp;loc=d3e14064-108612<br><br>Reference 19: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22583-107794<br><br>Reference 20: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -URI https://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 21: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 60B<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126958026&amp;loc=SL5780133-109256<br><br>Reference 22: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=114001798&amp;loc=d3e33918-111571<br><br>Reference 23: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 8<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22658-107794<br><br>Reference 24: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1A<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126968391&amp;loc=SL7669619-108580<br><br>Reference 25: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 31<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8924-108599<br><br>Reference 26: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22694-107794<br><br>Reference 27: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22694-107794<br><br>Reference 28: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 205<br> -SubTopic 20<br> -Section 50<br> -Paragraph 7<br> -URI https://asc.fasb.org/extlink&amp;oid=109222650&amp;loc=SL51721683-107760<br><br>Reference 29: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1B<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126968391&amp;loc=SL7669625-108580<br><br>Reference 30: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8736-108599<br><br>Reference 31: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(5))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 32: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(B))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 33: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(A))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 34: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8906-108599<br><br>Reference 35: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8933-108599<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NetIncomeLoss</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NonoperatingIncomeExpense">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The aggregate amount of income or expense from ancillary business-related activities (that is to say, excluding major activities considered part of the normal operations of the business).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03.7)<br> -URI https://asc.fasb.org/extlink&amp;oid=126953954&amp;loc=SL114868664-224227<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NonoperatingIncomeExpense</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NonoperatingIncomeExpenseAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NonoperatingIncomeExpenseAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OperatingExpenses">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Generally recurring costs associated with normal operations except for the portion of these expenses which can be clearly related to production and included in cost of sales or services. Includes selling, general and administrative expense.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OperatingExpenses</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OperatingExpensesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OperatingExpensesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OperatingIncomeLoss">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The net result for the period of deducting operating expenses from operating revenues.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 31<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8924-108599<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8906-108599<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8933-108599<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (f)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8933-108599<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8736-108599<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OperatingIncomeLoss</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ResearchAndDevelopmentExpense">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The aggregate costs incurred (1) in a planned search or critical investigation aimed at discovery of new knowledge with the hope that such knowledge will be useful in developing a new product or service, a new process or technique, or in bringing about a significant improvement to an existing product or process; or (2) to translate research findings or other knowledge into a plan or design for a new product or process or for a significant improvement to an existing product or process whether intended for sale or the entity's use, during the reporting period charged to research and development projects, including the costs of developing computer software up to the point in time of achieving technological feasibility, and costs allocated in accounting for a business combination to in-process projects deemed to have no alternative future use.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 912<br> -SubTopic 730<br> -Section 25<br> -Paragraph 1<br> -URI https://asc.fasb.org/extlink&amp;oid=6472174&amp;loc=d3e58812-109433<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 985<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -URI https://asc.fasb.org/extlink&amp;oid=6501960&amp;loc=d3e128462-111756<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 730<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -URI https://asc.fasb.org/extlink&amp;oid=6420194&amp;loc=d3e21568-108373<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ResearchAndDevelopmentExpense</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RevenueFromContractWithCustomerIncludingAssessedTax">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount, including tax collected from customer, of revenue from satisfaction of performance obligation by transferring promised good or service to customer. Tax collected from customer is tax assessed by governmental authority that is both imposed on and concurrent with specific revenue-producing transaction, including, but not limited to, sales, use, value-added and excise.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 41<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e9038-108599<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 606<br> -SubTopic 10<br> -Section 50<br> -Paragraph 5<br> -URI https://asc.fasb.org/extlink&amp;oid=126920106&amp;loc=SL49130545-203045<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8933-108599<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8933-108599<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8906-108599<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8736-108599<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8736-108599<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 606<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126920106&amp;loc=SL49130543-203045<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 42<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e9054-108599<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 40<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e9031-108599<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 924<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB Topic 11.L)<br> -URI https://asc.fasb.org/extlink&amp;oid=6472922&amp;loc=d3e499488-122856<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RevenueFromContractWithCustomerIncludingAssessedTax</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RevenuesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RevenuesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SellingAndMarketingExpense">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The aggregate total amount of expenses directly related to the marketing or selling of products or services.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SellingAndMarketingExpense</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The average number of shares or units issued and outstanding that are used in calculating diluted EPS or earnings per unit (EPU), determined based on the timing of issuance of shares or units in the period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=124432515&amp;loc=d3e3550-109257<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 16<br> -URI https://asc.fasb.org/extlink&amp;oid=126958026&amp;loc=d3e1505-109256<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Number of [basic] shares or units, after adjustment for contingently issuable shares or units and other shares or units not deemed outstanding, determined by relating the portion of time within a reporting period that common shares or units have been outstanding to the total time in that period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=124432515&amp;loc=d3e3550-109257<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 10<br> -URI https://asc.fasb.org/extlink&amp;oid=126958026&amp;loc=d3e1448-109256<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_WeightedAverageNumberOfSharesOutstandingBasic</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_ProductOrServiceAxis=dmtk_AssayMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_ProductOrServiceAxis=dmtk_AssayMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_ProductOrServiceAxis=dmtk_ContractualActivitiesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_ProductOrServiceAxis=dmtk_ContractualActivitiesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>28
<FILENAME>R5.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.2</span><table class="report" border="0" cellspacing="2" id="idm139763872640464">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Condensed Consolidated Statements of Comprehensive Loss - USD ($)<br> $ in Thousands</strong></div></th>
<th class="th" colspan="2">3 Months Ended</th>
<th class="th" colspan="2">6 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Jun. 30, 2022</div></th>
<th class="th"><div>Jun. 30, 2021</div></th>
<th class="th"><div>Jun. 30, 2022</div></th>
<th class="th"><div>Jun. 30, 2021</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StatementOfIncomeAndComprehensiveIncomeAbstract', window );"><strong>Statement of Comprehensive Income [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NetIncomeLoss', window );">Net loss</a></td>
<td class="num">$ (29,580)<span></span>
</td>
<td class="num">$ (17,102)<span></span>
</td>
<td class="num">$ (59,688)<span></span>
</td>
<td class="num">$ (32,170)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax', window );">Unrealized net (loss)/gain on available-for-sale marketable securities</a></td>
<td class="num">(171)<span></span>
</td>
<td class="num">(6)<span></span>
</td>
<td class="num">(741)<span></span>
</td>
<td class="nump">3<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ComprehensiveIncomeNetOfTax', window );">Comprehensive loss</a></td>
<td class="num">$ (29,751)<span></span>
</td>
<td class="num">$ (17,108)<span></span>
</td>
<td class="num">$ (60,429)<span></span>
</td>
<td class="num">$ (32,167)<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ComprehensiveIncomeNetOfTax">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount after tax of increase (decrease) in equity from transactions and other events and circumstances from net income and other comprehensive income, attributable to parent entity. Excludes changes in equity resulting from investments by owners and distributions to owners.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(22))<br> -URI https://asc.fasb.org/extlink&amp;oid=120400993&amp;loc=SL114874131-224263<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(24))<br> -URI https://asc.fasb.org/extlink&amp;oid=126953954&amp;loc=SL114868664-224227<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 5<br> -URI https://asc.fasb.org/extlink&amp;oid=126968391&amp;loc=d3e557-108580<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04(26))<br> -URI https://asc.fasb.org/extlink&amp;oid=120399700&amp;loc=SL114874048-224260<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1B<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=126968391&amp;loc=SL7669625-108580<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1A<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=126968391&amp;loc=SL7669619-108580<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ComprehensiveIncomeNetOfTax</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetIncomeLoss">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The portion of profit or loss for the period, net of income taxes, which is attributable to the parent.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04(22))<br> -URI https://asc.fasb.org/extlink&amp;oid=120399700&amp;loc=SL114874048-224260<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (f)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8933-108599<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22595-107794<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(18))<br> -URI https://asc.fasb.org/extlink&amp;oid=120400993&amp;loc=SL114874131-224263<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 40<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (f)<br> -URI https://asc.fasb.org/extlink&amp;oid=126732423&amp;loc=SL123482106-238011<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 50<br> -Paragraph 6<br> -URI https://asc.fasb.org/extlink&amp;oid=124431353&amp;loc=SL124452729-227067<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(5))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 8: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(20))<br> -URI https://asc.fasb.org/extlink&amp;oid=126953954&amp;loc=SL114868664-224227<br><br>Reference 9: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3602-108585<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)(2)<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22499-107794<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iv))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iii)(A))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(i))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(i))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 9<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22663-107794<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iv))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 17: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(ii))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 18: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -URI https://asc.fasb.org/extlink&amp;oid=123596393&amp;loc=d3e14064-108612<br><br>Reference 19: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22583-107794<br><br>Reference 20: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -URI https://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 21: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 60B<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126958026&amp;loc=SL5780133-109256<br><br>Reference 22: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=114001798&amp;loc=d3e33918-111571<br><br>Reference 23: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 8<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22658-107794<br><br>Reference 24: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1A<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126968391&amp;loc=SL7669619-108580<br><br>Reference 25: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 31<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8924-108599<br><br>Reference 26: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22694-107794<br><br>Reference 27: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22694-107794<br><br>Reference 28: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 205<br> -SubTopic 20<br> -Section 50<br> -Paragraph 7<br> -URI https://asc.fasb.org/extlink&amp;oid=109222650&amp;loc=SL51721683-107760<br><br>Reference 29: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1B<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126968391&amp;loc=SL7669625-108580<br><br>Reference 30: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8736-108599<br><br>Reference 31: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(5))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 32: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(B))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 33: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(A))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 34: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8906-108599<br><br>Reference 35: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8933-108599<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NetIncomeLoss</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount, after tax and before adjustment, of unrealized holding gain (loss) on investment in debt security measured at fair value with change in fair value recognized in other comprehensive income (available-for-sale). Excludes unrealized gain (loss) on investment in debt security measured at amortized cost (held-to-maturity) from transfer to available-for-sale.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 10A<br> -Subparagraph (e)<br> -URI https://asc.fasb.org/extlink&amp;oid=126968391&amp;loc=SL7669646-108580<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 11<br> -URI https://asc.fasb.org/extlink&amp;oid=126968391&amp;loc=d3e637-108580<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementOfIncomeAndComprehensiveIncomeAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementOfIncomeAndComprehensiveIncomeAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>29
<FILENAME>R6.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.2</span><table class="report" border="0" cellspacing="2" id="idm139763868105920">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Condensed Consolidated Statements of Stockholders&#8217; Equity - USD ($)<br> $ in Thousands</strong></div></th>
<th class="th"><div>Total</div></th>
<th class="th"><div>Common stock</div></th>
<th class="th"><div>Additional paid-in capital</div></th>
<th class="th"><div>Accumulated other comprehensive income/(loss)</div></th>
<th class="th"><div>Accumulated deficit</div></th>
</tr>
<tr class="rc">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SharesOutstanding', window );">Beginning balance (in shares) at Dec. 31, 2020</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">20,740,413<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockholdersEquity', window );">Beginning balance at Dec. 31, 2020</a></td>
<td class="nump">$ 61,840<span></span>
</td>
<td class="nump">$ 2<span></span>
</td>
<td class="nump">$ 189,868<span></span>
</td>
<td class="num">$ (1)<span></span>
</td>
<td class="num">$ (128,029)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodSharesNewIssues', window );">Issuance of stock, net of issuance costs shares (in shares)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">4,872,881<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodValueNewIssues', window );">Issuance of stock, net of issuance costs</a></td>
<td class="nump">134,582<span></span>
</td>
<td class="nump">$ 1<span></span>
</td>
<td class="nump">134,581<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dmtk_StockIssuedDuringPeriodSharesStockOptionsExercisedAndRSURelease', window );">Issuance of common stock from option exercises and RSU releases (in shares)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">176,673<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dmtk_StockIssuedDuringPeriodValueStockOptionsExercisedAndRSURelease', window );">Issuance of common stock from option exercises and RSU releases</a></td>
<td class="nump">408<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">408<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dmtk_AdjustmentsToAdditionalPaidInCapitalWarrantIssuedShares', window );">Issuance of common stock from warrant exercises (in shares)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">3,089,325<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AdjustmentsToAdditionalPaidInCapitalWarrantIssued', window );">Issuance of common stock from warrant exercises</a></td>
<td class="nump">72,081<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">72,081<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodSharesEmployeeStockPurchasePlans', window );">Issuance of common stock from Employee Stock Purchase Plan (in shares)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">39,960<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodValueEmployeeStockPurchasePlan', window );">Issuance of common stock from Employee Stock Purchase Plan</a></td>
<td class="nump">392<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">392<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax', window );">Unrealized net (loss)/gain on available-for-sale marketable securities</a></td>
<td class="nump">9<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">9<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue', window );">Stock-based compensation</a></td>
<td class="nump">2,172<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">2,172<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dmtk_ReclassificationOfWarrantLiabilityDueToPrivateSPACWarrantsNotHeldByOriginalHolder', window );">Reclassification of warrant liability due to Private SPAC Warrants not held by original holder</a></td>
<td class="nump">411<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">411<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NetIncomeLoss', window );">Net loss</a></td>
<td class="num">(15,068)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(15,068)<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SharesOutstanding', window );">Ending balance (in shares) at Mar. 31, 2021</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">28,919,252<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockholdersEquity', window );">Ending balance at Mar. 31, 2021</a></td>
<td class="nump">256,827<span></span>
</td>
<td class="nump">$ 3<span></span>
</td>
<td class="nump">399,913<span></span>
</td>
<td class="nump">8<span></span>
</td>
<td class="num">(143,097)<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SharesOutstanding', window );">Beginning balance (in shares) at Dec. 31, 2020</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">20,740,413<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockholdersEquity', window );">Beginning balance at Dec. 31, 2020</a></td>
<td class="nump">61,840<span></span>
</td>
<td class="nump">$ 2<span></span>
</td>
<td class="nump">189,868<span></span>
</td>
<td class="num">(1)<span></span>
</td>
<td class="num">(128,029)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax', window );">Unrealized net (loss)/gain on available-for-sale marketable securities</a></td>
<td class="nump">3<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dmtk_ReclassificationOfWarrantLiabilityDueToPrivateSPACWarrantsNotHeldByOriginalHolder', window );">Reclassification of warrant liability due to Private SPAC Warrants not held by original holder</a></td>
<td class="nump">434<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NetIncomeLoss', window );">Net loss</a></td>
<td class="num">(32,170)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SharesOutstanding', window );">Ending balance (in shares) at Jun. 30, 2021</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">29,607,394<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockholdersEquity', window );">Ending balance at Jun. 30, 2021</a></td>
<td class="nump">267,309<span></span>
</td>
<td class="nump">$ 3<span></span>
</td>
<td class="nump">427,503<span></span>
</td>
<td class="nump">2<span></span>
</td>
<td class="num">(160,199)<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SharesOutstanding', window );">Beginning balance (in shares) at Dec. 31, 2020</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">20,740,413<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockholdersEquity', window );">Beginning balance at Dec. 31, 2020</a></td>
<td class="nump">61,840<span></span>
</td>
<td class="nump">$ 2<span></span>
</td>
<td class="nump">189,868<span></span>
</td>
<td class="num">(1)<span></span>
</td>
<td class="num">(128,029)<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SharesOutstanding', window );">Ending balance (in shares) at Dec. 31, 2021</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">29,772,922<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockholdersEquity', window );">Ending balance at Dec. 31, 2021</a></td>
<td class="nump">229,698<span></span>
</td>
<td class="nump">$ 3<span></span>
</td>
<td class="nump">436,183<span></span>
</td>
<td class="num">(124)<span></span>
</td>
<td class="num">(206,364)<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SharesOutstanding', window );">Beginning balance (in shares) at Mar. 31, 2021</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">28,919,252<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockholdersEquity', window );">Beginning balance at Mar. 31, 2021</a></td>
<td class="nump">256,827<span></span>
</td>
<td class="nump">$ 3<span></span>
</td>
<td class="nump">399,913<span></span>
</td>
<td class="nump">8<span></span>
</td>
<td class="num">(143,097)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodSharesNewIssues', window );">Issuance of stock, net of issuance costs shares (in shares)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">530,551<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodValueNewIssues', window );">Issuance of stock, net of issuance costs</a></td>
<td class="nump">23,836<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">23,836<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dmtk_StockIssuedDuringPeriodSharesStockOptionsExercisedAndRSURelease', window );">Issuance of common stock from option exercises and RSU releases (in shares)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">157,277<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dmtk_StockIssuedDuringPeriodValueStockOptionsExercisedAndRSURelease', window );">Issuance of common stock from option exercises and RSU releases</a></td>
<td class="nump">188<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">188<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dmtk_AdjustmentsToAdditionalPaidInCapitalWarrantIssuedShares', window );">Issuance of common stock from warrant exercises (in shares)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">314<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AdjustmentsToAdditionalPaidInCapitalWarrantIssued', window );">Issuance of common stock from warrant exercises</a></td>
<td class="nump">5<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">5<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax', window );">Unrealized net (loss)/gain on available-for-sale marketable securities</a></td>
<td class="num">(6)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(6)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue', window );">Stock-based compensation</a></td>
<td class="nump">3,538<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">3,538<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dmtk_ReclassificationOfWarrantLiabilityDueToPrivateSPACWarrantsNotHeldByOriginalHolder', window );">Reclassification of warrant liability due to Private SPAC Warrants not held by original holder</a></td>
<td class="nump">23<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NetIncomeLoss', window );">Net loss</a></td>
<td class="num">(17,102)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(17,102)<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SharesOutstanding', window );">Ending balance (in shares) at Jun. 30, 2021</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">29,607,394<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockholdersEquity', window );">Ending balance at Jun. 30, 2021</a></td>
<td class="nump">267,309<span></span>
</td>
<td class="nump">$ 3<span></span>
</td>
<td class="nump">427,503<span></span>
</td>
<td class="nump">2<span></span>
</td>
<td class="num">(160,199)<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SharesOutstanding', window );">Beginning balance (in shares) at Dec. 31, 2021</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">29,772,922<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockholdersEquity', window );">Beginning balance at Dec. 31, 2021</a></td>
<td class="nump">229,698<span></span>
</td>
<td class="nump">$ 3<span></span>
</td>
<td class="nump">436,183<span></span>
</td>
<td class="num">(124)<span></span>
</td>
<td class="num">(206,364)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dmtk_StockIssuedDuringPeriodSharesStockOptionsExercisedAndRSURelease', window );">Issuance of common stock from option exercises and RSU releases (in shares)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">109,275<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dmtk_StockIssuedDuringPeriodValueStockOptionsExercisedAndRSURelease', window );">Issuance of common stock from option exercises and RSU releases</a></td>
<td class="nump">40<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">40<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dmtk_AdjustmentsToAdditionalPaidInCapitalWarrantIssuedShares', window );">Issuance of common stock from warrant exercises (in shares)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">11,101<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AdjustmentsToAdditionalPaidInCapitalWarrantIssued', window );">Issuance of common stock from warrant exercises</a></td>
<td class="nump">12<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">12<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodSharesEmployeeStockPurchasePlans', window );">Issuance of common stock from Employee Stock Purchase Plan (in shares)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">47,339<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodValueEmployeeStockPurchasePlan', window );">Issuance of common stock from Employee Stock Purchase Plan</a></td>
<td class="nump">515<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">515<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax', window );">Unrealized net (loss)/gain on available-for-sale marketable securities</a></td>
<td class="num">(570)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(570)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue', window );">Stock-based compensation</a></td>
<td class="nump">3,894<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">3,894<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NetIncomeLoss', window );">Net loss</a></td>
<td class="num">(30,108)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(30,108)<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SharesOutstanding', window );">Ending balance (in shares) at Mar. 31, 2022</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">29,940,637<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockholdersEquity', window );">Ending balance at Mar. 31, 2022</a></td>
<td class="nump">203,481<span></span>
</td>
<td class="nump">$ 3<span></span>
</td>
<td class="nump">440,644<span></span>
</td>
<td class="num">(694)<span></span>
</td>
<td class="num">(236,472)<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SharesOutstanding', window );">Beginning balance (in shares) at Dec. 31, 2021</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">29,772,922<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockholdersEquity', window );">Beginning balance at Dec. 31, 2021</a></td>
<td class="nump">229,698<span></span>
</td>
<td class="nump">$ 3<span></span>
</td>
<td class="nump">436,183<span></span>
</td>
<td class="num">(124)<span></span>
</td>
<td class="num">(206,364)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax', window );">Unrealized net (loss)/gain on available-for-sale marketable securities</a></td>
<td class="num">(741)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dmtk_ReclassificationOfWarrantLiabilityDueToPrivateSPACWarrantsNotHeldByOriginalHolder', window );">Reclassification of warrant liability due to Private SPAC Warrants not held by original holder</a></td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NetIncomeLoss', window );">Net loss</a></td>
<td class="num">(59,688)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SharesOutstanding', window );">Ending balance (in shares) at Jun. 30, 2022</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">30,038,447<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockholdersEquity', window );">Ending balance at Jun. 30, 2022</a></td>
<td class="nump">178,577<span></span>
</td>
<td class="nump">$ 3<span></span>
</td>
<td class="nump">445,491<span></span>
</td>
<td class="num">(865)<span></span>
</td>
<td class="num">(266,052)<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SharesOutstanding', window );">Beginning balance (in shares) at Mar. 31, 2022</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">29,940,637<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockholdersEquity', window );">Beginning balance at Mar. 31, 2022</a></td>
<td class="nump">203,481<span></span>
</td>
<td class="nump">$ 3<span></span>
</td>
<td class="nump">440,644<span></span>
</td>
<td class="num">(694)<span></span>
</td>
<td class="num">(236,472)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dmtk_StockIssuedDuringPeriodSharesStockOptionsExercisedAndRSURelease', window );">Issuance of common stock from option exercises and RSU releases (in shares)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">88,591<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dmtk_StockIssuedDuringPeriodValueStockOptionsExercisedAndRSURelease', window );">Issuance of common stock from option exercises and RSU releases</a></td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dmtk_AdjustmentsToAdditionalPaidInCapitalWarrantIssuedShares', window );">Issuance of common stock from warrant exercises (in shares)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">9,219<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AdjustmentsToAdditionalPaidInCapitalWarrantIssued', window );">Issuance of common stock from warrant exercises</a></td>
<td class="nump">10<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">10<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax', window );">Unrealized net (loss)/gain on available-for-sale marketable securities</a></td>
<td class="num">(171)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(171)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue', window );">Stock-based compensation</a></td>
<td class="nump">4,837<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">4,837<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NetIncomeLoss', window );">Net loss</a></td>
<td class="num">(29,580)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(29,580)<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SharesOutstanding', window );">Ending balance (in shares) at Jun. 30, 2022</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">30,038,447<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockholdersEquity', window );">Ending balance at Jun. 30, 2022</a></td>
<td class="nump">$ 178,577<span></span>
</td>
<td class="nump">$ 3<span></span>
</td>
<td class="nump">$ 445,491<span></span>
</td>
<td class="num">$ (865)<span></span>
</td>
<td class="num">$ (266,052)<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dmtk_AdjustmentsToAdditionalPaidInCapitalWarrantIssuedShares">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Adjustments to Additional Paid in Capital, Warrant Issued, Shares</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dmtk_AdjustmentsToAdditionalPaidInCapitalWarrantIssuedShares</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dmtk_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dmtk_ReclassificationOfWarrantLiabilityDueToPrivateSPACWarrantsNotHeldByOriginalHolder">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Reclassification of warrant liability due to private SPAC warrants not held by original holder.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dmtk_ReclassificationOfWarrantLiabilityDueToPrivateSPACWarrantsNotHeldByOriginalHolder</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dmtk_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dmtk_StockIssuedDuringPeriodSharesStockOptionsExercisedAndRSURelease">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Stock issued during period shares stock options exercised and RSU release.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dmtk_StockIssuedDuringPeriodSharesStockOptionsExercisedAndRSURelease</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dmtk_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dmtk_StockIssuedDuringPeriodValueStockOptionsExercisedAndRSURelease">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Stock issued during period value stock options exercised and RSU release.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dmtk_StockIssuedDuringPeriodValueStockOptionsExercisedAndRSURelease</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dmtk_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of increase to additional paid-in capital (APIC) for recognition of cost for award under share-based payment arrangement.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 20<br> -Section 55<br> -Paragraph 12<br> -URI https://asc.fasb.org/extlink&amp;oid=126964447&amp;loc=d3e11149-113907<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 20<br> -Section 55<br> -Paragraph 13<br> -URI https://asc.fasb.org/extlink&amp;oid=126964447&amp;loc=d3e11178-113907<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 35<br> -Paragraph 2<br> -URI https://asc.fasb.org/extlink&amp;oid=126961718&amp;loc=d3e4534-113899<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AdjustmentsToAdditionalPaidInCapitalWarrantIssued">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of increase in additional paid in capital (APIC) resulting from the issuance of warrants. Includes allocation of proceeds of debt securities issued with detachable stock purchase warrants.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 20<br> -Section 25<br> -Paragraph 2<br> -URI https://asc.fasb.org/extlink&amp;oid=123466302&amp;loc=d3e4724-112606<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI https://asc.fasb.org/extlink&amp;oid=126973232&amp;loc=d3e21463-112644<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.3-04)<br> -URI https://asc.fasb.org/extlink&amp;oid=120397183&amp;loc=d3e187085-122770<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AdjustmentsToAdditionalPaidInCapitalWarrantIssued</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetIncomeLoss">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The portion of profit or loss for the period, net of income taxes, which is attributable to the parent.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04(22))<br> -URI https://asc.fasb.org/extlink&amp;oid=120399700&amp;loc=SL114874048-224260<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (f)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8933-108599<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22595-107794<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(18))<br> -URI https://asc.fasb.org/extlink&amp;oid=120400993&amp;loc=SL114874131-224263<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 40<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (f)<br> -URI https://asc.fasb.org/extlink&amp;oid=126732423&amp;loc=SL123482106-238011<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 50<br> -Paragraph 6<br> -URI https://asc.fasb.org/extlink&amp;oid=124431353&amp;loc=SL124452729-227067<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(5))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 8: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(20))<br> -URI https://asc.fasb.org/extlink&amp;oid=126953954&amp;loc=SL114868664-224227<br><br>Reference 9: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3602-108585<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)(2)<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22499-107794<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iv))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iii)(A))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(i))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(i))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 9<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22663-107794<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iv))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 17: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(ii))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 18: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -URI https://asc.fasb.org/extlink&amp;oid=123596393&amp;loc=d3e14064-108612<br><br>Reference 19: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22583-107794<br><br>Reference 20: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -URI https://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 21: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 60B<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126958026&amp;loc=SL5780133-109256<br><br>Reference 22: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=114001798&amp;loc=d3e33918-111571<br><br>Reference 23: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 8<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22658-107794<br><br>Reference 24: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1A<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126968391&amp;loc=SL7669619-108580<br><br>Reference 25: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 31<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8924-108599<br><br>Reference 26: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22694-107794<br><br>Reference 27: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22694-107794<br><br>Reference 28: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 205<br> -SubTopic 20<br> -Section 50<br> -Paragraph 7<br> -URI https://asc.fasb.org/extlink&amp;oid=109222650&amp;loc=SL51721683-107760<br><br>Reference 29: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1B<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126968391&amp;loc=SL7669625-108580<br><br>Reference 30: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8736-108599<br><br>Reference 31: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(5))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 32: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(B))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 33: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(A))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 34: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8906-108599<br><br>Reference 35: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8933-108599<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NetIncomeLoss</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount, after tax and before adjustment, of unrealized holding gain (loss) on investment in debt security measured at fair value with change in fair value recognized in other comprehensive income (available-for-sale). Excludes unrealized gain (loss) on investment in debt security measured at amortized cost (held-to-maturity) from transfer to available-for-sale.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 10A<br> -Subparagraph (e)<br> -URI https://asc.fasb.org/extlink&amp;oid=126968391&amp;loc=SL7669646-108580<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 11<br> -URI https://asc.fasb.org/extlink&amp;oid=126968391&amp;loc=d3e637-108580<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SharesOutstanding">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Number of shares issued which are neither cancelled nor held in the treasury.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SharesOutstanding</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockIssuedDuringPeriodSharesEmployeeStockPurchasePlans">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Number of shares issued during the period as a result of an employee stock purchase plan.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI https://asc.fasb.org/extlink&amp;oid=126973232&amp;loc=d3e21463-112644<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.3-04)<br> -URI https://asc.fasb.org/extlink&amp;oid=120397183&amp;loc=d3e187085-122770<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(28))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockIssuedDuringPeriodSharesEmployeeStockPurchasePlans</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockIssuedDuringPeriodSharesNewIssues">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Number of new stock issued during the period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI https://asc.fasb.org/extlink&amp;oid=126973232&amp;loc=d3e21463-112644<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.3-04)<br> -URI https://asc.fasb.org/extlink&amp;oid=120397183&amp;loc=d3e187085-122770<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(28))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockIssuedDuringPeriodSharesNewIssues</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockIssuedDuringPeriodValueEmployeeStockPurchasePlan">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Aggregate change in value for stock issued during the period as a result of employee stock purchase plan.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.3-04)<br> -URI https://asc.fasb.org/extlink&amp;oid=120397183&amp;loc=d3e187085-122770<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(28))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI https://asc.fasb.org/extlink&amp;oid=126973232&amp;loc=d3e21463-112644<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockIssuedDuringPeriodValueEmployeeStockPurchasePlan</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockIssuedDuringPeriodValueNewIssues">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Equity impact of the value of new stock issued during the period. Includes shares issued in an initial public offering or a secondary public offering.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.3-04)<br> -URI https://asc.fasb.org/extlink&amp;oid=120397183&amp;loc=d3e187085-122770<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI https://asc.fasb.org/extlink&amp;oid=126973232&amp;loc=d3e21463-112644<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(28))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockIssuedDuringPeriodValueNewIssues</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockholdersEquity">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Total of all stockholders' equity (deficit) items, net of receivables from officers, directors, owners, and affiliates of the entity which are attributable to the parent. The amount of the economic entity's stockholders' equity attributable to the parent excludes the amount of stockholders' equity which is allocable to that ownership interest in subsidiary equity which is not attributable to the parent (noncontrolling interest, minority interest). This excludes temporary equity and is sometimes called permanent equity.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -URI https://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 852<br> -SubTopic 10<br> -Section 55<br> -Paragraph 10<br> -URI https://asc.fasb.org/extlink&amp;oid=84165509&amp;loc=d3e56426-112766<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 310<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SAB Topic 4.E)<br> -URI https://asc.fasb.org/extlink&amp;oid=122038336&amp;loc=d3e74512-122707<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(31))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 6: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(30))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 7: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -URI https://asc.fasb.org/extlink&amp;oid=123596393&amp;loc=d3e14064-108612<br><br>Reference 8: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=114001798&amp;loc=d3e33918-111571<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockholdersEquity</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>30
<FILENAME>R7.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.2</span><table class="report" border="0" cellspacing="2" id="idm139763877978960">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Condensed Consolidated Statements of Stockholders&#8217; Equity (Parenthetical) - USD ($)<br> $ in Millions</strong></div></th>
<th class="th" colspan="2">3 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Jun. 30, 2021</div></th>
<th class="th"><div>Mar. 31, 2021</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AdjustmentsToAdditionalPaidInCapitalStockIssuedIssuanceCosts', window );">Issuance costs</a></td>
<td class="nump">$ 0.7<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StatementEquityComponentsAxis=us-gaap_CommonStockMember', window );">Common stock</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SharesIssuedPricePerShare', window );">Issuance price per share (in usd per share)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 29.50<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AdjustmentsToAdditionalPaidInCapitalStockIssuedIssuanceCosts', window );">Issuance costs</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 9.1<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StatementEquityComponentsAxis=us-gaap_CommonStockMember', window );">Common stock | At-The Market Offering</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SharesIssuedPricePerShare', window );">Issuance price per share (in usd per share)</a></td>
<td class="nump">$ 46.33<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AdjustmentsToAdditionalPaidInCapitalStockIssuedIssuanceCosts">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of decrease in additional paid in capital (APIC) resulting from direct costs associated with issuing stock. Includes, but is not limited to, legal and accounting fees and direct costs associated with stock issues under a shelf registration.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI https://asc.fasb.org/extlink&amp;oid=126973232&amp;loc=d3e21463-112644<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.3-04)<br> -URI https://asc.fasb.org/extlink&amp;oid=120397183&amp;loc=d3e187085-122770<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AdjustmentsToAdditionalPaidInCapitalStockIssuedIssuanceCosts</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SharesIssuedPricePerShare">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Per share or per unit amount of equity securities issued.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SharesIssuedPricePerShare</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementEquityComponentsAxis=us-gaap_CommonStockMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementEquityComponentsAxis=us-gaap_CommonStockMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SubsidiarySaleOfStockAxis=dmtk_AtTheMarketOfferingMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SubsidiarySaleOfStockAxis=dmtk_AtTheMarketOfferingMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>31
<FILENAME>R8.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.2</span><table class="report" border="0" cellspacing="2" id="idm139763867239568">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Condensed Consolidated Statements of Cash Flows - USD ($)<br> $ in Thousands</strong></div></th>
<th class="th" colspan="3">3 Months Ended</th>
<th class="th" colspan="2">6 Months Ended</th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Jun. 30, 2022</div></th>
<th class="th"><div>Jun. 30, 2021</div></th>
<th class="th"><div>Mar. 31, 2021</div></th>
<th class="th"><div>Jun. 30, 2022</div></th>
<th class="th"><div>Jun. 30, 2021</div></th>
<th class="th"><div>Dec. 31, 2021</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract', window );"><strong>Cash flows from operating activities:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ProfitLoss', window );">Net loss</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">$ (59,688)<span></span>
</td>
<td class="num">$ (32,170)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract', window );"><strong>Adjustments to reconcile net loss to net cash used in operating activities:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_Depreciation', window );">Depreciation</a></td>
<td class="nump">$ 400<span></span>
</td>
<td class="nump">$ 200<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">766<span></span>
</td>
<td class="nump">401<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueAdjustmentOfWarrants', window );">Change in fair value of warrant liability</a></td>
<td class="num">(105)<span></span>
</td>
<td class="num">(170)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(122)<span></span>
</td>
<td class="nump">1,519<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OperatingLeaseRightOfUseAssetAmortizationExpense', window );">Amortization of operating lease right-of-use assets</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1,109<span></span>
</td>
<td class="nump">582<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensation', window );">Stock-based compensation</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">8,731<span></span>
</td>
<td class="nump">5,710<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AccretionAmortizationOfDiscountsAndPremiumsInvestments', window );">Amortization of premiums, net of accretion of discounts on marketable securities</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">283<span></span>
</td>
<td class="nump">337<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_GainLossOnDispositionOfAssets1', window );">Loss on disposal of equipment</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">285<span></span>
</td>
<td class="nump">13<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncreaseDecreaseInOperatingCapitalAbstract', window );"><strong>Changes in operating assets and liabilities:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncreaseDecreaseInAccountsReceivable', window );">Accounts receivable</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(2,115)<span></span>
</td>
<td class="num">(705)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncreaseDecreaseInInventories', window );">Inventory</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(952)<span></span>
</td>
<td class="num">(393)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets', window );">Prepaid expenses and other current assets</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">483<span></span>
</td>
<td class="nump">152<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncreaseDecreaseInOperatingLeaseLiability', window );">Operating lease liabilities, net</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(654)<span></span>
</td>
<td class="num">(328)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncreaseDecreaseInAccountsPayableAndAccruedLiabilities', window );">Accounts payable, accrued liabilities and deferred revenue</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(53)<span></span>
</td>
<td class="nump">263<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncreaseDecreaseInEmployeeRelatedLiabilities', window );">Accrued compensation</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">2,698<span></span>
</td>
<td class="nump">1,092<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NetCashProvidedByUsedInOperatingActivities', window );">Net cash used in operating activities</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(49,229)<span></span>
</td>
<td class="num">(23,527)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract', window );"><strong>Cash flows from investing activities:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PaymentsToAcquireMarketableSecurities', window );">Purchases of marketable securities</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(20,171)<span></span>
</td>
<td class="num">(4,899)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dmtk_ProceedsFromMaturityOfMarketableSecurities', window );">Maturities of marketable securities</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">14,139<span></span>
</td>
<td class="nump">5,450<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PaymentsToAcquirePropertyPlantAndEquipment', window );">Purchases of property and equipment</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(1,360)<span></span>
</td>
<td class="num">(944)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NetCashProvidedByUsedInInvestingActivities', window );">Net cash used in investing activities</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(7,392)<span></span>
</td>
<td class="num">(393)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract', window );"><strong>Cash flows from financing activities:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ProceedsFromWarrantExercises', window );">Proceeds from exercise of common stock warrants</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">22<span></span>
</td>
<td class="nump">69,928<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dmtk_ProceedsFromReleaseOfRSUsAndStockOptionsExercised', window );">Proceeds from RSU releases (par value only) and the exercise of stock options</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">40<span></span>
</td>
<td class="nump">596<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ProceedsFromStockPlans', window );">Proceeds from contributions to the employee stock purchase plan</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">515<span></span>
</td>
<td class="nump">392<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RepaymentsOfDebtAndCapitalLeaseObligations', window );">Principal repayments of capital lease obligations</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(60)<span></span>
</td>
<td class="num">(53)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NetCashProvidedByUsedInFinancingActivities', window );">Net cash provided by financing activities</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">517<span></span>
</td>
<td class="nump">229,281<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect', window );">Net (decrease)/increase in cash, cash equivalents and restricted cash</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(56,104)<span></span>
</td>
<td class="nump">205,361<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations', window );">Cash, cash equivalents and restricted cash, beginning of period</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 24,248<span></span>
</td>
<td class="nump">179,907<span></span>
</td>
<td class="nump">24,248<span></span>
</td>
<td class="nump">$ 24,248<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations', window );">Cash, cash equivalents and restricted cash, end of period</a></td>
<td class="nump">123,803<span></span>
</td>
<td class="nump">229,609<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">123,803<span></span>
</td>
<td class="nump">229,609<span></span>
</td>
<td class="nump">179,907<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RestrictedCashAndCashEquivalentsAbstract', window );"><strong>Reconciliation of cash, cash equivalents and restricted cash, end of period:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CashAndCashEquivalentsAtCarryingValue', window );">Cash and cash equivalents</a></td>
<td class="nump">120,333<span></span>
</td>
<td class="nump">229,609<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">120,333<span></span>
</td>
<td class="nump">229,609<span></span>
</td>
<td class="nump">$ 176,882<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RestrictedCash', window );">Restricted cash</a></td>
<td class="nump">3,470<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">3,470<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents', window );">Total cash, cash equivalents and restricted cash</a></td>
<td class="nump">$ 123,803<span></span>
</td>
<td class="nump">229,609<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">123,803<span></span>
</td>
<td class="nump">229,609<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SupplementalCashFlowInformationAbstract', window );"><strong>Supplemental cash flow information:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_InterestPaidNet', window );">Cash paid for interest on finance lease obligations</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">7<span></span>
</td>
<td class="nump">8<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NoncashInvestingAndFinancingItemsAbstract', window );"><strong>Supplemental disclosure of noncash investing and financing activities:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CapitalExpendituresIncurredButNotYetPaid', window );">Purchases of property and equipment recorded in accounts payable</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">11<span></span>
</td>
<td class="nump">24<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dmtk_ReclassificationOfWarrantLiabilityDueToPrivateSPACWarrantsNotHeldByOriginalHolder', window );">Reclassification of warrant liability due to Private SPAC Warrants not held by original holder</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 23<span></span>
</td>
<td class="nump">$ 411<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">434<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dmtk_CashlessExerciseOfCommonStockWarrants', window );">Cashless exercise of common stock warrants</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">2,158<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability', window );">Right-of-use assets obtained in exchange for lease obligations</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">17,059<span></span>
</td>
<td class="nump">2,831<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NoncashOrPartNoncashAcquisitionFixedAssetsAcquired1', window );">Property and equipment acquired under finance leases</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">48<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dmtk_ChangeInUnrealizedGainLossOnAvailableForSaleMarketableSecurities', window );">Change in net unrealized (losses)/gains on available-for-sale marketable securities</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(741)<span></span>
</td>
<td class="nump">3<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SubsidiarySaleOfStockAxis=dmtk_PublicFollowOnOfferingMember', window );">Public Follow-on Offering</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract', window );"><strong>Cash flows from financing activities:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ProceedsFromIssuanceOfCommonStock', window );">Proceeds from issuance of common stock</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">134,582<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SubsidiarySaleOfStockAxis=dmtk_AtTheMarketOfferingMember', window );">At-The Market Offering</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract', window );"><strong>Cash flows from financing activities:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ProceedsFromIssuanceOfCommonStock', window );">Proceeds from issuance of common stock</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 0<span></span>
</td>
<td class="nump">$ 23,836<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dmtk_CashlessExerciseOfCommonStockWarrants">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Cashless exercise of common stock warrants.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dmtk_CashlessExerciseOfCommonStockWarrants</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dmtk_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dmtk_ChangeInUnrealizedGainLossOnAvailableForSaleMarketableSecurities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Change in unrealized gain loss on available-for-sale marketable securities.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dmtk_ChangeInUnrealizedGainLossOnAvailableForSaleMarketableSecurities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dmtk_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dmtk_ProceedsFromMaturityOfMarketableSecurities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Proceeds From Maturity Of Marketable Securities</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dmtk_ProceedsFromMaturityOfMarketableSecurities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dmtk_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dmtk_ProceedsFromReleaseOfRSUsAndStockOptionsExercised">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Proceeds From Release Of RSUs And Stock Options Exercised</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dmtk_ProceedsFromReleaseOfRSUsAndStockOptionsExercised</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dmtk_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dmtk_ReclassificationOfWarrantLiabilityDueToPrivateSPACWarrantsNotHeldByOriginalHolder">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Reclassification of warrant liability due to private SPAC warrants not held by original holder.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dmtk_ReclassificationOfWarrantLiabilityDueToPrivateSPACWarrantsNotHeldByOriginalHolder</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dmtk_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AccretionAmortizationOfDiscountsAndPremiumsInvestments">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The sum of the periodic adjustments of the differences between securities' face values and purchase prices that are charged against earnings. This is called accretion if the security was purchased at a discount and amortization if it was purchased at premium. As a noncash item, this element is an adjustment to net income when calculating cash provided by or used in operations using the indirect method.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3602-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AccretionAmortizationOfDiscountsAndPremiumsInvestments</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CapitalExpendituresIncurredButNotYetPaid">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Future cash outflow to pay for purchases of fixed assets that have occurred.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 50<br> -Paragraph 5<br> -URI https://asc.fasb.org/extlink&amp;oid=126999549&amp;loc=d3e4332-108586<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -URI https://asc.fasb.org/extlink&amp;oid=126999549&amp;loc=d3e4313-108586<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -URI https://asc.fasb.org/extlink&amp;oid=126999549&amp;loc=d3e4304-108586<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CapitalExpendituresIncurredButNotYetPaid</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CashAndCashEquivalentsAtCarryingValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of currency on hand as well as demand deposits with banks or financial institutions. Includes other kinds of accounts that have the general characteristics of demand deposits. Also includes short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates. Excludes cash and cash equivalents within disposal group and discontinued operation.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 4<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3044-108585<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=124098289&amp;loc=d3e6676-107765<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(1))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CashAndCashEquivalentsAtCarryingValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of cash and cash equivalents, and cash and cash equivalents restricted to withdrawal or usage. Excludes amount for disposal group and discontinued operations. Cash includes, but is not limited to, currency on hand, demand deposits with banks or financial institutions, and other accounts with general characteristics of demand deposits. Cash equivalents include, but are not limited to, short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 24<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3521-108585<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 4<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3044-108585<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 50<br> -Paragraph 8<br> -URI https://asc.fasb.org/extlink&amp;oid=126999549&amp;loc=SL98516268-108586<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of cash and cash equivalents, and cash and cash equivalents restricted to withdrawal or usage; including, but not limited to, disposal group and discontinued operations. Cash includes, but is not limited to, currency on hand, demand deposits with banks or financial institutions, and other accounts with general characteristics of demand deposits. Cash equivalents include, but are not limited to, short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 50<br> -Paragraph 8<br> -URI https://asc.fasb.org/extlink&amp;oid=126999549&amp;loc=SL98516268-108586<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 24<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3521-108585<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 4<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3044-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of increase (decrease) in cash, cash equivalents, and cash and cash equivalents restricted to withdrawal or usage; including effect from exchange rate change. Cash includes, but is not limited to, currency on hand, demand deposits with banks or financial institutions, and other accounts with general characteristics of demand deposits. Cash equivalents include, but are not limited to, short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 830<br> -SubTopic 230<br> -Section 45<br> -Paragraph 1<br> -URI https://asc.fasb.org/extlink&amp;oid=123444420&amp;loc=d3e33268-110906<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 24<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3521-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_Depreciation">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The amount of expense recognized in the current period that reflects the allocation of the cost of tangible assets over the assets' useful lives. Includes production and non-production related depreciation.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 360<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=6391035&amp;loc=d3e2868-110229<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3602-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_Depreciation</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FairValueAdjustmentOfWarrants">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of expense (income) related to adjustment to fair value of warrant liability.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3602-108585<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 480<br> -SubTopic 10<br> -Section 25<br> -Paragraph 13<br> -URI https://asc.fasb.org/extlink&amp;oid=109262497&amp;loc=d3e20148-110875<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FairValueAdjustmentOfWarrants</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_GainLossOnDispositionOfAssets1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of gain (loss) on sale or disposal of assets, including but not limited to property plant and equipment, intangible assets and equity in securities of subsidiaries or equity method investee.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3602-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_GainLossOnDispositionOfAssets1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncreaseDecreaseInAccountsPayableAndAccruedLiabilities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The increase (decrease) during the reporting period in the amounts payable to vendors for goods and services received and the amount of obligations and expenses incurred but not paid.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3602-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncreaseDecreaseInAccountsPayableAndAccruedLiabilities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncreaseDecreaseInAccountsReceivable">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The increase (decrease) during the reporting period in amount due within one year (or one business cycle) from customers for the credit sale of goods and services.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3602-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncreaseDecreaseInAccountsReceivable</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncreaseDecreaseInEmployeeRelatedLiabilities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The increase (decrease) during the reporting period in the aggregate amount of obligations related to services received from employees, such as accrued salaries and bonuses, payroll taxes and fringe benefits.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3602-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncreaseDecreaseInEmployeeRelatedLiabilities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncreaseDecreaseInInventories">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The increase (decrease) during the reporting period in the aggregate value of all inventory held by the reporting entity, associated with underlying transactions that are classified as operating activities.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3602-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncreaseDecreaseInInventories</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncreaseDecreaseInOperatingCapitalAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncreaseDecreaseInOperatingCapitalAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncreaseDecreaseInOperatingLeaseLiability">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of increase (decrease) in obligation for operating lease.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (g)(1)<br> -URI https://asc.fasb.org/extlink&amp;oid=128292326&amp;loc=SL77918686-209980<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3602-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncreaseDecreaseInOperatingLeaseLiability</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of increase (decrease) in prepaid expenses, and assets classified as other.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3602-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InterestPaidNet">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of cash paid for interest, excluding capitalized interest, classified as operating activity. Includes, but is not limited to, payment to settle zero-coupon bond for accreted interest of debt discount and debt instrument with insignificant coupon interest rate in relation to effective interest rate of borrowing attributable to accreted interest of debt discount.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI https://asc.fasb.org/extlink&amp;oid=126999549&amp;loc=d3e4297-108586<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 17<br> -Subparagraph (d)<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3367-108585<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 25<br> -Subparagraph (e)<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3536-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InterestPaidNet</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetCashProvidedByUsedInFinancingActivities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of cash inflow (outflow) from financing activities, including discontinued operations. Financing activity cash flows include obtaining resources from owners and providing them with a return on, and a return of, their investment; borrowing money and repaying amounts borrowed, or settling the obligation; and obtaining and paying for other resources obtained from creditors on long-term credit.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 24<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3521-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NetCashProvidedByUsedInFinancingActivities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetCashProvidedByUsedInInvestingActivities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of cash inflow (outflow) from investing activities, including discontinued operations. Investing activity cash flows include making and collecting loans and acquiring and disposing of debt or equity instruments and property, plant, and equipment and other productive assets.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 24<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3521-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NetCashProvidedByUsedInInvestingActivities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetCashProvidedByUsedInOperatingActivities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of cash inflow (outflow) from operating activities, including discontinued operations. Operating activity cash flows include transactions, adjustments, and changes in value not defined as investing or financing activities.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 25<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3536-108585<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 24<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3521-108585<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3602-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NetCashProvidedByUsedInOperatingActivities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NoncashInvestingAndFinancingItemsAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NoncashInvestingAndFinancingItemsAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NoncashOrPartNoncashAcquisitionFixedAssetsAcquired1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The amount of fixed assets that an Entity acquires in a noncash (or part noncash) acquisition. Noncash is defined as information about all investing and financing activities of an enterprise during a period that affect recognized assets or liabilities but that do not result in cash receipts or cash payments in the period. "Part noncash" refers to that portion of the transaction not resulting in cash receipts or cash payments in the period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 50<br> -Paragraph 5<br> -URI https://asc.fasb.org/extlink&amp;oid=126999549&amp;loc=d3e4332-108586<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -URI https://asc.fasb.org/extlink&amp;oid=126999549&amp;loc=d3e4313-108586<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -URI https://asc.fasb.org/extlink&amp;oid=126999549&amp;loc=d3e4304-108586<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NoncashOrPartNoncashAcquisitionFixedAssetsAcquired1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OperatingLeaseRightOfUseAssetAmortizationExpense">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of amortization expense for right-of-use asset from operating lease.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3602-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OperatingLeaseRightOfUseAssetAmortizationExpense</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PaymentsToAcquireMarketableSecurities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of cash outflow for purchase of marketable security.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 320<br> -SubTopic 10<br> -Section 45<br> -Paragraph 11<br> -URI https://asc.fasb.org/extlink&amp;oid=124260329&amp;loc=d3e26853-111562<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PaymentsToAcquireMarketableSecurities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PaymentsToAcquirePropertyPlantAndEquipment">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The cash outflow associated with the acquisition of long-lived, physical assets that are used in the normal conduct of business to produce goods and services and not intended for resale; includes cash outflows to pay for construction of self-constructed assets.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 13<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3213-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PaymentsToAcquirePropertyPlantAndEquipment</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ProceedsFromIssuanceOfCommonStock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The cash inflow from the additional capital contribution to the entity.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 14<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3255-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ProceedsFromIssuanceOfCommonStock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ProceedsFromStockPlans">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The cash inflow associated with the amount received from the stock plan during the period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 14<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3255-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ProceedsFromStockPlans</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ProceedsFromWarrantExercises">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The cash inflow associated with the amount received from holders exercising their stock warrants.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 14<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3255-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ProceedsFromWarrantExercises</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ProfitLoss">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The consolidated profit or loss for the period, net of income taxes, including the portion attributable to the noncontrolling interest.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -URI https://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1A<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126968391&amp;loc=SL7669619-108580<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1A<br> -Subparagraph (a)(1)<br> -URI https://asc.fasb.org/extlink&amp;oid=109239629&amp;loc=SL4573702-111684<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 9<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22663-107794<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(i))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(i))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8736-108599<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8933-108599<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 40<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (f)<br> -URI https://asc.fasb.org/extlink&amp;oid=126732423&amp;loc=SL123482106-238011<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(5))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iv))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 12: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 50<br> -Paragraph 6<br> -URI https://asc.fasb.org/extlink&amp;oid=124431353&amp;loc=SL124452729-227067<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8906-108599<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 2<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3000-108585<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 45<br> -Paragraph 19<br> -URI https://asc.fasb.org/extlink&amp;oid=126929396&amp;loc=SL4569616-111683<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=114001798&amp;loc=d3e33918-111571<br><br>Reference 17: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (f)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8933-108599<br><br>Reference 18: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(A))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 19: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 205<br> -SubTopic 20<br> -Section 50<br> -Paragraph 7<br> -URI https://asc.fasb.org/extlink&amp;oid=109222650&amp;loc=SL51721683-107760<br><br>Reference 20: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)(2)<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22499-107794<br><br>Reference 21: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -URI https://asc.fasb.org/extlink&amp;oid=123596393&amp;loc=d3e14064-108612<br><br>Reference 22: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 235<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-05(b)(2))<br> -URI https://asc.fasb.org/extlink&amp;oid=120399901&amp;loc=d3e537907-122884<br><br>Reference 23: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 31<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8924-108599<br><br>Reference 24: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1B<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126968391&amp;loc=SL7669625-108580<br><br>Reference 25: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iv))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 26: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iii)(A))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 27: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(5))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 28: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(B))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 29: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(ii))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 30: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1A<br> -Subparagraph (c)(1)<br> -URI https://asc.fasb.org/extlink&amp;oid=109239629&amp;loc=SL4573702-111684<br><br>Reference 31: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 55<br> -Paragraph 4J<br> -URI https://asc.fasb.org/extlink&amp;oid=120409616&amp;loc=SL4591551-111686<br><br>Reference 32: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 55<br> -Paragraph 4K<br> -URI https://asc.fasb.org/extlink&amp;oid=120409616&amp;loc=SL4591552-111686<br><br>Reference 33: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 8<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22658-107794<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ProfitLoss</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RepaymentsOfDebtAndCapitalLeaseObligations">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of cash outflow for short-term and long-term debt and lease obligation.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RepaymentsOfDebtAndCapitalLeaseObligations</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RestrictedCash">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of cash restricted as to withdrawal or usage. Cash includes, but is not limited to, currency on hand, demand deposits with banks or financial institutions, and other accounts with general characteristics of demand deposits.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(1))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 50<br> -Paragraph 8<br> -URI https://asc.fasb.org/extlink&amp;oid=126999549&amp;loc=SL98516268-108586<br><br>Reference 3: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-03(1)(a))<br> -URI https://asc.fasb.org/extlink&amp;oid=126897435&amp;loc=d3e534808-122878<br><br>Reference 4: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(a)(2))<br> -URI https://asc.fasb.org/extlink&amp;oid=126734703&amp;loc=d3e572229-122910<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RestrictedCash</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RestrictedCashAndCashEquivalentsAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RestrictedCashAndCashEquivalentsAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of increase in right-of-use asset obtained in exchange for operating lease liability.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 55<br> -Paragraph 53<br> -URI https://asc.fasb.org/extlink&amp;oid=123414884&amp;loc=SL77918982-209971<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (g)(2)<br> -URI https://asc.fasb.org/extlink&amp;oid=128292326&amp;loc=SL77918686-209980<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensation">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of noncash expense for share-based payment arrangement.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3602-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensation</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SupplementalCashFlowInformationAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SupplementalCashFlowInformationAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SubsidiarySaleOfStockAxis=dmtk_PublicFollowOnOfferingMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SubsidiarySaleOfStockAxis=dmtk_PublicFollowOnOfferingMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SubsidiarySaleOfStockAxis=dmtk_AtTheMarketOfferingMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SubsidiarySaleOfStockAxis=dmtk_AtTheMarketOfferingMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>32
<FILENAME>R9.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.2</span><table class="report" border="0" cellspacing="2" id="idm139763963462864">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>The Company and a Summary of its Significant Accounting Policies<br></strong></div></th>
<th class="th" colspan="1">6 Months Ended</th>
</tr>
<tr><th class="th"><div>Jun. 30, 2022</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AccountingPoliciesAbstract', window );"><strong>Accounting Policies [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureAndSignificantAccountingPoliciesTextBlock', window );">The Company and a Summary of its Significant Accounting Policies</a></td>
<td class="text">The Company and a Summary of its Significant Accounting Policies<div style="margin-top:15pt;padding-left:27pt;text-indent:-27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">(a)&#160;&#160;&#160;&#160;Nature of Operations </span></div><div style="margin-top:9pt;padding-left:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">On August 29, 2019, DermTech, Inc., formerly known as Constellation Alpha Capital Corp, (the &#8220;Company&#8221;), and DermTech Operations, Inc., formerly known as DermTech, Inc., (&#8220;DermTech Operations&#8221;), consummated the transactions contemplated by the Agreement and Plan of Merger, dated as of May 29, 2019, by and among the Company, DT Merger Sub, Inc., a wholly owned subsidiary of the Company (&#8220;Merger Sub&#8221;), and DermTech Operations. The Company refers to this agreement, as amended by that certain First Amendment to Agreement and Plan of Merger dated as of August 1, 2019, as the Merger Agreement. Pursuant to the Merger Agreement, Merger Sub merged with and into DermTech Operations, with DermTech Operations surviving as a wholly-owned subsidiary of the Company. The Company refers to this transaction as the Business Combination. In connection with and two days prior to the completion of the Business Combination, the Company domesticated from the British Virgin Islands to Delaware. DermTech Operations changed its name from DermTech, Inc. to DermTech Operations, Inc. shortly before the completion of the Business Combination. On August 29, 2019, immediately following the completion of the Business Combination, the Company changed its name from Constellation Alpha Capital Corp. to DermTech, Inc., and then effected a one-for-two reverse stock split of its common stock. </span></div><div style="margin-top:9pt;padding-left:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company is a molecular diagnostic company developing and marketing its Clinical Laboratory Improvement Amendments of 1988 (&#8220;CLIA&#8221;) laboratory services including genomic tests to facilitate the diagnosis of dermatologic conditions including melanoma. The Company has developed a proprietary, non-invasive technique for sampling the surface layers of the skin using an adhesive patch called the DermTech Smart Sticker&#8482; (the &#8220;Smart Sticker&#8221;) to collect biological information for commercial applications in the medical diagnostic field.</span></div><div style="margin-top:9pt;padding-left:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">From the end of the first quarter of 2020 and through the second quarter of 2022, there has been a widespread worldwide impact from the COVID-19 pandemic. The Company is considered an essential business due to the importance of early melanoma detection, which has allowed the Company&#8217;s CLIA laboratory to remain fully operational. The Company implemented additional safety measures in accordance with Centers for Disease Control and Prevention (&#8220;CDC&#8221;), Occupational Safety and Health Administration (&#8220;OSHA&#8221;) and other guidance within its CLIA laboratory operations. Additionally, and during this time, the Company transitioned administrative functions to predominantly remote work. Beginning in March 2020 and continuing through the second quarter of 2022, the ongoing COVID-19 pandemic has reduced patient access to clinician offices for in-person testing and reduced access by the Company&#8217;s sales force for in-office sales calls, which has resulted in a reduced volume of billable samples received during the second quarter of 2022 relative to the Company&#8217;s pre-pandemic expectations. The Company expects the ongoing COVID-19 pandemic to continue to adversely impact billable sample volume until patient access to in-person testing fully resumes, in-office access by the Company&#8217;s sales force returns to pre-pandemic levels, or telemedicine options are more widely adopted. Additionally, the ongoing COVID-19 pandemic has negatively affected and may continue to negatively affect the Company&#8217;s pharmaceutical customers&#8217; clinical trials. The extent to which the COVID-19 pandemic will affect the Company&#8217;s future revenue is uncertain and will depend on the duration and extent of the effects of the ongoing COVID-19 pandemic, including the effects on the Company&#8217;s pharmaceutical customers&#8217; clinical trials.</span></div><div style="margin-top:15pt;padding-left:27pt;text-indent:-27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">(b)&#160;&#160;&#160;&#160;Basis of Presentation</span></div><div style="margin-top:9pt;padding-left:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The condensed consolidated financial statements include the accounts of DermTech, Inc. and its subsidiaries. All intercompany balances and transactions among the consolidated entity have been eliminated in consolidation. These unaudited condensed consolidated financial statements have been prepared in accordance with U.S. generally accepted accounting principles (&#8220;U.S. GAAP&#8221;) for interim financial information and with the instructions to Form 10-Q and Article 10 of Securities and Exchange Commission (&#8220;SEC&#8221;), Regulation S-X. Accordingly, these unaudited condensed consolidated financial statements and accompanying notes do not include all the information and disclosures required by U.S. GAAP for complete financial statements and should be read together with the audited consolidated financial statements included in the Company&#8217;s Annual Report on Form 10-K for the fiscal year ended December 31, 2021. In the opinion of management, all adjustments, which include only normal recurring adjustments considered necessary for a fair presentation, have been included. </span></div><div style="margin-top:9pt;padding-left:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The accompanying unaudited condensed consolidated financial statements reflect the application of certain significant accounting policies as described below and elsewhere in these notes to the unaudited condensed consolidated financial statements. As of June 30, 2022, there have been no material changes in the Company's significant accounting policies from those that were disclosed in the Company&#8217;s Annual Report on Form 10-K for the year ended December 31, 2021.</span></div><div style="margin-top:15pt;padding-left:27pt;text-indent:-27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">(c)&#160;&#160;&#160;&#160;Reclassifications</span></div><div style="margin-top:9pt;padding-left:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Certain prior period information on the condensed consolidated statement of cash flows for the six months ended June 30, 2021 has been reclassified to conform to the current year presentation as a result of adopting Accounting Standards Update ("ASU") No. 2016-02, </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Leases (Topic 842)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> ("ASU 2016-02"). These reclassifications did not have an impact on net cash flows. For additional disclosure and detail, see Note 4 of the notes to the unaudited condensed consolidated financial statements, &#8220;Adoption of ASC 842.&#8221;</span></div><div style="margin-top:15pt;padding-left:27pt;text-indent:-27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">(d)&#160;&#160;&#160;&#160;Use of Estimates </span></div><div style="margin-top:9pt;padding-left:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The preparation of condensed consolidated financial statements in conformity with U.S. GAAP requires that management make estimates and assumptions that affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the date of the condensed consolidated financial statements and the amounts of revenues and expenses reported during the period. On an ongoing basis, management evaluates these estimates and judgments, including but not limited to those related to assay revenue, stock-based compensation, short-term marketable securities, accounts receivable, accrued bonus, warrant liability, right-of-use (&#8220;ROU&#8221;) assets and the realization of deferred tax assets. Actual results may differ from those estimates.</span></div><div style="margin-top:15pt;padding-left:27pt;text-indent:-27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">(e)&#160;&#160;&#160;&#160;Cash, Cash Equivalents and Restricted Cash</span></div><div style="margin-top:9pt;padding-left:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company considers all highly liquid investments with remaining maturities of three months or less when purchased to be cash equivalents. The Company maintains its cash balances at banks and financial institutions. The balances are insured up to the Federal Deposit Insurance Corporation legal limit. The Company maintains cash balances that have in the past and may, at times, exceed this insured limit. </span></div><div style="margin-top:9pt;padding-left:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Restricted cash consists of cash deposited with a financial institution as collateral for the Company&#8217;s letters of credit for its facility leases. Restricted cash is classified as noncurrent based on the terms of the underlying lease arrangement.</span></div><div style="margin-top:15pt;padding-left:27pt;text-indent:-27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">(f)&#160;&#160;&#160;&#160;Property and Equipment, Net </span></div><div style="margin-top:9pt;padding-left:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Property and equipment, net is recorded at cost less accumulated depreciation. Property and equipment consists mainly of assets such as leasehold improvements, office, computer and laboratory equipment, including laboratory equipment acquired under finance lease arrangements. Depreciation is computed using the straight-line method over the estimated useful lives of the assets, which range from <span style="-sec-ix-hidden:id3VybDovL2RvY3MudjEvZG9jOmFlNWE5YmUwZWI5NDQ1ZDE5MmZhZTgyMmQyMmJlMDlmL3NlYzphZTVhOWJlMGViOTQ0NWQxOTJmYWU4MjJkMjJiZTA5Zl8zNy9mcmFnOjQ4OGNkZjBhODVlYzRiMDliYWFiN2JhZTlhODA5YjcwL3RleHRyZWdpb246NDg4Y2RmMGE4NWVjNGIwOWJhYWI3YmFlOWE4MDliNzBfMTQ0NDA_b7f0ce5d-c748-4105-a8ca-a2d7278a0959">two</span> to eleven years. Leasehold improvements are depreciated over the shorter of the remaining term of the lease or the useful life of the asset. The Company recorded depreciation expense of $0.4 million and $0.2 million for the three months ended June&#160;30, 2022 and 2021, respectively, which includes amortization of laboratory equipment acquired under finance leases (previously referred to as &#8220;capital leases&#8221;) of $21,000 and $17,000 for the three months ended June&#160;30, 2022 and 2021, respectively. The Company recorded depreciation expense of $0.8 million and $0.4 million for the six months ended June&#160;30, 2022 and 2021, respectively, which includes amortization of laboratory equipment acquired under finance leases of $41,000 and $34,000 for the six months ended June&#160;30, 2022 and 2021, respectively. </span></div><div style="margin-top:9pt;padding-left:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Amortization of assets that are recorded under finance leases in depreciation expense is included in cost of revenues on the condensed consolidated statements of operations. Gross assets recorded under finance leases were $0.4 million as of June&#160;30, 2022 and December&#160;31, 2021. Accumulated amortization associated with finance leases was $0.1 million as of June&#160;30, 2022 and December&#160;31, 2021. Maintenance and repairs are expensed as incurred, and material improvements are capitalized. When assets are retired or otherwise disposed of, the cost and accumulated depreciation are removed from the balance sheet and any resulting gain or loss is reflected in the condensed consolidated statements of operations in the period realized. </span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company disposed of $0.3 million of equipment for the three months ended June&#160;30, 2022 and no equipment for the three months ended June&#160;30, 2021</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">. The Company disposed of $0.3 million and $13,000 of equipment for the six months ended June&#160;30, 2022 and </span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">2021</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">, respectively. </span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company assesses its long-lived assets, consisting primarily of property and equipment, for impairment when material events or changes in circumstances indicate that the carrying value may not be recoverable. There were no impairment losses for the three or six months ended June&#160;30, 2022 and 2021</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">. </span></div><div style="margin-top:15pt;padding-left:27pt;text-indent:-27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">(g)&#160;&#160;&#160;&#160;Concentration of Credit Risk </span></div><div style="margin-top:9pt;padding-left:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Financial instruments that potentially subject the Company to significant concentrations of credit risk consist primarily of cash and cash equivalents. As of June&#160;30, 2022, the Company maintained $87.1 million in a sweep account, which maintains cash balances throughout various interest-bearing bank accounts under the $250,000 insurance limit provided by the Federal Deposit Insurance Corporation for one federally insured financial institution. Approximately $2.5 million was held in excess of the Federal Deposit Insurance Corporation insured limit as of June&#160;30, 2022. The Company has not experienced any losses in such accounts. </span></div><div style="margin-top:15pt;padding-left:27pt;text-indent:-27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">(h)&#160;&#160;&#160;&#160;Revenue Recognition </span></div><div style="margin-top:9pt;padding-left:27pt"><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company&#8217;s revenue is generated from two revenue streams: contract revenue and assay revenue. The Company accounts for revenue in accordance with Accounting Standards Codification (&#8220;ASC&#8221;) Topic 606, Revenue from Contracts with Customers (&#8220;ASC 606&#8221;). The core principle of ASC 606 is that the Company recognizes revenue to depict the transfer of promised goods or services to customers in an amount that reflects the consideration to which the Company expects to be entitled in exchange for those goods or services. The ASC 606 revenue recognition model consists of the following five steps: (1) identify the contracts with a customer, (2) identify the performance obligations in the contract, (3) determine the transaction price, (4) allocate the transaction price to the performance obligations in the contract and (5) recognize revenue when (or as) the entity satisfies a performance obligation.</span></div><div style="margin-top:9pt;padding-left:27pt"><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company recognizes revenue from its assay and contract services in accordance with the core principles and key aspects considered by the Company. These considerations are described in detail below, first for Assay Revenue and then for Contract Revenue.</span></div><div style="margin-top:15pt;padding-left:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Assay Revenue </span></div><div style="margin-top:9pt;padding-left:27pt"><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company generates revenues from its Pigmented Lesion Assay (&#8220;PLA&#8221;) and PLA</span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">plus</span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> (now referred to as the DermTech Melanoma Test or &#8220;DMT&#8221; which may consist at the option of the ordering clinician of either (i) the PLA or (ii) the PLA and PLA</span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">plus</span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">), which assists a clinician&#8217;s diagnosis of melanoma in patients. The Company provides prescribing clinicians with its Smart Sticker to perform non-invasive skin biopsies of clinically ambiguous pigmented skin lesions on patients. The Company also offers clinicians a telemedicine solution where they can request the Smart Sticker collection kit be sent to the patient&#8217;s home for a clinician-guided remote collection on ambiguous pigmented skin lesions. A patient can also initiate the process by downloading the Company&#8217;s telemedicine app, DermTech Connect, which uses store-and-forward technology to allow the patient to take a picture of a suspicious lesion with their phone and have the picture reviewed by an independent clinician who is subscribing to the DermTech Connect platform to assess the suspicious lesion, and if medically necessary, order a DMT where a collection kit would be sent to the patient&#8217;s home. The DermTech Connect app and telemedicine service were initially beta tested in Florida and is currently available in most states where permitted by law and applicable standards of practice guidelines. Once the sample is collected by the patient via the telemedicine solution or by a healthcare clinician in person, it is returned to the Company&#8217;s CLIA laboratory for analysis. The patient&#8217;s ribonucleic acid (&#8220;RNA&#8221;) and deoxyribonucleic acid (&#8220;DNA&#8221;) are extracted from the Smart Sticker and analyzed using gene expression and sequencing technology to determine if the pigmented skin lesion contains certain genomic features indicative of melanoma. Upon completion of the gene expression analysis, a final report is drafted and provided to the clinician detailing the test results for the pigmented skin lesion indicating whether the sample collected is indicative of melanoma or not. </span></div><div style="margin-top:9pt;padding-left:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company periodically updates its estimate of the variable consideration recognized for previously delivered performance obligations. These updates resulted in an additional $0.1 million and $8,000 of revenue reported for the three and six months ended June 30, 2022, respectively, and an additional $0.1 million and $0.1&#160;million of revenue reported for the three and six months ended June 30, 2021, respectively. These amounts included (i) adjustments for actual collections versus estimated variable consideration as of the beginning of the reporting period and (ii) cash collections and the related recognition of revenue in the current period for tests delivered in prior periods due to the release of the constraint on variable consideration, offset by (iii) reductions in revenue for the accrual for reimbursement claims and settlements.</span></div><div style="margin-top:15pt;padding-left:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Contract Revenue</span></div><div style="padding-left:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">Contract revenue is generated from the sale of laboratory services and Smart Stickers to third-party companies through contract research agreements. Revenues are generated from providing genomic services to facilitate the development of drugs designed to treat dermatologic conditions. The provision of services may include sample collection using the Company&#8217;s Smart Sticker, assay development for research partners, patient segmentation and stratification, extraction, isolation, expression, amplification and detection of RNA, DNA, protein and microbiome, including data analysis and reporting.</span></div><div style="margin-top:15pt;padding-left:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">(a) Disaggregation of Revenue </span></div><div style="margin-top:9pt;padding-left:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table presents the Company&#8217;s revenues disaggregated by revenue source during the three and six months ended June&#160;30, 2022 and 2021 (in thousands):</span></div><div style="margin-top:12pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:44.354%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.081%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.406%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.081%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.406%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.081%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.406%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.085%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Three Months Ended June 30,</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Six Months Ended June 30,</span></td></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2021</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Assay Revenue</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">DermTech Melanoma Test</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4,147&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,910&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">7,665&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5,100&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Contract Revenue</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Adhesive patch kits</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">38&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">125&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">104&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">314&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">RNA extractions</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">35&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">110&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">139&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Project management fees</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">48&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">49&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">72&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">90&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total revenues</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4,233&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,119&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">7,951&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5,643&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div style="margin-top:9pt;padding-left:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table sets forth the percentages of total revenue or accounts receivable for the Company&#8217;s third-party payors that represent 10% or more of the respective amounts for the periods shown:</span></div><div style="margin-top:12pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:16.778%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.081%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.406%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.081%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.406%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.081%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.406%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.081%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.406%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.081%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.406%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.087%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="21" style="border-bottom:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Total Revenues</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Accounts Receivable </span></td></tr><tr style="height:12pt"><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Three Months Ended June 30,</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="9" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Six Months Ended June 30,</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" rowspan="2" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">As of June 30, 2022</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" rowspan="2" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">As of December 31, 2021</span></td></tr><tr style="height:12pt"><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Assay Revenue</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Payor A</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">47&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">36&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">39&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">34&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">21&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">23&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Payor B</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">*</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">*</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">*</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">*</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">15&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">15&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr></table></div><div style="margin-top:6pt;padding-left:36pt;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">*</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%;padding-left:4pt">Less than 10%</span></div><div style="margin-top:9pt;padding-left:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">There were no other third-party payors or pharmaceutical customers that individually accounted for more than 10% of the Company&#8217;s total revenue or accounts receivable for the periods shown in the table above.</span></div><div style="margin-top:15pt;padding-left:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">(b) Deferred Revenue and Remaining Performance Obligations</span></div><div style="margin-top:9pt;padding-left:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The timing of revenue recognition, billings and cash collections results in billed accounts receivable and deferred revenue on the condensed consolidated balance sheets.</span></div><div style="margin-top:9pt;padding-left:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In a majority of historical agreements that produced contract revenue, the Company received a substantial up-front payment and additional payments upon the achievement of various milestones over the life of the agreement. This results in deferred revenue and is relieved upon delivery of the applicable Smart Stickers or RNA extraction results. Changes in accounts receivable and deferred revenue were not materially impacted by any other factors.</span></div><div style="margin-top:9pt;padding-left:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company records a deferred revenue liability if a customer pays consideration before the Company transfers a good or service to the customer. Deferred revenue primarily represents upfront milestone payments, for which consideration is received prior to when goods/services are completed or delivered. Upfront fees that are estimated to be recognized as revenue more than one year from the date of collection are classified as long-term deferred revenue. Short-term deferred revenue as of June&#160;30, 2022 and December&#160;31, 2021 was $1.3 million and $1.4 million, respectively. </span></div><div style="margin-top:9pt;padding-left:27pt"><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Remaining performance obligations include deferred revenue and amounts the Company expects to receive for goods and services that have not yet been delivered or provided under existing agreements. For agreements that have an original duration of one year </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">or</span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> less, the Company has elected the practical expedient applicable to such agreements and does not disclose the remaining performance obligations at the end of each reporting period. As of June&#160;30, 2022, the estimated revenue expected to be recognized in future periods related to performance obligations that are unsatisfied for executed agreements with an original duration of one year or more was approximatel</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">y $0.1 million</span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">. The Company expects to recognize revenue on the majority of these remaining performance obligations over the next <span style="-sec-ix-hidden:id3VybDovL2RvY3MudjEvZG9jOmFlNWE5YmUwZWI5NDQ1ZDE5MmZhZTgyMmQyMmJlMDlmL3NlYzphZTVhOWJlMGViOTQ0NWQxOTJmYWU4MjJkMjJiZTA5Zl8zNy9mcmFnOjQ4OGNkZjBhODVlYzRiMDliYWFiN2JhZTlhODA5YjcwL3RleHRyZWdpb246NDg4Y2RmMGE4NWVjNGIwOWJhYWI3YmFlOWE4MDliNzBfMjUxODY_b4f0c6ee-fd6c-49c3-80df-d66815f5e42f">two</span> to three years.</span></div><div style="margin-top:15pt;padding-left:27pt;text-indent:-27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">(i)&#160;&#160;&#160;&#160;Accounts Receivable </span></div><div style="margin-top:15pt;padding-left:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Assay Accounts Receivable </span></div><div style="margin-top:9pt;padding-left:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Due to the nature of the Company&#8217;s assay revenue, it can take a significant amount of time to collect upon billed tests. The Company prepares an analysis on reimbursement collections and data obtained for each financial reporting period to determine the amount of receivables to be recorded relating to tests performed in the applicable period. The Company generally does not perform evaluations of customers&#8217; financial condition and generally does not require collateral. Accounts receivables are written off when all efforts to collect the balance have been exhausted. Adjustments for implicit price concessions attributable to variable consideration are incorporated into the measurement of the accounts receivable balances. The Company recorded $5.8 million and $3.6 million of gross assay accounts receivable as of June&#160;30, 2022 and December&#160;31, 2021, respectively. Accounts receivable as of June&#160;30, 2022 included unbilled accounts receivable of $0.3 million. </span></div><div style="margin-top:15pt;padding-left:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Contract Accounts Receivable </span></div><div style="margin-top:9pt;padding-left:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Contract accounts receivable are recorded at the net invoice value and are not interest bearing. The Company reserves specific receivables if collectability is no longer reasonably assured, and as of June&#160;30, 2022, the Company did not maintain any reserves over contract receivables as they relate to large established credit worthy customers. The Company re-evaluates such reserves on a regular basis and adjusts its reserves as needed. Once a receivable is deemed to be uncollectible, such balance is charged against the reserve. The Company recorded $0.2 million and $0.2 million of contract accounts receivable as of June&#160;30, 2022 and December&#160;31, 2021, respectively. </span></div><div style="margin-top:15pt;padding-left:27pt;text-indent:-27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">(j)&#160;&#160;&#160;&#160;Net Loss Per Share </span></div><div style="margin-top:9pt;padding-left:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Basic and diluted net loss per share of common stock is determined by dividing net loss applicable to holders of common stock by the weighted average number of shares of common stock outstanding during the period. Because there is a net loss attributable to holders of common stock during the three and six months ended June&#160;30, 2022 and 2021, the outstanding common stock warrants, stock options, and restricted stock units (&#8220;RSUs&#8221;) have been excluded from the calculation of diluted loss per share of common stock because their effect would be anti-dilutive. Therefore, the weighted average shares used to calculate both basic and diluted loss per share are the same. Diluted net loss per share of common stock for the three and six</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"> </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">months ended June&#160;30, 2022 excludes the effect of anti-dilutive equity instruments including 714,261 shares of common stock issuable upon the exercise of outstanding common stock warrants and 4,670,069 shares of common stock issuable upon the exercise of stock options and release of RSUs. Diluted net loss per share of common stock for the three and six</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"> </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">months ended June&#160;30, 2021 excludes the effect of anti-dilutive equity instruments including 749,210 shares of common stock then issuable upon the exercise of outstanding warrants and 2,469,816 shares of common stock then issuable upon the exercise of stock options and release of RSUs.</span></div><div style="margin-top:15pt;padding-left:27pt;text-indent:-27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">(k)&#160;&#160;&#160;&#160;Fair Value Measurements</span></div><div style="margin-top:9pt;padding-left:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company measures certain financial assets and liabilities at fair value on a recurring basis. Fair value is defined as the price that would be received to sell an asset or paid to transfer a liability (an exit price) in an orderly transaction between market participants at the measurement date. The Company uses a three-tier fair value hierarchy to prioritize the inputs used in the Company&#8217;s fair value measurements. These tiers include: Level 1, defined as observable inputs such as quoted prices in active markets for identical assets; Level 2, defined as inputs other than quoted prices in active markets that are either directly or indirectly observable; and Level 3, defined as unobservable inputs in which little or no market data exists, therefore requiring an entity to develop its own assumptions. </span></div><div style="margin-top:9pt;padding-left:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table provides a summary of the assets and liabilities that are measured at fair value on a recurring basis as of June&#160;30, 2022 (in thousands): </span></div><div style="margin-top:12pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:44.354%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.081%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.406%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.081%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.406%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.081%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.406%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.085%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="21" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">June 30, 2022</span></td></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Level 1</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Level 2</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Level 3</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Total</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Assets:</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cash equivalents</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">30,723&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">30,723&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Restricted cash</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,470&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,470&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Marketable securities, available for sale:</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Corporate debt securities</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">15,092&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">15,092&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Municipal debt securities</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,641&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,641&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">U.S. government debt securities</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">34,724&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">34,724&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total marketable securities, available for sale</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">53,457&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">53,457&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Total assets measured at fair value on a recurring basis</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">34,193&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">53,457&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">87,650&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr style="height:15pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Liabilities:</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Warrant liability</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">24&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">24&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Total liabilities measured at fair value on a recurring basis</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">24&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">24&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div style="margin-top:9pt;padding-left:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table provides a summary of the assets and liabilities that are measured at fair value on a recurring basis as of December&#160;31, 2021 (in thousands): </span></div><div style="margin-top:12pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:44.354%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.081%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.406%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.081%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.406%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.081%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.406%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.085%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="21" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">December 31, 2021</span></td></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Level 1</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Level 2</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Level 3</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Total</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Assets:</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cash equivalents</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">16,380&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">16,380&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Restricted cash</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,025&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,025&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Marketable securities, available for sale:</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Corporate debt</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">15,352&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">15,352&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Municipal debt securities</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">7,412&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">7,412&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">U.S. government debt securities</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">25,685&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">25,685&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total marketable securities, available for sale</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">48,449&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">48,449&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Total assets measured at fair value on a recurring basis</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">19,405&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">48,449&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">67,854&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr style="height:15pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Liabilities:</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Warrant liability</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">146&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">146&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Total liabilities measured at fair value on a recurring basis</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">146&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">146&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div style="margin-top:9pt;padding-left:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company&#8217;s marketable debt securities are classified as available-for-sale securities based on management's intentions and are at Level 2 of the fair value hierarchy, as these investment securities are valued based upon quoted prices for identical or similar instruments in markets that are not active. The Company has classified marketable securities with original maturities of greater than one year as short-term investments based upon the Company&#8217;s ability to use all of those marketable securities to satisfy the liquidity needs of the Company&#8217;s current operations.</span></div><div style="margin-top:9pt;padding-left:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The fair value of the Private SPAC Warrants (as defined below) was determined using the Black-Scholes-Merton valuation model and included an unobservable input: expected volatility. Expected volatility is considered by the Company to be an unobservable input and is calculated using a weighted average of historical volatilities of a combination of the Company and peer companies, due to the lack of sufficient historical data of the Company&#8217;s own stock price. The model also incorporated several observable assumptions at each valuation date including: the price of the Company&#8217;s common stock on the date of valuation, the remaining contractual term of the warrant and the risk-free interest rate over the remaining term.</span></div><div style="margin-top:9pt;padding-left:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following assumptions were used to calculate the fair value of the Company&#8217;s warrant liability using the Black-Scholes-Merton valuation model:</span></div><div style="margin-top:12pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:32.233%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:15.112%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.406%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:15.112%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.406%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:15.112%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.406%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:15.113%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Three Months Ended June 30,</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Six Months Ended June 30,</span></td></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2021</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Assumed risk-free interest rate</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2.96%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.46%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2.37% -2.96%</span></div></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.46% - 0.64%</span></div></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Assumed volatility</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">96.21%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">88.28%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">92.77% - 96.21%</span></div></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">85.85% - 88.28%</span></div></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Expected term</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2.17 years</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3.17 years</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2.17 - 2.42 years</span></div></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3.17 - 3.42 years</span></div></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Expected dividend yield</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;</span></td></tr></table></div><div style="margin-top:9pt;padding-left:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table summarizes the changes in the fair value of the Company&#8217;s Level 3 liabilities (in thousands):</span></div><div style="margin-top:12pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:85.718%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.082%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Balance as of December 31, 2021</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">146&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Change in fair value of warrant liability</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(17)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Balance as of March 31, 2022</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">129&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Change in fair value of warrant liability</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(105)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Balance as of June 30, 2022</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">24&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div style="margin-top:9pt;padding-left:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">As of June&#160;30, 2022 and December&#160;31, 2021, the Company maintains letters of credit of $3.5 million and $3.0&#160;million, respectively, related to its lease arrangements, which are secured by money market accounts in accordance with certain of its lease agreements. The amounts are recorded at fair value using Level 1 inputs and included as restricted cash in the condensed consolidated balance sheets.</span></div><div style="margin-top:9pt;padding-left:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company believes the carrying amount of cash and cash equivalents, accounts payable and accrued expenses approximate their estimated fair values due to the short-term nature of these accounts.</span></div><div style="margin-top:15pt;padding-left:27pt;text-indent:-27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">(l)&#160;&#160;&#160;&#160;Accounting Pronouncements Issued But Not Yet Effective </span></div><div style="margin-top:9pt;padding-left:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In June 2022, the Financial Accounting Standards Board issued ASU No. 2022-03, </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Fair Value Measurement of Equity Securities Subject to Contractual Sale Restrictions </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">("ASU 2022-03"). Under the guidance of ASU 2022-03, a contractual restriction on the sale of an equity security is not considered in measuring the security's fair value. ASU 2022-03 also requires certain disclosures for equity securities that are subject to contractual restrictions. For public business entities, the provisions of ASU 2022-03 are effective for fiscal years beginning after December 15, 2023, and interim periods within those fiscal years. For all other entities, the amendments are effective for fiscal years beginning after December 15, 2024, and interim periods within those fiscal years. Early adoption is permitted for both interim and annual financial statements that have not yet been issued or made available for issuance. The Company is still evaluating the impact of this pronouncement on the consolidated financial statements.</span></div><div style="margin-top:9pt;padding-left:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company does not believe that any other recently issued, but not yet effective accounting pronouncements, if adopted, would have a material impact on its condensed consolidated financial statements or disclosures.</span></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AccountingPoliciesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AccountingPoliciesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureAndSignificantAccountingPoliciesTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for the organization, consolidation and basis of presentation of financial statements disclosure, and significant accounting policies of the reporting entity. May be provided in more than one note to the financial statements, as long as users are provided with an understanding of (1) the significant judgments and assumptions made by an enterprise in determining whether it must consolidate a VIE and/or disclose information about its involvement with a VIE, (2) the nature of restrictions on a consolidated VIE's assets reported by an enterprise in its statement of financial position, including the carrying amounts of such assets, (3) the nature of, and changes in, the risks associated with an enterprise's involvement with the VIE, and (4) how an enterprise's involvement with the VIE affects the enterprise's financial position, financial performance, and cash flows. Describes procedure if disclosures are provided in more than one note to the financial statements.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 205<br> -URI https://asc.fasb.org/topic&amp;trid=2122149<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -URI https://asc.fasb.org/topic&amp;trid=2197479<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -URI https://asc.fasb.org/topic&amp;trid=2122369<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 275<br> -URI https://asc.fasb.org/topic&amp;trid=2134479<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureAndSignificantAccountingPoliciesTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>33
<FILENAME>R10.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.2</span><table class="report" border="0" cellspacing="2" id="idm139763877168864">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Balance Sheet Details<br></strong></div></th>
<th class="th" colspan="1">6 Months Ended</th>
</tr>
<tr><th class="th"><div>Jun. 30, 2022</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract', window );"><strong>Organization, Consolidation and Presentation of Financial Statements [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SupplementalBalanceSheetDisclosuresTextBlock', window );">Balance Sheet Details</a></td>
<td class="text">Balance Sheet Details<div style="margin-top:15pt;padding-left:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Short-Term Marketable Securities</span></div><div style="margin-top:9pt;padding-left:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The amortized cost, gross unrealized holding gains, gross unrealized holding losses, and fair value of debt securities classified as available-for-sale securities by major security type and class of security as of June&#160;30, 2022 were as follows (in thousands):</span></div><div style="margin-top:12pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:44.354%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.081%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.406%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.081%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.406%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.081%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.406%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.085%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="21" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">June 30, 2022</span></td></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Amortized Cost</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Gross Unrealized<br/>Gains</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Gross Unrealized<br/>Losses</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Estimated<br/>Market<br/>Value</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Short-term marketable securities, available-for-sale:</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Corporate debt securities</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">15,361&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(269)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">15,092&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Municipal debt securities</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,666&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(25)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,641&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">U.S. government debt securities</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">35,295&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">9&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(580)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">34,724&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 28pt;text-align:left;text-indent:-9pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total short-term marketable securities, available-for-sale</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">54,322&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">9&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(874)</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">53,457&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div style="margin-top:9pt;padding-left:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The amortized cost, gross unrealized holding gains, gross unrealized holding losses, and fair value of debt securities classified as available-for-sale securities by major security type and class of security as of December&#160;31, 2021 were as follows (in thousands):</span></div><div style="margin-top:12pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:44.354%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.081%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.406%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.081%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.406%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.081%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.406%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.085%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="21" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">December 31, 2021</span></td></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Amortized Cost</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Gross Unrealized<br/>Gains</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Gross Unrealized<br/>Losses</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Estimated<br/>Market<br/>Value</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Short-term marketable securities, available-for-sale:</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Corporate debt securities</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">15,385&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(33)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">15,352&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Municipal debt securities</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">7,417&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(5)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">7,412&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">U.S. government debt securities</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">25,771&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(87)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">25,685&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 28pt;text-align:left;text-indent:-9pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total short-term marketable securities, available-for-sale</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">48,573&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(125)</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">48,449&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div style="margin-top:9pt;padding-left:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">As of June&#160;30, 2022, the estimated market value of debt securities with contractual maturities of less than twelve months was $25.8 million; the remaining debt securities that the Company held at that date had an estimated market value of $27.7 million and contractual maturities of up to 23 months. As of December&#160;31, 2021, the estimated market value of debt securities with contractual maturities of less than twelve months was $21.2 million; the remaining debt securities that the Company held at that date had an estimated market value of $27.2 million and contractual maturities of up to 23 months.</span></div><div style="margin-top:9pt;padding-left:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company evaluates securities with unrealized losses to determine whether such losses, if any, are due to credit-related factors. It was determined that no credit losses existed as of June&#160;30, 2022 or December&#160;31, 2021, because the change in market value for those securities in an unrealized loss position has resulted from fluctuating interest rates rather than a deterioration of the credit worthiness of the issuers. Gross realized gains and losses on the Company&#8217;s debt securities for the three and six months ended June&#160;30, 2022 and 2021 were not significant.</span></div><div style="margin-top:15pt;padding-left:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Prepaid Expenses and Property and Equipment, Net</span></div><div style="margin-top:9pt;padding-left:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Condensed consolidated balance sheet details are as follows (in thousands): </span></div><div style="margin-top:12pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:71.930%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.081%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.406%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.083%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">June 30,<br/>2022</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">December 31,<br/>2021</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Prepaid expenses and other current assets:</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Prepaid insurance</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">806&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,801&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Prepaid trade shows</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">241&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">440&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Prepaid software fees</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">907&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">551&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Prepaid employee compensation</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">227&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">238&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other current assets</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">500&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">136&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total prepaid expenses and other current assets</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,681&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,166&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Property and equipment, gross:</span></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Laboratory equipment</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4,856&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4,805&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Computer equipment</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">396&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">171&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Furniture and fixtures</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">555&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">124&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Leasehold improvements</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,208&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,074&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Construction-in-progress</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">139&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total property and equipment, gross</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">7,154&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6,174&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Less accumulated depreciation</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(2,238)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1,625)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total property and equipment, net</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4,916&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4,549&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div style="margin-top:15pt;padding-left:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Accrued Compensation and Accrued Liabilities </span></div><div style="margin-top:9pt;padding-left:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Condensed consolidated balance sheet details are as follows (in thousands):</span></div><div style="margin-top:12pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:71.930%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.081%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.406%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.083%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">June 30,<br/>2022</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">December 31,<br/>2021</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Accrued compensation:</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Accrued paid time off</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,689&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,245&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Accrued wages, bonus and other</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6,129&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,875&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total accrued compensation</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">7,818&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5,120&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Accrued liabilities:</span></td><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Accrued consulting services</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,201&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">775&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other accrued expenses</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,071&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">452&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total accrued liabilities</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,272&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,227&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SupplementalBalanceSheetDisclosuresTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for supplemental balance sheet disclosures, including descriptions and amounts for assets, liabilities, and equity.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -URI https://asc.fasb.org/topic&amp;trid=2122208<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SupplementalBalanceSheetDisclosuresTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>34
<FILENAME>R11.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.2</span><table class="report" border="0" cellspacing="2" id="idm139763956355472">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Stockholders' Equity<br></strong></div></th>
<th class="th" colspan="1">6 Months Ended</th>
</tr>
<tr><th class="th"><div>Jun. 30, 2022</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockholdersEquityNoteAbstract', window );"><strong>Stockholders' Equity Note [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockholdersEquityNoteDisclosureTextBlock', window );">Stockholders' Equity</a></td>
<td class="text">Stockholders&#8217; Equity<div style="margin-top:15pt;padding-left:27pt;text-indent:-27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">(a)&#160;&#160;&#160;&#160;Classes of Stock </span></div><div style="margin-top:9pt;padding-left:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company&#8217;s amended and restated certificate of incorporation authorizes it to issue 50,000,000 shares of common stock and 5,000,000 shares of preferred stock. Both classes of stock have a par value of $0.0001 per share. </span></div><div style="margin-top:15pt;padding-left:27pt;text-indent:-27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">(b)&#160;&#160;&#160;&#160;At-The Market Offering</span></div><div style="margin-top:9pt;padding-left:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">On November&#160;10, 2020, the Company entered into a sales agreement (the &#8220;Sales Agreement&#8221;) with Cowen and Company, LLC ("Cowen") relating to the sale of shares of the Company&#8217;s common stock from time to time with an aggregate offering price of up to $50.0 million. During 2020, the Company issued an aggregate of 951,792 shares of common stock pursuant to the Sales Agreement at a weighted average purchase price of $20.97 resulting in aggregate gross proceeds of approximately $20.0 million, reduced by $0.9 million in issuance costs, resulting in net proceeds to the Company of approximately $19.1 million. For the six months ended June&#160;30, 2022, the Company did not issue any shares pursuant to the Sales Agreement. For the year ended December 31, 2021, the Company issued an aggregate of 530,551 shares of common stock pursuant to the Sales Agreement at a weighted average purchase price of $46.33 resulting in aggregate gross proceeds of approximately $24.6 million, reduced by $0.7 million in issuance costs, resulting in net proceeds to the Company of approximately $23.8 million. </span></div><div style="margin-top:15pt;padding-left:27pt;text-indent:-27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">(c)&#160;&#160;&#160;&#160;2021 Underwritten Public Offering </span></div><div style="margin-top:9pt;padding-left:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">On January&#160;6, 2021, the Company entered into an Underwriting Agreement with Cowen and William Blair &amp; Company, L.L.C. as representatives of several underwriters (the "Underwriters"). The Company agreed to issue and sell up to 4,237,288 shares of its common stock including up to 635,593 shares that could be purchased by the Underwriters pursuant to a 30-day option granted to the Underwriters by the Company. On January&#160;11, 2021, the Company closed the underwritten public offering of 4,872,881 shares of its common stock, which included the exercise in full by the Underwriters of their option to purchase up to 635,593 additional shares, at a price to the public of $29.50 per share. The Company received aggregate gross proceeds of approximately $143.7 million, and net proceeds of approximately $134.6 million, after deducting underwriting discounts and commissions and other offering expenses.</span></div><div style="margin-top:15pt;padding-left:27pt;text-indent:-27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">(d)&#160;&#160;&#160;&#160;Warrants </span></div><div style="margin-top:15pt;padding-left:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">SPAC Warrants </span></div><div style="margin-top:9pt;padding-left:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company previously issued a total of 14,936,250 SPAC Warrants to purchase common stock in public and private placement offerings which were consummated on June&#160;23, 2017. As part of the public offering, the Company issued 14,375,000 warrants ("Public SPAC Warrants") and as part of the private placement offering, the Company issued 561,250 warrants ("Private SPAC Warrants"). The SPAC Warrants have a five-year life from the date the Business Combination was consummated and every four SPAC Warrants entitle the holder to purchase one whole share of common stock at an exercise price of $23.00 per whole share.</span></div><div style="margin-top:9pt;padding-left:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Private SPAC Warrants are identical to the Public SPAC Warrants, but they (i) are exercisable either for cash or on a cashless basis at the holder&#8217;s option, (ii) are not redeemable by the Company as long as such warrants are held by the initial purchasers or their affiliates and permitted transferees, and (iii) may be subject to the limitations on exercise as specified in the warrant agreement. As a result of these difference in features between the Public SPAC Warrants and Private SPAC Warrants, the Company concluded that the Private SPAC Warrants should be classified as a liability, if still held by the original Private SPAC Warrant holder, and marked to market each financial reporting period in the Company&#8217;s statement of operations.</span></div><div style="margin-top:9pt;padding-left:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Between January 1, 2021 and June&#160;30, 2021, a total of 12,120,397 SPAC Warrants were exercised, resulting in the Company&#8217;s issuance of 3,030,092 shares of common stock and the receipt of $69.7&#160;million in gross proceeds. </span></div><div style="margin-top:9pt;padding-left:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Outstanding SPAC Warrants totaled 2,815,853 as of June&#160;30, 2022 and December&#160;31, 2021. Private SPAC Warrants that were still owned by the original holder totaled 80,350 as of June&#160;30, 2022 and December&#160;31, 2021.</span></div><div style="margin-top:15pt;padding-left:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Placement Agent Warrants</span></div><div style="margin-top:9pt;padding-left:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In connection with several of DermTech Operations&#8217; financings that took place between 2015 and 2018, DermTech Operations engaged a registered placement agent to assist in marketing and selling of common and preferred units. From 2015 to 2016, DermTech Operations issued 168,522 seven-year warrants to purchase one share of common stock each at an exercise price of $8.68 per share. From 2016 to 2018, DermTech Operations issued 72,658 seven-year warrants to purchase one share of common stock at an exercise price of $9.54 per share. In 2020, the Company issued 15,724 seven-year warrants to purchase one share of common stock at an exercise price of $9.54 per share in connection with the Company&#8217;s 2018 bridge note financing. Outstanding placement agent warrants totaled 10,039 as of June&#160;30, 2022 and December&#160;31, 2021.</span></div><div style="margin-top:15pt;padding-left:27pt;text-indent:-27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">(i)&#160;&#160;&#160;&#160;Stock-Based Compensation </span></div><div style="margin-top:9pt;padding-left:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table sets forth assumptions used to determine the fair value of each option on the date of grant issued under the 2020 Equity Incentive Plan:</span></div><div style="margin-top:12pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:32.233%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:15.112%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.406%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:15.112%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.406%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:15.112%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.406%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:15.113%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Three Months Ended June 30,</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Six Months Ended June 30,</span></td></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2021</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Assumed risk-free interest rate</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2.97%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1.03% - 1.07%</span></div></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2.97% </span></div></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.52% - 1.13%</span></div></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Assumed volatility</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">81.65%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">77.69%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">81.65%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">74.88% - 77.69%</span></div></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Expected option term</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6.08 years</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6.08 years</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6.08 years</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6.08 years</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Expected dividend yield</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;</span></td></tr></table></div><div style="margin-top:9pt;padding-left:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table sets forth assumptions used to determine the fair value of the purchase rights issued under the 2020 Employee Stock Purchase Plan (the &#8220;ESPP&#8221;):</span></div><div style="margin-top:12pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:32.233%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:15.112%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.406%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:15.112%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.406%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:15.112%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.406%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:15.113%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Three Months Ended June 30,</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Six Months Ended June 30,</span></td></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2021</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Assumed risk-free interest rate</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1)</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.10%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.05% - 0.22%</span></div></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.10% - 0.18%</span></div></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Assumed volatility</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1)</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">69.34%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">52.58% - 64.55%</span></div></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">68.44% - 69.34%</span></div></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Expected option term</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1)</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.50 years</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.49 - 0.50 years</span></div></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.49 - 0.50 years</span></div></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Expected dividend yield</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1)</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;</span></td></tr></table></div><div style="padding-left:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(1) There were no ESPP purchases under its 2020 Employee Stock Purchase Plan during the period.</span></div><div style="margin-top:9pt;padding-left:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Stock-based compensation expense for employee options, RSUs, the purchase rights issued under the ESPP, and consultant options was recorded in the condensed consolidated statements of operations as follows (in thousands):</span></div><div style="margin-top:6pt;padding-left:27pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:95.000%"><tr><td style="width:1.0%"/><td style="width:41.483%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.775%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.437%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.775%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.437%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.775%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.437%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.781%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Three Months Ended June 30,</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Six Months Ended June 30,</span></td></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2021</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cost of revenue</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">298&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">259&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">633&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">410&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Sales and marketing</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,067&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">935&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,528&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,482&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Research and development</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,330&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">515&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,825&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">829&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">General and administrative</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,142&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,829&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,745&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,989&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total stock-based compensation</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4,837&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,538&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">8,731&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5,710&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div style="margin-top:9pt;padding-left:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The total compensation cost related to non-vested awards not yet recognized as of June&#160;30, 2022 was $50.3 million, which is expected to be recognized over a weighted average term of 2.90 years. </span></div><div style="margin-top:15pt;padding-left:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">2010 Stock Plan</span></div><div style="margin-top:9pt;padding-left:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In connection with the Business Combination, the Company assumed the DermTech Operations&#8217; Amended and Restated 2010 Stock Plan (the &#8220;2010 Plan&#8221;), which provided for the granting of incentive and non-statutory stock options and restricted stock purchase rights and bonus awards. The contractual term of options granted under the 2010 Plan was ten years. Vesting provisions varied based on the specific terms of the individual option awards. At the Company&#8217;s annual meeting held on May 26, 2020, the Company&#8217;s shareholders voted to approve the DermTech, Inc. 2020 Equity Incentive Plan (the &#8220;2020 Plan&#8221;), which terminated the 2010 Plan. No additional awards will be granted under the 2010 Plan, however, all outstanding awards under the 2010 Plan remain in effect. No shares remained available for issuance pursuant to future grants under the 2010 Plan as of June&#160;30, 2022 and December&#160;31, 2021, respectively. </span></div><div style="margin-top:15pt;padding-left:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">2020 Equity Incentive Plan</span></div><div style="margin-top:9pt;padding-left:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">On May 26, 2020, the Company&#8217;s stockholders approved the adoption of the 2020 Plan, which provides for the granting of incentive and non-qualified stock options, restricted stock and stock-based awards. Under the 2020 Plan, incentive and non-qualified stock options may be granted at not less than 100% of the fair market value of the Company&#8217;s common stock on the date of grant. If an incentive stock option is granted to an individual who owns more than 10% of the combined voting power of all classes of the Company&#8217;s capital stock, the exercise price may not be less than 110% of the fair market value of the Company&#8217;s common stock on the date of grant and the term of the option may not be longer than five years.</span></div><div style="margin-top:9pt;padding-left:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The 2020 Plan authorizes the Company to issue up to 1,900,000 shares of the Company&#8217;s common stock pursuant to awards granted under the 2020 Plan, plus the number of shares underlying any stock option and other stock-based awards previously granted under the 2010 Plan that are forfeited, canceled, or terminated (other than by exercise) on or after May 26, 2020; provided that no more than 1,400,000 shares may be added to the 2020 Plan pursuant to such forfeitures, cancellations and terminations. In addition, the number of shares available for issuance under the 2020 Plan will automatically increase on the first day of each fiscal year beginning in fiscal year 2021 and ending on the second day of fiscal year 2025, by an amount equal to the smaller of (i) 3.5% of the number of shares of common stock outstanding on such date and (ii) an amount determined by the administrator of the 2020 Plan. The 2020 Plan will expire on April 12, 2030 or an earlier date approved by a vote of the Company&#8217;s stockholders or board of directors. The contractual term of options granted under the 2020 Plan is not more than ten years. Vesting provisions vary based on the specific terms of the individual option awards. 431,107 shares remained available for future grant under the 2020 Plan as of June&#160;30, 2022.</span></div><div style="margin-top:15pt;padding-left:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">2020 Employee Stock Purchase Plan</span></div><div style="margin-top:9pt;padding-left:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">On May 26, 2020, the Company&#8217;s stockholders approved the adoption of the ESPP, which allows for full-time and certain part-time employees of the Company to purchase shares of common stock at a discount to fair market value. Eligible employees enroll in a six-month offering period during the open enrollment period prior to the start of that offering period. A new offering period begins approximately every March 1 and September 1. At the end of each offering period, the accumulated contributions are used to purchase shares of the Company&#8217;s common stock. Shares are purchased at a price equal to 85% of the lower of: (i) the fair market value of the Company&#8217;s common stock on the first business day of an offering period or (ii) the fair market value of the Company&#8217;s common stock on the last business day of an offering period. </span></div><div style="margin-top:9pt;padding-left:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The ESPP authorizes the Company to issue up to 400,000 shares of the Company&#8217;s common stock. In addition, the number of shares available for issuance under the ESPP will automatically increase on the first day of each of the Company&#8217;s fiscal years beginning in 2021 and ending on the first day of 2030, in an amount equal to the lesser of (i) 300,000 shares, (ii) 1% of the shares of Company common stock outstanding on the last day of the immediately preceding fiscal year, or (iii) such lesser number of shares as is determined by the board of directors of the Company, subject to adjustment upon changes in capitalization of the Company. On February 28, 2021 and August 31, 2021, the Company issued 39,960 and 18,155 shares of its common stock, respectively, pursuant to scheduled purchases under the ESPP. As of December&#160;31, 2021, 549,289 shares of common stock were reserved for future issuance under the ESPP. On January&#160;1, 2022, an additional 297,729 shares became available under the ESPP pursuant to an automatic annual increase. On February&#160;28, 2022, the Company issued 47,339 shares of its common stock pursuant to scheduled purchases under the ESPP. 799,679 shares remained available for future grant under the ESPP as of June&#160;30, 2022.</span></div><div style="margin-top:15pt;padding-left:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Management Warrants</span></div><div style="margin-top:9pt;padding-left:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Warrants to purchase DermTech Operations common stock were issued to executive officers of DermTech Operations in lieu of issuing certain stock options (the &#8220;Management Warrants&#8221;). The Management Warrants were assumed by the Company in connection with the Business Combination. The Management Warrants have a ten-year life and are exercisable for Company common stock at $1.08 per share. For the six months ended June&#160;30, 2022, the Company issued 20,320 shares of common stock pursuant to the exercise of Management Warrants. The Management Warrants vested monthly over a four-year period. Outstanding Management Warrants totaled zero and 22,320 as of June&#160;30, 2022 and December&#160;31, 2021, respectively.</span></div><div style="margin-top:15pt;padding-left:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Common Stock Reserved for Future Issuance </span></div><div style="margin-top:9pt;padding-left:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Common stock reserved for future issuance consists of the following as of June&#160;30, 2022 and December&#160;31, 2021 (in thousands): </span></div><div style="margin-top:12pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:71.930%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.081%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.406%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.083%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">June 30,<br/>2022</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">December 31,<br/>2021</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Warrants to purchase common stock</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">31&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">SPAC Warrants to purchase common stock*</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">704&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">704&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Stock options issued and outstanding</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,758&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,721&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">RSUs issued and outstanding</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,912&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">983&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Authorized for future equity grants</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">431&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">603&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Authorized for future ESPP purchases</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">800&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">549&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total common stock reserved for future issuance</span></td><td colspan="2" style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6,615&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4,591&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div style="margin-top:9pt;padding-left:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">*Four SPAC Warrants are needed to purchase one share of common stock. The numbers presented above reflect the amount of shares of common stock underlying SPAC Warrants.</span></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockholdersEquityNoteAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockholdersEquityNoteAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockholdersEquityNoteDisclosureTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for shareholders' equity comprised of portions attributable to the parent entity and noncontrolling interest, including other comprehensive income. Includes, but is not limited to, balances of common stock, preferred stock, additional paid-in capital, other capital and retained earnings, accumulated balance for each classification of other comprehensive income and amount of comprehensive income.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -URI https://asc.fasb.org/topic&amp;trid=2208762<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 13<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=126973232&amp;loc=SL123496158-112644<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 13<br> -URI https://asc.fasb.org/extlink&amp;oid=126973232&amp;loc=SL123496158-112644<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 14<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=126973232&amp;loc=SL123496171-112644<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 14<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=126973232&amp;loc=SL123496171-112644<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.3-04)<br> -URI https://asc.fasb.org/extlink&amp;oid=120397183&amp;loc=d3e187085-122770<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 18<br> -Subparagraph (d)<br> -URI https://asc.fasb.org/extlink&amp;oid=126973232&amp;loc=SL123496189-112644<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 13<br> -Subparagraph (g)<br> -URI https://asc.fasb.org/extlink&amp;oid=126973232&amp;loc=SL123496158-112644<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 18<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126973232&amp;loc=SL123496189-112644<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 13<br> -Subparagraph (h)<br> -URI https://asc.fasb.org/extlink&amp;oid=126973232&amp;loc=SL123496158-112644<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 14<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126973232&amp;loc=SL123496171-112644<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 18<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=126973232&amp;loc=SL123496189-112644<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 16<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=126973232&amp;loc=SL123496180-112644<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 13<br> -Subparagraph (i)<br> -URI https://asc.fasb.org/extlink&amp;oid=126973232&amp;loc=SL123496158-112644<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(e)(1))<br> -URI https://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 40<br> -Section 50<br> -Paragraph 6<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126731327&amp;loc=SL126733271-114008<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockholdersEquityNoteDisclosureTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>35
<FILENAME>R12.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.2</span><table class="report" border="0" cellspacing="2" id="idm139763878000960">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Leases, Commitments and Contingencies<br></strong></div></th>
<th class="th" colspan="1">6 Months Ended</th>
</tr>
<tr><th class="th"><div>Jun. 30, 2022</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CommitmentsAndContingenciesDisclosureAbstract', window );"><strong>Commitments and Contingencies Disclosure [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CommitmentsDisclosureTextBlock', window );">Leases, Commitments and Contingencies</a></td>
<td class="text">Leases, Commitments and Contingencies<div style="margin-top:15pt;padding-left:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Adoption of ASC 842</span></div><div style="margin-top:9pt;padding-left:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In the third quarter of 2021, the Company adopted ASU 2016-02</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">, </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">and</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"> </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">ASC</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"> </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Topic</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"> </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">842, </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Leases</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> (&#8220;ASC 842&#8221;) using the modified retrospective approach with an effective date of January 1, 2021. The adoption had no effect on the condensed consolidated statements of operations for the three and six months ended June 30, 2021. Net cash (used in) provided by operating activities, investing activities or financing activities for the six months ended June 30, 2021 were also unchanged, but the presentation of certain prior period amounts within the operating activities section of the condensed consolidated statements of cash flows have been retrospectively adjusted to give effect to the adoption of ASC 842. The changes are set forth in the table below (in thousands):</span></div><div style="margin-top:6pt;padding-left:27pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:62.081%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.021%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.406%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.263%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.406%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.023%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.5pt;font-weight:700;line-height:100%">Six Months Ended June 30, 2021</span></td></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.5pt;font-weight:700;line-height:100%">Before Adoption of ASC 842</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.5pt;font-weight:700;line-height:100%">Effect of Adoption</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.5pt;font-weight:700;line-height:100%">After Adoption of ASC 842</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:700;line-height:100%">Effect on Condensed Consolidated Statements of Cash Flows</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Cash flows from operating activities:</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Adjustments to reconcile net loss to net cash used in operating activities:</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 17.5pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Amortization of operating lease right-of-use assets</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">582&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">582&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Change in operating assets and liabilities:</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 11.5pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Operating lease liabilities, net</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(328)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(328)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 11.5pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Other liabilities</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">254&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(254)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div style="margin-top:15pt;padding-left:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Finance Leases</span></div><div style="margin-top:9pt;padding-left:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company leases certain laboratory equipment from various third parties, through equipment finance leases (previously referred to as &#8220;capital leases&#8221;). These leases either include a bargain purchase option or the terms of the leases are at least 75 percent of the useful lives of the assets and are therefore classified as finance leases. These leases are capitalized in property and equipment, net on the accompanying condensed consolidated balance sheets. Initial asset values and finance lease obligations are based on the present value of future minimum lease payments. Gross assets recorded under finance leases were $0.4 million and $0.4 million as of June&#160;30, 2022 and December&#160;31, 2021, respectively. Accumulated amortization associated with finance leases was $0.1 million and $0.1 million as of June&#160;30, 2022 and December&#160;31, 2021, respectively. Total finance lease interest expense was approximately $3,000 and $4,000 for the three months ended June&#160;30, 2022 and 2021, respectively, and $7,000 and $8,000 for the six months ended June 30, 2022 and 2021, respectively, and is included within interest income, net on the condensed consolidated statements of operations. Long-term finance lease obligations are as follows (in thousands): </span></div><div style="margin-top:12pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.696%"><tr><td style="width:1.0%"/><td style="width:69.264%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:13.337%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.407%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:13.492%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">June 30, 2022</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">December 31, 2021</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Gross finance lease obligations</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">262&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">274&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Less imputed interest</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(17)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(17)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Present value of net minimum lease payments</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">245&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">257&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Less current portion of finance lease obligations</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(134)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(121)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total long-term finance lease obligations</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">111&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">136&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div style="margin-top:15pt;padding-left:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Operating Leases</span></div><div style="margin-top:15pt;padding-left:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Del Mar Heights Lease </span></div><div style="margin-top:9pt;padding-left:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">On July&#160;1, 2021, the Company entered into an Office Lease (the &#8220;Del Mar Lease&#8221;) with Kilroy Realty, L.P. (the &#8220;Landlord&#8221;), with respect to an aggregate of 95,997 rentable square feet consisting of the entire building located at 12340 El Camino Real, San Diego, California 92130 (the &#8220;Entire Premises&#8221;). The Entire Premises covered by the Del Mar Lease will serve as the Company&#8217;s new principal office.</span></div><div style="margin-top:9pt;padding-left:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Del Mar Lease provides for a tenant improvement allowance of $125.00 per rentable square foot of the Entire Premises for a total of $12.0 million that the Landlord will use to fund the installation and/or construction of certain improvements to the Entire Premises in four phases, with each phase pertaining to a specified portion of the Entire Premises. The initial term of the Del Mar Lease is ten years and six months beginning on the earlier to occur of (i) January 1, 2023 and (ii) the date that Landlord tenders possession of the Phase III Premises (as defined in the Del Mar Lease) to the Company following the substantial completion of the improvements to the Phase III Premises required by the Del Mar Lease (the &#8220;Lease Commencement Date&#8221;). The Company has the option to extend the term of the Lease for two additional five-year periods, subject to the terms of the Del Mar Lease.</span></div><div style="margin-top:9pt;padding-left:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">As the Landlord tenders possession of each portion of the Entire Premises for which the applicable improvements required by the Del Mar Lease are substantially complete, the Company will be obligated to make monthly payments of base rent with respect to such portion of the Entire Premises as set forth on Schedule 1 to the Del Mar Lease. In the event the Company exercises its option to extend the Del Mar Lease term, the Lease provides for monthly rent payments during the additional five-year periods at the then-current market rent as determined in accordance with the Del Mar Lease. In addition to rent, the Del Mar Lease requires the Company to pay additional rent amounts for taxes, insurance, maintenance and other expenses.</span></div><div style="margin-top:9pt;padding-left:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">During year ended December 31, 2021, the Company took initial possession of the first phase of its corporate headquarters, and the Company capitalized a right-of-use asset and related lease liability of $5.7 million associated with the first phase. During the three months ended March 31, 2022, the lease for the second phase of the Company&#8217;s corporate headquarters commenced and the Company capitalized a right of use asset and related lease liability of $15.8&#160;million. The extension option periods were not considered in the determination of the right-of-use asset or the lease liability as the Company did not consider it reasonably certain that it would exercise such extension options. </span></div><div style="margin-top:15pt;padding-left:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Del Mar Lease Amendments</span></div><div style="margin-top:9pt;padding-left:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">During April 2022, the Company amended the Del Mar Lease through the execution of the First Amendment to Office Lease (the "First Amendment") and the Second Amendment to Office Lease (the "Second Amendment") (collectively, the "Del Mar Lease Amendments"). Pursuant to the First Amendment to the Del Mar Lease, the Company elected to utilize a one-time increase in an additional improvement allowance of $25.00 per rentable square foot, which increased the tenant improvement allowance by $2.4 million to $14.4 million, provided under the Del Mar Lease to make certain improvements to the Entire Premises. As a result, the Company will pay an increased monthly base rent to the Landlord, in order to repay costs relating to the additional design and construction. Pursuant to the Second Amendment to the Del Mar Lease, the Company elected to expand the Entire Premises to include 14,085 rentable square feet comprising the executive parking level (the &#8220;Expansion Premises&#8221;), which increased the tenant improvement allowance by $2.1 million to $16.5 million. The Landlord will tender possession of the Expansion Premises following substantial completion of improvements, pursuant to an agreed upon work letter and will run contemporaneously with the term of the Existing Premises. The Company intends to use the additional space for general office and laboratory use. As the Landlord tenders possession of the Expansion Premises, the Company will be obligated to pay the Landlord increased monthly installments of base rent for the Expansion Premises. Upon inclusion of the Expansion Premises, the Company will lease approximately 110,082 rentable square feet rentable square feet from the Landlord (the &#8220;New Entire Premises&#8221;). </span></div><div style="margin-top:9pt;padding-left:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company evaluated the Del Mar Lease Amendments under ASC 842 and concluded that the Del Mar Lease Amendments would be accounted for as a single contract with the Del Mar Lease because the additional lease payments due to the Del Mar Lease Amendments were not commensurate with ROU asset granted to the Company. Accordingly, the Company remeasured the lease liability using the additional monthly rent payments and the incremental borrowing rate at the effective date of the modification of 6.50%. The remeasurement for the modification resulted in an increase to the lease liability and the ROU asset of approximately $1.2 million. </span></div><div style="margin-top:9pt;padding-left:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The extension option periods were not considered in the determination of the right-of-use asset or the lease liability as the Company did not consider it reasonably certain that it would exercise such extension options. Pending execution of the Landlord's obligations to prepare leased spaces for occupancy, the Company expects the operating leases for the additional office and laboratory space to commence on various dates in the year ending December 31, 2022. The Company has an estimated future lease payment obligation of approximately $54.4 million related to corporate office facilities that were in the process of being constructed as of June&#160;30, 2022. The lease liabilities and the corresponding right-of-use assets associated with these lease obligations will be recorded upon the commencement date of the operating leases using the Company&#8217;s incremental borrowing rate based on the information available at commencement date in determining the present value of lease payments. The incremental borrowing rate is the rate of interest that a lessee would have to pay to borrow on a collateralized basis over a similar term and at an amount equal to the lease payments in a similar economic environment. The Company calculates its incremental borrowing rates for specific lease terms, used to discount future lease payments, as a function of the U.S. Treasury rate and an indicative Moody&#8217;s rating for operating leases.</span></div><div style="margin-top:9pt;padding-left:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In connection with the original lease agreement, in lieu of a cash security deposit, the Company&#8217;s bank issued a letter of credit on its behalf, which is secured by a deposit, of $3.0 million and is included in restricted cash on the condensed consolidated balance sheet based on the term of the underlying lease. In April 2022, pursuant to the Second Amendment</span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">, </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">the Company&#8217;s bank increased the letter of credit on its behalf</span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> by $0.5 million, totaling $3.5 million. </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">As of June&#160;30, 2022, none of the standby letter of credit amount has been used.</span></div><div style="margin-top:15pt;padding-left:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Torrey Pines Lease</span></div><div style="margin-top:9pt;padding-left:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In January&#160;2013, DermTech Operations entered into a non-cancelable lease agreement for its operating facilities in Torrey Pines (the &#8220;Torrey Lease&#8221;). In January&#160;2014, DermTech Operations signed an amendment to the Torrey Lease to extend the term through January&#160;2017. In November&#160;2016, DermTech Operations signed a second amendment to the Torrey Lease to extend the term through March&#160;2022. In August 2019, DermTech Operations signed a third amendment to the Torrey Lease to add additional space, and in September 2019, the Company signed a fourth amendment to the Torrey Lease to add additional space. In February 2020, the Company signed a fifth amendment to the Torrey Lease to add additional space. In connection with the Business Combination, the Company assumed all obligations under the Torrey Lease, as amended, from DermTech Operations. As part of the fifth amendment, the Company was entitled to a tenant improvement allowance for certain costs incurred while performing these improvements in the amount of $0.3 million, which amount may be increased by up to $0.1 million at the Company&#8217;s election and subject to a corresponding increase in rent. Under the terms of the facilities leases, the Company is required to pay its proportionate share of property taxes, insurance and normal maintenance costs.</span></div><div style="margin-top:9pt;padding-left:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The lease term for all leased space has an expiration date of April&#160;30, 2023, and an option to extend the lease term on all leased space for one additional three-year term, which the Company is not reasonably certain that it will exercise. As such, the Company did not include this option in the determination of the total lease term. On January 1, 2021, in conjunction with the adoption of the guidance in ASU 2016-02, the Company recognized a right-of-use asset and corresponding lease liability for its facility lease as the present value of lease payments not yet paid at January 1, 2021. The right-of-use asset and corresponding lease liability was estimated assuming the remaining lease term of 28 months at January&#160;1, 2021, and an estimated discount rate of 4.04%, which was the Company&#8217;s incremental borrowing rate at the date of adopting ASC 842. The Company recorded a lease liability of $3.1 million and a right-of-use asset of $2.8 million, which is net of $0.3 million of the Company&#8217;s previously capitalized tenant improvement allowance and deferred rent, upon adoption.</span></div><div style="margin-top:9pt;padding-left:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The components of lease expense for the three and six months ended June&#160;30, 2022 was as follows (in thousands):</span></div><div style="margin-top:12pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:43.803%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.750%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.390%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.750%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.390%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.750%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.390%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:13.677%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Three Months Ended June 30,</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Six Months Ended June 30,</span></td></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2021</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Operating lease cost</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 10pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Operating lease cost</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">1,044&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">319&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">1,667&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">638&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Variable lease costs </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.85pt;font-weight:400;line-height:100%;position:relative;top:-3.15pt;vertical-align:baseline">(1)</span></div></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">303&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">143&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">492&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">315&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Total operating lease cost</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">1,347&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">462&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">2,159&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">953&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr style="height:15pt"><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Finance lease cost</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 10pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Amortization of leased assets</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">21&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">17&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">41&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">34&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 10pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Interest on lease liabilities</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">3&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">4&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">7&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">8&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Total finance lease cost</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">24&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">21&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">48&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">42&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(1) Variable lease costs are primarily related to common area maintenance charges and property taxes.</span></div><div style="margin-top:9pt;padding-left:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Other information related to leases was as shown in the table below. </span></div><div style="margin-top:12pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:68.900%"/><td style="width:0.1%"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td style="width:0.1%"/><td style="width:0.406%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:13.293%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.406%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:13.295%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Six Months Ended June 30,</span></td></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2021</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Cash paid for amounts included in the measurement of lease liabilities:</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 10pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Operating cash flows from operating leases</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">1,179&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">684&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 10pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Operating cash flows from finance leases</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">7&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">8&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 10pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Financing cash flows from finance leases</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">60&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">53&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Right-of-use assets obtained in exchange for lease obligations:</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 10pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Operating leases</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">17,059&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">2,831&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 10pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Finance leases</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">48&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Weighted average remaining lease term in years:</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 10pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Operating leases</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">10.56</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">1.92</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 10pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Finance leases</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">1.50</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">2.50</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Weighted average discount rate:</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 10pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Operating leases</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">6.39&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">4.04&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 10pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Finance leases</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">5.78&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">5.54&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">%</span></td></tr></table></div><div style="margin-top:9pt;padding-left:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company&#8217;s future minimum lease payments under operating and financing leases at June&#160;30, 2022 are as follows (in thousands): </span></div><div style="margin-top:12pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:24.203%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:9.051%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.406%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:9.051%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.406%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:9.051%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.406%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:9.051%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.406%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:9.051%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.406%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:9.051%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.406%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:9.055%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2023</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2024</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2025</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2026</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Thereafter</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Total</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Operating lease obligations, including interest</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,524&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,948&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,774&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,853&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,934&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">20,612&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">33,645&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 10pt;text-align:left;text-indent:-9pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Finance lease obligations, including interest</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">72&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">133&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">19&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">19&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">15&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">262&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 16pt;text-align:left;text-indent:-9pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total future minimum lease payments</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,596&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,081&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,793&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,872&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,949&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">20,616&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">33,907&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div style="margin-top:9pt;padding-left:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Amounts presented in the table above exclude non-cancelable future minimum lease payments for operating leases that have not commenced as of June&#160;30, 2022.</span></div><div style="margin-top:18pt;padding-left:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Legal Proceedings</span></div>From time to time, the Company may be subject to legal proceedings and claims arising in the ordinary course of business. Management does not believe that the outcome of any of these matters will have a material effect on the Company&#8217;s consolidated financial position, results of operations or cash flows.<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CommitmentsAndContingenciesDisclosureAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CommitmentsAndContingenciesDisclosureAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CommitmentsDisclosureTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for significant arrangements with third parties, which includes operating lease arrangements and arrangements in which the entity has agreed to expend funds to procure goods or services, or has agreed to commit resources to supply goods or services, and operating lease arrangements. Descriptions may include identification of the specific goods and services, period of time covered, minimum quantities and amounts, and cancellation rights.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 440<br> -URI https://asc.fasb.org/topic&amp;trid=2144648<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CommitmentsDisclosureTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>36
<FILENAME>R13.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.2</span><table class="report" border="0" cellspacing="2" id="idm139763878000960">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Related Party Transactions<br></strong></div></th>
<th class="th" colspan="1">6 Months Ended</th>
</tr>
<tr><th class="th"><div>Jun. 30, 2022</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RelatedPartyTransactionsAbstract', window );"><strong>Related Party Transactions [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RelatedPartyTransactionsDisclosureTextBlock', window );">Related Party Transactions</a></td>
<td class="text">Related Party Transactions  During 2021 and 2022, the Company engaged EVERSANA Life Science Services, LLC (&#8220;EVERSANA&#8221;) to provide certain marketing services to the Company. Leana Wood, the spouse of Todd Wood, the Company&#8217;s Chief Commercial Offer, is an employee of EVERSANA. The Company incurred $0.9 million and $0.5 million in costs for the three months ended June&#160;30, 2022 and 2021, respectively, and $1.6 million and $0.9 million for the six months ended June&#160;30, 2022 and 2021, respectively.<div style="margin-top:9pt;padding-left:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">On October&#160;1, 2019, the Company entered into a consulting agreement with Michael Dobak pursuant to which the Company will compensate Michael Dobak, in an amount not to exceed $100,000, for certain public relations and marketing services. On July 28, 2020, the Company and Michael Dobak entered into an amendment to such consulting agreement to modify the terms of Michael Dobak&#8217;s compensation. The amended consulting agreement compensated Michael Dobak $15,000 per month for the period May 11, 2020 through June&#160;30, 2021 and also granted him a restricted stock unit award that fully vested in a single installment on August 31, 2020 and represented the contingent right to receive 5,000 shares of common stock on January&#160;2, 2021. On November&#160;11, 2020, the Company and Michael Dobak entered into an amendment to such consulting agreement to extend the term through December&#160;31, 2021 with a continued monthly payment of $15,000. On February&#160;26, 2021, the Company and Michael Dobak agreed to extend his agreement through April 30, 2021 with a revised monthly payment of $20,000. Michael Dobak is the brother of Dr. John Dobak, the Company&#8217;s Chief Executive Officer. The Company incurred zero and $20,000 in costs for the three months ended June&#160;30, 2022 and 2021, respectively, and zero and $0.1 million for the six months ended June&#160;30, 2022 and 2021.</span></div><div style="margin-top:9pt;padding-left:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">There were no other related party transactions identified during the six months ended June&#160;30, 2022 and 2021.</span></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RelatedPartyTransactionsAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RelatedPartyTransactionsAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RelatedPartyTransactionsDisclosureTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for related party transactions. Examples of related party transactions include transactions between (a) a parent company and its subsidiary; (b) subsidiaries of a common parent; (c) and entity and its principal owners; and (d) affiliates.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 850<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (d)<br> -URI https://asc.fasb.org/extlink&amp;oid=6457730&amp;loc=d3e39549-107864<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 850<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=6457730&amp;loc=d3e39549-107864<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 850<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=6457730&amp;loc=d3e39549-107864<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 850<br> -URI https://asc.fasb.org/topic&amp;trid=2122745<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 850<br> -SubTopic 10<br> -Section 50<br> -Paragraph 6<br> -URI https://asc.fasb.org/extlink&amp;oid=6457730&amp;loc=d3e39691-107864<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RelatedPartyTransactionsDisclosureTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>37
<FILENAME>R14.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.2</span><table class="report" border="0" cellspacing="2" id="idm139763877070608">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Subsequent Events<br></strong></div></th>
<th class="th" colspan="1">6 Months Ended</th>
</tr>
<tr><th class="th"><div>Jun. 30, 2022</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SubsequentEventsAbstract', window );"><strong>Subsequent Events [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SubsequentEventsTextBlock', window );">Subsequent Events</a></td>
<td class="text">.&#160;&#160;&#160;&#160;Subsequent EventsThe Company considered subsequent events through August&#160;8, 2022, the date the condensed consolidated financial statements were available to be issued, and determined there were no subsequent events that would require recognition or disclosure in the condensed consolidated financial statements.<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SubsequentEventsAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SubsequentEventsAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SubsequentEventsTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for significant events or transactions that occurred after the balance sheet date through the date the financial statements were issued or the date the financial statements were available to be issued. Examples include: the sale of a capital stock issue, purchase of a business, settlement of litigation, catastrophic loss, significant foreign exchange rate changes, loans to insiders or affiliates, and transactions not in the ordinary course of business.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 855<br> -URI https://asc.fasb.org/topic&amp;trid=2122774<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 855<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=6842918&amp;loc=SL6314017-165662<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SubsequentEventsTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>38
<FILENAME>R15.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.2</span><table class="report" border="0" cellspacing="2" id="idm139763871918240">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>The Company and a Summary of its Significant Accounting Policies (Policies)<br></strong></div></th>
<th class="th" colspan="1">6 Months Ended</th>
</tr>
<tr><th class="th"><div>Jun. 30, 2022</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AccountingPoliciesAbstract', window );"><strong>Accounting Policies [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NatureOfOperations', window );">Nature of Operations</a></td>
<td class="text">Nature of Operations <div style="margin-top:9pt;padding-left:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">On August 29, 2019, DermTech, Inc., formerly known as Constellation Alpha Capital Corp, (the &#8220;Company&#8221;), and DermTech Operations, Inc., formerly known as DermTech, Inc., (&#8220;DermTech Operations&#8221;), consummated the transactions contemplated by the Agreement and Plan of Merger, dated as of May 29, 2019, by and among the Company, DT Merger Sub, Inc., a wholly owned subsidiary of the Company (&#8220;Merger Sub&#8221;), and DermTech Operations. The Company refers to this agreement, as amended by that certain First Amendment to Agreement and Plan of Merger dated as of August 1, 2019, as the Merger Agreement. Pursuant to the Merger Agreement, Merger Sub merged with and into DermTech Operations, with DermTech Operations surviving as a wholly-owned subsidiary of the Company. The Company refers to this transaction as the Business Combination. In connection with and two days prior to the completion of the Business Combination, the Company domesticated from the British Virgin Islands to Delaware. DermTech Operations changed its name from DermTech, Inc. to DermTech Operations, Inc. shortly before the completion of the Business Combination. On August 29, 2019, immediately following the completion of the Business Combination, the Company changed its name from Constellation Alpha Capital Corp. to DermTech, Inc., and then effected a one-for-two reverse stock split of its common stock. </span></div><div style="margin-top:9pt;padding-left:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company is a molecular diagnostic company developing and marketing its Clinical Laboratory Improvement Amendments of 1988 (&#8220;CLIA&#8221;) laboratory services including genomic tests to facilitate the diagnosis of dermatologic conditions including melanoma. The Company has developed a proprietary, non-invasive technique for sampling the surface layers of the skin using an adhesive patch called the DermTech Smart Sticker&#8482; (the &#8220;Smart Sticker&#8221;) to collect biological information for commercial applications in the medical diagnostic field.</span></div><div style="margin-top:9pt;padding-left:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">From the end of the first quarter of 2020 and through the second quarter of 2022, there has been a widespread worldwide impact from the COVID-19 pandemic. The Company is considered an essential business due to the importance of early melanoma detection, which has allowed the Company&#8217;s CLIA laboratory to remain fully operational. The Company implemented additional safety measures in accordance with Centers for Disease Control and Prevention (&#8220;CDC&#8221;), Occupational Safety and Health Administration (&#8220;OSHA&#8221;) and other guidance within its CLIA laboratory operations. Additionally, and during this time, the Company transitioned administrative functions to predominantly remote work. Beginning in March 2020 and continuing through the second quarter of 2022, the ongoing COVID-19 pandemic has reduced patient access to clinician offices for in-person testing and reduced access by the Company&#8217;s sales force for in-office sales calls, which has resulted in a reduced volume of billable samples received during the second quarter of 2022 relative to the Company&#8217;s pre-pandemic expectations. The Company expects the ongoing COVID-19 pandemic to continue to adversely impact billable sample volume until patient access to in-person testing fully resumes, in-office access by the Company&#8217;s sales force returns to pre-pandemic levels, or telemedicine options are more widely adopted. Additionally, the ongoing COVID-19 pandemic has negatively affected and may continue to negatively affect the Company&#8217;s pharmaceutical customers&#8217; clinical trials. The extent to which the COVID-19 pandemic will affect the Company&#8217;s future revenue is uncertain and will depend on the duration and extent of the effects of the ongoing COVID-19 pandemic, including the effects on the Company&#8217;s pharmaceutical customers&#8217; clinical trials.</span></div><span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BasisOfAccountingPolicyPolicyTextBlock', window );">Basis of Presentation</a></td>
<td class="text">Basis of PresentationThe condensed consolidated financial statements include the accounts of DermTech, Inc. and its subsidiaries. All intercompany balances and transactions among the consolidated entity have been eliminated in consolidation. These unaudited condensed consolidated financial statements have been prepared in accordance with U.S. generally accepted accounting principles (&#8220;U.S. GAAP&#8221;) for interim financial information and with the instructions to Form 10-Q and Article 10 of Securities and Exchange Commission (&#8220;SEC&#8221;), Regulation S-X. Accordingly, these unaudited condensed consolidated financial statements and accompanying notes do not include all the information and disclosures required by U.S. GAAP for complete financial statements and should be read together with the audited consolidated financial statements included in the Company&#8217;s Annual Report on Form 10-K for the fiscal year ended December 31, 2021. In the opinion of management, all adjustments, which include only normal recurring adjustments considered necessary for a fair presentation, have been included. The accompanying unaudited condensed consolidated financial statements reflect the application of certain significant accounting policies as described below and elsewhere in these notes to the unaudited condensed consolidated financial statements. As of June 30, 2022, there have been no material changes in the Company's significant accounting policies from those that were disclosed in the Company&#8217;s Annual Report on Form 10-K for the year ended December 31, 2021.<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PriorPeriodReclassificationAdjustmentDescription', window );">Reclassifications</a></td>
<td class="text">Reclassifications<span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Certain prior period information on the condensed consolidated statement of cash flows for the six months ended June 30, 2021 has been reclassified to conform to the current year presentation as a result of adopting Accounting Standards Update ("ASU") No. 2016-02, </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Leases (Topic 842)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> ("ASU 2016-02"). These reclassifications did not have an impact on net cash flows. For additional disclosure and detail, see Note 4 of the notes to the unaudited condensed consolidated financial statements, &#8220;Adoption of ASC 842.&#8221;</span><span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_UseOfEstimates', window );">Use of Estimates</a></td>
<td class="text">Use of Estimates The preparation of condensed consolidated financial statements in conformity with U.S. GAAP requires that management make estimates and assumptions that affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the date of the condensed consolidated financial statements and the amounts of revenues and expenses reported during the period. On an ongoing basis, management evaluates these estimates and judgments, including but not limited to those related to assay revenue, stock-based compensation, short-term marketable securities, accounts receivable, accrued bonus, warrant liability, right-of-use (&#8220;ROU&#8221;) assets and the realization of deferred tax assets. Actual results may differ from those estimates.<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CashAndCashEquivalentsRestrictedCashAndCashEquivalentsPolicy', window );">Cash, Cash Equivalents and Restricted Cash</a></td>
<td class="text">Cash, Cash Equivalents and Restricted Cash<div style="margin-top:9pt;padding-left:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company considers all highly liquid investments with remaining maturities of three months or less when purchased to be cash equivalents. The Company maintains its cash balances at banks and financial institutions. The balances are insured up to the Federal Deposit Insurance Corporation legal limit. The Company maintains cash balances that have in the past and may, at times, exceed this insured limit. </span></div><div style="margin-top:9pt;padding-left:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Restricted cash consists of cash deposited with a financial institution as collateral for the Company&#8217;s letters of credit for its facility leases. Restricted cash is classified as noncurrent based on the terms of the underlying lease arrangement.</span></div><span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentPolicyTextBlock', window );">Property and Equipment, Net</a></td>
<td class="text">Property and Equipment, Net Property and equipment, net is recorded at cost less accumulated depreciation. Property and equipment consists mainly of assets such as leasehold improvements, office, computer and laboratory equipment, including laboratory equipment acquired under finance lease arrangements. Depreciation is computed using the straight-line method over the estimated useful lives of the assets, which range from <span style="-sec-ix-hidden:id3VybDovL2RvY3MudjEvZG9jOmFlNWE5YmUwZWI5NDQ1ZDE5MmZhZTgyMmQyMmJlMDlmL3NlYzphZTVhOWJlMGViOTQ0NWQxOTJmYWU4MjJkMjJiZTA5Zl8zNy9mcmFnOjQ4OGNkZjBhODVlYzRiMDliYWFiN2JhZTlhODA5YjcwL3RleHRyZWdpb246NDg4Y2RmMGE4NWVjNGIwOWJhYWI3YmFlOWE4MDliNzBfMTQ0NDA_b7f0ce5d-c748-4105-a8ca-a2d7278a0959">two</span> to eleven years. Leasehold improvements are depreciated over the shorter of the remaining term of the lease or the useful life of the asset. The Company recorded depreciation expense of $0.4 million and $0.2 million for the three months ended June&#160;30, 2022 and 2021, respectively, which includes amortization of laboratory equipment acquired under finance leases (previously referred to as &#8220;capital leases&#8221;) of $21,000 and $17,000 for the three months ended June&#160;30, 2022 and 2021, respectively. The Company recorded depreciation expense of $0.8 million and $0.4 million for the six months ended June&#160;30, 2022 and 2021, respectively, which includes amortization of laboratory equipment acquired under finance leases of $41,000 and $34,000 for the six months ended June&#160;30, 2022 and 2021, respectively. <span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Amortization of assets that are recorded under finance leases in depreciation expense is included in cost of revenues on the condensed consolidated statements of operations. Gross assets recorded under finance leases were $0.4 million as of June&#160;30, 2022 and December&#160;31, 2021. Accumulated amortization associated with finance leases was $0.1 million as of June&#160;30, 2022 and December&#160;31, 2021. Maintenance and repairs are expensed as incurred, and material improvements are capitalized. When assets are retired or otherwise disposed of, the cost and accumulated depreciation are removed from the balance sheet and any resulting gain or loss is reflected in the condensed consolidated statements of operations in the period realized. </span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company disposed of $0.3 million of equipment for the three months ended June&#160;30, 2022 and no equipment for the three months ended June&#160;30, 2021</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">. The Company disposed of $0.3 million and $13,000 of equipment for the six months ended June&#160;30, 2022 and </span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">2021</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">, respectively. </span>The Company assesses its long-lived assets, consisting primarily of property and equipment, for impairment when material events or changes in circumstances indicate that the carrying value may not be recoverable.<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ConcentrationRiskCreditRisk', window );">Concentration of Credit Risk</a></td>
<td class="text">Concentration of Credit Risk Financial instruments that potentially subject the Company to significant concentrations of credit risk consist primarily of cash and cash equivalents. As of June&#160;30, 2022, the Company maintained $87.1 million in a sweep account, which maintains cash balances throughout various interest-bearing bank accounts under the $250,000 insurance limit provided by the Federal Deposit Insurance Corporation for one federally insured financial institution.<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RevenueRecognitionPolicyTextBlock', window );">Revenue Recognition</a></td>
<td class="text">Revenue Recognition <div style="margin-top:9pt;padding-left:27pt"><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company&#8217;s revenue is generated from two revenue streams: contract revenue and assay revenue. The Company accounts for revenue in accordance with Accounting Standards Codification (&#8220;ASC&#8221;) Topic 606, Revenue from Contracts with Customers (&#8220;ASC 606&#8221;). The core principle of ASC 606 is that the Company recognizes revenue to depict the transfer of promised goods or services to customers in an amount that reflects the consideration to which the Company expects to be entitled in exchange for those goods or services. The ASC 606 revenue recognition model consists of the following five steps: (1) identify the contracts with a customer, (2) identify the performance obligations in the contract, (3) determine the transaction price, (4) allocate the transaction price to the performance obligations in the contract and (5) recognize revenue when (or as) the entity satisfies a performance obligation.</span></div><div style="margin-top:9pt;padding-left:27pt"><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company recognizes revenue from its assay and contract services in accordance with the core principles and key aspects considered by the Company. These considerations are described in detail below, first for Assay Revenue and then for Contract Revenue.</span></div><div style="margin-top:15pt;padding-left:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Assay Revenue </span></div><div style="margin-top:9pt;padding-left:27pt"><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company generates revenues from its Pigmented Lesion Assay (&#8220;PLA&#8221;) and PLA</span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">plus</span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> (now referred to as the DermTech Melanoma Test or &#8220;DMT&#8221; which may consist at the option of the ordering clinician of either (i) the PLA or (ii) the PLA and PLA</span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">plus</span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">), which assists a clinician&#8217;s diagnosis of melanoma in patients. The Company provides prescribing clinicians with its Smart Sticker to perform non-invasive skin biopsies of clinically ambiguous pigmented skin lesions on patients. The Company also offers clinicians a telemedicine solution where they can request the Smart Sticker collection kit be sent to the patient&#8217;s home for a clinician-guided remote collection on ambiguous pigmented skin lesions. A patient can also initiate the process by downloading the Company&#8217;s telemedicine app, DermTech Connect, which uses store-and-forward technology to allow the patient to take a picture of a suspicious lesion with their phone and have the picture reviewed by an independent clinician who is subscribing to the DermTech Connect platform to assess the suspicious lesion, and if medically necessary, order a DMT where a collection kit would be sent to the patient&#8217;s home. The DermTech Connect app and telemedicine service were initially beta tested in Florida and is currently available in most states where permitted by law and applicable standards of practice guidelines. Once the sample is collected by the patient via the telemedicine solution or by a healthcare clinician in person, it is returned to the Company&#8217;s CLIA laboratory for analysis. The patient&#8217;s ribonucleic acid (&#8220;RNA&#8221;) and deoxyribonucleic acid (&#8220;DNA&#8221;) are extracted from the Smart Sticker and analyzed using gene expression and sequencing technology to determine if the pigmented skin lesion contains certain genomic features indicative of melanoma. Upon completion of the gene expression analysis, a final report is drafted and provided to the clinician detailing the test results for the pigmented skin lesion indicating whether the sample collected is indicative of melanoma or not. </span></div><div style="margin-top:9pt;padding-left:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company periodically updates its estimate of the variable consideration recognized for previously delivered performance obligations. These updates resulted in an additional $0.1 million and $8,000 of revenue reported for the three and six months ended June 30, 2022, respectively, and an additional $0.1 million and $0.1&#160;million of revenue reported for the three and six months ended June 30, 2021, respectively. These amounts included (i) adjustments for actual collections versus estimated variable consideration as of the beginning of the reporting period and (ii) cash collections and the related recognition of revenue in the current period for tests delivered in prior periods due to the release of the constraint on variable consideration, offset by (iii) reductions in revenue for the accrual for reimbursement claims and settlements.</span></div><div style="margin-top:15pt;padding-left:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Contract Revenue</span></div><div style="padding-left:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">Contract revenue is generated from the sale of laboratory services and Smart Stickers to third-party companies through contract research agreements. Revenues are generated from providing genomic services to facilitate the development of drugs designed to treat dermatologic conditions. The provision of services may include sample collection using the Company&#8217;s Smart Sticker, assay development for research partners, patient segmentation and stratification, extraction, isolation, expression, amplification and detection of RNA, DNA, protein and microbiome, including data analysis and reporting.</span></div>Deferred Revenue and Remaining Performance Obligations<div style="margin-top:9pt;padding-left:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The timing of revenue recognition, billings and cash collections results in billed accounts receivable and deferred revenue on the condensed consolidated balance sheets.</span></div><div style="margin-top:9pt;padding-left:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In a majority of historical agreements that produced contract revenue, the Company received a substantial up-front payment and additional payments upon the achievement of various milestones over the life of the agreement. This results in deferred revenue and is relieved upon delivery of the applicable Smart Stickers or RNA extraction results. Changes in accounts receivable and deferred revenue were not materially impacted by any other factors.</span></div>The Company records a deferred revenue liability if a customer pays consideration before the Company transfers a good or service to the customer. Deferred revenue primarily represents upfront milestone payments, for which consideration is received prior to when goods/services are completed or delivered. Upfront fees that are estimated to be recognized as revenue more than one year from the date of collection are classified as long-term deferred revenue. Short-term deferred revenue as of June&#160;30, 2022 and December&#160;31, 2021 was $1.3 million and $1.4 million, respectively. <span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Remaining performance obligations include deferred revenue and amounts the Company expects to receive for goods and services that have not yet been delivered or provided under existing agreements. For agreements that have an original duration of one year </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">or</span> less, the Company has elected the practical expedient applicable to such agreements and does not disclose the remaining performance obligations at the end of each reporting period.<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ReceivablesPolicyTextBlock', window );">Accounts Receivable</a></td>
<td class="text">Accounts Receivable <div style="margin-top:15pt;padding-left:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Assay Accounts Receivable </span></div><div style="margin-top:9pt;padding-left:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Due to the nature of the Company&#8217;s assay revenue, it can take a significant amount of time to collect upon billed tests. The Company prepares an analysis on reimbursement collections and data obtained for each financial reporting period to determine the amount of receivables to be recorded relating to tests performed in the applicable period. The Company generally does not perform evaluations of customers&#8217; financial condition and generally does not require collateral. Accounts receivables are written off when all efforts to collect the balance have been exhausted. Adjustments for implicit price concessions attributable to variable consideration are incorporated into the measurement of the accounts receivable balances. The Company recorded $5.8 million and $3.6 million of gross assay accounts receivable as of June&#160;30, 2022 and December&#160;31, 2021, respectively. Accounts receivable as of June&#160;30, 2022 included unbilled accounts receivable of $0.3 million. </span></div><div style="margin-top:15pt;padding-left:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Contract Accounts Receivable </span></div>Contract accounts receivable are recorded at the net invoice value and are not interest bearing. The Company reserves specific receivables if collectability is no longer reasonably assured, and as of June&#160;30, 2022, the Company did not maintain any reserves over contract receivables as they relate to large established credit worthy customers. The Company re-evaluates such reserves on a regular basis and adjusts its reserves as needed. Once a receivable is deemed to be uncollectible, such balance is charged against the reserve.<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EarningsPerSharePolicyTextBlock', window );">Net Loss Per Share</a></td>
<td class="text">Net Loss Per Share <span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Basic and diluted net loss per share of common stock is determined by dividing net loss applicable to holders of common stock by the weighted average number of shares of common stock outstanding during the period. Because there is a net loss attributable to holders of common stock during the three and six months ended June&#160;30, 2022 and 2021, the outstanding common stock warrants, stock options, and restricted stock units (&#8220;RSUs&#8221;) have been excluded from the calculation of diluted loss per share of common stock because their effect would be anti-dilutive. Therefore, the weighted average shares used to calculate both basic and diluted loss per share are the same. Diluted net loss per share of common stock for the three and six</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"> </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">months ended June&#160;30, 2022 excludes the effect of anti-dilutive equity instruments including 714,261 shares of common stock issuable upon the exercise of outstanding common stock warrants and 4,670,069 shares of common stock issuable upon the exercise of stock options and release of RSUs. Diluted net loss per share of common stock for the three and six</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"> </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">months ended June&#160;30, 2021 excludes the effect of anti-dilutive equity instruments including 749,210 shares of common stock then issuable upon the exercise of outstanding warrants and 2,469,816 shares of common stock then issuable upon the exercise of stock options and release of RSUs.</span><span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueMeasurementPolicyPolicyTextBlock', window );">Fair Value Measurements</a></td>
<td class="text">Fair Value MeasurementsThe Company measures certain financial assets and liabilities at fair value on a recurring basis. Fair value is defined as the price that would be received to sell an asset or paid to transfer a liability (an exit price) in an orderly transaction between market participants at the measurement date. The Company uses a three-tier fair value hierarchy to prioritize the inputs used in the Company&#8217;s fair value measurements. These tiers include: Level 1, defined as observable inputs such as quoted prices in active markets for identical assets; Level 2, defined as inputs other than quoted prices in active markets that are either directly or indirectly observable; and Level 3, defined as unobservable inputs in which little or no market data exists, therefore requiring an entity to develop its own assumptions.<div style="margin-top:9pt;padding-left:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company&#8217;s marketable debt securities are classified as available-for-sale securities based on management's intentions and are at Level 2 of the fair value hierarchy, as these investment securities are valued based upon quoted prices for identical or similar instruments in markets that are not active. The Company has classified marketable securities with original maturities of greater than one year as short-term investments based upon the Company&#8217;s ability to use all of those marketable securities to satisfy the liquidity needs of the Company&#8217;s current operations.</span></div><div style="margin-top:9pt;padding-left:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The fair value of the Private SPAC Warrants (as defined below) was determined using the Black-Scholes-Merton valuation model and included an unobservable input: expected volatility. Expected volatility is considered by the Company to be an unobservable input and is calculated using a weighted average of historical volatilities of a combination of the Company and peer companies, due to the lack of sufficient historical data of the Company&#8217;s own stock price. The model also incorporated several observable assumptions at each valuation date including: the price of the Company&#8217;s common stock on the date of valuation, the remaining contractual term of the warrant and the risk-free interest rate over the remaining term.</span></div><div style="margin-top:9pt;padding-left:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">As of June&#160;30, 2022 and December&#160;31, 2021, the Company maintains letters of credit of $3.5 million and $3.0&#160;million, respectively, related to its lease arrangements, which are secured by money market accounts in accordance with certain of its lease agreements. The amounts are recorded at fair value using Level 1 inputs and included as restricted cash in the condensed consolidated balance sheets.</span></div><div style="margin-top:9pt;padding-left:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company believes the carrying amount of cash and cash equivalents, accounts payable and accrued expenses approximate their estimated fair values due to the short-term nature of these accounts.</span></div><span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock', window );">Accounting Pronouncements Issued But Not Yet Effective and Adoption of ASC 842</a></td>
<td class="text">Accounting Pronouncements Issued But Not Yet Effective <div style="margin-top:9pt;padding-left:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In June 2022, the Financial Accounting Standards Board issued ASU No. 2022-03, </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Fair Value Measurement of Equity Securities Subject to Contractual Sale Restrictions </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">("ASU 2022-03"). Under the guidance of ASU 2022-03, a contractual restriction on the sale of an equity security is not considered in measuring the security's fair value. ASU 2022-03 also requires certain disclosures for equity securities that are subject to contractual restrictions. For public business entities, the provisions of ASU 2022-03 are effective for fiscal years beginning after December 15, 2023, and interim periods within those fiscal years. For all other entities, the amendments are effective for fiscal years beginning after December 15, 2024, and interim periods within those fiscal years. Early adoption is permitted for both interim and annual financial statements that have not yet been issued or made available for issuance. The Company is still evaluating the impact of this pronouncement on the consolidated financial statements.</span></div><div style="margin-top:9pt;padding-left:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company does not believe that any other recently issued, but not yet effective accounting pronouncements, if adopted, would have a material impact on its condensed consolidated financial statements or disclosures.</span></div>Adoption of ASC 842<span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In the third quarter of 2021, the Company adopted ASU 2016-02</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">, </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">and</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"> </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">ASC</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"> </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Topic</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"> </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">842, </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Leases</span> (&#8220;ASC 842&#8221;) using the modified retrospective approach with an effective date of January 1, 2021. The adoption had no effect on the condensed consolidated statements of operations for the three and six months ended June 30, 2021. Net cash (used in) provided by operating activities, investing activities or financing activities for the six months ended June 30, 2021 were also unchanged, but the presentation of certain prior period amounts within the operating activities section of the condensed consolidated statements of cash flows have been retrospectively adjusted to give effect to the adoption of ASC 842.<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AccountingPoliciesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AccountingPoliciesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BasisOfAccountingPolicyPolicyTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy for basis of accounting, or basis of presentation, used to prepare the financial statements (for example, US Generally Accepted Accounting Principles, Other Comprehensive Basis of Accounting, IFRS).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BasisOfAccountingPolicyPolicyTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CashAndCashEquivalentsRestrictedCashAndCashEquivalentsPolicy">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Entity's cash and cash equivalents accounting policy with respect to restricted balances. Restrictions may include legally restricted deposits held as compensating balances against short-term borrowing arrangements, contracts entered into with others, or company statements of intention with regard to particular deposits; however, time deposits and short-term certificates of deposit are not generally included in legally restricted deposits.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-03(1)(a))<br> -URI https://asc.fasb.org/extlink&amp;oid=126897435&amp;loc=d3e534808-122878<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -URI https://asc.fasb.org/extlink&amp;oid=126999549&amp;loc=d3e4273-108586<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CashAndCashEquivalentsRestrictedCashAndCashEquivalentsPolicy</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ConcentrationRiskCreditRisk">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy for credit risk.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 275<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (d)<br> -URI https://asc.fasb.org/extlink&amp;oid=99393423&amp;loc=d3e5967-108592<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 825<br> -Section 50<br> -Paragraph 1<br> -URI https://asc.fasb.org/extlink&amp;oid=126941378&amp;loc=d3e61044-112788<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ConcentrationRiskCreditRisk</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EarningsPerSharePolicyTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy for computing basic and diluted earnings or loss per share for each class of common stock and participating security. Addresses all significant policy factors, including any antidilutive items that have been excluded from the computation and takes into account stock dividends, splits and reverse splits that occur after the balance sheet date of the latest reporting period but before the issuance of the financial statements.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=124432515&amp;loc=d3e3550-109257<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI https://asc.fasb.org/extlink&amp;oid=124432515&amp;loc=d3e3630-109257<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EarningsPerSharePolicyTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FairValueMeasurementPolicyPolicyTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy for fair value measurements of financial and non-financial assets, liabilities and instruments classified in shareholders' equity. Disclosures include, but are not limited to, how an entity that manages a group of financial assets and liabilities on the basis of its net exposure measures the fair value of those assets and liabilities.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FairValueMeasurementPolicyPolicyTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NatureOfOperations">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for the nature of an entity's business, major products or services, principal markets including location, and the relative importance of its operations in each business and the basis for the determination, including but not limited to, assets, revenues, or earnings. For an entity that has not commenced principal operations, disclosures about the risks and uncertainties related to the activities in which the entity is currently engaged and an understanding of what those activities are being directed toward.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 275<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=99393423&amp;loc=d3e5967-108592<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 275<br> -URI https://asc.fasb.org/topic&amp;trid=2134479<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NatureOfOperations</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy pertaining to new accounting pronouncements that may impact the entity's financial reporting. Includes, but is not limited to, quantification of the expected or actual impact.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PriorPeriodReclassificationAdjustmentDescription">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy for reclassification affecting comparability of financial statement. Excludes amendment to accounting standards, other change in accounting principle, and correction of error.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 205<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -URI https://asc.fasb.org/extlink&amp;oid=124429488&amp;loc=d3e326-107755<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PriorPeriodReclassificationAdjustmentDescription</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PropertyPlantAndEquipmentPolicyTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy for long-lived, physical asset used in normal conduct of business and not intended for resale. Includes, but is not limited to, work of art, historical treasure, and similar asset classified as collections.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 958<br> -SubTopic 360<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (d)<br> -URI https://asc.fasb.org/extlink&amp;oid=126982197&amp;loc=d3e99779-112916<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 958<br> -SubTopic 360<br> -Section 50<br> -Paragraph 6<br> -URI https://asc.fasb.org/extlink&amp;oid=126982197&amp;loc=d3e99893-112916<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 360<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -URI https://asc.fasb.org/extlink&amp;oid=6391035&amp;loc=d3e2868-110229<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PropertyPlantAndEquipmentPolicyTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ReceivablesPolicyTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy for receivable. Includes, but is not limited to, accounts receivable and financing receivable.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 310<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI https://asc.fasb.org/extlink&amp;oid=123577603&amp;loc=d3e5033-111524<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 310<br> -SubTopic 20<br> -Section 50<br> -Paragraph 4<br> -URI https://asc.fasb.org/extlink&amp;oid=84159169&amp;loc=d3e10178-111534<br><br>Reference 3: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 310<br> -SubTopic 20<br> -Section 50<br> -Paragraph 2<br> -URI https://asc.fasb.org/extlink&amp;oid=84159169&amp;loc=d3e10149-111534<br><br>Reference 4: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 310<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -URI https://asc.fasb.org/extlink&amp;oid=84159169&amp;loc=d3e10133-111534<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ReceivablesPolicyTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RevenueRecognitionPolicyTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy for revenue. Includes revenue from contract with customer and from other sources.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (e)<br> -URI https://asc.fasb.org/extlink&amp;oid=126899994&amp;loc=d3e18823-107790<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (f)<br> -URI https://asc.fasb.org/extlink&amp;oid=126899994&amp;loc=d3e18823-107790<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RevenueRecognitionPolicyTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_UseOfEstimates">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy for the use of estimates in the preparation of financial statements in conformity with generally accepted accounting principles.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 275<br> -SubTopic 10<br> -Section 50<br> -Paragraph 12<br> -URI https://asc.fasb.org/extlink&amp;oid=99393423&amp;loc=d3e6191-108592<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 275<br> -SubTopic 10<br> -Section 50<br> -Paragraph 11<br> -URI https://asc.fasb.org/extlink&amp;oid=99393423&amp;loc=d3e6161-108592<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 275<br> -SubTopic 10<br> -Section 50<br> -Paragraph 9<br> -URI https://asc.fasb.org/extlink&amp;oid=99393423&amp;loc=d3e6143-108592<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 275<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=99393423&amp;loc=d3e5967-108592<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 275<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -URI https://asc.fasb.org/extlink&amp;oid=99393423&amp;loc=d3e6061-108592<br><br>Reference 6: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 275<br> -SubTopic 10<br> -Section 50<br> -Paragraph 8<br> -URI https://asc.fasb.org/extlink&amp;oid=99393423&amp;loc=d3e6132-108592<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 275<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=99393423&amp;loc=d3e5967-108592<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_UseOfEstimates</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>39
<FILENAME>R16.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.2</span><table class="report" border="0" cellspacing="2" id="idm139763871886384">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>The Company and a Summary of its Significant Accounting Policies (Tables)<br></strong></div></th>
<th class="th" colspan="1">6 Months Ended</th>
</tr>
<tr><th class="th"><div>Jun. 30, 2022</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AccountingPoliciesAbstract', window );"><strong>Accounting Policies [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DisaggregationOfRevenueTableTextBlock', window );">Schedule of Revenues Disaggregated by Revenue Source</a></td>
<td class="text"><div style="margin-top:9pt;padding-left:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table presents the Company&#8217;s revenues disaggregated by revenue source during the three and six months ended June&#160;30, 2022 and 2021 (in thousands):</span></div><div style="margin-top:12pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:44.354%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.081%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.406%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.081%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.406%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.081%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.406%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.085%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Three Months Ended June 30,</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Six Months Ended June 30,</span></td></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2021</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Assay Revenue</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">DermTech Melanoma Test</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4,147&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,910&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">7,665&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5,100&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Contract Revenue</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Adhesive patch kits</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">38&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">125&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">104&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">314&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">RNA extractions</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">35&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">110&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">139&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Project management fees</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">48&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">49&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">72&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">90&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total revenues</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4,233&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,119&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">7,951&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5,643&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ScheduleOfProductInformationTableTextBlock', window );">Summary of Percentages of Total Revenue or Accounts Receivable for Third Party Payers and Pharmaceutical Customers</a></td>
<td class="text"><div style="margin-top:9pt;padding-left:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table sets forth the percentages of total revenue or accounts receivable for the Company&#8217;s third-party payors that represent 10% or more of the respective amounts for the periods shown:</span></div><div style="margin-top:12pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:16.778%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.081%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.406%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.081%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.406%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.081%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.406%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.081%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.406%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.081%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.406%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.087%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="21" style="border-bottom:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Total Revenues</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Accounts Receivable </span></td></tr><tr style="height:12pt"><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Three Months Ended June 30,</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="9" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Six Months Ended June 30,</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" rowspan="2" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">As of June 30, 2022</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" rowspan="2" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">As of December 31, 2021</span></td></tr><tr style="height:12pt"><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Assay Revenue</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Payor A</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">47&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">36&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">39&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">34&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">21&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">23&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Payor B</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">*</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">*</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">*</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">*</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">15&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">15&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr></table></div><div style="margin-top:6pt;padding-left:36pt;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">*</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%;padding-left:4pt">Less than 10%</span></div><span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ScheduleOfFairValueAssetsAndLiabilitiesMeasuredOnRecurringBasisTableTextBlock', window );">Summary of Assets and Liabilities Measured at Fair Value on Recurring Basis</a></td>
<td class="text"><div style="margin-top:9pt;padding-left:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table provides a summary of the assets and liabilities that are measured at fair value on a recurring basis as of June&#160;30, 2022 (in thousands): </span></div><div style="margin-top:12pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:44.354%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.081%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.406%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.081%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.406%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.081%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.406%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.085%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="21" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">June 30, 2022</span></td></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Level 1</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Level 2</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Level 3</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Total</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Assets:</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cash equivalents</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">30,723&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">30,723&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Restricted cash</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,470&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,470&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Marketable securities, available for sale:</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Corporate debt securities</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">15,092&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">15,092&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Municipal debt securities</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,641&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,641&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">U.S. government debt securities</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">34,724&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">34,724&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total marketable securities, available for sale</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">53,457&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">53,457&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Total assets measured at fair value on a recurring basis</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">34,193&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">53,457&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">87,650&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr style="height:15pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Liabilities:</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Warrant liability</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">24&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">24&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Total liabilities measured at fair value on a recurring basis</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">24&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">24&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div style="margin-top:9pt;padding-left:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table provides a summary of the assets and liabilities that are measured at fair value on a recurring basis as of December&#160;31, 2021 (in thousands): </span></div><div style="margin-top:12pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:44.354%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.081%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.406%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.081%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.406%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.081%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.406%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.085%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="21" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">December 31, 2021</span></td></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Level 1</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Level 2</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Level 3</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Total</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Assets:</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cash equivalents</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">16,380&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">16,380&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Restricted cash</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,025&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,025&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Marketable securities, available for sale:</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Corporate debt</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">15,352&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">15,352&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Municipal debt securities</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">7,412&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">7,412&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">U.S. government debt securities</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">25,685&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">25,685&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total marketable securities, available for sale</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">48,449&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">48,449&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Total assets measured at fair value on a recurring basis</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">19,405&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">48,449&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">67,854&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr style="height:15pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Liabilities:</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Warrant liability</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">146&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">146&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Total liabilities measured at fair value on a recurring basis</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">146&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">146&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ScheduleOfShareBasedPaymentAwardEmployeeStockPurchasePlanValuationAssumptionsTableTextBlock', window );">Schedule of Warrant Liability Valuation Method</a></td>
<td class="text"><div style="margin-top:9pt;padding-left:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following assumptions were used to calculate the fair value of the Company&#8217;s warrant liability using the Black-Scholes-Merton valuation model:</span></div><div style="margin-top:12pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:32.233%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:15.112%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.406%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:15.112%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.406%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:15.112%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.406%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:15.113%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Three Months Ended June 30,</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Six Months Ended June 30,</span></td></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2021</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Assumed risk-free interest rate</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2.96%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.46%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2.37% -2.96%</span></div></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.46% - 0.64%</span></div></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Assumed volatility</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">96.21%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">88.28%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">92.77% - 96.21%</span></div></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">85.85% - 88.28%</span></div></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Expected term</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2.17 years</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3.17 years</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2.17 - 2.42 years</span></div></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3.17 - 3.42 years</span></div></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Expected dividend yield</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;</span></td></tr></table></div><div style="margin-top:9pt;padding-left:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table sets forth assumptions used to determine the fair value of each option on the date of grant issued under the 2020 Equity Incentive Plan:</span></div><div style="margin-top:12pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:32.233%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:15.112%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.406%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:15.112%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.406%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:15.112%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.406%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:15.113%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Three Months Ended June 30,</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Six Months Ended June 30,</span></td></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2021</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Assumed risk-free interest rate</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2.97%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1.03% - 1.07%</span></div></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2.97% </span></div></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.52% - 1.13%</span></div></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Assumed volatility</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">81.65%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">77.69%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">81.65%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">74.88% - 77.69%</span></div></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Expected option term</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6.08 years</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6.08 years</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6.08 years</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6.08 years</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Expected dividend yield</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;</span></td></tr></table></div><div style="margin-top:9pt;padding-left:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table sets forth assumptions used to determine the fair value of the purchase rights issued under the 2020 Employee Stock Purchase Plan (the &#8220;ESPP&#8221;):</span></div><div style="margin-top:12pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:32.233%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:15.112%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.406%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:15.112%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.406%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:15.112%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.406%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:15.113%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Three Months Ended June 30,</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Six Months Ended June 30,</span></td></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2021</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Assumed risk-free interest rate</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1)</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.10%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.05% - 0.22%</span></div></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.10% - 0.18%</span></div></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Assumed volatility</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1)</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">69.34%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">52.58% - 64.55%</span></div></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">68.44% - 69.34%</span></div></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Expected option term</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1)</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.50 years</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.49 - 0.50 years</span></div></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.49 - 0.50 years</span></div></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Expected dividend yield</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1)</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;</span></td></tr></table></div><div style="padding-left:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(1) There were no ESPP purchases under its 2020 Employee Stock Purchase Plan during the period.</span></div><span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationTextBlock', window );">Summary of Changes in Fair Value of Level 3 Liabilities</a></td>
<td class="text"><div style="margin-top:9pt;padding-left:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table summarizes the changes in the fair value of the Company&#8217;s Level 3 liabilities (in thousands):</span></div><div style="margin-top:12pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:85.718%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.082%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Balance as of December 31, 2021</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">146&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Change in fair value of warrant liability</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(17)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Balance as of March 31, 2022</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">129&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Change in fair value of warrant liability</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(105)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Balance as of June 30, 2022</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">24&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AccountingPoliciesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AccountingPoliciesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DisaggregationOfRevenueTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of disaggregation of revenue into categories depicting how nature, amount, timing, and uncertainty of revenue and cash flows are affected by economic factor.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 606<br> -SubTopic 10<br> -Section 50<br> -Paragraph 5<br> -URI https://asc.fasb.org/extlink&amp;oid=126920106&amp;loc=SL49130545-203045<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DisaggregationOfRevenueTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of the fair value measurement of liabilities using significant unobservable inputs (Level 3), a reconciliation of the beginning and ending balances, separately presenting changes attributable to the following: (1) total gains or losses for the period (realized and unrealized), segregating those gains or losses included in earnings (or changes in net assets), and gains or losses recognized in other comprehensive income (loss) and a description of where those gains or losses included in earnings (or changes in net assets) are reported in the statement of income (or activities); (2) purchases, sales, issues, and settlements (each type disclosed separately); and (3) transfers in and transfers out of Level 3 (for example, transfers due to changes in the observability of significant inputs) by class of liability.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 820<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=126976982&amp;loc=d3e19207-110258<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 820<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -URI https://asc.fasb.org/extlink&amp;oid=126976982&amp;loc=d3e19279-110258<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfFairValueAssetsAndLiabilitiesMeasuredOnRecurringBasisTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of assets and liabilities, including [financial] instruments measured at fair value that are classified in stockholders' equity, if any, that are measured at fair value on a recurring basis. The disclosures contemplated herein include the fair value measurements at the reporting date by the level within the fair value hierarchy in which the fair value measurements in their entirety fall, segregating fair value measurements using quoted prices in active markets for identical assets (Level 1), significant other observable inputs (Level 2), and significant unobservable inputs (Level 3).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 820<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=126976982&amp;loc=d3e19207-110258<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 820<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126976982&amp;loc=d3e19207-110258<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfFairValueAssetsAndLiabilitiesMeasuredOnRecurringBasisTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfProductInformationTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of product information that are included in the discussion of the nature of an entity's operations.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfProductInformationTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfShareBasedPaymentAwardEmployeeStockPurchasePlanValuationAssumptionsTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of the significant assumptions used during the year to estimate the fair value of employee stock purchase plans, including, but not limited to: (a) expected term, (b) expected volatility of the entity's shares, (c) expected dividends, (d) risk-free rate(s), and (e) discount for post-vesting restrictions.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (f)(2)<br> -URI https://asc.fasb.org/extlink&amp;oid=128089324&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfShareBasedPaymentAwardEmployeeStockPurchasePlanValuationAssumptionsTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>40
<FILENAME>R17.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.2</span><table class="report" border="0" cellspacing="2" id="idm139763872717312">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Balance Sheet Details (Tables)<br></strong></div></th>
<th class="th" colspan="1">6 Months Ended</th>
</tr>
<tr><th class="th"><div>Jun. 30, 2022</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract', window );"><strong>Organization, Consolidation and Presentation of Financial Statements [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtSecuritiesAvailableForSaleTableTextBlock', window );">Schedule of Short-Term Marketable Securities</a></td>
<td class="text"><div style="margin-top:9pt;padding-left:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The amortized cost, gross unrealized holding gains, gross unrealized holding losses, and fair value of debt securities classified as available-for-sale securities by major security type and class of security as of June&#160;30, 2022 were as follows (in thousands):</span></div><div style="margin-top:12pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:44.354%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.081%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.406%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.081%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.406%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.081%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.406%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.085%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="21" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">June 30, 2022</span></td></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Amortized Cost</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Gross Unrealized<br/>Gains</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Gross Unrealized<br/>Losses</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Estimated<br/>Market<br/>Value</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Short-term marketable securities, available-for-sale:</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Corporate debt securities</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">15,361&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(269)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">15,092&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Municipal debt securities</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,666&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(25)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,641&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">U.S. government debt securities</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">35,295&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">9&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(580)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">34,724&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 28pt;text-align:left;text-indent:-9pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total short-term marketable securities, available-for-sale</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">54,322&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">9&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(874)</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">53,457&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div style="margin-top:9pt;padding-left:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The amortized cost, gross unrealized holding gains, gross unrealized holding losses, and fair value of debt securities classified as available-for-sale securities by major security type and class of security as of December&#160;31, 2021 were as follows (in thousands):</span></div><div style="margin-top:12pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:44.354%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.081%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.406%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.081%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.406%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.081%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.406%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.085%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="21" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">December 31, 2021</span></td></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Amortized Cost</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Gross Unrealized<br/>Gains</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Gross Unrealized<br/>Losses</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Estimated<br/>Market<br/>Value</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Short-term marketable securities, available-for-sale:</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Corporate debt securities</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">15,385&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(33)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">15,352&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Municipal debt securities</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">7,417&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(5)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">7,412&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">U.S. government debt securities</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">25,771&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(87)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">25,685&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 28pt;text-align:left;text-indent:-9pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total short-term marketable securities, available-for-sale</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">48,573&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(125)</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">48,449&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dmtk_ScheduleOfPrepaidExpensesAndPropertyAndEquipmentTableTextBlock', window );">Schedule of Prepaid Expenses and PP&amp;E</a></td>
<td class="text"><div style="margin-top:9pt;padding-left:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Condensed consolidated balance sheet details are as follows (in thousands): </span></div><div style="margin-top:12pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:71.930%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.081%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.406%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.083%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">June 30,<br/>2022</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">December 31,<br/>2021</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Prepaid expenses and other current assets:</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Prepaid insurance</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">806&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,801&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Prepaid trade shows</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">241&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">440&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Prepaid software fees</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">907&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">551&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Prepaid employee compensation</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">227&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">238&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other current assets</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">500&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">136&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total prepaid expenses and other current assets</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,681&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,166&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Property and equipment, gross:</span></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Laboratory equipment</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4,856&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4,805&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Computer equipment</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">396&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">171&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Furniture and fixtures</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">555&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">124&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Leasehold improvements</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,208&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,074&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Construction-in-progress</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">139&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total property and equipment, gross</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">7,154&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6,174&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Less accumulated depreciation</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(2,238)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1,625)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total property and equipment, net</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4,916&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4,549&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ScheduleOfAccountsPayableAndAccruedLiabilitiesTableTextBlock', window );">Schedule of Accrued Compensation and Accrued Liabilities</a></td>
<td class="text"><div style="margin-top:9pt;padding-left:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Condensed consolidated balance sheet details are as follows (in thousands):</span></div><div style="margin-top:12pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:71.930%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.081%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.406%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.083%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">June 30,<br/>2022</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">December 31,<br/>2021</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Accrued compensation:</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Accrued paid time off</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,689&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,245&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Accrued wages, bonus and other</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6,129&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,875&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total accrued compensation</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">7,818&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5,120&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Accrued liabilities:</span></td><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Accrued consulting services</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,201&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">775&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other accrued expenses</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,071&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">452&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total accrued liabilities</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,272&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,227&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dmtk_ScheduleOfPrepaidExpensesAndPropertyAndEquipmentTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Schedule of prepaid expenses and PP&amp;E.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dmtk_ScheduleOfPrepaidExpensesAndPropertyAndEquipmentTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dmtk_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtSecuritiesAvailableForSaleTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of investment in debt security measured at fair value with change in fair value recognized in other comprehensive income (available-for-sale).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 320<br> -URI https://asc.fasb.org/topic&amp;trid=2196928<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtSecuritiesAvailableForSaleTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfAccountsPayableAndAccruedLiabilitiesTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of the (a) carrying value as of the balance sheet date of liabilities incurred (and for which invoices have typically been received) and payable to vendors for goods and services received that are used in an entity's business (accounts payable); (b) other payables; and (c) accrued liabilities. Examples include taxes, interest, rent and utilities. Used to reflect the current portion of the liabilities (due within one year or within the normal operating cycle if longer). An alternative caption includes accrued expenses.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfAccountsPayableAndAccruedLiabilitiesTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>41
<FILENAME>R18.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.2</span><table class="report" border="0" cellspacing="2" id="idm139763877926000">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Stockholders' Equity (Tables)<br></strong></div></th>
<th class="th" colspan="1">6 Months Ended</th>
</tr>
<tr><th class="th"><div>Jun. 30, 2022</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockholdersEquityNoteAbstract', window );"><strong>Stockholders' Equity Note [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ScheduleOfStockByClassTextBlock', window );">Summary of Common Stock Reserved for Future Issuance</a></td>
<td class="text"><div style="margin-top:9pt;padding-left:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Common stock reserved for future issuance consists of the following as of June&#160;30, 2022 and December&#160;31, 2021 (in thousands): </span></div><div style="margin-top:12pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:71.930%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.081%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.406%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.083%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">June 30,<br/>2022</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">December 31,<br/>2021</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Warrants to purchase common stock</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">31&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">SPAC Warrants to purchase common stock*</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">704&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">704&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Stock options issued and outstanding</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,758&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,721&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">RSUs issued and outstanding</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,912&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">983&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Authorized for future equity grants</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">431&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">603&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Authorized for future ESPP purchases</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">800&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">549&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total common stock reserved for future issuance</span></td><td colspan="2" style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6,615&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4,591&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div style="margin-top:9pt;padding-left:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">*Four SPAC Warrants are needed to purchase one share of common stock. The numbers presented above reflect the amount of shares of common stock underlying SPAC Warrants.</span></div><span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ScheduleOfShareBasedPaymentAwardEmployeeStockPurchasePlanValuationAssumptionsTableTextBlock', window );">Schedule of Warrant Liability Valuation Method</a></td>
<td class="text"><div style="margin-top:9pt;padding-left:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following assumptions were used to calculate the fair value of the Company&#8217;s warrant liability using the Black-Scholes-Merton valuation model:</span></div><div style="margin-top:12pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:32.233%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:15.112%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.406%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:15.112%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.406%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:15.112%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.406%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:15.113%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Three Months Ended June 30,</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Six Months Ended June 30,</span></td></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2021</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Assumed risk-free interest rate</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2.96%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.46%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2.37% -2.96%</span></div></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.46% - 0.64%</span></div></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Assumed volatility</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">96.21%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">88.28%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">92.77% - 96.21%</span></div></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">85.85% - 88.28%</span></div></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Expected term</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2.17 years</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3.17 years</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2.17 - 2.42 years</span></div></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3.17 - 3.42 years</span></div></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Expected dividend yield</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;</span></td></tr></table></div><div style="margin-top:9pt;padding-left:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table sets forth assumptions used to determine the fair value of each option on the date of grant issued under the 2020 Equity Incentive Plan:</span></div><div style="margin-top:12pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:32.233%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:15.112%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.406%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:15.112%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.406%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:15.112%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.406%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:15.113%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Three Months Ended June 30,</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Six Months Ended June 30,</span></td></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2021</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Assumed risk-free interest rate</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2.97%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1.03% - 1.07%</span></div></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2.97% </span></div></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.52% - 1.13%</span></div></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Assumed volatility</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">81.65%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">77.69%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">81.65%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">74.88% - 77.69%</span></div></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Expected option term</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6.08 years</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6.08 years</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6.08 years</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6.08 years</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Expected dividend yield</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;</span></td></tr></table></div><div style="margin-top:9pt;padding-left:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table sets forth assumptions used to determine the fair value of the purchase rights issued under the 2020 Employee Stock Purchase Plan (the &#8220;ESPP&#8221;):</span></div><div style="margin-top:12pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:32.233%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:15.112%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.406%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:15.112%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.406%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:15.112%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.406%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:15.113%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Three Months Ended June 30,</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Six Months Ended June 30,</span></td></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2021</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Assumed risk-free interest rate</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1)</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.10%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.05% - 0.22%</span></div></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.10% - 0.18%</span></div></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Assumed volatility</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1)</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">69.34%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">52.58% - 64.55%</span></div></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">68.44% - 69.34%</span></div></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Expected option term</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1)</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.50 years</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.49 - 0.50 years</span></div></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.49 - 0.50 years</span></div></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Expected dividend yield</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1)</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;</span></td></tr></table></div><div style="padding-left:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(1) There were no ESPP purchases under its 2020 Employee Stock Purchase Plan during the period.</span></div><span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DisclosureOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTextBlock', window );">Disclosure of Share-Based Compensation Arrangements by Share-Based Payment Award</a></td>
<td class="text"><div style="margin-top:9pt;padding-left:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Stock-based compensation expense for employee options, RSUs, the purchase rights issued under the ESPP, and consultant options was recorded in the condensed consolidated statements of operations as follows (in thousands):</span></div><div style="margin-top:6pt;padding-left:27pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:95.000%"><tr><td style="width:1.0%"/><td style="width:41.483%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.775%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.437%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.775%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.437%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.775%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.437%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.781%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Three Months Ended June 30,</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Six Months Ended June 30,</span></td></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2021</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cost of revenue</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">298&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">259&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">633&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">410&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Sales and marketing</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,067&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">935&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,528&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,482&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Research and development</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,330&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">515&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,825&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">829&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">General and administrative</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,142&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,829&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,745&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,989&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total stock-based compensation</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4,837&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,538&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">8,731&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5,710&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DisclosureOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of share-based payment arrangement.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -URI https://asc.fasb.org/extlink&amp;oid=128089324&amp;loc=d3e5047-113901<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI https://asc.fasb.org/extlink&amp;oid=128089324&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DisclosureOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfShareBasedPaymentAwardEmployeeStockPurchasePlanValuationAssumptionsTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of the significant assumptions used during the year to estimate the fair value of employee stock purchase plans, including, but not limited to: (a) expected term, (b) expected volatility of the entity's shares, (c) expected dividends, (d) risk-free rate(s), and (e) discount for post-vesting restrictions.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (f)(2)<br> -URI https://asc.fasb.org/extlink&amp;oid=128089324&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfShareBasedPaymentAwardEmployeeStockPurchasePlanValuationAssumptionsTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfStockByClassTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of an entity's stock, including par or stated value per share, number and dollar amount of share subscriptions, shares authorized, shares issued, shares outstanding, number and dollar amount of shares held in an employee trust, dividend per share, total dividends, share conversion features, par value plus additional paid in capital, the value of treasury stock and other information necessary to a fair presentation, and EPS information. Stock by class includes common, convertible, and preferred stocks which are not redeemable or redeemable solely at the option of the issuer. Includes preferred stock with redemption features that are solely within the control of the issuer and mandatorily redeemable stock if redemption is required to occur only upon liquidation or termination of the reporting entity. If more than one issue is outstanding, state the title of each issue and the corresponding dollar amount; dollar amount of any shares subscribed but unissued and the deduction of subscriptions receivable there from; number of shares authorized, issued, and outstanding.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 45<br> -Paragraph 2<br> -URI https://asc.fasb.org/extlink&amp;oid=65888546&amp;loc=d3e21300-112643<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(28))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 10<br> -URI https://asc.fasb.org/extlink&amp;oid=126973232&amp;loc=d3e21553-112644<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 480<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -URI https://asc.fasb.org/extlink&amp;oid=122040564&amp;loc=d3e177068-122764<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 8<br> -URI https://asc.fasb.org/extlink&amp;oid=126973232&amp;loc=d3e21538-112644<br><br>Reference 6: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 7<br> -URI https://asc.fasb.org/extlink&amp;oid=126973232&amp;loc=d3e21521-112644<br><br>Reference 7: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 8: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 5<br> -URI https://asc.fasb.org/extlink&amp;oid=126973232&amp;loc=d3e21488-112644<br><br>Reference 9: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.3-04)<br> -URI https://asc.fasb.org/extlink&amp;oid=120397183&amp;loc=d3e187085-122770<br><br>Reference 10: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 6<br> -URI https://asc.fasb.org/extlink&amp;oid=126973232&amp;loc=d3e21506-112644<br><br>Reference 11: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(27))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 12: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -URI https://asc.fasb.org/extlink&amp;oid=126973232&amp;loc=d3e21484-112644<br><br>Reference 13: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -URI https://asc.fasb.org/extlink&amp;oid=126973232&amp;loc=d3e21475-112644<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfStockByClassTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockholdersEquityNoteAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockholdersEquityNoteAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>42
<FILENAME>R19.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.2</span><table class="report" border="0" cellspacing="2" id="idm139763872638640">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Leases, Commitments and Contingencies (Tables)<br></strong></div></th>
<th class="th" colspan="1">6 Months Ended</th>
</tr>
<tr><th class="th"><div>Jun. 30, 2022</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CommitmentsAndContingenciesDisclosureAbstract', window );"><strong>Commitments and Contingencies Disclosure [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ScheduleOfNewAccountingPronouncementsAndChangesInAccountingPrinciplesTextBlock', window );">Schedule of Adoption of ASC 842</a></td>
<td class="text">The changes are set forth in the table below (in thousands):<table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:62.081%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.021%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.406%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.263%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.406%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.023%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.5pt;font-weight:700;line-height:100%">Six Months Ended June 30, 2021</span></td></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.5pt;font-weight:700;line-height:100%">Before Adoption of ASC 842</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.5pt;font-weight:700;line-height:100%">Effect of Adoption</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.5pt;font-weight:700;line-height:100%">After Adoption of ASC 842</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:700;line-height:100%">Effect on Condensed Consolidated Statements of Cash Flows</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Cash flows from operating activities:</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Adjustments to reconcile net loss to net cash used in operating activities:</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 17.5pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Amortization of operating lease right-of-use assets</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">582&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">582&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Change in operating assets and liabilities:</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 11.5pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Operating lease liabilities, net</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(328)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(328)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 11.5pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Other liabilities</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">254&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(254)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table><span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dmtk_ScheduleOfLongTermFinanceLeaseObligationsTableTextBlock', window );">Schedule of Long Term Finance Lease Obligations</a></td>
<td class="text">Long-term finance lease obligations are as follows (in thousands): <table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.696%"><tr><td style="width:1.0%"/><td style="width:69.264%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:13.337%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.407%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:13.492%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">June 30, 2022</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">December 31, 2021</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Gross finance lease obligations</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">262&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">274&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Less imputed interest</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(17)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(17)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Present value of net minimum lease payments</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">245&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">257&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Less current portion of finance lease obligations</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(134)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(121)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total long-term finance lease obligations</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">111&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">136&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table><span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LeaseCostTableTextBlock', window );">Components of Lease Expense</a></td>
<td class="text"><div style="margin-top:9pt;padding-left:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The components of lease expense for the three and six months ended June&#160;30, 2022 was as follows (in thousands):</span></div><div style="margin-top:12pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:43.803%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.750%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.390%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.750%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.390%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.750%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.390%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:13.677%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Three Months Ended June 30,</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Six Months Ended June 30,</span></td></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2021</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Operating lease cost</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 10pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Operating lease cost</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">1,044&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">319&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">1,667&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">638&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Variable lease costs </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.85pt;font-weight:400;line-height:100%;position:relative;top:-3.15pt;vertical-align:baseline">(1)</span></div></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">303&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">143&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">492&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">315&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Total operating lease cost</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">1,347&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">462&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">2,159&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">953&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr style="height:15pt"><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Finance lease cost</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 10pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Amortization of leased assets</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">21&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">17&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">41&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">34&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 10pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Interest on lease liabilities</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">3&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">4&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">7&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">8&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Total finance lease cost</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">24&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">21&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">48&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">42&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(1) Variable lease costs are primarily related to common area maintenance charges and property taxes.</span></div><div style="margin-top:9pt;padding-left:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Other information related to leases was as shown in the table below. </span></div><div style="margin-top:12pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:68.900%"/><td style="width:0.1%"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td style="width:0.1%"/><td style="width:0.406%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:13.293%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.406%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:13.295%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Six Months Ended June 30,</span></td></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2021</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Cash paid for amounts included in the measurement of lease liabilities:</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 10pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Operating cash flows from operating leases</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">1,179&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">684&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 10pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Operating cash flows from finance leases</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">7&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">8&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 10pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Financing cash flows from finance leases</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">60&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">53&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Right-of-use assets obtained in exchange for lease obligations:</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 10pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Operating leases</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">17,059&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">2,831&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 10pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Finance leases</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">48&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Weighted average remaining lease term in years:</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 10pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Operating leases</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">10.56</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">1.92</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 10pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Finance leases</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">1.50</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">2.50</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Weighted average discount rate:</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 10pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Operating leases</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">6.39&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">4.04&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 10pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Finance leases</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">5.78&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">5.54&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">%</span></td></tr></table></div><span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dmtk_ScheduleOfFutureMinimumRentalPaymentsForOperatingAndCapitalLeasesTableTextBlock', window );">Schedule of Future Minimum Lease Payments Under Operating and Financing Leases</a></td>
<td class="text"><div style="margin-top:9pt;padding-left:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company&#8217;s future minimum lease payments under operating and financing leases at June&#160;30, 2022 are as follows (in thousands): </span></div><div style="margin-top:12pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:24.203%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:9.051%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.406%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:9.051%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.406%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:9.051%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.406%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:9.051%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.406%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:9.051%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.406%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:9.051%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.406%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:9.055%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2023</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2024</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2025</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2026</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Thereafter</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Total</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Operating lease obligations, including interest</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,524&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,948&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,774&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,853&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,934&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">20,612&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">33,645&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 10pt;text-align:left;text-indent:-9pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Finance lease obligations, including interest</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">72&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">133&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">19&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">19&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">15&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">262&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 16pt;text-align:left;text-indent:-9pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total future minimum lease payments</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,596&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,081&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,793&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,872&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,949&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">20,616&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">33,907&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dmtk_ScheduleOfFutureMinimumRentalPaymentsForOperatingAndCapitalLeasesTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Schedule of future minimum rental payments for operating and capital leases.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dmtk_ScheduleOfFutureMinimumRentalPaymentsForOperatingAndCapitalLeasesTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dmtk_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dmtk_ScheduleOfLongTermFinanceLeaseObligationsTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Schedule of long term finance lease obligations.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dmtk_ScheduleOfLongTermFinanceLeaseObligationsTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dmtk_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CommitmentsAndContingenciesDisclosureAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CommitmentsAndContingenciesDisclosureAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LeaseCostTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of lessee's lease cost. Includes, but is not limited to, interest expense for finance lease, amortization of right-of-use asset for finance lease, operating lease cost, short-term lease cost, variable lease cost and sublease income.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 50<br> -Paragraph 4<br> -URI https://asc.fasb.org/extlink&amp;oid=128292326&amp;loc=SL77918686-209980<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LeaseCostTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfNewAccountingPronouncementsAndChangesInAccountingPrinciplesTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of changes in accounting principles, including adoption of new accounting pronouncements, that describes the new methods, amount and effects on financial statement line items.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22499-107794<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 270<br> -SubTopic 10<br> -Section 45<br> -Paragraph 13<br> -URI https://asc.fasb.org/extlink&amp;oid=126900757&amp;loc=d3e765-108305<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 270<br> -SubTopic 10<br> -Section 45<br> -Paragraph 12<br> -URI https://asc.fasb.org/extlink&amp;oid=126900757&amp;loc=d3e725-108305<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22583-107794<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfNewAccountingPronouncementsAndChangesInAccountingPrinciplesTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>43
<FILENAME>R20.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.2</span><table class="report" border="0" cellspacing="2" id="idm139763865661504">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>The Company and a Summary of its Significant Accounting Policies - Additional Information (Details)<br></strong></div></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="2">3 Months Ended</th>
<th class="th" colspan="2">6 Months Ended</th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Aug. 29, 2019</div></th>
<th class="th">
<div>Jun. 30, 2022 </div>
<div>USD ($) </div>
<div>shares</div>
</th>
<th class="th">
<div>Jun. 30, 2021 </div>
<div>USD ($) </div>
<div>shares</div>
</th>
<th class="th">
<div>Jun. 30, 2022 </div>
<div>USD ($) </div>
<div>revenueStream </div>
<div>shares</div>
</th>
<th class="th">
<div>Jun. 30, 2021 </div>
<div>USD ($) </div>
<div>shares</div>
</th>
<th class="th">
<div>Dec. 31, 2021 </div>
<div>USD ($)</div>
</th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dmtk_TheCompanyAndSummaryOfItsSignificantAccountingPoliciesLineItems', window );"><strong>The Company and Summary of its Significant Accounting Policies [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockholdersEquityNoteStockSplitConversionRatio1', window );">Conversion ratio of reverse stock split</a></td>
<td class="nump">0.5<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_Depreciation', window );">Depreciation expense</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 400,000<span></span>
</td>
<td class="nump">$ 200,000<span></span>
</td>
<td class="nump">$ 766,000<span></span>
</td>
<td class="nump">$ 401,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentGross', window );">Gross assets</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">7,154,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">7,154,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 6,174,000<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DepreciationAndAmortization', window );">Accumulated amortization</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">100,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">100,000<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentDisposals', window );">Disposal of plant or equipment</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">300,000<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">300,000<span></span>
</td>
<td class="nump">13,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ImpairmentOfLongLivedAssetsToBeDisposedOf', window );">Impairment losses</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DepositsMoneyMarketDeposits', window );">Sweep account</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">87,100,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">87,100,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CashFDICInsuredAmount', window );">Insured amount by FDIC</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">250,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">250,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CashUninsuredAmount', window );">Cash held in excess of FDIC limit</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">2,500,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 2,500,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dmtk_NumberOfRevenueStreams', window );">Number of revenue streams (in number of streams) | revenueStream</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">2<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dmtk_RevenuePerformanceObligationSatisfiedVariableConsiderationUpdateIncreaseDecreaseInRevenue', window );">Increase (decrease) in revenue</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">100,000<span></span>
</td>
<td class="nump">$ 100,000<span></span>
</td>
<td class="nump">$ 8,000<span></span>
</td>
<td class="nump">$ 100,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DeferredRevenueCurrent', window );">Short-term deferred revenue</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1,310,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1,310,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1,380,000<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RevenueRemainingPerformanceObligation', window );">Remaining performance obligation, estimated revenue expected to be recognized</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">100,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">100,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_UnbilledReceivablesCurrent', window );">Unbilled receivables</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">300,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">300,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AccountsReceivableNetCurrent', window );">Accounts receivable</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">5,962,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">5,962,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">3,847,000<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueByFairValueHierarchyLevelAxis=us-gaap_FairValueInputsLevel1Member', window );">Level 1 | Restricted Cash</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dmtk_TheCompanyAndSummaryOfItsSignificantAccountingPoliciesLineItems', window );"><strong>The Company and Summary of its Significant Accounting Policies [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LettersOfCreditOutstandingAmount', window );">Letters of credit</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 3,500,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 3,500,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">3,000,000<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis=us-gaap_WarrantMember', window );">Common Stock Warrants</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dmtk_TheCompanyAndSummaryOfItsSignificantAccountingPoliciesLineItems', window );"><strong>The Company and Summary of its Significant Accounting Policies [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount', window );">Anti-dilutive equity instruments excluded from diluted net loss per share of common stock | shares</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">714,261<span></span>
</td>
<td class="nump">749,210<span></span>
</td>
<td class="nump">714,261<span></span>
</td>
<td class="nump">749,210<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis=dmtk_StockOptionsAndRestrictedStockUnitsMember', window );">Stock Options and RSUs</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dmtk_TheCompanyAndSummaryOfItsSignificantAccountingPoliciesLineItems', window );"><strong>The Company and Summary of its Significant Accounting Policies [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount', window );">Anti-dilutive equity instruments excluded from diluted net loss per share of common stock | shares</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">4,670,069<span></span>
</td>
<td class="nump">2,469,816<span></span>
</td>
<td class="nump">4,670,069<span></span>
</td>
<td class="nump">2,469,816<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_ProductOrServiceAxis=dmtk_AssayMember', window );">Assay revenue</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dmtk_TheCompanyAndSummaryOfItsSignificantAccountingPoliciesLineItems', window );"><strong>The Company and Summary of its Significant Accounting Policies [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AccountsReceivableGrossCurrent', window );">Accounts receivable gross</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 5,800,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 5,800,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">3,600,000<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_ProductOrServiceAxis=dmtk_ContractualActivitiesMember', window );">Contract revenue</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dmtk_TheCompanyAndSummaryOfItsSignificantAccountingPoliciesLineItems', window );"><strong>The Company and Summary of its Significant Accounting Policies [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AccountsReceivableNetCurrent', window );">Accounts receivable</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 200,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 200,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">200,000<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_RangeAxis=srt_MinimumMember', window );">Minimum</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dmtk_TheCompanyAndSummaryOfItsSignificantAccountingPoliciesLineItems', window );"><strong>The Company and Summary of its Significant Accounting Policies [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentUsefulLife', window );">Useful life of the assets</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">2 years<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionPeriod1', window );">Revenue, remaining performance obligation, expected timing of satisfaction, period</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">2 years<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">2 years<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_RangeAxis=srt_MaximumMember', window );">Maximum</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dmtk_TheCompanyAndSummaryOfItsSignificantAccountingPoliciesLineItems', window );"><strong>The Company and Summary of its Significant Accounting Policies [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentUsefulLife', window );">Useful life of the assets</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">11 years<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionPeriod1', window );">Revenue, remaining performance obligation, expected timing of satisfaction, period</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">3 years<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">3 years<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentByTypeAxis=dmtk_AmortizationOfLaboratoryEquipmentAcquiredUnderFinanceLeasesMember', window );">Amortization of Laboratory Equipment Acquired under Finance Leases</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dmtk_TheCompanyAndSummaryOfItsSignificantAccountingPoliciesLineItems', window );"><strong>The Company and Summary of its Significant Accounting Policies [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_Depreciation', window );">Depreciation expense</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 21,000<span></span>
</td>
<td class="nump">$ 17,000<span></span>
</td>
<td class="nump">$ 41,000<span></span>
</td>
<td class="nump">$ 34,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentByTypeAxis=dmtk_AssetsHeldUnderFinanceLeasesMember', window );">Assets Recorded under Finance Leases</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dmtk_TheCompanyAndSummaryOfItsSignificantAccountingPoliciesLineItems', window );"><strong>The Company and Summary of its Significant Accounting Policies [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentGross', window );">Gross assets</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 400,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">400,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">400,000<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DepreciationAndAmortization', window );">Accumulated amortization</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 100,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 100,000<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dmtk_NumberOfRevenueStreams">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Number of revenue streams.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dmtk_NumberOfRevenueStreams</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dmtk_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:integerItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dmtk_RevenuePerformanceObligationSatisfiedVariableConsiderationUpdateIncreaseDecreaseInRevenue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Revenue, Performance Obligation Satisfied, Variable Consideration Update, Increase (Decrease) In Revenue</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dmtk_RevenuePerformanceObligationSatisfiedVariableConsiderationUpdateIncreaseDecreaseInRevenue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dmtk_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dmtk_TheCompanyAndSummaryOfItsSignificantAccountingPoliciesLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The company and summary of its significant accounting policies.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dmtk_TheCompanyAndSummaryOfItsSignificantAccountingPoliciesLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dmtk_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AccountsReceivableGrossCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount, before allowance for credit loss, of right to consideration from customer for product sold and service rendered in normal course of business, classified as current.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 310<br> -SubTopic 10<br> -Section 45<br> -Paragraph 2<br> -URI https://asc.fasb.org/extlink&amp;oid=124259787&amp;loc=d3e4428-111522<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=124098289&amp;loc=d3e6676-107765<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 310<br> -SubTopic 10<br> -Section 45<br> -Paragraph 9<br> -URI https://asc.fasb.org/extlink&amp;oid=124259787&amp;loc=d3e4531-111522<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(3)(a)(1))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AccountsReceivableGrossCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AccountsReceivableNetCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount, after allowance for credit loss, of right to consideration from customer for product sold and service rendered in normal course of business, classified as current.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 310<br> -SubTopic 10<br> -Section 45<br> -Paragraph 2<br> -URI https://asc.fasb.org/extlink&amp;oid=124259787&amp;loc=d3e4428-111522<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 310<br> -SubTopic 10<br> -Section 45<br> -Paragraph 9<br> -URI https://asc.fasb.org/extlink&amp;oid=124259787&amp;loc=d3e4531-111522<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AccountsReceivableNetCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Securities (including those issuable pursuant to contingent stock agreements) that could potentially dilute basic earnings per share (EPS) or earnings per unit (EPU) in the future that were not included in the computation of diluted EPS or EPU because to do so would increase EPS or EPU amounts or decrease loss per share or unit amounts for the period presented.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=124432515&amp;loc=d3e3550-109257<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CashFDICInsuredAmount">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The amount of cash deposited in financial institutions as of the balance sheet date that is insured by the Federal Deposit Insurance Corporation.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CashFDICInsuredAmount</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CashUninsuredAmount">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The amount of cash as of the balance sheet date that is not insured by the Federal Deposit Insurance Corporation.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CashUninsuredAmount</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DeferredRevenueCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of deferred income and obligation to transfer product and service to customer for which consideration has been received or is receivable, classified as current.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(20))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DeferredRevenueCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DepositsMoneyMarketDeposits">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of deposits in accounts that offer many of the same services as checking accounts although transactions may be somewhat more limited, share some of the characteristics of a money market fund and are insured by the Federal government, also known as money market accounts.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-03.12)<br> -URI https://asc.fasb.org/extlink&amp;oid=126897435&amp;loc=d3e534808-122878<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DepositsMoneyMarketDeposits</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_Depreciation">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The amount of expense recognized in the current period that reflects the allocation of the cost of tangible assets over the assets' useful lives. Includes production and non-production related depreciation.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 360<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=6391035&amp;loc=d3e2868-110229<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3602-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_Depreciation</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DepreciationAndAmortization">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The current period expense charged against earnings on long-lived, physical assets not used in production, and which are not intended for resale, to allocate or recognize the cost of such assets over their useful lives; or to record the reduction in book value of an intangible asset over the benefit period of such asset; or to reflect consumption during the period of an asset that is not used in production.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 360<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=6391035&amp;loc=d3e2868-110229<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3602-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DepreciationAndAmortization</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ImpairmentOfLongLivedAssetsToBeDisposedOf">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The aggregate amount of write-downs for impairments recognized during the period for long-lived assets held for abandonment, exchange or sale.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3602-108585<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 360<br> -SubTopic 10<br> -Section 45<br> -Paragraph 15<br> -URI https://asc.fasb.org/extlink&amp;oid=126905981&amp;loc=d3e2611-110228<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ImpairmentOfLongLivedAssetsToBeDisposedOf</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LettersOfCreditOutstandingAmount">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The total amount of the contingent obligation under letters of credit outstanding as of the reporting date.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LettersOfCreditOutstandingAmount</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PropertyPlantAndEquipmentDisposals">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of divestiture of long-lived, physical assets used in the normal conduct of business and not intended for resale. Examples include, but are not limited to, land, buildings, machinery and equipment, office equipment, furniture and fixtures, and computer equipment.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PropertyPlantAndEquipmentDisposals</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PropertyPlantAndEquipmentGross">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount before accumulated depreciation, depletion and amortization of physical assets used in the normal conduct of business and not intended for resale. Examples include, but are not limited to, land, buildings, machinery and equipment, office equipment, and furniture and fixtures.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(13))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 360<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=6391035&amp;loc=d3e2868-110229<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PropertyPlantAndEquipmentGross</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PropertyPlantAndEquipmentUsefulLife">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Useful life of long lived, physical assets used in the normal conduct of business and not intended for resale, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents the reported fact of one year, five months, and thirteen days. Examples include, but not limited to, land, buildings, machinery and equipment, office equipment, furniture and fixtures, and computer equipment.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PropertyPlantAndEquipmentUsefulLife</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:durationItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RevenueRemainingPerformanceObligation">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of transaction price allocated to performance obligation that has not been recognized as revenue.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 606<br> -SubTopic 10<br> -Section 50<br> -Paragraph 13<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126920106&amp;loc=SL49130556-203045<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RevenueRemainingPerformanceObligation</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionPeriod1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Period in which remaining performance obligation is expected to be recognized as revenue, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents reported fact of one year, five months, and thirteen days.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 606<br> -SubTopic 10<br> -Section 50<br> -Paragraph 13<br> -Subparagraph (b)(1)<br> -URI https://asc.fasb.org/extlink&amp;oid=126920106&amp;loc=SL49130556-203045<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionPeriod1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:durationItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockholdersEquityNoteStockSplitConversionRatio1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Ratio applied to the conversion of stock split, for example but not limited to, one share converted to two or two shares converted to one.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section S99<br> -Paragraph 4<br> -Subparagraph (SAB TOPIC 4.C)<br> -URI https://asc.fasb.org/extlink&amp;oid=120397183&amp;loc=d3e187143-122770<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockholdersEquityNoteStockSplitConversionRatio1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:pureItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_UnbilledReceivablesCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount received for services rendered and products shipped, but not yet billed, for non-contractual agreements due within one year or the normal operating cycle, if longer.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_UnbilledReceivablesCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FairValueByFairValueHierarchyLevelAxis=us-gaap_FairValueInputsLevel1Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FairValueByFairValueHierarchyLevelAxis=us-gaap_FairValueInputsLevel1Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BalanceSheetLocationAxis=dmtk_RestrictedCashMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BalanceSheetLocationAxis=dmtk_RestrictedCashMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis=us-gaap_WarrantMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis=us-gaap_WarrantMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis=dmtk_StockOptionsAndRestrictedStockUnitsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis=dmtk_StockOptionsAndRestrictedStockUnitsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_ProductOrServiceAxis=dmtk_AssayMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_ProductOrServiceAxis=dmtk_AssayMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_ProductOrServiceAxis=dmtk_ContractualActivitiesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_ProductOrServiceAxis=dmtk_ContractualActivitiesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_RangeAxis=srt_MinimumMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_RangeAxis=srt_MinimumMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_RangeAxis=srt_MaximumMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_RangeAxis=srt_MaximumMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PropertyPlantAndEquipmentByTypeAxis=dmtk_AmortizationOfLaboratoryEquipmentAcquiredUnderFinanceLeasesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PropertyPlantAndEquipmentByTypeAxis=dmtk_AmortizationOfLaboratoryEquipmentAcquiredUnderFinanceLeasesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PropertyPlantAndEquipmentByTypeAxis=dmtk_AssetsHeldUnderFinanceLeasesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PropertyPlantAndEquipmentByTypeAxis=dmtk_AssetsHeldUnderFinanceLeasesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>44
<FILENAME>R21.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.2</span><table class="report" border="0" cellspacing="2" id="idm139763867209488">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>The Company and a Summary of its Significant Accounting Policies - Schedule of Revenues Disaggregated by Revenue Source (Details) - USD ($)<br> $ in Thousands</strong></div></th>
<th class="th" colspan="2">3 Months Ended</th>
<th class="th" colspan="2">6 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Jun. 30, 2022</div></th>
<th class="th"><div>Jun. 30, 2021</div></th>
<th class="th"><div>Jun. 30, 2022</div></th>
<th class="th"><div>Jun. 30, 2021</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DisaggregationOfRevenueLineItems', window );"><strong>Disaggregation Of Revenue [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax', window );">Total revenues</a></td>
<td class="nump">$ 4,233<span></span>
</td>
<td class="nump">$ 3,119<span></span>
</td>
<td class="nump">$ 7,951<span></span>
</td>
<td class="nump">$ 5,643<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_ProductOrServiceAxis=dmtk_AssayMember', window );">DermTech Melanoma Test</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DisaggregationOfRevenueLineItems', window );"><strong>Disaggregation Of Revenue [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax', window );">Total revenues</a></td>
<td class="nump">4,147<span></span>
</td>
<td class="nump">2,910<span></span>
</td>
<td class="nump">7,665<span></span>
</td>
<td class="nump">5,100<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_ProductOrServiceAxis=dmtk_ContractRevenueAdhesivePatchKitsMember', window );">Adhesive patch kits</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DisaggregationOfRevenueLineItems', window );"><strong>Disaggregation Of Revenue [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax', window );">Total revenues</a></td>
<td class="nump">38<span></span>
</td>
<td class="nump">125<span></span>
</td>
<td class="nump">104<span></span>
</td>
<td class="nump">314<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_ProductOrServiceAxis=dmtk_ContractRevenueRNAExtractionsMember', window );">RNA extractions</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DisaggregationOfRevenueLineItems', window );"><strong>Disaggregation Of Revenue [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax', window );">Total revenues</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">35<span></span>
</td>
<td class="nump">110<span></span>
</td>
<td class="nump">139<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_ProductOrServiceAxis=dmtk_ContractRevenueProjectManagementFeesMember', window );">Project management fees</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DisaggregationOfRevenueLineItems', window );"><strong>Disaggregation Of Revenue [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax', window );">Total revenues</a></td>
<td class="nump">$ 48<span></span>
</td>
<td class="nump">$ 49<span></span>
</td>
<td class="nump">$ 72<span></span>
</td>
<td class="nump">$ 90<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DisaggregationOfRevenueLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DisaggregationOfRevenueLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount, excluding tax collected from customer, of revenue from satisfaction of performance obligation by transferring promised good or service to customer. Tax collected from customer is tax assessed by governmental authority that is both imposed on and concurrent with specific revenue-producing transaction, including, but not limited to, sales, use, value added and excise.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8906-108599<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 40<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e9031-108599<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 41<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e9038-108599<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8933-108599<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8933-108599<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 606<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126920106&amp;loc=SL49130543-203045<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8736-108599<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8736-108599<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 42<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e9054-108599<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 606<br> -SubTopic 10<br> -Section 50<br> -Paragraph 5<br> -URI https://asc.fasb.org/extlink&amp;oid=126920106&amp;loc=SL49130545-203045<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 924<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB Topic 11.L)<br> -URI https://asc.fasb.org/extlink&amp;oid=6472922&amp;loc=d3e499488-122856<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_ProductOrServiceAxis=dmtk_AssayMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_ProductOrServiceAxis=dmtk_AssayMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_ProductOrServiceAxis=dmtk_ContractRevenueAdhesivePatchKitsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_ProductOrServiceAxis=dmtk_ContractRevenueAdhesivePatchKitsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_ProductOrServiceAxis=dmtk_ContractRevenueRNAExtractionsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_ProductOrServiceAxis=dmtk_ContractRevenueRNAExtractionsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_ProductOrServiceAxis=dmtk_ContractRevenueProjectManagementFeesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_ProductOrServiceAxis=dmtk_ContractRevenueProjectManagementFeesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>45
<FILENAME>R22.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.2</span><table class="report" border="0" cellspacing="2" id="idm139763872617728">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>The Company and a Summary of its Significant Accounting Policies - Summary of Percentages of Total Revenue or Accounts Receivable for Third Party Payers and Pharmaceutical Customers (Details) - Customer Concentration Risk<br></strong></div></th>
<th class="th" colspan="2">3 Months Ended</th>
<th class="th" colspan="2">6 Months Ended</th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Jun. 30, 2022</div></th>
<th class="th"><div>Jun. 30, 2021</div></th>
<th class="th"><div>Jun. 30, 2022</div></th>
<th class="th"><div>Jun. 30, 2021</div></th>
<th class="th"><div>Dec. 31, 2021</div></th>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ConcentrationRiskByBenchmarkAxis=us-gaap_SalesRevenueNetMember', window );">Total Revenues | Payor A</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ProductInformationLineItems', window );"><strong>Product Information [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ConcentrationRiskPercentage1', window );">Concentration risk, percentage</a></td>
<td class="nump">47.00%<span></span>
</td>
<td class="nump">36.00%<span></span>
</td>
<td class="nump">39.00%<span></span>
</td>
<td class="nump">34.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ConcentrationRiskByBenchmarkAxis=us-gaap_AccountsReceivableMember', window );">Accounts Receivable | Payor A</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ProductInformationLineItems', window );"><strong>Product Information [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ConcentrationRiskPercentage1', window );">Concentration risk, percentage</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">21.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">23.00%<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ConcentrationRiskByBenchmarkAxis=us-gaap_AccountsReceivableMember', window );">Accounts Receivable | Payor B</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ProductInformationLineItems', window );"><strong>Product Information [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ConcentrationRiskPercentage1', window );">Concentration risk, percentage</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">15.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">15.00%<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ConcentrationRiskPercentage1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>For an entity that discloses a concentration risk in relation to quantitative amount, which serves as the "benchmark" (or denominator) in the equation, this concept represents the concentration percentage derived from the division.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 42<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e9054-108599<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 275<br> -SubTopic 10<br> -Section 50<br> -Paragraph 18<br> -URI https://asc.fasb.org/extlink&amp;oid=99393423&amp;loc=d3e6351-108592<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 20<br> -URI https://asc.fasb.org/extlink&amp;oid=123594938&amp;loc=d3e13531-108611<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 21<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=123594938&amp;loc=d3e13537-108611<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 275<br> -SubTopic 10<br> -Section 50<br> -Paragraph 20<br> -URI https://asc.fasb.org/extlink&amp;oid=99393423&amp;loc=d3e6404-108592<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ConcentrationRiskPercentage1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ProductInformationLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ProductInformationLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ConcentrationRiskByBenchmarkAxis=us-gaap_SalesRevenueNetMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ConcentrationRiskByBenchmarkAxis=us-gaap_SalesRevenueNetMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_ProductOrServiceAxis=dmtk_AssayRevenuePayorAMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_ProductOrServiceAxis=dmtk_AssayRevenuePayorAMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ConcentrationRiskByTypeAxis=us-gaap_CustomerConcentrationRiskMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ConcentrationRiskByTypeAxis=us-gaap_CustomerConcentrationRiskMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ConcentrationRiskByBenchmarkAxis=us-gaap_AccountsReceivableMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ConcentrationRiskByBenchmarkAxis=us-gaap_AccountsReceivableMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_ProductOrServiceAxis=dmtk_AssayRevenuePayorBMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_ProductOrServiceAxis=dmtk_AssayRevenuePayorBMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>46
<FILENAME>R23.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.2</span><table class="report" border="0" cellspacing="2" id="idm139763871012080">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>The Company and a Summary of its Significant Accounting Policies - Summary of Assets and Liabilities Measured at Fair Value on Recurring Basis (Details) - USD ($)<br> $ in Thousands</strong></div></th>
<th class="th"><div>Jun. 30, 2022</div></th>
<th class="th"><div>Dec. 31, 2021</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AssetsFairValueDisclosureAbstract', window );"><strong>Assets:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RestrictedCashNoncurrent', window );">Restricted cash</a></td>
<td class="nump">$ 3,470<span></span>
</td>
<td class="nump">$ 3,025<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_InvestmentsFairValueDisclosureAbstract', window );"><strong>Marketable securities, available for sale:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AvailableForSaleSecuritiesDebtSecurities', window );">Total marketable securities, available for sale</a></td>
<td class="nump">53,457<span></span>
</td>
<td class="nump">48,449<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueByMeasurementFrequencyAxis=us-gaap_FairValueMeasurementsRecurringMember', window );">Fair Value, Recurring</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AssetsFairValueDisclosureAbstract', window );"><strong>Assets:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CashEquivalentsAtCarryingValue', window );">Cash equivalents</a></td>
<td class="nump">30,723<span></span>
</td>
<td class="nump">16,380<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RestrictedCashNoncurrent', window );">Restricted cash</a></td>
<td class="nump">3,470<span></span>
</td>
<td class="nump">3,025<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_InvestmentsFairValueDisclosureAbstract', window );"><strong>Marketable securities, available for sale:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AvailableForSaleSecuritiesDebtSecurities', window );">Total marketable securities, available for sale</a></td>
<td class="nump">53,457<span></span>
</td>
<td class="nump">48,449<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AssetsFairValueDisclosure', window );">Total assets measured at fair value on a recurring basis</a></td>
<td class="nump">87,650<span></span>
</td>
<td class="nump">67,854<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LiabilitiesFairValueDisclosureAbstract', window );"><strong>Liabilities:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dmtk_WarrantLiabilityFairValueDisclosure', window );">Warrant liability</a></td>
<td class="nump">24<span></span>
</td>
<td class="nump">146<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LiabilitiesFairValueDisclosure', window );">Total liabilities measured at fair value on a recurring basis</a></td>
<td class="nump">24<span></span>
</td>
<td class="nump">146<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueByMeasurementFrequencyAxis=us-gaap_FairValueMeasurementsRecurringMember', window );">Fair Value, Recurring | Level 1</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AssetsFairValueDisclosureAbstract', window );"><strong>Assets:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CashEquivalentsAtCarryingValue', window );">Cash equivalents</a></td>
<td class="nump">30,723<span></span>
</td>
<td class="nump">16,380<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RestrictedCashNoncurrent', window );">Restricted cash</a></td>
<td class="nump">3,470<span></span>
</td>
<td class="nump">3,025<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_InvestmentsFairValueDisclosureAbstract', window );"><strong>Marketable securities, available for sale:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AvailableForSaleSecuritiesDebtSecurities', window );">Total marketable securities, available for sale</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AssetsFairValueDisclosure', window );">Total assets measured at fair value on a recurring basis</a></td>
<td class="nump">34,193<span></span>
</td>
<td class="nump">19,405<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LiabilitiesFairValueDisclosureAbstract', window );"><strong>Liabilities:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dmtk_WarrantLiabilityFairValueDisclosure', window );">Warrant liability</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LiabilitiesFairValueDisclosure', window );">Total liabilities measured at fair value on a recurring basis</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueByMeasurementFrequencyAxis=us-gaap_FairValueMeasurementsRecurringMember', window );">Fair Value, Recurring | Level 2</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AssetsFairValueDisclosureAbstract', window );"><strong>Assets:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CashEquivalentsAtCarryingValue', window );">Cash equivalents</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RestrictedCashNoncurrent', window );">Restricted cash</a></td>
<td class="nump">0<span></span>
</td>
<td class="text"> <span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_InvestmentsFairValueDisclosureAbstract', window );"><strong>Marketable securities, available for sale:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AvailableForSaleSecuritiesDebtSecurities', window );">Total marketable securities, available for sale</a></td>
<td class="nump">53,457<span></span>
</td>
<td class="nump">48,449<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AssetsFairValueDisclosure', window );">Total assets measured at fair value on a recurring basis</a></td>
<td class="nump">53,457<span></span>
</td>
<td class="nump">48,449<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LiabilitiesFairValueDisclosureAbstract', window );"><strong>Liabilities:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dmtk_WarrantLiabilityFairValueDisclosure', window );">Warrant liability</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LiabilitiesFairValueDisclosure', window );">Total liabilities measured at fair value on a recurring basis</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueByMeasurementFrequencyAxis=us-gaap_FairValueMeasurementsRecurringMember', window );">Fair Value, Recurring | Level 3</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AssetsFairValueDisclosureAbstract', window );"><strong>Assets:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CashEquivalentsAtCarryingValue', window );">Cash equivalents</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RestrictedCashNoncurrent', window );">Restricted cash</a></td>
<td class="nump">0<span></span>
</td>
<td class="text"> <span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_InvestmentsFairValueDisclosureAbstract', window );"><strong>Marketable securities, available for sale:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AvailableForSaleSecuritiesDebtSecurities', window );">Total marketable securities, available for sale</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AssetsFairValueDisclosure', window );">Total assets measured at fair value on a recurring basis</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LiabilitiesFairValueDisclosureAbstract', window );"><strong>Liabilities:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dmtk_WarrantLiabilityFairValueDisclosure', window );">Warrant liability</a></td>
<td class="nump">24<span></span>
</td>
<td class="nump">146<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LiabilitiesFairValueDisclosure', window );">Total liabilities measured at fair value on a recurring basis</a></td>
<td class="nump">24<span></span>
</td>
<td class="nump">146<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FinancialInstrumentAxis=us-gaap_CorporateDebtSecuritiesMember', window );">Corporate debt securities</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_InvestmentsFairValueDisclosureAbstract', window );"><strong>Marketable securities, available for sale:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AvailableForSaleSecuritiesDebtSecurities', window );">Total marketable securities, available for sale</a></td>
<td class="nump">15,092<span></span>
</td>
<td class="nump">15,352<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FinancialInstrumentAxis=us-gaap_CorporateDebtSecuritiesMember', window );">Corporate debt securities | Fair Value, Recurring</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_InvestmentsFairValueDisclosureAbstract', window );"><strong>Marketable securities, available for sale:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AvailableForSaleSecuritiesDebtSecurities', window );">Total marketable securities, available for sale</a></td>
<td class="nump">15,092<span></span>
</td>
<td class="nump">15,352<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FinancialInstrumentAxis=us-gaap_CorporateDebtSecuritiesMember', window );">Corporate debt securities | Fair Value, Recurring | Level 1</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_InvestmentsFairValueDisclosureAbstract', window );"><strong>Marketable securities, available for sale:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AvailableForSaleSecuritiesDebtSecurities', window );">Total marketable securities, available for sale</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FinancialInstrumentAxis=us-gaap_CorporateDebtSecuritiesMember', window );">Corporate debt securities | Fair Value, Recurring | Level 2</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_InvestmentsFairValueDisclosureAbstract', window );"><strong>Marketable securities, available for sale:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AvailableForSaleSecuritiesDebtSecurities', window );">Total marketable securities, available for sale</a></td>
<td class="nump">15,092<span></span>
</td>
<td class="nump">15,352<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FinancialInstrumentAxis=us-gaap_CorporateDebtSecuritiesMember', window );">Corporate debt securities | Fair Value, Recurring | Level 3</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_InvestmentsFairValueDisclosureAbstract', window );"><strong>Marketable securities, available for sale:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AvailableForSaleSecuritiesDebtSecurities', window );">Total marketable securities, available for sale</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FinancialInstrumentAxis=us-gaap_MunicipalNotesMember', window );">Municipal debt securities</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_InvestmentsFairValueDisclosureAbstract', window );"><strong>Marketable securities, available for sale:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AvailableForSaleSecuritiesDebtSecurities', window );">Total marketable securities, available for sale</a></td>
<td class="nump">3,641<span></span>
</td>
<td class="nump">7,412<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FinancialInstrumentAxis=us-gaap_MunicipalNotesMember', window );">Municipal debt securities | Fair Value, Recurring</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_InvestmentsFairValueDisclosureAbstract', window );"><strong>Marketable securities, available for sale:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AvailableForSaleSecuritiesDebtSecurities', window );">Total marketable securities, available for sale</a></td>
<td class="nump">3,641<span></span>
</td>
<td class="nump">7,412<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FinancialInstrumentAxis=us-gaap_MunicipalNotesMember', window );">Municipal debt securities | Fair Value, Recurring | Level 1</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_InvestmentsFairValueDisclosureAbstract', window );"><strong>Marketable securities, available for sale:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AvailableForSaleSecuritiesDebtSecurities', window );">Total marketable securities, available for sale</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FinancialInstrumentAxis=us-gaap_MunicipalNotesMember', window );">Municipal debt securities | Fair Value, Recurring | Level 2</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_InvestmentsFairValueDisclosureAbstract', window );"><strong>Marketable securities, available for sale:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AvailableForSaleSecuritiesDebtSecurities', window );">Total marketable securities, available for sale</a></td>
<td class="nump">3,641<span></span>
</td>
<td class="nump">7,412<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FinancialInstrumentAxis=us-gaap_MunicipalNotesMember', window );">Municipal debt securities | Fair Value, Recurring | Level 3</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_InvestmentsFairValueDisclosureAbstract', window );"><strong>Marketable securities, available for sale:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AvailableForSaleSecuritiesDebtSecurities', window );">Total marketable securities, available for sale</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FinancialInstrumentAxis=us-gaap_USGovernmentAgenciesShorttermDebtSecuritiesMember', window );">U.S. government debt securities</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_InvestmentsFairValueDisclosureAbstract', window );"><strong>Marketable securities, available for sale:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AvailableForSaleSecuritiesDebtSecurities', window );">Total marketable securities, available for sale</a></td>
<td class="nump">34,724<span></span>
</td>
<td class="nump">25,685<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FinancialInstrumentAxis=us-gaap_USGovernmentAgenciesShorttermDebtSecuritiesMember', window );">U.S. government debt securities | Fair Value, Recurring</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_InvestmentsFairValueDisclosureAbstract', window );"><strong>Marketable securities, available for sale:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AvailableForSaleSecuritiesDebtSecurities', window );">Total marketable securities, available for sale</a></td>
<td class="nump">34,724<span></span>
</td>
<td class="nump">25,685<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FinancialInstrumentAxis=us-gaap_USGovernmentAgenciesShorttermDebtSecuritiesMember', window );">U.S. government debt securities | Fair Value, Recurring | Level 1</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_InvestmentsFairValueDisclosureAbstract', window );"><strong>Marketable securities, available for sale:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AvailableForSaleSecuritiesDebtSecurities', window );">Total marketable securities, available for sale</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FinancialInstrumentAxis=us-gaap_USGovernmentAgenciesShorttermDebtSecuritiesMember', window );">U.S. government debt securities | Fair Value, Recurring | Level 2</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_InvestmentsFairValueDisclosureAbstract', window );"><strong>Marketable securities, available for sale:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AvailableForSaleSecuritiesDebtSecurities', window );">Total marketable securities, available for sale</a></td>
<td class="nump">34,724<span></span>
</td>
<td class="nump">25,685<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FinancialInstrumentAxis=us-gaap_USGovernmentAgenciesShorttermDebtSecuritiesMember', window );">U.S. government debt securities | Fair Value, Recurring | Level 3</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_InvestmentsFairValueDisclosureAbstract', window );"><strong>Marketable securities, available for sale:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AvailableForSaleSecuritiesDebtSecurities', window );">Total marketable securities, available for sale</a></td>
<td class="nump">$ 0<span></span>
</td>
<td class="nump">$ 0<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dmtk_WarrantLiabilityFairValueDisclosure">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Warrant liability fair value disclosure.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dmtk_WarrantLiabilityFairValueDisclosure</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dmtk_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AssetsFairValueDisclosure">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Fair value portion of probable future economic benefits obtained or controlled by an entity as a result of past transactions or events.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 820<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126976982&amp;loc=d3e19207-110258<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AssetsFairValueDisclosure</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AssetsFairValueDisclosureAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AssetsFairValueDisclosureAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AvailableForSaleSecuritiesDebtSecurities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of investment in debt security measured at fair value with change in fair value recognized in other comprehensive income (available-for-sale).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-03(6))<br> -URI https://asc.fasb.org/extlink&amp;oid=126897435&amp;loc=d3e534808-122878<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 326<br> -SubTopic 30<br> -Section 45<br> -Paragraph 1<br> -URI https://asc.fasb.org/extlink&amp;oid=124258926&amp;loc=SL82898722-210454<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 320<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=124260329&amp;loc=d3e26610-111562<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 320<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (aa)<br> -URI https://asc.fasb.org/extlink&amp;oid=126970911&amp;loc=d3e27161-111563<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AvailableForSaleSecuritiesDebtSecurities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CashEquivalentsAtCarryingValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates. Excludes cash and cash equivalents within disposal group and discontinued operation.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(1))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CashEquivalentsAtCarryingValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InvestmentsFairValueDisclosureAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InvestmentsFairValueDisclosureAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LiabilitiesFairValueDisclosure">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Fair value of financial and nonfinancial obligations.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 820<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126976982&amp;loc=d3e19207-110258<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LiabilitiesFairValueDisclosure</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LiabilitiesFairValueDisclosureAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LiabilitiesFairValueDisclosureAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RestrictedCashNoncurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of cash restricted as to withdrawal or usage, classified as noncurrent. Cash includes, but is not limited to, currency on hand, demand deposits with banks or financial institutions, and other accounts with general characteristics of demand deposits.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(17))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 50<br> -Paragraph 8<br> -URI https://asc.fasb.org/extlink&amp;oid=126999549&amp;loc=SL98516268-108586<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 954<br> -SubTopic 210<br> -Section 45<br> -Paragraph 5<br> -URI https://asc.fasb.org/extlink&amp;oid=120413173&amp;loc=SL116631458-115580<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RestrictedCashNoncurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FairValueByMeasurementFrequencyAxis=us-gaap_FairValueMeasurementsRecurringMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FairValueByMeasurementFrequencyAxis=us-gaap_FairValueMeasurementsRecurringMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FairValueByFairValueHierarchyLevelAxis=us-gaap_FairValueInputsLevel1Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FairValueByFairValueHierarchyLevelAxis=us-gaap_FairValueInputsLevel1Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FairValueByFairValueHierarchyLevelAxis=us-gaap_FairValueInputsLevel2Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FairValueByFairValueHierarchyLevelAxis=us-gaap_FairValueInputsLevel2Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FairValueByFairValueHierarchyLevelAxis=us-gaap_FairValueInputsLevel3Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FairValueByFairValueHierarchyLevelAxis=us-gaap_FairValueInputsLevel3Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FinancialInstrumentAxis=us-gaap_CorporateDebtSecuritiesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FinancialInstrumentAxis=us-gaap_CorporateDebtSecuritiesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FinancialInstrumentAxis=us-gaap_MunicipalNotesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FinancialInstrumentAxis=us-gaap_MunicipalNotesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FinancialInstrumentAxis=us-gaap_USGovernmentAgenciesShorttermDebtSecuritiesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FinancialInstrumentAxis=us-gaap_USGovernmentAgenciesShorttermDebtSecuritiesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>47
<FILENAME>R24.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.2</span><table class="report" border="0" cellspacing="2" id="idm139763865349760">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>The Company and a Summary of its Significant Accounting Policies - Assumptions Used to Determine Fair Value of Each Option on Date of Grant Issued (Details) - Warranty liability<br></strong></div></th>
<th class="th" colspan="2">3 Months Ended</th>
<th class="th" colspan="2">6 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Jun. 30, 2022</div></th>
<th class="th"><div>Jun. 30, 2021</div></th>
<th class="th"><div>Jun. 30, 2022</div></th>
<th class="th"><div>Jun. 30, 2021</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems', window );"><strong>Share Based Compensation Arrangement By Share Based Payment Award [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate', window );">Assumed risk-free interest rate</a></td>
<td class="nump">2.96%<span></span>
</td>
<td class="nump">0.46%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMinimum', window );">Assumed risk-free interest rate, minimum</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">2.37%<span></span>
</td>
<td class="nump">0.46%<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMaximum', window );">Assumed risk-free interest rate, maximum</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">2.96%<span></span>
</td>
<td class="nump">0.64%<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate', window );">Assumed volatility</a></td>
<td class="nump">96.21%<span></span>
</td>
<td class="nump">88.28%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRateMinimum', window );">Assumed volatility, minimum</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">92.77%<span></span>
</td>
<td class="nump">85.85%<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRateMaximum', window );">Assumed volatility, maximum</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">96.21%<span></span>
</td>
<td class="nump">88.28%<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1', window );">Expected term</a></td>
<td class="text">2 years 2 months 1 day<span></span>
</td>
<td class="text">3 years 2 months 1 day<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate', window );">Expected dividend yield</a></td>
<td class="nump">0.00%<span></span>
</td>
<td class="nump">0.00%<span></span>
</td>
<td class="nump">0.00%<span></span>
</td>
<td class="nump">0.00%<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_RangeAxis=srt_MinimumMember', window );">Minimum</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems', window );"><strong>Share Based Compensation Arrangement By Share Based Payment Award [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1', window );">Expected term</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">2 years 2 months 1 day<span></span>
</td>
<td class="text">3 years 2 months 1 day<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_RangeAxis=srt_MaximumMember', window );">Maximum</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems', window );"><strong>Share Based Compensation Arrangement By Share Based Payment Award [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1', window );">Expected term</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">2 years 5 months 1 day<span></span>
</td>
<td class="text">3 years 5 months 1 day<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The estimated dividend rate (a percentage of the share price) to be paid (expected dividends) to holders of the underlying shares over the option's term.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (f)(2)(iii)<br> -URI https://asc.fasb.org/extlink&amp;oid=128089324&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The estimated measure of the percentage by which a share price is expected to fluctuate during a period. Volatility also may be defined as a probability-weighted measure of the dispersion of returns about the mean. The volatility of a share price is the standard deviation of the continuously compounded rates of return on the share over a specified period. That is the same as the standard deviation of the differences in the natural logarithms of the stock prices plus dividends, if any, over the period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (f)(2)(ii)<br> -URI https://asc.fasb.org/extlink&amp;oid=128089324&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRateMaximum">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The estimated measure of the maximum percentage by which a share price is expected to fluctuate during a period. Volatility also may be defined as a probability-weighted measure of the dispersion of returns about the mean. The volatility of a share price is the standard deviation of the continuously compounded rates of return on the share over a specified period. That is the same as the standard deviation of the differences in the natural logarithms of the stock prices plus dividends, if any, over the period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRateMaximum</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRateMinimum">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The estimated measure of the minimum percentage by which a share price is expected to fluctuate during a period. Volatility also may be defined as a probability-weighted measure of the dispersion of returns about the mean. The volatility of a share price is the standard deviation of the continuously compounded rates of return on the share over a specified period. That is the same as the standard deviation of the differences in the natural logarithms of the stock prices plus dividends, if any, over the period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRateMinimum</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The risk-free interest rate assumption that is used in valuing an option on its own shares.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (f)(2)(iv)<br> -URI https://asc.fasb.org/extlink&amp;oid=128089324&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMaximum">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The maximum risk-free interest rate assumption that is used in valuing an option on its own shares.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMaximum</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMinimum">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The minimum risk-free interest rate assumption that is used in valuing an option on its own shares.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMinimum</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Expected term of award under share-based payment arrangement, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents reported fact of one year, five months, and thirteen days.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (f)(2)(i)<br> -URI https://asc.fasb.org/extlink&amp;oid=128089324&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:durationItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FinancialInstrumentAxis=us-gaap_WarrantyRightsAndObligationsFairValueOptionMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FinancialInstrumentAxis=us-gaap_WarrantyRightsAndObligationsFairValueOptionMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_RangeAxis=srt_MinimumMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_RangeAxis=srt_MinimumMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_RangeAxis=srt_MaximumMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_RangeAxis=srt_MaximumMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>48
<FILENAME>R25.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.2</span><table class="report" border="0" cellspacing="2" id="idm139763865618864">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>The Company and a Summary of its Significant Accounting Policies - Summary of Changes in Fair Value of Level 3 Liabilities (Details) - Level 3 - Warrant Liability - USD ($)<br> $ in Thousands</strong></div></th>
<th class="th" colspan="2">3 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Jun. 30, 2022</div></th>
<th class="th"><div>Mar. 31, 2022</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationCalculationRollForward', window );"><strong>Fair Value, Liabilities Measured on Recurring Basis, Unobservable Input Reconciliation, Calculation [Roll Forward]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue', window );">Beginning balance</a></td>
<td class="nump">$ 129<span></span>
</td>
<td class="nump">$ 146<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityGainLossIncludedInEarnings', window );">Change in fair value of warrant liability</a></td>
<td class="num">(105)<span></span>
</td>
<td class="num">(17)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue', window );">Ending balance</a></td>
<td class="nump">$ 24<span></span>
</td>
<td class="nump">$ 129<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationCalculationRollForward">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>A roll forward is a reconciliation of a concept from the beginning of a period to the end of a period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationCalculationRollForward</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityGainLossIncludedInEarnings">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of gain (loss) recognized in income from liability measured at fair value on recurring basis using unobservable input (level 3).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 820<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)<br> -URI https://asc.fasb.org/extlink&amp;oid=126976982&amp;loc=d3e19207-110258<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityGainLossIncludedInEarnings</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Fair value of financial instrument classified as a liability measured using unobservable inputs that reflect the entity's own assumption about the assumptions market participants would use in pricing.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 820<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=126976982&amp;loc=d3e19207-110258<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FairValueByFairValueHierarchyLevelAxis=us-gaap_FairValueInputsLevel3Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FairValueByFairValueHierarchyLevelAxis=us-gaap_FairValueInputsLevel3Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FairValueByLiabilityClassAxis=dmtk_WarrantLiabilityMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FairValueByLiabilityClassAxis=dmtk_WarrantLiabilityMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>49
<FILENAME>R26.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.2</span><table class="report" border="0" cellspacing="2" id="idm139763872463520">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Balance Sheet Details - Schedule of Short-Term Marketable Securities (Details) - USD ($)<br> $ in Thousands</strong></div></th>
<th class="th"><div>Jun. 30, 2022</div></th>
<th class="th"><div>Dec. 31, 2021</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_InvestmentHoldingsLineItems', window );"><strong>Investment Holdings [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AvailableForSaleDebtSecuritiesAmortizedCostBasis', window );">Amortized Cost</a></td>
<td class="nump">$ 54,322<span></span>
</td>
<td class="nump">$ 48,573<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax', window );">Gross Unrealized Gains</a></td>
<td class="nump">9<span></span>
</td>
<td class="nump">1<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax', window );">Gross Unrealized Losses</a></td>
<td class="num">(874)<span></span>
</td>
<td class="num">(125)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AvailableForSaleSecuritiesDebtSecurities', window );">Estimated Market Value</a></td>
<td class="nump">53,457<span></span>
</td>
<td class="nump">48,449<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FinancialInstrumentAxis=us-gaap_CorporateDebtSecuritiesMember', window );">Corporate debt securities</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_InvestmentHoldingsLineItems', window );"><strong>Investment Holdings [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AvailableForSaleDebtSecuritiesAmortizedCostBasis', window );">Amortized Cost</a></td>
<td class="nump">15,361<span></span>
</td>
<td class="nump">15,385<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax', window );">Gross Unrealized Gains</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax', window );">Gross Unrealized Losses</a></td>
<td class="num">(269)<span></span>
</td>
<td class="num">(33)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AvailableForSaleSecuritiesDebtSecurities', window );">Estimated Market Value</a></td>
<td class="nump">15,092<span></span>
</td>
<td class="nump">15,352<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FinancialInstrumentAxis=us-gaap_MunicipalNotesMember', window );">Municipal debt securities</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_InvestmentHoldingsLineItems', window );"><strong>Investment Holdings [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AvailableForSaleDebtSecuritiesAmortizedCostBasis', window );">Amortized Cost</a></td>
<td class="nump">3,666<span></span>
</td>
<td class="nump">7,417<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax', window );">Gross Unrealized Gains</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax', window );">Gross Unrealized Losses</a></td>
<td class="num">(25)<span></span>
</td>
<td class="num">(5)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AvailableForSaleSecuritiesDebtSecurities', window );">Estimated Market Value</a></td>
<td class="nump">3,641<span></span>
</td>
<td class="nump">7,412<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FinancialInstrumentAxis=us-gaap_USGovernmentAgenciesShorttermDebtSecuritiesMember', window );">U.S. government debt securities</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_InvestmentHoldingsLineItems', window );"><strong>Investment Holdings [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AvailableForSaleDebtSecuritiesAmortizedCostBasis', window );">Amortized Cost</a></td>
<td class="nump">35,295<span></span>
</td>
<td class="nump">25,771<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax', window );">Gross Unrealized Gains</a></td>
<td class="nump">9<span></span>
</td>
<td class="nump">1<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax', window );">Gross Unrealized Losses</a></td>
<td class="num">(580)<span></span>
</td>
<td class="num">(87)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AvailableForSaleSecuritiesDebtSecurities', window );">Estimated Market Value</a></td>
<td class="nump">$ 34,724<span></span>
</td>
<td class="nump">$ 25,685<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount, before tax, of unrealized gain in accumulated other comprehensive income (AOCI) on investment in debt security measured at fair value with change in fair value recognized in other comprehensive income (available-for-sale).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 320<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=126970911&amp;loc=d3e27161-111563<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount, before tax, of unrealized loss in accumulated other comprehensive income (AOCI) on investment in debt security measured at fair value with change in fair value recognized in other comprehensive income (available-for-sale).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 320<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=126970911&amp;loc=d3e27161-111563<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AvailableForSaleDebtSecuritiesAmortizedCostBasis">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amortized cost of investment in debt security measured at fair value with change in fair value recognized in other comprehensive income (available-for-sale).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 320<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126970911&amp;loc=d3e27161-111563<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 326<br> -SubTopic 30<br> -Section 45<br> -Paragraph 1<br> -URI https://asc.fasb.org/extlink&amp;oid=124258926&amp;loc=SL82898722-210454<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AvailableForSaleDebtSecuritiesAmortizedCostBasis</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AvailableForSaleSecuritiesDebtSecurities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of investment in debt security measured at fair value with change in fair value recognized in other comprehensive income (available-for-sale).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-03(6))<br> -URI https://asc.fasb.org/extlink&amp;oid=126897435&amp;loc=d3e534808-122878<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 326<br> -SubTopic 30<br> -Section 45<br> -Paragraph 1<br> -URI https://asc.fasb.org/extlink&amp;oid=124258926&amp;loc=SL82898722-210454<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 320<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=124260329&amp;loc=d3e26610-111562<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 320<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (aa)<br> -URI https://asc.fasb.org/extlink&amp;oid=126970911&amp;loc=d3e27161-111563<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AvailableForSaleSecuritiesDebtSecurities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InvestmentHoldingsLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InvestmentHoldingsLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FinancialInstrumentAxis=us-gaap_CorporateDebtSecuritiesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FinancialInstrumentAxis=us-gaap_CorporateDebtSecuritiesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FinancialInstrumentAxis=us-gaap_MunicipalNotesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FinancialInstrumentAxis=us-gaap_MunicipalNotesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FinancialInstrumentAxis=us-gaap_USGovernmentAgenciesShorttermDebtSecuritiesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FinancialInstrumentAxis=us-gaap_USGovernmentAgenciesShorttermDebtSecuritiesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>50
<FILENAME>R27.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.2</span><table class="report" border="0" cellspacing="2" id="idm139763872613280">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Balance Sheet Details - Additional Information (Details) - USD ($)<br></strong></div></th>
<th class="th"><div>Jun. 30, 2022</div></th>
<th class="th"><div>Dec. 31, 2021</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract', window );"><strong>Organization, Consolidation and Presentation of Financial Statements [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dmtk_EstimatedMarketValueOfDebtSecuritiesWithContractualMaturitiesOfLessThan12Months', window );">Estimated market value of debt securities with contractual maturities of less than 12 months</a></td>
<td class="nump">$ 25,800,000<span></span>
</td>
<td class="nump">$ 21,200,000<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dmtk_EstimatedMarketValueOfRemainingDebtSecuritiesWithContractualMaturitiesOfUpTo23Months', window );">Estimated market value of remaining debt securities with contractual maturities of up to 23 months</a></td>
<td class="nump">27,700,000<span></span>
</td>
<td class="nump">27,200,000<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dmtk_CreditLosses', window );">Credit losses</a></td>
<td class="nump">$ 0<span></span>
</td>
<td class="nump">$ 0<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dmtk_CreditLosses">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Credit Losses</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dmtk_CreditLosses</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dmtk_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dmtk_EstimatedMarketValueOfDebtSecuritiesWithContractualMaturitiesOfLessThan12Months">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Estimated market value of debt securities with contractual maturities of less than 12 months.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dmtk_EstimatedMarketValueOfDebtSecuritiesWithContractualMaturitiesOfLessThan12Months</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dmtk_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dmtk_EstimatedMarketValueOfRemainingDebtSecuritiesWithContractualMaturitiesOfUpTo23Months">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Estimated market value of remaining debt securities with contractual maturities of up to 23 months.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dmtk_EstimatedMarketValueOfRemainingDebtSecuritiesWithContractualMaturitiesOfUpTo23Months</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dmtk_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>51
<FILENAME>R28.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.2</span><table class="report" border="0" cellspacing="2" id="idm139763867908960">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Balance Sheet Details - Schedule of Prepaid Expenses and PP&amp;E (Details) - USD ($)<br> $ in Thousands</strong></div></th>
<th class="th"><div>Jun. 30, 2022</div></th>
<th class="th"><div>Dec. 31, 2021</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PrepaidExpenseAndOtherAssetsCurrentAbstract', window );"><strong>Prepaid expenses and other current assets:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PrepaidInsurance', window );">Prepaid insurance</a></td>
<td class="nump">$ 806<span></span>
</td>
<td class="nump">$ 1,801<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dmtk_PrepaidTradeShowsCurrent', window );">Prepaid trade shows</a></td>
<td class="nump">241<span></span>
</td>
<td class="nump">440<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dmtk_PrepaidSoftwareFees', window );">Prepaid software fees</a></td>
<td class="nump">907<span></span>
</td>
<td class="nump">551<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dmtk_PrepaidEmployeeCompensation', window );">Prepaid employee compensation</a></td>
<td class="nump">227<span></span>
</td>
<td class="nump">238<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OtherAssetsCurrent', window );">Other current assets</a></td>
<td class="nump">500<span></span>
</td>
<td class="nump">136<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PrepaidExpenseAndOtherAssetsCurrent', window );">Total prepaid expenses and other current assets</a></td>
<td class="nump">2,681<span></span>
</td>
<td class="nump">3,166<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentGrossAbstract', window );"><strong>Property and equipment, gross:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_MachineryAndEquipmentGross', window );">Laboratory equipment</a></td>
<td class="nump">4,856<span></span>
</td>
<td class="nump">4,805<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dmtk_ComputerEquipmentGross', window );">Computer equipment</a></td>
<td class="nump">396<span></span>
</td>
<td class="nump">171<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FurnitureAndFixturesGross', window );">Furniture and fixtures</a></td>
<td class="nump">555<span></span>
</td>
<td class="nump">124<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LeaseholdImprovementsGross', window );">Leasehold improvements</a></td>
<td class="nump">1,208<span></span>
</td>
<td class="nump">1,074<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ConstructionInProgressGross', window );">Construction-in-progress</a></td>
<td class="nump">139<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentGross', window );">Total property and equipment, gross</a></td>
<td class="nump">7,154<span></span>
</td>
<td class="nump">6,174<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment', window );">Less accumulated depreciation</a></td>
<td class="num">(2,238)<span></span>
</td>
<td class="num">(1,625)<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentNet', window );">Total property and equipment, net</a></td>
<td class="nump">$ 4,916<span></span>
</td>
<td class="nump">$ 4,549<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dmtk_ComputerEquipmentGross">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Computer equipment gross.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dmtk_ComputerEquipmentGross</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dmtk_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dmtk_PrepaidEmployeeCompensation">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Prepaid employee compensation.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dmtk_PrepaidEmployeeCompensation</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dmtk_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dmtk_PrepaidSoftwareFees">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Prepaid software fees.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dmtk_PrepaidSoftwareFees</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dmtk_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dmtk_PrepaidTradeShowsCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Prepaid trade shows, current.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dmtk_PrepaidTradeShowsCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dmtk_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of accumulated depreciation, depletion and amortization for physical assets used in the normal conduct of business to produce goods and services.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 360<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=6391035&amp;loc=d3e2868-110229<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(14))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ConstructionInProgressGross">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of structure or a modification to a structure under construction. Includes recently completed structures or modifications to structures that have not been placed into service.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 360<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=6391035&amp;loc=d3e2868-110229<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ConstructionInProgressGross</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FurnitureAndFixturesGross">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount before accumulated depreciation of equipment commonly used in offices and stores that have no permanent connection to the structure of a building or utilities. Examples include, but are not limited to, desks, chairs, tables, and bookcases.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 360<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=6391035&amp;loc=d3e2868-110229<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FurnitureAndFixturesGross</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LeaseholdImprovementsGross">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount before accumulated depreciation of additions or improvements to assets held under a lease arrangement.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 360<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=6391035&amp;loc=d3e2868-110229<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LeaseholdImprovementsGross</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_MachineryAndEquipmentGross">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount before accumulated depreciation of tangible personal property used to produce goods and services, including, but is not limited to, tools, dies and molds, computer and office equipment.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 360<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=6391035&amp;loc=d3e2868-110229<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_MachineryAndEquipmentGross</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherAssetsCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of current assets classified as other.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(8))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 852<br> -SubTopic 10<br> -Section 55<br> -Paragraph 10<br> -URI https://asc.fasb.org/extlink&amp;oid=84165509&amp;loc=d3e56426-112766<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherAssetsCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PrepaidExpenseAndOtherAssetsCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of asset related to consideration paid in advance for costs that provide economic benefits in future periods, and amount of other assets that are expected to be realized or consumed within one year or the normal operating cycle, if longer.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(9))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PrepaidExpenseAndOtherAssetsCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PrepaidExpenseAndOtherAssetsCurrentAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PrepaidExpenseAndOtherAssetsCurrentAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PrepaidInsurance">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of asset related to consideration paid in advance for insurance that provides economic benefits within a future period of one year or the normal operating cycle, if longer.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 340<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1<br> -URI https://asc.fasb.org/extlink&amp;oid=6387103&amp;loc=d3e6435-108320<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1<br> -Subparagraph (g)(1)<br> -URI https://asc.fasb.org/extlink&amp;oid=124098289&amp;loc=d3e6676-107765<br><br>Reference 3: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 340<br> -SubTopic 10<br> -Section 05<br> -Paragraph 5<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126905020&amp;loc=d3e5879-108316<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PrepaidInsurance</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PropertyPlantAndEquipmentGross">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount before accumulated depreciation, depletion and amortization of physical assets used in the normal conduct of business and not intended for resale. Examples include, but are not limited to, land, buildings, machinery and equipment, office equipment, and furniture and fixtures.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(13))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 360<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=6391035&amp;loc=d3e2868-110229<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PropertyPlantAndEquipmentGross</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PropertyPlantAndEquipmentGrossAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PropertyPlantAndEquipmentGrossAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PropertyPlantAndEquipmentNet">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount after accumulated depreciation, depletion and amortization of physical assets used in the normal conduct of business to produce goods and services and not intended for resale. Examples include, but are not limited to, land, buildings, machinery and equipment, office equipment, and furniture and fixtures.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 360<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -URI https://asc.fasb.org/extlink&amp;oid=6391035&amp;loc=d3e2868-110229<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(a)(8))<br> -URI https://asc.fasb.org/extlink&amp;oid=126734703&amp;loc=d3e572229-122910<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 360<br> -Section 50<br> -Paragraph 1<br> -URI https://asc.fasb.org/extlink&amp;oid=124429447&amp;loc=SL124453093-239630<br><br>Reference 4: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 852<br> -SubTopic 10<br> -Section 55<br> -Paragraph 10<br> -URI https://asc.fasb.org/extlink&amp;oid=84165509&amp;loc=d3e56426-112766<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PropertyPlantAndEquipmentNet</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>52
<FILENAME>R29.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.2</span><table class="report" border="0" cellspacing="2" id="idm139763867193840">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Balance Sheet Details - Schedule of Accrued Compensation and Accrued Liabilities (Details) - USD ($)<br> $ in Thousands</strong></div></th>
<th class="th"><div>Jun. 30, 2022</div></th>
<th class="th"><div>Dec. 31, 2021</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EmployeeRelatedLiabilitiesCurrentAbstract', window );"><strong>Accrued compensation:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AccruedVacationCurrent', window );">Accrued paid time off</a></td>
<td class="nump">$ 1,689<span></span>
</td>
<td class="nump">$ 1,245<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dmtk_AccruedBonusAndDeferredCompensationCurrent', window );">Accrued wages, bonus and other</a></td>
<td class="nump">6,129<span></span>
</td>
<td class="nump">3,875<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EmployeeRelatedLiabilitiesCurrent', window );">Total accrued compensation</a></td>
<td class="nump">7,818<span></span>
</td>
<td class="nump">5,120<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AccruedLiabilitiesCurrentAbstract', window );"><strong>Accrued liabilities:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dmtk_AccruedConsultingServicesCurrent', window );">Accrued consulting services</a></td>
<td class="nump">2,201<span></span>
</td>
<td class="nump">775<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OtherAccruedLiabilitiesCurrent', window );">Other accrued expenses</a></td>
<td class="nump">1,071<span></span>
</td>
<td class="nump">452<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AccruedLiabilitiesCurrent', window );">Total accrued liabilities</a></td>
<td class="nump">$ 3,272<span></span>
</td>
<td class="nump">$ 1,227<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dmtk_AccruedBonusAndDeferredCompensationCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Accrued bonus and deferred compensation, current.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dmtk_AccruedBonusAndDeferredCompensationCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dmtk_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dmtk_AccruedConsultingServicesCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Accrued consulting services, current.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dmtk_AccruedConsultingServicesCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dmtk_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AccruedLiabilitiesCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Carrying value as of the balance sheet date of obligations incurred and payable, pertaining to costs that are statutory in nature, are incurred on contractual obligations, or accumulate over time and for which invoices have not yet been received or will not be rendered. Examples include taxes, interest, rent and utilities. Used to reflect the current portion of the liabilities (due within one year or within the normal operating cycle if longer).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.20)<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AccruedLiabilitiesCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AccruedLiabilitiesCurrentAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AccruedLiabilitiesCurrentAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AccruedVacationCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Carrying value as of the balance sheet date of obligations incurred and payable for unused vacation time owed to employees based on the entity's vacation benefit given to its employees. Used to reflect the current portion of the liabilities (due within one year or within the normal operating cycle if longer).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.20)<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 710<br> -SubTopic 10<br> -Section 25<br> -Paragraph 3<br> -URI https://asc.fasb.org/extlink&amp;oid=6409733&amp;loc=d3e19396-108361<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AccruedVacationCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EmployeeRelatedLiabilitiesCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Total of the carrying values as of the balance sheet date of obligations incurred through that date and payable for obligations related to services received from employees, such as accrued salaries and bonuses, payroll taxes and fringe benefits. Used to reflect the current portion of the liabilities (due within one year or within the normal operating cycle if longer).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.20)<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EmployeeRelatedLiabilitiesCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EmployeeRelatedLiabilitiesCurrentAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EmployeeRelatedLiabilitiesCurrentAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherAccruedLiabilitiesCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of expenses incurred but not yet paid classified as other, due within one year or the normal operating cycle, if longer.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.20)<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherAccruedLiabilitiesCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>53
<FILENAME>R30.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.2</span><table class="report" border="0" cellspacing="2" id="idm139763860123008">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Stockholders' Equity - Additional Information (Details)<br> $ / shares in Units, $ in Thousands</strong></div></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1">1 Months Ended</th>
<th class="th" colspan="1">2 Months Ended</th>
<th class="th" colspan="2">3 Months Ended</th>
<th class="th" colspan="2">6 Months Ended</th>
<th class="th" colspan="2">12 Months Ended</th>
<th class="th" colspan="1">24 Months Ended</th>
<th class="th" colspan="1">36 Months Ended</th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1"></th>
</tr>
<tr>
<th class="th">
<div>Feb. 28, 2021 </div>
<div>shares</div>
</th>
<th class="th">
<div>Jan. 11, 2021 </div>
<div>USD ($) </div>
<div>$ / shares </div>
<div>shares</div>
</th>
<th class="th">
<div>Jan. 06, 2021 </div>
<div>shares</div>
</th>
<th class="th">
<div>Nov. 10, 2020 </div>
<div>USD ($)</div>
</th>
<th class="th">
<div>Jun. 23, 2017 </div>
<div>shares</div>
</th>
<th class="th">
<div>Aug. 31, 2021 </div>
<div>shares</div>
</th>
<th class="th">
<div>Dec. 31, 2020 </div>
<div>USD ($) </div>
<div>$ / shares </div>
<div>shares</div>
</th>
<th class="th">
<div>Jun. 30, 2021 </div>
<div>USD ($) </div>
<div>shares</div>
</th>
<th class="th">
<div>Mar. 31, 2021 </div>
<div>USD ($) </div>
<div>shares</div>
</th>
<th class="th">
<div>Jun. 30, 2022 </div>
<div>USD ($) </div>
<div>Warrant </div>
<div>$ / shares </div>
<div>shares</div>
</th>
<th class="th">
<div>Jun. 30, 2021 </div>
<div>USD ($) </div>
<div>shares</div>
</th>
<th class="th">
<div>Dec. 31, 2021 </div>
<div>USD ($) </div>
<div>$ / shares </div>
<div>shares</div>
</th>
<th class="th">
<div>Dec. 31, 2020 </div>
<div>$ / shares </div>
<div>shares</div>
</th>
<th class="th">
<div>Dec. 31, 2016 </div>
<div>$ / shares </div>
<div>shares</div>
</th>
<th class="th">
<div>Dec. 31, 2018 </div>
<div>$ / shares </div>
<div>shares</div>
</th>
<th class="th">
<div>Feb. 28, 2022 </div>
<div>shares</div>
</th>
<th class="th">
<div>Jan. 01, 2022 </div>
<div>shares</div>
</th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ClassOfStockLineItems', window );"><strong>Class of Stock [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CommonStockSharesAuthorized', window );">Common stock, shares authorized (in shares)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">50,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">50,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PreferredStockSharesAuthorized', window );">Preferred stock, shares authorized (in shares)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">5,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CommonStockParOrStatedValuePerShare', window );">Common stock, par value per share (in usd per share) | $ / shares</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 0.0001<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 0.0001<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PreferredStockParOrStatedValuePerShare', window );">Preferred stock, par value per share (in usd per share) | $ / shares</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 0.0001<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodValueNewIssues', window );">Issuance of preferred stock, total offering amount | $</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 23,836<span></span>
</td>
<td class="nump">$ 134,582<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodSharesNewIssues', window );">Issuance of common stock, net of issuance costs shares (in shares)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">4,237,288<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ProceedsFromIssuanceOfCommonStock', window );">Proceeds from issuance of common stock | $</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 134,600<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dmtk_StockPurchasedByUnderwritersPursuantToOptionGranted', window );">Shares purchased by underwriters (in shares)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">635,593<span></span>
</td>
<td class="nump">635,593<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dmtk_UnderwritersGrantPeriodOption', window );">Number of days granted to underwriters option to purchase</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">30 days<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SaleOfStockNumberOfSharesIssuedInTransaction', window );">Sale of stock, number of shares issued in transaction (in shares)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">4,872,881<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SaleOfStockPricePerShare', window );">Public offering price (in usd per share) | $ / shares</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 29.50<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dmtk_GrossProceedsFromOfferingBeforeDeductingUnderwritingDiscountsAndCommissionsAndOtherOfferingExpenses', window );">Gross proceeds from offering, before deducting underwriting discounts and commissions and other offering expenses | $</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 143,700<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_WarrantsAndRightsOutstandingTerm', window );">Warrants expiration period</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">5 years<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ProceedsFromWarrantExercises', window );">Total proceeds from exercise of public warrants | $</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 22<span></span>
</td>
<td class="nump">$ 69,928<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized', window );">Compensation cost related to non-vested awards not yet recognized | $</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 50,300<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1', window );">Weighted average term expected to be recognized</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">2 years 10 months 24 days<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CommonStockCapitalSharesReservedForFutureIssuance', window );">Common stock available for issuance (in shares)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">6,615<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">4,591<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CommonStockSharesIssued', window );">Common stock, shares issued (in shares)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">30,038,447<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">29,772,922<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PlanNameAxis=dmtk_TwoThousandTenStockPlanMember', window );">2010 Stock Plan</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ClassOfStockLineItems', window );"><strong>Class of Stock [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardExpirationPeriod', window );">Contractual term of options granted</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">10 years<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant', window );">Options remain available for issuance pursuant to future grants (in shares)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PlanNameAxis=dmtk_TwoThousandTwentyEquityIncentivePlanMember', window );">2020 Equity Incentive Plan</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ClassOfStockLineItems', window );"><strong>Class of Stock [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CommonStockSharesAuthorized', window );">Common stock, shares authorized (in shares)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1,900,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardExpirationPeriod', window );">Contractual term of options granted</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">10 years<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant', window );">Options remain available for issuance pursuant to future grants (in shares)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">431,107<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dmtk_CommonStockOutstandingPercentage', window );">Common stock outstanding percentage</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">3.50%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PlanNameAxis=dmtk_TwoThousandTwentyEmployeeStockPurchasePlanMember', window );">2020 Employee Stock Purchase Plan</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ClassOfStockLineItems', window );"><strong>Class of Stock [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodSharesNewIssues', window );">Issuance of common stock, net of issuance costs shares (in shares)</a></td>
<td class="nump">39,960<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">18,155<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant', window );">Options remain available for issuance pursuant to future grants (in shares)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">799,679<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">297,729<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SharesIssued', window );">Shares, issued (in shares)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">300,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dmtk_CommonStockOutstandingPercentage', window );">Common stock outstanding percentage</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dmtk_PercentageOfPriceAtSharesPurchased', window );">Percentage of price at shares purchased</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">85.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CommonStockCapitalSharesReservedForFutureIssuance', window );">Common stock available for issuance (in shares)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">549,289<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CommonStockSharesIssued', window );">Common stock, shares issued (in shares)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">47,339<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ClassOfWarrantOrRightAxis=dmtk_SpecialPurposeAcquisitionCompaniesWarrantsMember', window );">SPAC Warrants</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ClassOfStockLineItems', window );"><strong>Class of Stock [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dmtk_ClassOfWarrantOrRightWarrantsOrRightsIssuedToPurchaseCommonStock', window );">Warrants issued to purchase common stock (in shares)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">14,936,250<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dmtk_NumberOfWarrantsEntitleHolderToPurchaseOneShare', window );">Number of warrants entitle holder to purchase one share | Warrant</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">4<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights', window );">Total number exercised of public warrants (in shares)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">12,120,397<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">12,120,397<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dmtk_CommonSharesIssuedUponExerciseOfWarrants', window );">Common shares issued upon exercise of warrants (in shares)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">3,030,092<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ProceedsFromWarrantExercises', window );">Total proceeds from exercise of public warrants | $</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 69,700<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ClassOfWarrantOrRightOutstanding', window );">Warrants outstanding (in shares)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">2,815,853<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">2,815,853<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ClassOfWarrantOrRightAxis=dmtk_PublicSpecialPurposeAcquisitionCompaniesWarrantsMember', window );">Public SPAC Warrants</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ClassOfStockLineItems', window );"><strong>Class of Stock [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dmtk_ClassOfWarrantOrRightWarrantsOrRightsIssuedToPurchaseCommonStock', window );">Warrants issued to purchase common stock (in shares)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">14,375,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ClassOfWarrantOrRightAxis=dmtk_PrivateSpecialPurposeAcquisitionCompaniesWarrantsMember', window );">Private SPAC Warrants</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ClassOfStockLineItems', window );"><strong>Class of Stock [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dmtk_ClassOfWarrantOrRightWarrantsOrRightsIssuedToPurchaseCommonStock', window );">Warrants issued to purchase common stock (in shares)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">561,250<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ClassOfWarrantOrRightOutstanding', window );">Warrants outstanding (in shares)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">80,350<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">80,350<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ClassOfWarrantOrRightAxis=dmtk_PlacementAgentWarrantsMember', window );">Placement Agent Warrants</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ClassOfStockLineItems', window );"><strong>Class of Stock [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dmtk_ClassOfWarrantOrRightWarrantsOrRightsIssuedToPurchaseCommonStock', window );">Warrants issued to purchase common stock (in shares)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">168,522<span></span>
</td>
<td class="nump">72,658<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_WarrantsAndRightsOutstandingTerm', window );">Warrants expiration period</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">7 years<span></span>
</td>
<td class="text">7 years<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ClassOfWarrantOrRightOutstanding', window );">Warrants outstanding (in shares)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">10,039<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">10,039<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ClassOfWarrantOrRightAxis=dmtk_PlacementAgentWarrantsMember', window );">Placement Agent Warrants | 2018 Convertible Bridge Notes</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ClassOfStockLineItems', window );"><strong>Class of Stock [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dmtk_ClassOfWarrantOrRightWarrantsOrRightsIssuedToPurchaseCommonStock', window );">Warrants issued to purchase common stock (in shares)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">15,724<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_WarrantsAndRightsOutstandingTerm', window );">Warrants expiration period</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">7 years<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">7 years<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ClassOfWarrantOrRightAxis=dmtk_ManagementWarrantsMember', window );">Management Warrants</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ClassOfStockLineItems', window );"><strong>Class of Stock [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_WarrantsAndRightsOutstandingTerm', window );">Warrants expiration period</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">10 years<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ClassOfWarrantOrRightOutstanding', window );">Warrants outstanding (in shares)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">22,320<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RelatedPartyTransactionsByRelatedPartyAxis=dmtk_CowenLimitedLiabilityCompanyMember', window );">Cowen and Company LLC</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ClassOfStockLineItems', window );"><strong>Class of Stock [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodValueNewIssues', window );">Issuance of preferred stock, total offering amount | $</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 50,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodSharesNewIssues', window );">Issuance of common stock, net of issuance costs shares (in shares)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">951,792<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">530,551<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dmtk_WeightedAveragePurchasePricePerShareInOffering', window );">Weighted average purchase price per share (in usd per share) | $ / shares</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 20.97<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 46.33<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dmtk_GrossProceedsFromIssuanceOfCommonStock', window );">Gross proceeds from issuance of common stock | $</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 20,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 24,600<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dmtk_IncreaseDecreaseInStockIssuanceCosts', window );">Decrease in issuance costs | $</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">900<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">700<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ProceedsFromIssuanceOfCommonStock', window );">Proceeds from issuance of common stock | $</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 19,100<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 23,800<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StatementEquityComponentsAxis=us-gaap_CommonStockMember', window );">Common stock</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ClassOfStockLineItems', window );"><strong>Class of Stock [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodValueNewIssues', window );">Issuance of preferred stock, total offering amount | $</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 1<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodSharesNewIssues', window );">Issuance of common stock, net of issuance costs shares (in shares)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">530,551<span></span>
</td>
<td class="nump">4,872,881<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ClassOfWarrantOrRightNumberOfSecuritiesCalledByEachWarrantOrRight', window );">Number of shares issued for each warrant (in shares)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0.25<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StatementEquityComponentsAxis=us-gaap_CommonStockMember', window );">Common stock | SPAC Warrants</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ClassOfStockLineItems', window );"><strong>Class of Stock [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1', window );">Exercise price of warrant (in usd per share) | $ / shares</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 23.00<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ClassOfWarrantOrRightNumberOfSecuritiesCalledByEachWarrantOrRight', window );">Number of shares issued for each warrant (in shares)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0.25<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StatementEquityComponentsAxis=us-gaap_CommonStockMember', window );">Common stock | Placement Agent Warrants</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ClassOfStockLineItems', window );"><strong>Class of Stock [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1', window );">Exercise price of warrant (in usd per share) | $ / shares</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 8.68<span></span>
</td>
<td class="nump">$ 9.54<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ClassOfWarrantOrRightNumberOfSecuritiesCalledByEachWarrantOrRight', window );">Number of shares issued for each warrant (in shares)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1<span></span>
</td>
<td class="nump">1<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StatementEquityComponentsAxis=us-gaap_CommonStockMember', window );">Common stock | Placement Agent Warrants | 2018 Convertible Bridge Notes</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ClassOfStockLineItems', window );"><strong>Class of Stock [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1', window );">Exercise price of warrant (in usd per share) | $ / shares</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 9.54<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 9.54<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ClassOfWarrantOrRightNumberOfSecuritiesCalledByEachWarrantOrRight', window );">Number of shares issued for each warrant (in shares)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StatementEquityComponentsAxis=us-gaap_CommonStockMember', window );">Common stock | Management Warrants</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ClassOfStockLineItems', window );"><strong>Class of Stock [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1', window );">Exercise price of warrant (in usd per share) | $ / shares</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 1.08<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ClassOfWarrantOrRightNumberOfSecuritiesCalledByEachWarrantOrRight', window );">Number of shares issued for each warrant (in shares)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">20,320<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dmtk_WarrantsVestingPeriod', window );">Warrants vesting period</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">4 years<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_RangeAxis=srt_MinimumMember', window );">Minimum | 2020 Equity Incentive Plan | Incentive Stock Options</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ClassOfStockLineItems', window );"><strong>Class of Stock [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardPurchasePriceOfCommonStockPercent', window );">Options granted, exercise price expressed as a percentage of fair market value</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">110.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_RangeAxis=srt_MinimumMember', window );">Minimum | 2020 Equity Incentive Plan | Incentive and Non-qualified Stock Options</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ClassOfStockLineItems', window );"><strong>Class of Stock [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardPurchasePriceOfCommonStockPercent', window );">Options granted, exercise price expressed as a percentage of fair market value</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">100.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_RangeAxis=srt_MaximumMember', window );">Maximum | 2020 Equity Incentive Plan</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ClassOfStockLineItems', window );"><strong>Class of Stock [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dmtk_EquityIncentivePlanOptionTerm', window );">Term of the option</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">5 years<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SharesIssued', window );">Shares, issued (in shares)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1,400,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_RangeAxis=srt_MaximumMember', window );">Maximum | 2020 Employee Stock Purchase Plan</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ClassOfStockLineItems', window );"><strong>Class of Stock [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CommonStockCapitalSharesReservedForFutureIssuance', window );">Common stock available for issuance (in shares)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">400,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dmtk_ClassOfWarrantOrRightWarrantsOrRightsIssuedToPurchaseCommonStock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Class of warrant or rights issued to purchase common stock.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dmtk_ClassOfWarrantOrRightWarrantsOrRightsIssuedToPurchaseCommonStock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dmtk_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dmtk_CommonSharesIssuedUponExerciseOfWarrants">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Common shares issued upon exercise of warrants.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dmtk_CommonSharesIssuedUponExerciseOfWarrants</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dmtk_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dmtk_CommonStockOutstandingPercentage">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Common stock outstanding percentage.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dmtk_CommonStockOutstandingPercentage</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dmtk_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dmtk_EquityIncentivePlanOptionTerm">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Equity incentive plan option term.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dmtk_EquityIncentivePlanOptionTerm</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dmtk_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:durationItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dmtk_GrossProceedsFromIssuanceOfCommonStock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Gross proceeds from issuance of common stock.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dmtk_GrossProceedsFromIssuanceOfCommonStock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dmtk_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dmtk_GrossProceedsFromOfferingBeforeDeductingUnderwritingDiscountsAndCommissionsAndOtherOfferingExpenses">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Gross proceeds from offering, before deducting underwriting discounts and commissions and other offering expenses.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dmtk_GrossProceedsFromOfferingBeforeDeductingUnderwritingDiscountsAndCommissionsAndOtherOfferingExpenses</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dmtk_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dmtk_IncreaseDecreaseInStockIssuanceCosts">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Increase decrease in stock issuance costs.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dmtk_IncreaseDecreaseInStockIssuanceCosts</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dmtk_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dmtk_NumberOfWarrantsEntitleHolderToPurchaseOneShare">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Number of warrants entitle holder to purchase one share.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dmtk_NumberOfWarrantsEntitleHolderToPurchaseOneShare</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dmtk_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:integerItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dmtk_PercentageOfPriceAtSharesPurchased">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Percentage of price at shares purchased</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dmtk_PercentageOfPriceAtSharesPurchased</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dmtk_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dmtk_StockPurchasedByUnderwritersPursuantToOptionGranted">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Stock purchased by underwriters pursuant to option granted.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dmtk_StockPurchasedByUnderwritersPursuantToOptionGranted</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dmtk_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dmtk_UnderwritersGrantPeriodOption">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Underwriters grant period option.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dmtk_UnderwritersGrantPeriodOption</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dmtk_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:durationItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dmtk_WarrantsVestingPeriod">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Warrants vesting period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dmtk_WarrantsVestingPeriod</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dmtk_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:durationItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dmtk_WeightedAveragePurchasePricePerShareInOffering">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Weighted average purchase price per share in offering.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dmtk_WeightedAveragePurchasePricePerShareInOffering</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dmtk_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ClassOfStockLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ClassOfStockLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Exercise price per share or per unit of warrants or rights outstanding.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -URI https://asc.fasb.org/extlink&amp;oid=126973232&amp;loc=d3e21475-112644<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ClassOfWarrantOrRightNumberOfSecuritiesCalledByEachWarrantOrRight">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Number of securities into which each warrant or right may be converted. For example, but not limited to, each warrant may be converted into two shares.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ClassOfWarrantOrRightNumberOfSecuritiesCalledByEachWarrantOrRight</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Number of securities into which the class of warrant or right may be converted. For example, but not limited to, 500,000 warrants may be converted into 1,000,000 shares.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -URI https://asc.fasb.org/extlink&amp;oid=126973232&amp;loc=d3e21475-112644<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ClassOfWarrantOrRightOutstanding">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Number of warrants or rights outstanding.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ClassOfWarrantOrRightOutstanding</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CommonStockCapitalSharesReservedForFutureIssuance">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Aggregate number of common shares reserved for future issuance.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.29)<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CommonStockCapitalSharesReservedForFutureIssuance</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CommonStockParOrStatedValuePerShare">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Face amount or stated value per share of common stock.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CommonStockParOrStatedValuePerShare</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CommonStockSharesAuthorized">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The maximum number of common shares permitted to be issued by an entity's charter and bylaws.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CommonStockSharesAuthorized</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CommonStockSharesIssued">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Total number of common shares of an entity that have been sold or granted to shareholders (includes common shares that were issued, repurchased and remain in the treasury). These shares represent capital invested by the firm's shareholders and owners, and may be all or only a portion of the number of shares authorized. Shares issued include shares outstanding and shares held in the treasury.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CommonStockSharesIssued</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of cost not yet recognized for nonvested award under share-based payment arrangement.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (i)<br> -URI https://asc.fasb.org/extlink&amp;oid=128089324&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Weighted-average period over which cost not yet recognized is expected to be recognized for award under share-based payment arrangement, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents reported fact of one year, five months, and thirteen days.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (i)<br> -URI https://asc.fasb.org/extlink&amp;oid=128089324&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:durationItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PreferredStockParOrStatedValuePerShare">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Face amount or stated value per share of preferred stock nonredeemable or redeemable solely at the option of the issuer.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(28))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 13<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126973232&amp;loc=SL123496158-112644<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PreferredStockParOrStatedValuePerShare</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PreferredStockSharesAuthorized">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The maximum number of nonredeemable preferred shares (or preferred stock redeemable solely at the option of the issuer) permitted to be issued by an entity's charter and bylaws.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(28))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PreferredStockSharesAuthorized</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ProceedsFromIssuanceOfCommonStock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The cash inflow from the additional capital contribution to the entity.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 14<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3255-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ProceedsFromIssuanceOfCommonStock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ProceedsFromWarrantExercises">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The cash inflow associated with the amount received from holders exercising their stock warrants.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 14<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3255-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ProceedsFromWarrantExercises</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SaleOfStockNumberOfSharesIssuedInTransaction">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The number of shares issued or sold by the subsidiary or equity method investee per stock transaction.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SaleOfStockNumberOfSharesIssuedInTransaction</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SaleOfStockPricePerShare">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Per share amount received by subsidiary or equity investee for each share of common stock issued or sold in the stock transaction.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SaleOfStockPricePerShare</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The difference between the maximum number of shares (or other type of equity) authorized for issuance under the plan (including the effects of amendments and adjustments), and the sum of: 1) the number of shares (or other type of equity) already issued upon exercise of options or other equity-based awards under the plan; and 2) shares (or other type of equity) reserved for issuance on granting of outstanding awards, net of cancellations and forfeitures, if applicable.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI https://asc.fasb.org/extlink&amp;oid=128089324&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardExpirationPeriod">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Period from grant date that an equity-based award expires, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents the reported fact of one year, five months, and thirteen days.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)(2)<br> -URI https://asc.fasb.org/extlink&amp;oid=128089324&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardExpirationPeriod</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:durationItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardPurchasePriceOfCommonStockPercent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Purchase price of common stock expressed as a percentage of its fair value.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardPurchasePriceOfCommonStockPercent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SharesIssued">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Number of shares of stock issued as of the balance sheet date, including shares that had been issued and were previously outstanding but which are now held in the treasury.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI https://asc.fasb.org/extlink&amp;oid=126973232&amp;loc=d3e21463-112644<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SharesIssued</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockIssuedDuringPeriodSharesNewIssues">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Number of new stock issued during the period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI https://asc.fasb.org/extlink&amp;oid=126973232&amp;loc=d3e21463-112644<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.3-04)<br> -URI https://asc.fasb.org/extlink&amp;oid=120397183&amp;loc=d3e187085-122770<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(28))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockIssuedDuringPeriodSharesNewIssues</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockIssuedDuringPeriodValueNewIssues">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Equity impact of the value of new stock issued during the period. Includes shares issued in an initial public offering or a secondary public offering.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.3-04)<br> -URI https://asc.fasb.org/extlink&amp;oid=120397183&amp;loc=d3e187085-122770<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI https://asc.fasb.org/extlink&amp;oid=126973232&amp;loc=d3e21463-112644<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(28))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockIssuedDuringPeriodValueNewIssues</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_WarrantsAndRightsOutstandingTerm">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Period between issuance and expiration of outstanding warrant and right embodying unconditional obligation requiring redemption by transferring asset at specified or determinable date or upon event certain to occur, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents reported fact of one year, five months, and thirteen days.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 820<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (bbb)(2)<br> -URI https://asc.fasb.org/extlink&amp;oid=126976982&amp;loc=d3e19207-110258<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_WarrantsAndRightsOutstandingTerm</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:durationItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PlanNameAxis=dmtk_TwoThousandTenStockPlanMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PlanNameAxis=dmtk_TwoThousandTenStockPlanMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PlanNameAxis=dmtk_TwoThousandTwentyEquityIncentivePlanMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PlanNameAxis=dmtk_TwoThousandTwentyEquityIncentivePlanMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PlanNameAxis=dmtk_TwoThousandTwentyEmployeeStockPurchasePlanMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PlanNameAxis=dmtk_TwoThousandTwentyEmployeeStockPurchasePlanMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ClassOfWarrantOrRightAxis=dmtk_SpecialPurposeAcquisitionCompaniesWarrantsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ClassOfWarrantOrRightAxis=dmtk_SpecialPurposeAcquisitionCompaniesWarrantsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ClassOfWarrantOrRightAxis=dmtk_PublicSpecialPurposeAcquisitionCompaniesWarrantsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ClassOfWarrantOrRightAxis=dmtk_PublicSpecialPurposeAcquisitionCompaniesWarrantsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ClassOfWarrantOrRightAxis=dmtk_PrivateSpecialPurposeAcquisitionCompaniesWarrantsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ClassOfWarrantOrRightAxis=dmtk_PrivateSpecialPurposeAcquisitionCompaniesWarrantsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ClassOfWarrantOrRightAxis=dmtk_PlacementAgentWarrantsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ClassOfWarrantOrRightAxis=dmtk_PlacementAgentWarrantsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentAxis=dmtk_TwoThousandEighteenConvertibleBridgeNotesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentAxis=dmtk_TwoThousandEighteenConvertibleBridgeNotesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ClassOfWarrantOrRightAxis=dmtk_ManagementWarrantsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ClassOfWarrantOrRightAxis=dmtk_ManagementWarrantsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RelatedPartyTransactionsByRelatedPartyAxis=dmtk_CowenLimitedLiabilityCompanyMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RelatedPartyTransactionsByRelatedPartyAxis=dmtk_CowenLimitedLiabilityCompanyMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementEquityComponentsAxis=us-gaap_CommonStockMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementEquityComponentsAxis=us-gaap_CommonStockMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_RangeAxis=srt_MinimumMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_RangeAxis=srt_MinimumMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AwardTypeAxis=dmtk_IncentiveStockOptionsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AwardTypeAxis=dmtk_IncentiveStockOptionsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AwardTypeAxis=dmtk_IncentiveAndNonQualifiedStockOptionsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AwardTypeAxis=dmtk_IncentiveAndNonQualifiedStockOptionsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_RangeAxis=srt_MaximumMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_RangeAxis=srt_MaximumMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>54
<FILENAME>R31.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.2</span><table class="report" border="0" cellspacing="2" id="idm139763870987952">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Stockholders' Equity - ESPP Valuation Method (Details)<br></strong></div></th>
<th class="th" colspan="2">3 Months Ended</th>
<th class="th" colspan="2">6 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Jun. 30, 2022</div></th>
<th class="th"><div>Jun. 30, 2021</div></th>
<th class="th"><div>Jun. 30, 2022</div></th>
<th class="th"><div>Jun. 30, 2021</div></th>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PlanNameAxis=dmtk_TwoThousandTwentyEquityIncentivePlanMember', window );">2020 Equity Incentive Plan</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ClassOfStockLineItems', window );"><strong>Class of Stock [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate', window );">Assumed risk-free interest rate</a></td>
<td class="nump">2.97%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">2.97%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMinimum', window );">Assumed risk-free interest rate, minimum</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1.03%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0.52%<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMaximum', window );">Assumed risk-free interest rate, maximum</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1.07%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1.13%<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate', window );">Assumed volatility</a></td>
<td class="nump">81.65%<span></span>
</td>
<td class="nump">77.69%<span></span>
</td>
<td class="nump">81.65%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRateMinimum', window );">Assumed volatility, minimum</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">74.88%<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRateMaximum', window );">Assumed volatility, maximum</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">77.69%<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1', window );">Expected term</a></td>
<td class="text">6 years 29 days<span></span>
</td>
<td class="text">6 years 29 days<span></span>
</td>
<td class="text">6 years 29 days<span></span>
</td>
<td class="text">6 years 29 days<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate', window );">Expected dividend yield</a></td>
<td class="nump">0.00%<span></span>
</td>
<td class="nump">0.00%<span></span>
</td>
<td class="nump">0.00%<span></span>
</td>
<td class="nump">0.00%<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PlanNameAxis=dmtk_TwoThousandTwentyEmployeeStockPurchasePlanMember', window );">2020 Employee Stock Purchase Plan</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ClassOfStockLineItems', window );"><strong>Class of Stock [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate', window );">Assumed risk-free interest rate</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0.10%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMinimum', window );">Assumed risk-free interest rate, minimum</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0.05%<span></span>
</td>
<td class="nump">0.10%<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMaximum', window );">Assumed risk-free interest rate, maximum</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0.22%<span></span>
</td>
<td class="nump">0.18%<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate', window );">Assumed volatility</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">69.34%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRateMinimum', window );">Assumed volatility, minimum</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">52.58%<span></span>
</td>
<td class="nump">68.44%<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRateMaximum', window );">Assumed volatility, maximum</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">64.55%<span></span>
</td>
<td class="nump">69.34%<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1', window );">Expected term</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">6 months<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate', window );">Expected dividend yield</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0.00%<span></span>
</td>
<td class="nump">0.00%<span></span>
</td>
<td class="nump">0.00%<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PlanNameAxis=dmtk_TwoThousandTwentyEmployeeStockPurchasePlanMember', window );">2020 Employee Stock Purchase Plan | Minimum</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ClassOfStockLineItems', window );"><strong>Class of Stock [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1', window );">Expected term</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">5 months 26 days<span></span>
</td>
<td class="text">5 months 26 days<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PlanNameAxis=dmtk_TwoThousandTwentyEmployeeStockPurchasePlanMember', window );">2020 Employee Stock Purchase Plan | Maximum</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ClassOfStockLineItems', window );"><strong>Class of Stock [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1', window );">Expected term</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">6 months<span></span>
</td>
<td class="text">6 months<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ClassOfStockLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ClassOfStockLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The estimated dividend rate (a percentage of the share price) to be paid (expected dividends) to holders of the underlying shares over the option's term.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (f)(2)(iii)<br> -URI https://asc.fasb.org/extlink&amp;oid=128089324&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The estimated measure of the percentage by which a share price is expected to fluctuate during a period. Volatility also may be defined as a probability-weighted measure of the dispersion of returns about the mean. The volatility of a share price is the standard deviation of the continuously compounded rates of return on the share over a specified period. That is the same as the standard deviation of the differences in the natural logarithms of the stock prices plus dividends, if any, over the period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (f)(2)(ii)<br> -URI https://asc.fasb.org/extlink&amp;oid=128089324&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRateMaximum">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The estimated measure of the maximum percentage by which a share price is expected to fluctuate during a period. Volatility also may be defined as a probability-weighted measure of the dispersion of returns about the mean. The volatility of a share price is the standard deviation of the continuously compounded rates of return on the share over a specified period. That is the same as the standard deviation of the differences in the natural logarithms of the stock prices plus dividends, if any, over the period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRateMaximum</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRateMinimum">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The estimated measure of the minimum percentage by which a share price is expected to fluctuate during a period. Volatility also may be defined as a probability-weighted measure of the dispersion of returns about the mean. The volatility of a share price is the standard deviation of the continuously compounded rates of return on the share over a specified period. That is the same as the standard deviation of the differences in the natural logarithms of the stock prices plus dividends, if any, over the period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRateMinimum</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The risk-free interest rate assumption that is used in valuing an option on its own shares.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (f)(2)(iv)<br> -URI https://asc.fasb.org/extlink&amp;oid=128089324&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMaximum">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The maximum risk-free interest rate assumption that is used in valuing an option on its own shares.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMaximum</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMinimum">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The minimum risk-free interest rate assumption that is used in valuing an option on its own shares.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMinimum</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Expected term of award under share-based payment arrangement, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents reported fact of one year, five months, and thirteen days.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (f)(2)(i)<br> -URI https://asc.fasb.org/extlink&amp;oid=128089324&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:durationItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PlanNameAxis=dmtk_TwoThousandTwentyEquityIncentivePlanMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PlanNameAxis=dmtk_TwoThousandTwentyEquityIncentivePlanMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PlanNameAxis=dmtk_TwoThousandTwentyEmployeeStockPurchasePlanMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PlanNameAxis=dmtk_TwoThousandTwentyEmployeeStockPurchasePlanMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_RangeAxis=srt_MinimumMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_RangeAxis=srt_MinimumMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_RangeAxis=srt_MaximumMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_RangeAxis=srt_MaximumMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>55
<FILENAME>R32.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.2</span><table class="report" border="0" cellspacing="2" id="idm139763871663840">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Stockholders' Equity - Share-Based Compensation Expense (Details) - USD ($)<br> $ in Thousands</strong></div></th>
<th class="th" colspan="2">3 Months Ended</th>
<th class="th" colspan="2">6 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Jun. 30, 2022</div></th>
<th class="th"><div>Jun. 30, 2021</div></th>
<th class="th"><div>Jun. 30, 2022</div></th>
<th class="th"><div>Jun. 30, 2021</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems', window );"><strong>Share Based Compensation Arrangement By Share Based Payment Award [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AllocatedShareBasedCompensationExpense', window );">Total stock-based compensation</a></td>
<td class="nump">$ 4,837<span></span>
</td>
<td class="nump">$ 3,538<span></span>
</td>
<td class="nump">$ 8,731<span></span>
</td>
<td class="nump">$ 5,710<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncomeStatementLocationAxis=us-gaap_CostOfSalesMember', window );">Cost of revenue</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems', window );"><strong>Share Based Compensation Arrangement By Share Based Payment Award [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AllocatedShareBasedCompensationExpense', window );">Total stock-based compensation</a></td>
<td class="nump">298<span></span>
</td>
<td class="nump">259<span></span>
</td>
<td class="nump">633<span></span>
</td>
<td class="nump">410<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncomeStatementLocationAxis=us-gaap_SellingAndMarketingExpenseMember', window );">Sales and marketing</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems', window );"><strong>Share Based Compensation Arrangement By Share Based Payment Award [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AllocatedShareBasedCompensationExpense', window );">Total stock-based compensation</a></td>
<td class="nump">1,067<span></span>
</td>
<td class="nump">935<span></span>
</td>
<td class="nump">2,528<span></span>
</td>
<td class="nump">1,482<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncomeStatementLocationAxis=us-gaap_ResearchAndDevelopmentExpenseMember', window );">Research and development</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems', window );"><strong>Share Based Compensation Arrangement By Share Based Payment Award [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AllocatedShareBasedCompensationExpense', window );">Total stock-based compensation</a></td>
<td class="nump">1,330<span></span>
</td>
<td class="nump">515<span></span>
</td>
<td class="nump">1,825<span></span>
</td>
<td class="nump">829<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncomeStatementLocationAxis=us-gaap_GeneralAndAdministrativeExpenseMember', window );">General and administrative</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems', window );"><strong>Share Based Compensation Arrangement By Share Based Payment Award [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AllocatedShareBasedCompensationExpense', window );">Total stock-based compensation</a></td>
<td class="nump">$ 2,142<span></span>
</td>
<td class="nump">$ 1,829<span></span>
</td>
<td class="nump">$ 3,745<span></span>
</td>
<td class="nump">$ 2,989<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AllocatedShareBasedCompensationExpense">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of expense for award under share-based payment arrangement. Excludes amount capitalized.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (h)(1)(i)<br> -URI https://asc.fasb.org/extlink&amp;oid=128089324&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AllocatedShareBasedCompensationExpense</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeStatementLocationAxis=us-gaap_CostOfSalesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeStatementLocationAxis=us-gaap_CostOfSalesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeStatementLocationAxis=us-gaap_SellingAndMarketingExpenseMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeStatementLocationAxis=us-gaap_SellingAndMarketingExpenseMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeStatementLocationAxis=us-gaap_ResearchAndDevelopmentExpenseMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeStatementLocationAxis=us-gaap_ResearchAndDevelopmentExpenseMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeStatementLocationAxis=us-gaap_GeneralAndAdministrativeExpenseMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeStatementLocationAxis=us-gaap_GeneralAndAdministrativeExpenseMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>56
<FILENAME>R33.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.2</span><table class="report" border="0" cellspacing="2" id="idm139763865638240">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Stockholders' Equity - Summary of Common Stock Reserved for Future Issuance (Detail)<br></strong></div></th>
<th class="th" colspan="1">6 Months Ended</th>
<th class="th" colspan="1"></th>
</tr>
<tr>
<th class="th">
<div>Jun. 30, 2022 </div>
<div>Warrant </div>
<div>shares</div>
</th>
<th class="th">
<div>Dec. 31, 2021 </div>
<div>shares</div>
</th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ClassOfStockLineItems', window );"><strong>Class of Stock [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CommonStockCapitalSharesReservedForFutureIssuance', window );">Total common stock reserved for future issuance</a></td>
<td class="nump">6,615<span></span>
</td>
<td class="nump">4,591<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ClassOfWarrantOrRightAxis=dmtk_SpecialPurposeAcquisitionCompaniesWarrantsMember', window );">SPAC Warrants</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ClassOfStockLineItems', window );"><strong>Class of Stock [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dmtk_NumberOfWarrantsEntitleHolderToPurchaseOneShare', window );">Number of warrants entitle holder to purchase one share | Warrant</a></td>
<td class="nump">4<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AwardTypeAxis=dmtk_WarrantsToPurchaseCommonStockMember', window );">Warrants to purchase common stock</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ClassOfStockLineItems', window );"><strong>Class of Stock [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CommonStockCapitalSharesReservedForFutureIssuance', window );">Total common stock reserved for future issuance</a></td>
<td class="nump">10<span></span>
</td>
<td class="nump">31<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AwardTypeAxis=dmtk_SpecialPurposeAcquisitionCompanyWarrantsToPurchaseCommonStockMember', window );">SPAC Warrants to purchase common stock*</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ClassOfStockLineItems', window );"><strong>Class of Stock [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CommonStockCapitalSharesReservedForFutureIssuance', window );">Total common stock reserved for future issuance</a></td>
<td class="nump">704<span></span>
</td>
<td class="nump">704<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AwardTypeAxis=us-gaap_EmployeeStockOptionMember', window );">Stock options issued and outstanding</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ClassOfStockLineItems', window );"><strong>Class of Stock [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CommonStockCapitalSharesReservedForFutureIssuance', window );">Total common stock reserved for future issuance</a></td>
<td class="nump">1,758<span></span>
</td>
<td class="nump">1,721<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AwardTypeAxis=us-gaap_RestrictedStockUnitsRSUMember', window );">RSUs issued and outstanding</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ClassOfStockLineItems', window );"><strong>Class of Stock [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CommonStockCapitalSharesReservedForFutureIssuance', window );">Total common stock reserved for future issuance</a></td>
<td class="nump">2,912<span></span>
</td>
<td class="nump">983<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AwardTypeAxis=dmtk_AuthorizedForFutureEquityGrantsMember', window );">Authorized for future equity grants</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ClassOfStockLineItems', window );"><strong>Class of Stock [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CommonStockCapitalSharesReservedForFutureIssuance', window );">Total common stock reserved for future issuance</a></td>
<td class="nump">431<span></span>
</td>
<td class="nump">603<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AwardTypeAxis=dmtk_AuthorizedForFutureESPPPurchasesMember', window );">Authorized for future ESPP purchases</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ClassOfStockLineItems', window );"><strong>Class of Stock [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CommonStockCapitalSharesReservedForFutureIssuance', window );">Total common stock reserved for future issuance</a></td>
<td class="nump">800<span></span>
</td>
<td class="nump">549<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dmtk_NumberOfWarrantsEntitleHolderToPurchaseOneShare">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Number of warrants entitle holder to purchase one share.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dmtk_NumberOfWarrantsEntitleHolderToPurchaseOneShare</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dmtk_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:integerItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ClassOfStockLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ClassOfStockLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CommonStockCapitalSharesReservedForFutureIssuance">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Aggregate number of common shares reserved for future issuance.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.29)<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CommonStockCapitalSharesReservedForFutureIssuance</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ClassOfWarrantOrRightAxis=dmtk_SpecialPurposeAcquisitionCompaniesWarrantsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ClassOfWarrantOrRightAxis=dmtk_SpecialPurposeAcquisitionCompaniesWarrantsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AwardTypeAxis=dmtk_WarrantsToPurchaseCommonStockMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AwardTypeAxis=dmtk_WarrantsToPurchaseCommonStockMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AwardTypeAxis=dmtk_SpecialPurposeAcquisitionCompanyWarrantsToPurchaseCommonStockMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AwardTypeAxis=dmtk_SpecialPurposeAcquisitionCompanyWarrantsToPurchaseCommonStockMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AwardTypeAxis=us-gaap_EmployeeStockOptionMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AwardTypeAxis=us-gaap_EmployeeStockOptionMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AwardTypeAxis=us-gaap_RestrictedStockUnitsRSUMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AwardTypeAxis=us-gaap_RestrictedStockUnitsRSUMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AwardTypeAxis=dmtk_AuthorizedForFutureEquityGrantsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AwardTypeAxis=dmtk_AuthorizedForFutureEquityGrantsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AwardTypeAxis=dmtk_AuthorizedForFutureESPPPurchasesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AwardTypeAxis=dmtk_AuthorizedForFutureESPPPurchasesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>57
<FILENAME>R34.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.2</span><table class="report" border="0" cellspacing="2" id="idm139763870798928">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Leases, Commitments and Contingencies - Adoption of ASC 842 (Details) - USD ($)<br> $ in Thousands</strong></div></th>
<th class="th" colspan="2">6 Months Ended</th>
<th class="th" colspan="1"></th>
</tr>
<tr>
<th class="th"><div>Jun. 30, 2022</div></th>
<th class="th"><div>Jun. 30, 2021</div></th>
<th class="th"><div>Jan. 01, 2021</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract', window );"><strong>Adjustments to reconcile net loss to net cash used in operating activities:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OperatingLeaseRightOfUseAssetAmortizationExpense', window );">Amortization of operating lease right-of-use assets</a></td>
<td class="nump">$ 1,109<span></span>
</td>
<td class="nump">$ 582<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncreaseDecreaseInOtherOperatingAssetsAndLiabilitiesNetAbstract', window );"><strong>Change in operating assets and liabilities:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OperatingLeaseLiability', window );">Operating lease liabilities, net</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 3,100<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AdjustmentsForNewAccountingPronouncementsAxis=us-gaap_AccountingStandardsUpdate201602Member', window );">Accounting Standards Update 2016-02</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract', window );"><strong>Adjustments to reconcile net loss to net cash used in operating activities:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OperatingLeaseRightOfUseAssetAmortizationExpense', window );">Amortization of operating lease right-of-use assets</a></td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncreaseDecreaseInOtherOperatingAssetsAndLiabilitiesNetAbstract', window );"><strong>Change in operating assets and liabilities:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OperatingLeaseLiability', window );">Operating lease liabilities, net</a></td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OtherLiabilities', window );">Other liabilities</a></td>
<td class="nump">254<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AdjustmentsForNewAccountingPronouncementsAxis=us-gaap_AccountingStandardsUpdate201602Member', window );">Accounting Standards Update 2016-02 | Effect of Adoption</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract', window );"><strong>Adjustments to reconcile net loss to net cash used in operating activities:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OperatingLeaseRightOfUseAssetAmortizationExpense', window );">Amortization of operating lease right-of-use assets</a></td>
<td class="nump">582<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncreaseDecreaseInOtherOperatingAssetsAndLiabilitiesNetAbstract', window );"><strong>Change in operating assets and liabilities:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OperatingLeaseLiability', window );">Operating lease liabilities, net</a></td>
<td class="num">(328)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OtherLiabilities', window );">Other liabilities</a></td>
<td class="num">(254)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AdjustmentsForNewAccountingPronouncementsAxis=us-gaap_AccountingStandardsUpdate201602Member', window );">Accounting Standards Update 2016-02 | After Adoption of ASC 842</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract', window );"><strong>Adjustments to reconcile net loss to net cash used in operating activities:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OperatingLeaseRightOfUseAssetAmortizationExpense', window );">Amortization of operating lease right-of-use assets</a></td>
<td class="nump">582<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncreaseDecreaseInOtherOperatingAssetsAndLiabilitiesNetAbstract', window );"><strong>Change in operating assets and liabilities:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OperatingLeaseLiability', window );">Operating lease liabilities, net</a></td>
<td class="num">(328)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OtherLiabilities', window );">Other liabilities</a></td>
<td class="nump">$ 0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncreaseDecreaseInOtherOperatingAssetsAndLiabilitiesNetAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncreaseDecreaseInOtherOperatingAssetsAndLiabilitiesNetAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OperatingLeaseLiability">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Present value of lessee's discounted obligation for lease payments from operating lease.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 45<br> -Paragraph 1<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=123391704&amp;loc=SL77918627-209977<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OperatingLeaseLiability</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OperatingLeaseRightOfUseAssetAmortizationExpense">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of amortization expense for right-of-use asset from operating lease.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3602-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OperatingLeaseRightOfUseAssetAmortizationExpense</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherLiabilities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of liabilities classified as other.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-03.15)<br> -URI https://asc.fasb.org/extlink&amp;oid=126897435&amp;loc=d3e534808-122878<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherLiabilities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AdjustmentsForNewAccountingPronouncementsAxis=us-gaap_AccountingStandardsUpdate201602Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AdjustmentsForNewAccountingPronouncementsAxis=us-gaap_AccountingStandardsUpdate201602Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_CumulativeEffectPeriodOfAdoptionAxis=srt_CumulativeEffectPeriodOfAdoptionAdjustmentMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_CumulativeEffectPeriodOfAdoptionAxis=srt_CumulativeEffectPeriodOfAdoptionAdjustmentMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_CumulativeEffectPeriodOfAdoptionAxis=srt_CumulativeEffectPeriodOfAdoptionAdjustedBalanceMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_CumulativeEffectPeriodOfAdoptionAxis=srt_CumulativeEffectPeriodOfAdoptionAdjustedBalanceMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>58
<FILENAME>R35.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.2</span><table class="report" border="0" cellspacing="2" id="idm139763866722160">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Leases, Commitments and Contingencies - Additional Information (Details)<br></strong></div></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1">1 Months Ended</th>
<th class="th" colspan="2">3 Months Ended</th>
<th class="th" colspan="2">6 Months Ended</th>
<th class="th" colspan="1">12 Months Ended</th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1"></th>
</tr>
<tr>
<th class="th">
<div>Apr. 22, 2022 </div>
<div>USD ($) </div>
<div>ft&#178;</div>
</th>
<th class="th">
<div>Jul. 01, 2021 </div>
<div>USD ($) </div>
<div>ft&#178; </div>
<div>$ / ft&#178;</div>
</th>
<th class="th">
<div>Apr. 30, 2022 </div>
<div>USD ($) </div>
<div>$ / ft&#178;</div>
</th>
<th class="th">
<div>Jun. 30, 2022 </div>
<div>USD ($) </div>
<div>period </div>
<div>phase</div>
</th>
<th class="th">
<div>Jun. 30, 2021 </div>
<div>USD ($)</div>
</th>
<th class="th">
<div>Jun. 30, 2022 </div>
<div>USD ($) </div>
<div>period </div>
<div>phase</div>
</th>
<th class="th">
<div>Jun. 30, 2021 </div>
<div>USD ($)</div>
</th>
<th class="th">
<div>Dec. 31, 2021 </div>
<div>USD ($)</div>
</th>
<th class="th">
<div>Mar. 31, 2022 </div>
<div>USD ($)</div>
</th>
<th class="th">
<div>Jan. 01, 2021 </div>
<div>USD ($)</div>
</th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dmtk_CommitmentsAndContingenciesLineItems', window );"><strong>Commitments And Contingencies [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dmtk_PercentageOfUsefulLivesOfAssets', window );">Percentage of useful lives of assets</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">75.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentGross', window );">Gross assets</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 7,154,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 7,154,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 6,174,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DepreciationAndAmortization', window );">Accumulated amortization</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">100,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">100,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FinanceLeaseInterestExpense', window );">Interest on lease liabilities</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 3,000<span></span>
</td>
<td class="nump">$ 4,000<span></span>
</td>
<td class="nump">$ 7,000<span></span>
</td>
<td class="nump">$ 8,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dmtk_NumberOfImprovementPhases', window );">Number of improvement phases | phase</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">4<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">4<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dmtk_LesseeOperatingLeaseNumberOfRenewalTerms', window );">Number of renewal terms | period</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LesseeOperatingLeaseRenewalTerm', window );">Renewal term</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">3 years<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">3 years<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OperatingLeaseRightOfUseAsset', window );">Operating lease right-of-use assets</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 23,694,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 23,694,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">7,744,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 2,800,000<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OperatingLeaseLiability', window );">Operating lease liabilities, net</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">3,100,000<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncreaseDecreaseInOperatingLeaseLiability', window );">Increase to operating lease liability</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(654,000)<span></span>
</td>
<td class="num">(328,000)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue', window );">Total</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">33,645,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">33,645,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dmtk_TenantImprovementAllowance', window );">Tenant improvement allowance</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 300,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">300,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 300,000<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LesseeOperatingLeaseRemainingLeaseTerm', window );">Remaining lease term</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">28 months<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LesseeOperatingLeaseDiscountRate', window );">Estimated discount rate</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">404.00%<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_RangeAxis=srt_MaximumMember', window );">Maximum</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dmtk_CommitmentsAndContingenciesLineItems', window );"><strong>Commitments And Contingencies [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dmtk_IncreaseInTenantImprovementAllowance', window );">Increase in tenant improvement allowance</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 100,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_CounterpartyNameAxis=dmtk_KilroyRealtyLPMember', window );">Kilroy Realty, L.P</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dmtk_CommitmentsAndContingenciesLineItems', window );"><strong>Commitments And Contingencies [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dmtk_AreaOfBuilding', window );">Area of building (in square feet) | ft&#178;</a></td>
<td class="nump">110,082<span></span>
</td>
<td class="nump">95,997<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dmtk_TenantImprovementAllowancePerRentableSquareFoot', window );">Tenant improvement allowance per rentable square foot (in usd per square foot) | $ / ft&#178;</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">125.00<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_TenantImprovements', window );">Tenant improvements</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 12,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dmtk_LesseeOperatingLeaseNumberOfRenewalTerms', window );">Number of renewal terms | period</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">2<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">2<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LesseeOperatingLeaseRenewalTerm', window );">Renewal term</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">5 years<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">5 years<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OperatingLeaseRightOfUseAsset', window );">Operating lease right-of-use assets</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 5,700,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 5,700,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 15,800,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OperatingLeaseLiability', window );">Operating lease liabilities, net</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">5,700,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">5,700,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 15,800,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dmtk_OperatingLeaseIncrementalBorrowingRateAtEffectiveDate', window );">Incremental borrowing rate</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">6.50%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncreaseDecreaseInOperatingLeaseLiability', window );">Increase to operating lease liability</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 1,200,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dmtk_IncreaseDecreaseInOperatingLeaseRightOfUseAsset', window );">Increase to operating right-of-use asset</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1,200,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue', window );">Total</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 54,400,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 54,400,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LesseeOperatingLeaseRemainingLeaseTerm', window );">Remaining lease term</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">10 years 6 months<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">10 years 6 months<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_CounterpartyNameAxis=dmtk_KilroyRealtyLPMember', window );">Kilroy Realty, L.P | First Amendment</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dmtk_CommitmentsAndContingenciesLineItems', window );"><strong>Commitments And Contingencies [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_TenantImprovements', window );">Tenant improvements</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 14,400,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dmtk_IncreaseInTenantImprovementAllowancePerRentableSquareFoot', window );">Increase in improvement allowance per rentable square foot (in usd per square foot) | $ / ft&#178;</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">25.00<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dmtk_IncreaseInTenantImprovementAllowance', window );">Increase in tenant improvement allowance</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 2,400,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_CounterpartyNameAxis=dmtk_KilroyRealtyLPMember', window );">Kilroy Realty, L.P | Second Amendment</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dmtk_CommitmentsAndContingenciesLineItems', window );"><strong>Commitments And Contingencies [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_TenantImprovements', window );">Tenant improvements</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">16,500,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dmtk_IncreaseInTenantImprovementAllowance', window );">Increase in tenant improvement allowance</a></td>
<td class="nump">$ 2,100,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dmtk_RentableAndUsableSquareFeet', window );">Expansion premise (in square feet) | ft&#178;</a></td>
<td class="nump">14,085<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_CounterpartyNameAxis=dmtk_KilroyRealtyLPMember', window );">Kilroy Realty, L.P | Letter of Credit | Demand Deposits</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dmtk_CommitmentsAndContingenciesLineItems', window );"><strong>Commitments And Contingencies [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RestrictedCashAndCashEquivalents', window );">Restricted cash and cash equivalents</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">3,500,000<span></span>
</td>
<td class="nump">$ 3,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 3,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dmtk_RestrictedCashAndCashEquivalentsIncreaseDecrease', window );">Increase (decrease) to restricted cash and cash equivalents</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 500,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_CounterpartyNameAxis=dmtk_KilroyRealtyLPMember', window );">Kilroy Realty, L.P | Standby Letter of Credit | Demand Deposits</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dmtk_CommitmentsAndContingenciesLineItems', window );"><strong>Commitments And Contingencies [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RestrictedCashAndCashEquivalents', window );">Restricted cash and cash equivalents</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncomeStatementLocationAxis=us-gaap_InterestIncomeMember', window );">Interest Income, Net</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dmtk_CommitmentsAndContingenciesLineItems', window );"><strong>Commitments And Contingencies [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FinanceLeaseInterestExpense', window );">Interest on lease liabilities</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">3,000<span></span>
</td>
<td class="nump">$ 4,000<span></span>
</td>
<td class="nump">7,000<span></span>
</td>
<td class="nump">$ 8,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentByTypeAxis=dmtk_AssetsHeldUnderFinanceLeasesMember', window );">Assets Recorded under Finance Leases</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dmtk_CommitmentsAndContingenciesLineItems', window );"><strong>Commitments And Contingencies [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentGross', window );">Gross assets</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 400,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">400,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">400,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DepreciationAndAmortization', window );">Accumulated amortization</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 100,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 100,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dmtk_AreaOfBuilding">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Area of building.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dmtk_AreaOfBuilding</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dmtk_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:areaItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dmtk_CommitmentsAndContingenciesLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Commitments and contingencies.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dmtk_CommitmentsAndContingenciesLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dmtk_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dmtk_IncreaseDecreaseInOperatingLeaseRightOfUseAsset">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Increase (Decrease) In Operating Lease, Right-Of-Use-Asset</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dmtk_IncreaseDecreaseInOperatingLeaseRightOfUseAsset</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dmtk_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dmtk_IncreaseInTenantImprovementAllowance">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Increase in tenant improvement allowance.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dmtk_IncreaseInTenantImprovementAllowance</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dmtk_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dmtk_IncreaseInTenantImprovementAllowancePerRentableSquareFoot">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Increase In Tenant Improvement Allowance Per Rentable Square Foot</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dmtk_IncreaseInTenantImprovementAllowancePerRentableSquareFoot</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dmtk_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>srt-types:perUnitItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dmtk_LesseeOperatingLeaseNumberOfRenewalTerms">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Lessee, Operating Lease, Number Of Renewal Terms</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dmtk_LesseeOperatingLeaseNumberOfRenewalTerms</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dmtk_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:integerItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dmtk_NumberOfImprovementPhases">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Number Of Improvement Phases</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dmtk_NumberOfImprovementPhases</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dmtk_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:integerItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dmtk_OperatingLeaseIncrementalBorrowingRateAtEffectiveDate">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Operating Lease, Incremental Borrowing Rate At Effective Date</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dmtk_OperatingLeaseIncrementalBorrowingRateAtEffectiveDate</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dmtk_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dmtk_PercentageOfUsefulLivesOfAssets">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Percentage of useful lives of assets.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dmtk_PercentageOfUsefulLivesOfAssets</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dmtk_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dmtk_RentableAndUsableSquareFeet">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Rentable And Usable Square Feet</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dmtk_RentableAndUsableSquareFeet</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dmtk_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:integerItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dmtk_RestrictedCashAndCashEquivalentsIncreaseDecrease">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Restricted Cash and Cash Equivalents, Increase (Decrease)</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dmtk_RestrictedCashAndCashEquivalentsIncreaseDecrease</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dmtk_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dmtk_TenantImprovementAllowance">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Tenant improvement allowance.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dmtk_TenantImprovementAllowance</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dmtk_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dmtk_TenantImprovementAllowancePerRentableSquareFoot">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Tenant improvement allowance per rentable square foot.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dmtk_TenantImprovementAllowancePerRentableSquareFoot</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dmtk_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>srt-types:perUnitItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DepreciationAndAmortization">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The current period expense charged against earnings on long-lived, physical assets not used in production, and which are not intended for resale, to allocate or recognize the cost of such assets over their useful lives; or to record the reduction in book value of an intangible asset over the benefit period of such asset; or to reflect consumption during the period of an asset that is not used in production.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 360<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=6391035&amp;loc=d3e2868-110229<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3602-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DepreciationAndAmortization</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FinanceLeaseInterestExpense">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of interest expense on finance lease liability.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=128292326&amp;loc=SL77918686-209980<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 45<br> -Paragraph 4<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=123391704&amp;loc=SL77918638-209977<br><br>Reference 3: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 55<br> -Paragraph 53<br> -URI https://asc.fasb.org/extlink&amp;oid=123414884&amp;loc=SL77918982-209971<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FinanceLeaseInterestExpense</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncreaseDecreaseInOperatingLeaseLiability">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of increase (decrease) in obligation for operating lease.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (g)(1)<br> -URI https://asc.fasb.org/extlink&amp;oid=128292326&amp;loc=SL77918686-209980<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3602-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncreaseDecreaseInOperatingLeaseLiability</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LesseeOperatingLeaseDiscountRate">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Discount rate used by lessee to determine present value of operating lease payments.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)(3)<br> -URI https://asc.fasb.org/extlink&amp;oid=128292326&amp;loc=SL77918673-209980<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LesseeOperatingLeaseDiscountRate</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of lessee's undiscounted obligation for lease payment for operating lease.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 50<br> -Paragraph 6<br> -URI https://asc.fasb.org/extlink&amp;oid=128292326&amp;loc=SL77918701-209980<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LesseeOperatingLeaseRemainingLeaseTerm">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Remaining lease term of operating lease, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents reported fact of one year, five months, and thirteen days.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (a)(1)<br> -URI https://asc.fasb.org/extlink&amp;oid=128292326&amp;loc=SL77918673-209980<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LesseeOperatingLeaseRemainingLeaseTerm</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:durationItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LesseeOperatingLeaseRenewalTerm">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Term of lessee's operating lease renewal, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents reported fact of one year, five months, and thirteen days.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (a)(3)<br> -URI https://asc.fasb.org/extlink&amp;oid=128292326&amp;loc=SL77918673-209980<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LesseeOperatingLeaseRenewalTerm</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:durationItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OperatingLeaseLiability">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Present value of lessee's discounted obligation for lease payments from operating lease.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 45<br> -Paragraph 1<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=123391704&amp;loc=SL77918627-209977<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OperatingLeaseLiability</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OperatingLeaseRightOfUseAsset">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of lessee's right to use underlying asset under operating lease.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 45<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=123391704&amp;loc=SL77918627-209977<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OperatingLeaseRightOfUseAsset</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PropertyPlantAndEquipmentGross">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount before accumulated depreciation, depletion and amortization of physical assets used in the normal conduct of business and not intended for resale. Examples include, but are not limited to, land, buildings, machinery and equipment, office equipment, and furniture and fixtures.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(13))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 360<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=6391035&amp;loc=d3e2868-110229<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PropertyPlantAndEquipmentGross</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RestrictedCashAndCashEquivalents">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of cash and cash equivalents restricted as to withdrawal or usage. Cash includes, but is not limited to, currency on hand, demand deposits with banks or financial institutions, and other accounts with general characteristics of demand deposits. Cash equivalents include, but are not limited to, short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(a)(2))<br> -URI https://asc.fasb.org/extlink&amp;oid=126734703&amp;loc=d3e572229-122910<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(1))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 50<br> -Paragraph 8<br> -URI https://asc.fasb.org/extlink&amp;oid=126999549&amp;loc=SL98516268-108586<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-03(1)(a))<br> -URI https://asc.fasb.org/extlink&amp;oid=126897435&amp;loc=d3e534808-122878<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 4<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3044-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RestrictedCashAndCashEquivalents</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_TenantImprovements">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Carrying amount as of the balance sheet date of improvements having a life longer than one year that were made for the benefit of one or more tenants.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03.1(f))<br> -URI https://asc.fasb.org/extlink&amp;oid=126734703&amp;loc=d3e572229-122910<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_TenantImprovements</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_RangeAxis=srt_MaximumMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_RangeAxis=srt_MaximumMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_CounterpartyNameAxis=dmtk_KilroyRealtyLPMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_CounterpartyNameAxis=dmtk_KilroyRealtyLPMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dmtk_LeaseAmendmentsAxis=dmtk_FirstAmendmentMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dmtk_LeaseAmendmentsAxis=dmtk_FirstAmendmentMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dmtk_LeaseAmendmentsAxis=dmtk_SecondAmendmentMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dmtk_LeaseAmendmentsAxis=dmtk_SecondAmendmentMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CreditFacilityAxis=us-gaap_LetterOfCreditMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CreditFacilityAxis=us-gaap_LetterOfCreditMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RestrictedCashAndCashEquivalentsCashAndCashEquivalentsAxis=us-gaap_DemandDepositsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RestrictedCashAndCashEquivalentsCashAndCashEquivalentsAxis=us-gaap_DemandDepositsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CreditFacilityAxis=us-gaap_StandbyLettersOfCreditMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CreditFacilityAxis=us-gaap_StandbyLettersOfCreditMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeStatementLocationAxis=us-gaap_InterestIncomeMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeStatementLocationAxis=us-gaap_InterestIncomeMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PropertyPlantAndEquipmentByTypeAxis=dmtk_AssetsHeldUnderFinanceLeasesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PropertyPlantAndEquipmentByTypeAxis=dmtk_AssetsHeldUnderFinanceLeasesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>59
<FILENAME>R36.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.2</span><table class="report" border="0" cellspacing="2" id="idm139763877930016">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Leases, Commitments and Contingencies - Schedule of Long Term Finance Lease Obligations (Details) - USD ($)<br> $ in Thousands</strong></div></th>
<th class="th"><div>Jun. 30, 2022</div></th>
<th class="th"><div>Dec. 31, 2021</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CommitmentsAndContingenciesDisclosureAbstract', window );"><strong>Commitments and Contingencies Disclosure [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FinanceLeaseLiabilityPaymentsDue', window );">Gross finance lease obligations</a></td>
<td class="nump">$ 262<span></span>
</td>
<td class="nump">$ 274<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FinanceLeaseLiabilityUndiscountedExcessAmount', window );">Less imputed interest</a></td>
<td class="num">(17)<span></span>
</td>
<td class="num">(17)<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FinanceLeaseLiability', window );">Present value of net minimum lease payments</a></td>
<td class="nump">245<span></span>
</td>
<td class="nump">257<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FinanceLeaseLiabilityCurrent', window );">Less current portion of finance lease obligations</a></td>
<td class="num">(134)<span></span>
</td>
<td class="num">(121)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FinanceLeaseLiabilityNoncurrent', window );">Long-term finance lease obligations, less current portion</a></td>
<td class="nump">$ 111<span></span>
</td>
<td class="nump">$ 136<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CommitmentsAndContingenciesDisclosureAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CommitmentsAndContingenciesDisclosureAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FinanceLeaseLiability">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Present value of lessee's discounted obligation for lease payments from finance lease.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 50<br> -Paragraph 6<br> -URI https://asc.fasb.org/extlink&amp;oid=128292326&amp;loc=SL77918701-209980<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 45<br> -Paragraph 1<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=123391704&amp;loc=SL77918627-209977<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FinanceLeaseLiability</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FinanceLeaseLiabilityCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Present value of lessee's discounted obligation for lease payments from finance lease, classified as current.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 45<br> -Paragraph 1<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=123391704&amp;loc=SL77918627-209977<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FinanceLeaseLiabilityCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FinanceLeaseLiabilityNoncurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Present value of lessee's discounted obligation for lease payments from finance lease, classified as noncurrent.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 45<br> -Paragraph 1<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=123391704&amp;loc=SL77918627-209977<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FinanceLeaseLiabilityNoncurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FinanceLeaseLiabilityPaymentsDue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of lessee's undiscounted obligation for lease payments for finance lease.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 50<br> -Paragraph 6<br> -URI https://asc.fasb.org/extlink&amp;oid=128292326&amp;loc=SL77918701-209980<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FinanceLeaseLiabilityPaymentsDue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FinanceLeaseLiabilityUndiscountedExcessAmount">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of lessee's undiscounted obligation for lease payments in excess of discounted obligation for lease payments for finance lease.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 50<br> -Paragraph 6<br> -URI https://asc.fasb.org/extlink&amp;oid=128292326&amp;loc=SL77918701-209980<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FinanceLeaseLiabilityUndiscountedExcessAmount</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>60
<FILENAME>R37.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.2</span><table class="report" border="0" cellspacing="2" id="idm139763871699408">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Leases, Commitments and Contingencies - Components of Lease Expense (Details) - USD ($)<br> $ in Thousands</strong></div></th>
<th class="th" colspan="2">3 Months Ended</th>
<th class="th" colspan="2">6 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Jun. 30, 2022</div></th>
<th class="th"><div>Jun. 30, 2021</div></th>
<th class="th"><div>Jun. 30, 2022</div></th>
<th class="th"><div>Jun. 30, 2021</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dmtk_OperatingLeaseCostAbstract', window );"><strong>Operating lease cost</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OperatingLeaseCost', window );">Operating lease cost</a></td>
<td class="nump">$ 1,044<span></span>
</td>
<td class="nump">$ 319<span></span>
</td>
<td class="nump">$ 1,667<span></span>
</td>
<td class="nump">$ 638<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_VariableLeaseCost', window );">Variable lease costs</a></td>
<td class="nump">303<span></span>
</td>
<td class="nump">143<span></span>
</td>
<td class="nump">492<span></span>
</td>
<td class="nump">315<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dmtk_OperatingLeaseCosts', window );">Total operating lease cost</a></td>
<td class="nump">1,347<span></span>
</td>
<td class="nump">462<span></span>
</td>
<td class="nump">2,159<span></span>
</td>
<td class="nump">953<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dmtk_FinanceLeaseCostsAbstract', window );"><strong>Finance lease cost</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FinanceLeaseRightOfUseAssetAmortization', window );">Amortization of leased assets</a></td>
<td class="nump">21<span></span>
</td>
<td class="nump">17<span></span>
</td>
<td class="nump">41<span></span>
</td>
<td class="nump">34<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FinanceLeaseInterestExpense', window );">Interest on lease liabilities</a></td>
<td class="nump">3<span></span>
</td>
<td class="nump">4<span></span>
</td>
<td class="nump">7<span></span>
</td>
<td class="nump">8<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dmtk_FinanceLeaseCost', window );">Total finance lease cost</a></td>
<td class="nump">24<span></span>
</td>
<td class="nump">21<span></span>
</td>
<td class="nump">48<span></span>
</td>
<td class="nump">42<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dmtk_CashPaidForAmountsIncludedInMeasurementOfLeaseLiabilitiesAbstract', window );"><strong>Cash paid for amounts included in the measurement of lease liabilities:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OperatingLeasePayments', window );">Operating cash flows from operating leases</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1,179<span></span>
</td>
<td class="nump">684<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FinanceLeaseInterestExpense', window );">Operating cash flows from finance leases</a></td>
<td class="nump">$ 3<span></span>
</td>
<td class="nump">$ 4<span></span>
</td>
<td class="nump">7<span></span>
</td>
<td class="nump">8<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FinanceLeasePrincipalPayments', window );">Financing cash flows from finance leases</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">60<span></span>
</td>
<td class="nump">53<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability', window );">Right-of-use assets obtained in exchange for operating lease obligations</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">17,059<span></span>
</td>
<td class="nump">2,831<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RightOfUseAssetObtainedInExchangeForFinanceLeaseLiability', window );">Right-of-use assets obtained in exchange for finance lease obligations</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 48<span></span>
</td>
<td class="nump">$ 0<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OperatingLeaseWeightedAverageRemainingLeaseTerm1', window );">Weighted-average remaining lease term of operating leases (in years)</a></td>
<td class="text">10 years 6 months 21 days<span></span>
</td>
<td class="text">1 year 11 months 1 day<span></span>
</td>
<td class="text">10 years 6 months 21 days<span></span>
</td>
<td class="text">1 year 11 months 1 day<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FinanceLeaseWeightedAverageRemainingLeaseTerm1', window );">Weighted-average remaining lease term of finance leases (in years)</a></td>
<td class="text">1 year 6 months<span></span>
</td>
<td class="text">2 years 6 months<span></span>
</td>
<td class="text">1 year 6 months<span></span>
</td>
<td class="text">2 years 6 months<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OperatingLeaseWeightedAverageDiscountRatePercent', window );">Weighted-average discount rate for operating leases (in percent)</a></td>
<td class="nump">6.39%<span></span>
</td>
<td class="nump">4.04%<span></span>
</td>
<td class="nump">6.39%<span></span>
</td>
<td class="nump">4.04%<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FinanceLeaseWeightedAverageDiscountRatePercent', window );">Weighted-average discount rate for finance leases (in percent)</a></td>
<td class="nump">5.78%<span></span>
</td>
<td class="nump">5.54%<span></span>
</td>
<td class="nump">5.78%<span></span>
</td>
<td class="nump">5.54%<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dmtk_CashPaidForAmountsIncludedInMeasurementOfLeaseLiabilitiesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Cash paid for amounts included in the measurement of lease liabilities.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dmtk_CashPaidForAmountsIncludedInMeasurementOfLeaseLiabilitiesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dmtk_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dmtk_FinanceLeaseCost">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Finance lease cost.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dmtk_FinanceLeaseCost</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dmtk_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dmtk_FinanceLeaseCostsAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Finance lease cost.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dmtk_FinanceLeaseCostsAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dmtk_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dmtk_OperatingLeaseCostAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Operating lease cost.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dmtk_OperatingLeaseCostAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dmtk_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dmtk_OperatingLeaseCosts">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Operating lease cost.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dmtk_OperatingLeaseCosts</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dmtk_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FinanceLeaseInterestExpense">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of interest expense on finance lease liability.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=128292326&amp;loc=SL77918686-209980<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 45<br> -Paragraph 4<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=123391704&amp;loc=SL77918638-209977<br><br>Reference 3: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 55<br> -Paragraph 53<br> -URI https://asc.fasb.org/extlink&amp;oid=123414884&amp;loc=SL77918982-209971<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FinanceLeaseInterestExpense</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FinanceLeasePrincipalPayments">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of cash outflow for principal payment on finance lease.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 45<br> -Paragraph 5<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=123391704&amp;loc=SL77918643-209977<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (g)(1)<br> -URI https://asc.fasb.org/extlink&amp;oid=128292326&amp;loc=SL77918686-209980<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FinanceLeasePrincipalPayments</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FinanceLeaseRightOfUseAssetAmortization">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of amortization expense attributable to right-of-use asset from finance lease.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=128292326&amp;loc=SL77918686-209980<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 45<br> -Paragraph 4<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=123391704&amp;loc=SL77918638-209977<br><br>Reference 3: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 55<br> -Paragraph 53<br> -URI https://asc.fasb.org/extlink&amp;oid=123414884&amp;loc=SL77918982-209971<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FinanceLeaseRightOfUseAssetAmortization</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FinanceLeaseWeightedAverageDiscountRatePercent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Weighted average discount rate for finance lease calculated at point in time.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (g)(4)<br> -URI https://asc.fasb.org/extlink&amp;oid=128292326&amp;loc=SL77918686-209980<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 55<br> -Paragraph 53<br> -URI https://asc.fasb.org/extlink&amp;oid=123414884&amp;loc=SL77918982-209971<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FinanceLeaseWeightedAverageDiscountRatePercent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FinanceLeaseWeightedAverageRemainingLeaseTerm1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Weighted average remaining lease term for finance lease, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents reported fact of one year, five months, and thirteen days.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (g)(3)<br> -URI https://asc.fasb.org/extlink&amp;oid=128292326&amp;loc=SL77918686-209980<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 55<br> -Paragraph 53<br> -URI https://asc.fasb.org/extlink&amp;oid=123414884&amp;loc=SL77918982-209971<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FinanceLeaseWeightedAverageRemainingLeaseTerm1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:durationItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OperatingLeaseCost">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of single lease cost, calculated by allocation of remaining cost of lease over remaining lease term. Includes, but is not limited to, single lease cost, after impairment of right-of-use asset, calculated by amortization of remaining right-of-use asset and accretion of lease liability.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 55<br> -Paragraph 53<br> -URI https://asc.fasb.org/extlink&amp;oid=123414884&amp;loc=SL77918982-209971<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=128292326&amp;loc=SL77918686-209980<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OperatingLeaseCost</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OperatingLeasePayments">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of cash outflow from operating lease, excluding payments to bring another asset to condition and location necessary for its intended use.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 45<br> -Paragraph 5<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=123391704&amp;loc=SL77918643-209977<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (g)(1)<br> -URI https://asc.fasb.org/extlink&amp;oid=128292326&amp;loc=SL77918686-209980<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OperatingLeasePayments</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OperatingLeaseWeightedAverageDiscountRatePercent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Weighted average discount rate for operating lease calculated at point in time.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (g)(4)<br> -URI https://asc.fasb.org/extlink&amp;oid=128292326&amp;loc=SL77918686-209980<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 55<br> -Paragraph 53<br> -URI https://asc.fasb.org/extlink&amp;oid=123414884&amp;loc=SL77918982-209971<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OperatingLeaseWeightedAverageDiscountRatePercent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OperatingLeaseWeightedAverageRemainingLeaseTerm1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Weighted average remaining lease term for operating lease, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents reported fact of one year, five months, and thirteen days.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 55<br> -Paragraph 53<br> -URI https://asc.fasb.org/extlink&amp;oid=123414884&amp;loc=SL77918982-209971<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (g)(3)<br> -URI https://asc.fasb.org/extlink&amp;oid=128292326&amp;loc=SL77918686-209980<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OperatingLeaseWeightedAverageRemainingLeaseTerm1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:durationItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RightOfUseAssetObtainedInExchangeForFinanceLeaseLiability">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of increase in right-of-use asset obtained in exchange for finance lease liability.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 55<br> -Paragraph 53<br> -URI https://asc.fasb.org/extlink&amp;oid=123414884&amp;loc=SL77918982-209971<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (g)(2)<br> -URI https://asc.fasb.org/extlink&amp;oid=128292326&amp;loc=SL77918686-209980<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RightOfUseAssetObtainedInExchangeForFinanceLeaseLiability</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of increase in right-of-use asset obtained in exchange for operating lease liability.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 55<br> -Paragraph 53<br> -URI https://asc.fasb.org/extlink&amp;oid=123414884&amp;loc=SL77918982-209971<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (g)(2)<br> -URI https://asc.fasb.org/extlink&amp;oid=128292326&amp;loc=SL77918686-209980<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_VariableLeaseCost">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of variable lease cost, excluded from lease liability, recognized when obligation for payment is incurred for finance and operating leases.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (d)<br> -URI https://asc.fasb.org/extlink&amp;oid=128292326&amp;loc=SL77918686-209980<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 55<br> -Paragraph 53<br> -URI https://asc.fasb.org/extlink&amp;oid=123414884&amp;loc=SL77918982-209971<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_VariableLeaseCost</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>61
<FILENAME>R38.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.2</span><table class="report" border="0" cellspacing="2" id="idm139763872722656">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Leases, Commitments and Contingencies - Future Minimum Payments (Details) - USD ($)<br> $ in Thousands</strong></div></th>
<th class="th"><div>Jun. 30, 2022</div></th>
<th class="th"><div>Dec. 31, 2021</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OperatingLeaseLiabilitiesPaymentsDueAbstract', window );"><strong>Operating lease obligations, including interest</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LesseeOperatingLeaseLiabilityPaymentsRemainderOfFiscalYear', window );">2022</a></td>
<td class="nump">$ 1,524<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths', window );">2023</a></td>
<td class="nump">2,948<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearTwo', window );">2024</a></td>
<td class="nump">2,774<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearThree', window );">2025</a></td>
<td class="nump">2,853<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFour', window );">2026</a></td>
<td class="nump">2,934<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dmtk_LesseeOperatingLeaseLiabilityToBePaidAfterYearFour', window );">Thereafter</a></td>
<td class="nump">20,612<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue', window );">Total</a></td>
<td class="nump">33,645<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FinanceLeaseLiabilitiesPaymentsDueAbstract', window );"><strong>Finance lease obligations, including interest</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FinanceLeaseLiabilityPaymentsRemainderOfFiscalYear', window );">2022</a></td>
<td class="nump">72<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FinanceLeaseLiabilityPaymentsDueNextTwelveMonths', window );">2023</a></td>
<td class="nump">133<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FinanceLeaseLiabilityPaymentsDueYearTwo', window );">2024</a></td>
<td class="nump">19<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FinanceLeaseLiabilityPaymentsDueYearThree', window );">2025</a></td>
<td class="nump">19<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FinanceLeaseLiabilityPaymentsDueYearFour', window );">2026</a></td>
<td class="nump">15<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dmtk_FinanceLeaseLiabilityPaymentsDueAfterYearFour', window );">Thereafter</a></td>
<td class="nump">4<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FinanceLeaseLiabilityPaymentsDue', window );">Gross finance lease obligations</a></td>
<td class="nump">262<span></span>
</td>
<td class="nump">$ 274<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dmtk_LesseeOperatingAndFinanceLeaseLiabilityToBePaidAbstract', window );"><strong>Total future minimum lease payments</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dmtk_OperatingAndFinanceLeaseLiabilityPaymentsRemainderOfFiscalYear', window );">Total future minimum lease payments due in 2022</a></td>
<td class="nump">1,596<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dmtk_OperatingAndFinanceLeaseLiabilityPaymentsDueNextTwelveMonths', window );">Total future minimum lease payments due in 2023</a></td>
<td class="nump">3,081<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dmtk_OperatingAndFinanceLeaseLiabilityPaymentsDueYearTwo', window );">Total future minimum lease payments due in 2024</a></td>
<td class="nump">2,793<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dmtk_OperatingAndFinanceLeaseLiabilityPaymentsDueYearThree', window );">Total future minimum lease payments due in 2025</a></td>
<td class="nump">2,872<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dmtk_OperatingAndFinanceLeaseLiabilityPaymentsDueYearFour', window );">Total future minimum lease payments due in 2026</a></td>
<td class="nump">2,949<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dmtk_OperatingAndFinanceLeaseLiabilityPaymentsDueThereafter', window );">Total future minimum lease payments due thereafter</a></td>
<td class="nump">20,616<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dmtk_OperatingAndFinanceLeaseLiabilityPaymentsDue', window );">Operating And Capital Lease Liability Payments Due</a></td>
<td class="nump">$ 33,907<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dmtk_FinanceLeaseLiabilityPaymentsDueAfterYearFour">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Finance lease liability payments due after year four.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dmtk_FinanceLeaseLiabilityPaymentsDueAfterYearFour</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dmtk_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dmtk_LesseeOperatingAndFinanceLeaseLiabilityToBePaidAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Lessee, Operating and Finance Lease, Liability, To Be Paid</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dmtk_LesseeOperatingAndFinanceLeaseLiabilityToBePaidAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dmtk_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dmtk_LesseeOperatingLeaseLiabilityToBePaidAfterYearFour">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Lessee, Operating Lease, Liability, to be Paid, after Year Four</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dmtk_LesseeOperatingLeaseLiabilityToBePaidAfterYearFour</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dmtk_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dmtk_OperatingAndFinanceLeaseLiabilityPaymentsDue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Operating and capital lease liability payments due.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dmtk_OperatingAndFinanceLeaseLiabilityPaymentsDue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dmtk_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dmtk_OperatingAndFinanceLeaseLiabilityPaymentsDueNextTwelveMonths">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Operating and capital lease liability payments due next twelve months.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dmtk_OperatingAndFinanceLeaseLiabilityPaymentsDueNextTwelveMonths</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dmtk_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dmtk_OperatingAndFinanceLeaseLiabilityPaymentsDueThereafter">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Operating and capital lease liability payments due thereafter.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dmtk_OperatingAndFinanceLeaseLiabilityPaymentsDueThereafter</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dmtk_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dmtk_OperatingAndFinanceLeaseLiabilityPaymentsDueYearFour">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Operating and capital lease liability payments due year four.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dmtk_OperatingAndFinanceLeaseLiabilityPaymentsDueYearFour</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dmtk_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dmtk_OperatingAndFinanceLeaseLiabilityPaymentsDueYearThree">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Operating and capital lease liability payments due year three.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dmtk_OperatingAndFinanceLeaseLiabilityPaymentsDueYearThree</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dmtk_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dmtk_OperatingAndFinanceLeaseLiabilityPaymentsDueYearTwo">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Operating and capital lease liability payments due year two.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dmtk_OperatingAndFinanceLeaseLiabilityPaymentsDueYearTwo</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dmtk_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dmtk_OperatingAndFinanceLeaseLiabilityPaymentsRemainderOfFiscalYear">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Operating and capital lease liability payments remainder of fiscal year.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dmtk_OperatingAndFinanceLeaseLiabilityPaymentsRemainderOfFiscalYear</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dmtk_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FinanceLeaseLiabilitiesPaymentsDueAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FinanceLeaseLiabilitiesPaymentsDueAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FinanceLeaseLiabilityPaymentsDue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of lessee's undiscounted obligation for lease payments for finance lease.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 50<br> -Paragraph 6<br> -URI https://asc.fasb.org/extlink&amp;oid=128292326&amp;loc=SL77918701-209980<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FinanceLeaseLiabilityPaymentsDue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FinanceLeaseLiabilityPaymentsDueNextTwelveMonths">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of lessee's undiscounted obligation for lease payment for finance lease to be paid in next fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 50<br> -Paragraph 6<br> -URI https://asc.fasb.org/extlink&amp;oid=128292326&amp;loc=SL77918701-209980<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FinanceLeaseLiabilityPaymentsDueNextTwelveMonths</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FinanceLeaseLiabilityPaymentsDueYearFour">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of lessee's undiscounted obligation for lease payment for finance lease to be paid in fourth fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 50<br> -Paragraph 6<br> -URI https://asc.fasb.org/extlink&amp;oid=128292326&amp;loc=SL77918701-209980<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FinanceLeaseLiabilityPaymentsDueYearFour</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FinanceLeaseLiabilityPaymentsDueYearThree">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of lessee's undiscounted obligation for lease payment for finance lease to be paid in third fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 50<br> -Paragraph 6<br> -URI https://asc.fasb.org/extlink&amp;oid=128292326&amp;loc=SL77918701-209980<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FinanceLeaseLiabilityPaymentsDueYearThree</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FinanceLeaseLiabilityPaymentsDueYearTwo">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of lessee's undiscounted obligation for lease payment for finance lease to be paid in second fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 50<br> -Paragraph 6<br> -URI https://asc.fasb.org/extlink&amp;oid=128292326&amp;loc=SL77918701-209980<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FinanceLeaseLiabilityPaymentsDueYearTwo</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FinanceLeaseLiabilityPaymentsRemainderOfFiscalYear">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of lessee's undiscounted obligation for lease payment for finance lease to be paid in remainder of current fiscal year.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 50<br> -Paragraph 6<br> -URI https://asc.fasb.org/extlink&amp;oid=128292326&amp;loc=SL77918701-209980<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FinanceLeaseLiabilityPaymentsRemainderOfFiscalYear</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of lessee's undiscounted obligation for lease payment for operating lease.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 50<br> -Paragraph 6<br> -URI https://asc.fasb.org/extlink&amp;oid=128292326&amp;loc=SL77918701-209980<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of lessee's undiscounted obligation for lease payment for operating lease to be paid in next fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 50<br> -Paragraph 6<br> -URI https://asc.fasb.org/extlink&amp;oid=128292326&amp;loc=SL77918701-209980<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFour">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of lessee's undiscounted obligation for lease payment for operating lease to be paid in fourth fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 50<br> -Paragraph 6<br> -URI https://asc.fasb.org/extlink&amp;oid=128292326&amp;loc=SL77918701-209980<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFour</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearThree">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of lessee's undiscounted obligation for lease payment for operating lease to be paid in third fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 50<br> -Paragraph 6<br> -URI https://asc.fasb.org/extlink&amp;oid=128292326&amp;loc=SL77918701-209980<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearThree</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearTwo">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of lessee's undiscounted obligation for lease payment for operating lease to be paid in second fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 50<br> -Paragraph 6<br> -URI https://asc.fasb.org/extlink&amp;oid=128292326&amp;loc=SL77918701-209980<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearTwo</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LesseeOperatingLeaseLiabilityPaymentsRemainderOfFiscalYear">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of lessee's undiscounted obligation for lease payment for operating lease having initial or remaining lease term in excess of one year to be paid in remainder of current fiscal year.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 50<br> -Paragraph 6<br> -URI https://asc.fasb.org/extlink&amp;oid=128292326&amp;loc=SL77918701-209980<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LesseeOperatingLeaseLiabilityPaymentsRemainderOfFiscalYear</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OperatingLeaseLiabilitiesPaymentsDueAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OperatingLeaseLiabilitiesPaymentsDueAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>62
<FILENAME>R39.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.2</span><table class="report" border="0" cellspacing="2" id="idm139763870996160">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Related Party Transactions - Additional Information (Details) - USD ($)<br></strong></div></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="2">3 Months Ended</th>
<th class="th" colspan="2">6 Months Ended</th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1"></th>
</tr>
<tr>
<th class="th"><div>Feb. 26, 2021</div></th>
<th class="th"><div>Nov. 11, 2020</div></th>
<th class="th"><div>May 11, 2020</div></th>
<th class="th"><div>Oct. 01, 2019</div></th>
<th class="th"><div>Jun. 30, 2022</div></th>
<th class="th"><div>Jun. 30, 2021</div></th>
<th class="th"><div>Jun. 30, 2022</div></th>
<th class="th"><div>Jun. 30, 2021</div></th>
<th class="th"><div>Dec. 31, 2021</div></th>
<th class="th"><div>Jan. 02, 2021</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RelatedPartyTransactionLineItems', window );"><strong>Related Party Transaction [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CommonStockSharesIssued', window );">Common stock, shares issued (in shares)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">30,038,447<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">30,038,447<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">29,772,922<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RelatedPartyTransactionExpensesFromTransactionsWithRelatedParty', window );">Related party transaction, other</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 0<span></span>
</td>
<td class="nump">$ 0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RelatedPartyTransactionAxis=dmtk_EVERSANALifeScienceServicesLLCMember', window );">EVERSANA | Leana Wood</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RelatedPartyTransactionLineItems', window );"><strong>Related Party Transaction [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RelatedPartyTransactionSellingGeneralAndAdministrativeExpensesFromTransactionsWithRelatedParty', window );">Related party certain marketing cost</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 900,000<span></span>
</td>
<td class="nump">$ 500,000<span></span>
</td>
<td class="nump">1,600,000<span></span>
</td>
<td class="nump">900,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RelatedPartyTransactionAxis=dmtk_DermTechOperationsIncMember', window );">DermTech Operations | Michael Dobak</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RelatedPartyTransactionLineItems', window );"><strong>Related Party Transaction [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RelatedPartyTransactionSellingGeneralAndAdministrativeExpensesFromTransactionsWithRelatedParty', window );">Related party certain marketing cost</a></td>
<td class="nump">$ 20,000<span></span>
</td>
<td class="nump">$ 15,000<span></span>
</td>
<td class="nump">$ 15,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 0<span></span>
</td>
<td class="nump">$ 20,000<span></span>
</td>
<td class="nump">$ 0<span></span>
</td>
<td class="nump">$ 100,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CommonStockSharesIssued', window );">Common stock, shares issued (in shares)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">5,000<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RelatedPartyTransactionAxis=dmtk_DermTechOperationsIncMember', window );">DermTech Operations | Michael Dobak | Maximum</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RelatedPartyTransactionLineItems', window );"><strong>Related Party Transaction [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RelatedPartyTransactionSellingGeneralAndAdministrativeExpensesFromTransactionsWithRelatedParty', window );">Related party certain marketing cost</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 100,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CommonStockSharesIssued">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Total number of common shares of an entity that have been sold or granted to shareholders (includes common shares that were issued, repurchased and remain in the treasury). These shares represent capital invested by the firm's shareholders and owners, and may be all or only a portion of the number of shares authorized. Shares issued include shares outstanding and shares held in the treasury.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CommonStockSharesIssued</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RelatedPartyTransactionExpensesFromTransactionsWithRelatedParty">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Expenses recognized resulting from transactions (excluding transactions that are eliminated in consolidated or combined financial statements) with related party.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 850<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=6457730&amp;loc=d3e39549-107864<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RelatedPartyTransactionExpensesFromTransactionsWithRelatedParty</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RelatedPartyTransactionLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RelatedPartyTransactionLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RelatedPartyTransactionSellingGeneralAndAdministrativeExpensesFromTransactionsWithRelatedParty">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of selling, general and administrative expenses resulting from transactions, excluding transactions that are eliminated in consolidated or combined financial statements, with related party.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RelatedPartyTransactionSellingGeneralAndAdministrativeExpensesFromTransactionsWithRelatedParty</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RelatedPartyTransactionAxis=dmtk_EVERSANALifeScienceServicesLLCMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RelatedPartyTransactionAxis=dmtk_EVERSANALifeScienceServicesLLCMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RelatedPartyTransactionsByRelatedPartyAxis=dmtk_SpouseOfChiefCommercialOfficerMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RelatedPartyTransactionsByRelatedPartyAxis=dmtk_SpouseOfChiefCommercialOfficerMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RelatedPartyTransactionAxis=dmtk_DermTechOperationsIncMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RelatedPartyTransactionAxis=dmtk_DermTechOperationsIncMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RelatedPartyTransactionsByRelatedPartyAxis=dmtk_BrotherOfChiefExecutiveOfficerMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RelatedPartyTransactionsByRelatedPartyAxis=dmtk_BrotherOfChiefExecutiveOfficerMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_RangeAxis=srt_MaximumMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_RangeAxis=srt_MaximumMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>63
<FILENAME>dmtk-20220630_htm.xml
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<XML>
<?xml version="1.0" encoding="utf-8"?>
<xbrl
  xml:lang="en-US"
  xmlns="http://www.xbrl.org/2003/instance"
  xmlns:dei="http://xbrl.sec.gov/dei/2022"
  xmlns:dmtk="http://dermtech.com/20220630"
  xmlns:iso4217="http://www.xbrl.org/2003/iso4217"
  xmlns:link="http://www.xbrl.org/2003/linkbase"
  xmlns:srt="http://fasb.org/srt/2022"
  xmlns:us-gaap="http://fasb.org/us-gaap/2022"
  xmlns:utr="http://www.xbrl.org/2009/utr"
  xmlns:xbrldi="http://xbrl.org/2006/xbrldi"
  xmlns:xlink="http://www.w3.org/1999/xlink"
  xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance">
    <link:schemaRef xlink:href="dmtk-20220630.xsd" xlink:type="simple"/>
    <context id="ia855382ada1f4f28aa8ef6da692ff177_D20220101-20220630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001651944</identifier>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-06-30</endDate>
        </period>
    </context>
    <context id="i0bb8b8c526d842f2a0e174c1375916cd_I20220805">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001651944</identifier>
        </entity>
        <period>
            <instant>2022-08-05</instant>
        </period>
    </context>
    <context id="i4c8f247d12134a9886d56e1c8b024425_I20220630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001651944</identifier>
        </entity>
        <period>
            <instant>2022-06-30</instant>
        </period>
    </context>
    <context id="i87bf777ccf5f4f93bc9be7a2cbba61c1_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001651944</identifier>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="i6e93ea7e6de54e3b99964d226c95da1b_D20220401-20220630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001651944</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">dmtk:AssayMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-04-01</startDate>
            <endDate>2022-06-30</endDate>
        </period>
    </context>
    <context id="i37138912f4f54957978d26b438559810_D20210401-20210630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001651944</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">dmtk:AssayMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-04-01</startDate>
            <endDate>2021-06-30</endDate>
        </period>
    </context>
    <context id="i162096998d12445db5b600d98dd798a7_D20220101-20220630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001651944</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">dmtk:AssayMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-06-30</endDate>
        </period>
    </context>
    <context id="ib998ae4e71544a4aa86f6166fce08ce5_D20210101-20210630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001651944</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">dmtk:AssayMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-06-30</endDate>
        </period>
    </context>
    <context id="i78ce1dff723a4a809549de43dc758409_D20220401-20220630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001651944</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">dmtk:ContractualActivitiesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-04-01</startDate>
            <endDate>2022-06-30</endDate>
        </period>
    </context>
    <context id="i56c0d5eff1614a048c29e3f98fd6e1bd_D20210401-20210630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001651944</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">dmtk:ContractualActivitiesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-04-01</startDate>
            <endDate>2021-06-30</endDate>
        </period>
    </context>
    <context id="i615ec51fc143458883f5b2236ee7fa4e_D20220101-20220630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001651944</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">dmtk:ContractualActivitiesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-06-30</endDate>
        </period>
    </context>
    <context id="i3b92d912bf1a4d219b2f1cafa797b274_D20210101-20210630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001651944</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">dmtk:ContractualActivitiesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-06-30</endDate>
        </period>
    </context>
    <context id="i2c5f0f28773744e5a2e202f2943ae976_D20220401-20220630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001651944</identifier>
        </entity>
        <period>
            <startDate>2022-04-01</startDate>
            <endDate>2022-06-30</endDate>
        </period>
    </context>
    <context id="id7bb773872394047ba26aa8a7a0f4d56_D20210401-20210630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001651944</identifier>
        </entity>
        <period>
            <startDate>2021-04-01</startDate>
            <endDate>2021-06-30</endDate>
        </period>
    </context>
    <context id="idaa4f31ca59a4a17a59c2580b97791ca_D20210101-20210630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001651944</identifier>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-06-30</endDate>
        </period>
    </context>
    <context id="i8dc9000c668a4aa984be19fb8519665b_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001651944</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="i152c9be1ba1e447486e5a7897ca085e6_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001651944</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="i922bc272fcd34b919d4804d77d0e0c27_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001651944</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedNetUnrealizedInvestmentGainLossMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="i9abcd2f792c74d59a334b58470c92ee1_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001651944</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="ibdd6f077db7e4453b764a24795f4ccab_D20220101-20220331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001651944</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-03-31</endDate>
        </period>
    </context>
    <context id="i0c3fc5bff94f42de9cc243e9bac95218_D20220101-20220331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001651944</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-03-31</endDate>
        </period>
    </context>
    <context id="i73a86f0089f6462d9bcb14d0d7b333b6_D20220101-20220331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001651944</identifier>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-03-31</endDate>
        </period>
    </context>
    <context id="i3b22eec6726b4166a994d025bc0ced72_D20220101-20220331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001651944</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedNetUnrealizedInvestmentGainLossMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-03-31</endDate>
        </period>
    </context>
    <context id="ic42372bda74e4cccb938ae9846b0efa8_D20220101-20220331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001651944</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-03-31</endDate>
        </period>
    </context>
    <context id="i39d067b2de814fdd942ed3afbc265b36_I20220331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001651944</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-03-31</instant>
        </period>
    </context>
    <context id="ie3d1daa21e224cc7bf51143498f4f8dc_I20220331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001651944</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-03-31</instant>
        </period>
    </context>
    <context id="ieaf99c642b3e451383632209bf030fa1_I20220331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001651944</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedNetUnrealizedInvestmentGainLossMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-03-31</instant>
        </period>
    </context>
    <context id="i842f2362497347869b657ca3d4a18b0e_I20220331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001651944</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-03-31</instant>
        </period>
    </context>
    <context id="id801924f698f4fbab568e7483b1a98ca_I20220331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001651944</identifier>
        </entity>
        <period>
            <instant>2022-03-31</instant>
        </period>
    </context>
    <context id="i3ac147ed027b4fccb1eb3b3b35fff118_D20220401-20220630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001651944</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-04-01</startDate>
            <endDate>2022-06-30</endDate>
        </period>
    </context>
    <context id="i5a6efd2e4aae4e7c98a64843742ef0b5_D20220401-20220630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001651944</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-04-01</startDate>
            <endDate>2022-06-30</endDate>
        </period>
    </context>
    <context id="i121c1a6b16ed46b4b77fad9886993828_D20220401-20220630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001651944</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedNetUnrealizedInvestmentGainLossMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-04-01</startDate>
            <endDate>2022-06-30</endDate>
        </period>
    </context>
    <context id="i6d917ab3db164f9196c80ba779ef6876_D20220401-20220630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001651944</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-04-01</startDate>
            <endDate>2022-06-30</endDate>
        </period>
    </context>
    <context id="ia9537308acbd431f87e3b44d01741f2c_I20220630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001651944</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-06-30</instant>
        </period>
    </context>
    <context id="ib9ab9bb551934102bae2904f11a4da20_I20220630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001651944</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-06-30</instant>
        </period>
    </context>
    <context id="i85b53adede47405198bcfa9202c16b00_I20220630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001651944</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedNetUnrealizedInvestmentGainLossMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-06-30</instant>
        </period>
    </context>
    <context id="i506a0b63797b4ba099490022c868c239_I20220630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001651944</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-06-30</instant>
        </period>
    </context>
    <context id="idf41ea014db640f1a2c27c2a769a0f37_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001651944</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="i770f7a8689db49a0b1de542ddda20759_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001651944</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="i5a3aac1f37e54bf194da81ac901f5ea9_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001651944</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedNetUnrealizedInvestmentGainLossMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="i8c8de78a03884c5eb87d8bfff7cb6c1c_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001651944</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="i299927d2cdfe46deaac8ee64dc7dce6c_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001651944</identifier>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="i9765c83c10a4499099d3ccc0868af9be_I20210331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001651944</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-03-31</instant>
        </period>
    </context>
    <context id="i936fe08107a14d5c927b5fa13e2af2c5_D20210101-20210331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001651944</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-03-31</endDate>
        </period>
    </context>
    <context id="i3f5ee0c6315d458da591b98ccf0afb7c_D20210101-20210331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001651944</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-03-31</endDate>
        </period>
    </context>
    <context id="icf9848cee57f48e1abdd659c090042db_D20210101-20210331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001651944</identifier>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-03-31</endDate>
        </period>
    </context>
    <context id="i7ae4ca8a5bb543418bbae64ee99ea8fb_D20210101-20210331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001651944</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedNetUnrealizedInvestmentGainLossMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-03-31</endDate>
        </period>
    </context>
    <context id="i7f3382225eda41b397ed5315a35090fd_D20210101-20210331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001651944</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-03-31</endDate>
        </period>
    </context>
    <context id="i7a5dc2cad8ab4a63b151726096e30d08_I20210331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001651944</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-03-31</instant>
        </period>
    </context>
    <context id="ib3a71fad6fed4582857b2c1740f068d3_I20210331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001651944</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedNetUnrealizedInvestmentGainLossMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-03-31</instant>
        </period>
    </context>
    <context id="i8a2b15e19ec44c569f05077b9a65f5bc_I20210331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001651944</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-03-31</instant>
        </period>
    </context>
    <context id="i8003b21ff858443fa0b721090f35eb8c_I20210331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001651944</identifier>
        </entity>
        <period>
            <instant>2021-03-31</instant>
        </period>
    </context>
    <context id="if87a65d6f2c04499a52e6465b24b991a_D20210401-20210630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001651944</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-04-01</startDate>
            <endDate>2021-06-30</endDate>
        </period>
    </context>
    <context id="idd2a0e0d7f8047ff823261ca459e9548_D20210401-20210630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001651944</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-04-01</startDate>
            <endDate>2021-06-30</endDate>
        </period>
    </context>
    <context id="ibf2eeb1965ed4f85aabca9700183b6c8_I20210630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001651944</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:SubsidiarySaleOfStockAxis">dmtk:AtTheMarketOfferingMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-06-30</instant>
        </period>
    </context>
    <context id="if148116e5f8f42ec91f0eb17fe3ed6f0_D20210401-20210630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001651944</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedNetUnrealizedInvestmentGainLossMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-04-01</startDate>
            <endDate>2021-06-30</endDate>
        </period>
    </context>
    <context id="idc14b05f084b42dcbd02996ad7fb090f_D20210401-20210630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001651944</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-04-01</startDate>
            <endDate>2021-06-30</endDate>
        </period>
    </context>
    <context id="i962e0f9643f54946bc90520b7ea86c76_I20210630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001651944</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-06-30</instant>
        </period>
    </context>
    <context id="i53a3c2269f654f2fb4637cd7af974436_I20210630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001651944</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-06-30</instant>
        </period>
    </context>
    <context id="i398f2a559ab64f81bd1a007c9fc04a0a_I20210630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001651944</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedNetUnrealizedInvestmentGainLossMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-06-30</instant>
        </period>
    </context>
    <context id="ice91fd1c5683472191e0ebaa1eed5a8a_I20210630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001651944</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-06-30</instant>
        </period>
    </context>
    <context id="ie036f155bf0e43bd97ef05b5b46857eb_I20210630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001651944</identifier>
        </entity>
        <period>
            <instant>2021-06-30</instant>
        </period>
    </context>
    <context id="iaa3380e4cf5a462aa71b09fba6701de9_D20220101-20220630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001651944</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:SubsidiarySaleOfStockAxis">dmtk:PublicFollowOnOfferingMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-06-30</endDate>
        </period>
    </context>
    <context id="ia87d864973504d67affd22c2a1bdc40c_D20210101-20210630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001651944</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:SubsidiarySaleOfStockAxis">dmtk:PublicFollowOnOfferingMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-06-30</endDate>
        </period>
    </context>
    <context id="i1c2f494e495e4547bd1776a4d5cb5c64_D20220101-20220630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001651944</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:SubsidiarySaleOfStockAxis">dmtk:AtTheMarketOfferingMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-06-30</endDate>
        </period>
    </context>
    <context id="i07f957c639484f23a8527b87b9caff7d_D20210101-20210630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001651944</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:SubsidiarySaleOfStockAxis">dmtk:AtTheMarketOfferingMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-06-30</endDate>
        </period>
    </context>
    <context id="if83fbbc281954a99aa695fe8757b3e08_D20220101-20220630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001651944</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MinimumMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-06-30</endDate>
        </period>
    </context>
    <context id="i9069aff5693b479db8eb460a09c920a0_D20220101-20220630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001651944</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MaximumMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-06-30</endDate>
        </period>
    </context>
    <context id="i6013cc6ffa8a44399380d7ab2a84d3ef_D20220401-20220630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001651944</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">dmtk:AmortizationOfLaboratoryEquipmentAcquiredUnderFinanceLeasesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-04-01</startDate>
            <endDate>2022-06-30</endDate>
        </period>
    </context>
    <context id="i746f81de13474498bf13734eea25d645_D20210401-20210630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001651944</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">dmtk:AmortizationOfLaboratoryEquipmentAcquiredUnderFinanceLeasesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-04-01</startDate>
            <endDate>2021-06-30</endDate>
        </period>
    </context>
    <context id="i74a9fc9070b8404997fc0c10022dc50e_D20220101-20220630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001651944</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">dmtk:AmortizationOfLaboratoryEquipmentAcquiredUnderFinanceLeasesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-06-30</endDate>
        </period>
    </context>
    <context id="i3e76258aea994808ac778298cc3389ab_D20210101-20210630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001651944</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">dmtk:AmortizationOfLaboratoryEquipmentAcquiredUnderFinanceLeasesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-06-30</endDate>
        </period>
    </context>
    <context id="ic89cf2db98344df4a59437fe3569a1d2_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001651944</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">dmtk:AssetsHeldUnderFinanceLeasesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="if5c0f2a68220406b8c328b2744af6512_I20220630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001651944</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">dmtk:AssetsHeldUnderFinanceLeasesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-06-30</instant>
        </period>
    </context>
    <context id="i72b0a574a3fc4d02a8355d41f4d3c3f7_D20220101-20220630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001651944</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">dmtk:AssetsHeldUnderFinanceLeasesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-06-30</endDate>
        </period>
    </context>
    <context id="i90781b7d5b3d4c93943bc5e09860112d_D20210101-20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001651944</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">dmtk:AssetsHeldUnderFinanceLeasesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="i44ab42a102594fac87f06c1ef8c068f7_D20220401-20220630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001651944</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">dmtk:ContractRevenueAdhesivePatchKitsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-04-01</startDate>
            <endDate>2022-06-30</endDate>
        </period>
    </context>
    <context id="i37bb372a6a6f42ad835fe2ef8ee1273a_D20210401-20210630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001651944</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">dmtk:ContractRevenueAdhesivePatchKitsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-04-01</startDate>
            <endDate>2021-06-30</endDate>
        </period>
    </context>
    <context id="ibaf8664002d140989e8264c6adb89fa7_D20220101-20220630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001651944</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">dmtk:ContractRevenueAdhesivePatchKitsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-06-30</endDate>
        </period>
    </context>
    <context id="iddc9e2beb1bb4562969f72a76d146829_D20210101-20210630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001651944</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">dmtk:ContractRevenueAdhesivePatchKitsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-06-30</endDate>
        </period>
    </context>
    <context id="i97ac1b6997a14b74b531fc469df2694d_D20220401-20220630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001651944</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">dmtk:ContractRevenueRNAExtractionsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-04-01</startDate>
            <endDate>2022-06-30</endDate>
        </period>
    </context>
    <context id="ib4f6baa70c784ecf9d59a3a86366bfc9_D20210401-20210630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001651944</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">dmtk:ContractRevenueRNAExtractionsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-04-01</startDate>
            <endDate>2021-06-30</endDate>
        </period>
    </context>
    <context id="i84a94952fcc541d9a3ed53a9fbe72d3f_D20220101-20220630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001651944</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">dmtk:ContractRevenueRNAExtractionsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-06-30</endDate>
        </period>
    </context>
    <context id="ia31f87e1f0644450bcc68070a72f9423_D20210101-20210630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001651944</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">dmtk:ContractRevenueRNAExtractionsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-06-30</endDate>
        </period>
    </context>
    <context id="i2f689fb0f6dd4303b138b093b1056dd9_D20220401-20220630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001651944</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">dmtk:ContractRevenueProjectManagementFeesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-04-01</startDate>
            <endDate>2022-06-30</endDate>
        </period>
    </context>
    <context id="i8648dde9ea3c4420a2537a1ebd36ce55_D20210401-20210630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001651944</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">dmtk:ContractRevenueProjectManagementFeesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-04-01</startDate>
            <endDate>2021-06-30</endDate>
        </period>
    </context>
    <context id="i7ce185f90d7b4357a581d645d094bd60_D20220101-20220630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001651944</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">dmtk:ContractRevenueProjectManagementFeesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-06-30</endDate>
        </period>
    </context>
    <context id="iba453607677b41a9a058e0d3ee2c4186_D20210101-20210630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001651944</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">dmtk:ContractRevenueProjectManagementFeesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-06-30</endDate>
        </period>
    </context>
    <context id="ibe700613e5304875bdd1ff268a855e3b_D20220401-20220630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001651944</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">dmtk:AssayRevenuePayorAMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByBenchmarkAxis">us-gaap:SalesRevenueNetMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByTypeAxis">us-gaap:CustomerConcentrationRiskMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-04-01</startDate>
            <endDate>2022-06-30</endDate>
        </period>
    </context>
    <context id="id2fc2250bf344e37938b871f12d01a85_D20210401-20210630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001651944</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">dmtk:AssayRevenuePayorAMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByBenchmarkAxis">us-gaap:SalesRevenueNetMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByTypeAxis">us-gaap:CustomerConcentrationRiskMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-04-01</startDate>
            <endDate>2021-06-30</endDate>
        </period>
    </context>
    <context id="i79283405fe744adabc208118150149f3_D20220101-20220630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001651944</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">dmtk:AssayRevenuePayorAMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByBenchmarkAxis">us-gaap:SalesRevenueNetMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByTypeAxis">us-gaap:CustomerConcentrationRiskMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-06-30</endDate>
        </period>
    </context>
    <context id="i0a6d383e97df42d3a6810885b8aee9e8_D20210101-20210630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001651944</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">dmtk:AssayRevenuePayorAMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByBenchmarkAxis">us-gaap:SalesRevenueNetMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByTypeAxis">us-gaap:CustomerConcentrationRiskMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-06-30</endDate>
        </period>
    </context>
    <context id="icab6abad6fea44f5ae78f4cbcce5b550_D20220101-20220630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001651944</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">dmtk:AssayRevenuePayorAMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByBenchmarkAxis">us-gaap:AccountsReceivableMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByTypeAxis">us-gaap:CustomerConcentrationRiskMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-06-30</endDate>
        </period>
    </context>
    <context id="ifb4b0086847d4c79aed7244eb498c89a_D20210101-20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001651944</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">dmtk:AssayRevenuePayorAMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByBenchmarkAxis">us-gaap:AccountsReceivableMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByTypeAxis">us-gaap:CustomerConcentrationRiskMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="ibc3b0a82341c40d6abc97b51b82572a2_D20220101-20220630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001651944</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">dmtk:AssayRevenuePayorBMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByBenchmarkAxis">us-gaap:AccountsReceivableMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByTypeAxis">us-gaap:CustomerConcentrationRiskMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-06-30</endDate>
        </period>
    </context>
    <context id="i024422eccd5d4383a66fc3f37bffe425_D20210101-20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001651944</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">dmtk:AssayRevenuePayorBMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByBenchmarkAxis">us-gaap:AccountsReceivableMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByTypeAxis">us-gaap:CustomerConcentrationRiskMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="i4e7d7d7304c048ca82f068a9a195f83b_I20220630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001651944</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MinimumMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-06-30</instant>
        </period>
    </context>
    <context id="i87a77119b42946ecbfc4ea54841338c0_I20220630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001651944</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MaximumMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-06-30</instant>
        </period>
    </context>
    <context id="i6635c095eae0429e88a27cd2f8145dc1_I20220630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001651944</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">dmtk:AssayMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-06-30</instant>
        </period>
    </context>
    <context id="i4d3ad48c30c04410bf8a55d9dabb735e_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001651944</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">dmtk:AssayMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="icfa56764c3ac46e89e85c1c2e548d685_I20220630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001651944</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">dmtk:ContractualActivitiesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-06-30</instant>
        </period>
    </context>
    <context id="i204f9e4e483143659a51c94f43ce8d11_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001651944</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">dmtk:ContractualActivitiesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="ie94c263c6992432a815e971cc90962ff_D20220101-20220630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001651944</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis">us-gaap:WarrantMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-06-30</endDate>
        </period>
    </context>
    <context id="i7ba402f3c4df43af97329ebc435cae8c_D20220401-20220630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001651944</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis">us-gaap:WarrantMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-04-01</startDate>
            <endDate>2022-06-30</endDate>
        </period>
    </context>
    <context id="i2823faffcae54e5d93a6030da77ad512_D20220101-20220630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001651944</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis">dmtk:StockOptionsAndRestrictedStockUnitsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-06-30</endDate>
        </period>
    </context>
    <context id="i4691cb5ab9d44fe4bb012ab3099c548d_D20220401-20220630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001651944</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis">dmtk:StockOptionsAndRestrictedStockUnitsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-04-01</startDate>
            <endDate>2022-06-30</endDate>
        </period>
    </context>
    <context id="icb0e8ee0be634262b34d17ccb551b284_D20210101-20210630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001651944</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis">us-gaap:WarrantMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-06-30</endDate>
        </period>
    </context>
    <context id="i249d87c65f444c66a0d32f915d17cf47_D20210401-20210630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001651944</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis">us-gaap:WarrantMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-04-01</startDate>
            <endDate>2021-06-30</endDate>
        </period>
    </context>
    <context id="i8302e4a3b08c40939cfabd8d8c7827e0_D20210401-20210630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001651944</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis">dmtk:StockOptionsAndRestrictedStockUnitsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-04-01</startDate>
            <endDate>2021-06-30</endDate>
        </period>
    </context>
    <context id="idde3250874484b9b9fbc3ab3b93032eb_D20210101-20210630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001651944</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis">dmtk:StockOptionsAndRestrictedStockUnitsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-06-30</endDate>
        </period>
    </context>
    <context id="if758224c2e474796966c7a56ed966de8_I20220630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001651944</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-06-30</instant>
        </period>
    </context>
    <context id="if8fdbfd7ecbc4f1e83abd5532a4f2776_I20220630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001651944</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-06-30</instant>
        </period>
    </context>
    <context id="id460d49e6dc845ddb03e35bcd01b0a02_I20220630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001651944</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-06-30</instant>
        </period>
    </context>
    <context id="i6f6e047d4cc946d5ab745668b1e79366_I20220630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001651944</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-06-30</instant>
        </period>
    </context>
    <context id="i41653ba801c2441dbaca0c02a6789086_I20220630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001651944</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:CorporateDebtSecuritiesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-06-30</instant>
        </period>
    </context>
    <context id="iea92d61cbcce431fa5e4090b90791f94_I20220630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001651944</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:CorporateDebtSecuritiesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-06-30</instant>
        </period>
    </context>
    <context id="i5b506509888b48d6a34efce6ba8f7e6e_I20220630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001651944</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:CorporateDebtSecuritiesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-06-30</instant>
        </period>
    </context>
    <context id="ie45f0b654eec485abbe4c0f2ba779d49_I20220630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001651944</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:CorporateDebtSecuritiesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-06-30</instant>
        </period>
    </context>
    <context id="i37da1f18c957414ba4dec5d09fe5fce0_I20220630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001651944</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:MunicipalNotesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-06-30</instant>
        </period>
    </context>
    <context id="i04cf5fc9b6ef4515a8ce5817a046a654_I20220630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001651944</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:MunicipalNotesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-06-30</instant>
        </period>
    </context>
    <context id="ibc090232bd5e457e8df72d86df61cf31_I20220630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001651944</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:MunicipalNotesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-06-30</instant>
        </period>
    </context>
    <context id="id3e9e3b412de4937a9a4ce62ef9086bd_I20220630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001651944</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:MunicipalNotesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-06-30</instant>
        </period>
    </context>
    <context id="i7a19194e0b6946c5a1307bef5ce3e7ea_I20220630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001651944</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:USGovernmentAgenciesShorttermDebtSecuritiesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-06-30</instant>
        </period>
    </context>
    <context id="i48acc600f436461fa46eb2fc48d5b8a3_I20220630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001651944</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:USGovernmentAgenciesShorttermDebtSecuritiesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-06-30</instant>
        </period>
    </context>
    <context id="ic46c00dd86944457b5ff2e30e0e14027_I20220630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001651944</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:USGovernmentAgenciesShorttermDebtSecuritiesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-06-30</instant>
        </period>
    </context>
    <context id="i7d779ec4227844e9a0d3371962d37354_I20220630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001651944</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:USGovernmentAgenciesShorttermDebtSecuritiesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-06-30</instant>
        </period>
    </context>
    <context id="id0495dc386634c17abe35f6f0b1c1cde_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001651944</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="i22164451262946e4b9911f313b7610c1_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001651944</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="ica20d3fdf2ff41fdb31ad57ccb72924b_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001651944</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="ie7dec283b83b43f99e003b79ec165d54_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001651944</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="ia276a40ecef74c489871bb3ea4f6856b_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001651944</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:CorporateDebtSecuritiesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="icf26e4a3bbe94872997aa67085685e63_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001651944</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:CorporateDebtSecuritiesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="i03ca2eb28be548fea6832470239a3e99_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001651944</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:CorporateDebtSecuritiesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="ieff44cf249a64087acf6cb16f4815cb7_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001651944</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:CorporateDebtSecuritiesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="i849cb6bacde4475a95c34f5707ff57c7_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001651944</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:MunicipalNotesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="iad8908ee30bb4929b29d53cdc31fbd4f_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001651944</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:MunicipalNotesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="id6a19bedaa7c4ff8a89b8887ce0c3750_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001651944</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:MunicipalNotesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="i319102f511954bcdb477a84723258d83_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001651944</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:MunicipalNotesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="i14a147d5e6494412ae4b21fe8bfddff7_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001651944</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:USGovernmentAgenciesShorttermDebtSecuritiesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="i4c05f919d71b4b4cb753c74dcc787cf4_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001651944</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:USGovernmentAgenciesShorttermDebtSecuritiesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="if678e473179340e9834400c14da4f7d6_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001651944</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:USGovernmentAgenciesShorttermDebtSecuritiesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="i4f60362ab2e44b07bbde43a025d24bba_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001651944</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:USGovernmentAgenciesShorttermDebtSecuritiesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="i2ff3fea135c346deae31b3b343050a34_D20220401-20220630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001651944</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:WarrantyRightsAndObligationsFairValueOptionMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-04-01</startDate>
            <endDate>2022-06-30</endDate>
        </period>
    </context>
    <context id="ifd6a2c580c134e25811ac19c23b2c1e5_D20210401-20210630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001651944</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:WarrantyRightsAndObligationsFairValueOptionMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-04-01</startDate>
            <endDate>2021-06-30</endDate>
        </period>
    </context>
    <context id="ib3db0d13e848432a9c205ce797c080f8_D20220101-20220630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001651944</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:WarrantyRightsAndObligationsFairValueOptionMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-06-30</endDate>
        </period>
    </context>
    <context id="i08f348302fbc42c98a41fcaf5cfcde43_D20210101-20210630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001651944</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:WarrantyRightsAndObligationsFairValueOptionMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-06-30</endDate>
        </period>
    </context>
    <context id="ife1b36ccabe240edb9560e64d1ffa4bc_D20220101-20220630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001651944</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MinimumMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:WarrantyRightsAndObligationsFairValueOptionMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-06-30</endDate>
        </period>
    </context>
    <context id="i40659e4bf5494460828fbdb823038ea6_D20220101-20220630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001651944</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MaximumMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:WarrantyRightsAndObligationsFairValueOptionMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-06-30</endDate>
        </period>
    </context>
    <context id="i2c2735b81bcc42bf8feeaa459dfad074_D20210101-20210630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001651944</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MinimumMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:WarrantyRightsAndObligationsFairValueOptionMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-06-30</endDate>
        </period>
    </context>
    <context id="ibf907753dcd34608bb600dff616c1c77_D20210101-20210630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001651944</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MaximumMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:WarrantyRightsAndObligationsFairValueOptionMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-06-30</endDate>
        </period>
    </context>
    <context id="i0e8a6876eeb946269d2c2405fcb009b4_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001651944</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByLiabilityClassAxis">dmtk:WarrantLiabilityMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="i4030b6b173eb4417a8b8aa5024f71cc6_D20220101-20220331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001651944</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByLiabilityClassAxis">dmtk:WarrantLiabilityMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-03-31</endDate>
        </period>
    </context>
    <context id="i253fb10d701144a8b699b8f06a9a82fd_I20220331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001651944</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByLiabilityClassAxis">dmtk:WarrantLiabilityMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-03-31</instant>
        </period>
    </context>
    <context id="i166b12bbf79f408e95f28a9eeaa9d48d_D20220401-20220630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001651944</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByLiabilityClassAxis">dmtk:WarrantLiabilityMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-04-01</startDate>
            <endDate>2022-06-30</endDate>
        </period>
    </context>
    <context id="ia41275e687284fbe8c0cd8cfc3637073_I20220630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001651944</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByLiabilityClassAxis">dmtk:WarrantLiabilityMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-06-30</instant>
        </period>
    </context>
    <context id="ieb434e1a310d48ce8a877397d66245d6_I20220630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001651944</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">dmtk:RestrictedCashMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-06-30</instant>
        </period>
    </context>
    <context id="if16c69c24d79407cacc36646afe73f31_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001651944</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">dmtk:RestrictedCashMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="i93b0b8d9a4ba4307b9aa1d2e18a0e2c3_D20190829-20190829">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001651944</identifier>
        </entity>
        <period>
            <startDate>2019-08-29</startDate>
            <endDate>2019-08-29</endDate>
        </period>
    </context>
    <context id="if86a878c756a461abc20e5dc5cf1667c_I20220630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001651944</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:CorporateDebtSecuritiesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-06-30</instant>
        </period>
    </context>
    <context id="ibd768261001c4410bcbcfa14c060fd74_I20220630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001651944</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:MunicipalNotesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-06-30</instant>
        </period>
    </context>
    <context id="i9b0f17d8e871417bbb113b30e575a8a5_I20220630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001651944</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:USGovernmentAgenciesShorttermDebtSecuritiesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-06-30</instant>
        </period>
    </context>
    <context id="i267f31f0cb5a4cb5bd58dd78cd514f48_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001651944</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:CorporateDebtSecuritiesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="i3ec37ec0a1104b00bb3614670349fb31_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001651944</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:MunicipalNotesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="i10f3d8ad519640d9bc20a9ada45d58e7_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001651944</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:USGovernmentAgenciesShorttermDebtSecuritiesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="ia4a7fd782f30475da7d3133d9c168885_D20201110-20201110">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001651944</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionsByRelatedPartyAxis">dmtk:CowenLimitedLiabilityCompanyMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-11-10</startDate>
            <endDate>2020-11-10</endDate>
        </period>
    </context>
    <context id="i415678d9707341f4acccc0fba869131d_D20201110-20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001651944</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionsByRelatedPartyAxis">dmtk:CowenLimitedLiabilityCompanyMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-11-10</startDate>
            <endDate>2020-12-31</endDate>
        </period>
    </context>
    <context id="i305721ec0ffb416391e577b9071cbf15_D20220101-20220630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001651944</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionsByRelatedPartyAxis">dmtk:CowenLimitedLiabilityCompanyMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-06-30</endDate>
        </period>
    </context>
    <context id="if05c806895254e84952b9538ed102dac_D20210101-20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001651944</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionsByRelatedPartyAxis">dmtk:CowenLimitedLiabilityCompanyMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="i7d0e216f45ca4f518d2c2732a59322ab_D20210106-20210106">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001651944</identifier>
        </entity>
        <period>
            <startDate>2021-01-06</startDate>
            <endDate>2021-01-06</endDate>
        </period>
    </context>
    <context id="ic368d6fe62464ba5bac452fa161672d6_D20210111-20210111">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001651944</identifier>
        </entity>
        <period>
            <startDate>2021-01-11</startDate>
            <endDate>2021-01-11</endDate>
        </period>
    </context>
    <context id="icbaabbad817c4953a4cfd55f31fb248d_I20210111">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001651944</identifier>
        </entity>
        <period>
            <instant>2021-01-11</instant>
        </period>
    </context>
    <context id="i6732e83066a44277a8539ee4f29b7c2f_D20170623-20170623">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001651944</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:ClassOfWarrantOrRightAxis">dmtk:SpecialPurposeAcquisitionCompaniesWarrantsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2017-06-23</startDate>
            <endDate>2017-06-23</endDate>
        </period>
    </context>
    <context id="i310af3399c354a2194fb2cb2350604d4_D20170623-20170623">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001651944</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:ClassOfWarrantOrRightAxis">dmtk:PublicSpecialPurposeAcquisitionCompaniesWarrantsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2017-06-23</startDate>
            <endDate>2017-06-23</endDate>
        </period>
    </context>
    <context id="i452e14998aaf4b87b88a33470c2536e4_D20170623-20170623">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001651944</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:ClassOfWarrantOrRightAxis">dmtk:PrivateSpecialPurposeAcquisitionCompaniesWarrantsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2017-06-23</startDate>
            <endDate>2017-06-23</endDate>
        </period>
    </context>
    <context id="i634967fade134dc69b40f7ae53806ba8_I20220630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001651944</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:ClassOfWarrantOrRightAxis">dmtk:SpecialPurposeAcquisitionCompaniesWarrantsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-06-30</instant>
        </period>
    </context>
    <context id="i21b78556448b464cb21d8774cfc796ea_I20210630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001651944</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:ClassOfWarrantOrRightAxis">dmtk:SpecialPurposeAcquisitionCompaniesWarrantsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-06-30</instant>
        </period>
    </context>
    <context id="iec153eacdc1c48dbb3a7a5f42f8d0173_D20210101-20210630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001651944</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:ClassOfWarrantOrRightAxis">dmtk:SpecialPurposeAcquisitionCompaniesWarrantsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-06-30</endDate>
        </period>
    </context>
    <context id="i803095f015594543bf9205dfd151c02e_I20220630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001651944</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:ClassOfWarrantOrRightAxis">dmtk:SpecialPurposeAcquisitionCompaniesWarrantsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-06-30</instant>
        </period>
    </context>
    <context id="i9641b453cb244341906e0d3f67453c08_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001651944</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:ClassOfWarrantOrRightAxis">dmtk:SpecialPurposeAcquisitionCompaniesWarrantsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="i0d9404419f2a4713a7b20a9438a2268d_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001651944</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:ClassOfWarrantOrRightAxis">dmtk:PrivateSpecialPurposeAcquisitionCompaniesWarrantsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="i80e526858964456d8f479d0e2dd63ca5_I20220630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001651944</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:ClassOfWarrantOrRightAxis">dmtk:PrivateSpecialPurposeAcquisitionCompaniesWarrantsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-06-30</instant>
        </period>
    </context>
    <context id="i5e6cf29a894e475589e2bb8262ac9033_D20150101-20161231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001651944</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:ClassOfWarrantOrRightAxis">dmtk:PlacementAgentWarrantsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2015-01-01</startDate>
            <endDate>2016-12-31</endDate>
        </period>
    </context>
    <context id="ic92102edfd1342a192f438b00ef88200_I20161231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001651944</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:ClassOfWarrantOrRightAxis">dmtk:PlacementAgentWarrantsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2016-12-31</instant>
        </period>
    </context>
    <context id="ic2ffccea2c90436fac0e9812ff060041_I20161231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001651944</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:ClassOfWarrantOrRightAxis">dmtk:PlacementAgentWarrantsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2016-12-31</instant>
        </period>
    </context>
    <context id="if35ae65dc07b452292756d42575f3dae_D20160101-20181231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001651944</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:ClassOfWarrantOrRightAxis">dmtk:PlacementAgentWarrantsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2016-01-01</startDate>
            <endDate>2018-12-31</endDate>
        </period>
    </context>
    <context id="i4159027d930b496eab94ec0daf363261_I20181231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001651944</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:ClassOfWarrantOrRightAxis">dmtk:PlacementAgentWarrantsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2018-12-31</instant>
        </period>
    </context>
    <context id="id7e5b24c3bb74b83a74aa64a7d327d4c_I20181231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001651944</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:ClassOfWarrantOrRightAxis">dmtk:PlacementAgentWarrantsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2018-12-31</instant>
        </period>
    </context>
    <context id="icf734323352a4de0a023df6ea904aaac_D20200101-20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001651944</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:ClassOfWarrantOrRightAxis">dmtk:PlacementAgentWarrantsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">dmtk:TwoThousandEighteenConvertibleBridgeNotesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-12-31</endDate>
        </period>
    </context>
    <context id="ibcc5eb12a4734bb39f49618ab345bde8_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001651944</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:ClassOfWarrantOrRightAxis">dmtk:PlacementAgentWarrantsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">dmtk:TwoThousandEighteenConvertibleBridgeNotesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="ifa5f19791fc8441d87a405ff98a53015_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001651944</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:ClassOfWarrantOrRightAxis">dmtk:PlacementAgentWarrantsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">dmtk:TwoThousandEighteenConvertibleBridgeNotesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="i2d6f98c2698e45af8da68430b3bfc742_I20220630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001651944</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:ClassOfWarrantOrRightAxis">dmtk:PlacementAgentWarrantsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-06-30</instant>
        </period>
    </context>
    <context id="if706627078bd4aa4984495209ba461b8_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001651944</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:ClassOfWarrantOrRightAxis">dmtk:PlacementAgentWarrantsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="i992097fa23d64aaa9f9ec09579943582_D20220401-20220630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001651944</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:PlanNameAxis">dmtk:TwoThousandTwentyEquityIncentivePlanMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-04-01</startDate>
            <endDate>2022-06-30</endDate>
        </period>
    </context>
    <context id="i0150b39d62c349949c09dc704f452a68_D20210401-20210630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001651944</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:PlanNameAxis">dmtk:TwoThousandTwentyEquityIncentivePlanMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-04-01</startDate>
            <endDate>2021-06-30</endDate>
        </period>
    </context>
    <context id="ie02bb53f63db46709e0bad3ea42b396b_D20220101-20220630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001651944</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:PlanNameAxis">dmtk:TwoThousandTwentyEquityIncentivePlanMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-06-30</endDate>
        </period>
    </context>
    <context id="i8e399d9e39504b2691c985ca006cfc1c_D20210101-20210630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001651944</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:PlanNameAxis">dmtk:TwoThousandTwentyEquityIncentivePlanMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-06-30</endDate>
        </period>
    </context>
    <context id="i45707f534a744db3b91064008ec1faf3_D20210401-20210630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001651944</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:PlanNameAxis">dmtk:TwoThousandTwentyEmployeeStockPurchasePlanMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-04-01</startDate>
            <endDate>2021-06-30</endDate>
        </period>
    </context>
    <context id="i017b877f28974f268d6f8d65791f6ccf_D20220101-20220630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001651944</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:PlanNameAxis">dmtk:TwoThousandTwentyEmployeeStockPurchasePlanMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-06-30</endDate>
        </period>
    </context>
    <context id="i39b710f935eb45c28f101a01178659a1_D20210101-20210630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001651944</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:PlanNameAxis">dmtk:TwoThousandTwentyEmployeeStockPurchasePlanMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-06-30</endDate>
        </period>
    </context>
    <context id="ia5465b10658f4233ba1e4baa3b943676_D20220101-20220630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001651944</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MinimumMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:PlanNameAxis">dmtk:TwoThousandTwentyEmployeeStockPurchasePlanMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-06-30</endDate>
        </period>
    </context>
    <context id="i88ad33d9abe64251a7d9379cd17f4be1_D20220101-20220630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001651944</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MaximumMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:PlanNameAxis">dmtk:TwoThousandTwentyEmployeeStockPurchasePlanMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-06-30</endDate>
        </period>
    </context>
    <context id="i1f1b6534cfc84ab0b6dde0c9dbabe32b_D20210101-20210630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001651944</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MinimumMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:PlanNameAxis">dmtk:TwoThousandTwentyEmployeeStockPurchasePlanMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-06-30</endDate>
        </period>
    </context>
    <context id="i8b65a3d5fc034de0bf1cc21839d1b39d_D20210101-20210630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001651944</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MaximumMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:PlanNameAxis">dmtk:TwoThousandTwentyEmployeeStockPurchasePlanMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-06-30</endDate>
        </period>
    </context>
    <context id="i34efb5ee40034834b0612db07b6ac538_D20220401-20220630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001651944</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:CostOfSalesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-04-01</startDate>
            <endDate>2022-06-30</endDate>
        </period>
    </context>
    <context id="i7756f068adac47afb60baa468c5ef026_D20210401-20210630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001651944</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:CostOfSalesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-04-01</startDate>
            <endDate>2021-06-30</endDate>
        </period>
    </context>
    <context id="i17e61074c4514eaf99a53572cb0fcf74_D20220101-20220630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001651944</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:CostOfSalesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-06-30</endDate>
        </period>
    </context>
    <context id="id38910781e2b4e58a9f2b8f671bfed35_D20210101-20210630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001651944</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:CostOfSalesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-06-30</endDate>
        </period>
    </context>
    <context id="i8cb435a01219406ba1ef713635ac68ba_D20220401-20220630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001651944</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:SellingAndMarketingExpenseMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-04-01</startDate>
            <endDate>2022-06-30</endDate>
        </period>
    </context>
    <context id="i86954732d12643d381b4531c01ebcfd8_D20210401-20210630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001651944</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:SellingAndMarketingExpenseMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-04-01</startDate>
            <endDate>2021-06-30</endDate>
        </period>
    </context>
    <context id="i778b6ff1b3184f42864e9d757af2f4bd_D20220101-20220630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001651944</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:SellingAndMarketingExpenseMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-06-30</endDate>
        </period>
    </context>
    <context id="ie6d29520a2674f6d9a7271efc6289984_D20210101-20210630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001651944</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:SellingAndMarketingExpenseMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-06-30</endDate>
        </period>
    </context>
    <context id="i561a7e21ce6a40039dc3d34e1397766f_D20220401-20220630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001651944</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:ResearchAndDevelopmentExpenseMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-04-01</startDate>
            <endDate>2022-06-30</endDate>
        </period>
    </context>
    <context id="i6ddfec946a484290af96cb60df8d77ed_D20210401-20210630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001651944</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:ResearchAndDevelopmentExpenseMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-04-01</startDate>
            <endDate>2021-06-30</endDate>
        </period>
    </context>
    <context id="i8910e2a23b804411a94de3c030ee3d6d_D20220101-20220630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001651944</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:ResearchAndDevelopmentExpenseMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-06-30</endDate>
        </period>
    </context>
    <context id="i35128ab55fdf4102bca836a519340c7f_D20210101-20210630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001651944</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:ResearchAndDevelopmentExpenseMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-06-30</endDate>
        </period>
    </context>
    <context id="ie9748d2474c1470fbedee2cfc150c874_D20220401-20220630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001651944</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:GeneralAndAdministrativeExpenseMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-04-01</startDate>
            <endDate>2022-06-30</endDate>
        </period>
    </context>
    <context id="if42f9fcfc62a442c8ed23e75ddd4b6dd_D20210401-20210630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001651944</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:GeneralAndAdministrativeExpenseMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-04-01</startDate>
            <endDate>2021-06-30</endDate>
        </period>
    </context>
    <context id="i50a7a6d1a7004169afd4ead8587d96b6_D20220101-20220630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001651944</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:GeneralAndAdministrativeExpenseMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-06-30</endDate>
        </period>
    </context>
    <context id="i3ff371283df84968a8de2a698b44e5b1_D20210101-20210630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001651944</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:GeneralAndAdministrativeExpenseMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-06-30</endDate>
        </period>
    </context>
    <context id="i3c1e467c7bea456e8c41b0e455ef5730_D20220101-20220630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001651944</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:PlanNameAxis">dmtk:TwoThousandTenStockPlanMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-06-30</endDate>
        </period>
    </context>
    <context id="i58d1b32270b14657a2a11820d5e6fa8d_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001651944</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:PlanNameAxis">dmtk:TwoThousandTenStockPlanMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="i5bd0ece4c3a9433ebf7e6f8058d14235_I20220630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001651944</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:PlanNameAxis">dmtk:TwoThousandTenStockPlanMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-06-30</instant>
        </period>
    </context>
    <context id="ied7a9ca9fd8040d59887525878d7cb79_D20220101-20220630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001651944</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MinimumMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">dmtk:IncentiveAndNonQualifiedStockOptionsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:PlanNameAxis">dmtk:TwoThousandTwentyEquityIncentivePlanMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-06-30</endDate>
        </period>
    </context>
    <context id="i2cb3f2789d9344f9a1099880c2a6b6ac_D20220101-20220630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001651944</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MinimumMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">dmtk:IncentiveStockOptionsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:PlanNameAxis">dmtk:TwoThousandTwentyEquityIncentivePlanMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-06-30</endDate>
        </period>
    </context>
    <context id="i695be12a2aa14dffb874c1e74a980c5b_D20220101-20220630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001651944</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MaximumMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:PlanNameAxis">dmtk:TwoThousandTwentyEquityIncentivePlanMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-06-30</endDate>
        </period>
    </context>
    <context id="i57b5170b75b149df8f3952976e4aeb64_I20220630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001651944</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:PlanNameAxis">dmtk:TwoThousandTwentyEquityIncentivePlanMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-06-30</instant>
        </period>
    </context>
    <context id="id1f6d22436f64f38a4bd51d0074f4a35_I20220630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001651944</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MaximumMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:PlanNameAxis">dmtk:TwoThousandTwentyEquityIncentivePlanMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-06-30</instant>
        </period>
    </context>
    <context id="i22cf6cdf250d424385f207471e8ff450_I20220630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001651944</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MaximumMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:PlanNameAxis">dmtk:TwoThousandTwentyEmployeeStockPurchasePlanMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-06-30</instant>
        </period>
    </context>
    <context id="i6808a2674aa947cbae46fd4581d39941_I20220630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001651944</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:PlanNameAxis">dmtk:TwoThousandTwentyEmployeeStockPurchasePlanMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-06-30</instant>
        </period>
    </context>
    <context id="idae0e59d93ee49ada1896eeec302b5ad_D20210228-20210228">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001651944</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:PlanNameAxis">dmtk:TwoThousandTwentyEmployeeStockPurchasePlanMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-02-28</startDate>
            <endDate>2021-02-28</endDate>
        </period>
    </context>
    <context id="i4953bff07aa94f8085ce64eca01ff01c_D20210801-20210831">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001651944</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:PlanNameAxis">dmtk:TwoThousandTwentyEmployeeStockPurchasePlanMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-08-01</startDate>
            <endDate>2021-08-31</endDate>
        </period>
    </context>
    <context id="i90db9a89ea084897a01e19ee9ba1df7d_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001651944</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:PlanNameAxis">dmtk:TwoThousandTwentyEmployeeStockPurchasePlanMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="if90b738ac124410e8756188bb3849132_I20220101">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001651944</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:PlanNameAxis">dmtk:TwoThousandTwentyEmployeeStockPurchasePlanMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-01-01</instant>
        </period>
    </context>
    <context id="i93962a6eeb67470a9a84c74d9a0daa4b_I20220228">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001651944</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:PlanNameAxis">dmtk:TwoThousandTwentyEmployeeStockPurchasePlanMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-02-28</instant>
        </period>
    </context>
    <context id="i3ae776d8a361420b98e7812cbc296a23_I20220630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001651944</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:ClassOfWarrantOrRightAxis">dmtk:ManagementWarrantsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-06-30</instant>
        </period>
    </context>
    <context id="icceae5e000e140b89495ae9f074cbf03_I20220630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001651944</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:ClassOfWarrantOrRightAxis">dmtk:ManagementWarrantsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-06-30</instant>
        </period>
    </context>
    <context id="i17c79d92ed9747bf964a280f627bbb4a_D20220101-20220630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001651944</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:ClassOfWarrantOrRightAxis">dmtk:ManagementWarrantsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-06-30</endDate>
        </period>
    </context>
    <context id="id48e52918d994150b696caa21ce59a38_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001651944</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:ClassOfWarrantOrRightAxis">dmtk:ManagementWarrantsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="i224d7d5c13f4473abacadb433d8efcf9_I20220630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001651944</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">dmtk:WarrantsToPurchaseCommonStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-06-30</instant>
        </period>
    </context>
    <context id="i3e751586f58d4d01a1fef025f865d0f3_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001651944</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">dmtk:WarrantsToPurchaseCommonStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="i518ef87c81764e97bfd3d740d82300fd_I20220630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001651944</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">dmtk:SpecialPurposeAcquisitionCompanyWarrantsToPurchaseCommonStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-06-30</instant>
        </period>
    </context>
    <context id="ib8e1d5497a8844f49561a3c895942e21_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001651944</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">dmtk:SpecialPurposeAcquisitionCompanyWarrantsToPurchaseCommonStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="id85b86a3ec0547afa49b47ee6b523100_I20220630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001651944</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:EmployeeStockOptionMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-06-30</instant>
        </period>
    </context>
    <context id="if9fd57fab22a46b58a6fed555cc40670_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001651944</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:EmployeeStockOptionMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="if59386ad3a864f49b56cf8b203a0bfc9_I20220630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001651944</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:RestrictedStockUnitsRSUMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-06-30</instant>
        </period>
    </context>
    <context id="ia2ce86db98734669afba2e88fbc221c0_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001651944</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:RestrictedStockUnitsRSUMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="idff1708d659844a99149a2c6dc434bbc_I20220630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001651944</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">dmtk:AuthorizedForFutureEquityGrantsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-06-30</instant>
        </period>
    </context>
    <context id="ia222e6a529804adeb78574b8095520eb_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001651944</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">dmtk:AuthorizedForFutureEquityGrantsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="if28f5d136fda458d8a8446a128205c60_I20220630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001651944</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">dmtk:AuthorizedForFutureESPPPurchasesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-06-30</instant>
        </period>
    </context>
    <context id="i5cb5de1a181c4857a7d503c399e272c8_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001651944</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">dmtk:AuthorizedForFutureESPPPurchasesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="ie2a82877a32d4e80a7f2d54460a79dcd_D20220101-20220630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001651944</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:ClassOfWarrantOrRightAxis">dmtk:SpecialPurposeAcquisitionCompaniesWarrantsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-06-30</endDate>
        </period>
    </context>
    <context id="if694b668e6db42e59488d953f4800965_D20220101-20220630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001651944</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AdjustmentsForNewAccountingPronouncementsAxis">us-gaap:AccountingStandardsUpdate201602Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-06-30</endDate>
        </period>
    </context>
    <context id="i637644f310444bb4bb137883228ca16b_D20220101-20220630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001651944</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:CumulativeEffectPeriodOfAdoptionAxis">srt:CumulativeEffectPeriodOfAdoptionAdjustmentMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:AdjustmentsForNewAccountingPronouncementsAxis">us-gaap:AccountingStandardsUpdate201602Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-06-30</endDate>
        </period>
    </context>
    <context id="i4628e2bd4b3a484e9970f7b8d824bdca_D20220101-20220630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001651944</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:CumulativeEffectPeriodOfAdoptionAxis">srt:CumulativeEffectPeriodOfAdoptionAdjustedBalanceMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:AdjustmentsForNewAccountingPronouncementsAxis">us-gaap:AccountingStandardsUpdate201602Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-06-30</endDate>
        </period>
    </context>
    <context id="ia085e149f0584e4aa75cec6634a0ee91_I20220630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001651944</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AdjustmentsForNewAccountingPronouncementsAxis">us-gaap:AccountingStandardsUpdate201602Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-06-30</instant>
        </period>
    </context>
    <context id="ie929f48c345b4dcab48cd9079f2d2e62_I20220630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001651944</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:CumulativeEffectPeriodOfAdoptionAxis">srt:CumulativeEffectPeriodOfAdoptionAdjustmentMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:AdjustmentsForNewAccountingPronouncementsAxis">us-gaap:AccountingStandardsUpdate201602Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-06-30</instant>
        </period>
    </context>
    <context id="i833f3dceaa1b4ef5bcdfa449605a0a35_I20220630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001651944</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:CumulativeEffectPeriodOfAdoptionAxis">srt:CumulativeEffectPeriodOfAdoptionAdjustedBalanceMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:AdjustmentsForNewAccountingPronouncementsAxis">us-gaap:AccountingStandardsUpdate201602Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-06-30</instant>
        </period>
    </context>
    <context id="icf690a1cf0024305b7396da4cb697adc_D20210101-20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001651944</identifier>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="i4ac87f578df0406d99e77dc768764559_D20220401-20220630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001651944</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:InterestIncomeMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-04-01</startDate>
            <endDate>2022-06-30</endDate>
        </period>
    </context>
    <context id="ie146fe37064c4413b6d561285cac9dcd_D20210401-20210630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001651944</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:InterestIncomeMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-04-01</startDate>
            <endDate>2021-06-30</endDate>
        </period>
    </context>
    <context id="i69bf0330ac3a4009ac4cc9f072eb2145_D20220101-20220630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001651944</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:InterestIncomeMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-06-30</endDate>
        </period>
    </context>
    <context id="ia60e98d0ecdb4e6fac0242d43b27bd2b_D20210101-20210630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001651944</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:InterestIncomeMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-06-30</endDate>
        </period>
    </context>
    <context id="i1618d3c7213a4aa5a35fb7ebe4eea53b_D20210701-20210701">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001651944</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:CounterpartyNameAxis">dmtk:KilroyRealtyLPMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-07-01</startDate>
            <endDate>2021-07-01</endDate>
        </period>
    </context>
    <context id="icbcfccaf50f84ffca456a076d115a21c_I20210701">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001651944</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:CounterpartyNameAxis">dmtk:KilroyRealtyLPMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-07-01</instant>
        </period>
    </context>
    <context id="i53405b48f5954e23b556c40be1389d0c_I20220630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001651944</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:CounterpartyNameAxis">dmtk:KilroyRealtyLPMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-06-30</instant>
        </period>
    </context>
    <context id="i75aabbdde1174af48e324feb000a8af2_I20220331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001651944</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:CounterpartyNameAxis">dmtk:KilroyRealtyLPMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-03-31</instant>
        </period>
    </context>
    <context id="i9841b134190d454987c9c0ed787bc2e8_D20220401-20220430">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001651944</identifier>
            <segment>
                <xbrldi:explicitMember dimension="dmtk:LeaseAmendmentsAxis">dmtk:FirstAmendmentMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:CounterpartyNameAxis">dmtk:KilroyRealtyLPMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-04-01</startDate>
            <endDate>2022-04-30</endDate>
        </period>
    </context>
    <context id="i87140271b1e742e28e8d60cec9e90bf4_I20220430">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001651944</identifier>
            <segment>
                <xbrldi:explicitMember dimension="dmtk:LeaseAmendmentsAxis">dmtk:FirstAmendmentMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:CounterpartyNameAxis">dmtk:KilroyRealtyLPMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-04-30</instant>
        </period>
    </context>
    <context id="if757ed00e77b443b929b902040ede6fe_D20220422-20220422">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001651944</identifier>
            <segment>
                <xbrldi:explicitMember dimension="dmtk:LeaseAmendmentsAxis">dmtk:SecondAmendmentMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:CounterpartyNameAxis">dmtk:KilroyRealtyLPMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-04-22</startDate>
            <endDate>2022-04-22</endDate>
        </period>
    </context>
    <context id="i21d961efb50e46f8a491229d676e3cca_I20220430">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001651944</identifier>
            <segment>
                <xbrldi:explicitMember dimension="dmtk:LeaseAmendmentsAxis">dmtk:SecondAmendmentMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:CounterpartyNameAxis">dmtk:KilroyRealtyLPMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-04-30</instant>
        </period>
    </context>
    <context id="i31c7d90c2ed74429be6d97f4216d8b3b_D20220422-20220422">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001651944</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:CounterpartyNameAxis">dmtk:KilroyRealtyLPMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-04-22</startDate>
            <endDate>2022-04-22</endDate>
        </period>
    </context>
    <context id="i40b956e3abae4c74a57f8271e4e2cc81_I20220430">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001651944</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:CounterpartyNameAxis">dmtk:KilroyRealtyLPMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-04-30</instant>
        </period>
    </context>
    <context id="iefc8a51c0ee64a2e92b3f718d0d8914b_D20220401-20220430">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001651944</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:CounterpartyNameAxis">dmtk:KilroyRealtyLPMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-04-01</startDate>
            <endDate>2022-04-30</endDate>
        </period>
    </context>
    <context id="i2d28646a716649a3bf03b33932b88ddc_I20220630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001651944</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:CounterpartyNameAxis">dmtk:KilroyRealtyLPMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:CreditFacilityAxis">us-gaap:LetterOfCreditMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:RestrictedCashAndCashEquivalentsCashAndCashEquivalentsAxis">us-gaap:DemandDepositsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-06-30</instant>
        </period>
    </context>
    <context id="i5c5f906de07546fbad68db3bc16af2da_D20220401-20220430">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001651944</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:CounterpartyNameAxis">dmtk:KilroyRealtyLPMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:CreditFacilityAxis">us-gaap:LetterOfCreditMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:RestrictedCashAndCashEquivalentsCashAndCashEquivalentsAxis">us-gaap:DemandDepositsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-04-01</startDate>
            <endDate>2022-04-30</endDate>
        </period>
    </context>
    <context id="ie106f93322ee42508b7a8c0522c1e6f8_I20220430">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001651944</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:CounterpartyNameAxis">dmtk:KilroyRealtyLPMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:CreditFacilityAxis">us-gaap:LetterOfCreditMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:RestrictedCashAndCashEquivalentsCashAndCashEquivalentsAxis">us-gaap:DemandDepositsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-04-30</instant>
        </period>
    </context>
    <context id="ie247503b8ef34dcca0fca78fe783bff5_I20220630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001651944</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:CounterpartyNameAxis">dmtk:KilroyRealtyLPMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:CreditFacilityAxis">us-gaap:StandbyLettersOfCreditMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:RestrictedCashAndCashEquivalentsCashAndCashEquivalentsAxis">us-gaap:DemandDepositsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-06-30</instant>
        </period>
    </context>
    <context id="i4976bcc83f7e4c978a094cc7482066ef_I20210101">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001651944</identifier>
        </entity>
        <period>
            <instant>2021-01-01</instant>
        </period>
    </context>
    <context id="i4d87d8619b7b49828e0354d3459d6bc4_D20220401-20220630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001651944</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionAxis">dmtk:EVERSANALifeScienceServicesLLCMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionsByRelatedPartyAxis">dmtk:SpouseOfChiefCommercialOfficerMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-04-01</startDate>
            <endDate>2022-06-30</endDate>
        </period>
    </context>
    <context id="iebe17418c5534164a125df7ed43c5ece_D20210401-20210630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001651944</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionAxis">dmtk:EVERSANALifeScienceServicesLLCMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionsByRelatedPartyAxis">dmtk:SpouseOfChiefCommercialOfficerMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-04-01</startDate>
            <endDate>2021-06-30</endDate>
        </period>
    </context>
    <context id="i0e1b8915a8614ad387c31cb5b81538f7_D20220101-20220630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001651944</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionAxis">dmtk:EVERSANALifeScienceServicesLLCMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionsByRelatedPartyAxis">dmtk:SpouseOfChiefCommercialOfficerMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-06-30</endDate>
        </period>
    </context>
    <context id="i681d541e73e1469a92851dbf2e1a96d4_D20210101-20210630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001651944</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionAxis">dmtk:EVERSANALifeScienceServicesLLCMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionsByRelatedPartyAxis">dmtk:SpouseOfChiefCommercialOfficerMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-06-30</endDate>
        </period>
    </context>
    <context id="ia139293fe3d744eea1b17b968bfcf5ad_D20191001-20191001">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001651944</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MaximumMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionAxis">dmtk:DermTechOperationsIncMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionsByRelatedPartyAxis">dmtk:BrotherOfChiefExecutiveOfficerMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-10-01</startDate>
            <endDate>2019-10-01</endDate>
        </period>
    </context>
    <context id="id5e6d28f8a04434285646197def78617_D20200511-20200511">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001651944</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionAxis">dmtk:DermTechOperationsIncMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionsByRelatedPartyAxis">dmtk:BrotherOfChiefExecutiveOfficerMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-05-11</startDate>
            <endDate>2020-05-11</endDate>
        </period>
    </context>
    <context id="i651d86ca5e54467a910cc1cdb8f31f8d_I20210102">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001651944</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionAxis">dmtk:DermTechOperationsIncMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionsByRelatedPartyAxis">dmtk:BrotherOfChiefExecutiveOfficerMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-01-02</instant>
        </period>
    </context>
    <context id="iee689bdd0154474d9e8d1bbbcec743b6_D20201111-20201111">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001651944</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionAxis">dmtk:DermTechOperationsIncMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionsByRelatedPartyAxis">dmtk:BrotherOfChiefExecutiveOfficerMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-11-11</startDate>
            <endDate>2020-11-11</endDate>
        </period>
    </context>
    <context id="ib0f91fba366d40acba994eb5d6addb9c_D20210226-20210226">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001651944</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionAxis">dmtk:DermTechOperationsIncMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionsByRelatedPartyAxis">dmtk:BrotherOfChiefExecutiveOfficerMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-02-26</startDate>
            <endDate>2021-02-26</endDate>
        </period>
    </context>
    <context id="i945b8bc570ef4af69046201719baea0d_D20220401-20220630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001651944</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionAxis">dmtk:DermTechOperationsIncMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionsByRelatedPartyAxis">dmtk:BrotherOfChiefExecutiveOfficerMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-04-01</startDate>
            <endDate>2022-06-30</endDate>
        </period>
    </context>
    <context id="idfbaf207ccb145e0804dfb68b580e154_D20210401-20210630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001651944</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionAxis">dmtk:DermTechOperationsIncMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionsByRelatedPartyAxis">dmtk:BrotherOfChiefExecutiveOfficerMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-04-01</startDate>
            <endDate>2021-06-30</endDate>
        </period>
    </context>
    <context id="i0d7a163c3890488dae0c374a84f12aa0_D20220101-20220630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001651944</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionAxis">dmtk:DermTechOperationsIncMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionsByRelatedPartyAxis">dmtk:BrotherOfChiefExecutiveOfficerMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-06-30</endDate>
        </period>
    </context>
    <context id="i690d64dd56474cd880eacb6ae348633b_D20210101-20210630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001651944</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionAxis">dmtk:DermTechOperationsIncMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionsByRelatedPartyAxis">dmtk:BrotherOfChiefExecutiveOfficerMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-06-30</endDate>
        </period>
    </context>
    <unit id="shares">
        <measure>shares</measure>
    </unit>
    <unit id="usd">
        <measure>iso4217:USD</measure>
    </unit>
    <unit id="usdPerShare">
        <divide>
            <unitNumerator>
                <measure>iso4217:USD</measure>
            </unitNumerator>
            <unitDenominator>
                <measure>shares</measure>
            </unitDenominator>
        </divide>
    </unit>
    <unit id="revenuestream">
        <measure>dmtk:revenueStream</measure>
    </unit>
    <unit id="number">
        <measure>pure</measure>
    </unit>
    <unit id="warrant">
        <measure>dmtk:Warrant</measure>
    </unit>
    <unit id="sqft">
        <measure>utr:sqft</measure>
    </unit>
    <unit id="usdPerSqft">
        <divide>
            <unitNumerator>
                <measure>iso4217:USD</measure>
            </unitNumerator>
            <unitDenominator>
                <measure>utr:sqft</measure>
            </unitDenominator>
        </divide>
    </unit>
    <unit id="phase">
        <measure>dmtk:phase</measure>
    </unit>
    <unit id="period">
        <measure>dmtk:period</measure>
    </unit>
    <dei:EntityCentralIndexKey
      contextRef="ia855382ada1f4f28aa8ef6da692ff177_D20220101-20220630"
      id="id3VybDovL2RvY3MudjEvZG9jOmFlNWE5YmUwZWI5NDQ1ZDE5MmZhZTgyMmQyMmJlMDlmL3NlYzphZTVhOWJlMGViOTQ0NWQxOTJmYWU4MjJkMjJiZTA5Zl80L2ZyYWc6OWRhMWI2YjY4YjM2NDBmMjgyYzc2MzFiNWJlM2E2ZjUvdGFibGU6ZDcxMjQxZjU3MDViNDc4MDhmOGZkNzczN2MwM2Y2OWMvdGFibGVyYW5nZTpkNzEyNDFmNTcwNWI0NzgwOGY4ZmQ3NzM3YzAzZjY5Y18yLTEtMS0xLTYyNg_b37992aa-9313-4acc-9018-d5b0bc581d47">0001651944</dei:EntityCentralIndexKey>
    <dei:CurrentFiscalYearEndDate
      contextRef="ia855382ada1f4f28aa8ef6da692ff177_D20220101-20220630"
      id="id3VybDovL2RvY3MudjEvZG9jOmFlNWE5YmUwZWI5NDQ1ZDE5MmZhZTgyMmQyMmJlMDlmL3NlYzphZTVhOWJlMGViOTQ0NWQxOTJmYWU4MjJkMjJiZTA5Zl80L2ZyYWc6OWRhMWI2YjY4YjM2NDBmMjgyYzc2MzFiNWJlM2E2ZjUvdGFibGU6ZDcxMjQxZjU3MDViNDc4MDhmOGZkNzczN2MwM2Y2OWMvdGFibGVyYW5nZTpkNzEyNDFmNTcwNWI0NzgwOGY4ZmQ3NzM3YzAzZjY5Y18zLTEtMS0xLTYyNg_ca7fed0f-9b9e-493e-ac4c-616ce01da6fe">--12-31</dei:CurrentFiscalYearEndDate>
    <dei:DocumentFiscalYearFocus
      contextRef="ia855382ada1f4f28aa8ef6da692ff177_D20220101-20220630"
      id="id3VybDovL2RvY3MudjEvZG9jOmFlNWE5YmUwZWI5NDQ1ZDE5MmZhZTgyMmQyMmJlMDlmL3NlYzphZTVhOWJlMGViOTQ0NWQxOTJmYWU4MjJkMjJiZTA5Zl80L2ZyYWc6OWRhMWI2YjY4YjM2NDBmMjgyYzc2MzFiNWJlM2E2ZjUvdGFibGU6ZDcxMjQxZjU3MDViNDc4MDhmOGZkNzczN2MwM2Y2OWMvdGFibGVyYW5nZTpkNzEyNDFmNTcwNWI0NzgwOGY4ZmQ3NzM3YzAzZjY5Y180LTEtMS0xLTYyNg_9469af44-fcfe-42e1-b110-2a4983aac827">2022</dei:DocumentFiscalYearFocus>
    <dei:DocumentFiscalPeriodFocus
      contextRef="ia855382ada1f4f28aa8ef6da692ff177_D20220101-20220630"
      id="id3VybDovL2RvY3MudjEvZG9jOmFlNWE5YmUwZWI5NDQ1ZDE5MmZhZTgyMmQyMmJlMDlmL3NlYzphZTVhOWJlMGViOTQ0NWQxOTJmYWU4MjJkMjJiZTA5Zl80L2ZyYWc6OWRhMWI2YjY4YjM2NDBmMjgyYzc2MzFiNWJlM2E2ZjUvdGFibGU6ZDcxMjQxZjU3MDViNDc4MDhmOGZkNzczN2MwM2Y2OWMvdGFibGVyYW5nZTpkNzEyNDFmNTcwNWI0NzgwOGY4ZmQ3NzM3YzAzZjY5Y181LTEtMS0xLTYyNg_5d8a309d-f5e9-405f-9e88-fa88e6e1532a">Q2</dei:DocumentFiscalPeriodFocus>
    <dei:AmendmentFlag
      contextRef="ia855382ada1f4f28aa8ef6da692ff177_D20220101-20220630"
      id="id3VybDovL2RvY3MudjEvZG9jOmFlNWE5YmUwZWI5NDQ1ZDE5MmZhZTgyMmQyMmJlMDlmL3NlYzphZTVhOWJlMGViOTQ0NWQxOTJmYWU4MjJkMjJiZTA5Zl80L2ZyYWc6OWRhMWI2YjY4YjM2NDBmMjgyYzc2MzFiNWJlM2E2ZjUvdGFibGU6ZDcxMjQxZjU3MDViNDc4MDhmOGZkNzczN2MwM2Y2OWMvdGFibGVyYW5nZTpkNzEyNDFmNTcwNWI0NzgwOGY4ZmQ3NzM3YzAzZjY5Y182LTEtMS0xLTYyNg_4c05cf63-5751-48aa-8470-616b9def7439">false</dei:AmendmentFlag>
    <us-gaap:PropertyPlantAndEquipmentUsefulLife
      contextRef="if83fbbc281954a99aa695fe8757b3e08_D20220101-20220630"
      id="id3VybDovL2RvY3MudjEvZG9jOmFlNWE5YmUwZWI5NDQ1ZDE5MmZhZTgyMmQyMmJlMDlmL3NlYzphZTVhOWJlMGViOTQ0NWQxOTJmYWU4MjJkMjJiZTA5Zl8zNy9mcmFnOjQ4OGNkZjBhODVlYzRiMDliYWFiN2JhZTlhODA5YjcwL3RleHRyZWdpb246NDg4Y2RmMGE4NWVjNGIwOWJhYWI3YmFlOWE4MDliNzBfMTQ0NDA_b7f0ce5d-c748-4105-a8ca-a2d7278a0959">P2Y</us-gaap:PropertyPlantAndEquipmentUsefulLife>
    <us-gaap:RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionPeriod1
      contextRef="i4e7d7d7304c048ca82f068a9a195f83b_I20220630"
      id="id3VybDovL2RvY3MudjEvZG9jOmFlNWE5YmUwZWI5NDQ1ZDE5MmZhZTgyMmQyMmJlMDlmL3NlYzphZTVhOWJlMGViOTQ0NWQxOTJmYWU4MjJkMjJiZTA5Zl8zNy9mcmFnOjQ4OGNkZjBhODVlYzRiMDliYWFiN2JhZTlhODA5YjcwL3RleHRyZWdpb246NDg4Y2RmMGE4NWVjNGIwOWJhYWI3YmFlOWE4MDliNzBfMjUxODY_b4f0c6ee-fd6c-49c3-80df-d66815f5e42f">P2Y</us-gaap:RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionPeriod1>
    <us-gaap:StockholdersEquityNoteStockSplitConversionRatio1
      contextRef="i93b0b8d9a4ba4307b9aa1d2e18a0e2c3_D20190829-20190829"
      decimals="1"
      id="id3VybDovL2RvY3MudjEvZG9jOmFlNWE5YmUwZWI5NDQ1ZDE5MmZhZTgyMmQyMmJlMDlmL3NlYzphZTVhOWJlMGViOTQ0NWQxOTJmYWU4MjJkMjJiZTA5Zl80MC9mcmFnOjY4ZTEzYjk4NTAxZTRkYzU5NGVlMWQ4ZjA2NzQ4Zjk1L3RhYmxlOmVkYTM5MWVkZGQyYjQyNzJhYjE3ZWMzYzBiYTM3MTE3L3RhYmxlcmFuZ2U6ZWRhMzkxZWRkZDJiNDI3MmFiMTdlYzNjMGJhMzcxMTdfMi0xLTEtMS02MjY_59d4e361-9efb-4340-bbe9-78823febe876"
      unitRef="number">0.5</us-gaap:StockholdersEquityNoteStockSplitConversionRatio1>
    <us-gaap:ClassOfWarrantOrRightNumberOfSecuritiesCalledByEachWarrantOrRight
      contextRef="i634967fade134dc69b40f7ae53806ba8_I20220630"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmFlNWE5YmUwZWI5NDQ1ZDE5MmZhZTgyMmQyMmJlMDlmL3NlYzphZTVhOWJlMGViOTQ0NWQxOTJmYWU4MjJkMjJiZTA5Zl80OS9mcmFnOjg0NmM4Nzk4ZmU0MDQyZjA4YTJmY2E4MTExOTk0NmU5L3RhYmxlOjIzNzRiZjMzNDc2MjQ0Mzg5NjllMjM4Njc1NzEwZDNhL3RhYmxlcmFuZ2U6MjM3NGJmMzM0NzYyNDQzODk2OWUyMzg2NzU3MTBkM2FfMi0xLTEtMS02MjY_c90f118e-6e82-4e86-b4e2-e33185fe4375"
      unitRef="shares">0.25</us-gaap:ClassOfWarrantOrRightNumberOfSecuritiesCalledByEachWarrantOrRight>
    <us-gaap:ClassOfWarrantOrRightNumberOfSecuritiesCalledByEachWarrantOrRight
      contextRef="ia9537308acbd431f87e3b44d01741f2c_I20220630"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmFlNWE5YmUwZWI5NDQ1ZDE5MmZhZTgyMmQyMmJlMDlmL3NlYzphZTVhOWJlMGViOTQ0NWQxOTJmYWU4MjJkMjJiZTA5Zl80OS9mcmFnOjg0NmM4Nzk4ZmU0MDQyZjA4YTJmY2E4MTExOTk0NmU5L3RhYmxlOjIzNzRiZjMzNDc2MjQ0Mzg5NjllMjM4Njc1NzEwZDNhL3RhYmxlcmFuZ2U6MjM3NGJmMzM0NzYyNDQzODk2OWUyMzg2NzU3MTBkM2FfMi0xLTEtMS02MjY_ea6aab91-1291-4b0f-a29f-1b71eb81e969"
      unitRef="shares">0.25</us-gaap:ClassOfWarrantOrRightNumberOfSecuritiesCalledByEachWarrantOrRight>
    <dmtk:NumberOfWarrantsEntitleHolderToPurchaseOneShare
      contextRef="ie2a82877a32d4e80a7f2d54460a79dcd_D20220101-20220630"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmFlNWE5YmUwZWI5NDQ1ZDE5MmZhZTgyMmQyMmJlMDlmL3NlYzphZTVhOWJlMGViOTQ0NWQxOTJmYWU4MjJkMjJiZTA5Zl80OS9mcmFnOjg0NmM4Nzk4ZmU0MDQyZjA4YTJmY2E4MTExOTk0NmU5L3RleHRyZWdpb246ODQ2Yzg3OThmZTQwNDJmMDhhMmZjYTgxMTE5OTQ2ZTlfMzI5ODUzNDg4MzQyNQ_9fdf8ca0-eea5-40e2-b781-30f40b3dd2c4"
      unitRef="warrant">4</dmtk:NumberOfWarrantsEntitleHolderToPurchaseOneShare>
    <us-gaap:LesseeOperatingLeaseRemainingLeaseTerm
      contextRef="i53405b48f5954e23b556c40be1389d0c_I20220630"
      id="id3VybDovL2RvY3MudjEvZG9jOmFlNWE5YmUwZWI5NDQ1ZDE5MmZhZTgyMmQyMmJlMDlmL3NlYzphZTVhOWJlMGViOTQ0NWQxOTJmYWU4MjJkMjJiZTA5Zl80MTMvZnJhZzpmZGQ1ODk4MWFkZTg0M2M3YTFiNmNhYmIxZWE0YjFjZS90ZXh0cmVnaW9uOmZkZDU4OTgxYWRlODQzYzdhMWI2Y2FiYjFlYTRiMWNlXzMyOTg1MzQ4ODM0NzA_1a89299a-757b-4a42-b393-0135eed5e2b9">P10Y6M</us-gaap:LesseeOperatingLeaseRemainingLeaseTerm>
    <dei:DocumentType
      contextRef="ia855382ada1f4f28aa8ef6da692ff177_D20220101-20220630"
      id="id3VybDovL2RvY3MudjEvZG9jOmFlNWE5YmUwZWI5NDQ1ZDE5MmZhZTgyMmQyMmJlMDlmL3NlYzphZTVhOWJlMGViOTQ0NWQxOTJmYWU4MjJkMjJiZTA5Zl8xL2ZyYWc6MTEwYjcyOWI5NDIwNDk4OGIyZDUxYzJhZTFlYzRlNjIvdGV4dHJlZ2lvbjoxMTBiNzI5Yjk0MjA0OTg4YjJkNTFjMmFlMWVjNGU2Ml8yMDc0_a02491b7-39ce-4593-99ec-f39893d1a370">10-Q</dei:DocumentType>
    <dei:DocumentQuarterlyReport
      contextRef="ia855382ada1f4f28aa8ef6da692ff177_D20220101-20220630"
      id="id3VybDovL2RvY3MudjEvZG9jOmFlNWE5YmUwZWI5NDQ1ZDE5MmZhZTgyMmQyMmJlMDlmL3NlYzphZTVhOWJlMGViOTQ0NWQxOTJmYWU4MjJkMjJiZTA5Zl8xL2ZyYWc6MTEwYjcyOWI5NDIwNDk4OGIyZDUxYzJhZTFlYzRlNjIvdGFibGU6MTc4ODU5ZDFkMDVlNGIwOGE3ZTFjMDZkYjk0ZmY4MmIvdGFibGVyYW5nZToxNzg4NTlkMWQwNWU0YjA4YTdlMWMwNmRiOTRmZjgyYl8wLTAtMS0xLTYyNg_4b9de10f-c8aa-4a99-af44-b47d444ff57d">true</dei:DocumentQuarterlyReport>
    <dei:DocumentPeriodEndDate
      contextRef="ia855382ada1f4f28aa8ef6da692ff177_D20220101-20220630"
      id="id3VybDovL2RvY3MudjEvZG9jOmFlNWE5YmUwZWI5NDQ1ZDE5MmZhZTgyMmQyMmJlMDlmL3NlYzphZTVhOWJlMGViOTQ0NWQxOTJmYWU4MjJkMjJiZTA5Zl8xL2ZyYWc6MTEwYjcyOWI5NDIwNDk4OGIyZDUxYzJhZTFlYzRlNjIvdGV4dHJlZ2lvbjoxMTBiNzI5Yjk0MjA0OTg4YjJkNTFjMmFlMWVjNGU2Ml8xODA_8815485c-4214-4eb6-8fca-4f3bdf163866">2022-06-30</dei:DocumentPeriodEndDate>
    <dei:DocumentTransitionReport
      contextRef="ia855382ada1f4f28aa8ef6da692ff177_D20220101-20220630"
      id="id3VybDovL2RvY3MudjEvZG9jOmFlNWE5YmUwZWI5NDQ1ZDE5MmZhZTgyMmQyMmJlMDlmL3NlYzphZTVhOWJlMGViOTQ0NWQxOTJmYWU4MjJkMjJiZTA5Zl8xL2ZyYWc6MTEwYjcyOWI5NDIwNDk4OGIyZDUxYzJhZTFlYzRlNjIvdGFibGU6NGEzNmZkNTZhMDM2NDI2ZWJlNzRlZmNhM2VhMDcxOGYvdGFibGVyYW5nZTo0YTM2ZmQ1NmEwMzY0MjZlYmU3NGVmY2EzZWEwNzE4Zl8wLTAtMS0xLTYyNg_bd7f6fd4-16e1-4c1a-90f7-2158598be3a3">false</dei:DocumentTransitionReport>
    <dei:EntityFileNumber
      contextRef="ia855382ada1f4f28aa8ef6da692ff177_D20220101-20220630"
      id="id3VybDovL2RvY3MudjEvZG9jOmFlNWE5YmUwZWI5NDQ1ZDE5MmZhZTgyMmQyMmJlMDlmL3NlYzphZTVhOWJlMGViOTQ0NWQxOTJmYWU4MjJkMjJiZTA5Zl8xL2ZyYWc6MTEwYjcyOWI5NDIwNDk4OGIyZDUxYzJhZTFlYzRlNjIvdGV4dHJlZ2lvbjoxMTBiNzI5Yjk0MjA0OTg4YjJkNTFjMmFlMWVjNGU2Ml8yMDc1_3b33700f-c0d3-49cf-994a-de9df63e23e4">001-38118</dei:EntityFileNumber>
    <dei:EntityRegistrantName
      contextRef="ia855382ada1f4f28aa8ef6da692ff177_D20220101-20220630"
      id="id3VybDovL2RvY3MudjEvZG9jOmFlNWE5YmUwZWI5NDQ1ZDE5MmZhZTgyMmQyMmJlMDlmL3NlYzphZTVhOWJlMGViOTQ0NWQxOTJmYWU4MjJkMjJiZTA5Zl8xL2ZyYWc6MTEwYjcyOWI5NDIwNDk4OGIyZDUxYzJhZTFlYzRlNjIvdGV4dHJlZ2lvbjoxMTBiNzI5Yjk0MjA0OTg4YjJkNTFjMmFlMWVjNGU2Ml8yMDY4_66843833-b862-4f02-b4a5-dfe6b68b67e0">DERMTECH, INC.</dei:EntityRegistrantName>
    <dei:EntityIncorporationStateCountryCode
      contextRef="ia855382ada1f4f28aa8ef6da692ff177_D20220101-20220630"
      id="id3VybDovL2RvY3MudjEvZG9jOmFlNWE5YmUwZWI5NDQ1ZDE5MmZhZTgyMmQyMmJlMDlmL3NlYzphZTVhOWJlMGViOTQ0NWQxOTJmYWU4MjJkMjJiZTA5Zl8xL2ZyYWc6MTEwYjcyOWI5NDIwNDk4OGIyZDUxYzJhZTFlYzRlNjIvdGFibGU6YTYxZDg4ZmExMjExNDUwZmE5OTE3N2Y5YjNmYThjNGEvdGFibGVyYW5nZTphNjFkODhmYTEyMTE0NTBmYTk5MTc3ZjliM2ZhOGM0YV8wLTAtMS0xLTYyNg_19864843-c034-4329-a5eb-e871da78f2df">DE</dei:EntityIncorporationStateCountryCode>
    <dei:EntityTaxIdentificationNumber
      contextRef="ia855382ada1f4f28aa8ef6da692ff177_D20220101-20220630"
      id="id3VybDovL2RvY3MudjEvZG9jOmFlNWE5YmUwZWI5NDQ1ZDE5MmZhZTgyMmQyMmJlMDlmL3NlYzphZTVhOWJlMGViOTQ0NWQxOTJmYWU4MjJkMjJiZTA5Zl8xL2ZyYWc6MTEwYjcyOWI5NDIwNDk4OGIyZDUxYzJhZTFlYzRlNjIvdGFibGU6YTYxZDg4ZmExMjExNDUwZmE5OTE3N2Y5YjNmYThjNGEvdGFibGVyYW5nZTphNjFkODhmYTEyMTE0NTBmYTk5MTc3ZjliM2ZhOGM0YV8wLTEtMS0xLTYyNg_e0da9391-bbf8-49b4-bec6-ca82ba470c05">84-2870849</dei:EntityTaxIdentificationNumber>
    <dei:EntityAddressAddressLine1
      contextRef="ia855382ada1f4f28aa8ef6da692ff177_D20220101-20220630"
      id="id3VybDovL2RvY3MudjEvZG9jOmFlNWE5YmUwZWI5NDQ1ZDE5MmZhZTgyMmQyMmJlMDlmL3NlYzphZTVhOWJlMGViOTQ0NWQxOTJmYWU4MjJkMjJiZTA5Zl8xL2ZyYWc6MTEwYjcyOWI5NDIwNDk4OGIyZDUxYzJhZTFlYzRlNjIvdGFibGU6YTYxZDg4ZmExMjExNDUwZmE5OTE3N2Y5YjNmYThjNGEvdGFibGVyYW5nZTphNjFkODhmYTEyMTE0NTBmYTk5MTc3ZjliM2ZhOGM0YV8zLTAtMS0xLTYyNi90ZXh0cmVnaW9uOjkzZDgwZDE5NzFlZDRmNDFiMzgzODJkMDlkNTA1NjM2XzU_94bdcd6f-3c47-4637-a870-ba9a1313a426">11099 N. Torrey Pines Road</dei:EntityAddressAddressLine1>
    <dei:EntityAddressAddressLine2
      contextRef="ia855382ada1f4f28aa8ef6da692ff177_D20220101-20220630"
      id="id3VybDovL2RvY3MudjEvZG9jOmFlNWE5YmUwZWI5NDQ1ZDE5MmZhZTgyMmQyMmJlMDlmL3NlYzphZTVhOWJlMGViOTQ0NWQxOTJmYWU4MjJkMjJiZTA5Zl8xL2ZyYWc6MTEwYjcyOWI5NDIwNDk4OGIyZDUxYzJhZTFlYzRlNjIvdGFibGU6YTYxZDg4ZmExMjExNDUwZmE5OTE3N2Y5YjNmYThjNGEvdGFibGVyYW5nZTphNjFkODhmYTEyMTE0NTBmYTk5MTc3ZjliM2ZhOGM0YV8zLTAtMS0xLTYyNi90ZXh0cmVnaW9uOjkzZDgwZDE5NzFlZDRmNDFiMzgzODJkMDlkNTA1NjM2Xzk_22db0309-5cd3-4d32-825d-e629540113f7">Suite 100</dei:EntityAddressAddressLine2>
    <dei:EntityAddressCityOrTown
      contextRef="ia855382ada1f4f28aa8ef6da692ff177_D20220101-20220630"
      id="id3VybDovL2RvY3MudjEvZG9jOmFlNWE5YmUwZWI5NDQ1ZDE5MmZhZTgyMmQyMmJlMDlmL3NlYzphZTVhOWJlMGViOTQ0NWQxOTJmYWU4MjJkMjJiZTA5Zl8xL2ZyYWc6MTEwYjcyOWI5NDIwNDk4OGIyZDUxYzJhZTFlYzRlNjIvdGFibGU6YTYxZDg4ZmExMjExNDUwZmE5OTE3N2Y5YjNmYThjNGEvdGFibGVyYW5nZTphNjFkODhmYTEyMTE0NTBmYTk5MTc3ZjliM2ZhOGM0YV8zLTAtMS0xLTYyNi90ZXh0cmVnaW9uOjkzZDgwZDE5NzFlZDRmNDFiMzgzODJkMDlkNTA1NjM2XzEy_e1ea5c6a-3719-435b-ae0c-dad9e1dbce96">La Jolla</dei:EntityAddressCityOrTown>
    <dei:EntityAddressStateOrProvince
      contextRef="ia855382ada1f4f28aa8ef6da692ff177_D20220101-20220630"
      id="id3VybDovL2RvY3MudjEvZG9jOmFlNWE5YmUwZWI5NDQ1ZDE5MmZhZTgyMmQyMmJlMDlmL3NlYzphZTVhOWJlMGViOTQ0NWQxOTJmYWU4MjJkMjJiZTA5Zl8xL2ZyYWc6MTEwYjcyOWI5NDIwNDk4OGIyZDUxYzJhZTFlYzRlNjIvdGFibGU6YTYxZDg4ZmExMjExNDUwZmE5OTE3N2Y5YjNmYThjNGEvdGFibGVyYW5nZTphNjFkODhmYTEyMTE0NTBmYTk5MTc3ZjliM2ZhOGM0YV8zLTAtMS0xLTYyNi90ZXh0cmVnaW9uOjkzZDgwZDE5NzFlZDRmNDFiMzgzODJkMDlkNTA1NjM2XzE2_5239fb48-2e3d-43e7-a70f-4f1170e81d06">CA</dei:EntityAddressStateOrProvince>
    <dei:EntityAddressPostalZipCode
      contextRef="ia855382ada1f4f28aa8ef6da692ff177_D20220101-20220630"
      id="id3VybDovL2RvY3MudjEvZG9jOmFlNWE5YmUwZWI5NDQ1ZDE5MmZhZTgyMmQyMmJlMDlmL3NlYzphZTVhOWJlMGViOTQ0NWQxOTJmYWU4MjJkMjJiZTA5Zl8xL2ZyYWc6MTEwYjcyOWI5NDIwNDk4OGIyZDUxYzJhZTFlYzRlNjIvdGFibGU6YTYxZDg4ZmExMjExNDUwZmE5OTE3N2Y5YjNmYThjNGEvdGFibGVyYW5nZTphNjFkODhmYTEyMTE0NTBmYTk5MTc3ZjliM2ZhOGM0YV8zLTEtMS0xLTYyNg_5a67e34e-3943-4502-b3b4-eb68170f3a0d">92037</dei:EntityAddressPostalZipCode>
    <dei:CityAreaCode
      contextRef="ia855382ada1f4f28aa8ef6da692ff177_D20220101-20220630"
      id="id3VybDovL2RvY3MudjEvZG9jOmFlNWE5YmUwZWI5NDQ1ZDE5MmZhZTgyMmQyMmJlMDlmL3NlYzphZTVhOWJlMGViOTQ0NWQxOTJmYWU4MjJkMjJiZTA5Zl8xL2ZyYWc6MTEwYjcyOWI5NDIwNDk4OGIyZDUxYzJhZTFlYzRlNjIvdGV4dHJlZ2lvbjoxMTBiNzI5Yjk0MjA0OTg4YjJkNTFjMmFlMWVjNGU2Ml8yMDY5_ee497845-fc49-441e-beb8-23e14d5ce94b">858</dei:CityAreaCode>
    <dei:LocalPhoneNumber
      contextRef="ia855382ada1f4f28aa8ef6da692ff177_D20220101-20220630"
      id="id3VybDovL2RvY3MudjEvZG9jOmFlNWE5YmUwZWI5NDQ1ZDE5MmZhZTgyMmQyMmJlMDlmL3NlYzphZTVhOWJlMGViOTQ0NWQxOTJmYWU4MjJkMjJiZTA5Zl8xL2ZyYWc6MTEwYjcyOWI5NDIwNDk4OGIyZDUxYzJhZTFlYzRlNjIvdGV4dHJlZ2lvbjoxMTBiNzI5Yjk0MjA0OTg4YjJkNTFjMmFlMWVjNGU2Ml8yMDcw_1be21261-9b3c-4a84-b475-2d04393aed1f">450-4222</dei:LocalPhoneNumber>
    <dei:Security12bTitle
      contextRef="ia855382ada1f4f28aa8ef6da692ff177_D20220101-20220630"
      id="id3VybDovL2RvY3MudjEvZG9jOmFlNWE5YmUwZWI5NDQ1ZDE5MmZhZTgyMmQyMmJlMDlmL3NlYzphZTVhOWJlMGViOTQ0NWQxOTJmYWU4MjJkMjJiZTA5Zl8xL2ZyYWc6MTEwYjcyOWI5NDIwNDk4OGIyZDUxYzJhZTFlYzRlNjIvdGFibGU6Yjc2NGU0OTJjODM2NDhiY2I1ODA3YjFkNmFlMGNiNmEvdGFibGVyYW5nZTpiNzY0ZTQ5MmM4MzY0OGJjYjU4MDdiMWQ2YWUwY2I2YV8xLTAtMS0xLTYyNg_ae603770-cf29-4e68-95dd-090e070deb50">Common Stock, par value $0.0001 per share</dei:Security12bTitle>
    <dei:TradingSymbol
      contextRef="ia855382ada1f4f28aa8ef6da692ff177_D20220101-20220630"
      id="id3VybDovL2RvY3MudjEvZG9jOmFlNWE5YmUwZWI5NDQ1ZDE5MmZhZTgyMmQyMmJlMDlmL3NlYzphZTVhOWJlMGViOTQ0NWQxOTJmYWU4MjJkMjJiZTA5Zl8xL2ZyYWc6MTEwYjcyOWI5NDIwNDk4OGIyZDUxYzJhZTFlYzRlNjIvdGFibGU6Yjc2NGU0OTJjODM2NDhiY2I1ODA3YjFkNmFlMGNiNmEvdGFibGVyYW5nZTpiNzY0ZTQ5MmM4MzY0OGJjYjU4MDdiMWQ2YWUwY2I2YV8xLTEtMS0xLTYyNg_dec0d27d-60f1-4d6a-9a1a-28d93152fa52">DMTK</dei:TradingSymbol>
    <dei:SecurityExchangeName
      contextRef="ia855382ada1f4f28aa8ef6da692ff177_D20220101-20220630"
      id="id3VybDovL2RvY3MudjEvZG9jOmFlNWE5YmUwZWI5NDQ1ZDE5MmZhZTgyMmQyMmJlMDlmL3NlYzphZTVhOWJlMGViOTQ0NWQxOTJmYWU4MjJkMjJiZTA5Zl8xL2ZyYWc6MTEwYjcyOWI5NDIwNDk4OGIyZDUxYzJhZTFlYzRlNjIvdGFibGU6Yjc2NGU0OTJjODM2NDhiY2I1ODA3YjFkNmFlMGNiNmEvdGFibGVyYW5nZTpiNzY0ZTQ5MmM4MzY0OGJjYjU4MDdiMWQ2YWUwY2I2YV8xLTItMS0xLTYyNi90ZXh0cmVnaW9uOjVmMGU5YWRiYzZjZjRlZGQ5YzI3NjdlZDEzNmJhYjVkXzg_bf1023b4-d69c-45f1-92bd-49443502ebb4">NASDAQ</dei:SecurityExchangeName>
    <dei:EntityCurrentReportingStatus
      contextRef="ia855382ada1f4f28aa8ef6da692ff177_D20220101-20220630"
      id="id3VybDovL2RvY3MudjEvZG9jOmFlNWE5YmUwZWI5NDQ1ZDE5MmZhZTgyMmQyMmJlMDlmL3NlYzphZTVhOWJlMGViOTQ0NWQxOTJmYWU4MjJkMjJiZTA5Zl8xL2ZyYWc6MTEwYjcyOWI5NDIwNDk4OGIyZDUxYzJhZTFlYzRlNjIvdGV4dHJlZ2lvbjoxMTBiNzI5Yjk0MjA0OTg4YjJkNTFjMmFlMWVjNGU2Ml8yMDc4_75b19a18-72c9-4803-878a-10f48cafd5fa">Yes</dei:EntityCurrentReportingStatus>
    <dei:EntityInteractiveDataCurrent
      contextRef="ia855382ada1f4f28aa8ef6da692ff177_D20220101-20220630"
      id="id3VybDovL2RvY3MudjEvZG9jOmFlNWE5YmUwZWI5NDQ1ZDE5MmZhZTgyMmQyMmJlMDlmL3NlYzphZTVhOWJlMGViOTQ0NWQxOTJmYWU4MjJkMjJiZTA5Zl8xL2ZyYWc6MTEwYjcyOWI5NDIwNDk4OGIyZDUxYzJhZTFlYzRlNjIvdGV4dHJlZ2lvbjoxMTBiNzI5Yjk0MjA0OTg4YjJkNTFjMmFlMWVjNGU2Ml8yMDcx_5b61d521-98ef-4383-8abf-109523284e81">Yes</dei:EntityInteractiveDataCurrent>
    <dei:EntityFilerCategory
      contextRef="ia855382ada1f4f28aa8ef6da692ff177_D20220101-20220630"
      id="id3VybDovL2RvY3MudjEvZG9jOmFlNWE5YmUwZWI5NDQ1ZDE5MmZhZTgyMmQyMmJlMDlmL3NlYzphZTVhOWJlMGViOTQ0NWQxOTJmYWU4MjJkMjJiZTA5Zl8xL2ZyYWc6MTEwYjcyOWI5NDIwNDk4OGIyZDUxYzJhZTFlYzRlNjIvdGFibGU6NGNlNzg5MjU0Mzg1NDFhOGEyZjAxYjkyZTQ0YWIwODkvdGFibGVyYW5nZTo0Y2U3ODkyNTQzODU0MWE4YTJmMDFiOTJlNDRhYjA4OV8wLTAtMS0xLTYzOTM_86d48a4f-2505-4f4b-8b52-1cb9fa12dc44">Large Accelerated Filer</dei:EntityFilerCategory>
    <dei:EntitySmallBusiness
      contextRef="ia855382ada1f4f28aa8ef6da692ff177_D20220101-20220630"
      id="id3VybDovL2RvY3MudjEvZG9jOmFlNWE5YmUwZWI5NDQ1ZDE5MmZhZTgyMmQyMmJlMDlmL3NlYzphZTVhOWJlMGViOTQ0NWQxOTJmYWU4MjJkMjJiZTA5Zl8xL2ZyYWc6MTEwYjcyOWI5NDIwNDk4OGIyZDUxYzJhZTFlYzRlNjIvdGFibGU6NGNlNzg5MjU0Mzg1NDFhOGEyZjAxYjkyZTQ0YWIwODkvdGFibGVyYW5nZTo0Y2U3ODkyNTQzODU0MWE4YTJmMDFiOTJlNDRhYjA4OV8xLTQtMS0xLTYyNg_70f978f2-9417-4e78-a57e-80b419fca3d5">true</dei:EntitySmallBusiness>
    <dei:EntityEmergingGrowthCompany
      contextRef="ia855382ada1f4f28aa8ef6da692ff177_D20220101-20220630"
      id="id3VybDovL2RvY3MudjEvZG9jOmFlNWE5YmUwZWI5NDQ1ZDE5MmZhZTgyMmQyMmJlMDlmL3NlYzphZTVhOWJlMGViOTQ0NWQxOTJmYWU4MjJkMjJiZTA5Zl8xL2ZyYWc6MTEwYjcyOWI5NDIwNDk4OGIyZDUxYzJhZTFlYzRlNjIvdGFibGU6NGNlNzg5MjU0Mzg1NDFhOGEyZjAxYjkyZTQ0YWIwODkvdGFibGVyYW5nZTo0Y2U3ODkyNTQzODU0MWE4YTJmMDFiOTJlNDRhYjA4OV8yLTEtMS0xLTYyNg_03158dd6-d5f3-4f58-946f-952b46a68910">false</dei:EntityEmergingGrowthCompany>
    <dei:EntityShellCompany
      contextRef="ia855382ada1f4f28aa8ef6da692ff177_D20220101-20220630"
      id="id3VybDovL2RvY3MudjEvZG9jOmFlNWE5YmUwZWI5NDQ1ZDE5MmZhZTgyMmQyMmJlMDlmL3NlYzphZTVhOWJlMGViOTQ0NWQxOTJmYWU4MjJkMjJiZTA5Zl8xL2ZyYWc6MTEwYjcyOWI5NDIwNDk4OGIyZDUxYzJhZTFlYzRlNjIvdGV4dHJlZ2lvbjoxMTBiNzI5Yjk0MjA0OTg4YjJkNTFjMmFlMWVjNGU2Ml8yMDcy_b5707ac4-7202-41e2-8a5e-c915e866cd62">false</dei:EntityShellCompany>
    <dei:EntityCommonStockSharesOutstanding
      contextRef="i0bb8b8c526d842f2a0e174c1375916cd_I20220805"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmFlNWE5YmUwZWI5NDQ1ZDE5MmZhZTgyMmQyMmJlMDlmL3NlYzphZTVhOWJlMGViOTQ0NWQxOTJmYWU4MjJkMjJiZTA5Zl8xL2ZyYWc6MTEwYjcyOWI5NDIwNDk4OGIyZDUxYzJhZTFlYzRlNjIvdGV4dHJlZ2lvbjoxMTBiNzI5Yjk0MjA0OTg4YjJkNTFjMmFlMWVjNGU2Ml8yMDcz_bff59164-1be3-4748-bd79-246aad88bab9"
      unitRef="shares">30039946</dei:EntityCommonStockSharesOutstanding>
    <us-gaap:CashAndCashEquivalentsAtCarryingValue
      contextRef="i4c8f247d12134a9886d56e1c8b024425_I20220630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmFlNWE5YmUwZWI5NDQ1ZDE5MmZhZTgyMmQyMmJlMDlmL3NlYzphZTVhOWJlMGViOTQ0NWQxOTJmYWU4MjJkMjJiZTA5Zl8xNi9mcmFnOmJjOWYxMWM1NjlkZjQyNzdhZDc1YjA3NzcyY2Q2NWQzL3RhYmxlOmNlMDdiOGQ2NDYwMDRjNDRhNDI1ZWY3YTgxZjQwMGI0L3RhYmxlcmFuZ2U6Y2UwN2I4ZDY0NjAwNGM0NGE0MjVlZjdhODFmNDAwYjRfMy0xLTEtMS02MjY_19c28462-1873-409f-b354-da27a44cedd4"
      unitRef="usd">120333000</us-gaap:CashAndCashEquivalentsAtCarryingValue>
    <us-gaap:CashAndCashEquivalentsAtCarryingValue
      contextRef="i87bf777ccf5f4f93bc9be7a2cbba61c1_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmFlNWE5YmUwZWI5NDQ1ZDE5MmZhZTgyMmQyMmJlMDlmL3NlYzphZTVhOWJlMGViOTQ0NWQxOTJmYWU4MjJkMjJiZTA5Zl8xNi9mcmFnOmJjOWYxMWM1NjlkZjQyNzdhZDc1YjA3NzcyY2Q2NWQzL3RhYmxlOmNlMDdiOGQ2NDYwMDRjNDRhNDI1ZWY3YTgxZjQwMGI0L3RhYmxlcmFuZ2U6Y2UwN2I4ZDY0NjAwNGM0NGE0MjVlZjdhODFmNDAwYjRfMy0zLTEtMS02MjY_208ad801-618f-457a-bdf5-e00a9b0011f2"
      unitRef="usd">176882000</us-gaap:CashAndCashEquivalentsAtCarryingValue>
    <us-gaap:MarketableSecuritiesCurrent
      contextRef="i4c8f247d12134a9886d56e1c8b024425_I20220630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmFlNWE5YmUwZWI5NDQ1ZDE5MmZhZTgyMmQyMmJlMDlmL3NlYzphZTVhOWJlMGViOTQ0NWQxOTJmYWU4MjJkMjJiZTA5Zl8xNi9mcmFnOmJjOWYxMWM1NjlkZjQyNzdhZDc1YjA3NzcyY2Q2NWQzL3RhYmxlOmNlMDdiOGQ2NDYwMDRjNDRhNDI1ZWY3YTgxZjQwMGI0L3RhYmxlcmFuZ2U6Y2UwN2I4ZDY0NjAwNGM0NGE0MjVlZjdhODFmNDAwYjRfNC0xLTEtMS02MjY_7477f116-c77e-4704-8e41-1853cee793e4"
      unitRef="usd">53457000</us-gaap:MarketableSecuritiesCurrent>
    <us-gaap:MarketableSecuritiesCurrent
      contextRef="i87bf777ccf5f4f93bc9be7a2cbba61c1_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmFlNWE5YmUwZWI5NDQ1ZDE5MmZhZTgyMmQyMmJlMDlmL3NlYzphZTVhOWJlMGViOTQ0NWQxOTJmYWU4MjJkMjJiZTA5Zl8xNi9mcmFnOmJjOWYxMWM1NjlkZjQyNzdhZDc1YjA3NzcyY2Q2NWQzL3RhYmxlOmNlMDdiOGQ2NDYwMDRjNDRhNDI1ZWY3YTgxZjQwMGI0L3RhYmxlcmFuZ2U6Y2UwN2I4ZDY0NjAwNGM0NGE0MjVlZjdhODFmNDAwYjRfNC0zLTEtMS02MjY_a9a1c436-b2b1-403a-8b03-f19133bc15a1"
      unitRef="usd">48449000</us-gaap:MarketableSecuritiesCurrent>
    <us-gaap:AccountsReceivableNetCurrent
      contextRef="i4c8f247d12134a9886d56e1c8b024425_I20220630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmFlNWE5YmUwZWI5NDQ1ZDE5MmZhZTgyMmQyMmJlMDlmL3NlYzphZTVhOWJlMGViOTQ0NWQxOTJmYWU4MjJkMjJiZTA5Zl8xNi9mcmFnOmJjOWYxMWM1NjlkZjQyNzdhZDc1YjA3NzcyY2Q2NWQzL3RhYmxlOmNlMDdiOGQ2NDYwMDRjNDRhNDI1ZWY3YTgxZjQwMGI0L3RhYmxlcmFuZ2U6Y2UwN2I4ZDY0NjAwNGM0NGE0MjVlZjdhODFmNDAwYjRfNS0xLTEtMS02MjY_aeb7cbba-a1b8-44cc-9366-b905817bb815"
      unitRef="usd">5962000</us-gaap:AccountsReceivableNetCurrent>
    <us-gaap:AccountsReceivableNetCurrent
      contextRef="i87bf777ccf5f4f93bc9be7a2cbba61c1_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmFlNWE5YmUwZWI5NDQ1ZDE5MmZhZTgyMmQyMmJlMDlmL3NlYzphZTVhOWJlMGViOTQ0NWQxOTJmYWU4MjJkMjJiZTA5Zl8xNi9mcmFnOmJjOWYxMWM1NjlkZjQyNzdhZDc1YjA3NzcyY2Q2NWQzL3RhYmxlOmNlMDdiOGQ2NDYwMDRjNDRhNDI1ZWY3YTgxZjQwMGI0L3RhYmxlcmFuZ2U6Y2UwN2I4ZDY0NjAwNGM0NGE0MjVlZjdhODFmNDAwYjRfNS0zLTEtMS02MjY_a582f496-41ab-439a-b3ce-02b021ae2061"
      unitRef="usd">3847000</us-gaap:AccountsReceivableNetCurrent>
    <us-gaap:InventoryNet
      contextRef="i4c8f247d12134a9886d56e1c8b024425_I20220630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmFlNWE5YmUwZWI5NDQ1ZDE5MmZhZTgyMmQyMmJlMDlmL3NlYzphZTVhOWJlMGViOTQ0NWQxOTJmYWU4MjJkMjJiZTA5Zl8xNi9mcmFnOmJjOWYxMWM1NjlkZjQyNzdhZDc1YjA3NzcyY2Q2NWQzL3RhYmxlOmNlMDdiOGQ2NDYwMDRjNDRhNDI1ZWY3YTgxZjQwMGI0L3RhYmxlcmFuZ2U6Y2UwN2I4ZDY0NjAwNGM0NGE0MjVlZjdhODFmNDAwYjRfNi0xLTEtMS02MjY_41fa4f74-b1bf-41f4-8956-ade0f89831e7"
      unitRef="usd">1432000</us-gaap:InventoryNet>
    <us-gaap:InventoryNet
      contextRef="i87bf777ccf5f4f93bc9be7a2cbba61c1_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmFlNWE5YmUwZWI5NDQ1ZDE5MmZhZTgyMmQyMmJlMDlmL3NlYzphZTVhOWJlMGViOTQ0NWQxOTJmYWU4MjJkMjJiZTA5Zl8xNi9mcmFnOmJjOWYxMWM1NjlkZjQyNzdhZDc1YjA3NzcyY2Q2NWQzL3RhYmxlOmNlMDdiOGQ2NDYwMDRjNDRhNDI1ZWY3YTgxZjQwMGI0L3RhYmxlcmFuZ2U6Y2UwN2I4ZDY0NjAwNGM0NGE0MjVlZjdhODFmNDAwYjRfNi0zLTEtMS02MjY_16ad1aae-2ba9-4c78-8efb-77e3396e7848"
      unitRef="usd">480000</us-gaap:InventoryNet>
    <us-gaap:PrepaidExpenseAndOtherAssetsCurrent
      contextRef="i4c8f247d12134a9886d56e1c8b024425_I20220630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmFlNWE5YmUwZWI5NDQ1ZDE5MmZhZTgyMmQyMmJlMDlmL3NlYzphZTVhOWJlMGViOTQ0NWQxOTJmYWU4MjJkMjJiZTA5Zl8xNi9mcmFnOmJjOWYxMWM1NjlkZjQyNzdhZDc1YjA3NzcyY2Q2NWQzL3RhYmxlOmNlMDdiOGQ2NDYwMDRjNDRhNDI1ZWY3YTgxZjQwMGI0L3RhYmxlcmFuZ2U6Y2UwN2I4ZDY0NjAwNGM0NGE0MjVlZjdhODFmNDAwYjRfNy0xLTEtMS02MjY_150e10c3-0995-4e51-8036-67d51ece2905"
      unitRef="usd">2681000</us-gaap:PrepaidExpenseAndOtherAssetsCurrent>
    <us-gaap:PrepaidExpenseAndOtherAssetsCurrent
      contextRef="i87bf777ccf5f4f93bc9be7a2cbba61c1_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmFlNWE5YmUwZWI5NDQ1ZDE5MmZhZTgyMmQyMmJlMDlmL3NlYzphZTVhOWJlMGViOTQ0NWQxOTJmYWU4MjJkMjJiZTA5Zl8xNi9mcmFnOmJjOWYxMWM1NjlkZjQyNzdhZDc1YjA3NzcyY2Q2NWQzL3RhYmxlOmNlMDdiOGQ2NDYwMDRjNDRhNDI1ZWY3YTgxZjQwMGI0L3RhYmxlcmFuZ2U6Y2UwN2I4ZDY0NjAwNGM0NGE0MjVlZjdhODFmNDAwYjRfNy0zLTEtMS02MjY_483967cc-3697-4fbc-83af-1de64655a11c"
      unitRef="usd">3166000</us-gaap:PrepaidExpenseAndOtherAssetsCurrent>
    <us-gaap:AssetsCurrent
      contextRef="i4c8f247d12134a9886d56e1c8b024425_I20220630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmFlNWE5YmUwZWI5NDQ1ZDE5MmZhZTgyMmQyMmJlMDlmL3NlYzphZTVhOWJlMGViOTQ0NWQxOTJmYWU4MjJkMjJiZTA5Zl8xNi9mcmFnOmJjOWYxMWM1NjlkZjQyNzdhZDc1YjA3NzcyY2Q2NWQzL3RhYmxlOmNlMDdiOGQ2NDYwMDRjNDRhNDI1ZWY3YTgxZjQwMGI0L3RhYmxlcmFuZ2U6Y2UwN2I4ZDY0NjAwNGM0NGE0MjVlZjdhODFmNDAwYjRfOC0xLTEtMS02MjY_0654893a-672f-4add-84c3-59fd1516d6be"
      unitRef="usd">183865000</us-gaap:AssetsCurrent>
    <us-gaap:AssetsCurrent
      contextRef="i87bf777ccf5f4f93bc9be7a2cbba61c1_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmFlNWE5YmUwZWI5NDQ1ZDE5MmZhZTgyMmQyMmJlMDlmL3NlYzphZTVhOWJlMGViOTQ0NWQxOTJmYWU4MjJkMjJiZTA5Zl8xNi9mcmFnOmJjOWYxMWM1NjlkZjQyNzdhZDc1YjA3NzcyY2Q2NWQzL3RhYmxlOmNlMDdiOGQ2NDYwMDRjNDRhNDI1ZWY3YTgxZjQwMGI0L3RhYmxlcmFuZ2U6Y2UwN2I4ZDY0NjAwNGM0NGE0MjVlZjdhODFmNDAwYjRfOC0zLTEtMS02MjY_71e40d52-808b-4758-8956-bbbf8d96d639"
      unitRef="usd">232824000</us-gaap:AssetsCurrent>
    <us-gaap:PropertyPlantAndEquipmentNet
      contextRef="i4c8f247d12134a9886d56e1c8b024425_I20220630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmFlNWE5YmUwZWI5NDQ1ZDE5MmZhZTgyMmQyMmJlMDlmL3NlYzphZTVhOWJlMGViOTQ0NWQxOTJmYWU4MjJkMjJiZTA5Zl8xNi9mcmFnOmJjOWYxMWM1NjlkZjQyNzdhZDc1YjA3NzcyY2Q2NWQzL3RhYmxlOmNlMDdiOGQ2NDYwMDRjNDRhNDI1ZWY3YTgxZjQwMGI0L3RhYmxlcmFuZ2U6Y2UwN2I4ZDY0NjAwNGM0NGE0MjVlZjdhODFmNDAwYjRfOS0xLTEtMS02MjY_fc67d20c-ab3b-4d17-9138-21cfb12b91b8"
      unitRef="usd">4916000</us-gaap:PropertyPlantAndEquipmentNet>
    <us-gaap:PropertyPlantAndEquipmentNet
      contextRef="i87bf777ccf5f4f93bc9be7a2cbba61c1_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmFlNWE5YmUwZWI5NDQ1ZDE5MmZhZTgyMmQyMmJlMDlmL3NlYzphZTVhOWJlMGViOTQ0NWQxOTJmYWU4MjJkMjJiZTA5Zl8xNi9mcmFnOmJjOWYxMWM1NjlkZjQyNzdhZDc1YjA3NzcyY2Q2NWQzL3RhYmxlOmNlMDdiOGQ2NDYwMDRjNDRhNDI1ZWY3YTgxZjQwMGI0L3RhYmxlcmFuZ2U6Y2UwN2I4ZDY0NjAwNGM0NGE0MjVlZjdhODFmNDAwYjRfOS0zLTEtMS02MjY_84831938-2d74-4381-b053-5e5a8b30281d"
      unitRef="usd">4549000</us-gaap:PropertyPlantAndEquipmentNet>
    <us-gaap:OperatingLeaseRightOfUseAsset
      contextRef="i4c8f247d12134a9886d56e1c8b024425_I20220630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmFlNWE5YmUwZWI5NDQ1ZDE5MmZhZTgyMmQyMmJlMDlmL3NlYzphZTVhOWJlMGViOTQ0NWQxOTJmYWU4MjJkMjJiZTA5Zl8xNi9mcmFnOmJjOWYxMWM1NjlkZjQyNzdhZDc1YjA3NzcyY2Q2NWQzL3RhYmxlOmNlMDdiOGQ2NDYwMDRjNDRhNDI1ZWY3YTgxZjQwMGI0L3RhYmxlcmFuZ2U6Y2UwN2I4ZDY0NjAwNGM0NGE0MjVlZjdhODFmNDAwYjRfMTAtMS0xLTEtNjI2_2d65198e-8e26-4582-8935-46a37f66c1ff"
      unitRef="usd">23694000</us-gaap:OperatingLeaseRightOfUseAsset>
    <us-gaap:OperatingLeaseRightOfUseAsset
      contextRef="i87bf777ccf5f4f93bc9be7a2cbba61c1_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmFlNWE5YmUwZWI5NDQ1ZDE5MmZhZTgyMmQyMmJlMDlmL3NlYzphZTVhOWJlMGViOTQ0NWQxOTJmYWU4MjJkMjJiZTA5Zl8xNi9mcmFnOmJjOWYxMWM1NjlkZjQyNzdhZDc1YjA3NzcyY2Q2NWQzL3RhYmxlOmNlMDdiOGQ2NDYwMDRjNDRhNDI1ZWY3YTgxZjQwMGI0L3RhYmxlcmFuZ2U6Y2UwN2I4ZDY0NjAwNGM0NGE0MjVlZjdhODFmNDAwYjRfMTAtMy0xLTEtNjI2_5f6dddb6-81d4-4ed2-ad4e-e696f011ad8a"
      unitRef="usd">7744000</us-gaap:OperatingLeaseRightOfUseAsset>
    <us-gaap:RestrictedCashNoncurrent
      contextRef="i4c8f247d12134a9886d56e1c8b024425_I20220630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmFlNWE5YmUwZWI5NDQ1ZDE5MmZhZTgyMmQyMmJlMDlmL3NlYzphZTVhOWJlMGViOTQ0NWQxOTJmYWU4MjJkMjJiZTA5Zl8xNi9mcmFnOmJjOWYxMWM1NjlkZjQyNzdhZDc1YjA3NzcyY2Q2NWQzL3RhYmxlOmNlMDdiOGQ2NDYwMDRjNDRhNDI1ZWY3YTgxZjQwMGI0L3RhYmxlcmFuZ2U6Y2UwN2I4ZDY0NjAwNGM0NGE0MjVlZjdhODFmNDAwYjRfMTEtMS0xLTEtNjI2_6f577974-c61b-4a0b-a793-25a301b63741"
      unitRef="usd">3470000</us-gaap:RestrictedCashNoncurrent>
    <us-gaap:RestrictedCashNoncurrent
      contextRef="i87bf777ccf5f4f93bc9be7a2cbba61c1_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmFlNWE5YmUwZWI5NDQ1ZDE5MmZhZTgyMmQyMmJlMDlmL3NlYzphZTVhOWJlMGViOTQ0NWQxOTJmYWU4MjJkMjJiZTA5Zl8xNi9mcmFnOmJjOWYxMWM1NjlkZjQyNzdhZDc1YjA3NzcyY2Q2NWQzL3RhYmxlOmNlMDdiOGQ2NDYwMDRjNDRhNDI1ZWY3YTgxZjQwMGI0L3RhYmxlcmFuZ2U6Y2UwN2I4ZDY0NjAwNGM0NGE0MjVlZjdhODFmNDAwYjRfMTEtMy0xLTEtNjI2_a7cbeeba-1893-4c95-be78-b398f0088e34"
      unitRef="usd">3025000</us-gaap:RestrictedCashNoncurrent>
    <us-gaap:OtherAssetsNoncurrent
      contextRef="i4c8f247d12134a9886d56e1c8b024425_I20220630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmFlNWE5YmUwZWI5NDQ1ZDE5MmZhZTgyMmQyMmJlMDlmL3NlYzphZTVhOWJlMGViOTQ0NWQxOTJmYWU4MjJkMjJiZTA5Zl8xNi9mcmFnOmJjOWYxMWM1NjlkZjQyNzdhZDc1YjA3NzcyY2Q2NWQzL3RhYmxlOmNlMDdiOGQ2NDYwMDRjNDRhNDI1ZWY3YTgxZjQwMGI0L3RhYmxlcmFuZ2U6Y2UwN2I4ZDY0NjAwNGM0NGE0MjVlZjdhODFmNDAwYjRfMTItMS0xLTEtNjI2_5d6921b5-b0cc-45ec-9699-f77166122b54"
      unitRef="usd">167000</us-gaap:OtherAssetsNoncurrent>
    <us-gaap:OtherAssetsNoncurrent
      contextRef="i87bf777ccf5f4f93bc9be7a2cbba61c1_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmFlNWE5YmUwZWI5NDQ1ZDE5MmZhZTgyMmQyMmJlMDlmL3NlYzphZTVhOWJlMGViOTQ0NWQxOTJmYWU4MjJkMjJiZTA5Zl8xNi9mcmFnOmJjOWYxMWM1NjlkZjQyNzdhZDc1YjA3NzcyY2Q2NWQzL3RhYmxlOmNlMDdiOGQ2NDYwMDRjNDRhNDI1ZWY3YTgxZjQwMGI0L3RhYmxlcmFuZ2U6Y2UwN2I4ZDY0NjAwNGM0NGE0MjVlZjdhODFmNDAwYjRfMTItMy0xLTEtNjI2_27ee53c6-ac08-4781-ab0e-cd89d1ddc18c"
      unitRef="usd">167000</us-gaap:OtherAssetsNoncurrent>
    <us-gaap:Assets
      contextRef="i4c8f247d12134a9886d56e1c8b024425_I20220630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmFlNWE5YmUwZWI5NDQ1ZDE5MmZhZTgyMmQyMmJlMDlmL3NlYzphZTVhOWJlMGViOTQ0NWQxOTJmYWU4MjJkMjJiZTA5Zl8xNi9mcmFnOmJjOWYxMWM1NjlkZjQyNzdhZDc1YjA3NzcyY2Q2NWQzL3RhYmxlOmNlMDdiOGQ2NDYwMDRjNDRhNDI1ZWY3YTgxZjQwMGI0L3RhYmxlcmFuZ2U6Y2UwN2I4ZDY0NjAwNGM0NGE0MjVlZjdhODFmNDAwYjRfMTMtMS0xLTEtNjI2_b60f5d42-c89e-4b9f-93b0-cd6859cd7f05"
      unitRef="usd">216112000</us-gaap:Assets>
    <us-gaap:Assets
      contextRef="i87bf777ccf5f4f93bc9be7a2cbba61c1_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmFlNWE5YmUwZWI5NDQ1ZDE5MmZhZTgyMmQyMmJlMDlmL3NlYzphZTVhOWJlMGViOTQ0NWQxOTJmYWU4MjJkMjJiZTA5Zl8xNi9mcmFnOmJjOWYxMWM1NjlkZjQyNzdhZDc1YjA3NzcyY2Q2NWQzL3RhYmxlOmNlMDdiOGQ2NDYwMDRjNDRhNDI1ZWY3YTgxZjQwMGI0L3RhYmxlcmFuZ2U6Y2UwN2I4ZDY0NjAwNGM0NGE0MjVlZjdhODFmNDAwYjRfMTMtMy0xLTEtNjI2_41e66a45-977f-4edf-95e6-b79e899bbbdd"
      unitRef="usd">248309000</us-gaap:Assets>
    <us-gaap:AccountsPayableCurrent
      contextRef="i4c8f247d12134a9886d56e1c8b024425_I20220630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmFlNWE5YmUwZWI5NDQ1ZDE5MmZhZTgyMmQyMmJlMDlmL3NlYzphZTVhOWJlMGViOTQ0NWQxOTJmYWU4MjJkMjJiZTA5Zl8xNi9mcmFnOmJjOWYxMWM1NjlkZjQyNzdhZDc1YjA3NzcyY2Q2NWQzL3RhYmxlOmNlMDdiOGQ2NDYwMDRjNDRhNDI1ZWY3YTgxZjQwMGI0L3RhYmxlcmFuZ2U6Y2UwN2I4ZDY0NjAwNGM0NGE0MjVlZjdhODFmNDAwYjRfMTYtMS0xLTEtNjI2_e8b36645-abca-4255-bf38-3ce6e522da70"
      unitRef="usd">861000</us-gaap:AccountsPayableCurrent>
    <us-gaap:AccountsPayableCurrent
      contextRef="i87bf777ccf5f4f93bc9be7a2cbba61c1_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmFlNWE5YmUwZWI5NDQ1ZDE5MmZhZTgyMmQyMmJlMDlmL3NlYzphZTVhOWJlMGViOTQ0NWQxOTJmYWU4MjJkMjJiZTA5Zl8xNi9mcmFnOmJjOWYxMWM1NjlkZjQyNzdhZDc1YjA3NzcyY2Q2NWQzL3RhYmxlOmNlMDdiOGQ2NDYwMDRjNDRhNDI1ZWY3YTgxZjQwMGI0L3RhYmxlcmFuZ2U6Y2UwN2I4ZDY0NjAwNGM0NGE0MjVlZjdhODFmNDAwYjRfMTYtMy0xLTEtNjI2_d33da315-fbc3-4aee-9b22-6d24c5a37352"
      unitRef="usd">2880000</us-gaap:AccountsPayableCurrent>
    <us-gaap:EmployeeRelatedLiabilitiesCurrent
      contextRef="i4c8f247d12134a9886d56e1c8b024425_I20220630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmFlNWE5YmUwZWI5NDQ1ZDE5MmZhZTgyMmQyMmJlMDlmL3NlYzphZTVhOWJlMGViOTQ0NWQxOTJmYWU4MjJkMjJiZTA5Zl8xNi9mcmFnOmJjOWYxMWM1NjlkZjQyNzdhZDc1YjA3NzcyY2Q2NWQzL3RhYmxlOmNlMDdiOGQ2NDYwMDRjNDRhNDI1ZWY3YTgxZjQwMGI0L3RhYmxlcmFuZ2U6Y2UwN2I4ZDY0NjAwNGM0NGE0MjVlZjdhODFmNDAwYjRfMTctMS0xLTEtNjI2_3179208d-581c-4790-9149-de906387f231"
      unitRef="usd">7818000</us-gaap:EmployeeRelatedLiabilitiesCurrent>
    <us-gaap:EmployeeRelatedLiabilitiesCurrent
      contextRef="i87bf777ccf5f4f93bc9be7a2cbba61c1_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmFlNWE5YmUwZWI5NDQ1ZDE5MmZhZTgyMmQyMmJlMDlmL3NlYzphZTVhOWJlMGViOTQ0NWQxOTJmYWU4MjJkMjJiZTA5Zl8xNi9mcmFnOmJjOWYxMWM1NjlkZjQyNzdhZDc1YjA3NzcyY2Q2NWQzL3RhYmxlOmNlMDdiOGQ2NDYwMDRjNDRhNDI1ZWY3YTgxZjQwMGI0L3RhYmxlcmFuZ2U6Y2UwN2I4ZDY0NjAwNGM0NGE0MjVlZjdhODFmNDAwYjRfMTctMy0xLTEtNjI2_0435afef-4f41-4005-b4c0-f1c08da5682a"
      unitRef="usd">5120000</us-gaap:EmployeeRelatedLiabilitiesCurrent>
    <us-gaap:AccruedLiabilitiesCurrent
      contextRef="i4c8f247d12134a9886d56e1c8b024425_I20220630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmFlNWE5YmUwZWI5NDQ1ZDE5MmZhZTgyMmQyMmJlMDlmL3NlYzphZTVhOWJlMGViOTQ0NWQxOTJmYWU4MjJkMjJiZTA5Zl8xNi9mcmFnOmJjOWYxMWM1NjlkZjQyNzdhZDc1YjA3NzcyY2Q2NWQzL3RhYmxlOmNlMDdiOGQ2NDYwMDRjNDRhNDI1ZWY3YTgxZjQwMGI0L3RhYmxlcmFuZ2U6Y2UwN2I4ZDY0NjAwNGM0NGE0MjVlZjdhODFmNDAwYjRfMTgtMS0xLTEtNjI2_12355abb-ae0c-4b16-818d-6403a7bde9b1"
      unitRef="usd">3272000</us-gaap:AccruedLiabilitiesCurrent>
    <us-gaap:AccruedLiabilitiesCurrent
      contextRef="i87bf777ccf5f4f93bc9be7a2cbba61c1_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmFlNWE5YmUwZWI5NDQ1ZDE5MmZhZTgyMmQyMmJlMDlmL3NlYzphZTVhOWJlMGViOTQ0NWQxOTJmYWU4MjJkMjJiZTA5Zl8xNi9mcmFnOmJjOWYxMWM1NjlkZjQyNzdhZDc1YjA3NzcyY2Q2NWQzL3RhYmxlOmNlMDdiOGQ2NDYwMDRjNDRhNDI1ZWY3YTgxZjQwMGI0L3RhYmxlcmFuZ2U6Y2UwN2I4ZDY0NjAwNGM0NGE0MjVlZjdhODFmNDAwYjRfMTgtMy0xLTEtNjI2_1ea3fe33-5cc5-46d3-ab7c-72509f339fe7"
      unitRef="usd">1227000</us-gaap:AccruedLiabilitiesCurrent>
    <us-gaap:DeferredRevenueCurrent
      contextRef="i4c8f247d12134a9886d56e1c8b024425_I20220630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmFlNWE5YmUwZWI5NDQ1ZDE5MmZhZTgyMmQyMmJlMDlmL3NlYzphZTVhOWJlMGViOTQ0NWQxOTJmYWU4MjJkMjJiZTA5Zl8xNi9mcmFnOmJjOWYxMWM1NjlkZjQyNzdhZDc1YjA3NzcyY2Q2NWQzL3RhYmxlOmNlMDdiOGQ2NDYwMDRjNDRhNDI1ZWY3YTgxZjQwMGI0L3RhYmxlcmFuZ2U6Y2UwN2I4ZDY0NjAwNGM0NGE0MjVlZjdhODFmNDAwYjRfMTktMS0xLTEtNjI2_e9e52a55-b2f3-43fc-8835-4a8f5ccccf91"
      unitRef="usd">1310000</us-gaap:DeferredRevenueCurrent>
    <us-gaap:DeferredRevenueCurrent
      contextRef="i87bf777ccf5f4f93bc9be7a2cbba61c1_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmFlNWE5YmUwZWI5NDQ1ZDE5MmZhZTgyMmQyMmJlMDlmL3NlYzphZTVhOWJlMGViOTQ0NWQxOTJmYWU4MjJkMjJiZTA5Zl8xNi9mcmFnOmJjOWYxMWM1NjlkZjQyNzdhZDc1YjA3NzcyY2Q2NWQzL3RhYmxlOmNlMDdiOGQ2NDYwMDRjNDRhNDI1ZWY3YTgxZjQwMGI0L3RhYmxlcmFuZ2U6Y2UwN2I4ZDY0NjAwNGM0NGE0MjVlZjdhODFmNDAwYjRfMTktMy0xLTEtNjI2_84d4c2c6-1513-41e1-9cc0-e51ab49852b7"
      unitRef="usd">1380000</us-gaap:DeferredRevenueCurrent>
    <us-gaap:OperatingLeaseLiabilityCurrent
      contextRef="i4c8f247d12134a9886d56e1c8b024425_I20220630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmFlNWE5YmUwZWI5NDQ1ZDE5MmZhZTgyMmQyMmJlMDlmL3NlYzphZTVhOWJlMGViOTQ0NWQxOTJmYWU4MjJkMjJiZTA5Zl8xNi9mcmFnOmJjOWYxMWM1NjlkZjQyNzdhZDc1YjA3NzcyY2Q2NWQzL3RhYmxlOmNlMDdiOGQ2NDYwMDRjNDRhNDI1ZWY3YTgxZjQwMGI0L3RhYmxlcmFuZ2U6Y2UwN2I4ZDY0NjAwNGM0NGE0MjVlZjdhODFmNDAwYjRfMjAtMS0xLTEtNjI2_67ec3aac-9ab4-4631-99f7-ebddf155815b"
      unitRef="usd">1693000</us-gaap:OperatingLeaseLiabilityCurrent>
    <us-gaap:OperatingLeaseLiabilityCurrent
      contextRef="i87bf777ccf5f4f93bc9be7a2cbba61c1_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmFlNWE5YmUwZWI5NDQ1ZDE5MmZhZTgyMmQyMmJlMDlmL3NlYzphZTVhOWJlMGViOTQ0NWQxOTJmYWU4MjJkMjJiZTA5Zl8xNi9mcmFnOmJjOWYxMWM1NjlkZjQyNzdhZDc1YjA3NzcyY2Q2NWQzL3RhYmxlOmNlMDdiOGQ2NDYwMDRjNDRhNDI1ZWY3YTgxZjQwMGI0L3RhYmxlcmFuZ2U6Y2UwN2I4ZDY0NjAwNGM0NGE0MjVlZjdhODFmNDAwYjRfMjAtMy0xLTEtNjI2_c0c06080-4fe6-4ccd-ba9d-5187f5777f2c"
      unitRef="usd">1453000</us-gaap:OperatingLeaseLiabilityCurrent>
    <us-gaap:FinanceLeaseLiabilityCurrent
      contextRef="i4c8f247d12134a9886d56e1c8b024425_I20220630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmFlNWE5YmUwZWI5NDQ1ZDE5MmZhZTgyMmQyMmJlMDlmL3NlYzphZTVhOWJlMGViOTQ0NWQxOTJmYWU4MjJkMjJiZTA5Zl8xNi9mcmFnOmJjOWYxMWM1NjlkZjQyNzdhZDc1YjA3NzcyY2Q2NWQzL3RhYmxlOmNlMDdiOGQ2NDYwMDRjNDRhNDI1ZWY3YTgxZjQwMGI0L3RhYmxlcmFuZ2U6Y2UwN2I4ZDY0NjAwNGM0NGE0MjVlZjdhODFmNDAwYjRfMjEtMS0xLTEtNjI2_7cac9871-5067-41c5-b3a4-c507423c6aec"
      unitRef="usd">134000</us-gaap:FinanceLeaseLiabilityCurrent>
    <us-gaap:FinanceLeaseLiabilityCurrent
      contextRef="i87bf777ccf5f4f93bc9be7a2cbba61c1_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmFlNWE5YmUwZWI5NDQ1ZDE5MmZhZTgyMmQyMmJlMDlmL3NlYzphZTVhOWJlMGViOTQ0NWQxOTJmYWU4MjJkMjJiZTA5Zl8xNi9mcmFnOmJjOWYxMWM1NjlkZjQyNzdhZDc1YjA3NzcyY2Q2NWQzL3RhYmxlOmNlMDdiOGQ2NDYwMDRjNDRhNDI1ZWY3YTgxZjQwMGI0L3RhYmxlcmFuZ2U6Y2UwN2I4ZDY0NjAwNGM0NGE0MjVlZjdhODFmNDAwYjRfMjEtMy0xLTEtNjI2_5261e5fa-7853-4fb3-9fe9-6293b2cf6e42"
      unitRef="usd">121000</us-gaap:FinanceLeaseLiabilityCurrent>
    <us-gaap:LiabilitiesCurrent
      contextRef="i4c8f247d12134a9886d56e1c8b024425_I20220630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmFlNWE5YmUwZWI5NDQ1ZDE5MmZhZTgyMmQyMmJlMDlmL3NlYzphZTVhOWJlMGViOTQ0NWQxOTJmYWU4MjJkMjJiZTA5Zl8xNi9mcmFnOmJjOWYxMWM1NjlkZjQyNzdhZDc1YjA3NzcyY2Q2NWQzL3RhYmxlOmNlMDdiOGQ2NDYwMDRjNDRhNDI1ZWY3YTgxZjQwMGI0L3RhYmxlcmFuZ2U6Y2UwN2I4ZDY0NjAwNGM0NGE0MjVlZjdhODFmNDAwYjRfMjItMS0xLTEtNjI2_155f7fc6-7bb2-4e61-8a9b-baa62ffc72aa"
      unitRef="usd">15088000</us-gaap:LiabilitiesCurrent>
    <us-gaap:LiabilitiesCurrent
      contextRef="i87bf777ccf5f4f93bc9be7a2cbba61c1_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmFlNWE5YmUwZWI5NDQ1ZDE5MmZhZTgyMmQyMmJlMDlmL3NlYzphZTVhOWJlMGViOTQ0NWQxOTJmYWU4MjJkMjJiZTA5Zl8xNi9mcmFnOmJjOWYxMWM1NjlkZjQyNzdhZDc1YjA3NzcyY2Q2NWQzL3RhYmxlOmNlMDdiOGQ2NDYwMDRjNDRhNDI1ZWY3YTgxZjQwMGI0L3RhYmxlcmFuZ2U6Y2UwN2I4ZDY0NjAwNGM0NGE0MjVlZjdhODFmNDAwYjRfMjItMy0xLTEtNjI2_95f56f30-9790-4371-9cf2-ba957ac03b13"
      unitRef="usd">12181000</us-gaap:LiabilitiesCurrent>
    <us-gaap:WarrantsAndRightsOutstanding
      contextRef="i4c8f247d12134a9886d56e1c8b024425_I20220630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmFlNWE5YmUwZWI5NDQ1ZDE5MmZhZTgyMmQyMmJlMDlmL3NlYzphZTVhOWJlMGViOTQ0NWQxOTJmYWU4MjJkMjJiZTA5Zl8xNi9mcmFnOmJjOWYxMWM1NjlkZjQyNzdhZDc1YjA3NzcyY2Q2NWQzL3RhYmxlOmNlMDdiOGQ2NDYwMDRjNDRhNDI1ZWY3YTgxZjQwMGI0L3RhYmxlcmFuZ2U6Y2UwN2I4ZDY0NjAwNGM0NGE0MjVlZjdhODFmNDAwYjRfMjQtMS0xLTEtNjI2_22ab1b64-c428-4fee-9679-398ce86f8f32"
      unitRef="usd">24000</us-gaap:WarrantsAndRightsOutstanding>
    <us-gaap:WarrantsAndRightsOutstanding
      contextRef="i87bf777ccf5f4f93bc9be7a2cbba61c1_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmFlNWE5YmUwZWI5NDQ1ZDE5MmZhZTgyMmQyMmJlMDlmL3NlYzphZTVhOWJlMGViOTQ0NWQxOTJmYWU4MjJkMjJiZTA5Zl8xNi9mcmFnOmJjOWYxMWM1NjlkZjQyNzdhZDc1YjA3NzcyY2Q2NWQzL3RhYmxlOmNlMDdiOGQ2NDYwMDRjNDRhNDI1ZWY3YTgxZjQwMGI0L3RhYmxlcmFuZ2U6Y2UwN2I4ZDY0NjAwNGM0NGE0MjVlZjdhODFmNDAwYjRfMjQtMy0xLTEtNjI2_5fd78fa9-a39c-4b83-9166-dc620d0018af"
      unitRef="usd">146000</us-gaap:WarrantsAndRightsOutstanding>
    <us-gaap:FinanceLeaseLiabilityNoncurrent
      contextRef="i4c8f247d12134a9886d56e1c8b024425_I20220630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmFlNWE5YmUwZWI5NDQ1ZDE5MmZhZTgyMmQyMmJlMDlmL3NlYzphZTVhOWJlMGViOTQ0NWQxOTJmYWU4MjJkMjJiZTA5Zl8xNi9mcmFnOmJjOWYxMWM1NjlkZjQyNzdhZDc1YjA3NzcyY2Q2NWQzL3RhYmxlOmNlMDdiOGQ2NDYwMDRjNDRhNDI1ZWY3YTgxZjQwMGI0L3RhYmxlcmFuZ2U6Y2UwN2I4ZDY0NjAwNGM0NGE0MjVlZjdhODFmNDAwYjRfMjYtMS0xLTEtNjI2_7c65afbc-c8fd-45b5-b097-7358548404db"
      unitRef="usd">111000</us-gaap:FinanceLeaseLiabilityNoncurrent>
    <us-gaap:FinanceLeaseLiabilityNoncurrent
      contextRef="i87bf777ccf5f4f93bc9be7a2cbba61c1_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmFlNWE5YmUwZWI5NDQ1ZDE5MmZhZTgyMmQyMmJlMDlmL3NlYzphZTVhOWJlMGViOTQ0NWQxOTJmYWU4MjJkMjJiZTA5Zl8xNi9mcmFnOmJjOWYxMWM1NjlkZjQyNzdhZDc1YjA3NzcyY2Q2NWQzL3RhYmxlOmNlMDdiOGQ2NDYwMDRjNDRhNDI1ZWY3YTgxZjQwMGI0L3RhYmxlcmFuZ2U6Y2UwN2I4ZDY0NjAwNGM0NGE0MjVlZjdhODFmNDAwYjRfMjYtMy0xLTEtNjI2_d9aa1088-589f-45d0-ab29-532d470b0d2e"
      unitRef="usd">136000</us-gaap:FinanceLeaseLiabilityNoncurrent>
    <us-gaap:OperatingLeaseLiabilityNoncurrent
      contextRef="i4c8f247d12134a9886d56e1c8b024425_I20220630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmFlNWE5YmUwZWI5NDQ1ZDE5MmZhZTgyMmQyMmJlMDlmL3NlYzphZTVhOWJlMGViOTQ0NWQxOTJmYWU4MjJkMjJiZTA5Zl8xNi9mcmFnOmJjOWYxMWM1NjlkZjQyNzdhZDc1YjA3NzcyY2Q2NWQzL3RhYmxlOmNlMDdiOGQ2NDYwMDRjNDRhNDI1ZWY3YTgxZjQwMGI0L3RhYmxlcmFuZ2U6Y2UwN2I4ZDY0NjAwNGM0NGE0MjVlZjdhODFmNDAwYjRfMjctMS0xLTEtNjk3_f41033a5-1f32-47e1-b486-4c5c10a93d9b"
      unitRef="usd">22312000</us-gaap:OperatingLeaseLiabilityNoncurrent>
    <us-gaap:OperatingLeaseLiabilityNoncurrent
      contextRef="i87bf777ccf5f4f93bc9be7a2cbba61c1_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmFlNWE5YmUwZWI5NDQ1ZDE5MmZhZTgyMmQyMmJlMDlmL3NlYzphZTVhOWJlMGViOTQ0NWQxOTJmYWU4MjJkMjJiZTA5Zl8xNi9mcmFnOmJjOWYxMWM1NjlkZjQyNzdhZDc1YjA3NzcyY2Q2NWQzL3RhYmxlOmNlMDdiOGQ2NDYwMDRjNDRhNDI1ZWY3YTgxZjQwMGI0L3RhYmxlcmFuZ2U6Y2UwN2I4ZDY0NjAwNGM0NGE0MjVlZjdhODFmNDAwYjRfMjctMy0xLTEtNjk3_17faf56a-95eb-4fb6-b1a1-38b09c58f3f1"
      unitRef="usd">6148000</us-gaap:OperatingLeaseLiabilityNoncurrent>
    <us-gaap:Liabilities
      contextRef="i4c8f247d12134a9886d56e1c8b024425_I20220630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmFlNWE5YmUwZWI5NDQ1ZDE5MmZhZTgyMmQyMmJlMDlmL3NlYzphZTVhOWJlMGViOTQ0NWQxOTJmYWU4MjJkMjJiZTA5Zl8xNi9mcmFnOmJjOWYxMWM1NjlkZjQyNzdhZDc1YjA3NzcyY2Q2NWQzL3RhYmxlOmNlMDdiOGQ2NDYwMDRjNDRhNDI1ZWY3YTgxZjQwMGI0L3RhYmxlcmFuZ2U6Y2UwN2I4ZDY0NjAwNGM0NGE0MjVlZjdhODFmNDAwYjRfMjctMS0xLTEtNjI2_9759e12e-65cf-4281-b5c1-3931b2fbc4d1"
      unitRef="usd">37535000</us-gaap:Liabilities>
    <us-gaap:Liabilities
      contextRef="i87bf777ccf5f4f93bc9be7a2cbba61c1_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmFlNWE5YmUwZWI5NDQ1ZDE5MmZhZTgyMmQyMmJlMDlmL3NlYzphZTVhOWJlMGViOTQ0NWQxOTJmYWU4MjJkMjJiZTA5Zl8xNi9mcmFnOmJjOWYxMWM1NjlkZjQyNzdhZDc1YjA3NzcyY2Q2NWQzL3RhYmxlOmNlMDdiOGQ2NDYwMDRjNDRhNDI1ZWY3YTgxZjQwMGI0L3RhYmxlcmFuZ2U6Y2UwN2I4ZDY0NjAwNGM0NGE0MjVlZjdhODFmNDAwYjRfMjctMy0xLTEtNjI2_6f6acea3-8265-42be-b39c-0df4c1a40a5c"
      unitRef="usd">18611000</us-gaap:Liabilities>
    <us-gaap:CommonStockParOrStatedValuePerShare
      contextRef="i87bf777ccf5f4f93bc9be7a2cbba61c1_I20211231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmFlNWE5YmUwZWI5NDQ1ZDE5MmZhZTgyMmQyMmJlMDlmL3NlYzphZTVhOWJlMGViOTQ0NWQxOTJmYWU4MjJkMjJiZTA5Zl8xNi9mcmFnOmJjOWYxMWM1NjlkZjQyNzdhZDc1YjA3NzcyY2Q2NWQzL3RhYmxlOmNlMDdiOGQ2NDYwMDRjNDRhNDI1ZWY3YTgxZjQwMGI0L3RhYmxlcmFuZ2U6Y2UwN2I4ZDY0NjAwNGM0NGE0MjVlZjdhODFmNDAwYjRfMjktMC0xLTEtNjI2L3RleHRyZWdpb246ZWM2NGNlM2UxMmFkNGJiNWE1NWVhM2QzZGQ1MzI4MWVfMTg_b4fb904c-2377-4972-bbfe-6fb369132e0c"
      unitRef="usdPerShare">0.0001</us-gaap:CommonStockParOrStatedValuePerShare>
    <us-gaap:CommonStockParOrStatedValuePerShare
      contextRef="i4c8f247d12134a9886d56e1c8b024425_I20220630"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmFlNWE5YmUwZWI5NDQ1ZDE5MmZhZTgyMmQyMmJlMDlmL3NlYzphZTVhOWJlMGViOTQ0NWQxOTJmYWU4MjJkMjJiZTA5Zl8xNi9mcmFnOmJjOWYxMWM1NjlkZjQyNzdhZDc1YjA3NzcyY2Q2NWQzL3RhYmxlOmNlMDdiOGQ2NDYwMDRjNDRhNDI1ZWY3YTgxZjQwMGI0L3RhYmxlcmFuZ2U6Y2UwN2I4ZDY0NjAwNGM0NGE0MjVlZjdhODFmNDAwYjRfMjktMC0xLTEtNjI2L3RleHRyZWdpb246ZWM2NGNlM2UxMmFkNGJiNWE1NWVhM2QzZGQ1MzI4MWVfMTg_d0fdbc64-e206-4645-b9c0-8d4d7b1e8642"
      unitRef="usdPerShare">0.0001</us-gaap:CommonStockParOrStatedValuePerShare>
    <us-gaap:CommonStockSharesAuthorized
      contextRef="i87bf777ccf5f4f93bc9be7a2cbba61c1_I20211231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmFlNWE5YmUwZWI5NDQ1ZDE5MmZhZTgyMmQyMmJlMDlmL3NlYzphZTVhOWJlMGViOTQ0NWQxOTJmYWU4MjJkMjJiZTA5Zl8xNi9mcmFnOmJjOWYxMWM1NjlkZjQyNzdhZDc1YjA3NzcyY2Q2NWQzL3RhYmxlOmNlMDdiOGQ2NDYwMDRjNDRhNDI1ZWY3YTgxZjQwMGI0L3RhYmxlcmFuZ2U6Y2UwN2I4ZDY0NjAwNGM0NGE0MjVlZjdhODFmNDAwYjRfMjktMC0xLTEtNjI2L3RleHRyZWdpb246ZWM2NGNlM2UxMmFkNGJiNWE1NWVhM2QzZGQ1MzI4MWVfNDI_6d64a2db-1c22-4095-a89e-cfbc65f71554"
      unitRef="shares">50000000</us-gaap:CommonStockSharesAuthorized>
    <us-gaap:CommonStockSharesAuthorized
      contextRef="i4c8f247d12134a9886d56e1c8b024425_I20220630"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmFlNWE5YmUwZWI5NDQ1ZDE5MmZhZTgyMmQyMmJlMDlmL3NlYzphZTVhOWJlMGViOTQ0NWQxOTJmYWU4MjJkMjJiZTA5Zl8xNi9mcmFnOmJjOWYxMWM1NjlkZjQyNzdhZDc1YjA3NzcyY2Q2NWQzL3RhYmxlOmNlMDdiOGQ2NDYwMDRjNDRhNDI1ZWY3YTgxZjQwMGI0L3RhYmxlcmFuZ2U6Y2UwN2I4ZDY0NjAwNGM0NGE0MjVlZjdhODFmNDAwYjRfMjktMC0xLTEtNjI2L3RleHRyZWdpb246ZWM2NGNlM2UxMmFkNGJiNWE1NWVhM2QzZGQ1MzI4MWVfNDI_7a900281-4c9f-40c1-8008-ea3365f90df6"
      unitRef="shares">50000000</us-gaap:CommonStockSharesAuthorized>
    <us-gaap:CommonStockSharesIssued
      contextRef="i4c8f247d12134a9886d56e1c8b024425_I20220630"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmFlNWE5YmUwZWI5NDQ1ZDE5MmZhZTgyMmQyMmJlMDlmL3NlYzphZTVhOWJlMGViOTQ0NWQxOTJmYWU4MjJkMjJiZTA5Zl8xNi9mcmFnOmJjOWYxMWM1NjlkZjQyNzdhZDc1YjA3NzcyY2Q2NWQzL3RhYmxlOmNlMDdiOGQ2NDYwMDRjNDRhNDI1ZWY3YTgxZjQwMGI0L3RhYmxlcmFuZ2U6Y2UwN2I4ZDY0NjAwNGM0NGE0MjVlZjdhODFmNDAwYjRfMjktMC0xLTEtNjI2L3RleHRyZWdpb246ZWM2NGNlM2UxMmFkNGJiNWE1NWVhM2QzZGQ1MzI4MWVfODA_2bc0a47d-555f-40a4-bdd9-6b013158252e"
      unitRef="shares">30038447</us-gaap:CommonStockSharesIssued>
    <us-gaap:CommonStockSharesOutstanding
      contextRef="i4c8f247d12134a9886d56e1c8b024425_I20220630"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmFlNWE5YmUwZWI5NDQ1ZDE5MmZhZTgyMmQyMmJlMDlmL3NlYzphZTVhOWJlMGViOTQ0NWQxOTJmYWU4MjJkMjJiZTA5Zl8xNi9mcmFnOmJjOWYxMWM1NjlkZjQyNzdhZDc1YjA3NzcyY2Q2NWQzL3RhYmxlOmNlMDdiOGQ2NDYwMDRjNDRhNDI1ZWY3YTgxZjQwMGI0L3RhYmxlcmFuZ2U6Y2UwN2I4ZDY0NjAwNGM0NGE0MjVlZjdhODFmNDAwYjRfMjktMC0xLTEtNjI2L3RleHRyZWdpb246ZWM2NGNlM2UxMmFkNGJiNWE1NWVhM2QzZGQ1MzI4MWVfODA_8222f86e-da45-47f2-a926-3251245c7824"
      unitRef="shares">30038447</us-gaap:CommonStockSharesOutstanding>
    <us-gaap:CommonStockSharesIssued
      contextRef="i87bf777ccf5f4f93bc9be7a2cbba61c1_I20211231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmFlNWE5YmUwZWI5NDQ1ZDE5MmZhZTgyMmQyMmJlMDlmL3NlYzphZTVhOWJlMGViOTQ0NWQxOTJmYWU4MjJkMjJiZTA5Zl8xNi9mcmFnOmJjOWYxMWM1NjlkZjQyNzdhZDc1YjA3NzcyY2Q2NWQzL3RhYmxlOmNlMDdiOGQ2NDYwMDRjNDRhNDI1ZWY3YTgxZjQwMGI0L3RhYmxlcmFuZ2U6Y2UwN2I4ZDY0NjAwNGM0NGE0MjVlZjdhODFmNDAwYjRfMjktMC0xLTEtNjI2L3RleHRyZWdpb246ZWM2NGNlM2UxMmFkNGJiNWE1NWVhM2QzZGQ1MzI4MWVfODc_7c91ead6-a9e4-4fc5-8cf6-a5de72be1ac9"
      unitRef="shares">29772922</us-gaap:CommonStockSharesIssued>
    <us-gaap:CommonStockSharesOutstanding
      contextRef="i87bf777ccf5f4f93bc9be7a2cbba61c1_I20211231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmFlNWE5YmUwZWI5NDQ1ZDE5MmZhZTgyMmQyMmJlMDlmL3NlYzphZTVhOWJlMGViOTQ0NWQxOTJmYWU4MjJkMjJiZTA5Zl8xNi9mcmFnOmJjOWYxMWM1NjlkZjQyNzdhZDc1YjA3NzcyY2Q2NWQzL3RhYmxlOmNlMDdiOGQ2NDYwMDRjNDRhNDI1ZWY3YTgxZjQwMGI0L3RhYmxlcmFuZ2U6Y2UwN2I4ZDY0NjAwNGM0NGE0MjVlZjdhODFmNDAwYjRfMjktMC0xLTEtNjI2L3RleHRyZWdpb246ZWM2NGNlM2UxMmFkNGJiNWE1NWVhM2QzZGQ1MzI4MWVfODc_fb1da55b-e6e2-4666-bf92-9f61eb11d95e"
      unitRef="shares">29772922</us-gaap:CommonStockSharesOutstanding>
    <us-gaap:CommonStockValue
      contextRef="i4c8f247d12134a9886d56e1c8b024425_I20220630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmFlNWE5YmUwZWI5NDQ1ZDE5MmZhZTgyMmQyMmJlMDlmL3NlYzphZTVhOWJlMGViOTQ0NWQxOTJmYWU4MjJkMjJiZTA5Zl8xNi9mcmFnOmJjOWYxMWM1NjlkZjQyNzdhZDc1YjA3NzcyY2Q2NWQzL3RhYmxlOmNlMDdiOGQ2NDYwMDRjNDRhNDI1ZWY3YTgxZjQwMGI0L3RhYmxlcmFuZ2U6Y2UwN2I4ZDY0NjAwNGM0NGE0MjVlZjdhODFmNDAwYjRfMjktMS0xLTEtNjI2_0471788c-ba7f-404a-9aaa-8cb1c33d9903"
      unitRef="usd">3000</us-gaap:CommonStockValue>
    <us-gaap:CommonStockValue
      contextRef="i87bf777ccf5f4f93bc9be7a2cbba61c1_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmFlNWE5YmUwZWI5NDQ1ZDE5MmZhZTgyMmQyMmJlMDlmL3NlYzphZTVhOWJlMGViOTQ0NWQxOTJmYWU4MjJkMjJiZTA5Zl8xNi9mcmFnOmJjOWYxMWM1NjlkZjQyNzdhZDc1YjA3NzcyY2Q2NWQzL3RhYmxlOmNlMDdiOGQ2NDYwMDRjNDRhNDI1ZWY3YTgxZjQwMGI0L3RhYmxlcmFuZ2U6Y2UwN2I4ZDY0NjAwNGM0NGE0MjVlZjdhODFmNDAwYjRfMjktMy0xLTEtNjI2_ca5d919e-686a-4734-84ac-2d802effd7c3"
      unitRef="usd">3000</us-gaap:CommonStockValue>
    <us-gaap:AdditionalPaidInCapitalCommonStock
      contextRef="i4c8f247d12134a9886d56e1c8b024425_I20220630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmFlNWE5YmUwZWI5NDQ1ZDE5MmZhZTgyMmQyMmJlMDlmL3NlYzphZTVhOWJlMGViOTQ0NWQxOTJmYWU4MjJkMjJiZTA5Zl8xNi9mcmFnOmJjOWYxMWM1NjlkZjQyNzdhZDc1YjA3NzcyY2Q2NWQzL3RhYmxlOmNlMDdiOGQ2NDYwMDRjNDRhNDI1ZWY3YTgxZjQwMGI0L3RhYmxlcmFuZ2U6Y2UwN2I4ZDY0NjAwNGM0NGE0MjVlZjdhODFmNDAwYjRfMzAtMS0xLTEtNjI2_135a8620-0946-44cd-9fae-442bc749c5b5"
      unitRef="usd">445491000</us-gaap:AdditionalPaidInCapitalCommonStock>
    <us-gaap:AdditionalPaidInCapitalCommonStock
      contextRef="i87bf777ccf5f4f93bc9be7a2cbba61c1_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmFlNWE5YmUwZWI5NDQ1ZDE5MmZhZTgyMmQyMmJlMDlmL3NlYzphZTVhOWJlMGViOTQ0NWQxOTJmYWU4MjJkMjJiZTA5Zl8xNi9mcmFnOmJjOWYxMWM1NjlkZjQyNzdhZDc1YjA3NzcyY2Q2NWQzL3RhYmxlOmNlMDdiOGQ2NDYwMDRjNDRhNDI1ZWY3YTgxZjQwMGI0L3RhYmxlcmFuZ2U6Y2UwN2I4ZDY0NjAwNGM0NGE0MjVlZjdhODFmNDAwYjRfMzAtMy0xLTEtNjI2_4d05958d-7a57-4b14-8644-27f784e82417"
      unitRef="usd">436183000</us-gaap:AdditionalPaidInCapitalCommonStock>
    <us-gaap:AccumulatedOtherComprehensiveIncomeLossNetOfTax
      contextRef="i4c8f247d12134a9886d56e1c8b024425_I20220630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmFlNWE5YmUwZWI5NDQ1ZDE5MmZhZTgyMmQyMmJlMDlmL3NlYzphZTVhOWJlMGViOTQ0NWQxOTJmYWU4MjJkMjJiZTA5Zl8xNi9mcmFnOmJjOWYxMWM1NjlkZjQyNzdhZDc1YjA3NzcyY2Q2NWQzL3RhYmxlOmNlMDdiOGQ2NDYwMDRjNDRhNDI1ZWY3YTgxZjQwMGI0L3RhYmxlcmFuZ2U6Y2UwN2I4ZDY0NjAwNGM0NGE0MjVlZjdhODFmNDAwYjRfMzEtMS0xLTEtNjI2_e7372875-0a16-4671-a15c-bea8b3d4d118"
      unitRef="usd">-865000</us-gaap:AccumulatedOtherComprehensiveIncomeLossNetOfTax>
    <us-gaap:AccumulatedOtherComprehensiveIncomeLossNetOfTax
      contextRef="i87bf777ccf5f4f93bc9be7a2cbba61c1_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmFlNWE5YmUwZWI5NDQ1ZDE5MmZhZTgyMmQyMmJlMDlmL3NlYzphZTVhOWJlMGViOTQ0NWQxOTJmYWU4MjJkMjJiZTA5Zl8xNi9mcmFnOmJjOWYxMWM1NjlkZjQyNzdhZDc1YjA3NzcyY2Q2NWQzL3RhYmxlOmNlMDdiOGQ2NDYwMDRjNDRhNDI1ZWY3YTgxZjQwMGI0L3RhYmxlcmFuZ2U6Y2UwN2I4ZDY0NjAwNGM0NGE0MjVlZjdhODFmNDAwYjRfMzEtMy0xLTEtNjI2_504e39f2-ab2d-4a9f-a6b8-affb01475e4c"
      unitRef="usd">-124000</us-gaap:AccumulatedOtherComprehensiveIncomeLossNetOfTax>
    <us-gaap:RetainedEarningsAccumulatedDeficit
      contextRef="i4c8f247d12134a9886d56e1c8b024425_I20220630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmFlNWE5YmUwZWI5NDQ1ZDE5MmZhZTgyMmQyMmJlMDlmL3NlYzphZTVhOWJlMGViOTQ0NWQxOTJmYWU4MjJkMjJiZTA5Zl8xNi9mcmFnOmJjOWYxMWM1NjlkZjQyNzdhZDc1YjA3NzcyY2Q2NWQzL3RhYmxlOmNlMDdiOGQ2NDYwMDRjNDRhNDI1ZWY3YTgxZjQwMGI0L3RhYmxlcmFuZ2U6Y2UwN2I4ZDY0NjAwNGM0NGE0MjVlZjdhODFmNDAwYjRfMzItMS0xLTEtNjI2_a3b960c5-4c09-46e3-969f-cad6bfcab856"
      unitRef="usd">-266052000</us-gaap:RetainedEarningsAccumulatedDeficit>
    <us-gaap:RetainedEarningsAccumulatedDeficit
      contextRef="i87bf777ccf5f4f93bc9be7a2cbba61c1_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmFlNWE5YmUwZWI5NDQ1ZDE5MmZhZTgyMmQyMmJlMDlmL3NlYzphZTVhOWJlMGViOTQ0NWQxOTJmYWU4MjJkMjJiZTA5Zl8xNi9mcmFnOmJjOWYxMWM1NjlkZjQyNzdhZDc1YjA3NzcyY2Q2NWQzL3RhYmxlOmNlMDdiOGQ2NDYwMDRjNDRhNDI1ZWY3YTgxZjQwMGI0L3RhYmxlcmFuZ2U6Y2UwN2I4ZDY0NjAwNGM0NGE0MjVlZjdhODFmNDAwYjRfMzItMy0xLTEtNjI2_9d91a5f1-6365-4dc6-af18-1a320a6d56ec"
      unitRef="usd">-206364000</us-gaap:RetainedEarningsAccumulatedDeficit>
    <us-gaap:StockholdersEquity
      contextRef="i4c8f247d12134a9886d56e1c8b024425_I20220630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmFlNWE5YmUwZWI5NDQ1ZDE5MmZhZTgyMmQyMmJlMDlmL3NlYzphZTVhOWJlMGViOTQ0NWQxOTJmYWU4MjJkMjJiZTA5Zl8xNi9mcmFnOmJjOWYxMWM1NjlkZjQyNzdhZDc1YjA3NzcyY2Q2NWQzL3RhYmxlOmNlMDdiOGQ2NDYwMDRjNDRhNDI1ZWY3YTgxZjQwMGI0L3RhYmxlcmFuZ2U6Y2UwN2I4ZDY0NjAwNGM0NGE0MjVlZjdhODFmNDAwYjRfMzMtMS0xLTEtNjI2_e2708b4e-2dea-415e-a8b4-d5b7b51a1362"
      unitRef="usd">178577000</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity
      contextRef="i87bf777ccf5f4f93bc9be7a2cbba61c1_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmFlNWE5YmUwZWI5NDQ1ZDE5MmZhZTgyMmQyMmJlMDlmL3NlYzphZTVhOWJlMGViOTQ0NWQxOTJmYWU4MjJkMjJiZTA5Zl8xNi9mcmFnOmJjOWYxMWM1NjlkZjQyNzdhZDc1YjA3NzcyY2Q2NWQzL3RhYmxlOmNlMDdiOGQ2NDYwMDRjNDRhNDI1ZWY3YTgxZjQwMGI0L3RhYmxlcmFuZ2U6Y2UwN2I4ZDY0NjAwNGM0NGE0MjVlZjdhODFmNDAwYjRfMzMtMy0xLTEtNjI2_6a274869-f17c-4c59-acab-c3b999f17b8e"
      unitRef="usd">229698000</us-gaap:StockholdersEquity>
    <us-gaap:LiabilitiesAndStockholdersEquity
      contextRef="i4c8f247d12134a9886d56e1c8b024425_I20220630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmFlNWE5YmUwZWI5NDQ1ZDE5MmZhZTgyMmQyMmJlMDlmL3NlYzphZTVhOWJlMGViOTQ0NWQxOTJmYWU4MjJkMjJiZTA5Zl8xNi9mcmFnOmJjOWYxMWM1NjlkZjQyNzdhZDc1YjA3NzcyY2Q2NWQzL3RhYmxlOmNlMDdiOGQ2NDYwMDRjNDRhNDI1ZWY3YTgxZjQwMGI0L3RhYmxlcmFuZ2U6Y2UwN2I4ZDY0NjAwNGM0NGE0MjVlZjdhODFmNDAwYjRfMzQtMS0xLTEtNjI2_51628990-6f0c-4ca5-be82-1ea9f80c0a1b"
      unitRef="usd">216112000</us-gaap:LiabilitiesAndStockholdersEquity>
    <us-gaap:LiabilitiesAndStockholdersEquity
      contextRef="i87bf777ccf5f4f93bc9be7a2cbba61c1_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmFlNWE5YmUwZWI5NDQ1ZDE5MmZhZTgyMmQyMmJlMDlmL3NlYzphZTVhOWJlMGViOTQ0NWQxOTJmYWU4MjJkMjJiZTA5Zl8xNi9mcmFnOmJjOWYxMWM1NjlkZjQyNzdhZDc1YjA3NzcyY2Q2NWQzL3RhYmxlOmNlMDdiOGQ2NDYwMDRjNDRhNDI1ZWY3YTgxZjQwMGI0L3RhYmxlcmFuZ2U6Y2UwN2I4ZDY0NjAwNGM0NGE0MjVlZjdhODFmNDAwYjRfMzQtMy0xLTEtNjI2_de9dfecb-e889-4ce2-aef6-0b839c3fe4c5"
      unitRef="usd">248309000</us-gaap:LiabilitiesAndStockholdersEquity>
    <us-gaap:RevenueFromContractWithCustomerIncludingAssessedTax
      contextRef="i6e93ea7e6de54e3b99964d226c95da1b_D20220401-20220630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmFlNWE5YmUwZWI5NDQ1ZDE5MmZhZTgyMmQyMmJlMDlmL3NlYzphZTVhOWJlMGViOTQ0NWQxOTJmYWU4MjJkMjJiZTA5Zl8xOS9mcmFnOmE1NTY4MGVlYzE3MzRiYjU4MWRkMDMwM2I4MjVjM2FlL3RhYmxlOjhhZTZlM2VjMmI5NDRjZjA5NDg4ZDVlZWIzOWQyZTQ4L3RhYmxlcmFuZ2U6OGFlNmUzZWMyYjk0NGNmMDk0ODhkNWVlYjM5ZDJlNDhfMy0xLTEtMS02MjY_1952f741-609f-4017-8e15-7a91b3c29d1f"
      unitRef="usd">4147000</us-gaap:RevenueFromContractWithCustomerIncludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerIncludingAssessedTax
      contextRef="i37138912f4f54957978d26b438559810_D20210401-20210630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmFlNWE5YmUwZWI5NDQ1ZDE5MmZhZTgyMmQyMmJlMDlmL3NlYzphZTVhOWJlMGViOTQ0NWQxOTJmYWU4MjJkMjJiZTA5Zl8xOS9mcmFnOmE1NTY4MGVlYzE3MzRiYjU4MWRkMDMwM2I4MjVjM2FlL3RhYmxlOjhhZTZlM2VjMmI5NDRjZjA5NDg4ZDVlZWIzOWQyZTQ4L3RhYmxlcmFuZ2U6OGFlNmUzZWMyYjk0NGNmMDk0ODhkNWVlYjM5ZDJlNDhfMy0zLTEtMS02MjY_7c1c61b0-c399-4621-8694-7cc7d46478fd"
      unitRef="usd">2910000</us-gaap:RevenueFromContractWithCustomerIncludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerIncludingAssessedTax
      contextRef="i162096998d12445db5b600d98dd798a7_D20220101-20220630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmFlNWE5YmUwZWI5NDQ1ZDE5MmZhZTgyMmQyMmJlMDlmL3NlYzphZTVhOWJlMGViOTQ0NWQxOTJmYWU4MjJkMjJiZTA5Zl8xOS9mcmFnOmE1NTY4MGVlYzE3MzRiYjU4MWRkMDMwM2I4MjVjM2FlL3RhYmxlOjhhZTZlM2VjMmI5NDRjZjA5NDg4ZDVlZWIzOWQyZTQ4L3RhYmxlcmFuZ2U6OGFlNmUzZWMyYjk0NGNmMDk0ODhkNWVlYjM5ZDJlNDhfMy01LTEtMS02MjY_35dfa1e7-4d95-40ab-bdfb-22ea4d262a85"
      unitRef="usd">7665000</us-gaap:RevenueFromContractWithCustomerIncludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerIncludingAssessedTax
      contextRef="ib998ae4e71544a4aa86f6166fce08ce5_D20210101-20210630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmFlNWE5YmUwZWI5NDQ1ZDE5MmZhZTgyMmQyMmJlMDlmL3NlYzphZTVhOWJlMGViOTQ0NWQxOTJmYWU4MjJkMjJiZTA5Zl8xOS9mcmFnOmE1NTY4MGVlYzE3MzRiYjU4MWRkMDMwM2I4MjVjM2FlL3RhYmxlOjhhZTZlM2VjMmI5NDRjZjA5NDg4ZDVlZWIzOWQyZTQ4L3RhYmxlcmFuZ2U6OGFlNmUzZWMyYjk0NGNmMDk0ODhkNWVlYjM5ZDJlNDhfMy03LTEtMS02MjY_5de820c0-b680-46a1-bfb0-d3f6461e5bda"
      unitRef="usd">5100000</us-gaap:RevenueFromContractWithCustomerIncludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerIncludingAssessedTax
      contextRef="i78ce1dff723a4a809549de43dc758409_D20220401-20220630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmFlNWE5YmUwZWI5NDQ1ZDE5MmZhZTgyMmQyMmJlMDlmL3NlYzphZTVhOWJlMGViOTQ0NWQxOTJmYWU4MjJkMjJiZTA5Zl8xOS9mcmFnOmE1NTY4MGVlYzE3MzRiYjU4MWRkMDMwM2I4MjVjM2FlL3RhYmxlOjhhZTZlM2VjMmI5NDRjZjA5NDg4ZDVlZWIzOWQyZTQ4L3RhYmxlcmFuZ2U6OGFlNmUzZWMyYjk0NGNmMDk0ODhkNWVlYjM5ZDJlNDhfNC0xLTEtMS02MjY_75d79c09-0cbb-4e06-8f35-552a51f5d4b7"
      unitRef="usd">86000</us-gaap:RevenueFromContractWithCustomerIncludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerIncludingAssessedTax
      contextRef="i56c0d5eff1614a048c29e3f98fd6e1bd_D20210401-20210630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmFlNWE5YmUwZWI5NDQ1ZDE5MmZhZTgyMmQyMmJlMDlmL3NlYzphZTVhOWJlMGViOTQ0NWQxOTJmYWU4MjJkMjJiZTA5Zl8xOS9mcmFnOmE1NTY4MGVlYzE3MzRiYjU4MWRkMDMwM2I4MjVjM2FlL3RhYmxlOjhhZTZlM2VjMmI5NDRjZjA5NDg4ZDVlZWIzOWQyZTQ4L3RhYmxlcmFuZ2U6OGFlNmUzZWMyYjk0NGNmMDk0ODhkNWVlYjM5ZDJlNDhfNC0zLTEtMS02MjY_2319375f-5653-4e81-a911-8babd95cba8d"
      unitRef="usd">209000</us-gaap:RevenueFromContractWithCustomerIncludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerIncludingAssessedTax
      contextRef="i615ec51fc143458883f5b2236ee7fa4e_D20220101-20220630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmFlNWE5YmUwZWI5NDQ1ZDE5MmZhZTgyMmQyMmJlMDlmL3NlYzphZTVhOWJlMGViOTQ0NWQxOTJmYWU4MjJkMjJiZTA5Zl8xOS9mcmFnOmE1NTY4MGVlYzE3MzRiYjU4MWRkMDMwM2I4MjVjM2FlL3RhYmxlOjhhZTZlM2VjMmI5NDRjZjA5NDg4ZDVlZWIzOWQyZTQ4L3RhYmxlcmFuZ2U6OGFlNmUzZWMyYjk0NGNmMDk0ODhkNWVlYjM5ZDJlNDhfNC01LTEtMS02MjY_82b17412-c081-4458-bc84-201df85bb5cf"
      unitRef="usd">286000</us-gaap:RevenueFromContractWithCustomerIncludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerIncludingAssessedTax
      contextRef="i3b92d912bf1a4d219b2f1cafa797b274_D20210101-20210630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmFlNWE5YmUwZWI5NDQ1ZDE5MmZhZTgyMmQyMmJlMDlmL3NlYzphZTVhOWJlMGViOTQ0NWQxOTJmYWU4MjJkMjJiZTA5Zl8xOS9mcmFnOmE1NTY4MGVlYzE3MzRiYjU4MWRkMDMwM2I4MjVjM2FlL3RhYmxlOjhhZTZlM2VjMmI5NDRjZjA5NDg4ZDVlZWIzOWQyZTQ4L3RhYmxlcmFuZ2U6OGFlNmUzZWMyYjk0NGNmMDk0ODhkNWVlYjM5ZDJlNDhfNC03LTEtMS02MjY_a923facf-c35e-42c5-9ce2-37dfee0f29c8"
      unitRef="usd">543000</us-gaap:RevenueFromContractWithCustomerIncludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerIncludingAssessedTax
      contextRef="i2c5f0f28773744e5a2e202f2943ae976_D20220401-20220630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmFlNWE5YmUwZWI5NDQ1ZDE5MmZhZTgyMmQyMmJlMDlmL3NlYzphZTVhOWJlMGViOTQ0NWQxOTJmYWU4MjJkMjJiZTA5Zl8xOS9mcmFnOmE1NTY4MGVlYzE3MzRiYjU4MWRkMDMwM2I4MjVjM2FlL3RhYmxlOjhhZTZlM2VjMmI5NDRjZjA5NDg4ZDVlZWIzOWQyZTQ4L3RhYmxlcmFuZ2U6OGFlNmUzZWMyYjk0NGNmMDk0ODhkNWVlYjM5ZDJlNDhfNS0xLTEtMS02MjY_88c00e36-6940-4623-9248-97319c7d1568"
      unitRef="usd">4233000</us-gaap:RevenueFromContractWithCustomerIncludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerIncludingAssessedTax
      contextRef="id7bb773872394047ba26aa8a7a0f4d56_D20210401-20210630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmFlNWE5YmUwZWI5NDQ1ZDE5MmZhZTgyMmQyMmJlMDlmL3NlYzphZTVhOWJlMGViOTQ0NWQxOTJmYWU4MjJkMjJiZTA5Zl8xOS9mcmFnOmE1NTY4MGVlYzE3MzRiYjU4MWRkMDMwM2I4MjVjM2FlL3RhYmxlOjhhZTZlM2VjMmI5NDRjZjA5NDg4ZDVlZWIzOWQyZTQ4L3RhYmxlcmFuZ2U6OGFlNmUzZWMyYjk0NGNmMDk0ODhkNWVlYjM5ZDJlNDhfNS0zLTEtMS02MjY_dce97772-8a67-44be-8114-22ead368b73b"
      unitRef="usd">3119000</us-gaap:RevenueFromContractWithCustomerIncludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerIncludingAssessedTax
      contextRef="ia855382ada1f4f28aa8ef6da692ff177_D20220101-20220630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmFlNWE5YmUwZWI5NDQ1ZDE5MmZhZTgyMmQyMmJlMDlmL3NlYzphZTVhOWJlMGViOTQ0NWQxOTJmYWU4MjJkMjJiZTA5Zl8xOS9mcmFnOmE1NTY4MGVlYzE3MzRiYjU4MWRkMDMwM2I4MjVjM2FlL3RhYmxlOjhhZTZlM2VjMmI5NDRjZjA5NDg4ZDVlZWIzOWQyZTQ4L3RhYmxlcmFuZ2U6OGFlNmUzZWMyYjk0NGNmMDk0ODhkNWVlYjM5ZDJlNDhfNS01LTEtMS02MjY_0c691900-7592-4eb1-9521-f3a07a224d0e"
      unitRef="usd">7951000</us-gaap:RevenueFromContractWithCustomerIncludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerIncludingAssessedTax
      contextRef="idaa4f31ca59a4a17a59c2580b97791ca_D20210101-20210630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmFlNWE5YmUwZWI5NDQ1ZDE5MmZhZTgyMmQyMmJlMDlmL3NlYzphZTVhOWJlMGViOTQ0NWQxOTJmYWU4MjJkMjJiZTA5Zl8xOS9mcmFnOmE1NTY4MGVlYzE3MzRiYjU4MWRkMDMwM2I4MjVjM2FlL3RhYmxlOjhhZTZlM2VjMmI5NDRjZjA5NDg4ZDVlZWIzOWQyZTQ4L3RhYmxlcmFuZ2U6OGFlNmUzZWMyYjk0NGNmMDk0ODhkNWVlYjM5ZDJlNDhfNS03LTEtMS02MjY_91ddc6be-f4d9-496a-8c5c-b4446f1490c3"
      unitRef="usd">5643000</us-gaap:RevenueFromContractWithCustomerIncludingAssessedTax>
    <us-gaap:CostOfRevenue
      contextRef="i6e93ea7e6de54e3b99964d226c95da1b_D20220401-20220630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmFlNWE5YmUwZWI5NDQ1ZDE5MmZhZTgyMmQyMmJlMDlmL3NlYzphZTVhOWJlMGViOTQ0NWQxOTJmYWU4MjJkMjJiZTA5Zl8xOS9mcmFnOmE1NTY4MGVlYzE3MzRiYjU4MWRkMDMwM2I4MjVjM2FlL3RhYmxlOjhhZTZlM2VjMmI5NDRjZjA5NDg4ZDVlZWIzOWQyZTQ4L3RhYmxlcmFuZ2U6OGFlNmUzZWMyYjk0NGNmMDk0ODhkNWVlYjM5ZDJlNDhfNy0xLTEtMS02MjY_ef1464b6-9d44-498e-bcc5-af6740c82b44"
      unitRef="usd">3236000</us-gaap:CostOfRevenue>
    <us-gaap:CostOfRevenue
      contextRef="i37138912f4f54957978d26b438559810_D20210401-20210630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmFlNWE5YmUwZWI5NDQ1ZDE5MmZhZTgyMmQyMmJlMDlmL3NlYzphZTVhOWJlMGViOTQ0NWQxOTJmYWU4MjJkMjJiZTA5Zl8xOS9mcmFnOmE1NTY4MGVlYzE3MzRiYjU4MWRkMDMwM2I4MjVjM2FlL3RhYmxlOjhhZTZlM2VjMmI5NDRjZjA5NDg4ZDVlZWIzOWQyZTQ4L3RhYmxlcmFuZ2U6OGFlNmUzZWMyYjk0NGNmMDk0ODhkNWVlYjM5ZDJlNDhfNy0zLTEtMS02MjY_a906e624-b88b-47cf-8d07-5b92d62ccea8"
      unitRef="usd">2604000</us-gaap:CostOfRevenue>
    <us-gaap:CostOfRevenue
      contextRef="i162096998d12445db5b600d98dd798a7_D20220101-20220630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmFlNWE5YmUwZWI5NDQ1ZDE5MmZhZTgyMmQyMmJlMDlmL3NlYzphZTVhOWJlMGViOTQ0NWQxOTJmYWU4MjJkMjJiZTA5Zl8xOS9mcmFnOmE1NTY4MGVlYzE3MzRiYjU4MWRkMDMwM2I4MjVjM2FlL3RhYmxlOjhhZTZlM2VjMmI5NDRjZjA5NDg4ZDVlZWIzOWQyZTQ4L3RhYmxlcmFuZ2U6OGFlNmUzZWMyYjk0NGNmMDk0ODhkNWVlYjM5ZDJlNDhfNy01LTEtMS02MjY_4031a8ca-bc57-4534-a104-b7311df0e280"
      unitRef="usd">6766000</us-gaap:CostOfRevenue>
    <us-gaap:CostOfRevenue
      contextRef="ib998ae4e71544a4aa86f6166fce08ce5_D20210101-20210630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmFlNWE5YmUwZWI5NDQ1ZDE5MmZhZTgyMmQyMmJlMDlmL3NlYzphZTVhOWJlMGViOTQ0NWQxOTJmYWU4MjJkMjJiZTA5Zl8xOS9mcmFnOmE1NTY4MGVlYzE3MzRiYjU4MWRkMDMwM2I4MjVjM2FlL3RhYmxlOjhhZTZlM2VjMmI5NDRjZjA5NDg4ZDVlZWIzOWQyZTQ4L3RhYmxlcmFuZ2U6OGFlNmUzZWMyYjk0NGNmMDk0ODhkNWVlYjM5ZDJlNDhfNy03LTEtMS02MjY_f51f344a-203b-411c-a1d6-b9ca3eae3347"
      unitRef="usd">4575000</us-gaap:CostOfRevenue>
    <us-gaap:CostOfRevenue
      contextRef="i78ce1dff723a4a809549de43dc758409_D20220401-20220630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmFlNWE5YmUwZWI5NDQ1ZDE5MmZhZTgyMmQyMmJlMDlmL3NlYzphZTVhOWJlMGViOTQ0NWQxOTJmYWU4MjJkMjJiZTA5Zl8xOS9mcmFnOmE1NTY4MGVlYzE3MzRiYjU4MWRkMDMwM2I4MjVjM2FlL3RhYmxlOjhhZTZlM2VjMmI5NDRjZjA5NDg4ZDVlZWIzOWQyZTQ4L3RhYmxlcmFuZ2U6OGFlNmUzZWMyYjk0NGNmMDk0ODhkNWVlYjM5ZDJlNDhfOC0xLTEtMS02MjY_d1c09510-786c-4062-bfdb-03868b9b9ff0"
      unitRef="usd">37000</us-gaap:CostOfRevenue>
    <us-gaap:CostOfRevenue
      contextRef="i56c0d5eff1614a048c29e3f98fd6e1bd_D20210401-20210630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmFlNWE5YmUwZWI5NDQ1ZDE5MmZhZTgyMmQyMmJlMDlmL3NlYzphZTVhOWJlMGViOTQ0NWQxOTJmYWU4MjJkMjJiZTA5Zl8xOS9mcmFnOmE1NTY4MGVlYzE3MzRiYjU4MWRkMDMwM2I4MjVjM2FlL3RhYmxlOjhhZTZlM2VjMmI5NDRjZjA5NDg4ZDVlZWIzOWQyZTQ4L3RhYmxlcmFuZ2U6OGFlNmUzZWMyYjk0NGNmMDk0ODhkNWVlYjM5ZDJlNDhfOC0zLTEtMS02MjY_d8aa20ef-0b38-4888-bd03-2d25f809437e"
      unitRef="usd">20000</us-gaap:CostOfRevenue>
    <us-gaap:CostOfRevenue
      contextRef="i615ec51fc143458883f5b2236ee7fa4e_D20220101-20220630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmFlNWE5YmUwZWI5NDQ1ZDE5MmZhZTgyMmQyMmJlMDlmL3NlYzphZTVhOWJlMGViOTQ0NWQxOTJmYWU4MjJkMjJiZTA5Zl8xOS9mcmFnOmE1NTY4MGVlYzE3MzRiYjU4MWRkMDMwM2I4MjVjM2FlL3RhYmxlOjhhZTZlM2VjMmI5NDRjZjA5NDg4ZDVlZWIzOWQyZTQ4L3RhYmxlcmFuZ2U6OGFlNmUzZWMyYjk0NGNmMDk0ODhkNWVlYjM5ZDJlNDhfOC01LTEtMS02MjY_94908829-8294-40a1-ba92-6f6718970b0c"
      unitRef="usd">61000</us-gaap:CostOfRevenue>
    <us-gaap:CostOfRevenue
      contextRef="i3b92d912bf1a4d219b2f1cafa797b274_D20210101-20210630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmFlNWE5YmUwZWI5NDQ1ZDE5MmZhZTgyMmQyMmJlMDlmL3NlYzphZTVhOWJlMGViOTQ0NWQxOTJmYWU4MjJkMjJiZTA5Zl8xOS9mcmFnOmE1NTY4MGVlYzE3MzRiYjU4MWRkMDMwM2I4MjVjM2FlL3RhYmxlOjhhZTZlM2VjMmI5NDRjZjA5NDg4ZDVlZWIzOWQyZTQ4L3RhYmxlcmFuZ2U6OGFlNmUzZWMyYjk0NGNmMDk0ODhkNWVlYjM5ZDJlNDhfOC03LTEtMS02MjY_084449e6-ffdb-42a3-9a36-0c4a0831b086"
      unitRef="usd">51000</us-gaap:CostOfRevenue>
    <us-gaap:CostOfRevenue
      contextRef="i2c5f0f28773744e5a2e202f2943ae976_D20220401-20220630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmFlNWE5YmUwZWI5NDQ1ZDE5MmZhZTgyMmQyMmJlMDlmL3NlYzphZTVhOWJlMGViOTQ0NWQxOTJmYWU4MjJkMjJiZTA5Zl8xOS9mcmFnOmE1NTY4MGVlYzE3MzRiYjU4MWRkMDMwM2I4MjVjM2FlL3RhYmxlOjhhZTZlM2VjMmI5NDRjZjA5NDg4ZDVlZWIzOWQyZTQ4L3RhYmxlcmFuZ2U6OGFlNmUzZWMyYjk0NGNmMDk0ODhkNWVlYjM5ZDJlNDhfOS0xLTEtMS02MjY_9ba656e4-181b-4152-bfa1-31c99481fe51"
      unitRef="usd">3273000</us-gaap:CostOfRevenue>
    <us-gaap:CostOfRevenue
      contextRef="id7bb773872394047ba26aa8a7a0f4d56_D20210401-20210630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmFlNWE5YmUwZWI5NDQ1ZDE5MmZhZTgyMmQyMmJlMDlmL3NlYzphZTVhOWJlMGViOTQ0NWQxOTJmYWU4MjJkMjJiZTA5Zl8xOS9mcmFnOmE1NTY4MGVlYzE3MzRiYjU4MWRkMDMwM2I4MjVjM2FlL3RhYmxlOjhhZTZlM2VjMmI5NDRjZjA5NDg4ZDVlZWIzOWQyZTQ4L3RhYmxlcmFuZ2U6OGFlNmUzZWMyYjk0NGNmMDk0ODhkNWVlYjM5ZDJlNDhfOS0zLTEtMS02MjY_9ef6ce82-8994-4275-bd0d-d7d5cddb531e"
      unitRef="usd">2624000</us-gaap:CostOfRevenue>
    <us-gaap:CostOfRevenue
      contextRef="ia855382ada1f4f28aa8ef6da692ff177_D20220101-20220630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmFlNWE5YmUwZWI5NDQ1ZDE5MmZhZTgyMmQyMmJlMDlmL3NlYzphZTVhOWJlMGViOTQ0NWQxOTJmYWU4MjJkMjJiZTA5Zl8xOS9mcmFnOmE1NTY4MGVlYzE3MzRiYjU4MWRkMDMwM2I4MjVjM2FlL3RhYmxlOjhhZTZlM2VjMmI5NDRjZjA5NDg4ZDVlZWIzOWQyZTQ4L3RhYmxlcmFuZ2U6OGFlNmUzZWMyYjk0NGNmMDk0ODhkNWVlYjM5ZDJlNDhfOS01LTEtMS02MjY_de2afb7c-32ca-47a2-b1e0-16e9b5d461b1"
      unitRef="usd">6827000</us-gaap:CostOfRevenue>
    <us-gaap:CostOfRevenue
      contextRef="idaa4f31ca59a4a17a59c2580b97791ca_D20210101-20210630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmFlNWE5YmUwZWI5NDQ1ZDE5MmZhZTgyMmQyMmJlMDlmL3NlYzphZTVhOWJlMGViOTQ0NWQxOTJmYWU4MjJkMjJiZTA5Zl8xOS9mcmFnOmE1NTY4MGVlYzE3MzRiYjU4MWRkMDMwM2I4MjVjM2FlL3RhYmxlOjhhZTZlM2VjMmI5NDRjZjA5NDg4ZDVlZWIzOWQyZTQ4L3RhYmxlcmFuZ2U6OGFlNmUzZWMyYjk0NGNmMDk0ODhkNWVlYjM5ZDJlNDhfOS03LTEtMS02MjY_67957f0d-5275-47c4-842d-bd29efaddf05"
      unitRef="usd">4626000</us-gaap:CostOfRevenue>
    <us-gaap:GrossProfit
      contextRef="i2c5f0f28773744e5a2e202f2943ae976_D20220401-20220630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmFlNWE5YmUwZWI5NDQ1ZDE5MmZhZTgyMmQyMmJlMDlmL3NlYzphZTVhOWJlMGViOTQ0NWQxOTJmYWU4MjJkMjJiZTA5Zl8xOS9mcmFnOmE1NTY4MGVlYzE3MzRiYjU4MWRkMDMwM2I4MjVjM2FlL3RhYmxlOjhhZTZlM2VjMmI5NDRjZjA5NDg4ZDVlZWIzOWQyZTQ4L3RhYmxlcmFuZ2U6OGFlNmUzZWMyYjk0NGNmMDk0ODhkNWVlYjM5ZDJlNDhfMTAtMS0xLTEtNjI2_08fe76f0-d0f7-45b8-b0be-b77a712864d2"
      unitRef="usd">960000</us-gaap:GrossProfit>
    <us-gaap:GrossProfit
      contextRef="id7bb773872394047ba26aa8a7a0f4d56_D20210401-20210630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmFlNWE5YmUwZWI5NDQ1ZDE5MmZhZTgyMmQyMmJlMDlmL3NlYzphZTVhOWJlMGViOTQ0NWQxOTJmYWU4MjJkMjJiZTA5Zl8xOS9mcmFnOmE1NTY4MGVlYzE3MzRiYjU4MWRkMDMwM2I4MjVjM2FlL3RhYmxlOjhhZTZlM2VjMmI5NDRjZjA5NDg4ZDVlZWIzOWQyZTQ4L3RhYmxlcmFuZ2U6OGFlNmUzZWMyYjk0NGNmMDk0ODhkNWVlYjM5ZDJlNDhfMTAtMy0xLTEtNjI2_015e274b-e779-4757-8d7f-3f48973625e3"
      unitRef="usd">495000</us-gaap:GrossProfit>
    <us-gaap:GrossProfit
      contextRef="ia855382ada1f4f28aa8ef6da692ff177_D20220101-20220630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmFlNWE5YmUwZWI5NDQ1ZDE5MmZhZTgyMmQyMmJlMDlmL3NlYzphZTVhOWJlMGViOTQ0NWQxOTJmYWU4MjJkMjJiZTA5Zl8xOS9mcmFnOmE1NTY4MGVlYzE3MzRiYjU4MWRkMDMwM2I4MjVjM2FlL3RhYmxlOjhhZTZlM2VjMmI5NDRjZjA5NDg4ZDVlZWIzOWQyZTQ4L3RhYmxlcmFuZ2U6OGFlNmUzZWMyYjk0NGNmMDk0ODhkNWVlYjM5ZDJlNDhfMTAtNS0xLTEtNjI2_1738b2c0-7248-424a-876f-8cadb3d53ace"
      unitRef="usd">1124000</us-gaap:GrossProfit>
    <us-gaap:GrossProfit
      contextRef="idaa4f31ca59a4a17a59c2580b97791ca_D20210101-20210630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmFlNWE5YmUwZWI5NDQ1ZDE5MmZhZTgyMmQyMmJlMDlmL3NlYzphZTVhOWJlMGViOTQ0NWQxOTJmYWU4MjJkMjJiZTA5Zl8xOS9mcmFnOmE1NTY4MGVlYzE3MzRiYjU4MWRkMDMwM2I4MjVjM2FlL3RhYmxlOjhhZTZlM2VjMmI5NDRjZjA5NDg4ZDVlZWIzOWQyZTQ4L3RhYmxlcmFuZ2U6OGFlNmUzZWMyYjk0NGNmMDk0ODhkNWVlYjM5ZDJlNDhfMTAtNy0xLTEtNjI2_90fee735-bddd-417b-8394-e08270d15e9f"
      unitRef="usd">1017000</us-gaap:GrossProfit>
    <us-gaap:SellingAndMarketingExpense
      contextRef="i2c5f0f28773744e5a2e202f2943ae976_D20220401-20220630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmFlNWE5YmUwZWI5NDQ1ZDE5MmZhZTgyMmQyMmJlMDlmL3NlYzphZTVhOWJlMGViOTQ0NWQxOTJmYWU4MjJkMjJiZTA5Zl8xOS9mcmFnOmE1NTY4MGVlYzE3MzRiYjU4MWRkMDMwM2I4MjVjM2FlL3RhYmxlOjhhZTZlM2VjMmI5NDRjZjA5NDg4ZDVlZWIzOWQyZTQ4L3RhYmxlcmFuZ2U6OGFlNmUzZWMyYjk0NGNmMDk0ODhkNWVlYjM5ZDJlNDhfMTItMS0xLTEtNjI2_ff40f361-62bc-4685-98f5-1491f8cd6a8b"
      unitRef="usd">15001000</us-gaap:SellingAndMarketingExpense>
    <us-gaap:SellingAndMarketingExpense
      contextRef="id7bb773872394047ba26aa8a7a0f4d56_D20210401-20210630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmFlNWE5YmUwZWI5NDQ1ZDE5MmZhZTgyMmQyMmJlMDlmL3NlYzphZTVhOWJlMGViOTQ0NWQxOTJmYWU4MjJkMjJiZTA5Zl8xOS9mcmFnOmE1NTY4MGVlYzE3MzRiYjU4MWRkMDMwM2I4MjVjM2FlL3RhYmxlOjhhZTZlM2VjMmI5NDRjZjA5NDg4ZDVlZWIzOWQyZTQ4L3RhYmxlcmFuZ2U6OGFlNmUzZWMyYjk0NGNmMDk0ODhkNWVlYjM5ZDJlNDhfMTItMy0xLTEtNjI2_406a7395-a4cd-4631-a48c-af28947a3398"
      unitRef="usd">7907000</us-gaap:SellingAndMarketingExpense>
    <us-gaap:SellingAndMarketingExpense
      contextRef="ia855382ada1f4f28aa8ef6da692ff177_D20220101-20220630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmFlNWE5YmUwZWI5NDQ1ZDE5MmZhZTgyMmQyMmJlMDlmL3NlYzphZTVhOWJlMGViOTQ0NWQxOTJmYWU4MjJkMjJiZTA5Zl8xOS9mcmFnOmE1NTY4MGVlYzE3MzRiYjU4MWRkMDMwM2I4MjVjM2FlL3RhYmxlOjhhZTZlM2VjMmI5NDRjZjA5NDg4ZDVlZWIzOWQyZTQ4L3RhYmxlcmFuZ2U6OGFlNmUzZWMyYjk0NGNmMDk0ODhkNWVlYjM5ZDJlNDhfMTItNS0xLTEtNjI2_31f58e47-7d64-46bd-ba27-4a9b1c0856da"
      unitRef="usd">30444000</us-gaap:SellingAndMarketingExpense>
    <us-gaap:SellingAndMarketingExpense
      contextRef="idaa4f31ca59a4a17a59c2580b97791ca_D20210101-20210630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmFlNWE5YmUwZWI5NDQ1ZDE5MmZhZTgyMmQyMmJlMDlmL3NlYzphZTVhOWJlMGViOTQ0NWQxOTJmYWU4MjJkMjJiZTA5Zl8xOS9mcmFnOmE1NTY4MGVlYzE3MzRiYjU4MWRkMDMwM2I4MjVjM2FlL3RhYmxlOjhhZTZlM2VjMmI5NDRjZjA5NDg4ZDVlZWIzOWQyZTQ4L3RhYmxlcmFuZ2U6OGFlNmUzZWMyYjk0NGNmMDk0ODhkNWVlYjM5ZDJlNDhfMTItNy0xLTEtNjI2_14533e33-c499-40c7-ad55-c560941176f7"
      unitRef="usd">14419000</us-gaap:SellingAndMarketingExpense>
    <us-gaap:ResearchAndDevelopmentExpense
      contextRef="i2c5f0f28773744e5a2e202f2943ae976_D20220401-20220630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmFlNWE5YmUwZWI5NDQ1ZDE5MmZhZTgyMmQyMmJlMDlmL3NlYzphZTVhOWJlMGViOTQ0NWQxOTJmYWU4MjJkMjJiZTA5Zl8xOS9mcmFnOmE1NTY4MGVlYzE3MzRiYjU4MWRkMDMwM2I4MjVjM2FlL3RhYmxlOjhhZTZlM2VjMmI5NDRjZjA5NDg4ZDVlZWIzOWQyZTQ4L3RhYmxlcmFuZ2U6OGFlNmUzZWMyYjk0NGNmMDk0ODhkNWVlYjM5ZDJlNDhfMTMtMS0xLTEtNjI2_038cf629-b883-4c0c-9eb6-6a2e94bb6a85"
      unitRef="usd">6915000</us-gaap:ResearchAndDevelopmentExpense>
    <us-gaap:ResearchAndDevelopmentExpense
      contextRef="id7bb773872394047ba26aa8a7a0f4d56_D20210401-20210630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmFlNWE5YmUwZWI5NDQ1ZDE5MmZhZTgyMmQyMmJlMDlmL3NlYzphZTVhOWJlMGViOTQ0NWQxOTJmYWU4MjJkMjJiZTA5Zl8xOS9mcmFnOmE1NTY4MGVlYzE3MzRiYjU4MWRkMDMwM2I4MjVjM2FlL3RhYmxlOjhhZTZlM2VjMmI5NDRjZjA5NDg4ZDVlZWIzOWQyZTQ4L3RhYmxlcmFuZ2U6OGFlNmUzZWMyYjk0NGNmMDk0ODhkNWVlYjM5ZDJlNDhfMTMtMy0xLTEtNjI2_8f01ea47-684b-4e31-8577-eb8e89f79e73"
      unitRef="usd">3594000</us-gaap:ResearchAndDevelopmentExpense>
    <us-gaap:ResearchAndDevelopmentExpense
      contextRef="ia855382ada1f4f28aa8ef6da692ff177_D20220101-20220630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmFlNWE5YmUwZWI5NDQ1ZDE5MmZhZTgyMmQyMmJlMDlmL3NlYzphZTVhOWJlMGViOTQ0NWQxOTJmYWU4MjJkMjJiZTA5Zl8xOS9mcmFnOmE1NTY4MGVlYzE3MzRiYjU4MWRkMDMwM2I4MjVjM2FlL3RhYmxlOjhhZTZlM2VjMmI5NDRjZjA5NDg4ZDVlZWIzOWQyZTQ4L3RhYmxlcmFuZ2U6OGFlNmUzZWMyYjk0NGNmMDk0ODhkNWVlYjM5ZDJlNDhfMTMtNS0xLTEtNjI2_216659c4-3f26-45f4-8a5b-ec7cdd66767c"
      unitRef="usd">13253000</us-gaap:ResearchAndDevelopmentExpense>
    <us-gaap:ResearchAndDevelopmentExpense
      contextRef="idaa4f31ca59a4a17a59c2580b97791ca_D20210101-20210630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmFlNWE5YmUwZWI5NDQ1ZDE5MmZhZTgyMmQyMmJlMDlmL3NlYzphZTVhOWJlMGViOTQ0NWQxOTJmYWU4MjJkMjJiZTA5Zl8xOS9mcmFnOmE1NTY4MGVlYzE3MzRiYjU4MWRkMDMwM2I4MjVjM2FlL3RhYmxlOjhhZTZlM2VjMmI5NDRjZjA5NDg4ZDVlZWIzOWQyZTQ4L3RhYmxlcmFuZ2U6OGFlNmUzZWMyYjk0NGNmMDk0ODhkNWVlYjM5ZDJlNDhfMTMtNy0xLTEtNjI2_87a99e1f-eb71-4096-892e-471321b15e94"
      unitRef="usd">5845000</us-gaap:ResearchAndDevelopmentExpense>
    <us-gaap:GeneralAndAdministrativeExpense
      contextRef="i2c5f0f28773744e5a2e202f2943ae976_D20220401-20220630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmFlNWE5YmUwZWI5NDQ1ZDE5MmZhZTgyMmQyMmJlMDlmL3NlYzphZTVhOWJlMGViOTQ0NWQxOTJmYWU4MjJkMjJiZTA5Zl8xOS9mcmFnOmE1NTY4MGVlYzE3MzRiYjU4MWRkMDMwM2I4MjVjM2FlL3RhYmxlOjhhZTZlM2VjMmI5NDRjZjA5NDg4ZDVlZWIzOWQyZTQ4L3RhYmxlcmFuZ2U6OGFlNmUzZWMyYjk0NGNmMDk0ODhkNWVlYjM5ZDJlNDhfMTQtMS0xLTEtNjI2_5df10db2-c4f3-46c5-b720-9aff88e80760"
      unitRef="usd">8878000</us-gaap:GeneralAndAdministrativeExpense>
    <us-gaap:GeneralAndAdministrativeExpense
      contextRef="id7bb773872394047ba26aa8a7a0f4d56_D20210401-20210630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmFlNWE5YmUwZWI5NDQ1ZDE5MmZhZTgyMmQyMmJlMDlmL3NlYzphZTVhOWJlMGViOTQ0NWQxOTJmYWU4MjJkMjJiZTA5Zl8xOS9mcmFnOmE1NTY4MGVlYzE3MzRiYjU4MWRkMDMwM2I4MjVjM2FlL3RhYmxlOjhhZTZlM2VjMmI5NDRjZjA5NDg4ZDVlZWIzOWQyZTQ4L3RhYmxlcmFuZ2U6OGFlNmUzZWMyYjk0NGNmMDk0ODhkNWVlYjM5ZDJlNDhfMTQtMy0xLTEtNjI2_28ce5d11-5c6d-4598-9033-7776e539b391"
      unitRef="usd">6301000</us-gaap:GeneralAndAdministrativeExpense>
    <us-gaap:GeneralAndAdministrativeExpense
      contextRef="ia855382ada1f4f28aa8ef6da692ff177_D20220101-20220630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmFlNWE5YmUwZWI5NDQ1ZDE5MmZhZTgyMmQyMmJlMDlmL3NlYzphZTVhOWJlMGViOTQ0NWQxOTJmYWU4MjJkMjJiZTA5Zl8xOS9mcmFnOmE1NTY4MGVlYzE3MzRiYjU4MWRkMDMwM2I4MjVjM2FlL3RhYmxlOjhhZTZlM2VjMmI5NDRjZjA5NDg4ZDVlZWIzOWQyZTQ4L3RhYmxlcmFuZ2U6OGFlNmUzZWMyYjk0NGNmMDk0ODhkNWVlYjM5ZDJlNDhfMTQtNS0xLTEtNjI2_792ae4f5-9777-4613-af02-b152f97d710b"
      unitRef="usd">17452000</us-gaap:GeneralAndAdministrativeExpense>
    <us-gaap:GeneralAndAdministrativeExpense
      contextRef="idaa4f31ca59a4a17a59c2580b97791ca_D20210101-20210630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmFlNWE5YmUwZWI5NDQ1ZDE5MmZhZTgyMmQyMmJlMDlmL3NlYzphZTVhOWJlMGViOTQ0NWQxOTJmYWU4MjJkMjJiZTA5Zl8xOS9mcmFnOmE1NTY4MGVlYzE3MzRiYjU4MWRkMDMwM2I4MjVjM2FlL3RhYmxlOjhhZTZlM2VjMmI5NDRjZjA5NDg4ZDVlZWIzOWQyZTQ4L3RhYmxlcmFuZ2U6OGFlNmUzZWMyYjk0NGNmMDk0ODhkNWVlYjM5ZDJlNDhfMTQtNy0xLTEtNjI2_21f80125-a4e1-4f4c-8f23-c873dcc88935"
      unitRef="usd">11473000</us-gaap:GeneralAndAdministrativeExpense>
    <us-gaap:OperatingExpenses
      contextRef="i2c5f0f28773744e5a2e202f2943ae976_D20220401-20220630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmFlNWE5YmUwZWI5NDQ1ZDE5MmZhZTgyMmQyMmJlMDlmL3NlYzphZTVhOWJlMGViOTQ0NWQxOTJmYWU4MjJkMjJiZTA5Zl8xOS9mcmFnOmE1NTY4MGVlYzE3MzRiYjU4MWRkMDMwM2I4MjVjM2FlL3RhYmxlOjhhZTZlM2VjMmI5NDRjZjA5NDg4ZDVlZWIzOWQyZTQ4L3RhYmxlcmFuZ2U6OGFlNmUzZWMyYjk0NGNmMDk0ODhkNWVlYjM5ZDJlNDhfMTUtMS0xLTEtNjI2_c5f37b70-b7f5-454e-b04f-a78bb6cff6a8"
      unitRef="usd">30794000</us-gaap:OperatingExpenses>
    <us-gaap:OperatingExpenses
      contextRef="id7bb773872394047ba26aa8a7a0f4d56_D20210401-20210630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmFlNWE5YmUwZWI5NDQ1ZDE5MmZhZTgyMmQyMmJlMDlmL3NlYzphZTVhOWJlMGViOTQ0NWQxOTJmYWU4MjJkMjJiZTA5Zl8xOS9mcmFnOmE1NTY4MGVlYzE3MzRiYjU4MWRkMDMwM2I4MjVjM2FlL3RhYmxlOjhhZTZlM2VjMmI5NDRjZjA5NDg4ZDVlZWIzOWQyZTQ4L3RhYmxlcmFuZ2U6OGFlNmUzZWMyYjk0NGNmMDk0ODhkNWVlYjM5ZDJlNDhfMTUtMy0xLTEtNjI2_0640b772-07c8-467c-9ca9-23cbc759f852"
      unitRef="usd">17802000</us-gaap:OperatingExpenses>
    <us-gaap:OperatingExpenses
      contextRef="ia855382ada1f4f28aa8ef6da692ff177_D20220101-20220630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmFlNWE5YmUwZWI5NDQ1ZDE5MmZhZTgyMmQyMmJlMDlmL3NlYzphZTVhOWJlMGViOTQ0NWQxOTJmYWU4MjJkMjJiZTA5Zl8xOS9mcmFnOmE1NTY4MGVlYzE3MzRiYjU4MWRkMDMwM2I4MjVjM2FlL3RhYmxlOjhhZTZlM2VjMmI5NDRjZjA5NDg4ZDVlZWIzOWQyZTQ4L3RhYmxlcmFuZ2U6OGFlNmUzZWMyYjk0NGNmMDk0ODhkNWVlYjM5ZDJlNDhfMTUtNS0xLTEtNjI2_a9ad70fb-c63f-46ba-8a70-f23c6a149f08"
      unitRef="usd">61149000</us-gaap:OperatingExpenses>
    <us-gaap:OperatingExpenses
      contextRef="idaa4f31ca59a4a17a59c2580b97791ca_D20210101-20210630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmFlNWE5YmUwZWI5NDQ1ZDE5MmZhZTgyMmQyMmJlMDlmL3NlYzphZTVhOWJlMGViOTQ0NWQxOTJmYWU4MjJkMjJiZTA5Zl8xOS9mcmFnOmE1NTY4MGVlYzE3MzRiYjU4MWRkMDMwM2I4MjVjM2FlL3RhYmxlOjhhZTZlM2VjMmI5NDRjZjA5NDg4ZDVlZWIzOWQyZTQ4L3RhYmxlcmFuZ2U6OGFlNmUzZWMyYjk0NGNmMDk0ODhkNWVlYjM5ZDJlNDhfMTUtNy0xLTEtNjI2_8deb7b55-da53-46d3-8cd7-8ee5b2850eb0"
      unitRef="usd">31737000</us-gaap:OperatingExpenses>
    <us-gaap:OperatingIncomeLoss
      contextRef="i2c5f0f28773744e5a2e202f2943ae976_D20220401-20220630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmFlNWE5YmUwZWI5NDQ1ZDE5MmZhZTgyMmQyMmJlMDlmL3NlYzphZTVhOWJlMGViOTQ0NWQxOTJmYWU4MjJkMjJiZTA5Zl8xOS9mcmFnOmE1NTY4MGVlYzE3MzRiYjU4MWRkMDMwM2I4MjVjM2FlL3RhYmxlOjhhZTZlM2VjMmI5NDRjZjA5NDg4ZDVlZWIzOWQyZTQ4L3RhYmxlcmFuZ2U6OGFlNmUzZWMyYjk0NGNmMDk0ODhkNWVlYjM5ZDJlNDhfMTYtMS0xLTEtNjI2_730135af-33ae-4402-bb0b-0a85cc2090c3"
      unitRef="usd">-29834000</us-gaap:OperatingIncomeLoss>
    <us-gaap:OperatingIncomeLoss
      contextRef="id7bb773872394047ba26aa8a7a0f4d56_D20210401-20210630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmFlNWE5YmUwZWI5NDQ1ZDE5MmZhZTgyMmQyMmJlMDlmL3NlYzphZTVhOWJlMGViOTQ0NWQxOTJmYWU4MjJkMjJiZTA5Zl8xOS9mcmFnOmE1NTY4MGVlYzE3MzRiYjU4MWRkMDMwM2I4MjVjM2FlL3RhYmxlOjhhZTZlM2VjMmI5NDRjZjA5NDg4ZDVlZWIzOWQyZTQ4L3RhYmxlcmFuZ2U6OGFlNmUzZWMyYjk0NGNmMDk0ODhkNWVlYjM5ZDJlNDhfMTYtMy0xLTEtNjI2_e6d68257-a07b-4ccb-980f-0db05e98e4fa"
      unitRef="usd">-17307000</us-gaap:OperatingIncomeLoss>
    <us-gaap:OperatingIncomeLoss
      contextRef="ia855382ada1f4f28aa8ef6da692ff177_D20220101-20220630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmFlNWE5YmUwZWI5NDQ1ZDE5MmZhZTgyMmQyMmJlMDlmL3NlYzphZTVhOWJlMGViOTQ0NWQxOTJmYWU4MjJkMjJiZTA5Zl8xOS9mcmFnOmE1NTY4MGVlYzE3MzRiYjU4MWRkMDMwM2I4MjVjM2FlL3RhYmxlOjhhZTZlM2VjMmI5NDRjZjA5NDg4ZDVlZWIzOWQyZTQ4L3RhYmxlcmFuZ2U6OGFlNmUzZWMyYjk0NGNmMDk0ODhkNWVlYjM5ZDJlNDhfMTYtNS0xLTEtNjI2_8f0411e9-627f-4f4c-8bfb-720f64b1edcc"
      unitRef="usd">-60025000</us-gaap:OperatingIncomeLoss>
    <us-gaap:OperatingIncomeLoss
      contextRef="idaa4f31ca59a4a17a59c2580b97791ca_D20210101-20210630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmFlNWE5YmUwZWI5NDQ1ZDE5MmZhZTgyMmQyMmJlMDlmL3NlYzphZTVhOWJlMGViOTQ0NWQxOTJmYWU4MjJkMjJiZTA5Zl8xOS9mcmFnOmE1NTY4MGVlYzE3MzRiYjU4MWRkMDMwM2I4MjVjM2FlL3RhYmxlOjhhZTZlM2VjMmI5NDRjZjA5NDg4ZDVlZWIzOWQyZTQ4L3RhYmxlcmFuZ2U6OGFlNmUzZWMyYjk0NGNmMDk0ODhkNWVlYjM5ZDJlNDhfMTYtNy0xLTEtNjI2_d27f1ed6-8f72-407b-b31f-f24c72508a90"
      unitRef="usd">-30720000</us-gaap:OperatingIncomeLoss>
    <us-gaap:InterestIncomeExpenseNonoperatingNet
      contextRef="i2c5f0f28773744e5a2e202f2943ae976_D20220401-20220630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmFlNWE5YmUwZWI5NDQ1ZDE5MmZhZTgyMmQyMmJlMDlmL3NlYzphZTVhOWJlMGViOTQ0NWQxOTJmYWU4MjJkMjJiZTA5Zl8xOS9mcmFnOmE1NTY4MGVlYzE3MzRiYjU4MWRkMDMwM2I4MjVjM2FlL3RhYmxlOjhhZTZlM2VjMmI5NDRjZjA5NDg4ZDVlZWIzOWQyZTQ4L3RhYmxlcmFuZ2U6OGFlNmUzZWMyYjk0NGNmMDk0ODhkNWVlYjM5ZDJlNDhfMTgtMS0xLTEtNjI2_60d06780-bc6e-49b6-ad95-a007ecf0dabd"
      unitRef="usd">149000</us-gaap:InterestIncomeExpenseNonoperatingNet>
    <us-gaap:InterestIncomeExpenseNonoperatingNet
      contextRef="id7bb773872394047ba26aa8a7a0f4d56_D20210401-20210630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmFlNWE5YmUwZWI5NDQ1ZDE5MmZhZTgyMmQyMmJlMDlmL3NlYzphZTVhOWJlMGViOTQ0NWQxOTJmYWU4MjJkMjJiZTA5Zl8xOS9mcmFnOmE1NTY4MGVlYzE3MzRiYjU4MWRkMDMwM2I4MjVjM2FlL3RhYmxlOjhhZTZlM2VjMmI5NDRjZjA5NDg4ZDVlZWIzOWQyZTQ4L3RhYmxlcmFuZ2U6OGFlNmUzZWMyYjk0NGNmMDk0ODhkNWVlYjM5ZDJlNDhfMTgtMy0xLTEtNjI2_0e039559-2ee7-4e39-b37b-83b18d2e6b92"
      unitRef="usd">35000</us-gaap:InterestIncomeExpenseNonoperatingNet>
    <us-gaap:InterestIncomeExpenseNonoperatingNet
      contextRef="ia855382ada1f4f28aa8ef6da692ff177_D20220101-20220630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmFlNWE5YmUwZWI5NDQ1ZDE5MmZhZTgyMmQyMmJlMDlmL3NlYzphZTVhOWJlMGViOTQ0NWQxOTJmYWU4MjJkMjJiZTA5Zl8xOS9mcmFnOmE1NTY4MGVlYzE3MzRiYjU4MWRkMDMwM2I4MjVjM2FlL3RhYmxlOjhhZTZlM2VjMmI5NDRjZjA5NDg4ZDVlZWIzOWQyZTQ4L3RhYmxlcmFuZ2U6OGFlNmUzZWMyYjk0NGNmMDk0ODhkNWVlYjM5ZDJlNDhfMTgtNS0xLTEtNjI2_675097e4-9502-4a94-9906-f3ba67811fe6"
      unitRef="usd">215000</us-gaap:InterestIncomeExpenseNonoperatingNet>
    <us-gaap:InterestIncomeExpenseNonoperatingNet
      contextRef="idaa4f31ca59a4a17a59c2580b97791ca_D20210101-20210630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmFlNWE5YmUwZWI5NDQ1ZDE5MmZhZTgyMmQyMmJlMDlmL3NlYzphZTVhOWJlMGViOTQ0NWQxOTJmYWU4MjJkMjJiZTA5Zl8xOS9mcmFnOmE1NTY4MGVlYzE3MzRiYjU4MWRkMDMwM2I4MjVjM2FlL3RhYmxlOjhhZTZlM2VjMmI5NDRjZjA5NDg4ZDVlZWIzOWQyZTQ4L3RhYmxlcmFuZ2U6OGFlNmUzZWMyYjk0NGNmMDk0ODhkNWVlYjM5ZDJlNDhfMTgtNy0xLTEtNjI2_4d77a4f5-eef9-470f-a416-f8be8e57973e"
      unitRef="usd">69000</us-gaap:InterestIncomeExpenseNonoperatingNet>
    <us-gaap:FairValueAdjustmentOfWarrants
      contextRef="i2c5f0f28773744e5a2e202f2943ae976_D20220401-20220630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmFlNWE5YmUwZWI5NDQ1ZDE5MmZhZTgyMmQyMmJlMDlmL3NlYzphZTVhOWJlMGViOTQ0NWQxOTJmYWU4MjJkMjJiZTA5Zl8xOS9mcmFnOmE1NTY4MGVlYzE3MzRiYjU4MWRkMDMwM2I4MjVjM2FlL3RhYmxlOjhhZTZlM2VjMmI5NDRjZjA5NDg4ZDVlZWIzOWQyZTQ4L3RhYmxlcmFuZ2U6OGFlNmUzZWMyYjk0NGNmMDk0ODhkNWVlYjM5ZDJlNDhfMTktMS0xLTEtNjI2_1665b506-c378-491e-a2ba-7a88a26ccc2d"
      unitRef="usd">-105000</us-gaap:FairValueAdjustmentOfWarrants>
    <us-gaap:FairValueAdjustmentOfWarrants
      contextRef="id7bb773872394047ba26aa8a7a0f4d56_D20210401-20210630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmFlNWE5YmUwZWI5NDQ1ZDE5MmZhZTgyMmQyMmJlMDlmL3NlYzphZTVhOWJlMGViOTQ0NWQxOTJmYWU4MjJkMjJiZTA5Zl8xOS9mcmFnOmE1NTY4MGVlYzE3MzRiYjU4MWRkMDMwM2I4MjVjM2FlL3RhYmxlOjhhZTZlM2VjMmI5NDRjZjA5NDg4ZDVlZWIzOWQyZTQ4L3RhYmxlcmFuZ2U6OGFlNmUzZWMyYjk0NGNmMDk0ODhkNWVlYjM5ZDJlNDhfMTktMy0xLTEtNjI2_013ab475-6c7d-4b1b-97db-7ca2038bfe81"
      unitRef="usd">-170000</us-gaap:FairValueAdjustmentOfWarrants>
    <us-gaap:FairValueAdjustmentOfWarrants
      contextRef="ia855382ada1f4f28aa8ef6da692ff177_D20220101-20220630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmFlNWE5YmUwZWI5NDQ1ZDE5MmZhZTgyMmQyMmJlMDlmL3NlYzphZTVhOWJlMGViOTQ0NWQxOTJmYWU4MjJkMjJiZTA5Zl8xOS9mcmFnOmE1NTY4MGVlYzE3MzRiYjU4MWRkMDMwM2I4MjVjM2FlL3RhYmxlOjhhZTZlM2VjMmI5NDRjZjA5NDg4ZDVlZWIzOWQyZTQ4L3RhYmxlcmFuZ2U6OGFlNmUzZWMyYjk0NGNmMDk0ODhkNWVlYjM5ZDJlNDhfMTktNS0xLTEtNjI2_7c8c8e54-8602-4548-8e1f-6b179990fd57"
      unitRef="usd">-122000</us-gaap:FairValueAdjustmentOfWarrants>
    <us-gaap:FairValueAdjustmentOfWarrants
      contextRef="idaa4f31ca59a4a17a59c2580b97791ca_D20210101-20210630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmFlNWE5YmUwZWI5NDQ1ZDE5MmZhZTgyMmQyMmJlMDlmL3NlYzphZTVhOWJlMGViOTQ0NWQxOTJmYWU4MjJkMjJiZTA5Zl8xOS9mcmFnOmE1NTY4MGVlYzE3MzRiYjU4MWRkMDMwM2I4MjVjM2FlL3RhYmxlOjhhZTZlM2VjMmI5NDRjZjA5NDg4ZDVlZWIzOWQyZTQ4L3RhYmxlcmFuZ2U6OGFlNmUzZWMyYjk0NGNmMDk0ODhkNWVlYjM5ZDJlNDhfMTktNy0xLTEtNjI2_eb2be508-f6a0-42b4-ac5e-ae25e3f42954"
      unitRef="usd">1519000</us-gaap:FairValueAdjustmentOfWarrants>
    <us-gaap:NonoperatingIncomeExpense
      contextRef="i2c5f0f28773744e5a2e202f2943ae976_D20220401-20220630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmFlNWE5YmUwZWI5NDQ1ZDE5MmZhZTgyMmQyMmJlMDlmL3NlYzphZTVhOWJlMGViOTQ0NWQxOTJmYWU4MjJkMjJiZTA5Zl8xOS9mcmFnOmE1NTY4MGVlYzE3MzRiYjU4MWRkMDMwM2I4MjVjM2FlL3RhYmxlOjhhZTZlM2VjMmI5NDRjZjA5NDg4ZDVlZWIzOWQyZTQ4L3RhYmxlcmFuZ2U6OGFlNmUzZWMyYjk0NGNmMDk0ODhkNWVlYjM5ZDJlNDhfMjAtMS0xLTEtNjI2_939705ee-6f40-4653-aca4-f2c1d3bf5c44"
      unitRef="usd">254000</us-gaap:NonoperatingIncomeExpense>
    <us-gaap:NonoperatingIncomeExpense
      contextRef="id7bb773872394047ba26aa8a7a0f4d56_D20210401-20210630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmFlNWE5YmUwZWI5NDQ1ZDE5MmZhZTgyMmQyMmJlMDlmL3NlYzphZTVhOWJlMGViOTQ0NWQxOTJmYWU4MjJkMjJiZTA5Zl8xOS9mcmFnOmE1NTY4MGVlYzE3MzRiYjU4MWRkMDMwM2I4MjVjM2FlL3RhYmxlOjhhZTZlM2VjMmI5NDRjZjA5NDg4ZDVlZWIzOWQyZTQ4L3RhYmxlcmFuZ2U6OGFlNmUzZWMyYjk0NGNmMDk0ODhkNWVlYjM5ZDJlNDhfMjAtMy0xLTEtNjI2_8880fbc8-3db4-475a-82ea-b780e56f4090"
      unitRef="usd">205000</us-gaap:NonoperatingIncomeExpense>
    <us-gaap:NonoperatingIncomeExpense
      contextRef="ia855382ada1f4f28aa8ef6da692ff177_D20220101-20220630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmFlNWE5YmUwZWI5NDQ1ZDE5MmZhZTgyMmQyMmJlMDlmL3NlYzphZTVhOWJlMGViOTQ0NWQxOTJmYWU4MjJkMjJiZTA5Zl8xOS9mcmFnOmE1NTY4MGVlYzE3MzRiYjU4MWRkMDMwM2I4MjVjM2FlL3RhYmxlOjhhZTZlM2VjMmI5NDRjZjA5NDg4ZDVlZWIzOWQyZTQ4L3RhYmxlcmFuZ2U6OGFlNmUzZWMyYjk0NGNmMDk0ODhkNWVlYjM5ZDJlNDhfMjAtNS0xLTEtNjI2_b4a6153a-d907-4543-8f4f-c4360487e984"
      unitRef="usd">337000</us-gaap:NonoperatingIncomeExpense>
    <us-gaap:NonoperatingIncomeExpense
      contextRef="idaa4f31ca59a4a17a59c2580b97791ca_D20210101-20210630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmFlNWE5YmUwZWI5NDQ1ZDE5MmZhZTgyMmQyMmJlMDlmL3NlYzphZTVhOWJlMGViOTQ0NWQxOTJmYWU4MjJkMjJiZTA5Zl8xOS9mcmFnOmE1NTY4MGVlYzE3MzRiYjU4MWRkMDMwM2I4MjVjM2FlL3RhYmxlOjhhZTZlM2VjMmI5NDRjZjA5NDg4ZDVlZWIzOWQyZTQ4L3RhYmxlcmFuZ2U6OGFlNmUzZWMyYjk0NGNmMDk0ODhkNWVlYjM5ZDJlNDhfMjAtNy0xLTEtNjI2_a125fb10-7735-4f60-970c-a0315678e596"
      unitRef="usd">-1450000</us-gaap:NonoperatingIncomeExpense>
    <us-gaap:NetIncomeLoss
      contextRef="i2c5f0f28773744e5a2e202f2943ae976_D20220401-20220630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmFlNWE5YmUwZWI5NDQ1ZDE5MmZhZTgyMmQyMmJlMDlmL3NlYzphZTVhOWJlMGViOTQ0NWQxOTJmYWU4MjJkMjJiZTA5Zl8xOS9mcmFnOmE1NTY4MGVlYzE3MzRiYjU4MWRkMDMwM2I4MjVjM2FlL3RhYmxlOjhhZTZlM2VjMmI5NDRjZjA5NDg4ZDVlZWIzOWQyZTQ4L3RhYmxlcmFuZ2U6OGFlNmUzZWMyYjk0NGNmMDk0ODhkNWVlYjM5ZDJlNDhfMjEtMS0xLTEtNjI2_5db39739-e94f-4bdf-aed3-d9981cfa2d36"
      unitRef="usd">-29580000</us-gaap:NetIncomeLoss>
    <us-gaap:NetIncomeLoss
      contextRef="id7bb773872394047ba26aa8a7a0f4d56_D20210401-20210630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmFlNWE5YmUwZWI5NDQ1ZDE5MmZhZTgyMmQyMmJlMDlmL3NlYzphZTVhOWJlMGViOTQ0NWQxOTJmYWU4MjJkMjJiZTA5Zl8xOS9mcmFnOmE1NTY4MGVlYzE3MzRiYjU4MWRkMDMwM2I4MjVjM2FlL3RhYmxlOjhhZTZlM2VjMmI5NDRjZjA5NDg4ZDVlZWIzOWQyZTQ4L3RhYmxlcmFuZ2U6OGFlNmUzZWMyYjk0NGNmMDk0ODhkNWVlYjM5ZDJlNDhfMjEtMy0xLTEtNjI2_bf46df11-83a1-455a-a018-f69fafafec55"
      unitRef="usd">-17102000</us-gaap:NetIncomeLoss>
    <us-gaap:NetIncomeLoss
      contextRef="ia855382ada1f4f28aa8ef6da692ff177_D20220101-20220630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmFlNWE5YmUwZWI5NDQ1ZDE5MmZhZTgyMmQyMmJlMDlmL3NlYzphZTVhOWJlMGViOTQ0NWQxOTJmYWU4MjJkMjJiZTA5Zl8xOS9mcmFnOmE1NTY4MGVlYzE3MzRiYjU4MWRkMDMwM2I4MjVjM2FlL3RhYmxlOjhhZTZlM2VjMmI5NDRjZjA5NDg4ZDVlZWIzOWQyZTQ4L3RhYmxlcmFuZ2U6OGFlNmUzZWMyYjk0NGNmMDk0ODhkNWVlYjM5ZDJlNDhfMjEtNS0xLTEtNjI2_234d2895-1d78-45aa-a750-64d6c896996e"
      unitRef="usd">-59688000</us-gaap:NetIncomeLoss>
    <us-gaap:NetIncomeLoss
      contextRef="idaa4f31ca59a4a17a59c2580b97791ca_D20210101-20210630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmFlNWE5YmUwZWI5NDQ1ZDE5MmZhZTgyMmQyMmJlMDlmL3NlYzphZTVhOWJlMGViOTQ0NWQxOTJmYWU4MjJkMjJiZTA5Zl8xOS9mcmFnOmE1NTY4MGVlYzE3MzRiYjU4MWRkMDMwM2I4MjVjM2FlL3RhYmxlOjhhZTZlM2VjMmI5NDRjZjA5NDg4ZDVlZWIzOWQyZTQ4L3RhYmxlcmFuZ2U6OGFlNmUzZWMyYjk0NGNmMDk0ODhkNWVlYjM5ZDJlNDhfMjEtNy0xLTEtNjI2_59eabc2f-f5cf-4327-b91f-5cfd6ce95a9e"
      unitRef="usd">-32170000</us-gaap:NetIncomeLoss>
    <us-gaap:WeightedAverageNumberOfSharesOutstandingBasic
      contextRef="i2c5f0f28773744e5a2e202f2943ae976_D20220401-20220630"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmFlNWE5YmUwZWI5NDQ1ZDE5MmZhZTgyMmQyMmJlMDlmL3NlYzphZTVhOWJlMGViOTQ0NWQxOTJmYWU4MjJkMjJiZTA5Zl8xOS9mcmFnOmE1NTY4MGVlYzE3MzRiYjU4MWRkMDMwM2I4MjVjM2FlL3RhYmxlOjhhZTZlM2VjMmI5NDRjZjA5NDg4ZDVlZWIzOWQyZTQ4L3RhYmxlcmFuZ2U6OGFlNmUzZWMyYjk0NGNmMDk0ODhkNWVlYjM5ZDJlNDhfMjItMS0xLTEtNjI2_40b26a95-a4ef-4019-84a1-6bb98fdbf281"
      unitRef="shares">29964849</us-gaap:WeightedAverageNumberOfSharesOutstandingBasic>
    <us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding
      contextRef="i2c5f0f28773744e5a2e202f2943ae976_D20220401-20220630"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmFlNWE5YmUwZWI5NDQ1ZDE5MmZhZTgyMmQyMmJlMDlmL3NlYzphZTVhOWJlMGViOTQ0NWQxOTJmYWU4MjJkMjJiZTA5Zl8xOS9mcmFnOmE1NTY4MGVlYzE3MzRiYjU4MWRkMDMwM2I4MjVjM2FlL3RhYmxlOjhhZTZlM2VjMmI5NDRjZjA5NDg4ZDVlZWIzOWQyZTQ4L3RhYmxlcmFuZ2U6OGFlNmUzZWMyYjk0NGNmMDk0ODhkNWVlYjM5ZDJlNDhfMjItMS0xLTEtNjI2_75e2cb55-c66a-4ebf-90ad-fd4907a8a377"
      unitRef="shares">29964849</us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding>
    <us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding
      contextRef="id7bb773872394047ba26aa8a7a0f4d56_D20210401-20210630"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmFlNWE5YmUwZWI5NDQ1ZDE5MmZhZTgyMmQyMmJlMDlmL3NlYzphZTVhOWJlMGViOTQ0NWQxOTJmYWU4MjJkMjJiZTA5Zl8xOS9mcmFnOmE1NTY4MGVlYzE3MzRiYjU4MWRkMDMwM2I4MjVjM2FlL3RhYmxlOjhhZTZlM2VjMmI5NDRjZjA5NDg4ZDVlZWIzOWQyZTQ4L3RhYmxlcmFuZ2U6OGFlNmUzZWMyYjk0NGNmMDk0ODhkNWVlYjM5ZDJlNDhfMjItMy0xLTEtNjI2_4036fdc8-b795-43f5-85cf-acab646b67a0"
      unitRef="shares">28979148</us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding>
    <us-gaap:WeightedAverageNumberOfSharesOutstandingBasic
      contextRef="id7bb773872394047ba26aa8a7a0f4d56_D20210401-20210630"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmFlNWE5YmUwZWI5NDQ1ZDE5MmZhZTgyMmQyMmJlMDlmL3NlYzphZTVhOWJlMGViOTQ0NWQxOTJmYWU4MjJkMjJiZTA5Zl8xOS9mcmFnOmE1NTY4MGVlYzE3MzRiYjU4MWRkMDMwM2I4MjVjM2FlL3RhYmxlOjhhZTZlM2VjMmI5NDRjZjA5NDg4ZDVlZWIzOWQyZTQ4L3RhYmxlcmFuZ2U6OGFlNmUzZWMyYjk0NGNmMDk0ODhkNWVlYjM5ZDJlNDhfMjItMy0xLTEtNjI2_fed12146-07c3-48bf-be32-0d482102efd6"
      unitRef="shares">28979148</us-gaap:WeightedAverageNumberOfSharesOutstandingBasic>
    <us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding
      contextRef="ia855382ada1f4f28aa8ef6da692ff177_D20220101-20220630"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmFlNWE5YmUwZWI5NDQ1ZDE5MmZhZTgyMmQyMmJlMDlmL3NlYzphZTVhOWJlMGViOTQ0NWQxOTJmYWU4MjJkMjJiZTA5Zl8xOS9mcmFnOmE1NTY4MGVlYzE3MzRiYjU4MWRkMDMwM2I4MjVjM2FlL3RhYmxlOjhhZTZlM2VjMmI5NDRjZjA5NDg4ZDVlZWIzOWQyZTQ4L3RhYmxlcmFuZ2U6OGFlNmUzZWMyYjk0NGNmMDk0ODhkNWVlYjM5ZDJlNDhfMjItNS0xLTEtNjI2_3465c27c-f26e-46d4-8b31-612a00936784"
      unitRef="shares">29904972</us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding>
    <us-gaap:WeightedAverageNumberOfSharesOutstandingBasic
      contextRef="ia855382ada1f4f28aa8ef6da692ff177_D20220101-20220630"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmFlNWE5YmUwZWI5NDQ1ZDE5MmZhZTgyMmQyMmJlMDlmL3NlYzphZTVhOWJlMGViOTQ0NWQxOTJmYWU4MjJkMjJiZTA5Zl8xOS9mcmFnOmE1NTY4MGVlYzE3MzRiYjU4MWRkMDMwM2I4MjVjM2FlL3RhYmxlOjhhZTZlM2VjMmI5NDRjZjA5NDg4ZDVlZWIzOWQyZTQ4L3RhYmxlcmFuZ2U6OGFlNmUzZWMyYjk0NGNmMDk0ODhkNWVlYjM5ZDJlNDhfMjItNS0xLTEtNjI2_631a0583-f370-4f23-80ee-e599f8f9daa6"
      unitRef="shares">29904972</us-gaap:WeightedAverageNumberOfSharesOutstandingBasic>
    <us-gaap:WeightedAverageNumberOfSharesOutstandingBasic
      contextRef="idaa4f31ca59a4a17a59c2580b97791ca_D20210101-20210630"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmFlNWE5YmUwZWI5NDQ1ZDE5MmZhZTgyMmQyMmJlMDlmL3NlYzphZTVhOWJlMGViOTQ0NWQxOTJmYWU4MjJkMjJiZTA5Zl8xOS9mcmFnOmE1NTY4MGVlYzE3MzRiYjU4MWRkMDMwM2I4MjVjM2FlL3RhYmxlOjhhZTZlM2VjMmI5NDRjZjA5NDg4ZDVlZWIzOWQyZTQ4L3RhYmxlcmFuZ2U6OGFlNmUzZWMyYjk0NGNmMDk0ODhkNWVlYjM5ZDJlNDhfMjItNy0xLTEtNjI2_0def862c-ede7-451f-8124-fceecb61b54e"
      unitRef="shares">28070539</us-gaap:WeightedAverageNumberOfSharesOutstandingBasic>
    <us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding
      contextRef="idaa4f31ca59a4a17a59c2580b97791ca_D20210101-20210630"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmFlNWE5YmUwZWI5NDQ1ZDE5MmZhZTgyMmQyMmJlMDlmL3NlYzphZTVhOWJlMGViOTQ0NWQxOTJmYWU4MjJkMjJiZTA5Zl8xOS9mcmFnOmE1NTY4MGVlYzE3MzRiYjU4MWRkMDMwM2I4MjVjM2FlL3RhYmxlOjhhZTZlM2VjMmI5NDRjZjA5NDg4ZDVlZWIzOWQyZTQ4L3RhYmxlcmFuZ2U6OGFlNmUzZWMyYjk0NGNmMDk0ODhkNWVlYjM5ZDJlNDhfMjItNy0xLTEtNjI2_acc8fabd-2ad2-44a5-83a6-937cdd60d147"
      unitRef="shares">28070539</us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding>
    <us-gaap:EarningsPerShareDiluted
      contextRef="i2c5f0f28773744e5a2e202f2943ae976_D20220401-20220630"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOmFlNWE5YmUwZWI5NDQ1ZDE5MmZhZTgyMmQyMmJlMDlmL3NlYzphZTVhOWJlMGViOTQ0NWQxOTJmYWU4MjJkMjJiZTA5Zl8xOS9mcmFnOmE1NTY4MGVlYzE3MzRiYjU4MWRkMDMwM2I4MjVjM2FlL3RhYmxlOjhhZTZlM2VjMmI5NDRjZjA5NDg4ZDVlZWIzOWQyZTQ4L3RhYmxlcmFuZ2U6OGFlNmUzZWMyYjk0NGNmMDk0ODhkNWVlYjM5ZDJlNDhfMjMtMS0xLTEtNjI2_dd3a3527-9c1c-456d-b270-3a5d1cdb674d"
      unitRef="usdPerShare">-0.99</us-gaap:EarningsPerShareDiluted>
    <us-gaap:EarningsPerShareBasic
      contextRef="i2c5f0f28773744e5a2e202f2943ae976_D20220401-20220630"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOmFlNWE5YmUwZWI5NDQ1ZDE5MmZhZTgyMmQyMmJlMDlmL3NlYzphZTVhOWJlMGViOTQ0NWQxOTJmYWU4MjJkMjJiZTA5Zl8xOS9mcmFnOmE1NTY4MGVlYzE3MzRiYjU4MWRkMDMwM2I4MjVjM2FlL3RhYmxlOjhhZTZlM2VjMmI5NDRjZjA5NDg4ZDVlZWIzOWQyZTQ4L3RhYmxlcmFuZ2U6OGFlNmUzZWMyYjk0NGNmMDk0ODhkNWVlYjM5ZDJlNDhfMjMtMS0xLTEtNjI2_efbaad8b-d7aa-463b-91f6-4be2d053a81c"
      unitRef="usdPerShare">-0.99</us-gaap:EarningsPerShareBasic>
    <us-gaap:EarningsPerShareBasic
      contextRef="id7bb773872394047ba26aa8a7a0f4d56_D20210401-20210630"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOmFlNWE5YmUwZWI5NDQ1ZDE5MmZhZTgyMmQyMmJlMDlmL3NlYzphZTVhOWJlMGViOTQ0NWQxOTJmYWU4MjJkMjJiZTA5Zl8xOS9mcmFnOmE1NTY4MGVlYzE3MzRiYjU4MWRkMDMwM2I4MjVjM2FlL3RhYmxlOjhhZTZlM2VjMmI5NDRjZjA5NDg4ZDVlZWIzOWQyZTQ4L3RhYmxlcmFuZ2U6OGFlNmUzZWMyYjk0NGNmMDk0ODhkNWVlYjM5ZDJlNDhfMjMtMy0xLTEtNjI2_dbea52f8-63c0-4968-987a-6f03a6f46ac9"
      unitRef="usdPerShare">-0.59</us-gaap:EarningsPerShareBasic>
    <us-gaap:EarningsPerShareDiluted
      contextRef="id7bb773872394047ba26aa8a7a0f4d56_D20210401-20210630"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOmFlNWE5YmUwZWI5NDQ1ZDE5MmZhZTgyMmQyMmJlMDlmL3NlYzphZTVhOWJlMGViOTQ0NWQxOTJmYWU4MjJkMjJiZTA5Zl8xOS9mcmFnOmE1NTY4MGVlYzE3MzRiYjU4MWRkMDMwM2I4MjVjM2FlL3RhYmxlOjhhZTZlM2VjMmI5NDRjZjA5NDg4ZDVlZWIzOWQyZTQ4L3RhYmxlcmFuZ2U6OGFlNmUzZWMyYjk0NGNmMDk0ODhkNWVlYjM5ZDJlNDhfMjMtMy0xLTEtNjI2_ee0460cf-3e11-453d-885f-35bf538556ac"
      unitRef="usdPerShare">-0.59</us-gaap:EarningsPerShareDiluted>
    <us-gaap:EarningsPerShareDiluted
      contextRef="ia855382ada1f4f28aa8ef6da692ff177_D20220101-20220630"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOmFlNWE5YmUwZWI5NDQ1ZDE5MmZhZTgyMmQyMmJlMDlmL3NlYzphZTVhOWJlMGViOTQ0NWQxOTJmYWU4MjJkMjJiZTA5Zl8xOS9mcmFnOmE1NTY4MGVlYzE3MzRiYjU4MWRkMDMwM2I4MjVjM2FlL3RhYmxlOjhhZTZlM2VjMmI5NDRjZjA5NDg4ZDVlZWIzOWQyZTQ4L3RhYmxlcmFuZ2U6OGFlNmUzZWMyYjk0NGNmMDk0ODhkNWVlYjM5ZDJlNDhfMjMtNS0xLTEtNjI2_60cd049d-c70e-4c23-a420-f518ae884980"
      unitRef="usdPerShare">-2.00</us-gaap:EarningsPerShareDiluted>
    <us-gaap:EarningsPerShareBasic
      contextRef="ia855382ada1f4f28aa8ef6da692ff177_D20220101-20220630"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOmFlNWE5YmUwZWI5NDQ1ZDE5MmZhZTgyMmQyMmJlMDlmL3NlYzphZTVhOWJlMGViOTQ0NWQxOTJmYWU4MjJkMjJiZTA5Zl8xOS9mcmFnOmE1NTY4MGVlYzE3MzRiYjU4MWRkMDMwM2I4MjVjM2FlL3RhYmxlOjhhZTZlM2VjMmI5NDRjZjA5NDg4ZDVlZWIzOWQyZTQ4L3RhYmxlcmFuZ2U6OGFlNmUzZWMyYjk0NGNmMDk0ODhkNWVlYjM5ZDJlNDhfMjMtNS0xLTEtNjI2_96b0c2a9-a563-4633-bf04-e23aadce179e"
      unitRef="usdPerShare">-2.00</us-gaap:EarningsPerShareBasic>
    <us-gaap:EarningsPerShareBasic
      contextRef="idaa4f31ca59a4a17a59c2580b97791ca_D20210101-20210630"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOmFlNWE5YmUwZWI5NDQ1ZDE5MmZhZTgyMmQyMmJlMDlmL3NlYzphZTVhOWJlMGViOTQ0NWQxOTJmYWU4MjJkMjJiZTA5Zl8xOS9mcmFnOmE1NTY4MGVlYzE3MzRiYjU4MWRkMDMwM2I4MjVjM2FlL3RhYmxlOjhhZTZlM2VjMmI5NDRjZjA5NDg4ZDVlZWIzOWQyZTQ4L3RhYmxlcmFuZ2U6OGFlNmUzZWMyYjk0NGNmMDk0ODhkNWVlYjM5ZDJlNDhfMjMtNy0xLTEtNjI2_2ad3ce28-f3b8-4ce1-a918-892a807e3587"
      unitRef="usdPerShare">-1.15</us-gaap:EarningsPerShareBasic>
    <us-gaap:EarningsPerShareDiluted
      contextRef="idaa4f31ca59a4a17a59c2580b97791ca_D20210101-20210630"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOmFlNWE5YmUwZWI5NDQ1ZDE5MmZhZTgyMmQyMmJlMDlmL3NlYzphZTVhOWJlMGViOTQ0NWQxOTJmYWU4MjJkMjJiZTA5Zl8xOS9mcmFnOmE1NTY4MGVlYzE3MzRiYjU4MWRkMDMwM2I4MjVjM2FlL3RhYmxlOjhhZTZlM2VjMmI5NDRjZjA5NDg4ZDVlZWIzOWQyZTQ4L3RhYmxlcmFuZ2U6OGFlNmUzZWMyYjk0NGNmMDk0ODhkNWVlYjM5ZDJlNDhfMjMtNy0xLTEtNjI2_addf9680-f80c-4ed2-983e-3205babdd636"
      unitRef="usdPerShare">-1.15</us-gaap:EarningsPerShareDiluted>
    <us-gaap:NetIncomeLoss
      contextRef="i2c5f0f28773744e5a2e202f2943ae976_D20220401-20220630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmFlNWE5YmUwZWI5NDQ1ZDE5MmZhZTgyMmQyMmJlMDlmL3NlYzphZTVhOWJlMGViOTQ0NWQxOTJmYWU4MjJkMjJiZTA5Zl8yMi9mcmFnOjVlYmVjNTcxMTlmYjQyZGM5ZWRlN2UyZTBiNzJlZmQwL3RhYmxlOmM5M2FlN2Y0MDZlNTQ1Y2M5YzIwYzc5OTcyZGMzZjM3L3RhYmxlcmFuZ2U6YzkzYWU3ZjQwNmU1NDVjYzljMjBjNzk5NzJkYzNmMzdfMi0xLTEtMS02MjY_bff17ef3-3717-407b-9c66-a23cc683a064"
      unitRef="usd">-29580000</us-gaap:NetIncomeLoss>
    <us-gaap:NetIncomeLoss
      contextRef="id7bb773872394047ba26aa8a7a0f4d56_D20210401-20210630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmFlNWE5YmUwZWI5NDQ1ZDE5MmZhZTgyMmQyMmJlMDlmL3NlYzphZTVhOWJlMGViOTQ0NWQxOTJmYWU4MjJkMjJiZTA5Zl8yMi9mcmFnOjVlYmVjNTcxMTlmYjQyZGM5ZWRlN2UyZTBiNzJlZmQwL3RhYmxlOmM5M2FlN2Y0MDZlNTQ1Y2M5YzIwYzc5OTcyZGMzZjM3L3RhYmxlcmFuZ2U6YzkzYWU3ZjQwNmU1NDVjYzljMjBjNzk5NzJkYzNmMzdfMi0zLTEtMS02MjY_d21a3d59-7712-499b-af02-98bd53928efa"
      unitRef="usd">-17102000</us-gaap:NetIncomeLoss>
    <us-gaap:NetIncomeLoss
      contextRef="ia855382ada1f4f28aa8ef6da692ff177_D20220101-20220630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmFlNWE5YmUwZWI5NDQ1ZDE5MmZhZTgyMmQyMmJlMDlmL3NlYzphZTVhOWJlMGViOTQ0NWQxOTJmYWU4MjJkMjJiZTA5Zl8yMi9mcmFnOjVlYmVjNTcxMTlmYjQyZGM5ZWRlN2UyZTBiNzJlZmQwL3RhYmxlOmM5M2FlN2Y0MDZlNTQ1Y2M5YzIwYzc5OTcyZGMzZjM3L3RhYmxlcmFuZ2U6YzkzYWU3ZjQwNmU1NDVjYzljMjBjNzk5NzJkYzNmMzdfMi01LTEtMS02MjY_68635b92-7620-48c6-abb9-9935fb4516a5"
      unitRef="usd">-59688000</us-gaap:NetIncomeLoss>
    <us-gaap:NetIncomeLoss
      contextRef="idaa4f31ca59a4a17a59c2580b97791ca_D20210101-20210630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmFlNWE5YmUwZWI5NDQ1ZDE5MmZhZTgyMmQyMmJlMDlmL3NlYzphZTVhOWJlMGViOTQ0NWQxOTJmYWU4MjJkMjJiZTA5Zl8yMi9mcmFnOjVlYmVjNTcxMTlmYjQyZGM5ZWRlN2UyZTBiNzJlZmQwL3RhYmxlOmM5M2FlN2Y0MDZlNTQ1Y2M5YzIwYzc5OTcyZGMzZjM3L3RhYmxlcmFuZ2U6YzkzYWU3ZjQwNmU1NDVjYzljMjBjNzk5NzJkYzNmMzdfMi03LTEtMS02MjY_6f05f163-491b-4d36-b00f-8f8e4b6339e1"
      unitRef="usd">-32170000</us-gaap:NetIncomeLoss>
    <us-gaap:OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax
      contextRef="i2c5f0f28773744e5a2e202f2943ae976_D20220401-20220630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmFlNWE5YmUwZWI5NDQ1ZDE5MmZhZTgyMmQyMmJlMDlmL3NlYzphZTVhOWJlMGViOTQ0NWQxOTJmYWU4MjJkMjJiZTA5Zl8yMi9mcmFnOjVlYmVjNTcxMTlmYjQyZGM5ZWRlN2UyZTBiNzJlZmQwL3RhYmxlOmM5M2FlN2Y0MDZlNTQ1Y2M5YzIwYzc5OTcyZGMzZjM3L3RhYmxlcmFuZ2U6YzkzYWU3ZjQwNmU1NDVjYzljMjBjNzk5NzJkYzNmMzdfMy0xLTEtMS02MjY_50920dd5-2b5d-4a9d-8912-2b1c5dbe42c8"
      unitRef="usd">-171000</us-gaap:OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax>
    <us-gaap:OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax
      contextRef="id7bb773872394047ba26aa8a7a0f4d56_D20210401-20210630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmFlNWE5YmUwZWI5NDQ1ZDE5MmZhZTgyMmQyMmJlMDlmL3NlYzphZTVhOWJlMGViOTQ0NWQxOTJmYWU4MjJkMjJiZTA5Zl8yMi9mcmFnOjVlYmVjNTcxMTlmYjQyZGM5ZWRlN2UyZTBiNzJlZmQwL3RhYmxlOmM5M2FlN2Y0MDZlNTQ1Y2M5YzIwYzc5OTcyZGMzZjM3L3RhYmxlcmFuZ2U6YzkzYWU3ZjQwNmU1NDVjYzljMjBjNzk5NzJkYzNmMzdfMy0zLTEtMS02MjY_67dd271e-c231-4875-bd86-eb107ff488cd"
      unitRef="usd">-6000</us-gaap:OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax>
    <us-gaap:OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax
      contextRef="ia855382ada1f4f28aa8ef6da692ff177_D20220101-20220630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmFlNWE5YmUwZWI5NDQ1ZDE5MmZhZTgyMmQyMmJlMDlmL3NlYzphZTVhOWJlMGViOTQ0NWQxOTJmYWU4MjJkMjJiZTA5Zl8yMi9mcmFnOjVlYmVjNTcxMTlmYjQyZGM5ZWRlN2UyZTBiNzJlZmQwL3RhYmxlOmM5M2FlN2Y0MDZlNTQ1Y2M5YzIwYzc5OTcyZGMzZjM3L3RhYmxlcmFuZ2U6YzkzYWU3ZjQwNmU1NDVjYzljMjBjNzk5NzJkYzNmMzdfMy01LTEtMS02MjY_80843abc-5395-4e2c-ad2e-c92b98e0dcc8"
      unitRef="usd">-741000</us-gaap:OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax>
    <us-gaap:OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax
      contextRef="idaa4f31ca59a4a17a59c2580b97791ca_D20210101-20210630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmFlNWE5YmUwZWI5NDQ1ZDE5MmZhZTgyMmQyMmJlMDlmL3NlYzphZTVhOWJlMGViOTQ0NWQxOTJmYWU4MjJkMjJiZTA5Zl8yMi9mcmFnOjVlYmVjNTcxMTlmYjQyZGM5ZWRlN2UyZTBiNzJlZmQwL3RhYmxlOmM5M2FlN2Y0MDZlNTQ1Y2M5YzIwYzc5OTcyZGMzZjM3L3RhYmxlcmFuZ2U6YzkzYWU3ZjQwNmU1NDVjYzljMjBjNzk5NzJkYzNmMzdfMy03LTEtMS02MjY_4e3f084e-2f0c-4a74-b8d1-773c4fa6e687"
      unitRef="usd">3000</us-gaap:OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax>
    <us-gaap:ComprehensiveIncomeNetOfTax
      contextRef="i2c5f0f28773744e5a2e202f2943ae976_D20220401-20220630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmFlNWE5YmUwZWI5NDQ1ZDE5MmZhZTgyMmQyMmJlMDlmL3NlYzphZTVhOWJlMGViOTQ0NWQxOTJmYWU4MjJkMjJiZTA5Zl8yMi9mcmFnOjVlYmVjNTcxMTlmYjQyZGM5ZWRlN2UyZTBiNzJlZmQwL3RhYmxlOmM5M2FlN2Y0MDZlNTQ1Y2M5YzIwYzc5OTcyZGMzZjM3L3RhYmxlcmFuZ2U6YzkzYWU3ZjQwNmU1NDVjYzljMjBjNzk5NzJkYzNmMzdfNC0xLTEtMS02MjY_3ba6b198-7068-42e6-821a-a4e55f21559f"
      unitRef="usd">-29751000</us-gaap:ComprehensiveIncomeNetOfTax>
    <us-gaap:ComprehensiveIncomeNetOfTax
      contextRef="id7bb773872394047ba26aa8a7a0f4d56_D20210401-20210630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmFlNWE5YmUwZWI5NDQ1ZDE5MmZhZTgyMmQyMmJlMDlmL3NlYzphZTVhOWJlMGViOTQ0NWQxOTJmYWU4MjJkMjJiZTA5Zl8yMi9mcmFnOjVlYmVjNTcxMTlmYjQyZGM5ZWRlN2UyZTBiNzJlZmQwL3RhYmxlOmM5M2FlN2Y0MDZlNTQ1Y2M5YzIwYzc5OTcyZGMzZjM3L3RhYmxlcmFuZ2U6YzkzYWU3ZjQwNmU1NDVjYzljMjBjNzk5NzJkYzNmMzdfNC0zLTEtMS02MjY_1376e460-53d6-4ae3-9bb2-a11296f1fe1d"
      unitRef="usd">-17108000</us-gaap:ComprehensiveIncomeNetOfTax>
    <us-gaap:ComprehensiveIncomeNetOfTax
      contextRef="ia855382ada1f4f28aa8ef6da692ff177_D20220101-20220630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmFlNWE5YmUwZWI5NDQ1ZDE5MmZhZTgyMmQyMmJlMDlmL3NlYzphZTVhOWJlMGViOTQ0NWQxOTJmYWU4MjJkMjJiZTA5Zl8yMi9mcmFnOjVlYmVjNTcxMTlmYjQyZGM5ZWRlN2UyZTBiNzJlZmQwL3RhYmxlOmM5M2FlN2Y0MDZlNTQ1Y2M5YzIwYzc5OTcyZGMzZjM3L3RhYmxlcmFuZ2U6YzkzYWU3ZjQwNmU1NDVjYzljMjBjNzk5NzJkYzNmMzdfNC01LTEtMS02MjY_501b079e-a93f-4010-9e0c-b4b2e53397e5"
      unitRef="usd">-60429000</us-gaap:ComprehensiveIncomeNetOfTax>
    <us-gaap:ComprehensiveIncomeNetOfTax
      contextRef="idaa4f31ca59a4a17a59c2580b97791ca_D20210101-20210630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmFlNWE5YmUwZWI5NDQ1ZDE5MmZhZTgyMmQyMmJlMDlmL3NlYzphZTVhOWJlMGViOTQ0NWQxOTJmYWU4MjJkMjJiZTA5Zl8yMi9mcmFnOjVlYmVjNTcxMTlmYjQyZGM5ZWRlN2UyZTBiNzJlZmQwL3RhYmxlOmM5M2FlN2Y0MDZlNTQ1Y2M5YzIwYzc5OTcyZGMzZjM3L3RhYmxlcmFuZ2U6YzkzYWU3ZjQwNmU1NDVjYzljMjBjNzk5NzJkYzNmMzdfNC03LTEtMS02MjY_48a0c045-5fa5-4e95-9e71-29170391dff8"
      unitRef="usd">-32167000</us-gaap:ComprehensiveIncomeNetOfTax>
    <us-gaap:SharesOutstanding
      contextRef="i8dc9000c668a4aa984be19fb8519665b_I20211231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmFlNWE5YmUwZWI5NDQ1ZDE5MmZhZTgyMmQyMmJlMDlmL3NlYzphZTVhOWJlMGViOTQ0NWQxOTJmYWU4MjJkMjJiZTA5Zl8yOC9mcmFnOmU0Nzg5YmZkNzY5YTRjYzc4NjI0YWU3MmUwNTE0OGM5L3RhYmxlOmQ4ZjY5OTZmZjM0ZDRlNGNiMmI2MjY3NTBkYTMxYTFiL3RhYmxlcmFuZ2U6ZDhmNjk5NmZmMzRkNGU0Y2IyYjYyNjc1MGRhMzFhMWJfMi0xLTEtMS02MjY_d181dd62-04a6-4e6a-b906-8398807ab6b1"
      unitRef="shares">29772922</us-gaap:SharesOutstanding>
    <us-gaap:StockholdersEquity
      contextRef="i8dc9000c668a4aa984be19fb8519665b_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmFlNWE5YmUwZWI5NDQ1ZDE5MmZhZTgyMmQyMmJlMDlmL3NlYzphZTVhOWJlMGViOTQ0NWQxOTJmYWU4MjJkMjJiZTA5Zl8yOC9mcmFnOmU0Nzg5YmZkNzY5YTRjYzc4NjI0YWU3MmUwNTE0OGM5L3RhYmxlOmQ4ZjY5OTZmZjM0ZDRlNGNiMmI2MjY3NTBkYTMxYTFiL3RhYmxlcmFuZ2U6ZDhmNjk5NmZmMzRkNGU0Y2IyYjYyNjc1MGRhMzFhMWJfMi0zLTEtMS02MjY_5b5ff646-f8ea-40f1-87b0-8548d8b7ba5b"
      unitRef="usd">3000</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity
      contextRef="i152c9be1ba1e447486e5a7897ca085e6_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmFlNWE5YmUwZWI5NDQ1ZDE5MmZhZTgyMmQyMmJlMDlmL3NlYzphZTVhOWJlMGViOTQ0NWQxOTJmYWU4MjJkMjJiZTA5Zl8yOC9mcmFnOmU0Nzg5YmZkNzY5YTRjYzc4NjI0YWU3MmUwNTE0OGM5L3RhYmxlOmQ4ZjY5OTZmZjM0ZDRlNGNiMmI2MjY3NTBkYTMxYTFiL3RhYmxlcmFuZ2U6ZDhmNjk5NmZmMzRkNGU0Y2IyYjYyNjc1MGRhMzFhMWJfMi01LTEtMS02MjY_688d6665-2b64-4cb0-b012-ff304738742c"
      unitRef="usd">436183000</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity
      contextRef="i922bc272fcd34b919d4804d77d0e0c27_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmFlNWE5YmUwZWI5NDQ1ZDE5MmZhZTgyMmQyMmJlMDlmL3NlYzphZTVhOWJlMGViOTQ0NWQxOTJmYWU4MjJkMjJiZTA5Zl8yOC9mcmFnOmU0Nzg5YmZkNzY5YTRjYzc4NjI0YWU3MmUwNTE0OGM5L3RhYmxlOmQ4ZjY5OTZmZjM0ZDRlNGNiMmI2MjY3NTBkYTMxYTFiL3RhYmxlcmFuZ2U6ZDhmNjk5NmZmMzRkNGU0Y2IyYjYyNjc1MGRhMzFhMWJfMi03LTEtMS02MjY_9a23f27f-ddcd-4a93-9f4e-5048bd308dbb"
      unitRef="usd">-124000</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity
      contextRef="i9abcd2f792c74d59a334b58470c92ee1_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmFlNWE5YmUwZWI5NDQ1ZDE5MmZhZTgyMmQyMmJlMDlmL3NlYzphZTVhOWJlMGViOTQ0NWQxOTJmYWU4MjJkMjJiZTA5Zl8yOC9mcmFnOmU0Nzg5YmZkNzY5YTRjYzc4NjI0YWU3MmUwNTE0OGM5L3RhYmxlOmQ4ZjY5OTZmZjM0ZDRlNGNiMmI2MjY3NTBkYTMxYTFiL3RhYmxlcmFuZ2U6ZDhmNjk5NmZmMzRkNGU0Y2IyYjYyNjc1MGRhMzFhMWJfMi05LTEtMS02MjY_c2b199c2-bb04-4748-91b3-c052f74120be"
      unitRef="usd">-206364000</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity
      contextRef="i87bf777ccf5f4f93bc9be7a2cbba61c1_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmFlNWE5YmUwZWI5NDQ1ZDE5MmZhZTgyMmQyMmJlMDlmL3NlYzphZTVhOWJlMGViOTQ0NWQxOTJmYWU4MjJkMjJiZTA5Zl8yOC9mcmFnOmU0Nzg5YmZkNzY5YTRjYzc4NjI0YWU3MmUwNTE0OGM5L3RhYmxlOmQ4ZjY5OTZmZjM0ZDRlNGNiMmI2MjY3NTBkYTMxYTFiL3RhYmxlcmFuZ2U6ZDhmNjk5NmZmMzRkNGU0Y2IyYjYyNjc1MGRhMzFhMWJfMi0xMS0xLTEtNjI2_18706d63-fcfd-4fc1-a05e-ba02fca9b7e3"
      unitRef="usd">229698000</us-gaap:StockholdersEquity>
    <dmtk:StockIssuedDuringPeriodSharesStockOptionsExercisedAndRSURelease
      contextRef="ibdd6f077db7e4453b764a24795f4ccab_D20220101-20220331"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmFlNWE5YmUwZWI5NDQ1ZDE5MmZhZTgyMmQyMmJlMDlmL3NlYzphZTVhOWJlMGViOTQ0NWQxOTJmYWU4MjJkMjJiZTA5Zl8yOC9mcmFnOmU0Nzg5YmZkNzY5YTRjYzc4NjI0YWU3MmUwNTE0OGM5L3RhYmxlOmQ4ZjY5OTZmZjM0ZDRlNGNiMmI2MjY3NTBkYTMxYTFiL3RhYmxlcmFuZ2U6ZDhmNjk5NmZmMzRkNGU0Y2IyYjYyNjc1MGRhMzFhMWJfNC0xLTEtMS02MjY_a4c5093b-27d4-4b7f-a680-2dcdcdd3ed6e"
      unitRef="shares">109275</dmtk:StockIssuedDuringPeriodSharesStockOptionsExercisedAndRSURelease>
    <dmtk:StockIssuedDuringPeriodValueStockOptionsExercisedAndRSURelease
      contextRef="i0c3fc5bff94f42de9cc243e9bac95218_D20220101-20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmFlNWE5YmUwZWI5NDQ1ZDE5MmZhZTgyMmQyMmJlMDlmL3NlYzphZTVhOWJlMGViOTQ0NWQxOTJmYWU4MjJkMjJiZTA5Zl8yOC9mcmFnOmU0Nzg5YmZkNzY5YTRjYzc4NjI0YWU3MmUwNTE0OGM5L3RhYmxlOmQ4ZjY5OTZmZjM0ZDRlNGNiMmI2MjY3NTBkYTMxYTFiL3RhYmxlcmFuZ2U6ZDhmNjk5NmZmMzRkNGU0Y2IyYjYyNjc1MGRhMzFhMWJfNC01LTEtMS02MjY_01aa6dab-2b08-41fb-8bf8-671d3b95f46d"
      unitRef="usd">40000</dmtk:StockIssuedDuringPeriodValueStockOptionsExercisedAndRSURelease>
    <dmtk:StockIssuedDuringPeriodValueStockOptionsExercisedAndRSURelease
      contextRef="i73a86f0089f6462d9bcb14d0d7b333b6_D20220101-20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmFlNWE5YmUwZWI5NDQ1ZDE5MmZhZTgyMmQyMmJlMDlmL3NlYzphZTVhOWJlMGViOTQ0NWQxOTJmYWU4MjJkMjJiZTA5Zl8yOC9mcmFnOmU0Nzg5YmZkNzY5YTRjYzc4NjI0YWU3MmUwNTE0OGM5L3RhYmxlOmQ4ZjY5OTZmZjM0ZDRlNGNiMmI2MjY3NTBkYTMxYTFiL3RhYmxlcmFuZ2U6ZDhmNjk5NmZmMzRkNGU0Y2IyYjYyNjc1MGRhMzFhMWJfNC0xMS0xLTEtNjI2_9f0f4d85-ca07-4cfd-aca5-cc9c76c5c294"
      unitRef="usd">40000</dmtk:StockIssuedDuringPeriodValueStockOptionsExercisedAndRSURelease>
    <dmtk:AdjustmentsToAdditionalPaidInCapitalWarrantIssuedShares
      contextRef="ibdd6f077db7e4453b764a24795f4ccab_D20220101-20220331"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmFlNWE5YmUwZWI5NDQ1ZDE5MmZhZTgyMmQyMmJlMDlmL3NlYzphZTVhOWJlMGViOTQ0NWQxOTJmYWU4MjJkMjJiZTA5Zl8yOC9mcmFnOmU0Nzg5YmZkNzY5YTRjYzc4NjI0YWU3MmUwNTE0OGM5L3RhYmxlOmQ4ZjY5OTZmZjM0ZDRlNGNiMmI2MjY3NTBkYTMxYTFiL3RhYmxlcmFuZ2U6ZDhmNjk5NmZmMzRkNGU0Y2IyYjYyNjc1MGRhMzFhMWJfNS0xLTEtMS02MjY_7e0f88f1-0dbf-458d-947b-6b40d492ac91"
      unitRef="shares">11101</dmtk:AdjustmentsToAdditionalPaidInCapitalWarrantIssuedShares>
    <us-gaap:AdjustmentsToAdditionalPaidInCapitalWarrantIssued
      contextRef="i0c3fc5bff94f42de9cc243e9bac95218_D20220101-20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmFlNWE5YmUwZWI5NDQ1ZDE5MmZhZTgyMmQyMmJlMDlmL3NlYzphZTVhOWJlMGViOTQ0NWQxOTJmYWU4MjJkMjJiZTA5Zl8yOC9mcmFnOmU0Nzg5YmZkNzY5YTRjYzc4NjI0YWU3MmUwNTE0OGM5L3RhYmxlOmQ4ZjY5OTZmZjM0ZDRlNGNiMmI2MjY3NTBkYTMxYTFiL3RhYmxlcmFuZ2U6ZDhmNjk5NmZmMzRkNGU0Y2IyYjYyNjc1MGRhMzFhMWJfNS01LTEtMS02MjY_460f90f8-2944-406f-acd1-e57fa1781652"
      unitRef="usd">12000</us-gaap:AdjustmentsToAdditionalPaidInCapitalWarrantIssued>
    <us-gaap:AdjustmentsToAdditionalPaidInCapitalWarrantIssued
      contextRef="i73a86f0089f6462d9bcb14d0d7b333b6_D20220101-20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmFlNWE5YmUwZWI5NDQ1ZDE5MmZhZTgyMmQyMmJlMDlmL3NlYzphZTVhOWJlMGViOTQ0NWQxOTJmYWU4MjJkMjJiZTA5Zl8yOC9mcmFnOmU0Nzg5YmZkNzY5YTRjYzc4NjI0YWU3MmUwNTE0OGM5L3RhYmxlOmQ4ZjY5OTZmZjM0ZDRlNGNiMmI2MjY3NTBkYTMxYTFiL3RhYmxlcmFuZ2U6ZDhmNjk5NmZmMzRkNGU0Y2IyYjYyNjc1MGRhMzFhMWJfNS0xMS0xLTEtNjI2_c6de2db0-9ec3-4d64-9da1-fca8ff059f5b"
      unitRef="usd">12000</us-gaap:AdjustmentsToAdditionalPaidInCapitalWarrantIssued>
    <us-gaap:StockIssuedDuringPeriodSharesEmployeeStockPurchasePlans
      contextRef="ibdd6f077db7e4453b764a24795f4ccab_D20220101-20220331"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmFlNWE5YmUwZWI5NDQ1ZDE5MmZhZTgyMmQyMmJlMDlmL3NlYzphZTVhOWJlMGViOTQ0NWQxOTJmYWU4MjJkMjJiZTA5Zl8yOC9mcmFnOmU0Nzg5YmZkNzY5YTRjYzc4NjI0YWU3MmUwNTE0OGM5L3RhYmxlOmQ4ZjY5OTZmZjM0ZDRlNGNiMmI2MjY3NTBkYTMxYTFiL3RhYmxlcmFuZ2U6ZDhmNjk5NmZmMzRkNGU0Y2IyYjYyNjc1MGRhMzFhMWJfNi0xLTEtMS02MjY_86cc42b2-31d3-4523-acea-b839f61c59b5"
      unitRef="shares">47339</us-gaap:StockIssuedDuringPeriodSharesEmployeeStockPurchasePlans>
    <us-gaap:StockIssuedDuringPeriodValueEmployeeStockPurchasePlan
      contextRef="i0c3fc5bff94f42de9cc243e9bac95218_D20220101-20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmFlNWE5YmUwZWI5NDQ1ZDE5MmZhZTgyMmQyMmJlMDlmL3NlYzphZTVhOWJlMGViOTQ0NWQxOTJmYWU4MjJkMjJiZTA5Zl8yOC9mcmFnOmU0Nzg5YmZkNzY5YTRjYzc4NjI0YWU3MmUwNTE0OGM5L3RhYmxlOmQ4ZjY5OTZmZjM0ZDRlNGNiMmI2MjY3NTBkYTMxYTFiL3RhYmxlcmFuZ2U6ZDhmNjk5NmZmMzRkNGU0Y2IyYjYyNjc1MGRhMzFhMWJfNi01LTEtMS02MjY_cff375a9-cbb2-436d-8cbd-5a5a9867d85a"
      unitRef="usd">515000</us-gaap:StockIssuedDuringPeriodValueEmployeeStockPurchasePlan>
    <us-gaap:StockIssuedDuringPeriodValueEmployeeStockPurchasePlan
      contextRef="i73a86f0089f6462d9bcb14d0d7b333b6_D20220101-20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmFlNWE5YmUwZWI5NDQ1ZDE5MmZhZTgyMmQyMmJlMDlmL3NlYzphZTVhOWJlMGViOTQ0NWQxOTJmYWU4MjJkMjJiZTA5Zl8yOC9mcmFnOmU0Nzg5YmZkNzY5YTRjYzc4NjI0YWU3MmUwNTE0OGM5L3RhYmxlOmQ4ZjY5OTZmZjM0ZDRlNGNiMmI2MjY3NTBkYTMxYTFiL3RhYmxlcmFuZ2U6ZDhmNjk5NmZmMzRkNGU0Y2IyYjYyNjc1MGRhMzFhMWJfNi0xMS0xLTEtNjI2_ea48f6a7-77ae-4b4d-be7b-1e6f3b7e2f1e"
      unitRef="usd">515000</us-gaap:StockIssuedDuringPeriodValueEmployeeStockPurchasePlan>
    <us-gaap:OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax
      contextRef="i3b22eec6726b4166a994d025bc0ced72_D20220101-20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmFlNWE5YmUwZWI5NDQ1ZDE5MmZhZTgyMmQyMmJlMDlmL3NlYzphZTVhOWJlMGViOTQ0NWQxOTJmYWU4MjJkMjJiZTA5Zl8yOC9mcmFnOmU0Nzg5YmZkNzY5YTRjYzc4NjI0YWU3MmUwNTE0OGM5L3RhYmxlOmQ4ZjY5OTZmZjM0ZDRlNGNiMmI2MjY3NTBkYTMxYTFiL3RhYmxlcmFuZ2U6ZDhmNjk5NmZmMzRkNGU0Y2IyYjYyNjc1MGRhMzFhMWJfNy03LTEtMS02MjY_f95f0431-b191-4f39-9260-a3840976f65b"
      unitRef="usd">-570000</us-gaap:OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax>
    <us-gaap:OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax
      contextRef="i73a86f0089f6462d9bcb14d0d7b333b6_D20220101-20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmFlNWE5YmUwZWI5NDQ1ZDE5MmZhZTgyMmQyMmJlMDlmL3NlYzphZTVhOWJlMGViOTQ0NWQxOTJmYWU4MjJkMjJiZTA5Zl8yOC9mcmFnOmU0Nzg5YmZkNzY5YTRjYzc4NjI0YWU3MmUwNTE0OGM5L3RhYmxlOmQ4ZjY5OTZmZjM0ZDRlNGNiMmI2MjY3NTBkYTMxYTFiL3RhYmxlcmFuZ2U6ZDhmNjk5NmZmMzRkNGU0Y2IyYjYyNjc1MGRhMzFhMWJfNy0xMS0xLTEtNjI2_90fa06d0-532f-4e4b-bfb2-94870716750e"
      unitRef="usd">-570000</us-gaap:OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax>
    <us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
      contextRef="i0c3fc5bff94f42de9cc243e9bac95218_D20220101-20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmFlNWE5YmUwZWI5NDQ1ZDE5MmZhZTgyMmQyMmJlMDlmL3NlYzphZTVhOWJlMGViOTQ0NWQxOTJmYWU4MjJkMjJiZTA5Zl8yOC9mcmFnOmU0Nzg5YmZkNzY5YTRjYzc4NjI0YWU3MmUwNTE0OGM5L3RhYmxlOmQ4ZjY5OTZmZjM0ZDRlNGNiMmI2MjY3NTBkYTMxYTFiL3RhYmxlcmFuZ2U6ZDhmNjk5NmZmMzRkNGU0Y2IyYjYyNjc1MGRhMzFhMWJfOC01LTEtMS02MjY_52f1bd94-dc48-41e8-b3a3-a052e023b076"
      unitRef="usd">3894000</us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue>
    <us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
      contextRef="i73a86f0089f6462d9bcb14d0d7b333b6_D20220101-20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmFlNWE5YmUwZWI5NDQ1ZDE5MmZhZTgyMmQyMmJlMDlmL3NlYzphZTVhOWJlMGViOTQ0NWQxOTJmYWU4MjJkMjJiZTA5Zl8yOC9mcmFnOmU0Nzg5YmZkNzY5YTRjYzc4NjI0YWU3MmUwNTE0OGM5L3RhYmxlOmQ4ZjY5OTZmZjM0ZDRlNGNiMmI2MjY3NTBkYTMxYTFiL3RhYmxlcmFuZ2U6ZDhmNjk5NmZmMzRkNGU0Y2IyYjYyNjc1MGRhMzFhMWJfOC0xMS0xLTEtNjI2_2a8c89d1-818a-4de8-b765-a150f5fa25f1"
      unitRef="usd">3894000</us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue>
    <us-gaap:NetIncomeLoss
      contextRef="ic42372bda74e4cccb938ae9846b0efa8_D20220101-20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmFlNWE5YmUwZWI5NDQ1ZDE5MmZhZTgyMmQyMmJlMDlmL3NlYzphZTVhOWJlMGViOTQ0NWQxOTJmYWU4MjJkMjJiZTA5Zl8yOC9mcmFnOmU0Nzg5YmZkNzY5YTRjYzc4NjI0YWU3MmUwNTE0OGM5L3RhYmxlOmQ4ZjY5OTZmZjM0ZDRlNGNiMmI2MjY3NTBkYTMxYTFiL3RhYmxlcmFuZ2U6ZDhmNjk5NmZmMzRkNGU0Y2IyYjYyNjc1MGRhMzFhMWJfMTAtOS0xLTEtNjI2_fae63adb-49b3-4848-a2a2-a9350d249e76"
      unitRef="usd">-30108000</us-gaap:NetIncomeLoss>
    <us-gaap:NetIncomeLoss
      contextRef="i73a86f0089f6462d9bcb14d0d7b333b6_D20220101-20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmFlNWE5YmUwZWI5NDQ1ZDE5MmZhZTgyMmQyMmJlMDlmL3NlYzphZTVhOWJlMGViOTQ0NWQxOTJmYWU4MjJkMjJiZTA5Zl8yOC9mcmFnOmU0Nzg5YmZkNzY5YTRjYzc4NjI0YWU3MmUwNTE0OGM5L3RhYmxlOmQ4ZjY5OTZmZjM0ZDRlNGNiMmI2MjY3NTBkYTMxYTFiL3RhYmxlcmFuZ2U6ZDhmNjk5NmZmMzRkNGU0Y2IyYjYyNjc1MGRhMzFhMWJfMTAtMTEtMS0xLTYyNg_b807a654-f0de-47c2-9670-7450e577410c"
      unitRef="usd">-30108000</us-gaap:NetIncomeLoss>
    <us-gaap:SharesOutstanding
      contextRef="i39d067b2de814fdd942ed3afbc265b36_I20220331"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmFlNWE5YmUwZWI5NDQ1ZDE5MmZhZTgyMmQyMmJlMDlmL3NlYzphZTVhOWJlMGViOTQ0NWQxOTJmYWU4MjJkMjJiZTA5Zl8yOC9mcmFnOmU0Nzg5YmZkNzY5YTRjYzc4NjI0YWU3MmUwNTE0OGM5L3RhYmxlOmQ4ZjY5OTZmZjM0ZDRlNGNiMmI2MjY3NTBkYTMxYTFiL3RhYmxlcmFuZ2U6ZDhmNjk5NmZmMzRkNGU0Y2IyYjYyNjc1MGRhMzFhMWJfMTEtMS0xLTEtNjI2_3ac2ca8e-0737-4856-9d37-5297193dd77e"
      unitRef="shares">29940637</us-gaap:SharesOutstanding>
    <us-gaap:StockholdersEquity
      contextRef="i39d067b2de814fdd942ed3afbc265b36_I20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmFlNWE5YmUwZWI5NDQ1ZDE5MmZhZTgyMmQyMmJlMDlmL3NlYzphZTVhOWJlMGViOTQ0NWQxOTJmYWU4MjJkMjJiZTA5Zl8yOC9mcmFnOmU0Nzg5YmZkNzY5YTRjYzc4NjI0YWU3MmUwNTE0OGM5L3RhYmxlOmQ4ZjY5OTZmZjM0ZDRlNGNiMmI2MjY3NTBkYTMxYTFiL3RhYmxlcmFuZ2U6ZDhmNjk5NmZmMzRkNGU0Y2IyYjYyNjc1MGRhMzFhMWJfMTEtMy0xLTEtNjI2_11dde216-2539-49e6-997a-04b065fe2e05"
      unitRef="usd">3000</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity
      contextRef="ie3d1daa21e224cc7bf51143498f4f8dc_I20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmFlNWE5YmUwZWI5NDQ1ZDE5MmZhZTgyMmQyMmJlMDlmL3NlYzphZTVhOWJlMGViOTQ0NWQxOTJmYWU4MjJkMjJiZTA5Zl8yOC9mcmFnOmU0Nzg5YmZkNzY5YTRjYzc4NjI0YWU3MmUwNTE0OGM5L3RhYmxlOmQ4ZjY5OTZmZjM0ZDRlNGNiMmI2MjY3NTBkYTMxYTFiL3RhYmxlcmFuZ2U6ZDhmNjk5NmZmMzRkNGU0Y2IyYjYyNjc1MGRhMzFhMWJfMTEtNS0xLTEtNjI2_05bfa2f5-6192-447e-abc8-a5e52e134138"
      unitRef="usd">440644000</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity
      contextRef="ieaf99c642b3e451383632209bf030fa1_I20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmFlNWE5YmUwZWI5NDQ1ZDE5MmZhZTgyMmQyMmJlMDlmL3NlYzphZTVhOWJlMGViOTQ0NWQxOTJmYWU4MjJkMjJiZTA5Zl8yOC9mcmFnOmU0Nzg5YmZkNzY5YTRjYzc4NjI0YWU3MmUwNTE0OGM5L3RhYmxlOmQ4ZjY5OTZmZjM0ZDRlNGNiMmI2MjY3NTBkYTMxYTFiL3RhYmxlcmFuZ2U6ZDhmNjk5NmZmMzRkNGU0Y2IyYjYyNjc1MGRhMzFhMWJfMTEtNy0xLTEtNjI2_af3177b5-bfda-4955-9460-f8c009e7ff74"
      unitRef="usd">-694000</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity
      contextRef="i842f2362497347869b657ca3d4a18b0e_I20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmFlNWE5YmUwZWI5NDQ1ZDE5MmZhZTgyMmQyMmJlMDlmL3NlYzphZTVhOWJlMGViOTQ0NWQxOTJmYWU4MjJkMjJiZTA5Zl8yOC9mcmFnOmU0Nzg5YmZkNzY5YTRjYzc4NjI0YWU3MmUwNTE0OGM5L3RhYmxlOmQ4ZjY5OTZmZjM0ZDRlNGNiMmI2MjY3NTBkYTMxYTFiL3RhYmxlcmFuZ2U6ZDhmNjk5NmZmMzRkNGU0Y2IyYjYyNjc1MGRhMzFhMWJfMTEtOS0xLTEtNjI2_151ca0d6-a2d7-49ff-b3ad-bc05d69d1d4b"
      unitRef="usd">-236472000</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity
      contextRef="id801924f698f4fbab568e7483b1a98ca_I20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmFlNWE5YmUwZWI5NDQ1ZDE5MmZhZTgyMmQyMmJlMDlmL3NlYzphZTVhOWJlMGViOTQ0NWQxOTJmYWU4MjJkMjJiZTA5Zl8yOC9mcmFnOmU0Nzg5YmZkNzY5YTRjYzc4NjI0YWU3MmUwNTE0OGM5L3RhYmxlOmQ4ZjY5OTZmZjM0ZDRlNGNiMmI2MjY3NTBkYTMxYTFiL3RhYmxlcmFuZ2U6ZDhmNjk5NmZmMzRkNGU0Y2IyYjYyNjc1MGRhMzFhMWJfMTEtMTEtMS0xLTYyNg_a8bb8178-04fe-4efe-b417-287fcd864f7f"
      unitRef="usd">203481000</us-gaap:StockholdersEquity>
    <dmtk:StockIssuedDuringPeriodSharesStockOptionsExercisedAndRSURelease
      contextRef="i3ac147ed027b4fccb1eb3b3b35fff118_D20220401-20220630"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmFlNWE5YmUwZWI5NDQ1ZDE5MmZhZTgyMmQyMmJlMDlmL3NlYzphZTVhOWJlMGViOTQ0NWQxOTJmYWU4MjJkMjJiZTA5Zl8yOC9mcmFnOmU0Nzg5YmZkNzY5YTRjYzc4NjI0YWU3MmUwNTE0OGM5L3RhYmxlOmQ4ZjY5OTZmZjM0ZDRlNGNiMmI2MjY3NTBkYTMxYTFiL3RhYmxlcmFuZ2U6ZDhmNjk5NmZmMzRkNGU0Y2IyYjYyNjc1MGRhMzFhMWJfMTItMS0xLTEtNjI2_c08d8669-36ce-4388-b525-5f6623b78d0f"
      unitRef="shares">88591</dmtk:StockIssuedDuringPeriodSharesStockOptionsExercisedAndRSURelease>
    <dmtk:StockIssuedDuringPeriodValueStockOptionsExercisedAndRSURelease
      contextRef="i5a6efd2e4aae4e7c98a64843742ef0b5_D20220401-20220630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmFlNWE5YmUwZWI5NDQ1ZDE5MmZhZTgyMmQyMmJlMDlmL3NlYzphZTVhOWJlMGViOTQ0NWQxOTJmYWU4MjJkMjJiZTA5Zl8yOC9mcmFnOmU0Nzg5YmZkNzY5YTRjYzc4NjI0YWU3MmUwNTE0OGM5L3RhYmxlOmQ4ZjY5OTZmZjM0ZDRlNGNiMmI2MjY3NTBkYTMxYTFiL3RhYmxlcmFuZ2U6ZDhmNjk5NmZmMzRkNGU0Y2IyYjYyNjc1MGRhMzFhMWJfMTItNS0xLTEtNjI2_72f3518e-8920-402e-836e-172e47a8c5c8"
      unitRef="usd">0</dmtk:StockIssuedDuringPeriodValueStockOptionsExercisedAndRSURelease>
    <dmtk:StockIssuedDuringPeriodValueStockOptionsExercisedAndRSURelease
      contextRef="i2c5f0f28773744e5a2e202f2943ae976_D20220401-20220630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmFlNWE5YmUwZWI5NDQ1ZDE5MmZhZTgyMmQyMmJlMDlmL3NlYzphZTVhOWJlMGViOTQ0NWQxOTJmYWU4MjJkMjJiZTA5Zl8yOC9mcmFnOmU0Nzg5YmZkNzY5YTRjYzc4NjI0YWU3MmUwNTE0OGM5L3RhYmxlOmQ4ZjY5OTZmZjM0ZDRlNGNiMmI2MjY3NTBkYTMxYTFiL3RhYmxlcmFuZ2U6ZDhmNjk5NmZmMzRkNGU0Y2IyYjYyNjc1MGRhMzFhMWJfMTItMTEtMS0xLTYyNg_d2b9d3cd-2795-4871-ada8-ddfb2101584d"
      unitRef="usd">0</dmtk:StockIssuedDuringPeriodValueStockOptionsExercisedAndRSURelease>
    <dmtk:AdjustmentsToAdditionalPaidInCapitalWarrantIssuedShares
      contextRef="i3ac147ed027b4fccb1eb3b3b35fff118_D20220401-20220630"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmFlNWE5YmUwZWI5NDQ1ZDE5MmZhZTgyMmQyMmJlMDlmL3NlYzphZTVhOWJlMGViOTQ0NWQxOTJmYWU4MjJkMjJiZTA5Zl8yOC9mcmFnOmU0Nzg5YmZkNzY5YTRjYzc4NjI0YWU3MmUwNTE0OGM5L3RhYmxlOmQ4ZjY5OTZmZjM0ZDRlNGNiMmI2MjY3NTBkYTMxYTFiL3RhYmxlcmFuZ2U6ZDhmNjk5NmZmMzRkNGU0Y2IyYjYyNjc1MGRhMzFhMWJfMTQtMS0xLTEtNjI2_9bb63ddb-ed43-4760-afd5-83379986d857"
      unitRef="shares">9219</dmtk:AdjustmentsToAdditionalPaidInCapitalWarrantIssuedShares>
    <us-gaap:AdjustmentsToAdditionalPaidInCapitalWarrantIssued
      contextRef="i5a6efd2e4aae4e7c98a64843742ef0b5_D20220401-20220630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmFlNWE5YmUwZWI5NDQ1ZDE5MmZhZTgyMmQyMmJlMDlmL3NlYzphZTVhOWJlMGViOTQ0NWQxOTJmYWU4MjJkMjJiZTA5Zl8yOC9mcmFnOmU0Nzg5YmZkNzY5YTRjYzc4NjI0YWU3MmUwNTE0OGM5L3RhYmxlOmQ4ZjY5OTZmZjM0ZDRlNGNiMmI2MjY3NTBkYTMxYTFiL3RhYmxlcmFuZ2U6ZDhmNjk5NmZmMzRkNGU0Y2IyYjYyNjc1MGRhMzFhMWJfMTQtNS0xLTEtNjI2_b4d1146e-b6a6-4c10-9130-0161f95aac16"
      unitRef="usd">10000</us-gaap:AdjustmentsToAdditionalPaidInCapitalWarrantIssued>
    <us-gaap:AdjustmentsToAdditionalPaidInCapitalWarrantIssued
      contextRef="i2c5f0f28773744e5a2e202f2943ae976_D20220401-20220630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmFlNWE5YmUwZWI5NDQ1ZDE5MmZhZTgyMmQyMmJlMDlmL3NlYzphZTVhOWJlMGViOTQ0NWQxOTJmYWU4MjJkMjJiZTA5Zl8yOC9mcmFnOmU0Nzg5YmZkNzY5YTRjYzc4NjI0YWU3MmUwNTE0OGM5L3RhYmxlOmQ4ZjY5OTZmZjM0ZDRlNGNiMmI2MjY3NTBkYTMxYTFiL3RhYmxlcmFuZ2U6ZDhmNjk5NmZmMzRkNGU0Y2IyYjYyNjc1MGRhMzFhMWJfMTQtMTEtMS0xLTYyNg_30b601a8-4137-464f-aa40-21054ca4f8b7"
      unitRef="usd">10000</us-gaap:AdjustmentsToAdditionalPaidInCapitalWarrantIssued>
    <us-gaap:OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax
      contextRef="i121c1a6b16ed46b4b77fad9886993828_D20220401-20220630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmFlNWE5YmUwZWI5NDQ1ZDE5MmZhZTgyMmQyMmJlMDlmL3NlYzphZTVhOWJlMGViOTQ0NWQxOTJmYWU4MjJkMjJiZTA5Zl8yOC9mcmFnOmU0Nzg5YmZkNzY5YTRjYzc4NjI0YWU3MmUwNTE0OGM5L3RhYmxlOmQ4ZjY5OTZmZjM0ZDRlNGNiMmI2MjY3NTBkYTMxYTFiL3RhYmxlcmFuZ2U6ZDhmNjk5NmZmMzRkNGU0Y2IyYjYyNjc1MGRhMzFhMWJfMTUtNy0xLTEtNjI2_cec8e8db-af9f-49e9-9542-95c85cc5f84b"
      unitRef="usd">-171000</us-gaap:OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax>
    <us-gaap:OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax
      contextRef="i2c5f0f28773744e5a2e202f2943ae976_D20220401-20220630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmFlNWE5YmUwZWI5NDQ1ZDE5MmZhZTgyMmQyMmJlMDlmL3NlYzphZTVhOWJlMGViOTQ0NWQxOTJmYWU4MjJkMjJiZTA5Zl8yOC9mcmFnOmU0Nzg5YmZkNzY5YTRjYzc4NjI0YWU3MmUwNTE0OGM5L3RhYmxlOmQ4ZjY5OTZmZjM0ZDRlNGNiMmI2MjY3NTBkYTMxYTFiL3RhYmxlcmFuZ2U6ZDhmNjk5NmZmMzRkNGU0Y2IyYjYyNjc1MGRhMzFhMWJfMTUtMTEtMS0xLTYyNg_a671b092-a64a-420e-8698-055b62e43d13"
      unitRef="usd">-171000</us-gaap:OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax>
    <us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
      contextRef="i5a6efd2e4aae4e7c98a64843742ef0b5_D20220401-20220630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmFlNWE5YmUwZWI5NDQ1ZDE5MmZhZTgyMmQyMmJlMDlmL3NlYzphZTVhOWJlMGViOTQ0NWQxOTJmYWU4MjJkMjJiZTA5Zl8yOC9mcmFnOmU0Nzg5YmZkNzY5YTRjYzc4NjI0YWU3MmUwNTE0OGM5L3RhYmxlOmQ4ZjY5OTZmZjM0ZDRlNGNiMmI2MjY3NTBkYTMxYTFiL3RhYmxlcmFuZ2U6ZDhmNjk5NmZmMzRkNGU0Y2IyYjYyNjc1MGRhMzFhMWJfMTYtNS0xLTEtNjI2_c96f7516-340b-44ef-b53b-ddcf0c60d2bf"
      unitRef="usd">4837000</us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue>
    <us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
      contextRef="i2c5f0f28773744e5a2e202f2943ae976_D20220401-20220630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmFlNWE5YmUwZWI5NDQ1ZDE5MmZhZTgyMmQyMmJlMDlmL3NlYzphZTVhOWJlMGViOTQ0NWQxOTJmYWU4MjJkMjJiZTA5Zl8yOC9mcmFnOmU0Nzg5YmZkNzY5YTRjYzc4NjI0YWU3MmUwNTE0OGM5L3RhYmxlOmQ4ZjY5OTZmZjM0ZDRlNGNiMmI2MjY3NTBkYTMxYTFiL3RhYmxlcmFuZ2U6ZDhmNjk5NmZmMzRkNGU0Y2IyYjYyNjc1MGRhMzFhMWJfMTYtMTEtMS0xLTYyNg_cf633023-c5cb-40c5-aaca-30e371f2b7ad"
      unitRef="usd">4837000</us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue>
    <us-gaap:NetIncomeLoss
      contextRef="i6d917ab3db164f9196c80ba779ef6876_D20220401-20220630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmFlNWE5YmUwZWI5NDQ1ZDE5MmZhZTgyMmQyMmJlMDlmL3NlYzphZTVhOWJlMGViOTQ0NWQxOTJmYWU4MjJkMjJiZTA5Zl8yOC9mcmFnOmU0Nzg5YmZkNzY5YTRjYzc4NjI0YWU3MmUwNTE0OGM5L3RhYmxlOmQ4ZjY5OTZmZjM0ZDRlNGNiMmI2MjY3NTBkYTMxYTFiL3RhYmxlcmFuZ2U6ZDhmNjk5NmZmMzRkNGU0Y2IyYjYyNjc1MGRhMzFhMWJfMTgtOS0xLTEtNjI2_725ee7b6-44cd-4067-81f9-7d89bcb5be36"
      unitRef="usd">-29580000</us-gaap:NetIncomeLoss>
    <us-gaap:NetIncomeLoss
      contextRef="i2c5f0f28773744e5a2e202f2943ae976_D20220401-20220630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmFlNWE5YmUwZWI5NDQ1ZDE5MmZhZTgyMmQyMmJlMDlmL3NlYzphZTVhOWJlMGViOTQ0NWQxOTJmYWU4MjJkMjJiZTA5Zl8yOC9mcmFnOmU0Nzg5YmZkNzY5YTRjYzc4NjI0YWU3MmUwNTE0OGM5L3RhYmxlOmQ4ZjY5OTZmZjM0ZDRlNGNiMmI2MjY3NTBkYTMxYTFiL3RhYmxlcmFuZ2U6ZDhmNjk5NmZmMzRkNGU0Y2IyYjYyNjc1MGRhMzFhMWJfMTgtMTEtMS0xLTYyNg_7daab40c-feee-4435-8dad-5f99931ddd1e"
      unitRef="usd">-29580000</us-gaap:NetIncomeLoss>
    <us-gaap:SharesOutstanding
      contextRef="ia9537308acbd431f87e3b44d01741f2c_I20220630"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmFlNWE5YmUwZWI5NDQ1ZDE5MmZhZTgyMmQyMmJlMDlmL3NlYzphZTVhOWJlMGViOTQ0NWQxOTJmYWU4MjJkMjJiZTA5Zl8yOC9mcmFnOmU0Nzg5YmZkNzY5YTRjYzc4NjI0YWU3MmUwNTE0OGM5L3RhYmxlOmQ4ZjY5OTZmZjM0ZDRlNGNiMmI2MjY3NTBkYTMxYTFiL3RhYmxlcmFuZ2U6ZDhmNjk5NmZmMzRkNGU0Y2IyYjYyNjc1MGRhMzFhMWJfMTktMS0xLTEtNjI2_8caa3ffe-71f1-4dec-a6e5-a901e97bf54a"
      unitRef="shares">30038447</us-gaap:SharesOutstanding>
    <us-gaap:StockholdersEquity
      contextRef="ia9537308acbd431f87e3b44d01741f2c_I20220630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmFlNWE5YmUwZWI5NDQ1ZDE5MmZhZTgyMmQyMmJlMDlmL3NlYzphZTVhOWJlMGViOTQ0NWQxOTJmYWU4MjJkMjJiZTA5Zl8yOC9mcmFnOmU0Nzg5YmZkNzY5YTRjYzc4NjI0YWU3MmUwNTE0OGM5L3RhYmxlOmQ4ZjY5OTZmZjM0ZDRlNGNiMmI2MjY3NTBkYTMxYTFiL3RhYmxlcmFuZ2U6ZDhmNjk5NmZmMzRkNGU0Y2IyYjYyNjc1MGRhMzFhMWJfMTktMy0xLTEtNjI2_aba8af4a-350e-41dd-b969-60ad3dd28d18"
      unitRef="usd">3000</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity
      contextRef="ib9ab9bb551934102bae2904f11a4da20_I20220630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmFlNWE5YmUwZWI5NDQ1ZDE5MmZhZTgyMmQyMmJlMDlmL3NlYzphZTVhOWJlMGViOTQ0NWQxOTJmYWU4MjJkMjJiZTA5Zl8yOC9mcmFnOmU0Nzg5YmZkNzY5YTRjYzc4NjI0YWU3MmUwNTE0OGM5L3RhYmxlOmQ4ZjY5OTZmZjM0ZDRlNGNiMmI2MjY3NTBkYTMxYTFiL3RhYmxlcmFuZ2U6ZDhmNjk5NmZmMzRkNGU0Y2IyYjYyNjc1MGRhMzFhMWJfMTktNS0xLTEtNjI2_9d91497b-79b9-44e2-81f9-cda15137e767"
      unitRef="usd">445491000</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity
      contextRef="i85b53adede47405198bcfa9202c16b00_I20220630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmFlNWE5YmUwZWI5NDQ1ZDE5MmZhZTgyMmQyMmJlMDlmL3NlYzphZTVhOWJlMGViOTQ0NWQxOTJmYWU4MjJkMjJiZTA5Zl8yOC9mcmFnOmU0Nzg5YmZkNzY5YTRjYzc4NjI0YWU3MmUwNTE0OGM5L3RhYmxlOmQ4ZjY5OTZmZjM0ZDRlNGNiMmI2MjY3NTBkYTMxYTFiL3RhYmxlcmFuZ2U6ZDhmNjk5NmZmMzRkNGU0Y2IyYjYyNjc1MGRhMzFhMWJfMTktNy0xLTEtNjI2_5307b018-2412-4acf-a052-a148babceb34"
      unitRef="usd">-865000</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity
      contextRef="i506a0b63797b4ba099490022c868c239_I20220630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmFlNWE5YmUwZWI5NDQ1ZDE5MmZhZTgyMmQyMmJlMDlmL3NlYzphZTVhOWJlMGViOTQ0NWQxOTJmYWU4MjJkMjJiZTA5Zl8yOC9mcmFnOmU0Nzg5YmZkNzY5YTRjYzc4NjI0YWU3MmUwNTE0OGM5L3RhYmxlOmQ4ZjY5OTZmZjM0ZDRlNGNiMmI2MjY3NTBkYTMxYTFiL3RhYmxlcmFuZ2U6ZDhmNjk5NmZmMzRkNGU0Y2IyYjYyNjc1MGRhMzFhMWJfMTktOS0xLTEtNjI2_5f4b4ad3-8bd8-4fb4-a875-855b0bdc3be1"
      unitRef="usd">-266052000</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity
      contextRef="i4c8f247d12134a9886d56e1c8b024425_I20220630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmFlNWE5YmUwZWI5NDQ1ZDE5MmZhZTgyMmQyMmJlMDlmL3NlYzphZTVhOWJlMGViOTQ0NWQxOTJmYWU4MjJkMjJiZTA5Zl8yOC9mcmFnOmU0Nzg5YmZkNzY5YTRjYzc4NjI0YWU3MmUwNTE0OGM5L3RhYmxlOmQ4ZjY5OTZmZjM0ZDRlNGNiMmI2MjY3NTBkYTMxYTFiL3RhYmxlcmFuZ2U6ZDhmNjk5NmZmMzRkNGU0Y2IyYjYyNjc1MGRhMzFhMWJfMTktMTEtMS0xLTYyNg_0c403391-bf80-4b67-8145-b48687c57a70"
      unitRef="usd">178577000</us-gaap:StockholdersEquity>
    <us-gaap:SharesOutstanding
      contextRef="idf41ea014db640f1a2c27c2a769a0f37_I20201231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmFlNWE5YmUwZWI5NDQ1ZDE5MmZhZTgyMmQyMmJlMDlmL3NlYzphZTVhOWJlMGViOTQ0NWQxOTJmYWU4MjJkMjJiZTA5Zl8yNS9mcmFnOjc2OWUyMzYyMzg3ZDQ5ZjA4NjU3M2M0YjQ1YWYzMTUyL3RhYmxlOmZiYzA0OWQ5ZjcyZDQxYzRiN2UyZjVlYTZiNzIyZTdkL3RhYmxlcmFuZ2U6ZmJjMDQ5ZDlmNzJkNDFjNGI3ZTJmNWVhNmI3MjJlN2RfMi0xNi0xLTEtNjI2_09c21b1f-6b60-4936-b5ff-08316b865f56"
      unitRef="shares">20740413</us-gaap:SharesOutstanding>
    <us-gaap:StockholdersEquity
      contextRef="idf41ea014db640f1a2c27c2a769a0f37_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmFlNWE5YmUwZWI5NDQ1ZDE5MmZhZTgyMmQyMmJlMDlmL3NlYzphZTVhOWJlMGViOTQ0NWQxOTJmYWU4MjJkMjJiZTA5Zl8yNS9mcmFnOjc2OWUyMzYyMzg3ZDQ5ZjA4NjU3M2M0YjQ1YWYzMTUyL3RhYmxlOmZiYzA0OWQ5ZjcyZDQxYzRiN2UyZjVlYTZiNzIyZTdkL3RhYmxlcmFuZ2U6ZmJjMDQ5ZDlmNzJkNDFjNGI3ZTJmNWVhNmI3MjJlN2RfMi0xOC0xLTEtNjI2_6501814a-5a2e-40b7-8b11-b5bfff9b7835"
      unitRef="usd">2000</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity
      contextRef="i770f7a8689db49a0b1de542ddda20759_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmFlNWE5YmUwZWI5NDQ1ZDE5MmZhZTgyMmQyMmJlMDlmL3NlYzphZTVhOWJlMGViOTQ0NWQxOTJmYWU4MjJkMjJiZTA5Zl8yNS9mcmFnOjc2OWUyMzYyMzg3ZDQ5ZjA4NjU3M2M0YjQ1YWYzMTUyL3RhYmxlOmZiYzA0OWQ5ZjcyZDQxYzRiN2UyZjVlYTZiNzIyZTdkL3RhYmxlcmFuZ2U6ZmJjMDQ5ZDlmNzJkNDFjNGI3ZTJmNWVhNmI3MjJlN2RfMi0yMC0xLTEtNjI2_07f1b3ee-b162-4320-877b-2ee384ce27e0"
      unitRef="usd">189868000</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity
      contextRef="i5a3aac1f37e54bf194da81ac901f5ea9_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmFlNWE5YmUwZWI5NDQ1ZDE5MmZhZTgyMmQyMmJlMDlmL3NlYzphZTVhOWJlMGViOTQ0NWQxOTJmYWU4MjJkMjJiZTA5Zl8yNS9mcmFnOjc2OWUyMzYyMzg3ZDQ5ZjA4NjU3M2M0YjQ1YWYzMTUyL3RhYmxlOmZiYzA0OWQ5ZjcyZDQxYzRiN2UyZjVlYTZiNzIyZTdkL3RhYmxlcmFuZ2U6ZmJjMDQ5ZDlmNzJkNDFjNGI3ZTJmNWVhNmI3MjJlN2RfMi04LTEtMS0xMTM5_e8d735e4-5532-4b29-83e8-ce055a625779"
      unitRef="usd">-1000</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity
      contextRef="i8c8de78a03884c5eb87d8bfff7cb6c1c_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmFlNWE5YmUwZWI5NDQ1ZDE5MmZhZTgyMmQyMmJlMDlmL3NlYzphZTVhOWJlMGViOTQ0NWQxOTJmYWU4MjJkMjJiZTA5Zl8yNS9mcmFnOjc2OWUyMzYyMzg3ZDQ5ZjA4NjU3M2M0YjQ1YWYzMTUyL3RhYmxlOmZiYzA0OWQ5ZjcyZDQxYzRiN2UyZjVlYTZiNzIyZTdkL3RhYmxlcmFuZ2U6ZmJjMDQ5ZDlmNzJkNDFjNGI3ZTJmNWVhNmI3MjJlN2RfMi0yMi0xLTEtNjI2_cd33b0ac-5a28-47ea-ad99-454da022cf91"
      unitRef="usd">-128029000</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity
      contextRef="i299927d2cdfe46deaac8ee64dc7dce6c_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmFlNWE5YmUwZWI5NDQ1ZDE5MmZhZTgyMmQyMmJlMDlmL3NlYzphZTVhOWJlMGViOTQ0NWQxOTJmYWU4MjJkMjJiZTA5Zl8yNS9mcmFnOjc2OWUyMzYyMzg3ZDQ5ZjA4NjU3M2M0YjQ1YWYzMTUyL3RhYmxlOmZiYzA0OWQ5ZjcyZDQxYzRiN2UyZjVlYTZiNzIyZTdkL3RhYmxlcmFuZ2U6ZmJjMDQ5ZDlmNzJkNDFjNGI3ZTJmNWVhNmI3MjJlN2RfMi0yNC0xLTEtNjI2_f35ef9e2-59e1-42b1-a708-c855c30b0c38"
      unitRef="usd">61840000</us-gaap:StockholdersEquity>
    <us-gaap:SharesIssuedPricePerShare
      contextRef="i9765c83c10a4499099d3ccc0868af9be_I20210331"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOmFlNWE5YmUwZWI5NDQ1ZDE5MmZhZTgyMmQyMmJlMDlmL3NlYzphZTVhOWJlMGViOTQ0NWQxOTJmYWU4MjJkMjJiZTA5Zl8yNS9mcmFnOjc2OWUyMzYyMzg3ZDQ5ZjA4NjU3M2M0YjQ1YWYzMTUyL3RhYmxlOmZiYzA0OWQ5ZjcyZDQxYzRiN2UyZjVlYTZiNzIyZTdkL3RhYmxlcmFuZ2U6ZmJjMDQ5ZDlmNzJkNDFjNGI3ZTJmNWVhNmI3MjJlN2RfMy0wLTEtMS02MjYvdGV4dHJlZ2lvbjo0OTU0NWI1YTQ2NjQ0NzAwYjI2MzUzN2YyMTdjZTMxM18zMg_e4109401-af0d-4b0d-9af2-3c49553a14ac"
      unitRef="usdPerShare">29.50</us-gaap:SharesIssuedPricePerShare>
    <us-gaap:AdjustmentsToAdditionalPaidInCapitalStockIssuedIssuanceCosts
      contextRef="i936fe08107a14d5c927b5fa13e2af2c5_D20210101-20210331"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmFlNWE5YmUwZWI5NDQ1ZDE5MmZhZTgyMmQyMmJlMDlmL3NlYzphZTVhOWJlMGViOTQ0NWQxOTJmYWU4MjJkMjJiZTA5Zl8yNS9mcmFnOjc2OWUyMzYyMzg3ZDQ5ZjA4NjU3M2M0YjQ1YWYzMTUyL3RhYmxlOmZiYzA0OWQ5ZjcyZDQxYzRiN2UyZjVlYTZiNzIyZTdkL3RhYmxlcmFuZ2U6ZmJjMDQ5ZDlmNzJkNDFjNGI3ZTJmNWVhNmI3MjJlN2RfMy0wLTEtMS02MjYvdGV4dHJlZ2lvbjo0OTU0NWI1YTQ2NjQ0NzAwYjI2MzUzN2YyMTdjZTMxM181Mw_833ef748-35fe-4d37-9323-db0d1487b95a"
      unitRef="usd">9100000</us-gaap:AdjustmentsToAdditionalPaidInCapitalStockIssuedIssuanceCosts>
    <us-gaap:StockIssuedDuringPeriodSharesNewIssues
      contextRef="i936fe08107a14d5c927b5fa13e2af2c5_D20210101-20210331"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmFlNWE5YmUwZWI5NDQ1ZDE5MmZhZTgyMmQyMmJlMDlmL3NlYzphZTVhOWJlMGViOTQ0NWQxOTJmYWU4MjJkMjJiZTA5Zl8yNS9mcmFnOjc2OWUyMzYyMzg3ZDQ5ZjA4NjU3M2M0YjQ1YWYzMTUyL3RhYmxlOmZiYzA0OWQ5ZjcyZDQxYzRiN2UyZjVlYTZiNzIyZTdkL3RhYmxlcmFuZ2U6ZmJjMDQ5ZDlmNzJkNDFjNGI3ZTJmNWVhNmI3MjJlN2RfMy0xNi0xLTEtNjI2_306aa494-aad1-4b7f-a835-f97921c93290"
      unitRef="shares">4872881</us-gaap:StockIssuedDuringPeriodSharesNewIssues>
    <us-gaap:StockIssuedDuringPeriodValueNewIssues
      contextRef="i936fe08107a14d5c927b5fa13e2af2c5_D20210101-20210331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmFlNWE5YmUwZWI5NDQ1ZDE5MmZhZTgyMmQyMmJlMDlmL3NlYzphZTVhOWJlMGViOTQ0NWQxOTJmYWU4MjJkMjJiZTA5Zl8yNS9mcmFnOjc2OWUyMzYyMzg3ZDQ5ZjA4NjU3M2M0YjQ1YWYzMTUyL3RhYmxlOmZiYzA0OWQ5ZjcyZDQxYzRiN2UyZjVlYTZiNzIyZTdkL3RhYmxlcmFuZ2U6ZmJjMDQ5ZDlmNzJkNDFjNGI3ZTJmNWVhNmI3MjJlN2RfMy0xOC0xLTEtNjI2_0f1fe65f-4eb0-47ff-a708-ecc769b18b32"
      unitRef="usd">1000</us-gaap:StockIssuedDuringPeriodValueNewIssues>
    <us-gaap:StockIssuedDuringPeriodValueNewIssues
      contextRef="i3f5ee0c6315d458da591b98ccf0afb7c_D20210101-20210331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmFlNWE5YmUwZWI5NDQ1ZDE5MmZhZTgyMmQyMmJlMDlmL3NlYzphZTVhOWJlMGViOTQ0NWQxOTJmYWU4MjJkMjJiZTA5Zl8yNS9mcmFnOjc2OWUyMzYyMzg3ZDQ5ZjA4NjU3M2M0YjQ1YWYzMTUyL3RhYmxlOmZiYzA0OWQ5ZjcyZDQxYzRiN2UyZjVlYTZiNzIyZTdkL3RhYmxlcmFuZ2U6ZmJjMDQ5ZDlmNzJkNDFjNGI3ZTJmNWVhNmI3MjJlN2RfMy0yMC0xLTEtNjI2_95b95270-f727-4b76-855e-69620503169f"
      unitRef="usd">134581000</us-gaap:StockIssuedDuringPeriodValueNewIssues>
    <us-gaap:StockIssuedDuringPeriodValueNewIssues
      contextRef="icf9848cee57f48e1abdd659c090042db_D20210101-20210331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmFlNWE5YmUwZWI5NDQ1ZDE5MmZhZTgyMmQyMmJlMDlmL3NlYzphZTVhOWJlMGViOTQ0NWQxOTJmYWU4MjJkMjJiZTA5Zl8yNS9mcmFnOjc2OWUyMzYyMzg3ZDQ5ZjA4NjU3M2M0YjQ1YWYzMTUyL3RhYmxlOmZiYzA0OWQ5ZjcyZDQxYzRiN2UyZjVlYTZiNzIyZTdkL3RhYmxlcmFuZ2U6ZmJjMDQ5ZDlmNzJkNDFjNGI3ZTJmNWVhNmI3MjJlN2RfMy0yNC0xLTEtNjI2_d6c8cbb9-fe36-46bf-8bc4-ee068832088a"
      unitRef="usd">134582000</us-gaap:StockIssuedDuringPeriodValueNewIssues>
    <dmtk:StockIssuedDuringPeriodSharesStockOptionsExercisedAndRSURelease
      contextRef="i936fe08107a14d5c927b5fa13e2af2c5_D20210101-20210331"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmFlNWE5YmUwZWI5NDQ1ZDE5MmZhZTgyMmQyMmJlMDlmL3NlYzphZTVhOWJlMGViOTQ0NWQxOTJmYWU4MjJkMjJiZTA5Zl8yNS9mcmFnOjc2OWUyMzYyMzg3ZDQ5ZjA4NjU3M2M0YjQ1YWYzMTUyL3RhYmxlOmZiYzA0OWQ5ZjcyZDQxYzRiN2UyZjVlYTZiNzIyZTdkL3RhYmxlcmFuZ2U6ZmJjMDQ5ZDlmNzJkNDFjNGI3ZTJmNWVhNmI3MjJlN2RfNi0xNi0xLTEtNjI2_995128ea-49ff-421f-8d3e-58ca5ad951d3"
      unitRef="shares">176673</dmtk:StockIssuedDuringPeriodSharesStockOptionsExercisedAndRSURelease>
    <dmtk:StockIssuedDuringPeriodValueStockOptionsExercisedAndRSURelease
      contextRef="i3f5ee0c6315d458da591b98ccf0afb7c_D20210101-20210331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmFlNWE5YmUwZWI5NDQ1ZDE5MmZhZTgyMmQyMmJlMDlmL3NlYzphZTVhOWJlMGViOTQ0NWQxOTJmYWU4MjJkMjJiZTA5Zl8yNS9mcmFnOjc2OWUyMzYyMzg3ZDQ5ZjA4NjU3M2M0YjQ1YWYzMTUyL3RhYmxlOmZiYzA0OWQ5ZjcyZDQxYzRiN2UyZjVlYTZiNzIyZTdkL3RhYmxlcmFuZ2U6ZmJjMDQ5ZDlmNzJkNDFjNGI3ZTJmNWVhNmI3MjJlN2RfNi0yMC0xLTEtNjI2_9581560d-3d75-4308-93db-ec9a10254dd1"
      unitRef="usd">408000</dmtk:StockIssuedDuringPeriodValueStockOptionsExercisedAndRSURelease>
    <dmtk:StockIssuedDuringPeriodValueStockOptionsExercisedAndRSURelease
      contextRef="icf9848cee57f48e1abdd659c090042db_D20210101-20210331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmFlNWE5YmUwZWI5NDQ1ZDE5MmZhZTgyMmQyMmJlMDlmL3NlYzphZTVhOWJlMGViOTQ0NWQxOTJmYWU4MjJkMjJiZTA5Zl8yNS9mcmFnOjc2OWUyMzYyMzg3ZDQ5ZjA4NjU3M2M0YjQ1YWYzMTUyL3RhYmxlOmZiYzA0OWQ5ZjcyZDQxYzRiN2UyZjVlYTZiNzIyZTdkL3RhYmxlcmFuZ2U6ZmJjMDQ5ZDlmNzJkNDFjNGI3ZTJmNWVhNmI3MjJlN2RfNi0yNC0xLTEtNjI2_9e4c47df-e147-4786-8795-5b20fff2c647"
      unitRef="usd">408000</dmtk:StockIssuedDuringPeriodValueStockOptionsExercisedAndRSURelease>
    <dmtk:AdjustmentsToAdditionalPaidInCapitalWarrantIssuedShares
      contextRef="i936fe08107a14d5c927b5fa13e2af2c5_D20210101-20210331"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmFlNWE5YmUwZWI5NDQ1ZDE5MmZhZTgyMmQyMmJlMDlmL3NlYzphZTVhOWJlMGViOTQ0NWQxOTJmYWU4MjJkMjJiZTA5Zl8yNS9mcmFnOjc2OWUyMzYyMzg3ZDQ5ZjA4NjU3M2M0YjQ1YWYzMTUyL3RhYmxlOmZiYzA0OWQ5ZjcyZDQxYzRiN2UyZjVlYTZiNzIyZTdkL3RhYmxlcmFuZ2U6ZmJjMDQ5ZDlmNzJkNDFjNGI3ZTJmNWVhNmI3MjJlN2RfNy0xNi0xLTEtNjI2_5af9a181-7386-4046-b5cb-75293ee821a0"
      unitRef="shares">3089325</dmtk:AdjustmentsToAdditionalPaidInCapitalWarrantIssuedShares>
    <us-gaap:AdjustmentsToAdditionalPaidInCapitalWarrantIssued
      contextRef="i3f5ee0c6315d458da591b98ccf0afb7c_D20210101-20210331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmFlNWE5YmUwZWI5NDQ1ZDE5MmZhZTgyMmQyMmJlMDlmL3NlYzphZTVhOWJlMGViOTQ0NWQxOTJmYWU4MjJkMjJiZTA5Zl8yNS9mcmFnOjc2OWUyMzYyMzg3ZDQ5ZjA4NjU3M2M0YjQ1YWYzMTUyL3RhYmxlOmZiYzA0OWQ5ZjcyZDQxYzRiN2UyZjVlYTZiNzIyZTdkL3RhYmxlcmFuZ2U6ZmJjMDQ5ZDlmNzJkNDFjNGI3ZTJmNWVhNmI3MjJlN2RfNy0yMC0xLTEtNjI2_a4a2797e-13e7-4ace-aec9-58d2ad48516b"
      unitRef="usd">72081000</us-gaap:AdjustmentsToAdditionalPaidInCapitalWarrantIssued>
    <us-gaap:AdjustmentsToAdditionalPaidInCapitalWarrantIssued
      contextRef="icf9848cee57f48e1abdd659c090042db_D20210101-20210331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmFlNWE5YmUwZWI5NDQ1ZDE5MmZhZTgyMmQyMmJlMDlmL3NlYzphZTVhOWJlMGViOTQ0NWQxOTJmYWU4MjJkMjJiZTA5Zl8yNS9mcmFnOjc2OWUyMzYyMzg3ZDQ5ZjA4NjU3M2M0YjQ1YWYzMTUyL3RhYmxlOmZiYzA0OWQ5ZjcyZDQxYzRiN2UyZjVlYTZiNzIyZTdkL3RhYmxlcmFuZ2U6ZmJjMDQ5ZDlmNzJkNDFjNGI3ZTJmNWVhNmI3MjJlN2RfNy0yNC0xLTEtNjI2_148f18c1-5b09-4a0f-a44c-1718f160d459"
      unitRef="usd">72081000</us-gaap:AdjustmentsToAdditionalPaidInCapitalWarrantIssued>
    <us-gaap:StockIssuedDuringPeriodSharesEmployeeStockPurchasePlans
      contextRef="i936fe08107a14d5c927b5fa13e2af2c5_D20210101-20210331"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmFlNWE5YmUwZWI5NDQ1ZDE5MmZhZTgyMmQyMmJlMDlmL3NlYzphZTVhOWJlMGViOTQ0NWQxOTJmYWU4MjJkMjJiZTA5Zl8yNS9mcmFnOjc2OWUyMzYyMzg3ZDQ5ZjA4NjU3M2M0YjQ1YWYzMTUyL3RhYmxlOmZiYzA0OWQ5ZjcyZDQxYzRiN2UyZjVlYTZiNzIyZTdkL3RhYmxlcmFuZ2U6ZmJjMDQ5ZDlmNzJkNDFjNGI3ZTJmNWVhNmI3MjJlN2RfOC0xNi0xLTEtNjI2_3e6b2aae-b41f-44cb-81a6-d8bf0de0f930"
      unitRef="shares">39960</us-gaap:StockIssuedDuringPeriodSharesEmployeeStockPurchasePlans>
    <us-gaap:StockIssuedDuringPeriodValueEmployeeStockPurchasePlan
      contextRef="i3f5ee0c6315d458da591b98ccf0afb7c_D20210101-20210331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmFlNWE5YmUwZWI5NDQ1ZDE5MmZhZTgyMmQyMmJlMDlmL3NlYzphZTVhOWJlMGViOTQ0NWQxOTJmYWU4MjJkMjJiZTA5Zl8yNS9mcmFnOjc2OWUyMzYyMzg3ZDQ5ZjA4NjU3M2M0YjQ1YWYzMTUyL3RhYmxlOmZiYzA0OWQ5ZjcyZDQxYzRiN2UyZjVlYTZiNzIyZTdkL3RhYmxlcmFuZ2U6ZmJjMDQ5ZDlmNzJkNDFjNGI3ZTJmNWVhNmI3MjJlN2RfOC0yMC0xLTEtNjI2_e59c7620-9fd9-4e89-8fc9-de2167a29b3f"
      unitRef="usd">392000</us-gaap:StockIssuedDuringPeriodValueEmployeeStockPurchasePlan>
    <us-gaap:StockIssuedDuringPeriodValueEmployeeStockPurchasePlan
      contextRef="icf9848cee57f48e1abdd659c090042db_D20210101-20210331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmFlNWE5YmUwZWI5NDQ1ZDE5MmZhZTgyMmQyMmJlMDlmL3NlYzphZTVhOWJlMGViOTQ0NWQxOTJmYWU4MjJkMjJiZTA5Zl8yNS9mcmFnOjc2OWUyMzYyMzg3ZDQ5ZjA4NjU3M2M0YjQ1YWYzMTUyL3RhYmxlOmZiYzA0OWQ5ZjcyZDQxYzRiN2UyZjVlYTZiNzIyZTdkL3RhYmxlcmFuZ2U6ZmJjMDQ5ZDlmNzJkNDFjNGI3ZTJmNWVhNmI3MjJlN2RfOC0yNC0xLTEtNjI2_0ec26110-97bb-4cc7-b56b-7a0301e9e242"
      unitRef="usd">392000</us-gaap:StockIssuedDuringPeriodValueEmployeeStockPurchasePlan>
    <us-gaap:OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax
      contextRef="i7ae4ca8a5bb543418bbae64ee99ea8fb_D20210101-20210331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmFlNWE5YmUwZWI5NDQ1ZDE5MmZhZTgyMmQyMmJlMDlmL3NlYzphZTVhOWJlMGViOTQ0NWQxOTJmYWU4MjJkMjJiZTA5Zl8yNS9mcmFnOjc2OWUyMzYyMzg3ZDQ5ZjA4NjU3M2M0YjQ1YWYzMTUyL3RhYmxlOmZiYzA0OWQ5ZjcyZDQxYzRiN2UyZjVlYTZiNzIyZTdkL3RhYmxlcmFuZ2U6ZmJjMDQ5ZDlmNzJkNDFjNGI3ZTJmNWVhNmI3MjJlN2RfNy04LTEtMS0xMTA3_73d42481-7443-4b86-a933-1e422c7eff6e"
      unitRef="usd">9000</us-gaap:OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax>
    <us-gaap:OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax
      contextRef="icf9848cee57f48e1abdd659c090042db_D20210101-20210331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmFlNWE5YmUwZWI5NDQ1ZDE5MmZhZTgyMmQyMmJlMDlmL3NlYzphZTVhOWJlMGViOTQ0NWQxOTJmYWU4MjJkMjJiZTA5Zl8yNS9mcmFnOjc2OWUyMzYyMzg3ZDQ5ZjA4NjU3M2M0YjQ1YWYzMTUyL3RhYmxlOmZiYzA0OWQ5ZjcyZDQxYzRiN2UyZjVlYTZiNzIyZTdkL3RhYmxlcmFuZ2U6ZmJjMDQ5ZDlmNzJkNDFjNGI3ZTJmNWVhNmI3MjJlN2RfNy0xMi0xLTEtMTEwNw_e1877e64-11ca-4065-a330-f599fc720bf9"
      unitRef="usd">9000</us-gaap:OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax>
    <us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
      contextRef="i3f5ee0c6315d458da591b98ccf0afb7c_D20210101-20210331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmFlNWE5YmUwZWI5NDQ1ZDE5MmZhZTgyMmQyMmJlMDlmL3NlYzphZTVhOWJlMGViOTQ0NWQxOTJmYWU4MjJkMjJiZTA5Zl8yNS9mcmFnOjc2OWUyMzYyMzg3ZDQ5ZjA4NjU3M2M0YjQ1YWYzMTUyL3RhYmxlOmZiYzA0OWQ5ZjcyZDQxYzRiN2UyZjVlYTZiNzIyZTdkL3RhYmxlcmFuZ2U6ZmJjMDQ5ZDlmNzJkNDFjNGI3ZTJmNWVhNmI3MjJlN2RfOS0yMC0xLTEtNjI2_3a6d8df2-a668-48d9-abac-a52afc5cbdf1"
      unitRef="usd">2172000</us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue>
    <us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
      contextRef="icf9848cee57f48e1abdd659c090042db_D20210101-20210331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmFlNWE5YmUwZWI5NDQ1ZDE5MmZhZTgyMmQyMmJlMDlmL3NlYzphZTVhOWJlMGViOTQ0NWQxOTJmYWU4MjJkMjJiZTA5Zl8yNS9mcmFnOjc2OWUyMzYyMzg3ZDQ5ZjA4NjU3M2M0YjQ1YWYzMTUyL3RhYmxlOmZiYzA0OWQ5ZjcyZDQxYzRiN2UyZjVlYTZiNzIyZTdkL3RhYmxlcmFuZ2U6ZmJjMDQ5ZDlmNzJkNDFjNGI3ZTJmNWVhNmI3MjJlN2RfOS0yNC0xLTEtNjI2_418c4467-5f35-4baf-971e-dd1a4b068a34"
      unitRef="usd">2172000</us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue>
    <dmtk:ReclassificationOfWarrantLiabilityDueToPrivateSPACWarrantsNotHeldByOriginalHolder
      contextRef="i3f5ee0c6315d458da591b98ccf0afb7c_D20210101-20210331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmFlNWE5YmUwZWI5NDQ1ZDE5MmZhZTgyMmQyMmJlMDlmL3NlYzphZTVhOWJlMGViOTQ0NWQxOTJmYWU4MjJkMjJiZTA5Zl8yNS9mcmFnOjc2OWUyMzYyMzg3ZDQ5ZjA4NjU3M2M0YjQ1YWYzMTUyL3RhYmxlOmZiYzA0OWQ5ZjcyZDQxYzRiN2UyZjVlYTZiNzIyZTdkL3RhYmxlcmFuZ2U6ZmJjMDQ5ZDlmNzJkNDFjNGI3ZTJmNWVhNmI3MjJlN2RfOS02LTEtMS0xMTI1_9c7e483a-572b-4c43-b8a7-9ed497dcc114"
      unitRef="usd">411000</dmtk:ReclassificationOfWarrantLiabilityDueToPrivateSPACWarrantsNotHeldByOriginalHolder>
    <dmtk:ReclassificationOfWarrantLiabilityDueToPrivateSPACWarrantsNotHeldByOriginalHolder
      contextRef="icf9848cee57f48e1abdd659c090042db_D20210101-20210331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmFlNWE5YmUwZWI5NDQ1ZDE5MmZhZTgyMmQyMmJlMDlmL3NlYzphZTVhOWJlMGViOTQ0NWQxOTJmYWU4MjJkMjJiZTA5Zl8yNS9mcmFnOjc2OWUyMzYyMzg3ZDQ5ZjA4NjU3M2M0YjQ1YWYzMTUyL3RhYmxlOmZiYzA0OWQ5ZjcyZDQxYzRiN2UyZjVlYTZiNzIyZTdkL3RhYmxlcmFuZ2U6ZmJjMDQ5ZDlmNzJkNDFjNGI3ZTJmNWVhNmI3MjJlN2RfOS0xMi0xLTEtMTEyNQ_5d490fc4-6af6-4ae9-b03f-2f1788a85d1e"
      unitRef="usd">411000</dmtk:ReclassificationOfWarrantLiabilityDueToPrivateSPACWarrantsNotHeldByOriginalHolder>
    <us-gaap:NetIncomeLoss
      contextRef="i7f3382225eda41b397ed5315a35090fd_D20210101-20210331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmFlNWE5YmUwZWI5NDQ1ZDE5MmZhZTgyMmQyMmJlMDlmL3NlYzphZTVhOWJlMGViOTQ0NWQxOTJmYWU4MjJkMjJiZTA5Zl8yNS9mcmFnOjc2OWUyMzYyMzg3ZDQ5ZjA4NjU3M2M0YjQ1YWYzMTUyL3RhYmxlOmZiYzA0OWQ5ZjcyZDQxYzRiN2UyZjVlYTZiNzIyZTdkL3RhYmxlcmFuZ2U6ZmJjMDQ5ZDlmNzJkNDFjNGI3ZTJmNWVhNmI3MjJlN2RfMTAtMjItMS0xLTYyNg_b35e62f7-cb71-4bd9-a538-894d9805bba7"
      unitRef="usd">-15068000</us-gaap:NetIncomeLoss>
    <us-gaap:NetIncomeLoss
      contextRef="icf9848cee57f48e1abdd659c090042db_D20210101-20210331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmFlNWE5YmUwZWI5NDQ1ZDE5MmZhZTgyMmQyMmJlMDlmL3NlYzphZTVhOWJlMGViOTQ0NWQxOTJmYWU4MjJkMjJiZTA5Zl8yNS9mcmFnOjc2OWUyMzYyMzg3ZDQ5ZjA4NjU3M2M0YjQ1YWYzMTUyL3RhYmxlOmZiYzA0OWQ5ZjcyZDQxYzRiN2UyZjVlYTZiNzIyZTdkL3RhYmxlcmFuZ2U6ZmJjMDQ5ZDlmNzJkNDFjNGI3ZTJmNWVhNmI3MjJlN2RfMTAtMjQtMS0xLTYyNg_2efafa4a-2c7b-4796-afb8-4c01c9b41ac3"
      unitRef="usd">-15068000</us-gaap:NetIncomeLoss>
    <us-gaap:SharesOutstanding
      contextRef="i9765c83c10a4499099d3ccc0868af9be_I20210331"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmFlNWE5YmUwZWI5NDQ1ZDE5MmZhZTgyMmQyMmJlMDlmL3NlYzphZTVhOWJlMGViOTQ0NWQxOTJmYWU4MjJkMjJiZTA5Zl8yNS9mcmFnOjc2OWUyMzYyMzg3ZDQ5ZjA4NjU3M2M0YjQ1YWYzMTUyL3RhYmxlOmZiYzA0OWQ5ZjcyZDQxYzRiN2UyZjVlYTZiNzIyZTdkL3RhYmxlcmFuZ2U6ZmJjMDQ5ZDlmNzJkNDFjNGI3ZTJmNWVhNmI3MjJlN2RfMTEtMTYtMS0xLTYyNg_1b8a3410-2932-4ef3-9ec0-7cba2a1b0167"
      unitRef="shares">28919252</us-gaap:SharesOutstanding>
    <us-gaap:StockholdersEquity
      contextRef="i9765c83c10a4499099d3ccc0868af9be_I20210331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmFlNWE5YmUwZWI5NDQ1ZDE5MmZhZTgyMmQyMmJlMDlmL3NlYzphZTVhOWJlMGViOTQ0NWQxOTJmYWU4MjJkMjJiZTA5Zl8yNS9mcmFnOjc2OWUyMzYyMzg3ZDQ5ZjA4NjU3M2M0YjQ1YWYzMTUyL3RhYmxlOmZiYzA0OWQ5ZjcyZDQxYzRiN2UyZjVlYTZiNzIyZTdkL3RhYmxlcmFuZ2U6ZmJjMDQ5ZDlmNzJkNDFjNGI3ZTJmNWVhNmI3MjJlN2RfMTEtMTgtMS0xLTYyNg_a678fe38-75ed-409c-a76b-914be63359f1"
      unitRef="usd">3000</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity
      contextRef="i7a5dc2cad8ab4a63b151726096e30d08_I20210331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmFlNWE5YmUwZWI5NDQ1ZDE5MmZhZTgyMmQyMmJlMDlmL3NlYzphZTVhOWJlMGViOTQ0NWQxOTJmYWU4MjJkMjJiZTA5Zl8yNS9mcmFnOjc2OWUyMzYyMzg3ZDQ5ZjA4NjU3M2M0YjQ1YWYzMTUyL3RhYmxlOmZiYzA0OWQ5ZjcyZDQxYzRiN2UyZjVlYTZiNzIyZTdkL3RhYmxlcmFuZ2U6ZmJjMDQ5ZDlmNzJkNDFjNGI3ZTJmNWVhNmI3MjJlN2RfMTEtMjAtMS0xLTYyNg_8440fdac-a437-4fe0-af59-c07345c334ce"
      unitRef="usd">399913000</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity
      contextRef="ib3a71fad6fed4582857b2c1740f068d3_I20210331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmFlNWE5YmUwZWI5NDQ1ZDE5MmZhZTgyMmQyMmJlMDlmL3NlYzphZTVhOWJlMGViOTQ0NWQxOTJmYWU4MjJkMjJiZTA5Zl8yNS9mcmFnOjc2OWUyMzYyMzg3ZDQ5ZjA4NjU3M2M0YjQ1YWYzMTUyL3RhYmxlOmZiYzA0OWQ5ZjcyZDQxYzRiN2UyZjVlYTZiNzIyZTdkL3RhYmxlcmFuZ2U6ZmJjMDQ5ZDlmNzJkNDFjNGI3ZTJmNWVhNmI3MjJlN2RfMTEtOC0xLTEtNjM5Ng_c1e3dc3e-6895-43a3-8517-05701b765814"
      unitRef="usd">8000</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity
      contextRef="i8a2b15e19ec44c569f05077b9a65f5bc_I20210331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmFlNWE5YmUwZWI5NDQ1ZDE5MmZhZTgyMmQyMmJlMDlmL3NlYzphZTVhOWJlMGViOTQ0NWQxOTJmYWU4MjJkMjJiZTA5Zl8yNS9mcmFnOjc2OWUyMzYyMzg3ZDQ5ZjA4NjU3M2M0YjQ1YWYzMTUyL3RhYmxlOmZiYzA0OWQ5ZjcyZDQxYzRiN2UyZjVlYTZiNzIyZTdkL3RhYmxlcmFuZ2U6ZmJjMDQ5ZDlmNzJkNDFjNGI3ZTJmNWVhNmI3MjJlN2RfMTEtMjItMS0xLTYyNg_998100b1-be6c-4ccb-8e02-6073989a48b7"
      unitRef="usd">-143097000</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity
      contextRef="i8003b21ff858443fa0b721090f35eb8c_I20210331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmFlNWE5YmUwZWI5NDQ1ZDE5MmZhZTgyMmQyMmJlMDlmL3NlYzphZTVhOWJlMGViOTQ0NWQxOTJmYWU4MjJkMjJiZTA5Zl8yNS9mcmFnOjc2OWUyMzYyMzg3ZDQ5ZjA4NjU3M2M0YjQ1YWYzMTUyL3RhYmxlOmZiYzA0OWQ5ZjcyZDQxYzRiN2UyZjVlYTZiNzIyZTdkL3RhYmxlcmFuZ2U6ZmJjMDQ5ZDlmNzJkNDFjNGI3ZTJmNWVhNmI3MjJlN2RfMTEtMjQtMS0xLTYyNg_e1cde9e2-b419-4b36-8516-4fa6ebc12a1c"
      unitRef="usd">256827000</us-gaap:StockholdersEquity>
    <dmtk:StockIssuedDuringPeriodSharesStockOptionsExercisedAndRSURelease
      contextRef="if87a65d6f2c04499a52e6465b24b991a_D20210401-20210630"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmFlNWE5YmUwZWI5NDQ1ZDE5MmZhZTgyMmQyMmJlMDlmL3NlYzphZTVhOWJlMGViOTQ0NWQxOTJmYWU4MjJkMjJiZTA5Zl8yNS9mcmFnOjc2OWUyMzYyMzg3ZDQ5ZjA4NjU3M2M0YjQ1YWYzMTUyL3RhYmxlOmZiYzA0OWQ5ZjcyZDQxYzRiN2UyZjVlYTZiNzIyZTdkL3RhYmxlcmFuZ2U6ZmJjMDQ5ZDlmNzJkNDFjNGI3ZTJmNWVhNmI3MjJlN2RfMTMtMTYtMS0xLTYyNg_3d2eb370-c3f2-4dfa-861f-6cbbc88e410e"
      unitRef="shares">157277</dmtk:StockIssuedDuringPeriodSharesStockOptionsExercisedAndRSURelease>
    <dmtk:StockIssuedDuringPeriodValueStockOptionsExercisedAndRSURelease
      contextRef="idd2a0e0d7f8047ff823261ca459e9548_D20210401-20210630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmFlNWE5YmUwZWI5NDQ1ZDE5MmZhZTgyMmQyMmJlMDlmL3NlYzphZTVhOWJlMGViOTQ0NWQxOTJmYWU4MjJkMjJiZTA5Zl8yNS9mcmFnOjc2OWUyMzYyMzg3ZDQ5ZjA4NjU3M2M0YjQ1YWYzMTUyL3RhYmxlOmZiYzA0OWQ5ZjcyZDQxYzRiN2UyZjVlYTZiNzIyZTdkL3RhYmxlcmFuZ2U6ZmJjMDQ5ZDlmNzJkNDFjNGI3ZTJmNWVhNmI3MjJlN2RfMTMtMjAtMS0xLTYyNg_976fec50-5ded-4211-9584-4e567ce77099"
      unitRef="usd">188000</dmtk:StockIssuedDuringPeriodValueStockOptionsExercisedAndRSURelease>
    <dmtk:StockIssuedDuringPeriodValueStockOptionsExercisedAndRSURelease
      contextRef="id7bb773872394047ba26aa8a7a0f4d56_D20210401-20210630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmFlNWE5YmUwZWI5NDQ1ZDE5MmZhZTgyMmQyMmJlMDlmL3NlYzphZTVhOWJlMGViOTQ0NWQxOTJmYWU4MjJkMjJiZTA5Zl8yNS9mcmFnOjc2OWUyMzYyMzg3ZDQ5ZjA4NjU3M2M0YjQ1YWYzMTUyL3RhYmxlOmZiYzA0OWQ5ZjcyZDQxYzRiN2UyZjVlYTZiNzIyZTdkL3RhYmxlcmFuZ2U6ZmJjMDQ5ZDlmNzJkNDFjNGI3ZTJmNWVhNmI3MjJlN2RfMTMtMjQtMS0xLTYyNg_ef462be1-a49b-4fbc-aeed-58501f2fb914"
      unitRef="usd">188000</dmtk:StockIssuedDuringPeriodValueStockOptionsExercisedAndRSURelease>
    <us-gaap:SharesIssuedPricePerShare
      contextRef="ibf2eeb1965ed4f85aabca9700183b6c8_I20210630"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOmFlNWE5YmUwZWI5NDQ1ZDE5MmZhZTgyMmQyMmJlMDlmL3NlYzphZTVhOWJlMGViOTQ0NWQxOTJmYWU4MjJkMjJiZTA5Zl8yNS9mcmFnOjc2OWUyMzYyMzg3ZDQ5ZjA4NjU3M2M0YjQ1YWYzMTUyL3RhYmxlOmZiYzA0OWQ5ZjcyZDQxYzRiN2UyZjVlYTZiNzIyZTdkL3RhYmxlcmFuZ2U6ZmJjMDQ5ZDlmNzJkNDFjNGI3ZTJmNWVhNmI3MjJlN2RfMTMtMC0xLTEtMTMwMS90ZXh0cmVnaW9uOjAzNDViMDBkM2QxZTQ0ODc5NzY2NTc4M2FmZTM4ZDA5XzU0OTc1NTgxNDA0Nw_532fc4fe-a77f-47ff-b9f6-dec3299a4563"
      unitRef="usdPerShare">46.33</us-gaap:SharesIssuedPricePerShare>
    <us-gaap:AdjustmentsToAdditionalPaidInCapitalStockIssuedIssuanceCosts
      contextRef="id7bb773872394047ba26aa8a7a0f4d56_D20210401-20210630"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmFlNWE5YmUwZWI5NDQ1ZDE5MmZhZTgyMmQyMmJlMDlmL3NlYzphZTVhOWJlMGViOTQ0NWQxOTJmYWU4MjJkMjJiZTA5Zl8yNS9mcmFnOjc2OWUyMzYyMzg3ZDQ5ZjA4NjU3M2M0YjQ1YWYzMTUyL3RhYmxlOmZiYzA0OWQ5ZjcyZDQxYzRiN2UyZjVlYTZiNzIyZTdkL3RhYmxlcmFuZ2U6ZmJjMDQ5ZDlmNzJkNDFjNGI3ZTJmNWVhNmI3MjJlN2RfMTMtMC0xLTEtMTMwMS90ZXh0cmVnaW9uOjAzNDViMDBkM2QxZTQ0ODc5NzY2NTc4M2FmZTM4ZDA5XzU0OTc1NTgxNDA3NQ_84e8a912-b100-4e21-8915-955428d2f5a0"
      unitRef="usd">700000</us-gaap:AdjustmentsToAdditionalPaidInCapitalStockIssuedIssuanceCosts>
    <us-gaap:StockIssuedDuringPeriodSharesNewIssues
      contextRef="if87a65d6f2c04499a52e6465b24b991a_D20210401-20210630"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmFlNWE5YmUwZWI5NDQ1ZDE5MmZhZTgyMmQyMmJlMDlmL3NlYzphZTVhOWJlMGViOTQ0NWQxOTJmYWU4MjJkMjJiZTA5Zl8yNS9mcmFnOjc2OWUyMzYyMzg3ZDQ5ZjA4NjU3M2M0YjQ1YWYzMTUyL3RhYmxlOmZiYzA0OWQ5ZjcyZDQxYzRiN2UyZjVlYTZiNzIyZTdkL3RhYmxlcmFuZ2U6ZmJjMDQ5ZDlmNzJkNDFjNGI3ZTJmNWVhNmI3MjJlN2RfMTMtMi0xLTEtMTM1NA_20621d98-a493-4007-a4c3-f4d0f8c819cb"
      unitRef="shares">530551</us-gaap:StockIssuedDuringPeriodSharesNewIssues>
    <us-gaap:StockIssuedDuringPeriodValueNewIssues
      contextRef="idd2a0e0d7f8047ff823261ca459e9548_D20210401-20210630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmFlNWE5YmUwZWI5NDQ1ZDE5MmZhZTgyMmQyMmJlMDlmL3NlYzphZTVhOWJlMGViOTQ0NWQxOTJmYWU4MjJkMjJiZTA5Zl8yNS9mcmFnOjc2OWUyMzYyMzg3ZDQ5ZjA4NjU3M2M0YjQ1YWYzMTUyL3RhYmxlOmZiYzA0OWQ5ZjcyZDQxYzRiN2UyZjVlYTZiNzIyZTdkL3RhYmxlcmFuZ2U6ZmJjMDQ5ZDlmNzJkNDFjNGI3ZTJmNWVhNmI3MjJlN2RfMTMtNi0xLTEtMTM1NA_a08e2c2e-6734-4140-be33-f1dc0992138f"
      unitRef="usd">23836000</us-gaap:StockIssuedDuringPeriodValueNewIssues>
    <us-gaap:StockIssuedDuringPeriodValueNewIssues
      contextRef="id7bb773872394047ba26aa8a7a0f4d56_D20210401-20210630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmFlNWE5YmUwZWI5NDQ1ZDE5MmZhZTgyMmQyMmJlMDlmL3NlYzphZTVhOWJlMGViOTQ0NWQxOTJmYWU4MjJkMjJiZTA5Zl8yNS9mcmFnOjc2OWUyMzYyMzg3ZDQ5ZjA4NjU3M2M0YjQ1YWYzMTUyL3RhYmxlOmZiYzA0OWQ5ZjcyZDQxYzRiN2UyZjVlYTZiNzIyZTdkL3RhYmxlcmFuZ2U6ZmJjMDQ5ZDlmNzJkNDFjNGI3ZTJmNWVhNmI3MjJlN2RfMTMtMTItMS0xLTYzOTY_a64cbe9b-9861-497d-843c-3e732ad42f10"
      unitRef="usd">23836000</us-gaap:StockIssuedDuringPeriodValueNewIssues>
    <dmtk:AdjustmentsToAdditionalPaidInCapitalWarrantIssuedShares
      contextRef="if87a65d6f2c04499a52e6465b24b991a_D20210401-20210630"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmFlNWE5YmUwZWI5NDQ1ZDE5MmZhZTgyMmQyMmJlMDlmL3NlYzphZTVhOWJlMGViOTQ0NWQxOTJmYWU4MjJkMjJiZTA5Zl8yNS9mcmFnOjc2OWUyMzYyMzg3ZDQ5ZjA4NjU3M2M0YjQ1YWYzMTUyL3RhYmxlOmZiYzA0OWQ5ZjcyZDQxYzRiN2UyZjVlYTZiNzIyZTdkL3RhYmxlcmFuZ2U6ZmJjMDQ5ZDlmNzJkNDFjNGI3ZTJmNWVhNmI3MjJlN2RfMTQtMTYtMS0xLTYyNg_0a66837d-898e-4517-9b6c-5dc23994c849"
      unitRef="shares">314</dmtk:AdjustmentsToAdditionalPaidInCapitalWarrantIssuedShares>
    <us-gaap:AdjustmentsToAdditionalPaidInCapitalWarrantIssued
      contextRef="idd2a0e0d7f8047ff823261ca459e9548_D20210401-20210630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmFlNWE5YmUwZWI5NDQ1ZDE5MmZhZTgyMmQyMmJlMDlmL3NlYzphZTVhOWJlMGViOTQ0NWQxOTJmYWU4MjJkMjJiZTA5Zl8yNS9mcmFnOjc2OWUyMzYyMzg3ZDQ5ZjA4NjU3M2M0YjQ1YWYzMTUyL3RhYmxlOmZiYzA0OWQ5ZjcyZDQxYzRiN2UyZjVlYTZiNzIyZTdkL3RhYmxlcmFuZ2U6ZmJjMDQ5ZDlmNzJkNDFjNGI3ZTJmNWVhNmI3MjJlN2RfMTQtMjAtMS0xLTYyNg_da5258fa-bf23-4409-bf06-d2dff13774ff"
      unitRef="usd">5000</us-gaap:AdjustmentsToAdditionalPaidInCapitalWarrantIssued>
    <us-gaap:AdjustmentsToAdditionalPaidInCapitalWarrantIssued
      contextRef="id7bb773872394047ba26aa8a7a0f4d56_D20210401-20210630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmFlNWE5YmUwZWI5NDQ1ZDE5MmZhZTgyMmQyMmJlMDlmL3NlYzphZTVhOWJlMGViOTQ0NWQxOTJmYWU4MjJkMjJiZTA5Zl8yNS9mcmFnOjc2OWUyMzYyMzg3ZDQ5ZjA4NjU3M2M0YjQ1YWYzMTUyL3RhYmxlOmZiYzA0OWQ5ZjcyZDQxYzRiN2UyZjVlYTZiNzIyZTdkL3RhYmxlcmFuZ2U6ZmJjMDQ5ZDlmNzJkNDFjNGI3ZTJmNWVhNmI3MjJlN2RfMTQtMjQtMS0xLTYyNg_5f34961f-aa1e-4c10-98f7-f51f7b99def9"
      unitRef="usd">5000</us-gaap:AdjustmentsToAdditionalPaidInCapitalWarrantIssued>
    <us-gaap:OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax
      contextRef="if148116e5f8f42ec91f0eb17fe3ed6f0_D20210401-20210630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmFlNWE5YmUwZWI5NDQ1ZDE5MmZhZTgyMmQyMmJlMDlmL3NlYzphZTVhOWJlMGViOTQ0NWQxOTJmYWU4MjJkMjJiZTA5Zl8yNS9mcmFnOjc2OWUyMzYyMzg3ZDQ5ZjA4NjU3M2M0YjQ1YWYzMTUyL3RhYmxlOmZiYzA0OWQ5ZjcyZDQxYzRiN2UyZjVlYTZiNzIyZTdkL3RhYmxlcmFuZ2U6ZmJjMDQ5ZDlmNzJkNDFjNGI3ZTJmNWVhNmI3MjJlN2RfMTQtOC0xLTEtMTI4OA_796184cb-b12c-4d78-b64a-2a05e440869a"
      unitRef="usd">-6000</us-gaap:OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax>
    <us-gaap:OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax
      contextRef="id7bb773872394047ba26aa8a7a0f4d56_D20210401-20210630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmFlNWE5YmUwZWI5NDQ1ZDE5MmZhZTgyMmQyMmJlMDlmL3NlYzphZTVhOWJlMGViOTQ0NWQxOTJmYWU4MjJkMjJiZTA5Zl8yNS9mcmFnOjc2OWUyMzYyMzg3ZDQ5ZjA4NjU3M2M0YjQ1YWYzMTUyL3RhYmxlOmZiYzA0OWQ5ZjcyZDQxYzRiN2UyZjVlYTZiNzIyZTdkL3RhYmxlcmFuZ2U6ZmJjMDQ5ZDlmNzJkNDFjNGI3ZTJmNWVhNmI3MjJlN2RfMTUtMjQtMS0xLTYyNg_c03bce47-58a0-429d-9015-ceb720245a70"
      unitRef="usd">-6000</us-gaap:OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax>
    <us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
      contextRef="idd2a0e0d7f8047ff823261ca459e9548_D20210401-20210630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmFlNWE5YmUwZWI5NDQ1ZDE5MmZhZTgyMmQyMmJlMDlmL3NlYzphZTVhOWJlMGViOTQ0NWQxOTJmYWU4MjJkMjJiZTA5Zl8yNS9mcmFnOjc2OWUyMzYyMzg3ZDQ5ZjA4NjU3M2M0YjQ1YWYzMTUyL3RhYmxlOmZiYzA0OWQ5ZjcyZDQxYzRiN2UyZjVlYTZiNzIyZTdkL3RhYmxlcmFuZ2U6ZmJjMDQ5ZDlmNzJkNDFjNGI3ZTJmNWVhNmI3MjJlN2RfMTYtMjAtMS0xLTYyNg_50b97f9b-4075-43ed-9e42-129ce10a1dfb"
      unitRef="usd">3538000</us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue>
    <us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
      contextRef="id7bb773872394047ba26aa8a7a0f4d56_D20210401-20210630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmFlNWE5YmUwZWI5NDQ1ZDE5MmZhZTgyMmQyMmJlMDlmL3NlYzphZTVhOWJlMGViOTQ0NWQxOTJmYWU4MjJkMjJiZTA5Zl8yNS9mcmFnOjc2OWUyMzYyMzg3ZDQ5ZjA4NjU3M2M0YjQ1YWYzMTUyL3RhYmxlOmZiYzA0OWQ5ZjcyZDQxYzRiN2UyZjVlYTZiNzIyZTdkL3RhYmxlcmFuZ2U6ZmJjMDQ5ZDlmNzJkNDFjNGI3ZTJmNWVhNmI3MjJlN2RfMTYtMjQtMS0xLTYyNg_04c0188a-7b89-40c2-9932-45ee043f03c3"
      unitRef="usd">3538000</us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue>
    <dmtk:ReclassificationOfWarrantLiabilityDueToPrivateSPACWarrantsNotHeldByOriginalHolder
      contextRef="id7bb773872394047ba26aa8a7a0f4d56_D20210401-20210630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmFlNWE5YmUwZWI5NDQ1ZDE5MmZhZTgyMmQyMmJlMDlmL3NlYzphZTVhOWJlMGViOTQ0NWQxOTJmYWU4MjJkMjJiZTA5Zl8yNS9mcmFnOjc2OWUyMzYyMzg3ZDQ5ZjA4NjU3M2M0YjQ1YWYzMTUyL3RhYmxlOmZiYzA0OWQ5ZjcyZDQxYzRiN2UyZjVlYTZiNzIyZTdkL3RhYmxlcmFuZ2U6ZmJjMDQ5ZDlmNzJkNDFjNGI3ZTJmNWVhNmI3MjJlN2RfMTYtNi0xLTEtMTI2Mg_a79a13d7-ac3f-46f1-99cb-53315b324bcb"
      unitRef="usd">23000</dmtk:ReclassificationOfWarrantLiabilityDueToPrivateSPACWarrantsNotHeldByOriginalHolder>
    <dmtk:ReclassificationOfWarrantLiabilityDueToPrivateSPACWarrantsNotHeldByOriginalHolder
      contextRef="id7bb773872394047ba26aa8a7a0f4d56_D20210401-20210630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmFlNWE5YmUwZWI5NDQ1ZDE5MmZhZTgyMmQyMmJlMDlmL3NlYzphZTVhOWJlMGViOTQ0NWQxOTJmYWU4MjJkMjJiZTA5Zl8yNS9mcmFnOjc2OWUyMzYyMzg3ZDQ5ZjA4NjU3M2M0YjQ1YWYzMTUyL3RhYmxlOmZiYzA0OWQ5ZjcyZDQxYzRiN2UyZjVlYTZiNzIyZTdkL3RhYmxlcmFuZ2U6ZmJjMDQ5ZDlmNzJkNDFjNGI3ZTJmNWVhNmI3MjJlN2RfMTctMTItMS0xLTYzOTY_95822698-75e6-49ae-8eca-5f6077b5ae72"
      unitRef="usd">23000</dmtk:ReclassificationOfWarrantLiabilityDueToPrivateSPACWarrantsNotHeldByOriginalHolder>
    <us-gaap:NetIncomeLoss
      contextRef="idc14b05f084b42dcbd02996ad7fb090f_D20210401-20210630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmFlNWE5YmUwZWI5NDQ1ZDE5MmZhZTgyMmQyMmJlMDlmL3NlYzphZTVhOWJlMGViOTQ0NWQxOTJmYWU4MjJkMjJiZTA5Zl8yNS9mcmFnOjc2OWUyMzYyMzg3ZDQ5ZjA4NjU3M2M0YjQ1YWYzMTUyL3RhYmxlOmZiYzA0OWQ5ZjcyZDQxYzRiN2UyZjVlYTZiNzIyZTdkL3RhYmxlcmFuZ2U6ZmJjMDQ5ZDlmNzJkNDFjNGI3ZTJmNWVhNmI3MjJlN2RfMTctMjItMS0xLTYyNg_06de5545-3f8c-4034-9aee-4b51f0d386d7"
      unitRef="usd">-17102000</us-gaap:NetIncomeLoss>
    <us-gaap:NetIncomeLoss
      contextRef="id7bb773872394047ba26aa8a7a0f4d56_D20210401-20210630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmFlNWE5YmUwZWI5NDQ1ZDE5MmZhZTgyMmQyMmJlMDlmL3NlYzphZTVhOWJlMGViOTQ0NWQxOTJmYWU4MjJkMjJiZTA5Zl8yNS9mcmFnOjc2OWUyMzYyMzg3ZDQ5ZjA4NjU3M2M0YjQ1YWYzMTUyL3RhYmxlOmZiYzA0OWQ5ZjcyZDQxYzRiN2UyZjVlYTZiNzIyZTdkL3RhYmxlcmFuZ2U6ZmJjMDQ5ZDlmNzJkNDFjNGI3ZTJmNWVhNmI3MjJlN2RfMTctMjQtMS0xLTYyNg_a4b4ef8c-e307-417b-a2f2-66f45fc4e74e"
      unitRef="usd">-17102000</us-gaap:NetIncomeLoss>
    <us-gaap:SharesOutstanding
      contextRef="i962e0f9643f54946bc90520b7ea86c76_I20210630"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmFlNWE5YmUwZWI5NDQ1ZDE5MmZhZTgyMmQyMmJlMDlmL3NlYzphZTVhOWJlMGViOTQ0NWQxOTJmYWU4MjJkMjJiZTA5Zl8yNS9mcmFnOjc2OWUyMzYyMzg3ZDQ5ZjA4NjU3M2M0YjQ1YWYzMTUyL3RhYmxlOmZiYzA0OWQ5ZjcyZDQxYzRiN2UyZjVlYTZiNzIyZTdkL3RhYmxlcmFuZ2U6ZmJjMDQ5ZDlmNzJkNDFjNGI3ZTJmNWVhNmI3MjJlN2RfMTgtMTYtMS0xLTYyNg_6349f5ca-6b3d-49ea-840b-079fddada0e2"
      unitRef="shares">29607394</us-gaap:SharesOutstanding>
    <us-gaap:StockholdersEquity
      contextRef="i962e0f9643f54946bc90520b7ea86c76_I20210630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmFlNWE5YmUwZWI5NDQ1ZDE5MmZhZTgyMmQyMmJlMDlmL3NlYzphZTVhOWJlMGViOTQ0NWQxOTJmYWU4MjJkMjJiZTA5Zl8yNS9mcmFnOjc2OWUyMzYyMzg3ZDQ5ZjA4NjU3M2M0YjQ1YWYzMTUyL3RhYmxlOmZiYzA0OWQ5ZjcyZDQxYzRiN2UyZjVlYTZiNzIyZTdkL3RhYmxlcmFuZ2U6ZmJjMDQ5ZDlmNzJkNDFjNGI3ZTJmNWVhNmI3MjJlN2RfMTgtMTgtMS0xLTYyNg_aab88af8-b247-4302-ae71-89332839626d"
      unitRef="usd">3000</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity
      contextRef="i53a3c2269f654f2fb4637cd7af974436_I20210630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmFlNWE5YmUwZWI5NDQ1ZDE5MmZhZTgyMmQyMmJlMDlmL3NlYzphZTVhOWJlMGViOTQ0NWQxOTJmYWU4MjJkMjJiZTA5Zl8yNS9mcmFnOjc2OWUyMzYyMzg3ZDQ5ZjA4NjU3M2M0YjQ1YWYzMTUyL3RhYmxlOmZiYzA0OWQ5ZjcyZDQxYzRiN2UyZjVlYTZiNzIyZTdkL3RhYmxlcmFuZ2U6ZmJjMDQ5ZDlmNzJkNDFjNGI3ZTJmNWVhNmI3MjJlN2RfMTgtMjAtMS0xLTYyNg_8fb2a3f6-0949-4399-a61e-972367bb4ccb"
      unitRef="usd">427503000</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity
      contextRef="i398f2a559ab64f81bd1a007c9fc04a0a_I20210630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmFlNWE5YmUwZWI5NDQ1ZDE5MmZhZTgyMmQyMmJlMDlmL3NlYzphZTVhOWJlMGViOTQ0NWQxOTJmYWU4MjJkMjJiZTA5Zl8yNS9mcmFnOjc2OWUyMzYyMzg3ZDQ5ZjA4NjU3M2M0YjQ1YWYzMTUyL3RhYmxlOmZiYzA0OWQ5ZjcyZDQxYzRiN2UyZjVlYTZiNzIyZTdkL3RhYmxlcmFuZ2U6ZmJjMDQ5ZDlmNzJkNDFjNGI3ZTJmNWVhNmI3MjJlN2RfMTktOC0xLTEtNjM5Ng_f5a97f8d-1e57-42bc-8e35-2ab412e5c98d"
      unitRef="usd">2000</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity
      contextRef="ice91fd1c5683472191e0ebaa1eed5a8a_I20210630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmFlNWE5YmUwZWI5NDQ1ZDE5MmZhZTgyMmQyMmJlMDlmL3NlYzphZTVhOWJlMGViOTQ0NWQxOTJmYWU4MjJkMjJiZTA5Zl8yNS9mcmFnOjc2OWUyMzYyMzg3ZDQ5ZjA4NjU3M2M0YjQ1YWYzMTUyL3RhYmxlOmZiYzA0OWQ5ZjcyZDQxYzRiN2UyZjVlYTZiNzIyZTdkL3RhYmxlcmFuZ2U6ZmJjMDQ5ZDlmNzJkNDFjNGI3ZTJmNWVhNmI3MjJlN2RfMTgtMjItMS0xLTYyNg_3697ec22-4ada-4b24-80bd-43b258574761"
      unitRef="usd">-160199000</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity
      contextRef="ie036f155bf0e43bd97ef05b5b46857eb_I20210630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmFlNWE5YmUwZWI5NDQ1ZDE5MmZhZTgyMmQyMmJlMDlmL3NlYzphZTVhOWJlMGViOTQ0NWQxOTJmYWU4MjJkMjJiZTA5Zl8yNS9mcmFnOjc2OWUyMzYyMzg3ZDQ5ZjA4NjU3M2M0YjQ1YWYzMTUyL3RhYmxlOmZiYzA0OWQ5ZjcyZDQxYzRiN2UyZjVlYTZiNzIyZTdkL3RhYmxlcmFuZ2U6ZmJjMDQ5ZDlmNzJkNDFjNGI3ZTJmNWVhNmI3MjJlN2RfMTgtMjQtMS0xLTYyNg_606548b4-39b4-4b44-9cee-a5ab2ede4ccf"
      unitRef="usd">267309000</us-gaap:StockholdersEquity>
    <us-gaap:ProfitLoss
      contextRef="ia855382ada1f4f28aa8ef6da692ff177_D20220101-20220630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmFlNWE5YmUwZWI5NDQ1ZDE5MmZhZTgyMmQyMmJlMDlmL3NlYzphZTVhOWJlMGViOTQ0NWQxOTJmYWU4MjJkMjJiZTA5Zl8zMS9mcmFnOmYxYWY1ZjE2MGM5YjRlYTdiNGQ5NDdjNTczMzZhM2ZkL3RhYmxlOjVkOTc3NDgxYzYzYTRlMzY5MWIwOGJkYWEwMTJmMThkL3RhYmxlcmFuZ2U6NWQ5Nzc0ODFjNjNhNGUzNjkxYjA4YmRhYTAxMmYxOGRfMy0xLTEtMS02MjY_00561008-9518-4a71-afcf-9c05f343993a"
      unitRef="usd">-59688000</us-gaap:ProfitLoss>
    <us-gaap:ProfitLoss
      contextRef="idaa4f31ca59a4a17a59c2580b97791ca_D20210101-20210630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmFlNWE5YmUwZWI5NDQ1ZDE5MmZhZTgyMmQyMmJlMDlmL3NlYzphZTVhOWJlMGViOTQ0NWQxOTJmYWU4MjJkMjJiZTA5Zl8zMS9mcmFnOmYxYWY1ZjE2MGM5YjRlYTdiNGQ5NDdjNTczMzZhM2ZkL3RhYmxlOjVkOTc3NDgxYzYzYTRlMzY5MWIwOGJkYWEwMTJmMThkL3RhYmxlcmFuZ2U6NWQ5Nzc0ODFjNjNhNGUzNjkxYjA4YmRhYTAxMmYxOGRfMy0zLTEtMS02MjY_d2560213-229a-4996-8d8e-5d5f87d52817"
      unitRef="usd">-32170000</us-gaap:ProfitLoss>
    <us-gaap:Depreciation
      contextRef="ia855382ada1f4f28aa8ef6da692ff177_D20220101-20220630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmFlNWE5YmUwZWI5NDQ1ZDE5MmZhZTgyMmQyMmJlMDlmL3NlYzphZTVhOWJlMGViOTQ0NWQxOTJmYWU4MjJkMjJiZTA5Zl8zMS9mcmFnOmYxYWY1ZjE2MGM5YjRlYTdiNGQ5NDdjNTczMzZhM2ZkL3RhYmxlOjVkOTc3NDgxYzYzYTRlMzY5MWIwOGJkYWEwMTJmMThkL3RhYmxlcmFuZ2U6NWQ5Nzc0ODFjNjNhNGUzNjkxYjA4YmRhYTAxMmYxOGRfNS0xLTEtMS02MjY_f7ed0a69-1026-4835-acaa-d34fcf55b96d"
      unitRef="usd">766000</us-gaap:Depreciation>
    <us-gaap:Depreciation
      contextRef="idaa4f31ca59a4a17a59c2580b97791ca_D20210101-20210630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmFlNWE5YmUwZWI5NDQ1ZDE5MmZhZTgyMmQyMmJlMDlmL3NlYzphZTVhOWJlMGViOTQ0NWQxOTJmYWU4MjJkMjJiZTA5Zl8zMS9mcmFnOmYxYWY1ZjE2MGM5YjRlYTdiNGQ5NDdjNTczMzZhM2ZkL3RhYmxlOjVkOTc3NDgxYzYzYTRlMzY5MWIwOGJkYWEwMTJmMThkL3RhYmxlcmFuZ2U6NWQ5Nzc0ODFjNjNhNGUzNjkxYjA4YmRhYTAxMmYxOGRfNS0zLTEtMS02MjY_958fa5c4-e7da-431b-bd09-167ab3098323"
      unitRef="usd">401000</us-gaap:Depreciation>
    <us-gaap:FairValueAdjustmentOfWarrants
      contextRef="ia855382ada1f4f28aa8ef6da692ff177_D20220101-20220630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmFlNWE5YmUwZWI5NDQ1ZDE5MmZhZTgyMmQyMmJlMDlmL3NlYzphZTVhOWJlMGViOTQ0NWQxOTJmYWU4MjJkMjJiZTA5Zl8zMS9mcmFnOmYxYWY1ZjE2MGM5YjRlYTdiNGQ5NDdjNTczMzZhM2ZkL3RhYmxlOjVkOTc3NDgxYzYzYTRlMzY5MWIwOGJkYWEwMTJmMThkL3RhYmxlcmFuZ2U6NWQ5Nzc0ODFjNjNhNGUzNjkxYjA4YmRhYTAxMmYxOGRfNi0xLTEtMS02MjY_f674e9fb-5b6f-4a0c-997f-4de101e6b525"
      unitRef="usd">-122000</us-gaap:FairValueAdjustmentOfWarrants>
    <us-gaap:FairValueAdjustmentOfWarrants
      contextRef="idaa4f31ca59a4a17a59c2580b97791ca_D20210101-20210630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmFlNWE5YmUwZWI5NDQ1ZDE5MmZhZTgyMmQyMmJlMDlmL3NlYzphZTVhOWJlMGViOTQ0NWQxOTJmYWU4MjJkMjJiZTA5Zl8zMS9mcmFnOmYxYWY1ZjE2MGM5YjRlYTdiNGQ5NDdjNTczMzZhM2ZkL3RhYmxlOjVkOTc3NDgxYzYzYTRlMzY5MWIwOGJkYWEwMTJmMThkL3RhYmxlcmFuZ2U6NWQ5Nzc0ODFjNjNhNGUzNjkxYjA4YmRhYTAxMmYxOGRfNi0zLTEtMS02MjY_3edb2a26-9283-4939-8577-749e21465783"
      unitRef="usd">1519000</us-gaap:FairValueAdjustmentOfWarrants>
    <us-gaap:OperatingLeaseRightOfUseAssetAmortizationExpense
      contextRef="ia855382ada1f4f28aa8ef6da692ff177_D20220101-20220630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmFlNWE5YmUwZWI5NDQ1ZDE5MmZhZTgyMmQyMmJlMDlmL3NlYzphZTVhOWJlMGViOTQ0NWQxOTJmYWU4MjJkMjJiZTA5Zl8zMS9mcmFnOmYxYWY1ZjE2MGM5YjRlYTdiNGQ5NDdjNTczMzZhM2ZkL3RhYmxlOjVkOTc3NDgxYzYzYTRlMzY5MWIwOGJkYWEwMTJmMThkL3RhYmxlcmFuZ2U6NWQ5Nzc0ODFjNjNhNGUzNjkxYjA4YmRhYTAxMmYxOGRfNy0xLTEtMS02MjY_1e4ae753-99fe-49a8-8afc-f713d4c8a544"
      unitRef="usd">1109000</us-gaap:OperatingLeaseRightOfUseAssetAmortizationExpense>
    <us-gaap:OperatingLeaseRightOfUseAssetAmortizationExpense
      contextRef="idaa4f31ca59a4a17a59c2580b97791ca_D20210101-20210630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmFlNWE5YmUwZWI5NDQ1ZDE5MmZhZTgyMmQyMmJlMDlmL3NlYzphZTVhOWJlMGViOTQ0NWQxOTJmYWU4MjJkMjJiZTA5Zl8zMS9mcmFnOmYxYWY1ZjE2MGM5YjRlYTdiNGQ5NDdjNTczMzZhM2ZkL3RhYmxlOjVkOTc3NDgxYzYzYTRlMzY5MWIwOGJkYWEwMTJmMThkL3RhYmxlcmFuZ2U6NWQ5Nzc0ODFjNjNhNGUzNjkxYjA4YmRhYTAxMmYxOGRfNy0zLTEtMS02MjY_2ec0e842-836d-4744-a26e-539bcc7fb1bb"
      unitRef="usd">582000</us-gaap:OperatingLeaseRightOfUseAssetAmortizationExpense>
    <us-gaap:ShareBasedCompensation
      contextRef="ia855382ada1f4f28aa8ef6da692ff177_D20220101-20220630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmFlNWE5YmUwZWI5NDQ1ZDE5MmZhZTgyMmQyMmJlMDlmL3NlYzphZTVhOWJlMGViOTQ0NWQxOTJmYWU4MjJkMjJiZTA5Zl8zMS9mcmFnOmYxYWY1ZjE2MGM5YjRlYTdiNGQ5NDdjNTczMzZhM2ZkL3RhYmxlOjVkOTc3NDgxYzYzYTRlMzY5MWIwOGJkYWEwMTJmMThkL3RhYmxlcmFuZ2U6NWQ5Nzc0ODFjNjNhNGUzNjkxYjA4YmRhYTAxMmYxOGRfOC0xLTEtMS02MjY_1f05403c-1b3c-4bcb-8e13-5a03805bdfff"
      unitRef="usd">8731000</us-gaap:ShareBasedCompensation>
    <us-gaap:ShareBasedCompensation
      contextRef="idaa4f31ca59a4a17a59c2580b97791ca_D20210101-20210630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmFlNWE5YmUwZWI5NDQ1ZDE5MmZhZTgyMmQyMmJlMDlmL3NlYzphZTVhOWJlMGViOTQ0NWQxOTJmYWU4MjJkMjJiZTA5Zl8zMS9mcmFnOmYxYWY1ZjE2MGM5YjRlYTdiNGQ5NDdjNTczMzZhM2ZkL3RhYmxlOjVkOTc3NDgxYzYzYTRlMzY5MWIwOGJkYWEwMTJmMThkL3RhYmxlcmFuZ2U6NWQ5Nzc0ODFjNjNhNGUzNjkxYjA4YmRhYTAxMmYxOGRfOC0zLTEtMS02MjY_fd4ff391-c54d-4791-8f25-32dde33823d1"
      unitRef="usd">5710000</us-gaap:ShareBasedCompensation>
    <us-gaap:AccretionAmortizationOfDiscountsAndPremiumsInvestments
      contextRef="ia855382ada1f4f28aa8ef6da692ff177_D20220101-20220630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmFlNWE5YmUwZWI5NDQ1ZDE5MmZhZTgyMmQyMmJlMDlmL3NlYzphZTVhOWJlMGViOTQ0NWQxOTJmYWU4MjJkMjJiZTA5Zl8zMS9mcmFnOmYxYWY1ZjE2MGM5YjRlYTdiNGQ5NDdjNTczMzZhM2ZkL3RhYmxlOjVkOTc3NDgxYzYzYTRlMzY5MWIwOGJkYWEwMTJmMThkL3RhYmxlcmFuZ2U6NWQ5Nzc0ODFjNjNhNGUzNjkxYjA4YmRhYTAxMmYxOGRfOS0xLTEtMS02MjY_1a7a22ae-3c5e-41d2-a849-6cc1b4d7b4a6"
      unitRef="usd">-283000</us-gaap:AccretionAmortizationOfDiscountsAndPremiumsInvestments>
    <us-gaap:AccretionAmortizationOfDiscountsAndPremiumsInvestments
      contextRef="idaa4f31ca59a4a17a59c2580b97791ca_D20210101-20210630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmFlNWE5YmUwZWI5NDQ1ZDE5MmZhZTgyMmQyMmJlMDlmL3NlYzphZTVhOWJlMGViOTQ0NWQxOTJmYWU4MjJkMjJiZTA5Zl8zMS9mcmFnOmYxYWY1ZjE2MGM5YjRlYTdiNGQ5NDdjNTczMzZhM2ZkL3RhYmxlOjVkOTc3NDgxYzYzYTRlMzY5MWIwOGJkYWEwMTJmMThkL3RhYmxlcmFuZ2U6NWQ5Nzc0ODFjNjNhNGUzNjkxYjA4YmRhYTAxMmYxOGRfOS0zLTEtMS02MjY_a5dce173-c772-4393-90f2-a22870422d64"
      unitRef="usd">-337000</us-gaap:AccretionAmortizationOfDiscountsAndPremiumsInvestments>
    <us-gaap:GainLossOnDispositionOfAssets1
      contextRef="ia855382ada1f4f28aa8ef6da692ff177_D20220101-20220630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmFlNWE5YmUwZWI5NDQ1ZDE5MmZhZTgyMmQyMmJlMDlmL3NlYzphZTVhOWJlMGViOTQ0NWQxOTJmYWU4MjJkMjJiZTA5Zl8zMS9mcmFnOmYxYWY1ZjE2MGM5YjRlYTdiNGQ5NDdjNTczMzZhM2ZkL3RhYmxlOjVkOTc3NDgxYzYzYTRlMzY5MWIwOGJkYWEwMTJmMThkL3RhYmxlcmFuZ2U6NWQ5Nzc0ODFjNjNhNGUzNjkxYjA4YmRhYTAxMmYxOGRfMTAtMS0xLTEtNjI2_be5ee68b-89ea-48e3-afb2-cca7bc5e98d5"
      unitRef="usd">-285000</us-gaap:GainLossOnDispositionOfAssets1>
    <us-gaap:GainLossOnDispositionOfAssets1
      contextRef="idaa4f31ca59a4a17a59c2580b97791ca_D20210101-20210630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmFlNWE5YmUwZWI5NDQ1ZDE5MmZhZTgyMmQyMmJlMDlmL3NlYzphZTVhOWJlMGViOTQ0NWQxOTJmYWU4MjJkMjJiZTA5Zl8zMS9mcmFnOmYxYWY1ZjE2MGM5YjRlYTdiNGQ5NDdjNTczMzZhM2ZkL3RhYmxlOjVkOTc3NDgxYzYzYTRlMzY5MWIwOGJkYWEwMTJmMThkL3RhYmxlcmFuZ2U6NWQ5Nzc0ODFjNjNhNGUzNjkxYjA4YmRhYTAxMmYxOGRfMTAtMy0xLTEtNjI2_23110378-5328-4de2-bee7-5d1a634e0a50"
      unitRef="usd">-13000</us-gaap:GainLossOnDispositionOfAssets1>
    <us-gaap:IncreaseDecreaseInAccountsReceivable
      contextRef="ia855382ada1f4f28aa8ef6da692ff177_D20220101-20220630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmFlNWE5YmUwZWI5NDQ1ZDE5MmZhZTgyMmQyMmJlMDlmL3NlYzphZTVhOWJlMGViOTQ0NWQxOTJmYWU4MjJkMjJiZTA5Zl8zMS9mcmFnOmYxYWY1ZjE2MGM5YjRlYTdiNGQ5NDdjNTczMzZhM2ZkL3RhYmxlOjVkOTc3NDgxYzYzYTRlMzY5MWIwOGJkYWEwMTJmMThkL3RhYmxlcmFuZ2U6NWQ5Nzc0ODFjNjNhNGUzNjkxYjA4YmRhYTAxMmYxOGRfMTItMS0xLTEtNjI2_0b9ac312-ed75-421a-aef8-398ffffadb0f"
      unitRef="usd">2115000</us-gaap:IncreaseDecreaseInAccountsReceivable>
    <us-gaap:IncreaseDecreaseInAccountsReceivable
      contextRef="idaa4f31ca59a4a17a59c2580b97791ca_D20210101-20210630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmFlNWE5YmUwZWI5NDQ1ZDE5MmZhZTgyMmQyMmJlMDlmL3NlYzphZTVhOWJlMGViOTQ0NWQxOTJmYWU4MjJkMjJiZTA5Zl8zMS9mcmFnOmYxYWY1ZjE2MGM5YjRlYTdiNGQ5NDdjNTczMzZhM2ZkL3RhYmxlOjVkOTc3NDgxYzYzYTRlMzY5MWIwOGJkYWEwMTJmMThkL3RhYmxlcmFuZ2U6NWQ5Nzc0ODFjNjNhNGUzNjkxYjA4YmRhYTAxMmYxOGRfMTItMy0xLTEtNjI2_fc3e78ec-b9ec-442b-b317-303d022c4959"
      unitRef="usd">705000</us-gaap:IncreaseDecreaseInAccountsReceivable>
    <us-gaap:IncreaseDecreaseInInventories
      contextRef="ia855382ada1f4f28aa8ef6da692ff177_D20220101-20220630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmFlNWE5YmUwZWI5NDQ1ZDE5MmZhZTgyMmQyMmJlMDlmL3NlYzphZTVhOWJlMGViOTQ0NWQxOTJmYWU4MjJkMjJiZTA5Zl8zMS9mcmFnOmYxYWY1ZjE2MGM5YjRlYTdiNGQ5NDdjNTczMzZhM2ZkL3RhYmxlOjVkOTc3NDgxYzYzYTRlMzY5MWIwOGJkYWEwMTJmMThkL3RhYmxlcmFuZ2U6NWQ5Nzc0ODFjNjNhNGUzNjkxYjA4YmRhYTAxMmYxOGRfMTMtMS0xLTEtNjI2_629b4878-9160-484f-af7f-99532d595bae"
      unitRef="usd">952000</us-gaap:IncreaseDecreaseInInventories>
    <us-gaap:IncreaseDecreaseInInventories
      contextRef="idaa4f31ca59a4a17a59c2580b97791ca_D20210101-20210630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmFlNWE5YmUwZWI5NDQ1ZDE5MmZhZTgyMmQyMmJlMDlmL3NlYzphZTVhOWJlMGViOTQ0NWQxOTJmYWU4MjJkMjJiZTA5Zl8zMS9mcmFnOmYxYWY1ZjE2MGM5YjRlYTdiNGQ5NDdjNTczMzZhM2ZkL3RhYmxlOjVkOTc3NDgxYzYzYTRlMzY5MWIwOGJkYWEwMTJmMThkL3RhYmxlcmFuZ2U6NWQ5Nzc0ODFjNjNhNGUzNjkxYjA4YmRhYTAxMmYxOGRfMTMtMy0xLTEtNjI2_1abab408-bf62-41db-9420-730fc7061e10"
      unitRef="usd">393000</us-gaap:IncreaseDecreaseInInventories>
    <us-gaap:IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets
      contextRef="ia855382ada1f4f28aa8ef6da692ff177_D20220101-20220630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmFlNWE5YmUwZWI5NDQ1ZDE5MmZhZTgyMmQyMmJlMDlmL3NlYzphZTVhOWJlMGViOTQ0NWQxOTJmYWU4MjJkMjJiZTA5Zl8zMS9mcmFnOmYxYWY1ZjE2MGM5YjRlYTdiNGQ5NDdjNTczMzZhM2ZkL3RhYmxlOjVkOTc3NDgxYzYzYTRlMzY5MWIwOGJkYWEwMTJmMThkL3RhYmxlcmFuZ2U6NWQ5Nzc0ODFjNjNhNGUzNjkxYjA4YmRhYTAxMmYxOGRfMTQtMS0xLTEtNjI2_1999a457-717b-4431-a4c1-5290f7f6869f"
      unitRef="usd">-483000</us-gaap:IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets>
    <us-gaap:IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets
      contextRef="idaa4f31ca59a4a17a59c2580b97791ca_D20210101-20210630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmFlNWE5YmUwZWI5NDQ1ZDE5MmZhZTgyMmQyMmJlMDlmL3NlYzphZTVhOWJlMGViOTQ0NWQxOTJmYWU4MjJkMjJiZTA5Zl8zMS9mcmFnOmYxYWY1ZjE2MGM5YjRlYTdiNGQ5NDdjNTczMzZhM2ZkL3RhYmxlOjVkOTc3NDgxYzYzYTRlMzY5MWIwOGJkYWEwMTJmMThkL3RhYmxlcmFuZ2U6NWQ5Nzc0ODFjNjNhNGUzNjkxYjA4YmRhYTAxMmYxOGRfMTQtMy0xLTEtNjI2_81ef1701-b22a-478c-8f14-54411879a52c"
      unitRef="usd">-152000</us-gaap:IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets>
    <us-gaap:IncreaseDecreaseInOperatingLeaseLiability
      contextRef="ia855382ada1f4f28aa8ef6da692ff177_D20220101-20220630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmFlNWE5YmUwZWI5NDQ1ZDE5MmZhZTgyMmQyMmJlMDlmL3NlYzphZTVhOWJlMGViOTQ0NWQxOTJmYWU4MjJkMjJiZTA5Zl8zMS9mcmFnOmYxYWY1ZjE2MGM5YjRlYTdiNGQ5NDdjNTczMzZhM2ZkL3RhYmxlOjVkOTc3NDgxYzYzYTRlMzY5MWIwOGJkYWEwMTJmMThkL3RhYmxlcmFuZ2U6NWQ5Nzc0ODFjNjNhNGUzNjkxYjA4YmRhYTAxMmYxOGRfMTUtMS0xLTEtNjI2_cf16c3e8-4850-4654-a207-fce87647728d"
      unitRef="usd">-654000</us-gaap:IncreaseDecreaseInOperatingLeaseLiability>
    <us-gaap:IncreaseDecreaseInOperatingLeaseLiability
      contextRef="idaa4f31ca59a4a17a59c2580b97791ca_D20210101-20210630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmFlNWE5YmUwZWI5NDQ1ZDE5MmZhZTgyMmQyMmJlMDlmL3NlYzphZTVhOWJlMGViOTQ0NWQxOTJmYWU4MjJkMjJiZTA5Zl8zMS9mcmFnOmYxYWY1ZjE2MGM5YjRlYTdiNGQ5NDdjNTczMzZhM2ZkL3RhYmxlOjVkOTc3NDgxYzYzYTRlMzY5MWIwOGJkYWEwMTJmMThkL3RhYmxlcmFuZ2U6NWQ5Nzc0ODFjNjNhNGUzNjkxYjA4YmRhYTAxMmYxOGRfMTUtMy0xLTEtNjI2_039de427-7866-46cb-82e8-b785649ed830"
      unitRef="usd">-328000</us-gaap:IncreaseDecreaseInOperatingLeaseLiability>
    <us-gaap:IncreaseDecreaseInAccountsPayableAndAccruedLiabilities
      contextRef="ia855382ada1f4f28aa8ef6da692ff177_D20220101-20220630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmFlNWE5YmUwZWI5NDQ1ZDE5MmZhZTgyMmQyMmJlMDlmL3NlYzphZTVhOWJlMGViOTQ0NWQxOTJmYWU4MjJkMjJiZTA5Zl8zMS9mcmFnOmYxYWY1ZjE2MGM5YjRlYTdiNGQ5NDdjNTczMzZhM2ZkL3RhYmxlOjVkOTc3NDgxYzYzYTRlMzY5MWIwOGJkYWEwMTJmMThkL3RhYmxlcmFuZ2U6NWQ5Nzc0ODFjNjNhNGUzNjkxYjA4YmRhYTAxMmYxOGRfMTYtMS0xLTEtNjI2_f978319e-f519-45e9-9512-ce6688724f11"
      unitRef="usd">-53000</us-gaap:IncreaseDecreaseInAccountsPayableAndAccruedLiabilities>
    <us-gaap:IncreaseDecreaseInAccountsPayableAndAccruedLiabilities
      contextRef="idaa4f31ca59a4a17a59c2580b97791ca_D20210101-20210630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmFlNWE5YmUwZWI5NDQ1ZDE5MmZhZTgyMmQyMmJlMDlmL3NlYzphZTVhOWJlMGViOTQ0NWQxOTJmYWU4MjJkMjJiZTA5Zl8zMS9mcmFnOmYxYWY1ZjE2MGM5YjRlYTdiNGQ5NDdjNTczMzZhM2ZkL3RhYmxlOjVkOTc3NDgxYzYzYTRlMzY5MWIwOGJkYWEwMTJmMThkL3RhYmxlcmFuZ2U6NWQ5Nzc0ODFjNjNhNGUzNjkxYjA4YmRhYTAxMmYxOGRfMTYtMy0xLTEtNjI2_e863bad4-a2fd-42ca-8842-ac79353f5b5d"
      unitRef="usd">263000</us-gaap:IncreaseDecreaseInAccountsPayableAndAccruedLiabilities>
    <us-gaap:IncreaseDecreaseInEmployeeRelatedLiabilities
      contextRef="ia855382ada1f4f28aa8ef6da692ff177_D20220101-20220630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmFlNWE5YmUwZWI5NDQ1ZDE5MmZhZTgyMmQyMmJlMDlmL3NlYzphZTVhOWJlMGViOTQ0NWQxOTJmYWU4MjJkMjJiZTA5Zl8zMS9mcmFnOmYxYWY1ZjE2MGM5YjRlYTdiNGQ5NDdjNTczMzZhM2ZkL3RhYmxlOjVkOTc3NDgxYzYzYTRlMzY5MWIwOGJkYWEwMTJmMThkL3RhYmxlcmFuZ2U6NWQ5Nzc0ODFjNjNhNGUzNjkxYjA4YmRhYTAxMmYxOGRfMTctMS0xLTEtNjI2_b18d28e3-a6df-4e31-809f-dbf44f3c92b3"
      unitRef="usd">2698000</us-gaap:IncreaseDecreaseInEmployeeRelatedLiabilities>
    <us-gaap:IncreaseDecreaseInEmployeeRelatedLiabilities
      contextRef="idaa4f31ca59a4a17a59c2580b97791ca_D20210101-20210630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmFlNWE5YmUwZWI5NDQ1ZDE5MmZhZTgyMmQyMmJlMDlmL3NlYzphZTVhOWJlMGViOTQ0NWQxOTJmYWU4MjJkMjJiZTA5Zl8zMS9mcmFnOmYxYWY1ZjE2MGM5YjRlYTdiNGQ5NDdjNTczMzZhM2ZkL3RhYmxlOjVkOTc3NDgxYzYzYTRlMzY5MWIwOGJkYWEwMTJmMThkL3RhYmxlcmFuZ2U6NWQ5Nzc0ODFjNjNhNGUzNjkxYjA4YmRhYTAxMmYxOGRfMTctMy0xLTEtNjI2_4bdfa11a-c280-4dcf-a1aa-0584b47a4cdf"
      unitRef="usd">1092000</us-gaap:IncreaseDecreaseInEmployeeRelatedLiabilities>
    <us-gaap:NetCashProvidedByUsedInOperatingActivities
      contextRef="ia855382ada1f4f28aa8ef6da692ff177_D20220101-20220630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmFlNWE5YmUwZWI5NDQ1ZDE5MmZhZTgyMmQyMmJlMDlmL3NlYzphZTVhOWJlMGViOTQ0NWQxOTJmYWU4MjJkMjJiZTA5Zl8zMS9mcmFnOmYxYWY1ZjE2MGM5YjRlYTdiNGQ5NDdjNTczMzZhM2ZkL3RhYmxlOjVkOTc3NDgxYzYzYTRlMzY5MWIwOGJkYWEwMTJmMThkL3RhYmxlcmFuZ2U6NWQ5Nzc0ODFjNjNhNGUzNjkxYjA4YmRhYTAxMmYxOGRfMTgtMS0xLTEtNjI2_580c64fe-6267-471e-9605-fa94154e26d2"
      unitRef="usd">-49229000</us-gaap:NetCashProvidedByUsedInOperatingActivities>
    <us-gaap:NetCashProvidedByUsedInOperatingActivities
      contextRef="idaa4f31ca59a4a17a59c2580b97791ca_D20210101-20210630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmFlNWE5YmUwZWI5NDQ1ZDE5MmZhZTgyMmQyMmJlMDlmL3NlYzphZTVhOWJlMGViOTQ0NWQxOTJmYWU4MjJkMjJiZTA5Zl8zMS9mcmFnOmYxYWY1ZjE2MGM5YjRlYTdiNGQ5NDdjNTczMzZhM2ZkL3RhYmxlOjVkOTc3NDgxYzYzYTRlMzY5MWIwOGJkYWEwMTJmMThkL3RhYmxlcmFuZ2U6NWQ5Nzc0ODFjNjNhNGUzNjkxYjA4YmRhYTAxMmYxOGRfMTgtMy0xLTEtNjI2_e2e6b5f4-6913-4b9d-9866-fc748766fb9e"
      unitRef="usd">-23527000</us-gaap:NetCashProvidedByUsedInOperatingActivities>
    <us-gaap:PaymentsToAcquireMarketableSecurities
      contextRef="ia855382ada1f4f28aa8ef6da692ff177_D20220101-20220630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmFlNWE5YmUwZWI5NDQ1ZDE5MmZhZTgyMmQyMmJlMDlmL3NlYzphZTVhOWJlMGViOTQ0NWQxOTJmYWU4MjJkMjJiZTA5Zl8zMS9mcmFnOmYxYWY1ZjE2MGM5YjRlYTdiNGQ5NDdjNTczMzZhM2ZkL3RhYmxlOjVkOTc3NDgxYzYzYTRlMzY5MWIwOGJkYWEwMTJmMThkL3RhYmxlcmFuZ2U6NWQ5Nzc0ODFjNjNhNGUzNjkxYjA4YmRhYTAxMmYxOGRfMjAtMS0xLTEtNjI2_98d380b9-2c09-41fb-8cf0-ac71ac6c3f8c"
      unitRef="usd">20171000</us-gaap:PaymentsToAcquireMarketableSecurities>
    <us-gaap:PaymentsToAcquireMarketableSecurities
      contextRef="idaa4f31ca59a4a17a59c2580b97791ca_D20210101-20210630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmFlNWE5YmUwZWI5NDQ1ZDE5MmZhZTgyMmQyMmJlMDlmL3NlYzphZTVhOWJlMGViOTQ0NWQxOTJmYWU4MjJkMjJiZTA5Zl8zMS9mcmFnOmYxYWY1ZjE2MGM5YjRlYTdiNGQ5NDdjNTczMzZhM2ZkL3RhYmxlOjVkOTc3NDgxYzYzYTRlMzY5MWIwOGJkYWEwMTJmMThkL3RhYmxlcmFuZ2U6NWQ5Nzc0ODFjNjNhNGUzNjkxYjA4YmRhYTAxMmYxOGRfMjAtMy0xLTEtNjI2_2091e497-eaba-4055-8f37-e97ab1b43339"
      unitRef="usd">4899000</us-gaap:PaymentsToAcquireMarketableSecurities>
    <dmtk:ProceedsFromMaturityOfMarketableSecurities
      contextRef="ia855382ada1f4f28aa8ef6da692ff177_D20220101-20220630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmFlNWE5YmUwZWI5NDQ1ZDE5MmZhZTgyMmQyMmJlMDlmL3NlYzphZTVhOWJlMGViOTQ0NWQxOTJmYWU4MjJkMjJiZTA5Zl8zMS9mcmFnOmYxYWY1ZjE2MGM5YjRlYTdiNGQ5NDdjNTczMzZhM2ZkL3RhYmxlOjVkOTc3NDgxYzYzYTRlMzY5MWIwOGJkYWEwMTJmMThkL3RhYmxlcmFuZ2U6NWQ5Nzc0ODFjNjNhNGUzNjkxYjA4YmRhYTAxMmYxOGRfMjItMS0xLTEtNjI2_b9920c23-29f9-42d8-890e-a32597c77018"
      unitRef="usd">14139000</dmtk:ProceedsFromMaturityOfMarketableSecurities>
    <dmtk:ProceedsFromMaturityOfMarketableSecurities
      contextRef="idaa4f31ca59a4a17a59c2580b97791ca_D20210101-20210630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmFlNWE5YmUwZWI5NDQ1ZDE5MmZhZTgyMmQyMmJlMDlmL3NlYzphZTVhOWJlMGViOTQ0NWQxOTJmYWU4MjJkMjJiZTA5Zl8zMS9mcmFnOmYxYWY1ZjE2MGM5YjRlYTdiNGQ5NDdjNTczMzZhM2ZkL3RhYmxlOjVkOTc3NDgxYzYzYTRlMzY5MWIwOGJkYWEwMTJmMThkL3RhYmxlcmFuZ2U6NWQ5Nzc0ODFjNjNhNGUzNjkxYjA4YmRhYTAxMmYxOGRfMjItMy0xLTEtNjI2_e68572d1-c3d1-43a2-8c17-a99ec34a830e"
      unitRef="usd">5450000</dmtk:ProceedsFromMaturityOfMarketableSecurities>
    <us-gaap:PaymentsToAcquirePropertyPlantAndEquipment
      contextRef="ia855382ada1f4f28aa8ef6da692ff177_D20220101-20220630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmFlNWE5YmUwZWI5NDQ1ZDE5MmZhZTgyMmQyMmJlMDlmL3NlYzphZTVhOWJlMGViOTQ0NWQxOTJmYWU4MjJkMjJiZTA5Zl8zMS9mcmFnOmYxYWY1ZjE2MGM5YjRlYTdiNGQ5NDdjNTczMzZhM2ZkL3RhYmxlOjVkOTc3NDgxYzYzYTRlMzY5MWIwOGJkYWEwMTJmMThkL3RhYmxlcmFuZ2U6NWQ5Nzc0ODFjNjNhNGUzNjkxYjA4YmRhYTAxMmYxOGRfMjMtMS0xLTEtNjI2_e51302df-83bc-4e61-8012-b0f399a38e36"
      unitRef="usd">1360000</us-gaap:PaymentsToAcquirePropertyPlantAndEquipment>
    <us-gaap:PaymentsToAcquirePropertyPlantAndEquipment
      contextRef="idaa4f31ca59a4a17a59c2580b97791ca_D20210101-20210630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmFlNWE5YmUwZWI5NDQ1ZDE5MmZhZTgyMmQyMmJlMDlmL3NlYzphZTVhOWJlMGViOTQ0NWQxOTJmYWU4MjJkMjJiZTA5Zl8zMS9mcmFnOmYxYWY1ZjE2MGM5YjRlYTdiNGQ5NDdjNTczMzZhM2ZkL3RhYmxlOjVkOTc3NDgxYzYzYTRlMzY5MWIwOGJkYWEwMTJmMThkL3RhYmxlcmFuZ2U6NWQ5Nzc0ODFjNjNhNGUzNjkxYjA4YmRhYTAxMmYxOGRfMjMtMy0xLTEtNjI2_01b5aa41-81fc-4120-a170-edd0c78e9074"
      unitRef="usd">944000</us-gaap:PaymentsToAcquirePropertyPlantAndEquipment>
    <us-gaap:NetCashProvidedByUsedInInvestingActivities
      contextRef="ia855382ada1f4f28aa8ef6da692ff177_D20220101-20220630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmFlNWE5YmUwZWI5NDQ1ZDE5MmZhZTgyMmQyMmJlMDlmL3NlYzphZTVhOWJlMGViOTQ0NWQxOTJmYWU4MjJkMjJiZTA5Zl8zMS9mcmFnOmYxYWY1ZjE2MGM5YjRlYTdiNGQ5NDdjNTczMzZhM2ZkL3RhYmxlOjVkOTc3NDgxYzYzYTRlMzY5MWIwOGJkYWEwMTJmMThkL3RhYmxlcmFuZ2U6NWQ5Nzc0ODFjNjNhNGUzNjkxYjA4YmRhYTAxMmYxOGRfMjQtMS0xLTEtNjI2_46a0624b-9f10-478c-ace1-cf03678553be"
      unitRef="usd">-7392000</us-gaap:NetCashProvidedByUsedInInvestingActivities>
    <us-gaap:NetCashProvidedByUsedInInvestingActivities
      contextRef="idaa4f31ca59a4a17a59c2580b97791ca_D20210101-20210630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmFlNWE5YmUwZWI5NDQ1ZDE5MmZhZTgyMmQyMmJlMDlmL3NlYzphZTVhOWJlMGViOTQ0NWQxOTJmYWU4MjJkMjJiZTA5Zl8zMS9mcmFnOmYxYWY1ZjE2MGM5YjRlYTdiNGQ5NDdjNTczMzZhM2ZkL3RhYmxlOjVkOTc3NDgxYzYzYTRlMzY5MWIwOGJkYWEwMTJmMThkL3RhYmxlcmFuZ2U6NWQ5Nzc0ODFjNjNhNGUzNjkxYjA4YmRhYTAxMmYxOGRfMjQtMy0xLTEtNjI2_504c9aa6-05e8-4b39-b017-3275406b8b44"
      unitRef="usd">-393000</us-gaap:NetCashProvidedByUsedInInvestingActivities>
    <us-gaap:ProceedsFromIssuanceOfCommonStock
      contextRef="iaa3380e4cf5a462aa71b09fba6701de9_D20220101-20220630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmFlNWE5YmUwZWI5NDQ1ZDE5MmZhZTgyMmQyMmJlMDlmL3NlYzphZTVhOWJlMGViOTQ0NWQxOTJmYWU4MjJkMjJiZTA5Zl8zMS9mcmFnOmYxYWY1ZjE2MGM5YjRlYTdiNGQ5NDdjNTczMzZhM2ZkL3RhYmxlOjVkOTc3NDgxYzYzYTRlMzY5MWIwOGJkYWEwMTJmMThkL3RhYmxlcmFuZ2U6NWQ5Nzc0ODFjNjNhNGUzNjkxYjA4YmRhYTAxMmYxOGRfMjctMS0xLTEtNjI2_21fee083-db75-401b-a995-fa0d0d0a609b"
      unitRef="usd">0</us-gaap:ProceedsFromIssuanceOfCommonStock>
    <us-gaap:ProceedsFromIssuanceOfCommonStock
      contextRef="ia87d864973504d67affd22c2a1bdc40c_D20210101-20210630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmFlNWE5YmUwZWI5NDQ1ZDE5MmZhZTgyMmQyMmJlMDlmL3NlYzphZTVhOWJlMGViOTQ0NWQxOTJmYWU4MjJkMjJiZTA5Zl8zMS9mcmFnOmYxYWY1ZjE2MGM5YjRlYTdiNGQ5NDdjNTczMzZhM2ZkL3RhYmxlOjVkOTc3NDgxYzYzYTRlMzY5MWIwOGJkYWEwMTJmMThkL3RhYmxlcmFuZ2U6NWQ5Nzc0ODFjNjNhNGUzNjkxYjA4YmRhYTAxMmYxOGRfMjctMy0xLTEtNjI2_97f42ccf-3a6e-4dad-bf23-a1ab202b5afd"
      unitRef="usd">134582000</us-gaap:ProceedsFromIssuanceOfCommonStock>
    <us-gaap:ProceedsFromIssuanceOfCommonStock
      contextRef="i1c2f494e495e4547bd1776a4d5cb5c64_D20220101-20220630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmFlNWE5YmUwZWI5NDQ1ZDE5MmZhZTgyMmQyMmJlMDlmL3NlYzphZTVhOWJlMGViOTQ0NWQxOTJmYWU4MjJkMjJiZTA5Zl8zMS9mcmFnOmYxYWY1ZjE2MGM5YjRlYTdiNGQ5NDdjNTczMzZhM2ZkL3RhYmxlOjVkOTc3NDgxYzYzYTRlMzY5MWIwOGJkYWEwMTJmMThkL3RhYmxlcmFuZ2U6NWQ5Nzc0ODFjNjNhNGUzNjkxYjA4YmRhYTAxMmYxOGRfMzEtMS0xLTEtNjI2_86348f2d-f9d1-4ed8-a7a2-4da2a5e2399e"
      unitRef="usd">0</us-gaap:ProceedsFromIssuanceOfCommonStock>
    <us-gaap:ProceedsFromIssuanceOfCommonStock
      contextRef="i07f957c639484f23a8527b87b9caff7d_D20210101-20210630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmFlNWE5YmUwZWI5NDQ1ZDE5MmZhZTgyMmQyMmJlMDlmL3NlYzphZTVhOWJlMGViOTQ0NWQxOTJmYWU4MjJkMjJiZTA5Zl8zMS9mcmFnOmYxYWY1ZjE2MGM5YjRlYTdiNGQ5NDdjNTczMzZhM2ZkL3RhYmxlOjVkOTc3NDgxYzYzYTRlMzY5MWIwOGJkYWEwMTJmMThkL3RhYmxlcmFuZ2U6NWQ5Nzc0ODFjNjNhNGUzNjkxYjA4YmRhYTAxMmYxOGRfMzEtMy0xLTEtNjI2_0e28697b-0bb5-4f95-880e-b4c2555a5d6e"
      unitRef="usd">23836000</us-gaap:ProceedsFromIssuanceOfCommonStock>
    <us-gaap:ProceedsFromWarrantExercises
      contextRef="ia855382ada1f4f28aa8ef6da692ff177_D20220101-20220630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmFlNWE5YmUwZWI5NDQ1ZDE5MmZhZTgyMmQyMmJlMDlmL3NlYzphZTVhOWJlMGViOTQ0NWQxOTJmYWU4MjJkMjJiZTA5Zl8zMS9mcmFnOmYxYWY1ZjE2MGM5YjRlYTdiNGQ5NDdjNTczMzZhM2ZkL3RhYmxlOjVkOTc3NDgxYzYzYTRlMzY5MWIwOGJkYWEwMTJmMThkL3RhYmxlcmFuZ2U6NWQ5Nzc0ODFjNjNhNGUzNjkxYjA4YmRhYTAxMmYxOGRfMzItMS0xLTEtNjI2_9f9129d0-9339-434f-b697-e9d1168938a4"
      unitRef="usd">22000</us-gaap:ProceedsFromWarrantExercises>
    <us-gaap:ProceedsFromWarrantExercises
      contextRef="idaa4f31ca59a4a17a59c2580b97791ca_D20210101-20210630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmFlNWE5YmUwZWI5NDQ1ZDE5MmZhZTgyMmQyMmJlMDlmL3NlYzphZTVhOWJlMGViOTQ0NWQxOTJmYWU4MjJkMjJiZTA5Zl8zMS9mcmFnOmYxYWY1ZjE2MGM5YjRlYTdiNGQ5NDdjNTczMzZhM2ZkL3RhYmxlOjVkOTc3NDgxYzYzYTRlMzY5MWIwOGJkYWEwMTJmMThkL3RhYmxlcmFuZ2U6NWQ5Nzc0ODFjNjNhNGUzNjkxYjA4YmRhYTAxMmYxOGRfMzItMy0xLTEtNjI2_8f624aea-059d-4487-b3f2-de7b71598f2f"
      unitRef="usd">69928000</us-gaap:ProceedsFromWarrantExercises>
    <dmtk:ProceedsFromReleaseOfRSUsAndStockOptionsExercised
      contextRef="ia855382ada1f4f28aa8ef6da692ff177_D20220101-20220630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmFlNWE5YmUwZWI5NDQ1ZDE5MmZhZTgyMmQyMmJlMDlmL3NlYzphZTVhOWJlMGViOTQ0NWQxOTJmYWU4MjJkMjJiZTA5Zl8zMS9mcmFnOmYxYWY1ZjE2MGM5YjRlYTdiNGQ5NDdjNTczMzZhM2ZkL3RhYmxlOjVkOTc3NDgxYzYzYTRlMzY5MWIwOGJkYWEwMTJmMThkL3RhYmxlcmFuZ2U6NWQ5Nzc0ODFjNjNhNGUzNjkxYjA4YmRhYTAxMmYxOGRfMzMtMS0xLTEtNjI2_3612c1df-e139-453c-88dd-4dd22bf95810"
      unitRef="usd">40000</dmtk:ProceedsFromReleaseOfRSUsAndStockOptionsExercised>
    <dmtk:ProceedsFromReleaseOfRSUsAndStockOptionsExercised
      contextRef="idaa4f31ca59a4a17a59c2580b97791ca_D20210101-20210630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmFlNWE5YmUwZWI5NDQ1ZDE5MmZhZTgyMmQyMmJlMDlmL3NlYzphZTVhOWJlMGViOTQ0NWQxOTJmYWU4MjJkMjJiZTA5Zl8zMS9mcmFnOmYxYWY1ZjE2MGM5YjRlYTdiNGQ5NDdjNTczMzZhM2ZkL3RhYmxlOjVkOTc3NDgxYzYzYTRlMzY5MWIwOGJkYWEwMTJmMThkL3RhYmxlcmFuZ2U6NWQ5Nzc0ODFjNjNhNGUzNjkxYjA4YmRhYTAxMmYxOGRfMzMtMy0xLTEtNjI2_99c8ca21-6645-4bb7-8d73-c13b515ebcf3"
      unitRef="usd">596000</dmtk:ProceedsFromReleaseOfRSUsAndStockOptionsExercised>
    <us-gaap:ProceedsFromStockPlans
      contextRef="ia855382ada1f4f28aa8ef6da692ff177_D20220101-20220630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmFlNWE5YmUwZWI5NDQ1ZDE5MmZhZTgyMmQyMmJlMDlmL3NlYzphZTVhOWJlMGViOTQ0NWQxOTJmYWU4MjJkMjJiZTA5Zl8zMS9mcmFnOmYxYWY1ZjE2MGM5YjRlYTdiNGQ5NDdjNTczMzZhM2ZkL3RhYmxlOjVkOTc3NDgxYzYzYTRlMzY5MWIwOGJkYWEwMTJmMThkL3RhYmxlcmFuZ2U6NWQ5Nzc0ODFjNjNhNGUzNjkxYjA4YmRhYTAxMmYxOGRfMzUtMS0xLTEtNjI2_6b86c5cd-981d-4a9d-8542-8b18a1b933e1"
      unitRef="usd">515000</us-gaap:ProceedsFromStockPlans>
    <us-gaap:ProceedsFromStockPlans
      contextRef="idaa4f31ca59a4a17a59c2580b97791ca_D20210101-20210630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmFlNWE5YmUwZWI5NDQ1ZDE5MmZhZTgyMmQyMmJlMDlmL3NlYzphZTVhOWJlMGViOTQ0NWQxOTJmYWU4MjJkMjJiZTA5Zl8zMS9mcmFnOmYxYWY1ZjE2MGM5YjRlYTdiNGQ5NDdjNTczMzZhM2ZkL3RhYmxlOjVkOTc3NDgxYzYzYTRlMzY5MWIwOGJkYWEwMTJmMThkL3RhYmxlcmFuZ2U6NWQ5Nzc0ODFjNjNhNGUzNjkxYjA4YmRhYTAxMmYxOGRfMzUtMy0xLTEtNjI2_e1b8d898-9234-4bd2-bbad-5402aa4b56c5"
      unitRef="usd">392000</us-gaap:ProceedsFromStockPlans>
    <us-gaap:RepaymentsOfDebtAndCapitalLeaseObligations
      contextRef="ia855382ada1f4f28aa8ef6da692ff177_D20220101-20220630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmFlNWE5YmUwZWI5NDQ1ZDE5MmZhZTgyMmQyMmJlMDlmL3NlYzphZTVhOWJlMGViOTQ0NWQxOTJmYWU4MjJkMjJiZTA5Zl8zMS9mcmFnOmYxYWY1ZjE2MGM5YjRlYTdiNGQ5NDdjNTczMzZhM2ZkL3RhYmxlOjVkOTc3NDgxYzYzYTRlMzY5MWIwOGJkYWEwMTJmMThkL3RhYmxlcmFuZ2U6NWQ5Nzc0ODFjNjNhNGUzNjkxYjA4YmRhYTAxMmYxOGRfMzYtMS0xLTEtNjI2_acf477c5-7f85-4ace-b8fe-35abb5aba1e6"
      unitRef="usd">60000</us-gaap:RepaymentsOfDebtAndCapitalLeaseObligations>
    <us-gaap:RepaymentsOfDebtAndCapitalLeaseObligations
      contextRef="idaa4f31ca59a4a17a59c2580b97791ca_D20210101-20210630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmFlNWE5YmUwZWI5NDQ1ZDE5MmZhZTgyMmQyMmJlMDlmL3NlYzphZTVhOWJlMGViOTQ0NWQxOTJmYWU4MjJkMjJiZTA5Zl8zMS9mcmFnOmYxYWY1ZjE2MGM5YjRlYTdiNGQ5NDdjNTczMzZhM2ZkL3RhYmxlOjVkOTc3NDgxYzYzYTRlMzY5MWIwOGJkYWEwMTJmMThkL3RhYmxlcmFuZ2U6NWQ5Nzc0ODFjNjNhNGUzNjkxYjA4YmRhYTAxMmYxOGRfMzYtMy0xLTEtNjI2_6a005dff-7cdf-4831-9c26-3e9508b4d9d8"
      unitRef="usd">53000</us-gaap:RepaymentsOfDebtAndCapitalLeaseObligations>
    <us-gaap:NetCashProvidedByUsedInFinancingActivities
      contextRef="ia855382ada1f4f28aa8ef6da692ff177_D20220101-20220630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmFlNWE5YmUwZWI5NDQ1ZDE5MmZhZTgyMmQyMmJlMDlmL3NlYzphZTVhOWJlMGViOTQ0NWQxOTJmYWU4MjJkMjJiZTA5Zl8zMS9mcmFnOmYxYWY1ZjE2MGM5YjRlYTdiNGQ5NDdjNTczMzZhM2ZkL3RhYmxlOjVkOTc3NDgxYzYzYTRlMzY5MWIwOGJkYWEwMTJmMThkL3RhYmxlcmFuZ2U6NWQ5Nzc0ODFjNjNhNGUzNjkxYjA4YmRhYTAxMmYxOGRfMzctMS0xLTEtNjI2_1cb6edd9-6f50-487b-8095-788c583ce882"
      unitRef="usd">517000</us-gaap:NetCashProvidedByUsedInFinancingActivities>
    <us-gaap:NetCashProvidedByUsedInFinancingActivities
      contextRef="idaa4f31ca59a4a17a59c2580b97791ca_D20210101-20210630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmFlNWE5YmUwZWI5NDQ1ZDE5MmZhZTgyMmQyMmJlMDlmL3NlYzphZTVhOWJlMGViOTQ0NWQxOTJmYWU4MjJkMjJiZTA5Zl8zMS9mcmFnOmYxYWY1ZjE2MGM5YjRlYTdiNGQ5NDdjNTczMzZhM2ZkL3RhYmxlOjVkOTc3NDgxYzYzYTRlMzY5MWIwOGJkYWEwMTJmMThkL3RhYmxlcmFuZ2U6NWQ5Nzc0ODFjNjNhNGUzNjkxYjA4YmRhYTAxMmYxOGRfMzctMy0xLTEtNjI2_a29273f1-7e28-4ac1-b390-a604467cba54"
      unitRef="usd">229281000</us-gaap:NetCashProvidedByUsedInFinancingActivities>
    <us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
      contextRef="ia855382ada1f4f28aa8ef6da692ff177_D20220101-20220630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmFlNWE5YmUwZWI5NDQ1ZDE5MmZhZTgyMmQyMmJlMDlmL3NlYzphZTVhOWJlMGViOTQ0NWQxOTJmYWU4MjJkMjJiZTA5Zl8zMS9mcmFnOmYxYWY1ZjE2MGM5YjRlYTdiNGQ5NDdjNTczMzZhM2ZkL3RhYmxlOjVkOTc3NDgxYzYzYTRlMzY5MWIwOGJkYWEwMTJmMThkL3RhYmxlcmFuZ2U6NWQ5Nzc0ODFjNjNhNGUzNjkxYjA4YmRhYTAxMmYxOGRfMzgtMS0xLTEtNjI2_09552c58-d0d2-4dbd-a7ea-4e4930d08db3"
      unitRef="usd">-56104000</us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect>
    <us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
      contextRef="idaa4f31ca59a4a17a59c2580b97791ca_D20210101-20210630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmFlNWE5YmUwZWI5NDQ1ZDE5MmZhZTgyMmQyMmJlMDlmL3NlYzphZTVhOWJlMGViOTQ0NWQxOTJmYWU4MjJkMjJiZTA5Zl8zMS9mcmFnOmYxYWY1ZjE2MGM5YjRlYTdiNGQ5NDdjNTczMzZhM2ZkL3RhYmxlOjVkOTc3NDgxYzYzYTRlMzY5MWIwOGJkYWEwMTJmMThkL3RhYmxlcmFuZ2U6NWQ5Nzc0ODFjNjNhNGUzNjkxYjA4YmRhYTAxMmYxOGRfMzgtMy0xLTEtNjI2_1aad1e6d-5f53-4cb2-bcd2-4b3ffb50bfa9"
      unitRef="usd">205361000</us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect>
    <us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations
      contextRef="i87bf777ccf5f4f93bc9be7a2cbba61c1_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmFlNWE5YmUwZWI5NDQ1ZDE5MmZhZTgyMmQyMmJlMDlmL3NlYzphZTVhOWJlMGViOTQ0NWQxOTJmYWU4MjJkMjJiZTA5Zl8zMS9mcmFnOmYxYWY1ZjE2MGM5YjRlYTdiNGQ5NDdjNTczMzZhM2ZkL3RhYmxlOjVkOTc3NDgxYzYzYTRlMzY5MWIwOGJkYWEwMTJmMThkL3RhYmxlcmFuZ2U6NWQ5Nzc0ODFjNjNhNGUzNjkxYjA4YmRhYTAxMmYxOGRfMzktMS0xLTEtNjI2_e288e249-e015-40bb-b99a-d5bbd95f406b"
      unitRef="usd">179907000</us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations>
    <us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations
      contextRef="i299927d2cdfe46deaac8ee64dc7dce6c_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmFlNWE5YmUwZWI5NDQ1ZDE5MmZhZTgyMmQyMmJlMDlmL3NlYzphZTVhOWJlMGViOTQ0NWQxOTJmYWU4MjJkMjJiZTA5Zl8zMS9mcmFnOmYxYWY1ZjE2MGM5YjRlYTdiNGQ5NDdjNTczMzZhM2ZkL3RhYmxlOjVkOTc3NDgxYzYzYTRlMzY5MWIwOGJkYWEwMTJmMThkL3RhYmxlcmFuZ2U6NWQ5Nzc0ODFjNjNhNGUzNjkxYjA4YmRhYTAxMmYxOGRfMzktMy0xLTEtNjI2_bf354918-9b84-4d7b-a53b-d743cf51d2ad"
      unitRef="usd">24248000</us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations>
    <us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations
      contextRef="i4c8f247d12134a9886d56e1c8b024425_I20220630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmFlNWE5YmUwZWI5NDQ1ZDE5MmZhZTgyMmQyMmJlMDlmL3NlYzphZTVhOWJlMGViOTQ0NWQxOTJmYWU4MjJkMjJiZTA5Zl8zMS9mcmFnOmYxYWY1ZjE2MGM5YjRlYTdiNGQ5NDdjNTczMzZhM2ZkL3RhYmxlOjVkOTc3NDgxYzYzYTRlMzY5MWIwOGJkYWEwMTJmMThkL3RhYmxlcmFuZ2U6NWQ5Nzc0ODFjNjNhNGUzNjkxYjA4YmRhYTAxMmYxOGRfNDAtMS0xLTEtNjI2_9c1234b2-7b32-4344-b4ac-b90947eaf87f"
      unitRef="usd">123803000</us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations>
    <us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations
      contextRef="ie036f155bf0e43bd97ef05b5b46857eb_I20210630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmFlNWE5YmUwZWI5NDQ1ZDE5MmZhZTgyMmQyMmJlMDlmL3NlYzphZTVhOWJlMGViOTQ0NWQxOTJmYWU4MjJkMjJiZTA5Zl8zMS9mcmFnOmYxYWY1ZjE2MGM5YjRlYTdiNGQ5NDdjNTczMzZhM2ZkL3RhYmxlOjVkOTc3NDgxYzYzYTRlMzY5MWIwOGJkYWEwMTJmMThkL3RhYmxlcmFuZ2U6NWQ5Nzc0ODFjNjNhNGUzNjkxYjA4YmRhYTAxMmYxOGRfNDAtMy0xLTEtNjI2_7608eb54-c964-437c-b8d7-7b59bc6cd711"
      unitRef="usd">229609000</us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations>
    <us-gaap:CashAndCashEquivalentsAtCarryingValue
      contextRef="i4c8f247d12134a9886d56e1c8b024425_I20220630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmFlNWE5YmUwZWI5NDQ1ZDE5MmZhZTgyMmQyMmJlMDlmL3NlYzphZTVhOWJlMGViOTQ0NWQxOTJmYWU4MjJkMjJiZTA5Zl8zMS9mcmFnOmYxYWY1ZjE2MGM5YjRlYTdiNGQ5NDdjNTczMzZhM2ZkL3RhYmxlOjVkOTc3NDgxYzYzYTRlMzY5MWIwOGJkYWEwMTJmMThkL3RhYmxlcmFuZ2U6NWQ5Nzc0ODFjNjNhNGUzNjkxYjA4YmRhYTAxMmYxOGRfMzgtMS0xLTEtMTk0Ng_2a754c0f-c3f9-416a-9a00-71d62f3d7b82"
      unitRef="usd">120333000</us-gaap:CashAndCashEquivalentsAtCarryingValue>
    <us-gaap:CashAndCashEquivalentsAtCarryingValue
      contextRef="ie036f155bf0e43bd97ef05b5b46857eb_I20210630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmFlNWE5YmUwZWI5NDQ1ZDE5MmZhZTgyMmQyMmJlMDlmL3NlYzphZTVhOWJlMGViOTQ0NWQxOTJmYWU4MjJkMjJiZTA5Zl8zMS9mcmFnOmYxYWY1ZjE2MGM5YjRlYTdiNGQ5NDdjNTczMzZhM2ZkL3RhYmxlOjVkOTc3NDgxYzYzYTRlMzY5MWIwOGJkYWEwMTJmMThkL3RhYmxlcmFuZ2U6NWQ5Nzc0ODFjNjNhNGUzNjkxYjA4YmRhYTAxMmYxOGRfMzgtMy0xLTEtMTk0Ng_d1de29c7-7352-41ac-8f7b-ce9d643113c8"
      unitRef="usd">229609000</us-gaap:CashAndCashEquivalentsAtCarryingValue>
    <us-gaap:RestrictedCash
      contextRef="i4c8f247d12134a9886d56e1c8b024425_I20220630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmFlNWE5YmUwZWI5NDQ1ZDE5MmZhZTgyMmQyMmJlMDlmL3NlYzphZTVhOWJlMGViOTQ0NWQxOTJmYWU4MjJkMjJiZTA5Zl8zMS9mcmFnOmYxYWY1ZjE2MGM5YjRlYTdiNGQ5NDdjNTczMzZhM2ZkL3RhYmxlOjVkOTc3NDgxYzYzYTRlMzY5MWIwOGJkYWEwMTJmMThkL3RhYmxlcmFuZ2U6NWQ5Nzc0ODFjNjNhNGUzNjkxYjA4YmRhYTAxMmYxOGRfMzktMS0xLTEtMTk0Ng_5aefc990-c72e-43a0-8712-6b42ed06e7ae"
      unitRef="usd">3470000</us-gaap:RestrictedCash>
    <us-gaap:RestrictedCash
      contextRef="ie036f155bf0e43bd97ef05b5b46857eb_I20210630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmFlNWE5YmUwZWI5NDQ1ZDE5MmZhZTgyMmQyMmJlMDlmL3NlYzphZTVhOWJlMGViOTQ0NWQxOTJmYWU4MjJkMjJiZTA5Zl8zMS9mcmFnOmYxYWY1ZjE2MGM5YjRlYTdiNGQ5NDdjNTczMzZhM2ZkL3RhYmxlOjVkOTc3NDgxYzYzYTRlMzY5MWIwOGJkYWEwMTJmMThkL3RhYmxlcmFuZ2U6NWQ5Nzc0ODFjNjNhNGUzNjkxYjA4YmRhYTAxMmYxOGRfMzktMy0xLTEtMTk0Ng_f614336a-d285-45eb-8041-5c7faec5c521"
      unitRef="usd">0</us-gaap:RestrictedCash>
    <us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
      contextRef="i4c8f247d12134a9886d56e1c8b024425_I20220630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmFlNWE5YmUwZWI5NDQ1ZDE5MmZhZTgyMmQyMmJlMDlmL3NlYzphZTVhOWJlMGViOTQ0NWQxOTJmYWU4MjJkMjJiZTA5Zl8zMS9mcmFnOmYxYWY1ZjE2MGM5YjRlYTdiNGQ5NDdjNTczMzZhM2ZkL3RhYmxlOjVkOTc3NDgxYzYzYTRlMzY5MWIwOGJkYWEwMTJmMThkL3RhYmxlcmFuZ2U6NWQ5Nzc0ODFjNjNhNGUzNjkxYjA4YmRhYTAxMmYxOGRfNDAtMS0xLTEtMTk0Ng_228eba9a-9331-4b7b-b1e3-113464dcdd16"
      unitRef="usd">123803000</us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents>
    <us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
      contextRef="ie036f155bf0e43bd97ef05b5b46857eb_I20210630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmFlNWE5YmUwZWI5NDQ1ZDE5MmZhZTgyMmQyMmJlMDlmL3NlYzphZTVhOWJlMGViOTQ0NWQxOTJmYWU4MjJkMjJiZTA5Zl8zMS9mcmFnOmYxYWY1ZjE2MGM5YjRlYTdiNGQ5NDdjNTczMzZhM2ZkL3RhYmxlOjVkOTc3NDgxYzYzYTRlMzY5MWIwOGJkYWEwMTJmMThkL3RhYmxlcmFuZ2U6NWQ5Nzc0ODFjNjNhNGUzNjkxYjA4YmRhYTAxMmYxOGRfNDAtMy0xLTEtMTk0Ng_80822920-5520-4406-b07c-de10e67fb539"
      unitRef="usd">229609000</us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents>
    <us-gaap:InterestPaidNet
      contextRef="ia855382ada1f4f28aa8ef6da692ff177_D20220101-20220630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmFlNWE5YmUwZWI5NDQ1ZDE5MmZhZTgyMmQyMmJlMDlmL3NlYzphZTVhOWJlMGViOTQ0NWQxOTJmYWU4MjJkMjJiZTA5Zl8zMS9mcmFnOmYxYWY1ZjE2MGM5YjRlYTdiNGQ5NDdjNTczMzZhM2ZkL3RhYmxlOjVkOTc3NDgxYzYzYTRlMzY5MWIwOGJkYWEwMTJmMThkL3RhYmxlcmFuZ2U6NWQ5Nzc0ODFjNjNhNGUzNjkxYjA4YmRhYTAxMmYxOGRfNDItMS0xLTEtNjI2_fa832f37-c0b5-4b6e-ba49-fec14b278f35"
      unitRef="usd">7000</us-gaap:InterestPaidNet>
    <us-gaap:InterestPaidNet
      contextRef="idaa4f31ca59a4a17a59c2580b97791ca_D20210101-20210630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmFlNWE5YmUwZWI5NDQ1ZDE5MmZhZTgyMmQyMmJlMDlmL3NlYzphZTVhOWJlMGViOTQ0NWQxOTJmYWU4MjJkMjJiZTA5Zl8zMS9mcmFnOmYxYWY1ZjE2MGM5YjRlYTdiNGQ5NDdjNTczMzZhM2ZkL3RhYmxlOjVkOTc3NDgxYzYzYTRlMzY5MWIwOGJkYWEwMTJmMThkL3RhYmxlcmFuZ2U6NWQ5Nzc0ODFjNjNhNGUzNjkxYjA4YmRhYTAxMmYxOGRfNDItMy0xLTEtNjI2_d67d6f7a-909e-4bc7-b05f-e9931effe8a1"
      unitRef="usd">8000</us-gaap:InterestPaidNet>
    <us-gaap:CapitalExpendituresIncurredButNotYetPaid
      contextRef="ia855382ada1f4f28aa8ef6da692ff177_D20220101-20220630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmFlNWE5YmUwZWI5NDQ1ZDE5MmZhZTgyMmQyMmJlMDlmL3NlYzphZTVhOWJlMGViOTQ0NWQxOTJmYWU4MjJkMjJiZTA5Zl8zMS9mcmFnOmYxYWY1ZjE2MGM5YjRlYTdiNGQ5NDdjNTczMzZhM2ZkL3RhYmxlOjVkOTc3NDgxYzYzYTRlMzY5MWIwOGJkYWEwMTJmMThkL3RhYmxlcmFuZ2U6NWQ5Nzc0ODFjNjNhNGUzNjkxYjA4YmRhYTAxMmYxOGRfNDUtMS0xLTEtNjI2_bc8bb211-50dc-4751-aa44-9ac92e38c1fc"
      unitRef="usd">11000</us-gaap:CapitalExpendituresIncurredButNotYetPaid>
    <us-gaap:CapitalExpendituresIncurredButNotYetPaid
      contextRef="idaa4f31ca59a4a17a59c2580b97791ca_D20210101-20210630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmFlNWE5YmUwZWI5NDQ1ZDE5MmZhZTgyMmQyMmJlMDlmL3NlYzphZTVhOWJlMGViOTQ0NWQxOTJmYWU4MjJkMjJiZTA5Zl8zMS9mcmFnOmYxYWY1ZjE2MGM5YjRlYTdiNGQ5NDdjNTczMzZhM2ZkL3RhYmxlOjVkOTc3NDgxYzYzYTRlMzY5MWIwOGJkYWEwMTJmMThkL3RhYmxlcmFuZ2U6NWQ5Nzc0ODFjNjNhNGUzNjkxYjA4YmRhYTAxMmYxOGRfNDUtMy0xLTEtNjI2_19c25aeb-890b-41bc-b227-05842cef5d76"
      unitRef="usd">24000</us-gaap:CapitalExpendituresIncurredButNotYetPaid>
    <dmtk:ReclassificationOfWarrantLiabilityDueToPrivateSPACWarrantsNotHeldByOriginalHolder
      contextRef="ia855382ada1f4f28aa8ef6da692ff177_D20220101-20220630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmFlNWE5YmUwZWI5NDQ1ZDE5MmZhZTgyMmQyMmJlMDlmL3NlYzphZTVhOWJlMGViOTQ0NWQxOTJmYWU4MjJkMjJiZTA5Zl8zMS9mcmFnOmYxYWY1ZjE2MGM5YjRlYTdiNGQ5NDdjNTczMzZhM2ZkL3RhYmxlOjVkOTc3NDgxYzYzYTRlMzY5MWIwOGJkYWEwMTJmMThkL3RhYmxlcmFuZ2U6NWQ5Nzc0ODFjNjNhNGUzNjkxYjA4YmRhYTAxMmYxOGRfNDYtMS0xLTEtNjI2_aeeca8b3-2975-4694-a566-c74a6f63a311"
      unitRef="usd">0</dmtk:ReclassificationOfWarrantLiabilityDueToPrivateSPACWarrantsNotHeldByOriginalHolder>
    <dmtk:ReclassificationOfWarrantLiabilityDueToPrivateSPACWarrantsNotHeldByOriginalHolder
      contextRef="idaa4f31ca59a4a17a59c2580b97791ca_D20210101-20210630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmFlNWE5YmUwZWI5NDQ1ZDE5MmZhZTgyMmQyMmJlMDlmL3NlYzphZTVhOWJlMGViOTQ0NWQxOTJmYWU4MjJkMjJiZTA5Zl8zMS9mcmFnOmYxYWY1ZjE2MGM5YjRlYTdiNGQ5NDdjNTczMzZhM2ZkL3RhYmxlOjVkOTc3NDgxYzYzYTRlMzY5MWIwOGJkYWEwMTJmMThkL3RhYmxlcmFuZ2U6NWQ5Nzc0ODFjNjNhNGUzNjkxYjA4YmRhYTAxMmYxOGRfNDYtMy0xLTEtNjI2_7f0a6b2a-c430-4e2f-9b1e-5e10566f0dc6"
      unitRef="usd">434000</dmtk:ReclassificationOfWarrantLiabilityDueToPrivateSPACWarrantsNotHeldByOriginalHolder>
    <dmtk:CashlessExerciseOfCommonStockWarrants
      contextRef="ia855382ada1f4f28aa8ef6da692ff177_D20220101-20220630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmFlNWE5YmUwZWI5NDQ1ZDE5MmZhZTgyMmQyMmJlMDlmL3NlYzphZTVhOWJlMGViOTQ0NWQxOTJmYWU4MjJkMjJiZTA5Zl8zMS9mcmFnOmYxYWY1ZjE2MGM5YjRlYTdiNGQ5NDdjNTczMzZhM2ZkL3RhYmxlOjVkOTc3NDgxYzYzYTRlMzY5MWIwOGJkYWEwMTJmMThkL3RhYmxlcmFuZ2U6NWQ5Nzc0ODFjNjNhNGUzNjkxYjA4YmRhYTAxMmYxOGRfNDctMS0xLTEtNjI2_ad71ec11-b3f4-44e5-879e-ca644f12a50c"
      unitRef="usd">0</dmtk:CashlessExerciseOfCommonStockWarrants>
    <dmtk:CashlessExerciseOfCommonStockWarrants
      contextRef="idaa4f31ca59a4a17a59c2580b97791ca_D20210101-20210630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmFlNWE5YmUwZWI5NDQ1ZDE5MmZhZTgyMmQyMmJlMDlmL3NlYzphZTVhOWJlMGViOTQ0NWQxOTJmYWU4MjJkMjJiZTA5Zl8zMS9mcmFnOmYxYWY1ZjE2MGM5YjRlYTdiNGQ5NDdjNTczMzZhM2ZkL3RhYmxlOjVkOTc3NDgxYzYzYTRlMzY5MWIwOGJkYWEwMTJmMThkL3RhYmxlcmFuZ2U6NWQ5Nzc0ODFjNjNhNGUzNjkxYjA4YmRhYTAxMmYxOGRfNDctMy0xLTEtNjI2_1d3dfa15-528b-45ec-8e1f-a56eba10b9cc"
      unitRef="usd">2158000</dmtk:CashlessExerciseOfCommonStockWarrants>
    <us-gaap:RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability
      contextRef="ia855382ada1f4f28aa8ef6da692ff177_D20220101-20220630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmFlNWE5YmUwZWI5NDQ1ZDE5MmZhZTgyMmQyMmJlMDlmL3NlYzphZTVhOWJlMGViOTQ0NWQxOTJmYWU4MjJkMjJiZTA5Zl8zMS9mcmFnOmYxYWY1ZjE2MGM5YjRlYTdiNGQ5NDdjNTczMzZhM2ZkL3RhYmxlOjVkOTc3NDgxYzYzYTRlMzY5MWIwOGJkYWEwMTJmMThkL3RhYmxlcmFuZ2U6NWQ5Nzc0ODFjNjNhNGUzNjkxYjA4YmRhYTAxMmYxOGRfNDgtMS0xLTEtNjI2_d6e77a73-6380-4a15-871b-2a36603cda5b"
      unitRef="usd">17059000</us-gaap:RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability>
    <us-gaap:RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability
      contextRef="idaa4f31ca59a4a17a59c2580b97791ca_D20210101-20210630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmFlNWE5YmUwZWI5NDQ1ZDE5MmZhZTgyMmQyMmJlMDlmL3NlYzphZTVhOWJlMGViOTQ0NWQxOTJmYWU4MjJkMjJiZTA5Zl8zMS9mcmFnOmYxYWY1ZjE2MGM5YjRlYTdiNGQ5NDdjNTczMzZhM2ZkL3RhYmxlOjVkOTc3NDgxYzYzYTRlMzY5MWIwOGJkYWEwMTJmMThkL3RhYmxlcmFuZ2U6NWQ5Nzc0ODFjNjNhNGUzNjkxYjA4YmRhYTAxMmYxOGRfNDgtMy0xLTEtNjI2_9c6c6ebe-ea94-4161-ba29-cc8e9465e7b6"
      unitRef="usd">2831000</us-gaap:RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability>
    <us-gaap:NoncashOrPartNoncashAcquisitionFixedAssetsAcquired1
      contextRef="ia855382ada1f4f28aa8ef6da692ff177_D20220101-20220630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmFlNWE5YmUwZWI5NDQ1ZDE5MmZhZTgyMmQyMmJlMDlmL3NlYzphZTVhOWJlMGViOTQ0NWQxOTJmYWU4MjJkMjJiZTA5Zl8zMS9mcmFnOmYxYWY1ZjE2MGM5YjRlYTdiNGQ5NDdjNTczMzZhM2ZkL3RhYmxlOjVkOTc3NDgxYzYzYTRlMzY5MWIwOGJkYWEwMTJmMThkL3RhYmxlcmFuZ2U6NWQ5Nzc0ODFjNjNhNGUzNjkxYjA4YmRhYTAxMmYxOGRfNDktMS0xLTEtNjI2_70449b45-0266-49e6-b60c-c641371b7161"
      unitRef="usd">48000</us-gaap:NoncashOrPartNoncashAcquisitionFixedAssetsAcquired1>
    <us-gaap:NoncashOrPartNoncashAcquisitionFixedAssetsAcquired1
      contextRef="idaa4f31ca59a4a17a59c2580b97791ca_D20210101-20210630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmFlNWE5YmUwZWI5NDQ1ZDE5MmZhZTgyMmQyMmJlMDlmL3NlYzphZTVhOWJlMGViOTQ0NWQxOTJmYWU4MjJkMjJiZTA5Zl8zMS9mcmFnOmYxYWY1ZjE2MGM5YjRlYTdiNGQ5NDdjNTczMzZhM2ZkL3RhYmxlOjVkOTc3NDgxYzYzYTRlMzY5MWIwOGJkYWEwMTJmMThkL3RhYmxlcmFuZ2U6NWQ5Nzc0ODFjNjNhNGUzNjkxYjA4YmRhYTAxMmYxOGRfNDktMy0xLTEtNjI2_08755c8e-9c3b-4a3f-8a02-8686c08a922f"
      unitRef="usd">0</us-gaap:NoncashOrPartNoncashAcquisitionFixedAssetsAcquired1>
    <dmtk:ChangeInUnrealizedGainLossOnAvailableForSaleMarketableSecurities
      contextRef="ia855382ada1f4f28aa8ef6da692ff177_D20220101-20220630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmFlNWE5YmUwZWI5NDQ1ZDE5MmZhZTgyMmQyMmJlMDlmL3NlYzphZTVhOWJlMGViOTQ0NWQxOTJmYWU4MjJkMjJiZTA5Zl8zMS9mcmFnOmYxYWY1ZjE2MGM5YjRlYTdiNGQ5NDdjNTczMzZhM2ZkL3RhYmxlOjVkOTc3NDgxYzYzYTRlMzY5MWIwOGJkYWEwMTJmMThkL3RhYmxlcmFuZ2U6NWQ5Nzc0ODFjNjNhNGUzNjkxYjA4YmRhYTAxMmYxOGRfNTAtMS0xLTEtNjI2_e6146fdb-67cc-4c37-a18a-4743bec155c3"
      unitRef="usd">-741000</dmtk:ChangeInUnrealizedGainLossOnAvailableForSaleMarketableSecurities>
    <dmtk:ChangeInUnrealizedGainLossOnAvailableForSaleMarketableSecurities
      contextRef="idaa4f31ca59a4a17a59c2580b97791ca_D20210101-20210630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmFlNWE5YmUwZWI5NDQ1ZDE5MmZhZTgyMmQyMmJlMDlmL3NlYzphZTVhOWJlMGViOTQ0NWQxOTJmYWU4MjJkMjJiZTA5Zl8zMS9mcmFnOmYxYWY1ZjE2MGM5YjRlYTdiNGQ5NDdjNTczMzZhM2ZkL3RhYmxlOjVkOTc3NDgxYzYzYTRlMzY5MWIwOGJkYWEwMTJmMThkL3RhYmxlcmFuZ2U6NWQ5Nzc0ODFjNjNhNGUzNjkxYjA4YmRhYTAxMmYxOGRfNTAtMy0xLTEtNjI2_cbb55498-7105-4f45-8b59-dcc5e1e06718"
      unitRef="usd">3000</dmtk:ChangeInUnrealizedGainLossOnAvailableForSaleMarketableSecurities>
    <us-gaap:OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureAndSignificantAccountingPoliciesTextBlock
      contextRef="ia855382ada1f4f28aa8ef6da692ff177_D20220101-20220630"
      id="id3VybDovL2RvY3MudjEvZG9jOmFlNWE5YmUwZWI5NDQ1ZDE5MmZhZTgyMmQyMmJlMDlmL3NlYzphZTVhOWJlMGViOTQ0NWQxOTJmYWU4MjJkMjJiZTA5Zl8zNy9mcmFnOjQ4OGNkZjBhODVlYzRiMDliYWFiN2JhZTlhODA5YjcwL3RleHRyZWdpb246NDg4Y2RmMGE4NWVjNGIwOWJhYWI3YmFlOWE4MDliNzBfNDYyNTA_5feb932c-094e-412e-ac7c-1d1fefa896a5">The Company and a Summary of its Significant Accounting Policies&lt;div style="margin-top:15pt;padding-left:27pt;text-indent:-27pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;(a)&#160;&#160;&#160;&#160;Nature of Operations &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:9pt;padding-left:27pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;On August 29, 2019, DermTech, Inc., formerly known as Constellation Alpha Capital Corp, (the &#x201c;Company&#x201d;), and DermTech Operations, Inc., formerly known as DermTech, Inc., (&#x201c;DermTech Operations&#x201d;), consummated the transactions contemplated by the Agreement and Plan of Merger, dated as of May 29, 2019, by and among the Company, DT Merger Sub, Inc., a wholly owned subsidiary of the Company (&#x201c;Merger Sub&#x201d;), and DermTech Operations. The Company refers to this agreement, as amended by that certain First Amendment to Agreement and Plan of Merger dated as of August 1, 2019, as the Merger Agreement. Pursuant to the Merger Agreement, Merger Sub merged with and into DermTech Operations, with DermTech Operations surviving as a wholly-owned subsidiary of the Company. The Company refers to this transaction as the Business Combination. In connection with and two days prior to the completion of the Business Combination, the Company domesticated from the British Virgin Islands to Delaware. DermTech Operations changed its name from DermTech, Inc. to DermTech Operations, Inc. shortly before the completion of the Business Combination. On August 29, 2019, immediately following the completion of the Business Combination, the Company changed its name from Constellation Alpha Capital Corp. to DermTech, Inc., and then effected a one-for-two reverse stock split of its common stock. &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:9pt;padding-left:27pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The Company is a molecular diagnostic company developing and marketing its Clinical Laboratory Improvement Amendments of 1988 (&#x201c;CLIA&#x201d;) laboratory services including genomic tests to facilitate the diagnosis of dermatologic conditions including melanoma. The Company has developed a proprietary, non-invasive technique for sampling the surface layers of the skin using an adhesive patch called the DermTech Smart Sticker&#x2122; (the &#x201c;Smart Sticker&#x201d;) to collect biological information for commercial applications in the medical diagnostic field.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:9pt;padding-left:27pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;From the end of the first quarter of 2020 and through the second quarter of 2022, there has been a widespread worldwide impact from the COVID-19 pandemic. The Company is considered an essential business due to the importance of early melanoma detection, which has allowed the Company&#x2019;s CLIA laboratory to remain fully operational. The Company implemented additional safety measures in accordance with Centers for Disease Control and Prevention (&#x201c;CDC&#x201d;), Occupational Safety and Health Administration (&#x201c;OSHA&#x201d;) and other guidance within its CLIA laboratory operations. Additionally, and during this time, the Company transitioned administrative functions to predominantly remote work. Beginning in March 2020 and continuing through the second quarter of 2022, the ongoing COVID-19 pandemic has reduced patient access to clinician offices for in-person testing and reduced access by the Company&#x2019;s sales force for in-office sales calls, which has resulted in a reduced volume of billable samples received during the second quarter of 2022 relative to the Company&#x2019;s pre-pandemic expectations. The Company expects the ongoing COVID-19 pandemic to continue to adversely impact billable sample volume until patient access to in-person testing fully resumes, in-office access by the Company&#x2019;s sales force returns to pre-pandemic levels, or telemedicine options are more widely adopted. Additionally, the ongoing COVID-19 pandemic has negatively affected and may continue to negatively affect the Company&#x2019;s pharmaceutical customers&#x2019; clinical trials. The extent to which the COVID-19 pandemic will affect the Company&#x2019;s future revenue is uncertain and will depend on the duration and extent of the effects of the ongoing COVID-19 pandemic, including the effects on the Company&#x2019;s pharmaceutical customers&#x2019; clinical trials.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:15pt;padding-left:27pt;text-indent:-27pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;(b)&#160;&#160;&#160;&#160;Basis of Presentation&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:9pt;padding-left:27pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The condensed consolidated financial statements include the accounts of DermTech, Inc. and its subsidiaries. All intercompany balances and transactions among the consolidated entity have been eliminated in consolidation. These unaudited condensed consolidated financial statements have been prepared in accordance with U.S. generally accepted accounting principles (&#x201c;U.S. GAAP&#x201d;) for interim financial information and with the instructions to Form 10-Q and Article 10 of Securities and Exchange Commission (&#x201c;SEC&#x201d;), Regulation S-X. Accordingly, these unaudited condensed consolidated financial statements and accompanying notes do not include all the information and disclosures required by U.S. GAAP for complete financial statements and should be read together with the audited consolidated financial statements included in the Company&#x2019;s Annual Report on Form 10-K for the fiscal year ended December 31, 2021. In the opinion of management, all adjustments, which include only normal recurring adjustments considered necessary for a fair presentation, have been included. &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:9pt;padding-left:27pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The accompanying unaudited condensed consolidated financial statements reflect the application of certain significant accounting policies as described below and elsewhere in these notes to the unaudited condensed consolidated financial statements. As of June 30, 2022, there have been no material changes in the Company's significant accounting policies from those that were disclosed in the Company&#x2019;s Annual Report on Form 10-K for the year ended December 31, 2021.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:15pt;padding-left:27pt;text-indent:-27pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;(c)&#160;&#160;&#160;&#160;Reclassifications&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:9pt;padding-left:27pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Certain prior period information on the condensed consolidated statement of cash flows for the six months ended June 30, 2021 has been reclassified to conform to the current year presentation as a result of adopting Accounting Standards Update ("ASU") No. 2016-02, &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Leases (Topic 842)&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt; ("ASU 2016-02"). These reclassifications did not have an impact on net cash flows. For additional disclosure and detail, see Note 4 of the notes to the unaudited condensed consolidated financial statements, &#x201c;Adoption of ASC 842.&#x201d;&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:15pt;padding-left:27pt;text-indent:-27pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;(d)&#160;&#160;&#160;&#160;Use of Estimates &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:9pt;padding-left:27pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The preparation of condensed consolidated financial statements in conformity with U.S. GAAP requires that management make estimates and assumptions that affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the date of the condensed consolidated financial statements and the amounts of revenues and expenses reported during the period. On an ongoing basis, management evaluates these estimates and judgments, including but not limited to those related to assay revenue, stock-based compensation, short-term marketable securities, accounts receivable, accrued bonus, warrant liability, right-of-use (&#x201c;ROU&#x201d;) assets and the realization of deferred tax assets. Actual results may differ from those estimates.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:15pt;padding-left:27pt;text-indent:-27pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;(e)&#160;&#160;&#160;&#160;Cash, Cash Equivalents and Restricted Cash&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:9pt;padding-left:27pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The Company considers all highly liquid investments with remaining maturities of three months or less when purchased to be cash equivalents. The Company maintains its cash balances at banks and financial institutions. The balances are insured up to the Federal Deposit Insurance Corporation legal limit. The Company maintains cash balances that have in the past and may, at times, exceed this insured limit. &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:9pt;padding-left:27pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Restricted cash consists of cash deposited with a financial institution as collateral for the Company&#x2019;s letters of credit for its facility leases. Restricted cash is classified as noncurrent based on the terms of the underlying lease arrangement.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:15pt;padding-left:27pt;text-indent:-27pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;(f)&#160;&#160;&#160;&#160;Property and Equipment, Net &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:9pt;padding-left:27pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Property and equipment, net is recorded at cost less accumulated depreciation. Property and equipment consists mainly of assets such as leasehold improvements, office, computer and laboratory equipment, including laboratory equipment acquired under finance lease arrangements. Depreciation is computed using the straight-line method over the estimated useful lives of the assets, which range from &lt;span style="-sec-ix-hidden:id3VybDovL2RvY3MudjEvZG9jOmFlNWE5YmUwZWI5NDQ1ZDE5MmZhZTgyMmQyMmJlMDlmL3NlYzphZTVhOWJlMGViOTQ0NWQxOTJmYWU4MjJkMjJiZTA5Zl8zNy9mcmFnOjQ4OGNkZjBhODVlYzRiMDliYWFiN2JhZTlhODA5YjcwL3RleHRyZWdpb246NDg4Y2RmMGE4NWVjNGIwOWJhYWI3YmFlOWE4MDliNzBfMTQ0NDA_b7f0ce5d-c748-4105-a8ca-a2d7278a0959"&gt;two&lt;/span&gt; to eleven years. Leasehold improvements are depreciated over the shorter of the remaining term of the lease or the useful life of the asset. The Company recorded depreciation expense of $0.4 million and $0.2 million for the three months ended June&#160;30, 2022 and 2021, respectively, which includes amortization of laboratory equipment acquired under finance leases (previously referred to as &#x201c;capital leases&#x201d;) of $21,000 and $17,000 for the three months ended June&#160;30, 2022 and 2021, respectively. The Company recorded depreciation expense of $0.8 million and $0.4 million for the six months ended June&#160;30, 2022 and 2021, respectively, which includes amortization of laboratory equipment acquired under finance leases of $41,000 and $34,000 for the six months ended June&#160;30, 2022 and 2021, respectively. &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:9pt;padding-left:27pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Amortization of assets that are recorded under finance leases in depreciation expense is included in cost of revenues on the condensed consolidated statements of operations. Gross assets recorded under finance leases were $0.4 million as of June&#160;30, 2022 and December&#160;31, 2021. Accumulated amortization associated with finance leases was $0.1 million as of June&#160;30, 2022 and December&#160;31, 2021. Maintenance and repairs are expensed as incurred, and material improvements are capitalized. When assets are retired or otherwise disposed of, the cost and accumulated depreciation are removed from the balance sheet and any resulting gain or loss is reflected in the condensed consolidated statements of operations in the period realized. &lt;/span&gt;&lt;span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The Company disposed of $0.3 million of equipment for the three months ended June&#160;30, 2022 and no equipment for the three months ended June&#160;30, 2021&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;. The Company disposed of $0.3 million and $13,000 of equipment for the six months ended June&#160;30, 2022 and &lt;/span&gt;&lt;span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;2021&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;, respectively. &lt;/span&gt;&lt;span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The Company assesses its long-lived assets, consisting primarily of property and equipment, for impairment when material events or changes in circumstances indicate that the carrying value may not be recoverable. There were no impairment losses for the three or six months ended June&#160;30, 2022 and 2021&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;. &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:15pt;padding-left:27pt;text-indent:-27pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;(g)&#160;&#160;&#160;&#160;Concentration of Credit Risk &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:9pt;padding-left:27pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Financial instruments that potentially subject the Company to significant concentrations of credit risk consist primarily of cash and cash equivalents. As of June&#160;30, 2022, the Company maintained $87.1 million in a sweep account, which maintains cash balances throughout various interest-bearing bank accounts under the $250,000 insurance limit provided by the Federal Deposit Insurance Corporation for one federally insured financial institution. Approximately $2.5 million was held in excess of the Federal Deposit Insurance Corporation insured limit as of June&#160;30, 2022. The Company has not experienced any losses in such accounts. &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:15pt;padding-left:27pt;text-indent:-27pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;(h)&#160;&#160;&#160;&#160;Revenue Recognition &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:9pt;padding-left:27pt"&gt;&lt;span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The Company&#x2019;s revenue is generated from two revenue streams: contract revenue and assay revenue. The Company accounts for revenue in accordance with Accounting Standards Codification (&#x201c;ASC&#x201d;) Topic 606, Revenue from Contracts with Customers (&#x201c;ASC 606&#x201d;). The core principle of ASC 606 is that the Company recognizes revenue to depict the transfer of promised goods or services to customers in an amount that reflects the consideration to which the Company expects to be entitled in exchange for those goods or services. The ASC 606 revenue recognition model consists of the following five steps: (1) identify the contracts with a customer, (2) identify the performance obligations in the contract, (3) determine the transaction price, (4) allocate the transaction price to the performance obligations in the contract and (5) recognize revenue when (or as) the entity satisfies a performance obligation.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:9pt;padding-left:27pt"&gt;&lt;span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The Company recognizes revenue from its assay and contract services in accordance with the core principles and key aspects considered by the Company. These considerations are described in detail below, first for Assay Revenue and then for Contract Revenue.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:15pt;padding-left:27pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;Assay Revenue &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:9pt;padding-left:27pt"&gt;&lt;span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The Company generates revenues from its Pigmented Lesion Assay (&#x201c;PLA&#x201d;) and PLA&lt;/span&gt;&lt;span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;plus&lt;/span&gt;&lt;span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt; (now referred to as the DermTech Melanoma Test or &#x201c;DMT&#x201d; which may consist at the option of the ordering clinician of either (i) the PLA or (ii) the PLA and PLA&lt;/span&gt;&lt;span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;plus&lt;/span&gt;&lt;span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;), which assists a clinician&#x2019;s diagnosis of melanoma in patients. The Company provides prescribing clinicians with its Smart Sticker to perform non-invasive skin biopsies of clinically ambiguous pigmented skin lesions on patients. The Company also offers clinicians a telemedicine solution where they can request the Smart Sticker collection kit be sent to the patient&#x2019;s home for a clinician-guided remote collection on ambiguous pigmented skin lesions. A patient can also initiate the process by downloading the Company&#x2019;s telemedicine app, DermTech Connect, which uses store-and-forward technology to allow the patient to take a picture of a suspicious lesion with their phone and have the picture reviewed by an independent clinician who is subscribing to the DermTech Connect platform to assess the suspicious lesion, and if medically necessary, order a DMT where a collection kit would be sent to the patient&#x2019;s home. The DermTech Connect app and telemedicine service were initially beta tested in Florida and is currently available in most states where permitted by law and applicable standards of practice guidelines. Once the sample is collected by the patient via the telemedicine solution or by a healthcare clinician in person, it is returned to the Company&#x2019;s CLIA laboratory for analysis. The patient&#x2019;s ribonucleic acid (&#x201c;RNA&#x201d;) and deoxyribonucleic acid (&#x201c;DNA&#x201d;) are extracted from the Smart Sticker and analyzed using gene expression and sequencing technology to determine if the pigmented skin lesion contains certain genomic features indicative of melanoma. Upon completion of the gene expression analysis, a final report is drafted and provided to the clinician detailing the test results for the pigmented skin lesion indicating whether the sample collected is indicative of melanoma or not. &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:9pt;padding-left:27pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The Company periodically updates its estimate of the variable consideration recognized for previously delivered performance obligations. These updates resulted in an additional $0.1 million and $8,000 of revenue reported for the three and six months ended June 30, 2022, respectively, and an additional $0.1 million and $0.1&#160;million of revenue reported for the three and six months ended June 30, 2021, respectively. These amounts included (i) adjustments for actual collections versus estimated variable consideration as of the beginning of the reporting period and (ii) cash collections and the related recognition of revenue in the current period for tests delivered in prior periods due to the release of the constraint on variable consideration, offset by (iii) reductions in revenue for the accrual for reimbursement claims and settlements.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:15pt;padding-left:27pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;Contract Revenue&lt;/span&gt;&lt;/div&gt;&lt;div style="padding-left:27pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%"&gt;Contract revenue is generated from the sale of laboratory services and Smart Stickers to third-party companies through contract research agreements. Revenues are generated from providing genomic services to facilitate the development of drugs designed to treat dermatologic conditions. The provision of services may include sample collection using the Company&#x2019;s Smart Sticker, assay development for research partners, patient segmentation and stratification, extraction, isolation, expression, amplification and detection of RNA, DNA, protein and microbiome, including data analysis and reporting.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:15pt;padding-left:27pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;(a) Disaggregation of Revenue &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:9pt;padding-left:27pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The following table presents the Company&#x2019;s revenues disaggregated by revenue source during the three and six months ended June&#160;30, 2022 and 2021 (in thousands):&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:12pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:44.354%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:12.081%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.406%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:12.081%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.406%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:12.081%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.406%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:12.085%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Three Months Ended June 30,&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Six Months Ended June 30,&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Assay Revenue&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;DermTech Melanoma Test&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4,147&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,910&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;7,665&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;5,100&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Contract Revenue&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Adhesive patch kits&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;38&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;125&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;104&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;314&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;RNA extractions&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;35&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;110&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;139&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Project management fees&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;48&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;49&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;72&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;90&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total revenues&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4,233&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3,119&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;7,951&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;5,643&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-top:9pt;padding-left:27pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The following table sets forth the percentages of total revenue or accounts receivable for the Company&#x2019;s third-party payors that represent 10% or more of the respective amounts for the periods shown:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:12pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:16.778%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:12.081%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.406%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:12.081%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.406%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:12.081%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.406%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:12.081%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.406%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:12.081%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.406%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:12.087%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="21" style="border-bottom:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Total Revenues&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Accounts Receivable &lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height:12pt"&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="9" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Three Months Ended June 30,&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="9" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Six Months Ended June 30,&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" rowspan="2" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;As of June 30, 2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" rowspan="2" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;As of December 31, 2021&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height:12pt"&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Assay Revenue&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Payor A&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;47&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;36&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;39&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;34&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;21&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;23&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Payor B&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;*&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;*&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;*&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;*&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;15&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;15&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-top:6pt;padding-left:36pt;text-indent:-9pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;*&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%;padding-left:4pt"&gt;Less than 10%&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:9pt;padding-left:27pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;There were no other third-party payors or pharmaceutical customers that individually accounted for more than 10% of the Company&#x2019;s total revenue or accounts receivable for the periods shown in the table above.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:15pt;padding-left:27pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;(b) Deferred Revenue and Remaining Performance Obligations&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:9pt;padding-left:27pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The timing of revenue recognition, billings and cash collections results in billed accounts receivable and deferred revenue on the condensed consolidated balance sheets.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:9pt;padding-left:27pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;In a majority of historical agreements that produced contract revenue, the Company received a substantial up-front payment and additional payments upon the achievement of various milestones over the life of the agreement. This results in deferred revenue and is relieved upon delivery of the applicable Smart Stickers or RNA extraction results. Changes in accounts receivable and deferred revenue were not materially impacted by any other factors.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:9pt;padding-left:27pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The Company records a deferred revenue liability if a customer pays consideration before the Company transfers a good or service to the customer. Deferred revenue primarily represents upfront milestone payments, for which consideration is received prior to when goods/services are completed or delivered. Upfront fees that are estimated to be recognized as revenue more than one year from the date of collection are classified as long-term deferred revenue. Short-term deferred revenue as of June&#160;30, 2022 and December&#160;31, 2021 was $1.3 million and $1.4 million, respectively. &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:9pt;padding-left:27pt"&gt;&lt;span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Remaining performance obligations include deferred revenue and amounts the Company expects to receive for goods and services that have not yet been delivered or provided under existing agreements. For agreements that have an original duration of one year &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;or&lt;/span&gt;&lt;span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt; less, the Company has elected the practical expedient applicable to such agreements and does not disclose the remaining performance obligations at the end of each reporting period. As of June&#160;30, 2022, the estimated revenue expected to be recognized in future periods related to performance obligations that are unsatisfied for executed agreements with an original duration of one year or more was approximatel&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;y $0.1 million&lt;/span&gt;&lt;span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;. The Company expects to recognize revenue on the majority of these remaining performance obligations over the next &lt;span style="-sec-ix-hidden:id3VybDovL2RvY3MudjEvZG9jOmFlNWE5YmUwZWI5NDQ1ZDE5MmZhZTgyMmQyMmJlMDlmL3NlYzphZTVhOWJlMGViOTQ0NWQxOTJmYWU4MjJkMjJiZTA5Zl8zNy9mcmFnOjQ4OGNkZjBhODVlYzRiMDliYWFiN2JhZTlhODA5YjcwL3RleHRyZWdpb246NDg4Y2RmMGE4NWVjNGIwOWJhYWI3YmFlOWE4MDliNzBfMjUxODY_b4f0c6ee-fd6c-49c3-80df-d66815f5e42f"&gt;two&lt;/span&gt; to three years.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:15pt;padding-left:27pt;text-indent:-27pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;(i)&#160;&#160;&#160;&#160;Accounts Receivable &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:15pt;padding-left:27pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Assay Accounts Receivable &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:9pt;padding-left:27pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Due to the nature of the Company&#x2019;s assay revenue, it can take a significant amount of time to collect upon billed tests. The Company prepares an analysis on reimbursement collections and data obtained for each financial reporting period to determine the amount of receivables to be recorded relating to tests performed in the applicable period. The Company generally does not perform evaluations of customers&#x2019; financial condition and generally does not require collateral. Accounts receivables are written off when all efforts to collect the balance have been exhausted. Adjustments for implicit price concessions attributable to variable consideration are incorporated into the measurement of the accounts receivable balances. The Company recorded $5.8 million and $3.6 million of gross assay accounts receivable as of June&#160;30, 2022 and December&#160;31, 2021, respectively. Accounts receivable as of June&#160;30, 2022 included unbilled accounts receivable of $0.3 million. &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:15pt;padding-left:27pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Contract Accounts Receivable &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:9pt;padding-left:27pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Contract accounts receivable are recorded at the net invoice value and are not interest bearing. The Company reserves specific receivables if collectability is no longer reasonably assured, and as of June&#160;30, 2022, the Company did not maintain any reserves over contract receivables as they relate to large established credit worthy customers. The Company re-evaluates such reserves on a regular basis and adjusts its reserves as needed. Once a receivable is deemed to be uncollectible, such balance is charged against the reserve. The Company recorded $0.2 million and $0.2 million of contract accounts receivable as of June&#160;30, 2022 and December&#160;31, 2021, respectively. &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:15pt;padding-left:27pt;text-indent:-27pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;(j)&#160;&#160;&#160;&#160;Net Loss Per Share &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:9pt;padding-left:27pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Basic and diluted net loss per share of common stock is determined by dividing net loss applicable to holders of common stock by the weighted average number of shares of common stock outstanding during the period. Because there is a net loss attributable to holders of common stock during the three and six months ended June&#160;30, 2022 and 2021, the outstanding common stock warrants, stock options, and restricted stock units (&#x201c;RSUs&#x201d;) have been excluded from the calculation of diluted loss per share of common stock because their effect would be anti-dilutive. Therefore, the weighted average shares used to calculate both basic and diluted loss per share are the same. Diluted net loss per share of common stock for the three and six&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"&gt; &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;months ended June&#160;30, 2022 excludes the effect of anti-dilutive equity instruments including 714,261 shares of common stock issuable upon the exercise of outstanding common stock warrants and 4,670,069 shares of common stock issuable upon the exercise of stock options and release of RSUs. Diluted net loss per share of common stock for the three and six&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"&gt; &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;months ended June&#160;30, 2021 excludes the effect of anti-dilutive equity instruments including 749,210 shares of common stock then issuable upon the exercise of outstanding warrants and 2,469,816 shares of common stock then issuable upon the exercise of stock options and release of RSUs.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:15pt;padding-left:27pt;text-indent:-27pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;(k)&#160;&#160;&#160;&#160;Fair Value Measurements&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:9pt;padding-left:27pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The Company measures certain financial assets and liabilities at fair value on a recurring basis. Fair value is defined as the price that would be received to sell an asset or paid to transfer a liability (an exit price) in an orderly transaction between market participants at the measurement date. The Company uses a three-tier fair value hierarchy to prioritize the inputs used in the Company&#x2019;s fair value measurements. These tiers include: Level 1, defined as observable inputs such as quoted prices in active markets for identical assets; Level 2, defined as inputs other than quoted prices in active markets that are either directly or indirectly observable; and Level 3, defined as unobservable inputs in which little or no market data exists, therefore requiring an entity to develop its own assumptions. &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:9pt;padding-left:27pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The following table provides a summary of the assets and liabilities that are measured at fair value on a recurring basis as of June&#160;30, 2022 (in thousands): &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:12pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:44.354%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:12.081%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.406%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:12.081%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.406%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:12.081%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.406%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:12.085%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="21" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;June 30, 2022&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Level 1&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Level 2&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Level 3&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Total&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Assets:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Cash equivalents&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;30,723&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;30,723&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Restricted cash&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3,470&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3,470&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Marketable securities, available for sale:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Corporate debt securities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;15,092&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;15,092&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Municipal debt securities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3,641&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3,641&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;U.S. government debt securities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;34,724&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;34,724&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total marketable securities, available for sale&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;53,457&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;53,457&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Total assets measured at fair value on a recurring basis&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;34,193&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;53,457&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;87,650&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr style="height:15pt"&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:3pt double #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:3pt double #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:3pt double #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:3pt double #000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Liabilities:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Warrant liability&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;24&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;24&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Total liabilities measured at fair value on a recurring basis&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;24&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;24&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-top:9pt;padding-left:27pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The following table provides a summary of the assets and liabilities that are measured at fair value on a recurring basis as of December&#160;31, 2021 (in thousands): &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:12pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:44.354%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:12.081%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.406%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:12.081%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.406%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:12.081%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.406%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:12.085%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="21" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;December 31, 2021&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Level 1&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Level 2&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Level 3&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Total&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Assets:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Cash equivalents&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;16,380&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;16,380&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Restricted cash&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3,025&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3,025&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Marketable securities, available for sale:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Corporate debt&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;15,352&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;15,352&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Municipal debt securities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;7,412&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;7,412&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;U.S. government debt securities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;25,685&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;25,685&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total marketable securities, available for sale&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;48,449&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;48,449&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Total assets measured at fair value on a recurring basis&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;19,405&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;48,449&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;67,854&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr style="height:15pt"&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:3pt double #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:3pt double #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:3pt double #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:3pt double #000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Liabilities:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Warrant liability&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;146&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;146&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Total liabilities measured at fair value on a recurring basis&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;146&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;146&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-top:9pt;padding-left:27pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The Company&#x2019;s marketable debt securities are classified as available-for-sale securities based on management's intentions and are at Level 2 of the fair value hierarchy, as these investment securities are valued based upon quoted prices for identical or similar instruments in markets that are not active. The Company has classified marketable securities with original maturities of greater than one year as short-term investments based upon the Company&#x2019;s ability to use all of those marketable securities to satisfy the liquidity needs of the Company&#x2019;s current operations.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:9pt;padding-left:27pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The fair value of the Private SPAC Warrants (as defined below) was determined using the Black-Scholes-Merton valuation model and included an unobservable input: expected volatility. Expected volatility is considered by the Company to be an unobservable input and is calculated using a weighted average of historical volatilities of a combination of the Company and peer companies, due to the lack of sufficient historical data of the Company&#x2019;s own stock price. The model also incorporated several observable assumptions at each valuation date including: the price of the Company&#x2019;s common stock on the date of valuation, the remaining contractual term of the warrant and the risk-free interest rate over the remaining term.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:9pt;padding-left:27pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The following assumptions were used to calculate the fair value of the Company&#x2019;s warrant liability using the Black-Scholes-Merton valuation model:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:12pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:32.233%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:15.112%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.406%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:15.112%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.406%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:15.112%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.406%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:15.113%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Three Months Ended June 30,&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Six Months Ended June 30,&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Assumed risk-free interest rate&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2.96%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;0.46%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="text-align:center"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2.37% -2.96%&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="text-align:center"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;0.46% - 0.64%&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Assumed volatility&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;96.21%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;88.28%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="text-align:center"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;92.77% - 96.21%&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="text-align:center"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;85.85% - 88.28%&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Expected term&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2.17 years&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3.17 years&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="text-align:center"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2.17 - 2.42 years&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="text-align:center"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3.17 - 3.42 years&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Expected dividend yield&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-top:9pt;padding-left:27pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The following table summarizes the changes in the fair value of the Company&#x2019;s Level 3 liabilities (in thousands):&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:12pt;text-align:center"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:85.718%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:12.082%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Balance as of December 31, 2021&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;146&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Change in fair value of warrant liability&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(17)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Balance as of March 31, 2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;129&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Change in fair value of warrant liability&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(105)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Balance as of June 30, 2022&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;24&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-top:9pt;padding-left:27pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;As of June&#160;30, 2022 and December&#160;31, 2021, the Company maintains letters of credit of $3.5 million and $3.0&#160;million, respectively, related to its lease arrangements, which are secured by money market accounts in accordance with certain of its lease agreements. The amounts are recorded at fair value using Level 1 inputs and included as restricted cash in the condensed consolidated balance sheets.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:9pt;padding-left:27pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The Company believes the carrying amount of cash and cash equivalents, accounts payable and accrued expenses approximate their estimated fair values due to the short-term nature of these accounts.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:15pt;padding-left:27pt;text-indent:-27pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;(l)&#160;&#160;&#160;&#160;Accounting Pronouncements Issued But Not Yet Effective &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:9pt;padding-left:27pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;In June 2022, the Financial Accounting Standards Board issued ASU No. 2022-03, &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Fair Value Measurement of Equity Securities Subject to Contractual Sale Restrictions &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;("ASU 2022-03"). Under the guidance of ASU 2022-03, a contractual restriction on the sale of an equity security is not considered in measuring the security's fair value. ASU 2022-03 also requires certain disclosures for equity securities that are subject to contractual restrictions. For public business entities, the provisions of ASU 2022-03 are effective for fiscal years beginning after December 15, 2023, and interim periods within those fiscal years. For all other entities, the amendments are effective for fiscal years beginning after December 15, 2024, and interim periods within those fiscal years. Early adoption is permitted for both interim and annual financial statements that have not yet been issued or made available for issuance. The Company is still evaluating the impact of this pronouncement on the consolidated financial statements.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:9pt;padding-left:27pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The Company does not believe that any other recently issued, but not yet effective accounting pronouncements, if adopted, would have a material impact on its condensed consolidated financial statements or disclosures.&lt;/span&gt;&lt;/div&gt;</us-gaap:OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureAndSignificantAccountingPoliciesTextBlock>
    <us-gaap:NatureOfOperations
      contextRef="ia855382ada1f4f28aa8ef6da692ff177_D20220101-20220630"
      id="id3VybDovL2RvY3MudjEvZG9jOmFlNWE5YmUwZWI5NDQ1ZDE5MmZhZTgyMmQyMmJlMDlmL3NlYzphZTVhOWJlMGViOTQ0NWQxOTJmYWU4MjJkMjJiZTA5Zl8zNy9mcmFnOjQ4OGNkZjBhODVlYzRiMDliYWFiN2JhZTlhODA5YjcwL3RleHRyZWdpb246NDg4Y2RmMGE4NWVjNGIwOWJhYWI3YmFlOWE4MDliNzBfNDYyNjM_00a9099f-e35d-4473-a8f6-35e3b0efc740">Nature of Operations &lt;div style="margin-top:9pt;padding-left:27pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;On August 29, 2019, DermTech, Inc., formerly known as Constellation Alpha Capital Corp, (the &#x201c;Company&#x201d;), and DermTech Operations, Inc., formerly known as DermTech, Inc., (&#x201c;DermTech Operations&#x201d;), consummated the transactions contemplated by the Agreement and Plan of Merger, dated as of May 29, 2019, by and among the Company, DT Merger Sub, Inc., a wholly owned subsidiary of the Company (&#x201c;Merger Sub&#x201d;), and DermTech Operations. The Company refers to this agreement, as amended by that certain First Amendment to Agreement and Plan of Merger dated as of August 1, 2019, as the Merger Agreement. Pursuant to the Merger Agreement, Merger Sub merged with and into DermTech Operations, with DermTech Operations surviving as a wholly-owned subsidiary of the Company. The Company refers to this transaction as the Business Combination. In connection with and two days prior to the completion of the Business Combination, the Company domesticated from the British Virgin Islands to Delaware. DermTech Operations changed its name from DermTech, Inc. to DermTech Operations, Inc. shortly before the completion of the Business Combination. On August 29, 2019, immediately following the completion of the Business Combination, the Company changed its name from Constellation Alpha Capital Corp. to DermTech, Inc., and then effected a one-for-two reverse stock split of its common stock. &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:9pt;padding-left:27pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The Company is a molecular diagnostic company developing and marketing its Clinical Laboratory Improvement Amendments of 1988 (&#x201c;CLIA&#x201d;) laboratory services including genomic tests to facilitate the diagnosis of dermatologic conditions including melanoma. The Company has developed a proprietary, non-invasive technique for sampling the surface layers of the skin using an adhesive patch called the DermTech Smart Sticker&#x2122; (the &#x201c;Smart Sticker&#x201d;) to collect biological information for commercial applications in the medical diagnostic field.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:9pt;padding-left:27pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;From the end of the first quarter of 2020 and through the second quarter of 2022, there has been a widespread worldwide impact from the COVID-19 pandemic. The Company is considered an essential business due to the importance of early melanoma detection, which has allowed the Company&#x2019;s CLIA laboratory to remain fully operational. The Company implemented additional safety measures in accordance with Centers for Disease Control and Prevention (&#x201c;CDC&#x201d;), Occupational Safety and Health Administration (&#x201c;OSHA&#x201d;) and other guidance within its CLIA laboratory operations. Additionally, and during this time, the Company transitioned administrative functions to predominantly remote work. Beginning in March 2020 and continuing through the second quarter of 2022, the ongoing COVID-19 pandemic has reduced patient access to clinician offices for in-person testing and reduced access by the Company&#x2019;s sales force for in-office sales calls, which has resulted in a reduced volume of billable samples received during the second quarter of 2022 relative to the Company&#x2019;s pre-pandemic expectations. The Company expects the ongoing COVID-19 pandemic to continue to adversely impact billable sample volume until patient access to in-person testing fully resumes, in-office access by the Company&#x2019;s sales force returns to pre-pandemic levels, or telemedicine options are more widely adopted. Additionally, the ongoing COVID-19 pandemic has negatively affected and may continue to negatively affect the Company&#x2019;s pharmaceutical customers&#x2019; clinical trials. The extent to which the COVID-19 pandemic will affect the Company&#x2019;s future revenue is uncertain and will depend on the duration and extent of the effects of the ongoing COVID-19 pandemic, including the effects on the Company&#x2019;s pharmaceutical customers&#x2019; clinical trials.&lt;/span&gt;&lt;/div&gt;</us-gaap:NatureOfOperations>
    <us-gaap:BasisOfAccountingPolicyPolicyTextBlock
      contextRef="ia855382ada1f4f28aa8ef6da692ff177_D20220101-20220630"
      id="id3VybDovL2RvY3MudjEvZG9jOmFlNWE5YmUwZWI5NDQ1ZDE5MmZhZTgyMmQyMmJlMDlmL3NlYzphZTVhOWJlMGViOTQ0NWQxOTJmYWU4MjJkMjJiZTA5Zl8zNy9mcmFnOjQ4OGNkZjBhODVlYzRiMDliYWFiN2JhZTlhODA5YjcwL3RleHRyZWdpb246NDg4Y2RmMGE4NWVjNGIwOWJhYWI3YmFlOWE4MDliNzBfNDYyNDE_0104ddc6-f405-4a17-a3e4-59336123921d">Basis of PresentationThe condensed consolidated financial statements include the accounts of DermTech, Inc. and its subsidiaries. All intercompany balances and transactions among the consolidated entity have been eliminated in consolidation. These unaudited condensed consolidated financial statements have been prepared in accordance with U.S. generally accepted accounting principles (&#x201c;U.S. GAAP&#x201d;) for interim financial information and with the instructions to Form 10-Q and Article 10 of Securities and Exchange Commission (&#x201c;SEC&#x201d;), Regulation S-X. Accordingly, these unaudited condensed consolidated financial statements and accompanying notes do not include all the information and disclosures required by U.S. GAAP for complete financial statements and should be read together with the audited consolidated financial statements included in the Company&#x2019;s Annual Report on Form 10-K for the fiscal year ended December 31, 2021. In the opinion of management, all adjustments, which include only normal recurring adjustments considered necessary for a fair presentation, have been included. The accompanying unaudited condensed consolidated financial statements reflect the application of certain significant accounting policies as described below and elsewhere in these notes to the unaudited condensed consolidated financial statements. As of June 30, 2022, there have been no material changes in the Company's significant accounting policies from those that were disclosed in the Company&#x2019;s Annual Report on Form 10-K for the year ended December 31, 2021.</us-gaap:BasisOfAccountingPolicyPolicyTextBlock>
    <us-gaap:PriorPeriodReclassificationAdjustmentDescription
      contextRef="ia855382ada1f4f28aa8ef6da692ff177_D20220101-20220630"
      id="id3VybDovL2RvY3MudjEvZG9jOmFlNWE5YmUwZWI5NDQ1ZDE5MmZhZTgyMmQyMmJlMDlmL3NlYzphZTVhOWJlMGViOTQ0NWQxOTJmYWU4MjJkMjJiZTA5Zl8zNy9mcmFnOjQ4OGNkZjBhODVlYzRiMDliYWFiN2JhZTlhODA5YjcwL3RleHRyZWdpb246NDg4Y2RmMGE4NWVjNGIwOWJhYWI3YmFlOWE4MDliNzBfNDYyMzg_d1729152-b764-4729-8889-ca25c3a823f8">Reclassifications&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Certain prior period information on the condensed consolidated statement of cash flows for the six months ended June 30, 2021 has been reclassified to conform to the current year presentation as a result of adopting Accounting Standards Update ("ASU") No. 2016-02, &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Leases (Topic 842)&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt; ("ASU 2016-02"). These reclassifications did not have an impact on net cash flows. For additional disclosure and detail, see Note 4 of the notes to the unaudited condensed consolidated financial statements, &#x201c;Adoption of ASC 842.&#x201d;&lt;/span&gt;</us-gaap:PriorPeriodReclassificationAdjustmentDescription>
    <us-gaap:UseOfEstimates
      contextRef="ia855382ada1f4f28aa8ef6da692ff177_D20220101-20220630"
      id="id3VybDovL2RvY3MudjEvZG9jOmFlNWE5YmUwZWI5NDQ1ZDE5MmZhZTgyMmQyMmJlMDlmL3NlYzphZTVhOWJlMGViOTQ0NWQxOTJmYWU4MjJkMjJiZTA5Zl8zNy9mcmFnOjQ4OGNkZjBhODVlYzRiMDliYWFiN2JhZTlhODA5YjcwL3RleHRyZWdpb246NDg4Y2RmMGE4NWVjNGIwOWJhYWI3YmFlOWE4MDliNzBfNDYyNTE_39f3a64e-ec66-477e-b404-79ea24ec3c80">Use of Estimates The preparation of condensed consolidated financial statements in conformity with U.S. GAAP requires that management make estimates and assumptions that affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the date of the condensed consolidated financial statements and the amounts of revenues and expenses reported during the period. On an ongoing basis, management evaluates these estimates and judgments, including but not limited to those related to assay revenue, stock-based compensation, short-term marketable securities, accounts receivable, accrued bonus, warrant liability, right-of-use (&#x201c;ROU&#x201d;) assets and the realization of deferred tax assets. Actual results may differ from those estimates.</us-gaap:UseOfEstimates>
    <us-gaap:CashAndCashEquivalentsRestrictedCashAndCashEquivalentsPolicy
      contextRef="ia855382ada1f4f28aa8ef6da692ff177_D20220101-20220630"
      id="id3VybDovL2RvY3MudjEvZG9jOmFlNWE5YmUwZWI5NDQ1ZDE5MmZhZTgyMmQyMmJlMDlmL3NlYzphZTVhOWJlMGViOTQ0NWQxOTJmYWU4MjJkMjJiZTA5Zl8zNy9mcmFnOjQ4OGNkZjBhODVlYzRiMDliYWFiN2JhZTlhODA5YjcwL3RleHRyZWdpb246NDg4Y2RmMGE4NWVjNGIwOWJhYWI3YmFlOWE4MDliNzBfNDYyNjQ_03c78806-f3ca-41ea-aa36-dcd7710467de">Cash, Cash Equivalents and Restricted Cash&lt;div style="margin-top:9pt;padding-left:27pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The Company considers all highly liquid investments with remaining maturities of three months or less when purchased to be cash equivalents. The Company maintains its cash balances at banks and financial institutions. The balances are insured up to the Federal Deposit Insurance Corporation legal limit. The Company maintains cash balances that have in the past and may, at times, exceed this insured limit. &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:9pt;padding-left:27pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Restricted cash consists of cash deposited with a financial institution as collateral for the Company&#x2019;s letters of credit for its facility leases. Restricted cash is classified as noncurrent based on the terms of the underlying lease arrangement.&lt;/span&gt;&lt;/div&gt;</us-gaap:CashAndCashEquivalentsRestrictedCashAndCashEquivalentsPolicy>
    <us-gaap:PropertyPlantAndEquipmentPolicyTextBlock
      contextRef="ia855382ada1f4f28aa8ef6da692ff177_D20220101-20220630"
      id="id3VybDovL2RvY3MudjEvZG9jOmFlNWE5YmUwZWI5NDQ1ZDE5MmZhZTgyMmQyMmJlMDlmL3NlYzphZTVhOWJlMGViOTQ0NWQxOTJmYWU4MjJkMjJiZTA5Zl8zNy9mcmFnOjQ4OGNkZjBhODVlYzRiMDliYWFiN2JhZTlhODA5YjcwL3RleHRyZWdpb246NDg4Y2RmMGE4NWVjNGIwOWJhYWI3YmFlOWE4MDliNzBfNDYyNTI_6fa27ab8-94d9-4562-9c38-7bcf7ea9071a">Property and Equipment, Net Property and equipment, net is recorded at cost less accumulated depreciation. Property and equipment consists mainly of assets such as leasehold improvements, office, computer and laboratory equipment, including laboratory equipment acquired under finance lease arrangements. Depreciation is computed using the straight-line method over the estimated useful lives of the assets, which range from &lt;span style="-sec-ix-hidden:id3VybDovL2RvY3MudjEvZG9jOmFlNWE5YmUwZWI5NDQ1ZDE5MmZhZTgyMmQyMmJlMDlmL3NlYzphZTVhOWJlMGViOTQ0NWQxOTJmYWU4MjJkMjJiZTA5Zl8zNy9mcmFnOjQ4OGNkZjBhODVlYzRiMDliYWFiN2JhZTlhODA5YjcwL3RleHRyZWdpb246NDg4Y2RmMGE4NWVjNGIwOWJhYWI3YmFlOWE4MDliNzBfMTQ0NDA_b7f0ce5d-c748-4105-a8ca-a2d7278a0959"&gt;two&lt;/span&gt; to eleven years. Leasehold improvements are depreciated over the shorter of the remaining term of the lease or the useful life of the asset. The Company recorded depreciation expense of $0.4 million and $0.2 million for the three months ended June&#160;30, 2022 and 2021, respectively, which includes amortization of laboratory equipment acquired under finance leases (previously referred to as &#x201c;capital leases&#x201d;) of $21,000 and $17,000 for the three months ended June&#160;30, 2022 and 2021, respectively. The Company recorded depreciation expense of $0.8 million and $0.4 million for the six months ended June&#160;30, 2022 and 2021, respectively, which includes amortization of laboratory equipment acquired under finance leases of $41,000 and $34,000 for the six months ended June&#160;30, 2022 and 2021, respectively. &lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Amortization of assets that are recorded under finance leases in depreciation expense is included in cost of revenues on the condensed consolidated statements of operations. Gross assets recorded under finance leases were $0.4 million as of June&#160;30, 2022 and December&#160;31, 2021. Accumulated amortization associated with finance leases was $0.1 million as of June&#160;30, 2022 and December&#160;31, 2021. Maintenance and repairs are expensed as incurred, and material improvements are capitalized. When assets are retired or otherwise disposed of, the cost and accumulated depreciation are removed from the balance sheet and any resulting gain or loss is reflected in the condensed consolidated statements of operations in the period realized. &lt;/span&gt;&lt;span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The Company disposed of $0.3 million of equipment for the three months ended June&#160;30, 2022 and no equipment for the three months ended June&#160;30, 2021&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;. The Company disposed of $0.3 million and $13,000 of equipment for the six months ended June&#160;30, 2022 and &lt;/span&gt;&lt;span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;2021&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;, respectively. &lt;/span&gt;The Company assesses its long-lived assets, consisting primarily of property and equipment, for impairment when material events or changes in circumstances indicate that the carrying value may not be recoverable.</us-gaap:PropertyPlantAndEquipmentPolicyTextBlock>
    <us-gaap:PropertyPlantAndEquipmentUsefulLife
      contextRef="i9069aff5693b479db8eb460a09c920a0_D20220101-20220630"
      id="id3VybDovL2RvY3MudjEvZG9jOmFlNWE5YmUwZWI5NDQ1ZDE5MmZhZTgyMmQyMmJlMDlmL3NlYzphZTVhOWJlMGViOTQ0NWQxOTJmYWU4MjJkMjJiZTA5Zl8zNy9mcmFnOjQ4OGNkZjBhODVlYzRiMDliYWFiN2JhZTlhODA5YjcwL3RleHRyZWdpb246NDg4Y2RmMGE4NWVjNGIwOWJhYWI3YmFlOWE4MDliNzBfMTQ0NDY_82c45ac1-77c4-4bfb-a17b-ac011ec8aa27">P11Y</us-gaap:PropertyPlantAndEquipmentUsefulLife>
    <us-gaap:Depreciation
      contextRef="i2c5f0f28773744e5a2e202f2943ae976_D20220401-20220630"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmFlNWE5YmUwZWI5NDQ1ZDE5MmZhZTgyMmQyMmJlMDlmL3NlYzphZTVhOWJlMGViOTQ0NWQxOTJmYWU4MjJkMjJiZTA5Zl8zNy9mcmFnOjQ4OGNkZjBhODVlYzRiMDliYWFiN2JhZTlhODA5YjcwL3RleHRyZWdpb246NDg4Y2RmMGE4NWVjNGIwOWJhYWI3YmFlOWE4MDliNzBfMTQ2MTk_e0d25151-be27-40c3-ab98-907592e11339"
      unitRef="usd">400000</us-gaap:Depreciation>
    <us-gaap:Depreciation
      contextRef="id7bb773872394047ba26aa8a7a0f4d56_D20210401-20210630"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmFlNWE5YmUwZWI5NDQ1ZDE5MmZhZTgyMmQyMmJlMDlmL3NlYzphZTVhOWJlMGViOTQ0NWQxOTJmYWU4MjJkMjJiZTA5Zl8zNy9mcmFnOjQ4OGNkZjBhODVlYzRiMDliYWFiN2JhZTlhODA5YjcwL3RleHRyZWdpb246NDg4Y2RmMGE4NWVjNGIwOWJhYWI3YmFlOWE4MDliNzBfMTQ2MjY_095d9948-2f33-48f4-aef8-c3e1292bb556"
      unitRef="usd">200000</us-gaap:Depreciation>
    <us-gaap:Depreciation
      contextRef="i6013cc6ffa8a44399380d7ab2a84d3ef_D20220401-20220630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmFlNWE5YmUwZWI5NDQ1ZDE5MmZhZTgyMmQyMmJlMDlmL3NlYzphZTVhOWJlMGViOTQ0NWQxOTJmYWU4MjJkMjJiZTA5Zl8zNy9mcmFnOjQ4OGNkZjBhODVlYzRiMDliYWFiN2JhZTlhODA5YjcwL3RleHRyZWdpb246NDg4Y2RmMGE4NWVjNGIwOWJhYWI3YmFlOWE4MDliNzBfMTQ4MTE_9a5d5cd1-b700-4935-9b95-b736ebdbbbfe"
      unitRef="usd">21000</us-gaap:Depreciation>
    <us-gaap:Depreciation
      contextRef="i746f81de13474498bf13734eea25d645_D20210401-20210630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmFlNWE5YmUwZWI5NDQ1ZDE5MmZhZTgyMmQyMmJlMDlmL3NlYzphZTVhOWJlMGViOTQ0NWQxOTJmYWU4MjJkMjJiZTA5Zl8zNy9mcmFnOjQ4OGNkZjBhODVlYzRiMDliYWFiN2JhZTlhODA5YjcwL3RleHRyZWdpb246NDg4Y2RmMGE4NWVjNGIwOWJhYWI3YmFlOWE4MDliNzBfMTQ4MTg_61d0e157-3929-492d-a267-c3983b2dda18"
      unitRef="usd">17000</us-gaap:Depreciation>
    <us-gaap:Depreciation
      contextRef="ia855382ada1f4f28aa8ef6da692ff177_D20220101-20220630"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmFlNWE5YmUwZWI5NDQ1ZDE5MmZhZTgyMmQyMmJlMDlmL3NlYzphZTVhOWJlMGViOTQ0NWQxOTJmYWU4MjJkMjJiZTA5Zl8zNy9mcmFnOjQ4OGNkZjBhODVlYzRiMDliYWFiN2JhZTlhODA5YjcwL3RleHRyZWdpb246NDg4Y2RmMGE4NWVjNGIwOWJhYWI3YmFlOWE4MDliNzBfMTQ5MTg_d7761aa4-cf2c-4f62-8586-f52e9a5553f1"
      unitRef="usd">800000</us-gaap:Depreciation>
    <us-gaap:Depreciation
      contextRef="idaa4f31ca59a4a17a59c2580b97791ca_D20210101-20210630"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmFlNWE5YmUwZWI5NDQ1ZDE5MmZhZTgyMmQyMmJlMDlmL3NlYzphZTVhOWJlMGViOTQ0NWQxOTJmYWU4MjJkMjJiZTA5Zl8zNy9mcmFnOjQ4OGNkZjBhODVlYzRiMDliYWFiN2JhZTlhODA5YjcwL3RleHRyZWdpb246NDg4Y2RmMGE4NWVjNGIwOWJhYWI3YmFlOWE4MDliNzBfMTQ5MjU_87bf0253-0479-4868-96d1-1f40bc0d9183"
      unitRef="usd">400000</us-gaap:Depreciation>
    <us-gaap:Depreciation
      contextRef="i74a9fc9070b8404997fc0c10022dc50e_D20220101-20220630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmFlNWE5YmUwZWI5NDQ1ZDE5MmZhZTgyMmQyMmJlMDlmL3NlYzphZTVhOWJlMGViOTQ0NWQxOTJmYWU4MjJkMjJiZTA5Zl8zNy9mcmFnOjQ4OGNkZjBhODVlYzRiMDliYWFiN2JhZTlhODA5YjcwL3RleHRyZWdpb246NDg4Y2RmMGE4NWVjNGIwOWJhYWI3YmFlOWE4MDliNzBfMTUwNjI_aa930421-94f9-4150-94d2-208f984bf772"
      unitRef="usd">41000</us-gaap:Depreciation>
    <us-gaap:Depreciation
      contextRef="i3e76258aea994808ac778298cc3389ab_D20210101-20210630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmFlNWE5YmUwZWI5NDQ1ZDE5MmZhZTgyMmQyMmJlMDlmL3NlYzphZTVhOWJlMGViOTQ0NWQxOTJmYWU4MjJkMjJiZTA5Zl8zNy9mcmFnOjQ4OGNkZjBhODVlYzRiMDliYWFiN2JhZTlhODA5YjcwL3RleHRyZWdpb246NDg4Y2RmMGE4NWVjNGIwOWJhYWI3YmFlOWE4MDliNzBfMTUwNjk_ae9523ab-41ba-4af5-8592-21966058c48c"
      unitRef="usd">34000</us-gaap:Depreciation>
    <us-gaap:PropertyPlantAndEquipmentGross
      contextRef="ic89cf2db98344df4a59437fe3569a1d2_I20211231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmFlNWE5YmUwZWI5NDQ1ZDE5MmZhZTgyMmQyMmJlMDlmL3NlYzphZTVhOWJlMGViOTQ0NWQxOTJmYWU4MjJkMjJiZTA5Zl8zNy9mcmFnOjQ4OGNkZjBhODVlYzRiMDliYWFiN2JhZTlhODA5YjcwL3RleHRyZWdpb246NDg4Y2RmMGE4NWVjNGIwOWJhYWI3YmFlOWE4MDliNzBfMTUzNDM_adb4fe1c-7364-446f-ba49-0e138ec0101d"
      unitRef="usd">400000</us-gaap:PropertyPlantAndEquipmentGross>
    <us-gaap:PropertyPlantAndEquipmentGross
      contextRef="if5c0f2a68220406b8c328b2744af6512_I20220630"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmFlNWE5YmUwZWI5NDQ1ZDE5MmZhZTgyMmQyMmJlMDlmL3NlYzphZTVhOWJlMGViOTQ0NWQxOTJmYWU4MjJkMjJiZTA5Zl8zNy9mcmFnOjQ4OGNkZjBhODVlYzRiMDliYWFiN2JhZTlhODA5YjcwL3RleHRyZWdpb246NDg4Y2RmMGE4NWVjNGIwOWJhYWI3YmFlOWE4MDliNzBfMTUzNDM_b9af2a6f-e493-4714-9a73-ba49bfaeea88"
      unitRef="usd">400000</us-gaap:PropertyPlantAndEquipmentGross>
    <us-gaap:DepreciationAndAmortization
      contextRef="i72b0a574a3fc4d02a8355d41f4d3c3f7_D20220101-20220630"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmFlNWE5YmUwZWI5NDQ1ZDE5MmZhZTgyMmQyMmJlMDlmL3NlYzphZTVhOWJlMGViOTQ0NWQxOTJmYWU4MjJkMjJiZTA5Zl8zNy9mcmFnOjQ4OGNkZjBhODVlYzRiMDliYWFiN2JhZTlhODA5YjcwL3RleHRyZWdpb246NDg4Y2RmMGE4NWVjNGIwOWJhYWI3YmFlOWE4MDliNzBfMTU0NDQ_91ff4285-a018-4b69-901c-f65ccfcd204d"
      unitRef="usd">100000</us-gaap:DepreciationAndAmortization>
    <us-gaap:DepreciationAndAmortization
      contextRef="i90781b7d5b3d4c93943bc5e09860112d_D20210101-20211231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmFlNWE5YmUwZWI5NDQ1ZDE5MmZhZTgyMmQyMmJlMDlmL3NlYzphZTVhOWJlMGViOTQ0NWQxOTJmYWU4MjJkMjJiZTA5Zl8zNy9mcmFnOjQ4OGNkZjBhODVlYzRiMDliYWFiN2JhZTlhODA5YjcwL3RleHRyZWdpb246NDg4Y2RmMGE4NWVjNGIwOWJhYWI3YmFlOWE4MDliNzBfMTU0NDQ_f3995695-affd-40bc-adf2-bba31f5094f5"
      unitRef="usd">100000</us-gaap:DepreciationAndAmortization>
    <us-gaap:PropertyPlantAndEquipmentDisposals
      contextRef="i2c5f0f28773744e5a2e202f2943ae976_D20220401-20220630"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmFlNWE5YmUwZWI5NDQ1ZDE5MmZhZTgyMmQyMmJlMDlmL3NlYzphZTVhOWJlMGViOTQ0NWQxOTJmYWU4MjJkMjJiZTA5Zl8zNy9mcmFnOjQ4OGNkZjBhODVlYzRiMDliYWFiN2JhZTlhODA5YjcwL3RleHRyZWdpb246NDg4Y2RmMGE4NWVjNGIwOWJhYWI3YmFlOWE4MDliNzBfMTU4NDg_4493a068-3ee4-44e8-9025-ea0e7e7f5320"
      unitRef="usd">300000</us-gaap:PropertyPlantAndEquipmentDisposals>
    <us-gaap:PropertyPlantAndEquipmentDisposals
      contextRef="id7bb773872394047ba26aa8a7a0f4d56_D20210401-20210630"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmFlNWE5YmUwZWI5NDQ1ZDE5MmZhZTgyMmQyMmJlMDlmL3NlYzphZTVhOWJlMGViOTQ0NWQxOTJmYWU4MjJkMjJiZTA5Zl8zNy9mcmFnOjQ4OGNkZjBhODVlYzRiMDliYWFiN2JhZTlhODA5YjcwL3RleHRyZWdpb246NDg4Y2RmMGE4NWVjNGIwOWJhYWI3YmFlOWE4MDliNzBfMTY0OTI2NzYxODA2MQ_a1f644cc-5911-4502-a592-4c7892fc1889"
      unitRef="usd">0</us-gaap:PropertyPlantAndEquipmentDisposals>
    <us-gaap:PropertyPlantAndEquipmentDisposals
      contextRef="ia855382ada1f4f28aa8ef6da692ff177_D20220101-20220630"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmFlNWE5YmUwZWI5NDQ1ZDE5MmZhZTgyMmQyMmJlMDlmL3NlYzphZTVhOWJlMGViOTQ0NWQxOTJmYWU4MjJkMjJiZTA5Zl8zNy9mcmFnOjQ4OGNkZjBhODVlYzRiMDliYWFiN2JhZTlhODA5YjcwL3RleHRyZWdpb246NDg4Y2RmMGE4NWVjNGIwOWJhYWI3YmFlOWE4MDliNzBfMTU5NDc_b5cf91a9-69e7-48c4-b7ae-91dad4777644"
      unitRef="usd">300000</us-gaap:PropertyPlantAndEquipmentDisposals>
    <us-gaap:PropertyPlantAndEquipmentDisposals
      contextRef="idaa4f31ca59a4a17a59c2580b97791ca_D20210101-20210630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmFlNWE5YmUwZWI5NDQ1ZDE5MmZhZTgyMmQyMmJlMDlmL3NlYzphZTVhOWJlMGViOTQ0NWQxOTJmYWU4MjJkMjJiZTA5Zl8zNy9mcmFnOjQ4OGNkZjBhODVlYzRiMDliYWFiN2JhZTlhODA5YjcwL3RleHRyZWdpb246NDg4Y2RmMGE4NWVjNGIwOWJhYWI3YmFlOWE4MDliNzBfMTU5NTQ_8e05f5da-7a08-459e-a24f-5f2c34d82068"
      unitRef="usd">13000</us-gaap:PropertyPlantAndEquipmentDisposals>
    <us-gaap:ImpairmentOfLongLivedAssetsToBeDisposedOf
      contextRef="id7bb773872394047ba26aa8a7a0f4d56_D20210401-20210630"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmFlNWE5YmUwZWI5NDQ1ZDE5MmZhZTgyMmQyMmJlMDlmL3NlYzphZTVhOWJlMGViOTQ0NWQxOTJmYWU4MjJkMjJiZTA5Zl8zNy9mcmFnOjQ4OGNkZjBhODVlYzRiMDliYWFiN2JhZTlhODA5YjcwL3RleHRyZWdpb246NDg4Y2RmMGE4NWVjNGIwOWJhYWI3YmFlOWE4MDliNzBfMTYyNDM_1b78d049-02ba-401c-b769-afe18d8123fc"
      unitRef="usd">0</us-gaap:ImpairmentOfLongLivedAssetsToBeDisposedOf>
    <us-gaap:ImpairmentOfLongLivedAssetsToBeDisposedOf
      contextRef="ia855382ada1f4f28aa8ef6da692ff177_D20220101-20220630"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmFlNWE5YmUwZWI5NDQ1ZDE5MmZhZTgyMmQyMmJlMDlmL3NlYzphZTVhOWJlMGViOTQ0NWQxOTJmYWU4MjJkMjJiZTA5Zl8zNy9mcmFnOjQ4OGNkZjBhODVlYzRiMDliYWFiN2JhZTlhODA5YjcwL3RleHRyZWdpb246NDg4Y2RmMGE4NWVjNGIwOWJhYWI3YmFlOWE4MDliNzBfMTYyNDM_236f9072-c8ab-4e17-aba7-4965cc4edcc3"
      unitRef="usd">0</us-gaap:ImpairmentOfLongLivedAssetsToBeDisposedOf>
    <us-gaap:ImpairmentOfLongLivedAssetsToBeDisposedOf
      contextRef="idaa4f31ca59a4a17a59c2580b97791ca_D20210101-20210630"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmFlNWE5YmUwZWI5NDQ1ZDE5MmZhZTgyMmQyMmJlMDlmL3NlYzphZTVhOWJlMGViOTQ0NWQxOTJmYWU4MjJkMjJiZTA5Zl8zNy9mcmFnOjQ4OGNkZjBhODVlYzRiMDliYWFiN2JhZTlhODA5YjcwL3RleHRyZWdpb246NDg4Y2RmMGE4NWVjNGIwOWJhYWI3YmFlOWE4MDliNzBfMTYyNDM_84d97e54-efab-49bf-abf2-75378115e828"
      unitRef="usd">0</us-gaap:ImpairmentOfLongLivedAssetsToBeDisposedOf>
    <us-gaap:ImpairmentOfLongLivedAssetsToBeDisposedOf
      contextRef="i2c5f0f28773744e5a2e202f2943ae976_D20220401-20220630"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmFlNWE5YmUwZWI5NDQ1ZDE5MmZhZTgyMmQyMmJlMDlmL3NlYzphZTVhOWJlMGViOTQ0NWQxOTJmYWU4MjJkMjJiZTA5Zl8zNy9mcmFnOjQ4OGNkZjBhODVlYzRiMDliYWFiN2JhZTlhODA5YjcwL3RleHRyZWdpb246NDg4Y2RmMGE4NWVjNGIwOWJhYWI3YmFlOWE4MDliNzBfMTYyNDM_e72f3feb-c1a2-4903-ae61-c1d3fb39dab4"
      unitRef="usd">0</us-gaap:ImpairmentOfLongLivedAssetsToBeDisposedOf>
    <us-gaap:ConcentrationRiskCreditRisk
      contextRef="ia855382ada1f4f28aa8ef6da692ff177_D20220101-20220630"
      id="id3VybDovL2RvY3MudjEvZG9jOmFlNWE5YmUwZWI5NDQ1ZDE5MmZhZTgyMmQyMmJlMDlmL3NlYzphZTVhOWJlMGViOTQ0NWQxOTJmYWU4MjJkMjJiZTA5Zl8zNy9mcmFnOjQ4OGNkZjBhODVlYzRiMDliYWFiN2JhZTlhODA5YjcwL3RleHRyZWdpb246NDg4Y2RmMGE4NWVjNGIwOWJhYWI3YmFlOWE4MDliNzBfNDYyNDA_8e9aa319-f9b2-40ad-9626-b1ba40871d45">Concentration of Credit Risk Financial instruments that potentially subject the Company to significant concentrations of credit risk consist primarily of cash and cash equivalents. As of June&#160;30, 2022, the Company maintained $87.1 million in a sweep account, which maintains cash balances throughout various interest-bearing bank accounts under the $250,000 insurance limit provided by the Federal Deposit Insurance Corporation for one federally insured financial institution.</us-gaap:ConcentrationRiskCreditRisk>
    <us-gaap:DepositsMoneyMarketDeposits
      contextRef="i4c8f247d12134a9886d56e1c8b024425_I20220630"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmFlNWE5YmUwZWI5NDQ1ZDE5MmZhZTgyMmQyMmJlMDlmL3NlYzphZTVhOWJlMGViOTQ0NWQxOTJmYWU4MjJkMjJiZTA5Zl8zNy9mcmFnOjQ4OGNkZjBhODVlYzRiMDliYWFiN2JhZTlhODA5YjcwL3RleHRyZWdpb246NDg4Y2RmMGE4NWVjNGIwOWJhYWI3YmFlOWE4MDliNzBfMTcyMTI_38ca6669-84c5-4426-b4bd-750011a5c506"
      unitRef="usd">87100000</us-gaap:DepositsMoneyMarketDeposits>
    <us-gaap:CashFDICInsuredAmount
      contextRef="i4c8f247d12134a9886d56e1c8b024425_I20220630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmFlNWE5YmUwZWI5NDQ1ZDE5MmZhZTgyMmQyMmJlMDlmL3NlYzphZTVhOWJlMGViOTQ0NWQxOTJmYWU4MjJkMjJiZTA5Zl8zNy9mcmFnOjQ4OGNkZjBhODVlYzRiMDliYWFiN2JhZTlhODA5YjcwL3RleHRyZWdpb246NDg4Y2RmMGE4NWVjNGIwOWJhYWI3YmFlOWE4MDliNzBfMTczMjU_44eeb4ec-f687-4b64-ba63-70e1c22cc0e0"
      unitRef="usd">250000</us-gaap:CashFDICInsuredAmount>
    <us-gaap:CashUninsuredAmount
      contextRef="i4c8f247d12134a9886d56e1c8b024425_I20220630"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmFlNWE5YmUwZWI5NDQ1ZDE5MmZhZTgyMmQyMmJlMDlmL3NlYzphZTVhOWJlMGViOTQ0NWQxOTJmYWU4MjJkMjJiZTA5Zl8zNy9mcmFnOjQ4OGNkZjBhODVlYzRiMDliYWFiN2JhZTlhODA5YjcwL3RleHRyZWdpb246NDg4Y2RmMGE4NWVjNGIwOWJhYWI3YmFlOWE4MDliNzBfMTc0NjE_91c48128-e956-44bb-bfd3-97f12ff55392"
      unitRef="usd">2500000</us-gaap:CashUninsuredAmount>
    <us-gaap:RevenueRecognitionPolicyTextBlock
      contextRef="ia855382ada1f4f28aa8ef6da692ff177_D20220101-20220630"
      id="id3VybDovL2RvY3MudjEvZG9jOmFlNWE5YmUwZWI5NDQ1ZDE5MmZhZTgyMmQyMmJlMDlmL3NlYzphZTVhOWJlMGViOTQ0NWQxOTJmYWU4MjJkMjJiZTA5Zl8zNy9mcmFnOjQ4OGNkZjBhODVlYzRiMDliYWFiN2JhZTlhODA5YjcwL3RleHRyZWdpb246NDg4Y2RmMGE4NWVjNGIwOWJhYWI3YmFlOWE4MDliNzBfNDYyMzU_8ff041ba-ee52-43f9-a2ae-ba6a97558a2e">Revenue Recognition &lt;div style="margin-top:9pt;padding-left:27pt"&gt;&lt;span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The Company&#x2019;s revenue is generated from two revenue streams: contract revenue and assay revenue. The Company accounts for revenue in accordance with Accounting Standards Codification (&#x201c;ASC&#x201d;) Topic 606, Revenue from Contracts with Customers (&#x201c;ASC 606&#x201d;). The core principle of ASC 606 is that the Company recognizes revenue to depict the transfer of promised goods or services to customers in an amount that reflects the consideration to which the Company expects to be entitled in exchange for those goods or services. The ASC 606 revenue recognition model consists of the following five steps: (1) identify the contracts with a customer, (2) identify the performance obligations in the contract, (3) determine the transaction price, (4) allocate the transaction price to the performance obligations in the contract and (5) recognize revenue when (or as) the entity satisfies a performance obligation.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:9pt;padding-left:27pt"&gt;&lt;span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The Company recognizes revenue from its assay and contract services in accordance with the core principles and key aspects considered by the Company. These considerations are described in detail below, first for Assay Revenue and then for Contract Revenue.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:15pt;padding-left:27pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;Assay Revenue &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:9pt;padding-left:27pt"&gt;&lt;span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The Company generates revenues from its Pigmented Lesion Assay (&#x201c;PLA&#x201d;) and PLA&lt;/span&gt;&lt;span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;plus&lt;/span&gt;&lt;span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt; (now referred to as the DermTech Melanoma Test or &#x201c;DMT&#x201d; which may consist at the option of the ordering clinician of either (i) the PLA or (ii) the PLA and PLA&lt;/span&gt;&lt;span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;plus&lt;/span&gt;&lt;span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;), which assists a clinician&#x2019;s diagnosis of melanoma in patients. The Company provides prescribing clinicians with its Smart Sticker to perform non-invasive skin biopsies of clinically ambiguous pigmented skin lesions on patients. The Company also offers clinicians a telemedicine solution where they can request the Smart Sticker collection kit be sent to the patient&#x2019;s home for a clinician-guided remote collection on ambiguous pigmented skin lesions. A patient can also initiate the process by downloading the Company&#x2019;s telemedicine app, DermTech Connect, which uses store-and-forward technology to allow the patient to take a picture of a suspicious lesion with their phone and have the picture reviewed by an independent clinician who is subscribing to the DermTech Connect platform to assess the suspicious lesion, and if medically necessary, order a DMT where a collection kit would be sent to the patient&#x2019;s home. The DermTech Connect app and telemedicine service were initially beta tested in Florida and is currently available in most states where permitted by law and applicable standards of practice guidelines. Once the sample is collected by the patient via the telemedicine solution or by a healthcare clinician in person, it is returned to the Company&#x2019;s CLIA laboratory for analysis. The patient&#x2019;s ribonucleic acid (&#x201c;RNA&#x201d;) and deoxyribonucleic acid (&#x201c;DNA&#x201d;) are extracted from the Smart Sticker and analyzed using gene expression and sequencing technology to determine if the pigmented skin lesion contains certain genomic features indicative of melanoma. Upon completion of the gene expression analysis, a final report is drafted and provided to the clinician detailing the test results for the pigmented skin lesion indicating whether the sample collected is indicative of melanoma or not. &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:9pt;padding-left:27pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The Company periodically updates its estimate of the variable consideration recognized for previously delivered performance obligations. These updates resulted in an additional $0.1 million and $8,000 of revenue reported for the three and six months ended June 30, 2022, respectively, and an additional $0.1 million and $0.1&#160;million of revenue reported for the three and six months ended June 30, 2021, respectively. These amounts included (i) adjustments for actual collections versus estimated variable consideration as of the beginning of the reporting period and (ii) cash collections and the related recognition of revenue in the current period for tests delivered in prior periods due to the release of the constraint on variable consideration, offset by (iii) reductions in revenue for the accrual for reimbursement claims and settlements.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:15pt;padding-left:27pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;Contract Revenue&lt;/span&gt;&lt;/div&gt;&lt;div style="padding-left:27pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%"&gt;Contract revenue is generated from the sale of laboratory services and Smart Stickers to third-party companies through contract research agreements. Revenues are generated from providing genomic services to facilitate the development of drugs designed to treat dermatologic conditions. The provision of services may include sample collection using the Company&#x2019;s Smart Sticker, assay development for research partners, patient segmentation and stratification, extraction, isolation, expression, amplification and detection of RNA, DNA, protein and microbiome, including data analysis and reporting.&lt;/span&gt;&lt;/div&gt;Deferred Revenue and Remaining Performance Obligations&lt;div style="margin-top:9pt;padding-left:27pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The timing of revenue recognition, billings and cash collections results in billed accounts receivable and deferred revenue on the condensed consolidated balance sheets.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:9pt;padding-left:27pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;In a majority of historical agreements that produced contract revenue, the Company received a substantial up-front payment and additional payments upon the achievement of various milestones over the life of the agreement. This results in deferred revenue and is relieved upon delivery of the applicable Smart Stickers or RNA extraction results. Changes in accounts receivable and deferred revenue were not materially impacted by any other factors.&lt;/span&gt;&lt;/div&gt;The Company records a deferred revenue liability if a customer pays consideration before the Company transfers a good or service to the customer. Deferred revenue primarily represents upfront milestone payments, for which consideration is received prior to when goods/services are completed or delivered. Upfront fees that are estimated to be recognized as revenue more than one year from the date of collection are classified as long-term deferred revenue. Short-term deferred revenue as of June&#160;30, 2022 and December&#160;31, 2021 was $1.3 million and $1.4 million, respectively. &lt;span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Remaining performance obligations include deferred revenue and amounts the Company expects to receive for goods and services that have not yet been delivered or provided under existing agreements. For agreements that have an original duration of one year &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;or&lt;/span&gt; less, the Company has elected the practical expedient applicable to such agreements and does not disclose the remaining performance obligations at the end of each reporting period.</us-gaap:RevenueRecognitionPolicyTextBlock>
    <dmtk:NumberOfRevenueStreams
      contextRef="ia855382ada1f4f28aa8ef6da692ff177_D20220101-20220630"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmFlNWE5YmUwZWI5NDQ1ZDE5MmZhZTgyMmQyMmJlMDlmL3NlYzphZTVhOWJlMGViOTQ0NWQxOTJmYWU4MjJkMjJiZTA5Zl8zNy9mcmFnOjQ4OGNkZjBhODVlYzRiMDliYWFiN2JhZTlhODA5YjcwL3RleHRyZWdpb246NDg4Y2RmMGE4NWVjNGIwOWJhYWI3YmFlOWE4MDliNzBfMTk0OTg_b9496efe-a565-42b8-b32a-a11019469f11"
      unitRef="revenuestream">2</dmtk:NumberOfRevenueStreams>
    <dmtk:RevenuePerformanceObligationSatisfiedVariableConsiderationUpdateIncreaseDecreaseInRevenue
      contextRef="i2c5f0f28773744e5a2e202f2943ae976_D20220401-20220630"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmFlNWE5YmUwZWI5NDQ1ZDE5MmZhZTgyMmQyMmJlMDlmL3NlYzphZTVhOWJlMGViOTQ0NWQxOTJmYWU4MjJkMjJiZTA5Zl8zNy9mcmFnOjQ4OGNkZjBhODVlYzRiMDliYWFiN2JhZTlhODA5YjcwL3RleHRyZWdpb246NDg4Y2RmMGE4NWVjNGIwOWJhYWI3YmFlOWE4MDliNzBfMTY0OTI2NzYyMzIwNw_e5340a77-d395-4746-8c67-1c29f011dd0c"
      unitRef="usd">100000</dmtk:RevenuePerformanceObligationSatisfiedVariableConsiderationUpdateIncreaseDecreaseInRevenue>
    <dmtk:RevenuePerformanceObligationSatisfiedVariableConsiderationUpdateIncreaseDecreaseInRevenue
      contextRef="ia855382ada1f4f28aa8ef6da692ff177_D20220101-20220630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmFlNWE5YmUwZWI5NDQ1ZDE5MmZhZTgyMmQyMmJlMDlmL3NlYzphZTVhOWJlMGViOTQ0NWQxOTJmYWU4MjJkMjJiZTA5Zl8zNy9mcmFnOjQ4OGNkZjBhODVlYzRiMDliYWFiN2JhZTlhODA5YjcwL3RleHRyZWdpb246NDg4Y2RmMGE4NWVjNGIwOWJhYWI3YmFlOWE4MDliNzBfMTY0OTI2NzYyMzI2Mw_4c23f30b-2c31-410c-9409-198a63775e37"
      unitRef="usd">8000</dmtk:RevenuePerformanceObligationSatisfiedVariableConsiderationUpdateIncreaseDecreaseInRevenue>
    <dmtk:RevenuePerformanceObligationSatisfiedVariableConsiderationUpdateIncreaseDecreaseInRevenue
      contextRef="id7bb773872394047ba26aa8a7a0f4d56_D20210401-20210630"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmFlNWE5YmUwZWI5NDQ1ZDE5MmZhZTgyMmQyMmJlMDlmL3NlYzphZTVhOWJlMGViOTQ0NWQxOTJmYWU4MjJkMjJiZTA5Zl8zNy9mcmFnOjQ4OGNkZjBhODVlYzRiMDliYWFiN2JhZTlhODA5YjcwL3RleHRyZWdpb246NDg4Y2RmMGE4NWVjNGIwOWJhYWI3YmFlOWE4MDliNzBfMTY0OTI2NzYyMzIyNQ_2f739d2b-5772-40d5-9631-9603528c6283"
      unitRef="usd">100000</dmtk:RevenuePerformanceObligationSatisfiedVariableConsiderationUpdateIncreaseDecreaseInRevenue>
    <dmtk:RevenuePerformanceObligationSatisfiedVariableConsiderationUpdateIncreaseDecreaseInRevenue
      contextRef="idaa4f31ca59a4a17a59c2580b97791ca_D20210101-20210630"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmFlNWE5YmUwZWI5NDQ1ZDE5MmZhZTgyMmQyMmJlMDlmL3NlYzphZTVhOWJlMGViOTQ0NWQxOTJmYWU4MjJkMjJiZTA5Zl8zNy9mcmFnOjQ4OGNkZjBhODVlYzRiMDliYWFiN2JhZTlhODA5YjcwL3RleHRyZWdpb246NDg4Y2RmMGE4NWVjNGIwOWJhYWI3YmFlOWE4MDliNzBfMTY0OTI2NzYyMzI0Mw_aecdea65-b6c2-4baa-b103-0a48e229b5f0"
      unitRef="usd">100000</dmtk:RevenuePerformanceObligationSatisfiedVariableConsiderationUpdateIncreaseDecreaseInRevenue>
    <us-gaap:DisaggregationOfRevenueTableTextBlock
      contextRef="ia855382ada1f4f28aa8ef6da692ff177_D20220101-20220630"
      id="id3VybDovL2RvY3MudjEvZG9jOmFlNWE5YmUwZWI5NDQ1ZDE5MmZhZTgyMmQyMmJlMDlmL3NlYzphZTVhOWJlMGViOTQ0NWQxOTJmYWU4MjJkMjJiZTA5Zl8zNy9mcmFnOjQ4OGNkZjBhODVlYzRiMDliYWFiN2JhZTlhODA5YjcwL3RleHRyZWdpb246NDg4Y2RmMGE4NWVjNGIwOWJhYWI3YmFlOWE4MDliNzBfNDYyNTM_2a2938a3-03bd-4cb1-b98c-b77cf1dc993e">&lt;div style="margin-top:9pt;padding-left:27pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The following table presents the Company&#x2019;s revenues disaggregated by revenue source during the three and six months ended June&#160;30, 2022 and 2021 (in thousands):&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:12pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:44.354%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:12.081%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.406%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:12.081%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.406%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:12.081%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.406%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:12.085%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Three Months Ended June 30,&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Six Months Ended June 30,&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Assay Revenue&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;DermTech Melanoma Test&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4,147&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,910&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;7,665&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;5,100&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Contract Revenue&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Adhesive patch kits&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;38&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;125&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;104&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;314&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;RNA extractions&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;35&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;110&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;139&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Project management fees&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;48&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;49&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;72&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;90&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total revenues&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4,233&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3,119&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;7,951&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;5,643&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;</us-gaap:DisaggregationOfRevenueTableTextBlock>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i6e93ea7e6de54e3b99964d226c95da1b_D20220401-20220630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmFlNWE5YmUwZWI5NDQ1ZDE5MmZhZTgyMmQyMmJlMDlmL3NlYzphZTVhOWJlMGViOTQ0NWQxOTJmYWU4MjJkMjJiZTA5Zl8zNy9mcmFnOjQ4OGNkZjBhODVlYzRiMDliYWFiN2JhZTlhODA5YjcwL3RhYmxlOjY4ZWE0MGIyMGE2YTQyOTM4ZDIyNTQxOTRjZjIxYTExL3RhYmxlcmFuZ2U6NjhlYTQwYjIwYTZhNDI5MzhkMjI1NDE5NGNmMjFhMTFfMy0xLTEtMS02MjY_24338e86-0ec9-4680-9a11-fa2432e0627a"
      unitRef="usd">4147000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i37138912f4f54957978d26b438559810_D20210401-20210630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmFlNWE5YmUwZWI5NDQ1ZDE5MmZhZTgyMmQyMmJlMDlmL3NlYzphZTVhOWJlMGViOTQ0NWQxOTJmYWU4MjJkMjJiZTA5Zl8zNy9mcmFnOjQ4OGNkZjBhODVlYzRiMDliYWFiN2JhZTlhODA5YjcwL3RhYmxlOjY4ZWE0MGIyMGE2YTQyOTM4ZDIyNTQxOTRjZjIxYTExL3RhYmxlcmFuZ2U6NjhlYTQwYjIwYTZhNDI5MzhkMjI1NDE5NGNmMjFhMTFfMy0zLTEtMS02MjY_7426fee5-e8a8-42a1-bb2f-225f69a22431"
      unitRef="usd">2910000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i162096998d12445db5b600d98dd798a7_D20220101-20220630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmFlNWE5YmUwZWI5NDQ1ZDE5MmZhZTgyMmQyMmJlMDlmL3NlYzphZTVhOWJlMGViOTQ0NWQxOTJmYWU4MjJkMjJiZTA5Zl8zNy9mcmFnOjQ4OGNkZjBhODVlYzRiMDliYWFiN2JhZTlhODA5YjcwL3RhYmxlOjY4ZWE0MGIyMGE2YTQyOTM4ZDIyNTQxOTRjZjIxYTExL3RhYmxlcmFuZ2U6NjhlYTQwYjIwYTZhNDI5MzhkMjI1NDE5NGNmMjFhMTFfMy01LTEtMS02MjY_1198b2bd-9fa7-4a8a-9141-905891b3bc1a"
      unitRef="usd">7665000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="ib998ae4e71544a4aa86f6166fce08ce5_D20210101-20210630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmFlNWE5YmUwZWI5NDQ1ZDE5MmZhZTgyMmQyMmJlMDlmL3NlYzphZTVhOWJlMGViOTQ0NWQxOTJmYWU4MjJkMjJiZTA5Zl8zNy9mcmFnOjQ4OGNkZjBhODVlYzRiMDliYWFiN2JhZTlhODA5YjcwL3RhYmxlOjY4ZWE0MGIyMGE2YTQyOTM4ZDIyNTQxOTRjZjIxYTExL3RhYmxlcmFuZ2U6NjhlYTQwYjIwYTZhNDI5MzhkMjI1NDE5NGNmMjFhMTFfMy03LTEtMS02MjY_237ddbb3-193a-4c77-8cb7-d4cc936393a1"
      unitRef="usd">5100000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i44ab42a102594fac87f06c1ef8c068f7_D20220401-20220630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmFlNWE5YmUwZWI5NDQ1ZDE5MmZhZTgyMmQyMmJlMDlmL3NlYzphZTVhOWJlMGViOTQ0NWQxOTJmYWU4MjJkMjJiZTA5Zl8zNy9mcmFnOjQ4OGNkZjBhODVlYzRiMDliYWFiN2JhZTlhODA5YjcwL3RhYmxlOjY4ZWE0MGIyMGE2YTQyOTM4ZDIyNTQxOTRjZjIxYTExL3RhYmxlcmFuZ2U6NjhlYTQwYjIwYTZhNDI5MzhkMjI1NDE5NGNmMjFhMTFfNS0xLTEtMS02MjY_a4a9197e-d4a7-4045-82d2-aa541b0a6cb6"
      unitRef="usd">38000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i37bb372a6a6f42ad835fe2ef8ee1273a_D20210401-20210630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmFlNWE5YmUwZWI5NDQ1ZDE5MmZhZTgyMmQyMmJlMDlmL3NlYzphZTVhOWJlMGViOTQ0NWQxOTJmYWU4MjJkMjJiZTA5Zl8zNy9mcmFnOjQ4OGNkZjBhODVlYzRiMDliYWFiN2JhZTlhODA5YjcwL3RhYmxlOjY4ZWE0MGIyMGE2YTQyOTM4ZDIyNTQxOTRjZjIxYTExL3RhYmxlcmFuZ2U6NjhlYTQwYjIwYTZhNDI5MzhkMjI1NDE5NGNmMjFhMTFfNS0zLTEtMS02MjY_2c59425e-bc89-4534-b4be-80a25f883c64"
      unitRef="usd">125000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="ibaf8664002d140989e8264c6adb89fa7_D20220101-20220630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmFlNWE5YmUwZWI5NDQ1ZDE5MmZhZTgyMmQyMmJlMDlmL3NlYzphZTVhOWJlMGViOTQ0NWQxOTJmYWU4MjJkMjJiZTA5Zl8zNy9mcmFnOjQ4OGNkZjBhODVlYzRiMDliYWFiN2JhZTlhODA5YjcwL3RhYmxlOjY4ZWE0MGIyMGE2YTQyOTM4ZDIyNTQxOTRjZjIxYTExL3RhYmxlcmFuZ2U6NjhlYTQwYjIwYTZhNDI5MzhkMjI1NDE5NGNmMjFhMTFfNS01LTEtMS02MjY_58f9708d-60f3-43ec-a7bf-eee35df0e4b3"
      unitRef="usd">104000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="iddc9e2beb1bb4562969f72a76d146829_D20210101-20210630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmFlNWE5YmUwZWI5NDQ1ZDE5MmZhZTgyMmQyMmJlMDlmL3NlYzphZTVhOWJlMGViOTQ0NWQxOTJmYWU4MjJkMjJiZTA5Zl8zNy9mcmFnOjQ4OGNkZjBhODVlYzRiMDliYWFiN2JhZTlhODA5YjcwL3RhYmxlOjY4ZWE0MGIyMGE2YTQyOTM4ZDIyNTQxOTRjZjIxYTExL3RhYmxlcmFuZ2U6NjhlYTQwYjIwYTZhNDI5MzhkMjI1NDE5NGNmMjFhMTFfNS03LTEtMS02MjY_00a914aa-9ae8-4c3e-afb3-47f0d67bad3d"
      unitRef="usd">314000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i97ac1b6997a14b74b531fc469df2694d_D20220401-20220630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmFlNWE5YmUwZWI5NDQ1ZDE5MmZhZTgyMmQyMmJlMDlmL3NlYzphZTVhOWJlMGViOTQ0NWQxOTJmYWU4MjJkMjJiZTA5Zl8zNy9mcmFnOjQ4OGNkZjBhODVlYzRiMDliYWFiN2JhZTlhODA5YjcwL3RhYmxlOjY4ZWE0MGIyMGE2YTQyOTM4ZDIyNTQxOTRjZjIxYTExL3RhYmxlcmFuZ2U6NjhlYTQwYjIwYTZhNDI5MzhkMjI1NDE5NGNmMjFhMTFfNi0xLTEtMS02MjY_2da3fd2f-cd6d-4b57-b0c0-39be62885154"
      unitRef="usd">0</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="ib4f6baa70c784ecf9d59a3a86366bfc9_D20210401-20210630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmFlNWE5YmUwZWI5NDQ1ZDE5MmZhZTgyMmQyMmJlMDlmL3NlYzphZTVhOWJlMGViOTQ0NWQxOTJmYWU4MjJkMjJiZTA5Zl8zNy9mcmFnOjQ4OGNkZjBhODVlYzRiMDliYWFiN2JhZTlhODA5YjcwL3RhYmxlOjY4ZWE0MGIyMGE2YTQyOTM4ZDIyNTQxOTRjZjIxYTExL3RhYmxlcmFuZ2U6NjhlYTQwYjIwYTZhNDI5MzhkMjI1NDE5NGNmMjFhMTFfNi0zLTEtMS02MjY_1980d484-45b2-48d9-9771-74a784103e47"
      unitRef="usd">35000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i84a94952fcc541d9a3ed53a9fbe72d3f_D20220101-20220630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmFlNWE5YmUwZWI5NDQ1ZDE5MmZhZTgyMmQyMmJlMDlmL3NlYzphZTVhOWJlMGViOTQ0NWQxOTJmYWU4MjJkMjJiZTA5Zl8zNy9mcmFnOjQ4OGNkZjBhODVlYzRiMDliYWFiN2JhZTlhODA5YjcwL3RhYmxlOjY4ZWE0MGIyMGE2YTQyOTM4ZDIyNTQxOTRjZjIxYTExL3RhYmxlcmFuZ2U6NjhlYTQwYjIwYTZhNDI5MzhkMjI1NDE5NGNmMjFhMTFfNi01LTEtMS02MjY_d2f64959-63a9-4e74-bc94-f9729cca1057"
      unitRef="usd">110000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="ia31f87e1f0644450bcc68070a72f9423_D20210101-20210630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmFlNWE5YmUwZWI5NDQ1ZDE5MmZhZTgyMmQyMmJlMDlmL3NlYzphZTVhOWJlMGViOTQ0NWQxOTJmYWU4MjJkMjJiZTA5Zl8zNy9mcmFnOjQ4OGNkZjBhODVlYzRiMDliYWFiN2JhZTlhODA5YjcwL3RhYmxlOjY4ZWE0MGIyMGE2YTQyOTM4ZDIyNTQxOTRjZjIxYTExL3RhYmxlcmFuZ2U6NjhlYTQwYjIwYTZhNDI5MzhkMjI1NDE5NGNmMjFhMTFfNi03LTEtMS02MjY_732b7949-fdd8-4626-a07b-3508753a117d"
      unitRef="usd">139000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i2f689fb0f6dd4303b138b093b1056dd9_D20220401-20220630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmFlNWE5YmUwZWI5NDQ1ZDE5MmZhZTgyMmQyMmJlMDlmL3NlYzphZTVhOWJlMGViOTQ0NWQxOTJmYWU4MjJkMjJiZTA5Zl8zNy9mcmFnOjQ4OGNkZjBhODVlYzRiMDliYWFiN2JhZTlhODA5YjcwL3RhYmxlOjY4ZWE0MGIyMGE2YTQyOTM4ZDIyNTQxOTRjZjIxYTExL3RhYmxlcmFuZ2U6NjhlYTQwYjIwYTZhNDI5MzhkMjI1NDE5NGNmMjFhMTFfNy0xLTEtMS02MjY_77b277c8-8e5b-41ed-b9b7-8865f37739dc"
      unitRef="usd">48000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i8648dde9ea3c4420a2537a1ebd36ce55_D20210401-20210630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmFlNWE5YmUwZWI5NDQ1ZDE5MmZhZTgyMmQyMmJlMDlmL3NlYzphZTVhOWJlMGViOTQ0NWQxOTJmYWU4MjJkMjJiZTA5Zl8zNy9mcmFnOjQ4OGNkZjBhODVlYzRiMDliYWFiN2JhZTlhODA5YjcwL3RhYmxlOjY4ZWE0MGIyMGE2YTQyOTM4ZDIyNTQxOTRjZjIxYTExL3RhYmxlcmFuZ2U6NjhlYTQwYjIwYTZhNDI5MzhkMjI1NDE5NGNmMjFhMTFfNy0zLTEtMS02MjY_0b375c2b-83a7-44dc-bb27-de631a105401"
      unitRef="usd">49000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i7ce185f90d7b4357a581d645d094bd60_D20220101-20220630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmFlNWE5YmUwZWI5NDQ1ZDE5MmZhZTgyMmQyMmJlMDlmL3NlYzphZTVhOWJlMGViOTQ0NWQxOTJmYWU4MjJkMjJiZTA5Zl8zNy9mcmFnOjQ4OGNkZjBhODVlYzRiMDliYWFiN2JhZTlhODA5YjcwL3RhYmxlOjY4ZWE0MGIyMGE2YTQyOTM4ZDIyNTQxOTRjZjIxYTExL3RhYmxlcmFuZ2U6NjhlYTQwYjIwYTZhNDI5MzhkMjI1NDE5NGNmMjFhMTFfNy01LTEtMS02MjY_f8d17b94-64ef-447b-856d-e9a5ff5e998c"
      unitRef="usd">72000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="iba453607677b41a9a058e0d3ee2c4186_D20210101-20210630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmFlNWE5YmUwZWI5NDQ1ZDE5MmZhZTgyMmQyMmJlMDlmL3NlYzphZTVhOWJlMGViOTQ0NWQxOTJmYWU4MjJkMjJiZTA5Zl8zNy9mcmFnOjQ4OGNkZjBhODVlYzRiMDliYWFiN2JhZTlhODA5YjcwL3RhYmxlOjY4ZWE0MGIyMGE2YTQyOTM4ZDIyNTQxOTRjZjIxYTExL3RhYmxlcmFuZ2U6NjhlYTQwYjIwYTZhNDI5MzhkMjI1NDE5NGNmMjFhMTFfNy03LTEtMS02MjY_cca7872d-338b-4955-9fb1-c3eca0f7fd97"
      unitRef="usd">90000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i2c5f0f28773744e5a2e202f2943ae976_D20220401-20220630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmFlNWE5YmUwZWI5NDQ1ZDE5MmZhZTgyMmQyMmJlMDlmL3NlYzphZTVhOWJlMGViOTQ0NWQxOTJmYWU4MjJkMjJiZTA5Zl8zNy9mcmFnOjQ4OGNkZjBhODVlYzRiMDliYWFiN2JhZTlhODA5YjcwL3RhYmxlOjY4ZWE0MGIyMGE2YTQyOTM4ZDIyNTQxOTRjZjIxYTExL3RhYmxlcmFuZ2U6NjhlYTQwYjIwYTZhNDI5MzhkMjI1NDE5NGNmMjFhMTFfOC0xLTEtMS02MjY_c5b729af-f8e4-4d77-96ed-e08c18c9d7f3"
      unitRef="usd">4233000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="id7bb773872394047ba26aa8a7a0f4d56_D20210401-20210630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmFlNWE5YmUwZWI5NDQ1ZDE5MmZhZTgyMmQyMmJlMDlmL3NlYzphZTVhOWJlMGViOTQ0NWQxOTJmYWU4MjJkMjJiZTA5Zl8zNy9mcmFnOjQ4OGNkZjBhODVlYzRiMDliYWFiN2JhZTlhODA5YjcwL3RhYmxlOjY4ZWE0MGIyMGE2YTQyOTM4ZDIyNTQxOTRjZjIxYTExL3RhYmxlcmFuZ2U6NjhlYTQwYjIwYTZhNDI5MzhkMjI1NDE5NGNmMjFhMTFfOC0zLTEtMS02MjY_b8f88667-4982-42c9-8019-3c7d6c1c1242"
      unitRef="usd">3119000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="ia855382ada1f4f28aa8ef6da692ff177_D20220101-20220630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmFlNWE5YmUwZWI5NDQ1ZDE5MmZhZTgyMmQyMmJlMDlmL3NlYzphZTVhOWJlMGViOTQ0NWQxOTJmYWU4MjJkMjJiZTA5Zl8zNy9mcmFnOjQ4OGNkZjBhODVlYzRiMDliYWFiN2JhZTlhODA5YjcwL3RhYmxlOjY4ZWE0MGIyMGE2YTQyOTM4ZDIyNTQxOTRjZjIxYTExL3RhYmxlcmFuZ2U6NjhlYTQwYjIwYTZhNDI5MzhkMjI1NDE5NGNmMjFhMTFfOC01LTEtMS02MjY_69a91d8b-0bc6-4a4c-9628-78875cd47032"
      unitRef="usd">7951000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="idaa4f31ca59a4a17a59c2580b97791ca_D20210101-20210630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmFlNWE5YmUwZWI5NDQ1ZDE5MmZhZTgyMmQyMmJlMDlmL3NlYzphZTVhOWJlMGViOTQ0NWQxOTJmYWU4MjJkMjJiZTA5Zl8zNy9mcmFnOjQ4OGNkZjBhODVlYzRiMDliYWFiN2JhZTlhODA5YjcwL3RhYmxlOjY4ZWE0MGIyMGE2YTQyOTM4ZDIyNTQxOTRjZjIxYTExL3RhYmxlcmFuZ2U6NjhlYTQwYjIwYTZhNDI5MzhkMjI1NDE5NGNmMjFhMTFfOC03LTEtMS02MjY_56316e50-3874-4e46-8107-1711b0379bd0"
      unitRef="usd">5643000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:ScheduleOfProductInformationTableTextBlock
      contextRef="ia855382ada1f4f28aa8ef6da692ff177_D20220101-20220630"
      id="id3VybDovL2RvY3MudjEvZG9jOmFlNWE5YmUwZWI5NDQ1ZDE5MmZhZTgyMmQyMmJlMDlmL3NlYzphZTVhOWJlMGViOTQ0NWQxOTJmYWU4MjJkMjJiZTA5Zl8zNy9mcmFnOjQ4OGNkZjBhODVlYzRiMDliYWFiN2JhZTlhODA5YjcwL3RleHRyZWdpb246NDg4Y2RmMGE4NWVjNGIwOWJhYWI3YmFlOWE4MDliNzBfNDYyMzY_a99c6f7a-b568-4101-b36b-cd9893fe9c8f">&lt;div style="margin-top:9pt;padding-left:27pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The following table sets forth the percentages of total revenue or accounts receivable for the Company&#x2019;s third-party payors that represent 10% or more of the respective amounts for the periods shown:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:12pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:16.778%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:12.081%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.406%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:12.081%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.406%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:12.081%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.406%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:12.081%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.406%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:12.081%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.406%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:12.087%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="21" style="border-bottom:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Total Revenues&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Accounts Receivable &lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height:12pt"&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="9" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Three Months Ended June 30,&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="9" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Six Months Ended June 30,&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" rowspan="2" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;As of June 30, 2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" rowspan="2" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;As of December 31, 2021&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height:12pt"&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Assay Revenue&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Payor A&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;47&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;36&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;39&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;34&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;21&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;23&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Payor B&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;*&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;*&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;*&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;*&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;15&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;15&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-top:6pt;padding-left:36pt;text-indent:-9pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;*&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%;padding-left:4pt"&gt;Less than 10%&lt;/span&gt;&lt;/div&gt;</us-gaap:ScheduleOfProductInformationTableTextBlock>
    <us-gaap:ConcentrationRiskPercentage1
      contextRef="ibe700613e5304875bdd1ff268a855e3b_D20220401-20220630"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOmFlNWE5YmUwZWI5NDQ1ZDE5MmZhZTgyMmQyMmJlMDlmL3NlYzphZTVhOWJlMGViOTQ0NWQxOTJmYWU4MjJkMjJiZTA5Zl8zNy9mcmFnOjQ4OGNkZjBhODVlYzRiMDliYWFiN2JhZTlhODA5YjcwL3RhYmxlOjNhMjUwMjY2OTI3MzQ3OGE4ZWNlNzU0MjJkMDNhYTQzL3RhYmxlcmFuZ2U6M2EyNTAyNjY5MjczNDc4YThlY2U3NTQyMmQwM2FhNDNfNC0xLTEtMS02MjY_e3d7f682-921f-4482-b894-1d157061e67b"
      unitRef="number">0.47</us-gaap:ConcentrationRiskPercentage1>
    <us-gaap:ConcentrationRiskPercentage1
      contextRef="id2fc2250bf344e37938b871f12d01a85_D20210401-20210630"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOmFlNWE5YmUwZWI5NDQ1ZDE5MmZhZTgyMmQyMmJlMDlmL3NlYzphZTVhOWJlMGViOTQ0NWQxOTJmYWU4MjJkMjJiZTA5Zl8zNy9mcmFnOjQ4OGNkZjBhODVlYzRiMDliYWFiN2JhZTlhODA5YjcwL3RhYmxlOjNhMjUwMjY2OTI3MzQ3OGE4ZWNlNzU0MjJkMDNhYTQzL3RhYmxlcmFuZ2U6M2EyNTAyNjY5MjczNDc4YThlY2U3NTQyMmQwM2FhNDNfNC0zLTEtMS02MjY_b19b00c3-a752-498d-86da-2ebaf09237fa"
      unitRef="number">0.36</us-gaap:ConcentrationRiskPercentage1>
    <us-gaap:ConcentrationRiskPercentage1
      contextRef="i79283405fe744adabc208118150149f3_D20220101-20220630"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOmFlNWE5YmUwZWI5NDQ1ZDE5MmZhZTgyMmQyMmJlMDlmL3NlYzphZTVhOWJlMGViOTQ0NWQxOTJmYWU4MjJkMjJiZTA5Zl8zNy9mcmFnOjQ4OGNkZjBhODVlYzRiMDliYWFiN2JhZTlhODA5YjcwL3RhYmxlOjNhMjUwMjY2OTI3MzQ3OGE4ZWNlNzU0MjJkMDNhYTQzL3RhYmxlcmFuZ2U6M2EyNTAyNjY5MjczNDc4YThlY2U3NTQyMmQwM2FhNDNfNC01LTEtMS02MjY_0b152ce2-f3b0-40df-ba05-4edf08ae181b"
      unitRef="number">0.39</us-gaap:ConcentrationRiskPercentage1>
    <us-gaap:ConcentrationRiskPercentage1
      contextRef="i0a6d383e97df42d3a6810885b8aee9e8_D20210101-20210630"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOmFlNWE5YmUwZWI5NDQ1ZDE5MmZhZTgyMmQyMmJlMDlmL3NlYzphZTVhOWJlMGViOTQ0NWQxOTJmYWU4MjJkMjJiZTA5Zl8zNy9mcmFnOjQ4OGNkZjBhODVlYzRiMDliYWFiN2JhZTlhODA5YjcwL3RhYmxlOjNhMjUwMjY2OTI3MzQ3OGE4ZWNlNzU0MjJkMDNhYTQzL3RhYmxlcmFuZ2U6M2EyNTAyNjY5MjczNDc4YThlY2U3NTQyMmQwM2FhNDNfNC03LTEtMS02MjY_8fa9ea91-1ac1-429f-a1ee-1b7e15b4ffd6"
      unitRef="number">0.34</us-gaap:ConcentrationRiskPercentage1>
    <us-gaap:ConcentrationRiskPercentage1
      contextRef="icab6abad6fea44f5ae78f4cbcce5b550_D20220101-20220630"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOmFlNWE5YmUwZWI5NDQ1ZDE5MmZhZTgyMmQyMmJlMDlmL3NlYzphZTVhOWJlMGViOTQ0NWQxOTJmYWU4MjJkMjJiZTA5Zl8zNy9mcmFnOjQ4OGNkZjBhODVlYzRiMDliYWFiN2JhZTlhODA5YjcwL3RhYmxlOjNhMjUwMjY2OTI3MzQ3OGE4ZWNlNzU0MjJkMDNhYTQzL3RhYmxlcmFuZ2U6M2EyNTAyNjY5MjczNDc4YThlY2U3NTQyMmQwM2FhNDNfNC05LTEtMS02MjY_85644cbc-ccc3-43ee-b75b-ea0fae8dcd16"
      unitRef="number">0.21</us-gaap:ConcentrationRiskPercentage1>
    <us-gaap:ConcentrationRiskPercentage1
      contextRef="ifb4b0086847d4c79aed7244eb498c89a_D20210101-20211231"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOmFlNWE5YmUwZWI5NDQ1ZDE5MmZhZTgyMmQyMmJlMDlmL3NlYzphZTVhOWJlMGViOTQ0NWQxOTJmYWU4MjJkMjJiZTA5Zl8zNy9mcmFnOjQ4OGNkZjBhODVlYzRiMDliYWFiN2JhZTlhODA5YjcwL3RhYmxlOjNhMjUwMjY2OTI3MzQ3OGE4ZWNlNzU0MjJkMDNhYTQzL3RhYmxlcmFuZ2U6M2EyNTAyNjY5MjczNDc4YThlY2U3NTQyMmQwM2FhNDNfNC0xMS0xLTEtNjI2_6fd66e02-e207-4e3b-af4f-8cb627e9a623"
      unitRef="number">0.23</us-gaap:ConcentrationRiskPercentage1>
    <us-gaap:ConcentrationRiskPercentage1
      contextRef="ibc3b0a82341c40d6abc97b51b82572a2_D20220101-20220630"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOmFlNWE5YmUwZWI5NDQ1ZDE5MmZhZTgyMmQyMmJlMDlmL3NlYzphZTVhOWJlMGViOTQ0NWQxOTJmYWU4MjJkMjJiZTA5Zl8zNy9mcmFnOjQ4OGNkZjBhODVlYzRiMDliYWFiN2JhZTlhODA5YjcwL3RhYmxlOjNhMjUwMjY2OTI3MzQ3OGE4ZWNlNzU0MjJkMDNhYTQzL3RhYmxlcmFuZ2U6M2EyNTAyNjY5MjczNDc4YThlY2U3NTQyMmQwM2FhNDNfNS05LTEtMS02MjY_c2f22e92-4cf1-405a-bc92-1f5aa3996c9f"
      unitRef="number">0.15</us-gaap:ConcentrationRiskPercentage1>
    <us-gaap:ConcentrationRiskPercentage1
      contextRef="i024422eccd5d4383a66fc3f37bffe425_D20210101-20211231"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOmFlNWE5YmUwZWI5NDQ1ZDE5MmZhZTgyMmQyMmJlMDlmL3NlYzphZTVhOWJlMGViOTQ0NWQxOTJmYWU4MjJkMjJiZTA5Zl8zNy9mcmFnOjQ4OGNkZjBhODVlYzRiMDliYWFiN2JhZTlhODA5YjcwL3RhYmxlOjNhMjUwMjY2OTI3MzQ3OGE4ZWNlNzU0MjJkMDNhYTQzL3RhYmxlcmFuZ2U6M2EyNTAyNjY5MjczNDc4YThlY2U3NTQyMmQwM2FhNDNfNS0xMS0xLTEtNjI2_7fc1509c-f6b9-4ebd-ad08-10aee69742f4"
      unitRef="number">0.15</us-gaap:ConcentrationRiskPercentage1>
    <us-gaap:DeferredRevenueCurrent
      contextRef="i4c8f247d12134a9886d56e1c8b024425_I20220630"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmFlNWE5YmUwZWI5NDQ1ZDE5MmZhZTgyMmQyMmJlMDlmL3NlYzphZTVhOWJlMGViOTQ0NWQxOTJmYWU4MjJkMjJiZTA5Zl8zNy9mcmFnOjQ4OGNkZjBhODVlYzRiMDliYWFiN2JhZTlhODA5YjcwL3RleHRyZWdpb246NDg4Y2RmMGE4NWVjNGIwOWJhYWI3YmFlOWE4MDliNzBfMjQzMTE_1830644f-b8da-4294-8727-84ac1f2fcda4"
      unitRef="usd">1300000</us-gaap:DeferredRevenueCurrent>
    <us-gaap:DeferredRevenueCurrent
      contextRef="i87bf777ccf5f4f93bc9be7a2cbba61c1_I20211231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmFlNWE5YmUwZWI5NDQ1ZDE5MmZhZTgyMmQyMmJlMDlmL3NlYzphZTVhOWJlMGViOTQ0NWQxOTJmYWU4MjJkMjJiZTA5Zl8zNy9mcmFnOjQ4OGNkZjBhODVlYzRiMDliYWFiN2JhZTlhODA5YjcwL3RleHRyZWdpb246NDg4Y2RmMGE4NWVjNGIwOWJhYWI3YmFlOWE4MDliNzBfMjQzMTg_de56695f-fe28-434c-9418-9905c7a59c54"
      unitRef="usd">1400000</us-gaap:DeferredRevenueCurrent>
    <us-gaap:RevenueRemainingPerformanceObligation
      contextRef="i4c8f247d12134a9886d56e1c8b024425_I20220630"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmFlNWE5YmUwZWI5NDQ1ZDE5MmZhZTgyMmQyMmJlMDlmL3NlYzphZTVhOWJlMGViOTQ0NWQxOTJmYWU4MjJkMjJiZTA5Zl8zNy9mcmFnOjQ4OGNkZjBhODVlYzRiMDliYWFiN2JhZTlhODA5YjcwL3RleHRyZWdpb246NDg4Y2RmMGE4NWVjNGIwOWJhYWI3YmFlOWE4MDliNzBfMjUwNjg_e08aba90-e827-4a8d-b63b-110a9017b9a9"
      unitRef="usd">100000</us-gaap:RevenueRemainingPerformanceObligation>
    <us-gaap:RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionPeriod1
      contextRef="i87a77119b42946ecbfc4ea54841338c0_I20220630"
      id="id3VybDovL2RvY3MudjEvZG9jOmFlNWE5YmUwZWI5NDQ1ZDE5MmZhZTgyMmQyMmJlMDlmL3NlYzphZTVhOWJlMGViOTQ0NWQxOTJmYWU4MjJkMjJiZTA5Zl8zNy9mcmFnOjQ4OGNkZjBhODVlYzRiMDliYWFiN2JhZTlhODA5YjcwL3RleHRyZWdpb246NDg4Y2RmMGE4NWVjNGIwOWJhYWI3YmFlOWE4MDliNzBfMjUxOTI_de202005-51e3-4004-bf39-146510089ec3">P3Y</us-gaap:RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionPeriod1>
    <us-gaap:ReceivablesPolicyTextBlock
      contextRef="ia855382ada1f4f28aa8ef6da692ff177_D20220101-20220630"
      id="id3VybDovL2RvY3MudjEvZG9jOmFlNWE5YmUwZWI5NDQ1ZDE5MmZhZTgyMmQyMmJlMDlmL3NlYzphZTVhOWJlMGViOTQ0NWQxOTJmYWU4MjJkMjJiZTA5Zl8zNy9mcmFnOjQ4OGNkZjBhODVlYzRiMDliYWFiN2JhZTlhODA5YjcwL3RleHRyZWdpb246NDg4Y2RmMGE4NWVjNGIwOWJhYWI3YmFlOWE4MDliNzBfNDYyNTY_13134795-6e16-49f1-80d1-4b23fa7d8982">Accounts Receivable &lt;div style="margin-top:15pt;padding-left:27pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Assay Accounts Receivable &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:9pt;padding-left:27pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Due to the nature of the Company&#x2019;s assay revenue, it can take a significant amount of time to collect upon billed tests. The Company prepares an analysis on reimbursement collections and data obtained for each financial reporting period to determine the amount of receivables to be recorded relating to tests performed in the applicable period. The Company generally does not perform evaluations of customers&#x2019; financial condition and generally does not require collateral. Accounts receivables are written off when all efforts to collect the balance have been exhausted. Adjustments for implicit price concessions attributable to variable consideration are incorporated into the measurement of the accounts receivable balances. The Company recorded $5.8 million and $3.6 million of gross assay accounts receivable as of June&#160;30, 2022 and December&#160;31, 2021, respectively. Accounts receivable as of June&#160;30, 2022 included unbilled accounts receivable of $0.3 million. &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:15pt;padding-left:27pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Contract Accounts Receivable &lt;/span&gt;&lt;/div&gt;Contract accounts receivable are recorded at the net invoice value and are not interest bearing. The Company reserves specific receivables if collectability is no longer reasonably assured, and as of June&#160;30, 2022, the Company did not maintain any reserves over contract receivables as they relate to large established credit worthy customers. The Company re-evaluates such reserves on a regular basis and adjusts its reserves as needed. Once a receivable is deemed to be uncollectible, such balance is charged against the reserve.</us-gaap:ReceivablesPolicyTextBlock>
    <us-gaap:AccountsReceivableGrossCurrent
      contextRef="i6635c095eae0429e88a27cd2f8145dc1_I20220630"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmFlNWE5YmUwZWI5NDQ1ZDE5MmZhZTgyMmQyMmJlMDlmL3NlYzphZTVhOWJlMGViOTQ0NWQxOTJmYWU4MjJkMjJiZTA5Zl8zNy9mcmFnOjQ4OGNkZjBhODVlYzRiMDliYWFiN2JhZTlhODA5YjcwL3RleHRyZWdpb246NDg4Y2RmMGE4NWVjNGIwOWJhYWI3YmFlOWE4MDliNzBfMjYwMzI_faedf6c0-c424-47bd-b8cb-37da755c2e75"
      unitRef="usd">5800000</us-gaap:AccountsReceivableGrossCurrent>
    <us-gaap:AccountsReceivableGrossCurrent
      contextRef="i4d3ad48c30c04410bf8a55d9dabb735e_I20211231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmFlNWE5YmUwZWI5NDQ1ZDE5MmZhZTgyMmQyMmJlMDlmL3NlYzphZTVhOWJlMGViOTQ0NWQxOTJmYWU4MjJkMjJiZTA5Zl8zNy9mcmFnOjQ4OGNkZjBhODVlYzRiMDliYWFiN2JhZTlhODA5YjcwL3RleHRyZWdpb246NDg4Y2RmMGE4NWVjNGIwOWJhYWI3YmFlOWE4MDliNzBfMjYwMzk_7b165ef9-e0c7-4e59-97ee-4d059fbdbd53"
      unitRef="usd">3600000</us-gaap:AccountsReceivableGrossCurrent>
    <us-gaap:UnbilledReceivablesCurrent
      contextRef="i4c8f247d12134a9886d56e1c8b024425_I20220630"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmFlNWE5YmUwZWI5NDQ1ZDE5MmZhZTgyMmQyMmJlMDlmL3NlYzphZTVhOWJlMGViOTQ0NWQxOTJmYWU4MjJkMjJiZTA5Zl8zNy9mcmFnOjQ4OGNkZjBhODVlYzRiMDliYWFiN2JhZTlhODA5YjcwL3RleHRyZWdpb246NDg4Y2RmMGE4NWVjNGIwOWJhYWI3YmFlOWE4MDliNzBfNTQ5NzU1OTg0MDM5_427b9ff1-f940-4597-8a8e-f5f4663e4101"
      unitRef="usd">300000</us-gaap:UnbilledReceivablesCurrent>
    <us-gaap:AccountsReceivableNetCurrent
      contextRef="icfa56764c3ac46e89e85c1c2e548d685_I20220630"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmFlNWE5YmUwZWI5NDQ1ZDE5MmZhZTgyMmQyMmJlMDlmL3NlYzphZTVhOWJlMGViOTQ0NWQxOTJmYWU4MjJkMjJiZTA5Zl8zNy9mcmFnOjQ4OGNkZjBhODVlYzRiMDliYWFiN2JhZTlhODA5YjcwL3RleHRyZWdpb246NDg4Y2RmMGE4NWVjNGIwOWJhYWI3YmFlOWE4MDliNzBfMjY2ODE_a0050c56-04a9-4da7-b990-4b60dfa1612f"
      unitRef="usd">200000</us-gaap:AccountsReceivableNetCurrent>
    <us-gaap:AccountsReceivableNetCurrent
      contextRef="i204f9e4e483143659a51c94f43ce8d11_I20211231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmFlNWE5YmUwZWI5NDQ1ZDE5MmZhZTgyMmQyMmJlMDlmL3NlYzphZTVhOWJlMGViOTQ0NWQxOTJmYWU4MjJkMjJiZTA5Zl8zNy9mcmFnOjQ4OGNkZjBhODVlYzRiMDliYWFiN2JhZTlhODA5YjcwL3RleHRyZWdpb246NDg4Y2RmMGE4NWVjNGIwOWJhYWI3YmFlOWE4MDliNzBfMjY2ODg_ee28a702-1dd4-422f-b3cc-dfec927624aa"
      unitRef="usd">200000</us-gaap:AccountsReceivableNetCurrent>
    <us-gaap:EarningsPerSharePolicyTextBlock
      contextRef="ia855382ada1f4f28aa8ef6da692ff177_D20220101-20220630"
      id="id3VybDovL2RvY3MudjEvZG9jOmFlNWE5YmUwZWI5NDQ1ZDE5MmZhZTgyMmQyMmJlMDlmL3NlYzphZTVhOWJlMGViOTQ0NWQxOTJmYWU4MjJkMjJiZTA5Zl8zNy9mcmFnOjQ4OGNkZjBhODVlYzRiMDliYWFiN2JhZTlhODA5YjcwL3RleHRyZWdpb246NDg4Y2RmMGE4NWVjNGIwOWJhYWI3YmFlOWE4MDliNzBfNDYyNDU_6e9eefb5-9ad8-45c2-8d6e-cbf08144188e">Net Loss Per Share &lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Basic and diluted net loss per share of common stock is determined by dividing net loss applicable to holders of common stock by the weighted average number of shares of common stock outstanding during the period. Because there is a net loss attributable to holders of common stock during the three and six months ended June&#160;30, 2022 and 2021, the outstanding common stock warrants, stock options, and restricted stock units (&#x201c;RSUs&#x201d;) have been excluded from the calculation of diluted loss per share of common stock because their effect would be anti-dilutive. Therefore, the weighted average shares used to calculate both basic and diluted loss per share are the same. Diluted net loss per share of common stock for the three and six&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"&gt; &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;months ended June&#160;30, 2022 excludes the effect of anti-dilutive equity instruments including 714,261 shares of common stock issuable upon the exercise of outstanding common stock warrants and 4,670,069 shares of common stock issuable upon the exercise of stock options and release of RSUs. Diluted net loss per share of common stock for the three and six&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"&gt; &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;months ended June&#160;30, 2021 excludes the effect of anti-dilutive equity instruments including 749,210 shares of common stock then issuable upon the exercise of outstanding warrants and 2,469,816 shares of common stock then issuable upon the exercise of stock options and release of RSUs.&lt;/span&gt;</us-gaap:EarningsPerSharePolicyTextBlock>
    <us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
      contextRef="ie94c263c6992432a815e971cc90962ff_D20220101-20220630"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmFlNWE5YmUwZWI5NDQ1ZDE5MmZhZTgyMmQyMmJlMDlmL3NlYzphZTVhOWJlMGViOTQ0NWQxOTJmYWU4MjJkMjJiZTA5Zl8zNy9mcmFnOjQ4OGNkZjBhODVlYzRiMDliYWFiN2JhZTlhODA5YjcwL3RleHRyZWdpb246NDg4Y2RmMGE4NWVjNGIwOWJhYWI3YmFlOWE4MDliNzBfMjg0ODU_631d124d-43fe-4385-90f6-11ece7ea1119"
      unitRef="shares">714261</us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount>
    <us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
      contextRef="i7ba402f3c4df43af97329ebc435cae8c_D20220401-20220630"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmFlNWE5YmUwZWI5NDQ1ZDE5MmZhZTgyMmQyMmJlMDlmL3NlYzphZTVhOWJlMGViOTQ0NWQxOTJmYWU4MjJkMjJiZTA5Zl8zNy9mcmFnOjQ4OGNkZjBhODVlYzRiMDliYWFiN2JhZTlhODA5YjcwL3RleHRyZWdpb246NDg4Y2RmMGE4NWVjNGIwOWJhYWI3YmFlOWE4MDliNzBfMjg0ODU_725ef6cc-c7e8-4ac6-8ecb-15530aedd97b"
      unitRef="shares">714261</us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount>
    <us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
      contextRef="i2823faffcae54e5d93a6030da77ad512_D20220101-20220630"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmFlNWE5YmUwZWI5NDQ1ZDE5MmZhZTgyMmQyMmJlMDlmL3NlYzphZTVhOWJlMGViOTQ0NWQxOTJmYWU4MjJkMjJiZTA5Zl8zNy9mcmFnOjQ4OGNkZjBhODVlYzRiMDliYWFiN2JhZTlhODA5YjcwL3RleHRyZWdpb246NDg4Y2RmMGE4NWVjNGIwOWJhYWI3YmFlOWE4MDliNzBfMjg1Nzk_49ddfe7f-fdf7-432a-8374-2b9efba34cb2"
      unitRef="shares">4670069</us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount>
    <us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
      contextRef="i4691cb5ab9d44fe4bb012ab3099c548d_D20220401-20220630"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmFlNWE5YmUwZWI5NDQ1ZDE5MmZhZTgyMmQyMmJlMDlmL3NlYzphZTVhOWJlMGViOTQ0NWQxOTJmYWU4MjJkMjJiZTA5Zl8zNy9mcmFnOjQ4OGNkZjBhODVlYzRiMDliYWFiN2JhZTlhODA5YjcwL3RleHRyZWdpb246NDg4Y2RmMGE4NWVjNGIwOWJhYWI3YmFlOWE4MDliNzBfMjg1Nzk_4bc2ca5a-4a6b-4a11-bbf1-6f2759b731da"
      unitRef="shares">4670069</us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount>
    <us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
      contextRef="icb0e8ee0be634262b34d17ccb551b284_D20210101-20210630"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmFlNWE5YmUwZWI5NDQ1ZDE5MmZhZTgyMmQyMmJlMDlmL3NlYzphZTVhOWJlMGViOTQ0NWQxOTJmYWU4MjJkMjJiZTA5Zl8zNy9mcmFnOjQ4OGNkZjBhODVlYzRiMDliYWFiN2JhZTlhODA5YjcwL3RleHRyZWdpb246NDg4Y2RmMGE4NWVjNGIwOWJhYWI3YmFlOWE4MDliNzBfMjg4MDY_1abeaaec-4c08-43d7-abb9-bc9181c2c97f"
      unitRef="shares">749210</us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount>
    <us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
      contextRef="i249d87c65f444c66a0d32f915d17cf47_D20210401-20210630"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmFlNWE5YmUwZWI5NDQ1ZDE5MmZhZTgyMmQyMmJlMDlmL3NlYzphZTVhOWJlMGViOTQ0NWQxOTJmYWU4MjJkMjJiZTA5Zl8zNy9mcmFnOjQ4OGNkZjBhODVlYzRiMDliYWFiN2JhZTlhODA5YjcwL3RleHRyZWdpb246NDg4Y2RmMGE4NWVjNGIwOWJhYWI3YmFlOWE4MDliNzBfMjg4MDY_f8899170-c295-413f-bc7f-f6993f052878"
      unitRef="shares">749210</us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount>
    <us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
      contextRef="i8302e4a3b08c40939cfabd8d8c7827e0_D20210401-20210630"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmFlNWE5YmUwZWI5NDQ1ZDE5MmZhZTgyMmQyMmJlMDlmL3NlYzphZTVhOWJlMGViOTQ0NWQxOTJmYWU4MjJkMjJiZTA5Zl8zNy9mcmFnOjQ4OGNkZjBhODVlYzRiMDliYWFiN2JhZTlhODA5YjcwL3RleHRyZWdpb246NDg4Y2RmMGE4NWVjNGIwOWJhYWI3YmFlOWE4MDliNzBfMjg4OTI_2c1481f2-7a14-471f-9276-2aa16f57b812"
      unitRef="shares">2469816</us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount>
    <us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
      contextRef="idde3250874484b9b9fbc3ab3b93032eb_D20210101-20210630"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmFlNWE5YmUwZWI5NDQ1ZDE5MmZhZTgyMmQyMmJlMDlmL3NlYzphZTVhOWJlMGViOTQ0NWQxOTJmYWU4MjJkMjJiZTA5Zl8zNy9mcmFnOjQ4OGNkZjBhODVlYzRiMDliYWFiN2JhZTlhODA5YjcwL3RleHRyZWdpb246NDg4Y2RmMGE4NWVjNGIwOWJhYWI3YmFlOWE4MDliNzBfMjg4OTI_49d1b508-193f-4010-8d27-d26871dbc168"
      unitRef="shares">2469816</us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount>
    <us-gaap:FairValueMeasurementPolicyPolicyTextBlock
      contextRef="ia855382ada1f4f28aa8ef6da692ff177_D20220101-20220630"
      id="id3VybDovL2RvY3MudjEvZG9jOmFlNWE5YmUwZWI5NDQ1ZDE5MmZhZTgyMmQyMmJlMDlmL3NlYzphZTVhOWJlMGViOTQ0NWQxOTJmYWU4MjJkMjJiZTA5Zl8zNy9mcmFnOjQ4OGNkZjBhODVlYzRiMDliYWFiN2JhZTlhODA5YjcwL3RleHRyZWdpb246NDg4Y2RmMGE4NWVjNGIwOWJhYWI3YmFlOWE4MDliNzBfNDYyNjc_ede8b027-56df-474f-903a-756e588d6fc6">Fair Value MeasurementsThe Company measures certain financial assets and liabilities at fair value on a recurring basis. Fair value is defined as the price that would be received to sell an asset or paid to transfer a liability (an exit price) in an orderly transaction between market participants at the measurement date. The Company uses a three-tier fair value hierarchy to prioritize the inputs used in the Company&#x2019;s fair value measurements. These tiers include: Level 1, defined as observable inputs such as quoted prices in active markets for identical assets; Level 2, defined as inputs other than quoted prices in active markets that are either directly or indirectly observable; and Level 3, defined as unobservable inputs in which little or no market data exists, therefore requiring an entity to develop its own assumptions.&lt;div style="margin-top:9pt;padding-left:27pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The Company&#x2019;s marketable debt securities are classified as available-for-sale securities based on management's intentions and are at Level 2 of the fair value hierarchy, as these investment securities are valued based upon quoted prices for identical or similar instruments in markets that are not active. The Company has classified marketable securities with original maturities of greater than one year as short-term investments based upon the Company&#x2019;s ability to use all of those marketable securities to satisfy the liquidity needs of the Company&#x2019;s current operations.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:9pt;padding-left:27pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The fair value of the Private SPAC Warrants (as defined below) was determined using the Black-Scholes-Merton valuation model and included an unobservable input: expected volatility. Expected volatility is considered by the Company to be an unobservable input and is calculated using a weighted average of historical volatilities of a combination of the Company and peer companies, due to the lack of sufficient historical data of the Company&#x2019;s own stock price. The model also incorporated several observable assumptions at each valuation date including: the price of the Company&#x2019;s common stock on the date of valuation, the remaining contractual term of the warrant and the risk-free interest rate over the remaining term.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:9pt;padding-left:27pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;As of June&#160;30, 2022 and December&#160;31, 2021, the Company maintains letters of credit of $3.5 million and $3.0&#160;million, respectively, related to its lease arrangements, which are secured by money market accounts in accordance with certain of its lease agreements. The amounts are recorded at fair value using Level 1 inputs and included as restricted cash in the condensed consolidated balance sheets.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:9pt;padding-left:27pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The Company believes the carrying amount of cash and cash equivalents, accounts payable and accrued expenses approximate their estimated fair values due to the short-term nature of these accounts.&lt;/span&gt;&lt;/div&gt;</us-gaap:FairValueMeasurementPolicyPolicyTextBlock>
    <us-gaap:ScheduleOfFairValueAssetsAndLiabilitiesMeasuredOnRecurringBasisTableTextBlock
      contextRef="ia855382ada1f4f28aa8ef6da692ff177_D20220101-20220630"
      id="id3VybDovL2RvY3MudjEvZG9jOmFlNWE5YmUwZWI5NDQ1ZDE5MmZhZTgyMmQyMmJlMDlmL3NlYzphZTVhOWJlMGViOTQ0NWQxOTJmYWU4MjJkMjJiZTA5Zl8zNy9mcmFnOjQ4OGNkZjBhODVlYzRiMDliYWFiN2JhZTlhODA5YjcwL3RleHRyZWdpb246NDg4Y2RmMGE4NWVjNGIwOWJhYWI3YmFlOWE4MDliNzBfNDYyNjE_6b78fcfb-da46-4d85-87e5-1874376a4243">&lt;div style="margin-top:9pt;padding-left:27pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The following table provides a summary of the assets and liabilities that are measured at fair value on a recurring basis as of June&#160;30, 2022 (in thousands): &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:12pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:44.354%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:12.081%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.406%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:12.081%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.406%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:12.081%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.406%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:12.085%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="21" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;June 30, 2022&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Level 1&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Level 2&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Level 3&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Total&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Assets:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Cash equivalents&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;30,723&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;30,723&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Restricted cash&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3,470&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3,470&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Marketable securities, available for sale:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Corporate debt securities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;15,092&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;15,092&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Municipal debt securities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3,641&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3,641&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;U.S. government debt securities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;34,724&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;34,724&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total marketable securities, available for sale&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;53,457&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;53,457&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Total assets measured at fair value on a recurring basis&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;34,193&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;53,457&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;87,650&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr style="height:15pt"&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:3pt double #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:3pt double #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:3pt double #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:3pt double #000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Liabilities:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Warrant liability&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;24&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;24&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Total liabilities measured at fair value on a recurring basis&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;24&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;24&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-top:9pt;padding-left:27pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The following table provides a summary of the assets and liabilities that are measured at fair value on a recurring basis as of December&#160;31, 2021 (in thousands): &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:12pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:44.354%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:12.081%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.406%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:12.081%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.406%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:12.081%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.406%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:12.085%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="21" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;December 31, 2021&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Level 1&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Level 2&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Level 3&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Total&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Assets:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Cash equivalents&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;16,380&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;16,380&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Restricted cash&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3,025&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3,025&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Marketable securities, available for sale:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Corporate debt&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;15,352&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;15,352&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Municipal debt securities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;7,412&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;7,412&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;U.S. government debt securities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;25,685&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;25,685&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total marketable securities, available for sale&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;48,449&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;48,449&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Total assets measured at fair value on a recurring basis&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;19,405&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;48,449&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;67,854&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr style="height:15pt"&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:3pt double #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:3pt double #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:3pt double #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:3pt double #000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Liabilities:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Warrant liability&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;146&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;146&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Total liabilities measured at fair value on a recurring basis&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;146&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;146&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;</us-gaap:ScheduleOfFairValueAssetsAndLiabilitiesMeasuredOnRecurringBasisTableTextBlock>
    <us-gaap:CashEquivalentsAtCarryingValue
      contextRef="if758224c2e474796966c7a56ed966de8_I20220630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmFlNWE5YmUwZWI5NDQ1ZDE5MmZhZTgyMmQyMmJlMDlmL3NlYzphZTVhOWJlMGViOTQ0NWQxOTJmYWU4MjJkMjJiZTA5Zl8zNy9mcmFnOjQ4OGNkZjBhODVlYzRiMDliYWFiN2JhZTlhODA5YjcwL3RhYmxlOjBhMmUxZWYwOGVmNjQ4ZWI4Y2MxNTJjZTRmNmM3YjgxL3RhYmxlcmFuZ2U6MGEyZTFlZjA4ZWY2NDhlYjhjYzE1MmNlNGY2YzdiODFfMy0xLTEtMS02MjY_49514757-b30b-4cfc-a04a-1ec2036c5db8"
      unitRef="usd">30723000</us-gaap:CashEquivalentsAtCarryingValue>
    <us-gaap:CashEquivalentsAtCarryingValue
      contextRef="if8fdbfd7ecbc4f1e83abd5532a4f2776_I20220630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmFlNWE5YmUwZWI5NDQ1ZDE5MmZhZTgyMmQyMmJlMDlmL3NlYzphZTVhOWJlMGViOTQ0NWQxOTJmYWU4MjJkMjJiZTA5Zl8zNy9mcmFnOjQ4OGNkZjBhODVlYzRiMDliYWFiN2JhZTlhODA5YjcwL3RhYmxlOjBhMmUxZWYwOGVmNjQ4ZWI4Y2MxNTJjZTRmNmM3YjgxL3RhYmxlcmFuZ2U6MGEyZTFlZjA4ZWY2NDhlYjhjYzE1MmNlNGY2YzdiODFfMy0zLTEtMS02MjY_391a5243-c586-4b19-a303-c57cb625d1ba"
      unitRef="usd">0</us-gaap:CashEquivalentsAtCarryingValue>
    <us-gaap:CashEquivalentsAtCarryingValue
      contextRef="id460d49e6dc845ddb03e35bcd01b0a02_I20220630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmFlNWE5YmUwZWI5NDQ1ZDE5MmZhZTgyMmQyMmJlMDlmL3NlYzphZTVhOWJlMGViOTQ0NWQxOTJmYWU4MjJkMjJiZTA5Zl8zNy9mcmFnOjQ4OGNkZjBhODVlYzRiMDliYWFiN2JhZTlhODA5YjcwL3RhYmxlOjBhMmUxZWYwOGVmNjQ4ZWI4Y2MxNTJjZTRmNmM3YjgxL3RhYmxlcmFuZ2U6MGEyZTFlZjA4ZWY2NDhlYjhjYzE1MmNlNGY2YzdiODFfMy01LTEtMS02MjY_41fa9109-42a5-4d83-9482-63fa29ce7a98"
      unitRef="usd">0</us-gaap:CashEquivalentsAtCarryingValue>
    <us-gaap:CashEquivalentsAtCarryingValue
      contextRef="i6f6e047d4cc946d5ab745668b1e79366_I20220630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmFlNWE5YmUwZWI5NDQ1ZDE5MmZhZTgyMmQyMmJlMDlmL3NlYzphZTVhOWJlMGViOTQ0NWQxOTJmYWU4MjJkMjJiZTA5Zl8zNy9mcmFnOjQ4OGNkZjBhODVlYzRiMDliYWFiN2JhZTlhODA5YjcwL3RhYmxlOjBhMmUxZWYwOGVmNjQ4ZWI4Y2MxNTJjZTRmNmM3YjgxL3RhYmxlcmFuZ2U6MGEyZTFlZjA4ZWY2NDhlYjhjYzE1MmNlNGY2YzdiODFfMy03LTEtMS02MjY_5ea852fe-03c5-4c13-a41b-b6852b9b3a73"
      unitRef="usd">30723000</us-gaap:CashEquivalentsAtCarryingValue>
    <us-gaap:RestrictedCashNoncurrent
      contextRef="if758224c2e474796966c7a56ed966de8_I20220630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmFlNWE5YmUwZWI5NDQ1ZDE5MmZhZTgyMmQyMmJlMDlmL3NlYzphZTVhOWJlMGViOTQ0NWQxOTJmYWU4MjJkMjJiZTA5Zl8zNy9mcmFnOjQ4OGNkZjBhODVlYzRiMDliYWFiN2JhZTlhODA5YjcwL3RhYmxlOjBhMmUxZWYwOGVmNjQ4ZWI4Y2MxNTJjZTRmNmM3YjgxL3RhYmxlcmFuZ2U6MGEyZTFlZjA4ZWY2NDhlYjhjYzE1MmNlNGY2YzdiODFfNC0xLTEtMS02MjY_c6a88e5f-cbe2-49e0-bbb6-fdb799dfe987"
      unitRef="usd">3470000</us-gaap:RestrictedCashNoncurrent>
    <us-gaap:RestrictedCashNoncurrent
      contextRef="if8fdbfd7ecbc4f1e83abd5532a4f2776_I20220630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmFlNWE5YmUwZWI5NDQ1ZDE5MmZhZTgyMmQyMmJlMDlmL3NlYzphZTVhOWJlMGViOTQ0NWQxOTJmYWU4MjJkMjJiZTA5Zl8zNy9mcmFnOjQ4OGNkZjBhODVlYzRiMDliYWFiN2JhZTlhODA5YjcwL3RhYmxlOjBhMmUxZWYwOGVmNjQ4ZWI4Y2MxNTJjZTRmNmM3YjgxL3RhYmxlcmFuZ2U6MGEyZTFlZjA4ZWY2NDhlYjhjYzE1MmNlNGY2YzdiODFfNC0zLTEtMS02MjY_bb173420-6d18-4f01-af59-3a4cb1f66326"
      unitRef="usd">0</us-gaap:RestrictedCashNoncurrent>
    <us-gaap:RestrictedCashNoncurrent
      contextRef="id460d49e6dc845ddb03e35bcd01b0a02_I20220630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmFlNWE5YmUwZWI5NDQ1ZDE5MmZhZTgyMmQyMmJlMDlmL3NlYzphZTVhOWJlMGViOTQ0NWQxOTJmYWU4MjJkMjJiZTA5Zl8zNy9mcmFnOjQ4OGNkZjBhODVlYzRiMDliYWFiN2JhZTlhODA5YjcwL3RhYmxlOjBhMmUxZWYwOGVmNjQ4ZWI4Y2MxNTJjZTRmNmM3YjgxL3RhYmxlcmFuZ2U6MGEyZTFlZjA4ZWY2NDhlYjhjYzE1MmNlNGY2YzdiODFfNC01LTEtMS02MjY_9a112aaf-cce6-4d67-bdb6-677074ebea1d"
      unitRef="usd">0</us-gaap:RestrictedCashNoncurrent>
    <us-gaap:RestrictedCashNoncurrent
      contextRef="i6f6e047d4cc946d5ab745668b1e79366_I20220630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmFlNWE5YmUwZWI5NDQ1ZDE5MmZhZTgyMmQyMmJlMDlmL3NlYzphZTVhOWJlMGViOTQ0NWQxOTJmYWU4MjJkMjJiZTA5Zl8zNy9mcmFnOjQ4OGNkZjBhODVlYzRiMDliYWFiN2JhZTlhODA5YjcwL3RhYmxlOjBhMmUxZWYwOGVmNjQ4ZWI4Y2MxNTJjZTRmNmM3YjgxL3RhYmxlcmFuZ2U6MGEyZTFlZjA4ZWY2NDhlYjhjYzE1MmNlNGY2YzdiODFfNC03LTEtMS02MjY_8aed2cf7-ddfe-464b-aac0-5aebc3826f26"
      unitRef="usd">3470000</us-gaap:RestrictedCashNoncurrent>
    <us-gaap:AvailableForSaleSecuritiesDebtSecurities
      contextRef="i41653ba801c2441dbaca0c02a6789086_I20220630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmFlNWE5YmUwZWI5NDQ1ZDE5MmZhZTgyMmQyMmJlMDlmL3NlYzphZTVhOWJlMGViOTQ0NWQxOTJmYWU4MjJkMjJiZTA5Zl8zNy9mcmFnOjQ4OGNkZjBhODVlYzRiMDliYWFiN2JhZTlhODA5YjcwL3RhYmxlOjBhMmUxZWYwOGVmNjQ4ZWI4Y2MxNTJjZTRmNmM3YjgxL3RhYmxlcmFuZ2U6MGEyZTFlZjA4ZWY2NDhlYjhjYzE1MmNlNGY2YzdiODFfNi0xLTEtMS02MjY_98a72e14-2729-4395-abdb-dcf379e455a1"
      unitRef="usd">0</us-gaap:AvailableForSaleSecuritiesDebtSecurities>
    <us-gaap:AvailableForSaleSecuritiesDebtSecurities
      contextRef="iea92d61cbcce431fa5e4090b90791f94_I20220630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmFlNWE5YmUwZWI5NDQ1ZDE5MmZhZTgyMmQyMmJlMDlmL3NlYzphZTVhOWJlMGViOTQ0NWQxOTJmYWU4MjJkMjJiZTA5Zl8zNy9mcmFnOjQ4OGNkZjBhODVlYzRiMDliYWFiN2JhZTlhODA5YjcwL3RhYmxlOjBhMmUxZWYwOGVmNjQ4ZWI4Y2MxNTJjZTRmNmM3YjgxL3RhYmxlcmFuZ2U6MGEyZTFlZjA4ZWY2NDhlYjhjYzE1MmNlNGY2YzdiODFfNi0zLTEtMS02MjY_b72306ed-53e2-4559-bf62-e7c4e6045012"
      unitRef="usd">15092000</us-gaap:AvailableForSaleSecuritiesDebtSecurities>
    <us-gaap:AvailableForSaleSecuritiesDebtSecurities
      contextRef="i5b506509888b48d6a34efce6ba8f7e6e_I20220630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmFlNWE5YmUwZWI5NDQ1ZDE5MmZhZTgyMmQyMmJlMDlmL3NlYzphZTVhOWJlMGViOTQ0NWQxOTJmYWU4MjJkMjJiZTA5Zl8zNy9mcmFnOjQ4OGNkZjBhODVlYzRiMDliYWFiN2JhZTlhODA5YjcwL3RhYmxlOjBhMmUxZWYwOGVmNjQ4ZWI4Y2MxNTJjZTRmNmM3YjgxL3RhYmxlcmFuZ2U6MGEyZTFlZjA4ZWY2NDhlYjhjYzE1MmNlNGY2YzdiODFfNi01LTEtMS02MjY_67deb25a-52e1-4e8b-a56f-419eeeec1986"
      unitRef="usd">0</us-gaap:AvailableForSaleSecuritiesDebtSecurities>
    <us-gaap:AvailableForSaleSecuritiesDebtSecurities
      contextRef="ie45f0b654eec485abbe4c0f2ba779d49_I20220630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmFlNWE5YmUwZWI5NDQ1ZDE5MmZhZTgyMmQyMmJlMDlmL3NlYzphZTVhOWJlMGViOTQ0NWQxOTJmYWU4MjJkMjJiZTA5Zl8zNy9mcmFnOjQ4OGNkZjBhODVlYzRiMDliYWFiN2JhZTlhODA5YjcwL3RhYmxlOjBhMmUxZWYwOGVmNjQ4ZWI4Y2MxNTJjZTRmNmM3YjgxL3RhYmxlcmFuZ2U6MGEyZTFlZjA4ZWY2NDhlYjhjYzE1MmNlNGY2YzdiODFfNi03LTEtMS02MjY_764b4e97-26de-4e78-a5df-60882d8a050a"
      unitRef="usd">15092000</us-gaap:AvailableForSaleSecuritiesDebtSecurities>
    <us-gaap:AvailableForSaleSecuritiesDebtSecurities
      contextRef="i37da1f18c957414ba4dec5d09fe5fce0_I20220630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmFlNWE5YmUwZWI5NDQ1ZDE5MmZhZTgyMmQyMmJlMDlmL3NlYzphZTVhOWJlMGViOTQ0NWQxOTJmYWU4MjJkMjJiZTA5Zl8zNy9mcmFnOjQ4OGNkZjBhODVlYzRiMDliYWFiN2JhZTlhODA5YjcwL3RhYmxlOjBhMmUxZWYwOGVmNjQ4ZWI4Y2MxNTJjZTRmNmM3YjgxL3RhYmxlcmFuZ2U6MGEyZTFlZjA4ZWY2NDhlYjhjYzE1MmNlNGY2YzdiODFfNy0xLTEtMS02MjY_7551aea1-6051-4464-8a50-0998287b9fe8"
      unitRef="usd">0</us-gaap:AvailableForSaleSecuritiesDebtSecurities>
    <us-gaap:AvailableForSaleSecuritiesDebtSecurities
      contextRef="i04cf5fc9b6ef4515a8ce5817a046a654_I20220630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmFlNWE5YmUwZWI5NDQ1ZDE5MmZhZTgyMmQyMmJlMDlmL3NlYzphZTVhOWJlMGViOTQ0NWQxOTJmYWU4MjJkMjJiZTA5Zl8zNy9mcmFnOjQ4OGNkZjBhODVlYzRiMDliYWFiN2JhZTlhODA5YjcwL3RhYmxlOjBhMmUxZWYwOGVmNjQ4ZWI4Y2MxNTJjZTRmNmM3YjgxL3RhYmxlcmFuZ2U6MGEyZTFlZjA4ZWY2NDhlYjhjYzE1MmNlNGY2YzdiODFfNy0zLTEtMS02MjY_079a3672-d10d-44c2-b4f7-95db68b79399"
      unitRef="usd">3641000</us-gaap:AvailableForSaleSecuritiesDebtSecurities>
    <us-gaap:AvailableForSaleSecuritiesDebtSecurities
      contextRef="ibc090232bd5e457e8df72d86df61cf31_I20220630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmFlNWE5YmUwZWI5NDQ1ZDE5MmZhZTgyMmQyMmJlMDlmL3NlYzphZTVhOWJlMGViOTQ0NWQxOTJmYWU4MjJkMjJiZTA5Zl8zNy9mcmFnOjQ4OGNkZjBhODVlYzRiMDliYWFiN2JhZTlhODA5YjcwL3RhYmxlOjBhMmUxZWYwOGVmNjQ4ZWI4Y2MxNTJjZTRmNmM3YjgxL3RhYmxlcmFuZ2U6MGEyZTFlZjA4ZWY2NDhlYjhjYzE1MmNlNGY2YzdiODFfNy01LTEtMS02MjY_febe6f08-f64f-4d53-b46d-0553067c508e"
      unitRef="usd">0</us-gaap:AvailableForSaleSecuritiesDebtSecurities>
    <us-gaap:AvailableForSaleSecuritiesDebtSecurities
      contextRef="id3e9e3b412de4937a9a4ce62ef9086bd_I20220630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmFlNWE5YmUwZWI5NDQ1ZDE5MmZhZTgyMmQyMmJlMDlmL3NlYzphZTVhOWJlMGViOTQ0NWQxOTJmYWU4MjJkMjJiZTA5Zl8zNy9mcmFnOjQ4OGNkZjBhODVlYzRiMDliYWFiN2JhZTlhODA5YjcwL3RhYmxlOjBhMmUxZWYwOGVmNjQ4ZWI4Y2MxNTJjZTRmNmM3YjgxL3RhYmxlcmFuZ2U6MGEyZTFlZjA4ZWY2NDhlYjhjYzE1MmNlNGY2YzdiODFfNy03LTEtMS02MjY_37373927-4260-49fa-b648-61f76ca89698"
      unitRef="usd">3641000</us-gaap:AvailableForSaleSecuritiesDebtSecurities>
    <us-gaap:AvailableForSaleSecuritiesDebtSecurities
      contextRef="i7a19194e0b6946c5a1307bef5ce3e7ea_I20220630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmFlNWE5YmUwZWI5NDQ1ZDE5MmZhZTgyMmQyMmJlMDlmL3NlYzphZTVhOWJlMGViOTQ0NWQxOTJmYWU4MjJkMjJiZTA5Zl8zNy9mcmFnOjQ4OGNkZjBhODVlYzRiMDliYWFiN2JhZTlhODA5YjcwL3RhYmxlOjBhMmUxZWYwOGVmNjQ4ZWI4Y2MxNTJjZTRmNmM3YjgxL3RhYmxlcmFuZ2U6MGEyZTFlZjA4ZWY2NDhlYjhjYzE1MmNlNGY2YzdiODFfOC0xLTEtMS02MjY_2613e3f1-0c55-4af8-9d8b-2b9dc921f7eb"
      unitRef="usd">0</us-gaap:AvailableForSaleSecuritiesDebtSecurities>
    <us-gaap:AvailableForSaleSecuritiesDebtSecurities
      contextRef="i48acc600f436461fa46eb2fc48d5b8a3_I20220630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmFlNWE5YmUwZWI5NDQ1ZDE5MmZhZTgyMmQyMmJlMDlmL3NlYzphZTVhOWJlMGViOTQ0NWQxOTJmYWU4MjJkMjJiZTA5Zl8zNy9mcmFnOjQ4OGNkZjBhODVlYzRiMDliYWFiN2JhZTlhODA5YjcwL3RhYmxlOjBhMmUxZWYwOGVmNjQ4ZWI4Y2MxNTJjZTRmNmM3YjgxL3RhYmxlcmFuZ2U6MGEyZTFlZjA4ZWY2NDhlYjhjYzE1MmNlNGY2YzdiODFfOC0zLTEtMS02MjY_da9bef21-bd27-43c2-a295-d59106bd76bd"
      unitRef="usd">34724000</us-gaap:AvailableForSaleSecuritiesDebtSecurities>
    <us-gaap:AvailableForSaleSecuritiesDebtSecurities
      contextRef="ic46c00dd86944457b5ff2e30e0e14027_I20220630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmFlNWE5YmUwZWI5NDQ1ZDE5MmZhZTgyMmQyMmJlMDlmL3NlYzphZTVhOWJlMGViOTQ0NWQxOTJmYWU4MjJkMjJiZTA5Zl8zNy9mcmFnOjQ4OGNkZjBhODVlYzRiMDliYWFiN2JhZTlhODA5YjcwL3RhYmxlOjBhMmUxZWYwOGVmNjQ4ZWI4Y2MxNTJjZTRmNmM3YjgxL3RhYmxlcmFuZ2U6MGEyZTFlZjA4ZWY2NDhlYjhjYzE1MmNlNGY2YzdiODFfOC01LTEtMS02MjY_74c94020-0c63-482a-8e4a-7d3841ed52a8"
      unitRef="usd">0</us-gaap:AvailableForSaleSecuritiesDebtSecurities>
    <us-gaap:AvailableForSaleSecuritiesDebtSecurities
      contextRef="i7d779ec4227844e9a0d3371962d37354_I20220630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmFlNWE5YmUwZWI5NDQ1ZDE5MmZhZTgyMmQyMmJlMDlmL3NlYzphZTVhOWJlMGViOTQ0NWQxOTJmYWU4MjJkMjJiZTA5Zl8zNy9mcmFnOjQ4OGNkZjBhODVlYzRiMDliYWFiN2JhZTlhODA5YjcwL3RhYmxlOjBhMmUxZWYwOGVmNjQ4ZWI4Y2MxNTJjZTRmNmM3YjgxL3RhYmxlcmFuZ2U6MGEyZTFlZjA4ZWY2NDhlYjhjYzE1MmNlNGY2YzdiODFfOC03LTEtMS02MjY_27b64eda-0adf-4c47-a059-ed62999a076c"
      unitRef="usd">34724000</us-gaap:AvailableForSaleSecuritiesDebtSecurities>
    <us-gaap:AvailableForSaleSecuritiesDebtSecurities
      contextRef="if758224c2e474796966c7a56ed966de8_I20220630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmFlNWE5YmUwZWI5NDQ1ZDE5MmZhZTgyMmQyMmJlMDlmL3NlYzphZTVhOWJlMGViOTQ0NWQxOTJmYWU4MjJkMjJiZTA5Zl8zNy9mcmFnOjQ4OGNkZjBhODVlYzRiMDliYWFiN2JhZTlhODA5YjcwL3RhYmxlOjBhMmUxZWYwOGVmNjQ4ZWI4Y2MxNTJjZTRmNmM3YjgxL3RhYmxlcmFuZ2U6MGEyZTFlZjA4ZWY2NDhlYjhjYzE1MmNlNGY2YzdiODFfOS0xLTEtMS02MjY_6af52d6d-de0c-45e5-b5f6-de6967e5cfea"
      unitRef="usd">0</us-gaap:AvailableForSaleSecuritiesDebtSecurities>
    <us-gaap:AvailableForSaleSecuritiesDebtSecurities
      contextRef="if8fdbfd7ecbc4f1e83abd5532a4f2776_I20220630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmFlNWE5YmUwZWI5NDQ1ZDE5MmZhZTgyMmQyMmJlMDlmL3NlYzphZTVhOWJlMGViOTQ0NWQxOTJmYWU4MjJkMjJiZTA5Zl8zNy9mcmFnOjQ4OGNkZjBhODVlYzRiMDliYWFiN2JhZTlhODA5YjcwL3RhYmxlOjBhMmUxZWYwOGVmNjQ4ZWI4Y2MxNTJjZTRmNmM3YjgxL3RhYmxlcmFuZ2U6MGEyZTFlZjA4ZWY2NDhlYjhjYzE1MmNlNGY2YzdiODFfOS0zLTEtMS02MjY_f6490113-b901-462e-9c4b-a6b5fefd17d1"
      unitRef="usd">53457000</us-gaap:AvailableForSaleSecuritiesDebtSecurities>
    <us-gaap:AvailableForSaleSecuritiesDebtSecurities
      contextRef="id460d49e6dc845ddb03e35bcd01b0a02_I20220630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmFlNWE5YmUwZWI5NDQ1ZDE5MmZhZTgyMmQyMmJlMDlmL3NlYzphZTVhOWJlMGViOTQ0NWQxOTJmYWU4MjJkMjJiZTA5Zl8zNy9mcmFnOjQ4OGNkZjBhODVlYzRiMDliYWFiN2JhZTlhODA5YjcwL3RhYmxlOjBhMmUxZWYwOGVmNjQ4ZWI4Y2MxNTJjZTRmNmM3YjgxL3RhYmxlcmFuZ2U6MGEyZTFlZjA4ZWY2NDhlYjhjYzE1MmNlNGY2YzdiODFfOS01LTEtMS02MjY_1bad5ab3-bc9f-4945-a74c-c0781018825c"
      unitRef="usd">0</us-gaap:AvailableForSaleSecuritiesDebtSecurities>
    <us-gaap:AvailableForSaleSecuritiesDebtSecurities
      contextRef="i6f6e047d4cc946d5ab745668b1e79366_I20220630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmFlNWE5YmUwZWI5NDQ1ZDE5MmZhZTgyMmQyMmJlMDlmL3NlYzphZTVhOWJlMGViOTQ0NWQxOTJmYWU4MjJkMjJiZTA5Zl8zNy9mcmFnOjQ4OGNkZjBhODVlYzRiMDliYWFiN2JhZTlhODA5YjcwL3RhYmxlOjBhMmUxZWYwOGVmNjQ4ZWI4Y2MxNTJjZTRmNmM3YjgxL3RhYmxlcmFuZ2U6MGEyZTFlZjA4ZWY2NDhlYjhjYzE1MmNlNGY2YzdiODFfOS03LTEtMS02MjY_21b6978c-3773-41de-a200-5460c827b6c2"
      unitRef="usd">53457000</us-gaap:AvailableForSaleSecuritiesDebtSecurities>
    <us-gaap:AssetsFairValueDisclosure
      contextRef="if758224c2e474796966c7a56ed966de8_I20220630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmFlNWE5YmUwZWI5NDQ1ZDE5MmZhZTgyMmQyMmJlMDlmL3NlYzphZTVhOWJlMGViOTQ0NWQxOTJmYWU4MjJkMjJiZTA5Zl8zNy9mcmFnOjQ4OGNkZjBhODVlYzRiMDliYWFiN2JhZTlhODA5YjcwL3RhYmxlOjBhMmUxZWYwOGVmNjQ4ZWI4Y2MxNTJjZTRmNmM3YjgxL3RhYmxlcmFuZ2U6MGEyZTFlZjA4ZWY2NDhlYjhjYzE1MmNlNGY2YzdiODFfMTAtMS0xLTEtNjI2_8fd5d4a4-08eb-40c9-b34b-1bd8c25a4dbd"
      unitRef="usd">34193000</us-gaap:AssetsFairValueDisclosure>
    <us-gaap:AssetsFairValueDisclosure
      contextRef="if8fdbfd7ecbc4f1e83abd5532a4f2776_I20220630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmFlNWE5YmUwZWI5NDQ1ZDE5MmZhZTgyMmQyMmJlMDlmL3NlYzphZTVhOWJlMGViOTQ0NWQxOTJmYWU4MjJkMjJiZTA5Zl8zNy9mcmFnOjQ4OGNkZjBhODVlYzRiMDliYWFiN2JhZTlhODA5YjcwL3RhYmxlOjBhMmUxZWYwOGVmNjQ4ZWI4Y2MxNTJjZTRmNmM3YjgxL3RhYmxlcmFuZ2U6MGEyZTFlZjA4ZWY2NDhlYjhjYzE1MmNlNGY2YzdiODFfMTAtMy0xLTEtNjI2_c1975ed6-3764-45d4-b0ea-bd5b850c447a"
      unitRef="usd">53457000</us-gaap:AssetsFairValueDisclosure>
    <us-gaap:AssetsFairValueDisclosure
      contextRef="id460d49e6dc845ddb03e35bcd01b0a02_I20220630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmFlNWE5YmUwZWI5NDQ1ZDE5MmZhZTgyMmQyMmJlMDlmL3NlYzphZTVhOWJlMGViOTQ0NWQxOTJmYWU4MjJkMjJiZTA5Zl8zNy9mcmFnOjQ4OGNkZjBhODVlYzRiMDliYWFiN2JhZTlhODA5YjcwL3RhYmxlOjBhMmUxZWYwOGVmNjQ4ZWI4Y2MxNTJjZTRmNmM3YjgxL3RhYmxlcmFuZ2U6MGEyZTFlZjA4ZWY2NDhlYjhjYzE1MmNlNGY2YzdiODFfMTAtNS0xLTEtNjI2_bfdf0787-985b-430e-846d-690d77a2bde7"
      unitRef="usd">0</us-gaap:AssetsFairValueDisclosure>
    <us-gaap:AssetsFairValueDisclosure
      contextRef="i6f6e047d4cc946d5ab745668b1e79366_I20220630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmFlNWE5YmUwZWI5NDQ1ZDE5MmZhZTgyMmQyMmJlMDlmL3NlYzphZTVhOWJlMGViOTQ0NWQxOTJmYWU4MjJkMjJiZTA5Zl8zNy9mcmFnOjQ4OGNkZjBhODVlYzRiMDliYWFiN2JhZTlhODA5YjcwL3RhYmxlOjBhMmUxZWYwOGVmNjQ4ZWI4Y2MxNTJjZTRmNmM3YjgxL3RhYmxlcmFuZ2U6MGEyZTFlZjA4ZWY2NDhlYjhjYzE1MmNlNGY2YzdiODFfMTAtNy0xLTEtNjI2_98e7e032-2de7-4209-a70f-66a512d17f52"
      unitRef="usd">87650000</us-gaap:AssetsFairValueDisclosure>
    <dmtk:WarrantLiabilityFairValueDisclosure
      contextRef="if758224c2e474796966c7a56ed966de8_I20220630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmFlNWE5YmUwZWI5NDQ1ZDE5MmZhZTgyMmQyMmJlMDlmL3NlYzphZTVhOWJlMGViOTQ0NWQxOTJmYWU4MjJkMjJiZTA5Zl8zNy9mcmFnOjQ4OGNkZjBhODVlYzRiMDliYWFiN2JhZTlhODA5YjcwL3RhYmxlOjBhMmUxZWYwOGVmNjQ4ZWI4Y2MxNTJjZTRmNmM3YjgxL3RhYmxlcmFuZ2U6MGEyZTFlZjA4ZWY2NDhlYjhjYzE1MmNlNGY2YzdiODFfMTMtMS0xLTEtNjI2_c1526d36-5315-481b-a091-204837ec8932"
      unitRef="usd">0</dmtk:WarrantLiabilityFairValueDisclosure>
    <dmtk:WarrantLiabilityFairValueDisclosure
      contextRef="if8fdbfd7ecbc4f1e83abd5532a4f2776_I20220630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmFlNWE5YmUwZWI5NDQ1ZDE5MmZhZTgyMmQyMmJlMDlmL3NlYzphZTVhOWJlMGViOTQ0NWQxOTJmYWU4MjJkMjJiZTA5Zl8zNy9mcmFnOjQ4OGNkZjBhODVlYzRiMDliYWFiN2JhZTlhODA5YjcwL3RhYmxlOjBhMmUxZWYwOGVmNjQ4ZWI4Y2MxNTJjZTRmNmM3YjgxL3RhYmxlcmFuZ2U6MGEyZTFlZjA4ZWY2NDhlYjhjYzE1MmNlNGY2YzdiODFfMTMtMy0xLTEtNjI2_4114f13b-af69-4876-b1c5-8d9962ed8cf8"
      unitRef="usd">0</dmtk:WarrantLiabilityFairValueDisclosure>
    <dmtk:WarrantLiabilityFairValueDisclosure
      contextRef="id460d49e6dc845ddb03e35bcd01b0a02_I20220630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmFlNWE5YmUwZWI5NDQ1ZDE5MmZhZTgyMmQyMmJlMDlmL3NlYzphZTVhOWJlMGViOTQ0NWQxOTJmYWU4MjJkMjJiZTA5Zl8zNy9mcmFnOjQ4OGNkZjBhODVlYzRiMDliYWFiN2JhZTlhODA5YjcwL3RhYmxlOjBhMmUxZWYwOGVmNjQ4ZWI4Y2MxNTJjZTRmNmM3YjgxL3RhYmxlcmFuZ2U6MGEyZTFlZjA4ZWY2NDhlYjhjYzE1MmNlNGY2YzdiODFfMTMtNS0xLTEtNjI2_1fb83491-cc78-4b9f-be71-5370a20e9ce1"
      unitRef="usd">24000</dmtk:WarrantLiabilityFairValueDisclosure>
    <dmtk:WarrantLiabilityFairValueDisclosure
      contextRef="i6f6e047d4cc946d5ab745668b1e79366_I20220630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmFlNWE5YmUwZWI5NDQ1ZDE5MmZhZTgyMmQyMmJlMDlmL3NlYzphZTVhOWJlMGViOTQ0NWQxOTJmYWU4MjJkMjJiZTA5Zl8zNy9mcmFnOjQ4OGNkZjBhODVlYzRiMDliYWFiN2JhZTlhODA5YjcwL3RhYmxlOjBhMmUxZWYwOGVmNjQ4ZWI4Y2MxNTJjZTRmNmM3YjgxL3RhYmxlcmFuZ2U6MGEyZTFlZjA4ZWY2NDhlYjhjYzE1MmNlNGY2YzdiODFfMTMtNy0xLTEtNjI2_06d5db3b-f058-417e-a5eb-9f9ea4e70861"
      unitRef="usd">24000</dmtk:WarrantLiabilityFairValueDisclosure>
    <us-gaap:LiabilitiesFairValueDisclosure
      contextRef="if758224c2e474796966c7a56ed966de8_I20220630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmFlNWE5YmUwZWI5NDQ1ZDE5MmZhZTgyMmQyMmJlMDlmL3NlYzphZTVhOWJlMGViOTQ0NWQxOTJmYWU4MjJkMjJiZTA5Zl8zNy9mcmFnOjQ4OGNkZjBhODVlYzRiMDliYWFiN2JhZTlhODA5YjcwL3RhYmxlOjBhMmUxZWYwOGVmNjQ4ZWI4Y2MxNTJjZTRmNmM3YjgxL3RhYmxlcmFuZ2U6MGEyZTFlZjA4ZWY2NDhlYjhjYzE1MmNlNGY2YzdiODFfMTQtMS0xLTEtNjI2_a88068ec-bcd1-4fb2-b121-a43b34c04e7c"
      unitRef="usd">0</us-gaap:LiabilitiesFairValueDisclosure>
    <us-gaap:LiabilitiesFairValueDisclosure
      contextRef="if8fdbfd7ecbc4f1e83abd5532a4f2776_I20220630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmFlNWE5YmUwZWI5NDQ1ZDE5MmZhZTgyMmQyMmJlMDlmL3NlYzphZTVhOWJlMGViOTQ0NWQxOTJmYWU4MjJkMjJiZTA5Zl8zNy9mcmFnOjQ4OGNkZjBhODVlYzRiMDliYWFiN2JhZTlhODA5YjcwL3RhYmxlOjBhMmUxZWYwOGVmNjQ4ZWI4Y2MxNTJjZTRmNmM3YjgxL3RhYmxlcmFuZ2U6MGEyZTFlZjA4ZWY2NDhlYjhjYzE1MmNlNGY2YzdiODFfMTQtMy0xLTEtNjI2_b7b8c40a-08b7-4086-ad97-ebf320fa237e"
      unitRef="usd">0</us-gaap:LiabilitiesFairValueDisclosure>
    <us-gaap:LiabilitiesFairValueDisclosure
      contextRef="id460d49e6dc845ddb03e35bcd01b0a02_I20220630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmFlNWE5YmUwZWI5NDQ1ZDE5MmZhZTgyMmQyMmJlMDlmL3NlYzphZTVhOWJlMGViOTQ0NWQxOTJmYWU4MjJkMjJiZTA5Zl8zNy9mcmFnOjQ4OGNkZjBhODVlYzRiMDliYWFiN2JhZTlhODA5YjcwL3RhYmxlOjBhMmUxZWYwOGVmNjQ4ZWI4Y2MxNTJjZTRmNmM3YjgxL3RhYmxlcmFuZ2U6MGEyZTFlZjA4ZWY2NDhlYjhjYzE1MmNlNGY2YzdiODFfMTQtNS0xLTEtNjI2_1707f1b4-5536-4178-bb3a-67d30dff0e50"
      unitRef="usd">24000</us-gaap:LiabilitiesFairValueDisclosure>
    <us-gaap:LiabilitiesFairValueDisclosure
      contextRef="i6f6e047d4cc946d5ab745668b1e79366_I20220630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmFlNWE5YmUwZWI5NDQ1ZDE5MmZhZTgyMmQyMmJlMDlmL3NlYzphZTVhOWJlMGViOTQ0NWQxOTJmYWU4MjJkMjJiZTA5Zl8zNy9mcmFnOjQ4OGNkZjBhODVlYzRiMDliYWFiN2JhZTlhODA5YjcwL3RhYmxlOjBhMmUxZWYwOGVmNjQ4ZWI4Y2MxNTJjZTRmNmM3YjgxL3RhYmxlcmFuZ2U6MGEyZTFlZjA4ZWY2NDhlYjhjYzE1MmNlNGY2YzdiODFfMTQtNy0xLTEtNjI2_2a87d2b5-6be1-4d9b-8b8f-94e7080fa937"
      unitRef="usd">24000</us-gaap:LiabilitiesFairValueDisclosure>
    <us-gaap:CashEquivalentsAtCarryingValue
      contextRef="id0495dc386634c17abe35f6f0b1c1cde_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmFlNWE5YmUwZWI5NDQ1ZDE5MmZhZTgyMmQyMmJlMDlmL3NlYzphZTVhOWJlMGViOTQ0NWQxOTJmYWU4MjJkMjJiZTA5Zl8zNy9mcmFnOjQ4OGNkZjBhODVlYzRiMDliYWFiN2JhZTlhODA5YjcwL3RhYmxlOmJlMGVkYmJlNTg1NDQyNWQ5YTZhODA0OWNiYzMxOGIyL3RhYmxlcmFuZ2U6YmUwZWRiYmU1ODU0NDI1ZDlhNmE4MDQ5Y2JjMzE4YjJfMy0xLTEtMS02MjY_edded454-8571-40c5-a006-cb69aa574d8d"
      unitRef="usd">16380000</us-gaap:CashEquivalentsAtCarryingValue>
    <us-gaap:CashEquivalentsAtCarryingValue
      contextRef="i22164451262946e4b9911f313b7610c1_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmFlNWE5YmUwZWI5NDQ1ZDE5MmZhZTgyMmQyMmJlMDlmL3NlYzphZTVhOWJlMGViOTQ0NWQxOTJmYWU4MjJkMjJiZTA5Zl8zNy9mcmFnOjQ4OGNkZjBhODVlYzRiMDliYWFiN2JhZTlhODA5YjcwL3RhYmxlOmJlMGVkYmJlNTg1NDQyNWQ5YTZhODA0OWNiYzMxOGIyL3RhYmxlcmFuZ2U6YmUwZWRiYmU1ODU0NDI1ZDlhNmE4MDQ5Y2JjMzE4YjJfMy0zLTEtMS02MjY_ff871978-e33b-40cf-88f6-a1d4635927ef"
      unitRef="usd">0</us-gaap:CashEquivalentsAtCarryingValue>
    <us-gaap:CashEquivalentsAtCarryingValue
      contextRef="ica20d3fdf2ff41fdb31ad57ccb72924b_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmFlNWE5YmUwZWI5NDQ1ZDE5MmZhZTgyMmQyMmJlMDlmL3NlYzphZTVhOWJlMGViOTQ0NWQxOTJmYWU4MjJkMjJiZTA5Zl8zNy9mcmFnOjQ4OGNkZjBhODVlYzRiMDliYWFiN2JhZTlhODA5YjcwL3RhYmxlOmJlMGVkYmJlNTg1NDQyNWQ5YTZhODA0OWNiYzMxOGIyL3RhYmxlcmFuZ2U6YmUwZWRiYmU1ODU0NDI1ZDlhNmE4MDQ5Y2JjMzE4YjJfMy01LTEtMS02MjY_325fdf6c-8093-41d7-b902-fb8465225eb6"
      unitRef="usd">0</us-gaap:CashEquivalentsAtCarryingValue>
    <us-gaap:CashEquivalentsAtCarryingValue
      contextRef="ie7dec283b83b43f99e003b79ec165d54_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmFlNWE5YmUwZWI5NDQ1ZDE5MmZhZTgyMmQyMmJlMDlmL3NlYzphZTVhOWJlMGViOTQ0NWQxOTJmYWU4MjJkMjJiZTA5Zl8zNy9mcmFnOjQ4OGNkZjBhODVlYzRiMDliYWFiN2JhZTlhODA5YjcwL3RhYmxlOmJlMGVkYmJlNTg1NDQyNWQ5YTZhODA0OWNiYzMxOGIyL3RhYmxlcmFuZ2U6YmUwZWRiYmU1ODU0NDI1ZDlhNmE4MDQ5Y2JjMzE4YjJfMy03LTEtMS02MjY_c60a9f51-d45d-4ad3-af1e-9da44cbf21b9"
      unitRef="usd">16380000</us-gaap:CashEquivalentsAtCarryingValue>
    <us-gaap:RestrictedCashNoncurrent
      contextRef="id0495dc386634c17abe35f6f0b1c1cde_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmFlNWE5YmUwZWI5NDQ1ZDE5MmZhZTgyMmQyMmJlMDlmL3NlYzphZTVhOWJlMGViOTQ0NWQxOTJmYWU4MjJkMjJiZTA5Zl8zNy9mcmFnOjQ4OGNkZjBhODVlYzRiMDliYWFiN2JhZTlhODA5YjcwL3RhYmxlOmJlMGVkYmJlNTg1NDQyNWQ5YTZhODA0OWNiYzMxOGIyL3RhYmxlcmFuZ2U6YmUwZWRiYmU1ODU0NDI1ZDlhNmE4MDQ5Y2JjMzE4YjJfNC0xLTEtMS0yMzAz_5c78599d-9aaa-4109-ada2-52704c53b02b"
      unitRef="usd">3025000</us-gaap:RestrictedCashNoncurrent>
    <us-gaap:RestrictedCashNoncurrent
      contextRef="i22164451262946e4b9911f313b7610c1_I20211231"
      id="id3VybDovL2RvY3MudjEvZG9jOmFlNWE5YmUwZWI5NDQ1ZDE5MmZhZTgyMmQyMmJlMDlmL3NlYzphZTVhOWJlMGViOTQ0NWQxOTJmYWU4MjJkMjJiZTA5Zl8zNy9mcmFnOjQ4OGNkZjBhODVlYzRiMDliYWFiN2JhZTlhODA5YjcwL3RhYmxlOmJlMGVkYmJlNTg1NDQyNWQ5YTZhODA0OWNiYzMxOGIyL3RhYmxlcmFuZ2U6YmUwZWRiYmU1ODU0NDI1ZDlhNmE4MDQ5Y2JjMzE4YjJfNC0zLTEtMS03NTYx_a2a82b6f-de84-45a5-a6a9-be825ae2502c"
      unitRef="usd"
      xsi:nil="true"/>
    <us-gaap:RestrictedCashNoncurrent
      contextRef="ica20d3fdf2ff41fdb31ad57ccb72924b_I20211231"
      id="id3VybDovL2RvY3MudjEvZG9jOmFlNWE5YmUwZWI5NDQ1ZDE5MmZhZTgyMmQyMmJlMDlmL3NlYzphZTVhOWJlMGViOTQ0NWQxOTJmYWU4MjJkMjJiZTA5Zl8zNy9mcmFnOjQ4OGNkZjBhODVlYzRiMDliYWFiN2JhZTlhODA5YjcwL3RhYmxlOmJlMGVkYmJlNTg1NDQyNWQ5YTZhODA0OWNiYzMxOGIyL3RhYmxlcmFuZ2U6YmUwZWRiYmU1ODU0NDI1ZDlhNmE4MDQ5Y2JjMzE4YjJfNC01LTEtMS03NTYx_a3f4d73c-3825-4266-be6a-1f65306be035"
      unitRef="usd"
      xsi:nil="true"/>
    <us-gaap:RestrictedCashNoncurrent
      contextRef="ie7dec283b83b43f99e003b79ec165d54_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmFlNWE5YmUwZWI5NDQ1ZDE5MmZhZTgyMmQyMmJlMDlmL3NlYzphZTVhOWJlMGViOTQ0NWQxOTJmYWU4MjJkMjJiZTA5Zl8zNy9mcmFnOjQ4OGNkZjBhODVlYzRiMDliYWFiN2JhZTlhODA5YjcwL3RhYmxlOmJlMGVkYmJlNTg1NDQyNWQ5YTZhODA0OWNiYzMxOGIyL3RhYmxlcmFuZ2U6YmUwZWRiYmU1ODU0NDI1ZDlhNmE4MDQ5Y2JjMzE4YjJfNC03LTEtMS0yMzAz_5e294ab7-af3d-4a88-8bbf-3bfbc98004a9"
      unitRef="usd">3025000</us-gaap:RestrictedCashNoncurrent>
    <us-gaap:AvailableForSaleSecuritiesDebtSecurities
      contextRef="ia276a40ecef74c489871bb3ea4f6856b_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmFlNWE5YmUwZWI5NDQ1ZDE5MmZhZTgyMmQyMmJlMDlmL3NlYzphZTVhOWJlMGViOTQ0NWQxOTJmYWU4MjJkMjJiZTA5Zl8zNy9mcmFnOjQ4OGNkZjBhODVlYzRiMDliYWFiN2JhZTlhODA5YjcwL3RhYmxlOmJlMGVkYmJlNTg1NDQyNWQ5YTZhODA0OWNiYzMxOGIyL3RhYmxlcmFuZ2U6YmUwZWRiYmU1ODU0NDI1ZDlhNmE4MDQ5Y2JjMzE4YjJfNi0xLTEtMS02MjY_0442ff7d-36a3-4f09-933c-ed41e7c89371"
      unitRef="usd">0</us-gaap:AvailableForSaleSecuritiesDebtSecurities>
    <us-gaap:AvailableForSaleSecuritiesDebtSecurities
      contextRef="icf26e4a3bbe94872997aa67085685e63_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmFlNWE5YmUwZWI5NDQ1ZDE5MmZhZTgyMmQyMmJlMDlmL3NlYzphZTVhOWJlMGViOTQ0NWQxOTJmYWU4MjJkMjJiZTA5Zl8zNy9mcmFnOjQ4OGNkZjBhODVlYzRiMDliYWFiN2JhZTlhODA5YjcwL3RhYmxlOmJlMGVkYmJlNTg1NDQyNWQ5YTZhODA0OWNiYzMxOGIyL3RhYmxlcmFuZ2U6YmUwZWRiYmU1ODU0NDI1ZDlhNmE4MDQ5Y2JjMzE4YjJfNi0zLTEtMS02MjY_b4c4b3bb-d8d4-4e16-bab3-c6004495046b"
      unitRef="usd">15352000</us-gaap:AvailableForSaleSecuritiesDebtSecurities>
    <us-gaap:AvailableForSaleSecuritiesDebtSecurities
      contextRef="i03ca2eb28be548fea6832470239a3e99_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmFlNWE5YmUwZWI5NDQ1ZDE5MmZhZTgyMmQyMmJlMDlmL3NlYzphZTVhOWJlMGViOTQ0NWQxOTJmYWU4MjJkMjJiZTA5Zl8zNy9mcmFnOjQ4OGNkZjBhODVlYzRiMDliYWFiN2JhZTlhODA5YjcwL3RhYmxlOmJlMGVkYmJlNTg1NDQyNWQ5YTZhODA0OWNiYzMxOGIyL3RhYmxlcmFuZ2U6YmUwZWRiYmU1ODU0NDI1ZDlhNmE4MDQ5Y2JjMzE4YjJfNi01LTEtMS02MjY_cb7c1b7b-1036-476c-9f8e-309533f511f1"
      unitRef="usd">0</us-gaap:AvailableForSaleSecuritiesDebtSecurities>
    <us-gaap:AvailableForSaleSecuritiesDebtSecurities
      contextRef="ieff44cf249a64087acf6cb16f4815cb7_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmFlNWE5YmUwZWI5NDQ1ZDE5MmZhZTgyMmQyMmJlMDlmL3NlYzphZTVhOWJlMGViOTQ0NWQxOTJmYWU4MjJkMjJiZTA5Zl8zNy9mcmFnOjQ4OGNkZjBhODVlYzRiMDliYWFiN2JhZTlhODA5YjcwL3RhYmxlOmJlMGVkYmJlNTg1NDQyNWQ5YTZhODA0OWNiYzMxOGIyL3RhYmxlcmFuZ2U6YmUwZWRiYmU1ODU0NDI1ZDlhNmE4MDQ5Y2JjMzE4YjJfNi03LTEtMS02MjY_02adb784-3bc7-4a5f-b2b7-05f3f6ba6ed1"
      unitRef="usd">15352000</us-gaap:AvailableForSaleSecuritiesDebtSecurities>
    <us-gaap:AvailableForSaleSecuritiesDebtSecurities
      contextRef="i849cb6bacde4475a95c34f5707ff57c7_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmFlNWE5YmUwZWI5NDQ1ZDE5MmZhZTgyMmQyMmJlMDlmL3NlYzphZTVhOWJlMGViOTQ0NWQxOTJmYWU4MjJkMjJiZTA5Zl8zNy9mcmFnOjQ4OGNkZjBhODVlYzRiMDliYWFiN2JhZTlhODA5YjcwL3RhYmxlOmJlMGVkYmJlNTg1NDQyNWQ5YTZhODA0OWNiYzMxOGIyL3RhYmxlcmFuZ2U6YmUwZWRiYmU1ODU0NDI1ZDlhNmE4MDQ5Y2JjMzE4YjJfNy0xLTEtMS02MjY_57cd7e13-04ed-4a27-a165-bb7b5480bbf4"
      unitRef="usd">0</us-gaap:AvailableForSaleSecuritiesDebtSecurities>
    <us-gaap:AvailableForSaleSecuritiesDebtSecurities
      contextRef="iad8908ee30bb4929b29d53cdc31fbd4f_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmFlNWE5YmUwZWI5NDQ1ZDE5MmZhZTgyMmQyMmJlMDlmL3NlYzphZTVhOWJlMGViOTQ0NWQxOTJmYWU4MjJkMjJiZTA5Zl8zNy9mcmFnOjQ4OGNkZjBhODVlYzRiMDliYWFiN2JhZTlhODA5YjcwL3RhYmxlOmJlMGVkYmJlNTg1NDQyNWQ5YTZhODA0OWNiYzMxOGIyL3RhYmxlcmFuZ2U6YmUwZWRiYmU1ODU0NDI1ZDlhNmE4MDQ5Y2JjMzE4YjJfNy0zLTEtMS02MjY_ca6fdc70-b576-4aee-9363-5d771f8ab7b9"
      unitRef="usd">7412000</us-gaap:AvailableForSaleSecuritiesDebtSecurities>
    <us-gaap:AvailableForSaleSecuritiesDebtSecurities
      contextRef="id6a19bedaa7c4ff8a89b8887ce0c3750_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmFlNWE5YmUwZWI5NDQ1ZDE5MmZhZTgyMmQyMmJlMDlmL3NlYzphZTVhOWJlMGViOTQ0NWQxOTJmYWU4MjJkMjJiZTA5Zl8zNy9mcmFnOjQ4OGNkZjBhODVlYzRiMDliYWFiN2JhZTlhODA5YjcwL3RhYmxlOmJlMGVkYmJlNTg1NDQyNWQ5YTZhODA0OWNiYzMxOGIyL3RhYmxlcmFuZ2U6YmUwZWRiYmU1ODU0NDI1ZDlhNmE4MDQ5Y2JjMzE4YjJfNy01LTEtMS02MjY_68f87b4d-90b7-4053-a61d-e45fae141ec9"
      unitRef="usd">0</us-gaap:AvailableForSaleSecuritiesDebtSecurities>
    <us-gaap:AvailableForSaleSecuritiesDebtSecurities
      contextRef="i319102f511954bcdb477a84723258d83_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmFlNWE5YmUwZWI5NDQ1ZDE5MmZhZTgyMmQyMmJlMDlmL3NlYzphZTVhOWJlMGViOTQ0NWQxOTJmYWU4MjJkMjJiZTA5Zl8zNy9mcmFnOjQ4OGNkZjBhODVlYzRiMDliYWFiN2JhZTlhODA5YjcwL3RhYmxlOmJlMGVkYmJlNTg1NDQyNWQ5YTZhODA0OWNiYzMxOGIyL3RhYmxlcmFuZ2U6YmUwZWRiYmU1ODU0NDI1ZDlhNmE4MDQ5Y2JjMzE4YjJfNy03LTEtMS02MjY_02af0cf7-66be-4a2e-b5b7-baa4ea230bb1"
      unitRef="usd">7412000</us-gaap:AvailableForSaleSecuritiesDebtSecurities>
    <us-gaap:AvailableForSaleSecuritiesDebtSecurities
      contextRef="i14a147d5e6494412ae4b21fe8bfddff7_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmFlNWE5YmUwZWI5NDQ1ZDE5MmZhZTgyMmQyMmJlMDlmL3NlYzphZTVhOWJlMGViOTQ0NWQxOTJmYWU4MjJkMjJiZTA5Zl8zNy9mcmFnOjQ4OGNkZjBhODVlYzRiMDliYWFiN2JhZTlhODA5YjcwL3RhYmxlOmJlMGVkYmJlNTg1NDQyNWQ5YTZhODA0OWNiYzMxOGIyL3RhYmxlcmFuZ2U6YmUwZWRiYmU1ODU0NDI1ZDlhNmE4MDQ5Y2JjMzE4YjJfOC0xLTEtMS02MjY_85580063-07e0-4d5a-815f-4a9980ebeb2e"
      unitRef="usd">0</us-gaap:AvailableForSaleSecuritiesDebtSecurities>
    <us-gaap:AvailableForSaleSecuritiesDebtSecurities
      contextRef="i4c05f919d71b4b4cb753c74dcc787cf4_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmFlNWE5YmUwZWI5NDQ1ZDE5MmZhZTgyMmQyMmJlMDlmL3NlYzphZTVhOWJlMGViOTQ0NWQxOTJmYWU4MjJkMjJiZTA5Zl8zNy9mcmFnOjQ4OGNkZjBhODVlYzRiMDliYWFiN2JhZTlhODA5YjcwL3RhYmxlOmJlMGVkYmJlNTg1NDQyNWQ5YTZhODA0OWNiYzMxOGIyL3RhYmxlcmFuZ2U6YmUwZWRiYmU1ODU0NDI1ZDlhNmE4MDQ5Y2JjMzE4YjJfOC0zLTEtMS02MjY_20e99fa4-be3f-4fc1-99d2-0f5bc7eb4335"
      unitRef="usd">25685000</us-gaap:AvailableForSaleSecuritiesDebtSecurities>
    <us-gaap:AvailableForSaleSecuritiesDebtSecurities
      contextRef="if678e473179340e9834400c14da4f7d6_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmFlNWE5YmUwZWI5NDQ1ZDE5MmZhZTgyMmQyMmJlMDlmL3NlYzphZTVhOWJlMGViOTQ0NWQxOTJmYWU4MjJkMjJiZTA5Zl8zNy9mcmFnOjQ4OGNkZjBhODVlYzRiMDliYWFiN2JhZTlhODA5YjcwL3RhYmxlOmJlMGVkYmJlNTg1NDQyNWQ5YTZhODA0OWNiYzMxOGIyL3RhYmxlcmFuZ2U6YmUwZWRiYmU1ODU0NDI1ZDlhNmE4MDQ5Y2JjMzE4YjJfOC01LTEtMS02MjY_d40ae057-efd7-4904-bde8-67f8c74a5e8a"
      unitRef="usd">0</us-gaap:AvailableForSaleSecuritiesDebtSecurities>
    <us-gaap:AvailableForSaleSecuritiesDebtSecurities
      contextRef="i4f60362ab2e44b07bbde43a025d24bba_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmFlNWE5YmUwZWI5NDQ1ZDE5MmZhZTgyMmQyMmJlMDlmL3NlYzphZTVhOWJlMGViOTQ0NWQxOTJmYWU4MjJkMjJiZTA5Zl8zNy9mcmFnOjQ4OGNkZjBhODVlYzRiMDliYWFiN2JhZTlhODA5YjcwL3RhYmxlOmJlMGVkYmJlNTg1NDQyNWQ5YTZhODA0OWNiYzMxOGIyL3RhYmxlcmFuZ2U6YmUwZWRiYmU1ODU0NDI1ZDlhNmE4MDQ5Y2JjMzE4YjJfOC03LTEtMS02MjY_1c88ab1d-4e78-403b-84f6-bb41245b4764"
      unitRef="usd">25685000</us-gaap:AvailableForSaleSecuritiesDebtSecurities>
    <us-gaap:AvailableForSaleSecuritiesDebtSecurities
      contextRef="id0495dc386634c17abe35f6f0b1c1cde_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmFlNWE5YmUwZWI5NDQ1ZDE5MmZhZTgyMmQyMmJlMDlmL3NlYzphZTVhOWJlMGViOTQ0NWQxOTJmYWU4MjJkMjJiZTA5Zl8zNy9mcmFnOjQ4OGNkZjBhODVlYzRiMDliYWFiN2JhZTlhODA5YjcwL3RhYmxlOmJlMGVkYmJlNTg1NDQyNWQ5YTZhODA0OWNiYzMxOGIyL3RhYmxlcmFuZ2U6YmUwZWRiYmU1ODU0NDI1ZDlhNmE4MDQ5Y2JjMzE4YjJfOS0xLTEtMS02MjY_9773285d-3a04-4317-a212-8780b4da725a"
      unitRef="usd">0</us-gaap:AvailableForSaleSecuritiesDebtSecurities>
    <us-gaap:AvailableForSaleSecuritiesDebtSecurities
      contextRef="i22164451262946e4b9911f313b7610c1_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmFlNWE5YmUwZWI5NDQ1ZDE5MmZhZTgyMmQyMmJlMDlmL3NlYzphZTVhOWJlMGViOTQ0NWQxOTJmYWU4MjJkMjJiZTA5Zl8zNy9mcmFnOjQ4OGNkZjBhODVlYzRiMDliYWFiN2JhZTlhODA5YjcwL3RhYmxlOmJlMGVkYmJlNTg1NDQyNWQ5YTZhODA0OWNiYzMxOGIyL3RhYmxlcmFuZ2U6YmUwZWRiYmU1ODU0NDI1ZDlhNmE4MDQ5Y2JjMzE4YjJfOS0zLTEtMS02MjY_8a1aec09-27e1-4c88-b1bb-a4f81c077158"
      unitRef="usd">48449000</us-gaap:AvailableForSaleSecuritiesDebtSecurities>
    <us-gaap:AvailableForSaleSecuritiesDebtSecurities
      contextRef="ica20d3fdf2ff41fdb31ad57ccb72924b_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmFlNWE5YmUwZWI5NDQ1ZDE5MmZhZTgyMmQyMmJlMDlmL3NlYzphZTVhOWJlMGViOTQ0NWQxOTJmYWU4MjJkMjJiZTA5Zl8zNy9mcmFnOjQ4OGNkZjBhODVlYzRiMDliYWFiN2JhZTlhODA5YjcwL3RhYmxlOmJlMGVkYmJlNTg1NDQyNWQ5YTZhODA0OWNiYzMxOGIyL3RhYmxlcmFuZ2U6YmUwZWRiYmU1ODU0NDI1ZDlhNmE4MDQ5Y2JjMzE4YjJfOS01LTEtMS02MjY_efd882ae-b73b-4cda-bed2-60a3e62a7f99"
      unitRef="usd">0</us-gaap:AvailableForSaleSecuritiesDebtSecurities>
    <us-gaap:AvailableForSaleSecuritiesDebtSecurities
      contextRef="ie7dec283b83b43f99e003b79ec165d54_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmFlNWE5YmUwZWI5NDQ1ZDE5MmZhZTgyMmQyMmJlMDlmL3NlYzphZTVhOWJlMGViOTQ0NWQxOTJmYWU4MjJkMjJiZTA5Zl8zNy9mcmFnOjQ4OGNkZjBhODVlYzRiMDliYWFiN2JhZTlhODA5YjcwL3RhYmxlOmJlMGVkYmJlNTg1NDQyNWQ5YTZhODA0OWNiYzMxOGIyL3RhYmxlcmFuZ2U6YmUwZWRiYmU1ODU0NDI1ZDlhNmE4MDQ5Y2JjMzE4YjJfOS03LTEtMS02MjY_c139b22f-b298-4f43-9778-ddeaf0cc3248"
      unitRef="usd">48449000</us-gaap:AvailableForSaleSecuritiesDebtSecurities>
    <us-gaap:AssetsFairValueDisclosure
      contextRef="id0495dc386634c17abe35f6f0b1c1cde_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmFlNWE5YmUwZWI5NDQ1ZDE5MmZhZTgyMmQyMmJlMDlmL3NlYzphZTVhOWJlMGViOTQ0NWQxOTJmYWU4MjJkMjJiZTA5Zl8zNy9mcmFnOjQ4OGNkZjBhODVlYzRiMDliYWFiN2JhZTlhODA5YjcwL3RhYmxlOmJlMGVkYmJlNTg1NDQyNWQ5YTZhODA0OWNiYzMxOGIyL3RhYmxlcmFuZ2U6YmUwZWRiYmU1ODU0NDI1ZDlhNmE4MDQ5Y2JjMzE4YjJfMTAtMS0xLTEtNjI2_48f14009-24ae-4b99-91a6-0a3505de5b59"
      unitRef="usd">19405000</us-gaap:AssetsFairValueDisclosure>
    <us-gaap:AssetsFairValueDisclosure
      contextRef="i22164451262946e4b9911f313b7610c1_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmFlNWE5YmUwZWI5NDQ1ZDE5MmZhZTgyMmQyMmJlMDlmL3NlYzphZTVhOWJlMGViOTQ0NWQxOTJmYWU4MjJkMjJiZTA5Zl8zNy9mcmFnOjQ4OGNkZjBhODVlYzRiMDliYWFiN2JhZTlhODA5YjcwL3RhYmxlOmJlMGVkYmJlNTg1NDQyNWQ5YTZhODA0OWNiYzMxOGIyL3RhYmxlcmFuZ2U6YmUwZWRiYmU1ODU0NDI1ZDlhNmE4MDQ5Y2JjMzE4YjJfMTAtMy0xLTEtNjI2_4795b0a5-be61-4344-a167-e168dbf7167a"
      unitRef="usd">48449000</us-gaap:AssetsFairValueDisclosure>
    <us-gaap:AssetsFairValueDisclosure
      contextRef="ica20d3fdf2ff41fdb31ad57ccb72924b_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmFlNWE5YmUwZWI5NDQ1ZDE5MmZhZTgyMmQyMmJlMDlmL3NlYzphZTVhOWJlMGViOTQ0NWQxOTJmYWU4MjJkMjJiZTA5Zl8zNy9mcmFnOjQ4OGNkZjBhODVlYzRiMDliYWFiN2JhZTlhODA5YjcwL3RhYmxlOmJlMGVkYmJlNTg1NDQyNWQ5YTZhODA0OWNiYzMxOGIyL3RhYmxlcmFuZ2U6YmUwZWRiYmU1ODU0NDI1ZDlhNmE4MDQ5Y2JjMzE4YjJfMTAtNS0xLTEtNjI2_caebf75d-707e-4cd0-9426-b3620f0c4dae"
      unitRef="usd">0</us-gaap:AssetsFairValueDisclosure>
    <us-gaap:AssetsFairValueDisclosure
      contextRef="ie7dec283b83b43f99e003b79ec165d54_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmFlNWE5YmUwZWI5NDQ1ZDE5MmZhZTgyMmQyMmJlMDlmL3NlYzphZTVhOWJlMGViOTQ0NWQxOTJmYWU4MjJkMjJiZTA5Zl8zNy9mcmFnOjQ4OGNkZjBhODVlYzRiMDliYWFiN2JhZTlhODA5YjcwL3RhYmxlOmJlMGVkYmJlNTg1NDQyNWQ5YTZhODA0OWNiYzMxOGIyL3RhYmxlcmFuZ2U6YmUwZWRiYmU1ODU0NDI1ZDlhNmE4MDQ5Y2JjMzE4YjJfMTAtNy0xLTEtNjI2_69ac51e8-e24e-4978-9553-2e1bd65c177b"
      unitRef="usd">67854000</us-gaap:AssetsFairValueDisclosure>
    <dmtk:WarrantLiabilityFairValueDisclosure
      contextRef="id0495dc386634c17abe35f6f0b1c1cde_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmFlNWE5YmUwZWI5NDQ1ZDE5MmZhZTgyMmQyMmJlMDlmL3NlYzphZTVhOWJlMGViOTQ0NWQxOTJmYWU4MjJkMjJiZTA5Zl8zNy9mcmFnOjQ4OGNkZjBhODVlYzRiMDliYWFiN2JhZTlhODA5YjcwL3RhYmxlOmJlMGVkYmJlNTg1NDQyNWQ5YTZhODA0OWNiYzMxOGIyL3RhYmxlcmFuZ2U6YmUwZWRiYmU1ODU0NDI1ZDlhNmE4MDQ5Y2JjMzE4YjJfMTMtMS0xLTEtNjI2_0f1f3fab-9404-4fe9-8849-28abe3304c4d"
      unitRef="usd">0</dmtk:WarrantLiabilityFairValueDisclosure>
    <dmtk:WarrantLiabilityFairValueDisclosure
      contextRef="i22164451262946e4b9911f313b7610c1_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmFlNWE5YmUwZWI5NDQ1ZDE5MmZhZTgyMmQyMmJlMDlmL3NlYzphZTVhOWJlMGViOTQ0NWQxOTJmYWU4MjJkMjJiZTA5Zl8zNy9mcmFnOjQ4OGNkZjBhODVlYzRiMDliYWFiN2JhZTlhODA5YjcwL3RhYmxlOmJlMGVkYmJlNTg1NDQyNWQ5YTZhODA0OWNiYzMxOGIyL3RhYmxlcmFuZ2U6YmUwZWRiYmU1ODU0NDI1ZDlhNmE4MDQ5Y2JjMzE4YjJfMTMtMy0xLTEtNjI2_dba2adde-cc46-4668-89c1-209499f6f6f1"
      unitRef="usd">0</dmtk:WarrantLiabilityFairValueDisclosure>
    <dmtk:WarrantLiabilityFairValueDisclosure
      contextRef="ica20d3fdf2ff41fdb31ad57ccb72924b_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmFlNWE5YmUwZWI5NDQ1ZDE5MmZhZTgyMmQyMmJlMDlmL3NlYzphZTVhOWJlMGViOTQ0NWQxOTJmYWU4MjJkMjJiZTA5Zl8zNy9mcmFnOjQ4OGNkZjBhODVlYzRiMDliYWFiN2JhZTlhODA5YjcwL3RhYmxlOmJlMGVkYmJlNTg1NDQyNWQ5YTZhODA0OWNiYzMxOGIyL3RhYmxlcmFuZ2U6YmUwZWRiYmU1ODU0NDI1ZDlhNmE4MDQ5Y2JjMzE4YjJfMTMtNS0xLTEtNjI2_a84b1005-7d9f-402a-95ae-c143f4a53d02"
      unitRef="usd">146000</dmtk:WarrantLiabilityFairValueDisclosure>
    <dmtk:WarrantLiabilityFairValueDisclosure
      contextRef="ie7dec283b83b43f99e003b79ec165d54_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmFlNWE5YmUwZWI5NDQ1ZDE5MmZhZTgyMmQyMmJlMDlmL3NlYzphZTVhOWJlMGViOTQ0NWQxOTJmYWU4MjJkMjJiZTA5Zl8zNy9mcmFnOjQ4OGNkZjBhODVlYzRiMDliYWFiN2JhZTlhODA5YjcwL3RhYmxlOmJlMGVkYmJlNTg1NDQyNWQ5YTZhODA0OWNiYzMxOGIyL3RhYmxlcmFuZ2U6YmUwZWRiYmU1ODU0NDI1ZDlhNmE4MDQ5Y2JjMzE4YjJfMTMtNy0xLTEtNjI2_c22c11cc-df99-42aa-9877-76db806d2004"
      unitRef="usd">146000</dmtk:WarrantLiabilityFairValueDisclosure>
    <us-gaap:LiabilitiesFairValueDisclosure
      contextRef="id0495dc386634c17abe35f6f0b1c1cde_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmFlNWE5YmUwZWI5NDQ1ZDE5MmZhZTgyMmQyMmJlMDlmL3NlYzphZTVhOWJlMGViOTQ0NWQxOTJmYWU4MjJkMjJiZTA5Zl8zNy9mcmFnOjQ4OGNkZjBhODVlYzRiMDliYWFiN2JhZTlhODA5YjcwL3RhYmxlOmJlMGVkYmJlNTg1NDQyNWQ5YTZhODA0OWNiYzMxOGIyL3RhYmxlcmFuZ2U6YmUwZWRiYmU1ODU0NDI1ZDlhNmE4MDQ5Y2JjMzE4YjJfMTQtMS0xLTEtNjI2_971b1ca1-771d-4659-b294-2d8754dfac0e"
      unitRef="usd">0</us-gaap:LiabilitiesFairValueDisclosure>
    <us-gaap:LiabilitiesFairValueDisclosure
      contextRef="i22164451262946e4b9911f313b7610c1_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmFlNWE5YmUwZWI5NDQ1ZDE5MmZhZTgyMmQyMmJlMDlmL3NlYzphZTVhOWJlMGViOTQ0NWQxOTJmYWU4MjJkMjJiZTA5Zl8zNy9mcmFnOjQ4OGNkZjBhODVlYzRiMDliYWFiN2JhZTlhODA5YjcwL3RhYmxlOmJlMGVkYmJlNTg1NDQyNWQ5YTZhODA0OWNiYzMxOGIyL3RhYmxlcmFuZ2U6YmUwZWRiYmU1ODU0NDI1ZDlhNmE4MDQ5Y2JjMzE4YjJfMTQtMy0xLTEtNjI2_15bbecde-fe27-4d48-9848-beaf7e73fdee"
      unitRef="usd">0</us-gaap:LiabilitiesFairValueDisclosure>
    <us-gaap:LiabilitiesFairValueDisclosure
      contextRef="ica20d3fdf2ff41fdb31ad57ccb72924b_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmFlNWE5YmUwZWI5NDQ1ZDE5MmZhZTgyMmQyMmJlMDlmL3NlYzphZTVhOWJlMGViOTQ0NWQxOTJmYWU4MjJkMjJiZTA5Zl8zNy9mcmFnOjQ4OGNkZjBhODVlYzRiMDliYWFiN2JhZTlhODA5YjcwL3RhYmxlOmJlMGVkYmJlNTg1NDQyNWQ5YTZhODA0OWNiYzMxOGIyL3RhYmxlcmFuZ2U6YmUwZWRiYmU1ODU0NDI1ZDlhNmE4MDQ5Y2JjMzE4YjJfMTQtNS0xLTEtNjI2_351b16ff-41a9-4449-b48e-252f3319e25b"
      unitRef="usd">146000</us-gaap:LiabilitiesFairValueDisclosure>
    <us-gaap:LiabilitiesFairValueDisclosure
      contextRef="ie7dec283b83b43f99e003b79ec165d54_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmFlNWE5YmUwZWI5NDQ1ZDE5MmZhZTgyMmQyMmJlMDlmL3NlYzphZTVhOWJlMGViOTQ0NWQxOTJmYWU4MjJkMjJiZTA5Zl8zNy9mcmFnOjQ4OGNkZjBhODVlYzRiMDliYWFiN2JhZTlhODA5YjcwL3RhYmxlOmJlMGVkYmJlNTg1NDQyNWQ5YTZhODA0OWNiYzMxOGIyL3RhYmxlcmFuZ2U6YmUwZWRiYmU1ODU0NDI1ZDlhNmE4MDQ5Y2JjMzE4YjJfMTQtNy0xLTEtNjI2_3efdd1c0-c71d-457f-a66f-a673e525bdab"
      unitRef="usd">146000</us-gaap:LiabilitiesFairValueDisclosure>
    <us-gaap:ScheduleOfShareBasedPaymentAwardEmployeeStockPurchasePlanValuationAssumptionsTableTextBlock
      contextRef="ia855382ada1f4f28aa8ef6da692ff177_D20220101-20220630"
      id="id3VybDovL2RvY3MudjEvZG9jOmFlNWE5YmUwZWI5NDQ1ZDE5MmZhZTgyMmQyMmJlMDlmL3NlYzphZTVhOWJlMGViOTQ0NWQxOTJmYWU4MjJkMjJiZTA5Zl8zNy9mcmFnOjQ4OGNkZjBhODVlYzRiMDliYWFiN2JhZTlhODA5YjcwL3RleHRyZWdpb246NDg4Y2RmMGE4NWVjNGIwOWJhYWI3YmFlOWE4MDliNzBfNDk0NzgwMjQ4ODMyMw_56359129-320f-4338-b122-70fb37d96f62">&lt;div style="margin-top:9pt;padding-left:27pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The following assumptions were used to calculate the fair value of the Company&#x2019;s warrant liability using the Black-Scholes-Merton valuation model:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:12pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:32.233%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:15.112%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.406%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:15.112%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.406%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:15.112%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.406%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:15.113%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Three Months Ended June 30,&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Six Months Ended June 30,&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Assumed risk-free interest rate&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2.96%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;0.46%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="text-align:center"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2.37% -2.96%&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="text-align:center"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;0.46% - 0.64%&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Assumed volatility&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;96.21%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;88.28%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="text-align:center"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;92.77% - 96.21%&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="text-align:center"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;85.85% - 88.28%&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Expected term&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2.17 years&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3.17 years&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="text-align:center"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2.17 - 2.42 years&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="text-align:center"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3.17 - 3.42 years&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Expected dividend yield&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-top:9pt;padding-left:27pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The following table sets forth assumptions used to determine the fair value of each option on the date of grant issued under the 2020 Equity Incentive Plan:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:12pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:32.233%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:15.112%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.406%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:15.112%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.406%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:15.112%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.406%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:15.113%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Three Months Ended June 30,&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Six Months Ended June 30,&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Assumed risk-free interest rate&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2.97%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="text-align:center"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1.03% - 1.07%&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="text-align:center"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2.97% &lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="text-align:center"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;0.52% - 1.13%&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Assumed volatility&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;81.65%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;77.69%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;81.65%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="text-align:center"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;74.88% - 77.69%&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Expected option term&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;6.08 years&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;6.08 years&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;6.08 years&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;6.08 years&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Expected dividend yield&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-top:9pt;padding-left:27pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The following table sets forth assumptions used to determine the fair value of the purchase rights issued under the 2020 Employee Stock Purchase Plan (the &#x201c;ESPP&#x201d;):&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:12pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:32.233%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:15.112%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.406%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:15.112%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.406%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:15.112%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.406%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:15.113%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Three Months Ended June 30,&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Six Months Ended June 30,&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Assumed risk-free interest rate&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(1)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;0.10%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="text-align:center"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;0.05% - 0.22%&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="text-align:center"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;0.10% - 0.18%&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Assumed volatility&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(1)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;69.34%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="text-align:center"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;52.58% - 64.55%&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="text-align:center"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;68.44% - 69.34%&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Expected option term&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(1)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;0.50 years&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="text-align:center"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;0.49 - 0.50 years&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="text-align:center"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;0.49 - 0.50 years&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Expected dividend yield&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(1)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="padding-left:27pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;(1) There were no ESPP purchases under its 2020 Employee Stock Purchase Plan during the period.&lt;/span&gt;&lt;/div&gt;</us-gaap:ScheduleOfShareBasedPaymentAwardEmployeeStockPurchasePlanValuationAssumptionsTableTextBlock>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate
      contextRef="i2ff3fea135c346deae31b3b343050a34_D20220401-20220630"
      decimals="4"
      id="id3VybDovL2RvY3MudjEvZG9jOmFlNWE5YmUwZWI5NDQ1ZDE5MmZhZTgyMmQyMmJlMDlmL3NlYzphZTVhOWJlMGViOTQ0NWQxOTJmYWU4MjJkMjJiZTA5Zl8zNy9mcmFnOjQ4OGNkZjBhODVlYzRiMDliYWFiN2JhZTlhODA5YjcwL3RhYmxlOmJlZmZiODc1NTNmNzQxYjVhZjFiZTQwMTA3M2ExOWQwL3RhYmxlcmFuZ2U6YmVmZmI4NzU1M2Y3NDFiNWFmMWJlNDAxMDczYTE5ZDBfMi0xLTEtMS0yMzQy_c019fb2e-0826-402e-b17c-2d0c472e5ad1"
      unitRef="number">0.0296</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate
      contextRef="ifd6a2c580c134e25811ac19c23b2c1e5_D20210401-20210630"
      decimals="4"
      id="id3VybDovL2RvY3MudjEvZG9jOmFlNWE5YmUwZWI5NDQ1ZDE5MmZhZTgyMmQyMmJlMDlmL3NlYzphZTVhOWJlMGViOTQ0NWQxOTJmYWU4MjJkMjJiZTA5Zl8zNy9mcmFnOjQ4OGNkZjBhODVlYzRiMDliYWFiN2JhZTlhODA5YjcwL3RhYmxlOmJlZmZiODc1NTNmNzQxYjVhZjFiZTQwMTA3M2ExOWQwL3RhYmxlcmFuZ2U6YmVmZmI4NzU1M2Y3NDFiNWFmMWJlNDAxMDczYTE5ZDBfMi0zLTEtMS0yMzQy_f82dd7b4-464d-41dc-b3a8-609e997298f5"
      unitRef="number">0.0046</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMinimum
      contextRef="ib3db0d13e848432a9c205ce797c080f8_D20220101-20220630"
      decimals="4"
      id="id3VybDovL2RvY3MudjEvZG9jOmFlNWE5YmUwZWI5NDQ1ZDE5MmZhZTgyMmQyMmJlMDlmL3NlYzphZTVhOWJlMGViOTQ0NWQxOTJmYWU4MjJkMjJiZTA5Zl8zNy9mcmFnOjQ4OGNkZjBhODVlYzRiMDliYWFiN2JhZTlhODA5YjcwL3RhYmxlOmJlZmZiODc1NTNmNzQxYjVhZjFiZTQwMTA3M2ExOWQwL3RhYmxlcmFuZ2U6YmVmZmI4NzU1M2Y3NDFiNWFmMWJlNDAxMDczYTE5ZDBfMi01LTEtMS0yMzQyL3RleHRyZWdpb246MTU0YjJhOGZlODQzNGUzM2ExZDEzOTI0ZDI2ODg0NDNfNTQ5NzU1ODEzOTEx_656ecbe0-1e5a-4c49-9750-2167a4272d3b"
      unitRef="number">0.0237</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMinimum>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMaximum
      contextRef="ib3db0d13e848432a9c205ce797c080f8_D20220101-20220630"
      decimals="4"
      id="id3VybDovL2RvY3MudjEvZG9jOmFlNWE5YmUwZWI5NDQ1ZDE5MmZhZTgyMmQyMmJlMDlmL3NlYzphZTVhOWJlMGViOTQ0NWQxOTJmYWU4MjJkMjJiZTA5Zl8zNy9mcmFnOjQ4OGNkZjBhODVlYzRiMDliYWFiN2JhZTlhODA5YjcwL3RhYmxlOmJlZmZiODc1NTNmNzQxYjVhZjFiZTQwMTA3M2ExOWQwL3RhYmxlcmFuZ2U6YmVmZmI4NzU1M2Y3NDFiNWFmMWJlNDAxMDczYTE5ZDBfMi01LTEtMS0yMzQyL3RleHRyZWdpb246MTU0YjJhOGZlODQzNGUzM2ExZDEzOTI0ZDI2ODg0NDNfNTQ5NzU1ODEzOTIx_947f6c16-7dc8-4c10-8774-1eee746fec4e"
      unitRef="number">0.0296</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMaximum>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMinimum
      contextRef="i08f348302fbc42c98a41fcaf5cfcde43_D20210101-20210630"
      decimals="4"
      id="id3VybDovL2RvY3MudjEvZG9jOmFlNWE5YmUwZWI5NDQ1ZDE5MmZhZTgyMmQyMmJlMDlmL3NlYzphZTVhOWJlMGViOTQ0NWQxOTJmYWU4MjJkMjJiZTA5Zl8zNy9mcmFnOjQ4OGNkZjBhODVlYzRiMDliYWFiN2JhZTlhODA5YjcwL3RhYmxlOmJlZmZiODc1NTNmNzQxYjVhZjFiZTQwMTA3M2ExOWQwL3RhYmxlcmFuZ2U6YmVmZmI4NzU1M2Y3NDFiNWFmMWJlNDAxMDczYTE5ZDBfMi03LTEtMS0yMzQyL3RleHRyZWdpb246NzU5MWVmMmQwYTg3NDE2ZjgyNGI4YjU5M2UyYTcyNzFfNTQ5NzU1ODEzOTIy_d515e97b-4ea3-4fb7-857f-e8d6abdd8767"
      unitRef="number">0.0046</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMinimum>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMaximum
      contextRef="i08f348302fbc42c98a41fcaf5cfcde43_D20210101-20210630"
      decimals="4"
      id="id3VybDovL2RvY3MudjEvZG9jOmFlNWE5YmUwZWI5NDQ1ZDE5MmZhZTgyMmQyMmJlMDlmL3NlYzphZTVhOWJlMGViOTQ0NWQxOTJmYWU4MjJkMjJiZTA5Zl8zNy9mcmFnOjQ4OGNkZjBhODVlYzRiMDliYWFiN2JhZTlhODA5YjcwL3RhYmxlOmJlZmZiODc1NTNmNzQxYjVhZjFiZTQwMTA3M2ExOWQwL3RhYmxlcmFuZ2U6YmVmZmI4NzU1M2Y3NDFiNWFmMWJlNDAxMDczYTE5ZDBfMi03LTEtMS0yMzQyL3RleHRyZWdpb246NzU5MWVmMmQwYTg3NDE2ZjgyNGI4YjU5M2UyYTcyNzFfNTQ5NzU1ODEzOTE1_78a22e10-6d97-4dc5-9dd2-e483b26c7169"
      unitRef="number">0.0064</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMaximum>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate
      contextRef="i2ff3fea135c346deae31b3b343050a34_D20220401-20220630"
      decimals="4"
      id="id3VybDovL2RvY3MudjEvZG9jOmFlNWE5YmUwZWI5NDQ1ZDE5MmZhZTgyMmQyMmJlMDlmL3NlYzphZTVhOWJlMGViOTQ0NWQxOTJmYWU4MjJkMjJiZTA5Zl8zNy9mcmFnOjQ4OGNkZjBhODVlYzRiMDliYWFiN2JhZTlhODA5YjcwL3RhYmxlOmJlZmZiODc1NTNmNzQxYjVhZjFiZTQwMTA3M2ExOWQwL3RhYmxlcmFuZ2U6YmVmZmI4NzU1M2Y3NDFiNWFmMWJlNDAxMDczYTE5ZDBfMy0xLTEtMS0yMzQy_c3e54528-86f7-4e4c-894e-aeae36027bbb"
      unitRef="number">0.9621</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate
      contextRef="ifd6a2c580c134e25811ac19c23b2c1e5_D20210401-20210630"
      decimals="4"
      id="id3VybDovL2RvY3MudjEvZG9jOmFlNWE5YmUwZWI5NDQ1ZDE5MmZhZTgyMmQyMmJlMDlmL3NlYzphZTVhOWJlMGViOTQ0NWQxOTJmYWU4MjJkMjJiZTA5Zl8zNy9mcmFnOjQ4OGNkZjBhODVlYzRiMDliYWFiN2JhZTlhODA5YjcwL3RhYmxlOmJlZmZiODc1NTNmNzQxYjVhZjFiZTQwMTA3M2ExOWQwL3RhYmxlcmFuZ2U6YmVmZmI4NzU1M2Y3NDFiNWFmMWJlNDAxMDczYTE5ZDBfMy0zLTEtMS0yNDAw_bdb36b92-8839-4fe7-a208-dc2e6d880123"
      unitRef="number">0.8828</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRateMinimum
      contextRef="ib3db0d13e848432a9c205ce797c080f8_D20220101-20220630"
      decimals="4"
      id="id3VybDovL2RvY3MudjEvZG9jOmFlNWE5YmUwZWI5NDQ1ZDE5MmZhZTgyMmQyMmJlMDlmL3NlYzphZTVhOWJlMGViOTQ0NWQxOTJmYWU4MjJkMjJiZTA5Zl8zNy9mcmFnOjQ4OGNkZjBhODVlYzRiMDliYWFiN2JhZTlhODA5YjcwL3RhYmxlOmJlZmZiODc1NTNmNzQxYjVhZjFiZTQwMTA3M2ExOWQwL3RhYmxlcmFuZ2U6YmVmZmI4NzU1M2Y3NDFiNWFmMWJlNDAxMDczYTE5ZDBfMy01LTEtMS0yMzQyL3RleHRyZWdpb246YzM5ZWIxNmJlMGZhNDVhZjk0ZjJmZTE5NDEzYzg3MDJfNTQ5NzU1ODEzOTEw_9def1834-da53-40b2-b42c-8d461adb438d"
      unitRef="number">0.9277</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRateMinimum>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRateMaximum
      contextRef="ib3db0d13e848432a9c205ce797c080f8_D20220101-20220630"
      decimals="4"
      id="id3VybDovL2RvY3MudjEvZG9jOmFlNWE5YmUwZWI5NDQ1ZDE5MmZhZTgyMmQyMmJlMDlmL3NlYzphZTVhOWJlMGViOTQ0NWQxOTJmYWU4MjJkMjJiZTA5Zl8zNy9mcmFnOjQ4OGNkZjBhODVlYzRiMDliYWFiN2JhZTlhODA5YjcwL3RhYmxlOmJlZmZiODc1NTNmNzQxYjVhZjFiZTQwMTA3M2ExOWQwL3RhYmxlcmFuZ2U6YmVmZmI4NzU1M2Y3NDFiNWFmMWJlNDAxMDczYTE5ZDBfMy01LTEtMS0yMzQyL3RleHRyZWdpb246YzM5ZWIxNmJlMGZhNDVhZjk0ZjJmZTE5NDEzYzg3MDJfNTQ5NzU1ODEzOTE1_486985cf-afff-4162-b1f6-4af9fe3827c6"
      unitRef="number">0.9621</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRateMaximum>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRateMinimum
      contextRef="i08f348302fbc42c98a41fcaf5cfcde43_D20210101-20210630"
      decimals="4"
      id="id3VybDovL2RvY3MudjEvZG9jOmFlNWE5YmUwZWI5NDQ1ZDE5MmZhZTgyMmQyMmJlMDlmL3NlYzphZTVhOWJlMGViOTQ0NWQxOTJmYWU4MjJkMjJiZTA5Zl8zNy9mcmFnOjQ4OGNkZjBhODVlYzRiMDliYWFiN2JhZTlhODA5YjcwL3RhYmxlOmJlZmZiODc1NTNmNzQxYjVhZjFiZTQwMTA3M2ExOWQwL3RhYmxlcmFuZ2U6YmVmZmI4NzU1M2Y3NDFiNWFmMWJlNDAxMDczYTE5ZDBfMy03LTEtMS0yMzQyL3RleHRyZWdpb246NDljN2M2YWE2NDhmNGM4NWJhMGE1MTlmYmQ4ZDM5YmVfNTQ5NzU1ODEzOTEz_1f939578-ec86-4f44-8944-b24883014158"
      unitRef="number">0.8585</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRateMinimum>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRateMaximum
      contextRef="i08f348302fbc42c98a41fcaf5cfcde43_D20210101-20210630"
      decimals="4"
      id="id3VybDovL2RvY3MudjEvZG9jOmFlNWE5YmUwZWI5NDQ1ZDE5MmZhZTgyMmQyMmJlMDlmL3NlYzphZTVhOWJlMGViOTQ0NWQxOTJmYWU4MjJkMjJiZTA5Zl8zNy9mcmFnOjQ4OGNkZjBhODVlYzRiMDliYWFiN2JhZTlhODA5YjcwL3RhYmxlOmJlZmZiODc1NTNmNzQxYjVhZjFiZTQwMTA3M2ExOWQwL3RhYmxlcmFuZ2U6YmVmZmI4NzU1M2Y3NDFiNWFmMWJlNDAxMDczYTE5ZDBfMy03LTEtMS0yMzQyL3RleHRyZWdpb246NDljN2M2YWE2NDhmNGM4NWJhMGE1MTlmYmQ4ZDM5YmVfNTQ5NzU1ODEzOTIy_32caf6ea-2b28-484e-954f-1a4c488f7233"
      unitRef="number">0.8828</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRateMaximum>
    <us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1
      contextRef="i2ff3fea135c346deae31b3b343050a34_D20220401-20220630"
      id="id3VybDovL2RvY3MudjEvZG9jOmFlNWE5YmUwZWI5NDQ1ZDE5MmZhZTgyMmQyMmJlMDlmL3NlYzphZTVhOWJlMGViOTQ0NWQxOTJmYWU4MjJkMjJiZTA5Zl8zNy9mcmFnOjQ4OGNkZjBhODVlYzRiMDliYWFiN2JhZTlhODA5YjcwL3RhYmxlOmJlZmZiODc1NTNmNzQxYjVhZjFiZTQwMTA3M2ExOWQwL3RhYmxlcmFuZ2U6YmVmZmI4NzU1M2Y3NDFiNWFmMWJlNDAxMDczYTE5ZDBfNC0xLTEtMS0yMzQy_363fe65e-bb07-42ea-833c-54619a980863">P2Y2M1D</us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1>
    <us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1
      contextRef="ifd6a2c580c134e25811ac19c23b2c1e5_D20210401-20210630"
      id="id3VybDovL2RvY3MudjEvZG9jOmFlNWE5YmUwZWI5NDQ1ZDE5MmZhZTgyMmQyMmJlMDlmL3NlYzphZTVhOWJlMGViOTQ0NWQxOTJmYWU4MjJkMjJiZTA5Zl8zNy9mcmFnOjQ4OGNkZjBhODVlYzRiMDliYWFiN2JhZTlhODA5YjcwL3RhYmxlOmJlZmZiODc1NTNmNzQxYjVhZjFiZTQwMTA3M2ExOWQwL3RhYmxlcmFuZ2U6YmVmZmI4NzU1M2Y3NDFiNWFmMWJlNDAxMDczYTE5ZDBfNC0zLTEtMS0yMzQy_62366a62-72e3-430e-b953-5e59e83b09c1">P3Y2M1D</us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1>
    <us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1
      contextRef="ife1b36ccabe240edb9560e64d1ffa4bc_D20220101-20220630"
      id="id3VybDovL2RvY3MudjEvZG9jOmFlNWE5YmUwZWI5NDQ1ZDE5MmZhZTgyMmQyMmJlMDlmL3NlYzphZTVhOWJlMGViOTQ0NWQxOTJmYWU4MjJkMjJiZTA5Zl8zNy9mcmFnOjQ4OGNkZjBhODVlYzRiMDliYWFiN2JhZTlhODA5YjcwL3RhYmxlOmJlZmZiODc1NTNmNzQxYjVhZjFiZTQwMTA3M2ExOWQwL3RhYmxlcmFuZ2U6YmVmZmI4NzU1M2Y3NDFiNWFmMWJlNDAxMDczYTE5ZDBfNC01LTEtMS0yMzQyL3RleHRyZWdpb246NjdiMWMwYTA3OGRlNGUxMGE3ZTI1MmIwYTYwNjI2ODZfNA_0798932c-4140-412c-91e3-e5489cba1870">P2Y2M1D</us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1>
    <us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1
      contextRef="i40659e4bf5494460828fbdb823038ea6_D20220101-20220630"
      id="id3VybDovL2RvY3MudjEvZG9jOmFlNWE5YmUwZWI5NDQ1ZDE5MmZhZTgyMmQyMmJlMDlmL3NlYzphZTVhOWJlMGViOTQ0NWQxOTJmYWU4MjJkMjJiZTA5Zl8zNy9mcmFnOjQ4OGNkZjBhODVlYzRiMDliYWFiN2JhZTlhODA5YjcwL3RhYmxlOmJlZmZiODc1NTNmNzQxYjVhZjFiZTQwMTA3M2ExOWQwL3RhYmxlcmFuZ2U6YmVmZmI4NzU1M2Y3NDFiNWFmMWJlNDAxMDczYTE5ZDBfNC01LTEtMS0yMzQyL3RleHRyZWdpb246NjdiMWMwYTA3OGRlNGUxMGE3ZTI1MmIwYTYwNjI2ODZfOQ_ee78bd37-5054-41e2-9899-e98e0bae4960">P2Y5M1D</us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1>
    <us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1
      contextRef="i2c2735b81bcc42bf8feeaa459dfad074_D20210101-20210630"
      id="id3VybDovL2RvY3MudjEvZG9jOmFlNWE5YmUwZWI5NDQ1ZDE5MmZhZTgyMmQyMmJlMDlmL3NlYzphZTVhOWJlMGViOTQ0NWQxOTJmYWU4MjJkMjJiZTA5Zl8zNy9mcmFnOjQ4OGNkZjBhODVlYzRiMDliYWFiN2JhZTlhODA5YjcwL3RhYmxlOmJlZmZiODc1NTNmNzQxYjVhZjFiZTQwMTA3M2ExOWQwL3RhYmxlcmFuZ2U6YmVmZmI4NzU1M2Y3NDFiNWFmMWJlNDAxMDczYTE5ZDBfNC03LTEtMS0yMzQyL3RleHRyZWdpb246OWVjNjA0NGIzYTRhNDQ4MzkyMTFlY2U0MTJiNGEyZmFfNA_bb8ef718-488a-409a-83d7-0f858af95fea">P3Y2M1D</us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1>
    <us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1
      contextRef="ibf907753dcd34608bb600dff616c1c77_D20210101-20210630"
      id="id3VybDovL2RvY3MudjEvZG9jOmFlNWE5YmUwZWI5NDQ1ZDE5MmZhZTgyMmQyMmJlMDlmL3NlYzphZTVhOWJlMGViOTQ0NWQxOTJmYWU4MjJkMjJiZTA5Zl8zNy9mcmFnOjQ4OGNkZjBhODVlYzRiMDliYWFiN2JhZTlhODA5YjcwL3RhYmxlOmJlZmZiODc1NTNmNzQxYjVhZjFiZTQwMTA3M2ExOWQwL3RhYmxlcmFuZ2U6YmVmZmI4NzU1M2Y3NDFiNWFmMWJlNDAxMDczYTE5ZDBfNC03LTEtMS0yMzQyL3RleHRyZWdpb246OWVjNjA0NGIzYTRhNDQ4MzkyMTFlY2U0MTJiNGEyZmFfOQ_f4b22cfe-33bf-4f50-87dd-0c68e8059f46">P3Y5M1D</us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate
      contextRef="i2ff3fea135c346deae31b3b343050a34_D20220401-20220630"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOmFlNWE5YmUwZWI5NDQ1ZDE5MmZhZTgyMmQyMmJlMDlmL3NlYzphZTVhOWJlMGViOTQ0NWQxOTJmYWU4MjJkMjJiZTA5Zl8zNy9mcmFnOjQ4OGNkZjBhODVlYzRiMDliYWFiN2JhZTlhODA5YjcwL3RhYmxlOmJlZmZiODc1NTNmNzQxYjVhZjFiZTQwMTA3M2ExOWQwL3RhYmxlcmFuZ2U6YmVmZmI4NzU1M2Y3NDFiNWFmMWJlNDAxMDczYTE5ZDBfNS0xLTEtMS0yMzQy_cb338f92-9896-4b38-b036-fd69ce9c1204"
      unitRef="number">0</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate
      contextRef="ifd6a2c580c134e25811ac19c23b2c1e5_D20210401-20210630"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOmFlNWE5YmUwZWI5NDQ1ZDE5MmZhZTgyMmQyMmJlMDlmL3NlYzphZTVhOWJlMGViOTQ0NWQxOTJmYWU4MjJkMjJiZTA5Zl8zNy9mcmFnOjQ4OGNkZjBhODVlYzRiMDliYWFiN2JhZTlhODA5YjcwL3RhYmxlOmJlZmZiODc1NTNmNzQxYjVhZjFiZTQwMTA3M2ExOWQwL3RhYmxlcmFuZ2U6YmVmZmI4NzU1M2Y3NDFiNWFmMWJlNDAxMDczYTE5ZDBfNS0zLTEtMS0yMzQy_ae37c91a-cea1-47bc-9181-4b726f6fd04e"
      unitRef="number">0</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate
      contextRef="ib3db0d13e848432a9c205ce797c080f8_D20220101-20220630"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOmFlNWE5YmUwZWI5NDQ1ZDE5MmZhZTgyMmQyMmJlMDlmL3NlYzphZTVhOWJlMGViOTQ0NWQxOTJmYWU4MjJkMjJiZTA5Zl8zNy9mcmFnOjQ4OGNkZjBhODVlYzRiMDliYWFiN2JhZTlhODA5YjcwL3RhYmxlOmJlZmZiODc1NTNmNzQxYjVhZjFiZTQwMTA3M2ExOWQwL3RhYmxlcmFuZ2U6YmVmZmI4NzU1M2Y3NDFiNWFmMWJlNDAxMDczYTE5ZDBfNS01LTEtMS0yMzQy_44cbca07-b922-4812-a62d-619d7fd57cfb"
      unitRef="number">0</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate
      contextRef="i08f348302fbc42c98a41fcaf5cfcde43_D20210101-20210630"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOmFlNWE5YmUwZWI5NDQ1ZDE5MmZhZTgyMmQyMmJlMDlmL3NlYzphZTVhOWJlMGViOTQ0NWQxOTJmYWU4MjJkMjJiZTA5Zl8zNy9mcmFnOjQ4OGNkZjBhODVlYzRiMDliYWFiN2JhZTlhODA5YjcwL3RhYmxlOmJlZmZiODc1NTNmNzQxYjVhZjFiZTQwMTA3M2ExOWQwL3RhYmxlcmFuZ2U6YmVmZmI4NzU1M2Y3NDFiNWFmMWJlNDAxMDczYTE5ZDBfNS03LTEtMS0yMzQy_724a78d3-f772-47bb-acf2-6f29a2bcfb91"
      unitRef="number">0</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate>
    <us-gaap:FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationTextBlock
      contextRef="ia855382ada1f4f28aa8ef6da692ff177_D20220101-20220630"
      id="id3VybDovL2RvY3MudjEvZG9jOmFlNWE5YmUwZWI5NDQ1ZDE5MmZhZTgyMmQyMmJlMDlmL3NlYzphZTVhOWJlMGViOTQ0NWQxOTJmYWU4MjJkMjJiZTA5Zl8zNy9mcmFnOjQ4OGNkZjBhODVlYzRiMDliYWFiN2JhZTlhODA5YjcwL3RleHRyZWdpb246NDg4Y2RmMGE4NWVjNGIwOWJhYWI3YmFlOWE4MDliNzBfNDYyNDk_5785d44c-cccf-40a3-9a95-50b82c9ad247">&lt;div style="margin-top:9pt;padding-left:27pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The following table summarizes the changes in the fair value of the Company&#x2019;s Level 3 liabilities (in thousands):&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:12pt;text-align:center"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:85.718%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:12.082%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Balance as of December 31, 2021&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;146&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Change in fair value of warrant liability&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(17)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Balance as of March 31, 2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;129&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Change in fair value of warrant liability&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(105)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Balance as of June 30, 2022&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;24&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;</us-gaap:FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationTextBlock>
    <us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue
      contextRef="i0e8a6876eeb946269d2c2405fcb009b4_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmFlNWE5YmUwZWI5NDQ1ZDE5MmZhZTgyMmQyMmJlMDlmL3NlYzphZTVhOWJlMGViOTQ0NWQxOTJmYWU4MjJkMjJiZTA5Zl8zNy9mcmFnOjQ4OGNkZjBhODVlYzRiMDliYWFiN2JhZTlhODA5YjcwL3RhYmxlOjlmYjdhODAxMjQzODRkOGE5NjQzMWU3OGY5MDZlN2I0L3RhYmxlcmFuZ2U6OWZiN2E4MDEyNDM4NGQ4YTk2NDMxZTc4ZjkwNmU3YjRfMC0xLTEtMS02MjY_83576e0c-3ea9-428c-a825-949438d8d5c2"
      unitRef="usd">146000</us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue>
    <us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityGainLossIncludedInEarnings
      contextRef="i4030b6b173eb4417a8b8aa5024f71cc6_D20220101-20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmFlNWE5YmUwZWI5NDQ1ZDE5MmZhZTgyMmQyMmJlMDlmL3NlYzphZTVhOWJlMGViOTQ0NWQxOTJmYWU4MjJkMjJiZTA5Zl8zNy9mcmFnOjQ4OGNkZjBhODVlYzRiMDliYWFiN2JhZTlhODA5YjcwL3RhYmxlOjlmYjdhODAxMjQzODRkOGE5NjQzMWU3OGY5MDZlN2I0L3RhYmxlcmFuZ2U6OWZiN2E4MDEyNDM4NGQ4YTk2NDMxZTc4ZjkwNmU3YjRfMy0xLTEtMS02MjY_1c0434d1-54f9-442d-a074-4960df5c7c6d"
      unitRef="usd">-17000</us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityGainLossIncludedInEarnings>
    <us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue
      contextRef="i253fb10d701144a8b699b8f06a9a82fd_I20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmFlNWE5YmUwZWI5NDQ1ZDE5MmZhZTgyMmQyMmJlMDlmL3NlYzphZTVhOWJlMGViOTQ0NWQxOTJmYWU4MjJkMjJiZTA5Zl8zNy9mcmFnOjQ4OGNkZjBhODVlYzRiMDliYWFiN2JhZTlhODA5YjcwL3RhYmxlOjlmYjdhODAxMjQzODRkOGE5NjQzMWU3OGY5MDZlN2I0L3RhYmxlcmFuZ2U6OWZiN2E4MDEyNDM4NGQ4YTk2NDMxZTc4ZjkwNmU3YjRfNC0xLTEtMS02MjY_dfe9ac51-cdc8-40fa-a532-2c38b12ce703"
      unitRef="usd">129000</us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue>
    <us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityGainLossIncludedInEarnings
      contextRef="i166b12bbf79f408e95f28a9eeaa9d48d_D20220401-20220630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmFlNWE5YmUwZWI5NDQ1ZDE5MmZhZTgyMmQyMmJlMDlmL3NlYzphZTVhOWJlMGViOTQ0NWQxOTJmYWU4MjJkMjJiZTA5Zl8zNy9mcmFnOjQ4OGNkZjBhODVlYzRiMDliYWFiN2JhZTlhODA5YjcwL3RhYmxlOjlmYjdhODAxMjQzODRkOGE5NjQzMWU3OGY5MDZlN2I0L3RhYmxlcmFuZ2U6OWZiN2E4MDEyNDM4NGQ4YTk2NDMxZTc4ZjkwNmU3YjRfNy0xLTEtMS02MjY_79f8ce7f-ab9d-4af6-968b-1eb4fd180b92"
      unitRef="usd">-105000</us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityGainLossIncludedInEarnings>
    <us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue
      contextRef="ia41275e687284fbe8c0cd8cfc3637073_I20220630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmFlNWE5YmUwZWI5NDQ1ZDE5MmZhZTgyMmQyMmJlMDlmL3NlYzphZTVhOWJlMGViOTQ0NWQxOTJmYWU4MjJkMjJiZTA5Zl8zNy9mcmFnOjQ4OGNkZjBhODVlYzRiMDliYWFiN2JhZTlhODA5YjcwL3RhYmxlOjlmYjdhODAxMjQzODRkOGE5NjQzMWU3OGY5MDZlN2I0L3RhYmxlcmFuZ2U6OWZiN2E4MDEyNDM4NGQ4YTk2NDMxZTc4ZjkwNmU3YjRfOC0xLTEtMS02MjY_142ce3d5-565b-4669-85e5-d5060bd53b1b"
      unitRef="usd">24000</us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue>
    <us-gaap:LettersOfCreditOutstandingAmount
      contextRef="ieb434e1a310d48ce8a877397d66245d6_I20220630"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmFlNWE5YmUwZWI5NDQ1ZDE5MmZhZTgyMmQyMmJlMDlmL3NlYzphZTVhOWJlMGViOTQ0NWQxOTJmYWU4MjJkMjJiZTA5Zl8zNy9mcmFnOjQ4OGNkZjBhODVlYzRiMDliYWFiN2JhZTlhODA5YjcwL3RleHRyZWdpb246NDg4Y2RmMGE4NWVjNGIwOWJhYWI3YmFlOWE4MDliNzBfMzY4NDY_f8d5690c-477f-417e-8674-ee20b0612974"
      unitRef="usd">3500000</us-gaap:LettersOfCreditOutstandingAmount>
    <us-gaap:LettersOfCreditOutstandingAmount
      contextRef="if16c69c24d79407cacc36646afe73f31_I20211231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmFlNWE5YmUwZWI5NDQ1ZDE5MmZhZTgyMmQyMmJlMDlmL3NlYzphZTVhOWJlMGViOTQ0NWQxOTJmYWU4MjJkMjJiZTA5Zl8zNy9mcmFnOjQ4OGNkZjBhODVlYzRiMDliYWFiN2JhZTlhODA5YjcwL3RleHRyZWdpb246NDg4Y2RmMGE4NWVjNGIwOWJhYWI3YmFlOWE4MDliNzBfMzY4NTM_9d5ca0a0-a56e-4aa0-897f-60711df9b503"
      unitRef="usd">3000000</us-gaap:LettersOfCreditOutstandingAmount>
    <us-gaap:NewAccountingPronouncementsPolicyPolicyTextBlock
      contextRef="ia855382ada1f4f28aa8ef6da692ff177_D20220101-20220630"
      id="id3VybDovL2RvY3MudjEvZG9jOmFlNWE5YmUwZWI5NDQ1ZDE5MmZhZTgyMmQyMmJlMDlmL3NlYzphZTVhOWJlMGViOTQ0NWQxOTJmYWU4MjJkMjJiZTA5Zl8zNy9mcmFnOjQ4OGNkZjBhODVlYzRiMDliYWFiN2JhZTlhODA5YjcwL3RleHRyZWdpb246NDg4Y2RmMGE4NWVjNGIwOWJhYWI3YmFlOWE4MDliNzBfNDYyNjA_cd04335a-1120-430d-aa7d-1a5023bd9291">Accounting Pronouncements Issued But Not Yet Effective &lt;div style="margin-top:9pt;padding-left:27pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;In June 2022, the Financial Accounting Standards Board issued ASU No. 2022-03, &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Fair Value Measurement of Equity Securities Subject to Contractual Sale Restrictions &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;("ASU 2022-03"). Under the guidance of ASU 2022-03, a contractual restriction on the sale of an equity security is not considered in measuring the security's fair value. ASU 2022-03 also requires certain disclosures for equity securities that are subject to contractual restrictions. For public business entities, the provisions of ASU 2022-03 are effective for fiscal years beginning after December 15, 2023, and interim periods within those fiscal years. For all other entities, the amendments are effective for fiscal years beginning after December 15, 2024, and interim periods within those fiscal years. Early adoption is permitted for both interim and annual financial statements that have not yet been issued or made available for issuance. The Company is still evaluating the impact of this pronouncement on the consolidated financial statements.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:9pt;padding-left:27pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The Company does not believe that any other recently issued, but not yet effective accounting pronouncements, if adopted, would have a material impact on its condensed consolidated financial statements or disclosures.&lt;/span&gt;&lt;/div&gt;Adoption of ASC 842&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;In the third quarter of 2021, the Company adopted ASU 2016-02&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;, &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;and&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt; &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;ASC&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt; &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Topic&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt; &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;842, &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Leases&lt;/span&gt; (&#x201c;ASC 842&#x201d;) using the modified retrospective approach with an effective date of January 1, 2021. The adoption had no effect on the condensed consolidated statements of operations for the three and six months ended June 30, 2021. Net cash (used in) provided by operating activities, investing activities or financing activities for the six months ended June 30, 2021 were also unchanged, but the presentation of certain prior period amounts within the operating activities section of the condensed consolidated statements of cash flows have been retrospectively adjusted to give effect to the adoption of ASC 842.</us-gaap:NewAccountingPronouncementsPolicyPolicyTextBlock>
    <us-gaap:SupplementalBalanceSheetDisclosuresTextBlock
      contextRef="ia855382ada1f4f28aa8ef6da692ff177_D20220101-20220630"
      id="id3VybDovL2RvY3MudjEvZG9jOmFlNWE5YmUwZWI5NDQ1ZDE5MmZhZTgyMmQyMmJlMDlmL3NlYzphZTVhOWJlMGViOTQ0NWQxOTJmYWU4MjJkMjJiZTA5Zl80My9mcmFnOmIzZWFmOGZlNmQ2MzQzYmVhMWUwZDUzYjc5MGQ5Njg2L3RleHRyZWdpb246YjNlYWY4ZmU2ZDYzNDNiZWExZTBkNTNiNzkwZDk2ODZfMTMwOA_683c36a4-345d-4ee7-9d5e-c212b3e14aad">Balance Sheet Details&lt;div style="margin-top:15pt;padding-left:27pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Short-Term Marketable Securities&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:9pt;padding-left:27pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The amortized cost, gross unrealized holding gains, gross unrealized holding losses, and fair value of debt securities classified as available-for-sale securities by major security type and class of security as of June&#160;30, 2022 were as follows (in thousands):&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:12pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:44.354%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:12.081%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.406%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:12.081%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.406%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:12.081%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.406%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:12.085%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="21" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;June 30, 2022&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Amortized Cost&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Gross Unrealized&lt;br/&gt;Gains&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Gross Unrealized&lt;br/&gt;Losses&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Estimated&lt;br/&gt;Market&lt;br/&gt;Value&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Short-term marketable securities, available-for-sale:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Corporate debt securities&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;15,361&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(269)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;15,092&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Municipal debt securities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3,666&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(25)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3,641&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;U.S. government debt securities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;35,295&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;9&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(580)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;34,724&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 28pt;text-align:left;text-indent:-9pt;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total short-term marketable securities, available-for-sale&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;54,322&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;9&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(874)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;53,457&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-top:9pt;padding-left:27pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The amortized cost, gross unrealized holding gains, gross unrealized holding losses, and fair value of debt securities classified as available-for-sale securities by major security type and class of security as of December&#160;31, 2021 were as follows (in thousands):&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:12pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:44.354%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:12.081%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.406%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:12.081%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.406%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:12.081%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.406%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:12.085%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="21" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;December 31, 2021&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Amortized Cost&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Gross Unrealized&lt;br/&gt;Gains&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Gross Unrealized&lt;br/&gt;Losses&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Estimated&lt;br/&gt;Market&lt;br/&gt;Value&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Short-term marketable securities, available-for-sale:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Corporate debt securities&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;15,385&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(33)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;15,352&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Municipal debt securities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;7,417&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(5)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;7,412&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;U.S. government debt securities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;25,771&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(87)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;25,685&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 28pt;text-align:left;text-indent:-9pt;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total short-term marketable securities, available-for-sale&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;48,573&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(125)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;48,449&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-top:9pt;padding-left:27pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;As of June&#160;30, 2022, the estimated market value of debt securities with contractual maturities of less than twelve months was $25.8 million; the remaining debt securities that the Company held at that date had an estimated market value of $27.7 million and contractual maturities of up to 23 months. As of December&#160;31, 2021, the estimated market value of debt securities with contractual maturities of less than twelve months was $21.2 million; the remaining debt securities that the Company held at that date had an estimated market value of $27.2 million and contractual maturities of up to 23 months.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:9pt;padding-left:27pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The Company evaluates securities with unrealized losses to determine whether such losses, if any, are due to credit-related factors. It was determined that no credit losses existed as of June&#160;30, 2022 or December&#160;31, 2021, because the change in market value for those securities in an unrealized loss position has resulted from fluctuating interest rates rather than a deterioration of the credit worthiness of the issuers. Gross realized gains and losses on the Company&#x2019;s debt securities for the three and six months ended June&#160;30, 2022 and 2021 were not significant.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:15pt;padding-left:27pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Prepaid Expenses and Property and Equipment, Net&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:9pt;padding-left:27pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Condensed consolidated balance sheet details are as follows (in thousands): &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:12pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:71.930%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:12.081%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.406%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:12.083%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;June 30,&lt;br/&gt;2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;December 31,&lt;br/&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Prepaid expenses and other current assets:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Prepaid insurance&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;806&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,801&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Prepaid trade shows&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;241&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;440&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Prepaid software fees&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;907&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;551&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Prepaid employee compensation&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;227&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;238&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Other current assets&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;500&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;136&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total prepaid expenses and other current assets&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,681&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3,166&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Property and equipment, gross:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:3pt double #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:3pt double #000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Laboratory equipment&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4,856&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4,805&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Computer equipment&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;396&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;171&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Furniture and fixtures&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;555&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;124&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Leasehold improvements&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,208&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,074&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Construction-in-progress&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;139&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total property and equipment, gross&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;7,154&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;6,174&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Less accumulated depreciation&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(2,238)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(1,625)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total property and equipment, net&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4,916&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4,549&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-top:15pt;padding-left:27pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Accrued Compensation and Accrued Liabilities &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:9pt;padding-left:27pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Condensed consolidated balance sheet details are as follows (in thousands):&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:12pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:71.930%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:12.081%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.406%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:12.083%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;June 30,&lt;br/&gt;2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;December 31,&lt;br/&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Accrued compensation:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Accrued paid time off&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,689&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,245&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Accrued wages, bonus and other&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;6,129&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3,875&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total accrued compensation&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;7,818&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;5,120&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Accrued liabilities:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:3pt double #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:3pt double #000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Accrued consulting services&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,201&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;775&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Other accrued expenses&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,071&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;452&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total accrued liabilities&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3,272&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,227&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;</us-gaap:SupplementalBalanceSheetDisclosuresTextBlock>
    <us-gaap:DebtSecuritiesAvailableForSaleTableTextBlock
      contextRef="ia855382ada1f4f28aa8ef6da692ff177_D20220101-20220630"
      id="id3VybDovL2RvY3MudjEvZG9jOmFlNWE5YmUwZWI5NDQ1ZDE5MmZhZTgyMmQyMmJlMDlmL3NlYzphZTVhOWJlMGViOTQ0NWQxOTJmYWU4MjJkMjJiZTA5Zl80My9mcmFnOmIzZWFmOGZlNmQ2MzQzYmVhMWUwZDUzYjc5MGQ5Njg2L3RleHRyZWdpb246YjNlYWY4ZmU2ZDYzNDNiZWExZTBkNTNiNzkwZDk2ODZfMTMwOQ_80275b72-dffb-429b-b1a3-5a12a89d4d4e">&lt;div style="margin-top:9pt;padding-left:27pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The amortized cost, gross unrealized holding gains, gross unrealized holding losses, and fair value of debt securities classified as available-for-sale securities by major security type and class of security as of June&#160;30, 2022 were as follows (in thousands):&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:12pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:44.354%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:12.081%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.406%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:12.081%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.406%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:12.081%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.406%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:12.085%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="21" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;June 30, 2022&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Amortized Cost&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Gross Unrealized&lt;br/&gt;Gains&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Gross Unrealized&lt;br/&gt;Losses&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Estimated&lt;br/&gt;Market&lt;br/&gt;Value&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Short-term marketable securities, available-for-sale:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Corporate debt securities&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;15,361&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(269)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;15,092&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Municipal debt securities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3,666&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(25)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3,641&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;U.S. government debt securities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;35,295&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;9&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(580)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;34,724&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 28pt;text-align:left;text-indent:-9pt;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total short-term marketable securities, available-for-sale&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;54,322&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;9&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(874)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;53,457&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-top:9pt;padding-left:27pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The amortized cost, gross unrealized holding gains, gross unrealized holding losses, and fair value of debt securities classified as available-for-sale securities by major security type and class of security as of December&#160;31, 2021 were as follows (in thousands):&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:12pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:44.354%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:12.081%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.406%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:12.081%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.406%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:12.081%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.406%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:12.085%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="21" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;December 31, 2021&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Amortized Cost&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Gross Unrealized&lt;br/&gt;Gains&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Gross Unrealized&lt;br/&gt;Losses&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Estimated&lt;br/&gt;Market&lt;br/&gt;Value&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Short-term marketable securities, available-for-sale:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Corporate debt securities&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;15,385&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(33)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;15,352&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Municipal debt securities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;7,417&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(5)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;7,412&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;U.S. government debt securities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;25,771&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(87)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;25,685&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 28pt;text-align:left;text-indent:-9pt;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total short-term marketable securities, available-for-sale&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;48,573&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(125)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;48,449&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;</us-gaap:DebtSecuritiesAvailableForSaleTableTextBlock>
    <us-gaap:AvailableForSaleDebtSecuritiesAmortizedCostBasis
      contextRef="if86a878c756a461abc20e5dc5cf1667c_I20220630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmFlNWE5YmUwZWI5NDQ1ZDE5MmZhZTgyMmQyMmJlMDlmL3NlYzphZTVhOWJlMGViOTQ0NWQxOTJmYWU4MjJkMjJiZTA5Zl80My9mcmFnOmIzZWFmOGZlNmQ2MzQzYmVhMWUwZDUzYjc5MGQ5Njg2L3RhYmxlOjMxYTQ1NzVlZTMxMDQ4ZDFhZGFiYmFmYjliZDg0OWZhL3RhYmxlcmFuZ2U6MzFhNDU3NWVlMzEwNDhkMWFkYWJiYWZiOWJkODQ5ZmFfMy0xLTEtMS02MjY_fd653a49-3e92-4d5d-8e61-8c301982d6e7"
      unitRef="usd">15361000</us-gaap:AvailableForSaleDebtSecuritiesAmortizedCostBasis>
    <us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax
      contextRef="if86a878c756a461abc20e5dc5cf1667c_I20220630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmFlNWE5YmUwZWI5NDQ1ZDE5MmZhZTgyMmQyMmJlMDlmL3NlYzphZTVhOWJlMGViOTQ0NWQxOTJmYWU4MjJkMjJiZTA5Zl80My9mcmFnOmIzZWFmOGZlNmQ2MzQzYmVhMWUwZDUzYjc5MGQ5Njg2L3RhYmxlOjMxYTQ1NzVlZTMxMDQ4ZDFhZGFiYmFmYjliZDg0OWZhL3RhYmxlcmFuZ2U6MzFhNDU3NWVlMzEwNDhkMWFkYWJiYWZiOWJkODQ5ZmFfMy0zLTEtMS02MjY_250fb7ab-d7a2-45a4-a98a-c0a7afd82ad9"
      unitRef="usd">0</us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax>
    <us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax
      contextRef="if86a878c756a461abc20e5dc5cf1667c_I20220630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmFlNWE5YmUwZWI5NDQ1ZDE5MmZhZTgyMmQyMmJlMDlmL3NlYzphZTVhOWJlMGViOTQ0NWQxOTJmYWU4MjJkMjJiZTA5Zl80My9mcmFnOmIzZWFmOGZlNmQ2MzQzYmVhMWUwZDUzYjc5MGQ5Njg2L3RhYmxlOjMxYTQ1NzVlZTMxMDQ4ZDFhZGFiYmFmYjliZDg0OWZhL3RhYmxlcmFuZ2U6MzFhNDU3NWVlMzEwNDhkMWFkYWJiYWZiOWJkODQ5ZmFfMy01LTEtMS02MjY_8a87f886-c09b-4c6e-abfd-9ca77c9992cd"
      unitRef="usd">269000</us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax>
    <us-gaap:AvailableForSaleSecuritiesDebtSecurities
      contextRef="if86a878c756a461abc20e5dc5cf1667c_I20220630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmFlNWE5YmUwZWI5NDQ1ZDE5MmZhZTgyMmQyMmJlMDlmL3NlYzphZTVhOWJlMGViOTQ0NWQxOTJmYWU4MjJkMjJiZTA5Zl80My9mcmFnOmIzZWFmOGZlNmQ2MzQzYmVhMWUwZDUzYjc5MGQ5Njg2L3RhYmxlOjMxYTQ1NzVlZTMxMDQ4ZDFhZGFiYmFmYjliZDg0OWZhL3RhYmxlcmFuZ2U6MzFhNDU3NWVlMzEwNDhkMWFkYWJiYWZiOWJkODQ5ZmFfMy03LTEtMS02MjY_3fca73b7-e773-46be-8130-e421485cf26b"
      unitRef="usd">15092000</us-gaap:AvailableForSaleSecuritiesDebtSecurities>
    <us-gaap:AvailableForSaleDebtSecuritiesAmortizedCostBasis
      contextRef="ibd768261001c4410bcbcfa14c060fd74_I20220630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmFlNWE5YmUwZWI5NDQ1ZDE5MmZhZTgyMmQyMmJlMDlmL3NlYzphZTVhOWJlMGViOTQ0NWQxOTJmYWU4MjJkMjJiZTA5Zl80My9mcmFnOmIzZWFmOGZlNmQ2MzQzYmVhMWUwZDUzYjc5MGQ5Njg2L3RhYmxlOjMxYTQ1NzVlZTMxMDQ4ZDFhZGFiYmFmYjliZDg0OWZhL3RhYmxlcmFuZ2U6MzFhNDU3NWVlMzEwNDhkMWFkYWJiYWZiOWJkODQ5ZmFfNC0xLTEtMS02MjY_942ccb5e-8716-405e-9eea-51a77a7eb68e"
      unitRef="usd">3666000</us-gaap:AvailableForSaleDebtSecuritiesAmortizedCostBasis>
    <us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax
      contextRef="ibd768261001c4410bcbcfa14c060fd74_I20220630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmFlNWE5YmUwZWI5NDQ1ZDE5MmZhZTgyMmQyMmJlMDlmL3NlYzphZTVhOWJlMGViOTQ0NWQxOTJmYWU4MjJkMjJiZTA5Zl80My9mcmFnOmIzZWFmOGZlNmQ2MzQzYmVhMWUwZDUzYjc5MGQ5Njg2L3RhYmxlOjMxYTQ1NzVlZTMxMDQ4ZDFhZGFiYmFmYjliZDg0OWZhL3RhYmxlcmFuZ2U6MzFhNDU3NWVlMzEwNDhkMWFkYWJiYWZiOWJkODQ5ZmFfNC0zLTEtMS02MjY_9d918720-02a2-4be0-8507-5901b23464d9"
      unitRef="usd">0</us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax>
    <us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax
      contextRef="ibd768261001c4410bcbcfa14c060fd74_I20220630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmFlNWE5YmUwZWI5NDQ1ZDE5MmZhZTgyMmQyMmJlMDlmL3NlYzphZTVhOWJlMGViOTQ0NWQxOTJmYWU4MjJkMjJiZTA5Zl80My9mcmFnOmIzZWFmOGZlNmQ2MzQzYmVhMWUwZDUzYjc5MGQ5Njg2L3RhYmxlOjMxYTQ1NzVlZTMxMDQ4ZDFhZGFiYmFmYjliZDg0OWZhL3RhYmxlcmFuZ2U6MzFhNDU3NWVlMzEwNDhkMWFkYWJiYWZiOWJkODQ5ZmFfNC01LTEtMS02MjY_7f6ccdce-046c-4d8a-9329-d8da32b2af0e"
      unitRef="usd">25000</us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax>
    <us-gaap:AvailableForSaleSecuritiesDebtSecurities
      contextRef="ibd768261001c4410bcbcfa14c060fd74_I20220630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmFlNWE5YmUwZWI5NDQ1ZDE5MmZhZTgyMmQyMmJlMDlmL3NlYzphZTVhOWJlMGViOTQ0NWQxOTJmYWU4MjJkMjJiZTA5Zl80My9mcmFnOmIzZWFmOGZlNmQ2MzQzYmVhMWUwZDUzYjc5MGQ5Njg2L3RhYmxlOjMxYTQ1NzVlZTMxMDQ4ZDFhZGFiYmFmYjliZDg0OWZhL3RhYmxlcmFuZ2U6MzFhNDU3NWVlMzEwNDhkMWFkYWJiYWZiOWJkODQ5ZmFfNC03LTEtMS02MjY_4b867e72-b04d-40ce-a868-939dbfb9df0c"
      unitRef="usd">3641000</us-gaap:AvailableForSaleSecuritiesDebtSecurities>
    <us-gaap:AvailableForSaleDebtSecuritiesAmortizedCostBasis
      contextRef="i9b0f17d8e871417bbb113b30e575a8a5_I20220630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmFlNWE5YmUwZWI5NDQ1ZDE5MmZhZTgyMmQyMmJlMDlmL3NlYzphZTVhOWJlMGViOTQ0NWQxOTJmYWU4MjJkMjJiZTA5Zl80My9mcmFnOmIzZWFmOGZlNmQ2MzQzYmVhMWUwZDUzYjc5MGQ5Njg2L3RhYmxlOjMxYTQ1NzVlZTMxMDQ4ZDFhZGFiYmFmYjliZDg0OWZhL3RhYmxlcmFuZ2U6MzFhNDU3NWVlMzEwNDhkMWFkYWJiYWZiOWJkODQ5ZmFfNS0xLTEtMS02MjY_59a04494-b970-4715-bc5c-2697e1bb4d6b"
      unitRef="usd">35295000</us-gaap:AvailableForSaleDebtSecuritiesAmortizedCostBasis>
    <us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax
      contextRef="i9b0f17d8e871417bbb113b30e575a8a5_I20220630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmFlNWE5YmUwZWI5NDQ1ZDE5MmZhZTgyMmQyMmJlMDlmL3NlYzphZTVhOWJlMGViOTQ0NWQxOTJmYWU4MjJkMjJiZTA5Zl80My9mcmFnOmIzZWFmOGZlNmQ2MzQzYmVhMWUwZDUzYjc5MGQ5Njg2L3RhYmxlOjMxYTQ1NzVlZTMxMDQ4ZDFhZGFiYmFmYjliZDg0OWZhL3RhYmxlcmFuZ2U6MzFhNDU3NWVlMzEwNDhkMWFkYWJiYWZiOWJkODQ5ZmFfNS0zLTEtMS02MjY_4b725a76-da5f-4d0e-b126-08f828dbe8fa"
      unitRef="usd">9000</us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax>
    <us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax
      contextRef="i9b0f17d8e871417bbb113b30e575a8a5_I20220630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmFlNWE5YmUwZWI5NDQ1ZDE5MmZhZTgyMmQyMmJlMDlmL3NlYzphZTVhOWJlMGViOTQ0NWQxOTJmYWU4MjJkMjJiZTA5Zl80My9mcmFnOmIzZWFmOGZlNmQ2MzQzYmVhMWUwZDUzYjc5MGQ5Njg2L3RhYmxlOjMxYTQ1NzVlZTMxMDQ4ZDFhZGFiYmFmYjliZDg0OWZhL3RhYmxlcmFuZ2U6MzFhNDU3NWVlMzEwNDhkMWFkYWJiYWZiOWJkODQ5ZmFfNS01LTEtMS02MjY_a9eeeb52-859e-4bc2-960b-084f0604d7aa"
      unitRef="usd">580000</us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax>
    <us-gaap:AvailableForSaleSecuritiesDebtSecurities
      contextRef="i9b0f17d8e871417bbb113b30e575a8a5_I20220630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmFlNWE5YmUwZWI5NDQ1ZDE5MmZhZTgyMmQyMmJlMDlmL3NlYzphZTVhOWJlMGViOTQ0NWQxOTJmYWU4MjJkMjJiZTA5Zl80My9mcmFnOmIzZWFmOGZlNmQ2MzQzYmVhMWUwZDUzYjc5MGQ5Njg2L3RhYmxlOjMxYTQ1NzVlZTMxMDQ4ZDFhZGFiYmFmYjliZDg0OWZhL3RhYmxlcmFuZ2U6MzFhNDU3NWVlMzEwNDhkMWFkYWJiYWZiOWJkODQ5ZmFfNS03LTEtMS02MjY_02b633f1-4285-4517-9fbf-58c855e6cffe"
      unitRef="usd">34724000</us-gaap:AvailableForSaleSecuritiesDebtSecurities>
    <us-gaap:AvailableForSaleDebtSecuritiesAmortizedCostBasis
      contextRef="i4c8f247d12134a9886d56e1c8b024425_I20220630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmFlNWE5YmUwZWI5NDQ1ZDE5MmZhZTgyMmQyMmJlMDlmL3NlYzphZTVhOWJlMGViOTQ0NWQxOTJmYWU4MjJkMjJiZTA5Zl80My9mcmFnOmIzZWFmOGZlNmQ2MzQzYmVhMWUwZDUzYjc5MGQ5Njg2L3RhYmxlOjMxYTQ1NzVlZTMxMDQ4ZDFhZGFiYmFmYjliZDg0OWZhL3RhYmxlcmFuZ2U6MzFhNDU3NWVlMzEwNDhkMWFkYWJiYWZiOWJkODQ5ZmFfNi0xLTEtMS02MjY_3e9a9200-a341-488d-90fc-bcda5730311f"
      unitRef="usd">54322000</us-gaap:AvailableForSaleDebtSecuritiesAmortizedCostBasis>
    <us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax
      contextRef="i4c8f247d12134a9886d56e1c8b024425_I20220630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmFlNWE5YmUwZWI5NDQ1ZDE5MmZhZTgyMmQyMmJlMDlmL3NlYzphZTVhOWJlMGViOTQ0NWQxOTJmYWU4MjJkMjJiZTA5Zl80My9mcmFnOmIzZWFmOGZlNmQ2MzQzYmVhMWUwZDUzYjc5MGQ5Njg2L3RhYmxlOjMxYTQ1NzVlZTMxMDQ4ZDFhZGFiYmFmYjliZDg0OWZhL3RhYmxlcmFuZ2U6MzFhNDU3NWVlMzEwNDhkMWFkYWJiYWZiOWJkODQ5ZmFfNi0zLTEtMS02MjY_46c892eb-a18d-4060-bd8d-48cdd022f41b"
      unitRef="usd">9000</us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax>
    <us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax
      contextRef="i4c8f247d12134a9886d56e1c8b024425_I20220630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmFlNWE5YmUwZWI5NDQ1ZDE5MmZhZTgyMmQyMmJlMDlmL3NlYzphZTVhOWJlMGViOTQ0NWQxOTJmYWU4MjJkMjJiZTA5Zl80My9mcmFnOmIzZWFmOGZlNmQ2MzQzYmVhMWUwZDUzYjc5MGQ5Njg2L3RhYmxlOjMxYTQ1NzVlZTMxMDQ4ZDFhZGFiYmFmYjliZDg0OWZhL3RhYmxlcmFuZ2U6MzFhNDU3NWVlMzEwNDhkMWFkYWJiYWZiOWJkODQ5ZmFfNi01LTEtMS02MjY_813aa756-108e-481c-b425-5c0d9da112b0"
      unitRef="usd">874000</us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax>
    <us-gaap:AvailableForSaleSecuritiesDebtSecurities
      contextRef="i4c8f247d12134a9886d56e1c8b024425_I20220630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmFlNWE5YmUwZWI5NDQ1ZDE5MmZhZTgyMmQyMmJlMDlmL3NlYzphZTVhOWJlMGViOTQ0NWQxOTJmYWU4MjJkMjJiZTA5Zl80My9mcmFnOmIzZWFmOGZlNmQ2MzQzYmVhMWUwZDUzYjc5MGQ5Njg2L3RhYmxlOjMxYTQ1NzVlZTMxMDQ4ZDFhZGFiYmFmYjliZDg0OWZhL3RhYmxlcmFuZ2U6MzFhNDU3NWVlMzEwNDhkMWFkYWJiYWZiOWJkODQ5ZmFfNi03LTEtMS02MjY_57b9650b-165a-4887-8f1d-204084c19975"
      unitRef="usd">53457000</us-gaap:AvailableForSaleSecuritiesDebtSecurities>
    <us-gaap:AvailableForSaleDebtSecuritiesAmortizedCostBasis
      contextRef="i267f31f0cb5a4cb5bd58dd78cd514f48_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmFlNWE5YmUwZWI5NDQ1ZDE5MmZhZTgyMmQyMmJlMDlmL3NlYzphZTVhOWJlMGViOTQ0NWQxOTJmYWU4MjJkMjJiZTA5Zl80My9mcmFnOmIzZWFmOGZlNmQ2MzQzYmVhMWUwZDUzYjc5MGQ5Njg2L3RhYmxlOmIyYmE0MDBlYmE4MDRiNzI5YzU5NzZlZWRmZDQ1NDAxL3RhYmxlcmFuZ2U6YjJiYTQwMGViYTgwNGI3MjljNTk3NmVlZGZkNDU0MDFfMy0xLTEtMS02MjY_ae6c3088-c11a-4ae9-b141-c24ee6d8421d"
      unitRef="usd">15385000</us-gaap:AvailableForSaleDebtSecuritiesAmortizedCostBasis>
    <us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax
      contextRef="i267f31f0cb5a4cb5bd58dd78cd514f48_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmFlNWE5YmUwZWI5NDQ1ZDE5MmZhZTgyMmQyMmJlMDlmL3NlYzphZTVhOWJlMGViOTQ0NWQxOTJmYWU4MjJkMjJiZTA5Zl80My9mcmFnOmIzZWFmOGZlNmQ2MzQzYmVhMWUwZDUzYjc5MGQ5Njg2L3RhYmxlOmIyYmE0MDBlYmE4MDRiNzI5YzU5NzZlZWRmZDQ1NDAxL3RhYmxlcmFuZ2U6YjJiYTQwMGViYTgwNGI3MjljNTk3NmVlZGZkNDU0MDFfMy0zLTEtMS02MjY_95a892cd-e4c8-4b42-8438-0f7c352ceef9"
      unitRef="usd">0</us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax>
    <us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax
      contextRef="i267f31f0cb5a4cb5bd58dd78cd514f48_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmFlNWE5YmUwZWI5NDQ1ZDE5MmZhZTgyMmQyMmJlMDlmL3NlYzphZTVhOWJlMGViOTQ0NWQxOTJmYWU4MjJkMjJiZTA5Zl80My9mcmFnOmIzZWFmOGZlNmQ2MzQzYmVhMWUwZDUzYjc5MGQ5Njg2L3RhYmxlOmIyYmE0MDBlYmE4MDRiNzI5YzU5NzZlZWRmZDQ1NDAxL3RhYmxlcmFuZ2U6YjJiYTQwMGViYTgwNGI3MjljNTk3NmVlZGZkNDU0MDFfMy01LTEtMS02MjY_741e9182-72ff-4052-bc79-7fb464c26512"
      unitRef="usd">33000</us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax>
    <us-gaap:AvailableForSaleSecuritiesDebtSecurities
      contextRef="i267f31f0cb5a4cb5bd58dd78cd514f48_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmFlNWE5YmUwZWI5NDQ1ZDE5MmZhZTgyMmQyMmJlMDlmL3NlYzphZTVhOWJlMGViOTQ0NWQxOTJmYWU4MjJkMjJiZTA5Zl80My9mcmFnOmIzZWFmOGZlNmQ2MzQzYmVhMWUwZDUzYjc5MGQ5Njg2L3RhYmxlOmIyYmE0MDBlYmE4MDRiNzI5YzU5NzZlZWRmZDQ1NDAxL3RhYmxlcmFuZ2U6YjJiYTQwMGViYTgwNGI3MjljNTk3NmVlZGZkNDU0MDFfMy03LTEtMS02MjY_17aa234f-d22a-4fef-b431-484b0c9845e6"
      unitRef="usd">15352000</us-gaap:AvailableForSaleSecuritiesDebtSecurities>
    <us-gaap:AvailableForSaleDebtSecuritiesAmortizedCostBasis
      contextRef="i3ec37ec0a1104b00bb3614670349fb31_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmFlNWE5YmUwZWI5NDQ1ZDE5MmZhZTgyMmQyMmJlMDlmL3NlYzphZTVhOWJlMGViOTQ0NWQxOTJmYWU4MjJkMjJiZTA5Zl80My9mcmFnOmIzZWFmOGZlNmQ2MzQzYmVhMWUwZDUzYjc5MGQ5Njg2L3RhYmxlOmIyYmE0MDBlYmE4MDRiNzI5YzU5NzZlZWRmZDQ1NDAxL3RhYmxlcmFuZ2U6YjJiYTQwMGViYTgwNGI3MjljNTk3NmVlZGZkNDU0MDFfNC0xLTEtMS02MjY_50652c22-ae4c-4393-a79b-6f04644786cc"
      unitRef="usd">7417000</us-gaap:AvailableForSaleDebtSecuritiesAmortizedCostBasis>
    <us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax
      contextRef="i3ec37ec0a1104b00bb3614670349fb31_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmFlNWE5YmUwZWI5NDQ1ZDE5MmZhZTgyMmQyMmJlMDlmL3NlYzphZTVhOWJlMGViOTQ0NWQxOTJmYWU4MjJkMjJiZTA5Zl80My9mcmFnOmIzZWFmOGZlNmQ2MzQzYmVhMWUwZDUzYjc5MGQ5Njg2L3RhYmxlOmIyYmE0MDBlYmE4MDRiNzI5YzU5NzZlZWRmZDQ1NDAxL3RhYmxlcmFuZ2U6YjJiYTQwMGViYTgwNGI3MjljNTk3NmVlZGZkNDU0MDFfNC0zLTEtMS02MjY_e318053a-7c30-4078-890d-e26bfa5d97ac"
      unitRef="usd">0</us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax>
    <us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax
      contextRef="i3ec37ec0a1104b00bb3614670349fb31_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmFlNWE5YmUwZWI5NDQ1ZDE5MmZhZTgyMmQyMmJlMDlmL3NlYzphZTVhOWJlMGViOTQ0NWQxOTJmYWU4MjJkMjJiZTA5Zl80My9mcmFnOmIzZWFmOGZlNmQ2MzQzYmVhMWUwZDUzYjc5MGQ5Njg2L3RhYmxlOmIyYmE0MDBlYmE4MDRiNzI5YzU5NzZlZWRmZDQ1NDAxL3RhYmxlcmFuZ2U6YjJiYTQwMGViYTgwNGI3MjljNTk3NmVlZGZkNDU0MDFfNC01LTEtMS02MjY_4b63c438-dd26-4b0e-936a-2fad526e756b"
      unitRef="usd">5000</us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax>
    <us-gaap:AvailableForSaleSecuritiesDebtSecurities
      contextRef="i3ec37ec0a1104b00bb3614670349fb31_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmFlNWE5YmUwZWI5NDQ1ZDE5MmZhZTgyMmQyMmJlMDlmL3NlYzphZTVhOWJlMGViOTQ0NWQxOTJmYWU4MjJkMjJiZTA5Zl80My9mcmFnOmIzZWFmOGZlNmQ2MzQzYmVhMWUwZDUzYjc5MGQ5Njg2L3RhYmxlOmIyYmE0MDBlYmE4MDRiNzI5YzU5NzZlZWRmZDQ1NDAxL3RhYmxlcmFuZ2U6YjJiYTQwMGViYTgwNGI3MjljNTk3NmVlZGZkNDU0MDFfNC03LTEtMS02MjY_cb9ea96d-0d70-4ec5-abfa-0551cf2b37b1"
      unitRef="usd">7412000</us-gaap:AvailableForSaleSecuritiesDebtSecurities>
    <us-gaap:AvailableForSaleDebtSecuritiesAmortizedCostBasis
      contextRef="i10f3d8ad519640d9bc20a9ada45d58e7_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmFlNWE5YmUwZWI5NDQ1ZDE5MmZhZTgyMmQyMmJlMDlmL3NlYzphZTVhOWJlMGViOTQ0NWQxOTJmYWU4MjJkMjJiZTA5Zl80My9mcmFnOmIzZWFmOGZlNmQ2MzQzYmVhMWUwZDUzYjc5MGQ5Njg2L3RhYmxlOmIyYmE0MDBlYmE4MDRiNzI5YzU5NzZlZWRmZDQ1NDAxL3RhYmxlcmFuZ2U6YjJiYTQwMGViYTgwNGI3MjljNTk3NmVlZGZkNDU0MDFfNS0xLTEtMS02MjY_04ad8e69-0080-47b5-b08b-aaf7d80d2ff9"
      unitRef="usd">25771000</us-gaap:AvailableForSaleDebtSecuritiesAmortizedCostBasis>
    <us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax
      contextRef="i10f3d8ad519640d9bc20a9ada45d58e7_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmFlNWE5YmUwZWI5NDQ1ZDE5MmZhZTgyMmQyMmJlMDlmL3NlYzphZTVhOWJlMGViOTQ0NWQxOTJmYWU4MjJkMjJiZTA5Zl80My9mcmFnOmIzZWFmOGZlNmQ2MzQzYmVhMWUwZDUzYjc5MGQ5Njg2L3RhYmxlOmIyYmE0MDBlYmE4MDRiNzI5YzU5NzZlZWRmZDQ1NDAxL3RhYmxlcmFuZ2U6YjJiYTQwMGViYTgwNGI3MjljNTk3NmVlZGZkNDU0MDFfNS0zLTEtMS02MjY_c10146d4-4350-48b4-8992-74cbc69a1eb0"
      unitRef="usd">1000</us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax>
    <us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax
      contextRef="i10f3d8ad519640d9bc20a9ada45d58e7_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmFlNWE5YmUwZWI5NDQ1ZDE5MmZhZTgyMmQyMmJlMDlmL3NlYzphZTVhOWJlMGViOTQ0NWQxOTJmYWU4MjJkMjJiZTA5Zl80My9mcmFnOmIzZWFmOGZlNmQ2MzQzYmVhMWUwZDUzYjc5MGQ5Njg2L3RhYmxlOmIyYmE0MDBlYmE4MDRiNzI5YzU5NzZlZWRmZDQ1NDAxL3RhYmxlcmFuZ2U6YjJiYTQwMGViYTgwNGI3MjljNTk3NmVlZGZkNDU0MDFfNS01LTEtMS02MjY_472ce746-74f7-4768-877f-b2caa87edd9b"
      unitRef="usd">87000</us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax>
    <us-gaap:AvailableForSaleSecuritiesDebtSecurities
      contextRef="i10f3d8ad519640d9bc20a9ada45d58e7_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmFlNWE5YmUwZWI5NDQ1ZDE5MmZhZTgyMmQyMmJlMDlmL3NlYzphZTVhOWJlMGViOTQ0NWQxOTJmYWU4MjJkMjJiZTA5Zl80My9mcmFnOmIzZWFmOGZlNmQ2MzQzYmVhMWUwZDUzYjc5MGQ5Njg2L3RhYmxlOmIyYmE0MDBlYmE4MDRiNzI5YzU5NzZlZWRmZDQ1NDAxL3RhYmxlcmFuZ2U6YjJiYTQwMGViYTgwNGI3MjljNTk3NmVlZGZkNDU0MDFfNS03LTEtMS02MjY_2e86c763-5890-4b06-9575-9dc4d109a15b"
      unitRef="usd">25685000</us-gaap:AvailableForSaleSecuritiesDebtSecurities>
    <us-gaap:AvailableForSaleDebtSecuritiesAmortizedCostBasis
      contextRef="i87bf777ccf5f4f93bc9be7a2cbba61c1_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmFlNWE5YmUwZWI5NDQ1ZDE5MmZhZTgyMmQyMmJlMDlmL3NlYzphZTVhOWJlMGViOTQ0NWQxOTJmYWU4MjJkMjJiZTA5Zl80My9mcmFnOmIzZWFmOGZlNmQ2MzQzYmVhMWUwZDUzYjc5MGQ5Njg2L3RhYmxlOmIyYmE0MDBlYmE4MDRiNzI5YzU5NzZlZWRmZDQ1NDAxL3RhYmxlcmFuZ2U6YjJiYTQwMGViYTgwNGI3MjljNTk3NmVlZGZkNDU0MDFfNi0xLTEtMS02MjY_0dc1d574-4472-4159-98cb-c2bcadd4c25b"
      unitRef="usd">48573000</us-gaap:AvailableForSaleDebtSecuritiesAmortizedCostBasis>
    <us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax
      contextRef="i87bf777ccf5f4f93bc9be7a2cbba61c1_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmFlNWE5YmUwZWI5NDQ1ZDE5MmZhZTgyMmQyMmJlMDlmL3NlYzphZTVhOWJlMGViOTQ0NWQxOTJmYWU4MjJkMjJiZTA5Zl80My9mcmFnOmIzZWFmOGZlNmQ2MzQzYmVhMWUwZDUzYjc5MGQ5Njg2L3RhYmxlOmIyYmE0MDBlYmE4MDRiNzI5YzU5NzZlZWRmZDQ1NDAxL3RhYmxlcmFuZ2U6YjJiYTQwMGViYTgwNGI3MjljNTk3NmVlZGZkNDU0MDFfNi0zLTEtMS02MjY_2361f021-c335-40c4-9f58-df41d072715b"
      unitRef="usd">1000</us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax>
    <us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax
      contextRef="i87bf777ccf5f4f93bc9be7a2cbba61c1_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmFlNWE5YmUwZWI5NDQ1ZDE5MmZhZTgyMmQyMmJlMDlmL3NlYzphZTVhOWJlMGViOTQ0NWQxOTJmYWU4MjJkMjJiZTA5Zl80My9mcmFnOmIzZWFmOGZlNmQ2MzQzYmVhMWUwZDUzYjc5MGQ5Njg2L3RhYmxlOmIyYmE0MDBlYmE4MDRiNzI5YzU5NzZlZWRmZDQ1NDAxL3RhYmxlcmFuZ2U6YjJiYTQwMGViYTgwNGI3MjljNTk3NmVlZGZkNDU0MDFfNi01LTEtMS02MjY_05246fb4-5fd8-46ec-b47c-6b7290e1b6c2"
      unitRef="usd">125000</us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax>
    <us-gaap:AvailableForSaleSecuritiesDebtSecurities
      contextRef="i87bf777ccf5f4f93bc9be7a2cbba61c1_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmFlNWE5YmUwZWI5NDQ1ZDE5MmZhZTgyMmQyMmJlMDlmL3NlYzphZTVhOWJlMGViOTQ0NWQxOTJmYWU4MjJkMjJiZTA5Zl80My9mcmFnOmIzZWFmOGZlNmQ2MzQzYmVhMWUwZDUzYjc5MGQ5Njg2L3RhYmxlOmIyYmE0MDBlYmE4MDRiNzI5YzU5NzZlZWRmZDQ1NDAxL3RhYmxlcmFuZ2U6YjJiYTQwMGViYTgwNGI3MjljNTk3NmVlZGZkNDU0MDFfNi03LTEtMS02MjY_6cb0e050-f107-4696-a036-9ac0200f0fca"
      unitRef="usd">48449000</us-gaap:AvailableForSaleSecuritiesDebtSecurities>
    <dmtk:EstimatedMarketValueOfDebtSecuritiesWithContractualMaturitiesOfLessThan12Months
      contextRef="i4c8f247d12134a9886d56e1c8b024425_I20220630"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmFlNWE5YmUwZWI5NDQ1ZDE5MmZhZTgyMmQyMmJlMDlmL3NlYzphZTVhOWJlMGViOTQ0NWQxOTJmYWU4MjJkMjJiZTA5Zl80My9mcmFnOmIzZWFmOGZlNmQ2MzQzYmVhMWUwZDUzYjc5MGQ5Njg2L3RleHRyZWdpb246YjNlYWY4ZmU2ZDYzNDNiZWExZTBkNTNiNzkwZDk2ODZfNjgw_9052912c-15ef-411a-8017-4326fa9dc702"
      unitRef="usd">25800000</dmtk:EstimatedMarketValueOfDebtSecuritiesWithContractualMaturitiesOfLessThan12Months>
    <dmtk:EstimatedMarketValueOfRemainingDebtSecuritiesWithContractualMaturitiesOfUpTo23Months
      contextRef="i4c8f247d12134a9886d56e1c8b024425_I20220630"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmFlNWE5YmUwZWI5NDQ1ZDE5MmZhZTgyMmQyMmJlMDlmL3NlYzphZTVhOWJlMGViOTQ0NWQxOTJmYWU4MjJkMjJiZTA5Zl80My9mcmFnOmIzZWFmOGZlNmQ2MzQzYmVhMWUwZDUzYjc5MGQ5Njg2L3RleHRyZWdpb246YjNlYWY4ZmU2ZDYzNDNiZWExZTBkNTNiNzkwZDk2ODZfNzcz_dc7bae55-96a3-450b-ad3e-8bd9f0f1aba1"
      unitRef="usd">27700000</dmtk:EstimatedMarketValueOfRemainingDebtSecuritiesWithContractualMaturitiesOfUpTo23Months>
    <dmtk:EstimatedMarketValueOfDebtSecuritiesWithContractualMaturitiesOfLessThan12Months
      contextRef="i87bf777ccf5f4f93bc9be7a2cbba61c1_I20211231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmFlNWE5YmUwZWI5NDQ1ZDE5MmZhZTgyMmQyMmJlMDlmL3NlYzphZTVhOWJlMGViOTQ0NWQxOTJmYWU4MjJkMjJiZTA5Zl80My9mcmFnOmIzZWFmOGZlNmQ2MzQzYmVhMWUwZDUzYjc5MGQ5Njg2L3RleHRyZWdpb246YjNlYWY4ZmU2ZDYzNDNiZWExZTBkNTNiNzkwZDk2ODZfOTM4_2c6a20f0-bf28-43fa-8256-5325c212acde"
      unitRef="usd">21200000</dmtk:EstimatedMarketValueOfDebtSecuritiesWithContractualMaturitiesOfLessThan12Months>
    <dmtk:EstimatedMarketValueOfRemainingDebtSecuritiesWithContractualMaturitiesOfUpTo23Months
      contextRef="i87bf777ccf5f4f93bc9be7a2cbba61c1_I20211231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmFlNWE5YmUwZWI5NDQ1ZDE5MmZhZTgyMmQyMmJlMDlmL3NlYzphZTVhOWJlMGViOTQ0NWQxOTJmYWU4MjJkMjJiZTA5Zl80My9mcmFnOmIzZWFmOGZlNmQ2MzQzYmVhMWUwZDUzYjc5MGQ5Njg2L3RleHRyZWdpb246YjNlYWY4ZmU2ZDYzNDNiZWExZTBkNTNiNzkwZDk2ODZfMTA5OTUxMTYyOTA4OQ_8d0ccd15-f4d2-41d7-8416-7583a973197e"
      unitRef="usd">27200000</dmtk:EstimatedMarketValueOfRemainingDebtSecuritiesWithContractualMaturitiesOfUpTo23Months>
    <dmtk:CreditLosses
      contextRef="i4c8f247d12134a9886d56e1c8b024425_I20220630"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmFlNWE5YmUwZWI5NDQ1ZDE5MmZhZTgyMmQyMmJlMDlmL3NlYzphZTVhOWJlMGViOTQ0NWQxOTJmYWU4MjJkMjJiZTA5Zl80My9mcmFnOmIzZWFmOGZlNmQ2MzQzYmVhMWUwZDUzYjc5MGQ5Njg2L3RleHRyZWdpb246YjNlYWY4ZmU2ZDYzNDNiZWExZTBkNTNiNzkwZDk2ODZfMTA5OTUxMTYyOTczMQ_05352dac-1f19-4dde-a2ca-d83d8243e473"
      unitRef="usd">0</dmtk:CreditLosses>
    <dmtk:CreditLosses
      contextRef="i87bf777ccf5f4f93bc9be7a2cbba61c1_I20211231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmFlNWE5YmUwZWI5NDQ1ZDE5MmZhZTgyMmQyMmJlMDlmL3NlYzphZTVhOWJlMGViOTQ0NWQxOTJmYWU4MjJkMjJiZTA5Zl80My9mcmFnOmIzZWFmOGZlNmQ2MzQzYmVhMWUwZDUzYjc5MGQ5Njg2L3RleHRyZWdpb246YjNlYWY4ZmU2ZDYzNDNiZWExZTBkNTNiNzkwZDk2ODZfMTA5OTUxMTYyOTczMQ_9598966c-e42c-45ed-a8c3-eb01f8502c6f"
      unitRef="usd">0</dmtk:CreditLosses>
    <dmtk:ScheduleOfPrepaidExpensesAndPropertyAndEquipmentTableTextBlock
      contextRef="ia855382ada1f4f28aa8ef6da692ff177_D20220101-20220630"
      id="id3VybDovL2RvY3MudjEvZG9jOmFlNWE5YmUwZWI5NDQ1ZDE5MmZhZTgyMmQyMmJlMDlmL3NlYzphZTVhOWJlMGViOTQ0NWQxOTJmYWU4MjJkMjJiZTA5Zl80My9mcmFnOmIzZWFmOGZlNmQ2MzQzYmVhMWUwZDUzYjc5MGQ5Njg2L3RleHRyZWdpb246YjNlYWY4ZmU2ZDYzNDNiZWExZTBkNTNiNzkwZDk2ODZfMTMxMA_f16c0dc2-8785-480a-baaf-7505f3c878db">&lt;div style="margin-top:9pt;padding-left:27pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Condensed consolidated balance sheet details are as follows (in thousands): &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:12pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:71.930%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:12.081%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.406%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:12.083%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;June 30,&lt;br/&gt;2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;December 31,&lt;br/&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Prepaid expenses and other current assets:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Prepaid insurance&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;806&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,801&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Prepaid trade shows&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;241&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;440&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Prepaid software fees&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;907&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;551&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Prepaid employee compensation&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;227&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;238&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Other current assets&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;500&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;136&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total prepaid expenses and other current assets&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,681&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3,166&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Property and equipment, gross:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:3pt double #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:3pt double #000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Laboratory equipment&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4,856&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4,805&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Computer equipment&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;396&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;171&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Furniture and fixtures&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;555&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;124&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Leasehold improvements&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,208&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,074&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Construction-in-progress&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;139&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total property and equipment, gross&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;7,154&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;6,174&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Less accumulated depreciation&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(2,238)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(1,625)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total property and equipment, net&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4,916&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4,549&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;</dmtk:ScheduleOfPrepaidExpensesAndPropertyAndEquipmentTableTextBlock>
    <us-gaap:PrepaidInsurance
      contextRef="i4c8f247d12134a9886d56e1c8b024425_I20220630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmFlNWE5YmUwZWI5NDQ1ZDE5MmZhZTgyMmQyMmJlMDlmL3NlYzphZTVhOWJlMGViOTQ0NWQxOTJmYWU4MjJkMjJiZTA5Zl80My9mcmFnOmIzZWFmOGZlNmQ2MzQzYmVhMWUwZDUzYjc5MGQ5Njg2L3RhYmxlOjAzYjg1ZTAwZDljNjRlOTZhYzllODA4NjY2MzMwN2YyL3RhYmxlcmFuZ2U6MDNiODVlMDBkOWM2NGU5NmFjOWU4MDg2NjYzMzA3ZjJfMi0xLTEtMS02MjY_d188ea62-da95-4a10-8b0f-376646ce9cfe"
      unitRef="usd">806000</us-gaap:PrepaidInsurance>
    <us-gaap:PrepaidInsurance
      contextRef="i87bf777ccf5f4f93bc9be7a2cbba61c1_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmFlNWE5YmUwZWI5NDQ1ZDE5MmZhZTgyMmQyMmJlMDlmL3NlYzphZTVhOWJlMGViOTQ0NWQxOTJmYWU4MjJkMjJiZTA5Zl80My9mcmFnOmIzZWFmOGZlNmQ2MzQzYmVhMWUwZDUzYjc5MGQ5Njg2L3RhYmxlOjAzYjg1ZTAwZDljNjRlOTZhYzllODA4NjY2MzMwN2YyL3RhYmxlcmFuZ2U6MDNiODVlMDBkOWM2NGU5NmFjOWU4MDg2NjYzMzA3ZjJfMi0zLTEtMS02MjY_c404474c-0ccd-4d5c-a71e-9f42241deec2"
      unitRef="usd">1801000</us-gaap:PrepaidInsurance>
    <dmtk:PrepaidTradeShowsCurrent
      contextRef="i4c8f247d12134a9886d56e1c8b024425_I20220630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmFlNWE5YmUwZWI5NDQ1ZDE5MmZhZTgyMmQyMmJlMDlmL3NlYzphZTVhOWJlMGViOTQ0NWQxOTJmYWU4MjJkMjJiZTA5Zl80My9mcmFnOmIzZWFmOGZlNmQ2MzQzYmVhMWUwZDUzYjc5MGQ5Njg2L3RhYmxlOjAzYjg1ZTAwZDljNjRlOTZhYzllODA4NjY2MzMwN2YyL3RhYmxlcmFuZ2U6MDNiODVlMDBkOWM2NGU5NmFjOWU4MDg2NjYzMzA3ZjJfMy0xLTEtMS02MjY_ed04f9dd-112c-443b-a911-64870d932bc6"
      unitRef="usd">241000</dmtk:PrepaidTradeShowsCurrent>
    <dmtk:PrepaidTradeShowsCurrent
      contextRef="i87bf777ccf5f4f93bc9be7a2cbba61c1_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmFlNWE5YmUwZWI5NDQ1ZDE5MmZhZTgyMmQyMmJlMDlmL3NlYzphZTVhOWJlMGViOTQ0NWQxOTJmYWU4MjJkMjJiZTA5Zl80My9mcmFnOmIzZWFmOGZlNmQ2MzQzYmVhMWUwZDUzYjc5MGQ5Njg2L3RhYmxlOjAzYjg1ZTAwZDljNjRlOTZhYzllODA4NjY2MzMwN2YyL3RhYmxlcmFuZ2U6MDNiODVlMDBkOWM2NGU5NmFjOWU4MDg2NjYzMzA3ZjJfMy0zLTEtMS02MjY_4fc630b1-a3a1-40ec-957e-ea25c63c69d5"
      unitRef="usd">440000</dmtk:PrepaidTradeShowsCurrent>
    <dmtk:PrepaidSoftwareFees
      contextRef="i4c8f247d12134a9886d56e1c8b024425_I20220630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmFlNWE5YmUwZWI5NDQ1ZDE5MmZhZTgyMmQyMmJlMDlmL3NlYzphZTVhOWJlMGViOTQ0NWQxOTJmYWU4MjJkMjJiZTA5Zl80My9mcmFnOmIzZWFmOGZlNmQ2MzQzYmVhMWUwZDUzYjc5MGQ5Njg2L3RhYmxlOjAzYjg1ZTAwZDljNjRlOTZhYzllODA4NjY2MzMwN2YyL3RhYmxlcmFuZ2U6MDNiODVlMDBkOWM2NGU5NmFjOWU4MDg2NjYzMzA3ZjJfNC0xLTEtMS02MjY_a851049d-0e3a-4308-91a8-eba7267b74b8"
      unitRef="usd">907000</dmtk:PrepaidSoftwareFees>
    <dmtk:PrepaidSoftwareFees
      contextRef="i87bf777ccf5f4f93bc9be7a2cbba61c1_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmFlNWE5YmUwZWI5NDQ1ZDE5MmZhZTgyMmQyMmJlMDlmL3NlYzphZTVhOWJlMGViOTQ0NWQxOTJmYWU4MjJkMjJiZTA5Zl80My9mcmFnOmIzZWFmOGZlNmQ2MzQzYmVhMWUwZDUzYjc5MGQ5Njg2L3RhYmxlOjAzYjg1ZTAwZDljNjRlOTZhYzllODA4NjY2MzMwN2YyL3RhYmxlcmFuZ2U6MDNiODVlMDBkOWM2NGU5NmFjOWU4MDg2NjYzMzA3ZjJfNC0zLTEtMS02MjY_ec97a46b-62fc-4bc2-8307-15aa14e9d902"
      unitRef="usd">551000</dmtk:PrepaidSoftwareFees>
    <dmtk:PrepaidEmployeeCompensation
      contextRef="i4c8f247d12134a9886d56e1c8b024425_I20220630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmFlNWE5YmUwZWI5NDQ1ZDE5MmZhZTgyMmQyMmJlMDlmL3NlYzphZTVhOWJlMGViOTQ0NWQxOTJmYWU4MjJkMjJiZTA5Zl80My9mcmFnOmIzZWFmOGZlNmQ2MzQzYmVhMWUwZDUzYjc5MGQ5Njg2L3RhYmxlOjAzYjg1ZTAwZDljNjRlOTZhYzllODA4NjY2MzMwN2YyL3RhYmxlcmFuZ2U6MDNiODVlMDBkOWM2NGU5NmFjOWU4MDg2NjYzMzA3ZjJfNi0xLTEtMS02MjY_61aea309-26dc-4506-b473-3d81fce1896f"
      unitRef="usd">227000</dmtk:PrepaidEmployeeCompensation>
    <dmtk:PrepaidEmployeeCompensation
      contextRef="i87bf777ccf5f4f93bc9be7a2cbba61c1_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmFlNWE5YmUwZWI5NDQ1ZDE5MmZhZTgyMmQyMmJlMDlmL3NlYzphZTVhOWJlMGViOTQ0NWQxOTJmYWU4MjJkMjJiZTA5Zl80My9mcmFnOmIzZWFmOGZlNmQ2MzQzYmVhMWUwZDUzYjc5MGQ5Njg2L3RhYmxlOjAzYjg1ZTAwZDljNjRlOTZhYzllODA4NjY2MzMwN2YyL3RhYmxlcmFuZ2U6MDNiODVlMDBkOWM2NGU5NmFjOWU4MDg2NjYzMzA3ZjJfNi0zLTEtMS02MjY_37813e9c-067e-41d1-bf5b-a6f957127fe5"
      unitRef="usd">238000</dmtk:PrepaidEmployeeCompensation>
    <us-gaap:OtherAssetsCurrent
      contextRef="i4c8f247d12134a9886d56e1c8b024425_I20220630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmFlNWE5YmUwZWI5NDQ1ZDE5MmZhZTgyMmQyMmJlMDlmL3NlYzphZTVhOWJlMGViOTQ0NWQxOTJmYWU4MjJkMjJiZTA5Zl80My9mcmFnOmIzZWFmOGZlNmQ2MzQzYmVhMWUwZDUzYjc5MGQ5Njg2L3RhYmxlOjAzYjg1ZTAwZDljNjRlOTZhYzllODA4NjY2MzMwN2YyL3RhYmxlcmFuZ2U6MDNiODVlMDBkOWM2NGU5NmFjOWU4MDg2NjYzMzA3ZjJfNy0xLTEtMS02MjY_002159a5-1b8d-44c3-add1-d21c5bacd28a"
      unitRef="usd">500000</us-gaap:OtherAssetsCurrent>
    <us-gaap:OtherAssetsCurrent
      contextRef="i87bf777ccf5f4f93bc9be7a2cbba61c1_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmFlNWE5YmUwZWI5NDQ1ZDE5MmZhZTgyMmQyMmJlMDlmL3NlYzphZTVhOWJlMGViOTQ0NWQxOTJmYWU4MjJkMjJiZTA5Zl80My9mcmFnOmIzZWFmOGZlNmQ2MzQzYmVhMWUwZDUzYjc5MGQ5Njg2L3RhYmxlOjAzYjg1ZTAwZDljNjRlOTZhYzllODA4NjY2MzMwN2YyL3RhYmxlcmFuZ2U6MDNiODVlMDBkOWM2NGU5NmFjOWU4MDg2NjYzMzA3ZjJfNy0zLTEtMS02MjY_0d96facc-e3f7-4411-971f-e105766cd8b9"
      unitRef="usd">136000</us-gaap:OtherAssetsCurrent>
    <us-gaap:PrepaidExpenseAndOtherAssetsCurrent
      contextRef="i4c8f247d12134a9886d56e1c8b024425_I20220630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmFlNWE5YmUwZWI5NDQ1ZDE5MmZhZTgyMmQyMmJlMDlmL3NlYzphZTVhOWJlMGViOTQ0NWQxOTJmYWU4MjJkMjJiZTA5Zl80My9mcmFnOmIzZWFmOGZlNmQ2MzQzYmVhMWUwZDUzYjc5MGQ5Njg2L3RhYmxlOjAzYjg1ZTAwZDljNjRlOTZhYzllODA4NjY2MzMwN2YyL3RhYmxlcmFuZ2U6MDNiODVlMDBkOWM2NGU5NmFjOWU4MDg2NjYzMzA3ZjJfOC0xLTEtMS02MjY_7ee5b6b0-7ddc-4251-86ad-2b2aad82574d"
      unitRef="usd">2681000</us-gaap:PrepaidExpenseAndOtherAssetsCurrent>
    <us-gaap:PrepaidExpenseAndOtherAssetsCurrent
      contextRef="i87bf777ccf5f4f93bc9be7a2cbba61c1_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmFlNWE5YmUwZWI5NDQ1ZDE5MmZhZTgyMmQyMmJlMDlmL3NlYzphZTVhOWJlMGViOTQ0NWQxOTJmYWU4MjJkMjJiZTA5Zl80My9mcmFnOmIzZWFmOGZlNmQ2MzQzYmVhMWUwZDUzYjc5MGQ5Njg2L3RhYmxlOjAzYjg1ZTAwZDljNjRlOTZhYzllODA4NjY2MzMwN2YyL3RhYmxlcmFuZ2U6MDNiODVlMDBkOWM2NGU5NmFjOWU4MDg2NjYzMzA3ZjJfOC0zLTEtMS02MjY_4749c4b3-4369-476b-9521-e689c050431b"
      unitRef="usd">3166000</us-gaap:PrepaidExpenseAndOtherAssetsCurrent>
    <us-gaap:MachineryAndEquipmentGross
      contextRef="i4c8f247d12134a9886d56e1c8b024425_I20220630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmFlNWE5YmUwZWI5NDQ1ZDE5MmZhZTgyMmQyMmJlMDlmL3NlYzphZTVhOWJlMGViOTQ0NWQxOTJmYWU4MjJkMjJiZTA5Zl80My9mcmFnOmIzZWFmOGZlNmQ2MzQzYmVhMWUwZDUzYjc5MGQ5Njg2L3RhYmxlOjAzYjg1ZTAwZDljNjRlOTZhYzllODA4NjY2MzMwN2YyL3RhYmxlcmFuZ2U6MDNiODVlMDBkOWM2NGU5NmFjOWU4MDg2NjYzMzA3ZjJfMTAtMS0xLTEtNjI2_06b7848f-114c-413f-b81f-e14cee9c784b"
      unitRef="usd">4856000</us-gaap:MachineryAndEquipmentGross>
    <us-gaap:MachineryAndEquipmentGross
      contextRef="i87bf777ccf5f4f93bc9be7a2cbba61c1_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmFlNWE5YmUwZWI5NDQ1ZDE5MmZhZTgyMmQyMmJlMDlmL3NlYzphZTVhOWJlMGViOTQ0NWQxOTJmYWU4MjJkMjJiZTA5Zl80My9mcmFnOmIzZWFmOGZlNmQ2MzQzYmVhMWUwZDUzYjc5MGQ5Njg2L3RhYmxlOjAzYjg1ZTAwZDljNjRlOTZhYzllODA4NjY2MzMwN2YyL3RhYmxlcmFuZ2U6MDNiODVlMDBkOWM2NGU5NmFjOWU4MDg2NjYzMzA3ZjJfMTAtMy0xLTEtNjI2_df6608d9-f0fe-4042-b638-ba6d85efc61f"
      unitRef="usd">4805000</us-gaap:MachineryAndEquipmentGross>
    <dmtk:ComputerEquipmentGross
      contextRef="i4c8f247d12134a9886d56e1c8b024425_I20220630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmFlNWE5YmUwZWI5NDQ1ZDE5MmZhZTgyMmQyMmJlMDlmL3NlYzphZTVhOWJlMGViOTQ0NWQxOTJmYWU4MjJkMjJiZTA5Zl80My9mcmFnOmIzZWFmOGZlNmQ2MzQzYmVhMWUwZDUzYjc5MGQ5Njg2L3RhYmxlOjAzYjg1ZTAwZDljNjRlOTZhYzllODA4NjY2MzMwN2YyL3RhYmxlcmFuZ2U6MDNiODVlMDBkOWM2NGU5NmFjOWU4MDg2NjYzMzA3ZjJfMTEtMS0xLTEtNjI2_43ff926c-89cb-4cd4-af8b-9fb6cd4b02a8"
      unitRef="usd">396000</dmtk:ComputerEquipmentGross>
    <dmtk:ComputerEquipmentGross
      contextRef="i87bf777ccf5f4f93bc9be7a2cbba61c1_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmFlNWE5YmUwZWI5NDQ1ZDE5MmZhZTgyMmQyMmJlMDlmL3NlYzphZTVhOWJlMGViOTQ0NWQxOTJmYWU4MjJkMjJiZTA5Zl80My9mcmFnOmIzZWFmOGZlNmQ2MzQzYmVhMWUwZDUzYjc5MGQ5Njg2L3RhYmxlOjAzYjg1ZTAwZDljNjRlOTZhYzllODA4NjY2MzMwN2YyL3RhYmxlcmFuZ2U6MDNiODVlMDBkOWM2NGU5NmFjOWU4MDg2NjYzMzA3ZjJfMTEtMy0xLTEtNjI2_60169e47-01eb-488f-a233-2c5b50463e81"
      unitRef="usd">171000</dmtk:ComputerEquipmentGross>
    <us-gaap:FurnitureAndFixturesGross
      contextRef="i4c8f247d12134a9886d56e1c8b024425_I20220630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmFlNWE5YmUwZWI5NDQ1ZDE5MmZhZTgyMmQyMmJlMDlmL3NlYzphZTVhOWJlMGViOTQ0NWQxOTJmYWU4MjJkMjJiZTA5Zl80My9mcmFnOmIzZWFmOGZlNmQ2MzQzYmVhMWUwZDUzYjc5MGQ5Njg2L3RhYmxlOjAzYjg1ZTAwZDljNjRlOTZhYzllODA4NjY2MzMwN2YyL3RhYmxlcmFuZ2U6MDNiODVlMDBkOWM2NGU5NmFjOWU4MDg2NjYzMzA3ZjJfMTItMS0xLTEtNjI2_b97bf0c0-3a62-4634-8174-71b073cd5ea6"
      unitRef="usd">555000</us-gaap:FurnitureAndFixturesGross>
    <us-gaap:FurnitureAndFixturesGross
      contextRef="i87bf777ccf5f4f93bc9be7a2cbba61c1_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmFlNWE5YmUwZWI5NDQ1ZDE5MmZhZTgyMmQyMmJlMDlmL3NlYzphZTVhOWJlMGViOTQ0NWQxOTJmYWU4MjJkMjJiZTA5Zl80My9mcmFnOmIzZWFmOGZlNmQ2MzQzYmVhMWUwZDUzYjc5MGQ5Njg2L3RhYmxlOjAzYjg1ZTAwZDljNjRlOTZhYzllODA4NjY2MzMwN2YyL3RhYmxlcmFuZ2U6MDNiODVlMDBkOWM2NGU5NmFjOWU4MDg2NjYzMzA3ZjJfMTItMy0xLTEtNjI2_dc32e420-1068-4dad-979d-36294b26c7aa"
      unitRef="usd">124000</us-gaap:FurnitureAndFixturesGross>
    <us-gaap:LeaseholdImprovementsGross
      contextRef="i4c8f247d12134a9886d56e1c8b024425_I20220630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmFlNWE5YmUwZWI5NDQ1ZDE5MmZhZTgyMmQyMmJlMDlmL3NlYzphZTVhOWJlMGViOTQ0NWQxOTJmYWU4MjJkMjJiZTA5Zl80My9mcmFnOmIzZWFmOGZlNmQ2MzQzYmVhMWUwZDUzYjc5MGQ5Njg2L3RhYmxlOjAzYjg1ZTAwZDljNjRlOTZhYzllODA4NjY2MzMwN2YyL3RhYmxlcmFuZ2U6MDNiODVlMDBkOWM2NGU5NmFjOWU4MDg2NjYzMzA3ZjJfMTMtMS0xLTEtNjI2_4959c27e-2026-4000-9d7d-e603a594d37c"
      unitRef="usd">1208000</us-gaap:LeaseholdImprovementsGross>
    <us-gaap:LeaseholdImprovementsGross
      contextRef="i87bf777ccf5f4f93bc9be7a2cbba61c1_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmFlNWE5YmUwZWI5NDQ1ZDE5MmZhZTgyMmQyMmJlMDlmL3NlYzphZTVhOWJlMGViOTQ0NWQxOTJmYWU4MjJkMjJiZTA5Zl80My9mcmFnOmIzZWFmOGZlNmQ2MzQzYmVhMWUwZDUzYjc5MGQ5Njg2L3RhYmxlOjAzYjg1ZTAwZDljNjRlOTZhYzllODA4NjY2MzMwN2YyL3RhYmxlcmFuZ2U6MDNiODVlMDBkOWM2NGU5NmFjOWU4MDg2NjYzMzA3ZjJfMTMtMy0xLTEtNjI2_e1ba4463-d049-4a25-8af7-796b14092429"
      unitRef="usd">1074000</us-gaap:LeaseholdImprovementsGross>
    <us-gaap:ConstructionInProgressGross
      contextRef="i4c8f247d12134a9886d56e1c8b024425_I20220630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmFlNWE5YmUwZWI5NDQ1ZDE5MmZhZTgyMmQyMmJlMDlmL3NlYzphZTVhOWJlMGViOTQ0NWQxOTJmYWU4MjJkMjJiZTA5Zl80My9mcmFnOmIzZWFmOGZlNmQ2MzQzYmVhMWUwZDUzYjc5MGQ5Njg2L3RhYmxlOjAzYjg1ZTAwZDljNjRlOTZhYzllODA4NjY2MzMwN2YyL3RhYmxlcmFuZ2U6MDNiODVlMDBkOWM2NGU5NmFjOWU4MDg2NjYzMzA3ZjJfMTQtMS0xLTEtMjY2MA_2b1b36bd-6bab-4ea0-a3af-7755927d175d"
      unitRef="usd">139000</us-gaap:ConstructionInProgressGross>
    <us-gaap:ConstructionInProgressGross
      contextRef="i87bf777ccf5f4f93bc9be7a2cbba61c1_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmFlNWE5YmUwZWI5NDQ1ZDE5MmZhZTgyMmQyMmJlMDlmL3NlYzphZTVhOWJlMGViOTQ0NWQxOTJmYWU4MjJkMjJiZTA5Zl80My9mcmFnOmIzZWFmOGZlNmQ2MzQzYmVhMWUwZDUzYjc5MGQ5Njg2L3RhYmxlOjAzYjg1ZTAwZDljNjRlOTZhYzllODA4NjY2MzMwN2YyL3RhYmxlcmFuZ2U6MDNiODVlMDBkOWM2NGU5NmFjOWU4MDg2NjYzMzA3ZjJfMTQtMy0xLTEtMjY1Mg_000460d2-9807-42cc-bda1-cb68e4b8d386"
      unitRef="usd">0</us-gaap:ConstructionInProgressGross>
    <us-gaap:PropertyPlantAndEquipmentGross
      contextRef="i4c8f247d12134a9886d56e1c8b024425_I20220630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmFlNWE5YmUwZWI5NDQ1ZDE5MmZhZTgyMmQyMmJlMDlmL3NlYzphZTVhOWJlMGViOTQ0NWQxOTJmYWU4MjJkMjJiZTA5Zl80My9mcmFnOmIzZWFmOGZlNmQ2MzQzYmVhMWUwZDUzYjc5MGQ5Njg2L3RhYmxlOjAzYjg1ZTAwZDljNjRlOTZhYzllODA4NjY2MzMwN2YyL3RhYmxlcmFuZ2U6MDNiODVlMDBkOWM2NGU5NmFjOWU4MDg2NjYzMzA3ZjJfMTQtMS0xLTEtNjI2_6f42bed2-84bf-4b36-a35c-4218259a1a41"
      unitRef="usd">7154000</us-gaap:PropertyPlantAndEquipmentGross>
    <us-gaap:PropertyPlantAndEquipmentGross
      contextRef="i87bf777ccf5f4f93bc9be7a2cbba61c1_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmFlNWE5YmUwZWI5NDQ1ZDE5MmZhZTgyMmQyMmJlMDlmL3NlYzphZTVhOWJlMGViOTQ0NWQxOTJmYWU4MjJkMjJiZTA5Zl80My9mcmFnOmIzZWFmOGZlNmQ2MzQzYmVhMWUwZDUzYjc5MGQ5Njg2L3RhYmxlOjAzYjg1ZTAwZDljNjRlOTZhYzllODA4NjY2MzMwN2YyL3RhYmxlcmFuZ2U6MDNiODVlMDBkOWM2NGU5NmFjOWU4MDg2NjYzMzA3ZjJfMTQtMy0xLTEtNjI2_30487ddc-0d3f-4baa-89fe-4001d4d3e232"
      unitRef="usd">6174000</us-gaap:PropertyPlantAndEquipmentGross>
    <us-gaap:AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment
      contextRef="i4c8f247d12134a9886d56e1c8b024425_I20220630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmFlNWE5YmUwZWI5NDQ1ZDE5MmZhZTgyMmQyMmJlMDlmL3NlYzphZTVhOWJlMGViOTQ0NWQxOTJmYWU4MjJkMjJiZTA5Zl80My9mcmFnOmIzZWFmOGZlNmQ2MzQzYmVhMWUwZDUzYjc5MGQ5Njg2L3RhYmxlOjAzYjg1ZTAwZDljNjRlOTZhYzllODA4NjY2MzMwN2YyL3RhYmxlcmFuZ2U6MDNiODVlMDBkOWM2NGU5NmFjOWU4MDg2NjYzMzA3ZjJfMTUtMS0xLTEtNjI2_0aa50ed5-4b2e-4d7c-918a-8056bfb41df3"
      unitRef="usd">2238000</us-gaap:AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment>
    <us-gaap:AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment
      contextRef="i87bf777ccf5f4f93bc9be7a2cbba61c1_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmFlNWE5YmUwZWI5NDQ1ZDE5MmZhZTgyMmQyMmJlMDlmL3NlYzphZTVhOWJlMGViOTQ0NWQxOTJmYWU4MjJkMjJiZTA5Zl80My9mcmFnOmIzZWFmOGZlNmQ2MzQzYmVhMWUwZDUzYjc5MGQ5Njg2L3RhYmxlOjAzYjg1ZTAwZDljNjRlOTZhYzllODA4NjY2MzMwN2YyL3RhYmxlcmFuZ2U6MDNiODVlMDBkOWM2NGU5NmFjOWU4MDg2NjYzMzA3ZjJfMTUtMy0xLTEtNjI2_868fb7ec-dd9d-4de8-b77a-4ceea687f1b2"
      unitRef="usd">1625000</us-gaap:AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment>
    <us-gaap:PropertyPlantAndEquipmentNet
      contextRef="i4c8f247d12134a9886d56e1c8b024425_I20220630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmFlNWE5YmUwZWI5NDQ1ZDE5MmZhZTgyMmQyMmJlMDlmL3NlYzphZTVhOWJlMGViOTQ0NWQxOTJmYWU4MjJkMjJiZTA5Zl80My9mcmFnOmIzZWFmOGZlNmQ2MzQzYmVhMWUwZDUzYjc5MGQ5Njg2L3RhYmxlOjAzYjg1ZTAwZDljNjRlOTZhYzllODA4NjY2MzMwN2YyL3RhYmxlcmFuZ2U6MDNiODVlMDBkOWM2NGU5NmFjOWU4MDg2NjYzMzA3ZjJfMTYtMS0xLTEtNjI2_db79321a-dab6-4921-9e42-a95b715e2500"
      unitRef="usd">4916000</us-gaap:PropertyPlantAndEquipmentNet>
    <us-gaap:PropertyPlantAndEquipmentNet
      contextRef="i87bf777ccf5f4f93bc9be7a2cbba61c1_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmFlNWE5YmUwZWI5NDQ1ZDE5MmZhZTgyMmQyMmJlMDlmL3NlYzphZTVhOWJlMGViOTQ0NWQxOTJmYWU4MjJkMjJiZTA5Zl80My9mcmFnOmIzZWFmOGZlNmQ2MzQzYmVhMWUwZDUzYjc5MGQ5Njg2L3RhYmxlOjAzYjg1ZTAwZDljNjRlOTZhYzllODA4NjY2MzMwN2YyL3RhYmxlcmFuZ2U6MDNiODVlMDBkOWM2NGU5NmFjOWU4MDg2NjYzMzA3ZjJfMTYtMy0xLTEtNjI2_c209d0fc-f3cf-49bc-b74c-7f758c173e4e"
      unitRef="usd">4549000</us-gaap:PropertyPlantAndEquipmentNet>
    <us-gaap:ScheduleOfAccountsPayableAndAccruedLiabilitiesTableTextBlock
      contextRef="ia855382ada1f4f28aa8ef6da692ff177_D20220101-20220630"
      id="id3VybDovL2RvY3MudjEvZG9jOmFlNWE5YmUwZWI5NDQ1ZDE5MmZhZTgyMmQyMmJlMDlmL3NlYzphZTVhOWJlMGViOTQ0NWQxOTJmYWU4MjJkMjJiZTA5Zl80My9mcmFnOmIzZWFmOGZlNmQ2MzQzYmVhMWUwZDUzYjc5MGQ5Njg2L3RleHRyZWdpb246YjNlYWY4ZmU2ZDYzNDNiZWExZTBkNTNiNzkwZDk2ODZfMTMxMQ_ce148590-79f5-4547-8a73-fb23202a88a9">&lt;div style="margin-top:9pt;padding-left:27pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Condensed consolidated balance sheet details are as follows (in thousands):&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:12pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:71.930%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:12.081%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.406%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:12.083%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;June 30,&lt;br/&gt;2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;December 31,&lt;br/&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Accrued compensation:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Accrued paid time off&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,689&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,245&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Accrued wages, bonus and other&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;6,129&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3,875&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total accrued compensation&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;7,818&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;5,120&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Accrued liabilities:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:3pt double #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:3pt double #000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Accrued consulting services&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,201&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;775&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Other accrued expenses&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,071&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;452&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total accrued liabilities&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3,272&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,227&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;</us-gaap:ScheduleOfAccountsPayableAndAccruedLiabilitiesTableTextBlock>
    <us-gaap:AccruedVacationCurrent
      contextRef="i4c8f247d12134a9886d56e1c8b024425_I20220630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmFlNWE5YmUwZWI5NDQ1ZDE5MmZhZTgyMmQyMmJlMDlmL3NlYzphZTVhOWJlMGViOTQ0NWQxOTJmYWU4MjJkMjJiZTA5Zl80My9mcmFnOmIzZWFmOGZlNmQ2MzQzYmVhMWUwZDUzYjc5MGQ5Njg2L3RhYmxlOmVlMzA5YTdhNmY1YzQwOTI4OGJhODVhMmVlOGY2ZmIxL3RhYmxlcmFuZ2U6ZWUzMDlhN2E2ZjVjNDA5Mjg4YmE4NWEyZWU4ZjZmYjFfMi0xLTEtMS02MjY_6793fb02-ad81-4cb8-83b4-c66112c9903a"
      unitRef="usd">1689000</us-gaap:AccruedVacationCurrent>
    <us-gaap:AccruedVacationCurrent
      contextRef="i87bf777ccf5f4f93bc9be7a2cbba61c1_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmFlNWE5YmUwZWI5NDQ1ZDE5MmZhZTgyMmQyMmJlMDlmL3NlYzphZTVhOWJlMGViOTQ0NWQxOTJmYWU4MjJkMjJiZTA5Zl80My9mcmFnOmIzZWFmOGZlNmQ2MzQzYmVhMWUwZDUzYjc5MGQ5Njg2L3RhYmxlOmVlMzA5YTdhNmY1YzQwOTI4OGJhODVhMmVlOGY2ZmIxL3RhYmxlcmFuZ2U6ZWUzMDlhN2E2ZjVjNDA5Mjg4YmE4NWEyZWU4ZjZmYjFfMi0zLTEtMS02MjY_3c1a4c33-d13f-49cc-b1e0-79eb604817d0"
      unitRef="usd">1245000</us-gaap:AccruedVacationCurrent>
    <dmtk:AccruedBonusAndDeferredCompensationCurrent
      contextRef="i4c8f247d12134a9886d56e1c8b024425_I20220630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmFlNWE5YmUwZWI5NDQ1ZDE5MmZhZTgyMmQyMmJlMDlmL3NlYzphZTVhOWJlMGViOTQ0NWQxOTJmYWU4MjJkMjJiZTA5Zl80My9mcmFnOmIzZWFmOGZlNmQ2MzQzYmVhMWUwZDUzYjc5MGQ5Njg2L3RhYmxlOmVlMzA5YTdhNmY1YzQwOTI4OGJhODVhMmVlOGY2ZmIxL3RhYmxlcmFuZ2U6ZWUzMDlhN2E2ZjVjNDA5Mjg4YmE4NWEyZWU4ZjZmYjFfMy0xLTEtMS02MjY_c29533d4-936f-4a3d-a249-4c9224110b67"
      unitRef="usd">6129000</dmtk:AccruedBonusAndDeferredCompensationCurrent>
    <dmtk:AccruedBonusAndDeferredCompensationCurrent
      contextRef="i87bf777ccf5f4f93bc9be7a2cbba61c1_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmFlNWE5YmUwZWI5NDQ1ZDE5MmZhZTgyMmQyMmJlMDlmL3NlYzphZTVhOWJlMGViOTQ0NWQxOTJmYWU4MjJkMjJiZTA5Zl80My9mcmFnOmIzZWFmOGZlNmQ2MzQzYmVhMWUwZDUzYjc5MGQ5Njg2L3RhYmxlOmVlMzA5YTdhNmY1YzQwOTI4OGJhODVhMmVlOGY2ZmIxL3RhYmxlcmFuZ2U6ZWUzMDlhN2E2ZjVjNDA5Mjg4YmE4NWEyZWU4ZjZmYjFfMy0zLTEtMS02MjY_09149e9e-5934-4c90-be9d-dc5bfc347532"
      unitRef="usd">3875000</dmtk:AccruedBonusAndDeferredCompensationCurrent>
    <us-gaap:EmployeeRelatedLiabilitiesCurrent
      contextRef="i4c8f247d12134a9886d56e1c8b024425_I20220630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmFlNWE5YmUwZWI5NDQ1ZDE5MmZhZTgyMmQyMmJlMDlmL3NlYzphZTVhOWJlMGViOTQ0NWQxOTJmYWU4MjJkMjJiZTA5Zl80My9mcmFnOmIzZWFmOGZlNmQ2MzQzYmVhMWUwZDUzYjc5MGQ5Njg2L3RhYmxlOmVlMzA5YTdhNmY1YzQwOTI4OGJhODVhMmVlOGY2ZmIxL3RhYmxlcmFuZ2U6ZWUzMDlhN2E2ZjVjNDA5Mjg4YmE4NWEyZWU4ZjZmYjFfNC0xLTEtMS02MjY_95b23e02-27c4-4a39-8d54-80aca1ba5d3f"
      unitRef="usd">7818000</us-gaap:EmployeeRelatedLiabilitiesCurrent>
    <us-gaap:EmployeeRelatedLiabilitiesCurrent
      contextRef="i87bf777ccf5f4f93bc9be7a2cbba61c1_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmFlNWE5YmUwZWI5NDQ1ZDE5MmZhZTgyMmQyMmJlMDlmL3NlYzphZTVhOWJlMGViOTQ0NWQxOTJmYWU4MjJkMjJiZTA5Zl80My9mcmFnOmIzZWFmOGZlNmQ2MzQzYmVhMWUwZDUzYjc5MGQ5Njg2L3RhYmxlOmVlMzA5YTdhNmY1YzQwOTI4OGJhODVhMmVlOGY2ZmIxL3RhYmxlcmFuZ2U6ZWUzMDlhN2E2ZjVjNDA5Mjg4YmE4NWEyZWU4ZjZmYjFfNC0zLTEtMS02MjY_ade3de29-bbaa-417e-aef2-a8182fca69a4"
      unitRef="usd">5120000</us-gaap:EmployeeRelatedLiabilitiesCurrent>
    <dmtk:AccruedConsultingServicesCurrent
      contextRef="i4c8f247d12134a9886d56e1c8b024425_I20220630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmFlNWE5YmUwZWI5NDQ1ZDE5MmZhZTgyMmQyMmJlMDlmL3NlYzphZTVhOWJlMGViOTQ0NWQxOTJmYWU4MjJkMjJiZTA5Zl80My9mcmFnOmIzZWFmOGZlNmQ2MzQzYmVhMWUwZDUzYjc5MGQ5Njg2L3RhYmxlOmVlMzA5YTdhNmY1YzQwOTI4OGJhODVhMmVlOGY2ZmIxL3RhYmxlcmFuZ2U6ZWUzMDlhN2E2ZjVjNDA5Mjg4YmE4NWEyZWU4ZjZmYjFfNi0xLTEtMS02MjY_8a729e43-6bbd-43c1-b392-e948a1c81aa7"
      unitRef="usd">2201000</dmtk:AccruedConsultingServicesCurrent>
    <dmtk:AccruedConsultingServicesCurrent
      contextRef="i87bf777ccf5f4f93bc9be7a2cbba61c1_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmFlNWE5YmUwZWI5NDQ1ZDE5MmZhZTgyMmQyMmJlMDlmL3NlYzphZTVhOWJlMGViOTQ0NWQxOTJmYWU4MjJkMjJiZTA5Zl80My9mcmFnOmIzZWFmOGZlNmQ2MzQzYmVhMWUwZDUzYjc5MGQ5Njg2L3RhYmxlOmVlMzA5YTdhNmY1YzQwOTI4OGJhODVhMmVlOGY2ZmIxL3RhYmxlcmFuZ2U6ZWUzMDlhN2E2ZjVjNDA5Mjg4YmE4NWEyZWU4ZjZmYjFfNi0zLTEtMS02MjY_61c05cae-356b-4a24-b1ea-71f4ef0d6ad8"
      unitRef="usd">775000</dmtk:AccruedConsultingServicesCurrent>
    <us-gaap:OtherAccruedLiabilitiesCurrent
      contextRef="i4c8f247d12134a9886d56e1c8b024425_I20220630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmFlNWE5YmUwZWI5NDQ1ZDE5MmZhZTgyMmQyMmJlMDlmL3NlYzphZTVhOWJlMGViOTQ0NWQxOTJmYWU4MjJkMjJiZTA5Zl80My9mcmFnOmIzZWFmOGZlNmQ2MzQzYmVhMWUwZDUzYjc5MGQ5Njg2L3RhYmxlOmVlMzA5YTdhNmY1YzQwOTI4OGJhODVhMmVlOGY2ZmIxL3RhYmxlcmFuZ2U6ZWUzMDlhN2E2ZjVjNDA5Mjg4YmE4NWEyZWU4ZjZmYjFfNy0xLTEtMS02MjY_fbac11e3-df60-421f-868b-13b3e09d2087"
      unitRef="usd">1071000</us-gaap:OtherAccruedLiabilitiesCurrent>
    <us-gaap:OtherAccruedLiabilitiesCurrent
      contextRef="i87bf777ccf5f4f93bc9be7a2cbba61c1_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmFlNWE5YmUwZWI5NDQ1ZDE5MmZhZTgyMmQyMmJlMDlmL3NlYzphZTVhOWJlMGViOTQ0NWQxOTJmYWU4MjJkMjJiZTA5Zl80My9mcmFnOmIzZWFmOGZlNmQ2MzQzYmVhMWUwZDUzYjc5MGQ5Njg2L3RhYmxlOmVlMzA5YTdhNmY1YzQwOTI4OGJhODVhMmVlOGY2ZmIxL3RhYmxlcmFuZ2U6ZWUzMDlhN2E2ZjVjNDA5Mjg4YmE4NWEyZWU4ZjZmYjFfNy0zLTEtMS02MjY_f6fba14a-d337-4abd-92ae-b91ddc5cad3c"
      unitRef="usd">452000</us-gaap:OtherAccruedLiabilitiesCurrent>
    <us-gaap:AccruedLiabilitiesCurrent
      contextRef="i4c8f247d12134a9886d56e1c8b024425_I20220630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmFlNWE5YmUwZWI5NDQ1ZDE5MmZhZTgyMmQyMmJlMDlmL3NlYzphZTVhOWJlMGViOTQ0NWQxOTJmYWU4MjJkMjJiZTA5Zl80My9mcmFnOmIzZWFmOGZlNmQ2MzQzYmVhMWUwZDUzYjc5MGQ5Njg2L3RhYmxlOmVlMzA5YTdhNmY1YzQwOTI4OGJhODVhMmVlOGY2ZmIxL3RhYmxlcmFuZ2U6ZWUzMDlhN2E2ZjVjNDA5Mjg4YmE4NWEyZWU4ZjZmYjFfOC0xLTEtMS02MjY_d6d9d88e-dca0-4d50-8616-9f4cdd3f6126"
      unitRef="usd">3272000</us-gaap:AccruedLiabilitiesCurrent>
    <us-gaap:AccruedLiabilitiesCurrent
      contextRef="i87bf777ccf5f4f93bc9be7a2cbba61c1_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmFlNWE5YmUwZWI5NDQ1ZDE5MmZhZTgyMmQyMmJlMDlmL3NlYzphZTVhOWJlMGViOTQ0NWQxOTJmYWU4MjJkMjJiZTA5Zl80My9mcmFnOmIzZWFmOGZlNmQ2MzQzYmVhMWUwZDUzYjc5MGQ5Njg2L3RhYmxlOmVlMzA5YTdhNmY1YzQwOTI4OGJhODVhMmVlOGY2ZmIxL3RhYmxlcmFuZ2U6ZWUzMDlhN2E2ZjVjNDA5Mjg4YmE4NWEyZWU4ZjZmYjFfOC0zLTEtMS02MjY_d6425747-c131-407a-8569-f93df4a51875"
      unitRef="usd">1227000</us-gaap:AccruedLiabilitiesCurrent>
    <us-gaap:StockholdersEquityNoteDisclosureTextBlock
      contextRef="ia855382ada1f4f28aa8ef6da692ff177_D20220101-20220630"
      id="id3VybDovL2RvY3MudjEvZG9jOmFlNWE5YmUwZWI5NDQ1ZDE5MmZhZTgyMmQyMmJlMDlmL3NlYzphZTVhOWJlMGViOTQ0NWQxOTJmYWU4MjJkMjJiZTA5Zl80Ni9mcmFnOjU5ZmVhYTYxNWVlYjRmZTJhOGQ1ZTQ5NTRkNjk5MzFiL3RleHRyZWdpb246NTlmZWFhNjE1ZWViNGZlMmE4ZDVlNDk1NGQ2OTkzMWJfMTU2NDU_f1fba61c-ec06-4d98-8c7f-c1146ea48c04">Stockholders&#x2019; Equity&lt;div style="margin-top:15pt;padding-left:27pt;text-indent:-27pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;(a)&#160;&#160;&#160;&#160;Classes of Stock &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:9pt;padding-left:27pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The Company&#x2019;s amended and restated certificate of incorporation authorizes it to issue 50,000,000 shares of common stock and 5,000,000 shares of preferred stock. Both classes of stock have a par value of $0.0001 per share. &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:15pt;padding-left:27pt;text-indent:-27pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;(b)&#160;&#160;&#160;&#160;At-The Market Offering&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:9pt;padding-left:27pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;On November&#160;10, 2020, the Company entered into a sales agreement (the &#x201c;Sales Agreement&#x201d;) with Cowen and Company, LLC ("Cowen") relating to the sale of shares of the Company&#x2019;s common stock from time to time with an aggregate offering price of up to $50.0 million. During 2020, the Company issued an aggregate of 951,792 shares of common stock pursuant to the Sales Agreement at a weighted average purchase price of $20.97 resulting in aggregate gross proceeds of approximately $20.0 million, reduced by $0.9 million in issuance costs, resulting in net proceeds to the Company of approximately $19.1 million. For the six months ended June&#160;30, 2022, the Company did not issue any shares pursuant to the Sales Agreement. For the year ended December 31, 2021, the Company issued an aggregate of 530,551 shares of common stock pursuant to the Sales Agreement at a weighted average purchase price of $46.33 resulting in aggregate gross proceeds of approximately $24.6 million, reduced by $0.7 million in issuance costs, resulting in net proceeds to the Company of approximately $23.8 million. &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:15pt;padding-left:27pt;text-indent:-27pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;(c)&#160;&#160;&#160;&#160;2021 Underwritten Public Offering &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:9pt;padding-left:27pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;On January&#160;6, 2021, the Company entered into an Underwriting Agreement with Cowen and William Blair &amp;amp; Company, L.L.C. as representatives of several underwriters (the "Underwriters"). The Company agreed to issue and sell up to 4,237,288 shares of its common stock including up to 635,593 shares that could be purchased by the Underwriters pursuant to a 30-day option granted to the Underwriters by the Company. On January&#160;11, 2021, the Company closed the underwritten public offering of 4,872,881 shares of its common stock, which included the exercise in full by the Underwriters of their option to purchase up to 635,593 additional shares, at a price to the public of $29.50 per share. The Company received aggregate gross proceeds of approximately $143.7 million, and net proceeds of approximately $134.6 million, after deducting underwriting discounts and commissions and other offering expenses.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:15pt;padding-left:27pt;text-indent:-27pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;(d)&#160;&#160;&#160;&#160;Warrants &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:15pt;padding-left:27pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;SPAC Warrants &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:9pt;padding-left:27pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The Company previously issued a total of 14,936,250 SPAC Warrants to purchase common stock in public and private placement offerings which were consummated on June&#160;23, 2017. As part of the public offering, the Company issued 14,375,000 warrants ("Public SPAC Warrants") and as part of the private placement offering, the Company issued 561,250 warrants ("Private SPAC Warrants"). The SPAC Warrants have a five-year life from the date the Business Combination was consummated and every four SPAC Warrants entitle the holder to purchase one whole share of common stock at an exercise price of $23.00 per whole share.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:9pt;padding-left:27pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The Private SPAC Warrants are identical to the Public SPAC Warrants, but they (i) are exercisable either for cash or on a cashless basis at the holder&#x2019;s option, (ii) are not redeemable by the Company as long as such warrants are held by the initial purchasers or their affiliates and permitted transferees, and (iii) may be subject to the limitations on exercise as specified in the warrant agreement. As a result of these difference in features between the Public SPAC Warrants and Private SPAC Warrants, the Company concluded that the Private SPAC Warrants should be classified as a liability, if still held by the original Private SPAC Warrant holder, and marked to market each financial reporting period in the Company&#x2019;s statement of operations.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:9pt;padding-left:27pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Between January 1, 2021 and June&#160;30, 2021, a total of 12,120,397 SPAC Warrants were exercised, resulting in the Company&#x2019;s issuance of 3,030,092 shares of common stock and the receipt of $69.7&#160;million in gross proceeds. &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:9pt;padding-left:27pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Outstanding SPAC Warrants totaled 2,815,853 as of June&#160;30, 2022 and December&#160;31, 2021. Private SPAC Warrants that were still owned by the original holder totaled 80,350 as of June&#160;30, 2022 and December&#160;31, 2021.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:15pt;padding-left:27pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Placement Agent Warrants&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:9pt;padding-left:27pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;In connection with several of DermTech Operations&#x2019; financings that took place between 2015 and 2018, DermTech Operations engaged a registered placement agent to assist in marketing and selling of common and preferred units. From 2015 to 2016, DermTech Operations issued 168,522 seven-year warrants to purchase one share of common stock each at an exercise price of $8.68 per share. From 2016 to 2018, DermTech Operations issued 72,658 seven-year warrants to purchase one share of common stock at an exercise price of $9.54 per share. In 2020, the Company issued 15,724 seven-year warrants to purchase one share of common stock at an exercise price of $9.54 per share in connection with the Company&#x2019;s 2018 bridge note financing. Outstanding placement agent warrants totaled 10,039 as of June&#160;30, 2022 and December&#160;31, 2021.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:15pt;padding-left:27pt;text-indent:-27pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;(i)&#160;&#160;&#160;&#160;Stock-Based Compensation &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:9pt;padding-left:27pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The following table sets forth assumptions used to determine the fair value of each option on the date of grant issued under the 2020 Equity Incentive Plan:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:12pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:32.233%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:15.112%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.406%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:15.112%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.406%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:15.112%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.406%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:15.113%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Three Months Ended June 30,&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Six Months Ended June 30,&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Assumed risk-free interest rate&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2.97%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="text-align:center"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1.03% - 1.07%&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="text-align:center"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2.97% &lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="text-align:center"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;0.52% - 1.13%&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Assumed volatility&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;81.65%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;77.69%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;81.65%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="text-align:center"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;74.88% - 77.69%&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Expected option term&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;6.08 years&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;6.08 years&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;6.08 years&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;6.08 years&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Expected dividend yield&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-top:9pt;padding-left:27pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The following table sets forth assumptions used to determine the fair value of the purchase rights issued under the 2020 Employee Stock Purchase Plan (the &#x201c;ESPP&#x201d;):&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:12pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:32.233%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:15.112%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.406%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:15.112%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.406%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:15.112%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.406%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:15.113%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Three Months Ended June 30,&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Six Months Ended June 30,&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Assumed risk-free interest rate&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(1)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;0.10%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="text-align:center"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;0.05% - 0.22%&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="text-align:center"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;0.10% - 0.18%&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Assumed volatility&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(1)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;69.34%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="text-align:center"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;52.58% - 64.55%&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="text-align:center"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;68.44% - 69.34%&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Expected option term&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(1)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;0.50 years&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="text-align:center"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;0.49 - 0.50 years&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="text-align:center"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;0.49 - 0.50 years&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Expected dividend yield&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(1)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="padding-left:27pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;(1) There were no ESPP purchases under its 2020 Employee Stock Purchase Plan during the period.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:9pt;padding-left:27pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Stock-based compensation expense for employee options, RSUs, the purchase rights issued under the ESPP, and consultant options was recorded in the condensed consolidated statements of operations as follows (in thousands):&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:6pt;padding-left:27pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:95.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:41.483%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:12.775%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.437%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:12.775%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.437%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:12.775%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.437%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:12.781%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Three Months Ended June 30,&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Six Months Ended June 30,&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Cost of revenue&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;298&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;259&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;633&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;410&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Sales and marketing&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,067&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;935&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,528&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,482&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Research and development&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,330&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;515&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,825&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;829&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;General and administrative&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,142&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,829&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3,745&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,989&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total stock-based compensation&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4,837&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3,538&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;8,731&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;5,710&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-top:9pt;padding-left:27pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The total compensation cost related to non-vested awards not yet recognized as of June&#160;30, 2022 was $50.3 million, which is expected to be recognized over a weighted average term of 2.90 years. &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:15pt;padding-left:27pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;2010 Stock Plan&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:9pt;padding-left:27pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;In connection with the Business Combination, the Company assumed the DermTech Operations&#x2019; Amended and Restated 2010 Stock Plan (the &#x201c;2010 Plan&#x201d;), which provided for the granting of incentive and non-statutory stock options and restricted stock purchase rights and bonus awards. The contractual term of options granted under the 2010 Plan was ten years. Vesting provisions varied based on the specific terms of the individual option awards. At the Company&#x2019;s annual meeting held on May 26, 2020, the Company&#x2019;s shareholders voted to approve the DermTech, Inc. 2020 Equity Incentive Plan (the &#x201c;2020 Plan&#x201d;), which terminated the 2010 Plan. No additional awards will be granted under the 2010 Plan, however, all outstanding awards under the 2010 Plan remain in effect. No shares remained available for issuance pursuant to future grants under the 2010 Plan as of June&#160;30, 2022 and December&#160;31, 2021, respectively. &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:15pt;padding-left:27pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;2020 Equity Incentive Plan&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:9pt;padding-left:27pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;On May 26, 2020, the Company&#x2019;s stockholders approved the adoption of the 2020 Plan, which provides for the granting of incentive and non-qualified stock options, restricted stock and stock-based awards. Under the 2020 Plan, incentive and non-qualified stock options may be granted at not less than 100% of the fair market value of the Company&#x2019;s common stock on the date of grant. If an incentive stock option is granted to an individual who owns more than 10% of the combined voting power of all classes of the Company&#x2019;s capital stock, the exercise price may not be less than 110% of the fair market value of the Company&#x2019;s common stock on the date of grant and the term of the option may not be longer than five years.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:9pt;padding-left:27pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The 2020 Plan authorizes the Company to issue up to 1,900,000 shares of the Company&#x2019;s common stock pursuant to awards granted under the 2020 Plan, plus the number of shares underlying any stock option and other stock-based awards previously granted under the 2010 Plan that are forfeited, canceled, or terminated (other than by exercise) on or after May 26, 2020; provided that no more than 1,400,000 shares may be added to the 2020 Plan pursuant to such forfeitures, cancellations and terminations. In addition, the number of shares available for issuance under the 2020 Plan will automatically increase on the first day of each fiscal year beginning in fiscal year 2021 and ending on the second day of fiscal year 2025, by an amount equal to the smaller of (i) 3.5% of the number of shares of common stock outstanding on such date and (ii) an amount determined by the administrator of the 2020 Plan. The 2020 Plan will expire on April 12, 2030 or an earlier date approved by a vote of the Company&#x2019;s stockholders or board of directors. The contractual term of options granted under the 2020 Plan is not more than ten years. Vesting provisions vary based on the specific terms of the individual option awards. 431,107 shares remained available for future grant under the 2020 Plan as of June&#160;30, 2022.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:15pt;padding-left:27pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;2020 Employee Stock Purchase Plan&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:9pt;padding-left:27pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;On May 26, 2020, the Company&#x2019;s stockholders approved the adoption of the ESPP, which allows for full-time and certain part-time employees of the Company to purchase shares of common stock at a discount to fair market value. Eligible employees enroll in a six-month offering period during the open enrollment period prior to the start of that offering period. A new offering period begins approximately every March 1 and September 1. At the end of each offering period, the accumulated contributions are used to purchase shares of the Company&#x2019;s common stock. Shares are purchased at a price equal to 85% of the lower of: (i) the fair market value of the Company&#x2019;s common stock on the first business day of an offering period or (ii) the fair market value of the Company&#x2019;s common stock on the last business day of an offering period. &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:9pt;padding-left:27pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The ESPP authorizes the Company to issue up to 400,000 shares of the Company&#x2019;s common stock. In addition, the number of shares available for issuance under the ESPP will automatically increase on the first day of each of the Company&#x2019;s fiscal years beginning in 2021 and ending on the first day of 2030, in an amount equal to the lesser of (i) 300,000 shares, (ii) 1% of the shares of Company common stock outstanding on the last day of the immediately preceding fiscal year, or (iii) such lesser number of shares as is determined by the board of directors of the Company, subject to adjustment upon changes in capitalization of the Company. On February 28, 2021 and August 31, 2021, the Company issued 39,960 and 18,155 shares of its common stock, respectively, pursuant to scheduled purchases under the ESPP. As of December&#160;31, 2021, 549,289 shares of common stock were reserved for future issuance under the ESPP. On January&#160;1, 2022, an additional 297,729 shares became available under the ESPP pursuant to an automatic annual increase. On February&#160;28, 2022, the Company issued 47,339 shares of its common stock pursuant to scheduled purchases under the ESPP. 799,679 shares remained available for future grant under the ESPP as of June&#160;30, 2022.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:15pt;padding-left:27pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Management Warrants&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:9pt;padding-left:27pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Warrants to purchase DermTech Operations common stock were issued to executive officers of DermTech Operations in lieu of issuing certain stock options (the &#x201c;Management Warrants&#x201d;). The Management Warrants were assumed by the Company in connection with the Business Combination. The Management Warrants have a ten-year life and are exercisable for Company common stock at $1.08 per share. For the six months ended June&#160;30, 2022, the Company issued 20,320 shares of common stock pursuant to the exercise of Management Warrants. The Management Warrants vested monthly over a four-year period. Outstanding Management Warrants totaled zero and 22,320 as of June&#160;30, 2022 and December&#160;31, 2021, respectively.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:15pt;padding-left:27pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Common Stock Reserved for Future Issuance &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:9pt;padding-left:27pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Common stock reserved for future issuance consists of the following as of June&#160;30, 2022 and December&#160;31, 2021 (in thousands): &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:12pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:71.930%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:12.081%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.406%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:12.083%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;June 30,&lt;br/&gt;2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;December 31,&lt;br/&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Warrants to purchase common stock&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;10&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;31&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;SPAC Warrants to purchase common stock*&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;704&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;704&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Stock options issued and outstanding&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,758&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,721&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;RSUs issued and outstanding&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,912&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;983&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Authorized for future equity grants&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;431&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;603&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Authorized for future ESPP purchases&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;800&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;549&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total common stock reserved for future issuance&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;6,615&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4,591&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-top:9pt;padding-left:27pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;*Four SPAC Warrants are needed to purchase one share of common stock. The numbers presented above reflect the amount of shares of common stock underlying SPAC Warrants.&lt;/span&gt;&lt;/div&gt;</us-gaap:StockholdersEquityNoteDisclosureTextBlock>
    <us-gaap:CommonStockSharesAuthorized
      contextRef="i4c8f247d12134a9886d56e1c8b024425_I20220630"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmFlNWE5YmUwZWI5NDQ1ZDE5MmZhZTgyMmQyMmJlMDlmL3NlYzphZTVhOWJlMGViOTQ0NWQxOTJmYWU4MjJkMjJiZTA5Zl80Ni9mcmFnOjU5ZmVhYTYxNWVlYjRmZTJhOGQ1ZTQ5NTRkNjk5MzFiL3RleHRyZWdpb246NTlmZWFhNjE1ZWViNGZlMmE4ZDVlNDk1NGQ2OTkzMWJfMTcw_ea0bf930-7bc9-46bb-a89d-ba5407dc1f18"
      unitRef="shares">50000000</us-gaap:CommonStockSharesAuthorized>
    <us-gaap:PreferredStockSharesAuthorized
      contextRef="i4c8f247d12134a9886d56e1c8b024425_I20220630"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmFlNWE5YmUwZWI5NDQ1ZDE5MmZhZTgyMmQyMmJlMDlmL3NlYzphZTVhOWJlMGViOTQ0NWQxOTJmYWU4MjJkMjJiZTA5Zl80Ni9mcmFnOjU5ZmVhYTYxNWVlYjRmZTJhOGQ1ZTQ5NTRkNjk5MzFiL3RleHRyZWdpb246NTlmZWFhNjE1ZWViNGZlMmE4ZDVlNDk1NGQ2OTkzMWJfMjAw_2848efef-2db0-4a5b-aa1a-bd41a9abf3a3"
      unitRef="shares">5000000</us-gaap:PreferredStockSharesAuthorized>
    <us-gaap:PreferredStockParOrStatedValuePerShare
      contextRef="i4c8f247d12134a9886d56e1c8b024425_I20220630"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmFlNWE5YmUwZWI5NDQ1ZDE5MmZhZTgyMmQyMmJlMDlmL3NlYzphZTVhOWJlMGViOTQ0NWQxOTJmYWU4MjJkMjJiZTA5Zl80Ni9mcmFnOjU5ZmVhYTYxNWVlYjRmZTJhOGQ1ZTQ5NTRkNjk5MzFiL3RleHRyZWdpb246NTlmZWFhNjE1ZWViNGZlMmE4ZDVlNDk1NGQ2OTkzMWJfMjcy_04da5637-a3c6-4015-87a5-02956f57f902"
      unitRef="usdPerShare">0.0001</us-gaap:PreferredStockParOrStatedValuePerShare>
    <us-gaap:CommonStockParOrStatedValuePerShare
      contextRef="i4c8f247d12134a9886d56e1c8b024425_I20220630"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmFlNWE5YmUwZWI5NDQ1ZDE5MmZhZTgyMmQyMmJlMDlmL3NlYzphZTVhOWJlMGViOTQ0NWQxOTJmYWU4MjJkMjJiZTA5Zl80Ni9mcmFnOjU5ZmVhYTYxNWVlYjRmZTJhOGQ1ZTQ5NTRkNjk5MzFiL3RleHRyZWdpb246NTlmZWFhNjE1ZWViNGZlMmE4ZDVlNDk1NGQ2OTkzMWJfMjcy_97f7c7c1-688b-4f7c-a6ed-6d91cf3c3446"
      unitRef="usdPerShare">0.0001</us-gaap:CommonStockParOrStatedValuePerShare>
    <us-gaap:StockIssuedDuringPeriodValueNewIssues
      contextRef="ia4a7fd782f30475da7d3133d9c168885_D20201110-20201110"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmFlNWE5YmUwZWI5NDQ1ZDE5MmZhZTgyMmQyMmJlMDlmL3NlYzphZTVhOWJlMGViOTQ0NWQxOTJmYWU4MjJkMjJiZTA5Zl80Ni9mcmFnOjU5ZmVhYTYxNWVlYjRmZTJhOGQ1ZTQ5NTRkNjk5MzFiL3RleHRyZWdpb246NTlmZWFhNjE1ZWViNGZlMmE4ZDVlNDk1NGQ2OTkzMWJfNDY3OA_eb83a798-9cc3-4067-a567-b2f508ebdf92"
      unitRef="usd">50000000</us-gaap:StockIssuedDuringPeriodValueNewIssues>
    <us-gaap:StockIssuedDuringPeriodSharesNewIssues
      contextRef="i415678d9707341f4acccc0fba869131d_D20201110-20201231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmFlNWE5YmUwZWI5NDQ1ZDE5MmZhZTgyMmQyMmJlMDlmL3NlYzphZTVhOWJlMGViOTQ0NWQxOTJmYWU4MjJkMjJiZTA5Zl80Ni9mcmFnOjU5ZmVhYTYxNWVlYjRmZTJhOGQ1ZTQ5NTRkNjk5MzFiL3RleHRyZWdpb246NTlmZWFhNjE1ZWViNGZlMmE4ZDVlNDk1NGQ2OTkzMWJfNDcyOA_c4e6d28b-ffba-48aa-bc68-c610c5fa49d3"
      unitRef="shares">951792</us-gaap:StockIssuedDuringPeriodSharesNewIssues>
    <dmtk:WeightedAveragePurchasePricePerShareInOffering
      contextRef="i415678d9707341f4acccc0fba869131d_D20201110-20201231"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOmFlNWE5YmUwZWI5NDQ1ZDE5MmZhZTgyMmQyMmJlMDlmL3NlYzphZTVhOWJlMGViOTQ0NWQxOTJmYWU4MjJkMjJiZTA5Zl80Ni9mcmFnOjU5ZmVhYTYxNWVlYjRmZTJhOGQ1ZTQ5NTRkNjk5MzFiL3RleHRyZWdpb246NTlmZWFhNjE1ZWViNGZlMmE4ZDVlNDk1NGQ2OTkzMWJfNDgyNg_290a1f59-a8d1-476d-b1f3-c09ff6065d87"
      unitRef="usdPerShare">20.97</dmtk:WeightedAveragePurchasePricePerShareInOffering>
    <dmtk:GrossProceedsFromIssuanceOfCommonStock
      contextRef="i415678d9707341f4acccc0fba869131d_D20201110-20201231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmFlNWE5YmUwZWI5NDQ1ZDE5MmZhZTgyMmQyMmJlMDlmL3NlYzphZTVhOWJlMGViOTQ0NWQxOTJmYWU4MjJkMjJiZTA5Zl80Ni9mcmFnOjU5ZmVhYTYxNWVlYjRmZTJhOGQ1ZTQ5NTRkNjk5MzFiL3RleHRyZWdpb246NTlmZWFhNjE1ZWViNGZlMmE4ZDVlNDk1NGQ2OTkzMWJfNDg4NA_8abc91c0-1777-43a9-aecb-5361d3024cfa"
      unitRef="usd">20000000</dmtk:GrossProceedsFromIssuanceOfCommonStock>
    <dmtk:IncreaseDecreaseInStockIssuanceCosts
      contextRef="i415678d9707341f4acccc0fba869131d_D20201110-20201231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmFlNWE5YmUwZWI5NDQ1ZDE5MmZhZTgyMmQyMmJlMDlmL3NlYzphZTVhOWJlMGViOTQ0NWQxOTJmYWU4MjJkMjJiZTA5Zl80Ni9mcmFnOjU5ZmVhYTYxNWVlYjRmZTJhOGQ1ZTQ5NTRkNjk5MzFiL3RleHRyZWdpb246NTlmZWFhNjE1ZWViNGZlMmE4ZDVlNDk1NGQ2OTkzMWJfNDg5OQ_1a18e2ca-04ee-40b2-ba64-9c8f1ef00ab2"
      unitRef="usd">-900000</dmtk:IncreaseDecreaseInStockIssuanceCosts>
    <us-gaap:ProceedsFromIssuanceOfCommonStock
      contextRef="i415678d9707341f4acccc0fba869131d_D20201110-20201231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmFlNWE5YmUwZWI5NDQ1ZDE5MmZhZTgyMmQyMmJlMDlmL3NlYzphZTVhOWJlMGViOTQ0NWQxOTJmYWU4MjJkMjJiZTA5Zl80Ni9mcmFnOjU5ZmVhYTYxNWVlYjRmZTJhOGQ1ZTQ5NTRkNjk5MzFiL3RleHRyZWdpb246NTlmZWFhNjE1ZWViNGZlMmE4ZDVlNDk1NGQ2OTkzMWJfNDk3OQ_17ed7c3a-0602-4e36-bab4-ca6fd58a817d"
      unitRef="usd">19100000</us-gaap:ProceedsFromIssuanceOfCommonStock>
    <us-gaap:StockIssuedDuringPeriodSharesNewIssues
      contextRef="i305721ec0ffb416391e577b9071cbf15_D20220101-20220630"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmFlNWE5YmUwZWI5NDQ1ZDE5MmZhZTgyMmQyMmJlMDlmL3NlYzphZTVhOWJlMGViOTQ0NWQxOTJmYWU4MjJkMjJiZTA5Zl80Ni9mcmFnOjU5ZmVhYTYxNWVlYjRmZTJhOGQ1ZTQ5NTRkNjk5MzFiL3RleHRyZWdpb246NTlmZWFhNjE1ZWViNGZlMmE4ZDVlNDk1NGQ2OTkzMWJfNTAzMA_5409aed0-11af-484d-a91b-770b2673a880"
      unitRef="shares">0</us-gaap:StockIssuedDuringPeriodSharesNewIssues>
    <us-gaap:StockIssuedDuringPeriodSharesNewIssues
      contextRef="if05c806895254e84952b9538ed102dac_D20210101-20211231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmFlNWE5YmUwZWI5NDQ1ZDE5MmZhZTgyMmQyMmJlMDlmL3NlYzphZTVhOWJlMGViOTQ0NWQxOTJmYWU4MjJkMjJiZTA5Zl80Ni9mcmFnOjU5ZmVhYTYxNWVlYjRmZTJhOGQ1ZTQ5NTRkNjk5MzFiL3RleHRyZWdpb246NTlmZWFhNjE1ZWViNGZlMmE4ZDVlNDk1NGQ2OTkzMWJfNTE0Ng_ba93f6a9-1ac1-4ee6-9a6d-e01131b01cff"
      unitRef="shares">530551</us-gaap:StockIssuedDuringPeriodSharesNewIssues>
    <dmtk:WeightedAveragePurchasePricePerShareInOffering
      contextRef="if05c806895254e84952b9538ed102dac_D20210101-20211231"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOmFlNWE5YmUwZWI5NDQ1ZDE5MmZhZTgyMmQyMmJlMDlmL3NlYzphZTVhOWJlMGViOTQ0NWQxOTJmYWU4MjJkMjJiZTA5Zl80Ni9mcmFnOjU5ZmVhYTYxNWVlYjRmZTJhOGQ1ZTQ5NTRkNjk5MzFiL3RleHRyZWdpb246NTlmZWFhNjE1ZWViNGZlMmE4ZDVlNDk1NGQ2OTkzMWJfNTI0NA_aae49c07-7dac-4abd-869c-f76b078c4b92"
      unitRef="usdPerShare">46.33</dmtk:WeightedAveragePurchasePricePerShareInOffering>
    <dmtk:GrossProceedsFromIssuanceOfCommonStock
      contextRef="if05c806895254e84952b9538ed102dac_D20210101-20211231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmFlNWE5YmUwZWI5NDQ1ZDE5MmZhZTgyMmQyMmJlMDlmL3NlYzphZTVhOWJlMGViOTQ0NWQxOTJmYWU4MjJkMjJiZTA5Zl80Ni9mcmFnOjU5ZmVhYTYxNWVlYjRmZTJhOGQ1ZTQ5NTRkNjk5MzFiL3RleHRyZWdpb246NTlmZWFhNjE1ZWViNGZlMmE4ZDVlNDk1NGQ2OTkzMWJfNTMwMg_35773268-0256-4483-976e-de1cc22c0c90"
      unitRef="usd">24600000</dmtk:GrossProceedsFromIssuanceOfCommonStock>
    <dmtk:IncreaseDecreaseInStockIssuanceCosts
      contextRef="if05c806895254e84952b9538ed102dac_D20210101-20211231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmFlNWE5YmUwZWI5NDQ1ZDE5MmZhZTgyMmQyMmJlMDlmL3NlYzphZTVhOWJlMGViOTQ0NWQxOTJmYWU4MjJkMjJiZTA5Zl80Ni9mcmFnOjU5ZmVhYTYxNWVlYjRmZTJhOGQ1ZTQ5NTRkNjk5MzFiL3RleHRyZWdpb246NTlmZWFhNjE1ZWViNGZlMmE4ZDVlNDk1NGQ2OTkzMWJfNTMxNw_df49cb76-76e7-41d8-9fac-32bcfd00636c"
      unitRef="usd">-700000</dmtk:IncreaseDecreaseInStockIssuanceCosts>
    <us-gaap:ProceedsFromIssuanceOfCommonStock
      contextRef="if05c806895254e84952b9538ed102dac_D20210101-20211231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmFlNWE5YmUwZWI5NDQ1ZDE5MmZhZTgyMmQyMmJlMDlmL3NlYzphZTVhOWJlMGViOTQ0NWQxOTJmYWU4MjJkMjJiZTA5Zl80Ni9mcmFnOjU5ZmVhYTYxNWVlYjRmZTJhOGQ1ZTQ5NTRkNjk5MzFiL3RleHRyZWdpb246NTlmZWFhNjE1ZWViNGZlMmE4ZDVlNDk1NGQ2OTkzMWJfNTM5Nw_f05be259-bd67-4c6d-a3d1-a49de94d7f5c"
      unitRef="usd">23800000</us-gaap:ProceedsFromIssuanceOfCommonStock>
    <us-gaap:StockIssuedDuringPeriodSharesNewIssues
      contextRef="i7d0e216f45ca4f518d2c2732a59322ab_D20210106-20210106"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmFlNWE5YmUwZWI5NDQ1ZDE5MmZhZTgyMmQyMmJlMDlmL3NlYzphZTVhOWJlMGViOTQ0NWQxOTJmYWU4MjJkMjJiZTA5Zl80Ni9mcmFnOjU5ZmVhYTYxNWVlYjRmZTJhOGQ1ZTQ5NTRkNjk5MzFiL3RleHRyZWdpb246NTlmZWFhNjE1ZWViNGZlMmE4ZDVlNDk1NGQ2OTkzMWJfNTY3MQ_038c7aa1-5514-4ac2-8f79-0369a3ee8b1b"
      unitRef="shares">4237288</us-gaap:StockIssuedDuringPeriodSharesNewIssues>
    <dmtk:StockPurchasedByUnderwritersPursuantToOptionGranted
      contextRef="i7d0e216f45ca4f518d2c2732a59322ab_D20210106-20210106"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmFlNWE5YmUwZWI5NDQ1ZDE5MmZhZTgyMmQyMmJlMDlmL3NlYzphZTVhOWJlMGViOTQ0NWQxOTJmYWU4MjJkMjJiZTA5Zl80Ni9mcmFnOjU5ZmVhYTYxNWVlYjRmZTJhOGQ1ZTQ5NTRkNjk5MzFiL3RleHRyZWdpb246NTlmZWFhNjE1ZWViNGZlMmE4ZDVlNDk1NGQ2OTkzMWJfNTcxNw_bb66526b-9001-4b89-81d8-46c4f35a2396"
      unitRef="shares">635593</dmtk:StockPurchasedByUnderwritersPursuantToOptionGranted>
    <dmtk:UnderwritersGrantPeriodOption
      contextRef="i7d0e216f45ca4f518d2c2732a59322ab_D20210106-20210106"
      id="id3VybDovL2RvY3MudjEvZG9jOmFlNWE5YmUwZWI5NDQ1ZDE5MmZhZTgyMmQyMmJlMDlmL3NlYzphZTVhOWJlMGViOTQ0NWQxOTJmYWU4MjJkMjJiZTA5Zl80Ni9mcmFnOjU5ZmVhYTYxNWVlYjRmZTJhOGQ1ZTQ5NTRkNjk5MzFiL3RleHRyZWdpb246NTlmZWFhNjE1ZWViNGZlMmE4ZDVlNDk1NGQ2OTkzMWJfNTc4NQ_b873f152-13ae-4227-bff9-8846bc009bea">P30D</dmtk:UnderwritersGrantPeriodOption>
    <us-gaap:SaleOfStockNumberOfSharesIssuedInTransaction
      contextRef="ic368d6fe62464ba5bac452fa161672d6_D20210111-20210111"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmFlNWE5YmUwZWI5NDQ1ZDE5MmZhZTgyMmQyMmJlMDlmL3NlYzphZTVhOWJlMGViOTQ0NWQxOTJmYWU4MjJkMjJiZTA5Zl80Ni9mcmFnOjU5ZmVhYTYxNWVlYjRmZTJhOGQ1ZTQ5NTRkNjk5MzFiL3RleHRyZWdpb246NTlmZWFhNjE1ZWViNGZlMmE4ZDVlNDk1NGQ2OTkzMWJfNTkwNQ_629a00c5-9831-4bdf-9c74-e32ac7301ea4"
      unitRef="shares">4872881</us-gaap:SaleOfStockNumberOfSharesIssuedInTransaction>
    <dmtk:StockPurchasedByUnderwritersPursuantToOptionGranted
      contextRef="ic368d6fe62464ba5bac452fa161672d6_D20210111-20210111"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmFlNWE5YmUwZWI5NDQ1ZDE5MmZhZTgyMmQyMmJlMDlmL3NlYzphZTVhOWJlMGViOTQ0NWQxOTJmYWU4MjJkMjJiZTA5Zl80Ni9mcmFnOjU5ZmVhYTYxNWVlYjRmZTJhOGQ1ZTQ5NTRkNjk5MzFiL3RleHRyZWdpb246NTlmZWFhNjE1ZWViNGZlMmE4ZDVlNDk1NGQ2OTkzMWJfNjAyNg_3ca58b52-13c9-4262-bdc3-c2062b79527f"
      unitRef="shares">635593</dmtk:StockPurchasedByUnderwritersPursuantToOptionGranted>
    <us-gaap:SaleOfStockPricePerShare
      contextRef="icbaabbad817c4953a4cfd55f31fb248d_I20210111"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmFlNWE5YmUwZWI5NDQ1ZDE5MmZhZTgyMmQyMmJlMDlmL3NlYzphZTVhOWJlMGViOTQ0NWQxOTJmYWU4MjJkMjJiZTA5Zl80Ni9mcmFnOjU5ZmVhYTYxNWVlYjRmZTJhOGQ1ZTQ5NTRkNjk5MzFiL3RleHRyZWdpb246NTlmZWFhNjE1ZWViNGZlMmE4ZDVlNDk1NGQ2OTkzMWJfNjA3Ng_5cf996a6-9c17-4bb2-b1c2-cdfc58924ad4"
      unitRef="usdPerShare">29.50</us-gaap:SaleOfStockPricePerShare>
    <dmtk:GrossProceedsFromOfferingBeforeDeductingUnderwritingDiscountsAndCommissionsAndOtherOfferingExpenses
      contextRef="ic368d6fe62464ba5bac452fa161672d6_D20210111-20210111"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmFlNWE5YmUwZWI5NDQ1ZDE5MmZhZTgyMmQyMmJlMDlmL3NlYzphZTVhOWJlMGViOTQ0NWQxOTJmYWU4MjJkMjJiZTA5Zl80Ni9mcmFnOjU5ZmVhYTYxNWVlYjRmZTJhOGQ1ZTQ5NTRkNjk5MzFiL3RleHRyZWdpb246NTlmZWFhNjE1ZWViNGZlMmE4ZDVlNDk1NGQ2OTkzMWJfNjE1Mw_57628e24-1a9b-45a1-bc09-35ba9e93846c"
      unitRef="usd">143700000</dmtk:GrossProceedsFromOfferingBeforeDeductingUnderwritingDiscountsAndCommissionsAndOtherOfferingExpenses>
    <us-gaap:ProceedsFromIssuanceOfCommonStock
      contextRef="ic368d6fe62464ba5bac452fa161672d6_D20210111-20210111"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmFlNWE5YmUwZWI5NDQ1ZDE5MmZhZTgyMmQyMmJlMDlmL3NlYzphZTVhOWJlMGViOTQ0NWQxOTJmYWU4MjJkMjJiZTA5Zl80Ni9mcmFnOjU5ZmVhYTYxNWVlYjRmZTJhOGQ1ZTQ5NTRkNjk5MzFiL3RleHRyZWdpb246NTlmZWFhNjE1ZWViNGZlMmE4ZDVlNDk1NGQ2OTkzMWJfNjE5MQ_01019b3e-c1f8-4fde-87f2-06b6ee7bd7d3"
      unitRef="usd">134600000</us-gaap:ProceedsFromIssuanceOfCommonStock>
    <dmtk:ClassOfWarrantOrRightWarrantsOrRightsIssuedToPurchaseCommonStock
      contextRef="i6732e83066a44277a8539ee4f29b7c2f_D20170623-20170623"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmFlNWE5YmUwZWI5NDQ1ZDE5MmZhZTgyMmQyMmJlMDlmL3NlYzphZTVhOWJlMGViOTQ0NWQxOTJmYWU4MjJkMjJiZTA5Zl80Ni9mcmFnOjU5ZmVhYTYxNWVlYjRmZTJhOGQ1ZTQ5NTRkNjk5MzFiL3RleHRyZWdpb246NTlmZWFhNjE1ZWViNGZlMmE4ZDVlNDk1NGQ2OTkzMWJfNjM0OQ_e244d404-cb17-4cf5-a8cf-05b8966608ee"
      unitRef="shares">14936250</dmtk:ClassOfWarrantOrRightWarrantsOrRightsIssuedToPurchaseCommonStock>
    <dmtk:ClassOfWarrantOrRightWarrantsOrRightsIssuedToPurchaseCommonStock
      contextRef="i310af3399c354a2194fb2cb2350604d4_D20170623-20170623"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmFlNWE5YmUwZWI5NDQ1ZDE5MmZhZTgyMmQyMmJlMDlmL3NlYzphZTVhOWJlMGViOTQ0NWQxOTJmYWU4MjJkMjJiZTA5Zl80Ni9mcmFnOjU5ZmVhYTYxNWVlYjRmZTJhOGQ1ZTQ5NTRkNjk5MzFiL3RleHRyZWdpb246NTlmZWFhNjE1ZWViNGZlMmE4ZDVlNDk1NGQ2OTkzMWJfNjUxNA_61123fb1-3269-44b6-ba89-32bdd96502f3"
      unitRef="shares">14375000</dmtk:ClassOfWarrantOrRightWarrantsOrRightsIssuedToPurchaseCommonStock>
    <dmtk:ClassOfWarrantOrRightWarrantsOrRightsIssuedToPurchaseCommonStock
      contextRef="i452e14998aaf4b87b88a33470c2536e4_D20170623-20170623"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmFlNWE5YmUwZWI5NDQ1ZDE5MmZhZTgyMmQyMmJlMDlmL3NlYzphZTVhOWJlMGViOTQ0NWQxOTJmYWU4MjJkMjJiZTA5Zl80Ni9mcmFnOjU5ZmVhYTYxNWVlYjRmZTJhOGQ1ZTQ5NTRkNjk5MzFiL3RleHRyZWdpb246NTlmZWFhNjE1ZWViNGZlMmE4ZDVlNDk1NGQ2OTkzMWJfNjYwNQ_a6008b44-3ea0-4344-bf52-484d98f1437e"
      unitRef="shares">561250</dmtk:ClassOfWarrantOrRightWarrantsOrRightsIssuedToPurchaseCommonStock>
    <us-gaap:WarrantsAndRightsOutstandingTerm
      contextRef="i4c8f247d12134a9886d56e1c8b024425_I20220630"
      id="id3VybDovL2RvY3MudjEvZG9jOmFlNWE5YmUwZWI5NDQ1ZDE5MmZhZTgyMmQyMmJlMDlmL3NlYzphZTVhOWJlMGViOTQ0NWQxOTJmYWU4MjJkMjJiZTA5Zl80Ni9mcmFnOjU5ZmVhYTYxNWVlYjRmZTJhOGQ1ZTQ5NTRkNjk5MzFiL3RleHRyZWdpb246NTlmZWFhNjE1ZWViNGZlMmE4ZDVlNDk1NGQ2OTkzMWJfMzI5ODUzNDkwNzU4NQ_e08eedac-7919-4177-aa93-999af8648fcb">P5Y</us-gaap:WarrantsAndRightsOutstandingTerm>
    <us-gaap:ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1
      contextRef="i634967fade134dc69b40f7ae53806ba8_I20220630"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOmFlNWE5YmUwZWI5NDQ1ZDE5MmZhZTgyMmQyMmJlMDlmL3NlYzphZTVhOWJlMGViOTQ0NWQxOTJmYWU4MjJkMjJiZTA5Zl80Ni9mcmFnOjU5ZmVhYTYxNWVlYjRmZTJhOGQ1ZTQ5NTRkNjk5MzFiL3RleHRyZWdpb246NTlmZWFhNjE1ZWViNGZlMmE4ZDVlNDk1NGQ2OTkzMWJfNjg0Mg_bdc04842-68ec-4593-b9d2-7a0cb31c8207"
      unitRef="usdPerShare">23.00</us-gaap:ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1>
    <us-gaap:ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights
      contextRef="i21b78556448b464cb21d8774cfc796ea_I20210630"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmFlNWE5YmUwZWI5NDQ1ZDE5MmZhZTgyMmQyMmJlMDlmL3NlYzphZTVhOWJlMGViOTQ0NWQxOTJmYWU4MjJkMjJiZTA5Zl80Ni9mcmFnOjU5ZmVhYTYxNWVlYjRmZTJhOGQ1ZTQ5NTRkNjk5MzFiL3RleHRyZWdpb246NTlmZWFhNjE1ZWViNGZlMmE4ZDVlNDk1NGQ2OTkzMWJfMTA5OTUxMTY0OTUyMQ_0ecae292-fc28-4555-b6f1-fdf2a4f78188"
      unitRef="shares">12120397</us-gaap:ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights>
    <dmtk:CommonSharesIssuedUponExerciseOfWarrants
      contextRef="iec153eacdc1c48dbb3a7a5f42f8d0173_D20210101-20210630"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmFlNWE5YmUwZWI5NDQ1ZDE5MmZhZTgyMmQyMmJlMDlmL3NlYzphZTVhOWJlMGViOTQ0NWQxOTJmYWU4MjJkMjJiZTA5Zl80Ni9mcmFnOjU5ZmVhYTYxNWVlYjRmZTJhOGQ1ZTQ5NTRkNjk5MzFiL3RleHRyZWdpb246NTlmZWFhNjE1ZWViNGZlMmE4ZDVlNDk1NGQ2OTkzMWJfMTA5OTUxMTY0OTUzMw_67744dce-bde1-44fc-918a-67a4346201ad"
      unitRef="shares">3030092</dmtk:CommonSharesIssuedUponExerciseOfWarrants>
    <us-gaap:ProceedsFromWarrantExercises
      contextRef="iec153eacdc1c48dbb3a7a5f42f8d0173_D20210101-20210630"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmFlNWE5YmUwZWI5NDQ1ZDE5MmZhZTgyMmQyMmJlMDlmL3NlYzphZTVhOWJlMGViOTQ0NWQxOTJmYWU4MjJkMjJiZTA5Zl80Ni9mcmFnOjU5ZmVhYTYxNWVlYjRmZTJhOGQ1ZTQ5NTRkNjk5MzFiL3RleHRyZWdpb246NTlmZWFhNjE1ZWViNGZlMmE4ZDVlNDk1NGQ2OTkzMWJfMTA5OTUxMTY0OTU0OQ_b8e6a795-e36e-44b2-8726-7b351adad2a1"
      unitRef="usd">69700000</us-gaap:ProceedsFromWarrantExercises>
    <us-gaap:ClassOfWarrantOrRightOutstanding
      contextRef="i803095f015594543bf9205dfd151c02e_I20220630"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmFlNWE5YmUwZWI5NDQ1ZDE5MmZhZTgyMmQyMmJlMDlmL3NlYzphZTVhOWJlMGViOTQ0NWQxOTJmYWU4MjJkMjJiZTA5Zl80Ni9mcmFnOjU5ZmVhYTYxNWVlYjRmZTJhOGQ1ZTQ5NTRkNjk5MzFiL3RleHRyZWdpb246NTlmZWFhNjE1ZWViNGZlMmE4ZDVlNDk1NGQ2OTkzMWJfNzgyOQ_4b0cfcd1-d17b-4372-8c22-e1f30c5e8ff5"
      unitRef="shares">2815853</us-gaap:ClassOfWarrantOrRightOutstanding>
    <us-gaap:ClassOfWarrantOrRightOutstanding
      contextRef="i9641b453cb244341906e0d3f67453c08_I20211231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmFlNWE5YmUwZWI5NDQ1ZDE5MmZhZTgyMmQyMmJlMDlmL3NlYzphZTVhOWJlMGViOTQ0NWQxOTJmYWU4MjJkMjJiZTA5Zl80Ni9mcmFnOjU5ZmVhYTYxNWVlYjRmZTJhOGQ1ZTQ5NTRkNjk5MzFiL3RleHRyZWdpb246NTlmZWFhNjE1ZWViNGZlMmE4ZDVlNDk1NGQ2OTkzMWJfNzgyOQ_bf3b148a-58ce-4c14-bdb4-4fe37a330ad1"
      unitRef="shares">2815853</us-gaap:ClassOfWarrantOrRightOutstanding>
    <us-gaap:ClassOfWarrantOrRightOutstanding
      contextRef="i0d9404419f2a4713a7b20a9438a2268d_I20211231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmFlNWE5YmUwZWI5NDQ1ZDE5MmZhZTgyMmQyMmJlMDlmL3NlYzphZTVhOWJlMGViOTQ0NWQxOTJmYWU4MjJkMjJiZTA5Zl80Ni9mcmFnOjU5ZmVhYTYxNWVlYjRmZTJhOGQ1ZTQ5NTRkNjk5MzFiL3RleHRyZWdpb246NTlmZWFhNjE1ZWViNGZlMmE4ZDVlNDk1NGQ2OTkzMWJfNzk0NQ_01be8917-61c6-4f82-948d-012478807389"
      unitRef="shares">80350</us-gaap:ClassOfWarrantOrRightOutstanding>
    <us-gaap:ClassOfWarrantOrRightOutstanding
      contextRef="i80e526858964456d8f479d0e2dd63ca5_I20220630"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmFlNWE5YmUwZWI5NDQ1ZDE5MmZhZTgyMmQyMmJlMDlmL3NlYzphZTVhOWJlMGViOTQ0NWQxOTJmYWU4MjJkMjJiZTA5Zl80Ni9mcmFnOjU5ZmVhYTYxNWVlYjRmZTJhOGQ1ZTQ5NTRkNjk5MzFiL3RleHRyZWdpb246NTlmZWFhNjE1ZWViNGZlMmE4ZDVlNDk1NGQ2OTkzMWJfNzk0NQ_e55c3c0b-f82c-492d-916f-8f54a31357b8"
      unitRef="shares">80350</us-gaap:ClassOfWarrantOrRightOutstanding>
    <dmtk:ClassOfWarrantOrRightWarrantsOrRightsIssuedToPurchaseCommonStock
      contextRef="i5e6cf29a894e475589e2bb8262ac9033_D20150101-20161231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmFlNWE5YmUwZWI5NDQ1ZDE5MmZhZTgyMmQyMmJlMDlmL3NlYzphZTVhOWJlMGViOTQ0NWQxOTJmYWU4MjJkMjJiZTA5Zl80Ni9mcmFnOjU5ZmVhYTYxNWVlYjRmZTJhOGQ1ZTQ5NTRkNjk5MzFiL3RleHRyZWdpb246NTlmZWFhNjE1ZWViNGZlMmE4ZDVlNDk1NGQ2OTkzMWJfODc2Nw_4617e945-e259-436b-992c-95c7d5ba3a97"
      unitRef="shares">168522</dmtk:ClassOfWarrantOrRightWarrantsOrRightsIssuedToPurchaseCommonStock>
    <us-gaap:WarrantsAndRightsOutstandingTerm
      contextRef="ic92102edfd1342a192f438b00ef88200_I20161231"
      id="id3VybDovL2RvY3MudjEvZG9jOmFlNWE5YmUwZWI5NDQ1ZDE5MmZhZTgyMmQyMmJlMDlmL3NlYzphZTVhOWJlMGViOTQ0NWQxOTJmYWU4MjJkMjJiZTA5Zl80Ni9mcmFnOjU5ZmVhYTYxNWVlYjRmZTJhOGQ1ZTQ5NTRkNjk5MzFiL3RleHRyZWdpb246NTlmZWFhNjE1ZWViNGZlMmE4ZDVlNDk1NGQ2OTkzMWJfMTU2NDc_256055f8-6f8b-4db1-a775-79f4eb2367ef">P7Y</us-gaap:WarrantsAndRightsOutstandingTerm>
    <us-gaap:ClassOfWarrantOrRightNumberOfSecuritiesCalledByEachWarrantOrRight
      contextRef="ic2ffccea2c90436fac0e9812ff060041_I20161231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmFlNWE5YmUwZWI5NDQ1ZDE5MmZhZTgyMmQyMmJlMDlmL3NlYzphZTVhOWJlMGViOTQ0NWQxOTJmYWU4MjJkMjJiZTA5Zl80Ni9mcmFnOjU5ZmVhYTYxNWVlYjRmZTJhOGQ1ZTQ5NTRkNjk5MzFiL3RleHRyZWdpb246NTlmZWFhNjE1ZWViNGZlMmE4ZDVlNDk1NGQ2OTkzMWJfODc5OQ_df1602f6-5202-4b8d-b8be-797e04760cad"
      unitRef="shares">1</us-gaap:ClassOfWarrantOrRightNumberOfSecuritiesCalledByEachWarrantOrRight>
    <us-gaap:ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1
      contextRef="ic2ffccea2c90436fac0e9812ff060041_I20161231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmFlNWE5YmUwZWI5NDQ1ZDE5MmZhZTgyMmQyMmJlMDlmL3NlYzphZTVhOWJlMGViOTQ0NWQxOTJmYWU4MjJkMjJiZTA5Zl80Ni9mcmFnOjU5ZmVhYTYxNWVlYjRmZTJhOGQ1ZTQ5NTRkNjk5MzFiL3RleHRyZWdpb246NTlmZWFhNjE1ZWViNGZlMmE4ZDVlNDk1NGQ2OTkzMWJfODg1Mw_69790e40-8ade-4ebc-9b8d-6fccc7e1c8a8"
      unitRef="usdPerShare">8.68</us-gaap:ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1>
    <dmtk:ClassOfWarrantOrRightWarrantsOrRightsIssuedToPurchaseCommonStock
      contextRef="if35ae65dc07b452292756d42575f3dae_D20160101-20181231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmFlNWE5YmUwZWI5NDQ1ZDE5MmZhZTgyMmQyMmJlMDlmL3NlYzphZTVhOWJlMGViOTQ0NWQxOTJmYWU4MjJkMjJiZTA5Zl80Ni9mcmFnOjU5ZmVhYTYxNWVlYjRmZTJhOGQ1ZTQ5NTRkNjk5MzFiL3RleHRyZWdpb246NTlmZWFhNjE1ZWViNGZlMmE4ZDVlNDk1NGQ2OTkzMWJfODkxMw_9fd4e2e4-9d61-4e75-b1a4-22ef2f41d2a2"
      unitRef="shares">72658</dmtk:ClassOfWarrantOrRightWarrantsOrRightsIssuedToPurchaseCommonStock>
    <us-gaap:WarrantsAndRightsOutstandingTerm
      contextRef="i4159027d930b496eab94ec0daf363261_I20181231"
      id="id3VybDovL2RvY3MudjEvZG9jOmFlNWE5YmUwZWI5NDQ1ZDE5MmZhZTgyMmQyMmJlMDlmL3NlYzphZTVhOWJlMGViOTQ0NWQxOTJmYWU4MjJkMjJiZTA5Zl80Ni9mcmFnOjU5ZmVhYTYxNWVlYjRmZTJhOGQ1ZTQ5NTRkNjk5MzFiL3RleHRyZWdpb246NTlmZWFhNjE1ZWViNGZlMmE4ZDVlNDk1NGQ2OTkzMWJfMTU2NDg_840181cf-4e82-4a0e-a8c2-419126695c9c">P7Y</us-gaap:WarrantsAndRightsOutstandingTerm>
    <us-gaap:ClassOfWarrantOrRightNumberOfSecuritiesCalledByEachWarrantOrRight
      contextRef="id7e5b24c3bb74b83a74aa64a7d327d4c_I20181231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmFlNWE5YmUwZWI5NDQ1ZDE5MmZhZTgyMmQyMmJlMDlmL3NlYzphZTVhOWJlMGViOTQ0NWQxOTJmYWU4MjJkMjJiZTA5Zl80Ni9mcmFnOjU5ZmVhYTYxNWVlYjRmZTJhOGQ1ZTQ5NTRkNjk5MzFiL3RleHRyZWdpb246NTlmZWFhNjE1ZWViNGZlMmE4ZDVlNDk1NGQ2OTkzMWJfODk0NQ_36ee496e-3ca6-4314-81c4-fb6d58375bc8"
      unitRef="shares">1</us-gaap:ClassOfWarrantOrRightNumberOfSecuritiesCalledByEachWarrantOrRight>
    <us-gaap:ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1
      contextRef="id7e5b24c3bb74b83a74aa64a7d327d4c_I20181231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmFlNWE5YmUwZWI5NDQ1ZDE5MmZhZTgyMmQyMmJlMDlmL3NlYzphZTVhOWJlMGViOTQ0NWQxOTJmYWU4MjJkMjJiZTA5Zl80Ni9mcmFnOjU5ZmVhYTYxNWVlYjRmZTJhOGQ1ZTQ5NTRkNjk5MzFiL3RleHRyZWdpb246NTlmZWFhNjE1ZWViNGZlMmE4ZDVlNDk1NGQ2OTkzMWJfODk5NA_fc7fb5f2-e7dc-4c08-8210-7aaf3f8248a1"
      unitRef="usdPerShare">9.54</us-gaap:ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1>
    <dmtk:ClassOfWarrantOrRightWarrantsOrRightsIssuedToPurchaseCommonStock
      contextRef="icf734323352a4de0a023df6ea904aaac_D20200101-20201231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmFlNWE5YmUwZWI5NDQ1ZDE5MmZhZTgyMmQyMmJlMDlmL3NlYzphZTVhOWJlMGViOTQ0NWQxOTJmYWU4MjJkMjJiZTA5Zl80Ni9mcmFnOjU5ZmVhYTYxNWVlYjRmZTJhOGQ1ZTQ5NTRkNjk5MzFiL3RleHRyZWdpb246NTlmZWFhNjE1ZWViNGZlMmE4ZDVlNDk1NGQ2OTkzMWJfOTAzNg_ec2cfd4e-43f6-4696-ad20-0f8a407fce46"
      unitRef="shares">15724</dmtk:ClassOfWarrantOrRightWarrantsOrRightsIssuedToPurchaseCommonStock>
    <us-gaap:WarrantsAndRightsOutstandingTerm
      contextRef="ibcc5eb12a4734bb39f49618ab345bde8_I20201231"
      id="id3VybDovL2RvY3MudjEvZG9jOmFlNWE5YmUwZWI5NDQ1ZDE5MmZhZTgyMmQyMmJlMDlmL3NlYzphZTVhOWJlMGViOTQ0NWQxOTJmYWU4MjJkMjJiZTA5Zl80Ni9mcmFnOjU5ZmVhYTYxNWVlYjRmZTJhOGQ1ZTQ5NTRkNjk5MzFiL3RleHRyZWdpb246NTlmZWFhNjE1ZWViNGZlMmE4ZDVlNDk1NGQ2OTkzMWJfMTU2NDE_a62e2548-5d7a-45e5-966e-07f06da386d2">P7Y</us-gaap:WarrantsAndRightsOutstandingTerm>
    <us-gaap:ClassOfWarrantOrRightNumberOfSecuritiesCalledByEachWarrantOrRight
      contextRef="ifa5f19791fc8441d87a405ff98a53015_I20201231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmFlNWE5YmUwZWI5NDQ1ZDE5MmZhZTgyMmQyMmJlMDlmL3NlYzphZTVhOWJlMGViOTQ0NWQxOTJmYWU4MjJkMjJiZTA5Zl80Ni9mcmFnOjU5ZmVhYTYxNWVlYjRmZTJhOGQ1ZTQ5NTRkNjk5MzFiL3RleHRyZWdpb246NTlmZWFhNjE1ZWViNGZlMmE4ZDVlNDk1NGQ2OTkzMWJfOTA2OA_cc97f7a2-a3fc-4d82-a181-064408055752"
      unitRef="shares">1</us-gaap:ClassOfWarrantOrRightNumberOfSecuritiesCalledByEachWarrantOrRight>
    <us-gaap:ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1
      contextRef="ifa5f19791fc8441d87a405ff98a53015_I20201231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmFlNWE5YmUwZWI5NDQ1ZDE5MmZhZTgyMmQyMmJlMDlmL3NlYzphZTVhOWJlMGViOTQ0NWQxOTJmYWU4MjJkMjJiZTA5Zl80Ni9mcmFnOjU5ZmVhYTYxNWVlYjRmZTJhOGQ1ZTQ5NTRkNjk5MzFiL3RleHRyZWdpb246NTlmZWFhNjE1ZWViNGZlMmE4ZDVlNDk1NGQ2OTkzMWJfOTExNw_eb283961-b214-4e3b-ba4d-64f89f40470e"
      unitRef="usdPerShare">9.54</us-gaap:ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1>
    <us-gaap:ClassOfWarrantOrRightOutstanding
      contextRef="i2d6f98c2698e45af8da68430b3bfc742_I20220630"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmFlNWE5YmUwZWI5NDQ1ZDE5MmZhZTgyMmQyMmJlMDlmL3NlYzphZTVhOWJlMGViOTQ0NWQxOTJmYWU4MjJkMjJiZTA5Zl80Ni9mcmFnOjU5ZmVhYTYxNWVlYjRmZTJhOGQ1ZTQ5NTRkNjk5MzFiL3RleHRyZWdpb246NTlmZWFhNjE1ZWViNGZlMmE4ZDVlNDk1NGQ2OTkzMWJfOTIzNw_2eb6a8e6-2553-4570-a31e-90db7b3e5c24"
      unitRef="shares">10039</us-gaap:ClassOfWarrantOrRightOutstanding>
    <us-gaap:ClassOfWarrantOrRightOutstanding
      contextRef="if706627078bd4aa4984495209ba461b8_I20211231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmFlNWE5YmUwZWI5NDQ1ZDE5MmZhZTgyMmQyMmJlMDlmL3NlYzphZTVhOWJlMGViOTQ0NWQxOTJmYWU4MjJkMjJiZTA5Zl80Ni9mcmFnOjU5ZmVhYTYxNWVlYjRmZTJhOGQ1ZTQ5NTRkNjk5MzFiL3RleHRyZWdpb246NTlmZWFhNjE1ZWViNGZlMmE4ZDVlNDk1NGQ2OTkzMWJfOTIzNw_e94996f7-4833-4c20-a0d9-faad8a795a7d"
      unitRef="shares">10039</us-gaap:ClassOfWarrantOrRightOutstanding>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate
      contextRef="i992097fa23d64aaa9f9ec09579943582_D20220401-20220630"
      decimals="4"
      id="id3VybDovL2RvY3MudjEvZG9jOmFlNWE5YmUwZWI5NDQ1ZDE5MmZhZTgyMmQyMmJlMDlmL3NlYzphZTVhOWJlMGViOTQ0NWQxOTJmYWU4MjJkMjJiZTA5Zl80Ni9mcmFnOjU5ZmVhYTYxNWVlYjRmZTJhOGQ1ZTQ5NTRkNjk5MzFiL3RhYmxlOmY3NTVmOTMwMjQyZDRhOThiY2I4ZTNlOGIyMzhhNDE0L3RhYmxlcmFuZ2U6Zjc1NWY5MzAyNDJkNGE5OGJjYjhlM2U4YjIzOGE0MTRfMi0xLTEtMS0yODg3_92c81ff3-6f76-4bb0-a640-1fc92c400092"
      unitRef="number">0.0297</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMinimum
      contextRef="i0150b39d62c349949c09dc704f452a68_D20210401-20210630"
      decimals="4"
      id="id3VybDovL2RvY3MudjEvZG9jOmFlNWE5YmUwZWI5NDQ1ZDE5MmZhZTgyMmQyMmJlMDlmL3NlYzphZTVhOWJlMGViOTQ0NWQxOTJmYWU4MjJkMjJiZTA5Zl80Ni9mcmFnOjU5ZmVhYTYxNWVlYjRmZTJhOGQ1ZTQ5NTRkNjk5MzFiL3RhYmxlOmY3NTVmOTMwMjQyZDRhOThiY2I4ZTNlOGIyMzhhNDE0L3RhYmxlcmFuZ2U6Zjc1NWY5MzAyNDJkNGE5OGJjYjhlM2U4YjIzOGE0MTRfMi0zLTEtMS0yODg3L3RleHRyZWdpb246MmMwZjA5NThiYmU0NDQyZjk1YTU2ZDIyMWRkMTEyZGRfNTQ5NzU1ODEzOTIy_9822e69f-07c9-4caf-a020-8687cf72e5b4"
      unitRef="number">0.0103</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMinimum>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMaximum
      contextRef="i0150b39d62c349949c09dc704f452a68_D20210401-20210630"
      decimals="4"
      id="id3VybDovL2RvY3MudjEvZG9jOmFlNWE5YmUwZWI5NDQ1ZDE5MmZhZTgyMmQyMmJlMDlmL3NlYzphZTVhOWJlMGViOTQ0NWQxOTJmYWU4MjJkMjJiZTA5Zl80Ni9mcmFnOjU5ZmVhYTYxNWVlYjRmZTJhOGQ1ZTQ5NTRkNjk5MzFiL3RhYmxlOmY3NTVmOTMwMjQyZDRhOThiY2I4ZTNlOGIyMzhhNDE0L3RhYmxlcmFuZ2U6Zjc1NWY5MzAyNDJkNGE5OGJjYjhlM2U4YjIzOGE0MTRfMi0zLTEtMS0yODg3L3RleHRyZWdpb246MmMwZjA5NThiYmU0NDQyZjk1YTU2ZDIyMWRkMTEyZGRfNTQ5NzU1ODEzOTE3_d56181a1-98a9-4dfb-8bd4-e5325deb97ba"
      unitRef="number">0.0107</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMaximum>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate
      contextRef="ie02bb53f63db46709e0bad3ea42b396b_D20220101-20220630"
      decimals="4"
      id="id3VybDovL2RvY3MudjEvZG9jOmFlNWE5YmUwZWI5NDQ1ZDE5MmZhZTgyMmQyMmJlMDlmL3NlYzphZTVhOWJlMGViOTQ0NWQxOTJmYWU4MjJkMjJiZTA5Zl80Ni9mcmFnOjU5ZmVhYTYxNWVlYjRmZTJhOGQ1ZTQ5NTRkNjk5MzFiL3RhYmxlOmY3NTVmOTMwMjQyZDRhOThiY2I4ZTNlOGIyMzhhNDE0L3RhYmxlcmFuZ2U6Zjc1NWY5MzAyNDJkNGE5OGJjYjhlM2U4YjIzOGE0MTRfMi01LTEtMS0yODg3L3RleHRyZWdpb246OTE3MmJmN2IyMTA1NDM5OGEwNDEyNzBjMDM5YzIyNTRfNA_b2417896-659e-4802-8ea7-3f4815422566"
      unitRef="number">0.0297</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMinimum
      contextRef="i8e399d9e39504b2691c985ca006cfc1c_D20210101-20210630"
      decimals="4"
      id="id3VybDovL2RvY3MudjEvZG9jOmFlNWE5YmUwZWI5NDQ1ZDE5MmZhZTgyMmQyMmJlMDlmL3NlYzphZTVhOWJlMGViOTQ0NWQxOTJmYWU4MjJkMjJiZTA5Zl80Ni9mcmFnOjU5ZmVhYTYxNWVlYjRmZTJhOGQ1ZTQ5NTRkNjk5MzFiL3RhYmxlOmY3NTVmOTMwMjQyZDRhOThiY2I4ZTNlOGIyMzhhNDE0L3RhYmxlcmFuZ2U6Zjc1NWY5MzAyNDJkNGE5OGJjYjhlM2U4YjIzOGE0MTRfMi03LTEtMS0yODg3L3RleHRyZWdpb246YTAyYjgzY2NhYmE5NDNhODg3Zjg5ZGVjMTc0ZGM4YmNfNA_64b7c198-b940-45a6-b16f-13e436c997d6"
      unitRef="number">0.0052</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMinimum>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMaximum
      contextRef="i8e399d9e39504b2691c985ca006cfc1c_D20210101-20210630"
      decimals="4"
      id="id3VybDovL2RvY3MudjEvZG9jOmFlNWE5YmUwZWI5NDQ1ZDE5MmZhZTgyMmQyMmJlMDlmL3NlYzphZTVhOWJlMGViOTQ0NWQxOTJmYWU4MjJkMjJiZTA5Zl80Ni9mcmFnOjU5ZmVhYTYxNWVlYjRmZTJhOGQ1ZTQ5NTRkNjk5MzFiL3RhYmxlOmY3NTVmOTMwMjQyZDRhOThiY2I4ZTNlOGIyMzhhNDE0L3RhYmxlcmFuZ2U6Zjc1NWY5MzAyNDJkNGE5OGJjYjhlM2U4YjIzOGE0MTRfMi03LTEtMS0yODg3L3RleHRyZWdpb246YTAyYjgzY2NhYmE5NDNhODg3Zjg5ZGVjMTc0ZGM4YmNfOQ_2908e7f5-58e3-4ccc-b4ac-289de19a034d"
      unitRef="number">0.0113</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMaximum>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate
      contextRef="i992097fa23d64aaa9f9ec09579943582_D20220401-20220630"
      decimals="4"
      id="id3VybDovL2RvY3MudjEvZG9jOmFlNWE5YmUwZWI5NDQ1ZDE5MmZhZTgyMmQyMmJlMDlmL3NlYzphZTVhOWJlMGViOTQ0NWQxOTJmYWU4MjJkMjJiZTA5Zl80Ni9mcmFnOjU5ZmVhYTYxNWVlYjRmZTJhOGQ1ZTQ5NTRkNjk5MzFiL3RhYmxlOmY3NTVmOTMwMjQyZDRhOThiY2I4ZTNlOGIyMzhhNDE0L3RhYmxlcmFuZ2U6Zjc1NWY5MzAyNDJkNGE5OGJjYjhlM2U4YjIzOGE0MTRfMy0xLTEtMS0yODg3_42e9926e-95d9-415d-9942-5de1014cd6ba"
      unitRef="number">0.8165</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate
      contextRef="i0150b39d62c349949c09dc704f452a68_D20210401-20210630"
      decimals="4"
      id="id3VybDovL2RvY3MudjEvZG9jOmFlNWE5YmUwZWI5NDQ1ZDE5MmZhZTgyMmQyMmJlMDlmL3NlYzphZTVhOWJlMGViOTQ0NWQxOTJmYWU4MjJkMjJiZTA5Zl80Ni9mcmFnOjU5ZmVhYTYxNWVlYjRmZTJhOGQ1ZTQ5NTRkNjk5MzFiL3RhYmxlOmY3NTVmOTMwMjQyZDRhOThiY2I4ZTNlOGIyMzhhNDE0L3RhYmxlcmFuZ2U6Zjc1NWY5MzAyNDJkNGE5OGJjYjhlM2U4YjIzOGE0MTRfMy0zLTEtMS0yODg3_eb37d1a6-7a69-4a36-86d5-28b3f3e59234"
      unitRef="number">0.7769</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate
      contextRef="ie02bb53f63db46709e0bad3ea42b396b_D20220101-20220630"
      decimals="4"
      id="id3VybDovL2RvY3MudjEvZG9jOmFlNWE5YmUwZWI5NDQ1ZDE5MmZhZTgyMmQyMmJlMDlmL3NlYzphZTVhOWJlMGViOTQ0NWQxOTJmYWU4MjJkMjJiZTA5Zl80Ni9mcmFnOjU5ZmVhYTYxNWVlYjRmZTJhOGQ1ZTQ5NTRkNjk5MzFiL3RhYmxlOmY3NTVmOTMwMjQyZDRhOThiY2I4ZTNlOGIyMzhhNDE0L3RhYmxlcmFuZ2U6Zjc1NWY5MzAyNDJkNGE5OGJjYjhlM2U4YjIzOGE0MTRfMy01LTEtMS0yODg3_a25752a6-e4fd-4342-b048-7767baa96304"
      unitRef="number">0.8165</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRateMinimum
      contextRef="i8e399d9e39504b2691c985ca006cfc1c_D20210101-20210630"
      decimals="4"
      id="id3VybDovL2RvY3MudjEvZG9jOmFlNWE5YmUwZWI5NDQ1ZDE5MmZhZTgyMmQyMmJlMDlmL3NlYzphZTVhOWJlMGViOTQ0NWQxOTJmYWU4MjJkMjJiZTA5Zl80Ni9mcmFnOjU5ZmVhYTYxNWVlYjRmZTJhOGQ1ZTQ5NTRkNjk5MzFiL3RhYmxlOmY3NTVmOTMwMjQyZDRhOThiY2I4ZTNlOGIyMzhhNDE0L3RhYmxlcmFuZ2U6Zjc1NWY5MzAyNDJkNGE5OGJjYjhlM2U4YjIzOGE0MTRfMy03LTEtMS0yODg3L3RleHRyZWdpb246ZjQ4MzBiNjExNjM1NDY0ZGJkYWZiMDdiYmIxYWI1Y2FfNA_4b0c2d89-22f6-499f-9266-1bea738fb1c0"
      unitRef="number">0.7488</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRateMinimum>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRateMaximum
      contextRef="i8e399d9e39504b2691c985ca006cfc1c_D20210101-20210630"
      decimals="4"
      id="id3VybDovL2RvY3MudjEvZG9jOmFlNWE5YmUwZWI5NDQ1ZDE5MmZhZTgyMmQyMmJlMDlmL3NlYzphZTVhOWJlMGViOTQ0NWQxOTJmYWU4MjJkMjJiZTA5Zl80Ni9mcmFnOjU5ZmVhYTYxNWVlYjRmZTJhOGQ1ZTQ5NTRkNjk5MzFiL3RhYmxlOmY3NTVmOTMwMjQyZDRhOThiY2I4ZTNlOGIyMzhhNDE0L3RhYmxlcmFuZ2U6Zjc1NWY5MzAyNDJkNGE5OGJjYjhlM2U4YjIzOGE0MTRfMy03LTEtMS0yODg3L3RleHRyZWdpb246ZjQ4MzBiNjExNjM1NDY0ZGJkYWZiMDdiYmIxYWI1Y2FfOQ_b617a5e9-a35d-4ca5-83a4-90cb15aaa372"
      unitRef="number">0.7769</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRateMaximum>
    <us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1
      contextRef="i992097fa23d64aaa9f9ec09579943582_D20220401-20220630"
      id="id3VybDovL2RvY3MudjEvZG9jOmFlNWE5YmUwZWI5NDQ1ZDE5MmZhZTgyMmQyMmJlMDlmL3NlYzphZTVhOWJlMGViOTQ0NWQxOTJmYWU4MjJkMjJiZTA5Zl80Ni9mcmFnOjU5ZmVhYTYxNWVlYjRmZTJhOGQ1ZTQ5NTRkNjk5MzFiL3RhYmxlOmY3NTVmOTMwMjQyZDRhOThiY2I4ZTNlOGIyMzhhNDE0L3RhYmxlcmFuZ2U6Zjc1NWY5MzAyNDJkNGE5OGJjYjhlM2U4YjIzOGE0MTRfNC0xLTEtMS0yODg3_de89e699-ce2d-4474-ba99-51d44b03466f">P6Y29D</us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1>
    <us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1
      contextRef="i0150b39d62c349949c09dc704f452a68_D20210401-20210630"
      id="id3VybDovL2RvY3MudjEvZG9jOmFlNWE5YmUwZWI5NDQ1ZDE5MmZhZTgyMmQyMmJlMDlmL3NlYzphZTVhOWJlMGViOTQ0NWQxOTJmYWU4MjJkMjJiZTA5Zl80Ni9mcmFnOjU5ZmVhYTYxNWVlYjRmZTJhOGQ1ZTQ5NTRkNjk5MzFiL3RhYmxlOmY3NTVmOTMwMjQyZDRhOThiY2I4ZTNlOGIyMzhhNDE0L3RhYmxlcmFuZ2U6Zjc1NWY5MzAyNDJkNGE5OGJjYjhlM2U4YjIzOGE0MTRfNC0zLTEtMS0yODg3_c6134333-9742-4f5c-8841-c48b009ab02c">P6Y29D</us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1>
    <us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1
      contextRef="ie02bb53f63db46709e0bad3ea42b396b_D20220101-20220630"
      id="id3VybDovL2RvY3MudjEvZG9jOmFlNWE5YmUwZWI5NDQ1ZDE5MmZhZTgyMmQyMmJlMDlmL3NlYzphZTVhOWJlMGViOTQ0NWQxOTJmYWU4MjJkMjJiZTA5Zl80Ni9mcmFnOjU5ZmVhYTYxNWVlYjRmZTJhOGQ1ZTQ5NTRkNjk5MzFiL3RhYmxlOmY3NTVmOTMwMjQyZDRhOThiY2I4ZTNlOGIyMzhhNDE0L3RhYmxlcmFuZ2U6Zjc1NWY5MzAyNDJkNGE5OGJjYjhlM2U4YjIzOGE0MTRfNC01LTEtMS0yODg3_0903b9ee-40b1-4c8c-8387-6d51ffbb1efe">P6Y29D</us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1>
    <us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1
      contextRef="i8e399d9e39504b2691c985ca006cfc1c_D20210101-20210630"
      id="id3VybDovL2RvY3MudjEvZG9jOmFlNWE5YmUwZWI5NDQ1ZDE5MmZhZTgyMmQyMmJlMDlmL3NlYzphZTVhOWJlMGViOTQ0NWQxOTJmYWU4MjJkMjJiZTA5Zl80Ni9mcmFnOjU5ZmVhYTYxNWVlYjRmZTJhOGQ1ZTQ5NTRkNjk5MzFiL3RhYmxlOmY3NTVmOTMwMjQyZDRhOThiY2I4ZTNlOGIyMzhhNDE0L3RhYmxlcmFuZ2U6Zjc1NWY5MzAyNDJkNGE5OGJjYjhlM2U4YjIzOGE0MTRfNC03LTEtMS0yODg3_ffab2a76-3b0d-4a5e-9048-e1a2de30b004">P6Y29D</us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate
      contextRef="i992097fa23d64aaa9f9ec09579943582_D20220401-20220630"
      decimals="4"
      id="id3VybDovL2RvY3MudjEvZG9jOmFlNWE5YmUwZWI5NDQ1ZDE5MmZhZTgyMmQyMmJlMDlmL3NlYzphZTVhOWJlMGViOTQ0NWQxOTJmYWU4MjJkMjJiZTA5Zl80Ni9mcmFnOjU5ZmVhYTYxNWVlYjRmZTJhOGQ1ZTQ5NTRkNjk5MzFiL3RhYmxlOmY3NTVmOTMwMjQyZDRhOThiY2I4ZTNlOGIyMzhhNDE0L3RhYmxlcmFuZ2U6Zjc1NWY5MzAyNDJkNGE5OGJjYjhlM2U4YjIzOGE0MTRfNS0xLTEtMS0yODg3_8ab80a0b-2894-44e1-aa03-9631d773b835"
      unitRef="number">0</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate
      contextRef="i0150b39d62c349949c09dc704f452a68_D20210401-20210630"
      decimals="4"
      id="id3VybDovL2RvY3MudjEvZG9jOmFlNWE5YmUwZWI5NDQ1ZDE5MmZhZTgyMmQyMmJlMDlmL3NlYzphZTVhOWJlMGViOTQ0NWQxOTJmYWU4MjJkMjJiZTA5Zl80Ni9mcmFnOjU5ZmVhYTYxNWVlYjRmZTJhOGQ1ZTQ5NTRkNjk5MzFiL3RhYmxlOmY3NTVmOTMwMjQyZDRhOThiY2I4ZTNlOGIyMzhhNDE0L3RhYmxlcmFuZ2U6Zjc1NWY5MzAyNDJkNGE5OGJjYjhlM2U4YjIzOGE0MTRfNS0zLTEtMS0yODg3_d0eb6c9a-b77d-4684-8846-f275136260a2"
      unitRef="number">0</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate
      contextRef="ie02bb53f63db46709e0bad3ea42b396b_D20220101-20220630"
      decimals="4"
      id="id3VybDovL2RvY3MudjEvZG9jOmFlNWE5YmUwZWI5NDQ1ZDE5MmZhZTgyMmQyMmJlMDlmL3NlYzphZTVhOWJlMGViOTQ0NWQxOTJmYWU4MjJkMjJiZTA5Zl80Ni9mcmFnOjU5ZmVhYTYxNWVlYjRmZTJhOGQ1ZTQ5NTRkNjk5MzFiL3RhYmxlOmY3NTVmOTMwMjQyZDRhOThiY2I4ZTNlOGIyMzhhNDE0L3RhYmxlcmFuZ2U6Zjc1NWY5MzAyNDJkNGE5OGJjYjhlM2U4YjIzOGE0MTRfNS01LTEtMS0yODg3_d961c9b5-7f84-41a7-ae87-c3790f501e85"
      unitRef="number">0</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate
      contextRef="i8e399d9e39504b2691c985ca006cfc1c_D20210101-20210630"
      decimals="4"
      id="id3VybDovL2RvY3MudjEvZG9jOmFlNWE5YmUwZWI5NDQ1ZDE5MmZhZTgyMmQyMmJlMDlmL3NlYzphZTVhOWJlMGViOTQ0NWQxOTJmYWU4MjJkMjJiZTA5Zl80Ni9mcmFnOjU5ZmVhYTYxNWVlYjRmZTJhOGQ1ZTQ5NTRkNjk5MzFiL3RhYmxlOmY3NTVmOTMwMjQyZDRhOThiY2I4ZTNlOGIyMzhhNDE0L3RhYmxlcmFuZ2U6Zjc1NWY5MzAyNDJkNGE5OGJjYjhlM2U4YjIzOGE0MTRfNS03LTEtMS0yODg3_992d3ad4-c421-4f30-bcdb-86494b8774ae"
      unitRef="number">0</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate
      contextRef="i45707f534a744db3b91064008ec1faf3_D20210401-20210630"
      decimals="4"
      id="id3VybDovL2RvY3MudjEvZG9jOmFlNWE5YmUwZWI5NDQ1ZDE5MmZhZTgyMmQyMmJlMDlmL3NlYzphZTVhOWJlMGViOTQ0NWQxOTJmYWU4MjJkMjJiZTA5Zl80Ni9mcmFnOjU5ZmVhYTYxNWVlYjRmZTJhOGQ1ZTQ5NTRkNjk5MzFiL3RhYmxlOjU0ZWY3ZGFiYThhMDRmMmU4NDBmOTRiYzdjOWRiNGUwL3RhYmxlcmFuZ2U6NTRlZjdkYWJhOGEwNGYyZTg0MGY5NGJjN2M5ZGI0ZTBfMi0zLTEtMS0yODg3_2e443b4a-eb15-476a-ab55-a43a858f5566"
      unitRef="number">0.0010</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMinimum
      contextRef="i017b877f28974f268d6f8d65791f6ccf_D20220101-20220630"
      decimals="4"
      id="id3VybDovL2RvY3MudjEvZG9jOmFlNWE5YmUwZWI5NDQ1ZDE5MmZhZTgyMmQyMmJlMDlmL3NlYzphZTVhOWJlMGViOTQ0NWQxOTJmYWU4MjJkMjJiZTA5Zl80Ni9mcmFnOjU5ZmVhYTYxNWVlYjRmZTJhOGQ1ZTQ5NTRkNjk5MzFiL3RhYmxlOjU0ZWY3ZGFiYThhMDRmMmU4NDBmOTRiYzdjOWRiNGUwL3RhYmxlcmFuZ2U6NTRlZjdkYWJhOGEwNGYyZTg0MGY5NGJjN2M5ZGI0ZTBfMi01LTEtMS0yODg3L3RleHRyZWdpb246Yjc0NGIyZTQ0YTM1NDJmNmI3NDE4MjlkNDk4Yjk4ODBfNA_d79db3a9-f849-44aa-b49c-58b674a6ef1e"
      unitRef="number">0.0005</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMinimum>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMaximum
      contextRef="i017b877f28974f268d6f8d65791f6ccf_D20220101-20220630"
      decimals="4"
      id="id3VybDovL2RvY3MudjEvZG9jOmFlNWE5YmUwZWI5NDQ1ZDE5MmZhZTgyMmQyMmJlMDlmL3NlYzphZTVhOWJlMGViOTQ0NWQxOTJmYWU4MjJkMjJiZTA5Zl80Ni9mcmFnOjU5ZmVhYTYxNWVlYjRmZTJhOGQ1ZTQ5NTRkNjk5MzFiL3RhYmxlOjU0ZWY3ZGFiYThhMDRmMmU4NDBmOTRiYzdjOWRiNGUwL3RhYmxlcmFuZ2U6NTRlZjdkYWJhOGEwNGYyZTg0MGY5NGJjN2M5ZGI0ZTBfMi01LTEtMS0yODg3L3RleHRyZWdpb246Yjc0NGIyZTQ0YTM1NDJmNmI3NDE4MjlkNDk4Yjk4ODBfOQ_40b5c09d-f407-48f1-904c-2cf9ebedfac0"
      unitRef="number">0.0022</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMaximum>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMinimum
      contextRef="i39b710f935eb45c28f101a01178659a1_D20210101-20210630"
      decimals="4"
      id="id3VybDovL2RvY3MudjEvZG9jOmFlNWE5YmUwZWI5NDQ1ZDE5MmZhZTgyMmQyMmJlMDlmL3NlYzphZTVhOWJlMGViOTQ0NWQxOTJmYWU4MjJkMjJiZTA5Zl80Ni9mcmFnOjU5ZmVhYTYxNWVlYjRmZTJhOGQ1ZTQ5NTRkNjk5MzFiL3RhYmxlOjU0ZWY3ZGFiYThhMDRmMmU4NDBmOTRiYzdjOWRiNGUwL3RhYmxlcmFuZ2U6NTRlZjdkYWJhOGEwNGYyZTg0MGY5NGJjN2M5ZGI0ZTBfMi03LTEtMS0yODg3L3RleHRyZWdpb246YjNiY2RiNzQ0ZjhkNDlmNDhlOTBhZGIxMjNkOWRmMDFfMTA5OTUxMTYyNzc4OA_8520479f-0e89-43f4-9391-0e2d6181222e"
      unitRef="number">0.0010</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMinimum>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMaximum
      contextRef="i39b710f935eb45c28f101a01178659a1_D20210101-20210630"
      decimals="4"
      id="id3VybDovL2RvY3MudjEvZG9jOmFlNWE5YmUwZWI5NDQ1ZDE5MmZhZTgyMmQyMmJlMDlmL3NlYzphZTVhOWJlMGViOTQ0NWQxOTJmYWU4MjJkMjJiZTA5Zl80Ni9mcmFnOjU5ZmVhYTYxNWVlYjRmZTJhOGQ1ZTQ5NTRkNjk5MzFiL3RhYmxlOjU0ZWY3ZGFiYThhMDRmMmU4NDBmOTRiYzdjOWRiNGUwL3RhYmxlcmFuZ2U6NTRlZjdkYWJhOGEwNGYyZTg0MGY5NGJjN2M5ZGI0ZTBfMi03LTEtMS0yODg3L3RleHRyZWdpb246YjNiY2RiNzQ0ZjhkNDlmNDhlOTBhZGIxMjNkOWRmMDFfMTA5OTUxMTYyNzc5Mg_8a6ffecb-fcc4-47de-871c-0bd1e3759b3e"
      unitRef="number">0.0018</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMaximum>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate
      contextRef="i45707f534a744db3b91064008ec1faf3_D20210401-20210630"
      decimals="4"
      id="id3VybDovL2RvY3MudjEvZG9jOmFlNWE5YmUwZWI5NDQ1ZDE5MmZhZTgyMmQyMmJlMDlmL3NlYzphZTVhOWJlMGViOTQ0NWQxOTJmYWU4MjJkMjJiZTA5Zl80Ni9mcmFnOjU5ZmVhYTYxNWVlYjRmZTJhOGQ1ZTQ5NTRkNjk5MzFiL3RhYmxlOjU0ZWY3ZGFiYThhMDRmMmU4NDBmOTRiYzdjOWRiNGUwL3RhYmxlcmFuZ2U6NTRlZjdkYWJhOGEwNGYyZTg0MGY5NGJjN2M5ZGI0ZTBfMy0zLTEtMS0yODg3_08fd6399-99c8-4fee-9135-0a09ff060e2b"
      unitRef="number">0.6934</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRateMinimum
      contextRef="i017b877f28974f268d6f8d65791f6ccf_D20220101-20220630"
      decimals="4"
      id="id3VybDovL2RvY3MudjEvZG9jOmFlNWE5YmUwZWI5NDQ1ZDE5MmZhZTgyMmQyMmJlMDlmL3NlYzphZTVhOWJlMGViOTQ0NWQxOTJmYWU4MjJkMjJiZTA5Zl80Ni9mcmFnOjU5ZmVhYTYxNWVlYjRmZTJhOGQ1ZTQ5NTRkNjk5MzFiL3RhYmxlOjU0ZWY3ZGFiYThhMDRmMmU4NDBmOTRiYzdjOWRiNGUwL3RhYmxlcmFuZ2U6NTRlZjdkYWJhOGEwNGYyZTg0MGY5NGJjN2M5ZGI0ZTBfMy01LTEtMS0yODg3L3RleHRyZWdpb246YWY4ZGVmNzNjMDMzNDJiZDk4ZDM3N2NkMmI1OGU3ZjRfNA_491af0cc-cdbc-442b-a842-5b5a20e315a8"
      unitRef="number">0.5258</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRateMinimum>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRateMaximum
      contextRef="i017b877f28974f268d6f8d65791f6ccf_D20220101-20220630"
      decimals="4"
      id="id3VybDovL2RvY3MudjEvZG9jOmFlNWE5YmUwZWI5NDQ1ZDE5MmZhZTgyMmQyMmJlMDlmL3NlYzphZTVhOWJlMGViOTQ0NWQxOTJmYWU4MjJkMjJiZTA5Zl80Ni9mcmFnOjU5ZmVhYTYxNWVlYjRmZTJhOGQ1ZTQ5NTRkNjk5MzFiL3RhYmxlOjU0ZWY3ZGFiYThhMDRmMmU4NDBmOTRiYzdjOWRiNGUwL3RhYmxlcmFuZ2U6NTRlZjdkYWJhOGEwNGYyZTg0MGY5NGJjN2M5ZGI0ZTBfMy01LTEtMS0yODg3L3RleHRyZWdpb246YWY4ZGVmNzNjMDMzNDJiZDk4ZDM3N2NkMmI1OGU3ZjRfOQ_5143ed57-5700-4a85-85ea-e9a9c5e1a942"
      unitRef="number">0.6455</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRateMaximum>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRateMinimum
      contextRef="i39b710f935eb45c28f101a01178659a1_D20210101-20210630"
      decimals="4"
      id="id3VybDovL2RvY3MudjEvZG9jOmFlNWE5YmUwZWI5NDQ1ZDE5MmZhZTgyMmQyMmJlMDlmL3NlYzphZTVhOWJlMGViOTQ0NWQxOTJmYWU4MjJkMjJiZTA5Zl80Ni9mcmFnOjU5ZmVhYTYxNWVlYjRmZTJhOGQ1ZTQ5NTRkNjk5MzFiL3RhYmxlOjU0ZWY3ZGFiYThhMDRmMmU4NDBmOTRiYzdjOWRiNGUwL3RhYmxlcmFuZ2U6NTRlZjdkYWJhOGEwNGYyZTg0MGY5NGJjN2M5ZGI0ZTBfMy03LTEtMS0yODg3L3RleHRyZWdpb246YTljMzcwNjMzZmNhNGNlNDk4YTZiZDk1YTgwMzQwMjNfMTA5OTUxMTYyNzc4OA_8ad0dfe4-1d5d-4c4b-a81c-3585b90fbd22"
      unitRef="number">0.6844</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRateMinimum>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRateMaximum
      contextRef="i39b710f935eb45c28f101a01178659a1_D20210101-20210630"
      decimals="4"
      id="id3VybDovL2RvY3MudjEvZG9jOmFlNWE5YmUwZWI5NDQ1ZDE5MmZhZTgyMmQyMmJlMDlmL3NlYzphZTVhOWJlMGViOTQ0NWQxOTJmYWU4MjJkMjJiZTA5Zl80Ni9mcmFnOjU5ZmVhYTYxNWVlYjRmZTJhOGQ1ZTQ5NTRkNjk5MzFiL3RhYmxlOjU0ZWY3ZGFiYThhMDRmMmU4NDBmOTRiYzdjOWRiNGUwL3RhYmxlcmFuZ2U6NTRlZjdkYWJhOGEwNGYyZTg0MGY5NGJjN2M5ZGI0ZTBfMy03LTEtMS0yODg3L3RleHRyZWdpb246YTljMzcwNjMzZmNhNGNlNDk4YTZiZDk1YTgwMzQwMjNfMTA5OTUxMTYyNzc5Mg_895566a8-2b94-46c1-a90c-4e99e0963f5b"
      unitRef="number">0.6934</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRateMaximum>
    <us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1
      contextRef="i45707f534a744db3b91064008ec1faf3_D20210401-20210630"
      id="id3VybDovL2RvY3MudjEvZG9jOmFlNWE5YmUwZWI5NDQ1ZDE5MmZhZTgyMmQyMmJlMDlmL3NlYzphZTVhOWJlMGViOTQ0NWQxOTJmYWU4MjJkMjJiZTA5Zl80Ni9mcmFnOjU5ZmVhYTYxNWVlYjRmZTJhOGQ1ZTQ5NTRkNjk5MzFiL3RhYmxlOjU0ZWY3ZGFiYThhMDRmMmU4NDBmOTRiYzdjOWRiNGUwL3RhYmxlcmFuZ2U6NTRlZjdkYWJhOGEwNGYyZTg0MGY5NGJjN2M5ZGI0ZTBfNC0zLTEtMS0yODg3_1dede3d8-6b60-424d-bd23-d525f4c3791e">P0Y6M</us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1>
    <us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1
      contextRef="ia5465b10658f4233ba1e4baa3b943676_D20220101-20220630"
      id="id3VybDovL2RvY3MudjEvZG9jOmFlNWE5YmUwZWI5NDQ1ZDE5MmZhZTgyMmQyMmJlMDlmL3NlYzphZTVhOWJlMGViOTQ0NWQxOTJmYWU4MjJkMjJiZTA5Zl80Ni9mcmFnOjU5ZmVhYTYxNWVlYjRmZTJhOGQ1ZTQ5NTRkNjk5MzFiL3RhYmxlOjU0ZWY3ZGFiYThhMDRmMmU4NDBmOTRiYzdjOWRiNGUwL3RhYmxlcmFuZ2U6NTRlZjdkYWJhOGEwNGYyZTg0MGY5NGJjN2M5ZGI0ZTBfNC01LTEtMS0yODg3L3RleHRyZWdpb246ZmIzZjJkMWRjOTQ2NGQyYmEwNGY1Y2VhMWY5ZGFiMzNfNA_bf21b9e2-662e-460a-84a3-181380b2a7b9">P0Y5M26D</us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1>
    <us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1
      contextRef="i88ad33d9abe64251a7d9379cd17f4be1_D20220101-20220630"
      id="id3VybDovL2RvY3MudjEvZG9jOmFlNWE5YmUwZWI5NDQ1ZDE5MmZhZTgyMmQyMmJlMDlmL3NlYzphZTVhOWJlMGViOTQ0NWQxOTJmYWU4MjJkMjJiZTA5Zl80Ni9mcmFnOjU5ZmVhYTYxNWVlYjRmZTJhOGQ1ZTQ5NTRkNjk5MzFiL3RhYmxlOjU0ZWY3ZGFiYThhMDRmMmU4NDBmOTRiYzdjOWRiNGUwL3RhYmxlcmFuZ2U6NTRlZjdkYWJhOGEwNGYyZTg0MGY5NGJjN2M5ZGI0ZTBfNC01LTEtMS0yODg3L3RleHRyZWdpb246ZmIzZjJkMWRjOTQ2NGQyYmEwNGY1Y2VhMWY5ZGFiMzNfOQ_94aa5647-88f5-422d-96f3-b1edc14ce0ef">P0Y6M</us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1>
    <us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1
      contextRef="i1f1b6534cfc84ab0b6dde0c9dbabe32b_D20210101-20210630"
      id="id3VybDovL2RvY3MudjEvZG9jOmFlNWE5YmUwZWI5NDQ1ZDE5MmZhZTgyMmQyMmJlMDlmL3NlYzphZTVhOWJlMGViOTQ0NWQxOTJmYWU4MjJkMjJiZTA5Zl80Ni9mcmFnOjU5ZmVhYTYxNWVlYjRmZTJhOGQ1ZTQ5NTRkNjk5MzFiL3RhYmxlOjU0ZWY3ZGFiYThhMDRmMmU4NDBmOTRiYzdjOWRiNGUwL3RhYmxlcmFuZ2U6NTRlZjdkYWJhOGEwNGYyZTg0MGY5NGJjN2M5ZGI0ZTBfNC03LTEtMS0yODg3L3RleHRyZWdpb246ZWY2NDk2ZGE0NzU2NDYyYjk5ZjBjNjhiOGVjYmVkOTJfMTA5OTUxMTYyNzc4OA_14b695f8-b7c1-4f93-96fd-9e2f4c63d9ce">P0Y5M26D</us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1>
    <us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1
      contextRef="i8b65a3d5fc034de0bf1cc21839d1b39d_D20210101-20210630"
      id="id3VybDovL2RvY3MudjEvZG9jOmFlNWE5YmUwZWI5NDQ1ZDE5MmZhZTgyMmQyMmJlMDlmL3NlYzphZTVhOWJlMGViOTQ0NWQxOTJmYWU4MjJkMjJiZTA5Zl80Ni9mcmFnOjU5ZmVhYTYxNWVlYjRmZTJhOGQ1ZTQ5NTRkNjk5MzFiL3RhYmxlOjU0ZWY3ZGFiYThhMDRmMmU4NDBmOTRiYzdjOWRiNGUwL3RhYmxlcmFuZ2U6NTRlZjdkYWJhOGEwNGYyZTg0MGY5NGJjN2M5ZGI0ZTBfNC03LTEtMS0yODg3L3RleHRyZWdpb246ZWY2NDk2ZGE0NzU2NDYyYjk5ZjBjNjhiOGVjYmVkOTJfMTA5OTUxMTYyNzc5Mg_34f3f724-ef15-49a4-972b-3ed90eda5f75">P0Y6M</us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate
      contextRef="i45707f534a744db3b91064008ec1faf3_D20210401-20210630"
      decimals="4"
      id="id3VybDovL2RvY3MudjEvZG9jOmFlNWE5YmUwZWI5NDQ1ZDE5MmZhZTgyMmQyMmJlMDlmL3NlYzphZTVhOWJlMGViOTQ0NWQxOTJmYWU4MjJkMjJiZTA5Zl80Ni9mcmFnOjU5ZmVhYTYxNWVlYjRmZTJhOGQ1ZTQ5NTRkNjk5MzFiL3RhYmxlOjU0ZWY3ZGFiYThhMDRmMmU4NDBmOTRiYzdjOWRiNGUwL3RhYmxlcmFuZ2U6NTRlZjdkYWJhOGEwNGYyZTg0MGY5NGJjN2M5ZGI0ZTBfNS0zLTEtMS0yODg3_4f42e10e-9f2f-40c0-a46b-aa716866feeb"
      unitRef="number">0</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate
      contextRef="i017b877f28974f268d6f8d65791f6ccf_D20220101-20220630"
      decimals="4"
      id="id3VybDovL2RvY3MudjEvZG9jOmFlNWE5YmUwZWI5NDQ1ZDE5MmZhZTgyMmQyMmJlMDlmL3NlYzphZTVhOWJlMGViOTQ0NWQxOTJmYWU4MjJkMjJiZTA5Zl80Ni9mcmFnOjU5ZmVhYTYxNWVlYjRmZTJhOGQ1ZTQ5NTRkNjk5MzFiL3RhYmxlOjU0ZWY3ZGFiYThhMDRmMmU4NDBmOTRiYzdjOWRiNGUwL3RhYmxlcmFuZ2U6NTRlZjdkYWJhOGEwNGYyZTg0MGY5NGJjN2M5ZGI0ZTBfNS01LTEtMS0yODg3_54361509-faff-4097-9c30-f0e0a3a24dcf"
      unitRef="number">0</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate
      contextRef="i39b710f935eb45c28f101a01178659a1_D20210101-20210630"
      decimals="4"
      id="id3VybDovL2RvY3MudjEvZG9jOmFlNWE5YmUwZWI5NDQ1ZDE5MmZhZTgyMmQyMmJlMDlmL3NlYzphZTVhOWJlMGViOTQ0NWQxOTJmYWU4MjJkMjJiZTA5Zl80Ni9mcmFnOjU5ZmVhYTYxNWVlYjRmZTJhOGQ1ZTQ5NTRkNjk5MzFiL3RhYmxlOjU0ZWY3ZGFiYThhMDRmMmU4NDBmOTRiYzdjOWRiNGUwL3RhYmxlcmFuZ2U6NTRlZjdkYWJhOGEwNGYyZTg0MGY5NGJjN2M5ZGI0ZTBfNS03LTEtMS0yODg3_09316334-e2d7-4c93-97c6-6711662fc62b"
      unitRef="number">0</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate>
    <us-gaap:DisclosureOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTextBlock
      contextRef="ia855382ada1f4f28aa8ef6da692ff177_D20220101-20220630"
      id="id3VybDovL2RvY3MudjEvZG9jOmFlNWE5YmUwZWI5NDQ1ZDE5MmZhZTgyMmQyMmJlMDlmL3NlYzphZTVhOWJlMGViOTQ0NWQxOTJmYWU4MjJkMjJiZTA5Zl80Ni9mcmFnOjU5ZmVhYTYxNWVlYjRmZTJhOGQ1ZTQ5NTRkNjk5MzFiL3RleHRyZWdpb246NTlmZWFhNjE1ZWViNGZlMmE4ZDVlNDk1NGQ2OTkzMWJfMzI5ODUzNDkwODcxMQ_d83e84a5-e9a2-42ed-b744-76fe250b02ab">&lt;div style="margin-top:9pt;padding-left:27pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Stock-based compensation expense for employee options, RSUs, the purchase rights issued under the ESPP, and consultant options was recorded in the condensed consolidated statements of operations as follows (in thousands):&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:6pt;padding-left:27pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:95.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:41.483%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:12.775%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.437%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:12.775%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.437%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:12.775%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.437%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:12.781%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Three Months Ended June 30,&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Six Months Ended June 30,&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Cost of revenue&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;298&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;259&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;633&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;410&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Sales and marketing&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,067&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;935&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,528&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,482&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Research and development&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,330&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;515&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,825&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;829&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;General and administrative&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,142&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,829&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3,745&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,989&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total stock-based compensation&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4,837&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3,538&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;8,731&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;5,710&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;</us-gaap:DisclosureOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTextBlock>
    <us-gaap:AllocatedShareBasedCompensationExpense
      contextRef="i34efb5ee40034834b0612db07b6ac538_D20220401-20220630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmFlNWE5YmUwZWI5NDQ1ZDE5MmZhZTgyMmQyMmJlMDlmL3NlYzphZTVhOWJlMGViOTQ0NWQxOTJmYWU4MjJkMjJiZTA5Zl80Ni9mcmFnOjU5ZmVhYTYxNWVlYjRmZTJhOGQ1ZTQ5NTRkNjk5MzFiL3RhYmxlOjJmNzdkOGFmNjVjMTQ5ZGU5Y2M1MTBhYmUwZGIzZWFkL3RhYmxlcmFuZ2U6MmY3N2Q4YWY2NWMxNDlkZTljYzUxMGFiZTBkYjNlYWRfMi0xLTEtMS05MDc1_3018bbc8-b08e-4f3f-9ce1-7c35e9d43e8f"
      unitRef="usd">298000</us-gaap:AllocatedShareBasedCompensationExpense>
    <us-gaap:AllocatedShareBasedCompensationExpense
      contextRef="i7756f068adac47afb60baa468c5ef026_D20210401-20210630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmFlNWE5YmUwZWI5NDQ1ZDE5MmZhZTgyMmQyMmJlMDlmL3NlYzphZTVhOWJlMGViOTQ0NWQxOTJmYWU4MjJkMjJiZTA5Zl80Ni9mcmFnOjU5ZmVhYTYxNWVlYjRmZTJhOGQ1ZTQ5NTRkNjk5MzFiL3RhYmxlOjJmNzdkOGFmNjVjMTQ5ZGU5Y2M1MTBhYmUwZGIzZWFkL3RhYmxlcmFuZ2U6MmY3N2Q4YWY2NWMxNDlkZTljYzUxMGFiZTBkYjNlYWRfMi0zLTEtMS05MTU1_37d092fb-37fa-430b-bee2-fa18e994fcf1"
      unitRef="usd">259000</us-gaap:AllocatedShareBasedCompensationExpense>
    <us-gaap:AllocatedShareBasedCompensationExpense
      contextRef="i17e61074c4514eaf99a53572cb0fcf74_D20220101-20220630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmFlNWE5YmUwZWI5NDQ1ZDE5MmZhZTgyMmQyMmJlMDlmL3NlYzphZTVhOWJlMGViOTQ0NWQxOTJmYWU4MjJkMjJiZTA5Zl80Ni9mcmFnOjU5ZmVhYTYxNWVlYjRmZTJhOGQ1ZTQ5NTRkNjk5MzFiL3RhYmxlOjJmNzdkOGFmNjVjMTQ5ZGU5Y2M1MTBhYmUwZGIzZWFkL3RhYmxlcmFuZ2U6MmY3N2Q4YWY2NWMxNDlkZTljYzUxMGFiZTBkYjNlYWRfMi01LTEtMS05MDc1_d692a090-9db9-4b17-b7ec-5c89e474301b"
      unitRef="usd">633000</us-gaap:AllocatedShareBasedCompensationExpense>
    <us-gaap:AllocatedShareBasedCompensationExpense
      contextRef="id38910781e2b4e58a9f2b8f671bfed35_D20210101-20210630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmFlNWE5YmUwZWI5NDQ1ZDE5MmZhZTgyMmQyMmJlMDlmL3NlYzphZTVhOWJlMGViOTQ0NWQxOTJmYWU4MjJkMjJiZTA5Zl80Ni9mcmFnOjU5ZmVhYTYxNWVlYjRmZTJhOGQ1ZTQ5NTRkNjk5MzFiL3RhYmxlOjJmNzdkOGFmNjVjMTQ5ZGU5Y2M1MTBhYmUwZGIzZWFkL3RhYmxlcmFuZ2U6MmY3N2Q4YWY2NWMxNDlkZTljYzUxMGFiZTBkYjNlYWRfMi03LTEtMS05MDc1_5de7bfab-98c9-4c15-8fa8-062ef992d6cf"
      unitRef="usd">410000</us-gaap:AllocatedShareBasedCompensationExpense>
    <us-gaap:AllocatedShareBasedCompensationExpense
      contextRef="i8cb435a01219406ba1ef713635ac68ba_D20220401-20220630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmFlNWE5YmUwZWI5NDQ1ZDE5MmZhZTgyMmQyMmJlMDlmL3NlYzphZTVhOWJlMGViOTQ0NWQxOTJmYWU4MjJkMjJiZTA5Zl80Ni9mcmFnOjU5ZmVhYTYxNWVlYjRmZTJhOGQ1ZTQ5NTRkNjk5MzFiL3RhYmxlOjJmNzdkOGFmNjVjMTQ5ZGU5Y2M1MTBhYmUwZGIzZWFkL3RhYmxlcmFuZ2U6MmY3N2Q4YWY2NWMxNDlkZTljYzUxMGFiZTBkYjNlYWRfMy0xLTEtMS05MDc1_4177bab7-ab74-4356-9474-bebff80ec2b1"
      unitRef="usd">1067000</us-gaap:AllocatedShareBasedCompensationExpense>
    <us-gaap:AllocatedShareBasedCompensationExpense
      contextRef="i86954732d12643d381b4531c01ebcfd8_D20210401-20210630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmFlNWE5YmUwZWI5NDQ1ZDE5MmZhZTgyMmQyMmJlMDlmL3NlYzphZTVhOWJlMGViOTQ0NWQxOTJmYWU4MjJkMjJiZTA5Zl80Ni9mcmFnOjU5ZmVhYTYxNWVlYjRmZTJhOGQ1ZTQ5NTRkNjk5MzFiL3RhYmxlOjJmNzdkOGFmNjVjMTQ5ZGU5Y2M1MTBhYmUwZGIzZWFkL3RhYmxlcmFuZ2U6MmY3N2Q4YWY2NWMxNDlkZTljYzUxMGFiZTBkYjNlYWRfMy0zLTEtMS05MTU1_27e16b1a-a871-4fab-b9e2-6e051d1ccc64"
      unitRef="usd">935000</us-gaap:AllocatedShareBasedCompensationExpense>
    <us-gaap:AllocatedShareBasedCompensationExpense
      contextRef="i778b6ff1b3184f42864e9d757af2f4bd_D20220101-20220630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmFlNWE5YmUwZWI5NDQ1ZDE5MmZhZTgyMmQyMmJlMDlmL3NlYzphZTVhOWJlMGViOTQ0NWQxOTJmYWU4MjJkMjJiZTA5Zl80Ni9mcmFnOjU5ZmVhYTYxNWVlYjRmZTJhOGQ1ZTQ5NTRkNjk5MzFiL3RhYmxlOjJmNzdkOGFmNjVjMTQ5ZGU5Y2M1MTBhYmUwZGIzZWFkL3RhYmxlcmFuZ2U6MmY3N2Q4YWY2NWMxNDlkZTljYzUxMGFiZTBkYjNlYWRfMy01LTEtMS05MDc1_3c900124-68db-4b8f-8430-f002cda038eb"
      unitRef="usd">2528000</us-gaap:AllocatedShareBasedCompensationExpense>
    <us-gaap:AllocatedShareBasedCompensationExpense
      contextRef="ie6d29520a2674f6d9a7271efc6289984_D20210101-20210630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmFlNWE5YmUwZWI5NDQ1ZDE5MmZhZTgyMmQyMmJlMDlmL3NlYzphZTVhOWJlMGViOTQ0NWQxOTJmYWU4MjJkMjJiZTA5Zl80Ni9mcmFnOjU5ZmVhYTYxNWVlYjRmZTJhOGQ1ZTQ5NTRkNjk5MzFiL3RhYmxlOjJmNzdkOGFmNjVjMTQ5ZGU5Y2M1MTBhYmUwZGIzZWFkL3RhYmxlcmFuZ2U6MmY3N2Q4YWY2NWMxNDlkZTljYzUxMGFiZTBkYjNlYWRfMy03LTEtMS05MDc1_6c7550e0-9683-46cc-9710-d834278e5bb0"
      unitRef="usd">1482000</us-gaap:AllocatedShareBasedCompensationExpense>
    <us-gaap:AllocatedShareBasedCompensationExpense
      contextRef="i561a7e21ce6a40039dc3d34e1397766f_D20220401-20220630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmFlNWE5YmUwZWI5NDQ1ZDE5MmZhZTgyMmQyMmJlMDlmL3NlYzphZTVhOWJlMGViOTQ0NWQxOTJmYWU4MjJkMjJiZTA5Zl80Ni9mcmFnOjU5ZmVhYTYxNWVlYjRmZTJhOGQ1ZTQ5NTRkNjk5MzFiL3RhYmxlOjJmNzdkOGFmNjVjMTQ5ZGU5Y2M1MTBhYmUwZGIzZWFkL3RhYmxlcmFuZ2U6MmY3N2Q4YWY2NWMxNDlkZTljYzUxMGFiZTBkYjNlYWRfNC0xLTEtMS05MDg5_a63740ea-9204-4b28-b502-53e6b9c524fd"
      unitRef="usd">1330000</us-gaap:AllocatedShareBasedCompensationExpense>
    <us-gaap:AllocatedShareBasedCompensationExpense
      contextRef="i6ddfec946a484290af96cb60df8d77ed_D20210401-20210630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmFlNWE5YmUwZWI5NDQ1ZDE5MmZhZTgyMmQyMmJlMDlmL3NlYzphZTVhOWJlMGViOTQ0NWQxOTJmYWU4MjJkMjJiZTA5Zl80Ni9mcmFnOjU5ZmVhYTYxNWVlYjRmZTJhOGQ1ZTQ5NTRkNjk5MzFiL3RhYmxlOjJmNzdkOGFmNjVjMTQ5ZGU5Y2M1MTBhYmUwZGIzZWFkL3RhYmxlcmFuZ2U6MmY3N2Q4YWY2NWMxNDlkZTljYzUxMGFiZTBkYjNlYWRfNC0zLTEtMS05MTU1_92145442-5788-4ce5-a8dc-ee2850e6d0a3"
      unitRef="usd">515000</us-gaap:AllocatedShareBasedCompensationExpense>
    <us-gaap:AllocatedShareBasedCompensationExpense
      contextRef="i8910e2a23b804411a94de3c030ee3d6d_D20220101-20220630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmFlNWE5YmUwZWI5NDQ1ZDE5MmZhZTgyMmQyMmJlMDlmL3NlYzphZTVhOWJlMGViOTQ0NWQxOTJmYWU4MjJkMjJiZTA5Zl80Ni9mcmFnOjU5ZmVhYTYxNWVlYjRmZTJhOGQ1ZTQ5NTRkNjk5MzFiL3RhYmxlOjJmNzdkOGFmNjVjMTQ5ZGU5Y2M1MTBhYmUwZGIzZWFkL3RhYmxlcmFuZ2U6MmY3N2Q4YWY2NWMxNDlkZTljYzUxMGFiZTBkYjNlYWRfNC01LTEtMS05MTU1_1a1c96ce-1044-4eab-b568-8b86a1bcc4b2"
      unitRef="usd">1825000</us-gaap:AllocatedShareBasedCompensationExpense>
    <us-gaap:AllocatedShareBasedCompensationExpense
      contextRef="i35128ab55fdf4102bca836a519340c7f_D20210101-20210630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmFlNWE5YmUwZWI5NDQ1ZDE5MmZhZTgyMmQyMmJlMDlmL3NlYzphZTVhOWJlMGViOTQ0NWQxOTJmYWU4MjJkMjJiZTA5Zl80Ni9mcmFnOjU5ZmVhYTYxNWVlYjRmZTJhOGQ1ZTQ5NTRkNjk5MzFiL3RhYmxlOjJmNzdkOGFmNjVjMTQ5ZGU5Y2M1MTBhYmUwZGIzZWFkL3RhYmxlcmFuZ2U6MmY3N2Q4YWY2NWMxNDlkZTljYzUxMGFiZTBkYjNlYWRfNC03LTEtMS05MTU1_82020732-599c-4b4b-9303-3c14942f5384"
      unitRef="usd">829000</us-gaap:AllocatedShareBasedCompensationExpense>
    <us-gaap:AllocatedShareBasedCompensationExpense
      contextRef="ie9748d2474c1470fbedee2cfc150c874_D20220401-20220630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmFlNWE5YmUwZWI5NDQ1ZDE5MmZhZTgyMmQyMmJlMDlmL3NlYzphZTVhOWJlMGViOTQ0NWQxOTJmYWU4MjJkMjJiZTA5Zl80Ni9mcmFnOjU5ZmVhYTYxNWVlYjRmZTJhOGQ1ZTQ5NTRkNjk5MzFiL3RhYmxlOjJmNzdkOGFmNjVjMTQ5ZGU5Y2M1MTBhYmUwZGIzZWFkL3RhYmxlcmFuZ2U6MmY3N2Q4YWY2NWMxNDlkZTljYzUxMGFiZTBkYjNlYWRfNC0xLTEtMS05MDc1_042134d8-bf69-498f-88db-8200572e8032"
      unitRef="usd">2142000</us-gaap:AllocatedShareBasedCompensationExpense>
    <us-gaap:AllocatedShareBasedCompensationExpense
      contextRef="if42f9fcfc62a442c8ed23e75ddd4b6dd_D20210401-20210630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmFlNWE5YmUwZWI5NDQ1ZDE5MmZhZTgyMmQyMmJlMDlmL3NlYzphZTVhOWJlMGViOTQ0NWQxOTJmYWU4MjJkMjJiZTA5Zl80Ni9mcmFnOjU5ZmVhYTYxNWVlYjRmZTJhOGQ1ZTQ5NTRkNjk5MzFiL3RhYmxlOjJmNzdkOGFmNjVjMTQ5ZGU5Y2M1MTBhYmUwZGIzZWFkL3RhYmxlcmFuZ2U6MmY3N2Q4YWY2NWMxNDlkZTljYzUxMGFiZTBkYjNlYWRfNS0zLTEtMS05MTU1_e7d0734b-66db-4c0f-97e7-d556af120c68"
      unitRef="usd">1829000</us-gaap:AllocatedShareBasedCompensationExpense>
    <us-gaap:AllocatedShareBasedCompensationExpense
      contextRef="i50a7a6d1a7004169afd4ead8587d96b6_D20220101-20220630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmFlNWE5YmUwZWI5NDQ1ZDE5MmZhZTgyMmQyMmJlMDlmL3NlYzphZTVhOWJlMGViOTQ0NWQxOTJmYWU4MjJkMjJiZTA5Zl80Ni9mcmFnOjU5ZmVhYTYxNWVlYjRmZTJhOGQ1ZTQ5NTRkNjk5MzFiL3RhYmxlOjJmNzdkOGFmNjVjMTQ5ZGU5Y2M1MTBhYmUwZGIzZWFkL3RhYmxlcmFuZ2U6MmY3N2Q4YWY2NWMxNDlkZTljYzUxMGFiZTBkYjNlYWRfNC01LTEtMS05MDc1_07c012ce-45b8-4cb7-9cfb-3499e3538c9b"
      unitRef="usd">3745000</us-gaap:AllocatedShareBasedCompensationExpense>
    <us-gaap:AllocatedShareBasedCompensationExpense
      contextRef="i3ff371283df84968a8de2a698b44e5b1_D20210101-20210630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmFlNWE5YmUwZWI5NDQ1ZDE5MmZhZTgyMmQyMmJlMDlmL3NlYzphZTVhOWJlMGViOTQ0NWQxOTJmYWU4MjJkMjJiZTA5Zl80Ni9mcmFnOjU5ZmVhYTYxNWVlYjRmZTJhOGQ1ZTQ5NTRkNjk5MzFiL3RhYmxlOjJmNzdkOGFmNjVjMTQ5ZGU5Y2M1MTBhYmUwZGIzZWFkL3RhYmxlcmFuZ2U6MmY3N2Q4YWY2NWMxNDlkZTljYzUxMGFiZTBkYjNlYWRfNC03LTEtMS05MDc1_f2e94e61-9046-4d16-83ec-8156ab222d58"
      unitRef="usd">2989000</us-gaap:AllocatedShareBasedCompensationExpense>
    <us-gaap:AllocatedShareBasedCompensationExpense
      contextRef="i2c5f0f28773744e5a2e202f2943ae976_D20220401-20220630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmFlNWE5YmUwZWI5NDQ1ZDE5MmZhZTgyMmQyMmJlMDlmL3NlYzphZTVhOWJlMGViOTQ0NWQxOTJmYWU4MjJkMjJiZTA5Zl80Ni9mcmFnOjU5ZmVhYTYxNWVlYjRmZTJhOGQ1ZTQ5NTRkNjk5MzFiL3RhYmxlOjJmNzdkOGFmNjVjMTQ5ZGU5Y2M1MTBhYmUwZGIzZWFkL3RhYmxlcmFuZ2U6MmY3N2Q4YWY2NWMxNDlkZTljYzUxMGFiZTBkYjNlYWRfNi0xLTEtMS05MDg5_c2087f84-a91f-45dd-9fd4-94a85fe238ef"
      unitRef="usd">4837000</us-gaap:AllocatedShareBasedCompensationExpense>
    <us-gaap:AllocatedShareBasedCompensationExpense
      contextRef="id7bb773872394047ba26aa8a7a0f4d56_D20210401-20210630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmFlNWE5YmUwZWI5NDQ1ZDE5MmZhZTgyMmQyMmJlMDlmL3NlYzphZTVhOWJlMGViOTQ0NWQxOTJmYWU4MjJkMjJiZTA5Zl80Ni9mcmFnOjU5ZmVhYTYxNWVlYjRmZTJhOGQ1ZTQ5NTRkNjk5MzFiL3RhYmxlOjJmNzdkOGFmNjVjMTQ5ZGU5Y2M1MTBhYmUwZGIzZWFkL3RhYmxlcmFuZ2U6MmY3N2Q4YWY2NWMxNDlkZTljYzUxMGFiZTBkYjNlYWRfNi0zLTEtMS05MTY2_4e82cb45-ec55-49df-bd02-fca4a5bb30b9"
      unitRef="usd">3538000</us-gaap:AllocatedShareBasedCompensationExpense>
    <us-gaap:AllocatedShareBasedCompensationExpense
      contextRef="ia855382ada1f4f28aa8ef6da692ff177_D20220101-20220630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmFlNWE5YmUwZWI5NDQ1ZDE5MmZhZTgyMmQyMmJlMDlmL3NlYzphZTVhOWJlMGViOTQ0NWQxOTJmYWU4MjJkMjJiZTA5Zl80Ni9mcmFnOjU5ZmVhYTYxNWVlYjRmZTJhOGQ1ZTQ5NTRkNjk5MzFiL3RhYmxlOjJmNzdkOGFmNjVjMTQ5ZGU5Y2M1MTBhYmUwZGIzZWFkL3RhYmxlcmFuZ2U6MmY3N2Q4YWY2NWMxNDlkZTljYzUxMGFiZTBkYjNlYWRfNi01LTEtMS05MTY2_3e5732a0-a641-41d4-b8f3-17252bda9857"
      unitRef="usd">8731000</us-gaap:AllocatedShareBasedCompensationExpense>
    <us-gaap:AllocatedShareBasedCompensationExpense
      contextRef="idaa4f31ca59a4a17a59c2580b97791ca_D20210101-20210630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmFlNWE5YmUwZWI5NDQ1ZDE5MmZhZTgyMmQyMmJlMDlmL3NlYzphZTVhOWJlMGViOTQ0NWQxOTJmYWU4MjJkMjJiZTA5Zl80Ni9mcmFnOjU5ZmVhYTYxNWVlYjRmZTJhOGQ1ZTQ5NTRkNjk5MzFiL3RhYmxlOjJmNzdkOGFmNjVjMTQ5ZGU5Y2M1MTBhYmUwZGIzZWFkL3RhYmxlcmFuZ2U6MmY3N2Q4YWY2NWMxNDlkZTljYzUxMGFiZTBkYjNlYWRfNi03LTEtMS05MTY2_ac0d958a-c7cc-4d84-b324-0be7be15c2fe"
      unitRef="usd">5710000</us-gaap:AllocatedShareBasedCompensationExpense>
    <us-gaap:EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized
      contextRef="i4c8f247d12134a9886d56e1c8b024425_I20220630"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmFlNWE5YmUwZWI5NDQ1ZDE5MmZhZTgyMmQyMmJlMDlmL3NlYzphZTVhOWJlMGViOTQ0NWQxOTJmYWU4MjJkMjJiZTA5Zl80Ni9mcmFnOjU5ZmVhYTYxNWVlYjRmZTJhOGQ1ZTQ5NTRkNjk5MzFiL3RleHRyZWdpb246NTlmZWFhNjE1ZWViNGZlMmE4ZDVlNDk1NGQ2OTkzMWJfMTA5OTUxMTY1MTE0Ng_17825316-bbcf-44bc-9f12-2d949e16e8fa"
      unitRef="usd">50300000</us-gaap:EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized>
    <us-gaap:EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1
      contextRef="ia855382ada1f4f28aa8ef6da692ff177_D20220101-20220630"
      id="id3VybDovL2RvY3MudjEvZG9jOmFlNWE5YmUwZWI5NDQ1ZDE5MmZhZTgyMmQyMmJlMDlmL3NlYzphZTVhOWJlMGViOTQ0NWQxOTJmYWU4MjJkMjJiZTA5Zl80Ni9mcmFnOjU5ZmVhYTYxNWVlYjRmZTJhOGQ1ZTQ5NTRkNjk5MzFiL3RleHRyZWdpb246NTlmZWFhNjE1ZWViNGZlMmE4ZDVlNDk1NGQ2OTkzMWJfMTA5OTUxMTY1MTIxOA_dc42ff35-4a7c-4402-a0ca-f88f0769efd5">P2Y10M24D</us-gaap:EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1>
    <us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardExpirationPeriod
      contextRef="i3c1e467c7bea456e8c41b0e455ef5730_D20220101-20220630"
      id="id3VybDovL2RvY3MudjEvZG9jOmFlNWE5YmUwZWI5NDQ1ZDE5MmZhZTgyMmQyMmJlMDlmL3NlYzphZTVhOWJlMGViOTQ0NWQxOTJmYWU4MjJkMjJiZTA5Zl80Ni9mcmFnOjU5ZmVhYTYxNWVlYjRmZTJhOGQ1ZTQ5NTRkNjk5MzFiL3RleHRyZWdpb246NTlmZWFhNjE1ZWViNGZlMmE4ZDVlNDk1NGQ2OTkzMWJfMTAyOTk_ba9518b0-b0cb-4865-8a40-692c14679298">P10Y</us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardExpirationPeriod>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant
      contextRef="i58d1b32270b14657a2a11820d5e6fa8d_I20211231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmFlNWE5YmUwZWI5NDQ1ZDE5MmZhZTgyMmQyMmJlMDlmL3NlYzphZTVhOWJlMGViOTQ0NWQxOTJmYWU4MjJkMjJiZTA5Zl80Ni9mcmFnOjU5ZmVhYTYxNWVlYjRmZTJhOGQ1ZTQ5NTRkNjk5MzFiL3RleHRyZWdpb246NTlmZWFhNjE1ZWViNGZlMmE4ZDVlNDk1NGQ2OTkzMWJfMTA3MTM_0af7f956-33f1-4881-afd4-2f10cd64649a"
      unitRef="shares">0</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant
      contextRef="i5bd0ece4c3a9433ebf7e6f8058d14235_I20220630"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmFlNWE5YmUwZWI5NDQ1ZDE5MmZhZTgyMmQyMmJlMDlmL3NlYzphZTVhOWJlMGViOTQ0NWQxOTJmYWU4MjJkMjJiZTA5Zl80Ni9mcmFnOjU5ZmVhYTYxNWVlYjRmZTJhOGQ1ZTQ5NTRkNjk5MzFiL3RleHRyZWdpb246NTlmZWFhNjE1ZWViNGZlMmE4ZDVlNDk1NGQ2OTkzMWJfMTA3MTM_c62cbef5-559b-447e-971b-ddfb3a68e731"
      unitRef="shares">0</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant>
    <us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardPurchasePriceOfCommonStockPercent
      contextRef="ied7a9ca9fd8040d59887525878d7cb79_D20220101-20220630"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmFlNWE5YmUwZWI5NDQ1ZDE5MmZhZTgyMmQyMmJlMDlmL3NlYzphZTVhOWJlMGViOTQ0NWQxOTJmYWU4MjJkMjJiZTA5Zl80Ni9mcmFnOjU5ZmVhYTYxNWVlYjRmZTJhOGQ1ZTQ5NTRkNjk5MzFiL3RleHRyZWdpb246NTlmZWFhNjE1ZWViNGZlMmE4ZDVlNDk1NGQ2OTkzMWJfMTExNTg_5a097d53-8b65-4ed8-85bf-be6fe02ebdb2"
      unitRef="number">1</us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardPurchasePriceOfCommonStockPercent>
    <us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardPurchasePriceOfCommonStockPercent
      contextRef="i2cb3f2789d9344f9a1099880c2a6b6ac_D20220101-20220630"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmFlNWE5YmUwZWI5NDQ1ZDE5MmZhZTgyMmQyMmJlMDlmL3NlYzphZTVhOWJlMGViOTQ0NWQxOTJmYWU4MjJkMjJiZTA5Zl80Ni9mcmFnOjU5ZmVhYTYxNWVlYjRmZTJhOGQ1ZTQ5NTRkNjk5MzFiL3RleHRyZWdpb246NTlmZWFhNjE1ZWViNGZlMmE4ZDVlNDk1NGQ2OTkzMWJfMTE0MzQ_13220b51-9f91-4f01-b385-6d63678e793c"
      unitRef="number">1.10</us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardPurchasePriceOfCommonStockPercent>
    <dmtk:EquityIncentivePlanOptionTerm
      contextRef="i695be12a2aa14dffb874c1e74a980c5b_D20220101-20220630"
      id="id3VybDovL2RvY3MudjEvZG9jOmFlNWE5YmUwZWI5NDQ1ZDE5MmZhZTgyMmQyMmJlMDlmL3NlYzphZTVhOWJlMGViOTQ0NWQxOTJmYWU4MjJkMjJiZTA5Zl80Ni9mcmFnOjU5ZmVhYTYxNWVlYjRmZTJhOGQ1ZTQ5NTRkNjk5MzFiL3RleHRyZWdpb246NTlmZWFhNjE1ZWViNGZlMmE4ZDVlNDk1NGQ2OTkzMWJfMTE1NjM_b862ee01-cb8f-4ad0-a6e0-c1804827f156">P5Y</dmtk:EquityIncentivePlanOptionTerm>
    <us-gaap:CommonStockSharesAuthorized
      contextRef="i57b5170b75b149df8f3952976e4aeb64_I20220630"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmFlNWE5YmUwZWI5NDQ1ZDE5MmZhZTgyMmQyMmJlMDlmL3NlYzphZTVhOWJlMGViOTQ0NWQxOTJmYWU4MjJkMjJiZTA5Zl80Ni9mcmFnOjU5ZmVhYTYxNWVlYjRmZTJhOGQ1ZTQ5NTRkNjk5MzFiL3RleHRyZWdpb246NTlmZWFhNjE1ZWViNGZlMmE4ZDVlNDk1NGQ2OTkzMWJfMTE2MTk_6e1360f6-44bf-45a9-8c66-41dabebbf9c3"
      unitRef="shares">1900000</us-gaap:CommonStockSharesAuthorized>
    <us-gaap:SharesIssued
      contextRef="id1f6d22436f64f38a4bd51d0074f4a35_I20220630"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmFlNWE5YmUwZWI5NDQ1ZDE5MmZhZTgyMmQyMmJlMDlmL3NlYzphZTVhOWJlMGViOTQ0NWQxOTJmYWU4MjJkMjJiZTA5Zl80Ni9mcmFnOjU5ZmVhYTYxNWVlYjRmZTJhOGQ1ZTQ5NTRkNjk5MzFiL3RleHRyZWdpb246NTlmZWFhNjE1ZWViNGZlMmE4ZDVlNDk1NGQ2OTkzMWJfMTE5NTE_0c8f7d1e-e4b5-46a0-988d-d572e96d901a"
      unitRef="shares">1400000</us-gaap:SharesIssued>
    <dmtk:CommonStockOutstandingPercentage
      contextRef="ie02bb53f63db46709e0bad3ea42b396b_D20220101-20220630"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmFlNWE5YmUwZWI5NDQ1ZDE5MmZhZTgyMmQyMmJlMDlmL3NlYzphZTVhOWJlMGViOTQ0NWQxOTJmYWU4MjJkMjJiZTA5Zl80Ni9mcmFnOjU5ZmVhYTYxNWVlYjRmZTJhOGQ1ZTQ5NTRkNjk5MzFiL3RleHRyZWdpb246NTlmZWFhNjE1ZWViNGZlMmE4ZDVlNDk1NGQ2OTkzMWJfMTIzMTQ_1a30a0ab-7cd2-436f-9091-ba4505fee9ed"
      unitRef="number">0.035</dmtk:CommonStockOutstandingPercentage>
    <us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardExpirationPeriod
      contextRef="ie02bb53f63db46709e0bad3ea42b396b_D20220101-20220630"
      id="id3VybDovL2RvY3MudjEvZG9jOmFlNWE5YmUwZWI5NDQ1ZDE5MmZhZTgyMmQyMmJlMDlmL3NlYzphZTVhOWJlMGViOTQ0NWQxOTJmYWU4MjJkMjJiZTA5Zl80Ni9mcmFnOjU5ZmVhYTYxNWVlYjRmZTJhOGQ1ZTQ5NTRkNjk5MzFiL3RleHRyZWdpb246NTlmZWFhNjE1ZWViNGZlMmE4ZDVlNDk1NGQ2OTkzMWJfMTI2NjM_756d5814-1cd0-4a2d-95b2-b93204836dfa">P10Y</us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardExpirationPeriod>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant
      contextRef="i57b5170b75b149df8f3952976e4aeb64_I20220630"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmFlNWE5YmUwZWI5NDQ1ZDE5MmZhZTgyMmQyMmJlMDlmL3NlYzphZTVhOWJlMGViOTQ0NWQxOTJmYWU4MjJkMjJiZTA5Zl80Ni9mcmFnOjU5ZmVhYTYxNWVlYjRmZTJhOGQ1ZTQ5NTRkNjk5MzFiL3RleHRyZWdpb246NTlmZWFhNjE1ZWViNGZlMmE4ZDVlNDk1NGQ2OTkzMWJfMTI3NTI_8084554e-e967-4a31-b4ca-834767d8b4ec"
      unitRef="shares">431107</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant>
    <dmtk:PercentageOfPriceAtSharesPurchased
      contextRef="i017b877f28974f268d6f8d65791f6ccf_D20220101-20220630"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmFlNWE5YmUwZWI5NDQ1ZDE5MmZhZTgyMmQyMmJlMDlmL3NlYzphZTVhOWJlMGViOTQ0NWQxOTJmYWU4MjJkMjJiZTA5Zl80Ni9mcmFnOjU5ZmVhYTYxNWVlYjRmZTJhOGQ1ZTQ5NTRkNjk5MzFiL3RleHRyZWdpb246NTlmZWFhNjE1ZWViNGZlMmE4ZDVlNDk1NGQ2OTkzMWJfMTM1MTM_a886124a-98d2-483d-815d-c672dc806856"
      unitRef="number">0.85</dmtk:PercentageOfPriceAtSharesPurchased>
    <us-gaap:CommonStockCapitalSharesReservedForFutureIssuance
      contextRef="i22cf6cdf250d424385f207471e8ff450_I20220630"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmFlNWE5YmUwZWI5NDQ1ZDE5MmZhZTgyMmQyMmJlMDlmL3NlYzphZTVhOWJlMGViOTQ0NWQxOTJmYWU4MjJkMjJiZTA5Zl80Ni9mcmFnOjU5ZmVhYTYxNWVlYjRmZTJhOGQ1ZTQ5NTRkNjk5MzFiL3RleHRyZWdpb246NTlmZWFhNjE1ZWViNGZlMmE4ZDVlNDk1NGQ2OTkzMWJfMTM3OTM_b455c170-6b22-4b9c-a996-93b5c283a178"
      unitRef="shares">400000</us-gaap:CommonStockCapitalSharesReservedForFutureIssuance>
    <us-gaap:SharesIssued
      contextRef="i6808a2674aa947cbae46fd4581d39941_I20220630"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmFlNWE5YmUwZWI5NDQ1ZDE5MmZhZTgyMmQyMmJlMDlmL3NlYzphZTVhOWJlMGViOTQ0NWQxOTJmYWU4MjJkMjJiZTA5Zl80Ni9mcmFnOjU5ZmVhYTYxNWVlYjRmZTJhOGQ1ZTQ5NTRkNjk5MzFiL3RleHRyZWdpb246NTlmZWFhNjE1ZWViNGZlMmE4ZDVlNDk1NGQ2OTkzMWJfMTQwODI_1b25dcfc-a6db-4b68-a744-9492d641ba55"
      unitRef="shares">300000</us-gaap:SharesIssued>
    <dmtk:CommonStockOutstandingPercentage
      contextRef="i017b877f28974f268d6f8d65791f6ccf_D20220101-20220630"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmFlNWE5YmUwZWI5NDQ1ZDE5MmZhZTgyMmQyMmJlMDlmL3NlYzphZTVhOWJlMGViOTQ0NWQxOTJmYWU4MjJkMjJiZTA5Zl80Ni9mcmFnOjU5ZmVhYTYxNWVlYjRmZTJhOGQ1ZTQ5NTRkNjk5MzFiL3RleHRyZWdpb246NTlmZWFhNjE1ZWViNGZlMmE4ZDVlNDk1NGQ2OTkzMWJfMTQwOTg_61d4f4b7-4d4a-4eec-8198-b2819c5ae84e"
      unitRef="number">0.01</dmtk:CommonStockOutstandingPercentage>
    <us-gaap:StockIssuedDuringPeriodSharesNewIssues
      contextRef="idae0e59d93ee49ada1896eeec302b5ad_D20210228-20210228"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmFlNWE5YmUwZWI5NDQ1ZDE5MmZhZTgyMmQyMmJlMDlmL3NlYzphZTVhOWJlMGViOTQ0NWQxOTJmYWU4MjJkMjJiZTA5Zl80Ni9mcmFnOjU5ZmVhYTYxNWVlYjRmZTJhOGQ1ZTQ5NTRkNjk5MzFiL3RleHRyZWdpb246NTlmZWFhNjE1ZWViNGZlMmE4ZDVlNDk1NGQ2OTkzMWJfMTQ0MjE_3b4f9be6-3cd2-4798-adef-eee50c89a2c2"
      unitRef="shares">39960</us-gaap:StockIssuedDuringPeriodSharesNewIssues>
    <us-gaap:StockIssuedDuringPeriodSharesNewIssues
      contextRef="i4953bff07aa94f8085ce64eca01ff01c_D20210801-20210831"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmFlNWE5YmUwZWI5NDQ1ZDE5MmZhZTgyMmQyMmJlMDlmL3NlYzphZTVhOWJlMGViOTQ0NWQxOTJmYWU4MjJkMjJiZTA5Zl80Ni9mcmFnOjU5ZmVhYTYxNWVlYjRmZTJhOGQ1ZTQ5NTRkNjk5MzFiL3RleHRyZWdpb246NTlmZWFhNjE1ZWViNGZlMmE4ZDVlNDk1NGQ2OTkzMWJfMTQ0Mjg_4bf7aa9d-b85a-412c-b8d2-528ea5ca60e2"
      unitRef="shares">18155</us-gaap:StockIssuedDuringPeriodSharesNewIssues>
    <us-gaap:CommonStockCapitalSharesReservedForFutureIssuance
      contextRef="i90db9a89ea084897a01e19ee9ba1df7d_I20211231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmFlNWE5YmUwZWI5NDQ1ZDE5MmZhZTgyMmQyMmJlMDlmL3NlYzphZTVhOWJlMGViOTQ0NWQxOTJmYWU4MjJkMjJiZTA5Zl80Ni9mcmFnOjU5ZmVhYTYxNWVlYjRmZTJhOGQ1ZTQ5NTRkNjk5MzFiL3RleHRyZWdpb246NTlmZWFhNjE1ZWViNGZlMmE4ZDVlNDk1NGQ2OTkzMWJfMTQ1MzE_6f878e1d-378f-421c-ba98-f5f6b3d1128e"
      unitRef="shares">549289</us-gaap:CommonStockCapitalSharesReservedForFutureIssuance>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant
      contextRef="if90b738ac124410e8756188bb3849132_I20220101"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmFlNWE5YmUwZWI5NDQ1ZDE5MmZhZTgyMmQyMmJlMDlmL3NlYzphZTVhOWJlMGViOTQ0NWQxOTJmYWU4MjJkMjJiZTA5Zl80Ni9mcmFnOjU5ZmVhYTYxNWVlYjRmZTJhOGQ1ZTQ5NTRkNjk5MzFiL3RleHRyZWdpb246NTlmZWFhNjE1ZWViNGZlMmE4ZDVlNDk1NGQ2OTkzMWJfMTQ2Mjg_a2a81a32-c8bd-41f4-86d9-729b5fc3ece0"
      unitRef="shares">297729</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant>
    <us-gaap:CommonStockSharesIssued
      contextRef="i93962a6eeb67470a9a84c74d9a0daa4b_I20220228"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmFlNWE5YmUwZWI5NDQ1ZDE5MmZhZTgyMmQyMmJlMDlmL3NlYzphZTVhOWJlMGViOTQ0NWQxOTJmYWU4MjJkMjJiZTA5Zl80Ni9mcmFnOjU5ZmVhYTYxNWVlYjRmZTJhOGQ1ZTQ5NTRkNjk5MzFiL3RleHRyZWdpb246NTlmZWFhNjE1ZWViNGZlMmE4ZDVlNDk1NGQ2OTkzMWJfMjE5OTAyMzI4MDA3MA_69da5455-cbc6-4af0-92f5-91122168a053"
      unitRef="shares">47339</us-gaap:CommonStockSharesIssued>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant
      contextRef="i6808a2674aa947cbae46fd4581d39941_I20220630"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmFlNWE5YmUwZWI5NDQ1ZDE5MmZhZTgyMmQyMmJlMDlmL3NlYzphZTVhOWJlMGViOTQ0NWQxOTJmYWU4MjJkMjJiZTA5Zl80Ni9mcmFnOjU5ZmVhYTYxNWVlYjRmZTJhOGQ1ZTQ5NTRkNjk5MzFiL3RleHRyZWdpb246NTlmZWFhNjE1ZWViNGZlMmE4ZDVlNDk1NGQ2OTkzMWJfMTQ3MTI_5b97cb2a-3acc-4e30-ad0a-50be504aeb46"
      unitRef="shares">799679</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant>
    <us-gaap:WarrantsAndRightsOutstandingTerm
      contextRef="i3ae776d8a361420b98e7812cbc296a23_I20220630"
      id="id3VybDovL2RvY3MudjEvZG9jOmFlNWE5YmUwZWI5NDQ1ZDE5MmZhZTgyMmQyMmJlMDlmL3NlYzphZTVhOWJlMGViOTQ0NWQxOTJmYWU4MjJkMjJiZTA5Zl80Ni9mcmFnOjU5ZmVhYTYxNWVlYjRmZTJhOGQ1ZTQ5NTRkNjk5MzFiL3RleHRyZWdpb246NTlmZWFhNjE1ZWViNGZlMmE4ZDVlNDk1NGQ2OTkzMWJfMTU2NDI_a2287e32-ad45-4ce5-b6ac-b0ea2f0ca4c6">P10Y</us-gaap:WarrantsAndRightsOutstandingTerm>
    <us-gaap:ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1
      contextRef="icceae5e000e140b89495ae9f074cbf03_I20220630"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmFlNWE5YmUwZWI5NDQ1ZDE5MmZhZTgyMmQyMmJlMDlmL3NlYzphZTVhOWJlMGViOTQ0NWQxOTJmYWU4MjJkMjJiZTA5Zl80Ni9mcmFnOjU5ZmVhYTYxNWVlYjRmZTJhOGQ1ZTQ5NTRkNjk5MzFiL3RleHRyZWdpb246NTlmZWFhNjE1ZWViNGZlMmE4ZDVlNDk1NGQ2OTkzMWJfMTUxNzM_ba873f7b-db75-43bf-a744-875d51e875e6"
      unitRef="usdPerShare">1.08</us-gaap:ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1>
    <us-gaap:ClassOfWarrantOrRightNumberOfSecuritiesCalledByEachWarrantOrRight
      contextRef="icceae5e000e140b89495ae9f074cbf03_I20220630"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmFlNWE5YmUwZWI5NDQ1ZDE5MmZhZTgyMmQyMmJlMDlmL3NlYzphZTVhOWJlMGViOTQ0NWQxOTJmYWU4MjJkMjJiZTA5Zl80Ni9mcmFnOjU5ZmVhYTYxNWVlYjRmZTJhOGQ1ZTQ5NTRkNjk5MzFiL3RleHRyZWdpb246NTlmZWFhNjE1ZWViNGZlMmE4ZDVlNDk1NGQ2OTkzMWJfMjE5OTAyMzI4MDEzNA_1d16e851-3a0a-4727-9615-2916c814c54e"
      unitRef="shares">20320</us-gaap:ClassOfWarrantOrRightNumberOfSecuritiesCalledByEachWarrantOrRight>
    <dmtk:WarrantsVestingPeriod
      contextRef="i17c79d92ed9747bf964a280f627bbb4a_D20220101-20220630"
      id="id3VybDovL2RvY3MudjEvZG9jOmFlNWE5YmUwZWI5NDQ1ZDE5MmZhZTgyMmQyMmJlMDlmL3NlYzphZTVhOWJlMGViOTQ0NWQxOTJmYWU4MjJkMjJiZTA5Zl80Ni9mcmFnOjU5ZmVhYTYxNWVlYjRmZTJhOGQ1ZTQ5NTRkNjk5MzFiL3RleHRyZWdpb246NTlmZWFhNjE1ZWViNGZlMmE4ZDVlNDk1NGQ2OTkzMWJfMTU2NDM_a46d6470-fc96-400d-aa8a-5a4323f6ba38">P4Y</dmtk:WarrantsVestingPeriod>
    <us-gaap:ClassOfWarrantOrRightOutstanding
      contextRef="i3ae776d8a361420b98e7812cbc296a23_I20220630"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmFlNWE5YmUwZWI5NDQ1ZDE5MmZhZTgyMmQyMmJlMDlmL3NlYzphZTVhOWJlMGViOTQ0NWQxOTJmYWU4MjJkMjJiZTA5Zl80Ni9mcmFnOjU5ZmVhYTYxNWVlYjRmZTJhOGQ1ZTQ5NTRkNjk5MzFiL3RleHRyZWdpb246NTlmZWFhNjE1ZWViNGZlMmE4ZDVlNDk1NGQ2OTkzMWJfMTUyODk_784b9ec4-ffd5-4be2-b968-2183a5106ddd"
      unitRef="shares">0</us-gaap:ClassOfWarrantOrRightOutstanding>
    <us-gaap:ClassOfWarrantOrRightOutstanding
      contextRef="id48e52918d994150b696caa21ce59a38_I20211231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmFlNWE5YmUwZWI5NDQ1ZDE5MmZhZTgyMmQyMmJlMDlmL3NlYzphZTVhOWJlMGViOTQ0NWQxOTJmYWU4MjJkMjJiZTA5Zl80Ni9mcmFnOjU5ZmVhYTYxNWVlYjRmZTJhOGQ1ZTQ5NTRkNjk5MzFiL3RleHRyZWdpb246NTlmZWFhNjE1ZWViNGZlMmE4ZDVlNDk1NGQ2OTkzMWJfMTUyOTY_e9ed1f79-08ca-4043-9350-5ed0b7a9cb99"
      unitRef="shares">22320</us-gaap:ClassOfWarrantOrRightOutstanding>
    <us-gaap:ScheduleOfStockByClassTextBlock
      contextRef="ia855382ada1f4f28aa8ef6da692ff177_D20220101-20220630"
      id="id3VybDovL2RvY3MudjEvZG9jOmFlNWE5YmUwZWI5NDQ1ZDE5MmZhZTgyMmQyMmJlMDlmL3NlYzphZTVhOWJlMGViOTQ0NWQxOTJmYWU4MjJkMjJiZTA5Zl80Ni9mcmFnOjU5ZmVhYTYxNWVlYjRmZTJhOGQ1ZTQ5NTRkNjk5MzFiL3RleHRyZWdpb246NTlmZWFhNjE1ZWViNGZlMmE4ZDVlNDk1NGQ2OTkzMWJfMTU2NDQ_c41fa990-3203-4ae5-9b88-1ad3490ff97b">&lt;div style="margin-top:9pt;padding-left:27pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Common stock reserved for future issuance consists of the following as of June&#160;30, 2022 and December&#160;31, 2021 (in thousands): &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:12pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:71.930%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:12.081%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.406%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:12.083%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;June 30,&lt;br/&gt;2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;December 31,&lt;br/&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Warrants to purchase common stock&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;10&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;31&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;SPAC Warrants to purchase common stock*&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;704&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;704&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Stock options issued and outstanding&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,758&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,721&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;RSUs issued and outstanding&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,912&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;983&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Authorized for future equity grants&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;431&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;603&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Authorized for future ESPP purchases&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;800&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;549&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total common stock reserved for future issuance&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;6,615&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4,591&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-top:9pt;padding-left:27pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;*Four SPAC Warrants are needed to purchase one share of common stock. The numbers presented above reflect the amount of shares of common stock underlying SPAC Warrants.&lt;/span&gt;&lt;/div&gt;</us-gaap:ScheduleOfStockByClassTextBlock>
    <us-gaap:CommonStockCapitalSharesReservedForFutureIssuance
      contextRef="i224d7d5c13f4473abacadb433d8efcf9_I20220630"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmFlNWE5YmUwZWI5NDQ1ZDE5MmZhZTgyMmQyMmJlMDlmL3NlYzphZTVhOWJlMGViOTQ0NWQxOTJmYWU4MjJkMjJiZTA5Zl80Ni9mcmFnOjU5ZmVhYTYxNWVlYjRmZTJhOGQ1ZTQ5NTRkNjk5MzFiL3RhYmxlOjA3OGQyMjlmN2EyYTQ2NDk5MTg3M2U2MzAyNGFmNTdkL3RhYmxlcmFuZ2U6MDc4ZDIyOWY3YTJhNDY0OTkxODczZTYzMDI0YWY1N2RfMS0xLTEtMS02MjY_5c1c5eed-8341-4aa3-9da9-73e2ac824be5"
      unitRef="shares">10</us-gaap:CommonStockCapitalSharesReservedForFutureIssuance>
    <us-gaap:CommonStockCapitalSharesReservedForFutureIssuance
      contextRef="i3e751586f58d4d01a1fef025f865d0f3_I20211231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmFlNWE5YmUwZWI5NDQ1ZDE5MmZhZTgyMmQyMmJlMDlmL3NlYzphZTVhOWJlMGViOTQ0NWQxOTJmYWU4MjJkMjJiZTA5Zl80Ni9mcmFnOjU5ZmVhYTYxNWVlYjRmZTJhOGQ1ZTQ5NTRkNjk5MzFiL3RhYmxlOjA3OGQyMjlmN2EyYTQ2NDk5MTg3M2U2MzAyNGFmNTdkL3RhYmxlcmFuZ2U6MDc4ZDIyOWY3YTJhNDY0OTkxODczZTYzMDI0YWY1N2RfMS0zLTEtMS02MjY_9a5e87ba-e069-43b1-8500-f1c5cdc61e94"
      unitRef="shares">31</us-gaap:CommonStockCapitalSharesReservedForFutureIssuance>
    <us-gaap:CommonStockCapitalSharesReservedForFutureIssuance
      contextRef="i518ef87c81764e97bfd3d740d82300fd_I20220630"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmFlNWE5YmUwZWI5NDQ1ZDE5MmZhZTgyMmQyMmJlMDlmL3NlYzphZTVhOWJlMGViOTQ0NWQxOTJmYWU4MjJkMjJiZTA5Zl80Ni9mcmFnOjU5ZmVhYTYxNWVlYjRmZTJhOGQ1ZTQ5NTRkNjk5MzFiL3RhYmxlOjA3OGQyMjlmN2EyYTQ2NDk5MTg3M2U2MzAyNGFmNTdkL3RhYmxlcmFuZ2U6MDc4ZDIyOWY3YTJhNDY0OTkxODczZTYzMDI0YWY1N2RfMi0xLTEtMS02MjY_a11d4ac0-6f41-4e08-b735-9271645f34ff"
      unitRef="shares">704</us-gaap:CommonStockCapitalSharesReservedForFutureIssuance>
    <us-gaap:CommonStockCapitalSharesReservedForFutureIssuance
      contextRef="ib8e1d5497a8844f49561a3c895942e21_I20211231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmFlNWE5YmUwZWI5NDQ1ZDE5MmZhZTgyMmQyMmJlMDlmL3NlYzphZTVhOWJlMGViOTQ0NWQxOTJmYWU4MjJkMjJiZTA5Zl80Ni9mcmFnOjU5ZmVhYTYxNWVlYjRmZTJhOGQ1ZTQ5NTRkNjk5MzFiL3RhYmxlOjA3OGQyMjlmN2EyYTQ2NDk5MTg3M2U2MzAyNGFmNTdkL3RhYmxlcmFuZ2U6MDc4ZDIyOWY3YTJhNDY0OTkxODczZTYzMDI0YWY1N2RfMi0zLTEtMS02MjY_666ad634-2d38-4e85-8257-bb290b20e131"
      unitRef="shares">704</us-gaap:CommonStockCapitalSharesReservedForFutureIssuance>
    <us-gaap:CommonStockCapitalSharesReservedForFutureIssuance
      contextRef="id85b86a3ec0547afa49b47ee6b523100_I20220630"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmFlNWE5YmUwZWI5NDQ1ZDE5MmZhZTgyMmQyMmJlMDlmL3NlYzphZTVhOWJlMGViOTQ0NWQxOTJmYWU4MjJkMjJiZTA5Zl80Ni9mcmFnOjU5ZmVhYTYxNWVlYjRmZTJhOGQ1ZTQ5NTRkNjk5MzFiL3RhYmxlOjA3OGQyMjlmN2EyYTQ2NDk5MTg3M2U2MzAyNGFmNTdkL3RhYmxlcmFuZ2U6MDc4ZDIyOWY3YTJhNDY0OTkxODczZTYzMDI0YWY1N2RfMy0xLTEtMS02MjY_7f059d5a-2386-42e1-b8ec-26d71cc70fc5"
      unitRef="shares">1758</us-gaap:CommonStockCapitalSharesReservedForFutureIssuance>
    <us-gaap:CommonStockCapitalSharesReservedForFutureIssuance
      contextRef="if9fd57fab22a46b58a6fed555cc40670_I20211231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmFlNWE5YmUwZWI5NDQ1ZDE5MmZhZTgyMmQyMmJlMDlmL3NlYzphZTVhOWJlMGViOTQ0NWQxOTJmYWU4MjJkMjJiZTA5Zl80Ni9mcmFnOjU5ZmVhYTYxNWVlYjRmZTJhOGQ1ZTQ5NTRkNjk5MzFiL3RhYmxlOjA3OGQyMjlmN2EyYTQ2NDk5MTg3M2U2MzAyNGFmNTdkL3RhYmxlcmFuZ2U6MDc4ZDIyOWY3YTJhNDY0OTkxODczZTYzMDI0YWY1N2RfMy0zLTEtMS02MjY_b12a7706-0fc9-4e14-a0b1-c189ccd8ebdd"
      unitRef="shares">1721</us-gaap:CommonStockCapitalSharesReservedForFutureIssuance>
    <us-gaap:CommonStockCapitalSharesReservedForFutureIssuance
      contextRef="if59386ad3a864f49b56cf8b203a0bfc9_I20220630"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmFlNWE5YmUwZWI5NDQ1ZDE5MmZhZTgyMmQyMmJlMDlmL3NlYzphZTVhOWJlMGViOTQ0NWQxOTJmYWU4MjJkMjJiZTA5Zl80Ni9mcmFnOjU5ZmVhYTYxNWVlYjRmZTJhOGQ1ZTQ5NTRkNjk5MzFiL3RhYmxlOjA3OGQyMjlmN2EyYTQ2NDk5MTg3M2U2MzAyNGFmNTdkL3RhYmxlcmFuZ2U6MDc4ZDIyOWY3YTJhNDY0OTkxODczZTYzMDI0YWY1N2RfNC0xLTEtMS02MjY_0ebeb701-4e78-4f43-91e9-6ff835de1864"
      unitRef="shares">2912</us-gaap:CommonStockCapitalSharesReservedForFutureIssuance>
    <us-gaap:CommonStockCapitalSharesReservedForFutureIssuance
      contextRef="ia2ce86db98734669afba2e88fbc221c0_I20211231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmFlNWE5YmUwZWI5NDQ1ZDE5MmZhZTgyMmQyMmJlMDlmL3NlYzphZTVhOWJlMGViOTQ0NWQxOTJmYWU4MjJkMjJiZTA5Zl80Ni9mcmFnOjU5ZmVhYTYxNWVlYjRmZTJhOGQ1ZTQ5NTRkNjk5MzFiL3RhYmxlOjA3OGQyMjlmN2EyYTQ2NDk5MTg3M2U2MzAyNGFmNTdkL3RhYmxlcmFuZ2U6MDc4ZDIyOWY3YTJhNDY0OTkxODczZTYzMDI0YWY1N2RfNC0zLTEtMS02MjY_37bc2f68-dfac-40ab-9837-3e1ad821fb03"
      unitRef="shares">983</us-gaap:CommonStockCapitalSharesReservedForFutureIssuance>
    <us-gaap:CommonStockCapitalSharesReservedForFutureIssuance
      contextRef="idff1708d659844a99149a2c6dc434bbc_I20220630"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmFlNWE5YmUwZWI5NDQ1ZDE5MmZhZTgyMmQyMmJlMDlmL3NlYzphZTVhOWJlMGViOTQ0NWQxOTJmYWU4MjJkMjJiZTA5Zl80Ni9mcmFnOjU5ZmVhYTYxNWVlYjRmZTJhOGQ1ZTQ5NTRkNjk5MzFiL3RhYmxlOjA3OGQyMjlmN2EyYTQ2NDk5MTg3M2U2MzAyNGFmNTdkL3RhYmxlcmFuZ2U6MDc4ZDIyOWY3YTJhNDY0OTkxODczZTYzMDI0YWY1N2RfNS0xLTEtMS02MjY_5202f3b4-773f-4759-bd41-14440abde7e1"
      unitRef="shares">431</us-gaap:CommonStockCapitalSharesReservedForFutureIssuance>
    <us-gaap:CommonStockCapitalSharesReservedForFutureIssuance
      contextRef="ia222e6a529804adeb78574b8095520eb_I20211231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmFlNWE5YmUwZWI5NDQ1ZDE5MmZhZTgyMmQyMmJlMDlmL3NlYzphZTVhOWJlMGViOTQ0NWQxOTJmYWU4MjJkMjJiZTA5Zl80Ni9mcmFnOjU5ZmVhYTYxNWVlYjRmZTJhOGQ1ZTQ5NTRkNjk5MzFiL3RhYmxlOjA3OGQyMjlmN2EyYTQ2NDk5MTg3M2U2MzAyNGFmNTdkL3RhYmxlcmFuZ2U6MDc4ZDIyOWY3YTJhNDY0OTkxODczZTYzMDI0YWY1N2RfNS0zLTEtMS02MjY_7e65f248-0d1a-4786-8f72-85a6dfe63739"
      unitRef="shares">603</us-gaap:CommonStockCapitalSharesReservedForFutureIssuance>
    <us-gaap:CommonStockCapitalSharesReservedForFutureIssuance
      contextRef="if28f5d136fda458d8a8446a128205c60_I20220630"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmFlNWE5YmUwZWI5NDQ1ZDE5MmZhZTgyMmQyMmJlMDlmL3NlYzphZTVhOWJlMGViOTQ0NWQxOTJmYWU4MjJkMjJiZTA5Zl80Ni9mcmFnOjU5ZmVhYTYxNWVlYjRmZTJhOGQ1ZTQ5NTRkNjk5MzFiL3RhYmxlOjA3OGQyMjlmN2EyYTQ2NDk5MTg3M2U2MzAyNGFmNTdkL3RhYmxlcmFuZ2U6MDc4ZDIyOWY3YTJhNDY0OTkxODczZTYzMDI0YWY1N2RfNi0xLTEtMS02MjY_11dae19b-bac2-4e91-b29b-42e4ee663045"
      unitRef="shares">800</us-gaap:CommonStockCapitalSharesReservedForFutureIssuance>
    <us-gaap:CommonStockCapitalSharesReservedForFutureIssuance
      contextRef="i5cb5de1a181c4857a7d503c399e272c8_I20211231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmFlNWE5YmUwZWI5NDQ1ZDE5MmZhZTgyMmQyMmJlMDlmL3NlYzphZTVhOWJlMGViOTQ0NWQxOTJmYWU4MjJkMjJiZTA5Zl80Ni9mcmFnOjU5ZmVhYTYxNWVlYjRmZTJhOGQ1ZTQ5NTRkNjk5MzFiL3RhYmxlOjA3OGQyMjlmN2EyYTQ2NDk5MTg3M2U2MzAyNGFmNTdkL3RhYmxlcmFuZ2U6MDc4ZDIyOWY3YTJhNDY0OTkxODczZTYzMDI0YWY1N2RfNi0zLTEtMS02MjY_8f0c76bf-f42d-45f6-afc8-496c8a5b8b27"
      unitRef="shares">549</us-gaap:CommonStockCapitalSharesReservedForFutureIssuance>
    <us-gaap:CommonStockCapitalSharesReservedForFutureIssuance
      contextRef="i4c8f247d12134a9886d56e1c8b024425_I20220630"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmFlNWE5YmUwZWI5NDQ1ZDE5MmZhZTgyMmQyMmJlMDlmL3NlYzphZTVhOWJlMGViOTQ0NWQxOTJmYWU4MjJkMjJiZTA5Zl80Ni9mcmFnOjU5ZmVhYTYxNWVlYjRmZTJhOGQ1ZTQ5NTRkNjk5MzFiL3RhYmxlOjA3OGQyMjlmN2EyYTQ2NDk5MTg3M2U2MzAyNGFmNTdkL3RhYmxlcmFuZ2U6MDc4ZDIyOWY3YTJhNDY0OTkxODczZTYzMDI0YWY1N2RfNy0xLTEtMS02MjY_4b8b4107-2ebd-42e6-94c7-97279afb4151"
      unitRef="shares">6615</us-gaap:CommonStockCapitalSharesReservedForFutureIssuance>
    <us-gaap:CommonStockCapitalSharesReservedForFutureIssuance
      contextRef="i87bf777ccf5f4f93bc9be7a2cbba61c1_I20211231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmFlNWE5YmUwZWI5NDQ1ZDE5MmZhZTgyMmQyMmJlMDlmL3NlYzphZTVhOWJlMGViOTQ0NWQxOTJmYWU4MjJkMjJiZTA5Zl80Ni9mcmFnOjU5ZmVhYTYxNWVlYjRmZTJhOGQ1ZTQ5NTRkNjk5MzFiL3RhYmxlOjA3OGQyMjlmN2EyYTQ2NDk5MTg3M2U2MzAyNGFmNTdkL3RhYmxlcmFuZ2U6MDc4ZDIyOWY3YTJhNDY0OTkxODczZTYzMDI0YWY1N2RfNy0zLTEtMS02MjY_29e35e17-f692-43c1-b53f-5336e9d071b1"
      unitRef="shares">4591</us-gaap:CommonStockCapitalSharesReservedForFutureIssuance>
    <dmtk:NumberOfWarrantsEntitleHolderToPurchaseOneShare
      contextRef="ie2a82877a32d4e80a7f2d54460a79dcd_D20220101-20220630"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmFlNWE5YmUwZWI5NDQ1ZDE5MmZhZTgyMmQyMmJlMDlmL3NlYzphZTVhOWJlMGViOTQ0NWQxOTJmYWU4MjJkMjJiZTA5Zl80Ni9mcmFnOjU5ZmVhYTYxNWVlYjRmZTJhOGQ1ZTQ5NTRkNjk5MzFiL3RleHRyZWdpb246NTlmZWFhNjE1ZWViNGZlMmE4ZDVlNDk1NGQ2OTkzMWJfMTU0Nzc_01647967-9780-42f4-9c1a-e72ff750dd0c"
      unitRef="warrant">4</dmtk:NumberOfWarrantsEntitleHolderToPurchaseOneShare>
    <us-gaap:CommitmentsDisclosureTextBlock
      contextRef="ia855382ada1f4f28aa8ef6da692ff177_D20220101-20220630"
      id="id3VybDovL2RvY3MudjEvZG9jOmFlNWE5YmUwZWI5NDQ1ZDE5MmZhZTgyMmQyMmJlMDlmL3NlYzphZTVhOWJlMGViOTQ0NWQxOTJmYWU4MjJkMjJiZTA5Zl81NS9mcmFnOjgzZWFhMzRhOThhOTQ3YWQ4ZDYzODA0Nzc5NGYxYjhmL3RleHRyZWdpb246ODNlYWEzNGE5OGE5NDdhZDhkNjM4MDQ3Nzk0ZjFiOGZfODM5Mw_4a279fc1-8150-428a-94e6-952e7af0b949">Leases, Commitments and Contingencies&lt;div style="margin-top:15pt;padding-left:27pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Adoption of ASC 842&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:9pt;padding-left:27pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;In the third quarter of 2021, the Company adopted ASU 2016-02&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;, &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;and&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt; &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;ASC&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt; &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Topic&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt; &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;842, &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Leases&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt; (&#x201c;ASC 842&#x201d;) using the modified retrospective approach with an effective date of January 1, 2021. The adoption had no effect on the condensed consolidated statements of operations for the three and six months ended June 30, 2021. Net cash (used in) provided by operating activities, investing activities or financing activities for the six months ended June 30, 2021 were also unchanged, but the presentation of certain prior period amounts within the operating activities section of the condensed consolidated statements of cash flows have been retrospectively adjusted to give effect to the adoption of ASC 842. The changes are set forth in the table below (in thousands):&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:6pt;padding-left:27pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:62.081%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.021%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.406%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.263%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.406%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.023%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.5pt;font-weight:700;line-height:100%"&gt;Six Months Ended June 30, 2021&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.5pt;font-weight:700;line-height:100%"&gt;Before Adoption of ASC 842&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.5pt;font-weight:700;line-height:100%"&gt;Effect of Adoption&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.5pt;font-weight:700;line-height:100%"&gt;After Adoption of ASC 842&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:700;line-height:100%"&gt;Effect on Condensed Consolidated Statements of Cash Flows&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Cash flows from operating activities:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Adjustments to reconcile net loss to net cash used in operating activities:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 17.5pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Amortization of operating lease right-of-use assets&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;582&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;582&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Change in operating assets and liabilities:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 11.5pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Operating lease liabilities, net&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(328)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(328)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 11.5pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Other liabilities&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;254&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(254)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-top:15pt;padding-left:27pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Finance Leases&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:9pt;padding-left:27pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The Company leases certain laboratory equipment from various third parties, through equipment finance leases (previously referred to as &#x201c;capital leases&#x201d;). These leases either include a bargain purchase option or the terms of the leases are at least 75 percent of the useful lives of the assets and are therefore classified as finance leases. These leases are capitalized in property and equipment, net on the accompanying condensed consolidated balance sheets. Initial asset values and finance lease obligations are based on the present value of future minimum lease payments. Gross assets recorded under finance leases were $0.4 million and $0.4 million as of June&#160;30, 2022 and December&#160;31, 2021, respectively. Accumulated amortization associated with finance leases was $0.1 million and $0.1 million as of June&#160;30, 2022 and December&#160;31, 2021, respectively. Total finance lease interest expense was approximately $3,000 and $4,000 for the three months ended June&#160;30, 2022 and 2021, respectively, and $7,000 and $8,000 for the six months ended June 30, 2022 and 2021, respectively, and is included within interest income, net on the condensed consolidated statements of operations. Long-term finance lease obligations are as follows (in thousands): &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:12pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.696%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:69.264%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:13.337%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.407%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:13.492%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;June 30, 2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;December 31, 2021&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Gross finance lease obligations&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;262&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;274&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Less imputed interest&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(17)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(17)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Present value of net minimum lease payments&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;245&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;257&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Less current portion of finance lease obligations&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(134)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(121)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total long-term finance lease obligations&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;111&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;136&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-top:15pt;padding-left:27pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Operating Leases&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:15pt;padding-left:27pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Del Mar Heights Lease &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:9pt;padding-left:27pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;On July&#160;1, 2021, the Company entered into an Office Lease (the &#x201c;Del Mar Lease&#x201d;) with Kilroy Realty, L.P. (the &#x201c;Landlord&#x201d;), with respect to an aggregate of 95,997 rentable square feet consisting of the entire building located at 12340 El Camino Real, San Diego, California 92130 (the &#x201c;Entire Premises&#x201d;). The Entire Premises covered by the Del Mar Lease will serve as the Company&#x2019;s new principal office.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:9pt;padding-left:27pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The Del Mar Lease provides for a tenant improvement allowance of $125.00 per rentable square foot of the Entire Premises for a total of $12.0 million that the Landlord will use to fund the installation and/or construction of certain improvements to the Entire Premises in four phases, with each phase pertaining to a specified portion of the Entire Premises. The initial term of the Del Mar Lease is ten years and six months beginning on the earlier to occur of (i) January 1, 2023 and (ii) the date that Landlord tenders possession of the Phase III Premises (as defined in the Del Mar Lease) to the Company following the substantial completion of the improvements to the Phase III Premises required by the Del Mar Lease (the &#x201c;Lease Commencement Date&#x201d;). The Company has the option to extend the term of the Lease for two additional five-year periods, subject to the terms of the Del Mar Lease.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:9pt;padding-left:27pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;As the Landlord tenders possession of each portion of the Entire Premises for which the applicable improvements required by the Del Mar Lease are substantially complete, the Company will be obligated to make monthly payments of base rent with respect to such portion of the Entire Premises as set forth on Schedule 1 to the Del Mar Lease. In the event the Company exercises its option to extend the Del Mar Lease term, the Lease provides for monthly rent payments during the additional five-year periods at the then-current market rent as determined in accordance with the Del Mar Lease. In addition to rent, the Del Mar Lease requires the Company to pay additional rent amounts for taxes, insurance, maintenance and other expenses.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:9pt;padding-left:27pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;During year ended December 31, 2021, the Company took initial possession of the first phase of its corporate headquarters, and the Company capitalized a right-of-use asset and related lease liability of $5.7 million associated with the first phase. During the three months ended March 31, 2022, the lease for the second phase of the Company&#x2019;s corporate headquarters commenced and the Company capitalized a right of use asset and related lease liability of $15.8&#160;million. The extension option periods were not considered in the determination of the right-of-use asset or the lease liability as the Company did not consider it reasonably certain that it would exercise such extension options. &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:15pt;padding-left:27pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Del Mar Lease Amendments&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:9pt;padding-left:27pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;During April 2022, the Company amended the Del Mar Lease through the execution of the First Amendment to Office Lease (the "First Amendment") and the Second Amendment to Office Lease (the "Second Amendment") (collectively, the "Del Mar Lease Amendments"). Pursuant to the First Amendment to the Del Mar Lease, the Company elected to utilize a one-time increase in an additional improvement allowance of $25.00 per rentable square foot, which increased the tenant improvement allowance by $2.4 million to $14.4 million, provided under the Del Mar Lease to make certain improvements to the Entire Premises. As a result, the Company will pay an increased monthly base rent to the Landlord, in order to repay costs relating to the additional design and construction. Pursuant to the Second Amendment to the Del Mar Lease, the Company elected to expand the Entire Premises to include 14,085 rentable square feet comprising the executive parking level (the &#x201c;Expansion Premises&#x201d;), which increased the tenant improvement allowance by $2.1 million to $16.5 million. The Landlord will tender possession of the Expansion Premises following substantial completion of improvements, pursuant to an agreed upon work letter and will run contemporaneously with the term of the Existing Premises. The Company intends to use the additional space for general office and laboratory use. As the Landlord tenders possession of the Expansion Premises, the Company will be obligated to pay the Landlord increased monthly installments of base rent for the Expansion Premises. Upon inclusion of the Expansion Premises, the Company will lease approximately 110,082 rentable square feet rentable square feet from the Landlord (the &#x201c;New Entire Premises&#x201d;). &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:9pt;padding-left:27pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The Company evaluated the Del Mar Lease Amendments under ASC 842 and concluded that the Del Mar Lease Amendments would be accounted for as a single contract with the Del Mar Lease because the additional lease payments due to the Del Mar Lease Amendments were not commensurate with ROU asset granted to the Company. Accordingly, the Company remeasured the lease liability using the additional monthly rent payments and the incremental borrowing rate at the effective date of the modification of 6.50%. The remeasurement for the modification resulted in an increase to the lease liability and the ROU asset of approximately $1.2 million. &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:9pt;padding-left:27pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The extension option periods were not considered in the determination of the right-of-use asset or the lease liability as the Company did not consider it reasonably certain that it would exercise such extension options. Pending execution of the Landlord's obligations to prepare leased spaces for occupancy, the Company expects the operating leases for the additional office and laboratory space to commence on various dates in the year ending December 31, 2022. The Company has an estimated future lease payment obligation of approximately $54.4 million related to corporate office facilities that were in the process of being constructed as of June&#160;30, 2022. The lease liabilities and the corresponding right-of-use assets associated with these lease obligations will be recorded upon the commencement date of the operating leases using the Company&#x2019;s incremental borrowing rate based on the information available at commencement date in determining the present value of lease payments. The incremental borrowing rate is the rate of interest that a lessee would have to pay to borrow on a collateralized basis over a similar term and at an amount equal to the lease payments in a similar economic environment. The Company calculates its incremental borrowing rates for specific lease terms, used to discount future lease payments, as a function of the U.S. Treasury rate and an indicative Moody&#x2019;s rating for operating leases.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:9pt;padding-left:27pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;In connection with the original lease agreement, in lieu of a cash security deposit, the Company&#x2019;s bank issued a letter of credit on its behalf, which is secured by a deposit, of $3.0 million and is included in restricted cash on the condensed consolidated balance sheet based on the term of the underlying lease. In April 2022, pursuant to the Second Amendment&lt;/span&gt;&lt;span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;, &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;the Company&#x2019;s bank increased the letter of credit on its behalf&lt;/span&gt;&lt;span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt; by $0.5 million, totaling $3.5 million. &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;As of June&#160;30, 2022, none of the standby letter of credit amount has been used.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:15pt;padding-left:27pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Torrey Pines Lease&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:9pt;padding-left:27pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;In January&#160;2013, DermTech Operations entered into a non-cancelable lease agreement for its operating facilities in Torrey Pines (the &#x201c;Torrey Lease&#x201d;). In January&#160;2014, DermTech Operations signed an amendment to the Torrey Lease to extend the term through January&#160;2017. In November&#160;2016, DermTech Operations signed a second amendment to the Torrey Lease to extend the term through March&#160;2022. In August 2019, DermTech Operations signed a third amendment to the Torrey Lease to add additional space, and in September 2019, the Company signed a fourth amendment to the Torrey Lease to add additional space. In February 2020, the Company signed a fifth amendment to the Torrey Lease to add additional space. In connection with the Business Combination, the Company assumed all obligations under the Torrey Lease, as amended, from DermTech Operations. As part of the fifth amendment, the Company was entitled to a tenant improvement allowance for certain costs incurred while performing these improvements in the amount of $0.3 million, which amount may be increased by up to $0.1 million at the Company&#x2019;s election and subject to a corresponding increase in rent. Under the terms of the facilities leases, the Company is required to pay its proportionate share of property taxes, insurance and normal maintenance costs.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:9pt;padding-left:27pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The lease term for all leased space has an expiration date of April&#160;30, 2023, and an option to extend the lease term on all leased space for one additional three-year term, which the Company is not reasonably certain that it will exercise. As such, the Company did not include this option in the determination of the total lease term. On January 1, 2021, in conjunction with the adoption of the guidance in ASU 2016-02, the Company recognized a right-of-use asset and corresponding lease liability for its facility lease as the present value of lease payments not yet paid at January 1, 2021. The right-of-use asset and corresponding lease liability was estimated assuming the remaining lease term of 28 months at January&#160;1, 2021, and an estimated discount rate of 4.04%, which was the Company&#x2019;s incremental borrowing rate at the date of adopting ASC 842. The Company recorded a lease liability of $3.1 million and a right-of-use asset of $2.8 million, which is net of $0.3 million of the Company&#x2019;s previously capitalized tenant improvement allowance and deferred rent, upon adoption.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:9pt;padding-left:27pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The components of lease expense for the three and six months ended June&#160;30, 2022 was as follows (in thousands):&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:12pt;text-align:center"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:43.803%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.750%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.390%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.750%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.390%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.750%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.390%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:13.677%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Three Months Ended June 30,&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Six Months Ended June 30,&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Operating lease cost&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 10pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Operating lease cost&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;1,044&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;319&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;1,667&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;638&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="padding-left:9pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Variable lease costs &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.85pt;font-weight:400;line-height:100%;position:relative;top:-3.15pt;vertical-align:baseline"&gt;(1)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;303&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;143&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;492&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;315&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Total operating lease cost&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;1,347&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;462&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;2,159&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;953&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr style="height:15pt"&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Finance lease cost&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 10pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Amortization of leased assets&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;21&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;17&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;41&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;34&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 10pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Interest on lease liabilities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;3&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;4&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;7&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;8&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Total finance lease cost&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;24&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;21&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;48&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;42&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;(1) Variable lease costs are primarily related to common area maintenance charges and property taxes.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:9pt;padding-left:27pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Other information related to leases was as shown in the table below. &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:12pt;text-align:center"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:68.900%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.406%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:13.293%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.406%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:13.295%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Six Months Ended June 30,&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Cash paid for amounts included in the measurement of lease liabilities:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 10pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Operating cash flows from operating leases&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;1,179&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;684&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 10pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Operating cash flows from finance leases&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;7&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;8&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 10pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Financing cash flows from finance leases&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;60&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;53&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Right-of-use assets obtained in exchange for lease obligations:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 10pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Operating leases&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;17,059&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;2,831&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 10pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Finance leases&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;48&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Weighted average remaining lease term in years:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 10pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Operating leases&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;10.56&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;1.92&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 10pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Finance leases&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;1.50&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;2.50&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Weighted average discount rate:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 10pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Operating leases&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;6.39&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;4.04&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 10pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Finance leases&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;5.78&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;5.54&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-top:9pt;padding-left:27pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The Company&#x2019;s future minimum lease payments under operating and financing leases at June&#160;30, 2022 are as follows (in thousands): &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:12pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:24.203%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:9.051%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.406%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:9.051%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.406%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:9.051%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.406%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:9.051%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.406%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:9.051%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.406%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:9.051%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.406%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:9.055%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2023&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2024&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2025&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2026&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Thereafter&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Total&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Operating lease obligations, including interest&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,524&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,948&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,774&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,853&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,934&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;20,612&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;33,645&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 10pt;text-align:left;text-indent:-9pt;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Finance lease obligations, including interest&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;72&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;133&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;19&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;19&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;15&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;262&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 16pt;text-align:left;text-indent:-9pt;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total future minimum lease payments&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,596&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3,081&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,793&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,872&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,949&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;20,616&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;33,907&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-top:9pt;padding-left:27pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Amounts presented in the table above exclude non-cancelable future minimum lease payments for operating leases that have not commenced as of June&#160;30, 2022.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:18pt;padding-left:27pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Legal Proceedings&lt;/span&gt;&lt;/div&gt;From time to time, the Company may be subject to legal proceedings and claims arising in the ordinary course of business. Management does not believe that the outcome of any of these matters will have a material effect on the Company&#x2019;s consolidated financial position, results of operations or cash flows.</us-gaap:CommitmentsDisclosureTextBlock>
    <us-gaap:ScheduleOfNewAccountingPronouncementsAndChangesInAccountingPrinciplesTextBlock
      contextRef="ia855382ada1f4f28aa8ef6da692ff177_D20220101-20220630"
      id="id3VybDovL2RvY3MudjEvZG9jOmFlNWE5YmUwZWI5NDQ1ZDE5MmZhZTgyMmQyMmJlMDlmL3NlYzphZTVhOWJlMGViOTQ0NWQxOTJmYWU4MjJkMjJiZTA5Zl81NS9mcmFnOjgzZWFhMzRhOThhOTQ3YWQ4ZDYzODA0Nzc5NGYxYjhmL3RleHRyZWdpb246ODNlYWEzNGE5OGE5NDdhZDhkNjM4MDQ3Nzk0ZjFiOGZfMzI5ODUzNDkzODcyMQ_67b098c4-d2fd-425b-afb8-e8a87dadef7b">The changes are set forth in the table below (in thousands):&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:62.081%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.021%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.406%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.263%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.406%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.023%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.5pt;font-weight:700;line-height:100%"&gt;Six Months Ended June 30, 2021&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.5pt;font-weight:700;line-height:100%"&gt;Before Adoption of ASC 842&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.5pt;font-weight:700;line-height:100%"&gt;Effect of Adoption&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.5pt;font-weight:700;line-height:100%"&gt;After Adoption of ASC 842&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:700;line-height:100%"&gt;Effect on Condensed Consolidated Statements of Cash Flows&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Cash flows from operating activities:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Adjustments to reconcile net loss to net cash used in operating activities:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 17.5pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Amortization of operating lease right-of-use assets&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;582&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;582&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Change in operating assets and liabilities:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 11.5pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Operating lease liabilities, net&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(328)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(328)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 11.5pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Other liabilities&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;254&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(254)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;</us-gaap:ScheduleOfNewAccountingPronouncementsAndChangesInAccountingPrinciplesTextBlock>
    <us-gaap:OperatingLeaseRightOfUseAssetAmortizationExpense
      contextRef="if694b668e6db42e59488d953f4800965_D20220101-20220630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmFlNWE5YmUwZWI5NDQ1ZDE5MmZhZTgyMmQyMmJlMDlmL3NlYzphZTVhOWJlMGViOTQ0NWQxOTJmYWU4MjJkMjJiZTA5Zl81NS9mcmFnOjgzZWFhMzRhOThhOTQ3YWQ4ZDYzODA0Nzc5NGYxYjhmL3RhYmxlOjE4ZWI5MDI1MzlhOTQyMjliMzYwYzYyMGVjNmEyZjY0L3RhYmxlcmFuZ2U6MThlYjkwMjUzOWE5NDIyOWIzNjBjNjIwZWM2YTJmNjRfNS0xLTEtMS05MjQ4_971e609c-14b5-44e0-8912-3c1490a46dd7"
      unitRef="usd">0</us-gaap:OperatingLeaseRightOfUseAssetAmortizationExpense>
    <us-gaap:OperatingLeaseRightOfUseAssetAmortizationExpense
      contextRef="i637644f310444bb4bb137883228ca16b_D20220101-20220630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmFlNWE5YmUwZWI5NDQ1ZDE5MmZhZTgyMmQyMmJlMDlmL3NlYzphZTVhOWJlMGViOTQ0NWQxOTJmYWU4MjJkMjJiZTA5Zl81NS9mcmFnOjgzZWFhMzRhOThhOTQ3YWQ4ZDYzODA0Nzc5NGYxYjhmL3RhYmxlOjE4ZWI5MDI1MzlhOTQyMjliMzYwYzYyMGVjNmEyZjY0L3RhYmxlcmFuZ2U6MThlYjkwMjUzOWE5NDIyOWIzNjBjNjIwZWM2YTJmNjRfNS0zLTEtMS05MjQ4_15e0dd50-6eb5-4f1e-a863-4b5c10af28f0"
      unitRef="usd">582000</us-gaap:OperatingLeaseRightOfUseAssetAmortizationExpense>
    <us-gaap:OperatingLeaseRightOfUseAssetAmortizationExpense
      contextRef="i4628e2bd4b3a484e9970f7b8d824bdca_D20220101-20220630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmFlNWE5YmUwZWI5NDQ1ZDE5MmZhZTgyMmQyMmJlMDlmL3NlYzphZTVhOWJlMGViOTQ0NWQxOTJmYWU4MjJkMjJiZTA5Zl81NS9mcmFnOjgzZWFhMzRhOThhOTQ3YWQ4ZDYzODA0Nzc5NGYxYjhmL3RhYmxlOjE4ZWI5MDI1MzlhOTQyMjliMzYwYzYyMGVjNmEyZjY0L3RhYmxlcmFuZ2U6MThlYjkwMjUzOWE5NDIyOWIzNjBjNjIwZWM2YTJmNjRfNS01LTEtMS05MjQ4_031361b0-5af8-49b6-a0a3-e1001b9e58ae"
      unitRef="usd">582000</us-gaap:OperatingLeaseRightOfUseAssetAmortizationExpense>
    <us-gaap:OperatingLeaseLiability
      contextRef="ia085e149f0584e4aa75cec6634a0ee91_I20220630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmFlNWE5YmUwZWI5NDQ1ZDE5MmZhZTgyMmQyMmJlMDlmL3NlYzphZTVhOWJlMGViOTQ0NWQxOTJmYWU4MjJkMjJiZTA5Zl81NS9mcmFnOjgzZWFhMzRhOThhOTQ3YWQ4ZDYzODA0Nzc5NGYxYjhmL3RhYmxlOjE4ZWI5MDI1MzlhOTQyMjliMzYwYzYyMGVjNmEyZjY0L3RhYmxlcmFuZ2U6MThlYjkwMjUzOWE5NDIyOWIzNjBjNjIwZWM2YTJmNjRfNy0xLTEtMS05MjQ4_63e0f18c-8281-41f5-87f3-57c08a26a2d9"
      unitRef="usd">0</us-gaap:OperatingLeaseLiability>
    <us-gaap:OperatingLeaseLiability
      contextRef="ie929f48c345b4dcab48cd9079f2d2e62_I20220630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmFlNWE5YmUwZWI5NDQ1ZDE5MmZhZTgyMmQyMmJlMDlmL3NlYzphZTVhOWJlMGViOTQ0NWQxOTJmYWU4MjJkMjJiZTA5Zl81NS9mcmFnOjgzZWFhMzRhOThhOTQ3YWQ4ZDYzODA0Nzc5NGYxYjhmL3RhYmxlOjE4ZWI5MDI1MzlhOTQyMjliMzYwYzYyMGVjNmEyZjY0L3RhYmxlcmFuZ2U6MThlYjkwMjUzOWE5NDIyOWIzNjBjNjIwZWM2YTJmNjRfNy0zLTEtMS05MjQ4_9cbc218b-691c-4120-b9a2-8f4ed3ac7a7e"
      unitRef="usd">-328000</us-gaap:OperatingLeaseLiability>
    <us-gaap:OperatingLeaseLiability
      contextRef="i833f3dceaa1b4ef5bcdfa449605a0a35_I20220630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmFlNWE5YmUwZWI5NDQ1ZDE5MmZhZTgyMmQyMmJlMDlmL3NlYzphZTVhOWJlMGViOTQ0NWQxOTJmYWU4MjJkMjJiZTA5Zl81NS9mcmFnOjgzZWFhMzRhOThhOTQ3YWQ4ZDYzODA0Nzc5NGYxYjhmL3RhYmxlOjE4ZWI5MDI1MzlhOTQyMjliMzYwYzYyMGVjNmEyZjY0L3RhYmxlcmFuZ2U6MThlYjkwMjUzOWE5NDIyOWIzNjBjNjIwZWM2YTJmNjRfNy01LTEtMS05MjQ4_a01d06cb-04d4-4ec1-8471-1113a111038b"
      unitRef="usd">-328000</us-gaap:OperatingLeaseLiability>
    <us-gaap:OtherLiabilities
      contextRef="ia085e149f0584e4aa75cec6634a0ee91_I20220630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmFlNWE5YmUwZWI5NDQ1ZDE5MmZhZTgyMmQyMmJlMDlmL3NlYzphZTVhOWJlMGViOTQ0NWQxOTJmYWU4MjJkMjJiZTA5Zl81NS9mcmFnOjgzZWFhMzRhOThhOTQ3YWQ4ZDYzODA0Nzc5NGYxYjhmL3RhYmxlOjE4ZWI5MDI1MzlhOTQyMjliMzYwYzYyMGVjNmEyZjY0L3RhYmxlcmFuZ2U6MThlYjkwMjUzOWE5NDIyOWIzNjBjNjIwZWM2YTJmNjRfOC0xLTEtMS05MjQ4_f7e017e8-17c3-471d-a5c4-a6afb738cd0a"
      unitRef="usd">254000</us-gaap:OtherLiabilities>
    <us-gaap:OtherLiabilities
      contextRef="ie929f48c345b4dcab48cd9079f2d2e62_I20220630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmFlNWE5YmUwZWI5NDQ1ZDE5MmZhZTgyMmQyMmJlMDlmL3NlYzphZTVhOWJlMGViOTQ0NWQxOTJmYWU4MjJkMjJiZTA5Zl81NS9mcmFnOjgzZWFhMzRhOThhOTQ3YWQ4ZDYzODA0Nzc5NGYxYjhmL3RhYmxlOjE4ZWI5MDI1MzlhOTQyMjliMzYwYzYyMGVjNmEyZjY0L3RhYmxlcmFuZ2U6MThlYjkwMjUzOWE5NDIyOWIzNjBjNjIwZWM2YTJmNjRfOC0zLTEtMS05MjQ4_868b448d-ebd1-49d2-90bc-dbd98d1b53e7"
      unitRef="usd">-254000</us-gaap:OtherLiabilities>
    <us-gaap:OtherLiabilities
      contextRef="i833f3dceaa1b4ef5bcdfa449605a0a35_I20220630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmFlNWE5YmUwZWI5NDQ1ZDE5MmZhZTgyMmQyMmJlMDlmL3NlYzphZTVhOWJlMGViOTQ0NWQxOTJmYWU4MjJkMjJiZTA5Zl81NS9mcmFnOjgzZWFhMzRhOThhOTQ3YWQ4ZDYzODA0Nzc5NGYxYjhmL3RhYmxlOjE4ZWI5MDI1MzlhOTQyMjliMzYwYzYyMGVjNmEyZjY0L3RhYmxlcmFuZ2U6MThlYjkwMjUzOWE5NDIyOWIzNjBjNjIwZWM2YTJmNjRfOC01LTEtMS05MjQ4_3ce0c228-056b-48d5-b8b8-e6a300bc02da"
      unitRef="usd">0</us-gaap:OtherLiabilities>
    <dmtk:PercentageOfUsefulLivesOfAssets
      contextRef="ia855382ada1f4f28aa8ef6da692ff177_D20220101-20220630"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOmFlNWE5YmUwZWI5NDQ1ZDE5MmZhZTgyMmQyMmJlMDlmL3NlYzphZTVhOWJlMGViOTQ0NWQxOTJmYWU4MjJkMjJiZTA5Zl81NS9mcmFnOjgzZWFhMzRhOThhOTQ3YWQ4ZDYzODA0Nzc5NGYxYjhmL3RleHRyZWdpb246ODNlYWEzNGE5OGE5NDdhZDhkNjM4MDQ3Nzk0ZjFiOGZfMzEw_a120d09c-b376-4707-94af-a93378e65d2a"
      unitRef="number">0.75</dmtk:PercentageOfUsefulLivesOfAssets>
    <us-gaap:PropertyPlantAndEquipmentGross
      contextRef="if5c0f2a68220406b8c328b2744af6512_I20220630"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmFlNWE5YmUwZWI5NDQ1ZDE5MmZhZTgyMmQyMmJlMDlmL3NlYzphZTVhOWJlMGViOTQ0NWQxOTJmYWU4MjJkMjJiZTA5Zl81NS9mcmFnOjgzZWFhMzRhOThhOTQ3YWQ4ZDYzODA0Nzc5NGYxYjhmL3RleHRyZWdpb246ODNlYWEzNGE5OGE5NDdhZDhkNjM4MDQ3Nzk0ZjFiOGZfNjc4_da9e8f61-5c57-4d49-ac71-2e0e753db619"
      unitRef="usd">400000</us-gaap:PropertyPlantAndEquipmentGross>
    <us-gaap:PropertyPlantAndEquipmentGross
      contextRef="ic89cf2db98344df4a59437fe3569a1d2_I20211231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmFlNWE5YmUwZWI5NDQ1ZDE5MmZhZTgyMmQyMmJlMDlmL3NlYzphZTVhOWJlMGViOTQ0NWQxOTJmYWU4MjJkMjJiZTA5Zl81NS9mcmFnOjgzZWFhMzRhOThhOTQ3YWQ4ZDYzODA0Nzc5NGYxYjhmL3RleHRyZWdpb246ODNlYWEzNGE5OGE5NDdhZDhkNjM4MDQ3Nzk0ZjFiOGZfNjg1_bcf371ab-5fa3-40a6-9147-623efa6cd5e0"
      unitRef="usd">400000</us-gaap:PropertyPlantAndEquipmentGross>
    <us-gaap:DepreciationAndAmortization
      contextRef="ia855382ada1f4f28aa8ef6da692ff177_D20220101-20220630"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmFlNWE5YmUwZWI5NDQ1ZDE5MmZhZTgyMmQyMmJlMDlmL3NlYzphZTVhOWJlMGViOTQ0NWQxOTJmYWU4MjJkMjJiZTA5Zl81NS9mcmFnOjgzZWFhMzRhOThhOTQ3YWQ4ZDYzODA0Nzc5NGYxYjhmL3RleHRyZWdpb246ODNlYWEzNGE5OGE5NDdhZDhkNjM4MDQ3Nzk0ZjFiOGZfNzc5_10d07f45-cb5d-448e-829f-371aaf51043e"
      unitRef="usd">100000</us-gaap:DepreciationAndAmortization>
    <us-gaap:DepreciationAndAmortization
      contextRef="icf690a1cf0024305b7396da4cb697adc_D20210101-20211231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmFlNWE5YmUwZWI5NDQ1ZDE5MmZhZTgyMmQyMmJlMDlmL3NlYzphZTVhOWJlMGViOTQ0NWQxOTJmYWU4MjJkMjJiZTA5Zl81NS9mcmFnOjgzZWFhMzRhOThhOTQ3YWQ4ZDYzODA0Nzc5NGYxYjhmL3RleHRyZWdpb246ODNlYWEzNGE5OGE5NDdhZDhkNjM4MDQ3Nzk0ZjFiOGZfNzg2_7f4db4d8-0efc-4220-a68b-4ebbb2444ff3"
      unitRef="usd">100000</us-gaap:DepreciationAndAmortization>
    <us-gaap:FinanceLeaseInterestExpense
      contextRef="i4ac87f578df0406d99e77dc768764559_D20220401-20220630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmFlNWE5YmUwZWI5NDQ1ZDE5MmZhZTgyMmQyMmJlMDlmL3NlYzphZTVhOWJlMGViOTQ0NWQxOTJmYWU4MjJkMjJiZTA5Zl81NS9mcmFnOjgzZWFhMzRhOThhOTQ3YWQ4ZDYzODA0Nzc5NGYxYjhmL3RleHRyZWdpb246ODNlYWEzNGE5OGE5NDdhZDhkNjM4MDQ3Nzk0ZjFiOGZfODc1_5920b682-1687-44bb-b511-ada2b212470b"
      unitRef="usd">3000</us-gaap:FinanceLeaseInterestExpense>
    <us-gaap:FinanceLeaseInterestExpense
      contextRef="ie146fe37064c4413b6d561285cac9dcd_D20210401-20210630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmFlNWE5YmUwZWI5NDQ1ZDE5MmZhZTgyMmQyMmJlMDlmL3NlYzphZTVhOWJlMGViOTQ0NWQxOTJmYWU4MjJkMjJiZTA5Zl81NS9mcmFnOjgzZWFhMzRhOThhOTQ3YWQ4ZDYzODA0Nzc5NGYxYjhmL3RleHRyZWdpb246ODNlYWEzNGE5OGE5NDdhZDhkNjM4MDQ3Nzk0ZjFiOGZfODgz_8d5bfc4e-febe-4836-ba26-ccf499f77d4d"
      unitRef="usd">4000</us-gaap:FinanceLeaseInterestExpense>
    <us-gaap:FinanceLeaseInterestExpense
      contextRef="i69bf0330ac3a4009ac4cc9f072eb2145_D20220101-20220630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmFlNWE5YmUwZWI5NDQ1ZDE5MmZhZTgyMmQyMmJlMDlmL3NlYzphZTVhOWJlMGViOTQ0NWQxOTJmYWU4MjJkMjJiZTA5Zl81NS9mcmFnOjgzZWFhMzRhOThhOTQ3YWQ4ZDYzODA0Nzc5NGYxYjhmL3RleHRyZWdpb246ODNlYWEzNGE5OGE5NDdhZDhkNjM4MDQ3Nzk0ZjFiOGZfOTQy_f5927bce-d2e8-43ed-bd41-8f1c2847636f"
      unitRef="usd">7000</us-gaap:FinanceLeaseInterestExpense>
    <us-gaap:FinanceLeaseInterestExpense
      contextRef="ia60e98d0ecdb4e6fac0242d43b27bd2b_D20210101-20210630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmFlNWE5YmUwZWI5NDQ1ZDE5MmZhZTgyMmQyMmJlMDlmL3NlYzphZTVhOWJlMGViOTQ0NWQxOTJmYWU4MjJkMjJiZTA5Zl81NS9mcmFnOjgzZWFhMzRhOThhOTQ3YWQ4ZDYzODA0Nzc5NGYxYjhmL3RleHRyZWdpb246ODNlYWEzNGE5OGE5NDdhZDhkNjM4MDQ3Nzk0ZjFiOGZfOTQ5_833dfaac-b76f-40b2-9f55-1cbcd0d8130e"
      unitRef="usd">8000</us-gaap:FinanceLeaseInterestExpense>
    <dmtk:ScheduleOfLongTermFinanceLeaseObligationsTableTextBlock
      contextRef="ia855382ada1f4f28aa8ef6da692ff177_D20220101-20220630"
      id="id3VybDovL2RvY3MudjEvZG9jOmFlNWE5YmUwZWI5NDQ1ZDE5MmZhZTgyMmQyMmJlMDlmL3NlYzphZTVhOWJlMGViOTQ0NWQxOTJmYWU4MjJkMjJiZTA5Zl81NS9mcmFnOjgzZWFhMzRhOThhOTQ3YWQ4ZDYzODA0Nzc5NGYxYjhmL3RleHRyZWdpb246ODNlYWEzNGE5OGE5NDdhZDhkNjM4MDQ3Nzk0ZjFiOGZfODM4OQ_bd2fbe8e-a78a-49fe-b6de-f34c9d0faf12">Long-term finance lease obligations are as follows (in thousands): &lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.696%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:69.264%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:13.337%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.407%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:13.492%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;June 30, 2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;December 31, 2021&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Gross finance lease obligations&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;262&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;274&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Less imputed interest&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(17)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(17)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Present value of net minimum lease payments&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;245&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;257&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Less current portion of finance lease obligations&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(134)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(121)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total long-term finance lease obligations&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;111&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;136&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;</dmtk:ScheduleOfLongTermFinanceLeaseObligationsTableTextBlock>
    <us-gaap:FinanceLeaseLiabilityPaymentsDue
      contextRef="i4c8f247d12134a9886d56e1c8b024425_I20220630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmFlNWE5YmUwZWI5NDQ1ZDE5MmZhZTgyMmQyMmJlMDlmL3NlYzphZTVhOWJlMGViOTQ0NWQxOTJmYWU4MjJkMjJiZTA5Zl81NS9mcmFnOjgzZWFhMzRhOThhOTQ3YWQ4ZDYzODA0Nzc5NGYxYjhmL3RhYmxlOjRjZmU2NzU5NGU0ZDQ3NzFhNTE0YTc3NGIxNzE4ODg0L3RhYmxlcmFuZ2U6NGNmZTY3NTk0ZTRkNDc3MWE1MTRhNzc0YjE3MTg4ODRfMS0xLTEtMS02MjY_02262fa4-237b-4626-acc6-8ee499d17f43"
      unitRef="usd">262000</us-gaap:FinanceLeaseLiabilityPaymentsDue>
    <us-gaap:FinanceLeaseLiabilityPaymentsDue
      contextRef="i87bf777ccf5f4f93bc9be7a2cbba61c1_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmFlNWE5YmUwZWI5NDQ1ZDE5MmZhZTgyMmQyMmJlMDlmL3NlYzphZTVhOWJlMGViOTQ0NWQxOTJmYWU4MjJkMjJiZTA5Zl81NS9mcmFnOjgzZWFhMzRhOThhOTQ3YWQ4ZDYzODA0Nzc5NGYxYjhmL3RhYmxlOjRjZmU2NzU5NGU0ZDQ3NzFhNTE0YTc3NGIxNzE4ODg0L3RhYmxlcmFuZ2U6NGNmZTY3NTk0ZTRkNDc3MWE1MTRhNzc0YjE3MTg4ODRfMS0zLTEtMS02MjY_c3a4ebb2-78ef-4fb3-80c1-2eb0862ace11"
      unitRef="usd">274000</us-gaap:FinanceLeaseLiabilityPaymentsDue>
    <us-gaap:FinanceLeaseLiabilityUndiscountedExcessAmount
      contextRef="i4c8f247d12134a9886d56e1c8b024425_I20220630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmFlNWE5YmUwZWI5NDQ1ZDE5MmZhZTgyMmQyMmJlMDlmL3NlYzphZTVhOWJlMGViOTQ0NWQxOTJmYWU4MjJkMjJiZTA5Zl81NS9mcmFnOjgzZWFhMzRhOThhOTQ3YWQ4ZDYzODA0Nzc5NGYxYjhmL3RhYmxlOjRjZmU2NzU5NGU0ZDQ3NzFhNTE0YTc3NGIxNzE4ODg0L3RhYmxlcmFuZ2U6NGNmZTY3NTk0ZTRkNDc3MWE1MTRhNzc0YjE3MTg4ODRfMi0xLTEtMS02MjY_9d86c9ce-42b2-4770-8b5f-de7cc5384c2f"
      unitRef="usd">17000</us-gaap:FinanceLeaseLiabilityUndiscountedExcessAmount>
    <us-gaap:FinanceLeaseLiabilityUndiscountedExcessAmount
      contextRef="i87bf777ccf5f4f93bc9be7a2cbba61c1_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmFlNWE5YmUwZWI5NDQ1ZDE5MmZhZTgyMmQyMmJlMDlmL3NlYzphZTVhOWJlMGViOTQ0NWQxOTJmYWU4MjJkMjJiZTA5Zl81NS9mcmFnOjgzZWFhMzRhOThhOTQ3YWQ4ZDYzODA0Nzc5NGYxYjhmL3RhYmxlOjRjZmU2NzU5NGU0ZDQ3NzFhNTE0YTc3NGIxNzE4ODg0L3RhYmxlcmFuZ2U6NGNmZTY3NTk0ZTRkNDc3MWE1MTRhNzc0YjE3MTg4ODRfMi0zLTEtMS02MjY_cc7e8dca-678c-4bda-91b2-563e2d43fd4b"
      unitRef="usd">17000</us-gaap:FinanceLeaseLiabilityUndiscountedExcessAmount>
    <us-gaap:FinanceLeaseLiability
      contextRef="i4c8f247d12134a9886d56e1c8b024425_I20220630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmFlNWE5YmUwZWI5NDQ1ZDE5MmZhZTgyMmQyMmJlMDlmL3NlYzphZTVhOWJlMGViOTQ0NWQxOTJmYWU4MjJkMjJiZTA5Zl81NS9mcmFnOjgzZWFhMzRhOThhOTQ3YWQ4ZDYzODA0Nzc5NGYxYjhmL3RhYmxlOjRjZmU2NzU5NGU0ZDQ3NzFhNTE0YTc3NGIxNzE4ODg0L3RhYmxlcmFuZ2U6NGNmZTY3NTk0ZTRkNDc3MWE1MTRhNzc0YjE3MTg4ODRfMy0xLTEtMS02MjY_6382b51a-9ba5-44fe-b963-9e1ca41eaeb2"
      unitRef="usd">245000</us-gaap:FinanceLeaseLiability>
    <us-gaap:FinanceLeaseLiability
      contextRef="i87bf777ccf5f4f93bc9be7a2cbba61c1_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmFlNWE5YmUwZWI5NDQ1ZDE5MmZhZTgyMmQyMmJlMDlmL3NlYzphZTVhOWJlMGViOTQ0NWQxOTJmYWU4MjJkMjJiZTA5Zl81NS9mcmFnOjgzZWFhMzRhOThhOTQ3YWQ4ZDYzODA0Nzc5NGYxYjhmL3RhYmxlOjRjZmU2NzU5NGU0ZDQ3NzFhNTE0YTc3NGIxNzE4ODg0L3RhYmxlcmFuZ2U6NGNmZTY3NTk0ZTRkNDc3MWE1MTRhNzc0YjE3MTg4ODRfMy0zLTEtMS02MjY_a2e85bc7-086b-42e4-bae5-8379d9c70cb4"
      unitRef="usd">257000</us-gaap:FinanceLeaseLiability>
    <us-gaap:FinanceLeaseLiabilityCurrent
      contextRef="i4c8f247d12134a9886d56e1c8b024425_I20220630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmFlNWE5YmUwZWI5NDQ1ZDE5MmZhZTgyMmQyMmJlMDlmL3NlYzphZTVhOWJlMGViOTQ0NWQxOTJmYWU4MjJkMjJiZTA5Zl81NS9mcmFnOjgzZWFhMzRhOThhOTQ3YWQ4ZDYzODA0Nzc5NGYxYjhmL3RhYmxlOjRjZmU2NzU5NGU0ZDQ3NzFhNTE0YTc3NGIxNzE4ODg0L3RhYmxlcmFuZ2U6NGNmZTY3NTk0ZTRkNDc3MWE1MTRhNzc0YjE3MTg4ODRfNC0xLTEtMS02MjY_b58bda5d-a491-45bd-875c-9b0da96bda86"
      unitRef="usd">134000</us-gaap:FinanceLeaseLiabilityCurrent>
    <us-gaap:FinanceLeaseLiabilityCurrent
      contextRef="i87bf777ccf5f4f93bc9be7a2cbba61c1_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmFlNWE5YmUwZWI5NDQ1ZDE5MmZhZTgyMmQyMmJlMDlmL3NlYzphZTVhOWJlMGViOTQ0NWQxOTJmYWU4MjJkMjJiZTA5Zl81NS9mcmFnOjgzZWFhMzRhOThhOTQ3YWQ4ZDYzODA0Nzc5NGYxYjhmL3RhYmxlOjRjZmU2NzU5NGU0ZDQ3NzFhNTE0YTc3NGIxNzE4ODg0L3RhYmxlcmFuZ2U6NGNmZTY3NTk0ZTRkNDc3MWE1MTRhNzc0YjE3MTg4ODRfNC0zLTEtMS02MjY_c9416b28-4af0-4ed7-992b-753f0d149012"
      unitRef="usd">121000</us-gaap:FinanceLeaseLiabilityCurrent>
    <us-gaap:FinanceLeaseLiabilityNoncurrent
      contextRef="i4c8f247d12134a9886d56e1c8b024425_I20220630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmFlNWE5YmUwZWI5NDQ1ZDE5MmZhZTgyMmQyMmJlMDlmL3NlYzphZTVhOWJlMGViOTQ0NWQxOTJmYWU4MjJkMjJiZTA5Zl81NS9mcmFnOjgzZWFhMzRhOThhOTQ3YWQ4ZDYzODA0Nzc5NGYxYjhmL3RhYmxlOjRjZmU2NzU5NGU0ZDQ3NzFhNTE0YTc3NGIxNzE4ODg0L3RhYmxlcmFuZ2U6NGNmZTY3NTk0ZTRkNDc3MWE1MTRhNzc0YjE3MTg4ODRfNS0xLTEtMS02MjY_7a296330-5158-4e62-9d5b-cd472d1388c8"
      unitRef="usd">111000</us-gaap:FinanceLeaseLiabilityNoncurrent>
    <us-gaap:FinanceLeaseLiabilityNoncurrent
      contextRef="i87bf777ccf5f4f93bc9be7a2cbba61c1_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmFlNWE5YmUwZWI5NDQ1ZDE5MmZhZTgyMmQyMmJlMDlmL3NlYzphZTVhOWJlMGViOTQ0NWQxOTJmYWU4MjJkMjJiZTA5Zl81NS9mcmFnOjgzZWFhMzRhOThhOTQ3YWQ4ZDYzODA0Nzc5NGYxYjhmL3RhYmxlOjRjZmU2NzU5NGU0ZDQ3NzFhNTE0YTc3NGIxNzE4ODg0L3RhYmxlcmFuZ2U6NGNmZTY3NTk0ZTRkNDc3MWE1MTRhNzc0YjE3MTg4ODRfNS0zLTEtMS02MjY_6f6997b2-c6eb-45e8-95ef-732408eb219f"
      unitRef="usd">136000</us-gaap:FinanceLeaseLiabilityNoncurrent>
    <dmtk:AreaOfBuilding
      contextRef="i1618d3c7213a4aa5a35fb7ebe4eea53b_D20210701-20210701"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmFlNWE5YmUwZWI5NDQ1ZDE5MmZhZTgyMmQyMmJlMDlmL3NlYzphZTVhOWJlMGViOTQ0NWQxOTJmYWU4MjJkMjJiZTA5Zl81NS9mcmFnOjgzZWFhMzRhOThhOTQ3YWQ4ZDYzODA0Nzc5NGYxYjhmL3RleHRyZWdpb246ODNlYWEzNGE5OGE5NDdhZDhkNjM4MDQ3Nzk0ZjFiOGZfMTM1NA_7df34cab-c5cf-45f3-9612-d0c9fa57b574"
      unitRef="sqft">95997</dmtk:AreaOfBuilding>
    <dmtk:TenantImprovementAllowancePerRentableSquareFoot
      contextRef="i1618d3c7213a4aa5a35fb7ebe4eea53b_D20210701-20210701"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOmFlNWE5YmUwZWI5NDQ1ZDE5MmZhZTgyMmQyMmJlMDlmL3NlYzphZTVhOWJlMGViOTQ0NWQxOTJmYWU4MjJkMjJiZTA5Zl81NS9mcmFnOjgzZWFhMzRhOThhOTQ3YWQ4ZDYzODA0Nzc5NGYxYjhmL3RleHRyZWdpb246ODNlYWEzNGE5OGE5NDdhZDhkNjM4MDQ3Nzk0ZjFiOGZfMTY1NA_b1902a8c-8500-44b5-ae1e-66bf0aaa48f6"
      unitRef="usdPerSqft">125.00</dmtk:TenantImprovementAllowancePerRentableSquareFoot>
    <us-gaap:TenantImprovements
      contextRef="icbcfccaf50f84ffca456a076d115a21c_I20210701"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmFlNWE5YmUwZWI5NDQ1ZDE5MmZhZTgyMmQyMmJlMDlmL3NlYzphZTVhOWJlMGViOTQ0NWQxOTJmYWU4MjJkMjJiZTA5Zl81NS9mcmFnOjgzZWFhMzRhOThhOTQ3YWQ4ZDYzODA0Nzc5NGYxYjhmL3RleHRyZWdpb246ODNlYWEzNGE5OGE5NDdhZDhkNjM4MDQ3Nzk0ZjFiOGZfMTcyMA_4e4fce7f-205a-4675-9f66-21b99612522d"
      unitRef="usd">12000000</us-gaap:TenantImprovements>
    <dmtk:NumberOfImprovementPhases
      contextRef="i4c8f247d12134a9886d56e1c8b024425_I20220630"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmFlNWE5YmUwZWI5NDQ1ZDE5MmZhZTgyMmQyMmJlMDlmL3NlYzphZTVhOWJlMGViOTQ0NWQxOTJmYWU4MjJkMjJiZTA5Zl81NS9mcmFnOjgzZWFhMzRhOThhOTQ3YWQ4ZDYzODA0Nzc5NGYxYjhmL3RleHRyZWdpb246ODNlYWEzNGE5OGE5NDdhZDhkNjM4MDQ3Nzk0ZjFiOGZfMzI5ODUzNDkwOTg1OA_5492d5b8-3501-4fc9-be5c-024bb8e6288b"
      unitRef="phase">4</dmtk:NumberOfImprovementPhases>
    <dmtk:LesseeOperatingLeaseNumberOfRenewalTerms
      contextRef="i53405b48f5954e23b556c40be1389d0c_I20220630"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmFlNWE5YmUwZWI5NDQ1ZDE5MmZhZTgyMmQyMmJlMDlmL3NlYzphZTVhOWJlMGViOTQ0NWQxOTJmYWU4MjJkMjJiZTA5Zl81NS9mcmFnOjgzZWFhMzRhOThhOTQ3YWQ4ZDYzODA0Nzc5NGYxYjhmL3RleHRyZWdpb246ODNlYWEzNGE5OGE5NDdhZDhkNjM4MDQ3Nzk0ZjFiOGZfMzI5ODUzNDkwOTg2Mg_654e4339-c608-4c48-bb4f-4c60191d7ff0"
      unitRef="period">2</dmtk:LesseeOperatingLeaseNumberOfRenewalTerms>
    <us-gaap:LesseeOperatingLeaseRenewalTerm
      contextRef="i53405b48f5954e23b556c40be1389d0c_I20220630"
      id="id3VybDovL2RvY3MudjEvZG9jOmFlNWE5YmUwZWI5NDQ1ZDE5MmZhZTgyMmQyMmJlMDlmL3NlYzphZTVhOWJlMGViOTQ0NWQxOTJmYWU4MjJkMjJiZTA5Zl81NS9mcmFnOjgzZWFhMzRhOThhOTQ3YWQ4ZDYzODA0Nzc5NGYxYjhmL3RleHRyZWdpb246ODNlYWEzNGE5OGE5NDdhZDhkNjM4MDQ3Nzk0ZjFiOGZfMzI5ODUzNDkwOTg2NA_27988201-13d9-4513-be3e-b2bd5c3cdc7b">P5Y</us-gaap:LesseeOperatingLeaseRenewalTerm>
    <us-gaap:LesseeOperatingLeaseRenewalTerm
      contextRef="i53405b48f5954e23b556c40be1389d0c_I20220630"
      id="id3VybDovL2RvY3MudjEvZG9jOmFlNWE5YmUwZWI5NDQ1ZDE5MmZhZTgyMmQyMmJlMDlmL3NlYzphZTVhOWJlMGViOTQ0NWQxOTJmYWU4MjJkMjJiZTA5Zl81NS9mcmFnOjgzZWFhMzRhOThhOTQ3YWQ4ZDYzODA0Nzc5NGYxYjhmL3RleHRyZWdpb246ODNlYWEzNGE5OGE5NDdhZDhkNjM4MDQ3Nzk0ZjFiOGZfMjk1Mw_65f164f0-99bb-48fc-ba48-d851092727cc">P5Y</us-gaap:LesseeOperatingLeaseRenewalTerm>
    <us-gaap:OperatingLeaseLiability
      contextRef="i53405b48f5954e23b556c40be1389d0c_I20220630"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmFlNWE5YmUwZWI5NDQ1ZDE5MmZhZTgyMmQyMmJlMDlmL3NlYzphZTVhOWJlMGViOTQ0NWQxOTJmYWU4MjJkMjJiZTA5Zl81NS9mcmFnOjgzZWFhMzRhOThhOTQ3YWQ4ZDYzODA0Nzc5NGYxYjhmL3RleHRyZWdpb246ODNlYWEzNGE5OGE5NDdhZDhkNjM4MDQ3Nzk0ZjFiOGZfMzM5NA_60f6c7b3-d309-4496-9790-8bbdbe9c3704"
      unitRef="usd">5700000</us-gaap:OperatingLeaseLiability>
    <us-gaap:OperatingLeaseRightOfUseAsset
      contextRef="i53405b48f5954e23b556c40be1389d0c_I20220630"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmFlNWE5YmUwZWI5NDQ1ZDE5MmZhZTgyMmQyMmJlMDlmL3NlYzphZTVhOWJlMGViOTQ0NWQxOTJmYWU4MjJkMjJiZTA5Zl81NS9mcmFnOjgzZWFhMzRhOThhOTQ3YWQ4ZDYzODA0Nzc5NGYxYjhmL3RleHRyZWdpb246ODNlYWEzNGE5OGE5NDdhZDhkNjM4MDQ3Nzk0ZjFiOGZfMzM5NA_e65f907d-1bf0-4c14-8ea3-f6f5bef894d3"
      unitRef="usd">5700000</us-gaap:OperatingLeaseRightOfUseAsset>
    <us-gaap:OperatingLeaseLiability
      contextRef="i75aabbdde1174af48e324feb000a8af2_I20220331"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmFlNWE5YmUwZWI5NDQ1ZDE5MmZhZTgyMmQyMmJlMDlmL3NlYzphZTVhOWJlMGViOTQ0NWQxOTJmYWU4MjJkMjJiZTA5Zl81NS9mcmFnOjgzZWFhMzRhOThhOTQ3YWQ4ZDYzODA0Nzc5NGYxYjhmL3RleHRyZWdpb246ODNlYWEzNGE5OGE5NDdhZDhkNjM4MDQ3Nzk0ZjFiOGZfMTY0OTI2NzQ5Njg5Mw_608e87ce-970b-4e87-bc7c-44ac908c9bee"
      unitRef="usd">15800000</us-gaap:OperatingLeaseLiability>
    <us-gaap:OperatingLeaseRightOfUseAsset
      contextRef="i75aabbdde1174af48e324feb000a8af2_I20220331"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmFlNWE5YmUwZWI5NDQ1ZDE5MmZhZTgyMmQyMmJlMDlmL3NlYzphZTVhOWJlMGViOTQ0NWQxOTJmYWU4MjJkMjJiZTA5Zl81NS9mcmFnOjgzZWFhMzRhOThhOTQ3YWQ4ZDYzODA0Nzc5NGYxYjhmL3RleHRyZWdpb246ODNlYWEzNGE5OGE5NDdhZDhkNjM4MDQ3Nzk0ZjFiOGZfMTY0OTI2NzQ5Njg5Mw_9dfb6908-0bd9-499b-934b-1d7e8d098bf5"
      unitRef="usd">15800000</us-gaap:OperatingLeaseRightOfUseAsset>
    <dmtk:IncreaseInTenantImprovementAllowancePerRentableSquareFoot
      contextRef="i9841b134190d454987c9c0ed787bc2e8_D20220401-20220430"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOmFlNWE5YmUwZWI5NDQ1ZDE5MmZhZTgyMmQyMmJlMDlmL3NlYzphZTVhOWJlMGViOTQ0NWQxOTJmYWU4MjJkMjJiZTA5Zl81NS9mcmFnOjgzZWFhMzRhOThhOTQ3YWQ4ZDYzODA0Nzc5NGYxYjhmL3RleHRyZWdpb246ODNlYWEzNGE5OGE5NDdhZDhkNjM4MDQ3Nzk0ZjFiOGZfMjE5OTAyMzMxMTUyNQ_a5120e21-7f29-4d6a-8ede-69076c2aecdc"
      unitRef="usdPerSqft">25.00</dmtk:IncreaseInTenantImprovementAllowancePerRentableSquareFoot>
    <dmtk:IncreaseInTenantImprovementAllowance
      contextRef="i9841b134190d454987c9c0ed787bc2e8_D20220401-20220430"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmFlNWE5YmUwZWI5NDQ1ZDE5MmZhZTgyMmQyMmJlMDlmL3NlYzphZTVhOWJlMGViOTQ0NWQxOTJmYWU4MjJkMjJiZTA5Zl81NS9mcmFnOjgzZWFhMzRhOThhOTQ3YWQ4ZDYzODA0Nzc5NGYxYjhmL3RleHRyZWdpb246ODNlYWEzNGE5OGE5NDdhZDhkNjM4MDQ3Nzk0ZjFiOGZfMTY0OTI2NzQ5NzU3MQ_d1c2c76f-6400-421d-b169-6545d0dcdb1b"
      unitRef="usd">2400000</dmtk:IncreaseInTenantImprovementAllowance>
    <us-gaap:TenantImprovements
      contextRef="i87140271b1e742e28e8d60cec9e90bf4_I20220430"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmFlNWE5YmUwZWI5NDQ1ZDE5MmZhZTgyMmQyMmJlMDlmL3NlYzphZTVhOWJlMGViOTQ0NWQxOTJmYWU4MjJkMjJiZTA5Zl81NS9mcmFnOjgzZWFhMzRhOThhOTQ3YWQ4ZDYzODA0Nzc5NGYxYjhmL3RleHRyZWdpb246ODNlYWEzNGE5OGE5NDdhZDhkNjM4MDQ3Nzk0ZjFiOGZfMjE5OTAyMzMxMTg5OQ_18f7d991-2ee1-4aa0-aaf5-01b211a998d0"
      unitRef="usd">14400000</us-gaap:TenantImprovements>
    <dmtk:RentableAndUsableSquareFeet
      contextRef="if757ed00e77b443b929b902040ede6fe_D20220422-20220422"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmFlNWE5YmUwZWI5NDQ1ZDE5MmZhZTgyMmQyMmJlMDlmL3NlYzphZTVhOWJlMGViOTQ0NWQxOTJmYWU4MjJkMjJiZTA5Zl81NS9mcmFnOjgzZWFhMzRhOThhOTQ3YWQ4ZDYzODA0Nzc5NGYxYjhmL3RleHRyZWdpb246ODNlYWEzNGE5OGE5NDdhZDhkNjM4MDQ3Nzk0ZjFiOGZfMTY0OTI2NzQ4MDEwNA_dc8de15d-bf6d-424c-9857-9e1d0319782e"
      unitRef="sqft">14085</dmtk:RentableAndUsableSquareFeet>
    <dmtk:IncreaseInTenantImprovementAllowance
      contextRef="if757ed00e77b443b929b902040ede6fe_D20220422-20220422"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmFlNWE5YmUwZWI5NDQ1ZDE5MmZhZTgyMmQyMmJlMDlmL3NlYzphZTVhOWJlMGViOTQ0NWQxOTJmYWU4MjJkMjJiZTA5Zl81NS9mcmFnOjgzZWFhMzRhOThhOTQ3YWQ4ZDYzODA0Nzc5NGYxYjhmL3RleHRyZWdpb246ODNlYWEzNGE5OGE5NDdhZDhkNjM4MDQ3Nzk0ZjFiOGZfMjE5OTAyMzMxMTc5Nw_1ede8b3d-3948-46bd-be07-007a29e29e88"
      unitRef="usd">2100000</dmtk:IncreaseInTenantImprovementAllowance>
    <us-gaap:TenantImprovements
      contextRef="i21d961efb50e46f8a491229d676e3cca_I20220430"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmFlNWE5YmUwZWI5NDQ1ZDE5MmZhZTgyMmQyMmJlMDlmL3NlYzphZTVhOWJlMGViOTQ0NWQxOTJmYWU4MjJkMjJiZTA5Zl81NS9mcmFnOjgzZWFhMzRhOThhOTQ3YWQ4ZDYzODA0Nzc5NGYxYjhmL3RleHRyZWdpb246ODNlYWEzNGE5OGE5NDdhZDhkNjM4MDQ3Nzk0ZjFiOGZfMjE5OTAyMzMxMTgwNw_83878af4-2a4a-4ee6-bdbc-637a3a6fa720"
      unitRef="usd">16500000</us-gaap:TenantImprovements>
    <dmtk:AreaOfBuilding
      contextRef="i31c7d90c2ed74429be6d97f4216d8b3b_D20220422-20220422"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmFlNWE5YmUwZWI5NDQ1ZDE5MmZhZTgyMmQyMmJlMDlmL3NlYzphZTVhOWJlMGViOTQ0NWQxOTJmYWU4MjJkMjJiZTA5Zl81NS9mcmFnOjgzZWFhMzRhOThhOTQ3YWQ4ZDYzODA0Nzc5NGYxYjhmL3RleHRyZWdpb246ODNlYWEzNGE5OGE5NDdhZDhkNjM4MDQ3Nzk0ZjFiOGZfMTY0OTI2NzQ4MDA3Ng_d86f071d-2913-41b0-8650-fb7901bccb28"
      unitRef="sqft">110082</dmtk:AreaOfBuilding>
    <dmtk:OperatingLeaseIncrementalBorrowingRateAtEffectiveDate
      contextRef="i40b956e3abae4c74a57f8271e4e2cc81_I20220430"
      decimals="4"
      id="id3VybDovL2RvY3MudjEvZG9jOmFlNWE5YmUwZWI5NDQ1ZDE5MmZhZTgyMmQyMmJlMDlmL3NlYzphZTVhOWJlMGViOTQ0NWQxOTJmYWU4MjJkMjJiZTA5Zl81NS9mcmFnOjgzZWFhMzRhOThhOTQ3YWQ4ZDYzODA0Nzc5NGYxYjhmL3RleHRyZWdpb246ODNlYWEzNGE5OGE5NDdhZDhkNjM4MDQ3Nzk0ZjFiOGZfMTY0OTI2NzQ5NTY2OA_aebe7a2a-1e32-4eed-a165-f7eceaa0d770"
      unitRef="number">0.0650</dmtk:OperatingLeaseIncrementalBorrowingRateAtEffectiveDate>
    <us-gaap:IncreaseDecreaseInOperatingLeaseLiability
      contextRef="iefc8a51c0ee64a2e92b3f718d0d8914b_D20220401-20220430"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmFlNWE5YmUwZWI5NDQ1ZDE5MmZhZTgyMmQyMmJlMDlmL3NlYzphZTVhOWJlMGViOTQ0NWQxOTJmYWU4MjJkMjJiZTA5Zl81NS9mcmFnOjgzZWFhMzRhOThhOTQ3YWQ4ZDYzODA0Nzc5NGYxYjhmL3RleHRyZWdpb246ODNlYWEzNGE5OGE5NDdhZDhkNjM4MDQ3Nzk0ZjFiOGZfMTY0OTI2NzQ5NTY4Nw_26d78d1f-c6d9-4030-8821-26c57dcd3fa0"
      unitRef="usd">1200000</us-gaap:IncreaseDecreaseInOperatingLeaseLiability>
    <dmtk:IncreaseDecreaseInOperatingLeaseRightOfUseAsset
      contextRef="iefc8a51c0ee64a2e92b3f718d0d8914b_D20220401-20220430"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmFlNWE5YmUwZWI5NDQ1ZDE5MmZhZTgyMmQyMmJlMDlmL3NlYzphZTVhOWJlMGViOTQ0NWQxOTJmYWU4MjJkMjJiZTA5Zl81NS9mcmFnOjgzZWFhMzRhOThhOTQ3YWQ4ZDYzODA0Nzc5NGYxYjhmL3RleHRyZWdpb246ODNlYWEzNGE5OGE5NDdhZDhkNjM4MDQ3Nzk0ZjFiOGZfMTY0OTI2NzQ5NTY4Nw_f415a3a9-6ed0-445a-abaa-90bcfc1f1f2d"
      unitRef="usd">1200000</dmtk:IncreaseDecreaseInOperatingLeaseRightOfUseAsset>
    <us-gaap:LesseeOperatingLeaseLiabilityPaymentsDue
      contextRef="i53405b48f5954e23b556c40be1389d0c_I20220630"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmFlNWE5YmUwZWI5NDQ1ZDE5MmZhZTgyMmQyMmJlMDlmL3NlYzphZTVhOWJlMGViOTQ0NWQxOTJmYWU4MjJkMjJiZTA5Zl81NS9mcmFnOjgzZWFhMzRhOThhOTQ3YWQ4ZDYzODA0Nzc5NGYxYjhmL3RleHRyZWdpb246ODNlYWEzNGE5OGE5NDdhZDhkNjM4MDQ3Nzk0ZjFiOGZfMzk3MQ_ee35bd24-00ae-410b-b3e1-72f7e8e3f9d8"
      unitRef="usd">54400000</us-gaap:LesseeOperatingLeaseLiabilityPaymentsDue>
    <us-gaap:RestrictedCashAndCashEquivalents
      contextRef="i2d28646a716649a3bf03b33932b88ddc_I20220630"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmFlNWE5YmUwZWI5NDQ1ZDE5MmZhZTgyMmQyMmJlMDlmL3NlYzphZTVhOWJlMGViOTQ0NWQxOTJmYWU4MjJkMjJiZTA5Zl81NS9mcmFnOjgzZWFhMzRhOThhOTQ3YWQ4ZDYzODA0Nzc5NGYxYjhmL3RleHRyZWdpb246ODNlYWEzNGE5OGE5NDdhZDhkNjM4MDQ3Nzk0ZjFiOGZfNDQxNg_a53f132e-2031-462a-81f1-914e8ef8198d"
      unitRef="usd">3000000</us-gaap:RestrictedCashAndCashEquivalents>
    <dmtk:RestrictedCashAndCashEquivalentsIncreaseDecrease
      contextRef="i5c5f906de07546fbad68db3bc16af2da_D20220401-20220430"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmFlNWE5YmUwZWI5NDQ1ZDE5MmZhZTgyMmQyMmJlMDlmL3NlYzphZTVhOWJlMGViOTQ0NWQxOTJmYWU4MjJkMjJiZTA5Zl81NS9mcmFnOjgzZWFhMzRhOThhOTQ3YWQ4ZDYzODA0Nzc5NGYxYjhmL3RleHRyZWdpb246ODNlYWEzNGE5OGE5NDdhZDhkNjM4MDQ3Nzk0ZjFiOGZfMTY0OTI2NzQ5NTEwMA_460aa295-18f3-4b8d-aa76-db8a41f094e8"
      unitRef="usd">500000</dmtk:RestrictedCashAndCashEquivalentsIncreaseDecrease>
    <us-gaap:RestrictedCashAndCashEquivalents
      contextRef="ie106f93322ee42508b7a8c0522c1e6f8_I20220430"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmFlNWE5YmUwZWI5NDQ1ZDE5MmZhZTgyMmQyMmJlMDlmL3NlYzphZTVhOWJlMGViOTQ0NWQxOTJmYWU4MjJkMjJiZTA5Zl81NS9mcmFnOjgzZWFhMzRhOThhOTQ3YWQ4ZDYzODA0Nzc5NGYxYjhmL3RleHRyZWdpb246ODNlYWEzNGE5OGE5NDdhZDhkNjM4MDQ3Nzk0ZjFiOGZfMTY0OTI2NzQ5NTExNw_1a007871-f7ea-4760-a68b-f270972879d4"
      unitRef="usd">3500000</us-gaap:RestrictedCashAndCashEquivalents>
    <us-gaap:RestrictedCashAndCashEquivalents
      contextRef="ie247503b8ef34dcca0fca78fe783bff5_I20220630"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmFlNWE5YmUwZWI5NDQ1ZDE5MmZhZTgyMmQyMmJlMDlmL3NlYzphZTVhOWJlMGViOTQ0NWQxOTJmYWU4MjJkMjJiZTA5Zl81NS9mcmFnOjgzZWFhMzRhOThhOTQ3YWQ4ZDYzODA0Nzc5NGYxYjhmL3RleHRyZWdpb246ODNlYWEzNGE5OGE5NDdhZDhkNjM4MDQ3Nzk0ZjFiOGZfNDU1MQ_0a2fb0b4-d097-4341-aa65-f5030c7c96d1"
      unitRef="usd">0</us-gaap:RestrictedCashAndCashEquivalents>
    <dmtk:TenantImprovementAllowance
      contextRef="i4c8f247d12134a9886d56e1c8b024425_I20220630"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmFlNWE5YmUwZWI5NDQ1ZDE5MmZhZTgyMmQyMmJlMDlmL3NlYzphZTVhOWJlMGViOTQ0NWQxOTJmYWU4MjJkMjJiZTA5Zl81NS9mcmFnOjgzZWFhMzRhOThhOTQ3YWQ4ZDYzODA0Nzc5NGYxYjhmL3RleHRyZWdpb246ODNlYWEzNGE5OGE5NDdhZDhkNjM4MDQ3Nzk0ZjFiOGZfNDgwNQ_d25dded1-54f9-4ef6-961c-6493022c29ba"
      unitRef="usd">300000</dmtk:TenantImprovementAllowance>
    <dmtk:IncreaseInTenantImprovementAllowance
      contextRef="i9069aff5693b479db8eb460a09c920a0_D20220101-20220630"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmFlNWE5YmUwZWI5NDQ1ZDE5MmZhZTgyMmQyMmJlMDlmL3NlYzphZTVhOWJlMGViOTQ0NWQxOTJmYWU4MjJkMjJiZTA5Zl81NS9mcmFnOjgzZWFhMzRhOThhOTQ3YWQ4ZDYzODA0Nzc5NGYxYjhmL3RleHRyZWdpb246ODNlYWEzNGE5OGE5NDdhZDhkNjM4MDQ3Nzk0ZjFiOGZfNDg0OA_0d4e7911-0139-4ff4-84d4-bf433d1380f5"
      unitRef="usd">100000</dmtk:IncreaseInTenantImprovementAllowance>
    <dmtk:LesseeOperatingLeaseNumberOfRenewalTerms
      contextRef="i4c8f247d12134a9886d56e1c8b024425_I20220630"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmFlNWE5YmUwZWI5NDQ1ZDE5MmZhZTgyMmQyMmJlMDlmL3NlYzphZTVhOWJlMGViOTQ0NWQxOTJmYWU4MjJkMjJiZTA5Zl81NS9mcmFnOjgzZWFhMzRhOThhOTQ3YWQ4ZDYzODA0Nzc5NGYxYjhmL3RleHRyZWdpb246ODNlYWEzNGE5OGE5NDdhZDhkNjM4MDQ3Nzk0ZjFiOGZfNTQ5NzU1ODY5MjUz_a2d8eaf5-659c-4a63-8f0c-7a914bcd3954"
      unitRef="period">1</dmtk:LesseeOperatingLeaseNumberOfRenewalTerms>
    <us-gaap:LesseeOperatingLeaseRenewalTerm
      contextRef="i4c8f247d12134a9886d56e1c8b024425_I20220630"
      id="id3VybDovL2RvY3MudjEvZG9jOmFlNWE5YmUwZWI5NDQ1ZDE5MmZhZTgyMmQyMmJlMDlmL3NlYzphZTVhOWJlMGViOTQ0NWQxOTJmYWU4MjJkMjJiZTA5Zl81NS9mcmFnOjgzZWFhMzRhOThhOTQ3YWQ4ZDYzODA0Nzc5NGYxYjhmL3RleHRyZWdpb246ODNlYWEzNGE5OGE5NDdhZDhkNjM4MDQ3Nzk0ZjFiOGZfMzI5ODUzNDkzODczMg_1362d7dd-e61b-4a93-8894-17753d07f765">P3Y</us-gaap:LesseeOperatingLeaseRenewalTerm>
    <us-gaap:LesseeOperatingLeaseRemainingLeaseTerm
      contextRef="i4976bcc83f7e4c978a094cc7482066ef_I20210101"
      id="id3VybDovL2RvY3MudjEvZG9jOmFlNWE5YmUwZWI5NDQ1ZDE5MmZhZTgyMmQyMmJlMDlmL3NlYzphZTVhOWJlMGViOTQ0NWQxOTJmYWU4MjJkMjJiZTA5Zl81NS9mcmFnOjgzZWFhMzRhOThhOTQ3YWQ4ZDYzODA0Nzc5NGYxYjhmL3RleHRyZWdpb246ODNlYWEzNGE5OGE5NDdhZDhkNjM4MDQ3Nzk0ZjFiOGZfNTY4NA_137cb891-8509-46ef-b78a-472bb7751168">P28M</us-gaap:LesseeOperatingLeaseRemainingLeaseTerm>
    <us-gaap:LesseeOperatingLeaseDiscountRate
      contextRef="i4976bcc83f7e4c978a094cc7482066ef_I20210101"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOmFlNWE5YmUwZWI5NDQ1ZDE5MmZhZTgyMmQyMmJlMDlmL3NlYzphZTVhOWJlMGViOTQ0NWQxOTJmYWU4MjJkMjJiZTA5Zl81NS9mcmFnOjgzZWFhMzRhOThhOTQ3YWQ4ZDYzODA0Nzc5NGYxYjhmL3RleHRyZWdpb246ODNlYWEzNGE5OGE5NDdhZDhkNjM4MDQ3Nzk0ZjFiOGZfNTcyOA_2d959b2b-5e43-4e58-9efd-f58a8941fc81"
      unitRef="number">4.04</us-gaap:LesseeOperatingLeaseDiscountRate>
    <us-gaap:OperatingLeaseLiability
      contextRef="i4976bcc83f7e4c978a094cc7482066ef_I20210101"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmFlNWE5YmUwZWI5NDQ1ZDE5MmZhZTgyMmQyMmJlMDlmL3NlYzphZTVhOWJlMGViOTQ0NWQxOTJmYWU4MjJkMjJiZTA5Zl81NS9mcmFnOjgzZWFhMzRhOThhOTQ3YWQ4ZDYzODA0Nzc5NGYxYjhmL3RleHRyZWdpb246ODNlYWEzNGE5OGE5NDdhZDhkNjM4MDQ3Nzk0ZjFiOGZfNTg1OA_d02bc1fa-2d19-4283-88f7-af4a3cba1b5c"
      unitRef="usd">3100000</us-gaap:OperatingLeaseLiability>
    <us-gaap:OperatingLeaseRightOfUseAsset
      contextRef="i4976bcc83f7e4c978a094cc7482066ef_I20210101"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmFlNWE5YmUwZWI5NDQ1ZDE5MmZhZTgyMmQyMmJlMDlmL3NlYzphZTVhOWJlMGViOTQ0NWQxOTJmYWU4MjJkMjJiZTA5Zl81NS9mcmFnOjgzZWFhMzRhOThhOTQ3YWQ4ZDYzODA0Nzc5NGYxYjhmL3RleHRyZWdpb246ODNlYWEzNGE5OGE5NDdhZDhkNjM4MDQ3Nzk0ZjFiOGZfNTg4OQ_ac125831-4e1b-4205-a0b6-297514eb2fdb"
      unitRef="usd">2800000</us-gaap:OperatingLeaseRightOfUseAsset>
    <dmtk:TenantImprovementAllowance
      contextRef="i4976bcc83f7e4c978a094cc7482066ef_I20210101"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmFlNWE5YmUwZWI5NDQ1ZDE5MmZhZTgyMmQyMmJlMDlmL3NlYzphZTVhOWJlMGViOTQ0NWQxOTJmYWU4MjJkMjJiZTA5Zl81NS9mcmFnOjgzZWFhMzRhOThhOTQ3YWQ4ZDYzODA0Nzc5NGYxYjhmL3RleHRyZWdpb246ODNlYWEzNGE5OGE5NDdhZDhkNjM4MDQ3Nzk0ZjFiOGZfNTkwOQ_d714b81e-fafd-4362-9b97-a4b73369a980"
      unitRef="usd">300000</dmtk:TenantImprovementAllowance>
    <us-gaap:LeaseCostTableTextBlock
      contextRef="ia855382ada1f4f28aa8ef6da692ff177_D20220101-20220630"
      id="id3VybDovL2RvY3MudjEvZG9jOmFlNWE5YmUwZWI5NDQ1ZDE5MmZhZTgyMmQyMmJlMDlmL3NlYzphZTVhOWJlMGViOTQ0NWQxOTJmYWU4MjJkMjJiZTA5Zl81NS9mcmFnOjgzZWFhMzRhOThhOTQ3YWQ4ZDYzODA0Nzc5NGYxYjhmL3RleHRyZWdpb246ODNlYWEzNGE5OGE5NDdhZDhkNjM4MDQ3Nzk0ZjFiOGZfODM5MQ_06ca15be-bb10-4bfc-b41f-3e812d36fc7f">&lt;div style="margin-top:9pt;padding-left:27pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The components of lease expense for the three and six months ended June&#160;30, 2022 was as follows (in thousands):&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:12pt;text-align:center"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:43.803%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.750%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.390%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.750%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.390%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.750%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.390%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:13.677%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Three Months Ended June 30,&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Six Months Ended June 30,&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Operating lease cost&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 10pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Operating lease cost&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;1,044&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;319&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;1,667&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;638&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="padding-left:9pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Variable lease costs &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.85pt;font-weight:400;line-height:100%;position:relative;top:-3.15pt;vertical-align:baseline"&gt;(1)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;303&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;143&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;492&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;315&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Total operating lease cost&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;1,347&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;462&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;2,159&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;953&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr style="height:15pt"&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Finance lease cost&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 10pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Amortization of leased assets&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;21&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;17&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;41&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;34&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 10pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Interest on lease liabilities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;3&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;4&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;7&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;8&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Total finance lease cost&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;24&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;21&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;48&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;42&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;(1) Variable lease costs are primarily related to common area maintenance charges and property taxes.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:9pt;padding-left:27pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Other information related to leases was as shown in the table below. &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:12pt;text-align:center"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:68.900%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.406%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:13.293%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.406%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:13.295%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Six Months Ended June 30,&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Cash paid for amounts included in the measurement of lease liabilities:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 10pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Operating cash flows from operating leases&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;1,179&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;684&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 10pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Operating cash flows from finance leases&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;7&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;8&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 10pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Financing cash flows from finance leases&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;60&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;53&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Right-of-use assets obtained in exchange for lease obligations:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 10pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Operating leases&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;17,059&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;2,831&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 10pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Finance leases&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;48&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Weighted average remaining lease term in years:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 10pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Operating leases&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;10.56&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;1.92&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 10pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Finance leases&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;1.50&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;2.50&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Weighted average discount rate:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 10pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Operating leases&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;6.39&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;4.04&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 10pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Finance leases&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;5.78&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;5.54&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;</us-gaap:LeaseCostTableTextBlock>
    <us-gaap:OperatingLeaseCost
      contextRef="i2c5f0f28773744e5a2e202f2943ae976_D20220401-20220630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmFlNWE5YmUwZWI5NDQ1ZDE5MmZhZTgyMmQyMmJlMDlmL3NlYzphZTVhOWJlMGViOTQ0NWQxOTJmYWU4MjJkMjJiZTA5Zl81NS9mcmFnOjgzZWFhMzRhOThhOTQ3YWQ4ZDYzODA0Nzc5NGYxYjhmL3RhYmxlOmY3NGQzNDMwOWUyMDQxOTY4MzJkNTAwMDc1YWFlZjBmL3RhYmxlcmFuZ2U6Zjc0ZDM0MzA5ZTIwNDE5NjgzMmQ1MDAwNzVhYWVmMGZfMi0xLTEtMS02MjY_c3bcc578-6391-4769-ada3-7d4c3fbcb18a"
      unitRef="usd">1044000</us-gaap:OperatingLeaseCost>
    <us-gaap:OperatingLeaseCost
      contextRef="id7bb773872394047ba26aa8a7a0f4d56_D20210401-20210630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmFlNWE5YmUwZWI5NDQ1ZDE5MmZhZTgyMmQyMmJlMDlmL3NlYzphZTVhOWJlMGViOTQ0NWQxOTJmYWU4MjJkMjJiZTA5Zl81NS9mcmFnOjgzZWFhMzRhOThhOTQ3YWQ4ZDYzODA0Nzc5NGYxYjhmL3RhYmxlOmY3NGQzNDMwOWUyMDQxOTY4MzJkNTAwMDc1YWFlZjBmL3RhYmxlcmFuZ2U6Zjc0ZDM0MzA5ZTIwNDE5NjgzMmQ1MDAwNzVhYWVmMGZfMi0zLTEtMS02MjY_9aa25943-ed98-44f8-8d98-7927ef943bd2"
      unitRef="usd">319000</us-gaap:OperatingLeaseCost>
    <us-gaap:OperatingLeaseCost
      contextRef="ia855382ada1f4f28aa8ef6da692ff177_D20220101-20220630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmFlNWE5YmUwZWI5NDQ1ZDE5MmZhZTgyMmQyMmJlMDlmL3NlYzphZTVhOWJlMGViOTQ0NWQxOTJmYWU4MjJkMjJiZTA5Zl81NS9mcmFnOjgzZWFhMzRhOThhOTQ3YWQ4ZDYzODA0Nzc5NGYxYjhmL3RhYmxlOmY3NGQzNDMwOWUyMDQxOTY4MzJkNTAwMDc1YWFlZjBmL3RhYmxlcmFuZ2U6Zjc0ZDM0MzA5ZTIwNDE5NjgzMmQ1MDAwNzVhYWVmMGZfMy01LTEtMS0zMDc4_d1dfd3f9-7226-4b58-9037-3a2ee76fbee0"
      unitRef="usd">1667000</us-gaap:OperatingLeaseCost>
    <us-gaap:OperatingLeaseCost
      contextRef="idaa4f31ca59a4a17a59c2580b97791ca_D20210101-20210630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmFlNWE5YmUwZWI5NDQ1ZDE5MmZhZTgyMmQyMmJlMDlmL3NlYzphZTVhOWJlMGViOTQ0NWQxOTJmYWU4MjJkMjJiZTA5Zl81NS9mcmFnOjgzZWFhMzRhOThhOTQ3YWQ4ZDYzODA0Nzc5NGYxYjhmL3RhYmxlOmY3NGQzNDMwOWUyMDQxOTY4MzJkNTAwMDc1YWFlZjBmL3RhYmxlcmFuZ2U6Zjc0ZDM0MzA5ZTIwNDE5NjgzMmQ1MDAwNzVhYWVmMGZfMy03LTEtMS0zMDc4_4d062333-5ddc-4729-b93d-8988c5d84314"
      unitRef="usd">638000</us-gaap:OperatingLeaseCost>
    <us-gaap:VariableLeaseCost
      contextRef="i2c5f0f28773744e5a2e202f2943ae976_D20220401-20220630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmFlNWE5YmUwZWI5NDQ1ZDE5MmZhZTgyMmQyMmJlMDlmL3NlYzphZTVhOWJlMGViOTQ0NWQxOTJmYWU4MjJkMjJiZTA5Zl81NS9mcmFnOjgzZWFhMzRhOThhOTQ3YWQ4ZDYzODA0Nzc5NGYxYjhmL3RhYmxlOmY3NGQzNDMwOWUyMDQxOTY4MzJkNTAwMDc1YWFlZjBmL3RhYmxlcmFuZ2U6Zjc0ZDM0MzA5ZTIwNDE5NjgzMmQ1MDAwNzVhYWVmMGZfMy0xLTEtMS02MjY_3c140478-80a5-4a9c-9886-196d183e38ac"
      unitRef="usd">303000</us-gaap:VariableLeaseCost>
    <us-gaap:VariableLeaseCost
      contextRef="id7bb773872394047ba26aa8a7a0f4d56_D20210401-20210630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmFlNWE5YmUwZWI5NDQ1ZDE5MmZhZTgyMmQyMmJlMDlmL3NlYzphZTVhOWJlMGViOTQ0NWQxOTJmYWU4MjJkMjJiZTA5Zl81NS9mcmFnOjgzZWFhMzRhOThhOTQ3YWQ4ZDYzODA0Nzc5NGYxYjhmL3RhYmxlOmY3NGQzNDMwOWUyMDQxOTY4MzJkNTAwMDc1YWFlZjBmL3RhYmxlcmFuZ2U6Zjc0ZDM0MzA5ZTIwNDE5NjgzMmQ1MDAwNzVhYWVmMGZfMy0zLTEtMS02MjY_a9aeaa28-5e95-417f-93ba-f527edabc98b"
      unitRef="usd">143000</us-gaap:VariableLeaseCost>
    <us-gaap:VariableLeaseCost
      contextRef="ia855382ada1f4f28aa8ef6da692ff177_D20220101-20220630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmFlNWE5YmUwZWI5NDQ1ZDE5MmZhZTgyMmQyMmJlMDlmL3NlYzphZTVhOWJlMGViOTQ0NWQxOTJmYWU4MjJkMjJiZTA5Zl81NS9mcmFnOjgzZWFhMzRhOThhOTQ3YWQ4ZDYzODA0Nzc5NGYxYjhmL3RhYmxlOmY3NGQzNDMwOWUyMDQxOTY4MzJkNTAwMDc1YWFlZjBmL3RhYmxlcmFuZ2U6Zjc0ZDM0MzA5ZTIwNDE5NjgzMmQ1MDAwNzVhYWVmMGZfNC01LTEtMS0zMDc4_579c9e65-e03d-41d2-9a7c-eb48fb9b6b41"
      unitRef="usd">492000</us-gaap:VariableLeaseCost>
    <us-gaap:VariableLeaseCost
      contextRef="idaa4f31ca59a4a17a59c2580b97791ca_D20210101-20210630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmFlNWE5YmUwZWI5NDQ1ZDE5MmZhZTgyMmQyMmJlMDlmL3NlYzphZTVhOWJlMGViOTQ0NWQxOTJmYWU4MjJkMjJiZTA5Zl81NS9mcmFnOjgzZWFhMzRhOThhOTQ3YWQ4ZDYzODA0Nzc5NGYxYjhmL3RhYmxlOmY3NGQzNDMwOWUyMDQxOTY4MzJkNTAwMDc1YWFlZjBmL3RhYmxlcmFuZ2U6Zjc0ZDM0MzA5ZTIwNDE5NjgzMmQ1MDAwNzVhYWVmMGZfNC03LTEtMS0zMDc4_b2099a5e-b12f-4212-9d45-a9a3395484e9"
      unitRef="usd">315000</us-gaap:VariableLeaseCost>
    <dmtk:OperatingLeaseCosts
      contextRef="i2c5f0f28773744e5a2e202f2943ae976_D20220401-20220630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmFlNWE5YmUwZWI5NDQ1ZDE5MmZhZTgyMmQyMmJlMDlmL3NlYzphZTVhOWJlMGViOTQ0NWQxOTJmYWU4MjJkMjJiZTA5Zl81NS9mcmFnOjgzZWFhMzRhOThhOTQ3YWQ4ZDYzODA0Nzc5NGYxYjhmL3RhYmxlOmY3NGQzNDMwOWUyMDQxOTY4MzJkNTAwMDc1YWFlZjBmL3RhYmxlcmFuZ2U6Zjc0ZDM0MzA5ZTIwNDE5NjgzMmQ1MDAwNzVhYWVmMGZfNC0xLTEtMS02MjY_bb0764b3-75c7-432b-8199-b2eb16625616"
      unitRef="usd">1347000</dmtk:OperatingLeaseCosts>
    <dmtk:OperatingLeaseCosts
      contextRef="id7bb773872394047ba26aa8a7a0f4d56_D20210401-20210630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmFlNWE5YmUwZWI5NDQ1ZDE5MmZhZTgyMmQyMmJlMDlmL3NlYzphZTVhOWJlMGViOTQ0NWQxOTJmYWU4MjJkMjJiZTA5Zl81NS9mcmFnOjgzZWFhMzRhOThhOTQ3YWQ4ZDYzODA0Nzc5NGYxYjhmL3RhYmxlOmY3NGQzNDMwOWUyMDQxOTY4MzJkNTAwMDc1YWFlZjBmL3RhYmxlcmFuZ2U6Zjc0ZDM0MzA5ZTIwNDE5NjgzMmQ1MDAwNzVhYWVmMGZfNC0zLTEtMS02MjY_f5e898ad-2337-48a2-9249-7e762417bd91"
      unitRef="usd">462000</dmtk:OperatingLeaseCosts>
    <dmtk:OperatingLeaseCosts
      contextRef="ia855382ada1f4f28aa8ef6da692ff177_D20220101-20220630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmFlNWE5YmUwZWI5NDQ1ZDE5MmZhZTgyMmQyMmJlMDlmL3NlYzphZTVhOWJlMGViOTQ0NWQxOTJmYWU4MjJkMjJiZTA5Zl81NS9mcmFnOjgzZWFhMzRhOThhOTQ3YWQ4ZDYzODA0Nzc5NGYxYjhmL3RhYmxlOmY3NGQzNDMwOWUyMDQxOTY4MzJkNTAwMDc1YWFlZjBmL3RhYmxlcmFuZ2U6Zjc0ZDM0MzA5ZTIwNDE5NjgzMmQ1MDAwNzVhYWVmMGZfNS01LTEtMS0zMDc4_df1b772f-a390-458a-b738-5e3495398a1f"
      unitRef="usd">2159000</dmtk:OperatingLeaseCosts>
    <dmtk:OperatingLeaseCosts
      contextRef="idaa4f31ca59a4a17a59c2580b97791ca_D20210101-20210630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmFlNWE5YmUwZWI5NDQ1ZDE5MmZhZTgyMmQyMmJlMDlmL3NlYzphZTVhOWJlMGViOTQ0NWQxOTJmYWU4MjJkMjJiZTA5Zl81NS9mcmFnOjgzZWFhMzRhOThhOTQ3YWQ4ZDYzODA0Nzc5NGYxYjhmL3RhYmxlOmY3NGQzNDMwOWUyMDQxOTY4MzJkNTAwMDc1YWFlZjBmL3RhYmxlcmFuZ2U6Zjc0ZDM0MzA5ZTIwNDE5NjgzMmQ1MDAwNzVhYWVmMGZfNS03LTEtMS0zMDc4_6c66437b-2a26-4336-abe9-0d9ad888747a"
      unitRef="usd">953000</dmtk:OperatingLeaseCosts>
    <us-gaap:FinanceLeaseRightOfUseAssetAmortization
      contextRef="i2c5f0f28773744e5a2e202f2943ae976_D20220401-20220630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmFlNWE5YmUwZWI5NDQ1ZDE5MmZhZTgyMmQyMmJlMDlmL3NlYzphZTVhOWJlMGViOTQ0NWQxOTJmYWU4MjJkMjJiZTA5Zl81NS9mcmFnOjgzZWFhMzRhOThhOTQ3YWQ4ZDYzODA0Nzc5NGYxYjhmL3RhYmxlOmY3NGQzNDMwOWUyMDQxOTY4MzJkNTAwMDc1YWFlZjBmL3RhYmxlcmFuZ2U6Zjc0ZDM0MzA5ZTIwNDE5NjgzMmQ1MDAwNzVhYWVmMGZfNy0xLTEtMS02MjY_bae6998b-cdf1-4493-9459-84d41fe11323"
      unitRef="usd">21000</us-gaap:FinanceLeaseRightOfUseAssetAmortization>
    <us-gaap:FinanceLeaseRightOfUseAssetAmortization
      contextRef="id7bb773872394047ba26aa8a7a0f4d56_D20210401-20210630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmFlNWE5YmUwZWI5NDQ1ZDE5MmZhZTgyMmQyMmJlMDlmL3NlYzphZTVhOWJlMGViOTQ0NWQxOTJmYWU4MjJkMjJiZTA5Zl81NS9mcmFnOjgzZWFhMzRhOThhOTQ3YWQ4ZDYzODA0Nzc5NGYxYjhmL3RhYmxlOmY3NGQzNDMwOWUyMDQxOTY4MzJkNTAwMDc1YWFlZjBmL3RhYmxlcmFuZ2U6Zjc0ZDM0MzA5ZTIwNDE5NjgzMmQ1MDAwNzVhYWVmMGZfNy0zLTEtMS02MjY_fd6edaa9-4205-44d2-a013-3bc80ae9441d"
      unitRef="usd">17000</us-gaap:FinanceLeaseRightOfUseAssetAmortization>
    <us-gaap:FinanceLeaseRightOfUseAssetAmortization
      contextRef="ia855382ada1f4f28aa8ef6da692ff177_D20220101-20220630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmFlNWE5YmUwZWI5NDQ1ZDE5MmZhZTgyMmQyMmJlMDlmL3NlYzphZTVhOWJlMGViOTQ0NWQxOTJmYWU4MjJkMjJiZTA5Zl81NS9mcmFnOjgzZWFhMzRhOThhOTQ3YWQ4ZDYzODA0Nzc5NGYxYjhmL3RhYmxlOmY3NGQzNDMwOWUyMDQxOTY4MzJkNTAwMDc1YWFlZjBmL3RhYmxlcmFuZ2U6Zjc0ZDM0MzA5ZTIwNDE5NjgzMmQ1MDAwNzVhYWVmMGZfOC01LTEtMS0zMDky_7ef2a62f-1869-4e60-ad04-52b239ff2ab3"
      unitRef="usd">41000</us-gaap:FinanceLeaseRightOfUseAssetAmortization>
    <us-gaap:FinanceLeaseRightOfUseAssetAmortization
      contextRef="idaa4f31ca59a4a17a59c2580b97791ca_D20210101-20210630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmFlNWE5YmUwZWI5NDQ1ZDE5MmZhZTgyMmQyMmJlMDlmL3NlYzphZTVhOWJlMGViOTQ0NWQxOTJmYWU4MjJkMjJiZTA5Zl81NS9mcmFnOjgzZWFhMzRhOThhOTQ3YWQ4ZDYzODA0Nzc5NGYxYjhmL3RhYmxlOmY3NGQzNDMwOWUyMDQxOTY4MzJkNTAwMDc1YWFlZjBmL3RhYmxlcmFuZ2U6Zjc0ZDM0MzA5ZTIwNDE5NjgzMmQ1MDAwNzVhYWVmMGZfOC03LTEtMS0zMDky_ad5a1b3f-0eb2-4850-b686-8ec09d7f2594"
      unitRef="usd">34000</us-gaap:FinanceLeaseRightOfUseAssetAmortization>
    <us-gaap:FinanceLeaseInterestExpense
      contextRef="i2c5f0f28773744e5a2e202f2943ae976_D20220401-20220630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmFlNWE5YmUwZWI5NDQ1ZDE5MmZhZTgyMmQyMmJlMDlmL3NlYzphZTVhOWJlMGViOTQ0NWQxOTJmYWU4MjJkMjJiZTA5Zl81NS9mcmFnOjgzZWFhMzRhOThhOTQ3YWQ4ZDYzODA0Nzc5NGYxYjhmL3RhYmxlOmY3NGQzNDMwOWUyMDQxOTY4MzJkNTAwMDc1YWFlZjBmL3RhYmxlcmFuZ2U6Zjc0ZDM0MzA5ZTIwNDE5NjgzMmQ1MDAwNzVhYWVmMGZfOC0xLTEtMS02MjY_31a34ab9-4045-44f9-bbc6-adee46ce863d"
      unitRef="usd">3000</us-gaap:FinanceLeaseInterestExpense>
    <us-gaap:FinanceLeaseInterestExpense
      contextRef="id7bb773872394047ba26aa8a7a0f4d56_D20210401-20210630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmFlNWE5YmUwZWI5NDQ1ZDE5MmZhZTgyMmQyMmJlMDlmL3NlYzphZTVhOWJlMGViOTQ0NWQxOTJmYWU4MjJkMjJiZTA5Zl81NS9mcmFnOjgzZWFhMzRhOThhOTQ3YWQ4ZDYzODA0Nzc5NGYxYjhmL3RhYmxlOmY3NGQzNDMwOWUyMDQxOTY4MzJkNTAwMDc1YWFlZjBmL3RhYmxlcmFuZ2U6Zjc0ZDM0MzA5ZTIwNDE5NjgzMmQ1MDAwNzVhYWVmMGZfOC0zLTEtMS02MjY_33cbbc06-e9a8-4e69-8fb3-b1f6dafec951"
      unitRef="usd">4000</us-gaap:FinanceLeaseInterestExpense>
    <us-gaap:FinanceLeaseInterestExpense
      contextRef="ia855382ada1f4f28aa8ef6da692ff177_D20220101-20220630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmFlNWE5YmUwZWI5NDQ1ZDE5MmZhZTgyMmQyMmJlMDlmL3NlYzphZTVhOWJlMGViOTQ0NWQxOTJmYWU4MjJkMjJiZTA5Zl81NS9mcmFnOjgzZWFhMzRhOThhOTQ3YWQ4ZDYzODA0Nzc5NGYxYjhmL3RhYmxlOmY3NGQzNDMwOWUyMDQxOTY4MzJkNTAwMDc1YWFlZjBmL3RhYmxlcmFuZ2U6Zjc0ZDM0MzA5ZTIwNDE5NjgzMmQ1MDAwNzVhYWVmMGZfOS01LTEtMS0zMDky_29d896f4-1b4c-403f-9830-10c92e31ad1e"
      unitRef="usd">7000</us-gaap:FinanceLeaseInterestExpense>
    <us-gaap:FinanceLeaseInterestExpense
      contextRef="idaa4f31ca59a4a17a59c2580b97791ca_D20210101-20210630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmFlNWE5YmUwZWI5NDQ1ZDE5MmZhZTgyMmQyMmJlMDlmL3NlYzphZTVhOWJlMGViOTQ0NWQxOTJmYWU4MjJkMjJiZTA5Zl81NS9mcmFnOjgzZWFhMzRhOThhOTQ3YWQ4ZDYzODA0Nzc5NGYxYjhmL3RhYmxlOmY3NGQzNDMwOWUyMDQxOTY4MzJkNTAwMDc1YWFlZjBmL3RhYmxlcmFuZ2U6Zjc0ZDM0MzA5ZTIwNDE5NjgzMmQ1MDAwNzVhYWVmMGZfOS03LTEtMS0zMDky_88537748-0fa9-4468-93e7-7575d7516c68"
      unitRef="usd">8000</us-gaap:FinanceLeaseInterestExpense>
    <dmtk:FinanceLeaseCost
      contextRef="i2c5f0f28773744e5a2e202f2943ae976_D20220401-20220630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmFlNWE5YmUwZWI5NDQ1ZDE5MmZhZTgyMmQyMmJlMDlmL3NlYzphZTVhOWJlMGViOTQ0NWQxOTJmYWU4MjJkMjJiZTA5Zl81NS9mcmFnOjgzZWFhMzRhOThhOTQ3YWQ4ZDYzODA0Nzc5NGYxYjhmL3RhYmxlOmY3NGQzNDMwOWUyMDQxOTY4MzJkNTAwMDc1YWFlZjBmL3RhYmxlcmFuZ2U6Zjc0ZDM0MzA5ZTIwNDE5NjgzMmQ1MDAwNzVhYWVmMGZfOS0xLTEtMS02MjY_11892418-cef9-4496-9166-00ac00671896"
      unitRef="usd">24000</dmtk:FinanceLeaseCost>
    <dmtk:FinanceLeaseCost
      contextRef="id7bb773872394047ba26aa8a7a0f4d56_D20210401-20210630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmFlNWE5YmUwZWI5NDQ1ZDE5MmZhZTgyMmQyMmJlMDlmL3NlYzphZTVhOWJlMGViOTQ0NWQxOTJmYWU4MjJkMjJiZTA5Zl81NS9mcmFnOjgzZWFhMzRhOThhOTQ3YWQ4ZDYzODA0Nzc5NGYxYjhmL3RhYmxlOmY3NGQzNDMwOWUyMDQxOTY4MzJkNTAwMDc1YWFlZjBmL3RhYmxlcmFuZ2U6Zjc0ZDM0MzA5ZTIwNDE5NjgzMmQ1MDAwNzVhYWVmMGZfOS0zLTEtMS02MjY_690e9c89-e94f-4f43-b42e-48691f68103d"
      unitRef="usd">21000</dmtk:FinanceLeaseCost>
    <dmtk:FinanceLeaseCost
      contextRef="ia855382ada1f4f28aa8ef6da692ff177_D20220101-20220630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmFlNWE5YmUwZWI5NDQ1ZDE5MmZhZTgyMmQyMmJlMDlmL3NlYzphZTVhOWJlMGViOTQ0NWQxOTJmYWU4MjJkMjJiZTA5Zl81NS9mcmFnOjgzZWFhMzRhOThhOTQ3YWQ4ZDYzODA0Nzc5NGYxYjhmL3RhYmxlOmY3NGQzNDMwOWUyMDQxOTY4MzJkNTAwMDc1YWFlZjBmL3RhYmxlcmFuZ2U6Zjc0ZDM0MzA5ZTIwNDE5NjgzMmQ1MDAwNzVhYWVmMGZfMTAtNS0xLTEtMzA5Mg_89ec24ff-9a09-4e2b-934f-f668b2e75c56"
      unitRef="usd">48000</dmtk:FinanceLeaseCost>
    <dmtk:FinanceLeaseCost
      contextRef="idaa4f31ca59a4a17a59c2580b97791ca_D20210101-20210630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmFlNWE5YmUwZWI5NDQ1ZDE5MmZhZTgyMmQyMmJlMDlmL3NlYzphZTVhOWJlMGViOTQ0NWQxOTJmYWU4MjJkMjJiZTA5Zl81NS9mcmFnOjgzZWFhMzRhOThhOTQ3YWQ4ZDYzODA0Nzc5NGYxYjhmL3RhYmxlOmY3NGQzNDMwOWUyMDQxOTY4MzJkNTAwMDc1YWFlZjBmL3RhYmxlcmFuZ2U6Zjc0ZDM0MzA5ZTIwNDE5NjgzMmQ1MDAwNzVhYWVmMGZfMTAtNy0xLTEtMzA5Mg_efacc199-07a2-455e-bb83-a045561d05a9"
      unitRef="usd">42000</dmtk:FinanceLeaseCost>
    <us-gaap:OperatingLeasePayments
      contextRef="ia855382ada1f4f28aa8ef6da692ff177_D20220101-20220630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmFlNWE5YmUwZWI5NDQ1ZDE5MmZhZTgyMmQyMmJlMDlmL3NlYzphZTVhOWJlMGViOTQ0NWQxOTJmYWU4MjJkMjJiZTA5Zl81NS9mcmFnOjgzZWFhMzRhOThhOTQ3YWQ4ZDYzODA0Nzc5NGYxYjhmL3RhYmxlOjlhYjMzYWUwZTNlMDQ1ZGE5MmEzNTAzZmFlODIwMDZmL3RhYmxlcmFuZ2U6OWFiMzNhZTBlM2UwNDVkYTkyYTM1MDNmYWU4MjAwNmZfMy01LTEtMS0zMTUz_dea3cfb9-4599-4480-99ad-0b1a773b4a51"
      unitRef="usd">1179000</us-gaap:OperatingLeasePayments>
    <us-gaap:OperatingLeasePayments
      contextRef="idaa4f31ca59a4a17a59c2580b97791ca_D20210101-20210630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmFlNWE5YmUwZWI5NDQ1ZDE5MmZhZTgyMmQyMmJlMDlmL3NlYzphZTVhOWJlMGViOTQ0NWQxOTJmYWU4MjJkMjJiZTA5Zl81NS9mcmFnOjgzZWFhMzRhOThhOTQ3YWQ4ZDYzODA0Nzc5NGYxYjhmL3RhYmxlOjlhYjMzYWUwZTNlMDQ1ZGE5MmEzNTAzZmFlODIwMDZmL3RhYmxlcmFuZ2U6OWFiMzNhZTBlM2UwNDVkYTkyYTM1MDNmYWU4MjAwNmZfMTQtNy0xLTEtMzEyMw_388a8e99-7aa7-4b45-8742-1d029a643871"
      unitRef="usd">684000</us-gaap:OperatingLeasePayments>
    <us-gaap:FinanceLeaseInterestExpense
      contextRef="ia855382ada1f4f28aa8ef6da692ff177_D20220101-20220630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmFlNWE5YmUwZWI5NDQ1ZDE5MmZhZTgyMmQyMmJlMDlmL3NlYzphZTVhOWJlMGViOTQ0NWQxOTJmYWU4MjJkMjJiZTA5Zl81NS9mcmFnOjgzZWFhMzRhOThhOTQ3YWQ4ZDYzODA0Nzc5NGYxYjhmL3RhYmxlOjlhYjMzYWUwZTNlMDQ1ZGE5MmEzNTAzZmFlODIwMDZmL3RhYmxlcmFuZ2U6OWFiMzNhZTBlM2UwNDVkYTkyYTM1MDNmYWU4MjAwNmZfNC01LTEtMS0zMTUz_ea690da6-80c9-4d46-8b34-611623810c02"
      unitRef="usd">7000</us-gaap:FinanceLeaseInterestExpense>
    <us-gaap:FinanceLeaseInterestExpense
      contextRef="idaa4f31ca59a4a17a59c2580b97791ca_D20210101-20210630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmFlNWE5YmUwZWI5NDQ1ZDE5MmZhZTgyMmQyMmJlMDlmL3NlYzphZTVhOWJlMGViOTQ0NWQxOTJmYWU4MjJkMjJiZTA5Zl81NS9mcmFnOjgzZWFhMzRhOThhOTQ3YWQ4ZDYzODA0Nzc5NGYxYjhmL3RhYmxlOjlhYjMzYWUwZTNlMDQ1ZGE5MmEzNTAzZmFlODIwMDZmL3RhYmxlcmFuZ2U6OWFiMzNhZTBlM2UwNDVkYTkyYTM1MDNmYWU4MjAwNmZfMTUtNy0xLTEtMzEyMw_4e10d6d3-a15c-44a0-9eea-f65ce191ca55"
      unitRef="usd">8000</us-gaap:FinanceLeaseInterestExpense>
    <us-gaap:FinanceLeasePrincipalPayments
      contextRef="ia855382ada1f4f28aa8ef6da692ff177_D20220101-20220630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmFlNWE5YmUwZWI5NDQ1ZDE5MmZhZTgyMmQyMmJlMDlmL3NlYzphZTVhOWJlMGViOTQ0NWQxOTJmYWU4MjJkMjJiZTA5Zl81NS9mcmFnOjgzZWFhMzRhOThhOTQ3YWQ4ZDYzODA0Nzc5NGYxYjhmL3RhYmxlOjlhYjMzYWUwZTNlMDQ1ZGE5MmEzNTAzZmFlODIwMDZmL3RhYmxlcmFuZ2U6OWFiMzNhZTBlM2UwNDVkYTkyYTM1MDNmYWU4MjAwNmZfNS01LTEtMS0zMTUz_c5fcf195-fcd8-48b2-937a-8d72800a8337"
      unitRef="usd">60000</us-gaap:FinanceLeasePrincipalPayments>
    <us-gaap:FinanceLeasePrincipalPayments
      contextRef="idaa4f31ca59a4a17a59c2580b97791ca_D20210101-20210630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmFlNWE5YmUwZWI5NDQ1ZDE5MmZhZTgyMmQyMmJlMDlmL3NlYzphZTVhOWJlMGViOTQ0NWQxOTJmYWU4MjJkMjJiZTA5Zl81NS9mcmFnOjgzZWFhMzRhOThhOTQ3YWQ4ZDYzODA0Nzc5NGYxYjhmL3RhYmxlOjlhYjMzYWUwZTNlMDQ1ZGE5MmEzNTAzZmFlODIwMDZmL3RhYmxlcmFuZ2U6OWFiMzNhZTBlM2UwNDVkYTkyYTM1MDNmYWU4MjAwNmZfMTYtNy0xLTEtMzEyMw_832ae879-3aa8-4dff-8f67-526f2936dae3"
      unitRef="usd">53000</us-gaap:FinanceLeasePrincipalPayments>
    <us-gaap:RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability
      contextRef="ia855382ada1f4f28aa8ef6da692ff177_D20220101-20220630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmFlNWE5YmUwZWI5NDQ1ZDE5MmZhZTgyMmQyMmJlMDlmL3NlYzphZTVhOWJlMGViOTQ0NWQxOTJmYWU4MjJkMjJiZTA5Zl81NS9mcmFnOjgzZWFhMzRhOThhOTQ3YWQ4ZDYzODA0Nzc5NGYxYjhmL3RhYmxlOjlhYjMzYWUwZTNlMDQ1ZGE5MmEzNTAzZmFlODIwMDZmL3RhYmxlcmFuZ2U6OWFiMzNhZTBlM2UwNDVkYTkyYTM1MDNmYWU4MjAwNmZfNi01LTEtMS0zMTUz_8f616ff6-1e85-47e7-8a32-d58dd2e1e0ae"
      unitRef="usd">17059000</us-gaap:RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability>
    <us-gaap:RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability
      contextRef="idaa4f31ca59a4a17a59c2580b97791ca_D20210101-20210630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmFlNWE5YmUwZWI5NDQ1ZDE5MmZhZTgyMmQyMmJlMDlmL3NlYzphZTVhOWJlMGViOTQ0NWQxOTJmYWU4MjJkMjJiZTA5Zl81NS9mcmFnOjgzZWFhMzRhOThhOTQ3YWQ4ZDYzODA0Nzc5NGYxYjhmL3RhYmxlOjlhYjMzYWUwZTNlMDQ1ZGE5MmEzNTAzZmFlODIwMDZmL3RhYmxlcmFuZ2U6OWFiMzNhZTBlM2UwNDVkYTkyYTM1MDNmYWU4MjAwNmZfMTctNy0xLTEtMzEyMw_15a04c95-b6c0-4ee4-ac0f-ed735efb6137"
      unitRef="usd">2831000</us-gaap:RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability>
    <us-gaap:RightOfUseAssetObtainedInExchangeForFinanceLeaseLiability
      contextRef="ia855382ada1f4f28aa8ef6da692ff177_D20220101-20220630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmFlNWE5YmUwZWI5NDQ1ZDE5MmZhZTgyMmQyMmJlMDlmL3NlYzphZTVhOWJlMGViOTQ0NWQxOTJmYWU4MjJkMjJiZTA5Zl81NS9mcmFnOjgzZWFhMzRhOThhOTQ3YWQ4ZDYzODA0Nzc5NGYxYjhmL3RhYmxlOjlhYjMzYWUwZTNlMDQ1ZGE5MmEzNTAzZmFlODIwMDZmL3RhYmxlcmFuZ2U6OWFiMzNhZTBlM2UwNDVkYTkyYTM1MDNmYWU4MjAwNmZfNy01LTEtMS0zMTUz_e4561a12-8ccc-48bb-b1d8-1a452c590d57"
      unitRef="usd">48000</us-gaap:RightOfUseAssetObtainedInExchangeForFinanceLeaseLiability>
    <us-gaap:RightOfUseAssetObtainedInExchangeForFinanceLeaseLiability
      contextRef="idaa4f31ca59a4a17a59c2580b97791ca_D20210101-20210630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmFlNWE5YmUwZWI5NDQ1ZDE5MmZhZTgyMmQyMmJlMDlmL3NlYzphZTVhOWJlMGViOTQ0NWQxOTJmYWU4MjJkMjJiZTA5Zl81NS9mcmFnOjgzZWFhMzRhOThhOTQ3YWQ4ZDYzODA0Nzc5NGYxYjhmL3RhYmxlOjlhYjMzYWUwZTNlMDQ1ZGE5MmEzNTAzZmFlODIwMDZmL3RhYmxlcmFuZ2U6OWFiMzNhZTBlM2UwNDVkYTkyYTM1MDNmYWU4MjAwNmZfMTgtNy0xLTEtMzEyMw_7699502e-164b-4c1d-8693-83ea58a40af6"
      unitRef="usd">0</us-gaap:RightOfUseAssetObtainedInExchangeForFinanceLeaseLiability>
    <us-gaap:OperatingLeaseWeightedAverageRemainingLeaseTerm1
      contextRef="i4c8f247d12134a9886d56e1c8b024425_I20220630"
      id="id3VybDovL2RvY3MudjEvZG9jOmFlNWE5YmUwZWI5NDQ1ZDE5MmZhZTgyMmQyMmJlMDlmL3NlYzphZTVhOWJlMGViOTQ0NWQxOTJmYWU4MjJkMjJiZTA5Zl81NS9mcmFnOjgzZWFhMzRhOThhOTQ3YWQ4ZDYzODA0Nzc5NGYxYjhmL3RhYmxlOjlhYjMzYWUwZTNlMDQ1ZGE5MmEzNTAzZmFlODIwMDZmL3RhYmxlcmFuZ2U6OWFiMzNhZTBlM2UwNDVkYTkyYTM1MDNmYWU4MjAwNmZfOS01LTEtMS0zMTUz_c05a18b5-4ecf-4872-8daf-8320ab8e499c">P10Y6M21D</us-gaap:OperatingLeaseWeightedAverageRemainingLeaseTerm1>
    <us-gaap:OperatingLeaseWeightedAverageRemainingLeaseTerm1
      contextRef="ie036f155bf0e43bd97ef05b5b46857eb_I20210630"
      id="id3VybDovL2RvY3MudjEvZG9jOmFlNWE5YmUwZWI5NDQ1ZDE5MmZhZTgyMmQyMmJlMDlmL3NlYzphZTVhOWJlMGViOTQ0NWQxOTJmYWU4MjJkMjJiZTA5Zl81NS9mcmFnOjgzZWFhMzRhOThhOTQ3YWQ4ZDYzODA0Nzc5NGYxYjhmL3RhYmxlOjlhYjMzYWUwZTNlMDQ1ZGE5MmEzNTAzZmFlODIwMDZmL3RhYmxlcmFuZ2U6OWFiMzNhZTBlM2UwNDVkYTkyYTM1MDNmYWU4MjAwNmZfMjAtNy0xLTEtMzEyMw_1f4f7894-8bbc-4d94-8d32-e7d672ded5bd">P1Y11M1D</us-gaap:OperatingLeaseWeightedAverageRemainingLeaseTerm1>
    <us-gaap:FinanceLeaseWeightedAverageRemainingLeaseTerm1
      contextRef="i4c8f247d12134a9886d56e1c8b024425_I20220630"
      id="id3VybDovL2RvY3MudjEvZG9jOmFlNWE5YmUwZWI5NDQ1ZDE5MmZhZTgyMmQyMmJlMDlmL3NlYzphZTVhOWJlMGViOTQ0NWQxOTJmYWU4MjJkMjJiZTA5Zl81NS9mcmFnOjgzZWFhMzRhOThhOTQ3YWQ4ZDYzODA0Nzc5NGYxYjhmL3RhYmxlOjlhYjMzYWUwZTNlMDQ1ZGE5MmEzNTAzZmFlODIwMDZmL3RhYmxlcmFuZ2U6OWFiMzNhZTBlM2UwNDVkYTkyYTM1MDNmYWU4MjAwNmZfMTAtNS0xLTEtMzE1Mw_c680e76a-4ae2-4917-8d91-8bef092913e5">P1Y6M</us-gaap:FinanceLeaseWeightedAverageRemainingLeaseTerm1>
    <us-gaap:FinanceLeaseWeightedAverageRemainingLeaseTerm1
      contextRef="ie036f155bf0e43bd97ef05b5b46857eb_I20210630"
      id="id3VybDovL2RvY3MudjEvZG9jOmFlNWE5YmUwZWI5NDQ1ZDE5MmZhZTgyMmQyMmJlMDlmL3NlYzphZTVhOWJlMGViOTQ0NWQxOTJmYWU4MjJkMjJiZTA5Zl81NS9mcmFnOjgzZWFhMzRhOThhOTQ3YWQ4ZDYzODA0Nzc5NGYxYjhmL3RhYmxlOjlhYjMzYWUwZTNlMDQ1ZGE5MmEzNTAzZmFlODIwMDZmL3RhYmxlcmFuZ2U6OWFiMzNhZTBlM2UwNDVkYTkyYTM1MDNmYWU4MjAwNmZfMjEtNy0xLTEtMzEyMw_d7646b9f-fa4d-47a8-8d7c-b06d54bd7980">P2Y6M</us-gaap:FinanceLeaseWeightedAverageRemainingLeaseTerm1>
    <us-gaap:OperatingLeaseWeightedAverageDiscountRatePercent
      contextRef="i4c8f247d12134a9886d56e1c8b024425_I20220630"
      decimals="4"
      id="id3VybDovL2RvY3MudjEvZG9jOmFlNWE5YmUwZWI5NDQ1ZDE5MmZhZTgyMmQyMmJlMDlmL3NlYzphZTVhOWJlMGViOTQ0NWQxOTJmYWU4MjJkMjJiZTA5Zl81NS9mcmFnOjgzZWFhMzRhOThhOTQ3YWQ4ZDYzODA0Nzc5NGYxYjhmL3RhYmxlOjlhYjMzYWUwZTNlMDQ1ZGE5MmEzNTAzZmFlODIwMDZmL3RhYmxlcmFuZ2U6OWFiMzNhZTBlM2UwNDVkYTkyYTM1MDNmYWU4MjAwNmZfMTEtNS0xLTEtMzE1Mw_2576fb3c-3baa-4247-990e-744bbba15083"
      unitRef="number">0.0639</us-gaap:OperatingLeaseWeightedAverageDiscountRatePercent>
    <us-gaap:OperatingLeaseWeightedAverageDiscountRatePercent
      contextRef="ie036f155bf0e43bd97ef05b5b46857eb_I20210630"
      decimals="4"
      id="id3VybDovL2RvY3MudjEvZG9jOmFlNWE5YmUwZWI5NDQ1ZDE5MmZhZTgyMmQyMmJlMDlmL3NlYzphZTVhOWJlMGViOTQ0NWQxOTJmYWU4MjJkMjJiZTA5Zl81NS9mcmFnOjgzZWFhMzRhOThhOTQ3YWQ4ZDYzODA0Nzc5NGYxYjhmL3RhYmxlOjlhYjMzYWUwZTNlMDQ1ZGE5MmEzNTAzZmFlODIwMDZmL3RhYmxlcmFuZ2U6OWFiMzNhZTBlM2UwNDVkYTkyYTM1MDNmYWU4MjAwNmZfMjItNy0xLTEtMzEyMw_968e7a5b-9c49-411c-965d-fe11471f1d76"
      unitRef="number">0.0404</us-gaap:OperatingLeaseWeightedAverageDiscountRatePercent>
    <us-gaap:FinanceLeaseWeightedAverageDiscountRatePercent
      contextRef="i4c8f247d12134a9886d56e1c8b024425_I20220630"
      decimals="4"
      id="id3VybDovL2RvY3MudjEvZG9jOmFlNWE5YmUwZWI5NDQ1ZDE5MmZhZTgyMmQyMmJlMDlmL3NlYzphZTVhOWJlMGViOTQ0NWQxOTJmYWU4MjJkMjJiZTA5Zl81NS9mcmFnOjgzZWFhMzRhOThhOTQ3YWQ4ZDYzODA0Nzc5NGYxYjhmL3RhYmxlOjlhYjMzYWUwZTNlMDQ1ZGE5MmEzNTAzZmFlODIwMDZmL3RhYmxlcmFuZ2U6OWFiMzNhZTBlM2UwNDVkYTkyYTM1MDNmYWU4MjAwNmZfMTItNS0xLTEtMzE1Mw_a4044565-af41-4354-8a53-54fda801ea90"
      unitRef="number">0.0578</us-gaap:FinanceLeaseWeightedAverageDiscountRatePercent>
    <us-gaap:FinanceLeaseWeightedAverageDiscountRatePercent
      contextRef="ie036f155bf0e43bd97ef05b5b46857eb_I20210630"
      decimals="4"
      id="id3VybDovL2RvY3MudjEvZG9jOmFlNWE5YmUwZWI5NDQ1ZDE5MmZhZTgyMmQyMmJlMDlmL3NlYzphZTVhOWJlMGViOTQ0NWQxOTJmYWU4MjJkMjJiZTA5Zl81NS9mcmFnOjgzZWFhMzRhOThhOTQ3YWQ4ZDYzODA0Nzc5NGYxYjhmL3RhYmxlOjlhYjMzYWUwZTNlMDQ1ZGE5MmEzNTAzZmFlODIwMDZmL3RhYmxlcmFuZ2U6OWFiMzNhZTBlM2UwNDVkYTkyYTM1MDNmYWU4MjAwNmZfMjMtNy0xLTEtMzEyMw_57ed3044-7b00-428a-8593-ac5a2e6d9879"
      unitRef="number">0.0554</us-gaap:FinanceLeaseWeightedAverageDiscountRatePercent>
    <dmtk:ScheduleOfFutureMinimumRentalPaymentsForOperatingAndCapitalLeasesTableTextBlock
      contextRef="ia855382ada1f4f28aa8ef6da692ff177_D20220101-20220630"
      id="id3VybDovL2RvY3MudjEvZG9jOmFlNWE5YmUwZWI5NDQ1ZDE5MmZhZTgyMmQyMmJlMDlmL3NlYzphZTVhOWJlMGViOTQ0NWQxOTJmYWU4MjJkMjJiZTA5Zl81NS9mcmFnOjgzZWFhMzRhOThhOTQ3YWQ4ZDYzODA0Nzc5NGYxYjhmL3RleHRyZWdpb246ODNlYWEzNGE5OGE5NDdhZDhkNjM4MDQ3Nzk0ZjFiOGZfODM5Mg_0b055f16-59c7-455d-8505-a362658989e9">&lt;div style="margin-top:9pt;padding-left:27pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The Company&#x2019;s future minimum lease payments under operating and financing leases at June&#160;30, 2022 are as follows (in thousands): &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:12pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:24.203%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:9.051%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.406%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:9.051%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.406%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:9.051%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.406%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:9.051%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.406%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:9.051%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.406%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:9.051%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.406%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:9.055%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2023&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2024&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2025&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2026&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Thereafter&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Total&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Operating lease obligations, including interest&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,524&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,948&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,774&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,853&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,934&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;20,612&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;33,645&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 10pt;text-align:left;text-indent:-9pt;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Finance lease obligations, including interest&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;72&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;133&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;19&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;19&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;15&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;262&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 16pt;text-align:left;text-indent:-9pt;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total future minimum lease payments&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,596&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3,081&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,793&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,872&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,949&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;20,616&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;33,907&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;</dmtk:ScheduleOfFutureMinimumRentalPaymentsForOperatingAndCapitalLeasesTableTextBlock>
    <us-gaap:LesseeOperatingLeaseLiabilityPaymentsRemainderOfFiscalYear
      contextRef="i4c8f247d12134a9886d56e1c8b024425_I20220630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmFlNWE5YmUwZWI5NDQ1ZDE5MmZhZTgyMmQyMmJlMDlmL3NlYzphZTVhOWJlMGViOTQ0NWQxOTJmYWU4MjJkMjJiZTA5Zl81NS9mcmFnOjgzZWFhMzRhOThhOTQ3YWQ4ZDYzODA0Nzc5NGYxYjhmL3RhYmxlOmJkNjkyNjQ2YTAxNzRiMWQ4ZGY2Y2I2YzA3ZDk1NmZhL3RhYmxlcmFuZ2U6YmQ2OTI2NDZhMDE3NGIxZDhkZjZjYjZjMDdkOTU2ZmFfMS0xLTEtMS02MjY_152fb216-f289-4ca9-bd23-bdce147dd8e8"
      unitRef="usd">1524000</us-gaap:LesseeOperatingLeaseLiabilityPaymentsRemainderOfFiscalYear>
    <us-gaap:LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths
      contextRef="i4c8f247d12134a9886d56e1c8b024425_I20220630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmFlNWE5YmUwZWI5NDQ1ZDE5MmZhZTgyMmQyMmJlMDlmL3NlYzphZTVhOWJlMGViOTQ0NWQxOTJmYWU4MjJkMjJiZTA5Zl81NS9mcmFnOjgzZWFhMzRhOThhOTQ3YWQ4ZDYzODA0Nzc5NGYxYjhmL3RhYmxlOmJkNjkyNjQ2YTAxNzRiMWQ4ZGY2Y2I2YzA3ZDk1NmZhL3RhYmxlcmFuZ2U6YmQ2OTI2NDZhMDE3NGIxZDhkZjZjYjZjMDdkOTU2ZmFfMS0zLTEtMS02MjY_05f1685e-cde2-4137-963d-b7417109c2df"
      unitRef="usd">2948000</us-gaap:LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths>
    <us-gaap:LesseeOperatingLeaseLiabilityPaymentsDueYearTwo
      contextRef="i4c8f247d12134a9886d56e1c8b024425_I20220630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmFlNWE5YmUwZWI5NDQ1ZDE5MmZhZTgyMmQyMmJlMDlmL3NlYzphZTVhOWJlMGViOTQ0NWQxOTJmYWU4MjJkMjJiZTA5Zl81NS9mcmFnOjgzZWFhMzRhOThhOTQ3YWQ4ZDYzODA0Nzc5NGYxYjhmL3RhYmxlOmJkNjkyNjQ2YTAxNzRiMWQ4ZGY2Y2I2YzA3ZDk1NmZhL3RhYmxlcmFuZ2U6YmQ2OTI2NDZhMDE3NGIxZDhkZjZjYjZjMDdkOTU2ZmFfMS01LTEtMS02MjY_fad99749-db3f-417e-98da-65b400dfabbc"
      unitRef="usd">2774000</us-gaap:LesseeOperatingLeaseLiabilityPaymentsDueYearTwo>
    <us-gaap:LesseeOperatingLeaseLiabilityPaymentsDueYearThree
      contextRef="i4c8f247d12134a9886d56e1c8b024425_I20220630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmFlNWE5YmUwZWI5NDQ1ZDE5MmZhZTgyMmQyMmJlMDlmL3NlYzphZTVhOWJlMGViOTQ0NWQxOTJmYWU4MjJkMjJiZTA5Zl81NS9mcmFnOjgzZWFhMzRhOThhOTQ3YWQ4ZDYzODA0Nzc5NGYxYjhmL3RhYmxlOmJkNjkyNjQ2YTAxNzRiMWQ4ZGY2Y2I2YzA3ZDk1NmZhL3RhYmxlcmFuZ2U6YmQ2OTI2NDZhMDE3NGIxZDhkZjZjYjZjMDdkOTU2ZmFfMS03LTEtMS02MjY_cf5c82b0-4683-4dff-a8df-9d720799c1df"
      unitRef="usd">2853000</us-gaap:LesseeOperatingLeaseLiabilityPaymentsDueYearThree>
    <us-gaap:LesseeOperatingLeaseLiabilityPaymentsDueYearFour
      contextRef="i4c8f247d12134a9886d56e1c8b024425_I20220630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmFlNWE5YmUwZWI5NDQ1ZDE5MmZhZTgyMmQyMmJlMDlmL3NlYzphZTVhOWJlMGViOTQ0NWQxOTJmYWU4MjJkMjJiZTA5Zl81NS9mcmFnOjgzZWFhMzRhOThhOTQ3YWQ4ZDYzODA0Nzc5NGYxYjhmL3RhYmxlOmJkNjkyNjQ2YTAxNzRiMWQ4ZGY2Y2I2YzA3ZDk1NmZhL3RhYmxlcmFuZ2U6YmQ2OTI2NDZhMDE3NGIxZDhkZjZjYjZjMDdkOTU2ZmFfMS05LTEtMS02MjY_b1977f3c-b38c-49f1-80e1-bbd8482ea598"
      unitRef="usd">2934000</us-gaap:LesseeOperatingLeaseLiabilityPaymentsDueYearFour>
    <dmtk:LesseeOperatingLeaseLiabilityToBePaidAfterYearFour
      contextRef="i4c8f247d12134a9886d56e1c8b024425_I20220630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmFlNWE5YmUwZWI5NDQ1ZDE5MmZhZTgyMmQyMmJlMDlmL3NlYzphZTVhOWJlMGViOTQ0NWQxOTJmYWU4MjJkMjJiZTA5Zl81NS9mcmFnOjgzZWFhMzRhOThhOTQ3YWQ4ZDYzODA0Nzc5NGYxYjhmL3RhYmxlOmJkNjkyNjQ2YTAxNzRiMWQ4ZGY2Y2I2YzA3ZDk1NmZhL3RhYmxlcmFuZ2U6YmQ2OTI2NDZhMDE3NGIxZDhkZjZjYjZjMDdkOTU2ZmFfMS0xMS0xLTEtNjI2_3845587d-61d9-44ce-9a7b-fad3beddc980"
      unitRef="usd">20612000</dmtk:LesseeOperatingLeaseLiabilityToBePaidAfterYearFour>
    <us-gaap:LesseeOperatingLeaseLiabilityPaymentsDue
      contextRef="i4c8f247d12134a9886d56e1c8b024425_I20220630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmFlNWE5YmUwZWI5NDQ1ZDE5MmZhZTgyMmQyMmJlMDlmL3NlYzphZTVhOWJlMGViOTQ0NWQxOTJmYWU4MjJkMjJiZTA5Zl81NS9mcmFnOjgzZWFhMzRhOThhOTQ3YWQ4ZDYzODA0Nzc5NGYxYjhmL3RhYmxlOmJkNjkyNjQ2YTAxNzRiMWQ4ZGY2Y2I2YzA3ZDk1NmZhL3RhYmxlcmFuZ2U6YmQ2OTI2NDZhMDE3NGIxZDhkZjZjYjZjMDdkOTU2ZmFfMS0xMy0xLTEtNjI2_54361053-b775-4ed7-98e5-420f20767294"
      unitRef="usd">33645000</us-gaap:LesseeOperatingLeaseLiabilityPaymentsDue>
    <us-gaap:FinanceLeaseLiabilityPaymentsRemainderOfFiscalYear
      contextRef="i4c8f247d12134a9886d56e1c8b024425_I20220630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmFlNWE5YmUwZWI5NDQ1ZDE5MmZhZTgyMmQyMmJlMDlmL3NlYzphZTVhOWJlMGViOTQ0NWQxOTJmYWU4MjJkMjJiZTA5Zl81NS9mcmFnOjgzZWFhMzRhOThhOTQ3YWQ4ZDYzODA0Nzc5NGYxYjhmL3RhYmxlOmJkNjkyNjQ2YTAxNzRiMWQ4ZGY2Y2I2YzA3ZDk1NmZhL3RhYmxlcmFuZ2U6YmQ2OTI2NDZhMDE3NGIxZDhkZjZjYjZjMDdkOTU2ZmFfMi0xLTEtMS02MjY_a60904de-5b86-4d14-849d-26b24e2a94a3"
      unitRef="usd">72000</us-gaap:FinanceLeaseLiabilityPaymentsRemainderOfFiscalYear>
    <us-gaap:FinanceLeaseLiabilityPaymentsDueNextTwelveMonths
      contextRef="i4c8f247d12134a9886d56e1c8b024425_I20220630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmFlNWE5YmUwZWI5NDQ1ZDE5MmZhZTgyMmQyMmJlMDlmL3NlYzphZTVhOWJlMGViOTQ0NWQxOTJmYWU4MjJkMjJiZTA5Zl81NS9mcmFnOjgzZWFhMzRhOThhOTQ3YWQ4ZDYzODA0Nzc5NGYxYjhmL3RhYmxlOmJkNjkyNjQ2YTAxNzRiMWQ4ZGY2Y2I2YzA3ZDk1NmZhL3RhYmxlcmFuZ2U6YmQ2OTI2NDZhMDE3NGIxZDhkZjZjYjZjMDdkOTU2ZmFfMi0zLTEtMS02MjY_2da7599d-d51f-433b-b780-492313ae8f14"
      unitRef="usd">133000</us-gaap:FinanceLeaseLiabilityPaymentsDueNextTwelveMonths>
    <us-gaap:FinanceLeaseLiabilityPaymentsDueYearTwo
      contextRef="i4c8f247d12134a9886d56e1c8b024425_I20220630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmFlNWE5YmUwZWI5NDQ1ZDE5MmZhZTgyMmQyMmJlMDlmL3NlYzphZTVhOWJlMGViOTQ0NWQxOTJmYWU4MjJkMjJiZTA5Zl81NS9mcmFnOjgzZWFhMzRhOThhOTQ3YWQ4ZDYzODA0Nzc5NGYxYjhmL3RhYmxlOmJkNjkyNjQ2YTAxNzRiMWQ4ZGY2Y2I2YzA3ZDk1NmZhL3RhYmxlcmFuZ2U6YmQ2OTI2NDZhMDE3NGIxZDhkZjZjYjZjMDdkOTU2ZmFfMi01LTEtMS02MjY_b3ef33e4-498f-4188-9654-09ba7d5c8e8a"
      unitRef="usd">19000</us-gaap:FinanceLeaseLiabilityPaymentsDueYearTwo>
    <us-gaap:FinanceLeaseLiabilityPaymentsDueYearThree
      contextRef="i4c8f247d12134a9886d56e1c8b024425_I20220630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmFlNWE5YmUwZWI5NDQ1ZDE5MmZhZTgyMmQyMmJlMDlmL3NlYzphZTVhOWJlMGViOTQ0NWQxOTJmYWU4MjJkMjJiZTA5Zl81NS9mcmFnOjgzZWFhMzRhOThhOTQ3YWQ4ZDYzODA0Nzc5NGYxYjhmL3RhYmxlOmJkNjkyNjQ2YTAxNzRiMWQ4ZGY2Y2I2YzA3ZDk1NmZhL3RhYmxlcmFuZ2U6YmQ2OTI2NDZhMDE3NGIxZDhkZjZjYjZjMDdkOTU2ZmFfMi03LTEtMS02MjY_17c27cde-08a3-4783-9297-516b89365f07"
      unitRef="usd">19000</us-gaap:FinanceLeaseLiabilityPaymentsDueYearThree>
    <us-gaap:FinanceLeaseLiabilityPaymentsDueYearFour
      contextRef="i4c8f247d12134a9886d56e1c8b024425_I20220630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmFlNWE5YmUwZWI5NDQ1ZDE5MmZhZTgyMmQyMmJlMDlmL3NlYzphZTVhOWJlMGViOTQ0NWQxOTJmYWU4MjJkMjJiZTA5Zl81NS9mcmFnOjgzZWFhMzRhOThhOTQ3YWQ4ZDYzODA0Nzc5NGYxYjhmL3RhYmxlOmJkNjkyNjQ2YTAxNzRiMWQ4ZGY2Y2I2YzA3ZDk1NmZhL3RhYmxlcmFuZ2U6YmQ2OTI2NDZhMDE3NGIxZDhkZjZjYjZjMDdkOTU2ZmFfMi05LTEtMS02MjY_4d9adc20-9c99-4f9c-89c2-f790d36d512c"
      unitRef="usd">15000</us-gaap:FinanceLeaseLiabilityPaymentsDueYearFour>
    <dmtk:FinanceLeaseLiabilityPaymentsDueAfterYearFour
      contextRef="i4c8f247d12134a9886d56e1c8b024425_I20220630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmFlNWE5YmUwZWI5NDQ1ZDE5MmZhZTgyMmQyMmJlMDlmL3NlYzphZTVhOWJlMGViOTQ0NWQxOTJmYWU4MjJkMjJiZTA5Zl81NS9mcmFnOjgzZWFhMzRhOThhOTQ3YWQ4ZDYzODA0Nzc5NGYxYjhmL3RhYmxlOmJkNjkyNjQ2YTAxNzRiMWQ4ZGY2Y2I2YzA3ZDk1NmZhL3RhYmxlcmFuZ2U6YmQ2OTI2NDZhMDE3NGIxZDhkZjZjYjZjMDdkOTU2ZmFfMi0xMS0xLTEtNjI2_9f82b374-8b14-454f-ad69-a30d5d729c7a"
      unitRef="usd">4000</dmtk:FinanceLeaseLiabilityPaymentsDueAfterYearFour>
    <us-gaap:FinanceLeaseLiabilityPaymentsDue
      contextRef="i4c8f247d12134a9886d56e1c8b024425_I20220630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmFlNWE5YmUwZWI5NDQ1ZDE5MmZhZTgyMmQyMmJlMDlmL3NlYzphZTVhOWJlMGViOTQ0NWQxOTJmYWU4MjJkMjJiZTA5Zl81NS9mcmFnOjgzZWFhMzRhOThhOTQ3YWQ4ZDYzODA0Nzc5NGYxYjhmL3RhYmxlOmJkNjkyNjQ2YTAxNzRiMWQ4ZGY2Y2I2YzA3ZDk1NmZhL3RhYmxlcmFuZ2U6YmQ2OTI2NDZhMDE3NGIxZDhkZjZjYjZjMDdkOTU2ZmFfMi0xMy0xLTEtNjI2_0ef06d50-5da4-4e45-b03c-0199beef32d6"
      unitRef="usd">262000</us-gaap:FinanceLeaseLiabilityPaymentsDue>
    <dmtk:OperatingAndFinanceLeaseLiabilityPaymentsRemainderOfFiscalYear
      contextRef="i4c8f247d12134a9886d56e1c8b024425_I20220630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmFlNWE5YmUwZWI5NDQ1ZDE5MmZhZTgyMmQyMmJlMDlmL3NlYzphZTVhOWJlMGViOTQ0NWQxOTJmYWU4MjJkMjJiZTA5Zl81NS9mcmFnOjgzZWFhMzRhOThhOTQ3YWQ4ZDYzODA0Nzc5NGYxYjhmL3RhYmxlOmJkNjkyNjQ2YTAxNzRiMWQ4ZGY2Y2I2YzA3ZDk1NmZhL3RhYmxlcmFuZ2U6YmQ2OTI2NDZhMDE3NGIxZDhkZjZjYjZjMDdkOTU2ZmFfMy0xLTEtMS02MjY_6846f6f3-1c96-4341-9ccd-a19070344983"
      unitRef="usd">1596000</dmtk:OperatingAndFinanceLeaseLiabilityPaymentsRemainderOfFiscalYear>
    <dmtk:OperatingAndFinanceLeaseLiabilityPaymentsDueNextTwelveMonths
      contextRef="i4c8f247d12134a9886d56e1c8b024425_I20220630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmFlNWE5YmUwZWI5NDQ1ZDE5MmZhZTgyMmQyMmJlMDlmL3NlYzphZTVhOWJlMGViOTQ0NWQxOTJmYWU4MjJkMjJiZTA5Zl81NS9mcmFnOjgzZWFhMzRhOThhOTQ3YWQ4ZDYzODA0Nzc5NGYxYjhmL3RhYmxlOmJkNjkyNjQ2YTAxNzRiMWQ4ZGY2Y2I2YzA3ZDk1NmZhL3RhYmxlcmFuZ2U6YmQ2OTI2NDZhMDE3NGIxZDhkZjZjYjZjMDdkOTU2ZmFfMy0zLTEtMS02MjY_707b0356-0656-49ec-b771-056d1dee6961"
      unitRef="usd">3081000</dmtk:OperatingAndFinanceLeaseLiabilityPaymentsDueNextTwelveMonths>
    <dmtk:OperatingAndFinanceLeaseLiabilityPaymentsDueYearTwo
      contextRef="i4c8f247d12134a9886d56e1c8b024425_I20220630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmFlNWE5YmUwZWI5NDQ1ZDE5MmZhZTgyMmQyMmJlMDlmL3NlYzphZTVhOWJlMGViOTQ0NWQxOTJmYWU4MjJkMjJiZTA5Zl81NS9mcmFnOjgzZWFhMzRhOThhOTQ3YWQ4ZDYzODA0Nzc5NGYxYjhmL3RhYmxlOmJkNjkyNjQ2YTAxNzRiMWQ4ZGY2Y2I2YzA3ZDk1NmZhL3RhYmxlcmFuZ2U6YmQ2OTI2NDZhMDE3NGIxZDhkZjZjYjZjMDdkOTU2ZmFfMy01LTEtMS02MjY_a92433e4-46cd-4b0d-9c64-42023c66db40"
      unitRef="usd">2793000</dmtk:OperatingAndFinanceLeaseLiabilityPaymentsDueYearTwo>
    <dmtk:OperatingAndFinanceLeaseLiabilityPaymentsDueYearThree
      contextRef="i4c8f247d12134a9886d56e1c8b024425_I20220630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmFlNWE5YmUwZWI5NDQ1ZDE5MmZhZTgyMmQyMmJlMDlmL3NlYzphZTVhOWJlMGViOTQ0NWQxOTJmYWU4MjJkMjJiZTA5Zl81NS9mcmFnOjgzZWFhMzRhOThhOTQ3YWQ4ZDYzODA0Nzc5NGYxYjhmL3RhYmxlOmJkNjkyNjQ2YTAxNzRiMWQ4ZGY2Y2I2YzA3ZDk1NmZhL3RhYmxlcmFuZ2U6YmQ2OTI2NDZhMDE3NGIxZDhkZjZjYjZjMDdkOTU2ZmFfMy03LTEtMS02MjY_4e006570-3345-40c7-b3fe-700ca7ec859b"
      unitRef="usd">2872000</dmtk:OperatingAndFinanceLeaseLiabilityPaymentsDueYearThree>
    <dmtk:OperatingAndFinanceLeaseLiabilityPaymentsDueYearFour
      contextRef="i4c8f247d12134a9886d56e1c8b024425_I20220630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmFlNWE5YmUwZWI5NDQ1ZDE5MmZhZTgyMmQyMmJlMDlmL3NlYzphZTVhOWJlMGViOTQ0NWQxOTJmYWU4MjJkMjJiZTA5Zl81NS9mcmFnOjgzZWFhMzRhOThhOTQ3YWQ4ZDYzODA0Nzc5NGYxYjhmL3RhYmxlOmJkNjkyNjQ2YTAxNzRiMWQ4ZGY2Y2I2YzA3ZDk1NmZhL3RhYmxlcmFuZ2U6YmQ2OTI2NDZhMDE3NGIxZDhkZjZjYjZjMDdkOTU2ZmFfMy05LTEtMS02MjY_99433b25-0c3a-4303-b9d3-1c55e9649d96"
      unitRef="usd">2949000</dmtk:OperatingAndFinanceLeaseLiabilityPaymentsDueYearFour>
    <dmtk:OperatingAndFinanceLeaseLiabilityPaymentsDueThereafter
      contextRef="i4c8f247d12134a9886d56e1c8b024425_I20220630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmFlNWE5YmUwZWI5NDQ1ZDE5MmZhZTgyMmQyMmJlMDlmL3NlYzphZTVhOWJlMGViOTQ0NWQxOTJmYWU4MjJkMjJiZTA5Zl81NS9mcmFnOjgzZWFhMzRhOThhOTQ3YWQ4ZDYzODA0Nzc5NGYxYjhmL3RhYmxlOmJkNjkyNjQ2YTAxNzRiMWQ4ZGY2Y2I2YzA3ZDk1NmZhL3RhYmxlcmFuZ2U6YmQ2OTI2NDZhMDE3NGIxZDhkZjZjYjZjMDdkOTU2ZmFfMy0xMS0xLTEtNjI2_6fa75553-45b0-4f9e-938c-6d0e26a93b7e"
      unitRef="usd">20616000</dmtk:OperatingAndFinanceLeaseLiabilityPaymentsDueThereafter>
    <dmtk:OperatingAndFinanceLeaseLiabilityPaymentsDue
      contextRef="i4c8f247d12134a9886d56e1c8b024425_I20220630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmFlNWE5YmUwZWI5NDQ1ZDE5MmZhZTgyMmQyMmJlMDlmL3NlYzphZTVhOWJlMGViOTQ0NWQxOTJmYWU4MjJkMjJiZTA5Zl81NS9mcmFnOjgzZWFhMzRhOThhOTQ3YWQ4ZDYzODA0Nzc5NGYxYjhmL3RhYmxlOmJkNjkyNjQ2YTAxNzRiMWQ4ZGY2Y2I2YzA3ZDk1NmZhL3RhYmxlcmFuZ2U6YmQ2OTI2NDZhMDE3NGIxZDhkZjZjYjZjMDdkOTU2ZmFfMy0xMy0xLTEtNjI2_add5ad08-e2ea-48b5-9c08-5fdc4ad22b52"
      unitRef="usd">33907000</dmtk:OperatingAndFinanceLeaseLiabilityPaymentsDue>
    <us-gaap:RelatedPartyTransactionsDisclosureTextBlock
      contextRef="ia855382ada1f4f28aa8ef6da692ff177_D20220101-20220630"
      id="id3VybDovL2RvY3MudjEvZG9jOmFlNWE5YmUwZWI5NDQ1ZDE5MmZhZTgyMmQyMmJlMDlmL3NlYzphZTVhOWJlMGViOTQ0NWQxOTJmYWU4MjJkMjJiZTA5Zl82MS9mcmFnOjAxODllZTY4MmY0MTQ4NmE5ZDgyMDk4NzAyZjU5YjZkL3RleHRyZWdpb246MDE4OWVlNjgyZjQxNDg2YTlkODIwOTg3MDJmNTliNmRfMTcyNw_7c47a5ed-f8db-4f1b-9870-a6794abac73e">Related Party Transactions  During 2021 and 2022, the Company engaged EVERSANA Life Science Services, LLC (&#x201c;EVERSANA&#x201d;) to provide certain marketing services to the Company. Leana Wood, the spouse of Todd Wood, the Company&#x2019;s Chief Commercial Offer, is an employee of EVERSANA. The Company incurred $0.9 million and $0.5 million in costs for the three months ended June&#160;30, 2022 and 2021, respectively, and $1.6 million and $0.9 million for the six months ended June&#160;30, 2022 and 2021, respectively.&lt;div style="margin-top:9pt;padding-left:27pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;On October&#160;1, 2019, the Company entered into a consulting agreement with Michael Dobak pursuant to which the Company will compensate Michael Dobak, in an amount not to exceed $100,000, for certain public relations and marketing services. On July 28, 2020, the Company and Michael Dobak entered into an amendment to such consulting agreement to modify the terms of Michael Dobak&#x2019;s compensation. The amended consulting agreement compensated Michael Dobak $15,000 per month for the period May 11, 2020 through June&#160;30, 2021 and also granted him a restricted stock unit award that fully vested in a single installment on August 31, 2020 and represented the contingent right to receive 5,000 shares of common stock on January&#160;2, 2021. On November&#160;11, 2020, the Company and Michael Dobak entered into an amendment to such consulting agreement to extend the term through December&#160;31, 2021 with a continued monthly payment of $15,000. On February&#160;26, 2021, the Company and Michael Dobak agreed to extend his agreement through April 30, 2021 with a revised monthly payment of $20,000. Michael Dobak is the brother of Dr. John Dobak, the Company&#x2019;s Chief Executive Officer. The Company incurred zero and $20,000 in costs for the three months ended June&#160;30, 2022 and 2021, respectively, and zero and $0.1 million for the six months ended June&#160;30, 2022 and 2021.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:9pt;padding-left:27pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;There were no other related party transactions identified during the six months ended June&#160;30, 2022 and 2021.&lt;/span&gt;&lt;/div&gt;</us-gaap:RelatedPartyTransactionsDisclosureTextBlock>
    <us-gaap:RelatedPartyTransactionSellingGeneralAndAdministrativeExpensesFromTransactionsWithRelatedParty
      contextRef="i4d87d8619b7b49828e0354d3459d6bc4_D20220401-20220630"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmFlNWE5YmUwZWI5NDQ1ZDE5MmZhZTgyMmQyMmJlMDlmL3NlYzphZTVhOWJlMGViOTQ0NWQxOTJmYWU4MjJkMjJiZTA5Zl82MS9mcmFnOjAxODllZTY4MmY0MTQ4NmE5ZDgyMDk4NzAyZjU5YjZkL3RleHRyZWdpb246MDE4OWVlNjgyZjQxNDg2YTlkODIwOTg3MDJmNTliNmRfMzAw_2c93e5e1-a107-4203-b3c2-ce3a3825d89d"
      unitRef="usd">900000</us-gaap:RelatedPartyTransactionSellingGeneralAndAdministrativeExpensesFromTransactionsWithRelatedParty>
    <us-gaap:RelatedPartyTransactionSellingGeneralAndAdministrativeExpensesFromTransactionsWithRelatedParty
      contextRef="iebe17418c5534164a125df7ed43c5ece_D20210401-20210630"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmFlNWE5YmUwZWI5NDQ1ZDE5MmZhZTgyMmQyMmJlMDlmL3NlYzphZTVhOWJlMGViOTQ0NWQxOTJmYWU4MjJkMjJiZTA5Zl82MS9mcmFnOjAxODllZTY4MmY0MTQ4NmE5ZDgyMDk4NzAyZjU5YjZkL3RleHRyZWdpb246MDE4OWVlNjgyZjQxNDg2YTlkODIwOTg3MDJmNTliNmRfMzA3_77ee6fd5-75cf-47df-976e-cb8ddb06679b"
      unitRef="usd">500000</us-gaap:RelatedPartyTransactionSellingGeneralAndAdministrativeExpensesFromTransactionsWithRelatedParty>
    <us-gaap:RelatedPartyTransactionSellingGeneralAndAdministrativeExpensesFromTransactionsWithRelatedParty
      contextRef="i0e1b8915a8614ad387c31cb5b81538f7_D20220101-20220630"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmFlNWE5YmUwZWI5NDQ1ZDE5MmZhZTgyMmQyMmJlMDlmL3NlYzphZTVhOWJlMGViOTQ0NWQxOTJmYWU4MjJkMjJiZTA5Zl82MS9mcmFnOjAxODllZTY4MmY0MTQ4NmE5ZDgyMDk4NzAyZjU5YjZkL3RleHRyZWdpb246MDE4OWVlNjgyZjQxNDg2YTlkODIwOTg3MDJmNTliNmRfMzc1_093f0866-2c8f-41b9-90e5-28a12b0f6e15"
      unitRef="usd">1600000</us-gaap:RelatedPartyTransactionSellingGeneralAndAdministrativeExpensesFromTransactionsWithRelatedParty>
    <us-gaap:RelatedPartyTransactionSellingGeneralAndAdministrativeExpensesFromTransactionsWithRelatedParty
      contextRef="i681d541e73e1469a92851dbf2e1a96d4_D20210101-20210630"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmFlNWE5YmUwZWI5NDQ1ZDE5MmZhZTgyMmQyMmJlMDlmL3NlYzphZTVhOWJlMGViOTQ0NWQxOTJmYWU4MjJkMjJiZTA5Zl82MS9mcmFnOjAxODllZTY4MmY0MTQ4NmE5ZDgyMDk4NzAyZjU5YjZkL3RleHRyZWdpb246MDE4OWVlNjgyZjQxNDg2YTlkODIwOTg3MDJmNTliNmRfMzgy_adac17bc-76af-42bc-abdd-9f8bc0ba00c6"
      unitRef="usd">900000</us-gaap:RelatedPartyTransactionSellingGeneralAndAdministrativeExpensesFromTransactionsWithRelatedParty>
    <us-gaap:RelatedPartyTransactionSellingGeneralAndAdministrativeExpensesFromTransactionsWithRelatedParty
      contextRef="ia139293fe3d744eea1b17b968bfcf5ad_D20191001-20191001"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmFlNWE5YmUwZWI5NDQ1ZDE5MmZhZTgyMmQyMmJlMDlmL3NlYzphZTVhOWJlMGViOTQ0NWQxOTJmYWU4MjJkMjJiZTA5Zl82MS9mcmFnOjAxODllZTY4MmY0MTQ4NmE5ZDgyMDk4NzAyZjU5YjZkL3RleHRyZWdpb246MDE4OWVlNjgyZjQxNDg2YTlkODIwOTg3MDJmNTliNmRfNTk2_cca2b631-7c1e-4685-8045-ac0bfbc66a51"
      unitRef="usd">100000</us-gaap:RelatedPartyTransactionSellingGeneralAndAdministrativeExpensesFromTransactionsWithRelatedParty>
    <us-gaap:RelatedPartyTransactionSellingGeneralAndAdministrativeExpensesFromTransactionsWithRelatedParty
      contextRef="id5e6d28f8a04434285646197def78617_D20200511-20200511"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmFlNWE5YmUwZWI5NDQ1ZDE5MmZhZTgyMmQyMmJlMDlmL3NlYzphZTVhOWJlMGViOTQ0NWQxOTJmYWU4MjJkMjJiZTA5Zl82MS9mcmFnOjAxODllZTY4MmY0MTQ4NmE5ZDgyMDk4NzAyZjU5YjZkL3RleHRyZWdpb246MDE4OWVlNjgyZjQxNDg2YTlkODIwOTg3MDJmNTliNmRfODY4_104dbfcb-1789-468a-975a-080af0ce9ec4"
      unitRef="usd">15000</us-gaap:RelatedPartyTransactionSellingGeneralAndAdministrativeExpensesFromTransactionsWithRelatedParty>
    <us-gaap:CommonStockSharesIssued
      contextRef="i651d86ca5e54467a910cc1cdb8f31f8d_I20210102"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmFlNWE5YmUwZWI5NDQ1ZDE5MmZhZTgyMmQyMmJlMDlmL3NlYzphZTVhOWJlMGViOTQ0NWQxOTJmYWU4MjJkMjJiZTA5Zl82MS9mcmFnOjAxODllZTY4MmY0MTQ4NmE5ZDgyMDk4NzAyZjU5YjZkL3RleHRyZWdpb246MDE4OWVlNjgyZjQxNDg2YTlkODIwOTg3MDJmNTliNmRfMTA4MA_1634c30d-35dc-42e9-bc3d-bff79f42ea37"
      unitRef="shares">5000</us-gaap:CommonStockSharesIssued>
    <us-gaap:RelatedPartyTransactionSellingGeneralAndAdministrativeExpensesFromTransactionsWithRelatedParty
      contextRef="iee689bdd0154474d9e8d1bbbcec743b6_D20201111-20201111"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmFlNWE5YmUwZWI5NDQ1ZDE5MmZhZTgyMmQyMmJlMDlmL3NlYzphZTVhOWJlMGViOTQ0NWQxOTJmYWU4MjJkMjJiZTA5Zl82MS9mcmFnOjAxODllZTY4MmY0MTQ4NmE5ZDgyMDk4NzAyZjU5YjZkL3RleHRyZWdpb246MDE4OWVlNjgyZjQxNDg2YTlkODIwOTg3MDJmNTliNmRfMTI3MQ_9ed5d753-0ed4-4ad3-8ca9-beb663df8dd7"
      unitRef="usd">15000</us-gaap:RelatedPartyTransactionSellingGeneralAndAdministrativeExpensesFromTransactionsWithRelatedParty>
    <us-gaap:RelatedPartyTransactionSellingGeneralAndAdministrativeExpensesFromTransactionsWithRelatedParty
      contextRef="ib0f91fba366d40acba994eb5d6addb9c_D20210226-20210226"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmFlNWE5YmUwZWI5NDQ1ZDE5MmZhZTgyMmQyMmJlMDlmL3NlYzphZTVhOWJlMGViOTQ0NWQxOTJmYWU4MjJkMjJiZTA5Zl82MS9mcmFnOjAxODllZTY4MmY0MTQ4NmE5ZDgyMDk4NzAyZjU5YjZkL3RleHRyZWdpb246MDE4OWVlNjgyZjQxNDg2YTlkODIwOTg3MDJmNTliNmRfMTQwMA_42ed104f-5304-4f9b-8c0c-d4baa92107c1"
      unitRef="usd">20000</us-gaap:RelatedPartyTransactionSellingGeneralAndAdministrativeExpensesFromTransactionsWithRelatedParty>
    <us-gaap:RelatedPartyTransactionSellingGeneralAndAdministrativeExpensesFromTransactionsWithRelatedParty
      contextRef="i945b8bc570ef4af69046201719baea0d_D20220401-20220630"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmFlNWE5YmUwZWI5NDQ1ZDE5MmZhZTgyMmQyMmJlMDlmL3NlYzphZTVhOWJlMGViOTQ0NWQxOTJmYWU4MjJkMjJiZTA5Zl82MS9mcmFnOjAxODllZTY4MmY0MTQ4NmE5ZDgyMDk4NzAyZjU5YjZkL3RleHRyZWdpb246MDE4OWVlNjgyZjQxNDg2YTlkODIwOTg3MDJmNTliNmRfMTUxMg_7803ae57-c581-40d1-ae8a-29ebb570d6eb"
      unitRef="usd">0</us-gaap:RelatedPartyTransactionSellingGeneralAndAdministrativeExpensesFromTransactionsWithRelatedParty>
    <us-gaap:RelatedPartyTransactionSellingGeneralAndAdministrativeExpensesFromTransactionsWithRelatedParty
      contextRef="idfbaf207ccb145e0804dfb68b580e154_D20210401-20210630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmFlNWE5YmUwZWI5NDQ1ZDE5MmZhZTgyMmQyMmJlMDlmL3NlYzphZTVhOWJlMGViOTQ0NWQxOTJmYWU4MjJkMjJiZTA5Zl82MS9mcmFnOjAxODllZTY4MmY0MTQ4NmE5ZDgyMDk4NzAyZjU5YjZkL3RleHRyZWdpb246MDE4OWVlNjgyZjQxNDg2YTlkODIwOTg3MDJmNTliNmRfMTUxOQ_0a3ee1e6-2c9a-46f3-b961-6e49abdb87e1"
      unitRef="usd">20000</us-gaap:RelatedPartyTransactionSellingGeneralAndAdministrativeExpensesFromTransactionsWithRelatedParty>
    <us-gaap:RelatedPartyTransactionSellingGeneralAndAdministrativeExpensesFromTransactionsWithRelatedParty
      contextRef="i0d7a163c3890488dae0c374a84f12aa0_D20220101-20220630"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmFlNWE5YmUwZWI5NDQ1ZDE5MmZhZTgyMmQyMmJlMDlmL3NlYzphZTVhOWJlMGViOTQ0NWQxOTJmYWU4MjJkMjJiZTA5Zl82MS9mcmFnOjAxODllZTY4MmY0MTQ4NmE5ZDgyMDk4NzAyZjU5YjZkL3RleHRyZWdpb246MDE4OWVlNjgyZjQxNDg2YTlkODIwOTg3MDJmNTliNmRfNTQ5NzU1ODIwOTA3_20a28361-43d5-4f48-9d5b-c5537f276480"
      unitRef="usd">0</us-gaap:RelatedPartyTransactionSellingGeneralAndAdministrativeExpensesFromTransactionsWithRelatedParty>
    <us-gaap:RelatedPartyTransactionSellingGeneralAndAdministrativeExpensesFromTransactionsWithRelatedParty
      contextRef="i690d64dd56474cd880eacb6ae348633b_D20210101-20210630"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmFlNWE5YmUwZWI5NDQ1ZDE5MmZhZTgyMmQyMmJlMDlmL3NlYzphZTVhOWJlMGViOTQ0NWQxOTJmYWU4MjJkMjJiZTA5Zl82MS9mcmFnOjAxODllZTY4MmY0MTQ4NmE5ZDgyMDk4NzAyZjU5YjZkL3RleHRyZWdpb246MDE4OWVlNjgyZjQxNDg2YTlkODIwOTg3MDJmNTliNmRfMTU4Nw_3ec8b251-20d6-4711-84a1-72f9e7045aba"
      unitRef="usd">100000</us-gaap:RelatedPartyTransactionSellingGeneralAndAdministrativeExpensesFromTransactionsWithRelatedParty>
    <us-gaap:RelatedPartyTransactionExpensesFromTransactionsWithRelatedParty
      contextRef="ia855382ada1f4f28aa8ef6da692ff177_D20220101-20220630"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmFlNWE5YmUwZWI5NDQ1ZDE5MmZhZTgyMmQyMmJlMDlmL3NlYzphZTVhOWJlMGViOTQ0NWQxOTJmYWU4MjJkMjJiZTA5Zl82MS9mcmFnOjAxODllZTY4MmY0MTQ4NmE5ZDgyMDk4NzAyZjU5YjZkL3RleHRyZWdpb246MDE4OWVlNjgyZjQxNDg2YTlkODIwOTg3MDJmNTliNmRfMTY0NA_b876ff27-5e3a-410e-a6aa-3f10d62e8844"
      unitRef="usd">0</us-gaap:RelatedPartyTransactionExpensesFromTransactionsWithRelatedParty>
    <us-gaap:RelatedPartyTransactionExpensesFromTransactionsWithRelatedParty
      contextRef="idaa4f31ca59a4a17a59c2580b97791ca_D20210101-20210630"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmFlNWE5YmUwZWI5NDQ1ZDE5MmZhZTgyMmQyMmJlMDlmL3NlYzphZTVhOWJlMGViOTQ0NWQxOTJmYWU4MjJkMjJiZTA5Zl82MS9mcmFnOjAxODllZTY4MmY0MTQ4NmE5ZDgyMDk4NzAyZjU5YjZkL3RleHRyZWdpb246MDE4OWVlNjgyZjQxNDg2YTlkODIwOTg3MDJmNTliNmRfMTY0NA_b96630b3-43a0-4b00-9c81-4e8999061583"
      unitRef="usd">0</us-gaap:RelatedPartyTransactionExpensesFromTransactionsWithRelatedParty>
    <us-gaap:SubsequentEventsTextBlock
      contextRef="ia855382ada1f4f28aa8ef6da692ff177_D20220101-20220630"
      id="id3VybDovL2RvY3MudjEvZG9jOmFlNWE5YmUwZWI5NDQ1ZDE5MmZhZTgyMmQyMmJlMDlmL3NlYzphZTVhOWJlMGViOTQ0NWQxOTJmYWU4MjJkMjJiZTA5Zl82NC9mcmFnOjBkOGMwZjc1M2FjNTQyMjRhYzM1YmE5MGNhZjFkZDRlL3RleHRyZWdpb246MGQ4YzBmNzUzYWM1NDIyNGFjMzViYTkwY2FmMWRkNGVfMTc3_70298189-1869-4c48-bf9f-d9a7ffaf6fdb">.&#160;&#160;&#160;&#160;Subsequent EventsThe Company considered subsequent events through August&#160;8, 2022, the date the condensed consolidated financial statements were available to be issued, and determined there were no subsequent events that would require recognition or disclosure in the condensed consolidated financial statements.</us-gaap:SubsequentEventsTextBlock>
</xbrl>
</XML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EXCEL
<SEQUENCE>64
<FILENAME>Financial_Report.xlsx
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
begin 644 Financial_Report.xlsx
M4$L#!!0    ( *Z""%4'04UB@0   +$    0    9&]C4')O<',O87!P+GAM
M;$V./0L",1!$_\IQO;=!P4)B0-!2L+(/>QLOD&1#LD)^OCG!CVX>;QA&WPIG
M*N*I#BV&5(_C(I(/ !47BK9.7:=N')=HI6-Y #OGD<Z,STA)8*O4'J@)I9GF
M3?X.CD:?<@X>K7A.YNJQ<&4GPZ4A!0W_<FW>J=0U[R;UEA_6\#MI7E!+ P04
M    " "N@@A5(RT99.T    K @  $0   &1O8U!R;W!S+V-O<F4N>&ULS9+!
M:@,A$(9?I7C?'== *;+92TI.*10::.E-=))(UU5TRF[>OJY--I3V 0I>G/G]
MYANPU4%J'_$Y^H"1+*:[R?5#DCJLV8DH2("D3^A4JG-BR,V#CTY1OL8C!*4_
MU!%!<'X/#DD910IF8!46(NM:HZ6.J,C'"][H!1\^8U]@1@/VZ'"@!$W= .OF
MB>$\]2W< #.,,+KT74"S$$OU3VSI +LDIV27U#B.];@JN;Q# V]/NY>R;F6'
M1&K0F%\E*^D<<,VNDU]7F\?]EG6""U'QAWSV@DO1R$:\SZX__&["SAM[L/_8
M^"K8M?#K7W1?4$L#!!0    ( *Z""%697)PC$ 8  )PG   3    >&PO=&AE
M;64O=&AE;64Q+GAM;.U:6W/:.!1^[Z_0>&?V;0O&-H&VM!-S:7;;M)F$[4X?
MA1%8C6QY9)&$?[]'-A#+E@WMDDVZFSP$+.G[SD5'Y^@X>?/N+F+HAHB4\GA@
MV2_;UKNW+][@5S(D$4$P&:>O\, *I4Q>M5II ,,X?<D3$L/<@HL(2W@4R]9<
MX%L:+R/6ZK3;W5:$:6RA&$=D8'U>+&A T%116F]?(+3E'S/X%<M4C66C 1-7
M02:YB+3R^6S%_-K>/F7/Z3H=,H%N,!M8('_.;Z?D3EJ(X53"Q,!J9S]6:\?1
MTDB @LE]E 6Z2?:CTQ4(,@T[.IU8SG9\]L3MGXS*VG0T;1K@X_%X.+;+THMP
M' 3@4;N>PIWT;+^D00FTHVG09-CVVJZ1IJJ-4T_3]WW?ZYMHG J-6T_3:W?=
MTXZ)QJW0> V^\4^'PZZ)QJO0=.MI)B?]KFNDZ19H0D;CZWH2%;7E0-,@ %AP
M=M;,T@.67BGZ=90:V1V[W4%<\%CN.8D1_L;%!-9ITAF6-$9RG9 %#@ WQ-%,
M4'RO0;:*X,*2TER0UL\IM5 :")K(@?5'@B'%W*_]]9>[R:0S>IU].LYKE']I
MJP&G[;N;SY/\<^CDGZ>3UTU"SG"\+ GQ^R-;88<G;CL3<CH<9T)\S_;VD:4E
M,L_O^0KK3CQG'U:6L%W/S^2>C'(CN]WV6'WV3T=N(]>IP+,BUY1&)$6?R"VZ
MY!$XM4D-,A,_")V&F&I0' *D"3&6H8;XM,:L$> 3?;>^",C?C8CWJV^:/5>A
M6$G:A/@01AKBG'/F<]%L^P>E1M'V5;S<HY=8%0&7&-\TJC4LQ=9XE<#QK9P\
M'1,2S90+!D&&ER0F$JDY?DU($_XKI=K^G-- \)0O)/I*D8]ILR.G=";-Z#,:
MP4:O&W6':-(\>OX%^9PU"AR1&QT"9QNS1B&$:;OP'J\DCIJMPA$K0CYB&38:
M<K46@;9QJ81@6A+&T7A.TK01_%FL-9,^8,CLS9%USM:1#A&27C="/F+.BY 1
MOQZ&.$J:[:)Q6 3]GE[#2<'H@LMF_;A^AM4S;"R.]T?4%TKD#R:G/^DR- >C
MFED)O816:I^JAS0^J!XR"@7QN1X^Y7IX"C>6QKQ0KH)[ ?_1VC?"J_B"P#E_
M+GW/I>^Y]#VATK<W(WUGP=.+6]Y&;EO$^ZXQVM<T+BAC5W+-R,=4KY,IV#F?
MP.S]:#Z>\>WZV22$KYI9+2,6D$N!LT$DN/R+RO JQ GH9%LE"<M4TV4WBA*>
M0AMNZ5/U2I77Y:^Y*+@\6^3IKZ%T/BS/^3Q?Y[3-"S-#MW)+ZK:4OK4F.$KT
ML<QP3A[+##MG/)(=MG>@'37[]EUVY".E,%.70[@:0KX#;;J=W#HXGIB1N0K3
M4I!OP_GIQ7@:XCG9!+E]F%=MY]C1T?OGP5&PH^\\EAW'B/*B(>ZAAIC/PT.'
M>7M?F&>5QE T%&ULK"0L1K=@N-?Q+!3@9& MH >#KU$"\E)58#%;Q@,KD*)\
M3(Q%Z'#GEUQ?X]&2X]NF9;5NKREW&6TB4CG":9@39ZO*WF6QP54=SU5;\K"^
M:CVT%4[/_EFMR)\,$4X6"Q)(8Y07IDJB\QE3ON<K2<15.+]%,[82EQB\X^;'
M<4Y3N!)VM@\",KF[.:EZ93%GIO+?+0P)+%N(61+B35WMU>>;G*YZ(G;ZEW?!
M8/+]<,E'#^4[YU_T74.N?O;=X_INDSM(3)QYQ1$!=$4"(Y4<!A87,N10[I*0
M!A,!S93)1/ "@F2F'("8^@N]\@RY*17.K3XY?T4L@X9.7M(E$A2*L P%(1=R
MX^_ODVIWC-?Z+(%MA%0R9-47RD.)P3TS<D/85"7SKMHF"X7;XE3-NQJ^)F!+
MPWING2TG_]M>U#VT%SU&\Z.9X!ZSAW.;>KC"1:S_6-8>^3+?.7#;.MX#7N83
M+$.D?L%]BHJ $:MBOKJO3_DEG#NT>_&!()O\UMND]MW@#'S4JUJE9"L1/TL'
M?!^2!F.,6_0T7X\48JVFL:W&VC$,>8!8\PRA9CC?AT6:&C/5BZPYC0IO0=5
MY3_;U UH]@TT')$%7C&9MC:CY$X*/-S^[PVPPL2.X>V+OP%02P,$%     @
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M#/XK0C8,=T#26)+?TI< 6XO#-MQAQ;K=/JN.T@BUK4R2T_5^_5%.&B>6K+;
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M$2$>]<NP^A4O0!VWZOA8?0J>[]TG>_=):X\.N=\HQ6N#F-;@YZG/GZV!V&_
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M@S"H[:\+VQLCU^T!_:TT1E;MY8HS &\%X/U22O-T8\_\][_QS/\'4$L#!!0
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MX@?HOZXEL:/U&P 4.FH  !#1%ET==(;]T1[;BU=L5J_=H@M.1-!M76$27UN
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M'1U/(^<\UB(&PGSU+*N##1<#-5  %3['(SL!T@MB8A;$SXW2<56=$"=R6IQ
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M:B_"M1\$VS8WO>Z8$&S3O%W3;$FK&B#_OV),/'VH!SA<1YS]!U!+ P04
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ML9)W$YI=&7R*3W$K?MNM!,HMD8%>P7+-"M87RI>C/YFH3M7PT,YRFE(N;6<
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M 8QL59I?6XV6([$*N,*Q",@]P*9A/5L47F$3>PL2@:R"*$Q4OM(TSD8UP,^
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M\@JL*T^A:-V!\J7$MT$K#<Q.@;&5-6S0/C;2XU\H+FA*>92RY=[K(G<%+2/
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M,'#H+U-=9"N5:3RC X? M)/O4.S/X_H(X[WP'[J4DS??U:#'0)O<O+NZ=B*
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ME(1K6*!H.,RS =/^(XY_L:IU'T[FREK5N,<*,)%H6H#S"Z7LYH4,]%_2KOX
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M)P66RI%XFZ>IKB#MJA0RB_$[JW2V45FD5?GRH@(J6G 16;!O#-CP -A+\2L
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MQA4K1 ]3G^RQ<.Y$Z]S?A%O7U);U"AK+6 Q4MB3*E]J0B@9H**@0.N@(G;C
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M$*8-]F#0W@'M&Z7L?N$/&+IZ\0=02P,$%     @ KH((554Y1M]I'@  ,V
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MW;7D+CC% $R3!T2\X9?6@NF57=6WK6!\%L)1<PX++<M]4R\ZBBS)K@')8"A
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M8C[;JU;G8(4F&?Z;O069A\T*HO$))K*&@E[\?4QE_ZJQ>PD,CY8H;YBM@,V
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M5/#<8N7"F=($A0ZT'2069":1/#\9V)O8;GCOK2-DC?TMOIP43EWX&&0C9X-
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MFI+ MCJ<!O<ZG=Z40LGOWMQ&)VC'1?[L6(M41IIN7IH\7KA'R)/\49L6:=V
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M8E*RTESF@#/@>H"ZOV9,'ALZ0'.D//\?4$L#!!0    ( *Z""%6V]+&WLP@
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MG.F//_@#[Q==:&R213;)8DMDC2#VZB#V3.Q350)$8"AF+Q^7%"& "U$ $..
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M 3@@2!D(0%Z^,?L@A;JBL+A"%+8EBLQ$7<N!+;:F_F>]F-]._Q3O<(I$.W;
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MUG!X5H1BGDM]"=!\A<P4-(;>(ROLK#G&CGOPQW2+PF/QB5J9T4F9/TR@V_C
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MP?KN8_B>S5?I6#?G*ZGI%WX._=[N!W!V4Y=<#Q/5+%2S4<U!-1?5/%3S42U
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M:A&JQ:B6H%I*:6(FMUVY/MJ5ZZ-=.5334<U -1/5+%2S4<U!-1?5/%3S42U
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M>FMYE\/*'\=9C+-Y+!WSYCPF-1W5#%0S4<U"-1O5'%1S4<T[:,),8N= "'3
M -5"5(M0+4:U!-522A.#N.VP#>0=MG\45;94UOLXSK_GY6RQJ3>)F^/0ME^7
MBUF;SY<VAM&V&JKIJ&:@FHEJ%JK9J.8,7K>"5$W5>OUIYR2-+CJNAVK^U<\B
M0,<-42U"M1C5$E1+*4W,U[:Q-I WUHX'.PA'.6R?ZKN.82ML!%\*6;31AFHZ
MJAFH9J*:A6HVJCFHYJ*:AVK^X%P_KM_K3;5N#J.5-E2+4"U&M0354DH3<[BM
MM WDE;;]=NY36<SR?+Y1[LMB)21P=VOW#^4O9P,8K;BAFHYJ!JJ9J&:AFHUJ
M#JJYJ.:AFG_01B<!/)J.N_WD !TT1+4(U6)42U MI30Q?MN*VT!><7O9Y7;:
M)KZTL8MVVU!-1S4#U4Q4LU#-1C4'U5Q4\P:O+]:F3=3A9-CO3NJB[;9KAPW1
M82-4BU$M0;64TL0@;8MK WEQ+=YOIUX^H!=MIZ&:CFH&JIFH9J&:C6H.JKFH
MYJ&:CVH!JH6H%J%:C&H)JJ64)L3PL.VP#?>%#>B WB':6T,U'=4,5#-1S4(U
M&]4<5'-1S4,U']4"5 M1+4*U&-425$LI34SCMMXVE-?;J -ZY</<'--H"P[5
M#%0S#YIX0&]_/'QULD(+'==&-0?57%3S4,U'M0#50E2+4"U&M0354DH3(UAK
M(UA^4;:X7#QG57YY8D+NW)RQ:+<-U0Q4,U'-0C4;U1Q4<U'-0S4?U0)4"U$M
M0K48U1)42RE-S.&VVS9$+\0V1"MLJ*:CFH%J)JI9J&:CFH-J+JIYJ.:C6H!J
M(:I%J!:C6H)J*:6):=S6W.J;_R43$])A;HYI4M-1S4 U\Z )9Q(<J:][QNBH
M-JHYJ.:BFH=J/JH%J!:B6H1J,:HEJ)92FAC ;;UM**^W_9GCSN3DS6&+-ME0
MS4 U$]4L5+-1S4$U%]6\X>M^VJ37[_[%\]%!@^L&#=%!(U2+42U!M932Q!!M
M.VQ#>8<M7M;V*E]7RB\/S7^ET[MH0PW5=%0S4,U$-0O5;%1S4,U%-0_5?%0+
M4"U$M0C58E1+4"VE-#&*VQK;<(Q.[Z)U-5334<U -1/5+%2S4<U!-1?5/%3S
M42U M1#5(E2+42U!M932Q#1N6VW#*UMM_^[T+MIT0S4=U0Q4,U'-0C4;U1Q4
M<U'-0S4?U0)4"U$M&KZNZJFCR5#KG+\B/O.XL38:3L2')>C*I90F)FM;<QO*
M:VXOR9I_?UJ46;6HH_0I+Q?%V:M@RK&;\Q,MNZ&:@6HFJEFH9J.:@VHNJGFH
MYJ-:@&HAJD47(F2L_,BS\MPD9?RGETS09Y!2FA"RH[;$-I)?B.W/[!R3D[=&
M+:KIJ&:@FHEJ%JK9J.:@FHMJWNCUU;K47J][M2X?'32X;M 0'31"M1C5$E1+
M*4T,T;9[-I)WS][:.:;\H6@]=:)\+M;/>5DMFLL+_UHNY@^Y$A95?G;GF7RH
MF\,5[9^AFH%J)JI9J&:CFH-J+JIYJ.:C6H!J(:I%J!:C6H)J*:6)4:VU48U>
MA6V$-M5034<U ]5,5+-0S48U!]5<5/-0S4>U -5"5(M0+4:U!-522A/3N&VJ
MC?YKKL(F'^;FF$8K;*AFH)J):A:JV:CFH)J+:AZJ^:@6H%HX.G/5O^%8ZUSC
M*$('C5$M0;64TL3\;;MI]4UN%YL<NSEE24U'-0/53%2S4,V^\ OR]FX0!UT/
M%]4\5/-1+4"U\$^_?A&Z'C&J):B64IH8LFW_;"3OGP79.GO83P_+6A-RY>9T
M12MGJ&:@FHEJ%JK9J.:@FHMJ'JKYJ!:@6HAJ$:K%J):@6DII8@JW!;;1")WX
M13MLJ*:CFH%J)JI9J&:CFH-J+JIYJ.:C6H!J(:I%J!:C6H)J*:6):=QVV$;R
M2['=./& 5MA034<U ]5,5+-0S48U!]5<5/,NO!74WIN?T7UT10)4"U$M0K48
MU1)42RE-3-ZVKS;BK\(F)V_.7[2;AFH&JIFH9J&:C6H.JKFHYHU>=Z>Z9\)!
M!PS.#*AI?:U[)AQTT C58E1+4"VE-#% VUK:2-X,^5Q\R]=*'9S*YV+UE*U_
M*+[_^6QJHHTT5--1S4 U$]4L5+-1S4$U%]4\5/-1+4"U$-4B5(M1+4&UE-*$
M'!ZWS;4Q>OFU,5I:0S4=U0Q4,U'-0C4;U1Q4<U'-0S4?U0)4"U$M0K48U1)4
M2RE-3..V C>65^"<S6:;K6=Y$\CU /=Y6>;S_<&[[Y6JJ+)E_9WZWF:V(5L5
MVW6E_*'\Y6Q0HP4X5--1S3AHHY//B<WETCJ?$TUT4 O5;%1S4,U%-0_5?%0+
M4"U$M0C58E1+4"VE-#&!M3:!Y5=?.TW@T^[$>V6=5\V=B^,#9L6FVASF>R]-
M_<H'O3F-T0(<JAFH9J*:A6KV03N=GYP.U?&T<](I!QW5137OS'/H3NJB P9G
M!ASV>\.AVIG514>-4"U&M0354DH3T[-MHHTO--'RQ<-C56^R9L]YF3WD;0_M
MJ5S4F?F4E_N8W 7F=C-O[_E;LR6KW!U2]&R(HO4T5--1S4 U$]4L5+,/VN1T
M)T_OPW3<S5"T=X9J'JKYJ!:<^?$.1A_Z_6[:HM=$0[48U1)42RE-3-NV=U;?
ME*6M51:;39VLQ2S/YQOEOBQ6[>9I9_OUS7D"Z1 WARJIZ:AFH)J):A:JV0=M
M)(3JJQD1!QW4134/U7Q4"\[]> >C[H\W1 >-4"U&M0354DH30[7MF8WE/3,]
MGY5YL\5:;Z!V/NN_%:%HY0S5=%0S4,U$-0O5[/'KRW!-7P<HVB1#-0_5?%0+
MSOQPQZ_C$RV(H5J,:@FJI90FQF=;$!M?N,+9O[<UBO;%4$U'-0/53%2S4,T^
M:*>;2^I4?1VF:!$,U3Q4\U$M.//CU?J3UW&*-KQ0+4:U!-522A/CM&UXC>6U
MEL\GH7DV,-%.%ZKIJ&:@FHEJ%JK9J.:@FHMJ'JKYJ!:@6HAJ$:K%J):@6DII
M8ORV-:_QO@5!'1V+-KQ034<U ]5,5+-0S48U!]5<5/-0S4>U -5"5(M0+4:U
M!-522A/3N.V,C>6=,?#H6+14AFHZJAFH9J*:A6HVJCFHYAXT80Y$_(#NH0/Z
MJ!:@6HAJ$:K%J):@6DII0OI.VJ;81'Z-L_^<(V/E@]Z:Q*BFHYJ!:B:J6:AF
MHYHS>7W1KW.'C+IG'C>8C+7)I)NTZ.KYJ!:@6HAJ$:K%J):@6DII8M*V+;")
MO 46;E=?\[*)U$.&'J[K<%^42I[-'I5O^[//7,Q6M .&:CJJ&:AFHIJ%:C:J
M.:CFHIIWT-3^2:#W/FC#3C\!'31 M1#5(E2+42U!M932Q/S5VOR5=\ ^BT<J
M?(E_^2P]Y[B<NSEGT787JAFH9J*:A6HVJCFHYJ*:AVH^J@6H%J):A&HQJB6H
MEE*:&,=MJ6S2)W?"3=":&*KIJ&:@FHEJ%JK9J.:@FHMJ'JKYJ!:@6HAJ$:K%
MJ):@6DII8AJWI;/ZIFSCV/B>E[/%2Z.WCN73V8@;*[WRL6[.:E+34<U -1/5
M+%2S4<U!-1?5O(,F'GK;G9X@1PQ0+42U"-5B5$M0+:4T,8';AMI$WE##IH?1
MWAJJZ:AFH)J):A:JV:CFH)J+:MY!NS@]C#;74"U$M0C58E1+4"VE-#%_VXK;
M1%YQZTP/Q\MZJ-UU*7]YN'1U2KE\<^2B_394,U#-1#4+U6Q4<U#-134/U7Q4
M"U M1+4(U6)42U MI30QF=NVW&2,SA2CY3E4TU'-0#43U2Q4LU'-0347U3Q4
M\U$M0+40U2)4BU$M0;64TL0T;LMS$_DUTMB98K1:AVHZJAFH9J*:A6HVJCFH
MYJ*:AVH^J@6H%J):=-!.SU\Y^3":B',\\9E'33\,^]/3?^(B";J:*:6)0=OV
MXB;R7APV(8RVXE!-1S4#U4Q4LU#-1C4'U5Q4\U#-1[4 U4)4BP[::6]&[0;L
MQ8<DZ#JEE"8$ZK2MNDWE5;<K9WCK;VD]=:)\+M;/>5DMOBYSY==R,7_(E;"H
MSF_'RD>^-6-134<U ]5,5+-0S48U!]5<5/-0S4>U -5"5(M0+4:U!-522A.3
MNZW.355R!GB*-N1034<U ]5,5+-0S48U!]5<5/-0S4>U -5"5(M0+4:U!-52
M2A/36&O36%ZD0V> Y6/=G-5HRP[5#%0S4<U"-?N@W3!SYZ KX**:AVH^J@6H
M%M[^PD7H"L2HEJ!:2FEBZK9]N:G\(FS4=+!\F)L#%RW2H9J!:B:J6:AF'S3)
M3)Z##NBBFH=J/JH%J!9>?J$B=, 8U1)42RE-#-2V\E;?O&$Z.,C6V<-^/EAV
MK*\<O3D^24U'-0/53%2S4,U&-0?57%3S4,U'M0#50E2+4"U&M0354DH30[EM
MP4V'Z$PO6G9#-1W5#%0S4<U"-1O5'%1S4<U#-1_5 E0+42U"M1C5$E1+*4U,
MX[83-Y5WXMB97K0EAVHZJAFH9J*:A6HVJCFHYJ*:=]!.IT;5#[W.,:L^.F:
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M66M-R[[DZN?16J\PR0;*HTKUU5#'J?FC$LN7M8@"GLJ?$/VV#=4!?4;T<;%
M7UFT97DY'[A:BP#]['/%PDC^,G64SIT1G.4QSVV1AS3DZ:,'D:BU1#0)>&"(
M]^WQGB7>T7TN.T[>.GY+K, _MLD5ZKN?$'$),=S/7?MP;.K.9=GIA[/7Q.B7
MHZ"?\P8-/(UQWXI_GRQYDLU>M(A88JJTE96M;-=RPY9\UM-+E^3ICO?F/_Z
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M-:75/GYUPLF^W*B^(YR3HCQ,$4P0E0;B^I80_G0B S1?4Q;_ 5!+ P04
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M.E.?^>9G5@UH8/0BGDG[%VVJ>P,/16NI>%X%ZQ[D:5%^TJ\5B*T K=,=0*H
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MQ7-[F# :,V%NT-\O.%=/)Z:!^O\/IO\!4$L#!!0    ( *Z""%7)1_RO7PX
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M#IKK$*KH-A&[$.5YM0G5NEQNGK#W>!.N(S=E>:_?GL&?;OVF --RGX80VO\
MU0*H1J!:"-4H5&-0C:,T.81='X4UM(]"V9^M5P9'I[\T;EH3Q:&Y!ZWK0[4
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MOHA%7A^C:<^&Z-VA@8)J'E3SH5H U0A4"Z$:A6H,JG&4)J>N:\-PS!<\&^)
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M]6%6\X3ZWYN;QOSXIBGPF!>_;5[.U5]02P,$%     @ KH((52:W60;R @
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MPYQ6W-S*]0=H\NE;ODQR[7[)NHD-/))5VLBB :."@HGZ21\;'S8 86\/(&H
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MA<&!3?DJE5:O4B7TOGJA,A)?R)0K::]A\;#Q>/@,D[?7 *QSHE\A3YI(OQ^
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M1Y>!N.9/%BL:E%70XT&2_2=/>=F!UB+>,A$\+,2R!J$?Y:_TN;@1&P*U^XI
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MEE;K-M$G%SP,I:]D)^L]')%D3F4(XB?)4MKO@Q\55^JZMO-&\*%>0\)T),Q
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ML_<:GS_P<$GC>U^.0 -V)T,IQP/9L#A_AB _$7R1;?V^Y4+P,#N<,SIC<5I
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MK=M?87KMN#E1FUQ<IFS!TE'=5=.Q;0:F8;+6%Q!VD1M[^1&,XS _ AB6!W.
M<1P+R_,_S:>'SL=AF+>>%^FAG![*<2P?,K(?+(^?DYC+/],DB:(XQE9T-/(Z
M&&'K%L?PXU?#O $#RP.9_FZM\=W&*V1_'6![NJ]"L)GBE8C-%%]K0/SK!HPD
M\>\VE@<8V"Y@M0/Y_7F@IOR<*()=Q;QA3S".) F&0"WZ:S2.D=6)X>/?'^PI
MB:(D\2. ^1U$$8; TX@CF /P@"%19-^#.^^C</6>"M?_OQS^!E!+ P04
M" "N@@A5EXJ[',     3 @  "P   %]R96QS+RYR96QSG9*Y;L,P#$!_Q=">
M, ?0(8@S9?$6!/D!5J(/V!(%BD6=OZ_:I7&0"QEY/3P2W!YI0.TXI+:+J1C]
M$%)I6M6X 4BV)8]ISI%"KM0L'C6'TD!$VV-#L%HL/D N&6:WO606IW.D5XA<
MUYVE/=LO3T%O@*\Z3'%":4A+,P[PS=)_,O?S##5%Y4HCE5L:>-/E_G;@2=&A
M(E@6FD7)TZ(=I7\=Q_:0T^FO8R*T>EOH^7%H5 J.W&,EC'%BM/XU@LD/['X
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M-:E5V1S\6?=78/8%4$L! A0#%     @ KH((50=!36*!    L0   !
M         ( !     &1O8U!R;W!S+V%P<"YX;6Q02P$"% ,4    " "N@@A5
M(RT99.T    K @  $0              @ &O    9&]C4')O<',O8V]R92YX
M;6Q02P$"% ,4    " "N@@A5F5R<(Q &  "<)P  $P              @ '+
M 0  >&PO=&AE;64O=&AE;64Q+GAM;%!+ 0(4 Q0    ( *Z""%7[AU:V[ 4
M +T?   8              " @0P(  !X;"]W;W)K<VAE971S+W-H965T,2YX
M;6Q02P$"% ,4    " "N@@A5RP%OA%0&  #O&0  &               @($N
M#@  >&PO=V]R:W-H965T<R]S:&5E=#(N>&UL4$L! A0#%     @ KH((58[#
MRNVN @  > <  !@              ("!N!0  'AL+W=O<FMS:&5E=',O<VAE
M970S+GAM;%!+ 0(4 Q0    ( *Z""%5N&PN>%@<  )HH   8
M  " @9P7  !X;"]W;W)K<VAE971S+W-H965T-"YX;6Q02P$"% ,4    " "N
M@@A5@[EM4R #  #L"0  &               @('H'@  >&PO=V]R:W-H965T
M<R]S:&5E=#4N>&UL4$L! A0#%     @ KH((58(P%P_)#   F'L  !@
M         ("!/B(  'AL+W=O<FMS:&5E=',O<VAE970V+GAM;%!+ 0(4 Q0
M   ( *Z""%7"?/XE[ (  &@)   8              " @3TO  !X;"]W;W)K
M<VAE971S+W-H965T-RYX;6Q02P$"% ,4    " "N@@A5KMU3*K,,   ,:0
M&               @(%?,@  >&PO=V]R:W-H965T<R]S:&5E=#@N>&UL4$L!
M A0#%     @ KH((51[S*"F;(P  >7$  !@              ("!2#\  'AL
M+W=O<FMS:&5E=',O<VAE970Y+GAM;%!+ 0(4 Q0    ( *Z""%66MC"RW 8
M %43   9              " @1EC  !X;"]W;W)K<VAE971S+W-H965T,3 N
M>&UL4$L! A0#%     @ KH((58-)"$3G$0  83D  !D              ("!
M+&H  'AL+W=O<FMS:&5E=',O<VAE970Q,2YX;6Q02P$"% ,4    " "N@@A5
M^#LIFB$3   Q/0  &0              @(%*?   >&PO=V]R:W-H965T<R]S
M:&5E=#$R+GAM;%!+ 0(4 Q0    ( *Z""%5<AF>CV00  &D,   9
M      " @:*/  !X;"]W;W)K<VAE971S+W-H965T,3,N>&UL4$L! A0#%
M  @ KH((5<3>@>6$ @  X04  !D              ("!LI0  'AL+W=O<FMS
M:&5E=',O<VAE970Q-"YX;6Q02P$"% ,4    " "N@@A553E&WVD>   S8
M&0              @(%MEP  >&PO=V]R:W-H965T<R]S:&5E=#$U+GAM;%!+
M 0(4 Q0    ( *Z""%7<G'4@[0<  +@9   9              " @0VV  !X
M;"]W;W)K<VAE971S+W-H965T,38N>&UL4$L! A0#%     @ KH((5<P%0H68
M!0  N@\  !D              ("!,;X  'AL+W=O<FMS:&5E=',O<VAE970Q
M-RYX;6Q02P$"% ,4    " "N@@A5"M&'$$\&  #]$   &0
M@($ Q   >&PO=V]R:W-H965T<R]S:&5E=#$X+GAM;%!+ 0(4 Q0    ( *Z"
M"%779=Z42 8  #$1   9              " @8;*  !X;"]W;W)K<VAE971S
M+W-H965T,3DN>&UL4$L! A0#%     @ KH((57<="96)"@  C&0  !D
M         ("!!=$  'AL+W=O<FMS:&5E=',O<VAE970R,"YX;6Q02P$"% ,4
M    " "N@@A5,+[*JE8$  !O&   &0              @('%VP  >&PO=V]R
M:W-H965T<R]S:&5E=#(Q+GAM;%!+ 0(4 Q0    ( *Z""%6]CD5LY@,  %X6
M   9              " @5+@  !X;"]W;W)K<VAE971S+W-H965T,C(N>&UL
M4$L! A0#%     @ KH((5;;TL;>S"   B5(  !D              ("!;^0
M 'AL+W=O<FMS:&5E=',O<VAE970R,RYX;6Q02P$"% ,4    " "N@@A5I3.T
MX*4$  !/&P  &0              @(%9[0  >&PO=V]R:W-H965T<R]S:&5E
M=#(T+GAM;%!+ 0(4 Q0    ( *Z""%4KZA4[% ,  ,0'   9
M  " @37R  !X;"]W;W)K<VAE971S+W-H965T,C4N>&UL4$L! A0#%     @
MKH((5=W4>NI*!   L!0  !D              ("!@/4  'AL+W=O<FMS:&5E
M=',O<VAE970R-BYX;6Q02P$"% ,4    " "N@@A5O:PV:K8"   7!P  &0
M            @($!^@  >&PO=V]R:W-H965T<R]S:&5E=#(W+GAM;%!+ 0(4
M Q0    ( *Z""%4N_MQ^"@0  +\.   9              " @>[\  !X;"]W
M;W)K<VAE971S+W-H965T,C@N>&UL4$L! A0#%     @ KH((5;BAV"CX @
M9@D  !D              ("!+P$! 'AL+W=O<FMS:&5E=',O<VAE970R.2YX
M;6Q02P$"% ,4    " "N@@A5# A]<3 A  !&9 ( &0              @(%>
M! $ >&PO=V]R:W-H965T<R]S:&5E=#,P+GAM;%!+ 0(4 Q0    ( *Z""%7$
MYC(%6P4  .4I   9              " @<4E 0!X;"]W;W)K<VAE971S+W-H
M965T,S$N>&UL4$L! A0#%     @ KH((58\ R617!   61D  !D
M     ("!5RL! 'AL+W=O<FMS:&5E=',O<VAE970S,BYX;6Q02P$"% ,4
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M+GAM;%!+ 0(4 Q0    ( *Z""%6D0LU4?04  . ;   9              "
M@4)+ 0!X;"]W;W)K<VAE971S+W-H965T,S<N>&UL4$L! A0#%     @ KH((
M5?G(&\Q?!   /!<  !D              ("!]E ! 'AL+W=O<FMS:&5E=',O
M<VAE970S."YX;6Q02P$"% ,4    " "N@@A52V4/NW8%  #5,0  &0
M        @(&,50$ >&PO=V]R:W-H965T<R]S:&5E=#,Y+GAM;%!+ 0(4 Q0
M   ( *Z""%7$]DD!0P,  ,P4   -              "  3E; 0!X;"]S='EL
M97,N>&UL4$L! A0#%     @ KH((59>*NQS     $P(   L
M ( !IUX! %]R96QS+RYR96QS4$L! A0#%     @ KH((5;(IBO18 P  MAH
M  \              ( !D%\! 'AL+W=O<FMB;V]K+GAM;%!+ 0(4 Q0    (
M *Z""%5 N\,MAP$  +P7   :              "  15C 0!X;"]?<F5L<R]W
M;W)K8F]O:RYX;6PN<F5L<U!+ 0(4 Q0    ( *Z""%7_>6J2GP$  !T8   3
M              "  =1D 0!;0V]N=&5N=%]4>7!E<UTN>&UL4$L%!@     O
- "\ P P  *1F 0    $!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>65
<FILENAME>Show.js
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
// Edgar(tm) Renderer was created by staff of the U.S. Securities and Exchange Commission.  Data and content created by government employees within the scope of their employment are not subject to domestic copyright protection. 17 U.S.C. 105.
var Show={};Show.LastAR=null,Show.showAR=function(a,r,w){if(Show.LastAR)Show.hideAR();var e=a;while(e&&e.nodeName!='TABLE')e=e.nextSibling;if(!e||e.nodeName!='TABLE'){var ref=((window)?w.document:document).getElementById(r);if(ref){e=ref.cloneNode(!0);
e.removeAttribute('id');a.parentNode.appendChild(e)}}
if(e)e.style.display='block';Show.LastAR=e};Show.hideAR=function(){Show.LastAR.style.display='none'};Show.toggleNext=function(a){var e=a;while(e.nodeName!='DIV')e=e.nextSibling;if(!e.style){}else if(!e.style.display){}else{var d,p_;if(e.style.display=='none'){d='block';p='-'}else{d='none';p='+'}
e.style.display=d;if(a.textContent){a.textContent=p+a.textContent.substring(1)}else{a.innerText=p+a.innerText.substring(1)}}}
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>66
<FILENAME>report.css
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
/* Updated 2009-11-04 */
/* v2.2.0.24 */

/* DefRef Styles */
..report table.authRefData{
	background-color: #def;
	border: 2px solid #2F4497;
	font-size: 1em;
	position: absolute;
}

..report table.authRefData a {
	display: block;
	font-weight: bold;
}

..report table.authRefData p {
	margin-top: 0px;
}

..report table.authRefData .hide {
	background-color: #2F4497;
	padding: 1px 3px 0px 0px;
	text-align: right;
}

..report table.authRefData .hide a:hover {
	background-color: #2F4497;
}

..report table.authRefData .body {
	height: 150px;
	overflow: auto;
	width: 400px;
}

..report table.authRefData table{
	font-size: 1em;
}

/* Report Styles */
..pl a, .pl a:visited {
	color: black;
	text-decoration: none;
}

/* table */
..report {
	background-color: white;
	border: 2px solid #acf;
	clear: both;
	color: black;
	font: normal 8pt Helvetica, Arial, san-serif;
	margin-bottom: 2em;
}

..report hr {
	border: 1px solid #acf;
}

/* Top labels */
..report th {
	background-color: #acf;
	color: black;
	font-weight: bold;
	text-align: center;
}

..report th.void	{
	background-color: transparent;
	color: #000000;
	font: bold 10pt Helvetica, Arial, san-serif;
	text-align: left;
}

..report .pl {
	text-align: left;
	vertical-align: top;
	white-space: normal;
	width: 200px;
	white-space: normal; /* word-wrap: break-word; */
}

..report td.pl a.a {
	cursor: pointer;
	display: block;
	width: 200px;
	overflow: hidden;
}

..report td.pl div.a {
	width: 200px;
}

..report td.pl a:hover {
	background-color: #ffc;
}

/* Header rows... */
..report tr.rh {
	background-color: #acf;
	color: black;
	font-weight: bold;
}

/* Calendars... */
..report .rc {
	background-color: #f0f0f0;
}

/* Even rows... */
..report .re, .report .reu {
	background-color: #def;
}

..report .reu td {
	border-bottom: 1px solid black;
}

/* Odd rows... */
..report .ro, .report .rou {
	background-color: white;
}

..report .rou td {
	border-bottom: 1px solid black;
}

..report .rou table td, .report .reu table td {
	border-bottom: 0px solid black;
}

/* styles for footnote marker */
..report .fn {
	white-space: nowrap;
}

/* styles for numeric types */
..report .num, .report .nump {
	text-align: right;
	white-space: nowrap;
}

..report .nump {
	padding-left: 2em;
}

..report .nump {
	padding: 0px 0.4em 0px 2em;
}

/* styles for text types */
..report .text {
	text-align: left;
	white-space: normal;
}

..report .text .big {
	margin-bottom: 1em;
	width: 17em;
}

..report .text .more {
	display: none;
}

..report .text .note {
	font-style: italic;
	font-weight: bold;
}

..report .text .small {
	width: 10em;
}

..report sup {
	font-style: italic;
}

..report .outerFootnotes {
	font-size: 1em;
}
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>67
<FILENAME>FilingSummary.xml
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<XML>
<?xml version='1.0' encoding='utf-8'?>
<FilingSummary>
  <Version>3.22.2</Version>
  <ProcessingTime/>
  <ReportFormat>html</ReportFormat>
  <ContextCount>291</ContextCount>
  <ElementCount>300</ElementCount>
  <EntityCount>1</EntityCount>
  <FootnotesReported>false</FootnotesReported>
  <SegmentCount>68</SegmentCount>
  <ScenarioCount>0</ScenarioCount>
  <TuplesReported>false</TuplesReported>
  <UnitCount>10</UnitCount>
  <MyReports>
    <Report instance="dmtk-20220630.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R1.htm</HtmlFileName>
      <LongName>0001001 - Document - Cover Page</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://dermtech.com/role/CoverPage</Role>
      <ShortName>Cover Page</ShortName>
      <MenuCategory>Cover</MenuCategory>
      <Position>1</Position>
    </Report>
    <Report instance="dmtk-20220630.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R2.htm</HtmlFileName>
      <LongName>1001002 - Statement - Condensed Consolidated Balance Sheets</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://dermtech.com/role/CondensedConsolidatedBalanceSheets</Role>
      <ShortName>Condensed Consolidated Balance Sheets</ShortName>
      <MenuCategory>Statements</MenuCategory>
      <Position>2</Position>
    </Report>
    <Report instance="dmtk-20220630.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R3.htm</HtmlFileName>
      <LongName>1002003 - Statement - Condensed Consolidated Balance Sheets (Parenthetical)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://dermtech.com/role/CondensedConsolidatedBalanceSheetsParenthetical</Role>
      <ShortName>Condensed Consolidated Balance Sheets (Parenthetical)</ShortName>
      <MenuCategory>Statements</MenuCategory>
      <Position>3</Position>
    </Report>
    <Report instance="dmtk-20220630.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R4.htm</HtmlFileName>
      <LongName>1003004 - Statement - Condensed Consolidated Statements of Operations</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://dermtech.com/role/CondensedConsolidatedStatementsofOperations</Role>
      <ShortName>Condensed Consolidated Statements of Operations</ShortName>
      <MenuCategory>Statements</MenuCategory>
      <Position>4</Position>
    </Report>
    <Report instance="dmtk-20220630.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R5.htm</HtmlFileName>
      <LongName>1004005 - Statement - Condensed Consolidated Statements of Comprehensive Loss</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://dermtech.com/role/CondensedConsolidatedStatementsofComprehensiveLoss</Role>
      <ShortName>Condensed Consolidated Statements of Comprehensive Loss</ShortName>
      <MenuCategory>Statements</MenuCategory>
      <Position>5</Position>
    </Report>
    <Report instance="dmtk-20220630.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R6.htm</HtmlFileName>
      <LongName>1005006 - Statement - Condensed Consolidated Statements of Stockholders??? Equity</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://dermtech.com/role/CondensedConsolidatedStatementsofStockholdersEquity</Role>
      <ShortName>Condensed Consolidated Statements of Stockholders??? Equity</ShortName>
      <MenuCategory>Statements</MenuCategory>
      <Position>6</Position>
    </Report>
    <Report instance="dmtk-20220630.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R7.htm</HtmlFileName>
      <LongName>1006007 - Statement - Condensed Consolidated Statements of Stockholders??? Equity (Parenthetical)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://dermtech.com/role/CondensedConsolidatedStatementsofStockholdersEquityParenthetical</Role>
      <ShortName>Condensed Consolidated Statements of Stockholders??? Equity (Parenthetical)</ShortName>
      <MenuCategory>Statements</MenuCategory>
      <Position>7</Position>
    </Report>
    <Report instance="dmtk-20220630.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R8.htm</HtmlFileName>
      <LongName>1007008 - Statement - Condensed Consolidated Statements of Cash Flows</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://dermtech.com/role/CondensedConsolidatedStatementsofCashFlows</Role>
      <ShortName>Condensed Consolidated Statements of Cash Flows</ShortName>
      <MenuCategory>Statements</MenuCategory>
      <Position>8</Position>
    </Report>
    <Report instance="dmtk-20220630.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R9.htm</HtmlFileName>
      <LongName>2101101 - Disclosure - The Company and a Summary of its Significant Accounting Policies</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://dermtech.com/role/TheCompanyandaSummaryofitsSignificantAccountingPolicies</Role>
      <ShortName>The Company and a Summary of its Significant Accounting Policies</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>9</Position>
    </Report>
    <Report instance="dmtk-20220630.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R10.htm</HtmlFileName>
      <LongName>2110102 - Disclosure - Balance Sheet Details</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://dermtech.com/role/BalanceSheetDetails</Role>
      <ShortName>Balance Sheet Details</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>10</Position>
    </Report>
    <Report instance="dmtk-20220630.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R11.htm</HtmlFileName>
      <LongName>2116103 - Disclosure - Stockholders' Equity</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://dermtech.com/role/StockholdersEquity</Role>
      <ShortName>Stockholders' Equity</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>11</Position>
    </Report>
    <Report instance="dmtk-20220630.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R12.htm</HtmlFileName>
      <LongName>2122104 - Disclosure - Leases, Commitments and Contingencies</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://dermtech.com/role/LeasesCommitmentsandContingencies</Role>
      <ShortName>Leases, Commitments and Contingencies</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>12</Position>
    </Report>
    <Report instance="dmtk-20220630.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R13.htm</HtmlFileName>
      <LongName>2129105 - Disclosure - Related Party Transactions</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://dermtech.com/role/RelatedPartyTransactions</Role>
      <ShortName>Related Party Transactions</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>13</Position>
    </Report>
    <Report instance="dmtk-20220630.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R14.htm</HtmlFileName>
      <LongName>2131106 - Disclosure - Subsequent Events</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://dermtech.com/role/SubsequentEvents</Role>
      <ShortName>Subsequent Events</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>14</Position>
    </Report>
    <Report instance="dmtk-20220630.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R15.htm</HtmlFileName>
      <LongName>2202201 - Disclosure - The Company and a Summary of its Significant Accounting Policies (Policies)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://dermtech.com/role/TheCompanyandaSummaryofitsSignificantAccountingPoliciesPolicies</Role>
      <ShortName>The Company and a Summary of its Significant Accounting Policies (Policies)</ShortName>
      <MenuCategory>Policies</MenuCategory>
      <ParentRole>http://dermtech.com/role/TheCompanyandaSummaryofitsSignificantAccountingPolicies</ParentRole>
      <Position>15</Position>
    </Report>
    <Report instance="dmtk-20220630.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R16.htm</HtmlFileName>
      <LongName>2303301 - Disclosure - The Company and a Summary of its Significant Accounting Policies (Tables)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://dermtech.com/role/TheCompanyandaSummaryofitsSignificantAccountingPoliciesTables</Role>
      <ShortName>The Company and a Summary of its Significant Accounting Policies (Tables)</ShortName>
      <MenuCategory>Tables</MenuCategory>
      <ParentRole>http://dermtech.com/role/TheCompanyandaSummaryofitsSignificantAccountingPolicies</ParentRole>
      <Position>16</Position>
    </Report>
    <Report instance="dmtk-20220630.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R17.htm</HtmlFileName>
      <LongName>2311302 - Disclosure - Balance Sheet Details (Tables)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://dermtech.com/role/BalanceSheetDetailsTables</Role>
      <ShortName>Balance Sheet Details (Tables)</ShortName>
      <MenuCategory>Tables</MenuCategory>
      <ParentRole>http://dermtech.com/role/BalanceSheetDetails</ParentRole>
      <Position>17</Position>
    </Report>
    <Report instance="dmtk-20220630.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R18.htm</HtmlFileName>
      <LongName>2317303 - Disclosure - Stockholders' Equity (Tables)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://dermtech.com/role/StockholdersEquityTables</Role>
      <ShortName>Stockholders' Equity (Tables)</ShortName>
      <MenuCategory>Tables</MenuCategory>
      <ParentRole>http://dermtech.com/role/StockholdersEquity</ParentRole>
      <Position>18</Position>
    </Report>
    <Report instance="dmtk-20220630.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R19.htm</HtmlFileName>
      <LongName>2323304 - Disclosure - Leases, Commitments and Contingencies (Tables)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://dermtech.com/role/LeasesCommitmentsandContingenciesTables</Role>
      <ShortName>Leases, Commitments and Contingencies (Tables)</ShortName>
      <MenuCategory>Tables</MenuCategory>
      <ParentRole>http://dermtech.com/role/LeasesCommitmentsandContingencies</ParentRole>
      <Position>19</Position>
    </Report>
    <Report instance="dmtk-20220630.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R20.htm</HtmlFileName>
      <LongName>2404401 - Disclosure - The Company and a Summary of its Significant Accounting Policies - Additional Information (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://dermtech.com/role/TheCompanyandaSummaryofitsSignificantAccountingPoliciesAdditionalInformationDetails</Role>
      <ShortName>The Company and a Summary of its Significant Accounting Policies - Additional Information (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>20</Position>
    </Report>
    <Report instance="dmtk-20220630.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R21.htm</HtmlFileName>
      <LongName>2405402 - Disclosure - The Company and a Summary of its Significant Accounting Policies - Schedule of Revenues Disaggregated by Revenue Source (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://dermtech.com/role/TheCompanyandaSummaryofitsSignificantAccountingPoliciesScheduleofRevenuesDisaggregatedbyRevenueSourceDetails</Role>
      <ShortName>The Company and a Summary of its Significant Accounting Policies - Schedule of Revenues Disaggregated by Revenue Source (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>21</Position>
    </Report>
    <Report instance="dmtk-20220630.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R22.htm</HtmlFileName>
      <LongName>2406403 - Disclosure - The Company and a Summary of its Significant Accounting Policies - Summary of Percentages of Total Revenue or Accounts Receivable for Third Party Payers and Pharmaceutical Customers (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://dermtech.com/role/TheCompanyandaSummaryofitsSignificantAccountingPoliciesSummaryofPercentagesofTotalRevenueorAccountsReceivableforThirdPartyPayersandPharmaceuticalCustomersDetails</Role>
      <ShortName>The Company and a Summary of its Significant Accounting Policies - Summary of Percentages of Total Revenue or Accounts Receivable for Third Party Payers and Pharmaceutical Customers (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>22</Position>
    </Report>
    <Report instance="dmtk-20220630.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R23.htm</HtmlFileName>
      <LongName>2407404 - Disclosure - The Company and a Summary of its Significant Accounting Policies - Summary of Assets and Liabilities Measured at Fair Value on Recurring Basis (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://dermtech.com/role/TheCompanyandaSummaryofitsSignificantAccountingPoliciesSummaryofAssetsandLiabilitiesMeasuredatFairValueonRecurringBasisDetails</Role>
      <ShortName>The Company and a Summary of its Significant Accounting Policies - Summary of Assets and Liabilities Measured at Fair Value on Recurring Basis (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>23</Position>
    </Report>
    <Report instance="dmtk-20220630.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R24.htm</HtmlFileName>
      <LongName>2408405 - Disclosure - The Company and a Summary of its Significant Accounting Policies - Assumptions Used to Determine Fair Value of Each Option on Date of Grant Issued (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://dermtech.com/role/TheCompanyandaSummaryofitsSignificantAccountingPoliciesAssumptionsUsedtoDetermineFairValueofEachOptiononDateofGrantIssuedDetails</Role>
      <ShortName>The Company and a Summary of its Significant Accounting Policies - Assumptions Used to Determine Fair Value of Each Option on Date of Grant Issued (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>24</Position>
    </Report>
    <Report instance="dmtk-20220630.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R25.htm</HtmlFileName>
      <LongName>2409406 - Disclosure - The Company and a Summary of its Significant Accounting Policies - Summary of Changes in Fair Value of Level 3 Liabilities (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://dermtech.com/role/TheCompanyandaSummaryofitsSignificantAccountingPoliciesSummaryofChangesinFairValueofLevel3LiabilitiesDetails</Role>
      <ShortName>The Company and a Summary of its Significant Accounting Policies - Summary of Changes in Fair Value of Level 3 Liabilities (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>25</Position>
    </Report>
    <Report instance="dmtk-20220630.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R26.htm</HtmlFileName>
      <LongName>2412407 - Disclosure - Balance Sheet Details - Schedule of Short-Term Marketable Securities (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://dermtech.com/role/BalanceSheetDetailsScheduleofShortTermMarketableSecuritiesDetails</Role>
      <ShortName>Balance Sheet Details - Schedule of Short-Term Marketable Securities (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>26</Position>
    </Report>
    <Report instance="dmtk-20220630.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R27.htm</HtmlFileName>
      <LongName>2413408 - Disclosure - Balance Sheet Details - Additional Information (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://dermtech.com/role/BalanceSheetDetailsAdditionalInformationDetails</Role>
      <ShortName>Balance Sheet Details - Additional Information (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>27</Position>
    </Report>
    <Report instance="dmtk-20220630.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R28.htm</HtmlFileName>
      <LongName>2414409 - Disclosure - Balance Sheet Details - Schedule of Prepaid Expenses and PP&amp;E (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://dermtech.com/role/BalanceSheetDetailsScheduleofPrepaidExpensesandPPEDetails</Role>
      <ShortName>Balance Sheet Details - Schedule of Prepaid Expenses and PP&amp;E (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>28</Position>
    </Report>
    <Report instance="dmtk-20220630.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R29.htm</HtmlFileName>
      <LongName>2415410 - Disclosure - Balance Sheet Details - Schedule of Accrued Compensation and Accrued Liabilities (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://dermtech.com/role/BalanceSheetDetailsScheduleofAccruedCompensationandAccruedLiabilitiesDetails</Role>
      <ShortName>Balance Sheet Details - Schedule of Accrued Compensation and Accrued Liabilities (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>29</Position>
    </Report>
    <Report instance="dmtk-20220630.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R30.htm</HtmlFileName>
      <LongName>2418411 - Disclosure - Stockholders' Equity - Additional Information (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://dermtech.com/role/StockholdersEquityAdditionalInformationDetails</Role>
      <ShortName>Stockholders' Equity - Additional Information (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>30</Position>
    </Report>
    <Report instance="dmtk-20220630.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R31.htm</HtmlFileName>
      <LongName>2419412 - Disclosure - Stockholders' Equity - ESPP Valuation Method (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://dermtech.com/role/StockholdersEquityESPPValuationMethodDetails</Role>
      <ShortName>Stockholders' Equity - ESPP Valuation Method (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>31</Position>
    </Report>
    <Report instance="dmtk-20220630.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R32.htm</HtmlFileName>
      <LongName>2420413 - Disclosure - Stockholders' Equity - Share-Based Compensation Expense (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://dermtech.com/role/StockholdersEquityShareBasedCompensationExpenseDetails</Role>
      <ShortName>Stockholders' Equity - Share-Based Compensation Expense (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>32</Position>
    </Report>
    <Report instance="dmtk-20220630.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R33.htm</HtmlFileName>
      <LongName>2421414 - Disclosure - Stockholders' Equity - Summary of Common Stock Reserved for Future Issuance (Detail)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://dermtech.com/role/StockholdersEquitySummaryofCommonStockReservedforFutureIssuanceDetail</Role>
      <ShortName>Stockholders' Equity - Summary of Common Stock Reserved for Future Issuance (Detail)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>33</Position>
    </Report>
    <Report instance="dmtk-20220630.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R34.htm</HtmlFileName>
      <LongName>2424415 - Disclosure - Leases, Commitments and Contingencies - Adoption of ASC 842 (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://dermtech.com/role/LeasesCommitmentsandContingenciesAdoptionofASC842Details</Role>
      <ShortName>Leases, Commitments and Contingencies - Adoption of ASC 842 (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>34</Position>
    </Report>
    <Report instance="dmtk-20220630.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R35.htm</HtmlFileName>
      <LongName>2425416 - Disclosure - Leases, Commitments and Contingencies - Additional Information (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://dermtech.com/role/LeasesCommitmentsandContingenciesAdditionalInformationDetails</Role>
      <ShortName>Leases, Commitments and Contingencies - Additional Information (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>35</Position>
    </Report>
    <Report instance="dmtk-20220630.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R36.htm</HtmlFileName>
      <LongName>2426417 - Disclosure - Leases, Commitments and Contingencies - Schedule of Long Term Finance Lease Obligations (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://dermtech.com/role/LeasesCommitmentsandContingenciesScheduleofLongTermFinanceLeaseObligationsDetails</Role>
      <ShortName>Leases, Commitments and Contingencies - Schedule of Long Term Finance Lease Obligations (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>36</Position>
    </Report>
    <Report instance="dmtk-20220630.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R37.htm</HtmlFileName>
      <LongName>2427418 - Disclosure - Leases, Commitments and Contingencies - Components of Lease Expense (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://dermtech.com/role/LeasesCommitmentsandContingenciesComponentsofLeaseExpenseDetails</Role>
      <ShortName>Leases, Commitments and Contingencies - Components of Lease Expense (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>37</Position>
    </Report>
    <Report instance="dmtk-20220630.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R38.htm</HtmlFileName>
      <LongName>2428419 - Disclosure - Leases, Commitments and Contingencies - Future Minimum Payments (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://dermtech.com/role/LeasesCommitmentsandContingenciesFutureMinimumPaymentsDetails</Role>
      <ShortName>Leases, Commitments and Contingencies - Future Minimum Payments (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>38</Position>
    </Report>
    <Report instance="dmtk-20220630.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R39.htm</HtmlFileName>
      <LongName>2430420 - Disclosure - Related Party Transactions - Additional Information (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://dermtech.com/role/RelatedPartyTransactionsAdditionalInformationDetails</Role>
      <ShortName>Related Party Transactions - Additional Information (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>39</Position>
    </Report>
    <Report>
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <LongName>All Reports</LongName>
      <ReportType>Book</ReportType>
      <ShortName>All Reports</ShortName>
    </Report>
  </MyReports>
  <InputFiles>
    <File doctype="10-Q" original="dmtk-20220630.htm">dmtk-20220630.htm</File>
    <File>dmtk-20210630xex311.htm</File>
    <File>dmtk-20210630xex312.htm</File>
    <File>dmtk-20210630xex321.htm</File>
    <File>dmtk-20220630.xsd</File>
    <File>dmtk-20220630_cal.xml</File>
    <File>dmtk-20220630_def.xml</File>
    <File>dmtk-20220630_lab.xml</File>
    <File>dmtk-20220630_pre.xml</File>
    <File>ex101firstamendment-kilroy.htm</File>
    <File>ex102secondamendment-kilro.htm</File>
    <File>ex103dermtech-secondamende.htm</File>
  </InputFiles>
  <SupplementalFiles/>
  <BaseTaxonomies>
    <BaseTaxonomy items="799">http://fasb.org/us-gaap/2022</BaseTaxonomy>
    <BaseTaxonomy items="30">http://xbrl.sec.gov/dei/2022</BaseTaxonomy>
  </BaseTaxonomies>
  <HasPresentationLinkbase>true</HasPresentationLinkbase>
  <HasCalculationLinkbase>true</HasCalculationLinkbase>
</FilingSummary>
</XML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>JSON
<SEQUENCE>70
<FILENAME>MetaLinks.json
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
{
 "instance": {
  "dmtk-20220630.htm": {
   "axisCustom": 1,
   "axisStandard": 25,
   "contextCount": 291,
   "dts": {
    "calculationLink": {
     "local": [
      "dmtk-20220630_cal.xml"
     ]
    },
    "definitionLink": {
     "local": [
      "dmtk-20220630_def.xml"
     ]
    },
    "inline": {
     "local": [
      "dmtk-20220630.htm"
     ]
    },
    "labelLink": {
     "local": [
      "dmtk-20220630_lab.xml"
     ]
    },
    "presentationLink": {
     "local": [
      "dmtk-20220630_pre.xml"
     ]
    },
    "schema": {
     "local": [
      "dmtk-20220630.xsd"
     ],
     "remote": [
      "http://www.xbrl.org/2003/xbrl-instance-2003-12-31.xsd",
      "http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd",
      "http://www.xbrl.org/2003/xl-2003-12-31.xsd",
      "http://www.xbrl.org/2003/xlink-2003-12-31.xsd",
      "http://www.xbrl.org/2005/xbrldt-2005.xsd",
      "http://www.xbrl.org/2006/ref-2006-02-27.xsd",
      "http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd",
      "http://www.xbrl.org/lrr/role/net-2009-12-16.xsd",
      "http://www.xbrl.org/lrr/role/reference-2009-12-16.xsd",
      "https://www.xbrl.org/2020/extensible-enumerations-2.0.xsd",
      "https://www.xbrl.org/dtr/type/2020-01-21/types.xsd",
      "https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd",
      "https://xbrl.fasb.org/srt/2022/elts/srt-roles-2022.xsd",
      "https://xbrl.fasb.org/srt/2022/elts/srt-types-2022.xsd",
      "https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd",
      "https://xbrl.fasb.org/us-gaap/2022/elts/us-roles-2022.xsd",
      "https://xbrl.fasb.org/us-gaap/2022/elts/us-types-2022.xsd",
      "https://xbrl.sec.gov/country/2022/country-2022.xsd",
      "https://xbrl.sec.gov/dei/2022/dei-2022.xsd"
     ]
    }
   },
   "elementCount": 489,
   "entityCount": 1,
   "hidden": {
    "http://dermtech.com/20220630": 1,
    "http://fasb.org/us-gaap/2022": 6,
    "http://xbrl.sec.gov/dei/2022": 5,
    "total": 12
   },
   "keyCustom": 59,
   "keyStandard": 241,
   "memberCustom": 37,
   "memberStandard": 31,
   "nsprefix": "dmtk",
   "nsuri": "http://dermtech.com/20220630",
   "report": {
    "R1": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "dmtk-20220630.htm",
      "contextRef": "ia855382ada1f4f28aa8ef6da692ff177_D20220101-20220630",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "dei:DocumentType",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "document",
     "isDefault": "true",
     "longName": "0001001 - Document - Cover Page",
     "role": "http://dermtech.com/role/CoverPage",
     "shortName": "Cover Page",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "dmtk-20220630.htm",
      "contextRef": "ia855382ada1f4f28aa8ef6da692ff177_D20220101-20220630",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "dei:DocumentType",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R10": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "dmtk-20220630.htm",
      "contextRef": "ia855382ada1f4f28aa8ef6da692ff177_D20220101-20220630",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:SupplementalBalanceSheetDisclosuresTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2110102 - Disclosure - Balance Sheet Details",
     "role": "http://dermtech.com/role/BalanceSheetDetails",
     "shortName": "Balance Sheet Details",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "dmtk-20220630.htm",
      "contextRef": "ia855382ada1f4f28aa8ef6da692ff177_D20220101-20220630",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:SupplementalBalanceSheetDisclosuresTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R11": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "dmtk-20220630.htm",
      "contextRef": "ia855382ada1f4f28aa8ef6da692ff177_D20220101-20220630",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:StockholdersEquityNoteDisclosureTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2116103 - Disclosure - Stockholders' Equity",
     "role": "http://dermtech.com/role/StockholdersEquity",
     "shortName": "Stockholders' Equity",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "dmtk-20220630.htm",
      "contextRef": "ia855382ada1f4f28aa8ef6da692ff177_D20220101-20220630",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:StockholdersEquityNoteDisclosureTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R12": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "dmtk-20220630.htm",
      "contextRef": "ia855382ada1f4f28aa8ef6da692ff177_D20220101-20220630",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:CommitmentsDisclosureTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2122104 - Disclosure - Leases, Commitments and Contingencies",
     "role": "http://dermtech.com/role/LeasesCommitmentsandContingencies",
     "shortName": "Leases, Commitments and Contingencies",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "dmtk-20220630.htm",
      "contextRef": "ia855382ada1f4f28aa8ef6da692ff177_D20220101-20220630",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:CommitmentsDisclosureTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R13": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "dmtk-20220630.htm",
      "contextRef": "ia855382ada1f4f28aa8ef6da692ff177_D20220101-20220630",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:RelatedPartyTransactionsDisclosureTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2129105 - Disclosure - Related Party Transactions",
     "role": "http://dermtech.com/role/RelatedPartyTransactions",
     "shortName": "Related Party Transactions",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "dmtk-20220630.htm",
      "contextRef": "ia855382ada1f4f28aa8ef6da692ff177_D20220101-20220630",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:RelatedPartyTransactionsDisclosureTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R14": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "dmtk-20220630.htm",
      "contextRef": "ia855382ada1f4f28aa8ef6da692ff177_D20220101-20220630",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:SubsequentEventsTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2131106 - Disclosure - Subsequent Events",
     "role": "http://dermtech.com/role/SubsequentEvents",
     "shortName": "Subsequent Events",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "dmtk-20220630.htm",
      "contextRef": "ia855382ada1f4f28aa8ef6da692ff177_D20220101-20220630",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:SubsequentEventsTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R15": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "dmtk-20220630.htm",
      "contextRef": "ia855382ada1f4f28aa8ef6da692ff177_D20220101-20220630",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:NatureOfOperations",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2202201 - Disclosure - The Company and a Summary of its Significant Accounting Policies (Policies)",
     "role": "http://dermtech.com/role/TheCompanyandaSummaryofitsSignificantAccountingPoliciesPolicies",
     "shortName": "The Company and a Summary of its Significant Accounting Policies (Policies)",
     "subGroupType": "policies",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "dmtk-20220630.htm",
      "contextRef": "ia855382ada1f4f28aa8ef6da692ff177_D20220101-20220630",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:NatureOfOperations",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R16": {
     "firstAnchor": {
      "ancestors": [
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "dmtk-20220630.htm",
      "contextRef": "ia855382ada1f4f28aa8ef6da692ff177_D20220101-20220630",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:DisaggregationOfRevenueTableTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2303301 - Disclosure - The Company and a Summary of its Significant Accounting Policies (Tables)",
     "role": "http://dermtech.com/role/TheCompanyandaSummaryofitsSignificantAccountingPoliciesTables",
     "shortName": "The Company and a Summary of its Significant Accounting Policies (Tables)",
     "subGroupType": "tables",
     "uniqueAnchor": {
      "ancestors": [
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "dmtk-20220630.htm",
      "contextRef": "ia855382ada1f4f28aa8ef6da692ff177_D20220101-20220630",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:DisaggregationOfRevenueTableTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R17": {
     "firstAnchor": {
      "ancestors": [
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "dmtk-20220630.htm",
      "contextRef": "ia855382ada1f4f28aa8ef6da692ff177_D20220101-20220630",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:DebtSecuritiesAvailableForSaleTableTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2311302 - Disclosure - Balance Sheet Details (Tables)",
     "role": "http://dermtech.com/role/BalanceSheetDetailsTables",
     "shortName": "Balance Sheet Details (Tables)",
     "subGroupType": "tables",
     "uniqueAnchor": {
      "ancestors": [
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "dmtk-20220630.htm",
      "contextRef": "ia855382ada1f4f28aa8ef6da692ff177_D20220101-20220630",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:DebtSecuritiesAvailableForSaleTableTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R18": {
     "firstAnchor": {
      "ancestors": [
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "dmtk-20220630.htm",
      "contextRef": "ia855382ada1f4f28aa8ef6da692ff177_D20220101-20220630",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ScheduleOfStockByClassTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2317303 - Disclosure - Stockholders' Equity (Tables)",
     "role": "http://dermtech.com/role/StockholdersEquityTables",
     "shortName": "Stockholders' Equity (Tables)",
     "subGroupType": "tables",
     "uniqueAnchor": {
      "ancestors": [
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "dmtk-20220630.htm",
      "contextRef": "ia855382ada1f4f28aa8ef6da692ff177_D20220101-20220630",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ScheduleOfStockByClassTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R19": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "dmtk-20220630.htm",
      "contextRef": "ia855382ada1f4f28aa8ef6da692ff177_D20220101-20220630",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ScheduleOfNewAccountingPronouncementsAndChangesInAccountingPrinciplesTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2323304 - Disclosure - Leases, Commitments and Contingencies (Tables)",
     "role": "http://dermtech.com/role/LeasesCommitmentsandContingenciesTables",
     "shortName": "Leases, Commitments and Contingencies (Tables)",
     "subGroupType": "tables",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "dmtk-20220630.htm",
      "contextRef": "ia855382ada1f4f28aa8ef6da692ff177_D20220101-20220630",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ScheduleOfNewAccountingPronouncementsAndChangesInAccountingPrinciplesTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R2": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "body",
       "html"
      ],
      "baseRef": "dmtk-20220630.htm",
      "contextRef": "i4c8f247d12134a9886d56e1c8b024425_I20220630",
      "decimals": "-3",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:CashAndCashEquivalentsAtCarryingValue",
      "reportCount": 1,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "statement",
     "isDefault": "false",
     "longName": "1001002 - Statement - Condensed Consolidated Balance Sheets",
     "role": "http://dermtech.com/role/CondensedConsolidatedBalanceSheets",
     "shortName": "Condensed Consolidated Balance Sheets",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "body",
       "html"
      ],
      "baseRef": "dmtk-20220630.htm",
      "contextRef": "i4c8f247d12134a9886d56e1c8b024425_I20220630",
      "decimals": "-3",
      "lang": "en-US",
      "name": "us-gaap:MarketableSecuritiesCurrent",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R20": {
     "firstAnchor": {
      "ancestors": [
       "ix:continuation",
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "dmtk-20220630.htm",
      "contextRef": "i2c5f0f28773744e5a2e202f2943ae976_D20220401-20220630",
      "decimals": "-5",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:Depreciation",
      "reportCount": 1,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2404401 - Disclosure - The Company and a Summary of its Significant Accounting Policies - Additional Information (Details)",
     "role": "http://dermtech.com/role/TheCompanyandaSummaryofitsSignificantAccountingPoliciesAdditionalInformationDetails",
     "shortName": "The Company and a Summary of its Significant Accounting Policies - Additional Information (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "ix:continuation",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "dmtk-20220630.htm",
      "contextRef": "i2c5f0f28773744e5a2e202f2943ae976_D20220401-20220630",
      "decimals": "-5",
      "lang": "en-US",
      "name": "us-gaap:PropertyPlantAndEquipmentDisposals",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R21": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:DisaggregationOfRevenueTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "dmtk-20220630.htm",
      "contextRef": "i2c5f0f28773744e5a2e202f2943ae976_D20220401-20220630",
      "decimals": "-3",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2405402 - Disclosure - The Company and a Summary of its Significant Accounting Policies - Schedule of Revenues Disaggregated by Revenue Source (Details)",
     "role": "http://dermtech.com/role/TheCompanyandaSummaryofitsSignificantAccountingPoliciesScheduleofRevenuesDisaggregatedbyRevenueSourceDetails",
     "shortName": "The Company and a Summary of its Significant Accounting Policies - Schedule of Revenues Disaggregated by Revenue Source (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:DisaggregationOfRevenueTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "dmtk-20220630.htm",
      "contextRef": "i2c5f0f28773744e5a2e202f2943ae976_D20220401-20220630",
      "decimals": "-3",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R22": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ScheduleOfProductInformationTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "dmtk-20220630.htm",
      "contextRef": "ibe700613e5304875bdd1ff268a855e3b_D20220401-20220630",
      "decimals": "2",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ConcentrationRiskPercentage1",
      "reportCount": 1,
      "unique": true,
      "unitRef": "number",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2406403 - Disclosure - The Company and a Summary of its Significant Accounting Policies - Summary of Percentages of Total Revenue or Accounts Receivable for Third Party Payers and Pharmaceutical Customers (Details)",
     "role": "http://dermtech.com/role/TheCompanyandaSummaryofitsSignificantAccountingPoliciesSummaryofPercentagesofTotalRevenueorAccountsReceivableforThirdPartyPayersandPharmaceuticalCustomersDetails",
     "shortName": "The Company and a Summary of its Significant Accounting Policies - Summary of Percentages of Total Revenue or Accounts Receivable for Third Party Payers and Pharmaceutical Customers (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ScheduleOfProductInformationTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "dmtk-20220630.htm",
      "contextRef": "ibe700613e5304875bdd1ff268a855e3b_D20220401-20220630",
      "decimals": "2",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ConcentrationRiskPercentage1",
      "reportCount": 1,
      "unique": true,
      "unitRef": "number",
      "xsiNil": "false"
     }
    },
    "R23": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "body",
       "html"
      ],
      "baseRef": "dmtk-20220630.htm",
      "contextRef": "i4c8f247d12134a9886d56e1c8b024425_I20220630",
      "decimals": "-3",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:RestrictedCashNoncurrent",
      "reportCount": 1,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2407404 - Disclosure - The Company and a Summary of its Significant Accounting Policies - Summary of Assets and Liabilities Measured at Fair Value on Recurring Basis (Details)",
     "role": "http://dermtech.com/role/TheCompanyandaSummaryofitsSignificantAccountingPoliciesSummaryofAssetsandLiabilitiesMeasuredatFairValueonRecurringBasisDetails",
     "shortName": "The Company and a Summary of its Significant Accounting Policies - Summary of Assets and Liabilities Measured at Fair Value on Recurring Basis (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ScheduleOfFairValueAssetsAndLiabilitiesMeasuredOnRecurringBasisTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "dmtk-20220630.htm",
      "contextRef": "i6f6e047d4cc946d5ab745668b1e79366_I20220630",
      "decimals": "-3",
      "lang": "en-US",
      "name": "us-gaap:CashEquivalentsAtCarryingValue",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R24": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ScheduleOfShareBasedPaymentAwardEmployeeStockPurchasePlanValuationAssumptionsTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "dmtk-20220630.htm",
      "contextRef": "i2ff3fea135c346deae31b3b343050a34_D20220401-20220630",
      "decimals": "4",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate",
      "reportCount": 1,
      "unique": true,
      "unitRef": "number",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2408405 - Disclosure - The Company and a Summary of its Significant Accounting Policies - Assumptions Used to Determine Fair Value of Each Option on Date of Grant Issued (Details)",
     "role": "http://dermtech.com/role/TheCompanyandaSummaryofitsSignificantAccountingPoliciesAssumptionsUsedtoDetermineFairValueofEachOptiononDateofGrantIssuedDetails",
     "shortName": "The Company and a Summary of its Significant Accounting Policies - Assumptions Used to Determine Fair Value of Each Option on Date of Grant Issued (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ScheduleOfShareBasedPaymentAwardEmployeeStockPurchasePlanValuationAssumptionsTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "dmtk-20220630.htm",
      "contextRef": "i2ff3fea135c346deae31b3b343050a34_D20220401-20220630",
      "decimals": "4",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate",
      "reportCount": 1,
      "unique": true,
      "unitRef": "number",
      "xsiNil": "false"
     }
    },
    "R25": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "dmtk-20220630.htm",
      "contextRef": "i253fb10d701144a8b699b8f06a9a82fd_I20220331",
      "decimals": "-3",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue",
      "reportCount": 1,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2409406 - Disclosure - The Company and a Summary of its Significant Accounting Policies - Summary of Changes in Fair Value of Level 3 Liabilities (Details)",
     "role": "http://dermtech.com/role/TheCompanyandaSummaryofitsSignificantAccountingPoliciesSummaryofChangesinFairValueofLevel3LiabilitiesDetails",
     "shortName": "The Company and a Summary of its Significant Accounting Policies - Summary of Changes in Fair Value of Level 3 Liabilities (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "dmtk-20220630.htm",
      "contextRef": "i0e8a6876eeb946269d2c2405fcb009b4_I20211231",
      "decimals": "-3",
      "lang": "en-US",
      "name": "us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R26": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:DebtSecuritiesAvailableForSaleTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "dmtk-20220630.htm",
      "contextRef": "i4c8f247d12134a9886d56e1c8b024425_I20220630",
      "decimals": "-3",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:AvailableForSaleDebtSecuritiesAmortizedCostBasis",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2412407 - Disclosure - Balance Sheet Details - Schedule of Short-Term Marketable Securities (Details)",
     "role": "http://dermtech.com/role/BalanceSheetDetailsScheduleofShortTermMarketableSecuritiesDetails",
     "shortName": "Balance Sheet Details - Schedule of Short-Term Marketable Securities (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:DebtSecuritiesAvailableForSaleTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "dmtk-20220630.htm",
      "contextRef": "i4c8f247d12134a9886d56e1c8b024425_I20220630",
      "decimals": "-3",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:AvailableForSaleDebtSecuritiesAmortizedCostBasis",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R27": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "dmtk-20220630.htm",
      "contextRef": "i4c8f247d12134a9886d56e1c8b024425_I20220630",
      "decimals": "-5",
      "first": true,
      "lang": "en-US",
      "name": "dmtk:EstimatedMarketValueOfDebtSecuritiesWithContractualMaturitiesOfLessThan12Months",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2413408 - Disclosure - Balance Sheet Details - Additional Information (Details)",
     "role": "http://dermtech.com/role/BalanceSheetDetailsAdditionalInformationDetails",
     "shortName": "Balance Sheet Details - Additional Information (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "dmtk-20220630.htm",
      "contextRef": "i4c8f247d12134a9886d56e1c8b024425_I20220630",
      "decimals": "-5",
      "first": true,
      "lang": "en-US",
      "name": "dmtk:EstimatedMarketValueOfDebtSecuritiesWithContractualMaturitiesOfLessThan12Months",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R28": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "dmtk:ScheduleOfPrepaidExpensesAndPropertyAndEquipmentTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "dmtk-20220630.htm",
      "contextRef": "i4c8f247d12134a9886d56e1c8b024425_I20220630",
      "decimals": "-3",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:PrepaidInsurance",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2414409 - Disclosure - Balance Sheet Details - Schedule of Prepaid Expenses and PP&E (Details)",
     "role": "http://dermtech.com/role/BalanceSheetDetailsScheduleofPrepaidExpensesandPPEDetails",
     "shortName": "Balance Sheet Details - Schedule of Prepaid Expenses and PP&E (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "dmtk:ScheduleOfPrepaidExpensesAndPropertyAndEquipmentTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "dmtk-20220630.htm",
      "contextRef": "i4c8f247d12134a9886d56e1c8b024425_I20220630",
      "decimals": "-3",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:PrepaidInsurance",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R29": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ScheduleOfAccountsPayableAndAccruedLiabilitiesTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "dmtk-20220630.htm",
      "contextRef": "i4c8f247d12134a9886d56e1c8b024425_I20220630",
      "decimals": "-3",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:AccruedVacationCurrent",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2415410 - Disclosure - Balance Sheet Details - Schedule of Accrued Compensation and Accrued Liabilities (Details)",
     "role": "http://dermtech.com/role/BalanceSheetDetailsScheduleofAccruedCompensationandAccruedLiabilitiesDetails",
     "shortName": "Balance Sheet Details - Schedule of Accrued Compensation and Accrued Liabilities (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ScheduleOfAccountsPayableAndAccruedLiabilitiesTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "dmtk-20220630.htm",
      "contextRef": "i4c8f247d12134a9886d56e1c8b024425_I20220630",
      "decimals": "-3",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:AccruedVacationCurrent",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R3": {
     "firstAnchor": {
      "ancestors": [
       "us-gaap:PreferredStockParOrStatedValuePerShare",
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "dmtk-20220630.htm",
      "contextRef": "i4c8f247d12134a9886d56e1c8b024425_I20220630",
      "decimals": "INF",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:CommonStockParOrStatedValuePerShare",
      "reportCount": 1,
      "unitRef": "usdPerShare",
      "xsiNil": "false"
     },
     "groupType": "statement",
     "isDefault": "false",
     "longName": "1002003 - Statement - Condensed Consolidated Balance Sheets (Parenthetical)",
     "role": "http://dermtech.com/role/CondensedConsolidatedBalanceSheetsParenthetical",
     "shortName": "Condensed Consolidated Balance Sheets (Parenthetical)",
     "subGroupType": "parenthetical",
     "uniqueAnchor": {
      "ancestors": [
       "us-gaap:CommonStockSharesIssued",
       "span",
       "div",
       "td",
       "tr",
       "table",
       "div",
       "body",
       "html"
      ],
      "baseRef": "dmtk-20220630.htm",
      "contextRef": "i4c8f247d12134a9886d56e1c8b024425_I20220630",
      "decimals": "INF",
      "lang": "en-US",
      "name": "us-gaap:CommonStockSharesOutstanding",
      "reportCount": 1,
      "unique": true,
      "unitRef": "shares",
      "xsiNil": "false"
     }
    },
    "R30": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "dmtk-20220630.htm",
      "contextRef": "i4c8f247d12134a9886d56e1c8b024425_I20220630",
      "decimals": "INF",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:CommonStockSharesAuthorized",
      "reportCount": 1,
      "unitRef": "shares",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2418411 - Disclosure - Stockholders' Equity - Additional Information (Details)",
     "role": "http://dermtech.com/role/StockholdersEquityAdditionalInformationDetails",
     "shortName": "Stockholders' Equity - Additional Information (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "dmtk-20220630.htm",
      "contextRef": "i4c8f247d12134a9886d56e1c8b024425_I20220630",
      "decimals": "INF",
      "lang": "en-US",
      "name": "us-gaap:PreferredStockSharesAuthorized",
      "reportCount": 1,
      "unique": true,
      "unitRef": "shares",
      "xsiNil": "false"
     }
    },
    "R31": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "ix:continuation",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "dmtk-20220630.htm",
      "contextRef": "i992097fa23d64aaa9f9ec09579943582_D20220401-20220630",
      "decimals": "4",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate",
      "reportCount": 1,
      "unique": true,
      "unitRef": "number",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2419412 - Disclosure - Stockholders' Equity - ESPP Valuation Method (Details)",
     "role": "http://dermtech.com/role/StockholdersEquityESPPValuationMethodDetails",
     "shortName": "Stockholders' Equity - ESPP Valuation Method (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "ix:continuation",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "dmtk-20220630.htm",
      "contextRef": "i992097fa23d64aaa9f9ec09579943582_D20220401-20220630",
      "decimals": "4",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate",
      "reportCount": 1,
      "unique": true,
      "unitRef": "number",
      "xsiNil": "false"
     }
    },
    "R32": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:DisclosureOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "dmtk-20220630.htm",
      "contextRef": "i2c5f0f28773744e5a2e202f2943ae976_D20220401-20220630",
      "decimals": "-3",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:AllocatedShareBasedCompensationExpense",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2420413 - Disclosure - Stockholders' Equity - Share-Based Compensation Expense (Details)",
     "role": "http://dermtech.com/role/StockholdersEquityShareBasedCompensationExpenseDetails",
     "shortName": "Stockholders' Equity - Share-Based Compensation Expense (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:DisclosureOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "dmtk-20220630.htm",
      "contextRef": "i2c5f0f28773744e5a2e202f2943ae976_D20220401-20220630",
      "decimals": "-3",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:AllocatedShareBasedCompensationExpense",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R33": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ScheduleOfStockByClassTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "dmtk-20220630.htm",
      "contextRef": "i4c8f247d12134a9886d56e1c8b024425_I20220630",
      "decimals": "INF",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:CommonStockCapitalSharesReservedForFutureIssuance",
      "reportCount": 1,
      "unitRef": "shares",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2421414 - Disclosure - Stockholders' Equity - Summary of Common Stock Reserved for Future Issuance (Detail)",
     "role": "http://dermtech.com/role/StockholdersEquitySummaryofCommonStockReservedforFutureIssuanceDetail",
     "shortName": "Stockholders' Equity - Summary of Common Stock Reserved for Future Issuance (Detail)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ScheduleOfStockByClassTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "dmtk-20220630.htm",
      "contextRef": "i224d7d5c13f4473abacadb433d8efcf9_I20220630",
      "decimals": "INF",
      "lang": "en-US",
      "name": "us-gaap:CommonStockCapitalSharesReservedForFutureIssuance",
      "reportCount": 1,
      "unique": true,
      "unitRef": "shares",
      "xsiNil": "false"
     }
    },
    "R34": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "body",
       "html"
      ],
      "baseRef": "dmtk-20220630.htm",
      "contextRef": "ia855382ada1f4f28aa8ef6da692ff177_D20220101-20220630",
      "decimals": "-3",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:OperatingLeaseRightOfUseAssetAmortizationExpense",
      "reportCount": 1,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2424415 - Disclosure - Leases, Commitments and Contingencies - Adoption of ASC 842 (Details)",
     "role": "http://dermtech.com/role/LeasesCommitmentsandContingenciesAdoptionofASC842Details",
     "shortName": "Leases, Commitments and Contingencies - Adoption of ASC 842 (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "ix:continuation",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "dmtk-20220630.htm",
      "contextRef": "if694b668e6db42e59488d953f4800965_D20220101-20220630",
      "decimals": "-3",
      "lang": "en-US",
      "name": "us-gaap:OperatingLeaseRightOfUseAssetAmortizationExpense",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R35": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "dmtk-20220630.htm",
      "contextRef": "ia855382ada1f4f28aa8ef6da692ff177_D20220101-20220630",
      "decimals": "2",
      "first": true,
      "lang": "en-US",
      "name": "dmtk:PercentageOfUsefulLivesOfAssets",
      "reportCount": 1,
      "unique": true,
      "unitRef": "number",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2425416 - Disclosure - Leases, Commitments and Contingencies - Additional Information (Details)",
     "role": "http://dermtech.com/role/LeasesCommitmentsandContingenciesAdditionalInformationDetails",
     "shortName": "Leases, Commitments and Contingencies - Additional Information (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "dmtk-20220630.htm",
      "contextRef": "ia855382ada1f4f28aa8ef6da692ff177_D20220101-20220630",
      "decimals": "2",
      "first": true,
      "lang": "en-US",
      "name": "dmtk:PercentageOfUsefulLivesOfAssets",
      "reportCount": 1,
      "unique": true,
      "unitRef": "number",
      "xsiNil": "false"
     }
    },
    "R36": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "dmtk:ScheduleOfFutureMinimumRentalPaymentsForOperatingAndCapitalLeasesTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "dmtk-20220630.htm",
      "contextRef": "i4c8f247d12134a9886d56e1c8b024425_I20220630",
      "decimals": "-3",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:FinanceLeaseLiabilityPaymentsDue",
      "reportCount": 1,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2426417 - Disclosure - Leases, Commitments and Contingencies - Schedule of Long Term Finance Lease Obligations (Details)",
     "role": "http://dermtech.com/role/LeasesCommitmentsandContingenciesScheduleofLongTermFinanceLeaseObligationsDetails",
     "shortName": "Leases, Commitments and Contingencies - Schedule of Long Term Finance Lease Obligations (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "ix:continuation",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "dmtk-20220630.htm",
      "contextRef": "i4c8f247d12134a9886d56e1c8b024425_I20220630",
      "decimals": "-3",
      "lang": "en-US",
      "name": "us-gaap:FinanceLeaseLiabilityUndiscountedExcessAmount",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R37": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:LeaseCostTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "dmtk-20220630.htm",
      "contextRef": "i2c5f0f28773744e5a2e202f2943ae976_D20220401-20220630",
      "decimals": "-3",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:OperatingLeaseCost",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2427418 - Disclosure - Leases, Commitments and Contingencies - Components of Lease Expense (Details)",
     "role": "http://dermtech.com/role/LeasesCommitmentsandContingenciesComponentsofLeaseExpenseDetails",
     "shortName": "Leases, Commitments and Contingencies - Components of Lease Expense (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:LeaseCostTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "dmtk-20220630.htm",
      "contextRef": "i2c5f0f28773744e5a2e202f2943ae976_D20220401-20220630",
      "decimals": "-3",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:OperatingLeaseCost",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R38": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "dmtk:ScheduleOfFutureMinimumRentalPaymentsForOperatingAndCapitalLeasesTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "dmtk-20220630.htm",
      "contextRef": "i4c8f247d12134a9886d56e1c8b024425_I20220630",
      "decimals": "-3",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:LesseeOperatingLeaseLiabilityPaymentsRemainderOfFiscalYear",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2428419 - Disclosure - Leases, Commitments and Contingencies - Future Minimum Payments (Details)",
     "role": "http://dermtech.com/role/LeasesCommitmentsandContingenciesFutureMinimumPaymentsDetails",
     "shortName": "Leases, Commitments and Contingencies - Future Minimum Payments (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "dmtk:ScheduleOfFutureMinimumRentalPaymentsForOperatingAndCapitalLeasesTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "dmtk-20220630.htm",
      "contextRef": "i4c8f247d12134a9886d56e1c8b024425_I20220630",
      "decimals": "-3",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:LesseeOperatingLeaseLiabilityPaymentsRemainderOfFiscalYear",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R39": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "td",
       "tr",
       "table",
       "div",
       "body",
       "html"
      ],
      "baseRef": "dmtk-20220630.htm",
      "contextRef": "i4c8f247d12134a9886d56e1c8b024425_I20220630",
      "decimals": "INF",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:CommonStockSharesIssued",
      "reportCount": 1,
      "unitRef": "shares",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2430420 - Disclosure - Related Party Transactions - Additional Information (Details)",
     "role": "http://dermtech.com/role/RelatedPartyTransactionsAdditionalInformationDetails",
     "shortName": "Related Party Transactions - Additional Information (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "dmtk-20220630.htm",
      "contextRef": "ia855382ada1f4f28aa8ef6da692ff177_D20220101-20220630",
      "decimals": "INF",
      "lang": "en-US",
      "name": "us-gaap:RelatedPartyTransactionExpensesFromTransactionsWithRelatedParty",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R4": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "body",
       "html"
      ],
      "baseRef": "dmtk-20220630.htm",
      "contextRef": "i2c5f0f28773744e5a2e202f2943ae976_D20220401-20220630",
      "decimals": "-3",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:RevenueFromContractWithCustomerIncludingAssessedTax",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "statement",
     "isDefault": "false",
     "longName": "1003004 - Statement - Condensed Consolidated Statements of Operations",
     "role": "http://dermtech.com/role/CondensedConsolidatedStatementsofOperations",
     "shortName": "Condensed Consolidated Statements of Operations",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "body",
       "html"
      ],
      "baseRef": "dmtk-20220630.htm",
      "contextRef": "i2c5f0f28773744e5a2e202f2943ae976_D20220401-20220630",
      "decimals": "-3",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:RevenueFromContractWithCustomerIncludingAssessedTax",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R5": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "body",
       "html"
      ],
      "baseRef": "dmtk-20220630.htm",
      "contextRef": "i2c5f0f28773744e5a2e202f2943ae976_D20220401-20220630",
      "decimals": "-3",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:NetIncomeLoss",
      "reportCount": 1,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "statement",
     "isDefault": "false",
     "longName": "1004005 - Statement - Condensed Consolidated Statements of Comprehensive Loss",
     "role": "http://dermtech.com/role/CondensedConsolidatedStatementsofComprehensiveLoss",
     "shortName": "Condensed Consolidated Statements of Comprehensive Loss",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "body",
       "html"
      ],
      "baseRef": "dmtk-20220630.htm",
      "contextRef": "i2c5f0f28773744e5a2e202f2943ae976_D20220401-20220630",
      "decimals": "-3",
      "lang": "en-US",
      "name": "us-gaap:ComprehensiveIncomeNetOfTax",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R6": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "body",
       "html"
      ],
      "baseRef": "dmtk-20220630.htm",
      "contextRef": "idf41ea014db640f1a2c27c2a769a0f37_I20201231",
      "decimals": "INF",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:SharesOutstanding",
      "reportCount": 1,
      "unitRef": "shares",
      "xsiNil": "false"
     },
     "groupType": "statement",
     "isDefault": "false",
     "longName": "1005006 - Statement - Condensed Consolidated Statements of Stockholders\u2019 Equity",
     "role": "http://dermtech.com/role/CondensedConsolidatedStatementsofStockholdersEquity",
     "shortName": "Condensed Consolidated Statements of Stockholders\u2019 Equity",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "body",
       "html"
      ],
      "baseRef": "dmtk-20220630.htm",
      "contextRef": "i3f5ee0c6315d458da591b98ccf0afb7c_D20210101-20210331",
      "decimals": "-3",
      "lang": "en-US",
      "name": "us-gaap:StockIssuedDuringPeriodValueNewIssues",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R7": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "td",
       "tr",
       "table",
       "div",
       "body",
       "html"
      ],
      "baseRef": "dmtk-20220630.htm",
      "contextRef": "id7bb773872394047ba26aa8a7a0f4d56_D20210401-20210630",
      "decimals": "-5",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:AdjustmentsToAdditionalPaidInCapitalStockIssuedIssuanceCosts",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "statement",
     "isDefault": "false",
     "longName": "1006007 - Statement - Condensed Consolidated Statements of Stockholders\u2019 Equity (Parenthetical)",
     "role": "http://dermtech.com/role/CondensedConsolidatedStatementsofStockholdersEquityParenthetical",
     "shortName": "Condensed Consolidated Statements of Stockholders\u2019 Equity (Parenthetical)",
     "subGroupType": "parenthetical",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "td",
       "tr",
       "table",
       "div",
       "body",
       "html"
      ],
      "baseRef": "dmtk-20220630.htm",
      "contextRef": "id7bb773872394047ba26aa8a7a0f4d56_D20210401-20210630",
      "decimals": "-5",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:AdjustmentsToAdditionalPaidInCapitalStockIssuedIssuanceCosts",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R8": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "body",
       "html"
      ],
      "baseRef": "dmtk-20220630.htm",
      "contextRef": "ia855382ada1f4f28aa8ef6da692ff177_D20220101-20220630",
      "decimals": "-3",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ProfitLoss",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "statement",
     "isDefault": "false",
     "longName": "1007008 - Statement - Condensed Consolidated Statements of Cash Flows",
     "role": "http://dermtech.com/role/CondensedConsolidatedStatementsofCashFlows",
     "shortName": "Condensed Consolidated Statements of Cash Flows",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "body",
       "html"
      ],
      "baseRef": "dmtk-20220630.htm",
      "contextRef": "ia855382ada1f4f28aa8ef6da692ff177_D20220101-20220630",
      "decimals": "-3",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ProfitLoss",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R9": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "dmtk-20220630.htm",
      "contextRef": "ia855382ada1f4f28aa8ef6da692ff177_D20220101-20220630",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureAndSignificantAccountingPoliciesTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2101101 - Disclosure - The Company and a Summary of its Significant Accounting Policies",
     "role": "http://dermtech.com/role/TheCompanyandaSummaryofitsSignificantAccountingPolicies",
     "shortName": "The Company and a Summary of its Significant Accounting Policies",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "dmtk-20220630.htm",
      "contextRef": "ia855382ada1f4f28aa8ef6da692ff177_D20220101-20220630",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureAndSignificantAccountingPoliciesTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    }
   },
   "segmentCount": 68,
   "tag": {
    "dei_AmendmentFlag": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Boolean flag that is true when the XBRL content amends previously-filed or accepted submission.",
        "label": "Amendment Flag",
        "terseLabel": "Amendment Flag"
       }
      }
     },
     "localname": "AmendmentFlag",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://dermtech.com/role/CoverPage"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_CityAreaCode": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Area code of city",
        "label": "City Area Code",
        "terseLabel": "City Area Code"
       }
      }
     },
     "localname": "CityAreaCode",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://dermtech.com/role/CoverPage"
     ],
     "xbrltype": "normalizedStringItemType"
    },
    "dei_CoverAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Cover page.",
        "label": "Cover [Abstract]",
        "terseLabel": "Cover [Abstract]"
       }
      }
     },
     "localname": "CoverAbstract",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "xbrltype": "stringItemType"
    },
    "dei_CurrentFiscalYearEndDate": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "End date of current fiscal year in the format --MM-DD.",
        "label": "Current Fiscal Year End Date",
        "terseLabel": "Current Fiscal Year End Date"
       }
      }
     },
     "localname": "CurrentFiscalYearEndDate",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://dermtech.com/role/CoverPage"
     ],
     "xbrltype": "gMonthDayItemType"
    },
    "dei_DocumentFiscalPeriodFocus": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Fiscal period values are FY, Q1, Q2, and Q3.  1st, 2nd and 3rd quarter 10-Q or 10-QT statements have value Q1, Q2, and Q3 respectively, with 10-K, 10-KT or other fiscal year statements having FY.",
        "label": "Document Fiscal Period Focus",
        "terseLabel": "Document Fiscal Period Focus"
       }
      }
     },
     "localname": "DocumentFiscalPeriodFocus",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://dermtech.com/role/CoverPage"
     ],
     "xbrltype": "fiscalPeriodItemType"
    },
    "dei_DocumentFiscalYearFocus": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "This is focus fiscal year of the document report in YYYY format. For a 2006 annual report, which may also provide financial information from prior periods, fiscal 2006 should be given as the fiscal year focus. Example: 2006.",
        "label": "Document Fiscal Year Focus",
        "terseLabel": "Document Fiscal Year Focus"
       }
      }
     },
     "localname": "DocumentFiscalYearFocus",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://dermtech.com/role/CoverPage"
     ],
     "xbrltype": "gYearItemType"
    },
    "dei_DocumentPeriodEndDate": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "For the EDGAR submission types of Form 8-K: the date of the report, the date of the earliest event reported; for the EDGAR submission types of Form N-1A: the filing date; for all other submission types: the end of the reporting or transition period.  The format of the date is YYYY-MM-DD.",
        "label": "Document Period End Date",
        "verboseLabel": "Document Period End Date"
       }
      }
     },
     "localname": "DocumentPeriodEndDate",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://dermtech.com/role/CoverPage"
     ],
     "xbrltype": "dateItemType"
    },
    "dei_DocumentQuarterlyReport": {
     "auth_ref": [
      "r560"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Boolean flag that is true only for a form used as an quarterly report.",
        "label": "Document Quarterly Report",
        "terseLabel": "Document Quarterly Report"
       }
      }
     },
     "localname": "DocumentQuarterlyReport",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://dermtech.com/role/CoverPage"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_DocumentTransitionReport": {
     "auth_ref": [
      "r561"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Boolean flag that is true only for a form used as a transition report.",
        "label": "Document Transition Report",
        "terseLabel": "Document Transition Report"
       }
      }
     },
     "localname": "DocumentTransitionReport",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://dermtech.com/role/CoverPage"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_DocumentType": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The type of document being provided (such as 10-K, 10-Q, 485BPOS, etc). The document type is limited to the same value as the supporting SEC submission type, or the word 'Other'.",
        "label": "Document Type",
        "terseLabel": "Document Type"
       }
      }
     },
     "localname": "DocumentType",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://dermtech.com/role/CoverPage"
     ],
     "xbrltype": "submissionTypeItemType"
    },
    "dei_EntityAddressAddressLine1": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Address Line 1 such as Attn, Building Name, Street Name",
        "label": "Entity Address, Address Line One",
        "terseLabel": "Entity Address, Address Line One"
       }
      }
     },
     "localname": "EntityAddressAddressLine1",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://dermtech.com/role/CoverPage"
     ],
     "xbrltype": "normalizedStringItemType"
    },
    "dei_EntityAddressAddressLine2": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Address Line 2 such as Street or Suite number",
        "label": "Entity Address, Address Line Two",
        "terseLabel": "Entity Address, Address Line Two"
       }
      }
     },
     "localname": "EntityAddressAddressLine2",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://dermtech.com/role/CoverPage"
     ],
     "xbrltype": "normalizedStringItemType"
    },
    "dei_EntityAddressCityOrTown": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Name of the City or Town",
        "label": "Entity Address, City or Town",
        "terseLabel": "Entity Address, City or Town"
       }
      }
     },
     "localname": "EntityAddressCityOrTown",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://dermtech.com/role/CoverPage"
     ],
     "xbrltype": "normalizedStringItemType"
    },
    "dei_EntityAddressPostalZipCode": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Code for the postal or zip code",
        "label": "Entity Address, Postal Zip Code",
        "terseLabel": "Entity Address, Postal Zip Code"
       }
      }
     },
     "localname": "EntityAddressPostalZipCode",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://dermtech.com/role/CoverPage"
     ],
     "xbrltype": "normalizedStringItemType"
    },
    "dei_EntityAddressStateOrProvince": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Name of the state or province.",
        "label": "Entity Address, State or Province",
        "terseLabel": "Entity Address, State or Province"
       }
      }
     },
     "localname": "EntityAddressStateOrProvince",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://dermtech.com/role/CoverPage"
     ],
     "xbrltype": "stateOrProvinceItemType"
    },
    "dei_EntityCentralIndexKey": {
     "auth_ref": [
      "r558"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "A unique 10-digit SEC-issued value to identify entities that have filed disclosures with the SEC. It is commonly abbreviated as CIK.",
        "label": "Entity Central Index Key",
        "terseLabel": "Entity Central Index Key"
       }
      }
     },
     "localname": "EntityCentralIndexKey",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://dermtech.com/role/CoverPage"
     ],
     "xbrltype": "centralIndexKeyItemType"
    },
    "dei_EntityCommonStockSharesOutstanding": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Indicate number of shares or other units outstanding of each of registrant's classes of capital or common stock or other ownership interests, if and as stated on cover of related periodic report. Where multiple classes or units exist define each class/interest by adding class of stock items such as Common Class A [Member], Common Class B [Member] or Partnership Interest [Member] onto the Instrument [Domain] of the Entity Listings, Instrument.",
        "label": "Entity Common Stock, Shares Outstanding",
        "terseLabel": "Entity Common Stock, Shares Outstanding"
       }
      }
     },
     "localname": "EntityCommonStockSharesOutstanding",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://dermtech.com/role/CoverPage"
     ],
     "xbrltype": "sharesItemType"
    },
    "dei_EntityCurrentReportingStatus": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Indicate 'Yes' or 'No' whether registrants (1) have filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that registrants were required to file such reports), and (2) have been subject to such filing requirements for the past 90 days. This information should be based on the registrant's current or most recent filing containing the related disclosure.",
        "label": "Entity Current Reporting Status",
        "terseLabel": "Entity Current Reporting Status"
       }
      }
     },
     "localname": "EntityCurrentReportingStatus",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://dermtech.com/role/CoverPage"
     ],
     "xbrltype": "yesNoItemType"
    },
    "dei_EntityEmergingGrowthCompany": {
     "auth_ref": [
      "r558"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Indicate if registrant meets the emerging growth company criteria.",
        "label": "Entity Emerging Growth Company",
        "terseLabel": "Entity Emerging Growth Company"
       }
      }
     },
     "localname": "EntityEmergingGrowthCompany",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://dermtech.com/role/CoverPage"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_EntityFileNumber": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Commission file number. The field allows up to 17 characters. The prefix may contain 1-3 digits, the sequence number may contain 1-8 digits, the optional suffix may contain 1-4 characters, and the fields are separated with a hyphen.",
        "label": "Entity File Number",
        "terseLabel": "Entity File Number"
       }
      }
     },
     "localname": "EntityFileNumber",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://dermtech.com/role/CoverPage"
     ],
     "xbrltype": "fileNumberItemType"
    },
    "dei_EntityFilerCategory": {
     "auth_ref": [
      "r558"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Indicate whether the registrant is one of the following: Large Accelerated Filer, Accelerated Filer, Non-accelerated Filer. Definitions of these categories are stated in Rule 12b-2 of the Exchange Act. This information should be based on the registrant's current or most recent filing containing the related disclosure.",
        "label": "Entity Filer Category",
        "terseLabel": "Entity Filer Category"
       }
      }
     },
     "localname": "EntityFilerCategory",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://dermtech.com/role/CoverPage"
     ],
     "xbrltype": "filerCategoryItemType"
    },
    "dei_EntityIncorporationStateCountryCode": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Two-character EDGAR code representing the state or country of incorporation.",
        "label": "Entity Incorporation, State or Country Code",
        "terseLabel": "Entity Incorporation, State or Country Code"
       }
      }
     },
     "localname": "EntityIncorporationStateCountryCode",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://dermtech.com/role/CoverPage"
     ],
     "xbrltype": "edgarStateCountryItemType"
    },
    "dei_EntityInteractiveDataCurrent": {
     "auth_ref": [
      "r569"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Boolean flag that is true when the registrant has submitted electronically every Interactive Data File required to be submitted pursuant to Rule 405 of Regulation S-T during the preceding 12 months (or for such shorter period that the registrant was required to submit such files).",
        "label": "Entity Interactive Data Current",
        "terseLabel": "Entity Interactive Data Current"
       }
      }
     },
     "localname": "EntityInteractiveDataCurrent",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://dermtech.com/role/CoverPage"
     ],
     "xbrltype": "yesNoItemType"
    },
    "dei_EntityRegistrantName": {
     "auth_ref": [
      "r558"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The exact name of the entity filing the report as specified in its charter, which is required by forms filed with the SEC.",
        "label": "Entity Registrant Name",
        "terseLabel": "Entity Registrant Name"
       }
      }
     },
     "localname": "EntityRegistrantName",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://dermtech.com/role/CoverPage"
     ],
     "xbrltype": "normalizedStringItemType"
    },
    "dei_EntityShellCompany": {
     "auth_ref": [
      "r558"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Boolean flag that is true when the registrant is a shell company as defined in Rule 12b-2 of the Exchange Act.",
        "label": "Entity Shell Company",
        "terseLabel": "Entity Shell Company"
       }
      }
     },
     "localname": "EntityShellCompany",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://dermtech.com/role/CoverPage"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_EntitySmallBusiness": {
     "auth_ref": [
      "r558"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Indicates that the company is a Smaller Reporting Company (SRC).",
        "label": "Entity Small Business",
        "terseLabel": "Entity Small Business"
       }
      }
     },
     "localname": "EntitySmallBusiness",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://dermtech.com/role/CoverPage"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_EntityTaxIdentificationNumber": {
     "auth_ref": [
      "r558"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The Tax Identification Number (TIN), also known as an Employer Identification Number (EIN), is a unique 9-digit value assigned by the IRS.",
        "label": "Entity Tax Identification Number",
        "terseLabel": "Entity Tax Identification Number"
       }
      }
     },
     "localname": "EntityTaxIdentificationNumber",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://dermtech.com/role/CoverPage"
     ],
     "xbrltype": "employerIdItemType"
    },
    "dei_LocalPhoneNumber": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Local phone number for entity.",
        "label": "Local Phone Number",
        "terseLabel": "Local Phone Number"
       }
      }
     },
     "localname": "LocalPhoneNumber",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://dermtech.com/role/CoverPage"
     ],
     "xbrltype": "normalizedStringItemType"
    },
    "dei_Security12bTitle": {
     "auth_ref": [
      "r557"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Title of a 12(b) registered security.",
        "label": "Title of 12(b) Security",
        "verboseLabel": "Title of 12(b) Security"
       }
      }
     },
     "localname": "Security12bTitle",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://dermtech.com/role/CoverPage"
     ],
     "xbrltype": "securityTitleItemType"
    },
    "dei_SecurityExchangeName": {
     "auth_ref": [
      "r559"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Name of the Exchange on which a security is registered.",
        "label": "Security Exchange Name",
        "terseLabel": "Security Exchange Name"
       }
      }
     },
     "localname": "SecurityExchangeName",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://dermtech.com/role/CoverPage"
     ],
     "xbrltype": "edgarExchangeCodeItemType"
    },
    "dei_TradingSymbol": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Trading symbol of an instrument as listed on an exchange.",
        "label": "Trading Symbol",
        "terseLabel": "Trading Symbol"
       }
      }
     },
     "localname": "TradingSymbol",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://dermtech.com/role/CoverPage"
     ],
     "xbrltype": "tradingSymbolItemType"
    },
    "dmtk_AccruedBonusAndDeferredCompensationCurrent": {
     "auth_ref": [],
     "calculation": {
      "http://dermtech.com/role/BalanceSheetDetailsScheduleofAccruedCompensationandAccruedLiabilitiesDetails": {
       "order": 2.0,
       "parentTag": "us-gaap_EmployeeRelatedLiabilitiesCurrent",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Accrued bonus and deferred compensation, current.",
        "label": "Accrued Bonus And Deferred Compensation Current",
        "terseLabel": "Accrued wages, bonus and other"
       }
      }
     },
     "localname": "AccruedBonusAndDeferredCompensationCurrent",
     "nsuri": "http://dermtech.com/20220630",
     "presentation": [
      "http://dermtech.com/role/BalanceSheetDetailsScheduleofAccruedCompensationandAccruedLiabilitiesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "dmtk_AccruedConsultingServicesCurrent": {
     "auth_ref": [],
     "calculation": {
      "http://dermtech.com/role/BalanceSheetDetailsScheduleofAccruedCompensationandAccruedLiabilitiesDetails": {
       "order": 1.0,
       "parentTag": "us-gaap_AccruedLiabilitiesCurrent",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Accrued consulting services, current.",
        "label": "Accrued Consulting Services Current",
        "terseLabel": "Accrued consulting services"
       }
      }
     },
     "localname": "AccruedConsultingServicesCurrent",
     "nsuri": "http://dermtech.com/20220630",
     "presentation": [
      "http://dermtech.com/role/BalanceSheetDetailsScheduleofAccruedCompensationandAccruedLiabilitiesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "dmtk_AdjustmentsToAdditionalPaidInCapitalWarrantIssuedShares": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Adjustments to Additional Paid in Capital, Warrant Issued, Shares",
        "label": "Adjustments to Additional Paid in Capital, Warrant Issued, Shares",
        "terseLabel": "Issuance of common stock from warrant exercises (in shares)"
       }
      }
     },
     "localname": "AdjustmentsToAdditionalPaidInCapitalWarrantIssuedShares",
     "nsuri": "http://dermtech.com/20220630",
     "presentation": [
      "http://dermtech.com/role/CondensedConsolidatedStatementsofStockholdersEquity"
     ],
     "xbrltype": "sharesItemType"
    },
    "dmtk_AmortizationOfLaboratoryEquipmentAcquiredUnderFinanceLeasesMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amortization of laboratory equipment acquired under finance leases.",
        "label": "Amortization Of Laboratory Equipment Acquired Under Finance Leases [Member]",
        "terseLabel": "Amortization of Laboratory Equipment Acquired under Finance Leases"
       }
      }
     },
     "localname": "AmortizationOfLaboratoryEquipmentAcquiredUnderFinanceLeasesMember",
     "nsuri": "http://dermtech.com/20220630",
     "presentation": [
      "http://dermtech.com/role/TheCompanyandaSummaryofitsSignificantAccountingPoliciesAdditionalInformationDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "dmtk_AreaOfBuilding": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Area of building.",
        "label": "Area Of Building",
        "terseLabel": "Area of building (in square feet)"
       }
      }
     },
     "localname": "AreaOfBuilding",
     "nsuri": "http://dermtech.com/20220630",
     "presentation": [
      "http://dermtech.com/role/LeasesCommitmentsandContingenciesAdditionalInformationDetails"
     ],
     "xbrltype": "areaItemType"
    },
    "dmtk_AssayMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Assay.",
        "label": "Assay [Member]",
        "terseLabel": "Assay revenue",
        "verboseLabel": "DermTech Melanoma Test"
       }
      }
     },
     "localname": "AssayMember",
     "nsuri": "http://dermtech.com/20220630",
     "presentation": [
      "http://dermtech.com/role/CondensedConsolidatedStatementsofOperations",
      "http://dermtech.com/role/TheCompanyandaSummaryofitsSignificantAccountingPoliciesAdditionalInformationDetails",
      "http://dermtech.com/role/TheCompanyandaSummaryofitsSignificantAccountingPoliciesScheduleofRevenuesDisaggregatedbyRevenueSourceDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "dmtk_AssayRevenuePayorAMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Assay Revenue Payor A.",
        "label": "Assay Revenue Payor A [Member]",
        "terseLabel": "Payor A"
       }
      }
     },
     "localname": "AssayRevenuePayorAMember",
     "nsuri": "http://dermtech.com/20220630",
     "presentation": [
      "http://dermtech.com/role/TheCompanyandaSummaryofitsSignificantAccountingPoliciesSummaryofPercentagesofTotalRevenueorAccountsReceivableforThirdPartyPayersandPharmaceuticalCustomersDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "dmtk_AssayRevenuePayorBMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Assay Revenue Payor B.",
        "label": "Assay Revenue Payor B [Member]",
        "terseLabel": "Payor B"
       }
      }
     },
     "localname": "AssayRevenuePayorBMember",
     "nsuri": "http://dermtech.com/20220630",
     "presentation": [
      "http://dermtech.com/role/TheCompanyandaSummaryofitsSignificantAccountingPoliciesSummaryofPercentagesofTotalRevenueorAccountsReceivableforThirdPartyPayersandPharmaceuticalCustomersDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "dmtk_AssetsHeldUnderFinanceLeasesMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Assets held under finance leases.",
        "label": "Assets Held Under Finance Leases [Member]",
        "terseLabel": "Assets Recorded under Finance Leases"
       }
      }
     },
     "localname": "AssetsHeldUnderFinanceLeasesMember",
     "nsuri": "http://dermtech.com/20220630",
     "presentation": [
      "http://dermtech.com/role/LeasesCommitmentsandContingenciesAdditionalInformationDetails",
      "http://dermtech.com/role/TheCompanyandaSummaryofitsSignificantAccountingPoliciesAdditionalInformationDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "dmtk_AtTheMarketOfferingMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "At the market offering.",
        "label": "At The Market Offering [Member]",
        "terseLabel": "At-The Market Offering"
       }
      }
     },
     "localname": "AtTheMarketOfferingMember",
     "nsuri": "http://dermtech.com/20220630",
     "presentation": [
      "http://dermtech.com/role/CondensedConsolidatedStatementsofCashFlows",
      "http://dermtech.com/role/CondensedConsolidatedStatementsofStockholdersEquityParenthetical"
     ],
     "xbrltype": "domainItemType"
    },
    "dmtk_AuthorizedForFutureESPPPurchasesMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Authorized for future ESPP purchases.",
        "label": "Authorized For Future E S P P Purchases [Member]",
        "terseLabel": "Authorized for future ESPP purchases"
       }
      }
     },
     "localname": "AuthorizedForFutureESPPPurchasesMember",
     "nsuri": "http://dermtech.com/20220630",
     "presentation": [
      "http://dermtech.com/role/StockholdersEquitySummaryofCommonStockReservedforFutureIssuanceDetail"
     ],
     "xbrltype": "domainItemType"
    },
    "dmtk_AuthorizedForFutureEquityGrantsMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Authorized for future equity grants.",
        "label": "Authorized For Future Equity Grants [Member]",
        "terseLabel": "Authorized for future equity grants"
       }
      }
     },
     "localname": "AuthorizedForFutureEquityGrantsMember",
     "nsuri": "http://dermtech.com/20220630",
     "presentation": [
      "http://dermtech.com/role/StockholdersEquitySummaryofCommonStockReservedforFutureIssuanceDetail"
     ],
     "xbrltype": "domainItemType"
    },
    "dmtk_BrotherOfChiefExecutiveOfficerMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Brother of chief executive officer.",
        "label": "Brother Of Chief Executive Officer [Member]",
        "terseLabel": "Michael Dobak"
       }
      }
     },
     "localname": "BrotherOfChiefExecutiveOfficerMember",
     "nsuri": "http://dermtech.com/20220630",
     "presentation": [
      "http://dermtech.com/role/RelatedPartyTransactionsAdditionalInformationDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "dmtk_CashPaidForAmountsIncludedInMeasurementOfLeaseLiabilitiesAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Cash paid for amounts included in the measurement of lease liabilities.",
        "label": "Cash Paid For Amounts Included In Measurement Of Lease Liabilities [Abstract]",
        "terseLabel": "Cash paid for amounts included in the measurement of lease liabilities:"
       }
      }
     },
     "localname": "CashPaidForAmountsIncludedInMeasurementOfLeaseLiabilitiesAbstract",
     "nsuri": "http://dermtech.com/20220630",
     "presentation": [
      "http://dermtech.com/role/LeasesCommitmentsandContingenciesComponentsofLeaseExpenseDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "dmtk_CashlessExerciseOfCommonStockWarrants": {
     "auth_ref": [],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Cashless exercise of common stock warrants.",
        "label": "Cashless Exercise Of Common Stock Warrants",
        "terseLabel": "Cashless exercise of common stock warrants"
       }
      }
     },
     "localname": "CashlessExerciseOfCommonStockWarrants",
     "nsuri": "http://dermtech.com/20220630",
     "presentation": [
      "http://dermtech.com/role/CondensedConsolidatedStatementsofCashFlows"
     ],
     "xbrltype": "monetaryItemType"
    },
    "dmtk_ChangeInUnrealizedGainLossOnAvailableForSaleMarketableSecurities": {
     "auth_ref": [],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Change in unrealized gain loss on available-for-sale marketable securities.",
        "label": "Change In Unrealized Gain (Loss) On Available For Sale Marketable Securities",
        "terseLabel": "Change in net unrealized (losses)/gains on available-for-sale marketable securities"
       }
      }
     },
     "localname": "ChangeInUnrealizedGainLossOnAvailableForSaleMarketableSecurities",
     "nsuri": "http://dermtech.com/20220630",
     "presentation": [
      "http://dermtech.com/role/CondensedConsolidatedStatementsofCashFlows"
     ],
     "xbrltype": "monetaryItemType"
    },
    "dmtk_ClassOfWarrantOrRightWarrantsOrRightsIssuedToPurchaseCommonStock": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Class of warrant or rights issued to purchase common stock.",
        "label": "Class Of Warrant Or Right, Warrants Or Rights Issued To Purchase Common Stock",
        "terseLabel": "Warrants issued to purchase common stock (in shares)"
       }
      }
     },
     "localname": "ClassOfWarrantOrRightWarrantsOrRightsIssuedToPurchaseCommonStock",
     "nsuri": "http://dermtech.com/20220630",
     "presentation": [
      "http://dermtech.com/role/StockholdersEquityAdditionalInformationDetails"
     ],
     "xbrltype": "sharesItemType"
    },
    "dmtk_CommitmentsAndContingenciesLineItems": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Commitments and contingencies.",
        "label": "Commitments And Contingencies [Line Items]",
        "terseLabel": "Commitments And Contingencies [Line Items]"
       }
      }
     },
     "localname": "CommitmentsAndContingenciesLineItems",
     "nsuri": "http://dermtech.com/20220630",
     "presentation": [
      "http://dermtech.com/role/LeasesCommitmentsandContingenciesAdditionalInformationDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "dmtk_CommitmentsAndContingenciesTable": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Commitments and contingencies.",
        "label": "Commitments And Contingencies [Table]",
        "terseLabel": "Commitments And Contingencies [Table]"
       }
      }
     },
     "localname": "CommitmentsAndContingenciesTable",
     "nsuri": "http://dermtech.com/20220630",
     "presentation": [
      "http://dermtech.com/role/LeasesCommitmentsandContingenciesAdditionalInformationDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "dmtk_CommonSharesIssuedUponExerciseOfWarrants": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Common shares issued upon exercise of warrants.",
        "label": "Common Shares Issued Upon Exercise Of Warrants",
        "verboseLabel": "Common shares issued upon exercise of warrants (in shares)"
       }
      }
     },
     "localname": "CommonSharesIssuedUponExerciseOfWarrants",
     "nsuri": "http://dermtech.com/20220630",
     "presentation": [
      "http://dermtech.com/role/StockholdersEquityAdditionalInformationDetails"
     ],
     "xbrltype": "sharesItemType"
    },
    "dmtk_CommonStockOutstandingPercentage": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Common stock outstanding percentage.",
        "label": "Common Stock Outstanding Percentage",
        "terseLabel": "Common stock outstanding percentage"
       }
      }
     },
     "localname": "CommonStockOutstandingPercentage",
     "nsuri": "http://dermtech.com/20220630",
     "presentation": [
      "http://dermtech.com/role/StockholdersEquityAdditionalInformationDetails"
     ],
     "xbrltype": "percentItemType"
    },
    "dmtk_ComputerEquipmentGross": {
     "auth_ref": [],
     "calculation": {
      "http://dermtech.com/role/BalanceSheetDetailsScheduleofPrepaidExpensesandPPEDetails": {
       "order": 2.0,
       "parentTag": "us-gaap_PropertyPlantAndEquipmentGross",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Computer equipment gross.",
        "label": "Computer Equipment Gross",
        "terseLabel": "Computer equipment"
       }
      }
     },
     "localname": "ComputerEquipmentGross",
     "nsuri": "http://dermtech.com/20220630",
     "presentation": [
      "http://dermtech.com/role/BalanceSheetDetailsScheduleofPrepaidExpensesandPPEDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "dmtk_ContractRevenueAdhesivePatchKitsMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Contract revenue, adhesive patch kits.",
        "label": "Contract Revenue Adhesive Patch Kits [Member]",
        "terseLabel": "Adhesive patch kits"
       }
      }
     },
     "localname": "ContractRevenueAdhesivePatchKitsMember",
     "nsuri": "http://dermtech.com/20220630",
     "presentation": [
      "http://dermtech.com/role/TheCompanyandaSummaryofitsSignificantAccountingPoliciesScheduleofRevenuesDisaggregatedbyRevenueSourceDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "dmtk_ContractRevenueProjectManagementFeesMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Contract revenue project management fees.",
        "label": "Contract Revenue Project Management Fees [Member]",
        "terseLabel": "Project management fees"
       }
      }
     },
     "localname": "ContractRevenueProjectManagementFeesMember",
     "nsuri": "http://dermtech.com/20220630",
     "presentation": [
      "http://dermtech.com/role/TheCompanyandaSummaryofitsSignificantAccountingPoliciesScheduleofRevenuesDisaggregatedbyRevenueSourceDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "dmtk_ContractRevenueRNAExtractionsMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Contract revenue, RNA extractions.",
        "label": "Contract Revenue R N A Extractions [Member]",
        "terseLabel": "RNA extractions"
       }
      }
     },
     "localname": "ContractRevenueRNAExtractionsMember",
     "nsuri": "http://dermtech.com/20220630",
     "presentation": [
      "http://dermtech.com/role/TheCompanyandaSummaryofitsSignificantAccountingPoliciesScheduleofRevenuesDisaggregatedbyRevenueSourceDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "dmtk_ContractualActivitiesMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Contract activities.",
        "label": "Contractual Activities [Member]",
        "terseLabel": "Contract revenue"
       }
      }
     },
     "localname": "ContractualActivitiesMember",
     "nsuri": "http://dermtech.com/20220630",
     "presentation": [
      "http://dermtech.com/role/CondensedConsolidatedStatementsofOperations",
      "http://dermtech.com/role/TheCompanyandaSummaryofitsSignificantAccountingPoliciesAdditionalInformationDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "dmtk_CowenLimitedLiabilityCompanyMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Cowen Limited Liability Company.",
        "label": "Cowen Limited Liability Company [Member]",
        "terseLabel": "Cowen and Company LLC"
       }
      }
     },
     "localname": "CowenLimitedLiabilityCompanyMember",
     "nsuri": "http://dermtech.com/20220630",
     "presentation": [
      "http://dermtech.com/role/StockholdersEquityAdditionalInformationDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "dmtk_CreditLosses": {
     "auth_ref": [],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Credit Losses",
        "label": "Credit Losses",
        "terseLabel": "Credit losses"
       }
      }
     },
     "localname": "CreditLosses",
     "nsuri": "http://dermtech.com/20220630",
     "presentation": [
      "http://dermtech.com/role/BalanceSheetDetailsAdditionalInformationDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "dmtk_DermTechOperationsIncMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "DermTech Operations, Inc.",
        "label": "Derm Tech Operations Inc [Member]",
        "terseLabel": "DermTech Operations"
       }
      }
     },
     "localname": "DermTechOperationsIncMember",
     "nsuri": "http://dermtech.com/20220630",
     "presentation": [
      "http://dermtech.com/role/RelatedPartyTransactionsAdditionalInformationDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "dmtk_EVERSANALifeScienceServicesLLCMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "EVERSANA Life Science Services, LLC.",
        "label": "EVERSANA Life Science Services LLC [Member]",
        "terseLabel": "EVERSANA"
       }
      }
     },
     "localname": "EVERSANALifeScienceServicesLLCMember",
     "nsuri": "http://dermtech.com/20220630",
     "presentation": [
      "http://dermtech.com/role/RelatedPartyTransactionsAdditionalInformationDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "dmtk_EquityIncentivePlanOptionTerm": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Equity incentive plan option term.",
        "label": "Equity Incentive Plan Option Term",
        "terseLabel": "Term of the option"
       }
      }
     },
     "localname": "EquityIncentivePlanOptionTerm",
     "nsuri": "http://dermtech.com/20220630",
     "presentation": [
      "http://dermtech.com/role/StockholdersEquityAdditionalInformationDetails"
     ],
     "xbrltype": "durationItemType"
    },
    "dmtk_EstimatedMarketValueOfDebtSecuritiesWithContractualMaturitiesOfLessThan12Months": {
     "auth_ref": [],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Estimated market value of debt securities with contractual maturities of less than 12 months.",
        "label": "Estimated Market Value Of Debt Securities With Contractual Maturities Of Less Than12 Months",
        "terseLabel": "Estimated market value of debt securities with contractual maturities of less than 12 months"
       }
      }
     },
     "localname": "EstimatedMarketValueOfDebtSecuritiesWithContractualMaturitiesOfLessThan12Months",
     "nsuri": "http://dermtech.com/20220630",
     "presentation": [
      "http://dermtech.com/role/BalanceSheetDetailsAdditionalInformationDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "dmtk_EstimatedMarketValueOfRemainingDebtSecuritiesWithContractualMaturitiesOfUpTo23Months": {
     "auth_ref": [],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Estimated market value of remaining debt securities with contractual maturities of up to 23 months.",
        "label": "Estimated Market Value Of Remaining Debt Securities With Contractual Maturities Of Up To23 Months",
        "terseLabel": "Estimated market value of remaining debt securities with contractual maturities of up to 23 months"
       }
      }
     },
     "localname": "EstimatedMarketValueOfRemainingDebtSecuritiesWithContractualMaturitiesOfUpTo23Months",
     "nsuri": "http://dermtech.com/20220630",
     "presentation": [
      "http://dermtech.com/role/BalanceSheetDetailsAdditionalInformationDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "dmtk_FinanceLeaseCost": {
     "auth_ref": [],
     "calculation": {
      "http://dermtech.com/role/LeasesCommitmentsandContingenciesComponentsofLeaseExpenseDetails": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Finance lease cost.",
        "label": "Finance Lease Cost",
        "totalLabel": "Total finance lease cost"
       }
      }
     },
     "localname": "FinanceLeaseCost",
     "nsuri": "http://dermtech.com/20220630",
     "presentation": [
      "http://dermtech.com/role/LeasesCommitmentsandContingenciesComponentsofLeaseExpenseDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "dmtk_FinanceLeaseCostsAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Finance lease cost.",
        "label": "Finance Lease Costs [Abstract]",
        "terseLabel": "Finance lease cost"
       }
      }
     },
     "localname": "FinanceLeaseCostsAbstract",
     "nsuri": "http://dermtech.com/20220630",
     "presentation": [
      "http://dermtech.com/role/LeasesCommitmentsandContingenciesComponentsofLeaseExpenseDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "dmtk_FinanceLeaseLiabilityPaymentsDueAfterYearFour": {
     "auth_ref": [],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Finance lease liability payments due after year four.",
        "label": "Finance Lease Liability Payments Due After Year Four",
        "terseLabel": "Thereafter"
       }
      }
     },
     "localname": "FinanceLeaseLiabilityPaymentsDueAfterYearFour",
     "nsuri": "http://dermtech.com/20220630",
     "presentation": [
      "http://dermtech.com/role/LeasesCommitmentsandContingenciesFutureMinimumPaymentsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "dmtk_FirstAmendmentMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "First Amendment",
        "label": "First Amendment [Member]",
        "terseLabel": "First Amendment"
       }
      }
     },
     "localname": "FirstAmendmentMember",
     "nsuri": "http://dermtech.com/20220630",
     "presentation": [
      "http://dermtech.com/role/LeasesCommitmentsandContingenciesAdditionalInformationDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "dmtk_GrossProceedsFromIssuanceOfCommonStock": {
     "auth_ref": [],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Gross proceeds from issuance of common stock.",
        "label": "Gross Proceeds From Issuance Of Common Stock",
        "terseLabel": "Gross proceeds from issuance of common stock"
       }
      }
     },
     "localname": "GrossProceedsFromIssuanceOfCommonStock",
     "nsuri": "http://dermtech.com/20220630",
     "presentation": [
      "http://dermtech.com/role/StockholdersEquityAdditionalInformationDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "dmtk_GrossProceedsFromOfferingBeforeDeductingUnderwritingDiscountsAndCommissionsAndOtherOfferingExpenses": {
     "auth_ref": [],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Gross proceeds from offering, before deducting underwriting discounts and commissions and other offering expenses.",
        "label": "Gross Proceeds From Offering Before Deducting Underwriting Discounts And Commissions And Other Offering Expenses",
        "terseLabel": "Gross proceeds from offering, before deducting underwriting discounts and commissions and other offering expenses"
       }
      }
     },
     "localname": "GrossProceedsFromOfferingBeforeDeductingUnderwritingDiscountsAndCommissionsAndOtherOfferingExpenses",
     "nsuri": "http://dermtech.com/20220630",
     "presentation": [
      "http://dermtech.com/role/StockholdersEquityAdditionalInformationDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "dmtk_IncentiveAndNonQualifiedStockOptionsMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Incentive and non-qualified stock options.",
        "label": "Incentive And Non Qualified Stock Options [Member]",
        "terseLabel": "Incentive and Non-qualified Stock Options"
       }
      }
     },
     "localname": "IncentiveAndNonQualifiedStockOptionsMember",
     "nsuri": "http://dermtech.com/20220630",
     "presentation": [
      "http://dermtech.com/role/StockholdersEquityAdditionalInformationDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "dmtk_IncentiveStockOptionsMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Incentive stock options.",
        "label": "Incentive Stock Options [Member]",
        "terseLabel": "Incentive Stock Options"
       }
      }
     },
     "localname": "IncentiveStockOptionsMember",
     "nsuri": "http://dermtech.com/20220630",
     "presentation": [
      "http://dermtech.com/role/StockholdersEquityAdditionalInformationDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "dmtk_IncreaseDecreaseInOperatingLeaseRightOfUseAsset": {
     "auth_ref": [],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Increase (Decrease) In Operating Lease, Right-Of-Use-Asset",
        "label": "Increase (Decrease) In Operating Lease, Right-Of-Use-Asset",
        "terseLabel": "Increase to operating right-of-use asset"
       }
      }
     },
     "localname": "IncreaseDecreaseInOperatingLeaseRightOfUseAsset",
     "nsuri": "http://dermtech.com/20220630",
     "presentation": [
      "http://dermtech.com/role/LeasesCommitmentsandContingenciesAdditionalInformationDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "dmtk_IncreaseDecreaseInStockIssuanceCosts": {
     "auth_ref": [],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Increase decrease in stock issuance costs.",
        "label": "Increase (Decrease) In Stock Issuance Costs",
        "negatedLabel": "Decrease in issuance costs"
       }
      }
     },
     "localname": "IncreaseDecreaseInStockIssuanceCosts",
     "nsuri": "http://dermtech.com/20220630",
     "presentation": [
      "http://dermtech.com/role/StockholdersEquityAdditionalInformationDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "dmtk_IncreaseInTenantImprovementAllowance": {
     "auth_ref": [],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Increase in tenant improvement allowance.",
        "label": "Increase In Tenant Improvement Allowance",
        "terseLabel": "Increase in tenant improvement allowance"
       }
      }
     },
     "localname": "IncreaseInTenantImprovementAllowance",
     "nsuri": "http://dermtech.com/20220630",
     "presentation": [
      "http://dermtech.com/role/LeasesCommitmentsandContingenciesAdditionalInformationDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "dmtk_IncreaseInTenantImprovementAllowancePerRentableSquareFoot": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Increase In Tenant Improvement Allowance Per Rentable Square Foot",
        "label": "Increase In Tenant Improvement Allowance Per Rentable Square Foot",
        "terseLabel": "Increase in improvement allowance per rentable square foot (in usd per square foot)"
       }
      }
     },
     "localname": "IncreaseInTenantImprovementAllowancePerRentableSquareFoot",
     "nsuri": "http://dermtech.com/20220630",
     "presentation": [
      "http://dermtech.com/role/LeasesCommitmentsandContingenciesAdditionalInformationDetails"
     ],
     "xbrltype": "perUnitItemType"
    },
    "dmtk_KilroyRealtyLPMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Kilroy Realty, L.P.",
        "label": "Kilroy Realty L P [Member]",
        "terseLabel": "Kilroy Realty, L.P"
       }
      }
     },
     "localname": "KilroyRealtyLPMember",
     "nsuri": "http://dermtech.com/20220630",
     "presentation": [
      "http://dermtech.com/role/LeasesCommitmentsandContingenciesAdditionalInformationDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "dmtk_LeaseAmendmentsAxis": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Lease Amendments",
        "label": "Lease Amendments [Axis]",
        "terseLabel": "Lease Amendments [Axis]"
       }
      }
     },
     "localname": "LeaseAmendmentsAxis",
     "nsuri": "http://dermtech.com/20220630",
     "presentation": [
      "http://dermtech.com/role/LeasesCommitmentsandContingenciesAdditionalInformationDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "dmtk_LeaseAmendmentsDomain": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Lease Amendments [Domain]",
        "label": "Lease Amendments [Domain]",
        "terseLabel": "Lease Amendments [Domain]"
       }
      }
     },
     "localname": "LeaseAmendmentsDomain",
     "nsuri": "http://dermtech.com/20220630",
     "presentation": [
      "http://dermtech.com/role/LeasesCommitmentsandContingenciesAdditionalInformationDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "dmtk_LesseeOperatingAndFinanceLeaseLiabilityToBePaidAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Lessee, Operating and Finance Lease, Liability, To Be Paid",
        "label": "Lessee, Operating and Finance Lease, Liability, To Be Paid [Abstract]",
        "terseLabel": "Total future minimum lease payments"
       }
      }
     },
     "localname": "LesseeOperatingAndFinanceLeaseLiabilityToBePaidAbstract",
     "nsuri": "http://dermtech.com/20220630",
     "presentation": [
      "http://dermtech.com/role/LeasesCommitmentsandContingenciesFutureMinimumPaymentsDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "dmtk_LesseeOperatingLeaseLiabilityToBePaidAfterYearFour": {
     "auth_ref": [],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Lessee, Operating Lease, Liability, to be Paid, after Year Four",
        "label": "Lessee, Operating Lease, Liability, to be Paid, after Year Four",
        "terseLabel": "Thereafter"
       }
      }
     },
     "localname": "LesseeOperatingLeaseLiabilityToBePaidAfterYearFour",
     "nsuri": "http://dermtech.com/20220630",
     "presentation": [
      "http://dermtech.com/role/LeasesCommitmentsandContingenciesFutureMinimumPaymentsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "dmtk_LesseeOperatingLeaseNumberOfRenewalTerms": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Lessee, Operating Lease, Number Of Renewal Terms",
        "label": "Lessee, Operating Lease, Number Of Renewal Terms",
        "terseLabel": "Number of renewal terms"
       }
      }
     },
     "localname": "LesseeOperatingLeaseNumberOfRenewalTerms",
     "nsuri": "http://dermtech.com/20220630",
     "presentation": [
      "http://dermtech.com/role/LeasesCommitmentsandContingenciesAdditionalInformationDetails"
     ],
     "xbrltype": "integerItemType"
    },
    "dmtk_ManagementWarrantsMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Management warrants.",
        "label": "Management Warrants [Member]",
        "terseLabel": "Management Warrants"
       }
      }
     },
     "localname": "ManagementWarrantsMember",
     "nsuri": "http://dermtech.com/20220630",
     "presentation": [
      "http://dermtech.com/role/StockholdersEquityAdditionalInformationDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "dmtk_NumberOfImprovementPhases": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Number Of Improvement Phases",
        "label": "Number Of Improvement Phases",
        "terseLabel": "Number of improvement phases"
       }
      }
     },
     "localname": "NumberOfImprovementPhases",
     "nsuri": "http://dermtech.com/20220630",
     "presentation": [
      "http://dermtech.com/role/LeasesCommitmentsandContingenciesAdditionalInformationDetails"
     ],
     "xbrltype": "integerItemType"
    },
    "dmtk_NumberOfRevenueStreams": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Number of revenue streams.",
        "label": "Number Of Revenue Streams",
        "terseLabel": "Number of revenue streams (in number of streams)"
       }
      }
     },
     "localname": "NumberOfRevenueStreams",
     "nsuri": "http://dermtech.com/20220630",
     "presentation": [
      "http://dermtech.com/role/TheCompanyandaSummaryofitsSignificantAccountingPoliciesAdditionalInformationDetails"
     ],
     "xbrltype": "integerItemType"
    },
    "dmtk_NumberOfWarrantsEntitleHolderToPurchaseOneShare": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Number of warrants entitle holder to purchase one share.",
        "label": "Number Of Warrants Entitle Holder To Purchase One Share",
        "terseLabel": "Number of warrants entitle holder to purchase one share"
       }
      }
     },
     "localname": "NumberOfWarrantsEntitleHolderToPurchaseOneShare",
     "nsuri": "http://dermtech.com/20220630",
     "presentation": [
      "http://dermtech.com/role/StockholdersEquityAdditionalInformationDetails",
      "http://dermtech.com/role/StockholdersEquitySummaryofCommonStockReservedforFutureIssuanceDetail"
     ],
     "xbrltype": "integerItemType"
    },
    "dmtk_OperatingAndFinanceLeaseLiabilityPaymentsDue": {
     "auth_ref": [],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Operating and capital lease liability payments due.",
        "label": "Operating And Finance Lease Liability Payments Due",
        "terseLabel": "Operating And Capital Lease Liability Payments Due"
       }
      }
     },
     "localname": "OperatingAndFinanceLeaseLiabilityPaymentsDue",
     "nsuri": "http://dermtech.com/20220630",
     "presentation": [
      "http://dermtech.com/role/LeasesCommitmentsandContingenciesFutureMinimumPaymentsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "dmtk_OperatingAndFinanceLeaseLiabilityPaymentsDueNextTwelveMonths": {
     "auth_ref": [],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Operating and capital lease liability payments due next twelve months.",
        "label": "Operating And Finance Lease Liability Payments Due Next Twelve Months",
        "terseLabel": "Total future minimum lease payments due in 2023"
       }
      }
     },
     "localname": "OperatingAndFinanceLeaseLiabilityPaymentsDueNextTwelveMonths",
     "nsuri": "http://dermtech.com/20220630",
     "presentation": [
      "http://dermtech.com/role/LeasesCommitmentsandContingenciesFutureMinimumPaymentsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "dmtk_OperatingAndFinanceLeaseLiabilityPaymentsDueThereafter": {
     "auth_ref": [],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Operating and capital lease liability payments due thereafter.",
        "label": "Operating And Finance Lease Liability Payments Due Thereafter",
        "terseLabel": "Total future minimum lease payments due thereafter"
       }
      }
     },
     "localname": "OperatingAndFinanceLeaseLiabilityPaymentsDueThereafter",
     "nsuri": "http://dermtech.com/20220630",
     "presentation": [
      "http://dermtech.com/role/LeasesCommitmentsandContingenciesFutureMinimumPaymentsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "dmtk_OperatingAndFinanceLeaseLiabilityPaymentsDueYearFour": {
     "auth_ref": [],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Operating and capital lease liability payments due year four.",
        "label": "Operating And Finance Lease Liability Payments Due Year Four",
        "terseLabel": "Total future minimum lease payments due in 2026"
       }
      }
     },
     "localname": "OperatingAndFinanceLeaseLiabilityPaymentsDueYearFour",
     "nsuri": "http://dermtech.com/20220630",
     "presentation": [
      "http://dermtech.com/role/LeasesCommitmentsandContingenciesFutureMinimumPaymentsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "dmtk_OperatingAndFinanceLeaseLiabilityPaymentsDueYearThree": {
     "auth_ref": [],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Operating and capital lease liability payments due year three.",
        "label": "Operating And Finance Lease Liability Payments Due Year Three",
        "terseLabel": "Total future minimum lease payments due in 2025"
       }
      }
     },
     "localname": "OperatingAndFinanceLeaseLiabilityPaymentsDueYearThree",
     "nsuri": "http://dermtech.com/20220630",
     "presentation": [
      "http://dermtech.com/role/LeasesCommitmentsandContingenciesFutureMinimumPaymentsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "dmtk_OperatingAndFinanceLeaseLiabilityPaymentsDueYearTwo": {
     "auth_ref": [],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Operating and capital lease liability payments due year two.",
        "label": "Operating And Finance Lease Liability Payments Due Year Two",
        "terseLabel": "Total future minimum lease payments due in 2024"
       }
      }
     },
     "localname": "OperatingAndFinanceLeaseLiabilityPaymentsDueYearTwo",
     "nsuri": "http://dermtech.com/20220630",
     "presentation": [
      "http://dermtech.com/role/LeasesCommitmentsandContingenciesFutureMinimumPaymentsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "dmtk_OperatingAndFinanceLeaseLiabilityPaymentsRemainderOfFiscalYear": {
     "auth_ref": [],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Operating and capital lease liability payments remainder of fiscal year.",
        "label": "Operating And Finance Lease Liability Payments Remainder Of Fiscal Year",
        "terseLabel": "Total future minimum lease payments due in 2022"
       }
      }
     },
     "localname": "OperatingAndFinanceLeaseLiabilityPaymentsRemainderOfFiscalYear",
     "nsuri": "http://dermtech.com/20220630",
     "presentation": [
      "http://dermtech.com/role/LeasesCommitmentsandContingenciesFutureMinimumPaymentsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "dmtk_OperatingLeaseCostAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Operating lease cost.",
        "label": "Operating Lease Cost [Abstract]",
        "terseLabel": "Operating lease cost"
       }
      }
     },
     "localname": "OperatingLeaseCostAbstract",
     "nsuri": "http://dermtech.com/20220630",
     "presentation": [
      "http://dermtech.com/role/LeasesCommitmentsandContingenciesComponentsofLeaseExpenseDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "dmtk_OperatingLeaseCosts": {
     "auth_ref": [],
     "calculation": {
      "http://dermtech.com/role/LeasesCommitmentsandContingenciesComponentsofLeaseExpenseDetails": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Operating lease cost.",
        "label": "Operating Lease Costs",
        "totalLabel": "Total operating lease cost"
       }
      }
     },
     "localname": "OperatingLeaseCosts",
     "nsuri": "http://dermtech.com/20220630",
     "presentation": [
      "http://dermtech.com/role/LeasesCommitmentsandContingenciesComponentsofLeaseExpenseDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "dmtk_OperatingLeaseIncrementalBorrowingRateAtEffectiveDate": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Operating Lease, Incremental Borrowing Rate At Effective Date",
        "label": "Operating Lease, Incremental Borrowing Rate At Effective Date",
        "terseLabel": "Incremental borrowing rate"
       }
      }
     },
     "localname": "OperatingLeaseIncrementalBorrowingRateAtEffectiveDate",
     "nsuri": "http://dermtech.com/20220630",
     "presentation": [
      "http://dermtech.com/role/LeasesCommitmentsandContingenciesAdditionalInformationDetails"
     ],
     "xbrltype": "percentItemType"
    },
    "dmtk_PercentageOfPriceAtSharesPurchased": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Percentage of price at shares purchased",
        "label": "Percentage Of Price At Shares Purchased",
        "terseLabel": "Percentage of price at shares purchased"
       }
      }
     },
     "localname": "PercentageOfPriceAtSharesPurchased",
     "nsuri": "http://dermtech.com/20220630",
     "presentation": [
      "http://dermtech.com/role/StockholdersEquityAdditionalInformationDetails"
     ],
     "xbrltype": "percentItemType"
    },
    "dmtk_PercentageOfUsefulLivesOfAssets": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Percentage of useful lives of assets.",
        "label": "Percentage Of Useful Lives Of Assets",
        "terseLabel": "Percentage of useful lives of assets"
       }
      }
     },
     "localname": "PercentageOfUsefulLivesOfAssets",
     "nsuri": "http://dermtech.com/20220630",
     "presentation": [
      "http://dermtech.com/role/LeasesCommitmentsandContingenciesAdditionalInformationDetails"
     ],
     "xbrltype": "percentItemType"
    },
    "dmtk_PlacementAgentWarrantsMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Placement agent warrants.",
        "label": "Placement Agent Warrants [Member]",
        "terseLabel": "Placement Agent Warrants"
       }
      }
     },
     "localname": "PlacementAgentWarrantsMember",
     "nsuri": "http://dermtech.com/20220630",
     "presentation": [
      "http://dermtech.com/role/StockholdersEquityAdditionalInformationDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "dmtk_PrepaidEmployeeCompensation": {
     "auth_ref": [],
     "calculation": {
      "http://dermtech.com/role/BalanceSheetDetailsScheduleofPrepaidExpensesandPPEDetails": {
       "order": 4.0,
       "parentTag": "us-gaap_PrepaidExpenseAndOtherAssetsCurrent",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Prepaid employee compensation.",
        "label": "Prepaid Employee Compensation",
        "terseLabel": "Prepaid employee compensation"
       }
      }
     },
     "localname": "PrepaidEmployeeCompensation",
     "nsuri": "http://dermtech.com/20220630",
     "presentation": [
      "http://dermtech.com/role/BalanceSheetDetailsScheduleofPrepaidExpensesandPPEDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "dmtk_PrepaidSoftwareFees": {
     "auth_ref": [],
     "calculation": {
      "http://dermtech.com/role/BalanceSheetDetailsScheduleofPrepaidExpensesandPPEDetails": {
       "order": 3.0,
       "parentTag": "us-gaap_PrepaidExpenseAndOtherAssetsCurrent",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Prepaid software fees.",
        "label": "Prepaid Software Fees",
        "terseLabel": "Prepaid software fees"
       }
      }
     },
     "localname": "PrepaidSoftwareFees",
     "nsuri": "http://dermtech.com/20220630",
     "presentation": [
      "http://dermtech.com/role/BalanceSheetDetailsScheduleofPrepaidExpensesandPPEDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "dmtk_PrepaidTradeShowsCurrent": {
     "auth_ref": [],
     "calculation": {
      "http://dermtech.com/role/BalanceSheetDetailsScheduleofPrepaidExpensesandPPEDetails": {
       "order": 2.0,
       "parentTag": "us-gaap_PrepaidExpenseAndOtherAssetsCurrent",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Prepaid trade shows, current.",
        "label": "Prepaid Trade Shows Current",
        "terseLabel": "Prepaid trade shows"
       }
      }
     },
     "localname": "PrepaidTradeShowsCurrent",
     "nsuri": "http://dermtech.com/20220630",
     "presentation": [
      "http://dermtech.com/role/BalanceSheetDetailsScheduleofPrepaidExpensesandPPEDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "dmtk_PrivateSpecialPurposeAcquisitionCompaniesWarrantsMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Private special purpose acquisition companies warrants.",
        "label": "Private Special Purpose Acquisition Companies Warrants [Member]",
        "terseLabel": "Private SPAC Warrants"
       }
      }
     },
     "localname": "PrivateSpecialPurposeAcquisitionCompaniesWarrantsMember",
     "nsuri": "http://dermtech.com/20220630",
     "presentation": [
      "http://dermtech.com/role/StockholdersEquityAdditionalInformationDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "dmtk_ProceedsFromMaturityOfMarketableSecurities": {
     "auth_ref": [],
     "calculation": {
      "http://dermtech.com/role/CondensedConsolidatedStatementsofCashFlows": {
       "order": 3.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInInvestingActivities",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Proceeds From Maturity Of Marketable Securities",
        "label": "Proceeds From Maturity Of Marketable Securities",
        "terseLabel": "Maturities of marketable securities"
       }
      }
     },
     "localname": "ProceedsFromMaturityOfMarketableSecurities",
     "nsuri": "http://dermtech.com/20220630",
     "presentation": [
      "http://dermtech.com/role/CondensedConsolidatedStatementsofCashFlows"
     ],
     "xbrltype": "monetaryItemType"
    },
    "dmtk_ProceedsFromReleaseOfRSUsAndStockOptionsExercised": {
     "auth_ref": [],
     "calculation": {
      "http://dermtech.com/role/CondensedConsolidatedStatementsofCashFlows": {
       "order": 5.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInFinancingActivities",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Proceeds From Release Of RSUs And Stock Options Exercised",
        "label": "Proceeds From Release Of RSUs And Stock Options Exercised",
        "terseLabel": "Proceeds from RSU releases (par value only) and the exercise of stock options"
       }
      }
     },
     "localname": "ProceedsFromReleaseOfRSUsAndStockOptionsExercised",
     "nsuri": "http://dermtech.com/20220630",
     "presentation": [
      "http://dermtech.com/role/CondensedConsolidatedStatementsofCashFlows"
     ],
     "xbrltype": "monetaryItemType"
    },
    "dmtk_PublicFollowOnOfferingMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Public follow on offering.",
        "label": "Public Follow On Offering [Member]",
        "terseLabel": "Public Follow-on Offering"
       }
      }
     },
     "localname": "PublicFollowOnOfferingMember",
     "nsuri": "http://dermtech.com/20220630",
     "presentation": [
      "http://dermtech.com/role/CondensedConsolidatedStatementsofCashFlows"
     ],
     "xbrltype": "domainItemType"
    },
    "dmtk_PublicSpecialPurposeAcquisitionCompaniesWarrantsMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Public special purpose acquisition companies warrants.",
        "label": "Public Special Purpose Acquisition Companies Warrants [Member]",
        "terseLabel": "Public SPAC Warrants"
       }
      }
     },
     "localname": "PublicSpecialPurposeAcquisitionCompaniesWarrantsMember",
     "nsuri": "http://dermtech.com/20220630",
     "presentation": [
      "http://dermtech.com/role/StockholdersEquityAdditionalInformationDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "dmtk_ReclassificationOfWarrantLiabilityDueToPrivateSPACWarrantsNotHeldByOriginalHolder": {
     "auth_ref": [],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Reclassification of warrant liability due to private SPAC warrants not held by original holder.",
        "label": "Reclassification Of Warrant Liability Due To Private SPAC Warrants Not Held By Original Holder",
        "terseLabel": "Reclassification of warrant liability due to Private SPAC Warrants not held by original holder",
        "verboseLabel": "Reclassification of warrant liability due to Private SPAC Warrants not held by original holder"
       }
      }
     },
     "localname": "ReclassificationOfWarrantLiabilityDueToPrivateSPACWarrantsNotHeldByOriginalHolder",
     "nsuri": "http://dermtech.com/20220630",
     "presentation": [
      "http://dermtech.com/role/CondensedConsolidatedStatementsofCashFlows",
      "http://dermtech.com/role/CondensedConsolidatedStatementsofStockholdersEquity"
     ],
     "xbrltype": "monetaryItemType"
    },
    "dmtk_RentableAndUsableSquareFeet": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Rentable And Usable Square Feet",
        "label": "Rentable And Usable Square Feet",
        "terseLabel": "Expansion premise (in square feet)"
       }
      }
     },
     "localname": "RentableAndUsableSquareFeet",
     "nsuri": "http://dermtech.com/20220630",
     "presentation": [
      "http://dermtech.com/role/LeasesCommitmentsandContingenciesAdditionalInformationDetails"
     ],
     "xbrltype": "integerItemType"
    },
    "dmtk_RestrictedCashAndCashEquivalentsIncreaseDecrease": {
     "auth_ref": [],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Restricted Cash and Cash Equivalents, Increase (Decrease)",
        "label": "Restricted Cash and Cash Equivalents, Increase (Decrease)",
        "terseLabel": "Increase (decrease) to restricted cash and cash equivalents"
       }
      }
     },
     "localname": "RestrictedCashAndCashEquivalentsIncreaseDecrease",
     "nsuri": "http://dermtech.com/20220630",
     "presentation": [
      "http://dermtech.com/role/LeasesCommitmentsandContingenciesAdditionalInformationDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "dmtk_RestrictedCashMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Restricted Cash.",
        "label": "Restricted Cash [Member]",
        "terseLabel": "Restricted Cash"
       }
      }
     },
     "localname": "RestrictedCashMember",
     "nsuri": "http://dermtech.com/20220630",
     "presentation": [
      "http://dermtech.com/role/TheCompanyandaSummaryofitsSignificantAccountingPoliciesAdditionalInformationDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "dmtk_RevenuePerformanceObligationSatisfiedVariableConsiderationUpdateIncreaseDecreaseInRevenue": {
     "auth_ref": [],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Revenue, Performance Obligation Satisfied, Variable Consideration Update, Increase (Decrease) In Revenue",
        "label": "Revenue, Performance Obligation Satisfied, Variable Consideration Update, Increase (Decrease) In Revenue",
        "terseLabel": "Increase (decrease) in revenue"
       }
      }
     },
     "localname": "RevenuePerformanceObligationSatisfiedVariableConsiderationUpdateIncreaseDecreaseInRevenue",
     "nsuri": "http://dermtech.com/20220630",
     "presentation": [
      "http://dermtech.com/role/TheCompanyandaSummaryofitsSignificantAccountingPoliciesAdditionalInformationDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "dmtk_ScheduleOfFutureMinimumRentalPaymentsForOperatingAndCapitalLeasesTableTextBlock": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Schedule of future minimum rental payments for operating and capital leases.",
        "label": "Schedule Of Future Minimum Rental Payments For Operating And Capital Leases Table [Text Block]",
        "terseLabel": "Schedule of Future Minimum Lease Payments Under Operating and Financing Leases"
       }
      }
     },
     "localname": "ScheduleOfFutureMinimumRentalPaymentsForOperatingAndCapitalLeasesTableTextBlock",
     "nsuri": "http://dermtech.com/20220630",
     "presentation": [
      "http://dermtech.com/role/LeasesCommitmentsandContingenciesTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "dmtk_ScheduleOfLongTermFinanceLeaseObligationsTableTextBlock": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Schedule of long term finance lease obligations.",
        "label": "Schedule Of Long Term Finance Lease Obligations Table [Text Block]",
        "terseLabel": "Schedule of Long Term Finance Lease Obligations"
       }
      }
     },
     "localname": "ScheduleOfLongTermFinanceLeaseObligationsTableTextBlock",
     "nsuri": "http://dermtech.com/20220630",
     "presentation": [
      "http://dermtech.com/role/LeasesCommitmentsandContingenciesTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "dmtk_ScheduleOfPrepaidExpensesAndPropertyAndEquipmentTableTextBlock": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Schedule of prepaid expenses and PP&amp;E.",
        "label": "Schedule Of Prepaid Expenses And Property And Equipment Table [Text Block]",
        "terseLabel": "Schedule of Prepaid Expenses and PP&amp;E"
       }
      }
     },
     "localname": "ScheduleOfPrepaidExpensesAndPropertyAndEquipmentTableTextBlock",
     "nsuri": "http://dermtech.com/20220630",
     "presentation": [
      "http://dermtech.com/role/BalanceSheetDetailsTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "dmtk_SecondAmendmentMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Second Amendment",
        "label": "Second Amendment [Member]",
        "terseLabel": "Second Amendment"
       }
      }
     },
     "localname": "SecondAmendmentMember",
     "nsuri": "http://dermtech.com/20220630",
     "presentation": [
      "http://dermtech.com/role/LeasesCommitmentsandContingenciesAdditionalInformationDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "dmtk_SpecialPurposeAcquisitionCompaniesWarrantsMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Special purpose acquisition companies warrants.",
        "label": "Special Purpose Acquisition Companies Warrants [Member]",
        "terseLabel": "SPAC Warrants"
       }
      }
     },
     "localname": "SpecialPurposeAcquisitionCompaniesWarrantsMember",
     "nsuri": "http://dermtech.com/20220630",
     "presentation": [
      "http://dermtech.com/role/StockholdersEquityAdditionalInformationDetails",
      "http://dermtech.com/role/StockholdersEquitySummaryofCommonStockReservedforFutureIssuanceDetail"
     ],
     "xbrltype": "domainItemType"
    },
    "dmtk_SpecialPurposeAcquisitionCompanyWarrantsToPurchaseCommonStockMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "SPAC warrants to purchase common stock.",
        "label": "Special Purpose Acquisition Company Warrants To Purchase Common Stock [Member]",
        "terseLabel": "SPAC Warrants to purchase common stock*"
       }
      }
     },
     "localname": "SpecialPurposeAcquisitionCompanyWarrantsToPurchaseCommonStockMember",
     "nsuri": "http://dermtech.com/20220630",
     "presentation": [
      "http://dermtech.com/role/StockholdersEquitySummaryofCommonStockReservedforFutureIssuanceDetail"
     ],
     "xbrltype": "domainItemType"
    },
    "dmtk_SpouseOfChiefCommercialOfficerMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Spouse of chief commercial officer.",
        "label": "Spouse Of Chief Commercial Officer [Member]",
        "terseLabel": "Leana Wood"
       }
      }
     },
     "localname": "SpouseOfChiefCommercialOfficerMember",
     "nsuri": "http://dermtech.com/20220630",
     "presentation": [
      "http://dermtech.com/role/RelatedPartyTransactionsAdditionalInformationDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "dmtk_StockIssuedDuringPeriodSharesStockOptionsExercisedAndRSURelease": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Stock issued during period shares stock options exercised and RSU release.",
        "label": "Stock Issued During Period, Shares, Stock Options Exercised And RSU Release",
        "terseLabel": "Issuance of common stock from option exercises and RSU releases (in shares)"
       }
      }
     },
     "localname": "StockIssuedDuringPeriodSharesStockOptionsExercisedAndRSURelease",
     "nsuri": "http://dermtech.com/20220630",
     "presentation": [
      "http://dermtech.com/role/CondensedConsolidatedStatementsofStockholdersEquity"
     ],
     "xbrltype": "sharesItemType"
    },
    "dmtk_StockIssuedDuringPeriodValueStockOptionsExercisedAndRSURelease": {
     "auth_ref": [],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Stock issued during period value stock options exercised and RSU release.",
        "label": "Stock Issued During Period, Value, Stock Options Exercised And RSU Release",
        "terseLabel": "Issuance of common stock from option exercises and RSU releases"
       }
      }
     },
     "localname": "StockIssuedDuringPeriodValueStockOptionsExercisedAndRSURelease",
     "nsuri": "http://dermtech.com/20220630",
     "presentation": [
      "http://dermtech.com/role/CondensedConsolidatedStatementsofStockholdersEquity"
     ],
     "xbrltype": "monetaryItemType"
    },
    "dmtk_StockOptionsAndRestrictedStockUnitsMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Stock options and restricted stock units.",
        "label": "Stock Options And Restricted Stock Units [Member]",
        "terseLabel": "Stock Options and RSUs"
       }
      }
     },
     "localname": "StockOptionsAndRestrictedStockUnitsMember",
     "nsuri": "http://dermtech.com/20220630",
     "presentation": [
      "http://dermtech.com/role/TheCompanyandaSummaryofitsSignificantAccountingPoliciesAdditionalInformationDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "dmtk_StockPurchasedByUnderwritersPursuantToOptionGranted": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Stock purchased by underwriters pursuant to option granted.",
        "label": "Stock Purchased By Underwriters Pursuant To Option Granted",
        "terseLabel": "Shares purchased by underwriters (in shares)"
       }
      }
     },
     "localname": "StockPurchasedByUnderwritersPursuantToOptionGranted",
     "nsuri": "http://dermtech.com/20220630",
     "presentation": [
      "http://dermtech.com/role/StockholdersEquityAdditionalInformationDetails"
     ],
     "xbrltype": "sharesItemType"
    },
    "dmtk_TenantImprovementAllowance": {
     "auth_ref": [],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tenant improvement allowance.",
        "label": "Tenant Improvement Allowance",
        "terseLabel": "Tenant improvement allowance"
       }
      }
     },
     "localname": "TenantImprovementAllowance",
     "nsuri": "http://dermtech.com/20220630",
     "presentation": [
      "http://dermtech.com/role/LeasesCommitmentsandContingenciesAdditionalInformationDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "dmtk_TenantImprovementAllowancePerRentableSquareFoot": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tenant improvement allowance per rentable square foot.",
        "label": "Tenant Improvement Allowance Per Rentable Square Foot",
        "terseLabel": "Tenant improvement allowance per rentable square foot (in usd per square foot)"
       }
      }
     },
     "localname": "TenantImprovementAllowancePerRentableSquareFoot",
     "nsuri": "http://dermtech.com/20220630",
     "presentation": [
      "http://dermtech.com/role/LeasesCommitmentsandContingenciesAdditionalInformationDetails"
     ],
     "xbrltype": "perUnitItemType"
    },
    "dmtk_TheCompanyAndSummaryOfItsSignificantAccountingPoliciesLineItems": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The company and summary of its significant accounting policies.",
        "label": "The Company And Summary Of Its Significant Accounting Policies [Line Items]",
        "terseLabel": "The Company and Summary of its Significant Accounting Policies [Line Items]"
       }
      }
     },
     "localname": "TheCompanyAndSummaryOfItsSignificantAccountingPoliciesLineItems",
     "nsuri": "http://dermtech.com/20220630",
     "presentation": [
      "http://dermtech.com/role/TheCompanyandaSummaryofitsSignificantAccountingPoliciesAdditionalInformationDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "dmtk_TheCompanyAndSummaryOfItsSignificantAccountingPoliciesTable": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The company and summary of its significant accounting policies.",
        "label": "The Company And Summary Of Its Significant Accounting Policies [Table]",
        "terseLabel": "Accounting Policies"
       }
      }
     },
     "localname": "TheCompanyAndSummaryOfItsSignificantAccountingPoliciesTable",
     "nsuri": "http://dermtech.com/20220630",
     "presentation": [
      "http://dermtech.com/role/TheCompanyandaSummaryofitsSignificantAccountingPoliciesAdditionalInformationDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "dmtk_TwoThousandEighteenConvertibleBridgeNotesMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Two thousand eighteen convertible bridge notes.",
        "label": "Two Thousand Eighteen Convertible Bridge Notes [Member]",
        "terseLabel": "2018 Convertible Bridge Notes"
       }
      }
     },
     "localname": "TwoThousandEighteenConvertibleBridgeNotesMember",
     "nsuri": "http://dermtech.com/20220630",
     "presentation": [
      "http://dermtech.com/role/StockholdersEquityAdditionalInformationDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "dmtk_TwoThousandTenStockPlanMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Two thousand ten stock plan.",
        "label": "Two Thousand Ten Stock Plan [Member]",
        "terseLabel": "2010 Stock Plan"
       }
      }
     },
     "localname": "TwoThousandTenStockPlanMember",
     "nsuri": "http://dermtech.com/20220630",
     "presentation": [
      "http://dermtech.com/role/StockholdersEquityAdditionalInformationDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "dmtk_TwoThousandTwentyEmployeeStockPurchasePlanMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Two thousand twenty employee stock purchase plan.",
        "label": "Two Thousand Twenty Employee Stock Purchase Plan [Member]",
        "terseLabel": "2020 Employee Stock Purchase Plan"
       }
      }
     },
     "localname": "TwoThousandTwentyEmployeeStockPurchasePlanMember",
     "nsuri": "http://dermtech.com/20220630",
     "presentation": [
      "http://dermtech.com/role/StockholdersEquityAdditionalInformationDetails",
      "http://dermtech.com/role/StockholdersEquityESPPValuationMethodDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "dmtk_TwoThousandTwentyEquityIncentivePlanMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Two thousand twenty equity incentive plan.",
        "label": "Two Thousand Twenty Equity Incentive Plan [Member]",
        "terseLabel": "2020 Equity Incentive Plan"
       }
      }
     },
     "localname": "TwoThousandTwentyEquityIncentivePlanMember",
     "nsuri": "http://dermtech.com/20220630",
     "presentation": [
      "http://dermtech.com/role/StockholdersEquityAdditionalInformationDetails",
      "http://dermtech.com/role/StockholdersEquityESPPValuationMethodDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "dmtk_UnderwritersGrantPeriodOption": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Underwriters grant period option.",
        "label": "Underwriters Grant Period Option",
        "verboseLabel": "Number of days granted to underwriters option to purchase"
       }
      }
     },
     "localname": "UnderwritersGrantPeriodOption",
     "nsuri": "http://dermtech.com/20220630",
     "presentation": [
      "http://dermtech.com/role/StockholdersEquityAdditionalInformationDetails"
     ],
     "xbrltype": "durationItemType"
    },
    "dmtk_WarrantLiabilityFairValueDisclosure": {
     "auth_ref": [],
     "calculation": {
      "http://dermtech.com/role/TheCompanyandaSummaryofitsSignificantAccountingPoliciesSummaryofAssetsandLiabilitiesMeasuredatFairValueonRecurringBasisDetails": {
       "order": 1.0,
       "parentTag": "us-gaap_LiabilitiesFairValueDisclosure",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Warrant liability fair value disclosure.",
        "label": "Warrant Liability Fair Value Disclosure",
        "terseLabel": "Warrant liability"
       }
      }
     },
     "localname": "WarrantLiabilityFairValueDisclosure",
     "nsuri": "http://dermtech.com/20220630",
     "presentation": [
      "http://dermtech.com/role/TheCompanyandaSummaryofitsSignificantAccountingPoliciesSummaryofAssetsandLiabilitiesMeasuredatFairValueonRecurringBasisDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "dmtk_WarrantLiabilityMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Warrant liability.",
        "label": "Warrant Liability [Member]",
        "terseLabel": "Warrant Liability"
       }
      }
     },
     "localname": "WarrantLiabilityMember",
     "nsuri": "http://dermtech.com/20220630",
     "presentation": [
      "http://dermtech.com/role/TheCompanyandaSummaryofitsSignificantAccountingPoliciesSummaryofChangesinFairValueofLevel3LiabilitiesDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "dmtk_WarrantsToPurchaseCommonStockMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Warrants to purchase common stock.",
        "label": "Warrants To Purchase Common Stock [Member]",
        "terseLabel": "Warrants to purchase common stock"
       }
      }
     },
     "localname": "WarrantsToPurchaseCommonStockMember",
     "nsuri": "http://dermtech.com/20220630",
     "presentation": [
      "http://dermtech.com/role/StockholdersEquitySummaryofCommonStockReservedforFutureIssuanceDetail"
     ],
     "xbrltype": "domainItemType"
    },
    "dmtk_WarrantsVestingPeriod": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Warrants vesting period.",
        "label": "Warrants Vesting Period",
        "terseLabel": "Warrants vesting period"
       }
      }
     },
     "localname": "WarrantsVestingPeriod",
     "nsuri": "http://dermtech.com/20220630",
     "presentation": [
      "http://dermtech.com/role/StockholdersEquityAdditionalInformationDetails"
     ],
     "xbrltype": "durationItemType"
    },
    "dmtk_WeightedAveragePurchasePricePerShareInOffering": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Weighted average purchase price per share in offering.",
        "label": "Weighted Average Purchase Price Per Share In Offering",
        "terseLabel": "Weighted average purchase price per share (in usd per share)"
       }
      }
     },
     "localname": "WeightedAveragePurchasePricePerShareInOffering",
     "nsuri": "http://dermtech.com/20220630",
     "presentation": [
      "http://dermtech.com/role/StockholdersEquityAdditionalInformationDetails"
     ],
     "xbrltype": "perShareItemType"
    },
    "srt_CounterpartyNameAxis": {
     "auth_ref": [
      "r44",
      "r46",
      "r93",
      "r94",
      "r231",
      "r257"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Counterparty Name [Axis]",
        "terseLabel": "Counterparty Name"
       }
      }
     },
     "localname": "CounterpartyNameAxis",
     "nsuri": "http://fasb.org/srt/2022",
     "presentation": [
      "http://dermtech.com/role/LeasesCommitmentsandContingenciesAdditionalInformationDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "srt_CumulativeEffectPeriodOfAdoptionAdjustedBalanceMember": {
     "auth_ref": [
      "r2",
      "r100",
      "r108",
      "r185",
      "r340",
      "r341",
      "r342",
      "r348",
      "r349",
      "r371",
      "r376",
      "r377",
      "r437"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Cumulative Effect, Period of Adoption, Adjusted Balance [Member]",
        "terseLabel": "After Adoption of ASC 842"
       }
      }
     },
     "localname": "CumulativeEffectPeriodOfAdoptionAdjustedBalanceMember",
     "nsuri": "http://fasb.org/srt/2022",
     "presentation": [
      "http://dermtech.com/role/LeasesCommitmentsandContingenciesAdoptionofASC842Details"
     ],
     "xbrltype": "domainItemType"
    },
    "srt_CumulativeEffectPeriodOfAdoptionAdjustmentMember": {
     "auth_ref": [
      "r2",
      "r100",
      "r108",
      "r114",
      "r185",
      "r340",
      "r341",
      "r342",
      "r348",
      "r349",
      "r371",
      "r374",
      "r376",
      "r377",
      "r437"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Cumulative Effect, Period of Adoption, Adjustment [Member]",
        "terseLabel": "Effect of Adoption"
       }
      }
     },
     "localname": "CumulativeEffectPeriodOfAdoptionAdjustmentMember",
     "nsuri": "http://fasb.org/srt/2022",
     "presentation": [
      "http://dermtech.com/role/LeasesCommitmentsandContingenciesAdoptionofASC842Details"
     ],
     "xbrltype": "domainItemType"
    },
    "srt_CumulativeEffectPeriodOfAdoptionAxis": {
     "auth_ref": [
      "r2",
      "r100",
      "r108",
      "r114",
      "r185",
      "r340",
      "r341",
      "r342",
      "r348",
      "r349",
      "r371",
      "r374",
      "r376",
      "r377",
      "r437"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Cumulative Effect, Period of Adoption [Axis]",
        "terseLabel": "Cumulative Effect, Period of Adoption [Axis]"
       }
      }
     },
     "localname": "CumulativeEffectPeriodOfAdoptionAxis",
     "nsuri": "http://fasb.org/srt/2022",
     "presentation": [
      "http://dermtech.com/role/LeasesCommitmentsandContingenciesAdoptionofASC842Details"
     ],
     "xbrltype": "stringItemType"
    },
    "srt_CumulativeEffectPeriodOfAdoptionDomain": {
     "auth_ref": [
      "r2",
      "r100",
      "r108",
      "r114",
      "r185",
      "r340",
      "r341",
      "r342",
      "r348",
      "r349",
      "r371",
      "r374",
      "r376",
      "r377",
      "r437"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Cumulative Effect, Period of Adoption [Domain]",
        "terseLabel": "Cumulative Effect, Period of Adoption [Domain]"
       }
      }
     },
     "localname": "CumulativeEffectPeriodOfAdoptionDomain",
     "nsuri": "http://fasb.org/srt/2022",
     "presentation": [
      "http://dermtech.com/role/LeasesCommitmentsandContingenciesAdoptionofASC842Details"
     ],
     "xbrltype": "domainItemType"
    },
    "srt_MaximumMember": {
     "auth_ref": [
      "r209",
      "r210",
      "r211",
      "r212",
      "r230",
      "r256",
      "r303",
      "r304",
      "r459",
      "r460",
      "r461",
      "r462",
      "r463",
      "r464",
      "r483",
      "r528",
      "r530",
      "r554",
      "r555"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Maximum [Member]",
        "terseLabel": "Maximum"
       }
      }
     },
     "localname": "MaximumMember",
     "nsuri": "http://fasb.org/srt/2022",
     "presentation": [
      "http://dermtech.com/role/LeasesCommitmentsandContingenciesAdditionalInformationDetails",
      "http://dermtech.com/role/RelatedPartyTransactionsAdditionalInformationDetails",
      "http://dermtech.com/role/StockholdersEquityAdditionalInformationDetails",
      "http://dermtech.com/role/StockholdersEquityESPPValuationMethodDetails",
      "http://dermtech.com/role/TheCompanyandaSummaryofitsSignificantAccountingPoliciesAdditionalInformationDetails",
      "http://dermtech.com/role/TheCompanyandaSummaryofitsSignificantAccountingPoliciesAssumptionsUsedtoDetermineFairValueofEachOptiononDateofGrantIssuedDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "srt_MinimumMember": {
     "auth_ref": [
      "r209",
      "r210",
      "r211",
      "r212",
      "r230",
      "r256",
      "r303",
      "r304",
      "r459",
      "r460",
      "r461",
      "r462",
      "r463",
      "r464",
      "r483",
      "r528",
      "r530",
      "r554",
      "r555"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Minimum [Member]",
        "terseLabel": "Minimum"
       }
      }
     },
     "localname": "MinimumMember",
     "nsuri": "http://fasb.org/srt/2022",
     "presentation": [
      "http://dermtech.com/role/StockholdersEquityAdditionalInformationDetails",
      "http://dermtech.com/role/StockholdersEquityESPPValuationMethodDetails",
      "http://dermtech.com/role/TheCompanyandaSummaryofitsSignificantAccountingPoliciesAdditionalInformationDetails",
      "http://dermtech.com/role/TheCompanyandaSummaryofitsSignificantAccountingPoliciesAssumptionsUsedtoDetermineFairValueofEachOptiononDateofGrantIssuedDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "srt_ProductOrServiceAxis": {
     "auth_ref": [
      "r157",
      "r210",
      "r211",
      "r284",
      "r285",
      "r485",
      "r527",
      "r529"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Product and Service [Axis]",
        "terseLabel": "Product and Service"
       }
      }
     },
     "localname": "ProductOrServiceAxis",
     "nsuri": "http://fasb.org/srt/2022",
     "presentation": [
      "http://dermtech.com/role/CondensedConsolidatedStatementsofOperations",
      "http://dermtech.com/role/TheCompanyandaSummaryofitsSignificantAccountingPoliciesAdditionalInformationDetails",
      "http://dermtech.com/role/TheCompanyandaSummaryofitsSignificantAccountingPoliciesScheduleofRevenuesDisaggregatedbyRevenueSourceDetails",
      "http://dermtech.com/role/TheCompanyandaSummaryofitsSignificantAccountingPoliciesSummaryofPercentagesofTotalRevenueorAccountsReceivableforThirdPartyPayersandPharmaceuticalCustomersDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "srt_ProductsAndServicesDomain": {
     "auth_ref": [
      "r157",
      "r210",
      "r211",
      "r284",
      "r285",
      "r485",
      "r527",
      "r529"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Product and Service [Domain]",
        "terseLabel": "Product and Service"
       }
      }
     },
     "localname": "ProductsAndServicesDomain",
     "nsuri": "http://fasb.org/srt/2022",
     "presentation": [
      "http://dermtech.com/role/CondensedConsolidatedStatementsofOperations",
      "http://dermtech.com/role/TheCompanyandaSummaryofitsSignificantAccountingPoliciesAdditionalInformationDetails",
      "http://dermtech.com/role/TheCompanyandaSummaryofitsSignificantAccountingPoliciesScheduleofRevenuesDisaggregatedbyRevenueSourceDetails",
      "http://dermtech.com/role/TheCompanyandaSummaryofitsSignificantAccountingPoliciesSummaryofPercentagesofTotalRevenueorAccountsReceivableforThirdPartyPayersandPharmaceuticalCustomersDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "srt_RangeAxis": {
     "auth_ref": [
      "r206",
      "r209",
      "r210",
      "r211",
      "r212",
      "r230",
      "r256",
      "r293",
      "r303",
      "r304",
      "r333",
      "r334",
      "r335",
      "r459",
      "r460",
      "r461",
      "r462",
      "r463",
      "r464",
      "r483",
      "r528",
      "r530",
      "r554",
      "r555"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Statistical Measurement [Axis]",
        "terseLabel": "Statistical Measurement"
       }
      }
     },
     "localname": "RangeAxis",
     "nsuri": "http://fasb.org/srt/2022",
     "presentation": [
      "http://dermtech.com/role/LeasesCommitmentsandContingenciesAdditionalInformationDetails",
      "http://dermtech.com/role/RelatedPartyTransactionsAdditionalInformationDetails",
      "http://dermtech.com/role/StockholdersEquityAdditionalInformationDetails",
      "http://dermtech.com/role/StockholdersEquityESPPValuationMethodDetails",
      "http://dermtech.com/role/TheCompanyandaSummaryofitsSignificantAccountingPoliciesAdditionalInformationDetails",
      "http://dermtech.com/role/TheCompanyandaSummaryofitsSignificantAccountingPoliciesAssumptionsUsedtoDetermineFairValueofEachOptiononDateofGrantIssuedDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "srt_RangeMember": {
     "auth_ref": [
      "r206",
      "r209",
      "r210",
      "r211",
      "r212",
      "r230",
      "r256",
      "r293",
      "r303",
      "r304",
      "r333",
      "r334",
      "r335",
      "r459",
      "r460",
      "r461",
      "r462",
      "r463",
      "r464",
      "r483",
      "r528",
      "r530",
      "r554",
      "r555"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Statistical Measurement [Domain]",
        "terseLabel": "Statistical Measurement"
       }
      }
     },
     "localname": "RangeMember",
     "nsuri": "http://fasb.org/srt/2022",
     "presentation": [
      "http://dermtech.com/role/LeasesCommitmentsandContingenciesAdditionalInformationDetails",
      "http://dermtech.com/role/RelatedPartyTransactionsAdditionalInformationDetails",
      "http://dermtech.com/role/StockholdersEquityAdditionalInformationDetails",
      "http://dermtech.com/role/StockholdersEquityESPPValuationMethodDetails",
      "http://dermtech.com/role/TheCompanyandaSummaryofitsSignificantAccountingPoliciesAdditionalInformationDetails",
      "http://dermtech.com/role/TheCompanyandaSummaryofitsSignificantAccountingPoliciesAssumptionsUsedtoDetermineFairValueofEachOptiononDateofGrantIssuedDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "srt_RepurchaseAgreementCounterpartyNameDomain": {
     "auth_ref": [
      "r45",
      "r46",
      "r93",
      "r94",
      "r231",
      "r257"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Counterparty Name [Domain]",
        "terseLabel": "Counterparty Name"
       }
      }
     },
     "localname": "RepurchaseAgreementCounterpartyNameDomain",
     "nsuri": "http://fasb.org/srt/2022",
     "presentation": [
      "http://dermtech.com/role/LeasesCommitmentsandContingenciesAdditionalInformationDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_AccountingPoliciesAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Accounting Policies [Abstract]",
        "terseLabel": "Accounting Policies [Abstract]"
       }
      }
     },
     "localname": "AccountingPoliciesAbstract",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "xbrltype": "stringItemType"
    },
    "us-gaap_AccountingStandardsUpdate201602Member": {
     "auth_ref": [
      "r411"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Accounting Standards Update 2016-02 Leases (Topic 842).",
        "label": "Accounting Standards Update 2016-02 [Member]",
        "terseLabel": "Accounting Standards Update 2016-02"
       }
      }
     },
     "localname": "AccountingStandardsUpdate201602Member",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://dermtech.com/role/LeasesCommitmentsandContingenciesAdoptionofASC842Details"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_AccountsPayableCurrent": {
     "auth_ref": [
      "r37",
      "r450"
     ],
     "calculation": {
      "http://dermtech.com/role/CondensedConsolidatedBalanceSheets": {
       "order": 1.0,
       "parentTag": "us-gaap_LiabilitiesCurrent",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Carrying value as of the balance sheet date of liabilities incurred (and for which invoices have typically been received) and payable to vendors for goods and services received that are used in an entity's business. Used to reflect the current portion of the liabilities (due within one year or within the normal operating cycle if longer).",
        "label": "Accounts Payable, Current",
        "terseLabel": "Accounts payable"
       }
      }
     },
     "localname": "AccountsPayableCurrent",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://dermtech.com/role/CondensedConsolidatedBalanceSheets"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_AccountsReceivableGrossCurrent": {
     "auth_ref": [
      "r10",
      "r26",
      "r160",
      "r161"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount, before allowance for credit loss, of right to consideration from customer for product sold and service rendered in normal course of business, classified as current.",
        "label": "Accounts Receivable, before Allowance for Credit Loss, Current",
        "terseLabel": "Accounts receivable gross"
       }
      }
     },
     "localname": "AccountsReceivableGrossCurrent",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://dermtech.com/role/TheCompanyandaSummaryofitsSignificantAccountingPoliciesAdditionalInformationDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_AccountsReceivableMember": {
     "auth_ref": [
      "r551"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Due from customers or clients for goods or services that have been delivered or sold.",
        "label": "Accounts Receivable [Member]",
        "terseLabel": "Accounts Receivable"
       }
      }
     },
     "localname": "AccountsReceivableMember",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://dermtech.com/role/TheCompanyandaSummaryofitsSignificantAccountingPoliciesSummaryofPercentagesofTotalRevenueorAccountsReceivableforThirdPartyPayersandPharmaceuticalCustomersDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_AccountsReceivableNetCurrent": {
     "auth_ref": [
      "r160",
      "r161"
     ],
     "calculation": {
      "http://dermtech.com/role/CondensedConsolidatedBalanceSheets": {
       "order": 3.0,
       "parentTag": "us-gaap_AssetsCurrent",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount, after allowance for credit loss, of right to consideration from customer for product sold and service rendered in normal course of business, classified as current.",
        "label": "Accounts Receivable, after Allowance for Credit Loss, Current",
        "terseLabel": "Accounts receivable"
       }
      }
     },
     "localname": "AccountsReceivableNetCurrent",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://dermtech.com/role/CondensedConsolidatedBalanceSheets",
      "http://dermtech.com/role/TheCompanyandaSummaryofitsSignificantAccountingPoliciesAdditionalInformationDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_AccretionAmortizationOfDiscountsAndPremiumsInvestments": {
     "auth_ref": [
      "r79"
     ],
     "calculation": {
      "http://dermtech.com/role/CondensedConsolidatedStatementsofCashFlows": {
       "order": 13.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": -1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The sum of the periodic adjustments of the differences between securities' face values and purchase prices that are charged against earnings. This is called accretion if the security was purchased at a discount and amortization if it was purchased at premium. As a noncash item, this element is an adjustment to net income when calculating cash provided by or used in operations using the indirect method.",
        "label": "Accretion (Amortization) of Discounts and Premiums, Investments",
        "negatedLabel": "Amortization of premiums, net of accretion of discounts on marketable securities"
       }
      }
     },
     "localname": "AccretionAmortizationOfDiscountsAndPremiumsInvestments",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://dermtech.com/role/CondensedConsolidatedStatementsofCashFlows"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_AccruedLiabilitiesCurrent": {
     "auth_ref": [
      "r39"
     ],
     "calculation": {
      "http://dermtech.com/role/BalanceSheetDetailsScheduleofAccruedCompensationandAccruedLiabilitiesDetails": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      },
      "http://dermtech.com/role/CondensedConsolidatedBalanceSheets": {
       "order": 3.0,
       "parentTag": "us-gaap_LiabilitiesCurrent",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Carrying value as of the balance sheet date of obligations incurred and payable, pertaining to costs that are statutory in nature, are incurred on contractual obligations, or accumulate over time and for which invoices have not yet been received or will not be rendered. Examples include taxes, interest, rent and utilities. Used to reflect the current portion of the liabilities (due within one year or within the normal operating cycle if longer).",
        "label": "Accrued Liabilities, Current",
        "terseLabel": "Accrued liabilities",
        "totalLabel": "Total accrued liabilities"
       }
      }
     },
     "localname": "AccruedLiabilitiesCurrent",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://dermtech.com/role/BalanceSheetDetailsScheduleofAccruedCompensationandAccruedLiabilitiesDetails",
      "http://dermtech.com/role/CondensedConsolidatedBalanceSheets"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_AccruedLiabilitiesCurrentAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Accrued Liabilities, Current [Abstract]",
        "terseLabel": "Accrued liabilities:"
       }
      }
     },
     "localname": "AccruedLiabilitiesCurrentAbstract",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://dermtech.com/role/BalanceSheetDetailsScheduleofAccruedCompensationandAccruedLiabilitiesDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_AccruedVacationCurrent": {
     "auth_ref": [
      "r39",
      "r292"
     ],
     "calculation": {
      "http://dermtech.com/role/BalanceSheetDetailsScheduleofAccruedCompensationandAccruedLiabilitiesDetails": {
       "order": 1.0,
       "parentTag": "us-gaap_EmployeeRelatedLiabilitiesCurrent",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Carrying value as of the balance sheet date of obligations incurred and payable for unused vacation time owed to employees based on the entity's vacation benefit given to its employees. Used to reflect the current portion of the liabilities (due within one year or within the normal operating cycle if longer).",
        "label": "Accrued Vacation, Current",
        "terseLabel": "Accrued paid time off"
       }
      }
     },
     "localname": "AccruedVacationCurrent",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://dermtech.com/role/BalanceSheetDetailsScheduleofAccruedCompensationandAccruedLiabilitiesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment": {
     "auth_ref": [
      "r16",
      "r203"
     ],
     "calculation": {
      "http://dermtech.com/role/BalanceSheetDetailsScheduleofPrepaidExpensesandPPEDetails": {
       "order": 2.0,
       "parentTag": "us-gaap_PropertyPlantAndEquipmentNet",
       "weight": -1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of accumulated depreciation, depletion and amortization for physical assets used in the normal conduct of business to produce goods and services.",
        "label": "Accumulated Depreciation, Depletion and Amortization, Property, Plant, and Equipment",
        "negatedLabel": "Less accumulated depreciation"
       }
      }
     },
     "localname": "AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://dermtech.com/role/BalanceSheetDetailsScheduleofPrepaidExpensesandPPEDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_AccumulatedNetUnrealizedInvestmentGainLossMember": {
     "auth_ref": [
      "r48",
      "r49",
      "r50",
      "r53",
      "r59",
      "r60",
      "r61"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Accumulated unrealized gain (loss) on investment in debt security measured at fair value with change in fair value recognized in other comprehensive income (available-for-sale), attributable to parent.",
        "label": "AOCI, Accumulated Gain (Loss), Debt Securities, Available-for-Sale, Parent [Member]",
        "terseLabel": "Accumulated other comprehensive income/(loss)"
       }
      }
     },
     "localname": "AccumulatedNetUnrealizedInvestmentGainLossMember",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://dermtech.com/role/CondensedConsolidatedStatementsofStockholdersEquity"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax": {
     "auth_ref": [
      "r29",
      "r51",
      "r52",
      "r53",
      "r519",
      "r538",
      "r542"
     ],
     "calculation": {
      "http://dermtech.com/role/CondensedConsolidatedBalanceSheets": {
       "order": 3.0,
       "parentTag": "us-gaap_StockholdersEquity",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Accumulated change in equity from transactions and other events and circumstances from non-owner sources, net of tax effect, at period end. Excludes Net Income (Loss), and accumulated changes in equity from transactions resulting from investments by owners and distributions to owners. Includes foreign currency translation items, certain pension adjustments, unrealized gains and losses on certain investments in debt and equity securities, other than temporary impairment (OTTI) losses related to factors other than credit losses on available-for-sale and held-to-maturity debt securities that an entity does not intend to sell and it is not more likely than not that the entity will be required to sell before recovery of the amortized cost basis, as well as changes in the fair value of derivatives related to the effective portion of a designated cash flow hedge.",
        "label": "Accumulated Other Comprehensive Income (Loss), Net of Tax",
        "terseLabel": "Accumulated other comprehensive loss"
       }
      }
     },
     "localname": "AccumulatedOtherComprehensiveIncomeLossNetOfTax",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://dermtech.com/role/CondensedConsolidatedBalanceSheets"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_AdditionalPaidInCapitalCommonStock": {
     "auth_ref": [
      "r27"
     ],
     "calculation": {
      "http://dermtech.com/role/CondensedConsolidatedBalanceSheets": {
       "order": 2.0,
       "parentTag": "us-gaap_StockholdersEquity",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Value received from shareholders in common stock-related transactions that are in excess of par value or stated value and amounts received from other stock-related transactions. Includes only common stock transactions (excludes preferred stock transactions). May be called contributed capital, capital in excess of par, capital surplus, or paid-in capital.",
        "label": "Additional Paid in Capital, Common Stock",
        "terseLabel": "Additional paid-in capital"
       }
      }
     },
     "localname": "AdditionalPaidInCapitalCommonStock",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://dermtech.com/role/CondensedConsolidatedBalanceSheets"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_AdditionalPaidInCapitalMember": {
     "auth_ref": [
      "r97",
      "r98",
      "r99",
      "r340",
      "r341",
      "r342",
      "r376"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Excess of issue price over par or stated value of the entity's capital stock and amounts received from other transactions involving the entity's stock or stockholders.",
        "label": "Additional Paid-in Capital [Member]",
        "terseLabel": "Additional paid-in capital"
       }
      }
     },
     "localname": "AdditionalPaidInCapitalMember",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://dermtech.com/role/CondensedConsolidatedStatementsofStockholdersEquity"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_AdjustmentsForNewAccountingPronouncementsAxis": {
     "auth_ref": [
      "r0",
      "r1",
      "r2",
      "r3",
      "r4",
      "r101",
      "r102",
      "r103",
      "r104",
      "r114",
      "r167",
      "r168",
      "r182",
      "r183",
      "r184",
      "r185",
      "r186",
      "r187",
      "r340",
      "r341",
      "r342",
      "r346",
      "r347",
      "r348",
      "r349",
      "r350",
      "r351",
      "r352",
      "r368",
      "r369",
      "r370",
      "r371",
      "r372",
      "r373",
      "r374",
      "r375",
      "r376",
      "r377",
      "r378",
      "r379",
      "r393",
      "r394",
      "r395",
      "r396",
      "r397",
      "r398",
      "r399",
      "r400",
      "r408",
      "r409",
      "r412",
      "r413",
      "r414",
      "r415",
      "r434",
      "r435",
      "r436",
      "r437",
      "r438",
      "r439",
      "r486",
      "r487",
      "r488",
      "r531",
      "r532",
      "r533",
      "r534",
      "r535",
      "r536",
      "r537",
      "r538",
      "r539",
      "r540",
      "r541",
      "r542"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by amendment to accounting standards.",
        "label": "Accounting Standards Update [Axis]",
        "terseLabel": "Accounting Standards Update [Axis]"
       }
      }
     },
     "localname": "AdjustmentsForNewAccountingPronouncementsAxis",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://dermtech.com/role/LeasesCommitmentsandContingenciesAdoptionofASC842Details"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue": {
     "auth_ref": [
      "r306",
      "r343",
      "r344"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of increase to additional paid-in capital (APIC) for recognition of cost for award under share-based payment arrangement.",
        "label": "APIC, Share-Based Payment Arrangement, Increase for Cost Recognition",
        "terseLabel": "Stock-based compensation"
       }
      }
     },
     "localname": "AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://dermtech.com/role/CondensedConsolidatedStatementsofStockholdersEquity"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_AdjustmentsToAdditionalPaidInCapitalStockIssuedIssuanceCosts": {
     "auth_ref": [
      "r270",
      "r277"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of decrease in additional paid in capital (APIC) resulting from direct costs associated with issuing stock. Includes, but is not limited to, legal and accounting fees and direct costs associated with stock issues under a shelf registration.",
        "label": "Adjustments to Additional Paid in Capital, Stock Issued, Issuance Costs",
        "verboseLabel": "Issuance costs"
       }
      }
     },
     "localname": "AdjustmentsToAdditionalPaidInCapitalStockIssuedIssuanceCosts",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://dermtech.com/role/CondensedConsolidatedStatementsofStockholdersEquityParenthetical"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_AdjustmentsToAdditionalPaidInCapitalWarrantIssued": {
     "auth_ref": [
      "r226",
      "r270",
      "r277"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of increase in additional paid in capital (APIC) resulting from the issuance of warrants. Includes allocation of proceeds of debt securities issued with detachable stock purchase warrants.",
        "label": "Adjustments to Additional Paid in Capital, Warrant Issued",
        "terseLabel": "Issuance of common stock from warrant exercises"
       }
      }
     },
     "localname": "AdjustmentsToAdditionalPaidInCapitalWarrantIssued",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://dermtech.com/role/CondensedConsolidatedStatementsofStockholdersEquity"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Adjustments to Reconcile Net Income (Loss) to Cash Provided by (Used in) Operating Activities [Abstract]",
        "terseLabel": "Adjustments to reconcile net loss to net cash used in operating activities:",
        "verboseLabel": "Adjustments to reconcile net loss to net cash used in operating activities:"
       }
      }
     },
     "localname": "AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://dermtech.com/role/CondensedConsolidatedStatementsofCashFlows",
      "http://dermtech.com/role/LeasesCommitmentsandContingenciesAdoptionofASC842Details"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_AllocatedShareBasedCompensationExpense": {
     "auth_ref": [
      "r337"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of expense for award under share-based payment arrangement. Excludes amount capitalized.",
        "label": "Share-Based Payment Arrangement, Expense",
        "terseLabel": "Total stock-based compensation"
       }
      }
     },
     "localname": "AllocatedShareBasedCompensationExpense",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://dermtech.com/role/StockholdersEquityShareBasedCompensationExpenseDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount": {
     "auth_ref": [
      "r122"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Securities (including those issuable pursuant to contingent stock agreements) that could potentially dilute basic earnings per share (EPS) or earnings per unit (EPU) in the future that were not included in the computation of diluted EPS or EPU because to do so would increase EPS or EPU amounts or decrease loss per share or unit amounts for the period presented.",
        "label": "Antidilutive Securities Excluded from Computation of Earnings Per Share, Amount",
        "terseLabel": "Anti-dilutive equity instruments excluded from diluted net loss per share of common stock"
       }
      }
     },
     "localname": "AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://dermtech.com/role/TheCompanyandaSummaryofitsSignificantAccountingPoliciesAdditionalInformationDetails"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis": {
     "auth_ref": [
      "r122"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by type of antidilutive security.",
        "label": "Antidilutive Securities [Axis]",
        "terseLabel": "Antidilutive Securities"
       }
      }
     },
     "localname": "AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://dermtech.com/role/TheCompanyandaSummaryofitsSignificantAccountingPoliciesAdditionalInformationDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_AntidilutiveSecuritiesNameDomain": {
     "auth_ref": [
      "r122"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Incremental common shares attributable to securities that were not included in diluted earnings per share (EPS) because to do so would increase EPS amounts or decrease loss per share amounts for the period presented.",
        "label": "Antidilutive Securities, Name [Domain]",
        "terseLabel": "Antidilutive Securities, Name"
       }
      }
     },
     "localname": "AntidilutiveSecuritiesNameDomain",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://dermtech.com/role/TheCompanyandaSummaryofitsSignificantAccountingPoliciesAdditionalInformationDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_Assets": {
     "auth_ref": [
      "r18",
      "r92",
      "r146",
      "r149",
      "r155",
      "r181",
      "r215",
      "r216",
      "r217",
      "r218",
      "r219",
      "r220",
      "r221",
      "r222",
      "r223",
      "r224",
      "r225",
      "r355",
      "r359",
      "r392",
      "r448",
      "r450",
      "r502",
      "r517"
     ],
     "calculation": {
      "http://dermtech.com/role/CondensedConsolidatedBalanceSheets": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Sum of the carrying amounts as of the balance sheet date of all assets that are recognized. Assets are probable future economic benefits obtained or controlled by an entity as a result of past transactions or events.",
        "label": "Assets",
        "totalLabel": "Total assets"
       }
      }
     },
     "localname": "Assets",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://dermtech.com/role/CondensedConsolidatedBalanceSheets"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_AssetsAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Assets [Abstract]",
        "terseLabel": "Assets"
       }
      }
     },
     "localname": "AssetsAbstract",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://dermtech.com/role/CondensedConsolidatedBalanceSheets"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_AssetsCurrent": {
     "auth_ref": [
      "r12",
      "r35",
      "r92",
      "r181",
      "r215",
      "r216",
      "r217",
      "r218",
      "r219",
      "r220",
      "r221",
      "r222",
      "r223",
      "r224",
      "r225",
      "r355",
      "r359",
      "r392",
      "r448",
      "r450"
     ],
     "calculation": {
      "http://dermtech.com/role/CondensedConsolidatedBalanceSheets": {
       "order": 1.0,
       "parentTag": "us-gaap_Assets",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Sum of the carrying amounts as of the balance sheet date of all assets that are expected to be realized in cash, sold, or consumed within one year (or the normal operating cycle, if longer). Assets are probable future economic benefits obtained or controlled by an entity as a result of past transactions or events.",
        "label": "Assets, Current",
        "totalLabel": "Total current assets"
       }
      }
     },
     "localname": "AssetsCurrent",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://dermtech.com/role/CondensedConsolidatedBalanceSheets"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_AssetsCurrentAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Assets, Current [Abstract]",
        "terseLabel": "Current assets:"
       }
      }
     },
     "localname": "AssetsCurrentAbstract",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://dermtech.com/role/CondensedConsolidatedBalanceSheets"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_AssetsFairValueDisclosure": {
     "auth_ref": [
      "r380"
     ],
     "calculation": {
      "http://dermtech.com/role/TheCompanyandaSummaryofitsSignificantAccountingPoliciesSummaryofAssetsandLiabilitiesMeasuredatFairValueonRecurringBasisDetails": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Fair value portion of probable future economic benefits obtained or controlled by an entity as a result of past transactions or events.",
        "label": "Assets, Fair Value Disclosure",
        "totalLabel": "Total assets measured at fair value on a recurring basis"
       }
      }
     },
     "localname": "AssetsFairValueDisclosure",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://dermtech.com/role/TheCompanyandaSummaryofitsSignificantAccountingPoliciesSummaryofAssetsandLiabilitiesMeasuredatFairValueonRecurringBasisDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_AssetsFairValueDisclosureAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Assets, Fair Value Disclosure [Abstract]",
        "terseLabel": "Assets:"
       }
      }
     },
     "localname": "AssetsFairValueDisclosureAbstract",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://dermtech.com/role/TheCompanyandaSummaryofitsSignificantAccountingPoliciesSummaryofAssetsandLiabilitiesMeasuredatFairValueonRecurringBasisDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax": {
     "auth_ref": [
      "r173"
     ],
     "calculation": {
      "http://dermtech.com/role/BalanceSheetDetailsScheduleofShortTermMarketableSecuritiesDetails": {
       "order": 1.0,
       "parentTag": "us-gaap_AvailableForSaleDebtSecuritiesAmortizedCostBasis",
       "weight": -1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount, before tax, of unrealized gain in accumulated other comprehensive income (AOCI) on investment in debt security measured at fair value with change in fair value recognized in other comprehensive income (available-for-sale).",
        "label": "Debt Securities, Available-for-Sale, Accumulated Gross Unrealized Gain, before Tax",
        "terseLabel": "Gross Unrealized Gains"
       }
      }
     },
     "localname": "AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://dermtech.com/role/BalanceSheetDetailsScheduleofShortTermMarketableSecuritiesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax": {
     "auth_ref": [
      "r174"
     ],
     "calculation": {
      "http://dermtech.com/role/BalanceSheetDetailsScheduleofShortTermMarketableSecuritiesDetails": {
       "order": 2.0,
       "parentTag": "us-gaap_AvailableForSaleDebtSecuritiesAmortizedCostBasis",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount, before tax, of unrealized loss in accumulated other comprehensive income (AOCI) on investment in debt security measured at fair value with change in fair value recognized in other comprehensive income (available-for-sale).",
        "label": "Debt Securities, Available-for-Sale, Accumulated Gross Unrealized Loss, before Tax",
        "negatedLabel": "Gross Unrealized Losses"
       }
      }
     },
     "localname": "AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://dermtech.com/role/BalanceSheetDetailsScheduleofShortTermMarketableSecuritiesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_AvailableForSaleDebtSecuritiesAmortizedCostBasis": {
     "auth_ref": [
      "r171",
      "r193"
     ],
     "calculation": {
      "http://dermtech.com/role/BalanceSheetDetailsScheduleofShortTermMarketableSecuritiesDetails": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amortized cost of investment in debt security measured at fair value with change in fair value recognized in other comprehensive income (available-for-sale).",
        "label": "Debt Securities, Available-for-Sale, Amortized Cost",
        "totalLabel": "Amortized Cost"
       }
      }
     },
     "localname": "AvailableForSaleDebtSecuritiesAmortizedCostBasis",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://dermtech.com/role/BalanceSheetDetailsScheduleofShortTermMarketableSecuritiesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_AvailableForSaleSecuritiesDebtSecurities": {
     "auth_ref": [
      "r169",
      "r172",
      "r193",
      "r506"
     ],
     "calculation": {
      "http://dermtech.com/role/BalanceSheetDetailsScheduleofShortTermMarketableSecuritiesDetails": {
       "order": 3.0,
       "parentTag": "us-gaap_AvailableForSaleDebtSecuritiesAmortizedCostBasis",
       "weight": 1.0
      },
      "http://dermtech.com/role/TheCompanyandaSummaryofitsSignificantAccountingPoliciesSummaryofAssetsandLiabilitiesMeasuredatFairValueonRecurringBasisDetails": {
       "order": 3.0,
       "parentTag": "us-gaap_AssetsFairValueDisclosure",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of investment in debt security measured at fair value with change in fair value recognized in other comprehensive income (available-for-sale).",
        "label": "Debt Securities, Available-for-Sale",
        "terseLabel": "Total marketable securities, available for sale",
        "verboseLabel": "Estimated Market Value"
       }
      }
     },
     "localname": "AvailableForSaleSecuritiesDebtSecurities",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://dermtech.com/role/BalanceSheetDetailsScheduleofShortTermMarketableSecuritiesDetails",
      "http://dermtech.com/role/TheCompanyandaSummaryofitsSignificantAccountingPoliciesSummaryofAssetsandLiabilitiesMeasuredatFairValueonRecurringBasisDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_AwardTypeAxis": {
     "auth_ref": [
      "r310",
      "r311",
      "r312",
      "r313",
      "r314",
      "r315",
      "r316",
      "r317",
      "r318",
      "r319",
      "r320",
      "r321",
      "r322",
      "r323",
      "r324",
      "r325",
      "r326",
      "r327",
      "r328",
      "r329",
      "r330",
      "r332",
      "r333",
      "r334",
      "r335",
      "r336"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by type of award under share-based payment arrangement.",
        "label": "Award Type [Axis]",
        "terseLabel": "Award Type"
       }
      }
     },
     "localname": "AwardTypeAxis",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://dermtech.com/role/StockholdersEquityAdditionalInformationDetails",
      "http://dermtech.com/role/StockholdersEquitySummaryofCommonStockReservedforFutureIssuanceDetail"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_BalanceSheetLocationAxis": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by location on balance sheet (statement of financial position).",
        "label": "Balance Sheet Location [Axis]",
        "terseLabel": "Balance Sheet Location"
       }
      }
     },
     "localname": "BalanceSheetLocationAxis",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://dermtech.com/role/TheCompanyandaSummaryofitsSignificantAccountingPoliciesAdditionalInformationDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_BalanceSheetLocationDomain": {
     "auth_ref": [
      "r364",
      "r365"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Location in the balance sheet (statement of financial position).",
        "label": "Balance Sheet Location [Domain]",
        "terseLabel": "Balance Sheet Location"
       }
      }
     },
     "localname": "BalanceSheetLocationDomain",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://dermtech.com/role/TheCompanyandaSummaryofitsSignificantAccountingPoliciesAdditionalInformationDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_BasisOfAccountingPolicyPolicyTextBlock": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disclosure of accounting policy for basis of accounting, or basis of presentation, used to prepare the financial statements (for example, US Generally Accepted Accounting Principles, Other Comprehensive Basis of Accounting, IFRS).",
        "label": "Basis of Accounting, Policy [Policy Text Block]",
        "terseLabel": "Basis of Presentation"
       }
      }
     },
     "localname": "BasisOfAccountingPolicyPolicyTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://dermtech.com/role/TheCompanyandaSummaryofitsSignificantAccountingPoliciesPolicies"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_CapitalExpendituresIncurredButNotYetPaid": {
     "auth_ref": [
      "r83",
      "r84",
      "r85"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Future cash outflow to pay for purchases of fixed assets that have occurred.",
        "label": "Capital Expenditures Incurred but Not yet Paid",
        "terseLabel": "Purchases of property and equipment recorded in accounts payable"
       }
      }
     },
     "localname": "CapitalExpendituresIncurredButNotYetPaid",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://dermtech.com/role/CondensedConsolidatedStatementsofCashFlows"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_CashAndCashEquivalentsAtCarryingValue": {
     "auth_ref": [
      "r8",
      "r14",
      "r80"
     ],
     "calculation": {
      "http://dermtech.com/role/CondensedConsolidatedBalanceSheets": {
       "order": 1.0,
       "parentTag": "us-gaap_AssetsCurrent",
       "weight": 1.0
      },
      "http://dermtech.com/role/CondensedConsolidatedStatementsofCashFlows": {
       "order": 1.0,
       "parentTag": "us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of currency on hand as well as demand deposits with banks or financial institutions. Includes other kinds of accounts that have the general characteristics of demand deposits. Also includes short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates. Excludes cash and cash equivalents within disposal group and discontinued operation.",
        "label": "Cash and Cash Equivalents, at Carrying Value",
        "terseLabel": "Cash and cash equivalents"
       }
      }
     },
     "localname": "CashAndCashEquivalentsAtCarryingValue",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://dermtech.com/role/CondensedConsolidatedBalanceSheets",
      "http://dermtech.com/role/CondensedConsolidatedStatementsofCashFlows"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_CashAndCashEquivalentsRestrictedCashAndCashEquivalentsPolicy": {
     "auth_ref": [
      "r81",
      "r501"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Entity's cash and cash equivalents accounting policy with respect to restricted balances. Restrictions may include legally restricted deposits held as compensating balances against short-term borrowing arrangements, contracts entered into with others, or company statements of intention with regard to particular deposits; however, time deposits and short-term certificates of deposit are not generally included in legally restricted deposits.",
        "label": "Cash and Cash Equivalents, Restricted Cash and Cash Equivalents, Policy [Policy Text Block]",
        "terseLabel": "Cash, Cash Equivalents and Restricted Cash"
       }
      }
     },
     "localname": "CashAndCashEquivalentsRestrictedCashAndCashEquivalentsPolicy",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://dermtech.com/role/TheCompanyandaSummaryofitsSignificantAccountingPoliciesPolicies"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents": {
     "auth_ref": [
      "r74",
      "r80",
      "r86"
     ],
     "calculation": {
      "http://dermtech.com/role/CondensedConsolidatedStatementsofCashFlows": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of cash and cash equivalents, and cash and cash equivalents restricted to withdrawal or usage. Excludes amount for disposal group and discontinued operations. Cash includes, but is not limited to, currency on hand, demand deposits with banks or financial institutions, and other accounts with general characteristics of demand deposits. Cash equivalents include, but are not limited to, short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates.",
        "label": "Cash, Cash Equivalents, Restricted Cash, and Restricted Cash Equivalents",
        "totalLabel": "Total cash, cash equivalents and restricted cash"
       }
      }
     },
     "localname": "CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://dermtech.com/role/CondensedConsolidatedStatementsofCashFlows"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations": {
     "auth_ref": [
      "r74",
      "r80",
      "r86"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of cash and cash equivalents, and cash and cash equivalents restricted to withdrawal or usage; including, but not limited to, disposal group and discontinued operations. Cash includes, but is not limited to, currency on hand, demand deposits with banks or financial institutions, and other accounts with general characteristics of demand deposits. Cash equivalents include, but are not limited to, short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates.",
        "label": "Cash, Cash Equivalents, Restricted Cash, and Restricted Cash Equivalents, Including Disposal Group and Discontinued Operations",
        "periodEndLabel": "Cash, cash equivalents and restricted cash, end of period",
        "periodStartLabel": "Cash, cash equivalents and restricted cash, beginning of period"
       }
      }
     },
     "localname": "CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://dermtech.com/role/CondensedConsolidatedStatementsofCashFlows"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect": {
     "auth_ref": [
      "r74",
      "r401"
     ],
     "calculation": {
      "http://dermtech.com/role/CondensedConsolidatedStatementsofCashFlows": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of increase (decrease) in cash, cash equivalents, and cash and cash equivalents restricted to withdrawal or usage; including effect from exchange rate change. Cash includes, but is not limited to, currency on hand, demand deposits with banks or financial institutions, and other accounts with general characteristics of demand deposits. Cash equivalents include, but are not limited to, short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates.",
        "label": "Cash, Cash Equivalents, Restricted Cash, and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect",
        "totalLabel": "Net (decrease)/increase in cash, cash equivalents and restricted cash"
       }
      }
     },
     "localname": "CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://dermtech.com/role/CondensedConsolidatedStatementsofCashFlows"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_CashEquivalentsAtCarryingValue": {
     "auth_ref": [
      "r14"
     ],
     "calculation": {
      "http://dermtech.com/role/TheCompanyandaSummaryofitsSignificantAccountingPoliciesSummaryofAssetsandLiabilitiesMeasuredatFairValueonRecurringBasisDetails": {
       "order": 1.0,
       "parentTag": "us-gaap_AssetsFairValueDisclosure",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates. Excludes cash and cash equivalents within disposal group and discontinued operation.",
        "label": "Cash Equivalents, at Carrying Value",
        "terseLabel": "Cash equivalents"
       }
      }
     },
     "localname": "CashEquivalentsAtCarryingValue",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://dermtech.com/role/TheCompanyandaSummaryofitsSignificantAccountingPoliciesSummaryofAssetsandLiabilitiesMeasuredatFairValueonRecurringBasisDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_CashFDICInsuredAmount": {
     "auth_ref": [],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The amount of cash deposited in financial institutions as of the balance sheet date that is insured by the Federal Deposit Insurance Corporation.",
        "label": "Cash, FDIC Insured Amount",
        "terseLabel": "Insured amount by FDIC"
       }
      }
     },
     "localname": "CashFDICInsuredAmount",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://dermtech.com/role/TheCompanyandaSummaryofitsSignificantAccountingPoliciesAdditionalInformationDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_CashUninsuredAmount": {
     "auth_ref": [],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The amount of cash as of the balance sheet date that is not insured by the Federal Deposit Insurance Corporation.",
        "label": "Cash, Uninsured Amount",
        "terseLabel": "Cash held in excess of FDIC limit"
       }
      }
     },
     "localname": "CashUninsuredAmount",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://dermtech.com/role/TheCompanyandaSummaryofitsSignificantAccountingPoliciesAdditionalInformationDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_ClassOfStockLineItems": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.",
        "label": "Class of Stock [Line Items]",
        "terseLabel": "Class of Stock [Line Items]"
       }
      }
     },
     "localname": "ClassOfStockLineItems",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://dermtech.com/role/StockholdersEquityAdditionalInformationDetails",
      "http://dermtech.com/role/StockholdersEquityESPPValuationMethodDetails",
      "http://dermtech.com/role/StockholdersEquitySummaryofCommonStockReservedforFutureIssuanceDetail"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_ClassOfWarrantOrRightAxis": {
     "auth_ref": [
      "r279",
      "r308"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by type of warrant or right issued.",
        "label": "Class of Warrant or Right [Axis]",
        "terseLabel": "Class of Warrant or Right"
       }
      }
     },
     "localname": "ClassOfWarrantOrRightAxis",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://dermtech.com/role/StockholdersEquityAdditionalInformationDetails",
      "http://dermtech.com/role/StockholdersEquitySummaryofCommonStockReservedforFutureIssuanceDetail"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_ClassOfWarrantOrRightDomain": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Name of the class or type of warrant or right outstanding. Warrants and rights represent derivative securities that give the holder the right to purchase securities (usually equity) from the issuer at a specific price within a certain time frame. Warrants are often included in a new debt issue to entice investors by a higher return potential. The main difference between warrants and call options is that warrants are issued and guaranteed by the company, whereas options are exchange instruments and are not issued by the company. Also, the lifetime of a warrant is often measured in years, while the lifetime of a typical option is measured in months.",
        "label": "Class of Warrant or Right [Domain]",
        "terseLabel": "Class of Warrant or Right"
       }
      }
     },
     "localname": "ClassOfWarrantOrRightDomain",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://dermtech.com/role/StockholdersEquityAdditionalInformationDetails",
      "http://dermtech.com/role/StockholdersEquitySummaryofCommonStockReservedforFutureIssuanceDetail"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1": {
     "auth_ref": [
      "r271"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Exercise price per share or per unit of warrants or rights outstanding.",
        "label": "Class of Warrant or Right, Exercise Price of Warrants or Rights",
        "terseLabel": "Exercise price of warrant (in usd per share)"
       }
      }
     },
     "localname": "ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://dermtech.com/role/StockholdersEquityAdditionalInformationDetails"
     ],
     "xbrltype": "perShareItemType"
    },
    "us-gaap_ClassOfWarrantOrRightNumberOfSecuritiesCalledByEachWarrantOrRight": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Number of securities into which each warrant or right may be converted. For example, but not limited to, each warrant may be converted into two shares.",
        "label": "Class of Warrant or Right, Number of Securities Called by Each Warrant or Right",
        "terseLabel": "Number of shares issued for each warrant (in shares)"
       }
      }
     },
     "localname": "ClassOfWarrantOrRightNumberOfSecuritiesCalledByEachWarrantOrRight",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://dermtech.com/role/StockholdersEquityAdditionalInformationDetails"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights": {
     "auth_ref": [
      "r271"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Number of securities into which the class of warrant or right may be converted. For example, but not limited to, 500,000 warrants may be converted into 1,000,000 shares.",
        "label": "Class of Warrant or Right, Number of Securities Called by Warrants or Rights",
        "terseLabel": "Total number exercised of public warrants (in shares)"
       }
      }
     },
     "localname": "ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://dermtech.com/role/StockholdersEquityAdditionalInformationDetails"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_ClassOfWarrantOrRightOutstanding": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Number of warrants or rights outstanding.",
        "label": "Class of Warrant or Right, Outstanding",
        "terseLabel": "Warrants outstanding (in shares)"
       }
      }
     },
     "localname": "ClassOfWarrantOrRightOutstanding",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://dermtech.com/role/StockholdersEquityAdditionalInformationDetails"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_CommitmentsAndContingenciesDisclosureAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Commitments and Contingencies Disclosure [Abstract]",
        "terseLabel": "Commitments and Contingencies Disclosure [Abstract]"
       }
      }
     },
     "localname": "CommitmentsAndContingenciesDisclosureAbstract",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "xbrltype": "stringItemType"
    },
    "us-gaap_CommitmentsDisclosureTextBlock": {
     "auth_ref": [
      "r208"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The entire disclosure for significant arrangements with third parties, which includes operating lease arrangements and arrangements in which the entity has agreed to expend funds to procure goods or services, or has agreed to commit resources to supply goods or services, and operating lease arrangements. Descriptions may include identification of the specific goods and services, period of time covered, minimum quantities and amounts, and cancellation rights.",
        "label": "Commitments Disclosure [Text Block]",
        "terseLabel": "Leases, Commitments and Contingencies"
       }
      }
     },
     "localname": "CommitmentsDisclosureTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://dermtech.com/role/LeasesCommitmentsandContingencies"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_CommonStockCapitalSharesReservedForFutureIssuance": {
     "auth_ref": [
      "r42"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Aggregate number of common shares reserved for future issuance.",
        "label": "Common Stock, Capital Shares Reserved for Future Issuance",
        "terseLabel": "Total common stock reserved for future issuance",
        "verboseLabel": "Common stock available for issuance (in shares)"
       }
      }
     },
     "localname": "CommonStockCapitalSharesReservedForFutureIssuance",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://dermtech.com/role/StockholdersEquityAdditionalInformationDetails",
      "http://dermtech.com/role/StockholdersEquitySummaryofCommonStockReservedforFutureIssuanceDetail"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_CommonStockMember": {
     "auth_ref": [
      "r97",
      "r98",
      "r376"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Stock that is subordinate to all other stock of the issuer.",
        "label": "Common Stock [Member]",
        "terseLabel": "Common stock",
        "verboseLabel": "Common stock"
       }
      }
     },
     "localname": "CommonStockMember",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://dermtech.com/role/CondensedConsolidatedStatementsofStockholdersEquity",
      "http://dermtech.com/role/CondensedConsolidatedStatementsofStockholdersEquityParenthetical",
      "http://dermtech.com/role/StockholdersEquityAdditionalInformationDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_CommonStockParOrStatedValuePerShare": {
     "auth_ref": [
      "r25"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Face amount or stated value per share of common stock.",
        "label": "Common Stock, Par or Stated Value Per Share",
        "terseLabel": "Common stock, par value per share (in usd per share)",
        "verboseLabel": "Common stock, par value per share (in usd per share)"
       }
      }
     },
     "localname": "CommonStockParOrStatedValuePerShare",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://dermtech.com/role/CondensedConsolidatedBalanceSheetsParenthetical",
      "http://dermtech.com/role/StockholdersEquityAdditionalInformationDetails"
     ],
     "xbrltype": "perShareItemType"
    },
    "us-gaap_CommonStockSharesAuthorized": {
     "auth_ref": [
      "r25"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The maximum number of common shares permitted to be issued by an entity's charter and bylaws.",
        "label": "Common Stock, Shares Authorized",
        "terseLabel": "Common stock, shares authorized (in shares)"
       }
      }
     },
     "localname": "CommonStockSharesAuthorized",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://dermtech.com/role/CondensedConsolidatedBalanceSheetsParenthetical",
      "http://dermtech.com/role/StockholdersEquityAdditionalInformationDetails"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_CommonStockSharesIssued": {
     "auth_ref": [
      "r25"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Total number of common shares of an entity that have been sold or granted to shareholders (includes common shares that were issued, repurchased and remain in the treasury). These shares represent capital invested by the firm's shareholders and owners, and may be all or only a portion of the number of shares authorized. Shares issued include shares outstanding and shares held in the treasury.",
        "label": "Common Stock, Shares, Issued",
        "terseLabel": "Common stock, shares issued (in shares)"
       }
      }
     },
     "localname": "CommonStockSharesIssued",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://dermtech.com/role/CondensedConsolidatedBalanceSheetsParenthetical",
      "http://dermtech.com/role/RelatedPartyTransactionsAdditionalInformationDetails",
      "http://dermtech.com/role/StockholdersEquityAdditionalInformationDetails"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_CommonStockSharesOutstanding": {
     "auth_ref": [
      "r25",
      "r270"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Number of shares of common stock outstanding. Common stock represent the ownership interest in a corporation.",
        "label": "Common Stock, Shares, Outstanding",
        "terseLabel": "Common stock, shares outstanding (in shares)"
       }
      }
     },
     "localname": "CommonStockSharesOutstanding",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://dermtech.com/role/CondensedConsolidatedBalanceSheetsParenthetical"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_CommonStockValue": {
     "auth_ref": [
      "r25",
      "r450"
     ],
     "calculation": {
      "http://dermtech.com/role/CondensedConsolidatedBalanceSheets": {
       "order": 1.0,
       "parentTag": "us-gaap_StockholdersEquity",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Aggregate par or stated value of issued nonredeemable common stock (or common stock redeemable solely at the option of the issuer). This item includes treasury stock repurchased by the entity. Note: elements for number of nonredeemable common shares, par value and other disclosure concepts are in another section within stockholders' equity.",
        "label": "Common Stock, Value, Issued",
        "terseLabel": "Common stock, $0.0001 par value per share; 50,000,000 shares authorized as of June\u00a030, 2022 and December\u00a031, 2021; 30,038,447 and 29,772,922 shares issued and outstanding at June\u00a030, 2022 and December\u00a031, 2021, respectively"
       }
      }
     },
     "localname": "CommonStockValue",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://dermtech.com/role/CondensedConsolidatedBalanceSheets"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_ComprehensiveIncomeNetOfTax": {
     "auth_ref": [
      "r55",
      "r57",
      "r58",
      "r63",
      "r510",
      "r525"
     ],
     "calculation": {
      "http://dermtech.com/role/CondensedConsolidatedStatementsofComprehensiveLoss": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount after tax of increase (decrease) in equity from transactions and other events and circumstances from net income and other comprehensive income, attributable to parent entity. Excludes changes in equity resulting from investments by owners and distributions to owners.",
        "label": "Comprehensive Income (Loss), Net of Tax, Attributable to Parent",
        "totalLabel": "Comprehensive loss"
       }
      }
     },
     "localname": "ComprehensiveIncomeNetOfTax",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://dermtech.com/role/CondensedConsolidatedStatementsofComprehensiveLoss"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_ConcentrationRiskBenchmarkDomain": {
     "auth_ref": [
      "r138",
      "r139",
      "r159",
      "r390",
      "r391",
      "r551"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The denominator in a calculation of a disclosed concentration risk percentage.",
        "label": "Concentration Risk Benchmark [Domain]",
        "terseLabel": "Concentration Risk Benchmark"
       }
      }
     },
     "localname": "ConcentrationRiskBenchmarkDomain",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://dermtech.com/role/TheCompanyandaSummaryofitsSignificantAccountingPoliciesSummaryofPercentagesofTotalRevenueorAccountsReceivableforThirdPartyPayersandPharmaceuticalCustomersDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_ConcentrationRiskByBenchmarkAxis": {
     "auth_ref": [
      "r138",
      "r139",
      "r159",
      "r390",
      "r391",
      "r544",
      "r551"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by benchmark of concentration risk.",
        "label": "Concentration Risk Benchmark [Axis]",
        "terseLabel": "Concentration Risk Benchmark"
       }
      }
     },
     "localname": "ConcentrationRiskByBenchmarkAxis",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://dermtech.com/role/TheCompanyandaSummaryofitsSignificantAccountingPoliciesSummaryofPercentagesofTotalRevenueorAccountsReceivableforThirdPartyPayersandPharmaceuticalCustomersDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_ConcentrationRiskByTypeAxis": {
     "auth_ref": [
      "r138",
      "r139",
      "r159",
      "r390",
      "r391",
      "r544",
      "r551"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by type of concentration risk, for example, but not limited to, asset, liability, net assets, geographic, customer, employees, supplier, lender.",
        "label": "Concentration Risk Type [Axis]",
        "terseLabel": "Concentration Risk Type"
       }
      }
     },
     "localname": "ConcentrationRiskByTypeAxis",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://dermtech.com/role/TheCompanyandaSummaryofitsSignificantAccountingPoliciesSummaryofPercentagesofTotalRevenueorAccountsReceivableforThirdPartyPayersandPharmaceuticalCustomersDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_ConcentrationRiskCreditRisk": {
     "auth_ref": [
      "r134",
      "r515"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disclosure of accounting policy for credit risk.",
        "label": "Concentration Risk, Credit Risk, Policy [Policy Text Block]",
        "terseLabel": "Concentration of Credit Risk"
       }
      }
     },
     "localname": "ConcentrationRiskCreditRisk",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://dermtech.com/role/TheCompanyandaSummaryofitsSignificantAccountingPoliciesPolicies"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_ConcentrationRiskPercentage1": {
     "auth_ref": [
      "r138",
      "r139",
      "r159",
      "r390",
      "r391"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "For an entity that discloses a concentration risk in relation to quantitative amount, which serves as the \"benchmark\" (or denominator) in the equation, this concept represents the concentration percentage derived from the division.",
        "label": "Concentration Risk, Percentage",
        "terseLabel": "Concentration risk, percentage"
       }
      }
     },
     "localname": "ConcentrationRiskPercentage1",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://dermtech.com/role/TheCompanyandaSummaryofitsSignificantAccountingPoliciesSummaryofPercentagesofTotalRevenueorAccountsReceivableforThirdPartyPayersandPharmaceuticalCustomersDetails"
     ],
     "xbrltype": "percentItemType"
    },
    "us-gaap_ConcentrationRiskTypeDomain": {
     "auth_ref": [
      "r138",
      "r139",
      "r159",
      "r390",
      "r391",
      "r551"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "For an entity that discloses a concentration risk as a percentage of some financial balance or benchmark, identifies the type (for example, asset, liability, net assets, geographic, customer, employees, supplier, lender) of the concentration.",
        "label": "Concentration Risk Type [Domain]",
        "terseLabel": "Concentration Risk Type"
       }
      }
     },
     "localname": "ConcentrationRiskTypeDomain",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://dermtech.com/role/TheCompanyandaSummaryofitsSignificantAccountingPoliciesSummaryofPercentagesofTotalRevenueorAccountsReceivableforThirdPartyPayersandPharmaceuticalCustomersDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_ConstructionInProgressGross": {
     "auth_ref": [
      "r202"
     ],
     "calculation": {
      "http://dermtech.com/role/BalanceSheetDetailsScheduleofPrepaidExpensesandPPEDetails": {
       "order": 4.0,
       "parentTag": "us-gaap_PropertyPlantAndEquipmentGross",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of structure or a modification to a structure under construction. Includes recently completed structures or modifications to structures that have not been placed into service.",
        "label": "Construction in Progress, Gross",
        "terseLabel": "Construction-in-progress"
       }
      }
     },
     "localname": "ConstructionInProgressGross",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://dermtech.com/role/BalanceSheetDetailsScheduleofPrepaidExpensesandPPEDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_CorporateDebtSecuritiesMember": {
     "auth_ref": [
      "r294",
      "r302",
      "r543"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Debt securities issued by domestic or foreign corporate business, banks and other entities with a promise of repayment.",
        "label": "Corporate Debt Securities [Member]",
        "terseLabel": "Corporate debt securities"
       }
      }
     },
     "localname": "CorporateDebtSecuritiesMember",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://dermtech.com/role/BalanceSheetDetailsScheduleofShortTermMarketableSecuritiesDetails",
      "http://dermtech.com/role/TheCompanyandaSummaryofitsSignificantAccountingPoliciesSummaryofAssetsandLiabilitiesMeasuredatFairValueonRecurringBasisDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_CostOfRevenue": {
     "auth_ref": [
      "r67",
      "r92",
      "r181",
      "r215",
      "r216",
      "r217",
      "r219",
      "r220",
      "r221",
      "r222",
      "r223",
      "r224",
      "r225",
      "r392"
     ],
     "calculation": {
      "http://dermtech.com/role/CondensedConsolidatedStatementsofOperations": {
       "order": 2.0,
       "parentTag": "us-gaap_GrossProfit",
       "weight": -1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The aggregate cost of goods produced and sold and services rendered during the reporting period.",
        "label": "Cost of Revenue",
        "terseLabel": "Total cost of revenues"
       }
      }
     },
     "localname": "CostOfRevenue",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://dermtech.com/role/CondensedConsolidatedStatementsofOperations"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_CostOfRevenueAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Cost of Revenue [Abstract]",
        "terseLabel": "Cost of revenues:"
       }
      }
     },
     "localname": "CostOfRevenueAbstract",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://dermtech.com/role/CondensedConsolidatedStatementsofOperations"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_CostOfSalesMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Primary financial statement caption encompassing cost of sales.",
        "label": "Cost of Sales [Member]",
        "terseLabel": "Cost of revenue"
       }
      }
     },
     "localname": "CostOfSalesMember",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://dermtech.com/role/StockholdersEquityShareBasedCompensationExpenseDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_CreditFacilityAxis": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by type of credit facility. Credit facilities provide capital to borrowers without the need to structure a loan for each borrowing.",
        "label": "Credit Facility [Axis]",
        "terseLabel": "Credit Facility"
       }
      }
     },
     "localname": "CreditFacilityAxis",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://dermtech.com/role/LeasesCommitmentsandContingenciesAdditionalInformationDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_CreditFacilityDomain": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Type of credit facility. Credit facilities provide capital to borrowers without the need to structure a loan for each borrowing.",
        "label": "Credit Facility [Domain]",
        "terseLabel": "Credit Facility"
       }
      }
     },
     "localname": "CreditFacilityDomain",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://dermtech.com/role/LeasesCommitmentsandContingenciesAdditionalInformationDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_CustomerConcentrationRiskMember": {
     "auth_ref": [
      "r137",
      "r159"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Reflects the percentage that revenues in the period from one or more significant customers is to net revenues, as defined by the entity, such as total net revenues, product line revenues, segment revenues. The risk is the materially adverse effects of loss of a significant customer.",
        "label": "Customer Concentration Risk [Member]",
        "terseLabel": "Customer Concentration Risk"
       }
      }
     },
     "localname": "CustomerConcentrationRiskMember",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://dermtech.com/role/TheCompanyandaSummaryofitsSignificantAccountingPoliciesSummaryofPercentagesofTotalRevenueorAccountsReceivableforThirdPartyPayersandPharmaceuticalCustomersDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_DebtInstrumentAxis": {
     "auth_ref": [
      "r19",
      "r20",
      "r21",
      "r91",
      "r95",
      "r227",
      "r228",
      "r229",
      "r230",
      "r231",
      "r232",
      "r233",
      "r234",
      "r235",
      "r236",
      "r237",
      "r238",
      "r239",
      "r240",
      "r241",
      "r242",
      "r243",
      "r245",
      "r246",
      "r247",
      "r248",
      "r410",
      "r503",
      "r504",
      "r516"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by type of debt instrument, including, but not limited to, draws against credit facilities.",
        "label": "Debt Instrument [Axis]",
        "terseLabel": "Debt Instrument"
       }
      }
     },
     "localname": "DebtInstrumentAxis",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://dermtech.com/role/StockholdersEquityAdditionalInformationDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_DebtInstrumentNameDomain": {
     "auth_ref": [
      "r41",
      "r91",
      "r95",
      "r227",
      "r228",
      "r229",
      "r230",
      "r231",
      "r232",
      "r233",
      "r234",
      "r235",
      "r236",
      "r237",
      "r238",
      "r239",
      "r240",
      "r241",
      "r242",
      "r243",
      "r245",
      "r246",
      "r247",
      "r248",
      "r410"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The name for the particular debt instrument or borrowing that distinguishes it from other debt instruments or borrowings, including draws against credit facilities.",
        "label": "Debt Instrument, Name [Domain]",
        "terseLabel": "Debt Instrument, Name"
       }
      }
     },
     "localname": "DebtInstrumentNameDomain",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://dermtech.com/role/StockholdersEquityAdditionalInformationDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_DebtSecuritiesAvailableForSaleTableTextBlock": {
     "auth_ref": [
      "r177"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of investment in debt security measured at fair value with change in fair value recognized in other comprehensive income (available-for-sale).",
        "label": "Debt Securities, Available-for-Sale [Table Text Block]",
        "terseLabel": "Schedule of Short-Term Marketable Securities"
       }
      }
     },
     "localname": "DebtSecuritiesAvailableForSaleTableTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://dermtech.com/role/BalanceSheetDetailsTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_DeferredRevenueCurrent": {
     "auth_ref": [
      "r20"
     ],
     "calculation": {
      "http://dermtech.com/role/CondensedConsolidatedBalanceSheets": {
       "order": 4.0,
       "parentTag": "us-gaap_LiabilitiesCurrent",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of deferred income and obligation to transfer product and service to customer for which consideration has been received or is receivable, classified as current.",
        "label": "Deferred Revenue, Current",
        "verboseLabel": "Short-term deferred revenue"
       }
      }
     },
     "localname": "DeferredRevenueCurrent",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://dermtech.com/role/CondensedConsolidatedBalanceSheets",
      "http://dermtech.com/role/TheCompanyandaSummaryofitsSignificantAccountingPoliciesAdditionalInformationDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DemandDepositsMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Accounts that may or may not bear interest and that depositor is entitled to withdraw at anytime without prior notice. Checking and negotiable order of withdrawal (NOW) accounts are the most common forms of demand deposits.",
        "label": "Demand Deposits [Member]",
        "terseLabel": "Demand Deposits"
       }
      }
     },
     "localname": "DemandDepositsMember",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://dermtech.com/role/LeasesCommitmentsandContingenciesAdditionalInformationDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_DepositsMoneyMarketDeposits": {
     "auth_ref": [
      "r507"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of deposits in accounts that offer many of the same services as checking accounts although transactions may be somewhat more limited, share some of the characteristics of a money market fund and are insured by the Federal government, also known as money market accounts.",
        "label": "Deposits, Money Market Deposits",
        "terseLabel": "Sweep account"
       }
      }
     },
     "localname": "DepositsMoneyMarketDeposits",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://dermtech.com/role/TheCompanyandaSummaryofitsSignificantAccountingPoliciesAdditionalInformationDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_Depreciation": {
     "auth_ref": [
      "r78",
      "r201"
     ],
     "calculation": {
      "http://dermtech.com/role/CondensedConsolidatedStatementsofCashFlows": {
       "order": 11.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The amount of expense recognized in the current period that reflects the allocation of the cost of tangible assets over the assets' useful lives. Includes production and non-production related depreciation.",
        "label": "Depreciation",
        "terseLabel": "Depreciation",
        "verboseLabel": "Depreciation expense"
       }
      }
     },
     "localname": "Depreciation",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://dermtech.com/role/CondensedConsolidatedStatementsofCashFlows",
      "http://dermtech.com/role/TheCompanyandaSummaryofitsSignificantAccountingPoliciesAdditionalInformationDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DepreciationAndAmortization": {
     "auth_ref": [
      "r78",
      "r201"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The current period expense charged against earnings on long-lived, physical assets not used in production, and which are not intended for resale, to allocate or recognize the cost of such assets over their useful lives; or to record the reduction in book value of an intangible asset over the benefit period of such asset; or to reflect consumption during the period of an asset that is not used in production.",
        "label": "Depreciation, Depletion and Amortization, Nonproduction",
        "terseLabel": "Accumulated amortization",
        "verboseLabel": "Accumulated amortization"
       }
      }
     },
     "localname": "DepreciationAndAmortization",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://dermtech.com/role/LeasesCommitmentsandContingenciesAdditionalInformationDetails",
      "http://dermtech.com/role/TheCompanyandaSummaryofitsSignificantAccountingPoliciesAdditionalInformationDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DisaggregationOfRevenueLineItems": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.",
        "label": "Disaggregation of Revenue [Line Items]",
        "terseLabel": "Disaggregation Of Revenue [Line Items]"
       }
      }
     },
     "localname": "DisaggregationOfRevenueLineItems",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://dermtech.com/role/TheCompanyandaSummaryofitsSignificantAccountingPoliciesScheduleofRevenuesDisaggregatedbyRevenueSourceDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_DisaggregationOfRevenueTable": {
     "auth_ref": [
      "r284",
      "r285",
      "r286",
      "r287",
      "r288",
      "r289",
      "r290",
      "r291"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disclosure of information about disaggregation of revenue into categories depicting how nature, amount, timing, and uncertainty of revenue and cash flows are affected by economic factor.",
        "label": "Disaggregation of Revenue [Table]",
        "terseLabel": "Disaggregation Of Revenue [Table]"
       }
      }
     },
     "localname": "DisaggregationOfRevenueTable",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://dermtech.com/role/TheCompanyandaSummaryofitsSignificantAccountingPoliciesScheduleofRevenuesDisaggregatedbyRevenueSourceDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_DisaggregationOfRevenueTableTextBlock": {
     "auth_ref": [
      "r284"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of disaggregation of revenue into categories depicting how nature, amount, timing, and uncertainty of revenue and cash flows are affected by economic factor.",
        "label": "Disaggregation of Revenue [Table Text Block]",
        "terseLabel": "Schedule of Revenues Disaggregated by Revenue Source"
       }
      }
     },
     "localname": "DisaggregationOfRevenueTableTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://dermtech.com/role/TheCompanyandaSummaryofitsSignificantAccountingPoliciesTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_DisclosureOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTextBlock": {
     "auth_ref": [
      "r309",
      "r339"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of share-based payment arrangement.",
        "label": "Disclosure of Share-Based Compensation Arrangements by Share-Based Payment Award [Table Text Block]",
        "terseLabel": "Disclosure of Share-Based Compensation Arrangements by Share-Based Payment Award"
       }
      }
     },
     "localname": "DisclosureOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://dermtech.com/role/StockholdersEquityTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_EarningsPerShareBasic": {
     "auth_ref": [
      "r64",
      "r106",
      "r107",
      "r108",
      "r109",
      "r110",
      "r115",
      "r117",
      "r119",
      "r120",
      "r121",
      "r124",
      "r125",
      "r377",
      "r378",
      "r511",
      "r526"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The amount of net income (loss) for the period per each share of common stock or unit outstanding during the reporting period.",
        "label": "Earnings Per Share, Basic",
        "terseLabel": "Net loss per share of common stock outstanding, basic (in usd per share)"
       }
      }
     },
     "localname": "EarningsPerShareBasic",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://dermtech.com/role/CondensedConsolidatedStatementsofOperations"
     ],
     "xbrltype": "perShareItemType"
    },
    "us-gaap_EarningsPerShareDiluted": {
     "auth_ref": [
      "r64",
      "r106",
      "r107",
      "r108",
      "r109",
      "r110",
      "r117",
      "r119",
      "r120",
      "r121",
      "r124",
      "r125",
      "r377",
      "r378",
      "r511",
      "r526"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The amount of net income (loss) for the period available to each share of common stock or common unit outstanding during the reporting period and to each share or unit that would have been outstanding assuming the issuance of common shares or units for all dilutive potential common shares or units outstanding during the reporting period.",
        "label": "Earnings Per Share, Diluted",
        "terseLabel": "Net loss per share of common stock outstanding, diluted (in usd per share)"
       }
      }
     },
     "localname": "EarningsPerShareDiluted",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://dermtech.com/role/CondensedConsolidatedStatementsofOperations"
     ],
     "xbrltype": "perShareItemType"
    },
    "us-gaap_EarningsPerSharePolicyTextBlock": {
     "auth_ref": [
      "r122",
      "r123"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disclosure of accounting policy for computing basic and diluted earnings or loss per share for each class of common stock and participating security. Addresses all significant policy factors, including any antidilutive items that have been excluded from the computation and takes into account stock dividends, splits and reverse splits that occur after the balance sheet date of the latest reporting period but before the issuance of the financial statements.",
        "label": "Earnings Per Share, Policy [Policy Text Block]",
        "terseLabel": "Net Loss Per Share"
       }
      }
     },
     "localname": "EarningsPerSharePolicyTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://dermtech.com/role/TheCompanyandaSummaryofitsSignificantAccountingPoliciesPolicies"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_EmployeeRelatedLiabilitiesCurrent": {
     "auth_ref": [
      "r39"
     ],
     "calculation": {
      "http://dermtech.com/role/BalanceSheetDetailsScheduleofAccruedCompensationandAccruedLiabilitiesDetails": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      },
      "http://dermtech.com/role/CondensedConsolidatedBalanceSheets": {
       "order": 2.0,
       "parentTag": "us-gaap_LiabilitiesCurrent",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Total of the carrying values as of the balance sheet date of obligations incurred through that date and payable for obligations related to services received from employees, such as accrued salaries and bonuses, payroll taxes and fringe benefits. Used to reflect the current portion of the liabilities (due within one year or within the normal operating cycle if longer).",
        "label": "Employee-related Liabilities, Current",
        "terseLabel": "Accrued compensation",
        "totalLabel": "Total accrued compensation"
       }
      }
     },
     "localname": "EmployeeRelatedLiabilitiesCurrent",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://dermtech.com/role/BalanceSheetDetailsScheduleofAccruedCompensationandAccruedLiabilitiesDetails",
      "http://dermtech.com/role/CondensedConsolidatedBalanceSheets"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_EmployeeRelatedLiabilitiesCurrentAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Employee-related Liabilities, Current [Abstract]",
        "terseLabel": "Accrued compensation:"
       }
      }
     },
     "localname": "EmployeeRelatedLiabilitiesCurrentAbstract",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://dermtech.com/role/BalanceSheetDetailsScheduleofAccruedCompensationandAccruedLiabilitiesDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized": {
     "auth_ref": [
      "r338"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of cost not yet recognized for nonvested award under share-based payment arrangement.",
        "label": "Share-Based Payment Arrangement, Nonvested Award, Cost Not yet Recognized, Amount",
        "terseLabel": "Compensation cost related to non-vested awards not yet recognized"
       }
      }
     },
     "localname": "EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://dermtech.com/role/StockholdersEquityAdditionalInformationDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1": {
     "auth_ref": [
      "r338"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Weighted-average period over which cost not yet recognized is expected to be recognized for award under share-based payment arrangement, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents reported fact of one year, five months, and thirteen days.",
        "label": "Share-Based Payment Arrangement, Nonvested Award, Cost Not yet Recognized, Period for Recognition",
        "terseLabel": "Weighted average term expected to be recognized"
       }
      }
     },
     "localname": "EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://dermtech.com/role/StockholdersEquityAdditionalInformationDetails"
     ],
     "xbrltype": "durationItemType"
    },
    "us-gaap_EmployeeStockOptionMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Share-based payment arrangement granting right, subject to vesting and other restrictions, to purchase or sell certain number of shares at predetermined price for specified period of time.",
        "label": "Share-Based Payment Arrangement, Option [Member]",
        "terseLabel": "Stock options issued and outstanding"
       }
      }
     },
     "localname": "EmployeeStockOptionMember",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://dermtech.com/role/StockholdersEquitySummaryofCommonStockReservedforFutureIssuanceDetail"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_EquityAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Equity [Abstract]"
       }
      }
     },
     "localname": "EquityAbstract",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "xbrltype": "stringItemType"
    },
    "us-gaap_EquityComponentDomain": {
     "auth_ref": [
      "r2",
      "r59",
      "r60",
      "r61",
      "r97",
      "r98",
      "r99",
      "r102",
      "r111",
      "r113",
      "r128",
      "r185",
      "r270",
      "r277",
      "r340",
      "r341",
      "r342",
      "r348",
      "r349",
      "r376",
      "r402",
      "r403",
      "r404",
      "r405",
      "r406",
      "r407",
      "r439",
      "r533",
      "r534",
      "r535"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Components of equity are the parts of the total Equity balance including that which is allocated to common, preferred, treasury stock, retained earnings, etc.",
        "label": "Equity Component [Domain]",
        "terseLabel": "Equity Component"
       }
      }
     },
     "localname": "EquityComponentDomain",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://dermtech.com/role/CondensedConsolidatedStatementsofStockholdersEquity",
      "http://dermtech.com/role/CondensedConsolidatedStatementsofStockholdersEquityParenthetical",
      "http://dermtech.com/role/StockholdersEquityAdditionalInformationDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_FairValueAdjustmentOfWarrants": {
     "auth_ref": [
      "r78",
      "r249"
     ],
     "calculation": {
      "http://dermtech.com/role/CondensedConsolidatedStatementsofCashFlows": {
       "order": 1.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": 1.0
      },
      "http://dermtech.com/role/CondensedConsolidatedStatementsofOperations": {
       "order": 2.0,
       "parentTag": "us-gaap_NonoperatingIncomeExpense",
       "weight": -1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of expense (income) related to adjustment to fair value of warrant liability.",
        "label": "Fair Value Adjustment of Warrants",
        "negatedLabel": "Change in fair value of warrant liability",
        "terseLabel": "Change in fair value of warrant liability"
       }
      }
     },
     "localname": "FairValueAdjustmentOfWarrants",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://dermtech.com/role/CondensedConsolidatedStatementsofCashFlows",
      "http://dermtech.com/role/CondensedConsolidatedStatementsofOperations"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.",
        "label": "Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]",
        "terseLabel": "Fair Value Assets And Liabilities Measured On Recurring And Nonrecurring Basis [Line Items]"
       }
      }
     },
     "localname": "FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://dermtech.com/role/TheCompanyandaSummaryofitsSignificantAccountingPoliciesSummaryofAssetsandLiabilitiesMeasuredatFairValueonRecurringBasisDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable": {
     "auth_ref": [
      "r380",
      "r381",
      "r387"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disclosure of information about asset and liability measured at fair value on recurring and nonrecurring basis.",
        "label": "Fair Value, Recurring and Nonrecurring [Table]",
        "terseLabel": "Fair Value Assets And Liabilities Measured On Recurring And Nonrecurring Basis [Table]"
       }
      }
     },
     "localname": "FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://dermtech.com/role/TheCompanyandaSummaryofitsSignificantAccountingPoliciesSummaryofAssetsandLiabilitiesMeasuredatFairValueonRecurringBasisDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_FairValueByFairValueHierarchyLevelAxis": {
     "auth_ref": [
      "r236",
      "r245",
      "r246",
      "r294",
      "r295",
      "r296",
      "r297",
      "r298",
      "r299",
      "r300",
      "r302",
      "r381",
      "r456",
      "r457",
      "r458"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by level within fair value hierarchy and fair value measured at net asset value per share as practical expedient.",
        "label": "Fair Value Hierarchy and NAV [Axis]",
        "terseLabel": "Fair Value Hierarchy and NAV"
       }
      }
     },
     "localname": "FairValueByFairValueHierarchyLevelAxis",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://dermtech.com/role/TheCompanyandaSummaryofitsSignificantAccountingPoliciesAdditionalInformationDetails",
      "http://dermtech.com/role/TheCompanyandaSummaryofitsSignificantAccountingPoliciesSummaryofAssetsandLiabilitiesMeasuredatFairValueonRecurringBasisDetails",
      "http://dermtech.com/role/TheCompanyandaSummaryofitsSignificantAccountingPoliciesSummaryofChangesinFairValueofLevel3LiabilitiesDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_FairValueByLiabilityClassAxis": {
     "auth_ref": [
      "r386",
      "r387"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by class of liability.",
        "label": "Liability Class [Axis]",
        "terseLabel": "Liability Class"
       }
      }
     },
     "localname": "FairValueByLiabilityClassAxis",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://dermtech.com/role/TheCompanyandaSummaryofitsSignificantAccountingPoliciesSummaryofChangesinFairValueofLevel3LiabilitiesDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_FairValueByMeasurementFrequencyAxis": {
     "auth_ref": [
      "r380",
      "r381",
      "r382",
      "r383",
      "r388"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by measurement frequency.",
        "label": "Measurement Frequency [Axis]",
        "terseLabel": "Measurement Frequency"
       }
      }
     },
     "localname": "FairValueByMeasurementFrequencyAxis",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://dermtech.com/role/TheCompanyandaSummaryofitsSignificantAccountingPoliciesSummaryofAssetsandLiabilitiesMeasuredatFairValueonRecurringBasisDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_FairValueInputsLevel1Member": {
     "auth_ref": [
      "r236",
      "r294",
      "r295",
      "r300",
      "r302",
      "r381",
      "r456"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Quoted prices in active markets for identical assets or liabilities that the reporting entity can access at the measurement date.",
        "label": "Fair Value, Inputs, Level 1 [Member]",
        "terseLabel": "Level 1"
       }
      }
     },
     "localname": "FairValueInputsLevel1Member",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://dermtech.com/role/TheCompanyandaSummaryofitsSignificantAccountingPoliciesAdditionalInformationDetails",
      "http://dermtech.com/role/TheCompanyandaSummaryofitsSignificantAccountingPoliciesSummaryofAssetsandLiabilitiesMeasuredatFairValueonRecurringBasisDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_FairValueInputsLevel2Member": {
     "auth_ref": [
      "r236",
      "r245",
      "r246",
      "r294",
      "r295",
      "r300",
      "r302",
      "r381",
      "r457"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Inputs other than quoted prices included within level 1 that are observable for an asset or liability, either directly or indirectly, including, but not limited to, quoted prices for similar assets or liabilities in active markets, or quoted prices for identical or similar assets or liabilities in inactive markets.",
        "label": "Fair Value, Inputs, Level 2 [Member]",
        "terseLabel": "Level 2"
       }
      }
     },
     "localname": "FairValueInputsLevel2Member",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://dermtech.com/role/TheCompanyandaSummaryofitsSignificantAccountingPoliciesSummaryofAssetsandLiabilitiesMeasuredatFairValueonRecurringBasisDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_FairValueInputsLevel3Member": {
     "auth_ref": [
      "r236",
      "r245",
      "r246",
      "r294",
      "r295",
      "r296",
      "r297",
      "r298",
      "r299",
      "r300",
      "r302",
      "r381",
      "r458"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Unobservable inputs that reflect the entity's own assumption about the assumptions market participants would use in pricing.",
        "label": "Fair Value, Inputs, Level 3 [Member]",
        "terseLabel": "Level 3"
       }
      }
     },
     "localname": "FairValueInputsLevel3Member",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://dermtech.com/role/TheCompanyandaSummaryofitsSignificantAccountingPoliciesSummaryofAssetsandLiabilitiesMeasuredatFairValueonRecurringBasisDetails",
      "http://dermtech.com/role/TheCompanyandaSummaryofitsSignificantAccountingPoliciesSummaryofChangesinFairValueofLevel3LiabilitiesDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationByLiabilityClassDomain": {
     "auth_ref": [
      "r384"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Represents classes of liabilities measured and disclosed at fair value.",
        "label": "Fair Value by Liability Class [Domain]",
        "terseLabel": "Fair Value by Liability Class"
       }
      }
     },
     "localname": "FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationByLiabilityClassDomain",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://dermtech.com/role/TheCompanyandaSummaryofitsSignificantAccountingPoliciesSummaryofChangesinFairValueofLevel3LiabilitiesDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationCalculationRollForward": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "A roll forward is a reconciliation of a concept from the beginning of a period to the end of a period.",
        "label": "Fair Value, Liabilities Measured on Recurring Basis, Unobservable Input Reconciliation, Calculation [Roll Forward]",
        "terseLabel": "Fair Value, Liabilities Measured on Recurring Basis, Unobservable Input Reconciliation, Calculation [Roll Forward]"
       }
      }
     },
     "localname": "FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationCalculationRollForward",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://dermtech.com/role/TheCompanyandaSummaryofitsSignificantAccountingPoliciesSummaryofChangesinFairValueofLevel3LiabilitiesDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationLineItems": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.",
        "label": "Fair Value, Liabilities Measured on Recurring Basis, Unobservable Input Reconciliation [Line Items]",
        "terseLabel": "Fair Value Liabilities Measured On Recurring Basis Unobservable Input Reconciliation [Line Items]"
       }
      }
     },
     "localname": "FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationLineItems",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://dermtech.com/role/TheCompanyandaSummaryofitsSignificantAccountingPoliciesSummaryofChangesinFairValueofLevel3LiabilitiesDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationTable": {
     "auth_ref": [
      "r384",
      "r387"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Schedule of information required and determined to be provided for purposes of reconciling beginning and ending balances of fair value measurements of liabilities using significant unobservable inputs (level 3). Separately presenting changes during the period, attributable to: (1) total gains or losses for the period (realized and unrealized) and location reported in the statement of income (or activities); (2) purchases, sales, issuances, and settlements (net); (3) transfers in and/or out of Level 3.",
        "label": "Fair Value, Liabilities Measured on Recurring Basis, Unobservable Input Reconciliation [Table]",
        "terseLabel": "Fair Value Liabilities Measured On Recurring Basis Unobservable Input Reconciliation [Table]"
       }
      }
     },
     "localname": "FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationTable",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://dermtech.com/role/TheCompanyandaSummaryofitsSignificantAccountingPoliciesSummaryofChangesinFairValueofLevel3LiabilitiesDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationTextBlock": {
     "auth_ref": [
      "r384",
      "r387"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of the fair value measurement of liabilities using significant unobservable inputs (Level 3), a reconciliation of the beginning and ending balances, separately presenting changes attributable to the following: (1) total gains or losses for the period (realized and unrealized), segregating those gains or losses included in earnings (or changes in net assets), and gains or losses recognized in other comprehensive income (loss) and a description of where those gains or losses included in earnings (or changes in net assets) are reported in the statement of income (or activities); (2) purchases, sales, issues, and settlements (each type disclosed separately); and (3) transfers in and transfers out of Level 3 (for example, transfers due to changes in the observability of significant inputs) by class of liability.",
        "label": "Fair Value, Liabilities Measured on Recurring Basis, Unobservable Input Reconciliation [Table Text Block]",
        "terseLabel": "Summary of Changes in Fair Value of Level 3 Liabilities"
       }
      }
     },
     "localname": "FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://dermtech.com/role/TheCompanyandaSummaryofitsSignificantAccountingPoliciesTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_FairValueMeasurementFrequencyDomain": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Measurement frequency.",
        "label": "Measurement Frequency [Domain]",
        "terseLabel": "Measurement Frequency"
       }
      }
     },
     "localname": "FairValueMeasurementFrequencyDomain",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://dermtech.com/role/TheCompanyandaSummaryofitsSignificantAccountingPoliciesSummaryofAssetsandLiabilitiesMeasuredatFairValueonRecurringBasisDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_FairValueMeasurementPolicyPolicyTextBlock": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disclosure of accounting policy for fair value measurements of financial and non-financial assets, liabilities and instruments classified in shareholders' equity. Disclosures include, but are not limited to, how an entity that manages a group of financial assets and liabilities on the basis of its net exposure measures the fair value of those assets and liabilities.",
        "label": "Fair Value Measurement, Policy [Policy Text Block]",
        "terseLabel": "Fair Value Measurements"
       }
      }
     },
     "localname": "FairValueMeasurementPolicyPolicyTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://dermtech.com/role/TheCompanyandaSummaryofitsSignificantAccountingPoliciesPolicies"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityGainLossIncludedInEarnings": {
     "auth_ref": [
      "r385"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of gain (loss) recognized in income from liability measured at fair value on recurring basis using unobservable input (level 3).",
        "label": "Fair Value, Measurement with Unobservable Inputs Reconciliation, Recurring Basis, Liability, Gain (Loss) Included in Earnings",
        "terseLabel": "Change in fair value of warrant liability"
       }
      }
     },
     "localname": "FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityGainLossIncludedInEarnings",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://dermtech.com/role/TheCompanyandaSummaryofitsSignificantAccountingPoliciesSummaryofChangesinFairValueofLevel3LiabilitiesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue": {
     "auth_ref": [
      "r384"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Fair value of financial instrument classified as a liability measured using unobservable inputs that reflect the entity's own assumption about the assumptions market participants would use in pricing.",
        "label": "Fair Value, Measurement with Unobservable Inputs Reconciliation, Recurring Basis, Liability Value",
        "periodEndLabel": "Ending balance",
        "periodStartLabel": "Beginning balance"
       }
      }
     },
     "localname": "FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://dermtech.com/role/TheCompanyandaSummaryofitsSignificantAccountingPoliciesSummaryofChangesinFairValueofLevel3LiabilitiesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_FairValueMeasurementsFairValueHierarchyDomain": {
     "auth_ref": [
      "r236",
      "r245",
      "r246",
      "r294",
      "r295",
      "r296",
      "r297",
      "r298",
      "r299",
      "r300",
      "r302",
      "r456",
      "r457",
      "r458"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Categories used to prioritize the inputs to valuation techniques to measure fair value.",
        "label": "Fair Value Hierarchy and NAV [Domain]",
        "terseLabel": "Fair Value Hierarchy and NAV"
       }
      }
     },
     "localname": "FairValueMeasurementsFairValueHierarchyDomain",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://dermtech.com/role/TheCompanyandaSummaryofitsSignificantAccountingPoliciesAdditionalInformationDetails",
      "http://dermtech.com/role/TheCompanyandaSummaryofitsSignificantAccountingPoliciesSummaryofAssetsandLiabilitiesMeasuredatFairValueonRecurringBasisDetails",
      "http://dermtech.com/role/TheCompanyandaSummaryofitsSignificantAccountingPoliciesSummaryofChangesinFairValueofLevel3LiabilitiesDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_FairValueMeasurementsRecurringMember": {
     "auth_ref": [
      "r386",
      "r388"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Frequent fair value measurement. Includes, but is not limited to, fair value adjustment for impairment of asset, liability or equity, frequently measured at fair value.",
        "label": "Fair Value, Recurring [Member]",
        "terseLabel": "Fair Value, Recurring"
       }
      }
     },
     "localname": "FairValueMeasurementsRecurringMember",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://dermtech.com/role/TheCompanyandaSummaryofitsSignificantAccountingPoliciesSummaryofAssetsandLiabilitiesMeasuredatFairValueonRecurringBasisDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_FinanceLeaseInterestExpense": {
     "auth_ref": [
      "r418",
      "r424",
      "r433"
     ],
     "calculation": {
      "http://dermtech.com/role/LeasesCommitmentsandContingenciesComponentsofLeaseExpenseDetails": {
       "order": 2.0,
       "parentTag": "dmtk_FinanceLeaseCost",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of interest expense on finance lease liability.",
        "label": "Finance Lease, Interest Expense",
        "terseLabel": "Interest on lease liabilities",
        "verboseLabel": "Operating cash flows from finance leases"
       }
      }
     },
     "localname": "FinanceLeaseInterestExpense",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://dermtech.com/role/LeasesCommitmentsandContingenciesAdditionalInformationDetails",
      "http://dermtech.com/role/LeasesCommitmentsandContingenciesComponentsofLeaseExpenseDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_FinanceLeaseLiabilitiesPaymentsDueAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Finance Lease, Liability, to be Paid [Abstract]",
        "terseLabel": "Finance lease obligations, including interest"
       }
      }
     },
     "localname": "FinanceLeaseLiabilitiesPaymentsDueAbstract",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://dermtech.com/role/LeasesCommitmentsandContingenciesFutureMinimumPaymentsDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_FinanceLeaseLiability": {
     "auth_ref": [
      "r417",
      "r432"
     ],
     "calculation": {
      "http://dermtech.com/role/LeasesCommitmentsandContingenciesScheduleofLongTermFinanceLeaseObligationsDetails": {
       "order": 2.0,
       "parentTag": "us-gaap_FinanceLeaseLiabilityPaymentsDue",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Present value of lessee's discounted obligation for lease payments from finance lease.",
        "label": "Finance Lease, Liability",
        "totalLabel": "Present value of net minimum lease payments"
       }
      }
     },
     "localname": "FinanceLeaseLiability",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://dermtech.com/role/LeasesCommitmentsandContingenciesScheduleofLongTermFinanceLeaseObligationsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_FinanceLeaseLiabilityCurrent": {
     "auth_ref": [
      "r417"
     ],
     "calculation": {
      "http://dermtech.com/role/CondensedConsolidatedBalanceSheets": {
       "order": 6.0,
       "parentTag": "us-gaap_LiabilitiesCurrent",
       "weight": 1.0
      },
      "http://dermtech.com/role/LeasesCommitmentsandContingenciesScheduleofLongTermFinanceLeaseObligationsDetails": {
       "order": 1.0,
       "parentTag": "us-gaap_FinanceLeaseLiability",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Present value of lessee's discounted obligation for lease payments from finance lease, classified as current.",
        "label": "Finance Lease, Liability, Current",
        "negatedLabel": "Less current portion of finance lease obligations",
        "terseLabel": "Current portion of finance lease obligations"
       }
      }
     },
     "localname": "FinanceLeaseLiabilityCurrent",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://dermtech.com/role/CondensedConsolidatedBalanceSheets",
      "http://dermtech.com/role/LeasesCommitmentsandContingenciesScheduleofLongTermFinanceLeaseObligationsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_FinanceLeaseLiabilityNoncurrent": {
     "auth_ref": [
      "r417"
     ],
     "calculation": {
      "http://dermtech.com/role/CondensedConsolidatedBalanceSheets": {
       "order": 4.0,
       "parentTag": "us-gaap_Liabilities",
       "weight": 1.0
      },
      "http://dermtech.com/role/LeasesCommitmentsandContingenciesScheduleofLongTermFinanceLeaseObligationsDetails": {
       "order": 2.0,
       "parentTag": "us-gaap_FinanceLeaseLiability",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Present value of lessee's discounted obligation for lease payments from finance lease, classified as noncurrent.",
        "label": "Finance Lease, Liability, Noncurrent",
        "terseLabel": "Long-term finance lease obligations, less current portion"
       }
      }
     },
     "localname": "FinanceLeaseLiabilityNoncurrent",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://dermtech.com/role/CondensedConsolidatedBalanceSheets",
      "http://dermtech.com/role/LeasesCommitmentsandContingenciesScheduleofLongTermFinanceLeaseObligationsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_FinanceLeaseLiabilityPaymentsDue": {
     "auth_ref": [
      "r432"
     ],
     "calculation": {
      "http://dermtech.com/role/LeasesCommitmentsandContingenciesScheduleofLongTermFinanceLeaseObligationsDetails": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of lessee's undiscounted obligation for lease payments for finance lease.",
        "label": "Finance Lease, Liability, to be Paid",
        "terseLabel": "Gross finance lease obligations",
        "totalLabel": "Gross finance lease obligations"
       }
      }
     },
     "localname": "FinanceLeaseLiabilityPaymentsDue",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://dermtech.com/role/LeasesCommitmentsandContingenciesFutureMinimumPaymentsDetails",
      "http://dermtech.com/role/LeasesCommitmentsandContingenciesScheduleofLongTermFinanceLeaseObligationsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_FinanceLeaseLiabilityPaymentsDueNextTwelveMonths": {
     "auth_ref": [
      "r432"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of lessee's undiscounted obligation for lease payment for finance lease to be paid in next fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).",
        "label": "Finance Lease, Liability, to be Paid, Year One",
        "terseLabel": "2023"
       }
      }
     },
     "localname": "FinanceLeaseLiabilityPaymentsDueNextTwelveMonths",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://dermtech.com/role/LeasesCommitmentsandContingenciesFutureMinimumPaymentsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_FinanceLeaseLiabilityPaymentsDueYearFour": {
     "auth_ref": [
      "r432"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of lessee's undiscounted obligation for lease payment for finance lease to be paid in fourth fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).",
        "label": "Finance Lease, Liability, to be Paid, Year Four",
        "terseLabel": "2026"
       }
      }
     },
     "localname": "FinanceLeaseLiabilityPaymentsDueYearFour",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://dermtech.com/role/LeasesCommitmentsandContingenciesFutureMinimumPaymentsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_FinanceLeaseLiabilityPaymentsDueYearThree": {
     "auth_ref": [
      "r432"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of lessee's undiscounted obligation for lease payment for finance lease to be paid in third fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).",
        "label": "Finance Lease, Liability, to be Paid, Year Three",
        "terseLabel": "2025"
       }
      }
     },
     "localname": "FinanceLeaseLiabilityPaymentsDueYearThree",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://dermtech.com/role/LeasesCommitmentsandContingenciesFutureMinimumPaymentsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_FinanceLeaseLiabilityPaymentsDueYearTwo": {
     "auth_ref": [
      "r432"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of lessee's undiscounted obligation for lease payment for finance lease to be paid in second fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).",
        "label": "Finance Lease, Liability, to be Paid, Year Two",
        "terseLabel": "2024"
       }
      }
     },
     "localname": "FinanceLeaseLiabilityPaymentsDueYearTwo",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://dermtech.com/role/LeasesCommitmentsandContingenciesFutureMinimumPaymentsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_FinanceLeaseLiabilityPaymentsRemainderOfFiscalYear": {
     "auth_ref": [
      "r432"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of lessee's undiscounted obligation for lease payment for finance lease to be paid in remainder of current fiscal year.",
        "label": "Finance Lease, Liability, to be Paid, Remainder of Fiscal Year",
        "terseLabel": "2022"
       }
      }
     },
     "localname": "FinanceLeaseLiabilityPaymentsRemainderOfFiscalYear",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://dermtech.com/role/LeasesCommitmentsandContingenciesFutureMinimumPaymentsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_FinanceLeaseLiabilityUndiscountedExcessAmount": {
     "auth_ref": [
      "r432"
     ],
     "calculation": {
      "http://dermtech.com/role/LeasesCommitmentsandContingenciesScheduleofLongTermFinanceLeaseObligationsDetails": {
       "order": 1.0,
       "parentTag": "us-gaap_FinanceLeaseLiabilityPaymentsDue",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of lessee's undiscounted obligation for lease payments in excess of discounted obligation for lease payments for finance lease.",
        "label": "Finance Lease, Liability, Undiscounted Excess Amount",
        "negatedLabel": "Less imputed interest"
       }
      }
     },
     "localname": "FinanceLeaseLiabilityUndiscountedExcessAmount",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://dermtech.com/role/LeasesCommitmentsandContingenciesScheduleofLongTermFinanceLeaseObligationsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_FinanceLeasePrincipalPayments": {
     "auth_ref": [
      "r419",
      "r427"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of cash outflow for principal payment on finance lease.",
        "label": "Finance Lease, Principal Payments",
        "terseLabel": "Financing cash flows from finance leases"
       }
      }
     },
     "localname": "FinanceLeasePrincipalPayments",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://dermtech.com/role/LeasesCommitmentsandContingenciesComponentsofLeaseExpenseDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_FinanceLeaseRightOfUseAssetAmortization": {
     "auth_ref": [
      "r418",
      "r424",
      "r433"
     ],
     "calculation": {
      "http://dermtech.com/role/LeasesCommitmentsandContingenciesComponentsofLeaseExpenseDetails": {
       "order": 1.0,
       "parentTag": "dmtk_FinanceLeaseCost",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of amortization expense attributable to right-of-use asset from finance lease.",
        "label": "Finance Lease, Right-of-Use Asset, Amortization",
        "terseLabel": "Amortization of leased assets"
       }
      }
     },
     "localname": "FinanceLeaseRightOfUseAssetAmortization",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://dermtech.com/role/LeasesCommitmentsandContingenciesComponentsofLeaseExpenseDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_FinanceLeaseWeightedAverageDiscountRatePercent": {
     "auth_ref": [
      "r430",
      "r433"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Weighted average discount rate for finance lease calculated at point in time.",
        "label": "Finance Lease, Weighted Average Discount Rate, Percent",
        "terseLabel": "Weighted-average discount rate for finance leases (in percent)"
       }
      }
     },
     "localname": "FinanceLeaseWeightedAverageDiscountRatePercent",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://dermtech.com/role/LeasesCommitmentsandContingenciesComponentsofLeaseExpenseDetails"
     ],
     "xbrltype": "percentItemType"
    },
    "us-gaap_FinanceLeaseWeightedAverageRemainingLeaseTerm1": {
     "auth_ref": [
      "r429",
      "r433"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Weighted average remaining lease term for finance lease, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents reported fact of one year, five months, and thirteen days.",
        "label": "Finance Lease, Weighted Average Remaining Lease Term",
        "terseLabel": "Weighted-average remaining lease term of finance leases (in years)"
       }
      }
     },
     "localname": "FinanceLeaseWeightedAverageRemainingLeaseTerm1",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://dermtech.com/role/LeasesCommitmentsandContingenciesComponentsofLeaseExpenseDetails"
     ],
     "xbrltype": "durationItemType"
    },
    "us-gaap_FinancialInstrumentAxis": {
     "auth_ref": [
      "r175",
      "r176",
      "r178",
      "r179",
      "r180",
      "r188",
      "r189",
      "r190",
      "r191",
      "r192",
      "r194",
      "r195",
      "r196",
      "r197",
      "r244",
      "r268",
      "r366",
      "r453",
      "r454",
      "r455",
      "r456",
      "r457",
      "r458",
      "r459",
      "r460",
      "r461",
      "r462",
      "r463",
      "r464",
      "r465",
      "r466",
      "r467",
      "r468",
      "r469",
      "r470",
      "r471",
      "r472",
      "r473",
      "r474",
      "r475",
      "r476",
      "r477",
      "r478",
      "r479",
      "r480",
      "r481",
      "r482",
      "r562",
      "r563",
      "r564",
      "r565",
      "r566",
      "r567",
      "r568"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by type of financial instrument.",
        "label": "Financial Instrument [Axis]",
        "terseLabel": "Financial Instrument"
       }
      }
     },
     "localname": "FinancialInstrumentAxis",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://dermtech.com/role/BalanceSheetDetailsScheduleofShortTermMarketableSecuritiesDetails",
      "http://dermtech.com/role/TheCompanyandaSummaryofitsSignificantAccountingPoliciesAssumptionsUsedtoDetermineFairValueofEachOptiononDateofGrantIssuedDetails",
      "http://dermtech.com/role/TheCompanyandaSummaryofitsSignificantAccountingPoliciesSummaryofAssetsandLiabilitiesMeasuredatFairValueonRecurringBasisDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_FurnitureAndFixturesGross": {
     "auth_ref": [
      "r202"
     ],
     "calculation": {
      "http://dermtech.com/role/BalanceSheetDetailsScheduleofPrepaidExpensesandPPEDetails": {
       "order": 1.0,
       "parentTag": "us-gaap_PropertyPlantAndEquipmentGross",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount before accumulated depreciation of equipment commonly used in offices and stores that have no permanent connection to the structure of a building or utilities. Examples include, but are not limited to, desks, chairs, tables, and bookcases.",
        "label": "Furniture and Fixtures, Gross",
        "terseLabel": "Furniture and fixtures"
       }
      }
     },
     "localname": "FurnitureAndFixturesGross",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://dermtech.com/role/BalanceSheetDetailsScheduleofPrepaidExpensesandPPEDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_GainLossOnDispositionOfAssets1": {
     "auth_ref": [
      "r78"
     ],
     "calculation": {
      "http://dermtech.com/role/CondensedConsolidatedStatementsofCashFlows": {
       "order": 10.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": -1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of gain (loss) on sale or disposal of assets, including but not limited to property plant and equipment, intangible assets and equity in securities of subsidiaries or equity method investee.",
        "label": "Gain (Loss) on Disposition of Assets",
        "negatedLabel": "Loss on disposal of equipment"
       }
      }
     },
     "localname": "GainLossOnDispositionOfAssets1",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://dermtech.com/role/CondensedConsolidatedStatementsofCashFlows"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_GeneralAndAdministrativeExpense": {
     "auth_ref": [
      "r68"
     ],
     "calculation": {
      "http://dermtech.com/role/CondensedConsolidatedStatementsofOperations": {
       "order": 3.0,
       "parentTag": "us-gaap_OperatingExpenses",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The aggregate total of expenses of managing and administering the affairs of an entity, including affiliates of the reporting entity, which are not directly or indirectly associated with the manufacture, sale or creation of a product or product line.",
        "label": "General and Administrative Expense",
        "terseLabel": "General and administrative"
       }
      }
     },
     "localname": "GeneralAndAdministrativeExpense",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://dermtech.com/role/CondensedConsolidatedStatementsofOperations"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_GeneralAndAdministrativeExpenseMember": {
     "auth_ref": [
      "r65"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Primary financial statement caption encompassing general and administrative expense.",
        "label": "General and Administrative Expense [Member]",
        "terseLabel": "General and administrative"
       }
      }
     },
     "localname": "GeneralAndAdministrativeExpenseMember",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://dermtech.com/role/StockholdersEquityShareBasedCompensationExpenseDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_GrossProfit": {
     "auth_ref": [
      "r66",
      "r92",
      "r146",
      "r148",
      "r151",
      "r154",
      "r156",
      "r181",
      "r215",
      "r216",
      "r217",
      "r219",
      "r220",
      "r221",
      "r222",
      "r223",
      "r224",
      "r225",
      "r392"
     ],
     "calculation": {
      "http://dermtech.com/role/CondensedConsolidatedStatementsofOperations": {
       "order": 1.0,
       "parentTag": "us-gaap_OperatingIncomeLoss",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Aggregate revenue less cost of goods and services sold or operating expenses directly attributable to the revenue generation activity.",
        "label": "Gross Profit",
        "totalLabel": "Gross profit"
       }
      }
     },
     "localname": "GrossProfit",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://dermtech.com/role/CondensedConsolidatedStatementsofOperations"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_ImpairmentOfLongLivedAssetsToBeDisposedOf": {
     "auth_ref": [
      "r78",
      "r200"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The aggregate amount of write-downs for impairments recognized during the period for long-lived assets held for abandonment, exchange or sale.",
        "label": "Impairment of Long-Lived Assets to be Disposed of",
        "terseLabel": "Impairment losses"
       }
      }
     },
     "localname": "ImpairmentOfLongLivedAssetsToBeDisposedOf",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://dermtech.com/role/TheCompanyandaSummaryofitsSignificantAccountingPoliciesAdditionalInformationDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_IncomeStatementAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Income Statement [Abstract]",
        "terseLabel": "Income Statement [Abstract]"
       }
      }
     },
     "localname": "IncomeStatementAbstract",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "xbrltype": "stringItemType"
    },
    "us-gaap_IncomeStatementLocationAxis": {
     "auth_ref": [
      "r205",
      "r207"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by location in the income statement.",
        "label": "Income Statement Location [Axis]",
        "terseLabel": "Income Statement Location"
       }
      }
     },
     "localname": "IncomeStatementLocationAxis",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://dermtech.com/role/LeasesCommitmentsandContingenciesAdditionalInformationDetails",
      "http://dermtech.com/role/StockholdersEquityShareBasedCompensationExpenseDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_IncomeStatementLocationDomain": {
     "auth_ref": [
      "r207"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Location in the income statement.",
        "label": "Income Statement Location [Domain]",
        "terseLabel": "Income Statement Location"
       }
      }
     },
     "localname": "IncomeStatementLocationDomain",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://dermtech.com/role/LeasesCommitmentsandContingenciesAdditionalInformationDetails",
      "http://dermtech.com/role/StockholdersEquityShareBasedCompensationExpenseDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_IncreaseDecreaseInAccountsPayableAndAccruedLiabilities": {
     "auth_ref": [
      "r77"
     ],
     "calculation": {
      "http://dermtech.com/role/CondensedConsolidatedStatementsofCashFlows": {
       "order": 12.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The increase (decrease) during the reporting period in the amounts payable to vendors for goods and services received and the amount of obligations and expenses incurred but not paid.",
        "label": "Increase (Decrease) in Accounts Payable and Accrued Liabilities",
        "terseLabel": "Accounts payable, accrued liabilities and deferred revenue"
       }
      }
     },
     "localname": "IncreaseDecreaseInAccountsPayableAndAccruedLiabilities",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://dermtech.com/role/CondensedConsolidatedStatementsofCashFlows"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_IncreaseDecreaseInAccountsReceivable": {
     "auth_ref": [
      "r77"
     ],
     "calculation": {
      "http://dermtech.com/role/CondensedConsolidatedStatementsofCashFlows": {
       "order": 4.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": -1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The increase (decrease) during the reporting period in amount due within one year (or one business cycle) from customers for the credit sale of goods and services.",
        "label": "Increase (Decrease) in Accounts Receivable",
        "negatedLabel": "Accounts receivable"
       }
      }
     },
     "localname": "IncreaseDecreaseInAccountsReceivable",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://dermtech.com/role/CondensedConsolidatedStatementsofCashFlows"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_IncreaseDecreaseInEmployeeRelatedLiabilities": {
     "auth_ref": [
      "r77"
     ],
     "calculation": {
      "http://dermtech.com/role/CondensedConsolidatedStatementsofCashFlows": {
       "order": 8.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The increase (decrease) during the reporting period in the aggregate amount of obligations related to services received from employees, such as accrued salaries and bonuses, payroll taxes and fringe benefits.",
        "label": "Increase (Decrease) in Employee Related Liabilities",
        "terseLabel": "Accrued compensation"
       }
      }
     },
     "localname": "IncreaseDecreaseInEmployeeRelatedLiabilities",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://dermtech.com/role/CondensedConsolidatedStatementsofCashFlows"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_IncreaseDecreaseInInventories": {
     "auth_ref": [
      "r77"
     ],
     "calculation": {
      "http://dermtech.com/role/CondensedConsolidatedStatementsofCashFlows": {
       "order": 7.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": -1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The increase (decrease) during the reporting period in the aggregate value of all inventory held by the reporting entity, associated with underlying transactions that are classified as operating activities.",
        "label": "Increase (Decrease) in Inventories",
        "negatedLabel": "Inventory"
       }
      }
     },
     "localname": "IncreaseDecreaseInInventories",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://dermtech.com/role/CondensedConsolidatedStatementsofCashFlows"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_IncreaseDecreaseInOperatingCapitalAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Increase (Decrease) in Operating Capital [Abstract]",
        "terseLabel": "Changes in operating assets and liabilities:"
       }
      }
     },
     "localname": "IncreaseDecreaseInOperatingCapitalAbstract",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://dermtech.com/role/CondensedConsolidatedStatementsofCashFlows"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_IncreaseDecreaseInOperatingLeaseLiability": {
     "auth_ref": [
      "r77",
      "r427"
     ],
     "calculation": {
      "http://dermtech.com/role/CondensedConsolidatedStatementsofCashFlows": {
       "order": 9.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of increase (decrease) in obligation for operating lease.",
        "label": "Increase (Decrease) in Operating Lease Liability",
        "terseLabel": "Operating lease liabilities, net",
        "verboseLabel": "Increase to operating lease liability"
       }
      }
     },
     "localname": "IncreaseDecreaseInOperatingLeaseLiability",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://dermtech.com/role/CondensedConsolidatedStatementsofCashFlows",
      "http://dermtech.com/role/LeasesCommitmentsandContingenciesAdditionalInformationDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_IncreaseDecreaseInOtherOperatingAssetsAndLiabilitiesNetAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Increase (Decrease) in Other Operating Assets and Liabilities, Net [Abstract]",
        "terseLabel": "Change in operating assets and liabilities:"
       }
      }
     },
     "localname": "IncreaseDecreaseInOtherOperatingAssetsAndLiabilitiesNetAbstract",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://dermtech.com/role/LeasesCommitmentsandContingenciesAdoptionofASC842Details"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets": {
     "auth_ref": [
      "r77"
     ],
     "calculation": {
      "http://dermtech.com/role/CondensedConsolidatedStatementsofCashFlows": {
       "order": 2.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": -1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of increase (decrease) in prepaid expenses, and assets classified as other.",
        "label": "Increase (Decrease) in Prepaid Expense and Other Assets",
        "negatedLabel": "Prepaid expenses and other current assets"
       }
      }
     },
     "localname": "IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://dermtech.com/role/CondensedConsolidatedStatementsofCashFlows"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_InterestIncomeExpenseNonoperatingNet": {
     "auth_ref": [],
     "calculation": {
      "http://dermtech.com/role/CondensedConsolidatedStatementsofOperations": {
       "order": 1.0,
       "parentTag": "us-gaap_NonoperatingIncomeExpense",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The net amount of nonoperating interest income (expense).",
        "label": "Interest Income (Expense), Nonoperating, Net",
        "terseLabel": "Interest income, net"
       }
      }
     },
     "localname": "InterestIncomeExpenseNonoperatingNet",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://dermtech.com/role/CondensedConsolidatedStatementsofOperations"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_InterestIncomeMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Primary financial statement caption in which reported facts about interest income have been included.",
        "label": "Interest Income [Member]",
        "terseLabel": "Interest Income, Net"
       }
      }
     },
     "localname": "InterestIncomeMember",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://dermtech.com/role/LeasesCommitmentsandContingenciesAdditionalInformationDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_InterestPaidNet": {
     "auth_ref": [
      "r72",
      "r75",
      "r82"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of cash paid for interest, excluding capitalized interest, classified as operating activity. Includes, but is not limited to, payment to settle zero-coupon bond for accreted interest of debt discount and debt instrument with insignificant coupon interest rate in relation to effective interest rate of borrowing attributable to accreted interest of debt discount.",
        "label": "Interest Paid, Excluding Capitalized Interest, Operating Activities",
        "terseLabel": "Cash paid for interest on finance lease obligations"
       }
      }
     },
     "localname": "InterestPaidNet",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://dermtech.com/role/CondensedConsolidatedStatementsofCashFlows"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_InventoryNet": {
     "auth_ref": [
      "r9",
      "r33",
      "r450"
     ],
     "calculation": {
      "http://dermtech.com/role/CondensedConsolidatedBalanceSheets": {
       "order": 4.0,
       "parentTag": "us-gaap_AssetsCurrent",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount after valuation and LIFO reserves of inventory expected to be sold, or consumed within one year or operating cycle, if longer.",
        "label": "Inventory, Net",
        "terseLabel": "Inventory"
       }
      }
     },
     "localname": "InventoryNet",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://dermtech.com/role/CondensedConsolidatedBalanceSheets"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_InvestmentHoldingsLineItems": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.",
        "label": "Investment Holdings [Line Items]",
        "terseLabel": "Investment Holdings [Line Items]"
       }
      }
     },
     "localname": "InvestmentHoldingsLineItems",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://dermtech.com/role/BalanceSheetDetailsScheduleofShortTermMarketableSecuritiesDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_InvestmentHoldingsTable": {
     "auth_ref": [
      "r546",
      "r547",
      "r548",
      "r549"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The investment holdings table is used for any listing of investments. The \"Investment [Axis]\" identifies the investment for which the line items apply. The other axes are used for categorizing the investments and creating useful subtotals. These axes cover different categorizations. The appropriate axes are expected to be used. Additional axes can be added for alternative categorizations.",
        "label": "Investment Holdings [Table]",
        "terseLabel": "Investment Holdings [Table]"
       }
      }
     },
     "localname": "InvestmentHoldingsTable",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://dermtech.com/role/BalanceSheetDetailsScheduleofShortTermMarketableSecuritiesDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_InvestmentsFairValueDisclosureAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Investments, Fair Value Disclosure [Abstract]",
        "terseLabel": "Marketable securities, available for sale:"
       }
      }
     },
     "localname": "InvestmentsFairValueDisclosureAbstract",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://dermtech.com/role/TheCompanyandaSummaryofitsSignificantAccountingPoliciesSummaryofAssetsandLiabilitiesMeasuredatFairValueonRecurringBasisDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_LeaseCostTableTextBlock": {
     "auth_ref": [
      "r431"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of lessee's lease cost. Includes, but is not limited to, interest expense for finance lease, amortization of right-of-use asset for finance lease, operating lease cost, short-term lease cost, variable lease cost and sublease income.",
        "label": "Lease, Cost [Table Text Block]",
        "terseLabel": "Components of Lease Expense"
       }
      }
     },
     "localname": "LeaseCostTableTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://dermtech.com/role/LeasesCommitmentsandContingenciesTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_LeaseholdImprovementsGross": {
     "auth_ref": [
      "r202"
     ],
     "calculation": {
      "http://dermtech.com/role/BalanceSheetDetailsScheduleofPrepaidExpensesandPPEDetails": {
       "order": 5.0,
       "parentTag": "us-gaap_PropertyPlantAndEquipmentGross",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount before accumulated depreciation of additions or improvements to assets held under a lease arrangement.",
        "label": "Leasehold Improvements, Gross",
        "terseLabel": "Leasehold improvements"
       }
      }
     },
     "localname": "LeaseholdImprovementsGross",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://dermtech.com/role/BalanceSheetDetailsScheduleofPrepaidExpensesandPPEDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_LesseeOperatingLeaseDiscountRate": {
     "auth_ref": [
      "r423"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Discount rate used by lessee to determine present value of operating lease payments.",
        "label": "Lessee, Operating Lease, Discount Rate",
        "terseLabel": "Estimated discount rate"
       }
      }
     },
     "localname": "LesseeOperatingLeaseDiscountRate",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://dermtech.com/role/LeasesCommitmentsandContingenciesAdditionalInformationDetails"
     ],
     "xbrltype": "percentItemType"
    },
    "us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue": {
     "auth_ref": [
      "r432"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of lessee's undiscounted obligation for lease payment for operating lease.",
        "label": "Lessee, Operating Lease, Liability, to be Paid",
        "terseLabel": "Total"
       }
      }
     },
     "localname": "LesseeOperatingLeaseLiabilityPaymentsDue",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://dermtech.com/role/LeasesCommitmentsandContingenciesAdditionalInformationDetails",
      "http://dermtech.com/role/LeasesCommitmentsandContingenciesFutureMinimumPaymentsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths": {
     "auth_ref": [
      "r432"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of lessee's undiscounted obligation for lease payment for operating lease to be paid in next fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).",
        "label": "Lessee, Operating Lease, Liability, to be Paid, Year One",
        "terseLabel": "2023"
       }
      }
     },
     "localname": "LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://dermtech.com/role/LeasesCommitmentsandContingenciesFutureMinimumPaymentsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFour": {
     "auth_ref": [
      "r432"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of lessee's undiscounted obligation for lease payment for operating lease to be paid in fourth fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).",
        "label": "Lessee, Operating Lease, Liability, to be Paid, Year Four",
        "terseLabel": "2026"
       }
      }
     },
     "localname": "LesseeOperatingLeaseLiabilityPaymentsDueYearFour",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://dermtech.com/role/LeasesCommitmentsandContingenciesFutureMinimumPaymentsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearThree": {
     "auth_ref": [
      "r432"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of lessee's undiscounted obligation for lease payment for operating lease to be paid in third fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).",
        "label": "Lessee, Operating Lease, Liability, to be Paid, Year Three",
        "terseLabel": "2025"
       }
      }
     },
     "localname": "LesseeOperatingLeaseLiabilityPaymentsDueYearThree",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://dermtech.com/role/LeasesCommitmentsandContingenciesFutureMinimumPaymentsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearTwo": {
     "auth_ref": [
      "r432"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of lessee's undiscounted obligation for lease payment for operating lease to be paid in second fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).",
        "label": "Lessee, Operating Lease, Liability, to be Paid, Year Two",
        "terseLabel": "2024"
       }
      }
     },
     "localname": "LesseeOperatingLeaseLiabilityPaymentsDueYearTwo",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://dermtech.com/role/LeasesCommitmentsandContingenciesFutureMinimumPaymentsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_LesseeOperatingLeaseLiabilityPaymentsRemainderOfFiscalYear": {
     "auth_ref": [
      "r432"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of lessee's undiscounted obligation for lease payment for operating lease having initial or remaining lease term in excess of one year to be paid in remainder of current fiscal year.",
        "label": "Lessee, Operating Lease, Liability, to be Paid, Remainder of Fiscal Year",
        "terseLabel": "2022"
       }
      }
     },
     "localname": "LesseeOperatingLeaseLiabilityPaymentsRemainderOfFiscalYear",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://dermtech.com/role/LeasesCommitmentsandContingenciesFutureMinimumPaymentsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_LesseeOperatingLeaseRemainingLeaseTerm": {
     "auth_ref": [
      "r421"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Remaining lease term of operating lease, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents reported fact of one year, five months, and thirteen days.",
        "label": "Lessee, Operating Lease, Remaining Lease Term",
        "terseLabel": "Remaining lease term"
       }
      }
     },
     "localname": "LesseeOperatingLeaseRemainingLeaseTerm",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://dermtech.com/role/LeasesCommitmentsandContingenciesAdditionalInformationDetails"
     ],
     "xbrltype": "durationItemType"
    },
    "us-gaap_LesseeOperatingLeaseRenewalTerm": {
     "auth_ref": [
      "r422"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Term of lessee's operating lease renewal, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents reported fact of one year, five months, and thirteen days.",
        "label": "Lessee, Operating Lease, Renewal Term",
        "terseLabel": "Renewal term"
       }
      }
     },
     "localname": "LesseeOperatingLeaseRenewalTerm",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://dermtech.com/role/LeasesCommitmentsandContingenciesAdditionalInformationDetails"
     ],
     "xbrltype": "durationItemType"
    },
    "us-gaap_LetterOfCreditMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "A document typically issued by a financial institution which acts as a guarantee of payment to a beneficiary, or as the source of payment for a specific transaction (for example, wiring funds to a foreign exporter if and when specified merchandise is accepted pursuant to the terms of the letter of credit).",
        "label": "Letter of Credit [Member]",
        "terseLabel": "Letter of Credit"
       }
      }
     },
     "localname": "LetterOfCreditMember",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://dermtech.com/role/LeasesCommitmentsandContingenciesAdditionalInformationDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_LettersOfCreditOutstandingAmount": {
     "auth_ref": [],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The total amount of the contingent obligation under letters of credit outstanding as of the reporting date.",
        "label": "Letters of Credit Outstanding, Amount",
        "terseLabel": "Letters of credit"
       }
      }
     },
     "localname": "LettersOfCreditOutstandingAmount",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://dermtech.com/role/TheCompanyandaSummaryofitsSignificantAccountingPoliciesAdditionalInformationDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_Liabilities": {
     "auth_ref": [
      "r38",
      "r92",
      "r150",
      "r181",
      "r215",
      "r216",
      "r217",
      "r219",
      "r220",
      "r221",
      "r222",
      "r223",
      "r224",
      "r225",
      "r356",
      "r359",
      "r360",
      "r392",
      "r448",
      "r449"
     ],
     "calculation": {
      "http://dermtech.com/role/CondensedConsolidatedBalanceSheets": {
       "order": 1.0,
       "parentTag": "us-gaap_LiabilitiesAndStockholdersEquity",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Sum of the carrying amounts as of the balance sheet date of all liabilities that are recognized. Liabilities are probable future sacrifices of economic benefits arising from present obligations of an entity to transfer assets or provide services to other entities in the future.",
        "label": "Liabilities",
        "totalLabel": "Total liabilities"
       }
      }
     },
     "localname": "Liabilities",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://dermtech.com/role/CondensedConsolidatedBalanceSheets"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_LiabilitiesAndStockholdersEquity": {
     "auth_ref": [
      "r32",
      "r92",
      "r181",
      "r392",
      "r450",
      "r505",
      "r521"
     ],
     "calculation": {
      "http://dermtech.com/role/CondensedConsolidatedBalanceSheets": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of liabilities and equity items, including the portion of equity attributable to noncontrolling interests, if any.",
        "label": "Liabilities and Equity",
        "totalLabel": "Total liabilities and stockholders\u2019 equity"
       }
      }
     },
     "localname": "LiabilitiesAndStockholdersEquity",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://dermtech.com/role/CondensedConsolidatedBalanceSheets"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_LiabilitiesAndStockholdersEquityAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Liabilities and Equity [Abstract]",
        "terseLabel": "Liabilities and Stockholders\u2019 Equity"
       }
      }
     },
     "localname": "LiabilitiesAndStockholdersEquityAbstract",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://dermtech.com/role/CondensedConsolidatedBalanceSheets"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_LiabilitiesCurrent": {
     "auth_ref": [
      "r13",
      "r40",
      "r92",
      "r181",
      "r215",
      "r216",
      "r217",
      "r219",
      "r220",
      "r221",
      "r222",
      "r223",
      "r224",
      "r225",
      "r356",
      "r359",
      "r360",
      "r392",
      "r448",
      "r449",
      "r450"
     ],
     "calculation": {
      "http://dermtech.com/role/CondensedConsolidatedBalanceSheets": {
       "order": 1.0,
       "parentTag": "us-gaap_Liabilities",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Total obligations incurred as part of normal operations that are expected to be paid during the following twelve months or within one business cycle, if longer.",
        "label": "Liabilities, Current",
        "totalLabel": "Total current liabilities"
       }
      }
     },
     "localname": "LiabilitiesCurrent",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://dermtech.com/role/CondensedConsolidatedBalanceSheets"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_LiabilitiesCurrentAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Liabilities, Current [Abstract]",
        "terseLabel": "Current liabilities:"
       }
      }
     },
     "localname": "LiabilitiesCurrentAbstract",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://dermtech.com/role/CondensedConsolidatedBalanceSheets"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_LiabilitiesFairValueDisclosure": {
     "auth_ref": [
      "r380"
     ],
     "calculation": {
      "http://dermtech.com/role/TheCompanyandaSummaryofitsSignificantAccountingPoliciesSummaryofAssetsandLiabilitiesMeasuredatFairValueonRecurringBasisDetails": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Fair value of financial and nonfinancial obligations.",
        "label": "Liabilities, Fair Value Disclosure",
        "totalLabel": "Total liabilities measured at fair value on a recurring basis"
       }
      }
     },
     "localname": "LiabilitiesFairValueDisclosure",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://dermtech.com/role/TheCompanyandaSummaryofitsSignificantAccountingPoliciesSummaryofAssetsandLiabilitiesMeasuredatFairValueonRecurringBasisDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_LiabilitiesFairValueDisclosureAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Liabilities, Fair Value Disclosure [Abstract]",
        "terseLabel": "Liabilities:"
       }
      }
     },
     "localname": "LiabilitiesFairValueDisclosureAbstract",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://dermtech.com/role/TheCompanyandaSummaryofitsSignificantAccountingPoliciesSummaryofAssetsandLiabilitiesMeasuredatFairValueonRecurringBasisDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_MachineryAndEquipmentGross": {
     "auth_ref": [
      "r202"
     ],
     "calculation": {
      "http://dermtech.com/role/BalanceSheetDetailsScheduleofPrepaidExpensesandPPEDetails": {
       "order": 3.0,
       "parentTag": "us-gaap_PropertyPlantAndEquipmentGross",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount before accumulated depreciation of tangible personal property used to produce goods and services, including, but is not limited to, tools, dies and molds, computer and office equipment.",
        "label": "Machinery and Equipment, Gross",
        "terseLabel": "Laboratory equipment"
       }
      }
     },
     "localname": "MachineryAndEquipmentGross",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://dermtech.com/role/BalanceSheetDetailsScheduleofPrepaidExpensesandPPEDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_MarketableSecuritiesCurrent": {
     "auth_ref": [],
     "calculation": {
      "http://dermtech.com/role/CondensedConsolidatedBalanceSheets": {
       "order": 2.0,
       "parentTag": "us-gaap_AssetsCurrent",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of investment in marketable security, classified as current.",
        "label": "Marketable Securities, Current",
        "terseLabel": "Short-term marketable securities"
       }
      }
     },
     "localname": "MarketableSecuritiesCurrent",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://dermtech.com/role/CondensedConsolidatedBalanceSheets"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_MunicipalNotesMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Short-term debt securities issued by state, city or local governments or the agencies operated by state, city or local governments.",
        "label": "Municipal Notes [Member]",
        "terseLabel": "Municipal debt securities"
       }
      }
     },
     "localname": "MunicipalNotesMember",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://dermtech.com/role/BalanceSheetDetailsScheduleofShortTermMarketableSecuritiesDetails",
      "http://dermtech.com/role/TheCompanyandaSummaryofitsSignificantAccountingPoliciesSummaryofAssetsandLiabilitiesMeasuredatFairValueonRecurringBasisDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_NatureOfOperations": {
     "auth_ref": [
      "r131",
      "r143"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The entire disclosure for the nature of an entity's business, major products or services, principal markets including location, and the relative importance of its operations in each business and the basis for the determination, including but not limited to, assets, revenues, or earnings. For an entity that has not commenced principal operations, disclosures about the risks and uncertainties related to the activities in which the entity is currently engaged and an understanding of what those activities are being directed toward.",
        "label": "Nature of Operations [Text Block]",
        "terseLabel": "Nature of Operations"
       }
      }
     },
     "localname": "NatureOfOperations",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://dermtech.com/role/TheCompanyandaSummaryofitsSignificantAccountingPoliciesPolicies"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_NetCashProvidedByUsedInFinancingActivities": {
     "auth_ref": [
      "r74"
     ],
     "calculation": {
      "http://dermtech.com/role/CondensedConsolidatedStatementsofCashFlows": {
       "order": 3.0,
       "parentTag": "us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of cash inflow (outflow) from financing activities, including discontinued operations. Financing activity cash flows include obtaining resources from owners and providing them with a return on, and a return of, their investment; borrowing money and repaying amounts borrowed, or settling the obligation; and obtaining and paying for other resources obtained from creditors on long-term credit.",
        "label": "Net Cash Provided by (Used in) Financing Activities",
        "totalLabel": "Net cash provided by financing activities"
       }
      }
     },
     "localname": "NetCashProvidedByUsedInFinancingActivities",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://dermtech.com/role/CondensedConsolidatedStatementsofCashFlows"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Net Cash Provided by (Used in) Financing Activities [Abstract]",
        "terseLabel": "Cash flows from financing activities:"
       }
      }
     },
     "localname": "NetCashProvidedByUsedInFinancingActivitiesAbstract",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://dermtech.com/role/CondensedConsolidatedStatementsofCashFlows"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_NetCashProvidedByUsedInInvestingActivities": {
     "auth_ref": [
      "r74"
     ],
     "calculation": {
      "http://dermtech.com/role/CondensedConsolidatedStatementsofCashFlows": {
       "order": 2.0,
       "parentTag": "us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of cash inflow (outflow) from investing activities, including discontinued operations. Investing activity cash flows include making and collecting loans and acquiring and disposing of debt or equity instruments and property, plant, and equipment and other productive assets.",
        "label": "Net Cash Provided by (Used in) Investing Activities",
        "totalLabel": "Net cash used in investing activities"
       }
      }
     },
     "localname": "NetCashProvidedByUsedInInvestingActivities",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://dermtech.com/role/CondensedConsolidatedStatementsofCashFlows"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Net Cash Provided by (Used in) Investing Activities [Abstract]",
        "terseLabel": "Cash flows from investing activities:"
       }
      }
     },
     "localname": "NetCashProvidedByUsedInInvestingActivitiesAbstract",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://dermtech.com/role/CondensedConsolidatedStatementsofCashFlows"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_NetCashProvidedByUsedInOperatingActivities": {
     "auth_ref": [
      "r74",
      "r76",
      "r79"
     ],
     "calculation": {
      "http://dermtech.com/role/CondensedConsolidatedStatementsofCashFlows": {
       "order": 1.0,
       "parentTag": "us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect",
       "weight": 1.0
      }
     },
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of cash inflow (outflow) from operating activities, including discontinued operations. Operating activity cash flows include transactions, adjustments, and changes in value not defined as investing or financing activities.",
        "label": "Net Cash Provided by (Used in) Operating Activities",
        "totalLabel": "Net cash used in operating activities"
       }
      }
     },
     "localname": "NetCashProvidedByUsedInOperatingActivities",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://dermtech.com/role/CondensedConsolidatedStatementsofCashFlows"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Net Cash Provided by (Used in) Operating Activities [Abstract]",
        "terseLabel": "Cash flows from operating activities:"
       }
      }
     },
     "localname": "NetCashProvidedByUsedInOperatingActivitiesAbstract",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://dermtech.com/role/CondensedConsolidatedStatementsofCashFlows"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_NetIncomeLoss": {
     "auth_ref": [
      "r6",
      "r54",
      "r56",
      "r61",
      "r62",
      "r79",
      "r92",
      "r101",
      "r106",
      "r107",
      "r108",
      "r109",
      "r112",
      "r113",
      "r118",
      "r146",
      "r148",
      "r151",
      "r154",
      "r156",
      "r181",
      "r215",
      "r216",
      "r217",
      "r219",
      "r220",
      "r221",
      "r222",
      "r223",
      "r224",
      "r225",
      "r378",
      "r392",
      "r509",
      "r524"
     ],
     "calculation": {
      "http://dermtech.com/role/CondensedConsolidatedStatementsofComprehensiveLoss": {
       "order": 1.0,
       "parentTag": "us-gaap_ComprehensiveIncomeNetOfTax",
       "weight": 1.0
      },
      "http://dermtech.com/role/CondensedConsolidatedStatementsofOperations": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The portion of profit or loss for the period, net of income taxes, which is attributable to the parent.",
        "label": "Net Income (Loss) Attributable to Parent",
        "terseLabel": "Net loss",
        "totalLabel": "Net loss",
        "verboseLabel": "Net loss"
       }
      }
     },
     "localname": "NetIncomeLoss",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://dermtech.com/role/CondensedConsolidatedStatementsofComprehensiveLoss",
      "http://dermtech.com/role/CondensedConsolidatedStatementsofOperations",
      "http://dermtech.com/role/CondensedConsolidatedStatementsofStockholdersEquity"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_NewAccountingPronouncementsOrChangeInAccountingPrincipleLineItems": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.",
        "label": "New Accounting Pronouncements or Change in Accounting Principle [Line Items]",
        "terseLabel": "New Accounting Pronouncements or Change in Accounting Principle [Line Items]"
       }
      }
     },
     "localname": "NewAccountingPronouncementsOrChangeInAccountingPrincipleLineItems",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://dermtech.com/role/LeasesCommitmentsandContingenciesAdoptionofASC842Details"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_NewAccountingPronouncementsOrChangeInAccountingPrincipleTable": {
     "auth_ref": [
      "r0",
      "r1",
      "r2",
      "r3",
      "r4",
      "r100",
      "r101",
      "r102",
      "r103",
      "r104",
      "r105",
      "r108",
      "r114",
      "r124",
      "r167",
      "r168",
      "r182",
      "r183",
      "r184",
      "r185",
      "r186",
      "r187",
      "r340",
      "r341",
      "r342",
      "r346",
      "r347",
      "r348",
      "r349",
      "r350",
      "r351",
      "r352",
      "r368",
      "r369",
      "r370",
      "r371",
      "r372",
      "r373",
      "r374",
      "r375",
      "r376",
      "r377",
      "r378",
      "r379",
      "r393",
      "r394",
      "r395",
      "r396",
      "r397",
      "r398",
      "r399",
      "r400",
      "r408",
      "r409",
      "r412",
      "r413",
      "r414",
      "r415",
      "r434",
      "r435",
      "r436",
      "r437",
      "r438",
      "r439",
      "r486",
      "r487",
      "r488",
      "r531",
      "r532",
      "r533",
      "r534",
      "r535",
      "r536",
      "r537",
      "r538",
      "r539",
      "r540",
      "r541",
      "r542"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Summarization of the changes in an accounting principle or a new accounting pronouncement, including the line items affected by the change and the financial effects of the change on those particular line items.",
        "label": "Accounting Standards Update and Change in Accounting Principle [Table]",
        "terseLabel": "Accounting Standards Update and Change in Accounting Principle [Table]"
       }
      }
     },
     "localname": "NewAccountingPronouncementsOrChangeInAccountingPrincipleTable",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://dermtech.com/role/LeasesCommitmentsandContingenciesAdoptionofASC842Details"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disclosure of accounting policy pertaining to new accounting pronouncements that may impact the entity's financial reporting. Includes, but is not limited to, quantification of the expected or actual impact.",
        "label": "New Accounting Pronouncements, Policy [Policy Text Block]",
        "terseLabel": "Accounting Pronouncements Issued But Not Yet Effective and Adoption of ASC 842"
       }
      }
     },
     "localname": "NewAccountingPronouncementsPolicyPolicyTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://dermtech.com/role/TheCompanyandaSummaryofitsSignificantAccountingPoliciesPolicies"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_NoncashInvestingAndFinancingItemsAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Noncash Investing and Financing Items [Abstract]",
        "terseLabel": "Supplemental disclosure of noncash investing and financing activities:"
       }
      }
     },
     "localname": "NoncashInvestingAndFinancingItemsAbstract",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://dermtech.com/role/CondensedConsolidatedStatementsofCashFlows"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_NoncashOrPartNoncashAcquisitionFixedAssetsAcquired1": {
     "auth_ref": [
      "r83",
      "r84",
      "r85"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The amount of fixed assets that an Entity acquires in a noncash (or part noncash) acquisition. Noncash is defined as information about all investing and financing activities of an enterprise during a period that affect recognized assets or liabilities but that do not result in cash receipts or cash payments in the period. \"Part noncash\" refers to that portion of the transaction not resulting in cash receipts or cash payments in the period.",
        "label": "Noncash or Part Noncash Acquisition, Fixed Assets Acquired",
        "terseLabel": "Property and equipment acquired under finance leases"
       }
      }
     },
     "localname": "NoncashOrPartNoncashAcquisitionFixedAssetsAcquired1",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://dermtech.com/role/CondensedConsolidatedStatementsofCashFlows"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_NonoperatingIncomeExpense": {
     "auth_ref": [
      "r69"
     ],
     "calculation": {
      "http://dermtech.com/role/CondensedConsolidatedStatementsofOperations": {
       "order": 2.0,
       "parentTag": "us-gaap_NetIncomeLoss",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The aggregate amount of income or expense from ancillary business-related activities (that is to say, excluding major activities considered part of the normal operations of the business).",
        "label": "Nonoperating Income (Expense)",
        "totalLabel": "Total other income/(expense)"
       }
      }
     },
     "localname": "NonoperatingIncomeExpense",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://dermtech.com/role/CondensedConsolidatedStatementsofOperations"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_NonoperatingIncomeExpenseAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Nonoperating Income (Expense) [Abstract]",
        "terseLabel": "Other income/(expense):"
       }
      }
     },
     "localname": "NonoperatingIncomeExpenseAbstract",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://dermtech.com/role/CondensedConsolidatedStatementsofOperations"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_OperatingExpenses": {
     "auth_ref": [],
     "calculation": {
      "http://dermtech.com/role/CondensedConsolidatedStatementsofOperations": {
       "order": 2.0,
       "parentTag": "us-gaap_OperatingIncomeLoss",
       "weight": -1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Generally recurring costs associated with normal operations except for the portion of these expenses which can be clearly related to production and included in cost of sales or services. Includes selling, general and administrative expense.",
        "label": "Operating Expenses",
        "totalLabel": "Total operating expenses"
       }
      }
     },
     "localname": "OperatingExpenses",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://dermtech.com/role/CondensedConsolidatedStatementsofOperations"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_OperatingExpensesAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Operating Expenses [Abstract]",
        "terseLabel": "Operating expenses:"
       }
      }
     },
     "localname": "OperatingExpensesAbstract",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://dermtech.com/role/CondensedConsolidatedStatementsofOperations"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_OperatingIncomeLoss": {
     "auth_ref": [
      "r146",
      "r148",
      "r151",
      "r154",
      "r156"
     ],
     "calculation": {
      "http://dermtech.com/role/CondensedConsolidatedStatementsofOperations": {
       "order": 1.0,
       "parentTag": "us-gaap_NetIncomeLoss",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The net result for the period of deducting operating expenses from operating revenues.",
        "label": "Operating Income (Loss)",
        "totalLabel": "Loss from operations"
       }
      }
     },
     "localname": "OperatingIncomeLoss",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://dermtech.com/role/CondensedConsolidatedStatementsofOperations"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_OperatingLeaseCost": {
     "auth_ref": [
      "r425",
      "r433"
     ],
     "calculation": {
      "http://dermtech.com/role/LeasesCommitmentsandContingenciesComponentsofLeaseExpenseDetails": {
       "order": 1.0,
       "parentTag": "dmtk_OperatingLeaseCosts",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of single lease cost, calculated by allocation of remaining cost of lease over remaining lease term. Includes, but is not limited to, single lease cost, after impairment of right-of-use asset, calculated by amortization of remaining right-of-use asset and accretion of lease liability.",
        "label": "Operating Lease, Cost",
        "terseLabel": "Operating lease cost"
       }
      }
     },
     "localname": "OperatingLeaseCost",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://dermtech.com/role/LeasesCommitmentsandContingenciesComponentsofLeaseExpenseDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_OperatingLeaseLiabilitiesPaymentsDueAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Lessee, Operating Lease, Liability, to be Paid [Abstract]",
        "terseLabel": "Operating lease obligations, including interest"
       }
      }
     },
     "localname": "OperatingLeaseLiabilitiesPaymentsDueAbstract",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://dermtech.com/role/LeasesCommitmentsandContingenciesFutureMinimumPaymentsDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_OperatingLeaseLiability": {
     "auth_ref": [
      "r417"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Present value of lessee's discounted obligation for lease payments from operating lease.",
        "label": "Operating Lease, Liability",
        "terseLabel": "Operating lease liabilities, net"
       }
      }
     },
     "localname": "OperatingLeaseLiability",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://dermtech.com/role/LeasesCommitmentsandContingenciesAdditionalInformationDetails",
      "http://dermtech.com/role/LeasesCommitmentsandContingenciesAdoptionofASC842Details"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_OperatingLeaseLiabilityCurrent": {
     "auth_ref": [
      "r417"
     ],
     "calculation": {
      "http://dermtech.com/role/CondensedConsolidatedBalanceSheets": {
       "order": 5.0,
       "parentTag": "us-gaap_LiabilitiesCurrent",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Present value of lessee's discounted obligation for lease payments from operating lease, classified as current.",
        "label": "Operating Lease, Liability, Current",
        "terseLabel": "Current portion of operating lease liabilities"
       }
      }
     },
     "localname": "OperatingLeaseLiabilityCurrent",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://dermtech.com/role/CondensedConsolidatedBalanceSheets"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_OperatingLeaseLiabilityNoncurrent": {
     "auth_ref": [
      "r417"
     ],
     "calculation": {
      "http://dermtech.com/role/CondensedConsolidatedBalanceSheets": {
       "order": 2.0,
       "parentTag": "us-gaap_Liabilities",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Present value of lessee's discounted obligation for lease payments from operating lease, classified as noncurrent.",
        "label": "Operating Lease, Liability, Noncurrent",
        "terseLabel": "Operating lease liabilities, long-term"
       }
      }
     },
     "localname": "OperatingLeaseLiabilityNoncurrent",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://dermtech.com/role/CondensedConsolidatedBalanceSheets"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_OperatingLeasePayments": {
     "auth_ref": [
      "r420",
      "r427"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of cash outflow from operating lease, excluding payments to bring another asset to condition and location necessary for its intended use.",
        "label": "Operating Lease, Payments",
        "terseLabel": "Operating cash flows from operating leases"
       }
      }
     },
     "localname": "OperatingLeasePayments",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://dermtech.com/role/LeasesCommitmentsandContingenciesComponentsofLeaseExpenseDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_OperatingLeaseRightOfUseAsset": {
     "auth_ref": [
      "r416"
     ],
     "calculation": {
      "http://dermtech.com/role/CondensedConsolidatedBalanceSheets": {
       "order": 3.0,
       "parentTag": "us-gaap_Assets",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of lessee's right to use underlying asset under operating lease.",
        "label": "Operating Lease, Right-of-Use Asset",
        "terseLabel": "Operating lease right-of-use assets"
       }
      }
     },
     "localname": "OperatingLeaseRightOfUseAsset",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://dermtech.com/role/CondensedConsolidatedBalanceSheets",
      "http://dermtech.com/role/LeasesCommitmentsandContingenciesAdditionalInformationDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_OperatingLeaseRightOfUseAssetAmortizationExpense": {
     "auth_ref": [
      "r78"
     ],
     "calculation": {
      "http://dermtech.com/role/CondensedConsolidatedStatementsofCashFlows": {
       "order": 5.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of amortization expense for right-of-use asset from operating lease.",
        "label": "Operating Lease, Right-of-Use Asset, Amortization Expense",
        "terseLabel": "Amortization of operating lease right-of-use assets"
       }
      }
     },
     "localname": "OperatingLeaseRightOfUseAssetAmortizationExpense",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://dermtech.com/role/CondensedConsolidatedStatementsofCashFlows",
      "http://dermtech.com/role/LeasesCommitmentsandContingenciesAdoptionofASC842Details"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_OperatingLeaseWeightedAverageDiscountRatePercent": {
     "auth_ref": [
      "r430",
      "r433"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Weighted average discount rate for operating lease calculated at point in time.",
        "label": "Operating Lease, Weighted Average Discount Rate, Percent",
        "terseLabel": "Weighted-average discount rate for operating leases (in percent)"
       }
      }
     },
     "localname": "OperatingLeaseWeightedAverageDiscountRatePercent",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://dermtech.com/role/LeasesCommitmentsandContingenciesComponentsofLeaseExpenseDetails"
     ],
     "xbrltype": "percentItemType"
    },
    "us-gaap_OperatingLeaseWeightedAverageRemainingLeaseTerm1": {
     "auth_ref": [
      "r429",
      "r433"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Weighted average remaining lease term for operating lease, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents reported fact of one year, five months, and thirteen days.",
        "label": "Operating Lease, Weighted Average Remaining Lease Term",
        "terseLabel": "Weighted-average remaining lease term of operating leases (in years)"
       }
      }
     },
     "localname": "OperatingLeaseWeightedAverageRemainingLeaseTerm1",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://dermtech.com/role/LeasesCommitmentsandContingenciesComponentsofLeaseExpenseDetails"
     ],
     "xbrltype": "durationItemType"
    },
    "us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Organization, Consolidation and Presentation of Financial Statements [Abstract]",
        "terseLabel": "Organization, Consolidation and Presentation of Financial Statements [Abstract]"
       }
      }
     },
     "localname": "OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "xbrltype": "stringItemType"
    },
    "us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureAndSignificantAccountingPoliciesTextBlock": {
     "auth_ref": [
      "r7",
      "r96",
      "r143",
      "r363"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The entire disclosure for the organization, consolidation and basis of presentation of financial statements disclosure, and significant accounting policies of the reporting entity. May be provided in more than one note to the financial statements, as long as users are provided with an understanding of (1) the significant judgments and assumptions made by an enterprise in determining whether it must consolidate a VIE and/or disclose information about its involvement with a VIE, (2) the nature of restrictions on a consolidated VIE's assets reported by an enterprise in its statement of financial position, including the carrying amounts of such assets, (3) the nature of, and changes in, the risks associated with an enterprise's involvement with the VIE, and (4) how an enterprise's involvement with the VIE affects the enterprise's financial position, financial performance, and cash flows. Describes procedure if disclosures are provided in more than one note to the financial statements.",
        "label": "Organization, Consolidation and Presentation of Financial Statements Disclosure and Significant Accounting Policies [Text Block]",
        "terseLabel": "The Company and a Summary of its Significant Accounting Policies"
       }
      }
     },
     "localname": "OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureAndSignificantAccountingPoliciesTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://dermtech.com/role/TheCompanyandaSummaryofitsSignificantAccountingPolicies"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_OtherAccruedLiabilitiesCurrent": {
     "auth_ref": [
      "r39"
     ],
     "calculation": {
      "http://dermtech.com/role/BalanceSheetDetailsScheduleofAccruedCompensationandAccruedLiabilitiesDetails": {
       "order": 2.0,
       "parentTag": "us-gaap_AccruedLiabilitiesCurrent",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of expenses incurred but not yet paid classified as other, due within one year or the normal operating cycle, if longer.",
        "label": "Other Accrued Liabilities, Current",
        "terseLabel": "Other accrued expenses"
       }
      }
     },
     "localname": "OtherAccruedLiabilitiesCurrent",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://dermtech.com/role/BalanceSheetDetailsScheduleofAccruedCompensationandAccruedLiabilitiesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_OtherAssetsCurrent": {
     "auth_ref": [
      "r34",
      "r450"
     ],
     "calculation": {
      "http://dermtech.com/role/BalanceSheetDetailsScheduleofPrepaidExpensesandPPEDetails": {
       "order": 5.0,
       "parentTag": "us-gaap_PrepaidExpenseAndOtherAssetsCurrent",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of current assets classified as other.",
        "label": "Other Assets, Current",
        "terseLabel": "Other current assets"
       }
      }
     },
     "localname": "OtherAssetsCurrent",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://dermtech.com/role/BalanceSheetDetailsScheduleofPrepaidExpensesandPPEDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_OtherAssetsNoncurrent": {
     "auth_ref": [
      "r17"
     ],
     "calculation": {
      "http://dermtech.com/role/CondensedConsolidatedBalanceSheets": {
       "order": 5.0,
       "parentTag": "us-gaap_Assets",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of noncurrent assets classified as other.",
        "label": "Other Assets, Noncurrent",
        "terseLabel": "Other assets"
       }
      }
     },
     "localname": "OtherAssetsNoncurrent",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://dermtech.com/role/CondensedConsolidatedBalanceSheets"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax": {
     "auth_ref": [
      "r48",
      "r51"
     ],
     "calculation": {
      "http://dermtech.com/role/CondensedConsolidatedStatementsofComprehensiveLoss": {
       "order": 2.0,
       "parentTag": "us-gaap_ComprehensiveIncomeNetOfTax",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount, after tax and before adjustment, of unrealized holding gain (loss) on investment in debt security measured at fair value with change in fair value recognized in other comprehensive income (available-for-sale). Excludes unrealized gain (loss) on investment in debt security measured at amortized cost (held-to-maturity) from transfer to available-for-sale.",
        "label": "OCI, Debt Securities, Available-for-Sale, Unrealized Holding Gain (Loss), before Adjustment, after Tax",
        "terseLabel": "Unrealized net (loss)/gain on available-for-sale marketable securities"
       }
      }
     },
     "localname": "OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://dermtech.com/role/CondensedConsolidatedStatementsofComprehensiveLoss",
      "http://dermtech.com/role/CondensedConsolidatedStatementsofStockholdersEquity"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_OtherLiabilities": {
     "auth_ref": [
      "r508"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of liabilities classified as other.",
        "label": "Other Liabilities",
        "terseLabel": "Other liabilities"
       }
      }
     },
     "localname": "OtherLiabilities",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://dermtech.com/role/LeasesCommitmentsandContingenciesAdoptionofASC842Details"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_PaymentsToAcquireMarketableSecurities": {
     "auth_ref": [
      "r170"
     ],
     "calculation": {
      "http://dermtech.com/role/CondensedConsolidatedStatementsofCashFlows": {
       "order": 2.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInInvestingActivities",
       "weight": -1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of cash outflow for purchase of marketable security.",
        "label": "Payments to Acquire Marketable Securities",
        "negatedLabel": "Purchases of marketable securities"
       }
      }
     },
     "localname": "PaymentsToAcquireMarketableSecurities",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://dermtech.com/role/CondensedConsolidatedStatementsofCashFlows"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_PaymentsToAcquirePropertyPlantAndEquipment": {
     "auth_ref": [
      "r70"
     ],
     "calculation": {
      "http://dermtech.com/role/CondensedConsolidatedStatementsofCashFlows": {
       "order": 1.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInInvestingActivities",
       "weight": -1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The cash outflow associated with the acquisition of long-lived, physical assets that are used in the normal conduct of business to produce goods and services and not intended for resale; includes cash outflows to pay for construction of self-constructed assets.",
        "label": "Payments to Acquire Property, Plant, and Equipment",
        "negatedLabel": "Purchases of property and equipment"
       }
      }
     },
     "localname": "PaymentsToAcquirePropertyPlantAndEquipment",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://dermtech.com/role/CondensedConsolidatedStatementsofCashFlows"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_PlanNameAxis": {
     "auth_ref": [
      "r310",
      "r311",
      "r312",
      "r313",
      "r314",
      "r315",
      "r316",
      "r317",
      "r318",
      "r319",
      "r320",
      "r321",
      "r322",
      "r323",
      "r324",
      "r325",
      "r326",
      "r327",
      "r328",
      "r329",
      "r330",
      "r332",
      "r333",
      "r334",
      "r335",
      "r336"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by plan name for share-based payment arrangement.",
        "label": "Plan Name [Axis]",
        "terseLabel": "Plan Name"
       }
      }
     },
     "localname": "PlanNameAxis",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://dermtech.com/role/StockholdersEquityAdditionalInformationDetails",
      "http://dermtech.com/role/StockholdersEquityESPPValuationMethodDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_PlanNameDomain": {
     "auth_ref": [
      "r310",
      "r311",
      "r312",
      "r313",
      "r314",
      "r315",
      "r316",
      "r317",
      "r318",
      "r319",
      "r320",
      "r321",
      "r322",
      "r323",
      "r324",
      "r325",
      "r326",
      "r327",
      "r328",
      "r329",
      "r330",
      "r332",
      "r333",
      "r334",
      "r335",
      "r336"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Plan name for share-based payment arrangement.",
        "label": "Plan Name [Domain]",
        "terseLabel": "Plan Name"
       }
      }
     },
     "localname": "PlanNameDomain",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://dermtech.com/role/StockholdersEquityAdditionalInformationDetails",
      "http://dermtech.com/role/StockholdersEquityESPPValuationMethodDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_PreferredStockParOrStatedValuePerShare": {
     "auth_ref": [
      "r24",
      "r254"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Face amount or stated value per share of preferred stock nonredeemable or redeemable solely at the option of the issuer.",
        "label": "Preferred Stock, Par or Stated Value Per Share",
        "verboseLabel": "Preferred stock, par value per share (in usd per share)"
       }
      }
     },
     "localname": "PreferredStockParOrStatedValuePerShare",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://dermtech.com/role/StockholdersEquityAdditionalInformationDetails"
     ],
     "xbrltype": "perShareItemType"
    },
    "us-gaap_PreferredStockSharesAuthorized": {
     "auth_ref": [
      "r24"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The maximum number of nonredeemable preferred shares (or preferred stock redeemable solely at the option of the issuer) permitted to be issued by an entity's charter and bylaws.",
        "label": "Preferred Stock, Shares Authorized",
        "verboseLabel": "Preferred stock, shares authorized (in shares)"
       }
      }
     },
     "localname": "PreferredStockSharesAuthorized",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://dermtech.com/role/StockholdersEquityAdditionalInformationDetails"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_PrepaidExpenseAndOtherAssetsCurrent": {
     "auth_ref": [
      "r35"
     ],
     "calculation": {
      "http://dermtech.com/role/BalanceSheetDetailsScheduleofPrepaidExpensesandPPEDetails": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      },
      "http://dermtech.com/role/CondensedConsolidatedBalanceSheets": {
       "order": 5.0,
       "parentTag": "us-gaap_AssetsCurrent",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of asset related to consideration paid in advance for costs that provide economic benefits in future periods, and amount of other assets that are expected to be realized or consumed within one year or the normal operating cycle, if longer.",
        "label": "Prepaid Expense and Other Assets, Current",
        "terseLabel": "Prepaid expenses and other current assets",
        "totalLabel": "Total prepaid expenses and other current assets"
       }
      }
     },
     "localname": "PrepaidExpenseAndOtherAssetsCurrent",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://dermtech.com/role/BalanceSheetDetailsScheduleofPrepaidExpensesandPPEDetails",
      "http://dermtech.com/role/CondensedConsolidatedBalanceSheets"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_PrepaidExpenseAndOtherAssetsCurrentAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Prepaid Expense and Other Assets, Current [Abstract]",
        "terseLabel": "Prepaid expenses and other current assets:"
       }
      }
     },
     "localname": "PrepaidExpenseAndOtherAssetsCurrentAbstract",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://dermtech.com/role/BalanceSheetDetailsScheduleofPrepaidExpensesandPPEDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_PrepaidInsurance": {
     "auth_ref": [
      "r11",
      "r198",
      "r199"
     ],
     "calculation": {
      "http://dermtech.com/role/BalanceSheetDetailsScheduleofPrepaidExpensesandPPEDetails": {
       "order": 1.0,
       "parentTag": "us-gaap_PrepaidExpenseAndOtherAssetsCurrent",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of asset related to consideration paid in advance for insurance that provides economic benefits within a future period of one year or the normal operating cycle, if longer.",
        "label": "Prepaid Insurance",
        "terseLabel": "Prepaid insurance"
       }
      }
     },
     "localname": "PrepaidInsurance",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://dermtech.com/role/BalanceSheetDetailsScheduleofPrepaidExpensesandPPEDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_PriorPeriodReclassificationAdjustmentDescription": {
     "auth_ref": [
      "r5"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disclosure of accounting policy for reclassification affecting comparability of financial statement. Excludes amendment to accounting standards, other change in accounting principle, and correction of error.",
        "label": "Reclassification, Comparability Adjustment [Policy Text Block]",
        "terseLabel": "Reclassifications"
       }
      }
     },
     "localname": "PriorPeriodReclassificationAdjustmentDescription",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://dermtech.com/role/TheCompanyandaSummaryofitsSignificantAccountingPoliciesPolicies"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_ProceedsFromIssuanceOfCommonStock": {
     "auth_ref": [
      "r71"
     ],
     "calculation": {
      "http://dermtech.com/role/CondensedConsolidatedStatementsofCashFlows": {
       "order": 1.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInFinancingActivities",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The cash inflow from the additional capital contribution to the entity.",
        "label": "Proceeds from Issuance of Common Stock",
        "terseLabel": "Proceeds from issuance of common stock"
       }
      }
     },
     "localname": "ProceedsFromIssuanceOfCommonStock",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://dermtech.com/role/CondensedConsolidatedStatementsofCashFlows",
      "http://dermtech.com/role/StockholdersEquityAdditionalInformationDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_ProceedsFromStockPlans": {
     "auth_ref": [
      "r71"
     ],
     "calculation": {
      "http://dermtech.com/role/CondensedConsolidatedStatementsofCashFlows": {
       "order": 3.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInFinancingActivities",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The cash inflow associated with the amount received from the stock plan during the period.",
        "label": "Proceeds from Stock Plans",
        "terseLabel": "Proceeds from contributions to the employee stock purchase plan"
       }
      }
     },
     "localname": "ProceedsFromStockPlans",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://dermtech.com/role/CondensedConsolidatedStatementsofCashFlows"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_ProceedsFromWarrantExercises": {
     "auth_ref": [
      "r71"
     ],
     "calculation": {
      "http://dermtech.com/role/CondensedConsolidatedStatementsofCashFlows": {
       "order": 2.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInFinancingActivities",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The cash inflow associated with the amount received from holders exercising their stock warrants.",
        "label": "Proceeds from Warrant Exercises",
        "terseLabel": "Proceeds from exercise of common stock warrants",
        "verboseLabel": "Total proceeds from exercise of public warrants"
       }
      }
     },
     "localname": "ProceedsFromWarrantExercises",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://dermtech.com/role/CondensedConsolidatedStatementsofCashFlows",
      "http://dermtech.com/role/StockholdersEquityAdditionalInformationDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_ProductInformationLineItems": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.",
        "label": "Product Information [Line Items]",
        "terseLabel": "Product Information [Line Items]"
       }
      }
     },
     "localname": "ProductInformationLineItems",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://dermtech.com/role/TheCompanyandaSummaryofitsSignificantAccountingPoliciesSummaryofPercentagesofTotalRevenueorAccountsReceivableforThirdPartyPayersandPharmaceuticalCustomersDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_ProfitLoss": {
     "auth_ref": [
      "r6",
      "r54",
      "r56",
      "r61",
      "r73",
      "r92",
      "r101",
      "r112",
      "r113",
      "r146",
      "r148",
      "r151",
      "r154",
      "r156",
      "r181",
      "r215",
      "r216",
      "r217",
      "r219",
      "r220",
      "r221",
      "r222",
      "r223",
      "r224",
      "r225",
      "r354",
      "r357",
      "r358",
      "r361",
      "r362",
      "r378",
      "r392",
      "r512"
     ],
     "calculation": {
      "http://dermtech.com/role/CondensedConsolidatedStatementsofCashFlows": {
       "order": 3.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The consolidated profit or loss for the period, net of income taxes, including the portion attributable to the noncontrolling interest.",
        "label": "Net Income (Loss), Including Portion Attributable to Noncontrolling Interest",
        "terseLabel": "Net loss"
       }
      }
     },
     "localname": "ProfitLoss",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://dermtech.com/role/CondensedConsolidatedStatementsofCashFlows"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_PropertyPlantAndEquipmentByTypeAxis": {
     "auth_ref": [
      "r204"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by type of long-lived, physical assets used to produce goods and services and not intended for resale.",
        "label": "Long-Lived Tangible Asset [Axis]",
        "terseLabel": "Long-Lived Tangible Asset"
       }
      }
     },
     "localname": "PropertyPlantAndEquipmentByTypeAxis",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://dermtech.com/role/LeasesCommitmentsandContingenciesAdditionalInformationDetails",
      "http://dermtech.com/role/TheCompanyandaSummaryofitsSignificantAccountingPoliciesAdditionalInformationDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_PropertyPlantAndEquipmentDisposals": {
     "auth_ref": [],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of divestiture of long-lived, physical assets used in the normal conduct of business and not intended for resale. Examples include, but are not limited to, land, buildings, machinery and equipment, office equipment, furniture and fixtures, and computer equipment.",
        "label": "Property, Plant and Equipment, Disposals",
        "terseLabel": "Disposal of plant or equipment"
       }
      }
     },
     "localname": "PropertyPlantAndEquipmentDisposals",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://dermtech.com/role/TheCompanyandaSummaryofitsSignificantAccountingPoliciesAdditionalInformationDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_PropertyPlantAndEquipmentGross": {
     "auth_ref": [
      "r15",
      "r202"
     ],
     "calculation": {
      "http://dermtech.com/role/BalanceSheetDetailsScheduleofPrepaidExpensesandPPEDetails": {
       "order": 1.0,
       "parentTag": "us-gaap_PropertyPlantAndEquipmentNet",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount before accumulated depreciation, depletion and amortization of physical assets used in the normal conduct of business and not intended for resale. Examples include, but are not limited to, land, buildings, machinery and equipment, office equipment, and furniture and fixtures.",
        "label": "Property, Plant and Equipment, Gross",
        "terseLabel": "Gross assets",
        "totalLabel": "Total property and equipment, gross",
        "verboseLabel": "Gross assets"
       }
      }
     },
     "localname": "PropertyPlantAndEquipmentGross",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://dermtech.com/role/BalanceSheetDetailsScheduleofPrepaidExpensesandPPEDetails",
      "http://dermtech.com/role/LeasesCommitmentsandContingenciesAdditionalInformationDetails",
      "http://dermtech.com/role/TheCompanyandaSummaryofitsSignificantAccountingPoliciesAdditionalInformationDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_PropertyPlantAndEquipmentGrossAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Property, Plant and Equipment, Gross [Abstract]",
        "terseLabel": "Property and equipment, gross:"
       }
      }
     },
     "localname": "PropertyPlantAndEquipmentGrossAbstract",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://dermtech.com/role/BalanceSheetDetailsScheduleofPrepaidExpensesandPPEDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_PropertyPlantAndEquipmentNet": {
     "auth_ref": [
      "r204",
      "r450",
      "r514",
      "r522"
     ],
     "calculation": {
      "http://dermtech.com/role/BalanceSheetDetailsScheduleofPrepaidExpensesandPPEDetails": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      },
      "http://dermtech.com/role/CondensedConsolidatedBalanceSheets": {
       "order": 2.0,
       "parentTag": "us-gaap_Assets",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount after accumulated depreciation, depletion and amortization of physical assets used in the normal conduct of business to produce goods and services and not intended for resale. Examples include, but are not limited to, land, buildings, machinery and equipment, office equipment, and furniture and fixtures.",
        "label": "Property, Plant and Equipment, Net",
        "terseLabel": "Property and equipment, net",
        "totalLabel": "Total property and equipment, net"
       }
      }
     },
     "localname": "PropertyPlantAndEquipmentNet",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://dermtech.com/role/BalanceSheetDetailsScheduleofPrepaidExpensesandPPEDetails",
      "http://dermtech.com/role/CondensedConsolidatedBalanceSheets"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_PropertyPlantAndEquipmentPolicyTextBlock": {
     "auth_ref": [
      "r204",
      "r552",
      "r553"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disclosure of accounting policy for long-lived, physical asset used in normal conduct of business and not intended for resale. Includes, but is not limited to, work of art, historical treasure, and similar asset classified as collections.",
        "label": "Property, Plant and Equipment, Policy [Policy Text Block]",
        "terseLabel": "Property and Equipment, Net"
       }
      }
     },
     "localname": "PropertyPlantAndEquipmentPolicyTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://dermtech.com/role/TheCompanyandaSummaryofitsSignificantAccountingPoliciesPolicies"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_PropertyPlantAndEquipmentTypeDomain": {
     "auth_ref": [
      "r202"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Listing of long-lived, physical assets that are used in the normal conduct of business to produce goods and services and not intended for resale. Examples include land, buildings, machinery and equipment, and other types of furniture and equipment including, but not limited to, office equipment, furniture and fixtures, and computer equipment and software.",
        "label": "Long-Lived Tangible Asset [Domain]",
        "terseLabel": "Long-Lived Tangible Asset"
       }
      }
     },
     "localname": "PropertyPlantAndEquipmentTypeDomain",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://dermtech.com/role/LeasesCommitmentsandContingenciesAdditionalInformationDetails",
      "http://dermtech.com/role/TheCompanyandaSummaryofitsSignificantAccountingPoliciesAdditionalInformationDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_PropertyPlantAndEquipmentUsefulLife": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Useful life of long lived, physical assets used in the normal conduct of business and not intended for resale, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents the reported fact of one year, five months, and thirteen days. Examples include, but not limited to, land, buildings, machinery and equipment, office equipment, furniture and fixtures, and computer equipment.",
        "label": "Property, Plant and Equipment, Useful Life",
        "terseLabel": "Useful life of the assets"
       }
      }
     },
     "localname": "PropertyPlantAndEquipmentUsefulLife",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://dermtech.com/role/TheCompanyandaSummaryofitsSignificantAccountingPoliciesAdditionalInformationDetails"
     ],
     "xbrltype": "durationItemType"
    },
    "us-gaap_ReceivablesPolicyTextBlock": {
     "auth_ref": [
      "r162",
      "r164",
      "r165",
      "r166"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disclosure of accounting policy for receivable. Includes, but is not limited to, accounts receivable and financing receivable.",
        "label": "Receivable [Policy Text Block]",
        "terseLabel": "Accounts Receivable"
       }
      }
     },
     "localname": "ReceivablesPolicyTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://dermtech.com/role/TheCompanyandaSummaryofitsSignificantAccountingPoliciesPolicies"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_RelatedPartyDomain": {
     "auth_ref": [
      "r301",
      "r442",
      "r443"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Related parties include affiliates; other entities for which investments are accounted for by the equity method by the entity; trusts for benefit of employees; and principal owners, management, and members of immediate families. It also may include other parties with which the entity may control or can significantly influence the management or operating policies of the other to an extent that one of the transacting parties might be prevented from fully pursuing its own separate interests.",
        "label": "Related Party [Domain]",
        "terseLabel": "Related Party"
       }
      }
     },
     "localname": "RelatedPartyDomain",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://dermtech.com/role/RelatedPartyTransactionsAdditionalInformationDetails",
      "http://dermtech.com/role/StockholdersEquityAdditionalInformationDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_RelatedPartyTransactionAxis": {
     "auth_ref": [
      "r301",
      "r442",
      "r443",
      "r445"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by type of related party transaction.",
        "label": "Related Party Transaction [Axis]",
        "terseLabel": "Related Party Transaction"
       }
      }
     },
     "localname": "RelatedPartyTransactionAxis",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://dermtech.com/role/RelatedPartyTransactionsAdditionalInformationDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_RelatedPartyTransactionDomain": {
     "auth_ref": [
      "r301"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Transaction between related party.",
        "label": "Related Party Transaction [Domain]",
        "terseLabel": "Related Party Transaction"
       }
      }
     },
     "localname": "RelatedPartyTransactionDomain",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://dermtech.com/role/RelatedPartyTransactionsAdditionalInformationDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_RelatedPartyTransactionExpensesFromTransactionsWithRelatedParty": {
     "auth_ref": [
      "r442"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Expenses recognized resulting from transactions (excluding transactions that are eliminated in consolidated or combined financial statements) with related party.",
        "label": "Related Party Transaction, Expenses from Transactions with Related Party",
        "terseLabel": "Related party transaction, other"
       }
      }
     },
     "localname": "RelatedPartyTransactionExpensesFromTransactionsWithRelatedParty",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://dermtech.com/role/RelatedPartyTransactionsAdditionalInformationDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_RelatedPartyTransactionLineItems": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.",
        "label": "Related Party Transaction [Line Items]",
        "terseLabel": "Related Party Transaction [Line Items]"
       }
      }
     },
     "localname": "RelatedPartyTransactionLineItems",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://dermtech.com/role/RelatedPartyTransactionsAdditionalInformationDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_RelatedPartyTransactionSellingGeneralAndAdministrativeExpensesFromTransactionsWithRelatedParty": {
     "auth_ref": [],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of selling, general and administrative expenses resulting from transactions, excluding transactions that are eliminated in consolidated or combined financial statements, with related party.",
        "label": "Related Party Transaction, Selling, General and Administrative Expenses from Transactions with Related Party",
        "terseLabel": "Related party certain marketing cost"
       }
      }
     },
     "localname": "RelatedPartyTransactionSellingGeneralAndAdministrativeExpensesFromTransactionsWithRelatedParty",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://dermtech.com/role/RelatedPartyTransactionsAdditionalInformationDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_RelatedPartyTransactionsAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Related Party Transactions [Abstract]",
        "terseLabel": "Related Party Transactions [Abstract]"
       }
      }
     },
     "localname": "RelatedPartyTransactionsAbstract",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "xbrltype": "stringItemType"
    },
    "us-gaap_RelatedPartyTransactionsByRelatedPartyAxis": {
     "auth_ref": [
      "r301",
      "r442",
      "r445",
      "r489",
      "r490",
      "r491",
      "r492",
      "r493",
      "r494",
      "r495",
      "r496",
      "r497",
      "r498",
      "r499",
      "r500"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by type of related party. Related parties include, but not limited to, affiliates; other entities for which investments are accounted for by the equity method by the entity; trusts for benefit of employees; and principal owners, management, and members of immediate families. It also may include other parties with which the entity may control or can significantly influence the management or operating policies of the other to an extent that one of the transacting parties might be prevented from fully pursuing its own separate interests.",
        "label": "Related Party [Axis]",
        "terseLabel": "Related Party"
       }
      }
     },
     "localname": "RelatedPartyTransactionsByRelatedPartyAxis",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://dermtech.com/role/RelatedPartyTransactionsAdditionalInformationDetails",
      "http://dermtech.com/role/StockholdersEquityAdditionalInformationDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_RelatedPartyTransactionsDisclosureTextBlock": {
     "auth_ref": [
      "r440",
      "r441",
      "r443",
      "r446",
      "r447"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The entire disclosure for related party transactions. Examples of related party transactions include transactions between (a) a parent company and its subsidiary; (b) subsidiaries of a common parent; (c) and entity and its principal owners; and (d) affiliates.",
        "label": "Related Party Transactions Disclosure [Text Block]",
        "terseLabel": "Related Party Transactions"
       }
      }
     },
     "localname": "RelatedPartyTransactionsDisclosureTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://dermtech.com/role/RelatedPartyTransactions"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_RepaymentsOfDebtAndCapitalLeaseObligations": {
     "auth_ref": [],
     "calculation": {
      "http://dermtech.com/role/CondensedConsolidatedStatementsofCashFlows": {
       "order": 4.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInFinancingActivities",
       "weight": -1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of cash outflow for short-term and long-term debt and lease obligation.",
        "label": "Repayments of Debt and Lease Obligation",
        "negatedLabel": "Principal repayments of capital lease obligations"
       }
      }
     },
     "localname": "RepaymentsOfDebtAndCapitalLeaseObligations",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://dermtech.com/role/CondensedConsolidatedStatementsofCashFlows"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_ResearchAndDevelopmentExpense": {
     "auth_ref": [
      "r345",
      "r484",
      "r556"
     ],
     "calculation": {
      "http://dermtech.com/role/CondensedConsolidatedStatementsofOperations": {
       "order": 2.0,
       "parentTag": "us-gaap_OperatingExpenses",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The aggregate costs incurred (1) in a planned search or critical investigation aimed at discovery of new knowledge with the hope that such knowledge will be useful in developing a new product or service, a new process or technique, or in bringing about a significant improvement to an existing product or process; or (2) to translate research findings or other knowledge into a plan or design for a new product or process or for a significant improvement to an existing product or process whether intended for sale or the entity's use, during the reporting period charged to research and development projects, including the costs of developing computer software up to the point in time of achieving technological feasibility, and costs allocated in accounting for a business combination to in-process projects deemed to have no alternative future use.",
        "label": "Research and Development Expense",
        "terseLabel": "Research and development"
       }
      }
     },
     "localname": "ResearchAndDevelopmentExpense",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://dermtech.com/role/CondensedConsolidatedStatementsofOperations"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_ResearchAndDevelopmentExpenseMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Primary financial statement caption in which the reported facts about research and development expense have been included.",
        "label": "Research and Development Expense [Member]",
        "terseLabel": "Research and development"
       }
      }
     },
     "localname": "ResearchAndDevelopmentExpenseMember",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://dermtech.com/role/StockholdersEquityShareBasedCompensationExpenseDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_RestrictedCash": {
     "auth_ref": [
      "r14",
      "r86",
      "r501",
      "r518"
     ],
     "calculation": {
      "http://dermtech.com/role/CondensedConsolidatedStatementsofCashFlows": {
       "order": 2.0,
       "parentTag": "us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of cash restricted as to withdrawal or usage. Cash includes, but is not limited to, currency on hand, demand deposits with banks or financial institutions, and other accounts with general characteristics of demand deposits.",
        "label": "Restricted Cash",
        "terseLabel": "Restricted cash"
       }
      }
     },
     "localname": "RestrictedCash",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://dermtech.com/role/CondensedConsolidatedStatementsofCashFlows"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_RestrictedCashAndCashEquivalents": {
     "auth_ref": [
      "r14",
      "r80",
      "r86",
      "r501",
      "r518"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of cash and cash equivalents restricted as to withdrawal or usage. Cash includes, but is not limited to, currency on hand, demand deposits with banks or financial institutions, and other accounts with general characteristics of demand deposits. Cash equivalents include, but are not limited to, short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates.",
        "label": "Restricted Cash and Cash Equivalents",
        "terseLabel": "Restricted cash and cash equivalents"
       }
      }
     },
     "localname": "RestrictedCashAndCashEquivalents",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://dermtech.com/role/LeasesCommitmentsandContingenciesAdditionalInformationDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_RestrictedCashAndCashEquivalentsAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Restricted Cash and Cash Equivalents [Abstract]",
        "terseLabel": "Reconciliation of cash, cash equivalents and restricted cash, end of period:"
       }
      }
     },
     "localname": "RestrictedCashAndCashEquivalentsAbstract",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://dermtech.com/role/CondensedConsolidatedStatementsofCashFlows"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_RestrictedCashAndCashEquivalentsCashAndCashEquivalentsAxis": {
     "auth_ref": [
      "r36"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by category of cash or cash equivalent items which are restricted as to withdrawal or usage.",
        "label": "Restricted Cash and Cash Equivalents [Axis]",
        "terseLabel": "Restricted Cash and Cash Equivalents [Axis]"
       }
      }
     },
     "localname": "RestrictedCashAndCashEquivalentsCashAndCashEquivalentsAxis",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://dermtech.com/role/LeasesCommitmentsandContingenciesAdditionalInformationDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_RestrictedCashAndCashEquivalentsCashAndCashEquivalentsMember": {
     "auth_ref": [
      "r14"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Type of cash and cash equivalent. Cash is currency on hand as well as demand deposits with banks or financial institutions. Includes other kinds of accounts that have the general characteristics of demand deposits. Also includes short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates.",
        "label": "Cash and Cash Equivalents [Domain]",
        "terseLabel": "Cash and Cash Equivalents [Domain]"
       }
      }
     },
     "localname": "RestrictedCashAndCashEquivalentsCashAndCashEquivalentsMember",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://dermtech.com/role/LeasesCommitmentsandContingenciesAdditionalInformationDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_RestrictedCashNoncurrent": {
     "auth_ref": [
      "r17",
      "r86",
      "r550"
     ],
     "calculation": {
      "http://dermtech.com/role/CondensedConsolidatedBalanceSheets": {
       "order": 4.0,
       "parentTag": "us-gaap_Assets",
       "weight": 1.0
      },
      "http://dermtech.com/role/TheCompanyandaSummaryofitsSignificantAccountingPoliciesSummaryofAssetsandLiabilitiesMeasuredatFairValueonRecurringBasisDetails": {
       "order": 2.0,
       "parentTag": "us-gaap_AssetsFairValueDisclosure",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of cash restricted as to withdrawal or usage, classified as noncurrent. Cash includes, but is not limited to, currency on hand, demand deposits with banks or financial institutions, and other accounts with general characteristics of demand deposits.",
        "label": "Restricted Cash, Noncurrent",
        "terseLabel": "Restricted cash",
        "verboseLabel": "Restricted cash"
       }
      }
     },
     "localname": "RestrictedCashNoncurrent",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://dermtech.com/role/CondensedConsolidatedBalanceSheets",
      "http://dermtech.com/role/TheCompanyandaSummaryofitsSignificantAccountingPoliciesSummaryofAssetsandLiabilitiesMeasuredatFairValueonRecurringBasisDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_RestrictedStockUnitsRSUMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Share instrument which is convertible to stock or an equivalent amount of cash, after a specified period of time or when specified performance conditions are met.",
        "label": "Restricted Stock Units (RSUs) [Member]",
        "terseLabel": "RSUs issued and outstanding"
       }
      }
     },
     "localname": "RestrictedStockUnitsRSUMember",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://dermtech.com/role/StockholdersEquitySummaryofCommonStockReservedforFutureIssuanceDetail"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_RetainedEarningsAccumulatedDeficit": {
     "auth_ref": [
      "r28",
      "r277",
      "r450",
      "r520",
      "r537",
      "r542"
     ],
     "calculation": {
      "http://dermtech.com/role/CondensedConsolidatedBalanceSheets": {
       "order": 4.0,
       "parentTag": "us-gaap_StockholdersEquity",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The cumulative amount of the reporting entity's undistributed earnings or deficit.",
        "label": "Retained Earnings (Accumulated Deficit)",
        "terseLabel": "Accumulated deficit"
       }
      }
     },
     "localname": "RetainedEarningsAccumulatedDeficit",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://dermtech.com/role/CondensedConsolidatedBalanceSheets"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_RetainedEarningsMember": {
     "auth_ref": [
      "r2",
      "r97",
      "r98",
      "r99",
      "r102",
      "r111",
      "r113",
      "r185",
      "r340",
      "r341",
      "r342",
      "r348",
      "r349",
      "r376",
      "r533",
      "r535"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The cumulative amount of the reporting entity's undistributed earnings or deficit.",
        "label": "Retained Earnings [Member]",
        "terseLabel": "Accumulated deficit"
       }
      }
     },
     "localname": "RetainedEarningsMember",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://dermtech.com/role/CondensedConsolidatedStatementsofStockholdersEquity"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax": {
     "auth_ref": [
      "r144",
      "r145",
      "r147",
      "r152",
      "r153",
      "r157",
      "r158",
      "r159",
      "r283",
      "r284",
      "r485"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount, excluding tax collected from customer, of revenue from satisfaction of performance obligation by transferring promised good or service to customer. Tax collected from customer is tax assessed by governmental authority that is both imposed on and concurrent with specific revenue-producing transaction, including, but not limited to, sales, use, value added and excise.",
        "label": "Revenue from Contract with Customer, Excluding Assessed Tax",
        "terseLabel": "Total revenues"
       }
      }
     },
     "localname": "RevenueFromContractWithCustomerExcludingAssessedTax",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://dermtech.com/role/TheCompanyandaSummaryofitsSignificantAccountingPoliciesScheduleofRevenuesDisaggregatedbyRevenueSourceDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_RevenueFromContractWithCustomerIncludingAssessedTax": {
     "auth_ref": [
      "r144",
      "r145",
      "r147",
      "r152",
      "r153",
      "r157",
      "r158",
      "r159",
      "r283",
      "r284",
      "r485"
     ],
     "calculation": {
      "http://dermtech.com/role/CondensedConsolidatedStatementsofOperations": {
       "order": 1.0,
       "parentTag": "us-gaap_GrossProfit",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount, including tax collected from customer, of revenue from satisfaction of performance obligation by transferring promised good or service to customer. Tax collected from customer is tax assessed by governmental authority that is both imposed on and concurrent with specific revenue-producing transaction, including, but not limited to, sales, use, value-added and excise.",
        "label": "Revenue from Contract with Customer, Including Assessed Tax",
        "terseLabel": "Total revenues"
       }
      }
     },
     "localname": "RevenueFromContractWithCustomerIncludingAssessedTax",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://dermtech.com/role/CondensedConsolidatedStatementsofOperations"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_RevenueRecognitionPolicyTextBlock": {
     "auth_ref": [
      "r87",
      "r88"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disclosure of accounting policy for revenue. Includes revenue from contract with customer and from other sources.",
        "label": "Revenue [Policy Text Block]",
        "terseLabel": "Revenue Recognition"
       }
      }
     },
     "localname": "RevenueRecognitionPolicyTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://dermtech.com/role/TheCompanyandaSummaryofitsSignificantAccountingPoliciesPolicies"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_RevenueRemainingPerformanceObligation": {
     "auth_ref": [
      "r281"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of transaction price allocated to performance obligation that has not been recognized as revenue.",
        "label": "Revenue, Remaining Performance Obligation, Amount",
        "terseLabel": "Remaining performance obligation, estimated revenue expected to be recognized"
       }
      }
     },
     "localname": "RevenueRemainingPerformanceObligation",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://dermtech.com/role/TheCompanyandaSummaryofitsSignificantAccountingPoliciesAdditionalInformationDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionPeriod1": {
     "auth_ref": [
      "r282"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Period in which remaining performance obligation is expected to be recognized as revenue, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents reported fact of one year, five months, and thirteen days.",
        "label": "Revenue, Remaining Performance Obligation, Expected Timing of Satisfaction, Period",
        "terseLabel": "Revenue, remaining performance obligation, expected timing of satisfaction, period"
       }
      }
     },
     "localname": "RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionPeriod1",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://dermtech.com/role/TheCompanyandaSummaryofitsSignificantAccountingPoliciesAdditionalInformationDetails"
     ],
     "xbrltype": "durationItemType"
    },
    "us-gaap_RevenuesAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Revenues [Abstract]",
        "terseLabel": "Revenues:"
       }
      }
     },
     "localname": "RevenuesAbstract",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://dermtech.com/role/CondensedConsolidatedStatementsofOperations"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_RightOfUseAssetObtainedInExchangeForFinanceLeaseLiability": {
     "auth_ref": [
      "r428",
      "r433"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of increase in right-of-use asset obtained in exchange for finance lease liability.",
        "label": "Right-of-Use Asset Obtained in Exchange for Finance Lease Liability",
        "terseLabel": "Right-of-use assets obtained in exchange for finance lease obligations"
       }
      }
     },
     "localname": "RightOfUseAssetObtainedInExchangeForFinanceLeaseLiability",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://dermtech.com/role/LeasesCommitmentsandContingenciesComponentsofLeaseExpenseDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability": {
     "auth_ref": [
      "r428",
      "r433"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of increase in right-of-use asset obtained in exchange for operating lease liability.",
        "label": "Right-of-Use Asset Obtained in Exchange for Operating Lease Liability",
        "terseLabel": "Right-of-use assets obtained in exchange for lease obligations",
        "verboseLabel": "Right-of-use assets obtained in exchange for operating lease obligations"
       }
      }
     },
     "localname": "RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://dermtech.com/role/CondensedConsolidatedStatementsofCashFlows",
      "http://dermtech.com/role/LeasesCommitmentsandContingenciesComponentsofLeaseExpenseDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_SaleOfStockNameOfTransactionDomain": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Sale of the entity's stock, including, but not limited to, initial public offering (IPO) and private placement.",
        "label": "Sale of Stock [Domain]",
        "terseLabel": "Sale of Stock"
       }
      }
     },
     "localname": "SaleOfStockNameOfTransactionDomain",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://dermtech.com/role/CondensedConsolidatedStatementsofCashFlows",
      "http://dermtech.com/role/CondensedConsolidatedStatementsofStockholdersEquityParenthetical"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_SaleOfStockNumberOfSharesIssuedInTransaction": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The number of shares issued or sold by the subsidiary or equity method investee per stock transaction.",
        "label": "Sale of Stock, Number of Shares Issued in Transaction",
        "terseLabel": "Sale of stock, number of shares issued in transaction (in shares)"
       }
      }
     },
     "localname": "SaleOfStockNumberOfSharesIssuedInTransaction",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://dermtech.com/role/StockholdersEquityAdditionalInformationDetails"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_SaleOfStockPricePerShare": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Per share amount received by subsidiary or equity investee for each share of common stock issued or sold in the stock transaction.",
        "label": "Sale of Stock, Price Per Share",
        "terseLabel": "Public offering price (in usd per share)"
       }
      }
     },
     "localname": "SaleOfStockPricePerShare",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://dermtech.com/role/StockholdersEquityAdditionalInformationDetails"
     ],
     "xbrltype": "perShareItemType"
    },
    "us-gaap_SalesRevenueNetMember": {
     "auth_ref": [
      "r138",
      "r159"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Revenue from sale of product and rendering of service and other sources of income, when it serves as benchmark in concentration of risk calculation.",
        "label": "Revenue Benchmark [Member]",
        "verboseLabel": "Total Revenues"
       }
      }
     },
     "localname": "SalesRevenueNetMember",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://dermtech.com/role/TheCompanyandaSummaryofitsSignificantAccountingPoliciesSummaryofPercentagesofTotalRevenueorAccountsReceivableforThirdPartyPayersandPharmaceuticalCustomersDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_ScheduleOfAccountsPayableAndAccruedLiabilitiesTableTextBlock": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of the (a) carrying value as of the balance sheet date of liabilities incurred (and for which invoices have typically been received) and payable to vendors for goods and services received that are used in an entity's business (accounts payable); (b) other payables; and (c) accrued liabilities. Examples include taxes, interest, rent and utilities. Used to reflect the current portion of the liabilities (due within one year or within the normal operating cycle if longer). An alternative caption includes accrued expenses.",
        "label": "Schedule of Accounts Payable and Accrued Liabilities [Table Text Block]",
        "terseLabel": "Schedule of Accrued Compensation and Accrued Liabilities"
       }
      }
     },
     "localname": "ScheduleOfAccountsPayableAndAccruedLiabilitiesTableTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://dermtech.com/role/BalanceSheetDetailsTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_ScheduleOfFairValueAssetsAndLiabilitiesMeasuredOnRecurringBasisTableTextBlock": {
     "auth_ref": [
      "r380",
      "r381"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of assets and liabilities, including [financial] instruments measured at fair value that are classified in stockholders' equity, if any, that are measured at fair value on a recurring basis. The disclosures contemplated herein include the fair value measurements at the reporting date by the level within the fair value hierarchy in which the fair value measurements in their entirety fall, segregating fair value measurements using quoted prices in active markets for identical assets (Level 1), significant other observable inputs (Level 2), and significant unobservable inputs (Level 3).",
        "label": "Schedule of Fair Value, Assets and Liabilities Measured on Recurring Basis [Table Text Block]",
        "terseLabel": "Summary of Assets and Liabilities Measured at Fair Value on Recurring Basis"
       }
      }
     },
     "localname": "ScheduleOfFairValueAssetsAndLiabilitiesMeasuredOnRecurringBasisTableTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://dermtech.com/role/TheCompanyandaSummaryofitsSignificantAccountingPoliciesTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_ScheduleOfNewAccountingPronouncementsAndChangesInAccountingPrinciplesTextBlock": {
     "auth_ref": [
      "r105",
      "r108",
      "r126",
      "r127"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of changes in accounting principles, including adoption of new accounting pronouncements, that describes the new methods, amount and effects on financial statement line items.",
        "label": "Accounting Standards Update and Change in Accounting Principle [Table Text Block]",
        "terseLabel": "Schedule of Adoption of ASC 842"
       }
      }
     },
     "localname": "ScheduleOfNewAccountingPronouncementsAndChangesInAccountingPrinciplesTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://dermtech.com/role/LeasesCommitmentsandContingenciesTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_ScheduleOfProductInformationTable": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Schedule detailing quantitative information concerning products or product lines by product or product line.",
        "label": "Schedule of Product Information [Table]",
        "terseLabel": "Schedule Of Product Information [Table]"
       }
      }
     },
     "localname": "ScheduleOfProductInformationTable",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://dermtech.com/role/TheCompanyandaSummaryofitsSignificantAccountingPoliciesSummaryofPercentagesofTotalRevenueorAccountsReceivableforThirdPartyPayersandPharmaceuticalCustomersDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_ScheduleOfProductInformationTableTextBlock": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of product information that are included in the discussion of the nature of an entity's operations.",
        "label": "Schedule of Product Information [Table Text Block]",
        "terseLabel": "Summary of Percentages of Total Revenue or Accounts Receivable for Third Party Payers and Pharmaceutical Customers"
       }
      }
     },
     "localname": "ScheduleOfProductInformationTableTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://dermtech.com/role/TheCompanyandaSummaryofitsSignificantAccountingPoliciesTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_ScheduleOfRelatedPartyTransactionsByRelatedPartyTable": {
     "auth_ref": [
      "r444",
      "r445"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Schedule of quantitative and qualitative information pertaining to related party transactions. Examples of related party transactions include transactions between (a) a parent company and its subsidiary; (b) subsidiaries of a common parent; (c) and entity and its principal owners; and (d) affiliates.",
        "label": "Schedule of Related Party Transactions, by Related Party [Table]",
        "terseLabel": "Schedule Of Related Party Transactions By Related Party [Table]"
       }
      }
     },
     "localname": "ScheduleOfRelatedPartyTransactionsByRelatedPartyTable",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://dermtech.com/role/RelatedPartyTransactionsAdditionalInformationDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable": {
     "auth_ref": [
      "r305",
      "r307",
      "r310",
      "r311",
      "r312",
      "r313",
      "r314",
      "r315",
      "r316",
      "r317",
      "r318",
      "r319",
      "r320",
      "r321",
      "r322",
      "r323",
      "r324",
      "r325",
      "r326",
      "r327",
      "r328",
      "r329",
      "r330",
      "r332",
      "r333",
      "r334",
      "r335",
      "r336"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disclosure of information about share-based payment arrangement.",
        "label": "Schedule of Share-Based Compensation Arrangements by Share-Based Payment Award [Table]",
        "terseLabel": "Schedule Of Share Based Compensation Arrangements By Share Based Payment Award [Table]"
       }
      }
     },
     "localname": "ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://dermtech.com/role/StockholdersEquityShareBasedCompensationExpenseDetails",
      "http://dermtech.com/role/TheCompanyandaSummaryofitsSignificantAccountingPoliciesAssumptionsUsedtoDetermineFairValueofEachOptiononDateofGrantIssuedDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_ScheduleOfShareBasedPaymentAwardEmployeeStockPurchasePlanValuationAssumptionsTableTextBlock": {
     "auth_ref": [
      "r331"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of the significant assumptions used during the year to estimate the fair value of employee stock purchase plans, including, but not limited to: (a) expected term, (b) expected volatility of the entity's shares, (c) expected dividends, (d) risk-free rate(s), and (e) discount for post-vesting restrictions.",
        "label": "Schedule of Share-Based Payment Award, Employee Stock Purchase Plan, Valuation Assumptions [Table Text Block]",
        "terseLabel": "Schedule of Warrant Liability Valuation Method"
       }
      }
     },
     "localname": "ScheduleOfShareBasedPaymentAwardEmployeeStockPurchasePlanValuationAssumptionsTableTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://dermtech.com/role/StockholdersEquityTables",
      "http://dermtech.com/role/TheCompanyandaSummaryofitsSignificantAccountingPoliciesTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_ScheduleOfStockByClassTable": {
     "auth_ref": [
      "r22",
      "r24",
      "r25",
      "r89",
      "r129",
      "r130",
      "r250",
      "r252",
      "r253",
      "r254",
      "r255",
      "r256",
      "r257",
      "r259",
      "r263",
      "r268",
      "r270",
      "r271",
      "r272",
      "r273",
      "r274",
      "r275",
      "r276",
      "r277"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Schedule detailing information related to equity by class of stock. Class of stock includes common, convertible, and preferred stocks which are not redeemable or redeemable solely at the option of the issuer. It also includes preferred stock with redemption features that are solely within the control of the issuer and mandatorily redeemable stock if redemption is required to occur only upon liquidation or termination of the reporting entity.",
        "label": "Schedule of Stock by Class [Table]",
        "terseLabel": "Schedule Of Stock By Class [Table]"
       }
      }
     },
     "localname": "ScheduleOfStockByClassTable",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://dermtech.com/role/StockholdersEquityAdditionalInformationDetails",
      "http://dermtech.com/role/StockholdersEquityESPPValuationMethodDetails",
      "http://dermtech.com/role/StockholdersEquitySummaryofCommonStockReservedforFutureIssuanceDetail"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_ScheduleOfStockByClassTextBlock": {
     "auth_ref": [
      "r23",
      "r24",
      "r25",
      "r251",
      "r252",
      "r253",
      "r271",
      "r272",
      "r273",
      "r274",
      "r275",
      "r276",
      "r277"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of an entity's stock, including par or stated value per share, number and dollar amount of share subscriptions, shares authorized, shares issued, shares outstanding, number and dollar amount of shares held in an employee trust, dividend per share, total dividends, share conversion features, par value plus additional paid in capital, the value of treasury stock and other information necessary to a fair presentation, and EPS information. Stock by class includes common, convertible, and preferred stocks which are not redeemable or redeemable solely at the option of the issuer. Includes preferred stock with redemption features that are solely within the control of the issuer and mandatorily redeemable stock if redemption is required to occur only upon liquidation or termination of the reporting entity. If more than one issue is outstanding, state the title of each issue and the corresponding dollar amount; dollar amount of any shares subscribed but unissued and the deduction of subscriptions receivable there from; number of shares authorized, issued, and outstanding.",
        "label": "Schedule of Stock by Class [Table Text Block]",
        "terseLabel": "Summary of Common Stock Reserved for Future Issuance"
       }
      }
     },
     "localname": "ScheduleOfStockByClassTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://dermtech.com/role/StockholdersEquityTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_SellingAndMarketingExpense": {
     "auth_ref": [],
     "calculation": {
      "http://dermtech.com/role/CondensedConsolidatedStatementsofOperations": {
       "order": 1.0,
       "parentTag": "us-gaap_OperatingExpenses",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The aggregate total amount of expenses directly related to the marketing or selling of products or services.",
        "label": "Selling and Marketing Expense",
        "terseLabel": "Sales and marketing"
       }
      }
     },
     "localname": "SellingAndMarketingExpense",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://dermtech.com/role/CondensedConsolidatedStatementsofOperations"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_SellingAndMarketingExpenseMember": {
     "auth_ref": [
      "r65"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Primary financial statement caption encompassing selling and marketing expense.",
        "label": "Selling and Marketing Expense [Member]",
        "terseLabel": "Sales and marketing"
       }
      }
     },
     "localname": "SellingAndMarketingExpenseMember",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://dermtech.com/role/StockholdersEquityShareBasedCompensationExpenseDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_ShareBasedCompensation": {
     "auth_ref": [
      "r77"
     ],
     "calculation": {
      "http://dermtech.com/role/CondensedConsolidatedStatementsofCashFlows": {
       "order": 6.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of noncash expense for share-based payment arrangement.",
        "label": "Share-Based Payment Arrangement, Noncash Expense",
        "terseLabel": "Stock-based compensation"
       }
      }
     },
     "localname": "ShareBasedCompensation",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://dermtech.com/role/CondensedConsolidatedStatementsofCashFlows"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate": {
     "auth_ref": [
      "r334"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The estimated dividend rate (a percentage of the share price) to be paid (expected dividends) to holders of the underlying shares over the option's term.",
        "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Fair Value Assumptions, Expected Dividend Rate",
        "terseLabel": "Expected dividend yield"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://dermtech.com/role/StockholdersEquityESPPValuationMethodDetails",
      "http://dermtech.com/role/TheCompanyandaSummaryofitsSignificantAccountingPoliciesAssumptionsUsedtoDetermineFairValueofEachOptiononDateofGrantIssuedDetails"
     ],
     "xbrltype": "percentItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate": {
     "auth_ref": [
      "r333"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The estimated measure of the percentage by which a share price is expected to fluctuate during a period. Volatility also may be defined as a probability-weighted measure of the dispersion of returns about the mean. The volatility of a share price is the standard deviation of the continuously compounded rates of return on the share over a specified period. That is the same as the standard deviation of the differences in the natural logarithms of the stock prices plus dividends, if any, over the period.",
        "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Fair Value Assumptions, Expected Volatility Rate",
        "terseLabel": "Assumed volatility"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://dermtech.com/role/StockholdersEquityESPPValuationMethodDetails",
      "http://dermtech.com/role/TheCompanyandaSummaryofitsSignificantAccountingPoliciesAssumptionsUsedtoDetermineFairValueofEachOptiononDateofGrantIssuedDetails"
     ],
     "xbrltype": "percentItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRateMaximum": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The estimated measure of the maximum percentage by which a share price is expected to fluctuate during a period. Volatility also may be defined as a probability-weighted measure of the dispersion of returns about the mean. The volatility of a share price is the standard deviation of the continuously compounded rates of return on the share over a specified period. That is the same as the standard deviation of the differences in the natural logarithms of the stock prices plus dividends, if any, over the period.",
        "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Fair Value Assumptions, Expected Volatility Rate, Maximum",
        "terseLabel": "Assumed volatility, maximum"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRateMaximum",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://dermtech.com/role/StockholdersEquityESPPValuationMethodDetails",
      "http://dermtech.com/role/TheCompanyandaSummaryofitsSignificantAccountingPoliciesAssumptionsUsedtoDetermineFairValueofEachOptiononDateofGrantIssuedDetails"
     ],
     "xbrltype": "percentItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRateMinimum": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The estimated measure of the minimum percentage by which a share price is expected to fluctuate during a period. Volatility also may be defined as a probability-weighted measure of the dispersion of returns about the mean. The volatility of a share price is the standard deviation of the continuously compounded rates of return on the share over a specified period. That is the same as the standard deviation of the differences in the natural logarithms of the stock prices plus dividends, if any, over the period.",
        "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Fair Value Assumptions, Expected Volatility Rate, Minimum",
        "terseLabel": "Assumed volatility, minimum"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRateMinimum",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://dermtech.com/role/StockholdersEquityESPPValuationMethodDetails",
      "http://dermtech.com/role/TheCompanyandaSummaryofitsSignificantAccountingPoliciesAssumptionsUsedtoDetermineFairValueofEachOptiononDateofGrantIssuedDetails"
     ],
     "xbrltype": "percentItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate": {
     "auth_ref": [
      "r335"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The risk-free interest rate assumption that is used in valuing an option on its own shares.",
        "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Fair Value Assumptions, Risk Free Interest Rate",
        "terseLabel": "Assumed risk-free interest rate"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://dermtech.com/role/StockholdersEquityESPPValuationMethodDetails",
      "http://dermtech.com/role/TheCompanyandaSummaryofitsSignificantAccountingPoliciesAssumptionsUsedtoDetermineFairValueofEachOptiononDateofGrantIssuedDetails"
     ],
     "xbrltype": "percentItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMaximum": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The maximum risk-free interest rate assumption that is used in valuing an option on its own shares.",
        "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Fair Value Assumptions, Risk Free Interest Rate, Maximum",
        "terseLabel": "Assumed risk-free interest rate, maximum"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMaximum",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://dermtech.com/role/StockholdersEquityESPPValuationMethodDetails",
      "http://dermtech.com/role/TheCompanyandaSummaryofitsSignificantAccountingPoliciesAssumptionsUsedtoDetermineFairValueofEachOptiononDateofGrantIssuedDetails"
     ],
     "xbrltype": "percentItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMinimum": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The minimum risk-free interest rate assumption that is used in valuing an option on its own shares.",
        "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Fair Value Assumptions, Risk Free Interest Rate, Minimum",
        "terseLabel": "Assumed risk-free interest rate, minimum"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMinimum",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://dermtech.com/role/StockholdersEquityESPPValuationMethodDetails",
      "http://dermtech.com/role/TheCompanyandaSummaryofitsSignificantAccountingPoliciesAssumptionsUsedtoDetermineFairValueofEachOptiononDateofGrantIssuedDetails"
     ],
     "xbrltype": "percentItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.",
        "label": "Share-Based Compensation Arrangement by Share-Based Payment Award [Line Items]",
        "terseLabel": "Share Based Compensation Arrangement By Share Based Payment Award [Line Items]"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://dermtech.com/role/StockholdersEquityShareBasedCompensationExpenseDetails",
      "http://dermtech.com/role/TheCompanyandaSummaryofitsSignificantAccountingPoliciesAssumptionsUsedtoDetermineFairValueofEachOptiononDateofGrantIssuedDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant": {
     "auth_ref": [
      "r339"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The difference between the maximum number of shares (or other type of equity) authorized for issuance under the plan (including the effects of amendments and adjustments), and the sum of: 1) the number of shares (or other type of equity) already issued upon exercise of options or other equity-based awards under the plan; and 2) shares (or other type of equity) reserved for issuance on granting of outstanding awards, net of cancellations and forfeitures, if applicable.",
        "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Number of Shares Available for Grant",
        "terseLabel": "Options remain available for issuance pursuant to future grants (in shares)"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://dermtech.com/role/StockholdersEquityAdditionalInformationDetails"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain": {
     "auth_ref": [
      "r310",
      "r311",
      "r312",
      "r313",
      "r314",
      "r315",
      "r316",
      "r317",
      "r318",
      "r319",
      "r320",
      "r321",
      "r322",
      "r323",
      "r324",
      "r325",
      "r326",
      "r327",
      "r328",
      "r329",
      "r330",
      "r332",
      "r333",
      "r334",
      "r335",
      "r336"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Award under share-based payment arrangement.",
        "label": "Award Type [Domain]",
        "terseLabel": "Award Type"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://dermtech.com/role/StockholdersEquityAdditionalInformationDetails",
      "http://dermtech.com/role/StockholdersEquitySummaryofCommonStockReservedforFutureIssuanceDetail"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardExpirationPeriod": {
     "auth_ref": [
      "r311"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Period from grant date that an equity-based award expires, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents the reported fact of one year, five months, and thirteen days.",
        "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Expiration Period",
        "terseLabel": "Contractual term of options granted"
       }
      }
     },
     "localname": "SharebasedCompensationArrangementBySharebasedPaymentAwardExpirationPeriod",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://dermtech.com/role/StockholdersEquityAdditionalInformationDetails"
     ],
     "xbrltype": "durationItemType"
    },
    "us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1": {
     "auth_ref": [
      "r332"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Expected term of award under share-based payment arrangement, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents reported fact of one year, five months, and thirteen days.",
        "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Fair Value Assumptions, Expected Term",
        "terseLabel": "Expected term"
       }
      }
     },
     "localname": "SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://dermtech.com/role/StockholdersEquityESPPValuationMethodDetails",
      "http://dermtech.com/role/TheCompanyandaSummaryofitsSignificantAccountingPoliciesAssumptionsUsedtoDetermineFairValueofEachOptiononDateofGrantIssuedDetails"
     ],
     "xbrltype": "durationItemType"
    },
    "us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardPurchasePriceOfCommonStockPercent": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Purchase price of common stock expressed as a percentage of its fair value.",
        "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Purchase Price of Common Stock, Percent",
        "terseLabel": "Options granted, exercise price expressed as a percentage of fair market value"
       }
      }
     },
     "localname": "SharebasedCompensationArrangementBySharebasedPaymentAwardPurchasePriceOfCommonStockPercent",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://dermtech.com/role/StockholdersEquityAdditionalInformationDetails"
     ],
     "xbrltype": "percentItemType"
    },
    "us-gaap_SharesIssued": {
     "auth_ref": [
      "r270"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Number of shares of stock issued as of the balance sheet date, including shares that had been issued and were previously outstanding but which are now held in the treasury.",
        "label": "Shares, Issued",
        "verboseLabel": "Shares, issued (in shares)"
       }
      }
     },
     "localname": "SharesIssued",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://dermtech.com/role/StockholdersEquityAdditionalInformationDetails"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_SharesIssuedPricePerShare": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Per share or per unit amount of equity securities issued.",
        "label": "Shares Issued, Price Per Share",
        "terseLabel": "Issuance price per share (in usd per share)"
       }
      }
     },
     "localname": "SharesIssuedPricePerShare",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://dermtech.com/role/CondensedConsolidatedStatementsofStockholdersEquityParenthetical"
     ],
     "xbrltype": "perShareItemType"
    },
    "us-gaap_SharesOutstanding": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Number of shares issued which are neither cancelled nor held in the treasury.",
        "label": "Shares, Outstanding",
        "periodEndLabel": "Ending balance (in shares)",
        "periodStartLabel": "Beginning balance (in shares)"
       }
      }
     },
     "localname": "SharesOutstanding",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://dermtech.com/role/CondensedConsolidatedStatementsofStockholdersEquity"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_StandbyLettersOfCreditMember": {
     "auth_ref": [
      "r213",
      "r214",
      "r353",
      "r545"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "An irrevocable undertaking (typically by a financial institution) to guarantee payment of a specified financial obligation.",
        "label": "Standby Letters of Credit [Member]",
        "terseLabel": "Standby Letter of Credit"
       }
      }
     },
     "localname": "StandbyLettersOfCreditMember",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://dermtech.com/role/LeasesCommitmentsandContingenciesAdditionalInformationDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_StatementEquityComponentsAxis": {
     "auth_ref": [
      "r2",
      "r43",
      "r59",
      "r60",
      "r61",
      "r97",
      "r98",
      "r99",
      "r102",
      "r111",
      "r113",
      "r128",
      "r185",
      "r270",
      "r277",
      "r340",
      "r341",
      "r342",
      "r348",
      "r349",
      "r376",
      "r402",
      "r403",
      "r404",
      "r405",
      "r406",
      "r407",
      "r439",
      "r533",
      "r534",
      "r535"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by component of equity.",
        "label": "Equity Components [Axis]",
        "terseLabel": "Equity Components"
       }
      }
     },
     "localname": "StatementEquityComponentsAxis",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://dermtech.com/role/CondensedConsolidatedStatementsofStockholdersEquity",
      "http://dermtech.com/role/CondensedConsolidatedStatementsofStockholdersEquityParenthetical",
      "http://dermtech.com/role/StockholdersEquityAdditionalInformationDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_StatementLineItems": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.",
        "label": "Statement [Line Items]",
        "terseLabel": "Statement [Line Items]"
       }
      }
     },
     "localname": "StatementLineItems",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://dermtech.com/role/CondensedConsolidatedStatementsofCashFlows",
      "http://dermtech.com/role/CondensedConsolidatedStatementsofOperations",
      "http://dermtech.com/role/CondensedConsolidatedStatementsofStockholdersEquity",
      "http://dermtech.com/role/CondensedConsolidatedStatementsofStockholdersEquityParenthetical"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_StatementOfCashFlowsAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Statement of Cash Flows [Abstract]",
        "terseLabel": "Statement of Cash Flows [Abstract]"
       }
      }
     },
     "localname": "StatementOfCashFlowsAbstract",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "xbrltype": "stringItemType"
    },
    "us-gaap_StatementOfFinancialPositionAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Statement of Financial Position [Abstract]",
        "terseLabel": "Statement of Financial Position [Abstract]"
       }
      }
     },
     "localname": "StatementOfFinancialPositionAbstract",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "xbrltype": "stringItemType"
    },
    "us-gaap_StatementOfIncomeAndComprehensiveIncomeAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Statement of Comprehensive Income [Abstract]"
       }
      }
     },
     "localname": "StatementOfIncomeAndComprehensiveIncomeAbstract",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "xbrltype": "stringItemType"
    },
    "us-gaap_StatementOfStockholdersEquityAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Statement of Stockholders' Equity [Abstract]",
        "terseLabel": "Statement of Stockholders' Equity [Abstract]"
       }
      }
     },
     "localname": "StatementOfStockholdersEquityAbstract",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "xbrltype": "stringItemType"
    },
    "us-gaap_StatementTable": {
     "auth_ref": [
      "r97",
      "r98",
      "r99",
      "r128",
      "r485"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Schedule reflecting a Statement of Income, Statement of Cash Flows, Statement of Financial Position, Statement of Shareholders' Equity and Other Comprehensive Income, or other statement as needed.",
        "label": "Statement [Table]",
        "terseLabel": "Statement [Table]"
       }
      }
     },
     "localname": "StatementTable",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://dermtech.com/role/CondensedConsolidatedStatementsofCashFlows",
      "http://dermtech.com/role/CondensedConsolidatedStatementsofOperations",
      "http://dermtech.com/role/CondensedConsolidatedStatementsofStockholdersEquity",
      "http://dermtech.com/role/CondensedConsolidatedStatementsofStockholdersEquityParenthetical"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_StockIssuedDuringPeriodSharesEmployeeStockPurchasePlans": {
     "auth_ref": [
      "r24",
      "r25",
      "r270",
      "r277"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Number of shares issued during the period as a result of an employee stock purchase plan.",
        "label": "Stock Issued During Period, Shares, Employee Stock Purchase Plans",
        "terseLabel": "Issuance of common stock from Employee Stock Purchase Plan (in shares)"
       }
      }
     },
     "localname": "StockIssuedDuringPeriodSharesEmployeeStockPurchasePlans",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://dermtech.com/role/CondensedConsolidatedStatementsofStockholdersEquity"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_StockIssuedDuringPeriodSharesNewIssues": {
     "auth_ref": [
      "r24",
      "r25",
      "r270",
      "r277"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Number of new stock issued during the period.",
        "label": "Stock Issued During Period, Shares, New Issues",
        "terseLabel": "Issuance of stock, net of issuance costs shares (in shares)",
        "verboseLabel": "Issuance of common stock, net of issuance costs shares (in shares)"
       }
      }
     },
     "localname": "StockIssuedDuringPeriodSharesNewIssues",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://dermtech.com/role/CondensedConsolidatedStatementsofStockholdersEquity",
      "http://dermtech.com/role/StockholdersEquityAdditionalInformationDetails"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_StockIssuedDuringPeriodValueEmployeeStockPurchasePlan": {
     "auth_ref": [
      "r24",
      "r25",
      "r270",
      "r277"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Aggregate change in value for stock issued during the period as a result of employee stock purchase plan.",
        "label": "Stock Issued During Period, Value, Employee Stock Purchase Plan",
        "terseLabel": "Issuance of common stock from Employee Stock Purchase Plan"
       }
      }
     },
     "localname": "StockIssuedDuringPeriodValueEmployeeStockPurchasePlan",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://dermtech.com/role/CondensedConsolidatedStatementsofStockholdersEquity"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_StockIssuedDuringPeriodValueNewIssues": {
     "auth_ref": [
      "r24",
      "r25",
      "r270",
      "r277"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Equity impact of the value of new stock issued during the period. Includes shares issued in an initial public offering or a secondary public offering.",
        "label": "Stock Issued During Period, Value, New Issues",
        "terseLabel": "Issuance of stock, net of issuance costs",
        "verboseLabel": "Issuance of preferred stock, total offering amount"
       }
      }
     },
     "localname": "StockIssuedDuringPeriodValueNewIssues",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://dermtech.com/role/CondensedConsolidatedStatementsofStockholdersEquity",
      "http://dermtech.com/role/StockholdersEquityAdditionalInformationDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_StockholdersEquity": {
     "auth_ref": [
      "r25",
      "r30",
      "r31",
      "r92",
      "r163",
      "r181",
      "r392",
      "r450"
     ],
     "calculation": {
      "http://dermtech.com/role/CondensedConsolidatedBalanceSheets": {
       "order": 2.0,
       "parentTag": "us-gaap_LiabilitiesAndStockholdersEquity",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Total of all stockholders' equity (deficit) items, net of receivables from officers, directors, owners, and affiliates of the entity which are attributable to the parent. The amount of the economic entity's stockholders' equity attributable to the parent excludes the amount of stockholders' equity which is allocable to that ownership interest in subsidiary equity which is not attributable to the parent (noncontrolling interest, minority interest). This excludes temporary equity and is sometimes called permanent equity.",
        "label": "Stockholders' Equity Attributable to Parent",
        "periodEndLabel": "Ending balance",
        "periodStartLabel": "Beginning balance",
        "totalLabel": "Total stockholders\u2019 equity"
       }
      }
     },
     "localname": "StockholdersEquity",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://dermtech.com/role/CondensedConsolidatedBalanceSheets",
      "http://dermtech.com/role/CondensedConsolidatedStatementsofStockholdersEquity"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_StockholdersEquityAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Stockholders' Equity Attributable to Parent [Abstract]",
        "terseLabel": "Stockholders\u2019 equity:"
       }
      }
     },
     "localname": "StockholdersEquityAbstract",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://dermtech.com/role/CondensedConsolidatedBalanceSheets"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_StockholdersEquityNoteAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Stockholders' Equity Note [Abstract]",
        "terseLabel": "Stockholders' Equity Note [Abstract]"
       }
      }
     },
     "localname": "StockholdersEquityNoteAbstract",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "xbrltype": "stringItemType"
    },
    "us-gaap_StockholdersEquityNoteDisclosureTextBlock": {
     "auth_ref": [
      "r90",
      "r255",
      "r258",
      "r259",
      "r260",
      "r261",
      "r262",
      "r263",
      "r264",
      "r265",
      "r266",
      "r267",
      "r269",
      "r277",
      "r280",
      "r367"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The entire disclosure for shareholders' equity comprised of portions attributable to the parent entity and noncontrolling interest, including other comprehensive income. Includes, but is not limited to, balances of common stock, preferred stock, additional paid-in capital, other capital and retained earnings, accumulated balance for each classification of other comprehensive income and amount of comprehensive income.",
        "label": "Stockholders' Equity Note Disclosure [Text Block]",
        "terseLabel": "Stockholders' Equity"
       }
      }
     },
     "localname": "StockholdersEquityNoteDisclosureTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://dermtech.com/role/StockholdersEquity"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_StockholdersEquityNoteStockSplitConversionRatio1": {
     "auth_ref": [
      "r278"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Ratio applied to the conversion of stock split, for example but not limited to, one share converted to two or two shares converted to one.",
        "label": "Stockholders' Equity Note, Stock Split, Conversion Ratio",
        "terseLabel": "Conversion ratio of reverse stock split"
       }
      }
     },
     "localname": "StockholdersEquityNoteStockSplitConversionRatio1",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://dermtech.com/role/TheCompanyandaSummaryofitsSignificantAccountingPoliciesAdditionalInformationDetails"
     ],
     "xbrltype": "pureItemType"
    },
    "us-gaap_SubsequentEventsAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Subsequent Events [Abstract]",
        "terseLabel": "Subsequent Events [Abstract]"
       }
      }
     },
     "localname": "SubsequentEventsAbstract",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "xbrltype": "stringItemType"
    },
    "us-gaap_SubsequentEventsTextBlock": {
     "auth_ref": [
      "r451",
      "r452"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The entire disclosure for significant events or transactions that occurred after the balance sheet date through the date the financial statements were issued or the date the financial statements were available to be issued. Examples include: the sale of a capital stock issue, purchase of a business, settlement of litigation, catastrophic loss, significant foreign exchange rate changes, loans to insiders or affiliates, and transactions not in the ordinary course of business.",
        "label": "Subsequent Events [Text Block]",
        "terseLabel": "Subsequent Events"
       }
      }
     },
     "localname": "SubsequentEventsTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://dermtech.com/role/SubsequentEvents"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_SubsidiarySaleOfStockAxis": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by type of sale of the entity's stock.",
        "label": "Sale of Stock [Axis]",
        "terseLabel": "Sale of Stock"
       }
      }
     },
     "localname": "SubsidiarySaleOfStockAxis",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://dermtech.com/role/CondensedConsolidatedStatementsofCashFlows",
      "http://dermtech.com/role/CondensedConsolidatedStatementsofStockholdersEquityParenthetical"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_SupplementalBalanceSheetDisclosuresTextBlock": {
     "auth_ref": [
      "r47"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The entire disclosure for supplemental balance sheet disclosures, including descriptions and amounts for assets, liabilities, and equity.",
        "label": "Supplemental Balance Sheet Disclosures [Text Block]",
        "terseLabel": "Balance Sheet Details"
       }
      }
     },
     "localname": "SupplementalBalanceSheetDisclosuresTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://dermtech.com/role/BalanceSheetDetails"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_SupplementalCashFlowInformationAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Supplemental Cash Flow Information [Abstract]",
        "terseLabel": "Supplemental cash flow information:"
       }
      }
     },
     "localname": "SupplementalCashFlowInformationAbstract",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://dermtech.com/role/CondensedConsolidatedStatementsofCashFlows"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_TenantImprovements": {
     "auth_ref": [
      "r523"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Carrying amount as of the balance sheet date of improvements having a life longer than one year that were made for the benefit of one or more tenants.",
        "label": "Tenant Improvements",
        "terseLabel": "Tenant improvements"
       }
      }
     },
     "localname": "TenantImprovements",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://dermtech.com/role/LeasesCommitmentsandContingenciesAdditionalInformationDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain": {
     "auth_ref": [
      "r175",
      "r176",
      "r178",
      "r179",
      "r180",
      "r244",
      "r268",
      "r366",
      "r453",
      "r454",
      "r455",
      "r456",
      "r457",
      "r458",
      "r459",
      "r460",
      "r461",
      "r462",
      "r463",
      "r464",
      "r465",
      "r466",
      "r467",
      "r468",
      "r469",
      "r470",
      "r471",
      "r472",
      "r473",
      "r474",
      "r475",
      "r476",
      "r477",
      "r478",
      "r479",
      "r480",
      "r481",
      "r482",
      "r562",
      "r563",
      "r564",
      "r565",
      "r566",
      "r567",
      "r568"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Instrument or contract that imposes a contractual obligation to deliver cash or another financial instrument or to exchange other financial instruments on potentially unfavorable terms and conveys a contractual right to receive cash or another financial instrument or to exchange other financial instruments on potentially favorable terms.",
        "label": "Financial Instruments [Domain]",
        "terseLabel": "Financial Instruments"
       }
      }
     },
     "localname": "TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://dermtech.com/role/BalanceSheetDetailsScheduleofShortTermMarketableSecuritiesDetails",
      "http://dermtech.com/role/TheCompanyandaSummaryofitsSignificantAccountingPoliciesAssumptionsUsedtoDetermineFairValueofEachOptiononDateofGrantIssuedDetails",
      "http://dermtech.com/role/TheCompanyandaSummaryofitsSignificantAccountingPoliciesSummaryofAssetsandLiabilitiesMeasuredatFairValueonRecurringBasisDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_TypeOfAdoptionMember": {
     "auth_ref": [
      "r0",
      "r1",
      "r2",
      "r3",
      "r4",
      "r101",
      "r102",
      "r103",
      "r104",
      "r114",
      "r167",
      "r168",
      "r182",
      "r183",
      "r184",
      "r185",
      "r186",
      "r187",
      "r340",
      "r341",
      "r342",
      "r346",
      "r347",
      "r348",
      "r349",
      "r350",
      "r351",
      "r352",
      "r368",
      "r369",
      "r370",
      "r371",
      "r372",
      "r373",
      "r374",
      "r375",
      "r376",
      "r377",
      "r378",
      "r379",
      "r393",
      "r394",
      "r395",
      "r396",
      "r397",
      "r398",
      "r399",
      "r400",
      "r408",
      "r409",
      "r412",
      "r413",
      "r414",
      "r415",
      "r434",
      "r435",
      "r436",
      "r437",
      "r438",
      "r439",
      "r486",
      "r487",
      "r488",
      "r531",
      "r532",
      "r533",
      "r534",
      "r535",
      "r536",
      "r537",
      "r538",
      "r539",
      "r540",
      "r541",
      "r542"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amendment to accounting standards.",
        "label": "Accounting Standards Update [Domain]",
        "terseLabel": "Accounting Standards Update [Domain]"
       }
      }
     },
     "localname": "TypeOfAdoptionMember",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://dermtech.com/role/LeasesCommitmentsandContingenciesAdoptionofASC842Details"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_USGovernmentAgenciesShorttermDebtSecuritiesMember": {
     "auth_ref": [
      "r513"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Debt securities issued by US government agencies, for example, but not limited to, Government National Mortgage Association (GNMA or Ginnie Mae) which have maturities of one year or less. Excludes US Treasury securities and debt issued by Government-sponsored Enterprises (GSEs), for example, but not limited to, Federal Home Loan Mortgage Corporation (FHLMC or Freddie Mac), Federal National Mortgage Association (FNMA or Fannie Mae).",
        "label": "US Government Agencies Short-Term Debt Securities [Member]",
        "terseLabel": "U.S. government debt securities"
       }
      }
     },
     "localname": "USGovernmentAgenciesShorttermDebtSecuritiesMember",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://dermtech.com/role/BalanceSheetDetailsScheduleofShortTermMarketableSecuritiesDetails",
      "http://dermtech.com/role/TheCompanyandaSummaryofitsSignificantAccountingPoliciesSummaryofAssetsandLiabilitiesMeasuredatFairValueonRecurringBasisDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_UnbilledReceivablesCurrent": {
     "auth_ref": [],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount received for services rendered and products shipped, but not yet billed, for non-contractual agreements due within one year or the normal operating cycle, if longer.",
        "label": "Unbilled Receivables, Current",
        "terseLabel": "Unbilled receivables"
       }
      }
     },
     "localname": "UnbilledReceivablesCurrent",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://dermtech.com/role/TheCompanyandaSummaryofitsSignificantAccountingPoliciesAdditionalInformationDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_UseOfEstimates": {
     "auth_ref": [
      "r132",
      "r133",
      "r135",
      "r136",
      "r140",
      "r141",
      "r142"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disclosure of accounting policy for the use of estimates in the preparation of financial statements in conformity with generally accepted accounting principles.",
        "label": "Use of Estimates, Policy [Policy Text Block]",
        "terseLabel": "Use of Estimates"
       }
      }
     },
     "localname": "UseOfEstimates",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://dermtech.com/role/TheCompanyandaSummaryofitsSignificantAccountingPoliciesPolicies"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_VariableLeaseCost": {
     "auth_ref": [
      "r426",
      "r433"
     ],
     "calculation": {
      "http://dermtech.com/role/LeasesCommitmentsandContingenciesComponentsofLeaseExpenseDetails": {
       "order": 2.0,
       "parentTag": "dmtk_OperatingLeaseCosts",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of variable lease cost, excluded from lease liability, recognized when obligation for payment is incurred for finance and operating leases.",
        "label": "Variable Lease, Cost",
        "terseLabel": "Variable lease costs"
       }
      }
     },
     "localname": "VariableLeaseCost",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://dermtech.com/role/LeasesCommitmentsandContingenciesComponentsofLeaseExpenseDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_WarrantMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Security that gives the holder the right to purchase shares of stock in accordance with the terms of the instrument, usually upon payment of a specified amount.",
        "label": "Warrant [Member]",
        "verboseLabel": "Common Stock Warrants"
       }
      }
     },
     "localname": "WarrantMember",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://dermtech.com/role/TheCompanyandaSummaryofitsSignificantAccountingPoliciesAdditionalInformationDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_WarrantsAndRightsOutstanding": {
     "auth_ref": [],
     "calculation": {
      "http://dermtech.com/role/CondensedConsolidatedBalanceSheets": {
       "order": 3.0,
       "parentTag": "us-gaap_Liabilities",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Value of outstanding derivative securities that permit the holder the right to purchase securities (usually equity) from the issuer at a specified price.",
        "label": "Warrants and Rights Outstanding",
        "terseLabel": "Warrant liability"
       }
      }
     },
     "localname": "WarrantsAndRightsOutstanding",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://dermtech.com/role/CondensedConsolidatedBalanceSheets"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_WarrantsAndRightsOutstandingTerm": {
     "auth_ref": [
      "r383"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Period between issuance and expiration of outstanding warrant and right embodying unconditional obligation requiring redemption by transferring asset at specified or determinable date or upon event certain to occur, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents reported fact of one year, five months, and thirteen days.",
        "label": "Warrants and Rights Outstanding, Term",
        "terseLabel": "Warrants expiration period"
       }
      }
     },
     "localname": "WarrantsAndRightsOutstandingTerm",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://dermtech.com/role/StockholdersEquityAdditionalInformationDetails"
     ],
     "xbrltype": "durationItemType"
    },
    "us-gaap_WarrantyRightsAndObligationsFairValueOptionMember": {
     "auth_ref": [
      "r389"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "This element represents the rights and obligations under a warranty that is not a financial instrument (because it requires or permits the warrantor to provide goods or services rather than a cash settlement) but whose terms permit the warrantor to settle by paying a third party to provide those goods or services.",
        "label": "Warranty, Rights and Obligations, Fair Value Option [Member]",
        "terseLabel": "Warranty liability"
       }
      }
     },
     "localname": "WarrantyRightsAndObligationsFairValueOptionMember",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://dermtech.com/role/TheCompanyandaSummaryofitsSignificantAccountingPoliciesAssumptionsUsedtoDetermineFairValueofEachOptiononDateofGrantIssuedDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding": {
     "auth_ref": [
      "r116",
      "r121"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The average number of shares or units issued and outstanding that are used in calculating diluted EPS or earnings per unit (EPU), determined based on the timing of issuance of shares or units in the period.",
        "label": "Weighted Average Number of Shares Outstanding, Diluted",
        "terseLabel": "Weighted average shares outstanding used in computing net loss per share, diluted (in shares)"
       }
      }
     },
     "localname": "WeightedAverageNumberOfDilutedSharesOutstanding",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://dermtech.com/role/CondensedConsolidatedStatementsofOperations"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_WeightedAverageNumberOfSharesOutstandingBasic": {
     "auth_ref": [
      "r115",
      "r121"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Number of [basic] shares or units, after adjustment for contingently issuable shares or units and other shares or units not deemed outstanding, determined by relating the portion of time within a reporting period that common shares or units have been outstanding to the total time in that period.",
        "label": "Weighted Average Number of Shares Outstanding, Basic",
        "terseLabel": "Weighted average shares outstanding used in computing net loss per share, basic (in shares)"
       }
      }
     },
     "localname": "WeightedAverageNumberOfSharesOutstandingBasic",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://dermtech.com/role/CondensedConsolidatedStatementsofOperations"
     ],
     "xbrltype": "sharesItemType"
    }
   },
   "unitCount": 10
  }
 },
 "std_ref": {
  "r0": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "6",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "105",
   "URI": "https://asc.fasb.org/extlink&oid=126987489&loc=SL124442142-165695"
  },
  "r1": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "6",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "105",
   "URI": "https://asc.fasb.org/extlink&oid=126987489&loc=SL124442142-165695"
  },
  "r10": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "210",
   "URI": "https://asc.fasb.org/extlink&oid=124098289&loc=d3e6676-107765"
  },
  "r100": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "6",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "250",
   "URI": "https://asc.fasb.org/extlink&oid=124436220&loc=d3e21728-107793"
  },
  "r101": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)(2)",
   "Topic": "250",
   "URI": "https://asc.fasb.org/extlink&oid=124431687&loc=d3e22499-107794"
  },
  "r102": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)(3)",
   "Topic": "250",
   "URI": "https://asc.fasb.org/extlink&oid=124431687&loc=d3e22499-107794"
  },
  "r103": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)(4)",
   "Topic": "250",
   "URI": "https://asc.fasb.org/extlink&oid=124431687&loc=d3e22499-107794"
  },
  "r104": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)(2)",
   "Topic": "250",
   "URI": "https://asc.fasb.org/extlink&oid=124431687&loc=d3e22499-107794"
  },
  "r105": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "250",
   "URI": "https://asc.fasb.org/extlink&oid=124431687&loc=d3e22499-107794"
  },
  "r106": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "11",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "250",
   "URI": "https://asc.fasb.org/extlink&oid=124431687&loc=d3e22694-107794"
  },
  "r107": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "11",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "250",
   "URI": "https://asc.fasb.org/extlink&oid=124431687&loc=d3e22694-107794"
  },
  "r108": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "250",
   "URI": "https://asc.fasb.org/extlink&oid=124431687&loc=d3e22583-107794"
  },
  "r109": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "250",
   "URI": "https://asc.fasb.org/extlink&oid=124431687&loc=d3e22595-107794"
  },
  "r11": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(g)(1)",
   "Topic": "210",
   "URI": "https://asc.fasb.org/extlink&oid=124098289&loc=d3e6676-107765"
  },
  "r110": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "7",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "250",
   "URI": "https://asc.fasb.org/extlink&oid=124431687&loc=d3e22644-107794"
  },
  "r111": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "7",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "250",
   "URI": "https://asc.fasb.org/extlink&oid=124431687&loc=d3e22644-107794"
  },
  "r112": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "8",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "250",
   "URI": "https://asc.fasb.org/extlink&oid=124431687&loc=d3e22658-107794"
  },
  "r113": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "9",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "250",
   "URI": "https://asc.fasb.org/extlink&oid=124431687&loc=d3e22663-107794"
  },
  "r114": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SAB Topic 11.M.Q2)",
   "Topic": "250",
   "URI": "https://asc.fasb.org/extlink&oid=122038215&loc=d3e31137-122693"
  },
  "r115": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "10",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "260",
   "URI": "https://asc.fasb.org/extlink&oid=126958026&loc=d3e1448-109256"
  },
  "r116": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "16",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "260",
   "URI": "https://asc.fasb.org/extlink&oid=126958026&loc=d3e1505-109256"
  },
  "r117": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "260",
   "URI": "https://asc.fasb.org/extlink&oid=126958026&loc=d3e1252-109256"
  },
  "r118": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "60B",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "260",
   "URI": "https://asc.fasb.org/extlink&oid=126958026&loc=SL5780133-109256"
  },
  "r119": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "60B",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(d)",
   "Topic": "260",
   "URI": "https://asc.fasb.org/extlink&oid=126958026&loc=SL5780133-109256"
  },
  "r12": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "210",
   "URI": "https://asc.fasb.org/extlink&oid=124098289&loc=d3e6676-107765"
  },
  "r120": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "7",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "260",
   "URI": "https://asc.fasb.org/extlink&oid=126958026&loc=d3e1337-109256"
  },
  "r121": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "260",
   "URI": "https://asc.fasb.org/extlink&oid=124432515&loc=d3e3550-109257"
  },
  "r122": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "260",
   "URI": "https://asc.fasb.org/extlink&oid=124432515&loc=d3e3550-109257"
  },
  "r123": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "260",
   "URI": "https://asc.fasb.org/extlink&oid=124432515&loc=d3e3630-109257"
  },
  "r124": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "15",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "10",
   "Topic": "260",
   "URI": "https://asc.fasb.org/extlink&oid=128363288&loc=d3e3842-109258"
  },
  "r125": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "52",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "10",
   "Topic": "260",
   "URI": "https://asc.fasb.org/extlink&oid=128363288&loc=d3e4984-109258"
  },
  "r126": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "12",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "270",
   "URI": "https://asc.fasb.org/extlink&oid=126900757&loc=d3e725-108305"
  },
  "r127": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "13",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "270",
   "URI": "https://asc.fasb.org/extlink&oid=126900757&loc=d3e765-108305"
  },
  "r128": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "272",
   "URI": "https://asc.fasb.org/extlink&oid=125520817&loc=d3e70191-108054"
  },
  "r129": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "272",
   "URI": "https://asc.fasb.org/extlink&oid=125520817&loc=d3e70229-108054"
  },
  "r13": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "210",
   "URI": "https://asc.fasb.org/extlink&oid=124098289&loc=d3e6904-107765"
  },
  "r130": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "272",
   "URI": "https://asc.fasb.org/extlink&oid=6373374&loc=d3e70434-108055"
  },
  "r131": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "275",
   "URI": "https://asc.fasb.org/extlink&oid=99393423&loc=d3e5967-108592"
  },
  "r132": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "275",
   "URI": "https://asc.fasb.org/extlink&oid=99393423&loc=d3e5967-108592"
  },
  "r133": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "275",
   "URI": "https://asc.fasb.org/extlink&oid=99393423&loc=d3e5967-108592"
  },
  "r134": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(d)",
   "Topic": "275",
   "URI": "https://asc.fasb.org/extlink&oid=99393423&loc=d3e5967-108592"
  },
  "r135": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "11",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "275",
   "URI": "https://asc.fasb.org/extlink&oid=99393423&loc=d3e6161-108592"
  },
  "r136": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "12",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "275",
   "URI": "https://asc.fasb.org/extlink&oid=99393423&loc=d3e6191-108592"
  },
  "r137": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "18",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "275",
   "URI": "https://asc.fasb.org/extlink&oid=99393423&loc=d3e6351-108592"
  },
  "r138": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "18",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "275",
   "URI": "https://asc.fasb.org/extlink&oid=99393423&loc=d3e6351-108592"
  },
  "r139": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "20",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "275",
   "URI": "https://asc.fasb.org/extlink&oid=99393423&loc=d3e6404-108592"
  },
  "r14": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(1))",
   "Topic": "210",
   "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r140": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "275",
   "URI": "https://asc.fasb.org/extlink&oid=99393423&loc=d3e6061-108592"
  },
  "r141": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "8",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "275",
   "URI": "https://asc.fasb.org/extlink&oid=99393423&loc=d3e6132-108592"
  },
  "r142": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "9",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "275",
   "URI": "https://asc.fasb.org/extlink&oid=99393423&loc=d3e6143-108592"
  },
  "r143": {
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "Topic": "275",
   "URI": "https://asc.fasb.org/topic&trid=2134479"
  },
  "r144": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "22",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "280",
   "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e8736-108599"
  },
  "r145": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "22",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "280",
   "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e8736-108599"
  },
  "r146": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "22",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "280",
   "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e8736-108599"
  },
  "r147": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "30",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "280",
   "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e8906-108599"
  },
  "r148": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "30",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "280",
   "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e8906-108599"
  },
  "r149": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "30",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "280",
   "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e8906-108599"
  },
  "r15": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(13))",
   "Topic": "210",
   "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r150": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "30",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(d)",
   "Topic": "280",
   "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e8906-108599"
  },
  "r151": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "31",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "280",
   "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e8924-108599"
  },
  "r152": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "32",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "280",
   "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e8933-108599"
  },
  "r153": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "32",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "280",
   "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e8933-108599"
  },
  "r154": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "32",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "280",
   "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e8933-108599"
  },
  "r155": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "32",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(d)",
   "Topic": "280",
   "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e8933-108599"
  },
  "r156": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "32",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(f)",
   "Topic": "280",
   "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e8933-108599"
  },
  "r157": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "40",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "280",
   "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e9031-108599"
  },
  "r158": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "41",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "280",
   "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e9038-108599"
  },
  "r159": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "42",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "280",
   "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e9054-108599"
  },
  "r16": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(14))",
   "Topic": "210",
   "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r160": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "310",
   "URI": "https://asc.fasb.org/extlink&oid=124259787&loc=d3e4428-111522"
  },
  "r161": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "9",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "310",
   "URI": "https://asc.fasb.org/extlink&oid=124259787&loc=d3e4531-111522"
  },
  "r162": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "310",
   "URI": "https://asc.fasb.org/extlink&oid=123577603&loc=d3e5033-111524"
  },
  "r163": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SAB Topic 4.E)",
   "Topic": "310",
   "URI": "https://asc.fasb.org/extlink&oid=122038336&loc=d3e74512-122707"
  },
  "r164": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Topic": "310",
   "URI": "https://asc.fasb.org/extlink&oid=84159169&loc=d3e10133-111534"
  },
  "r165": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Topic": "310",
   "URI": "https://asc.fasb.org/extlink&oid=84159169&loc=d3e10149-111534"
  },
  "r166": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Topic": "310",
   "URI": "https://asc.fasb.org/extlink&oid=84159169&loc=d3e10178-111534"
  },
  "r167": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "20",
   "Subparagraph": "(a)",
   "Topic": "310",
   "URI": "https://asc.fasb.org/extlink&oid=126986314&loc=SL124402458-218513"
  },
  "r168": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "20",
   "Subparagraph": "(b)",
   "Topic": "310",
   "URI": "https://asc.fasb.org/extlink&oid=126986314&loc=SL124402458-218513"
  },
  "r169": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "320",
   "URI": "https://asc.fasb.org/extlink&oid=124260329&loc=d3e26610-111562"
  },
  "r17": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(17))",
   "Topic": "210",
   "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r170": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "11",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "320",
   "URI": "https://asc.fasb.org/extlink&oid=124260329&loc=d3e26853-111562"
  },
  "r171": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "320",
   "URI": "https://asc.fasb.org/extlink&oid=126970911&loc=d3e27161-111563"
  },
  "r172": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(aa)",
   "Topic": "320",
   "URI": "https://asc.fasb.org/extlink&oid=126970911&loc=d3e27161-111563"
  },
  "r173": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "320",
   "URI": "https://asc.fasb.org/extlink&oid=126970911&loc=d3e27161-111563"
  },
  "r174": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "320",
   "URI": "https://asc.fasb.org/extlink&oid=126970911&loc=d3e27161-111563"
  },
  "r175": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "320",
   "URI": "https://asc.fasb.org/extlink&oid=126970911&loc=d3e27232-111563"
  },
  "r176": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5A",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "320",
   "URI": "https://asc.fasb.org/extlink&oid=126970911&loc=SL120269820-111563"
  },
  "r177": {
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "Topic": "320",
   "URI": "https://asc.fasb.org/topic&trid=2196928"
  },
  "r178": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "321",
   "URI": "https://asc.fasb.org/extlink&oid=126980263&loc=SL75117539-209714"
  },
  "r179": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "321",
   "URI": "https://asc.fasb.org/extlink&oid=126980263&loc=SL75117539-209714"
  },
  "r18": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(18))",
   "Topic": "210",
   "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r180": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "321",
   "URI": "https://asc.fasb.org/extlink&oid=126980263&loc=SL75117539-209714"
  },
  "r181": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "323",
   "URI": "https://asc.fasb.org/extlink&oid=114001798&loc=d3e33918-111571"
  },
  "r182": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "326",
   "URI": "https://asc.fasb.org/extlink&oid=122640432&loc=SL121648383-210437"
  },
  "r183": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "326",
   "URI": "https://asc.fasb.org/extlink&oid=122640432&loc=SL121648383-210437"
  },
  "r184": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "326",
   "URI": "https://asc.fasb.org/extlink&oid=122640432&loc=SL121648383-210437"
  },
  "r185": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(d)",
   "Topic": "326",
   "URI": "https://asc.fasb.org/extlink&oid=122640432&loc=SL121648383-210437"
  },
  "r186": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(e)(3)",
   "Topic": "326",
   "URI": "https://asc.fasb.org/extlink&oid=122640432&loc=SL121648383-210437"
  },
  "r187": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(e)(4)",
   "Topic": "326",
   "URI": "https://asc.fasb.org/extlink&oid=122640432&loc=SL121648383-210437"
  },
  "r188": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "11",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Topic": "326",
   "URI": "https://asc.fasb.org/extlink&oid=124255953&loc=SL82919244-210447"
  },
  "r189": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "13",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Topic": "326",
   "URI": "https://asc.fasb.org/extlink&oid=124255953&loc=SL82919249-210447"
  },
  "r19": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(19))",
   "Topic": "210",
   "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r190": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "14",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Topic": "326",
   "URI": "https://asc.fasb.org/extlink&oid=124255953&loc=SL82919253-210447"
  },
  "r191": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "16",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Topic": "326",
   "URI": "https://asc.fasb.org/extlink&oid=124255953&loc=SL82919258-210447"
  },
  "r192": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Topic": "326",
   "URI": "https://asc.fasb.org/extlink&oid=124255953&loc=SL82919230-210447"
  },
  "r193": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "30",
   "Topic": "326",
   "URI": "https://asc.fasb.org/extlink&oid=124258926&loc=SL82898722-210454"
  },
  "r194": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "30",
   "Topic": "326",
   "URI": "https://asc.fasb.org/extlink&oid=124269663&loc=SL82922888-210455"
  },
  "r195": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "7",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "30",
   "Topic": "326",
   "URI": "https://asc.fasb.org/extlink&oid=124269663&loc=SL82922895-210455"
  },
  "r196": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "9",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "30",
   "Topic": "326",
   "URI": "https://asc.fasb.org/extlink&oid=124269663&loc=SL82922900-210455"
  },
  "r197": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "8",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "30",
   "Topic": "326",
   "URI": "https://asc.fasb.org/extlink&oid=121590138&loc=SL82922954-210456"
  },
  "r198": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5",
   "Publisher": "FASB",
   "Section": "05",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "340",
   "URI": "https://asc.fasb.org/extlink&oid=126905020&loc=d3e5879-108316"
  },
  "r199": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "340",
   "URI": "https://asc.fasb.org/extlink&oid=6387103&loc=d3e6435-108320"
  },
  "r2": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "6",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "105",
   "URI": "https://asc.fasb.org/extlink&oid=126987489&loc=SL124442142-165695"
  },
  "r20": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(20))",
   "Topic": "210",
   "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r200": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "15",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "360",
   "URI": "https://asc.fasb.org/extlink&oid=126905981&loc=d3e2611-110228"
  },
  "r201": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "360",
   "URI": "https://asc.fasb.org/extlink&oid=6391035&loc=d3e2868-110229"
  },
  "r202": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "360",
   "URI": "https://asc.fasb.org/extlink&oid=6391035&loc=d3e2868-110229"
  },
  "r203": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "360",
   "URI": "https://asc.fasb.org/extlink&oid=6391035&loc=d3e2868-110229"
  },
  "r204": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "360",
   "URI": "https://asc.fasb.org/extlink&oid=6391035&loc=d3e2868-110229"
  },
  "r205": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(d)",
   "Topic": "360",
   "URI": "https://asc.fasb.org/extlink&oid=109226691&loc=d3e2941-110230"
  },
  "r206": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "10",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "30",
   "Subparagraph": "(c)",
   "Topic": "410",
   "URI": "https://asc.fasb.org/extlink&oid=6393242&loc=d3e13237-110859"
  },
  "r207": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "420",
   "URI": "https://asc.fasb.org/extlink&oid=6394359&loc=d3e17939-110869"
  },
  "r208": {
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "Topic": "440",
   "URI": "https://asc.fasb.org/topic&trid=2144648"
  },
  "r209": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(b)",
   "Topic": "450",
   "URI": "https://asc.fasb.org/extlink&oid=121557415&loc=d3e14435-108349"
  },
  "r21": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(22))",
   "Topic": "210",
   "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r210": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "9",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(b)",
   "Topic": "450",
   "URI": "https://asc.fasb.org/extlink&oid=121557415&loc=d3e14557-108349"
  },
  "r211": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "20",
   "Subparagraph": "(SAB Topic 5.Y.Q2)",
   "Topic": "450",
   "URI": "https://asc.fasb.org/extlink&oid=27011672&loc=d3e149879-122751"
  },
  "r212": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "20",
   "Subparagraph": "(SAB Topic 5.Y.Q4)",
   "Topic": "450",
   "URI": "https://asc.fasb.org/extlink&oid=27011672&loc=d3e149879-122751"
  },
  "r213": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "460",
   "URI": "https://asc.fasb.org/extlink&oid=124440162&loc=d3e12021-110248"
  },
  "r214": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "460",
   "URI": "https://asc.fasb.org/extlink&oid=126907907&loc=d3e12803-110250"
  },
  "r215": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1A",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.13-01(a)(4)(i))",
   "Topic": "470",
   "URI": "https://asc.fasb.org/extlink&oid=126975872&loc=SL124442526-122756"
  },
  "r216": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1A",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.13-01(a)(4)(ii))",
   "Topic": "470",
   "URI": "https://asc.fasb.org/extlink&oid=126975872&loc=SL124442526-122756"
  },
  "r217": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1A",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.13-01(a)(4)(iii)(A))",
   "Topic": "470",
   "URI": "https://asc.fasb.org/extlink&oid=126975872&loc=SL124442526-122756"
  },
  "r218": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1A",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.13-01(a)(4)(iii))",
   "Topic": "470",
   "URI": "https://asc.fasb.org/extlink&oid=126975872&loc=SL124442526-122756"
  },
  "r219": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1A",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.13-01(a)(4)(iv))",
   "Topic": "470",
   "URI": "https://asc.fasb.org/extlink&oid=126975872&loc=SL124442526-122756"
  },
  "r22": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(27)(b))",
   "Topic": "210",
   "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r220": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1A",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.13-01(a)(5))",
   "Topic": "470",
   "URI": "https://asc.fasb.org/extlink&oid=126975872&loc=SL124442526-122756"
  },
  "r221": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1B",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.13-02(a)(4)(i))",
   "Topic": "470",
   "URI": "https://asc.fasb.org/extlink&oid=126975872&loc=SL124442552-122756"
  },
  "r222": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1B",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.13-02(a)(4)(iii)(A))",
   "Topic": "470",
   "URI": "https://asc.fasb.org/extlink&oid=126975872&loc=SL124442552-122756"
  },
  "r223": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1B",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.13-02(a)(4)(iii)(B))",
   "Topic": "470",
   "URI": "https://asc.fasb.org/extlink&oid=126975872&loc=SL124442552-122756"
  },
  "r224": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1B",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.13-02(a)(4)(iv))",
   "Topic": "470",
   "URI": "https://asc.fasb.org/extlink&oid=126975872&loc=SL124442552-122756"
  },
  "r225": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1B",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.13-02(a)(5))",
   "Topic": "470",
   "URI": "https://asc.fasb.org/extlink&oid=126975872&loc=SL124442552-122756"
  },
  "r226": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "25",
   "SubTopic": "20",
   "Topic": "470",
   "URI": "https://asc.fasb.org/extlink&oid=123466302&loc=d3e4724-112606"
  },
  "r227": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1B",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(a)",
   "Topic": "470",
   "URI": "https://asc.fasb.org/extlink&oid=123466505&loc=SL123495323-112611"
  },
  "r228": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1B",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(b)",
   "Topic": "470",
   "URI": "https://asc.fasb.org/extlink&oid=123466505&loc=SL123495323-112611"
  },
  "r229": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1B",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(c)",
   "Topic": "470",
   "URI": "https://asc.fasb.org/extlink&oid=123466505&loc=SL123495323-112611"
  },
  "r23": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(27))",
   "Topic": "210",
   "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r230": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1B",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(d)",
   "Topic": "470",
   "URI": "https://asc.fasb.org/extlink&oid=123466505&loc=SL123495323-112611"
  },
  "r231": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1B",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(e)",
   "Topic": "470",
   "URI": "https://asc.fasb.org/extlink&oid=123466505&loc=SL123495323-112611"
  },
  "r232": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1B",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(f)",
   "Topic": "470",
   "URI": "https://asc.fasb.org/extlink&oid=123466505&loc=SL123495323-112611"
  },
  "r233": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1B",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(h)",
   "Topic": "470",
   "URI": "https://asc.fasb.org/extlink&oid=123466505&loc=SL123495323-112611"
  },
  "r234": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1D",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(a)",
   "Topic": "470",
   "URI": "https://asc.fasb.org/extlink&oid=123466505&loc=SL123495340-112611"
  },
  "r235": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1D",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(b)",
   "Topic": "470",
   "URI": "https://asc.fasb.org/extlink&oid=123466505&loc=SL123495340-112611"
  },
  "r236": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1D",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(c)",
   "Topic": "470",
   "URI": "https://asc.fasb.org/extlink&oid=123466505&loc=SL123495340-112611"
  },
  "r237": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1E",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(a)",
   "Topic": "470",
   "URI": "https://asc.fasb.org/extlink&oid=123466505&loc=SL123495348-112611"
  },
  "r238": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1E",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(c)",
   "Topic": "470",
   "URI": "https://asc.fasb.org/extlink&oid=123466505&loc=SL123495348-112611"
  },
  "r239": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1E",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(d)",
   "Topic": "470",
   "URI": "https://asc.fasb.org/extlink&oid=123466505&loc=SL123495348-112611"
  },
  "r24": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(28))",
   "Topic": "210",
   "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r240": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1F",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(a)",
   "Topic": "470",
   "URI": "https://asc.fasb.org/extlink&oid=123466505&loc=SL123495355-112611"
  },
  "r241": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1F",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(b)",
   "Topic": "470",
   "URI": "https://asc.fasb.org/extlink&oid=123466505&loc=SL123495355-112611"
  },
  "r242": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1F",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(b)(1)",
   "Topic": "470",
   "URI": "https://asc.fasb.org/extlink&oid=123466505&loc=SL123495355-112611"
  },
  "r243": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1F",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(b)(2)",
   "Topic": "470",
   "URI": "https://asc.fasb.org/extlink&oid=123466505&loc=SL123495355-112611"
  },
  "r244": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1I",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(c)",
   "Topic": "470",
   "URI": "https://asc.fasb.org/extlink&oid=123466505&loc=SL123495371-112611"
  },
  "r245": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "69B",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "20",
   "Topic": "470",
   "URI": "https://asc.fasb.org/extlink&oid=123466577&loc=SL123495735-112612"
  },
  "r246": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "69C",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "20",
   "Topic": "470",
   "URI": "https://asc.fasb.org/extlink&oid=123466577&loc=SL123495737-112612"
  },
  "r247": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "69E",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "20",
   "Topic": "470",
   "URI": "https://asc.fasb.org/extlink&oid=123466577&loc=SL123495743-112612"
  },
  "r248": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "69F",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "20",
   "Topic": "470",
   "URI": "https://asc.fasb.org/extlink&oid=123466577&loc=SL123495745-112612"
  },
  "r249": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "13",
   "Publisher": "FASB",
   "Section": "25",
   "SubTopic": "10",
   "Topic": "480",
   "URI": "https://asc.fasb.org/extlink&oid=109262497&loc=d3e20148-110875"
  },
  "r25": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(29))",
   "Topic": "210",
   "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r250": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(CFRR 211.02)",
   "Topic": "480",
   "URI": "https://asc.fasb.org/extlink&oid=122040564&loc=d3e177068-122764"
  },
  "r251": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Topic": "480",
   "URI": "https://asc.fasb.org/extlink&oid=122040564&loc=d3e177068-122764"
  },
  "r252": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "505",
   "URI": "https://asc.fasb.org/extlink&oid=65888546&loc=d3e21300-112643"
  },
  "r253": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "10",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "505",
   "URI": "https://asc.fasb.org/extlink&oid=126973232&loc=d3e21553-112644"
  },
  "r254": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "13",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "505",
   "URI": "https://asc.fasb.org/extlink&oid=126973232&loc=SL123496158-112644"
  },
  "r255": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "13",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "505",
   "URI": "https://asc.fasb.org/extlink&oid=126973232&loc=SL123496158-112644"
  },
  "r256": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "13",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(d)",
   "Topic": "505",
   "URI": "https://asc.fasb.org/extlink&oid=126973232&loc=SL123496158-112644"
  },
  "r257": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "13",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(e)",
   "Topic": "505",
   "URI": "https://asc.fasb.org/extlink&oid=126973232&loc=SL123496158-112644"
  },
  "r258": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "13",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(g)",
   "Topic": "505",
   "URI": "https://asc.fasb.org/extlink&oid=126973232&loc=SL123496158-112644"
  },
  "r259": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "13",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(h)",
   "Topic": "505",
   "URI": "https://asc.fasb.org/extlink&oid=126973232&loc=SL123496158-112644"
  },
  "r26": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(3)(a)(1))",
   "Topic": "210",
   "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r260": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "13",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(i)",
   "Topic": "505",
   "URI": "https://asc.fasb.org/extlink&oid=126973232&loc=SL123496158-112644"
  },
  "r261": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "13",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "505",
   "URI": "https://asc.fasb.org/extlink&oid=126973232&loc=SL123496158-112644"
  },
  "r262": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "14",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "505",
   "URI": "https://asc.fasb.org/extlink&oid=126973232&loc=SL123496171-112644"
  },
  "r263": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "14",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "505",
   "URI": "https://asc.fasb.org/extlink&oid=126973232&loc=SL123496171-112644"
  },
  "r264": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "14",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "505",
   "URI": "https://asc.fasb.org/extlink&oid=126973232&loc=SL123496171-112644"
  },
  "r265": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "16",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "505",
   "URI": "https://asc.fasb.org/extlink&oid=126973232&loc=SL123496180-112644"
  },
  "r266": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "18",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "505",
   "URI": "https://asc.fasb.org/extlink&oid=126973232&loc=SL123496189-112644"
  },
  "r267": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "18",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "505",
   "URI": "https://asc.fasb.org/extlink&oid=126973232&loc=SL123496189-112644"
  },
  "r268": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "18",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "505",
   "URI": "https://asc.fasb.org/extlink&oid=126973232&loc=SL123496189-112644"
  },
  "r269": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "18",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(d)",
   "Topic": "505",
   "URI": "https://asc.fasb.org/extlink&oid=126973232&loc=SL123496189-112644"
  },
  "r27": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(30)(a)(1))",
   "Topic": "210",
   "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r270": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "505",
   "URI": "https://asc.fasb.org/extlink&oid=126973232&loc=d3e21463-112644"
  },
  "r271": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "505",
   "URI": "https://asc.fasb.org/extlink&oid=126973232&loc=d3e21475-112644"
  },
  "r272": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "505",
   "URI": "https://asc.fasb.org/extlink&oid=126973232&loc=d3e21484-112644"
  },
  "r273": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "505",
   "URI": "https://asc.fasb.org/extlink&oid=126973232&loc=d3e21488-112644"
  },
  "r274": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "6",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "505",
   "URI": "https://asc.fasb.org/extlink&oid=126973232&loc=d3e21506-112644"
  },
  "r275": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "7",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "505",
   "URI": "https://asc.fasb.org/extlink&oid=126973232&loc=d3e21521-112644"
  },
  "r276": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "8",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "505",
   "URI": "https://asc.fasb.org/extlink&oid=126973232&loc=d3e21538-112644"
  },
  "r277": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.3-04)",
   "Topic": "505",
   "URI": "https://asc.fasb.org/extlink&oid=120397183&loc=d3e187085-122770"
  },
  "r278": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SAB TOPIC 4.C)",
   "Topic": "505",
   "URI": "https://asc.fasb.org/extlink&oid=120397183&loc=d3e187143-122770"
  },
  "r279": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "50",
   "Topic": "505",
   "URI": "https://asc.fasb.org/extlink&oid=6784392&loc=d3e188667-122775"
  },
  "r28": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(30)(a)(3))",
   "Topic": "210",
   "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r280": {
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "Topic": "505",
   "URI": "https://asc.fasb.org/topic&trid=2208762"
  },
  "r281": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "13",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "606",
   "URI": "https://asc.fasb.org/extlink&oid=126920106&loc=SL49130556-203045"
  },
  "r282": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "13",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)(1)",
   "Topic": "606",
   "URI": "https://asc.fasb.org/extlink&oid=126920106&loc=SL49130556-203045"
  },
  "r283": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "606",
   "URI": "https://asc.fasb.org/extlink&oid=126920106&loc=SL49130543-203045"
  },
  "r284": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "606",
   "URI": "https://asc.fasb.org/extlink&oid=126920106&loc=SL49130545-203045"
  },
  "r285": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "91",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "606",
   "URI": "https://asc.fasb.org/extlink&oid=126920602&loc=SL49130690-203046-203046"
  },
  "r286": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "91",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "606",
   "URI": "https://asc.fasb.org/extlink&oid=126920602&loc=SL49130690-203046-203046"
  },
  "r287": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "91",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "606",
   "URI": "https://asc.fasb.org/extlink&oid=126920602&loc=SL49130690-203046-203046"
  },
  "r288": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "91",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "10",
   "Subparagraph": "(d)",
   "Topic": "606",
   "URI": "https://asc.fasb.org/extlink&oid=126920602&loc=SL49130690-203046-203046"
  },
  "r289": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "91",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "10",
   "Subparagraph": "(e)",
   "Topic": "606",
   "URI": "https://asc.fasb.org/extlink&oid=126920602&loc=SL49130690-203046-203046"
  },
  "r29": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(30)(a)(4))",
   "Topic": "210",
   "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r290": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "91",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "10",
   "Subparagraph": "(f)",
   "Topic": "606",
   "URI": "https://asc.fasb.org/extlink&oid=126920602&loc=SL49130690-203046-203046"
  },
  "r291": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "91",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "10",
   "Subparagraph": "(g)",
   "Topic": "606",
   "URI": "https://asc.fasb.org/extlink&oid=126920602&loc=SL49130690-203046-203046"
  },
  "r292": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "25",
   "SubTopic": "10",
   "Topic": "710",
   "URI": "https://asc.fasb.org/extlink&oid=6409733&loc=d3e19396-108361"
  },
  "r293": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(d)(i)",
   "Topic": "715",
   "URI": "https://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920"
  },
  "r294": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(d)(ii)",
   "Topic": "715",
   "URI": "https://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920"
  },
  "r295": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(d)(iv)(01)",
   "Topic": "715",
   "URI": "https://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920"
  },
  "r296": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(d)(iv)(02)",
   "Topic": "715",
   "URI": "https://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920"
  },
  "r297": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(d)(iv)(02)(A)",
   "Topic": "715",
   "URI": "https://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920"
  },
  "r298": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(d)(iv)(02)(B)",
   "Topic": "715",
   "URI": "https://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920"
  },
  "r299": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(d)(iv)(02)(C)",
   "Topic": "715",
   "URI": "https://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920"
  },
  "r3": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "6",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(d)",
   "Topic": "105",
   "URI": "https://asc.fasb.org/extlink&oid=126987489&loc=SL124442142-165695"
  },
  "r30": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(30))",
   "Topic": "210",
   "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r300": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(d)(iv)(03)",
   "Topic": "715",
   "URI": "https://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920"
  },
  "r301": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(n)",
   "Topic": "715",
   "URI": "https://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920"
  },
  "r302": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "17",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "20",
   "Topic": "715",
   "URI": "https://asc.fasb.org/extlink&oid=123450688&loc=d3e4179-114921"
  },
  "r303": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "80",
   "Subparagraph": "(d)",
   "Topic": "715",
   "URI": "https://asc.fasb.org/extlink&oid=65877416&loc=SL14450657-114947"
  },
  "r304": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "8",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "80",
   "Topic": "715",
   "URI": "https://asc.fasb.org/extlink&oid=35742348&loc=SL14450788-114948"
  },
  "r305": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1D",
   "Publisher": "FASB",
   "Section": "35",
   "SubTopic": "10",
   "Topic": "718",
   "URI": "https://asc.fasb.org/extlink&oid=126961718&loc=SL116886442-113899"
  },
  "r306": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "35",
   "SubTopic": "10",
   "Topic": "718",
   "URI": "https://asc.fasb.org/extlink&oid=126961718&loc=d3e4534-113899"
  },
  "r307": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "35",
   "SubTopic": "10",
   "Topic": "718",
   "URI": "https://asc.fasb.org/extlink&oid=126961718&loc=d3e4549-113899"
  },
  "r308": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "718",
   "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5047-113901"
  },
  "r309": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "718",
   "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5047-113901"
  },
  "r31": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(31))",
   "Topic": "210",
   "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r310": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)(1)",
   "Topic": "718",
   "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901"
  },
  "r311": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)(2)",
   "Topic": "718",
   "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901"
  },
  "r312": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)(3)",
   "Topic": "718",
   "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901"
  },
  "r313": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)(1)(i)",
   "Topic": "718",
   "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901"
  },
  "r314": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)(1)(ii)",
   "Topic": "718",
   "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901"
  },
  "r315": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)(1)(iii)",
   "Topic": "718",
   "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901"
  },
  "r316": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)(1)(iv)",
   "Topic": "718",
   "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901"
  },
  "r317": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)(1)(iv)(01)",
   "Topic": "718",
   "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901"
  },
  "r318": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)(1)(iv)(02)",
   "Topic": "718",
   "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901"
  },
  "r319": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)(1)(iv)(03)",
   "Topic": "718",
   "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901"
  },
  "r32": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(32))",
   "Topic": "210",
   "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r320": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)(1)(iv)(04)",
   "Topic": "718",
   "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901"
  },
  "r321": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)(2)(i)",
   "Topic": "718",
   "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901"
  },
  "r322": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)(2)(ii)",
   "Topic": "718",
   "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901"
  },
  "r323": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)(2)(iii)",
   "Topic": "718",
   "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901"
  },
  "r324": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)(2)(iii)(01)",
   "Topic": "718",
   "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901"
  },
  "r325": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)(2)(iii)(02)",
   "Topic": "718",
   "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901"
  },
  "r326": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)(2)(iii)(03)",
   "Topic": "718",
   "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901"
  },
  "r327": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(d)(1)",
   "Topic": "718",
   "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901"
  },
  "r328": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(d)(2)",
   "Topic": "718",
   "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901"
  },
  "r329": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(e)(1)",
   "Topic": "718",
   "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901"
  },
  "r33": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(6))",
   "Topic": "210",
   "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r330": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(e)(2)",
   "Topic": "718",
   "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901"
  },
  "r331": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(f)(2)",
   "Topic": "718",
   "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901"
  },
  "r332": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(f)(2)(i)",
   "Topic": "718",
   "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901"
  },
  "r333": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(f)(2)(ii)",
   "Topic": "718",
   "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901"
  },
  "r334": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(f)(2)(iii)",
   "Topic": "718",
   "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901"
  },
  "r335": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(f)(2)(iv)",
   "Topic": "718",
   "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901"
  },
  "r336": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(f)(2)(v)",
   "Topic": "718",
   "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901"
  },
  "r337": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(h)(1)(i)",
   "Topic": "718",
   "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901"
  },
  "r338": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(i)",
   "Topic": "718",
   "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901"
  },
  "r339": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "718",
   "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901"
  },
  "r34": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(8))",
   "Topic": "210",
   "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r340": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "15",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(e)",
   "Topic": "718",
   "URI": "https://asc.fasb.org/extlink&oid=128097895&loc=SL121327923-165333"
  },
  "r341": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "15",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(f)(1)",
   "Topic": "718",
   "URI": "https://asc.fasb.org/extlink&oid=128097895&loc=SL121327923-165333"
  },
  "r342": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "15",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(f)(2)",
   "Topic": "718",
   "URI": "https://asc.fasb.org/extlink&oid=128097895&loc=SL121327923-165333"
  },
  "r343": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "12",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "20",
   "Topic": "718",
   "URI": "https://asc.fasb.org/extlink&oid=126964447&loc=d3e11149-113907"
  },
  "r344": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "13",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "20",
   "Topic": "718",
   "URI": "https://asc.fasb.org/extlink&oid=126964447&loc=d3e11178-113907"
  },
  "r345": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "730",
   "URI": "https://asc.fasb.org/extlink&oid=6420194&loc=d3e21568-108373"
  },
  "r346": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "8",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "740",
   "URI": "https://asc.fasb.org/extlink&oid=126983759&loc=SL121830611-158277"
  },
  "r347": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "8",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "740",
   "URI": "https://asc.fasb.org/extlink&oid=126983759&loc=SL121830611-158277"
  },
  "r348": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "8",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(d)(2)",
   "Topic": "740",
   "URI": "https://asc.fasb.org/extlink&oid=126983759&loc=SL121830611-158277"
  },
  "r349": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "8",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(d)(3)",
   "Topic": "740",
   "URI": "https://asc.fasb.org/extlink&oid=126983759&loc=SL121830611-158277"
  },
  "r35": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(9))",
   "Topic": "210",
   "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r350": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "20",
   "Subparagraph": "(a)",
   "Topic": "805",
   "URI": "https://asc.fasb.org/extlink&oid=128092918&loc=SL128093175-196984"
  },
  "r351": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "20",
   "Subparagraph": "(b)",
   "Topic": "805",
   "URI": "https://asc.fasb.org/extlink&oid=128092918&loc=SL128093175-196984"
  },
  "r352": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "20",
   "Subparagraph": "(d)",
   "Topic": "805",
   "URI": "https://asc.fasb.org/extlink&oid=128092918&loc=SL128093175-196984"
  },
  "r353": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "12",
   "Publisher": "FASB",
   "Section": "15",
   "SubTopic": "10",
   "Subparagraph": "(f)(2)",
   "Topic": "810",
   "URI": "https://asc.fasb.org/extlink&oid=116873149&loc=d3e923-111674"
  },
  "r354": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "19",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "810",
   "URI": "https://asc.fasb.org/extlink&oid=126929396&loc=SL4569616-111683"
  },
  "r355": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "25",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "810",
   "URI": "https://asc.fasb.org/extlink&oid=116870748&loc=SL6758485-165988"
  },
  "r356": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "25",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "810",
   "URI": "https://asc.fasb.org/extlink&oid=116870748&loc=SL6758485-165988"
  },
  "r357": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1A",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)(1)",
   "Topic": "810",
   "URI": "https://asc.fasb.org/extlink&oid=109239629&loc=SL4573702-111684"
  },
  "r358": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1A",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)(1)",
   "Topic": "810",
   "URI": "https://asc.fasb.org/extlink&oid=109239629&loc=SL4573702-111684"
  },
  "r359": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(bb)",
   "Topic": "810",
   "URI": "https://asc.fasb.org/extlink&oid=123419778&loc=d3e5710-111685"
  },
  "r36": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02.1)",
   "Topic": "210",
   "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r360": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "810",
   "URI": "https://asc.fasb.org/extlink&oid=123419778&loc=d3e5710-111685"
  },
  "r361": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4J",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "10",
   "Topic": "810",
   "URI": "https://asc.fasb.org/extlink&oid=120409616&loc=SL4591551-111686"
  },
  "r362": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4K",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "10",
   "Topic": "810",
   "URI": "https://asc.fasb.org/extlink&oid=120409616&loc=SL4591552-111686"
  },
  "r363": {
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "Topic": "810",
   "URI": "https://asc.fasb.org/topic&trid=2197479"
  },
  "r364": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4A",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "815",
   "URI": "https://asc.fasb.org/extlink&oid=125515794&loc=SL5618551-113959"
  },
  "r365": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4B",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(d)",
   "Topic": "815",
   "URI": "https://asc.fasb.org/extlink&oid=125515794&loc=SL5624163-113959"
  },
  "r366": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "40",
   "Subparagraph": "(f)",
   "Topic": "815",
   "URI": "https://asc.fasb.org/extlink&oid=126731327&loc=d3e90205-114008"
  },
  "r367": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "6",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "40",
   "Subparagraph": "(a)",
   "Topic": "815",
   "URI": "https://asc.fasb.org/extlink&oid=126731327&loc=SL126733271-114008"
  },
  "r368": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "40",
   "Subparagraph": "(a)(1)",
   "Topic": "815",
   "URI": "https://asc.fasb.org/extlink&oid=126732423&loc=SL123482106-238011"
  },
  "r369": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "40",
   "Subparagraph": "(a)(2)",
   "Topic": "815",
   "URI": "https://asc.fasb.org/extlink&oid=126732423&loc=SL123482106-238011"
  },
  "r37": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02.19(a))",
   "Topic": "210",
   "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r370": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "40",
   "Subparagraph": "(a)(3)",
   "Topic": "815",
   "URI": "https://asc.fasb.org/extlink&oid=126732423&loc=SL123482106-238011"
  },
  "r371": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "40",
   "Subparagraph": "(b)(1)",
   "Topic": "815",
   "URI": "https://asc.fasb.org/extlink&oid=126732423&loc=SL123482106-238011"
  },
  "r372": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "40",
   "Subparagraph": "(b)(2)",
   "Topic": "815",
   "URI": "https://asc.fasb.org/extlink&oid=126732423&loc=SL123482106-238011"
  },
  "r373": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "40",
   "Subparagraph": "(c)",
   "Topic": "815",
   "URI": "https://asc.fasb.org/extlink&oid=126732423&loc=SL123482106-238011"
  },
  "r374": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "40",
   "Subparagraph": "(d)",
   "Topic": "815",
   "URI": "https://asc.fasb.org/extlink&oid=126732423&loc=SL123482106-238011"
  },
  "r375": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "40",
   "Subparagraph": "(e)(2)",
   "Topic": "815",
   "URI": "https://asc.fasb.org/extlink&oid=126732423&loc=SL123482106-238011"
  },
  "r376": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "40",
   "Subparagraph": "(e)(3)",
   "Topic": "815",
   "URI": "https://asc.fasb.org/extlink&oid=126732423&loc=SL123482106-238011"
  },
  "r377": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "40",
   "Subparagraph": "(e)(4)",
   "Topic": "815",
   "URI": "https://asc.fasb.org/extlink&oid=126732423&loc=SL123482106-238011"
  },
  "r378": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "40",
   "Subparagraph": "(f)",
   "Topic": "815",
   "URI": "https://asc.fasb.org/extlink&oid=126732423&loc=SL123482106-238011"
  },
  "r379": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "40",
   "Subparagraph": "(a)",
   "Topic": "815",
   "URI": "https://asc.fasb.org/extlink&oid=126732423&loc=SL126732908-238011"
  },
  "r38": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02.19-26)",
   "Topic": "210",
   "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r380": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "820",
   "URI": "https://asc.fasb.org/extlink&oid=126976982&loc=d3e19207-110258"
  },
  "r381": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "820",
   "URI": "https://asc.fasb.org/extlink&oid=126976982&loc=d3e19207-110258"
  },
  "r382": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(bbb)(1)",
   "Topic": "820",
   "URI": "https://asc.fasb.org/extlink&oid=126976982&loc=d3e19207-110258"
  },
  "r383": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(bbb)(2)",
   "Topic": "820",
   "URI": "https://asc.fasb.org/extlink&oid=126976982&loc=d3e19207-110258"
  },
  "r384": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "820",
   "URI": "https://asc.fasb.org/extlink&oid=126976982&loc=d3e19207-110258"
  },
  "r385": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)(1)",
   "Topic": "820",
   "URI": "https://asc.fasb.org/extlink&oid=126976982&loc=d3e19207-110258"
  },
  "r386": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "820",
   "URI": "https://asc.fasb.org/extlink&oid=126976982&loc=d3e19207-110258"
  },
  "r387": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "820",
   "URI": "https://asc.fasb.org/extlink&oid=126976982&loc=d3e19279-110258"
  },
  "r388": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "6A",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "820",
   "URI": "https://asc.fasb.org/extlink&oid=126976982&loc=SL6742756-110258"
  },
  "r389": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "15",
   "SubTopic": "10",
   "Subparagraph": "(e)",
   "Topic": "825",
   "URI": "https://asc.fasb.org/extlink&oid=123478648&loc=d3e12026-108606"
  },
  "r39": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02.20)",
   "Topic": "210",
   "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r390": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "20",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "825",
   "URI": "https://asc.fasb.org/extlink&oid=123594938&loc=d3e13531-108611"
  },
  "r391": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "21",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "825",
   "URI": "https://asc.fasb.org/extlink&oid=123594938&loc=d3e13537-108611"
  },
  "r392": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "28",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(f)",
   "Topic": "825",
   "URI": "https://asc.fasb.org/extlink&oid=123596393&loc=d3e14064-108612"
  },
  "r393": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "825",
   "URI": "https://asc.fasb.org/extlink&oid=126983955&loc=SL120254526-165497"
  },
  "r394": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "825",
   "URI": "https://asc.fasb.org/extlink&oid=126983955&loc=SL120254526-165497"
  },
  "r395": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "6",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "825",
   "URI": "https://asc.fasb.org/extlink&oid=126983955&loc=SL121967933-165497"
  },
  "r396": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "6",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "825",
   "URI": "https://asc.fasb.org/extlink&oid=126983955&loc=SL121967933-165497"
  },
  "r397": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "6",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(c)(1)",
   "Topic": "825",
   "URI": "https://asc.fasb.org/extlink&oid=126983955&loc=SL121967933-165497"
  },
  "r398": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "6",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(c)(2)",
   "Topic": "825",
   "URI": "https://asc.fasb.org/extlink&oid=126983955&loc=SL121967933-165497"
  },
  "r399": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "7",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "825",
   "URI": "https://asc.fasb.org/extlink&oid=126983955&loc=SL122642865-165497"
  },
  "r4": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "6",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(e)",
   "Topic": "105",
   "URI": "https://asc.fasb.org/extlink&oid=126987489&loc=SL124442142-165695"
  },
  "r40": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02.21)",
   "Topic": "210",
   "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r400": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "7",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "825",
   "URI": "https://asc.fasb.org/extlink&oid=126983955&loc=SL122642865-165497"
  },
  "r401": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "230",
   "Topic": "830",
   "URI": "https://asc.fasb.org/extlink&oid=123444420&loc=d3e33268-110906"
  },
  "r402": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "17",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "30",
   "Topic": "830",
   "URI": "https://asc.fasb.org/extlink&oid=118261656&loc=d3e32136-110900"
  },
  "r403": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "20",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "30",
   "Subparagraph": "(a)",
   "Topic": "830",
   "URI": "https://asc.fasb.org/extlink&oid=118261656&loc=d3e32211-110900"
  },
  "r404": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "20",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "30",
   "Subparagraph": "(b)",
   "Topic": "830",
   "URI": "https://asc.fasb.org/extlink&oid=118261656&loc=d3e32211-110900"
  },
  "r405": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "20",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "30",
   "Subparagraph": "(c)",
   "Topic": "830",
   "URI": "https://asc.fasb.org/extlink&oid=118261656&loc=d3e32211-110900"
  },
  "r406": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "20",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "30",
   "Subparagraph": "(d)",
   "Topic": "830",
   "URI": "https://asc.fasb.org/extlink&oid=118261656&loc=d3e32211-110900"
  },
  "r407": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "30",
   "Topic": "830",
   "URI": "https://asc.fasb.org/extlink&oid=6450520&loc=d3e32583-110901"
  },
  "r408": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "832",
   "URI": "https://asc.fasb.org/extlink&oid=128342835&loc=SL128342857-244232"
  },
  "r409": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "832",
   "URI": "https://asc.fasb.org/extlink&oid=128342835&loc=SL128342857-244232"
  },
  "r41": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02.22)",
   "Topic": "210",
   "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r410": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "30",
   "Topic": "835",
   "URI": "https://asc.fasb.org/extlink&oid=124429444&loc=SL124452920-239629"
  },
  "r411": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Topic": "842",
   "URI": "https://asc.fasb.org/extlink&oid=128293352&loc=SL77916155-209984"
  },
  "r412": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "842",
   "URI": "https://asc.fasb.org/extlink&oid=128293352&loc=SL126838806-209984"
  },
  "r413": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "842",
   "URI": "https://asc.fasb.org/extlink&oid=128293352&loc=SL126838806-209984"
  },
  "r414": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "842",
   "URI": "https://asc.fasb.org/extlink&oid=128293352&loc=SL126838806-209984"
  },
  "r415": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(d)(1)",
   "Topic": "842",
   "URI": "https://asc.fasb.org/extlink&oid=128293352&loc=SL126838806-209984"
  },
  "r416": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "20",
   "Subparagraph": "(a)",
   "Topic": "842",
   "URI": "https://asc.fasb.org/extlink&oid=123391704&loc=SL77918627-209977"
  },
  "r417": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "20",
   "Subparagraph": "(b)",
   "Topic": "842",
   "URI": "https://asc.fasb.org/extlink&oid=123391704&loc=SL77918627-209977"
  },
  "r418": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "20",
   "Subparagraph": "(a)",
   "Topic": "842",
   "URI": "https://asc.fasb.org/extlink&oid=123391704&loc=SL77918638-209977"
  },
  "r419": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "20",
   "Subparagraph": "(a)",
   "Topic": "842",
   "URI": "https://asc.fasb.org/extlink&oid=123391704&loc=SL77918643-209977"
  },
  "r42": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02.29)",
   "Topic": "210",
   "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r420": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "20",
   "Subparagraph": "(c)",
   "Topic": "842",
   "URI": "https://asc.fasb.org/extlink&oid=123391704&loc=SL77918643-209977"
  },
  "r421": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(a)(1)",
   "Topic": "842",
   "URI": "https://asc.fasb.org/extlink&oid=128292326&loc=SL77918673-209980"
  },
  "r422": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(a)(3)",
   "Topic": "842",
   "URI": "https://asc.fasb.org/extlink&oid=128292326&loc=SL77918673-209980"
  },
  "r423": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(c)(3)",
   "Topic": "842",
   "URI": "https://asc.fasb.org/extlink&oid=128292326&loc=SL77918673-209980"
  },
  "r424": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(a)",
   "Topic": "842",
   "URI": "https://asc.fasb.org/extlink&oid=128292326&loc=SL77918686-209980"
  },
  "r425": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(b)",
   "Topic": "842",
   "URI": "https://asc.fasb.org/extlink&oid=128292326&loc=SL77918686-209980"
  },
  "r426": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(d)",
   "Topic": "842",
   "URI": "https://asc.fasb.org/extlink&oid=128292326&loc=SL77918686-209980"
  },
  "r427": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(g)(1)",
   "Topic": "842",
   "URI": "https://asc.fasb.org/extlink&oid=128292326&loc=SL77918686-209980"
  },
  "r428": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(g)(2)",
   "Topic": "842",
   "URI": "https://asc.fasb.org/extlink&oid=128292326&loc=SL77918686-209980"
  },
  "r429": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(g)(3)",
   "Topic": "842",
   "URI": "https://asc.fasb.org/extlink&oid=128292326&loc=SL77918686-209980"
  },
  "r43": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02.29-31)",
   "Topic": "210",
   "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r430": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(g)(4)",
   "Topic": "842",
   "URI": "https://asc.fasb.org/extlink&oid=128292326&loc=SL77918686-209980"
  },
  "r431": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Topic": "842",
   "URI": "https://asc.fasb.org/extlink&oid=128292326&loc=SL77918686-209980"
  },
  "r432": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "6",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Topic": "842",
   "URI": "https://asc.fasb.org/extlink&oid=128292326&loc=SL77918701-209980"
  },
  "r433": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "53",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "20",
   "Topic": "842",
   "URI": "https://asc.fasb.org/extlink&oid=123414884&loc=SL77918982-209971"
  },
  "r434": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "848",
   "URI": "https://asc.fasb.org/extlink&oid=125980421&loc=SL122150809-237846"
  },
  "r435": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "848",
   "URI": "https://asc.fasb.org/extlink&oid=125980421&loc=SL125981372-237846"
  },
  "r436": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(a)(1)",
   "Topic": "848",
   "URI": "https://asc.fasb.org/extlink&oid=125980421&loc=SL125981372-237846"
  },
  "r437": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(a)(2)",
   "Topic": "848",
   "URI": "https://asc.fasb.org/extlink&oid=125980421&loc=SL125981372-237846"
  },
  "r438": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(a)(3)(iii)(01)",
   "Topic": "848",
   "URI": "https://asc.fasb.org/extlink&oid=125980421&loc=SL125981372-237846"
  },
  "r439": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(a)(3)(iii)(03)",
   "Topic": "848",
   "URI": "https://asc.fasb.org/extlink&oid=125980421&loc=SL125981372-237846"
  },
  "r44": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "16",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "20",
   "Topic": "210",
   "URI": "https://asc.fasb.org/extlink&oid=99393222&loc=SL20226024-175313"
  },
  "r440": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "850",
   "URI": "https://asc.fasb.org/extlink&oid=6457730&loc=d3e39549-107864"
  },
  "r441": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "850",
   "URI": "https://asc.fasb.org/extlink&oid=6457730&loc=d3e39549-107864"
  },
  "r442": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "850",
   "URI": "https://asc.fasb.org/extlink&oid=6457730&loc=d3e39549-107864"
  },
  "r443": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(d)",
   "Topic": "850",
   "URI": "https://asc.fasb.org/extlink&oid=6457730&loc=d3e39549-107864"
  },
  "r444": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "850",
   "URI": "https://asc.fasb.org/extlink&oid=6457730&loc=d3e39549-107864"
  },
  "r445": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "850",
   "URI": "https://asc.fasb.org/extlink&oid=6457730&loc=d3e39603-107864"
  },
  "r446": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "6",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "850",
   "URI": "https://asc.fasb.org/extlink&oid=6457730&loc=d3e39691-107864"
  },
  "r447": {
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "Topic": "850",
   "URI": "https://asc.fasb.org/topic&trid=2122745"
  },
  "r448": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "7",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "852",
   "URI": "https://asc.fasb.org/extlink&oid=124433192&loc=SL2890621-112765"
  },
  "r449": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "7",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "852",
   "URI": "https://asc.fasb.org/extlink&oid=124433192&loc=SL2890621-112765"
  },
  "r45": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "21",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "20",
   "Topic": "210",
   "URI": "https://asc.fasb.org/extlink&oid=99393222&loc=SL20226049-175313"
  },
  "r450": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "10",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "10",
   "Topic": "852",
   "URI": "https://asc.fasb.org/extlink&oid=84165509&loc=d3e56426-112766"
  },
  "r451": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "855",
   "URI": "https://asc.fasb.org/extlink&oid=6842918&loc=SL6314017-165662"
  },
  "r452": {
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "Topic": "855",
   "URI": "https://asc.fasb.org/topic&trid=2122774"
  },
  "r453": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(b)(2)(i)",
   "Topic": "860",
   "URI": "https://asc.fasb.org/extlink&oid=121570589&loc=d3e107207-111719"
  },
  "r454": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(b)(2)(ii)",
   "Topic": "860",
   "URI": "https://asc.fasb.org/extlink&oid=121570589&loc=d3e107207-111719"
  },
  "r455": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(b)(3)",
   "Topic": "860",
   "URI": "https://asc.fasb.org/extlink&oid=121570589&loc=d3e107207-111719"
  },
  "r456": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(bb)(1)",
   "Topic": "860",
   "URI": "https://asc.fasb.org/extlink&oid=121570589&loc=d3e107207-111719"
  },
  "r457": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(bb)(2)",
   "Topic": "860",
   "URI": "https://asc.fasb.org/extlink&oid=121570589&loc=d3e107207-111719"
  },
  "r458": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(bb)(3)",
   "Topic": "860",
   "URI": "https://asc.fasb.org/extlink&oid=121570589&loc=d3e107207-111719"
  },
  "r459": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(c)(1)",
   "Topic": "860",
   "URI": "https://asc.fasb.org/extlink&oid=121570589&loc=d3e107207-111719"
  },
  "r46": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "22",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "20",
   "Topic": "210",
   "URI": "https://asc.fasb.org/extlink&oid=99393222&loc=SL20226052-175313"
  },
  "r460": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(c)(2)",
   "Topic": "860",
   "URI": "https://asc.fasb.org/extlink&oid=121570589&loc=d3e107207-111719"
  },
  "r461": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(c)(3)",
   "Topic": "860",
   "URI": "https://asc.fasb.org/extlink&oid=121570589&loc=d3e107207-111719"
  },
  "r462": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(b)(1)",
   "Topic": "860",
   "URI": "https://asc.fasb.org/extlink&oid=121570589&loc=d3e107314-111719"
  },
  "r463": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(b)(2)",
   "Topic": "860",
   "URI": "https://asc.fasb.org/extlink&oid=121570589&loc=d3e107314-111719"
  },
  "r464": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(b)(3)",
   "Topic": "860",
   "URI": "https://asc.fasb.org/extlink&oid=121570589&loc=d3e107314-111719"
  },
  "r465": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(c)",
   "Topic": "860",
   "URI": "https://asc.fasb.org/extlink&oid=121570589&loc=d3e107314-111719"
  },
  "r466": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "30",
   "Topic": "860",
   "URI": "https://asc.fasb.org/extlink&oid=66007379&loc=d3e113888-111728"
  },
  "r467": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "7",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "30",
   "Subparagraph": "(a)",
   "Topic": "860",
   "URI": "https://asc.fasb.org/extlink&oid=109249958&loc=SL34722452-111729"
  },
  "r468": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "50",
   "Subparagraph": "(a)(1)",
   "Topic": "860",
   "URI": "https://asc.fasb.org/extlink&oid=128311188&loc=d3e122625-111746"
  },
  "r469": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "50",
   "Subparagraph": "(a)(2)",
   "Topic": "860",
   "URI": "https://asc.fasb.org/extlink&oid=128311188&loc=d3e122625-111746"
  },
  "r47": {
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "Topic": "210",
   "URI": "https://asc.fasb.org/topic&trid=2122208"
  },
  "r470": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "50",
   "Subparagraph": "(a)(3)",
   "Topic": "860",
   "URI": "https://asc.fasb.org/extlink&oid=128311188&loc=d3e122625-111746"
  },
  "r471": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "50",
   "Subparagraph": "(a)(4)(i)",
   "Topic": "860",
   "URI": "https://asc.fasb.org/extlink&oid=128311188&loc=d3e122625-111746"
  },
  "r472": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "50",
   "Subparagraph": "(a)(1)",
   "Topic": "860",
   "URI": "https://asc.fasb.org/extlink&oid=128311188&loc=d3e122739-111746"
  },
  "r473": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "50",
   "Subparagraph": "(a)(2)",
   "Topic": "860",
   "URI": "https://asc.fasb.org/extlink&oid=128311188&loc=d3e122739-111746"
  },
  "r474": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "50",
   "Subparagraph": "(a)(3)",
   "Topic": "860",
   "URI": "https://asc.fasb.org/extlink&oid=128311188&loc=d3e122739-111746"
  },
  "r475": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "50",
   "Subparagraph": "(a)(4)",
   "Topic": "860",
   "URI": "https://asc.fasb.org/extlink&oid=128311188&loc=d3e122739-111746"
  },
  "r476": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "50",
   "Subparagraph": "(a)(5)",
   "Topic": "860",
   "URI": "https://asc.fasb.org/extlink&oid=128311188&loc=d3e122739-111746"
  },
  "r477": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "50",
   "Subparagraph": "(a)(6)",
   "Topic": "860",
   "URI": "https://asc.fasb.org/extlink&oid=128311188&loc=d3e122739-111746"
  },
  "r478": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "50",
   "Subparagraph": "(a)(7)",
   "Topic": "860",
   "URI": "https://asc.fasb.org/extlink&oid=128311188&loc=d3e122739-111746"
  },
  "r479": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "50",
   "Subparagraph": "(b)",
   "Topic": "860",
   "URI": "https://asc.fasb.org/extlink&oid=128311188&loc=d3e122739-111746"
  },
  "r48": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "10A",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(e)",
   "Topic": "220",
   "URI": "https://asc.fasb.org/extlink&oid=126968391&loc=SL7669646-108580"
  },
  "r480": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "50",
   "Subparagraph": "(e)(1)",
   "Topic": "860",
   "URI": "https://asc.fasb.org/extlink&oid=128311188&loc=d3e122739-111746"
  },
  "r481": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "50",
   "Subparagraph": "(e)(2)",
   "Topic": "860",
   "URI": "https://asc.fasb.org/extlink&oid=128311188&loc=d3e122739-111746"
  },
  "r482": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "50",
   "Subparagraph": "(e)(3)",
   "Topic": "860",
   "URI": "https://asc.fasb.org/extlink&oid=128311188&loc=d3e122739-111746"
  },
  "r483": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "6",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "910",
   "URI": "https://asc.fasb.org/extlink&oid=126937589&loc=SL119991595-234733"
  },
  "r484": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "25",
   "SubTopic": "730",
   "Topic": "912",
   "URI": "https://asc.fasb.org/extlink&oid=6472174&loc=d3e58812-109433"
  },
  "r485": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SAB Topic 11.L)",
   "Topic": "924",
   "URI": "https://asc.fasb.org/extlink&oid=6472922&loc=d3e499488-122856"
  },
  "r486": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "20",
   "Subparagraph": "(a)",
   "Topic": "926",
   "URI": "https://asc.fasb.org/extlink&oid=120154821&loc=SL120154904-197079"
  },
  "r487": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "20",
   "Subparagraph": "(b)",
   "Topic": "926",
   "URI": "https://asc.fasb.org/extlink&oid=120154821&loc=SL120154904-197079"
  },
  "r488": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "20",
   "Subparagraph": "(c)",
   "Topic": "926",
   "URI": "https://asc.fasb.org/extlink&oid=120154821&loc=SL120154904-197079"
  },
  "r489": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "15",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "235",
   "Subparagraph": "(a)",
   "Topic": "932",
   "URI": "https://asc.fasb.org/extlink&oid=126939881&loc=d3e61929-109447"
  },
  "r49": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "10A",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(f)",
   "Topic": "220",
   "URI": "https://asc.fasb.org/extlink&oid=126968391&loc=SL7669646-108580"
  },
  "r490": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "15",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "235",
   "Subparagraph": "(b)",
   "Topic": "932",
   "URI": "https://asc.fasb.org/extlink&oid=126939881&loc=d3e61929-109447"
  },
  "r491": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "20",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "235",
   "Subparagraph": "(a)",
   "Topic": "932",
   "URI": "https://asc.fasb.org/extlink&oid=126939881&loc=d3e62059-109447"
  },
  "r492": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "20",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "235",
   "Subparagraph": "(b)",
   "Topic": "932",
   "URI": "https://asc.fasb.org/extlink&oid=126939881&loc=d3e62059-109447"
  },
  "r493": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "28",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "235",
   "Subparagraph": "(a)",
   "Topic": "932",
   "URI": "https://asc.fasb.org/extlink&oid=126939881&loc=d3e62395-109447"
  },
  "r494": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "28",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "235",
   "Subparagraph": "(b)",
   "Topic": "932",
   "URI": "https://asc.fasb.org/extlink&oid=126939881&loc=d3e62395-109447"
  },
  "r495": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "33",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "235",
   "Subparagraph": "(a)",
   "Topic": "932",
   "URI": "https://asc.fasb.org/extlink&oid=126939881&loc=d3e62479-109447"
  },
  "r496": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "33",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "235",
   "Subparagraph": "(b)",
   "Topic": "932",
   "URI": "https://asc.fasb.org/extlink&oid=126939881&loc=d3e62479-109447"
  },
  "r497": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "35A",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "235",
   "Subparagraph": "(a)",
   "Topic": "932",
   "URI": "https://asc.fasb.org/extlink&oid=126939881&loc=SL6807758-109447"
  },
  "r498": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "35A",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "235",
   "Subparagraph": "(b)",
   "Topic": "932",
   "URI": "https://asc.fasb.org/extlink&oid=126939881&loc=SL6807758-109447"
  },
  "r499": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "8",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "235",
   "Subparagraph": "(c)(1)",
   "Topic": "932",
   "URI": "https://asc.fasb.org/extlink&oid=126939881&loc=d3e61872-109447"
  },
  "r5": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "205",
   "URI": "https://asc.fasb.org/extlink&oid=124429488&loc=d3e326-107755"
  },
  "r50": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "10A",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(h)",
   "Topic": "220",
   "URI": "https://asc.fasb.org/extlink&oid=126968391&loc=SL7669646-108580"
  },
  "r500": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "8",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "235",
   "Subparagraph": "(c)(2)",
   "Topic": "932",
   "URI": "https://asc.fasb.org/extlink&oid=126939881&loc=d3e61872-109447"
  },
  "r501": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.9-03(1)(a))",
   "Topic": "942",
   "URI": "https://asc.fasb.org/extlink&oid=126897435&loc=d3e534808-122878"
  },
  "r502": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.9-03(11))",
   "Topic": "942",
   "URI": "https://asc.fasb.org/extlink&oid=126897435&loc=d3e534808-122878"
  },
  "r503": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.9-03(13))",
   "Topic": "942",
   "URI": "https://asc.fasb.org/extlink&oid=126897435&loc=d3e534808-122878"
  },
  "r504": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.9-03(16))",
   "Topic": "942",
   "URI": "https://asc.fasb.org/extlink&oid=126897435&loc=d3e534808-122878"
  },
  "r505": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.9-03(23))",
   "Topic": "942",
   "URI": "https://asc.fasb.org/extlink&oid=126897435&loc=d3e534808-122878"
  },
  "r506": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.9-03(6))",
   "Topic": "942",
   "URI": "https://asc.fasb.org/extlink&oid=126897435&loc=d3e534808-122878"
  },
  "r507": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.9-03.12)",
   "Topic": "942",
   "URI": "https://asc.fasb.org/extlink&oid=126897435&loc=d3e534808-122878"
  },
  "r508": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.9-03.15)",
   "Topic": "942",
   "URI": "https://asc.fasb.org/extlink&oid=126897435&loc=d3e534808-122878"
  },
  "r509": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "220",
   "Subparagraph": "(SX 210.9-04(22))",
   "Topic": "942",
   "URI": "https://asc.fasb.org/extlink&oid=120399700&loc=SL114874048-224260"
  },
  "r51": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "11",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "220",
   "URI": "https://asc.fasb.org/extlink&oid=126968391&loc=d3e637-108580"
  },
  "r510": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "220",
   "Subparagraph": "(SX 210.9-04(26))",
   "Topic": "942",
   "URI": "https://asc.fasb.org/extlink&oid=120399700&loc=SL114874048-224260"
  },
  "r511": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "220",
   "Subparagraph": "(SX 210.9-04(27))",
   "Topic": "942",
   "URI": "https://asc.fasb.org/extlink&oid=120399700&loc=SL114874048-224260"
  },
  "r512": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "235",
   "Subparagraph": "(SX 210.9-05(b)(2))",
   "Topic": "942",
   "URI": "https://asc.fasb.org/extlink&oid=120399901&loc=d3e537907-122884"
  },
  "r513": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "320",
   "Subparagraph": "(b)",
   "Topic": "942",
   "URI": "https://asc.fasb.org/extlink&oid=126980459&loc=d3e62557-112803"
  },
  "r514": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "360",
   "Topic": "942",
   "URI": "https://asc.fasb.org/extlink&oid=124429447&loc=SL124453093-239630"
  },
  "r515": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "825",
   "Topic": "942",
   "URI": "https://asc.fasb.org/extlink&oid=126941378&loc=d3e61044-112788"
  },
  "r516": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.7-03(16))",
   "Topic": "944",
   "URI": "https://asc.fasb.org/extlink&oid=126734703&loc=d3e572229-122910"
  },
  "r517": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.7-03(a)(12))",
   "Topic": "944",
   "URI": "https://asc.fasb.org/extlink&oid=126734703&loc=d3e572229-122910"
  },
  "r518": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.7-03(a)(2))",
   "Topic": "944",
   "URI": "https://asc.fasb.org/extlink&oid=126734703&loc=d3e572229-122910"
  },
  "r519": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.7-03(a)(23)(a)(3))",
   "Topic": "944",
   "URI": "https://asc.fasb.org/extlink&oid=126734703&loc=d3e572229-122910"
  },
  "r52": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "14",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "220",
   "URI": "https://asc.fasb.org/extlink&oid=126968391&loc=d3e681-108580"
  },
  "r520": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.7-03(a)(23)(a)(4))",
   "Topic": "944",
   "URI": "https://asc.fasb.org/extlink&oid=126734703&loc=d3e572229-122910"
  },
  "r521": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.7-03(a)(25))",
   "Topic": "944",
   "URI": "https://asc.fasb.org/extlink&oid=126734703&loc=d3e572229-122910"
  },
  "r522": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.7-03(a)(8))",
   "Topic": "944",
   "URI": "https://asc.fasb.org/extlink&oid=126734703&loc=d3e572229-122910"
  },
  "r523": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.7-03.1(f))",
   "Topic": "944",
   "URI": "https://asc.fasb.org/extlink&oid=126734703&loc=d3e572229-122910"
  },
  "r524": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "220",
   "Subparagraph": "(SX 210.7-04(18))",
   "Topic": "944",
   "URI": "https://asc.fasb.org/extlink&oid=120400993&loc=SL114874131-224263"
  },
  "r525": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "220",
   "Subparagraph": "(SX 210.7-04(22))",
   "Topic": "944",
   "URI": "https://asc.fasb.org/extlink&oid=120400993&loc=SL114874131-224263"
  },
  "r526": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "220",
   "Subparagraph": "(SX 210.7-04(23))",
   "Topic": "944",
   "URI": "https://asc.fasb.org/extlink&oid=120400993&loc=SL114874131-224263"
  },
  "r527": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4H",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "40",
   "Topic": "944",
   "URI": "https://asc.fasb.org/extlink&oid=116884468&loc=SL65671331-158438"
  },
  "r528": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "7A",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "40",
   "Subparagraph": "(d)",
   "Topic": "944",
   "URI": "https://asc.fasb.org/extlink&oid=124506351&loc=SL117782755-158439"
  },
  "r529": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "13H",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "40",
   "Subparagraph": "(a)",
   "Topic": "944",
   "URI": "https://asc.fasb.org/extlink&oid=126561865&loc=SL117783719-158441"
  },
  "r53": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "14A",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "220",
   "URI": "https://asc.fasb.org/extlink&oid=126968391&loc=SL7669686-108580"
  },
  "r530": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "29F",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "40",
   "Topic": "944",
   "URI": "https://asc.fasb.org/extlink&oid=126561865&loc=SL117819544-158441"
  },
  "r531": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "40",
   "Subparagraph": "(a)",
   "Topic": "944",
   "URI": "https://asc.fasb.org/extlink&oid=124501264&loc=SL117420844-207641"
  },
  "r532": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "40",
   "Subparagraph": "(b)",
   "Topic": "944",
   "URI": "https://asc.fasb.org/extlink&oid=124501264&loc=SL117420844-207641"
  },
  "r533": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "40",
   "Subparagraph": "(e)",
   "Topic": "944",
   "URI": "https://asc.fasb.org/extlink&oid=124501264&loc=SL117420844-207641"
  },
  "r534": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "40",
   "Subparagraph": "(f)(1)",
   "Topic": "944",
   "URI": "https://asc.fasb.org/extlink&oid=124501264&loc=SL117420844-207641"
  },
  "r535": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "40",
   "Subparagraph": "(f)(2)",
   "Topic": "944",
   "URI": "https://asc.fasb.org/extlink&oid=124501264&loc=SL117420844-207641"
  },
  "r536": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "40",
   "Subparagraph": "(g)(1)",
   "Topic": "944",
   "URI": "https://asc.fasb.org/extlink&oid=124501264&loc=SL117420844-207641"
  },
  "r537": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "40",
   "Subparagraph": "(g)(2)(i)",
   "Topic": "944",
   "URI": "https://asc.fasb.org/extlink&oid=124501264&loc=SL117420844-207641"
  },
  "r538": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "40",
   "Subparagraph": "(g)(2)(ii)",
   "Topic": "944",
   "URI": "https://asc.fasb.org/extlink&oid=124501264&loc=SL117420844-207641"
  },
  "r539": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "40",
   "Subparagraph": "(g)(2)(iii)",
   "Topic": "944",
   "URI": "https://asc.fasb.org/extlink&oid=124501264&loc=SL117420844-207641"
  },
  "r54": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1A",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "220",
   "URI": "https://asc.fasb.org/extlink&oid=126968391&loc=SL7669619-108580"
  },
  "r540": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "40",
   "Subparagraph": "(g)(2)(iv)",
   "Topic": "944",
   "URI": "https://asc.fasb.org/extlink&oid=124501264&loc=SL117420844-207641"
  },
  "r541": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "40",
   "Subparagraph": "(h)(1)",
   "Topic": "944",
   "URI": "https://asc.fasb.org/extlink&oid=124501264&loc=SL117420844-207641"
  },
  "r542": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "40",
   "Subparagraph": "(h)(2)",
   "Topic": "944",
   "URI": "https://asc.fasb.org/extlink&oid=124501264&loc=SL117420844-207641"
  },
  "r543": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "80",
   "Subparagraph": "(e)",
   "Topic": "944",
   "URI": "https://asc.fasb.org/extlink&oid=124508989&loc=d3e19393-158473"
  },
  "r544": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1B",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "825",
   "Topic": "944",
   "URI": "https://asc.fasb.org/extlink&oid=123600520&loc=SL75241803-196195"
  },
  "r545": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "15",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(a)",
   "Topic": "946",
   "URI": "https://asc.fasb.org/extlink&oid=66023616&loc=SL35737432-115832"
  },
  "r546": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "320",
   "Subparagraph": "(SX 210.12-12)",
   "Topic": "946",
   "URI": "https://asc.fasb.org/extlink&oid=122147990&loc=d3e611133-123010"
  },
  "r547": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "320",
   "Subparagraph": "(SX 210.12-12B)",
   "Topic": "946",
   "URI": "https://asc.fasb.org/extlink&oid=122147990&loc=d3e611197-123010"
  },
  "r548": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5D",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "320",
   "Subparagraph": "(SX 210.12-13D)",
   "Topic": "946",
   "URI": "https://asc.fasb.org/extlink&oid=122147990&loc=SL120429264-123010"
  },
  "r549": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "6",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "320",
   "Subparagraph": "(SX 210.12-14)",
   "Topic": "946",
   "URI": "https://asc.fasb.org/extlink&oid=122147990&loc=d3e611322-123010"
  },
  "r55": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1A",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "220",
   "URI": "https://asc.fasb.org/extlink&oid=126968391&loc=SL7669619-108580"
  },
  "r550": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "210",
   "Topic": "954",
   "URI": "https://asc.fasb.org/extlink&oid=120413173&loc=SL116631458-115580"
  },
  "r551": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "310",
   "Topic": "954",
   "URI": "https://asc.fasb.org/extlink&oid=126942805&loc=d3e3115-115594"
  },
  "r552": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "360",
   "Subparagraph": "(d)",
   "Topic": "958",
   "URI": "https://asc.fasb.org/extlink&oid=126982197&loc=d3e99779-112916"
  },
  "r553": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "6",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "360",
   "Topic": "958",
   "URI": "https://asc.fasb.org/extlink&oid=126982197&loc=d3e99893-112916"
  },
  "r554": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "310",
   "Subparagraph": "(c)",
   "Topic": "976",
   "URI": "https://asc.fasb.org/extlink&oid=6497875&loc=d3e22274-108663"
  },
  "r555": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "310",
   "Subparagraph": "(b)",
   "Topic": "978",
   "URI": "https://asc.fasb.org/extlink&oid=126945304&loc=d3e27327-108691"
  },
  "r556": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Topic": "985",
   "URI": "https://asc.fasb.org/extlink&oid=6501960&loc=d3e128462-111756"
  },
  "r557": {
   "Name": "Exchange Act",
   "Number": "240",
   "Publisher": "SEC",
   "Section": "12",
   "Subsection": "b"
  },
  "r558": {
   "Name": "Exchange Act",
   "Number": "240",
   "Publisher": "SEC",
   "Section": "12",
   "Subsection": "b-2"
  },
  "r559": {
   "Name": "Exchange Act",
   "Number": "240",
   "Publisher": "SEC",
   "Section": "12",
   "Subsection": "d1-1"
  },
  "r56": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1B",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "220",
   "URI": "https://asc.fasb.org/extlink&oid=126968391&loc=SL7669625-108580"
  },
  "r560": {
   "Name": "Form 10-Q",
   "Number": "240",
   "Publisher": "SEC",
   "Section": "308",
   "Subsection": "a"
  },
  "r561": {
   "Name": "Forms 10-K, 10-Q, 20-F",
   "Number": "240",
   "Publisher": "SEC",
   "Section": "13",
   "Subsection": "a-1"
  },
  "r562": {
   "Name": "Regulation S-K (SK)",
   "Number": "229",
   "Paragraph": "(a)",
   "Publisher": "SEC",
   "Section": "1402"
  },
  "r563": {
   "Name": "Regulation S-K (SK)",
   "Number": "229",
   "Paragraph": "(b)",
   "Publisher": "SEC",
   "Section": "1402",
   "Subparagraph": "(1)"
  },
  "r564": {
   "Name": "Regulation S-K (SK)",
   "Number": "229",
   "Paragraph": "(b)",
   "Publisher": "SEC",
   "Section": "1402",
   "Subparagraph": "(2)"
  },
  "r565": {
   "Name": "Regulation S-K (SK)",
   "Number": "229",
   "Paragraph": "(b)",
   "Publisher": "SEC",
   "Section": "1402",
   "Subparagraph": "(3)"
  },
  "r566": {
   "Name": "Regulation S-K (SK)",
   "Number": "229",
   "Paragraph": "(c)",
   "Publisher": "SEC",
   "Section": "1402",
   "Subparagraph": "(2)(i)"
  },
  "r567": {
   "Name": "Regulation S-K (SK)",
   "Number": "229",
   "Paragraph": "(c)",
   "Publisher": "SEC",
   "Section": "1402",
   "Subparagraph": "(2)(ii)"
  },
  "r568": {
   "Name": "Regulation S-K (SK)",
   "Number": "229",
   "Paragraph": "(c)",
   "Publisher": "SEC",
   "Section": "1402",
   "Subparagraph": "(2)(iii)"
  },
  "r569": {
   "Name": "Regulation S-T",
   "Number": "232",
   "Publisher": "SEC",
   "Section": "405"
  },
  "r57": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1B",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "220",
   "URI": "https://asc.fasb.org/extlink&oid=126968391&loc=SL7669625-108580"
  },
  "r58": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "220",
   "URI": "https://asc.fasb.org/extlink&oid=126968391&loc=d3e557-108580"
  },
  "r59": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "220",
   "URI": "https://asc.fasb.org/extlink&oid=124431353&loc=SL124442407-227067"
  },
  "r6": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "7",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Topic": "205",
   "URI": "https://asc.fasb.org/extlink&oid=109222650&loc=SL51721683-107760"
  },
  "r60": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "220",
   "URI": "https://asc.fasb.org/extlink&oid=124431353&loc=SL124442411-227067"
  },
  "r61": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "6",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "220",
   "URI": "https://asc.fasb.org/extlink&oid=124431353&loc=SL124452729-227067"
  },
  "r62": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-03(20))",
   "Topic": "220",
   "URI": "https://asc.fasb.org/extlink&oid=126953954&loc=SL114868664-224227"
  },
  "r63": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-03(24))",
   "Topic": "220",
   "URI": "https://asc.fasb.org/extlink&oid=126953954&loc=SL114868664-224227"
  },
  "r64": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-03(25))",
   "Topic": "220",
   "URI": "https://asc.fasb.org/extlink&oid=126953954&loc=SL114868664-224227"
  },
  "r65": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-03(4))",
   "Topic": "220",
   "URI": "https://asc.fasb.org/extlink&oid=126953954&loc=SL114868664-224227"
  },
  "r66": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-03.1,2)",
   "Topic": "220",
   "URI": "https://asc.fasb.org/extlink&oid=126953954&loc=SL114868664-224227"
  },
  "r67": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-03.2)",
   "Topic": "220",
   "URI": "https://asc.fasb.org/extlink&oid=126953954&loc=SL114868664-224227"
  },
  "r68": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-03.4)",
   "Topic": "220",
   "URI": "https://asc.fasb.org/extlink&oid=126953954&loc=SL114868664-224227"
  },
  "r69": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-03.7)",
   "Topic": "220",
   "URI": "https://asc.fasb.org/extlink&oid=126953954&loc=SL114868664-224227"
  },
  "r7": {
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "Topic": "205",
   "URI": "https://asc.fasb.org/topic&trid=2122149"
  },
  "r70": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "13",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "230",
   "URI": "https://asc.fasb.org/extlink&oid=126954810&loc=d3e3213-108585"
  },
  "r71": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "14",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "230",
   "URI": "https://asc.fasb.org/extlink&oid=126954810&loc=d3e3255-108585"
  },
  "r72": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "17",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(d)",
   "Topic": "230",
   "URI": "https://asc.fasb.org/extlink&oid=126954810&loc=d3e3367-108585"
  },
  "r73": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "230",
   "URI": "https://asc.fasb.org/extlink&oid=126954810&loc=d3e3000-108585"
  },
  "r74": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "24",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "230",
   "URI": "https://asc.fasb.org/extlink&oid=126954810&loc=d3e3521-108585"
  },
  "r75": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "25",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(e)",
   "Topic": "230",
   "URI": "https://asc.fasb.org/extlink&oid=126954810&loc=d3e3536-108585"
  },
  "r76": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "25",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "230",
   "URI": "https://asc.fasb.org/extlink&oid=126954810&loc=d3e3536-108585"
  },
  "r77": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "28",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "230",
   "URI": "https://asc.fasb.org/extlink&oid=126954810&loc=d3e3602-108585"
  },
  "r78": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "28",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "230",
   "URI": "https://asc.fasb.org/extlink&oid=126954810&loc=d3e3602-108585"
  },
  "r79": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "28",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "230",
   "URI": "https://asc.fasb.org/extlink&oid=126954810&loc=d3e3602-108585"
  },
  "r8": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "210",
   "URI": "https://asc.fasb.org/extlink&oid=124098289&loc=d3e6676-107765"
  },
  "r80": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "230",
   "URI": "https://asc.fasb.org/extlink&oid=126954810&loc=d3e3044-108585"
  },
  "r81": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "230",
   "URI": "https://asc.fasb.org/extlink&oid=126999549&loc=d3e4273-108586"
  },
  "r82": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "230",
   "URI": "https://asc.fasb.org/extlink&oid=126999549&loc=d3e4297-108586"
  },
  "r83": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "230",
   "URI": "https://asc.fasb.org/extlink&oid=126999549&loc=d3e4304-108586"
  },
  "r84": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "230",
   "URI": "https://asc.fasb.org/extlink&oid=126999549&loc=d3e4313-108586"
  },
  "r85": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "230",
   "URI": "https://asc.fasb.org/extlink&oid=126999549&loc=d3e4332-108586"
  },
  "r86": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "8",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "230",
   "URI": "https://asc.fasb.org/extlink&oid=126999549&loc=SL98516268-108586"
  },
  "r87": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(e)",
   "Topic": "235",
   "URI": "https://asc.fasb.org/extlink&oid=126899994&loc=d3e18823-107790"
  },
  "r88": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(f)",
   "Topic": "235",
   "URI": "https://asc.fasb.org/extlink&oid=126899994&loc=d3e18823-107790"
  },
  "r89": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.4-08(d))",
   "Topic": "235",
   "URI": "https://asc.fasb.org/extlink&oid=120395691&loc=d3e23780-122690"
  },
  "r9": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "210",
   "URI": "https://asc.fasb.org/extlink&oid=124098289&loc=d3e6676-107765"
  },
  "r90": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.4-08(e)(1))",
   "Topic": "235",
   "URI": "https://asc.fasb.org/extlink&oid=120395691&loc=d3e23780-122690"
  },
  "r91": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.4-08(f))",
   "Topic": "235",
   "URI": "https://asc.fasb.org/extlink&oid=120395691&loc=d3e23780-122690"
  },
  "r92": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.4-08(g)(1)(ii))",
   "Topic": "235",
   "URI": "https://asc.fasb.org/extlink&oid=120395691&loc=d3e23780-122690"
  },
  "r93": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.4-08(m)(1)(iii))",
   "Topic": "235",
   "URI": "https://asc.fasb.org/extlink&oid=120395691&loc=d3e23780-122690"
  },
  "r94": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.4-08(m)(2)(ii))",
   "Topic": "235",
   "URI": "https://asc.fasb.org/extlink&oid=120395691&loc=d3e23780-122690"
  },
  "r95": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.12-04(a))",
   "Topic": "235",
   "URI": "https://asc.fasb.org/extlink&oid=120395691&loc=d3e24072-122690"
  },
  "r96": {
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "Topic": "235",
   "URI": "https://asc.fasb.org/topic&trid=2122369"
  },
  "r97": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "23",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "250",
   "URI": "https://asc.fasb.org/extlink&oid=124436220&loc=d3e21914-107793"
  },
  "r98": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "24",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "250",
   "URI": "https://asc.fasb.org/extlink&oid=124436220&loc=d3e21930-107793"
  },
  "r99": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "250",
   "URI": "https://asc.fasb.org/extlink&oid=124436220&loc=d3e21711-107793"
  }
 },
 "version": "2.1"
}
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>ZIP
<SEQUENCE>71
<FILENAME>0001651944-22-000027-xbrl.zip
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
begin 644 0001651944-22-000027-xbrl.zip
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M  XP(S_G*;PY"$[J%\UZV6<;&9$>J&0$85PF@S2LXGR>OX;Y;.S=?+ZC&N<
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M<3G;D:0R@ 99)&7JE&%9*<,\YL3MZ)8S8IG.L8<O#E9K&OP6  DB_6)_$%]
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MONS" UQMN5WO\HF+A,6GO]/H;E=>_ %02P,$%     @ KH((5=4'%M_F!0
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MV?ZX>_#'_L;J.[K/9H?NV=EY3U"+/^F>7?I]1>T<Q.-7<K.+_]H\W7V?#H,
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M^A@U8QFD!LVS!XU!9(JS4RD+))="O?!\<WH:-B]"'<D\,Y:(?KI2W=P$E;-
MR9 A!R9,K81Z24:70EW1CV2,PPA"& N KJ0$2\.=%DD:N1P96,K1'2,>!DZE
M**W6$B(W/J!466<6>.0QS?&2ZWF6H[FGC--;!"L$U^15N=!5S0H(SG&>)9?!
M:,[B'*],7G !NM\\P"G6&_""?%=.6>0,/*<@N4^J+'0RP@D(M1*@GXF>S8L
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MWLLII8YH,D,BA&Q<!F;1J2RL=X5"NU2O72"7(O.WENCA!_H]<&$4$BT2%G)
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M1L0HF0C*7TRL"&&;%Q^6<'W76*QH"GO'L=BKI_Y([0:G9,B9F:*!F=111=2
MT3-.OUY6Y+ 7P^VVMF-YL\;6WGV<W4ZG\J5C*90-!] S"]89PA2Y0W3!\Y1-
M_8=G9VA=IS=BFQU%)D1Z(Q< G*$U2G-K0Y 6')<7-?THFEVB]!T^\&JX^2.U
MXZ33PI/7"\16#/.D5Q -).=9\A2PG*.T='W?A])5;_8#*$F/QNADO=0<! O.
MHK%<Q!"%TU[(^>>3?U> L>7[?J^:3JY9;<RR#P<JI%Y##BQ81\S#H\MEM6#(
M[&>$YLY/GK-ZMM,3"FZBH;A"8')D54-V&KRP+&MA0@C@:S22^W-+Q^P'>1-8
M5,)QF\K @6)!.QV]+ZLNE/-R 6KO/K#IGQ[#%0*222IRF0&,],%'GP)(F2SF
MF-W\F_[;)O(N0-@>7!"E^MG?DA[+E=59V02)<<]S*;N@LM4JL2SG7VGF"YDI
MYO%PT@UKHN6FK/0DWYAD,L"2%9*QG.JI,W^SJ^/I(NA4L,B3 F>\M0"9:*[F
M7D;KE .!@M=3I^87N>GI7+(J6.TE1J9*,1H/+H!!U$$16JP&LU$WD+OX^5I8
M/TDYJ8DR99>3,MD'(3P0#M;KC$DI%2,P;5CME&E6D$QQO%(Y25J2I+>ZF+>@
M=,PV""8]"SG6C\U=61,W'G;B^#QW\&V_,QYM;KVMB:9X$='J%)PU$G19&A.\
M0&MSB(*"H/IJRBQ@F:)/R9D;5BIFE\U@O',<'$&E4X2R&UFLG;94;&#E:+P_
M&';.,+T8#%\<C8^&.!E\>%FG(4DOA$#ME7"6@4\8C%5E:TKFE!(,0^U49N;8
M3-'+")M5XE+GY(&B4^M)?;3GP@JFHJX?%_LJ-ENO7U]0YKHHCHI!)>2>6QZ!
M=,:;I)B,TCD41L0:C+7-'3C3TQP4W@IKC)<B 5KF3184CX*F3R[%.M6J^+L1
MT;\)2CLX>IC]KA]LQ/N(R$^%\O'DO2Z!ZZ$?D;Q>&_^ZN,?%L8OOY2:WVUSM
M(&AMD6@D"%0.K$U.R0R6,:=5C21G)1T<C<;EHA$I<QN/5V(<'/5+H:G7PT&?
M/DZVL;LQ1_+YK"U2OT0V8O3V,!$^U7;P8D&DZ'H*IC0:($O. (B0TO^Y--9*
M(6STO!8;;96\U^='O:/N9.%TSAC'KZL>V,@K:7#X>='UG<Z\%)VI+0-:"N-=
MLQ&UL"A"@B!+*2UTSK!L M$_ 2'%.LP'WX<P8OK#=SU)R5(B'UHB/;,**6;/
M3)$\@O=&18Q:2_ ,T=4@0[TN6-_/VFLG'-&76/9Z!S(@@3XGQXPC3DRQ_QQO
MF+QT:G,L5E;*+%-$[WD S"K$E#V TTQY-M<KUI;N:=YE*U(8QCR/F3$!DJE@
MI-/)0PS:&9]N[I'Z$*,LW^JIOZFJT+5QCQ_ACCY:DY6Q*3-@.CF'QJ1HM*4
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MCYIL2,WGS1; "M.HC5N'A5L4WO'FMX9DZRUJ+=Y6?92[-V\268$B]XR 4SH
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M4 %?EP%2 +]BP,_:))I'+B)%H'-]-J,R9TXBR:$,+HU#U&*:;9(V7GYV]5H
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M)M>+F6XU\[H5F53\-KC<"2TS7LS>:[?2AYV&]-F?0N_R(*?O?BJ%S:O+\<^
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M,&9X+BL2H*ETW@OD,9.5_X(D:G.ZJ?&Q6MOG;5R&JG,MUY2[Z;G!R<D@7\O
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M/O>]C\7)T5:WO_5['_O]YQ@2Y6(WZV+YG3[V!]5=/ZP6UM=>>D-L8\(DZXD
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MP1V%5#+;K -.<\OS0!P83Q+X-;%:!>1=UNZ2%>V^07A?;^RBH+R)*)\+<+!
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M:1.D=!\QIC(V>5U<.Q=!LLQCS$0 *XP YC "C2D"A 6.FIND:\7.+K[>1[A
MN-$0+D1;I%2DM+FAF:(.U^9ZS =>*+("89-;Y^;CQH)%,(8A(!AQY@R+RLJ&
M*<0'74=4)MN5[EE%2D5*14I%2DN>>L$$.VR$Q2)X)BRS4D;CM5)":ZK(CP++
M98A2TXV]-_,G %UP*BAOP40=<VL&#9HSDGXXQ5VRY%4^)X/E]:K)TK2NJ7@O
MK+P)4EJ$E6MPJ0LK-YN5KY[T$1);I D8P0PP@@(D%:P <6X%"8QZ3!O$RP^@
M"V$9;E>BM45*14H/)\5<YN\TPS@XG$]7.RVBY%@ 9<A",@<C6$XM>.\B<@)Y
M8N/.+FNKVOJ %D8HO%VD5*2T45)J>L:Z:->F:-<KKK>+@E)$*#CNDGY%CH,Q
MS@!%@4H<B97&-T^_EOEV6QHG+-'<(J4BI2*E(J4BI29):9'\E? :2V.IMUBP
MJ+$63B%KI-0A"K5,_JJ,QEJ16?QAOI^F)#P$:04PYGPRBH4$A:,&Z56><\9M
MH**:0,/5];+04BJP#2!>71*Z@'AE(+[BVTIOC$TN+<000L(RY:"\\<"CUIIB
M[ST.S8+Q \@L?YMO]\=9/[0HJFV\W>2FKC4R>+C#[XSF5%*DC+.>41R5#-0R
MYA&6#$=R,6KE]M/R9?C=&ECKX_Q1>.6,H3$&D#AB8&E-P8C P6B$D]ZQD3-3
MS>1$5+49JWGXW5(8VHR&W_731-,8]F?;@2^W,IM)G-<-OY]CS3)6;Q7$.#>]
MQ1IE(C- .4K&7++>P&JA02#CJ?=$>:QJ'ZM7^+#PX0/G0ZN-U=9RCC5E&!%K
M M&(18P-\X:@9?BP^+[UD>5<U93V&K-D+8+45N>J*3()8#EO,,=4!BED'MC'
MVVSY%N&%,@ME;C]E+C1-BUM.C0\^,,E08DYE730Z$:7#PJ+O<&89!;@R?IPU
M)CE%TB*L@#!,@!D7P2!.P&"FK+$N6,IV=I7@M0W+*K18:/&ATR)'PB KJ$R6
M";,&:<TT2D3HE%".4%T++1:;LC[.G$N*\L@L2[XV*.L5L&@9&"4Y*,XMLMY1
M&_#.+A&BG9BT\&;AS<*;]7C@S*E(F/288,I,[D[AN0C8*8L(8X07#[P9;'DE
M^XP<0Y1J##8J!,Q6122,@V5)W4G'I9$H'VI6;2ZW(8WS@]RU[XY.>^8\WV3X
M/L^65V[F*\L&>."O+!O@@;^R;( '_LJR 1[X*\L&>."O+!O@@;^RV@"_5%V7
MT[^^^VGW/^G'Q3M.S/!#MS]Q0<E\T,J%_C@,ZX[&J!]%8TC5[BJ$EG&YT97I
MGR='N-4?C-.'CP>ML[XY\]UQU08K]\.>-,3J5[ZSR0_';M_T7=?TTB6G!ZIC
M\(^^^>U7[W_ZK8RGRSH=C*I#[H^'H6?&W4_AU\]=/SZZ"!#-O&OJSZ/+MQB;
MKN!L?/M;5KZP5=_P'Z\LFU^*V9_Y:JO D@G<:!M0L)HQ[K$FT01%B"<D/:KC
M>\)W+MYT-+RX@U/S(8 =!O,13$PW^-CT/IOST<XO\QLN[;;91;^Z7K>N2HPK
M6Y7)KO?!#895&X3'9VEG#?.KTC69QEQ+ZVB8XX__\V/YR)W=@ZK-^B"VGN;0
M9<+ ?WXQNS?)_C[)X-J*R!OW[+/GK_8.GC_]O=UZV7EZ.Y:;<KE/OQ'3TUEB
M>OV-CK)89H._U9%3^6MK$@1N_/W]J]MOC8\&9^DS_*C="E]<R-'+?"BAE1YJ
MG8;A]*]TX^;?S;^?-Q<ZY?9KO0*-=*73.087"J&*Y*8K[IG347A\\<NO%QJY
MVZ^^MWK3K],/FVH1?GV<0[4RDZ<O"?(1FI#DU)B;?O/TZ4?54U?"TI/GJ'I$
M!+OU:?0(_^1S7,B?>N?W+E8]8E2OX%H)5>5:R[66:UW%M3)^IW=.7=$KIC?A
M$SJ]T:'YX;GH!5ZJK[WTADS]1!'=3V+Z-FOB<E;QK:<R%UNQX>#SY'>RF4MR
MV=/L/W;XR^ZIZ7KH]JO?W:2]65FHR4(Y=W9RULOF9[4Z@]QO?;).LTW7JT>Z
MU1GX7_Z5>UQ=*PXJZU>MD0^QZ[KCLCK5ZAP,QE,$CJX[,]7C8=ZA67"Y;M87
M&*])7\P4FMVU3J.Q\IKTD*^.C=]!&C^^WX>S:$].!F?]NA#?Z)<^@!Z.WWI=
M/ LNG-@P;%%<];M =T'%*IOW/-RN&#XR' S"S%O!4,2&."(=,5)H@R*5534E
MPH3B[>R*T7D]K:8\=F3_[9OSO:^'Z?\?Z+MG?_-WQT]8Y_@-W2-[Z/#X;WSX
M]O#KWL&;\\MJRG?=PZ]/T/[;_%IWGM[SY?#KJVZ'O#E_=_Q/[_#@7;?S]>7Y
MNP/_\5HUY<D?QWOY.])U=[[^\;'S[+?CSHN7]%VZSL[;?XXZ)R]INLY>A[R*
M>UWTI=.=J3U'VA%L<01A!0*FJ0#+8P2D*!96"1YY;LB%VI*A-L-+GP)?""7W
MW+-KA5!O&I_>O8Y\L7O?3'J[7BG^<]RV4;TK-H6^]I_.T)?@""O,#.0V<L"0
ME: LQHG#;(Q16ZDH3_156*NPU@-D+2E1E$8)I;UEB:@L]H$SXGUN+R&Y7H:U
M-N%\RX90VOG>+*4A&;&E(8#%@@"C!(&2T@()@2KF I$AGVY1NIT$6XBM$-NV
M$-M"!YX--<;A9'DE0K,1:^:-PL9IA",/YCO,MGE](#:$Q=B?TU-Z>P=[_'U0
M7E(>&'!.$XM9HD'1H, %Q+D1A$NI$XLMWQRV4%>AKGN_Z85:V#CE@U0&4974
M.0]62:^RMR*=%0Z[6JBK6&<U6F>S\3+G*;7(N.QP*F R&#!>:V \::#<<2-J
MG'B-J#8BNK!;8;<M8+=%FOMKK8GTQ/D8F/ A&6DJ!,&\D]X%\1UR*YRV3D[K
MS'J<,1EJ40<"7 <,C%@,1J)DJRG.'446.:IV=@5N*W:]F__F.)SUY$J7G LP
M4XD\_0C(KW^L+SZCFTO.QX]!5]>X7K17Q2 O1Z.SG%O-M>UNIF2M9<:M__T>
M%?P5AE7F[@HE:"FX4]1A9!C3&FGMJ7,.*:%,U#94E( 1G:<$<G-2,%]<\'\-
M)R,MIU]7\G]WQ_XY^CSUTW*7ED_^Q3_,__Y'[QWI?;+' [1_\";=XTM\>/ W
MZ1RG^_WZY/-AXHB]KV^^=DBZGP-__.Y@[\L>5E_W/KP/#".=)[68B'SR\M(/
M;2(!ZIA.CI_!S+@\!^01OTX<EZ<+VJU^&.?M]MWM=75;41$#4AC)]"V>NZ1V
M+(\&TT#2%;C)*'.,\&2,S+7]!?RGAJUF($SVX 5,G@Y&X]'=E),H&W2=&Q3O
M?7ZO* U1,@64QP#,4PF:$@H^;57,E+2:FYU=_>AZ(**5F+67]V W_>^"$ET6
M]I6S5XL8TF62\IVK29;$]TUE)9?@?78V3&LW&8H\42SI%JNG[@CEHFON!.7Y
M6A.*A#%,,S#&)SO3R@A&40Y12TVP2\#4J)J(+$E;J;JZ9S>H;>$#Q7?]ROMF
M?_$ZMJLIYS/0+E[B0NB=*[5 $<<@> 06+ (F8YQXB<$Y*;3%RE)R4T2_H'9;
M4$LC#P$Y03'WC"MON,96*^<B,M%*MRK4EL!/;9">+S70/-F_1"*(DLBLD$7N
M.1Q :$$01Q0+'1.D*6OSHHXW#=@_-_ZZ2*E(J4AI"27IHE9,N1"XC$P%;*SW
M@FN'-$*,>%N49/.5Y%QVQ NGG+4:8J "F+ 1E'4,DBDDE*($*64NE.32A<8K
M!_8J#XQ-H(QNR(9<S6PT"=NWYCOB<'#2&IQ6@ ]?PM!U1^E+<U^<5Z_?M(:A
M%\SH;J<PR[#X)L0!_<GXX_>#@-63^Y7$1\^G$O=/^C[)^]5$W"4Z6!?/=JZ>
M1-.:8Z*" :9C!$9PXEE/ W#E##<^/>MI[NHOVD+6=0RM044TVXWYGS-SBY0:
MPLPKC 5]CY4K&_<NI%SLVT5X]VH02&$ND ?J)0=&D0)-O87@M,&(<.8]WMEE
MJ*ZS)@7-A7.+E(J4-DI*]Q$ *IIQ_9IQ+O*C W-,^@@!,PE,*@%*:@[<$A1C
M<CX%DYNA&5=9^KJ-49_/9C@T_?%EV.>GHCPE9'Y?49Z[U'*^G<AXPJVOIQ=5
MHCLU<>G5VB]N8G(G% 9)$XTRQ'*?(6=!<J)I",D&,FAGE[:1TFU*KD\';UH<
MO:"]I#$W3DKW6>NS,"67E&:-9#P?\C',$*EE@*1?DV%K7  3G(8D9V(\4QP+
MN[,K26+C4O:S81@O3%RD5*2TN5&?HB\;H2_G D&8J8B5P\ MTDE?H@B&,0=8
MXO2$0,E"TANC+TL%T&*QH.<GI[W!>0B305^MO\Z&[LB,0NNOGNF7XI]-"0O=
MZ1#@A:BK%UT(.LNY1(9J(]=\IFC^5& 0EA@3P#(<(=&J!86-@-P4"?F HJ8Y
M,J3;6M35?:*DS1IMYA8I-823[_D(V*UT7*S9Q0AW/OH3DELB!4&@HT_6;% :
M5'0Z:3."A31$6QHSX=;5-;O@N+!MD5*1TD9)J:DGOHI.K$LGSD5X4'!$8)QT
MHK06F',2+!<6I$$4X: #860S=&(CNMS= V#?](<A7<77X*MN8A],M]]*N#6?
M3+>79W5#<N!AE!#2.C'#CV$Z]#NX!+!QMQ3XE!1&D5*14I%2D5(M-J$T@3FC
M#+>6,\JPLM8$P4+0.A@5%[<)]_/ YZ>SLYY?5F.>+]7>[X->7L\72?'].1B-
M]ONOORFW)\/N*#TU:TQVPG@_'I@OQ6Q<+#$X,^7B"7TOJ6>$Y:I&QB@PJP08
M32G@P AQ,EEZ(NSL7N\#7X#>:* 7.MX$*=VGBU[HN!ET_.5B.,?>P?//G<_O
M U92)D4+&#L## D.AE($D6L=G23(1KT)A/Q0YWI782VP9A3R+9Z<)FR9+*!2
M:%'"S$5*14J-MS3NY=Q$5;U4D>;3&<Y\%?[O+!D:X_ Z##]-!F8D2^-5<(,/
M_>I3JH1"*1NM+:GP^DJBG1KAE8\$C! *F/(:3$(%&$Y,=-Q9'_'.+FECV?RT
M0F&$PMM%2D5*6^;'%^VZ2=IU+F7/L'*,"0D\4@[,F@A:X@#>8\,L$LI0MBG:
MM?3GN$H*"4@],QIU8[J>BA4&\5M7CE[7V&ZO.SYO^;/0&@]:?PV[G\PXM%[_
M]>1I:WHH:M3J#\:MH]#S+7O>&B31=!.P6Y.9DB7;7T+B14I%2HTW>.IMLWF5
M5/?CE"S_O&#49V?A8#"ET\RF%V3:&8Q_3U3ZW_/]*9'^7O%HL6 6LV#(9?;X
M)7ZOG0Q,40-<DEQTR"A8923HX)F6WCF,DP7#<///E!: %QHN4BI2VI+H0%&6
M35"6L[G]\\[?[Y,%I%%T#(2) I@)&BRB$4C$4BFCN,=A,]3E0\WN=T)RW@>C
M,C.E1+*+E(J4BI2*E(J4-EI*_UKD3$2D5!%">/"&84NU#)Y3S WER4*/_@[F
M^2C=;_KM:A8OV163\MM<:5M2;K6-0CQX,MX[?ED%K/X\.#SO?'AO*0^"1 G.
M2@S,YI(63A4HS;Q6B%MKY,XNYFTDKG?%_W>!\1; N 8ON\!X_3#^>Q;&)$03
M#3- G+3 I!9@HE7 ',).6X:-HYL XX=ZV/V_II<;%K9;>V;HCEH4MUL9:_>=
MUK:#H0]#& ].'V<YCP:]KF_EQ=A 2ERP4:$4W"GJ,#*,:8VT]M0YAY10)FH;
MWK^\:W_"ZM/WS\:CL>GG)2N=!^OCP1Q*/)SE06QSE1!&0#0EP$*DH(-#()TU
MQ&"+L$CF#%%MC76;\+K&.]\-)_><5E@AV)M&I_^[&@$N(+@F$=QUD^_GV.V6
MQD:3"JS1\_\[ZX[/BR&W,(%]F"4P(Z2*(3E@,GG5P)!V8*2PH#&S05#*=3YB
ML/2XY,);A;>:<M,+=>'@WA%GO#*6&4$MYE@2@;0(%'FDEN&MXIW62&K'3V9)
M33&&HL\'I1B5P&) R3OE&AR2E'%'*7,A-V/3R2PKU%:H[2%2FZ5&XFB\B"$7
MAA+%I24.RX0<))2GQ21;&WOM?SN5LL<3>SD<J'<T@% ZSU,W%%12.X"X1-@F
M2UKEJLZE9\86WBJ\U92;7B1]H Q)9EC .CC&'!<Z(HZDM-H('KEUMQ/7+5F#
M8IRMVCB;RP!JK9+0+8;D7[K<*=>""HB 2,:95MHP97,&D-$VTG*)W$'AM\)O
M3;GI1>@-(6H)CE'QY,;0:)"5B<XTBI0'J[Y#;X75ULMJ<PG1@)W/7;[S$"(-
MS%*1C3:1G$\C@G68&.QV=@D7;?7_V7OWIC:295_TJR@X^\2=N4%YU?LQ<X((
MQO;,\KX#>&R\YGC^<=039 N)K8=M_.EO5G6WD(0P"(01T'OMP2"U6M55F;_Z
MY:,RZ454>SC4K6W^MEKSM\%I4?CX-0Y]=P1?:ONA\^;MN\XP]J(=W;!N^!IS
M36:$B,$2A,$DUS5_$C'7I!5P1K" J<<Y+&$%C9)+X2AWQA!;)Z+P)A%%,GQ)
M\+6<]_AN9[CRYD$1AM'+6AC";C^ *+RI)*&-TZX/GO<6X[0LT.B8PLBS1!$/
MR2(M24+2.^>UCIS@F/-5U#95MX;GU33K >6E/2JLN%5^<+NV&[VV*_#M$*C%
M$0>5-.8*:#=E5!)ON3#1"*ZOV 06SOQ]K_/.=;: EH2OAO+S<1^C9(I>8"1"
M#F930I !*PKQ**3R42EL#*"\OK7OM$6!AX "+<*W:]NN[<-;VU5V;^6<4DPK
MR@R'_=M9*JW55EF<>!"RW;TW>O>>=Z$E+JF+!%EN'.+)>60C[.-""TP23<[D
MN.<#W[TWXL!!Z'Y>& _*U_]B3B^ZVC;,J6;''=NI/AI#Q\(3VJ/8.1UVJVO_
MZWO8 =I<G#&+F1")QNB(D2(&GK2PUGEK%,9$,R=]D^2U !UT>>)]A1ZOAU5!
MS_KK6M_-:KCPO"G;L?=E[ZW!__S?8^Q/_M.W?YO)P<?=;_LO_M/=>_';ISWZ
MU]=_X)D/7GBQ_^T]W3_T?(_^?O+/X1[_Y\6N^+_?WN&#0T_V#X^^[K_8Q?M?
M/@A&D^<I(JM40MG>0\XDF=ULC!H#5I]D6SM</F,7\\(ZXV-0PJ-CD$$T/F[:
M0(+4I9CWBNW2-O(J&5SS_B5N5(_V?)MK].SY8#2^YHDYV4KQ?4HQV__K@^91
M6T,H<H"68-U2@K0A HQ=P:D.- F+MW;PLXN>S Y =2_+9!?^O\%8GQ=_NGO"
MYM"6E]K\D,,5O9ZKW0@>L;QU3=5N-ZAKJO:TKM0>V=_]0+&D)!B=B2M#("8*
M?O,, 8+CI+TFQKNM'<'PMA";7UNJU>^VR-^#6Z7[</A?@<#%:[ B +>>@^L!
M\/X\ %NL(_4T(JD81YQPC%QD , D>&P,)4RGK1W*MC63+?X^+,UN\;==I7:5
M'JYCO=TE[S$':IIX_^W@\/T'*[EWT3ADM"0H5XA'FC./6%2,VL!I(OC!;)-M
M(NIJB:A-[YMI)NI])YX^(OC\$=FEUW'LUO7#*Y1]6P^J]>VL )I_+2:.XMQZ
MDV6D-#HBGL]A&B<]RG4!F#'<:VZV=ACA&]\BK%7FMCSL@UNE^_3KK(RX+4%=
M%6OGTS<#;)%")XM<H@QQC@W\AB4*-*1$F%(\I:T=T2+MP]+A%FG;56I7Z>%[
M<-K]\.[WP[F$2)$8-_F4FK4$; ]/,#(Z*90$20ILR!"3>0C[8=N<>%&-W_6'
M$4;Q+8:2-)9;&G5 F^UGV^U9UXLH#89H!+I3)YGEUSJCZ"=#4+H;NFZ>M.>[
MC4^TJ]2N4KM*3V>55BFIE0C7A,@HDDZ<1F](PM$1E2*+029\#:IX26VM@_%Q
M'#X?G)P.XW'LC[J?8]6@XWP#S*TM86;_L-U^[MIQT'\[W>9VA]T1O#4;+MR/
MXX-T:+^VU')%:GDPS49^Q0]V/RC@E9I[AQRA'O&@-'(RM_.P6$3.L9;&;NU<
MC *N7'ZKU?<6E=M5NA$JK\& ;U%YDU'YW:+![S%S/G*%A+88<6H",I@(Y*-3
ML,1<6(4W')6?:F?BDMZ$G!W%_(@GIZ!6I>EWFV71.J+;56I7:?/#!?<1/B\Y
M2@4TG\]@YIOX/Q/@&./X-@X_5P>I@62\B7YPU"]W*4FC;:[H^IC(^\50O,#.
MJ)3+,&"5:]!'8"*14T2H\9%@2T)R6SML6[!U56-H,:%%[G:5VE5Z4*NTZ>'X
M=G_=G/UUSM+'N5&RUA8IIPULLIXB4SJ(BA@Q9PFSW#_Y8>RO;7A_$19 E7IV
M-.HF&$_!A4&:GK_H=:WK]KKCLTZ8Q,YXT'D]['ZVX]AY^WKW>:?.GQEU^H-Q
MYSCV0L>==0:P-%U0[4Y5SK^-_K>^\7:5VE5Z.I2G'(!:!-6#5(/EGPVBOIC$
MPT$-IQE-&S#='XS_#5#ZV]E!#:3_+CC:<I@5.<QYU857=._H@U7&$A84LIXE
MQ&4BP&&\0X(Q(ARCW.6R-W1=#39;#6]QN%VE=I4>U"JUN^43W2W]A>H+1FA*
MI=%(B2@1-S8B';U%(LG<OE+8J.B#V"Z?:HA_O\[4;T/ZK3.[7:5VE=I5:E>I
M7:6'O$HK9>-ZPAT6"6ON. W>!4R-D3:HY')WWIMGXP*OJ-)O<Z9M&W5;*P>?
M;SV.98A"<(%8TAYQS#@"&AX1=X(D')B6(;<>5]L$TULDV6Z>&M]:=3>-BU^_
MB_BR)WP\H'1G1P1:4+I#4)I+!;"PG\2,1Y%AA3A1#EF:*)(R<9$\CXK'AP!*
M&]'9Z![T]3?;RU47MSO_/>G'#L/;G:QJ]QVDKYM;51-SH;_5]3K'/PP2MUI5
M1B-IQ,E(SI+@ADOG#184.Q6MEE[)Y<V>EO7=*'<_F(Q'8]O/4]:VV%@?2!XM
MEF&4C)LDO$72L8"XB19ICAW"RJ00;+ X9N>IV998;<->N"8GZCJTZ)[C*_<&
M%)N&T]>GC.N<F8<)G1>9YLUP\Y(RX%4>V^CE_TRZX[.6/ZX,C4=S_-$ZK6W2
MR%$._)%ABFQ4N2,88U0S6#@9MG;6%59J$;%%Q!81,R(*9IG/$=TD!<_M:;ED
MR@=EDU&<LULA8FMNKQ$NYT^VZ>2H94DB;+@!N#0&64DB,HHRJ9SC/F>M<:JV
M!6Y!LP7-%C37"9K,Z$2M$,8ZR9,F+A"+L?(F><PMMBV-_$&X^&E:$6K_XYX
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M,;"7OG^V78(\P.C..I_Z@R_]CAT53C".O5XU&[N]TV/;J4MKP'O#T^W.3V-
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M;I -%?/?&R@%$6Q6(I7-\7\F,'NP.<&+P.AQC03#P>3HN%JOF.5FX3):@ @
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M,NK\!#+PN3N8C'KUD?AAXV)N HN^/CA=?6#JX%T1JR0FS'N9$D@LY\P8IG$
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M#\,S?# D):   EE,-.).&F0PP OHOO?)!P"%U? $3'%-G K"L<"] 9[!G!?
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ML"JAU_]T7I.N2B[+$O<#Q.N".S.7T/K]Q:OGKZHJ1KNE4&#KP;Q$L+[ELR-
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MZ6WWV&?S!8#BB8O##B-E1I>VOELK-#[&AH%MC\65IZSMU]G*TH;*TGIJ23_
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MLWA2A5!&6K3X85[.O;HWY_['5_2#!/(@(Z8H4JS  &$.V<13;H4MJ8K&2LH
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M[\B>E&$L^3;XL3^"*8H_<Y@@M&N/COJ]G\")PYC? <L"4UW^&:96:= (L%1
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M(V(DQ\'D<FK6V&"Y"$)'57L,5AZLYC(/8VZ#CM(@C'7./.P$<E@[9&U20>-
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M'Q?#@Y*O\WJ.;!L>&$ZNP>WM.!A BS"^X7%L_XB-#MQZ (_90>-_[S]+N9B
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MCBWA ;<#OA U@K"0V!J,X=>_66LM@23$9(0MS.IH@]"2UE"5^>2365F9DRQ
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MQ&/"0=J@5];5XP/0]:+WCVG;3E[;O@Q Q^\Y_EPW#GKZR&LQ[M?WZM1$:-&
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M.,<KG.+TJ=\[*0O?Y7/DW\6E86SM(=S58>DEEM,%#+#MBPN,3O/';V5U,SS
M<JM24)HFAKD2P:K "&/!> +V2HLB4(4)(1B-7TS%J\7<L-5V]D[#YBC?';"
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MFCV%O[[#= UCY_Q!=NN1HG%EMPK9*+KNOJ]N["V8W@PWN9[[3IKP;VNK=8/
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M"Z^QU$90P:/F\-L9P70,!--@?2%S9"QSUW+/:J]LP8*WA8%(.VM8DL"&B/5
MI&.4R%A@TQ%L!R,.$Y\2>/. .T+,P:XE],H>*6:U5_9#PK2-@61;&[GQ6"$%
MXUQNT $ZXE%2TF&E/7<Y-,3E&F._Q"M[I&C47MD"!:9YUCP\8$ Z&)4:82HD
MXEPS9)2,,#S$>TH]]@;,'N5KUSO*/MHK6X PU%[9@F7B>^OL("3 $*<D D$
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M).9*SWQ5*[JJ]:W1Q5E+MMHX.VK[H\J@58(5O\>^;P]B=O'2"#C1/,PJL]N
MK%6B#B)^&7?\$:.X./FKC>)"9?!X(R>*,&]S=FU&P[RKB4H*SJ!GR%,LJ5/@
MH*MTBU','DQ^!42]G/W5,G9=1J@K>+S$L!^*5WMGK7.Y):GRW AFN4]!B,1(
M@F?6H=R)_S#<FHI/OV018" "PB=CI)4 /D0!#.5E?@*LVH?DA3:4VP P1,V:
MF)/[,;&?8=(-ZT<?P9,+3Q2H?B2HW!6H'GOR;R(@1]S,\=/LYDZZO'DC=V_4
M'>9673G<!-XFW'/^JRAP-C[#5E4>L@Y#S1? +=(\.Q!*4ATI1\0:A[@ WPZ(
MF$$,YM5$PX"8^95UPMDM,<W5PM.?"EPNAX35D<K'BHC(3C^,L'$L(D\2>&PI
M1*15H@A+)V-4+JB<'$O8[2LAQ28AF*5*GZ^8=OXCC#6ZD"1_I=-7'4VO:/BX
M[.O:[QG]##=&/[_8?F95@T>$?7_!8\Z/>WYZO_%WXT$/M$Q1VTES>]J/W]J]
MT:!SE8H"Y"L7&WRPOR@5HU$S+*7EG"IEM6 F1IZH<<K3E(&/*""'#(U?W,;7
MBP(0.ZD:Y9W^Q_P$XS&O_JP<Q]W>F-<_&!5?'G-KXIT/!V S>>"8(^\R<_-)
M(*M]0E@X;:246,>8#>>J87*5SJ-OTRHPZ>O-Q$7')#YC(9#[;YG1G7:L+Z/^
M8UP<5&[G6>S'LOG)R4E1'0/.=)6D1UF.@!"UUM@8Y WMP_&6JIE@Q]P<JP?F
M\1%L$V/&>":XI<1P<!J\HTQ@B6'L:FE>"FG^_+VU<2#S>F]R!#$JP17E+N>(
M:I,7MD,P4F":6"'-3(GY117.QH+\QTJU)C<EWRM_%N)K9X3N1FE>@/P!9XR$
M&Z.M3=QIY;2VC'&%/15,QEK^ED/^]G(XSDJ,M>,<L9@+;C)XY9*@1;:IT0G\
M#P5H*B29#Z63PE>)U(STE2[R-.1693UN6QMX2*V':9]C?!7P2DO1V!D-!T/0
M 1#NW=@_F;LP<-;KAT'LOC 9:%YLBYW-SQ?P_EGKXG->*(C9?.9$/66(R8WX
M%++6,&2,L4E+KI-W*^NI_2VBG"D\NU[0Z+13K#8"P[2'+!#YQ9O1 +C<8)"!
MQ;6[Y1;X,SN8LI<9I_("^#G,T*@_(S. 4>UAISQ;6=ULRG+WNA',< \^4$#2
M]7I#P[Q^?QD,?E0RJ63<2)5LB"";P4OC.$[*1L$TN&96SZ]#0J]5(9F':UO5
M'1;!NLN#ES!'7C!>'>+FX8$+'@,V421U](@+$$UG D7*8N\8X /%JLC>F6<J
M<]QN0DCNY<<NF_<S%V8;6>3;V:G.)3/'(>AY=&"UX4;#?/2\\4?[S^)[E5(4
MA2QBNW#Y 2$;W@Z.&O [5W(K_NAD_75VT!YD;;K2P\MB .7BR2J<N#ISMS?,
MB9@QGA0GGUXDS)2DT^L>YM^#4>;/DP]S%#N7R\MM4,DV/-98V?."3;]:L+$I
MM3MM&) R8@$S?)+7$$-CF-?C@-+$(CP/A^"NX+9.['E>PAZ,W''TEZGHG39\
MJP"E07[>2YC(MW8*&IS:11)0\=GJ-J^*,!2,WE;)A!7!@N^&=F94,:<;YJ6G
M:(>CO&[EXO LQNZ-$U3<Z]Q)GED[[5VM<E73,5\T!D?C=?NBO%;Y+#;?\;@6
M__EJHYTK;K4[G:EQ[_7;H 4P\/-.7$U^.;8GN19'L3)\4E;EB!8F-,&7NS[/
M7#^>]OI%P.FT6*(?C^5L.8FBK&!%1T&<8EF;Y7X!IV52U#?5)%=KX(UJ];L8
MJVO[MN#@#P<N*'%*"R$Y!Q(G.3AY)&BEP"OVRLAHJW6B>Y3$FF>,+E>ZHQ_U
MRSK.MM/)*Y"S=JGFV/-+*&Z(G=W/WYN[>QA^G^>8;O0V4D-1\E2#_1(".9D(
M2B%1RY/21&OP]VCN=+S*YFU4G];N(N@PQJLPD](\3\4N<Z ?+&O1$P%>@@^>
M>*Z#<\PJ*Q*G20=PX]A,'O,M0E>Z=:6'-I%$\?FTUQWSGROJ4XO6/43KHGEV
M($'O@8Y&Y("8(LZ31X9HBZ2RX-=)<+5MR+T3,. .?D UC0Q:69**Y<W3X9VL
M>;%B<_NB4B4D8ZFIEQSO(RPYBNITE%89@2*3,<>=*-**2J0<$R G-E!+5M:E
MF;/Z6!JOB6T5TXO<]TN.7R9K/1$@N!8;!JO\X/B7!@TS(F$BA.&",Y<,Q2*D
M0 3QF,;[UZF<9Y0G[K:&QKF>XL7A.4@X=QA84" H$.409PHDW%.*(DD,YZ+F
M*8E;RI#.G5DC.7%<,.!9'#"5&"PCSFUI5'X3Z_D-,NJ97>S,NL0<X6#9A 9K
MQSWA8/(<1SQ%IBQCV :2NU1K(E:UN)[ -2>CJ[!ZURLJ%+9OO V^.E1Q^;4;
MW*W"&RM86>E0]<ZZ\;I'=1G!^A%\P<%PS$'Z,F54!.RIH]@:SK2E5(Z3PVHI
M?#(I_(I;.3O#16V(0I+D,L=)4V2 WR!,*%=:8\6T>2B^:!P%S*#0 #1<R* 3
M5R9GR8<@<])B;3E^QLQ&(3R@N4,PIQYQ0P,0:9F03H);1IA0#GPT#?[9G"61
MQ8!+72;YEC+)LBZ3O 3W\A/+)-]9]GBF3+)BUB5E=<Z#X+DBH$Y>16*YMP[L
MI'Y@F>2ER=UZ?[E:OW&8?XY)QW-SN+:[><*ZL32)Q>[9\<Y7$)'-V#_9C?ZH
ML7,9 ![W,:HBRCGGIHQZ]WI?RQR&R[@Z!;>K0%9XH5?GG:P1NX< #J&(V1^V
M!^46WZM,"%N,;=Z]-AC T>SAEE'M[!^.M]96VY*J0$F9(#1N:9%M/+C!.3Y1
MW@Z<"W[+^7?S0RD6(DJ?J+':\,B5 ,(0J7.:2FJ]P:P(JA!1!56(O(4+UBD6
M3T8G=C8];9T=<$E4-%R@HNH 9WDSI@%B881703C+K,F]Y*5>%71.5.ZV+ EO
M*,$TYM "X]1FZ 4OP&$<D]84X\P7Q[-?9TD\JGF;/Z!"8B&21C+EIAC!$625
M$DB9Q*.C3*J85M8SD'7GYT:<7865KA(7'KBQC*;D?;04M!PD*5F/H]$$WL42
M8TXF)WR1ZSU;UA]-?_:Z@(#:7PK(R]7X7$,T)"#S-$DD:"[\Z, K=-I%D!05
M,5<2^QR)[W7C#3'X:R'X8CEUD2DL3RM'=1++C?)QF/?^2*,,CAPC;4-$ !Y@
M#+*02)B33%2]MMG!7)-S"CE,[#T;$PQ9$8P;Z,X/$8Q<&R!*$3Q6CH-=,E0)
M&7*/69%8L+$@&'),,'1-,'Z-.'W]#N)D4N"11HY,D+E<(]@D!\X.HC0F( 0D
M4$M7UA5=E6*.0-V:A4F$P50%P[#C.9\ 7+SH<;")249E"1.ZYA<+X!>'!YKG
ML?0)9E"#U; XYHT-\(H80J4$NFC\4_.+H** ^_?,.<6+GA[<6LESAQ40 ^XG
M)[SF%[]"X7. DLD8LSHBYJT$CX)P!(+#47(R",V4<%X_B%\LDEH\K0C5U.)F
MT1"MC8/D57(B4115\(A[K)$&'Q$I"YB=-.4ZK^N;-<%OI1;;W9O;\#S08TF*
M<489$]3R$+'%E(4$I@2(I[55]4,\3O^XK>U.322>3GAV-RY:AP?14Y^Y!$ *
M."]<&HELH!CAI"W'*OF8VSX2L:KH'/&YC4@X[T5T)*]7,NX< Y?92**M8URX
M$,N%<UP3B040B:T#*VFD@FLD@K*(BRB0D6 M8 :Q#)9I&>A3$XED12+@YI#D
M-<_U6A5(D$C):"L8)F)RPFLB\2L4GN;V6SYW>K4469; 6@3@G19L,\*2<ZRQ
M &^/_C(B\;0B5!.)&T5C*Q<.C(YJ!AB-',T5)R-SR($!1Y(G#>B-N<+Q3B*1
MUTYF5WKF)25G1MAP_78X+#:-Q*N%GK7&9';>["+-V>,2]6B0($V>2J,C%S;I
M8*7FX.LR!SR*TSK=XHDE;?L")(U&)ZV.$E$A&)@KA0&.2$0&!Z<<B\)3_M!$
MFJ2PE%1AI5T FLD-((@1%!N084E<G:CW4V8V&FZ,3 IQS6!F/5!)BX-!R=J@
M<_:Q+1H@X57,KK?3>HI$FM^E5$W[QE(UA9.#WA3563/*QNZ@3*28'HBY:18P
M*< ."1$XI;R9R#)'="*Y'11X\=3?F#:Q3+D%>8]DZG4ZO;.BF7&1=S*(8")
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MO?M =W:_7C2_@/M_L2UV-C]?P/MG.YO^>_/#0= L:FY%3FND",AF0 X\#J2
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M[<!%Y]<0_,$]&U7=/ :#$'JC7(6OV+=1[_%Z[-#\-EA/O4@X4:T44QG=+8V
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MTU;S[2:X?>>@\-@X'D8C"]:<KGH8:Q]'O6'M_CIH/$+!(?2 9/F :/+=C_%
M^.<S];S>L<V4V1_"7+Y,'7PSFNNA>SERV4]D6!(@2KPYUBX7@=^[U&/;]N2_
M[[7";Y2:N=[2;KJ:=;'^+!-<95EA,Z-X;%/!B\*(-"EY0:G(TEORO4BRZ  ]
M;DC+!2[\76?EV]KN(U6UZ?#%YPM4+V^][2YYFD[0D)CY@N.<#@]>L<,O/?P.
M)FE6AU_>7;[[\NX*WO_AJ/_BZOV'=W0I,?/DO/?NP\?+PP]OOQS_C8Y33-)\
M]>7HPV\?CCZ\@K4>QN]@SD<?YJK=T\,/?_%3D3.;4:$)XRHEG%M*"L%BDFC&
M!<6+%DV^\PSC+RS^=8N*7!Y(:^G ZKL$JRS),\[+A%'.N5+P_RS)BR*)XT)+
MEJFO %8=*&T"2E_F0(FEEAJ34I)9!*6262*++"$ 49I1B:70=.=96GR'';TZ
M0/HN 8EG<6%C9;A*)"^X%2*G9:X*@]<%&;WZ9N@.D+X=(+$Y0*()2S*F*$EE
MB<6_*B.2RH18( 2FA$T+:;<-D'X@?XK/D5CPD3CCU.7>]"JIJE[G+WEZ_A*V
M[?Z2XP7_2(O4=M&#][VTM'EP@2AID5HP,4N:@CCD4N:IMCK+$BZIM8*MKAF_
M30[^$;;_JG,6/(08O%IP%F2)I24K-"GB@A'.RI04>9F0-->TD'$F8R.^8V?!
M]\V\/VW O5;$HN2%3GBJ.*BO"GXV@N:BC$ULL_AZ[JUAF?#3VFS<L>LF[#IO
M1@NM=,P*13+!-+!K3(D2,B9%R:U)I,YE#EIK$B]?SO%SQZ7? 9<625(F1ELI
MF>*V3)4VI>1<9#1%Z^6:OBP=ESXVE\[;EI(R0S.M".6&$VZQ9)3GC##&$@G_
MT*106\2E#]I=:OOU^_&Y';6U^OOT!_W._'6K5KC5V/DMS!.DGS]FY--!Y090
M>?Q\P?XH<TM9;@O"<IT0 $E#9*HYD9G$VC'00:G<>1:G][X<<?MZ<W<X\W1P
MYMM:4AWBW MQYDVH(BL4YX4A5AE&N# Q$51I8I01A6$J36R^&G'65\XZL.G
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MG7_BD?C+E^'T;L]9O*/R%K("$S@",YQ@CJ%3X+H ]'VW9KMA>UOTJJ/A0'?
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M:<./4X-@6?,NJU$]#D8'_ D1 \[P J\IL=&YE08](W#&M6^HUQZY?1&#C%R
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M>5':O !]JKR]J=O=R+*L/EM#OMC1\(>--Q\=O&6'?YU2&9>**DX,$!WA"6>
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ML-]2*$NM$IRGAHFXE+:(8P1?2T5YBCD!-S-3NHK.YI-7OPKE+5T:Y2@OW?,
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MEAE.I592"&Y5:C*PP930P0L6QQEI?NCH>/OH^*]+@'P =0,*3$G2A'+,"59
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M)\Q1;/"FMGRU<#C#@2\_\!:2[$ULD_BU:FCXSKF5/0! ]-,'K[WCRXL)6*.
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M6B5C$R@HNR4<%1UV(3<X7@KAZ%;U=#HAE;QQE^-A?WNQH9\N+P_>D-9QSF<
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M%:7(9H-5C#Q CQHN77R_7'Z]TO)C(&OB!)MYA$JLK$=*9A!4* W3(H &6K5
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M HSZ&C/L3T"_OS @^?HB>%E0"Y!BJ)Z5HD@LOT:>]!<!/(??9*J9*U^M2:+
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M'TTF<1YE$$V_2\D]?2QW:\*V@]5AV\-Q/%W*_\RR>?C3_P-02P,$%     @
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MK@2XRCTZAM[A\\>'N\V>C"&9-(XQQCB3SGRN@R<*_Y%:XEG7B($D"/KSZ2K
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M1B56O<?U$O/K@ U$3_(GL+W]7N<J>J^^"OU7YKF7\Z[D8PB#O+^:]':F'A^
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M6YPGZTI3210+(/JIPLS;1K<S.\[>&?%K>^K&0BW.X*C."\\,/3<VW8\GYW)
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MN325_<D5N=L2_7;8JC*>GOO1$3X(L LY*D505-5N1*41 TE=UI^(YZU+>#9
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MLX%HMDK=++,KL=>>@.8C,@KT8$H___3_4$L#!!0    ( *Z""%7F]H0(*!L
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M$7Y(T_KSYP^] ))6JW/1JK,1%O+D%+GX43<)AJP]2%4(2#96&71 [[CC@CO
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M&VK37OQKY\V>GO CML42>T/-$FA*BO=00J U7.B>SHL23"DZQY[+(KD;\[(
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M[ZO%_'VO;3GNH8"7CTO>P_#G![&O]3_PM#"Y .=O^;7QJJ.I#4T3;55J_:5
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M&%-Q.6HIF2N#;1Y415H)-9JD"\\=U>5U<LJ'48@XZKX[.)G!IQ"^#$X_E+2
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MP+,%:<D?43$8B(%92+P(RV@%E\GT$?#<<"V]<T(]9]$@O?_@=*T:]H)#5+I
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M%DG.6-M*8GY&\7_XA.].INESF.&[Z3"=KGAOQD>%%D;"/T *(57T%D36=4@
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M[9,6.FO8:K8#$KZ=!Q)"]I9WIS<9%(]U%IAC8%4]SLGDR-F-BN]O,][YASY
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M>M?B%.<\.3W8ZDE-<JTO-?I2DD5FA*#8C]5&7]* +UJ 9D5X;H25JG5_]+5
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M3W>?5D#0Q)R+CL!9+0F6.8*+B8/Q"36&9)GIU"%ZC^:^6W3D&,FQ8I^VD-D
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M]$0"XNJ/Z_]BF.-__L?_ U!+ P04    " "N@@A50--U9O3K  "%@PD %0
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M.-D'8"Q@..54 Y94"QQ!D 9A!)&>V6G$*0V2T"TRO3=DXX2F^P#-;L'J#<3
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MJH$2NOI"MSO?Z\6]C)@.UA<B^]EBO;7:S[[^)-L[\3?JC62K%VD_;K9G9K,
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MD)0FB/>*6C[L:VK$4,D&4,^XY"-8VMD-GA :F 2VL<=7H!94;XEJP :(&+#
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MPYAS$M& FE*XUI$S1[N8'+FU=UF>:BE-M@@MID,4R'$DNQG)#SX#<\X&FD9
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M4NF_Z-]6R]&#N?HZQ'!8FON^(1[:HJ_RXC1)6&J)&V_-59L;V-Q0K^7V64;
M 29O]01L^ARYL( ##(<5!EQ>[I.T2J]*<UF6;_^4!<]+>:-V\H"T7I=91H.
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MN&3X+$EEI$$9FH3VQZ-2!#2:G!H+\'NE#C#Z@$HAGX$X'G#UQ7:7B#(N.WH
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MN(XO*\4/7%MV;_6CE;</C_/ELY2?Y+Q*"WWH%I L8U$69I!@*2%.LU ;(DS
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M]?=\=?]ZK0WO!UF\7_#Y6IA*=F4I]?\37^B?LX!*F:1Q"@5BRERZDY"A1,)
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MBF'(6"STCP'- L'3-'1(.-[=V=06D:VXAI?6E<!@;B0V/[O47K&"VL)K[Q'
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M<)2A$"+&),1Z2P<95Q*J4/(TC27)I)-)]*+]J;%<E</M4<L&E)Y$>2,L6"Z
M:N)GZG"-Y;86I:M#:Q]?6T]5;]0&=T$U$!G1#"GQ^;H*^']=A[?D_Y0"M ]=
M@9V8)+[*G[R[H8["Y,V_M-_ZR(ZCHZH=>H2./]:/#-[2PMS%*6]ET?KP<S[#
M* XB1/3>2(6!-H]B 0G'#'+%4!1&(F6I4[*CH[U,C1@TF&"^U&OQQLHQ*RY?
M/CQH;F@*5V[S'ET!9I2XV#0Z/@!VG'$QK ,S1RN?"3NICSVOJILDW!\?=$+@
MB16.]S$J-W2J^9(ANA_NX1*N*\[?J)VZ0+?W>HTL9RE%-&81A3S56R@<" I)
M&$0P1DG$-6]P(4-KQ_#);B;'%)6@U27_K:C@L9+5P1EZ&E8+3[$7L :>_PU.
M-VJWM!>X]8>3@^O8"UXC.9![X>;F3#X+1Z=+^?3;XSF6SVJPYUX^_W0/7ORZ
MT ]^*W+#.;^:/=IM=>.VKL4\$UPR1K7IE%&]I<*)Q# +@@QB)*,HDC'5!&E7
MWNQ\9RX?\3@ESK8<*>AS">Z,Q'J?L%J"]8XB32EP\^M'W;,9$0=BZ,;?@D2]
M83HPD>[*"2I!02UI4XK>&V8.A.H-NY%(=0_#ZG,$]07YYAOT=?O""I=.=NUN
M83R&M=)DCV7MWNA;9K8LI=QX%RSN'R4R$HKQ!*91IB .40()X0@FFGY%$D1I
M2)WR;#I+,#6[U?[:77_0[7:N@T(Y,!G7LN\ZNBKQ=[(C7)GUC,G&869QXZY'
M-=N>^'DK<NO:_\BU;WO"<U@2MV]#/<S)SX_2Y$RZ71>/VCZ[YO]8YV5>)ULR
M.>9R6;9' 4V^;!PJ'E"L[<HTU'8ECC D 6,P"1'F+$,4A:GU[MNU]ZF1V^?;
MZ]>;\S$'@\@9=0N[<D@L!V:W1G30R YVA <;Z;?GD#V*F3D#[F"4#@G\2'9J
M.P"/S0#0G0'@FP%H3N:]E3?K"URG(>O<Z'BV;5]]]\S=WHWTOA]<KHHU-SV\
M7]P6RSO]W=4%VF><4Q3)&,,DD]S44H\AX9Q#*3E+8\4BSEVO!Y_J:VK$ORLJ
MS!?PL1'6^5[P27#M;%I/D W,[[M2FIL$K9Q7H)+4Z[7@<W#XNQ5\LJ>Q+P6?
M4_G(G>"SK_1CBX_RVTYNS6*YT/_D=2[.F^+UO;F[M;E,4#V1+WC^.)=?S*V"
MF2"1D)S$4*8TAIBE"C*" DA3@11C(4'(ZF#'BS138YR=O+R?S7$P+40)OCX*
MNJHOXM3Z[-S3J3+XMBJ!WRNE'--K73:<=@PVVB -S'$#CX\S%7K!U1-97B;+
MJ'3J!;:7A.NG44\)7K[H=IJ0>LP8IFD2P<@DG\4HDY#@D&I[+L0AYVD4)$X)
M"#OZFAJ='JEI8X2],*_+#K;6]IL/Q(:WWXZ!-<3MA?-X#)769:>G[YO5Y5#E
MLTE=CKSBQA9EL9I]DNUQZ+4V""MZ>FT821:/M%@]?]0?2/-MIZ$,,2-ZXX>(
MN<Z0(G/*'$&)"69)F'"46?D G7J='H-LI01&3#ON<$.ZFT4&PV]P/GD!G4<F
MZ85)%Z?H!G?X1/^TY1*WOD9AE5[JM_S2[^6>V:/D?%ZGNJO+JNI_FS0=BU+.
MDB -,"4AS%0@(,:A-DN0%# 1F"<LQBA@3KDQ3G<U-4[Y3.=-?HN'5E+'K$RG
M4;4S2/Q@-?1Y02UD!=1&3-#(Z3$MT5DL?*41.MW1N&E_SBI\D*;G_!L]#B5O
MUVR>\W?+^7SY[69QHY0TF=F;DQD54<(S(2&/S5U*E)E[ ED* RXRF8B(9<*J
M^N#9GJ9&#K6LH!86:D.\%=>E"'L7LA:'C+[P&I@@]J "-UNH^IP==F+F4JK>
M$W9C%:>O,50UAE4QL5IB7\=_-GAT5Y[O:F#$6O,6>NQ7E[=YH:=59:X,W2_G
M^HWR[3_6^>IYQA!.$JGW:8RJ$&*2Q9":2O(FEWRDTC#DYMJYR:-N:4T==.%$
ME)N.AOMRZZ3PY8Z<_^-?LQ"E_PO(2EY'D^H0TB#D+$0X@BA(*,0BPI"94&L9
MBH32B"&1$/=Z7)<!^]^FF-81/!,I210%>C5/I=1+>B3,)YI"F= DB/2"GR21
M:R4L'VA.NXS5$2 M;?R+H!G:MM\1[G^"6CQPO5H5.5NOJK1SJR6XI85> #U:
M^B<1\67A'W8PKF5_4L$#B_[TDST/(&AY;_Z_:>Q)[V\7IO92J<?39.0T?]";
MA_U?[#SY?M%<_'Z3EX_+DLY_+9;K1_V&*>VX-*<E:RF:4,GEHIQ%(6*2$PF#
M3#'-S)A"DE$.DY2&@J8I(S1U9^8Q59@FYQN=K@ W:0SD5K5J UYL%*_^?@78
M9GU8JN:Z@^.QRIA?C R$H$H)B .50:R2#-* 22BQ))1EL8P3YRJ,T_Y>AE_5
M7+X6J7_YW^$[L3S/F^C(#^W0KX:RRG*RHX\IYK@9[?H1\PF\^.7^&QL,0 L"
MJ%"HWMS% 6R!\'C\^!V&S]=YYIBBCWM ^AT&Y>#$]7O(T,_>JA(VW:BOI<F
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MVZ<Z->RYV?&06V5+A=L7VR/ \,H^Z^;!D7MB8%[<)Y/9T,_:E5I2>N<,V.U
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MLUA!3B*:844Q04YSGJLMF1I1^!T<I$/L39_JKY#'!E?VPK0.#8PSP'H#*G=
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M5M)*^KY3>K56C^ROF9 X%SA)8(*TC<F-$:0YCJ'2*<XPCW0483]]UR!V.7V
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M8$WU^[S/8NKVF8= :N#/_21( ZB;7((BT)=_MIE1&>"2LZ^9X.+UU^[+MT\
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MZLWVP,XYW;4)=O:>*Y4N'&75S 6?5\OU0=[TI_E2W9DQIIAEF2(19PBF:9I
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M?%/.6WBYS?;ZHC PJ^W,ZA;^Z9$F?NQNL'3PUJ-'3OL^=NHXO?O$-;VCF\O
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M2HJEHE"E-F4X9\*,ES*!E,DLP3JGB722>NW9_M3&Q<?ORG2;M="#*'O [C"
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M1"E5D/$HA2I-"&4QQCSU.H>\U.#4!JO:WE(_J[3X_^WN6WL<QY4LO\^O(+#
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MC>UJ,QBOV\W0>*7&85M3?9DCK<.E:; S4A[ '=@F-1*:KI9&QAFHI?1G?Z[
MX,G<7!IE5.MR1=5C8W+MZST9$Y0E>I#F7.:3FOL'V4K@K!K!SU-*>1;' F98
M9A#QF&@SDL,HQ%DL YXEJ5-ZY?4AIV91M,3:AAB9'1D*KN-K9Q_\HC:PJ3@
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M%>/O:!)/;278-[^=@9;.H%%:$_SLU 9&;\T'L]<<&-7!H>XST-(>_*'U!S4
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M'(884R[7?Y55QV#9B [(3O;_[4A1X#XO=J9F6+0'MD&:NM: W8BOJQI^TAJ
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M@.ZG9-@P4$_HJ2#T0;L[W1\4O1#615N2$4(].15+XQ&;B(P1O58E@5@?2ZZ
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MRZ,2+7UXA]\N1MQGYB&47H 2B(Q6$:^5+@UX(J,NZ/JUBW>I:"3HMKL!44G
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MD)?YLM)F<F?$4E(B1:LMT2F@5R"$):[(!_\?@!FF,^M_T'$CFTDEK.PGY+;
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M:5<"62W D:?4110BL;$T1A)H-]B<,V'<ET)+)1/=;,/;D8#FJKYV!MLA--"
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M!7+WVL@9I3A:_\0:B$0&R_ [20D$"Q),DL"KIWH]1$PC[M..6K[WFF)?D3>
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M9#7BEM>"PD-0JZ271J&VN%RQZ_V<1@[HXA4KMQB].29BF8@$<+4RI@*-L;?
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M=QMT/3QI>G<--6 =/-0VG$M%O566Q*RZ?L>9N "9Y&189@I_E:OGZ>\Q+>
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M9]P$9E-X"L-]$/8<[KFW >B-3+DAE3QTHN?]O'^"$I?#0VQC(7P]_3+C8BT
M\,XZ7JIV+93Z@H@.J96>""V2C18D\T_NU+U1]QR20BM#_8#J'AKOK_!YXV6Q
MUM%DHIDZ"EH2&DJ]H&29!,8UH=9FJZGGRO"-<'K]4Y]#=N;.^-I9O#]=JN6M
MI&J/XOWXIJ\4RT<?UF]JY>9\-F6M@M1.A:B)#XS^_^6]ZW);R8XF^G^>8EX
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M1!$=V@A*F4PN$4=RA$39""6T[DFZEZ"!<T"-?8/V.A@!H'9XV$XW+5;Y:(V
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M!GQ]-8 (3B3-F&%&7>(>.<3Q.G.1X\BWRC&X^"^R8VX/6H:D)RO!.ZR2*:1
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MJ.Q%1R/'W&T59&8I"RD@I/KD4L1"^ZD^>HNT<;W22L=.[\1.1-V0)<?]:/\
M:!VABI&#Z][YN#761;DD)2?_0GM0.C (D8Z#PK671@2=0SZ'<=NA:[R .P83
MAUBS4Q1T$>##_"I<URN@VQ=N"1G6VHU@2VUZI!C$$!,$+D(IEBFA.C4G;8+
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M23RT,U1MSYG)?:-SV0D7=1*9)&4;8VLO0=V0=6$)ZO:J&/KTNVT*^F9V:-#
M@U-TE&N(GB%%I(@0I31@+4LYL9)%[%8E<30)W2!V8;GJ,VKE$K W49FBB61]
M;:,M0"7&(*)"$/0_%[@IQG>[@NVR6C=$75BFNA]9#PV>6^R3K/Y</M@$6 VP
MQ8"UN; +B<*/'"R%'[YVQ@LI*<3DV(O]=E]:I!M4+BP'W52RHW.9[GN9HUQ7
MN"9@'CTH5@N5>!1D-"ENI4!5)SFJ/O,7EL!N*?ZA[<QC'M9FM$HL7+^:+Q;S
MO^@''\(*KU:;46K3[_@K?3LA(YK)UT- 4=\UF7JIS.J@W:B<(O89\FZW'4<M
MWPU4EYC9[E\;([!:3S3J?V8CY>#H@";!N9)4?7*?P"LE2*Q:DI5F,AC5V(YU
M)JX;""\T'=Z/B@:=G?7(37R.KY]"W82IJ/KD-P3R!RQ2J"L4!TO?:A<M"^4P
M[[SCPMW =8E)]3XU, +;]E1.[FZSO \_-M7)-S@)VKH<A(=<R\B5H*]\)#:C
MY(SE(J2RK0M.NM+6#7P7EICO54$C -Y++^4F-J?LR1I#474FA)<)'-8*4V$=
MRXD)Q-8)U)=HZE:+>:'9^:8*&3I*>(F97:L^42Q+X8H#;5+M<J,E!&<M\(SH
MB@BRB&[7SH>NW U3%Y:7[U\'0P-L7]9.:RS%:N#.FYJ)T1"+JYLE&^*"W$_7
MS0<[,2\J+C'3WDBN(SC@GK[MK,^\;K];7WK:;*W@S$(=V4Y6E4GP+&;P3@CC
MK5%2MS[FNE'6#6,7EGOO43DCA5P=M%5[W]8\S$38P#-G"$D["2JF HZ.;^#&
M<2^R2W*WN*H7L#VDJ1O,+BQOWXM"+G+LXL?T!?/--<[+V_GL<]U4#^OIW\7K
MZ><U <L^1S$>3$3_XQE/D\L@(QME\$Z:@("*]H#*MH!/D1%J>332VEQ4ZX&M
M9QG9^-1#CR<C;)6,#W7KEU@;^CJ*L,GGD&!33CPA%R[U^>;F^-1':^/9/W[V
M/<(Y63?'&]+Y*EPW?]IUQ\^?L[P]&S#_]G>BL^/J:_UNPJ7W*B0!+)$OHH))
M$(VV(.K;V^0%E[;U]>A!! [<#G=8%#;1VN&0]!M(SI#.B>WO]@+*20K!&6XR
M",DT*$VQE_,J46B>8X@4E:?0^D7TDX0,\VAU)" [2 MCM6^_W"RJJ"<\QZRY
M">"2I4!>:@.^U"HGE+X4%S#(ULV\]]$SS./5D0#K&)V,UUC],9^E+4.).21_
M($/(A:POCQ:"CQZ2$+8HPUE@K?,J+Y TS-/8D>#L2,U<9,Q+/_HVG]6?4'17
M?WG[7+S/$/>E-?N/: _B>I  UGBN(B9=WRP54(BQMG\(4(()P@AI5/.6SV<)
M8)^HQ/IEOES=\1VCY-+4^M"$N68Q&<2D)?B8.2IMBA/=+B2>7^.2XM!#8+"G
MV.UH$8\@4?PS)Q-9#%'-R0Q'EXB#B."U$Y"*12RVN"1:OX7[F8H!FVBU4N[>
MDMN#)3T"K/Q[6$QKU?D#!IBSV20&+N9(0M$*G%(%T!B=)6J-JO60N)^(&+ M
M5D](.4W.0]^'_RR4Y41[[P./&G@0-69ED<)5U! E4UHG$7/IUKKUB0\?L(55
M8_TW$=^ (?^V_>R]S[^F_DXDO)@8E=(@:^=9)2T'+U6BTU8PG9F+%&9V L&S
M2UQ2]O%HWZ.-@$=PG#QD9*=V]E&O-A6]YKEDH%!4UAJS#*ZP L)8@XX9E9UK
M?,AT)&U )Z41"O8$[*U4,C*D[39N*ZJ^D$-/YKE.A"[,@0N"?#!%C'!OE&@^
M4>74]GG].#/](^H4T0_MU>Q*9Z*$Y#&G#!'K1(W"D)PS%\ H@PP-,P*[/;+?
M_>0!_9FV$#A=;D/[,K5,]7V8YM?SQ>8FKU:J7M]DS&]FOQ-'-YLW;N_*HPPG
MG?=W<M.!O,"('()1""JC!4<( )D*>?1!VQ2ZC54_F91+NC0[VC<ZK\)&<+(]
MCA9NRR FB$$XG3Q@JFT#8[W-J:7Z5BJ4TK%@>*>AIT>G<&XI&;(7^GFQL#?;
M<Y1B1@"O?:=W('M-D2="X$:!,I:"6W0%& J4%/T&[?MTR\?C. T+M%8J&O2%
MZU/,O%],Z7SX%J[O-T\L/'%4!(PJ)ETB.$P.4HHEJN1$:EZSO)>@(9NGCP9S
MIZEI!#9N)\Y]%U=A.JMR_.WO]*6.U249/_>$W)$Q]]Y)D-(F4$PP"(4"&B.L
M2@5%$;XU(D\@]Y+*6XYQ <^MT5&8S"[,/EU()A&3B=;3<>#(%]$\0K3$+^<^
M",5\,KEU\=71Q%Y2Q4S?T#U=FR.PNH_WWW]@Y1OS%>V,\/F)]U=\$DAZY,PD
M\F ,\5=4+5 S"5C($:.S0N_.?VL<TKQ,XS!=Z\\/TEYU-P)L/MQ@';BSOJ"K
MG1:8X_59&.?@@Q(@9"+VA"97JC4R#Z-PF.[WY\=ECWH; 2KW[KJ'3PFW8]HF
M/!=N8LA@]+H-B*Q#L[0#IYVAP- 5X?(Y+>83- [3@']D%O-4W8T FWMVWE/<
MZ:AM-*Z^VK=U&CF%B3'0'XYQES+7D>]V >W38AZ+R^9MA$9E,4_5VT76:[^^
M69%H?Z>3XNO-U[M'A3T6:^]=L/]*[>[\#E*F+:+61L8 GA<ZH7FH_190@@W6
MQNR8R+)U)>I9WQD_G82@I1Z\9[U/V&FCC/01LL<ZZ-<C"<-X*$D%8[7%O'N5
MV%-GW*?INZ2Z[T-PU:US;@.=C> 8[]1A;N-*YSH1YC6)-ES_;PR+B4%R2[*T
MP%@DAR76"E63))B WB7I15&M;QR/IW98K/:'H&,:!IZNSDL!+HGU#SK&/OV%
MU]_Q=S(17Y:3P$1 [15P'FK7%1<@"L_J]'3%8DE)\'.TP>E"Z[#%K>,"[:FJ
MO"#(UNWXZ:_YQ!84QA0ZI%SME.U<(M^;2P@6Z?SRC,?F/5<.)''8"J/1 ?08
MQ5T:+@EH.)&*=I>GB#,D3E&A]+7*H"BPPEFNE==&M,XS'4SDL%>?X\3FP<J[
M,'2^GM\L)IZVGXM%0)3UZ8P*"J)!5]^99RX,]]FTCIH.I7'8N\U18O-@U0U=
M'KZ7N4_S5UB+=:X*K7;'GA558(Q!<-& RK$V!5(14&$I(B5F4K<W<8>O/>Q%
M9>^(.X=&+L@63A*++!O'(-HZJU4P#S$F!EPF17N,27V6X:9'=ZWK[6IR=+;O
M(%6- ()/E:(\(S[.HK:U#)5XJBV]0X;(:@MYYIWT03H56\<OW:F[I(>CIR0O
M>]+72)'X0H[+!Y8=N;D02JK/SSR)M-;["8V6"QN4/4\OQ1&G*OO"RR$]/4]7
MWMCA^60V2Q95&P@ =[H.<:S[7=H"F0(RM%84.GO."<[1)23' ,U3%7<!P+S-
M8CE5M"DVUSEIA=@RDLX?J\$GU$X&X7(Y2Z?&L:4=1P+#8]1T*>A;YZF\CNC(
M*:XCAQAQ1Y8_&DT!FE<L:"TRN<=#X&_XY.*8$'BPJBX$@^OT@ Q6"^$Y8' 4
M &:'$#FQ&3+9?&.2S;T^>!QO"G%$"#Q844,G#E]BZG&&RO&LA0RA%M)KBOT<
MAZ!% <V3D)$Q7>*.%>S0=.+%98=-%_:,KIZU< $&;I)<*$Q$2SZJ4O7F/ +Y
M"@A"9F_)AM?7H&<V;,/F!4=BT Y2S-"&;"?%>37+3[)WEWF_%: U(EL9/;@4
M/"BM(_@Z]\BA88Z1'2]2=3)I1Q)P27U1CDG]G4TY0P/P1>[V)Y2<)&\!C:C3
MO (HRS,$DR6@U3JIDFA7=^M.>!H= S9,.0M(GFQUV;_&+@:<3Z64LN1"1\TI
MED($%7*JHJYSZT/Q66D?>3>O[Q0J!FRP,EY@GJJM2X+E78J)>-/*>!!1$I/)
M*XB%93"!12/I=)(N-4?CH+F^\8/P&-U<'/8V]6I1L5P*@\QC?;0;$D1G,B0>
MT'.3K=_MN-(*?<-E^BX$?P?KY](0N*E*"T&ALQFT\5A[&7!PIC;&5)AY*<E8
MT]A/'#S/=QGX.U@[EP2_3U]P@:%FH<B_T,QH6U^%>W)[9;(0.:M=#(1 S8(V
MMOWY>[_^,,G \4/P2 U=$@@GA9%_H:0 'TV=!8:9!*D1M+4A:%1![KZ6:@"]
M85*!XP?<0=H8XVO\#WA=9P"^#PL2X2+,EB2Z.N?Z,<W='MH_^UDGOZ'O1F6C
MY_'/+7:?;O8QF)#JA;Y@9%JD!Z_KT'A64&!)4?#6590OT71R [MG/O\^__F)
MI/N*_LD_)Q:S]SS6GGP45BMG**P6@6RL4=:98CC#UJV6#B!OV%J]IMCYJ2]=
M3TJZ)+MTE?.T?A&NW\S*?/%UO<@)S4&.6J<W>]:=NW/9NJQREBXYD"BK+Q\=
MQ&($Y)"=E03ER%K76_1MZSZF+YAOKO%=>6ZE5S\>_:2. 9O8XJ43FE$0+6M/
M4B[!.XJNA<.8,Q,E->\R>Q2A([=_A^!IU_[UK[@1% H\P]K5W]/EQ++$>2:1
M)2MK=6&,)#S)(3!?6"E1>]WZ#=$><H9%VAG T.WX/5@SXP79K_-ZQ3>A6-DE
M8T@JVD>*G!3Y*"(S*#+Y8"Q7VIS)YF\(&J5).USMW>!TA Z&3E_\]N^_??AX
M]<?5VVG!CVF*%#!_Q,7W:<+EV[>__(Y?(RXF(5>!Y C99DEN:*FM[KT!&7*,
M*9'=S]V&\'19;92(.4:S\S[%/#1N?B6_^!/YQ=N$"YGL-[.TY2-K@P%9!N%K
M^HYV&7BD<(8B)!MLBK&H;M?M>Q89]NU,3RAI)=3QGE([!_O:$"NG-8\1(:@Z
MTL>+1(%OJ?TWI0TA*H&^]3/"[M0-B[/1.$JGZFUDB-QN5)4]UY$1R5AG58B@
MZ?0/ 5B="2RT5GGW*K(I\D;L(9VL[SVP.D+X0Y]V'[_-;Y:T"W_Y,L522TYQ
MD:;A^ETI=((OMA::&2^4EQH,]\20(5_21X'UX:+WDGXF.AY[758;#VJ.4>>\
M3]D.#997B_GJ2RVU7'/TV]^8;E;3[[C#4&!2R82@T=7>/$5"5)9<OZ)I=WF=
M(X9.8.FRVGB<I5/!TERV X)EN5A-/M21-&OK:C@/T=,IK76]C$R,[&ST%)UJ
MQDR*9%]W8ZRGSR+ZU ?G$'UW?P8]6G#8LOWS.3;'2WD,T+AU_BDP=(*"">EC
MIJ,W"8A:>K#!)U:(=)="*W ,>;Z<H*Q==1\AN8$5_GOXNW:1WQ).SE9*.7HB
M-W&*]W*JR?8"2C(F+ '=RQ;VX-&B RO]&)7-6\AO9-') S/X=CK#-RO\NIP$
MI0N+=% :5ST@GH@S5A*0350Y"92H4A<\G!XEW]$T[+/]T<3&Q^EHO)C[B-?T
M+S[_ V>X"-=7LWR5OTYGTWH)6'VM[6S<Y6O2R$-I_\=T]>7A)TZ"50IMT< $
MJ^;;6O ^*F!&9^Y"E-Z=Z2JB$4?CB;E.1U\W: \!A1%LC!J%$O.K>?KGQR^D
MG.6;Y?(&\P0I9$FRCH,6PM?F@I*^RK[F0F)2DL(+W]H&/T/*>"*ZYE!L(?P1
M8.@9&77>,N2PD.=3H^.B(FV9I"%R:8"3[*)D&J4]4[U 4_/86T0YA'GL19EC
MK.C[>!.7^']OZ&-^^UZKIX^IUOOI,TZNQ-M/5:,JN]U%[JNABA4!'86C)5"
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MD:C"O9$(BF;/114SI)Q[3FZ?7I7]F*I$542#8*^Z4"N/AD%9Z!NHA929.Q[
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MIR.?\^>E2L<:8P,'"#<UIA#'A':."ZI,3, LF'&X<,;O!%%7 !R9S05W\3P
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MKG)CM_EMG]4ZO_[Z^>7I/V?G60+U6AIYW)_TH5EJ<DXJ-RW)"#WUJ*.HM&#
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MW5DA''5P/6;/VMUDZD'Z=>98>@NE-P#%+(I./CDTD+MO9F+AN5Z.Q5'!<I#
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M,C$N:'1M4$L! A0#%     @ KH((52I5L[.X 0( ?E06 !$
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M;G0M:VEL<F\N:'1M4$L! A0#%     @ KH((5<;&'FAY#0  C6$  !X
M         ( !0&L$ &5X,3 S9&5R;71E8V@M<V5C;VYD86UE;F1E+FAT;5!+
4!08     #  , #T#  #U> 0    !

end
</TEXT>
</DOCUMENT>
</SEC-DOCUMENT>
